Citrus Sinensis ID: 010519
Local Sequence Feature Prediction
| Prediction and (Method) | Result |
|---|
|
|
Close Homologs for Annotation Transfer
Close Homologs in SWISS-PROT Database Detected by BLAST 
Original result of BLAST against SWISS-PROT Database
| ID | Alignment graph | Length |
Definition |
RBH(Q2H) |
RBH(H2Q) |
Q cover |
H cover |
Identity |
E-value |
| Query | 508 | 2.2.26 [Sep-21-2011] | |||||||
| Q9SJG2 | 494 | Probable receptor-like pr | no | no | 0.944 | 0.971 | 0.766 | 0.0 | |
| Q8LEB6 | 484 | Probable receptor-like pr | no | no | 0.903 | 0.948 | 0.612 | 1e-163 | |
| Q9LRP3 | 467 | Probable receptor-like pr | no | no | 0.816 | 0.888 | 0.599 | 1e-152 | |
| Q3EDL4 | 472 | Probable serine/threonine | no | no | 0.846 | 0.911 | 0.559 | 1e-146 | |
| Q6NKZ9 | 437 | Probable receptor-like se | no | no | 0.842 | 0.979 | 0.514 | 1e-127 | |
| Q9ZUE0 | 720 | Proline-rich receptor-lik | no | no | 0.779 | 0.55 | 0.393 | 6e-86 | |
| Q9CAL8 | 710 | Proline-rich receptor-lik | no | no | 0.773 | 0.553 | 0.401 | 2e-81 | |
| Q9SGY7 | 718 | Putative proline-rich rec | no | no | 0.669 | 0.473 | 0.445 | 8e-79 | |
| Q9FFW5 | 681 | Proline-rich receptor-lik | no | no | 0.559 | 0.417 | 0.5 | 6e-78 | |
| Q9LV48 | 652 | Proline-rich receptor-lik | no | no | 0.559 | 0.435 | 0.496 | 1e-77 |
| >sp|Q9SJG2|Y2296_ARATH Probable receptor-like protein kinase At2g42960 OS=Arabidopsis thaliana GN=At2g42960 PE=3 SV=1 | Back alignment and function desciption |
|---|
Score = 763 bits (1971), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 378/493 (76%), Positives = 430/493 (87%), Gaps = 13/493 (2%)
Query: 1 MSSEGSLNTELSKKTSFLGLK---LWVLIGISVGAFIVLILCILSVWVSFRRKSRKSLDK 57
M E SLN E+SKK SF GLK LWV + + VG FIV+ILCILS+W++FRRKSR+S K
Sbjct: 1 MPPESSLNAEMSKKISFFGLKGLKLWVWVCLVVGVFIVMILCILSLWITFRRKSRRSSSK 60
Query: 58 FSLTQIPNVSKDIKVDRIVGQNFNDHPESVFLSVHDKSSDKNSEKMHVHLGMSKSSDPDN 117
F QIP+VSKDI+VDR QN HPES+++ ++DKS+ K M HLG +KSSD D
Sbjct: 61 FPFNQIPHVSKDIRVDRAGFQN--PHPESLYIEMNDKSTGKT---MMSHLGRTKSSDNDT 115
Query: 118 ISQCSSVHHHERACSSQSGEEGSSG-AGHKHSSLSYGGLVTASPLIGLPEISHLGWGHWF 176
+SQCSSV+HHERACSS SGEEG G AG ++ GG VTASPL+GLPEISHLGWGHWF
Sbjct: 116 LSQCSSVNHHERACSSHSGEEGGFGSAGRQYG----GGPVTASPLVGLPEISHLGWGHWF 171
Query: 177 TLRDLEIATNRFSAENVLGEGGYGVVYKGRLINGSEVAVKKLLNNLGQAEKEFRVEVEAI 236
TLRDLE+ATNRF+ NVLGEGGYGVVY+G+L+NG+EVAVKKLLNNLGQAEKEFRVEVEAI
Sbjct: 172 TLRDLELATNRFAPVNVLGEGGYGVVYRGKLVNGTEVAVKKLLNNLGQAEKEFRVEVEAI 231
Query: 237 GHVRHKNLVRLLGYCIEGVHRMLVYEYVNNGNLEQWLHGAMRNQGNLTWEARMKVIIGTA 296
GHVRHKNLVRLLGYCIEGVHRMLVYEYVN+GNLEQWLHGAMR GNLTWEARMK+I GTA
Sbjct: 232 GHVRHKNLVRLLGYCIEGVHRMLVYEYVNSGNLEQWLHGAMRQHGNLTWEARMKIITGTA 291
Query: 297 KALAYLHEAIEPKVVHRDIKSSNILIDDEFNAKVSDFGLAKLLDSGESHITTRVMGTFGY 356
+ALAYLHEAIEPKVVHRDIK+SNILIDDEFNAK+SDFGLAKLLDSGESHITTRVMGTFGY
Sbjct: 292 QALAYLHEAIEPKVVHRDIKASNILIDDEFNAKLSDFGLAKLLDSGESHITTRVMGTFGY 351
Query: 357 VAPEYANTGMLNEKSDIYSFGVLLLEAVTGRDPVDYGRPANEVNLVEWLKMMVGTRRAEE 416
VAPEYANTG+LNEKSDIYSFGVLLLEA+TGRDPVDYGRPANEVNLVEWLKMMVGTRRAEE
Sbjct: 352 VAPEYANTGLLNEKSDIYSFGVLLLEAITGRDPVDYGRPANEVNLVEWLKMMVGTRRAEE 411
Query: 417 VVDPNLEVKPATRALKRSLLVALRCVDPDSEKRPKMSQVVRMLEADDYPFREDRRNRKSR 476
VVDP LE +P+ ALKR+LLV+LRCVDP++EKRP+MSQV RMLE+D++PF ++RRN++S+
Sbjct: 412 VVDPRLEPRPSKSALKRALLVSLRCVDPEAEKRPRMSQVARMLESDEHPFHKERRNKRSK 471
Query: 477 TTSMEIESLKEST 489
T MEI K+ +
Sbjct: 472 TAGMEIVETKDES 484
|
Arabidopsis thaliana (taxid: 3702) EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1 |
| >sp|Q8LEB6|Y5185_ARATH Probable receptor-like protein kinase At5g18500 OS=Arabidopsis thaliana GN=At5g18500 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 574 bits (1480), Expect = e-163, Method: Compositional matrix adjust.
Identities = 303/495 (61%), Positives = 377/495 (76%), Gaps = 36/495 (7%)
Query: 7 LNTELSKKTSFLGLKLWVLIGISVGAFIVLILCILSVWVSFRRK-SRKSLDKFSLTQ--- 62
LN LS+ ++ GL+LW +I I + A V++L I S+W++FRRK SR S + +++
Sbjct: 5 LNDTLSR--NYNGLELWEIIVIVLSAIFVVVLAI-SLWLTFRRKTSRSSSNLIPVSRQIP 61
Query: 63 --IPNVSKDIKVDRIVGQNF-NDHPESVFLSVHDKSSDKNSEKMHVHLGMSKSSDPDNIS 119
+P K+I+VD + N N +P S+ +K DK EK G+ S+ + S
Sbjct: 62 PSVPEEIKEIRVDEVSSSNGGNGYP-----SISEKFGDKEPEK-----GIKAESENGDSS 111
Query: 120 QCSSVHHHERACSSQSGEEGSSGAGHKHSSLSYGGLVTASPLIGLPEISHLGWGHWFTLR 179
+ S +H E+ ++GSS + S L SPL GLPE SHLGWGHWFTLR
Sbjct: 112 RSGSFNHLEK-------KDGSSVS-------SANPLTAPSPLSGLPEFSHLGWGHWFTLR 157
Query: 180 DLEIATNRFSAENVLGEGGYGVVYKGRLINGSEVAVKKLLNNLGQAEKEFRVEVEAIGHV 239
DL++ATN+FS +N++G+GGYGVVY+G L+NG+ VAVKKLLNNLGQA+K+FRVEVEAIGHV
Sbjct: 158 DLQMATNQFSRDNIIGDGGYGVVYRGNLVNGTPVAVKKLLNNLGQADKDFRVEVEAIGHV 217
Query: 240 RHKNLVRLLGYCIEGVHRMLVYEYVNNGNLEQWLHGAMRNQGNLTWEARMKVIIGTAKAL 299
RHKNLVRLLGYC+EG RMLVYEYVNNGNLEQWL G +N LTWEAR+K++IGTAKAL
Sbjct: 218 RHKNLVRLLGYCMEGTQRMLVYEYVNNGNLEQWLRGDNQNHEYLTWEARVKILIGTAKAL 277
Query: 300 AYLHEAIEPKVVHRDIKSSNILIDDEFNAKVSDFGLAKLLDSGESHITTRVMGTFGYVAP 359
AYLHEAIEPKVVHRDIKSSNILIDD+FN+K+SDFGLAKLL + +S ITTRVMGTFGYVAP
Sbjct: 278 AYLHEAIEPKVVHRDIKSSNILIDDKFNSKISDFGLAKLLGADKSFITTRVMGTFGYVAP 337
Query: 360 EYANTGMLNEKSDIYSFGVLLLEAVTGRDPVDYGRPANEVNLVEWLKMMVGTRRAEEVVD 419
EYAN+G+LNEKSD+YSFGV+LLEA+TGR PVDY RP EV+LVEWLKMMV RR+EEVVD
Sbjct: 338 EYANSGLLNEKSDVYSFGVVLLEAITGRYPVDYARPPPEVHLVEWLKMMVQQRRSEEVVD 397
Query: 420 PNLEVKPATRALKRSLLVALRCVDPDSEKRPKMSQVVRMLEADDYPF-REDRRNRKSRT- 477
PNLE KP+T ALKR+LL ALRCVDP SEKRP+MSQV RMLE+++YP REDRR R+S+
Sbjct: 398 PNLETKPSTSALKRTLLTALRCVDPMSEKRPRMSQVARMLESEEYPIAREDRRRRRSQNG 457
Query: 478 TSMEIESLKESTEIE 492
T+ + + + ST+ +
Sbjct: 458 TTRDSDPPRNSTDTD 472
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9LRP3|Y3174_ARATH Probable receptor-like protein kinase At3g17420 OS=Arabidopsis thaliana GN=At3g17420 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 538 bits (1385), Expect = e-152, Method: Compositional matrix adjust.
Identities = 268/447 (59%), Positives = 333/447 (74%), Gaps = 32/447 (7%)
Query: 20 LKLWVLIGISVGAFIVLILCILSVWVSFRRKSRKS-LDKFSLTQIPNVSKDIKVDRIVGQ 78
L+LW +I I++ A ++IL +LSVW+SFR+KS++S +TQ P +++IK
Sbjct: 16 LELWEIIVIALFAAFIVIL-VLSVWLSFRKKSKRSNATTLPVTQSPRFTEEIKE------ 68
Query: 79 NFNDHPESVFLSVHDKSSDKNSEKMHVHLGMSKSSDPDNISQCSSVHHHERACSSQSGEE 138
+SV SS+ N L D +N + S + S
Sbjct: 69 ----------ISVDHGSSNNNGTSYQT-LDEKFVEDIENGDKFSGSLEKKPLVGS----- 112
Query: 139 GSSGAGHKHSSLSYGGLVTASPLIGLPEISHLGWGHWFTLRDLEIATNRFSAENVLGEGG 198
H S SPL+GLPE+SH+GWGHWFTLRDL++ATN FS E+++G+GG
Sbjct: 113 --------HLPPSTPSTTAPSPLLGLPEVSHIGWGHWFTLRDLQLATNHFSKESIIGDGG 164
Query: 199 YGVVYKGRLINGSEVAVKKLLNNLGQAEKEFRVEVEAIGHVRHKNLVRLLGYCIEGVHRM 258
YGVVY G L N + VAVKKLLNN GQA+K+FRVEVEAIGHVRHKNLVRLLGYC+EG HRM
Sbjct: 165 YGVVYHGTLTNKTPVAVKKLLNNPGQADKDFRVEVEAIGHVRHKNLVRLLGYCVEGTHRM 224
Query: 259 LVYEYVNNGNLEQWLHGAMRNQGNLTWEARMKVIIGTAKALAYLHEAIEPKVVHRDIKSS 318
LVYEY+NNGNLEQWLHG M ++G+LTWEAR+KV++GTAKALAYLHEAIEPKVVHRDIKSS
Sbjct: 225 LVYEYMNNGNLEQWLHGDMIHKGHLTWEARIKVLVGTAKALAYLHEAIEPKVVHRDIKSS 284
Query: 319 NILIDDEFNAKVSDFGLAKLLDSGESHITTRVMGTFGYVAPEYANTGMLNEKSDIYSFGV 378
NIL+DD F+AK+SDFGLAKLL + ++++TRVMGTFGYVAPEYAN+G+LNEKSD+YS+GV
Sbjct: 285 NILMDDNFDAKLSDFGLAKLLGADSNYVSTRVMGTFGYVAPEYANSGLLNEKSDVYSYGV 344
Query: 379 LLLEAVTGRDPVDYGRPANEVNLVEWLKMMVGTRRAEEVVDPNLEVKPATRALKRSLLVA 438
+LLEA+TGR PVDY RP EV++VEWLK+MV ++ EEVVD LE+KP T LKR+LL A
Sbjct: 345 VLLEAITGRYPVDYARPKEEVHMVEWLKLMVQQKQFEEVVDKELEIKPTTSELKRALLTA 404
Query: 439 LRCVDPDSEKRPKMSQVVRMLEADDYP 465
LRCVDPD++KRPKMSQV RMLE+D+YP
Sbjct: 405 LRCVDPDADKRPKMSQVARMLESDEYP 431
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q3EDL4|Y1154_ARATH Probable serine/threonine-protein kinase At1g01540 OS=Arabidopsis thaliana GN=At1g01540 PE=1 SV=2 | Back alignment and function description |
|---|
Score = 519 bits (1336), Expect = e-146, Method: Compositional matrix adjust.
Identities = 263/470 (55%), Positives = 326/470 (69%), Gaps = 40/470 (8%)
Query: 7 LNTELSKKTSFLGLKLWVLIGISVGAFIVLILCILSVWVSFRRKSRKSLDKFSLTQI--P 64
LNTELSK TS GL+LWV+IGI +G+ IV+ L +LS+ ++ RRK+RK F+ I P
Sbjct: 9 LNTELSKPTSIFGLRLWVVIGILLGSLIVIALFLLSLCLTSRRKNRKPRADFASAAIATP 68
Query: 65 NVSKDIKVDRIVGQNFNDHPESVFLSVHDKSSDKNSEKMHVHLGMSKSSDPDNISQCSSV 124
+SK+IK + + QN S P I
Sbjct: 69 PISKEIK-EIVPAQN--------------------------------QSVPAEIQVDIGK 95
Query: 125 HHHERACSSQSGEEGSSGAGHKHSSLSYGGLVTASPLIGLPEISHLGWGHWFTLRDLEIA 184
H S + S G + SY G P E+SHLGWG W+TLR+LE A
Sbjct: 96 IEHRVVFSDRVSSGESRGTASASETASYSGSGNCGP-----EVSHLGWGRWYTLRELEAA 150
Query: 185 TNRFSAENVLGEGGYGVVYKGRLINGSEVAVKKLLNNLGQAEKEFRVEVEAIGHVRHKNL 244
TN ENV+GEGGYG+VY+G L +G++VAVK LLNN GQAEKEF+VEVE IG VRHKNL
Sbjct: 151 TNGLCEENVIGEGGYGIVYRGILTDGTKVAVKNLLNNRGQAEKEFKVEVEVIGRVRHKNL 210
Query: 245 VRLLGYCIEGVHRMLVYEYVNNGNLEQWLHGAMRNQGNLTWEARMKVIIGTAKALAYLHE 304
VRLLGYC+EG +RMLVY++V+NGNLEQW+HG + + LTW+ RM +I+G AK LAYLHE
Sbjct: 211 VRLLGYCVEGAYRMLVYDFVDNGNLEQWIHGDVGDVSPLTWDIRMNIILGMAKGLAYLHE 270
Query: 305 AIEPKVVHRDIKSSNILIDDEFNAKVSDFGLAKLLDSGESHITTRVMGTFGYVAPEYANT 364
+EPKVVHRDIKSSNIL+D ++NAKVSDFGLAKLL S S++TTRVMGTFGYVAPEYA T
Sbjct: 271 GLEPKVVHRDIKSSNILLDRQWNAKVSDFGLAKLLGSESSYVTTRVMGTFGYVAPEYACT 330
Query: 365 GMLNEKSDIYSFGVLLLEAVTGRDPVDYGRPANEVNLVEWLKMMVGTRRAEEVVDPNLEV 424
GMLNEKSDIYSFG+L++E +TGR+PVDY RP E NLV+WLK MVG RR+EEVVDP +
Sbjct: 331 GMLNEKSDIYSFGILIMEIITGRNPVDYSRPQGETNLVDWLKSMVGNRRSEEVVDPKIPE 390
Query: 425 KPATRALKRSLLVALRCVDPDSEKRPKMSQVVRMLEADDYPFREDRRNRK 474
P+++ALKR LLVALRCVDPD+ KRPKM ++ MLEA+D +R++RR +
Sbjct: 391 PPSSKALKRVLLVALRCVDPDANKRPKMGHIIHMLEAEDLLYRDERRTTR 440
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q6NKZ9|Y4345_ARATH Probable receptor-like serine/threonine-protein kinase At4g34500 OS=Arabidopsis thaliana GN=At4g34500 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 455 bits (1170), Expect = e-127, Method: Compositional matrix adjust.
Identities = 247/480 (51%), Positives = 316/480 (65%), Gaps = 52/480 (10%)
Query: 3 SEGSLNTELSKKTSFLGLKLWVLIGI-SVGAFIVLILCILSVWVSFRRKSRKSLDKFSLT 61
S G + + K S GL L+++I I SV ++ +L L V ++ ++R+ K S
Sbjct: 4 SGGGSHKSSTTKPSVFGLNLYLVIAICSVFILLISLLIFLFVCLNRVSRARRMRVKHSSG 63
Query: 62 QIPNVSKDIKVDRIVGQNFNDHPESVFLSVHDKSSDKNSEKMHVHLGMSK--SSDPDNIS 119
IP VSK+I + VG+ F++ D +E + V SK +S D +S
Sbjct: 64 SIPLVSKEISEIKTVGK---------FINSDDSKGKIGNEVVVVVSATSKEATSGFDTLS 114
Query: 120 QCSSVHHHERACSSQSGEEGSSGAGHKHSSLSYGGLVTASPLIGLPEISHLGWGHWFTLR 179
SS G+ G+S A +GWG W++L+
Sbjct: 115 VASS------------GDVGTSEA--------------------------MGWGKWYSLK 136
Query: 180 DLEIATNRFSAENVLGEGGYGVVYKGRLINGSEVAVKKLLNNLGQAEKEFRVEVEAIGHV 239
DLEIAT FS +N++GEGGYGVVY+ +GS AVK LLNN GQAEKEF+VEVEAIG V
Sbjct: 137 DLEIATRGFSDDNMIGEGGYGVVYRADFSDGSVAAVKNLLNNKGQAEKEFKVEVEAIGKV 196
Query: 240 RHKNLVRLLGYCIEGVH--RMLVYEYVNNGNLEQWLHGAMRNQGNLTWEARMKVIIGTAK 297
RHKNLV L+GYC + RMLVYEY++NGNLEQWLHG + LTW+ RMK+ IGTAK
Sbjct: 197 RHKNLVGLMGYCADSAQSQRMLVYEYIDNGNLEQWLHGDVGPVSPLTWDIRMKIAIGTAK 256
Query: 298 ALAYLHEAIEPKVVHRDIKSSNILIDDEFNAKVSDFGLAKLLDSGESHITTRVMGTFGYV 357
LAYLHE +EPKVVHRD+KSSNIL+D ++NAKVSDFGLAKLL S S++TTRVMGTFGYV
Sbjct: 257 GLAYLHEGLEPKVVHRDVKSSNILLDKKWNAKVSDFGLAKLLGSETSYVTTRVMGTFGYV 316
Query: 358 APEYANTGMLNEKSDIYSFGVLLLEAVTGRDPVDYGRPANEVNLVEWLKMMVGTRRAEEV 417
+PEYA+TGMLNE SD+YSFGVLL+E +TGR PVDY RP E+NLV+W K MV +RR EEV
Sbjct: 317 SPEYASTGMLNECSDVYSFGVLLMEIITGRSPVDYSRPPGEMNLVDWFKGMVASRRGEEV 376
Query: 418 VDPNLEVKPATRALKRSLLVALRCVDPDSEKRPKMSQVVRMLEADDYPFREDRRNRKSRT 477
+DP ++ P RALKR+LLV LRC+D DS KRPKM Q++ MLEA+D+PFR + R+ + R+
Sbjct: 377 IDPKIKTSPPPRALKRALLVCLRCIDLDSSKRPKMGQIIHMLEAEDFPFRPEHRSNQERS 436
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9ZUE0|PEK12_ARATH Proline-rich receptor-like protein kinase PERK12 OS=Arabidopsis thaliana GN=PERK12 PE=2 SV=2 | Back alignment and function description |
|---|
Score = 318 bits (815), Expect = 6e-86, Method: Compositional matrix adjust.
Identities = 175/445 (39%), Positives = 261/445 (58%), Gaps = 49/445 (11%)
Query: 24 VLIGISVGAFIVLILCILSVWVSFRRKSRKSLDKFSLTQ-IPNVSKDIKVDRIVGQNFND 82
++G++V F I+ ++ V RRK ++++D ++ +Q +P+ + +K D + +
Sbjct: 246 TMVGMAVAGFA--IMALIGVVFLVRRKKKRNIDSYNHSQYLPHPNFSVKSDGFL---YGQ 300
Query: 83 HPESVFLSVHDKSSDKNSEKMHVHLGMSKSSDPDNISQCSSVHHHERACSSQSGEEGSSG 142
P + S + S NS++ +G S G++G
Sbjct: 301 DPGKGYSSGPNGSMYNNSQQQQSSMGNSY---------------------------GTAG 333
Query: 143 AGHKHSSLSYGGLVTASPLIGLPEISHLGWGHW-FTLRDLEIATNRFSAENVLGEGGYGV 201
G+ H + G P+ + LG G F+ +L T F+ +N+LGEGG+G
Sbjct: 334 GGYPHHQMQSSGT---------PDSAILGSGQTHFSYEELAEITQGFARKNILGEGGFGC 384
Query: 202 VYKGRLINGSEVAVKKLLNNLGQAEKEFRVEVEAIGHVRHKNLVRLLGYCIEGVHRMLVY 261
VYKG L +G VAVK+L GQ ++EF+ EVE I V H++LV L+GYCI HR+L+Y
Sbjct: 385 VYKGTLQDGKVVAVKQLKAGSGQGDREFKAEVEIISRVHHRHLVSLVGYCISDQHRLLIY 444
Query: 262 EYVNNGNLEQWLHGAMRNQGNLTWEARMKVIIGTAKALAYLHEAIEPKVVHRDIKSSNIL 321
EYV+N LE LHG + L W R+++ IG+AK LAYLHE PK++HRDIKS+NIL
Sbjct: 445 EYVSNQTLEHHLHG--KGLPVLEWSKRVRIAIGSAKGLAYLHEDCHPKIIHRDIKSANIL 502
Query: 322 IDDEFNAKVSDFGLAKLLDSGESHITTRVMGTFGYVAPEYANTGMLNEKSDIYSFGVLLL 381
+DDE+ A+V+DFGLA+L D+ ++H++TRVMGTFGY+APEYA++G L ++SD++SFGV+LL
Sbjct: 503 LDDEYEAQVADFGLARLNDTTQTHVSTRVMGTFGYLAPEYASSGKLTDRSDVFSFGVVLL 562
Query: 382 EAVTGRDPVDYGRPANEVNLVEWLKMM----VGTRRAEEVVDPNLEVKPATRALKRSLLV 437
E VTGR PVD +P E +LVEW + + + T E++D LE + + R +
Sbjct: 563 ELVTGRKPVDQTQPLGEESLVEWARPLLLKAIETGDLSELIDTRLEKRYVEHEVFRMIET 622
Query: 438 ALRCVDPDSEKRPKMSQVVRMLEAD 462
A CV KRP+M QVVR L+ D
Sbjct: 623 AAACVRHSGPKRPRMVQVVRALDCD 647
|
Regulates the auxin-related MAX (More Axillary Growth) pathway during the shoot branching. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9CAL8|PEK13_ARATH Proline-rich receptor-like protein kinase PERK13 OS=Arabidopsis thaliana GN=PERK13 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 303 bits (776), Expect = 2e-81, Method: Compositional matrix adjust.
Identities = 181/451 (40%), Positives = 255/451 (56%), Gaps = 58/451 (12%)
Query: 19 GLKLWVLIGISVGAFIVLILCILSVWVSFRRKSRKSLDKFSLTQ-IPNVSKDIKVDRIV- 76
G + + G ++ F V+ L ++V RRK ++++D +S +Q +P + IK D +
Sbjct: 230 GYQGKTMAGFAIAGFAVIAL--MAVVFLVRRKKKRNIDAYSDSQYLPPSNFSIKSDGFLY 287
Query: 77 GQNFNDHPESVFLSVHDKSSDKNSEKMHVHLGMSKSSDPDNISQCSSVHHHERACSSQSG 136
GQN P + +S + S + + SQ G
Sbjct: 288 GQN----PTKGYSGPGGYNSQQQSNSGN-------------------------SFGSQRG 318
Query: 137 EEGSSGAGHKHSSLSYGGLVTASPLIGLPEISHLGWGHW-FTLRDLEIATNRFSAENVLG 195
G G+ S + P+ + +G G FT +L T FS N+LG
Sbjct: 319 -----GGGYTRSGSA-------------PDSAVMGSGQTHFTYEELTDITEGFSKHNILG 360
Query: 196 EGGYGVVYKGRLINGSEVAVKKLLNNLGQAEKEFRVEVEAIGHVRHKNLVRLLGYCIEGV 255
EGG+G VYKG+L +G VAVK+L GQ ++EF+ EVE I V H++LV L+GYCI
Sbjct: 361 EGGFGCVYKGKLNDGKLVAVKQLKVGSGQGDREFKAEVEIISRVHHRHLVSLVGYCIADS 420
Query: 256 HRMLVYEYVNNGNLEQWLHGAMRNQGNLTWEARMKVIIGTAKALAYLHEAIEPKVVHRDI 315
R+L+YEYV N LE LHG R L W R+++ IG+AK LAYLHE PK++HRDI
Sbjct: 421 ERLLIYEYVPNQTLEHHLHGKGRPV--LEWARRVRIAIGSAKGLAYLHEDCHPKIIHRDI 478
Query: 316 KSSNILIDDEFNAKVSDFGLAKLLDSGESHITTRVMGTFGYVAPEYANTGMLNEKSDIYS 375
KS+NIL+DDEF A+V+DFGLAKL DS ++H++TRVMGTFGY+APEYA +G L ++SD++S
Sbjct: 479 KSANILLDDEFEAQVADFGLAKLNDSTQTHVSTRVMGTFGYLAPEYAQSGKLTDRSDVFS 538
Query: 376 FGVLLLEAVTGRDPVDYGRPANEVNLVEWLKMM----VGTRRAEEVVDPNLEVKPATRAL 431
FGV+LLE +TGR PVD +P E +LVEW + + + T E+VD LE +
Sbjct: 539 FGVVLLELITGRKPVDQYQPLGEESLVEWARPLLHKAIETGDFSELVDRRLEKHYVENEV 598
Query: 432 KRSLLVALRCVDPDSEKRPKMSQVVRMLEAD 462
R + A CV KRP+M QVVR L+++
Sbjct: 599 FRMIETAAACVRHSGPKRPRMVQVVRALDSE 629
|
Regulates negatively root hairs elongation. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9SGY7|PEK11_ARATH Putative proline-rich receptor-like protein kinase PERK11 OS=Arabidopsis thaliana GN=PERK11 PE=2 SV=2 | Back alignment and function description |
|---|
Score = 295 bits (754), Expect = 8e-79, Method: Compositional matrix adjust.
Identities = 158/355 (44%), Positives = 221/355 (62%), Gaps = 15/355 (4%)
Query: 115 PDNISQCSS--VHHHERACSSQSGEEGSSGAGHKHSSLSYGGLVTASPLIGLPEISHLGW 172
P N+S + +H+ ++ + S + SS + + +G S +IG +I
Sbjct: 302 PANVSVNTEGFIHYRQKPGNGNSSAQNSSPDTNSLGNPKHGRGTPDSAVIGTSKI----- 356
Query: 173 GHWFTLRDLEIATNRFSAENVLGEGGYGVVYKGRLINGSEVAVKKLLNNLGQAEKEFRVE 232
FT +L T F V+GEGG+G VYKG L G VA+K+L + + +EF+ E
Sbjct: 357 --HFTYEELSQITEGFCKSFVVGEGGFGCVYKGILFEGKPVAIKQLKSVSAEGYREFKAE 414
Query: 233 VEAIGHVRHKNLVRLLGYCIEGVHRMLVYEYVNNGNLEQWLHGAMRNQGNLTWEARMKVI 292
VE I V H++LV L+GYCI HR L+YE+V N L+ LHG +N L W R+++
Sbjct: 415 VEIISRVHHRHLVSLVGYCISEQHRFLIYEFVPNNTLDYHLHG--KNLPVLEWSRRVRIA 472
Query: 293 IGTAKALAYLHEAIEPKVVHRDIKSSNILIDDEFNAKVSDFGLAKLLDSGESHITTRVMG 352
IG AK LAYLHE PK++HRDIKSSNIL+DDEF A+V+DFGLA+L D+ +SHI+TRVMG
Sbjct: 473 IGAAKGLAYLHEDCHPKIIHRDIKSSNILLDDEFEAQVADFGLARLNDTAQSHISTRVMG 532
Query: 353 TFGYVAPEYANTGMLNEKSDIYSFGVLLLEAVTGRDPVDYGRPANEVNLVEWL--KMMVG 410
TFGY+APEYA++G L ++SD++SFGV+LLE +TGR PVD +P E +LVEW +++
Sbjct: 533 TFGYLAPEYASSGKLTDRSDVFSFGVVLLELITGRKPVDTSQPLGEESLVEWARPRLIEA 592
Query: 411 TRRAE--EVVDPNLEVKPATRALKRSLLVALRCVDPDSEKRPKMSQVVRMLEADD 463
+ + EVVDP LE + + + A CV + KRP+M QVVR L+ D
Sbjct: 593 IEKGDISEVVDPRLENDYVESEVYKMIETAASCVRHSALKRPRMVQVVRALDTRD 647
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9FFW5|PERK8_ARATH Proline-rich receptor-like protein kinase PERK8 OS=Arabidopsis thaliana GN=PERK8 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 291 bits (746), Expect = 6e-78, Method: Compositional matrix adjust.
Identities = 146/292 (50%), Positives = 197/292 (67%), Gaps = 8/292 (2%)
Query: 175 WFTLRDLEIATNRFSAENVLGEGGYGVVYKGRLINGSEVAVKKLLNNLGQAEKEFRVEVE 234
WF+ +L T+ FS +N+LGEGG+G VYKG L +G EVAVK+L Q E+EF+ EVE
Sbjct: 326 WFSYDELSQVTSGFSEKNLLGEGGFGCVYKGVLSDGREVAVKQLKIGGSQGEREFKAEVE 385
Query: 235 AIGHVRHKNLVRLLGYCIEGVHRMLVYEYVNNGNLEQWLHGAMRNQGNLTWEARMKVIIG 294
I V H++LV L+GYCI HR+LVY+YV N L LH R +TWE R++V G
Sbjct: 386 IISRVHHRHLVTLVGYCISEQHRLLVYDYVPNNTLHYHLHAPGRPV--MTWETRVRVAAG 443
Query: 295 TAKALAYLHEAIEPKVVHRDIKSSNILIDDEFNAKVSDFGLAKLLDSGE--SHITTRVMG 352
A+ +AYLHE P+++HRDIKSSNIL+D+ F A V+DFGLAK+ + +H++TRVMG
Sbjct: 444 AARGIAYLHEDCHPRIIHRDIKSSNILLDNSFEALVADFGLAKIAQELDLNTHVSTRVMG 503
Query: 353 TFGYVAPEYANTGMLNEKSDIYSFGVLLLEAVTGRDPVDYGRPANEVNLVEWLKMMVG-- 410
TFGY+APEYA +G L+EK+D+YS+GV+LLE +TGR PVD +P + +LVEW + ++G
Sbjct: 504 TFGYMAPEYATSGKLSEKADVYSYGVILLELITGRKPVDTSQPLGDESLVEWARPLLGQA 563
Query: 411 --TRRAEEVVDPNLEVKPATRALKRSLLVALRCVDPDSEKRPKMSQVVRMLE 460
+E+VDP L + R + A CV + KRPKMSQVVR L+
Sbjct: 564 IENEEFDELVDPRLGKNFIPGEMFRMVEAAAACVRHSAAKRPKMSQVVRALD 615
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9LV48|PERK1_ARATH Proline-rich receptor-like protein kinase PERK1 OS=Arabidopsis thaliana GN=PERK1 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 291 bits (744), Expect = 1e-77, Method: Compositional matrix adjust.
Identities = 145/292 (49%), Positives = 200/292 (68%), Gaps = 8/292 (2%)
Query: 176 FTLRDLEIATNRFSAENVLGEGGYGVVYKGRLINGSEVAVKKLLNNLGQAEKEFRVEVEA 235
FT +L ATN FS N+LG+GG+G V+KG L +G EVAVK+L GQ E+EF+ EVE
Sbjct: 268 FTYEELSRATNGFSEANLLGQGGFGYVHKGILPSGKEVAVKQLKAGSGQGEREFQAEVEI 327
Query: 236 IGHVRHKNLVRLLGYCIEGVHRMLVYEYVNNGNLEQWLHGAMRNQGNLTWEARMKVIIGT 295
I V H++LV L+GYC+ GV R+LVYE+V N NLE LHG + + + W R+K+ +G+
Sbjct: 328 ISRVHHRHLVSLIGYCMAGVQRLLVYEFVPNNNLEFHLHG--KGRPTMEWSTRLKIALGS 385
Query: 296 AKALAYLHEAIEPKVVHRDIKSSNILIDDEFNAKVSDFGLAKLLDSGESHITTRVMGTFG 355
AK L+YLHE PK++HRDIK+SNILID +F AKV+DFGLAK+ +H++TRVMGTFG
Sbjct: 386 AKGLSYLHEDCNPKIIHRDIKASNILIDFKFEAKVADFGLAKIASDTNTHVSTRVMGTFG 445
Query: 356 YVAPEYANTGMLNEKSDIYSFGVLLLEAVTGRDPVDYGRPANEVNLVEWLKMMVGTRRAE 415
Y+APEYA +G L EKSD++SFGV+LLE +TGR PVD + +LV+W + ++ R +E
Sbjct: 446 YLAPEYAASGKLTEKSDVFSFGVVLLELITGRRPVDANNVYVDDSLVDWARPLL-NRASE 504
Query: 416 E-----VVDPNLEVKPATRALKRSLLVALRCVDPDSEKRPKMSQVVRMLEAD 462
E + D + + + R + A CV + +RP+MSQ+VR LE +
Sbjct: 505 EGDFEGLADSKMGNEYDREEMARMVACAAACVRHSARRRPRMSQIVRALEGN 556
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
Close Homologs in the Non-Redundant Database Detected by BLAST
Original result of BLAST against Nonredundant Database
| GI | Alignment Graph | Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 508 | ||||||
| 255571408 | 509 | ATP binding protein, putative [Ricinus c | 0.998 | 0.996 | 0.870 | 0.0 | |
| 224062702 | 508 | predicted protein [Populus trichocarpa] | 0.998 | 0.998 | 0.860 | 0.0 | |
| 359485362 | 503 | PREDICTED: probable receptor-like protei | 0.984 | 0.994 | 0.864 | 0.0 | |
| 302143546 | 633 | unnamed protein product [Vitis vinifera] | 0.984 | 0.789 | 0.864 | 0.0 | |
| 224085356 | 490 | predicted protein [Populus trichocarpa] | 0.962 | 0.997 | 0.863 | 0.0 | |
| 356501467 | 507 | PREDICTED: probable receptor-like protei | 0.958 | 0.960 | 0.825 | 0.0 | |
| 356553717 | 506 | PREDICTED: probable receptor-like protei | 0.958 | 0.962 | 0.817 | 0.0 | |
| 356567426 | 510 | PREDICTED: probable receptor-like protei | 1.0 | 0.996 | 0.811 | 0.0 | |
| 449444122 | 509 | PREDICTED: probable receptor-like protei | 0.978 | 0.976 | 0.821 | 0.0 | |
| 356524227 | 508 | PREDICTED: probable receptor-like protei | 1.0 | 1.0 | 0.793 | 0.0 |
| >gi|255571408|ref|XP_002526652.1| ATP binding protein, putative [Ricinus communis] gi|223534019|gb|EEF35740.1| ATP binding protein, putative [Ricinus communis] | Back alignment and taxonomy information |
|---|
Score = 888 bits (2294), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 442/508 (87%), Positives = 472/508 (92%), Gaps = 1/508 (0%)
Query: 1 MSSEGSLNTELSKKTSFLGLKLWVLIGISVGAFIVLILCILSVWVSFRRKSRKSLDKFSL 60
MSSE +LN ELSKKTSFLGLKLWVLIGISVG FI LIL ILSVW++FRR++R+S+DKFSL
Sbjct: 1 MSSE-NLNAELSKKTSFLGLKLWVLIGISVGVFIFLILGILSVWLTFRRRTRRSMDKFSL 59
Query: 61 TQIPNVSKDIKVDRIVGQNFNDHPESVFLSVHDKSSDKNSEKMHVHLGMSKSSDPDNISQ 120
+QIPNVSKDIKVDR+ QNFN+HP+S+ L+VHDKSSDKNSEKM HLGMSKSSDPDNISQ
Sbjct: 60 SQIPNVSKDIKVDRVGAQNFNEHPKSLVLTVHDKSSDKNSEKMINHLGMSKSSDPDNISQ 119
Query: 121 CSSVHHHERACSSQSGEEGSSGAGHKHSSLSYGGLVTASPLIGLPEISHLGWGHWFTLRD 180
SSV+HHER SS SGEEGSSG K S LSY GLVTASPL+GLPE+SHLGWGHWFTLRD
Sbjct: 120 SSSVYHHERGFSSHSGEEGSSGTVRKQSLLSYAGLVTASPLVGLPEVSHLGWGHWFTLRD 179
Query: 181 LEIATNRFSAENVLGEGGYGVVYKGRLINGSEVAVKKLLNNLGQAEKEFRVEVEAIGHVR 240
LE AT+RF+AENVLGEGGYGVVYKGRLING+EVAVKKLLNNLGQAEKEFRVEVEAIGHVR
Sbjct: 180 LEFATDRFAAENVLGEGGYGVVYKGRLINGTEVAVKKLLNNLGQAEKEFRVEVEAIGHVR 239
Query: 241 HKNLVRLLGYCIEGVHRMLVYEYVNNGNLEQWLHGAMRNQGNLTWEARMKVIIGTAKALA 300
HKNLVRLLGYCIEGVHRMLVYEYVNNGNLEQWLHGAMR+ G LTWEARMKV++GTAKALA
Sbjct: 240 HKNLVRLLGYCIEGVHRMLVYEYVNNGNLEQWLHGAMRHHGTLTWEARMKVLLGTAKALA 299
Query: 301 YLHEAIEPKVVHRDIKSSNILIDDEFNAKVSDFGLAKLLDSGESHITTRVMGTFGYVAPE 360
YLHEAIEPKVVHRDIKSSNILIDDEFNAKVSDFGLAKLL SGESHITTRVMGTFGYVAPE
Sbjct: 300 YLHEAIEPKVVHRDIKSSNILIDDEFNAKVSDFGLAKLLGSGESHITTRVMGTFGYVAPE 359
Query: 361 YANTGMLNEKSDIYSFGVLLLEAVTGRDPVDYGRPANEVNLVEWLKMMVGTRRAEEVVDP 420
YANTG+LNEKSDIYSFGVLLLEAVTGRDPVDY RPANEVNLVEWLKMMVGTRRAEEVVDP
Sbjct: 360 YANTGLLNEKSDIYSFGVLLLEAVTGRDPVDYARPANEVNLVEWLKMMVGTRRAEEVVDP 419
Query: 421 NLEVKPATRALKRSLLVALRCVDPDSEKRPKMSQVVRMLEADDYPFREDRRNRKSRTTSM 480
NLEV P TRALKR+LLVALRCVDPD+EKRPKMSQVVRMLEAD+YPF EDRRNRKSRTTSM
Sbjct: 420 NLEVNPTTRALKRALLVALRCVDPDAEKRPKMSQVVRMLEADEYPFHEDRRNRKSRTTSM 479
Query: 481 EIESLKESTEIESKVEDSEGRISEKTHG 508
EIES+KES +IE+KV DSE +E G
Sbjct: 480 EIESMKESNDIENKVGDSESTANEINLG 507
|
Source: Ricinus communis Species: Ricinus communis Genus: Ricinus Family: Euphorbiaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224062702|ref|XP_002300876.1| predicted protein [Populus trichocarpa] gi|222842602|gb|EEE80149.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 884 bits (2285), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 438/509 (86%), Positives = 471/509 (92%), Gaps = 2/509 (0%)
Query: 1 MSSEGSLNTELSKKTSFLGLKLWVLIGISVGAFIVLILCILSVWVSFRRKSRKSLDKFSL 60
MSSE SLN ELSKKTS GLKLWVLIG+SVG FI+ ILC LS WV+FRRKSR+S+DK+S
Sbjct: 1 MSSE-SLNAELSKKTSVFGLKLWVLIGVSVGVFIISILCALSAWVTFRRKSRRSVDKYSH 59
Query: 61 TQIPNVSKDIKVDRIVGQNFNDHPESVFLSVHDKSSDKNSEKMHVHLGMSKSSDPDNISQ 120
++IPN SKDIKVDR+ QNFNDHPES+FL+V+DK SDKNSEKM VHLGMSKSSDPDN SQ
Sbjct: 60 SKIPNTSKDIKVDRVGVQNFNDHPESLFLTVNDKLSDKNSEKMQVHLGMSKSSDPDNASQ 119
Query: 121 CSSVHHHERACSSQSGEEGSSGAGHKHSSLSYGGLVTASPLIGLPEISHLGWGHWFTLRD 180
CSS++HHERACSS SGEEGSSG K SSLS+ GLVTASPLIGLPE SHLGWGHWFTLRD
Sbjct: 120 CSSIYHHERACSSHSGEEGSSGTFRKQSSLSHAGLVTASPLIGLPEFSHLGWGHWFTLRD 179
Query: 181 LEIATNRFSAENVLGEGGYGVVYKGRLINGSEVAVKKLLNNLGQAEKEFRVEVEAIGHVR 240
LE ATN F+ ENVLGEGGYGVVYKG LING+EVAVKKLLNNLGQAEKEFRVEVEAIGHVR
Sbjct: 180 LEFATNSFAVENVLGEGGYGVVYKGTLINGTEVAVKKLLNNLGQAEKEFRVEVEAIGHVR 239
Query: 241 HKNLVRLLGYCIEGVHRMLVYEYVNNGNLEQWLHGAMRNQGNLTWEARMKVIIGTAKALA 300
HKNLVRLLGYCIEGVHRMLVYEYVNNGNLEQWLHGAM + G LTWEARMKV++GTAKALA
Sbjct: 240 HKNLVRLLGYCIEGVHRMLVYEYVNNGNLEQWLHGAMHHHGILTWEARMKVLLGTAKALA 299
Query: 301 YLHEAIEPKVVHRDIKSSNILIDDEFNAKVSDFGLAKLLDSGESHITTRVMGTFGYVAPE 360
YLHEAIEPKVVHRDIKSSNILIDDEFNAKVSDFGLAKLL SGESHITTRVMGTFGYVAPE
Sbjct: 300 YLHEAIEPKVVHRDIKSSNILIDDEFNAKVSDFGLAKLLGSGESHITTRVMGTFGYVAPE 359
Query: 361 YANTGMLNEKSDIYSFGVLLLEAVTGRDPVDYGRPANEVNLVEWLKMMVGTRRAEEVVDP 420
YANTG+LNEKSDIYSFGVLLLEAVTGRDPVDYGRPANEVNL+EWLKMMVGTRRAEEVVDP
Sbjct: 360 YANTGLLNEKSDIYSFGVLLLEAVTGRDPVDYGRPANEVNLLEWLKMMVGTRRAEEVVDP 419
Query: 421 NLEVKPATRALKRSLLVALRCVDPDSEKRPKMSQVVRMLEADDYPFREDRRNRKSRTTSM 480
NLEVKP TRALKR+LLVALRCVDPD+E+RPKM+QVVRMLEAD+YP REDRRNRK+RTTSM
Sbjct: 420 NLEVKPTTRALKRALLVALRCVDPDAERRPKMTQVVRMLEADEYPLREDRRNRKTRTTSM 479
Query: 481 EIESLK-ESTEIESKVEDSEGRISEKTHG 508
EIES++ ESTE E+K DSE R++E THG
Sbjct: 480 EIESMREESTESENKGVDSESRLAETTHG 508
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|359485362|ref|XP_002283589.2| PREDICTED: probable receptor-like protein kinase At2g42960-like [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 871 bits (2251), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 442/511 (86%), Positives = 477/511 (93%), Gaps = 11/511 (2%)
Query: 1 MSSEGSLNTELSKKTSFLGLKLWVLIGISVGAFIVLILCILSVWVSFRRKSRKSLDKFSL 60
MSS+ SL+TELSKK FLGLKLWVLIG+ VGAFIVLILCILS+WV FRRKSR++LDKF+L
Sbjct: 1 MSSQKSLDTELSKK--FLGLKLWVLIGVCVGAFIVLILCILSIWVMFRRKSRRTLDKFTL 58
Query: 61 TQIPNVSKDIKVDRIVGQNFNDHPESVFLSVHDKSSDKNSEKMHVHLGMSKSSDPDNISQ 120
+QIPNVSKDIKVDRI QNF+D ES+FL+V+DKS+D+NSEKM+ HLG+SKSSDPDN+SQ
Sbjct: 59 SQIPNVSKDIKVDRIGTQNFHD--ESLFLNVNDKSTDRNSEKMY-HLGVSKSSDPDNVSQ 115
Query: 121 CSSVHHHERACSSQSGEEGSSGAGHKHSSLSYGGLVTASPLIGLPEISHLGWGHWFTLRD 180
CSS++HHER CSSQSGEEGSSG KHSSLSYG L +ASPLIGLPE+SHLGWGHWFTLRD
Sbjct: 116 CSSIYHHERGCSSQSGEEGSSGTVRKHSSLSYG-LASASPLIGLPEVSHLGWGHWFTLRD 174
Query: 181 LEIATNRFSAENVLGEGGYGVVYKGRLINGSEVAVKKLLNNLGQAEKEFRVEVEAIGHVR 240
LE AT+RFSAENVLGEGGYGVVYKGRLING+EVAVKKLLNNLGQAEKEFRVEVEAIGHVR
Sbjct: 175 LEYATSRFSAENVLGEGGYGVVYKGRLINGAEVAVKKLLNNLGQAEKEFRVEVEAIGHVR 234
Query: 241 HKNLVRLLGYCIEGVHRMLVYEYVNNGNLEQWLHGAMRNQGNLTWEARMKVIIGTAKALA 300
HKNLVRLLGYCIEGVHRMLVYEYVNNGNLEQWLHGAMR GNLTWEARMKVI+GTAKALA
Sbjct: 235 HKNLVRLLGYCIEGVHRMLVYEYVNNGNLEQWLHGAMRQYGNLTWEARMKVILGTAKALA 294
Query: 301 YLHEAIEPKVVHRDIKSSNILIDDEFNAKVSDFGLAKLLDSGESHITTRVMGTFGYVAPE 360
YLHEAIEPKVVHRDIKSSNILIDDEFNAKVSDFGLAKLL SGESHITTRVMGTFGYVAPE
Sbjct: 295 YLHEAIEPKVVHRDIKSSNILIDDEFNAKVSDFGLAKLLGSGESHITTRVMGTFGYVAPE 354
Query: 361 YANTGMLNEKSDIYSFGVLLLEAVTGRDPVDYGRPANEVNLVEWLKMMVGTRRAEEVVDP 420
YANTG+LNEKSDIYSFGVLLLEAVTGRDPVDYGRPANEVNLVEWLK+MVGTRRAEEVVDP
Sbjct: 355 YANTGLLNEKSDIYSFGVLLLEAVTGRDPVDYGRPANEVNLVEWLKVMVGTRRAEEVVDP 414
Query: 421 NLEVKPATRALKRSLLVALRCVDPDSEKRPKMSQVVRMLEADDYPFREDRRNRKSRTTSM 480
NLEVKP TRALKR+LLVALRCVDPDSEKRPKMSQVVRMLE D+YPFREDR RKSRTTSM
Sbjct: 415 NLEVKPTTRALKRALLVALRCVDPDSEKRPKMSQVVRMLEQDEYPFREDR--RKSRTTSM 472
Query: 481 EIESLKE---STEIESKVEDSEGRISEKTHG 508
++ES+KE S ++E+KV +SE SE HG
Sbjct: 473 DLESMKENSGSGDVENKVNESECHTSEAIHG 503
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|302143546|emb|CBI22107.3| unnamed protein product [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 869 bits (2245), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 442/511 (86%), Positives = 477/511 (93%), Gaps = 11/511 (2%)
Query: 1 MSSEGSLNTELSKKTSFLGLKLWVLIGISVGAFIVLILCILSVWVSFRRKSRKSLDKFSL 60
MSS+ SL+TELSKK FLGLKLWVLIG+ VGAFIVLILCILS+WV FRRKSR++LDKF+L
Sbjct: 131 MSSQKSLDTELSKK--FLGLKLWVLIGVCVGAFIVLILCILSIWVMFRRKSRRTLDKFTL 188
Query: 61 TQIPNVSKDIKVDRIVGQNFNDHPESVFLSVHDKSSDKNSEKMHVHLGMSKSSDPDNISQ 120
+QIPNVSKDIKVDRI QNF+D ES+FL+V+DKS+D+NSEKM+ HLG+SKSSDPDN+SQ
Sbjct: 189 SQIPNVSKDIKVDRIGTQNFHD--ESLFLNVNDKSTDRNSEKMY-HLGVSKSSDPDNVSQ 245
Query: 121 CSSVHHHERACSSQSGEEGSSGAGHKHSSLSYGGLVTASPLIGLPEISHLGWGHWFTLRD 180
CSS++HHER CSSQSGEEGSSG KHSSLSYG L +ASPLIGLPE+SHLGWGHWFTLRD
Sbjct: 246 CSSIYHHERGCSSQSGEEGSSGTVRKHSSLSYG-LASASPLIGLPEVSHLGWGHWFTLRD 304
Query: 181 LEIATNRFSAENVLGEGGYGVVYKGRLINGSEVAVKKLLNNLGQAEKEFRVEVEAIGHVR 240
LE AT+RFSAENVLGEGGYGVVYKGRLING+EVAVKKLLNNLGQAEKEFRVEVEAIGHVR
Sbjct: 305 LEYATSRFSAENVLGEGGYGVVYKGRLINGAEVAVKKLLNNLGQAEKEFRVEVEAIGHVR 364
Query: 241 HKNLVRLLGYCIEGVHRMLVYEYVNNGNLEQWLHGAMRNQGNLTWEARMKVIIGTAKALA 300
HKNLVRLLGYCIEGVHRMLVYEYVNNGNLEQWLHGAMR GNLTWEARMKVI+GTAKALA
Sbjct: 365 HKNLVRLLGYCIEGVHRMLVYEYVNNGNLEQWLHGAMRQYGNLTWEARMKVILGTAKALA 424
Query: 301 YLHEAIEPKVVHRDIKSSNILIDDEFNAKVSDFGLAKLLDSGESHITTRVMGTFGYVAPE 360
YLHEAIEPKVVHRDIKSSNILIDDEFNAKVSDFGLAKLL SGESHITTRVMGTFGYVAPE
Sbjct: 425 YLHEAIEPKVVHRDIKSSNILIDDEFNAKVSDFGLAKLLGSGESHITTRVMGTFGYVAPE 484
Query: 361 YANTGMLNEKSDIYSFGVLLLEAVTGRDPVDYGRPANEVNLVEWLKMMVGTRRAEEVVDP 420
YANTG+LNEKSDIYSFGVLLLEAVTGRDPVDYGRPANEVNLVEWLK+MVGTRRAEEVVDP
Sbjct: 485 YANTGLLNEKSDIYSFGVLLLEAVTGRDPVDYGRPANEVNLVEWLKVMVGTRRAEEVVDP 544
Query: 421 NLEVKPATRALKRSLLVALRCVDPDSEKRPKMSQVVRMLEADDYPFREDRRNRKSRTTSM 480
NLEVKP TRALKR+LLVALRCVDPDSEKRPKMSQVVRMLE D+YPFREDR RKSRTTSM
Sbjct: 545 NLEVKPTTRALKRALLVALRCVDPDSEKRPKMSQVVRMLEQDEYPFREDR--RKSRTTSM 602
Query: 481 EIESLKE---STEIESKVEDSEGRISEKTHG 508
++ES+KE S ++E+KV +SE SE HG
Sbjct: 603 DLESMKENSGSGDVENKVNESECHTSEAIHG 633
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224085356|ref|XP_002307552.1| predicted protein [Populus trichocarpa] gi|222857001|gb|EEE94548.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 855 bits (2208), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 423/490 (86%), Positives = 459/490 (93%), Gaps = 1/490 (0%)
Query: 1 MSSEGSLNTELSKKTSFLGLKLWVLIGISVGAFIVLILCILSVWVSFRRKSRKSLDKFSL 60
MSSE SLN ELSKKTS LGLKLWVLIGISVG FI+ ILC+LSVW++F+RKSR+S+DK+
Sbjct: 1 MSSE-SLNAELSKKTSVLGLKLWVLIGISVGVFIISILCVLSVWITFQRKSRRSVDKYCH 59
Query: 61 TQIPNVSKDIKVDRIVGQNFNDHPESVFLSVHDKSSDKNSEKMHVHLGMSKSSDPDNISQ 120
++IPNVSKDIK+DR+ QN H ES FL+++DKSSDKNS+KM HLGMSKSSDPD SQ
Sbjct: 60 SKIPNVSKDIKIDRVGVQNPIHHHESAFLTINDKSSDKNSDKMLAHLGMSKSSDPDIASQ 119
Query: 121 CSSVHHHERACSSQSGEEGSSGAGHKHSSLSYGGLVTASPLIGLPEISHLGWGHWFTLRD 180
SS++H+ERACSS SGEEGSSG K SSLSY GLVTASPLIGLPEISHLGWGHWFTLRD
Sbjct: 120 SSSIYHNERACSSHSGEEGSSGTVRKQSSLSYAGLVTASPLIGLPEISHLGWGHWFTLRD 179
Query: 181 LEIATNRFSAENVLGEGGYGVVYKGRLINGSEVAVKKLLNNLGQAEKEFRVEVEAIGHVR 240
LE ATNRF+AENVLGEGGYGVVYKGRLING+EVAVKKLLNNLGQAEKEFRVEVEAIGHVR
Sbjct: 180 LEFATNRFAAENVLGEGGYGVVYKGRLINGTEVAVKKLLNNLGQAEKEFRVEVEAIGHVR 239
Query: 241 HKNLVRLLGYCIEGVHRMLVYEYVNNGNLEQWLHGAMRNQGNLTWEARMKVIIGTAKALA 300
HKNLVRLLGYCIEGVHRMLVYEYVNNGNLEQWLHGAM++ G LTWEARMKV++GTAKALA
Sbjct: 240 HKNLVRLLGYCIEGVHRMLVYEYVNNGNLEQWLHGAMQHHGMLTWEARMKVLLGTAKALA 299
Query: 301 YLHEAIEPKVVHRDIKSSNILIDDEFNAKVSDFGLAKLLDSGESHITTRVMGTFGYVAPE 360
YLHEAIEPKVVHRDIKSSNILID+EFNAKVSDFGLAKLLDSGESHITTRVMGTFGYVAPE
Sbjct: 300 YLHEAIEPKVVHRDIKSSNILIDNEFNAKVSDFGLAKLLDSGESHITTRVMGTFGYVAPE 359
Query: 361 YANTGMLNEKSDIYSFGVLLLEAVTGRDPVDYGRPANEVNLVEWLKMMVGTRRAEEVVDP 420
YANTGMLNEKSDIYSFGVLLLE+VTGRDPVD+GRPANEVNLVEWLKMMVGTRR+EEVVDP
Sbjct: 360 YANTGMLNEKSDIYSFGVLLLESVTGRDPVDHGRPANEVNLVEWLKMMVGTRRSEEVVDP 419
Query: 421 NLEVKPATRALKRSLLVALRCVDPDSEKRPKMSQVVRMLEADDYPFREDRRNRKSRTTSM 480
NLEVKP TRALKR+LLVALRCVDPD+EKRP+M+QV RMLEAD+YP REDRRNRKSRTTSM
Sbjct: 420 NLEVKPTTRALKRALLVALRCVDPDAEKRPRMTQVARMLEADEYPSREDRRNRKSRTTSM 479
Query: 481 EIESLKESTE 490
EIES+K+STE
Sbjct: 480 EIESMKDSTE 489
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356501467|ref|XP_003519546.1| PREDICTED: probable receptor-like protein kinase At2g42960-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 844 bits (2181), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 402/487 (82%), Positives = 444/487 (91%)
Query: 1 MSSEGSLNTELSKKTSFLGLKLWVLIGISVGAFIVLILCILSVWVSFRRKSRKSLDKFSL 60
MSS SLN ELSKKTSFLGLK WVLIGI VGAFIVLILCILS+W FRRK R+SLDK+S+
Sbjct: 1 MSSNSSLNMELSKKTSFLGLKRWVLIGIGVGAFIVLILCILSIWAMFRRKCRRSLDKYSV 60
Query: 61 TQIPNVSKDIKVDRIVGQNFNDHPESVFLSVHDKSSDKNSEKMHVHLGMSKSSDPDNISQ 120
+QIPNVSKDI VD++ Q+ + PE+V + VHDK+SDKNS+ + VHLG SKS DPDNISQ
Sbjct: 61 SQIPNVSKDIDVDKVGVQSSHVQPENVVIPVHDKASDKNSDNVSVHLGKSKSGDPDNISQ 120
Query: 121 CSSVHHHERACSSQSGEEGSSGAGHKHSSLSYGGLVTASPLIGLPEISHLGWGHWFTLRD 180
CSS++HHER SS S EEGSSG K S+LS+GGL TASPL+GLPE SHLGWGHWFTLRD
Sbjct: 121 CSSIYHHERGFSSMSAEEGSSGNVKKQSTLSHGGLATASPLVGLPEFSHLGWGHWFTLRD 180
Query: 181 LEIATNRFSAENVLGEGGYGVVYKGRLINGSEVAVKKLLNNLGQAEKEFRVEVEAIGHVR 240
LE+ATNRFS+EN++GEGGYG+VY+GRLING+EVAVKKLLNNLGQAEKEFRVEVEAIGHVR
Sbjct: 181 LEMATNRFSSENIIGEGGYGIVYRGRLINGTEVAVKKLLNNLGQAEKEFRVEVEAIGHVR 240
Query: 241 HKNLVRLLGYCIEGVHRMLVYEYVNNGNLEQWLHGAMRNQGNLTWEARMKVIIGTAKALA 300
HK+LVRLLGYC+EGVHR+LVYEYVNNGNLEQWLHG M G LTWEARMKVI+GTAKALA
Sbjct: 241 HKHLVRLLGYCVEGVHRLLVYEYVNNGNLEQWLHGNMHQYGTLTWEARMKVILGTAKALA 300
Query: 301 YLHEAIEPKVVHRDIKSSNILIDDEFNAKVSDFGLAKLLDSGESHITTRVMGTFGYVAPE 360
YLHEAIEPKV+HRDIKSSNILIDDEFNAKVSDFGLAKLLDSGESHITTRVMGTFGYVAPE
Sbjct: 301 YLHEAIEPKVIHRDIKSSNILIDDEFNAKVSDFGLAKLLDSGESHITTRVMGTFGYVAPE 360
Query: 361 YANTGMLNEKSDIYSFGVLLLEAVTGRDPVDYGRPANEVNLVEWLKMMVGTRRAEEVVDP 420
YAN+G+LNEKSDIYSFGVLLLEAVTGRDPVDY RPANEVNLVEWLK MVGTRRAEEVVD
Sbjct: 361 YANSGLLNEKSDIYSFGVLLLEAVTGRDPVDYARPANEVNLVEWLKTMVGTRRAEEVVDS 420
Query: 421 NLEVKPATRALKRSLLVALRCVDPDSEKRPKMSQVVRMLEADDYPFREDRRNRKSRTTSM 480
+LEVKP RALKR+LLVALRC+DPD++KRPKMSQVVRMLEAD+YPFREDRR RKS T SM
Sbjct: 421 SLEVKPPLRALKRTLLVALRCIDPDADKRPKMSQVVRMLEADEYPFREDRRKRKSGTASM 480
Query: 481 EIESLKE 487
EIE++K+
Sbjct: 481 EIETVKD 487
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356553717|ref|XP_003545199.1| PREDICTED: probable receptor-like protein kinase At2g42960-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 838 bits (2164), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 398/487 (81%), Positives = 442/487 (90%)
Query: 1 MSSEGSLNTELSKKTSFLGLKLWVLIGISVGAFIVLILCILSVWVSFRRKSRKSLDKFSL 60
MSS SLN ELSKKTSFLGLK WVLIGI VGAFIVLILCILS+W FRRKSR+SLDK+S+
Sbjct: 1 MSSNSSLNMELSKKTSFLGLKRWVLIGIGVGAFIVLILCILSIWAMFRRKSRRSLDKYSV 60
Query: 61 TQIPNVSKDIKVDRIVGQNFNDHPESVFLSVHDKSSDKNSEKMHVHLGMSKSSDPDNISQ 120
+QIPN SKDI VD++ Q+ + PE+V + VHDK+SDKNS+ + VHLG SKS DPDNISQ
Sbjct: 61 SQIPNFSKDIDVDKVGVQSSHVQPENVVIPVHDKASDKNSDNVSVHLGNSKSGDPDNISQ 120
Query: 121 CSSVHHHERACSSQSGEEGSSGAGHKHSSLSYGGLVTASPLIGLPEISHLGWGHWFTLRD 180
CSS++HHER SS S EEGSSG K S+LS+GGL TASPL+GLPE SHLGWGHWFTLRD
Sbjct: 121 CSSIYHHERGLSSMSAEEGSSGNVKKQSTLSHGGLATASPLVGLPEFSHLGWGHWFTLRD 180
Query: 181 LEIATNRFSAENVLGEGGYGVVYKGRLINGSEVAVKKLLNNLGQAEKEFRVEVEAIGHVR 240
LE+ATN FS+EN++GEGGYG+VY+GRL+NG+EVAVKKLLNNLGQAEKEFRVEVEAIGHVR
Sbjct: 181 LEMATNHFSSENIIGEGGYGIVYRGRLVNGTEVAVKKLLNNLGQAEKEFRVEVEAIGHVR 240
Query: 241 HKNLVRLLGYCIEGVHRMLVYEYVNNGNLEQWLHGAMRNQGNLTWEARMKVIIGTAKALA 300
HK+LVRLLGYC+EGVHR+LVYEYVNNGNLEQWLHG M G LTWEARMKVI+GTAKALA
Sbjct: 241 HKHLVRLLGYCVEGVHRLLVYEYVNNGNLEQWLHGDMHQYGTLTWEARMKVILGTAKALA 300
Query: 301 YLHEAIEPKVVHRDIKSSNILIDDEFNAKVSDFGLAKLLDSGESHITTRVMGTFGYVAPE 360
YLHEAIEPKV+HRDIKSSNILIDDEFNAKVSDFGLAKLLDSGESHITTRVMGTFGYVAPE
Sbjct: 301 YLHEAIEPKVIHRDIKSSNILIDDEFNAKVSDFGLAKLLDSGESHITTRVMGTFGYVAPE 360
Query: 361 YANTGMLNEKSDIYSFGVLLLEAVTGRDPVDYGRPANEVNLVEWLKMMVGTRRAEEVVDP 420
YAN+G+LNEKSDIYSFGVLLLEAVTGRDPVDY RPANEVNLVEWLK MVGTRRAEEVVD
Sbjct: 361 YANSGLLNEKSDIYSFGVLLLEAVTGRDPVDYARPANEVNLVEWLKTMVGTRRAEEVVDS 420
Query: 421 NLEVKPATRALKRSLLVALRCVDPDSEKRPKMSQVVRMLEADDYPFREDRRNRKSRTTSM 480
+L+VKP RALKR+LLVALRC+DPD++KRPKMSQVVRMLEAD+YP REDRR RKS T SM
Sbjct: 421 SLQVKPPLRALKRTLLVALRCIDPDADKRPKMSQVVRMLEADEYPLREDRRKRKSGTASM 480
Query: 481 EIESLKE 487
EIE++K+
Sbjct: 481 EIETVKD 487
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356567426|ref|XP_003551921.1| PREDICTED: probable receptor-like protein kinase At2g42960-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 828 bits (2139), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 414/510 (81%), Positives = 454/510 (89%), Gaps = 2/510 (0%)
Query: 1 MSSEGSLNTELSKKTSFLGLKLWVLIGISVGAFIVLILCILSVWVSFRRKSRKSLDKFSL 60
MS+ SL+ ELS+KTSFLGL+LWVLIGI VG FIV+ILC+LSVWV FRRKS++SLDK+SL
Sbjct: 1 MSANSSLHVELSRKTSFLGLRLWVLIGIGVGVFIVVILCVLSVWVMFRRKSKRSLDKYSL 60
Query: 61 TQIPNVSKDIKVDRIVGQNFNDHPESVFLSVHDKSSDKNSEKMHVHLGMSKSSDPDNISQ 120
+QIP+VSKDI VD + Q +D ESV + VHDK S+ NS K+ HL SKS D DNISQ
Sbjct: 61 SQIPHVSKDIIVDMVGVQISHDQSESVAIPVHDKPSENNSNKLFSHLHKSKSGDADNISQ 120
Query: 121 CSSVHHHERACSSQSGEEGSSGAGHKHSSLSYGGLVTASPLIGLPEISHLGWGHWFTLRD 180
CSSV+HHER SS SGEEGSSG K S+LS+GG+VTASPL+GLPEISHLGWGHWFTLRD
Sbjct: 121 CSSVYHHERGFSSMSGEEGSSGTVKKQSALSFGGMVTASPLVGLPEISHLGWGHWFTLRD 180
Query: 181 LEIATNRFSAENVLGEGGYGVVYKGRLINGSEVAVKKLLNNLGQAEKEFRVEVEAIGHVR 240
LE+ATNRFS ENV+GEGGYGVVY+G+LINGSEVAVKK+LNNLGQAEKEFRVEVEAIGHVR
Sbjct: 181 LELATNRFSPENVIGEGGYGVVYRGKLINGSEVAVKKILNNLGQAEKEFRVEVEAIGHVR 240
Query: 241 HKNLVRLLGYCIEGVHRMLVYEYVNNGNLEQWLHGAMRNQGNLTWEARMKVIIGTAKALA 300
HKNLVRLLGYC+EGVHR+LVYEYVNNGNLEQWLHGAM QG LTWEARMKVI GTAKALA
Sbjct: 241 HKNLVRLLGYCVEGVHRLLVYEYVNNGNLEQWLHGAMSQQGTLTWEARMKVITGTAKALA 300
Query: 301 YLHEAIEPKVVHRDIKSSNILIDDEFNAKVSDFGLAKLLDSGESHITTRVMGTFGYVAPE 360
YLHEAIEPKVVHRDIKSSNILID EFNAKVSDFGLAKLLDSGESHITTRVMGTFGYVAPE
Sbjct: 301 YLHEAIEPKVVHRDIKSSNILIDTEFNAKVSDFGLAKLLDSGESHITTRVMGTFGYVAPE 360
Query: 361 YANTGMLNEKSDIYSFGVLLLEAVTGRDPVDYGRPANEVNLVEWLKMMVGTRRAEEVVDP 420
YANTG+LNE+SDIYSFGVLLLEAVTG+DPVDY RPANEVNLVEWLKMMVGTRRAEEVVD
Sbjct: 361 YANTGLLNERSDIYSFGVLLLEAVTGKDPVDYSRPANEVNLVEWLKMMVGTRRAEEVVDS 420
Query: 421 NLEVKPATRALKRSLLVALRCVDPDSEKRPKMSQVVRMLEADDYPFREDRRNRKSRTTSM 480
LEVKP+ RALKR+LLVALRCVDP++EKRPKMSQVVRMLEAD+YPFREDRRNRKSRT SM
Sbjct: 421 RLEVKPSIRALKRALLVALRCVDPEAEKRPKMSQVVRMLEADEYPFREDRRNRKSRTASM 480
Query: 481 EIESLKEST--EIESKVEDSEGRISEKTHG 508
EIESLK+ + K++ SEG E T G
Sbjct: 481 EIESLKDISGPSDAEKLKGSEGHEPETTQG 510
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|449444122|ref|XP_004139824.1| PREDICTED: probable receptor-like protein kinase At2g42960-like [Cucumis sativus] gi|449519539|ref|XP_004166792.1| PREDICTED: probable receptor-like protein kinase At2g42960-like [Cucumis sativus] | Back alignment and taxonomy information |
|---|
Score = 824 bits (2128), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 413/503 (82%), Positives = 456/503 (90%), Gaps = 6/503 (1%)
Query: 3 SEGSLNTELSKKTSFLGLKLWVLIGISVGAFIVLILCILSVWVSFRRKSRKSLDKFSLTQ 62
S +LNTELSKKT FLGL LWVLI + VGAFIVLIL ILSVWV FRRK+R+S + FS +Q
Sbjct: 5 SSSTLNTELSKKTPFLGLSLWVLICLCVGAFIVLILGILSVWVMFRRKTRRSPENFSTSQ 64
Query: 63 IPNVSKDIKVDRIVGQN-FNDHPESVFLSVHDKSSDKNSEKMHVHLGMSKSSDPDNISQC 121
IPN+SKDIKVDRI Q+ ++H ES+++S++DKSS+KNSEKM HLGMSKSSDPDNISQC
Sbjct: 65 IPNISKDIKVDRIATQSAHHNHLESLYISINDKSSEKNSEKMIGHLGMSKSSDPDNISQC 124
Query: 122 SSVHHHERACSSQSGEEGSSGAGHKHSSLSYGG---LVTASPLIGLPEISHLGWGHWFTL 178
SS +HHER SS SGEEGSSG K SS+SYGG LVTASPL+GLPEISHLGWGHWFTL
Sbjct: 125 SSNYHHERVFSSHSGEEGSSGTVRKQSSMSYGGYGGLVTASPLVGLPEISHLGWGHWFTL 184
Query: 179 RDLEIATNRFSAENVLGEGGYGVVYKGRLINGSEVAVKKLLNNLGQAEKEFRVEVEAIGH 238
RDLE ATNRF+A+NVLGEGGYGVVYKGRLING+EVAVKKLLNNLGQAEKEFRVEVEAIGH
Sbjct: 185 RDLEFATNRFAADNVLGEGGYGVVYKGRLINGTEVAVKKLLNNLGQAEKEFRVEVEAIGH 244
Query: 239 VRHKNLVRLLGYCIEGVHRMLVYEYVNNGNLEQWLHGAMRNQGNLTWEARMKVIIGTAKA 298
VRHKNLVRLLGYCIEGVHRMLVYEYVNNGNLEQWLHGAMR G LTWEARMKV++GTAKA
Sbjct: 245 VRHKNLVRLLGYCIEGVHRMLVYEYVNNGNLEQWLHGAMRQHGTLTWEARMKVLLGTAKA 304
Query: 299 LAYLHEAIEPKVVHRDIKSSNILIDDEFNAKVSDFGLAKLLDSGESHITTRVMGTFGYVA 358
LAYLHEAIEPKVVHRDIKSSNILIDDEFNAKVSDFGLAKLLD+GESHITTRVMGTFGYVA
Sbjct: 305 LAYLHEAIEPKVVHRDIKSSNILIDDEFNAKVSDFGLAKLLDAGESHITTRVMGTFGYVA 364
Query: 359 PEYANTGMLNEKSDIYSFGVLLLEAVTGRDPVDYGRPANEVNLVEWLKMMVGTRRAEEVV 418
PEYANTG+LNEKSDIYSFGVLLLEA+TGRDPVDYGRPANEVNLVEWLK+MVGTRRAEEV+
Sbjct: 365 PEYANTGLLNEKSDIYSFGVLLLEAITGRDPVDYGRPANEVNLVEWLKVMVGTRRAEEVI 424
Query: 419 DPNLEVKPATRALKRSLLVALRCVDPDSEKRPKMSQVVRMLEADDYPFREDRRNRKSRTT 478
DP+LE KP+TRALKR+LL+ALRCVDP+++KRPKM+QVVRMLEADDYP REDRR++KS T
Sbjct: 425 DPSLETKPSTRALKRALLIALRCVDPEADKRPKMTQVVRMLEADDYPSREDRRSQKSSTA 484
Query: 479 SMEIESLKESTEIESKVEDSEGR 501
+ EIES EI SK +S+ +
Sbjct: 485 NSEIES--SQGEIGSKPGESQSK 505
|
Source: Cucumis sativus Species: Cucumis sativus Genus: Cucumis Family: Cucurbitaceae Order: Cucurbitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356524227|ref|XP_003530732.1| PREDICTED: probable receptor-like protein kinase At2g42960-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 811 bits (2095), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 403/508 (79%), Positives = 444/508 (87%)
Query: 1 MSSEGSLNTELSKKTSFLGLKLWVLIGISVGAFIVLILCILSVWVSFRRKSRKSLDKFSL 60
MS SL+ LS+KTSFLGL+LWVLIGI VG FIV+ILC+LS WV FRRKSR SLDK+SL
Sbjct: 1 MSGNSSLHVGLSRKTSFLGLRLWVLIGIGVGVFIVVILCVLSAWVMFRRKSRGSLDKYSL 60
Query: 61 TQIPNVSKDIKVDRIVGQNFNDHPESVFLSVHDKSSDKNSEKMHVHLGMSKSSDPDNISQ 120
+QIP++SKDI+VD++ Q +D P+SV + V+DK S+ NS+K HL +KS D DNISQ
Sbjct: 61 SQIPHISKDIRVDKVGVQTSHDQPDSVAIPVYDKPSENNSDKFLAHLSKNKSGDADNISQ 120
Query: 121 CSSVHHHERACSSQSGEEGSSGAGHKHSSLSYGGLVTASPLIGLPEISHLGWGHWFTLRD 180
CSSV+HHER SS SGEEGSSG K S+ S+GG+VTASPL+GLPE SHLGWGHWFTLRD
Sbjct: 121 CSSVYHHERGFSSMSGEEGSSGTVKKQSASSFGGMVTASPLVGLPEFSHLGWGHWFTLRD 180
Query: 181 LEIATNRFSAENVLGEGGYGVVYKGRLINGSEVAVKKLLNNLGQAEKEFRVEVEAIGHVR 240
LEIATNRFS ENV+GEGGYGVVY+G LINGSEVAVKK+LNNLGQAEKEFRVEVEAIGHVR
Sbjct: 181 LEIATNRFSPENVIGEGGYGVVYRGSLINGSEVAVKKILNNLGQAEKEFRVEVEAIGHVR 240
Query: 241 HKNLVRLLGYCIEGVHRMLVYEYVNNGNLEQWLHGAMRNQGNLTWEARMKVIIGTAKALA 300
HKNLVRLLGYC+EGVHR+LVYEYVNNGNLEQWLHGAM QG LTWEARMKVI GTAKALA
Sbjct: 241 HKNLVRLLGYCVEGVHRLLVYEYVNNGNLEQWLHGAMSQQGTLTWEARMKVITGTAKALA 300
Query: 301 YLHEAIEPKVVHRDIKSSNILIDDEFNAKVSDFGLAKLLDSGESHITTRVMGTFGYVAPE 360
YLHEAIEPKVVHRDIKSSNILID +FNAKVSDFGLAKLLDSGESHITTRVMGTFGYVAPE
Sbjct: 301 YLHEAIEPKVVHRDIKSSNILIDTDFNAKVSDFGLAKLLDSGESHITTRVMGTFGYVAPE 360
Query: 361 YANTGMLNEKSDIYSFGVLLLEAVTGRDPVDYGRPANEVNLVEWLKMMVGTRRAEEVVDP 420
YANTG+LNE+SDIYSFGVLLLEAVTGRDPVDY RP+NEVNLVEWLKMMVGTRR EEVVD
Sbjct: 361 YANTGLLNERSDIYSFGVLLLEAVTGRDPVDYSRPSNEVNLVEWLKMMVGTRRTEEVVDS 420
Query: 421 NLEVKPATRALKRSLLVALRCVDPDSEKRPKMSQVVRMLEADDYPFREDRRNRKSRTTSM 480
LEVKP+ RALK +LLVALRCVDP++EKRPKMSQVVRMLEAD+YPFREDRRNRKSRT SM
Sbjct: 421 RLEVKPSIRALKCALLVALRCVDPEAEKRPKMSQVVRMLEADEYPFREDRRNRKSRTASM 480
Query: 481 EIESLKESTEIESKVEDSEGRISEKTHG 508
EIESLK+ + + G E T G
Sbjct: 481 EIESLKDISGPSDAEKLKGGHAPETTQG 508
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
Prediction of Gene Ontology (GO) Terms
Close Homologs with Gene Ontology terms Detected by BLAST
Original result of BLAST against Gene Ontology (AMIGO)
| ID |
Alignment graph |
Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 508 | ||||||
| TAIR|locus:2077730 | 512 | AT3G59110 [Arabidopsis thalian | 0.994 | 0.986 | 0.746 | 9.1e-203 | |
| TAIR|locus:2045620 | 494 | AT2G42960 [Arabidopsis thalian | 0.946 | 0.973 | 0.747 | 2.9e-197 | |
| TAIR|locus:2027559 | 492 | AT1G56720 [Arabidopsis thalian | 0.950 | 0.981 | 0.655 | 9.4e-169 | |
| TAIR|locus:2012325 | 466 | AT1G09440 [Arabidopsis thalian | 0.903 | 0.984 | 0.628 | 5.1e-154 | |
| TAIR|locus:2146203 | 484 | AT5G18500 [Arabidopsis thalian | 0.675 | 0.708 | 0.745 | 1.9e-151 | |
| TAIR|locus:2093591 | 467 | GPK1 "glyoxysomal protein kina | 0.645 | 0.702 | 0.724 | 5.5e-143 | |
| TAIR|locus:2025396 | 472 | AT1G01540 [Arabidopsis thalian | 0.610 | 0.656 | 0.696 | 1.1e-135 | |
| TAIR|locus:2132353 | 492 | AT4G02630 [Arabidopsis thalian | 0.659 | 0.680 | 0.650 | 1.1e-135 | |
| TAIR|locus:2139559 | 437 | AT4G34500 [Arabidopsis thalian | 0.629 | 0.732 | 0.651 | 1.5e-121 | |
| TAIR|locus:2028911 | 720 | PERK12 "proline-rich extensin- | 0.586 | 0.413 | 0.495 | 1.9e-81 |
| TAIR|locus:2077730 AT3G59110 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1962 (695.7 bits), Expect = 9.1e-203, P = 9.1e-203
Identities = 383/513 (74%), Positives = 435/513 (84%)
Query: 1 MSSEGSLNTELSKKTSFLGLK---LWVLIGISVGAFIVLILCILSVWVSFRRKSRKSLDK 57
MSSE SL+ ++SKK SFLGLK LWVLI + VG F+VL+ CILS+W++FRRKSR+S K
Sbjct: 1 MSSESSLSADMSKKVSFLGLKGMKLWVLICLVVGTFVVLVFCILSLWIAFRRKSRRSSHK 60
Query: 58 F-SLTQIPNVSKDIKVDRIVGQNFNDHPESVFLSVHDKSSDKNSEKMHVHLGMSKSSDPD 116
+QIP V+KDI+VD VG F +H E++ ++ DKSSD+NS KM +LG +KSSD D
Sbjct: 61 LLPFSQIPRVAKDIRVDDRVG--FQNHNENLSITNADKSSDRNSGKMMSYLGRTKSSDND 118
Query: 117 NISQCSSVHHHERACXXXXXXXXXXXXXXXXXXXXYGGLVTASPLIGLPEISHLGWGHWF 176
+ISQCSSVHHHERAC GGLVTASPL+GLPEISHLGWGHWF
Sbjct: 119 SISQCSSVHHHERACSSHSGEDGSFGAAWRQNSLSQGGLVTASPLVGLPEISHLGWGHWF 178
Query: 177 TLRDLEIATNRFSAENVLGEGGYGVVYKGRLINGSEVAVKKLLNNLGQAEKEFRVEVEAI 236
TLRDL++ATNRF+AENV+GEGGYGVVYKGRLING++VAVKKLLNNLGQAEKEFRVEVEAI
Sbjct: 179 TLRDLQLATNRFAAENVIGEGGYGVVYKGRLINGNDVAVKKLLNNLGQAEKEFRVEVEAI 238
Query: 237 GHVRHKNLVRLLGYCIEGVHRMLVYEYVNNGNLEQWLHGAMRNQGNLTWEARMKVIIGTA 296
GHVRHKNLVRLLGYCIEGV+RMLVYEYVN+GNLEQWLHGAM Q LTWEARMK+++GTA
Sbjct: 239 GHVRHKNLVRLLGYCIEGVNRMLVYEYVNSGNLEQWLHGAMGKQSTLTWEARMKILVGTA 298
Query: 297 KALAYLHEAIEPKVVHRDIKSSNILIDDEFNAKVSDFGLAKLLDSGESHITTRVMGTFGY 356
+ALAYLHEAIEPKVVHRDIK+SNILIDD+FNAK+SDFGLAKLLDSGESHITTRVMGTFGY
Sbjct: 299 QALAYLHEAIEPKVVHRDIKASNILIDDDFNAKLSDFGLAKLLDSGESHITTRVMGTFGY 358
Query: 357 VAPEYANTGMLNEKSDIYSFGVLLLEAVTGRDPVDYGRPANEVNLVEWLKMMVGTRRAEE 416
VAPEYANTG+LNEKSDIYSFGVLLLE +TGRDPVDY RPANEVNLVEWLKMMVGTRRAEE
Sbjct: 359 VAPEYANTGLLNEKSDIYSFGVLLLETITGRDPVDYERPANEVNLVEWLKMMVGTRRAEE 418
Query: 417 VVDPNLEVKPATRALKRSLLVALRCVDPDSEKRPKMSQVVRMLEADDYPFREDRRNRKSR 476
VVD +E PATRALKR+LLVALRCVDP+++KRPKMSQVVRMLE+D++PFRE+RRNRKSR
Sbjct: 419 VVDSRIEPPPATRALKRALLVALRCVDPEAQKRPKMSQVVRMLESDEHPFREERRNRKSR 478
Query: 477 TTSMEI-ESLKESTEIESKVEDSEGRIS-EKTH 507
T SMEI E+ +ES + SE EKTH
Sbjct: 479 TASMEIVETTEESADTSKGPGHSENTTKPEKTH 511
|
|
| TAIR|locus:2045620 AT2G42960 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1910 (677.4 bits), Expect = 2.9e-197, P = 2.9e-197
Identities = 368/492 (74%), Positives = 418/492 (84%)
Query: 1 MSSEGSLNTELSKKTSFLGLK---LWVLIGISVGAFIVLILCILSVWVSFRRKSRKSLDK 57
M E SLN E+SKK SF GLK LWV + + VG FIV+ILCILS+W++FRRKSR+S K
Sbjct: 1 MPPESSLNAEMSKKISFFGLKGLKLWVWVCLVVGVFIVMILCILSLWITFRRKSRRSSSK 60
Query: 58 FSLTQIPNVSKDIKVDRIVGQNFNDHPESVFLSVHDKSSDKNSEKMHVHLGMSKSSDPDN 117
F QIP+VSKDI+VDR QN HPES+++ ++DKS+ K M HLG +KSSD D
Sbjct: 61 FPFNQIPHVSKDIRVDRAGFQN--PHPESLYIEMNDKSTGKT---MMSHLGRTKSSDNDT 115
Query: 118 ISQCSSVHHHERACXXXXXXXXXXXXXXXXXXXXYGGLVTASPLIGLPEISHLGWGHWFT 177
+SQCSSV+HHERAC GG VTASPL+GLPEISHLGWGHWFT
Sbjct: 116 LSQCSSVNHHERACSSHSGEEGGFGSAGRQYG---GGPVTASPLVGLPEISHLGWGHWFT 172
Query: 178 LRDLEIATNRFSAENVLGEGGYGVVYKGRLINGSEVAVKKLLNNLGQAEKEFRVEVEAIG 237
LRDLE+ATNRF+ NVLGEGGYGVVY+G+L+NG+EVAVKKLLNNLGQAEKEFRVEVEAIG
Sbjct: 173 LRDLELATNRFAPVNVLGEGGYGVVYRGKLVNGTEVAVKKLLNNLGQAEKEFRVEVEAIG 232
Query: 238 HVRHKNLVRLLGYCIEGVHRMLVYEYVNNGNLEQWLHGAMRNQGNLTWEARMKVIIGTAK 297
HVRHKNLVRLLGYCIEGVHRMLVYEYVN+GNLEQWLHGAMR GNLTWEARMK+I GTA+
Sbjct: 233 HVRHKNLVRLLGYCIEGVHRMLVYEYVNSGNLEQWLHGAMRQHGNLTWEARMKIITGTAQ 292
Query: 298 ALAYLHEAIEPKVVHRDIKSSNILIDDEFNAKVSDFGLAKLLDSGESHITTRVMGTFGYV 357
ALAYLHEAIEPKVVHRDIK+SNILIDDEFNAK+SDFGLAKLLDSGESHITTRVMGTFGYV
Sbjct: 293 ALAYLHEAIEPKVVHRDIKASNILIDDEFNAKLSDFGLAKLLDSGESHITTRVMGTFGYV 352
Query: 358 APEYANTGMLNEKSDIYSFGVLLLEAVTGRDPVDYGRPANEVNLVEWLKMMVGTRRAEEV 417
APEYANTG+LNEKSDIYSFGVLLLEA+TGRDPVDYGRPANEVNLVEWLKMMVGTRRAEEV
Sbjct: 353 APEYANTGLLNEKSDIYSFGVLLLEAITGRDPVDYGRPANEVNLVEWLKMMVGTRRAEEV 412
Query: 418 VDPNLEVKPATRALKRSLLVALRCVDPDSEKRPKMSQVVRMLEADDYPFREDRRNRKSRT 477
VDP LE +P+ ALKR+LLV+LRCVDP++EKRP+MSQV RMLE+D++PF ++RRN++S+T
Sbjct: 413 VDPRLEPRPSKSALKRALLVSLRCVDPEAEKRPRMSQVARMLESDEHPFHKERRNKRSKT 472
Query: 478 TSMEIESLKEST 489
MEI K+ +
Sbjct: 473 AGMEIVETKDES 484
|
|
| TAIR|locus:2027559 AT1G56720 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1641 (582.7 bits), Expect = 9.4e-169, P = 9.4e-169
Identities = 329/502 (65%), Positives = 392/502 (78%)
Query: 5 GSLNTELSKKTSFLGLKLWVLIGISVGAFIVLILCILSVWVSFRRKSRKSLDKFSLTQIP 64
G L ++LS+++ GLK+W +IGI+V I+ IL +LS ++ ++KSR+S + Q P
Sbjct: 3 GDLKSQLSRESHVFGLKVWEVIGIAVALLIIAILSVLSCCLTSKKKSRRSKTGLPVIQTP 62
Query: 65 NV-SKDIK---VDRIVGQNFNDHPESVFLSVHDKSSDKNSEKMHVHLGMSKSSDPDNISQ 120
V SK+I+ V+ + NF E + L++ DK++ K+SEK+ VHL M K S
Sbjct: 63 PVVSKEIREVRVEHVSASNFAPG-EGILLTIQDKNN-KDSEKVMVHLDMRKKRSSSGRS- 119
Query: 121 CSSVHHHERACXXXXXXXXXXXXXXXXXXXXYGGLVTASPLIGLPEISHLGWGHWFTLRD 180
S HH E Y + T SPL GLPE SHLGWGHWFTLRD
Sbjct: 120 -GSFHHLE-----IIDKHSDSAEEVSASSSLYN-IATPSPLSGLPE-SHLGWGHWFTLRD 171
Query: 181 LEIATNRFSAENVLGEGGYGVVYKGRLINGSEVAVKKLLNNLGQAEKEFRVEVEAIGHVR 240
LE ATNRFS ENV+GEGGYGVVY+G L+NG+ VAVKK+LN LGQAEKEFRVEV+AIGHVR
Sbjct: 172 LETATNRFSKENVIGEGGYGVVYRGELMNGTPVAVKKILNQLGQAEKEFRVEVDAIGHVR 231
Query: 241 HKNLVRLLGYCIEGVHRMLVYEYVNNGNLEQWLHGAMRNQGNLTWEARMKVIIGTAKALA 300
HKNLVRLLGYCIEG HR+LVYEYVNNGNLEQWLHGAMR G LTWEARMKV+IGT+KALA
Sbjct: 232 HKNLVRLLGYCIEGTHRILVYEYVNNGNLEQWLHGAMRQHGYLTWEARMKVLIGTSKALA 291
Query: 301 YLHEAIEPKVVHRDIKSSNILIDDEFNAKVSDFGLAKLLDSGESHITTRVMGTFGYVAPE 360
YLHEAIEPKVVHRDIKSSNILI+DEFNAKVSDFGLAKLL +G+SH+TTRVMGTFGYVAPE
Sbjct: 292 YLHEAIEPKVVHRDIKSSNILINDEFNAKVSDFGLAKLLGAGKSHVTTRVMGTFGYVAPE 351
Query: 361 YANTGMLNEKSDIYSFGVLLLEAVTGRDPVDYGRPANEVNLVEWLKMMVGTRRAEEVVDP 420
YAN+G+LNEKSD+YSFGV+LLEA+TGRDPVDYGRPA+EVNLV+WLKMMVGTRR+EEVVDP
Sbjct: 352 YANSGLLNEKSDVYSFGVVLLEAITGRDPVDYGRPAHEVNLVDWLKMMVGTRRSEEVVDP 411
Query: 421 NLEVKPATRALKRSLLVALRCVDPDSEKRPKMSQVVRMLEADDYPF-REDRRNRKSRTTS 479
N+EVKP TR+LKR+LL ALRCVDPDS+KRPKMSQVVRMLE+++YP REDRR ++R S
Sbjct: 412 NIEVKPPTRSLKRALLTALRCVDPDSDKRPKMSQVVRMLESEEYPIPREDRRRSRTREGS 471
Query: 480 MEIESLKESTEIESKVEDSEGR 501
MEI S T++ + V S+ +
Sbjct: 472 MEINS---DTDMSTPVSRSQSK 490
|
|
| TAIR|locus:2012325 AT1G09440 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1502 (533.8 bits), Expect = 5.1e-154, P = 5.1e-154
Identities = 301/479 (62%), Positives = 365/479 (76%)
Query: 19 GLKLWVLIGISVGAFIVLILCILSVWVSFRRKSRKSLD-KFSLTQIPNVSKDIKVDRIVG 77
GLK+W I I++ I+++L +LS + +++KSR+S + Q P VSK+IK RI
Sbjct: 3 GLKIWQAIFITIALIIIVVLSVLSFCLIWKKKSRRSKTLSLPIIQTPVVSKEIKEVRI-- 60
Query: 78 QNFNDHPESVFLSVHDKSSDKN-SEKMHVHLGMSKSSDPDNISQCSSVHHHERACXXXXX 136
+H S + + + N S+K ++L M K+ + S S C
Sbjct: 61 ----EHVVSTSSNFDPQDENNNESDKFLLNLEMEKNRENGLSSSRSGSGKEGYLCVANRS 116
Query: 137 XXXXXXXXXXXXXXXYGGLVTASPLIGLPEISHLGWGHWFTLRDLEIATNRFSAENVLGE 196
+ SPL GLPE SHLGWGHWFTLRDLEIATNRFS ENV+GE
Sbjct: 117 TSSLYEMATP----------SPSPLSGLPE-SHLGWGHWFTLRDLEIATNRFSKENVIGE 165
Query: 197 GGYGVVYKGRLINGSEVAVKKLLNNLGQAEKEFRVEVEAIGHVRHKNLVRLLGYCIEGVH 256
GGYGVVY+G L+NGS VAVKK+LN+LGQAEKEFRVEV+AIGHVRHKNLVRLLGYCIEG +
Sbjct: 166 GGYGVVYRGELVNGSLVAVKKILNHLGQAEKEFRVEVDAIGHVRHKNLVRLLGYCIEGTN 225
Query: 257 RMLVYEYVNNGNLEQWLHGAMRNQGNLTWEARMKVIIGTAKALAYLHEAIEPKVVHRDIK 316
R+LVYEY+NNGNLE+WLHGAM++ G LTWEARMKV+ GT+KALAYLHEAIEPKVVHRDIK
Sbjct: 226 RILVYEYMNNGNLEEWLHGAMKHHGYLTWEARMKVLTGTSKALAYLHEAIEPKVVHRDIK 285
Query: 317 SSNILIDDEFNAKVSDFGLAKLLDSGESHITTRVMGTFGYVAPEYANTGMLNEKSDIYSF 376
SSNILIDD FNAK+SDFGLAKLL G+SH+TTRVMGTFGYVAPEYANTG+LNEKSD+YSF
Sbjct: 286 SSNILIDDRFNAKISDFGLAKLLGDGKSHVTTRVMGTFGYVAPEYANTGLLNEKSDVYSF 345
Query: 377 GVLLLEAVTGRDPVDYGRPANEVNLVEWLKMMVGTRRAEEVVDPNLEVKPATRALKRSLL 436
GVL+LEA+TGRDPVDY RPANEVNLVEWLKMMVG++R EEV+DPN+ V+PATRALKR LL
Sbjct: 346 GVLVLEAITGRDPVDYARPANEVNLVEWLKMMVGSKRLEEVIDPNIAVRPATRALKRVLL 405
Query: 437 VALRCVDPDSEKRPKMSQVVRMLEADDYPF-REDRRNRKSRTTSMEIESLKESTEIESK 494
ALRC+DPDSEKRPKMSQVVRMLE+++YP RE+RR R+++ + + + + + +SK
Sbjct: 406 TALRCIDPDSEKRPKMSQVVRMLESEEYPVPREERRVRRTQEENSDTDRSRPVSRSQSK 464
|
|
| TAIR|locus:2146203 AT5G18500 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1361 (484.2 bits), Expect = 1.9e-151, Sum P(2) = 1.9e-151
Identities = 258/346 (74%), Positives = 302/346 (87%)
Query: 155 LVTASPLIGLPEISHLGWGHWFTLRDLEIATNRFSAENVLGEGGYGVVYKGRLINGSEVA 214
L SPL GLPE SHLGWGHWFTLRDL++ATN+FS +N++G+GGYGVVY+G L+NG+ VA
Sbjct: 133 LTAPSPLSGLPEFSHLGWGHWFTLRDLQMATNQFSRDNIIGDGGYGVVYRGNLVNGTPVA 192
Query: 215 VKKLLNNLGQAEKEFRVEVEAIGHVRHKNLVRLLGYCIEGVHRMLVYEYVNNGNLEQWLH 274
VKKLLNNLGQA+K+FRVEVEAIGHVRHKNLVRLLGYC+EG RMLVYEYVNNGNLEQWL
Sbjct: 193 VKKLLNNLGQADKDFRVEVEAIGHVRHKNLVRLLGYCMEGTQRMLVYEYVNNGNLEQWLR 252
Query: 275 GAMRNQGNLTWEARMKVIIGTAKALAYLHEAIEPKVVHRDIKSSNILIDDEFNAKVSDFG 334
G +N LTWEAR+K++IGTAKALAYLHEAIEPKVVHRDIKSSNILIDD+FN+K+SDFG
Sbjct: 253 GDNQNHEYLTWEARVKILIGTAKALAYLHEAIEPKVVHRDIKSSNILIDDKFNSKISDFG 312
Query: 335 LAKLLDSGESHITTRVMGTFGYVAPEYANTGMLNEKSDIYSFGVLLLEAVTGRDPVDYGR 394
LAKLL + +S ITTRVMGTFGYVAPEYAN+G+LNEKSD+YSFGV+LLEA+TGR PVDY R
Sbjct: 313 LAKLLGADKSFITTRVMGTFGYVAPEYANSGLLNEKSDVYSFGVVLLEAITGRYPVDYAR 372
Query: 395 PANEVNLVEWLKMMVGTRRAEEVVDPNLEVKPATRALKRSLLVALRCVDPDSEKRPKMSQ 454
P EV+LVEWLKMMV RR+EEVVDPNLE KP+T ALKR+LL ALRCVDP SEKRP+MSQ
Sbjct: 373 PPPEVHLVEWLKMMVQQRRSEEVVDPNLETKPSTSALKRTLLTALRCVDPMSEKRPRMSQ 432
Query: 455 VVRMLEADDYPF-REDRRNRKSRT-TSMEIESLKESTEIE-SKVED 497
V RMLE+++YP REDRR R+S+ T+ + + + ST+ + S+ D
Sbjct: 433 VARMLESEEYPIAREDRRRRRSQNGTTRDSDPPRNSTDTDKSEYHD 478
|
|
| TAIR|locus:2093591 GPK1 "glyoxysomal protein kinase 1" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1313 (467.3 bits), Expect = 5.5e-143, Sum P(2) = 5.5e-143
Identities = 242/334 (72%), Positives = 294/334 (88%)
Query: 159 SPLIGLPEISHLGWGHWFTLRDLEIATNRFSAENVLGEGGYGVVYKGRLINGSEVAVKKL 218
SPL+GLPE+SH+GWGHWFTLRDL++ATN FS E+++G+GGYGVVY G L N + VAVKKL
Sbjct: 125 SPLLGLPEVSHIGWGHWFTLRDLQLATNHFSKESIIGDGGYGVVYHGTLTNKTPVAVKKL 184
Query: 219 LNNLGQAEKEFRVEVEAIGHVRHKNLVRLLGYCIEGVHRMLVYEYVNNGNLEQWLHGAMR 278
LNN GQA+K+FRVEVEAIGHVRHKNLVRLLGYC+EG HRMLVYEY+NNGNLEQWLHG M
Sbjct: 185 LNNPGQADKDFRVEVEAIGHVRHKNLVRLLGYCVEGTHRMLVYEYMNNGNLEQWLHGDMI 244
Query: 279 NQGNLTWEARMKVIIGTAKALAYLHEAIEPKVVHRDIKSSNILIDDEFNAKVSDFGLAKL 338
++G+LTWEAR+KV++GTAKALAYLHEAIEPKVVHRDIKSSNIL+DD F+AK+SDFGLAKL
Sbjct: 245 HKGHLTWEARIKVLVGTAKALAYLHEAIEPKVVHRDIKSSNILMDDNFDAKLSDFGLAKL 304
Query: 339 LDSGESHITTRVMGTFGYVAPEYANTGMLNEKSDIYSFGVLLLEAVTGRDPVDYGRPANE 398
L + ++++TRVMGTFGYVAPEYAN+G+LNEKSD+YS+GV+LLEA+TGR PVDY RP E
Sbjct: 305 LGADSNYVSTRVMGTFGYVAPEYANSGLLNEKSDVYSYGVVLLEAITGRYPVDYARPKEE 364
Query: 399 VNLVEWLKMMVGTRRAEEVVDPNLEVKPATRALKRSLLVALRCVDPDSEKRPKMSQVVRM 458
V++VEWLK+MV ++ EEVVD LE+KP T LKR+LL ALRCVDPD++KRPKMSQV RM
Sbjct: 365 VHMVEWLKLMVQQKQFEEVVDKELEIKPTTSELKRALLTALRCVDPDADKRPKMSQVARM 424
Query: 459 LEADDYPF--REDRRNRKSRTTSMEIESLKESTE 490
LE+D+YP RE+RR R+++ E+ +EST+
Sbjct: 425 LESDEYPVMPREERRRRRNQNA----ETHRESTD 454
|
|
| TAIR|locus:2025396 AT1G01540 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1190 (424.0 bits), Expect = 1.1e-135, Sum P(2) = 1.1e-135
Identities = 216/310 (69%), Positives = 262/310 (84%)
Query: 165 PEISHLGWGHWFTLRDLEIATNRFSAENVLGEGGYGVVYKGRLINGSEVAVKKLLNNLGQ 224
PE+SHLGWG W+TLR+LE ATN ENV+GEGGYG+VY+G L +G++VAVK LLNN GQ
Sbjct: 131 PEVSHLGWGRWYTLRELEAATNGLCEENVIGEGGYGIVYRGILTDGTKVAVKNLLNNRGQ 190
Query: 225 AEKEFRVEVEAIGHVRHKNLVRLLGYCIEGVHRMLVYEYVNNGNLEQWLHGAMRNQGNLT 284
AEKEF+VEVE IG VRHKNLVRLLGYC+EG +RMLVY++V+NGNLEQW+HG + + LT
Sbjct: 191 AEKEFKVEVEVIGRVRHKNLVRLLGYCVEGAYRMLVYDFVDNGNLEQWIHGDVGDVSPLT 250
Query: 285 WEARMKVIIGTAKALAYLHEAIEPKVVHRDIKSSNILIDDEFNAKVSDFGLAKLLDSGES 344
W+ RM +I+G AK LAYLHE +EPKVVHRDIKSSNIL+D ++NAKVSDFGLAKLL S S
Sbjct: 251 WDIRMNIILGMAKGLAYLHEGLEPKVVHRDIKSSNILLDRQWNAKVSDFGLAKLLGSESS 310
Query: 345 HITTRVMGTFGYVAPEYANTGMLNEKSDIYSFGVLLLEAVTGRDPVDYGRPANEVNLVEW 404
++TTRVMGTFGYVAPEYA TGMLNEKSDIYSFG+L++E +TGR+PVDY RP E NLV+W
Sbjct: 311 YVTTRVMGTFGYVAPEYACTGMLNEKSDIYSFGILIMEIITGRNPVDYSRPQGETNLVDW 370
Query: 405 LKMMVGTRRAEEVVDPNLEVKPATRALKRSLLVALRCVDPDSEKRPKMSQVVRMLEADDY 464
LK MVG RR+EEVVDP + P+++ALKR LLVALRCVDPD+ KRPKM ++ MLEA+D
Sbjct: 371 LKSMVGNRRSEEVVDPKIPEPPSSKALKRVLLVALRCVDPDANKRPKMGHIIHMLEAEDL 430
Query: 465 PFREDRRNRK 474
+R++RR +
Sbjct: 431 LYRDERRTTR 440
|
|
| TAIR|locus:2132353 AT4G02630 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1178 (419.7 bits), Expect = 1.1e-135, Sum P(2) = 1.1e-135
Identities = 220/338 (65%), Positives = 272/338 (80%)
Query: 165 PEISHLGWGHWFTLRDLEIATNRFSAENVLGEGGYGVVYKGRLINGSEVAVKKLLNNLGQ 224
PE+SHLGWGHW+TLR+LE++TN F+ ENV+G+GGYG+VY+G L + S VA+K LLNN GQ
Sbjct: 139 PEVSHLGWGHWYTLRELEVSTNGFADENVIGQGGYGIVYRGVLEDKSMVAIKNLLNNRGQ 198
Query: 225 AEKEFRVEVEAIGHVRHKNLVRLLGYCIEGVHRMLVYEYVNNGNLEQWLHGA-MRNQGNL 283
AEKEF+VEVEAIG VRHKNLVRLLGYC+EG HRMLVYEYV+NGNLEQW+HG + + L
Sbjct: 199 AEKEFKVEVEAIGRVRHKNLVRLLGYCVEGAHRMLVYEYVDNGNLEQWIHGGGLGFKSPL 258
Query: 284 TWEARMKVIIGTAKALAYLHEAIEPKVVHRDIKSSNILIDDEFNAKVSDFGLAKLLDSGE 343
TWE RM +++GTAK L YLHE +EPKVVHRDIKSSNIL+D ++N+KVSDFGLAKLL S
Sbjct: 259 TWEIRMNIVLGTAKGLMYLHEGLEPKVVHRDIKSSNILLDKQWNSKVSDFGLAKLLGSEM 318
Query: 344 SHITTRVMGTFGYVAPEYANTGMLNEKSDIYSFGVLLLEAVTGRDPVDYGRPANEVNLVE 403
S++TTRVMGTFGYVAPEYA+TGMLNE+SD+YSFGVL++E ++GR PVDY R EVNLVE
Sbjct: 319 SYVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGVLVMEIISGRSPVDYSRAPGEVNLVE 378
Query: 404 WLKMMVGTRRAEEVVDPNLEVKPATRALKRSLLVALRCVDPDSEKRPKMSQVVRMLEADD 463
WLK +V R AE V+DP + KP+ R+LKR+LLVALRCVDP+++KRPKM ++ MLEA+D
Sbjct: 379 WLKRLVTNRDAEGVLDPRMVDKPSLRSLKRTLLVALRCVDPNAQKRPKMGHIIHMLEAED 438
Query: 464 YPFREDRRNRKSRTTSMEI-ESLKESTEIESKVEDSEG 500
++DRRN +E S + T + ED G
Sbjct: 439 LVSKDDRRNSGGGGGGIEQGRSPRRKTNVNES-EDESG 475
|
|
| TAIR|locus:2139559 AT4G34500 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1127 (401.8 bits), Expect = 1.5e-121, Sum P(2) = 1.5e-121
Identities = 211/324 (65%), Positives = 258/324 (79%)
Query: 156 VTASPLIGLPEISHLGWGHWFTLRDLEIATNRFSAENVLGEGGYGVVYKGRLINGSEVAV 215
V +S +G E +GWG W++L+DLEIAT FS +N++GEGGYGVVY+ +GS AV
Sbjct: 115 VASSGDVGTSEA--MGWGKWYSLKDLEIATRGFSDDNMIGEGGYGVVYRADFSDGSVAAV 172
Query: 216 KKLLNNLGQAEKEFRVEVEAIGHVRHKNLVRLLGYCIEGVH--RMLVYEYVNNGNLEQWL 273
K LLNN GQAEKEF+VEVEAIG VRHKNLV L+GYC + RMLVYEY++NGNLEQWL
Sbjct: 173 KNLLNNKGQAEKEFKVEVEAIGKVRHKNLVGLMGYCADSAQSQRMLVYEYIDNGNLEQWL 232
Query: 274 HGAMRNQGNLTWEARMKVIIGTAKALAYLHEAIEPKVVHRDIKSSNILIDDEFNAKVSDF 333
HG + LTW+ RMK+ IGTAK LAYLHE +EPKVVHRD+KSSNIL+D ++NAKVSDF
Sbjct: 233 HGDVGPVSPLTWDIRMKIAIGTAKGLAYLHEGLEPKVVHRDVKSSNILLDKKWNAKVSDF 292
Query: 334 GLAKLLDSGESHITTRVMGTFGYVAPEYANTGMLNEKSDIYSFGVLLLEAVTGRDPVDYG 393
GLAKLL S S++TTRVMGTFGYV+PEYA+TGMLNE SD+YSFGVLL+E +TGR PVDY
Sbjct: 293 GLAKLLGSETSYVTTRVMGTFGYVSPEYASTGMLNECSDVYSFGVLLMEIITGRSPVDYS 352
Query: 394 RPANEVNLVEWLKMMVGTRRAEEVVDPNLEVKPATRALKRSLLVALRCVDPDSEKRPKMS 453
RP E+NLV+W K MV +RR EEV+DP ++ P RALKR+LLV LRC+D DS KRPKM
Sbjct: 353 RPPGEMNLVDWFKGMVASRRGEEVIDPKIKTSPPPRALKRALLVCLRCIDLDSSKRPKMG 412
Query: 454 QVVRMLEADDYPFREDRRNRKSRT 477
Q++ MLEA+D+PFR + R+ + R+
Sbjct: 413 QIIHMLEAEDFPFRPEHRSNQERS 436
|
|
| TAIR|locus:2028911 PERK12 "proline-rich extensin-like receptor kinase 12" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 764 (274.0 bits), Expect = 1.9e-81, Sum P(2) = 1.9e-81
Identities = 151/305 (49%), Positives = 208/305 (68%)
Query: 163 GLPEISHLGWGHW-FTLRDLEIATNRFSAENVLGEGGYGVVYKGRLINGSEVAVKKLLNN 221
G P+ + LG G F+ +L T F+ +N+LGEGG+G VYKG L +G VAVK+L
Sbjct: 345 GTPDSAILGSGQTHFSYEELAEITQGFARKNILGEGGFGCVYKGTLQDGKVVAVKQLKAG 404
Query: 222 LGQAEKEFRVEVEAIGHVRHKNLVRLLGYCIEGVHRMLVYEYVNNGNLEQWLHGAMRNQG 281
GQ ++EF+ EVE I V H++LV L+GYCI HR+L+YEYV+N LE LHG +
Sbjct: 405 SGQGDREFKAEVEIISRVHHRHLVSLVGYCISDQHRLLIYEYVSNQTLEHHLHG--KGLP 462
Query: 282 NLTWEARMKVIIGTAKALAYLHEAIEPKVVHRDIKSSNILIDDEFNAKVSDFGLAKLLDS 341
L W R+++ IG+AK LAYLHE PK++HRDIKS+NIL+DDE+ A+V+DFGLA+L D+
Sbjct: 463 VLEWSKRVRIAIGSAKGLAYLHEDCHPKIIHRDIKSANILLDDEYEAQVADFGLARLNDT 522
Query: 342 GESHITTRVMGTFGYVAPEYANTGMLNEKSDIYSFGVLLLEAVTGRDPVDYGRPANEVNL 401
++H++TRVMGTFGY+APEYA++G L ++SD++SFGV+LLE VTGR PVD +P E +L
Sbjct: 523 TQTHVSTRVMGTFGYLAPEYASSGKLTDRSDVFSFGVVLLELVTGRKPVDQTQPLGEESL 582
Query: 402 VEWLKMM----VGTRRAEEVVDPNLEVKPATRALKRSLLVALRCVDPDSEKRPKMSQVVR 457
VEW + + + T E++D LE + + R + A CV KRP+M QVVR
Sbjct: 583 VEWARPLLLKAIETGDLSELIDTRLEKRYVEHEVFRMIETAAACVRHSGPKRPRMVQVVR 642
Query: 458 MLEAD 462
L+ D
Sbjct: 643 ALDCD 647
|
|
Prediction of Enzyme Commission (EC) Number
EC Number Prediction by Annotation Transfer from SWISS-PROT Entries
Original result of BLAST against SWISS-PROT
| ID | Name | Annotated EC number | Identity | Query coverage | Hit coverage | RBH(Q2H) | RBH(H2Q) |
| Q9SJG2 | Y2296_ARATH | 2, ., 7, ., 1, 1, ., 1 | 0.7667 | 0.9448 | 0.9716 | no | no |
EC Number Prediction by Ezypred Server
Original result from Ezypred Server
Fail to connect to Ezypred Server
EC Number Prediction by EFICAz Software
| Prediction Level | EC number | Confidence of Prediction |
| 4th Layer | 2.7.11.1 | LOW CONFIDENCE prediction! |
| 3rd Layer | 2.7.11 | 0.766 |
Prediction of Functionally Associated Proteins
Functionally Associated Proteins Detected by STRING
Original result from the STRING server
| Your Input: |  |
 |
 |
 |
 |
 |
 |
 |
 |
||
 | estExt_fgenesh4_pm.C_LG_II0279 | hypothetical protein (508 aa) | |||||||||
(Populus trichocarpa) | |||||||||||
Predicted Functional Partners: | |||||||||||
| Sorry, there are no predicted associations at the current settings. | |||||||||||
Conserved Domains and Related Protein Families
Conserved Domains Detected by RPS-BLAST
Original result of RPS-BLAST against CDD database part I
| ID | Alignment Graph | Length |
Definition |
E-value |
| Query | 508 | |||
| cd00180 | 215 | cd00180, PKc, Catalytic domain of Protein Kinases | 6e-55 | |
| smart00219 | 257 | smart00219, TyrKc, Tyrosine kinase, catalytic doma | 1e-52 | |
| smart00221 | 258 | smart00221, STYKc, Protein kinase; unclassified sp | 2e-51 | |
| smart00220 | 254 | smart00220, S_TKc, Serine/Threonine protein kinase | 4e-50 | |
| cd00192 | 262 | cd00192, PTKc, Catalytic domain of Protein Tyrosin | 6e-50 | |
| pfam07714 | 258 | pfam07714, Pkinase_Tyr, Protein tyrosine kinase | 9e-50 | |
| pfam00069 | 260 | pfam00069, Pkinase, Protein kinase domain | 2e-47 | |
| cd06606 | 260 | cd06606, STKc_MAPKKK, Catalytic domain of the Prot | 1e-37 | |
| cd05122 | 253 | cd05122, PKc_STE, Catalytic domain of STE family P | 4e-36 | |
| cd08215 | 258 | cd08215, STKc_Nek, Catalytic domain of the Protein | 1e-35 | |
| cd05039 | 256 | cd05039, PTKc_Csk_like, Catalytic domain of C-term | 1e-33 | |
| cd06627 | 254 | cd06627, STKc_Cdc7_like, Catalytic domain of Cell | 4e-32 | |
| COG0515 | 384 | COG0515, SPS1, Serine/threonine protein kinase [Ge | 3e-31 | |
| cd08529 | 256 | cd08529, STKc_FA2-like, Catalytic domain of the Pr | 9e-31 | |
| cd05057 | 279 | cd05057, PTKc_EGFR_like, Catalytic domain of Epide | 6e-30 | |
| cd05148 | 261 | cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro | 8e-30 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 3e-29 | |
| cd05034 | 261 | cd05034, PTKc_Src_like, Catalytic domain of Src ki | 7e-29 | |
| cd05033 | 266 | cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec | 5e-28 | |
| cd05060 | 257 | cd05060, PTKc_Syk_like, Catalytic domain of Spleen | 1e-27 | |
| cd06623 | 264 | cd06623, PKc_MAPKK_plant_like, Catalytic domain of | 1e-27 | |
| cd06624 | 268 | cd06624, STKc_ASK, Catalytic domain of the Protein | 3e-27 | |
| cd08217 | 265 | cd08217, STKc_Nek2, Catalytic domain of the Protei | 4e-27 | |
| cd05038 | 284 | cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai | 6e-27 | |
| cd05041 | 251 | cd05041, PTKc_Fes_like, Catalytic domain of Fes-li | 2e-26 | |
| cd05581 | 280 | cd05581, STKc_PDK1, Catalytic domain of the Protei | 3e-25 | |
| cd05068 | 261 | cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re | 4e-25 | |
| cd05048 | 283 | cd05048, PTKc_Ror, Catalytic Domain of the Protein | 4e-25 | |
| cd08530 | 256 | cd08530, STKc_CNK2-like, Catalytic domain of the P | 4e-25 | |
| cd05123 | 250 | cd05123, STKc_AGC, Catalytic domain of AGC family | 8e-25 | |
| cd05112 | 256 | cd05112, PTKc_Itk, Catalytic domain of the Protein | 2e-24 | |
| cd08221 | 256 | cd08221, STKc_Nek9, Catalytic domain of the Protei | 2e-24 | |
| cd05049 | 280 | cd05049, PTKc_Trk, Catalytic domain of the Protein | 3e-24 | |
| cd05063 | 268 | cd05063, PTKc_EphR_A2, Catalytic domain of the Pro | 3e-24 | |
| cd05059 | 256 | cd05059, PTKc_Tec_like, Catalytic domain of Tec-li | 5e-24 | |
| cd07840 | 287 | cd07840, STKc_CDK9_like, Catalytic domain of Cycli | 9e-24 | |
| cd06612 | 256 | cd06612, STKc_MST1_2, Catalytic domain of the Prot | 2e-23 | |
| cd06610 | 267 | cd06610, STKc_OSR1_SPAK, Catalytic domain of the P | 2e-23 | |
| cd06631 | 265 | cd06631, STKc_YSK4, Catalytic domain of the Protei | 2e-23 | |
| cd07833 | 288 | cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep | 3e-23 | |
| cd06626 | 264 | cd06626, STKc_MEKK4, Catalytic domain of the Prote | 5e-23 | |
| cd06614 | 286 | cd06614, STKc_PAK, Catalytic domain of the Protein | 5e-23 | |
| cd05085 | 250 | cd05085, PTKc_Fer, Catalytic domain of the Protein | 6e-23 | |
| cd05032 | 277 | cd05032, PTKc_InsR_like, Catalytic domain of Insul | 7e-23 | |
| cd06621 | 287 | cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of | 8e-23 | |
| cd05083 | 254 | cd05083, PTKc_Chk, Catalytic domain of the Protein | 8e-23 | |
| cd05036 | 277 | cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro | 9e-23 | |
| cd05118 | 283 | cd05118, STKc_CMGC, Catalytic domain of CMGC famil | 2e-22 | |
| cd07834 | 330 | cd07834, STKc_MAPK, Catalytic domain of the Serine | 2e-22 | |
| cd05065 | 269 | cd05065, PTKc_EphR_B, Catalytic domain of the Prot | 3e-22 | |
| cd05046 | 275 | cd05046, PTK_CCK4, Pseudokinase domain of the Prot | 4e-22 | |
| cd06605 | 265 | cd06605, PKc_MAPKK, Catalytic domain of the dual-s | 4e-22 | |
| cd05066 | 267 | cd05066, PTKc_EphR_A, Catalytic domain of the Prot | 5e-22 | |
| cd05067 | 260 | cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro | 6e-22 | |
| cd06630 | 268 | cd06630, STKc_MEKK1, Catalytic domain of the Prote | 7e-22 | |
| cd06628 | 267 | cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o | 9e-22 | |
| cd06613 | 262 | cd06613, STKc_MAP4K3_like, Catalytic domain of Mit | 1e-21 | |
| cd07829 | 282 | cd07829, STKc_CDK_like, Catalytic domain of Cyclin | 1e-21 | |
| cd07832 | 286 | cd07832, STKc_CCRK, Catalytic domain of the Serine | 1e-21 | |
| cd05058 | 262 | cd05058, PTKc_Met_Ron, Catalytic domain of the Pro | 1e-21 | |
| cd07845 | 309 | cd07845, STKc_CDK10, Catalytic domain of the Serin | 2e-21 | |
| cd06608 | 275 | cd06608, STKc_myosinIII_like, Catalytic domain of | 2e-21 | |
| cd06632 | 258 | cd06632, STKc_MEKK1_plant, Catalytic domain of the | 3e-21 | |
| cd08224 | 267 | cd08224, STKc_Nek6_Nek7, Catalytic domain of the P | 3e-21 | |
| cd05071 | 262 | cd05071, PTKc_Src, Catalytic domain of the Protein | 3e-21 | |
| cd08220 | 256 | cd08220, STKc_Nek8, Catalytic domain of the Protei | 9e-21 | |
| cd06917 | 277 | cd06917, STKc_NAK1_like, Catalytic domain of Funga | 1e-20 | |
| cd05052 | 263 | cd05052, PTKc_Abl, Catalytic domain of the Protein | 1e-20 | |
| cd05040 | 257 | cd05040, PTKc_Ack_like, Catalytic domain of the Pr | 2e-20 | |
| cd05053 | 293 | cd05053, PTKc_FGFR, Catalytic domain of the Protei | 2e-20 | |
| cd08528 | 269 | cd08528, STKc_Nek10, Catalytic domain of the Prote | 2e-20 | |
| cd06616 | 288 | cd06616, PKc_MKK4, Catalytic domain of the dual-sp | 2e-20 | |
| cd08229 | 267 | cd08229, STKc_Nek7, Catalytic domain of the Protei | 4e-20 | |
| cd05082 | 256 | cd05082, PTKc_Csk, Catalytic domain of the Protein | 6e-20 | |
| cd05110 | 303 | cd05110, PTKc_HER4, Catalytic domain of the Protei | 7e-20 | |
| cd05070 | 260 | cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro | 9e-20 | |
| cd06609 | 274 | cd06609, STKc_MST3_like, Catalytic domain of Mamma | 9e-20 | |
| cd05084 | 252 | cd05084, PTKc_Fes, Catalytic domain of the Protein | 9e-20 | |
| cd05092 | 280 | cd05092, PTKc_TrkA, Catalytic domain of the Protei | 1e-19 | |
| cd05081 | 284 | cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) | 1e-19 | |
| cd05094 | 291 | cd05094, PTKc_TrkC, Catalytic domain of the Protei | 2e-19 | |
| cd05114 | 256 | cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro | 2e-19 | |
| cd06625 | 263 | cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ | 3e-19 | |
| cd07852 | 337 | cd07852, STKc_MAPK15, Catalytic domain of the Seri | 3e-19 | |
| cd05093 | 288 | cd05093, PTKc_TrkB, Catalytic domain of the Protei | 3e-19 | |
| PLN00034 | 353 | PLN00034, PLN00034, mitogen-activated protein kina | 3e-19 | |
| cd05056 | 270 | cd05056, PTKc_FAK, Catalytic domain of the Protein | 3e-19 | |
| cd05088 | 303 | cd05088, PTKc_Tie2, Catalytic domain of the Protei | 8e-19 | |
| cd06611 | 280 | cd06611, STKc_SLK_like, Catalytic domain of Ste20- | 8e-19 | |
| cd05072 | 261 | cd05072, PTKc_Lyn, Catalytic domain of the Protein | 9e-19 | |
| cd05044 | 269 | cd05044, PTKc_c-ros, Catalytic domain of the Prote | 1e-18 | |
| cd07830 | 283 | cd07830, STKc_MAK_like, Catalytic domain of Male g | 2e-18 | |
| cd08228 | 267 | cd08228, STKc_Nek6, Catalytic domain of the Protei | 2e-18 | |
| cd07849 | 336 | cd07849, STKc_ERK1_2_like, Catalytic domain of Ext | 2e-18 | |
| cd05116 | 257 | cd05116, PTKc_Syk, Catalytic domain of the Protein | 2e-18 | |
| cd05111 | 279 | cd05111, PTK_HER3, Pseudokinase domain of the Prot | 4e-18 | |
| cd05035 | 273 | cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li | 4e-18 | |
| cd05113 | 256 | cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro | 4e-18 | |
| cd05579 | 265 | cd05579, STKc_MAST_like, Catalytic domain of Micro | 6e-18 | |
| cd05109 | 279 | cd05109, PTKc_HER2, Catalytic domain of the Protei | 6e-18 | |
| cd06629 | 272 | cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o | 7e-18 | |
| cd06655 | 296 | cd06655, STKc_PAK2, Catalytic domain of the Protei | 7e-18 | |
| cd05042 | 269 | cd05042, PTKc_Aatyk, Catalytic domain of the Prote | 7e-18 | |
| cd07856 | 328 | cd07856, STKc_Sty1_Hog1, Catalytic domain of the S | 9e-18 | |
| cd05045 | 290 | cd05045, PTKc_RET, Catalytic domain of the Protein | 9e-18 | |
| cd05069 | 260 | cd05069, PTKc_Yes, Catalytic domain of the Protein | 1e-17 | |
| cd07841 | 298 | cd07841, STKc_CDK7, Catalytic domain of the Serine | 1e-17 | |
| TIGR03903 | 1266 | TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas | 1e-17 | |
| cd05115 | 257 | cd05115, PTKc_Zap-70, Catalytic domain of the Prot | 1e-17 | |
| cd06654 | 296 | cd06654, STKc_PAK1, Catalytic domain of the Protei | 1e-17 | |
| cd05043 | 280 | cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece | 2e-17 | |
| cd05108 | 316 | cd05108, PTKc_EGFR, Catalytic domain of the Protei | 2e-17 | |
| cd05090 | 283 | cd05090, PTKc_Ror1, Catalytic domain of the Protei | 2e-17 | |
| cd05080 | 283 | cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma | 3e-17 | |
| cd06656 | 297 | cd06656, STKc_PAK3, Catalytic domain of the Protei | 4e-17 | |
| cd05055 | 302 | cd05055, PTKc_PDGFR, Catalytic domain of the Prote | 7e-17 | |
| cd07838 | 287 | cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc | 7e-17 | |
| cd05079 | 284 | cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma | 9e-17 | |
| cd05583 | 288 | cd05583, STKc_MSK_N, N-terminal catalytic domain o | 9e-17 | |
| cd07847 | 286 | cd07847, STKc_CDKL1_4, Catalytic domain of the Ser | 1e-16 | |
| cd06647 | 293 | cd06647, STKc_PAK_I, Catalytic domain of the Prote | 1e-16 | |
| cd06648 | 285 | cd06648, STKc_PAK_II, Catalytic domain of the Prot | 1e-16 | |
| cd05089 | 297 | cd05089, PTKc_Tie1, Catalytic domain of the Protei | 1e-16 | |
| cd07835 | 283 | cd07835, STKc_CDK1_like, Catalytic domain of Cycli | 1e-16 | |
| cd05572 | 262 | cd05572, STKc_cGK_PKG, Catalytic domain of the Pro | 2e-16 | |
| cd07859 | 338 | cd07859, STKc_TDY_MAPK_plant, Catalytic domain of | 2e-16 | |
| cd06617 | 283 | cd06617, PKc_MKK3_6, Catalytic domain of the dual- | 3e-16 | |
| cd07846 | 286 | cd07846, STKc_CDKL2_3, Catalytic domain of the Ser | 4e-16 | |
| cd05097 | 295 | cd05097, PTKc_DDR_like, Catalytic domain of Discoi | 4e-16 | |
| cd07864 | 302 | cd07864, STKc_CDK12, Catalytic domain of the Serin | 5e-16 | |
| cd05073 | 260 | cd05073, PTKc_Hck, Catalytic domain of the Protein | 5e-16 | |
| cd06620 | 284 | cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of | 5e-16 | |
| cd05101 | 304 | cd05101, PTKc_FGFR2, Catalytic domain of the Prote | 6e-16 | |
| cd05051 | 296 | cd05051, PTKc_DDR, Catalytic domain of the Protein | 6e-16 | |
| cd06637 | 272 | cd06637, STKc_TNIK, Catalytic domain of the Protei | 7e-16 | |
| cd05096 | 304 | cd05096, PTKc_DDR1, Catalytic domain of the Protei | 8e-16 | |
| cd08225 | 257 | cd08225, STKc_Nek5, Catalytic domain of the Protei | 9e-16 | |
| cd05050 | 288 | cd05050, PTKc_Musk, Catalytic domain of the Protei | 9e-16 | |
| cd06640 | 277 | cd06640, STKc_MST4, Catalytic domain of the Protei | 9e-16 | |
| cd05100 | 334 | cd05100, PTKc_FGFR3, Catalytic domain of the Prote | 9e-16 | |
| cd05580 | 290 | cd05580, STKc_PKA, Catalytic domain of the Protein | 1e-15 | |
| cd06636 | 282 | cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr | 1e-15 | |
| cd08218 | 256 | cd08218, STKc_Nek1, Catalytic domain of the Protei | 3e-15 | |
| cd07866 | 311 | cd07866, STKc_BUR1, Catalytic domain of the Serine | 3e-15 | |
| cd07860 | 284 | cd07860, STKc_CDK2_3, Catalytic domain of the Seri | 3e-15 | |
| cd06618 | 296 | cd06618, PKc_MKK7, Catalytic domain of the dual-sp | 3e-15 | |
| cd06642 | 277 | cd06642, STKc_STK25-YSK1, Catalytic domain of the | 4e-15 | |
| cd05064 | 266 | cd05064, PTKc_EphR_A10, Catalytic domain of the Pr | 5e-15 | |
| cd05098 | 307 | cd05098, PTKc_FGFR1, Catalytic domain of the Prote | 5e-15 | |
| cd05577 | 277 | cd05577, STKc_GRK, Catalytic domain of the Protein | 6e-15 | |
| cd05614 | 332 | cd05614, STKc_MSK2_N, N-terminal catalytic domain | 6e-15 | |
| cd05578 | 258 | cd05578, STKc_Yank1, Catalytic domain of the Prote | 6e-15 | |
| cd07836 | 284 | cd07836, STKc_Pho85, Catalytic domain of the Serin | 7e-15 | |
| cd05613 | 290 | cd05613, STKc_MSK1_N, N-terminal catalytic domain | 7e-15 | |
| cd05061 | 288 | cd05061, PTKc_InsR, Catalytic domain of the Protei | 8e-15 | |
| cd05075 | 272 | cd05075, PTKc_Axl, Catalytic domain of the Protein | 8e-15 | |
| cd05091 | 283 | cd05091, PTKc_Ror2, Catalytic domain of the Protei | 1e-14 | |
| cd05062 | 277 | cd05062, PTKc_IGF-1R, Catalytic domain of the Prot | 1e-14 | |
| cd05600 | 333 | cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun | 1e-14 | |
| cd07858 | 337 | cd07858, STKc_TEY_MAPK_plant, Catalytic domain of | 1e-14 | |
| cd08219 | 255 | cd08219, STKc_Nek3, Catalytic domain of the Protei | 1e-14 | |
| cd05047 | 270 | cd05047, PTKc_Tie, Catalytic domain of Tie Protein | 2e-14 | |
| cd06650 | 333 | cd06650, PKc_MEK1, Catalytic domain of the dual-sp | 2e-14 | |
| cd05099 | 314 | cd05099, PTKc_FGFR4, Catalytic domain of the Prote | 2e-14 | |
| cd06649 | 331 | cd06649, PKc_MEK2, Catalytic domain of the dual-sp | 3e-14 | |
| cd06659 | 297 | cd06659, STKc_PAK6, Catalytic domain of the Protei | 3e-14 | |
| cd05095 | 296 | cd05095, PTKc_DDR2, Catalytic domain of the Protei | 5e-14 | |
| cd07851 | 343 | cd07851, STKc_p38, Catalytic domain of the Serine/ | 5e-14 | |
| cd07871 | 288 | cd07871, STKc_PCTAIRE3, Catalytic domain of the Se | 7e-14 | |
| cd06658 | 292 | cd06658, STKc_PAK5, Catalytic domain of the Protei | 7e-14 | |
| cd07855 | 334 | cd07855, STKc_ERK5, Catalytic domain of the Serine | 8e-14 | |
| cd06651 | 266 | cd06651, STKc_MEKK3, Catalytic domain of the Prote | 1e-13 | |
| cd06607 | 307 | cd06607, STKc_TAO, Catalytic domain of the Protein | 1e-13 | |
| cd06652 | 265 | cd06652, STKc_MEKK2, Catalytic domain of the Prote | 1e-13 | |
| cd06646 | 267 | cd06646, STKc_MAP4K5, Catalytic domain of the Prot | 1e-13 | |
| cd06657 | 292 | cd06657, STKc_PAK4, Catalytic domain of the Protei | 2e-13 | |
| cd05632 | 285 | cd05632, STKc_GRK5, Catalytic domain of the Protei | 2e-13 | |
| cd06615 | 308 | cd06615, PKc_MEK, Catalytic domain of the dual-spe | 2e-13 | |
| PTZ00283 | 496 | PTZ00283, PTZ00283, serine/threonine protein kinas | 3e-13 | |
| cd05631 | 285 | cd05631, STKc_GRK4, Catalytic domain of the Protei | 3e-13 | |
| cd05570 | 318 | cd05570, STKc_PKC, Catalytic domain of the Protein | 4e-13 | |
| cd05582 | 318 | cd05582, STKc_RSK_N, N-terminal catalytic domain o | 4e-13 | |
| cd05589 | 324 | cd05589, STKc_PKN, Catalytic domain of the Protein | 4e-13 | |
| cd05618 | 329 | cd05618, STKc_aPKC_iota, Catalytic domain of the P | 4e-13 | |
| cd07848 | 287 | cd07848, STKc_CDKL5, Catalytic domain of the Serin | 5e-13 | |
| cd06644 | 292 | cd06644, STKc_STK10_LOK, Catalytic domain of the P | 5e-13 | |
| cd06643 | 282 | cd06643, STKc_SLK, Catalytic domain of the Protein | 6e-13 | |
| cd06639 | 291 | cd06639, STKc_myosinIIIB, Catalytic domain of the | 6e-13 | |
| cd07877 | 345 | cd07877, STKc_p38alpha_MAPK14, Catalytic domain of | 7e-13 | |
| cd05611 | 260 | cd05611, STKc_Rim15_like, Catalytic domain of fung | 7e-13 | |
| cd05037 | 259 | cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) dom | 8e-13 | |
| cd05607 | 277 | cd05607, STKc_GRK7, Catalytic domain of the Protei | 8e-13 | |
| cd06645 | 267 | cd06645, STKc_MAP4K3, Catalytic domain of the Prot | 1e-12 | |
| PLN00009 | 294 | PLN00009, PLN00009, cyclin-dependent kinase A; Pro | 1e-12 | |
| cd05617 | 327 | cd05617, STKc_aPKC_zeta, Catalytic domain of the P | 1e-12 | |
| cd07853 | 372 | cd07853, STKc_NLK, Catalytic domain of the Serine/ | 1e-12 | |
| cd06653 | 264 | cd06653, STKc_MEKK3_like_1, Catalytic domain of MA | 2e-12 | |
| cd07861 | 285 | cd07861, STKc_CDK1_euk, Catalytic domain of the Se | 2e-12 | |
| cd07857 | 332 | cd07857, STKc_MPK1, Catalytic domain of the Serine | 2e-12 | |
| cd07873 | 301 | cd07873, STKc_PCTAIRE1, Catalytic domain of the Se | 2e-12 | |
| cd05592 | 316 | cd05592, STKc_nPKC_theta_delta, Catalytic domain o | 2e-12 | |
| cd05588 | 329 | cd05588, STKc_aPKC, Catalytic domain of the Protei | 3e-12 | |
| cd06641 | 277 | cd06641, STKc_MST3, Catalytic domain of the Protei | 3e-12 | |
| cd05590 | 320 | cd05590, STKc_nPKC_eta, Catalytic domain of the Pr | 3e-12 | |
| cd08223 | 257 | cd08223, STKc_Nek4, Catalytic domain of the Protei | 4e-12 | |
| cd06638 | 286 | cd06638, STKc_myosinIIIA, Catalytic domain of the | 5e-12 | |
| cd05605 | 285 | cd05605, STKc_GRK4_like, Catalytic domain of G pro | 5e-12 | |
| cd05608 | 280 | cd05608, STKc_GRK1, Catalytic domain of the Protei | 5e-12 | |
| cd07872 | 309 | cd07872, STKc_PCTAIRE2, Catalytic domain of the Se | 5e-12 | |
| cd05615 | 323 | cd05615, STKc_cPKC_alpha, Catalytic domain of the | 5e-12 | |
| cd07862 | 290 | cd07862, STKc_CDK6, Catalytic domain of the Serine | 1e-11 | |
| cd06634 | 308 | cd06634, STKc_TAO2, Catalytic domain of the Protei | 2e-11 | |
| cd05619 | 316 | cd05619, STKc_nPKC_theta, Catalytic domain of the | 2e-11 | |
| cd07869 | 303 | cd07869, STKc_PFTAIRE1, Catalytic domain of the Se | 2e-11 | |
| cd06619 | 279 | cd06619, PKc_MKK5, Catalytic domain of the dual-sp | 2e-11 | |
| cd06635 | 317 | cd06635, STKc_TAO1, Catalytic domain of the Protei | 2e-11 | |
| cd05612 | 291 | cd05612, STKc_PRKX_like, Catalytic domain of PRKX- | 2e-11 | |
| cd05086 | 268 | cd05086, PTKc_Aatyk2, Catalytic domain of the Prot | 2e-11 | |
| cd05630 | 285 | cd05630, STKc_GRK6, Catalytic domain of the Protei | 2e-11 | |
| cd07839 | 284 | cd07839, STKc_CDK5, Catalytic domain of the Serine | 2e-11 | |
| PTZ00024 | 335 | PTZ00024, PTZ00024, cyclin-dependent protein kinas | 2e-11 | |
| cd06622 | 286 | cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of | 3e-11 | |
| cd05591 | 321 | cd05591, STKc_nPKC_epsilon, Catalytic domain of th | 4e-11 | |
| cd05078 | 258 | cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat | 4e-11 | |
| cd05604 | 325 | cd05604, STKc_SGK3, Catalytic domain of the Protei | 5e-11 | |
| cd05087 | 269 | cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t | 7e-11 | |
| cd07876 | 359 | cd07876, STKc_JNK2, Catalytic domain of the Serine | 8e-11 | |
| cd07844 | 291 | cd07844, STKc_PCTAIRE_like, Catalytic domain of PC | 8e-11 | |
| cd05616 | 323 | cd05616, STKc_cPKC_beta, Catalytic domain of the P | 9e-11 | |
| cd05054 | 337 | cd05054, PTKc_VEGFR, Catalytic domain of the Prote | 9e-11 | |
| cd07879 | 342 | cd07879, STKc_p38delta_MAPK13, Catalytic domain of | 9e-11 | |
| cd07865 | 310 | cd07865, STKc_CDK9, Catalytic domain of the Serine | 1e-10 | |
| cd07878 | 343 | cd07878, STKc_p38beta_MAPK11, Catalytic domain of | 1e-10 | |
| PTZ00036 | 440 | PTZ00036, PTZ00036, glycogen synthase kinase; Prov | 2e-10 | |
| cd05571 | 323 | cd05571, STKc_PKB, Catalytic domain of the Protein | 2e-10 | |
| cd07880 | 343 | cd07880, STKc_p38gamma_MAPK12, Catalytic domain of | 2e-10 | |
| cd05587 | 324 | cd05587, STKc_cPKC, Catalytic domain of the Protei | 3e-10 | |
| cd07837 | 295 | cd07837, STKc_CdkB_plant, Catalytic domain of the | 3e-10 | |
| cd07874 | 355 | cd07874, STKc_JNK3, Catalytic domain of the Serine | 3e-10 | |
| cd05633 | 279 | cd05633, STKc_GRK3, Catalytic domain of the Protei | 4e-10 | |
| cd05603 | 321 | cd05603, STKc_SGK2, Catalytic domain of the Protei | 4e-10 | |
| cd05606 | 278 | cd05606, STKc_beta_ARK, Catalytic domain of the Pr | 5e-10 | |
| cd07843 | 293 | cd07843, STKc_CDC2L1, Catalytic domain of the Seri | 5e-10 | |
| cd05602 | 325 | cd05602, STKc_SGK1, Catalytic domain of the Protei | 6e-10 | |
| cd05584 | 323 | cd05584, STKc_p70S6K, Catalytic domain of the Prot | 7e-10 | |
| cd07850 | 353 | cd07850, STKc_JNK, Catalytic domain of the Serine/ | 8e-10 | |
| PHA02988 | 283 | PHA02988, PHA02988, hypothetical protein; Provisio | 8e-10 | |
| cd07863 | 288 | cd07863, STKc_CDK4, Catalytic domain of the Serine | 9e-10 | |
| PTZ00426 | 340 | PTZ00426, PTZ00426, cAMP-dependent protein kinase | 1e-09 | |
| PTZ00263 | 329 | PTZ00263, PTZ00263, protein kinase A catalytic sub | 1e-09 | |
| cd05575 | 323 | cd05575, STKc_SGK, Catalytic domain of the Protein | 1e-09 | |
| cd05074 | 273 | cd05074, PTKc_Tyro3, Catalytic domain of the Prote | 1e-09 | |
| cd07870 | 291 | cd07870, STKc_PFTAIRE2, Catalytic domain of the Se | 1e-09 | |
| cd06633 | 313 | cd06633, STKc_TAO3, Catalytic domain of the Protei | 2e-09 | |
| cd08222 | 260 | cd08222, STKc_Nek11, Catalytic domain of the Prote | 2e-09 | |
| cd07831 | 282 | cd07831, STKc_MOK, Catalytic domain of the Serine/ | 2e-09 | |
| cd05593 | 328 | cd05593, STKc_PKB_gamma, Catalytic domain of the P | 2e-09 | |
| cd07875 | 364 | cd07875, STKc_JNK1, Catalytic domain of the Serine | 2e-09 | |
| cd05620 | 316 | cd05620, STKc_nPKC_delta, Catalytic domain of the | 3e-09 | |
| cd07842 | 316 | cd07842, STKc_CDK8_like, Catalytic domain of Cycli | 3e-09 | |
| cd05621 | 370 | cd05621, STKc_ROCK2, Catalytic domain of the Prote | 4e-09 | |
| cd07854 | 342 | cd07854, STKc_MAPK4_6, Catalytic domain of the Ser | 5e-09 | |
| cd05609 | 305 | cd05609, STKc_MAST, Catalytic domain of the Protei | 5e-09 | |
| PTZ00266 | 1021 | PTZ00266, PTZ00266, NIMA-related protein kinase; P | 6e-09 | |
| cd05595 | 323 | cd05595, STKc_PKB_beta, Catalytic domain of the Pr | 6e-09 | |
| cd05601 | 330 | cd05601, STKc_CRIK, Catalytic domain of the Protei | 7e-09 | |
| cd05077 | 262 | cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) do | 8e-09 | |
| cd05585 | 312 | cd05585, STKc_YPK1_like, Catalytic domain of Yeast | 1e-08 | |
| cd05623 | 332 | cd05623, STKc_MRCK_alpha, Catalytic domain of the | 1e-08 | |
| PHA03209 | 357 | PHA03209, PHA03209, serine/threonine kinase US3; P | 2e-08 | |
| cd05586 | 330 | cd05586, STKc_Sck1_like, Catalytic domain of Suppr | 3e-08 | |
| cd05573 | 350 | cd05573, STKc_ROCK_NDR_like, Catalytic domain of R | 3e-08 | |
| PRK13184 | 932 | PRK13184, pknD, serine/threonine-protein kinase; R | 4e-08 | |
| cd05622 | 371 | cd05622, STKc_ROCK1, Catalytic domain of the Prote | 5e-08 | |
| cd05594 | 325 | cd05594, STKc_PKB_alpha, Catalytic domain of the P | 6e-08 | |
| cd05628 | 363 | cd05628, STKc_NDR1, Catalytic domain of the Protei | 7e-08 | |
| cd05599 | 364 | cd05599, STKc_NDR_like, Catalytic domain of Nuclea | 9e-08 | |
| cd05102 | 338 | cd05102, PTKc_VEGFR3, Catalytic domain of the Prot | 1e-07 | |
| cd05596 | 370 | cd05596, STKc_ROCK, Catalytic domain of the Protei | 2e-07 | |
| PHA03207 | 392 | PHA03207, PHA03207, serine/threonine kinase US3; P | 3e-07 | |
| cd05610 | 669 | cd05610, STKc_MASTL, Catalytic domain of the Prote | 4e-07 | |
| PTZ00267 | 478 | PTZ00267, PTZ00267, NIMA-related protein kinase; P | 4e-07 | |
| cd05576 | 237 | cd05576, STKc_RPK118_like, Catalytic domain of the | 5e-07 | |
| cd05107 | 401 | cd05107, PTKc_PDGFR_beta, Catalytic domain of the | 1e-06 | |
| PHA03212 | 391 | PHA03212, PHA03212, serine/threonine kinase US3; P | 1e-06 | |
| PHA03210 | 501 | PHA03210, PHA03210, serine/threonine kinase US3; P | 2e-06 | |
| cd05076 | 274 | cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) do | 2e-06 | |
| cd05627 | 360 | cd05627, STKc_NDR2, Catalytic domain of the Protei | 3e-06 | |
| cd05624 | 331 | cd05624, STKc_MRCK_beta, Catalytic domain of the P | 3e-06 | |
| cd05597 | 331 | cd05597, STKc_DMPK_like, Catalytic domain of Myoto | 3e-06 | |
| cd05103 | 343 | cd05103, PTKc_VEGFR2, Catalytic domain of the Prot | 5e-06 | |
| cd07867 | 317 | cd07867, STKc_CDC2L6, Catalytic domain of Serine/T | 1e-05 | |
| cd05104 | 375 | cd05104, PTKc_Kit, Catalytic domain of the Protein | 2e-05 | |
| cd08226 | 328 | cd08226, PK_STRAD_beta, Pseudokinase domain of STE | 2e-05 | |
| cd05106 | 374 | cd05106, PTKc_CSF-1R, Catalytic domain of the Prot | 2e-05 | |
| PTZ00284 | 467 | PTZ00284, PTZ00284, protein kinase; Provisional | 2e-05 | |
| cd05574 | 316 | cd05574, STKc_phototropin_like, Catalytic domain o | 3e-05 | |
| cd07868 | 317 | cd07868, STKc_CDK8, Catalytic domain of the Serine | 3e-05 | |
| PLN03225 | 566 | PLN03225, PLN03225, Serine/threonine-protein kinas | 8e-05 | |
| cd05598 | 376 | cd05598, STKc_LATS, Catalytic domain of the Protei | 9e-05 | |
| cd05105 | 400 | cd05105, PTKc_PDGFR_alpha, Catalytic domain of the | 2e-04 | |
| cd08216 | 314 | cd08216, PK_STRAD, Pseudokinase domain of STE20-re | 2e-04 | |
| PHA03390 | 267 | PHA03390, pk1, serine/threonine-protein kinase 1; | 4e-04 | |
| cd05625 | 382 | cd05625, STKc_LATS1, Catalytic domain of the Prote | 9e-04 | |
| cd05106 | 374 | cd05106, PTKc_CSF-1R, Catalytic domain of the Prot | 0.001 | |
| cd05629 | 377 | cd05629, STKc_NDR_like_fungal, Catalytic domain of | 0.001 | |
| cd05626 | 381 | cd05626, STKc_LATS2, Catalytic domain of the Prote | 0.002 | |
| PHA03211 | 461 | PHA03211, PHA03211, serine/threonine kinase US3; P | 0.002 | |
| cd08227 | 327 | cd08227, PK_STRAD_alpha, Pseudokinase domain of ST | 0.003 |
| >gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Score = 183 bits (466), Expect = 6e-55
Identities = 74/193 (38%), Positives = 110/193 (56%), Gaps = 11/193 (5%)
Query: 194 LGEGGYGVVYKGR-LINGSEVAVKKL-LNNLGQAEKEFRVEVEAIGHVRHKNLVRLLGYC 251
LGEGG+G VY R G +VA+K + + +E E+E + + H N+V+L G
Sbjct: 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVF 60
Query: 252 IEGVHRMLVYEYVNNGNLEQWLHGAMRNQGNLTWEARMKVIIGTAKALAYLHEAIEPKVV 311
+ H LV EY G+L+ L N+G L+ + +++++ + L YLH ++
Sbjct: 61 EDENHLYLVMEYCEGGSLKDLLK---ENEGKLSEDEILRILLQILEGLEYLHSN---GII 114
Query: 312 HRDIKSSNILID-DEFNAKVSDFGLAKLLDSGESHITTRVMGTFGYVAPE-YANTGMLNE 369
HRD+K NIL+D D K++DFGL+KLL S +S + T V GT Y+APE G +E
Sbjct: 115 HRDLKPENILLDSDNGKVKLADFGLSKLLTSDKSLLKTIV-GTPAYMAPEVLLGKGYYSE 173
Query: 370 KSDIYSFGVLLLE 382
KSDI+S GV+L E
Sbjct: 174 KSDIWSLGVILYE 186
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215 |
| >gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Score = 178 bits (455), Expect = 1e-52
Identities = 87/276 (31%), Positives = 127/276 (46%), Gaps = 29/276 (10%)
Query: 191 ENVLGEGGYGVVYKGRLINGS-----EVAVKKLLNN-LGQAEKEFRVEVEAIGHVRHKNL 244
LGEG +G VYKG+L EVAVK L + Q +EF E + + H N+
Sbjct: 4 GKKLGEGAFGEVYKGKLKGKGGKKKVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPNV 63
Query: 245 VRLLGYCIEGVHRMLVYEYVNNGNLEQWLHGAMRNQGNLTWEARMKVIIGTAKALAYLHE 304
V+LLG C E +V EY+ G+L +L +N+ L+ + + A+ + YL
Sbjct: 64 VKLLGVCTEEEPLYIVMEYMEGGDLLSYLR---KNRPKLSLSDLLSFALQIARGMEYLES 120
Query: 305 AIEPKVVHRDIKSSNILIDDEFNAKVSDFGLAKLLDSGESHITTRVMGTFGYVAPEYANT 364
+HRD+ + N L+ + K+SDFGL++ L + + ++APE
Sbjct: 121 K---NFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYRKRGGKLPIRWMAPESLKE 177
Query: 365 GMLNEKSDIYSFGVLLLEAVT-GRDPVDYGRPANEVNLVEWLKMMVGTRRAEEVVDPNLE 423
G KSD++SFGVLL E T G P G EV +E+LK G R P
Sbjct: 178 GKFTSKSDVWSFGVLLWEIFTLGEQPY-PGMSNEEV--LEYLK--NGYRL------PQPP 226
Query: 424 VKPATRALKRSLLVALRCVDPDSEKRPKMSQVVRML 459
P + L+C D E RP S++V +L
Sbjct: 227 NCPPELY-----DLMLQCWAEDPEDRPTFSELVEIL 257
|
Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257 |
| >gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Score = 175 bits (446), Expect = 2e-51
Identities = 87/277 (31%), Positives = 129/277 (46%), Gaps = 30/277 (10%)
Query: 191 ENVLGEGGYGVVYKGRLINGS-----EVAVKKLLNN-LGQAEKEFRVEVEAIGHVRHKNL 244
LGEG +G VYKG L EVAVK L + Q +EF E + + H N+
Sbjct: 4 GKKLGEGAFGEVYKGTLKGKGDGKEVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPNI 63
Query: 245 VRLLGYCIEGVHRMLVYEYVNNGNLEQWLHGAMRNQGN-LTWEARMKVIIGTAKALAYLH 303
V+LLG C E M+V EY+ G+L +L +N+ L+ + + A+ + YL
Sbjct: 64 VKLLGVCTEEEPLMIVMEYMPGGDLLDYLR---KNRPKELSLSDLLSFALQIARGMEYLE 120
Query: 304 EAIEPKVVHRDIKSSNILIDDEFNAKVSDFGLAKLLDSGESHITTRVMGTFGYVAPEYAN 363
+HRD+ + N L+ + K+SDFGL++ L + + ++APE
Sbjct: 121 SK---NFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYKVKGGKLPIRWMAPESLK 177
Query: 364 TGMLNEKSDIYSFGVLLLEAVT-GRDPVDYGRPANEVNLVEWLKMMVGTRRAEEVVDPNL 422
G KSD++SFGVLL E T G +P Y +N ++E+LK G R P
Sbjct: 178 EGKFTSKSDVWSFGVLLWEIFTLGEEP--YPGMSNA-EVLEYLKK--GYRL------PKP 226
Query: 423 EVKPATRALKRSLLVALRCVDPDSEKRPKMSQVVRML 459
P + L+C D E RP S++V +L
Sbjct: 227 PNCPPELY-----KLMLQCWAEDPEDRPTFSELVEIL 258
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258 |
| >gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Score = 171 bits (437), Expect = 4e-50
Identities = 86/270 (31%), Positives = 131/270 (48%), Gaps = 26/270 (9%)
Query: 192 NVLGEGGYGVVYKGRLIN-GSEVAVKKL-LNNLGQAEKEFRVEVEAIGHVRHKNLVRLLG 249
LGEG +G VY R G VA+K + + + + E++ + ++H N+VRL
Sbjct: 5 EKLGEGSFGKVYLARDKKTGKLVAIKVIKKKKIKKDRERILREIKILKKLKHPNIVRLYD 64
Query: 250 YCIEGVHRMLVYEYVNNGNLEQWLHGAMRNQGNLTWEARMKVIIG-TAKALAYLHEAIEP 308
+ LV EY G+L L + +G L+ E + + AL YLH
Sbjct: 65 VFEDEDKLYLVMEYCEGGDLFDLL----KKRGRLS-EDEARFYLRQILSALEYLHSK--- 116
Query: 309 KVVHRDIKSSNILIDDEFNAKVSDFGLAKLLDSGESHITTRVMGTFGYVAPEYANTGMLN 368
+VHRD+K NIL+D++ + K++DFGLA+ LD GE +TT V GT Y+APE
Sbjct: 117 GIVHRDLKPENILLDEDGHVKLADFGLARQLDPGE-KLTTFV-GTPEYMAPEVLLGKGYG 174
Query: 369 EKSDIYSFGVLLLEAVTGRDPVDYGRPANEVNLVEWLKMMVGTRRAEEVVDPNLEVKPAT 428
+ DI+S GV+L E +TG+ P + L+E K + + P ++ P
Sbjct: 175 KAVDIWSLGVILYELLTGKPPFP-----GDDQLLELFKKIG--KPKPPFPPPEWDISPEA 227
Query: 429 RALKRSLLVALRCVDPDSEKRPKMSQVVRM 458
+ L R LLV DP EKR + ++
Sbjct: 228 KDLIRKLLV----KDP--EKRLTAEEALQH 251
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254 |
| >gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 171 bits (436), Expect = 6e-50
Identities = 95/290 (32%), Positives = 131/290 (45%), Gaps = 49/290 (16%)
Query: 192 NVLGEGGYGVVYKGRLINGS----EVAVKKLLNN-LGQAEKEFRVEVEAIGHVRHKNLVR 246
LGEG +G VYKG+L EVAVK L + + K+F E + + H N+VR
Sbjct: 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVR 60
Query: 247 LLGYCIEGVHRMLVYEYVNNGNLEQWLHGAMRNQ-----GNLTWEARMKVIIGTAKALAY 301
LLG C E LV EY+ G+L +L + L+ + + I AK + Y
Sbjct: 61 LLGVCTEEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEY 120
Query: 302 LHEAIEPKVVHRDIKSSNILIDDEFNAKVSDFGLAKLLDSGESHITT-------RVMGTF 354
L K VHRD+ + N L+ ++ K+SDFGL++ + + + R M
Sbjct: 121 LAS---KKFVHRDLAARNCLVGEDLVVKISDFGLSRDVYDDDYYRKKTGGKLPIRWM--- 174
Query: 355 GYVAPEYANTGMLNEKSDIYSFGVLLLEAVT-GRDPVDY-GRPANEVNLVEWLKMMVGTR 412
APE G+ KSD++SFGVLL E T G P Y G EV +E+L+ G R
Sbjct: 175 ---APESLKDGIFTSKSDVWSFGVLLWEIFTLGATP--YPGLSNEEV--LEYLR--KGYR 225
Query: 413 RAEEVVDPNLEVKP--ATRALKRSLLVALRCVDPDSEKRPKMSQVVRMLE 460
L KP L + L C D E RP S++V LE
Sbjct: 226 ---------LP-KPEYCPDELYE---LMLSCWQLDPEDRPTFSELVERLE 262
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262 |
| >gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase | Back alignment and domain information |
|---|
Score = 171 bits (435), Expect = 9e-50
Identities = 91/278 (32%), Positives = 131/278 (47%), Gaps = 36/278 (12%)
Query: 193 VLGEGGYGVVYKGRLINGSE-----VAVKKLLNNLGQAEK-EFRVEVEAIGHVRHKNLVR 246
LGEG +G VYKG L E VAVK L + E+ EF E + + H N+VR
Sbjct: 6 KLGEGAFGEVYKGTLKGDGEGTETKVAVKTLKEGASEEEREEFLEEASIMKKLSHPNIVR 65
Query: 247 LLGYCIEGVHRMLVYEYVNNGNLEQWLHGAMRNQGNLTWEARMKVIIGTAKALAYLHEAI 306
LLG C +G +V EY+ G+L +L ++ LT + +++ + AK + YL
Sbjct: 66 LLGVCTQGEPLYIVTEYMPGGDLLDFLR---KHGEKLTLKDLLQMALQIAKGMEYLESK- 121
Query: 307 EPKVVHRDIKSSNILIDDEFNAKVSDFGLAKLLDSGESHITTRVMGTF--GYVAPEYANT 364
VHRD+ + N L+ + K+SDFGL++ + + + R G ++APE
Sbjct: 122 --NFVHRDLAARNCLVTENLVVKISDFGLSRDIYEDDYY-RKRGGGKLPIKWMAPESLKD 178
Query: 365 GMLNEKSDIYSFGVLLLEAVT-GRDPVDYGRPANEVNLVEWLKMMVGTRRAEEVVDPNLE 423
G KSD++SFGVLL E T G P G EV +E L+ G R L
Sbjct: 179 GKFTSKSDVWSFGVLLWEIFTLGEQPY-PGMSNEEV--LELLE--DGYR---------LP 224
Query: 424 VKP--ATRALKRSLLVALRCVDPDSEKRPKMSQVVRML 459
+P L + L+C D E RP S++V L
Sbjct: 225 -RPENCPDELYE---LMLQCWAYDPEDRPTFSELVEDL 258
|
Length = 258 |
| >gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain | Back alignment and domain information |
|---|
Score = 165 bits (419), Expect = 2e-47
Identities = 81/268 (30%), Positives = 133/268 (49%), Gaps = 22/268 (8%)
Query: 193 VLGEGGYGVVYKGRLIN-GSEVAVKKL--LNNLGQAEKEFRVEVEAIGHVRHKNLVRLLG 249
LG G +G VYK + G VAVK L + + ++ R E+ + + H N+VRL+
Sbjct: 6 KLGSGSFGTVYKAKHKGTGKIVAVKILKKRSEKSKKDQTARREIRILRRLSHPNIVRLID 65
Query: 250 YCIEGVHRMLVYEYVNNGNLEQWLHGAMRNQGNLTWEARMKVIIGTAKALAYLHEAIEPK 309
+ H LV EY G+L +L G L+ + K+ + + L YLH
Sbjct: 66 AFEDKDHLYLVMEYCEGGDLFDYL----SRGGPLSEDEAKKIALQILRGLEYLHSN---G 118
Query: 310 VVHRDIKSSNILIDDEFNAKVSDFGLAKLLDSGESHITTRVMGTFGYVAPEYANTG-MLN 368
++HRD+K NIL+D+ K++DFGLAK L S +TT V GT Y+APE G
Sbjct: 119 IIHRDLKPENILLDENGVVKIADFGLAKKLLKSSSSLTTFV-GTPWYMAPEVLLGGNGYG 177
Query: 369 EKSDIYSFGVLLLEAVTGRDPVDYGRPANEVNLVEWLKMMVGTRRAEEVVDPNLEVKPAT 428
K D++S GV+L E +TG+ P N ++ ++ ++ ++G + + + A
Sbjct: 178 PKVDVWSLGVILYELLTGKPPF---SGENILDQLQLIRRILGPPLEFDEPKWSSGSEEA- 233
Query: 429 RALKRSLLVALRCVDPDSEKRPKMSQVV 456
+ L+ +C++ D KRP +++
Sbjct: 234 ----KDLI--KKCLNKDPSKRPTAEEIL 255
|
Length = 260 |
| >gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Score = 138 bits (351), Expect = 1e-37
Identities = 64/208 (30%), Positives = 101/208 (48%), Gaps = 21/208 (10%)
Query: 192 NVLGEGGYGVVYKGR-LINGSEVAVKK--LLNNLGQAEKEFRVEVEAIGHVRHKNLVRLL 248
+LG G +G VY G +AVK L + + + E+ + ++H N+VR
Sbjct: 6 ELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYY 65
Query: 249 GYCIEGVHRML-VY-EYVNNGNLEQWLHGAMRNQGNLTWEARMKV----IIGTAKALAYL 302
G + L ++ EYV+ G+L ++ G L E ++ I+ + LAYL
Sbjct: 66 GSERDEEKNTLNIFLEYVSGGSLSS----LLKKFGKLP-EPVIRKYTRQIL---EGLAYL 117
Query: 303 HEAIEPKVVHRDIKSSNILIDDEFNAKVSDFGLAKLLDSGESHITTRVM-GTFGYVAPEY 361
H +VHRDIK +NIL+D + K++DFG AK L E+ T + GT ++APE
Sbjct: 118 HSN---GIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGEGTGSVRGTPYWMAPEV 174
Query: 362 ANTGMLNEKSDIYSFGVLLLEAVTGRDP 389
+DI+S G ++E TG+ P
Sbjct: 175 IRGEEYGRAADIWSLGCTVIEMATGKPP 202
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260 |
| >gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Score = 134 bits (339), Expect = 4e-36
Identities = 60/203 (29%), Positives = 103/203 (50%), Gaps = 9/203 (4%)
Query: 188 FSAENVLGEGGYGVVYKGR-LINGSEVAVKKLLNNLGQAEKEFRVEVEAIGHVRHKNLVR 246
F +G+GG+G VYK R G EVA+K + + +++ E++ + +H N+V+
Sbjct: 2 FEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVK 61
Query: 247 LLGYCIEGVHRMLVYEYVNNGNLEQWLHGAMRNQGNLTWEARMKVIIGTAKALAYLHEAI 306
G ++ +V E+ + G+L+ L + + A V K L YLH
Sbjct: 62 YYGSYLKKDELWIVMEFCSGGSLKDLLKSTNQTL-TESQIA--YVCKELLKGLEYLHSN- 117
Query: 307 EPKVVHRDIKSSNILIDDEFNAKVSDFGLAKLLDSGESHITTRVMGTFGYVAPEYANTGM 366
++HRDIK++NIL+ + K+ DFGL+ L ++ T +GT ++APE N
Sbjct: 118 --GIIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKARNTM--VGTPYWMAPEVINGKP 173
Query: 367 LNEKSDIYSFGVLLLEAVTGRDP 389
+ K+DI+S G+ +E G+ P
Sbjct: 174 YDYKADIWSLGITAIELAEGKPP 196
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253 |
| >gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Score = 133 bits (336), Expect = 1e-35
Identities = 63/212 (29%), Positives = 102/212 (48%), Gaps = 19/212 (8%)
Query: 187 RFSAENVLGEGGYGVVYKGR-LINGSEVAVKKL-LNNLGQAEKEFRV-EVEAIGHVRHKN 243
++ +G+G +G VY R +G +K++ L+N+ + E+E + EV+ + + H N
Sbjct: 1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPN 60
Query: 244 LVRLLGYCIEGVHRMLVYEYVNNGNLEQWLHGAMRNQGNLTWEARMKVIIGTAKALAYLH 303
+++ E +V EY + G+L Q + + E + + AL YLH
Sbjct: 61 IIKYYESFEEKGKLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLH 120
Query: 304 EAIEPKVVHRDIKSSNILIDDEFNAKVSDFGLAKLLDSGESHITTRVMGTFGYVAPE--- 360
K++HRDIK NI + K+ DFG++K+L S T V GT Y++PE
Sbjct: 121 SR---KILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTVDLAKTVV-GTPYYLSPELCQ 176
Query: 361 ---YANTGMLNEKSDIYSFGVLLLEAVTGRDP 389
Y N KSDI+S G +L E T + P
Sbjct: 177 NKPY------NYKSDIWSLGCVLYELCTLKHP 202
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258 |
| >gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 127 bits (321), Expect = 1e-33
Identities = 72/212 (33%), Positives = 110/212 (51%), Gaps = 23/212 (10%)
Query: 194 LGEGGYGVVYKGRLINGSEVAVKKLLNNLGQAEKEFRVEVEAIGHVRHKNLVRLLGYCIE 253
+G+G +G V G G +VAVK L ++ A+ F E + +RH NLV+LLG ++
Sbjct: 14 IGKGEFGDVMLG-DYRGQKVAVKCLKDDSTAAQA-FLAEASVMTTLRHPNLVQLLGVVLQ 71
Query: 254 GVHRMLVYEYVNNGNLEQWLHGAMRNQGNLTWEARMKVIIGTAKALAYLHEAIEPKVVHR 313
G +V EY+ G+L +L R + +T ++ + + + YL E VHR
Sbjct: 72 GNPLYIVTEYMAKGSLVDYLRS--RGRAVITLAQQLGFALDVCEGMEYLEEK---NFVHR 126
Query: 314 DIKSSNILIDDEFNAKVSDFGLAKL----LDSGESHITTRVMGTFGYVAPEYANTGMLNE 369
D+ + N+L+ ++ AKVSDFGLAK DSG+ + + APE +
Sbjct: 127 DLAARNVLVSEDLVAKVSDFGLAKEASQGQDSGKLPVK--------WTAPEALREKKFST 178
Query: 370 KSDIYSFGVLLLEAVT-GRDPVDYGR-PANEV 399
KSD++SFG+LL E + GR P Y R P +V
Sbjct: 179 KSDVWSFGILLWEIYSFGRVP--YPRIPLKDV 208
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256 |
| >gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 123 bits (310), Expect = 4e-32
Identities = 65/214 (30%), Positives = 106/214 (49%), Gaps = 11/214 (5%)
Query: 187 RFSAENVLGEGGYGVVYKG-RLINGSEVAVKKL-LNNLGQAE-KEFRVEVEAIGHVRHKN 243
+ +++G G +GVVYKG L G VA+K++ L + + K E++ + +++H N
Sbjct: 1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPN 60
Query: 244 LVRLLGYCIEGVHRMLVYEYVNNGNLEQWLHGAMRNQGNLTWEARMKVIIGTAKALAYLH 303
+V+ +G ++ EY NG+L Q + G + + LAYLH
Sbjct: 61 IVKYIGSIETSDSLYIILEYAENGSLRQIIK----KFGPFPESLVAVYVYQVLQGLAYLH 116
Query: 304 EAIEPKVVHRDIKSSNILIDDEFNAKVSDFGLAKLLDSGESHITTRVMGTFGYVAPEYAN 363
E V+HRDIK++NIL + K++DFG+A L+ S V+GT ++APE
Sbjct: 117 EQ---GVIHRDIKAANILTTKDGVVKLADFGVATKLND-VSKDDASVVGTPYWMAPEVIE 172
Query: 364 TGMLNEKSDIYSFGVLLLEAVTGRDPVDYGRPAN 397
+ SDI+S G ++E +TG P P
Sbjct: 173 MSGASTASDIWSLGCTVIELLTGNPPYYDLNPMA 206
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254 |
| >gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Score = 124 bits (311), Expect = 3e-31
Identities = 84/331 (25%), Positives = 137/331 (41%), Gaps = 28/331 (8%)
Query: 193 VLGEGGYGVVYKGRLINGSEVAVKKL---LNNLGQAEKEFRVEVEAIGHVRH-KNLVRLL 248
LGEG +G VY R VA+K L L + + + F E++ + + H N+V+L
Sbjct: 7 KLGEGSFGEVYLARDR--KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLY 64
Query: 249 GYCIEGVHRMLVYEYVNNGNLEQWLHGAMRNQGNLTWEARMKVIIGTAKALAYLHEAIEP 308
+ + LV EYV+ G+LE L + +G L+ + ++ AL YLH
Sbjct: 65 DFFQDEGSLYLVMEYVDGGSLEDLLK-KIGRKGPLSESEALFILAQILSALEYLHSK--- 120
Query: 309 KVVHRDIKSSNILID-DEFNAKVSDFGLAKLLDSGESH-----ITTRVMGTFGYVAPEYA 362
++HRDIK NIL+D D K+ DFGLAKLL S + + +GT GY+APE
Sbjct: 121 GIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPGYMAPEVL 180
Query: 363 ---NTGMLNEKSDIYSFGVLLLEAVTGRDPVDYGRPANEVNLVEWLKMMVGTRRAEEVVD 419
+ + SDI+S G+ L E +TG P + N + LK+++
Sbjct: 181 LGLSLAYASSSSDIWSLGITLYELLTGLPPFE--GEKNSSATSQTLKIILELPTPSLASP 238
Query: 420 PNLEVKPATRALKRSLLVALRCVDPDSEKRPKMSQ-----VVRMLEADDYPFREDRRNRK 474
+ LL + + D + R S ++ L+ + + +
Sbjct: 239 LSPSNPELISKAASDLL--KKLLAKDPKNRLSSSSDLSHDLLAHLKLKESDLSDLLKPDD 296
Query: 475 SRTTSMEIESLKESTEIESKVEDSEGRISEK 505
S + + E+ G +
Sbjct: 297 SAPLRLSLPPSLEALISSLNSLAISGSDLKL 327
|
Length = 384 |
| >gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Score = 119 bits (300), Expect = 9e-31
Identities = 78/276 (28%), Positives = 136/276 (49%), Gaps = 31/276 (11%)
Query: 188 FSAENVLGEGGYGVVYKG-RLINGSEVAVKKL-LNNLGQAEKEFRV-EVEAIGHVRHKNL 244
F N +G+G +GVV+K R + A+K++ L+ + + E+E + E + + +
Sbjct: 2 FEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYI 61
Query: 245 VRLLGYCIEGVHRMLVYEYVNNGNLEQWLHGAM--RNQGNLTWEARMKVIIGTAKALAYL 302
+R ++ +V EY NG+L + L + W +++++G LA+L
Sbjct: 62 IRYYESFLDKGKLNIVMEYAENGDLHKLLKMQRGRPLPEDQVWRFFIQILLG----LAHL 117
Query: 303 HEAIEPKVVHRDIKSSNILIDDEFNAKVSDFGLAKLLDSGESHITTRVMGTFGYVAPEYA 362
H K++HRDIKS N+ +D N K+ D G+AKLL S ++ ++GT Y++PE
Sbjct: 118 HSK---KILHRDIKSLNLFLDAYDNVKIGDLGVAKLL-SDNTNFANTIVGTPYYLSPELC 173
Query: 363 NTGMLNEKSDIYSFGVLLLEAVTGRDPVDYGRPANEVNLVEWLKMMVGTRRAEEVVDPNL 422
NEKSD+++ GV+L E TG+ P D N+ L+ LK++ G
Sbjct: 174 EDKPYNEKSDVWALGVVLYECCTGKHPFD---ANNQGALI--LKIIRGV----------- 217
Query: 423 EVKPATRALKRSLLVALR-CVDPDSEKRPKMSQVVR 457
P ++ + L + C+ D +RP Q++R
Sbjct: 218 -FPPVSQMYSQQLAQLIDQCLTKDYRQRPDTFQLLR 252
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256 |
| >gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 117 bits (296), Expect = 6e-30
Identities = 82/277 (29%), Positives = 130/277 (46%), Gaps = 39/277 (14%)
Query: 193 VLGEGGYGVVYKGRLINGSE-----VAVKKLLNNLG-QAEKEFRVEVEAIGHVRHKNLVR 246
VLG G +G VYKG I E VA+K L +A KE E + V H ++VR
Sbjct: 14 VLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVR 73
Query: 247 LLGYCIEGVHRMLVYEYVNNGNLEQWLH---GAMRNQGNLTWEARMKVIIGTAKALAYLH 303
LLG C+ L+ + + G L ++ + +Q L W ++ AK ++YL
Sbjct: 74 LLGICLSSQV-QLITQLMPLGCLLDYVRNHKDNIGSQYLLNWCVQI------AKGMSYLE 126
Query: 304 EAIEPKVVHRDIKSSNILIDDEFNAKVSDFGLAKLLDSGESH-ITTRVMGTFGYVAPEYA 362
E ++VHRD+ + N+L+ + K++DFGLAKLLD E ++A E
Sbjct: 127 EK---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLDVDEKEYHAEGGKVPIKWMALESI 183
Query: 363 NTGMLNEKSDIYSFGVLLLEAVT-GRDPVDYGRPANEV-NLVEWLKMMVGTRRAEEVVDP 420
+ KSD++S+GV + E +T G P + G PA E+ +L+E G R +
Sbjct: 184 LHRIYTHKSDVWSYGVTVWELMTFGAKPYE-GIPAVEIPDLLE-----KGERLPQ----- 232
Query: 421 NLEVKPATRALKRSLLVALRCVDPDSEKRPKMSQVVR 457
P + +V ++C D+E RP +++
Sbjct: 233 -----PPICTID-VYMVLVKCWMIDAESRPTFKELIN 263
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279 |
| >gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Score = 117 bits (294), Expect = 8e-30
Identities = 65/203 (32%), Positives = 108/203 (53%), Gaps = 16/203 (7%)
Query: 188 FSAENVLGEGGYGVVYKGRLINGSEVAVKKLLNNLGQAEKEFRVEVEAIGHVRHKNLVRL 247
F+ E LG G +G V++G N VA+K L ++ +++F+ EV+A+ +RHK+L+ L
Sbjct: 8 FTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISL 67
Query: 248 LGYCIEGVHRMLVYEYVNNGNLEQWLHGAMRNQGNLTWEARMKVIIGTAKALAYLHEAIE 307
C G ++ E + G+L +L L + + + A+ +AYL E
Sbjct: 68 FAVCSVGEPVYIITELMEKGSLLAFLRSP--EGQVLPVASLIDMACQVAEGMAYLEEQ-- 123
Query: 308 PKVVHRDIKSSNILIDDEFNAKVSDFGLAKLLD-----SGESHITTRVMGTFGYVAPEYA 362
+HRD+ + NIL+ ++ KV+DFGLA+L+ S + I + + APE A
Sbjct: 124 -NSIHRDLAARNILVGEDLVCKVADFGLARLIKEDVYLSSDKKIPYK------WTAPEAA 176
Query: 363 NTGMLNEKSDIYSFGVLLLEAVT 385
+ G + KSD++SFG+LL E T
Sbjct: 177 SHGTFSTKSDVWSFGILLYEMFT 199
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 122 bits (307), Expect = 3e-29
Identities = 94/315 (29%), Positives = 152/315 (48%), Gaps = 35/315 (11%)
Query: 176 FTLRDLEIATNRFSAENVLGEGGYGVVYKGRLI-NGSEVAVKKL--LNNLGQAEKEFRVE 232
T+ D+ + ENV+ G G YKG+ I NG + VK++ +N++ +E
Sbjct: 683 ITINDILSSLKE---ENVISRGKKGASYKGKSIKNGMQFVVKEINDVNSIPSSE------ 733
Query: 233 VEAIGHVRHKNLVRLLGYCIEGVHRMLVYEYVNNGNLEQWLHGAMRNQGNLTWEARMKVI 292
+ +G ++H N+V+L+G C L++EY+ NL + L NL+WE R K+
Sbjct: 734 IADMGKLQHPNIVKLIGLCRSEKGAYLIHEYIEGKNLSEVLR-------NLSWERRRKIA 786
Query: 293 IGTAKALAYLHEAIEPKVVHRDIKSSNILIDDEFNAKVSDFGLAKLLDSGESHITTRVMG 352
IG AKAL +LH P VV ++ I+ID + + L LL T+
Sbjct: 787 IGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGLL-----CTDTKCFI 840
Query: 353 TFGYVAPEYANTGMLNEKSDIYSFGVLLLEAVTGRDPVDYGRPANEVNLVEWLKMMVGTR 412
+ YVAPE T + EKSDIY FG++L+E +TG+ P D + ++VEW +
Sbjct: 841 SSAYVAPETRETKDITEKSDIYGFGLILIELLTGKSPADAEFGVHG-SIVEWARYCYSDC 899
Query: 413 RAEEVVDPNL--EVKPATRALKRSLLVALRCVDPDSEKRPKMSQVVRMLEADDYPFREDR 470
+ +DP++ +V + + +AL C D RP + V++ LE+
Sbjct: 900 HLDMWIDPSIRGDVSVNQNEIVEVMNLALHCTATDPTARPCANDVLKTLES-------AS 952
Query: 471 RNRKSRTTSMEIESL 485
R+ S T ++ SL
Sbjct: 953 RSSSSCVTGLKFSSL 967
|
Length = 968 |
| >gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 114 bits (288), Expect = 7e-29
Identities = 74/212 (34%), Positives = 105/212 (49%), Gaps = 13/212 (6%)
Query: 182 EIATNRFSAENVLGEGGYGVVYKGRLINGSEVAVKKLLNNLGQAEKE-FRVEVEAIGHVR 240
EI E LG G +G V+ G ++VAVK L G E F E + + +R
Sbjct: 2 EIPRESLKLERKLGAGQFGEVWMGTWNGTTKVAVKTL--KPGTMSPEAFLQEAQIMKKLR 59
Query: 241 HKNLVRLLGYCIEGVHRMLVYEYVNNGNLEQWLHGAMRNQGNLTWEARMKVIIGTAKALA 300
H LV+L C E +V EY++ G+L +L + L M I A+ +A
Sbjct: 60 HDKLVQLYAVCSEEEPIYIVTEYMSKGSLLDFLKSGEGKKLRLPQLVDMAAQI--AEGMA 117
Query: 301 YLHEAIEPKVVHRDIKSSNILIDDEFNAKVSDFGLAKLLDSGESHITTRVMGTF--GYVA 358
YL +HRD+ + NIL+ + K++DFGLA+L++ + T R F + A
Sbjct: 118 YLESR---NYIHRDLAARNILVGENLVCKIADFGLARLIE--DDEYTAREGAKFPIKWTA 172
Query: 359 PEYANTGMLNEKSDIYSFGVLLLEAVT-GRDP 389
PE AN G KSD++SFG+LL E VT GR P
Sbjct: 173 PEAANYGRFTIKSDVWSFGILLTEIVTYGRVP 204
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261 |
| >gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 112 bits (281), Expect = 5e-28
Identities = 85/286 (29%), Positives = 138/286 (48%), Gaps = 45/286 (15%)
Query: 191 ENVLGEGGYGVVYKGRLINGSE----VAVKKLLNNLGQAEKE---FRVEVEAIGHVRHKN 243
E V+G G +G V +GRL + VA+K L G ++K+ F E +G H N
Sbjct: 9 EKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTL--KAGSSDKQRLDFLTEASIMGQFDHPN 66
Query: 244 LVRLLGYCIEGVHRMLVYEYVNNGNLEQWLHGAMRNQGNLTWEARMKVIIGTAKALAYLH 303
++RL G + M++ EY+ NG+L+++L N G T + ++ G A + YL
Sbjct: 67 IIRLEGVVTKSRPVMIITEYMENGSLDKFLR---ENDGKFTVGQLVGMLRGIASGMKYLS 123
Query: 304 EAIEPKVVHRDIKSSNILIDDEFNAKVSDFGLAKLLDSGESHITTRVMGTFG------YV 357
E VHRD+ + NIL++ KVSDFGL++ L+ E+ TT+ G +
Sbjct: 124 EM---NYVHRDLAARNILVNSNLVCKVSDFGLSRRLEDSEATYTTK-----GGKIPIRWT 175
Query: 358 APEYANTGMLNEKSDIYSFGVLLLEAVTGRDPVDYG-RPANEVNLVEWLK-MMVGTRRAE 415
APE SD++SFG+++ E ++ YG RP +++ + +K + G R
Sbjct: 176 APEAIAYRKFTSASDVWSFGIVMWEVMS------YGERPYWDMSNQDVIKAVEDGYRLPP 229
Query: 416 EVVDPNLEVKPATRALKRSLLVALRCVDPDSEKRPKMSQVVRMLEA 461
+ P+ AL + + L C D +RP SQ+V L+
Sbjct: 230 PMDCPS--------ALYQ---LMLDCWQKDRNERPTFSQIVSTLDK 264
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 111 bits (279), Expect = 1e-27
Identities = 81/281 (28%), Positives = 123/281 (43%), Gaps = 36/281 (12%)
Query: 194 LGEGGYGVVYKG--RLINGSE--VAVKKLLNN-LGQAEKEFRVEVEAIGHVRHKNLVRLL 248
LG G +G V KG + +G E VAVK L + +KEF E + + H +VRL+
Sbjct: 3 LGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLI 62
Query: 249 GYCIEGVHRMLVYEYVNNGNLEQWL--HGAMRNQGNLTWEARMKVIIGTAKALAYLHEAI 306
G C +G MLV E G L ++L + ++ A +AYL
Sbjct: 63 GVC-KGEPLMLVMELAPLGPLLKYLKKRREIPVSDLKELAHQV------AMGMAYLESK- 114
Query: 307 EPKVVHRDIKSSNILIDDEFNAKVSDFGLAKLLDSGESHITTRVMGTF--GYVAPEYANT 364
VHRD+ + N+L+ + AK+SDFG+++ L +G + G + + APE N
Sbjct: 115 --HFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYRATTAGRWPLKWYAPECINY 172
Query: 365 GMLNEKSDIYSFGVLLLEAVTGRDPVDYG-RPANEVNLVEWLKMMVGTRRAEEVVDPNLE 423
G + KSD++S+GV L EA + YG +P E+ E + M+ R P E
Sbjct: 173 GKFSSKSDVWSYGVTLWEAFS------YGAKPYGEMKGAEVIAMLESGERLPR---PE-E 222
Query: 424 VKPATRALKRSLLVALRCVDPDSEKRPKMSQVVRMLEADDY 464
++ L C E RP S++ D
Sbjct: 223 CPQEIYSI------MLSCWKYRPEDRPTFSELESTFRRDPE 257
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257 |
| >gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Score = 111 bits (279), Expect = 1e-27
Identities = 62/201 (30%), Positives = 104/201 (51%), Gaps = 13/201 (6%)
Query: 193 VLGEGGYGVVYKGRLI-NGSEVAVKKL-LNNLGQAEKEFRVEVEAIGHVRHKNLVRLLG- 249
VLG+G GVVYK R G A+KK+ ++ + K+ E++ + +V+ G
Sbjct: 8 VLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGA 67
Query: 250 YCIEG-VHRMLVYEYVNNGNLEQWLHGAMRNQGNLTWEARMKVIIGTAKALAYLHEAIEP 308
+ EG + +V EY++ G+L ++ G + + K L YLH +
Sbjct: 68 FYKEGEIS--IVLEYMDGGSL----ADLLKKVGKIPEPVLAYIARQILKGLDYLHT--KR 119
Query: 309 KVVHRDIKSSNILIDDEFNAKVSDFGLAKLLDSGESHITTRVMGTFGYVAPEYANTGMLN 368
++HRDIK SN+LI+ + K++DFG++K+L++ T V GT Y++PE +
Sbjct: 120 HIIHRDIKPSNLLINSKGEVKIADFGISKVLENTLDQCNTFV-GTVTYMSPERIQGESYS 178
Query: 369 EKSDIYSFGVLLLEAVTGRDP 389
+DI+S G+ LLE G+ P
Sbjct: 179 YAADIWSLGLTLLECALGKFP 199
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264 |
| >gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Score = 109 bits (275), Expect = 3e-27
Identities = 78/273 (28%), Positives = 131/273 (47%), Gaps = 31/273 (11%)
Query: 193 VLGEGGYGVVYKGR-LINGSEVAVKKLLNNLGQAEKEFRVEVEAIGHVRHKNLVRLLGYC 251
VLG+G YG+VY R L +A+K++ + + E+ +++H+N+V+ LG
Sbjct: 15 VLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYLGSD 74
Query: 252 IEGVHRMLVYEYVNNGNLEQWLH---GAMRNQGNLTWEARMKVIIGTAKALAYLHEAIEP 308
E + E V G+L L G +++ T K I+ + L YLH+
Sbjct: 75 SENGFFKIFMEQVPGGSLSALLRSKWGPLKDNEQ-TIIFYTKQIL---EGLKYLHDN--- 127
Query: 309 KVVHRDIKSSNILIDDEFNA-KVSDFGLAKLLDSGESHITTRVMGTFGYVAPEYANTGM- 366
++VHRDIK N+L++ K+SDFG +K L +G + T GT Y+APE + G
Sbjct: 128 QIVHRDIKGDNVLVNTYSGVVKISDFGTSKRL-AGINPCTETFTGTLQYMAPEVIDKGPR 186
Query: 367 -LNEKSDIYSFGVLLLEAVTGRDP-VDYGRPANEVNLVEWLKMMVGTRRAEEVVDPNLEV 424
+DI+S G ++E TG+ P ++ G P + V K + P E+
Sbjct: 187 GYGAPADIWSLGCTIVEMATGKPPFIELGEPQAAMFKVGMFK-----------IHP--EI 233
Query: 425 KPATRALKRSLLVALRCVDPDSEKRPKMSQVVR 457
+ A ++ + LRC +PD +KR +++
Sbjct: 234 PESLSAEAKNFI--LRCFEPDPDKRASAHDLLQ 264
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268 |
| >gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Score = 109 bits (275), Expect = 4e-27
Identities = 67/208 (32%), Positives = 104/208 (50%), Gaps = 14/208 (6%)
Query: 192 NVLGEGGYGVVYKGRLINGSEVAVKKLLN--NLGQAEKEFRV-EVEAIGHVRHKNLVRLL 248
+G+G +G V K R + ++ V K ++ N+ + EK+ V EV + ++H N+VR
Sbjct: 6 ETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVR-- 63
Query: 249 GYCIEGVHR-----MLVYEYVNNGNLEQWLHGAMRNQGNLTWEARMKVIIGTAKALAYLH 303
Y + R +V EY G+L Q + + + + E +++ AL H
Sbjct: 64 -YYDRIIDRSNQTLYIVMEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECH 122
Query: 304 EAIEPK--VVHRDIKSSNILIDDEFNAKVSDFGLAKLLDSGESHITTRVMGTFGYVAPEY 361
+P V+HRD+K +NI +D N K+ DFGLAK+L S T V GT Y++PE
Sbjct: 123 NRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKILGHDSSFAKTYV-GTPYYMSPEQ 181
Query: 362 ANTGMLNEKSDIYSFGVLLLEAVTGRDP 389
N +EKSDI+S G L+ E P
Sbjct: 182 LNHMSYDEKSDIWSLGCLIYELCALSPP 209
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265 |
| >gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 109 bits (275), Expect = 6e-27
Identities = 75/233 (32%), Positives = 113/233 (48%), Gaps = 27/233 (11%)
Query: 192 NVLGEGGYGVVYKGRLIN-----GSEVAVKKLLNNLG-QAEKEFRVEVEAIGHVRHKNLV 245
LGEG +G V R G +VAVK L ++ Q +F E+E + + H+N+V
Sbjct: 10 KQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIV 69
Query: 246 RLLGYCIEGVHR---MLVYEYVNNGNLEQWLHGAMRNQGNLTWEARMKVIIGTAKALAYL 302
+ G C E L+ EY+ +G+L +L R+Q NL I K + YL
Sbjct: 70 KYKGVC-EKPGGRSLRLIMEYLPSGSLRDYLQR-HRDQINLKRLLLFSSQI--CKGMDYL 125
Query: 303 HEAIEPKVVHRDIKSSNILIDDEFNAKVSDFGLAKLLDSGESHITTRVMG---TFGYVAP 359
+ +HRD+ + NIL++ E K+SDFGLAK+L + + + G F Y AP
Sbjct: 126 GSQ---RYIHRDLAARNILVESEDLVKISDFGLAKVLPEDKDYYYVKEPGESPIFWY-AP 181
Query: 360 EYANTGMLNEKSDIYSFGVLLLEAVTGRDPVDYGRPANEVNLVEWLKMMVGTR 412
E T + SD++SFGV L E T YG P ++ E+L+M+ +
Sbjct: 182 ECLRTSKFSSASDVWSFGVTLYELFT------YGDP-SQSPPAEFLRMIGIAQ 227
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284 |
| >gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 107 bits (269), Expect = 2e-26
Identities = 72/272 (26%), Positives = 126/272 (46%), Gaps = 27/272 (9%)
Query: 194 LGEGGYGVVYKGRLINGSEVAVKKLLNNLGQAEKE-FRVEVEAIGHVRHKNLVRLLGYCI 252
+G+G +G VYKG L +EVAVK + L K F E E + H N+V+L+G C+
Sbjct: 3 IGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVCV 62
Query: 253 EGVHRMLVYEYVNNGNLEQWLHGAMRNQGNLTWEARMKVIIGTAKALAYLHEAIEPK-VV 311
+ +V E V G+L +L + + LT + +++ + A + YL E K +
Sbjct: 63 QKQPIYIVMELVPGGSLLTFLR---KKKNRLTVKKLLQMSLDAAAGMEYL----ESKNCI 115
Query: 312 HRDIKSSNILIDDEFNAKVSDFGLAKLLDSGESHITTRVMGTF--GYVAPEYANTGMLNE 369
HRD+ + N L+ + K+SDFG+++ + G + + + + APE N G
Sbjct: 116 HRDLAARNCLVGENNVLKISDFGMSREEEGGI-YTVSDGLKQIPIKWTAPEALNYGRYTS 174
Query: 370 KSDIYSFGVLLLEAVTGRDPVDYGRPANEVNLVEWLKMMVGTRRAEEVVDPNLEVKPATR 429
+SD++S+G+LL E + D Y +N ++ E ++ +
Sbjct: 175 ESDVWSYGILLWETFSLGD-TPYPGMSN--------------QQTRERIESGYRMPAPQL 219
Query: 430 ALKRSLLVALRCVDPDSEKRPKMSQVVRMLEA 461
+ + L+C D E RP S++ L+
Sbjct: 220 CPEEIYRLMLQCWAYDPENRPSFSEIYNELQI 251
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251 |
| >gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Score = 104 bits (263), Expect = 3e-25
Identities = 64/243 (26%), Positives = 103/243 (42%), Gaps = 61/243 (25%)
Query: 186 NRFSAENVLGEGGYGVVYKGRLI-NGSEVAVK----KLLNNLGQAEKEFRVEVEAIGHV- 239
+ F ++GEG + V + E A+K + L + K ++E E + +
Sbjct: 1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKE-KKVKYVKIEKEVLTRLN 59
Query: 240 RHKNLVRLLG--------YCIEGVHRMLVYEYVNNGNLEQWLHGAMRNQGNLTWEARMKV 291
H +++L Y V EY NG L Q +R G+L E +
Sbjct: 60 GHPGIIKLYYTFQDEENLY--------FVLEYAPNGELLQ----YIRKYGSLD-EKCTRF 106
Query: 292 IIGT-AKALAYLHEAIEPKVVHRDIKSSNILIDDEFNAKVSDFGLAKLLDSGESHITTRV 350
AL YLH ++HRD+K NIL+D + + K++DFG AK+LD S + +
Sbjct: 107 YAAEILLALEYLHSK---GIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPESNKG 163
Query: 351 M-------------------GTFGYVAPEYANTGMLNEK-----SDIYSFGVLLLEAVTG 386
GT YV+PE +LNEK SD+++ G ++ + +TG
Sbjct: 164 DATNIDSQIEKNRRRFASFVGTAEYVSPE-----LLNEKPAGKSSDLWALGCIIYQMLTG 218
Query: 387 RDP 389
+ P
Sbjct: 219 KPP 221
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280 |
| >gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 104 bits (260), Expect = 4e-25
Identities = 63/199 (31%), Positives = 97/199 (48%), Gaps = 11/199 (5%)
Query: 194 LGEGGYGVVYKGRLINGSEVAVKKLLNNLGQAEKEFRVEVEAIGHVRHKNLVRLLGYCIE 253
LG G +G V++G N + VAVK L + +F E + + +RH L++L C
Sbjct: 14 LGAGQFGEVWEGLWNNTTPVAVKTLKPGTMDPK-DFLAEAQIMKKLRHPKLIQLYAVCTL 72
Query: 254 GVHRMLVYEYVNNGNLEQWLHGAMRNQGNLTWEARMKVIIGTAKALAYLHEAIEPKVVHR 313
+V E + G+L ++L G L + + A +AYL +HR
Sbjct: 73 EEPIYIVTELMKYGSLLEYLQG--GAGRALKLPQLIDMAAQVASGMAYLEAQ---NYIHR 127
Query: 314 DIKSSNILIDDEFNAKVSDFGLAKLLDSGESHITTRVMGTF--GYVAPEYANTGMLNEKS 371
D+ + N+L+ + KV+DFGLA+++ E R F + APE A + KS
Sbjct: 128 DLAARNVLVGENNICKVADFGLARVIK--EDIYEAREGAKFPIKWTAPEAALYNRFSIKS 185
Query: 372 DIYSFGVLLLEAVT-GRDP 389
D++SFG+LL E VT GR P
Sbjct: 186 DVWSFGILLTEIVTYGRMP 204
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261 |
| >gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Score = 104 bits (261), Expect = 4e-25
Identities = 76/237 (32%), Positives = 120/237 (50%), Gaps = 33/237 (13%)
Query: 187 RFSAENVLGEGGYGVVYKGRLINGSE------VAVKKLL-NNLGQAEKEFRVEVEAIGHV 239
RF E LGEG +G VYKG L +E VA+K L N + ++EFR E E + +
Sbjct: 8 RFLEE--LGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDL 65
Query: 240 RHKNLVRLLGYCIEGVHRMLVYEYVNNGNLEQWLHGAMRNQGN--LTWEARMKVIIGTAK 297
+H N+V LLG C + +++EY+ +G+L ++L +RN + + E+ + + +
Sbjct: 66 QHPNIVCLLGVCTKEQPTCMLFEYLAHGDLHEFL---VRNSPHSDVGAESGDETVKSSLD 122
Query: 298 ALAYLHEAIE----------PKVVHRDIKSSNILIDDEFNAKVSDFGLAKLLDSGESHIT 347
+LH AI+ VHRD+ + N L+ + K+SDFGL++ + S + +
Sbjct: 123 CSDFLHIAIQIAAGMEYLSSHHFVHRDLAARNCLVGEGLTVKISDFGLSRDIYSADYY-- 180
Query: 348 TRVMGT----FGYVAPEYANTGMLNEKSDIYSFGVLLLEAVT-GRDPVDYGRPANEV 399
RV ++ PE G +SDI+SFGV+L E + G P YG EV
Sbjct: 181 -RVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPY-YGFSNQEV 235
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283 |
| >gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Score = 103 bits (259), Expect = 4e-25
Identities = 72/255 (28%), Positives = 119/255 (46%), Gaps = 23/255 (9%)
Query: 187 RFSAENVLGEGGYGVVYK-GRLINGSEVAVKKL-LNNLGQAEKEFRV-EVEAIGHVRHKN 243
F LG+G YG VYK RL + A+K++ L ++ Q E+E V E+ + V H N
Sbjct: 1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPN 60
Query: 244 LVRLLGYCIEGVHRMLVYEYVNNGNLEQWLHGAMRNQGNLTWEARMKVIIGTAKALAYLH 303
++ ++G +V EY G+L + + + + + + ++ I + L LH
Sbjct: 61 IISYKEAFLDGNKLCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALH 120
Query: 304 EAIEPKVVHRDIKSSNILIDDEFNAKVSDFGLAKLLDSGESHITTRVMGTFGYVAPEYAN 363
E K++HRD+KS+NIL+ K+ D G++K+L + +GT Y+APE
Sbjct: 121 EQ---KILHRDLKSANILLVANDLVKIGDLGISKVLKKN---MAKTQIGTPHYMAPEVWK 174
Query: 364 TGMLNEKSDIYSFGVLLLEAVTGRDPVDYGRPANEVNLVEWLKMMVGT---------RRA 414
+ KSDI+S G LL E T P + R ++ K+ G +
Sbjct: 175 GRPYSYKSDIWSLGCLLYEMATFAPPFE-ARSMQDLR----YKVQRGKYPPIPPIYSQDL 229
Query: 415 EEVVDPNLEVKPATR 429
+ + L+VKP R
Sbjct: 230 QNFIRSMLQVKPKLR 244
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256 |
| >gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 102 bits (258), Expect = 8e-25
Identities = 65/218 (29%), Positives = 100/218 (45%), Gaps = 29/218 (13%)
Query: 194 LGEGGYGVVYKGRLINGSEV-AVKKLLNNLGQAEKEFRVEVEAIGH----------VRHK 242
LG+G +G V R + ++ A+K L +K+ ++ + + H + H
Sbjct: 1 LGKGSFGKVLLVRKKDTGKLYAMKVL-------KKKKIIKRKEVEHTLTERNILSRINHP 53
Query: 243 NLVRLLGYCIEGVHRMLVYEYVNNGNLEQWLHGAMRNQGNLTWEARMKVIIG-TAKALAY 301
+V+L LV EY G L + H + +G + E R + AL Y
Sbjct: 54 FIVKLHYAFQTEEKLYLVLEYAPGGEL--FSH--LSKEGRFS-EERARFYAAEIVLALEY 108
Query: 302 LHEAIEPKVVHRDIKSSNILIDDEFNAKVSDFGLAKLLDSGESHITTRVMGTFGYVAPEY 361
LH +++RD+K NIL+D + + K++DFGLAK L S S T GT Y+APE
Sbjct: 109 LHSL---GIIYRDLKPENILLDADGHIKLTDFGLAKELSSEGSRTNTFC-GTPEYLAPEV 164
Query: 362 ANTGMLNEKSDIYSFGVLLLEAVTGRDPVDYGRPANEV 399
+ D +S GVLL E +TG+ P Y E+
Sbjct: 165 LLGKGYGKAVDWWSLGVLLYEMLTGKPPF-YAEDRKEI 201
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250 |
| >gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Score = 101 bits (253), Expect = 2e-24
Identities = 58/207 (28%), Positives = 107/207 (51%), Gaps = 9/207 (4%)
Query: 194 LGEGGYGVVYKGRLINGSEVAVKKLLNNLGQAEKEFRVEVEAIGHVRHKNLVRLLGYCIE 253
+G G +G+V+ G + +VA+K + +E++F E + + + H LV+L G C E
Sbjct: 12 IGSGQFGLVWLGYWLEKRKVAIKTIREGA-MSEEDFIEEAQVMMKLSHPKLVQLYGVCTE 70
Query: 254 GVHRMLVYEYVNNGNLEQWLHGAMRNQGNLTWEARMKVIIGTAKALAYLHEAIEPKVVHR 313
LV+E++ +G L +L +G + E + + + + +AYL + V+HR
Sbjct: 71 RSPICLVFEFMEHGCLSDYLRA---QRGKFSQETLLGMCLDVCEGMAYLESS---NVIHR 124
Query: 314 DIKSSNILIDDEFNAKVSDFGLAKLLDSGESHITTRVMGTFGYVAPEYANTGMLNEKSDI 373
D+ + N L+ + KVSDFG+ + + + +T + +PE + + KSD+
Sbjct: 125 DLAARNCLVGENQVVKVSDFGMTRFVLDDQYTSSTGTKFPVKWSSPEVFSFSKYSSKSDV 184
Query: 374 YSFGVLLLEAVT-GRDPVDYGRPANEV 399
+SFGVL+ E + G+ P + R +EV
Sbjct: 185 WSFGVLMWEVFSEGKTPYE-NRSNSEV 210
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256 |
| >gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Score = 101 bits (254), Expect = 2e-24
Identities = 77/274 (28%), Positives = 129/274 (47%), Gaps = 33/274 (12%)
Query: 193 VLGEGGYG--VVYKGRLINGSEVAVKKLLNNLGQ-AEKEFRV---EVEAIGHVRHKNLVR 246
VLG+G +G +Y+ R + S V K++ NL + +EKE R E+ + ++H N++
Sbjct: 7 VLGKGAFGEATLYR-RTEDDSLVVWKEV--NLTRLSEKERRDALNEIVILSLLQHPNIIA 63
Query: 247 LLGYCIEGVHRMLVYEYVNNGNLEQWLHGAMRNQGNLTWEAR-MKVIIGTAKALAYLHEA 305
+ ++ ++ EY N G L + +R +G L E + + A++Y+H+A
Sbjct: 64 YYNHFMDDNTLLIEMEYANGGTLYDKI---VRQKGQLFEEEMVLWYLFQIVSAVSYIHKA 120
Query: 306 IEPKVVHRDIKSSNILIDDEFNAKVSDFGLAKLLDSGESHITTRVMGTFGYVAPEYANTG 365
++HRDIK+ NI + K+ DFG++K+L S S T V+GT Y++PE
Sbjct: 121 ---GILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYSMAET-VVGTPYYMSPELCQGV 176
Query: 366 MLNEKSDIYSFGVLLLEAVTGRDPVDYGRPANEVNLVEWLKMMVGTRRAEEVVDPNLEVK 425
N KSDI++ G +L E +T + D P N V K++ G V
Sbjct: 177 KYNFKSDIWALGCVLYELLTLKRTFDATNPLNLVV-----KIVQGNY--------TPVVS 223
Query: 426 PATRALKRSLLVALRCVDPDSEKRPKMSQVVRML 459
+ L + + D EKRP +V+
Sbjct: 224 VYSSELIS---LVHSLLQQDPEKRPTADEVLDQP 254
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256 |
| >gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Score = 102 bits (255), Expect = 3e-24
Identities = 67/226 (29%), Positives = 110/226 (48%), Gaps = 23/226 (10%)
Query: 193 VLGEGGYGVVYKGRLINGSE------VAVKKLLN-NLGQAEKEFRVEVEAIGHVRHKNLV 245
LGEG +G V+ G + VAVK L A K+F E E + + +H+N+V
Sbjct: 12 ELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIV 71
Query: 246 RLLGYCIEGVHRMLVYEYVNNGNLEQWL--HG--AMR------NQGNLTWEARMKVIIGT 295
+ G C EG ++V+EY+ +G+L ++L HG A G LT +++ +
Sbjct: 72 KFYGVCTEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQI 131
Query: 296 AKALAYLHEAIEPKVVHRDIKSSNILIDDEFNAKVSDFGLAKLLDSGESH-ITTRVMGTF 354
A + YL VHRD+ + N L+ + K+ DFG+++ + + + + + M
Sbjct: 132 ASGMVYLASQ---HFVHRDLATRNCLVGYDLVVKIGDFGMSRDVYTTDYYRVGGHTMLPI 188
Query: 355 GYVAPEYANTGMLNEKSDIYSFGVLLLEAVT-GRDPVDYGRPANEV 399
++ PE +SD++SFGV+L E T G+ P YG EV
Sbjct: 189 RWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPW-YGLSNEEV 233
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280 |
| >gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Score = 101 bits (254), Expect = 3e-24
Identities = 78/289 (26%), Positives = 137/289 (47%), Gaps = 34/289 (11%)
Query: 182 EIATNRFSAENVLGEGGYGVVYKGRL-ING---SEVAVKKLLNNLGQAEKE---FRVEVE 234
EI + + + V+G G +G V++G L + G VA+K L G EK+ F E
Sbjct: 1 EIHPSHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTL--KPGYTEKQRQDFLSEAS 58
Query: 235 AIGHVRHKNLVRLLGYCIEGVHRMLVYEYVNNGNLEQWLHGAMRNQGNLTWEARMKVIIG 294
+G H N++RL G + M++ EY+ NG L+++L + G + + ++ G
Sbjct: 59 IMGQFSHHNIIRLEGVVTKFKPAMIITEYMENGALDKYLR---DHDGEFSSYQLVGMLRG 115
Query: 295 TAKALAYLHEAIEPKVVHRDIKSSNILIDDEFNAKVSDFGLAKLL--DSGESHITTRVMG 352
A + YL + VHRD+ + NIL++ KVSDFGL+++L D ++ T+
Sbjct: 116 IAAGMKYLSDM---NYVHRDLAARNILVNSNLECKVSDFGLSRVLEDDPEGTYTTSGGKI 172
Query: 353 TFGYVAPEYANTGMLNEKSDIYSFGVLLLEAVTGRDPVDYG-RPANEVNLVEWLKMMVGT 411
+ APE SD++SFG+++ E ++ +G RP +++ E +K +
Sbjct: 173 PIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMS------FGERPYWDMSNHEVMKAINDG 226
Query: 412 RRAEEVVDPNLEVKPATRALKRSLLVALRCVDPDSEKRPKMSQVVRMLE 460
R +D V + L+C D +RP+ +V +L+
Sbjct: 227 FRLPAPMDCPSAVYQ----------LMLQCWQQDRARRPRFVDIVNLLD 265
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268 |
| >gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 100 bits (251), Expect = 5e-24
Identities = 73/272 (26%), Positives = 116/272 (42%), Gaps = 34/272 (12%)
Query: 194 LGEGGYGVVYKGRLINGSEVAVKKLLNNLGQAEKEFRVEVEAIGHVRHKNLVRLLGYCIE 253
LG G +GVV+ G+ +VA+K ++ +E +F E + + + H NLV+L G C +
Sbjct: 12 LGSGQFGVVHLGKWRGKIDVAIK-MIREGAMSEDDFIEEAKVMMKLSHPNLVQLYGVCTK 70
Query: 254 GVHRMLVYEYVNNGNLEQWLHGAMRNQGNLTWEARMKVIIGTAKALAYLHEAIEPKVVHR 313
+V EY+ NG L +L +G L E + + +A+ YL +HR
Sbjct: 71 QRPIFIVTEYMANGCLLNYLR---ERKGKLGTEWLLDMCSDVCEAMEYLESN---GFIHR 124
Query: 314 DIKSSNILIDDEFNAKVSDFGLAK--LLDSGESHITTRVMGTFGYVAPEYANTGMLNEKS 371
D+ + N L+ ++ KVSDFGLA+ L D S T+ + PE + + KS
Sbjct: 125 DLAARNCLVGEDNVVKVSDFGLARYVLDDQYTSSQGTKF--PVKWAPPEVFDYSRFSSKS 182
Query: 372 DIYSFGVLLLEAVTGRDPVDYGRPANEVNLVEWLKMMVGTRRAEEVVDPNLE----VKPA 427
D++SFGVL+ E + KM EVV+ +P
Sbjct: 183 DVWSFGVLMWEVFSEG------------------KMPYERFSNSEVVESVSAGYRLYRP- 223
Query: 428 TRALKRSLLVALRCVDPDSEKRPKMSQVVRML 459
A + C E RP +++ L
Sbjct: 224 KLAPTEVYTIMYSCWHEKPEDRPAFKKLLSQL 255
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256 |
| >gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 100 bits (252), Expect = 9e-24
Identities = 69/232 (29%), Positives = 109/232 (46%), Gaps = 48/232 (20%)
Query: 194 LGEGGYGVVYKGR-LINGSEVAVKKLLNNLGQAEKEFRV----EVEAIGHVRHKNLVRLL 248
+GEG YG VYK R G VA+KK+ + ++ F + E++ + +RH N+VRL
Sbjct: 7 IGEGTYGQVYKARNKKTGELVALKKI--RMENEKEGFPITAIREIKLLQKLRHPNIVRL- 63
Query: 249 GYCIEGVHRM------LVYEYVNNGNLEQWLHGAMRNQGNLTWEAR----MKVIIGTAKA 298
E V +V+EY ++ L G + + E++ MK ++ +
Sbjct: 64 ---KEIVTSKGKGSIYMVFEY-----MDHDLTGLLDSPEVKFTESQIKCYMKQLL---EG 112
Query: 299 LAYLHEAIEPKVVHRDIKSSNILIDDEFNAKVSDFGLAKLLDSGESHITTRVMGTFGYVA 358
L YLH ++HRDIK SNILI+++ K++DFGLA+ S T + T Y
Sbjct: 113 LQYLHSN---GILHRDIKGSNILINNDGVLKLADFGLARPYTKRNSADYTNRVITLWYRP 169
Query: 359 PE-------YANTGMLNEKSDIYSFGVLLLEAVTGRDPVDYGRPANEVNLVE 403
PE Y + D++S G +L E G+ P+ G E+ +E
Sbjct: 170 PELLLGATRY------GPEVDMWSVGCILAELFLGK-PIFQGS--TELEQLE 212
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287 |
| >gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Score = 99.3 bits (248), Expect = 2e-23
Identities = 64/206 (31%), Positives = 96/206 (46%), Gaps = 16/206 (7%)
Query: 188 FSAENVLGEGGYGVVYKGR-LINGSEVAVKKLLNN--LGQAEKEFRVEVEAIGHVRHKNL 244
F LGEG YG VYK G VA+K + L + KE + + +
Sbjct: 5 FDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEEDLQEIIKEISI----LKQCDSPYI 60
Query: 245 VRLLGYCIEGVHRMLVYEYVNNGNLEQWLHGAMRNQGNLTWEARMKVII-GTAKALAYLH 303
V+ G + +V EY G++ M+ E + I+ T K L YLH
Sbjct: 61 VKYYGSYFKNTDLWIVMEYCGAGSVSD----IMKITNKTLTEEEIAAILYQTLKGLEYLH 116
Query: 304 EAIEPKVVHRDIKSSNILIDDEFNAKVSDFGLAKLLDSGESHITTRVMGTFGYVAPEYAN 363
K +HRDIK+ NIL+++E AK++DFG++ L + T V+GT ++APE
Sbjct: 117 SN---KKIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMAKRNT-VIGTPFWMAPEVIQ 172
Query: 364 TGMLNEKSDIYSFGVLLLEAVTGRDP 389
N K+DI+S G+ +E G+ P
Sbjct: 173 EIGYNNKADIWSLGITAIEMAEGKPP 198
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256 |
| >gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Score = 99.4 bits (248), Expect = 2e-23
Identities = 75/273 (27%), Positives = 133/273 (48%), Gaps = 23/273 (8%)
Query: 192 NVLGEGGYGVVYKGRLI-NGSEVAVKKL-LNNLGQAEKEFRVEVEAIGHVRHKNLVRLLG 249
V+G G VVY + N +VA+K++ L + E R EV+A+ H N+V+
Sbjct: 7 EVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYT 66
Query: 250 YCIEGVHRMLVYEYVNNGNLEQWLHGAMRNQGNLTWEARMKVII-GTAKALAYLHEAIEP 308
+ G LV Y++ G+L + + G EA + ++ K L YLH
Sbjct: 67 SFVVGDELWLVMPYLSGGSLLDIMKSSYPRGGLD--EAIIATVLKEVLKGLEYLHSN--- 121
Query: 309 KVVHRDIKSSNILIDDEFNAKVSDFGL-AKLLDSGESHITTR--VMGTFGYVAPEYANTG 365
+HRDIK+ NIL+ ++ + K++DFG+ A L D G+ R +GT ++APE
Sbjct: 122 GQIHRDIKAGNILLGEDGSVKIADFGVSASLADGGDRTRKVRKTFVGTPCWMAPEVMEQV 181
Query: 366 M-LNEKSDIYSFGVLLLEAVTGRDPVDYGRPANEVNLVEWLKMMVGTRRAEEVVDPNLEV 424
+ K+DI+SFG+ +E TG P P +V +M+ + ++ +
Sbjct: 182 HGYDFKADIWSFGITAIELATGAAPY-SKYPPMKV-------LMLTLQNDPPSLETGADY 233
Query: 425 KPATRALKRSLLVALRCVDPDSEKRPKMSQVVR 457
K +++ ++ +++L C+ D KRP ++++
Sbjct: 234 KKYSKSFRK--MISL-CLQKDPSKRPTAEELLK 263
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267 |
| >gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Score = 99.2 bits (247), Expect = 2e-23
Identities = 67/209 (32%), Positives = 102/209 (48%), Gaps = 18/209 (8%)
Query: 192 NVLGEGGYGVVYKGRLINGSEVAVKKLL---NNLGQAEKEFRV---EVEAIGHVRHKNLV 245
VLG+G YG VY G G +AVK++ +N+ AEKE+ EV+ + ++H N+V
Sbjct: 6 EVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIV 65
Query: 246 RLLGYCIEGVHRMLVYEYVNNGNLEQWLHGAMRNQGNLTWEARMKVIIGTAKALAYLHEA 305
+ LG C++ + E+V G++ + G L K +AYLH
Sbjct: 66 QYLGTCLDDNTISIFMEFVPGGSISS----ILNRFGPLPEPVFCKYTKQILDGVAYLHNN 121
Query: 306 IEPKVVHRDIKSSNILIDDEFNAKVSDFGLAKLL-----DSGESHITTRVMGTFGYVAPE 360
VVHRDIK +N+++ K+ DFG A+ L S++ + GT ++APE
Sbjct: 122 ---CVVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHGTHSNMLKSMHGTPYWMAPE 178
Query: 361 YANTGMLNEKSDIYSFGVLLLEAVTGRDP 389
N KSDI+S G + E TG+ P
Sbjct: 179 VINESGYGRKSDIWSIGCTVFEMATGKPP 207
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265 |
| >gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 99.3 bits (248), Expect = 3e-23
Identities = 67/210 (31%), Positives = 100/210 (47%), Gaps = 19/210 (9%)
Query: 186 NRFSAENVLGEGGYGVVYKGRLINGSE-VAVKKLLNNLGQAE-KEFRV-EVEAIGHVRHK 242
N++ V+GEG YGVV K R E VA+KK + + K+ + EV+ + +RH+
Sbjct: 1 NKYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHE 60
Query: 243 NLVRLLGYCIEGVHRMLVYEYVNNGNLEQWLHGAMRNQGNLTWEARMKVIIGTAKALAYL 302
N+V L LV+EYV L + L + G L +A I +A+AY
Sbjct: 61 NIVNLKEAFRRKGRLYLVFEYVER-TLLELLE---ASPGGLPPDAVRSYIWQLLQAIAYC 116
Query: 303 HEAIEPKVVHRDIKSSNILIDDEFNAKVSDFGLAKLL-DSGESHITTRVMGTFGYVAPE- 360
H ++HRDIK NIL+ + K+ DFG A+ L S +T V T Y APE
Sbjct: 117 HSH---NIIHRDIKPENILVSESGVLKLCDFGFARALRARPASPLTDYV-ATRWYRAPEL 172
Query: 361 ---YANTGMLNEKSDIYSFGVLLLEAVTGR 387
N G + D+++ G ++ E + G
Sbjct: 173 LVGDTNYG---KPVDVWAIGCIMAELLDGE 199
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288 |
| >gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Score = 98.2 bits (245), Expect = 5e-23
Identities = 71/211 (33%), Positives = 107/211 (50%), Gaps = 24/211 (11%)
Query: 192 NVLGEGGYGVVYKGRLINGSEV-AVK--KLLNNLGQAEKEFRVEVEAIGHVRHKNLVRLL 248
N +G G +G VY ++ E+ AVK ++ +N + KE E++ + ++H NLV+
Sbjct: 6 NKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYY 65
Query: 249 GYCIEGVHRMLVY---EYVNNGNLEQWLHGAMRNQGNLTWEARMKV-IIGTAKALAYLHE 304
G +E VHR VY EY + G LE+ L G + E ++V + + LAYLH
Sbjct: 66 G--VE-VHREKVYIFMEYCSGGTLEELLEH-----GRILDEHVIRVYTLQLLEGLAYLHS 117
Query: 305 AIEPKVVHRDIKSSNILIDDEFNAKVSDFGLAKLLDSGESHITTRV---MGTFGYVAPEY 361
+VHRDIK +NI +D K+ DFG A L + + + V GT Y+APE
Sbjct: 118 H---GIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMGEEVQSLAGTPAYMAPEV 174
Query: 362 ANTGMLNEK---SDIYSFGVLLLEAVTGRDP 389
G +DI+S G ++LE TG+ P
Sbjct: 175 ITGGKGKGHGRAADIWSLGCVVLEMATGKRP 205
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264 |
| >gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Score = 98.4 bits (246), Expect = 5e-23
Identities = 63/200 (31%), Positives = 98/200 (49%), Gaps = 13/200 (6%)
Query: 193 VLGEGGYGVVYKG-RLINGSEVAVKKLLNNLGQAEKEFRV-EVEAIGHVRHKNLVRLLGY 250
+GEG G VYK G EVA+KK+ L + KE + E+ + +H N+V
Sbjct: 26 KIGEGASGEVYKATDRATGKEVAIKKM--RLRKQNKELIINEILIMKDCKHPNIVDYYDS 83
Query: 251 CIEGVHRMLVYEYVNNGNLEQWLHGAMRNQGNLTWEARMKVIIG-TAKALAYLHEAIEPK 309
+ G +V EY++ G+L + +N + E ++ + + L YLH
Sbjct: 84 YLVGDELWVVMEYMDGGSLTDIIT---QNFVRMN-EPQIAYVCREVLQGLEYLHSQ---N 136
Query: 310 VVHRDIKSSNILIDDEFNAKVSDFGLAKLLDSGESHITTRVMGTFGYVAPEYANTGMLNE 369
V+HRDIKS NIL+ + + K++DFG A L +S + V GT ++APE
Sbjct: 137 VIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEKSKRNSVV-GTPYWMAPEVIKRKDYGP 195
Query: 370 KSDIYSFGVLLLEAVTGRDP 389
K DI+S G++ +E G P
Sbjct: 196 KVDIWSLGIMCIEMAEGEPP 215
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286 |
| >gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Score = 97.4 bits (242), Expect = 6e-23
Identities = 76/271 (28%), Positives = 124/271 (45%), Gaps = 24/271 (8%)
Query: 193 VLGEGGYGVVYKGRLINGSEVAVKKLLNNLGQAEK-EFRVEVEAIGHVRHKNLVRLLGYC 251
+LG+G +G V+KG L + + VAVK +L Q K +F E + H N+V+L+G C
Sbjct: 2 LLGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVC 61
Query: 252 IEGVHRMLVYEYVNNGNLEQWLHGAMRNQGNLTWEARMKVIIGTAKALAYLHEAIEPKVV 311
+ +V E V G+ +L + + L + +K + A +AYL +
Sbjct: 62 TQRQPIYIVMELVPGGDFLSFLR---KKKDELKTKQLVKFALDAAAGMAYLESK---NCI 115
Query: 312 HRDIKSSNILIDDEFNAKVSDFGLAKLLDSGESHITTRVMGTFGYVAPEYANTGMLNEKS 371
HRD+ + N L+ + K+SDFG+++ D G + + APE N G + +S
Sbjct: 116 HRDLAARNCLVGENNVLKISDFGMSRQEDDGIYSSSGLKQIPIKWTAPEALNYGRYSSES 175
Query: 372 DIYSFGVLLLEAVT-GRDPVDYGRPANEVNLVEWLKMMVGTRRAEEVVDPNLEVKPATRA 430
D++S+G+LL E + G P Y N+ +A E V+ + +
Sbjct: 176 DVWSYGILLWETFSLGVCP--YPGMTNQ--------------QAREQVEKGYRMSCPQKC 219
Query: 431 LKRSLLVALRCVDPDSEKRPKMSQVVRMLEA 461
V RC D E RPK S++ + L A
Sbjct: 220 PDDVYKVMQRCWDYKPENRPKFSELQKELAA 250
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250 |
| >gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 97.8 bits (244), Expect = 7e-23
Identities = 59/212 (27%), Positives = 97/212 (45%), Gaps = 29/212 (13%)
Query: 194 LGEGGYGVVYKGRLIN------GSEVAVKKLLNNLGQAEK-EFRVEVEAIGHVRHKNLVR 246
LG+G +G+VY+G + VA+K + N E+ EF E + ++VR
Sbjct: 14 LGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVR 73
Query: 247 LLGYCIEGVHRMLVYEYVNNGNLEQWLHGAM------RNQGNLTWEARMKVIIGTAKALA 300
LLG G ++V E + G+L+ +L G T + +++ A +A
Sbjct: 74 LLGVVSTGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMA 133
Query: 301 YLHEAIEPKVVHRDIKSSNILIDDEFNAKVSDFGLAKLL-------DSGESHITTRVMGT 353
YL K VHRD+ + N ++ ++ K+ DFG+ + + G+ + R M
Sbjct: 134 YLAAK---KFVHRDLAARNCMVAEDLTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWM-- 188
Query: 354 FGYVAPEYANTGMLNEKSDIYSFGVLLLEAVT 385
APE G+ KSD++SFGV+L E T
Sbjct: 189 ----APESLKDGVFTTKSDVWSFGVVLWEMAT 216
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277 |
| >gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 97.9 bits (244), Expect = 8e-23
Identities = 74/275 (26%), Positives = 122/275 (44%), Gaps = 22/275 (8%)
Query: 192 NVLGEGGYGVVYKGRLINGSEVAVKKLLNNLGQAE--KEFRVEVEAIGHVRHKNLVRLLG 249
+ LGEG G V K RL N + K + + K+ E+E + +V+ G
Sbjct: 7 SRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYIVKYYG 66
Query: 250 YCIEGVHRML--VYEYVNNGNLEQWLHGAMRNQGNLTWEARM-KVIIGTAKALAYLHEAI 306
++ + EY G+L+ ++ ++ +G E + K+ K L+YLH
Sbjct: 67 AFLDESSSSIGIAMEYCEGGSLDS-IYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSR- 124
Query: 307 EPKVVHRDIKSSNILIDDEFNAKVSDFGLA-KLLDSGESHITTRVMGTFGYVAPEYANTG 365
K++HRDIK SNIL+ + K+ DFG++ +L++S T GT Y+APE
Sbjct: 125 --KIIHRDIKPSNILLTRKGQVKLCDFGVSGELVNSLAGTFT----GTSFYMAPERIQGK 178
Query: 366 MLNEKSDIYSFGVLLLEAVTGRDPVDYGRPANEVNLVEWLKMMVGTRRAEEVVDPNLEVK 425
+ SD++S G+ LLE R P + +E L +V E +P +K
Sbjct: 179 PYSITSDVWSLGLTLLEVAQNRFPFPPEGEPP-LGPIELLSYIVNMPNPELKDEPGNGIK 237
Query: 426 PATRALKRSLLVALRCVDPDSEKRPKMSQVVRMLE 460
+ K + +C++ D +RP MLE
Sbjct: 238 -WSEEFKDFI---KQCLEKDPTRRPTPWD---MLE 265
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287 |
| >gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Score = 97.3 bits (242), Expect = 8e-23
Identities = 81/272 (29%), Positives = 134/272 (49%), Gaps = 32/272 (11%)
Query: 193 VLGEGGYGVVYKGRLINGSEVAVKKLLNNLGQAEKEFRVEVEAIGHVRHKNLVRLLGYCI 252
++GEG +G V +G G +VAVK + ++ + F E + + HKNLVRLLG +
Sbjct: 13 IIGEGEFGAVLQGEYT-GQKVAVKNIKCDV--TAQAFLEETAVMTKLHHKNLVRLLGVIL 69
Query: 253 -EGVHRMLVYEYVNNGNLEQWLHGAMRNQGNLTWEARMKVIIGTAKALAYLHEAIEPKVV 311
G++ +V E ++ GNL +L R + ++ ++ + A+ + YL K+V
Sbjct: 70 HNGLY--IVMELMSKGNLVNFLR--TRGRALVSVIQLLQFSLDVAEGMEYLESK---KLV 122
Query: 312 HRDIKSSNILIDDEFNAKVSDFGLAKLLDSGESHITTRVMGTFGYVAPEYANTGMLNEKS 371
HRD+ + NIL+ ++ AKVSDFGLA++ G + V T APE + KS
Sbjct: 123 HRDLAARNILVSEDGVAKVSDFGLARVGSMGVDNSKLPVKWT----APEALKHKKFSSKS 178
Query: 372 DIYSFGVLLLEAVTGRDPVDYGR-PANEVNLVEWLKMMVGTRRAEEVVDPNLEVKPATRA 430
D++S+GVLL E + YGR P +++L E + + R ++P
Sbjct: 179 DVWSYGVLLWEVFS------YGRAPYPKMSLKEVKECVEKGYR----MEPPEGCPADVYV 228
Query: 431 LKRSLLVALRCVDPDSEKRPKMSQVVRMLEAD 462
L S C + + +KRP ++ LE +
Sbjct: 229 LMTS------CWETEPKKRPSFHKLREKLEKE 254
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254 |
| >gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Score = 97.5 bits (243), Expect = 9e-23
Identities = 78/296 (26%), Positives = 128/296 (43%), Gaps = 36/296 (12%)
Query: 182 EIATNRFSAENVLGEGGYGVVYKG--RLINGS----EVAVKKLLNNL-GQAEKEFRVEVE 234
E+ + + LG G +G VY+G R +G +VAVK L + Q E +F +E
Sbjct: 2 EVPRDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEAL 61
Query: 235 AIGHVRHKNLVRLLGYCIEGVHRMLVYEYVNNGNLEQWLHGAMRNQGN---LTWEARMKV 291
+ H+N+VRL+G E + R ++ E + G+L+ +L LT + +
Sbjct: 62 IMSKFNHQNIVRLIGVSFERLPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFC 121
Query: 292 IIGTAKALAYLHEAIEPKVVHRDIKSSNILIDDEFN---AKVSDFGLAK-LLDSGESHIT 347
AK YL E +HRDI + N L+ + AK++DFG+A+ + +
Sbjct: 122 ARDVAKGCKYLEEN---HFIHRDIAARNCLLTCKGPGRVAKIADFGMARDIYRASYYRKG 178
Query: 348 TRVMGTFGYVAPEYANTGMLNEKSDIYSFGVLLLEAVT-GRDPVDY-GRPANEVNLVEWL 405
R M ++ PE G+ K+D++SFGVLL E + G P Y GR EV +
Sbjct: 179 GRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMP--YPGRTNQEV-----M 231
Query: 406 KMMVGTRRAEEVVDPNLEVKPATRALKRSLLVALRCVDPDSEKRPKMSQVVRMLEA 461
+ + G R + P + C E RP + ++ ++
Sbjct: 232 EFVTGGGRLD----------PPKGCPGPVYRIMTDCWQHTPEDRPNFATILERIQY 277
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277 |
| >gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 97.0 bits (242), Expect = 2e-22
Identities = 59/200 (29%), Positives = 100/200 (50%), Gaps = 16/200 (8%)
Query: 194 LGEGGYGVVYKGR-LINGSEVAVKKLL---NNLGQAEKEFRVEVEAIGHVRHKNLVRLLG 249
+GEG YGVVYK R + G VA+KK+ + G + R E++ + + H N+++LL
Sbjct: 7 IGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALR-EIKLLKELNHPNIIKLLD 65
Query: 250 YCIEGVHRMLVYEYVNNGNLEQWLHGAMRNQGNLTWEARMKVII-GTAKALAYLHEAIEP 308
LV+E+ ++ L+ ++++ E+ +K + + LA+ H
Sbjct: 66 VFRHKGDLYLVFEF-----MDTDLYKLIKDRQRGLPESLIKSYLYQLLQGLAFCHSH--- 117
Query: 309 KVVHRDIKSSNILIDDEFNAKVSDFGLAKLLDSGESHITTRVMGTFGYVAPE-YANTGML 367
++HRD+K N+LI+ E K++DFGLA+ S T V+ T Y APE
Sbjct: 118 GILHRDLKPENLLINTEGVLKLADFGLARSFGSPVRPYTHYVV-TRWYRAPELLLGDKGY 176
Query: 368 NEKSDIYSFGVLLLEAVTGR 387
+ DI+S G + E ++ R
Sbjct: 177 STPVDIWSVGCIFAELLSRR 196
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283 |
| >gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 98.0 bits (245), Expect = 2e-22
Identities = 66/225 (29%), Positives = 108/225 (48%), Gaps = 45/225 (20%)
Query: 187 RFSAENVLGEGGYGVVYKGR-LINGSEVAVKKLLN---NLGQAEKEFRVEVEAIGHVRHK 242
R+ +G G YGVV G +VA+KK+ N +L A++ R E++ + H+RH+
Sbjct: 1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILR-EIKLLRHLRHE 59
Query: 243 NLVRLL-------GYCIEGVHRMLVYEYVNNGNLEQWLHGAMRNQGNLTWEARMKVIIGT 295
N++ LL V+ +V E +E LH +++ LT + ++ +
Sbjct: 60 NIIGLLDILRPPSPEDFNDVY--IVTEL-----METDLHKVIKSPQPLT-DDHIQYFLYQ 111
Query: 296 A-KALAYLHEAIEPKVVHRDIKSSNILIDDEFNAKVSDFGLAKLLDSGES-------HIT 347
+ L YLH A V+HRD+K SNIL++ + K+ DFGLA+ +D E ++
Sbjct: 112 ILRGLKYLHSA---NVIHRDLKPSNILVNSNCDLKICDFGLARGVDPDEDEKGFLTEYVV 168
Query: 348 TRVMGTFGYVAPEYANTGMLNEKS-----DIYSFGVLLLEAVTGR 387
TR Y APE +L+ DI+S G + E +T +
Sbjct: 169 TRW-----YRAPEL----LLSSSRYTKAIDIWSVGCIFAELLTRK 204
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330 |
| >gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Score = 95.7 bits (238), Expect = 3e-22
Identities = 80/282 (28%), Positives = 129/282 (45%), Gaps = 36/282 (12%)
Query: 191 ENVLGEGGYGVVYKGRL-INGSE---VAVKKLLNNLGQAE-KEFRVEVEAIGHVRHKNLV 245
E V+G G +G V +GRL + G VA+K L + + + ++F E +G H N++
Sbjct: 9 EEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNII 68
Query: 246 RLLGYCIEGVHRMLVYEYVNNGNLEQWLHGAMRNQGNLTWEARMKVIIGTAKALAYLHEA 305
L G + M++ E++ NG L+ +L +N G T + ++ G A + YL E
Sbjct: 69 HLEGVVTKSRPVMIITEFMENGALDSFLR---QNDGQFTVIQLVGMLRGIAAGMKYLSEM 125
Query: 306 IEPKVVHRDIKSSNILIDDEFNAKVSDFGLAKLLDSGESHIT-TRVMG---TFGYVAPEY 361
VHRD+ + NIL++ KVSDFGL++ L+ S T T +G + APE
Sbjct: 126 ---NYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSSLGGKIPIRWTAPEA 182
Query: 362 ANTGMLNEKSDIYSFGVLLLEAVT-GRDPVDYGRPANE--VNLVEWLKMMVGTRRAEEVV 418
SD++S+G+++ E ++ G P Y +N+ +N +E
Sbjct: 183 IAYRKFTSASDVWSYGIVMWEVMSYGERP--YWDMSNQDVINAIEQ-------------- 226
Query: 419 DPNLEVKPATRALKRSLLVALRCVDPDSEKRPKMSQVVRMLE 460
D L L+ L C D RPK Q+V L+
Sbjct: 227 DYRLPPPMDCPTALHQLM--LDCWQKDRNARPKFGQIVSTLD 266
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269 |
| >gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Score = 95.6 bits (238), Expect = 4e-22
Identities = 74/280 (26%), Positives = 120/280 (42%), Gaps = 29/280 (10%)
Query: 193 VLGEGGYGVVYKGRLINGSE------VAVKKLLN-NLGQAEKEFRVEVEAIGHVRHKNLV 245
LG G +G V+ + E V VK L + EFR E++ + HKN+V
Sbjct: 12 TLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVV 71
Query: 246 RLLGYCIEGVHRMLVYEYVNNGNLEQWLHGA-----MRNQGNLTWEARMKVIIGTAKALA 300
RLLG C E ++ EY + G+L+Q+L L+ + ++ + A +
Sbjct: 72 RLLGLCREAEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMD 131
Query: 301 YLHEAIEPKVVHRDIKSSNILIDDEFNAKVSDFGLAKLLDSGESHITTRVMGTFGYVAPE 360
+L A + VHRD+ + N L+ + KVS L+K + + E + + ++APE
Sbjct: 132 HLSNA---RFVHRDLAARNCLVSSQREVKVSLLSLSKDVYNSEYYKLRNALIPLRWLAPE 188
Query: 361 YANTGMLNEKSDIYSFGVLLLEAVTGRDPVDYGRPANEVNLVEWLKMMVGTRRAEEVVDP 420
+ KSD++SFGVL+ E T + YG EV + L+
Sbjct: 189 AVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLSDEEV--LNRLQ------------AG 234
Query: 421 NLEVKPATRALKRSLLVALRCVDPDSEKRPKMSQVVRMLE 460
LE+ R + RC + + RP S++V L
Sbjct: 235 KLELPVPEGCPSRLYKLMTRCWAVNPKDRPSFSELVSALG 274
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275 |
| >gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Score = 95.5 bits (238), Expect = 4e-22
Identities = 63/203 (31%), Positives = 99/203 (48%), Gaps = 12/203 (5%)
Query: 192 NVLGEGGYGVVYKGRLI-NGSEVAVKKLLNNLGQAE-KEFRVEVEAIGHVRHKNLVRLLG 249
LG G GVV K G +AVK + + +A K+ E++ + +V G
Sbjct: 7 GELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYG 66
Query: 250 YCIEGVHRMLVYEYVNNGNLEQWLHGAMRNQGNLTWEARMKVIIGTAKALAYLHEAIEPK 309
+ EY++ G+L++ L QG + K+ + K L YLHE K
Sbjct: 67 AFYNNGDISICMEYMDGGSLDKILK---EVQGRIPERILGKIAVAVLKGLTYLHEKH--K 121
Query: 310 VVHRDIKSSNILIDDEFNAKVSDFGLA-KLLDSGESHITTRVMGTFGYVAPEYANTGMLN 368
++HRD+K SNIL++ K+ DFG++ +L++S + +GT Y+APE +
Sbjct: 122 IIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNS----LAKTFVGTSSYMAPERIQGNDYS 177
Query: 369 EKSDIYSFGVLLLEAVTGRDPVD 391
KSDI+S G+ L+E TGR P
Sbjct: 178 VKSDIWSLGLSLIELATGRFPYP 200
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265 |
| >gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Score = 95.4 bits (237), Expect = 5e-22
Identities = 87/288 (30%), Positives = 138/288 (47%), Gaps = 34/288 (11%)
Query: 183 IATNRFSAENVLGEGGYGVVYKGRLINGSE----VAVKKLLNNLGQAEKE---FRVEVEA 235
I + E V+G G +G V GRL + VA+K L G EK+ F E
Sbjct: 1 IDASCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTL--KAGYTEKQRRDFLSEASI 58
Query: 236 IGHVRHKNLVRLLGYCIEGVHRMLVYEYVNNGNLEQWLHGAMRNQGNLTWEARMKVIIGT 295
+G H N++ L G + M+V EY+ NG+L+ +L ++ G T + ++ G
Sbjct: 59 MGQFDHPNIIHLEGVVTKSKPVMIVTEYMENGSLDAFLR---KHDGQFTVIQLVGMLRGI 115
Query: 296 AKALAYLHEAIEPKVVHRDIKSSNILIDDEFNAKVSDFGLAKLL-DSGESHITTRVMGT- 353
A + YL + VHRD+ + NIL++ KVSDFGL+++L D E+ TTR
Sbjct: 116 ASGMKYLSDM---GYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIP 172
Query: 354 FGYVAPEYANTGMLNEKSDIYSFGVLLLEAVTGRDPVDYG-RPANEVNLVEWLKMMVGTR 412
+ APE SD++S+G+++ E ++ YG RP E++ + +K +
Sbjct: 173 IRWTAPEAIAYRKFTSASDVWSYGIVMWEVMS------YGERPYWEMSNQDVIKAIEEGY 226
Query: 413 RAEEVVDPNLEVKPATRALKRSLLVALRCVDPDSEKRPKMSQVVRMLE 460
R +D PA AL + + L C D +RPK Q+V +L+
Sbjct: 227 RLPAPMDC-----PA--ALHQ---LMLDCWQKDRNERPKFEQIVSILD 264
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267 |
| >gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Score = 94.9 bits (236), Expect = 6e-22
Identities = 67/213 (31%), Positives = 105/213 (49%), Gaps = 16/213 (7%)
Query: 182 EIATNRFSAENVLGEGGYGVVYKGRLINGSEVAVKKLLNNLGQAEKE-FRVEVEAIGHVR 240
E+ LG G +G V+ G ++VA+K L G E F E + ++
Sbjct: 2 EVPRETLKLVKKLGAGQFGEVWMGYYNGHTKVAIKSLKQ--GSMSPEAFLAEANLMKQLQ 59
Query: 241 HKNLVRLLGYCI-EGVHRMLVYEYVNNGNLEQWLHGAMRNQGNLTWEARMKVIIGTAKAL 299
H LVRL E ++ ++ EY+ NG+L +L + + M I A+ +
Sbjct: 60 HPRLVRLYAVVTQEPIY--IITEYMENGSLVDFLKTPEGIKLTINKLIDMAAQI--AEGM 115
Query: 300 AYLHEAIEPKVVHRDIKSSNILIDDEFNAKVSDFGLAKLLDSGESHITTRVMGTF--GYV 357
A++ +HRD++++NIL+ + K++DFGLA+L++ E T R F +
Sbjct: 116 AFIERK---NYIHRDLRAANILVSETLCCKIADFGLARLIEDNE--YTAREGAKFPIKWT 170
Query: 358 APEYANTGMLNEKSDIYSFGVLLLEAVT-GRDP 389
APE N G KSD++SFG+LL E VT GR P
Sbjct: 171 APEAINYGTFTIKSDVWSFGILLTEIVTYGRIP 203
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260 |
| >gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 94.9 bits (236), Expect = 7e-22
Identities = 66/270 (24%), Positives = 122/270 (45%), Gaps = 30/270 (11%)
Query: 193 VLGEGGYGVVYKGRLI-NGSEVAVKKLL---NNLGQAEK---EFRVEVEAIGHVRHKNLV 245
LG G + Y+ R + G+ +AVK++ N + E+ R E+ + + H +++
Sbjct: 7 QLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHII 66
Query: 246 RLLGYCIEGVHRMLVYEYVNNGNLEQWLHGAMRNQGNLTWEARMKVIIGTAKALAYLHEA 305
R+LG E H L E++ G++ L + + +++ G L+YLHE
Sbjct: 67 RMLGATCEDSHFNLFVEWMAGGSVSHLLSKYGAFKEAVIINYTEQLLRG----LSYLHEN 122
Query: 306 IEPKVVHRDIKSSNILIDDE-FNAKVSDFGLAKLLDS---GESHITTRVMGTFGYVAPEY 361
+++HRD+K +N+LID +++DFG A L + G +++GT ++APE
Sbjct: 123 ---QIIHRDVKGANLLIDSTGQRLRIADFGAAARLAAKGTGAGEFQGQLLGTIAFMAPEV 179
Query: 362 ANTGMLNEKSDIYSFGVLLLEAVTGRDPVDYGRPANEVNLVEWLKMMVGTRRAEEVVDPN 421
D++S G +++E T + P + + +N + L+ + E
Sbjct: 180 LRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNHLALIFKIASATTAPSIPE----- 234
Query: 422 LEVKPATRALKRSLLVALRCVDPDSEKRPK 451
+ P R V LRC++ E RP
Sbjct: 235 -HLSPGLRD------VTLRCLELQPEDRPP 257
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268 |
| >gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 94.5 bits (235), Expect = 9e-22
Identities = 62/213 (29%), Positives = 107/213 (50%), Gaps = 24/213 (11%)
Query: 193 VLGEGGYGVVYKG-RLINGSEVAVKKLLNNLGQAEKEFRV---------EVEAIGHVRHK 242
++G G +G VY G +G +AVK++ A + R E+ + ++H+
Sbjct: 7 LIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHE 66
Query: 243 NLVRLLGYCIEGVHRMLVYEYVNNGNLEQWLHGAMRNQGNLTWEARMKVII-GTAKALAY 301
N+V+ LG ++ H + EYV G++ A+ N E ++ + K L Y
Sbjct: 67 NIVQYLGSSLDADHLNIFLEYVPGGSVA-----ALLNNYGAFEETLVRNFVRQILKGLNY 121
Query: 302 LHEAIEPKVVHRDIKSSNILIDDEFNAKVSDFGLAKLLDSGESHITTR-----VMGTFGY 356
LH ++HRDIK +NIL+D++ K+SDFG++K L++ T + G+ +
Sbjct: 122 LHNR---GIIHRDIKGANILVDNKGGIKISDFGISKKLEANSLSTKTNGARPSLQGSVFW 178
Query: 357 VAPEYANTGMLNEKSDIYSFGVLLLEAVTGRDP 389
+APE K+DI+S G L++E +TG+ P
Sbjct: 179 MAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHP 211
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267 |
| >gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 94.3 bits (235), Expect = 1e-21
Identities = 62/202 (30%), Positives = 98/202 (48%), Gaps = 11/202 (5%)
Query: 192 NVLGEGGYGVVYKGRLINGSE-VAVKKLLNNLGQAEKEFRVEVEAIGHVRHKNLVRLLGY 250
+G G YG VYK R I E VA+K + G + + E+ + RH N+V G
Sbjct: 9 QRIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVAYFGS 68
Query: 251 CIEGVHRMLVYEYVNNGNLEQWLHGAMRNQGNLTWEARMKVIIGTAKALAYLHEAIEPKV 310
+ +V EY G+L+ +G L+ V T K LAYLHE
Sbjct: 69 YLRRDKLWIVMEYCGGGSLQDIYQ---VTRGPLSELQIAYVCRETLKGLAYLHET---GK 122
Query: 311 VHRDIKSSNILIDDEFNAKVSDFGLAKLLDSGESHITTRVMGTFGYVAPEYAN---TGML 367
+HRDIK +NIL+ ++ + K++DFG++ L + + + + GT ++APE A G
Sbjct: 123 IHRDIKGANILLTEDGDVKLADFGVSAQLTATIAKRKSFI-GTPYWMAPEVAAVERKGGY 181
Query: 368 NEKSDIYSFGVLLLEAVTGRDP 389
+ K DI++ G+ +E + P
Sbjct: 182 DGKCDIWALGITAIELAELQPP 203
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262 |
| >gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 94.5 bits (236), Expect = 1e-21
Identities = 67/218 (30%), Positives = 100/218 (45%), Gaps = 40/218 (18%)
Query: 188 FSAENVLGEGGYGVVYKGR-LINGSEVAVKKLLNNLGQAEKEFRV----EVEAIGHVRHK 242
+ LGEG YGVVYK R G VA+KK+ L E+ E+ + ++H
Sbjct: 1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIR--LDNEEEGIPSTALREISLLKELKHP 58
Query: 243 NLVRLLGYCIEGVHRMLVYEYVNNGNLEQWLHGAMRNQGNLTWEARMKVIIGTAK----- 297
N+V+LL LV+EY + +L+++L + G L+ K
Sbjct: 59 NIVKLLDVIHTERKLYLVFEYCDM-DLKKYLD---KRPGPLS--------PNLIKSIMYQ 106
Query: 298 ---ALAYLHEAIEPKVVHRDIKSSNILIDDEFNAKVSDFGLAKLLDSGESHITTRVMGTF 354
LAY H +++HRD+K NILI+ + K++DFGLA+ T V+ T
Sbjct: 107 LLRGLAYCHSH---RILHRDLKPQNILINRDGVLKLADFGLARAFGIPLRTYTHEVV-TL 162
Query: 355 GYVAPEYANTGMLNEKS-----DIYSFGVLLLEAVTGR 387
Y APE +L K DI+S G + E +TG+
Sbjct: 163 WYRAPEI----LLGSKHYSTAVDIWSVGCIFAEMITGK 196
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282 |
| >gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Score = 94.3 bits (235), Expect = 1e-21
Identities = 55/175 (31%), Positives = 94/175 (53%), Gaps = 20/175 (11%)
Query: 194 LGEGGYGVVYKGRLI-NGSEVAVKKL-LNNL--GQAEKEFRVEVEAIGHVRHKNLVRLLG 249
+GEG +G+V+K + G VA+KK+ L L G + R E++A+ +H +V+LL
Sbjct: 8 IGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALR-EIKALQACQHPYVVKLLD 66
Query: 250 YCIEGVHRMLVYEYVNNGNLEQWLHGAMRNQGNLTWEAR----MKVIIGTAKALAYLHEA 305
G +LV EY+ + L +R++ EA+ M++++ K +AY+H
Sbjct: 67 VFPHGSGFVLVMEYMPSD-----LSEVLRDEERPLPEAQVKSYMRMLL---KGVAYMHAN 118
Query: 306 IEPKVVHRDIKSSNILIDDEFNAKVSDFGLAKLLDSGESHITTRVMGTFGYVAPE 360
++HRD+K +N+LI + K++DFGLA+L E + + + T Y APE
Sbjct: 119 ---GIMHRDLKPANLLISADGVLKIADFGLARLFSEEEPRLYSHQVATRWYRAPE 170
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286 |
| >gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Score = 93.7 bits (233), Expect = 1e-21
Identities = 89/290 (30%), Positives = 135/290 (46%), Gaps = 52/290 (17%)
Query: 192 NVLGEGGYGVVYKGRLI--NGSEV--AVKKL--LNNLGQAEKEFRVEVEAIGHVRHKNLV 245
V+G+G +G VY G LI +G ++ AVK L + +L + E+ F E + H N++
Sbjct: 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQ-FLKEGIIMKDFSHPNVL 59
Query: 246 RLLGYCI--EGVHRMLVYEYVNNGNLEQWLHGAMRNQGNLTWEARMKVIIG----TAKAL 299
LLG C+ EG ++V Y+ +G+L ++ N +K +IG AK +
Sbjct: 60 SLLGICLPSEGS-PLVVLPYMKHGDLRNFIRSETHN-------PTVKDLIGFGLQVAKGM 111
Query: 300 AYLHEAIEPKVVHRDIKSSNILIDDEFNAKVSDFGLA-----KLLDSGESHITTRVMGTF 354
YL K VHRD+ + N ++D+ F KV+DFGLA K S +H ++
Sbjct: 112 EYLASK---KFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSVHNHTGAKL--PV 166
Query: 355 GYVAPEYANTGMLNEKSDIYSFGVLLLEAVTGRDPVDYGRPANEVNLVEWLKMMVGTRR- 413
++A E T KSD++SFGVLL E +T P P +V+ + ++ RR
Sbjct: 167 KWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAP-----PYPDVDSFDITVYLLQGRRL 221
Query: 414 --AEEVVDPNLEVKPATRALKRSLLVALRCVDPDSEKRPKMSQVVRMLEA 461
E DP E V L C P E RP S++V +E
Sbjct: 222 LQPEYCPDPLYE-------------VMLSCWHPKPEMRPTFSELVSRIEQ 258
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262 |
| >gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Score = 94.4 bits (235), Expect = 2e-21
Identities = 75/259 (28%), Positives = 128/259 (49%), Gaps = 43/259 (16%)
Query: 188 FSAENVLGEGGYGVVYKGR-LINGSEVAVKKL-LNNLGQAEKE------FRVEVEAIGHV 239
F N +GEG YG+VY+ R +G VA+KK+ ++N E++ R E+ + ++
Sbjct: 9 FEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDN----ERDGIPISSLR-EITLLLNL 63
Query: 240 RHKNLVRLL----GYCIEGVHRMLVYEYVNNGNLEQWLHGAMRNQGNLTWEARMKVI-IG 294
RH N+V L G ++ + LV EY EQ L + N E+++K + +
Sbjct: 64 RHPNIVELKEVVVGKHLDSI--FLVMEYC-----EQDLASLLDNMPTPFSESQVKCLMLQ 116
Query: 295 TAKALAYLHEAIEPKVVHRDIKSSNILIDDEFNAKVSDFGLAKLLDSGESHITTRVMGTF 354
+ L YLHE ++HRD+K SN+L+ D+ K++DFGLA+ +T +V+ T
Sbjct: 117 LLRGLQYLHENF---IIHRDLKVSNLLLTDKGCLKIADFGLARTYGLPAKPMTPKVV-TL 172
Query: 355 GYVAPEYANTGMLNEKS--DIYSFGVLLLEAVTGRDPVDYGRPANEVNLVEWLKMMVGTR 412
Y APE G + D+++ G +L E + + P+ G +E+ ++ + ++GT
Sbjct: 173 WYRAPELL-LGCTTYTTAIDMWAVGCILAELLAHK-PLLPG--KSEIEQLDLIIQLLGT- 227
Query: 413 RAEEVVDPNLEVKPATRAL 431
PN + P L
Sbjct: 228 -------PNESIWPGFSDL 239
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309 |
| >gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 93.5 bits (233), Expect = 2e-21
Identities = 69/220 (31%), Positives = 103/220 (46%), Gaps = 20/220 (9%)
Query: 184 ATNRFSAENVLGEGGYGVVYKGRLI-NGSEVAVKKLLNNLGQAEKEFRVEVEAI-GHVRH 241
T F V+GEG YG VYK R G VA+K +++ + E+E + E + + H
Sbjct: 4 PTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIK-IMDIIEDEEEEIKEEYNILRKYSNH 62
Query: 242 KNLVRLLGYCIEGVHRM------LVYEYVNNGNLEQWLHGAMRNQGNLTWEARMKVII-G 294
N+ G I+ LV E G++ L +R +G E + I+
Sbjct: 63 PNIATFYGAFIKKNPPGNDDQLWLVMELCGGGSVTD-LVKGLRKKGKRLKEEWIAYILRE 121
Query: 295 TAKALAYLHEAIEPKVVHRDIKSSNILIDDEFNAKVSDFGLAKLLDSGESHITTRVMGTF 354
T + LAYLHE KV+HRDIK NIL+ K+ DFG++ LDS T + GT
Sbjct: 122 TLRGLAYLHEN---KVIHRDIKGQNILLTKNAEVKLVDFGVSAQLDSTLGRRNTFI-GTP 177
Query: 355 GYVAPE-----YANTGMLNEKSDIYSFGVLLLEAVTGRDP 389
++APE + +SD++S G+ +E G+ P
Sbjct: 178 YWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPP 217
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275 |
| >gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 92.9 bits (231), Expect = 3e-21
Identities = 62/212 (29%), Positives = 96/212 (45%), Gaps = 34/212 (16%)
Query: 194 LGEGGYGVVYKG-RLINGSEVAVK--KLLNNLGQAE---KEFRVEVEAIGHVRHKNLVRL 247
LG G +G VY+G L +G AVK L ++ + K+ E+ + ++H N+V+
Sbjct: 8 LGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQY 67
Query: 248 LGYCIEGVHRMLVYEYVNNGNLEQWLHGAMRNQGNLTWEARMKVIIGTAK----ALAYLH 303
LG E + + E V G+L ++ G+ VI + L YLH
Sbjct: 68 LGTEREEDNLYIFLELVPGGSL----AKLLKKYGSFPEP----VIRLYTRQILLGLEYLH 119
Query: 304 EAIEPKVVHRDIKSSNILIDDEFNAKVSDFGLAKLLDSGESHITTRVM-----GTFGYVA 358
+ VHRDIK +NIL+D K++DFG+AK + G+ ++A
Sbjct: 120 DR---NTVHRDIKGANILVDTNGVVKLADFGMAK-------QVVEFSFAKSFKGSPYWMA 169
Query: 359 PEYAN-TGMLNEKSDIYSFGVLLLEAVTGRDP 389
PE G +DI+S G +LE TG+ P
Sbjct: 170 PEVIAQQGGYGLAADIWSLGCTVLEMATGKPP 201
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258 |
| >gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Score = 92.9 bits (231), Expect = 3e-21
Identities = 80/277 (28%), Positives = 132/277 (47%), Gaps = 25/277 (9%)
Query: 185 TNRFSAENVLGEGGYGVVYKGR-LINGSEVAVKKL----LNNLGQAEKEFRVEVEAIGHV 239
F E +G+G + VVYK L++G VA+KK+ + + + + E++ + +
Sbjct: 1 LGNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLK-EIDLLKQL 59
Query: 240 RHKNLVRLLGYCIEGVHRMLVYEYVNNGNLEQWLHGAMRNQGNLTWEARM-KVIIGTAKA 298
H N+++ L IE +V E + G+L + + + Q L E + K + A
Sbjct: 60 DHPNVIKYLASFIENNELNIVLELADAGDLSRMIKHF-KKQKRLIPERTIWKYFVQLCSA 118
Query: 299 LAYLHEAIEPKVVHRDIKSSNILIDDEFNAKVSDFGLAKLLDSGESHITTRVMGTFGYVA 358
L ++H +++HRDIK +N+ I K+ D GL + S + + V GT Y++
Sbjct: 119 LEHMHSK---RIMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLV-GTPYYMS 174
Query: 359 PEYANTGMLNEKSDIYSFGVLLLEAVTGRDPVDYGRPANEVNLVEWLKMMVGTRRAEEVV 418
PE + N KSDI+S G LL E + P YG N +L ++ E+
Sbjct: 175 PERIHENGYNFKSDIWSLGCLLYEMAALQSPF-YGDKMNLYSLC---------KKIEKCD 224
Query: 419 DPNLEVKPATRALKRSLLVALRCVDPDSEKRPKMSQV 455
P L + L+ LV+ RC++PD EKRP +S V
Sbjct: 225 YPPLPADHYSEELRD--LVS-RCINPDPEKRPDISYV 258
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Score = 92.8 bits (230), Expect = 3e-21
Identities = 73/211 (34%), Positives = 104/211 (49%), Gaps = 12/211 (5%)
Query: 182 EIATNRFSAENVLGEGGYGVVYKGRLINGSEVAVKKLLNNLGQAEKEFRVEVEAIGHVRH 241
EI E LG+G +G V+ G + VA+K L E F E + + +RH
Sbjct: 2 EIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEA-FLQEAQVMKKLRH 60
Query: 242 KNLVRLLGYCIEGVHRMLVYEYVNNGNLEQWLHGAMRNQGNLTWEARMKVIIGTAKALAY 301
+ LV+L E +V EY++ G+L +L G M L M I A +AY
Sbjct: 61 EKLVQLYAVVSEE-PIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQI--ASGMAY 117
Query: 302 LHEAIEPKVVHRDIKSSNILIDDEFNAKVSDFGLAKLLDSGESHITTRVMGTF--GYVAP 359
+ VHRD++++NIL+ + KV+DFGLA+L++ E T R F + AP
Sbjct: 118 VERM---NYVHRDLRAANILVGENLVCKVADFGLARLIEDNE--YTARQGAKFPIKWTAP 172
Query: 360 EYANTGMLNEKSDIYSFGVLLLEAVT-GRDP 389
E A G KSD++SFG+LL E T GR P
Sbjct: 173 EAALYGRFTIKSDVWSFGILLTELTTKGRVP 203
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262 |
| >gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Score = 91.5 bits (227), Expect = 9e-21
Identities = 73/269 (27%), Positives = 130/269 (48%), Gaps = 29/269 (10%)
Query: 193 VLGEGGYGVVYKGRLINGSEVAVKKLLNNLGQAEKE---FRVEVEAIGHVRHKNLVRLLG 249
V+G G +G+V+ R ++ + K + + E + E + + + H N++
Sbjct: 7 VVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYE 66
Query: 250 YCIEGVHRMLVYEYVNNGNLEQWLHGAMRNQGNLTWEARMKVIIGTAKALAYLHEAIEPK 309
+E M+V EY G L +++ R L + + + AL ++H +
Sbjct: 67 NFLEDKALMIVMEYAPGGTLAEYIQK--RCNSLLDEDTILHFFVQILLALHHVHTKL--- 121
Query: 310 VVHRDIKSSNILIDDEFNA-KVSDFGLAKLLDSGESHITTRVMGTFGYVAPEYANTGMLN 368
++HRD+K+ NIL+D K+ DFG++K+L S T V+GT Y++PE N
Sbjct: 122 ILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKSKAYT--VVGTPCYISPELCEGKPYN 179
Query: 369 EKSDIYSFGVLLLEAVTGRDPVDYGRPANEVNLVEWLKMMVGTRRA-EEVVDPNLEVKPA 427
+KSDI++ G +L E + + + AN LV LK+M GT + P+L
Sbjct: 180 QKSDIWALGCVLYELASLKRAFE---AANLPALV--LKIMSGTFAPISDRYSPDL----- 229
Query: 428 TRALKRSLLVALRCVDPDSEKRPKMSQVV 456
R L++++ +DP KRP++SQ++
Sbjct: 230 -----RQLILSMLNLDPS--KRPQLSQIM 251
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256 |
| >gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 91.7 bits (228), Expect = 1e-20
Identities = 66/207 (31%), Positives = 107/207 (51%), Gaps = 23/207 (11%)
Query: 193 VLGEGGYGVVYKGRLI-NGSEVAVKKLLNNLGQAEKE---FRVEVEAIGHVRH---KNLV 245
++G G YG VY+G+ + G VA+K + NL + + + EV + +R N+
Sbjct: 8 LIGRGAYGAVYRGKHVPTGRVVALKII--NLDTPDDDVSDIQREVALLSQLRQSQPPNIT 65
Query: 246 RLLGYCIEGVHRMLVYEYVNNGNLEQWLH-GAMRNQGNLTWEARMKVII-GTAKALAYLH 303
+ G ++G ++ EY G++ + G + E + VII AL Y+H
Sbjct: 66 KYYGSYLKGPRLWIIMEYAEGGSVRTLMKAGPIA-------EKYISVIIREVLVALKYIH 118
Query: 304 EAIEPKVVHRDIKSSNILIDDEFNAKVSDFGLAKLLDSGESHITTRVMGTFGYVAPEYAN 363
+ V+HRDIK++NIL+ + N K+ DFG+A LL+ S +T V GT ++APE
Sbjct: 119 KV---GVIHRDIKAANILVTNTGNVKLCDFGVAALLNQNSSKRSTFV-GTPYWMAPEVIT 174
Query: 364 TG-MLNEKSDIYSFGVLLLEAVTGRDP 389
G + K+DI+S G+ + E TG P
Sbjct: 175 EGKYYDTKADIWSLGITIYEMATGNPP 201
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277 |
| >gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Score = 91.1 bits (226), Expect = 1e-20
Identities = 65/207 (31%), Positives = 103/207 (49%), Gaps = 11/207 (5%)
Query: 182 EIATNRFSAENVLGEGGYGVVYKGRLIN-GSEVAVKKLLNNLGQAEKEFRVEVEAIGHVR 240
E+ + ++ LG G YG VY+G VAVK L + +EF E + ++
Sbjct: 2 EMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED-TMEVEEFLKEAAVMKEIK 60
Query: 241 HKNLVRLLGYCIEGVHRMLVYEYVNNGNLEQWLHGAMRNQGNLTWEARMKVIIGTAKALA 300
H NLV+LLG C ++ E++ GNL +L R + N M I + A+
Sbjct: 61 HPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQI--SSAME 118
Query: 301 YLHEAIEPKVVHRDIKSSNILIDDEFNAKVSDFGLAKLLDSGESHITTRVMGTF--GYVA 358
YL + +HRD+ + N L+ + KV+DFGL++L+ +G+++ T F + A
Sbjct: 119 YLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLM-TGDTY-TAHAGAKFPIKWTA 173
Query: 359 PEYANTGMLNEKSDIYSFGVLLLEAVT 385
PE + KSD+++FGVLL E T
Sbjct: 174 PESLAYNKFSIKSDVWAFGVLLWEIAT 200
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263 |
| >gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Score = 90.5 bits (225), Expect = 2e-20
Identities = 71/281 (25%), Positives = 114/281 (40%), Gaps = 43/281 (15%)
Query: 194 LGEGGYGVVYKGRLINGS----EVAVKKLL-NNLGQAEKEFRVEVEAIGHVRHKNLVRLL 248
LG+G +GVV +G VAVK L + L +F E + + H+NL+RL
Sbjct: 3 LGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRLY 62
Query: 249 GYCIEGVHRMLVYEYVNNGNLEQWLHGAMRNQGNLT--WEARMKVIIGTAKALAYLHEAI 306
G + M+V E G+L L ++ + +++ A + YL
Sbjct: 63 GVVLTH-PLMMVTELAPLGSLLDRLRKDALGHFLISTLCDYAVQI----ANGMRYLESK- 116
Query: 307 EPKVVHRDIKSSNILIDDEFNAKVSDFGLAKLLDSGESHITT----RVMGTFGYVAPEYA 362
+ +HRD+ + NIL+ + K+ DFGL + L E H +V F + APE
Sbjct: 117 --RFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVMEEHLKV--PFAWCAPESL 172
Query: 363 NTGMLNEKSDIYSFGVLLLEAVT-GRDPVDYGRPANEVNLVEWLKMMVGTRRAE--EVVD 419
T + SD++ FGV L E T G +P W G ++ + +D
Sbjct: 173 RTRTFSHASDVWMFGVTLWEMFTYGEEP--------------W----AGLSGSQILKKID 214
Query: 420 PNLEVKPATRALKRSLL-VALRCVDPDSEKRPKMSQVVRML 459
E A + + V L+C + RP + + L
Sbjct: 215 KEGERLERPEACPQDIYNVMLQCWAHNPADRPTFAALREFL 255
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257 |
| >gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 90.9 bits (226), Expect = 2e-20
Identities = 81/305 (26%), Positives = 134/305 (43%), Gaps = 47/305 (15%)
Query: 182 EIATNRFSAENVLGEGGYGVVYKGRLI------NGSEVAVKKLLNNLGQAE-KEFRVEVE 234
E+ +R + LGEG +G V K + S VAVK L ++ + + + E+E
Sbjct: 8 ELPRDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEME 67
Query: 235 ---AIGHVRHKNLVRLLGYCIEGVHRMLVYEYVNNGNLEQWLHGAMRNQG---------- 281
IG +HKN++ LLG C + +V EY +GNL +L A R G
Sbjct: 68 MMKMIG--KHKNIINLLGVCTQEGPLYVVVEYAAHGNLRDFLR-ARRPPGEYASPDDPRP 124
Query: 282 ---NLTWEARMKVIIGTAKALAYLHEAIEPKVVHRDIKSSNILIDDEFNAKVSDFGLAKL 338
LT + + A+ + +L K +HRD+ + N+L+ ++ K++DFGLA+
Sbjct: 125 PEETLTQKDLVSFAYQVARGMEFLASK---KCIHRDLAARNVLVTEDHVMKIADFGLARD 181
Query: 339 LDSGESH-ITTRVMGTFGYVAPEYANTGMLNEKSDIYSFGVLLLEAVT-GRDPVDYGRPA 396
+ + + TT ++APE + +SD++SFGVLL E T G G P
Sbjct: 182 IHHIDYYRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLG------GSPY 235
Query: 397 NEVNLVEWLKMMVGTRRAEEVVDPNLEVKPATRALKRSLLVALRCVDPDSEKRPKMSQVV 456
+ + E K++ R E+ + E+ + C +RP Q+V
Sbjct: 236 PGIPVEELFKLLKEGYRMEKPQNCTQEL----------YHLMRDCWHEVPSQRPTFKQLV 285
Query: 457 RMLEA 461
L+
Sbjct: 286 EDLDR 290
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293 |
| >gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Score = 90.6 bits (225), Expect = 2e-20
Identities = 74/279 (26%), Positives = 123/279 (44%), Gaps = 32/279 (11%)
Query: 194 LGEGGYGVVYKGRLINGSE--VAVKKLL---NNLGQAEKEFRVEVEAI--------GHVR 240
LG G +G VYK R N + +A+K++ G+ ++E + I +R
Sbjct: 8 LGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLR 67
Query: 241 HKNLVRLLGYCIEGVHRMLVYEYVNNGNLEQWLHGAMRNQGNLTWEARMKVIIGTAKALA 300
H N+VR +E +V + + L + + + T E + + AL
Sbjct: 68 HPNIVRYYKTFLENDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALR 127
Query: 301 YLHEAIEPKVVHRDIKSSNILIDDEFNAKVSDFGLAKLLDSGESHITTRVMGTFGYVAPE 360
YLH+ E ++VHRD+ +NI++ ++ ++DFGLAK T V+GT Y PE
Sbjct: 128 YLHK--EKRIVHRDLTPNNIMLGEDDKVTITDFGLAK--QKQPESKLTSVVGTILYSCPE 183
Query: 361 YANTGMLNEKSDIYSFGVLLLEAVTGRDPVDYGRPANEVNLVEWLKMMVGTRRAEEVVDP 420
EK+D+++FG +L + T P Y N ++L A ++V+
Sbjct: 184 IVKNEPYGEKADVWAFGCILYQMCT-LQPPFYS--TNMLSL------------ATKIVEA 228
Query: 421 NLEVKPATRALKRSLLVALRCVDPDSEKRPKMSQVVRML 459
E P + V C+ PD+E RP + QV M+
Sbjct: 229 VYEPLPEGMYSEDVTDVITSCLTPDAEARPDIIQVSAMI 267
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269 |
| >gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Score = 90.9 bits (226), Expect = 2e-20
Identities = 75/294 (25%), Positives = 125/294 (42%), Gaps = 50/294 (17%)
Query: 188 FSAENV-----LGEGGYGVVYKGRLIN-GSEVAVKKL-LNNLGQAEKEFRVEVEAIGHVR 240
F+AE++ +G G +G V K G+ +AVK++ + +K ++++ +
Sbjct: 1 FTAEDLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSS 60
Query: 241 H-KNLVRLLG---------YCIEGVHRML--VYEYVNNGNLEQWLHGAMRNQGNLTWEAR 288
+V+ G C+E + L Y+YV + + E
Sbjct: 61 DCPYIVKFYGALFREGDCWICMELMDISLDKFYKYVY-----------EVLKSVIPEEIL 109
Query: 289 MKVIIGTAKALAYLHEAIEPKVVHRDIKSSNILIDDEFNAKVSDFGLA-KLLDSGESHIT 347
K+ + T KAL YL E E K++HRD+K SNIL+D N K+ DFG++ +L+DS
Sbjct: 110 GKIAVATVKALNYLKE--ELKIIHRDVKPSNILLDRNGNIKLCDFGISGQLVDSIAK--- 164
Query: 348 TRVMGTFGYVAPEYANTGMLNE---KSDIYSFGVLLLEAVTGRDPVDYGRPANEVNLVEW 404
TR G Y+APE + + +SD++S G+ L E TG+ P + +
Sbjct: 165 TRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWNS-----VFDQ 219
Query: 405 LKMMVGTRRAEEVVDPNLEVKPATRALKRSLLVALRCVDPDSEKRPKMSQVVRM 458
L +V E P+ L+ D KRPK +++
Sbjct: 220 LTQVVKGDPPILSNSEEREFSPSFVNFINLCLIK------DESKRPKYKELLEH 267
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288 |
| >gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Score = 89.7 bits (222), Expect = 4e-20
Identities = 74/275 (26%), Positives = 132/275 (48%), Gaps = 21/275 (7%)
Query: 188 FSAENVLGEGGYGVVYKGR-LINGSEVAVKKL-LNNL--GQAEKEFRVEVEAIGHVRHKN 243
F E +G G + VY+ L++G VA+KK+ + +L +A + E++ + + H N
Sbjct: 4 FRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPN 63
Query: 244 LVRLLGYCIEGVHRMLVYEYVNNGNLEQWLHGAMRNQGNLTWEARMKVIIGTAKALAYLH 303
+++ IE +V E + G+L + + + + + + K + AL ++H
Sbjct: 64 VIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMH 123
Query: 304 EAIEPKVVHRDIKSSNILIDDEFNAKVSDFGLAKLLDSGESHITTRVMGTFGYVAPEYAN 363
+V+HRDIK +N+ I K+ D GL + S ++ ++GT Y++PE +
Sbjct: 124 SR---RVMHRDIKPANVFITATGVVKLGDLGLGRFFSS-KTTAAHSLVGTPYYMSPERIH 179
Query: 364 TGMLNEKSDIYSFGVLLLEAVTGRDPVDYGRPANEVNLVEWLKMMVGTRRAEEVVDPNLE 423
N KSDI+S G LL E + P YG N +L ++ E+ P L
Sbjct: 180 ENGYNFKSDIWSLGCLLYEMAALQSPF-YGDKMNLYSLC---------KKIEQCDYPPLP 229
Query: 424 VKPATRALKRSLLVALRCVDPDSEKRPKMSQVVRM 458
+ L++ LV + C++PD EKRP ++ V +
Sbjct: 230 SDHYSEELRQ--LVNM-CINPDPEKRPDITYVYDV 261
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Score = 88.9 bits (220), Expect = 6e-20
Identities = 71/212 (33%), Positives = 107/212 (50%), Gaps = 17/212 (8%)
Query: 191 ENVLGEGGYGVVYKGRLINGSEVAVKKLLNNLGQAEKEFRVEVEAIGHVRHKNLVRLLGY 250
+G+G +G V G G++VAVK + N+ + F E + +RH NLV+LLG
Sbjct: 11 LQTIGKGEFGDVMLGDY-RGNKVAVKCIKND--ATAQAFLAEASVMTQLRHSNLVQLLGV 67
Query: 251 CIEGVHRM-LVYEYVNNGNLEQWLHGAMRNQGNLTWEARMKVIIGTAKALAYLHEAIEPK 309
+E + +V EY+ G+L +L R + L + +K + +A+ YL
Sbjct: 68 IVEEKGGLYIVTEYMAKGSLVDYLRS--RGRSVLGGDCLLKFSLDVCEAMEYLEAN---N 122
Query: 310 VVHRDIKSSNILIDDEFNAKVSDFGLAKLLDSGESHITTRVMGTFGYVAPEYANTGMLNE 369
VHRD+ + N+L+ ++ AKVSDFGL K S + V T APE +
Sbjct: 123 FVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLPVKWT----APEALREKKFST 178
Query: 370 KSDIYSFGVLLLEAVT-GRDPVDYGR-PANEV 399
KSD++SFG+LL E + GR P Y R P +V
Sbjct: 179 KSDVWSFGILLWEIYSFGRVP--YPRIPLKDV 208
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256 |
| >gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Score = 89.7 bits (222), Expect = 7e-20
Identities = 81/275 (29%), Positives = 131/275 (47%), Gaps = 39/275 (14%)
Query: 193 VLGEGGYGVVYKGRLINGSE-----VAVKKLLNNLG-QAEKEFRVEVEAIGHVRHKNLVR 246
VLG G +G VYKG + E VA+K L G +A EF E + + H +LVR
Sbjct: 14 VLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVR 73
Query: 247 LLGYCIEGVHRMLVYEYVNNGNLEQWLHGAMRNQGN---LTWEARMKVIIGTAKALAYLH 303
LLG C+ + LV + + +G L ++H N G+ L W + AK + YL
Sbjct: 74 LLGVCLSPTIQ-LVTQLMPHGCLLDYVHEHKDNIGSQLLLNW------CVQIAKGMMYLE 126
Query: 304 EAIEPKVVHRDIKSSNILIDDEFNAKVSDFGLAKLLDSGESHITTRVMGT-FGYVAPEYA 362
E ++VHRD+ + N+L+ + K++DFGLA+LL+ E ++A E
Sbjct: 127 ER---RLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKMPIKWMALECI 183
Query: 363 NTGMLNEKSDIYSFGVLLLEAVT-GRDPVDYGRPANEV-NLVEWLKMMVGTRRAEEVVDP 420
+ +SD++S+GV + E +T G P D G P E+ +L+E + E + P
Sbjct: 184 HYRKFTHQSDVWSYGVTIWELMTFGGKPYD-GIPTREIPDLLE---------KGERLPQP 233
Query: 421 NLEVKPATRALKRSLLVALRCVDPDSEKRPKMSQV 455
+ +V ++C D++ RPK ++
Sbjct: 234 PI-------CTIDVYMVMVKCWMIDADSRPKFKEL 261
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303 |
| >gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Score = 88.5 bits (219), Expect = 9e-20
Identities = 72/212 (33%), Positives = 103/212 (48%), Gaps = 14/212 (6%)
Query: 182 EIATNRFSAENVLGEGGYGVVYKGRLINGSEVAVKKLLNNLGQAEKEFRVEVEAIGHVRH 241
EI LG G +G V+ G ++VAVK L E F E + + +RH
Sbjct: 2 EIPRESLQLIKKLGNGQFGEVWMGTWNGNTKVAVKTLKPGTMSPES-FLEEAQIMKKLRH 60
Query: 242 KNLVRLLGYCIEGVHRMLVYEYVNNGNLEQWLH-GAMRNQGNLTWEARMKVIIGTAKALA 300
LV+L E +V EY++ G+L +L G R L + + A +A
Sbjct: 61 DKLVQLYAVVSEE-PIYIVTEYMSKGSLLDFLKDGEGRA---LKLPNLVDMAAQVAAGMA 116
Query: 301 YLHEAIEPKVVHRDIKSSNILIDDEFNAKVSDFGLAKLLDSGESHITTRVMGTF--GYVA 358
Y+ +HRD++S+NIL+ D K++DFGLA+L++ E T R F + A
Sbjct: 117 YIERM---NYIHRDLRSANILVGDGLVCKIADFGLARLIEDNE--YTARQGAKFPIKWTA 171
Query: 359 PEYANTGMLNEKSDIYSFGVLLLEAVT-GRDP 389
PE A G KSD++SFG+LL E VT GR P
Sbjct: 172 PEAALYGRFTIKSDVWSFGILLTELVTKGRVP 203
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260 |
| >gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 88.8 bits (221), Expect = 9e-20
Identities = 63/209 (30%), Positives = 100/209 (47%), Gaps = 17/209 (8%)
Query: 186 NRFSAENVLGEGGYGVVYKGR-LINGSEVAVKKLLNNLGQAEKEFRV---EVEAIGHVRH 241
F+ +G+G +G VYK VA+K + +L +AE E E++ + R
Sbjct: 1 ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVI--DLEEAEDEIEDIQQEIQFLSQCRS 58
Query: 242 KNLVRLLGYCIEGVHRMLVYEYVNNGNLEQWLHGAMRNQGNLTWEARMKVII-GTAKALA 300
+ + G ++G ++ EY G+ L G L E + I+ L
Sbjct: 59 PYITKYYGSFLKGSKLWIIMEYCGGGSCLDLL-----KPGKLD-ETYIAFILREVLLGLE 112
Query: 301 YLHEAIEPKVVHRDIKSSNILIDDEFNAKVSDFGLAKLLDSGESHITTRVMGTFGYVAPE 360
YLHE +HRDIK++NIL+ +E + K++DFG++ L S S T V GT ++APE
Sbjct: 113 YLHEE---GKIHRDIKAANILLSEEGDVKLADFGVSGQLTSTMSKRNTFV-GTPFWMAPE 168
Query: 361 YANTGMLNEKSDIYSFGVLLLEAVTGRDP 389
+EK+DI+S G+ +E G P
Sbjct: 169 VIKQSGYDEKADIWSLGITAIELAKGEPP 197
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274 |
| >gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Score = 88.5 bits (219), Expect = 9e-20
Identities = 74/273 (27%), Positives = 125/273 (45%), Gaps = 28/273 (10%)
Query: 194 LGEGGYGVVYKGRL-INGSEVAVKKLLNNLGQAEK-EFRVEVEAIGHVRHKNLVRLLGYC 251
+G G +G V+ GRL + + VAVK L K +F E + H N+VRL+G C
Sbjct: 3 IGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVC 62
Query: 252 IEGVHRMLVYEYVNNGNLEQWLHGAMRNQGNLTWEARMKVIIGTAKALAYLHEAIEPK-V 310
+ +V E V G+ +L R +G ++K +I + A E +E K
Sbjct: 63 TQKQPIYIVMELVQGGDFLTFL----RTEGP---RLKVKELIQMVENAAAGMEYLESKHC 115
Query: 311 VHRDIKSSNILIDDEFNAKVSDFGLAKLLDSGESHITTRVMGT-FGYVAPEYANTGMLNE 369
+HRD+ + N L+ ++ K+SDFG+++ + G T + + APE N G +
Sbjct: 116 IHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTGGMKQIPVKWTAPEALNYGRYSS 175
Query: 370 KSDIYSFGVLLLEAVT-GRDPVDYGRPANEVNLVEWLKMMVGTRRAEEVVDPNLEVKPAT 428
+SD++SFG+LL EA + G P Y +N+ + E ++ + +
Sbjct: 176 ESDVWSFGILLWEAFSLGAVP--YANLSNQ--------------QTREAIEQGVRLPCPE 219
Query: 429 RALKRSLLVALRCVDPDSEKRPKMSQVVRMLEA 461
+ RC + D +RP S V + L++
Sbjct: 220 LCPDAVYRLMERCWEYDPGQRPSFSTVHQELQS 252
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252 |
| >gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Score = 88.9 bits (220), Expect = 1e-19
Identities = 63/215 (29%), Positives = 102/215 (47%), Gaps = 22/215 (10%)
Query: 194 LGEGGYGVVYKGRLINGSE------VAVKKLLNNLGQAEKEFRVEVEAIGHVRHKNLVRL 247
LGEG +G V+ N VAVK L A ++F+ E E + ++H+++VR
Sbjct: 13 LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVRF 72
Query: 248 LGYCIEGVHRMLVYEYVNNGNLEQWLH-----------GAMRNQGNLTWEARMKVIIGTA 296
G C EG ++V+EY+ +G+L ++L G G LT + + A
Sbjct: 73 YGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIA 132
Query: 297 KALAYLHEAIEPKVVHRDIKSSNILIDDEFNAKVSDFGLAKLLDSGESH-ITTRVMGTFG 355
+ YL VHRD+ + N L+ K+ DFG+++ + S + + + R M
Sbjct: 133 SGMVYLASL---HFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIR 189
Query: 356 YVAPEYANTGMLNEKSDIYSFGVLLLEAVT-GRDP 389
++ PE +SDI+SFGV+L E T G+ P
Sbjct: 190 WMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQP 224
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280 |
| >gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 88.7 bits (220), Expect = 1e-19
Identities = 78/285 (27%), Positives = 128/285 (44%), Gaps = 31/285 (10%)
Query: 194 LGEGGYGVVYKGRL-----INGSEVAVKKLLNNLGQAEKEFRVEVEAIGHVRHKNLVRLL 248
LG+G +G V R G VAVKKL ++ + ++F E+E + ++H N+V+
Sbjct: 12 LGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKYK 71
Query: 249 GYCIEGVHR--MLVYEYVNNGNLEQWLHGAMRNQGNLTWEARMKVIIGTAKALAYLHEAI 306
G C R LV EY+ G+L +L +++ L + K + YL
Sbjct: 72 GVCYSAGRRNLRLVMEYLPYGSLRDYL---QKHRERLDHRKLLLYASQICKGMEYLGSK- 127
Query: 307 EPKVVHRDIKSSNILIDDEFNAKVSDFGLAKLLDSGESHITTRVMG---TFGYVAPEYAN 363
+ VHRD+ + NIL++ E K+ DFGL K+L + + R G F Y APE
Sbjct: 128 --RYVHRDLATRNILVESENRVKIGDFGLTKVLPQDKEYYKVREPGESPIFWY-APESLT 184
Query: 364 TGMLNEKSDIYSFGVLLLEAVTGRDPVDYGRPANEVNLVEWLKMMVGTRRAEEVVDPNLE 423
+ SD++SFGV+L E T D + E+++MM ++ + +V +E
Sbjct: 185 ESKFSVASDVWSFGVVLYELFTYSD-------KSCSPPAEFMRMMGNDKQGQMIVYHLIE 237
Query: 424 VKPATRALKRSL-------LVALRCVDPDSEKRPKMSQVVRMLEA 461
+ L + C + D +RP S++ +EA
Sbjct: 238 LLKNNGRLPAPPGCPAEIYAIMKECWNNDPSQRPSFSELALQVEA 282
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284 |
| >gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Score = 88.5 bits (219), Expect = 2e-19
Identities = 61/216 (28%), Positives = 106/216 (49%), Gaps = 23/216 (10%)
Query: 194 LGEGGYGVVYKGRLINGSE------VAVKKLLNNLGQAEKEFRVEVEAIGHVRHKNLVRL 247
LGEG +G V+ N S VAVK L + A K+F+ E E + +++H+++V+
Sbjct: 13 LGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKF 72
Query: 248 LGYCIEGVHRMLVYEYVNNGNLEQWL--HG----------AMRNQGNLTWEARMKVIIGT 295
G C +G ++V+EY+ +G+L ++L HG + +G L + +
Sbjct: 73 YGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQI 132
Query: 296 AKALAYLHEAIEPKVVHRDIKSSNILIDDEFNAKVSDFGLAKLLDSGESH-ITTRVMGTF 354
A + YL VHRD+ + N L+ K+ DFG+++ + S + + + M
Sbjct: 133 ASGMVYLASQ---HFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGGHTMLPI 189
Query: 355 GYVAPEYANTGMLNEKSDIYSFGVLLLEAVT-GRDP 389
++ PE +SD++SFGV+L E T G+ P
Sbjct: 190 RWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQP 225
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291 |
| >gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Score = 87.6 bits (217), Expect = 2e-19
Identities = 69/267 (25%), Positives = 119/267 (44%), Gaps = 24/267 (8%)
Query: 194 LGEGGYGVVYKGRLINGSEVAVKKLLNNLGQAEKEFRVEVEAIGHVRHKNLVRLLGYCIE 253
LG G +GVV+ G+ +VA+K + N +E++F E + + + H LV+L G C +
Sbjct: 12 LGSGQFGVVHLGKWRAQIKVAIKAI-NEGAMSEEDFIEEAKVMMKLSHPKLVQLYGVCTQ 70
Query: 254 GVHRMLVYEYVNNGNLEQWLHGAMRNQGNLTWEARMKVIIGTAKALAYLHEAIEPKVVHR 313
+V E++ NG L +L + QG L+ + + + + + YL +HR
Sbjct: 71 QKPLYIVTEFMENGCLLNYLR---QRQGKLSKDMLLSMCQDVCEGMEYLERN---SFIHR 124
Query: 314 DIKSSNILIDDEFNAKVSDFGLAKLLDSGESHITTRVMGTFGYVAPEYANTGMLNEKSDI 373
D+ + N L+ KVSDFG+ + + E ++ + PE N + KSD+
Sbjct: 125 DLAARNCLVSSTGVVKVSDFGMTRYVLDDEYTSSSGAKFPVKWSPPEVFNFSKYSSKSDV 184
Query: 374 YSFGVLLLEAVT-GRDPVDYGRPANEVNLVEWLKMMVGTRRAEEVVDPNLEVKPATRALK 432
+SFGVL+ E T G+ P + N +++ R + P L A
Sbjct: 185 WSFGVLMWEVFTEGKMPF-----EKKSN----YEVVEMISRGFRLYRPKL-------ASM 228
Query: 433 RSLLVALRCVDPDSEKRPKMSQVVRML 459
V C E RP ++++R +
Sbjct: 229 TVYEVMYSCWHEKPEGRPTFAELLRAI 255
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256 |
| >gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 87.2 bits (216), Expect = 3e-19
Identities = 60/208 (28%), Positives = 105/208 (50%), Gaps = 23/208 (11%)
Query: 194 LGEGGYGVVYKGRLIN-GSEVAVKKLLNNLGQAEKEFRVEVEAI-------GHVRHKNLV 245
LG+G +G VY ++ G E+AVK++ E + EV A+ +++H+ +V
Sbjct: 10 LGQGAFGRVYLCYDVDTGRELAVKQV--PFDPDSPETKKEVNALECEIQLLKNLQHERIV 67
Query: 246 RLLGYCIEGVHRMLVYEYVNNGNLEQWL--HGAMRNQGNLTWEARMKVIIGTAKALAYLH 303
+ G + + EY+ G+++ L +GA+ +T + +++ G + YLH
Sbjct: 68 QYYGCLRDDETLSIFMEYMPGGSVKDQLKAYGALTE--TVTRKYTRQILEG----VEYLH 121
Query: 304 EAIEPKVVHRDIKSSNILIDDEFNAKVSDFGLAKLLDSGESHIT--TRVMGTFGYVAPEY 361
+VHRDIK +NIL D N K+ DFG +K L + S T V GT +++PE
Sbjct: 122 SN---MIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICSSGTGMKSVTGTPYWMSPEV 178
Query: 362 ANTGMLNEKSDIYSFGVLLLEAVTGRDP 389
+ K+D++S G ++E +T + P
Sbjct: 179 ISGEGYGRKADVWSVGCTVVEMLTEKPP 206
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263 |
| >gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Score = 88.4 bits (220), Expect = 3e-19
Identities = 69/220 (31%), Positives = 107/220 (48%), Gaps = 50/220 (22%)
Query: 194 LGEGGYGVVYKGRLI-NGSEVAVKKLLN---NLGQAEKEFRVEV---EAIGHVRHKNLVR 246
LG+G YG+V+K VA+KK+ + N A++ FR E+ + +G H N+V+
Sbjct: 15 LGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFR-EIMFLQELGD--HPNIVK 71
Query: 247 LLGYCIEGVHRM-------LVYEYVNNGNLEQWLHGAMRNQGNLTWEARMKVII-GTAKA 298
LL V + LV+EY +E LH +R N+ + + I+ KA
Sbjct: 72 LLN-----VIKAENDKDIYLVFEY-----METDLHAVIR--ANILEDVHKRYIMYQLLKA 119
Query: 299 LAYLHEAIEPKVVHRDIKSSNILIDDEFNAKVSDFGLAKLLDSGESHITTRVM----GTF 354
L Y+H V+HRD+K SNIL++ + K++DFGLA+ L E + V+ T
Sbjct: 120 LKYIHSG---NVIHRDLKPSNILLNSDCRVKLADFGLARSLSELEENPENPVLTDYVATR 176
Query: 355 GYVAPE-------YANTGMLNEKSDIYSFGVLLLEAVTGR 387
Y APE Y G+ D++S G +L E + G+
Sbjct: 177 WYRAPEILLGSTRY-TKGV-----DMWSVGCILGEMLLGK 210
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337 |
| >gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Score = 87.8 bits (217), Expect = 3e-19
Identities = 66/223 (29%), Positives = 111/223 (49%), Gaps = 21/223 (9%)
Query: 194 LGEGGYGVVYKGRLINGSE------VAVKKLLNNLGQAEKEFRVEVEAIGHVRHKNLVRL 247
LGEG +G V+ N VAVK L + A K+F E E + +++H+++V+
Sbjct: 13 LGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKF 72
Query: 248 LGYCIEGVHRMLVYEYVNNGNLEQWL--HG---AMRNQGN----LTWEARMKVIIGTAKA 298
G C+EG ++V+EY+ +G+L ++L HG + +GN LT + + A
Sbjct: 73 YGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAG 132
Query: 299 LAYLHEAIEPKVVHRDIKSSNILIDDEFNAKVSDFGLAKLLDSGESH-ITTRVMGTFGYV 357
+ YL VHRD+ + N L+ + K+ DFG+++ + S + + + M ++
Sbjct: 133 MVYLASQ---HFVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWM 189
Query: 358 APEYANTGMLNEKSDIYSFGVLLLEAVT-GRDPVDYGRPANEV 399
PE +SD++S GV+L E T G+ P Y NEV
Sbjct: 190 PPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPW-YQLSNNEV 231
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288 |
| >gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Score = 88.7 bits (220), Expect = 3e-19
Identities = 65/211 (30%), Positives = 99/211 (46%), Gaps = 21/211 (9%)
Query: 192 NVLGEGGYGVVYKGR-LINGSEVAVKKLLNNLGQA-EKEFRVEVEAIGHVRHKNLVRLLG 249
N +G G G VYK G A+K + N ++ E+E + V H N+V+
Sbjct: 80 NRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILRDVNHPNVVKCHD 139
Query: 250 YCIEGVHRMLVYEYVNNGNLEQWLHGAMRNQGNLTWEARMKVIIGTAKALAYLHEAIEPK 309
++ E+++ G+LE G + +++ G +AYLH
Sbjct: 140 MFDHNGEIQVLLEFMDGGSLE----GTHIADEQFLADVARQILSG----IAYLHRR---H 188
Query: 310 VVHRDIKSSNILIDDEFNAKVSDFGLAKLLDSGESHITTRVMGTFGYVAPEYANTGMLNE 369
+VHRDIK SN+LI+ N K++DFG++++L + V GT Y++PE NT LN
Sbjct: 189 IVHRDIKPSNLLINSAKNVKIADFGVSRILAQTMDPCNSSV-GTIAYMSPERINTD-LNH 246
Query: 370 ------KSDIYSFGVLLLEAVTGRDPVDYGR 394
DI+S GV +LE GR P GR
Sbjct: 247 GAYDGYAGDIWSLGVSILEFYLGRFPFGVGR 277
|
Length = 353 |
| >gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Score = 87.1 bits (216), Expect = 3e-19
Identities = 57/206 (27%), Positives = 93/206 (45%), Gaps = 12/206 (5%)
Query: 182 EIATNRFSAENVLGEGGYGVVYKGRLINGS----EVAVKKLLNNLGQAEKE-FRVEVEAI 236
EI + +GEG +G VY+G ++ VAVK N + +E F E +
Sbjct: 2 EIQREDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIM 61
Query: 237 GHVRHKNLVRLLGYCIEGVHRMLVYEYVNNGNLEQWLHGAMRNQGNLTWEARMKVIIGTA 296
H ++V+L+G E +V E G L +L N+ +L + + +
Sbjct: 62 RQFDHPHIVKLIGVITEN-PVWIVMELAPLGELRSYLQ---VNKYSLDLASLILYSYQLS 117
Query: 297 KALAYLHEAIEPKVVHRDIKSSNILIDDEFNAKVSDFGLAKLLDSGESHITTRVMGTFGY 356
ALAYL + VHRDI + N+L+ K+ DFGL++ L+ + ++ +
Sbjct: 118 TALAYLESK---RFVHRDIAARNVLVSSPDCVKLGDFGLSRYLEDESYYKASKGKLPIKW 174
Query: 357 VAPEYANTGMLNEKSDIYSFGVLLLE 382
+APE N SD++ FGV + E
Sbjct: 175 MAPESINFRRFTSASDVWMFGVCMWE 200
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270 |
| >gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Score = 86.6 bits (214), Expect = 8e-19
Identities = 76/295 (25%), Positives = 134/295 (45%), Gaps = 49/295 (16%)
Query: 191 ENVLGEGGYGVVYKGRLINGS---EVAVKKLLNNLGQAE-KEFRVEVEAI---GHVRHKN 243
++V+GEG +G V K R+ + A+K++ + + ++F E+E + GH H N
Sbjct: 12 QDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGH--HPN 69
Query: 244 LVRLLGYCIEGVHRMLVYEYVNNGNLEQWLHG------------AMRNQGNLTWEARMKV 291
++ LLG C + L EY +GNL +L A L+ + +
Sbjct: 70 IINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHF 129
Query: 292 IIGTAKALAYLHEAIEPKVVHRDIKSSNILIDDEFNAKVSDFGLAKLLDSGESHITTRVM 351
A+ + YL + + +HRD+ + NIL+ + + AK++DFGL++ G+ + M
Sbjct: 130 AADVARGMDYLSQK---QFIHRDLAARNILVGENYVAKIADFGLSR----GQEVYVKKTM 182
Query: 352 GTFG--YVAPEYANTGMLNEKSDIYSFGVLLLEAVTGRDPVDYGRPANEVNLVEWLKMMV 409
G ++A E N + SD++S+GVLL E V+ G P + E + +
Sbjct: 183 GRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLG-----GTPYCGMTCAELYEKLP 237
Query: 410 GTRRAEEVVDPNLEVKPATRALKRSLLVALRCVDPDSEKRPKMSQVV----RMLE 460
R E+ ++ + EV R +C +RP +Q++ RMLE
Sbjct: 238 QGYRLEKPLNCDDEVYDLMR----------QCWREKPYERPSFAQILVSLNRMLE 282
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303 |
| >gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 86.3 bits (214), Expect = 8e-19
Identities = 59/205 (28%), Positives = 100/205 (48%), Gaps = 19/205 (9%)
Query: 194 LGEGGYGVVYKGRLINGSEVAVKKLLNNLGQAEKE-FRVEVEAIGHVRHKNLVRLL-GYC 251
LG+G +G VYK + A K++ + E E F VE++ + +H N+V L Y
Sbjct: 13 LGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYF 72
Query: 252 IEGVHRMLVYEYVNNGNLEQWLHGAMRNQGNLTWEARMKVII-GTAKALAYLHEAIEPKV 310
E +L+ E+ + G L+ M E +++ + +AL +LH KV
Sbjct: 73 YENKLWILI-EFCDGGALDS----IMLELERGLTEPQIRYVCRQMLEALNFLHSH---KV 124
Query: 311 VHRDIKSSNILIDDEFNAKVSDFGL-AKLLDSGESHITTRVMGTFGYVAPEYANTGML-- 367
+HRD+K+ NIL+ + + K++DFG+ AK + + T +GT ++APE
Sbjct: 125 IHRDLKAGNILLTLDGDVKLADFGVSAKNKSTLQKRDT--FIGTPYWMAPEVVACETFKD 182
Query: 368 ---NEKSDIYSFGVLLLEAVTGRDP 389
+ K+DI+S G+ L+E P
Sbjct: 183 NPYDYKADIWSLGITLIELAQMEPP 207
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280 |
| >gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Score = 85.8 bits (212), Expect = 9e-19
Identities = 64/200 (32%), Positives = 101/200 (50%), Gaps = 13/200 (6%)
Query: 194 LGEGGYGVVYKGRLINGSEVAVKKLLNNLGQAEKEFRVEVEAIGHVRHKNLVRLLGYCIE 253
LG G +G V+ G N ++VAVK L + F E + ++H LVRL +
Sbjct: 14 LGAGQFGEVWMGYYNNSTKVAVKTLKPGTMSVQA-FLEEANLMKTLQHDKLVRLYAVVTK 72
Query: 254 GVHRMLVYEYVNNGNLEQWLHGAMRNQGNLTWEARMKVIIGTAKALAYLHEAIEPK-VVH 312
++ EY+ G+L +L G + + A+ +AY IE K +H
Sbjct: 73 EEPIYIITEYMAKGSLLDFLKS--DEGGKVLLPKLIDFSAQIAEGMAY----IERKNYIH 126
Query: 313 RDIKSSNILIDDEFNAKVSDFGLAKLLDSGESHITTRVMGTF--GYVAPEYANTGMLNEK 370
RD++++N+L+ + K++DFGLA++++ E T R F + APE N G K
Sbjct: 127 RDLRAANVLVSESLMCKIADFGLARVIEDNE--YTAREGAKFPIKWTAPEAINFGSFTIK 184
Query: 371 SDIYSFGVLLLEAVT-GRDP 389
SD++SFG+LL E VT G+ P
Sbjct: 185 SDVWSFGILLYEIVTYGKIP 204
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261 |
| >gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Score = 85.7 bits (212), Expect = 1e-18
Identities = 69/222 (31%), Positives = 104/222 (46%), Gaps = 33/222 (14%)
Query: 192 NVLGEGGYGVVYKGRLIN----GSE---VAVKKLLNNLGQAEK-EFRVEVEAIGHVRHKN 243
N LG G +G VY+G + GS VAVK L EK EF E + + H N
Sbjct: 1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPN 60
Query: 244 LVRLLGYCIEGVHRMLVYEYVNNGNLEQWLHGAMRNQGN---LTWEARMKVIIGTAKALA 300
+V+LLG C+ + ++ E + G+L +L A + LT + + + + AK
Sbjct: 61 IVKLLGVCLLNEPQYIIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCV 120
Query: 301 YLHEAIEPKVVHRDIKSSNILI-----DDEFNAKVSDFGLAKLLDS-------GESHITT 348
YL + +HRD+ + N L+ D + K+ DFGLA+ + GE +
Sbjct: 121 YLEQM---HFIHRDLAARNCLVSEKGYDADRVVKIGDFGLARDIYKSDYYRKEGEGLLPV 177
Query: 349 RVMGTFGYVAPEYANTGMLNEKSDIYSFGVLLLEAVT-GRDP 389
R M APE G +SD++SFGVL+ E +T G+ P
Sbjct: 178 RWM------APESLLDGKFTTQSDVWSFGVLMWEILTLGQQP 213
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269 |
| >gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 85.3 bits (212), Expect = 2e-18
Identities = 61/204 (29%), Positives = 98/204 (48%), Gaps = 24/204 (11%)
Query: 194 LGEGGYGVVYKGRLI-NGSEVAVKKLLNNLGQAEKEFRV-EVEAIGHV-RHKNLVRLLGY 250
LG+G +G VY R G VA+KK+ E+ + EV+++ + H N+V+L
Sbjct: 7 LGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNEHPNIVKLKEV 66
Query: 251 CIEGVHRMLVYEYVNNGNLEQWLHGAMRNQGNLTWEARMKVIIG-TAKALAYLHEAIEPK 309
E V+EY+ GNL Q + +G E+ ++ II + LA++H+
Sbjct: 67 FRENDELYFVFEYME-GNLYQLM---KDRKGKPFSESVIRSIIYQILQGLAHIHKH---G 119
Query: 310 VVHRDIKSSNILIDDEFNAKVSDFGLAKLLDSGESHITTRVMGTFGYVAPEYANTGML-- 367
HRD+K N+L+ K++DFGLA+ + S + T V T Y APE +L
Sbjct: 120 FFHRDLKPENLLVSGPEVVKIADFGLAREIRSRPPY-TDYV-STRWYRAPE-----ILLR 172
Query: 368 ----NEKSDIYSFGVLLLEAVTGR 387
+ DI++ G ++ E T R
Sbjct: 173 STSYSSPVDIWALGCIMAELYTLR 196
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283 |
| >gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Score = 85.1 bits (210), Expect = 2e-18
Identities = 71/277 (25%), Positives = 131/277 (47%), Gaps = 25/277 (9%)
Query: 188 FSAENVLGEGGYGVVYKGR-LINGSEVAVKK-----LLNNLGQAEKEFRVEVEAIGHVRH 241
F E +G G + VY+ L++ VA+KK +++ +A ++ E++ + + H
Sbjct: 4 FQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMD--AKARQDCVKEIDLLKQLNH 61
Query: 242 KNLVRLLGYCIEGVHRMLVYEYVNNGNLEQWLHGAMRNQGNLTWEARMKVIIGTAKALAY 301
N+++ L IE +V E + G+L Q + + + + K + A+ +
Sbjct: 62 PNVIKYLDSFIEDNELNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEH 121
Query: 302 LHEAIEPKVVHRDIKSSNILIDDEFNAKVSDFGLAKLLDSGESHITTRVMGTFGYVAPEY 361
+H +V+HRDIK +N+ I K+ D GL + S ++ ++GT Y++PE
Sbjct: 122 MHSR---RVMHRDIKPANVFITATGVVKLGDLGLGRFFSS-KTTAAHSLVGTPYYMSPER 177
Query: 362 ANTGMLNEKSDIYSFGVLLLEAVTGRDPVDYGRPANEVNLVEWLKMMVGTRRAEEVVDPN 421
+ N KSDI+S G LL E + P YG N +L + + E+ P
Sbjct: 178 IHENGYNFKSDIWSLGCLLYEMAALQSPF-YGDKMNLFSLCQ---------KIEQCDYPP 227
Query: 422 LEVKPATRALKRSLLVALRCVDPDSEKRPKMSQVVRM 458
L + + L+ LV++ C+ PD ++RP + V ++
Sbjct: 228 LPTEHYSEKLRE--LVSM-CIYPDPDQRPDIGYVHQI 261
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267 |
| >gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 86.2 bits (214), Expect = 2e-18
Identities = 61/216 (28%), Positives = 106/216 (49%), Gaps = 29/216 (13%)
Query: 187 RFSAENVLGEGGYGVVYKG-RLINGSEVAVKKL--LNNLGQAEKEFRVEVEAIGHVRHKN 243
R+ + +GEG YG+V G +VA+KK+ + ++ R E++ + +H+N
Sbjct: 6 RYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLR-EIKILRRFKHEN 64
Query: 244 LVRLLGYCIEGVHRMLVYEYVNNGNLEQW-----LHGAMRNQGNLTWEARMKVIIGTAKA 298
++ +L + R +E N+ + Q L+ ++ Q +L+ + + +
Sbjct: 65 IIGILD-----IIRPPSFESFNDVYIVQELMETDLYKLIKTQ-HLSNDHIQYFLYQILRG 118
Query: 299 LAYLHEAIEPKVVHRDIKSSNILIDDEFNAKVSDFGLAKLLDSGESH--ITTRVMGTFGY 356
L Y+H A V+HRD+K SN+L++ + K+ DFGLA++ D H T + T Y
Sbjct: 119 LKYIHSA---NVLHRDLKPSNLLLNTNCDLKICDFGLARIADPEHDHTGFLTEYVATRWY 175
Query: 357 VAPEYANTGMLNEKS-----DIYSFGVLLLEAVTGR 387
APE MLN K DI+S G +L E ++ R
Sbjct: 176 RAPEI----MLNSKGYTKAIDIWSVGCILAEMLSNR 207
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336 |
| >gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Score = 84.6 bits (209), Expect = 2e-18
Identities = 70/214 (32%), Positives = 112/214 (52%), Gaps = 17/214 (7%)
Query: 194 LGEGGYGVVYKG--RLINGSE-VAVKKLLN--NLGQAEKEFRVEVEAIGHVRHKNLVRLL 248
LG G +G V KG ++ + VAVK L N N + E E + + + +VR++
Sbjct: 3 LGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMI 62
Query: 249 GYCIEGVHRMLVYEYVNNGNLEQWLHGAMRNQGNLTWEARMKVIIGTAKALAYLHEAIEP 308
G C E MLV E G L ++L +N+ ++T + +++ + + YL E
Sbjct: 63 GIC-EAESWMLVMELAELGPLNKFLQ---KNK-HVTEKNITELVHQVSMGMKYLEET--- 114
Query: 309 KVVHRDIKSSNILIDDEFNAKVSDFGLAKLLDSGESHITTRVMGTF--GYVAPEYANTGM 366
VHRD+ + N+L+ + AK+SDFGL+K L + E++ + G + + APE N
Sbjct: 115 NFVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKAKTHGKWPVKWYAPECMNYYK 174
Query: 367 LNEKSDIYSFGVLLLEAVT-GRDPVDYGRPANEV 399
+ KSD++SFGVL+ EA + G+ P G NEV
Sbjct: 175 FSSKSDVWSFGVLMWEAFSYGQKPYK-GMKGNEV 207
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257 |
| >gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Score = 84.2 bits (208), Expect = 4e-18
Identities = 61/219 (27%), Positives = 110/219 (50%), Gaps = 15/219 (6%)
Query: 193 VLGEGGYGVVYKGRLINGSE-----VAVKKLLNNLG-QAEKEFRVEVEAIGHVRHKNLVR 246
+LG G +G V+KG I + VA+K + + G Q +E + A+G + H +VR
Sbjct: 14 LLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVR 73
Query: 247 LLGYCIEGVHRMLVYEYVNNGNLEQWLHGAMRNQGNLTWEARMKVIIGTAKALAYLHEAI 306
LLG C G LV + G+L + +++ +L + + + AK + YL E
Sbjct: 74 LLGIC-PGASLQLVTQLSPLGSLLDHVR---QHRDSLDPQRLLNWCVQIAKGMYYLEEH- 128
Query: 307 EPKVVHRDIKSSNILIDDEFNAKVSDFGLAKLL-DSGESHITTRVMGTFGYVAPEYANTG 365
++VHR++ + NIL+ + +++DFG+A LL + + + ++A E G
Sbjct: 129 --RMVHRNLAARNILLKSDSIVQIADFGVADLLYPDDKKYFYSEHKTPIKWMALESILFG 186
Query: 366 MLNEKSDIYSFGVLLLEAVT-GRDPVDYGRPANEVNLVE 403
+SD++S+GV + E ++ G +P RP +L+E
Sbjct: 187 RYTHQSDVWSYGVTVWEMMSYGAEPYAGMRPHEVPDLLE 225
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279 |
| >gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 84.1 bits (208), Expect = 4e-18
Identities = 61/214 (28%), Positives = 109/214 (50%), Gaps = 21/214 (9%)
Query: 193 VLGEGGYGVVYKGRLI--NGS--EVAVKKL-LNNLGQAE-KEFRVEVEAIGHVRHKNLVR 246
+LGEG +G V +G+L +GS +VAVK + L+ +E +EF E + H N+++
Sbjct: 6 ILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMK 65
Query: 247 LLGYCIEGVHR------MLVYEYVNNGNLEQWLHGAMRNQG---NLTWEARMKVIIGTAK 297
L+G C E M++ ++ +G+L +L R G L + +K ++ A
Sbjct: 66 LIGVCFEASSLQKIPKPMVILPFMKHGDLHSFLL-YSRLGGLPEKLPLQTLLKFMVDIAL 124
Query: 298 ALAYLHEAIEPKVVHRDIKSSNILIDDEFNAKVSDFGLAKLLDSGESHITTRVMGT-FGY 356
+ YL +HRD+ + N ++ ++ V+DFGL+K + SG+ + R+ +
Sbjct: 125 GMEYLSNR---NFIHRDLAARNCMLREDMTVCVADFGLSKKIYSGDYYRQGRIAKMPVKW 181
Query: 357 VAPEYANTGMLNEKSDIYSFGVLLLEAVT-GRDP 389
+A E + KSD+++FGV + E T G+ P
Sbjct: 182 IAIESLADRVYTSKSDVWAFGVTMWEIATRGQTP 215
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273 |
| >gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Score = 83.8 bits (207), Expect = 4e-18
Identities = 61/202 (30%), Positives = 103/202 (50%), Gaps = 14/202 (6%)
Query: 194 LGEGGYGVVYKGRLINGSEVAVKKLLNNLGQAEKEFRVEVEAIGHVRHKNLVRLLGYCIE 253
LG G +GVV G+ +VA+K ++ +E EF E + + + H+ LV+L G C +
Sbjct: 12 LGTGQFGVVKYGKWRGQYDVAIK-MIKEGSMSEDEFIEEAKVMMKLSHEKLVQLYGVCTK 70
Query: 254 GVHRMLVYEYVNNGNLEQWLHGAMRNQGNLTWEARMKVIIGTAKALAYLHEAIEPKVVHR 313
+V EY++NG L +L + +++ + +AYL + +HR
Sbjct: 71 QRPIYIVTEYMSNGCLLNYLREHGKR---FQPSQLLEMCKDVCEGMAYLESK---QFIHR 124
Query: 314 DIKSSNILIDDEFNAKVSDFGLAK-LLDSGESHITTRVMGTF--GYVAPEYANTGMLNEK 370
D+ + N L+DD+ KVSDFGL++ +LD T+ V F + PE + K
Sbjct: 125 DLAARNCLVDDQGCVKVSDFGLSRYVLD---DEYTSSVGSKFPVRWSPPEVLLYSKFSSK 181
Query: 371 SDIYSFGVLLLEAVT-GRDPVD 391
SD+++FGVL+ E + G+ P +
Sbjct: 182 SDVWAFGVLMWEVYSLGKMPYE 203
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256 |
| >gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Score = 83.5 bits (207), Expect = 6e-18
Identities = 60/212 (28%), Positives = 93/212 (43%), Gaps = 34/212 (16%)
Query: 197 GGYGVVYKGRLIN-GSEVAVK---------KLLNNLGQAEKEFRVEVEAIGHVRHKNLVR 246
G YG V+ + + G A+K K + E++ + +V+
Sbjct: 4 GAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILS------QAQSPYVVK 57
Query: 247 LLGYCIEGVHRM-LVYEYVNNGNLEQWLHGAMRNQGNLTWEARMKVIIGTAKALAYLHEA 305
L Y +G + LV EY+ G+L L N G+L + I AL YLH
Sbjct: 58 LY-YSFQGKKNLYLVMEYLPGGDLASLLE----NVGSLDEDVARIYIAEIVLALEYLHSN 112
Query: 306 IEPKVVHRDIKSSNILIDDEFNAKVSDFGLAKL--------LDSGESHITTRVMGTFGYV 357
++HRD+K NILID + K++DFGL+K+ L+ E R++GT Y+
Sbjct: 113 ---GIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKE-DKRIVGTPDYI 168
Query: 358 APEYANTGMLNEKSDIYSFGVLLLEAVTGRDP 389
APE ++ D +S G +L E + G P
Sbjct: 169 APEVILGQGHSKTVDWWSLGCILYEFLVGIPP 200
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265 |
| >gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Score = 83.5 bits (206), Expect = 6e-18
Identities = 81/275 (29%), Positives = 130/275 (47%), Gaps = 37/275 (13%)
Query: 193 VLGEGGYGVVYKGRLINGSE-----VAVKKLLNNLG-QAEKEFRVEVEAIGHVRHKNLVR 246
VLG G +G VYKG I E VA+K L N +A KE E + V + R
Sbjct: 14 VLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCR 73
Query: 247 LLGYCIEGVHRMLVYEYVNNGNLEQWLHGAMRNQGNLTWEARMKVIIGTAKALAYLHEAI 306
LLG C+ + LV + + G L L N+ + + + + AK ++YL E
Sbjct: 74 LLGICLTSTVQ-LVTQLMPYGCL---LDYVRENKDRIGSQDLLNWCVQIAKGMSYLEEV- 128
Query: 307 EPKVVHRDIKSSNILIDDEFNAKVSDFGLAKLLDSGESHITT---RVMGTFGYVAPEYAN 363
++VHRD+ + N+L+ + K++DFGLA+LLD E+ +V ++A E
Sbjct: 129 --RLVHRDLAARNVLVKSPNHVKITDFGLARLLDIDETEYHADGGKV--PIKWMALESIL 184
Query: 364 TGMLNEKSDIYSFGVLLLEAVT-GRDPVDYGRPANEV-NLVEWLKMMVGTRRAEEVVDPN 421
+SD++S+GV + E +T G P D G PA E+ +L+E + E + P
Sbjct: 185 HRRFTHQSDVWSYGVTVWELMTFGAKPYD-GIPAREIPDLLE---------KGERLPQPP 234
Query: 422 LEVKPATRALKRSLLVALRCVDPDSEKRPKMSQVV 456
+ ++ ++C DSE RP+ ++V
Sbjct: 235 I-------CTIDVYMIMVKCWMIDSECRPRFRELV 262
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279 |
| >gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 83.3 bits (206), Expect = 7e-18
Identities = 60/211 (28%), Positives = 100/211 (47%), Gaps = 21/211 (9%)
Query: 193 VLGEGGYGVVYKGRLINGSEV-AVKKLLNNLGQAEKE----------FRVEVEAIGHVRH 241
++G+G YG VY + E+ AVK++ A + R E+E + + H
Sbjct: 8 LIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDH 67
Query: 242 KNLVRLLGYCIEGVHRMLVYEYVNNGNLEQWLHGAMRNQGNLTWEARMKVIIGTAKALAY 301
N+V+ LG+ + + EYV G++ L R G + + LAY
Sbjct: 68 LNIVQYLGFETTEEYLSIFLEYVPGGSIGSCL----RTYGRFEEQLVRFFTEQVLEGLAY 123
Query: 302 LHEAIEPKVVHRDIKSSNILIDDEFNAKVSDFGLAKLLDSGESHITTRVM-GTFGYVAPE 360
LH ++HRD+K+ N+L+D + K+SDFG++K D + M G+ ++APE
Sbjct: 124 LHSK---GILHRDLKADNLLVDADGICKISDFGISKKSDDIYDNDQNMSMQGSVFWMAPE 180
Query: 361 YANTGM--LNEKSDIYSFGVLLLEAVTGRDP 389
++ + K DI+S G ++LE GR P
Sbjct: 181 VIHSYSQGYSAKVDIWSLGCVVLEMFAGRRP 211
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272 |
| >gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Score = 84.0 bits (207), Expect = 7e-18
Identities = 71/273 (26%), Positives = 129/273 (47%), Gaps = 26/273 (9%)
Query: 187 RFSAENVLGEGGYGVVYKGRLIN-GSEVAVKKLLNNLGQAEKEFRV-EVEAIGHVRHKNL 244
+++ +G+G G V+ + G EVA+K++ N Q +KE + E+ + +++ N+
Sbjct: 20 KYTRYEKIGQGASGTVFTAIDVATGQEVAIKQI-NLQKQPKKELIINEILVMKELKNPNI 78
Query: 245 VRLLGYCIEGVHRMLVYEYVNNGNLEQWLHGAMRNQGNLTWEARMKVIIGTAKALAYLHE 304
V L + G +V EY+ G+L + ++ + R + +AL +LH
Sbjct: 79 VNFLDSFLVGDELFVVMEYLAGGSLTDVVTETCMDEAQIAAVCRECL-----QALEFLHA 133
Query: 305 AIEPKVVHRDIKSSNILIDDEFNAKVSDFGLAKLLDSGESHITTRVMGTFGYVAPEYANT 364
+V+HRDIKS N+L+ + + K++DFG + +S +T V GT ++APE
Sbjct: 134 N---QVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQSKRSTMV-GTPYWMAPEVVTR 189
Query: 365 GMLNEKSDIYSFGVLLLEAVTGRDPVDYGRPANEVNLVEWLKMMVGTRRAEEVVDPNLEV 424
K DI+S G++ +E V G P P + L + T E+ +P ++
Sbjct: 190 KAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYL-------IATNGTPELQNPE-KL 241
Query: 425 KPATRALKRSLLVALRCVDPDSEKRPKMSQVVR 457
P R RC++ D EKR ++++
Sbjct: 242 SPIFRDFLN------RCLEMDVEKRGSAKELLQ 268
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296 |
| >gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Score = 83.4 bits (206), Expect = 7e-18
Identities = 73/282 (25%), Positives = 126/282 (44%), Gaps = 33/282 (11%)
Query: 194 LGEGGYGVVYKG---RLINGSEVAVKKLLNNLGQAEK-EFRVEVEAIGHVRHKNLVRLLG 249
+G G +G V G R ++ + V VK+L + E+ F EV+ + H N+++ LG
Sbjct: 3 IGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLG 62
Query: 250 YCIEGVHRMLVYEYVNNGNLEQWL---HGAMRNQGNLTWEARMKVIIGTAKALAYLHEAI 306
CIE + +LV E+ G+L+ +L G + RM + A L +LH+A
Sbjct: 63 QCIESIPYLLVLEFCPLGDLKNYLRSNRGMVAQMAQKDVLQRMACEV--ASGLLWLHQA- 119
Query: 307 EPKVVHRDIKSSNILIDDEFNAKVSDFGLAKLLDSGESHITTRVMGTFG--YVAPEYAN- 363
+H D+ N + + + K+ D+GLA L E + T+ ++APE
Sbjct: 120 --DFIHSDLALRNCQLTADLSVKIGDYGLA-LEQYPEDYYITKDCHAVPLRWLAPELVEI 176
Query: 364 ------TGMLNEKSDIYSFGVLLLEAVTGRDPVDYGRPANEVNLVEWLKMMVGTRRAEEV 417
+KS+I+S GV + E T D +P +++ + LK +V + ++
Sbjct: 177 RGQDLLPKDQTKKSNIWSLGVTMWELFTAAD-----QPYPDLSDEQVLKQVVREQDI-KL 230
Query: 418 VDPNLEVKPATRALKRSLLVALRCVDPDSEKRPKMSQVVRML 459
P L++K + R + L D E RP +V +L
Sbjct: 231 PKPQLDLKYSDRWYEVMQFCWL-----DPETRPTAEEVHELL 267
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269 |
| >gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Score = 84.1 bits (208), Expect = 9e-18
Identities = 69/252 (27%), Positives = 113/252 (44%), Gaps = 68/252 (26%)
Query: 185 TNRFSAENVLGEGGYGVVYKGR-LINGSEVAVKKLLNNLGQ---AEKEFRVEVEAIGHVR 240
TNR+ +G G +G+V R + G VA+KK++ A++ +R E++ + H+R
Sbjct: 9 TNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYR-ELKLLKHLR 67
Query: 241 HKNLVRLLGYCIE--------------GVHRMLVYEYVNNGNLEQWLHGAMRNQGNLTWE 286
H+N++ L I +HR+L + ++ +L+ +R
Sbjct: 68 HENIISLSDIFISPLEDIYFVTELLGTDLHRLLTSRPLEKQFIQYFLYQILR-------- 119
Query: 287 ARMKVIIGTAKALAYLHEAIEPKVVHRDIKSSNILIDDEFNAKVSDFGLAKLLDSGESHI 346
L Y+H A VVHRD+K SNILI++ + K+ DFGLA++ D +
Sbjct: 120 -----------GLKYVHSA---GVVHRDLKPSNILINENCDLKICDFGLARIQD---PQM 162
Query: 347 TTRVMGTFGYVAPEYANTGML-----NEKSDIYSFGVLLLEAVT------GRDPVD---- 391
T V T Y APE ML + + DI+S G + E + G+D V+
Sbjct: 163 TGYV-STRYYRAPEI----MLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSI 217
Query: 392 ----YGRPANEV 399
G P ++V
Sbjct: 218 ITDLLGTPPDDV 229
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328 |
| >gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Score = 83.5 bits (206), Expect = 9e-18
Identities = 68/240 (28%), Positives = 111/240 (46%), Gaps = 32/240 (13%)
Query: 193 VLGEGGYGVVYKGRL--ING----SEVAVKKLLNNLGQAE-KEFRVEVEAIGHVRHKNLV 245
LGEG +G V K + G + VAVK L N +E ++ E + V H +++
Sbjct: 7 TLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVI 66
Query: 246 RLLGYCIEGVHRMLVYEYVNNGNLEQWLH------------GAMRNQGNLTWEA----RM 289
+L G C + +L+ EY G+L +L RN L M
Sbjct: 67 KLYGACSQDGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTM 126
Query: 290 KVIIGTA----KALAYLHEAIEPKVVHRDIKSSNILIDDEFNAKVSDFGLAKLLDSGESH 345
+I A + + YL E K+VHRD+ + N+L+ + K+SDFGL++ + +S+
Sbjct: 127 GDLISFAWQISRGMQYLAEM---KLVHRDLAARNVLVAEGRKMKISDFGLSRDVYEEDSY 183
Query: 346 IT-TRVMGTFGYVAPEYANTGMLNEKSDIYSFGVLLLEAVT-GRDPVDYGRPANEVNLVE 403
+ ++ ++A E + +SD++SFGVLL E VT G +P P NL++
Sbjct: 184 VKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIAPERLFNLLK 243
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290 |
| >gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Score = 82.8 bits (204), Expect = 1e-17
Identities = 69/211 (32%), Positives = 101/211 (47%), Gaps = 12/211 (5%)
Query: 182 EIATNRFSAENVLGEGGYGVVYKGRLINGSEVAVKKLLNNLGQAEKEFRVEVEAIGHVRH 241
EI + LG+G +G V+ G ++VA+K L E F E + + +RH
Sbjct: 2 EIPRESLRLDVKLGQGCFGEVWMGTWNGTTKVAIKTLKPGTMMPEA-FLQEAQIMKKLRH 60
Query: 242 KNLVRLLGYCIEGVHRMLVYEYVNNGNLEQWLHGAMRNQGNLTWEARMKVIIGTAKALAY 301
LV L E +V E++ G+L +L L M I A +AY
Sbjct: 61 DKLVPLYAVVSEE-PIYIVTEFMGKGSLLDFLKEGDGKYLKLPQLVDMAAQI--ADGMAY 117
Query: 302 LHEAIEPKVVHRDIKSSNILIDDEFNAKVSDFGLAKLLDSGESHITTRVMGTF--GYVAP 359
+ +HRD++++NIL+ D K++DFGLA+L++ E T R F + AP
Sbjct: 118 IERM---NYIHRDLRAANILVGDNLVCKIADFGLARLIEDNE--YTARQGAKFPIKWTAP 172
Query: 360 EYANTGMLNEKSDIYSFGVLLLEAVT-GRDP 389
E A G KSD++SFG+LL E VT GR P
Sbjct: 173 EAALYGRFTIKSDVWSFGILLTELVTKGRVP 203
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260 |
| >gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Score = 83.4 bits (207), Expect = 1e-17
Identities = 63/212 (29%), Positives = 105/212 (49%), Gaps = 33/212 (15%)
Query: 187 RFSAENVLGEGGYGVVYKGR-LINGSEVAVKKLLNNLGQAEKE------FRVEVEAIGHV 239
R+ LGEG Y VVYK R G VA+KK+ + K+ R E++ + +
Sbjct: 1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALR-EIKLLQEL 59
Query: 240 RHKNLVRLLG-YCIEG-VHRMLVYEYVNNGNLEQWLHGAMRNQGNLTWEARMKVIIG-TA 296
+H N++ LL + + ++ LV+E++ +LE+ + LT A +K + T
Sbjct: 60 KHPNIIGLLDVFGHKSNIN--LVFEFME-TDLEKVIK---DKSIVLT-PADIKSYMLMTL 112
Query: 297 KALAYLHEAIEPKVVHRDIKSSNILIDDEFNAKVSDFGLAKLLDSGESHITTRVMGTFGY 356
+ L YLH ++HRD+K +N+LI + K++DFGLA+ S +T +V+ T Y
Sbjct: 113 RGLEYLHSNW---ILHRDLKPNNLLIASDGVLKLADFGLARSFGSPNRKMTHQVV-TRWY 168
Query: 357 VAPE------YANTGMLNEKSDIYSFGVLLLE 382
APE + G+ D++S G + E
Sbjct: 169 RAPELLFGARHYGVGV-----DMWSVGCIFAE 195
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298 |
| >gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein | Back alignment and domain information |
|---|
Score = 86.4 bits (214), Expect = 1e-17
Identities = 62/192 (32%), Positives = 93/192 (48%), Gaps = 22/192 (11%)
Query: 210 GSEVAVKKLLNNLGQAEKE---FRVEVEAIGHVRHKNLVRLL--GYCIEGVHRMLVYEYV 264
G EVA+K L + + E + FR E + H N+V LL G G+ V+EYV
Sbjct: 3 GHEVAIKLLRTDAPEEEHQRARFRRETALCARLYHPNIVALLDSGEAPPGL-LFAVFEYV 61
Query: 265 NNGNLEQWLHGAMRNQGNLTWEARMKVIIGTAKALAYLHEAIEPKVVHRDIKSSNILI-- 322
L + L G L ++++ ALA H +VHRD+K NI++
Sbjct: 62 PGRTLREVL----AADGALPAGETGRLMLQVLDALACAHNQ---GIVHRDLKPQNIMVSQ 114
Query: 323 -DDEFNAKVSDFGLAKLL----DSGESHIT--TRVMGTFGYVAPEYANTGMLNEKSDIYS 375
+AKV DFG+ LL D+ + +T T V+GT Y APE + SD+Y+
Sbjct: 115 TGVRPHAKVLDFGIGTLLPGVRDADVATLTRTTEVLGTPTYCAPEQLRGEPVTPNSDLYA 174
Query: 376 FGVLLLEAVTGR 387
+G++ LE +TG+
Sbjct: 175 WGLIFLECLTGQ 186
|
This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266 |
| >gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Score = 82.3 bits (203), Expect = 1e-17
Identities = 62/206 (30%), Positives = 108/206 (52%), Gaps = 20/206 (9%)
Query: 194 LGEGGYGVVYKG------RLINGSEVAVKKLLNNLGQAEK-EFRVEVEAIGHVRHKNLVR 246
LG G +G V KG + I +VA+K L N ++ + E E E + + + +VR
Sbjct: 3 LGSGNFGCVKKGVYKMRKKQI---DVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVR 59
Query: 247 LLGYCIEGVHRMLVYEYVNNGNLEQWLHGAMRNQGNLTWEARMKVIIGTAKALAYLHEAI 306
++G C E MLV E + G L ++L G + +T ++++ + + YL
Sbjct: 60 MIGVC-EAEALMLVMEMASGGPLNKFLSG---KKDEITVSNVVELMHQVSMGMKYLEGK- 114
Query: 307 EPKVVHRDIKSSNILIDDEFNAKVSDFGLAKLLDSGESHITTRVMGTF--GYVAPEYANT 364
VHRD+ + N+L+ ++ AK+SDFGL+K L + +S+ R G + + APE N
Sbjct: 115 --NFVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKARSAGKWPLKWYAPECINF 172
Query: 365 GMLNEKSDIYSFGVLLLEAVT-GRDP 389
+ +SD++S+G+ + EA + G+ P
Sbjct: 173 RKFSSRSDVWSYGITMWEAFSYGQKP 198
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257 |
| >gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Score = 82.8 bits (204), Expect = 1e-17
Identities = 73/266 (27%), Positives = 126/266 (47%), Gaps = 26/266 (9%)
Query: 194 LGEGGYGVVYKGR-LINGSEVAVKKLLNNLGQAEKEFRV-EVEAIGHVRHKNLVRLLGYC 251
+G+G G VY + G EVA++++ N Q +KE + E+ + ++ N+V L
Sbjct: 28 IGQGASGTVYTAMDVATGQEVAIRQM-NLQQQPKKELIINEILVMRENKNPNIVNYLDSY 86
Query: 252 IEGVHRMLVYEYVNNGNLEQWLHGAMRNQGNLTWEARMKVIIGTAKALAYLHEAIEPKVV 311
+ G +V EY+ G+L + ++G + R + +AL +LH +V+
Sbjct: 87 LVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAAVCRECL-----QALEFLHSN---QVI 138
Query: 312 HRDIKSSNILIDDEFNAKVSDFGLAKLLDSGESHITTRVMGTFGYVAPEYANTGMLNEKS 371
HRDIKS NIL+ + + K++DFG + +S + ++GT ++APE K
Sbjct: 139 HRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSK-RSTMVGTPYWMAPEVVTRKAYGPKV 197
Query: 372 DIYSFGVLLLEAVTGRDPVDYGRPANEVNLVEWLKMMVGTRRAEEVVDPNLEVKPATRAL 431
DI+S G++ +E + G P P + L+ GT P L+ A+
Sbjct: 198 DIWSLGIMAIEMIEGEPPYLNENPLRALYLIA----TNGT--------PELQNPEKLSAI 245
Query: 432 KRSLLVALRCVDPDSEKRPKMSQVVR 457
R L RC+D D EKR ++++
Sbjct: 246 FRDFLN--RCLDMDVEKRGSAKELLQ 269
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296 |
| >gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Score = 82.5 bits (204), Expect = 2e-17
Identities = 79/297 (26%), Positives = 139/297 (46%), Gaps = 42/297 (14%)
Query: 181 LEIATNRFSAENVLGEGGYGVVYKGRLINGS-----EVAVKKLLNNLGQAEKEFRV-EVE 234
+ I+ +R + ++L EG +G ++ G LI+ EV VK + ++ + + + E
Sbjct: 1 IAISRDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESC 60
Query: 235 AIGHVRHKNLVRLLGYCIEGVHR-MLVYEYVNNGNLEQWL----HGAMRNQGNLTWEARM 289
+ + H+N++ +L CIE ++Y Y+N GNL+ +L G N L+ + +
Sbjct: 61 LLYGLSHQNILPILHVCIEDGEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLV 120
Query: 290 KVIIGTAKALAYLHEAIEPKVVHRDIKSSNILIDDEFNAKVSDFGLAKLLDSGESHITTR 349
+ I A ++YLH+ V+H+DI + N +ID+E K++D L++ L + H
Sbjct: 121 HMAIQIACGMSYLHKR---GVIHKDIAARNCVIDEELQVKITDNALSRDLFPMDYH---- 173
Query: 350 VMGT-----FGYVAPEYANTGMLNEKSDIYSFGVLLLEAVT-GRDPVDYGRPANEVNLVE 403
+G ++A E + SD++SFGVLL E +T G P E++ E
Sbjct: 174 CLGDNENRPVKWMALESLVNKEYSSASDVWSFGVLLWELMTLG------QTPYVEIDPFE 227
Query: 404 WLKMMV-GTRRAEEVVDPNLEVKPATRALKRSLLVALRCVDPDSEKRPKMSQVVRML 459
+ G R A+ + P+ V C D E+RP SQ+V+ L
Sbjct: 228 MAAYLKDGYRLAQPINCPD-----------ELFAVMACCWALDPEERPSFSQLVQCL 273
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280 |
| >gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Score = 82.7 bits (204), Expect = 2e-17
Identities = 77/281 (27%), Positives = 135/281 (48%), Gaps = 39/281 (13%)
Query: 188 FSAENVLGEGGYGVVYKGRLINGSE-----VAVKKLLNNLG-QAEKEFRVEVEAIGHVRH 241
F VLG G +G VYKG I E VA+K+L +A KE E + V +
Sbjct: 9 FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 68
Query: 242 KNLVRLLGYCIEGVHRMLVYEYVNNGNLEQWLHGAMRNQGNLTWEARMKVIIGTAKALAY 301
++ RLLG C+ + L+ + + G L ++ ++ N+ + + + AK + Y
Sbjct: 69 PHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVR---EHKDNIGSQYLLNWCVQIAKGMNY 124
Query: 302 LHEAIEPKVVHRDIKSSNILIDDEFNAKVSDFGLAKLL--DSGESHITTRVMGTFGYVAP 359
L E ++VHRD+ + N+L+ + K++DFGLAKLL D E H + ++A
Sbjct: 125 LEER---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGADEKEYHAEGGKV-PIKWMAL 180
Query: 360 EYANTGMLNEKSDIYSFGVLLLEAVT-GRDPVDYGRPANEVNLVEWLKMMVGTRRAEEVV 418
E + +SD++S+GV + E +T G P D G PA+E++ + + E +
Sbjct: 181 ESILHRIYTHQSDVWSYGVTVWELMTFGSKPYD-GIPASEISSI--------LEKGERLP 231
Query: 419 DP---NLEVKPATRALKRSLLVALRCVDPDSEKRPKMSQVV 456
P ++V ++ ++C D++ RPK +++
Sbjct: 232 QPPICTIDV----------YMIMVKCWMIDADSRPKFRELI 262
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316 |
| >gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Score = 82.0 bits (202), Expect = 2e-17
Identities = 72/243 (29%), Positives = 120/243 (49%), Gaps = 31/243 (12%)
Query: 180 DLEIATNRFSAENVLGEGGYGVVYKGRL-INGSE----VAVKKLLN-NLGQAEKEFRVEV 233
+L ++ RF E LGE +G +YKG L + G + VA+K L + N Q EF+ E
Sbjct: 1 ELPLSAVRFMEE--LGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEA 58
Query: 234 EAIGHVRHKNLVRLLGYCIEGVHRMLVYEYVNNGNLEQWLHGAMRN-------------- 279
+ + H N+V LLG + +++EY+N G+L ++L MR+
Sbjct: 59 SLMAELHHPNIVCLLGVVTQEQPVCMLFEYLNQGDLHEFL--IMRSPHSDVGCSSDEDGT 116
Query: 280 -QGNLTWEARMKVIIGTAKALAYLHEAIEPKVVHRDIKSSNILIDDEFNAKVSDFGLAKL 338
+ +L + + I A + YL VH+D+ + NILI ++ + K+SD GL++
Sbjct: 117 VKSSLDHGDFLHIAIQIAAGMEYLSSHF---FVHKDLAARNILIGEQLHVKISDLGLSRE 173
Query: 339 LDSGESH-ITTRVMGTFGYVAPEYANTGMLNEKSDIYSFGVLLLEAVT-GRDPVDYGRPA 396
+ S + + + + + ++ PE G + SDI+SFGV+L E + G P YG
Sbjct: 174 IYSADYYRVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPY-YGFSN 232
Query: 397 NEV 399
EV
Sbjct: 233 QEV 235
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283 |
| >gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 81.5 bits (201), Expect = 3e-17
Identities = 68/208 (32%), Positives = 98/208 (47%), Gaps = 20/208 (9%)
Query: 193 VLGEGGYGVV--YKGRLIN---GSEVAVKKLLNNLGQAEKE-FRVEVEAIGHVRHKNLVR 246
VLGEG +G V Y N G VAVK L GQ ++ E+ + + H+N+V+
Sbjct: 11 VLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVK 70
Query: 247 LLGYCIEGVHR--MLVYEYVNNGNLEQWLHGAMRNQGNLTWEARMKVIIGTAKALAYLHE 304
G C E + L+ EYV G+L +L N L A+ + +AYLH
Sbjct: 71 YKGCCSEQGGKGLQLIMEYVPLGSLRDYLPKHKLNLAQLLLFAQQ-----ICEGMAYLHS 125
Query: 305 AIEPKVVHRDIKSSNILIDDEFNAKVSDFGLAKLLDSGESHITTRVMG---TFGYVAPEY 361
+HRD+ + N+L+D++ K+ DFGLAK + G + R G F Y A E
Sbjct: 126 Q---HYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWY-AVEC 181
Query: 362 ANTGMLNEKSDIYSFGVLLLEAVTGRDP 389
+ SD++SFGV L E +T D
Sbjct: 182 LKENKFSYASDVWSFGVTLYELLTHCDS 209
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283 |
| >gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Score = 81.3 bits (200), Expect = 4e-17
Identities = 74/266 (27%), Positives = 126/266 (47%), Gaps = 26/266 (9%)
Query: 194 LGEGGYGVVYKG-RLINGSEVAVKKLLNNLGQAEKEFRV-EVEAIGHVRHKNLVRLLGYC 251
+G+G G VY + G EVA+K++ N Q +KE + E+ + ++ N+V L
Sbjct: 27 IGQGASGTVYTAIDIATGQEVAIKQM-NLQQQPKKELIINEILVMRENKNPNIVNYLDSY 85
Query: 252 IEGVHRMLVYEYVNNGNLEQWLHGAMRNQGNLTWEARMKVIIGTAKALAYLHEAIEPKVV 311
+ G +V EY+ G+L + ++G + R + +AL +LH +V+
Sbjct: 86 LVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAAVCRECL-----QALDFLHSN---QVI 137
Query: 312 HRDIKSSNILIDDEFNAKVSDFGLAKLLDSGESHITTRVMGTFGYVAPEYANTGMLNEKS 371
HRDIKS NIL+ + + K++DFG + +S +T V GT ++APE K
Sbjct: 138 HRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMV-GTPYWMAPEVVTRKAYGPKV 196
Query: 372 DIYSFGVLLLEAVTGRDPVDYGRPANEVNLVEWLKMMVGTRRAEEVVDPNLEVKPATRAL 431
DI+S G++ +E V G P P + L+ GT P L+ A+
Sbjct: 197 DIWSLGIMAIEMVEGEPPYLNENPLRALYLIA----TNGT--------PELQNPERLSAV 244
Query: 432 KRSLLVALRCVDPDSEKRPKMSQVVR 457
R L RC++ D ++R ++++
Sbjct: 245 FRDFLN--RCLEMDVDRRGSAKELLQ 268
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297 |
| >gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 81.0 bits (200), Expect = 7e-17
Identities = 78/292 (26%), Positives = 131/292 (44%), Gaps = 36/292 (12%)
Query: 182 EIATNRFSAENVLGEGGYGVVYKGRLINGS------EVAVKKLLNNLGQAEKE-FRVEVE 234
E N S LG G +G V + S +VAVK L +E+E E++
Sbjct: 31 EFPRNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELK 90
Query: 235 AIGHV-RHKNLVRLLGYCIEGVHRMLVYEYVNNGNLEQWLHGAMRNQGN-LTWEARMKVI 292
+ H+ H+N+V LLG C G +++ EY G+L +L R + + LT E +
Sbjct: 91 IMSHLGNHENIVNLLGACTIGGPILVITEYCCYGDLLNFLR---RKRESFLTLEDLLSFS 147
Query: 293 IGTAKALAYLHEAIEPKVVHRDIKSSNILIDDEFNAKVSDFGLAKLLDSGESHI---TTR 349
AK +A+L +HRD+ + N+L+ K+ DFGLA+ + + +++ R
Sbjct: 148 YQVAKGMAFLASK---NCIHRDLAARNVLLTHGKIVKICDFGLARDIMNDSNYVVKGNAR 204
Query: 350 VMGTFGYVAPEYANTGMLNEKSDIYSFGVLLLEAVT-GRDPVDYGRPANEVNLVEWLKMM 408
+ ++APE + +SD++S+G+LL E + G +P P V+ + +
Sbjct: 205 L--PVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPY----PGMPVDSKFYKLIK 258
Query: 409 VGTRRAEEVVDPNLEVKPATRALKRSLLVALRCVDPDSEKRPKMSQVVRMLE 460
G R A +P A + C D D KRP Q+V+++
Sbjct: 259 EGYRMA----------QPE-HAPAEIYDIMKTCWDADPLKRPTFKQIVQLIG 299
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302 |
| >gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 80.8 bits (200), Expect = 7e-17
Identities = 64/214 (29%), Positives = 99/214 (46%), Gaps = 43/214 (20%)
Query: 192 NVLGEGGYGVVYKGR-LINGSEVAVKKL---LNNLGQAEKEFRVEVEAIGHVR---HKNL 244
+GEG YG VYK R L G VA+KK+ L+ G R E+ + + H N+
Sbjct: 5 AEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLR-EIALLKQLESFEHPNI 63
Query: 245 VRLLGYCI-----EGVHRMLVYEYVNNGNLEQWLHGAMRN---QGNLTWEAR--MKVIIG 294
VRLL C + LV+E+V +Q L + G + M+ ++
Sbjct: 64 VRLLDVCHGPRTDRELKLTLVFEHV-----DQDLATYLSKCPKPGLPPETIKDLMRQLL- 117
Query: 295 TAKALAYLHEAIEPKVVHRDIKSSNILIDDEFNAKVSDFGLAKLLDSGESHITTRVMGTF 354
+ + +LH ++VHRD+K NIL+ + K++DFGLA++ E +T+ V+ T
Sbjct: 118 --RGVDFLHSH---RIVHRDLKPQNILVTSDGQVKIADFGLARIYSF-EMALTSVVV-TL 170
Query: 355 GYVAPE------YANTGMLNEKSDIYSFGVLLLE 382
Y APE YA D++S G + E
Sbjct: 171 WYRAPEVLLQSSYATP------VDMWSVGCIFAE 198
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287 |
| >gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 80.4 bits (198), Expect = 9e-17
Identities = 62/203 (30%), Positives = 104/203 (51%), Gaps = 18/203 (8%)
Query: 194 LGEGGYGVV----YKGRLIN-GSEVAVKKLL-NNLGQAEKEFRVEVEAIGHVRHKNLVRL 247
LGEG +G V Y N G +VAVK L + G + + E+E + ++ H+N+V+
Sbjct: 12 LGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKY 71
Query: 248 LGYCIEGVHR--MLVYEYVNNGNLEQWLHGAMRNQGNLTWEARMKVIIGTAKALAYLHEA 305
G C E L+ E++ +G+L+++L RN+ + + ++K + K + YL
Sbjct: 72 KGICTEDGGNGIKLIMEFLPSGSLKEYLP---RNKNKINLKQQLKYAVQICKGMDYLGSR 128
Query: 306 IEPKVVHRDIKSSNILIDDEFNAKVSDFGLAKLLDSGESHITT---RVMGTFGYVAPEYA 362
+ VHRD+ + N+L++ E K+ DFGL K +++ + + T F Y APE
Sbjct: 129 ---QYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDLDSPVFWY-APECL 184
Query: 363 NTGMLNEKSDIYSFGVLLLEAVT 385
SD++SFGV L E +T
Sbjct: 185 IQSKFYIASDVWSFGVTLYELLT 207
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284 |
| >gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Score = 80.2 bits (198), Expect = 9e-17
Identities = 64/209 (30%), Positives = 100/209 (47%), Gaps = 20/209 (9%)
Query: 193 VLGEGGYGVVYKGRLINGSE---VAVKKLLNNLGQAEKE-----FRVEVEAIGHVRHKNL 244
VLG G YG V+ R + G + + K+L +K R E + + VR
Sbjct: 7 VLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPF 66
Query: 245 VRLLGYCIEGVHRM-LVYEYVNNGNLEQWLHGAMRNQGNLTWEARMKVIIG-TAKALAYL 302
+ L Y + ++ L+ +YVN G L L+ + + T E+ ++V I AL +L
Sbjct: 67 LVTLHYAFQTDTKLHLILDYVNGGELFTHLY----QREHFT-ESEVRVYIAEIVLALDHL 121
Query: 303 HEAIEPKVVHRDIKSSNILIDDEFNAKVSDFGLAKLLDSGESHITTRVMGTFGYVAPEYA 362
H+ +++RDIK NIL+D E + ++DFGL+K + E GT Y+APE
Sbjct: 122 HQL---GIIYRDIKLENILLDSEGHVVLTDFGLSKEFLAEEEERAYSFCGTIEYMAPEVI 178
Query: 363 NTGML--NEKSDIYSFGVLLLEAVTGRDP 389
G ++ D +S GVL E +TG P
Sbjct: 179 RGGSGGHDKAVDWWSLGVLTFELLTGASP 207
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288 |
| >gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Score = 80.1 bits (198), Expect = 1e-16
Identities = 58/182 (31%), Positives = 85/182 (46%), Gaps = 35/182 (19%)
Query: 194 LGEGGYGVVYKGRLI-NGSEVAVKKLLNNLGQAEKE-------FRVEVEAIGHVRHKNLV 245
+GEG YGVV+K R G VA+KK + ++E + R E+ + ++H NLV
Sbjct: 9 IGEGSYGVVFKCRNRETGQIVAIKKFV----ESEDDPVIKKIALR-EIRMLKQLKHPNLV 63
Query: 246 RLLGYCIEGVHRM----LVYEYVNN---GNLEQWLHGAMRNQGNLTWEARMKVIIGTAKA 298
L IE R LV+EY ++ LE+ G + K+I T +A
Sbjct: 64 NL----IEVFRRKRKLHLVFEYCDHTVLNELEKNPRGVPEHLI-------KKIIWQTLQA 112
Query: 299 LAYLHEAIEPKVVHRDIKSSNILIDDEFNAKVSDFGLAKLLDSGESHITTRVMGTFGYVA 358
+ + H+ +HRD+K NILI + K+ DFG A++L T V T Y A
Sbjct: 113 VNFCHKH---NCIHRDVKPENILITKQGQIKLCDFGFARILTGPGDDYTDYV-ATRWYRA 168
Query: 359 PE 360
PE
Sbjct: 169 PE 170
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286 |
| >gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Score = 80.3 bits (198), Expect = 1e-16
Identities = 77/266 (28%), Positives = 126/266 (47%), Gaps = 26/266 (9%)
Query: 194 LGEGGYGVVYKG-RLINGSEVAVKKLLNNLGQAEKEFRV-EVEAIGHVRHKNLVRLLGYC 251
+G+G G VY + G EVA+K++ N Q +KE + E+ + +H N+V L
Sbjct: 27 IGQGASGTVYTAIDVATGQEVAIKQM-NLQQQPKKELIINEILVMRENKHPNIVNYLDSY 85
Query: 252 IEGVHRMLVYEYVNNGNLEQWLHGAMRNQGNLTWEARMKVIIGTAKALAYLHEAIEPKVV 311
+ G +V EY+ G+L + ++G + R + +AL +LH +V+
Sbjct: 86 LVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAAVCRECL-----QALEFLHSN---QVI 137
Query: 312 HRDIKSSNILIDDEFNAKVSDFGLAKLLDSGESHITTRVMGTFGYVAPEYANTGMLNEKS 371
HRDIKS NIL+ + + K++DFG + +S +T V GT ++APE K
Sbjct: 138 HRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMV-GTPYWMAPEVVTRKAYGPKV 196
Query: 372 DIYSFGVLLLEAVTGRDPVDYGRPANEVNLVEWLKMMVGTRRAEEVVDPNLEVKPATRAL 431
DI+S G++ +E V G P P + L+ GT P L+ A+
Sbjct: 197 DIWSLGIMAIEMVEGEPPYLNENPLRALYLIA----TNGT--------PELQNPEKLSAI 244
Query: 432 KRSLLVALRCVDPDSEKRPKMSQVVR 457
R L RC++ D EKR ++++
Sbjct: 245 FRDFLN--RCLEMDVEKRGSAKELLQ 268
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293 |
| >gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Score = 80.2 bits (198), Expect = 1e-16
Identities = 59/198 (29%), Positives = 96/198 (48%), Gaps = 12/198 (6%)
Query: 194 LGEGGYGVVYKGRLIN-GSEVAVKKLLNNLGQAEKEFRV-EVEAIGHVRHKNLVRLLGYC 251
+GEG G+V + G +VAVKK+ + Q +E EV + +H N+V +
Sbjct: 27 IGEGSTGIVCIATDKSTGRQVAVKKM-DLRKQQRRELLFNEVVIMRDYQHPNIVEMYSSY 85
Query: 252 IEGVHRMLVYEYVNNGNLEQWLHGAMRNQGNLTWEARMKVIIGTAKALAYLHEAIEPKVV 311
+ G +V E++ G L + + E V + KAL++LH V+
Sbjct: 86 LVGDELWVVMEFLEGGALTD-----IVTHTRMNEEQIATVCLAVLKALSFLHAQ---GVI 137
Query: 312 HRDIKSSNILIDDEFNAKVSDFGLAKLLDSGESHITTRVMGTFGYVAPEYANTGMLNEKS 371
HRDIKS +IL+ + K+SDFG + S E ++GT ++APE + +
Sbjct: 138 HRDIKSDSILLTSDGRVKLSDFGFCAQV-SKEVPRRKSLVGTPYWMAPEVISRLPYGTEV 196
Query: 372 DIYSFGVLLLEAVTGRDP 389
DI+S G++++E V G P
Sbjct: 197 DIWSLGIMVIEMVDGEPP 214
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285 |
| >gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Score = 80.0 bits (197), Expect = 1e-16
Identities = 60/214 (28%), Positives = 103/214 (48%), Gaps = 26/214 (12%)
Query: 191 ENVLGEGGYGVVYKGRLI---NGSEVAVKKLLNNLGQAE-KEFRVEVEAIGHV-RHKNLV 245
E+V+GEG +G V + + A+K L + + ++F E+E + + H N++
Sbjct: 7 EDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNII 66
Query: 246 RLLGYCIEGVHRMLVYEYVNNGNLEQWLHGA---------MRNQGN---LTWEARMKVII 293
LLG C + + EY GNL +L + + G LT + ++
Sbjct: 67 NLLGACENRGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFAS 126
Query: 294 GTAKALAYLHEAIEPKVVHRDIKSSNILIDDEFNAKVSDFGLAKLLDSGESHITTRVMGT 353
A + YL E + +HRD+ + N+L+ + +K++DFGL++ GE + MG
Sbjct: 127 DVATGMQYLSEK---QFIHRDLAARNVLVGENLASKIADFGLSR----GEEVYVKKTMGR 179
Query: 354 FG--YVAPEYANTGMLNEKSDIYSFGVLLLEAVT 385
++A E N + KSD++SFGVLL E V+
Sbjct: 180 LPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVS 213
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297 |
| >gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 79.7 bits (197), Expect = 1e-16
Identities = 66/209 (31%), Positives = 96/209 (45%), Gaps = 33/209 (15%)
Query: 194 LGEGGYGVVYKGR-LINGSEVAVKKLLNNLGQAEKE------FRVEVEAIGHVRHKNLVR 246
+GEG YGVVYK R + G VA+KK+ L + E E R E+ + + H N+VR
Sbjct: 7 IGEGTYGVVYKARDKLTGEIVALKKI--RL-ETEDEGVPSTAIR-EISLLKELNHPNIVR 62
Query: 247 LLGYCIEGVHRMLVYEYVNNGNLEQWLHGAMRNQGNLTWEARM--KVIIGTAKALAYLHE 304
LL LV+E+ L+ L M + + + + + +AY H
Sbjct: 63 LLDVVHSENKLYLVFEF-----LDLDLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCHS 117
Query: 305 AIEPKVVHRDIKSSNILIDDEFNAKVSDFGLAKLLDSGESHITTRVMGTFGYVAPE---- 360
+V+HRD+K N+LID E K++DFGLA+ T V+ T Y APE
Sbjct: 118 H---RVLHRDLKPQNLLIDREGALKLADFGLARAFGVPVRTYTHEVV-TLWYRAPEILLG 173
Query: 361 --YANTGMLNEKSDIYSFGVLLLEAVTGR 387
+T + DI+S G + E V R
Sbjct: 174 SRQYSTPV-----DIWSIGCIFAEMVNRR 197
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283 |
| >gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 78.8 bits (195), Expect = 2e-16
Identities = 62/204 (30%), Positives = 95/204 (46%), Gaps = 21/204 (10%)
Query: 194 LGEGGYGVVYKGRLINGSEV----AVKKLLNNLGQAEKEFRVEVEAIGHVRHKNLVRLLG 249
LG GG+G V ++ + + VKK ++ E E + H +V+L
Sbjct: 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYR 60
Query: 250 YCIEGVHRMLVYEYVNNGNLEQWLHGAMRNQGNL-TWEARMKV--IIGTAKALAYLHEAI 306
+ + ++ EY G L W +R++G + AR + ++ A YLH
Sbjct: 61 TFKDKKYIYMLMEYCLGGEL--W--TILRDRGLFDEYTARFYIACVV---LAFEYLHNR- 112
Query: 307 EPKVVHRDIKSSNILIDDEFNAKVSDFGLAKLLDSGESHITTRVMGTFGYVAPEY-ANTG 365
+++RD+K N+L+D K+ DFG AK L SG+ T GT YVAPE N G
Sbjct: 113 --GIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQK--TWTFCGTPEYVAPEIILNKG 168
Query: 366 MLNEKSDIYSFGVLLLEAVTGRDP 389
+ D +S G+LL E +TGR P
Sbjct: 169 Y-DFSVDYWSLGILLYELLTGRPP 191
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262 |
| >gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 80.2 bits (198), Expect = 2e-16
Identities = 81/286 (28%), Positives = 134/286 (46%), Gaps = 27/286 (9%)
Query: 187 RFSAENVLGEGGYGVVYKGR-LINGSEVAVKKLLN---NLGQAEKEFRVEVEAIGHVRHK 242
R+ + V+G+G YGVV G +VA+KK+ + ++ A + R E++ + +RH
Sbjct: 1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILR-EIKLLRLLRHP 59
Query: 243 NLVRLLGYCIEGVHRMLVYEYVNNGNLEQWLHGAMRNQGNLTWEARMKVIIGTAKALAYL 302
++V + + R YV +E LH ++ +LT E + +AL Y+
Sbjct: 60 DIVEIKHIMLPPSRREFKDIYVVFELMESDLHQVIKANDDLTPEHHQFFLYQLLRALKYI 119
Query: 303 HEAIEPKVVHRDIKSSNILIDDEFNAKVSDFGLAK--LLDSGESHITTRVMGTFGYVAPE 360
H A V HRD+K NIL + + K+ DFGLA+ D+ + T + T Y APE
Sbjct: 120 HTA---NVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPE 176
Query: 361 YANT--GMLNEKSDIYSFGVLLLEAVTGRDPVDYGRPANEVNLVEWLKMMVGTRRAEEVV 418
+ DI+S G + E +TG+ P+ G+ N V+ ++ + ++GT
Sbjct: 177 LCGSFFSKYTPAIDIWSIGCIFAEVLTGK-PLFPGK--NVVHQLDLITDLLGT------- 226
Query: 419 DPNLEVKPATRALK-RSLLVALRCVDPD--SEKRPKM-SQVVRMLE 460
P+ E R K R L ++R P S+K P +R+LE
Sbjct: 227 -PSPETISRVRNEKARRYLSSMRKKQPVPFSQKFPNADPLALRLLE 271
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338 |
| >gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Score = 79.0 bits (195), Expect = 3e-16
Identities = 78/305 (25%), Positives = 131/305 (42%), Gaps = 54/305 (17%)
Query: 194 LGEGGYGVVYKGRLI-NGSEVAVKKLLNNLGQAE-KEFRVEVEAIGHVRH-KNLVRLLG- 249
LG G YGVV K R + G+ +AVK++ + E K ++++ V G
Sbjct: 9 LGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDCPYTVTFYGA 68
Query: 250 --------YCIEGVHRMLVYEYVNNGNLEQWLHGAMRNQGNLTWEARMKVIIGTAKALAY 301
C+E V + +L+++ + + K+ + KAL Y
Sbjct: 69 LFREGDVWICME----------VMDTSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEY 118
Query: 302 LHEAIEPKVVHRDIKSSNILIDDEFNAKVSDFGLA-KLLDSGESHITTRVMGTFGYVAPE 360
LH + V+HRD+K SN+LI+ K+ DFG++ L+D S T G Y+APE
Sbjct: 119 LHSKL--SVIHRDVKPSNVLINRNGQVKLCDFGISGYLVD---SVAKTIDAGCKPYMAPE 173
Query: 361 YANTGM----LNEKSDIYSFGVLLLEAVTGRDPVD-YGRPANEVNLVEWLKMMVGTRRAE 415
N + + KSD++S G+ ++E TGR P D + P + LK +V
Sbjct: 174 RINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTP------FQQLKQVV------ 221
Query: 416 EVVDPNLEVKPATRALKRSLLVALRCVDPDSEKRPKMSQVVRMLEADDYPFREDRRNRKS 475
E P L PA + +C+ + ++RP ++++ PF E ++ +
Sbjct: 222 EEPSPQL---PAEKFSPEFQDFVNKCLKKNYKERPNYPELLQH------PFFELHLSKNT 272
Query: 476 RTTSM 480
S
Sbjct: 273 DVASF 277
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283 |
| >gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Score = 78.6 bits (194), Expect = 4e-16
Identities = 76/291 (26%), Positives = 135/291 (46%), Gaps = 42/291 (14%)
Query: 193 VLGEGGYGVVYKGRLIN-GSEVAVKKLLNNLGQAEKE---FRVEVEAIGHVRHKNLVRLL 248
++GEG YG+V K + G VA+KK L + + R E+ + +RH+NLV L+
Sbjct: 8 LVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMR-EIRMLKQLRHENLVNLI 66
Query: 249 GYCIEGVHRMLVYEYVNN---GNLEQWLHGAMRNQGNLTWEARMKVIIGTAKALAYLHEA 305
LV+E+V++ +LE++ +G L K + + + + H
Sbjct: 67 EVFRRKKRLYLVFEFVDHTVLDDLEKYPNG-------LDESRVRKYLFQILRGIEFCHSH 119
Query: 306 IEPKVVHRDIKSSNILIDDEFNAKVSDFGLAKLLDS-GESHITTRVMGTFGYVAPEYANT 364
++HRDIK NIL+ K+ DFG A+ L + GE + T + T Y APE
Sbjct: 120 ---NIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVY--TDYVATRWYRAPELLVG 174
Query: 365 GMLNEKS-DIYSFGVLLLEAVTGRDPVDYGRPANEVNLVEWLKMMVGT--RRAEEVVDPN 421
++ DI++ G L+ E +TG +P+ G ++++ + + +G R +E+ N
Sbjct: 175 DTKYGRAVDIWAVGCLVTEMLTG-EPLFPG--DSDIDQLYHIIKCLGNLIPRHQEIFQKN 231
Query: 422 -----------LEVKPATRALKR----SLLVALRCVDPDSEKRPKMSQVVR 457
E++P + + L +A +C+ D + RP SQ++
Sbjct: 232 PLFAGMRLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLH 282
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286 |
| >gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 78.5 bits (193), Expect = 4e-16
Identities = 57/226 (25%), Positives = 106/226 (46%), Gaps = 22/226 (9%)
Query: 182 EIATNRFSAENVLGEGGYGVVY----KGRL----INGSE-------VAVKKLLNNLGQ-A 225
E + + LGEG +G V+ +G E VAVK L ++ + A
Sbjct: 1 EFPRQQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTA 60
Query: 226 EKEFRVEVEAIGHVRHKNLVRLLGYCIEGVHRMLVYEYVNNGNLEQWL-----HGAMRNQ 280
+F E++ + +++ N++RLLG C+ ++ EY+ NG+L Q+L +
Sbjct: 61 RNDFLKEIKIMSRLKNPNIIRLLGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHA 120
Query: 281 GNLTWEARMKVIIGTAKALAYLHEAIEPKVVHRDIKSSNILIDDEFNAKVSDFGLAKLLD 340
N+ + ++ + + + VHRD+ + N L+ + + K++DFG+++ L
Sbjct: 121 NNIPSVSIANLLYMAVQIASGMKYLASLNFVHRDLATRNCLVGNHYTIKIADFGMSRNLY 180
Query: 341 SGESH-ITTRVMGTFGYVAPEYANTGMLNEKSDIYSFGVLLLEAVT 385
SG+ + I R + ++A E G SD+++FGV L E T
Sbjct: 181 SGDYYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFT 226
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295 |
| >gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Score = 78.3 bits (193), Expect = 5e-16
Identities = 69/222 (31%), Positives = 111/222 (50%), Gaps = 37/222 (16%)
Query: 188 FSAENVLGEGGYGVVYKGR-LINGSEVAVKKL-LNNLGQAEKE-FRV----EVEAIGHVR 240
F +GEG YG VYK R G VA+KK+ L+N EKE F + E++ + +
Sbjct: 9 FDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDN----EKEGFPITAIREIKILRQLN 64
Query: 241 HKNLVRLLGYCIEGVHRM----------LVYEYVNNGNLEQWLHGAMRNQGNLTWEARMK 290
H+N+V L + + LV+EY+++ +L L + + ++ MK
Sbjct: 65 HRNIVNLKEIVTDKQDALDFKKDKGAFYLVFEYMDH-DLMGLLESGLVHFSEDHIKSFMK 123
Query: 291 VIIGTAKALAYLHEAIEPKVVHRDIKSSNILIDDEFNAKVSDFGLAKLLDSGESHITTRV 350
++ + L Y H+ +HRDIK SNIL++++ K++DFGLA+L +S ES T
Sbjct: 124 QLL---EGLNYCHKK---NFLHRDIKCSNILLNNKGQIKLADFGLARLYNSEESRPYTNK 177
Query: 351 MGTFGYVAPEYANTGMLNEKS-----DIYSFGVLLLEAVTGR 387
+ T Y PE +L E+ D++S G +L E T +
Sbjct: 178 VITLWYRPPEL----LLGEERYGPAIDVWSCGCILGELFTKK 215
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302 |
| >gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Score = 77.8 bits (191), Expect = 5e-16
Identities = 60/210 (28%), Positives = 101/210 (48%), Gaps = 10/210 (4%)
Query: 182 EIATNRFSAENVLGEGGYGVVYKGRLINGSEVAVKKLLNNLGQAEKEFRVEVEAIGHVRH 241
EI E LG G +G V+ ++VAVK + E F E + ++H
Sbjct: 2 EIPRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGSMSVEA-FLAEANVMKTLQH 60
Query: 242 KNLVRLLGYCI-EGVHRMLVYEYVNNGNLEQWLHGAMRNQGNLTWEARMKVIIGTAKALA 300
LV+L E ++ ++ E++ G+L +L ++ L I A+ +A
Sbjct: 61 DKLVKLHAVVTKEPIY--IITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQI--AEGMA 116
Query: 301 YLHEAIEPKVVHRDIKSSNILIDDEFNAKVSDFGLAKLLDSGESHITTRVMGTFGYVAPE 360
++ + +HRD++++NIL+ K++DFGLA++++ E + APE
Sbjct: 117 FIEQR---NYIHRDLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKFPIKWTAPE 173
Query: 361 YANTGMLNEKSDIYSFGVLLLEAVT-GRDP 389
N G KSD++SFG+LL+E VT GR P
Sbjct: 174 AINFGSFTIKSDVWSFGILLMEIVTYGRIP 203
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260 |
| >gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 77.9 bits (192), Expect = 5e-16
Identities = 68/274 (24%), Positives = 124/274 (45%), Gaps = 29/274 (10%)
Query: 194 LGEGGYGVVYKGRLINGSEVAVKKLLNNLGQAE--KEFRVEVEAIGHVRHKNLVRLLGYC 251
LG G G V K + I V KK+++ ++ K+ E++ + R +V G
Sbjct: 13 LGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYGAF 72
Query: 252 IEGVHRMLVYEYVNNGNLEQWLHGAMRNQGNLTWEARMKVIIGTAKALAYLHEAIEPKVV 311
+ + + E+++ G+L+ + G + E K+ + + L YL+ +++
Sbjct: 73 LNENNICMCMEFMDCGSLD----RIYKKGGPIPVEILGKIAVAVVEGLTYLYN--VHRIM 126
Query: 312 HRDIKSSNILIDDEFNAKVSDFGLAKLLDSGE--SHITTRVMGTFGYVAPEYANTGMLNE 369
HRDIK SNIL++ K+ DFG+ SGE + I +GT Y++PE G
Sbjct: 127 HRDIKPSNILVNSRGQIKLCDFGV-----SGELINSIADTFVGTSTYMSPERIQGGKYTV 181
Query: 370 KSDIYSFGVLLLEAVTGRDP-----VDYGRPANEVNLVEWLKMMVGTRRAEEVVDPNLEV 424
KSD++S G+ ++E G+ P +D + + +++ L+ +V E P L
Sbjct: 182 KSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDLLQQIV----QEP--PPRL-- 233
Query: 425 KPATRALKRSLLVALRCVDPDSEKRPKMSQVVRM 458
P++ + C+ D +RP Q+ M
Sbjct: 234 -PSSDFPEDLRDFVDACLLKDPTERPTPQQLCAM 266
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284 |
| >gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 78.1 bits (192), Expect = 6e-16
Identities = 77/304 (25%), Positives = 136/304 (44%), Gaps = 45/304 (14%)
Query: 182 EIATNRFSAENVLGEGGYGVVY--------KGRLINGSEVAVKKLLNNLGQAE-KEFRVE 232
E + ++ + LGEG +G V K + VAVK L ++ + + + E
Sbjct: 11 EFSRDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSE 70
Query: 233 VEAIGHV-RHKNLVRLLGYCIEGVHRMLVYEYVNNGNLEQWLHGAMRNQG---------- 281
+E + + +HKN++ LLG C + ++ EY + GNL ++L A R G
Sbjct: 71 MEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLR-ARRPPGMEYSYDIARV 129
Query: 282 ---NLTWEARMKVIIGTAKALAYLHEAIEPKVVHRDIKSSNILIDDEFNAKVSDFGLAKL 338
+T++ + A+ + YL K +HRD+ + N+L+ + K++DFGLA+
Sbjct: 130 PDEQMTFKDLVSCTYQVARGMEYLASQ---KCIHRDLAARNVLVTENNVMKIADFGLARD 186
Query: 339 LDSGESH-ITTRVMGTFGYVAPEYANTGMLNEKSDIYSFGVLLLEAVTGRDPVDYGRPAN 397
+++ + + TT ++APE + +SD++SFGVL+ E T G P
Sbjct: 187 VNNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLG-----GSPYP 241
Query: 398 EVNLVEWLKMMVGTRRAEEVVDPNLEVKPATRALKRSLLVALR-CVDPDSEKRPKMSQVV 456
+ + E K++ R + KPA L + +R C RP Q+V
Sbjct: 242 GIPVEELFKLLKEGHRMD---------KPAN--CTNELYMMMRDCWHAIPSHRPTFKQLV 290
Query: 457 RMLE 460
L+
Sbjct: 291 EDLD 294
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304 |
| >gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Score = 78.2 bits (193), Expect = 6e-16
Identities = 62/230 (26%), Positives = 101/230 (43%), Gaps = 29/230 (12%)
Query: 182 EIATNRFSAENVLGEGGYGVVY------------KGRLINGSE-----VAVKKLLNNLGQ 224
E + LGEG +G V+ K N + VAVK L +
Sbjct: 1 EFPRQPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASD 60
Query: 225 -AEKEFRVEVEAIGHVRHKNLVRLLGYCIEGVHRMLVYEYVNNGNLEQWLH-------GA 276
A ++F EV+ + + N+ RLLG C ++ EY+ NG+L Q+L G
Sbjct: 61 NAREDFLKEVKILSRLSDPNIARLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGL 120
Query: 277 MRNQGNLTWEARMKVIIGTAKALAYLHEAIEPKVVHRDIKSSNILIDDEFNAKVSDFGLA 336
N +L++ + + A + YL VHRD+ + N L+ + K++DFG++
Sbjct: 121 ACNSKSLSFSTLLYMATQIASGMRYLESL---NFVHRDLATRNCLVGKNYTIKIADFGMS 177
Query: 337 KLLDSGE-SHITTRVMGTFGYVAPEYANTGMLNEKSDIYSFGVLLLEAVT 385
+ L S + + R ++A E G KSD+++FGV L E +T
Sbjct: 178 RNLYSSDYYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILT 227
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296 |
| >gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Score = 77.4 bits (190), Expect = 7e-16
Identities = 61/215 (28%), Positives = 103/215 (47%), Gaps = 18/215 (8%)
Query: 188 FSAENVLGEGGYGVVYKGRLINGSEVAVKKLLNNLGQAEKEFRVEVEAI-GHVRHKNLVR 246
F ++G G YG VYKGR + ++A K+++ G E+E + E+ + + H+N+
Sbjct: 8 FELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSHHRNIAT 67
Query: 247 LLGYCIE----GV--HRMLVYEYVNNGNLEQWLHGAMRNQGNLTWEARMKVIIGTAKALA 300
G I+ G+ LV E+ G++ + N W A + I + L+
Sbjct: 68 YYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREI--LRGLS 125
Query: 301 YLHEAIEPKVVHRDIKSSNILIDDEFNAKVSDFGLAKLLDSGESHITTRVMGTFGYVAPE 360
+LH+ KV+HRDIK N+L+ + K+ DFG++ LD T +GT ++APE
Sbjct: 126 HLHQH---KVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNT-FIGTPYWMAPE 181
Query: 361 YANT-----GMLNEKSDIYSFGVLLLEAVTGRDPV 390
+ KSD++S G+ +E G P+
Sbjct: 182 VIACDENPDATYDFKSDLWSLGITAIEMAEGAPPL 216
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272 |
| >gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Score = 77.7 bits (191), Expect = 8e-16
Identities = 73/300 (24%), Positives = 130/300 (43%), Gaps = 44/300 (14%)
Query: 194 LGEGGYGVVYKGRLINGSE-----------------VAVKKLLNNLGQ-AEKEFRVEVEA 235
LGEG +G V+ ++N + VAVK L + + A +F EV+
Sbjct: 13 LGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVKI 72
Query: 236 IGHVRHKNLVRLLGYCIEGVHRMLVYEYVNNGNLEQWL--HGAMRNQGN----------- 282
+ ++ N++RLLG C++ ++ EY+ NG+L Q+L H + N
Sbjct: 73 LSRLKDPNIIRLLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCL 132
Query: 283 --LTWEARMKVIIGTAKALAYLHEAIEPKVVHRDIKSSNILIDDEFNAKVSDFGLAKLLD 340
+++ + + V + A + YL VHRD+ + N L+ + K++DFG+++ L
Sbjct: 133 PAISYSSLLHVALQIASGMKYLSSL---NFVHRDLATRNCLVGENLTIKIADFGMSRNLY 189
Query: 341 SGESH-ITTRVMGTFGYVAPEYANTGMLNEKSDIYSFGVLLLEAVTGRDPVDYGRPANEV 399
+G+ + I R + ++A E G SD+++FGV L E + YG +E
Sbjct: 190 AGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILMLCKEQPYGELTDEQ 249
Query: 400 NLVEWLKMMVGTRRAEEVVDPNLEVKPATRALKRSLLVALRCVDPDSEKRPKMSQVVRML 459
+ + R + P P + L + L+C D +RP S + L
Sbjct: 250 VIENAGEFFRDQGRQVYLFRP----PPCPQGLYE---LMLQCWSRDCRERPSFSDIHAFL 302
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304 |
| >gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Score = 76.9 bits (189), Expect = 9e-16
Identities = 64/214 (29%), Positives = 106/214 (49%), Gaps = 20/214 (9%)
Query: 187 RFSAENVLGEGGYGVVYKGRLINGSEVAVKKLLN--NLGQAEKEF-RVEVEAIGHVRHKN 243
R+ +GEG +G +Y + + SE V K ++ + EKE + EV + ++H N
Sbjct: 1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPN 60
Query: 244 LVRLLGYCIEGVHRMLVYEYVNNGNLEQWL---HGAMRNQGN-LTWEARMKVIIGTAKAL 299
+V E +V EY + G+L + + G + ++ L+W + + L
Sbjct: 61 IVTFFASFQENGRLFIVMEYCDGGDLMKRINRQRGVLFSEDQILSW------FVQISLGL 114
Query: 300 AYLHEAIEPKVVHRDIKSSNILIDDE-FNAKVSDFGLAKLL-DSGESHITTRVMGTFGYV 357
++H+ K++HRDIKS NI + AK+ DFG+A+ L DS E T +GT Y+
Sbjct: 115 KHIHDR---KILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSMELAYT--CVGTPYYL 169
Query: 358 APEYANTGMLNEKSDIYSFGVLLLEAVTGRDPVD 391
+PE N K+DI+S G +L E T + P +
Sbjct: 170 SPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFE 203
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257 |
| >gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Score = 77.6 bits (191), Expect = 9e-16
Identities = 63/233 (27%), Positives = 102/233 (43%), Gaps = 41/233 (17%)
Query: 182 EIATNRFSAENVLGEGGYGVVYKGR---LINGSE---VAVKKLLNNLG-QAEKEFRVEVE 234
E N +G+G +G V++ R L+ VAVK L + +F+ E
Sbjct: 1 EYPRNNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAA 60
Query: 235 AIGHVRHKNLVRLLGYCIEGVHRMLVYEYVNNGNLEQWL-HGAMRNQGNLTWEARMKVII 293
+ H N+V+LLG C G L++EY+ G+L ++L H + R Q +L+
Sbjct: 61 LMAEFDHPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKC 120
Query: 294 G-----------------TAKALAYLHEAIEPKVVHRDIKSSNILIDDEFNAKVSDFGLA 336
G A +AYL E K VHRD+ + N L+ + K++DFGL+
Sbjct: 121 GLNPLPLSCTEQLCIAKQVAAGMAYLSER---KFVHRDLATRNCLVGENMVVKIADFGLS 177
Query: 337 KLLDSGESH-------ITTRVMGTFGYVAPEYANTGMLNEKSDIYSFGVLLLE 382
+ + S + + I R M PE +SD++++GV+L E
Sbjct: 178 RNIYSADYYKASENDAIPIRWM------PPESIFYNRYTTESDVWAYGVVLWE 224
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288 |
| >gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Score = 77.0 bits (189), Expect = 9e-16
Identities = 66/256 (25%), Positives = 121/256 (47%), Gaps = 17/256 (6%)
Query: 188 FSAENVLGEGGYGVVYKGRLINGSEVAVKKLLNNLGQAEKEF---RVEVEAIGHVRHKNL 244
F+ +G+G +G V+KG + N ++ V + +L +AE E + E+ + +
Sbjct: 6 FTKLERIGKGSFGEVFKG-IDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYV 64
Query: 245 VRLLGYCIEGVHRMLVYEYVNNGNLEQWLHGAMRNQGNLTWEARMKVIIGTAKALAYLHE 304
+ G ++G ++ EY+ G+ L ++ + +K I+ K L YLH
Sbjct: 65 TKYYGSYLKGTKLWIIMEYLGGGSALDLLRAGPFDEFQIA--TMLKEIL---KGLDYLHS 119
Query: 305 AIEPKVVHRDIKSSNILIDDEFNAKVSDFGLAKLLDSGESHITTRVMGTFGYVAPEYANT 364
K +HRDIK++N+L+ ++ + K++DFG+A L + T V GT ++APE
Sbjct: 120 E---KKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTFV-GTPFWMAPEVIQQ 175
Query: 365 GMLNEKSDIYSFGVLLLEAVTGRDPVDYGRPANEVNLVEWLK--MMVG--TRRAEEVVDP 420
+ K+DI+S G+ +E G P P + L+ + G ++ +E +D
Sbjct: 176 SAYDSKADIWSLGITAIELAKGEPPNSDMHPMRVLFLIPKNNPPTLTGEFSKPFKEFIDA 235
Query: 421 NLEVKPATRALKRSLL 436
L P+ R + LL
Sbjct: 236 CLNKDPSFRPTAKELL 251
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277 |
| >gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 78.1 bits (192), Expect = 9e-16
Identities = 80/304 (26%), Positives = 136/304 (44%), Gaps = 45/304 (14%)
Query: 182 EIATNRFSAENVLGEGGYGVVY--------KGRLINGSEVAVKKLLNNLGQAE-KEFRVE 232
E++ R + LGEG +G V K + VAVK L ++ + + E
Sbjct: 8 ELSRTRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSE 67
Query: 233 VEAIGHV-RHKNLVRLLGYCIEGVHRMLVYEYVNNGNLEQWLHGAMRNQG---------- 281
+E + + +HKN++ LLG C + ++ EY + GNL ++L A R G
Sbjct: 68 MEMMKMIGKHKNIINLLGACTQDGPLYVLVEYASKGNLREYLR-ARRPPGMDYSFDTCKL 126
Query: 282 ---NLTWEARMKVIIGTAKALAYLHEAIEPKVVHRDIKSSNILIDDEFNAKVSDFGLAKL 338
LT++ + A+ + YL K +HRD+ + N+L+ ++ K++DFGLA+
Sbjct: 127 PEEQLTFKDLVSCAYQVARGMEYLASQ---KCIHRDLAARNVLVTEDNVMKIADFGLARD 183
Query: 339 LDSGESH-ITTRVMGTFGYVAPEYANTGMLNEKSDIYSFGVLLLEAVTGRDPVDYGRPAN 397
+ + + + TT ++APE + +SD++SFGVLL E T G P
Sbjct: 184 VHNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLG-----GSPYP 238
Query: 398 EVNLVEWLKMMVGTRRAEEVVDPNLEVKPATRALKRSLLVALR-CVDPDSEKRPKMSQVV 456
+ + E K++ R + KPA L + +R C +RP Q+V
Sbjct: 239 GIPVEELFKLLKEGHRMD---------KPAN--CTHELYMIMRECWHAVPSQRPTFKQLV 287
Query: 457 RMLE 460
L+
Sbjct: 288 EDLD 291
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334 |
| >gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 77.2 bits (191), Expect = 1e-15
Identities = 63/222 (28%), Positives = 90/222 (40%), Gaps = 57/222 (25%)
Query: 193 VLGEGGYGVVYKGRLINGSEVAVKKLLN-----NLGQAEKEFRVEVEAIGHVRHKNLVRL 247
LG G +G V R + K+L+ L Q E E + +RH LV L
Sbjct: 8 TLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLN-EKRILQSIRHPFLVNL 66
Query: 248 LG--------YCIEGVHRMLVYEYVNNGNLEQWLHGAMRNQGNLTWEARMKVIIGTAK-- 297
G Y LV EYV G L L R G A+
Sbjct: 67 YGSFQDDSNLY--------LVMEYVPGGELFSHL----RKSGRFP--------EPVARFY 106
Query: 298 ------ALAYLHEAIEPKVVHRDIKSSNILIDDEFNAKVSDFGLAKLLDSGESHITTRVM 351
AL YLH +V+RD+K N+L+D + K++DFG AK + T +
Sbjct: 107 AAQVVLALEYLHSL---DIVYRDLKPENLLLDSDGYIKITDFGFAKRVKGR----TYTLC 159
Query: 352 GTFGYVAPEYANTGMLNE---KS-DIYSFGVLLLEAVTGRDP 389
GT Y+APE +L++ K+ D ++ G+L+ E + G P
Sbjct: 160 GTPEYLAPEI----ILSKGYGKAVDWWALGILIYEMLAGYPP 197
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290 |
| >gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Score = 77.0 bits (189), Expect = 1e-15
Identities = 64/231 (27%), Positives = 108/231 (46%), Gaps = 23/231 (9%)
Query: 177 TLRDLEIATNR-----FSAENVLGEGGYGVVYKGRLINGSEVAVKKLLNNLGQAEKEFRV 231
+L D++++ R F V+G G YG VYKGR + ++A K+++ E+E ++
Sbjct: 2 SLDDIDLSALRDPAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTEDEEEEIKL 61
Query: 232 EVEAI-GHVRHKNLVRLLGYCIEGV------HRMLVYEYVNNGNLEQWLHGAMRNQGNLT 284
E+ + + H+N+ G I+ LV E+ G++ + N
Sbjct: 62 EINMLKKYSHHRNIATYYGAFIKKSPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKED 121
Query: 285 WEARMKVIIGTAKALAYLHEAIEPKVVHRDIKSSNILIDDEFNAKVSDFGLAKLLDSGES 344
W A + I + LA+LH KV+HRDIK N+L+ + K+ DFG++ LD
Sbjct: 122 WIAYICREI--LRGLAHLHAH---KVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVG 176
Query: 345 HITTRVMGTFGYVAPEYANT-----GMLNEKSDIYSFGVLLLEAVTGRDPV 390
T +GT ++APE + +SDI+S G+ +E G P+
Sbjct: 177 RRNT-FIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPL 226
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282 |
| >gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Score = 75.3 bits (185), Expect = 3e-15
Identities = 64/223 (28%), Positives = 119/223 (53%), Gaps = 18/223 (8%)
Query: 194 LGEGGYG--VVYKGRLINGSEVAVKKL-LNNLGQAEK-EFRVEVEAIGHVRHKNLVRLLG 249
+GEG +G ++ K + +G + +K++ ++ + E+ E R EV + +++H N+V+
Sbjct: 8 IGEGSFGKAILVKSK-EDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQE 66
Query: 250 YCIEGVHRMLVYEYVNNGNLEQWLHGAMRNQGNLTWEAR-MKVIIGTAKALAYLHEAIEP 308
E + +V +Y G+L + ++ +G L E + + + AL ++H+
Sbjct: 67 SFEENGNLYIVMDYCEGGDLYKKINA---QRGVLFPEDQILDWFVQICLALKHVHDR--- 120
Query: 309 KVVHRDIKSSNILIDDEFNAKVSDFGLAKLLDSGESHITTRVMGTFGYVAPEYANTGMLN 368
K++HRDIKS NI + + K+ DFG+A++L+S + +GT Y++PE N
Sbjct: 121 KILHRDIKSQNIFLTKDGTIKLGDFGIARVLNS-TVELARTCIGTPYYLSPEICENRPYN 179
Query: 369 EKSDIYSFGVLLLEAVTGRDPVDYGRPANEVNLVEWLKMMVGT 411
KSDI++ G +L E T + + G N NLV LK++ G+
Sbjct: 180 NKSDIWALGCVLYEMCTLKHAFEAG---NMKNLV--LKIIRGS 217
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256 |
| >gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Score = 76.2 bits (188), Expect = 3e-15
Identities = 75/242 (30%), Positives = 111/242 (45%), Gaps = 54/242 (22%)
Query: 177 TLRDLEIATNRFSAENVLGEGGYGVVYKGRLI-NGSEVAVKKLLNNLGQAEKE------F 229
LRD EI LGEG +G VYK R I G VA+KK+L EK+
Sbjct: 6 KLRDYEILGK-------LGEGTFGEVYKARQIKTGRVVALKKILM---HNEKDGFPITAL 55
Query: 230 RVEVEAIGHVRHKNLVRLLGYCIE---GVHRMLVYEYVNNGNLEQWLHGAMRNQG-NLTW 285
R E++ + ++H N+V L+ +E R Y+ ++ L G + N LT
Sbjct: 56 R-EIKILKKLKHPNVVPLIDMAVERPDKSKRKRGSVYMVTPYMDHDLSGLLENPSVKLT- 113
Query: 286 EARMKVII-----GTAKALAYLHEAIEPKVVHRDIKSSNILIDDEFNAKVSDFGLAKLLD 340
E+++K + G YLHE ++HRDIK++NILID++ K++DFGLA+ D
Sbjct: 114 ESQIKCYMLQLLEGIN----YLHEN---HILHRDIKAANILIDNQGILKIADFGLARPYD 166
Query: 341 ----------SGESHITTRVMGTFGYVAPEYANTGMLNEKS-----DIYSFGVLLLEAVT 385
G + T ++ T Y PE +L E+ DI+ G + E T
Sbjct: 167 GPPPNPKGGGGGGTRKYTNLVVTRWYRPPEL----LLGERRYTTAVDIWGIGCVFAEMFT 222
Query: 386 GR 387
R
Sbjct: 223 RR 224
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311 |
| >gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Score = 75.6 bits (186), Expect = 3e-15
Identities = 60/199 (30%), Positives = 95/199 (47%), Gaps = 13/199 (6%)
Query: 194 LGEGGYGVVYKGR-LINGSEVAVKKL---LNNLGQAEKEFRVEVEAIGHVRHKNLVRLLG 249
+GEG YGVVYK R + G VA+KK+ G R E+ + + H N+V+LL
Sbjct: 8 IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIR-EISLLKELNHPNIVKLLD 66
Query: 250 YCIEGVHRMLVYEYVNNGNLEQWLHGAMRNQGNLTWEARMKVIIGTAKALAYLHEAIEPK 309
LV+E+++ +L++++ + + + + LA+ H +
Sbjct: 67 VIHTENKLYLVFEFLHQ-DLKKFMDAS--PLSGIPLPLIKSYLFQLLQGLAFCHSH---R 120
Query: 310 VVHRDIKSSNILIDDEFNAKVSDFGLAKLLDSGESHITTRVMGTFGYVAPE-YANTGMLN 368
V+HRD+K N+LI+ E K++DFGLA+ T V+ T Y APE +
Sbjct: 121 VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVV-TLWYRAPEILLGCKYYS 179
Query: 369 EKSDIYSFGVLLLEAVTGR 387
DI+S G + E VT R
Sbjct: 180 TAVDIWSLGCIFAEMVTRR 198
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284 |
| >gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Score = 75.9 bits (187), Expect = 3e-15
Identities = 68/206 (33%), Positives = 104/206 (50%), Gaps = 21/206 (10%)
Query: 194 LGEGGYGVVYKGRLINGSEV-AVKKLLNNLGQAEKEFRV----EVEAIGHVRHKNLVRLL 248
+G G G VYK R V AVK++ G E+ R+ +V H +V+
Sbjct: 23 IGSGTCGQVYKMRFKKTGHVMAVKQMRRT-GNKEENKRILMDLDVVLKSH-DCPYIVKCY 80
Query: 249 GYCIEGVHRMLVYEYVNNGNLEQWLHGAMRNQGNLTWEARMKVIIGTAKALAYLHEAIEP 308
GY I + E ++ L++ L R QG + + K+ + KAL YL E +
Sbjct: 81 GYFITDSDVFICMELMSTC-LDKLL---KRIQGPIPEDILGKMTVAIVKALHYLKE--KH 134
Query: 309 KVVHRDIKSSNILIDDEFNAKVSDFGLA-KLLDSGESHITTRVMGTFGYVAPEYANTGML 367
V+HRD+K SNIL+D N K+ DFG++ +L+DS ++ TR G Y+APE +
Sbjct: 135 GVIHRDVKPSNILLDASGNVKLCDFGISGRLVDS-KAK--TRSAGCAAYMAPERIDPPDP 191
Query: 368 NEK----SDIYSFGVLLLEAVTGRDP 389
N K +D++S G+ L+E TG+ P
Sbjct: 192 NPKYDIRADVWSLGISLVELATGQFP 217
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296 |
| >gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Score = 75.1 bits (184), Expect = 4e-15
Identities = 58/205 (28%), Positives = 98/205 (47%), Gaps = 13/205 (6%)
Query: 188 FSAENVLGEGGYGVVYKGRLINGSEVAVKKLLNNLGQAEKEF---RVEVEAIGHVRHKNL 244
F+ +G+G +G VYKG EV K+++ L +AE E + E+ + +
Sbjct: 6 FTKLERIGKGSFGEVYKGIDNRTKEVVAIKIID-LEEAEDEIEDIQQEITVLSQCDSPYI 64
Query: 245 VRLLGYCIEGVHRMLVYEYVNNGNLEQWLHGAMRNQGNLTWEARMKVIIGTAKALAYLHE 304
R G ++G ++ EY+ G+ L G L ++ K L YLH
Sbjct: 65 TRYYGSYLKGTKLWIIMEYLGGGSALDLL-----KPGPLEETYIATILREILKGLDYLHS 119
Query: 305 AIEPKVVHRDIKSSNILIDDEFNAKVSDFGLAKLLDSGESHITTRVMGTFGYVAPEYANT 364
+ +HRDIK++N+L+ ++ + K++DFG+A L + T V GT ++APE
Sbjct: 120 E---RKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTFV-GTPFWMAPEVIKQ 175
Query: 365 GMLNEKSDIYSFGVLLLEAVTGRDP 389
+ K+DI+S G+ +E G P
Sbjct: 176 SAYDFKADIWSLGITAIELAKGEPP 200
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277 |
| >gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Score = 75.0 bits (184), Expect = 5e-15
Identities = 55/209 (26%), Positives = 96/209 (45%), Gaps = 11/209 (5%)
Query: 182 EIATNRFSAENVLGEGGYGVVYKGRLINGSE----VAVKKLLNNLGQAEKE-FRVEVEAI 236
E+ E +LG G +G + +G L S+ VA+ L ++ F E +
Sbjct: 1 ELDNKSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTL 60
Query: 237 GHVRHKNLVRLLGYCIEGVHRMLVYEYVNNGNLEQWLHGAMRNQGNLTWEARMKVIIGTA 296
G H N+VRL G G M+V EY++NG L+ +L +++G L M ++ G A
Sbjct: 61 GQFDHSNIVRLEGVITRGNTMMIVTEYMSNGALDSFLR---KHEGQLVAGQLMGMLPGLA 117
Query: 297 KALAYLHEAIEPKVVHRDIKSSNILIDDEFNAKVSDFGLAKLLDSGESHITTRVMGTFGY 356
+ YL E VH+ + + +L++ + K+S F + S + T +
Sbjct: 118 SGMKYLSEM---GYVHKGLAAHKVLVNSDLVCKISGFRRLQEDKSEAIYTTMSGKSPVLW 174
Query: 357 VAPEYANTGMLNEKSDIYSFGVLLLEAVT 385
APE + SD++SFG+++ E ++
Sbjct: 175 AAPEAIQYHHFSSASDVWSFGIVMWEVMS 203
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Score = 75.4 bits (185), Expect = 5e-15
Identities = 81/308 (26%), Positives = 136/308 (44%), Gaps = 53/308 (17%)
Query: 182 EIATNRFSAENVLGEGGYGVVYKGRLI--------NGSEVAVKKLLNNLGQAE-KEFRVE 232
E+ +R LGEG +G V I ++VAVK L ++ + + + E
Sbjct: 14 EVPRDRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISE 73
Query: 233 VEAIGHV-RHKNLVRLLGYCIEGVHRMLVYEYVNNGNLEQWLHGAMRNQG---------- 281
+E + + +HKN++ LLG C + ++ EY + GNL ++L A R G
Sbjct: 74 MEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLR-ARRPPGMEYCYNPTQV 132
Query: 282 ---NLTWEARMKVIIGTAKALAYLHEAIEPKVVHRDIKSSNILIDDEFNAKVSDFGLAKL 338
L+++ + A+ + YL K +HRD+ + N+L+ ++ K++DFGLA+
Sbjct: 133 PEEQLSFKDLVSCAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARD 189
Query: 339 LDSGESHITTRVMGTFG-----YVAPEYANTGMLNEKSDIYSFGVLLLEAVTGRDPVDYG 393
+ HI T G ++APE + +SD++SFGVLL E T G
Sbjct: 190 I----HHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLG-----G 240
Query: 394 RPANEVNLVEWLKMMVGTRRAEEVVDPNLEVKPATRALKRSLLVALR-CVDPDSEKRPKM 452
P V + E K++ R + KP+ L + +R C +RP
Sbjct: 241 SPYPGVPVEELFKLLKEGHRMD---------KPSN--CTNELYMMMRDCWHAVPSQRPTF 289
Query: 453 SQVVRMLE 460
Q+V L+
Sbjct: 290 KQLVEDLD 297
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307 |
| >gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Score = 74.8 bits (184), Expect = 6e-15
Identities = 76/262 (29%), Positives = 109/262 (41%), Gaps = 28/262 (10%)
Query: 194 LGEGGYGVVYKGRLIN-GSEVAVKKLLNN---LGQAEKEFRVEVEAIGHVRHKNLVRLLG 249
LG+GG+G V ++ G A KKL + E+ E + + V + L
Sbjct: 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKV-SSRFIVSLA 59
Query: 250 YCIEG-VHRMLVYEYVNNGNLEQWLHGAMRNQGNLTWEARMKVIIGTAKALAYLHEAIEP 308
Y E LV +N G+L+ H + EAR I A+ + L +
Sbjct: 60 YAFETKDDLCLVMTLMNGGDLK--YHIYNVGEPGFP-EARA--IFYAAQIICGLEHLHQR 114
Query: 309 KVVHRDIKSSNILIDDEFNAKVSDFGLAKLLDSGESHITTRVMGTFGYVAPEYANTGMLN 368
++V+RD+K N+L+DD N ++SD GLA L G I R GT GY+APE + +
Sbjct: 115 RIVYRDLKPENVLLDDHGNVRISDLGLAVEL-KGGKKIKGRA-GTPGYMAPEVLQGEVYD 172
Query: 369 EKSDIYSFGVLLLEAVTGRDPV-DYGRPANEVNLVEWLKMMVGTRRAEEVVDPNLEVKPA 427
D ++ G L E + GR P + E LK A E D P
Sbjct: 173 FSVDWFALGCTLYEMIAGRSPFRQRKEKVEK----EELKRRTLE-MAVEYPDKF---SPE 224
Query: 428 TRALKRSLLVALRCVDPDSEKR 449
+ L +LL DP EKR
Sbjct: 225 AKDLCEALL----QKDP--EKR 240
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277 |
| >gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Score = 75.4 bits (185), Expect = 6e-15
Identities = 66/213 (30%), Positives = 100/213 (46%), Gaps = 19/213 (8%)
Query: 188 FSAENVLGEGGYGVVYKGRLINGSE--------VAVKKLLNNLGQAEKEFRVEVEAIGHV 239
F VLG G YG V+ R + G + V K L + + R E + HV
Sbjct: 2 FELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHV 61
Query: 240 RHKNLVRLLGYCIEGVHRM-LVYEYVNNGNLEQWLHGAMRNQGNLTWEARMKVIIG-TAK 297
R + L Y + ++ L+ +YV+ G E + H R+ + E ++ G
Sbjct: 62 RQSPFLVTLHYAFQTEAKLHLILDYVSGG--EMFTHLYQRDNFS---EDEVRFYSGEIIL 116
Query: 298 ALAYLHEAIEPKVVHRDIKSSNILIDDEFNAKVSDFGLAKLLDSGESHITTRVMGTFGYV 357
AL +LH+ +V+RDIK NIL+D E + ++DFGL+K S E T GT Y+
Sbjct: 117 ALEHLHKL---GIVYRDIKLENILLDSEGHVVLTDFGLSKEFLSEEKERTYSFCGTIEYM 173
Query: 358 APEYANTGMLNEKS-DIYSFGVLLLEAVTGRDP 389
APE + K+ D +S G+L+ E +TG P
Sbjct: 174 APEIIRGKGGHGKAVDWWSLGILIFELLTGASP 206
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332 |
| >gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Score = 74.3 bits (183), Expect = 6e-15
Identities = 56/212 (26%), Positives = 93/212 (43%), Gaps = 19/212 (8%)
Query: 188 FSAENVLGEGGYGVVYKGRLINGSEVAVKKLLNN-----LGQAEKEFRVEVEAIGHVRHK 242
F V+G+G +G V + + ++ K +N G E + + H
Sbjct: 2 FELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLN-ERRILQELNHP 60
Query: 243 NLVRLLGYCIEGVHRM-LVYEYVNNGNLEQWLHGAMRNQGNLTWEARMKVIIG-TAKALA 300
LV L Y + M LV + + G+L L ++ E ++K I AL
Sbjct: 61 FLVNLW-YSFQDEENMYLVVDLLLGGDLRYHLSQKVKFS-----EEQVKFWICEIVLALE 114
Query: 301 YLHEAIEPKVVHRDIKSSNILIDDEFNAKVSDFGLAKLLDSGESHITTRVMGTFGYVAPE 360
YLH ++HRDIK NIL+D++ + ++DF +A + + ++ T+ GT GY+APE
Sbjct: 115 YLHSK---GIIHRDIKPDNILLDEQGHVHITDFNIATKV-TPDTLTTSTS-GTPGYMAPE 169
Query: 361 YANTGMLNEKSDIYSFGVLLLEAVTGRDPVDY 392
+ D +S GV E + G+ P
Sbjct: 170 VLCRQGYSVAVDWWSLGVTAYECLRGKRPYRG 201
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258 |
| >gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Score = 74.8 bits (184), Expect = 7e-15
Identities = 72/224 (32%), Positives = 113/224 (50%), Gaps = 18/224 (8%)
Query: 194 LGEGGYGVVYKGR-LINGSEVAVK--KLLNNLGQAEKEFRVEVEAIGHVRHKNLVRLLGY 250
LGEG Y VYKGR G VA+K L G R E+ + ++H+N+VRL
Sbjct: 8 LGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIR-EISLMKELKHENIVRLHDV 66
Query: 251 CIEGVHRMLVYEYVNNGNLEQWL--HGAMRNQGNLTWEARMKVIIGTAKALAYLHEAIEP 308
MLV+EY++ +L++++ HG +G L K +A+ HE
Sbjct: 67 IHTENKLMLVFEYMDK-DLKKYMDTHG---VRGALDPNTVKSFTYQLLKGIAFCHEN--- 119
Query: 309 KVVHRDIKSSNILIDDEFNAKVSDFGLAKLLDSGESHITTRVMGTFGYVAPE-YANTGML 367
+V+HRD+K N+LI+ K++DFGLA+ + + V+ T Y AP+ +
Sbjct: 120 RVLHRDLKPQNLLINKRGELKLADFGLARAFGIPVNTFSNEVV-TLWYRAPDVLLGSRTY 178
Query: 368 NEKSDIYSFGVLLLEAVTGRDPVDYGRPANEVNLVEWLKMMVGT 411
+ DI+S G ++ E +TGR P+ G NE L++ ++M GT
Sbjct: 179 STSIDIWSVGCIMAEMITGR-PLFPGT-NNEDQLLKIFRIM-GT 219
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284 |
| >gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Score = 74.6 bits (183), Expect = 7e-15
Identities = 60/214 (28%), Positives = 100/214 (46%), Gaps = 20/214 (9%)
Query: 188 FSAENVLGEGGYGVVYKGRLINGSE--------VAVKKLLNNLGQAEKEFRVEVEAIGHV 239
F VLG G YG V+ R ++G + V K + + + R E + + H+
Sbjct: 2 FELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHI 61
Query: 240 RHKNLVRLLGYCIEGVHRM-LVYEYVNNGNLEQWLHGAMRNQGNLTWEARMKVIIG-TAK 297
R + L Y + ++ L+ +Y+N G L + H + R + E +++ G
Sbjct: 62 RQSPFLVTLHYAFQTDTKLHLILDYINGGEL--FTHLSQRERFK---EQEVQIYSGEIVL 116
Query: 298 ALAYLHEAIEPKVVHRDIKSSNILIDDEFNAKVSDFGLAKLLDSGESHITTRVMGTFGYV 357
AL +LH+ +++RDIK NIL+D + ++DFGL+K E GT Y+
Sbjct: 117 ALEHLHKL---GIIYRDIKLENILLDSNGHVVLTDFGLSKEFHEDEVERAYSFCGTIEYM 173
Query: 358 APEYANTGML--NEKSDIYSFGVLLLEAVTGRDP 389
AP+ G ++ D +S GVL+ E +TG P
Sbjct: 174 APDIVRGGDGGHDKAVDWWSMGVLMYELLTGASP 207
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290 |
| >gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Score = 74.6 bits (183), Expect = 8e-15
Identities = 63/224 (28%), Positives = 109/224 (48%), Gaps = 29/224 (12%)
Query: 182 EIATNRFSAENVLGEGGYGVVYKG---RLING---SEVAVKKLLNNLGQAEK-EFRVEVE 234
E++ + + LG+G +G+VY+G +I G + VAVK + + E+ EF E
Sbjct: 2 EVSREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEAS 61
Query: 235 AIGHVRHKNLVRLLGYCIEGVHRMLVYEYVNNGNLEQWLHG----AMRNQGNL--TWEAR 288
+ ++VRLLG +G ++V E + +G+L+ +L A N G T +
Sbjct: 62 VMKGFTCHHVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEM 121
Query: 289 MKVIIGTAKALAYLHEAIEPKVVHRDIKSSNILIDDEFNAKVSDFGLAKLL-------DS 341
+++ A +AYL+ K VHRD+ + N ++ +F K+ DFG+ + +
Sbjct: 122 IQMAAEIADGMAYLNAK---KFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKG 178
Query: 342 GESHITTRVMGTFGYVAPEYANTGMLNEKSDIYSFGVLLLEAVT 385
G+ + R M APE G+ SD++SFGV+L E +
Sbjct: 179 GKGLLPVRWM------APESLKDGVFTTSSDMWSFGVVLWEITS 216
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288 |
| >gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Score = 74.3 bits (182), Expect = 8e-15
Identities = 57/211 (27%), Positives = 104/211 (49%), Gaps = 18/211 (8%)
Query: 194 LGEGGYGVVYKGRLINGS---EVAVKKL-LNNLGQAEKE-FRVEVEAIGHVRHKNLVRLL 248
LGEG +G V +G+L +VAVK + + ++E E F E + H N++RL+
Sbjct: 7 LGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLI 66
Query: 249 GYCIEGVHR------MLVYEYVNNGNLEQWLHGAMRNQGNLTWEARM--KVIIGTAKALA 300
G C++ V +++ ++ +G+L +L + +M K + A +
Sbjct: 67 GVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGME 126
Query: 301 YLHEAIEPKVVHRDIKSSNILIDDEFNAKVSDFGLAKLLDSGESHITTRVMGT-FGYVAP 359
YL +HRD+ + N ++++ N V+DFGL+K + +G+ + R+ ++A
Sbjct: 127 YLSSK---SFIHRDLAARNCMLNENMNVCVADFGLSKKIYNGDYYRQGRIAKMPVKWIAI 183
Query: 360 EYANTGMLNEKSDIYSFGVLLLEAVT-GRDP 389
E + KSD++SFGV + E T G+ P
Sbjct: 184 ESLADRVYTTKSDVWSFGVTMWEIATRGQTP 214
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272 |
| >gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Score = 73.9 bits (181), Expect = 1e-14
Identities = 61/228 (26%), Positives = 111/228 (48%), Gaps = 35/228 (15%)
Query: 180 DLEIATNRFSAENVLGEGGYGVVYKGRLINGS------EVAVKKLLNNL-GQAEKEFRVE 232
++ ++T RF E LGE +G VYKG L + VA+K L + G +EF+ E
Sbjct: 1 EINLSTVRFMEE--LGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHE 58
Query: 233 VEAIGHVRHKNLVRLLGYCIEGVHRMLVYEYVNNGNLEQWLHGAMRN------------- 279
++H N+V LLG + +++ Y ++ +L ++L MR+
Sbjct: 59 AMMRSRLQHPNIVCLLGVVTKEQPLSMIFSYCSHSDLHEFL--VMRSPHSDVGSTDDDKT 116
Query: 280 -QGNLTWEARMKVIIGTAKALAYLHEAIEPKVVHRDIKSSNILIDDEFNAKVSDFGLAKL 338
+ L + ++ A + +L VVH+D+ + N+L+ D+ N K+SD GL +
Sbjct: 117 VKSTLEPADFVHIVTQIAAGMEFLSSH---HVVHKDLATRNVLVFDKLNVKISDLGLFRE 173
Query: 339 LDSGESHITTRVMGT----FGYVAPEYANTGMLNEKSDIYSFGVLLLE 382
+ + + + ++MG +++PE G + SDI+S+GV+L E
Sbjct: 174 VYAADYY---KLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWE 218
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283 |
| >gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 73.9 bits (181), Expect = 1e-14
Identities = 58/219 (26%), Positives = 107/219 (48%), Gaps = 19/219 (8%)
Query: 182 EIATNRFSAENVLGEGGYGVVYKGRLING-------SEVAVKKLLNNLGQAEK-EFRVEV 233
E+A + + LG+G +G+VY+G + G + VA+K + E+ EF E
Sbjct: 2 EVAREKITMSRELGQGSFGMVYEG-IAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEA 60
Query: 234 EAIGHVRHKNLVRLLGYCIEGVHRMLVYEYVNNGNLEQWLHGAMRNQGNLTWEA-----R 288
+ ++VRLLG +G +++ E + G+L+ +L N +A +
Sbjct: 61 SVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKK 120
Query: 289 MKVIIG-TAKALAYLHEAIEPKVVHRDIKSSNILIDDEFNAKVSDFGLAK-LLDSGESHI 346
M + G A +AYL+ K VHRD+ + N ++ ++F K+ DFG+ + + ++
Sbjct: 121 MIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRK 177
Query: 347 TTRVMGTFGYVAPEYANTGMLNEKSDIYSFGVLLLEAVT 385
+ + +++PE G+ SD++SFGV+L E T
Sbjct: 178 GGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT 216
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277 |
| >gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 74.4 bits (183), Expect = 1e-14
Identities = 60/229 (26%), Positives = 95/229 (41%), Gaps = 34/229 (14%)
Query: 194 LGEGGYGVVYKGRLINGSEVAVKKLLNNLGQAEKEFRVEVEAIGHV----------RHKN 243
+G+GGYG V+ + + E+ K + K ++ + HV + +
Sbjct: 9 VGQGGYGQVFLAKKKDTGEIVALKRMK------KSLLFKLNEVRHVLTERDILTTTKSEW 62
Query: 244 LVRLLGYCIEGVHRMLVYEYVNNGNLEQWLH--GAMRNQGNLTWEARMKVIIGTAKALAY 301
LV+LL + + L EYV G+ L+ G + + A M + L Y
Sbjct: 63 LVKLLYAFQDDEYLYLAMEYVPGGDFRTLLNNLGVLSEDHARFYMAEMFEAVDALHELGY 122
Query: 302 LHEAIEPKVVHRDIKSSNILIDDEFNAKVSDFGLAKLLDSGESHITTRVMGTFGYVAPEY 361
+HRD+K N LID + K++DFGL+K G V+G+ Y+APE
Sbjct: 123 ---------IHRDLKPENFLIDASGHIKLTDFGLSK----GIVTYANSVVGSPDYMAPEV 169
Query: 362 ANTGMLNEKSDIYSFGVLLLEAVTGRDPVDYGRPANEV--NLVEWLKMM 408
+ D +S G +L E + G P G NE NL W + +
Sbjct: 170 LRGKGYDFTVDYWSLGCMLYEFLCGFPPFS-GSTPNETWENLKYWKETL 217
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333 |
| >gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 74.7 bits (184), Expect = 1e-14
Identities = 61/216 (28%), Positives = 105/216 (48%), Gaps = 31/216 (14%)
Query: 194 LGEGGYGVVYKGR-LINGSEVAVKKLLN---NLGQAEKEFRVEVEAIGHVRHKNLVRLLG 249
+G G YG+V + +VA+KK+ N N A++ R E++ + H+ H+N++ +
Sbjct: 13 IGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLR-EIKLLRHLDHENVIAIKD 71
Query: 250 YCIEGVHRM------LVYEYVNNGNLEQWLHGAMRNQGNLTWEARMKVIIGTAKALAYLH 303
+ HR +VYE ++ LH +R+ L+ + + + L Y+H
Sbjct: 72 -IMPPPHREAFNDVYIVYELMDTD-----LHQIIRSSQTLSDDHCQYFLYQLLRGLKYIH 125
Query: 304 EAIEPKVVHRDIKSSNILIDDEFNAKVSDFGLAKLLDSGESHITTRVMGTFGYVAPEYAN 363
A V+HRD+K SN+L++ + K+ DFGLA+ +T V+ T Y APE
Sbjct: 126 SA---NVLHRDLKPSNLLLNANCDLKICDFGLARTTSEKGDFMTEYVV-TRWYRAPEL-- 179
Query: 364 TGMLNEKS-----DIYSFGVLLLEAVTGRDPVDYGR 394
+LN D++S G + E + GR P+ G+
Sbjct: 180 --LLNCSEYTTAIDVWSVGCIFAE-LLGRKPLFPGK 212
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337 |
| >gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Score = 73.1 bits (179), Expect = 1e-14
Identities = 63/203 (31%), Positives = 94/203 (46%), Gaps = 16/203 (7%)
Query: 193 VLGEGGYGVVYKGRLINGSEVAVKK--LLNNLGQAEKEFRVEVEAIGHVRHKNLVRLLGY 250
V+GEG +G + +N + K L A ++ R E + ++H N+V
Sbjct: 7 VVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVAFKES 66
Query: 251 CIEGVHRMLVYEYVNNGNLEQWL---HGAM-RNQGNLTWEARMKVIIGTAKALAYLHEAI 306
H +V EY + G+L Q + G + L W +M + + ++HE
Sbjct: 67 FEADGHLYIVMEYCDGGDLMQKIKLQRGKLFPEDTILQWFVQMCL------GVQHIHEK- 119
Query: 307 EPKVVHRDIKSSNILIDDEFNAKVSDFGLAKLLDSGESHITTRVMGTFGYVAPEYANTGM 366
+V+HRDIKS NI + K+ DFG A+LL S ++ T V GT YV PE
Sbjct: 120 --RVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGAYACTYV-GTPYYVPPEIWENMP 176
Query: 367 LNEKSDIYSFGVLLLEAVTGRDP 389
N KSDI+S G +L E T + P
Sbjct: 177 YNNKSDIWSLGCILYELCTLKHP 199
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255 |
| >gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 73.6 bits (180), Expect = 2e-14
Identities = 59/215 (27%), Positives = 105/215 (48%), Gaps = 30/215 (13%)
Query: 192 NVLGEGGYGVVYKGRLINGS---EVAVKKLLNNLGQAE-KEFRVEVEAI---GHVRHKNL 244
+V+GEG +G V K R+ + A+K++ + + ++F E+E + GH H N+
Sbjct: 1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGH--HPNI 58
Query: 245 VRLLGYCIEGVHRMLVYEYVNNGNLEQWLHGA---------MRNQGN---LTWEARMKVI 292
+ LLG C + L EY +GNL +L + L+ + +
Sbjct: 59 INLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFA 118
Query: 293 IGTAKALAYLHEAIEPKVVHRDIKSSNILIDDEFNAKVSDFGLAKLLDSGESHITTRVMG 352
A+ + YL + + +HRD+ + NIL+ + + AK++DFGL++ G+ + MG
Sbjct: 119 ADVARGMDYLSQK---QFIHRDLAARNILVGENYVAKIADFGLSR----GQEVYVKKTMG 171
Query: 353 TFG--YVAPEYANTGMLNEKSDIYSFGVLLLEAVT 385
++A E N + SD++S+GVLL E V+
Sbjct: 172 RLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS 206
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270 |
| >gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Score = 73.9 bits (181), Expect = 2e-14
Identities = 61/212 (28%), Positives = 104/212 (49%), Gaps = 13/212 (6%)
Query: 182 EIATNRFSAENVLGEGGYGVVYKGRLINGSEVAVKKLLN-NLGQA-EKEFRVEVEAIGHV 239
E+ + F + LG G GVV+K + +KL++ + A + E++ +
Sbjct: 1 ELKDDDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHEC 60
Query: 240 RHKNLVRLLGYCIEGVHRMLVYEYVNNGNLEQWLHGAMRNQGNLTWEARMKVIIGTAKAL 299
+V G + E+++ G+L+Q L A G + + KV I K L
Sbjct: 61 NSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKA----GRIPEQILGKVSIAVIKGL 116
Query: 300 AYLHEAIEPKVVHRDIKSSNILIDDEFNAKVSDFGLA-KLLDSGESHITTRVMGTFGYVA 358
YL E + K++HRD+K SNIL++ K+ DFG++ +L+DS + +GT Y++
Sbjct: 117 TYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS----MANSFVGTRSYMS 170
Query: 359 PEYANTGMLNEKSDIYSFGVLLLEAVTGRDPV 390
PE + +SDI+S G+ L+E GR P+
Sbjct: 171 PERLQGTHYSVQSDIWSMGLSLVEMAIGRYPI 202
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333 |
| >gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Score = 73.8 bits (181), Expect = 2e-14
Identities = 60/233 (25%), Positives = 103/233 (44%), Gaps = 34/233 (14%)
Query: 180 DLEIATNRFSAENVLGEGGYGVVY--------KGRLINGSEVAVKKLLNNLGQAE-KEFR 230
E +R LGEG +G V K R VAVK L +N + +
Sbjct: 6 KWEFPRDRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLI 65
Query: 231 VEVEAIGHV-RHKNLVRLLGYCIEGVHRMLVYEYVNNGNLEQWLH------------GAM 277
E+E + + +HKN++ LLG C + ++ EY GNL ++L
Sbjct: 66 SEMELMKLIGKHKNIINLLGVCTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITK 125
Query: 278 RNQGNLTWEARMKVIIGTAKALAYLHEAIEPKVVHRDIKSSNILIDDEFNAKVSDFGLAK 337
+ L+++ + A+ + YL + +HRD+ + N+L+ ++ K++DFGLA+
Sbjct: 126 VPEEQLSFKDLVSCAYQVARGMEYLESR---RCIHRDLAARNVLVTEDNVMKIADFGLAR 182
Query: 338 LLDSGESHI-----TTRVMGTFGYVAPEYANTGMLNEKSDIYSFGVLLLEAVT 385
G I T+ ++APE + +SD++SFG+L+ E T
Sbjct: 183 ----GVHDIDYYKKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFT 231
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314 |
| >gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Score = 73.5 bits (180), Expect = 3e-14
Identities = 64/227 (28%), Positives = 109/227 (48%), Gaps = 23/227 (10%)
Query: 182 EIATNRFSAENVLGEGGYGVVYKGRLINGSEVAVKKLLN-NLGQA-EKEFRVEVEAIGHV 239
E+ + F + LG G GVV K + + +KL++ + A + E++ +
Sbjct: 1 ELKDDDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHEC 60
Query: 240 RHKNLVRLLGYCIEGVHRMLVYEYVNNGNLEQWLHGAMRNQGNLTWEARMKVIIGTAKAL 299
+V G + E+++ G+L+Q L A R + E KV I + L
Sbjct: 61 NSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKEAKR----IPEEILGKVSIAVLRGL 116
Query: 300 AYLHEAIEPKVVHRDIKSSNILIDDEFNAKVSDFGLA-KLLDSGESHITTRVMGTFGYVA 358
AYL E + +++HRD+K SNIL++ K+ DFG++ +L+DS + +GT Y++
Sbjct: 117 AYLRE--KHQIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS----MANSFVGTRSYMS 170
Query: 359 PEYANTGMLNEKSDIYSFGVLLLEAVTGRDPVD----------YGRP 395
PE + +SDI+S G+ L+E GR P+ +GRP
Sbjct: 171 PERLQGTHYSVQSDIWSMGLSLVELAIGRYPIPPPDAKELEAIFGRP 217
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331 |
| >gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Score = 73.1 bits (179), Expect = 3e-14
Identities = 58/197 (29%), Positives = 95/197 (48%), Gaps = 10/197 (5%)
Query: 194 LGEGGYGVVYKGRLI-NGSEVAVKKLLNNLGQAEKEFRVEVEAIGHVRHKNLVRLLGYCI 252
+GEG G+V R +G +VAVK + Q + EV + +H+N+V + +
Sbjct: 29 IGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSYL 88
Query: 253 EGVHRMLVYEYVNNGNLEQWLHGAMRNQGNLTWEARMKVIIGTAKALAYLHEAIEPKVVH 312
G ++ E++ G L + +Q L E V +AL YLH V+H
Sbjct: 89 VGEELWVLMEFLQGGALTD-----IVSQTRLNEEQIATVCESVLQALCYLHSQ---GVIH 140
Query: 313 RDIKSSNILIDDEFNAKVSDFGLAKLLDSGESHITTRVMGTFGYVAPEYANTGMLNEKSD 372
RDIKS +IL+ + K+SDFG + S + ++GT ++APE + + D
Sbjct: 141 RDIKSDSILLTLDGRVKLSDFGFCAQI-SKDVPKRKSLVGTPYWMAPEVISRTPYGTEVD 199
Query: 373 IYSFGVLLLEAVTGRDP 389
I+S G++++E V G P
Sbjct: 200 IWSLGIMVIEMVDGEPP 216
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297 |
| >gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Score = 72.6 bits (178), Expect = 5e-14
Identities = 61/231 (26%), Positives = 104/231 (45%), Gaps = 31/231 (13%)
Query: 182 EIATNRFSAENVLGEGGYGVVY------------KGRLINGSE-----VAVKKLLNNLGQ 224
E R + + LGEG +G V+ K ++ S VAVK L + +
Sbjct: 1 EFPRKRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANK 60
Query: 225 -AEKEFRVEVEAIGHVRHKNLVRLLGYCIEGVHRMLVYEYVNNGNLEQWLHGAMRNQGNL 283
A +F E++ + ++ N++RLL CI ++ EY+ NG+L Q+L Q
Sbjct: 61 NARNDFLKEIKIMSRLKDPNIIRLLAVCITSDPLCMITEYMENGDLNQFL-SRHEPQEAA 119
Query: 284 TWEARMKVIIGTAKALA--------YLHEAIEPKVVHRDIKSSNILIDDEFNAKVSDFGL 335
+ + T +A YL VHRD+ + N L+ + K++DFG+
Sbjct: 120 EKADVVTISYSTLIFMATQIASGMKYLSSL---NFVHRDLATRNCLVGKNYTIKIADFGM 176
Query: 336 AKLLDSGESH-ITTRVMGTFGYVAPEYANTGMLNEKSDIYSFGVLLLEAVT 385
++ L SG+ + I R + +++ E G SD+++FGV L E +T
Sbjct: 177 SRNLYSGDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILT 227
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296 |
| >gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 73.1 bits (180), Expect = 5e-14
Identities = 58/209 (27%), Positives = 104/209 (49%), Gaps = 17/209 (8%)
Query: 186 NRFSAENVLGEGGYGVVYKGRLI-NGSEVAVKKLL---NNLGQAEKEFRVEVEAIGHVRH 241
+R+ + +G G YG V G +VA+KKL + A++ +R E+ + H+ H
Sbjct: 15 DRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYR-ELRLLKHMDH 73
Query: 242 KNLVRLLGYCIEGVHRMLVYE-YVNNGNLEQWLHGAMRNQGNLTWEARMKVII-GTAKAL 299
+N++ LL + Y+ + L+ ++ Q L+ + ++ ++ + L
Sbjct: 74 ENVIGLLDVFTPASSLEDFQDVYLVTHLMGADLNNIVKCQ-KLS-DDHIQFLVYQILRGL 131
Query: 300 AYLHEAIEPKVVHRDIKSSNILIDDEFNAKVSDFGLAKLLDSGESHITTRVMGTFGYVAP 359
Y+H A ++HRD+K SNI ++++ K+ DFGLA+ D +T V T Y AP
Sbjct: 132 KYIHSA---GIIHRDLKPSNIAVNEDCELKILDFGLARHTD---DEMTGYV-ATRWYRAP 184
Query: 360 EYA-NTGMLNEKSDIYSFGVLLLEAVTGR 387
E N N+ DI+S G ++ E +TG+
Sbjct: 185 EIMLNWMHYNQTVDIWSVGCIMAELLTGK 213
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343 |
| >gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Score = 72.0 bits (176), Expect = 7e-14
Identities = 61/199 (30%), Positives = 103/199 (51%), Gaps = 15/199 (7%)
Query: 194 LGEGGYGVVYKGRL-INGSEVAVK--KLLNNLGQAEKEFRVEVEAIGHVRHKNLVRLLGY 250
LGEG Y V+KGR + + VA+K +L + G R EV + +++H N+V L
Sbjct: 13 LGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIR-EVSLLKNLKHANIVTLHDI 71
Query: 251 CIEGVHRMLVYEYVNNGNLEQWLHGAMRNQGNLTWEARMKVII-GTAKALAYLHEAIEPK 309
LV+EY+++ +L+Q+L N GNL +K+ + + L+Y H+ K
Sbjct: 72 IHTERCLTLVFEYLDS-DLKQYLD----NCGNLMSMHNVKIFMFQLLRGLSYCHKR---K 123
Query: 310 VVHRDIKSSNILIDDEFNAKVSDFGLAKLLDSGESHITTRVMGTFGYVAPE-YANTGMLN 368
++HRD+K N+LI+++ K++DFGLA+ + V+ T Y P+ + +
Sbjct: 124 ILHRDLKPQNLLINEKGELKLADFGLARAKSVPTKTYSNEVV-TLWYRPPDVLLGSTEYS 182
Query: 369 EKSDIYSFGVLLLEAVTGR 387
D++ G +L E TGR
Sbjct: 183 TPIDMWGVGCILYEMATGR 201
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288 |
| >gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Score = 72.0 bits (176), Expect = 7e-14
Identities = 58/197 (29%), Positives = 94/197 (47%), Gaps = 10/197 (5%)
Query: 194 LGEGGYGVV-YKGRLINGSEVAVKKLLNNLGQAEKEFRVEVEAIGHVRHKNLVRLLGYCI 252
+GEG G+V G +VAVKK+ Q + EV + H+N+V + +
Sbjct: 30 IGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSYL 89
Query: 253 EGVHRMLVYEYVNNGNLEQWLHGAMRNQGNLTWEARMKVIIGTAKALAYLHEAIEPKVVH 312
G +V E++ G L + N+ E V + +AL+YLH V+H
Sbjct: 90 VGDELWVVMEFLEGGALTDIVTHTRMNE-----EQIATVCLSVLRALSYLHNQ---GVIH 141
Query: 313 RDIKSSNILIDDEFNAKVSDFGLAKLLDSGESHITTRVMGTFGYVAPEYANTGMLNEKSD 372
RDIKS +IL+ + K+SDFG + S E ++GT ++APE + + D
Sbjct: 142 RDIKSDSILLTSDGRIKLSDFGFCAQV-SKEVPKRKSLVGTPYWMAPEVISRLPYGTEVD 200
Query: 373 IYSFGVLLLEAVTGRDP 389
I+S G++++E + G P
Sbjct: 201 IWSLGIMVIEMIDGEPP 217
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292 |
| >gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Score = 72.0 bits (177), Expect = 8e-14
Identities = 60/248 (24%), Positives = 113/248 (45%), Gaps = 46/248 (18%)
Query: 187 RFSAENVLGEGGYGVVYKG-RLINGSEVAVKKLLN---NLGQAEKEFRVEVEAIGHVRHK 242
R+ +G G YGVV +G +VA+KK+ + A++ R E++ + H +H
Sbjct: 6 RYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLR-ELKILRHFKHD 64
Query: 243 NLVRLLGYCI------EGVHRMLVYEYVNNGNLEQWLHGAMRNQGNLTWEARMKVIIGTA 296
N++ + I + +V + + + +L +H LT E +
Sbjct: 65 NIIAIRD--ILRPPGADFKDVYVVMDLMES-DLHHIIHS----DQPLTEEHIRYFLYQLL 117
Query: 297 KALAYLHEAIEPKVVHRDIKSSNILIDDEFNAKVSDFGLAKLLDSGE--------SHITT 348
+ L Y+H A V+HRD+K SN+L++++ ++ DFG+A+ L S ++ T
Sbjct: 118 RGLKYIHSA---NVIHRDLKPSNLLVNEDCELRIGDFGMARGLSSSPTEHKYFMTEYVAT 174
Query: 349 RVMGTFGYVAPEYANTGML-----NEKSDIYSFGVLLLEAVTGRDPVDYGRPANEVNLVE 403
R Y APE +L D++S G + E + GR + G+ N V+ ++
Sbjct: 175 R-----WYRAPEL----LLSLPEYTTAIDMWSVGCIFAEML-GRRQLFPGK--NYVHQLK 222
Query: 404 WLKMMVGT 411
+ ++G+
Sbjct: 223 LILSVLGS 230
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334 |
| >gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Score = 70.9 bits (173), Expect = 1e-13
Identities = 71/277 (25%), Positives = 126/277 (45%), Gaps = 37/277 (13%)
Query: 193 VLGEGGYGVVYKGRLIN-GSEVAVKKLLNNLGQAEKEFRV-----EVEAIGHVRHKNLVR 246
+LG+G +G VY ++ G E+A K++ + E V E++ + +++H+ +V+
Sbjct: 9 LLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQ 68
Query: 247 LLGYCIEGVHRMLV--YEYVNNGNLEQWLHGAMRNQGNLTWEARMKVIIGTAKALAYLHE 304
G + + L EY+ G+++ L + G LT K + ++YLH
Sbjct: 69 YYGCLRDRAEKTLTIFMEYMPGGSVKDQL----KAYGALTESVTRKYTRQILEGMSYLHS 124
Query: 305 AIEPKVVHRDIKSSNILIDDEFNAKVSDFGLAKLLD----SGESHITTRVMGTFGYVAPE 360
+ +VHRDIK +NIL D N K+ DFG +K L SG V GT +++PE
Sbjct: 125 NM---IVHRDIKGANILRDSAGNVKLGDFGASKRLQTICMSGTG--IRSVTGTPYWMSPE 179
Query: 361 YANTGMLNEKSDIYSFGVLLLEAVTGRDPVDYGRPANEVNLVEWLKMMVGTRRAEEVVDP 420
+ K+D++S G ++E +T + P E+ M + A + +P
Sbjct: 180 VISGEGYGRKADVWSLGCTVVEMLTEKPP-----------WAEYEAMAAIFKIATQPTNP 228
Query: 421 NLEVKPATRALKRSLLVALRCVDPDSEKRPKMSQVVR 457
L + A R L C+ ++ RP +++R
Sbjct: 229 QLPSHISEHA--RDF---LGCIFVEARHRPSAEELLR 260
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266 |
| >gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Score = 71.4 bits (175), Expect = 1e-13
Identities = 64/235 (27%), Positives = 108/235 (45%), Gaps = 33/235 (14%)
Query: 165 PEISHLGWGHWFTLRDLEIATNRFSAENVLGEGGYGVVYKGR-LINGSEVAVKKLLNNLG 223
PEI+ L F+ D E F+ +G G +G VY R + VA+KK+ +
Sbjct: 2 PEIAEL-----FSKDDPE---KLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGK 53
Query: 224 QAEKEFR---VEVEAIGHVRHKNLVRLLGYCIEGVHRMLVYEYV--NNGNLEQWLHGAMR 278
Q+ ++++ EV + +RH N + G + LV EY + ++ + ++
Sbjct: 54 QSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLREHTAWLVMEYCLGSASDILEVHKKPLQ 113
Query: 279 NQGNLTWEARMKVII-GTAKALAYLHEAIEPKVVHRDIKSSNILIDDEFNAKVSDFGLAK 337
E + I G + LAYLH + +HRDIK+ NIL+ + K++DFG A
Sbjct: 114 -------EVEIAAICHGALQGLAYLHSH---ERIHRDIKAGNILLTEPGTVKLADFGSAS 163
Query: 338 LLDSGESHITTRVMGTFGYVAPEY---ANTGMLNEKSDIYSFGVLLLEAVTGRDP 389
L+ S + GT ++APE + G + K D++S G+ +E + P
Sbjct: 164 LVSPANSFV-----GTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPP 213
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307 |
| >gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Score = 70.8 bits (173), Expect = 1e-13
Identities = 61/209 (29%), Positives = 105/209 (50%), Gaps = 21/209 (10%)
Query: 193 VLGEGGYGVVYKGRLIN-GSEVAVKKLLNNLGQAEKEFRV-----EVEAIGHVRHKNLVR 246
+LG+G +G VY + G E+AVK++ + E V E++ + ++ H+ +V+
Sbjct: 9 LLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQ 68
Query: 247 LLGYCIEGVHRML--VYEYVNNGNLEQWLHGAMRNQGNLTWEARMKVIIGTAKALAYLHE 304
G + + R L E++ G+++ L ++ G LT K + ++YLH
Sbjct: 69 YYGCLRDPMERTLSIFMEHMPGGSIKDQL----KSYGALTENVTRKYTRQILEGVSYLHS 124
Query: 305 AIEPKVVHRDIKSSNILIDDEFNAKVSDFGLAKLLD----SGESHITTRVMGTFGYVAPE 360
+ +VHRDIK +NIL D N K+ DFG +K L SG + V GT +++PE
Sbjct: 125 NM---IVHRDIKGANILRDSVGNVKLGDFGASKRLQTICLSGTGMKS--VTGTPYWMSPE 179
Query: 361 YANTGMLNEKSDIYSFGVLLLEAVTGRDP 389
+ K+DI+S G ++E +T + P
Sbjct: 180 VISGEGYGRKADIWSVGCTVVEMLTEKPP 208
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265 |
| >gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Score = 70.8 bits (173), Expect = 1e-13
Identities = 58/201 (28%), Positives = 97/201 (48%), Gaps = 12/201 (5%)
Query: 194 LGEGGYGVVYKGRLINGSEVAVKKLLN-NLGQAEKEFRVEVEAIGHVRHKNLVRLLGYCI 252
+G G YG VYK R ++ E+A K++ G + E+ + +H N+V G +
Sbjct: 17 VGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIVAYFGSYL 76
Query: 253 EGVHRMLVYEYVNNGNLEQWLHGAMRNQGNLTWEARMKVIIGTAKALAYLHEAIEPKVVH 312
+ EY G+L+ H G L+ V T + LAYLH + +H
Sbjct: 77 SREKLWICMEYCGGGSLQDIYHVT----GPLSELQIAYVCRETLQGLAYLHSKGK---MH 129
Query: 313 RDIKSSNILIDDEFNAKVSDFGLAKLLDSGESHITTRVMGTFGYVAPEYA---NTGMLNE 369
RDIK +NIL+ D + K++DFG+A + + + + +GT ++APE A G N+
Sbjct: 130 RDIKGANILLTDNGDVKLADFGVAAKITATIAKRKS-FIGTPYWMAPEVAAVEKNGGYNQ 188
Query: 370 KSDIYSFGVLLLEAVTGRDPV 390
DI++ G+ +E + P+
Sbjct: 189 LCDIWAVGITAIELAELQPPM 209
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267 |
| >gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Score = 70.8 bits (173), Expect = 2e-13
Identities = 59/197 (29%), Positives = 95/197 (48%), Gaps = 10/197 (5%)
Query: 194 LGEGGYGVVYKGRL-INGSEVAVKKLLNNLGQAEKEFRVEVEAIGHVRHKNLVRLLGYCI 252
+GEG G+V + +G VAVKK+ Q + EV + +H+N+V + +
Sbjct: 28 IGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYL 87
Query: 253 EGVHRMLVYEYVNNGNLEQWLHGAMRNQGNLTWEARMKVIIGTAKALAYLHEAIEPKVVH 312
G +V E++ G L + N+ E V + KAL+ LH V+H
Sbjct: 88 VGDELWVVMEFLEGGALTDIVTHTRMNE-----EQIAAVCLAVLKALSVLHAQ---GVIH 139
Query: 313 RDIKSSNILIDDEFNAKVSDFGLAKLLDSGESHITTRVMGTFGYVAPEYANTGMLNEKSD 372
RDIKS +IL+ + K+SDFG + S E ++GT ++APE + + D
Sbjct: 140 RDIKSDSILLTHDGRVKLSDFGFCAQV-SKEVPRRKSLVGTPYWMAPELISRLPYGPEVD 198
Query: 373 IYSFGVLLLEAVTGRDP 389
I+S G++++E V G P
Sbjct: 199 IWSLGIMVIEMVDGEPP 215
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292 |
| >gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Score = 70.4 bits (172), Expect = 2e-13
Identities = 64/206 (31%), Positives = 96/206 (46%), Gaps = 11/206 (5%)
Query: 188 FSAENVLGEGGYGVVYKGRL-INGSEVAVKKLLNNLGQAEK--EFRVEVEAIGHVRHKNL 244
F VLG+GG+G V ++ G A K+L + K + + I +
Sbjct: 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQF 61
Query: 245 VRLLGYCIEGVHRM-LVYEYVNNGNLEQWLHGAMRNQGNLTWEARMKVIIGTAKALAYLH 303
V L Y E + LV +N G+L+ ++ N GN +E + + A+ L L
Sbjct: 62 VVNLAYAYETKDALCLVLTIMNGGDLKFHIY----NMGNPGFEEE-RALFYAAEILCGLE 116
Query: 304 EAIEPKVVHRDIKSSNILIDDEFNAKVSDFGLAKLLDSGESHITTRVMGTFGYVAPEYAN 363
+ V+RD+K NIL+DD + ++SD GLA + GES I RV GT GY+APE N
Sbjct: 117 DLHRENTVYRDLKPENILLDDYGHIRISDLGLAVKIPEGES-IRGRV-GTVGYMAPEVLN 174
Query: 364 TGMLNEKSDIYSFGVLLLEAVTGRDP 389
D + G L+ E + G+ P
Sbjct: 175 NQRYTLSPDYWGLGCLIYEMIEGQSP 200
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285 |
| >gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Score = 70.5 bits (173), Expect = 2e-13
Identities = 42/130 (32%), Positives = 72/130 (55%), Gaps = 11/130 (8%)
Query: 262 EYVNNGNLEQWLHGAMRNQGNLTWEARMKVIIGTAKALAYLHEAIEPKVVHRDIKSSNIL 321
E+++ G+L+Q ++ G + K+ I + L YL E + K++HRD+K SNIL
Sbjct: 79 EHMDGGSLDQ----VLKKAGRIPENILGKISIAVLRGLTYLRE--KHKIMHRDVKPSNIL 132
Query: 322 IDDEFNAKVSDFGLA-KLLDSGESHITTRVMGTFGYVAPEYANTGMLNEKSDIYSFGVLL 380
++ K+ DFG++ +L+DS + +GT Y++PE +SDI+S G+ L
Sbjct: 133 VNSRGEIKLCDFGVSGQLIDS----MANSFVGTRSYMSPERLQGTHYTVQSDIWSLGLSL 188
Query: 381 LEAVTGRDPV 390
+E GR P+
Sbjct: 189 VEMAIGRYPI 198
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308 |
| >gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 71.4 bits (175), Expect = 3e-13
Identities = 82/287 (28%), Positives = 132/287 (45%), Gaps = 37/287 (12%)
Query: 187 RFSAENVLGEGGYG-VVYKGRLINGSEVAVKKL--------LNNLGQAEKEFRVEVEAIG 237
++ VLG G G V+ R+ +G AVK + N QAE + +
Sbjct: 33 KYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFS 92
Query: 238 HVR-HKNLVRLLGYCIEGVHRM-LVYEYVNNGNLEQWLHGAMRNQGNLTW---EARMKVI 292
V+ H++ + E V + LV +Y N G+L Q + R + N T+ EA + I
Sbjct: 93 IVKCHEDFAKKDPRNPENVLMIALVLDYANAGDLRQEIKS--RAKTNRTFREHEAGLLFI 150
Query: 293 IGTAKALAYLHEAIEPKVVHRDIKSSNILIDDEFNAKVSDFGLAKLLDSGESHITTRVM- 351
+ L +H ++HRDIKS+NIL+ K+ DFG +K+ + S R
Sbjct: 151 ----QVLLAVHHVHSKHMIHRDIKSANILLCSNGLVKLGDFGFSKMYAATVSDDVGRTFC 206
Query: 352 GTFGYVAPEYANTGMLNEKSDIYSFGVLLLEAVTGRDPVDYGRPANEVNLVEWLKMMVGT 411
GT YVAPE ++K+D++S GVLL E +T + RP + N+ E + +
Sbjct: 207 GTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLK------RPFDGENMEEVMHKTLAG 260
Query: 412 RRAEEVVDPNLEVKPATRALKRSLLVALRCVDPDSEKRPKMSQVVRM 458
R DP + P+ + ++ AL DP ++RP S+++ M
Sbjct: 261 R-----YDP---LPPSISPEMQEIVTALLSSDP--KRRPSSSKLLNM 297
|
Length = 496 |
| >gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Score = 69.6 bits (170), Expect = 3e-13
Identities = 64/209 (30%), Positives = 101/209 (48%), Gaps = 17/209 (8%)
Query: 188 FSAENVLGEGGYGVVYKGRL-INGSEVAVKKLLNNLGQAEKEFRVEVEAIGHVR-----H 241
F VLG+GG+G V ++ G A KKL + K+ + E A+ R +
Sbjct: 2 FRHYRVLGKGGFGEVCACQVRATGKMYACKKLEK---KRIKKRKGEAMALNEKRILEKVN 58
Query: 242 KNLVRLLGYCIEGVHRM-LVYEYVNNGNLEQWLHGAMRNQGNLTWEARMKVIIGTAKALA 300
V L Y E + LV +N G+L+ ++ N GN ++ + + I A+
Sbjct: 59 SRFVVSLAYAYETKDALCLVLTIMNGGDLKFHIY----NMGNPGFDEQ-RAIFYAAELCC 113
Query: 301 YLHEAIEPKVVHRDIKSSNILIDDEFNAKVSDFGLAKLLDSGESHITTRVMGTFGYVAPE 360
L + ++V+RD+K NIL+DD + ++SD GLA + GE+ + RV GT GY+APE
Sbjct: 114 GLEDLQRERIVYRDLKPENILLDDRGHIRISDLGLAVQIPEGET-VRGRV-GTVGYMAPE 171
Query: 361 YANTGMLNEKSDIYSFGVLLLEAVTGRDP 389
N D + G L+ E + G+ P
Sbjct: 172 VINNEKYTFSPDWWGLGCLIYEMIQGQSP 200
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285 |
| >gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Score = 70.1 bits (172), Expect = 4e-13
Identities = 62/212 (29%), Positives = 99/212 (46%), Gaps = 29/212 (13%)
Query: 193 VLGEGGYGVVYKGRLINGSEV-AVKKLLNNLGQAEKEFR-VEVEAIGHV-----RHKNLV 245
VLG+G +G V L E+ AVK L ++ + + E V +H L
Sbjct: 2 VLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEK--RVLALAGKHPFLT 59
Query: 246 RLLGYCIEGVHRM-LVYEYVNNGNLEQWLHGAMRNQGNLTWEARMK-----VIIGTAKAL 299
+L C + R+ V EYVN G+L H ++ G E R + +++G L
Sbjct: 60 QLHS-CFQTKDRLFFVMEYVNGGDL--MFH--IQRSGRFD-EPRARFYAAEIVLG----L 109
Query: 300 AYLHEAIEPKVVHRDIKSSNILIDDEFNAKVSDFGLAKLLDSGESHITTRVMGTFGYVAP 359
+LHE +++RD+K N+L+D E + K++DFG+ K T+ GT Y+AP
Sbjct: 110 QFLHER---GIIYRDLKLDNVLLDSEGHIKIADFGMCK-EGILGGVTTSTFCGTPDYIAP 165
Query: 360 EYANTGMLNEKSDIYSFGVLLLEAVTGRDPVD 391
E + D ++ GVLL E + G+ P +
Sbjct: 166 EILSYQPYGPAVDWWALGVLLYEMLAGQSPFE 197
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318 |
| >gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 69.8 bits (171), Expect = 4e-13
Identities = 62/205 (30%), Positives = 101/205 (49%), Gaps = 18/205 (8%)
Query: 193 VLGEGGYGVVYKGRLINGSEVAVKKLLNNLGQAEKEFR------VEVEAIGHVRHKNLVR 246
VLG+G +G V+ R I G + + L +A + R +E + + V H +V+
Sbjct: 3 VLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVK 62
Query: 247 L-LGYCIEGVHRMLVYEYVNNGNLEQWLHGAMRNQGNLTWEARMKVIIGT-AKALAYLHE 304
L + EG L+ +++ G+L L + + E +K + A AL +LH
Sbjct: 63 LHYAFQTEG-KLYLILDFLRGGDLFTRLSKEV-----MFTEEDVKFYLAELALALDHLHS 116
Query: 305 AIEPKVVHRDIKSSNILIDDEFNAKVSDFGLAKLLDSGESHITTRVMGTFGYVAPEYANT 364
+++RD+K NIL+D+E + K++DFGL+K E GT Y+APE N
Sbjct: 117 L---GIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKK-AYSFCGTVEYMAPEVVNR 172
Query: 365 GMLNEKSDIYSFGVLLLEAVTGRDP 389
+ +D +SFGVL+ E +TG P
Sbjct: 173 RGHTQSADWWSFGVLMFEMLTGSLP 197
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318 |
| >gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Score = 70.1 bits (172), Expect = 4e-13
Identities = 69/219 (31%), Positives = 96/219 (43%), Gaps = 46/219 (21%)
Query: 193 VLGEGGYGVV----YKGRLINGSEVAVKKLLNNLGQAEKEF---RVEVEAI--------- 236
VLG G +G V YK G A+K L +K R EVE++
Sbjct: 6 VLGRGHFGKVLLAEYKK---TGELYAIKAL-------KKGDIIARDEVESLMCEKRIFET 55
Query: 237 -GHVRHKNLVRLLGYCIEGVHRMLVYEYVNNGNLEQWLHGAMRNQGNLTWEARMKVIIGT 295
RH LV L H V EY G+L +H + ++ + A V++G
Sbjct: 56 ANSERHPFLVNLFACFQTEDHVCFVMEYAAGGDLMMHIHTDVFSEPRAVFYA-ACVVLG- 113
Query: 296 AKALAYLHEAIEPKVVHRDIKSSNILIDDEFNAKVSDFGLAKLLDSGESHITTRVMGTFG 355
L YLHE K+V+RD+K N+L+D E K++DFGL K G T+ GT
Sbjct: 114 ---LQYLHEN---KIVYRDLKLDNLLLDTEGFVKIADFGLCK-EGMGFGDRTSTFCGTPE 166
Query: 356 YVAPEYANTGMLNEKS-----DIYSFGVLLLEAVTGRDP 389
++APE +L E S D + GVL+ E + G P
Sbjct: 167 FLAPE-----VLTETSYTRAVDWWGLGVLIYEMLVGESP 200
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324 |
| >gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Score = 70.1 bits (171), Expect = 4e-13
Identities = 63/205 (30%), Positives = 93/205 (45%), Gaps = 15/205 (7%)
Query: 193 VLGEGGYGVVYKGRLINGSEV----AVKKLLNNLGQAEKEFRVEVEAIGHVRHKNLVRLL 248
V+G G Y V RL + VKK L N + + E + + L
Sbjct: 2 VIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGL 61
Query: 249 GYCIEGVHRML-VYEYVNNGNLEQWLHGAMRNQGNLTWEARMKVIIGTAKALAYLHEAIE 307
C + R+ V EYVN G+L H M+ Q L E + AL YLHE
Sbjct: 62 HSCFQTESRLFFVIEYVNGGDL--MFH--MQRQRKLPEEHARFYSAEISLALNYLHER-- 115
Query: 308 PKVVHRDIKSSNILIDDEFNAKVSDFGLAKL-LDSGESHITTRVMGTFGYVAPEYANTGM 366
+++RD+K N+L+D E + K++D+G+ K L G++ T+ GT Y+APE
Sbjct: 116 -GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDT--TSTFCGTPNYIAPEILRGED 172
Query: 367 LNEKSDIYSFGVLLLEAVTGRDPVD 391
D ++ GVL+ E + GR P D
Sbjct: 173 YGFSVDWWALGVLMFEMMAGRSPFD 197
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329 |
| >gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Score = 69.3 bits (169), Expect = 5e-13
Identities = 69/209 (33%), Positives = 99/209 (47%), Gaps = 18/209 (8%)
Query: 186 NRFSAENVLGEGGYGVVYKGRLINGSE-VAVKKLLNNLGQAE-KEFRV-EVEAIGHVRHK 242
N+F V+GEG YGVV K R E VA+KK ++ E KE + E++ + ++ +
Sbjct: 1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQE 60
Query: 243 NLVRLLGYCIEGVHR----MLVYEYVNNGNLEQWLHGAMRNQGNLTWEARMKVIIGTAKA 298
N+V L E R LV+EYV LE L M N G + R I KA
Sbjct: 61 NIVELK----EAFRRRGKLYLVFEYVEKNMLE--LLEEMPN-GVPPEKVR-SYIYQLIKA 112
Query: 299 LAYLHEAIEPKVVHRDIKSSNILIDDEFNAKVSDFGLAKLLDSGESHITTRVMGTFGYVA 358
+ + H+ +VHRDIK N+LI K+ DFG A+ L G + T + T Y +
Sbjct: 113 IHWCHKN---DIVHRDIKPENLLISHNDVLKLCDFGFARNLSEGSNANYTEYVATRWYRS 169
Query: 359 PEYANTGMLNEKSDIYSFGVLLLEAVTGR 387
PE + D++S G +L E G+
Sbjct: 170 PELLLGAPYGKAVDMWSVGCILGELSDGQ 198
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287 |
| >gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Score = 69.3 bits (169), Expect = 5e-13
Identities = 58/201 (28%), Positives = 103/201 (51%), Gaps = 25/201 (12%)
Query: 194 LGEGGYGVVYKGRLINGSEVAVKKLLNNLGQAEKE-FRVEVEAIGHVRHKNLVRLLG-YC 251
LG+G +G VYK + +A K++ + E E + VE+E + H +V+LLG +
Sbjct: 20 LGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAFY 79
Query: 252 IEGVHRMLVYEYVNNGNLEQWLHGAMRNQGNLTWEARMKVIIGTA-KALAYLHEAIEPKV 310
+G +++ E+ G ++ M E +++VI +AL YLH K+
Sbjct: 80 WDGKLWIMI-EFCPGGAVD----AIMLELDRGLTEPQIQVICRQMLEALQYLHSM---KI 131
Query: 311 VHRDIKSSNILIDDEFNAKVSDFGLA----KLLDSGESHITTRVMGTFGYVAPEYANTGM 366
+HRD+K+ N+L+ + + K++DFG++ K L +S I GT ++APE
Sbjct: 132 IHRDLKAGNVLLTLDGDIKLADFGVSAKNVKTLQRRDSFI-----GTPYWMAPEVVMCET 186
Query: 367 LNE-----KSDIYSFGVLLLE 382
+ + K+DI+S G+ L+E
Sbjct: 187 MKDTPYDYKADIWSLGITLIE 207
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292 |
| >gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Score = 68.9 bits (168), Expect = 6e-13
Identities = 56/200 (28%), Positives = 106/200 (53%), Gaps = 23/200 (11%)
Query: 194 LGEGGYGVVYKGRLINGSEVAVKKLLNNLGQAEKE-FRVEVEAIGHVRHKNLVRLLGYCI 252
LG+G +G VYK + +A K+++ + E E + VE++ + H N+V+LL
Sbjct: 13 LGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFY 72
Query: 253 EGVHRMLVYEYVNNGNLEQWLHGAMRNQGNLTWEARMKVIIG-TAKALAYLHEAIEPKVV 311
+ ++ E+ G ++ + + + LT E +++V+ T +AL YLHE K++
Sbjct: 73 YENNLWILIEFCAGGAVDAVM---LELERPLT-EPQIRVVCKQTLEALNYLHEN---KII 125
Query: 312 HRDIKSSNILIDDEFNAKVSDFGLA----KLLDSGESHITTRVMGTFGYVAPEY-----A 362
HRD+K+ NIL + + K++DFG++ + + +S I GT ++APE +
Sbjct: 126 HRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDSFI-----GTPYWMAPEVVMCETS 180
Query: 363 NTGMLNEKSDIYSFGVLLLE 382
+ K+D++S G+ L+E
Sbjct: 181 KDRPYDYKADVWSLGITLIE 200
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282 |
| >gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Score = 68.9 bits (168), Expect = 6e-13
Identities = 61/226 (26%), Positives = 102/226 (45%), Gaps = 19/226 (8%)
Query: 178 LRDLEIATNRFSAENVLGEGGYGVVYK-GRLINGSEVAVKKLLNNLGQAEKEFRVEVEAI 236
L L T+ + +G+G YG VYK +GS AVK +L+ + ++E E +
Sbjct: 14 LESLGDPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVK-ILDPISDVDEEIEAEYNIL 72
Query: 237 GHV-RHKNLVRLLG------YCIEGVHRMLVYEYVNNGNLEQWLHGAMRNQGNLTWEARM 289
+ H N+V+ G + G LV E N G++ + + G + L
Sbjct: 73 QSLPNHPNVVKFYGMFYKADKLVGG-QLWLVLELCNGGSVTELVKGLLICGQRLDEAMIS 131
Query: 290 KVIIGTAKALAYLHEAIEPKVVHRDIKSSNILIDDEFNAKVSDFGLAKLLDSGESHITTR 349
++ G L +LH +++HRD+K +NIL+ E K+ DFG++ L S T
Sbjct: 132 YILYGALLGLQHLHNN---RIIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRRNTS 188
Query: 350 VMGTFGYVAPEYANTGM-----LNEKSDIYSFGVLLLEAVTGRDPV 390
V GT ++APE + + D++S G+ +E G P+
Sbjct: 189 V-GTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPL 233
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291 |
| >gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 69.7 bits (170), Expect = 7e-13
Identities = 64/212 (30%), Positives = 102/212 (48%), Gaps = 25/212 (11%)
Query: 187 RFSAENVLGEGGYGVV---YKGRLINGSEVAVKKL---LNNLGQAEKEFRVEVEAIGHVR 240
R+ + +G G YG V + + G VAVKKL ++ A++ +R E+ + H++
Sbjct: 18 RYQNLSPVGSGAYGSVCAAFDTK--TGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMK 74
Query: 241 HKNLVRLLGYCIEGVHRMLVYEYVNNGNLEQWLHGAMRNQ----GNLTWEARMKVIIGTA 296
H+N++ LL E N+ L L GA N LT + +I
Sbjct: 75 HENVIGLLDVFTPARS----LEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQIL 130
Query: 297 KALAYLHEAIEPKVVHRDIKSSNILIDDEFNAKVSDFGLAKLLDSGESHITTRVMGTFGY 356
+ L Y+H A ++HRD+K SN+ ++++ K+ DFGLA+ D T + T Y
Sbjct: 131 RGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE----MTGYVATRWY 183
Query: 357 VAPEYANTGM-LNEKSDIYSFGVLLLEAVTGR 387
APE M N+ DI+S G ++ E +TGR
Sbjct: 184 RAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 215
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345 |
| >gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 68.3 bits (167), Expect = 7e-13
Identities = 45/178 (25%), Positives = 79/178 (44%), Gaps = 19/178 (10%)
Query: 259 LVYEYVNNGNLEQWLHGAMRNQGNLTWEARMKVIIGTAKALAYLHEAIEPKVVHRDIKSS 318
LV EY+N G+ + + G L + + I + LH+ ++HRDIK
Sbjct: 74 LVMEYLNGGDCASLI----KTLGGLPEDWAKQYIAEVVLGVEDLHQR---GIIHRDIKPE 126
Query: 319 NILIDDEFNAKVSDFGLAKLLDSGESHITTRVMGTFGYVAPEYANTGMLNEKSDIYSFGV 378
N+LID + K++DFGL++ + +GT Y+APE ++ SD +S G
Sbjct: 127 NLLIDQTGHLKLTDFGLSRN-----GLENKKFVGTPDYLAPETILGVGDDKMSDWWSLGC 181
Query: 379 LLLEAVTGRDPVDYGRPAN-----EVNLVEWLKMMVG--TRRAEEVVDPNLEVKPATR 429
++ E + G P P + W + + + A ++++ L + PA R
Sbjct: 182 VIFEFLFGYPPFHAETPDAVFDNILSRRINWPEEVKEFCSPEAVDLINRLLCMDPAKR 239
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260 |
| >gnl|CDD|173627 cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 68.3 bits (167), Expect = 8e-13
Identities = 72/285 (25%), Positives = 117/285 (41%), Gaps = 48/285 (16%)
Query: 194 LGEGGYGVVYKGRLIN-------GSEVAVKKLLNNLGQAEKEFRVEVEAIG---HVRHKN 243
LG+G + +YKG L G V +L LG ++ E + HK+
Sbjct: 3 LGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRDSLAFFETASLMSQLSHKH 62
Query: 244 LVRLLGYCIEGVHRMLVYEYVNNGNLEQWLHGAMRNQGNLTWEARMKVIIGTAKALAYLH 303
LV+L G C+ + M V EYV G L+ +LH R + N++ ++ V A AL YL
Sbjct: 63 LVKLYGVCVRDENIM-VEEYVKFGPLDVFLH---REKNNVSLHWKLDVAKQLASALHYLE 118
Query: 304 EAIEPKVVHRDIKSSNILI----DDEFN---AKVSDFGLAKLLDSGESHITTRVMGTFGY 356
+ K+VH ++ NIL+ +E K+SD G+ + S E + +
Sbjct: 119 DK---KLVHGNVCGKNILVARYGLNEGYVPFIKLSDPGIPITVLSREERVE-----RIPW 170
Query: 357 VAPEYANTGM--LNEKSDIYSFGVLLLEAVTGRDPVDYGRPANEVNLVEWLKMMVGTRRA 414
+APE G L +D +SFG LLE + + P + ++ E +
Sbjct: 171 IAPECIRNGQASLTIAADKWSFGTTLLEICSNGE-----EPLSTLSSSEKER-----FYQ 220
Query: 415 EEVVDPNLEVKPATRALKRSLLVALRCVDPDSEKRPKMSQVVRML 459
++ P + + +C D KRP ++R L
Sbjct: 221 DQHRLPMPDCAELANLIN-------QCWTYDPTKRPSFRAILRDL 258
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 259 |
| >gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Score = 68.4 bits (167), Expect = 8e-13
Identities = 67/205 (32%), Positives = 100/205 (48%), Gaps = 21/205 (10%)
Query: 194 LGEGGYGVVYKGRLIN-GSEVAVKKL----LNNLGQAEKEFRVEVEAIGHVRHKNLVRLL 248
LG+GG+G V ++ N G A KKL L EK +E E + V +V L
Sbjct: 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKS-GEKMALLEKEILEKVNSPFIVNL- 58
Query: 249 GYCIEG-VHRMLVYEYVNNGNLEQWLHGAMRNQGNLTWEARMKVIIGTAK---ALAYLHE 304
Y E H LV +N G+L+ ++ N G E +VI +A+ + +LH
Sbjct: 59 AYAFESKTHLCLVMSLMNGGDLKYHIY----NVGERGLEME-RVIHYSAQITCGILHLHS 113
Query: 305 AIEPKVVHRDIKSSNILIDDEFNAKVSDFGLAKLLDSGESHITTRVMGTFGYVAPEYANT 364
+V+RD+K N+L+DD+ N ++SD GLA L G++ T+ GT GY+APE
Sbjct: 114 M---DIVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGKT--ITQRAGTNGYMAPEILKE 168
Query: 365 GMLNEKSDIYSFGVLLLEAVTGRDP 389
+ D ++ G + E V GR P
Sbjct: 169 EPYSYPVDWFAMGCSIYEMVAGRTP 193
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277 |
| >gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Score = 67.8 bits (165), Expect = 1e-12
Identities = 56/201 (27%), Positives = 97/201 (48%), Gaps = 12/201 (5%)
Query: 194 LGEGGYGVVYKGRLINGSEVAVKKLLN-NLGQAEKEFRVEVEAIGHVRHKNLVRLLGYCI 252
+G G YG VYK R +N E+A K++ G+ + E+ + +H N+V G +
Sbjct: 17 IGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIVAYFGSYL 76
Query: 253 EGVHRMLVYEYVNNGNLEQWLHGAMRNQGNLTWEARMKVIIGTAKALAYLHEAIEPKVVH 312
+ E+ G+L+ H G L+ V T + L YLH + +H
Sbjct: 77 RRDKLWICMEFCGGGSLQDIYHVT----GPLSESQIAYVSRETLQGLYYLHSKGK---MH 129
Query: 313 RDIKSSNILIDDEFNAKVSDFGLAKLLDSGESHITTRVMGTFGYVAPEYA---NTGMLNE 369
RDIK +NIL+ D + K++DFG++ + + + + +GT ++APE A G N+
Sbjct: 130 RDIKGANILLTDNGHVKLADFGVSAQITATIAKRKS-FIGTPYWMAPEVAAVERKGGYNQ 188
Query: 370 KSDIYSFGVLLLEAVTGRDPV 390
DI++ G+ +E + P+
Sbjct: 189 LCDIWAVGITAIELAELQPPM 209
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267 |
| >gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Score = 68.3 bits (167), Expect = 1e-12
Identities = 63/206 (30%), Positives = 95/206 (46%), Gaps = 26/206 (12%)
Query: 194 LGEGGYGVVYKGR-LINGSEVAVKKL---LNNLGQAEKEFRVEVEAIGHVRHKNLVRLLG 249
+GEG YGVVYK R + +A+KK+ + G R E+ + ++H N+VRL
Sbjct: 10 IGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIR-EISLLKEMQHGNIVRLQD 68
Query: 250 YCIEGVHRMLVYEYVNNGNLEQWLHGAMRNQGNLTWEARM--KVIIGTAKALAYLHEAIE 307
LV+EY L+ L M + + R+ + + +AY H
Sbjct: 69 VVHSEKRLYLVFEY-----LDLDLKKHMDSSPDFAKNPRLIKTYLYQILRGIAYCHSH-- 121
Query: 308 PKVVHRDIKSSNILIDDEFNA-KVSDFGLAKLLDSGESHITTRVMGTFGYVAPEYANTGM 366
+V+HRD+K N+LID NA K++DFGLA+ T V+ T Y APE +
Sbjct: 122 -RVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFTHEVV-TLWYRAPEI----L 175
Query: 367 LNEKS-----DIYSFGVLLLEAVTGR 387
L + DI+S G + E V +
Sbjct: 176 LGSRHYSTPVDIWSVGCIFAEMVNQK 201
|
Length = 294 |
| >gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Score = 68.5 bits (167), Expect = 1e-12
Identities = 63/219 (28%), Positives = 99/219 (45%), Gaps = 15/219 (6%)
Query: 193 VLGEGGYGVVYKGRLINGSEV----AVKKLLNNLGQAEKEFRVEVEAIGHVRHKNLVRLL 248
V+G G Y V RL ++ VKK L + + + E + L
Sbjct: 2 VIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGL 61
Query: 249 GYCIEGVHRM-LVYEYVNNGNLEQWLHGAMRNQGNLTWEARMKVIIGTAKALAYLHEAIE 307
C + R+ LV EYVN G+L H M+ Q L E AL +LHE
Sbjct: 62 HSCFQTTSRLFLVIEYVNGGDL--MFH--MQRQRKLPEEHARFYAAEICIALNFLHER-- 115
Query: 308 PKVVHRDIKSSNILIDDEFNAKVSDFGLAKL-LDSGESHITTRVMGTFGYVAPEYANTGM 366
+++RD+K N+L+D + + K++D+G+ K L G++ T+ GT Y+APE
Sbjct: 116 -GIIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPGDT--TSTFCGTPNYIAPEILRGEE 172
Query: 367 LNEKSDIYSFGVLLLEAVTGRDPVDYGRPANEVNLVEWL 405
D ++ GVL+ E + GR P D ++N ++L
Sbjct: 173 YGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYL 211
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327 |
| >gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Score = 68.6 bits (168), Expect = 1e-12
Identities = 63/204 (30%), Positives = 103/204 (50%), Gaps = 19/204 (9%)
Query: 194 LGEGGYGVVYK---GRLINGSEVAVKKLLN---NLGQAEKEFRVEVEAIGHVRHKNLVRL 247
+G G +GVV+ R +G VA+KK+ N NL ++ FR E++ + +H N++
Sbjct: 8 IGYGAFGVVWSVTDPR--DGKRVALKKMPNVFQNLVSCKRVFR-ELKMLCFFKHDNVLSA 64
Query: 248 LGYCIEGVHRMLVYE-YVNNGNLEQWLHGAMRNQGNLTWEARMKVII-GTAKALAYLHEA 305
L ++ H E YV ++ LH + + L+ + +KV + + L YLH A
Sbjct: 65 LD-ILQPPHIDPFEEIYVVTELMQSDLHKIIVSPQPLSSD-HVKVFLYQILRGLKYLHSA 122
Query: 306 IEPKVVHRDIKSSNILIDDEFNAKVSDFGLAKLLDSGESHITTRVMGTFGYVAPEYANTG 365
++HRDIK N+L++ K+ DFGLA++ + ES T+ + T Y APE G
Sbjct: 123 ---GILHRDIKPGNLLVNSNCVLKICDFGLARVEEPDESKHMTQEVVTQYYRAPEIL-MG 178
Query: 366 MLNEKS--DIYSFGVLLLEAVTGR 387
+ S DI+S G + E + R
Sbjct: 179 SRHYTSAVDIWSVGCIFAELLGRR 202
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372 |
| >gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 67.4 bits (164), Expect = 2e-12
Identities = 58/209 (27%), Positives = 100/209 (47%), Gaps = 21/209 (10%)
Query: 193 VLGEGGYGVVYKGRLIN-GSEVAVKKLLNNLGQAEKEFRV-----EVEAIGHVRHKNLVR 246
+LG G +G VY + G E+AVK++ + E V E++ + ++RH +V+
Sbjct: 9 LLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQ 68
Query: 247 LLGYCIEGVHRML--VYEYVNNGNLEQWLHGAMRNQGNLTWEARMKVIIGTAKALAYLHE 304
G + + L EY+ G+++ L + G LT + + ++YLH
Sbjct: 69 YYGCLRDPEEKKLSIFVEYMPGGSIKDQL----KAYGALTENVTRRYTRQILQGVSYLHS 124
Query: 305 AIEPKVVHRDIKSSNILIDDEFNAKVSDFGLAKLLD----SGESHITTRVMGTFGYVAPE 360
+ +VHRDIK +NIL D N K+ DFG +K + SG V GT +++PE
Sbjct: 125 NM---IVHRDIKGANILRDSAGNVKLGDFGASKRIQTICMSGTG--IKSVTGTPYWMSPE 179
Query: 361 YANTGMLNEKSDIYSFGVLLLEAVTGRDP 389
+ K+D++S ++E +T + P
Sbjct: 180 VISGEGYGRKADVWSVACTVVEMLTEKPP 208
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264 |
| >gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Score = 67.4 bits (165), Expect = 2e-12
Identities = 60/210 (28%), Positives = 102/210 (48%), Gaps = 34/210 (16%)
Query: 194 LGEGGYGVVYKGR-LINGSEVAVKKL-LNNL--GQAEKEFRVEVEAIGHVRHKNLVRLLG 249
+GEG YGVVYKGR G VA+KK+ L + G R E+ + ++H N+V L
Sbjct: 8 IGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIR-EISLLKELQHPNIVCLQD 66
Query: 250 YCIEGVHRMLVYEYVNNGNLEQWLHGAMRNQGNLTWEARMKVIIGTAKALAYLHEAIEP- 308
++ L++E+++ +L+++L + Q + +YL++ ++
Sbjct: 67 VLMQESRLYLIFEFLSM-DLKKYLDSLPKGQ-----------YMDAELVKSYLYQILQGI 114
Query: 309 ------KVVHRDIKSSNILIDDEFNAKVSDFGLAKLLDSGESHITTRV----MGTFGYVA 358
+V+HRD+K N+LID++ K++DFGLA+ I RV + T Y A
Sbjct: 115 LFCHSRRVLHRDLKPQNLLIDNKGVIKLADFGLARAFG-----IPVRVYTHEVVTLWYRA 169
Query: 359 PE-YANTGMLNEKSDIYSFGVLLLEAVTGR 387
PE + + DI+S G + E T +
Sbjct: 170 PEVLLGSPRYSTPVDIWSIGTIFAEMATKK 199
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285 |
| >gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Score = 67.8 bits (166), Expect = 2e-12
Identities = 71/221 (32%), Positives = 108/221 (48%), Gaps = 35/221 (15%)
Query: 194 LGEGGYGVVYKGRLINGSE---VAVKKLLNNLGQ---AEKEFRVEVEAIGHVR-HKNLVR 246
LG+G YG+V R SE VA+KK+ N + A++ R E++ + H R HKN+
Sbjct: 8 LGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALR-ELKLLRHFRGHKNITC 66
Query: 247 LLGYCI---EGVHRMLVYEYVNNGNLEQWLHGAMRNQGNLTWEARMKVII-GTAKALAYL 302
L I + + +YE + +E LH +R+ LT +A + I L Y+
Sbjct: 67 LYDMDIVFPGNFNELYLYEEL----MEADLHQIIRSGQPLT-DAHFQSFIYQILCGLKYI 121
Query: 303 HEAIEPKVVHRDIKSSNILIDDEFNAKVSDFGLAKLLDSG----ESHITTRVMGTFGYVA 358
H A V+HRD+K N+L++ + K+ DFGLA+ +T V T Y A
Sbjct: 122 HSA---NVLHRDLKPGNLLVNADCELKICDFGLARGFSENPGENAGFMTEYV-ATRWYRA 177
Query: 359 PEYANTGMLNEKS-----DIYSFGVLLLEAVTGRDPVDYGR 394
PE ML+ +S D++S G +L E + GR PV G+
Sbjct: 178 PEI----MLSFQSYTKAIDVWSVGCILAE-LLGRKPVFKGK 213
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332 |
| >gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 67.3 bits (164), Expect = 2e-12
Identities = 65/208 (31%), Positives = 97/208 (46%), Gaps = 33/208 (15%)
Query: 194 LGEGGYGVVYKGRLINGSEVAVKKLLNNLGQAEKEFRVEVE------AIGHV------RH 241
LGEG Y VYKGR KL +NL A KE R+E E AI V +H
Sbjct: 14 LGEGTYATVYKGR---------SKLTDNL-VALKEIRLEHEEGAPCTAIREVSLLKDLKH 63
Query: 242 KNLVRLLGYCIEGVHRMLVYEYVNNGNLEQWLHGAMRNQGNLTWEARMKVII-GTAKALA 300
N+V L LV+EY++ +L+Q+L + GN +K+ + + L
Sbjct: 64 ANIVTLHDIIHTEKSLTLVFEYLDK-DLKQYLD----DCGNSINMHNVKLFLFQLLRGLN 118
Query: 301 YLHEAIEPKVVHRDIKSSNILIDDEFNAKVSDFGLAKLLDSGESHITTRVMGTFGYVAPE 360
Y H KV+HRD+K N+LI++ K++DFGLA+ + V+ T Y P+
Sbjct: 119 YCHRR---KVLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTYSNEVV-TLWYRPPD 174
Query: 361 -YANTGMLNEKSDIYSFGVLLLEAVTGR 387
+ + + D++ G + E TGR
Sbjct: 175 ILLGSTDYSTQIDMWGVGCIFYEMSTGR 202
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301 |
| >gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Score = 67.5 bits (165), Expect = 2e-12
Identities = 45/134 (33%), Positives = 70/134 (52%), Gaps = 8/134 (5%)
Query: 256 HRMLVYEYVNNGNLEQWLHGAMRNQGNLTWEARMKVIIGTAKALAYLHEAIEPKVVHRDI 315
H V EY+N G+L + + R ++I G L +LH+ +++RD+
Sbjct: 70 HLFFVMEYLNGGDLMFHIQSSGRFDEARARFYAAEIICG----LQFLHKK---GIIYRDL 122
Query: 316 KSSNILIDDEFNAKVSDFGLAKLLDSGESHITTRVMGTFGYVAPEYANTGMLNEKSDIYS 375
K N+L+D + + K++DFG+ K +GE +T GT Y+APE NE D +S
Sbjct: 123 KLDNVLLDKDGHIKIADFGMCKENMNGEGKAST-FCGTPDYIAPEILKGQKYNESVDWWS 181
Query: 376 FGVLLLEAVTGRDP 389
FGVLL E + G+ P
Sbjct: 182 FGVLLYEMLIGQSP 195
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316 |
| >gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Score = 67.5 bits (165), Expect = 3e-12
Identities = 62/210 (29%), Positives = 98/210 (46%), Gaps = 25/210 (11%)
Query: 193 VLGEGGYGVVYKGRLINGSEVAVKKLLNNLGQAEKEFRVEVEAIGHV-----RHKNLVRL 247
V+G G Y V L + K++ + E V+ HV H LV L
Sbjct: 2 VIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGL 61
Query: 248 LGYCIEGVHRM-LVYEYVNNGNLEQWLHGAMRNQGNLTWE-ARM---KVIIGTAKALAYL 302
C + R+ V E+V+ G+L H M+ Q L E AR ++ + AL +L
Sbjct: 62 HS-CFQTESRLFFVIEFVSGGDL--MFH--MQRQRKLPEEHARFYSAEISL----ALNFL 112
Query: 303 HEAIEPKVVHRDIKSSNILIDDEFNAKVSDFGLAKL-LDSGESHITTRVMGTFGYVAPEY 361
HE +++RD+K N+L+D E + K++D+G+ K + G++ T+ GT Y+APE
Sbjct: 113 HER---GIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPGDT--TSTFCGTPNYIAPEI 167
Query: 362 ANTGMLNEKSDIYSFGVLLLEAVTGRDPVD 391
D ++ GVL+ E + GR P D
Sbjct: 168 LRGEDYGFSVDWWALGVLMFEMMAGRSPFD 197
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329 |
| >gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Score = 67.0 bits (163), Expect = 3e-12
Identities = 53/205 (25%), Positives = 95/205 (46%), Gaps = 13/205 (6%)
Query: 188 FSAENVLGEGGYGVVYKGRLINGSEVAVKKLLNNLGQAEKEF---RVEVEAIGHVRHKNL 244
F+ +G+G +G V+KG + N ++ V + +L +AE E + E+ + +
Sbjct: 6 FTKLEKIGKGSFGEVFKG-IDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYV 64
Query: 245 VRLLGYCIEGVHRMLVYEYVNNGNLEQWLHGAMRNQGNLTWEARMKVIIGTAKALAYLHE 304
+ G ++ ++ EY+ G+ L G L ++ K L YLH
Sbjct: 65 TKYYGSYLKDTKLWIIMEYLGGGSALDLLE-----PGPLDETQIATILREILKGLDYLHS 119
Query: 305 AIEPKVVHRDIKSSNILIDDEFNAKVSDFGLAKLLDSGESHITTRVMGTFGYVAPEYANT 364
K +HRDIK++N+L+ + K++DFG+A L + +GT ++APE
Sbjct: 120 E---KKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIK-RNTFVGTPFWMAPEVIKQ 175
Query: 365 GMLNEKSDIYSFGVLLLEAVTGRDP 389
+ K+DI+S G+ +E G P
Sbjct: 176 SAYDSKADIWSLGITAIELAKGEPP 200
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277 |
| >gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Score = 67.2 bits (164), Expect = 3e-12
Identities = 67/254 (26%), Positives = 110/254 (43%), Gaps = 34/254 (13%)
Query: 193 VLGEGGYGVVYKGRLINGSEV-AVKKLLNNLGQAEKEFR---VEVEAIGHVRHKNLVRLL 248
VLG+G +G V RL + AVK L ++ + + E + R+ + L
Sbjct: 2 VLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQL 61
Query: 249 GYCIEGVHRML-VYEYVNNGNLEQWLHGAMRNQGNLTWEARMKVIIG-TAKALAYLHEAI 306
C + R+ V E+VN G+L + + R EAR + AL +LH+
Sbjct: 62 YCCFQTPDRLFFVMEFVNGGDLMFHIQKSRRFD-----EARARFYAAEITSALMFLHDK- 115
Query: 307 EPKVVHRDIKSSNILIDDEFNAKVSDFGLAKLLDSGESHITTRVMGTFGYVAPEYANTGM 366
+++RD+K N+L+D E + K++DFG+ K T+ GT Y+APE +
Sbjct: 116 --GIIYRDLKLDNVLLDHEGHCKLADFGMCK-EGIFNGKTTSTFCGTPDYIAPEILQEML 172
Query: 367 LNEKSDIYSFGVLLLEAVTGRDPVDYGRPANEVNLVE-----------WLKMMVGTRRAE 415
D ++ GVLL E + G P + NE +L E WL ++ A
Sbjct: 173 YGPSVDWWAMGVLLYEMLCGHAPFE---AENEDDLFEAILNDEVVYPTWL-----SQDAV 224
Query: 416 EVVDPNLEVKPATR 429
+++ + P R
Sbjct: 225 DILKAFMTKNPTMR 238
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320 |
| >gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Score = 65.8 bits (160), Expect = 4e-12
Identities = 56/199 (28%), Positives = 98/199 (49%), Gaps = 14/199 (7%)
Query: 193 VLGEGGYGVVYKGRLINGSEVAVKKLLNNLGQAEKEFRV---EVEAIGHVRHKNLVRLLG 249
V+G+G YG V R + V K LN + +E + E + + ++H N+V
Sbjct: 7 VVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIV-AYR 65
Query: 250 YCIEGVHRML--VYEYVNNGNLEQWLHGAMRNQGNLTWEAR-MKVIIGTAKALAYLHEAI 306
EG +L V + G+L H +G L E + ++ + A AL YLHE
Sbjct: 66 ESWEGEDGLLYIVMGFCEGGDL---YHKLKEQKGKLLPENQVVEWFVQIAMALQYLHEK- 121
Query: 307 EPKVVHRDIKSSNILIDDEFNAKVSDFGLAKLLDSGESHITTRVMGTFGYVAPEYANTGM 366
++HRD+K+ N+ + KV D G+A++L++ + + + ++GT Y++PE +
Sbjct: 122 --HILHRDLKTQNVFLTRTNIIKVGDLGIARVLEN-QCDMASTLIGTPYYMSPELFSNKP 178
Query: 367 LNEKSDIYSFGVLLLEAVT 385
N KSD+++ G + E T
Sbjct: 179 YNYKSDVWALGCCVYEMAT 197
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257 |
| >gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Score = 66.2 bits (161), Expect = 5e-12
Identities = 61/210 (29%), Positives = 99/210 (47%), Gaps = 19/210 (9%)
Query: 194 LGEGGYGVVYK-GRLINGSEVAVKKLLNNLGQAEKEFRVEVEAIGHVR-HKNLVRLLGY- 250
+G+G YG V+K NGS+ AVK +L+ + ++E E + + H N+V+ G
Sbjct: 26 IGKGTYGKVFKVLNKKNGSKAAVK-ILDPIHDIDEEIEAEYNILKALSDHPNVVKFYGMY 84
Query: 251 ----CIEGVHRMLVYEYVNNGNLEQWLHGAMRNQGNLTWEARMKVIIGTA-KALAYLHEA 305
G LV E N G++ + G ++ +G E + I+ A L +LH
Sbjct: 85 YKKDVKNGDQLWLVLELCNGGSVTDLVKGFLK-RGERMEEPIIAYILHEALMGLQHLHVN 143
Query: 306 IEPKVVHRDIKSSNILIDDEFNAKVSDFGLAKLLDSGESHITTRVMGTFGYVAPEYANT- 364
K +HRD+K +NIL+ E K+ DFG++ L S T V GT ++APE
Sbjct: 144 ---KTIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRRNTSV-GTPFWMAPEVIACE 199
Query: 365 ----GMLNEKSDIYSFGVLLLEAVTGRDPV 390
+ + D++S G+ +E G P+
Sbjct: 200 QQLDSTYDARCDVWSLGITAIELGDGDPPL 229
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286 |
| >gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 66.4 bits (162), Expect = 5e-12
Identities = 62/213 (29%), Positives = 97/213 (45%), Gaps = 25/213 (11%)
Query: 188 FSAENVLGEGGYGVVYKGRL-INGSEVAVKKLLNN---------LGQAEKEFRVEVEAIG 237
F VLG+GG+G V ++ G A KKL + EK+ +V +
Sbjct: 2 FRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSR- 60
Query: 238 HVRHKNLVRLLGYCIEGVHRM-LVYEYVNNGNLEQWLHGAMRNQGNLTWEARMKVIIGTA 296
V L Y E + LV +N G+L+ ++ N GN ++ + + A
Sbjct: 61 ------FVVSLAYAYETKDALCLVLTLMNGGDLKFHIY----NMGNPGFDEE-RAVFYAA 109
Query: 297 KALAYLHEAIEPKVVHRDIKSSNILIDDEFNAKVSDFGLAKLLDSGESHITTRVMGTFGY 356
+ L + ++V+RD+K NIL+DD + ++SD GLA + GE+ I RV GT GY
Sbjct: 110 EITCGLEDLHRERIVYRDLKPENILLDDYGHIRISDLGLAVEIPEGET-IRGRV-GTVGY 167
Query: 357 VAPEYANTGMLNEKSDIYSFGVLLLEAVTGRDP 389
+APE D + G L+ E + G+ P
Sbjct: 168 MAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSP 200
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285 |
| >gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Score = 66.0 bits (161), Expect = 5e-12
Identities = 57/201 (28%), Positives = 93/201 (46%), Gaps = 10/201 (4%)
Query: 194 LGEGGYGVVYKGRL-INGSEVAVKKLLNNLGQAEKEFR---VEVEAIGHVRHKNLVRLLG 249
LG+GG+G V ++ G A KKL + K + VE + V H + L
Sbjct: 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKV-HSRFIVSLA 59
Query: 250 YCIEGVHRM-LVYEYVNNGNLEQWLHGAMRNQGNLTWEARMKVIIGTAKALAYLHEAIEP 308
Y + + LV +N G+L ++ E R TA+ ++ L +
Sbjct: 60 YAFQTKTDLCLVMTIMNGGDLRYHIYNVDEENPGFP-EPR--ACFYTAQIISGLEHLHQR 116
Query: 309 KVVHRDIKSSNILIDDEFNAKVSDFGLAKLLDSGESHITTRVMGTFGYVAPEYANTGMLN 368
++++RD+K N+L+D++ N ++SD GLA L G+S T GT G++APE +
Sbjct: 117 RIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQSK-TKGYAGTPGFMAPELLQGEEYD 175
Query: 369 EKSDIYSFGVLLLEAVTGRDP 389
D ++ GV L E + R P
Sbjct: 176 FSVDYFALGVTLYEMIAARGP 196
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280 |
| >gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 66.6 bits (162), Expect = 5e-12
Identities = 61/208 (29%), Positives = 97/208 (46%), Gaps = 33/208 (15%)
Query: 194 LGEGGYGVVYKGRLINGSEVAVKKLLNNLGQAEKEFRVE------------VEAIGHVRH 241
LGEG Y V+KGR KL NL A KE R+E V + ++H
Sbjct: 14 LGEGTYATVFKGR---------SKLTENL-VALKEIRLEHEEGAPCTAIREVSLLKDLKH 63
Query: 242 KNLVRLLGYCIEGVHRMLVYEYVNNGNLEQWLHGAMRNQGNLTWEARMKVII-GTAKALA 300
N+V L LV+EY++ +L+Q+ M + GN+ +K+ + + LA
Sbjct: 64 ANIVTLHDIVHTDKSLTLVFEYLDK-DLKQY----MDDCGNIMSMHNVKIFLYQILRGLA 118
Query: 301 YLHEAIEPKVVHRDIKSSNILIDDEFNAKVSDFGLAKLLDSGESHITTRVMGTFGYVAPE 360
Y H KV+HRD+K N+LI++ K++DFGLA+ + V+ T Y P+
Sbjct: 119 YCHRR---KVLHRDLKPQNLLINERGELKLADFGLARAKSVPTKTYSNEVV-TLWYRPPD 174
Query: 361 -YANTGMLNEKSDIYSFGVLLLEAVTGR 387
+ + + D++ G + E +GR
Sbjct: 175 VLLGSSEYSTQIDMWGVGCIFFEMASGR 202
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309 |
| >gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Score = 66.6 bits (162), Expect = 5e-12
Identities = 46/148 (31%), Positives = 75/148 (50%), Gaps = 15/148 (10%)
Query: 248 LGYCIEGVHRM-LVYEYVNNGNLEQWLH--GAMRNQGNLTWEARMKVIIGTAKALAYLHE 304
L C + V R+ V EYVN G+L + G + + + A + V L +LH
Sbjct: 66 LHSCFQTVDRLYFVMEYVNGGDLMYHIQQVGKFKEPQAVFYAAEISV------GLFFLHR 119
Query: 305 AIEPKVVHRDIKSSNILIDDEFNAKVSDFGLAKLLDSGESHITTRVM-GTFGYVAPEYAN 363
+++RD+K N+++D E + K++DFG+ K + +TTR GT Y+APE
Sbjct: 120 R---GIIYRDLKLDNVMLDSEGHIKIADFGMCK--EHMVDGVTTRTFCGTPDYIAPEIIA 174
Query: 364 TGMLNEKSDIYSFGVLLLEAVTGRDPVD 391
+ D +++GVLL E + G+ P D
Sbjct: 175 YQPYGKSVDWWAYGVLLYEMLAGQPPFD 202
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323 |
| >gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Score = 65.0 bits (158), Expect = 1e-11
Identities = 63/204 (30%), Positives = 93/204 (45%), Gaps = 26/204 (12%)
Query: 194 LGEGGYGVVYKGR-LINGSE-VAVKKL---LNNLGQAEKEFRVEVEAIGHVR---HKNLV 245
+GEG YG V+K R L NG VA+K++ G R EV + H+ H N+V
Sbjct: 9 IGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIR-EVAVLRHLETFEHPNVV 67
Query: 246 RLLGYCIEGVHRM-------LVYEYVNNGNLEQWLHGAMRNQGNLTWEARMKVIIGTAKA 298
RL C V R LV+E+V+ +L +L + + E ++ +
Sbjct: 68 RLFDVCT--VSRTDRETKLTLVFEHVDQ-DLTTYLDKV--PEPGVPTETIKDMMFQLLRG 122
Query: 299 LAYLHEAIEPKVVHRDIKSSNILIDDEFNAKVSDFGLAKLLDSGESHITTRVMGTFGYVA 358
L +LH +VVHRD+K NIL+ K++DFGLA++ T V+ T Y A
Sbjct: 123 LDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGLARIYSF--QMALTSVVVTLWYRA 177
Query: 359 PEYANTGMLNEKSDIYSFGVLLLE 382
PE D++S G + E
Sbjct: 178 PEVLLQSSYATPVDLWSVGCIFAE 201
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290 |
| >gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Score = 65.1 bits (158), Expect = 2e-11
Identities = 57/204 (27%), Positives = 97/204 (47%), Gaps = 19/204 (9%)
Query: 194 LGEGGYGVVYKGRLINGSEV-AVKKLLNNLGQAEKEFR---VEVEAIGHVRHKNLVRLLG 249
+G G +G VY R + SEV A+KK+ + Q+ ++++ EV + +RH N ++ G
Sbjct: 23 IGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRG 82
Query: 250 YCIEGVHRMLVYEYVNNGNLEQWLHGAMRNQGNLTWEARMKVIIGTAKALAYLHEAIEPK 309
+ LV EY G+ L + + A V G + LAYLH
Sbjct: 83 CYLREHTAWLVMEYCL-GSASDLLEVHKKPLQEVEIAA---VTHGALQGLAYLHSH---N 135
Query: 310 VVHRDIKSSNILIDDEFNAKVSDFGLAKLLDSGESHITTRVMGTFGYVAPEY---ANTGM 366
++HRD+K+ NIL+ + K+ DFG A ++ + GT ++APE + G
Sbjct: 136 MIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANXFV-----GTPYWMAPEVILAMDEGQ 190
Query: 367 LNEKSDIYSFGVLLLEAVTGRDPV 390
+ K D++S G+ +E + P+
Sbjct: 191 YDGKVDVWSLGITCIELAERKPPL 214
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308 |
| >gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Score = 65.0 bits (158), Expect = 2e-11
Identities = 45/135 (33%), Positives = 70/135 (51%), Gaps = 10/135 (7%)
Query: 256 HRMLVYEYVNNGNLEQWLHGAMR-NQGNLTWEARMKVIIGTAKALAYLHEAIEPKVVHRD 314
+ V EY+N G+L + + + T+ A ++I G L +LH +V+RD
Sbjct: 70 NLFFVMEYLNGGDLMFHIQSCHKFDLPRATFYA-AEIICG----LQFLHSK---GIVYRD 121
Query: 315 IKSSNILIDDEFNAKVSDFGLAKLLDSGESHITTRVMGTFGYVAPEYANTGMLNEKSDIY 374
+K NIL+D + + K++DFG+ K G++ T GT Y+APE N D +
Sbjct: 122 LKLDNILLDTDGHIKIADFGMCKENMLGDAK-TCTFCGTPDYIAPEILLGQKYNTSVDWW 180
Query: 375 SFGVLLLEAVTGRDP 389
SFGVLL E + G+ P
Sbjct: 181 SFGVLLYEMLIGQSP 195
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316 |
| >gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 64.7 bits (157), Expect = 2e-11
Identities = 59/197 (29%), Positives = 96/197 (48%), Gaps = 13/197 (6%)
Query: 194 LGEGGYGVVYKGRL-INGSEVAVK--KLLNNLGQAEKEFRVEVEAIGHVRHKNLVRLLGY 250
LGEG Y VYKG+ +NG VA+K +L G R E + ++H N+V L
Sbjct: 13 LGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIR-EASLLKGLKHANIVLLHDI 71
Query: 251 CIEGVHRMLVYEYVNNGNLEQWLHGAMRNQGNLTWEARMKVIIGTAKALAYLHEAIEPKV 310
LV+EYV+ +L Q++ ++ G L E + + L+Y+H+ +
Sbjct: 72 IHTKETLTLVFEYVHT-DLCQYMD---KHPGGLHPENVKLFLFQLLRGLSYIHQRY---I 124
Query: 311 VHRDIKSSNILIDDEFNAKVSDFGLAKLLDSGESHITTRVMGTFGYVAPE-YANTGMLNE 369
+HRD+K N+LI D K++DFGLA+ S SH + + T Y P+ + +
Sbjct: 125 LHRDLKPQNLLISDTGELKLADFGLAR-AKSVPSHTYSNEVVTLWYRPPDVLLGSTEYST 183
Query: 370 KSDIYSFGVLLLEAVTG 386
D++ G + +E + G
Sbjct: 184 CLDMWGVGCIFVEMIQG 200
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303 |
| >gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Score = 64.5 bits (157), Expect = 2e-11
Identities = 53/203 (26%), Positives = 98/203 (48%), Gaps = 20/203 (9%)
Query: 191 ENVLGEGGYGVVYKG-RLINGSEVAVKKL-LNNLGQAEKEFRVEVEAIGHVRHKNLVRLL 248
+ +LG G G VYK L+ +AVK + L+ + +K+ E+E + ++
Sbjct: 6 QEILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFY 65
Query: 249 G-YCIEGVHRMLVYEYVNNGNLEQWLHGAMRNQGNLTWEARMKVIIGTAKALAYLHEAIE 307
G + +E + E+++ G+L+ + + ++ + K L YL
Sbjct: 66 GAFFVENRISICT-EFMDGGSLDVY--------RKIPEHVLGRIAVAVVKGLTYLWSL-- 114
Query: 308 PKVVHRDIKSSNILIDDEFNAKVSDFGLA-KLLDSGESHITTRVMGTFGYVAPEYANTGM 366
K++HRD+K SN+L++ K+ DFG++ +L++S I +GT Y+APE +
Sbjct: 115 -KILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNS----IAKTYVGTNAYMAPERISGEQ 169
Query: 367 LNEKSDIYSFGVLLLEAVTGRDP 389
SD++S G+ +E GR P
Sbjct: 170 YGIHSDVWSLGISFMELALGRFP 192
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279 |
| >gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Score = 64.7 bits (157), Expect = 2e-11
Identities = 62/229 (27%), Positives = 107/229 (46%), Gaps = 27/229 (11%)
Query: 177 TLRDLEIAT--------NRFSAENVLGEGGYGVVYKGRLINGSEV-AVKKLLNNLGQAEK 227
+L+D EIA F+ +G G +G VY R + +EV A+KK+ + Q+ +
Sbjct: 8 SLKDPEIAELFFKEDPEKLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNE 67
Query: 228 EFR---VEVEAIGHVRHKNLVRLLGYCIEGVHRMLVYEYVNNGNLEQWLHGAMRNQGNLT 284
+++ EV+ + ++H N + G + LV EY G+ L + +
Sbjct: 68 KWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAWLVMEYCL-GSASDLLEVHKKPLQEVE 126
Query: 285 WEARMKVIIGTAKALAYLHEAIEPKVVHRDIKSSNILIDDEFNAKVSDFGLAKLLDSGES 344
A + G + LAYLH ++HRDIK+ NIL+ + K++DFG A + S
Sbjct: 127 IAA---ITHGALQGLAYLHSH---NMIHRDIKAGNILLTEPGQVKLADFGSASIASPANS 180
Query: 345 HITTRVMGTFGYVAPEY---ANTGMLNEKSDIYSFGVLLLEAVTGRDPV 390
+ GT ++APE + G + K D++S G+ +E + P+
Sbjct: 181 FV-----GTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPL 224
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317 |
| >gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 64.4 bits (157), Expect = 2e-11
Identities = 60/203 (29%), Positives = 96/203 (47%), Gaps = 21/203 (10%)
Query: 194 LGEGGYGVVYKGR-LINGSEVAVKKL----LNNLGQAEKEFRVEVEAIGHVRHKNLVRLL 248
+G G +G V+ R I+ A+K + + L Q E+ E + V H ++RL
Sbjct: 9 VGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQ-EQHVHNEKRVLKEVSHPFIIRLF 67
Query: 249 GYCIEGVHRMLVYEYVNNGNLEQWLHGAMR--NQGNLTWEARMKVIIGTAKALAYLHEAI 306
+ ++ EYV G L +L + R N L + + + AL YLH
Sbjct: 68 WTEHDQRFLYMLMEYVPGGELFSYLRNSGRFSNSTGLFYASEI------VCALEYLHSK- 120
Query: 307 EPKVVHRDIKSSNILIDDEFNAKVSDFGLAKLLDSGESHITTRVMGTFGYVAPEYANTGM 366
++V+RD+K NIL+D E + K++DFG AK L T + GT Y+APE +
Sbjct: 121 --EIVYRDLKPENILLDKEGHIKLTDFGFAKKL----RDRTWTLCGTPEYLAPEVIQSKG 174
Query: 367 LNEKSDIYSFGVLLLEAVTGRDP 389
N+ D ++ G+L+ E + G P
Sbjct: 175 HNKAVDWWALGILIYEMLVGYPP 197
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291 |
| >gnl|CDD|133217 cd05086, PTKc_Aatyk2, Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 64.1 bits (156), Expect = 2e-11
Identities = 52/204 (25%), Positives = 92/204 (45%), Gaps = 21/204 (10%)
Query: 194 LGEGGYGVVYKGRLINGSEVA---VKKLLNNLGQAEK-EFRVEVEAIGHVRHKNLVRLLG 249
+G G +G V + + VA VK+L N E+ EF + + ++H N+++ LG
Sbjct: 3 IGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCLG 62
Query: 250 YCIEGVHRMLVYEYVNNGNLEQWL--HGAMRNQGNLTWEARMKVIIGTAKALAYLHEAIE 307
C+E + +LV+EY G+L+ +L R L RM I A + ++H+
Sbjct: 63 QCVEAIPYLLVFEYCELGDLKSYLSQEQWHRRNSQLLLLQRMACEI--AAGVTHMHKH-- 118
Query: 308 PKVVHRDIKSSNILIDDEFNAKVSDFGLAKLLDSGESHITT--RVMGTFGYVAPEYANT- 364
+H D+ N + + KV D+G+ E +I T ++APE
Sbjct: 119 -NFLHSDLALRNCFLTSDLTVKVGDYGIG-PSRYKEDYIETEDDKCVPLRWLAPELVGEF 176
Query: 365 --GML----NEKSDIYSFGVLLLE 382
G++ + S++++ GV L E
Sbjct: 177 HGGLITAEQTKPSNVWALGVTLWE 200
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage spermatogenesis. Although it is classified as a tyr kinase based on sequence similarity and the phylogenetic tree, Aatyk2 has been characterized as a serine/threonine kinase. Length = 268 |
| >gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Score = 64.3 bits (156), Expect = 2e-11
Identities = 59/213 (27%), Positives = 101/213 (47%), Gaps = 25/213 (11%)
Query: 188 FSAENVLGEGGYGVV------YKGRLINGSEVAVKKLLNNLGQA----EKEFRVEVEAIG 237
F VLG+GG+G V G++ ++ K++ G++ EK+ +V +
Sbjct: 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNS-- 59
Query: 238 HVRHKNLVRLLGYCIEGVHRM-LVYEYVNNGNLEQWLHGAMRNQGNLTWEARMKVIIGTA 296
V L Y E + LV +N G+L+ ++ + G +E + + A
Sbjct: 60 -----RFVVSLAYAYETKDALCLVLTLMNGGDLKFHIY----HMGEAGFEEG-RAVFYAA 109
Query: 297 KALAYLHEAIEPKVVHRDIKSSNILIDDEFNAKVSDFGLAKLLDSGESHITTRVMGTFGY 356
+ L + + ++V+RD+K NIL+DD + ++SD GLA + G++ I RV GT GY
Sbjct: 110 EICCGLEDLHQERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQT-IKGRV-GTVGY 167
Query: 357 VAPEYANTGMLNEKSDIYSFGVLLLEAVTGRDP 389
+APE D ++ G LL E + G+ P
Sbjct: 168 MAPEVVKNERYTFSPDWWALGCLLYEMIAGQSP 200
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285 |
| >gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Score = 64.4 bits (157), Expect = 2e-11
Identities = 45/148 (30%), Positives = 75/148 (50%), Gaps = 12/148 (8%)
Query: 194 LGEGGYGVVYKGRLINGSE-VAVKKLL---NNLGQAEKEFRVEVEAIGHVRHKNLVRLLG 249
+GEG YG V+K + E VA+K++ ++ G R E+ + ++HKN+VRL
Sbjct: 8 IGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALR-EICLLKELKHKNIVRLYD 66
Query: 250 YCIEGVHRMLVYEYVNNGNLEQWLHGAMRNQGNLTWEARMKVIIGTAKALAYLHEAIEPK 309
LV+EY + +L+++ G++ E + K LA+ H
Sbjct: 67 VLHSDKKLTLVFEYCDQ-DLKKYFDSC---NGDIDPEIVKSFMFQLLKGLAFCHSH---N 119
Query: 310 VVHRDIKSSNILIDDEFNAKVSDFGLAK 337
V+HRD+K N+LI+ K++DFGLA+
Sbjct: 120 VLHRDLKPQNLLINKNGELKLADFGLAR 147
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284 |
| >gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 64.8 bits (158), Expect = 2e-11
Identities = 60/229 (26%), Positives = 104/229 (45%), Gaps = 45/229 (19%)
Query: 192 NVLGEGGYGVVYKGR-LINGSEVAVKKLLNN------------LGQAEKEFRV--EVEAI 236
LGEG YG V K + G VA+KK+ +G F E++ +
Sbjct: 15 AHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIM 74
Query: 237 GHVRHKNLVRLLGYCIEGVHRMLVYEYVNNGNLEQWLHGAMRNQGNLTWEARMKVII-GT 295
++H+N++ L+ +EG LV + + +L++ + +R LT E+++K I+
Sbjct: 75 NEIKHENIMGLVDVYVEGDFINLVMDIMA-SDLKKVVDRKIR----LT-ESQVKCILLQI 128
Query: 296 AKALAYLHEAIEPKVVHRDIKSSNILIDDEFNAKVSDFGLAK------LLDSGESHI--- 346
L LH+ +HRD+ +NI I+ + K++DFGLA+ D+
Sbjct: 129 LNGLNVLHKW---YFMHRDLSPANIFINSKGICKIADFGLARRYGYPPYSDTLSKDETMQ 185
Query: 347 -----TTRVMGTFGYVAPEY---ANTGMLNEKSDIYSFGVLLLEAVTGR 387
T++V+ T Y APE A + D++S G + E +TG+
Sbjct: 186 RREEMTSKVV-TLWYRAPELLMGAEK--YHFAVDMWSVGCIFAELLTGK 231
|
Length = 335 |
| >gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 64.1 bits (156), Expect = 3e-11
Identities = 56/205 (27%), Positives = 104/205 (50%), Gaps = 16/205 (7%)
Query: 194 LGEGGYGVVYKGR-LINGSEVAVKKLLNNLGQAE-KEFRVEVEAIGHVRHKNLVRLLG-Y 250
LG+G YG VYK G +A+K++ L +++ + +E++ + +V G +
Sbjct: 9 LGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFYGAF 68
Query: 251 CIEGVHRMLVYEYVNNGNLEQWLHGAMRNQGNLTWEARMKVIIGTAKALAYLHEAIEPKV 310
IEG M + EY++ G+L++ L+ + + ++ K L +L E E +
Sbjct: 69 FIEGAVYMCM-EYMDAGSLDK-LYAGGVATEGIPEDVLRRITYAVVKGLKFLKE--EHNI 124
Query: 311 VHRDIKSSNILIDDEFNAKVSDFGLAKLLDSGESHITTRVMGTFGYVAPEYANTGMLNE- 369
+HRD+K +N+L++ K+ DFG++ L + + +G Y+APE +G N+
Sbjct: 125 IHRDVKPTNVLVNGNGQVKLCDFGVSGNL---VASLAKTNIGCQSYMAPERIKSGGPNQN 181
Query: 370 -----KSDIYSFGVLLLEAVTGRDP 389
+SD++S G+ +LE GR P
Sbjct: 182 PTYTVQSDVWSLGLSILEMALGRYP 206
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286 |
| >gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Score = 63.7 bits (155), Expect = 4e-11
Identities = 64/221 (28%), Positives = 96/221 (43%), Gaps = 26/221 (11%)
Query: 193 VLGEGGYGVVYKGRLINGSEVAVKKLL--------NNLGQAEKEFRVEVEAIGHVRHKNL 244
VLG+G +G V L EV K+L +++ E R+ A H
Sbjct: 2 VLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKH----PF 57
Query: 245 VRLLGYCIEGVHRML-VYEYVNNGNLEQWLHGAMRNQGNLTWEARMKVIIG-TAKALAYL 302
+ L C + R+ V EYVN G+L + + + E R + AL +L
Sbjct: 58 LTALHCCFQTKDRLFFVMEYVNGGDLMFQIQRSRKFD-----EPRSRFYAAEVTLALMFL 112
Query: 303 HEAIEPKVVHRDIKSSNILIDDEFNAKVSDFGLAKLLDSGESHITTRVMGTFGYVAPEYA 362
H V++RD+K NIL+D E + K++DFG+ K TT GT Y+APE
Sbjct: 113 HRH---GVIYRDLKLDNILLDAEGHCKLADFGMCK-EGILNGVTTTTFCGTPDYIAPEIL 168
Query: 363 NTGMLNEKSDIYSFGVLLLEAVTGRDPVDYGRPANEVNLVE 403
D ++ GVL+ E + G+ P + NE +L E
Sbjct: 169 QELEYGPSVDWWALGVLMYEMMAGQPPFE---ADNEDDLFE 206
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321 |
| >gnl|CDD|133209 cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 62.9 bits (153), Expect = 4e-11
Identities = 69/281 (24%), Positives = 124/281 (44%), Gaps = 41/281 (14%)
Query: 194 LGEGGYGVVYKG--------RLINGSEVAVKKLLNNLGQAEKEFRVEVEAIGHVRHKNLV 245
LG+G + ++KG ++ +EV +K L + + F + + HK+LV
Sbjct: 3 LGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLV 62
Query: 246 RLLGYCIEGVHRMLVYEYVNNGNLEQWLHGAMRNQGNLTWEARMKVIIGTAKALAY-LHE 304
G C+ G ++V EYV G+L+ +L +N N++W+ + AK LA+ LH
Sbjct: 63 LNYGVCVCGDESIMVQEYVKFGSLDTYLK-KNKNLINISWKLEV------AKQLAWALHF 115
Query: 305 AIEPKVVHRDIKSSNILIDDEFNAKVSDFGLAKLLDSGESHITTR----VMGTFGYVAPE 360
+ + H ++ + N+L+ E + K + KL D G S IT ++ +V PE
Sbjct: 116 LEDKGLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGIS-ITVLPKEILLERIPWVPPE 174
Query: 361 -YANTGMLNEKSDIYSFGVLLLEAVTGRD-PVDYGRPANEVNLVEWLKMMVGTRRAEEVV 418
N L+ +D +SFG L E +G D P+ ++ E +
Sbjct: 175 CIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDSQKKLQFYEDRHQL---------- 224
Query: 419 DPNLEVKPATRALKRSLLVALRCVDPDSEKRPKMSQVVRML 459
PA + + + L+ +C+D + + RP ++R L
Sbjct: 225 -------PAPKWTELANLIN-QCMDYEPDFRPSFRAIIRDL 257
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 258 |
| >gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Score = 63.5 bits (154), Expect = 5e-11
Identities = 64/214 (29%), Positives = 103/214 (48%), Gaps = 18/214 (8%)
Query: 193 VLGEGGYG-VVYKGRLINGSEVAVKKLLNNL---GQAEKEFRVEVEAI-GHVRHKNLVRL 247
V+G+G +G V+ R ++G AVK L + + +K E + +V+H LV L
Sbjct: 2 VIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGL 61
Query: 248 LGYCIEGVHRM-LVYEYVNNGNLEQWLHGAMRNQGNLTWEARMKVIIG-TAKALAYLHEA 305
Y + ++ V ++VN G L + H ++ + + E R + A AL YLH
Sbjct: 62 -HYSFQTTEKLYFVLDFVNGGEL--FFH--LQRERSFP-EPRARFYAAEIASALGYLHSI 115
Query: 306 IEPKVVHRDIKSSNILIDDEFNAKVSDFGLAKLLDSGESHITTRVMGTFGYVAPEYANTG 365
+V+RD+K NIL+D + + ++DFGL K + +S TT GT Y+APE
Sbjct: 116 ---NIVYRDLKPENILLDSQGHVVLTDFGLCKEGIA-QSDTTTTFCGTPEYLAPEVIRKQ 171
Query: 366 MLNEKSDIYSFGVLLLEAVTGRDPVDYGRPANEV 399
+ D + G +L E + G P Y R E+
Sbjct: 172 PYDNTVDWWCLGAVLYEMLYGLPPF-YCRDVAEM 204
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325 |
| >gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Score = 62.3 bits (151), Expect = 7e-11
Identities = 49/203 (24%), Positives = 96/203 (47%), Gaps = 18/203 (8%)
Query: 194 LGEGGYGVVYKGRL---INGSEVAVKKLLNNLG-QAEKEFRVEVEAIGHVRHKNLVRLLG 249
+G G +G V G + ++V VK+L + Q + +F E + ++H NL++ LG
Sbjct: 3 IGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLG 62
Query: 250 YCIEGVHRMLVYEYVNNGNLEQWLHGAMRNQGNLTWEARM--KVIIGTAKALAYLHEAIE 307
C E +LV E+ G+L+ +L + R +T + ++ A L +LH+
Sbjct: 63 QCTEVTPYLLVMEFCPLGDLKGYLR-SCRKAELMTPDPTTLQRMACEIALGLLHLHKN-- 119
Query: 308 PKVVHRDIKSSNILIDDEFNAKVSDFGLAKLLDSGESHITT-RVMGTFGYVAPEYANTGM 366
+H D+ N L+ + K+ D+GL+ + ++T ++ ++APE +
Sbjct: 120 -NFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYVTPDQLWVPLRWIAPELVDEVH 178
Query: 367 LN-------EKSDIYSFGVLLLE 382
N ++S+++S GV + E
Sbjct: 179 GNLLVVDQTKESNVWSLGVTIWE 201
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269 |
| >gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Score = 63.1 bits (153), Expect = 8e-11
Identities = 59/210 (28%), Positives = 98/210 (46%), Gaps = 23/210 (10%)
Query: 187 RFSAENVLGEGGYGVVYKG-RLINGSEVAVKKL---LNNLGQAEKEFRVEVEAIGHVRHK 242
R+ +G G G+V + G VAVKKL N A++ +R E+ + V HK
Sbjct: 22 RYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYR-ELVLLKCVNHK 80
Query: 243 NLVRLLGY-----CIEGVHRMLVYEYVNNGNLEQWLHGAMRNQGNLTWEARMKVII-GTA 296
N++ LL +E + + + + NL Q +H + ++ RM ++
Sbjct: 81 NIISLLNVFTPQKSLEEFQDVYLVMELMDANLCQVIHMELDHE-------RMSYLLYQML 133
Query: 297 KALAYLHEAIEPKVVHRDIKSSNILIDDEFNAKVSDFGLAKLLDSGESHITTRVMGTFGY 356
+ +LH A ++HRD+K SNI++ + K+ DFGLA+ + + + T + T Y
Sbjct: 134 CGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLAR--TACTNFMMTPYVVTRYY 188
Query: 357 VAPEYANTGMLNEKSDIYSFGVLLLEAVTG 386
APE E DI+S G ++ E V G
Sbjct: 189 RAPEVILGMGYKENVDIWSVGCIMGELVKG 218
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359 |
| >gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 62.4 bits (152), Expect = 8e-11
Identities = 66/220 (30%), Positives = 98/220 (44%), Gaps = 55/220 (25%)
Query: 193 VLGEGGYGVVYKGRLINGSEVAVKKLLNNLGQAEKEFRVEVE------AIGHV------R 240
LGEG Y VYKGR KL L A KE R+E E AI +
Sbjct: 12 KLGEGSYATVYKGR---------SKLTGQL-VALKEIRLEHEEGAPFTAIREASLLKDLK 61
Query: 241 HKNLVRLLGYCIEGVHR----MLVYEYVNNGNLEQWL--HGAMRNQGNLTWEARMKVIIG 294
H N+V L + +H LV+EY++ +L+Q++ G + N R+ +
Sbjct: 62 HANIVTLH----DIIHTKKTLTLVFEYLDT-DLKQYMDDCGGGLSMHN----VRL-FLFQ 111
Query: 295 TAKALAYLHEAIEPKVVHRDIKSSNILIDDEFNAKVSDFGLAKLLDSGESHITTRVMGTF 354
+ LAY H+ +V+HRD+K N+LI + K++DFGLA+ S S + + T
Sbjct: 112 LLRGLAYCHQR---RVLHRDLKPQNLLISERGELKLADFGLAR-AKSVPSKTYSNEVVTL 167
Query: 355 GYVAP-------EYANTGMLNEKSDIYSFGVLLLEAVTGR 387
Y P EY+ + D++ G + E TGR
Sbjct: 168 WYRPPDVLLGSTEYSTS------LDMWGVGCIFYEMATGR 201
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291 |
| >gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Score = 62.7 bits (152), Expect = 9e-11
Identities = 56/209 (26%), Positives = 98/209 (46%), Gaps = 23/209 (11%)
Query: 193 VLGEGGYGVVYKGRLINGSEV-AVKKLLNNLGQAEKEFR---VEVEAIGHVRHKNLVRLL 248
VLG+G +G V E+ A+K L ++ + + VE + + L
Sbjct: 7 VLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQL 66
Query: 249 GYCIEGVHRM-LVYEYVNNGNLEQWLH--GAMRNQGNLTWEARMKVIIGTAKALAYLHEA 305
C + + R+ V EYVN G+L + G + + + A + + L +LH
Sbjct: 67 HSCFQTMDRLYFVMEYVNGGDLMYQIQQVGRFKEPHAVFYAAEIAI------GLFFLHSK 120
Query: 306 IEPKVVHRDIKSSNILIDDEFNAKVSDFGLAK--LLDSGESHITTRVM-GTFGYVAPEYA 362
+++RD+K N+++D E + K++DFG+ K + D +TT+ GT Y+APE
Sbjct: 121 ---GIIYRDLKLDNVMLDSEGHIKIADFGMCKENMWDG----VTTKTFCGTPDYIAPEII 173
Query: 363 NTGMLNEKSDIYSFGVLLLEAVTGRDPVD 391
+ D ++FGVLL E + G+ P +
Sbjct: 174 AYQPYGKSVDWWAFGVLLYEMLAGQAPFE 202
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323 |
| >gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 62.9 bits (153), Expect = 9e-11
Identities = 85/350 (24%), Positives = 130/350 (37%), Gaps = 94/350 (26%)
Query: 182 EIATNRFSAENVLGEGGYGVVYKGRL--INGSE----VAVKKLLNNLGQAE-KEFRVEVE 234
E +R LG G +G V + I S VAVK L +E K E++
Sbjct: 3 EFPRDRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGATASEYKALMTELK 62
Query: 235 AIGHV-RHKNLVRLLGYCIE-GVHRMLVYEYVNNGNLEQWL----HGAMRNQGNLTWEAR 288
+ H+ H N+V LLG C + G M++ EY GNL +L + T +
Sbjct: 63 ILIHIGHHLNVVNLLGACTKPGGPLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKRE 122
Query: 289 MKVIIGTAKALAYL-------------------HEAIEP--------------------- 308
MK G + L + E E
Sbjct: 123 MKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEEGDELYKEPLTLEDLISYSFQV 182
Query: 309 ----------KVVHRDIKSSNILIDDEFNAKVSDFGLAK-------LLDSGESHITTRVM 351
K +HRD+ + NIL+ + K+ DFGLA+ + G++ + + M
Sbjct: 183 ARGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLKWM 242
Query: 352 GTFGYVAPEYANTGMLNEKSDIYSFGVLLLEAVT-GRDPVDYGRPANEVNLVEWLKMMVG 410
APE + +SD++SFGVLL E + G P P +++ ++ G
Sbjct: 243 ------APESIFDKVYTTQSDVWSFGVLLWEIFSLGASPY----PGVQIDEEFCRRLKEG 292
Query: 411 TR-RAEEVVDPNLEVKPATRALKRSLLVALRCVDPDSEKRPKMSQVVRML 459
TR RA E P + + L C + E RP S++V +L
Sbjct: 293 TRMRAPEYATPEI------------YSIMLDCWHNNPEDRPTFSELVEIL 330
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337 |
| >gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 63.0 bits (153), Expect = 9e-11
Identities = 58/212 (27%), Positives = 101/212 (47%), Gaps = 26/212 (12%)
Query: 187 RFSAENVLGEGGYGVVYKG-RLINGSEVAVKKLLNNLGQ---AEKEFRVEVEAIGHVRHK 242
R+++ +G G YG V G +VA+KKL A++ +R E+ + H++H+
Sbjct: 16 RYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYR-ELTLLKHMQHE 74
Query: 243 NLVRLLGYCIEGV--HRM----LVYEYVNNGNLEQWLHGAMRNQGNLTWEARMKVIIGTA 296
N++ LL V LV Y+ L M + L+ + ++
Sbjct: 75 NVIGLLDVFTSAVSGDEFQDFYLVMPYMQTD-----LQKIMGHP--LSEDKVQYLVYQML 127
Query: 297 KALAYLHEAIEPKVVHRDIKSSNILIDDEFNAKVSDFGLAKLLDSGESHITTRVMGTFGY 356
L Y+H A ++HRD+K N+ ++++ K+ DFGLA+ ++ +T V+ T Y
Sbjct: 128 CGLKYIHSA---GIIHRDLKPGNLAVNEDCELKILDFGLAR---HADAEMTGYVV-TRWY 180
Query: 357 VAPEYANTGM-LNEKSDIYSFGVLLLEAVTGR 387
APE M N+ DI+S G ++ E +TG+
Sbjct: 181 RAPEVILNWMHYNQTVDIWSVGCIMAEMLTGK 212
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342 |
| >gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Score = 62.4 bits (152), Expect = 1e-10
Identities = 55/185 (29%), Positives = 92/185 (49%), Gaps = 29/185 (15%)
Query: 194 LGEGGYGVVYKGR-LINGSEVAVKKLLNNLGQAEKEFRV----EVEAIGHVRHKNLVRLL 248
+G+G +G V+K R VA+KK+L + ++ F + E++ + ++H+N+V L+
Sbjct: 20 IGQGTFGEVFKARHKKTKQIVALKKVL--MENEKEGFPITALREIKILQLLKHENVVNLI 77
Query: 249 GYC---IEGVHR-----MLVYEYVNNGNLEQWLHGAMRNQG-NLTWEARMKVIIGTAKAL 299
C +R LV+E+ E L G + N+ T KV+ L
Sbjct: 78 EICRTKATPYNRYKGSFYLVFEFC-----EHDLAGLLSNKNVKFTLSEIKKVMKMLLNGL 132
Query: 300 AYLHEAIEPKVVHRDIKSSNILIDDEFNAKVSDFGLAKLL----DSGESHITTRVMGTFG 355
Y+H K++HRD+K++NILI + K++DFGLA+ +S + T RV+ T
Sbjct: 133 YYIHRN---KILHRDMKAANILITKDGILKLADFGLARAFSLSKNSKPNRYTNRVV-TLW 188
Query: 356 YVAPE 360
Y PE
Sbjct: 189 YRPPE 193
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310 |
| >gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 62.8 bits (152), Expect = 1e-10
Identities = 64/212 (30%), Positives = 99/212 (46%), Gaps = 25/212 (11%)
Query: 187 RFSAENVLGEGGYGVV---YKGRLINGSEVAVKKL---LNNLGQAEKEFRVEVEAIGHVR 240
R+ +G G YG V Y RL +VAVKKL +L A + +R E+ + H++
Sbjct: 16 RYQNLTPVGSGAYGSVCSAYDTRL--RQKVAVKKLSRPFQSLIHARRTYR-ELRLLKHMK 72
Query: 241 HKNLVRLLGYCIEGVHRMLVYEYVNNGNLEQWLHGAMRNQ----GNLTWEARMKVIIGTA 296
H+N++ LL E N L L GA N L+ E +I
Sbjct: 73 HENVIGLLDVFTPATS----IENFNEVYLVTNLMGADLNNIVKCQKLSDEHVQFLIYQLL 128
Query: 297 KALAYLHEAIEPKVVHRDIKSSNILIDDEFNAKVSDFGLAKLLDSGESHITTRVMGTFGY 356
+ L Y+H A ++HRD+K SN+ ++++ ++ DFGLA+ D T + T Y
Sbjct: 129 RGLKYIHSA---GIIHRDLKPSNVAVNEDCELRILDFGLARQADDE----MTGYVATRWY 181
Query: 357 VAPEYANTGM-LNEKSDIYSFGVLLLEAVTGR 387
APE M N+ DI+S G ++ E + G+
Sbjct: 182 RAPEIMLNWMHYNQTVDIWSVGCIMAELLKGK 213
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343 |
| >gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Score = 62.7 bits (152), Expect = 2e-10
Identities = 61/210 (29%), Positives = 102/210 (48%), Gaps = 29/210 (13%)
Query: 192 NVLGEGGYGVVYKGRLINGSE-VAVKKLLNNLGQAEKEFRVEVEAIGHVRHKNLVRLLGY 250
N++G G +GVVY+ I+ SE VA+KK+L + +E + + ++ H N++ L Y
Sbjct: 72 NIIGNGSFGVVYEAICIDTSEKVAIKKVLQDPQYKNRELLI----MKNLNHINIIFLKDY 127
Query: 251 ----CI----EGVHRMLVYEYVNNGNLEQWLHGAMRNQGNLTWEARMKVIIGTAKALAYL 302
C + + +V E++ + +++ RN L +ALAY+
Sbjct: 128 YYTECFKKNEKNIFLNVVMEFIPQ-TVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYI 186
Query: 303 HEAIEPKVVHRDIKSSNILIDDEFNA-KVSDFGLAKLLDSGE---SHITTRVMGTFGYVA 358
H + HRD+K N+LID + K+ DFG AK L +G+ S+I +R Y A
Sbjct: 187 HSKF---ICHRDLKPQNLLIDPNTHTLKLCDFGSAKNLLAGQRSVSYICSRF-----YRA 238
Query: 359 PEYANTGMLNEKS--DIYSFGVLLLEAVTG 386
PE G N + D++S G ++ E + G
Sbjct: 239 PELM-LGATNYTTHIDLWSLGCIIAEMILG 267
|
Length = 440 |
| >gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Score = 61.8 bits (150), Expect = 2e-10
Identities = 58/212 (27%), Positives = 90/212 (42%), Gaps = 34/212 (16%)
Query: 193 VLGEGGYGVVYKGRLINGSEVAVKKLLNNLGQAEKEFRVEVEAIGHV----------RHK 242
+LG+G +G V R + K+L +KE + + + H RH
Sbjct: 2 LLGKGTFGKVILVREKATGKYYAMKIL------KKEVIIAKDEVAHTLTESRVLQNTRHP 55
Query: 243 NLVRLLGYCIEGVHRM-LVYEYVNNGNLEQWLHGAMRNQGNLTWEARMKV----IIGTAK 297
L L Y + R+ V EY N G L + H + + + E R + I+
Sbjct: 56 FLTAL-KYSFQTHDRLCFVMEYANGGEL--FFH--LSRERVFS-EDRARFYGAEIV---S 106
Query: 298 ALAYLHEAIEPKVVHRDIKSSNILIDDEFNAKVSDFGLAKLLDSGESHITTRVMGTFGYV 357
AL YLH VV+RD+K N+++D + + K++DFGL K + GT Y+
Sbjct: 107 ALGYLHSC---DVVYRDLKLENLMLDKDGHIKITDFGLCK-EGISDGATMKTFCGTPEYL 162
Query: 358 APEYANTGMLNEKSDIYSFGVLLLEAVTGRDP 389
APE D + GV++ E + GR P
Sbjct: 163 APEVLEDNDYGRAVDWWGLGVVMYEMMCGRLP 194
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323 |
| >gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 61.5 bits (149), Expect = 2e-10
Identities = 58/207 (28%), Positives = 100/207 (48%), Gaps = 29/207 (14%)
Query: 194 LGEGGYGVV---YKGRLINGSEVAVKKLLNNLGQ---AEKEFRVEVEAIGHVRHKNLVRL 247
+G G YG V R G++VA+KKL A++ +R E+ + H++H+N++ L
Sbjct: 23 VGSGAYGTVCSALDRR--TGAKVAIKKLYRPFQSELFAKRAYR-ELRLLKHMKHENVIGL 79
Query: 248 LGY-----CIEGVHRM-LVYEYVNNGNLEQWLHGAMRNQGNLTWEARMKVIIGTAKALAY 301
L ++ H LV ++ G + L+ + ++ K L Y
Sbjct: 80 LDVFTPDLSLDRFHDFYLVMPFMGTD------LGKLMKHEKLSEDRIQFLVYQMLKGLKY 133
Query: 302 LHEAIEPKVVHRDIKSSNILIDDEFNAKVSDFGLAKLLDSGESHITTRVMGTFGYVAPEY 361
+H A ++HRD+K N+ ++++ K+ DFGLA+ D S +T V+ T Y APE
Sbjct: 134 IHAA---GIIHRDLKPGNLAVNEDCELKILDFGLARQTD---SEMTGYVV-TRWYRAPEV 186
Query: 362 ANTGM-LNEKSDIYSFGVLLLEAVTGR 387
M + DI+S G ++ E +TG+
Sbjct: 187 ILNWMHYTQTVDIWSVGCIMAEMLTGK 213
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343 |
| >gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Score = 61.3 bits (149), Expect = 3e-10
Identities = 46/149 (30%), Positives = 74/149 (49%), Gaps = 23/149 (15%)
Query: 251 CIEGVHRM-LVYEYVNNGNLEQWLH--GAMRNQGNLTWEARMKVIIGTAKALAYLHEAIE 307
C + + R+ V EYVN G+L + G + + + A + A L +LH
Sbjct: 69 CFQTMDRLYFVMEYVNGGDLMYHIQQVGKFKEPHAVFYAAEI------AIGLFFLHSK-- 120
Query: 308 PKVVHRDIKSSNILIDDEFNAKVSDFGLAKLLDSGESHI----TTRVM-GTFGYVAPEYA 362
+++RD+K N+++D E + K++DFG+ K +I TTR GT Y+APE
Sbjct: 121 -GIIYRDLKLDNVMLDAEGHIKIADFGMCK------ENIFGGKTTRTFCGTPDYIAPEII 173
Query: 363 NTGMLNEKSDIYSFGVLLLEAVTGRDPVD 391
+ D ++FGVLL E + G+ P D
Sbjct: 174 AYQPYGKSVDWWAFGVLLYEMLAGQPPFD 202
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324 |
| >gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Score = 61.0 bits (148), Expect = 3e-10
Identities = 57/208 (27%), Positives = 93/208 (44%), Gaps = 23/208 (11%)
Query: 194 LGEGGYGVVYKGR-LINGSEVAVKKLLNNL---GQAEKEFRVEVEAIGHVRHKN-LVRLL 248
+GEG YG VYK R G VA+KK + G R E+ + + +VRLL
Sbjct: 9 IGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALR-EISLLQMLSESIYIVRLL 67
Query: 249 GYCIEGVHR-------MLVYEYVNNGNLEQWLHGAMRNQGN-LTWEARMKVIIGTAKALA 300
+E V LV+EY+++ +L++++ R G L + + K +A
Sbjct: 68 --DVEHVEEKNGKPSLYLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVA 124
Query: 301 YLHEAIEPKVVHRDIKSSNILIDDEFNA-KVSDFGLAKLLDSGESHITTRVMGTFGYVAP 359
+ H+ V+HRD+K N+L+D + K++D GL + T ++ T Y AP
Sbjct: 125 HCHKH---GVMHRDLKPQNLLVDKQKGLLKIADLGLGRAFSIPVKSYTHEIV-TLWYRAP 180
Query: 360 E-YANTGMLNEKSDIYSFGVLLLEAVTG 386
E + + DI+S G + E
Sbjct: 181 EVLLGSTHYSTPVDIWSVGCIFAEMSRK 208
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295 |
| >gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Score = 61.3 bits (148), Expect = 3e-10
Identities = 64/222 (28%), Positives = 100/222 (45%), Gaps = 31/222 (13%)
Query: 187 RFSAENVLGEGGYGVV---YKGRLINGSEVAVKKL---LNNLGQAEKEFRVEVEAIGHVR 240
R+ +G G G+V Y L VA+KKL N A++ +R E+ + V
Sbjct: 18 RYQNLKPIGSGAQGIVCAAYDAVL--DRNVAIKKLSRPFQNQTHAKRAYR-ELVLMKCVN 74
Query: 241 HKNLVRLLGY-----CIEGVHRMLVYEYVNNGNLEQWLHGAMRNQGNLTWEARMKVIIGT 295
HKN++ LL +E + + + + NL Q + Q L E ++
Sbjct: 75 HKNIISLLNVFTPQKSLEEFQDVYLVMELMDANLCQVI------QMELDHERMSYLLYQM 128
Query: 296 AKALAYLHEAIEPKVVHRDIKSSNILIDDEFNAKVSDFGLAKLLDSGESHITTRVMGTFG 355
+ +LH A ++HRD+K SNI++ + K+ DFGLA+ +G S + T + T
Sbjct: 129 LCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLAR--TAGTSFMMTPYVVTRY 183
Query: 356 YVAPEYANTGMLNEKSDIYSFGVLLLEAV------TGRDPVD 391
Y APE E DI+S G ++ E V GRD +D
Sbjct: 184 YRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYID 225
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355 |
| >gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Score = 60.4 bits (146), Expect = 4e-10
Identities = 54/207 (26%), Positives = 96/207 (46%), Gaps = 22/207 (10%)
Query: 193 VLGEGGYGVVYKGRLINGSEVAVKKLLNN----LGQAEKEFRVEVEAIGHVRHKN--LVR 246
++G GG+G VY R + ++ K L+ + Q E E + V + +
Sbjct: 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIV 60
Query: 247 LLGYCIEGVHRM-LVYEYVNNGNLEQWL--HGAMRNQGNLTWEARMKVIIGTAKALAYLH 303
+ Y ++ + + +N G+L L HG + + ++I+G L ++H
Sbjct: 61 CMTYAFHTPDKLCFILDLMNGGDLHYHLSQHGVFSEKEMRFYAT--EIILG----LEHMH 114
Query: 304 EAIEPKVVHRDIKSSNILIDDEFNAKVSDFGLAKLLDSGESHITTRVMGTFGYVAPEYAN 363
VV+RD+K +NIL+D+ + ++SD GLA + H + +GT GY+APE
Sbjct: 115 NRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHAS---VGTHGYMAPEVLQ 168
Query: 364 TGMLNEKS-DIYSFGVLLLEAVTGRDP 389
G + S D +S G +L + + G P
Sbjct: 169 KGTAYDSSADWFSLGCMLFKLLRGHSP 195
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279 |
| >gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Score = 60.8 bits (147), Expect = 4e-10
Identities = 63/205 (30%), Positives = 97/205 (47%), Gaps = 19/205 (9%)
Query: 193 VLGEGGYG-VVYKGRLINGSEVAVKKLLNNLGQAEKEFRVEVEA-----IGHVRHKNLVR 246
V+G+G +G V+ R +GS AVK L +KE + + A + +++H LV
Sbjct: 2 VIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKE-QNHIMAERNVLLKNLKHPFLVG 60
Query: 247 LLGYCIEGVHRM-LVYEYVNNGNLEQWLHGAMRNQGNLTWEARMKVIIGTAKALAYLHEA 305
L Y + ++ V +YVN G L + H R + L AR A A+ YLH
Sbjct: 61 L-HYSFQTAEKLYFVLDYVNGGEL--FFH-LQRERCFLEPRARFYAA-EVASAIGYLHSL 115
Query: 306 IEPKVVHRDIKSSNILIDDEFNAKVSDFGLAKLLDSGESHITTRVM-GTFGYVAPEYANT 364
+++RD+K NIL+D + + ++DFGL K + E TT GT Y+APE
Sbjct: 116 ---NIIYRDLKPENILLDSQGHVVLTDFGLCK--EGVEPEETTSTFCGTPEYLAPEVLRK 170
Query: 365 GMLNEKSDIYSFGVLLLEAVTGRDP 389
+ D + G +L E + G P
Sbjct: 171 EPYDRTVDWWCLGAVLYEMLYGLPP 195
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321 |
| >gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Score = 59.9 bits (145), Expect = 5e-10
Identities = 55/207 (26%), Positives = 97/207 (46%), Gaps = 22/207 (10%)
Query: 193 VLGEGGYGVVYKGRLINGSEVAVKKLLNN----LGQAEKEFRVEVEAIGHVRHKN--LVR 246
++G GG+G VY R + ++ K L+ + Q E E + V + +
Sbjct: 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIV 60
Query: 247 LLGYCIEGVHRM-LVYEYVNNGNLEQWL--HGAMRNQGNLTWEARMKVIIGTAKALAYLH 303
+ Y ++ + + +N G+L L HG + A ++I+G L ++H
Sbjct: 61 CMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEAEMRFYAA--EIILG----LEHMH 114
Query: 304 EAIEPKVVHRDIKSSNILIDDEFNAKVSDFGLAKLLDSGESHITTRVMGTFGYVAPEYAN 363
VV+RD+K +NIL+D+ + ++SD GLA + H + +GT GY+APE
Sbjct: 115 NRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHAS---VGTHGYMAPEVLQ 168
Query: 364 TGMLNEKS-DIYSFGVLLLEAVTGRDP 389
G+ + S D +S G +L + + G P
Sbjct: 169 KGVAYDSSADWFSLGCMLFKLLRGHSP 195
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278 |
| >gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Score = 60.3 bits (147), Expect = 5e-10
Identities = 67/238 (28%), Positives = 117/238 (49%), Gaps = 41/238 (17%)
Query: 192 NVLGEGGYGVVYKGRLINGSE-VAVKKLLNNLGQAEKE---FRV----EVEAIGHVRHKN 243
N + EG YGVVY+ R E VA+KKL + EKE F + E+ + ++H N
Sbjct: 11 NRIEEGTYGVVYRARDKKTGEIVALKKL-----KMEKEKEGFPITSLREINILLKLQHPN 65
Query: 244 LVRL----LGYCIEGVHRMLVYEYVNNGNLEQWLHGAM-RNQGNLTWEARMKVIIGTAKA 298
+V + +G ++ ++ +V EYV E L M + +++
Sbjct: 66 IVTVKEVVVGSNLDKIY--MVMEYV-----EHDLKSLMETMKQPFLQSEVKCLMLQLLSG 118
Query: 299 LAYLHEAIEPKVVHRDIKSSNILIDDEFNAKVSDFGLAKLLDSGESHITTRVMGTFGYVA 358
+A+LH+ ++HRD+K+SN+L+++ K+ DFGLA+ S T V+ T Y A
Sbjct: 119 VAHLHDN---WILHRDLKTSNLLLNNRGILKICDFGLAREYGSPLKPYTQLVV-TLWYRA 174
Query: 359 PEYANTGMLNEKS-----DIYSFGVLLLEAVTGRDPVDYGRPANEVNLVEWLKMMVGT 411
PE +L K D++S G + E +T + P+ G+ +E++ + + ++GT
Sbjct: 175 PEL----LLGAKEYSTAIDMWSVGCIFAELLT-KKPLFPGK--SEIDQLNKIFKLLGT 225
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293 |
| >gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Score = 60.4 bits (146), Expect = 6e-10
Identities = 72/264 (27%), Positives = 114/264 (43%), Gaps = 34/264 (12%)
Query: 193 VLGEGGYGVVYKGRLINGSEVAVKKLLNNLG----QAEKEFRVEVEAI-GHVRHKNLVRL 247
V+G+G +G V R + K+L + EK E + +V+H LV L
Sbjct: 2 VIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGL 61
Query: 248 LGYCIEGVHRM-LVYEYVNNGNLEQWLHGAMRNQGNLTWEARMKVIIGTAKALAYLHEAI 306
+ + ++ V +Y+N G L + R + L AR A AL YLH
Sbjct: 62 -HFSFQTADKLYFVLDYINGGEL---FYHLQRERCFLEPRARFYAA-EIASALGYLHSL- 115
Query: 307 EPKVVHRDIKSSNILIDDEFNAKVSDFGLAKLLDSGESHITTRVM-GTFGYVAPEYANTG 365
+V+RD+K NIL+D + + ++DFGL K ++ E + TT GT Y+APE +
Sbjct: 116 --NIVYRDLKPENILLDSQGHIVLTDFGLCK--ENIEHNGTTSTFCGTPEYLAPEVLHKQ 171
Query: 366 MLNEKSDIYSFGVLLLEAVTGRDPVDYGRPANEVNLVEWLKMMVGTRRAEEVVDPNLEVK 425
+ D + G +L E + G P Y R E+ + +++ L++K
Sbjct: 172 PYDRTVDWWCLGAVLYEMLYGLPPF-YSRNTAEM--------------YDNILNKPLQLK 216
Query: 426 PATRALKRSLLVALRCVDPDSEKR 449
P R LL L + D KR
Sbjct: 217 PNITNSARHLLEGL--LQKDRTKR 238
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325 |
| >gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 60.2 bits (146), Expect = 7e-10
Identities = 60/206 (29%), Positives = 105/206 (50%), Gaps = 18/206 (8%)
Query: 193 VLGEGGYGVVYKGRLINGSE----VAVKKLLN-NLGQAEKEF---RVEVEAIGHVRHKNL 244
VLG+GGYG V++ R + G++ A+K L + + +K+ + E + V+H +
Sbjct: 3 VLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFI 62
Query: 245 VRLLGYCIEGVHRMLVYEYVNNGNLEQWLHGAMRNQGNLTWEARMKVIIGTAKALAYLHE 304
V L+ G L+ EY++ G L ++H + +G + + + AL +LH+
Sbjct: 63 VDLIYAFQTGGKLYLILEYLSGGEL--FMH--LEREGIFMEDTACFYLSEISLALEHLHQ 118
Query: 305 AIEPKVVHRDIKSSNILIDDEFNAKVSDFGLAKLLDS-GESHITTRVMGTFGYVAPEYAN 363
+++RD+K NIL+D + + K++DFGL K +S E +T GT Y+APE
Sbjct: 119 Q---GIIYRDLKPENILLDAQGHVKLTDFGLCK--ESIHEGTVTHTFCGTIEYMAPEILM 173
Query: 364 TGMLNEKSDIYSFGVLLLEAVTGRDP 389
+ D +S G L+ + +TG P
Sbjct: 174 RSGHGKAVDWWSLGALMYDMLTGAPP 199
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323 |
| >gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Score = 60.1 bits (146), Expect = 8e-10
Identities = 63/214 (29%), Positives = 101/214 (47%), Gaps = 27/214 (12%)
Query: 186 NRFSAENVLGEGGYGVVYKG-RLINGSEVAVKKL---LNNLGQAEKEFRVEVEAIGHVRH 241
R+ +G G G+V + G VA+KKL N+ A++ +R E+ + V H
Sbjct: 16 KRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYR-ELVLMKLVNH 74
Query: 242 KNLVRLLGYCI------EGVHRMLVYEYVNNGNLEQWLHGAMRNQGNLTWEARMKVII-G 294
KN++ LL E LV E ++ NL Q + + ++ RM ++
Sbjct: 75 KNIIGLLNVFTPQKSLEEFQDVYLVMELMD-ANLCQVIQMDLDHE-------RMSYLLYQ 126
Query: 295 TAKALAYLHEAIEPKVVHRDIKSSNILIDDEFNAKVSDFGLAKLLDSGESHITTRVMGTF 354
+ +LH A ++HRD+K SNI++ + K+ DFGLA+ +G S + T + T
Sbjct: 127 MLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLART--AGTSFMMTPYVVTR 181
Query: 355 GYVAPEYANTGM-LNEKSDIYSFGVLLLEAVTGR 387
Y APE GM E DI+S G ++ E + G
Sbjct: 182 YYRAPEVI-LGMGYKENVDIWSVGCIMGEMIRGT 214
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353 |
| >gnl|CDD|165291 PHA02988, PHA02988, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 59.4 bits (144), Expect = 8e-10
Identities = 58/269 (21%), Positives = 114/269 (42%), Gaps = 37/269 (13%)
Query: 202 VYKGRLINGSEVAV---KKLLNNLGQAEKEFRVEVEAIGHVRHKNLVRLLGYCIEGVHRM 258
+YKG N EV + KK E++ + + N++++ G+ I+ V +
Sbjct: 36 IYKGIF-NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDL 94
Query: 259 ----LVYEYVNNGNLEQWLHGAMRNQGNLTWEARMKVIIGTAKALAYLHEAIEPKVVHRD 314
L+ EY G L + L + +L+++ ++ + I K L L++ +++
Sbjct: 95 PRLSLILEYCTRGYLREVL----DKEKDLSFKTKLDMAIDCCKGLYNLYKYT--NKPYKN 148
Query: 315 IKSSNILIDDEFNAKVSDFGLAKLLDSGESHITTRVMGTFGYVAPEYANT--GMLNEKSD 372
+ S + L+ + + K+ GL K+L S + + Y + + N K D
Sbjct: 149 LTSVSFLVTENYKLKIICHGLEKILSSPPF----KNVNFMVYFSYKMLNDIFSEYTIKDD 204
Query: 373 IYSFGVLLLEAVTGRDPVDYGRPANEVNLVEWLKMMVGTRRAEEV-VDPNLEVKPATRAL 431
IYS GV+L E TG+ P + + E +++ + ++ +D LE+K
Sbjct: 205 IYSLGVVLWEIFTGKIPFE------NLTTKEIYDLIINKNNSLKLPLDCPLEIKC----- 253
Query: 432 KRSLLVALRCVDPDSEKRPKMSQVVRMLE 460
+ C DS KRP + +++ L
Sbjct: 254 -----IVEACTSHDSIKRPNIKEILYNLS 277
|
Length = 283 |
| >gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Score = 59.6 bits (144), Expect = 9e-10
Identities = 55/200 (27%), Positives = 84/200 (42%), Gaps = 19/200 (9%)
Query: 194 LGEGGYGVVYKGR-LINGSEVAVKKLLNNLGQAEKEFRVEVEA-----IGHVRHKNLVRL 247
+G G YG VYK R +G VA+K + + E + H N+VRL
Sbjct: 8 IGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRL 67
Query: 248 LGYCI-----EGVHRMLVYEYVNNGNLEQWLHGAMRNQGNLTWEARMKVIIGTAKALAYL 302
+ C LV+E+V+ +L +L L E ++ + L +L
Sbjct: 68 MDVCATSRTDRETKVTLVFEHVDQ-DLRTYLDKV--PPPGLPAETIKDLMRQFLRGLDFL 124
Query: 303 HEAIEPKVVHRDIKSSNILIDDEFNAKVSDFGLAKLLDSGESHITTRVMGTFGYVAPEYA 362
H +VHRD+K NIL+ K++DFGLA++ + T V+ T Y APE
Sbjct: 125 HAN---CIVHRDLKPENILVTSGGQVKLADFGLARIYSCQMA--LTPVVVTLWYRAPEVL 179
Query: 363 NTGMLNEKSDIYSFGVLLLE 382
D++S G + E
Sbjct: 180 LQSTYATPVDMWSVGCIFAE 199
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288 |
| >gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 59.6 bits (144), Expect = 1e-09
Identities = 57/217 (26%), Positives = 97/217 (44%), Gaps = 24/217 (11%)
Query: 188 FSAENVLGEGGYGVVYKGRLINGS--EVAVKKL----LNNLGQAEKEFRVEVEAIGHVRH 241
F+ LG G +G V N VA+K+ + Q + F E + + ++ H
Sbjct: 32 FNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFS-ERKILNYINH 90
Query: 242 KNLVRLLGYCIEGVHRMLVYEYVNNGNLEQWLHGAMR--NQGNLTWEARMKVIIGTAKAL 299
V L G + + LV E+V G +L R N + A++ +I ++L
Sbjct: 91 PFCVNLYGSFKDESYLYLVLEFVIGGEFFTFLRRNKRFPNDVGCFYAAQIVLIFEYLQSL 150
Query: 300 AYLHEAIEPKVVHRDIKSSNILIDDEFNAKVSDFGLAKLLDSGESHITTRVMGTFGYVAP 359
+V+RD+K N+L+D + K++DFG AK++D+ T + GT Y+AP
Sbjct: 151 ---------NIVYRDLKPENLLLDKDGFIKMTDFGFAKVVDTR----TYTLCGTPEYIAP 197
Query: 360 E-YANTGMLNEKSDIYSFGVLLLEAVTGRDPVDYGRP 395
E N G + +D ++ G+ + E + G P P
Sbjct: 198 EILLNVGH-GKAADWWTLGIFIYEILVGCPPFYANEP 233
|
Length = 340 |
| >gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 59.4 bits (144), Expect = 1e-09
Identities = 39/131 (29%), Positives = 65/131 (49%), Gaps = 11/131 (8%)
Query: 259 LVYEYVNNGNLEQWLHGAMRNQGNLTWEARMKVIIGTAKALAYLHEAIEPKVVHRDIKSS 318
+ E+V G L L A R ++ ++++ A YLH +++RD+K
Sbjct: 95 FLLEFVVGGELFTHLRKAGRFPNDVAKFYHAELVL----AFEYLHSK---DIIYRDLKPE 147
Query: 319 NILIDDEFNAKVSDFGLAKLLDSGESHITTRVMGTFGYVAPEYANTGMLNEKSDIYSFGV 378
N+L+D++ + KV+DFG AK + T + GT Y+APE + + D ++ GV
Sbjct: 148 NLLLDNKGHVKVTDFGFAKKV----PDRTFTLCGTPEYLAPEVIQSKGHGKAVDWWTMGV 203
Query: 379 LLLEAVTGRDP 389
LL E + G P
Sbjct: 204 LLYEFIAGYPP 214
|
Length = 329 |
| >gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Score = 59.4 bits (144), Expect = 1e-09
Identities = 64/213 (30%), Positives = 96/213 (45%), Gaps = 16/213 (7%)
Query: 193 VLGEGGYGVVYKGR-LINGSEVAVKKLLNNLGQAEKEFR-VEVEA---IGHVRHKNLVRL 247
V+G+G +G V + +G AVK L +KE + + E + +V+H LV L
Sbjct: 2 VIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGL 61
Query: 248 LGYCIEGVHRM-LVYEYVNNGNLEQWLHGAMRNQGNLTWEARMKVIIGTAKALAYLHEAI 306
Y + ++ V +YVN G L L R + AR A AL YLH
Sbjct: 62 -HYSFQTADKLYFVLDYVNGGELFFHLQ---RERSFPEPRARFYAA-EIASALGYLHSL- 115
Query: 307 EPKVVHRDIKSSNILIDDEFNAKVSDFGLAKLLDSGESHITTRVMGTFGYVAPEYANTGM 366
+++RD+K NIL+D + + ++DFGL K S T+ GT Y+APE
Sbjct: 116 --NIIYRDLKPENILLDSQGHVVLTDFGLCK-EGIEHSKTTSTFCGTPEYLAPEVLRKQP 172
Query: 367 LNEKSDIYSFGVLLLEAVTGRDPVDYGRPANEV 399
+ D + G +L E + G P Y R E+
Sbjct: 173 YDRTVDWWCLGAVLYEMLYGLPPF-YSRDTAEM 204
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323 |
| >gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Score = 58.8 bits (142), Expect = 1e-09
Identities = 51/218 (23%), Positives = 104/218 (47%), Gaps = 19/218 (8%)
Query: 188 FSAENVLGEGGYGVVYKGRLI----NGSEVAVKKLLNNLGQAE--KEFRVEVEAIGHVRH 241
F+ +LG+G +G V + +L + +VAVK L ++ + +EF E + H
Sbjct: 1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDH 60
Query: 242 KNLVRLLGYCIEGVHR------MLVYEYVNNGNLEQWLHGAM--RNQGNLTWEARMKVII 293
N+++L+G + + M++ ++ +G+L +L + L + ++ +I
Sbjct: 61 PNVIKLIGVSLRSRAKGRLPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMI 120
Query: 294 GTAKALAYLHEAIEPKVVHRDIKSSNILIDDEFNAKVSDFGLAKLLDSGESHITTRVMG- 352
A + YL +HRD+ + N ++++ V+DFGL+K + SG+ +
Sbjct: 121 DIASGMEYLSSK---NFIHRDLAARNCMLNENMTVCVADFGLSKKIYSGDYYRQGCASKL 177
Query: 353 TFGYVAPEYANTGMLNEKSDIYSFGVLLLEAVT-GRDP 389
++A E + SD+++FGV + E +T G+ P
Sbjct: 178 PVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTP 215
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273 |
| >gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 59.2 bits (143), Expect = 1e-09
Identities = 60/200 (30%), Positives = 95/200 (47%), Gaps = 17/200 (8%)
Query: 194 LGEGGYGVVYKG-RLINGSEVAVKKLLNNL--GQAEKEFRVEVEAIGHVRHKNLVRLLGY 250
LGEG Y VYKG ING VA+K + G R E + ++H N+V LL
Sbjct: 13 LGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIR-EASLLKGLKHANIV-LLHD 70
Query: 251 CIEGVHRM-LVYEYVNNGNLEQWLHGAMRNQGNLTWEARMKVIIGTAKALAYLHEAIEPK 309
I + V+EY++ +L Q++ +++ G L + + LAY+H
Sbjct: 71 IIHTKETLTFVFEYMHT-DLAQYM---IQHPGGLHPYNVRLFMFQLLRGLAYIHGQ---H 123
Query: 310 VVHRDIKSSNILIDDEFNAKVSDFGLAKLLDSGESHITTRVMGTFGYVAPEYANTGMLNE 369
++HRD+K N+LI K++DFGLA+ S S + + T Y P+ G +
Sbjct: 124 ILHRDLKPQNLLISYLGELKLADFGLAR-AKSIPSQTYSSEVVTLWYRPPD-VLLGATDY 181
Query: 370 KS--DIYSFGVLLLEAVTGR 387
S DI+ G + +E + G+
Sbjct: 182 SSALDIWGAGCIFIEMLQGQ 201
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291 |
| >gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Score = 58.9 bits (142), Expect = 2e-09
Identities = 56/204 (27%), Positives = 96/204 (47%), Gaps = 19/204 (9%)
Query: 194 LGEGGYGVVYKGRLINGSE-VAVKKLLNNLGQAEKEFR---VEVEAIGHVRHKNLVRLLG 249
+G G +G VY + +E VAVKK+ + Q ++++ EV+ + ++H N + G
Sbjct: 29 IGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKG 88
Query: 250 YCIEGVHRMLVYEYVNNGNLEQWLHGAMRNQGNLTWEARMKVIIGTAKALAYLHEAIEPK 309
++ LV EY G+ L + + A + G + LAYLH
Sbjct: 89 CYLKEHTAWLVMEYCL-GSASDLLEVHKKPLQEVEIAA---ITHGALQGLAYLHSH---N 141
Query: 310 VVHRDIKSSNILIDDEFNAKVSDFGLAKLLDSGESHITTRVMGTFGYVAPEY---ANTGM 366
++HRDIK+ NIL+ + K++DFG A S + GT ++APE + G
Sbjct: 142 MIHRDIKAGNILLTEPGQVKLADFGSASKSSPANSFV-----GTPYWMAPEVILAMDEGQ 196
Query: 367 LNEKSDIYSFGVLLLEAVTGRDPV 390
+ K D++S G+ +E + P+
Sbjct: 197 YDGKVDVWSLGITCIELAERKPPL 220
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313 |
| >gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Score = 58.4 bits (141), Expect = 2e-09
Identities = 54/206 (26%), Positives = 93/206 (45%), Gaps = 19/206 (9%)
Query: 187 RFSAENVLGEGGYGVVY---------KGRLINGSEVAVKKL-LNNLGQAEKEFRVEVEAI 236
R+ + LG+G +G VY + RL E+ V +L N QA E + +
Sbjct: 1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQAN----QEAQLL 56
Query: 237 GHVRHKNLVRLLGYCIEGVHRMLVYEYVNNGNLEQWLHGAMRNQGNLTWEARMKVIIGTA 296
+ H +V+ +E ++ EY +L+ L L+ + I
Sbjct: 57 SKLDHPAIVKFHASFLERDAFCIITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLL 116
Query: 297 KALAYLHEAIEPKVVHRDIKSSNILIDDEFNAKVSDFGLAKLLDSGESHITTRVMGTFGY 356
+ Y+H+ +++HRD+K+ NI + + K+ DFG+++LL G + T GT Y
Sbjct: 117 LGVHYMHQR---RILHRDLKAKNIFLKNNL-LKIGDFGVSRLL-MGSCDLATTFTGTPYY 171
Query: 357 VAPEYANTGMLNEKSDIYSFGVLLLE 382
++PE + KSDI+S G +L E
Sbjct: 172 MSPEALKHQGYDSKSDIWSLGCILYE 197
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260 |
| >gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Score = 58.4 bits (142), Expect = 2e-09
Identities = 61/232 (26%), Positives = 103/232 (44%), Gaps = 40/232 (17%)
Query: 194 LGEGGYGVVYKGRLI-NGSEVAVKKLLNNLGQAEK--EFRVEVEAIGHVR-HKNLVRLLG 249
+GEG + V K + G A+K + + E+ R E++A+ + H N++RL+
Sbjct: 7 IGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNLR-EIQALRRLSPHPNILRLIE 65
Query: 250 YCIEGVHR--MLVYEYVNNGNLEQWLHGAMRNQGNLTWEARMKVII-GTAKALAYLHEAI 306
+ LV+E ++ L+ ++ + E R+K + K+L ++H
Sbjct: 66 VLFDRKTGRLALVFEL-----MDMNLYELIKGRKRPLPEKRVKSYMYQLLKSLDHMHRN- 119
Query: 307 EPKVVHRDIKSSNILIDDEFNAKVSDFGLAKLLDSGESH---ITTRVMGTFGYVAPEYAN 363
+ HRDIK NILI D+ K++DFG + + S + I+TR Y APE
Sbjct: 120 --GIFHRDIKPENILIKDD-ILKLADFGSCRGIYSKPPYTEYISTR-----WYRAPECLL 171
Query: 364 T-GMLNEKSDIYSFGVLLLEAVT------GRDPVD--------YGRPANEVN 400
T G K DI++ G + E ++ G + +D G P EV
Sbjct: 172 TDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNELDQIAKIHDVLGTPDAEVL 223
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282 |
| >gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Score = 58.9 bits (142), Expect = 2e-09
Identities = 60/203 (29%), Positives = 95/203 (46%), Gaps = 16/203 (7%)
Query: 193 VLGEGGYG-VVYKGRLINGSEVAVKKLLNNLGQAEKEFR---VEVEAIGHVRHKNLVRLL 248
+LG+G +G V+ +G A+K L + A+ E E + + RH L L
Sbjct: 2 LLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSL- 60
Query: 249 GYCIEGVHRM-LVYEYVNNGNLEQWLHGAMRNQGNLTWEARMKVI-IGTAKALAYLHEAI 306
Y + R+ V EYVN G L + H ++ + E R + AL YLH
Sbjct: 61 KYSFQTKDRLCFVMEYVNGGEL--FFH---LSRERVFSEDRTRFYGAEIVSALDYLHSG- 114
Query: 307 EPKVVHRDIKSSNILIDDEFNAKVSDFGLAKLLDSGESHITTRVMGTFGYVAPEYANTGM 366
K+V+RD+K N+++D + + K++DFGL K + + + T GT Y+APE
Sbjct: 115 --KIVYRDLKLENLMLDKDGHIKITDFGLCKEGITDAATMKT-FCGTPEYLAPEVLEDND 171
Query: 367 LNEKSDIYSFGVLLLEAVTGRDP 389
D + GV++ E + GR P
Sbjct: 172 YGRAVDWWGLGVVMYEMMCGRLP 194
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328 |
| >gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Score = 58.9 bits (142), Expect = 2e-09
Identities = 61/220 (27%), Positives = 98/220 (44%), Gaps = 27/220 (12%)
Query: 187 RFSAENVLGEGGYGVVYKG-RLINGSEVAVKKL---LNNLGQAEKEFRVEVEAIGHVRHK 242
R+ +G G G+V I VA+KKL N A++ +R E+ + V HK
Sbjct: 25 RYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYR-ELVLMKCVNHK 83
Query: 243 NLVRLLGY-----CIEGVHRMLVYEYVNNGNLEQWLHGAMRNQGNLTWEARMKVIIGTAK 297
N++ LL +E + + + + NL Q + Q L E ++
Sbjct: 84 NIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVI------QMELDHERMSYLLYQMLC 137
Query: 298 ALAYLHEAIEPKVVHRDIKSSNILIDDEFNAKVSDFGLAKLLDSGESHITTRVMGTFGYV 357
+ +LH A ++HRD+K SNI++ + K+ DFGLA+ +G S + T + T Y
Sbjct: 138 GIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLAR--TAGTSFMMTPYVVTRYYR 192
Query: 358 APEYANTGMLNEKSDIYSFGVLLLEAVT------GRDPVD 391
APE E DI+S G ++ E + G D +D
Sbjct: 193 APEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHID 232
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364 |
| >gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Score = 58.0 bits (140), Expect = 3e-09
Identities = 42/137 (30%), Positives = 72/137 (52%), Gaps = 14/137 (10%)
Query: 256 HRMLVYEYVNNGNLEQWLHGAMRNQGNL---TWEARMKVIIGTAKALAYLHEAIEPKVVH 312
H V E++N G+L H + + +L T+ A +++ G L +LH +++
Sbjct: 70 HLFFVMEFLNGGDL--MFHIQDKGRFDLYRATFYA-AEIVCG----LQFLHSK---GIIY 119
Query: 313 RDIKSSNILIDDEFNAKVSDFGLAKLLDSGESHITTRVMGTFGYVAPEYANTGMLNEKSD 372
RD+K N+++D + + K++DFG+ K G++ +T GT Y+APE D
Sbjct: 120 RDLKLDNVMLDRDGHIKIADFGMCKENVFGDNRAST-FCGTPDYIAPEILQGLKYTFSVD 178
Query: 373 IYSFGVLLLEAVTGRDP 389
+SFGVLL E + G+ P
Sbjct: 179 WWSFGVLLYEMLIGQSP 195
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316 |
| >gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 58.1 bits (141), Expect = 3e-09
Identities = 61/231 (26%), Positives = 104/231 (45%), Gaps = 47/231 (20%)
Query: 195 GEGGYGVVYKGRLINGS---EVAVKKLLNNLGQAEKEFRV--------EVEAIGHVRHKN 243
G G YG VYK + NG E A+KK + +KE E+ + ++H+N
Sbjct: 9 GRGTYGRVYKAKRKNGKDGKEYAIKKF-----KGDKEQYTGISQSACREIALLRELKHEN 63
Query: 244 LVRLLGYCIEGVHRM--LVYEYVNNGNLEQWLHGAMRNQGNLTWEARMKVII-----GTA 296
+V L+ +E + L+++Y + +L Q + + + + +K ++ G
Sbjct: 64 VVSLVEVFLEHADKSVYLLFDYAEH-DLWQIIKFHRQAKRVSIPPSMVKSLLWQILNG-- 120
Query: 297 KALAYLHEAIEPKVVHRDIKSSNILIDDEFNA----KVSDFGLAKLLDSGESHITT--RV 350
+ YLH V+HRD+K +NIL+ E K+ D GLA+L ++ + V
Sbjct: 121 --VHYLHSNW---VLHRDLKPANILVMGEGPERGVVKIGDLGLARLFNAPLKPLADLDPV 175
Query: 351 MGTFGYVAPEYANTGMLNEKS-----DIYSFGVLLLEAVTGRDPVDYGRPA 396
+ T Y APE +L + DI++ G + E +T P+ GR A
Sbjct: 176 VVTIWYRAPEL----LLGARHYTKAIDIWAIGCIFAELLTLE-PIFKGREA 221
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316 |
| >gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Score = 58.1 bits (140), Expect = 4e-09
Identities = 56/221 (25%), Positives = 95/221 (42%), Gaps = 18/221 (8%)
Query: 178 LRDLEIATNRFSAENVLGEGGYGVVYKGRLINGSEVAVKKLLNNLGQAEKE----FRVEV 233
+R L++ + V+G G +G V R + +V KLL+ ++ F E
Sbjct: 35 IRKLQMKAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEER 94
Query: 234 EAIGHVRHKNLVRLLGYCIEGVHRMLVYEYVNNGNLEQWLHGAMRNQGNLTWEARMKVII 293
+ + +V+L + + +V EY+ G+L M N A+
Sbjct: 95 DIMAFANSPWVVQLFCAFQDDKYLYMVMEYMPGGDLVN----LMSNYDVPEKWAKFY--- 147
Query: 294 GTAKALAYLHEAIEPKVVHRDIKSSNILIDDEFNAKVSDFGLAKLLD-SGESHITTRVMG 352
TA+ + L ++HRD+K N+L+D + K++DFG +D +G T V G
Sbjct: 148 -TAEVVLALDAIHSMGLIHRDVKPDNMLLDKHGHLKLADFGTCMKMDETGMVRCDTAV-G 205
Query: 353 TFGYVAPEYANT----GMLNEKSDIYSFGVLLLEAVTGRDP 389
T Y++PE + G + D +S GV L E + G P
Sbjct: 206 TPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTP 246
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370 |
| >gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Score = 57.5 bits (139), Expect = 5e-09
Identities = 54/215 (25%), Positives = 97/215 (45%), Gaps = 32/215 (14%)
Query: 194 LGEGGYGVVYKGRLIN---GSEVAVKKLLNNLGQAEKEFRVEVEAIGHVRHKNLVRLLGY 250
LG G G+V+ ++ VAVKK++ Q+ K E++ I + H N+V++
Sbjct: 13 LGCGSNGLVFSA--VDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVYEV 70
Query: 251 CIEGVHRM--------------LVYEYVNNGNLEQWLHGAMRNQGNLTWEARMKVIIGTA 296
+ +V EY+ +L L QG L+ E +
Sbjct: 71 LGPSGSDLTEDVGSLTELNSVYIVQEYMET-DLANVL-----EQGPLSEEHARLFMYQLL 124
Query: 297 KALAYLHEAIEPKVVHRDIKSSNILID-DEFNAKVSDFGLAKLLDSGESH--ITTRVMGT 353
+ L Y+H A V+HRD+K +N+ I+ ++ K+ DFGLA+++D SH + + T
Sbjct: 125 RGLKYIHSA---NVLHRDLKPANVFINTEDLVLKIGDFGLARIVDPHYSHKGYLSEGLVT 181
Query: 354 FGYVAPEYA-NTGMLNEKSDIYSFGVLLLEAVTGR 387
Y +P + + D+++ G + E +TG+
Sbjct: 182 KWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGK 216
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342 |
| >gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Score = 57.1 bits (138), Expect = 5e-09
Identities = 52/149 (34%), Positives = 71/149 (47%), Gaps = 23/149 (15%)
Query: 256 HRMLVYEYVNNGNLEQWLHGAMRNQGNLTWE-ARMKVIIGTAKALAYLHEAIEPKVVHRD 314
H +V EYV G+ L +N G L + ARM T AL YLH +VHRD
Sbjct: 75 HLCMVMEYVEGGDCATLL----KNIGALPVDMARMYFA-ETVLALEYLHNY---GIVHRD 126
Query: 315 IKSSNILIDDEFNAKVSDFGLAK--LLDSG----ESHIT--TR------VMGTFGYVAPE 360
+K N+LI + K++DFGL+K L+ E HI TR V GT Y+APE
Sbjct: 127 LKPDNLLITSMGHIKLTDFGLSKIGLMSLTTNLYEGHIEKDTREFLDKQVCGTPEYIAPE 186
Query: 361 YANTGMLNEKSDIYSFGVLLLEAVTGRDP 389
+ D ++ G++L E + G P
Sbjct: 187 VILRQGYGKPVDWWAMGIILYEFLVGCVP 215
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305 |
| >gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 58.6 bits (141), Expect = 6e-09
Identities = 63/255 (24%), Positives = 114/255 (44%), Gaps = 32/255 (12%)
Query: 180 DLEIATNRFSAENVLGEGGYGVVYKGRLINGSEVAVKKLLNNLGQAEKE---FRVEVEAI 236
D E N + +G G +G V+ + E K ++ G E+E +EV +
Sbjct: 7 DGESRLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVM 66
Query: 237 GHVRHKNLVRLLGYCIEGVHRML--VYEYVNNGNLEQWLHGAMRNQGNLTWEARMKVIIG 294
++HKN+VR + + ++ L + E+ + G+L + + + G + A + +
Sbjct: 67 RELKHKNIVRYIDRFLNKANQKLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQ 126
Query: 295 TAKALAYLHEAIE----PKVVHRDIKSSNILID-------------DEFN----AKVSDF 333
ALAY H + +V+HRD+K NI + + N AK+ DF
Sbjct: 127 LLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQANNLNGRPIAKIGDF 186
Query: 334 GLAKLLDSGESHITTRVMGTFGYVAPEYA--NTGMLNEKSDIYSFGVLLLEAVTGRDPVD 391
GL+K + G + +GT Y +PE T ++KSD+++ G ++ E +G+ P
Sbjct: 187 GLSK--NIGIESMAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTP-- 242
Query: 392 YGRPANEVNLVEWLK 406
+ + N L+ LK
Sbjct: 243 FHKANNFSQLISELK 257
|
Length = 1021 |
| >gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Score = 57.3 bits (138), Expect = 6e-09
Identities = 61/202 (30%), Positives = 90/202 (44%), Gaps = 14/202 (6%)
Query: 193 VLGEGGYG-VVYKGRLINGSEVAVKKLLNNLGQAEKEFR---VEVEAIGHVRHKNLVRLL 248
+LG+G +G V+ G A+K L + A+ E E + + RH L L
Sbjct: 2 LLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTAL- 60
Query: 249 GYCIEGVHRM-LVYEYVNNGNLEQWLHGAMRNQGNLTWEARMKVIIGTAKALAYLHEAIE 307
Y + R+ V EY N G L + H + + T E AL YLH
Sbjct: 61 KYAFQTHDRLCFVMEYANGGEL--FFH--LSRERVFTEERARFYGAEIVSALEYLHSR-- 114
Query: 308 PKVVHRDIKSSNILIDDEFNAKVSDFGLAKLLDSGESHITTRVMGTFGYVAPEYANTGML 367
VV+RDIK N+++D + + K++DFGL K S + + T GT Y+APE
Sbjct: 115 -DVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKT-FCGTPEYLAPEVLEDNDY 172
Query: 368 NEKSDIYSFGVLLLEAVTGRDP 389
D + GV++ E + GR P
Sbjct: 173 GRAVDWWGLGVVMYEMMCGRLP 194
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323 |
| >gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Score = 57.1 bits (138), Expect = 7e-09
Identities = 40/112 (35%), Positives = 54/112 (48%), Gaps = 10/112 (8%)
Query: 299 LAYLHEAI----EPKVVHRDIKSSNILIDDEFNAKVSDFGLAKLLDSGESHITTRVMGTF 354
LA L AI + VHRDIK N+LID + K++DFG A L + + + +GT
Sbjct: 108 LAELVLAIHSVHQMGYVHRDIKPENVLIDRTGHIKLADFGSAARLTANKMVNSKLPVGTP 167
Query: 355 GYVAPEYANT------GMLNEKSDIYSFGVLLLEAVTGRDPVDYGRPANEVN 400
Y+APE T G + D +S GV+ E + GR P G A N
Sbjct: 168 DYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSAKTYN 219
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330 |
| >gnl|CDD|173643 cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 56.1 bits (135), Expect = 8e-09
Identities = 58/210 (27%), Positives = 93/210 (44%), Gaps = 32/210 (15%)
Query: 194 LGEGGYGVVYKGRL---------INGSEVAVKKLLNNLGQAEKE----FRVEVEAIGHVR 240
LG G +Y G L E +K +L L + ++ F + V
Sbjct: 3 LGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHRDISLAFFETASMMRQVS 62
Query: 241 HKNLVRLLGYCIEGVHRMLVYEYVNNGNLEQWLHGAMRNQGNLTWEARMKVIIGTAKALA 300
HK++V L G C+ V ++V E+V G L+ ++H R LT + KV A AL+
Sbjct: 63 HKHIVLLYGVCVRDVENIMVEEFVEFGPLDLFMH---RKSDVLTTPWKFKVAKQLASALS 119
Query: 301 YLHEAIEPKVVHRDIKSSNIL-----IDDEFNA--KVSDFGLAKLLDSGESHITTRVMGT 353
YL + +VH ++ + NIL ID E K+SD G+ + S + +
Sbjct: 120 YLEDK---DLVHGNVCTKNILLAREGIDGECGPFIKLSDPGIPITVLSRQECVE-----R 171
Query: 354 FGYVAPE-YANTGMLNEKSDIYSFGVLLLE 382
++APE ++ L+ +D +SFG L E
Sbjct: 172 IPWIAPECVEDSKNLSIAADKWSFGTTLWE 201
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 262 |
| >gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 56.5 bits (136), Expect = 1e-08
Identities = 43/131 (32%), Positives = 61/131 (46%), Gaps = 8/131 (6%)
Query: 259 LVYEYVNNGNLEQWLHGAMRNQGNLTWEARMKVIIGTAKALAYLHEAIEPKVVHRDIKSS 318
LV ++N G L H R AR TA+ L L + V++RD+K
Sbjct: 70 LVLAFINGGEL---FHHLQREGRFDLSRARFY----TAELLCALENLHKFNVIYRDLKPE 122
Query: 319 NILIDDEFNAKVSDFGLAKLLDSGESHITTRVMGTFGYVAPEYANTGMLNEKSDIYSFGV 378
NIL+D + + + DFGL K L+ + T GT Y+APE + D ++ GV
Sbjct: 123 NILLDYQGHIALCDFGLCK-LNMKDDDKTNTFCGTPEYLAPELLLGHGYTKAVDWWTLGV 181
Query: 379 LLLEAVTGRDP 389
LL E +TG P
Sbjct: 182 LLYEMLTGLPP 192
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312 |
| >gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Score = 56.2 bits (135), Expect = 1e-08
Identities = 61/216 (28%), Positives = 96/216 (44%), Gaps = 25/216 (11%)
Query: 188 FSAENVLGEGGYGVVYKGRLINGSEVAVKKLLNN---LGQAEKE-FRVEVEAIGHVRHKN 243
F V+G G +G V +L N +V K+LN L +AE FR E + + + ++
Sbjct: 3 FEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQ- 61
Query: 244 LVRLLGYCIEGVHRM-LVYEYVNNGNLEQWL---HGAMRNQGNLTWEARMKVIIGTAKAL 299
+ L Y + + + LV +Y G+L L + + A M + I + L
Sbjct: 62 WITTLHYAFQDENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVIAIDSVHQL 121
Query: 300 AYLHEAIEPKVVHRDIKSSNILIDDEFNAKVSDFG-LAKLLDSGESHITTRVMGTFGYVA 358
Y VHRDIK NIL+D + +++DFG KL++ G + V GT Y++
Sbjct: 122 HY---------VHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVAV-GTPDYIS 171
Query: 359 PEYANT-----GMLNEKSDIYSFGVLLLEAVTGRDP 389
PE G + D +S GV + E + G P
Sbjct: 172 PEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETP 207
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332 |
| >gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 55.7 bits (134), Expect = 2e-08
Identities = 38/157 (24%), Positives = 70/157 (44%), Gaps = 19/157 (12%)
Query: 231 VEVEAIGHVRHKNLVRLLGYCIEGVHRMLVYEYVNNGNLEQWLHGAMRNQGNLTWEARMK 290
+E + +V H +++R+ + G +V + ++ +L +L + L + +
Sbjct: 106 IEAMLLQNVNHPSVIRMKDTLVSGAITCMVLPHYSS-DLYTYL---TKRSRPLPIDQALI 161
Query: 291 VIIGTAKALAYLHEAIEPKVVHRDIKSSNILIDDEFNAKVSDFGLAKL-----LDSGESH 345
+ + L YLH +++HRD+K+ NI I+D + D G A+ G
Sbjct: 162 IEKQILEGLRYLHAQ---RIIHRDVKTENIFINDVDQVCIGDLGAAQFPVVAPAFLG--- 215
Query: 346 ITTRVMGTFGYVAPEYANTGMLNEKSDIYSFGVLLLE 382
+ GT APE N K+DI+S G++L E
Sbjct: 216 ----LAGTVETNAPEVLARDKYNSKADIWSAGIVLFE 248
|
Length = 357 |
| >gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 55.3 bits (133), Expect = 3e-08
Identities = 46/137 (33%), Positives = 71/137 (51%), Gaps = 19/137 (13%)
Query: 259 LVYEYVNNGNLEQWLHGAMRNQGNLTWEARMKVIIGT-AKALAYLHEAIEPKVVHRDIKS 317
LV +Y++ G L + H ++ +G + E R K I AL +LH+ +V+RD+K
Sbjct: 73 LVTDYMSGGEL--FWH--LQKEGRFS-EDRAKFYIAELVLALEHLHKY---DIVYRDLKP 124
Query: 318 SNILIDDEFNAKVSDFGLAKLLDSGESHITTRVMGTFGYVAPEYANTGMLNEKS-----D 372
NIL+D + + DFGL+K + ++ T GT Y+APE +L+EK D
Sbjct: 125 ENILLDATGHIALCDFGLSK-ANLTDNKTTNTFCGTTEYLAPEV----LLDEKGYTKHVD 179
Query: 373 IYSFGVLLLEAVTGRDP 389
+S GVL+ E G P
Sbjct: 180 FWSLGVLVFEMCCGWSP 196
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330 |
| >gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 55.4 bits (134), Expect = 3e-08
Identities = 63/243 (25%), Positives = 95/243 (39%), Gaps = 67/243 (27%)
Query: 193 VLGEGGYGVVYKGRLINGSEVAVKKLLNNLGQAEKEFRVEVEAIGHVRHKN--------- 243
V+G G +G V+ R + +V K+L K ++ I HVR +
Sbjct: 8 VIGRGAFGEVWLVRDKDTGQVYAMKVLR------KSDMIKRNQIAHVRAERDILADADSP 61
Query: 244 -LVRLLGYCIEGVHRM-LVYEYVNNGNLEQWLHGAMRNQGNLTWE-ARMKVIIGTAKALA 300
+V+L Y + + LV EY+ G+L L + E AR A+ +
Sbjct: 62 WIVKLY-YSFQDEEHLYLVMEYMPGGDLMNLL----IRKDVFPEETARFY----IAELVL 112
Query: 301 YLHEAIEPKVVHRDIKSSNILIDDEFNAKVSDFGLA-KLLDSGES--------------- 344
L + +HRDIK NILID + + K++DFGL K+ + +
Sbjct: 113 ALDSVHKLGFIHRDIKPDNILIDADGHIKLADFGLCKKMNKAKDREYYLNDSHNLLFRDN 172
Query: 345 -------HITTRVM-----GTFGYVAPE------YANTGMLNEKSDIYSFGVLLLEAVTG 386
H RV GT Y+APE Y + D +S GV+L E + G
Sbjct: 173 VLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPY------GLECDWWSLGVILYEMLYG 226
Query: 387 RDP 389
P
Sbjct: 227 FPP 229
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350 |
| >gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Score = 55.9 bits (135), Expect = 4e-08
Identities = 68/286 (23%), Positives = 116/286 (40%), Gaps = 49/286 (17%)
Query: 194 LGEGGYGVVYKGR-LINGSEVAVKKLLNNLGQAE---KEFRVEVEAIGHVRHKNLVRLLG 249
+G+GG G VY + VA+KK+ +L + K F E + + H +V +
Sbjct: 10 IGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYS 69
Query: 250 YCIEGVHRMLVYEYVNNGNLEQWLHGAMRNQGNLTWEARMKVIIGT--------AKALAY 301
C +G Y+ L+ L ++ + +L+ E K +G + Y
Sbjct: 70 ICSDGDPVYYTMPYIEGYTLKSLLK-SVWQKESLSKELAEKTSVGAFLSIFHKICATIEY 128
Query: 302 LHEAIEPKVVHRDIKSSNILIDDEFNAKVSDFGLAKLLDSGE---------------SHI 346
+H V+HRD+K NIL+ + D+G A E S +
Sbjct: 129 VHSK---GVLHRDLKPDNILLGLFGEVVILDWGAAIFKKLEEEDLLDIDVDERNICYSSM 185
Query: 347 TT--RVMGTFGYVAPEYANTGMLNEKSDIYSFGVLLLEAVTGRDPVDYGRPANEVNLVEW 404
T +++GT Y+APE +E +DIY+ GV+L + +T P Y R
Sbjct: 186 TIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFP--YRRKKGR------ 237
Query: 405 LKMMVGTRRAEEVVDPNLEVKPATRALKRSL-LVALRCVDPDSEKR 449
K+ +V+ +EV P R + L +A++ + D +R
Sbjct: 238 -KISY-----RDVILSPIEVAP-YREIPPFLSQIAMKALAVDPAER 276
|
Length = 932 |
| >gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Score = 54.6 bits (131), Expect = 5e-08
Identities = 58/221 (26%), Positives = 93/221 (42%), Gaps = 18/221 (8%)
Query: 178 LRDLEIATNRFSAENVLGEGGYGVVYKGRLINGSEVAVKKLLNNLGQAEKE----FRVEV 233
+RDL + + V+G G +G V R + +V KLL+ ++ F E
Sbjct: 35 IRDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEER 94
Query: 234 EAIGHVRHKNLVRLLGYCIEGVHRMLVYEYVNNGNLEQWLHGAMRNQGNLTWEARMKVII 293
+ + +V+L + + +V EY+ G+L M N AR
Sbjct: 95 DIMAFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVN----LMSNYDVPEKWARFY--- 147
Query: 294 GTAKALAYLHEAIEPKVVHRDIKSSNILIDDEFNAKVSDFGLA-KLLDSGESHITTRVMG 352
TA+ + L +HRD+K N+L+D + K++DFG K+ G T V G
Sbjct: 148 -TAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAV-G 205
Query: 353 TFGYVAPEYANT----GMLNEKSDIYSFGVLLLEAVTGRDP 389
T Y++PE + G + D +S GV L E + G P
Sbjct: 206 TPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTP 246
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371 |
| >gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Score = 54.3 bits (130), Expect = 6e-08
Identities = 61/204 (29%), Positives = 93/204 (45%), Gaps = 17/204 (8%)
Query: 193 VLGEGGYG-VVYKGRLINGSEVAVKKLLNNLGQAEKEFR---VEVEAIGHVRHKNLVRLL 248
+LG+G +G V+ G A+K L + A+ E E + + RH L L
Sbjct: 2 LLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTAL- 60
Query: 249 GYCIEGVHRM-LVYEYVNNGNLEQWLHGAMRNQGNLTWEARMKVI-IGTAKALAYLHEAI 306
Y + R+ V EY N G L + H ++ + E R + AL YLH
Sbjct: 61 KYSFQTHDRLCFVMEYANGGEL--FFH---LSRERVFSEDRARFYGAEIVSALDYLHS-- 113
Query: 307 EPKVVHRDIKSSNILIDDEFNAKVSDFGLAKL-LDSGESHITTRVMGTFGYVAPEYANTG 365
E VV+RD+K N+++D + + K++DFGL K + G + T GT Y+APE
Sbjct: 114 EKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKT--FCGTPEYLAPEVLEDN 171
Query: 366 MLNEKSDIYSFGVLLLEAVTGRDP 389
D + GV++ E + GR P
Sbjct: 172 DYGRAVDWWGLGVVMYEMMCGRLP 195
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325 |
| >gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Score = 54.3 bits (130), Expect = 7e-08
Identities = 56/246 (22%), Positives = 95/246 (38%), Gaps = 57/246 (23%)
Query: 188 FSAENVLGEGGYGVVYKGRLINGSEVAVKKLLNNLGQAEKEFRVEVEAIGHVRHKN---- 243
F + V+G G +G V + + V K+L EKE +GH+R +
Sbjct: 3 FESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKE------QVGHIRAERDILV 56
Query: 244 ------LVRLLGYCIEGVHRMLVYEYVNNGNLEQWLHGAMRNQGNLTWEARMKVIIGTAK 297
+V++ + ++ L+ E++ G++ L + LT E I T
Sbjct: 57 EADSLWVVKMFYSFQDKLNLYLIMEFLPGGDMMTLL----MKKDTLTEEETQFYIAETVL 112
Query: 298 ALAYLHEAIEPKVVHRDIKSSNILIDDEFNAKVSDFGL---------------------- 335
A+ +H+ +HRDIK N+L+D + + K+SDFGL
Sbjct: 113 AIDSIHQL---GFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHRTEFYRNLNHSLPS 169
Query: 336 ------------AKLLDSGESHITTRVMGTFGYVAPEYANTGMLNEKSDIYSFGVLLLEA 383
A+ + +GT Y+APE N+ D +S GV++ E
Sbjct: 170 DFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEM 229
Query: 384 VTGRDP 389
+ G P
Sbjct: 230 LIGYPP 235
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363 |
| >gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 53.9 bits (130), Expect = 9e-08
Identities = 69/258 (26%), Positives = 103/258 (39%), Gaps = 74/258 (28%)
Query: 186 NRFSAENVLGEGGYGVVYKGRLI----NGSEVAVKKLLNNLGQAEKEFRVEVEAIGHVR- 240
+ F + V+G G +G V RL+ G A+KKL K +E E + HVR
Sbjct: 1 DDFESIKVIGRGAFGEV---RLVQKKDTGHIYAMKKLR-------KSEMLEKEQVAHVRA 50
Query: 241 --------HKNLVRLLGYCIE-GVHRMLVYEYVNNGNLEQWLHGAMRNQGNLTWEARMKV 291
V L Y + + L+ EY+ G++ L M+ + T E
Sbjct: 51 ERDILAEADNPWVVKLYYSFQDENYLYLIMEYLPGGDMMTLL---MK-KDTFTEEETRFY 106
Query: 292 IIGTAKALAYLHEAIEPKVVHRDIKSSNILIDDEFNAKVSDFGLAKLLDSGESHITT--- 348
I T A+ +H+ +HRDIK N+L+D + + K+SDFGL L SH T
Sbjct: 107 IAETILAIDSIHKL---GYIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKK--SHRTEFYR 161
Query: 349 -------------------------------RVM-----GTFGYVAPE-YANTGMLNEKS 371
R + GT Y+APE + TG N++
Sbjct: 162 ILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGY-NKEC 220
Query: 372 DIYSFGVLLLEAVTGRDP 389
D +S GV++ E + G P
Sbjct: 221 DWWSLGVIMYEMLVGYPP 238
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364 |
| >gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 53.5 bits (128), Expect = 1e-07
Identities = 47/156 (30%), Positives = 76/156 (48%), Gaps = 23/156 (14%)
Query: 309 KVVHRDIKSSNILIDDEFNAKVSDFGLAKLLDSGESHI---TTRVMGTFGYVAPEYANTG 365
K +HRD+ + NIL+ + K+ DFGLA+ + ++ + R+ ++APE
Sbjct: 194 KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARL--PLKWMAPESIFDK 251
Query: 366 MLNEKSDIYSFGVLLLEAVT-GRDPVDYGRPANEVNLVEWLKMMVGTR-RAEEVVDPNLE 423
+ +SD++SFGVLL E + G P P ++N ++ GTR RA E
Sbjct: 252 VYTTQSDVWSFGVLLWEIFSLGASPY----PGVQINEEFCQRLKDGTRMRAPEN------ 301
Query: 424 VKPATRALKRSLLVALRCVDPDSEKRPKMSQVVRML 459
AT + R + L C D ++RP S +V +L
Sbjct: 302 ---ATPEIYR---IMLACWQGDPKERPTFSALVEIL 331
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338 |
| >gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Score = 52.9 bits (127), Expect = 2e-07
Identities = 59/234 (25%), Positives = 97/234 (41%), Gaps = 44/234 (18%)
Query: 178 LRDLEIATNRFSAENVLGEGGYGVVYKGRLINGSEVAVKKLLNNLGQAEKE----FRVEV 233
+ L + F V+G G +G V R + +V KLL+ ++ F E
Sbjct: 35 ITKLRMKAEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEER 94
Query: 234 EAIGHVRHKNLVRLLGYCIEGVHRMLVYEYVNNGNL----------EQWLHGAMRNQGNL 283
+ + H + +V+L + + +V EY+ G+L E+W
Sbjct: 95 DIMAHANSEWIVQLHYAFQDDKYLYMVMEYMPGGDLVNLMSNYDIPEKW----------- 143
Query: 284 TWEAR---MKVIIGTAKALAYLHEAIEPKVVHRDIKSSNILIDDEFNAKVSDFGLAKLLD 340
AR +V++ AL +H +HRD+K N+L+D + K++DFG +D
Sbjct: 144 ---ARFYTAEVVL----ALDAIHSM---GFIHRDVKPDNMLLDKSGHLKLADFGTCMKMD 193
Query: 341 S-GESHITTRVMGTFGYVAPEY----ANTGMLNEKSDIYSFGVLLLEAVTGRDP 389
+ G T V GT Y++PE G + D +S GV L E + G P
Sbjct: 194 ANGMVRCDTAV-GTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTP 246
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370 |
| >gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 52.2 bits (125), Expect = 3e-07
Identities = 32/86 (37%), Positives = 46/86 (53%), Gaps = 4/86 (4%)
Query: 298 ALAYLHEAIEPKVVHRDIKSSNILIDDEFNAKVSDFGLA-KLLDSGESHITTRVMGTFGY 356
ALAYLH ++HRD+K+ NI +D+ NA + DFG A KL ++ GT
Sbjct: 197 ALAYLHGR---GIIHRDVKTENIFLDEPENAVLGDFGAACKLDAHPDTPQCYGWSGTLET 253
Query: 357 VAPEYANTGMLNEKSDIYSFGVLLLE 382
+PE K+DI+S G++L E
Sbjct: 254 NSPELLALDPYCAKTDIWSAGLVLFE 279
|
Length = 392 |
| >gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Score = 52.6 bits (126), Expect = 4e-07
Identities = 46/147 (31%), Positives = 76/147 (51%), Gaps = 13/147 (8%)
Query: 197 GGYGVVYKGRLINGSEVAVKKLLNNLGQAEK----EFRVEVEAIGHVRHKNLVRLLGYCI 252
G +G VY GR N S++ K++ K + + E +A+ + +V L Y +
Sbjct: 15 GAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLY-YSL 73
Query: 253 EGVHRM-LVYEYVNNGNLEQWLHGAMRNQGNLTWEARMKVIIGTAKALAYLHEAIEPKVV 311
+ + + LV EY+ G+++ LH G E +K I A AL YLH ++
Sbjct: 74 QSANNVYLVMEYLIGGDVKSLLH----IYGYFDEEMAVKYISEVALALDYLHRH---GII 126
Query: 312 HRDIKSSNILIDDEFNAKVSDFGLAKL 338
HRD+K N+LI +E + K++DFGL+K+
Sbjct: 127 HRDLKPDNMLISNEGHIKLTDFGLSKV 153
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669 |
| >gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 52.3 bits (125), Expect = 4e-07
Identities = 51/178 (28%), Positives = 86/178 (48%), Gaps = 5/178 (2%)
Query: 213 VAVKKLLNNLGQAEKEFRVEVEAIGHVRHKNLVRLLGYCIEGVHRMLVYEYVNNGNLEQW 272
VA +LN+ QA R E+ + H +V+ +L+ EY + G+L +
Sbjct: 97 VAKFVMLNDERQAAYA-RSELHCLAACDHFGIVKHFDDFKSDDKLLLIMEYGSGGDLNKQ 155
Query: 273 LHGAMRNQGNLTWEARMKVIIGTAKALAYLHEAIEPKVVHRDIKSSNILIDDEFNAKVSD 332
+ R + +L ++ ++ LA L E K++HRD+KS+NI + K+ D
Sbjct: 156 IK--QRLKEHLPFQEYEVGLLFYQIVLA-LDEVHSRKMMHRDLKSANIFLMPTGIIKLGD 212
Query: 333 FGLAK-LLDSGESHITTRVMGTFGYVAPEYANTGMLNEKSDIYSFGVLLLEAVTGRDP 389
FG +K DS + + GT Y+APE ++K+D++S GV+L E +T P
Sbjct: 213 FGFSKQYSDSVSLDVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRP 270
|
Length = 478 |
| >gnl|CDD|173667 cd05576, STKc_RPK118_like, Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Score = 50.6 bits (121), Expect = 5e-07
Identities = 48/195 (24%), Positives = 80/195 (41%), Gaps = 28/195 (14%)
Query: 243 NLVRLLGYCIEGVHRMLVYEYVNNGNLEQWLHGAMRNQGNLT--WEARMKVIIGTAKALA 300
N+V L Y + LV ++ G L + + W A M V AL
Sbjct: 46 NMVCLHKYIVSEDSVFLVLQHAEGGKLWSHISKFLNIPEECVKRWAAEMVV------ALD 99
Query: 301 YLHEAIEPKVVHRDIKSSNILIDDEFNAKVSDFG-LAKLLDSGESHITTRVMGTFGYVAP 359
LH +V RD+ +NIL+DD + +++ F +++ DS + + Y AP
Sbjct: 100 ALHRE---GIVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDSCDGEAVENM-----YCAP 151
Query: 360 EYANTGMLNEKSDIYSFGVLLLEAVTGRDPVDYGRPA-----NEVNLVEWLKMMVGTRRA 414
E E D +S G +L E +TG+ V+ P+ +N+ EW+ + A
Sbjct: 152 EVGGISEETEACDWWSLGAILFELLTGKTLVE-CHPSGINTHTTLNIPEWV-----SEEA 205
Query: 415 EEVVDPNLEVKPATR 429
++ L+ P R
Sbjct: 206 RSLLQQLLQFNPTER 220
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phosphate (SPP), a lipid messenger involved in many cellular events. RPK118 may be involved in transmitting SPP-mediated signaling. RPK118 also binds the antioxidant peroxiredoxin-3 (PRDX3). RPK118 may be involved in the transport of PRDX3 from the cytoplasm to its site of function in the mitochondria. Length = 237 |
| >gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Score = 50.8 bits (121), Expect = 1e-06
Identities = 46/154 (29%), Positives = 71/154 (46%), Gaps = 21/154 (13%)
Query: 311 VHRDIKSSNILIDDEFNAKVSDFGLAKLLDSGESHITTRVMGTF---GYVAPEYANTGML 367
VHRD+ + N+LI + K+ DFGLA+ + ++I+ TF ++APE +
Sbjct: 261 VHRDLAARNVLICEGKLVKICDFGLARDIMRDSNYISKG--STFLPLKWMAPESIFNNLY 318
Query: 368 NEKSDIYSFGVLLLEAVT-GRDPVDYGRPANEVNLVEWLKMMVGTRRAEEVVDPNLEVKP 426
SD++SFG+LL E T G P P +N + + G R A KP
Sbjct: 319 TTLSDVWSFGILLWEIFTLGGTPY----PELPMNEQFYNAIKRGYRMA----------KP 364
Query: 427 ATRALKRSLLVALRCVDPDSEKRPKMSQVVRMLE 460
A A + +C + E RP SQ+V ++
Sbjct: 365 A-HASDEIYEIMQKCWEEKFEIRPDFSQLVHLVG 397
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401 |
| >gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 50.0 bits (119), Expect = 1e-06
Identities = 30/92 (32%), Positives = 44/92 (47%), Gaps = 3/92 (3%)
Query: 297 KALAYLHEAIEPKVVHRDIKSSNILIDDEFNAKVSDFGLAKLLDSGESHITTRVMGTFGY 356
+A+ YLHE +++HRDIK+ NI I+ + + DFG A ++ GT
Sbjct: 193 RAIQYLHEN---RIIHRDIKAENIFINHPGDVCLGDFGAACFPVDINANKYYGWAGTIAT 249
Query: 357 VAPEYANTGMLNEKSDIYSFGVLLLEAVTGRD 388
APE DI+S G++L E T D
Sbjct: 250 NAPELLARDPYGPAVDIWSAGIVLFEMATCHD 281
|
Length = 391 |
| >gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 50.1 bits (119), Expect = 2e-06
Identities = 46/195 (23%), Positives = 85/195 (43%), Gaps = 21/195 (10%)
Query: 200 GVVYKGRLINGSEVAVKKLLNNLGQAEKEFRVEVEAIGHVRHKNLVRLLGYCIEGVHRML 259
GV + E + K + +A + E+ A+G + H+N+++ IE + R
Sbjct: 181 GVNSTNQGKPKCERLIAKRVKAGSRAAIQLENEILALGRLNHENILK-----IEEILRSE 235
Query: 260 VYEYVNNGNLEQWLHGAMRNQGNLTWEAR---------MKVIIGTAKALAYLHEAIEPKV 310
Y+ + L+ M + W+ R MK ++ A+ Y+H+ K+
Sbjct: 236 ANTYMITQKYDFDLYSFMYD-EAFDWKDRPLLKQTRAIMKQLLC---AVEYIHDK---KL 288
Query: 311 VHRDIKSSNILIDDEFNAKVSDFGLAKLLDSGESHITTRVMGTFGYVAPEYANTGMLNEK 370
+HRDIK NI ++ + + DFG A + +GT +PE E
Sbjct: 289 IHRDIKLENIFLNCDGKIVLGDFGTAMPFEKEREAFDYGWVGTVATNSPEILAGDGYCEI 348
Query: 371 SDIYSFGVLLLEAVT 385
+DI+S G++LL+ ++
Sbjct: 349 TDIWSCGLILLDMLS 363
|
Length = 501 |
| >gnl|CDD|133207 cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 49.1 bits (117), Expect = 2e-06
Identities = 42/155 (27%), Positives = 72/155 (46%), Gaps = 19/155 (12%)
Query: 236 IGHVRHKNLVRLLGYCIEGVHRMLVYEYVNNGNLEQWLHGAMRNQGNLTWEARMKVIIGT 295
+ V H +L + G C+ G ++V E+V +G L+ L + +G + ++ V
Sbjct: 70 MSQVSHIHLAFVHGVCVRGSENIMVEEFVEHGPLDVCLR---KEKGRVPVAWKITVAQQL 126
Query: 296 AKALAYLHEAIEPKVVHRDIKSSNILIDDEFNA-------KVSDFGLAKLLDSGESHITT 348
A AL+YL + +VH ++ + NIL+ A K+SD G++ S E +
Sbjct: 127 ASALSYLEDK---NLVHGNVCAKNILLARLGLAEGTSPFIKLSDPGVSFTALSREERVE- 182
Query: 349 RVMGTFGYVAPE-YANTGMLNEKSDIYSFGVLLLE 382
++APE L+ +D +SFG LLE
Sbjct: 183 ----RIPWIAPECVPGGNSLSTAADKWSFGTTLLE 213
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 274 |
| >gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Score = 49.3 bits (117), Expect = 3e-06
Identities = 56/241 (23%), Positives = 96/241 (39%), Gaps = 47/241 (19%)
Query: 188 FSAENVLGEGGYGVVYKGRLINGSEVAVKKLLNNLGQAEKE----FRVEVEAIGHVRHKN 243
F + V+G G +G V + + + K+L EKE R E + +
Sbjct: 3 FESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAW 62
Query: 244 LVRLLGYCIEGVHRMLVYEYVNNGNLEQWLHGAMRNQGNLTWEARMKVIIGTAKALAYLH 303
+V++ + + L+ E++ G++ L + L+ EA I T A+ +H
Sbjct: 63 VVKMFYSFQDKRNLYLIMEFLPGGDMMTLL----MKKDTLSEEATQFYIAETVLAIDAIH 118
Query: 304 EAIEPKVVHRDIKSSNILIDDEFNAKVSDFGL---------------------------- 335
+ +HRDIK N+L+D + + K+SDFGL
Sbjct: 119 QL---GFIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHRTEFYRNLTHNPPSDFSFQN 175
Query: 336 ------AKLLDSGESHITTRVMGTFGYVAPE-YANTGMLNEKSDIYSFGVLLLEAVTGRD 388
A+ + +GT Y+APE + TG N+ D +S GV++ E + G
Sbjct: 176 MNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGY-NKLCDWWSLGVIMYEMLIGYP 234
Query: 389 P 389
P
Sbjct: 235 P 235
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360 |
| >gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Score = 48.8 bits (116), Expect = 3e-06
Identities = 54/215 (25%), Positives = 91/215 (42%), Gaps = 23/215 (10%)
Query: 188 FSAENVLGEGGYGVVYKGRLINGSEVAVKKLLNN---LGQAEKE-FRVEVEAIGHVRHKN 243
F V+G G +G V ++ + + K+LN L +AE FR E + + +
Sbjct: 3 FEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQW 62
Query: 244 LVRLLGYCIEGVHRMLVYEYVNNGNLEQWLHGAMRNQGNLTWEARMKVIIG---TAKALA 300
+ L + + LV +Y G+L L +E R+ + A+ +
Sbjct: 63 ITTLHYAFQDENYLYLVMDYYVGGDLLTLLS---------KFEDRLPEDMARFYIAEMVL 113
Query: 301 YLHEAIEPKVVHRDIKSSNILIDDEFNAKVSDFG-LAKLLDSGESHITTRVMGTFGYVAP 359
+H + VHRDIK N+L+D + +++DFG K+ G + V GT Y++P
Sbjct: 114 AIHSIHQLHYVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDGTVQSSVAV-GTPDYISP 172
Query: 360 EYANT-----GMLNEKSDIYSFGVLLLEAVTGRDP 389
E G + D +S GV + E + G P
Sbjct: 173 EILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETP 207
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331 |
| >gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 49.0 bits (117), Expect = 3e-06
Identities = 60/219 (27%), Positives = 94/219 (42%), Gaps = 31/219 (14%)
Query: 188 FSAENVLGEGGYGVVYKGRLINGSEVAVKKLLNN---LGQAEKE-FRVEVEAIGHVRHKN 243
F V+G G +G V ++ N +V K+LN L +AE FR E + + + +
Sbjct: 3 FEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRW 62
Query: 244 LVRLLGYCIEGVHRMLVYEYVNNGNLEQWLHGAMRNQGNLTWEARMKVIIGTAKALAYLH 303
+ L + + LV +Y G+L LT ++ + + A YL
Sbjct: 63 ITNLHYAFQDENNLYLVMDYYVGGDL-------------LTLLSKFEDRLPEDMARFYLA 109
Query: 304 E---AIEP----KVVHRDIKSSNILIDDEFNAKVSDFG-LAKLLDSGESHITTRVMGTFG 355
E AI+ VHRDIK N+L+D + +++DFG +LL G V GT
Sbjct: 110 EMVLAIDSVHQLGYVHRDIKPDNVLLDKNGHIRLADFGSCLRLLADGTVQSNVAV-GTPD 168
Query: 356 YVAPEY-----ANTGMLNEKSDIYSFGVLLLEAVTGRDP 389
Y++PE G + D +S GV + E + G P
Sbjct: 169 YISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETP 207
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331 |
| >gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 48.5 bits (115), Expect = 5e-06
Identities = 43/160 (26%), Positives = 71/160 (44%), Gaps = 31/160 (19%)
Query: 309 KVVHRDIKSSNILIDDEFNAKVSDFGLAK-------LLDSGESHITTRVMGTFGYVAPEY 361
K +HRD+ + NIL+ + K+ DFGLA+ + G++ + + M APE
Sbjct: 199 KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLKWM------APET 252
Query: 362 ANTGMLNEKSDIYSFGVLLLEAVT-GRDPVDYGRPANEVNLVEWLKMMVGTR-RAEEVVD 419
+ +SD++SFGVLL E + G P P +++ ++ GTR RA +
Sbjct: 253 IFDRVYTIQSDVWSFGVLLWEIFSLGASPY----PGVKIDEEFCRRLKEGTRMRAPDYTT 308
Query: 420 PNLEVKPATRALKRSLLVALRCVDPDSEKRPKMSQVVRML 459
P + L C + +RP S++V L
Sbjct: 309 PEM------------YQTMLDCWHGEPSQRPTFSELVEHL 336
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343 |
| >gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Score = 47.0 bits (111), Expect = 1e-05
Identities = 57/218 (26%), Positives = 102/218 (46%), Gaps = 24/218 (11%)
Query: 194 LGEGGYGVVYKGRLINGS---EVAVKKLLNNLGQAEKEFRVEVEAIGHVRHKNLVRLLGY 250
+G G YG VYK + +G E A+K++ G + R E+ + ++H N++ L
Sbjct: 9 VGRGTYGHVYKAKRKDGKDEKEYALKQI-EGTGISMSACR-EIALLRELKHPNVIALQKV 66
Query: 251 CIEGVHRM--LVYEYVNNGNLEQWLHGAMRNQGNLTWEARMKVIIGTAKALAY-----LH 303
+ R L+++Y + + W H ++ + + M++ K+L Y +H
Sbjct: 67 FLSHSDRKVWLLFDYAEH---DLW-HIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIH 122
Query: 304 EAIEPKVVHRDIKSSNILIDDE----FNAKVSDFGLAKLLDSGESHIT--TRVMGTFGYV 357
V+HRD+K +NIL+ E K++D G A+L +S + V+ TF Y
Sbjct: 123 YLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYR 182
Query: 358 APEYANTGMLNEKS-DIYSFGVLLLEAVTGRDPVDYGR 394
APE K+ DI++ G + E +T +P+ + R
Sbjct: 183 APELLLGARHYTKAIDIWAIGCIFAELLTS-EPIFHCR 219
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317 |
| >gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Score = 46.8 bits (111), Expect = 2e-05
Identities = 44/170 (25%), Positives = 78/170 (45%), Gaps = 26/170 (15%)
Query: 296 AKALAYLHEAIEPKVVHRDIKSSNILIDDEFNAKVSDFGLAKLLDSGESHITTRVMGT-- 353
AK +++L +HRD+ + NIL+ K+ DFGLA+ + + +++ V G
Sbjct: 224 AKGMSFL---ASKNCIHRDLAARNILLTHGRITKICDFGLARDIRNDSNYV---VKGNAR 277
Query: 354 --FGYVAPEYANTGMLNEKSDIYSFGVLLLEAVT-GRDPVDYGRPANEVNLVEWLKMMVG 410
++APE + +SD++S+G+LL E + G P G P + ++ KM+
Sbjct: 278 LPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYP-GMPVDS----KFYKMIKE 332
Query: 411 TRRAEEVVDPNLEVKPATRALKRSLLVALRCVDPDSEKRPKMSQVVRMLE 460
R E+ ++ C D D KRP Q+V+++E
Sbjct: 333 GYRMLSPECAPSEMYDIMKS----------CWDADPLKRPTFKQIVQLIE 372
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375 |
| >gnl|CDD|173766 cd08226, PK_STRAD_beta, Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Score = 46.5 bits (110), Expect = 2e-05
Identities = 33/107 (30%), Positives = 51/107 (47%), Gaps = 11/107 (10%)
Query: 291 VIIGTAKALAYLHEAIEPKVVHRDIKSSNILIDDEFNAKVSDFG-LAKLLDSGESHITTR 349
++ G + L YLH+ +HR+IK+S+ILI + +S L L+ +G+
Sbjct: 106 ILFGALRGLNYLHQN---GYIHRNIKASHILISGDGLVSLSGLSHLYSLVRNGQKAKVVY 162
Query: 350 VMGTFG-----YVAPEYANTGM--LNEKSDIYSFGVLLLEAVTGRDP 389
F +++PE + N KSDIYS G+ E TGR P
Sbjct: 163 DFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVP 209
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. STRAD-beta is also referred to as ALS2CR2 (Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 2 protein), since the human gene encoding it is located within the juvenile ALS2 critical region on chromosome 2q33-q34. It is not linked to the development of ALS2. Length = 328 |
| >gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 46.8 bits (111), Expect = 2e-05
Identities = 40/155 (25%), Positives = 78/155 (50%), Gaps = 23/155 (14%)
Query: 311 VHRDIKSSNILIDDEFNAKVSDFGLAKLLDSGESHITTRVMGT----FGYVAPEYANTGM 366
+HRD+ + N+L+ D AK+ DFGLA+ + + +++ V G ++APE +
Sbjct: 234 IHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYV---VKGNARLPVKWMAPESIFDCV 290
Query: 367 LNEKSDIYSFGVLLLEAVT-GRDPVDYGRPANEVNLVEWLKMMVGTRRAEEVVDPNLEVK 425
+SD++S+G+LL E + G+ P P VN ++ KM+ +R ++ P+
Sbjct: 291 YTVQSDVWSYGILLWEIFSLGKSPY----PGILVN-SKFYKMV---KRGYQMSRPDFAPP 342
Query: 426 PATRALKRSLLVALRCVDPDSEKRPKMSQVVRMLE 460
+K C + + +RP SQ+ ++++
Sbjct: 343 EIYSIMK-------MCWNLEPTERPTFSQISQLIQ 370
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374 |
| >gnl|CDD|140307 PTZ00284, PTZ00284, protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 46.5 bits (110), Expect = 2e-05
Identities = 71/326 (21%), Positives = 130/326 (39%), Gaps = 62/326 (19%)
Query: 173 GHWFTL--RDLEIATNRFSAENVLGEGGYGVVYKGRLINGSEVAVKKLLNNLGQAEKEFR 230
GH++ + D++++T RF ++LGEG +G V + E K++ N+ + ++ +
Sbjct: 114 GHFYVVLGEDIDVSTQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVPKYTRDAK 173
Query: 231 VEVEAIGHVRHKN------LVRLLGYCIEGVHRMLVYEYVNNGNLEQWL--HGAMRNQGN 282
+E++ + VR + L+++ Y M + L W+ HG + +
Sbjct: 174 IEIQFMEKVRQADPADRFPLMKIQRYFQNETGHMCIVMPKYGPCLLDWIMKHGPF-SHRH 232
Query: 283 LTWEARMKVIIGTAKALAYLHEAIEPKVVHRDIKSSNILID----------------DEF 326
L ++I T AL Y H E ++H D+K NIL++ D
Sbjct: 233 LA-----QIIFQTGVALDYFHT--ELHLMHTDLKPENILMETSDTVVDPVTNRALPPDPC 285
Query: 327 NAKVSDFGLAKLLDSGESHITTRVMGTFGYVAPEYANTGMLNEKSDIYSFGVLLLEAVTG 386
++ D G E H T ++ T Y +PE +D++S G ++ E TG
Sbjct: 286 RVRICDLGGC----CDERHSRTAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYELYTG 341
Query: 387 RDPVDYGRPANEVNLVE---------WLKMMVGTRRAEEVVDPNLEVKPATRALKRSLLV 437
+ D ++L+E W GT A + + +++P
Sbjct: 342 KLLYDTHDNLEHLHLMEKTLGRLPSEW-AGRCGTEEARLLYNSAGQLRP----------- 389
Query: 438 ALRCVDPDSEKRPKMSQVVRMLEADD 463
C DP R ++ VR + DD
Sbjct: 390 ---CTDPKHLARIARARPVREVIRDD 412
|
Length = 467 |
| >gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 45.7 bits (109), Expect = 3e-05
Identities = 57/235 (24%), Positives = 89/235 (37%), Gaps = 49/235 (20%)
Query: 193 VLGEGGYGVVYKGRLINGSEV-AVKKLLNNLGQAEKEF-RVEVEA--IGHVRHKNLVRLL 248
+LG+G G V+ RL ++ A+K L + RV E + + H L L
Sbjct: 8 LLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLY 67
Query: 249 GYCIEGVHRMLVYEYVNNGNLEQWLHGAMRNQ-GNLTWEARMK-----VIIGTAKALAYL 302
+ LV +Y G L ++ Q G E + V++ AL YL
Sbjct: 68 ASFQTETYLCLVMDYCPGGEL----FRLLQRQPGKCLSEEVARFYAAEVLL----ALEYL 119
Query: 303 HEAIEPKVVHRDIKSSNILIDDEFNAKVSDFGLAKLLDSGESHI---------------- 346
H +V+RD+K NIL+ + + +SDF L+K D +
Sbjct: 120 HLL---GIVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPPPVSKALRKGSRRSSVNSI 176
Query: 347 ---------TTRVM---GTFGYVAPEYANTGMLNEKSDIYSFGVLLLEAVTGRDP 389
+ R GT Y+APE + D ++ G+LL E + G P
Sbjct: 177 PSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGTTP 231
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316 |
| >gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Score = 45.4 bits (107), Expect = 3e-05
Identities = 56/218 (25%), Positives = 103/218 (47%), Gaps = 24/218 (11%)
Query: 194 LGEGGYGVVYKGRLINGSE---VAVKKLLNNLGQAEKEFRVEVEAIGHVRHKNLVRLLGY 250
+G G YG VYK + +G + A+K++ G + R E+ + ++H N++ L
Sbjct: 9 VGRGTYGHVYKAKRKDGKDDRDYALKQI-EGTGISMSACR-EIALLRELKHPNVISLQKV 66
Query: 251 CIEGVHRM--LVYEYVNNGNLEQWLHGAMRNQGNLTWEARMKVIIGTAKALAY-----LH 303
+ R L+++Y + + W H ++ + + +++ G K+L Y +H
Sbjct: 67 FLSHADRKVWLLFDYAEH---DLW-HIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIH 122
Query: 304 EAIEPKVVHRDIKSSNILIDDE----FNAKVSDFGLAKLLDSGESHIT--TRVMGTFGYV 357
V+HRD+K +NIL+ E K++D G A+L +S + V+ TF Y
Sbjct: 123 YLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYR 182
Query: 358 APEYANTGMLNEKS-DIYSFGVLLLEAVTGRDPVDYGR 394
APE K+ DI++ G + E +T +P+ + R
Sbjct: 183 APELLLGARHYTKAIDIWAIGCIFAELLTS-EPIFHCR 219
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317 |
| >gnl|CDD|215638 PLN03225, PLN03225, Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Score = 44.8 bits (106), Expect = 8e-05
Identities = 71/298 (23%), Positives = 108/298 (36%), Gaps = 77/298 (25%)
Query: 188 FSAENVLGEGGYGVVYKGRLINGSEVAVKKLLNNLGQAEKEFRVEVEAIGHVRHKNLVRL 247
F LGEG +GVVYK L+N K + L +A E+ VE + R +
Sbjct: 134 FVLGKKLGEGAFGVVYKASLVNKQSKKEGKYV--LKKA-TEYG-AVEIWMNERVRRACP- 188
Query: 248 LGYCIEGVHRM-------------LVYEYVNNG-------------NLEQWLHGAMRNQG 281
C + V+ LV+ Y N+E +L G + Q
Sbjct: 189 -NSCADFVYGFLEPVSSKKEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKV--QD 245
Query: 282 NLTWEARMKVIIGTA-----KALAYLHEAIEPKVVHRDIKSSNILIDDEFNA-KVSDFGL 335
R II T AL LH +VHRD+K NI+ + + K+ D G
Sbjct: 246 LPKGLERENKIIQTIMRQILFALDGLHST---GIVHRDVKPQNIIFSEGSGSFKIIDLGA 302
Query: 336 AKLLDSGESHITTRVMGTFGYVAPE-YANTGM---------------------LNEKSDI 373
A L G ++I + Y APE Y + L ++ DI
Sbjct: 303 AADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDI 362
Query: 374 YSFGVLLLEAV-----TGRDPVDYGRPANEVN--LVEWLKMMVGTRRAE-----EVVD 419
YS G++ L+ + + + + R + LV W K++ + EV+D
Sbjct: 363 YSAGLIFLQMAFPNLRSDSNLIQFNRQLKRNDYDLVAWRKLVEPRASPDLRRGFEVLD 420
|
Length = 566 |
| >gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Score = 44.4 bits (105), Expect = 9e-05
Identities = 35/122 (28%), Positives = 49/122 (40%), Gaps = 44/122 (36%)
Query: 311 VHRDIKSSNILIDDEFNAKVSDFGL---------AKLLDSGESHIT-------------- 347
+HRDIK NILID + + K++DFGL +K G+ H
Sbjct: 123 IHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQKGDHHRQDSMEPSEEWSEIDR 182
Query: 348 --------------TRVM-----GTFGYVAPE-YANTGMLNEKSDIYSFGVLLLEAVTGR 387
R + GT Y+APE TG + D +S GV+L E + G+
Sbjct: 183 CRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGY-TQLCDWWSVGVILYEMLVGQ 241
Query: 388 DP 389
P
Sbjct: 242 PP 243
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376 |
| >gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Score = 43.5 bits (102), Expect = 2e-04
Identities = 41/155 (26%), Positives = 73/155 (47%), Gaps = 21/155 (13%)
Query: 311 VHRDIKSSNILIDDEFNAKVSDFGLAKLLDSGESHITTRVMGTF---GYVAPEYANTGML 367
VHRD+ + N+L+ K+ DFGLA+ + ++++ TF ++APE +
Sbjct: 259 VHRDLAARNVLLAQGKIVKICDFGLARDIMHDSNYVSKG--STFLPVKWMAPESIFDNLY 316
Query: 368 NEKSDIYSFGVLLLEAVT-GRDPVDYGRPANEVNLVEWLKMMVGTRRAEEVVDPNLEVKP 426
SD++S+G+LL E + G P P V+ + K+ G R A KP
Sbjct: 317 TTLSDVWSYGILLWEIFSLGGTPY----PGMIVDSTFYNKIKSGYRMA----------KP 362
Query: 427 ATRALKRSLLVALRCVDPDSEKRPKMSQVVRMLEA 461
A + + ++C + + EKRP + ++E+
Sbjct: 363 -DHATQEVYDIMVKCWNSEPEKRPSFLHLSDIVES 396
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400 |
| >gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Score = 42.7 bits (101), Expect = 2e-04
Identities = 45/193 (23%), Positives = 75/193 (38%), Gaps = 19/193 (9%)
Query: 209 NGSEVAVKKLLNNLGQAEKE----FRVEVEAIGHVRHKNLVRLLGYCIEGVHRMLVYEYV 264
+ VAVKK+ NL KE + E+ ++H N++ + I +V +
Sbjct: 24 TNTLVAVKKI--NLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSPLM 81
Query: 265 NNGNLEQWLHGAMRNQGNLTWEARMKVIIGTAKALAYLHEAIEPKVVHRDIKSSNILIDD 324
G+ E L A ++ AL Y+H +HR +K+S+IL+
Sbjct: 82 AYGSCEDLLKTHFPEGLPEL--AIAFILKDVLNALDYIHSK---GFIHRSVKASHILLSG 136
Query: 325 EFNAKVSDFGLA-KLLDSGESHITTRVMGTFG-----YVAPE--YANTGMLNEKSDIYSF 376
+ +S + ++ G+ +++PE N NEKSDIYS
Sbjct: 137 DGKVVLSGLRYSVSMIKHGKRQRVVHDFPKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSV 196
Query: 377 GVLLLEAVTGRDP 389
G+ E G P
Sbjct: 197 GITACELANGHVP 209
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314 |
| >gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Score = 41.8 bits (99), Expect = 4e-04
Identities = 47/155 (30%), Positives = 75/155 (48%), Gaps = 23/155 (14%)
Query: 241 HKNLVRLLGYCIEGV-HRMLVYEYVNNGNLEQWLHGAMRNQGNLTWEARMKVIIGT-AKA 298
+ N ++L Y + + +L+ +Y+ +G+L L +G L+ EA +K II +A
Sbjct: 68 NPNFIKLY-YSVTTLKGHVLIMDYIKDGDLFDLLK----KEGKLS-EAEVKKIIRQLVEA 121
Query: 299 LAYLHEAIEPKVVHRDIKSSNILIDD-EFNAKVSDFGLAKLLDSGESHITTRVM--GTFG 355
L LH+ ++H DIK N+L D + + D+GL K I T GT
Sbjct: 122 LNDLHKH---NIIHNDIKLENVLYDRAKDRIYLCDYGLCK-------IIGTPSCYDGTLD 171
Query: 356 YVAPEYANTGMLNEKS-DIYSFGVLLLEAVTGRDP 389
Y +PE G + S D ++ GVL E +TG+ P
Sbjct: 172 YFSPEKIK-GHNYDVSFDWWAVGVLTYELLTGKHP 205
|
Length = 267 |
| >gnl|CDD|173714 cd05625, STKc_LATS1, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Score = 41.1 bits (96), Expect = 9e-04
Identities = 36/142 (25%), Positives = 54/142 (38%), Gaps = 49/142 (34%)
Query: 311 VHRDIKSSNILIDDEFNAKVSDFGL---------AKLLDSGESHITTRVM---------- 351
+HRDIK NILID + + K++DFGL +K SG+ H+ M
Sbjct: 123 IHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQSGD-HVRQDSMDFSNEWGDPA 181
Query: 352 ----------------------------GTFGYVAPEYANTGMLNEKSDIYSFGVLLLEA 383
GT Y+APE + D +S GV+L E
Sbjct: 182 NCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYEM 241
Query: 384 VTGRDPVDYGRP-ANEVNLVEW 404
+ G+ P P ++ ++ W
Sbjct: 242 LVGQPPFLAQTPLETQMKVINW 263
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype and poor prognosis. LATS1 induces G2 arrest and promotes cytokinesis. It may be a component of the mitotic exit network in higher eukaryotes. Length = 382 |
| >gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 40.6 bits (95), Expect = 0.001
Identities = 30/89 (33%), Positives = 46/89 (51%), Gaps = 8/89 (8%)
Query: 193 VLGEGGYGVVYK------GRLINGSEVAVKKLLNNLGQAEKE-FRVEVEAIGHV-RHKNL 244
LG G +G V + G+ N VAVK L + E+E E++ + H+ +HKN+
Sbjct: 45 TLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTDEREALMSELKILSHLGQHKNI 104
Query: 245 VRLLGYCIEGVHRMLVYEYVNNGNLEQWL 273
V LLG C G +++ EY G+L +L
Sbjct: 105 VNLLGACTHGGPVLVITEYCCYGDLLNFL 133
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374 |
| >gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 41.0 bits (96), Expect = 0.001
Identities = 38/126 (30%), Positives = 50/126 (39%), Gaps = 48/126 (38%)
Query: 311 VHRDIKSSNILIDDEFNAKVSDFGLA-------------KLLD----------------- 340
+HRDIK NILID + K+SDFGL+ KLL
Sbjct: 123 IHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQHDSAYYQKLLQGKSNKNRIDNRNSVAVD 182
Query: 341 ------SGESHITT-----RVM-----GTFGYVAPE-YANTGMLNEKSDIYSFGVLLLEA 383
S + I T R+M GT Y+APE + G E D +S G ++ E
Sbjct: 183 SINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQE-CDWWSLGAIMFEC 241
Query: 384 VTGRDP 389
+ G P
Sbjct: 242 LIGWPP 247
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377 |
| >gnl|CDD|173715 cd05626, STKc_LATS2, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Score = 40.0 bits (93), Expect = 0.002
Identities = 37/142 (26%), Positives = 53/142 (37%), Gaps = 49/142 (34%)
Query: 311 VHRDIKSSNILIDDEFNAKVSDFGL---------AKLLDSGESHITTRVM---------- 351
+HRDIK NILID + + K++DFGL +K G SHI M
Sbjct: 123 IHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTHNSKYYQKG-SHIRQDSMEPSDLWDDVS 181
Query: 352 ----------------------------GTFGYVAPEYANTGMLNEKSDIYSFGVLLLEA 383
GT Y+APE + D +S GV+L E
Sbjct: 182 NCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSVGVILFEM 241
Query: 384 VTGRDPVDYGRPA-NEVNLVEW 404
+ G+ P P ++ ++ W
Sbjct: 242 LVGQPPFLAPTPTETQLKVINW 263
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with poor prognosis in acute lymphoblastic leukemia and breast cancer. Length = 381 |
| >gnl|CDD|223009 PHA03211, PHA03211, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 40.3 bits (94), Expect = 0.002
Identities = 28/88 (31%), Positives = 43/88 (48%), Gaps = 6/88 (6%)
Query: 298 ALAYLH-EAIEPKVVHRDIKSSNILIDDEFNAKVSDFGLAKLLD-SGESHITTRVMGTFG 355
A+ Y+H E I +HRDIK+ N+L++ + + DFG A S + + GT
Sbjct: 272 AIDYIHGEGI----IHRDIKTENVLVNGPEDICLGDFGAACFARGSWSTPFHYGIAGTVD 327
Query: 356 YVAPEYANTGMLNEKSDIYSFGVLLLEA 383
APE DI+S G+++ EA
Sbjct: 328 TNAPEVLAGDPYTPSVDIWSAGLVIFEA 355
|
Length = 461 |
| >gnl|CDD|173767 cd08227, PK_STRAD_alpha, Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Score = 39.5 bits (92), Expect = 0.003
Identities = 35/109 (32%), Positives = 48/109 (44%), Gaps = 15/109 (13%)
Query: 291 VIIGTAKALAYLHEAIEPKVVHRDIKSSNILIDDEFNAKVSDFGLAKLLDSGESHITTRV 350
++ G KAL Y+H VHR +K+S+ILI + KV GL L RV
Sbjct: 106 ILQGVLKALDYIHHM---GYVHRSVKASHILI--SVDGKVYLSGLRSNLSMINHGQRLRV 160
Query: 351 MGTFG--------YVAPEY--ANTGMLNEKSDIYSFGVLLLEAVTGRDP 389
+ F +++PE N + KSDIYS G+ E G P
Sbjct: 161 VHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVP 209
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha, stabilized through ATP and MO25, may be needed to activate LKB1. A mutation which results in a truncation of a C-terminal part of the human STRAD-alpha pseudokinase domain and disrupts its association with LKB1, leads to PMSE (polyhydramnios, megalencephaly, symptomatic epilepsy) syndrome. Several splice variants of STRAD-alpha exist which exhibit different effects on the localization and activation of LKB1. Length = 327 |
Conserved Domains Detected by HHsearch
Original result of HHsearch against CDD database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 508 | |||
| KOG1187 | 361 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0581 | 364 | consensus Mitogen-activated protein kinase kinase | 100.0 | |
| KOG0192 | 362 | consensus Tyrosine kinase specific for activated ( | 100.0 | |
| KOG0197 | 468 | consensus Tyrosine kinases [Signal transduction me | 100.0 | |
| KOG0575 | 592 | consensus Polo-like serine/threonine protein kinas | 100.0 | |
| KOG0595 | 429 | consensus Serine/threonine-protein kinase involved | 100.0 | |
| KOG0615 | 475 | consensus Serine/threonine protein kinase Chk2 and | 100.0 | |
| KOG0591 | 375 | consensus NIMA (never in mitosis)-related G2-speci | 100.0 | |
| KOG0598 | 357 | consensus Ribosomal protein S6 kinase and related | 100.0 | |
| KOG0592 | 604 | consensus 3-phosphoinositide-dependent protein kin | 100.0 | |
| KOG1026 | 774 | consensus Nerve growth factor receptor TRKA and re | 100.0 | |
| KOG0593 | 396 | consensus Predicted protein kinase KKIAMRE [Genera | 100.0 | |
| KOG4721 | 904 | consensus Serine/threonine protein kinase, contain | 100.0 | |
| KOG0583 | 370 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0582 | 516 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| KOG1094 | 807 | consensus Discoidin domain receptor DDR1 [Signal t | 100.0 | |
| KOG0578 | 550 | consensus p21-activated serine/threonine protein k | 100.0 | |
| KOG0198 | 313 | consensus MEKK and related serine/threonine protei | 100.0 | |
| KOG0600 | 560 | consensus Cdc2-related protein kinase [Cell cycle | 100.0 | |
| KOG0605 | 550 | consensus NDR and related serine/threonine kinases | 100.0 | |
| KOG0616 | 355 | consensus cAMP-dependent protein kinase catalytic | 100.0 | |
| KOG0193 | 678 | consensus Serine/threonine protein kinase RAF [Sig | 100.0 | |
| KOG0196 | 996 | consensus Tyrosine kinase, EPH (ephrin) receptor f | 100.0 | |
| KOG1989 | 738 | consensus ARK protein kinase family [Signal transd | 100.0 | |
| cd05102 | 338 | PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG0611 | 668 | consensus Predicted serine/threonine protein kinas | 100.0 | |
| KOG0661 | 538 | consensus MAPK related serine/threonine protein ki | 100.0 | |
| KOG0588 | 786 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| KOG0597 | 808 | consensus Serine-threonine protein kinase FUSED [G | 100.0 | |
| KOG0659 | 318 | consensus Cdk activating kinase (CAK)/RNA polymera | 100.0 | |
| cd05064 | 266 | PTKc_EphR_A10 Catalytic domain of the Protein Tyro | 100.0 | |
| PHA02988 | 283 | hypothetical protein; Provisional | 100.0 | |
| cd05096 | 304 | PTKc_DDR1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05612 | 291 | STKc_PRKX_like Catalytic domain of PRKX-like Prote | 100.0 | |
| KOG0201 | 467 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05631 | 285 | STKc_GRK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05072 | 261 | PTKc_Lyn Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG2345 | 302 | consensus Serine/threonine protein kinase/TGF-beta | 100.0 | |
| cd07848 | 287 | STKc_CDKL5 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd05600 | 333 | STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- | 100.0 | |
| cd05114 | 256 | PTKc_Tec_Rlk Catalytic domain of the Protein Tyros | 100.0 | |
| cd06649 | 331 | PKc_MEK2 Catalytic domain of the dual-specificity | 100.0 | |
| PTZ00263 | 329 | protein kinase A catalytic subunit; Provisional | 100.0 | |
| cd05148 | 261 | PTKc_Srm_Brk Catalytic domain of the Protein Tyros | 100.0 | |
| KOG0585 | 576 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd05068 | 261 | PTKc_Frk_like Catalytic domain of Fyn-related kina | 100.0 | |
| cd05571 | 323 | STKc_PKB Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG0610 | 459 | consensus Putative serine/threonine protein kinase | 100.0 | |
| KOG1095 | 1025 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| PTZ00267 | 478 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd05104 | 375 | PTKc_Kit Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0194 | 474 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd05573 | 350 | STKc_ROCK_NDR_like Catalytic domain of ROCK- and N | 100.0 | |
| cd05052 | 263 | PTKc_Abl Catalytic domain of the Protein Tyrosine | 100.0 | |
| PTZ00426 | 340 | cAMP-dependent protein kinase catalytic subunit; P | 100.0 | |
| cd07871 | 288 | STKc_PCTAIRE3 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05599 | 364 | STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel | 100.0 | |
| cd05595 | 323 | STKc_PKB_beta Catalytic domain of the Protein Seri | 100.0 | |
| cd05113 | 256 | PTKc_Btk_Bmx Catalytic domain of the Protein Tyros | 100.0 | |
| cd05601 | 330 | STKc_CRIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05593 | 328 | STKc_PKB_gamma Catalytic domain of the Protein Ser | 100.0 | |
| PHA03212 | 391 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd06650 | 333 | PKc_MEK1 Catalytic domain of the dual-specificity | 100.0 | |
| KOG0694 | 694 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05048 | 283 | PTKc_Ror Catalytic Domain of the Protein Tyrosine | 100.0 | |
| KOG0663 | 419 | consensus Protein kinase PITSLRE and related kinas | 100.0 | |
| cd05106 | 374 | PTKc_CSF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05049 | 280 | PTKc_Trk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05070 | 260 | PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros | 100.0 | |
| PF07714 | 259 | Pkinase_Tyr: Protein tyrosine kinase Protein kinas | 100.0 | |
| KOG0580 | 281 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| cd05614 | 332 | STKc_MSK2_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd05071 | 262 | PTKc_Src Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05067 | 260 | PTKc_Lck_Blk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05585 | 312 | STKc_YPK1_like Catalytic domain of Yeast Protein K | 100.0 | |
| cd05059 | 256 | PTKc_Tec_like Catalytic domain of Tec-like Protein | 100.0 | |
| cd07869 | 303 | STKc_PFTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd08228 | 267 | STKc_Nek6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05108 | 316 | PTKc_EGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05062 | 277 | PTKc_IGF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05596 | 370 | STKc_ROCK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05628 | 363 | STKc_NDR1 Catalytic domain of the Protein Serine/T | 100.0 | |
| PLN00034 | 353 | mitogen-activated protein kinase kinase; Provision | 100.0 | |
| PTZ00283 | 496 | serine/threonine protein kinase; Provisional | 100.0 | |
| cd05626 | 381 | STKc_LATS2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05033 | 266 | PTKc_EphR Catalytic domain of Ephrin Receptor Prot | 100.0 | |
| KOG0589 | 426 | consensus Serine/threonine protein kinase [General | 100.0 | |
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 100.0 | |
| cd05069 | 260 | PTKc_Yes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05093 | 288 | PTKc_TrkB Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05588 | 329 | STKc_aPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05034 | 261 | PTKc_Src_like Catalytic domain of Src kinase-like | 100.0 | |
| cd05105 | 400 | PTKc_PDGFR_alpha Catalytic domain of the Protein T | 100.0 | |
| cd05594 | 325 | STKc_PKB_alpha Catalytic domain of the Protein Ser | 100.0 | |
| cd05584 | 323 | STKc_p70S6K Catalytic domain of the Protein Serine | 100.0 | |
| cd07859 | 338 | STKc_TDY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd07862 | 290 | STKc_CDK6 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05608 | 280 | STKc_GRK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05622 | 371 | STKc_ROCK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0658 | 364 | consensus Glycogen synthase kinase-3 [Carbohydrate | 100.0 | |
| cd05589 | 324 | STKc_PKN Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05094 | 291 | PTKc_TrkC Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05587 | 324 | STKc_cPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05590 | 320 | STKc_nPKC_eta Catalytic domain of the Protein Seri | 100.0 | |
| cd05084 | 252 | PTKc_Fes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05085 | 250 | PTKc_Fer Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05605 | 285 | STKc_GRK4_like Catalytic domain of G protein-coupl | 100.0 | |
| cd05621 | 370 | STKc_ROCK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0599 | 411 | consensus Phosphorylase kinase gamma subunit [Carb | 100.0 | |
| cd05629 | 377 | STKc_NDR_like_fungal Catalytic domain of Fungal Nu | 100.0 | |
| cd05054 | 337 | PTKc_VEGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| PTZ00036 | 440 | glycogen synthase kinase; Provisional | 100.0 | |
| cd05618 | 329 | STKc_aPKC_iota Catalytic domain of the Protein Ser | 100.0 | |
| cd05625 | 382 | STKc_LATS1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05592 | 316 | STKc_nPKC_theta_delta Catalytic domain of the Prot | 100.0 | |
| cd05598 | 376 | STKc_LATS Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06646 | 267 | STKc_MAP4K5 Catalytic domain of the Protein Serine | 100.0 | |
| cd05053 | 293 | PTKc_FGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05073 | 260 | PTKc_Hck Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0032 | 382 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd05032 | 277 | PTKc_InsR_like Catalytic domain of Insulin Recepto | 100.0 | |
| cd05617 | 327 | STKc_aPKC_zeta Catalytic domain of the Protein Ser | 100.0 | |
| cd08224 | 267 | STKc_Nek6_Nek7 Catalytic domain of the Protein Ser | 100.0 | |
| cd05081 | 284 | PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of | 100.0 | |
| cd05620 | 316 | STKc_nPKC_delta Catalytic domain of the Protein Se | 100.0 | |
| cd05036 | 277 | PTKc_ALK_LTK Catalytic domain of the Protein Tyros | 100.0 | |
| cd05616 | 323 | STKc_cPKC_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd05092 | 280 | PTKc_TrkA Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06625 | 263 | STKc_MEKK3_like Catalytic domain of MAP/ERK kinase | 100.0 | |
| cd05039 | 256 | PTKc_Csk_like Catalytic domain of C-terminal Src k | 100.0 | |
| cd05591 | 321 | STKc_nPKC_epsilon Catalytic domain of the Protein | 100.0 | |
| cd05090 | 283 | PTKc_Ror1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05570 | 318 | STKc_PKC Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05080 | 283 | PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd07853 | 372 | STKc_NLK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd08529 | 256 | STKc_FA2-like Catalytic domain of the Protein Seri | 100.0 | |
| cd05111 | 279 | PTK_HER3 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd05597 | 331 | STKc_DMPK_like Catalytic domain of Myotonic Dystro | 100.0 | |
| cd05575 | 323 | STKc_SGK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05043 | 280 | PTK_Ryk Pseudokinase domain of Ryk (Receptor relat | 100.0 | |
| cd05045 | 290 | PTKc_RET Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08229 | 267 | STKc_Nek7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05619 | 316 | STKc_nPKC_theta Catalytic domain of the Protein Se | 100.0 | |
| cd05063 | 268 | PTKc_EphR_A2 Catalytic domain of the Protein Tyros | 100.0 | |
| cd05061 | 288 | PTKc_InsR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05091 | 283 | PTKc_Ror2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05582 | 318 | STKc_RSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| PTZ00284 | 467 | protein kinase; Provisional | 100.0 | |
| cd05112 | 256 | PTKc_Itk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05109 | 279 | PTKc_HER2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0660 | 359 | consensus Mitogen-activated protein kinase [Signal | 100.0 | |
| cd05066 | 267 | PTKc_EphR_A Catalytic domain of the Protein Tyrosi | 100.0 | |
| PHA03207 | 392 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05035 | 273 | PTKc_Axl_like Catalytic Domain of Axl-like Protein | 100.0 | |
| cd05098 | 307 | PTKc_FGFR1 Catalytic domain of the Protein Tyrosin | 100.0 | |
| KOG4278 | 1157 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| KOG0033 | 355 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd05075 | 272 | PTKc_Axl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05116 | 257 | PTKc_Syk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05607 | 277 | STKc_GRK7 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG4257 | 974 | consensus Focal adhesion tyrosine kinase FAK, cont | 100.0 | |
| cd05604 | 325 | STKc_SGK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0594 | 323 | consensus Protein kinase PCTAIRE and related kinas | 100.0 | |
| cd05082 | 256 | PTKc_Csk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06619 | 279 | PKc_MKK5 Catalytic domain of the dual-specificity | 100.0 | |
| cd08219 | 255 | STKc_Nek3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05107 | 401 | PTKc_PDGFR_beta Catalytic domain of the Protein Ty | 100.0 | |
| cd05056 | 270 | PTKc_FAK Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05089 | 297 | PTKc_Tie1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06654 | 296 | STKc_PAK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05095 | 296 | PTKc_DDR2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05055 | 302 | PTKc_PDGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05615 | 323 | STKc_cPKC_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd05115 | 257 | PTKc_Zap-70 Catalytic domain of the Protein Tyrosi | 100.0 | |
| PF00069 | 260 | Pkinase: Protein kinase domain Protein kinase; unc | 100.0 | |
| KOG4717 | 864 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd06615 | 308 | PKc_MEK Catalytic domain of the dual-specificity P | 100.0 | |
| PTZ00266 | 1021 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd06613 | 262 | STKc_MAP4K3_like Catalytic domain of Mitogen-activ | 100.0 | |
| cd05097 | 295 | PTKc_DDR_like Catalytic domain of Discoidin Domain | 100.0 | |
| cd05624 | 331 | STKc_MRCK_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd05065 | 269 | PTKc_EphR_B Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05627 | 360 | STKc_NDR2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05041 | 251 | PTKc_Fes_like Catalytic domain of Fes-like Protein | 100.0 | |
| cd05101 | 304 | PTKc_FGFR2 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd00192 | 262 | PTKc Catalytic domain of Protein Tyrosine Kinases. | 100.0 | |
| cd05602 | 325 | STKc_SGK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07872 | 309 | STKc_PCTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05088 | 303 | PTKc_Tie2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07876 | 359 | STKc_JNK2 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05060 | 257 | PTKc_Syk_like Catalytic domain of Spleen Tyrosine | 100.0 | |
| cd06612 | 256 | STKc_MST1_2 Catalytic domain of the Protein Serine | 100.0 | |
| cd05603 | 321 | STKc_SGK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| PHA03209 | 357 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd06624 | 268 | STKc_ASK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06645 | 267 | STKc_MAP4K3 Catalytic domain of the Protein Serine | 100.0 | |
| cd05050 | 288 | PTKc_Musk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05099 | 314 | PTKc_FGFR4 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05630 | 285 | STKc_GRK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05051 | 296 | PTKc_DDR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05077 | 262 | PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| PHA03211 | 461 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd06643 | 282 | STKc_SLK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05632 | 285 | STKc_GRK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06655 | 296 | STKc_PAK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06656 | 297 | STKc_PAK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07863 | 288 | STKc_CDK4 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05623 | 332 | STKc_MRCK_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd06611 | 280 | STKc_SLK_like Catalytic domain of Ste20-like kinas | 100.0 | |
| cd06628 | 267 | STKc_MAPKKK_Byr2_like Catalytic domain of fungal B | 100.0 | |
| cd05103 | 343 | PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG2052 | 513 | consensus Activin A type IB receptor, serine/threo | 100.0 | |
| cd06631 | 265 | STKc_YSK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05047 | 270 | PTKc_Tie Catalytic domain of Tie Protein Tyrosine | 100.0 | |
| cd06644 | 292 | STKc_STK10_LOK Catalytic domain of the Protein Ser | 100.0 | |
| cd05079 | 284 | PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd05046 | 275 | PTK_CCK4 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| KOG3653 | 534 | consensus Transforming growth factor beta/activin | 100.0 | |
| cd06638 | 286 | STKc_myosinIIIA Catalytic domain of the Protein Se | 100.0 | |
| cd06620 | 284 | PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr | 100.0 | |
| cd05100 | 334 | PTKc_FGFR3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| PRK13184 | 932 | pknD serine/threonine-protein kinase; Reviewed | 100.0 | |
| cd08221 | 256 | STKc_Nek9 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06637 | 272 | STKc_TNIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05076 | 274 | PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| KOG0667 | 586 | consensus Dual-specificity tyrosine-phosphorylatio | 100.0 | |
| cd08223 | 257 | STKc_Nek4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07873 | 301 | STKc_PCTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd06609 | 274 | STKc_MST3_like Catalytic domain of Mammalian Ste20 | 100.0 | |
| cd07861 | 285 | STKc_CDK1_euk Catalytic domain of the Serine/Threo | 100.0 | |
| cd05083 | 254 | PTKc_Chk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05058 | 262 | PTKc_Met_Ron Catalytic domain of the Protein Tyros | 100.0 | |
| cd07875 | 364 | STKc_JNK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd08528 | 269 | STKc_Nek10 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06621 | 287 | PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek | 100.0 | |
| cd07874 | 355 | STKc_JNK3 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05044 | 269 | PTKc_c-ros Catalytic domain of the Protein Tyrosin | 100.0 | |
| smart00219 | 258 | TyrKc Tyrosine kinase, catalytic domain. Phosphotr | 100.0 | |
| cd06640 | 277 | STKc_MST4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05040 | 257 | PTKc_Ack_like Catalytic domain of the Protein Tyro | 100.0 | |
| cd08218 | 256 | STKc_Nek1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07868 | 317 | STKc_CDK8 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05087 | 269 | PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein | 100.0 | |
| cd05574 | 316 | STKc_phototropin_like Catalytic domain of Phototro | 100.0 | |
| cd05038 | 284 | PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P | 100.0 | |
| cd05057 | 279 | PTKc_EGFR_like Catalytic domain of Epidermal Growt | 100.0 | |
| cd08217 | 265 | STKc_Nek2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06622 | 286 | PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS | 100.0 | |
| cd08227 | 327 | PK_STRAD_alpha Pseudokinase domain of STE20-relate | 100.0 | |
| cd06639 | 291 | STKc_myosinIIIB Catalytic domain of the Protein Se | 100.0 | |
| cd06630 | 268 | STKc_MEKK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06642 | 277 | STKc_STK25-YSK1 Catalytic domain of the Protein Se | 100.0 | |
| cd07847 | 286 | STKc_CDKL1_4 Catalytic domain of the Serine/Threon | 100.0 | |
| cd05037 | 259 | PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the | 100.0 | |
| cd05110 | 303 | PTKc_HER4 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06626 | 264 | STKc_MEKK4 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05586 | 330 | STKc_Sck1_like Catalytic domain of Suppressor of l | 100.0 | |
| cd06632 | 258 | STKc_MEKK1_plant Catalytic domain of the Protein S | 100.0 | |
| cd05580 | 290 | STKc_PKA Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06658 | 292 | STKc_PAK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| PHA03210 | 501 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd07832 | 286 | STKc_CCRK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd08220 | 256 | STKc_Nek8 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05078 | 258 | PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain | 100.0 | |
| cd06605 | 265 | PKc_MAPKK Catalytic domain of the dual-specificity | 100.0 | |
| cd07878 | 343 | STKc_p38beta_MAPK11 Catalytic domain of the Serine | 100.0 | |
| cd06651 | 266 | STKc_MEKK3 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06636 | 282 | STKc_MAP4K4_6 Catalytic domain of the Protein Seri | 100.0 | |
| cd06623 | 264 | PKc_MAPKK_plant_like Catalytic domain of Plant dua | 100.0 | |
| cd07833 | 288 | STKc_CDKL Catalytic domain of Cyclin-Dependent pro | 100.0 | |
| KOG0577 | 948 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd06610 | 267 | STKc_OSR1_SPAK Catalytic domain of the Protein Ser | 100.0 | |
| KOG0199 | 1039 | consensus ACK and related non-receptor tyrosine ki | 100.0 | |
| KOG0574 | 502 | consensus STE20-like serine/threonine kinase MST [ | 100.0 | |
| cd06652 | 265 | STKc_MEKK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07846 | 286 | STKc_CDKL2_3 Catalytic domain of the Serine/Threon | 100.0 | |
| cd06629 | 272 | STKc_MAPKKK_Bck1_like Catalytic domain of fungal B | 100.0 | |
| cd07839 | 284 | STKc_CDK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05042 | 269 | PTKc_Aatyk Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05086 | 268 | PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd06608 | 275 | STKc_myosinIII_like Catalytic domain of Class III | 100.0 | |
| cd06617 | 283 | PKc_MKK3_6 Catalytic domain of the dual-specificit | 100.0 | |
| cd07867 | 317 | STKc_CDC2L6 Catalytic domain of Serine/Threonine K | 100.0 | |
| cd05609 | 305 | STKc_MAST Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0579 | 1187 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| cd06659 | 297 | STKc_PAK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05074 | 273 | PTKc_Tyro3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd06647 | 293 | STKc_PAK_I Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05122 | 253 | PKc_STE Catalytic domain of STE family Protein Kin | 100.0 | |
| cd07844 | 291 | STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like | 100.0 | |
| cd07870 | 291 | STKc_PFTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| KOG4279 | 1226 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd06607 | 307 | STKc_TAO Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07841 | 298 | STKc_CDK7 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06641 | 277 | STKc_MST3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06648 | 285 | STKc_PAK_II Catalytic domain of the Protein Serine | 100.0 | |
| KOG0612 | 1317 | consensus Rho-associated, coiled-coil containing p | 100.0 | |
| KOG0596 | 677 | consensus Dual specificity; serine/threonine and t | 100.0 | |
| cd05578 | 258 | STKc_Yank1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07842 | 316 | STKc_CDK8_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd06614 | 286 | STKc_PAK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07860 | 284 | STKc_CDK2_3 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd08225 | 257 | STKc_Nek5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06917 | 277 | STKc_NAK1_like Catalytic domain of Fungal Nak1-lik | 100.0 | |
| cd08215 | 258 | STKc_Nek Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06616 | 288 | PKc_MKK4 Catalytic domain of the dual-specificity | 100.0 | |
| KOG0983 | 391 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| cd08530 | 256 | STKc_CNK2-like Catalytic domain of the Protein Ser | 100.0 | |
| cd05633 | 279 | STKc_GRK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05572 | 262 | STKc_cGK_PKG Catalytic domain of the Protein Serin | 100.0 | |
| KOG0584 | 632 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd07843 | 293 | STKc_CDC2L1 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd07837 | 295 | STKc_CdkB_plant Catalytic domain of the Serine/Thr | 100.0 | |
| cd07831 | 282 | STKc_MOK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06635 | 317 | STKc_TAO1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06606 | 260 | STKc_MAPKKK Catalytic domain of the Protein Serine | 100.0 | |
| cd07840 | 287 | STKc_CDK9_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd07835 | 283 | STKc_CDK1_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd06627 | 254 | STKc_Cdc7_like Catalytic domain of Cell division c | 100.0 | |
| cd07850 | 353 | STKc_JNK Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0586 | 596 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd07864 | 302 | STKc_CDK12 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd06653 | 264 | STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina | 100.0 | |
| cd07845 | 309 | STKc_CDK10 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd06657 | 292 | STKc_PAK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0690 | 516 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd07836 | 284 | STKc_Pho85 Catalytic domain of the Serine/Threonin | 100.0 | |
| PHA02882 | 294 | putative serine/threonine kinase; Provisional | 100.0 | |
| cd05577 | 277 | STKc_GRK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07865 | 310 | STKc_CDK9 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07849 | 336 | STKc_ERK1_2_like Catalytic domain of Extracellular | 100.0 | |
| KOG1025 | 1177 | consensus Epidermal growth factor receptor EGFR an | 100.0 | |
| cd05581 | 280 | STKc_PDK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05613 | 290 | STKc_MSK1_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd08226 | 328 | PK_STRAD_beta Pseudokinase domain of STE20-related | 100.0 | |
| PHA03390 | 267 | pk1 serine/threonine-protein kinase 1; Provisional | 100.0 | |
| cd07858 | 337 | STKc_TEY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd05118 | 283 | STKc_CMGC Catalytic domain of CMGC family Serine/T | 100.0 | |
| KOG1024 | 563 | consensus Receptor-like protein tyrosine kinase RY | 100.0 | |
| cd05579 | 265 | STKc_MAST_like Catalytic domain of Microtubule-ass | 100.0 | |
| PLN00009 | 294 | cyclin-dependent kinase A; Provisional | 100.0 | |
| cd05611 | 260 | STKc_Rim15_like Catalytic domain of fungal Rim15-l | 100.0 | |
| cd05583 | 288 | STKc_MSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd07852 | 337 | STKc_MAPK15 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd08216 | 314 | PK_STRAD Pseudokinase domain of STE20-related kina | 100.0 | |
| cd05606 | 278 | STKc_beta_ARK Catalytic domain of the Protein Seri | 100.0 | |
| cd07855 | 334 | STKc_ERK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06618 | 296 | PKc_MKK7 Catalytic domain of the dual-specificity | 100.0 | |
| cd06633 | 313 | STKc_TAO3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06634 | 308 | STKc_TAO2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07834 | 330 | STKc_MAPK Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0607 | 463 | consensus MAP kinase-interacting kinase and relate | 100.0 | |
| cd07838 | 287 | STKc_CDK4_6_like Catalytic domain of Cyclin-Depend | 100.0 | |
| cd08222 | 260 | STKc_Nek11 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07866 | 311 | STKc_BUR1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07830 | 283 | STKc_MAK_like Catalytic domain of Male germ cell-A | 100.0 | |
| KOG4645 | 1509 | consensus MAPKKK (MAP kinase kinase kinase) SSK2 a | 100.0 | |
| KOG0604 | 400 | consensus MAP kinase-activated protein kinase 2 [S | 100.0 | |
| cd07877 | 345 | STKc_p38alpha_MAPK14 Catalytic domain of the Serin | 100.0 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 100.0 | |
| PTZ00024 | 335 | cyclin-dependent protein kinase; Provisional | 100.0 | |
| KOG0986 | 591 | consensus G protein-coupled receptor kinase [Signa | 100.0 | |
| cd07856 | 328 | STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre | 100.0 | |
| cd07854 | 342 | STKc_MAPK4_6 Catalytic domain of the Serine/Threon | 100.0 | |
| KOG0200 | 609 | consensus Fibroblast/platelet-derived growth facto | 100.0 | |
| cd07879 | 342 | STKc_p38delta_MAPK13 Catalytic domain of the Serin | 100.0 | |
| cd07880 | 343 | STKc_p38gamma_MAPK12 Catalytic domain of the Serin | 100.0 | |
| KOG4236 | 888 | consensus Serine/threonine protein kinase PKC mu/P | 100.0 | |
| cd07829 | 282 | STKc_CDK_like Catalytic domain of Cyclin-Dependent | 100.0 | |
| cd05123 | 250 | STKc_AGC Catalytic domain of AGC family Protein Se | 100.0 | |
| KOG0671 | 415 | consensus LAMMER dual specificity kinases [Signal | 100.0 | |
| cd07857 | 332 | STKc_MPK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG1006 | 361 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| cd07851 | 343 | STKc_p38 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG4250 | 732 | consensus TANK binding protein kinase TBK1 [Signal | 100.0 | |
| cd05610 | 669 | STKc_MASTL Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0666 | 438 | consensus Cyclin C-dependent kinase CDK8 [Transcri | 100.0 | |
| cd05576 | 237 | STKc_RPK118_like Catalytic domain of the Protein S | 100.0 | |
| KOG0587 | 953 | consensus Traf2- and Nck-interacting kinase and re | 100.0 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 100.0 | |
| KOG0696 | 683 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG1151 | 775 | consensus Tousled-like protein kinase [Signal tran | 100.0 | |
| PLN03225 | 566 | Serine/threonine-protein kinase SNT7; Provisional | 100.0 | |
| KOG0614 | 732 | consensus cGMP-dependent protein kinase [Signal tr | 100.0 | |
| KOG0984 | 282 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| KOG0695 | 593 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| smart00220 | 244 | S_TKc Serine/Threonine protein kinases, catalytic | 100.0 | |
| PLN03224 | 507 | probable serine/threonine protein kinase; Provisio | 100.0 | |
| KOG0608 | 1034 | consensus Warts/lats-like serine threonine kinases | 100.0 | |
| KOG0662 | 292 | consensus Cyclin-dependent kinase CDK5 [Intracellu | 100.0 | |
| KOG1027 | 903 | consensus Serine/threonine protein kinase and endo | 100.0 | |
| KOG0669 | 376 | consensus Cyclin T-dependent kinase CDK9 [Cell cyc | 99.97 | |
| KOG0670 | 752 | consensus U4/U6-associated splicing factor PRP4 [R | 99.97 | |
| KOG0664 | 449 | consensus Nemo-like MAPK-related serine/threonine | 99.97 | |
| KOG1290 | 590 | consensus Serine/threonine protein kinase [Signal | 99.97 | |
| cd00180 | 215 | PKc Catalytic domain of Protein Kinases. Protein K | 99.97 | |
| KOG1152 | 772 | consensus Signal transduction serine/threonine kin | 99.96 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 99.96 | |
| smart00221 | 225 | STYKc Protein kinase; unclassified specificity. Ph | 99.96 | |
| KOG0668 | 338 | consensus Casein kinase II, alpha subunit [Signal | 99.96 | |
| KOG0665 | 369 | consensus Jun-N-terminal kinase (JNK) [Signal tran | 99.96 | |
| KOG1345 | 378 | consensus Serine/threonine kinase [Signal transduc | 99.95 | |
| PLN00181 | 793 | protein SPA1-RELATED; Provisional | 99.95 | |
| smart00750 | 176 | KIND kinase non-catalytic C-lobe domain. It is an | 99.94 | |
| KOG1167 | 418 | consensus Serine/threonine protein kinase of the C | 99.94 | |
| KOG1165 | 449 | consensus Casein kinase (serine/threonine/tyrosine | 99.92 | |
| KOG0195 | 448 | consensus Integrin-linked kinase [Signal transduct | 99.92 | |
| PRK09188 | 365 | serine/threonine protein kinase; Provisional | 99.92 | |
| KOG1164 | 322 | consensus Casein kinase (serine/threonine/tyrosine | 99.91 | |
| COG0515 | 384 | SPS1 Serine/threonine protein kinase [General func | 99.9 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.89 | |
| KOG1163 | 341 | consensus Casein kinase (serine/threonine/tyrosine | 99.89 | |
| KOG1240 | 1431 | consensus Protein kinase containing WD40 repeats [ | 99.89 | |
| PRK10359 | 232 | lipopolysaccharide core biosynthesis protein; Prov | 99.87 | |
| cd05147 | 190 | RIO1_euk RIO kinase family; eukaryotic RIO1, catal | 99.86 | |
| cd05145 | 190 | RIO1_like RIO kinase family; RIO1, RIO3 and simila | 99.85 | |
| KOG1023 | 484 | consensus Natriuretic peptide receptor, guanylate | 99.84 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.84 | |
| PF14531 | 288 | Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_ | 99.84 | |
| PRK12274 | 218 | serine/threonine protein kinase; Provisional | 99.83 | |
| KOG4158 | 598 | consensus BRPK/PTEN-induced protein kinase [Signal | 99.83 | |
| KOG1166 | 974 | consensus Mitotic checkpoint serine/threonine prot | 99.81 | |
| PRK10345 | 210 | hypothetical protein; Provisional | 99.8 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.78 | |
| smart00090 | 237 | RIO RIO-like kinase. | 99.77 | |
| PRK14879 | 211 | serine/threonine protein kinase; Provisional | 99.75 | |
| TIGR03724 | 199 | arch_bud32 Kae1-associated kinase Bud32. Members o | 99.75 | |
| KOG1033 | 516 | consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati | 99.75 | |
| PRK09605 | 535 | bifunctional UGMP family protein/serine/threonine | 99.74 | |
| cd05144 | 198 | RIO2_C RIO kinase family; RIO2, C-terminal catalyt | 99.72 | |
| cd05120 | 155 | APH_ChoK_like Aminoglycoside 3'-phosphotransferase | 99.64 | |
| cd05119 | 187 | RIO RIO kinase family, catalytic domain. The RIO k | 99.64 | |
| PRK01723 | 239 | 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | 99.62 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.6 | |
| KOG1266 | 458 | consensus Protein kinase [Signal transduction mech | 99.56 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.49 | |
| TIGR01982 | 437 | UbiB 2-polyprenylphenol 6-hydroxylase. This model | 99.47 | |
| PRK04750 | 537 | ubiB putative ubiquinone biosynthesis protein UbiB | 99.36 | |
| cd05151 | 170 | ChoK Choline Kinase (ChoK). The ChoK subfamily is | 99.32 | |
| KOG1243 | 690 | consensus Protein kinase [General function predict | 99.32 | |
| KOG3087 | 229 | consensus Serine/threonine protein kinase [General | 99.22 | |
| cd05146 | 197 | RIO3_euk RIO kinase family; eukaryotic RIO3, catal | 99.21 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.17 | |
| COG3642 | 204 | Mn2+-dependent serine/threonine protein kinase [Si | 99.14 | |
| cd05154 | 223 | ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an | 99.13 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.11 | |
| COG4248 | 637 | Uncharacterized protein with protein kinase and he | 99.09 | |
| KOG3741 | 655 | consensus Poly(A) ribonuclease subunit [RNA proces | 99.07 | |
| PRK15123 | 268 | lipopolysaccharide core heptose(I) kinase RfaP; Pr | 98.99 | |
| PF01163 | 188 | RIO1: RIO1 family; InterPro: IPR018934 Protein pho | 98.88 | |
| COG0478 | 304 | RIO-like serine/threonine protein kinase fused to | 98.8 | |
| PF06293 | 206 | Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; | 98.69 | |
| PRK09902 | 216 | hypothetical protein; Provisional | 98.63 | |
| COG0661 | 517 | AarF Predicted unusual protein kinase [General fun | 98.62 | |
| KOG2137 | 700 | consensus Protein kinase [Signal transduction mech | 98.56 | |
| PF06176 | 229 | WaaY: Lipopolysaccharide core biosynthesis protein | 98.48 | |
| TIGR02172 | 226 | Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou | 98.34 | |
| PF01636 | 239 | APH: Phosphotransferase enzyme family This family | 98.29 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 98.21 | |
| KOG1235 | 538 | consensus Predicted unusual protein kinase [Genera | 98.2 | |
| COG1718 | 268 | RIO1 Serine/threonine protein kinase involved in c | 98.2 | |
| PF12260 | 188 | PIP49_C: Protein-kinase domain of FAM69; InterPro: | 98.17 | |
| PF10707 | 199 | YrbL-PhoP_reg: PhoP regulatory network protein Yrb | 98.11 | |
| cd05150 | 244 | APH Aminoglycoside 3'-phosphotransferase (APH). Th | 98.1 | |
| PLN02876 | 822 | acyl-CoA dehydrogenase | 98.03 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 97.98 | |
| COG2112 | 201 | Predicted Ser/Thr protein kinase [Signal transduct | 97.84 | |
| PRK10593 | 297 | hypothetical protein; Provisional | 97.74 | |
| cd05157 | 235 | ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes. | 97.57 | |
| PF13095 | 207 | FTA2: Kinetochore Sim4 complex subunit FTA2 | 97.57 | |
| cd05155 | 235 | APH_ChoK_like_1 Uncharacterized bacterial proteins | 97.57 | |
| PRK09550 | 401 | mtnK methylthioribose kinase; Reviewed | 97.54 | |
| TIGR02721 | 256 | ycfN_thiK thiamine kinase. Members of this family | 97.41 | |
| PRK05231 | 319 | homoserine kinase; Provisional | 97.4 | |
| cd05153 | 296 | HomoserineK_II Homoserine Kinase, type II. Homoser | 97.31 | |
| KOG2268 | 465 | consensus Serine/threonine protein kinase [Signal | 97.18 | |
| TIGR00938 | 307 | thrB_alt homoserine kinase, Neisseria type. Homose | 97.16 | |
| KOG1826 | 2724 | consensus Ras GTPase activating protein RasGAP/neu | 97.05 | |
| cd05156 | 302 | ChoK_euk Choline Kinase (ChoK) in eukaryotes. The | 97.05 | |
| PF03881 | 288 | Fructosamin_kin: Fructosamine kinase; InterPro: IP | 96.91 | |
| cd05152 | 276 | MPH2' Macrolide 2'-Phosphotransferase (MPH2'). MPH | 96.84 | |
| KOG2270 | 520 | consensus Serine/threonine protein kinase involved | 96.73 | |
| PLN02756 | 418 | S-methyl-5-thioribose kinase | 96.58 | |
| PF01102 | 122 | Glycophorin_A: Glycophorin A; InterPro: IPR001195 | 96.57 | |
| COG3173 | 321 | Predicted aminoglycoside phosphotransferase [Gener | 96.53 | |
| TIGR02906 | 313 | spore_CotS spore coat protein, CotS family. Member | 96.33 | |
| TIGR01767 | 370 | MTRK 5-methylthioribose kinase. This enzyme is inv | 96.24 | |
| COG2334 | 331 | Putative homoserine kinase type II (protein kinase | 96.13 | |
| COG3001 | 286 | Uncharacterized protein conserved in bacteria [Fun | 96.09 | |
| PLN02236 | 344 | choline kinase | 96.09 | |
| TIGR02904 | 309 | spore_ysxE spore coat protein YsxE. Members of thi | 95.85 | |
| PTZ00382 | 96 | Variant-specific surface protein (VSP); Provisiona | 95.79 | |
| KOG1093 | 725 | consensus Predicted protein kinase (contains TBC a | 95.71 | |
| PRK12396 | 409 | 5-methylribose kinase; Reviewed | 95.37 | |
| PRK11768 | 325 | serine/threonine protein kinase; Provisional | 95.31 | |
| COG5072 | 488 | ALK1 Serine/threonine kinase of the haspin family | 95.26 | |
| PLN02421 | 330 | phosphotransferase, alcohol group as acceptor/kina | 94.96 | |
| PRK06148 | 1013 | hypothetical protein; Provisional | 94.88 | |
| PF14575 | 75 | EphA2_TM: Ephrin type-A receptor 2 transmembrane d | 94.68 | |
| PF12273 | 130 | RCR: Chitin synthesis regulation, resistance to Co | 94.42 |
| >KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-54 Score=431.43 Aligned_cols=289 Identities=55% Similarity=0.930 Sum_probs=253.1
Q ss_pred CcceeHHHHHHhhCCcccceeEeeeCceEEEEEEEcCCCEEEEEEEcccchhhHHHHHHHHHHHhcCCCCCceeEEEEEE
Q 010519 173 GHWFTLRDLEIATNRFSAENVLGEGGYGVVYKGRLINGSEVAVKKLLNNLGQAEKEFRVEVEAIGHVRHKNLVRLLGYCI 252 (508)
Q Consensus 173 ~~~~~~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~ei~~l~~l~h~niv~~~~~~~ 252 (508)
...|++.++..++++|...+.||+|+||.||+|...+|..||||++.....+...+|..|+.++.+++|||+|+++|||.
T Consensus 62 ~~~fs~~el~~AT~~Fs~~~~ig~Ggfg~VYkG~l~~~~~vAVK~~~~~~~~~~~eF~~Ei~~ls~l~H~Nlv~LlGyC~ 141 (361)
T KOG1187|consen 62 LRSFSYDELRKATNNFSESNLIGEGGFGTVYKGVLSDGTVVAVKRLSSNSGQGEREFLNEVEILSRLRHPNLVKLLGYCL 141 (361)
T ss_pred cceeeHHHHHHHHhCCchhcceecCCCeEEEEEEECCCCEEEEEEecCCCCcchhHHHHHHHHHhcCCCcCcccEEEEEe
Confidence 45689999999999999999999999999999999888999999886654431456999999999999999999999999
Q ss_pred eCc-eeeEEEeecCCCCHHHHHhhhhccCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCEEEcCCCcEEEE
Q 010519 253 EGV-HRMLVYEYVNNGNLEQWLHGAMRNQGNLTWEARMKVIIGTAKALAYLHEAIEPKVVHRDIKSSNILIDDEFNAKVS 331 (508)
Q Consensus 253 ~~~-~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~ 331 (508)
+.+ +.+||||||++|+|.++|+..... .++|..+++|+.++|+||+|||....|+||||||||+|||||+++++||+
T Consensus 142 e~~~~~~LVYEym~nGsL~d~L~~~~~~--~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~~~aKls 219 (361)
T KOG1187|consen 142 EGGEHRLLVYEYMPNGSLEDHLHGKKGE--PLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDEDFNAKLS 219 (361)
T ss_pred cCCceEEEEEEccCCCCHHHHhCCCCCC--CCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCCCCEEcc
Confidence 998 599999999999999999853211 89999999999999999999999888899999999999999999999999
Q ss_pred ecCCccccCCCCCcccccccccccccCccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCCCchhcHHHHHHHHhcc
Q 010519 332 DFGLAKLLDSGESHITTRVMGTFGYVAPEYANTGMLNEKSDIYSFGVLLLEAVTGRDPVDYGRPANEVNLVEWLKMMVGT 411 (508)
Q Consensus 332 Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~ 411 (508)
|||+++..........+...||.+|+|||++..+..+.|+|||||||+|+||+||+.|.+...+..+..+..|.......
T Consensus 220 DFGLa~~~~~~~~~~~~~~~gt~gY~~PEy~~~g~lt~KsDVySFGVvllElitgr~~~d~~~~~~~~~l~~w~~~~~~~ 299 (361)
T KOG1187|consen 220 DFGLAKLGPEGDTSVSTTVMGTFGYLAPEYASTGKLTEKSDVYSFGVVLLELITGRKAVDQSRPRGELSLVEWAKPLLEE 299 (361)
T ss_pred CccCcccCCccccceeeecCCCCccCChhhhccCCcCcccccccchHHHHHHHhCCcccCCCCCcccccHHHHHHHHHHC
Confidence 99999765431111111117999999999999999999999999999999999999998877766777799999888888
Q ss_pred cccccccCCCCC-CChhH-HHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhhcCC
Q 010519 412 RRAEEVVDPNLE-VKPAT-RALKRSLLVALRCVDPDSEKRPKMSQVVRMLEADD 463 (508)
Q Consensus 412 ~~~~~~~~~~~~-~~~~~-~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~ 463 (508)
..+.+++|+.+. ..... ....++..++.+|++.+|.+||+|.||+++|+...
T Consensus 300 ~~~~eiiD~~l~~~~~~~~~~~~~~~~~a~~C~~~~~~~RP~m~~Vv~~L~~~~ 353 (361)
T KOG1187|consen 300 GKLREIVDPRLKEGEYPDEKEVKKLAELALRCLRPDPKERPTMSQVVKELEGIL 353 (361)
T ss_pred cchhheeCCCccCCCCChHHHHHHHHHHHHHHcCcCCCcCcCHHHHHHHHHhhc
Confidence 899999999987 33332 67888999999999999999999999999995543
|
|
| >KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-49 Score=378.13 Aligned_cols=258 Identities=29% Similarity=0.431 Sum_probs=213.1
Q ss_pred CCcccceeEeeeCceEEEEEEEc-CCCEEEEEEEcccc-hhhHHHHHHHHHHHhcCCCCCceeEEEEEEeCc-eeeEEEe
Q 010519 186 NRFSAENVLGEGGYGVVYKGRLI-NGSEVAVKKLLNNL-GQAEKEFRVEVEAIGHVRHKNLVRLLGYCIEGV-HRMLVYE 262 (508)
Q Consensus 186 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~ei~~l~~l~h~niv~~~~~~~~~~-~~~lv~E 262 (508)
.+++..+.||+|..|+||+++++ ++..+|+|++..+. ....+++.+|+++++.++|||||.+||.|.... ...|+||
T Consensus 79 ~dle~~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~~~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~~~~isI~mE 158 (364)
T KOG0581|consen 79 SDLERLGVLGSGNGGTVYKVRHKPTGKIYALKVILLNIDPALQKQILRELEILRSCQSPYIVGFYGAFYSNGEEISICME 158 (364)
T ss_pred HHhhhhhhcccCCCcEEEEEEEcCCCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEeCCceEEeehh
Confidence 34556788999999999999987 57788999985444 445578999999999999999999999999998 4999999
Q ss_pred ecCCCCHHHHHhhhhccCCCccHHHHHHHHHHHHHHHHHHHh-cCCCCeEeecCCCCCEEEcCCCcEEEEecCCccccCC
Q 010519 263 YVNNGNLEQWLHGAMRNQGNLTWEARMKVIIGTAKALAYLHE-AIEPKVVHRDIKSSNILIDDEFNAKVSDFGLAKLLDS 341 (508)
Q Consensus 263 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~yLH~-~~~~~iiH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~ 341 (508)
||++|+|.+++. ..+++++....+|+.+|++||.|||+ . +||||||||+|||++..|.+||||||.+..+.+
T Consensus 159 YMDgGSLd~~~k----~~g~i~E~~L~~ia~~VL~GL~YLh~~~---~IIHRDIKPsNlLvNskGeVKicDFGVS~~lvn 231 (364)
T KOG0581|consen 159 YMDGGSLDDILK----RVGRIPEPVLGKIARAVLRGLSYLHEER---KIIHRDIKPSNLLVNSKGEVKICDFGVSGILVN 231 (364)
T ss_pred hcCCCCHHHHHh----hcCCCCHHHHHHHHHHHHHHHHHHhhcc---CeeeccCCHHHeeeccCCCEEeccccccHHhhh
Confidence 999999999984 44789999999999999999999996 5 999999999999999999999999999997755
Q ss_pred CCCcccccccccccccCccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCCCchhcHHHHHHHHhcccccccccCCC
Q 010519 342 GESHITTRVMGTFGYVAPEYANTGMLNEKSDIYSFGVLLLEAVTGRDPVDYGRPANEVNLVEWLKMMVGTRRAEEVVDPN 421 (508)
Q Consensus 342 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 421 (508)
. ....++||..|||||.+.+..|+.++||||||+.++|+.+|+.||....+ ......+.+........ |.
T Consensus 232 S---~a~tfvGT~~YMsPERi~g~~Ys~~sDIWSLGLsllE~a~GrfP~~~~~~-~~~~~~~Ll~~Iv~~pp------P~ 301 (364)
T KOG0581|consen 232 S---IANTFVGTSAYMSPERISGESYSVKSDIWSLGLSLLELAIGRFPYPPPNP-PYLDIFELLCAIVDEPP------PR 301 (364)
T ss_pred h---hcccccccccccChhhhcCCcCCcccceecccHHHHHHhhCCCCCCCcCC-CCCCHHHHHHHHhcCCC------CC
Confidence 4 45678999999999999999999999999999999999999999975421 12222333333322211 22
Q ss_pred CCCChhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhhcCC
Q 010519 422 LEVKPATRALKRSLLVALRCVDPDSEKRPKMSQVVRMLEADD 463 (508)
Q Consensus 422 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~ 463 (508)
+... ....++..++..||++||.+|||+.|+++|-.-..
T Consensus 302 lP~~---~fS~ef~~FV~~CL~Kdp~~R~s~~qLl~Hpfi~~ 340 (364)
T KOG0581|consen 302 LPEG---EFSPEFRSFVSCCLRKDPSERPSAKQLLQHPFIKK 340 (364)
T ss_pred CCcc---cCCHHHHHHHHHHhcCCcccCCCHHHHhcCHHHhh
Confidence 2222 34556777999999999999999999998765443
|
|
| >KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-48 Score=388.95 Aligned_cols=260 Identities=33% Similarity=0.541 Sum_probs=210.3
Q ss_pred HhhCCcccceeEeeeCceEEEEEEEcCCCE-EEEEEEcccch--hhHHHHHHHHHHHhcCCCCCceeEEEEEEeCc-eee
Q 010519 183 IATNRFSAENVLGEGGYGVVYKGRLINGSE-VAVKKLLNNLG--QAEKEFRVEVEAIGHVRHKNLVRLLGYCIEGV-HRM 258 (508)
Q Consensus 183 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~-vavK~~~~~~~--~~~~~~~~ei~~l~~l~h~niv~~~~~~~~~~-~~~ 258 (508)
+....+...+.||.|+||+||+|.+ .|+. ||||++..... .....|..|+.+|.+++|||||+|+|+|.+.. .++
T Consensus 38 i~~~~l~~~~~iG~G~~g~V~~~~~-~g~~~vavK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~f~G~~~~~~~~~~ 116 (362)
T KOG0192|consen 38 IDPDELPIEEVLGSGSFGTVYKGKW-RGTDVVAVKIISDPDFDDESRKAFRREASLLSRLRHPNIVQFYGACTSPPGSLC 116 (362)
T ss_pred cChHHhhhhhhcccCCceeEEEEEe-CCceeEEEEEecchhcChHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCceE
Confidence 3334555566799999999999999 5555 99999865432 22568999999999999999999999999887 789
Q ss_pred EEEeecCCCCHHHHHhhhhccCCCccHHHHHHHHHHHHHHHHHHHhcCCCC-eEeecCCCCCEEEcCCC-cEEEEecCCc
Q 010519 259 LVYEYVNNGNLEQWLHGAMRNQGNLTWEARMKVIIGTAKALAYLHEAIEPK-VVHRDIKSSNILIDDEF-NAKVSDFGLA 336 (508)
Q Consensus 259 lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~-iiH~Dlk~~NIll~~~~-~~kl~Dfgla 336 (508)
+||||+++|+|.++|+.. ....+++..++.++.|||.|+.|||++ + ||||||||+||||+.++ ++||+|||++
T Consensus 117 iVtEy~~~GsL~~~l~~~--~~~~l~~~~~l~~aldiArGm~YLH~~---~~iIHrDLK~~NiLv~~~~~~~KI~DFGls 191 (362)
T KOG0192|consen 117 IVTEYMPGGSLSVLLHKK--RKRKLPLKVRLRIALDIARGMEYLHSE---GPIIHRDLKSDNILVDLKGKTLKIADFGLS 191 (362)
T ss_pred EEEEeCCCCcHHHHHhhc--ccCCCCHHHHHHHHHHHHHHHHHHhcC---CCeeecccChhhEEEcCCCCEEEECCCccc
Confidence 999999999999999752 467899999999999999999999998 7 99999999999999998 9999999999
Q ss_pred cccCCCCCcccccccccccccCccccC--CCCCCChhhHHHHHHHHHHHHhCCCCCCCCCCCchhcHHHHHHHHhccccc
Q 010519 337 KLLDSGESHITTRVMGTFGYVAPEYAN--TGMLNEKSDIYSFGVLLLEAVTGRDPVDYGRPANEVNLVEWLKMMVGTRRA 414 (508)
Q Consensus 337 ~~~~~~~~~~~~~~~gt~~y~aPE~~~--~~~~~~~~DvwS~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~ 414 (508)
+...... ...+...||+.|||||++. ...|+.|+||||||++||||+||..||....+ ... ...+.....
T Consensus 192 r~~~~~~-~~~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~~---~~~---~~~v~~~~~- 263 (362)
T KOG0192|consen 192 REKVISK-TSMTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFEDLAP---VQV---ASAVVVGGL- 263 (362)
T ss_pred eeecccc-ccccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCCCCCH---HHH---HHHHHhcCC-
Confidence 8765432 2344468999999999999 56999999999999999999999999975432 111 111111111
Q ss_pred ccccCCCCCCChhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhhcCCC
Q 010519 415 EEVVDPNLEVKPATRALKRSLLVALRCVDPDSEKRPKMSQVVRMLEADDY 464 (508)
Q Consensus 415 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~ 464 (508)
.+.+... ....+..|+.+||+.||..||++.+++..|+....
T Consensus 264 ----Rp~~p~~----~~~~l~~l~~~CW~~dp~~RP~f~ei~~~l~~~~~ 305 (362)
T KOG0192|consen 264 ----RPPIPKE----CPPHLSSLMERCWLVDPSRRPSFLEIVSRLESIMS 305 (362)
T ss_pred ----CCCCCcc----CCHHHHHHHHHhCCCCCCcCCCHHHHHHHHHHHHH
Confidence 1221211 45556668889999999999999999999987554
|
|
| >KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-49 Score=393.43 Aligned_cols=263 Identities=30% Similarity=0.466 Sum_probs=226.9
Q ss_pred HHHHHhhCCcccceeEeeeCceEEEEEEEcCCCEEEEEEEcccchhhHHHHHHHHHHHhcCCCCCceeEEEEEEeCceee
Q 010519 179 RDLEIATNRFSAENVLGEGGYGVVYKGRLINGSEVAVKKLLNNLGQAEKEFRVEVEAIGHVRHKNLVRLLGYCIEGVHRM 258 (508)
Q Consensus 179 ~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~ei~~l~~l~h~niv~~~~~~~~~~~~~ 258 (508)
..+++..+.+.+++.||+|.||+||.|.+++...||+|.+.... ...+.|.+|+++|++|+|+|||+++++|..+..+|
T Consensus 199 d~wei~r~~l~l~~~LG~G~FG~V~~g~~~~~~~vavk~ik~~~-m~~~~f~~Ea~iMk~L~H~~lV~l~gV~~~~~piy 277 (468)
T KOG0197|consen 199 DPWEIPREELKLIRELGSGQFGEVWLGKWNGSTKVAVKTIKEGS-MSPEAFLREAQIMKKLRHEKLVKLYGVCTKQEPIY 277 (468)
T ss_pred CCeeecHHHHHHHHHhcCCccceEEEEEEcCCCcccceEEeccc-cChhHHHHHHHHHHhCcccCeEEEEEEEecCCceE
Confidence 44566677788889999999999999999777799999987653 34567889999999999999999999999988999
Q ss_pred EEEeecCCCCHHHHHhhhhccCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCEEEcCCCcEEEEecCCccc
Q 010519 259 LVYEYVNNGNLEQWLHGAMRNQGNLTWEARMKVIIGTAKALAYLHEAIEPKVVHRDIKSSNILIDDEFNAKVSDFGLAKL 338 (508)
Q Consensus 259 lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~Dfgla~~ 338 (508)
||||||+.|+|.+||+. ..+..+...+.+.++.|||+|++||+++ ++|||||..+||||++++.+||+|||+++.
T Consensus 278 IVtE~m~~GsLl~yLr~--~~~~~l~~~~Ll~~a~qIaeGM~YLes~---~~IHRDLAARNiLV~~~~~vKIsDFGLAr~ 352 (468)
T KOG0197|consen 278 IVTEYMPKGSLLDYLRT--REGGLLNLPQLLDFAAQIAEGMAYLESK---NYIHRDLAARNILVDEDLVVKISDFGLARL 352 (468)
T ss_pred EEEEecccCcHHHHhhh--cCCCccchHHHHHHHHHHHHHHHHHHhC---CccchhhhhhheeeccCceEEEcccccccc
Confidence 99999999999999974 3567899999999999999999999999 999999999999999999999999999997
Q ss_pred cCCCCCcccccccccccccCccccCCCCCCChhhHHHHHHHHHHHHh-CCCCCCCCCCCchhcHHHHHHHHhcccccccc
Q 010519 339 LDSGESHITTRVMGTFGYVAPEYANTGMLNEKSDIYSFGVLLLEAVT-GRDPVDYGRPANEVNLVEWLKMMVGTRRAEEV 417 (508)
Q Consensus 339 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 417 (508)
..++.........-...|.|||.+..+.++.|+|||||||+||||+| |+.||.... ..+.+..
T Consensus 353 ~~d~~Y~~~~~~kfPIkWtAPEa~~~~~FS~kSDVWSFGVlL~E~fT~G~~py~~ms------n~ev~~~---------- 416 (468)
T KOG0197|consen 353 IGDDEYTASEGGKFPIKWTAPEALNYGKFSSKSDVWSFGVLLWELFTYGRVPYPGMS------NEEVLEL---------- 416 (468)
T ss_pred cCCCceeecCCCCCCceecCHHHHhhCCcccccceeehhhhHHHHhccCCCCCCCCC------HHHHHHH----------
Confidence 76666555554555678999999999999999999999999999999 899986432 2222222
Q ss_pred cCCCCCCChhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhhcCC
Q 010519 418 VDPNLEVKPATRALKRSLLVALRCVDPDSEKRPKMSQVVRMLEADD 463 (508)
Q Consensus 418 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~ 463 (508)
++...+.+.+..++..+.+++..||+.+|++|||++.+...|++..
T Consensus 417 le~GyRlp~P~~CP~~vY~lM~~CW~~~P~~RPtF~~L~~~l~~~~ 462 (468)
T KOG0197|consen 417 LERGYRLPRPEGCPDEVYELMKSCWHEDPEDRPTFETLREVLEDFF 462 (468)
T ss_pred HhccCcCCCCCCCCHHHHHHHHHHhhCCcccCCCHHHHHHHHHHhh
Confidence 2355666777778889999999999999999999999999888754
|
|
| >KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-48 Score=391.74 Aligned_cols=249 Identities=24% Similarity=0.421 Sum_probs=212.2
Q ss_pred CCcccceeEeeeCceEEEEEEE-cCCCEEEEEEEcccc---hhhHHHHHHHHHHHhcCCCCCceeEEEEEEeCceeeEEE
Q 010519 186 NRFSAENVLGEGGYGVVYKGRL-INGSEVAVKKLLNNL---GQAEKEFRVEVEAIGHVRHKNLVRLLGYCIEGVHRMLVY 261 (508)
Q Consensus 186 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~ei~~l~~l~h~niv~~~~~~~~~~~~~lv~ 261 (508)
.+|...+.||+|+|+.||.+++ ..|..||+|++.+.. ....+.+.+||++.+.|+|||||+++++|++.++.|||.
T Consensus 18 ~~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~FEDs~nVYivL 97 (592)
T KOG0575|consen 18 KRYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHFFEDSNNVYIVL 97 (592)
T ss_pred ceeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeEeecCCceEEEE
Confidence 5799999999999999999998 789999999996532 344567888999999999999999999999999999999
Q ss_pred eecCCCCHHHHHhhhhccCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCEEEcCCCcEEEEecCCccccCC
Q 010519 262 EYVNNGNLEQWLHGAMRNQGNLTWEARMKVIIGTAKALAYLHEAIEPKVVHRDIKSSNILIDDEFNAKVSDFGLAKLLDS 341 (508)
Q Consensus 262 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~ 341 (508)
|+|.+++|..++ +..+.+++..++.++.||+.||.|||++ +|+|||||..|+||+++.++||+|||||..+..
T Consensus 98 ELC~~~sL~el~----Krrk~ltEpEary~l~QIv~GlkYLH~~---~IiHRDLKLGNlfL~~~~~VKIgDFGLAt~le~ 170 (592)
T KOG0575|consen 98 ELCHRGSLMELL----KRRKPLTEPEARYFLRQIVEGLKYLHSL---GIIHRDLKLGNLFLNENMNVKIGDFGLATQLEY 170 (592)
T ss_pred EecCCccHHHHH----HhcCCCCcHHHHHHHHHHHHHHHHHHhc---CceecccchhheeecCcCcEEecccceeeeecC
Confidence 999999999988 4567899999999999999999999999 999999999999999999999999999998875
Q ss_pred CCCcccccccccccccCccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCCCchhcHHHHHHHHhcccccccccCCC
Q 010519 342 GESHITTRVMGTFGYVAPEYANTGMLNEKSDIYSFGVLLLEAVTGRDPVDYGRPANEVNLVEWLKMMVGTRRAEEVVDPN 421 (508)
Q Consensus 342 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 421 (508)
+... ....||||.|+|||++....++..+||||+|||||.||.|++||.... +.+....... ..
T Consensus 171 ~~Er-k~TlCGTPNYIAPEVl~k~gHsfEvDiWSlGcvmYtLL~G~PPFetk~------vkety~~Ik~---------~~ 234 (592)
T KOG0575|consen 171 DGER-KKTLCGTPNYIAPEVLNKSGHSFEVDIWSLGCVMYTLLVGRPPFETKT------VKETYNKIKL---------NE 234 (592)
T ss_pred cccc-cceecCCCcccChhHhccCCCCCchhhhhhhhHHHhhhhCCCCcccch------HHHHHHHHHh---------cC
Confidence 5333 455799999999999999999999999999999999999999997432 2222222111 11
Q ss_pred CCCChhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHh
Q 010519 422 LEVKPATRALKRSLLVALRCVDPDSEKRPKMSQVVRML 459 (508)
Q Consensus 422 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L 459 (508)
.. .+........+||.++|++||.+|||+.+||.+=
T Consensus 235 Y~--~P~~ls~~A~dLI~~lL~~~P~~Rpsl~~vL~h~ 270 (592)
T KOG0575|consen 235 YS--MPSHLSAEAKDLIRKLLRPNPSERPSLDEVLDHP 270 (592)
T ss_pred cc--cccccCHHHHHHHHHHhcCCcccCCCHHHHhcCH
Confidence 11 1113445566799999999999999999999854
|
|
| >KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-47 Score=369.97 Aligned_cols=251 Identities=27% Similarity=0.460 Sum_probs=203.3
Q ss_pred CCcccceeEeeeCceEEEEEEEc-CCCEEEEEEEccc--chhhHHHHHHHHHHHhcCCCCCceeEEEEEEeCceeeEEEe
Q 010519 186 NRFSAENVLGEGGYGVVYKGRLI-NGSEVAVKKLLNN--LGQAEKEFRVEVEAIGHVRHKNLVRLLGYCIEGVHRMLVYE 262 (508)
Q Consensus 186 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~ei~~l~~l~h~niv~~~~~~~~~~~~~lv~E 262 (508)
.+|.+.+.||.|+||+||+|+++ ++..||||.+... ..+..+.+..|+.+|+.++|||||.++++++.++.+|+|||
T Consensus 10 ~~y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~~~~i~lVME 89 (429)
T KOG0595|consen 10 GDYELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKLNKKLVELLLSEIKILKELKHPNIVRLLDCIEDDDFIYLVME 89 (429)
T ss_pred ccceehhhccCcceEEEEEeEeccCCceEEeeeehhhccCHHHHHHHHHHHHHHHhcCCcceeeEEEEEecCCeEEEEEE
Confidence 47888899999999999999975 6899999999765 45566778889999999999999999999999999999999
Q ss_pred ecCCCCHHHHHhhhhccCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCEEEcCC------CcEEEEecCCc
Q 010519 263 YVNNGNLEQWLHGAMRNQGNLTWEARMKVIIGTAKALAYLHEAIEPKVVHRDIKSSNILIDDE------FNAKVSDFGLA 336 (508)
Q Consensus 263 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiH~Dlk~~NIll~~~------~~~kl~Dfgla 336 (508)
||.||+|.+||+ ..+.+++..+..++.||+.||++||++ +||||||||.||||+.. -.+||+|||+|
T Consensus 90 yC~gGDLs~yi~----~~~~l~e~t~r~Fm~QLA~alq~L~~~---~IiHRDLKPQNiLLs~~~~~~~~~~LKIADFGfA 162 (429)
T KOG0595|consen 90 YCNGGDLSDYIR----RRGRLPEATARHFMQQLASALQFLHEN---NIIHRDLKPQNILLSTTARNDTSPVLKIADFGFA 162 (429)
T ss_pred eCCCCCHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCCcceEEeccCCCCCCCceEEecccchh
Confidence 999999999995 456899999999999999999999999 99999999999999865 45899999999
Q ss_pred cccCCCCCcccccccccccccCccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCCCchhcHHHHHHHHhccccccc
Q 010519 337 KLLDSGESHITTRVMGTFGYVAPEYANTGMLNEKSDIYSFGVLLLEAVTGRDPVDYGRPANEVNLVEWLKMMVGTRRAEE 416 (508)
Q Consensus 337 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 416 (508)
+.+.... .....+|+|.|||||++..+.|+.|+|+||+|+|||++++|+.||+..... +.+..........
T Consensus 163 R~L~~~~--~a~tlcGSplYMAPEV~~~~~YdAKADLWSiG~Ilyq~l~g~~Pf~a~t~~------eL~~~~~k~~~~~- 233 (429)
T KOG0595|consen 163 RFLQPGS--MAETLCGSPLYMAPEVIMSQQYDAKADLWSIGTILYQCLTGKPPFDAETPK------ELLLYIKKGNEIV- 233 (429)
T ss_pred hhCCchh--HHHHhhCCccccCHHHHHhccccchhhHHHHHHHHHHHHhCCCCccccCHH------HHHHHHhcccccc-
Confidence 9887543 355679999999999999999999999999999999999999999754332 2222111111111
Q ss_pred ccCCCCCCChhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHh
Q 010519 417 VVDPNLEVKPATRALKRSLLVALRCVDPDSEKRPKMSQVVRML 459 (508)
Q Consensus 417 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L 459 (508)
...+......+.+|+...+..+|.+|-++.+-+.+.
T Consensus 234 -------~~~~~~~s~~~~~Ll~~ll~~~~~~~~~~~~~~~~~ 269 (429)
T KOG0595|consen 234 -------PVLPAELSNPLRELLISLLQRNPKDRISFEDFFDHP 269 (429)
T ss_pred -------CchhhhccCchhhhhhHHHhcCccccCchHHhhhhh
Confidence 111111222233466667778888887777665544
|
|
| >KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-48 Score=373.51 Aligned_cols=262 Identities=26% Similarity=0.375 Sum_probs=214.8
Q ss_pred hhCCcccceeEeeeCceEEEEEEEc-CCCEEEEEEEcccchh-------hHHHHHHHHHHHhcCCCCCceeEEEEEEeCc
Q 010519 184 ATNRFSAENVLGEGGYGVVYKGRLI-NGSEVAVKKLLNNLGQ-------AEKEFRVEVEAIGHVRHKNLVRLLGYCIEGV 255 (508)
Q Consensus 184 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-------~~~~~~~ei~~l~~l~h~niv~~~~~~~~~~ 255 (508)
..+.|.+.+.||+|+||.|-+|..+ +|+.||||.+.+.... ....+.+|+++|++|+|||||+++++|....
T Consensus 170 ~~d~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f~~~d 249 (475)
T KOG0615|consen 170 FNDYYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFFEVPD 249 (475)
T ss_pred hcceeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeeeecCC
Confidence 3457888999999999999999754 7999999998543311 1223568999999999999999999999999
Q ss_pred eeeEEEeecCCCCHHHHHhhhhccCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCEEEcCC---CcEEEEe
Q 010519 256 HRMLVYEYVNNGNLEQWLHGAMRNQGNLTWEARMKVIIGTAKALAYLHEAIEPKVVHRDIKSSNILIDDE---FNAKVSD 332 (508)
Q Consensus 256 ~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiH~Dlk~~NIll~~~---~~~kl~D 332 (508)
..||||||+.||+|.+++ ...+.+.+.....++.|++.|+.|||++ ||+||||||+|||++.+ ..+||+|
T Consensus 250 s~YmVlE~v~GGeLfd~v----v~nk~l~ed~~K~~f~Qll~avkYLH~~---GI~HRDiKPeNILl~~~~e~~llKItD 322 (475)
T KOG0615|consen 250 SSYMVLEYVEGGELFDKV----VANKYLREDLGKLLFKQLLTAVKYLHSQ---GIIHRDIKPENILLSNDAEDCLLKITD 322 (475)
T ss_pred ceEEEEEEecCccHHHHH----HhccccccchhHHHHHHHHHHHHHHHHc---CcccccCCcceEEeccCCcceEEEecc
Confidence 999999999999999999 4566788888899999999999999999 99999999999999766 6799999
Q ss_pred cCCccccCCCCCcccccccccccccCccccCCCC---CCChhhHHHHHHHHHHHHhCCCCCCCCCCCchhcHHHHHHHHh
Q 010519 333 FGLAKLLDSGESHITTRVMGTFGYVAPEYANTGM---LNEKSDIYSFGVLLLEAVTGRDPVDYGRPANEVNLVEWLKMMV 409 (508)
Q Consensus 333 fgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~---~~~~~DvwS~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~ 409 (508)
||+|+..+.. ..+...||||.|.|||++.++. +..++|+||+||+||-+++|.+||....... .+.+.
T Consensus 323 FGlAK~~g~~--sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~~~--sl~eQ----- 393 (475)
T KOG0615|consen 323 FGLAKVSGEG--SFMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYTDP--SLKEQ----- 393 (475)
T ss_pred cchhhccccc--eehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCcccccCCc--cHHHH-----
Confidence 9999987643 4578899999999999997654 3358899999999999999999997543322 12221
Q ss_pred cccccccccCCCCCCC--hhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhhcCCCCCch
Q 010519 410 GTRRAEEVVDPNLEVK--PATRALKRSLLVALRCVDPDSEKRPKMSQVVRMLEADDYPFRE 468 (508)
Q Consensus 410 ~~~~~~~~~~~~~~~~--~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~~~~ 468 (508)
+....+... ...+...+.++||.+||..||++|||+.|+|+|-|-.+.+...
T Consensus 394 -------I~~G~y~f~p~~w~~Iseea~dlI~~mL~VdP~~R~s~~eaL~hpW~~~~~~~s 447 (475)
T KOG0615|consen 394 -------ILKGRYAFGPLQWDRISEEALDLINWMLVVDPENRPSADEALNHPWFKDAPCLS 447 (475)
T ss_pred -------HhcCcccccChhhhhhhHHHHHHHHHhhEeCcccCcCHHHHhcChhhhcccccc
Confidence 111233322 2345677888999999999999999999999988877766444
|
|
| >KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-47 Score=352.74 Aligned_cols=260 Identities=27% Similarity=0.396 Sum_probs=212.2
Q ss_pred CCcccceeEeeeCceEEEEEEE-cCCCEEEEEEEcccc--hhhHHHHHHHHHHHhcCCCCCceeEEE-EEEeCce-eeEE
Q 010519 186 NRFSAENVLGEGGYGVVYKGRL-INGSEVAVKKLLNNL--GQAEKEFRVEVEAIGHVRHKNLVRLLG-YCIEGVH-RMLV 260 (508)
Q Consensus 186 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~ei~~l~~l~h~niv~~~~-~~~~~~~-~~lv 260 (508)
.+|.+++.||+|.||+||++.. .+|..+|.|.+.-.. .+..+.+..|+.+|++|+|||||++++ .|.++.. ++||
T Consensus 19 ~~y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~~evlniv 98 (375)
T KOG0591|consen 19 ADYQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGMMDAKARQDCVKEISLLKQLNHPNIVQYYAHSFIEDNEVLNIV 98 (375)
T ss_pred HHHHHHHHHcCCcchheEEeeeccCcchhhhhhcchhhccHHHHHHHHHHHHHHHhcCCchHHHHHHHhhhccchhhHHH
Confidence 3688889999999999999975 489999999886332 344567888999999999999999999 4545555 7899
Q ss_pred EeecCCCCHHHHHhhhhccCCCccHHHHHHHHHHHHHHHHHHHhcCCC-CeEeecCCCCCEEEcCCCcEEEEecCCcccc
Q 010519 261 YEYVNNGNLEQWLHGAMRNQGNLTWEARMKVIIGTAKALAYLHEAIEP-KVVHRDIKSSNILIDDEFNAKVSDFGLAKLL 339 (508)
Q Consensus 261 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~-~iiH~Dlk~~NIll~~~~~~kl~Dfgla~~~ 339 (508)
||||.+|+|...+.........+++..+|+++.|++.||..+|+.... -|+||||||.||+++.+|.+||+|||+++.+
T Consensus 99 mE~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl~~~gvvKLGDfGL~r~l 178 (375)
T KOG0591|consen 99 MELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFLTANGVVKLGDFGLGRFL 178 (375)
T ss_pred HHhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEEcCCCceeeccchhHhHh
Confidence 999999999999988877888899999999999999999999983221 3999999999999999999999999999988
Q ss_pred CCCCCcccccccccccccCccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCCCchhcHHHHHHHHhcccccccccC
Q 010519 340 DSGESHITTRVMGTFGYVAPEYANTGMLNEKSDIYSFGVLLLEAVTGRDPVDYGRPANEVNLVEWLKMMVGTRRAEEVVD 419 (508)
Q Consensus 340 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 419 (508)
..... .....+|||.||+||.+.+..|+.++||||+||++|||+.-+.||... ++........ .
T Consensus 179 ~s~~t-fA~S~VGTPyYMSPE~i~~~~Y~~kSDiWslGCllyEMcaL~~PF~g~------n~~~L~~KI~-q-------- 242 (375)
T KOG0591|consen 179 SSKTT-FAHSLVGTPYYMSPERIHESGYNFKSDIWSLGCLLYEMCALQSPFYGD------NLLSLCKKIE-Q-------- 242 (375)
T ss_pred cchhH-HHHhhcCCCcccCHHHHhcCCCCcchhHHHHHHHHHHHHhcCCCcccc------cHHHHHHHHH-c--------
Confidence 65543 355679999999999999999999999999999999999999999633 3333332222 1
Q ss_pred CCCCCChhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhhc
Q 010519 420 PNLEVKPATRALKRSLLVALRCVDPDSEKRPKMSQVVRMLEA 461 (508)
Q Consensus 420 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~ 461 (508)
..+..-+.......+..||..|+.+||..||+.-.+++.++.
T Consensus 243 gd~~~~p~~~YS~~l~~li~~ci~vd~~~RP~t~~~v~di~~ 284 (375)
T KOG0591|consen 243 GDYPPLPDEHYSTDLRELINMCIAVDPEQRPDTVPYVQDIQS 284 (375)
T ss_pred CCCCCCcHHHhhhHHHHHHHHHccCCcccCCCcchHHHHHHH
Confidence 111112234456677789999999999999986666665554
|
|
| >KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-46 Score=359.02 Aligned_cols=249 Identities=25% Similarity=0.376 Sum_probs=205.9
Q ss_pred hCCcccceeEeeeCceEEEEEEEc-CCCEEEEEEEcccc---hhhHHHHHHHHHHHhcCCCCCceeEEEEEEeCceeeEE
Q 010519 185 TNRFSAENVLGEGGYGVVYKGRLI-NGSEVAVKKLLNNL---GQAEKEFRVEVEAIGHVRHKNLVRLLGYCIEGVHRMLV 260 (508)
Q Consensus 185 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~ei~~l~~l~h~niv~~~~~~~~~~~~~lv 260 (508)
.++|++.++||+|+||+||.++.. .++.+|+|++.+.. ....+....|.++|..++||+||+++-.|++...+|+|
T Consensus 24 ~~dF~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ysFQt~~kLylV 103 (357)
T KOG0598|consen 24 PDDFEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYSFQTEEKLYLV 103 (357)
T ss_pred hhheeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEecccCCeEEEE
Confidence 468999999999999999999865 68889999886543 23346688899999999999999999999999999999
Q ss_pred EeecCCCCHHHHHhhhhccCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCEEEcCCCcEEEEecCCccccC
Q 010519 261 YEYVNNGNLEQWLHGAMRNQGNLTWEARMKVIIGTAKALAYLHEAIEPKVVHRDIKSSNILIDDEFNAKVSDFGLAKLLD 340 (508)
Q Consensus 261 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~Dfgla~~~~ 340 (508)
+||+.||.|+.+| +..+.+++..+.-++..|+.||.|||++ +||||||||+||||+++|+++|+|||+++...
T Consensus 104 ld~~~GGeLf~hL----~~eg~F~E~~arfYlaEi~lAL~~LH~~---gIiyRDlKPENILLd~~GHi~LtDFgL~k~~~ 176 (357)
T KOG0598|consen 104 LDYLNGGELFYHL----QREGRFSEDRARFYLAEIVLALGYLHSK---GIIYRDLKPENILLDEQGHIKLTDFGLCKEDL 176 (357)
T ss_pred EeccCCccHHHHH----HhcCCcchhHHHHHHHHHHHHHHHHHhC---CeeeccCCHHHeeecCCCcEEEeccccchhcc
Confidence 9999999999999 5678899999999999999999999999 99999999999999999999999999999654
Q ss_pred CCCCcccccccccccccCccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCCCchhcHHHHHHHHhcccccccccCC
Q 010519 341 SGESHITTRVMGTFGYVAPEYANTGMLNEKSDIYSFGVLLLEAVTGRDPVDYGRPANEVNLVEWLKMMVGTRRAEEVVDP 420 (508)
Q Consensus 341 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 420 (508)
.... ....++||+.|||||++.+..|+.++|+||+|+++|||++|..||.... ..++........
T Consensus 177 ~~~~-~t~tfcGT~eYmAPEil~~~gy~~~vDWWsLGillYeML~G~pPF~~~~------~~~~~~~I~~~k-------- 241 (357)
T KOG0598|consen 177 KDGD-ATRTFCGTPEYMAPEILLGKGYDKAVDWWSLGILLYEMLTGKPPFYAED------VKKMYDKILKGK-------- 241 (357)
T ss_pred cCCC-ccccccCCccccChHHHhcCCCCcccchHhHHHHHHHHhhCCCCCcCcc------HHHHHHHHhcCc--------
Confidence 4332 3445899999999999999999999999999999999999999996442 223333332221
Q ss_pred CCCCChhHHHHHHHHHHHHHhcCCCCCCCC----CHHHHHH
Q 010519 421 NLEVKPATRALKRSLLVALRCVDPDSEKRP----KMSQVVR 457 (508)
Q Consensus 421 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RP----s~~evl~ 457 (508)
+ ..++.-......+++...|+.||.+|. .+.+|-+
T Consensus 242 -~-~~~p~~ls~~ardll~~LL~rdp~~RLg~~~d~~~ik~ 280 (357)
T KOG0598|consen 242 -L-PLPPGYLSEEARDLLKKLLKRDPRQRLGGPGDAEEIKR 280 (357)
T ss_pred -C-CCCCccCCHHHHHHHHHHhccCHHHhcCCCCChHHhhc
Confidence 0 111111334566688999999999996 4555443
|
|
| >KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-45 Score=363.54 Aligned_cols=255 Identities=25% Similarity=0.361 Sum_probs=211.7
Q ss_pred HHhhCCcccceeEeeeCceEEEEEEEc-CCCEEEEEEEcccc---hhhHHHHHHHHHHHhcC-CCCCceeEEEEEEeCce
Q 010519 182 EIATNRFSAENVLGEGGYGVVYKGRLI-NGSEVAVKKLLNNL---GQAEKEFRVEVEAIGHV-RHKNLVRLLGYCIEGVH 256 (508)
Q Consensus 182 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~ei~~l~~l-~h~niv~~~~~~~~~~~ 256 (508)
....++|.+++.||+|+|++|++|+.. .+..+|||++.+.. ....+.+..|-++|.+| .||.|++++-.|+++..
T Consensus 69 kk~~~DF~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD~~s 148 (604)
T KOG0592|consen 69 KKTPNDFKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQDEES 148 (604)
T ss_pred cCChhhcchhheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEeecccc
Confidence 345578999999999999999999865 78999999885443 22235677899999999 89999999999999999
Q ss_pred eeEEEeecCCCCHHHHHhhhhccCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCEEEcCCCcEEEEecCCc
Q 010519 257 RMLVYEYVNNGNLEQWLHGAMRNQGNLTWEARMKVIIGTAKALAYLHEAIEPKVVHRDIKSSNILIDDEFNAKVSDFGLA 336 (508)
Q Consensus 257 ~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~Dfgla 336 (508)
+|+|+||+++|+|.++|+ +.+.+++...+.++.+|+.||.|||++ |||||||||+||||++|+++||+|||.|
T Consensus 149 LYFvLe~A~nGdll~~i~----K~Gsfde~caR~YAAeIldAleylH~~---GIIHRDlKPENILLd~dmhikITDFGsA 221 (604)
T KOG0592|consen 149 LYFVLEYAPNGDLLDLIK----KYGSFDETCARFYAAEILDALEYLHSN---GIIHRDLKPENILLDKDGHIKITDFGSA 221 (604)
T ss_pred eEEEEEecCCCcHHHHHH----HhCcchHHHHHHHHHHHHHHHHHHHhc---CceeccCChhheeEcCCCcEEEeecccc
Confidence 999999999999999995 558899999999999999999999999 9999999999999999999999999999
Q ss_pred cccCCCCCc------------ccccccccccccCccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCCCchhcHHHH
Q 010519 337 KLLDSGESH------------ITTRVMGTFGYVAPEYANTGMLNEKSDIYSFGVLLLEAVTGRDPVDYGRPANEVNLVEW 404 (508)
Q Consensus 337 ~~~~~~~~~------------~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltG~~Pf~~~~~~~~~~~~~~ 404 (508)
+.+...... ....++||..|.+||++..+..+..+|+|+||||||+|+.|..||........
T Consensus 222 K~l~~~~~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~~~~~~sDiWAlGCilyQmlaG~PPFra~Neyli------ 295 (604)
T KOG0592|consen 222 KILSPSQKSQENPVDPNQASSRRSSFVGTAEYVSPELLNDSPAGPSSDLWALGCILYQMLAGQPPFRAANEYLI------ 295 (604)
T ss_pred ccCChhhccccCccCcccccCcccceeeeecccCHHHhcCCCCCcccchHHHHHHHHHHhcCCCCCccccHHHH------
Confidence 877532211 12458999999999999999999999999999999999999999975532211
Q ss_pred HHHHhcccccccccCCCCCCChhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhh
Q 010519 405 LKMMVGTRRAEEVVDPNLEVKPATRALKRSLLVALRCVDPDSEKRPKMSQVVRMLE 460 (508)
Q Consensus 405 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 460 (508)
++.++ .+....+...+..+.+|+.+.|..||.+|+|.+||-+|.-
T Consensus 296 FqkI~-----------~l~y~fp~~fp~~a~dLv~KLLv~dp~~Rlt~~qIk~HpF 340 (604)
T KOG0592|consen 296 FQKIQ-----------ALDYEFPEGFPEDARDLIKKLLVRDPSDRLTSQQIKAHPF 340 (604)
T ss_pred HHHHH-----------HhcccCCCCCCHHHHHHHHHHHccCccccccHHHHhhCcc
Confidence 11111 1112222223356677999999999999999999988763
|
|
| >KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-45 Score=385.02 Aligned_cols=265 Identities=28% Similarity=0.486 Sum_probs=219.2
Q ss_pred HHHhhCCcccceeEeeeCceEEEEEEEcC------CCEEEEEEEcccchh-hHHHHHHHHHHHhcCCCCCceeEEEEEEe
Q 010519 181 LEIATNRFSAENVLGEGGYGVVYKGRLIN------GSEVAVKKLLNNLGQ-AEKEFRVEVEAIGHVRHKNLVRLLGYCIE 253 (508)
Q Consensus 181 ~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~------~~~vavK~~~~~~~~-~~~~~~~ei~~l~~l~h~niv~~~~~~~~ 253 (508)
.++.+.+..+.+.||+|+||+||+|+..+ ..-||||.++..... ...+|++|++++..++|||||+++|+|.+
T Consensus 481 ~~i~r~~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a~~~~~~dF~REaeLla~l~H~nIVrLlGVC~~ 560 (774)
T KOG1026|consen 481 LEIPRSDIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKAENQARQDFRREAELLAELQHPNIVRLLGVCRE 560 (774)
T ss_pred eEechhheeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhcccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEcc
Confidence 35566777788999999999999997542 346999999877655 77899999999999999999999999999
Q ss_pred CceeeEEEeecCCCCHHHHHhhhhc------c----CCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCEEEc
Q 010519 254 GVHRMLVYEYVNNGNLEQWLHGAMR------N----QGNLTWEARMKVIIGTAKALAYLHEAIEPKVVHRDIKSSNILID 323 (508)
Q Consensus 254 ~~~~~lv~E~~~~gsL~~~l~~~~~------~----~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiH~Dlk~~NIll~ 323 (508)
++.++||+|||..|||.+||..+.. . ..+|+..+.+.|+.|||.|+.||-++ .+|||||..+|+||.
T Consensus 561 ~~P~~MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~~---~FVHRDLATRNCLVg 637 (774)
T KOG1026|consen 561 GDPLCMVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSSH---HFVHRDLATRNCLVG 637 (774)
T ss_pred CCeeEEEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhC---cccccchhhhhceec
Confidence 9999999999999999999975321 1 22378899999999999999999999 999999999999999
Q ss_pred CCCcEEEEecCCccccCCCCCc-ccccccccccccCccccCCCCCCChhhHHHHHHHHHHHHh-CCCCCCCCCCCchhcH
Q 010519 324 DEFNAKVSDFGLAKLLDSGESH-ITTRVMGTFGYVAPEYANTGMLNEKSDIYSFGVLLLEAVT-GRDPVDYGRPANEVNL 401 (508)
Q Consensus 324 ~~~~~kl~Dfgla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~ellt-G~~Pf~~~~~~~~~~~ 401 (508)
++..|||+|||+++..-..+.. ......-..+||+||.+.-++|+.++|||||||+|||+++ |+.||..-... .+
T Consensus 638 e~l~VKIsDfGLsRdiYssDYYk~~~~t~lPIRWMppEsIly~kFTteSDVWs~GVvLWEIFsyG~QPy~glSn~---EV 714 (774)
T KOG1026|consen 638 ENLVVKISDFGLSRDIYSSDYYKVRGNTLLPIRWMPPESILYGKFTTESDVWSFGVVLWEIFSYGKQPYYGLSNQ---EV 714 (774)
T ss_pred cceEEEecccccchhhhhhhhhcccCCceeeeecCCHHHhhcCcccchhhhhhhhhhhhhhhccccCcccccchH---HH
Confidence 9999999999999955433332 2223445679999999999999999999999999999999 99998643321 12
Q ss_pred HHHHHHHhcccccccccCCCCCCChhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhhcCCC
Q 010519 402 VEWLKMMVGTRRAEEVVDPNLEVKPATRALKRSLLVALRCVDPDSEKRPKMSQVVRMLEADDY 464 (508)
Q Consensus 402 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~ 464 (508)
++.++ . ..+ ...+..++..+..|+..||+.+|.+||+++||-..|+....
T Consensus 715 Ie~i~----~--------g~l-L~~Pe~CP~~vY~LM~~CW~~~P~~RPsF~eI~~~L~~~~~ 764 (774)
T KOG1026|consen 715 IECIR----A--------GQL-LSCPENCPTEVYSLMLECWNENPKRRPSFKEIHSRLQAWAQ 764 (774)
T ss_pred HHHHH----c--------CCc-ccCCCCCCHHHHHHHHHHhhcCcccCCCHHHHHHHHHHHHh
Confidence 22211 1 223 56667778889999999999999999999999999987543
|
|
| >KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-45 Score=339.63 Aligned_cols=263 Identities=25% Similarity=0.351 Sum_probs=207.4
Q ss_pred CCcccceeEeeeCceEEEEEEEc-CCCEEEEEEEcccch--hhHHHHHHHHHHHhcCCCCCceeEEEEEEeCceeeEEEe
Q 010519 186 NRFSAENVLGEGGYGVVYKGRLI-NGSEVAVKKLLNNLG--QAEKEFRVEVEAIGHVRHKNLVRLLGYCIEGVHRMLVYE 262 (508)
Q Consensus 186 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~ei~~l~~l~h~niv~~~~~~~~~~~~~lv~E 262 (508)
+.|+.+.++|+|+||+||+|+++ .|+.||||++..... .-.+-..+||.+|++++|+|+|.++.+|.....+++|||
T Consensus 2 ekYE~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Esedd~~VkKIAlREIrmLKqLkH~NLVnLiEVFrrkrklhLVFE 81 (396)
T KOG0593|consen 2 EKYEKLGKVGEGSYGVVMKCRNKDTGQIVAIKKFVESEDDPVVKKIALREIRMLKQLKHENLVNLIEVFRRKRKLHLVFE 81 (396)
T ss_pred cHHhhhhccccCcceEEEEeccCCcccEEEEEeeccCCccHHHHHHHHHHHHHHHhcccchHHHHHHHHHhcceeEEEee
Confidence 46888889999999999999976 689999999965442 333556779999999999999999999999999999999
Q ss_pred ecCCCCHHHHHhhhhccCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCEEEcCCCcEEEEecCCccccCCC
Q 010519 263 YVNNGNLEQWLHGAMRNQGNLTWEARMKVIIGTAKALAYLHEAIEPKVVHRDIKSSNILIDDEFNAKVSDFGLAKLLDSG 342 (508)
Q Consensus 263 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~~ 342 (508)
||+. ++.+-|. .....++.....+++.|++.|+.|+|++ ++|||||||+|||++.+|.+||||||+|+.+...
T Consensus 82 ~~dh-TvL~eLe---~~p~G~~~~~vk~~l~Q~l~ai~~cHk~---n~IHRDIKPENILit~~gvvKLCDFGFAR~L~~p 154 (396)
T KOG0593|consen 82 YCDH-TVLHELE---RYPNGVPSELVKKYLYQLLKAIHFCHKN---NCIHRDIKPENILITQNGVVKLCDFGFARTLSAP 154 (396)
T ss_pred ecch-HHHHHHH---hccCCCCHHHHHHHHHHHHHHhhhhhhc---CeecccCChhheEEecCCcEEeccchhhHhhcCC
Confidence 9987 4444443 3455688899999999999999999999 9999999999999999999999999999987642
Q ss_pred CCcccccccccccccCccccCC-CCCCChhhHHHHHHHHHHHHhCCCCCCCCCCCchhcHHHHHHHHhccc---------
Q 010519 343 ESHITTRVMGTFGYVAPEYANT-GMLNEKSDIYSFGVLLLEAVTGRDPVDYGRPANEVNLVEWLKMMVGTR--------- 412 (508)
Q Consensus 343 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwS~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~--------- 412 (508)
. ...+..+.|.+|.|||.+.| ..|+..+|||++||++.||++|..-|.... +.+....+...++.-
T Consensus 155 g-d~YTDYVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG~S---DiDQLy~I~ktLG~L~prhq~iF~ 230 (396)
T KOG0593|consen 155 G-DNYTDYVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWPGRS---DIDQLYLIRKTLGNLIPRHQSIFS 230 (396)
T ss_pred c-chhhhhhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCCCcc---hHHHHHHHHHHHcccCHHHHHHhc
Confidence 2 34566788999999999987 789999999999999999999998886443 222222233333221
Q ss_pred ---c-----cccccCCCCCCChhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHh
Q 010519 413 ---R-----AEEVVDPNLEVKPATRALKRSLLVALRCVDPDSEKRPKMSQVVRML 459 (508)
Q Consensus 413 ---~-----~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L 459 (508)
. +.+.-++..--...+....-+++|+..||+.||.+|++-+|++.|-
T Consensus 231 ~N~~F~Gv~lP~~~~~epLe~k~p~~s~~~ld~~k~cL~~dP~~R~sc~qll~H~ 285 (396)
T KOG0593|consen 231 SNPFFHGVRLPEPEHPEPLERKYPKISNVLLDLLKKCLKMDPDDRLSCEQLLHHP 285 (396)
T ss_pred cCCceeeeecCCCCCccchhhhcccchHHHHHHHHHHhcCCccccccHHHHhcCh
Confidence 1 1111111111112234445678899999999999999999999754
|
|
| >KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-45 Score=364.98 Aligned_cols=254 Identities=29% Similarity=0.425 Sum_probs=220.0
Q ss_pred HHHHHhhCCcccceeEeeeCceEEEEEEEcCCCEEEEEEEcccchhhHHHHHHHHHHHhcCCCCCceeEEEEEEeCceee
Q 010519 179 RDLEIATNRFSAENVLGEGGYGVVYKGRLINGSEVAVKKLLNNLGQAEKEFRVEVEAIGHVRHKNLVRLLGYCIEGVHRM 258 (508)
Q Consensus 179 ~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~ei~~l~~l~h~niv~~~~~~~~~~~~~ 258 (508)
+.|+++.+.+.-++-||.|+-|.||+|++ .++.||||++.... ..+|+-|++|+||||+.|.|+|.....++
T Consensus 117 e~WeiPFe~IsELeWlGSGaQGAVF~Grl-~netVAVKKV~elk-------ETdIKHLRkLkH~NII~FkGVCtqsPcyC 188 (904)
T KOG4721|consen 117 ELWEIPFEEISELEWLGSGAQGAVFLGRL-HNETVAVKKVRELK-------ETDIKHLRKLKHPNIITFKGVCTQSPCYC 188 (904)
T ss_pred hhccCCHHHhhhhhhhccCcccceeeeec-cCceehhHHHhhhh-------hhhHHHHHhccCcceeeEeeeecCCceeE
Confidence 45778888888889999999999999998 77899999874322 23788899999999999999999999999
Q ss_pred EEEeecCCCCHHHHHhhhhccCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCEEEcCCCcEEEEecCCccc
Q 010519 259 LVYEYVNNGNLEQWLHGAMRNQGNLTWEARMKVIIGTAKALAYLHEAIEPKVVHRDIKSSNILIDDEFNAKVSDFGLAKL 338 (508)
Q Consensus 259 lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~Dfgla~~ 338 (508)
||||||..|-|.+.| +.+..++......+..+||.|++|||.+ .|||||||+-||||+.+..|||+|||-++.
T Consensus 189 IiMEfCa~GqL~~VL----ka~~~itp~llv~Wsk~IA~GM~YLH~h---KIIHRDLKSPNiLIs~~d~VKIsDFGTS~e 261 (904)
T KOG4721|consen 189 IIMEFCAQGQLYEVL----KAGRPITPSLLVDWSKGIAGGMNYLHLH---KIIHRDLKSPNILISYDDVVKISDFGTSKE 261 (904)
T ss_pred EeeeccccccHHHHH----hccCccCHHHHHHHHHHhhhhhHHHHHh---hHhhhccCCCceEeeccceEEeccccchHh
Confidence 999999999999999 4677888899999999999999999999 999999999999999999999999999987
Q ss_pred cCCCCCcccccccccccccCccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCCCchhcHHHHHHHHhccccccccc
Q 010519 339 LDSGESHITTRVMGTFGYVAPEYANTGMLNEKSDIYSFGVLLLEAVTGRDPVDYGRPANEVNLVEWLKMMVGTRRAEEVV 418 (508)
Q Consensus 339 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 418 (508)
..+. .....++||..|||||++.+++.++|+|||||||||||||||..||..-.. ...+..+-
T Consensus 262 ~~~~--STkMSFaGTVaWMAPEvIrnePcsEKVDIwSfGVVLWEmLT~EiPYkdVds---------------sAIIwGVG 324 (904)
T KOG4721|consen 262 LSDK--STKMSFAGTVAWMAPEVIRNEPCSEKVDIWSFGVVLWEMLTGEIPYKDVDS---------------SAIIWGVG 324 (904)
T ss_pred hhhh--hhhhhhhhhHhhhCHHHhhcCCcccccceehhHHHHHHHHhcCCCccccch---------------heeEEecc
Confidence 7654 335568999999999999999999999999999999999999999963321 11334444
Q ss_pred CCCCCCChhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhhcCCC
Q 010519 419 DPNLEVKPATRALKRSLLVALRCVDPDSEKRPKMSQVVRMLEADDY 464 (508)
Q Consensus 419 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~ 464 (508)
...+....+..++.-+..|+++||+-.|.+||++.+++.||+....
T Consensus 325 sNsL~LpvPstcP~GfklL~Kqcw~sKpRNRPSFrqil~HldIa~p 370 (904)
T KOG4721|consen 325 SNSLHLPVPSTCPDGFKLLLKQCWNSKPRNRPSFRQILLHLDIASP 370 (904)
T ss_pred CCcccccCcccCchHHHHHHHHHHhcCCCCCccHHHHHHHHhhcCH
Confidence 4556666666777778889999999999999999999999987654
|
|
| >KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-44 Score=360.28 Aligned_cols=256 Identities=25% Similarity=0.413 Sum_probs=209.9
Q ss_pred hhCCcccceeEeeeCceEEEEEEEc-CCCEEEEEEEccc----ch-hhHHHHHHHHHHHhcCC-CCCceeEEEEEEeCce
Q 010519 184 ATNRFSAENVLGEGGYGVVYKGRLI-NGSEVAVKKLLNN----LG-QAEKEFRVEVEAIGHVR-HKNLVRLLGYCIEGVH 256 (508)
Q Consensus 184 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~----~~-~~~~~~~~ei~~l~~l~-h~niv~~~~~~~~~~~ 256 (508)
...+|.+.+.||+|+||+|+.|.+. .+..||+|.+... .. ...+.+.+|+.+++.++ ||||++++.++.....
T Consensus 15 ~~g~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~~~ 94 (370)
T KOG0583|consen 15 SIGKYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFATPTK 94 (370)
T ss_pred ccCceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEecCCe
Confidence 3468999999999999999999764 6899999966443 11 23456778999999998 9999999999999999
Q ss_pred eeEEEeecCCCCHHHHHhhhhccCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCEEEcCC-CcEEEEecCC
Q 010519 257 RMLVYEYVNNGNLEQWLHGAMRNQGNLTWEARMKVIIGTAKALAYLHEAIEPKVVHRDIKSSNILIDDE-FNAKVSDFGL 335 (508)
Q Consensus 257 ~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiH~Dlk~~NIll~~~-~~~kl~Dfgl 335 (508)
.|+||||+.||+|++++. ..+++.+..+..++.|++.|++|||++ +|+||||||+|||++.+ +++||+|||+
T Consensus 95 ~~ivmEy~~gGdL~~~i~----~~g~l~E~~ar~~F~Qlisav~y~H~~---gi~HRDLK~ENilld~~~~~~Kl~DFG~ 167 (370)
T KOG0583|consen 95 IYIVMEYCSGGDLFDYIV----NKGRLKEDEARKYFRQLISAVAYCHSR---GIVHRDLKPENILLDGNEGNLKLSDFGL 167 (370)
T ss_pred EEEEEEecCCccHHHHHH----HcCCCChHHHHHHHHHHHHHHHHHHhC---CEeeCCCCHHHEEecCCCCCEEEecccc
Confidence 999999999999999994 477899999999999999999999999 99999999999999999 9999999999
Q ss_pred ccccCCCCCcccccccccccccCccccCCCC-CC-ChhhHHHHHHHHHHHHhCCCCCCCCCCCchhcHHHHHHHHhcccc
Q 010519 336 AKLLDSGESHITTRVMGTFGYVAPEYANTGM-LN-EKSDIYSFGVLLLEAVTGRDPVDYGRPANEVNLVEWLKMMVGTRR 413 (508)
Q Consensus 336 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~-~~~DvwS~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~ 413 (508)
+.... .........+||+.|+|||++.+.. |+ .++||||+||+||.|++|+.||+... ........
T Consensus 168 s~~~~-~~~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d~~------~~~l~~ki----- 235 (370)
T KOG0583|consen 168 SAISP-GEDGLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDDSN------VPNLYRKI----- 235 (370)
T ss_pred ccccC-CCCCcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCCcc------HHHHHHHH-----
Confidence 99774 2223466789999999999999977 86 79999999999999999999998632 11212121
Q ss_pred cccccCCCCCCChhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhhcCC
Q 010519 414 AEEVVDPNLEVKPATRALKRSLLVALRCVDPDSEKRPKMSQVVRMLEADD 463 (508)
Q Consensus 414 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~ 463 (508)
....+..+.... ...+..|+.+||.+||.+|+|+.+++.+-+-..
T Consensus 236 ----~~~~~~~p~~~~-S~~~~~Li~~mL~~~P~~R~t~~~i~~h~w~~~ 280 (370)
T KOG0583|consen 236 ----RKGEFKIPSYLL-SPEARSLIEKMLVPDPSTRITLLEILEHPWFQK 280 (370)
T ss_pred ----hcCCccCCCCcC-CHHHHHHHHHHcCCCcccCCCHHHHhhChhhcc
Confidence 111122211111 455666999999999999999999997665554
|
|
| >KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-43 Score=344.45 Aligned_cols=265 Identities=25% Similarity=0.365 Sum_probs=213.9
Q ss_pred HhhCCcccceeEeeeCceEEEEEEEc-CCCEEEEEEEcccc-hhhHHHHHHHHHHHhcCCCCCceeEEEEEEeCceeeEE
Q 010519 183 IATNRFSAENVLGEGGYGVVYKGRLI-NGSEVAVKKLLNNL-GQAEKEFRVEVEAIGHVRHKNLVRLLGYCIEGVHRMLV 260 (508)
Q Consensus 183 ~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~ei~~l~~l~h~niv~~~~~~~~~~~~~lv 260 (508)
...+.|++...||.|..++||+|+.. .+..||||++.... ......+++|+..|+.++||||++++..|..+..+|+|
T Consensus 23 ~n~~~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~~~ld~l~kE~~~msl~~HPNIv~~~~sFvv~~~LWvV 102 (516)
T KOG0582|consen 23 LNAKDYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCNNDLDALRKEVQTMSLIDHPNIVTYHCSFVVDSELWVV 102 (516)
T ss_pred CCccceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhhhhhHHHHHHHHHHhhhcCCCCcceEEEEEEecceeEEe
Confidence 34568999999999999999999864 67999999985433 33357899999999999999999999999999999999
Q ss_pred EeecCCCCHHHHHhhhhccCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCEEEcCCCcEEEEecCCccccC
Q 010519 261 YEYVNNGNLEQWLHGAMRNQGNLTWEARMKVIIGTAKALAYLHEAIEPKVVHRDIKSSNILIDDEFNAKVSDFGLAKLLD 340 (508)
Q Consensus 261 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~Dfgla~~~~ 340 (508)
|.||.+|++.+.+...+.. .+.+..+..|+.++++||.|||.+ |.||||||+.||||+++|.|||+|||.+-.+.
T Consensus 103 mpfMa~GS~ldIik~~~~~--Gl~E~~Ia~iLre~LkaL~YLH~~---G~IHRdvKAgnILi~~dG~VkLadFgvsa~l~ 177 (516)
T KOG0582|consen 103 MPFMAGGSLLDIIKTYYPD--GLEEASIATILREVLKALDYLHQN---GHIHRDVKAGNILIDSDGTVKLADFGVSASLF 177 (516)
T ss_pred ehhhcCCcHHHHHHHHccc--cccHHHHHHHHHHHHHHHHHHHhc---CceecccccccEEEcCCCcEEEcCceeeeeec
Confidence 9999999999999875543 499999999999999999999999 99999999999999999999999999886543
Q ss_pred CCCCcc---cccccccccccCccccCC--CCCCChhhHHHHHHHHHHHHhCCCCCCCCCCCchhcHHHHHHHHhcccccc
Q 010519 341 SGESHI---TTRVMGTFGYVAPEYANT--GMLNEKSDIYSFGVLLLEAVTGRDPVDYGRPANEVNLVEWLKMMVGTRRAE 415 (508)
Q Consensus 341 ~~~~~~---~~~~~gt~~y~aPE~~~~--~~~~~~~DvwS~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~ 415 (508)
+..... ...++||+.|||||++.. ..|+.|+||||||+...||.+|..||..-.+- +.+...+.+.. .
T Consensus 178 ~~G~R~~~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~pPm------kvLl~tLqn~p-p 250 (516)
T KOG0582|consen 178 DSGDRQVTRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSKYPPM------KVLLLTLQNDP-P 250 (516)
T ss_pred ccCceeeEeeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcccCChH------HHHHHHhcCCC-C
Confidence 322211 155789999999999543 56999999999999999999999999744321 22222222211 1
Q ss_pred cccCCCCCCChhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHh
Q 010519 416 EVVDPNLEVKPATRALKRSLLVALRCVDPDSEKRPKMSQVVRML 459 (508)
Q Consensus 416 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L 459 (508)
......++.+......+.+.+++..||..||.+|||+++++++-
T Consensus 251 ~~~t~~~~~d~~k~~~ksf~e~i~~CL~kDP~kRptAskLlkh~ 294 (516)
T KOG0582|consen 251 TLLTSGLDKDEDKKFSKSFREMIALCLVKDPSKRPTASKLLKHA 294 (516)
T ss_pred CcccccCChHHhhhhcHHHHHHHHHHhhcCcccCCCHHHHhccH
Confidence 11123344444445556778899999999999999999999854
|
|
| >KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-43 Score=352.12 Aligned_cols=269 Identities=27% Similarity=0.437 Sum_probs=216.0
Q ss_pred HHHhhCCcccceeEeeeCceEEEEEEEcCCCEEEEEEEcccchhh-HHHHHHHHHHHhcCCCCCceeEEEEEEeCceeeE
Q 010519 181 LEIATNRFSAENVLGEGGYGVVYKGRLINGSEVAVKKLLNNLGQA-EKEFRVEVEAIGHVRHKNLVRLLGYCIEGVHRML 259 (508)
Q Consensus 181 ~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~-~~~~~~ei~~l~~l~h~niv~~~~~~~~~~~~~l 259 (508)
-+++.+...+.++||+|-||.|.++...++..||||++....... ..+|..|+++|.+|+|||||.++|+|..++.++|
T Consensus 533 ~EfPRs~L~~~ekiGeGqFGEVhLCeveg~lkVAVK~Lr~~a~~~~r~~F~kEIkiLsqLkhPNIveLvGVC~~DePicm 612 (807)
T KOG1094|consen 533 VEFPRSRLRFKEKIGEGQFGEVHLCEVEGPLKVAVKILRPDATKNARNDFLKEIKILSRLKHPNIVELLGVCVQDDPLCM 612 (807)
T ss_pred hhcchhheehhhhhcCcccceeEEEEecCceEEEEeecCcccchhHHHHHHHHHHHHhccCCCCeeEEEeeeecCCchHH
Confidence 456778888999999999999999998778999999998765444 4789999999999999999999999999999999
Q ss_pred EEeecCCCCHHHHHhhhhccCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCEEEcCCCcEEEEecCCcccc
Q 010519 260 VYEYVNNGNLEQWLHGAMRNQGNLTWEARMKVIIGTAKALAYLHEAIEPKVVHRDIKSSNILIDDEFNAKVSDFGLAKLL 339 (508)
Q Consensus 260 v~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~Dfgla~~~ 339 (508)
|+|||++|+|.+||..+.. ..+.-....+|+.||+.|++||.+. ++|||||.++|+|++.++++||+|||+++-+
T Consensus 613 I~EYmEnGDLnqFl~ahea--pt~~t~~~vsi~tqiasgmaYLes~---nfVHrd~a~rNcLv~~e~~iKiadfgmsR~l 687 (807)
T KOG1094|consen 613 ITEYMENGDLNQFLSAHEL--PTAETAPGVSICTQIASGMAYLESL---NFVHRDLATRNCLVDGEFTIKIADFGMSRNL 687 (807)
T ss_pred HHHHHhcCcHHHHHHhccC--cccccchhHHHHHHHHHHHHHHHhh---chhhccccccceeecCcccEEecCccccccc
Confidence 9999999999999964321 2234456678999999999999998 9999999999999999999999999999955
Q ss_pred CCCCC-cccccccccccccCccccCCCCCCChhhHHHHHHHHHHHHh--CCCCCCCCCCCchhcHHHHHHHHhccccccc
Q 010519 340 DSGES-HITTRVMGTFGYVAPEYANTGMLNEKSDIYSFGVLLLEAVT--GRDPVDYGRPANEVNLVEWLKMMVGTRRAEE 416 (508)
Q Consensus 340 ~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~ellt--G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 416 (508)
-.+.. ......+-..+|||||.+.-++++.++|||+||+.|||+++ ...||...... +..+-...+.....
T Consensus 688 ysg~yy~vqgr~vlpiRwmawEsillgkFttaSDvWafgvTlwE~~~~C~e~Py~~lt~e---~vven~~~~~~~~~--- 761 (807)
T KOG1094|consen 688 YSGDYYRVQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEVFMLCREQPYSQLTDE---QVVENAGEFFRDQG--- 761 (807)
T ss_pred ccCCceeeecceeeeeeehhHHHHHhccccchhhhhhhHHHHHHHHHHHhhCchhhhhHH---HHHHhhhhhcCCCC---
Confidence 44433 34555667789999999999999999999999999999987 67788643221 22222222221111
Q ss_pred ccCCCCCCChhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhhcCC
Q 010519 417 VVDPNLEVKPATRALKRSLLVALRCVDPDSEKRPKMSQVVRMLEADD 463 (508)
Q Consensus 417 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~ 463 (508)
.......+.-++..+++++.+||..|-.+|||++++..+|+...
T Consensus 762 ---~~~~l~~P~~cp~~lyelml~Cw~~es~~RPsFe~lh~~lq~~~ 805 (807)
T KOG1094|consen 762 ---RQVVLSRPPACPQGLYELMLRCWRRESEQRPSFEQLHLFLQEDA 805 (807)
T ss_pred ---cceeccCCCcCcHHHHHHHHHHhchhhhcCCCHHHHHHHHHHhc
Confidence 11112223345667778999999999999999999999998753
|
|
| >KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-44 Score=360.05 Aligned_cols=251 Identities=25% Similarity=0.379 Sum_probs=214.6
Q ss_pred CCcccceeEeeeCceEEEEEEEc-CCCEEEEEEEcccchhhHHHHHHHHHHHhcCCCCCceeEEEEEEeCceeeEEEeec
Q 010519 186 NRFSAENVLGEGGYGVVYKGRLI-NGSEVAVKKLLNNLGQAEKEFRVEVEAIGHVRHKNLVRLLGYCIEGVHRMLVYEYV 264 (508)
Q Consensus 186 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~ei~~l~~l~h~niv~~~~~~~~~~~~~lv~E~~ 264 (508)
..|..-..||+|+.|.||.+... .++.||||++........+-+.+|+.+|+..+|+|||++++.|..++.+++|||||
T Consensus 273 ~~y~~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~Q~~keLilnEi~Vm~~~~H~NiVnfl~Sylv~deLWVVMEym 352 (550)
T KOG0578|consen 273 SKYTDFKKIGQGATGGVYVARKISTKQEVAIKRMDLRKQPKKELLLNEILVMRDLHHPNIVNFLDSYLVGDELWVVMEYM 352 (550)
T ss_pred hhhcchhhhccccccceeeeeeccCCceEEEEEEEeccCCchhhhHHHHHHHHhccchHHHHHHHHhcccceeEEEEeec
Confidence 56777889999999999999754 78899999997776666677899999999999999999999999999999999999
Q ss_pred CCCCHHHHHhhhhccCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCEEEcCCCcEEEEecCCccccCCCCC
Q 010519 265 NNGNLEQWLHGAMRNQGNLTWEARMKVIIGTAKALAYLHEAIEPKVVHRDIKSSNILIDDEFNAKVSDFGLAKLLDSGES 344 (508)
Q Consensus 265 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~ 344 (508)
+||+|.+.+. ...+++.+++.|+.++++||+|||.+ +|+|||||.+|||++.+|.+||+|||++..+.....
T Consensus 353 ~ggsLTDvVt-----~~~~~E~qIA~Icre~l~aL~fLH~~---gIiHrDIKSDnILL~~~g~vKltDFGFcaqi~~~~~ 424 (550)
T KOG0578|consen 353 EGGSLTDVVT-----KTRMTEGQIAAICREILQGLKFLHAR---GIIHRDIKSDNILLTMDGSVKLTDFGFCAQISEEQS 424 (550)
T ss_pred CCCchhhhhh-----cccccHHHHHHHHHHHHHHHHHHHhc---ceeeeccccceeEeccCCcEEEeeeeeeeccccccC
Confidence 9999999874 34589999999999999999999999 999999999999999999999999999988765544
Q ss_pred cccccccccccccCccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCCCchhcHHHHHHHHhcccccccccCCCCCC
Q 010519 345 HITTRVMGTFGYVAPEYANTGMLNEKSDIYSFGVLLLEAVTGRDPVDYGRPANEVNLVEWLKMMVGTRRAEEVVDPNLEV 424 (508)
Q Consensus 345 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 424 (508)
.....+|||.|||||+.....|++|+||||||++++||+-|..||-...+- . .+..+..+ .....
T Consensus 425 -KR~TmVGTPYWMAPEVvtrk~YG~KVDIWSLGIMaIEMveGEPPYlnE~Pl-----r-AlyLIa~n--------g~P~l 489 (550)
T KOG0578|consen 425 -KRSTMVGTPYWMAPEVVTRKPYGPKVDIWSLGIMAIEMVEGEPPYLNENPL-----R-ALYLIATN--------GTPKL 489 (550)
T ss_pred -ccccccCCCCccchhhhhhcccCccccchhhhhHHHHHhcCCCCccCCChH-----H-HHHHHhhc--------CCCCc
Confidence 345568999999999999999999999999999999999999999753321 1 11111111 33344
Q ss_pred ChhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHh
Q 010519 425 KPATRALKRSLLVALRCVDPDSEKRPKMSQVVRML 459 (508)
Q Consensus 425 ~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L 459 (508)
.........+.+|+.+||..|+.+|+++.|+|+|-
T Consensus 490 k~~~klS~~~kdFL~~cL~~dv~~RasA~eLL~Hp 524 (550)
T KOG0578|consen 490 KNPEKLSPELKDFLDRCLVVDVEQRASAKELLEHP 524 (550)
T ss_pred CCccccCHHHHHHHHHHhhcchhcCCCHHHHhcCh
Confidence 44555667778899999999999999999999864
|
|
| >KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-44 Score=346.27 Aligned_cols=257 Identities=28% Similarity=0.412 Sum_probs=203.4
Q ss_pred CcccceeEeeeCceEEEEEEEc-CCCEEEEEEEcccchhhHHHHHHHHHHHhcCCCCCceeEEEEEEeCc--eeeEEEee
Q 010519 187 RFSAENVLGEGGYGVVYKGRLI-NGSEVAVKKLLNNLGQAEKEFRVEVEAIGHVRHKNLVRLLGYCIEGV--HRMLVYEY 263 (508)
Q Consensus 187 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~ei~~l~~l~h~niv~~~~~~~~~~--~~~lv~E~ 263 (508)
++...+.||+|+||+||++.+. +|...|||.+........+.+.+|+.+|.+++|||||+++|...... .++++|||
T Consensus 18 ~~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~~~~~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~~~~~i~mEy 97 (313)
T KOG0198|consen 18 NWSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELEDSPTSESLEREIRILSRLNHPNIVQYYGSSSSRENDEYNIFMEY 97 (313)
T ss_pred hhhhhccccCccceEEEEEEecCCCcceeeeeeecccchhHHHHHHHHHHHHhCCCCCEEeeCCccccccCeeeEeeeec
Confidence 5777889999999999999875 48999999886553333566889999999999999999999754444 58899999
Q ss_pred cCCCCHHHHHhhhhccCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCEEEcC-CCcEEEEecCCccccCC-
Q 010519 264 VNNGNLEQWLHGAMRNQGNLTWEARMKVIIGTAKALAYLHEAIEPKVVHRDIKSSNILIDD-EFNAKVSDFGLAKLLDS- 341 (508)
Q Consensus 264 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiH~Dlk~~NIll~~-~~~~kl~Dfgla~~~~~- 341 (508)
+++|+|.+++.. .++.+++..+..+..||++||.|||++ +|+||||||+|||++. ++.+||+|||++.....
T Consensus 98 ~~~GsL~~~~~~---~g~~l~E~~v~~ytr~iL~GL~ylHs~---g~vH~DiK~~NiLl~~~~~~~KlaDFG~a~~~~~~ 171 (313)
T KOG0198|consen 98 APGGSLSDLIKR---YGGKLPEPLVRRYTRQILEGLAYLHSK---GIVHCDIKPANILLDPSNGDVKLADFGLAKKLESK 171 (313)
T ss_pred cCCCcHHHHHHH---cCCCCCHHHHHHHHHHHHHHHHHHHhC---CEeccCcccceEEEeCCCCeEEeccCccccccccc
Confidence 999999999963 233799999999999999999999999 9999999999999999 79999999999987663
Q ss_pred -CCCcccccccccccccCccccCCC-CCCChhhHHHHHHHHHHHHhCCCCCCCCCCCchhcHHHHHHHHhcccccccccC
Q 010519 342 -GESHITTRVMGTFGYVAPEYANTG-MLNEKSDIYSFGVLLLEAVTGRDPVDYGRPANEVNLVEWLKMMVGTRRAEEVVD 419 (508)
Q Consensus 342 -~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwS~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 419 (508)
..........||+.|||||++.++ ....++|||||||++.||+||+.||... .....++.........
T Consensus 172 ~~~~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~-----~~~~~~~~~ig~~~~~----- 241 (313)
T KOG0198|consen 172 GTKSDSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSEF-----FEEAEALLLIGREDSL----- 241 (313)
T ss_pred cccccccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchhh-----cchHHHHHHHhccCCC-----
Confidence 222234457899999999999853 3335999999999999999999999642 1111222121111111
Q ss_pred CCCCCChhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhhcCC
Q 010519 420 PNLEVKPATRALKRSLLVALRCVDPDSEKRPKMSQVVRMLEADD 463 (508)
Q Consensus 420 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~ 463 (508)
|. .+........+++.+|+..||.+||||.++|.|.....
T Consensus 242 P~----ip~~ls~~a~~Fl~~C~~~~p~~Rpta~eLL~hpf~~~ 281 (313)
T KOG0198|consen 242 PE----IPDSLSDEAKDFLRKCFKRDPEKRPTAEELLEHPFLKQ 281 (313)
T ss_pred CC----CCcccCHHHHHHHHHHhhcCcccCcCHHHHhhChhhhc
Confidence 21 12224456667999999999999999999999876544
|
|
| >KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-43 Score=346.73 Aligned_cols=265 Identities=26% Similarity=0.319 Sum_probs=212.9
Q ss_pred hCCcccceeEeeeCceEEEEEEE-cCCCEEEEEEEcccc--hhhHHHHHHHHHHHhcCCCCCceeEEEEEEeC--ceeeE
Q 010519 185 TNRFSAENVLGEGGYGVVYKGRL-INGSEVAVKKLLNNL--GQAEKEFRVEVEAIGHVRHKNLVRLLGYCIEG--VHRML 259 (508)
Q Consensus 185 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~ei~~l~~l~h~niv~~~~~~~~~--~~~~l 259 (508)
.+.|+.+++||+|+||.||++++ .+|+.||+|++.... ........+||.+|++|+||||+++.+...+. ..+||
T Consensus 116 ~~~feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~~~~~~~t~~REI~ILr~l~HpNIikL~eivt~~~~~siYl 195 (560)
T KOG0600|consen 116 ADSFEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDNEKEGFPITAIREIKILRRLDHPNIIKLEEIVTSKLSGSIYL 195 (560)
T ss_pred hHHHHHHHHhcCcchhheeEeeecccCcEEEEEEeecccCCCcchHHHHHHHHHHHhcCCCcccceeeEEEecCCceEEE
Confidence 35688889999999999999986 478999999997554 33345667799999999999999999998876 68899
Q ss_pred EEeecCCCCHHHHHhhhhccCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCEEEcCCCcEEEEecCCcccc
Q 010519 260 VYEYVNNGNLEQWLHGAMRNQGNLTWEARMKVIIGTAKALAYLHEAIEPKVVHRDIKSSNILIDDEFNAKVSDFGLAKLL 339 (508)
Q Consensus 260 v~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~Dfgla~~~ 339 (508)
|||||+. +|.-++. ...-.+++.++..++.||+.||.|+|.+ +|+|||||.+|||||.+|.+||+|||||+++
T Consensus 196 VFeYMdh-DL~GLl~---~p~vkft~~qIKc~mkQLl~Gl~~cH~~---gvlHRDIK~SNiLidn~G~LKiaDFGLAr~y 268 (560)
T KOG0600|consen 196 VFEYMDH-DLSGLLS---SPGVKFTEPQIKCYMKQLLEGLEYCHSR---GVLHRDIKGSNILIDNNGVLKIADFGLARFY 268 (560)
T ss_pred EEecccc-hhhhhhc---CCCcccChHHHHHHHHHHHHHHHHHhhc---CeeeccccccceEEcCCCCEEeccccceeec
Confidence 9999987 9999885 3456799999999999999999999999 9999999999999999999999999999988
Q ss_pred CCCCCcccccccccccccCccccCC-CCCCChhhHHHHHHHHHHHHhCCCCCCCCCCCchhcHHHHHHHHhccccccccc
Q 010519 340 DSGESHITTRVMGTFGYVAPEYANT-GMLNEKSDIYSFGVLLLEAVTGRDPVDYGRPANEVNLVEWLKMMVGTRRAEEVV 418 (508)
Q Consensus 340 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwS~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 418 (508)
........+..+-|.+|.|||++.| ..|+.++|+||.||||.||+.|+..|.... ++...+.+..+++........
T Consensus 269 ~~~~~~~~T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~G~t---EveQl~kIfklcGSP~e~~W~ 345 (560)
T KOG0600|consen 269 TPSGSAPYTSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPILQGRT---EVEQLHKIFKLCGSPTEDYWP 345 (560)
T ss_pred cCCCCcccccceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCcCCcc---HHHHHHHHHHHhCCCChhccc
Confidence 7766665777788999999999987 479999999999999999999998886442 333334444555443222211
Q ss_pred CCCCC------C-Ch--------hHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHh
Q 010519 419 DPNLE------V-KP--------ATRALKRSLLVALRCVDPDSEKRPKMSQVVRML 459 (508)
Q Consensus 419 ~~~~~------~-~~--------~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L 459 (508)
-..+. . .+ ........++|+..+|..||.+|.|+.++|+.=
T Consensus 346 ~~kLP~~~~~kp~~~y~r~l~E~~~~~~~~~l~Ll~~lL~ldP~kR~tA~~aL~se 401 (560)
T KOG0600|consen 346 VSKLPHATIFKPQQPYKRRLRETFKDFPASALDLLEKLLSLDPDKRGTASSALQSE 401 (560)
T ss_pred cccCCcccccCCCCcccchHHHHhccCCHHHHHHHHHHhccCccccccHHHHhcCc
Confidence 01111 0 01 011234557789999999999999999998753
|
|
| >KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-43 Score=348.95 Aligned_cols=256 Identities=25% Similarity=0.354 Sum_probs=208.4
Q ss_pred HHhhCCcccceeEeeeCceEEEEEEEc-CCCEEEEEEEcccch---hhHHHHHHHHHHHhcCCCCCceeEEEEEEeCcee
Q 010519 182 EIATNRFSAENVLGEGGYGVVYKGRLI-NGSEVAVKKLLNNLG---QAEKEFRVEVEAIGHVRHKNLVRLLGYCIEGVHR 257 (508)
Q Consensus 182 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~ei~~l~~l~h~niv~~~~~~~~~~~~ 257 (508)
.+..++|.+++.||+|+||.||+|+-+ .|..+|+|++.+..- ...+.++.|-++|...++|+||+++-.|++..++
T Consensus 137 r~~~~DFe~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYsFQD~~~L 216 (550)
T KOG0605|consen 137 RLSLDDFELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYSFQDKEYL 216 (550)
T ss_pred cCCcccchhheeeccccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEEecCCCee
Confidence 345689999999999999999999864 688999999876542 2235688899999999999999999999999999
Q ss_pred eEEEeecCCCCHHHHHhhhhccCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCEEEcCCCcEEEEecCCcc
Q 010519 258 MLVYEYVNNGNLEQWLHGAMRNQGNLTWEARMKVIIGTAKALAYLHEAIEPKVVHRDIKSSNILIDDEFNAKVSDFGLAK 337 (508)
Q Consensus 258 ~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~Dfgla~ 337 (508)
||||||++||++.++| ...+.|++..+..++.+.+.||..||.. |+|||||||+|+|||..|++||+||||+.
T Consensus 217 YLiMEylPGGD~mTLL----~~~~~L~e~~arfYiaE~vlAI~~iH~~---gyIHRDIKPdNlLiD~~GHiKLSDFGLs~ 289 (550)
T KOG0605|consen 217 YLIMEYLPGGDMMTLL----MRKDTLTEDWARFYIAETVLAIESIHQL---GYIHRDIKPDNLLIDAKGHIKLSDFGLST 289 (550)
T ss_pred EEEEEecCCccHHHHH----HhcCcCchHHHHHHHHHHHHHHHHHHHc---CcccccCChhheeecCCCCEeeccccccc
Confidence 9999999999999999 5678899999999999999999999999 99999999999999999999999999985
Q ss_pred ccCC----------------------CCCc------------------------ccccccccccccCccccCCCCCCChh
Q 010519 338 LLDS----------------------GESH------------------------ITTRVMGTFGYVAPEYANTGMLNEKS 371 (508)
Q Consensus 338 ~~~~----------------------~~~~------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~ 371 (508)
-+.. .... .....+|||.|+|||++.+..|+..+
T Consensus 290 gl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~kgY~~~c 369 (550)
T KOG0605|consen 290 GLDKKHRIESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGKGYGKEC 369 (550)
T ss_pred hhhhhhhhhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcCCCCccc
Confidence 3211 0000 01126899999999999999999999
Q ss_pred hHHHHHHHHHHHHhCCCCCCCCCCCchh-cHHHHHHHHhcccccccccCCCCCCChhHHHHHHHHHHHHHhcCCCCCCCC
Q 010519 372 DIYSFGVLLLEAVTGRDPVDYGRPANEV-NLVEWLKMMVGTRRAEEVVDPNLEVKPATRALKRSLLVALRCVDPDSEKRP 450 (508)
Q Consensus 372 DvwS~Gvvl~elltG~~Pf~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP 450 (508)
|+||||||+||||.|.+||....+.... ++..|-. .+..+.......+..+||.+|+. ||.+|.
T Consensus 370 DwWSLG~ImyEmLvGyPPF~s~tp~~T~rkI~nwr~--------------~l~fP~~~~~s~eA~DLI~rll~-d~~~RL 434 (550)
T KOG0605|consen 370 DWWSLGCIMYEMLVGYPPFCSETPQETYRKIVNWRE--------------TLKFPEEVDLSDEAKDLITRLLC-DPENRL 434 (550)
T ss_pred cHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhh--------------hccCCCcCcccHHHHHHHHHHhc-CHHHhc
Confidence 9999999999999999999755443221 1222221 12222233334677789999999 999997
Q ss_pred C---HHHHHHHh
Q 010519 451 K---MSQVVRML 459 (508)
Q Consensus 451 s---~~evl~~L 459 (508)
- ++||-+|-
T Consensus 435 G~~G~~EIK~HP 446 (550)
T KOG0605|consen 435 GSKGAEEIKKHP 446 (550)
T ss_pred CcccHHHHhcCC
Confidence 4 77777654
|
|
| >KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-43 Score=326.88 Aligned_cols=236 Identities=26% Similarity=0.377 Sum_probs=198.2
Q ss_pred CCcccceeEeeeCceEEEEEEEc-CCCEEEEEEEcccc---hhhHHHHHHHHHHHhcCCCCCceeEEEEEEeCceeeEEE
Q 010519 186 NRFSAENVLGEGGYGVVYKGRLI-NGSEVAVKKLLNNL---GQAEKEFRVEVEAIGHVRHKNLVRLLGYCIEGVHRMLVY 261 (508)
Q Consensus 186 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~ei~~l~~l~h~niv~~~~~~~~~~~~~lv~ 261 (508)
++|+..+.||.|+||.|.+++.+ +|.-+|+|++.+.. ....+...+|..+|+.+.||+++++++.|.+...+||||
T Consensus 44 ~dfe~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~~d~~~lymvm 123 (355)
T KOG0616|consen 44 QDFERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTFKDNSNLYMVM 123 (355)
T ss_pred hhhhheeeeccCccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEeeccCCeEEEEE
Confidence 47888999999999999999876 68889999986543 223356778999999999999999999999999999999
Q ss_pred eecCCCCHHHHHhhhhccCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCEEEcCCCcEEEEecCCccccCC
Q 010519 262 EYVNNGNLEQWLHGAMRNQGNLTWEARMKVIIGTAKALAYLHEAIEPKVVHRDIKSSNILIDDEFNAKVSDFGLAKLLDS 341 (508)
Q Consensus 262 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~ 341 (508)
||.+||.|+.+|+ .-+++++..++.++.+|+.||.|||+. +|++|||||+|||+|.+|++||+|||+|+....
T Consensus 124 eyv~GGElFS~Lr----k~~rF~e~~arFYAAeivlAleylH~~---~iiYRDLKPENiLlD~~G~iKitDFGFAK~v~~ 196 (355)
T KOG0616|consen 124 EYVPGGELFSYLR----KSGRFSEPHARFYAAEIVLALEYLHSL---DIIYRDLKPENLLLDQNGHIKITDFGFAKRVSG 196 (355)
T ss_pred eccCCccHHHHHH----hcCCCCchhHHHHHHHHHHHHHHHHhc---CeeeccCChHHeeeccCCcEEEEeccceEEecC
Confidence 9999999999994 567899999999999999999999999 999999999999999999999999999997754
Q ss_pred CCCcccccccccccccCccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCCCchhcHHHHHHHHhcccccccccCCC
Q 010519 342 GESHITTRVMGTFGYVAPEYANTGMLNEKSDIYSFGVLLLEAVTGRDPVDYGRPANEVNLVEWLKMMVGTRRAEEVVDPN 421 (508)
Q Consensus 342 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 421 (508)
. +...||||.|+|||++..+.|+.++|+|+|||++|||+.|..||....+ . ..... ++...
T Consensus 197 r----T~TlCGTPeYLAPEii~sk~ynkavDWWalGVLIYEMlaG~pPF~~~~~---~---~iY~K---------I~~~~ 257 (355)
T KOG0616|consen 197 R----TWTLCGTPEYLAPEIIQSKGYNKAVDWWALGVLIYEMLAGYPPFYDDNP---I---QIYEK---------ILEGK 257 (355)
T ss_pred c----EEEecCCccccChHHhhcCCCCcchhHHHHHHHHHHHHcCCCCCcCCCh---H---HHHHH---------HHhCc
Confidence 3 5567999999999999999999999999999999999999999975543 1 11111 11122
Q ss_pred CCCChhHHHHHHHHHHHHHhcCCCCCCC
Q 010519 422 LEVKPATRALKRSLLVALRCVDPDSEKR 449 (508)
Q Consensus 422 ~~~~~~~~~~~~l~~li~~cl~~dP~~R 449 (508)
+.. +......+.+|+...|+.|-.+|
T Consensus 258 v~f--P~~fs~~~kdLl~~LL~vD~t~R 283 (355)
T KOG0616|consen 258 VKF--PSYFSSDAKDLLKKLLQVDLTKR 283 (355)
T ss_pred ccC--CcccCHHHHHHHHHHHhhhhHhh
Confidence 222 22223445568888899998888
|
|
| >KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-42 Score=350.02 Aligned_cols=273 Identities=26% Similarity=0.440 Sum_probs=215.4
Q ss_pred eHHHHHHhhCCcccceeEeeeCceEEEEEEEcCCCEEEEEEEcccc--hhhHHHHHHHHHHHhcCCCCCceeEEEEEEeC
Q 010519 177 TLRDLEIATNRFSAENVLGEGGYGVVYKGRLINGSEVAVKKLLNNL--GQAEKEFRVEVEAIGHVRHKNLVRLLGYCIEG 254 (508)
Q Consensus 177 ~~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~--~~~~~~~~~ei~~l~~l~h~niv~~~~~~~~~ 254 (508)
+..+|++..+++.+...||+|.||+||+|+|. ..||||++.... ....+.|++|+..+++-+|.||+-|.|+|-..
T Consensus 383 s~~~WeIp~~ev~l~~rIGsGsFGtV~Rg~wh--GdVAVK~Lnv~~pt~~qlqaFKnEVa~lkkTRH~NIlLFMG~~~~p 460 (678)
T KOG0193|consen 383 SLEEWEIPPEEVLLGERIGSGSFGTVYRGRWH--GDVAVKLLNVDDPTPEQLQAFKNEVAVLKKTRHENILLFMGACMNP 460 (678)
T ss_pred cccccccCHHHhhccceeccccccceeecccc--cceEEEEEecCCCCHHHHHHHHHHHHHHhhcchhhheeeehhhcCC
Confidence 45788999999999999999999999999984 359999985443 44567899999999999999999999999887
Q ss_pred ceeeEEEeecCCCCHHHHHhhhhccCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCEEEcCCCcEEEEecC
Q 010519 255 VHRMLVYEYVNNGNLEQWLHGAMRNQGNLTWEARMKVIIGTAKALAYLHEAIEPKVVHRDIKSSNILIDDEFNAKVSDFG 334 (508)
Q Consensus 255 ~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~Dfg 334 (508)
.. .||.-+|.|-+|+.+|| .....+.....+.|+.||++|+.|||.+ +|||||||+.|||+.+++.|||+|||
T Consensus 461 ~~-AIiTqwCeGsSLY~hlH---v~etkfdm~~~idIAqQiaqGM~YLHAK---~IIHrDLKSnNIFl~~~~kVkIgDFG 533 (678)
T KOG0193|consen 461 PL-AIITQWCEGSSLYTHLH---VQETKFDMNTTIDIAQQIAQGMDYLHAK---NIIHRDLKSNNIFLHEDLKVKIGDFG 533 (678)
T ss_pred ce-eeeehhccCchhhhhcc---chhhhhhHHHHHHHHHHHHHhhhhhhhh---hhhhhhccccceEEccCCcEEEeccc
Confidence 77 99999999999999998 3457789999999999999999999999 99999999999999999999999999
Q ss_pred CccccCCC-CCcccccccccccccCccccC---CCCCCChhhHHHHHHHHHHHHhCCCCCCCCCCCchhcHHHHHHHHhc
Q 010519 335 LAKLLDSG-ESHITTRVMGTFGYVAPEYAN---TGMLNEKSDIYSFGVLLLEAVTGRDPVDYGRPANEVNLVEWLKMMVG 410 (508)
Q Consensus 335 la~~~~~~-~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DvwS~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~ 410 (508)
++..-... .........|...|||||++. ..+|++.+||||||+|+|||++|..||... ..+ .+--+.+
T Consensus 534 Latvk~~w~g~~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPysi~-~~d------qIifmVG 606 (678)
T KOG0193|consen 534 LATVKTRWSGEQQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYSIQ-NRD------QIIFMVG 606 (678)
T ss_pred ceeeeeeeccccccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcCCC-Chh------heEEEec
Confidence 98633211 001122234677899999985 357999999999999999999999999722 111 1111122
Q ss_pred ccccccccCCCCCCChhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhhcCCCCCchhh
Q 010519 411 TRRAEEVVDPNLEVKPATRALKRSLLVALRCVDPDSEKRPKMSQVVRMLEADDYPFREDR 470 (508)
Q Consensus 411 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~~~~~~ 470 (508)
.+.+ ..|. ......+.+++.+|+..||+.++++||++.+|+..|+.......+-+
T Consensus 607 rG~l--~pd~---s~~~s~~pk~mk~Ll~~C~~~~~~eRP~F~~il~~l~~l~~~~pki~ 661 (678)
T KOG0193|consen 607 RGYL--MPDL---SKIRSNCPKAMKRLLSDCWKFDREERPLFPQLLSKLEELLPSLPKIN 661 (678)
T ss_pred cccc--Cccc---hhhhccCHHHHHHHHHHHHhcCcccCccHHHHHHHHHHhhhcccccc
Confidence 1110 1111 11223345566678889999999999999999999988776443333
|
|
| >KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-44 Score=366.31 Aligned_cols=260 Identities=28% Similarity=0.503 Sum_probs=222.6
Q ss_pred HHhhCCcccceeEeeeCceEEEEEEEc-C---CCEEEEEEEcccc-hhhHHHHHHHHHHHhcCCCCCceeEEEEEEeCce
Q 010519 182 EIATNRFSAENVLGEGGYGVVYKGRLI-N---GSEVAVKKLLNNL-GQAEKEFRVEVEAIGHVRHKNLVRLLGYCIEGVH 256 (508)
Q Consensus 182 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~-~---~~~vavK~~~~~~-~~~~~~~~~ei~~l~~l~h~niv~~~~~~~~~~~ 256 (508)
++..+...++++||.|.||+|++|+++ . ...||||.++... .+....|..|..+|.+++||||+++.|+......
T Consensus 625 EId~s~i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~GytekqrrdFL~EAsIMGQFdHPNIIrLEGVVTks~P 704 (996)
T KOG0196|consen 625 EIDPSCVKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIRLEGVVTKSKP 704 (996)
T ss_pred hcChhheEEEEEEecccccceecccccCCCCcceeEEEeeeccCccHHHHhhhhhhhhhcccCCCCcEEEEEEEEecCce
Confidence 455677889999999999999999975 2 3579999997654 4555789999999999999999999999999999
Q ss_pred eeEEEeecCCCCHHHHHhhhhccCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCEEEcCCCcEEEEecCCc
Q 010519 257 RMLVYEYVNNGNLEQWLHGAMRNQGNLTWEARMKVIIGTAKALAYLHEAIEPKVVHRDIKSSNILIDDEFNAKVSDFGLA 336 (508)
Q Consensus 257 ~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~Dfgla 336 (508)
.+||.|||++|+|..||+ .+.+.+++.+...++.+|+.|+.||-+. ++|||||..+||||+.+..+|++|||++
T Consensus 705 vMIiTEyMENGsLDsFLR---~~DGqftviQLVgMLrGIAsGMkYLsdm---~YVHRDLAARNILVNsnLvCKVsDFGLS 778 (996)
T KOG0196|consen 705 VMIITEYMENGSLDSFLR---QNDGQFTVIQLVGMLRGIASGMKYLSDM---NYVHRDLAARNILVNSNLVCKVSDFGLS 778 (996)
T ss_pred eEEEhhhhhCCcHHHHHh---hcCCceEeehHHHHHHHHHHHhHHHhhc---CchhhhhhhhheeeccceEEEeccccce
Confidence 999999999999999997 5667899999999999999999999999 9999999999999999999999999999
Q ss_pred cccCCCCCcccccc--cccccccCccccCCCCCCChhhHHHHHHHHHHHHh-CCCCCCCCCCCchhcHHHHHHHHhcccc
Q 010519 337 KLLDSGESHITTRV--MGTFGYVAPEYANTGMLNEKSDIYSFGVLLLEAVT-GRDPVDYGRPANEVNLVEWLKMMVGTRR 413 (508)
Q Consensus 337 ~~~~~~~~~~~~~~--~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~ 413 (508)
+.+.++.....+.. .-..+|.|||.+....++.++||||||++|||.++ |..||......+ .+..
T Consensus 779 Rvledd~~~~ytt~GGKIPiRWTAPEAIa~RKFTsASDVWSyGIVmWEVmSyGERPYWdmSNQd------VIka------ 846 (996)
T KOG0196|consen 779 RVLEDDPEAAYTTLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQD------VIKA------ 846 (996)
T ss_pred eecccCCCccccccCCccceeecChhHhhhcccCchhhccccceEEEEecccCCCcccccchHH------HHHH------
Confidence 98866553322222 23568999999999999999999999999999998 999986443221 1222
Q ss_pred cccccCCCCCCChhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhhcCC
Q 010519 414 AEEVVDPNLEVKPATRALKRSLLVALRCVDPDSEKRPKMSQVVRMLEADD 463 (508)
Q Consensus 414 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~ 463 (508)
++..++.+++.+++..+.+|++.||++|-.+||++.||+.+|...-
T Consensus 847 ----Ie~gyRLPpPmDCP~aL~qLMldCWqkdR~~RP~F~qiV~~lDklI 892 (996)
T KOG0196|consen 847 ----IEQGYRLPPPMDCPAALYQLMLDCWQKDRNRRPKFAQIVSTLDKLI 892 (996)
T ss_pred ----HHhccCCCCCCCCcHHHHHHHHHHHHHHhhcCCCHHHHHHHHHHHh
Confidence 2256777888889999999999999999999999999999997643
|
|
| >KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-43 Score=367.67 Aligned_cols=260 Identities=25% Similarity=0.410 Sum_probs=219.2
Q ss_pred HHHhhCCcccceeEeeeCceEEEEEEEcCC-CEEEEEEEcccchhhHHHHHHHHHHHhcCC-CCCceeEEE-EEEeC---
Q 010519 181 LEIATNRFSAENVLGEGGYGVVYKGRLING-SEVAVKKLLNNLGQAEKEFRVEVEAIGHVR-HKNLVRLLG-YCIEG--- 254 (508)
Q Consensus 181 ~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~-~~vavK~~~~~~~~~~~~~~~ei~~l~~l~-h~niv~~~~-~~~~~--- 254 (508)
+.+...++++.+.|.+|||+.||++++.++ .++|+|++..........+++||++|+.|. |+|||.+++ .....
T Consensus 32 ~~Vg~~~v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~~~ 111 (738)
T KOG1989|consen 32 FTVGSHRVTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVNDEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRSSN 111 (738)
T ss_pred EEECCEEEEEEEEEccCCcEEEEEEEecCCCceeeeeeeecCCHHHHHHHHHHHHHHHHhcCCCceeeEeccccccccCC
Confidence 356667899999999999999999998766 999999998888888889999999999996 999999999 33221
Q ss_pred ---ceeeEEEeecCCCCHHHHHhhhhccCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCEEEcCCCcEEEE
Q 010519 255 ---VHRMLVYEYVNNGNLEQWLHGAMRNQGNLTWEARMKVIIGTAKALAYLHEAIEPKVVHRDIKSSNILIDDEFNAKVS 331 (508)
Q Consensus 255 ---~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~ 331 (508)
-..+|+||||.||.|-|+++.+... .|++..+++|+.++++|+++||. +.|+|||||||-+||||+.+++.|||
T Consensus 112 ~~~~EvllLmEyC~gg~Lvd~mn~Rlq~--~lte~eVLkIf~dv~~AVa~mH~-~~pPiIHRDLKiENvLls~~g~~KLC 188 (738)
T KOG1989|consen 112 NGVWEVLLLMEYCKGGSLVDFMNTRLQT--RLTEDEVLKIFYDVCEAVAAMHY-LKPPIIHRDLKIENVLLSADGNYKLC 188 (738)
T ss_pred CceeEEEeehhhccCCcHHHHHHHHHhc--cCChHHHHHHHHHHHHHHHHHhc-CCCccchhhhhhhheEEcCCCCEEeC
Confidence 3457999999999999999875443 49999999999999999999998 68889999999999999999999999
Q ss_pred ecCCccccCCCC-Cc-c------cccccccccccCcccc---CCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCCCchhc
Q 010519 332 DFGLAKLLDSGE-SH-I------TTRVMGTFGYVAPEYA---NTGMLNEKSDIYSFGVLLLEAVTGRDPVDYGRPANEVN 400 (508)
Q Consensus 332 Dfgla~~~~~~~-~~-~------~~~~~gt~~y~aPE~~---~~~~~~~~~DvwS~Gvvl~elltG~~Pf~~~~~~~~~~ 400 (508)
|||.+.-..... .. . .-...-|+.|.|||++ .+..+++|+|||+|||+||-|+...+||+....
T Consensus 189 DFGSatt~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~PFe~sg~----- 263 (738)
T KOG1989|consen 189 DFGSATTKILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTTPFEESGK----- 263 (738)
T ss_pred cccccccccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCCCcCcCcc-----
Confidence 999986322111 10 0 0112459999999987 578899999999999999999999999975432
Q ss_pred HHHHHHHHhcccccccccCCCCCCChhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhhcC
Q 010519 401 LVEWLKMMVGTRRAEEVVDPNLEVKPATRALKRSLLVALRCVDPDSEKRPKMSQVVRMLEAD 462 (508)
Q Consensus 401 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~ 462 (508)
-.+++..+.+++.+.....+..||..||++||.+||++.||+..+...
T Consensus 264 --------------laIlng~Y~~P~~p~ys~~l~~LI~~mL~~nP~~RPnI~Qv~~~~~~l 311 (738)
T KOG1989|consen 264 --------------LAILNGNYSFPPFPNYSDRLKDLIRTMLQPNPDERPNIYQVLEEIFEL 311 (738)
T ss_pred --------------eeEEeccccCCCCccHHHHHHHHHHHHhccCcccCCCHHHHHHHHHHH
Confidence 345567777777778888999999999999999999999999988653
|
|
| >cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-43 Score=353.20 Aligned_cols=263 Identities=27% Similarity=0.425 Sum_probs=204.1
Q ss_pred HHhhCCcccceeEeeeCceEEEEEEEc------CCCEEEEEEEcccch-hhHHHHHHHHHHHhcC-CCCCceeEEEEEEe
Q 010519 182 EIATNRFSAENVLGEGGYGVVYKGRLI------NGSEVAVKKLLNNLG-QAEKEFRVEVEAIGHV-RHKNLVRLLGYCIE 253 (508)
Q Consensus 182 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~-~~~~~~~~ei~~l~~l-~h~niv~~~~~~~~ 253 (508)
.++.++|.+.+.||+|+||.||+|.+. .+..||+|++..... .....+..|+.++..+ +||||++++++|..
T Consensus 3 ~~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~ 82 (338)
T cd05102 3 EFPRDRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGATASEHKALMSELKILIHIGNHLNVVNLLGACTK 82 (338)
T ss_pred ccchhHceeeeEeccCCcceEEEEEEeccCCcccchhhheeccccccchHHHHHHHHHHHHHHHhccCcceeeEEeEecC
Confidence 456678999999999999999999742 346799998865432 3345688899999999 89999999998876
Q ss_pred C-ceeeEEEeecCCCCHHHHHhhhhcc-----------------------------------------------------
Q 010519 254 G-VHRMLVYEYVNNGNLEQWLHGAMRN----------------------------------------------------- 279 (508)
Q Consensus 254 ~-~~~~lv~E~~~~gsL~~~l~~~~~~----------------------------------------------------- 279 (508)
. ...++||||+++|+|.+++......
T Consensus 83 ~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 162 (338)
T cd05102 83 PNGPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQE 162 (338)
T ss_pred CCCceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccchh
Confidence 4 4578999999999999999642110
Q ss_pred -----CCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCEEEcCCCcEEEEecCCccccCCCCCc-cccccccc
Q 010519 280 -----QGNLTWEARMKVIIGTAKALAYLHEAIEPKVVHRDIKSSNILIDDEFNAKVSDFGLAKLLDSGESH-ITTRVMGT 353 (508)
Q Consensus 280 -----~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~-~~~~~~gt 353 (508)
...+++..+..++.||++||.|||+. +|+||||||+|||+++++.+||+|||+++........ ......++
T Consensus 163 ~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~ 239 (338)
T cd05102 163 TDDLWKSPLTMEDLICYSFQVARGMEFLASR---KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLP 239 (338)
T ss_pred ccccccCCCCHHHHHHHHHHHHHHHHHHHHC---CEECCCCccceEEEcCCCcEEEeecccccccccCcchhcccCCCCC
Confidence 13477888999999999999999998 9999999999999999999999999999865432221 12223456
Q ss_pred ccccCccccCCCCCCChhhHHHHHHHHHHHHh-CCCCCCCCCCCchhcHHHHHHHHhcccccccccCCCCCCChhHHHHH
Q 010519 354 FGYVAPEYANTGMLNEKSDIYSFGVLLLEAVT-GRDPVDYGRPANEVNLVEWLKMMVGTRRAEEVVDPNLEVKPATRALK 432 (508)
Q Consensus 354 ~~y~aPE~~~~~~~~~~~DvwS~Gvvl~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 432 (508)
+.|+|||++.+..++.++|||||||+||||++ |..||....... ........... .. .+.....
T Consensus 240 ~~y~aPE~~~~~~~~~~sDiwslG~il~el~~~g~~pf~~~~~~~-----~~~~~~~~~~~------~~----~~~~~~~ 304 (338)
T cd05102 240 LKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQINE-----EFCQRLKDGTR------MR----APENATP 304 (338)
T ss_pred ccccCcHHhhcCCCCcccCHHHHHHHHHHHHhCCCCCCCCCCccH-----HHHHHHhcCCC------CC----CCCCCCH
Confidence 78999999999999999999999999999997 999996433211 11111111110 00 1112234
Q ss_pred HHHHHHHHhcCCCCCCCCCHHHHHHHhhcC
Q 010519 433 RSLLVALRCVDPDSEKRPKMSQVVRMLEAD 462 (508)
Q Consensus 433 ~l~~li~~cl~~dP~~RPs~~evl~~L~~~ 462 (508)
.+.+|+.+||+.||.+|||+.++++.|+..
T Consensus 305 ~l~~li~~cl~~dp~~RPs~~el~~~l~~~ 334 (338)
T cd05102 305 EIYRIMLACWQGDPKERPTFSALVEILGDL 334 (338)
T ss_pred HHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence 567799999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V |
| >KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-44 Score=341.31 Aligned_cols=252 Identities=24% Similarity=0.366 Sum_probs=213.4
Q ss_pred hCCcccceeEeeeCceEEEEEEE-cCCCEEEEEEEcccch---hhHHHHHHHHHHHhcCCCCCceeEEEEEEeCceeeEE
Q 010519 185 TNRFSAENVLGEGGYGVVYKGRL-INGSEVAVKKLLNNLG---QAEKEFRVEVEAIGHVRHKNLVRLLGYCIEGVHRMLV 260 (508)
Q Consensus 185 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~---~~~~~~~~ei~~l~~l~h~niv~~~~~~~~~~~~~lv 260 (508)
..+|++.+.||+|.||.|-++.. ..|+.||||.+.+..- +..-.+++||++|..|+||||+.+|.+|++.+...||
T Consensus 52 kHRyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEVFENkdKIviv 131 (668)
T KOG0611|consen 52 KHRYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEVFENKDKIVIV 131 (668)
T ss_pred hhHHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhhhcCCceEEEE
Confidence 35899999999999999999975 6899999999876543 3345688999999999999999999999999999999
Q ss_pred EeecCCCCHHHHHhhhhccCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCEEEcCCCcEEEEecCCccccC
Q 010519 261 YEYVNNGNLEQWLHGAMRNQGNLTWEARMKVIIGTAKALAYLHEAIEPKVVHRDIKSSNILIDDEFNAKVSDFGLAKLLD 340 (508)
Q Consensus 261 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~Dfgla~~~~ 340 (508)
|||..+|.|++|+ ...+.|++..++.++.||..|+.|+|.+ +++|||||.+|||||.++++||+|||++..+.
T Consensus 132 MEYaS~GeLYDYi----Ser~~LsErEaRhfFRQIvSAVhYCHkn---rVvHRDLKLENILLD~N~NiKIADFGLSNly~ 204 (668)
T KOG0611|consen 132 MEYASGGELYDYI----SERGSLSEREARHFFRQIVSAVHYCHKN---RVVHRDLKLENILLDQNNNIKIADFGLSNLYA 204 (668)
T ss_pred EEecCCccHHHHH----HHhccccHHHHHHHHHHHHHHHHHHhhc---cceecccchhheeecCCCCeeeeccchhhhhc
Confidence 9999999999999 5678899999999999999999999999 99999999999999999999999999999886
Q ss_pred CCCCcccccccccccccCccccCCCCCC-ChhhHHHHHHHHHHHHhCCCCCCCCCCCchhcHHHHHHHHhcccccccccC
Q 010519 341 SGESHITTRVMGTFGYVAPEYANTGMLN-EKSDIYSFGVLLLEAVTGRDPVDYGRPANEVNLVEWLKMMVGTRRAEEVVD 419 (508)
Q Consensus 341 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DvwS~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 419 (508)
... ....+||+|.|.+||+++|.+|. +.+|.|||||+||.|+.|..||+..+ ....+++.. .+
T Consensus 205 ~~k--fLqTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG~D------hk~lvrQIs-~G------- 268 (668)
T KOG0611|consen 205 DKK--FLQTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDGRD------HKRLVRQIS-RG------- 268 (668)
T ss_pred ccc--HHHHhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCCch------HHHHHHHhh-cc-------
Confidence 553 46678999999999999999885 79999999999999999999997432 222232221 11
Q ss_pred CCCCCChhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhhcCC
Q 010519 420 PNLEVKPATRALKRSLLVALRCVDPDSEKRPKMSQVVRMLEADD 463 (508)
Q Consensus 420 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~ 463 (508)
...-+. .+....-||++||..||.+|.|+.+|..|+|-++
T Consensus 269 -aYrEP~---~PSdA~gLIRwmLmVNP~RRATieDiAsHWWvNw 308 (668)
T KOG0611|consen 269 -AYREPE---TPSDASGLIRWMLMVNPERRATIEDIASHWWVNW 308 (668)
T ss_pred -cccCCC---CCchHHHHHHHHHhcCcccchhHHHHhhhheeec
Confidence 111111 1223344899999999999999999999998654
|
|
| >KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-43 Score=348.05 Aligned_cols=263 Identities=24% Similarity=0.340 Sum_probs=208.6
Q ss_pred hhCCcccceeEeeeCceEEEEEEEc-CCCEEEEEEEcccchhhH-HHHHHHHHHHhcCC-CCCceeEEEEEEeCc-eeeE
Q 010519 184 ATNRFSAENVLGEGGYGVVYKGRLI-NGSEVAVKKLLNNLGQAE-KEFRVEVEAIGHVR-HKNLVRLLGYCIEGV-HRML 259 (508)
Q Consensus 184 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~-~~~~~ei~~l~~l~-h~niv~~~~~~~~~~-~~~l 259 (508)
.-++|.+.++||.|+||.||+|+.. .|..||||++......-. -.=.+|++.|++|+ |||||++.+++.+.+ .+|+
T Consensus 8 ~m~RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s~ee~~nLREvksL~kln~hpniikL~Evi~d~~~~L~f 87 (538)
T KOG0661|consen 8 FMDRYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNPHPNIIKLKEVIRDNDRILYF 87 (538)
T ss_pred HHHHHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhccHHHHHHHHHHHHHHhcCCCCcchhhHHHhhccCceEee
Confidence 4468999999999999999999854 788999999876543322 22345999999998 999999999999887 8999
Q ss_pred EEeecCCCCHHHHHhhhhccCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCEEEcCCCcEEEEecCCcccc
Q 010519 260 VYEYVNNGNLEQWLHGAMRNQGNLTWEARMKVIIGTAKALAYLHEAIEPKVVHRDIKSSNILIDDEFNAKVSDFGLAKLL 339 (508)
Q Consensus 260 v~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~Dfgla~~~ 339 (508)
|||||+ .+|+++++. .+..+++..++.|+.||++||+|+|.+ |+.|||+||+|||+..+..+||+|||+|+..
T Consensus 88 VfE~Md-~NLYqLmK~---R~r~fse~~irnim~QilqGL~hiHk~---GfFHRDlKPENiLi~~~~~iKiaDFGLARev 160 (538)
T KOG0661|consen 88 VFEFMD-CNLYQLMKD---RNRLFSESDIRNIMYQILQGLAHIHKH---GFFHRDLKPENILISGNDVIKIADFGLAREV 160 (538)
T ss_pred eHHhhh-hhHHHHHhh---cCCcCCHHHHHHHHHHHHHHHHHHHhc---CcccccCChhheEecccceeEeccccccccc
Confidence 999995 599999974 377899999999999999999999999 9999999999999998889999999999987
Q ss_pred CCCCCcccccccccccccCcccc-CCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCCCchhcHHHHHHHHhcccccc---
Q 010519 340 DSGESHITTRVMGTFGYVAPEYA-NTGMLNEKSDIYSFGVLLLEAVTGRDPVDYGRPANEVNLVEWLKMMVGTRRAE--- 415 (508)
Q Consensus 340 ~~~~~~~~~~~~gt~~y~aPE~~-~~~~~~~~~DvwS~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~--- 415 (508)
..... .+..+.|.+|.|||++ ....|+.+.|+|++|||++|+.+-+.-|......+. +.+ +-.+++.....
T Consensus 161 ~SkpP--YTeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE~Dq--i~K-Ic~VLGtP~~~~~~ 235 (538)
T KOG0661|consen 161 RSKPP--YTEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPGASEIDQ--IYK-ICEVLGTPDKDSWP 235 (538)
T ss_pred ccCCC--cchhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCCCCcHHHH--HHH-HHHHhCCCccccch
Confidence 66544 5667899999999987 457899999999999999999998888864432221 111 11222221111
Q ss_pred --------------cccCCCCCCChhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHh
Q 010519 416 --------------EVVDPNLEVKPATRALKRSLLVALRCVDPDSEKRPKMSQVVRML 459 (508)
Q Consensus 416 --------------~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L 459 (508)
......+..- .+.+..+..+++.+|++.||.+|||+.|+|++-
T Consensus 236 eg~~La~~mnf~~P~~~~~~l~~L-~p~~s~~~~~li~~ll~WDP~kRpTA~~al~~p 292 (538)
T KOG0661|consen 236 EGYNLASAMNFRFPQVKPSPLKDL-LPNASSEAASLIERLLAWDPDKRPTASQALQHP 292 (538)
T ss_pred hHHHHHHHhccCCCcCCCCChHHh-CcccCHHHHHHHHHHhcCCCccCccHHHHhcCc
Confidence 1111111111 122566778899999999999999999999865
|
|
| >KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-43 Score=355.30 Aligned_cols=253 Identities=25% Similarity=0.371 Sum_probs=213.2
Q ss_pred CcccceeEeeeCceEEEEEEE-cCCCEEEEEEEcccc---hhhHHHHHHHHHHHhcCCCCCceeEEEEEEeCceeeEEEe
Q 010519 187 RFSAENVLGEGGYGVVYKGRL-INGSEVAVKKLLNNL---GQAEKEFRVEVEAIGHVRHKNLVRLLGYCIEGVHRMLVYE 262 (508)
Q Consensus 187 ~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~ei~~l~~l~h~niv~~~~~~~~~~~~~lv~E 262 (508)
-|.+++.||.|+.|.|-+|++ .+|+.+|||.+.+.. ......+.+||-+|+-+.|||++++|+++++..++|+|.|
T Consensus 13 pwkLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydVwe~~~~lylvlE 92 (786)
T KOG0588|consen 13 PWKLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDVWENKQHLYLVLE 92 (786)
T ss_pred ceeccccccCCCCceehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeeeeccCceEEEEEE
Confidence 477889999999999999986 489999999986542 2223567889999999999999999999999999999999
Q ss_pred ecCCCCHHHHHhhhhccCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCEEEcCCCcEEEEecCCccccCCC
Q 010519 263 YVNNGNLEQWLHGAMRNQGNLTWEARMKVIIGTAKALAYLHEAIEPKVVHRDIKSSNILIDDEFNAKVSDFGLAKLLDSG 342 (508)
Q Consensus 263 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~~ 342 (508)
|+++|.|+++| ...+++++..+++++.||+.|+.|+|.. +|+||||||+|+||+..+++||+|||+|..-..+
T Consensus 93 yv~gGELFdyl----v~kG~l~e~eaa~ff~QIi~gv~yCH~~---~icHRDLKpENlLLd~~~nIKIADFGMAsLe~~g 165 (786)
T KOG0588|consen 93 YVPGGELFDYL----VRKGPLPEREAAHFFRQILDGVSYCHAF---NICHRDLKPENLLLDVKNNIKIADFGMASLEVPG 165 (786)
T ss_pred ecCCchhHHHH----HhhCCCCCHHHHHHHHHHHHHHHHHhhh---cceeccCCchhhhhhcccCEeeeccceeecccCC
Confidence 99999999999 5678899999999999999999999998 9999999999999999999999999999865443
Q ss_pred CCcccccccccccccCccccCCCCCC-ChhhHHHHHHHHHHHHhCCCCCCCCCCCchhcHHHHHHHHhcccccccccCCC
Q 010519 343 ESHITTRVMGTFGYVAPEYANTGMLN-EKSDIYSFGVLLLEAVTGRDPVDYGRPANEVNLVEWLKMMVGTRRAEEVVDPN 421 (508)
Q Consensus 343 ~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DvwS~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 421 (508)
......||+|.|.|||++.|.+|+ .++||||.|||||.||+|++||++. ++...+..+.. ..
T Consensus 166 --klLeTSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFdDd------Nir~LLlKV~~---------G~ 228 (786)
T KOG0588|consen 166 --KLLETSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFDDD------NIRVLLLKVQR---------GV 228 (786)
T ss_pred --ccccccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCCCc------cHHHHHHHHHc---------Cc
Confidence 345667999999999999999886 7999999999999999999999732 33333333221 11
Q ss_pred CCCChhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhhcCCCC
Q 010519 422 LEVKPATRALKRSLLVALRCVDPDSEKRPKMSQVVRMLEADDYP 465 (508)
Q Consensus 422 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~ 465 (508)
+ ..+.....+..+|+.+|+..||.+|.|++||++|..-..+.
T Consensus 229 f--~MPs~Is~eaQdLLr~ml~VDp~~RiT~~eI~kHP~l~g~~ 270 (786)
T KOG0588|consen 229 F--EMPSNISSEAQDLLRRMLDVDPSTRITTEEILKHPFLSGYT 270 (786)
T ss_pred c--cCCCcCCHHHHHHHHHHhccCccccccHHHHhhCchhhcCC
Confidence 1 11233455666799999999999999999999998776553
|
|
| >KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-43 Score=350.73 Aligned_cols=248 Identities=28% Similarity=0.442 Sum_probs=209.8
Q ss_pred CCcccceeEeeeCceEEEEEEEc-CCCEEEEEEEcccc--hhhHHHHHHHHHHHhcCCCCCceeEEEEEEeCceeeEEEe
Q 010519 186 NRFSAENVLGEGGYGVVYKGRLI-NGSEVAVKKLLNNL--GQAEKEFRVEVEAIGHVRHKNLVRLLGYCIEGVHRMLVYE 262 (508)
Q Consensus 186 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~ei~~l~~l~h~niv~~~~~~~~~~~~~lv~E 262 (508)
++|.+.+.||+|.||+||+|+.+ +.+.||+|.+.+.. .+..+.+.+|+++++.++|||||.++++|+...+.++|.|
T Consensus 2 e~yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr~~k~l~~l~~ev~i~r~lkHpniv~m~esfEt~~~~~vVte 81 (808)
T KOG0597|consen 2 EQYHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGRNEKELKNLRQEVRILRSLKHPNIVEMLESFETSAHLWVVTE 81 (808)
T ss_pred cchhHHHHhcCCccceeeecccccceeEEEEEEehhcCCchHHHHHHHHHHHHHHhcCCcchhhHHHhhcccceEEEEeh
Confidence 57888899999999999999865 67889999886543 3344678899999999999999999999999999999999
Q ss_pred ecCCCCHHHHHhhhhccCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCEEEcCCCcEEEEecCCccccCCC
Q 010519 263 YVNNGNLEQWLHGAMRNQGNLTWEARMKVIIGTAKALAYLHEAIEPKVVHRDIKSSNILIDDEFNAKVSDFGLAKLLDSG 342 (508)
Q Consensus 263 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~~ 342 (508)
|+.| +|+.+| ...+.++++.+..++.+++.||.|||+. +|+|||+||.|||+...+.+|+||||+++.+...
T Consensus 82 ~a~g-~L~~il----~~d~~lpEe~v~~~a~~LVsaL~yLhs~---rilhrd~kPqniLl~~~~~~KlcdFg~Ar~m~~~ 153 (808)
T KOG0597|consen 82 YAVG-DLFTIL----EQDGKLPEEQVRAIAYDLVSALYYLHSN---RILHRDMKPQNILLEKGGTLKLCDFGLARAMSTN 153 (808)
T ss_pred hhhh-hHHHHH----HhccCCCHHHHHHHHHHHHHHHHHHHhc---CcccccCCcceeeecCCCceeechhhhhhhcccC
Confidence 9976 999999 5678899999999999999999999999 9999999999999999999999999999977643
Q ss_pred CCcccccccccccccCccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCCCchhcHHHHHHHHhcccccccccCCCC
Q 010519 343 ESHITTRVMGTFGYVAPEYANTGMLNEKSDIYSFGVLLLEAVTGRDPVDYGRPANEVNLVEWLKMMVGTRRAEEVVDPNL 422 (508)
Q Consensus 343 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 422 (508)
....+...|||.|||||+..+..|+..+|+||+||||||+++|++||... .+.+.++..... +
T Consensus 154 -t~vltsikGtPlYmAPElv~e~pyd~~sDlWslGcilYE~~~G~PPF~a~------si~~Lv~~I~~d--------~-- 216 (808)
T KOG0597|consen 154 -TSVLTSIKGTPLYMAPELVEEQPYDHTSDLWSLGCILYELYVGQPPFYAR------SITQLVKSILKD--------P-- 216 (808)
T ss_pred -ceeeeeccCcccccCHHHHcCCCccchhhHHHHHHHHHHHhcCCCCchHH------HHHHHHHHHhcC--------C--
Confidence 34567788999999999999999999999999999999999999999522 122222222211 1
Q ss_pred CCChhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHh
Q 010519 423 EVKPATRALKRSLLVALRCVDPDSEKRPKMSQVVRML 459 (508)
Q Consensus 423 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L 459 (508)
..++......+..++...|.+||.+|.|+.+++.|-
T Consensus 217 -v~~p~~~S~~f~nfl~gLL~kdP~~RltW~~Ll~Hp 252 (808)
T KOG0597|consen 217 -VKPPSTASSSFVNFLQGLLIKDPAQRLTWTDLLGHP 252 (808)
T ss_pred -CCCcccccHHHHHHHHHHhhcChhhcccHHHHhcCh
Confidence 112234556667788899999999999999999753
|
|
| >KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-42 Score=314.05 Aligned_cols=264 Identities=25% Similarity=0.359 Sum_probs=206.8
Q ss_pred CCcccceeEeeeCceEEEEEEEc-CCCEEEEEEEcccchh--hHHHHHHHHHHHhcCCCCCceeEEEEEEeCceeeEEEe
Q 010519 186 NRFSAENVLGEGGYGVVYKGRLI-NGSEVAVKKLLNNLGQ--AEKEFRVEVEAIGHVRHKNLVRLLGYCIEGVHRMLVYE 262 (508)
Q Consensus 186 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~--~~~~~~~ei~~l~~l~h~niv~~~~~~~~~~~~~lv~E 262 (508)
.+|...+.||+|.||.||+|++. +|+.||||++...... -.....+||+.|+.++|+||+.++++|.....+.+|+|
T Consensus 2 ~rY~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kdGi~~talREIK~Lqel~h~nIi~LiD~F~~~~~l~lVfE 81 (318)
T KOG0659|consen 2 DRYEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKDGINRTALREIKLLQELKHPNIIELIDVFPHKSNLSLVFE 81 (318)
T ss_pred chhhhhhhhcCcceEEEEEEEecCCCcEEEEEEeeccccccCccHHHHHHHHHHHHccCcchhhhhhhccCCCceEEEEE
Confidence 46888899999999999999864 7999999999654322 12346679999999999999999999999999999999
Q ss_pred ecCCCCHHHHHhhhhccCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCEEEcCCCcEEEEecCCccccCCC
Q 010519 263 YVNNGNLEQWLHGAMRNQGNLTWEARMKVIIGTAKALAYLHEAIEPKVVHRDIKSSNILIDDEFNAKVSDFGLAKLLDSG 342 (508)
Q Consensus 263 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~~ 342 (508)
||+. +|...++ .+...++..++..++.++++||+|||.+ .|+||||||+|+|++++|.+||+|||+++.+...
T Consensus 82 fm~t-dLe~vIk---d~~i~l~pa~iK~y~~m~LkGl~y~H~~---~IlHRDlKPnNLLis~~g~lKiADFGLAr~f~~p 154 (318)
T KOG0659|consen 82 FMPT-DLEVVIK---DKNIILSPADIKSYMLMTLKGLAYCHSK---WILHRDLKPNNLLISSDGQLKIADFGLARFFGSP 154 (318)
T ss_pred eccc-cHHHHhc---ccccccCHHHHHHHHHHHHHHHHHHHhh---hhhcccCCccceEEcCCCcEEeecccchhccCCC
Confidence 9976 9999986 4566788999999999999999999999 9999999999999999999999999999988765
Q ss_pred CCcccccccccccccCccccCC-CCCCChhhHHHHHHHHHHHHhCCCCCCCCCCCchhcHHHHHHHHhcccccccccC--
Q 010519 343 ESHITTRVMGTFGYVAPEYANT-GMLNEKSDIYSFGVLLLEAVTGRDPVDYGRPANEVNLVEWLKMMVGTRRAEEVVD-- 419 (508)
Q Consensus 343 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwS~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-- 419 (508)
... .+..+-|.+|.|||++.| ..|+..+|+||.|||+.||+-|.+-|. +.. +.+....+....+........+
T Consensus 155 ~~~-~~~~V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~fp-G~s--DidQL~~If~~LGTP~~~~WP~~~ 230 (318)
T KOG0659|consen 155 NRI-QTHQVVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFFP-GDS--DIDQLSKIFRALGTPTPDQWPEMT 230 (318)
T ss_pred Ccc-cccceeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCCCC-CCc--hHHHHHHHHHHcCCCCcccCcccc
Confidence 443 333367999999998876 579999999999999999998765443 322 2222223333333332222111
Q ss_pred -------------CCCCCChhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhhc
Q 010519 420 -------------PNLEVKPATRALKRSLLVALRCVDPDSEKRPKMSQVVRMLEA 461 (508)
Q Consensus 420 -------------~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~ 461 (508)
+.+.. --.......++|+..||..||.+|+|+.|++++=--
T Consensus 231 ~lpdY~~~~~~P~~~~~~-lf~aas~d~ldLl~~m~~ynP~~Rita~qaL~~~yf 284 (318)
T KOG0659|consen 231 SLPDYVKIQQFPKPPLNN-LFPAASSDALDLLSKMLTYNPKKRITASQALKHPYF 284 (318)
T ss_pred ccccHHHHhcCCCCcccc-ccccccHHHHHHHHhhhccCchhcccHHHHhcchhh
Confidence 11110 112234556889999999999999999999986543
|
|
| >cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-41 Score=331.96 Aligned_cols=256 Identities=25% Similarity=0.402 Sum_probs=203.4
Q ss_pred hhCCcccceeEeeeCceEEEEEEEc----CCCEEEEEEEcccc-hhhHHHHHHHHHHHhcCCCCCceeEEEEEEeCceee
Q 010519 184 ATNRFSAENVLGEGGYGVVYKGRLI----NGSEVAVKKLLNNL-GQAEKEFRVEVEAIGHVRHKNLVRLLGYCIEGVHRM 258 (508)
Q Consensus 184 ~~~~~~~~~~lg~G~~g~Vy~~~~~----~~~~vavK~~~~~~-~~~~~~~~~ei~~l~~l~h~niv~~~~~~~~~~~~~ 258 (508)
..++|++.+.||+|+||.||+|.+. .+..||+|.+.... ......+.+|+..+..++||||+++++++..+...+
T Consensus 3 ~~~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 82 (266)
T cd05064 3 DNKSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRLEGVITRGNTMM 82 (266)
T ss_pred chHHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEecCCCcE
Confidence 3457999999999999999999763 35689999886543 233456888999999999999999999999999999
Q ss_pred EEEeecCCCCHHHHHhhhhccCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCEEEcCCCcEEEEecCCccc
Q 010519 259 LVYEYVNNGNLEQWLHGAMRNQGNLTWEARMKVIIGTAKALAYLHEAIEPKVVHRDIKSSNILIDDEFNAKVSDFGLAKL 338 (508)
Q Consensus 259 lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~Dfgla~~ 338 (508)
+||||+++|+|.+++.. ....+++..++.++.|++.||+|||+. +++||||||+|||++.++.+|++|||.+..
T Consensus 83 lv~e~~~~~~L~~~l~~---~~~~l~~~~~~~~~~~i~~al~~lH~~---~iiH~dikp~nili~~~~~~~l~dfg~~~~ 156 (266)
T cd05064 83 IVTEYMSNGALDSFLRK---HEGQLVAGQLMGMLPGLASGMKYLSEM---GYVHKGLAAHKVLVNSDLVCKISGFRRLQE 156 (266)
T ss_pred EEEEeCCCCcHHHHHHh---CCCCCCHHHHHHHHHHHHHHHHHHHHC---CEeeccccHhhEEEcCCCcEEECCCccccc
Confidence 99999999999999863 345789999999999999999999999 999999999999999999999999998765
Q ss_pred cCCCCCcccccccccccccCccccCCCCCCChhhHHHHHHHHHHHHh-CCCCCCCCCCCchhcHHHHHHHHhcccccccc
Q 010519 339 LDSGESHITTRVMGTFGYVAPEYANTGMLNEKSDIYSFGVLLLEAVT-GRDPVDYGRPANEVNLVEWLKMMVGTRRAEEV 417 (508)
Q Consensus 339 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 417 (508)
.............++..|+|||.+.+..++.++|||||||++||+++ |..||...... ..+.......
T Consensus 157 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~p~~~~~~~------~~~~~~~~~~----- 225 (266)
T cd05064 157 DKSEAIYTTMSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERPYWDMSGQ------DVIKAVEDGF----- 225 (266)
T ss_pred ccccchhcccCCCCceeecCHHHHhhCCccchhHHHHHHHHHHHHhcCCCCCcCcCCHH------HHHHHHHCCC-----
Confidence 43222111222345678999999999999999999999999999775 99998643221 1122211110
Q ss_pred cCCCCCCChhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhhc
Q 010519 418 VDPNLEVKPATRALKRSLLVALRCVDPDSEKRPKMSQVVRMLEA 461 (508)
Q Consensus 418 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~ 461 (508)
..+.+...+..+.+++.+||+.+|.+|||+.+|++.|..
T Consensus 226 -----~~~~~~~~~~~~~~li~~c~~~~p~~RP~~~~i~~~l~~ 264 (266)
T cd05064 226 -----RLPAPRNCPNLLHQLMLDCWQKERGERPRFSQIHSILSK 264 (266)
T ss_pred -----CCCCCCCCCHHHHHHHHHHcCCCchhCCCHHHHHHHHHh
Confidence 011112234556779999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor |
| >PHA02988 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-41 Score=336.08 Aligned_cols=245 Identities=22% Similarity=0.356 Sum_probs=197.0
Q ss_pred eeEeeeCceEEEEEEEcCCCEEEEEEEcccchhh---HHHHHHHHHHHhcCCCCCceeEEEEEEe----CceeeEEEeec
Q 010519 192 NVLGEGGYGVVYKGRLINGSEVAVKKLLNNLGQA---EKEFRVEVEAIGHVRHKNLVRLLGYCIE----GVHRMLVYEYV 264 (508)
Q Consensus 192 ~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~---~~~~~~ei~~l~~l~h~niv~~~~~~~~----~~~~~lv~E~~ 264 (508)
..||+|++|.||+|.+ +|..||||++....... .+.+.+|+.+|.+++||||+++++++.+ ....++||||+
T Consensus 26 ~~i~~g~~~~v~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~~~~~~~~~lv~Ey~ 104 (283)
T PHA02988 26 VLIKENDQNSIYKGIF-NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDLPRLSLILEYC 104 (283)
T ss_pred eEEeeCCceEEEEEEE-CCEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEEeeeEEecccCCCceEEEEEeC
Confidence 6799999999999988 78999999986543222 3567899999999999999999999977 34678999999
Q ss_pred CCCCHHHHHhhhhccCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCEEEcCCCcEEEEecCCccccCCCCC
Q 010519 265 NNGNLEQWLHGAMRNQGNLTWEARMKVIIGTAKALAYLHEAIEPKVVHRDIKSSNILIDDEFNAKVSDFGLAKLLDSGES 344 (508)
Q Consensus 265 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~ 344 (508)
++|+|.+++. ....+++.....++.+++.||.|||... +++||||||+|||+++++.+||+|||+++......
T Consensus 105 ~~g~L~~~l~----~~~~~~~~~~~~i~~~i~~~l~~lH~~~--~~~Hrdlkp~nill~~~~~~kl~dfg~~~~~~~~~- 177 (283)
T PHA02988 105 TRGYLREVLD----KEKDLSFKTKLDMAIDCCKGLYNLYKYT--NKPYKNLTSVSFLVTENYKLKIICHGLEKILSSPP- 177 (283)
T ss_pred CCCcHHHHHh----hCCCCChhHHHHHHHHHHHHHHHHHhcC--CCCCCcCChhhEEECCCCcEEEcccchHhhhcccc-
Confidence 9999999995 3457889999999999999999999732 78899999999999999999999999998654322
Q ss_pred cccccccccccccCccccCC--CCCCChhhHHHHHHHHHHHHhCCCCCCCCCCCchhcHHHHHHHHhcccccccccCCCC
Q 010519 345 HITTRVMGTFGYVAPEYANT--GMLNEKSDIYSFGVLLLEAVTGRDPVDYGRPANEVNLVEWLKMMVGTRRAEEVVDPNL 422 (508)
Q Consensus 345 ~~~~~~~gt~~y~aPE~~~~--~~~~~~~DvwS~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 422 (508)
....|+..|+|||++.+ ..++.++|||||||++|||++|+.||..... .+.......... ...+
T Consensus 178 ---~~~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~~~~------~~~~~~i~~~~~-----~~~~ 243 (283)
T PHA02988 178 ---FKNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLTT------KEIYDLIINKNN-----SLKL 243 (283)
T ss_pred ---ccccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCCCCCH------HHHHHHHHhcCC-----CCCC
Confidence 23457899999999976 6899999999999999999999999974321 122222211110 0111
Q ss_pred CCChhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhhcC
Q 010519 423 EVKPATRALKRSLLVALRCVDPDSEKRPKMSQVVRMLEAD 462 (508)
Q Consensus 423 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~ 462 (508)
. ......+.+++.+||+.||.+|||+.++++.|+..
T Consensus 244 ~----~~~~~~l~~li~~cl~~dp~~Rps~~ell~~l~~~ 279 (283)
T PHA02988 244 P----LDCPLEIKCIVEACTSHDSIKRPNIKEILYNLSLY 279 (283)
T ss_pred C----CcCcHHHHHHHHHHhcCCcccCcCHHHHHHHHHHH
Confidence 1 12344567799999999999999999999999864
|
|
| >cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-41 Score=335.45 Aligned_cols=266 Identities=25% Similarity=0.423 Sum_probs=203.0
Q ss_pred hhCCcccceeEeeeCceEEEEEEEcC-----------------CCEEEEEEEcccc-hhhHHHHHHHHHHHhcCCCCCce
Q 010519 184 ATNRFSAENVLGEGGYGVVYKGRLIN-----------------GSEVAVKKLLNNL-GQAEKEFRVEVEAIGHVRHKNLV 245 (508)
Q Consensus 184 ~~~~~~~~~~lg~G~~g~Vy~~~~~~-----------------~~~vavK~~~~~~-~~~~~~~~~ei~~l~~l~h~niv 245 (508)
..++|.+.+.||+|+||.||+|.+.+ +..||+|.+.... ......+.+|+.++.+++||||+
T Consensus 3 ~~~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv 82 (304)
T cd05096 3 PRGHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVKILSRLKDPNII 82 (304)
T ss_pred chhhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCCCHHHHHHHHHHHHHHhhcCCCCee
Confidence 34689999999999999999997532 2369999886543 33346788999999999999999
Q ss_pred eEEEEEEeCceeeEEEeecCCCCHHHHHhhhhc---------------cCCCccHHHHHHHHHHHHHHHHHHHhcCCCCe
Q 010519 246 RLLGYCIEGVHRMLVYEYVNNGNLEQWLHGAMR---------------NQGNLTWEARMKVIIGTAKALAYLHEAIEPKV 310 (508)
Q Consensus 246 ~~~~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~---------------~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~i 310 (508)
++++++.+....++||||+++|+|.+++..... ....+++..++.++.||+.||.|||+. +|
T Consensus 83 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~---~i 159 (304)
T cd05096 83 RLLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSL---NF 159 (304)
T ss_pred EEEEEEecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHC---Cc
Confidence 999999999999999999999999999864211 113467889999999999999999998 99
Q ss_pred EeecCCCCCEEEcCCCcEEEEecCCccccCCCCC-cccccccccccccCccccCCCCCCChhhHHHHHHHHHHHHh--CC
Q 010519 311 VHRDIKSSNILIDDEFNAKVSDFGLAKLLDSGES-HITTRVMGTFGYVAPEYANTGMLNEKSDIYSFGVLLLEAVT--GR 387 (508)
Q Consensus 311 iH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~ellt--G~ 387 (508)
+||||||+|||+++++.+||+|||++........ .......++..|+|||++.+..++.++|||||||++|||++ +.
T Consensus 160 vH~dlkp~Nill~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~ 239 (304)
T cd05096 160 VHRDLATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILMLCKE 239 (304)
T ss_pred cccCcchhheEEcCCccEEECCCccceecccCceeEecCcCCCCccccCHHHHhcCCCCchhhhHHHHHHHHHHHHccCC
Confidence 9999999999999999999999999986543322 12233445788999999988899999999999999999987 55
Q ss_pred CCCCCCCCCchhcHHHHHHHHhcccccccccCCCCCCChhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhhc
Q 010519 388 DPVDYGRPANEVNLVEWLKMMVGTRRAEEVVDPNLEVKPATRALKRSLLVALRCVDPDSEKRPKMSQVVRMLEA 461 (508)
Q Consensus 388 ~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~ 461 (508)
.||..... ................. . ....+...+..+.+|+.+||+.||.+|||+.+|.+.|+.
T Consensus 240 ~p~~~~~~---~~~~~~~~~~~~~~~~~-~-----~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~~i~~~l~~ 304 (304)
T cd05096 240 QPYGELTD---EQVIENAGEFFRDQGRQ-V-----YLFRPPPCPQGLYELMLQCWSRDCRERPSFSDIHAFLTE 304 (304)
T ss_pred CCCCcCCH---HHHHHHHHHHhhhcccc-c-----cccCCCCCCHHHHHHHHHHccCCchhCcCHHHHHHHHhC
Confidence 67653321 11222221111111000 0 000111223567779999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k |
| >cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-42 Score=338.97 Aligned_cols=250 Identities=25% Similarity=0.306 Sum_probs=203.8
Q ss_pred CCcccceeEeeeCceEEEEEEEc-CCCEEEEEEEcccc---hhhHHHHHHHHHHHhcCCCCCceeEEEEEEeCceeeEEE
Q 010519 186 NRFSAENVLGEGGYGVVYKGRLI-NGSEVAVKKLLNNL---GQAEKEFRVEVEAIGHVRHKNLVRLLGYCIEGVHRMLVY 261 (508)
Q Consensus 186 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~ei~~l~~l~h~niv~~~~~~~~~~~~~lv~ 261 (508)
++|++.+.||+|+||.||+|.+. +++.||+|++.... ......+.+|+.+++.++||||+++++++.+....++||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 80 (291)
T cd05612 1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHDQRFLYMLM 80 (291)
T ss_pred CCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhccCCeEEEEE
Confidence 37889999999999999999875 68899999985432 123456888999999999999999999999999999999
Q ss_pred eecCCCCHHHHHhhhhccCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCEEEcCCCcEEEEecCCccccCC
Q 010519 262 EYVNNGNLEQWLHGAMRNQGNLTWEARMKVIIGTAKALAYLHEAIEPKVVHRDIKSSNILIDDEFNAKVSDFGLAKLLDS 341 (508)
Q Consensus 262 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~ 341 (508)
||+++|+|.+++. ....+++..+..++.|++.||+|||++ +|+||||||+|||+++++.+||+|||++.....
T Consensus 81 e~~~~~~L~~~~~----~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~NIli~~~~~~kl~Dfg~~~~~~~ 153 (291)
T cd05612 81 EYVPGGELFSYLR----NSGRFSNSTGLFYASEIVCALEYLHSK---EIVYRDLKPENILLDKEGHIKLTDFGFAKKLRD 153 (291)
T ss_pred eCCCCCCHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHeEECCCCCEEEEecCcchhccC
Confidence 9999999999984 445788999999999999999999999 999999999999999999999999999986543
Q ss_pred CCCcccccccccccccCccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCCCchhcHHHHHHHHhcccccccccCCC
Q 010519 342 GESHITTRVMGTFGYVAPEYANTGMLNEKSDIYSFGVLLLEAVTGRDPVDYGRPANEVNLVEWLKMMVGTRRAEEVVDPN 421 (508)
Q Consensus 342 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 421 (508)
. .....|++.|+|||++.+..++.++|||||||++|+|++|+.||..... .......... .
T Consensus 154 ~----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~------~~~~~~i~~~---------~ 214 (291)
T cd05612 154 R----TWTLCGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPPFFDDNP------FGIYEKILAG---------K 214 (291)
T ss_pred C----cccccCChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH------HHHHHHHHhC---------C
Confidence 2 2234689999999999999999999999999999999999999964322 1111121111 0
Q ss_pred CCCChhHHHHHHHHHHHHHhcCCCCCCCCC-----HHHHHHHhhcCC
Q 010519 422 LEVKPATRALKRSLLVALRCVDPDSEKRPK-----MSQVVRMLEADD 463 (508)
Q Consensus 422 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPs-----~~evl~~L~~~~ 463 (508)
... +......+.+|+.+||+.||.+||+ ++++++|-+-..
T Consensus 215 ~~~--~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h~~~~~ 259 (291)
T cd05612 215 LEF--PRHLDLYAKDLIKKLLVVDRTRRLGNMKNGADDVKNHRWFKS 259 (291)
T ss_pred cCC--CccCCHHHHHHHHHHcCCCHHHccCCccCCHHHHhcCccccC
Confidence 111 1111345667999999999999995 999998765443
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt |
| >KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-43 Score=340.03 Aligned_cols=250 Identities=24% Similarity=0.367 Sum_probs=208.6
Q ss_pred CCcccceeEeeeCceEEEEEEEc-CCCEEEEEEEcccc-hhhHHHHHHHHHHHhcCCCCCceeEEEEEEeCceeeEEEee
Q 010519 186 NRFSAENVLGEGGYGVVYKGRLI-NGSEVAVKKLLNNL-GQAEKEFRVEVEAIGHVRHKNLVRLLGYCIEGVHRMLVYEY 263 (508)
Q Consensus 186 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~ei~~l~~l~h~niv~~~~~~~~~~~~~lv~E~ 263 (508)
..|+..+.||+|.||.||+|.+. .++.||+|.+.... ....+.++.|+.+|..++++||.++|+.+..+..++++|||
T Consensus 13 ~~~~~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~~~deIediqqei~~Ls~~~~~~it~yygsyl~g~~LwiiMey 92 (467)
T KOG0201|consen 13 LLYTKLELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEEAEDEIEDIQQEISVLSQCDSPNITEYYGSYLKGTKLWIIMEY 92 (467)
T ss_pred cccccchhccccccceeeeeeeccccceEEEEEechhhcchhhHHHHHHHHHHHhcCcchHHhhhhheeecccHHHHHHH
Confidence 46777789999999999999864 67889999985544 33346788899999999999999999999999999999999
Q ss_pred cCCCCHHHHHhhhhccCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCEEEcCCCcEEEEecCCccccCCCC
Q 010519 264 VNNGNLEQWLHGAMRNQGNLTWEARMKVIIGTAKALAYLHEAIEPKVVHRDIKSSNILIDDEFNAKVSDFGLAKLLDSGE 343 (508)
Q Consensus 264 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~~~ 343 (508)
|.||++.++| .....+.+..+.-++.+++.|+.|||.+ +.+|||||+.|||+..+|.+||+|||.+..+....
T Consensus 93 ~~gGsv~~lL----~~~~~~~E~~i~~ilre~l~~l~ylH~~---~kiHrDIKaanil~s~~g~vkl~DfgVa~ql~~~~ 165 (467)
T KOG0201|consen 93 CGGGSVLDLL----KSGNILDEFEIAVILREVLKGLDYLHSE---KKIHRDIKAANILLSESGDVKLADFGVAGQLTNTV 165 (467)
T ss_pred hcCcchhhhh----ccCCCCccceeeeehHHHHHHhhhhhhc---ceecccccccceeEeccCcEEEEecceeeeeechh
Confidence 9999999998 4555668888888999999999999999 99999999999999999999999999998776655
Q ss_pred CcccccccccccccCccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCCCchhcHHHHHHHHhcccccccccCCCCC
Q 010519 344 SHITTRVMGTFGYVAPEYANTGMLNEKSDIYSFGVLLLEAVTGRDPVDYGRPANEVNLVEWLKMMVGTRRAEEVVDPNLE 423 (508)
Q Consensus 344 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 423 (508)
... ..++|||.|||||++.+..|+.|+||||||++.+||++|.+|+....+..-. ..+..-..|.+.
T Consensus 166 ~rr-~tfvGTPfwMAPEVI~~~~Y~~KADIWSLGITaiEla~GePP~s~~hPmrvl------------flIpk~~PP~L~ 232 (467)
T KOG0201|consen 166 KRR-KTFVGTPFWMAPEVIKQSGYDTKADIWSLGITAIELAKGEPPHSKLHPMRVL------------FLIPKSAPPRLD 232 (467)
T ss_pred hcc-ccccccccccchhhhccccccchhhhhhhhHHHHHHhcCCCCCcccCcceEE------------EeccCCCCCccc
Confidence 443 6789999999999999999999999999999999999999998754441111 011111223333
Q ss_pred CChhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHh
Q 010519 424 VKPATRALKRSLLVALRCVDPDSEKRPKMSQVVRML 459 (508)
Q Consensus 424 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L 459 (508)
. .....+.+++..||+.||+.||||.++|+|-
T Consensus 233 ~----~~S~~~kEFV~~CL~k~P~~RpsA~~LLKh~ 264 (467)
T KOG0201|consen 233 G----DFSPPFKEFVEACLDKNPEFRPSAKELLKHK 264 (467)
T ss_pred c----ccCHHHHHHHHHHhhcCcccCcCHHHHhhhH
Confidence 2 3344566789999999999999999999864
|
|
| >cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-41 Score=332.47 Aligned_cols=253 Identities=23% Similarity=0.289 Sum_probs=201.6
Q ss_pred cccceeEeeeCceEEEEEEEc-CCCEEEEEEEcccc---hhhHHHHHHHHHHHhcCCCCCceeEEEEEEeCceeeEEEee
Q 010519 188 FSAENVLGEGGYGVVYKGRLI-NGSEVAVKKLLNNL---GQAEKEFRVEVEAIGHVRHKNLVRLLGYCIEGVHRMLVYEY 263 (508)
Q Consensus 188 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~ei~~l~~l~h~niv~~~~~~~~~~~~~lv~E~ 263 (508)
|...+.||+|+||+||+|.+. +|..||+|.+.... ......+.+|+.++..++|+||+++++++.+....++||||
T Consensus 2 f~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~~~~~~lv~e~ 81 (285)
T cd05631 2 FRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYETKDALCLVLTI 81 (285)
T ss_pred ceEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEEccCCeEEEEEEe
Confidence 677899999999999999864 78999999886432 22234577899999999999999999999999999999999
Q ss_pred cCCCCHHHHHhhhhccCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCEEEcCCCcEEEEecCCccccCCCC
Q 010519 264 VNNGNLEQWLHGAMRNQGNLTWEARMKVIIGTAKALAYLHEAIEPKVVHRDIKSSNILIDDEFNAKVSDFGLAKLLDSGE 343 (508)
Q Consensus 264 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~~~ 343 (508)
+++|+|.+++.. .....+++..+..++.|++.||.|||+. +|+||||||+|||+++++.+||+|||++.......
T Consensus 82 ~~~g~L~~~~~~--~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~~ 156 (285)
T cd05631 82 MNGGDLKFHIYN--MGNPGFDEQRAIFYAAELCCGLEDLQRE---RIVYRDLKPENILLDDRGHIRISDLGLAVQIPEGE 156 (285)
T ss_pred cCCCcHHHHHHh--hCCCCCCHHHHHHHHHHHHHHHHHHHhC---CEEeCCCCHHHEEECCCCCEEEeeCCCcEEcCCCC
Confidence 999999988853 2334688999999999999999999999 99999999999999999999999999998754332
Q ss_pred CcccccccccccccCccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCCCchhcHHHHHHHHhcccccccccCCCCC
Q 010519 344 SHITTRVMGTFGYVAPEYANTGMLNEKSDIYSFGVLLLEAVTGRDPVDYGRPANEVNLVEWLKMMVGTRRAEEVVDPNLE 423 (508)
Q Consensus 344 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 423 (508)
......|++.|+|||++.+..++.++|||||||+||||++|+.||......... ..+....... ..
T Consensus 157 --~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~---~~~~~~~~~~--------~~- 222 (285)
T cd05631 157 --TVRGRVGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPFRKRKERVKR---EEVDRRVKED--------QE- 222 (285)
T ss_pred --eecCCCCCCCccCHhhhcCCCCCcccCchhHHHHHHHHHhCCCCCCCCCcchhH---HHHHHHhhcc--------cc-
Confidence 223457899999999999999999999999999999999999999754332111 1111111100 00
Q ss_pred CChhHHHHHHHHHHHHHhcCCCCCCCCC-----HHHHHHHhh
Q 010519 424 VKPATRALKRSLLVALRCVDPDSEKRPK-----MSQVVRMLE 460 (508)
Q Consensus 424 ~~~~~~~~~~l~~li~~cl~~dP~~RPs-----~~evl~~L~ 460 (508)
.........+.+|+.+||+.||.+||+ +++++++-+
T Consensus 223 -~~~~~~s~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~h~~ 263 (285)
T cd05631 223 -EYSEKFSEDAKSICRMLLTKNPKERLGCRGNGAAGVKQHPI 263 (285)
T ss_pred -cCCccCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHhcCHh
Confidence 011112345667999999999999997 889888644
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i |
| >cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-41 Score=329.23 Aligned_cols=257 Identities=25% Similarity=0.437 Sum_probs=208.2
Q ss_pred HhhCCcccceeEeeeCceEEEEEEEcCCCEEEEEEEcccchhhHHHHHHHHHHHhcCCCCCceeEEEEEEeCceeeEEEe
Q 010519 183 IATNRFSAENVLGEGGYGVVYKGRLINGSEVAVKKLLNNLGQAEKEFRVEVEAIGHVRHKNLVRLLGYCIEGVHRMLVYE 262 (508)
Q Consensus 183 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~ei~~l~~l~h~niv~~~~~~~~~~~~~lv~E 262 (508)
+..++|++.+.||+|+||.||+|.+.++..||+|.+.... ...+.+..|+.+++.++|+||+++++++......+++||
T Consensus 3 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~v~iK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 81 (261)
T cd05072 3 IPRESIKLVKKLGAGQFGEVWMGYYNNSTKVAVKTLKPGT-MSVQAFLEEANLMKTLQHDKLVRLYAVVTKEEPIYIITE 81 (261)
T ss_pred CchHHeEEeeecCCcCCceEEEEEecCCceEEEEEccCCc-hhHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCcEEEEe
Confidence 4456899999999999999999998888899999876433 234678889999999999999999999999999999999
Q ss_pred ecCCCCHHHHHhhhhccCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCEEEcCCCcEEEEecCCccccCCC
Q 010519 263 YVNNGNLEQWLHGAMRNQGNLTWEARMKVIIGTAKALAYLHEAIEPKVVHRDIKSSNILIDDEFNAKVSDFGLAKLLDSG 342 (508)
Q Consensus 263 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~~ 342 (508)
|+++|+|.+++.. .....+++..++.++.+++.||+|||+. +++|+||||+||+++.++.++|+|||++......
T Consensus 82 ~~~~~~L~~~l~~--~~~~~~~~~~~~~~~~~l~~~l~~LH~~---~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~ 156 (261)
T cd05072 82 YMAKGSLLDFLKS--DEGGKVLLPKLIDFSAQIAEGMAYIERK---NYIHRDLRAANVLVSESLMCKIADFGLARVIEDN 156 (261)
T ss_pred cCCCCcHHHHHHH--hcCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccccchhhEEecCCCcEEECCCccceecCCC
Confidence 9999999999964 2345688899999999999999999998 9999999999999999999999999999876543
Q ss_pred CCcccccccccccccCccccCCCCCCChhhHHHHHHHHHHHHh-CCCCCCCCCCCchhcHHHHHHHHhcccccccccCCC
Q 010519 343 ESHITTRVMGTFGYVAPEYANTGMLNEKSDIYSFGVLLLEAVT-GRDPVDYGRPANEVNLVEWLKMMVGTRRAEEVVDPN 421 (508)
Q Consensus 343 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 421 (508)
.........++..|+|||++.+..++.++|||||||++|+|++ |..||...... .. .........
T Consensus 157 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~---~~---~~~~~~~~~-------- 222 (261)
T cd05072 157 EYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLYEIVTYGKIPYPGMSNS---DV---MSALQRGYR-------- 222 (261)
T ss_pred ceeccCCCccceecCCHHHhccCCCChhhhhhhhHHHHHHHHccCCCCCCCCCHH---HH---HHHHHcCCC--------
Confidence 3222233345678999999998889999999999999999998 99998643211 11 111111111
Q ss_pred CCCChhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhhc
Q 010519 422 LEVKPATRALKRSLLVALRCVDPDSEKRPKMSQVVRMLEA 461 (508)
Q Consensus 422 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~ 461 (508)
.+........+.+++.+||+.+|++||+++++++.|++
T Consensus 223 --~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 260 (261)
T cd05072 223 --MPRMENCPDELYDIMKTCWKEKAEERPTFDYLQSVLDD 260 (261)
T ss_pred --CCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHhc
Confidence 01111223456779999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa |
| >KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-42 Score=311.94 Aligned_cols=267 Identities=24% Similarity=0.317 Sum_probs=220.4
Q ss_pred HHhhCCcccceeEeeeCceEEEEEEE-cCCCEEEEEEEcccchhhHHHHHHHHHHHhcCCCCCceeEEEEEEeC-----c
Q 010519 182 EIATNRFSAENVLGEGGYGVVYKGRL-INGSEVAVKKLLNNLGQAEKEFRVEVEAIGHVRHKNLVRLLGYCIEG-----V 255 (508)
Q Consensus 182 ~~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~ei~~l~~l~h~niv~~~~~~~~~-----~ 255 (508)
.+..++|.+.+.||+|||+-||+++. .++..+|+|++.....+..+...+|++..++++|||+++++++...+ .
T Consensus 17 ~In~~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~~~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~~D~~~ 96 (302)
T KOG2345|consen 17 IINNKRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCHSQEDIEEALREIDNHRKFNSPNVLRLVDHQLREEKDGKH 96 (302)
T ss_pred EEcCceEEEeeeecCCCceeeeeecccCcccchhhheeeccchHHHHHHHHHHHHHHhhCCcchHHHHHHHHHhhccCce
Confidence 45678999999999999999999984 47889999999887777778888999999999999999999987543 3
Q ss_pred eeeEEEeecCCCCHHHHHhhhhccCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCEEEcCCCcEEEEecCC
Q 010519 256 HRMLVYEYVNNGNLEQWLHGAMRNQGNLTWEARMKVIIGTAKALAYLHEAIEPKVVHRDIKSSNILIDDEFNAKVSDFGL 335 (508)
Q Consensus 256 ~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~Dfgl 335 (508)
..|++++|+..|+|.+.+.....++..+++.++++|+.+|++||.+||+. .|+++||||||.|||+++.+.++|.|||.
T Consensus 97 ~~yll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~-~~~yAH~DiKP~NILls~~~~~vl~D~GS 175 (302)
T KOG2345|consen 97 EAYLLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEK-EPPYAHRDIKPANILLSDSGLPVLMDLGS 175 (302)
T ss_pred eEEEEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhcc-CCcccccCCCcceeEecCCCceEEEeccC
Confidence 48999999999999999988777778999999999999999999999985 56699999999999999999999999999
Q ss_pred ccccCCCCCcc--------cccccccccccCccccC---CCCCCChhhHHHHHHHHHHHHhCCCCCCCCCCCchhcHHHH
Q 010519 336 AKLLDSGESHI--------TTRVMGTFGYVAPEYAN---TGMLNEKSDIYSFGVLLLEAVTGRDPVDYGRPANEVNLVEW 404 (508)
Q Consensus 336 a~~~~~~~~~~--------~~~~~gt~~y~aPE~~~---~~~~~~~~DvwS~Gvvl~elltG~~Pf~~~~~~~~~~~~~~ 404 (508)
+....-..... -..-..|..|.|||.+. +...++++|||||||+||+|+.|..||+..-.
T Consensus 176 ~~~a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~~~~--------- 246 (302)
T KOG2345|consen 176 ATQAPIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFERIYQ--------- 246 (302)
T ss_pred ccccceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcchHHhh---------
Confidence 97553211100 11123588999999885 45678999999999999999999999963221
Q ss_pred HHHHhcccccccccCCCCCCChhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhhcC
Q 010519 405 LKMMVGTRRAEEVVDPNLEVKPATRALKRSLLVALRCVDPDSEKRPKMSQVVRMLEAD 462 (508)
Q Consensus 405 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~ 462 (508)
.+....-.+..+.+..+...+....+.+++..|+++||.+||++.+++.++++.
T Consensus 247 ----~GgSlaLAv~n~q~s~P~~~~yse~l~~lik~mlqvdP~qRP~i~~ll~~~d~L 300 (302)
T KOG2345|consen 247 ----QGGSLALAVQNAQISIPNSSRYSEALHQLIKSMLQVDPNQRPTIPELLSKLDDL 300 (302)
T ss_pred ----cCCeEEEeeeccccccCCCCCccHHHHHHHHHHhcCCcccCCCHHHHHHHHHhh
Confidence 111222334445566666666788889999999999999999999999998753
|
|
| >cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-41 Score=333.54 Aligned_cols=266 Identities=24% Similarity=0.295 Sum_probs=202.4
Q ss_pred CCcccceeEeeeCceEEEEEEEc-CCCEEEEEEEcccc--hhhHHHHHHHHHHHhcCCCCCceeEEEEEEeCceeeEEEe
Q 010519 186 NRFSAENVLGEGGYGVVYKGRLI-NGSEVAVKKLLNNL--GQAEKEFRVEVEAIGHVRHKNLVRLLGYCIEGVHRMLVYE 262 (508)
Q Consensus 186 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~ei~~l~~l~h~niv~~~~~~~~~~~~~lv~E 262 (508)
++|++.+.||+|+||+||+|++. ++..+|+|++.... ......+..|+.+++.++||||+++++++......++|||
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 80 (287)
T cd07848 1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEAFRRRGKLYLVFE 80 (287)
T ss_pred CCceEEEEecccCCEEEEEEEECCCCcEEEEEEEecccccccchhhHHHHHHHHHhCCCccccchhhhEecCCEEEEEEe
Confidence 47899999999999999999986 57889999886432 2234567789999999999999999999999999999999
Q ss_pred ecCCCCHHHHHhhhhccCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCEEEcCCCcEEEEecCCccccCCC
Q 010519 263 YVNNGNLEQWLHGAMRNQGNLTWEARMKVIIGTAKALAYLHEAIEPKVVHRDIKSSNILIDDEFNAKVSDFGLAKLLDSG 342 (508)
Q Consensus 263 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~~ 342 (508)
|++++.+..+. .....+++..++.++.||+.||.|||+. +|+||||||+||+++.++.+||+|||++......
T Consensus 81 ~~~~~~l~~~~----~~~~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~ 153 (287)
T cd07848 81 YVEKNMLELLE----EMPNGVPPEKVRSYIYQLIKAIHWCHKN---DIVHRDIKPENLLISHNDVLKLCDFGFARNLSEG 153 (287)
T ss_pred cCCCCHHHHHH----hcCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCcEEEeeccCccccccc
Confidence 99987665543 2345688999999999999999999998 9999999999999999999999999999876543
Q ss_pred CCcccccccccccccCccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCCCchhcHHHH---------HHHHhcccc
Q 010519 343 ESHITTRVMGTFGYVAPEYANTGMLNEKSDIYSFGVLLLEAVTGRDPVDYGRPANEVNLVEW---------LKMMVGTRR 413 (508)
Q Consensus 343 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltG~~Pf~~~~~~~~~~~~~~---------~~~~~~~~~ 413 (508)
.........|++.|+|||++.+..++.++|||||||++|||++|+.||......+....... .........
T Consensus 154 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (287)
T cd07848 154 SNANYTEYVATRWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQPLFPGESEIDQLFTIQKVLGPLPAEQMKLFYSNPR 233 (287)
T ss_pred ccccccccccccccCCcHHHcCCCCCCchhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCHHHHHhhhccch
Confidence 33233445789999999999998999999999999999999999999965332111110000 000000000
Q ss_pred cccccCCCCCCCh------hHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 010519 414 AEEVVDPNLEVKP------ATRALKRSLLVALRCVDPDSEKRPKMSQVVRM 458 (508)
Q Consensus 414 ~~~~~~~~~~~~~------~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 458 (508)
......+...... .......+.+|+.+||+.||.+|||++|+++|
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~s~~~~l~h 284 (287)
T cd07848 234 FHGLRFPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLNH 284 (287)
T ss_pred hcccccCcccCcccHHHhhhcccCHHHHHHHHHHccCCcccCCCHHHHhcC
Confidence 0000001000000 01123457889999999999999999999975
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes |
| >cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-41 Score=341.89 Aligned_cols=258 Identities=24% Similarity=0.335 Sum_probs=206.4
Q ss_pred CCcccceeEeeeCceEEEEEEEc-CCCEEEEEEEcccc---hhhHHHHHHHHHHHhcCCCCCceeEEEEEEeCceeeEEE
Q 010519 186 NRFSAENVLGEGGYGVVYKGRLI-NGSEVAVKKLLNNL---GQAEKEFRVEVEAIGHVRHKNLVRLLGYCIEGVHRMLVY 261 (508)
Q Consensus 186 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~ei~~l~~l~h~niv~~~~~~~~~~~~~lv~ 261 (508)
++|.+.+.||+|+||.||+|++. +++.||+|++.... ......+..|+.++..++||||+++++++.+....|+||
T Consensus 1 ~~y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~ 80 (333)
T cd05600 1 KDFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQDDEYLYLAM 80 (333)
T ss_pred CCcEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEEEcCCEEEEEE
Confidence 37899999999999999999876 58899999986442 123356788999999999999999999999999999999
Q ss_pred eecCCCCHHHHHhhhhccCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCEEEcCCCcEEEEecCCccccCC
Q 010519 262 EYVNNGNLEQWLHGAMRNQGNLTWEARMKVIIGTAKALAYLHEAIEPKVVHRDIKSSNILIDDEFNAKVSDFGLAKLLDS 341 (508)
Q Consensus 262 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~ 341 (508)
||+++|+|.+++. ....+++..+..++.||+.||.|||+. +|+||||||+|||++.++.+||+|||++.....
T Consensus 81 e~~~g~~L~~~l~----~~~~l~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kL~Dfg~a~~~~~ 153 (333)
T cd05600 81 EYVPGGDFRTLLN----NLGVLSEDHARFYMAEMFEAVDALHEL---GYIHRDLKPENFLIDASGHIKLTDFGLSKGIVT 153 (333)
T ss_pred eCCCCCCHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEECCCCCEEEEeCcCCccccc
Confidence 9999999999984 445788999999999999999999999 999999999999999999999999999986543
Q ss_pred CCCcccccccccccccCccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCCCchhcHHHHHHHHhcccccccccCCC
Q 010519 342 GESHITTRVMGTFGYVAPEYANTGMLNEKSDIYSFGVLLLEAVTGRDPVDYGRPANEVNLVEWLKMMVGTRRAEEVVDPN 421 (508)
Q Consensus 342 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 421 (508)
......||+.|+|||++.+..++.++|||||||+||||++|..||........ ......... .+..+.
T Consensus 154 ----~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~------~~~i~~~~~--~~~~~~ 221 (333)
T cd05600 154 ----YANSVVGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSGSTPNET------WENLKYWKE--TLQRPV 221 (333)
T ss_pred ----ccCCcccCccccChhHhcCCCCCCccceecchHHHhhhhhCCCCCCCCCHHHH------HHHHHhccc--cccCCC
Confidence 23345789999999999999999999999999999999999999964432111 111110000 000011
Q ss_pred CCCChhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhhcCC
Q 010519 422 LEVKPATRALKRSLLVALRCVDPDSEKRPKMSQVVRMLEADD 463 (508)
Q Consensus 422 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~ 463 (508)
. ..+.......+.+++.+||..+|.+||++.+++++..-..
T Consensus 222 ~-~~~~~~~s~~~~~li~~~l~~~~~rr~s~~~ll~h~~~~~ 262 (333)
T cd05600 222 Y-DDPRFNLSDEAWDLITKLINDPSRRFGSLEDIKNHPFFKE 262 (333)
T ss_pred C-CccccccCHHHHHHHHHHhhChhhhcCCHHHHHhCcccCC
Confidence 0 1111123456677999999999999999999999865443
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. |
| >cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-41 Score=327.17 Aligned_cols=252 Identities=27% Similarity=0.444 Sum_probs=202.8
Q ss_pred CCcccceeEeeeCceEEEEEEEcCCCEEEEEEEcccchhhHHHHHHHHHHHhcCCCCCceeEEEEEEeCceeeEEEeecC
Q 010519 186 NRFSAENVLGEGGYGVVYKGRLINGSEVAVKKLLNNLGQAEKEFRVEVEAIGHVRHKNLVRLLGYCIEGVHRMLVYEYVN 265 (508)
Q Consensus 186 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~ei~~l~~l~h~niv~~~~~~~~~~~~~lv~E~~~ 265 (508)
++|++.+.||+|+||.||++.+.++..+|+|.+.... .....+..|+.++++++||||+++++++......++||||++
T Consensus 4 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~a~K~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~~~ 82 (256)
T cd05114 4 SELTFMKELGSGQFGVVHLGKWRAQIKVAIKAINEGA-MSEEDFIEEAKVMMKLSHPKLVQLYGVCTQQKPLYIVTEFME 82 (256)
T ss_pred HHcEEeeEecCCcCceEEEEEeccCceEEEEecccCC-ccHHHHHHHHHHHHHCCCCCceeEEEEEccCCCEEEEEEcCC
Confidence 4688889999999999999998888889999875432 334568889999999999999999999999999999999999
Q ss_pred CCCHHHHHhhhhccCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCEEEcCCCcEEEEecCCccccCCCCCc
Q 010519 266 NGNLEQWLHGAMRNQGNLTWEARMKVIIGTAKALAYLHEAIEPKVVHRDIKSSNILIDDEFNAKVSDFGLAKLLDSGESH 345 (508)
Q Consensus 266 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~ 345 (508)
+|+|.++++. ....+++..++.++.+++.||.|||+. +++|+||||+||++++++.+||+|||++.........
T Consensus 83 ~~~L~~~~~~---~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~ni~i~~~~~~kl~d~g~~~~~~~~~~~ 156 (256)
T cd05114 83 NGCLLNYLRQ---RQGKLSKDMLLSMCQDVCEGMEYLERN---SFIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEYT 156 (256)
T ss_pred CCcHHHHHHh---CccCCCHHHHHHHHHHHHHHHHHHHHC---CccccccCcceEEEcCCCeEEECCCCCccccCCCcee
Confidence 9999999863 234688999999999999999999998 9999999999999999999999999999865433222
Q ss_pred ccccccccccccCccccCCCCCCChhhHHHHHHHHHHHHh-CCCCCCCCCCCchhcHHHHHHHHhcccccccccCCCCCC
Q 010519 346 ITTRVMGTFGYVAPEYANTGMLNEKSDIYSFGVLLLEAVT-GRDPVDYGRPANEVNLVEWLKMMVGTRRAEEVVDPNLEV 424 (508)
Q Consensus 346 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 424 (508)
......++..|+|||++.+..++.++||||||+++|||++ |+.||..... . +.+........ ...+.
T Consensus 157 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~s~G~~l~el~~~g~~p~~~~~~---~---~~~~~i~~~~~---~~~~~--- 224 (256)
T cd05114 157 SSSGAKFPVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMPFEKKSN---Y---EVVEMISRGFR---LYRPK--- 224 (256)
T ss_pred ccCCCCCchhhCChhhcccCccchhhhhHHHHHHHHHHHcCCCCCCCCCCH---H---HHHHHHHCCCC---CCCCC---
Confidence 2223345668999999998889999999999999999999 8999864322 1 11111111111 11111
Q ss_pred ChhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhh
Q 010519 425 KPATRALKRSLLVALRCVDPDSEKRPKMSQVVRMLE 460 (508)
Q Consensus 425 ~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 460 (508)
.....+.+++.+||+.||.+||++.++++.|.
T Consensus 225 ----~~~~~~~~li~~c~~~~p~~Rps~~~l~~~l~ 256 (256)
T cd05114 225 ----LASMTVYEVMYSCWHEKPEGRPTFAELLRAIT 256 (256)
T ss_pred ----CCCHHHHHHHHHHccCCcccCcCHHHHHHhhC
Confidence 12345678999999999999999999998873
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h |
| >cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-41 Score=340.50 Aligned_cols=266 Identities=23% Similarity=0.307 Sum_probs=206.1
Q ss_pred hhCCcccceeEeeeCceEEEEEEEc-CCCEEEEEEEcccc-hhhHHHHHHHHHHHhcCCCCCceeEEEEEEeCceeeEEE
Q 010519 184 ATNRFSAENVLGEGGYGVVYKGRLI-NGSEVAVKKLLNNL-GQAEKEFRVEVEAIGHVRHKNLVRLLGYCIEGVHRMLVY 261 (508)
Q Consensus 184 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~ei~~l~~l~h~niv~~~~~~~~~~~~~lv~ 261 (508)
..++|++.+.||+|+||.||++++. ++..+|+|.+.... ......+.+|+++++.++||||+++++++..+...++||
T Consensus 3 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 82 (331)
T cd06649 3 KDDDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICM 82 (331)
T ss_pred CcccceEEEeecCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEe
Confidence 3578999999999999999999876 57788898876543 233467889999999999999999999999999999999
Q ss_pred eecCCCCHHHHHhhhhccCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCEEEcCCCcEEEEecCCccccCC
Q 010519 262 EYVNNGNLEQWLHGAMRNQGNLTWEARMKVIIGTAKALAYLHEAIEPKVVHRDIKSSNILIDDEFNAKVSDFGLAKLLDS 341 (508)
Q Consensus 262 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~ 341 (508)
||+++|+|.+++. ....+++..+..++.|++.||.|||+.. +|+||||||+|||++.++.+||+|||++.....
T Consensus 83 e~~~~~~L~~~l~----~~~~~~~~~~~~~~~~i~~~l~~lH~~~--~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~ 156 (331)
T cd06649 83 EHMDGGSLDQVLK----EAKRIPEEILGKVSIAVLRGLAYLREKH--QIMHRDVKPSNILVNSRGEIKLCDFGVSGQLID 156 (331)
T ss_pred ecCCCCcHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHhhcC--CEEcCCCChhhEEEcCCCcEEEccCcccccccc
Confidence 9999999999985 3456889999999999999999999751 599999999999999999999999999976543
Q ss_pred CCCcccccccccccccCccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCCCchhcHHHHHHHHhccc--cc-----
Q 010519 342 GESHITTRVMGTFGYVAPEYANTGMLNEKSDIYSFGVLLLEAVTGRDPVDYGRPANEVNLVEWLKMMVGTR--RA----- 414 (508)
Q Consensus 342 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~--~~----- 414 (508)
. ......|++.|+|||++.+..++.++|||||||++|||++|+.||....... +...+....... ..
T Consensus 157 ~---~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~ 230 (331)
T cd06649 157 S---MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPIPPPDAKE---LEAIFGRPVVDGEEGEPHSIS 230 (331)
T ss_pred c---ccccCCCCcCcCCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHH---HHHHhcccccccccCCccccC
Confidence 2 2234568999999999999999999999999999999999999996433211 111110000000 00
Q ss_pred ---------------------------ccccCCCCCCChhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhhc
Q 010519 415 ---------------------------EEVVDPNLEVKPATRALKRSLLVALRCVDPDSEKRPKMSQVVRMLEA 461 (508)
Q Consensus 415 ---------------------------~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~ 461 (508)
..+........+.......+.+|+.+||+.||++|||+.+++++.+-
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~~P~~Rpt~~ell~h~~~ 304 (331)
T cd06649 231 PRPRPPGRPVSGHGMDSRPAMAIFELLDYIVNEPPPKLPNGVFTPDFQEFVNKCLIKNPAERADLKMLMNHTFI 304 (331)
T ss_pred cccccccccccccccccccchhHHHHHHHHHhCCCcCCCCccccHHHHHHHHHHccCCcccCCCHHHHhcChHH
Confidence 00000000000111234567789999999999999999999987654
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst |
| >PTZ00263 protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-41 Score=341.50 Aligned_cols=248 Identities=23% Similarity=0.310 Sum_probs=202.6
Q ss_pred CCcccceeEeeeCceEEEEEEEc-CCCEEEEEEEcccc---hhhHHHHHHHHHHHhcCCCCCceeEEEEEEeCceeeEEE
Q 010519 186 NRFSAENVLGEGGYGVVYKGRLI-NGSEVAVKKLLNNL---GQAEKEFRVEVEAIGHVRHKNLVRLLGYCIEGVHRMLVY 261 (508)
Q Consensus 186 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~ei~~l~~l~h~niv~~~~~~~~~~~~~lv~ 261 (508)
++|.+.+.||+|+||.||+|++. +++.||+|.+.... ......+..|+.++++++||||+++++++.+....++||
T Consensus 18 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 97 (329)
T PTZ00263 18 SDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQDENRVYFLL 97 (329)
T ss_pred hheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEEcCCEEEEEE
Confidence 57999999999999999999875 57899999886432 123356888999999999999999999999999999999
Q ss_pred eecCCCCHHHHHhhhhccCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCEEEcCCCcEEEEecCCccccCC
Q 010519 262 EYVNNGNLEQWLHGAMRNQGNLTWEARMKVIIGTAKALAYLHEAIEPKVVHRDIKSSNILIDDEFNAKVSDFGLAKLLDS 341 (508)
Q Consensus 262 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~ 341 (508)
||+++|+|.+++. ....+++..+..++.||+.||.|||++ +|+||||||+|||++.++.+||+|||++.....
T Consensus 98 e~~~~~~L~~~l~----~~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~ 170 (329)
T PTZ00263 98 EFVVGGELFTHLR----KAGRFPNDVAKFYHAELVLAFEYLHSK---DIIYRDLKPENLLLDNKGHVKVTDFGFAKKVPD 170 (329)
T ss_pred cCCCCChHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHEEECCCCCEEEeeccCceEcCC
Confidence 9999999999984 445788999999999999999999999 999999999999999999999999999986643
Q ss_pred CCCcccccccccccccCccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCCCchhcHHHHHHHHhcccccccccCCC
Q 010519 342 GESHITTRVMGTFGYVAPEYANTGMLNEKSDIYSFGVLLLEAVTGRDPVDYGRPANEVNLVEWLKMMVGTRRAEEVVDPN 421 (508)
Q Consensus 342 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 421 (508)
.. ....||+.|+|||++.+..++.++|||||||++|||++|..||....+ .......... .
T Consensus 171 ~~----~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~------~~~~~~i~~~---------~ 231 (329)
T PTZ00263 171 RT----FTLCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFDDTP------FRIYEKILAG---------R 231 (329)
T ss_pred Cc----ceecCChhhcCHHHHcCCCCCCcceeechHHHHHHHHcCCCCCCCCCH------HHHHHHHhcC---------C
Confidence 22 235689999999999999999999999999999999999999964321 1111111111 1
Q ss_pred CCCChhHHHHHHHHHHHHHhcCCCCCCCCC-----HHHHHHHhhc
Q 010519 422 LEVKPATRALKRSLLVALRCVDPDSEKRPK-----MSQVVRMLEA 461 (508)
Q Consensus 422 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPs-----~~evl~~L~~ 461 (508)
+..+ ......+.+|+.+||+.||.+||+ +.+++.|-+-
T Consensus 232 ~~~p--~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~hp~f 274 (329)
T PTZ00263 232 LKFP--NWFDGRARDLVKGLLQTDHTKRLGTLKGGVADVKNHPYF 274 (329)
T ss_pred cCCC--CCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcCCcc
Confidence 1111 112234567999999999999997 7888877543
|
|
| >cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-41 Score=329.46 Aligned_cols=257 Identities=28% Similarity=0.469 Sum_probs=211.1
Q ss_pred HhhCCcccceeEeeeCceEEEEEEEcCCCEEEEEEEcccchhhHHHHHHHHHHHhcCCCCCceeEEEEEEeCceeeEEEe
Q 010519 183 IATNRFSAENVLGEGGYGVVYKGRLINGSEVAVKKLLNNLGQAEKEFRVEVEAIGHVRHKNLVRLLGYCIEGVHRMLVYE 262 (508)
Q Consensus 183 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~ei~~l~~l~h~niv~~~~~~~~~~~~~lv~E 262 (508)
.+..+|++.+.||.|+||.||+|.+.++..+++|.+..........+..|+.+++.++||||+++++++......++|||
T Consensus 3 ~~~~~y~~~~~ig~g~~~~vy~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e 82 (261)
T cd05148 3 RPREEFTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISLFAVCSVGEPVYIITE 82 (261)
T ss_pred CcHHHHHHhhhhccCCCccEEEeEecCCCcEEEEeccccchhhHHHHHHHHHHHhcCCCcchhheeeeEecCCCeEEEEe
Confidence 34567999999999999999999988889999999876665556778899999999999999999999999999999999
Q ss_pred ecCCCCHHHHHhhhhccCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCEEEcCCCcEEEEecCCccccCCC
Q 010519 263 YVNNGNLEQWLHGAMRNQGNLTWEARMKVIIGTAKALAYLHEAIEPKVVHRDIKSSNILIDDEFNAKVSDFGLAKLLDSG 342 (508)
Q Consensus 263 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~~ 342 (508)
|+++|+|.+++.. .....+++..++.++.+|+.||.|||+. +++|+||+|+||++++++.+||+|||++......
T Consensus 83 ~~~~~~L~~~~~~--~~~~~~~~~~~~~~~~~i~~al~~lH~~---~i~h~dl~~~nilv~~~~~~kl~d~g~~~~~~~~ 157 (261)
T cd05148 83 LMEKGSLLAFLRS--PEGQVLPVASLIDMACQVAEGMAYLEEQ---NSIHRDLAARNILVGEDLVCKVADFGLARLIKED 157 (261)
T ss_pred ecccCCHHHHHhc--CCCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccccCcceEEEcCCceEEEccccchhhcCCc
Confidence 9999999999964 2345689999999999999999999998 9999999999999999999999999999866443
Q ss_pred CCcccccccccccccCccccCCCCCCChhhHHHHHHHHHHHHh-CCCCCCCCCCCchhcHHHHHHHHhcccccccccCCC
Q 010519 343 ESHITTRVMGTFGYVAPEYANTGMLNEKSDIYSFGVLLLEAVT-GRDPVDYGRPANEVNLVEWLKMMVGTRRAEEVVDPN 421 (508)
Q Consensus 343 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 421 (508)
... .....++..|+|||.+.+..++.++||||||+++|+|++ |+.||..... .+.+.......
T Consensus 158 ~~~-~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~~l~~l~~~g~~p~~~~~~------~~~~~~~~~~~--------- 221 (261)
T cd05148 158 VYL-SSDKKIPYKWTAPEAASHGTFSTKSDVWSFGILLYEMFTYGQVPYPGMNN------HEVYDQITAGY--------- 221 (261)
T ss_pred ccc-ccCCCCceEecCHHHHccCCCCchhhHHHHHHHHHHHHcCCCCCCCcCCH------HHHHHHHHhCC---------
Confidence 221 223345678999999998899999999999999999998 8999864321 11112221111
Q ss_pred CCCChhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhhc
Q 010519 422 LEVKPATRALKRSLLVALRCVDPDSEKRPKMSQVVRMLEA 461 (508)
Q Consensus 422 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~ 461 (508)
....+......+.+++.+||+.||.+|||+.++++.|++
T Consensus 222 -~~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~l~~~L~~ 260 (261)
T cd05148 222 -RMPCPAKCPQEIYKIMLECWAAEPEDRPSFKALREELDN 260 (261)
T ss_pred -cCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHhc
Confidence 111112234567789999999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom |
| >KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-42 Score=334.80 Aligned_cols=261 Identities=25% Similarity=0.329 Sum_probs=208.5
Q ss_pred HHHhhCCcccceeEeeeCceEEEEEEEc-CCCEEEEEEEcccchh--------------hHHHHHHHHHHHhcCCCCCce
Q 010519 181 LEIATNRFSAENVLGEGGYGVVYKGRLI-NGSEVAVKKLLNNLGQ--------------AEKEFRVEVEAIGHVRHKNLV 245 (508)
Q Consensus 181 ~~~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~--------------~~~~~~~ei~~l~~l~h~niv 245 (508)
....-++|++.+.||+|.||.|-+|+.. +++.||||++.+.... ..+.+.+||.+|++++|||||
T Consensus 92 ~~k~lNqy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~nVV 171 (576)
T KOG0585|consen 92 DRKQLNQYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPNVV 171 (576)
T ss_pred cceehhheehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcCee
Confidence 3445589999999999999999999865 6889999998543211 124688899999999999999
Q ss_pred eEEEEEEeC--ceeeEEEeecCCCCHHHHHhhhhccCCC-ccHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCEEE
Q 010519 246 RLLGYCIEG--VHRMLVYEYVNNGNLEQWLHGAMRNQGN-LTWEARMKVIIGTAKALAYLHEAIEPKVVHRDIKSSNILI 322 (508)
Q Consensus 246 ~~~~~~~~~--~~~~lv~E~~~~gsL~~~l~~~~~~~~~-l~~~~~~~i~~~i~~al~yLH~~~~~~iiH~Dlk~~NIll 322 (508)
+++.+..+. ..+|||+|||..|.+... ...+. +.+.++++++.+++.||.|||.+ +||||||||+|+||
T Consensus 172 ~LiEvLDDP~s~~~YlVley~s~G~v~w~-----p~d~~els~~~Ar~ylrDvv~GLEYLH~Q---giiHRDIKPsNLLl 243 (576)
T KOG0585|consen 172 KLIEVLDDPESDKLYLVLEYCSKGEVKWC-----PPDKPELSEQQARKYLRDVVLGLEYLHYQ---GIIHRDIKPSNLLL 243 (576)
T ss_pred EEEEeecCcccCceEEEEEeccCCccccC-----CCCcccccHHHHHHHHHHHHHHHHHHHhc---CeeccccchhheEE
Confidence 999988654 678999999999987653 34445 99999999999999999999999 99999999999999
Q ss_pred cCCCcEEEEecCCccccCCC----CCcccccccccccccCccccCCCC----CCChhhHHHHHHHHHHHHhCCCCCCCCC
Q 010519 323 DDEFNAKVSDFGLAKLLDSG----ESHITTRVMGTFGYVAPEYANTGM----LNEKSDIYSFGVLLLEAVTGRDPVDYGR 394 (508)
Q Consensus 323 ~~~~~~kl~Dfgla~~~~~~----~~~~~~~~~gt~~y~aPE~~~~~~----~~~~~DvwS~Gvvl~elltG~~Pf~~~~ 394 (508)
+++|++||+|||.+.....+ ........+|||.|+|||...++. .+.+.||||+||+||.|+.|+.||....
T Consensus 244 ~~~g~VKIsDFGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF~~~~ 323 (576)
T KOG0585|consen 244 SSDGTVKISDFGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLPFFDDF 323 (576)
T ss_pred cCCCcEEeeccceeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCCcccch
Confidence 99999999999999866322 111234478999999999886632 3468999999999999999999996321
Q ss_pred CCchhcHHHHHHHHhcccccccccCCCCCCChhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhhcCCC
Q 010519 395 PANEVNLVEWLKMMVGTRRAEEVVDPNLEVKPATRALKRSLLVALRCVDPDSEKRPKMSQVVRMLEADDY 464 (508)
Q Consensus 395 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~ 464 (508)
..+.+ ..++...+.++.....-..+.+||.++|.+||.+|.+..+|..|.+-...
T Consensus 324 ------~~~l~---------~KIvn~pL~fP~~pe~~e~~kDli~~lL~KdP~~Ri~l~~ik~Hpwvt~~ 378 (576)
T KOG0585|consen 324 ------ELELF---------DKIVNDPLEFPENPEINEDLKDLIKRLLEKDPEQRITLPDIKLHPWVTRD 378 (576)
T ss_pred ------HHHHH---------HHHhcCcccCCCcccccHHHHHHHHHHhhcChhheeehhhheecceeccC
Confidence 11222 22333444444444556677789999999999999999999998876543
|
|
| >cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-41 Score=326.32 Aligned_cols=258 Identities=29% Similarity=0.417 Sum_probs=207.6
Q ss_pred HHhhCCcccceeEeeeCceEEEEEEEcCCCEEEEEEEcccchhhHHHHHHHHHHHhcCCCCCceeEEEEEEeCceeeEEE
Q 010519 182 EIATNRFSAENVLGEGGYGVVYKGRLINGSEVAVKKLLNNLGQAEKEFRVEVEAIGHVRHKNLVRLLGYCIEGVHRMLVY 261 (508)
Q Consensus 182 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~ei~~l~~l~h~niv~~~~~~~~~~~~~lv~ 261 (508)
++..++|++.+.||+|++|.||+|.+.++..||+|.+.... .....+.+|+.++++++||||+++++++......+++|
T Consensus 2 ~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~v~iK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 80 (261)
T cd05068 2 EIDRTSIQLLRKLGAGQFGEVWEGLWNNTTPVAVKTLKPGT-MDPKDFLAEAQIMKKLRHPKLIQLYAVCTLEEPIYIVT 80 (261)
T ss_pred ccchhheeeEEEecccCCccEEEEEecCCeEEEEEeeCCCc-ccHHHHHHHHHHHHHCCCCCccceeEEEecCCCeeeee
Confidence 34567899999999999999999998778889999886543 33466888999999999999999999999999999999
Q ss_pred eecCCCCHHHHHhhhhccCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCEEEcCCCcEEEEecCCccccCC
Q 010519 262 EYVNNGNLEQWLHGAMRNQGNLTWEARMKVIIGTAKALAYLHEAIEPKVVHRDIKSSNILIDDEFNAKVSDFGLAKLLDS 341 (508)
Q Consensus 262 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~ 341 (508)
||+++++|.+++.. .....+++..+..++.+++.||.|||+. +++|+||||+||++++++.+||+|||++.....
T Consensus 81 e~~~~~~L~~~~~~--~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~ 155 (261)
T cd05068 81 ELMKYGSLLEYLQG--GAGRALKLPQLIDMAAQVASGMAYLEAQ---NYIHRDLAARNVLVGENNICKVADFGLARVIKE 155 (261)
T ss_pred ecccCCcHHHHHhc--cCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeccCCcceEEEcCCCCEEECCcceEEEccC
Confidence 99999999999864 2235689999999999999999999998 999999999999999999999999999987653
Q ss_pred CCCcccccccccccccCccccCCCCCCChhhHHHHHHHHHHHHh-CCCCCCCCCCCchhcHHHHHHHHhcccccccccCC
Q 010519 342 GESHITTRVMGTFGYVAPEYANTGMLNEKSDIYSFGVLLLEAVT-GRDPVDYGRPANEVNLVEWLKMMVGTRRAEEVVDP 420 (508)
Q Consensus 342 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 420 (508)
...........+..|+|||++.+..++.++||||||+++|||++ |+.||..... ............
T Consensus 156 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~------~~~~~~~~~~~~------- 222 (261)
T cd05068 156 DIYEAREGAKFPIKWTAPEAALYNRFSIKSDVWSFGILLTEIVTYGRMPYPGMTN------AEVLQQVDQGYR------- 222 (261)
T ss_pred CcccccCCCcCceeccCccccccCCCCchhhHHHHHHHHHHHHhcCCCCCCCCCH------HHHHHHHHcCCC-------
Confidence 32221222223457999999999999999999999999999999 9999863321 111111111111
Q ss_pred CCCCChhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhhc
Q 010519 421 NLEVKPATRALKRSLLVALRCVDPDSEKRPKMSQVVRMLEA 461 (508)
Q Consensus 421 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~ 461 (508)
..........+.+++.+||+.||.+||++.++++.|++
T Consensus 223 ---~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~l~~~l~~ 260 (261)
T cd05068 223 ---MPCPPGCPKELYDIMLDCWKEDPDDRPTFETLQWKLED 260 (261)
T ss_pred ---CCCCCcCCHHHHHHHHHHhhcCcccCCCHHHHHHHHhc
Confidence 11112234567779999999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a |
| >cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-41 Score=339.50 Aligned_cols=244 Identities=23% Similarity=0.275 Sum_probs=197.2
Q ss_pred eeEeeeCceEEEEEEEc-CCCEEEEEEEcccc---hhhHHHHHHHHHHHhcCCCCCceeEEEEEEeCceeeEEEeecCCC
Q 010519 192 NVLGEGGYGVVYKGRLI-NGSEVAVKKLLNNL---GQAEKEFRVEVEAIGHVRHKNLVRLLGYCIEGVHRMLVYEYVNNG 267 (508)
Q Consensus 192 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~ei~~l~~l~h~niv~~~~~~~~~~~~~lv~E~~~~g 267 (508)
+.||+|+||.||+++.. +|+.+|+|++.... ......+..|+.++++++||||+++++++......++||||+++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~ 80 (323)
T cd05571 1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQTHDRLCFVMEYANGG 80 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEcCCEEEEEEeCCCCC
Confidence 46999999999999874 68899999986432 222345778999999999999999999999999999999999999
Q ss_pred CHHHHHhhhhccCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCEEEcCCCcEEEEecCCccccCCCCCccc
Q 010519 268 NLEQWLHGAMRNQGNLTWEARMKVIIGTAKALAYLHEAIEPKVVHRDIKSSNILIDDEFNAKVSDFGLAKLLDSGESHIT 347 (508)
Q Consensus 268 sL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~~ 347 (508)
+|.+++. ....+++..+..++.||+.||.|||+. +|+||||||+|||++.++.+||+|||+++...... ...
T Consensus 81 ~L~~~l~----~~~~~~~~~~~~~~~qi~~~L~~lH~~---~ivHrDlkp~NIll~~~~~~kl~DfG~a~~~~~~~-~~~ 152 (323)
T cd05571 81 ELFFHLS----RERVFSEDRARFYGAEIVSALGYLHSC---DVVYRDLKLENLMLDKDGHIKITDFGLCKEGISDG-ATM 152 (323)
T ss_pred cHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHhC---CeEeCCCCHHHEEECCCCCEEEeeCCCCcccccCC-Ccc
Confidence 9999984 456789999999999999999999999 99999999999999999999999999987542221 123
Q ss_pred ccccccccccCccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCCCchhcHHHHHHHHhcccccccccCCCCCCChh
Q 010519 348 TRVMGTFGYVAPEYANTGMLNEKSDIYSFGVLLLEAVTGRDPVDYGRPANEVNLVEWLKMMVGTRRAEEVVDPNLEVKPA 427 (508)
Q Consensus 348 ~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 427 (508)
...+||+.|+|||++.+..++.++|||||||++|||++|+.||..... .......... . ..+ +
T Consensus 153 ~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~------~~~~~~~~~~-~------~~~----p 215 (323)
T cd05571 153 KTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH------EKLFELILME-E------IRF----P 215 (323)
T ss_pred cceecCccccChhhhcCCCCCccccCcccchhhhhhhcCCCCCCCCCH------HHHHHHHHcC-C------CCC----C
Confidence 345799999999999999999999999999999999999999964321 1111111111 0 011 1
Q ss_pred HHHHHHHHHHHHHhcCCCCCCCC-----CHHHHHHHhh
Q 010519 428 TRALKRSLLVALRCVDPDSEKRP-----KMSQVVRMLE 460 (508)
Q Consensus 428 ~~~~~~l~~li~~cl~~dP~~RP-----s~~evl~~L~ 460 (508)
......+.+++.+||+.||.+|| ++.++++|-.
T Consensus 216 ~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~h~~ 253 (323)
T cd05571 216 RTLSPEAKSLLAGLLKKDPKQRLGGGPEDAKEIMEHRF 253 (323)
T ss_pred CCCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHHcCCC
Confidence 12344566799999999999999 8999987643
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be |
| >KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-41 Score=323.69 Aligned_cols=258 Identities=23% Similarity=0.270 Sum_probs=211.0
Q ss_pred HHhhCCcccceeEeeeCceEEEEEEEcC-CCEEEEEEEcccchh---hHHHHHHHHHHHhcCCCCCceeEEEEEEeCcee
Q 010519 182 EIATNRFSAENVLGEGGYGVVYKGRLIN-GSEVAVKKLLNNLGQ---AEKEFRVEVEAIGHVRHKNLVRLLGYCIEGVHR 257 (508)
Q Consensus 182 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~---~~~~~~~ei~~l~~l~h~niv~~~~~~~~~~~~ 257 (508)
.+..+.|++.+.||.|.-|+||++.+.+ +..+|+|++.+..-. .......|-++|..++||.++.+|+.|+.+...
T Consensus 73 ~l~l~~f~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~fet~~~~ 152 (459)
T KOG0610|consen 73 SLGLRHFRLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLYASFETDKYS 152 (459)
T ss_pred ccCHHHHHHHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhhheeecccee
Confidence 3444678889999999999999999864 588999999765432 234566799999999999999999999999999
Q ss_pred eEEEeecCCCCHHHHHhhhhccCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCEEEcCCCcEEEEecCCcc
Q 010519 258 MLVYEYVNNGNLEQWLHGAMRNQGNLTWEARMKVIIGTAKALAYLHEAIEPKVVHRDIKSSNILIDDEFNAKVSDFGLAK 337 (508)
Q Consensus 258 ~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~Dfgla~ 337 (508)
|++||||+||+|..+++. +..+.+++..++.++..|+-||.|||.. |||+|||||+||||.++|++.|+||.|+.
T Consensus 153 cl~meyCpGGdL~~Lrqk--Qp~~~fse~~aRFYaAEvl~ALEYLHml---GivYRDLKPENILvredGHIMLsDFDLS~ 227 (459)
T KOG0610|consen 153 CLVMEYCPGGDLHSLRQK--QPGKRFSESAARFYAAEVLLALEYLHML---GIVYRDLKPENILVREDGHIMLSDFDLSL 227 (459)
T ss_pred EEEEecCCCccHHHHHhh--CCCCccchhhHHHHHHHHHHHHHHHHhh---ceeeccCCcceeEEecCCcEEeeeccccc
Confidence 999999999999999875 6778899999999999999999999999 99999999999999999999999999875
Q ss_pred ccCC---------------------------------CCC----------------------cccccccccccccCcccc
Q 010519 338 LLDS---------------------------------GES----------------------HITTRVMGTFGYVAPEYA 362 (508)
Q Consensus 338 ~~~~---------------------------------~~~----------------------~~~~~~~gt~~y~aPE~~ 362 (508)
.... ... .....++||-.|+|||++
T Consensus 228 ~~~~~Pt~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAPEvI 307 (459)
T KOG0610|consen 228 RCPVSPTLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAPEVI 307 (459)
T ss_pred cCCCCCeeeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCccccccccccccccceee
Confidence 3310 000 012236899999999999
Q ss_pred CCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCCCchhcHHHHHHHHhcccccccccCCCCCCChhHHHHHHHHHHHHHhc
Q 010519 363 NTGMLNEKSDIYSFGVLLLEAVTGRDPVDYGRPANEVNLVEWLKMMVGTRRAEEVVDPNLEVKPATRALKRSLLVALRCV 442 (508)
Q Consensus 363 ~~~~~~~~~DvwS~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl 442 (508)
.|+..+.++|+|+|||+||||+.|..||....... . +.. ++...+..+........+.+||++.|
T Consensus 308 ~G~GHgsAVDWWtfGIflYEmLyG~TPFKG~~~~~--T----l~N---------Iv~~~l~Fp~~~~vs~~akDLIr~LL 372 (459)
T KOG0610|consen 308 RGEGHGSAVDWWTFGIFLYEMLYGTTPFKGSNNKE--T----LRN---------IVGQPLKFPEEPEVSSAAKDLIRKLL 372 (459)
T ss_pred ecCCCCchhhHHHHHHHHHHHHhCCCCcCCCCchh--h----HHH---------HhcCCCcCCCCCcchhHHHHHHHHHh
Confidence 99999999999999999999999999997544322 1 111 22233333334455667788999999
Q ss_pred CCCCCCCCC----HHHHHHHh
Q 010519 443 DPDSEKRPK----MSQVVRML 459 (508)
Q Consensus 443 ~~dP~~RPs----~~evl~~L 459 (508)
.+||.+|.- +.||-+|-
T Consensus 373 vKdP~kRlg~~rGA~eIK~Hp 393 (459)
T KOG0610|consen 373 VKDPSKRLGSKRGAAEIKRHP 393 (459)
T ss_pred ccChhhhhccccchHHhhcCc
Confidence 999999998 88888754
|
|
| >KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-42 Score=369.09 Aligned_cols=264 Identities=28% Similarity=0.475 Sum_probs=215.7
Q ss_pred HhhCCcccceeEeeeCceEEEEEEEc--CCC----EEEEEEEcccc-hhhHHHHHHHHHHHhcCCCCCceeEEEEEEeCc
Q 010519 183 IATNRFSAENVLGEGGYGVVYKGRLI--NGS----EVAVKKLLNNL-GQAEKEFRVEVEAIGHVRHKNLVRLLGYCIEGV 255 (508)
Q Consensus 183 ~~~~~~~~~~~lg~G~~g~Vy~~~~~--~~~----~vavK~~~~~~-~~~~~~~~~ei~~l~~l~h~niv~~~~~~~~~~ 255 (508)
+...+.++.+.||+|.||.||.|... +|. .||||.+.... .+...+|.+|..+|+.++|||||+++|+|.+..
T Consensus 689 v~~~~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~~~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~~~ 768 (1025)
T KOG1095|consen 689 VPRKNVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRLSSEQEVSDFLKEALLMSKFDHPNIVSLIGVCLDSG 768 (1025)
T ss_pred CChhheEeeeeeccccccceEEEEEecCCCCccceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCcceeeEEEeecCCC
Confidence 33457788899999999999999875 333 48999986654 455678999999999999999999999999999
Q ss_pred eeeEEEeecCCCCHHHHHhhhhcc---CCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCEEEcCCCcEEEEe
Q 010519 256 HRMLVYEYVNNGNLEQWLHGAMRN---QGNLTWEARMKVIIGTAKALAYLHEAIEPKVVHRDIKSSNILIDDEFNAKVSD 332 (508)
Q Consensus 256 ~~~lv~E~~~~gsL~~~l~~~~~~---~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~D 332 (508)
..+|++|||.+|+|..||++.+.. ...++..+.+.++.|||+|+.||+++ ++|||||..+|+||++...+||+|
T Consensus 769 ~~~i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~~---~fvHRDLAaRNCLL~~~r~VKIaD 845 (1025)
T KOG1095|consen 769 PPLILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLESK---HFVHRDLAARNCLLDERRVVKIAD 845 (1025)
T ss_pred CcEEEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHhC---CCcCcchhhhheeecccCcEEEcc
Confidence 999999999999999999754221 34688999999999999999999999 999999999999999999999999
Q ss_pred cCCccccCCCCCc-ccccccccccccCccccCCCCCCChhhHHHHHHHHHHHHh-CCCCCCCCCCCchhcHHHHHHHHhc
Q 010519 333 FGLAKLLDSGESH-ITTRVMGTFGYVAPEYANTGMLNEKSDIYSFGVLLLEAVT-GRDPVDYGRPANEVNLVEWLKMMVG 410 (508)
Q Consensus 333 fgla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~ 410 (508)
||+|+.+...+.. ......-...|||||.+..+.++.|+|||||||+|||++| |..||....+. +.+.....
T Consensus 846 FGlArDiy~~~yyr~~~~a~lPvkWm~PEsl~d~iFtskSDvWsFGVllWEifslG~~PY~~~~n~------~v~~~~~~ 919 (1025)
T KOG1095|consen 846 FGLARDIYDKDYYRKHGEAMLPVKWMPPESLKDGIFTSKSDVWSFGVLLWEIFSLGATPYPSRSNF------EVLLDVLE 919 (1025)
T ss_pred cchhHhhhhchheeccCccccceecCCHHHHhhcccccccchhhhHHHHHHHHhCCCCCCCCcchH------HHHHHHHh
Confidence 9999944433322 2222234568999999999999999999999999999999 99999654332 11111111
Q ss_pred ccccccccCCCCCCChhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhhcCCCC
Q 010519 411 TRRAEEVVDPNLEVKPATRALKRSLLVALRCVDPDSEKRPKMSQVVRMLEADDYP 465 (508)
Q Consensus 411 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~ 465 (508)
.. +.+++..++..+.++|.+||+.+|.+||++..|++.+..+...
T Consensus 920 ---------gg-RL~~P~~CP~~ly~lM~~CW~~~pe~RP~F~~i~~q~~~i~~~ 964 (1025)
T KOG1095|consen 920 ---------GG-RLDPPSYCPEKLYQLMLQCWKHDPEDRPSFRTIVEQDPAISNA 964 (1025)
T ss_pred ---------CC-ccCCCCCCChHHHHHHHHHccCChhhCccHHHHHhhhhhhhhh
Confidence 11 4555666777888899999999999999999999988775543
|
|
| >PTZ00267 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-40 Score=352.26 Aligned_cols=253 Identities=20% Similarity=0.264 Sum_probs=205.9
Q ss_pred CcccceeEeeeCceEEEEEEEc-C-CCEEEEEEEcccchhhHHHHHHHHHHHhcCCCCCceeEEEEEEeCceeeEEEeec
Q 010519 187 RFSAENVLGEGGYGVVYKGRLI-N-GSEVAVKKLLNNLGQAEKEFRVEVEAIGHVRHKNLVRLLGYCIEGVHRMLVYEYV 264 (508)
Q Consensus 187 ~~~~~~~lg~G~~g~Vy~~~~~-~-~~~vavK~~~~~~~~~~~~~~~ei~~l~~l~h~niv~~~~~~~~~~~~~lv~E~~ 264 (508)
.|.+.+.||+|+||.||++... + +..||+|.+..........+..|+.+++.++|||||+++++|......||||||+
T Consensus 68 ~y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~E~~ 147 (478)
T PTZ00267 68 MYVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLNDERQAAYARSELHCLAACDHFGIVKHFDDFKSDDKLLLIMEYG 147 (478)
T ss_pred eEEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEECCEEEEEEECC
Confidence 4889999999999999999754 3 5778888775555555567888999999999999999999999999999999999
Q ss_pred CCCCHHHHHhhhhccCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCEEEcCCCcEEEEecCCccccCCCCC
Q 010519 265 NNGNLEQWLHGAMRNQGNLTWEARMKVIIGTAKALAYLHEAIEPKVVHRDIKSSNILIDDEFNAKVSDFGLAKLLDSGES 344 (508)
Q Consensus 265 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~ 344 (508)
++|+|.++|.........+++..+..++.||+.||.|||+. +|+||||||+|||++.++.+||+|||++........
T Consensus 148 ~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~---~ivHrDlkp~NIll~~~~~~kL~DFgla~~~~~~~~ 224 (478)
T PTZ00267 148 SGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSR---KMMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSVS 224 (478)
T ss_pred CCCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhC---CEEECCcCHHhEEECCCCcEEEEeCcCceecCCccc
Confidence 99999999876555566789999999999999999999998 999999999999999999999999999987643322
Q ss_pred -cccccccccccccCccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCCCchhcHHHHHHHHhcccccccccCCCCC
Q 010519 345 -HITTRVMGTFGYVAPEYANTGMLNEKSDIYSFGVLLLEAVTGRDPVDYGRPANEVNLVEWLKMMVGTRRAEEVVDPNLE 423 (508)
Q Consensus 345 -~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 423 (508)
......+||+.|+|||++.+..++.++|||||||++|||++|+.||..... .+.+........ .+
T Consensus 225 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~Pf~~~~~------~~~~~~~~~~~~-----~~--- 290 (478)
T PTZ00267 225 LDVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFKGPSQ------REIMQQVLYGKY-----DP--- 290 (478)
T ss_pred cccccccCCCccccCHhHhCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCH------HHHHHHHHhCCC-----CC---
Confidence 223456799999999999999999999999999999999999999964321 122222211100 00
Q ss_pred CChhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 010519 424 VKPATRALKRSLLVALRCVDPDSEKRPKMSQVVRM 458 (508)
Q Consensus 424 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 458 (508)
.+......+.+++.+||..||.+||++.+++.+
T Consensus 291 --~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~~ 323 (478)
T PTZ00267 291 --FPCPVSSGMKALLDPLLSKNPALRPTTQQLLHT 323 (478)
T ss_pred --CCccCCHHHHHHHHHHhccChhhCcCHHHHHhC
Confidence 011123456779999999999999999999864
|
|
| >cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-41 Score=345.42 Aligned_cols=263 Identities=27% Similarity=0.416 Sum_probs=204.6
Q ss_pred HHHhhCCcccceeEeeeCceEEEEEEEc------CCCEEEEEEEcccc-hhhHHHHHHHHHHHhcC-CCCCceeEEEEEE
Q 010519 181 LEIATNRFSAENVLGEGGYGVVYKGRLI------NGSEVAVKKLLNNL-GQAEKEFRVEVEAIGHV-RHKNLVRLLGYCI 252 (508)
Q Consensus 181 ~~~~~~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~-~~~~~~~~~ei~~l~~l-~h~niv~~~~~~~ 252 (508)
+.+..++|++.+.||+|+||.||+|++. .+..||+|++.... ....+.+.+|+.++..+ +||||++++++|.
T Consensus 30 ~~~~~~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~~ 109 (375)
T cd05104 30 WEFPRNRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHINIVNLLGACT 109 (375)
T ss_pred cccchHHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCcCcHHHHHHHHHHHHHHHhcCCcceeeeeeeec
Confidence 4555678999999999999999999742 35679999886433 23345688899999999 8999999999999
Q ss_pred eCceeeEEEeecCCCCHHHHHhhhhc------------------------------------------------------
Q 010519 253 EGVHRMLVYEYVNNGNLEQWLHGAMR------------------------------------------------------ 278 (508)
Q Consensus 253 ~~~~~~lv~E~~~~gsL~~~l~~~~~------------------------------------------------------ 278 (508)
.....++||||+++|+|.+++.....
T Consensus 110 ~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~ 189 (375)
T cd05104 110 VGGPTLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRSV 189 (375)
T ss_pred cCCcceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCccccccccccccccc
Confidence 99999999999999999999964210
Q ss_pred -----------------cCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCEEEcCCCcEEEEecCCccccCC
Q 010519 279 -----------------NQGNLTWEARMKVIIGTAKALAYLHEAIEPKVVHRDIKSSNILIDDEFNAKVSDFGLAKLLDS 341 (508)
Q Consensus 279 -----------------~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~ 341 (508)
....+++..+..++.||+.||.|||+. +|+||||||+|||+++++.+||+|||++.....
T Consensus 190 ~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~~ 266 (375)
T cd05104 190 RSGSYIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASK---NCIHRDLAARNILLTHGRITKICDFGLARDIRN 266 (375)
T ss_pred ccceecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCchhhEEEECCCcEEEecCccceeccC
Confidence 112478889999999999999999998 999999999999999999999999999986543
Q ss_pred CCCcc-cccccccccccCccccCCCCCCChhhHHHHHHHHHHHHh-CCCCCCCCCCCchhcHHHHHHHHhcccccccccC
Q 010519 342 GESHI-TTRVMGTFGYVAPEYANTGMLNEKSDIYSFGVLLLEAVT-GRDPVDYGRPANEVNLVEWLKMMVGTRRAEEVVD 419 (508)
Q Consensus 342 ~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 419 (508)
..... .....++..|+|||++.+..++.++|||||||++|||++ |..||...... .....++. .... ...
T Consensus 267 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDi~slG~~l~ellt~g~~p~~~~~~~--~~~~~~~~---~~~~---~~~ 338 (375)
T cd05104 267 DSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGMPVD--SKFYKMIK---EGYR---MLS 338 (375)
T ss_pred cccccccCCCCCCcceeChhHhcCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCCCch--HHHHHHHH---hCcc---CCC
Confidence 32211 122334667999999999999999999999999999998 88888643221 11111111 1100 000
Q ss_pred CCCCCChhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhhc
Q 010519 420 PNLEVKPATRALKRSLLVALRCVDPDSEKRPKMSQVVRMLEA 461 (508)
Q Consensus 420 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~ 461 (508)
+ ......+.+|+.+||+.||.+|||+.+|++.|+.
T Consensus 339 ~-------~~~~~~l~~li~~cl~~dP~~RPs~~eil~~l~~ 373 (375)
T cd05104 339 P-------ECAPSEMYDIMKSCWDADPLKRPTFKQIVQLIEQ 373 (375)
T ss_pred C-------CCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHh
Confidence 1 1123456779999999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce |
| >KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-42 Score=347.23 Aligned_cols=267 Identities=31% Similarity=0.450 Sum_probs=213.9
Q ss_pred HHHHHHhhCCcccceeEeeeCceEEEEEEEcC--C---CEEEEEEEcc---cchhhHHHHHHHHHHHhcCCCCCceeEEE
Q 010519 178 LRDLEIATNRFSAENVLGEGGYGVVYKGRLIN--G---SEVAVKKLLN---NLGQAEKEFRVEVEAIGHVRHKNLVRLLG 249 (508)
Q Consensus 178 ~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~--~---~~vavK~~~~---~~~~~~~~~~~ei~~l~~l~h~niv~~~~ 249 (508)
-..|++..++..+.++||+|+||+||+|++.. + ..||||.... .......+|..|..+|+.++|||||++||
T Consensus 149 r~~Wel~H~~v~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NVVr~yG 228 (474)
T KOG0194|consen 149 RQKWELSHSDIELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNVVRFYG 228 (474)
T ss_pred ccccEEeccCccccceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCCCCCEEEEEE
Confidence 35567888888999999999999999998753 2 2389998874 22455678999999999999999999999
Q ss_pred EEEeCceeeEEEeecCCCCHHHHHhhhhccCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCEEEcCCCcEE
Q 010519 250 YCIEGVHRMLVYEYVNNGNLEQWLHGAMRNQGNLTWEARMKVIIGTAKALAYLHEAIEPKVVHRDIKSSNILIDDEFNAK 329 (508)
Q Consensus 250 ~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiH~Dlk~~NIll~~~~~~k 329 (508)
++.....+|+|||+|.||+|.++|. ...+.++..++..++.+.|.||+|||++ ++|||||..+|+|++.++.+|
T Consensus 229 Va~~~~Pl~ivmEl~~gGsL~~~L~---k~~~~v~~~ek~~~~~~AA~Gl~YLh~k---~~IHRDIAARNcL~~~~~~vK 302 (474)
T KOG0194|consen 229 VAVLEEPLMLVMELCNGGSLDDYLK---KNKKSLPTLEKLRFCYDAARGLEYLHSK---NCIHRDIAARNCLYSKKGVVK 302 (474)
T ss_pred EEcCCCccEEEEEecCCCcHHHHHH---hCCCCCCHHHHHHHHHHHHhHHHHHHHC---CCcchhHhHHHheecCCCeEE
Confidence 9999999999999999999999996 3444799999999999999999999999 999999999999999999999
Q ss_pred EEecCCccccCCCCCcccc-cccccccccCccccCCCCCCChhhHHHHHHHHHHHHh-CCCCCCCCCCCchhcHHHHHHH
Q 010519 330 VSDFGLAKLLDSGESHITT-RVMGTFGYVAPEYANTGMLNEKSDIYSFGVLLLEAVT-GRDPVDYGRPANEVNLVEWLKM 407 (508)
Q Consensus 330 l~Dfgla~~~~~~~~~~~~-~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~ellt-G~~Pf~~~~~~~~~~~~~~~~~ 407 (508)
|+|||+++..... .... ...-...|+|||.+....|+.++|||||||++||+++ |..||..... .+....
T Consensus 303 ISDFGLs~~~~~~--~~~~~~~klPirWLAPEtl~~~~~s~kTDV~sfGV~~~Eif~~g~~Py~g~~~------~~v~~k 374 (474)
T KOG0194|consen 303 ISDFGLSRAGSQY--VMKKFLKKLPIRWLAPETLNTGIFSFKTDVWSFGVLLWEIFENGAEPYPGMKN------YEVKAK 374 (474)
T ss_pred eCccccccCCcce--eeccccccCcceecChhhhccCccccccchhheeeeEEeeeccCCCCCCCCCH------HHHHHH
Confidence 9999999854311 1111 1123568999999999999999999999999999999 8889864322 111111
Q ss_pred HhcccccccccCCCCCCChhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhhcCCCCCc
Q 010519 408 MVGTRRAEEVVDPNLEVKPATRALKRSLLVALRCVDPDSEKRPKMSQVVRMLEADDYPFR 467 (508)
Q Consensus 408 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~~~ 467 (508)
... .......+...+..+..++.+||..||++||||.++.+.|+.......
T Consensus 375 I~~---------~~~r~~~~~~~p~~~~~~~~~c~~~~p~~R~tm~~i~~~l~~~~~~~~ 425 (474)
T KOG0194|consen 375 IVK---------NGYRMPIPSKTPKELAKVMKQCWKKDPEDRPTMSTIKKKLEALEKKKE 425 (474)
T ss_pred HHh---------cCccCCCCCCCHHHHHHHHHHhccCChhhccCHHHHHHHHHHHHhccc
Confidence 111 222222233445566668889999999999999999999987655433
|
|
| >cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-41 Score=344.20 Aligned_cols=258 Identities=25% Similarity=0.326 Sum_probs=207.1
Q ss_pred CCcccceeEeeeCceEEEEEEEc-CCCEEEEEEEcccc---hhhHHHHHHHHHHHhcCCCCCceeEEEEEEeCceeeEEE
Q 010519 186 NRFSAENVLGEGGYGVVYKGRLI-NGSEVAVKKLLNNL---GQAEKEFRVEVEAIGHVRHKNLVRLLGYCIEGVHRMLVY 261 (508)
Q Consensus 186 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~ei~~l~~l~h~niv~~~~~~~~~~~~~lv~ 261 (508)
++|.+.+.||+|+||+||+|++. +++.||+|++.... ......+..|+.++..++||||+++++++.++...++||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (350)
T cd05573 1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSFQDEEHLYLVM 80 (350)
T ss_pred CCceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhheecCCeEEEEE
Confidence 47899999999999999999875 68899999986432 133456888999999999999999999999999999999
Q ss_pred eecCCCCHHHHHhhhhccCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCEEEcCCCcEEEEecCCccccCC
Q 010519 262 EYVNNGNLEQWLHGAMRNQGNLTWEARMKVIIGTAKALAYLHEAIEPKVVHRDIKSSNILIDDEFNAKVSDFGLAKLLDS 341 (508)
Q Consensus 262 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~ 341 (508)
||+++|+|.+++.. ...+++..++.++.||+.||.|||+. +|+||||||+|||++.++.+||+|||++.....
T Consensus 81 e~~~~~~L~~~l~~----~~~l~~~~~~~i~~qi~~aL~~LH~~---giiH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~ 153 (350)
T cd05573 81 EYMPGGDLMNLLIR----KDVFPEETARFYIAELVLALDSVHKL---GFIHRDIKPDNILIDADGHIKLADFGLCKKMNK 153 (350)
T ss_pred cCCCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHeEECCCCCEEeecCCCCccCcc
Confidence 99999999999853 36789999999999999999999998 999999999999999999999999999986654
Q ss_pred CC----------------------------CcccccccccccccCccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCC
Q 010519 342 GE----------------------------SHITTRVMGTFGYVAPEYANTGMLNEKSDIYSFGVLLLEAVTGRDPVDYG 393 (508)
Q Consensus 342 ~~----------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltG~~Pf~~~ 393 (508)
.. ........||+.|+|||++.+..++.++|||||||+||||++|+.||...
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~ 233 (350)
T cd05573 154 AKDREYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPPFYSD 233 (350)
T ss_pred cCcccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCceeeEecchhhhhhccCCCCCCCC
Confidence 32 11233456899999999999999999999999999999999999999754
Q ss_pred CCCchhcHHHHHHHHhcccccccccCCCCCCChhHHHHHHHHHHHHHhcCCCCCCCCC-HHHHHHHhhcCCC
Q 010519 394 RPANEVNLVEWLKMMVGTRRAEEVVDPNLEVKPATRALKRSLLVALRCVDPDSEKRPK-MSQVVRMLEADDY 464 (508)
Q Consensus 394 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs-~~evl~~L~~~~~ 464 (508)
... .......... ..+..+........+.+|+.+|+. ||.+||+ +.+++++..-...
T Consensus 234 ~~~------~~~~~i~~~~-------~~~~~p~~~~~~~~~~~li~~ll~-dp~~R~~s~~~ll~hp~~~~~ 291 (350)
T cd05573 234 TLQ------ETYNKIINWK-------ESLRFPPDPPVSPEAIDLICRLLC-DPEDRLGSFEEIKSHPFFKGI 291 (350)
T ss_pred CHH------HHHHHHhccC-------CcccCCCCCCCCHHHHHHHHHHcc-ChhhcCCCHHHHhcCCCcCCC
Confidence 311 1111111100 001111111134556678999997 9999999 9999998655443
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the |
| >cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-40 Score=324.37 Aligned_cols=258 Identities=25% Similarity=0.406 Sum_probs=206.9
Q ss_pred HhhCCcccceeEeeeCceEEEEEEEc-CCCEEEEEEEcccchhhHHHHHHHHHHHhcCCCCCceeEEEEEEeCceeeEEE
Q 010519 183 IATNRFSAENVLGEGGYGVVYKGRLI-NGSEVAVKKLLNNLGQAEKEFRVEVEAIGHVRHKNLVRLLGYCIEGVHRMLVY 261 (508)
Q Consensus 183 ~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~ei~~l~~l~h~niv~~~~~~~~~~~~~lv~ 261 (508)
+...+|.+.+.||+|+||.||+|.+. .+..+++|.+... ......+..|+++++.++||||+++++++......+++|
T Consensus 3 ~~~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 81 (263)
T cd05052 3 MERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED-TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIIT 81 (263)
T ss_pred CchHHeEEeeecCCcccceEEEEEEecCCceEEEEEecCC-chHHHHHHHHHHHHHhCCCCChhheEEEEcCCCCcEEEE
Confidence 34457888999999999999999875 5788999987644 333467888999999999999999999999999999999
Q ss_pred eecCCCCHHHHHhhhhccCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCEEEcCCCcEEEEecCCccccCC
Q 010519 262 EYVNNGNLEQWLHGAMRNQGNLTWEARMKVIIGTAKALAYLHEAIEPKVVHRDIKSSNILIDDEFNAKVSDFGLAKLLDS 341 (508)
Q Consensus 262 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~ 341 (508)
||+++++|.+++.. .....+++..++.++.|+++||.|||+. +++||||||+|||+++++.+||+|||++.....
T Consensus 82 e~~~~~~L~~~~~~--~~~~~l~~~~~~~~~~ql~~~l~~lH~~---~i~H~dlkp~nil~~~~~~~kl~df~~~~~~~~ 156 (263)
T cd05052 82 EFMTYGNLLDYLRE--CNRQEVNAVVLLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLMTG 156 (263)
T ss_pred EeCCCCcHHHHHHh--CCCCCCCHHHHHHHHHHHHHHHHHHHhC---CEeecccCcceEEEcCCCcEEeCCCcccccccc
Confidence 99999999999864 2345689999999999999999999998 999999999999999999999999999987654
Q ss_pred CCCcccccccccccccCccccCCCCCCChhhHHHHHHHHHHHHh-CCCCCCCCCCCchhcHHHHHHHHhcccccccccCC
Q 010519 342 GESHITTRVMGTFGYVAPEYANTGMLNEKSDIYSFGVLLLEAVT-GRDPVDYGRPANEVNLVEWLKMMVGTRRAEEVVDP 420 (508)
Q Consensus 342 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 420 (508)
..........++..|+|||.+.+..++.++|||||||++|||++ |..||..... .+........
T Consensus 157 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~------~~~~~~~~~~--------- 221 (263)
T cd05052 157 DTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDL------SQVYELLEKG--------- 221 (263)
T ss_pred ceeeccCCCCCccccCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCH------HHHHHHHHCC---------
Confidence 33222222334568999999999999999999999999999998 8899864321 1222222111
Q ss_pred CCCCChhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhhcC
Q 010519 421 NLEVKPATRALKRSLLVALRCVDPDSEKRPKMSQVVRMLEAD 462 (508)
Q Consensus 421 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~ 462 (508)
.....+......+.+++.+||+.||++|||+.++++.|+..
T Consensus 222 -~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~~l~~~ 262 (263)
T cd05052 222 -YRMERPEGCPPKVYELMRACWQWNPSDRPSFAEIHQAFETM 262 (263)
T ss_pred -CCCCCCCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHhh
Confidence 01111122345677799999999999999999999999753
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays |
| >PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-41 Score=340.01 Aligned_cols=251 Identities=22% Similarity=0.272 Sum_probs=202.6
Q ss_pred hhCCcccceeEeeeCceEEEEEEEcC--CCEEEEEEEcccc---hhhHHHHHHHHHHHhcCCCCCceeEEEEEEeCceee
Q 010519 184 ATNRFSAENVLGEGGYGVVYKGRLIN--GSEVAVKKLLNNL---GQAEKEFRVEVEAIGHVRHKNLVRLLGYCIEGVHRM 258 (508)
Q Consensus 184 ~~~~~~~~~~lg~G~~g~Vy~~~~~~--~~~vavK~~~~~~---~~~~~~~~~ei~~l~~l~h~niv~~~~~~~~~~~~~ 258 (508)
..++|.+.+.||+|+||.||+|.+.+ +..||+|++.... ......+..|+.+++.++||||+++++++.+....+
T Consensus 28 ~~~~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~ 107 (340)
T PTZ00426 28 KYEDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKDESYLY 107 (340)
T ss_pred ChhhcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEEEeCCEEE
Confidence 34579999999999999999998653 3589999885432 223356788999999999999999999999999999
Q ss_pred EEEeecCCCCHHHHHhhhhccCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCEEEcCCCcEEEEecCCccc
Q 010519 259 LVYEYVNNGNLEQWLHGAMRNQGNLTWEARMKVIIGTAKALAYLHEAIEPKVVHRDIKSSNILIDDEFNAKVSDFGLAKL 338 (508)
Q Consensus 259 lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~Dfgla~~ 338 (508)
+||||+++|+|.+++. ....+++..+..++.|++.||.|||+. +|+||||||+|||++.++.+||+|||++..
T Consensus 108 lv~Ey~~~g~L~~~i~----~~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDLkp~NILl~~~~~ikL~DFG~a~~ 180 (340)
T PTZ00426 108 LVLEFVIGGEFFTFLR----RNKRFPNDVGCFYAAQIVLIFEYLQSL---NIVYRDLKPENLLLDKDGFIKMTDFGFAKV 180 (340)
T ss_pred EEEeCCCCCcHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEccCCCHHHEEECCCCCEEEecCCCCee
Confidence 9999999999999984 345789999999999999999999999 999999999999999999999999999986
Q ss_pred cCCCCCcccccccccccccCccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCCCchhcHHHHHHHHhccccccccc
Q 010519 339 LDSGESHITTRVMGTFGYVAPEYANTGMLNEKSDIYSFGVLLLEAVTGRDPVDYGRPANEVNLVEWLKMMVGTRRAEEVV 418 (508)
Q Consensus 339 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 418 (508)
.... .....||+.|+|||++.+..++.++|||||||++|||++|..||....+. ......... .
T Consensus 181 ~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~------~~~~~i~~~-~----- 244 (340)
T PTZ00426 181 VDTR----TYTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPFYANEPL------LIYQKILEG-I----- 244 (340)
T ss_pred cCCC----cceecCChhhcCHHHHhCCCCCccccccchhhHHHHHhcCCCCCCCCCHH------HHHHHHhcC-C-----
Confidence 5432 23457899999999999988999999999999999999999999643221 111111111 0
Q ss_pred CCCCCCChhHHHHHHHHHHHHHhcCCCCCCCC-----CHHHHHHHhhcC
Q 010519 419 DPNLEVKPATRALKRSLLVALRCVDPDSEKRP-----KMSQVVRMLEAD 462 (508)
Q Consensus 419 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~evl~~L~~~ 462 (508)
... +......+.+++.+||+.||.+|+ ++++++++-+-.
T Consensus 245 ---~~~--p~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~~~hp~f~ 288 (340)
T PTZ00426 245 ---IYF--PKFLDNNCKHLMKKLLSHDLTKRYGNLKKGAQNVKEHPWFG 288 (340)
T ss_pred ---CCC--CCCCCHHHHHHHHHHcccCHHHcCCCCCCCHHHHHcCCCcC
Confidence 000 111223456699999999999995 899999875543
|
|
| >cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-40 Score=327.79 Aligned_cols=262 Identities=24% Similarity=0.343 Sum_probs=200.2
Q ss_pred CCcccceeEeeeCceEEEEEEEc-CCCEEEEEEEcccc-hhhHHHHHHHHHHHhcCCCCCceeEEEEEEeCceeeEEEee
Q 010519 186 NRFSAENVLGEGGYGVVYKGRLI-NGSEVAVKKLLNNL-GQAEKEFRVEVEAIGHVRHKNLVRLLGYCIEGVHRMLVYEY 263 (508)
Q Consensus 186 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~ei~~l~~l~h~niv~~~~~~~~~~~~~lv~E~ 263 (508)
++|.+.+.||.|+||+||+|... ++..||+|.+.... ......+.+|+.+++.++||||+++++++......++||||
T Consensus 5 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 84 (288)
T cd07871 5 ETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDIIHTERCLTLVFEY 84 (288)
T ss_pred ccceEeeEEecCCCEEEEEEEECCCCCEEEEEEecccccCCcchhHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEEEeC
Confidence 47999999999999999999875 68899999886432 22334677899999999999999999999999999999999
Q ss_pred cCCCCHHHHHhhhhccCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCEEEcCCCcEEEEecCCccccCCCC
Q 010519 264 VNNGNLEQWLHGAMRNQGNLTWEARMKVIIGTAKALAYLHEAIEPKVVHRDIKSSNILIDDEFNAKVSDFGLAKLLDSGE 343 (508)
Q Consensus 264 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~~~ 343 (508)
+++ +|.+++.. ....+++..+..++.||+.||.|||++ +|+||||||+|||+++++.+||+|||+++......
T Consensus 85 ~~~-~l~~~l~~---~~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~dlkp~Nil~~~~~~~kl~DfG~~~~~~~~~ 157 (288)
T cd07871 85 LDS-DLKQYLDN---CGNLMSMHNVKIFMFQLLRGLSYCHKR---KILHRDLKPQNLLINEKGELKLADFGLARAKSVPT 157 (288)
T ss_pred CCc-CHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEECCCCCEEECcCcceeeccCCC
Confidence 975 99998852 344678899999999999999999999 99999999999999999999999999997654322
Q ss_pred CcccccccccccccCccccCC-CCCCChhhHHHHHHHHHHHHhCCCCCCCCCCCchhcHHHHHHHHhccc----------
Q 010519 344 SHITTRVMGTFGYVAPEYANT-GMLNEKSDIYSFGVLLLEAVTGRDPVDYGRPANEVNLVEWLKMMVGTR---------- 412 (508)
Q Consensus 344 ~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwS~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~---------- 412 (508)
. ......+++.|+|||++.+ ..++.++|||||||++|+|++|+.||......... .......+..
T Consensus 158 ~-~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~ 233 (288)
T cd07871 158 K-TYSNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEEL---HLIFRLLGTPTEETWPGITS 233 (288)
T ss_pred c-cccCceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHH---HHHHHHhCCCChHHhhcccc
Confidence 1 2234467999999998865 56899999999999999999999999644322111 1111111110
Q ss_pred --ccccccCCCCCCCh----hHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 010519 413 --RAEEVVDPNLEVKP----ATRALKRSLLVALRCVDPDSEKRPKMSQVVRM 458 (508)
Q Consensus 413 --~~~~~~~~~~~~~~----~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 458 (508)
.......+.....+ .........+|+.+||..||.+|||++|+++|
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dp~~R~t~~~~l~h 285 (288)
T cd07871 234 NEEFRSYLFPQYRAQPLINHAPRLDTDGIDLLSSLLLYETKSRISAEAALRH 285 (288)
T ss_pred chhhhccccCccCCCchHHhCCCCCHHHHHHHHHhcCcCcccCCCHHHHhcC
Confidence 00001111111101 01123456789999999999999999999975
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament |
| >cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-40 Score=340.30 Aligned_cols=257 Identities=24% Similarity=0.324 Sum_probs=202.5
Q ss_pred CCcccceeEeeeCceEEEEEEEc-CCCEEEEEEEcccc---hhhHHHHHHHHHHHhcCCCCCceeEEEEEEeCceeeEEE
Q 010519 186 NRFSAENVLGEGGYGVVYKGRLI-NGSEVAVKKLLNNL---GQAEKEFRVEVEAIGHVRHKNLVRLLGYCIEGVHRMLVY 261 (508)
Q Consensus 186 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~ei~~l~~l~h~niv~~~~~~~~~~~~~lv~ 261 (508)
++|++.+.||+|+||+||+|++. +++.||||++.... ......+..|+.++..++||||+++++++.+....++||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~ 80 (364)
T cd05599 1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSFQDENYLYLIM 80 (364)
T ss_pred CCceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCeEEEEE
Confidence 47899999999999999999875 68899999986432 223356788999999999999999999999999999999
Q ss_pred eecCCCCHHHHHhhhhccCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCEEEcCCCcEEEEecCCccccCC
Q 010519 262 EYVNNGNLEQWLHGAMRNQGNLTWEARMKVIIGTAKALAYLHEAIEPKVVHRDIKSSNILIDDEFNAKVSDFGLAKLLDS 341 (508)
Q Consensus 262 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~ 341 (508)
||+++|+|.+++. ..+.+++..+..++.||+.||.|||+. +|+||||||+|||++.++.+||+|||++..+..
T Consensus 81 E~~~~g~L~~~l~----~~~~l~~~~~~~~~~qi~~aL~~lH~~---~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~ 153 (364)
T cd05599 81 EYLPGGDMMTLLM----KKDTFTEEETRFYIAETILAIDSIHKL---GYIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKK 153 (364)
T ss_pred CCCCCcHHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCCHHHeEECCCCCEEEeecccceeccc
Confidence 9999999999985 345789999999999999999999999 999999999999999999999999999875432
Q ss_pred CCCc-------------------------------------ccccccccccccCccccCCCCCCChhhHHHHHHHHHHHH
Q 010519 342 GESH-------------------------------------ITTRVMGTFGYVAPEYANTGMLNEKSDIYSFGVLLLEAV 384 (508)
Q Consensus 342 ~~~~-------------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~ell 384 (508)
.... .....+||+.|+|||++.+..++.++|||||||++|||+
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~ 233 (364)
T cd05599 154 SHRTEFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEML 233 (364)
T ss_pred cccccccccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcCCCCCCeeeeecchhHHHHhh
Confidence 1100 011246999999999999999999999999999999999
Q ss_pred hCCCCCCCCCCCchhcHHHHHHHHhcccccccccCCCCCCChhHHHHHHHHHHHHHhcCCCCCCCCC---HHHHHHHhhc
Q 010519 385 TGRDPVDYGRPANEVNLVEWLKMMVGTRRAEEVVDPNLEVKPATRALKRSLLVALRCVDPDSEKRPK---MSQVVRMLEA 461 (508)
Q Consensus 385 tG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs---~~evl~~L~~ 461 (508)
+|..||...... +......... ..+..+........+.+++.+|+. +|.+|++ +.+++++-.-
T Consensus 234 ~G~~Pf~~~~~~------~~~~~i~~~~-------~~~~~~~~~~~s~~~~~li~~ll~-~p~~R~~~~~~~~ll~h~~~ 299 (364)
T cd05599 234 VGYPPFCSDNPQ------ETYRKIINWK-------ETLQFPDEVPLSPEAKDLIKRLCC-EAERRLGNNGVNEIKSHPFF 299 (364)
T ss_pred cCCCCCCCCCHH------HHHHHHHcCC-------CccCCCCCCCCCHHHHHHHHHHcc-CHhhcCCCCCHHHHhcCCCc
Confidence 999999643321 1111221111 011111111123455668888996 9999998 9999987654
Q ss_pred CC
Q 010519 462 DD 463 (508)
Q Consensus 462 ~~ 463 (508)
..
T Consensus 300 ~~ 301 (364)
T cd05599 300 KG 301 (364)
T ss_pred CC
Confidence 33
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica |
| >cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-40 Score=335.00 Aligned_cols=244 Identities=25% Similarity=0.284 Sum_probs=196.3
Q ss_pred eeEeeeCceEEEEEEEc-CCCEEEEEEEcccc---hhhHHHHHHHHHHHhcCCCCCceeEEEEEEeCceeeEEEeecCCC
Q 010519 192 NVLGEGGYGVVYKGRLI-NGSEVAVKKLLNNL---GQAEKEFRVEVEAIGHVRHKNLVRLLGYCIEGVHRMLVYEYVNNG 267 (508)
Q Consensus 192 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~ei~~l~~l~h~niv~~~~~~~~~~~~~lv~E~~~~g 267 (508)
+.||+|+||.||+++.. +|..||+|++.... ......+..|+.+++.++||||+++++++......++||||+++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 80 (323)
T cd05595 1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGG 80 (323)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEEecCCEEEEEEeCCCCC
Confidence 46999999999999874 68899999986542 223345677999999999999999999999999999999999999
Q ss_pred CHHHHHhhhhccCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCEEEcCCCcEEEEecCCccccCCCCCccc
Q 010519 268 NLEQWLHGAMRNQGNLTWEARMKVIIGTAKALAYLHEAIEPKVVHRDIKSSNILIDDEFNAKVSDFGLAKLLDSGESHIT 347 (508)
Q Consensus 268 sL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~~ 347 (508)
+|..++. ....+++..++.++.||+.||.|||++ +|+||||||+|||++.++.+||+|||++....... ...
T Consensus 81 ~L~~~l~----~~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~-~~~ 152 (323)
T cd05595 81 ELFFHLS----RERVFTEERARFYGAEIVSALEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDG-ATM 152 (323)
T ss_pred cHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHEEEcCCCCEEecccHHhccccCCC-Ccc
Confidence 9998884 345789999999999999999999999 99999999999999999999999999987532221 123
Q ss_pred ccccccccccCccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCCCchhcHHHHHHHHhcccccccccCCCCCCChh
Q 010519 348 TRVMGTFGYVAPEYANTGMLNEKSDIYSFGVLLLEAVTGRDPVDYGRPANEVNLVEWLKMMVGTRRAEEVVDPNLEVKPA 427 (508)
Q Consensus 348 ~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 427 (508)
....||+.|+|||++.+..++.++|||||||++|||++|+.||...... ......... .... +
T Consensus 153 ~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~------~~~~~~~~~---------~~~~--p 215 (323)
T cd05595 153 KTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE------RLFELILME---------EIRF--P 215 (323)
T ss_pred ccccCCcCcCCcccccCCCCCchhchhhhHHHHHHHHhCCCCCCCCCHH------HHHHHHhcC---------CCCC--C
Confidence 3457899999999999999999999999999999999999999643221 111111110 0000 1
Q ss_pred HHHHHHHHHHHHHhcCCCCCCCC-----CHHHHHHHhh
Q 010519 428 TRALKRSLLVALRCVDPDSEKRP-----KMSQVVRMLE 460 (508)
Q Consensus 428 ~~~~~~l~~li~~cl~~dP~~RP-----s~~evl~~L~ 460 (508)
......+.+++.+||+.||.+|| ++.+++++-+
T Consensus 216 ~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~l~h~~ 253 (323)
T cd05595 216 RTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRF 253 (323)
T ss_pred CCCCHHHHHHHHHHccCCHHHhCCCCCCCHHHHHcCCC
Confidence 11234566799999999999998 8999988653
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in |
| >cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-40 Score=323.07 Aligned_cols=252 Identities=26% Similarity=0.416 Sum_probs=202.6
Q ss_pred CCcccceeEeeeCceEEEEEEEcCCCEEEEEEEcccchhhHHHHHHHHHHHhcCCCCCceeEEEEEEeCceeeEEEeecC
Q 010519 186 NRFSAENVLGEGGYGVVYKGRLINGSEVAVKKLLNNLGQAEKEFRVEVEAIGHVRHKNLVRLLGYCIEGVHRMLVYEYVN 265 (508)
Q Consensus 186 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~ei~~l~~l~h~niv~~~~~~~~~~~~~lv~E~~~ 265 (508)
++|.+.+.||+|+||+||+|.+.++..+|+|.+.... .....+..|+.++++++||||+++++++.+....++||||+.
T Consensus 4 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~aik~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 82 (256)
T cd05113 4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGS-MSEDEFIEEAKVMMKLSHEKLVQLYGVCTKQRPIYIVTEYMS 82 (256)
T ss_pred HHeEEeeEecCcccceEEEEEecCCCcEEEEEcCCCc-ccHHHHHHHHHHHhcCCCCCeeeEEEEEccCCCcEEEEEcCC
Confidence 4688899999999999999988777789999876443 334668889999999999999999999998888999999999
Q ss_pred CCCHHHHHhhhhccCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCEEEcCCCcEEEEecCCccccCCCCCc
Q 010519 266 NGNLEQWLHGAMRNQGNLTWEARMKVIIGTAKALAYLHEAIEPKVVHRDIKSSNILIDDEFNAKVSDFGLAKLLDSGESH 345 (508)
Q Consensus 266 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~ 345 (508)
+|+|.+++.. ....+++..++.++.||+.||.|||+. +++|+||||+|||+++++.+||+|||++.........
T Consensus 83 ~~~l~~~i~~---~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~nili~~~~~~kl~d~g~~~~~~~~~~~ 156 (256)
T cd05113 83 NGCLLNYLRE---HGKRFQPSQLLEMCKDVCEGMAYLESK---QFIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDEYT 156 (256)
T ss_pred CCcHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccccCcceEEEcCCCCEEECCCccceecCCCcee
Confidence 9999999863 234689999999999999999999998 9999999999999999999999999999866443322
Q ss_pred ccccccccccccCccccCCCCCCChhhHHHHHHHHHHHHh-CCCCCCCCCCCchhcHHHHHHHHhcccccccccCCCCCC
Q 010519 346 ITTRVMGTFGYVAPEYANTGMLNEKSDIYSFGVLLLEAVT-GRDPVDYGRPANEVNLVEWLKMMVGTRRAEEVVDPNLEV 424 (508)
Q Consensus 346 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 424 (508)
......++..|+|||.+.+..++.++|||||||++|+|++ |..||...... ........... ..
T Consensus 157 ~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~------~~~~~~~~~~~------~~--- 221 (256)
T cd05113 157 SSVGSKFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYERFNNS------ETVEKVSQGLR------LY--- 221 (256)
T ss_pred ecCCCccChhhCCHHHHhcCcccchhHHHHHHHHHHHHhcCCCCCcCcCCHH------HHHHHHhcCCC------CC---
Confidence 2222335678999999998889999999999999999998 99998643211 11111111111 00
Q ss_pred ChhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhh
Q 010519 425 KPATRALKRSLLVALRCVDPDSEKRPKMSQVVRMLE 460 (508)
Q Consensus 425 ~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 460 (508)
........+.+++.+||+.||.+|||+.+++..|+
T Consensus 222 -~~~~~~~~~~~li~~cl~~~p~~Rp~~~~ll~~~~ 256 (256)
T cd05113 222 -RPHLASEKVYAIMYSCWHEKAEERPTFQQLLSSIE 256 (256)
T ss_pred -CCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHhhC
Confidence 01112356677999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds |
| >cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-41 Score=339.31 Aligned_cols=255 Identities=23% Similarity=0.281 Sum_probs=204.2
Q ss_pred CCcccceeEeeeCceEEEEEEEc-CCCEEEEEEEcccch---hhHHHHHHHHHHHhcCCCCCceeEEEEEEeCceeeEEE
Q 010519 186 NRFSAENVLGEGGYGVVYKGRLI-NGSEVAVKKLLNNLG---QAEKEFRVEVEAIGHVRHKNLVRLLGYCIEGVHRMLVY 261 (508)
Q Consensus 186 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~ei~~l~~l~h~niv~~~~~~~~~~~~~lv~ 261 (508)
++|.+.+.||+|+||+||++... +++.+|+|++..... .....+..|+.+++.++||||+++++++.+....++||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (330)
T cd05601 1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQDKDNLYLVM 80 (330)
T ss_pred CCceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEEecCCeEEEEE
Confidence 47899999999999999999875 688999999865432 23456888999999999999999999999999999999
Q ss_pred eecCCCCHHHHHhhhhccCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCEEEcCCCcEEEEecCCccccCC
Q 010519 262 EYVNNGNLEQWLHGAMRNQGNLTWEARMKVIIGTAKALAYLHEAIEPKVVHRDIKSSNILIDDEFNAKVSDFGLAKLLDS 341 (508)
Q Consensus 262 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~ 341 (508)
||+++|+|.+++.. ....+++..+..++.||+.||.|||+. +|+||||||+|||++.++.+||+|||++.....
T Consensus 81 e~~~~~~L~~~l~~---~~~~l~~~~~~~~~~qi~~aL~~lH~~---~i~H~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~ 154 (330)
T cd05601 81 EYQPGGDLLSLLNR---YEDQFDEDMAQFYLAELVLAIHSVHQM---GYVHRDIKPENVLIDRTGHIKLADFGSAARLTA 154 (330)
T ss_pred CCCCCCCHHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEcccCchHheEECCCCCEEeccCCCCeECCC
Confidence 99999999999863 345789999999999999999999999 999999999999999999999999999987654
Q ss_pred CCCcccccccccccccCccccC------CCCCCChhhHHHHHHHHHHHHhCCCCCCCCCCCchhcHHHHHHHHhcccccc
Q 010519 342 GESHITTRVMGTFGYVAPEYAN------TGMLNEKSDIYSFGVLLLEAVTGRDPVDYGRPANEVNLVEWLKMMVGTRRAE 415 (508)
Q Consensus 342 ~~~~~~~~~~gt~~y~aPE~~~------~~~~~~~~DvwS~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~ 415 (508)
..........||+.|+|||++. +..++.++|||||||+||||++|+.||...... ...........
T Consensus 155 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~------~~~~~i~~~~~-- 226 (330)
T cd05601 155 NKMVNSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSA------KTYNNIMNFQR-- 226 (330)
T ss_pred CCceeeecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCCCHH------HHHHHHHcCCC--
Confidence 4333333457899999999986 456889999999999999999999999644321 11222211111
Q ss_pred cccCCCCCCChhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhh
Q 010519 416 EVVDPNLEVKPATRALKRSLLVALRCVDPDSEKRPKMSQVVRMLE 460 (508)
Q Consensus 416 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 460 (508)
.+..+........+.+|+..||. ||.+|||+.+++.+-.
T Consensus 227 -----~~~~~~~~~~~~~~~~li~~ll~-~p~~R~t~~~l~~h~~ 265 (330)
T cd05601 227 -----FLKFPEDPKVSSDFLDLIQSLLC-GQKERLGYEGLCCHPF 265 (330)
T ss_pred -----ccCCCCCCCCCHHHHHHHHHHcc-ChhhCCCHHHHhCCCC
Confidence 01111111234456678889998 9999999999998644
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor |
| >cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-40 Score=335.35 Aligned_cols=245 Identities=24% Similarity=0.279 Sum_probs=197.6
Q ss_pred eeEeeeCceEEEEEEEc-CCCEEEEEEEcccc---hhhHHHHHHHHHHHhcCCCCCceeEEEEEEeCceeeEEEeecCCC
Q 010519 192 NVLGEGGYGVVYKGRLI-NGSEVAVKKLLNNL---GQAEKEFRVEVEAIGHVRHKNLVRLLGYCIEGVHRMLVYEYVNNG 267 (508)
Q Consensus 192 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~ei~~l~~l~h~niv~~~~~~~~~~~~~lv~E~~~~g 267 (508)
+.||+|+||.||++... ++..||+|++.... ......+..|+.+++.++||||+++++++......++||||+++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~Ey~~~g 80 (328)
T cd05593 1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTKDRLCFVMEYVNGG 80 (328)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCEEEEEEeCCCCC
Confidence 46999999999999875 68899999986542 223356778999999999999999999999999999999999999
Q ss_pred CHHHHHhhhhccCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCEEEcCCCcEEEEecCCccccCCCCCccc
Q 010519 268 NLEQWLHGAMRNQGNLTWEARMKVIIGTAKALAYLHEAIEPKVVHRDIKSSNILIDDEFNAKVSDFGLAKLLDSGESHIT 347 (508)
Q Consensus 268 sL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~~ 347 (508)
+|.+++. ....+++..+..++.||+.||.|||++ +|+||||||+|||++.++.+||+|||+++...... ...
T Consensus 81 ~L~~~l~----~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDikp~NIll~~~~~~kL~DfG~~~~~~~~~-~~~ 152 (328)
T cd05593 81 ELFFHLS----RERVFSEDRTRFYGAEIVSALDYLHSG---KIVYRDLKLENLMLDKDGHIKITDFGLCKEGITDA-ATM 152 (328)
T ss_pred CHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHhC---CeEecccCHHHeEECCCCcEEEecCcCCccCCCcc-ccc
Confidence 9999884 345789999999999999999999999 99999999999999999999999999987543221 123
Q ss_pred ccccccccccCccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCCCchhcHHHHHHHHhcccccccccCCCCCCChh
Q 010519 348 TRVMGTFGYVAPEYANTGMLNEKSDIYSFGVLLLEAVTGRDPVDYGRPANEVNLVEWLKMMVGTRRAEEVVDPNLEVKPA 427 (508)
Q Consensus 348 ~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 427 (508)
...+||+.|+|||++.+..++.++|||||||+||+|++|+.||..... .......... . ..+ +
T Consensus 153 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~------~~~~~~~~~~-~------~~~----p 215 (328)
T cd05593 153 KTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH------EKLFELILME-D------IKF----P 215 (328)
T ss_pred ccccCCcCccChhhhcCCCCCccCCccccchHHHHHhhCCCCCCCCCH------HHHHHHhccC-C------ccC----C
Confidence 345799999999999999999999999999999999999999964321 1111111110 0 011 1
Q ss_pred HHHHHHHHHHHHHhcCCCCCCCC-----CHHHHHHHhhc
Q 010519 428 TRALKRSLLVALRCVDPDSEKRP-----KMSQVVRMLEA 461 (508)
Q Consensus 428 ~~~~~~l~~li~~cl~~dP~~RP-----s~~evl~~L~~ 461 (508)
......+.+++.+||+.||.+|| ++.+++++.+-
T Consensus 216 ~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h~~~ 254 (328)
T cd05593 216 RTLSADAKSLLSGLLIKDPNKRLGGGPDDAKEIMRHSFF 254 (328)
T ss_pred CCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHhcCCCc
Confidence 11234566799999999999997 89999987543
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate |
| >PHA03212 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-40 Score=339.76 Aligned_cols=262 Identities=19% Similarity=0.238 Sum_probs=200.4
Q ss_pred hhCCcccceeEeeeCceEEEEEEEc-CCCEEEEEEEcccchhhHHHHHHHHHHHhcCCCCCceeEEEEEEeCceeeEEEe
Q 010519 184 ATNRFSAENVLGEGGYGVVYKGRLI-NGSEVAVKKLLNNLGQAEKEFRVEVEAIGHVRHKNLVRLLGYCIEGVHRMLVYE 262 (508)
Q Consensus 184 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~ei~~l~~l~h~niv~~~~~~~~~~~~~lv~E 262 (508)
...+|.+.+.||+|+||.||++.+. .++.||+|+.. ...+.+|+.++++++||||+++++++......++|+|
T Consensus 90 ~~~~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~------~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~e 163 (391)
T PHA03212 90 EKAGFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQ------RGGTATEAHILRAINHPSIIQLKGTFTYNKFTCLILP 163 (391)
T ss_pred ccCCcEEEEEEcCCCCeEEEEEEECCCCCEEEEechh------hhhhHHHHHHHHhCCCCCCCCEeEEEEECCeeEEEEe
Confidence 4468999999999999999999874 67889999643 2346679999999999999999999999999999999
Q ss_pred ecCCCCHHHHHhhhhccCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCEEEcCCCcEEEEecCCccccCCC
Q 010519 263 YVNNGNLEQWLHGAMRNQGNLTWEARMKVIIGTAKALAYLHEAIEPKVVHRDIKSSNILIDDEFNAKVSDFGLAKLLDSG 342 (508)
Q Consensus 263 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~~ 342 (508)
++. ++|..++. ....+++..++.++.||+.||.|||++ +|+||||||+|||++.++.+||+|||++......
T Consensus 164 ~~~-~~L~~~l~----~~~~l~~~~~~~i~~qi~~aL~ylH~~---~IvHrDiKP~NIll~~~~~vkL~DFG~a~~~~~~ 235 (391)
T PHA03212 164 RYK-TDLYCYLA----AKRNIAICDILAIERSVLRAIQYLHEN---RIIHRDIKAENIFINHPGDVCLGDFGAACFPVDI 235 (391)
T ss_pred cCC-CCHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCChHhEEEcCCCCEEEEeCCcccccccc
Confidence 995 68988884 345688999999999999999999998 9999999999999999999999999999754332
Q ss_pred CCcccccccccccccCccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCCCc-----hhcHHHHHHHHhcccccc--
Q 010519 343 ESHITTRVMGTFGYVAPEYANTGMLNEKSDIYSFGVLLLEAVTGRDPVDYGRPAN-----EVNLVEWLKMMVGTRRAE-- 415 (508)
Q Consensus 343 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltG~~Pf~~~~~~~-----~~~~~~~~~~~~~~~~~~-- 415 (508)
.........||+.|+|||++.+..++.++|||||||+||||++|+.||....... ...+...+. ..+.....
T Consensus 236 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~l~~i~~-~~g~~p~~~~ 314 (391)
T PHA03212 236 NANKYYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIKLIIR-RSGTHPNEFP 314 (391)
T ss_pred cccccccccCccCCCChhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCcCCcccccccCchhHHHHHHHH-HhcCChhhcC
Confidence 2223345679999999999999999999999999999999999998874332111 011111110 00000000
Q ss_pred -----------------cccCCCCC--CChhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhh
Q 010519 416 -----------------EVVDPNLE--VKPATRALKRSLLVALRCVDPDSEKRPKMSQVVRMLE 460 (508)
Q Consensus 416 -----------------~~~~~~~~--~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 460 (508)
....+... ..........+.+|+.+||+.||.+|||+.|++++-.
T Consensus 315 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~mL~~dP~~Rpta~elL~hp~ 378 (391)
T PHA03212 315 IDAQANLDEIYIGLAKKSSRKPGSRPLWTNLYELPIDLEYLICKMLAFDAHHRPSAEALLDFAA 378 (391)
T ss_pred cchhHHHHHHHHHHHhccCCCCCCCCCHHHHhhhhhhHHHHHHHHhcCChhhCCCHHHHhcChh
Confidence 00000000 0111223456778999999999999999999997654
|
|
| >cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-40 Score=336.30 Aligned_cols=201 Identities=28% Similarity=0.417 Sum_probs=174.6
Q ss_pred hhCCcccceeEeeeCceEEEEEEEc-CCCEEEEEEEcccc-hhhHHHHHHHHHHHhcCCCCCceeEEEEEEeCceeeEEE
Q 010519 184 ATNRFSAENVLGEGGYGVVYKGRLI-NGSEVAVKKLLNNL-GQAEKEFRVEVEAIGHVRHKNLVRLLGYCIEGVHRMLVY 261 (508)
Q Consensus 184 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~ei~~l~~l~h~niv~~~~~~~~~~~~~lv~ 261 (508)
..++|++.+.||+|+||.||++.+. ++..+|+|.+.... ......+..|+++++.++||||++++++|.+.+..++||
T Consensus 3 ~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 82 (333)
T cd06650 3 KDDDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICM 82 (333)
T ss_pred chhhhheeccccCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCcccceeEEEEECCEEEEEE
Confidence 4578999999999999999999886 57778888776543 233456889999999999999999999999999999999
Q ss_pred eecCCCCHHHHHhhhhccCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCEEEcCCCcEEEEecCCccccCC
Q 010519 262 EYVNNGNLEQWLHGAMRNQGNLTWEARMKVIIGTAKALAYLHEAIEPKVVHRDIKSSNILIDDEFNAKVSDFGLAKLLDS 341 (508)
Q Consensus 262 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~ 341 (508)
||+++|+|.+++. ..+.+++..+..++.+++.||.|||+.. +++|+||||+|||+++++.+||+|||++.....
T Consensus 83 e~~~~~~L~~~l~----~~~~~~~~~~~~~~~~l~~~l~~lH~~~--~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~ 156 (333)
T cd06650 83 EHMDGGSLDQVLK----KAGRIPEQILGKVSIAVIKGLTYLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLID 156 (333)
T ss_pred ecCCCCcHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHhcC--CEEecCCChhhEEEcCCCCEEEeeCCcchhhhh
Confidence 9999999999984 3456888999999999999999999741 699999999999999999999999999976533
Q ss_pred CCCcccccccccccccCccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCC
Q 010519 342 GESHITTRVMGTFGYVAPEYANTGMLNEKSDIYSFGVLLLEAVTGRDPVDYG 393 (508)
Q Consensus 342 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltG~~Pf~~~ 393 (508)
. ......|+..|+|||++.+..++.++|||||||++|+|++|+.||...
T Consensus 157 ~---~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~ 205 (333)
T cd06650 157 S---MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPIPPP 205 (333)
T ss_pred h---ccccCCCCccccCHHHhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCc
Confidence 2 123346899999999999989999999999999999999999999644
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst |
| >KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-41 Score=343.93 Aligned_cols=246 Identities=26% Similarity=0.328 Sum_probs=200.4
Q ss_pred HHHhhCCcccceeEeeeCceEEEEEEEc-CCCEEEEEEEcccc---hhhHHHHHHHHHHHhcC-CCCCceeEEEEEEeCc
Q 010519 181 LEIATNRFSAENVLGEGGYGVVYKGRLI-NGSEVAVKKLLNNL---GQAEKEFRVEVEAIGHV-RHKNLVRLLGYCIEGV 255 (508)
Q Consensus 181 ~~~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~ei~~l~~l-~h~niv~~~~~~~~~~ 255 (508)
..+.-++|.+.++||+|.||+|+++..+ +++.+|||.+.+.. ....+....|..++... +||++++++..|+...
T Consensus 363 ~~~~l~~F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT~~ 442 (694)
T KOG0694|consen 363 GPLTLDDFRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCFQTKE 442 (694)
T ss_pred CcccccceEEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeecccccccCC
Confidence 3456679999999999999999999886 57789999987654 23335566677777666 5999999999999999
Q ss_pred eeeEEEeecCCCCHHHHHhhhhccCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCEEEcCCCcEEEEecCC
Q 010519 256 HRMLVYEYVNNGNLEQWLHGAMRNQGNLTWEARMKVIIGTAKALAYLHEAIEPKVVHRDIKSSNILIDDEFNAKVSDFGL 335 (508)
Q Consensus 256 ~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~Dfgl 335 (508)
++|+||||+.||++..+ ...+.+++..+.-++..|+.||+|||++ +|||||||.+|||||.+|++||+|||+
T Consensus 443 ~l~fvmey~~Ggdm~~~-----~~~~~F~e~rarfyaAev~l~L~fLH~~---~IIYRDlKLdNiLLD~eGh~kiADFGl 514 (694)
T KOG0694|consen 443 HLFFVMEYVAGGDLMHH-----IHTDVFSEPRARFYAAEVVLGLQFLHEN---GIIYRDLKLDNLLLDTEGHVKIADFGL 514 (694)
T ss_pred eEEEEEEecCCCcEEEE-----EecccccHHHHHHHHHHHHHHHHHHHhc---CceeeecchhheEEcccCcEEeccccc
Confidence 99999999999994443 4557899999999999999999999999 999999999999999999999999999
Q ss_pred ccccCCCCCcccccccccccccCccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCCCchhcHHHHHHHHhcccccc
Q 010519 336 AKLLDSGESHITTRVMGTFGYVAPEYANTGMLNEKSDIYSFGVLLLEAVTGRDPVDYGRPANEVNLVEWLKMMVGTRRAE 415 (508)
Q Consensus 336 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~ 415 (508)
++..--.. ..+..++|||.|||||++.+..|+.++|+|+|||+||||+.|..||...+..+ .+..+.. .
T Consensus 515 cKe~m~~g-~~TsTfCGTpey~aPEil~e~~Yt~aVDWW~lGVLlyeML~Gq~PF~gddEee------~FdsI~~----d 583 (694)
T KOG0694|consen 515 CKEGMGQG-DRTSTFCGTPEFLAPEVLTEQSYTRAVDWWGLGVLLYEMLVGESPFPGDDEEE------VFDSIVN----D 583 (694)
T ss_pred ccccCCCC-CccccccCChhhcChhhhccCcccchhhHHHHHHHHHHHHcCCCCCCCCCHHH------HHHHHhc----C
Confidence 99643222 24677899999999999999999999999999999999999999997443221 1211111 1
Q ss_pred cccCCCCCCChhHHHHHHHHHHHHHhcCCCCCCCCCH
Q 010519 416 EVVDPNLEVKPATRALKRSLLVALRCVDPDSEKRPKM 452 (508)
Q Consensus 416 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~ 452 (508)
+.. .+.....+.+.++.++|.+||.+|.-+
T Consensus 584 ~~~-------yP~~ls~ea~~il~~ll~k~p~kRLG~ 613 (694)
T KOG0694|consen 584 EVR-------YPRFLSKEAIAIMRRLLRKNPEKRLGS 613 (694)
T ss_pred CCC-------CCCcccHHHHHHHHHHhccCcccccCC
Confidence 111 122345667779999999999999865
|
|
| >cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-40 Score=326.50 Aligned_cols=257 Identities=28% Similarity=0.510 Sum_probs=204.6
Q ss_pred CCcccceeEeeeCceEEEEEEEcCC------CEEEEEEEcccc-hhhHHHHHHHHHHHhcCCCCCceeEEEEEEeCceee
Q 010519 186 NRFSAENVLGEGGYGVVYKGRLING------SEVAVKKLLNNL-GQAEKEFRVEVEAIGHVRHKNLVRLLGYCIEGVHRM 258 (508)
Q Consensus 186 ~~~~~~~~lg~G~~g~Vy~~~~~~~------~~vavK~~~~~~-~~~~~~~~~ei~~l~~l~h~niv~~~~~~~~~~~~~ 258 (508)
++|++.+.||+|+||.||+|.+... ..|++|.+.... ......+.+|+..+..++||||+++++++......+
T Consensus 5 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~ 84 (283)
T cd05048 5 SAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVCLLGVCTKEQPTC 84 (283)
T ss_pred HHcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCCCHHHHHHHHHHHHHHHhcCCcccceEEEEEcCCCceE
Confidence 4788899999999999999986432 468999886443 233467889999999999999999999999988999
Q ss_pred EEEeecCCCCHHHHHhhhhcc------------CCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCEEEcCCC
Q 010519 259 LVYEYVNNGNLEQWLHGAMRN------------QGNLTWEARMKVIIGTAKALAYLHEAIEPKVVHRDIKSSNILIDDEF 326 (508)
Q Consensus 259 lv~E~~~~gsL~~~l~~~~~~------------~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiH~Dlk~~NIll~~~~ 326 (508)
++|||+++|+|.+++...... ...+++..++.++.|++.||.|||+. +++|+||||+||++++++
T Consensus 85 ~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~~---~i~H~dlkp~Nil~~~~~ 161 (283)
T cd05048 85 MLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSH---HFVHRDLAARNCLVGEGL 161 (283)
T ss_pred EEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccccccceEEEcCCC
Confidence 999999999999999643111 14578899999999999999999999 999999999999999999
Q ss_pred cEEEEecCCccccCCCCC-cccccccccccccCccccCCCCCCChhhHHHHHHHHHHHHh-CCCCCCCCCCCchhcHHHH
Q 010519 327 NAKVSDFGLAKLLDSGES-HITTRVMGTFGYVAPEYANTGMLNEKSDIYSFGVLLLEAVT-GRDPVDYGRPANEVNLVEW 404 (508)
Q Consensus 327 ~~kl~Dfgla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~ellt-G~~Pf~~~~~~~~~~~~~~ 404 (508)
.+||+|||++........ .......+++.|+|||.+.+..++.++|||||||++|||++ |..||...... ....
T Consensus 162 ~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~slG~il~el~~~g~~p~~~~~~~---~~~~- 237 (283)
T cd05048 162 TVKISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPYYGFSNQ---EVIE- 237 (283)
T ss_pred cEEECCCcceeeccccccccccCCCcccccccCHHHhccCcCchhhhHHHHHHHHHHHHcCCCCCCCCCCHH---HHHH-
Confidence 999999999986533221 22333456889999999988899999999999999999998 99998643221 1111
Q ss_pred HHHHhcccccccccCCCCCCChhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhhc
Q 010519 405 LKMMVGTRRAEEVVDPNLEVKPATRALKRSLLVALRCVDPDSEKRPKMSQVVRMLEA 461 (508)
Q Consensus 405 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~ 461 (508)
... .... ...+...+..+.+|+.+||+.||.+||++.+|+++|+.
T Consensus 238 --~i~-~~~~---------~~~~~~~~~~~~~l~~~c~~~~p~~Rp~~~~i~~~l~~ 282 (283)
T cd05048 238 --MIR-SRQL---------LPCPEDCPARVYALMIECWNEIPARRPRFKDIHTRLRS 282 (283)
T ss_pred --HHH-cCCc---------CCCcccCCHHHHHHHHHHccCChhhCcCHHHHHHHHhc
Confidence 111 1110 01122345667789999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer |
| >KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-40 Score=314.02 Aligned_cols=270 Identities=22% Similarity=0.288 Sum_probs=209.0
Q ss_pred CCcccceeEeeeCceEEEEEEEc-CCCEEEEEEEcccchhh--HHHHHHHHHHHhcCCCCCceeEEEEEEeC--ceeeEE
Q 010519 186 NRFSAENVLGEGGYGVVYKGRLI-NGSEVAVKKLLNNLGQA--EKEFRVEVEAIGHVRHKNLVRLLGYCIEG--VHRMLV 260 (508)
Q Consensus 186 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~--~~~~~~ei~~l~~l~h~niv~~~~~~~~~--~~~~lv 260 (508)
++|+.++.|++|+||.||+|+++ ++..||+|++.-..... .-.-.+||++|.+++|||||.+-.+.... +..|||
T Consensus 76 ~efe~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmekek~GFPItsLREIniLl~~~H~NIV~vkEVVvG~~~d~iy~V 155 (419)
T KOG0663|consen 76 EEFEKLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKEKEGFPITSLREINILLKARHPNIVEVKEVVVGSNMDKIYIV 155 (419)
T ss_pred HHHHHHhhcccCcceeEEEeccCCcceeEEeeecccccccCCCcchhHHHHHHHHhcCCCCeeeeEEEEeccccceeeee
Confidence 46778899999999999999875 67889999986433211 12345699999999999999999988754 568999
Q ss_pred EeecCCCCHHHHHhhhhccCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCEEEcCCCcEEEEecCCccccC
Q 010519 261 YEYVNNGNLEQWLHGAMRNQGNLTWEARMKVIIGTAKALAYLHEAIEPKVVHRDIKSSNILIDDEFNAKVSDFGLAKLLD 340 (508)
Q Consensus 261 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~Dfgla~~~~ 340 (508)
||||+. +|..+++. -..++...++..+..|++.|++|||.+ .|+|||||++|+|++..|.+||+|||+|+.++
T Consensus 156 Me~~Eh-DLksl~d~---m~q~F~~~evK~L~~QlL~glk~lH~~---wilHRDLK~SNLLm~~~G~lKiaDFGLAR~yg 228 (419)
T KOG0663|consen 156 MEYVEH-DLKSLMET---MKQPFLPGEVKTLMLQLLRGLKHLHDN---WILHRDLKTSNLLLSHKGILKIADFGLAREYG 228 (419)
T ss_pred HHHHHh-hHHHHHHh---ccCCCchHHHHHHHHHHHHHHHHHhhc---eeEecccchhheeeccCCcEEecccchhhhhc
Confidence 999977 99999974 346788999999999999999999999 99999999999999999999999999999988
Q ss_pred CCCCcccccccccccccCccccCC-CCCCChhhHHHHHHHHHHHHhCCCCCCCCCCCchhcHHHHHHHHhcccccccc--
Q 010519 341 SGESHITTRVMGTFGYVAPEYANT-GMLNEKSDIYSFGVLLLEAVTGRDPVDYGRPANEVNLVEWLKMMVGTRRAEEV-- 417 (508)
Q Consensus 341 ~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwS~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~-- 417 (508)
.... ..+..+-|.+|.|||++.+ ..|+.+.|+||+|||+.||++++.-|.... +.+..+.+..+.+.......
T Consensus 229 sp~k-~~T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~G~s---E~dQl~~If~llGtPte~iwpg 304 (419)
T KOG0663|consen 229 SPLK-PYTPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFPGKS---EIDQLDKIFKLLGTPSEAIWPG 304 (419)
T ss_pred CCcc-cCcceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCCCCc---hHHHHHHHHHHhCCCccccCCC
Confidence 7643 3566677999999999877 579999999999999999999998886443 23333333444433211100
Q ss_pred ----c---CCCCCCChhH---------HHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhhcCCCCC
Q 010519 418 ----V---DPNLEVKPAT---------RALKRSLLVALRCVDPDSEKRPKMSQVVRMLEADDYPF 466 (508)
Q Consensus 418 ----~---~~~~~~~~~~---------~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~~ 466 (508)
. .-.+...+.. .....-++|+..+|..||.+|.|++|.|++=.-.+.+.
T Consensus 305 ~~~lp~~k~~~f~~~pyn~lr~kF~~~~lse~g~~Lln~llt~dP~kR~tA~~~L~h~~F~e~P~ 369 (419)
T KOG0663|consen 305 YSELPAVKKMTFSEHPYNNLRKKFGALSLSEQGFDLLNKLLTYDPGKRITAEDGLKHEYFRETPL 369 (419)
T ss_pred ccccchhhccccCCCCchhhhhhccccccchhHHHHHHHHhccCccccccHHHhhcccccccCCC
Confidence 0 0111111111 12345677899999999999999999998766555433
|
|
| >cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-41 Score=342.69 Aligned_cols=263 Identities=24% Similarity=0.419 Sum_probs=204.2
Q ss_pred HHhhCCcccceeEeeeCceEEEEEEEc------CCCEEEEEEEcccc-hhhHHHHHHHHHHHhcC-CCCCceeEEEEEEe
Q 010519 182 EIATNRFSAENVLGEGGYGVVYKGRLI------NGSEVAVKKLLNNL-GQAEKEFRVEVEAIGHV-RHKNLVRLLGYCIE 253 (508)
Q Consensus 182 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~-~~~~~~~~~ei~~l~~l-~h~niv~~~~~~~~ 253 (508)
....++|.+.+.||+|+||.||+|++. ++..||+|++.... ......+..|+.+++.+ +|+||++++++|..
T Consensus 34 ~~~~~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~~h~nIv~~~~~~~~ 113 (374)
T cd05106 34 EFPRDNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTDEREALMSELKILSHLGQHKNIVNLLGACTH 113 (374)
T ss_pred cccHHHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCCCHHHHHHHHHHHHHHHhhccCCceeeEeeEecC
Confidence 455668999999999999999998752 23579999986543 23345688899999999 89999999999999
Q ss_pred CceeeEEEeecCCCCHHHHHhhhhc-------------------------------------------------------
Q 010519 254 GVHRMLVYEYVNNGNLEQWLHGAMR------------------------------------------------------- 278 (508)
Q Consensus 254 ~~~~~lv~E~~~~gsL~~~l~~~~~------------------------------------------------------- 278 (508)
....++||||+++|+|.+++.....
T Consensus 114 ~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 193 (374)
T cd05106 114 GGPVLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSSSQ 193 (374)
T ss_pred CCCeEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCccccccc
Confidence 9999999999999999999864211
Q ss_pred -----------cCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCEEEcCCCcEEEEecCCccccCCCCCc-c
Q 010519 279 -----------NQGNLTWEARMKVIIGTAKALAYLHEAIEPKVVHRDIKSSNILIDDEFNAKVSDFGLAKLLDSGESH-I 346 (508)
Q Consensus 279 -----------~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~-~ 346 (508)
....+++..+++++.||+.||.|||++ +|+||||||+|||+++++.+||+|||++......... .
T Consensus 194 ~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~---giiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~~~~~~~ 270 (374)
T cd05106 194 SSDSKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASK---NCIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYVV 270 (374)
T ss_pred cccccchhccCCCCCcCHHHHHHHHHHHHHHHHHHHHC---CEEeccCchheEEEeCCCeEEEeeceeeeeccCCcceee
Confidence 112478888999999999999999998 9999999999999999999999999999865433221 1
Q ss_pred cccccccccccCccccCCCCCCChhhHHHHHHHHHHHHh-CCCCCCCCCCCchhcHHHHHHHHhcccccccccCCCCCCC
Q 010519 347 TTRVMGTFGYVAPEYANTGMLNEKSDIYSFGVLLLEAVT-GRDPVDYGRPANEVNLVEWLKMMVGTRRAEEVVDPNLEVK 425 (508)
Q Consensus 347 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 425 (508)
.....++..|+|||++.+..++.++|||||||++|||++ |+.||....... . ...... .. ....
T Consensus 271 ~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~~~--~---~~~~~~-~~---------~~~~ 335 (374)
T cd05106 271 KGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGILVNS--K---FYKMVK-RG---------YQMS 335 (374)
T ss_pred ccCCCCccceeCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCccccccH--H---HHHHHH-cc---------cCcc
Confidence 122234568999999999999999999999999999997 999996432211 1 111111 10 0000
Q ss_pred hhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhhcC
Q 010519 426 PATRALKRSLLVALRCVDPDSEKRPKMSQVVRMLEAD 462 (508)
Q Consensus 426 ~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~ 462 (508)
.+......+.+++.+||+.||.+|||+.+|++.|+..
T Consensus 336 ~~~~~~~~l~~li~~cl~~dp~~RPs~~~l~~~l~~~ 372 (374)
T cd05106 336 RPDFAPPEIYSIMKMCWNLEPTERPTFSQISQLIQRQ 372 (374)
T ss_pred CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence 0111234667799999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti |
| >cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-40 Score=325.93 Aligned_cols=257 Identities=26% Similarity=0.471 Sum_probs=204.9
Q ss_pred hCCcccceeEeeeCceEEEEEEEcC------CCEEEEEEEcccchh-hHHHHHHHHHHHhcCCCCCceeEEEEEEeCcee
Q 010519 185 TNRFSAENVLGEGGYGVVYKGRLIN------GSEVAVKKLLNNLGQ-AEKEFRVEVEAIGHVRHKNLVRLLGYCIEGVHR 257 (508)
Q Consensus 185 ~~~~~~~~~lg~G~~g~Vy~~~~~~------~~~vavK~~~~~~~~-~~~~~~~ei~~l~~l~h~niv~~~~~~~~~~~~ 257 (508)
.++|.+.+.||+|+||.||+|.+.+ +..||+|.+...... ....+.+|+++++.++|+||+++++++......
T Consensus 4 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~ 83 (280)
T cd05049 4 RDTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVKFYGVCTEGDPP 83 (280)
T ss_pred hHHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccCCHHHHHHHHHHHHHHHhcCCCCchheeeEEecCCCe
Confidence 3578889999999999999998643 478999988654433 456889999999999999999999999999999
Q ss_pred eEEEeecCCCCHHHHHhhhh----------ccCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCEEEcCCCc
Q 010519 258 MLVYEYVNNGNLEQWLHGAM----------RNQGNLTWEARMKVIIGTAKALAYLHEAIEPKVVHRDIKSSNILIDDEFN 327 (508)
Q Consensus 258 ~lv~E~~~~gsL~~~l~~~~----------~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiH~Dlk~~NIll~~~~~ 327 (508)
++||||+++++|.+++.... .....+++..+..++.|++.|+.|||++ +++||||||+||+++.++.
T Consensus 84 ~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~---~i~h~dlkp~nili~~~~~ 160 (280)
T cd05049 84 IMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQ---HFVHRDLATRNCLVGYDLV 160 (280)
T ss_pred EEEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhhC---CeeccccccceEEEcCCCe
Confidence 99999999999999996431 1234578899999999999999999999 9999999999999999999
Q ss_pred EEEEecCCccccCCCCC-cccccccccccccCccccCCCCCCChhhHHHHHHHHHHHHh-CCCCCCCCCCCchhcHHHHH
Q 010519 328 AKVSDFGLAKLLDSGES-HITTRVMGTFGYVAPEYANTGMLNEKSDIYSFGVLLLEAVT-GRDPVDYGRPANEVNLVEWL 405 (508)
Q Consensus 328 ~kl~Dfgla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~ellt-G~~Pf~~~~~~~~~~~~~~~ 405 (508)
+||+|||++........ .......+++.|+|||++.+..++.++|||||||++|||++ |..||...... ...
T Consensus 161 ~kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~e~~~~g~~p~~~~~~~------~~~ 234 (280)
T cd05049 161 VKIGDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYGLSNE------EVI 234 (280)
T ss_pred EEECCcccceecccCcceecCCCCcccceecChhhhccCCcchhhhHHHHHHHHHHHHhcCCCCCCCCCHH------HHH
Confidence 99999999975533221 11233345788999999999999999999999999999998 99998643321 111
Q ss_pred HHHhcccccccccCCCCCCChhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhh
Q 010519 406 KMMVGTRRAEEVVDPNLEVKPATRALKRSLLVALRCVDPDSEKRPKMSQVVRMLE 460 (508)
Q Consensus 406 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 460 (508)
.... ..... ..+......+.+++.+||+.||.+||++.||++.|+
T Consensus 235 ~~~~-~~~~~---------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~l~ 279 (280)
T cd05049 235 ECIT-QGRLL---------QRPRTCPSEVYDIMLGCWKRDPQQRINIKDIHERLQ 279 (280)
T ss_pred HHHH-cCCcC---------CCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhh
Confidence 1111 11100 011123455677999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt |
| >cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-40 Score=321.94 Aligned_cols=256 Identities=29% Similarity=0.427 Sum_probs=204.5
Q ss_pred HhhCCcccceeEeeeCceEEEEEEEcCCCEEEEEEEcccchhhHHHHHHHHHHHhcCCCCCceeEEEEEEeCceeeEEEe
Q 010519 183 IATNRFSAENVLGEGGYGVVYKGRLINGSEVAVKKLLNNLGQAEKEFRVEVEAIGHVRHKNLVRLLGYCIEGVHRMLVYE 262 (508)
Q Consensus 183 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~ei~~l~~l~h~niv~~~~~~~~~~~~~lv~E 262 (508)
+..++|++.+.||+|+||.||+|.+.++..+|+|.+..... ....+.+|+.++++++|+|++++++++. ....+++||
T Consensus 3 ~~~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~k~~~~~~~-~~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~lv~e 80 (260)
T cd05070 3 IPRESLQLIKKLGNGQFGEVWMGTWNGNTKVAVKTLKPGTM-SPESFLEEAQIMKKLRHDKLVQLYAVVS-EEPIYIVTE 80 (260)
T ss_pred CchHHhhhhheeccccCceEEEEEecCCceeEEEEecCCCC-CHHHHHHHHHHHHhcCCCceEEEEeEEC-CCCcEEEEE
Confidence 44568899999999999999999887888899998865433 3456888999999999999999999875 456789999
Q ss_pred ecCCCCHHHHHhhhhccCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCEEEcCCCcEEEEecCCccccCCC
Q 010519 263 YVNNGNLEQWLHGAMRNQGNLTWEARMKVIIGTAKALAYLHEAIEPKVVHRDIKSSNILIDDEFNAKVSDFGLAKLLDSG 342 (508)
Q Consensus 263 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~~ 342 (508)
|+++++|.++++. .....+++..++.++.+++.||.|||+. +++|+||||+||++++++.++|+|||++......
T Consensus 81 ~~~~~~L~~~~~~--~~~~~~~~~~~~~~~~~l~~al~~lH~~---~i~H~di~p~Nili~~~~~~~l~dfg~~~~~~~~ 155 (260)
T cd05070 81 YMSKGSLLDFLKD--GEGRALKLPNLVDMAAQVAAGMAYIERM---NYIHRDLRSANILVGDGLVCKIADFGLARLIEDN 155 (260)
T ss_pred ecCCCcHHHHHHh--cCCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCccceEEEeCCceEEeCCceeeeeccCc
Confidence 9999999999864 2344689999999999999999999998 9999999999999999999999999999866443
Q ss_pred CCcccccccccccccCccccCCCCCCChhhHHHHHHHHHHHHh-CCCCCCCCCCCchhcHHHHHHHHhcccccccccCCC
Q 010519 343 ESHITTRVMGTFGYVAPEYANTGMLNEKSDIYSFGVLLLEAVT-GRDPVDYGRPANEVNLVEWLKMMVGTRRAEEVVDPN 421 (508)
Q Consensus 343 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 421 (508)
.........++..|+|||.+.+..++.++||||||+++|+|++ |..||..... .+.........
T Consensus 156 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~------~~~~~~~~~~~--------- 220 (260)
T cd05070 156 EYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMNN------REVLEQVERGY--------- 220 (260)
T ss_pred ccccccCCCCCccccChHHHhcCCCcchhhhHHHHHHHHHHHhcCCCCCCCCCH------HHHHHHHHcCC---------
Confidence 3222222335668999999988899999999999999999999 8889854321 12222221111
Q ss_pred CCCChhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhhc
Q 010519 422 LEVKPATRALKRSLLVALRCVDPDSEKRPKMSQVVRMLEA 461 (508)
Q Consensus 422 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~ 461 (508)
..+.+......+.+++.+||++||.+|||+.++++.|+.
T Consensus 221 -~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~ 259 (260)
T cd05070 221 -RMPCPQDCPISLHELMLQCWKKDPEERPTFEYLQSFLED 259 (260)
T ss_pred -CCCCCCcCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence 011112234567779999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r |
| >PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-41 Score=325.95 Aligned_cols=250 Identities=32% Similarity=0.555 Sum_probs=193.8
Q ss_pred ccceeEeeeCceEEEEEEEc-----CCCEEEEEEEcccc-hhhHHHHHHHHHHHhcCCCCCceeEEEEEEeCceeeEEEe
Q 010519 189 SAENVLGEGGYGVVYKGRLI-----NGSEVAVKKLLNNL-GQAEKEFRVEVEAIGHVRHKNLVRLLGYCIEGVHRMLVYE 262 (508)
Q Consensus 189 ~~~~~lg~G~~g~Vy~~~~~-----~~~~vavK~~~~~~-~~~~~~~~~ei~~l~~l~h~niv~~~~~~~~~~~~~lv~E 262 (508)
.+.+.||.|.||.||+|.+. .+..|+||.+.... ......+.+|++.+++++||||++++|++......++|+|
T Consensus 2 ~~~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~~~~~lv~e 81 (259)
T PF07714_consen 2 KLIKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPSSSEEEEEEFLNEIQILRKLRHPNIVKLYGFCIENEPLFLVME 81 (259)
T ss_dssp EEEEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTTSSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEESSSSEEEEEE
T ss_pred EEeeEEccCCCcEEEEEEEEcccCCCCEEEEEEEeccccccccceeeeeccccccccccccccccccccccccccccccc
Confidence 35678999999999999986 25679999985533 3346789999999999999999999999998888999999
Q ss_pred ecCCCCHHHHHhhhhccCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCEEEcCCCcEEEEecCCccccCCC
Q 010519 263 YVNNGNLEQWLHGAMRNQGNLTWEARMKVIIGTAKALAYLHEAIEPKVVHRDIKSSNILIDDEFNAKVSDFGLAKLLDSG 342 (508)
Q Consensus 263 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~~ 342 (508)
|+++|+|.++|.. .....+++..++.++.||+.||.|||+. +++|+||+++|||+++++.+||+|||++......
T Consensus 82 ~~~~g~L~~~L~~--~~~~~~~~~~~~~i~~~i~~~l~~Lh~~---~iiH~~l~~~nill~~~~~~Kl~~f~~~~~~~~~ 156 (259)
T PF07714_consen 82 YCPGGSLDDYLKS--KNKEPLSEQQRLSIAIQIAEALSYLHSN---NIIHGNLSPSNILLDSNGQVKLSDFGLSRPISEK 156 (259)
T ss_dssp --TTEBHHHHHHH--TCTTTSBHHHHHHHHHHHHHHHHHHHHT---TEEEST-SGGGEEEETTTEEEEESTTTGEETTTS
T ss_pred ccccccccccccc--cccccccccccccccccccccccccccc---cccccccccccccccccccccccccccccccccc
Confidence 9999999999974 2356799999999999999999999999 9999999999999999999999999999876322
Q ss_pred CC-cccccccccccccCccccCCCCCCChhhHHHHHHHHHHHHh-CCCCCCCCCCCchhcHHHHHHHHhcccccccccCC
Q 010519 343 ES-HITTRVMGTFGYVAPEYANTGMLNEKSDIYSFGVLLLEAVT-GRDPVDYGRPANEVNLVEWLKMMVGTRRAEEVVDP 420 (508)
Q Consensus 343 ~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 420 (508)
.. ...........|+|||.+.+..++.++||||||+++|||++ |+.||.... ..+..........
T Consensus 157 ~~~~~~~~~~~~~~~~aPE~~~~~~~~~ksDVysfG~~l~ei~~~~~~p~~~~~------~~~~~~~~~~~~~------- 223 (259)
T PF07714_consen 157 SKYKNDSSQQLPLRYLAPEVLKDGEYTKKSDVYSFGMLLYEILTLGKFPFSDYD------NEEIIEKLKQGQR------- 223 (259)
T ss_dssp SSEEESTTSESGGGGS-HHHHHHSEESHHHHHHHHHHHHHHHHTTSSGTTTTSC------HHHHHHHHHTTEE-------
T ss_pred cccccccccccccccccccccccccccccccccccccccccccccccccccccc------ccccccccccccc-------
Confidence 21 22233456778999999988889999999999999999999 788885431 1222222221111
Q ss_pred CCCCChhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHh
Q 010519 421 NLEVKPATRALKRSLLVALRCVDPDSEKRPKMSQVVRML 459 (508)
Q Consensus 421 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L 459 (508)
...+......+.+++.+||+.||.+|||+.++++.|
T Consensus 224 ---~~~~~~~~~~~~~li~~C~~~~p~~RPs~~~i~~~L 259 (259)
T PF07714_consen 224 ---LPIPDNCPKDIYSLIQQCWSHDPEKRPSFQEILQEL 259 (259)
T ss_dssp ---TTSBTTSBHHHHHHHHHHT-SSGGGS--HHHHHHHH
T ss_pred ---ceeccchhHHHHHHHHHHcCCChhhCcCHHHHHhcC
Confidence 111122345566799999999999999999999876
|
Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A .... |
| >KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-41 Score=306.83 Aligned_cols=252 Identities=27% Similarity=0.383 Sum_probs=210.5
Q ss_pred hCCcccceeEeeeCceEEEEEEEc-CCCEEEEEEEcccc---hhhHHHHHHHHHHHhcCCCCCceeEEEEEEeCceeeEE
Q 010519 185 TNRFSAENVLGEGGYGVVYKGRLI-NGSEVAVKKLLNNL---GQAEKEFRVEVEAIGHVRHKNLVRLLGYCIEGVHRMLV 260 (508)
Q Consensus 185 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~ei~~l~~l~h~niv~~~~~~~~~~~~~lv 260 (508)
-++|++++.||+|-||.||+|+.+ ++-.||+|++.+.. .+...++++|+++-..|+||||+++|++|.+....|++
T Consensus 21 l~dfeigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~fhd~~riyLi 100 (281)
T KOG0580|consen 21 LDDFEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGYFHDSKRIYLI 100 (281)
T ss_pred hhhccccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhheeccceeEEE
Confidence 358889999999999999999865 67789999986543 23346799999999999999999999999999999999
Q ss_pred EeecCCCCHHHHHhhhhccCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCEEEcCCCcEEEEecCCccccC
Q 010519 261 YEYVNNGNLEQWLHGAMRNQGNLTWEARMKVIIGTAKALAYLHEAIEPKVVHRDIKSSNILIDDEFNAKVSDFGLAKLLD 340 (508)
Q Consensus 261 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~Dfgla~~~~ 340 (508)
+||.++|+|+..|.. ....++++...+.++.|+|.|+.|+|.. ++|||||||+|+|++.++.+||+|||.+....
T Consensus 101 lEya~~gel~k~L~~--~~~~~f~e~~~a~Yi~q~A~Al~y~h~k---~VIhRdiKpenlLlg~~~~lkiAdfGwsV~~p 175 (281)
T KOG0580|consen 101 LEYAPRGELYKDLQE--GRMKRFDEQRAATYIKQLANALLYCHLK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAP 175 (281)
T ss_pred EEecCCchHHHHHHh--cccccccccchhHHHHHHHHHHHHhccC---CcccCCCCHHHhccCCCCCeeccCCCceeecC
Confidence 999999999999964 3556788999999999999999999998 99999999999999999999999999998654
Q ss_pred CCCCcccccccccccccCccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCCCchhcHHHHHHHHhcccccccccCC
Q 010519 341 SGESHITTRVMGTFGYVAPEYANTGMLNEKSDIYSFGVLLLEAVTGRDPVDYGRPANEVNLVEWLKMMVGTRRAEEVVDP 420 (508)
Q Consensus 341 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 420 (508)
. ......|||..|.+||+..+..++..+|+|++|++.||++.|..||..... + +..+...
T Consensus 176 ~---~kR~tlcgt~dyl~pEmv~~~~hd~~Vd~w~lgvl~yeflvg~ppFes~~~-~-----etYkrI~----------- 235 (281)
T KOG0580|consen 176 S---NKRKTLCGTLDYLPPEMVEGRGHDKFVDLWSLGVLCYEFLVGLPPFESQSH-S-----ETYKRIR----------- 235 (281)
T ss_pred C---CCceeeecccccCCHhhcCCCCccchhhHHHHHHHHHHHHhcCCchhhhhh-H-----HHHHHHH-----------
Confidence 2 234557899999999999999999999999999999999999999974331 1 1111111
Q ss_pred CCCCChhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhhc
Q 010519 421 NLEVKPATRALKRSLLVALRCVDPDSEKRPKMSQVVRMLEA 461 (508)
Q Consensus 421 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~ 461 (508)
..+...+........++|.+|+..+|.+|.+..|++.+.+.
T Consensus 236 k~~~~~p~~is~~a~dlI~~ll~~~p~~r~~l~~v~~hpwI 276 (281)
T KOG0580|consen 236 KVDLKFPSTISGGAADLISRLLVKNPIERLALTEVMDHPWI 276 (281)
T ss_pred HccccCCcccChhHHHHHHHHhccCccccccHHHHhhhHHH
Confidence 11111123344566779999999999999999999988764
|
|
| >cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-40 Score=334.59 Aligned_cols=256 Identities=27% Similarity=0.328 Sum_probs=201.5
Q ss_pred CcccceeEeeeCceEEEEEEEc----CCCEEEEEEEcccc----hhhHHHHHHHHHHHhcC-CCCCceeEEEEEEeCcee
Q 010519 187 RFSAENVLGEGGYGVVYKGRLI----NGSEVAVKKLLNNL----GQAEKEFRVEVEAIGHV-RHKNLVRLLGYCIEGVHR 257 (508)
Q Consensus 187 ~~~~~~~lg~G~~g~Vy~~~~~----~~~~vavK~~~~~~----~~~~~~~~~ei~~l~~l-~h~niv~~~~~~~~~~~~ 257 (508)
+|++.+.||+|+||.||+++.. .+..+|+|.+.... ......+..|+.++..+ +||||+.+++++......
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~ 80 (332)
T cd05614 1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQTEAKL 80 (332)
T ss_pred CceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEecCCEE
Confidence 4888999999999999999753 57889999885432 22234577899999999 599999999999999999
Q ss_pred eEEEeecCCCCHHHHHhhhhccCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCEEEcCCCcEEEEecCCcc
Q 010519 258 MLVYEYVNNGNLEQWLHGAMRNQGNLTWEARMKVIIGTAKALAYLHEAIEPKVVHRDIKSSNILIDDEFNAKVSDFGLAK 337 (508)
Q Consensus 258 ~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~Dfgla~ 337 (508)
++||||+++|+|.+++. ....+++..+..++.||+.||.|||+. +|+||||||+|||++.++.+||+|||++.
T Consensus 81 ~lv~e~~~~g~L~~~l~----~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivHrDlkp~Nili~~~~~~kl~DfG~~~ 153 (332)
T cd05614 81 HLILDYVSGGEMFTHLY----QRDNFSEDEVRFYSGEIILALEHLHKL---GIVYRDIKLENILLDSEGHVVLTDFGLSK 153 (332)
T ss_pred EEEEeCCCCCcHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHHC---CcEecCCCHHHeEECCCCCEEEeeCcCCc
Confidence 99999999999999984 345689999999999999999999998 99999999999999999999999999998
Q ss_pred ccCCCCCcccccccccccccCccccCCC-CCCChhhHHHHHHHHHHHHhCCCCCCCCCCCchhcHHHHHHHHhccccccc
Q 010519 338 LLDSGESHITTRVMGTFGYVAPEYANTG-MLNEKSDIYSFGVLLLEAVTGRDPVDYGRPANEVNLVEWLKMMVGTRRAEE 416 (508)
Q Consensus 338 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwS~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 416 (508)
..............||+.|+|||++.+. .++.++|||||||+||||++|+.||......... ..........
T Consensus 154 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~--~~~~~~~~~~----- 226 (332)
T cd05614 154 EFLSEEKERTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQ--SEVSRRILKC----- 226 (332)
T ss_pred cccccCCCccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCCCCCCCCH--HHHHHHHhcC-----
Confidence 6544333333456799999999999875 4788999999999999999999999643322111 1111111110
Q ss_pred ccCCCCCCChhHHHHHHHHHHHHHhcCCCCCCCC-----CHHHHHHHhhcC
Q 010519 417 VVDPNLEVKPATRALKRSLLVALRCVDPDSEKRP-----KMSQVVRMLEAD 462 (508)
Q Consensus 417 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~evl~~L~~~ 462 (508)
++.+. ......+.+++.+||+.||.+|| ++++++++-+-.
T Consensus 227 --~~~~~----~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h~~~~ 271 (332)
T cd05614 227 --DPPFP----SFIGPEAQDLLHKLLRKDPKKRLGAGPQGASEIKEHPFFK 271 (332)
T ss_pred --CCCCC----CCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHHcCCCcC
Confidence 01111 11234456789999999999999 788998875543
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-40 Score=321.75 Aligned_cols=257 Identities=28% Similarity=0.415 Sum_probs=204.6
Q ss_pred HhhCCcccceeEeeeCceEEEEEEEcCCCEEEEEEEcccchhhHHHHHHHHHHHhcCCCCCceeEEEEEEeCceeeEEEe
Q 010519 183 IATNRFSAENVLGEGGYGVVYKGRLINGSEVAVKKLLNNLGQAEKEFRVEVEAIGHVRHKNLVRLLGYCIEGVHRMLVYE 262 (508)
Q Consensus 183 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~ei~~l~~l~h~niv~~~~~~~~~~~~~lv~E 262 (508)
+..++|.+.+.||+|+||.||+|++.++..||+|++.... .....+..|+.+++.++||||+++++++. ....++|||
T Consensus 3 ~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~valK~~~~~~-~~~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~lv~e 80 (262)
T cd05071 3 IPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVS-EEPIYIVTE 80 (262)
T ss_pred CChHHeeEeeecCCCCCCcEEEEEecCCceEEEEecccCc-cCHHHHHHHHHHHHhCCCCCcceEEEEEC-CCCcEEEEE
Confidence 3456899999999999999999988777789999886433 23456888999999999999999999875 456789999
Q ss_pred ecCCCCHHHHHhhhhccCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCEEEcCCCcEEEEecCCccccCCC
Q 010519 263 YVNNGNLEQWLHGAMRNQGNLTWEARMKVIIGTAKALAYLHEAIEPKVVHRDIKSSNILIDDEFNAKVSDFGLAKLLDSG 342 (508)
Q Consensus 263 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~~ 342 (508)
|+++|+|.+++... ....+++..+..++.+++.||.|||+. +++|+||||+||++++++.+||+|||++......
T Consensus 81 ~~~~~~L~~~~~~~--~~~~~~~~~~~~~~~~l~~aL~~lH~~---~i~H~dl~p~Nill~~~~~~~L~dfg~~~~~~~~ 155 (262)
T cd05071 81 YMSKGSLLDFLKGE--MGKYLRLPQLVDMAAQIASGMAYVERM---NYVHRDLRAANILVGENLVCKVADFGLARLIEDN 155 (262)
T ss_pred cCCCCcHHHHHhhc--cccCCCHHHHHHHHHHHHHHHHHHHHC---CccccccCcccEEEcCCCcEEeccCCceeecccc
Confidence 99999999999642 234678999999999999999999998 9999999999999999999999999999866543
Q ss_pred CCcccccccccccccCccccCCCCCCChhhHHHHHHHHHHHHh-CCCCCCCCCCCchhcHHHHHHHHhcccccccccCCC
Q 010519 343 ESHITTRVMGTFGYVAPEYANTGMLNEKSDIYSFGVLLLEAVT-GRDPVDYGRPANEVNLVEWLKMMVGTRRAEEVVDPN 421 (508)
Q Consensus 343 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 421 (508)
.........++..|+|||++.+..++.++|||||||++|||++ |..||...... ..........
T Consensus 156 ~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~ellt~g~~p~~~~~~~------~~~~~~~~~~--------- 220 (262)
T cd05071 156 EYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNR------EVLDQVERGY--------- 220 (262)
T ss_pred ccccccCCcccceecCHhHhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCChH------HHHHHHhcCC---------
Confidence 3222223345678999999998899999999999999999999 88888643211 1111111110
Q ss_pred CCCChhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhhcC
Q 010519 422 LEVKPATRALKRSLLVALRCVDPDSEKRPKMSQVVRMLEAD 462 (508)
Q Consensus 422 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~ 462 (508)
...........+.+++.+||++||.+||++.++++.|+..
T Consensus 221 -~~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~~~~~l~~~ 260 (262)
T cd05071 221 -RMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDY 260 (262)
T ss_pred -CCCCccccCHHHHHHHHHHccCCcccCCCHHHHHHHHHHh
Confidence 0111223455677899999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo |
| >cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-40 Score=321.36 Aligned_cols=257 Identities=27% Similarity=0.432 Sum_probs=207.1
Q ss_pred HHhhCCcccceeEeeeCceEEEEEEEcCCCEEEEEEEcccchhhHHHHHHHHHHHhcCCCCCceeEEEEEEeCceeeEEE
Q 010519 182 EIATNRFSAENVLGEGGYGVVYKGRLINGSEVAVKKLLNNLGQAEKEFRVEVEAIGHVRHKNLVRLLGYCIEGVHRMLVY 261 (508)
Q Consensus 182 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~ei~~l~~l~h~niv~~~~~~~~~~~~~lv~ 261 (508)
++..++|.+.++||+|+||.||+|...++..+|+|.+..... ....+..|+.++++++|+||+++++++. ....+++|
T Consensus 2 ~~~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~a~K~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~ 79 (260)
T cd05067 2 EVPRETLKLVKKLGAGQFGEVWMGYYNGHTKVAIKSLKQGSM-SPEAFLAEANLMKQLQHPRLVRLYAVVT-QEPIYIIT 79 (260)
T ss_pred ccchHHceeeeeeccCccceEEeeecCCCceEEEEEecCCCC-cHHHHHHHHHHHHhcCCcCeeeEEEEEc-cCCcEEEE
Confidence 455678999999999999999999988899999998865433 3457888999999999999999999874 45689999
Q ss_pred eecCCCCHHHHHhhhhccCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCEEEcCCCcEEEEecCCccccCC
Q 010519 262 EYVNNGNLEQWLHGAMRNQGNLTWEARMKVIIGTAKALAYLHEAIEPKVVHRDIKSSNILIDDEFNAKVSDFGLAKLLDS 341 (508)
Q Consensus 262 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~ 341 (508)
||+.+++|.+++.. .....+++..+..++.|++.||.|||+. +++|+||||+||++++++.++|+|||++.....
T Consensus 80 e~~~~~~L~~~~~~--~~~~~~~~~~~~~i~~~i~~al~~LH~~---~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~ 154 (260)
T cd05067 80 EYMENGSLVDFLKT--PEGIKLTINKLIDMAAQIAEGMAFIERK---NYIHRDLRAANILVSETLCCKIADFGLARLIED 154 (260)
T ss_pred EcCCCCCHHHHHHh--cCCCCCCHHHHHHHHHHHHHHHHHHhcC---CeecccccHHhEEEcCCCCEEEccCcceeecCC
Confidence 99999999999864 2345788999999999999999999998 999999999999999999999999999987653
Q ss_pred CCCcccccccccccccCccccCCCCCCChhhHHHHHHHHHHHHh-CCCCCCCCCCCchhcHHHHHHHHhcccccccccCC
Q 010519 342 GESHITTRVMGTFGYVAPEYANTGMLNEKSDIYSFGVLLLEAVT-GRDPVDYGRPANEVNLVEWLKMMVGTRRAEEVVDP 420 (508)
Q Consensus 342 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 420 (508)
..........++..|+|||++.+..++.++||||||+++|||++ |+.||...... .....+.....
T Consensus 155 ~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~------~~~~~~~~~~~------- 221 (260)
T cd05067 155 NEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTYGRIPYPGMTNP------EVIQNLERGYR------- 221 (260)
T ss_pred CCcccccCCcccccccCHHHhccCCcCcccchHHHHHHHHHHHhCCCCCCCCCChH------HHHHHHHcCCC-------
Confidence 33222233345678999999998889999999999999999999 99999643211 11111111100
Q ss_pred CCCCChhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhhc
Q 010519 421 NLEVKPATRALKRSLLVALRCVDPDSEKRPKMSQVVRMLEA 461 (508)
Q Consensus 421 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~ 461 (508)
..........+.+++.+||+.+|++|||+++++..|++
T Consensus 222 ---~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~ 259 (260)
T cd05067 222 ---MPRPDNCPEELYELMRLCWKEKPEERPTFEYLRSVLED 259 (260)
T ss_pred ---CCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHhhc
Confidence 01111223467779999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr |
| >cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-40 Score=332.31 Aligned_cols=242 Identities=23% Similarity=0.263 Sum_probs=194.7
Q ss_pred EeeeCceEEEEEEEc-CCCEEEEEEEcccc---hhhHHHHHHHHHHHhcCCCCCceeEEEEEEeCceeeEEEeecCCCCH
Q 010519 194 LGEGGYGVVYKGRLI-NGSEVAVKKLLNNL---GQAEKEFRVEVEAIGHVRHKNLVRLLGYCIEGVHRMLVYEYVNNGNL 269 (508)
Q Consensus 194 lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~ei~~l~~l~h~niv~~~~~~~~~~~~~lv~E~~~~gsL 269 (508)
||+|+||.||+|++. ++..||+|.+.... ......+..|+.++.+++||||+++++++.+....++||||+++|+|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L 80 (312)
T cd05585 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSPEKLYLVLAFINGGEL 80 (312)
T ss_pred CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEecCCeEEEEEcCCCCCcH
Confidence 699999999999875 57889999886432 23335677899999999999999999999999999999999999999
Q ss_pred HHHHhhhhccCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCEEEcCCCcEEEEecCCccccCCCCCccccc
Q 010519 270 EQWLHGAMRNQGNLTWEARMKVIIGTAKALAYLHEAIEPKVVHRDIKSSNILIDDEFNAKVSDFGLAKLLDSGESHITTR 349 (508)
Q Consensus 270 ~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~ 349 (508)
.+++. ....+++..+..++.||+.||.|||+. +|+||||||+|||++.++.+||+|||++....... .....
T Consensus 81 ~~~l~----~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~-~~~~~ 152 (312)
T cd05585 81 FHHLQ----REGRFDLSRARFYTAELLCALENLHKF---NVIYRDLKPENILLDYQGHIALCDFGLCKLNMKDD-DKTNT 152 (312)
T ss_pred HHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHhC---CeEeCCCCHHHeEECCCCcEEEEECcccccCccCC-Ccccc
Confidence 99984 345689999999999999999999999 99999999999999999999999999998543222 12344
Q ss_pred ccccccccCccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCCCchhcHHHHHHHHhcccccccccCCCCCCChhHH
Q 010519 350 VMGTFGYVAPEYANTGMLNEKSDIYSFGVLLLEAVTGRDPVDYGRPANEVNLVEWLKMMVGTRRAEEVVDPNLEVKPATR 429 (508)
Q Consensus 350 ~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 429 (508)
..||+.|+|||++.+..++.++|||||||++|||++|+.||.... ..+........ ... .+..
T Consensus 153 ~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~------~~~~~~~~~~~---------~~~--~~~~ 215 (312)
T cd05585 153 FCGTPEYLAPELLLGHGYTKAVDWWTLGVLLYEMLTGLPPFYDEN------VNEMYRKILQE---------PLR--FPDG 215 (312)
T ss_pred ccCCcccCCHHHHcCCCCCCccceechhHHHHHHHhCCCCcCCCC------HHHHHHHHHcC---------CCC--CCCc
Confidence 578999999999999999999999999999999999999996432 11222222211 011 1112
Q ss_pred HHHHHHHHHHHhcCCCCCCCCC---HHHHHHHhh
Q 010519 430 ALKRSLLVALRCVDPDSEKRPK---MSQVVRMLE 460 (508)
Q Consensus 430 ~~~~l~~li~~cl~~dP~~RPs---~~evl~~L~ 460 (508)
....+.+++.+||+.||.+||+ +.+++.|-.
T Consensus 216 ~~~~~~~li~~~L~~dp~~R~~~~~~~e~l~hp~ 249 (312)
T cd05585 216 FDRDAKDLLIGLLSRDPTRRLGYNGAQEIKNHPF 249 (312)
T ss_pred CCHHHHHHHHHHcCCCHHHcCCCCCHHHHHcCCC
Confidence 2345667999999999999975 677777644
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl |
| >cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-40 Score=321.24 Aligned_cols=252 Identities=27% Similarity=0.428 Sum_probs=201.3
Q ss_pred CCcccceeEeeeCceEEEEEEEcCCCEEEEEEEcccchhhHHHHHHHHHHHhcCCCCCceeEEEEEEeCceeeEEEeecC
Q 010519 186 NRFSAENVLGEGGYGVVYKGRLINGSEVAVKKLLNNLGQAEKEFRVEVEAIGHVRHKNLVRLLGYCIEGVHRMLVYEYVN 265 (508)
Q Consensus 186 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~ei~~l~~l~h~niv~~~~~~~~~~~~~lv~E~~~ 265 (508)
.+|++.+.||+|+||.||+|.+.++..+|+|.+..... ....+..|+++++.++||||+++++++......++||||++
T Consensus 4 ~~~~~~~~lg~G~~~~v~~~~~~~~~~~~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~ 82 (256)
T cd05059 4 SELTFLKELGSGQFGVVHLGKWRGKIDVAIKMIREGAM-SEDDFIEEAKVMMKLSHPNLVQLYGVCTKQRPIFIVTEYMA 82 (256)
T ss_pred HHcchhhhhccCCCceEEEeEecCCccEEEEEeccCCC-CHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCceEEEEecCC
Confidence 46888899999999999999887777899998754332 33567789999999999999999999999999999999999
Q ss_pred CCCHHHHHhhhhccCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCEEEcCCCcEEEEecCCccccCCCCCc
Q 010519 266 NGNLEQWLHGAMRNQGNLTWEARMKVIIGTAKALAYLHEAIEPKVVHRDIKSSNILIDDEFNAKVSDFGLAKLLDSGESH 345 (508)
Q Consensus 266 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~ 345 (508)
+++|.+++.. ....+++..++.++.|++.||.|||+. +++||||||+||++++++.+||+|||+++...+....
T Consensus 83 ~~~L~~~l~~---~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dl~p~ni~i~~~~~~kl~dfg~~~~~~~~~~~ 156 (256)
T cd05059 83 NGCLLNYLRE---RKGKLGTEWLLDMCSDVCEAMEYLESN---GFIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQYT 156 (256)
T ss_pred CCCHHHHHHh---cccCCCHHHHHHHHHHHHHHHHHHHHC---CcccccccHhhEEECCCCcEEECCcccceeccccccc
Confidence 9999999863 344789999999999999999999999 9999999999999999999999999999865433222
Q ss_pred ccccccccccccCccccCCCCCCChhhHHHHHHHHHHHHh-CCCCCCCCCCCchhcHHHHHHHHhcccccccccCCCCCC
Q 010519 346 ITTRVMGTFGYVAPEYANTGMLNEKSDIYSFGVLLLEAVT-GRDPVDYGRPANEVNLVEWLKMMVGTRRAEEVVDPNLEV 424 (508)
Q Consensus 346 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 424 (508)
......++..|+|||.+.+..++.++||||||+++|+|++ |..||...... ... ........ .
T Consensus 157 ~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~---~~~---~~~~~~~~------~---- 220 (256)
T cd05059 157 SSQGTKFPVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYERFSNS---EVV---ESVSAGYR------L---- 220 (256)
T ss_pred ccCCCCCCccccCHHHhccCCCCchhhHHHHHHHHHHHhccCCCCCCCCCHH---HHH---HHHHcCCc------C----
Confidence 2222233457999999999899999999999999999999 88998643221 111 11111100 0
Q ss_pred ChhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhh
Q 010519 425 KPATRALKRSLLVALRCVDPDSEKRPKMSQVVRMLE 460 (508)
Q Consensus 425 ~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 460 (508)
..+......+.+++.+||+.+|++|||+.++++.|.
T Consensus 221 ~~~~~~~~~~~~li~~cl~~~p~~Rpt~~~~l~~l~ 256 (256)
T cd05059 221 YRPKLAPTEVYTIMYSCWHEKPEDRPAFKKLLSQLT 256 (256)
T ss_pred CCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHhC
Confidence 011113446777999999999999999999999873
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows |
| >cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-40 Score=326.37 Aligned_cols=267 Identities=22% Similarity=0.309 Sum_probs=200.6
Q ss_pred hCCcccceeEeeeCceEEEEEEEc-CCCEEEEEEEcccch-hhHHHHHHHHHHHhcCCCCCceeEEEEEEeCceeeEEEe
Q 010519 185 TNRFSAENVLGEGGYGVVYKGRLI-NGSEVAVKKLLNNLG-QAEKEFRVEVEAIGHVRHKNLVRLLGYCIEGVHRMLVYE 262 (508)
Q Consensus 185 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~ei~~l~~l~h~niv~~~~~~~~~~~~~lv~E 262 (508)
.++|.+.+.||+|+||.||+|+.. +++.||+|++..... .....+.+|+.+++.++||||+++++++.+....++|||
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 83 (303)
T cd07869 4 ADSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHANIVLLHDIIHTKETLTLVFE 83 (303)
T ss_pred cccceEeeeEEecCCEEEEEEEECCCCCEEEEEEeccccccccchhHHHHHHHHhhCCCCCcCeEEEEEecCCeEEEEEE
Confidence 368999999999999999999876 688999998864432 223456779999999999999999999999999999999
Q ss_pred ecCCCCHHHHHhhhhccCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCEEEcCCCcEEEEecCCccccCCC
Q 010519 263 YVNNGNLEQWLHGAMRNQGNLTWEARMKVIIGTAKALAYLHEAIEPKVVHRDIKSSNILIDDEFNAKVSDFGLAKLLDSG 342 (508)
Q Consensus 263 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~~ 342 (508)
|+. ++|.+++. .....+++..+..++.||+.||.|||+. +|+||||||+|||+++++.+||+|||++......
T Consensus 84 ~~~-~~l~~~~~---~~~~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~ 156 (303)
T cd07869 84 YVH-TDLCQYMD---KHPGGLHPENVKLFLFQLLRGLSYIHQR---YILHRDLKPQNLLISDTGELKLADFGLARAKSVP 156 (303)
T ss_pred CCC-cCHHHHHH---hCCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEECCCCcceeccCC
Confidence 995 68888885 3345688899999999999999999999 9999999999999999999999999998754322
Q ss_pred CCcccccccccccccCccccCC-CCCCChhhHHHHHHHHHHHHhCCCCCCCCCCCchhcHHHHHHHHhccccc-------
Q 010519 343 ESHITTRVMGTFGYVAPEYANT-GMLNEKSDIYSFGVLLLEAVTGRDPVDYGRPANEVNLVEWLKMMVGTRRA------- 414 (508)
Q Consensus 343 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwS~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~------- 414 (508)
. .......+++.|+|||++.+ ..++.++|||||||++|+|++|..||..... .......+....+....
T Consensus 157 ~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~ 233 (303)
T cd07869 157 S-HTYSNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKD--IQDQLERIFLVLGTPNEDTWPGVH 233 (303)
T ss_pred C-ccCCCCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCcc--HHHHHHHHHHHhCCCChhhccchh
Confidence 2 22334568999999998865 4688999999999999999999999964322 11111111111111000
Q ss_pred --ccccCCCCCCChh---H------HHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhhc
Q 010519 415 --EEVVDPNLEVKPA---T------RALKRSLLVALRCVDPDSEKRPKMSQVVRMLEA 461 (508)
Q Consensus 415 --~~~~~~~~~~~~~---~------~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~ 461 (508)
.......+....+ . .....+.+|+.+||+.||.+|||+.|+++|-.-
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dp~~R~s~~~~l~h~~f 291 (303)
T cd07869 234 SLPHFKPERFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQAALSHEYF 291 (303)
T ss_pred hccccccccccccCCccHHHHhhccCCChHHHHHHHHHhccCchhccCHHHHhcCccc
Confidence 0000000000000 0 012356679999999999999999999975443
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an |
| >cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-39 Score=317.66 Aligned_cols=260 Identities=25% Similarity=0.390 Sum_probs=208.9
Q ss_pred CCcccceeEeeeCceEEEEEEEc-CCCEEEEEEEcccc---hhhHHHHHHHHHHHhcCCCCCceeEEEEEEeCceeeEEE
Q 010519 186 NRFSAENVLGEGGYGVVYKGRLI-NGSEVAVKKLLNNL---GQAEKEFRVEVEAIGHVRHKNLVRLLGYCIEGVHRMLVY 261 (508)
Q Consensus 186 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~ei~~l~~l~h~niv~~~~~~~~~~~~~lv~ 261 (508)
++|++.+.||+|+||.||+|+.. ++..||||.+.... ......+..|+.+++.++||||+++++++......++++
T Consensus 2 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 81 (267)
T cd08228 2 ANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIEDNELNIVL 81 (267)
T ss_pred cceeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEECCeEEEEE
Confidence 47899999999999999999865 78999999875322 233456888999999999999999999999999999999
Q ss_pred eecCCCCHHHHHhhhhccCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCEEEcCCCcEEEEecCCccccCC
Q 010519 262 EYVNNGNLEQWLHGAMRNQGNLTWEARMKVIIGTAKALAYLHEAIEPKVVHRDIKSSNILIDDEFNAKVSDFGLAKLLDS 341 (508)
Q Consensus 262 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~ 341 (508)
||+++|+|.+++.........+++..++.++.|++.||.|||++ +++|+||||+||+++.++.++|+|||++.....
T Consensus 82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dl~~~nil~~~~~~~~l~d~g~~~~~~~ 158 (267)
T cd08228 82 ELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSR---RVMHRDIKPANVFITATGVVKLGDLGLGRFFSS 158 (267)
T ss_pred EecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhC---CeeCCCCCHHHEEEcCCCCEEECccccceeccc
Confidence 99999999999865434455688999999999999999999998 999999999999999999999999999986643
Q ss_pred CCCcccccccccccccCccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCCCchhcHHHHHHHHhcccccccccCCC
Q 010519 342 GESHITTRVMGTFGYVAPEYANTGMLNEKSDIYSFGVLLLEAVTGRDPVDYGRPANEVNLVEWLKMMVGTRRAEEVVDPN 421 (508)
Q Consensus 342 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 421 (508)
... ......+++.|+|||.+.+..++.++|+||||+++|||++|+.||..... ....+........ .+.
T Consensus 159 ~~~-~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~----~~~~~~~~~~~~~------~~~ 227 (267)
T cd08228 159 KTT-AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKM----NLFSLCQKIEQCD------YPP 227 (267)
T ss_pred hhH-HHhcCCCCccccChhhhccCCCCchhhHHHHHHHHHHHhcCCCCCccccc----cHHHHHHHHhcCC------CCC
Confidence 322 12234688899999999888899999999999999999999999854322 1112222211100 011
Q ss_pred CCCChhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhhcC
Q 010519 422 LEVKPATRALKRSLLVALRCVDPDSEKRPKMSQVVRMLEAD 462 (508)
Q Consensus 422 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~ 462 (508)
.+.......+.+++.+||+.+|.+||++.++++.|+..
T Consensus 228 ---~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~vl~~~~~~ 265 (267)
T cd08228 228 ---LPTEHYSEKLRELVSMCIYPDPDQRPDIGYVHQIAKQM 265 (267)
T ss_pred ---CChhhcCHHHHHHHHHHCCCCcccCcCHHHHHHHHHHh
Confidence 11222345677899999999999999999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase |
| >cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-40 Score=329.79 Aligned_cols=257 Identities=27% Similarity=0.447 Sum_probs=201.7
Q ss_pred hCCcccceeEeeeCceEEEEEEEc-CCC----EEEEEEEcccc-hhhHHHHHHHHHHHhcCCCCCceeEEEEEEeCceee
Q 010519 185 TNRFSAENVLGEGGYGVVYKGRLI-NGS----EVAVKKLLNNL-GQAEKEFRVEVEAIGHVRHKNLVRLLGYCIEGVHRM 258 (508)
Q Consensus 185 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~----~vavK~~~~~~-~~~~~~~~~ei~~l~~l~h~niv~~~~~~~~~~~~~ 258 (508)
..+|+..+.||+|+||.||+|++. ++. .||+|.+.... ......+..|+.+++.++||||++++++|... ..+
T Consensus 6 ~~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~~-~~~ 84 (316)
T cd05108 6 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQ 84 (316)
T ss_pred hhhceeeeeeecCCCceEEEEEEecCCCccceeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcCC-Cce
Confidence 357999999999999999999864 333 38999886443 34456788899999999999999999998765 567
Q ss_pred EEEeecCCCCHHHHHhhhhccCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCEEEcCCCcEEEEecCCccc
Q 010519 259 LVYEYVNNGNLEQWLHGAMRNQGNLTWEARMKVIIGTAKALAYLHEAIEPKVVHRDIKSSNILIDDEFNAKVSDFGLAKL 338 (508)
Q Consensus 259 lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~Dfgla~~ 338 (508)
+++||+++|+|.+++.. ....+++..++.++.||+.||.|||+. +|+||||||+|||+++++.+||+|||+++.
T Consensus 85 ~v~e~~~~g~l~~~l~~---~~~~~~~~~~~~~~~qi~~~L~~LH~~---~iiH~dlkp~Nill~~~~~~kl~DfG~a~~ 158 (316)
T cd05108 85 LITQLMPFGCLLDYVRE---HKDNIGSQYLLNWCVQIAKGMNYLEER---RLVHRDLAARNVLVKTPQHVKITDFGLAKL 158 (316)
T ss_pred eeeecCCCCCHHHHHHh---ccccCCHHHHHHHHHHHHHHHHHHHhc---CeeccccchhheEecCCCcEEEcccccccc
Confidence 99999999999999863 345688899999999999999999999 999999999999999999999999999987
Q ss_pred cCCCCCcc-cccccccccccCccccCCCCCCChhhHHHHHHHHHHHHh-CCCCCCCCCCCchhcHHHHHHHHhccccccc
Q 010519 339 LDSGESHI-TTRVMGTFGYVAPEYANTGMLNEKSDIYSFGVLLLEAVT-GRDPVDYGRPANEVNLVEWLKMMVGTRRAEE 416 (508)
Q Consensus 339 ~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 416 (508)
........ .....++..|+|||++.+..++.++|||||||++|||++ |..||..... .++.........
T Consensus 159 ~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slGv~l~el~t~g~~p~~~~~~------~~~~~~~~~~~~--- 229 (316)
T cd05108 159 LGADEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPA------SEISSILEKGER--- 229 (316)
T ss_pred ccCCCcceeccCCccceeecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCH------HHHHHHHhCCCC---
Confidence 65433221 122234668999999999999999999999999999998 9999864321 111111111100
Q ss_pred ccCCCCCCChhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhhcCCC
Q 010519 417 VVDPNLEVKPATRALKRSLLVALRCVDPDSEKRPKMSQVVRMLEADDY 464 (508)
Q Consensus 417 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~ 464 (508)
...+......+..++.+||..||.+|||+.+++..|.....
T Consensus 230 -------~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~l~~~l~~~~~ 270 (316)
T cd05108 230 -------LPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMAR 270 (316)
T ss_pred -------CCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHc
Confidence 00111123456679999999999999999999999876543
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor |
| >cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-40 Score=324.13 Aligned_cols=261 Identities=22% Similarity=0.405 Sum_probs=203.4
Q ss_pred HHhhCCcccceeEeeeCceEEEEEEEc------CCCEEEEEEEcccc-hhhHHHHHHHHHHHhcCCCCCceeEEEEEEeC
Q 010519 182 EIATNRFSAENVLGEGGYGVVYKGRLI------NGSEVAVKKLLNNL-GQAEKEFRVEVEAIGHVRHKNLVRLLGYCIEG 254 (508)
Q Consensus 182 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~-~~~~~~~~~ei~~l~~l~h~niv~~~~~~~~~ 254 (508)
.+..++|++.+.||+|+||.||+|.+. .+..||+|++.... ......+..|+.+++.++||||+++++++...
T Consensus 2 ~~~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~ 81 (277)
T cd05062 2 EVAREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQG 81 (277)
T ss_pred cccHHHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCC
Confidence 356778999999999999999999753 24679999875432 23345688899999999999999999999999
Q ss_pred ceeeEEEeecCCCCHHHHHhhhhcc------CCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCEEEcCCCcE
Q 010519 255 VHRMLVYEYVNNGNLEQWLHGAMRN------QGNLTWEARMKVIIGTAKALAYLHEAIEPKVVHRDIKSSNILIDDEFNA 328 (508)
Q Consensus 255 ~~~~lv~E~~~~gsL~~~l~~~~~~------~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiH~Dlk~~NIll~~~~~~ 328 (508)
...++||||+++|+|.+++...... ...+++..+..++.|++.||.|||+. +++|+||||+||++++++.+
T Consensus 82 ~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~~vH~dlkp~Nil~~~~~~~ 158 (277)
T cd05062 82 QPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTV 158 (277)
T ss_pred CCeEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCcchheEEEcCCCCE
Confidence 9999999999999999999642211 23467888999999999999999998 99999999999999999999
Q ss_pred EEEecCCccccCCCCCcc-cccccccccccCccccCCCCCCChhhHHHHHHHHHHHHh-CCCCCCCCCCCchhcHHHHHH
Q 010519 329 KVSDFGLAKLLDSGESHI-TTRVMGTFGYVAPEYANTGMLNEKSDIYSFGVLLLEAVT-GRDPVDYGRPANEVNLVEWLK 406 (508)
Q Consensus 329 kl~Dfgla~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~ellt-G~~Pf~~~~~~~~~~~~~~~~ 406 (508)
+|+|||++.......... .....+++.|+|||++.+..++.++|||||||++|||++ |..||..... .....
T Consensus 159 ~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~p~~~~~~------~~~~~ 232 (277)
T cd05062 159 KIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMSN------EQVLR 232 (277)
T ss_pred EECCCCCccccCCcceeecCCCCccCHhhcChhHhhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCH------HHHHH
Confidence 999999997554322211 122345778999999999899999999999999999999 7888854321 11121
Q ss_pred HHhcccccccccCCCCCCChhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhhc
Q 010519 407 MMVGTRRAEEVVDPNLEVKPATRALKRSLLVALRCVDPDSEKRPKMSQVVRMLEA 461 (508)
Q Consensus 407 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~ 461 (508)
....... . .. +......+.+++.+||+.||.+|||+.|++++|+.
T Consensus 233 ~~~~~~~-~-----~~----~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~~ 277 (277)
T cd05062 233 FVMEGGL-L-----DK----PDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKE 277 (277)
T ss_pred HHHcCCc-C-----CC----CCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHhhC
Confidence 1111110 0 00 11123456779999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh |
| >cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-40 Score=337.68 Aligned_cols=261 Identities=20% Similarity=0.261 Sum_probs=205.6
Q ss_pred HHHhhCCcccceeEeeeCceEEEEEEEc-CCCEEEEEEEcccc---hhhHHHHHHHHHHHhcCCCCCceeEEEEEEeCce
Q 010519 181 LEIATNRFSAENVLGEGGYGVVYKGRLI-NGSEVAVKKLLNNL---GQAEKEFRVEVEAIGHVRHKNLVRLLGYCIEGVH 256 (508)
Q Consensus 181 ~~~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~ei~~l~~l~h~niv~~~~~~~~~~~ 256 (508)
+....++|++.+.||+|+||.||+++.. ++..+|+|.+.... ......+..|+.+++.++||||+++++++.+...
T Consensus 38 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~~~~~~ 117 (370)
T cd05596 38 LRMKAEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAFQDDKY 117 (370)
T ss_pred CCCCHHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEEEecCCE
Confidence 3445678999999999999999999875 68899999985432 2233457789999999999999999999999999
Q ss_pred eeEEEeecCCCCHHHHHhhhhccCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCEEEcCCCcEEEEecCCc
Q 010519 257 RMLVYEYVNNGNLEQWLHGAMRNQGNLTWEARMKVIIGTAKALAYLHEAIEPKVVHRDIKSSNILIDDEFNAKVSDFGLA 336 (508)
Q Consensus 257 ~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~Dfgla 336 (508)
.++||||+++|+|.+++.. ..+++..+..++.||+.||.|||+. +|+||||||+|||++.++.+||+|||++
T Consensus 118 ~~lv~Ey~~gg~L~~~l~~-----~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDLkp~NILl~~~~~~kL~DfG~~ 189 (370)
T cd05596 118 LYMVMEYMPGGDLVNLMSN-----YDIPEKWARFYTAEVVLALDAIHSM---GFIHRDVKPDNMLLDKSGHLKLADFGTC 189 (370)
T ss_pred EEEEEcCCCCCcHHHHHHh-----cCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHEEEcCCCCEEEEeccce
Confidence 9999999999999998853 3478888999999999999999998 9999999999999999999999999999
Q ss_pred cccCCCCCcccccccccccccCccccCCC----CCCChhhHHHHHHHHHHHHhCCCCCCCCCCCchhcHHHHHHHHhccc
Q 010519 337 KLLDSGESHITTRVMGTFGYVAPEYANTG----MLNEKSDIYSFGVLLLEAVTGRDPVDYGRPANEVNLVEWLKMMVGTR 412 (508)
Q Consensus 337 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----~~~~~~DvwS~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~ 412 (508)
..............+||+.|+|||++.+. .++.++|||||||+||||++|+.||..... ...........
T Consensus 190 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~------~~~~~~i~~~~ 263 (370)
T cd05596 190 MKMDANGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSL------VGTYSKIMDHK 263 (370)
T ss_pred eeccCCCcccCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCCCH------HHHHHHHHcCC
Confidence 86654332223445799999999998653 478999999999999999999999964322 11111221111
Q ss_pred ccccccCCCCCCChhHHHHHHHHHHHHHhcCCCCCC--CCCHHHHHHHhhcC
Q 010519 413 RAEEVVDPNLEVKPATRALKRSLLVALRCVDPDSEK--RPKMSQVVRMLEAD 462 (508)
Q Consensus 413 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~--RPs~~evl~~L~~~ 462 (508)
..+..+........+.+|+.+||+.+|.+ |||+.++++|-.-.
T Consensus 264 -------~~~~~~~~~~~s~~~~~li~~~L~~~p~r~~R~s~~ell~h~~~~ 308 (370)
T cd05596 264 -------NSLTFPDDIEISKQAKDLICAFLTDREVRLGRNGVDEIKSHPFFK 308 (370)
T ss_pred -------CcCCCCCcCCCCHHHHHHHHHHccChhhccCCCCHHHHhcCcccC
Confidence 01111111123456667999999999988 99999999986543
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in |
| >cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-40 Score=337.51 Aligned_cols=201 Identities=26% Similarity=0.379 Sum_probs=174.5
Q ss_pred CCcccceeEeeeCceEEEEEEEc-CCCEEEEEEEcccc---hhhHHHHHHHHHHHhcCCCCCceeEEEEEEeCceeeEEE
Q 010519 186 NRFSAENVLGEGGYGVVYKGRLI-NGSEVAVKKLLNNL---GQAEKEFRVEVEAIGHVRHKNLVRLLGYCIEGVHRMLVY 261 (508)
Q Consensus 186 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~ei~~l~~l~h~niv~~~~~~~~~~~~~lv~ 261 (508)
++|++.+.||+|+||+||++... +++.+|+|++.... ......+..|+.++..++||||+++++++.+....|+||
T Consensus 1 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~~~~~~lv~ 80 (363)
T cd05628 1 EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQDKLNLYLIM 80 (363)
T ss_pred CCceEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEEecCCeEEEEE
Confidence 47899999999999999999875 58899999986432 222356788999999999999999999999999999999
Q ss_pred eecCCCCHHHHHhhhhccCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCEEEcCCCcEEEEecCCccccCC
Q 010519 262 EYVNNGNLEQWLHGAMRNQGNLTWEARMKVIIGTAKALAYLHEAIEPKVVHRDIKSSNILIDDEFNAKVSDFGLAKLLDS 341 (508)
Q Consensus 262 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~ 341 (508)
||+++|+|.+++. ..+.+++..+..++.|++.||.|||++ +|+||||||+|||++.++.+||+|||+++....
T Consensus 81 E~~~gg~L~~~l~----~~~~l~~~~~~~~~~qi~~aL~~lH~~---givHrDlKp~NILi~~~~~vkL~DFGla~~~~~ 153 (363)
T cd05628 81 EFLPGGDMMTLLM----KKDTLTEEETQFYIAETVLAIDSIHQL---GFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKK 153 (363)
T ss_pred cCCCCCcHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHhC---CeEecCCCHHHeEECCCCCEEEeeccCcccccc
Confidence 9999999999984 456789999999999999999999999 999999999999999999999999999875432
Q ss_pred CCC----------------------------------cccccccccccccCccccCCCCCCChhhHHHHHHHHHHHHhCC
Q 010519 342 GES----------------------------------HITTRVMGTFGYVAPEYANTGMLNEKSDIYSFGVLLLEAVTGR 387 (508)
Q Consensus 342 ~~~----------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltG~ 387 (508)
... ......+||+.|+|||++.+..++.++|||||||+||||++|+
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~ 233 (363)
T cd05628 154 AHRTEFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGY 233 (363)
T ss_pred cccccccccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCCCCCCchhhhhhHHHHHHHHhCC
Confidence 110 0012357999999999999999999999999999999999999
Q ss_pred CCCCCC
Q 010519 388 DPVDYG 393 (508)
Q Consensus 388 ~Pf~~~ 393 (508)
.||...
T Consensus 234 ~Pf~~~ 239 (363)
T cd05628 234 PPFCSE 239 (363)
T ss_pred CCCCCC
Confidence 999643
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus |
| >PLN00034 mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-39 Score=331.56 Aligned_cols=252 Identities=26% Similarity=0.356 Sum_probs=195.7
Q ss_pred CCcccceeEeeeCceEEEEEEEc-CCCEEEEEEEcccc-hhhHHHHHHHHHHHhcCCCCCceeEEEEEEeCceeeEEEee
Q 010519 186 NRFSAENVLGEGGYGVVYKGRLI-NGSEVAVKKLLNNL-GQAEKEFRVEVEAIGHVRHKNLVRLLGYCIEGVHRMLVYEY 263 (508)
Q Consensus 186 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~ei~~l~~l~h~niv~~~~~~~~~~~~~lv~E~ 263 (508)
++|+..+.||+|+||+||+|++. +++.||||.+.... ......+.+|+++++.++|+||+++++++......++||||
T Consensus 74 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 153 (353)
T PLN00034 74 SELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILRDVNHPNVVKCHDMFDHNGEIQVLLEF 153 (353)
T ss_pred HHHhhhhhccCCCCeEEEEEEECCCCCEEEEEEEecCCcHHHHHHHHHHHHHHHhCCCCCcceeeeEeccCCeEEEEEec
Confidence 35667789999999999999875 68999999986543 23346788999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhhhhccCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCEEEcCCCcEEEEecCCccccCCCC
Q 010519 264 VNNGNLEQWLHGAMRNQGNLTWEARMKVIIGTAKALAYLHEAIEPKVVHRDIKSSNILIDDEFNAKVSDFGLAKLLDSGE 343 (508)
Q Consensus 264 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~~~ 343 (508)
+++|+|.+.. ...+..+..++.||+.||.|||++ +|+||||||+|||+++++.+||+|||++.......
T Consensus 154 ~~~~~L~~~~--------~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~~~~kL~DfG~~~~~~~~~ 222 (353)
T PLN00034 154 MDGGSLEGTH--------IADEQFLADVARQILSGIAYLHRR---HIVHRDIKPSNLLINSAKNVKIADFGVSRILAQTM 222 (353)
T ss_pred CCCCcccccc--------cCCHHHHHHHHHHHHHHHHHHHHC---CEeecCCCHHHEEEcCCCCEEEcccccceeccccc
Confidence 9999986532 245677888999999999999999 99999999999999999999999999998664322
Q ss_pred CcccccccccccccCccccCC-----CCCCChhhHHHHHHHHHHHHhCCCCCCCCCCCchhcHHHHHHHHhccccccccc
Q 010519 344 SHITTRVMGTFGYVAPEYANT-----GMLNEKSDIYSFGVLLLEAVTGRDPVDYGRPANEVNLVEWLKMMVGTRRAEEVV 418 (508)
Q Consensus 344 ~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~DvwS~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 418 (508)
. ......||..|+|||++.. ...+.++|||||||+||||++|+.||......... ..........
T Consensus 223 ~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~---~~~~~~~~~~------ 292 (353)
T PLN00034 223 D-PCNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQGDWA---SLMCAICMSQ------ 292 (353)
T ss_pred c-cccccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccHH---HHHHHHhccC------
Confidence 1 1234578999999998743 33456899999999999999999999743322111 1111110000
Q ss_pred CCCCCCChhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhhcC
Q 010519 419 DPNLEVKPATRALKRSLLVALRCVDPDSEKRPKMSQVVRMLEAD 462 (508)
Q Consensus 419 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~ 462 (508)
...........+.+|+.+||+.||.+|||+.|++++-+-.
T Consensus 293 ----~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~ell~hp~~~ 332 (353)
T PLN00034 293 ----PPEAPATASREFRHFISCCLQREPAKRWSAMQLLQHPFIL 332 (353)
T ss_pred ----CCCCCCccCHHHHHHHHHHccCChhhCcCHHHHhcCcccc
Confidence 0001112344577799999999999999999999865443
|
|
| >PTZ00283 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-40 Score=348.86 Aligned_cols=258 Identities=26% Similarity=0.351 Sum_probs=206.3
Q ss_pred HHhhCCcccceeEeeeCceEEEEEEEc-CCCEEEEEEEcccc--hhhHHHHHHHHHHHhcCCCCCceeEEEEEEeCc---
Q 010519 182 EIATNRFSAENVLGEGGYGVVYKGRLI-NGSEVAVKKLLNNL--GQAEKEFRVEVEAIGHVRHKNLVRLLGYCIEGV--- 255 (508)
Q Consensus 182 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~ei~~l~~l~h~niv~~~~~~~~~~--- 255 (508)
+...++|.+.+.||+|+||+||++++. +|+.||||.+.... ......+..|+..+..++|+|+++++..+....
T Consensus 28 ~~~~~rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~~~~ 107 (496)
T PTZ00283 28 KEQAKKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKDPRN 107 (496)
T ss_pred cccCCCEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccCCHHHHHHHHHHHHHHhcCCCCcEEEeecceecccccC
Confidence 344579999999999999999999864 78999999985432 333456788999999999999999988775432
Q ss_pred -----eeeEEEeecCCCCHHHHHhhhhccCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCEEEcCCCcEEE
Q 010519 256 -----HRMLVYEYVNNGNLEQWLHGAMRNQGNLTWEARMKVIIGTAKALAYLHEAIEPKVVHRDIKSSNILIDDEFNAKV 330 (508)
Q Consensus 256 -----~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl 330 (508)
..++||||+++|+|.++|.........+++..+..++.|++.||.|||+. +|+||||||+|||++.++.+||
T Consensus 108 ~~~~~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH~~---~IiHrDLKP~NILl~~~~~vkL 184 (496)
T PTZ00283 108 PENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSK---HMIHRDIKSANILLCSNGLVKL 184 (496)
T ss_pred cccceEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEeCCCCEEE
Confidence 35799999999999999976555566799999999999999999999999 9999999999999999999999
Q ss_pred EecCCccccCCCCC-cccccccccccccCccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCCCchhcHHHHHHHHh
Q 010519 331 SDFGLAKLLDSGES-HITTRVMGTFGYVAPEYANTGMLNEKSDIYSFGVLLLEAVTGRDPVDYGRPANEVNLVEWLKMMV 409 (508)
Q Consensus 331 ~Dfgla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~ 409 (508)
+|||+++.+..... .......||+.|+|||++.+..++.++|||||||+||||++|+.||.... ....+....
T Consensus 185 ~DFGls~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~k~DVwSlGvilyeLltG~~Pf~~~~------~~~~~~~~~ 258 (496)
T PTZ00283 185 GDFGFSKMYAATVSDDVGRTFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDGEN------MEEVMHKTL 258 (496)
T ss_pred EecccCeeccccccccccccccCCcceeCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCC------HHHHHHHHh
Confidence 99999986543221 22334679999999999999999999999999999999999999996432 122222222
Q ss_pred cccccccccCCCCCCChhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 010519 410 GTRRAEEVVDPNLEVKPATRALKRSLLVALRCVDPDSEKRPKMSQVVRM 458 (508)
Q Consensus 410 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 458 (508)
.... .+ + +......+.+++.+||+.||.+||++.+++++
T Consensus 259 ~~~~-----~~-~----~~~~~~~l~~li~~~L~~dP~~RPs~~ell~~ 297 (496)
T PTZ00283 259 AGRY-----DP-L----PPSISPEMQEIVTALLSSDPKRRPSSSKLLNM 297 (496)
T ss_pred cCCC-----CC-C----CCCCCHHHHHHHHHHcccChhhCcCHHHHHhC
Confidence 1110 00 1 11223456779999999999999999999876
|
|
| >cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-40 Score=338.52 Aligned_cols=255 Identities=21% Similarity=0.279 Sum_probs=198.2
Q ss_pred CcccceeEeeeCceEEEEEEEc-CCCEEEEEEEcccc---hhhHHHHHHHHHHHhcCCCCCceeEEEEEEeCceeeEEEe
Q 010519 187 RFSAENVLGEGGYGVVYKGRLI-NGSEVAVKKLLNNL---GQAEKEFRVEVEAIGHVRHKNLVRLLGYCIEGVHRMLVYE 262 (508)
Q Consensus 187 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~ei~~l~~l~h~niv~~~~~~~~~~~~~lv~E 262 (508)
.|...+.||+|+||+||+|++. ++..+|+|++.... ......+..|+.+++.++||||+++++++.+....++|||
T Consensus 2 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lv~E 81 (381)
T cd05626 2 MFVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMD 81 (381)
T ss_pred CceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEecCCEEEEEEe
Confidence 6888999999999999999875 67899999986432 2234568889999999999999999999999999999999
Q ss_pred ecCCCCHHHHHhhhhccCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCEEEcCCCcEEEEecCCccccCCC
Q 010519 263 YVNNGNLEQWLHGAMRNQGNLTWEARMKVIIGTAKALAYLHEAIEPKVVHRDIKSSNILIDDEFNAKVSDFGLAKLLDSG 342 (508)
Q Consensus 263 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~~ 342 (508)
|+++|+|.+++. ....+++..+..++.||+.||.|||+. +|+||||||+|||++.++.+||+|||++......
T Consensus 82 ~~~gg~L~~~l~----~~~~~~e~~~~~~~~qi~~aL~~LH~~---givHrDlKp~Nili~~~~~~kL~DFGl~~~~~~~ 154 (381)
T cd05626 82 YIPGGDMMSLLI----RMEVFPEVLARFYIAELTLAIESVHKM---GFIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWT 154 (381)
T ss_pred cCCCCcHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecCCcHHHEEECCCCCEEEeeCcCCcccccc
Confidence 999999999984 345688999999999999999999998 9999999999999999999999999997533110
Q ss_pred C----------------------------------------------CcccccccccccccCccccCCCCCCChhhHHHH
Q 010519 343 E----------------------------------------------SHITTRVMGTFGYVAPEYANTGMLNEKSDIYSF 376 (508)
Q Consensus 343 ~----------------------------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~ 376 (508)
. .......+||+.|+|||++.+..++.++|||||
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSl 234 (381)
T cd05626 155 HNSKYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSV 234 (381)
T ss_pred cccccccccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcCCCCCCccceeeh
Confidence 0 000123579999999999999899999999999
Q ss_pred HHHHHHHHhCCCCCCCCCCCchhcHHHHHHHHhcccccccccCCCCCCChhHHHHHHHHHHHHH--hcCCCCCCCCCHHH
Q 010519 377 GVLLLEAVTGRDPVDYGRPANEVNLVEWLKMMVGTRRAEEVVDPNLEVKPATRALKRSLLVALR--CVDPDSEKRPKMSQ 454 (508)
Q Consensus 377 Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~--cl~~dP~~RPs~~e 454 (508)
||++|||++|..||........ ........ ..+..+........+.+|+.+ |+..+|..||++.+
T Consensus 235 G~il~elltG~~Pf~~~~~~~~------~~~i~~~~-------~~~~~~~~~~~s~~~~dli~~ll~~~~~~~~R~~~~~ 301 (381)
T cd05626 235 GVILFEMLVGQPPFLAPTPTET------QLKVINWE-------NTLHIPPQVKLSPEAVDLITKLCCSAEERLGRNGADD 301 (381)
T ss_pred hhHHHHHHhCCCCCcCCCHHHH------HHHHHccc-------cccCCCCCCCCCHHHHHHHHHHccCcccccCCCCHHH
Confidence 9999999999999975432111 11111100 011111111123345556666 56677777999999
Q ss_pred HHHHhhc
Q 010519 455 VVRMLEA 461 (508)
Q Consensus 455 vl~~L~~ 461 (508)
++.|-.-
T Consensus 302 ~l~hp~f 308 (381)
T cd05626 302 IKAHPFF 308 (381)
T ss_pred HhcCccc
Confidence 9987543
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po |
| >cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-40 Score=320.15 Aligned_cols=256 Identities=30% Similarity=0.493 Sum_probs=204.5
Q ss_pred hCCcccceeEeeeCceEEEEEEEcC----CCEEEEEEEcccc-hhhHHHHHHHHHHHhcCCCCCceeEEEEEEeCceeeE
Q 010519 185 TNRFSAENVLGEGGYGVVYKGRLIN----GSEVAVKKLLNNL-GQAEKEFRVEVEAIGHVRHKNLVRLLGYCIEGVHRML 259 (508)
Q Consensus 185 ~~~~~~~~~lg~G~~g~Vy~~~~~~----~~~vavK~~~~~~-~~~~~~~~~ei~~l~~l~h~niv~~~~~~~~~~~~~l 259 (508)
.++|++.+.||+|+||+||+|.+.. ...||+|.+.... ......+..|+.+++.++||||+++++++......++
T Consensus 3 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~i 82 (266)
T cd05033 3 PSYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIRLEGVVTKSRPVMI 82 (266)
T ss_pred hHHceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCcceEeEEEecCCceEE
Confidence 3578999999999999999998742 3578999876443 3344678889999999999999999999999999999
Q ss_pred EEeecCCCCHHHHHhhhhccCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCEEEcCCCcEEEEecCCcccc
Q 010519 260 VYEYVNNGNLEQWLHGAMRNQGNLTWEARMKVIIGTAKALAYLHEAIEPKVVHRDIKSSNILIDDEFNAKVSDFGLAKLL 339 (508)
Q Consensus 260 v~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~Dfgla~~~ 339 (508)
+|||+++++|.+++.. ..+.+++..++.++.|++.||.|||+. +|+|+||||+|||+++++.++|+|||++...
T Consensus 83 v~e~~~~~~L~~~~~~---~~~~~~~~~~~~~~~~l~~~l~~Lh~~---~i~H~di~p~nili~~~~~~~l~dfg~~~~~ 156 (266)
T cd05033 83 ITEYMENGSLDKFLRE---NDGKFTVGQLVGMLRGIASGMKYLSEM---NYVHRDLAARNILVNSNLVCKVSDFGLSRRL 156 (266)
T ss_pred EEEcCCCCCHHHHHHh---ccCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCcceEEEcCCCCEEECccchhhcc
Confidence 9999999999999863 345789999999999999999999998 9999999999999999999999999999876
Q ss_pred CCCCC-cccccccccccccCccccCCCCCCChhhHHHHHHHHHHHHh-CCCCCCCCCCCchhcHHHHHHHHhcccccccc
Q 010519 340 DSGES-HITTRVMGTFGYVAPEYANTGMLNEKSDIYSFGVLLLEAVT-GRDPVDYGRPANEVNLVEWLKMMVGTRRAEEV 417 (508)
Q Consensus 340 ~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 417 (508)
..... .......++..|+|||.+.+..++.++||||||+++|+|++ |..||...... +...........
T Consensus 157 ~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Dv~slG~~l~~l~~~g~~p~~~~~~~------~~~~~~~~~~~~--- 227 (266)
T cd05033 157 EDSEATYTTKGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGERPYWDMSNQ------DVIKAVEDGYRL--- 227 (266)
T ss_pred cccccceeccCCCCCccccChhhhccCCCccccchHHHHHHHHHHHccCCCCCCCCCHH------HHHHHHHcCCCC---
Confidence 52221 11222344678999999998899999999999999999998 99998533211 111111111000
Q ss_pred cCCCCCCChhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhhcC
Q 010519 418 VDPNLEVKPATRALKRSLLVALRCVDPDSEKRPKMSQVVRMLEAD 462 (508)
Q Consensus 418 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~ 462 (508)
..+......+.+++.+||+.+|.+||++.+|+++|+..
T Consensus 228 -------~~~~~~~~~l~~li~~cl~~~p~~Rp~~~ei~~~l~~~ 265 (266)
T cd05033 228 -------PPPMDCPSALYQLMLDCWQKDRNERPTFSQIVSTLDKM 265 (266)
T ss_pred -------CCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 11112345677899999999999999999999999753
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment |
| >KOG0589 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-41 Score=335.55 Aligned_cols=251 Identities=25% Similarity=0.356 Sum_probs=209.6
Q ss_pred CCcccceeEeeeCceEEEEEEEc-CCCEEEEEEEcccc--hhhHHHHHHHHHHHhcCCCCCceeEEEEEEeCce-eeEEE
Q 010519 186 NRFSAENVLGEGGYGVVYKGRLI-NGSEVAVKKLLNNL--GQAEKEFRVEVEAIGHVRHKNLVRLLGYCIEGVH-RMLVY 261 (508)
Q Consensus 186 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~ei~~l~~l~h~niv~~~~~~~~~~~-~~lv~ 261 (508)
++|..++++|+|+||.+++++++ ++..+++|++.... .........|+.+++++.|||||.+++.|.+++. .+|||
T Consensus 4 ~~Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~~r~~A~~E~~lis~~~hP~iv~y~ds~~~~~~~l~Ivm 83 (426)
T KOG0589|consen 4 DNYEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEPERRSAIQEMDLLSKLLHPNIVEYKDSFEEDGQLLCIVM 83 (426)
T ss_pred chhhhhhhcCccccchhhhhhhccCCceEEEEEEeccccCchhhHHHHHHHHHHHhccCCCeeeeccchhcCCceEEEEE
Confidence 57889999999999999999875 67789999885433 2333466779999999999999999999999888 89999
Q ss_pred eecCCCCHHHHHhhhhccCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCEEEcCCCcEEEEecCCccccCC
Q 010519 262 EYVNNGNLEQWLHGAMRNQGNLTWEARMKVIIGTAKALAYLHEAIEPKVVHRDIKSSNILIDDEFNAKVSDFGLAKLLDS 341 (508)
Q Consensus 262 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~ 341 (508)
+||+||+|.+.|.. .++..++++.+..++.|++.|+.|||++ .|+|||||+.|||++.++.|||+|||+|+.++.
T Consensus 84 ~Y~eGg~l~~~i~~--~k~~~f~E~~i~~~~~Q~~~av~ylH~~---~iLHRDlK~~Nifltk~~~VkLgDfGlaK~l~~ 158 (426)
T KOG0589|consen 84 EYCEGGDLAQLIKE--QKGVLFPEERILKWFVQILLAVNYLHEN---RVLHRDLKCANIFLTKDKKVKLGDFGLAKILNP 158 (426)
T ss_pred eecCCCCHHHHHHH--HhhccccHHHHHHHHHHHHHHHHHHHhh---hhhcccchhhhhhccccCceeecchhhhhhcCC
Confidence 99999999999975 3457799999999999999999999998 999999999999999999999999999998876
Q ss_pred CCCcccccccccccccCccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCCCchhcHHHHHHHHhcccccccccCCC
Q 010519 342 GESHITTRVMGTFGYVAPEYANTGMLNEKSDIYSFGVLLLEAVTGRDPVDYGRPANEVNLVEWLKMMVGTRRAEEVVDPN 421 (508)
Q Consensus 342 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 421 (508)
... .....+||+.|+.||++.+.+|+.|+|||||||++|||++-+.+|...+.. ..+.... ..
T Consensus 159 ~~~-~a~tvvGTp~YmcPEil~d~pYn~KSDiWsLGC~~yEm~~lk~aF~a~~m~------~Li~ki~----------~~ 221 (426)
T KOG0589|consen 159 EDS-LASTVVGTPYYMCPEILSDIPYNEKSDIWSLGCCLYEMCTLKPAFKASNMS------ELILKIN----------RG 221 (426)
T ss_pred chh-hhheecCCCcccCHHHhCCCCCCccCcchhhcchHHHHHhcccccCccchH------HHHHHHh----------hc
Confidence 542 345678999999999999999999999999999999999999999754322 1111111 11
Q ss_pred CCCChhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 010519 422 LEVKPATRALKRSLLVALRCVDPDSEKRPKMSQVVRM 458 (508)
Q Consensus 422 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 458 (508)
.-.+.+......+..++..|+..+|..||++.++|.+
T Consensus 222 ~~~Plp~~ys~el~~lv~~~l~~~P~~RPsa~~LL~~ 258 (426)
T KOG0589|consen 222 LYSPLPSMYSSELRSLVKSMLRKNPEHRPSALELLRR 258 (426)
T ss_pred cCCCCCccccHHHHHHHHHHhhcCCccCCCHHHHhhC
Confidence 1112233345566679999999999999999999987
|
|
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-39 Score=372.64 Aligned_cols=261 Identities=32% Similarity=0.550 Sum_probs=208.9
Q ss_pred CCcccceeEeeeCceEEEEEEE-cCCCEEEEEEEcccchhhHHHHHHHHHHHhcCCCCCceeEEEEEEeCceeeEEEeec
Q 010519 186 NRFSAENVLGEGGYGVVYKGRL-INGSEVAVKKLLNNLGQAEKEFRVEVEAIGHVRHKNLVRLLGYCIEGVHRMLVYEYV 264 (508)
Q Consensus 186 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~ei~~l~~l~h~niv~~~~~~~~~~~~~lv~E~~ 264 (508)
..|...+.||+|+||.||+|++ .++..||||++...... ...|++.+++++|||||+++++|.+....++||||+
T Consensus 690 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~----~~~~~~~l~~l~HpnIv~~~~~~~~~~~~~lv~Ey~ 765 (968)
T PLN00113 690 SSLKEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNSI----PSSEIADMGKLQHPNIVKLIGLCRSEKGAYLIHEYI 765 (968)
T ss_pred hhCCcccEEccCCCeeEEEEEECCCCcEEEEEEccCCccc----cHHHHHHHhhCCCCCcceEEEEEEcCCCCEEEEeCC
Confidence 4567778999999999999987 47899999988543322 123688899999999999999999999999999999
Q ss_pred CCCCHHHHHhhhhccCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCEEEcCCCcEEEEecCCccccCCCCC
Q 010519 265 NNGNLEQWLHGAMRNQGNLTWEARMKVIIGTAKALAYLHEAIEPKVVHRDIKSSNILIDDEFNAKVSDFGLAKLLDSGES 344 (508)
Q Consensus 265 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~ 344 (508)
++|+|.++++ .++|..+.+++.||++||+|||....++|+||||||+||+++.++..++. ||........
T Consensus 766 ~~g~L~~~l~-------~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~~~~~~~-~~~~~~~~~~-- 835 (968)
T PLN00113 766 EGKNLSEVLR-------NLSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGLLCTD-- 835 (968)
T ss_pred CCCcHHHHHh-------cCCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECCCCceEEE-eccccccccC--
Confidence 9999999984 27899999999999999999996556699999999999999999888875 6655433211
Q ss_pred cccccccccccccCccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCCCchhcHHHHHHHHhcccccccccCCCCCC
Q 010519 345 HITTRVMGTFGYVAPEYANTGMLNEKSDIYSFGVLLLEAVTGRDPVDYGRPANEVNLVEWLKMMVGTRRAEEVVDPNLEV 424 (508)
Q Consensus 345 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 424 (508)
....+++.|+|||++.+..++.++|||||||++|||++|+.||+... .......+|.............+++.+..
T Consensus 836 ---~~~~~t~~y~aPE~~~~~~~~~~sDv~S~Gvvl~el~tg~~p~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 911 (968)
T PLN00113 836 ---TKCFISSAYVAPETRETKDITEKSDIYGFGLILIELLTGKSPADAEF-GVHGSIVEWARYCYSDCHLDMWIDPSIRG 911 (968)
T ss_pred ---CCccccccccCcccccCCCCCcccchhhHHHHHHHHHhCCCCCCccc-CCCCcHHHHHHHhcCccchhheeCccccC
Confidence 22357899999999999999999999999999999999999985332 22334556665544444444445554432
Q ss_pred --ChhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhhcCCC
Q 010519 425 --KPATRALKRSLLVALRCVDPDSEKRPKMSQVVRMLEADDY 464 (508)
Q Consensus 425 --~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~ 464 (508)
........++.+++.+||+.||.+||||.|+++.|+....
T Consensus 912 ~~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~L~~~~~ 953 (968)
T PLN00113 912 DVSVNQNEIVEVMNLALHCTATDPTARPCANDVLKTLESASR 953 (968)
T ss_pred CCCccHHHHHHHHHHHHhhCcCCchhCcCHHHHHHHHHHhhc
Confidence 2234556678889999999999999999999999987643
|
|
| >cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-40 Score=317.99 Aligned_cols=256 Identities=27% Similarity=0.417 Sum_probs=203.2
Q ss_pred HhhCCcccceeEeeeCceEEEEEEEcCCCEEEEEEEcccchhhHHHHHHHHHHHhcCCCCCceeEEEEEEeCceeeEEEe
Q 010519 183 IATNRFSAENVLGEGGYGVVYKGRLINGSEVAVKKLLNNLGQAEKEFRVEVEAIGHVRHKNLVRLLGYCIEGVHRMLVYE 262 (508)
Q Consensus 183 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~ei~~l~~l~h~niv~~~~~~~~~~~~~lv~E 262 (508)
+..++|.+...||+|++|.||++.+..+..+|+|.+.... .....+..|+.+++.++|+|++++++++. ....+++||
T Consensus 3 ~~~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~lK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e 80 (260)
T cd05069 3 IPRESLRLDVKLGQGCFGEVWMGTWNGTTKVAIKTLKPGT-MMPEAFLQEAQIMKKLRHDKLVPLYAVVS-EEPIYIVTE 80 (260)
T ss_pred CChHHeeeeeeecCcCCCeEEEEEEcCCceEEEEEcccCC-ccHHHHHHHHHHHHhCCCCCeeeEEEEEc-CCCcEEEEE
Confidence 3446789999999999999999998777789999875433 23456888999999999999999999875 456789999
Q ss_pred ecCCCCHHHHHhhhhccCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCEEEcCCCcEEEEecCCccccCCC
Q 010519 263 YVNNGNLEQWLHGAMRNQGNLTWEARMKVIIGTAKALAYLHEAIEPKVVHRDIKSSNILIDDEFNAKVSDFGLAKLLDSG 342 (508)
Q Consensus 263 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~~ 342 (508)
|+.+|+|.++++. .....+++..+..++.+++.||.|||+. +++|+||||+||++++++.++|+|||++......
T Consensus 81 ~~~~~~L~~~~~~--~~~~~~~~~~~~~~~~~l~~al~~lH~~---~i~H~dl~~~Nill~~~~~~~l~dfg~~~~~~~~ 155 (260)
T cd05069 81 FMGKGSLLDFLKE--GDGKYLKLPQLVDMAAQIADGMAYIERM---NYIHRDLRAANILVGDNLVCKIADFGLARLIEDN 155 (260)
T ss_pred cCCCCCHHHHHhh--CCCCCCCHHHHHHHHHHHHHHHHHHHhC---CEeecccCcceEEEcCCCeEEECCCccceEccCC
Confidence 9999999999964 2334588999999999999999999998 9999999999999999999999999999866433
Q ss_pred CCcccccccccccccCccccCCCCCCChhhHHHHHHHHHHHHh-CCCCCCCCCCCchhcHHHHHHHHhcccccccccCCC
Q 010519 343 ESHITTRVMGTFGYVAPEYANTGMLNEKSDIYSFGVLLLEAVT-GRDPVDYGRPANEVNLVEWLKMMVGTRRAEEVVDPN 421 (508)
Q Consensus 343 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 421 (508)
.........++..|+|||.+.+..++.++|||||||++|||++ |..||...... ...........
T Consensus 156 ~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~------~~~~~~~~~~~-------- 221 (260)
T cd05069 156 EYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMVNR------EVLEQVERGYR-------- 221 (260)
T ss_pred cccccCCCccchhhCCHHHhccCCcChHHHHHHHHHHHHHHHhCCCCCCCCCCHH------HHHHHHHcCCC--------
Confidence 2222222345678999999998899999999999999999999 89998643211 11111111100
Q ss_pred CCCChhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhhc
Q 010519 422 LEVKPATRALKRSLLVALRCVDPDSEKRPKMSQVVRMLEA 461 (508)
Q Consensus 422 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~ 461 (508)
...+......+.+++.+||++||.+||++.++++.|+.
T Consensus 222 --~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 259 (260)
T cd05069 222 --MPCPQGCPESLHELMKLCWKKDPDERPTFEYIQSFLED 259 (260)
T ss_pred --CCCCcccCHHHHHHHHHHccCCcccCcCHHHHHHHHhc
Confidence 01112234567779999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an |
| >cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-40 Score=324.15 Aligned_cols=260 Identities=25% Similarity=0.435 Sum_probs=206.2
Q ss_pred hCCcccceeEeeeCceEEEEEEEc------CCCEEEEEEEcccchhhHHHHHHHHHHHhcCCCCCceeEEEEEEeCceee
Q 010519 185 TNRFSAENVLGEGGYGVVYKGRLI------NGSEVAVKKLLNNLGQAEKEFRVEVEAIGHVRHKNLVRLLGYCIEGVHRM 258 (508)
Q Consensus 185 ~~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~ei~~l~~l~h~niv~~~~~~~~~~~~~ 258 (508)
.++|.+.+.||+|+||.||++... ++..+|+|.+..........+..|+.++++++||||+++++++......+
T Consensus 4 ~~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 83 (288)
T cd05093 4 RHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLI 83 (288)
T ss_pred hHHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCcCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccE
Confidence 457899999999999999999752 24568899886655555667889999999999999999999999999999
Q ss_pred EEEeecCCCCHHHHHhhhh---------ccCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCEEEcCCCcEE
Q 010519 259 LVYEYVNNGNLEQWLHGAM---------RNQGNLTWEARMKVIIGTAKALAYLHEAIEPKVVHRDIKSSNILIDDEFNAK 329 (508)
Q Consensus 259 lv~E~~~~gsL~~~l~~~~---------~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiH~Dlk~~NIll~~~~~~k 329 (508)
+||||+++++|.+++.... .....+++..++.++.|++.||.|||+. +++||||||+|||+++++.+|
T Consensus 84 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~---~i~H~dlkp~Nili~~~~~~k 160 (288)
T cd05093 84 MVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQ---HFVHRDLATRNCLVGENLLVK 160 (288)
T ss_pred EEEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecccCcceEEEccCCcEE
Confidence 9999999999999996421 1123589999999999999999999998 999999999999999999999
Q ss_pred EEecCCccccCCCCC-cccccccccccccCccccCCCCCCChhhHHHHHHHHHHHHh-CCCCCCCCCCCchhcHHHHHHH
Q 010519 330 VSDFGLAKLLDSGES-HITTRVMGTFGYVAPEYANTGMLNEKSDIYSFGVLLLEAVT-GRDPVDYGRPANEVNLVEWLKM 407 (508)
Q Consensus 330 l~Dfgla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~ellt-G~~Pf~~~~~~~~~~~~~~~~~ 407 (508)
|+|||++........ .......++..|+|||++.+..++.++|||||||++|+|++ |..||...... .....
T Consensus 161 l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t~g~~p~~~~~~~------~~~~~ 234 (288)
T cd05093 161 IGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNN------EVIEC 234 (288)
T ss_pred eccCCccccccCCceeecCCCCCccccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHH------HHHHH
Confidence 999999986543221 11223345778999999999899999999999999999998 89998643321 11111
Q ss_pred HhcccccccccCCCCCCChhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhhcCC
Q 010519 408 MVGTRRAEEVVDPNLEVKPATRALKRSLLVALRCVDPDSEKRPKMSQVVRMLEADD 463 (508)
Q Consensus 408 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~ 463 (508)
.... ... ... ......+.+|+.+||++||.+|||+.+++..|+...
T Consensus 235 i~~~-~~~-----~~~----~~~~~~l~~li~~~l~~~p~~Rpt~~~v~~~l~~~~ 280 (288)
T cd05093 235 ITQG-RVL-----QRP----RTCPKEVYDLMLGCWQREPHMRLNIKEIHSLLQNLA 280 (288)
T ss_pred HHcC-CcC-----CCC----CCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHH
Confidence 1111 100 000 112345777999999999999999999999998754
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly |
| >cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-40 Score=330.21 Aligned_cols=251 Identities=24% Similarity=0.310 Sum_probs=196.8
Q ss_pred eeEeeeCceEEEEEEEc-CCCEEEEEEEcccc---hhhHHHHHHHHHHHhcC-CCCCceeEEEEEEeCceeeEEEeecCC
Q 010519 192 NVLGEGGYGVVYKGRLI-NGSEVAVKKLLNNL---GQAEKEFRVEVEAIGHV-RHKNLVRLLGYCIEGVHRMLVYEYVNN 266 (508)
Q Consensus 192 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~ei~~l~~l-~h~niv~~~~~~~~~~~~~lv~E~~~~ 266 (508)
+.||+|+||.||++++. ++..||+|.+.... ......+..|..++..+ +||||+++++++.+....|+||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~~~lv~e~~~~ 80 (329)
T cd05588 1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTESRLFFVIEFVSG 80 (329)
T ss_pred CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcCCEEEEEEeCCCC
Confidence 46999999999999875 68899999986532 22334577899999888 799999999999999999999999999
Q ss_pred CCHHHHHhhhhccCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCEEEcCCCcEEEEecCCccccCCCCCcc
Q 010519 267 GNLEQWLHGAMRNQGNLTWEARMKVIIGTAKALAYLHEAIEPKVVHRDIKSSNILIDDEFNAKVSDFGLAKLLDSGESHI 346 (508)
Q Consensus 267 gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~ 346 (508)
|+|.+++. ....+++..++.++.||+.||.|||++ +++||||||+|||++.++.+||+|||++....... ..
T Consensus 81 g~L~~~~~----~~~~l~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~~-~~ 152 (329)
T cd05588 81 GDLMFHMQ----RQRKLPEEHARFYSAEISLALNFLHER---GIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPG-DT 152 (329)
T ss_pred CCHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHeEECCCCCEEECcCccccccccCC-Cc
Confidence 99999884 446799999999999999999999999 99999999999999999999999999987432211 12
Q ss_pred cccccccccccCccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCCCc--hhcHHHHHHHHhcccccccccCCCCCC
Q 010519 347 TTRVMGTFGYVAPEYANTGMLNEKSDIYSFGVLLLEAVTGRDPVDYGRPAN--EVNLVEWLKMMVGTRRAEEVVDPNLEV 424 (508)
Q Consensus 347 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltG~~Pf~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~ 424 (508)
....+||+.|+|||++.+..++.++|||||||++|+|++|+.||....... .....++......... ...
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~--------~~~ 224 (329)
T cd05588 153 TSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQVILEKQ--------IRI 224 (329)
T ss_pred cccccCCccccCHHHHcCCCCCCccceechHHHHHHHHHCCCCcccccccccccccchHHHHHHHHcCC--------CCC
Confidence 334578999999999999999999999999999999999999996332211 1111222222211111 111
Q ss_pred ChhHHHHHHHHHHHHHhcCCCCCCCCC------HHHHHHHhh
Q 010519 425 KPATRALKRSLLVALRCVDPDSEKRPK------MSQVVRMLE 460 (508)
Q Consensus 425 ~~~~~~~~~l~~li~~cl~~dP~~RPs------~~evl~~L~ 460 (508)
+ ......+.+++.+||+.||.+||+ +.++++|-+
T Consensus 225 p--~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~hp~ 264 (329)
T cd05588 225 P--RSLSVKASSVLKGFLNKDPKERLGCHPQTGFRDIKSHPF 264 (329)
T ss_pred C--CCCCHHHHHHHHHHhccCHHHcCCCCCCCCHHHHhcCCC
Confidence 1 112345667999999999999997 678887643
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl |
| >cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-40 Score=318.21 Aligned_cols=258 Identities=31% Similarity=0.481 Sum_probs=208.0
Q ss_pred HHhhCCcccceeEeeeCceEEEEEEEcCCCEEEEEEEcccchhhHHHHHHHHHHHhcCCCCCceeEEEEEEeCceeeEEE
Q 010519 182 EIATNRFSAENVLGEGGYGVVYKGRLINGSEVAVKKLLNNLGQAEKEFRVEVEAIGHVRHKNLVRLLGYCIEGVHRMLVY 261 (508)
Q Consensus 182 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~ei~~l~~l~h~niv~~~~~~~~~~~~~lv~ 261 (508)
++..++|.+.+.||+|+||.||++.+.++..+|+|.+.... .....+..|+.+++.++|+||+++++++......++||
T Consensus 2 ~~~~~~~~i~~~ig~g~~~~v~~~~~~~~~~~~vK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 80 (261)
T cd05034 2 EIPRESLKLERKLGAGQFGEVWMGTWNGTTKVAVKTLKPGT-MSPEAFLQEAQIMKKLRHDKLVQLYAVCSEEEPIYIVT 80 (261)
T ss_pred ccchhheeeeeeeccCcceEEEEEEEcCCceEEEEEecCCc-cCHHHHHHHHHHHhhCCCCCEeeeeeeeecCCceEEEE
Confidence 35567899999999999999999998778889999886543 23467888999999999999999999999888999999
Q ss_pred eecCCCCHHHHHhhhhccCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCEEEcCCCcEEEEecCCccccCC
Q 010519 262 EYVNNGNLEQWLHGAMRNQGNLTWEARMKVIIGTAKALAYLHEAIEPKVVHRDIKSSNILIDDEFNAKVSDFGLAKLLDS 341 (508)
Q Consensus 262 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~ 341 (508)
||+++++|.+++.. .....+++..+..++.+++.|+.|||++ +++|+||||+||++++++.+||+|||++.....
T Consensus 81 e~~~~~~L~~~i~~--~~~~~~~~~~~~~~~~~i~~al~~lh~~---~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~ 155 (261)
T cd05034 81 EYMSKGSLLDFLKS--GEGKKLRLPQLVDMAAQIAEGMAYLESR---NYIHRDLAARNILVGENLVCKIADFGLARLIED 155 (261)
T ss_pred eccCCCCHHHHHhc--cccCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCcchheEEEcCCCCEEECccccceeccc
Confidence 99999999999964 2335689999999999999999999999 999999999999999999999999999986653
Q ss_pred CCCcccccccccccccCccccCCCCCCChhhHHHHHHHHHHHHh-CCCCCCCCCCCchhcHHHHHHHHhcccccccccCC
Q 010519 342 GESHITTRVMGTFGYVAPEYANTGMLNEKSDIYSFGVLLLEAVT-GRDPVDYGRPANEVNLVEWLKMMVGTRRAEEVVDP 420 (508)
Q Consensus 342 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 420 (508)
..........++..|+|||.+.+..++.++|+|||||++|+|++ |+.||..... ............
T Consensus 156 ~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~------~~~~~~~~~~~~------- 222 (261)
T cd05034 156 DEYTAREGAKFPIKWTAPEAANYGRFTIKSDVWSFGILLTEIVTYGRVPYPGMTN------REVLEQVERGYR------- 222 (261)
T ss_pred hhhhhhhccCCCccccCHHHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCH------HHHHHHHHcCCC-------
Confidence 32222222334568999999999899999999999999999998 9999853321 111222211110
Q ss_pred CCCCChhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhhc
Q 010519 421 NLEVKPATRALKRSLLVALRCVDPDSEKRPKMSQVVRMLEA 461 (508)
Q Consensus 421 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~ 461 (508)
...+......+.+++.+||+.+|.+||++.++++.|+.
T Consensus 223 ---~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~l~~ 260 (261)
T cd05034 223 ---MPRPPNCPEELYDLMLQCWDKDPEERPTFEYLQSFLED 260 (261)
T ss_pred ---CCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHHhc
Confidence 00111123467779999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t |
| >cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-40 Score=338.54 Aligned_cols=263 Identities=24% Similarity=0.390 Sum_probs=206.1
Q ss_pred HHhhCCcccceeEeeeCceEEEEEEEcC------CCEEEEEEEcccch-hhHHHHHHHHHHHhcCC-CCCceeEEEEEEe
Q 010519 182 EIATNRFSAENVLGEGGYGVVYKGRLIN------GSEVAVKKLLNNLG-QAEKEFRVEVEAIGHVR-HKNLVRLLGYCIE 253 (508)
Q Consensus 182 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~~------~~~vavK~~~~~~~-~~~~~~~~ei~~l~~l~-h~niv~~~~~~~~ 253 (508)
....++|.+.+.||+|+||.||+|++.. +..||||++..... ...+.+..|++++.++. ||||++++++|.+
T Consensus 33 ~~~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~~~ 112 (400)
T cd05105 33 EFPRDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTARSSEKQALMSELKIMTHLGPHLNIVNLLGACTK 112 (400)
T ss_pred eccccceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCCeeeEEEEEcc
Confidence 4566789999999999999999998631 34699999865432 33457888999999996 9999999999999
Q ss_pred CceeeEEEeecCCCCHHHHHhhhhc-------------------------------------------------------
Q 010519 254 GVHRMLVYEYVNNGNLEQWLHGAMR------------------------------------------------------- 278 (508)
Q Consensus 254 ~~~~~lv~E~~~~gsL~~~l~~~~~------------------------------------------------------- 278 (508)
....||||||+++|+|.++|+....
T Consensus 113 ~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 192 (400)
T cd05105 113 SGPIYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYVPML 192 (400)
T ss_pred CCceEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccccchhh
Confidence 9999999999999999999864311
Q ss_pred -------------------------------------cCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCEE
Q 010519 279 -------------------------------------NQGNLTWEARMKVIIGTAKALAYLHEAIEPKVVHRDIKSSNIL 321 (508)
Q Consensus 279 -------------------------------------~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiH~Dlk~~NIl 321 (508)
....+++..+..++.||+.||.|||+. +|+|+||||+|||
T Consensus 193 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivH~dikp~Nil 269 (400)
T cd05105 193 EIKEASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASK---NCVHRDLAARNVL 269 (400)
T ss_pred hhhhhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChHhEE
Confidence 012477888899999999999999998 9999999999999
Q ss_pred EcCCCcEEEEecCCccccCCCCCc-ccccccccccccCccccCCCCCCChhhHHHHHHHHHHHHh-CCCCCCCCCCCchh
Q 010519 322 IDDEFNAKVSDFGLAKLLDSGESH-ITTRVMGTFGYVAPEYANTGMLNEKSDIYSFGVLLLEAVT-GRDPVDYGRPANEV 399 (508)
Q Consensus 322 l~~~~~~kl~Dfgla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~ellt-G~~Pf~~~~~~~~~ 399 (508)
+++++.+||+|||++......... ......+++.|+|||.+.+..++.++|||||||+||||++ |..||........
T Consensus 270 l~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt~g~~P~~~~~~~~~- 348 (400)
T cd05105 270 LAQGKIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFSLGGTPYPGMIVDST- 348 (400)
T ss_pred EeCCCEEEEEeCCcceeccccccccccCCcCCCcceEChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCcccchhHH-
Confidence 999999999999999865432221 1223456788999999999999999999999999999997 9999864322111
Q ss_pred cHHHHHHHHhcccccccccCCCCCCChhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhhcC
Q 010519 400 NLVEWLKMMVGTRRAEEVVDPNLEVKPATRALKRSLLVALRCVDPDSEKRPKMSQVVRMLEAD 462 (508)
Q Consensus 400 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~ 462 (508)
. ....... .....+......+.+++.+||+.||.+|||+.+|.+.|+..
T Consensus 349 -~---~~~~~~~----------~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~l~~l 397 (400)
T cd05105 349 -F---YNKIKSG----------YRMAKPDHATQEVYDIMVKCWNSEPEKRPSFLHLSDIVESL 397 (400)
T ss_pred -H---HHHHhcC----------CCCCCCccCCHHHHHHHHHHCccCHhHCcCHHHHHHHHHHH
Confidence 1 1111111 01111122345677899999999999999999999999853
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF- |
| >cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-40 Score=334.67 Aligned_cols=245 Identities=22% Similarity=0.265 Sum_probs=196.2
Q ss_pred eeEeeeCceEEEEEEEc-CCCEEEEEEEcccc---hhhHHHHHHHHHHHhcCCCCCceeEEEEEEeCceeeEEEeecCCC
Q 010519 192 NVLGEGGYGVVYKGRLI-NGSEVAVKKLLNNL---GQAEKEFRVEVEAIGHVRHKNLVRLLGYCIEGVHRMLVYEYVNNG 267 (508)
Q Consensus 192 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~ei~~l~~l~h~niv~~~~~~~~~~~~~lv~E~~~~g 267 (508)
+.||+|+||.||++... +|..||+|.+.... ......+..|+.++..++||||+++++++......++||||+++|
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 80 (325)
T cd05594 1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGG 80 (325)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEcCCEEEEEEeCCCCC
Confidence 46999999999999864 68899999986532 223345677999999999999999999999999999999999999
Q ss_pred CHHHHHhhhhccCCCccHHHHHHHHHHHHHHHHHHHh-cCCCCeEeecCCCCCEEEcCCCcEEEEecCCccccCCCCCcc
Q 010519 268 NLEQWLHGAMRNQGNLTWEARMKVIIGTAKALAYLHE-AIEPKVVHRDIKSSNILIDDEFNAKVSDFGLAKLLDSGESHI 346 (508)
Q Consensus 268 sL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~yLH~-~~~~~iiH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~ 346 (508)
+|.+++. ....+++..+..++.||+.||.|||+ . +|+||||||+|||++.++.+||+|||++........ .
T Consensus 81 ~L~~~l~----~~~~l~~~~~~~~~~qi~~aL~~lH~~~---~ivHrDikp~NIll~~~~~~kL~Dfg~~~~~~~~~~-~ 152 (325)
T cd05594 81 ELFFHLS----RERVFSEDRARFYGAEIVSALDYLHSEK---NVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGA-T 152 (325)
T ss_pred cHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHhcC---CEEecCCCCCeEEECCCCCEEEecCCCCeecCCCCc-c
Confidence 9999884 44578999999999999999999997 6 999999999999999999999999999875432221 2
Q ss_pred cccccccccccCccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCCCchhcHHHHHHHHhcccccccccCCCCCCCh
Q 010519 347 TTRVMGTFGYVAPEYANTGMLNEKSDIYSFGVLLLEAVTGRDPVDYGRPANEVNLVEWLKMMVGTRRAEEVVDPNLEVKP 426 (508)
Q Consensus 347 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 426 (508)
.....||+.|+|||++.+..++.++|||||||+||||++|..||...... ......... . ..+
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tG~~Pf~~~~~~------~~~~~i~~~-~------~~~---- 215 (325)
T cd05594 153 MKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE------KLFELILME-E------IRF---- 215 (325)
T ss_pred cccccCCcccCCHHHHccCCCCCccccccccceeeeeccCCCCCCCCCHH------HHHHHHhcC-C------CCC----
Confidence 33456899999999999999999999999999999999999999643221 111111100 0 001
Q ss_pred hHHHHHHHHHHHHHhcCCCCCCCC-----CHHHHHHHhhc
Q 010519 427 ATRALKRSLLVALRCVDPDSEKRP-----KMSQVVRMLEA 461 (508)
Q Consensus 427 ~~~~~~~l~~li~~cl~~dP~~RP-----s~~evl~~L~~ 461 (508)
+......+.+++.+||+.||.+|+ ++.+++++-.-
T Consensus 216 p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h~~~ 255 (325)
T cd05594 216 PRTLSPEAKSLLSGLLKKDPKQRLGGGPDDAKEIMQHKFF 255 (325)
T ss_pred CCCCCHHHHHHHHHHhhcCHHHhCCCCCCCHHHHhcCCCc
Confidence 111234566799999999999996 89999987543
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien |
| >cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-40 Score=331.93 Aligned_cols=244 Identities=25% Similarity=0.353 Sum_probs=195.7
Q ss_pred eeEeeeCceEEEEEEEc----CCCEEEEEEEcccc----hhhHHHHHHHHHHHhcCCCCCceeEEEEEEeCceeeEEEee
Q 010519 192 NVLGEGGYGVVYKGRLI----NGSEVAVKKLLNNL----GQAEKEFRVEVEAIGHVRHKNLVRLLGYCIEGVHRMLVYEY 263 (508)
Q Consensus 192 ~~lg~G~~g~Vy~~~~~----~~~~vavK~~~~~~----~~~~~~~~~ei~~l~~l~h~niv~~~~~~~~~~~~~lv~E~ 263 (508)
+.||+|+||.||+++.. .++.||+|.+.... ......+..|+.+++.++||||+++++++..+...|+||||
T Consensus 2 ~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~e~ 81 (323)
T cd05584 2 KVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQTGGKLYLILEY 81 (323)
T ss_pred ceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEecCCeEEEEEeC
Confidence 67999999999999752 57889999886432 12234577899999999999999999999999999999999
Q ss_pred cCCCCHHHHHhhhhccCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCEEEcCCCcEEEEecCCccccCCCC
Q 010519 264 VNNGNLEQWLHGAMRNQGNLTWEARMKVIIGTAKALAYLHEAIEPKVVHRDIKSSNILIDDEFNAKVSDFGLAKLLDSGE 343 (508)
Q Consensus 264 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~~~ 343 (508)
+++|+|.+++. ..+.+.+..+..++.||+.||.|||++ +|+||||||+|||++.++.+||+|||+++......
T Consensus 82 ~~~~~L~~~~~----~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 154 (323)
T cd05584 82 LSGGELFMHLE----REGIFMEDTACFYLSEISLALEHLHQQ---GIIYRDLKPENILLDAQGHVKLTDFGLCKESIHEG 154 (323)
T ss_pred CCCchHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCCEEEeeCcCCeecccCC
Confidence 99999999984 345678888999999999999999999 99999999999999999999999999987543222
Q ss_pred CcccccccccccccCccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCCCchhcHHHHHHHHhcccccccccCCCCC
Q 010519 344 SHITTRVMGTFGYVAPEYANTGMLNEKSDIYSFGVLLLEAVTGRDPVDYGRPANEVNLVEWLKMMVGTRRAEEVVDPNLE 423 (508)
Q Consensus 344 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 423 (508)
. ......|++.|+|||++.+..++.++|||||||+||||++|+.||..... .......... ...
T Consensus 155 ~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~pf~~~~~------~~~~~~~~~~---------~~~ 218 (323)
T cd05584 155 T-VTHTFCGTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPFTAENR------KKTIDKILKG---------KLN 218 (323)
T ss_pred C-cccccCCCccccChhhccCCCCCCcceecccHHHHHHHhcCCCCCCCCCH------HHHHHHHHcC---------CCC
Confidence 1 23345789999999999998899999999999999999999999964321 1112222111 111
Q ss_pred CChhHHHHHHHHHHHHHhcCCCCCCCC-----CHHHHHHHhh
Q 010519 424 VKPATRALKRSLLVALRCVDPDSEKRP-----KMSQVVRMLE 460 (508)
Q Consensus 424 ~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~evl~~L~ 460 (508)
. +......+.+++.+||+.||.+|| ++.+++++-.
T Consensus 219 ~--~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~l~~h~~ 258 (323)
T cd05584 219 L--PPYLTPEARDLLKKLLKRNPSSRLGAGPGDAAEVQSHPF 258 (323)
T ss_pred C--CCCCCHHHHHHHHHHcccCHhHcCCCCCCCHHHHhcCCC
Confidence 1 111234566799999999999999 8999888654
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in |
| >cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-40 Score=333.66 Aligned_cols=263 Identities=25% Similarity=0.368 Sum_probs=196.7
Q ss_pred CcccceeEeeeCceEEEEEEEc-CCCEEEEEEEcccc--hhhHHHHHHHHHHHhcCCCCCceeEEEEEEeC-----ceee
Q 010519 187 RFSAENVLGEGGYGVVYKGRLI-NGSEVAVKKLLNNL--GQAEKEFRVEVEAIGHVRHKNLVRLLGYCIEG-----VHRM 258 (508)
Q Consensus 187 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~ei~~l~~l~h~niv~~~~~~~~~-----~~~~ 258 (508)
+|++.+.||+|+||.||+|++. ++..||||++.... ......+.+|+.+++.++||||+++++++... ...|
T Consensus 1 ry~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~ 80 (338)
T cd07859 1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIY 80 (338)
T ss_pred CeEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhhccchhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCceEE
Confidence 5888999999999999999875 68999999886432 22335678899999999999999999988643 2478
Q ss_pred EEEeecCCCCHHHHHhhhhccCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCEEEcCCCcEEEEecCCccc
Q 010519 259 LVYEYVNNGNLEQWLHGAMRNQGNLTWEARMKVIIGTAKALAYLHEAIEPKVVHRDIKSSNILIDDEFNAKVSDFGLAKL 338 (508)
Q Consensus 259 lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~Dfgla~~ 338 (508)
+||||+. ++|.+++. ....+++..+..++.||+.||.|||+. +|+||||||+|||++.++.+||+|||+++.
T Consensus 81 lv~e~~~-~~L~~~l~----~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIll~~~~~~kL~Dfg~~~~ 152 (338)
T cd07859 81 VVFELME-SDLHQVIK----ANDDLTPEHHQFFLYQLLRALKYIHTA---NVFHRDLKPKNILANADCKLKICDFGLARV 152 (338)
T ss_pred EEEecCC-CCHHHHHH----hcccCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCcEEEccCccccc
Confidence 9999995 69999884 445689999999999999999999999 999999999999999999999999999985
Q ss_pred cCCCCC--cccccccccccccCccccCC--CCCCChhhHHHHHHHHHHHHhCCCCCCCCCCCchhcHHHHHHHHhccccc
Q 010519 339 LDSGES--HITTRVMGTFGYVAPEYANT--GMLNEKSDIYSFGVLLLEAVTGRDPVDYGRPANEVNLVEWLKMMVGTRRA 414 (508)
Q Consensus 339 ~~~~~~--~~~~~~~gt~~y~aPE~~~~--~~~~~~~DvwS~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~ 414 (508)
...... .......||+.|+|||++.+ ..++.++|||||||++|||++|+.||....... ....+....+....
T Consensus 153 ~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~~~~~---~~~~~~~~~~~~~~ 229 (338)
T cd07859 153 AFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVH---QLDLITDLLGTPSP 229 (338)
T ss_pred cccccCccccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCCCChHH---HHHHHHHHhCCCCH
Confidence 432211 12234578999999999876 678999999999999999999999996433211 11111111110000
Q ss_pred -----------cc---ccCCCCCCChh---HHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhh
Q 010519 415 -----------EE---VVDPNLEVKPA---TRALKRSLLVALRCVDPDSEKRPKMSQVVRMLE 460 (508)
Q Consensus 415 -----------~~---~~~~~~~~~~~---~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 460 (508)
.. ........... ......+.+++.+||+.||.+|||++|++++-.
T Consensus 230 ~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~e~l~hp~ 292 (338)
T cd07859 230 ETISRVRNEKARRYLSSMRKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRPTAEEALADPY 292 (338)
T ss_pred HHHHHhhhhhHHHHHHhhcccCCCchHHhcCCCChHHHHHHHHHcCcCcccCCCHHHHhcCch
Confidence 00 00000000000 012234567999999999999999999998643
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos |
| >cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-40 Score=324.70 Aligned_cols=262 Identities=25% Similarity=0.366 Sum_probs=194.1
Q ss_pred CCcccceeEeeeCceEEEEEEEc--CCCEEEEEEEcccch--hhHHHHHHHHHHHhcC---CCCCceeEEEEEEe-----
Q 010519 186 NRFSAENVLGEGGYGVVYKGRLI--NGSEVAVKKLLNNLG--QAEKEFRVEVEAIGHV---RHKNLVRLLGYCIE----- 253 (508)
Q Consensus 186 ~~~~~~~~lg~G~~g~Vy~~~~~--~~~~vavK~~~~~~~--~~~~~~~~ei~~l~~l---~h~niv~~~~~~~~----- 253 (508)
++|++.+.||+|+||+||+|++. ++..||+|++..... .....+.+|+.+++.+ +||||++++++|..
T Consensus 1 ~~Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~~ 80 (290)
T cd07862 1 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDR 80 (290)
T ss_pred CCcceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCCCchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCCC
Confidence 37899999999999999999863 467899998854331 1223455577666655 69999999999863
Q ss_pred CceeeEEEeecCCCCHHHHHhhhhccCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCEEEcCCCcEEEEec
Q 010519 254 GVHRMLVYEYVNNGNLEQWLHGAMRNQGNLTWEARMKVIIGTAKALAYLHEAIEPKVVHRDIKSSNILIDDEFNAKVSDF 333 (508)
Q Consensus 254 ~~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~Df 333 (508)
....++||||++ ++|.+++.. .....+++..+..++.||+.||.|||+. +|+||||||+|||++.++.+||+||
T Consensus 81 ~~~~~lv~e~~~-~~l~~~~~~--~~~~~~~~~~~~~i~~qi~~aL~~lH~~---~iiH~dlkp~Nil~~~~~~~kl~Df 154 (290)
T cd07862 81 ETKLTLVFEHVD-QDLTTYLDK--VPEPGVPTETIKDMMFQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADF 154 (290)
T ss_pred CCcEEEEEccCC-CCHHHHHHh--CCCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHHHEEEcCCCCEEEccc
Confidence 345789999996 699999864 2345688999999999999999999999 9999999999999999999999999
Q ss_pred CCccccCCCCCcccccccccccccCccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCCCchhcHHHHHHHHhcccc
Q 010519 334 GLAKLLDSGESHITTRVMGTFGYVAPEYANTGMLNEKSDIYSFGVLLLEAVTGRDPVDYGRPANEVNLVEWLKMMVGTRR 413 (508)
Q Consensus 334 gla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~ 413 (508)
|++...... .......|++.|+|||++.+..++.++|||||||++|||++|+.||....... ....+....+...
T Consensus 155 g~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~---~~~~i~~~~~~~~ 229 (290)
T cd07862 155 GLARIYSFQ--MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVD---QLGKILDVIGLPG 229 (290)
T ss_pred cceEeccCC--cccccccccccccChHHHhCCCCCCccchHHHHHHHHHHHcCCCCcCCCCHHH---HHHHHHHHhCCCC
Confidence 999865433 22344568999999999998899999999999999999999999997543211 1111111111000
Q ss_pred cc----------cccCCCCCCCh---hHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 010519 414 AE----------EVVDPNLEVKP---ATRALKRSLLVALRCVDPDSEKRPKMSQVVRM 458 (508)
Q Consensus 414 ~~----------~~~~~~~~~~~---~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 458 (508)
.. ........... .......+.+|+.+||+.||++|||+.|++++
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~h 287 (290)
T cd07862 230 EEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSH 287 (290)
T ss_pred hhhchhhhcccchhccCCCCCCHHHHccCCCHHHHHHHHHHhccCchhcCCHHHHhcC
Confidence 00 00000000000 01123455679999999999999999999964
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla |
| >cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-40 Score=321.69 Aligned_cols=250 Identities=24% Similarity=0.291 Sum_probs=197.8
Q ss_pred EeeeCceEEEEEEEc-CCCEEEEEEEcccch---hhHHHHHHHHHHHhcCCCCCceeEEEEEEeCceeeEEEeecCCCCH
Q 010519 194 LGEGGYGVVYKGRLI-NGSEVAVKKLLNNLG---QAEKEFRVEVEAIGHVRHKNLVRLLGYCIEGVHRMLVYEYVNNGNL 269 (508)
Q Consensus 194 lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~ei~~l~~l~h~niv~~~~~~~~~~~~~lv~E~~~~gsL 269 (508)
||+|+||+||++.+. +++.+|+|++..... .....+..|+.+++.++|+||+++++++......++||||+++|+|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~g~L 80 (280)
T cd05608 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQTKTDLCLVMTIMNGGDL 80 (280)
T ss_pred CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcCCCeEEEEEeCCCCCCH
Confidence 699999999999875 688999999864332 2224567899999999999999999999999999999999999999
Q ss_pred HHHHhhhhccCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCEEEcCCCcEEEEecCCccccCCCCCccccc
Q 010519 270 EQWLHGAMRNQGNLTWEARMKVIIGTAKALAYLHEAIEPKVVHRDIKSSNILIDDEFNAKVSDFGLAKLLDSGESHITTR 349 (508)
Q Consensus 270 ~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~ 349 (508)
.+++.........+++..+..++.||+.||.|||+. +|+||||||+||++++++.+||+|||++........ ....
T Consensus 81 ~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~-~~~~ 156 (280)
T cd05608 81 RYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQR---RIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQS-KTKG 156 (280)
T ss_pred HHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEeeCccceecCCCCc-cccc
Confidence 998864434456789999999999999999999999 999999999999999999999999999986544322 2234
Q ss_pred ccccccccCccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCCCchhcHHHHHHHHhcccccccccCCCCCCChhHH
Q 010519 350 VMGTFGYVAPEYANTGMLNEKSDIYSFGVLLLEAVTGRDPVDYGRPANEVNLVEWLKMMVGTRRAEEVVDPNLEVKPATR 429 (508)
Q Consensus 350 ~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 429 (508)
..|++.|+|||++.+..++.++|||||||++|||++|+.||........ ......... .... ..+..
T Consensus 157 ~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~--~~~~~~~~~---------~~~~--~~~~~ 223 (280)
T cd05608 157 YAGTPGFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVE--NKELKQRIL---------NDSV--TYPDK 223 (280)
T ss_pred cCCCcCccCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCcchh--HHHHHHhhc---------ccCC--CCccc
Confidence 5689999999999999999999999999999999999999964332111 111111111 0111 11112
Q ss_pred HHHHHHHHHHHhcCCCCCCCC-----CHHHHHHHhh
Q 010519 430 ALKRSLLVALRCVDPDSEKRP-----KMSQVVRMLE 460 (508)
Q Consensus 430 ~~~~l~~li~~cl~~dP~~RP-----s~~evl~~L~ 460 (508)
....+.+++.+||+.||.+|| ++++++++-+
T Consensus 224 ~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~l~h~~ 259 (280)
T cd05608 224 FSPASKSFCEALLAKDPEKRLGFRDGNCDGLRTHPL 259 (280)
T ss_pred CCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHhcChh
Confidence 344566799999999999999 7788887643
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g |
| >cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-39 Score=333.48 Aligned_cols=265 Identities=20% Similarity=0.275 Sum_probs=206.7
Q ss_pred HHHHHHhhCCcccceeEeeeCceEEEEEEEc-CCCEEEEEEEcccc---hhhHHHHHHHHHHHhcCCCCCceeEEEEEEe
Q 010519 178 LRDLEIATNRFSAENVLGEGGYGVVYKGRLI-NGSEVAVKKLLNNL---GQAEKEFRVEVEAIGHVRHKNLVRLLGYCIE 253 (508)
Q Consensus 178 ~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~ei~~l~~l~h~niv~~~~~~~~ 253 (508)
+.++....++|++.+.||+|+||.||++.+. +++.+|+|.+.... ......+.+|+.+++.++||||+++++++.+
T Consensus 35 ~~~~~~~~~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~ 114 (371)
T cd05622 35 IRDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQD 114 (371)
T ss_pred HhhcCcchhhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEc
Confidence 4566777789999999999999999999876 57889999885422 2223457789999999999999999999999
Q ss_pred CceeeEEEeecCCCCHHHHHhhhhccCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCEEEcCCCcEEEEec
Q 010519 254 GVHRMLVYEYVNNGNLEQWLHGAMRNQGNLTWEARMKVIIGTAKALAYLHEAIEPKVVHRDIKSSNILIDDEFNAKVSDF 333 (508)
Q Consensus 254 ~~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~Df 333 (508)
....++||||+++|+|.+++.. ..+++..+..++.||+.||.|||++ +|+||||||+|||++.++.+||+||
T Consensus 115 ~~~~~lv~Ey~~gg~L~~~~~~-----~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDLkp~NIll~~~~~ikL~Df 186 (371)
T cd05622 115 DRYLYMVMEYMPGGDLVNLMSN-----YDVPEKWARFYTAEVVLALDAIHSM---GFIHRDVKPDNMLLDKSGHLKLADF 186 (371)
T ss_pred CCEEEEEEcCCCCCcHHHHHHh-----cCCCHHHHHHHHHHHHHHHHHHHHC---CEEeCCCCHHHEEECCCCCEEEEeC
Confidence 9999999999999999998842 3478888999999999999999999 9999999999999999999999999
Q ss_pred CCccccCCCCCcccccccccccccCccccCCC----CCCChhhHHHHHHHHHHHHhCCCCCCCCCCCchhcHHHHHHHHh
Q 010519 334 GLAKLLDSGESHITTRVMGTFGYVAPEYANTG----MLNEKSDIYSFGVLLLEAVTGRDPVDYGRPANEVNLVEWLKMMV 409 (508)
Q Consensus 334 gla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----~~~~~~DvwS~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~ 409 (508)
|++..............+||+.|+|||++.+. .++.++|||||||+||||++|..||..... ........
T Consensus 187 G~a~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~------~~~~~~i~ 260 (371)
T cd05622 187 GTCMKMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSL------VGTYSKIM 260 (371)
T ss_pred CceeEcCcCCcccccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCCCCH------HHHHHHHH
Confidence 99987654333233456799999999998654 378999999999999999999999964321 11122221
Q ss_pred cccccccccCCCCCCChhHHHHHHHHHHHHHhcCCCCCC--CCCHHHHHHHhhcCC
Q 010519 410 GTRRAEEVVDPNLEVKPATRALKRSLLVALRCVDPDSEK--RPKMSQVVRMLEADD 463 (508)
Q Consensus 410 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~--RPs~~evl~~L~~~~ 463 (508)
.... .+..+........+.+++.+||..++.+ |+++.+++++..-..
T Consensus 261 ~~~~-------~~~~~~~~~~s~~~~~li~~~L~~~~~r~~r~~~~ei~~h~~~~~ 309 (371)
T cd05622 261 NHKN-------SLTFPDDNDISKEAKNLICAFLTDREVRLGRNGVEEIKRHLFFKN 309 (371)
T ss_pred cCCC-------cccCCCcCCCCHHHHHHHHHHcCChhhhcCCCCHHHHhcCcccCC
Confidence 1111 1111111223445666889999844443 789999999875543
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an |
| >KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-40 Score=319.07 Aligned_cols=259 Identities=28% Similarity=0.381 Sum_probs=202.4
Q ss_pred CcccceeEeeeCceEEEEEEEc-CCCEEEEEEEcccchhhHHHHHHHHHHHhcCCCCCceeEEEEEEeCc-----eeeEE
Q 010519 187 RFSAENVLGEGGYGVVYKGRLI-NGSEVAVKKLLNNLGQAEKEFRVEVEAIGHVRHKNLVRLLGYCIEGV-----HRMLV 260 (508)
Q Consensus 187 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~ei~~l~~l~h~niv~~~~~~~~~~-----~~~lv 260 (508)
.|...+++|.|+||.||+|... ++..||||++..+.... .+|+.+|+.++|||||++.-+|.... ...+|
T Consensus 25 ~~~~~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~r~k----nrEl~im~~l~HpNIV~L~~~f~~~~~~d~~~lnlV 100 (364)
T KOG0658|consen 25 SYEAVRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDKRYK----NRELQIMRKLDHPNIVRLLYFFSSSTESDEVYLNLV 100 (364)
T ss_pred EEEeeEEEeecccceEEEEEEcCCCceeEEEEecCCCCcC----cHHHHHHHhcCCcCeeeEEEEEEecCCCchhHHHHH
Confidence 5777899999999999999875 57899999997765432 34899999999999999999887542 23489
Q ss_pred EeecCCCCHHHHHhhhhccCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCEEEcCC-CcEEEEecCCcccc
Q 010519 261 YEYVNNGNLEQWLHGAMRNQGNLTWEARMKVIIGTAKALAYLHEAIEPKVVHRDIKSSNILIDDE-FNAKVSDFGLAKLL 339 (508)
Q Consensus 261 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiH~Dlk~~NIll~~~-~~~kl~Dfgla~~~ 339 (508)
||||+. +|.++++.+...+..++...+.-+..||++||.|||+. +|+||||||.|+|+|.+ |.+||||||.|+.+
T Consensus 101 leymP~-tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~~---~IcHRDIKPqNlLvD~~tg~LKicDFGSAK~L 176 (364)
T KOG0658|consen 101 LEYMPE-TLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHSH---GICHRDIKPQNLLVDPDTGVLKICDFGSAKVL 176 (364)
T ss_pred HHhchH-HHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHhc---CcccCCCChheEEEcCCCCeEEeccCCcceee
Confidence 999987 99999986656677888888999999999999999998 99999999999999966 88999999999988
Q ss_pred CCCCCcccccccccccccCccccCC-CCCCChhhHHHHHHHHHHHHhCCCCCCCCCCCchhcHHHHHHHHhcccccc---
Q 010519 340 DSGESHITTRVMGTFGYVAPEYANT-GMLNEKSDIYSFGVLLLEAVTGRDPVDYGRPANEVNLVEWLKMMVGTRRAE--- 415 (508)
Q Consensus 340 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwS~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~--- 415 (508)
..++... ....|..|.|||.+.| ..|+.+.||||.|||+.||+-|+.-|...... .++...+ .+.+.....
T Consensus 177 ~~~epni--SYicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFpG~s~~--dQL~eIi-k~lG~Pt~e~I~ 251 (364)
T KOG0658|consen 177 VKGEPNI--SYICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFPGDSSV--DQLVEII-KVLGTPTREDIK 251 (364)
T ss_pred ccCCCce--eEEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccCCCCHH--HHHHHHH-HHhCCCCHHHHh
Confidence 7766543 3356889999998876 67999999999999999999999888653322 2222222 222222111
Q ss_pred -------cccCCCCCCC-----hhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 010519 416 -------EVVDPNLEVK-----PATRALKRSLLVALRCVDPDSEKRPKMSQVVRM 458 (508)
Q Consensus 416 -------~~~~~~~~~~-----~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 458 (508)
....+.+... .......+.++|+.++|..+|.+|.++.|++.+
T Consensus 252 ~mn~~y~~~~~p~ik~~~~~~~~~~~~~~d~~dll~~~L~Y~P~~R~~~~~~l~h 306 (364)
T KOG0658|consen 252 SMNPNYTEFKFPQIKAHPWHKVFFKRLPPDALDLLSKLLQYSPSKRLSALEALAH 306 (364)
T ss_pred hcCcccccccCcccccccceeecccCCCHHHHHHHHHHhccChhhcCCHHHHhcc
Confidence 1111222211 122345577889999999999999999999875
|
|
| >cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-40 Score=330.33 Aligned_cols=247 Identities=26% Similarity=0.324 Sum_probs=194.9
Q ss_pred cccceeEeeeCceEEEEEEEc-CCCEEEEEEEcccc---hhhHHHHHHHHHH---HhcCCCCCceeEEEEEEeCceeeEE
Q 010519 188 FSAENVLGEGGYGVVYKGRLI-NGSEVAVKKLLNNL---GQAEKEFRVEVEA---IGHVRHKNLVRLLGYCIEGVHRMLV 260 (508)
Q Consensus 188 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~ei~~---l~~l~h~niv~~~~~~~~~~~~~lv 260 (508)
|.+.+.||+|+||.||+|.+. +++.||||.+.... ......+..|+.+ ++.++||||+++++++.+....|+|
T Consensus 1 y~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv 80 (324)
T cd05589 1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQTEDHVCFV 80 (324)
T ss_pred CeEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEEcCCEEEEE
Confidence 667899999999999999875 68899999986432 1223445556555 4567899999999999999999999
Q ss_pred EeecCCCCHHHHHhhhhccCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCEEEcCCCcEEEEecCCccccC
Q 010519 261 YEYVNNGNLEQWLHGAMRNQGNLTWEARMKVIIGTAKALAYLHEAIEPKVVHRDIKSSNILIDDEFNAKVSDFGLAKLLD 340 (508)
Q Consensus 261 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~Dfgla~~~~ 340 (508)
|||+++|+|..+++ ...+++..+..++.||+.||.|||+. +++||||||+|||++.++.+||+|||++....
T Consensus 81 ~E~~~~~~L~~~~~-----~~~l~~~~~~~~~~qi~~al~~lH~~---~ivHrdlkp~Nill~~~~~~kL~Dfg~~~~~~ 152 (324)
T cd05589 81 MEYAAGGDLMMHIH-----TDVFSEPRAVFYAACVVLGLQYLHEN---KIVYRDLKLDNLLLDTEGFVKIADFGLCKEGM 152 (324)
T ss_pred EcCCCCCcHHHHhh-----cCCCCHHHHHHHHHHHHHHHHHHHhC---CeEecCCCHHHeEECCCCcEEeCcccCCccCC
Confidence 99999999998874 34689999999999999999999999 99999999999999999999999999987543
Q ss_pred CCCCcccccccccccccCccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCCCchhcHHHHHHHHhcccccccccCC
Q 010519 341 SGESHITTRVMGTFGYVAPEYANTGMLNEKSDIYSFGVLLLEAVTGRDPVDYGRPANEVNLVEWLKMMVGTRRAEEVVDP 420 (508)
Q Consensus 341 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 420 (508)
... ......+|++.|+|||++.+..++.++|||||||++|||++|+.||..... .+......... .
T Consensus 153 ~~~-~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~G~~pf~~~~~------~~~~~~i~~~~-------~ 218 (324)
T cd05589 153 GFG-DRTSTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESPFPGDDE------EEVFDSIVNDE-------V 218 (324)
T ss_pred CCC-CcccccccCccccCHhHhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCCH------HHHHHHHHhCC-------C
Confidence 222 123446789999999999999999999999999999999999999964321 11122221111 0
Q ss_pred CCCCChhHHHHHHHHHHHHHhcCCCCCCCC-----CHHHHHHHhh
Q 010519 421 NLEVKPATRALKRSLLVALRCVDPDSEKRP-----KMSQVVRMLE 460 (508)
Q Consensus 421 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~evl~~L~ 460 (508)
.. +......+.+++.+||+.||.+|| ++.+++++..
T Consensus 219 ~~----p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~l~~~~~ 259 (324)
T cd05589 219 RY----PRFLSREAISIMRRLLRRNPERRLGSGEKDAEDVKKQPF 259 (324)
T ss_pred CC----CCCCCHHHHHHHHHHhhcCHhHcCCCCCCCHHHHhhCCC
Confidence 01 111234566799999999999999 5778877653
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved |
| >cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-39 Score=322.83 Aligned_cols=259 Identities=25% Similarity=0.448 Sum_probs=206.9
Q ss_pred CCcccceeEeeeCceEEEEEEEc------CCCEEEEEEEcccchhhHHHHHHHHHHHhcCCCCCceeEEEEEEeCceeeE
Q 010519 186 NRFSAENVLGEGGYGVVYKGRLI------NGSEVAVKKLLNNLGQAEKEFRVEVEAIGHVRHKNLVRLLGYCIEGVHRML 259 (508)
Q Consensus 186 ~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~ei~~l~~l~h~niv~~~~~~~~~~~~~l 259 (508)
.+|.+.+.||+|+||.||+|.+. ++..+++|.+..........+.+|+..+++++|+||+++++++......++
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 84 (291)
T cd05094 5 RDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKFYGVCGDGDPLIM 84 (291)
T ss_pred HHeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCccHHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCceEE
Confidence 46888899999999999999753 345688888766655556778899999999999999999999999999999
Q ss_pred EEeecCCCCHHHHHhhhhc------------cCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCEEEcCCCc
Q 010519 260 VYEYVNNGNLEQWLHGAMR------------NQGNLTWEARMKVIIGTAKALAYLHEAIEPKVVHRDIKSSNILIDDEFN 327 (508)
Q Consensus 260 v~E~~~~gsL~~~l~~~~~------------~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiH~Dlk~~NIll~~~~~ 327 (508)
||||+++++|.+++..... ....+++..++.++.||+.||.|||++ +++||||||+|||+++++.
T Consensus 85 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~---~i~H~dlkp~Nil~~~~~~ 161 (291)
T cd05094 85 VFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQ---HFVHRDLATRNCLVGANLL 161 (291)
T ss_pred EEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecccCcceEEEccCCc
Confidence 9999999999999964211 224588999999999999999999999 9999999999999999999
Q ss_pred EEEEecCCccccCCCCC-cccccccccccccCccccCCCCCCChhhHHHHHHHHHHHHh-CCCCCCCCCCCchhcHHHHH
Q 010519 328 AKVSDFGLAKLLDSGES-HITTRVMGTFGYVAPEYANTGMLNEKSDIYSFGVLLLEAVT-GRDPVDYGRPANEVNLVEWL 405 (508)
Q Consensus 328 ~kl~Dfgla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~ellt-G~~Pf~~~~~~~~~~~~~~~ 405 (508)
++|+|||++........ .......++..|+|||.+.+..++.++|||||||++|||++ |..||...... .. .
T Consensus 162 ~~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~---~~---~ 235 (291)
T cd05094 162 VKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNT---EV---I 235 (291)
T ss_pred EEECCCCcccccCCCceeecCCCCCcceeecChHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHH---HH---H
Confidence 99999999976543321 12233456788999999999999999999999999999999 99998643321 11 1
Q ss_pred HHHhcccccccccCCCCCCChhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhhcCC
Q 010519 406 KMMVGTRRAEEVVDPNLEVKPATRALKRSLLVALRCVDPDSEKRPKMSQVVRMLEADD 463 (508)
Q Consensus 406 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~ 463 (508)
..... ..... .....+..+.+++.+||+.||.+|||+.+|++.|+...
T Consensus 236 ~~~~~-~~~~~---------~~~~~~~~~~~li~~~l~~~P~~Rpt~~~v~~~l~~~~ 283 (291)
T cd05094 236 ECITQ-GRVLE---------RPRVCPKEVYDIMLGCWQREPQQRLNIKEIYKILHALG 283 (291)
T ss_pred HHHhC-CCCCC---------CCccCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHH
Confidence 11111 11100 01112345677999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n |
| >cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-40 Score=330.01 Aligned_cols=247 Identities=24% Similarity=0.310 Sum_probs=195.6
Q ss_pred CcccceeEeeeCceEEEEEEEc-CCCEEEEEEEcccc---hhhHHHHHHHHHHHhcCCCC-CceeEEEEEEeCceeeEEE
Q 010519 187 RFSAENVLGEGGYGVVYKGRLI-NGSEVAVKKLLNNL---GQAEKEFRVEVEAIGHVRHK-NLVRLLGYCIEGVHRMLVY 261 (508)
Q Consensus 187 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~ei~~l~~l~h~-niv~~~~~~~~~~~~~lv~ 261 (508)
+|++.+.||+|+||.||+|++. +++.||+|++.... ......+..|+.++..+.|+ +|+.+++++.+.+..|+||
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (324)
T cd05587 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVM 80 (324)
T ss_pred CceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCEEEEEE
Confidence 5888999999999999999875 56789999986432 22335577789999998764 6888999999999999999
Q ss_pred eecCCCCHHHHHhhhhccCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCEEEcCCCcEEEEecCCccccCC
Q 010519 262 EYVNNGNLEQWLHGAMRNQGNLTWEARMKVIIGTAKALAYLHEAIEPKVVHRDIKSSNILIDDEFNAKVSDFGLAKLLDS 341 (508)
Q Consensus 262 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~ 341 (508)
||+++|+|.+++. ....+++..++.++.||+.||.|||+. +|+||||||+|||++.++.+||+|||++.....
T Consensus 81 E~~~~g~L~~~~~----~~~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~ 153 (324)
T cd05587 81 EYVNGGDLMYHIQ----QVGKFKEPHAVFYAAEIAIGLFFLHSK---GIIYRDLKLDNVMLDAEGHIKIADFGMCKENIF 153 (324)
T ss_pred cCCCCCcHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHeEEcCCCCEEEeecCcceecCC
Confidence 9999999999884 445688999999999999999999998 999999999999999999999999999875322
Q ss_pred CCCcccccccccccccCccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCCCchhcHHHHHHHHhcccccccccCCC
Q 010519 342 GESHITTRVMGTFGYVAPEYANTGMLNEKSDIYSFGVLLLEAVTGRDPVDYGRPANEVNLVEWLKMMVGTRRAEEVVDPN 421 (508)
Q Consensus 342 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 421 (508)
.. .......||+.|+|||++.+..++.++|||||||++|||++|+.||..... . +......... ..
T Consensus 154 ~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~---~---~~~~~i~~~~-------~~ 219 (324)
T cd05587 154 GG-KTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDE---D---ELFQSIMEHN-------VS 219 (324)
T ss_pred CC-CceeeecCCccccChhhhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCH---H---HHHHHHHcCC-------CC
Confidence 21 123345789999999999999999999999999999999999999964321 1 1111111110 01
Q ss_pred CCCChhHHHHHHHHHHHHHhcCCCCCCCCCH-----HHHHHH
Q 010519 422 LEVKPATRALKRSLLVALRCVDPDSEKRPKM-----SQVVRM 458 (508)
Q Consensus 422 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~-----~evl~~ 458 (508)
+ +......+.+++.+||..||.+|++. .+++++
T Consensus 220 ~----~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~h 257 (324)
T cd05587 220 Y----PKSLSKEAVSICKGLLTKHPAKRLGCGPTGERDIREH 257 (324)
T ss_pred C----CCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcC
Confidence 1 11123456679999999999999986 566655
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory |
| >cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-40 Score=328.92 Aligned_cols=244 Identities=23% Similarity=0.320 Sum_probs=193.9
Q ss_pred eeEeeeCceEEEEEEEc-CCCEEEEEEEcccc---hhhHHHHHHHHHHHhcC-CCCCceeEEEEEEeCceeeEEEeecCC
Q 010519 192 NVLGEGGYGVVYKGRLI-NGSEVAVKKLLNNL---GQAEKEFRVEVEAIGHV-RHKNLVRLLGYCIEGVHRMLVYEYVNN 266 (508)
Q Consensus 192 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~ei~~l~~l-~h~niv~~~~~~~~~~~~~lv~E~~~~ 266 (508)
+.||+|+||+||+|++. +++.||+|.+.... ......+..|..++..+ +||||+++++++......|+||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~iv~Ey~~~ 80 (320)
T cd05590 1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPDRLFFVMEFVNG 80 (320)
T ss_pred CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEcCCEEEEEEcCCCC
Confidence 36999999999999875 57889999886432 22234566788888776 799999999999999999999999999
Q ss_pred CCHHHHHhhhhccCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCEEEcCCCcEEEEecCCccccCCCCCcc
Q 010519 267 GNLEQWLHGAMRNQGNLTWEARMKVIIGTAKALAYLHEAIEPKVVHRDIKSSNILIDDEFNAKVSDFGLAKLLDSGESHI 346 (508)
Q Consensus 267 gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~ 346 (508)
|+|.+++. ....+++..+..++.|++.||.|||+. +|+||||||+|||++.++.+||+|||++....... ..
T Consensus 81 g~L~~~i~----~~~~l~~~~~~~~~~ql~~~L~~lH~~---~ivH~dlkp~NIli~~~~~~kL~DfG~~~~~~~~~-~~ 152 (320)
T cd05590 81 GDLMFHIQ----KSRRFDEARARFYAAEITSALMFLHDK---GIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNG-KT 152 (320)
T ss_pred chHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCCHHHeEECCCCcEEEeeCCCCeecCcCC-Cc
Confidence 99999884 345689999999999999999999999 99999999999999999999999999987543221 12
Q ss_pred cccccccccccCccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCCCchhcHHHHHHHHhcccccccccCCCCCCCh
Q 010519 347 TTRVMGTFGYVAPEYANTGMLNEKSDIYSFGVLLLEAVTGRDPVDYGRPANEVNLVEWLKMMVGTRRAEEVVDPNLEVKP 426 (508)
Q Consensus 347 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 426 (508)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||..... ........... .. .
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~------~~~~~~i~~~~---------~~--~ 215 (320)
T cd05590 153 TSTFCGTPDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAPFEAENE------DDLFEAILNDE---------VV--Y 215 (320)
T ss_pred ccccccCccccCHHHHcCCCCCCccchhhhHHHHHHHhhCCCCCCCCCH------HHHHHHHhcCC---------CC--C
Confidence 3345789999999999999999999999999999999999999964321 12222221111 00 0
Q ss_pred hHHHHHHHHHHHHHhcCCCCCCCCCH------HHHHHHhh
Q 010519 427 ATRALKRSLLVALRCVDPDSEKRPKM------SQVVRMLE 460 (508)
Q Consensus 427 ~~~~~~~l~~li~~cl~~dP~~RPs~------~evl~~L~ 460 (508)
+......+.+++.+||+.||.+||++ +++++|-.
T Consensus 216 ~~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~~~~h~~ 255 (320)
T cd05590 216 PTWLSQDAVDILKAFMTKNPTMRLGSLTLGGEEAILRHPF 255 (320)
T ss_pred CCCCCHHHHHHHHHHcccCHHHCCCCCCCCCHHHHHcCCC
Confidence 11123456779999999999999998 77776544
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal |
| >cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-39 Score=314.69 Aligned_cols=247 Identities=27% Similarity=0.433 Sum_probs=195.8
Q ss_pred eeEeeeCceEEEEEEEc-CCCEEEEEEEcccc-hhhHHHHHHHHHHHhcCCCCCceeEEEEEEeCceeeEEEeecCCCCH
Q 010519 192 NVLGEGGYGVVYKGRLI-NGSEVAVKKLLNNL-GQAEKEFRVEVEAIGHVRHKNLVRLLGYCIEGVHRMLVYEYVNNGNL 269 (508)
Q Consensus 192 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~ei~~l~~l~h~niv~~~~~~~~~~~~~lv~E~~~~gsL 269 (508)
+.||+|+||.||+|++. +++.+|+|.+.... ......+..|+++++.++||||+++++++......++||||+++++|
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (252)
T cd05084 1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDF 80 (252)
T ss_pred CccCcccCccEEEEEEecCCceEEEEecCccCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCCeEEEEeeccCCcH
Confidence 36899999999999875 78889999876443 33446788899999999999999999999999999999999999999
Q ss_pred HHHHhhhhccCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCEEEcCCCcEEEEecCCccccCCCCCccc-c
Q 010519 270 EQWLHGAMRNQGNLTWEARMKVIIGTAKALAYLHEAIEPKVVHRDIKSSNILIDDEFNAKVSDFGLAKLLDSGESHIT-T 348 (508)
Q Consensus 270 ~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~~-~ 348 (508)
.+++.. ....+++..++.++.|++.||.|||+. +++|+||||+|||++.++.+||+|||++........... .
T Consensus 81 ~~~~~~---~~~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~ 154 (252)
T cd05084 81 LTFLRT---EGPRLKVKELIQMVENAAAGMEYLESK---HCIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTGG 154 (252)
T ss_pred HHHHHh---CCCCCCHHHHHHHHHHHHHHHHHHHhC---CccccccchheEEEcCCCcEEECccccCcccccccccccCC
Confidence 999852 345688999999999999999999998 999999999999999999999999999986543211111 1
Q ss_pred cccccccccCccccCCCCCCChhhHHHHHHHHHHHHh-CCCCCCCCCCCchhcHHHHHHHHhcccccccccCCCCCCChh
Q 010519 349 RVMGTFGYVAPEYANTGMLNEKSDIYSFGVLLLEAVT-GRDPVDYGRPANEVNLVEWLKMMVGTRRAEEVVDPNLEVKPA 427 (508)
Q Consensus 349 ~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 427 (508)
....+..|+|||.+.+..++.++|||||||++|||++ |..||...... .. ....... .....+
T Consensus 155 ~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~e~~~~~~~p~~~~~~~---~~---~~~~~~~----------~~~~~~ 218 (252)
T cd05084 155 MKQIPVKWTAPEALNYGRYSSESDVWSFGILLWEAFSLGAVPYANLSNQ---QT---REAIEQG----------VRLPCP 218 (252)
T ss_pred CCCCceeecCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccCHH---HH---HHHHHcC----------CCCCCc
Confidence 1123457999999999899999999999999999998 88888533211 11 1111110 011111
Q ss_pred HHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhh
Q 010519 428 TRALKRSLLVALRCVDPDSEKRPKMSQVVRMLE 460 (508)
Q Consensus 428 ~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 460 (508)
......+.+++.+||+.||.+|||+.++++.|+
T Consensus 219 ~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~ 251 (252)
T cd05084 219 ELCPDAVYRLMERCWEYDPGQRPSFSTVHQELQ 251 (252)
T ss_pred ccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHh
Confidence 223456777999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular |
| >cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-39 Score=313.10 Aligned_cols=247 Identities=28% Similarity=0.448 Sum_probs=197.6
Q ss_pred eeEeeeCceEEEEEEEcCCCEEEEEEEcccch-hhHHHHHHHHHHHhcCCCCCceeEEEEEEeCceeeEEEeecCCCCHH
Q 010519 192 NVLGEGGYGVVYKGRLINGSEVAVKKLLNNLG-QAEKEFRVEVEAIGHVRHKNLVRLLGYCIEGVHRMLVYEYVNNGNLE 270 (508)
Q Consensus 192 ~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~-~~~~~~~~ei~~l~~l~h~niv~~~~~~~~~~~~~lv~E~~~~gsL~ 270 (508)
++||+|+||.||+|...++..+|+|.+..... .....+..|+++++.++||||+++++++......++||||+++++|.
T Consensus 1 ~~ig~g~~g~vy~~~~~~~~~~a~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~ 80 (250)
T cd05085 1 ELLGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVCTQRQPIYIVMELVPGGDFL 80 (250)
T ss_pred CccCCCCCceEEEEEecCCcEEEEEecCCcCCHHHHHHHHHHHHHHHhCCCCCcCeEEEEEecCCccEEEEECCCCCcHH
Confidence 36899999999999987889999998765442 33456888999999999999999999999999999999999999999
Q ss_pred HHHhhhhccCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCEEEcCCCcEEEEecCCccccCCCCCcccccc
Q 010519 271 QWLHGAMRNQGNLTWEARMKVIIGTAKALAYLHEAIEPKVVHRDIKSSNILIDDEFNAKVSDFGLAKLLDSGESHITTRV 350 (508)
Q Consensus 271 ~~l~~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~~ 350 (508)
+++.. ....+.+..++.++.+++.||.|||+. +++|+||+|+||++++++.+||+|||++..............
T Consensus 81 ~~~~~---~~~~~~~~~~~~~~~~i~~~l~~lH~~---~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~ 154 (250)
T cd05085 81 SFLRK---KKDELKTKQLVKFALDAAAGMAYLESK---NCIHRDLAARNCLVGENNVLKISDFGMSRQEDDGIYSSSGLK 154 (250)
T ss_pred HHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecccChheEEEcCCCeEEECCCccceeccccccccCCCC
Confidence 99853 345688999999999999999999998 999999999999999999999999999976543322212222
Q ss_pred cccccccCccccCCCCCCChhhHHHHHHHHHHHHh-CCCCCCCCCCCchhcHHHHHHHHhcccccccccCCCCCCChhHH
Q 010519 351 MGTFGYVAPEYANTGMLNEKSDIYSFGVLLLEAVT-GRDPVDYGRPANEVNLVEWLKMMVGTRRAEEVVDPNLEVKPATR 429 (508)
Q Consensus 351 ~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 429 (508)
.++..|+|||++.+..++.++||||||+++|+|++ |..||...... .. ......... . ..+..
T Consensus 155 ~~~~~y~aPE~~~~~~~~~~~Di~slG~ll~~~~~~g~~p~~~~~~~---~~---~~~~~~~~~------~----~~~~~ 218 (250)
T cd05085 155 QIPIKWTAPEALNYGRYSSESDVWSYGILLWETFSLGVCPYPGMTNQ---QA---REQVEKGYR------M----SCPQK 218 (250)
T ss_pred CCcccccCHHHhccCCCCchhHHHHHHHHHHHHhcCCCCCCCCCCHH---HH---HHHHHcCCC------C----CCCCC
Confidence 34567999999998889999999999999999998 99998643211 11 111111100 0 11112
Q ss_pred HHHHHHHHHHHhcCCCCCCCCCHHHHHHHhh
Q 010519 430 ALKRSLLVALRCVDPDSEKRPKMSQVVRMLE 460 (508)
Q Consensus 430 ~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 460 (508)
....+.+++.+||+.+|.+||++.++++.|.
T Consensus 219 ~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~ 249 (250)
T cd05085 219 CPDDVYKVMQRCWDYKPENRPKFSELQKELA 249 (250)
T ss_pred CCHHHHHHHHHHcccCcccCCCHHHHHHHhc
Confidence 3456777999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c |
| >cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-39 Score=321.14 Aligned_cols=258 Identities=24% Similarity=0.277 Sum_probs=203.9
Q ss_pred CcccceeEeeeCceEEEEEEEc-CCCEEEEEEEcccch---hhHHHHHHHHHHHhcCCCCCceeEEEEEEeCceeeEEEe
Q 010519 187 RFSAENVLGEGGYGVVYKGRLI-NGSEVAVKKLLNNLG---QAEKEFRVEVEAIGHVRHKNLVRLLGYCIEGVHRMLVYE 262 (508)
Q Consensus 187 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~ei~~l~~l~h~niv~~~~~~~~~~~~~lv~E 262 (508)
.|+..+.||+|+||+||++.+. ++..||+|++..... .....+.+|+.+++.++||||+++++++..+...++|||
T Consensus 1 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 80 (285)
T cd05605 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLT 80 (285)
T ss_pred CceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeeecCCCeEEEEEe
Confidence 4778899999999999999875 688999998864322 223456779999999999999999999999999999999
Q ss_pred ecCCCCHHHHHhhhhccCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCEEEcCCCcEEEEecCCccccCCC
Q 010519 263 YVNNGNLEQWLHGAMRNQGNLTWEARMKVIIGTAKALAYLHEAIEPKVVHRDIKSSNILIDDEFNAKVSDFGLAKLLDSG 342 (508)
Q Consensus 263 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~~ 342 (508)
|+.+|+|.+++.. .....+++..+..++.|++.||.|||+. +++||||||+||++++++.++|+|||++......
T Consensus 81 ~~~~~~L~~~~~~--~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~ 155 (285)
T cd05605 81 LMNGGDLKFHIYN--MGNPGFDEERAVFYAAEITCGLEDLHRE---RIVYRDLKPENILLDDYGHIRISDLGLAVEIPEG 155 (285)
T ss_pred ccCCCcHHHHHHh--cCcCCCCHHHHHHHHHHHHHHHHHHHHC---CcEecCCCHHHEEECCCCCEEEeeCCCceecCCC
Confidence 9999999998853 2345689999999999999999999999 9999999999999999999999999999865433
Q ss_pred CCcccccccccccccCccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCCCchhcHHHHHHHHhcccccccccCCCC
Q 010519 343 ESHITTRVMGTFGYVAPEYANTGMLNEKSDIYSFGVLLLEAVTGRDPVDYGRPANEVNLVEWLKMMVGTRRAEEVVDPNL 422 (508)
Q Consensus 343 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 422 (508)
.. .....|++.|+|||++.+..++.++|||||||++|||++|..||....... ........ ....
T Consensus 156 ~~--~~~~~~~~~y~aPE~~~~~~~~~~~Diws~G~~l~el~~g~~pf~~~~~~~--~~~~~~~~-~~~~---------- 220 (285)
T cd05605 156 ET--IRGRVGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQRKEKV--KREEVERR-VKED---------- 220 (285)
T ss_pred Cc--cccccCCCCccCcHHhcCCCCCccccchhHHHHHHHHHHCCCCCCCCchhh--HHHHHHHH-hhhc----------
Confidence 21 233468999999999999899999999999999999999999997432211 11111111 1000
Q ss_pred CCChhHHHHHHHHHHHHHhcCCCCCCCC-----CHHHHHHHhhcCCC
Q 010519 423 EVKPATRALKRSLLVALRCVDPDSEKRP-----KMSQVVRMLEADDY 464 (508)
Q Consensus 423 ~~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~evl~~L~~~~~ 464 (508)
....+......+.+|+.+||+.||.+|| ++.+++++-+-...
T Consensus 221 ~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~~~~~~~ 267 (285)
T cd05605 221 QEEYSEKFSEAARSICRQLLTKDPGFRLGCRGEGAEEVKAHPFFRTA 267 (285)
T ss_pred ccccCcccCHHHHHHHHHHccCCHHHhcCCCCCCHHHHhcCcCccCC
Confidence 0011112344566799999999999999 88899887554433
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, |
| >cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-39 Score=333.29 Aligned_cols=262 Identities=20% Similarity=0.269 Sum_probs=203.9
Q ss_pred HHHHHhhCCcccceeEeeeCceEEEEEEEc-CCCEEEEEEEcccc---hhhHHHHHHHHHHHhcCCCCCceeEEEEEEeC
Q 010519 179 RDLEIATNRFSAENVLGEGGYGVVYKGRLI-NGSEVAVKKLLNNL---GQAEKEFRVEVEAIGHVRHKNLVRLLGYCIEG 254 (508)
Q Consensus 179 ~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~ei~~l~~l~h~niv~~~~~~~~~ 254 (508)
..+....++|++.+.||+|+||.||++++. +++.+|+|.+.... ......+.+|+.+++.++||||+++++++.++
T Consensus 36 ~~~~~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~ 115 (370)
T cd05621 36 RKLQMKAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQDD 115 (370)
T ss_pred HhcCCCHHHCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcC
Confidence 445556689999999999999999999876 57889999885422 22334577899999999999999999999999
Q ss_pred ceeeEEEeecCCCCHHHHHhhhhccCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCEEEcCCCcEEEEecC
Q 010519 255 VHRMLVYEYVNNGNLEQWLHGAMRNQGNLTWEARMKVIIGTAKALAYLHEAIEPKVVHRDIKSSNILIDDEFNAKVSDFG 334 (508)
Q Consensus 255 ~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~Dfg 334 (508)
...|+||||+++|+|.+++.. ..+++..+..++.||+.||.|||+. +|+||||||+|||+++++.+||+|||
T Consensus 116 ~~~~lv~Ey~~gg~L~~~l~~-----~~~~~~~~~~~~~qil~aL~~LH~~---~IvHrDLKp~NILl~~~~~~kL~DFG 187 (370)
T cd05621 116 KYLYMVMEYMPGGDLVNLMSN-----YDVPEKWAKFYTAEVVLALDAIHSM---GLIHRDVKPDNMLLDKHGHLKLADFG 187 (370)
T ss_pred CEEEEEEcCCCCCcHHHHHHh-----cCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHEEECCCCCEEEEecc
Confidence 999999999999999999842 2478889999999999999999999 99999999999999999999999999
Q ss_pred CccccCCCCCcccccccccccccCccccCCC----CCCChhhHHHHHHHHHHHHhCCCCCCCCCCCchhcHHHHHHHHhc
Q 010519 335 LAKLLDSGESHITTRVMGTFGYVAPEYANTG----MLNEKSDIYSFGVLLLEAVTGRDPVDYGRPANEVNLVEWLKMMVG 410 (508)
Q Consensus 335 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----~~~~~~DvwS~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~ 410 (508)
++..............+||+.|+|||++.+. .++.++|||||||+||||++|+.||..... .........
T Consensus 188 ~a~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~~~------~~~~~~i~~ 261 (370)
T cd05621 188 TCMKMDETGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSL------VGTYSKIMD 261 (370)
T ss_pred cceecccCCceecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCCCH------HHHHHHHHh
Confidence 9987654332233456799999999998754 378899999999999999999999964321 111112211
Q ss_pred ccccccccCCCCCCChhHHHHHHHHHHHHHhcCCCCCC--CCCHHHHHHHhhc
Q 010519 411 TRRAEEVVDPNLEVKPATRALKRSLLVALRCVDPDSEK--RPKMSQVVRMLEA 461 (508)
Q Consensus 411 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~--RPs~~evl~~L~~ 461 (508)
... .+..+........+.+++..||..++.+ |+|+.|+++|-+-
T Consensus 262 ~~~-------~~~~p~~~~~s~~~~~li~~~L~~~~~r~~R~~~~e~l~hp~~ 307 (370)
T cd05621 262 HKN-------SLNFPEDVEISKHAKNLICAFLTDREVRLGRNGVEEIKQHPFF 307 (370)
T ss_pred CCc-------ccCCCCcccCCHHHHHHHHHHccCchhccCCCCHHHHhcCccc
Confidence 110 1111111222345556888899755543 8999999998543
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found |
| >KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-41 Score=307.41 Aligned_cols=255 Identities=24% Similarity=0.360 Sum_probs=208.1
Q ss_pred hCCcccceeEeeeCceEEEEEEEc-CCCEEEEEEEcccc--------hhhHHHHHHHHHHHhcC-CCCCceeEEEEEEeC
Q 010519 185 TNRFSAENVLGEGGYGVVYKGRLI-NGSEVAVKKLLNNL--------GQAEKEFRVEVEAIGHV-RHKNLVRLLGYCIEG 254 (508)
Q Consensus 185 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--------~~~~~~~~~ei~~l~~l-~h~niv~~~~~~~~~ 254 (508)
.+.|...+.||.|..++|-++.++ +|++.|+|++.... ....++-..|+.+|+++ .||||+.+.++++.+
T Consensus 16 y~~y~pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~yes~ 95 (411)
T KOG0599|consen 16 YAKYEPKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVYESD 95 (411)
T ss_pred HhhcChHHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeeccCc
Confidence 457888899999999999998765 78899999885322 12224456699999998 699999999999999
Q ss_pred ceeeEEEeecCCCCHHHHHhhhhccCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCEEEcCCCcEEEEecC
Q 010519 255 VHRMLVYEYVNNGNLEQWLHGAMRNQGNLTWEARMKVIIGTAKALAYLHEAIEPKVVHRDIKSSNILIDDEFNAKVSDFG 334 (508)
Q Consensus 255 ~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~Dfg 334 (508)
...++|+|.|+.|.|+|+|. ..-.++++...+|+.|+.+|+.|||.+ +|+||||||+|||++++.++||+|||
T Consensus 96 sF~FlVFdl~prGELFDyLt----s~VtlSEK~tR~iMrqlfegVeylHa~---~IVHRDLKpENILlddn~~i~isDFG 168 (411)
T KOG0599|consen 96 AFVFLVFDLMPRGELFDYLT----SKVTLSEKETRRIMRQLFEGVEYLHAR---NIVHRDLKPENILLDDNMNIKISDFG 168 (411)
T ss_pred chhhhhhhhcccchHHHHhh----hheeecHHHHHHHHHHHHHHHHHHHHh---hhhhcccChhheeeccccceEEeccc
Confidence 99999999999999999994 566799999999999999999999999 99999999999999999999999999
Q ss_pred CccccCCCCCcccccccccccccCccccCC------CCCCChhhHHHHHHHHHHHHhCCCCCCCCCCCchhcHHHHHHHH
Q 010519 335 LAKLLDSGESHITTRVMGTFGYVAPEYANT------GMLNEKSDIYSFGVLLLEAVTGRDPVDYGRPANEVNLVEWLKMM 408 (508)
Q Consensus 335 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~------~~~~~~~DvwS~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~ 408 (508)
+++.+..++ .....||||+|+|||.+.. ..|+..+|+|++|||+|.|+.|..||..... .-.++..
T Consensus 169 Fa~~l~~Ge--kLrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwHRkQ------mlMLR~I 240 (411)
T KOG0599|consen 169 FACQLEPGE--KLRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFWHRKQ------MLMLRMI 240 (411)
T ss_pred eeeccCCch--hHHHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchhHHHH------HHHHHHH
Confidence 999887765 3567899999999998853 4578899999999999999999999963321 1111111
Q ss_pred hcccccccccCCCCCCChhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhhc
Q 010519 409 VGTRRAEEVVDPNLEVKPATRALKRSLLVALRCVDPDSEKRPKMSQVVRMLEA 461 (508)
Q Consensus 409 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~ 461 (508)
. .+. -.+..+...+......+||.+||+.||.+|.|++|+|.|-.-
T Consensus 241 m-eGk------yqF~speWadis~~~KdLIsrlLqVdp~~Ritake~LaHpff 286 (411)
T KOG0599|consen 241 M-EGK------YQFRSPEWADISATVKDLISRLLQVDPTKRITAKEALAHPFF 286 (411)
T ss_pred H-hcc------cccCCcchhhccccHHHHHHHHHeeCchhcccHHHHhcChHH
Confidence 1 111 122333334556667789999999999999999999986543
|
|
| >cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-40 Score=336.91 Aligned_cols=256 Identities=21% Similarity=0.285 Sum_probs=199.5
Q ss_pred CCcccceeEeeeCceEEEEEEEc-CCCEEEEEEEcccc---hhhHHHHHHHHHHHhcCCCCCceeEEEEEEeCceeeEEE
Q 010519 186 NRFSAENVLGEGGYGVVYKGRLI-NGSEVAVKKLLNNL---GQAEKEFRVEVEAIGHVRHKNLVRLLGYCIEGVHRMLVY 261 (508)
Q Consensus 186 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~ei~~l~~l~h~niv~~~~~~~~~~~~~lv~ 261 (508)
++|.+.+.||+|+||+||++... +++.||||++.... ......+..|+++++.++||||+++++++.+....|+||
T Consensus 1 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~ 80 (377)
T cd05629 1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQDAQYLYLIM 80 (377)
T ss_pred CCceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCeeEEEE
Confidence 47889999999999999999865 78899999885432 223356788999999999999999999999999999999
Q ss_pred eecCCCCHHHHHhhhhccCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCEEEcCCCcEEEEecCCccccCC
Q 010519 262 EYVNNGNLEQWLHGAMRNQGNLTWEARMKVIIGTAKALAYLHEAIEPKVVHRDIKSSNILIDDEFNAKVSDFGLAKLLDS 341 (508)
Q Consensus 262 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~ 341 (508)
||+++|+|.+++. ....+++..+..++.|++.||.|||+. +|+||||||+|||++.++.+||+|||+++.+..
T Consensus 81 E~~~gg~L~~~l~----~~~~~~~~~~~~~~~ql~~aL~~LH~~---givHrDlkp~NIll~~~~~~kl~DfGla~~~~~ 153 (377)
T cd05629 81 EFLPGGDLMTMLI----KYDTFSEDVTRFYMAECVLAIEAVHKL---GFIHRDIKPDNILIDRGGHIKLSDFGLSTGFHK 153 (377)
T ss_pred eCCCCCcHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHEEECCCCCEEEeeccccccccc
Confidence 9999999999984 345788999999999999999999999 999999999999999999999999999963321
Q ss_pred CCCc----------------------------------------------ccccccccccccCccccCCCCCCChhhHHH
Q 010519 342 GESH----------------------------------------------ITTRVMGTFGYVAPEYANTGMLNEKSDIYS 375 (508)
Q Consensus 342 ~~~~----------------------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS 375 (508)
.... .....+||+.|+|||++.+..++.++||||
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwS 233 (377)
T cd05629 154 QHDSAYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQECDWWS 233 (377)
T ss_pred ccccccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHccCCCCCceeeEe
Confidence 0000 001246999999999999999999999999
Q ss_pred HHHHHHHHHhCCCCCCCCCCCchhcHHHHHHHHhcccccccccCCCCCCChhHHHHHHHHHHHHHhcCCCCCCC---CCH
Q 010519 376 FGVLLLEAVTGRDPVDYGRPANEVNLVEWLKMMVGTRRAEEVVDPNLEVKPATRALKRSLLVALRCVDPDSEKR---PKM 452 (508)
Q Consensus 376 ~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~R---Ps~ 452 (508)
|||+||||++|..||...... +......... ..+..+........+.+|+.+||. +|.+| +|+
T Consensus 234 lGvil~elltG~~Pf~~~~~~------~~~~~i~~~~-------~~~~~p~~~~~s~~~~dli~~lL~-~~~~r~~r~~~ 299 (377)
T cd05629 234 LGAIMFECLIGWPPFCSENSH------ETYRKIINWR-------ETLYFPDDIHLSVEAEDLIRRLIT-NAENRLGRGGA 299 (377)
T ss_pred cchhhhhhhcCCCCCCCCCHH------HHHHHHHccC-------CccCCCCCCCCCHHHHHHHHHHhc-CHhhcCCCCCH
Confidence 999999999999999643321 1111111110 011111111123456678889997 66665 599
Q ss_pred HHHHHHhhcC
Q 010519 453 SQVVRMLEAD 462 (508)
Q Consensus 453 ~evl~~L~~~ 462 (508)
.+++.+-.-.
T Consensus 300 ~~~l~hp~~~ 309 (377)
T cd05629 300 HEIKSHPFFR 309 (377)
T ss_pred HHHhcCCCcC
Confidence 9999886543
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of |
| >cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-40 Score=332.02 Aligned_cols=263 Identities=27% Similarity=0.415 Sum_probs=203.5
Q ss_pred HHhhCCcccceeEeeeCceEEEEEEEc------CCCEEEEEEEcccch-hhHHHHHHHHHHHhcC-CCCCceeEEEEEEe
Q 010519 182 EIATNRFSAENVLGEGGYGVVYKGRLI------NGSEVAVKKLLNNLG-QAEKEFRVEVEAIGHV-RHKNLVRLLGYCIE 253 (508)
Q Consensus 182 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~-~~~~~~~~ei~~l~~l-~h~niv~~~~~~~~ 253 (508)
+++.++|.+.+.||+|+||.||+|.+. .++.||+|++..... .....+..|+.++.++ +|+||++++++|..
T Consensus 3 ~~~~~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~~~ 82 (337)
T cd05054 3 EFPRDRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGATASEYKALMTELKILIHIGHHLNVVNLLGACTK 82 (337)
T ss_pred ccCHHHhhhhcccccCcCceEEeccccccccccccceeeeeeccCCCCHHHHHHHHHHHHHHHhhccCcchhheeeeEec
Confidence 455678999999999999999999642 246899998864332 2335677899999999 89999999998875
Q ss_pred C-ceeeEEEeecCCCCHHHHHhhhhc------------------------------------------------------
Q 010519 254 G-VHRMLVYEYVNNGNLEQWLHGAMR------------------------------------------------------ 278 (508)
Q Consensus 254 ~-~~~~lv~E~~~~gsL~~~l~~~~~------------------------------------------------------ 278 (508)
. ...+++|||+++|+|.+++.....
T Consensus 83 ~~~~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 162 (337)
T cd05054 83 PGGPLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEEG 162 (337)
T ss_pred CCCCEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccchhh
Confidence 4 567899999999999999864211
Q ss_pred ---cCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCEEEcCCCcEEEEecCCccccCCCCCc-ccccccccc
Q 010519 279 ---NQGNLTWEARMKVIIGTAKALAYLHEAIEPKVVHRDIKSSNILIDDEFNAKVSDFGLAKLLDSGESH-ITTRVMGTF 354 (508)
Q Consensus 279 ---~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~-~~~~~~gt~ 354 (508)
....+++..+..++.||+.||.|||++ +|+||||||+|||+++++.+||+|||++..+...... ......++.
T Consensus 163 ~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~---~ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~~~~~~~~~~~~~ 239 (337)
T cd05054 163 DELYKEPLTLEDLISYSFQVARGMEFLASR---KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPL 239 (337)
T ss_pred hHHhhcCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCcceEEEeCCCcEEEeccccchhcccCcchhhccCCCCCc
Confidence 013688999999999999999999998 9999999999999999999999999999865433221 122334567
Q ss_pred cccCccccCCCCCCChhhHHHHHHHHHHHHh-CCCCCCCCCCCchhcHHHHHHHHhcccccccccCCCCCCChhHHHHHH
Q 010519 355 GYVAPEYANTGMLNEKSDIYSFGVLLLEAVT-GRDPVDYGRPANEVNLVEWLKMMVGTRRAEEVVDPNLEVKPATRALKR 433 (508)
Q Consensus 355 ~y~aPE~~~~~~~~~~~DvwS~Gvvl~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 433 (508)
.|+|||++.+..++.++|||||||+||||++ |..||....... .+. ........ ...+......
T Consensus 240 ~y~aPE~~~~~~~~~~~Di~SlGv~l~el~t~g~~p~~~~~~~~--~~~----~~~~~~~~---------~~~~~~~~~~ 304 (337)
T cd05054 240 KWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIDE--EFC----RRLKEGTR---------MRAPEYATPE 304 (337)
T ss_pred cccCcHHhcCCCCCccccHHHHHHHHHHHHHcCCCCCCCCCccH--HHH----HHHhccCC---------CCCCccCCHH
Confidence 8999999999999999999999999999998 999986432211 111 11111100 0011122346
Q ss_pred HHHHHHHhcCCCCCCCCCHHHHHHHhhcC
Q 010519 434 SLLVALRCVDPDSEKRPKMSQVVRMLEAD 462 (508)
Q Consensus 434 l~~li~~cl~~dP~~RPs~~evl~~L~~~ 462 (508)
+.+++.+||+.+|.+||++.|++++|+..
T Consensus 305 ~~~l~~~cl~~~p~~RPs~~ell~~l~~~ 333 (337)
T cd05054 305 IYSIMLDCWHNNPEDRPTFSELVEILGDL 333 (337)
T ss_pred HHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence 77799999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto |
| >PTZ00036 glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-40 Score=341.65 Aligned_cols=264 Identities=23% Similarity=0.341 Sum_probs=198.0
Q ss_pred hhCCcccceeEeeeCceEEEEEEEc-CCCEEEEEEEcccchhhHHHHHHHHHHHhcCCCCCceeEEEEEEeC--------
Q 010519 184 ATNRFSAENVLGEGGYGVVYKGRLI-NGSEVAVKKLLNNLGQAEKEFRVEVEAIGHVRHKNLVRLLGYCIEG-------- 254 (508)
Q Consensus 184 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~ei~~l~~l~h~niv~~~~~~~~~-------- 254 (508)
...+|.+.+.||+|+||.||+|.+. ++..||||++.... ....+|+.+|+.++||||+++++++...
T Consensus 64 ~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~----~~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~~~~~ 139 (440)
T PTZ00036 64 PNKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDP----QYKNRELLIMKNLNHINIIFLKDYYYTECFKKNEKN 139 (440)
T ss_pred cCCeEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecCc----chHHHHHHHHHhcCCCCCcceeeeEeecccccCCCc
Confidence 4468999999999999999999874 68899999885432 2234699999999999999999987532
Q ss_pred ceeeEEEeecCCCCHHHHHhhhhccCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCEEEcCCC-cEEEEec
Q 010519 255 VHRMLVYEYVNNGNLEQWLHGAMRNQGNLTWEARMKVIIGTAKALAYLHEAIEPKVVHRDIKSSNILIDDEF-NAKVSDF 333 (508)
Q Consensus 255 ~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiH~Dlk~~NIll~~~~-~~kl~Df 333 (508)
..+++||||+++ +|.+++.........+++..++.++.||+.||.|||+. +|+||||||+|||++.++ .+||+||
T Consensus 140 ~~l~lvmE~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH~~---~IiHrDLKp~NILl~~~~~~vkL~DF 215 (440)
T PTZ00036 140 IFLNVVMEFIPQ-TVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHSK---FICHRDLKPQNLLIDPNTHTLKLCDF 215 (440)
T ss_pred eEEEEEEecCCc-cHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCcCHHHEEEcCCCCceeeecc
Confidence 245689999974 88888865545667899999999999999999999999 999999999999998665 6999999
Q ss_pred CCccccCCCCCcccccccccccccCccccCC-CCCCChhhHHHHHHHHHHHHhCCCCCCCCCCCchhcHHHHHHHHhccc
Q 010519 334 GLAKLLDSGESHITTRVMGTFGYVAPEYANT-GMLNEKSDIYSFGVLLLEAVTGRDPVDYGRPANEVNLVEWLKMMVGTR 412 (508)
Q Consensus 334 gla~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwS~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~ 412 (508)
|+++....... .....||+.|+|||++.+ ..|+.++|||||||+||||++|..||....... .+...+. ..+..
T Consensus 216 Gla~~~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~--~~~~i~~-~~~~p 290 (440)
T PTZ00036 216 GSAKNLLAGQR--SVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVD--QLVRIIQ-VLGTP 290 (440)
T ss_pred ccchhccCCCC--cccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHH--HHHHHHH-HhCCC
Confidence 99986643322 233568999999998866 468999999999999999999999996443211 1111111 11110
Q ss_pred c----------cccccCCCCCC-----ChhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhh
Q 010519 413 R----------AEEVVDPNLEV-----KPATRALKRSLLVALRCVDPDSEKRPKMSQVVRMLE 460 (508)
Q Consensus 413 ~----------~~~~~~~~~~~-----~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 460 (508)
. ...+.-+.... ..+......+.+|+.+||..||.+|||+.|+++|-.
T Consensus 291 ~~~~~~~~~~~~~~~~~~~~~~~~l~~~~p~~~~~~~~~li~~~L~~dP~~R~ta~e~l~hp~ 353 (440)
T PTZ00036 291 TEDQLKEMNPNYADIKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEALADPF 353 (440)
T ss_pred CHHHHHHhchhhhcccCCccCchhHHHHhccCCCHHHHHHHHHHCCCChhHCcCHHHHhCChh
Confidence 0 00000011000 001112356778999999999999999999998754
|
|
| >cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-40 Score=328.99 Aligned_cols=250 Identities=25% Similarity=0.343 Sum_probs=194.7
Q ss_pred eeEeeeCceEEEEEEEc-CCCEEEEEEEcccc---hhhHHHHHHHHHHHhcC-CCCCceeEEEEEEeCceeeEEEeecCC
Q 010519 192 NVLGEGGYGVVYKGRLI-NGSEVAVKKLLNNL---GQAEKEFRVEVEAIGHV-RHKNLVRLLGYCIEGVHRMLVYEYVNN 266 (508)
Q Consensus 192 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~ei~~l~~l-~h~niv~~~~~~~~~~~~~lv~E~~~~ 266 (508)
+.||+|+||.||++++. +++.+|+|.+.... ......+..|+.++.++ +||||+++++++......++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~~ 80 (329)
T cd05618 1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNG 80 (329)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCCEEEEEEeCCCC
Confidence 46999999999999875 57889999986532 22334577788888776 899999999999999999999999999
Q ss_pred CCHHHHHhhhhccCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCEEEcCCCcEEEEecCCccccCCCCCcc
Q 010519 267 GNLEQWLHGAMRNQGNLTWEARMKVIIGTAKALAYLHEAIEPKVVHRDIKSSNILIDDEFNAKVSDFGLAKLLDSGESHI 346 (508)
Q Consensus 267 gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~ 346 (508)
|+|..++. ....+++..++.++.||+.||.|||++ +|+||||||+|||++.++.+||+|||+++....... .
T Consensus 81 ~~L~~~~~----~~~~l~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dikp~Nili~~~~~~kL~DfG~~~~~~~~~~-~ 152 (329)
T cd05618 81 GDLMFHMQ----RQRKLPEEHARFYSAEISLALNYLHER---GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGD-T 152 (329)
T ss_pred CCHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHHHEEECCCCCEEEeeCCccccccCCCC-c
Confidence 99998874 445789999999999999999999999 999999999999999999999999999975422211 2
Q ss_pred cccccccccccCccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCCCc--hhcHHHHHHHHhcccccccccCCCCCC
Q 010519 347 TTRVMGTFGYVAPEYANTGMLNEKSDIYSFGVLLLEAVTGRDPVDYGRPAN--EVNLVEWLKMMVGTRRAEEVVDPNLEV 424 (508)
Q Consensus 347 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltG~~Pf~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~ 424 (508)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||....... ......++........ ...
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~--------~~~ 224 (329)
T cd05618 153 TSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQ--------IRI 224 (329)
T ss_pred cccccCCccccCHHHHcCCCCCCccceecccHHHHHHhhCCCCCccCCCcCCcccccHHHHHHHHhcCC--------CCC
Confidence 334578999999999999999999999999999999999999996322111 1111222222211111 111
Q ss_pred ChhHHHHHHHHHHHHHhcCCCCCCCCC------HHHHHHHh
Q 010519 425 KPATRALKRSLLVALRCVDPDSEKRPK------MSQVVRML 459 (508)
Q Consensus 425 ~~~~~~~~~l~~li~~cl~~dP~~RPs------~~evl~~L 459 (508)
+......+.+++.+||+.||.+||+ +.++++|-
T Consensus 225 --p~~~~~~~~~ll~~~L~~dP~~R~~~~~~~~~~~i~~hp 263 (329)
T cd05618 225 --PRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHP 263 (329)
T ss_pred --CCCCCHHHHHHHHHHhcCCHHHcCCCCCCCCHHHHhcCC
Confidence 1112345667999999999999998 46777663
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o |
| >cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-40 Score=338.69 Aligned_cols=253 Identities=23% Similarity=0.305 Sum_probs=196.2
Q ss_pred CcccceeEeeeCceEEEEEEEc-CCCEEEEEEEcccc---hhhHHHHHHHHHHHhcCCCCCceeEEEEEEeCceeeEEEe
Q 010519 187 RFSAENVLGEGGYGVVYKGRLI-NGSEVAVKKLLNNL---GQAEKEFRVEVEAIGHVRHKNLVRLLGYCIEGVHRMLVYE 262 (508)
Q Consensus 187 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~ei~~l~~l~h~niv~~~~~~~~~~~~~lv~E 262 (508)
+|+..+.||+|+||+||+|+.. +++.+|+|++.... ......+..|+.+++.++||||+++++++.+....|+|||
T Consensus 2 ~f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~~~~~~lv~E 81 (382)
T cd05625 2 MFVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMD 81 (382)
T ss_pred CcEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEeCCEEEEEEe
Confidence 6889999999999999999875 67889999886432 2233568889999999999999999999999999999999
Q ss_pred ecCCCCHHHHHhhhhccCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCEEEcCCCcEEEEecCCccccCCC
Q 010519 263 YVNNGNLEQWLHGAMRNQGNLTWEARMKVIIGTAKALAYLHEAIEPKVVHRDIKSSNILIDDEFNAKVSDFGLAKLLDSG 342 (508)
Q Consensus 263 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~~ 342 (508)
|+++|+|.+++. ..+.+++..+..++.||+.||.|||+. +|+||||||+|||++.++.+||+|||++..+...
T Consensus 82 ~~~gg~L~~~l~----~~~~~~e~~~~~~~~qi~~al~~lH~~---~ivHrDlKp~NILl~~~g~~kL~DFGla~~~~~~ 154 (382)
T cd05625 82 YIPGGDMMSLLI----RMGIFPEDLARFYIAELTCAVESVHKM---GFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWT 154 (382)
T ss_pred CCCCCcHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCEEEeECCCCcccccc
Confidence 999999999985 345688899999999999999999999 9999999999999999999999999997532100
Q ss_pred C----------------------------------------------CcccccccccccccCccccCCCCCCChhhHHHH
Q 010519 343 E----------------------------------------------SHITTRVMGTFGYVAPEYANTGMLNEKSDIYSF 376 (508)
Q Consensus 343 ~----------------------------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~ 376 (508)
. .......+||+.|+|||++.+..++.++|||||
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSl 234 (382)
T cd05625 155 HDSKYYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSV 234 (382)
T ss_pred ccccccccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcCCCCCCeeeEEec
Confidence 0 000123478999999999999999999999999
Q ss_pred HHHHHHHHhCCCCCCCCCCCchhcHHHHHHHHhcccccccccCCCCCCChhHHHHHHHHHHHHHhcCCCCCCCCC---HH
Q 010519 377 GVLLLEAVTGRDPVDYGRPANEVNLVEWLKMMVGTRRAEEVVDPNLEVKPATRALKRSLLVALRCVDPDSEKRPK---MS 453 (508)
Q Consensus 377 Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs---~~ 453 (508)
||+||||++|+.||....+. +......... ..+..+..........+++.+|+ .+|.+|++ +.
T Consensus 235 Gvil~elltG~~Pf~~~~~~------~~~~~i~~~~-------~~~~~p~~~~~s~~~~~li~~l~-~~p~~R~~~~~~~ 300 (382)
T cd05625 235 GVILYEMLVGQPPFLAQTPL------ETQMKVINWQ-------TSLHIPPQAKLSPEASDLIIKLC-RGPEDRLGKNGAD 300 (382)
T ss_pred hHHHHHHHhCCCCCCCCCHH------HHHHHHHccC-------CCcCCCCcccCCHHHHHHHHHHc-cCHhHcCCCCCHH
Confidence 99999999999999644321 1111111100 11111111122334555666665 59999997 88
Q ss_pred HHHHHhh
Q 010519 454 QVVRMLE 460 (508)
Q Consensus 454 evl~~L~ 460 (508)
++++|-.
T Consensus 301 ei~~hp~ 307 (382)
T cd05625 301 EIKAHPF 307 (382)
T ss_pred HHhcCCC
Confidence 8887643
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an |
| >cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-39 Score=326.96 Aligned_cols=242 Identities=26% Similarity=0.382 Sum_probs=190.0
Q ss_pred eeEeeeCceEEEEEEEc-CCCEEEEEEEcccc---hhhHHHHHHHHHHHhc-CCCCCceeEEEEEEeCceeeEEEeecCC
Q 010519 192 NVLGEGGYGVVYKGRLI-NGSEVAVKKLLNNL---GQAEKEFRVEVEAIGH-VRHKNLVRLLGYCIEGVHRMLVYEYVNN 266 (508)
Q Consensus 192 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~ei~~l~~-l~h~niv~~~~~~~~~~~~~lv~E~~~~ 266 (508)
+.||+|+||.||+|++. ++..||+|.+.... ......+..|..++.. .+||||+++++++......++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~g 80 (316)
T cd05592 1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQTKEHLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 36999999999999875 57789999886532 1222344556666654 4899999999999999999999999999
Q ss_pred CCHHHHHhhhhccCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCEEEcCCCcEEEEecCCccccCCCCCcc
Q 010519 267 GNLEQWLHGAMRNQGNLTWEARMKVIIGTAKALAYLHEAIEPKVVHRDIKSSNILIDDEFNAKVSDFGLAKLLDSGESHI 346 (508)
Q Consensus 267 gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~ 346 (508)
|+|.+++. ....+++..+..++.||+.||.|||+. +|+||||||+|||++.++.+||+|||++....... ..
T Consensus 81 g~L~~~~~----~~~~~~~~~~~~~~~qi~~al~~LH~~---~ivH~dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~-~~ 152 (316)
T cd05592 81 GDLMFHIQ----SSGRFDEARARFYAAEIICGLQFLHKK---GIIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGE-GK 152 (316)
T ss_pred CcHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHHC---CEEeCCCCHHHeEECCCCCEEEccCcCCeECCCCC-Cc
Confidence 99999884 345689999999999999999999998 99999999999999999999999999998543322 22
Q ss_pred cccccccccccCccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCCCchhcHHHHHHHHhcccccccccCCCCCCCh
Q 010519 347 TTRVMGTFGYVAPEYANTGMLNEKSDIYSFGVLLLEAVTGRDPVDYGRPANEVNLVEWLKMMVGTRRAEEVVDPNLEVKP 426 (508)
Q Consensus 347 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 426 (508)
....+||+.|+|||++.+..++.++|||||||++|||++|+.||..... .+......... +.+.
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~Pf~~~~~------~~~~~~i~~~~-------~~~~--- 216 (316)
T cd05592 153 ASTFCGTPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSPFHGEDE------DELFDSILNDR-------PHFP--- 216 (316)
T ss_pred cccccCCccccCHHHHcCCCCCCcccchhHHHHHHHHHhCCCCCCCCCH------HHHHHHHHcCC-------CCCC---
Confidence 3445789999999999999999999999999999999999999964321 11122221110 1111
Q ss_pred hHHHHHHHHHHHHHhcCCCCCCCCCHH-HHHHH
Q 010519 427 ATRALKRSLLVALRCVDPDSEKRPKMS-QVVRM 458 (508)
Q Consensus 427 ~~~~~~~l~~li~~cl~~dP~~RPs~~-evl~~ 458 (508)
......+.+++.+||+.||.+||++. +++++
T Consensus 217 -~~~~~~~~~ll~~~l~~~P~~R~~~~~~l~~h 248 (316)
T cd05592 217 -RWISKEAKDCLSKLFERDPTKRLGVDGDIRQH 248 (316)
T ss_pred -CCCCHHHHHHHHHHccCCHHHcCCChHHHHcC
Confidence 11234556789999999999999875 56554
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp |
| >cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-40 Score=338.18 Aligned_cols=255 Identities=22% Similarity=0.294 Sum_probs=198.7
Q ss_pred CCcccceeEeeeCceEEEEEEEc-CCCEEEEEEEcccc---hhhHHHHHHHHHHHhcCCCCCceeEEEEEEeCceeeEEE
Q 010519 186 NRFSAENVLGEGGYGVVYKGRLI-NGSEVAVKKLLNNL---GQAEKEFRVEVEAIGHVRHKNLVRLLGYCIEGVHRMLVY 261 (508)
Q Consensus 186 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~ei~~l~~l~h~niv~~~~~~~~~~~~~lv~ 261 (508)
++|++.+.||+|+||+||+++.. +++.||+|.+.... ......+.+|+.+++.++||||+++++.+.+++..++||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~ 80 (376)
T cd05598 1 SMFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVM 80 (376)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEEEcCCEEEEEE
Confidence 37899999999999999999875 58899999885432 122356788999999999999999999999999999999
Q ss_pred eecCCCCHHHHHhhhhccCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCEEEcCCCcEEEEecCCccccCC
Q 010519 262 EYVNNGNLEQWLHGAMRNQGNLTWEARMKVIIGTAKALAYLHEAIEPKVVHRDIKSSNILIDDEFNAKVSDFGLAKLLDS 341 (508)
Q Consensus 262 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~ 341 (508)
||+++|+|.+++. ..+.+++..+..++.||+.||.|||++ +|+||||||+|||++.++.+||+|||++..+..
T Consensus 81 E~~~~g~L~~~i~----~~~~~~~~~~~~~~~qi~~al~~lH~~---~ivHrDlkp~Nill~~~~~ikL~DFG~a~~~~~ 153 (376)
T cd05598 81 DYIPGGDMMSLLI----RLGIFEEDLARFYIAELTCAIESVHKM---GFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRW 153 (376)
T ss_pred eCCCCCcHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCCHHHEEECCCCCEEEEeCCCCccccc
Confidence 9999999999984 345688899999999999999999999 999999999999999999999999999753210
Q ss_pred C------------------------------------------CCcccccccccccccCccccCCCCCCChhhHHHHHHH
Q 010519 342 G------------------------------------------ESHITTRVMGTFGYVAPEYANTGMLNEKSDIYSFGVL 379 (508)
Q Consensus 342 ~------------------------------------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvv 379 (508)
. ........+||+.|+|||++.+..++.++|||||||+
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvi 233 (376)
T cd05598 154 THDSKYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVI 233 (376)
T ss_pred cccccccccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCCCCCcceeeeeccce
Confidence 0 0001123579999999999999999999999999999
Q ss_pred HHHHHhCCCCCCCCCCCchhcHHHHHHHHhcccccccccCCCCCCChhHHHHHHHHHHHHHhcCCCCCCCC---CHHHHH
Q 010519 380 LLEAVTGRDPVDYGRPANEVNLVEWLKMMVGTRRAEEVVDPNLEVKPATRALKRSLLVALRCVDPDSEKRP---KMSQVV 456 (508)
Q Consensus 380 l~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP---s~~evl 456 (508)
||||++|+.||....+.. ......... ..+...........+.+++.+|+ .+|.+|+ |+.+++
T Consensus 234 lyell~G~~Pf~~~~~~~------~~~~i~~~~-------~~~~~~~~~~~s~~~~~li~~l~-~~p~~R~~~~t~~ell 299 (376)
T cd05598 234 LYEMLVGQPPFLADTPAE------TQLKVINWE-------TTLHIPSQAKLSREASDLILRLC-CGAEDRLGKNGADEIK 299 (376)
T ss_pred eeehhhCCCCCCCCCHHH------HHHHHhccC-------ccccCCCCCCCCHHHHHHHHHHh-cCHhhcCCCCCHHHHh
Confidence 999999999997543211 111111110 01111111112334555777766 5999999 999999
Q ss_pred HHhhc
Q 010519 457 RMLEA 461 (508)
Q Consensus 457 ~~L~~ 461 (508)
++-.-
T Consensus 300 ~h~~~ 304 (376)
T cd05598 300 AHPFF 304 (376)
T ss_pred CCCCc
Confidence 88543
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. |
| >cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-39 Score=316.50 Aligned_cols=255 Identities=27% Similarity=0.381 Sum_probs=202.6
Q ss_pred hCCcccceeEeeeCceEEEEEEEc-CCCEEEEEEEcccchhhHHHHHHHHHHHhcCCCCCceeEEEEEEeCceeeEEEee
Q 010519 185 TNRFSAENVLGEGGYGVVYKGRLI-NGSEVAVKKLLNNLGQAEKEFRVEVEAIGHVRHKNLVRLLGYCIEGVHRMLVYEY 263 (508)
Q Consensus 185 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~ei~~l~~l~h~niv~~~~~~~~~~~~~lv~E~ 263 (508)
.++|++.+.||+|+||.||+|+.. ++..+|+|++..........+..|+.++..++||||+++++++......++||||
T Consensus 8 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~~e~~~l~~~~h~~ii~~~~~~~~~~~~~iv~e~ 87 (267)
T cd06646 8 QHDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIVAYFGSYLSREKLWICMEY 87 (267)
T ss_pred hhhcchhheeecCCCeEEEEEEECCCCeEEEEEEEecCccchHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCEEEEEEeC
Confidence 357999999999999999999874 6788999988655444456688899999999999999999999999999999999
Q ss_pred cCCCCHHHHHhhhhccCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCEEEcCCCcEEEEecCCccccCCCC
Q 010519 264 VNNGNLEQWLHGAMRNQGNLTWEARMKVIIGTAKALAYLHEAIEPKVVHRDIKSSNILIDDEFNAKVSDFGLAKLLDSGE 343 (508)
Q Consensus 264 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~~~ 343 (508)
+++++|.++++ ....+++..+..++.|++.||.|||+. +|+|+||+|+||++++++.+||+|||++.......
T Consensus 88 ~~~~~L~~~~~----~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~ 160 (267)
T cd06646 88 CGGGSLQDIYH----VTGPLSELQIAYVCRETLQGLAYLHSK---GKMHRDIKGANILLTDNGDVKLADFGVAAKITATI 160 (267)
T ss_pred CCCCcHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEECCCCCEEECcCccceeecccc
Confidence 99999999984 345688999999999999999999998 99999999999999999999999999998654322
Q ss_pred CcccccccccccccCccccC---CCCCCChhhHHHHHHHHHHHHhCCCCCCCCCCCchhcHHHHHHHHhcccccccccCC
Q 010519 344 SHITTRVMGTFGYVAPEYAN---TGMLNEKSDIYSFGVLLLEAVTGRDPVDYGRPANEVNLVEWLKMMVGTRRAEEVVDP 420 (508)
Q Consensus 344 ~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DvwS~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 420 (508)
. ......+++.|+|||.+. ...++.++|||||||++|||++|+.||....+..... .+. ......+
T Consensus 161 ~-~~~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~~~~~~------~~~----~~~~~~~ 229 (267)
T cd06646 161 A-KRKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALF------LMS----KSNFQPP 229 (267)
T ss_pred c-ccCccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccccchhhhhe------eee----cCCCCCC
Confidence 1 123346888999999884 4457889999999999999999999985433211100 000 0000111
Q ss_pred CCCCChhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHh
Q 010519 421 NLEVKPATRALKRSLLVALRCVDPDSEKRPKMSQVVRML 459 (508)
Q Consensus 421 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L 459 (508)
... ........+.+++.+||+.||.+|||+++++++|
T Consensus 230 ~~~--~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~l 266 (267)
T cd06646 230 KLK--DKTKWSSTFHNFVKISLTKNPKKRPTAERLLTHL 266 (267)
T ss_pred CCc--cccccCHHHHHHHHHHhhCChhhCcCHHHHhcCC
Confidence 111 1112345677899999999999999999999876
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-40 Score=323.56 Aligned_cols=264 Identities=27% Similarity=0.432 Sum_probs=208.0
Q ss_pred HHHHhhCCcccceeEeeeCceEEEEEEEcC------CCEEEEEEEcccc-hhhHHHHHHHHHHHhcC-CCCCceeEEEEE
Q 010519 180 DLEIATNRFSAENVLGEGGYGVVYKGRLIN------GSEVAVKKLLNNL-GQAEKEFRVEVEAIGHV-RHKNLVRLLGYC 251 (508)
Q Consensus 180 ~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~------~~~vavK~~~~~~-~~~~~~~~~ei~~l~~l-~h~niv~~~~~~ 251 (508)
++++..++|++.+.||+|+||.||++.+.. ...+|+|.+.... ......+..|+.++.++ +|+||+++++++
T Consensus 6 ~~~~~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~ 85 (293)
T cd05053 6 EWELPRDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGVC 85 (293)
T ss_pred ccccCHhHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCCCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEE
Confidence 345667789999999999999999998642 3578999876543 23345688899999999 899999999999
Q ss_pred EeCceeeEEEeecCCCCHHHHHhhhh------------ccCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCC
Q 010519 252 IEGVHRMLVYEYVNNGNLEQWLHGAM------------RNQGNLTWEARMKVIIGTAKALAYLHEAIEPKVVHRDIKSSN 319 (508)
Q Consensus 252 ~~~~~~~lv~E~~~~gsL~~~l~~~~------------~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiH~Dlk~~N 319 (508)
..+...+++|||+++|+|.+++.... .....+++..++.++.|++.||.|||+. +|+||||||+|
T Consensus 86 ~~~~~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~---~ivH~dlkp~N 162 (293)
T cd05053 86 TQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASK---KCIHRDLAARN 162 (293)
T ss_pred cCCCCeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHC---Cccccccceee
Confidence 99999999999999999999996421 2345688999999999999999999998 99999999999
Q ss_pred EEEcCCCcEEEEecCCccccCCCCCc-ccccccccccccCccccCCCCCCChhhHHHHHHHHHHHHh-CCCCCCCCCCCc
Q 010519 320 ILIDDEFNAKVSDFGLAKLLDSGESH-ITTRVMGTFGYVAPEYANTGMLNEKSDIYSFGVLLLEAVT-GRDPVDYGRPAN 397 (508)
Q Consensus 320 Ill~~~~~~kl~Dfgla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~ellt-G~~Pf~~~~~~~ 397 (508)
||+++++.+||+|||+++.+...... ......++..|+|||.+.+..++.++|||||||++|||++ |..||.....
T Consensus 163 il~~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~-- 240 (293)
T cd05053 163 VLVTEDHVMKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPV-- 240 (293)
T ss_pred EEEcCCCeEEeCccccccccccccceeccCCCCCCccccCHHHhccCCcCcccceeehhhHHHHHhcCCCCCCCCCCH--
Confidence 99999999999999999866543221 1222334678999999998899999999999999999998 9999863321
Q ss_pred hhcHHHHHHHHhcccccccccCCCCCCChhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhhcC
Q 010519 398 EVNLVEWLKMMVGTRRAEEVVDPNLEVKPATRALKRSLLVALRCVDPDSEKRPKMSQVVRMLEAD 462 (508)
Q Consensus 398 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~ 462 (508)
.+......... ....+......+.+|+.+||+.||.+|||+.++++.|+..
T Consensus 241 ----~~~~~~~~~~~----------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~eil~~l~~~ 291 (293)
T cd05053 241 ----EELFKLLKEGY----------RMEKPQNCTQELYHLMRDCWHEVPSQRPTFKQLVEDLDRM 291 (293)
T ss_pred ----HHHHHHHHcCC----------cCCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHHHHh
Confidence 11111111111 0011112345677799999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, |
| >cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-39 Score=315.41 Aligned_cols=257 Identities=25% Similarity=0.427 Sum_probs=206.0
Q ss_pred HHhhCCcccceeEeeeCceEEEEEEEcCCCEEEEEEEcccchhhHHHHHHHHHHHhcCCCCCceeEEEEEEeCceeeEEE
Q 010519 182 EIATNRFSAENVLGEGGYGVVYKGRLINGSEVAVKKLLNNLGQAEKEFRVEVEAIGHVRHKNLVRLLGYCIEGVHRMLVY 261 (508)
Q Consensus 182 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~ei~~l~~l~h~niv~~~~~~~~~~~~~lv~ 261 (508)
++..++|.+.+.||+|+||.||++.+..+..+++|.+.... .....+.+|+.+++.++|+||+++++++.+ ...+++|
T Consensus 2 ~~~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~iK~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~v~ 79 (260)
T cd05073 2 EIPRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGS-MSVEAFLAEANVMKTLQHDKLVKLHAVVTK-EPIYIIT 79 (260)
T ss_pred cccccceeEEeEecCccceEEEEEEecCCccEEEEecCCCh-hHHHHHHHHHHHHHhcCCCCcceEEEEEcC-CCeEEEE
Confidence 45667899999999999999999988777889999876432 334578889999999999999999999887 6789999
Q ss_pred eecCCCCHHHHHhhhhccCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCEEEcCCCcEEEEecCCccccCC
Q 010519 262 EYVNNGNLEQWLHGAMRNQGNLTWEARMKVIIGTAKALAYLHEAIEPKVVHRDIKSSNILIDDEFNAKVSDFGLAKLLDS 341 (508)
Q Consensus 262 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~ 341 (508)
||+++++|.+++.. .....+++..++.++.+++.||.|||+. +++|+||+|+||+++.++.+||+|||++.....
T Consensus 80 e~~~~~~L~~~~~~--~~~~~~~~~~~~~~~~~l~~aL~~lH~~---~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~ 154 (260)
T cd05073 80 EFMAKGSLLDFLKS--DEGSKQPLPKLIDFSAQIAEGMAFIEQR---NYIHRDLRAANILVSASLVCKIADFGLARVIED 154 (260)
T ss_pred EeCCCCcHHHHHHh--CCccccCHHHHHHHHHHHHHHHHHHHhC---CccccccCcceEEEcCCCcEEECCCcceeeccC
Confidence 99999999999964 2345678889999999999999999998 999999999999999999999999999986644
Q ss_pred CCCcccccccccccccCccccCCCCCCChhhHHHHHHHHHHHHh-CCCCCCCCCCCchhcHHHHHHHHhcccccccccCC
Q 010519 342 GESHITTRVMGTFGYVAPEYANTGMLNEKSDIYSFGVLLLEAVT-GRDPVDYGRPANEVNLVEWLKMMVGTRRAEEVVDP 420 (508)
Q Consensus 342 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 420 (508)
..........++..|+|||++.+..++.++|+|||||++|++++ |..||..... .....++ ...
T Consensus 155 ~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~---~~~~~~~---~~~--------- 219 (260)
T cd05073 155 NEYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSN---PEVIRAL---ERG--------- 219 (260)
T ss_pred CCcccccCCcccccccCHhHhccCCcCccccchHHHHHHHHHHhcCCCCCCCCCH---HHHHHHH---hCC---------
Confidence 33222223345678999999998889999999999999999999 8999864321 1111111 111
Q ss_pred CCCCChhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhhc
Q 010519 421 NLEVKPATRALKRSLLVALRCVDPDSEKRPKMSQVVRMLEA 461 (508)
Q Consensus 421 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~ 461 (508)
............+.+++.+||++||++||++.++++.|+.
T Consensus 220 -~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~L~~ 259 (260)
T cd05073 220 -YRMPRPENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDD 259 (260)
T ss_pred -CCCCCcccCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence 0111112234567789999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa |
| >KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-39 Score=328.43 Aligned_cols=254 Identities=26% Similarity=0.358 Sum_probs=212.5
Q ss_pred hhCCcccceeEeeeCceEEEEEEEc-CCCEEEEEEEcccchh---hHHHHHHHHHHHhcCC-CCCceeEEEEEEeCceee
Q 010519 184 ATNRFSAENVLGEGGYGVVYKGRLI-NGSEVAVKKLLNNLGQ---AEKEFRVEVEAIGHVR-HKNLVRLLGYCIEGVHRM 258 (508)
Q Consensus 184 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~---~~~~~~~ei~~l~~l~-h~niv~~~~~~~~~~~~~ 258 (508)
....|.+.+.||.|.||.||+++.+ +|+.+|+|.+.+.... ....+.+|+.+|+++. |||||.++++|++....+
T Consensus 33 ~~~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~~~~~ 112 (382)
T KOG0032|consen 33 IKEKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFEDPDSVY 112 (382)
T ss_pred ccccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEEcCCeEE
Confidence 3457899999999999999999986 4999999999665432 3468899999999998 999999999999999999
Q ss_pred EEEeecCCCCHHHHHhhhhccCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCEEEcCC----CcEEEEecC
Q 010519 259 LVYEYVNNGNLEQWLHGAMRNQGNLTWEARMKVIIGTAKALAYLHEAIEPKVVHRDIKSSNILIDDE----FNAKVSDFG 334 (508)
Q Consensus 259 lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiH~Dlk~~NIll~~~----~~~kl~Dfg 334 (508)
+|||++.||.|++.+... .+++..+..++.|++.|+.|||+. +|+||||||+|+|+... +.+|++|||
T Consensus 113 lvmEL~~GGeLfd~i~~~-----~~sE~da~~~~~~il~av~~lH~~---gvvHrDlKpEN~L~~~~~~~~~~ik~~DFG 184 (382)
T KOG0032|consen 113 LVMELCEGGELFDRIVKK-----HYSERDAAGIIRQILEAVKYLHSL---GVVHRDLKPENLLLASKDEGSGRIKLIDFG 184 (382)
T ss_pred EEEEecCCchHHHHHHHc-----cCCHHHHHHHHHHHHHHHHHHHhC---CceeccCCHHHeeeccccCCCCcEEEeeCC
Confidence 999999999999999643 399999999999999999999998 99999999999999643 479999999
Q ss_pred CccccCCCCCcccccccccccccCccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCCCchhcHHHHHHHHhccccc
Q 010519 335 LAKLLDSGESHITTRVMGTFGYVAPEYANTGMLNEKSDIYSFGVLLLEAVTGRDPVDYGRPANEVNLVEWLKMMVGTRRA 414 (508)
Q Consensus 335 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~ 414 (508)
++..... .......+||+.|+|||++....|+..+||||+||++|.|++|..||......... .....+.
T Consensus 185 la~~~~~--~~~~~~~~Gtp~y~APEvl~~~~y~~~~DiWS~Gvi~yiLL~G~~PF~~~~~~~~~-----~~i~~~~--- 254 (382)
T KOG0032|consen 185 LAKFIKP--GERLHTIVGTPEYVAPEVLGGRPYGDEVDVWSIGVILYILLSGVPPFWGETEFEIF-----LAILRGD--- 254 (382)
T ss_pred CceEccC--CceEeeecCCccccCchhhcCCCCCcccchhHHHHHHHHHhhCCCCCcCCChhHHH-----HHHHcCC---
Confidence 9998876 33466789999999999999999999999999999999999999999744322111 1111111
Q ss_pred ccccCCCCCCChhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhh
Q 010519 415 EEVVDPNLEVKPATRALKRSLLVALRCVDPDSEKRPKMSQVVRMLE 460 (508)
Q Consensus 415 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 460 (508)
..+.............+++..|+..||..|+|+.++|+|-|
T Consensus 255 -----~~f~~~~w~~is~~akd~i~~ll~~dp~~R~ta~~~L~HpW 295 (382)
T KOG0032|consen 255 -----FDFTSEPWDDISESAKDFIRKLLEFDPRKRLTAAQALQHPW 295 (382)
T ss_pred -----CCCCCCCccccCHHHHHHHHHhcccCcccCCCHHHHhcCcc
Confidence 12333334445666777999999999999999999999754
|
|
| >cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-39 Score=319.80 Aligned_cols=261 Identities=25% Similarity=0.441 Sum_probs=205.8
Q ss_pred HHhhCCcccceeEeeeCceEEEEEEEcC------CCEEEEEEEcccc-hhhHHHHHHHHHHHhcCCCCCceeEEEEEEeC
Q 010519 182 EIATNRFSAENVLGEGGYGVVYKGRLIN------GSEVAVKKLLNNL-GQAEKEFRVEVEAIGHVRHKNLVRLLGYCIEG 254 (508)
Q Consensus 182 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~~------~~~vavK~~~~~~-~~~~~~~~~ei~~l~~l~h~niv~~~~~~~~~ 254 (508)
++..++|.+.+.||+|+||.||+|.+.+ +..||+|.+.... ......+.+|+.++..++||||+++++++...
T Consensus 2 ~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~ 81 (277)
T cd05032 2 ELPREKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVRLLGVVSTG 81 (277)
T ss_pred ccchHHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCccCHHHHHHHHHHHHHHHhCCCCceeEEEEEEcCC
Confidence 3456789999999999999999998642 3679999876443 23345688899999999999999999999999
Q ss_pred ceeeEEEeecCCCCHHHHHhhhhcc------CCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCEEEcCCCcE
Q 010519 255 VHRMLVYEYVNNGNLEQWLHGAMRN------QGNLTWEARMKVIIGTAKALAYLHEAIEPKVVHRDIKSSNILIDDEFNA 328 (508)
Q Consensus 255 ~~~~lv~E~~~~gsL~~~l~~~~~~------~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiH~Dlk~~NIll~~~~~~ 328 (508)
...++||||+++|+|.+++...... ...+++..++.++.|++.||.|||+. +++|+||||+|||+++++.+
T Consensus 82 ~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~di~p~nill~~~~~~ 158 (277)
T cd05032 82 QPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAK---KFVHRDLAARNCMVAEDLTV 158 (277)
T ss_pred CCcEEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHhC---CccccccChheEEEcCCCCE
Confidence 9999999999999999999643221 23478889999999999999999998 99999999999999999999
Q ss_pred EEEecCCccccCCCCC-cccccccccccccCccccCCCCCCChhhHHHHHHHHHHHHh-CCCCCCCCCCCchhcHHHHHH
Q 010519 329 KVSDFGLAKLLDSGES-HITTRVMGTFGYVAPEYANTGMLNEKSDIYSFGVLLLEAVT-GRDPVDYGRPANEVNLVEWLK 406 (508)
Q Consensus 329 kl~Dfgla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~ellt-G~~Pf~~~~~~~~~~~~~~~~ 406 (508)
||+|||+++....... .......++..|+|||.+.+..++.++|||||||++|||++ |..||...... ....+.
T Consensus 159 kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~---~~~~~~- 234 (277)
T cd05032 159 KIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLSNE---EVLKFV- 234 (277)
T ss_pred EECCcccchhhccCcccccCCCCCccccccCHHHHhcCCCCcccchHHHHHHHHHhhccCCCCCccCCHH---HHHHHH-
Confidence 9999999986543321 11223446788999999988889999999999999999998 89998643221 111111
Q ss_pred HHhcccccccccCCCCCCChhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhhc
Q 010519 407 MMVGTRRAEEVVDPNLEVKPATRALKRSLLVALRCVDPDSEKRPKMSQVVRMLEA 461 (508)
Q Consensus 407 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~ 461 (508)
..... .... ......+.+++.+||+.+|.+|||+.+++..|+.
T Consensus 235 --~~~~~------~~~~----~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~ 277 (277)
T cd05032 235 --IDGGH------LDLP----ENCPDKLLELMRMCWQYNPKMRPTFLEIVSSLKD 277 (277)
T ss_pred --hcCCC------CCCC----CCCCHHHHHHHHHHcCCChhhCCCHHHHHHHhcC
Confidence 11110 1111 1124567779999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological |
| >cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-39 Score=325.88 Aligned_cols=250 Identities=25% Similarity=0.324 Sum_probs=196.2
Q ss_pred eeEeeeCceEEEEEEEc-CCCEEEEEEEcccch---hhHHHHHHHHHHHhcC-CCCCceeEEEEEEeCceeeEEEeecCC
Q 010519 192 NVLGEGGYGVVYKGRLI-NGSEVAVKKLLNNLG---QAEKEFRVEVEAIGHV-RHKNLVRLLGYCIEGVHRMLVYEYVNN 266 (508)
Q Consensus 192 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~ei~~l~~l-~h~niv~~~~~~~~~~~~~lv~E~~~~ 266 (508)
+.||+|+||+||+|+.. +++.+|+|.+..... .....+..|+.++.++ +||||+.+++++.+....++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (327)
T cd05617 1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRLFLVIEYVNG 80 (327)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCCEEEEEEeCCCC
Confidence 46999999999999875 678899999865432 2334577899998888 699999999999999999999999999
Q ss_pred CCHHHHHhhhhccCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCEEEcCCCcEEEEecCCccccCCCCCcc
Q 010519 267 GNLEQWLHGAMRNQGNLTWEARMKVIIGTAKALAYLHEAIEPKVVHRDIKSSNILIDDEFNAKVSDFGLAKLLDSGESHI 346 (508)
Q Consensus 267 gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~ 346 (508)
|+|..++. ....+++..+..++.||+.||.|||++ +|+||||||+|||++.++.+||+|||++....... ..
T Consensus 81 ~~L~~~~~----~~~~l~~~~~~~~~~qi~~al~~lH~~---~ivHrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~-~~ 152 (327)
T cd05617 81 GDLMFHMQ----RQRKLPEEHARFYAAEICIALNFLHER---GIIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPG-DT 152 (327)
T ss_pred CcHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHEEEeCCCCEEEeccccceeccCCC-Cc
Confidence 99998884 345799999999999999999999999 99999999999999999999999999997532221 12
Q ss_pred cccccccccccCccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCCCchhcHHHHHHHHhcccccccccCCCCCCCh
Q 010519 347 TTRVMGTFGYVAPEYANTGMLNEKSDIYSFGVLLLEAVTGRDPVDYGRPANEVNLVEWLKMMVGTRRAEEVVDPNLEVKP 426 (508)
Q Consensus 347 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 426 (508)
....+||+.|+|||++.+..++.++|||||||+||||++|..||............+++........ ...
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~--------~~~-- 222 (327)
T cd05617 153 TSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQVILEKP--------IRI-- 222 (327)
T ss_pred eecccCCcccCCHHHHCCCCCCchheeehhHHHHHHHHhCCCCCCccCCCcccccHHHHHHHHHhCC--------CCC--
Confidence 3346799999999999999999999999999999999999999964333222222222222221111 111
Q ss_pred hHHHHHHHHHHHHHhcCCCCCCCCCH------HHHHHHh
Q 010519 427 ATRALKRSLLVALRCVDPDSEKRPKM------SQVVRML 459 (508)
Q Consensus 427 ~~~~~~~l~~li~~cl~~dP~~RPs~------~evl~~L 459 (508)
+......+.+++.+||+.||.+|+++ .++++|-
T Consensus 223 p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~h~ 261 (327)
T cd05617 223 PRFLSVKASHVLKGFLNKDPKERLGCQPQTGFSDIKSHT 261 (327)
T ss_pred CCCCCHHHHHHHHHHhccCHHHcCCCCCCCCHHHHHcCC
Confidence 11123445679999999999999984 5777654
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways |
| >cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-39 Score=311.55 Aligned_cols=260 Identities=27% Similarity=0.431 Sum_probs=209.6
Q ss_pred CCcccceeEeeeCceEEEEEEEc-CCCEEEEEEEcccc---hhhHHHHHHHHHHHhcCCCCCceeEEEEEEeCceeeEEE
Q 010519 186 NRFSAENVLGEGGYGVVYKGRLI-NGSEVAVKKLLNNL---GQAEKEFRVEVEAIGHVRHKNLVRLLGYCIEGVHRMLVY 261 (508)
Q Consensus 186 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~ei~~l~~l~h~niv~~~~~~~~~~~~~lv~ 261 (508)
++|++.+.||+|+||.||+|... +|+.+|+|.+.... ......+..|++++++++|+|++++++++...+..++||
T Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 81 (267)
T cd08224 2 GNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFIENNELNIVL 81 (267)
T ss_pred CceeeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEEE
Confidence 57999999999999999999886 78999999875322 233567888999999999999999999999999999999
Q ss_pred eecCCCCHHHHHhhhhccCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCEEEcCCCcEEEEecCCccccCC
Q 010519 262 EYVNNGNLEQWLHGAMRNQGNLTWEARMKVIIGTAKALAYLHEAIEPKVVHRDIKSSNILIDDEFNAKVSDFGLAKLLDS 341 (508)
Q Consensus 262 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~ 341 (508)
||+++|+|.+++.........+++..++.++.+++.||.|||+. +++|+||+|+||+++.++.++|+|||++.....
T Consensus 82 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~dl~p~nil~~~~~~~~l~d~~~~~~~~~ 158 (267)
T cd08224 82 ELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSK---RIMHRDIKPANVFITATGVVKLGDLGLGRFFSS 158 (267)
T ss_pred ecCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHHhC---CEecCCcChhhEEECCCCcEEEeccceeeeccC
Confidence 99999999999865434456689999999999999999999998 999999999999999999999999999876543
Q ss_pred CCCcccccccccccccCccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCCCchhcHHHHHHHHhcccccccccCCC
Q 010519 342 GESHITTRVMGTFGYVAPEYANTGMLNEKSDIYSFGVLLLEAVTGRDPVDYGRPANEVNLVEWLKMMVGTRRAEEVVDPN 421 (508)
Q Consensus 342 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 421 (508)
... ......+++.|+|||.+.+..++.++|+|||||++|+|++|+.||.... ............. .
T Consensus 159 ~~~-~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~----~~~~~~~~~~~~~---------~ 224 (267)
T cd08224 159 KTT-AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDK----MNLYSLCKKIEKC---------D 224 (267)
T ss_pred CCc-ccceecCCccccCHHHhccCCCCchhcHHHHHHHHHHHHHCCCCcccCC----ccHHHHHhhhhcC---------C
Confidence 221 1233467889999999998889999999999999999999999985332 1122222111110 0
Q ss_pred CCCChhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhhcC
Q 010519 422 LEVKPATRALKRSLLVALRCVDPDSEKRPKMSQVVRMLEAD 462 (508)
Q Consensus 422 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~ 462 (508)
....+.......+.+++.+||+.+|.+|||+.+|++.|+..
T Consensus 225 ~~~~~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~il~~~~~~ 265 (267)
T cd08224 225 YPPLPADHYSEELRDLVSRCINPDPEKRPDISYVLQVAKEM 265 (267)
T ss_pred CCCCChhhcCHHHHHHHHHHcCCCcccCCCHHHHHHHHHHh
Confidence 11111113345667799999999999999999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a |
| >cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-39 Score=321.19 Aligned_cols=264 Identities=27% Similarity=0.424 Sum_probs=201.3
Q ss_pred CCcccceeEeeeCceEEEEEEEc-----CCCEEEEEEEcccchhhHHHHHHHHHHHhcCCCCCceeEEEEEEeC--ceee
Q 010519 186 NRFSAENVLGEGGYGVVYKGRLI-----NGSEVAVKKLLNNLGQAEKEFRVEVEAIGHVRHKNLVRLLGYCIEG--VHRM 258 (508)
Q Consensus 186 ~~~~~~~~lg~G~~g~Vy~~~~~-----~~~~vavK~~~~~~~~~~~~~~~ei~~l~~l~h~niv~~~~~~~~~--~~~~ 258 (508)
++|.+.+.||+|+||.||++... ++..||+|++..........+..|+.+++.++||||+++++++... ...+
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 83 (284)
T cd05081 4 RHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLR 83 (284)
T ss_pred ccceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEccCCCCceE
Confidence 47888999999999999999742 5788999998766555567788999999999999999999987543 4678
Q ss_pred EEEeecCCCCHHHHHhhhhccCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCEEEcCCCcEEEEecCCccc
Q 010519 259 LVYEYVNNGNLEQWLHGAMRNQGNLTWEARMKVIIGTAKALAYLHEAIEPKVVHRDIKSSNILIDDEFNAKVSDFGLAKL 338 (508)
Q Consensus 259 lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~Dfgla~~ 338 (508)
+||||+++|+|.+++.. ....+++..++.++.|++.||.|||+. +++||||||+||++++++.+||+|||++..
T Consensus 84 lv~e~~~~~~L~~~l~~---~~~~l~~~~~~~~~~~l~~aL~~LH~~---~i~H~dlkp~nili~~~~~~~l~dfg~~~~ 157 (284)
T cd05081 84 LVMEYLPYGSLRDYLQK---HRERLDHRKLLLYASQICKGMEYLGSK---RYVHRDLATRNILVESENRVKIGDFGLTKV 157 (284)
T ss_pred EEEEecCCCCHHHHHHh---cCcCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCCHhhEEECCCCeEEECCCccccc
Confidence 99999999999999853 345689999999999999999999999 999999999999999999999999999986
Q ss_pred cCCCCCcc--cccccccccccCccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCCCchhcHHHHHHHHhcccc---
Q 010519 339 LDSGESHI--TTRVMGTFGYVAPEYANTGMLNEKSDIYSFGVLLLEAVTGRDPVDYGRPANEVNLVEWLKMMVGTRR--- 413 (508)
Q Consensus 339 ~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~--- 413 (508)
........ .....++..|+|||++.+..++.++|||||||++|||++|..|+..... .+...+.....
T Consensus 158 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~-------~~~~~~~~~~~~~~ 230 (284)
T cd05081 158 LPQDKEYYKVREPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYSDKSCSPPA-------EFMRMMGNDKQGQM 230 (284)
T ss_pred ccCCCcceeecCCCCCceEeeCHHHhccCCcChHHHHHHHHHHHHHHhhcCCcCCCcch-------hhhhhccccccccc
Confidence 64332211 1112234569999999988999999999999999999998877532211 00000000000
Q ss_pred ----cccccCCCCCCChhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhhcC
Q 010519 414 ----AEEVVDPNLEVKPATRALKRSLLVALRCVDPDSEKRPKMSQVVRMLEAD 462 (508)
Q Consensus 414 ----~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~ 462 (508)
....+...............+.+|+.+||+.+|.+|||+.+|++.|+..
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~~ 283 (284)
T cd05081 231 IVYHLIELLKNNGRLPAPPGCPAEIYAIMKECWNNDPSQRPSFSELALQVEAI 283 (284)
T ss_pred chHHHHHHHhcCCcCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHhc
Confidence 0000001111111122345677799999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th |
| >cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-39 Score=326.35 Aligned_cols=243 Identities=24% Similarity=0.340 Sum_probs=191.4
Q ss_pred eeEeeeCceEEEEEEEc-CCCEEEEEEEcccc---hhhHHHHHHHHHHHhc-CCCCCceeEEEEEEeCceeeEEEeecCC
Q 010519 192 NVLGEGGYGVVYKGRLI-NGSEVAVKKLLNNL---GQAEKEFRVEVEAIGH-VRHKNLVRLLGYCIEGVHRMLVYEYVNN 266 (508)
Q Consensus 192 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~ei~~l~~-l~h~niv~~~~~~~~~~~~~lv~E~~~~ 266 (508)
+.||+|+||.||+|++. +|..||+|.+.... ......+..|..++.. ++||||+++++++.+.+..|+||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~ 80 (316)
T cd05620 1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQTKEHLFFVMEFLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEeCCEEEEEECCCCC
Confidence 46999999999999875 67899999986532 1223445667777765 4899999999999999999999999999
Q ss_pred CCHHHHHhhhhccCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCEEEcCCCcEEEEecCCccccCCCCCcc
Q 010519 267 GNLEQWLHGAMRNQGNLTWEARMKVIIGTAKALAYLHEAIEPKVVHRDIKSSNILIDDEFNAKVSDFGLAKLLDSGESHI 346 (508)
Q Consensus 267 gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~ 346 (508)
|+|.+++. ....+++..+..++.||+.||.|||++ +|+||||||+|||++.++.+||+|||++....... ..
T Consensus 81 g~L~~~i~----~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~-~~ 152 (316)
T cd05620 81 GDLMFHIQ----DKGRFDLYRATFYAAEIVCGLQFLHSK---GIIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGD-NR 152 (316)
T ss_pred CcHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHeEECCCCCEEeCccCCCeecccCC-Cc
Confidence 99999884 345788999999999999999999999 99999999999999999999999999987432221 12
Q ss_pred cccccccccccCccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCCCchhcHHHHHHHHhcccccccccCCCCCCCh
Q 010519 347 TTRVMGTFGYVAPEYANTGMLNEKSDIYSFGVLLLEAVTGRDPVDYGRPANEVNLVEWLKMMVGTRRAEEVVDPNLEVKP 426 (508)
Q Consensus 347 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 426 (508)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||..... ... ....... .+.+..
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~Pf~~~~~---~~~---~~~~~~~-------~~~~~~-- 217 (316)
T cd05620 153 ASTFCGTPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFHGDDE---DEL---FESIRVD-------TPHYPR-- 217 (316)
T ss_pred eeccCCCcCccCHHHHcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCH---HHH---HHHHHhC-------CCCCCC--
Confidence 3446789999999999999999999999999999999999999964321 111 1111110 011111
Q ss_pred hHHHHHHHHHHHHHhcCCCCCCCCCHH-HHHHHh
Q 010519 427 ATRALKRSLLVALRCVDPDSEKRPKMS-QVVRML 459 (508)
Q Consensus 427 ~~~~~~~l~~li~~cl~~dP~~RPs~~-evl~~L 459 (508)
.....+.+++.+||+.||.+||++. ++++|-
T Consensus 218 --~~~~~~~~li~~~l~~dP~~R~~~~~~~~~h~ 249 (316)
T cd05620 218 --WITKESKDILEKLFERDPTRRLGVVGNIRGHP 249 (316)
T ss_pred --CCCHHHHHHHHHHccCCHHHcCCChHHHHcCC
Confidence 1234566799999999999999984 666554
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I |
| >cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-39 Score=318.66 Aligned_cols=258 Identities=28% Similarity=0.451 Sum_probs=201.6
Q ss_pred hhCCcccceeEeeeCceEEEEEEEcC------CCEEEEEEEcccc-hhhHHHHHHHHHHHhcCCCCCceeEEEEEEeCce
Q 010519 184 ATNRFSAENVLGEGGYGVVYKGRLIN------GSEVAVKKLLNNL-GQAEKEFRVEVEAIGHVRHKNLVRLLGYCIEGVH 256 (508)
Q Consensus 184 ~~~~~~~~~~lg~G~~g~Vy~~~~~~------~~~vavK~~~~~~-~~~~~~~~~ei~~l~~l~h~niv~~~~~~~~~~~ 256 (508)
..++|.+.+.||+|+||.||+|.+.+ +..|++|.+.... ......+..|+.+++.++|+||+++++++.+...
T Consensus 4 ~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~ 83 (277)
T cd05036 4 PRDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNIVRLIGVSFERLP 83 (277)
T ss_pred CHHHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCC
Confidence 44679999999999999999998753 4678888775443 3334568889999999999999999999999888
Q ss_pred eeEEEeecCCCCHHHHHhhhhc---cCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCEEEcCCC---cEEE
Q 010519 257 RMLVYEYVNNGNLEQWLHGAMR---NQGNLTWEARMKVIIGTAKALAYLHEAIEPKVVHRDIKSSNILIDDEF---NAKV 330 (508)
Q Consensus 257 ~~lv~E~~~~gsL~~~l~~~~~---~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiH~Dlk~~NIll~~~~---~~kl 330 (508)
.++||||+++++|.+++..... ....+++..++.++.||+.||.|||+. +++|+||||+|||++.++ .+||
T Consensus 84 ~~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivH~dlkp~nil~~~~~~~~~~kl 160 (277)
T cd05036 84 RFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEEN---HFIHRDIAARNCLLTCKGPGRVAKI 160 (277)
T ss_pred cEEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccchheEEEeccCCCcceEe
Confidence 9999999999999999964321 123588999999999999999999998 999999999999998765 5999
Q ss_pred EecCCccccCCCCCc-ccccccccccccCccccCCCCCCChhhHHHHHHHHHHHHh-CCCCCCCCCCCchhcHHHHHHHH
Q 010519 331 SDFGLAKLLDSGESH-ITTRVMGTFGYVAPEYANTGMLNEKSDIYSFGVLLLEAVT-GRDPVDYGRPANEVNLVEWLKMM 408 (508)
Q Consensus 331 ~Dfgla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~ellt-G~~Pf~~~~~~~~~~~~~~~~~~ 408 (508)
+|||+++........ .......+..|+|||++.+..++.++|||||||++|||++ |..||...... +.....
T Consensus 161 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~~g~~pf~~~~~~------~~~~~~ 234 (277)
T cd05036 161 ADFGMARDIYRASYYRKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQ------EVMEFV 234 (277)
T ss_pred ccCccccccCCccceecCCCCCccHhhCCHHHHhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHH------HHHHHH
Confidence 999999866322211 1112233568999999998899999999999999999997 99998643321 112222
Q ss_pred hcccccccccCCCCCCChhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhh
Q 010519 409 VGTRRAEEVVDPNLEVKPATRALKRSLLVALRCVDPDSEKRPKMSQVVRMLE 460 (508)
Q Consensus 409 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 460 (508)
...... ..+......+.+++.+||+.||++|||+.+|+++|+
T Consensus 235 ~~~~~~----------~~~~~~~~~~~~~i~~cl~~~p~~Rps~~~vl~~l~ 276 (277)
T cd05036 235 TGGGRL----------DPPKGCPGPVYRIMTDCWQHTPEDRPNFATILERIQ 276 (277)
T ss_pred HcCCcC----------CCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHhh
Confidence 111110 111122356677999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well |
| >cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-39 Score=328.12 Aligned_cols=247 Identities=23% Similarity=0.299 Sum_probs=195.2
Q ss_pred CcccceeEeeeCceEEEEEEEc-CCCEEEEEEEcccch---hhHHHHHHHHHHHhcC-CCCCceeEEEEEEeCceeeEEE
Q 010519 187 RFSAENVLGEGGYGVVYKGRLI-NGSEVAVKKLLNNLG---QAEKEFRVEVEAIGHV-RHKNLVRLLGYCIEGVHRMLVY 261 (508)
Q Consensus 187 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~ei~~l~~l-~h~niv~~~~~~~~~~~~~lv~ 261 (508)
+|.+.+.||+|+||.||+|.+. ++..||+|.+..... .....+..|..++..+ +|++|+.+++++...+..++||
T Consensus 1 df~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (323)
T cd05616 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTMDRLYFVM 80 (323)
T ss_pred CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEecCCEEEEEE
Confidence 5788999999999999999876 567899998865431 2223456677777776 5899999999999999999999
Q ss_pred eecCCCCHHHHHhhhhccCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCEEEcCCCcEEEEecCCccccCC
Q 010519 262 EYVNNGNLEQWLHGAMRNQGNLTWEARMKVIIGTAKALAYLHEAIEPKVVHRDIKSSNILIDDEFNAKVSDFGLAKLLDS 341 (508)
Q Consensus 262 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~ 341 (508)
||+++|+|.+++. ....+++..+..++.||+.||.|||+. +|+||||||+|||+++++.+||+|||++.....
T Consensus 81 E~~~~g~L~~~~~----~~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~Nill~~~~~~kL~DfG~~~~~~~ 153 (323)
T cd05616 81 EYVNGGDLMYQIQ----QVGRFKEPHAVFYAAEIAIGLFFLHSK---GIIYRDLKLDNVMLDSEGHIKIADFGMCKENMW 153 (323)
T ss_pred cCCCCCCHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHHC---CEEecCCCHHHeEECCCCcEEEccCCCceecCC
Confidence 9999999999884 345688999999999999999999998 999999999999999999999999999975432
Q ss_pred CCCcccccccccccccCccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCCCchhcHHHHHHHHhcccccccccCCC
Q 010519 342 GESHITTRVMGTFGYVAPEYANTGMLNEKSDIYSFGVLLLEAVTGRDPVDYGRPANEVNLVEWLKMMVGTRRAEEVVDPN 421 (508)
Q Consensus 342 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 421 (508)
.. .......||+.|+|||++.+..++.++|||||||++|||++|+.||..... . ......... .
T Consensus 154 ~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~---~---~~~~~i~~~---------~ 217 (323)
T cd05616 154 DG-VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDE---D---ELFQSIMEH---------N 217 (323)
T ss_pred CC-CccccCCCChhhcCHHHhcCCCCCCccchhchhHHHHHHHhCCCCCCCCCH---H---HHHHHHHhC---------C
Confidence 21 123345789999999999999999999999999999999999999964321 1 111111111 0
Q ss_pred CCCChhHHHHHHHHHHHHHhcCCCCCCCCCH-----HHHHHH
Q 010519 422 LEVKPATRALKRSLLVALRCVDPDSEKRPKM-----SQVVRM 458 (508)
Q Consensus 422 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~-----~evl~~ 458 (508)
.. .+......+.+++.+||+.||.+|++. .+++++
T Consensus 218 ~~--~p~~~s~~~~~li~~~l~~~p~~R~~~~~~~~~~i~~h 257 (323)
T cd05616 218 VA--YPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEH 257 (323)
T ss_pred CC--CCCcCCHHHHHHHHHHcccCHHhcCCCCCCCHHHHhcC
Confidence 00 111223456779999999999999984 566554
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and |
| >cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-39 Score=318.89 Aligned_cols=258 Identities=26% Similarity=0.436 Sum_probs=203.7
Q ss_pred hCCcccceeEeeeCceEEEEEEEc------CCCEEEEEEEcccchhhHHHHHHHHHHHhcCCCCCceeEEEEEEeCceee
Q 010519 185 TNRFSAENVLGEGGYGVVYKGRLI------NGSEVAVKKLLNNLGQAEKEFRVEVEAIGHVRHKNLVRLLGYCIEGVHRM 258 (508)
Q Consensus 185 ~~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~ei~~l~~l~h~niv~~~~~~~~~~~~~ 258 (508)
..+|...+.||+|+||.||++... ++..+++|.+..........+..|+++++.++|+||+++++++......+
T Consensus 4 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 83 (280)
T cd05092 4 RRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVRFYGVCTEGRPLL 83 (280)
T ss_pred hHhceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcCCHHHHHHHHHHHHHHhcCCCCCCceEEEEEecCCceE
Confidence 457888999999999999999642 35578899887665565678999999999999999999999999999999
Q ss_pred EEEeecCCCCHHHHHhhhhc-----------cCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCEEEcCCCc
Q 010519 259 LVYEYVNNGNLEQWLHGAMR-----------NQGNLTWEARMKVIIGTAKALAYLHEAIEPKVVHRDIKSSNILIDDEFN 327 (508)
Q Consensus 259 lv~E~~~~gsL~~~l~~~~~-----------~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiH~Dlk~~NIll~~~~~ 327 (508)
++|||+++|+|.+++..... ....+++..++.++.|++.||.|||+. +++|+||||+|||+++++.
T Consensus 84 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~---~i~H~dlkp~nil~~~~~~ 160 (280)
T cd05092 84 MVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASL---HFVHRDLATRNCLVGQGLV 160 (280)
T ss_pred EEEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHHC---CeecccccHhhEEEcCCCC
Confidence 99999999999999964311 113578999999999999999999998 9999999999999999999
Q ss_pred EEEEecCCccccCCCCC-cccccccccccccCccccCCCCCCChhhHHHHHHHHHHHHh-CCCCCCCCCCCchhcHHHHH
Q 010519 328 AKVSDFGLAKLLDSGES-HITTRVMGTFGYVAPEYANTGMLNEKSDIYSFGVLLLEAVT-GRDPVDYGRPANEVNLVEWL 405 (508)
Q Consensus 328 ~kl~Dfgla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~ellt-G~~Pf~~~~~~~~~~~~~~~ 405 (508)
+||+|||++........ .......+++.|+|||.+.+..++.++|||||||++|||++ |..||...... ...
T Consensus 161 ~kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~------~~~ 234 (280)
T cd05092 161 VKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQLSNT------EAI 234 (280)
T ss_pred EEECCCCceeEcCCCceeecCCCccccccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCccCCHH------HHH
Confidence 99999999975543221 11222345678999999999999999999999999999998 89998533221 111
Q ss_pred HHHhcccccccccCCCCCCChhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhhc
Q 010519 406 KMMVGTRRAEEVVDPNLEVKPATRALKRSLLVALRCVDPDSEKRPKMSQVVRMLEA 461 (508)
Q Consensus 406 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~ 461 (508)
........ . ..+...+..+.+++.+||+.||.+||++.+|++.|+.
T Consensus 235 ~~~~~~~~------~----~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~l~~~l~~ 280 (280)
T cd05092 235 ECITQGRE------L----ERPRTCPPEVYAIMQGCWQREPQQRMVIKDIHSRLQA 280 (280)
T ss_pred HHHHcCcc------C----CCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHhC
Confidence 11111110 0 0011123456679999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory |
| >cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-39 Score=314.27 Aligned_cols=252 Identities=25% Similarity=0.376 Sum_probs=201.5
Q ss_pred CCcccceeEeeeCceEEEEEEEc-CCCEEEEEEEcccc-----hhhHHHHHHHHHHHhcCCCCCceeEEEEEEeCceeeE
Q 010519 186 NRFSAENVLGEGGYGVVYKGRLI-NGSEVAVKKLLNNL-----GQAEKEFRVEVEAIGHVRHKNLVRLLGYCIEGVHRML 259 (508)
Q Consensus 186 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-----~~~~~~~~~ei~~l~~l~h~niv~~~~~~~~~~~~~l 259 (508)
++|.+.+.||+|++|.||++... ++..+++|.+.... ......+.+|++++++++||||+++++++.+....++
T Consensus 2 ~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~ 81 (263)
T cd06625 2 TNWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRDDETLSI 81 (263)
T ss_pred CcccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEccCCeEEE
Confidence 57889999999999999999864 68899999875432 1123568889999999999999999999999999999
Q ss_pred EEeecCCCCHHHHHhhhhccCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCEEEcCCCcEEEEecCCcccc
Q 010519 260 VYEYVNNGNLEQWLHGAMRNQGNLTWEARMKVIIGTAKALAYLHEAIEPKVVHRDIKSSNILIDDEFNAKVSDFGLAKLL 339 (508)
Q Consensus 260 v~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~Dfgla~~~ 339 (508)
|+||+++++|.+++. ....+++..+..++.|++.||.|||+. +++|+||+|+||++++++.++|+|||++...
T Consensus 82 v~e~~~~~~l~~~~~----~~~~~~~~~~~~~~~~l~~~l~~lH~~---~i~H~dl~p~nilv~~~~~~~l~dfg~~~~~ 154 (263)
T cd06625 82 FMEYMPGGSVKDQLK----AYGALTETVTRKYTRQILEGVEYLHSN---MIVHRDIKGANILRDSAGNVKLGDFGASKRL 154 (263)
T ss_pred EEEECCCCcHHHHHH----HhCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEeecccceec
Confidence 999999999999984 345688899999999999999999999 9999999999999999999999999999765
Q ss_pred CCCCCccc--ccccccccccCccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCCCchhcHHHHHHHHhcccccccc
Q 010519 340 DSGESHIT--TRVMGTFGYVAPEYANTGMLNEKSDIYSFGVLLLEAVTGRDPVDYGRPANEVNLVEWLKMMVGTRRAEEV 417 (508)
Q Consensus 340 ~~~~~~~~--~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 417 (508)
........ ....++..|+|||++.+..++.++||||||+++|||++|+.||...... .. .........
T Consensus 155 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~-----~~-~~~~~~~~~---- 224 (263)
T cd06625 155 QTICSSGTGMKSVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPPWAEFEAM-----AA-IFKIATQPT---- 224 (263)
T ss_pred cccccccccccCCCcCccccCcceeccCCCCchhhhHHHHHHHHHHHhCCCCccccchH-----HH-HHHHhccCC----
Confidence 43221111 2345788999999999988999999999999999999999998643211 11 111111100
Q ss_pred cCCCCCCChhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHh
Q 010519 418 VDPNLEVKPATRALKRSLLVALRCVDPDSEKRPKMSQVVRML 459 (508)
Q Consensus 418 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L 459 (508)
... .+......+.+++.+||..+|.+|||+.+++++.
T Consensus 225 -~~~----~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~~ 261 (263)
T cd06625 225 -NPQ----LPSHVSPDARNFLRRTFVENAKKRPSAEELLRHF 261 (263)
T ss_pred -CCC----CCccCCHHHHHHHHHHhhcCcccCCCHHHHhhCC
Confidence 011 1112344566799999999999999999999864
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t |
| >cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-39 Score=313.07 Aligned_cols=251 Identities=30% Similarity=0.483 Sum_probs=204.2
Q ss_pred hhCCcccceeEeeeCceEEEEEEEcCCCEEEEEEEcccchhhHHHHHHHHHHHhcCCCCCceeEEEEEEeCceeeEEEee
Q 010519 184 ATNRFSAENVLGEGGYGVVYKGRLINGSEVAVKKLLNNLGQAEKEFRVEVEAIGHVRHKNLVRLLGYCIEGVHRMLVYEY 263 (508)
Q Consensus 184 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~ei~~l~~l~h~niv~~~~~~~~~~~~~lv~E~ 263 (508)
..++|++.+.||.|+||.||+|.. .|+.||+|.+..... ..+.+..|+.+++.++|+||+++++++.+....++||||
T Consensus 4 ~~~~~~~~~~ig~g~~g~v~~~~~-~~~~v~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~ 81 (256)
T cd05039 4 NSKELKLGATIGKGEFGDVMLGDY-RGQKVAVKCLKDDST-AAQAFLAEASVMTTLRHPNLVQLLGVVLQGNPLYIVTEY 81 (256)
T ss_pred ChhhccceeeeecCCCceEEEEEe-cCcEEEEEEeccchh-HHHHHHHHHHHHHhcCCcceeeeEEEEcCCCCeEEEEEe
Confidence 345788899999999999999987 589999999876544 456788899999999999999999999988899999999
Q ss_pred cCCCCHHHHHhhhhccCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCEEEcCCCcEEEEecCCccccCCCC
Q 010519 264 VNNGNLEQWLHGAMRNQGNLTWEARMKVIIGTAKALAYLHEAIEPKVVHRDIKSSNILIDDEFNAKVSDFGLAKLLDSGE 343 (508)
Q Consensus 264 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~~~ 343 (508)
+++++|.+++.. .....+++..+..++.|++.||.|||+. +++|+||||+||+++.++.+||+|||++.......
T Consensus 82 ~~~~~L~~~~~~--~~~~~~~~~~~~~~~~qi~~~l~~lh~~---~i~H~di~p~Nili~~~~~~~l~d~g~~~~~~~~~ 156 (256)
T cd05039 82 MAKGSLVDYLRS--RGRAVITLAQQLGFALDVCEGMEYLEEK---NFVHRDLAARNVLVSEDLVAKVSDFGLAKEASQGQ 156 (256)
T ss_pred cCCCcHHHHHHh--cCCCCCCHHHHHHHHHHHHHHHHHHHhC---CccchhcccceEEEeCCCCEEEccccccccccccc
Confidence 999999999863 2234689999999999999999999999 99999999999999999999999999998663322
Q ss_pred CcccccccccccccCccccCCCCCCChhhHHHHHHHHHHHHh-CCCCCCCCCCCchhcHHHHHHHHhcccccccccCCCC
Q 010519 344 SHITTRVMGTFGYVAPEYANTGMLNEKSDIYSFGVLLLEAVT-GRDPVDYGRPANEVNLVEWLKMMVGTRRAEEVVDPNL 422 (508)
Q Consensus 344 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 422 (508)
. ....+..|+|||.+.+..++.++||||||+++|||++ |..||..... ..+.. ....... .
T Consensus 157 ~----~~~~~~~~~ape~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~---~~~~~---~~~~~~~------~-- 218 (256)
T cd05039 157 D----SGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPL---KDVVP---HVEKGYR------M-- 218 (256)
T ss_pred c----cCCCcccccCchhhcCCcCCcHHHHHHHHHHHHHHHhcCCCCCCCCCH---HHHHH---HHhcCCC------C--
Confidence 1 2234667999999988889999999999999999997 9999863321 11111 1111100 0
Q ss_pred CCChhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhhc
Q 010519 423 EVKPATRALKRSLLVALRCVDPDSEKRPKMSQVVRMLEA 461 (508)
Q Consensus 423 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~ 461 (508)
..+......+.+++.+||..+|.+|||+.+++.+|+.
T Consensus 219 --~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~ 255 (256)
T cd05039 219 --EAPEGCPPEVYKVMKDCWELDPAKRPTFKQLREQLAL 255 (256)
T ss_pred --CCccCCCHHHHHHHHHHhccChhhCcCHHHHHHHHhc
Confidence 0111223566779999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk |
| >cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-39 Score=327.30 Aligned_cols=245 Identities=23% Similarity=0.286 Sum_probs=195.2
Q ss_pred eeEeeeCceEEEEEEEc-CCCEEEEEEEcccc---hhhHHHHHHHHHHHhcC-CCCCceeEEEEEEeCceeeEEEeecCC
Q 010519 192 NVLGEGGYGVVYKGRLI-NGSEVAVKKLLNNL---GQAEKEFRVEVEAIGHV-RHKNLVRLLGYCIEGVHRMLVYEYVNN 266 (508)
Q Consensus 192 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~ei~~l~~l-~h~niv~~~~~~~~~~~~~lv~E~~~~ 266 (508)
+.||+|+||.||+|++. +++.||+|.+.... ......+..|..++..+ +||||+++++++.+....|+||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~ 80 (321)
T cd05591 1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKDRLFFVMEYVNG 80 (321)
T ss_pred CccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCeEEEEEeCCCC
Confidence 36999999999999875 57899999986542 22234566788888765 799999999999999999999999999
Q ss_pred CCHHHHHhhhhccCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCEEEcCCCcEEEEecCCccccCCCCCcc
Q 010519 267 GNLEQWLHGAMRNQGNLTWEARMKVIIGTAKALAYLHEAIEPKVVHRDIKSSNILIDDEFNAKVSDFGLAKLLDSGESHI 346 (508)
Q Consensus 267 gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~ 346 (508)
|+|.+++. ....+++..+..++.||+.||.|||++ +|+||||||+|||++.++.+||+|||++....... ..
T Consensus 81 ~~L~~~l~----~~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDikp~Nill~~~~~~kL~Dfg~~~~~~~~~-~~ 152 (321)
T cd05591 81 GDLMFQIQ----RSRKFDEPRSRFYAAEVTLALMFLHRH---GVIYRDLKLDNILLDAEGHCKLADFGMCKEGILNG-VT 152 (321)
T ss_pred CcHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHeEECCCCCEEEeecccceecccCC-cc
Confidence 99999884 345688999999999999999999999 99999999999999999999999999987543222 12
Q ss_pred cccccccccccCccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCCCchhcHHHHHHHHhcccccccccCCCCCCCh
Q 010519 347 TTRVMGTFGYVAPEYANTGMLNEKSDIYSFGVLLLEAVTGRDPVDYGRPANEVNLVEWLKMMVGTRRAEEVVDPNLEVKP 426 (508)
Q Consensus 347 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 426 (508)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||..... . .......... ...
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~~---~---~~~~~i~~~~---------~~~-- 215 (321)
T cd05591 153 TTTFCGTPDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPPFEADNE---D---DLFESILHDD---------VLY-- 215 (321)
T ss_pred ccccccCccccCHHHHcCCCCCCccceechhHHHHHHhcCCCCCCCCCH---H---HHHHHHHcCC---------CCC--
Confidence 3345789999999999999999999999999999999999999964321 1 1122221111 000
Q ss_pred hHHHHHHHHHHHHHhcCCCCCCCC-------CHHHHHHHhhc
Q 010519 427 ATRALKRSLLVALRCVDPDSEKRP-------KMSQVVRMLEA 461 (508)
Q Consensus 427 ~~~~~~~l~~li~~cl~~dP~~RP-------s~~evl~~L~~ 461 (508)
+......+.+++.+||+.||.+|| ++.+++++-.-
T Consensus 216 p~~~~~~~~~ll~~~L~~dp~~R~~~~~~~~~~~~~~~hp~~ 257 (321)
T cd05591 216 PVWLSKEAVSILKAFMTKNPNKRLGCVASQGGEDAIKQHPFF 257 (321)
T ss_pred CCCCCHHHHHHHHHHhccCHHHcCCCCCCCCCHHHHhcCCcc
Confidence 111234566799999999999999 88999887543
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to |
| >cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-39 Score=318.04 Aligned_cols=257 Identities=26% Similarity=0.437 Sum_probs=201.8
Q ss_pred CCcccceeEeeeCceEEEEEEE-----cCCCEEEEEEEcccc-hhhHHHHHHHHHHHhcCCCCCceeEEEEEEeCceeeE
Q 010519 186 NRFSAENVLGEGGYGVVYKGRL-----INGSEVAVKKLLNNL-GQAEKEFRVEVEAIGHVRHKNLVRLLGYCIEGVHRML 259 (508)
Q Consensus 186 ~~~~~~~~lg~G~~g~Vy~~~~-----~~~~~vavK~~~~~~-~~~~~~~~~ei~~l~~l~h~niv~~~~~~~~~~~~~l 259 (508)
++|++.+.||+|+||.||+|.+ ..+..+++|.+.... ......+..|+.+++.++||||+++++++......++
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 84 (283)
T cd05090 5 SAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCLLGVVTQEQPVCM 84 (283)
T ss_pred hhceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCceEE
Confidence 4688889999999999999975 245789999886433 3334678889999999999999999999999999999
Q ss_pred EEeecCCCCHHHHHhhhhc-------------cCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCEEEcCCC
Q 010519 260 VYEYVNNGNLEQWLHGAMR-------------NQGNLTWEARMKVIIGTAKALAYLHEAIEPKVVHRDIKSSNILIDDEF 326 (508)
Q Consensus 260 v~E~~~~gsL~~~l~~~~~-------------~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiH~Dlk~~NIll~~~~ 326 (508)
||||+++++|.+++..... ....+++.....++.|++.||.|||++ +++|+||||+|||+++++
T Consensus 85 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~---~i~H~dlkp~nili~~~~ 161 (283)
T cd05090 85 LFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSH---FFVHKDLAARNILIGEQL 161 (283)
T ss_pred EEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHhc---CeehhccccceEEEcCCC
Confidence 9999999999999853211 123478889999999999999999999 999999999999999999
Q ss_pred cEEEEecCCccccCCCCC-cccccccccccccCccccCCCCCCChhhHHHHHHHHHHHHh-CCCCCCCCCCCchhcHHHH
Q 010519 327 NAKVSDFGLAKLLDSGES-HITTRVMGTFGYVAPEYANTGMLNEKSDIYSFGVLLLEAVT-GRDPVDYGRPANEVNLVEW 404 (508)
Q Consensus 327 ~~kl~Dfgla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~ellt-G~~Pf~~~~~~~~~~~~~~ 404 (508)
.+||+|||++........ .......++..|+|||++.+..++.++|||||||+||||++ |..||..... ....+
T Consensus 162 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~g~~p~~~~~~---~~~~~- 237 (283)
T cd05090 162 HVKISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYGFSN---QEVIE- 237 (283)
T ss_pred cEEeccccccccccCCcceecccCCCccceecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCH---HHHHH-
Confidence 999999999986543221 12233345678999999998889999999999999999998 8889853321 11111
Q ss_pred HHHHhcccccccccCCCCCCChhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhhc
Q 010519 405 LKMMVGTRRAEEVVDPNLEVKPATRALKRSLLVALRCVDPDSEKRPKMSQVVRMLEA 461 (508)
Q Consensus 405 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~ 461 (508)
... .... ...+......+.+++.+||+.||.+||++.+|+++|..
T Consensus 238 --~~~-~~~~---------~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~ 282 (283)
T cd05090 238 --MVR-KRQL---------LPCSEDCPPRMYSLMTECWQEGPSRRPRFKDIHTRLRS 282 (283)
T ss_pred --HHH-cCCc---------CCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHhhc
Confidence 111 1110 00111223456679999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-39 Score=325.76 Aligned_cols=244 Identities=25% Similarity=0.323 Sum_probs=194.8
Q ss_pred eeEeeeCceEEEEEEEc-CCCEEEEEEEcccc---hhhHHHHHHHHHHHhcC-CCCCceeEEEEEEeCceeeEEEeecCC
Q 010519 192 NVLGEGGYGVVYKGRLI-NGSEVAVKKLLNNL---GQAEKEFRVEVEAIGHV-RHKNLVRLLGYCIEGVHRMLVYEYVNN 266 (508)
Q Consensus 192 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~ei~~l~~l-~h~niv~~~~~~~~~~~~~lv~E~~~~ 266 (508)
+.||+|+||+||+|.+. ++..+|+|.+.... ......+..|+.++..+ +||||+++++++.+....++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (318)
T cd05570 1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRLFFVMEYVNG 80 (318)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 46999999999999875 57889999986542 22234566788888877 799999999999999999999999999
Q ss_pred CCHHHHHhhhhccCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCEEEcCCCcEEEEecCCccccCCCCCcc
Q 010519 267 GNLEQWLHGAMRNQGNLTWEARMKVIIGTAKALAYLHEAIEPKVVHRDIKSSNILIDDEFNAKVSDFGLAKLLDSGESHI 346 (508)
Q Consensus 267 gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~ 346 (508)
|+|.+++. ....+++..+..++.||+.||.|||+. +|+||||||+|||+++++.+||+|||++........ .
T Consensus 81 ~~L~~~~~----~~~~l~~~~~~~~~~qi~~~l~~LH~~---~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~-~ 152 (318)
T cd05570 81 GDLMFHIQ----RSGRFDEPRARFYAAEIVLGLQFLHER---GIIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGGV-T 152 (318)
T ss_pred CCHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHhC---CeEccCCCHHHeEECCCCcEEecccCCCeecCcCCC-c
Confidence 99999884 345789999999999999999999999 999999999999999999999999999875322211 2
Q ss_pred cccccccccccCccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCCCchhcHHHHHHHHhcccccccccCCCCCCCh
Q 010519 347 TTRVMGTFGYVAPEYANTGMLNEKSDIYSFGVLLLEAVTGRDPVDYGRPANEVNLVEWLKMMVGTRRAEEVVDPNLEVKP 426 (508)
Q Consensus 347 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 426 (508)
....+|++.|+|||++.+..++.++|||||||++|+|++|+.||..... . .......... ..+
T Consensus 153 ~~~~~g~~~y~aPE~~~~~~~~~~~DiwslGvil~~l~~G~~pf~~~~~---~---~~~~~i~~~~-------~~~---- 215 (318)
T cd05570 153 TSTFCGTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPFEGDDE---D---ELFQSILEDE-------VRY---- 215 (318)
T ss_pred ccceecCccccCHHHhcCCCCCcchhhhhHHHHHHHHhhCCCCCCCCCH---H---HHHHHHHcCC-------CCC----
Confidence 3345689999999999999999999999999999999999999964321 1 1111111110 000
Q ss_pred hHHHHHHHHHHHHHhcCCCCCCCCCH-----HHHHHHhh
Q 010519 427 ATRALKRSLLVALRCVDPDSEKRPKM-----SQVVRMLE 460 (508)
Q Consensus 427 ~~~~~~~l~~li~~cl~~dP~~RPs~-----~evl~~L~ 460 (508)
+......+.+|+.+||..||.+|||+ .+++++-.
T Consensus 216 ~~~~~~~~~~li~~~l~~dP~~R~s~~~~~~~~ll~~~~ 254 (318)
T cd05570 216 PRWLSKEAKSILKSFLTKNPEKRLGCLPTGEQDIKGHPF 254 (318)
T ss_pred CCcCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHhcCCC
Confidence 11123456779999999999999999 88887643
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re |
| >cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-39 Score=319.21 Aligned_cols=267 Identities=25% Similarity=0.378 Sum_probs=200.6
Q ss_pred Cc-ccceeEeeeCceEEEEEEE-----cCCCEEEEEEEcccc-hhhHHHHHHHHHHHhcCCCCCceeEEEEEEeC--cee
Q 010519 187 RF-SAENVLGEGGYGVVYKGRL-----INGSEVAVKKLLNNL-GQAEKEFRVEVEAIGHVRHKNLVRLLGYCIEG--VHR 257 (508)
Q Consensus 187 ~~-~~~~~lg~G~~g~Vy~~~~-----~~~~~vavK~~~~~~-~~~~~~~~~ei~~l~~l~h~niv~~~~~~~~~--~~~ 257 (508)
+| ...+.||+|+||+||++.+ .++..||+|.+.... ......+.+|+++++.++||||+++++++... ...
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 83 (283)
T cd05080 4 RYLKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKYKGCCSEQGGKGL 83 (283)
T ss_pred hhceeceecccCCCcEEEEeeEccccCCCCceEEEEEeccccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCceE
Confidence 44 8889999999999988753 257789999886543 23456788899999999999999999988754 457
Q ss_pred eEEEeecCCCCHHHHHhhhhccCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCEEEcCCCcEEEEecCCcc
Q 010519 258 MLVYEYVNNGNLEQWLHGAMRNQGNLTWEARMKVIIGTAKALAYLHEAIEPKVVHRDIKSSNILIDDEFNAKVSDFGLAK 337 (508)
Q Consensus 258 ~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~Dfgla~ 337 (508)
+++|||+++|+|.+++.. ..+++..++.++.|++.||.|||++ +++|+||||+|||+++++.+||+|||++.
T Consensus 84 ~lv~e~~~~~~l~~~~~~-----~~l~~~~~~~i~~~l~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~~l~dfg~~~ 155 (283)
T cd05080 84 QLIMEYVPLGSLRDYLPK-----HKLNLAQLLLFAQQICEGMAYLHSQ---HYIHRDLAARNVLLDNDRLVKIGDFGLAK 155 (283)
T ss_pred EEEecCCCCCCHHHHHHH-----cCCCHHHHHHHHHHHHHHHHHHHHC---CeeccccChheEEEcCCCcEEEeeccccc
Confidence 899999999999999852 3589999999999999999999999 99999999999999999999999999998
Q ss_pred ccCCCCCc--ccccccccccccCccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCCCchhcHHHHHHHHhcccccc
Q 010519 338 LLDSGESH--ITTRVMGTFGYVAPEYANTGMLNEKSDIYSFGVLLLEAVTGRDPVDYGRPANEVNLVEWLKMMVGTRRAE 415 (508)
Q Consensus 338 ~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~ 415 (508)
........ ......++..|+|||.+.+..++.++||||||+++|||++|..||......- .................
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~-~~~~~~~~~~~~~~~~~ 234 (283)
T cd05080 156 AVPEGHEYYRVREDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYELLTHCDSKQSPPKKF-EEMIGPKQGQMTVVRLI 234 (283)
T ss_pred ccCCcchhhccCCCCCCCceeeCHhHhcccCCCcccccHHHHHHHHHHHhCCCCCCCCcchh-hhhhcccccccchhhhh
Confidence 66543221 1122335667999999988889999999999999999999999986432210 00000000000000000
Q ss_pred cccCCCCCCChhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhhcC
Q 010519 416 EVVDPNLEVKPATRALKRSLLVALRCVDPDSEKRPKMSQVVRMLEAD 462 (508)
Q Consensus 416 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~ 462 (508)
...+.......+......+.+++.+||+.||++|||++++++.|+..
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~i~~~l~~~ 281 (283)
T cd05080 235 ELLERGMRLPCPKNCPQEVYILMKNCWETEAKFRPTFRSLIPILKEM 281 (283)
T ss_pred hhhhcCCCCCCCCCCCHHHHHHHHHHhccChhhCCCHHHHHHHHHHh
Confidence 11111111111222345677899999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign |
| >cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-39 Score=332.10 Aligned_cols=263 Identities=23% Similarity=0.325 Sum_probs=200.7
Q ss_pred CcccceeEeeeCceEEEEEEEc-CCCEEEEEEEcccc--hhhHHHHHHHHHHHhcCCCCCceeEEEEEEeCc-----eee
Q 010519 187 RFSAENVLGEGGYGVVYKGRLI-NGSEVAVKKLLNNL--GQAEKEFRVEVEAIGHVRHKNLVRLLGYCIEGV-----HRM 258 (508)
Q Consensus 187 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~ei~~l~~l~h~niv~~~~~~~~~~-----~~~ 258 (508)
+|++.+.||+|+||.||++.+. ++..||+|++.... ......+.+|+.+++.++||||+++++++.... ..|
T Consensus 1 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 80 (372)
T cd07853 1 DVEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEIY 80 (372)
T ss_pred CCcccceeeeCCCEEEEEEEECCCCCEEEEEeccccccchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccceEE
Confidence 4788899999999999999874 78999999885432 233456788999999999999999999998776 789
Q ss_pred EEEeecCCCCHHHHHhhhhccCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCEEEcCCCcEEEEecCCccc
Q 010519 259 LVYEYVNNGNLEQWLHGAMRNQGNLTWEARMKVIIGTAKALAYLHEAIEPKVVHRDIKSSNILIDDEFNAKVSDFGLAKL 338 (508)
Q Consensus 259 lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~Dfgla~~ 338 (508)
+||||+. ++|.+++. ....+++..+..++.||+.||.|||+. +++||||||+|||++.++.+||+|||++..
T Consensus 81 lv~e~~~-~~l~~~~~----~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivH~dlkp~Nili~~~~~~kL~Dfg~a~~ 152 (372)
T cd07853 81 VVTELMQ-SDLHKIIV----SPQPLSSDHVKVFLYQILRGLKYLHSA---GILHRDIKPGNLLVNSNCVLKICDFGLARV 152 (372)
T ss_pred EEeeccc-cCHHHHHh----cCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChHHEEECCCCCEEeccccceee
Confidence 9999996 58888773 456789999999999999999999999 999999999999999999999999999986
Q ss_pred cCCCCCcccccccccccccCccccCCC-CCCChhhHHHHHHHHHHHHhCCCCCCCCCCCchhcHHHHHHHHhccccccc-
Q 010519 339 LDSGESHITTRVMGTFGYVAPEYANTG-MLNEKSDIYSFGVLLLEAVTGRDPVDYGRPANEVNLVEWLKMMVGTRRAEE- 416 (508)
Q Consensus 339 ~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwS~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~- 416 (508)
.............+++.|+|||++.+. .++.++|||||||++|||++|+.||....+.... ..+....+......
T Consensus 153 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~---~~i~~~~g~~~~~~~ 229 (372)
T cd07853 153 EEPDESKHMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQL---DLITDLLGTPSLEAM 229 (372)
T ss_pred cccCccccCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCCCCHHHHH---HHHHHHcCCCCHHHH
Confidence 544333334445678999999998774 5789999999999999999999999754332111 11111111100000
Q ss_pred ----------ccCCCCCC-------ChhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhh
Q 010519 417 ----------VVDPNLEV-------KPATRALKRSLLVALRCVDPDSEKRPKMSQVVRMLE 460 (508)
Q Consensus 417 ----------~~~~~~~~-------~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 460 (508)
+....... .........+.+|+.+||+.||.+|||+.|++++-.
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~ 290 (372)
T cd07853 230 RSACEGARAHILRGPHKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRISAADALAHPY 290 (372)
T ss_pred HHhhHHHHHHHHhCCCCCCchHHhcccCCCCCHHHHHHHHHhCCCChhhCcCHHHHhcCHh
Confidence 00000000 000112345678999999999999999999998754
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription |
| >cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-39 Score=311.15 Aligned_cols=250 Identities=28% Similarity=0.418 Sum_probs=203.6
Q ss_pred CcccceeEeeeCceEEEEEEEc-CCCEEEEEEEccc--chhhHHHHHHHHHHHhcCCCCCceeEEEEEEeCceeeEEEee
Q 010519 187 RFSAENVLGEGGYGVVYKGRLI-NGSEVAVKKLLNN--LGQAEKEFRVEVEAIGHVRHKNLVRLLGYCIEGVHRMLVYEY 263 (508)
Q Consensus 187 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~ei~~l~~l~h~niv~~~~~~~~~~~~~lv~E~ 263 (508)
+|++.+.||+|++|.||+|++. ++..+++|.+... .......+..|+.+++.++||||+++++++.+....++||||
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08529 1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYESFLDKGKLNIVMEY 80 (256)
T ss_pred CceEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhCCHHHHHHHHHHHHHHHhcCCCCeehheeeeccCCEEEEEEEe
Confidence 4778899999999999999875 6889999987543 234456788899999999999999999999999999999999
Q ss_pred cCCCCHHHHHhhhhccCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCEEEcCCCcEEEEecCCccccCCCC
Q 010519 264 VNNGNLEQWLHGAMRNQGNLTWEARMKVIIGTAKALAYLHEAIEPKVVHRDIKSSNILIDDEFNAKVSDFGLAKLLDSGE 343 (508)
Q Consensus 264 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~~~ 343 (508)
+++++|.+++... ....+++..++.++.+++.||.|||+. +++|+||+|+||++++++.++|+|||++.......
T Consensus 81 ~~~~~L~~~l~~~--~~~~~~~~~~~~i~~~l~~al~~lH~~---~i~h~dl~~~nili~~~~~~~l~df~~~~~~~~~~ 155 (256)
T cd08529 81 AENGDLHKLLKMQ--RGRPLPEDQVWRFFIQILLGLAHLHSK---KILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNT 155 (256)
T ss_pred CCCCcHHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCcceEEEeCCCCEEEcccccceeccCcc
Confidence 9999999999742 345788999999999999999999998 99999999999999999999999999998665432
Q ss_pred CcccccccccccccCccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCCCchhcHHHHHHHHhcccccccccCCCCC
Q 010519 344 SHITTRVMGTFGYVAPEYANTGMLNEKSDIYSFGVLLLEAVTGRDPVDYGRPANEVNLVEWLKMMVGTRRAEEVVDPNLE 423 (508)
Q Consensus 344 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 423 (508)
. ......|++.|+|||++.+..++.++|+|||||++|+|++|+.||..... ... ....... .. +.
T Consensus 156 ~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~---~~~---~~~~~~~-~~-----~~-- 220 (256)
T cd08529 156 N-FANTIVGTPYYLSPELCEDKPYNEKSDVWALGVVLYECCTGKHPFDANNQ---GAL---ILKIIRG-VF-----PP-- 220 (256)
T ss_pred c-hhhccccCccccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCH---HHH---HHHHHcC-CC-----CC--
Confidence 2 22334688999999999998999999999999999999999999964331 111 1111110 00 11
Q ss_pred CChhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 010519 424 VKPATRALKRSLLVALRCVDPDSEKRPKMSQVVRM 458 (508)
Q Consensus 424 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 458 (508)
........+.+++.+||+.+|++||++.+++++
T Consensus 221 --~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~ 253 (256)
T cd08529 221 --VSQMYSQQLAQLIDQCLTKDYRQRPDTFQLLRN 253 (256)
T ss_pred --CccccCHHHHHHHHHHccCCcccCcCHHHHhhC
Confidence 111234567779999999999999999999975
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc |
| >cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-39 Score=317.70 Aligned_cols=254 Identities=26% Similarity=0.442 Sum_probs=197.7
Q ss_pred CCcccceeEeeeCceEEEEEEEc-CCC----EEEEEEEcccch-hhHHHHHHHHHHHhcCCCCCceeEEEEEEeCceeeE
Q 010519 186 NRFSAENVLGEGGYGVVYKGRLI-NGS----EVAVKKLLNNLG-QAEKEFRVEVEAIGHVRHKNLVRLLGYCIEGVHRML 259 (508)
Q Consensus 186 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~----~vavK~~~~~~~-~~~~~~~~ei~~l~~l~h~niv~~~~~~~~~~~~~l 259 (508)
++|.+.+.||+|+||+||+|.+. ++. .+++|.+..... ....++..|+..+++++||||+++++++. ....++
T Consensus 7 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~-~~~~~~ 85 (279)
T cd05111 7 TELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVRLLGICP-GASLQL 85 (279)
T ss_pred hhceeccccCccCCcceEEEEEcCCCCceeeEEEEeecccccchHHHHHHHHHHHHHhcCCCCCcceEEEEEC-CCccEE
Confidence 47888899999999999999874 344 477777654332 23356777888999999999999999875 455789
Q ss_pred EEeecCCCCHHHHHhhhhccCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCEEEcCCCcEEEEecCCcccc
Q 010519 260 VYEYVNNGNLEQWLHGAMRNQGNLTWEARMKVIIGTAKALAYLHEAIEPKVVHRDIKSSNILIDDEFNAKVSDFGLAKLL 339 (508)
Q Consensus 260 v~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~Dfgla~~~ 339 (508)
++||+++|+|.+++.. ....+++..+..++.||+.||.|||+. +++|+||||+|||+++++.+||+|||+++..
T Consensus 86 i~e~~~~gsL~~~l~~---~~~~~~~~~~~~i~~qi~~~l~~lH~~---~iiH~dlkp~nili~~~~~~kl~Dfg~~~~~ 159 (279)
T cd05111 86 VTQLSPLGSLLDHVRQ---HRDSLDPQRLLNWCVQIAKGMYYLEEH---RMVHRNLAARNILLKSDSIVQIADFGVADLL 159 (279)
T ss_pred EEEeCCCCcHHHHHHh---cccCCCHHHHHHHHHHHHHHHHHHHHC---CEeccccCcceEEEcCCCcEEEcCCccceec
Confidence 9999999999999963 345789999999999999999999998 9999999999999999999999999999865
Q ss_pred CCCCC-cccccccccccccCccccCCCCCCChhhHHHHHHHHHHHHh-CCCCCCCCCCCchhcHHHHHHHHhcccccccc
Q 010519 340 DSGES-HITTRVMGTFGYVAPEYANTGMLNEKSDIYSFGVLLLEAVT-GRDPVDYGRPANEVNLVEWLKMMVGTRRAEEV 417 (508)
Q Consensus 340 ~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 417 (508)
..... .......++..|+|||.+.+..++.++|||||||++|||++ |..||....+. ...+.+ .... ..
T Consensus 160 ~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~---~~~~~~----~~~~--~~ 230 (279)
T cd05111 160 YPDDKKYFYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRPH---EVPDLL----EKGE--RL 230 (279)
T ss_pred cCCCcccccCCCCCcccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCCCCCHH---HHHHHH----HCCC--cC
Confidence 43322 12233456778999999998899999999999999999998 99998643221 111111 1111 00
Q ss_pred cCCCCCCChhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhhcC
Q 010519 418 VDPNLEVKPATRALKRSLLVALRCVDPDSEKRPKMSQVVRMLEAD 462 (508)
Q Consensus 418 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~ 462 (508)
..+. .....+.+++.+||..||.+|||+.|+++.|...
T Consensus 231 ~~~~-------~~~~~~~~li~~c~~~~p~~Rps~~el~~~l~~~ 268 (279)
T cd05111 231 AQPQ-------ICTIDVYMVMVKCWMIDENVRPTFKELANEFTRM 268 (279)
T ss_pred CCCC-------CCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHH
Confidence 0111 1223456688999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r |
| >cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-39 Score=322.54 Aligned_cols=260 Identities=21% Similarity=0.261 Sum_probs=199.2
Q ss_pred CCcccceeEeeeCceEEEEEEEc-CCCEEEEEEEcccc---hhhHHHHHHHHHHHhcCCCCCceeEEEEEEeCceeeEEE
Q 010519 186 NRFSAENVLGEGGYGVVYKGRLI-NGSEVAVKKLLNNL---GQAEKEFRVEVEAIGHVRHKNLVRLLGYCIEGVHRMLVY 261 (508)
Q Consensus 186 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~ei~~l~~l~h~niv~~~~~~~~~~~~~lv~ 261 (508)
++|.+.+.||+|+||+||+++.. +++.||+|.+.... ......+..|+.++..++|+||+++++++.++...|+||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (331)
T cd05597 1 DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAFQDENNLYLVM 80 (331)
T ss_pred CCceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEEecCCeEEEEE
Confidence 47899999999999999999875 58899999985422 223355788999999999999999999999999999999
Q ss_pred eecCCCCHHHHHhhhhccCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCEEEcCCCcEEEEecCCccccCC
Q 010519 262 EYVNNGNLEQWLHGAMRNQGNLTWEARMKVIIGTAKALAYLHEAIEPKVVHRDIKSSNILIDDEFNAKVSDFGLAKLLDS 341 (508)
Q Consensus 262 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~ 341 (508)
||+++|+|.+++.. ....+++..+..++.||+.||.|||++ +|+||||||+|||++.++.+||+|||++.....
T Consensus 81 e~~~g~~L~~~l~~---~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~ 154 (331)
T cd05597 81 DYYVGGDLLTLLSK---FEDRLPEDMARFYLAEMVLAIDSVHQL---GYVHRDIKPDNVLLDKNGHIRLADFGSCLRLLA 154 (331)
T ss_pred ecCCCCcHHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHhC---CeEECCCCHHHEEECCCCCEEEEECCceeecCC
Confidence 99999999999852 345688999999999999999999999 999999999999999999999999999976544
Q ss_pred CCCcccccccccccccCccccCC-----CCCCChhhHHHHHHHHHHHHhCCCCCCCCCCCchhcHHHHHHHHhccccccc
Q 010519 342 GESHITTRVMGTFGYVAPEYANT-----GMLNEKSDIYSFGVLLLEAVTGRDPVDYGRPANEVNLVEWLKMMVGTRRAEE 416 (508)
Q Consensus 342 ~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~DvwS~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 416 (508)
..........||+.|+|||++.+ ..++.++|||||||++|||++|+.||..... .+.............
T Consensus 155 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~------~~~~~~i~~~~~~~~ 228 (331)
T cd05597 155 DGTVQSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAESL------VETYGKIMNHKEHFQ 228 (331)
T ss_pred CCCccccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCCCCH------HHHHHHHHcCCCccc
Confidence 33222333568999999999863 4578899999999999999999999964321 122222211111000
Q ss_pred ccCCCCCCChhHHHHHHHHHHHHHhcCC--CCCCCCCHHHHHHHhhcCC
Q 010519 417 VVDPNLEVKPATRALKRSLLVALRCVDP--DSEKRPKMSQVVRMLEADD 463 (508)
Q Consensus 417 ~~~~~~~~~~~~~~~~~l~~li~~cl~~--dP~~RPs~~evl~~L~~~~ 463 (508)
+. +. .......+.+++.+|+.. ++..||++.+++++-+-..
T Consensus 229 ~~-~~-----~~~~~~~~~~li~~ll~~~~~r~~r~~~~~~l~hp~~~~ 271 (331)
T cd05597 229 FP-PD-----VTDVSEEAKDLIRRLICSPETRLGRNGLQDFKDHPFFEG 271 (331)
T ss_pred CC-Cc-----cCCCCHHHHHHHHHHccCcccccCCCCHHHHhcCCCCCC
Confidence 00 00 011234455677777654 3444889999999865433
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, |
| >cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-39 Score=326.49 Aligned_cols=242 Identities=25% Similarity=0.318 Sum_probs=190.5
Q ss_pred eeEeeeCceEEEEEEEc-CCCEEEEEEEcccch---hhHHHHHHHHH-HHhcCCCCCceeEEEEEEeCceeeEEEeecCC
Q 010519 192 NVLGEGGYGVVYKGRLI-NGSEVAVKKLLNNLG---QAEKEFRVEVE-AIGHVRHKNLVRLLGYCIEGVHRMLVYEYVNN 266 (508)
Q Consensus 192 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~ei~-~l~~l~h~niv~~~~~~~~~~~~~lv~E~~~~ 266 (508)
+.||+|+||+||+|++. +|+.||+|++..... .....+..|.. +++.++||||+++++++.+....++||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~ 80 (323)
T cd05575 1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTADKLYFVLDYVNG 80 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEeCCEEEEEEcCCCC
Confidence 46999999999999875 688999999864321 12233444544 56789999999999999999999999999999
Q ss_pred CCHHHHHhhhhccCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCEEEcCCCcEEEEecCCccccCCCCCcc
Q 010519 267 GNLEQWLHGAMRNQGNLTWEARMKVIIGTAKALAYLHEAIEPKVVHRDIKSSNILIDDEFNAKVSDFGLAKLLDSGESHI 346 (508)
Q Consensus 267 gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~ 346 (508)
|+|.+++. ....+++..+..++.||+.||.|||++ +|+||||||+|||++.++.+||+|||++....... ..
T Consensus 81 g~L~~~l~----~~~~~~~~~~~~~~~qi~~~l~~lH~~---givH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~~-~~ 152 (323)
T cd05575 81 GELFFHLQ----RERSFPEPRARFYAAEIASALGYLHSL---NIIYRDLKPENILLDSQGHVVLTDFGLCKEGIEHS-KT 152 (323)
T ss_pred CCHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCCHHHeEECCCCcEEEeccCCCcccccCC-Cc
Confidence 99999884 455788999999999999999999999 99999999999999999999999999987543222 22
Q ss_pred cccccccccccCccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCCCchhcHHHHHHHHhcccccccccCCCCCCCh
Q 010519 347 TTRVMGTFGYVAPEYANTGMLNEKSDIYSFGVLLLEAVTGRDPVDYGRPANEVNLVEWLKMMVGTRRAEEVVDPNLEVKP 426 (508)
Q Consensus 347 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 426 (508)
.....||+.|+|||++.+..++.++|||||||++|||++|..||..... .+........ .....
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~------~~~~~~i~~~---------~~~~~- 216 (323)
T cd05575 153 TSTFCGTPEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRDT------AEMYDNILNK---------PLRLK- 216 (323)
T ss_pred cccccCChhhcChhhhcCCCCCccccccccchhhhhhhcCCCCCCCCCH------HHHHHHHHcC---------CCCCC-
Confidence 3445789999999999999999999999999999999999999964321 1222222211 01111
Q ss_pred hHHHHHHHHHHHHHhcCCCCCCCCCHH----HHHHH
Q 010519 427 ATRALKRSLLVALRCVDPDSEKRPKMS----QVVRM 458 (508)
Q Consensus 427 ~~~~~~~l~~li~~cl~~dP~~RPs~~----evl~~ 458 (508)
......+.+++.+||+.||.+||++. +++++
T Consensus 217 -~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~il~~ 251 (323)
T cd05575 217 -PNISVSARHLLEGLLQKDRTKRLGAKDDFLEIKNH 251 (323)
T ss_pred -CCCCHHHHHHHHHHhhcCHHhCCCCCCCHHHHHcC
Confidence 11244566799999999999999984 55554
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr |
| >cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-39 Score=317.58 Aligned_cols=262 Identities=29% Similarity=0.439 Sum_probs=206.3
Q ss_pred HhhCCcccceeEeeeCceEEEEEEEcC-----CCEEEEEEEcccc-hhhHHHHHHHHHHHhcCCCCCceeEEEEEEe-Cc
Q 010519 183 IATNRFSAENVLGEGGYGVVYKGRLIN-----GSEVAVKKLLNNL-GQAEKEFRVEVEAIGHVRHKNLVRLLGYCIE-GV 255 (508)
Q Consensus 183 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~-----~~~vavK~~~~~~-~~~~~~~~~ei~~l~~l~h~niv~~~~~~~~-~~ 255 (508)
+..++|.+.+.||+|+||.||+|.+.+ +..|++|++.... ......+..|+.+++.++||||+++++++.. ..
T Consensus 3 ~~~~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~ 82 (280)
T cd05043 3 ISRDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNILPILHVCIEDGE 82 (280)
T ss_pred cchhheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCC
Confidence 345789999999999999999998765 6788999876543 3334668889999999999999999998776 46
Q ss_pred eeeEEEeecCCCCHHHHHhhhhcc----CCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCEEEcCCCcEEEE
Q 010519 256 HRMLVYEYVNNGNLEQWLHGAMRN----QGNLTWEARMKVIIGTAKALAYLHEAIEPKVVHRDIKSSNILIDDEFNAKVS 331 (508)
Q Consensus 256 ~~~lv~E~~~~gsL~~~l~~~~~~----~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~ 331 (508)
..++++||+++|+|.+++...... ...+++..++.++.+++.||.|||+. +++|+||||+||++++++.+||+
T Consensus 83 ~~~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~---~i~H~di~p~nil~~~~~~~kl~ 159 (280)
T cd05043 83 PPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKR---GVIHKDIAARNCVIDEELQVKIT 159 (280)
T ss_pred CCEEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccCHhhEEEcCCCcEEEC
Confidence 778999999999999999653221 15689999999999999999999998 99999999999999999999999
Q ss_pred ecCCccccCCCCCc-ccccccccccccCccccCCCCCCChhhHHHHHHHHHHHHh-CCCCCCCCCCCchhcHHHHHHHHh
Q 010519 332 DFGLAKLLDSGESH-ITTRVMGTFGYVAPEYANTGMLNEKSDIYSFGVLLLEAVT-GRDPVDYGRPANEVNLVEWLKMMV 409 (508)
Q Consensus 332 Dfgla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~ 409 (508)
|||+++.+...... ......++..|+|||++.+..++.++|||||||++||+++ |+.||....+ .....++.
T Consensus 160 d~g~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~---~~~~~~~~--- 233 (280)
T cd05043 160 DNALSRDLFPMDYHCLGDNENRPVKWMALESLVNKEYSSASDVWSFGVLLWELMTLGQTPYVEIDP---FEMAAYLK--- 233 (280)
T ss_pred CCCCcccccCCceEEeCCCCCcchhccCHHHHhcCCCCchhhHHHhHHHHHHHhcCCCCCcCcCCH---HHHHHHHH---
Confidence 99999865433221 1122345668999999998889999999999999999999 9999964322 11222111
Q ss_pred cccccccccCCCCCCChhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhhcCC
Q 010519 410 GTRRAEEVVDPNLEVKPATRALKRSLLVALRCVDPDSEKRPKMSQVVRMLEADD 463 (508)
Q Consensus 410 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~ 463 (508)
.... ..........+.+++.+||..||++|||+.++++.|+...
T Consensus 234 ~~~~----------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~~~~ 277 (280)
T cd05043 234 DGYR----------LAQPINCPDELFAVMACCWALDPEERPSFSQLVQCLTDFH 277 (280)
T ss_pred cCCC----------CCCCCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHH
Confidence 1110 0111112345678999999999999999999999998653
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It |
| >cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-39 Score=318.52 Aligned_cols=257 Identities=27% Similarity=0.438 Sum_probs=201.4
Q ss_pred CcccceeEeeeCceEEEEEEEc------CCCEEEEEEEcccch-hhHHHHHHHHHHHhcCCCCCceeEEEEEEeCceeeE
Q 010519 187 RFSAENVLGEGGYGVVYKGRLI------NGSEVAVKKLLNNLG-QAEKEFRVEVEAIGHVRHKNLVRLLGYCIEGVHRML 259 (508)
Q Consensus 187 ~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~-~~~~~~~~ei~~l~~l~h~niv~~~~~~~~~~~~~l 259 (508)
+|.+.+.||+|+||.||+|+.. ....+++|.+..... .....+..|+.+++.++||||+++++.+......++
T Consensus 1 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 80 (290)
T cd05045 1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIKLYGACSQDGPLLL 80 (290)
T ss_pred CccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCCcEE
Confidence 4778899999999999999763 224688887765442 334578889999999999999999999999999999
Q ss_pred EEeecCCCCHHHHHhhhhc--------------------cCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCC
Q 010519 260 VYEYVNNGNLEQWLHGAMR--------------------NQGNLTWEARMKVIIGTAKALAYLHEAIEPKVVHRDIKSSN 319 (508)
Q Consensus 260 v~E~~~~gsL~~~l~~~~~--------------------~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiH~Dlk~~N 319 (508)
+|||+.+|+|.+++..... ....+++..++.++.|++.||.|||+. +++||||||+|
T Consensus 81 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~---~ivH~dikp~n 157 (290)
T cd05045 81 IVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEM---KLVHRDLAARN 157 (290)
T ss_pred EEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHHC---Ceehhhhhhhe
Confidence 9999999999999864211 123578899999999999999999998 99999999999
Q ss_pred EEEcCCCcEEEEecCCccccCCCCCc-ccccccccccccCccccCCCCCCChhhHHHHHHHHHHHHh-CCCCCCCCCCCc
Q 010519 320 ILIDDEFNAKVSDFGLAKLLDSGESH-ITTRVMGTFGYVAPEYANTGMLNEKSDIYSFGVLLLEAVT-GRDPVDYGRPAN 397 (508)
Q Consensus 320 Ill~~~~~~kl~Dfgla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~ellt-G~~Pf~~~~~~~ 397 (508)
||+++++.+||+|||+++........ ......++..|+|||.+.+..++.++||||||+++|||++ |..||....+
T Consensus 158 ill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~-- 235 (290)
T cd05045 158 VLVAEGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIAP-- 235 (290)
T ss_pred EEEcCCCcEEeccccccccccCccchhcccCCCCCccccCHHHHccCCcchHhHHHHHHHHHHHHHhcCCCCCCCCCH--
Confidence 99999999999999999865332211 1222345678999999988889999999999999999998 9999854322
Q ss_pred hhcHHHHHHHHhcccccccccCCCCCCChhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhhcC
Q 010519 398 EVNLVEWLKMMVGTRRAEEVVDPNLEVKPATRALKRSLLVALRCVDPDSEKRPKMSQVVRMLEAD 462 (508)
Q Consensus 398 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~ 462 (508)
..+.++.. .. .....+......+.+++.+||+.||.+||++.++++.|+..
T Consensus 236 -~~~~~~~~---~~----------~~~~~~~~~~~~~~~~i~~cl~~~P~~Rp~~~~i~~~l~~~ 286 (290)
T cd05045 236 -ERLFNLLK---TG----------YRMERPENCSEEMYNLMLTCWKQEPDKRPTFADISKELEKM 286 (290)
T ss_pred -HHHHHHHh---CC----------CCCCCCCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHHH
Confidence 11112111 10 01111122335677799999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi |
| >cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-39 Score=313.69 Aligned_cols=259 Identities=26% Similarity=0.415 Sum_probs=207.3
Q ss_pred CCcccceeEeeeCceEEEEEEEc-CCCEEEEEEEcccc---hhhHHHHHHHHHHHhcCCCCCceeEEEEEEeCceeeEEE
Q 010519 186 NRFSAENVLGEGGYGVVYKGRLI-NGSEVAVKKLLNNL---GQAEKEFRVEVEAIGHVRHKNLVRLLGYCIEGVHRMLVY 261 (508)
Q Consensus 186 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~ei~~l~~l~h~niv~~~~~~~~~~~~~lv~ 261 (508)
++|++.+.||.|+||.||++... ++..++||.+.... ......+..|+.+++.++||||+++++++......+++|
T Consensus 2 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~ 81 (267)
T cd08229 2 ANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVL 81 (267)
T ss_pred chhhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeEeCCeEEEEE
Confidence 46888899999999999999864 78899999875422 233457888999999999999999999999999999999
Q ss_pred eecCCCCHHHHHhhhhccCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCEEEcCCCcEEEEecCCccccCC
Q 010519 262 EYVNNGNLEQWLHGAMRNQGNLTWEARMKVIIGTAKALAYLHEAIEPKVVHRDIKSSNILIDDEFNAKVSDFGLAKLLDS 341 (508)
Q Consensus 262 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~ 341 (508)
||+++++|.+++.........+++..++.++.+|+.||.|||+. +++|+||||+||+++.++.++|+|||++.....
T Consensus 82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~ 158 (267)
T cd08229 82 ELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSR---RVMHRDIKPANVFITATGVVKLGDLGLGRFFSS 158 (267)
T ss_pred EecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCCEEECcchhhhcccc
Confidence 99999999999865434456789999999999999999999999 999999999999999999999999999886543
Q ss_pred CCCcccccccccccccCccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCCCchhcHHHHHHHHhcccccccccCCC
Q 010519 342 GESHITTRVMGTFGYVAPEYANTGMLNEKSDIYSFGVLLLEAVTGRDPVDYGRPANEVNLVEWLKMMVGTRRAEEVVDPN 421 (508)
Q Consensus 342 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 421 (508)
... ......++..|+|||.+.+..++.++|+||||+++|+|++|..||..... ....+..... ....+.
T Consensus 159 ~~~-~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~----~~~~~~~~~~------~~~~~~ 227 (267)
T cd08229 159 KTT-AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKM----NLYSLCKKIE------QCDYPP 227 (267)
T ss_pred CCc-ccccccCCcCccCHHHhcCCCccchhhHHHHHHHHHHHHhCCCCcccccc----hHHHHhhhhh------cCCCCC
Confidence 322 12334688999999999988899999999999999999999999853321 1111111111 011111
Q ss_pred CCCChhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhhc
Q 010519 422 LEVKPATRALKRSLLVALRCVDPDSEKRPKMSQVVRMLEA 461 (508)
Q Consensus 422 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~ 461 (508)
. +.......+.+++.+||+.||.+|||+.+|++.++.
T Consensus 228 ~---~~~~~~~~~~~li~~~l~~~p~~Rpt~~~i~~~~~~ 264 (267)
T cd08229 228 L---PSDHYSEELRQLVNMCINPDPEKRPDITYVYDVAKR 264 (267)
T ss_pred C---CcccccHHHHHHHHHhcCCCcccCCCHHHHHHHHhh
Confidence 1 112234567779999999999999999999988864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. |
| >cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-39 Score=323.14 Aligned_cols=242 Identities=24% Similarity=0.339 Sum_probs=190.6
Q ss_pred eeEeeeCceEEEEEEEc-CCCEEEEEEEcccc---hhhHHHHHHHHHHHhc-CCCCCceeEEEEEEeCceeeEEEeecCC
Q 010519 192 NVLGEGGYGVVYKGRLI-NGSEVAVKKLLNNL---GQAEKEFRVEVEAIGH-VRHKNLVRLLGYCIEGVHRMLVYEYVNN 266 (508)
Q Consensus 192 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~ei~~l~~-l~h~niv~~~~~~~~~~~~~lv~E~~~~ 266 (508)
+.||+|+||+||+|++. ++..||+|.+.... ......+..|..++.. ++||||+++++++.+....++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ey~~~ 80 (316)
T cd05619 1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKENLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEeCCEEEEEEeCCCC
Confidence 46999999999999875 57889999986542 1223445557777765 4899999999999999999999999999
Q ss_pred CCHHHHHhhhhccCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCEEEcCCCcEEEEecCCccccCCCCCcc
Q 010519 267 GNLEQWLHGAMRNQGNLTWEARMKVIIGTAKALAYLHEAIEPKVVHRDIKSSNILIDDEFNAKVSDFGLAKLLDSGESHI 346 (508)
Q Consensus 267 gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~ 346 (508)
|+|.+++. ....+++..+..++.|++.||.|||+. +|+||||||+|||++.++.+||+|||++........ .
T Consensus 81 g~L~~~l~----~~~~~~~~~~~~~~~qi~~al~~LH~~---~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~-~ 152 (316)
T cd05619 81 GDLMFHIQ----SCHKFDLPRATFYAAEIICGLQFLHSK---GIVYRDLKLDNILLDTDGHIKIADFGMCKENMLGDA-K 152 (316)
T ss_pred CcHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHhC---CeEeCCCCHHHEEECCCCCEEEccCCcceECCCCCC-c
Confidence 99999984 345688999999999999999999999 999999999999999999999999999875322211 2
Q ss_pred cccccccccccCccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCCCchhcHHHHHHHHhcccccccccCCCCCCCh
Q 010519 347 TTRVMGTFGYVAPEYANTGMLNEKSDIYSFGVLLLEAVTGRDPVDYGRPANEVNLVEWLKMMVGTRRAEEVVDPNLEVKP 426 (508)
Q Consensus 347 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 426 (508)
.....||+.|+|||++.+..++.++|||||||++|||++|..||..... . +......... +.+.
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~---~---~~~~~i~~~~-------~~~~--- 216 (316)
T cd05619 153 TCTFCGTPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSPFHGHDE---E---ELFQSIRMDN-------PCYP--- 216 (316)
T ss_pred eeeecCCccccCHHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCCCH---H---HHHHHHHhCC-------CCCC---
Confidence 3345789999999999999999999999999999999999999964321 1 1111111000 1111
Q ss_pred hHHHHHHHHHHHHHhcCCCCCCCCCHH-HHHHH
Q 010519 427 ATRALKRSLLVALRCVDPDSEKRPKMS-QVVRM 458 (508)
Q Consensus 427 ~~~~~~~l~~li~~cl~~dP~~RPs~~-evl~~ 458 (508)
......+.+++.+||+.||.+||++. +++++
T Consensus 217 -~~~~~~~~~li~~~l~~~P~~R~~~~~~l~~h 248 (316)
T cd05619 217 -RWLTREAKDILVKLFVREPERRLGVKGDIRQH 248 (316)
T ss_pred -ccCCHHHHHHHHHHhccCHhhcCCChHHHHcC
Confidence 11234566789999999999999997 66654
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in |
| >cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-39 Score=313.84 Aligned_cols=257 Identities=26% Similarity=0.485 Sum_probs=203.8
Q ss_pred hhCCcccceeEeeeCceEEEEEEEc-CCC---EEEEEEEcccc-hhhHHHHHHHHHHHhcCCCCCceeEEEEEEeCceee
Q 010519 184 ATNRFSAENVLGEGGYGVVYKGRLI-NGS---EVAVKKLLNNL-GQAEKEFRVEVEAIGHVRHKNLVRLLGYCIEGVHRM 258 (508)
Q Consensus 184 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~---~vavK~~~~~~-~~~~~~~~~ei~~l~~l~h~niv~~~~~~~~~~~~~ 258 (508)
..++|+..+.||+|+||.||+|++. ++. .+++|.+.... ......+..|+.+++.++|||++++++++......+
T Consensus 3 ~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 82 (268)
T cd05063 3 HPSHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRLEGVVTKFKPAM 82 (268)
T ss_pred ChHHceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCCCeeEEEEEEccCCCcE
Confidence 3457888999999999999999875 333 68899876543 333467888999999999999999999999999999
Q ss_pred EEEeecCCCCHHHHHhhhhccCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCEEEcCCCcEEEEecCCccc
Q 010519 259 LVYEYVNNGNLEQWLHGAMRNQGNLTWEARMKVIIGTAKALAYLHEAIEPKVVHRDIKSSNILIDDEFNAKVSDFGLAKL 338 (508)
Q Consensus 259 lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~Dfgla~~ 338 (508)
+||||+++++|.+++.. ....+++..+..++.|++.||.|||+. +++|+||||+||++++++.+||+|||++..
T Consensus 83 lv~e~~~~~~L~~~~~~---~~~~~~~~~~~~~~~~l~~al~~lH~~---~i~H~dlkp~Nili~~~~~~kl~dfg~~~~ 156 (268)
T cd05063 83 IITEYMENGALDKYLRD---HDGEFSSYQLVGMLRGIAAGMKYLSDM---NYVHRDLAARNILVNSNLECKVSDFGLSRV 156 (268)
T ss_pred EEEEcCCCCCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccccchhhEEEcCCCcEEECCCcccee
Confidence 99999999999999853 346789999999999999999999998 999999999999999999999999999986
Q ss_pred cCCCCCccc--ccccccccccCccccCCCCCCChhhHHHHHHHHHHHHh-CCCCCCCCCCCchhcHHHHHHHHhcccccc
Q 010519 339 LDSGESHIT--TRVMGTFGYVAPEYANTGMLNEKSDIYSFGVLLLEAVT-GRDPVDYGRPANEVNLVEWLKMMVGTRRAE 415 (508)
Q Consensus 339 ~~~~~~~~~--~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~ 415 (508)
......... .....+..|+|||++.+..++.++|||||||++|||++ |+.||..... .++........
T Consensus 157 ~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~il~ell~~g~~p~~~~~~------~~~~~~i~~~~--- 227 (268)
T cd05063 157 LEDDPEGTYTTSGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWDMSN------HEVMKAINDGF--- 227 (268)
T ss_pred cccccccceeccCCCcCceecCHHHhhcCCcChHhHHHHHHHHHHHHHhCCCCCCCcCCH------HHHHHHHhcCC---
Confidence 643322111 11223457999999998889999999999999999997 9999864321 12222221111
Q ss_pred cccCCCCCCChhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhhcC
Q 010519 416 EVVDPNLEVKPATRALKRSLLVALRCVDPDSEKRPKMSQVVRMLEAD 462 (508)
Q Consensus 416 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~ 462 (508)
..+........+.+++.+||+.+|.+||++.+|++.|+..
T Consensus 228 -------~~~~~~~~~~~~~~li~~c~~~~p~~Rp~~~~i~~~l~~~ 267 (268)
T cd05063 228 -------RLPAPMDCPSAVYQLMLQCWQQDRARRPRFVDIVNLLDKL 267 (268)
T ss_pred -------CCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 1111112345677899999999999999999999999753
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored |
| >cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-39 Score=318.23 Aligned_cols=266 Identities=24% Similarity=0.413 Sum_probs=205.8
Q ss_pred HHhhCCcccceeEeeeCceEEEEEEEc------CCCEEEEEEEcccc-hhhHHHHHHHHHHHhcCCCCCceeEEEEEEeC
Q 010519 182 EIATNRFSAENVLGEGGYGVVYKGRLI------NGSEVAVKKLLNNL-GQAEKEFRVEVEAIGHVRHKNLVRLLGYCIEG 254 (508)
Q Consensus 182 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~-~~~~~~~~~ei~~l~~l~h~niv~~~~~~~~~ 254 (508)
++..++|++.+.||+|+||.||+|... .+..||+|.+.... ......+.+|+..++.++||||+++++++.+.
T Consensus 2 ~~~~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~ 81 (288)
T cd05061 2 EVSREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVRLLGVVSKG 81 (288)
T ss_pred cccHHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCC
Confidence 456779999999999999999999753 24579999875433 22334677899999999999999999999998
Q ss_pred ceeeEEEeecCCCCHHHHHhhhhcc------CCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCEEEcCCCcE
Q 010519 255 VHRMLVYEYVNNGNLEQWLHGAMRN------QGNLTWEARMKVIIGTAKALAYLHEAIEPKVVHRDIKSSNILIDDEFNA 328 (508)
Q Consensus 255 ~~~~lv~E~~~~gsL~~~l~~~~~~------~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiH~Dlk~~NIll~~~~~~ 328 (508)
...++||||+++|+|.+++...... ...+.+..+..++.|++.||.|||++ +++||||||+|||+++++.+
T Consensus 82 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~i~H~dikp~nili~~~~~~ 158 (288)
T cd05061 82 QPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAK---KFVHRDLAARNCMVAHDFTV 158 (288)
T ss_pred CCcEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CCcCCCCChheEEEcCCCcE
Confidence 9999999999999999999642211 23456778899999999999999998 99999999999999999999
Q ss_pred EEEecCCccccCCCCCc-ccccccccccccCccccCCCCCCChhhHHHHHHHHHHHHh-CCCCCCCCCCCchhcHHHHHH
Q 010519 329 KVSDFGLAKLLDSGESH-ITTRVMGTFGYVAPEYANTGMLNEKSDIYSFGVLLLEAVT-GRDPVDYGRPANEVNLVEWLK 406 (508)
Q Consensus 329 kl~Dfgla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~ellt-G~~Pf~~~~~~~~~~~~~~~~ 406 (508)
+|+|||+++........ ......++..|+|||.+.+..++.++|||||||++|||++ |..||..... .+...
T Consensus 159 ~L~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~DvwslG~~l~el~~~~~~p~~~~~~------~~~~~ 232 (288)
T cd05061 159 KIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSN------EQVLK 232 (288)
T ss_pred EECcCCccccccccccccccCCCcccccccCHHHhccCCCChHhHHHHHHHHHHHHHhCCCCCCCCCCH------HHHHH
Confidence 99999999855432211 1222345678999999998899999999999999999998 7888853221 12222
Q ss_pred HHhcccccccccCCCCCCChhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhhcCCCCC
Q 010519 407 MMVGTRRAEEVVDPNLEVKPATRALKRSLLVALRCVDPDSEKRPKMSQVVRMLEADDYPF 466 (508)
Q Consensus 407 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~~ 466 (508)
....... ... +......+.+++.+||+.||.+|||+.++++.|+....+.
T Consensus 233 ~~~~~~~------~~~----~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~~~~~~ 282 (288)
T cd05061 233 FVMDGGY------LDQ----PDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDDLHPS 282 (288)
T ss_pred HHHcCCC------CCC----CCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHhhcCCC
Confidence 2111111 000 1112346777999999999999999999999998865543
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta |
| >cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-39 Score=319.42 Aligned_cols=257 Identities=23% Similarity=0.390 Sum_probs=202.0
Q ss_pred CCcccceeEeeeCceEEEEEEEcC------CCEEEEEEEcccch-hhHHHHHHHHHHHhcCCCCCceeEEEEEEeCceee
Q 010519 186 NRFSAENVLGEGGYGVVYKGRLIN------GSEVAVKKLLNNLG-QAEKEFRVEVEAIGHVRHKNLVRLLGYCIEGVHRM 258 (508)
Q Consensus 186 ~~~~~~~~lg~G~~g~Vy~~~~~~------~~~vavK~~~~~~~-~~~~~~~~ei~~l~~l~h~niv~~~~~~~~~~~~~ 258 (508)
.+|.+.+.||+|+||.||+|.+.+ +..||+|++..... .....+..|+.++..++||||+++++++......+
T Consensus 5 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~ 84 (283)
T cd05091 5 STVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIVCLLGVVTKEQPLS 84 (283)
T ss_pred HHHHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcCCCceE
Confidence 357778899999999999998643 46799999865443 23456888999999999999999999999999999
Q ss_pred EEEeecCCCCHHHHHhhhh------------ccCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCEEEcCCC
Q 010519 259 LVYEYVNNGNLEQWLHGAM------------RNQGNLTWEARMKVIIGTAKALAYLHEAIEPKVVHRDIKSSNILIDDEF 326 (508)
Q Consensus 259 lv~E~~~~gsL~~~l~~~~------------~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiH~Dlk~~NIll~~~~ 326 (508)
+++||+++++|.+++.... .....+++..+..++.|++.||.|||+. +++||||||.|||+++++
T Consensus 85 ~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~~---gi~H~dlkp~Nil~~~~~ 161 (283)
T cd05091 85 MIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSH---HVVHKDLATRNVLVFDKL 161 (283)
T ss_pred EEEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHc---CccccccchhheEecCCC
Confidence 9999999999999985321 1123578888999999999999999998 999999999999999999
Q ss_pred cEEEEecCCccccCCCCC-cccccccccccccCccccCCCCCCChhhHHHHHHHHHHHHh-CCCCCCCCCCCchhcHHHH
Q 010519 327 NAKVSDFGLAKLLDSGES-HITTRVMGTFGYVAPEYANTGMLNEKSDIYSFGVLLLEAVT-GRDPVDYGRPANEVNLVEW 404 (508)
Q Consensus 327 ~~kl~Dfgla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~ellt-G~~Pf~~~~~~~~~~~~~~ 404 (508)
.+||+|||+++....... .......+++.|+|||.+.+..++.++|||||||++|||++ |..||..... .++
T Consensus 162 ~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~------~~~ 235 (283)
T cd05091 162 NVKISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSN------QDV 235 (283)
T ss_pred ceEecccccccccccchheeeccCccCCccccCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCH------HHH
Confidence 999999999886543221 11233345789999999988889999999999999999998 7888753221 122
Q ss_pred HHHHhcccccccccCCCCCCChhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhhc
Q 010519 405 LKMMVGTRRAEEVVDPNLEVKPATRALKRSLLVALRCVDPDSEKRPKMSQVVRMLEA 461 (508)
Q Consensus 405 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~ 461 (508)
......... . ..+......+.+++.+||+.+|.+||++.+|+..|+.
T Consensus 236 ~~~i~~~~~-~---------~~~~~~~~~~~~li~~cl~~~p~~RP~~~~i~~~l~~ 282 (283)
T cd05091 236 IEMIRNRQV-L---------PCPDDCPAWVYTLMLECWNEFPSRRPRFKDIHSRLRT 282 (283)
T ss_pred HHHHHcCCc-C---------CCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHhhC
Confidence 222221111 0 0111234456679999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-40 Score=329.67 Aligned_cols=238 Identities=26% Similarity=0.328 Sum_probs=191.0
Q ss_pred eeEeeeCceEEEEEEE----cCCCEEEEEEEcccch--hhHHHHHHHHHHHhcCCCCCceeEEEEEEeCceeeEEEeecC
Q 010519 192 NVLGEGGYGVVYKGRL----INGSEVAVKKLLNNLG--QAEKEFRVEVEAIGHVRHKNLVRLLGYCIEGVHRMLVYEYVN 265 (508)
Q Consensus 192 ~~lg~G~~g~Vy~~~~----~~~~~vavK~~~~~~~--~~~~~~~~ei~~l~~l~h~niv~~~~~~~~~~~~~lv~E~~~ 265 (508)
+.||+|+||.||+++. .+|..+|+|++..... .....+..|++++++++||||+++++++.+....|+||||++
T Consensus 2 ~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 81 (318)
T cd05582 2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKLHYAFQTEGKLYLILDFLR 81 (318)
T ss_pred ceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhCCCCCcccEEEEEEcCCEEEEEEcCCC
Confidence 5799999999999875 2578999999865332 223456779999999999999999999999999999999999
Q ss_pred CCCHHHHHhhhhccCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCEEEcCCCcEEEEecCCccccCCCCCc
Q 010519 266 NGNLEQWLHGAMRNQGNLTWEARMKVIIGTAKALAYLHEAIEPKVVHRDIKSSNILIDDEFNAKVSDFGLAKLLDSGESH 345 (508)
Q Consensus 266 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~ 345 (508)
+|+|.+++. ....+++..+..++.||+.||.|||+. +|+||||||+|||+++++.+||+|||++........
T Consensus 82 ~~~L~~~l~----~~~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~- 153 (318)
T cd05582 82 GGDLFTRLS----KEVMFTEEDVKFYLAELALALDHLHSL---GIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEK- 153 (318)
T ss_pred CCcHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHeEECCCCcEEEeeccCCcccCCCCC-
Confidence 999999984 345689999999999999999999999 999999999999999999999999999986543322
Q ss_pred ccccccccccccCccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCCCchhcHHHHHHHHhcccccccccCCCCCCC
Q 010519 346 ITTRVMGTFGYVAPEYANTGMLNEKSDIYSFGVLLLEAVTGRDPVDYGRPANEVNLVEWLKMMVGTRRAEEVVDPNLEVK 425 (508)
Q Consensus 346 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 425 (508)
......|++.|+|||++.+..++.++|||||||++|||++|+.||..... .......... ....
T Consensus 154 ~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~------~~~~~~i~~~---------~~~~- 217 (318)
T cd05582 154 KAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLPFQGKDR------KETMTMILKA---------KLGM- 217 (318)
T ss_pred ceecccCChhhcCHHHHcCCCCCCccceeccceEeeeeccCCCCCCCCCH------HHHHHHHHcC---------CCCC-
Confidence 23345789999999999998899999999999999999999999964321 1111111111 0111
Q ss_pred hhHHHHHHHHHHHHHhcCCCCCCCCCHHH
Q 010519 426 PATRALKRSLLVALRCVDPDSEKRPKMSQ 454 (508)
Q Consensus 426 ~~~~~~~~l~~li~~cl~~dP~~RPs~~e 454 (508)
+......+.+|+.+||+.||.+||++.+
T Consensus 218 -p~~~~~~~~~li~~~l~~~P~~R~~a~~ 245 (318)
T cd05582 218 -PQFLSPEAQSLLRALFKRNPANRLGAGP 245 (318)
T ss_pred -CCCCCHHHHHHHHHHhhcCHhHcCCCCC
Confidence 1112345667999999999999999544
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate |
| >PTZ00284 protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-38 Score=332.90 Aligned_cols=268 Identities=21% Similarity=0.287 Sum_probs=196.4
Q ss_pred HHHHHhhCCcccceeEeeeCceEEEEEEEc-CCCEEEEEEEcccchhhHHHHHHHHHHHhcCC------CCCceeEEEEE
Q 010519 179 RDLEIATNRFSAENVLGEGGYGVVYKGRLI-NGSEVAVKKLLNNLGQAEKEFRVEVEAIGHVR------HKNLVRLLGYC 251 (508)
Q Consensus 179 ~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~ei~~l~~l~------h~niv~~~~~~ 251 (508)
.++....++|.+.+.||+|+||+||+|.+. .++.||||++.... .....+..|+.++..++ |.+++.+++++
T Consensus 122 ~~~~~~~~~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~~-~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~ 200 (467)
T PTZ00284 122 EDIDVSTQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVP-KYTRDAKIEIQFMEKVRQADPADRFPLMKIQRYF 200 (467)
T ss_pred CccccCCCcEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecch-hhHHHHHHHHHHHHHHhhcCcccCcceeeeEEEE
Confidence 445566789999999999999999999875 57789999885432 22334555666666654 45689999988
Q ss_pred EeC-ceeeEEEeecCCCCHHHHHhhhhccCCCccHHHHHHHHHHHHHHHHHHHh-cCCCCeEeecCCCCCEEEcCCC---
Q 010519 252 IEG-VHRMLVYEYVNNGNLEQWLHGAMRNQGNLTWEARMKVIIGTAKALAYLHE-AIEPKVVHRDIKSSNILIDDEF--- 326 (508)
Q Consensus 252 ~~~-~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~yLH~-~~~~~iiH~Dlk~~NIll~~~~--- 326 (508)
... .+.++|||++ +++|.+++. ....+++..+..++.||+.||.|||+ . +||||||||+|||++.++
T Consensus 201 ~~~~~~~~iv~~~~-g~~l~~~l~----~~~~l~~~~~~~i~~qi~~aL~yLH~~~---gIiHrDlKP~NILl~~~~~~~ 272 (467)
T PTZ00284 201 QNETGHMCIVMPKY-GPCLLDWIM----KHGPFSHRHLAQIIFQTGVALDYFHTEL---HLMHTDLKPENILMETSDTVV 272 (467)
T ss_pred EcCCceEEEEEecc-CCCHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHhcC---CeecCCCCHHHEEEecCCccc
Confidence 765 5678999998 779999884 34578999999999999999999997 5 899999999999998765
Q ss_pred -------------cEEEEecCCccccCCCCCcccccccccccccCccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCC
Q 010519 327 -------------NAKVSDFGLAKLLDSGESHITTRVMGTFGYVAPEYANTGMLNEKSDIYSFGVLLLEAVTGRDPVDYG 393 (508)
Q Consensus 327 -------------~~kl~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltG~~Pf~~~ 393 (508)
.+||+|||++..... .....+||+.|+|||++.+..|+.++|||||||+||||++|+.||...
T Consensus 273 ~~~~~~~~~~~~~~vkl~DfG~~~~~~~----~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~ 348 (467)
T PTZ00284 273 DPVTNRALPPDPCRVRICDLGGCCDERH----SRTAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYELYTGKLLYDTH 348 (467)
T ss_pred ccccccccCCCCceEEECCCCccccCcc----ccccccCCccccCcHHhhcCCCCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence 499999998864322 234467999999999999999999999999999999999999999754
Q ss_pred CCCchhcHHHHHHHHhcccc-----------cccc------cCCCCCC---------C--hhHHHHHHHHHHHHHhcCCC
Q 010519 394 RPANEVNLVEWLKMMVGTRR-----------AEEV------VDPNLEV---------K--PATRALKRSLLVALRCVDPD 445 (508)
Q Consensus 394 ~~~~~~~~~~~~~~~~~~~~-----------~~~~------~~~~~~~---------~--~~~~~~~~l~~li~~cl~~d 445 (508)
...... ..+....+... ...+ +.+.... . ........+++|+.+||..|
T Consensus 349 ~~~~~~---~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~d 425 (467)
T PTZ00284 349 DNLEHL---HLMEKTLGRLPSEWAGRCGTEEARLLYNSAGQLRPCTDPKHLARIARARPVREVIRDDLLCDLIYGLLHYD 425 (467)
T ss_pred ChHHHH---HHHHHHcCCCCHHHHhhccchhHHHHhhhcccccccCCHHHHHhhhcccchhhhhchHHHHHHHHHhCCcC
Confidence 322111 11111111000 0000 0000000 0 00001235678999999999
Q ss_pred CCCCCCHHHHHHHhhcC
Q 010519 446 SEKRPKMSQVVRMLEAD 462 (508)
Q Consensus 446 P~~RPs~~evl~~L~~~ 462 (508)
|.+|||+.|+|+|-.-.
T Consensus 426 P~~R~ta~e~L~Hp~~~ 442 (467)
T PTZ00284 426 RQKRLNARQMTTHPYVL 442 (467)
T ss_pred hhhCCCHHHHhcCcccc
Confidence 99999999999865543
|
|
| >cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-39 Score=311.52 Aligned_cols=252 Identities=26% Similarity=0.484 Sum_probs=202.5
Q ss_pred CCcccceeEeeeCceEEEEEEEcCCCEEEEEEEcccchhhHHHHHHHHHHHhcCCCCCceeEEEEEEeCceeeEEEeecC
Q 010519 186 NRFSAENVLGEGGYGVVYKGRLINGSEVAVKKLLNNLGQAEKEFRVEVEAIGHVRHKNLVRLLGYCIEGVHRMLVYEYVN 265 (508)
Q Consensus 186 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~ei~~l~~l~h~niv~~~~~~~~~~~~~lv~E~~~ 265 (508)
.+|++.+.||.|+||.||++.+.++..+|+|.+..... ....+..|++++++++|||++++++++......++||||+.
T Consensus 4 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~k~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~ 82 (256)
T cd05112 4 SELTLVQEIGSGQFGLVWLGYWLEKRKVAIKTIREGAM-SEEDFIEEAQVMMKLSHPKLVQLYGVCTERSPICLVFEFME 82 (256)
T ss_pred hHeEEEeeecCcccceEEEEEEeCCCeEEEEECCCCCC-CHHHHHHHHHHHHhCCCCCeeeEEEEEccCCceEEEEEcCC
Confidence 47888899999999999999887788999998764432 34568889999999999999999999999999999999999
Q ss_pred CCCHHHHHhhhhccCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCEEEcCCCcEEEEecCCccccCCCCCc
Q 010519 266 NGNLEQWLHGAMRNQGNLTWEARMKVIIGTAKALAYLHEAIEPKVVHRDIKSSNILIDDEFNAKVSDFGLAKLLDSGESH 345 (508)
Q Consensus 266 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~ 345 (508)
+++|.+++.. ....+++..++.++.+++.|+.|||+. +++|+||||+||+++.++.+||+|||++.........
T Consensus 83 ~~~L~~~~~~---~~~~~~~~~~~~~~~~l~~~l~~lH~~---~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~~ 156 (256)
T cd05112 83 HGCLSDYLRA---QRGKFSQETLLGMCLDVCEGMAYLESS---NVIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQYT 156 (256)
T ss_pred CCcHHHHHHh---CccCCCHHHHHHHHHHHHHHHHHHHHC---CccccccccceEEEcCCCeEEECCCcceeecccCccc
Confidence 9999999852 345688999999999999999999998 9999999999999999999999999999865433222
Q ss_pred ccccccccccccCccccCCCCCCChhhHHHHHHHHHHHHh-CCCCCCCCCCCchhcHHHHHHHHhcccccccccCCCCCC
Q 010519 346 ITTRVMGTFGYVAPEYANTGMLNEKSDIYSFGVLLLEAVT-GRDPVDYGRPANEVNLVEWLKMMVGTRRAEEVVDPNLEV 424 (508)
Q Consensus 346 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 424 (508)
......++..|+|||.+.+..++.++||||||+++|||++ |..||..... ........... ....+..
T Consensus 157 ~~~~~~~~~~~~aPe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~------~~~~~~~~~~~---~~~~~~~-- 225 (256)
T cd05112 157 SSTGTKFPVKWSSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGKTPYENRSN------SEVVETINAGF---RLYKPRL-- 225 (256)
T ss_pred ccCCCccchhhcCHhHhccCCcChHHHHHHHHHHHHHHHcCCCCCCCcCCH------HHHHHHHhCCC---CCCCCCC--
Confidence 2222334678999999998899999999999999999998 9999864321 11222211110 1111111
Q ss_pred ChhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhh
Q 010519 425 KPATRALKRSLLVALRCVDPDSEKRPKMSQVVRMLE 460 (508)
Q Consensus 425 ~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 460 (508)
....+.+|+.+||+.+|.+|||+.+++++|.
T Consensus 226 -----~~~~~~~l~~~~l~~~p~~Rp~~~~~l~~l~ 256 (256)
T cd05112 226 -----ASQSVYELMQHCWKERPEDRPSFSLLLHQLA 256 (256)
T ss_pred -----CCHHHHHHHHHHcccChhhCCCHHHHHHhhC
Confidence 2356777999999999999999999999873
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ |
| >cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-39 Score=315.06 Aligned_cols=257 Identities=28% Similarity=0.445 Sum_probs=201.5
Q ss_pred hCCcccceeEeeeCceEEEEEEEc-CCC----EEEEEEEcccc-hhhHHHHHHHHHHHhcCCCCCceeEEEEEEeCceee
Q 010519 185 TNRFSAENVLGEGGYGVVYKGRLI-NGS----EVAVKKLLNNL-GQAEKEFRVEVEAIGHVRHKNLVRLLGYCIEGVHRM 258 (508)
Q Consensus 185 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~----~vavK~~~~~~-~~~~~~~~~ei~~l~~l~h~niv~~~~~~~~~~~~~ 258 (508)
.++|.+.+.||+|+||+||+|++. ++. .||+|.+.... ......+..|+.++..++||||+++++++... ..+
T Consensus 6 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~~ 84 (279)
T cd05109 6 ETELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCRLLGICLTS-TVQ 84 (279)
T ss_pred hhheeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCCCHHHHHHHHHHHHHHHhcCCCCCceEEEEEcCC-CcE
Confidence 457889999999999999999864 444 47999886543 33456788899999999999999999998754 567
Q ss_pred EEEeecCCCCHHHHHhhhhccCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCEEEcCCCcEEEEecCCccc
Q 010519 259 LVYEYVNNGNLEQWLHGAMRNQGNLTWEARMKVIIGTAKALAYLHEAIEPKVVHRDIKSSNILIDDEFNAKVSDFGLAKL 338 (508)
Q Consensus 259 lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~Dfgla~~ 338 (508)
+++||+++|+|.+++.. ....+++..++.++.||+.||.|||++ +++||||||+|||+++++.+||+|||+++.
T Consensus 85 l~~~~~~~g~l~~~l~~---~~~~~~~~~~~~~~~qi~~~L~~lH~~---~iiH~dlkp~Nil~~~~~~~kL~dfG~~~~ 158 (279)
T cd05109 85 LVTQLMPYGCLLDYVRE---NKDRIGSQDLLNWCVQIAKGMSYLEEV---RLVHRDLAARNVLVKSPNHVKITDFGLARL 158 (279)
T ss_pred EEEEcCCCCCHHHHHhh---ccCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccccccceEEEcCCCcEEECCCCceee
Confidence 99999999999999853 345689999999999999999999999 999999999999999999999999999987
Q ss_pred cCCCCCcc-cccccccccccCccccCCCCCCChhhHHHHHHHHHHHHh-CCCCCCCCCCCchhcHHHHHHHHhccccccc
Q 010519 339 LDSGESHI-TTRVMGTFGYVAPEYANTGMLNEKSDIYSFGVLLLEAVT-GRDPVDYGRPANEVNLVEWLKMMVGTRRAEE 416 (508)
Q Consensus 339 ~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 416 (508)
........ .....+++.|+|||.+.+..++.++|||||||++|||++ |..||..... ..+..++.. ..
T Consensus 159 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~---~~~~~~~~~----~~--- 228 (279)
T cd05109 159 LDIDETEYHADGGKVPIKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDGIPA---REIPDLLEK----GE--- 228 (279)
T ss_pred cccccceeecCCCccchhhCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCH---HHHHHHHHC----CC---
Confidence 64332211 112234678999999998899999999999999999998 8999864321 111121111 00
Q ss_pred ccCCCCCCChhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhhcCCC
Q 010519 417 VVDPNLEVKPATRALKRSLLVALRCVDPDSEKRPKMSQVVRMLEADDY 464 (508)
Q Consensus 417 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~ 464 (508)
...........+.+++.+||+.||.+||++.++++.|+....
T Consensus 229 ------~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~l~~~l~~~~~ 270 (279)
T cd05109 229 ------RLPQPPICTIDVYMIMVKCWMIDSECRPRFRELVDEFSRMAR 270 (279)
T ss_pred ------cCCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhc
Confidence 001111234456779999999999999999999999876543
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve |
| >KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-40 Score=313.13 Aligned_cols=265 Identities=27% Similarity=0.393 Sum_probs=203.4
Q ss_pred hhCCcccceeEeeeCceEEEEEEEc-CCCEEEEEEEcc--cchhhHHHHHHHHHHHhcCCCCCceeEEEEEEe-----Cc
Q 010519 184 ATNRFSAENVLGEGGYGVVYKGRLI-NGSEVAVKKLLN--NLGQAEKEFRVEVEAIGHVRHKNLVRLLGYCIE-----GV 255 (508)
Q Consensus 184 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~--~~~~~~~~~~~ei~~l~~l~h~niv~~~~~~~~-----~~ 255 (508)
....|...+.||+|+||.|..+.+. +|..||||++.. ......+...+|+++|+.++|+||+.+++++.. -+
T Consensus 20 i~~~y~~~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~F~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~~~f~ 99 (359)
T KOG0660|consen 20 IPRYYVLIEPIGRGAYGVVCSAKDKRTGEKVAIKKILNPFENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSRDKFN 99 (359)
T ss_pred ccceecccccccCcceeeEEEEEEcCCCCEeehhhhhhhhhchHHHHHHHHHHHHHHHhcCCCcceEEeecccccccccc
Confidence 3456666789999999999999875 789999999973 334455677789999999999999999999865 25
Q ss_pred eeeEEEeecCCCCHHHHHhhhhccCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCEEEcCCCcEEEEecCC
Q 010519 256 HRMLVYEYVNNGNLEQWLHGAMRNQGNLTWEARMKVIIGTAKALAYLHEAIEPKVVHRDIKSSNILIDDEFNAKVSDFGL 335 (508)
Q Consensus 256 ~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~Dfgl 335 (508)
..|+|+|+| +.+|...+ ..+..|+...+..++.||+.||.|+|+. +|+||||||.|+|++.+..+||+|||+
T Consensus 100 DvYiV~elM-etDL~~ii----k~~~~L~d~H~q~f~YQiLrgLKyiHSA---nViHRDLKPsNll~n~~c~lKI~DFGL 171 (359)
T KOG0660|consen 100 DVYLVFELM-ETDLHQII----KSQQDLTDDHAQYFLYQILRGLKYIHSA---NVIHRDLKPSNLLLNADCDLKICDFGL 171 (359)
T ss_pred eeEEehhHH-hhHHHHHH----HcCccccHHHHHHHHHHHHHhcchhhcc---cccccccchhheeeccCCCEEeccccc
Confidence 679999999 55888887 4566699999999999999999999999 999999999999999999999999999
Q ss_pred ccccCCC-CCcccccccccccccCccccC-CCCCCChhhHHHHHHHHHHHHhCCCCCCCCCCCchhcHHHHHHHHhcccc
Q 010519 336 AKLLDSG-ESHITTRVMGTFGYVAPEYAN-TGMLNEKSDIYSFGVLLLEAVTGRDPVDYGRPANEVNLVEWLKMMVGTRR 413 (508)
Q Consensus 336 a~~~~~~-~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~DvwS~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~ 413 (508)
|+..... ....++..+-|.+|.|||++. ...|+.+.||||.||||.||++|+.-|...+...... .+....+...
T Consensus 172 AR~~~~~~~~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d~v~Ql~---lI~~~lGtP~ 248 (359)
T KOG0660|consen 172 ARYLDKFFEDGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFPGKDYVHQLQ---LILELLGTPS 248 (359)
T ss_pred eeeccccCcccchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCCCCCchHHHHH---HHHHhcCCCC
Confidence 9977532 223457778899999999875 5789999999999999999999999886554322221 1111111110
Q ss_pred -----------cccccC--CCC-CCCh---hHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHh
Q 010519 414 -----------AEEVVD--PNL-EVKP---ATRALKRSLLVALRCVDPDSEKRPKMSQVVRML 459 (508)
Q Consensus 414 -----------~~~~~~--~~~-~~~~---~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L 459 (508)
....+. +.. ..+. .+......++|+.+||..||.+|+|++|+|.|-
T Consensus 249 ~e~l~~i~s~~ar~yi~slp~~p~~~f~~~fp~a~p~AidLlekmL~fdP~kRita~eAL~hP 311 (359)
T KOG0660|consen 249 EEDLQKIRSEKARPYIKSLPQIPKQPFSSIFPNANPLAIDLLEKMLVFDPKKRITAEEALAHP 311 (359)
T ss_pred HHHHHHhccHHHHHHHHhCCCCCCCCHHHHcCCCCHHHHHHHHHHhccCccccCCHHHHhcCh
Confidence 000000 000 1110 112334567789999999999999999999854
|
|
| >cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-39 Score=313.64 Aligned_cols=255 Identities=27% Similarity=0.469 Sum_probs=202.3
Q ss_pred CCcccceeEeeeCceEEEEEEEc-C---CCEEEEEEEcccc-hhhHHHHHHHHHHHhcCCCCCceeEEEEEEeCceeeEE
Q 010519 186 NRFSAENVLGEGGYGVVYKGRLI-N---GSEVAVKKLLNNL-GQAEKEFRVEVEAIGHVRHKNLVRLLGYCIEGVHRMLV 260 (508)
Q Consensus 186 ~~~~~~~~lg~G~~g~Vy~~~~~-~---~~~vavK~~~~~~-~~~~~~~~~ei~~l~~l~h~niv~~~~~~~~~~~~~lv 260 (508)
.+|.+.+.||+|+||.||+|.+. + +..+|+|.+.... ......+..|+.++++++||||+++++++..+...++|
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 83 (267)
T cd05066 4 SCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSKPVMIV 83 (267)
T ss_pred HHeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEEE
Confidence 57888999999999999999864 2 2368999876433 23346788899999999999999999999999999999
Q ss_pred EeecCCCCHHHHHhhhhccCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCEEEcCCCcEEEEecCCccccC
Q 010519 261 YEYVNNGNLEQWLHGAMRNQGNLTWEARMKVIIGTAKALAYLHEAIEPKVVHRDIKSSNILIDDEFNAKVSDFGLAKLLD 340 (508)
Q Consensus 261 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~Dfgla~~~~ 340 (508)
|||+++++|.+++.. ....+++..++.++.|++.||.|||+. +++|+||||+|||++.++.++|+|||++....
T Consensus 84 ~e~~~~~~L~~~~~~---~~~~~~~~~~~~i~~~i~~~l~~lH~~---~i~h~dlkp~nili~~~~~~~l~dfg~~~~~~ 157 (267)
T cd05066 84 TEYMENGSLDAFLRK---HDGQFTVIQLVGMLRGIASGMKYLSDM---GYVHRDLAARNILVNSNLVCKVSDFGLSRVLE 157 (267)
T ss_pred EEcCCCCCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHC---CEeehhhchhcEEECCCCeEEeCCCCcccccc
Confidence 999999999999963 345689999999999999999999998 99999999999999999999999999998665
Q ss_pred CCCCccc--ccccccccccCccccCCCCCCChhhHHHHHHHHHHHHh-CCCCCCCCCCCchhcHHHHHHHHhcccccccc
Q 010519 341 SGESHIT--TRVMGTFGYVAPEYANTGMLNEKSDIYSFGVLLLEAVT-GRDPVDYGRPANEVNLVEWLKMMVGTRRAEEV 417 (508)
Q Consensus 341 ~~~~~~~--~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 417 (508)
....... ....++..|+|||.+.+..++.++|+|||||++||+++ |..||...... .... .......
T Consensus 158 ~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~ell~~g~~p~~~~~~~---~~~~---~~~~~~~---- 227 (267)
T cd05066 158 DDPEAAYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWEMSNQ---DVIK---AIEEGYR---- 227 (267)
T ss_pred cccceeeecCCCccceeecCHhHhccCccCchhhhHHHHHHHHHHhcCCCCCcccCCHH---HHHH---HHhCCCc----
Confidence 4322211 11223568999999998889999999999999999887 99998643321 1111 1111110
Q ss_pred cCCCCCCChhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhhcC
Q 010519 418 VDPNLEVKPATRALKRSLLVALRCVDPDSEKRPKMSQVVRMLEAD 462 (508)
Q Consensus 418 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~ 462 (508)
.+.....+..+.+++.+||+.+|.+||++.++++.|+..
T Consensus 228 ------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 266 (267)
T cd05066 228 ------LPAPMDCPAALHQLMLDCWQKDRNERPKFEQIVSILDKL 266 (267)
T ss_pred ------CCCCCCCCHHHHHHHHHHcccCchhCCCHHHHHHHHHhh
Confidence 011112244567799999999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul |
| >PHA03207 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-38 Score=325.70 Aligned_cols=264 Identities=22% Similarity=0.276 Sum_probs=201.3
Q ss_pred hhCCcccceeEeeeCceEEEEEEEc---CCCEEEEEEEcccchhhHHHHHHHHHHHhcCCCCCceeEEEEEEeCceeeEE
Q 010519 184 ATNRFSAENVLGEGGYGVVYKGRLI---NGSEVAVKKLLNNLGQAEKEFRVEVEAIGHVRHKNLVRLLGYCIEGVHRMLV 260 (508)
Q Consensus 184 ~~~~~~~~~~lg~G~~g~Vy~~~~~---~~~~vavK~~~~~~~~~~~~~~~ei~~l~~l~h~niv~~~~~~~~~~~~~lv 260 (508)
...+|.+.+.||+|+||.||++... .+..|++|.+... ..+.+|+.+++.++||||+++++++......+++
T Consensus 90 ~~~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~-----~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv 164 (392)
T PHA03207 90 VRMQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGG-----KTPGREIDILKTISHRAIINLIHAYRWKSTVCMV 164 (392)
T ss_pred ccCceEEEEeecCCCCeEEEEEEEcCCccceeEEEEecccc-----ccHHHHHHHHHhcCCCCccceeeeEeeCCEEEEE
Confidence 4568999999999999999999753 3567899987543 2345699999999999999999999999999999
Q ss_pred EeecCCCCHHHHHhhhhccCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCEEEcCCCcEEEEecCCccccC
Q 010519 261 YEYVNNGNLEQWLHGAMRNQGNLTWEARMKVIIGTAKALAYLHEAIEPKVVHRDIKSSNILIDDEFNAKVSDFGLAKLLD 340 (508)
Q Consensus 261 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~Dfgla~~~~ 340 (508)
||++. ++|.+++ .....+++..++.++.||+.||.|||+. +|+||||||+|||++.++.+||+|||++....
T Consensus 165 ~e~~~-~~l~~~l----~~~~~l~~~~~~~i~~ql~~aL~~LH~~---givHrDlkp~Nill~~~~~~~l~DfG~a~~~~ 236 (392)
T PHA03207 165 MPKYK-CDLFTYV----DRSGPLPLEQAITIQRRLLEALAYLHGR---GIIHRDVKTENIFLDEPENAVLGDFGAACKLD 236 (392)
T ss_pred ehhcC-CCHHHHH----HhcCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEEcCCCCEEEccCccccccC
Confidence 99995 6899988 3456789999999999999999999999 99999999999999999999999999998654
Q ss_pred CCCC-cccccccccccccCccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCCCchh-cHHHHHHHHhcccccc---
Q 010519 341 SGES-HITTRVMGTFGYVAPEYANTGMLNEKSDIYSFGVLLLEAVTGRDPVDYGRPANEV-NLVEWLKMMVGTRRAE--- 415 (508)
Q Consensus 341 ~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltG~~Pf~~~~~~~~~-~~~~~~~~~~~~~~~~--- 415 (508)
.... .......||+.|+|||++.+..|+.++|||||||+||||++|+.||......... .+...+.. .+.....
T Consensus 237 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~l~~i~~~-~~~~~~~~~~ 315 (392)
T PHA03207 237 AHPDTPQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQLRSIIRC-MQVHPLEFPQ 315 (392)
T ss_pred cccccccccccccccCccCHhHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCCCCcHHHHHHHHHH-hccCccccCC
Confidence 3322 1223457999999999999999999999999999999999999998654332211 11111111 1100000
Q ss_pred --------------cccCCCCCCChh---HHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhhc
Q 010519 416 --------------EVVDPNLEVKPA---TRALKRSLLVALRCVDPDSEKRPKMSQVVRMLEA 461 (508)
Q Consensus 416 --------------~~~~~~~~~~~~---~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~ 461 (508)
....+....+.. ......+.+++.+||..||.+|||+.|++.+-.-
T Consensus 316 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~Rpsa~e~l~~p~f 378 (392)
T PHA03207 316 NGSTNLCKHFKQYAIVLRPPYTIPPVIRKYGMHMDVEYLIAKMLTFDQEFRPSAQDILSLPLF 378 (392)
T ss_pred ccchhHHHHHHhhcccccCCccccchhhccCcchhHHHHHHHHhccChhhCCCHHHHhhCchh
Confidence 000010110000 0123456678999999999999999999987543
|
|
| >cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-39 Score=312.55 Aligned_cols=256 Identities=25% Similarity=0.429 Sum_probs=199.6
Q ss_pred cccceeEeeeCceEEEEEEEcC----CCEEEEEEEcccc--hhhHHHHHHHHHHHhcCCCCCceeEEEEEEeCce-----
Q 010519 188 FSAENVLGEGGYGVVYKGRLIN----GSEVAVKKLLNNL--GQAEKEFRVEVEAIGHVRHKNLVRLLGYCIEGVH----- 256 (508)
Q Consensus 188 ~~~~~~lg~G~~g~Vy~~~~~~----~~~vavK~~~~~~--~~~~~~~~~ei~~l~~l~h~niv~~~~~~~~~~~----- 256 (508)
|.+.+.||+|+||.||+|.+.. +..||+|++.... ......+..|+..++.++||||+++++++.....
T Consensus 1 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 80 (273)
T cd05035 1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKIP 80 (273)
T ss_pred CccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccccCc
Confidence 5678899999999999998642 3679999886433 2334578889999999999999999998876544
Q ss_pred -eeEEEeecCCCCHHHHHhhhhc--cCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCEEEcCCCcEEEEec
Q 010519 257 -RMLVYEYVNNGNLEQWLHGAMR--NQGNLTWEARMKVIIGTAKALAYLHEAIEPKVVHRDIKSSNILIDDEFNAKVSDF 333 (508)
Q Consensus 257 -~~lv~E~~~~gsL~~~l~~~~~--~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~Df 333 (508)
.+++|||+++|+|..++..... ....+++..++.++.|++.||.|||+. +++||||||+||++++++.+||+||
T Consensus 81 ~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~df 157 (273)
T cd05035 81 KPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNR---NFIHRDLAARNCMLREDMTVCVADF 157 (273)
T ss_pred ccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhC---CeeccccchheEEECCCCeEEECCc
Confidence 6899999999999999864321 234688999999999999999999998 9999999999999999999999999
Q ss_pred CCccccCCCCCcc-cccccccccccCccccCCCCCCChhhHHHHHHHHHHHHh-CCCCCCCCCCCchhcHHHHHHHHhcc
Q 010519 334 GLAKLLDSGESHI-TTRVMGTFGYVAPEYANTGMLNEKSDIYSFGVLLLEAVT-GRDPVDYGRPANEVNLVEWLKMMVGT 411 (508)
Q Consensus 334 gla~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~ 411 (508)
|+++......... .....++..|+|||.+.+..++.++|||||||++|||++ |..||..... .+........
T Consensus 158 g~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~SlG~il~el~~~g~~p~~~~~~------~~~~~~~~~~ 231 (273)
T cd05035 158 GLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVEN------HEIYDYLRHG 231 (273)
T ss_pred cceeeccccccccccccccCCccccCHhhcccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCH------HHHHHHHHcC
Confidence 9998654332211 112234678999999998899999999999999999999 8888854321 1222222211
Q ss_pred cccccccCCCCCCChhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhhcC
Q 010519 412 RRAEEVVDPNLEVKPATRALKRSLLVALRCVDPDSEKRPKMSQVVRMLEAD 462 (508)
Q Consensus 412 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~ 462 (508)
.. . ..+......+.+++.+||+.||.+|||+.++++.|+..
T Consensus 232 ~~------~----~~~~~~~~~~~~li~~~l~~~p~~Rp~~~e~~~~l~~~ 272 (273)
T cd05035 232 NR------L----KQPEDCLDELYDLMYSCWRADPKDRPTFTKLREVLENI 272 (273)
T ss_pred CC------C----CCCcCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 11 0 01112345677899999999999999999999999753
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu |
| >cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-39 Score=321.44 Aligned_cols=263 Identities=27% Similarity=0.436 Sum_probs=204.8
Q ss_pred HHhhCCcccceeEeeeCceEEEEEEEc--------CCCEEEEEEEcccc-hhhHHHHHHHHHHHhcC-CCCCceeEEEEE
Q 010519 182 EIATNRFSAENVLGEGGYGVVYKGRLI--------NGSEVAVKKLLNNL-GQAEKEFRVEVEAIGHV-RHKNLVRLLGYC 251 (508)
Q Consensus 182 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~--------~~~~vavK~~~~~~-~~~~~~~~~ei~~l~~l-~h~niv~~~~~~ 251 (508)
++..++|.+.+.||+|+||.||++.+. .+..+|+|.+.... ......+..|+.++..+ +||||+++++++
T Consensus 14 ~~~~~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~ 93 (307)
T cd05098 14 EVPRDRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGAC 93 (307)
T ss_pred eeehHHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCCChHHHHHHHHHHHHHHHhcCCCCEeeEEEEE
Confidence 444568999999999999999999753 23469999886543 23345678899999999 799999999999
Q ss_pred EeCceeeEEEeecCCCCHHHHHhhhhc------------cCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCC
Q 010519 252 IEGVHRMLVYEYVNNGNLEQWLHGAMR------------NQGNLTWEARMKVIIGTAKALAYLHEAIEPKVVHRDIKSSN 319 (508)
Q Consensus 252 ~~~~~~~lv~E~~~~gsL~~~l~~~~~------------~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiH~Dlk~~N 319 (508)
......++||||+++|+|.+++..... ....+++..++.++.|++.||+|||+. +++||||||+|
T Consensus 94 ~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~---gi~H~dlkp~N 170 (307)
T cd05098 94 TQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASK---KCIHRDLAARN 170 (307)
T ss_pred ecCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHC---CcccccccHHh
Confidence 999999999999999999999965321 123588999999999999999999998 99999999999
Q ss_pred EEEcCCCcEEEEecCCccccCCCCCcc-cccccccccccCccccCCCCCCChhhHHHHHHHHHHHHh-CCCCCCCCCCCc
Q 010519 320 ILIDDEFNAKVSDFGLAKLLDSGESHI-TTRVMGTFGYVAPEYANTGMLNEKSDIYSFGVLLLEAVT-GRDPVDYGRPAN 397 (508)
Q Consensus 320 Ill~~~~~~kl~Dfgla~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~ellt-G~~Pf~~~~~~~ 397 (508)
||++.++.+||+|||++.......... .....+++.|+|||.+.+..++.++|||||||++|||++ |..||....
T Consensus 171 ill~~~~~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~~g~~p~~~~~--- 247 (307)
T cd05098 171 VLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVP--- 247 (307)
T ss_pred eEEcCCCcEEECCCcccccccccchhhccccCCCccceeChHHhccCCCCcHHHHHHHHHHHHHHHcCCCCCCCcCC---
Confidence 999999999999999997654322111 112234568999999999899999999999999999998 888885322
Q ss_pred hhcHHHHHHHHhcccccccccCCCCCCChhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhhcCC
Q 010519 398 EVNLVEWLKMMVGTRRAEEVVDPNLEVKPATRALKRSLLVALRCVDPDSEKRPKMSQVVRMLEADD 463 (508)
Q Consensus 398 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~ 463 (508)
..+......... ....+......+.+++.+||..+|.+|||+.++++.|+..-
T Consensus 248 ---~~~~~~~~~~~~----------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~~l~~~~ 300 (307)
T cd05098 248 ---VEELFKLLKEGH----------RMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIL 300 (307)
T ss_pred ---HHHHHHHHHcCC----------CCCCCCcCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHH
Confidence 122222221111 01111123456667999999999999999999999998743
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-40 Score=330.80 Aligned_cols=263 Identities=25% Similarity=0.418 Sum_probs=225.2
Q ss_pred HHHHHHhhCCcccceeEeeeCceEEEEEEEcC-CCEEEEEEEcccchhhHHHHHHHHHHHhcCCCCCceeEEEEEEeCce
Q 010519 178 LRDLEIATNRFSAENVLGEGGYGVVYKGRLIN-GSEVAVKKLLNNLGQAEKEFRVEVEAIGHVRHKNLVRLLGYCIEGVH 256 (508)
Q Consensus 178 ~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~ei~~l~~l~h~niv~~~~~~~~~~~ 256 (508)
.++|+....++....+||-|.||.||.|.|+. .-.||||.+..+.. ..++|..|..+|+.++|||+|+++|+|..+..
T Consensus 259 ~DkWEmeRtdItMkhKLGGGQYGeVYeGvWKkyslTvAVKtLKEDtM-eveEFLkEAAvMKeikHpNLVqLLGVCT~EpP 337 (1157)
T KOG4278|consen 259 ADKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM-EVEEFLKEAAVMKEIKHPNLVQLLGVCTHEPP 337 (1157)
T ss_pred cchhhccchheeeeeccCCCcccceeeeeeeccceeeehhhhhhcch-hHHHHHHHHHHHHhhcCccHHHHhhhhccCCC
Confidence 47788888899999999999999999999864 66799999876643 35789999999999999999999999999999
Q ss_pred eeEEEeecCCCCHHHHHhhhhccCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCEEEcCCCcEEEEecCCc
Q 010519 257 RMLVYEYVNNGNLEQWLHGAMRNQGNLTWEARMKVIIGTAKALAYLHEAIEPKVVHRDIKSSNILIDDEFNAKVSDFGLA 336 (508)
Q Consensus 257 ~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~Dfgla 336 (508)
.|||.|||.+|+|.+||+. .++..++.-..+.++.||..|+.||..+ ++|||||..+|+|+.++..+|++|||++
T Consensus 338 FYIiTEfM~yGNLLdYLRe--cnr~ev~avvLlyMAtQIsSaMeYLEkk---nFIHRDLAARNCLVgEnhiVKvADFGLs 412 (1157)
T KOG4278|consen 338 FYIITEFMCYGNLLDYLRE--CNRSEVPAVVLLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHIVKVADFGLS 412 (1157)
T ss_pred eEEEEecccCccHHHHHHH--hchhhcchhHHHHHHHHHHHHHHHHHHh---hhhhhhhhhhhccccccceEEeeccchh
Confidence 9999999999999999975 4556677788899999999999999998 9999999999999999999999999999
Q ss_pred cccCCCCCcccccccccccccCccccCCCCCCChhhHHHHHHHHHHHHh-CCCCCCCCCCCchhcHHHHHHHHhcccccc
Q 010519 337 KLLDSGESHITTRVMGTFGYVAPEYANTGMLNEKSDIYSFGVLLLEAVT-GRDPVDYGRPANEVNLVEWLKMMVGTRRAE 415 (508)
Q Consensus 337 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~ 415 (508)
+++..+.........-...|.|||-+.-..++.|+|||+|||+||||.| |..||.. .++.+. .
T Consensus 413 RlMtgDTYTAHAGAKFPIKWTAPEsLAyNtFSiKSDVWAFGVLLWEIATYGMsPYPG------idlSqV----------Y 476 (1157)
T KOG4278|consen 413 RLMTGDTYTAHAGAKFPIKWTAPESLAYNTFSIKSDVWAFGVLLWEIATYGMSPYPG------IDLSQV----------Y 476 (1157)
T ss_pred hhhcCCceecccCccCcccccCcccccccccccchhhHHHHHHHHHHHhcCCCCCCC------ccHHHH----------H
Confidence 9887655444444444668999999988899999999999999999999 8888853 222221 2
Q ss_pred cccCCCCCCChhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhhcC
Q 010519 416 EVVDPNLEVKPATRALKRSLLVALRCVDPDSEKRPKMSQVVRMLEAD 462 (508)
Q Consensus 416 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~ 462 (508)
.++...++.+.+..++....+|++.||+.+|.+||++.|+-+.++..
T Consensus 477 ~LLEkgyRM~~PeGCPpkVYeLMraCW~WsPsDRPsFaeiHqafEtm 523 (1157)
T KOG4278|consen 477 GLLEKGYRMDGPEGCPPKVYELMRACWNWSPSDRPSFAEIHQAFETM 523 (1157)
T ss_pred HHHhccccccCCCCCCHHHHHHHHHHhcCCcccCccHHHHHHHHHHH
Confidence 23345666677777888899999999999999999999999988764
|
|
| >KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-41 Score=305.33 Aligned_cols=254 Identities=23% Similarity=0.319 Sum_probs=204.4
Q ss_pred hCCcccceeEeeeCceEEEEEEEc-CCCEEEEEEEcccc--hhhHHHHHHHHHHHhcCCCCCceeEEEEEEeCceeeEEE
Q 010519 185 TNRFSAENVLGEGGYGVVYKGRLI-NGSEVAVKKLLNNL--GQAEKEFRVEVEAIGHVRHKNLVRLLGYCIEGVHRMLVY 261 (508)
Q Consensus 185 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~ei~~l~~l~h~niv~~~~~~~~~~~~~lv~ 261 (508)
.+.|++-+.||+|.|+.||++.+. .|+.+|+|.+..+. ....+++.+|+.+.+.|+|||||++++.+.+....||||
T Consensus 10 ~d~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~~~e~l~rEarIC~~LqHP~IvrL~~ti~~~~~~ylvF 89 (355)
T KOG0033|consen 10 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVF 89 (355)
T ss_pred chhhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhccccHHHHHHHHHHHHhcCCCcEeehhhhhcccceeEEEE
Confidence 457888899999999999999654 78889988774322 334578899999999999999999999999999999999
Q ss_pred eecCCCCHHHHHhhhhccCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCEEEcC---CCcEEEEecCCccc
Q 010519 262 EYVNNGNLEQWLHGAMRNQGNLTWEARMKVIIGTAKALAYLHEAIEPKVVHRDIKSSNILIDD---EFNAKVSDFGLAKL 338 (508)
Q Consensus 262 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiH~Dlk~~NIll~~---~~~~kl~Dfgla~~ 338 (508)
|+|.||+|..-|-. +..+++..+-.++.||++||.|+|.+ +|||||+||+|+|+.. ...+||+|||++..
T Consensus 90 e~m~G~dl~~eIV~----R~~ySEa~aSH~~rQiLeal~yCH~n---~IvHRDvkP~nllLASK~~~A~vKL~~FGvAi~ 162 (355)
T KOG0033|consen 90 DLVTGGELFEDIVA----REFYSEADASHCIQQILEALAYCHSN---GIVHRDLKPENLLLASKAKGAAVKLADFGLAIE 162 (355)
T ss_pred ecccchHHHHHHHH----HHHHHHHHHHHHHHHHHHHHHHHHhc---CceeccCChhheeeeeccCCCceeecccceEEE
Confidence 99999999877742 24577888899999999999999999 9999999999999953 33499999999998
Q ss_pred cCCCCCcccccccccccccCccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCCCchhcHHHHHHHHhccccccccc
Q 010519 339 LDSGESHITTRVMGTFGYVAPEYANTGMLNEKSDIYSFGVLLLEAVTGRDPVDYGRPANEVNLVEWLKMMVGTRRAEEVV 418 (508)
Q Consensus 339 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 418 (508)
+..+ ......+|||.|||||++...+|+..+|||+.|||||-|+.|.+||...... .+.+ ...
T Consensus 163 l~~g--~~~~G~~GtP~fmaPEvvrkdpy~kpvDiW~cGViLfiLL~G~~PF~~~~~~---rlye---~I~--------- 225 (355)
T KOG0033|consen 163 VNDG--EAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQH---RLYE---QIK--------- 225 (355)
T ss_pred eCCc--cccccccCCCcccCHHHhhcCCCCCcchhhhhhHHHHHHHhCCCCCCCccHH---HHHH---HHh---------
Confidence 8733 3456678999999999999999999999999999999999999999642211 1111 111
Q ss_pred CCCCCCC--hhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhhcC
Q 010519 419 DPNLEVK--PATRALKRSLLVALRCVDPDSEKRPKMSQVVRMLEAD 462 (508)
Q Consensus 419 ~~~~~~~--~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~ 462 (508)
....+.+ .......+..+|+++||..||.+|.|+.|.|+|-+.-
T Consensus 226 ~g~yd~~~~~w~~is~~Ak~LvrrML~~dP~kRIta~EAL~HpWi~ 271 (355)
T KOG0033|consen 226 AGAYDYPSPEWDTVTPEAKSLIRRMLTVNPKKRITADEALKHPWIC 271 (355)
T ss_pred ccccCCCCcccCcCCHHHHHHHHHHhccChhhhccHHHHhCCchhc
Confidence 1111111 1222344566699999999999999999999876543
|
|
| >cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-38 Score=312.19 Aligned_cols=255 Identities=24% Similarity=0.398 Sum_probs=195.8
Q ss_pred cccceeEeeeCceEEEEEEEcCCC---EEEEEEEcccc--hhhHHHHHHHHHHHhcCCCCCceeEEEEEEeC------ce
Q 010519 188 FSAENVLGEGGYGVVYKGRLINGS---EVAVKKLLNNL--GQAEKEFRVEVEAIGHVRHKNLVRLLGYCIEG------VH 256 (508)
Q Consensus 188 ~~~~~~lg~G~~g~Vy~~~~~~~~---~vavK~~~~~~--~~~~~~~~~ei~~l~~l~h~niv~~~~~~~~~------~~ 256 (508)
|.+.+.||+|+||.||+|++.... .+|+|.+.... ......+..|+.+++.++||||+++++++... ..
T Consensus 1 ~~i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 80 (272)
T cd05075 1 LALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPS 80 (272)
T ss_pred CccccccCcccCceEEEeEEccCCCeeeEEEEecccCcCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCCC
Confidence 356788999999999999875433 58899775432 33346788899999999999999999987532 24
Q ss_pred eeEEEeecCCCCHHHHHhhhhc--cCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCEEEcCCCcEEEEecC
Q 010519 257 RMLVYEYVNNGNLEQWLHGAMR--NQGNLTWEARMKVIIGTAKALAYLHEAIEPKVVHRDIKSSNILIDDEFNAKVSDFG 334 (508)
Q Consensus 257 ~~lv~E~~~~gsL~~~l~~~~~--~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~Dfg 334 (508)
.+++|||+++|+|.+++..... ....+++..+..++.|++.||.|||++ +|+||||||+|||+++++.+||+|||
T Consensus 81 ~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~Dfg 157 (272)
T cd05075 81 PVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSSK---SFIHRDLAARNCMLNENMNVCVADFG 157 (272)
T ss_pred cEEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHHC---CeeccccchhheEEcCCCCEEECCCC
Confidence 5799999999999998843211 234588999999999999999999998 99999999999999999999999999
Q ss_pred CccccCCCCCcc-cccccccccccCccccCCCCCCChhhHHHHHHHHHHHHh-CCCCCCCCCCCchhcHHHHHHHHhccc
Q 010519 335 LAKLLDSGESHI-TTRVMGTFGYVAPEYANTGMLNEKSDIYSFGVLLLEAVT-GRDPVDYGRPANEVNLVEWLKMMVGTR 412 (508)
Q Consensus 335 la~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~ 412 (508)
++.......... .....+++.|+|||.+.+..++.++|||||||++|||++ |..||..... . ..........
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~---~---~~~~~~~~~~ 231 (272)
T cd05075 158 LSKKIYNGDYYRQGRIAKMPVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVEN---S---EIYDYLRQGN 231 (272)
T ss_pred cccccCcccceecCCcccCCcccCCHHHccCCCcChHHHHHHHHHHHHHHHcCCCCCCCCCCH---H---HHHHHHHcCC
Confidence 998764332211 122345678999999999999999999999999999999 7888854221 1 1111111111
Q ss_pred ccccccCCCCCCChhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhhc
Q 010519 413 RAEEVVDPNLEVKPATRALKRSLLVALRCVDPDSEKRPKMSQVVRMLEA 461 (508)
Q Consensus 413 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~ 461 (508)
.. . ........+.+++.+||+.||.+|||+.++++.|+.
T Consensus 232 ~~--------~--~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~~ 270 (272)
T cd05075 232 RL--------K--QPPDCLDGLYSLMSSCWLLNPKDRPSFETLRCELEK 270 (272)
T ss_pred CC--------C--CCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHh
Confidence 10 0 011223456779999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor |
| >cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-39 Score=310.76 Aligned_cols=246 Identities=29% Similarity=0.415 Sum_probs=194.4
Q ss_pred eEeeeCceEEEEEEEc---CCCEEEEEEEcccc--hhhHHHHHHHHHHHhcCCCCCceeEEEEEEeCceeeEEEeecCCC
Q 010519 193 VLGEGGYGVVYKGRLI---NGSEVAVKKLLNNL--GQAEKEFRVEVEAIGHVRHKNLVRLLGYCIEGVHRMLVYEYVNNG 267 (508)
Q Consensus 193 ~lg~G~~g~Vy~~~~~---~~~~vavK~~~~~~--~~~~~~~~~ei~~l~~l~h~niv~~~~~~~~~~~~~lv~E~~~~g 267 (508)
.||+|+||.||+|.+. ++..+|+|++.... ....+.+..|+.+++.++||||+++++++. ....++||||+++|
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-~~~~~lv~e~~~~~ 80 (257)
T cd05116 2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMIGICE-AESWMLVMELAELG 80 (257)
T ss_pred cCCCcCCcceEEeEEecCCCceEEEEEEccCCCCcHHHHHHHHHHHHHHHhCCCCCcceEEEEEc-CCCcEEEEecCCCC
Confidence 5899999999999753 57789999875433 234467888999999999999999999875 45678999999999
Q ss_pred CHHHHHhhhhccCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCEEEcCCCcEEEEecCCccccCCCCCcc-
Q 010519 268 NLEQWLHGAMRNQGNLTWEARMKVIIGTAKALAYLHEAIEPKVVHRDIKSSNILIDDEFNAKVSDFGLAKLLDSGESHI- 346 (508)
Q Consensus 268 sL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~- 346 (508)
+|.+++. ....+++..+..++.|++.||.|||++ +++||||||.||++++++.+||+|||++..........
T Consensus 81 ~L~~~l~----~~~~~~~~~~~~i~~qi~~al~~lH~~---~i~H~dlkp~nill~~~~~~kl~Dfg~~~~~~~~~~~~~ 153 (257)
T cd05116 81 PLNKFLQ----KNKHVTEKNITELVHQVSMGMKYLEET---NFVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYK 153 (257)
T ss_pred cHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccchhhEEEcCCCeEEECCCccccccCCCCCeee
Confidence 9999984 345689999999999999999999998 99999999999999999999999999998665433211
Q ss_pred -cccccccccccCccccCCCCCCChhhHHHHHHHHHHHHh-CCCCCCCCCCCchhcHHHHHHHHhcccccccccCCCCCC
Q 010519 347 -TTRVMGTFGYVAPEYANTGMLNEKSDIYSFGVLLLEAVT-GRDPVDYGRPANEVNLVEWLKMMVGTRRAEEVVDPNLEV 424 (508)
Q Consensus 347 -~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 424 (508)
.....++..|+|||.+.+..++.++|+|||||++|||++ |..||..... . .+......... +
T Consensus 154 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~---~---~~~~~i~~~~~------~---- 217 (257)
T cd05116 154 AKTHGKWPVKWYAPECMNYYKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKG---N---EVTQMIESGER------M---- 217 (257)
T ss_pred ecCCCCCCccccCHhHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCH---H---HHHHHHHCCCC------C----
Confidence 122234578999999988889999999999999999998 9999964322 1 11222111110 1
Q ss_pred ChhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhhcC
Q 010519 425 KPATRALKRSLLVALRCVDPDSEKRPKMSQVVRMLEAD 462 (508)
Q Consensus 425 ~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~ 462 (508)
..+......+.+++.+||+.||.+||++.+|.+.|++.
T Consensus 218 ~~~~~~~~~l~~li~~~~~~~p~~Rp~~~~i~~~l~~~ 255 (257)
T cd05116 218 ECPQRCPPEMYDLMKLCWTYGVDERPGFAVVELRLRNY 255 (257)
T ss_pred CCCCCCCHHHHHHHHHHhccCchhCcCHHHHHHHHhcc
Confidence 11112345567799999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio |
| >cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-39 Score=313.85 Aligned_cols=249 Identities=26% Similarity=0.318 Sum_probs=194.5
Q ss_pred EeeeCceEEEEEEEc-CCCEEEEEEEcccc---hhhHHHHHHHHHHHhcCCCCCceeEEEEEEeCceeeEEEeecCCCCH
Q 010519 194 LGEGGYGVVYKGRLI-NGSEVAVKKLLNNL---GQAEKEFRVEVEAIGHVRHKNLVRLLGYCIEGVHRMLVYEYVNNGNL 269 (508)
Q Consensus 194 lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~ei~~l~~l~h~niv~~~~~~~~~~~~~lv~E~~~~gsL 269 (508)
||+|+||+||++... +|+.+|+|.+.... ......+..|++++++++||||+++++++.++...++||||+++++|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~~~~~~lv~e~~~g~~L 80 (277)
T cd05607 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAFESKTHLCLVMSLMNGGDL 80 (277)
T ss_pred CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEEecCCeEEEEEecCCCCCH
Confidence 699999999999875 68999999885432 12234456699999999999999999999999999999999999999
Q ss_pred HHHHhhhhccCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCEEEcCCCcEEEEecCCccccCCCCCccccc
Q 010519 270 EQWLHGAMRNQGNLTWEARMKVIIGTAKALAYLHEAIEPKVVHRDIKSSNILIDDEFNAKVSDFGLAKLLDSGESHITTR 349 (508)
Q Consensus 270 ~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~ 349 (508)
.+++.. .....+++..+..++.||+.||.|||+. +++||||||+|||+++++.++|+|||++....... ....
T Consensus 81 ~~~~~~--~~~~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~--~~~~ 153 (277)
T cd05607 81 KYHIYN--VGERGLEMERVIHYSAQITCGILHLHSM---DIVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGK--TITQ 153 (277)
T ss_pred HHHHHh--ccccCCCHHHHHHHHHHHHHHHHHHHHC---CEEEccCChHhEEEcCCCCEEEeeceeeeecCCCc--eeec
Confidence 998853 2344588899999999999999999998 99999999999999999999999999998665432 2234
Q ss_pred ccccccccCccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCCCchhcHHHHHHHHhcccccccccCCCCCCChhHH
Q 010519 350 VMGTFGYVAPEYANTGMLNEKSDIYSFGVLLLEAVTGRDPVDYGRPANEVNLVEWLKMMVGTRRAEEVVDPNLEVKPATR 429 (508)
Q Consensus 350 ~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 429 (508)
..|++.|+|||++.+..++.++|||||||++|||++|+.||...... ............ ...... ...
T Consensus 154 ~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~p~~~~~~~--~~~~~~~~~~~~---------~~~~~~-~~~ 221 (277)
T cd05607 154 RAGTNGYMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTPFKDHKEK--VAKEELKRRTLE---------DEVKFE-HQN 221 (277)
T ss_pred cCCCCCccCHHHHccCCCCCchhHHHHHHHHHHHHhCCCCCCCCcch--hhHHHHHHHhhc---------cccccc-ccc
Confidence 56899999999999988999999999999999999999998643221 111111111111 011100 011
Q ss_pred HHHHHHHHHHHhcCCCCCCCCCHHHHHHHhhc
Q 010519 430 ALKRSLLVALRCVDPDSEKRPKMSQVVRMLEA 461 (508)
Q Consensus 430 ~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~ 461 (508)
....+.+|+.+||+.||.+||++.|+++.+..
T Consensus 222 ~~~~~~~li~~~L~~~P~~R~~~~~~~~~~~~ 253 (277)
T cd05607 222 FTEESKDICRLFLAKKPEDRLGSREKNDDPRK 253 (277)
T ss_pred CCHHHHHHHHHHhccCHhhCCCCccchhhhhc
Confidence 23456779999999999999999776654443
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr |
| >KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-40 Score=329.13 Aligned_cols=262 Identities=25% Similarity=0.439 Sum_probs=221.7
Q ss_pred HHHHHHhhCCcccceeEeeeCceEEEEEEEcC---CC--EEEEEEEcccc-hhhHHHHHHHHHHHhcCCCCCceeEEEEE
Q 010519 178 LRDLEIATNRFSAENVLGEGGYGVVYKGRLIN---GS--EVAVKKLLNNL-GQAEKEFRVEVEAIGHVRHKNLVRLLGYC 251 (508)
Q Consensus 178 ~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~---~~--~vavK~~~~~~-~~~~~~~~~ei~~l~~l~h~niv~~~~~~ 251 (508)
.+..++..+...+.+.||.|.||.||+|.+.+ |. -||||..+.+. ....+.|..|..+|+.++|||||+++|+|
T Consensus 381 ~rnyel~Re~Itl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~t~d~tekflqEa~iMrnfdHphIikLIGv~ 460 (974)
T KOG4257|consen 381 VRNYELRRELITLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDCTPDDTEKFLQEASIMRNFDHPHIIKLIGVC 460 (974)
T ss_pred CCcceeehhhccHHHhhcCCcccceeeeEecccccCcceeeeeehhccCCChhhHHHHHHHHHHHHhCCCcchhheeeee
Confidence 45667778888889999999999999998643 33 48899887643 45567899999999999999999999999
Q ss_pred EeCceeeEEEeecCCCCHHHHHhhhhccCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCEEEcCCCcEEEE
Q 010519 252 IEGVHRMLVYEYVNNGNLEQWLHGAMRNQGNLTWEARMKVIIGTAKALAYLHEAIEPKVVHRDIKSSNILIDDEFNAKVS 331 (508)
Q Consensus 252 ~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~ 331 (508)
.+ ...+||||+++-|.|..||. .+...|+......++.||+.||.|||+. .+|||||..+|||+.....+||+
T Consensus 461 ~e-~P~WivmEL~~~GELr~yLq---~nk~sL~l~tL~ly~~Qi~talaYLeSk---rfVHRDIAaRNiLVsSp~CVKLa 533 (974)
T KOG4257|consen 461 VE-QPMWIVMELAPLGELREYLQ---QNKDSLPLRTLTLYCYQICTALAYLESK---RFVHRDIAARNILVSSPQCVKLA 533 (974)
T ss_pred ec-cceeEEEecccchhHHHHHH---hccccchHHHHHHHHHHHHHHHHHHHhh---chhhhhhhhhheeecCcceeeec
Confidence 75 46789999999999999997 5677899999999999999999999999 99999999999999999999999
Q ss_pred ecCCccccCCCCCcccccccccccccCccccCCCCCCChhhHHHHHHHHHHHHh-CCCCCCCCCCCchhcHHHHHHHHhc
Q 010519 332 DFGLAKLLDSGESHITTRVMGTFGYVAPEYANTGMLNEKSDIYSFGVLLLEAVT-GRDPVDYGRPANEVNLVEWLKMMVG 410 (508)
Q Consensus 332 Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~ 410 (508)
|||+++.+.+..........-...|||||-++-.+++.++|||.|||.+||+++ |..||..-...+-
T Consensus 534 DFGLSR~~ed~~yYkaS~~kLPIKWmaPESINfRrFTtASDVWMFgVCmWEIl~lGvkPfqgvkNsDV------------ 601 (974)
T KOG4257|consen 534 DFGLSRYLEDDAYYKASRGKLPIKWMAPESINFRRFTTASDVWMFGVCMWEILSLGVKPFQGVKNSDV------------ 601 (974)
T ss_pred ccchhhhccccchhhccccccceeecCccccchhcccchhhHHHHHHHHHHHHHhcCCccccccccce------------
Confidence 999999988776655555555668999999999999999999999999999998 9999975443321
Q ss_pred ccccccccCCCCCCChhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhhcC
Q 010519 411 TRRAEEVVDPNLEVKPATRALKRSLLVALRCVDPDSEKRPKMSQVVRMLEAD 462 (508)
Q Consensus 411 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~ 462 (508)
-..+...-+.+.++.++..+..|+.+||+.+|.+||.+.|+...|.+.
T Consensus 602 ----I~~iEnGeRlP~P~nCPp~LYslmskcWayeP~kRPrftei~~~lsdv 649 (974)
T KOG4257|consen 602 ----IGHIENGERLPCPPNCPPALYSLMSKCWAYEPSKRPRFTEIKAILSDV 649 (974)
T ss_pred ----EEEecCCCCCCCCCCCChHHHHHHHHHhccCcccCCcHHHHHHHHHHH
Confidence 122334445566677778888899999999999999999998877553
|
|
| >cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-39 Score=326.18 Aligned_cols=242 Identities=26% Similarity=0.335 Sum_probs=189.6
Q ss_pred eeEeeeCceEEEEEEEc-CCCEEEEEEEcccc---hhhHHHHHHHHH-HHhcCCCCCceeEEEEEEeCceeeEEEeecCC
Q 010519 192 NVLGEGGYGVVYKGRLI-NGSEVAVKKLLNNL---GQAEKEFRVEVE-AIGHVRHKNLVRLLGYCIEGVHRMLVYEYVNN 266 (508)
Q Consensus 192 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~ei~-~l~~l~h~niv~~~~~~~~~~~~~lv~E~~~~ 266 (508)
+.||+|+||+||+++.. +|+.+|+|++.... ......+..|.. +++.++||||+++++++......++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~~~~~lv~e~~~~ 80 (325)
T cd05604 1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTEKLYFVLDFVNG 80 (325)
T ss_pred CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEecCCEEEEEEcCCCC
Confidence 46999999999999875 68899999986432 122234444554 56779999999999999999999999999999
Q ss_pred CCHHHHHhhhhccCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCEEEcCCCcEEEEecCCccccCCCCCcc
Q 010519 267 GNLEQWLHGAMRNQGNLTWEARMKVIIGTAKALAYLHEAIEPKVVHRDIKSSNILIDDEFNAKVSDFGLAKLLDSGESHI 346 (508)
Q Consensus 267 gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~ 346 (508)
|+|..++. ....+++..+..++.||+.||.|||+. +|+||||||+|||+++++.+||+|||++....... ..
T Consensus 81 ~~L~~~l~----~~~~~~~~~~~~~~~qi~~al~~lH~~---givH~Dlkp~NIll~~~~~~kL~DfG~~~~~~~~~-~~ 152 (325)
T cd05604 81 GELFFHLQ----RERSFPEPRARFYAAEIASALGYLHSI---NIVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQS-DT 152 (325)
T ss_pred CCHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHeEECCCCCEEEeecCCcccCCCCC-CC
Confidence 99998884 456789999999999999999999999 99999999999999999999999999987543222 12
Q ss_pred cccccccccccCccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCCCchhcHHHHHHHHhcccccccccCCCCCCCh
Q 010519 347 TTRVMGTFGYVAPEYANTGMLNEKSDIYSFGVLLLEAVTGRDPVDYGRPANEVNLVEWLKMMVGTRRAEEVVDPNLEVKP 426 (508)
Q Consensus 347 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 426 (508)
....+||+.|+|||++.+..++.++|||||||++|||++|..||..... .+........ .+...+
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~------~~~~~~~~~~---------~~~~~~ 217 (325)
T cd05604 153 TTTFCGTPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPPFYCRDV------AEMYDNILHK---------PLVLRP 217 (325)
T ss_pred cccccCChhhCCHHHHcCCCCCCcCccccccceehhhhcCCCCCCCCCH------HHHHHHHHcC---------CccCCC
Confidence 3445789999999999999999999999999999999999999964321 1112222111 011111
Q ss_pred hHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 010519 427 ATRALKRSLLVALRCVDPDSEKRPKMSQVVRM 458 (508)
Q Consensus 427 ~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 458 (508)
.....+.+++.+||..||.+||++.+.+..
T Consensus 218 --~~~~~~~~ll~~ll~~~p~~R~~~~~~~~~ 247 (325)
T cd05604 218 --GASLTAWSILEELLEKDRQRRLGAKEDFLE 247 (325)
T ss_pred --CCCHHHHHHHHHHhccCHHhcCCCCCCHHH
Confidence 123455678999999999999988643333
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, |
| >KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-39 Score=308.66 Aligned_cols=265 Identities=24% Similarity=0.323 Sum_probs=204.2
Q ss_pred CCcccceeEeeeCceEEEEEEEc-CCCEEEEEEEcccchh--hHHHHHHHHHHHhcCCCCC-ceeEEEEEEeCc------
Q 010519 186 NRFSAENVLGEGGYGVVYKGRLI-NGSEVAVKKLLNNLGQ--AEKEFRVEVEAIGHVRHKN-LVRLLGYCIEGV------ 255 (508)
Q Consensus 186 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~--~~~~~~~ei~~l~~l~h~n-iv~~~~~~~~~~------ 255 (508)
..|...++||+|+||+||+|+.. +|+.||+|++...... ......+|+.+|+.++|+| ||++++++...+
T Consensus 11 ~~~~~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~~~ 90 (323)
T KOG0594|consen 11 FDYEKVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEEEGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHRGIG 90 (323)
T ss_pred HHHHHHHHhCCCCceEEEEEEEecCCCEEEEEEEeccccccCCCchhhHHHHHHHHhCCCcceEEEEeeeeecccccccc
Confidence 45777788999999999999865 7889999999655432 2234567999999999999 999999999877
Q ss_pred eeeEEEeecCCCCHHHHHhhhhccCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCEEEcCCCcEEEEecCC
Q 010519 256 HRMLVYEYVNNGNLEQWLHGAMRNQGNLTWEARMKVIIGTAKALAYLHEAIEPKVVHRDIKSSNILIDDEFNAKVSDFGL 335 (508)
Q Consensus 256 ~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~Dfgl 335 (508)
.+++||||++. +|..++.........++...+..++.||+.||+|||++ +|+||||||.||||+++|.+||+|||+
T Consensus 91 ~l~lvfe~~d~-DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H~~---~IlHRDLKPQNlLi~~~G~lKlaDFGl 166 (323)
T KOG0594|consen 91 KLYLVFEFLDR-DLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLHSH---GILHRDLKPQNLLISSSGVLKLADFGL 166 (323)
T ss_pred eEEEEEEeecc-cHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHHhC---CeecccCCcceEEECCCCcEeeeccch
Confidence 78899999965 99999975332224567788999999999999999999 999999999999999999999999999
Q ss_pred ccccCCCCCcccccccccccccCccccCCC-CCCChhhHHHHHHHHHHHHhCCCCCCCCCCCchhcHHHHHHHHhccccc
Q 010519 336 AKLLDSGESHITTRVMGTFGYVAPEYANTG-MLNEKSDIYSFGVLLLEAVTGRDPVDYGRPANEVNLVEWLKMMVGTRRA 414 (508)
Q Consensus 336 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwS~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~ 414 (508)
|+...-... ..+..++|.+|.|||++.+. .|+...||||+|||++||++++.-|..... .+....+....+....
T Consensus 167 Ara~~ip~~-~yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se---~~ql~~If~~lGtP~e 242 (323)
T KOG0594|consen 167 ARAFSIPMR-TYTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLFPGDSE---IDQLFRIFRLLGTPNE 242 (323)
T ss_pred HHHhcCCcc-cccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCCCCCCcH---HHHHHHHHHHcCCCCc
Confidence 996653322 24556789999999999886 799999999999999999998888864432 2222233333333211
Q ss_pred ------ccccCCCCC---CChhH-------HHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 010519 415 ------EEVVDPNLE---VKPAT-------RALKRSLLVALRCVDPDSEKRPKMSQVVRM 458 (508)
Q Consensus 415 ------~~~~~~~~~---~~~~~-------~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 458 (508)
..+.+-... ..... .......+++.+||+.+|.+|.|+..++.|
T Consensus 243 ~~Wp~v~~~~~~k~~f~~~~~~~~l~~~~~~~~~~~~dll~~~L~y~p~~R~Sa~~al~h 302 (323)
T KOG0594|consen 243 KDWPGVSSLPDYKAPFPKWPGPKDLSSILPKLDPDGIELLSKLLQYDPAKRISAKGALTH 302 (323)
T ss_pred cCCCCccccccccccCcCCCCccchHHhccccCccHHHHHHHHhccCcccCcCHHHHhcC
Confidence 111111111 11011 111367789999999999999999999987
|
|
| >cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-39 Score=310.64 Aligned_cols=249 Identities=30% Similarity=0.444 Sum_probs=199.1
Q ss_pred hCCcccceeEeeeCceEEEEEEEcCCCEEEEEEEcccchhhHHHHHHHHHHHhcCCCCCceeEEEEEE-eCceeeEEEee
Q 010519 185 TNRFSAENVLGEGGYGVVYKGRLINGSEVAVKKLLNNLGQAEKEFRVEVEAIGHVRHKNLVRLLGYCI-EGVHRMLVYEY 263 (508)
Q Consensus 185 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~ei~~l~~l~h~niv~~~~~~~-~~~~~~lv~E~ 263 (508)
..+|.+.+.||+|+||.||++.. .|..+++|.+.... ..+.+..|+.++++++|+|++++++++. .+...+++|||
T Consensus 5 ~~~~~~~~~lg~g~~~~v~~~~~-~~~~~~~k~~~~~~--~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e~ 81 (256)
T cd05082 5 MKELKLLQTIGKGEFGDVMLGDY-RGNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEY 81 (256)
T ss_pred HHhCeeeeeecccCCCeEEEEEE-cCCcEEEEEeCCCc--hHHHHHHHHHHHHhCCCCCeeeEEEEEEcCCCceEEEEEC
Confidence 35788999999999999999976 68889999875432 2456888999999999999999999765 45678999999
Q ss_pred cCCCCHHHHHhhhhccCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCEEEcCCCcEEEEecCCccccCCCC
Q 010519 264 VNNGNLEQWLHGAMRNQGNLTWEARMKVIIGTAKALAYLHEAIEPKVVHRDIKSSNILIDDEFNAKVSDFGLAKLLDSGE 343 (508)
Q Consensus 264 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~~~ 343 (508)
+++++|.+++.. .....+++..++.++.|++.||+|||++ +++||||||+||++++++.+||+|||++.......
T Consensus 82 ~~~~~L~~~~~~--~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~ 156 (256)
T cd05082 82 MAKGSLVDYLRS--RGRSVLGGDCLLKFSLDVCEAMEYLEAN---NFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ 156 (256)
T ss_pred CCCCcHHHHHHh--cCCCCCCHHHHHHHHHHHHHHHHHHHhC---CEeccccchheEEEcCCCcEEecCCccceeccccC
Confidence 999999999864 2334588999999999999999999998 99999999999999999999999999988554322
Q ss_pred CcccccccccccccCccccCCCCCCChhhHHHHHHHHHHHHh-CCCCCCCCCCCchhcHHHHHHHHhcccccccccCCCC
Q 010519 344 SHITTRVMGTFGYVAPEYANTGMLNEKSDIYSFGVLLLEAVT-GRDPVDYGRPANEVNLVEWLKMMVGTRRAEEVVDPNL 422 (508)
Q Consensus 344 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 422 (508)
....++..|+|||++.+..++.++|||||||++|+|++ |+.||.... ..+.......... +
T Consensus 157 ----~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~~l~~~g~~p~~~~~------~~~~~~~~~~~~~------~-- 218 (256)
T cd05082 157 ----DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIP------LKDVVPRVEKGYK------M-- 218 (256)
T ss_pred ----CCCccceeecCHHHHccCCCCchhhhHHHHHHHHHHHhCCCCCCCCCC------HHHHHHHHhcCCC------C--
Confidence 22234568999999999899999999999999999998 999986332 1122222111100 0
Q ss_pred CCChhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhhc
Q 010519 423 EVKPATRALKRSLLVALRCVDPDSEKRPKMSQVVRMLEA 461 (508)
Q Consensus 423 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~ 461 (508)
.........+.+++.+||+.||.+|||+.++++.|+.
T Consensus 219 --~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~ 255 (256)
T cd05082 219 --DAPDGCPPVVYDVMKQCWHLDAATRPSFLQLREQLEH 255 (256)
T ss_pred --CCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHhc
Confidence 1111234456679999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re |
| >cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-38 Score=312.33 Aligned_cols=253 Identities=22% Similarity=0.361 Sum_probs=200.0
Q ss_pred CCcccceeEeeeCceEEEEEEEc-CCCEEEEEEEcccc-hhhHHHHHHHHHHHhcCCCCCceeEEEEEEeCceeeEEEee
Q 010519 186 NRFSAENVLGEGGYGVVYKGRLI-NGSEVAVKKLLNNL-GQAEKEFRVEVEAIGHVRHKNLVRLLGYCIEGVHRMLVYEY 263 (508)
Q Consensus 186 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~ei~~l~~l~h~niv~~~~~~~~~~~~~lv~E~ 263 (508)
++|++.+.||+|+||.||+|.+. ++..+|+|.+.... ......+..|++++++++||||+++++++......++||||
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 80 (279)
T cd06619 1 QDIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGAFFVENRISICTEF 80 (279)
T ss_pred CcchheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCCChHHHHHHHHHHHHHHhCCCCCeeeEEEEEEECCEEEEEEec
Confidence 36788899999999999999864 68889999886542 33446788899999999999999999999999999999999
Q ss_pred cCCCCHHHHHhhhhccCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCEEEcCCCcEEEEecCCccccCCCC
Q 010519 264 VNNGNLEQWLHGAMRNQGNLTWEARMKVIIGTAKALAYLHEAIEPKVVHRDIKSSNILIDDEFNAKVSDFGLAKLLDSGE 343 (508)
Q Consensus 264 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~~~ 343 (508)
+++++|..+. .+++..+..++.|++.||.|||+. +|+|+||||+|||++.++.++|+|||++.......
T Consensus 81 ~~~~~l~~~~--------~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nill~~~~~~~l~dfg~~~~~~~~~ 149 (279)
T cd06619 81 MDGGSLDVYR--------KIPEHVLGRIAVAVVKGLTYLWSL---KILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNSI 149 (279)
T ss_pred CCCCChHHhh--------cCCHHHHHHHHHHHHHHHHHHHHC---CEeeCCCCHHHEEECCCCCEEEeeCCcceeccccc
Confidence 9999987542 367888899999999999999999 99999999999999999999999999998654322
Q ss_pred CcccccccccccccCccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCCCchh-cHHHHHHHHhcccccccccCCCC
Q 010519 344 SHITTRVMGTFGYVAPEYANTGMLNEKSDIYSFGVLLLEAVTGRDPVDYGRPANEV-NLVEWLKMMVGTRRAEEVVDPNL 422 (508)
Q Consensus 344 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltG~~Pf~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~ 422 (508)
.....|+..|+|||++.+..++.++|+|||||++|+|++|+.||......... ............. .+.+
T Consensus 150 ---~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~------~~~~ 220 (279)
T cd06619 150 ---AKTYVGTNAYMAPERISGEQYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQLLQCIVDED------PPVL 220 (279)
T ss_pred ---ccCCCCChhhcCceeecCCCCCCcchHHHHHHHHHHHHhCCCCchhhcccccccchHHHHHHHhccC------CCCC
Confidence 23457899999999999989999999999999999999999999643221111 1111111111110 0111
Q ss_pred CCChhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhhc
Q 010519 423 EVKPATRALKRSLLVALRCVDPDSEKRPKMSQVVRMLEA 461 (508)
Q Consensus 423 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~ 461 (508)
. .......+.+++.+||+.||.+||++.+++++.+-
T Consensus 221 ~---~~~~~~~~~~li~~~l~~~P~~Rp~~~eil~~~~~ 256 (279)
T cd06619 221 P---VGQFSEKFVHFITQCMRKQPKERPAPENLMDHPFI 256 (279)
T ss_pred C---CCcCCHHHHHHHHHHhhCChhhCCCHHHHhcCccc
Confidence 1 11123456779999999999999999999987543
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p |
| >cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-38 Score=308.98 Aligned_cols=250 Identities=24% Similarity=0.332 Sum_probs=201.6
Q ss_pred CcccceeEeeeCceEEEEEEEc-CCCEEEEEEEcccc-hhhHHHHHHHHHHHhcCCCCCceeEEEEEEeCceeeEEEeec
Q 010519 187 RFSAENVLGEGGYGVVYKGRLI-NGSEVAVKKLLNNL-GQAEKEFRVEVEAIGHVRHKNLVRLLGYCIEGVHRMLVYEYV 264 (508)
Q Consensus 187 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~ei~~l~~l~h~niv~~~~~~~~~~~~~lv~E~~ 264 (508)
+|++.+.||.|+||.||++++. ++..+|+|.+.... ....+.+..|+.+++.++|+||+++++.+..+...+++|||+
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 80 (255)
T cd08219 1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVAFKESFEADGHLYIVMEYC 80 (255)
T ss_pred CceEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCcchHHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEeeC
Confidence 5788899999999999999875 68899999885432 334467788999999999999999999999999999999999
Q ss_pred CCCCHHHHHhhhhccCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCEEEcCCCcEEEEecCCccccCCCCC
Q 010519 265 NNGNLEQWLHGAMRNQGNLTWEARMKVIIGTAKALAYLHEAIEPKVVHRDIKSSNILIDDEFNAKVSDFGLAKLLDSGES 344 (508)
Q Consensus 265 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~ 344 (508)
++|+|.+++.. .....+++..++.++.|++.||.|||++ +++|+||||+||++++++.++|+|||++........
T Consensus 81 ~~~~l~~~~~~--~~~~~~~~~~~~~~~~~i~~al~~lH~~---~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~ 155 (255)
T cd08219 81 DGGDLMQKIKL--QRGKLFPEDTILQWFVQMCLGVQHIHEK---RVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGA 155 (255)
T ss_pred CCCcHHHHHHh--ccCCCCCHHHHHHHHHHHHHHHHHHhhC---CcccCCCCcceEEECCCCcEEEcccCcceeeccccc
Confidence 99999998853 2345688999999999999999999998 999999999999999999999999999986543221
Q ss_pred cccccccccccccCccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCCCchhcHHHHHHHHhcccccccccCCCCCC
Q 010519 345 HITTRVMGTFGYVAPEYANTGMLNEKSDIYSFGVLLLEAVTGRDPVDYGRPANEVNLVEWLKMMVGTRRAEEVVDPNLEV 424 (508)
Q Consensus 345 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 424 (508)
......|++.|+|||++.+..++.++|+||||+++|+|++|..||..... ......... .... .+
T Consensus 156 -~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~------~~~~~~~~~-~~~~-----~~-- 220 (255)
T cd08219 156 -YACTYVGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHPFQANSW------KNLILKVCQ-GSYK-----PL-- 220 (255)
T ss_pred -ccccccCCccccCHHHHccCCcCchhhhhhhchhheehhhccCCCCCCCH------HHHHHHHhc-CCCC-----CC--
Confidence 22345688999999999988899999999999999999999999964321 111111111 1100 00
Q ss_pred ChhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 010519 425 KPATRALKRSLLVALRCVDPDSEKRPKMSQVVRM 458 (508)
Q Consensus 425 ~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 458 (508)
+......+.+++.+||+.||.+|||+.+++..
T Consensus 221 --~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~ 252 (255)
T cd08219 221 --PSHYSYELRSLIKQMFKRNPRSRPSATTILSR 252 (255)
T ss_pred --CcccCHHHHHHHHHHHhCCcccCCCHHHHhhc
Confidence 11223456779999999999999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati |
| >cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-39 Score=332.22 Aligned_cols=264 Identities=25% Similarity=0.391 Sum_probs=205.6
Q ss_pred HHHhhCCcccceeEeeeCceEEEEEEEc------CCCEEEEEEEcccch-hhHHHHHHHHHHHhcCC-CCCceeEEEEEE
Q 010519 181 LEIATNRFSAENVLGEGGYGVVYKGRLI------NGSEVAVKKLLNNLG-QAEKEFRVEVEAIGHVR-HKNLVRLLGYCI 252 (508)
Q Consensus 181 ~~~~~~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~-~~~~~~~~ei~~l~~l~-h~niv~~~~~~~ 252 (508)
+++..++|.+.+.||+|+||.||+|++. .+..||+|++..... .....+..|+.+|.++. ||||++++++|.
T Consensus 32 ~~~~~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~~H~niv~~~~~~~ 111 (401)
T cd05107 32 WEMPRDNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTARSSEKQALMSELKIMSHLGPHLNIVNLLGACT 111 (401)
T ss_pred ceecHHHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCCChhHHHHHHHHHHHHHhcCCCCCeEEEEEEEc
Confidence 4666778999999999999999999863 245799999865432 22346888999999997 999999999999
Q ss_pred eCceeeEEEeecCCCCHHHHHhhhhc------------------------------------------------------
Q 010519 253 EGVHRMLVYEYVNNGNLEQWLHGAMR------------------------------------------------------ 278 (508)
Q Consensus 253 ~~~~~~lv~E~~~~gsL~~~l~~~~~------------------------------------------------------ 278 (508)
.....++||||+++|+|.++++....
T Consensus 112 ~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 191 (401)
T cd05107 112 KGGPIYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADYVP 191 (401)
T ss_pred cCCCcEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccCccc
Confidence 99999999999999999999964211
Q ss_pred ----------------------------------------cCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCC
Q 010519 279 ----------------------------------------NQGNLTWEARMKVIIGTAKALAYLHEAIEPKVVHRDIKSS 318 (508)
Q Consensus 279 ----------------------------------------~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiH~Dlk~~ 318 (508)
....+++...+.++.||+.||.|||+. +++||||||+
T Consensus 192 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrdlkp~ 268 (401)
T cd05107 192 MQDMKGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASK---NCVHRDLAAR 268 (401)
T ss_pred hhcchhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcC---CcCcccCCcc
Confidence 112467778899999999999999998 9999999999
Q ss_pred CEEEcCCCcEEEEecCCccccCCCCC-cccccccccccccCccccCCCCCCChhhHHHHHHHHHHHHh-CCCCCCCCCCC
Q 010519 319 NILIDDEFNAKVSDFGLAKLLDSGES-HITTRVMGTFGYVAPEYANTGMLNEKSDIYSFGVLLLEAVT-GRDPVDYGRPA 396 (508)
Q Consensus 319 NIll~~~~~~kl~Dfgla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~ellt-G~~Pf~~~~~~ 396 (508)
|||+++++.+||+|||+++....... .......++..|+|||.+.+..++.++|||||||+||||++ |..||......
T Consensus 269 NiLl~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~e~l~~g~~P~~~~~~~ 348 (401)
T cd05107 269 NVLICEGKLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFTLGGTPYPELPMN 348 (401)
T ss_pred eEEEeCCCEEEEEecCcceecccccccccCCCcCCCCceeChHHhcCCCCCcHhHHHHHHHHHHHHHHcCCCCCCCCCch
Confidence 99999999999999999986532221 11223456788999999998889999999999999999998 88998643211
Q ss_pred chhcHHHHHHHHhcccccccccCCCCCCChhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhhcC
Q 010519 397 NEVNLVEWLKMMVGTRRAEEVVDPNLEVKPATRALKRSLLVALRCVDPDSEKRPKMSQVVRMLEAD 462 (508)
Q Consensus 397 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~ 462 (508)
+......... .....+......+.+|+.+||..+|.+||++.+|++.|+..
T Consensus 349 ------~~~~~~~~~~---------~~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~ell~~L~~~ 399 (401)
T cd05107 349 ------EQFYNAIKRG---------YRMAKPAHASDEIYEIMQKCWEEKFEIRPDFSQLVHLVGDL 399 (401)
T ss_pred ------HHHHHHHHcC---------CCCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHH
Confidence 1111111111 00011112235677799999999999999999999999853
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D |
| >cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-39 Score=313.29 Aligned_cols=256 Identities=25% Similarity=0.375 Sum_probs=202.2
Q ss_pred hhCCcccceeEeeeCceEEEEEEEcCC----CEEEEEEEcccc-hhhHHHHHHHHHHHhcCCCCCceeEEEEEEeCceee
Q 010519 184 ATNRFSAENVLGEGGYGVVYKGRLING----SEVAVKKLLNNL-GQAEKEFRVEVEAIGHVRHKNLVRLLGYCIEGVHRM 258 (508)
Q Consensus 184 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~----~~vavK~~~~~~-~~~~~~~~~ei~~l~~l~h~niv~~~~~~~~~~~~~ 258 (508)
..++|.+.+.||+|+||.||+|.+.+. ..|++|...... ....+.+.+|+.++++++||||+++++++.+ ...+
T Consensus 4 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-~~~~ 82 (270)
T cd05056 4 QREDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKLIGVITE-NPVW 82 (270)
T ss_pred chhhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcCCHHHHHHHHHHHHHHHhCCCCchhceeEEEcC-CCcE
Confidence 345788999999999999999986432 468889876554 3445678899999999999999999998875 4568
Q ss_pred EEEeecCCCCHHHHHhhhhccCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCEEEcCCCcEEEEecCCccc
Q 010519 259 LVYEYVNNGNLEQWLHGAMRNQGNLTWEARMKVIIGTAKALAYLHEAIEPKVVHRDIKSSNILIDDEFNAKVSDFGLAKL 338 (508)
Q Consensus 259 lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~Dfgla~~ 338 (508)
+||||+++|+|.+++.. ....+++..++.++.+++.||.|||+. +++|+||||+|||++.++.+||+|||++..
T Consensus 83 lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~~~l~~~l~~lH~~---~~~H~dl~p~nili~~~~~~~l~d~g~~~~ 156 (270)
T cd05056 83 IVMELAPLGELRSYLQV---NKYSLDLASLILYSYQLSTALAYLESK---RFVHRDIAARNVLVSSPDCVKLGDFGLSRY 156 (270)
T ss_pred EEEEcCCCCcHHHHHHh---CCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccccChheEEEecCCCeEEccCceeee
Confidence 99999999999999953 344689999999999999999999998 999999999999999999999999999986
Q ss_pred cCCCCCcccccccccccccCccccCCCCCCChhhHHHHHHHHHHHHh-CCCCCCCCCCCchhcHHHHHHHHhcccccccc
Q 010519 339 LDSGESHITTRVMGTFGYVAPEYANTGMLNEKSDIYSFGVLLLEAVT-GRDPVDYGRPANEVNLVEWLKMMVGTRRAEEV 417 (508)
Q Consensus 339 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 417 (508)
.............++..|+|||.+.+..++.++|||||||++|||++ |..||...... ..... .......
T Consensus 157 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~---~~~~~---~~~~~~~--- 227 (270)
T cd05056 157 LEDESYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMLGVKPFQGVKNN---DVIGR---IENGERL--- 227 (270)
T ss_pred cccccceecCCCCccccccChhhhccCCCCchhhhHHHHHHHHHHHHcCCCCCCCCCHH---HHHHH---HHcCCcC---
Confidence 64432222222334568999999988889999999999999999996 99999644321 11111 1111100
Q ss_pred cCCCCCCChhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhhcC
Q 010519 418 VDPNLEVKPATRALKRSLLVALRCVDPDSEKRPKMSQVVRMLEAD 462 (508)
Q Consensus 418 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~ 462 (508)
..+......+.+++.+|+..+|.+|||+.+++..|++.
T Consensus 228 -------~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~~~~l~~~ 265 (270)
T cd05056 228 -------PMPPNCPPTLYSLMTKCWAYDPSKRPRFTELKAQLSDI 265 (270)
T ss_pred -------CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence 11112344677799999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions |
| >cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-39 Score=317.55 Aligned_cols=259 Identities=25% Similarity=0.378 Sum_probs=200.8
Q ss_pred CCcccceeEeeeCceEEEEEEEcC-CC--EEEEEEEcccc-hhhHHHHHHHHHHHhcC-CCCCceeEEEEEEeCceeeEE
Q 010519 186 NRFSAENVLGEGGYGVVYKGRLIN-GS--EVAVKKLLNNL-GQAEKEFRVEVEAIGHV-RHKNLVRLLGYCIEGVHRMLV 260 (508)
Q Consensus 186 ~~~~~~~~lg~G~~g~Vy~~~~~~-~~--~vavK~~~~~~-~~~~~~~~~ei~~l~~l-~h~niv~~~~~~~~~~~~~lv 260 (508)
++|++.+.||+|+||.||+|.+.+ +. .+++|.+.... ......+..|+.++.++ +||||+++++++......+++
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv 81 (297)
T cd05089 2 EDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINLLGACENRGYLYIA 81 (297)
T ss_pred ccceeeeeecCCCcceEEEEEecCCCCcceeEEEEccccCCHHHHHHHHHHHHHHHhhcCCCchhheEEEEccCCcceEE
Confidence 578999999999999999998753 32 46888775422 33345688899999999 799999999999998899999
Q ss_pred EeecCCCCHHHHHhhhhc------------cCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCEEEcCCCcE
Q 010519 261 YEYVNNGNLEQWLHGAMR------------NQGNLTWEARMKVIIGTAKALAYLHEAIEPKVVHRDIKSSNILIDDEFNA 328 (508)
Q Consensus 261 ~E~~~~gsL~~~l~~~~~------------~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiH~Dlk~~NIll~~~~~~ 328 (508)
|||+++|+|.++++.... ....+++..++.++.|++.||.|||+. +++||||||+|||+++++.+
T Consensus 82 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~---~ivH~dlkp~Nill~~~~~~ 158 (297)
T cd05089 82 IEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEK---QFIHRDLAARNVLVGENLAS 158 (297)
T ss_pred EEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCcCCcceEEECCCCeE
Confidence 999999999999964211 113588899999999999999999998 99999999999999999999
Q ss_pred EEEecCCccccCCCCCcccccccccccccCccccCCCCCCChhhHHHHHHHHHHHHh-CCCCCCCCCCCchhcHHHHHHH
Q 010519 329 KVSDFGLAKLLDSGESHITTRVMGTFGYVAPEYANTGMLNEKSDIYSFGVLLLEAVT-GRDPVDYGRPANEVNLVEWLKM 407 (508)
Q Consensus 329 kl~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~ellt-G~~Pf~~~~~~~~~~~~~~~~~ 407 (508)
||+|||++....... .......+..|+|||++.+..++.++|||||||++|||++ |..||...... +....
T Consensus 159 kl~dfg~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~el~t~g~~pf~~~~~~------~~~~~ 230 (297)
T cd05089 159 KIADFGLSRGEEVYV--KKTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGMTCA------ELYEK 230 (297)
T ss_pred EECCcCCCcccccee--ccCCCCcCccccCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHH------HHHHH
Confidence 999999987432211 1111223457999999999899999999999999999997 99999643321 11211
Q ss_pred HhcccccccccCCCCCCChhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhhcCCCC
Q 010519 408 MVGTRRAEEVVDPNLEVKPATRALKRSLLVALRCVDPDSEKRPKMSQVVRMLEADDYP 465 (508)
Q Consensus 408 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~ 465 (508)
.... .....+......+.+|+.+||+.+|.+|||++++++.|+.....
T Consensus 231 ~~~~----------~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~~~~ 278 (297)
T cd05089 231 LPQG----------YRMEKPRNCDDEVYELMRQCWRDRPYERPPFAQISVQLSRMLEA 278 (297)
T ss_pred HhcC----------CCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHh
Confidence 1111 01111112334567799999999999999999999998876543
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. |
| >cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-39 Score=317.20 Aligned_cols=250 Identities=24% Similarity=0.381 Sum_probs=203.4
Q ss_pred CCcccceeEeeeCceEEEEEEEc-CCCEEEEEEEcccchhhHHHHHHHHHHHhcCCCCCceeEEEEEEeCceeeEEEeec
Q 010519 186 NRFSAENVLGEGGYGVVYKGRLI-NGSEVAVKKLLNNLGQAEKEFRVEVEAIGHVRHKNLVRLLGYCIEGVHRMLVYEYV 264 (508)
Q Consensus 186 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~ei~~l~~l~h~niv~~~~~~~~~~~~~lv~E~~ 264 (508)
.+|++.+.||+|+||.||+|... ++..+++|.+..........+..|+.+++.++|+||+++++++......++||||+
T Consensus 20 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~v~~~~~~~~~~~~~~lv~e~~ 99 (296)
T cd06654 20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYL 99 (296)
T ss_pred cceeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCCcchHHHHHHHHHHHHhCCCCCEeeEEEEEEeCCEEEEeeccc
Confidence 58999999999999999999864 68899999987655555567888999999999999999999999999999999999
Q ss_pred CCCCHHHHHhhhhccCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCEEEcCCCcEEEEecCCccccCCCCC
Q 010519 265 NNGNLEQWLHGAMRNQGNLTWEARMKVIIGTAKALAYLHEAIEPKVVHRDIKSSNILIDDEFNAKVSDFGLAKLLDSGES 344 (508)
Q Consensus 265 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~ 344 (508)
++++|.+++.. ..+++..+..++.|++.||.|||+. +|+|+||||+|||++.++.+||+|||++........
T Consensus 100 ~~~~L~~~~~~-----~~~~~~~~~~i~~ql~~aL~~LH~~---gi~H~dLkp~Nill~~~~~~kl~dfg~~~~~~~~~~ 171 (296)
T cd06654 100 AGGSLTDVVTE-----TCMDEGQIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS 171 (296)
T ss_pred CCCCHHHHHHh-----cCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEcCCCCEEECccccchhcccccc
Confidence 99999998842 3578899999999999999999999 999999999999999999999999999886543221
Q ss_pred cccccccccccccCccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCCCchhcHHHHHHHHhcccccccccCCCCCC
Q 010519 345 HITTRVMGTFGYVAPEYANTGMLNEKSDIYSFGVLLLEAVTGRDPVDYGRPANEVNLVEWLKMMVGTRRAEEVVDPNLEV 424 (508)
Q Consensus 345 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 424 (508)
......+++.|+|||.+.+..++.++|||||||++|+|++|+.||....+.. .+.. .... .....
T Consensus 172 -~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~~l~~g~~pf~~~~~~~-----~~~~-~~~~--------~~~~~ 236 (296)
T cd06654 172 -KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLR-----ALYL-IATN--------GTPEL 236 (296)
T ss_pred -ccCcccCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCHHH-----hHHH-HhcC--------CCCCC
Confidence 1233468899999999998889999999999999999999999996443211 1111 1100 00011
Q ss_pred ChhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 010519 425 KPATRALKRSLLVALRCVDPDSEKRPKMSQVVRM 458 (508)
Q Consensus 425 ~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 458 (508)
..+......+.+++.+||..||.+|||+.+++++
T Consensus 237 ~~~~~~~~~l~~li~~~l~~~p~~Rpt~~eil~~ 270 (296)
T cd06654 237 QNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQH 270 (296)
T ss_pred CCccccCHHHHHHHHHHCcCCcccCcCHHHHhhC
Confidence 1112234556779999999999999999999985
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-38 Score=316.67 Aligned_cols=266 Identities=24% Similarity=0.400 Sum_probs=201.4
Q ss_pred hhCCcccceeEeeeCceEEEEEEEc-----------------CCCEEEEEEEcccc-hhhHHHHHHHHHHHhcCCCCCce
Q 010519 184 ATNRFSAENVLGEGGYGVVYKGRLI-----------------NGSEVAVKKLLNNL-GQAEKEFRVEVEAIGHVRHKNLV 245 (508)
Q Consensus 184 ~~~~~~~~~~lg~G~~g~Vy~~~~~-----------------~~~~vavK~~~~~~-~~~~~~~~~ei~~l~~l~h~niv 245 (508)
+.++|++.+.||+|+||.||++.+. ++..+|+|.+.... ......+..|+.+++.++|+||+
T Consensus 3 ~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~ 82 (296)
T cd05095 3 PRKRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIKIMSRLKDPNII 82 (296)
T ss_pred ChhhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcc
Confidence 3467999999999999999998542 23468899886543 33446788999999999999999
Q ss_pred eEEEEEEeCceeeEEEeecCCCCHHHHHhhhhcc-------CCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCC
Q 010519 246 RLLGYCIEGVHRMLVYEYVNNGNLEQWLHGAMRN-------QGNLTWEARMKVIIGTAKALAYLHEAIEPKVVHRDIKSS 318 (508)
Q Consensus 246 ~~~~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~-------~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiH~Dlk~~ 318 (508)
++++++......++||||+++|+|.+++...... ...+++..+..++.|++.||.|||+. +++|+||||+
T Consensus 83 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~---~i~H~dlkp~ 159 (296)
T cd05095 83 RLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSL---NFVHRDLATR 159 (296)
T ss_pred eEEEEEecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHHC---CeecccCChh
Confidence 9999999999999999999999999999653211 13477889999999999999999999 9999999999
Q ss_pred CEEEcCCCcEEEEecCCccccCCCCCc-ccccccccccccCccccCCCCCCChhhHHHHHHHHHHHHh--CCCCCCCCCC
Q 010519 319 NILIDDEFNAKVSDFGLAKLLDSGESH-ITTRVMGTFGYVAPEYANTGMLNEKSDIYSFGVLLLEAVT--GRDPVDYGRP 395 (508)
Q Consensus 319 NIll~~~~~~kl~Dfgla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~ellt--G~~Pf~~~~~ 395 (508)
|||+++++.++|+|||++..+...... ......++..|+|||...++.++.++|||||||++|||++ |..||.....
T Consensus 160 Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~DiwSlG~~l~el~~~~~~~p~~~~~~ 239 (296)
T cd05095 160 NCLVGKNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTLCKEQPYSQLSD 239 (296)
T ss_pred eEEEcCCCCEEeccCcccccccCCcceeccCcCcCccccCCHHHHhcCCccchhhhhHHHHHHHHHHHhCCCCCccccCh
Confidence 999999999999999999865432211 1222334678999999888889999999999999999998 6788853322
Q ss_pred CchhcHHHHHHHHhcccccccccCCCCCCChhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhhc
Q 010519 396 ANEVNLVEWLKMMVGTRRAEEVVDPNLEVKPATRALKRSLLVALRCVDPDSEKRPKMSQVVRMLEA 461 (508)
Q Consensus 396 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~ 461 (508)
.. ............. .... ...+......+.+|+.+||+.||.+|||+.+|++.|+.
T Consensus 240 ~~---~~~~~~~~~~~~~-~~~~-----~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~ 296 (296)
T cd05095 240 EQ---VIENTGEFFRDQG-RQVY-----LPKPALCPDSLYKLMLSCWRRNAKERPSFQEIHATLLE 296 (296)
T ss_pred HH---HHHHHHHHHhhcc-cccc-----CCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHHhC
Confidence 11 1111111100000 0000 01111123566779999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit |
| >cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-39 Score=319.45 Aligned_cols=260 Identities=26% Similarity=0.424 Sum_probs=203.9
Q ss_pred HHhhCCcccceeEeeeCceEEEEEEEc------CCCEEEEEEEcccc-hhhHHHHHHHHHHHhcC-CCCCceeEEEEEEe
Q 010519 182 EIATNRFSAENVLGEGGYGVVYKGRLI------NGSEVAVKKLLNNL-GQAEKEFRVEVEAIGHV-RHKNLVRLLGYCIE 253 (508)
Q Consensus 182 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~-~~~~~~~~~ei~~l~~l-~h~niv~~~~~~~~ 253 (508)
....++|.+.+.||+|+||.||++.+. .+..+|+|++.... ....+.+..|+.+++++ +||||+++++++..
T Consensus 31 ~~~~~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~ 110 (302)
T cd05055 31 EFPRNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHENIVNLLGACTI 110 (302)
T ss_pred cccHHHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccCChHHHHHHHHHHHHHHhccCCCCcceEEEEEec
Confidence 344567999999999999999999752 24579999876543 23345788899999999 79999999999999
Q ss_pred CceeeEEEeecCCCCHHHHHhhhhccCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCEEEcCCCcEEEEec
Q 010519 254 GVHRMLVYEYVNNGNLEQWLHGAMRNQGNLTWEARMKVIIGTAKALAYLHEAIEPKVVHRDIKSSNILIDDEFNAKVSDF 333 (508)
Q Consensus 254 ~~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~Df 333 (508)
....++||||+++|+|.++++. .....+++..+..++.+++.||.|||++ +++|+||||+|||++.++.++|+||
T Consensus 111 ~~~~~lv~e~~~~~~L~~~i~~--~~~~~l~~~~~~~i~~~i~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~~l~df 185 (302)
T cd05055 111 GGPILVITEYCCYGDLLNFLRR--KRESFLTLEDLLSFSYQVAKGMAFLASK---NCIHRDLAARNVLLTHGKIVKICDF 185 (302)
T ss_pred CCceEEEEEcCCCCcHHHHHHh--CCCCCCCHHHHHHHHHHHHHHHHHHHHC---CeehhhhccceEEEcCCCeEEECCC
Confidence 9999999999999999999863 2233489999999999999999999998 9999999999999999999999999
Q ss_pred CCccccCCCCCc-ccccccccccccCccccCCCCCCChhhHHHHHHHHHHHHh-CCCCCCCCCCCchhcHHHHHHHHhcc
Q 010519 334 GLAKLLDSGESH-ITTRVMGTFGYVAPEYANTGMLNEKSDIYSFGVLLLEAVT-GRDPVDYGRPANEVNLVEWLKMMVGT 411 (508)
Q Consensus 334 gla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~ 411 (508)
|++......... ......++..|+|||.+.+..++.++|||||||++|||++ |..||........ ... ....
T Consensus 186 g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~t~g~~p~~~~~~~~~--~~~----~~~~ 259 (302)
T cd05055 186 GLARDIMNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPYPGMPVDSK--FYK----LIKE 259 (302)
T ss_pred cccccccCCCceeecCCCCcccccCCHhhhccCCCCcHhHHHHHHHHHHHHHhCCCCCcCCCCchHH--HHH----HHHc
Confidence 999865433211 1222345778999999999899999999999999999998 9999864322111 111 1111
Q ss_pred cccccccCCCCCCChhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhhc
Q 010519 412 RRAEEVVDPNLEVKPATRALKRSLLVALRCVDPDSEKRPKMSQVVRMLEA 461 (508)
Q Consensus 412 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~ 461 (508)
. ............+.+++.+||+++|++|||+.|+++.|+.
T Consensus 260 ~---------~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ell~~l~~ 300 (302)
T cd05055 260 G---------YRMAQPEHAPAEIYDIMKTCWDADPLKRPTFKQIVQLIGK 300 (302)
T ss_pred C---------CcCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHh
Confidence 1 0000011123456779999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept |
| >cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-39 Score=323.19 Aligned_cols=241 Identities=23% Similarity=0.313 Sum_probs=191.5
Q ss_pred CcccceeEeeeCceEEEEEEEc-CCCEEEEEEEcccc---hhhHHHHHHHHHHHhcCC-CCCceeEEEEEEeCceeeEEE
Q 010519 187 RFSAENVLGEGGYGVVYKGRLI-NGSEVAVKKLLNNL---GQAEKEFRVEVEAIGHVR-HKNLVRLLGYCIEGVHRMLVY 261 (508)
Q Consensus 187 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~ei~~l~~l~-h~niv~~~~~~~~~~~~~lv~ 261 (508)
+|+..+.||+|+||+||+|... +|..||+|++.... ......+..|+.++..+. |++|+++++++.+....|+||
T Consensus 1 ~f~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (323)
T cd05615 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTVDRLYFVM 80 (323)
T ss_pred CceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEecCCEEEEEE
Confidence 4677899999999999999875 68899999886432 222345667888888875 578888999999999999999
Q ss_pred eecCCCCHHHHHhhhhccCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCEEEcCCCcEEEEecCCccccCC
Q 010519 262 EYVNNGNLEQWLHGAMRNQGNLTWEARMKVIIGTAKALAYLHEAIEPKVVHRDIKSSNILIDDEFNAKVSDFGLAKLLDS 341 (508)
Q Consensus 262 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~ 341 (508)
||+++|+|.+++. ....+++..++.++.||+.||.|||++ +|+||||||+|||++.++.+||+|||++.....
T Consensus 81 Ey~~~g~L~~~i~----~~~~l~~~~~~~i~~qi~~al~~lH~~---~ivHrDikp~Nill~~~~~ikL~Dfg~~~~~~~ 153 (323)
T cd05615 81 EYVNGGDLMYHIQ----QVGKFKEPQAVFYAAEISVGLFFLHRR---GIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMV 153 (323)
T ss_pred cCCCCCcHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHeEECCCCCEEEeccccccccCC
Confidence 9999999999884 445789999999999999999999999 999999999999999999999999999875432
Q ss_pred CCCcccccccccccccCccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCCCchhcHHHHHHHHhcccccccccCCC
Q 010519 342 GESHITTRVMGTFGYVAPEYANTGMLNEKSDIYSFGVLLLEAVTGRDPVDYGRPANEVNLVEWLKMMVGTRRAEEVVDPN 421 (508)
Q Consensus 342 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 421 (508)
... ......||+.|+|||++.+..++.++|||||||++|||++|+.||..... ... ........
T Consensus 154 ~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~---~~~---~~~i~~~~--------- 217 (323)
T cd05615 154 DGV-TTRTFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGEDE---DEL---FQSIMEHN--------- 217 (323)
T ss_pred CCc-cccCccCCccccCHHHHcCCCCCCccchhhhHHHHHHHHhCCCCCCCCCH---HHH---HHHHHhCC---------
Confidence 221 23345689999999999999999999999999999999999999964321 111 11111110
Q ss_pred CCCChhHHHHHHHHHHHHHhcCCCCCCCCCH
Q 010519 422 LEVKPATRALKRSLLVALRCVDPDSEKRPKM 452 (508)
Q Consensus 422 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~ 452 (508)
... +......+.+++.+||+.||.+|++.
T Consensus 218 ~~~--p~~~~~~~~~li~~~l~~~p~~R~~~ 246 (323)
T cd05615 218 VSY--PKSLSKEAVSICKGLMTKHPSKRLGC 246 (323)
T ss_pred CCC--CccCCHHHHHHHHHHcccCHhhCCCC
Confidence 000 11123456679999999999999984
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a |
| >cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-38 Score=309.54 Aligned_cols=247 Identities=26% Similarity=0.437 Sum_probs=194.3
Q ss_pred eEeeeCceEEEEEEEc---CCCEEEEEEEcccch-hhHHHHHHHHHHHhcCCCCCceeEEEEEEeCceeeEEEeecCCCC
Q 010519 193 VLGEGGYGVVYKGRLI---NGSEVAVKKLLNNLG-QAEKEFRVEVEAIGHVRHKNLVRLLGYCIEGVHRMLVYEYVNNGN 268 (508)
Q Consensus 193 ~lg~G~~g~Vy~~~~~---~~~~vavK~~~~~~~-~~~~~~~~ei~~l~~l~h~niv~~~~~~~~~~~~~lv~E~~~~gs 268 (508)
.||+|+||.||+|.+. .+..||+|.+..... ...+.+..|+.++++++||||+++++++. ....++||||+++|+
T Consensus 2 ~ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~-~~~~~lv~e~~~~~~ 80 (257)
T cd05115 2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIGVCE-AEALMLVMEMASGGP 80 (257)
T ss_pred ccCCCCcccEEEEEEecCCCceeEEEEEcccccChHHHHHHHHHHHHHHhcCCCCeEEEEEEEc-CCCeEEEEEeCCCCC
Confidence 3899999999999764 345689998865433 33466889999999999999999999885 456789999999999
Q ss_pred HHHHHhhhhccCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCEEEcCCCcEEEEecCCccccCCCCCcc--
Q 010519 269 LEQWLHGAMRNQGNLTWEARMKVIIGTAKALAYLHEAIEPKVVHRDIKSSNILIDDEFNAKVSDFGLAKLLDSGESHI-- 346 (508)
Q Consensus 269 L~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~-- 346 (508)
|.+++.. ....+++..++.++.|++.||.|||++ +++|+||||+|||++.++.+||+|||++..........
T Consensus 81 L~~~l~~---~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~ 154 (257)
T cd05115 81 LNKFLSG---KKDEITVSNVVELMHQVSMGMKYLEGK---NFVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKA 154 (257)
T ss_pred HHHHHHh---CCCCCCHHHHHHHHHHHHHHHHHHHhc---CeeecccchheEEEcCCCcEEeccCCccccccCCccceec
Confidence 9999852 345789999999999999999999998 99999999999999999999999999998654433221
Q ss_pred cccccccccccCccccCCCCCCChhhHHHHHHHHHHHHh-CCCCCCCCCCCchhcHHHHHHHHhcccccccccCCCCCCC
Q 010519 347 TTRVMGTFGYVAPEYANTGMLNEKSDIYSFGVLLLEAVT-GRDPVDYGRPANEVNLVEWLKMMVGTRRAEEVVDPNLEVK 425 (508)
Q Consensus 347 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 425 (508)
.....++..|+|||.+.+..++.++|||||||++|||++ |..||...... .+......... ..
T Consensus 155 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~------~~~~~~~~~~~----------~~ 218 (257)
T cd05115 155 RSAGKWPLKWYAPECINFRKFSSRSDVWSYGITMWEAFSYGQKPYKKMKGP------EVMSFIEQGKR----------LD 218 (257)
T ss_pred cCCCCCCcccCCHHHHccCCCCchhhHHHHHHHHHHHhcCCCCCcCcCCHH------HHHHHHHCCCC----------CC
Confidence 111223578999999988889999999999999999996 99998643221 11211111111 11
Q ss_pred hhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhhcC
Q 010519 426 PATRALKRSLLVALRCVDPDSEKRPKMSQVVRMLEAD 462 (508)
Q Consensus 426 ~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~ 462 (508)
.+......+.+++.+||..||++||++.+|++.|+..
T Consensus 219 ~~~~~~~~l~~li~~c~~~~~~~Rp~~~~i~~~l~~~ 255 (257)
T cd05115 219 CPAECPPEMYALMKDCWIYKWEDRPNFAKVEERMRTY 255 (257)
T ss_pred CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHhhh
Confidence 1112345666799999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho |
| >PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-39 Score=311.15 Aligned_cols=253 Identities=29% Similarity=0.469 Sum_probs=200.6
Q ss_pred cccceeEeeeCceEEEEEEEcC-CCEEEEEEEcccchhhH--HHHHHHHHHHhcCCCCCceeEEEEEEeCceeeEEEeec
Q 010519 188 FSAENVLGEGGYGVVYKGRLIN-GSEVAVKKLLNNLGQAE--KEFRVEVEAIGHVRHKNLVRLLGYCIEGVHRMLVYEYV 264 (508)
Q Consensus 188 ~~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~--~~~~~ei~~l~~l~h~niv~~~~~~~~~~~~~lv~E~~ 264 (508)
|++.+.||+|+||+||+++... ++.+|+|.+........ .....|+.++++++||||+++++++.+....++||||+
T Consensus 1 y~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~v~~~~ 80 (260)
T PF00069_consen 1 YRLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIEEEEREENIREIKILRRLRHPNIVQILDVFQDDNYLYIVMEYC 80 (260)
T ss_dssp EEEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHHHHHHHHHHHHHHHHHHHTBTTBCHEEEEEEESSEEEEEEEEE
T ss_pred CEEeEEEEeCCCEEEEEEEECCCCeEEEEEEeccccccccccchhhhhhhcccccccccccccccccccccccccccccc
Confidence 6788999999999999999864 55899999876553332 23455999999999999999999999999999999999
Q ss_pred CCCCHHHHHhhhhccCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCEEEcCCCcEEEEecCCccccCCCCC
Q 010519 265 NNGNLEQWLHGAMRNQGNLTWEARMKVIIGTAKALAYLHEAIEPKVVHRDIKSSNILIDDEFNAKVSDFGLAKLLDSGES 344 (508)
Q Consensus 265 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~ 344 (508)
++++|.+++. ....+++..++.++.|+++||.|||+. +++|+||||+||++++++.++|+|||.+..... ..
T Consensus 81 ~~~~L~~~l~----~~~~~~~~~~~~~~~qi~~~L~~Lh~~---~i~H~dikp~NIl~~~~~~~~l~Dfg~~~~~~~-~~ 152 (260)
T PF00069_consen 81 PGGSLQDYLQ----KNKPLSEEEILKIAYQILEALAYLHSK---GIVHRDIKPENILLDENGEVKLIDFGSSVKLSE-NN 152 (260)
T ss_dssp TTEBHHHHHH----HHSSBBHHHHHHHHHHHHHHHHHHHHT---TEEESSBSGGGEEESTTSEEEESSGTTTEESTS-TT
T ss_pred cccccccccc----ccccccccccccccccccccccccccc---ccccccccccccccccccccccccccccccccc-cc
Confidence 9999999995 456789999999999999999999999 999999999999999999999999999986422 12
Q ss_pred cccccccccccccCccccC-CCCCCChhhHHHHHHHHHHHHhCCCCCCCCCCCchhcHHHHHHHHhcccccccccCCCCC
Q 010519 345 HITTRVMGTFGYVAPEYAN-TGMLNEKSDIYSFGVLLLEAVTGRDPVDYGRPANEVNLVEWLKMMVGTRRAEEVVDPNLE 423 (508)
Q Consensus 345 ~~~~~~~gt~~y~aPE~~~-~~~~~~~~DvwS~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 423 (508)
.......++..|+|||++. +..++.++||||||+++|+|++|..||......+. ...+.......... ....
T Consensus 153 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~~~~~~---~~~~~~~~~~~~~~----~~~~ 225 (260)
T PF00069_consen 153 ENFNPFVGTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEESNSDDQ---LEIIEKILKRPLPS----SSQQ 225 (260)
T ss_dssp SEBSSSSSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTSSHHHH---HHHHHHHHHTHHHH----HTTS
T ss_pred cccccccccccccccccccccccccccccccccccccccccccccccccccchhh---hhhhhhcccccccc----cccc
Confidence 2344567899999999998 88899999999999999999999999975411111 11111111100000 0000
Q ss_pred CChhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 010519 424 VKPATRALKRSLLVALRCVDPDSEKRPKMSQVVRM 458 (508)
Q Consensus 424 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 458 (508)
.......+.+++.+||+.||.+|||+.+++++
T Consensus 226 ---~~~~~~~l~~li~~~l~~~p~~R~~~~~l~~~ 257 (260)
T PF00069_consen 226 ---SREKSEELRDLIKKMLSKDPEQRPSAEELLKH 257 (260)
T ss_dssp ---HTTSHHHHHHHHHHHSSSSGGGSTTHHHHHTS
T ss_pred ---cchhHHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 00012667779999999999999999999975
|
Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A .... |
| >KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-39 Score=319.49 Aligned_cols=250 Identities=25% Similarity=0.384 Sum_probs=212.1
Q ss_pred CCcccceeEeeeCceEEEEEEE-cCCCEEEEEEEcccch--hhHHHHHHHHHHHhcCCCCCceeEEEEEEeCceeeEEEe
Q 010519 186 NRFSAENVLGEGGYGVVYKGRL-INGSEVAVKKLLNNLG--QAEKEFRVEVEAIGHVRHKNLVRLLGYCIEGVHRMLVYE 262 (508)
Q Consensus 186 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~--~~~~~~~~ei~~l~~l~h~niv~~~~~~~~~~~~~lv~E 262 (508)
.-|.+++.||+|-|..|-++++ ..|..||||++.+..- .....+..|+..|+-++|||||++|.+......+|+|+|
T Consensus 18 GLYDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD~~st~hlfqEVRCMKLVQHpNiVRLYEViDTQTKlyLiLE 97 (864)
T KOG4717|consen 18 GLYDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDTLSTGHLFQEVRCMKLVQHPNIVRLYEVIDTQTKLYLILE 97 (864)
T ss_pred eeehhhhhhcCCceehhhhhhhhcccceeEEEEecccccchhhhhHHHHHHHHHHHhcCcCeeeeeehhcccceEEEEEE
Confidence 4588889999999999999975 4899999999966542 334567789999999999999999999999999999999
Q ss_pred ecCCCCHHHHHhhhhccCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCEEE-cCCCcEEEEecCCccccCC
Q 010519 263 YVNNGNLEQWLHGAMRNQGNLTWEARMKVIIGTAKALAYLHEAIEPKVVHRDIKSSNILI-DDEFNAKVSDFGLAKLLDS 341 (508)
Q Consensus 263 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiH~Dlk~~NIll-~~~~~~kl~Dfgla~~~~~ 341 (508)
+-++|+|++||- +....+.+..+.+++.||+.|+.|+|.. .+|||||||+||.+ ..-|-+||+|||++..+..
T Consensus 98 LGD~GDl~DyIm---KHe~Gl~E~La~kYF~QI~~AI~YCHqL---HVVHRDLKPENVVFFEKlGlVKLTDFGFSNkf~P 171 (864)
T KOG4717|consen 98 LGDGGDLFDYIM---KHEEGLNEDLAKKYFAQIVHAISYCHQL---HVVHRDLKPENVVFFEKLGLVKLTDFGFSNKFQP 171 (864)
T ss_pred ecCCchHHHHHH---hhhccccHHHHHHHHHHHHHHHHHHhhh---hhhcccCCcceeEEeeecCceEeeeccccccCCC
Confidence 999999999996 5667799999999999999999999998 99999999999877 5678899999999998876
Q ss_pred CCCcccccccccccccCccccCCCCCC-ChhhHHHHHHHHHHHHhCCCCCCCCCCCchhcHHHHHHHHhcccccccccCC
Q 010519 342 GESHITTRVMGTFGYVAPEYANTGMLN-EKSDIYSFGVLLLEAVTGRDPVDYGRPANEVNLVEWLKMMVGTRRAEEVVDP 420 (508)
Q Consensus 342 ~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DvwS~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 420 (508)
+.. .+..||+..|-|||++.|..|+ +++||||||||||-|++|+.||......+...+ ++|
T Consensus 172 G~k--L~TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeANDSETLTm---------------ImD- 233 (864)
T KOG4717|consen 172 GKK--LTTSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEANDSETLTM---------------IMD- 233 (864)
T ss_pred cch--hhcccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCccccccchhhhhh---------------hhc-
Confidence 653 5667999999999999999887 689999999999999999999986554332211 111
Q ss_pred CCCCChhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhh
Q 010519 421 NLEVKPATRALKRSLLVALRCVDPDSEKRPKMSQVVRMLE 460 (508)
Q Consensus 421 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 460 (508)
-+...+.....++.+||..||..||.+|.|.++|...-|
T Consensus 234 -CKYtvPshvS~eCrdLI~sMLvRdPkkRAslEeI~s~~W 272 (864)
T KOG4717|consen 234 -CKYTVPSHVSKECRDLIQSMLVRDPKKRASLEEIVSTSW 272 (864)
T ss_pred -ccccCchhhhHHHHHHHHHHHhcCchhhccHHHHhcccc
Confidence 122334456778888999999999999999999998654
|
|
| >cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-38 Score=316.91 Aligned_cols=263 Identities=24% Similarity=0.330 Sum_probs=202.0
Q ss_pred CCcccceeEeeeCceEEEEEEEc-CCCEEEEEEEcccc-hhhHHHHHHHHHHHhcCCCCCceeEEEEEEeCceeeEEEee
Q 010519 186 NRFSAENVLGEGGYGVVYKGRLI-NGSEVAVKKLLNNL-GQAEKEFRVEVEAIGHVRHKNLVRLLGYCIEGVHRMLVYEY 263 (508)
Q Consensus 186 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~ei~~l~~l~h~niv~~~~~~~~~~~~~lv~E~ 263 (508)
++|++.+.||+|+||.||++.+. ++..+|+|.+.... ......+..|++++.+++||||++++++|.++...++||||
T Consensus 1 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ey 80 (308)
T cd06615 1 DDFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEIKPAIRNQIIRELKVLHECNSPYIVGFYGAFYSDGEISICMEH 80 (308)
T ss_pred CCceEEeeccCCCCeEEEEEEEcCCCeEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCEEEEEeec
Confidence 46889999999999999999875 57778888775432 23345688899999999999999999999999999999999
Q ss_pred cCCCCHHHHHhhhhccCCCccHHHHHHHHHHHHHHHHHHHh-cCCCCeEeecCCCCCEEEcCCCcEEEEecCCccccCCC
Q 010519 264 VNNGNLEQWLHGAMRNQGNLTWEARMKVIIGTAKALAYLHE-AIEPKVVHRDIKSSNILIDDEFNAKVSDFGLAKLLDSG 342 (508)
Q Consensus 264 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~yLH~-~~~~~iiH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~~ 342 (508)
+++++|.+++. ....+++..+..++.|+++||.|||+ . +++|+||||+|||+++++.+||+|||++......
T Consensus 81 ~~~~~L~~~l~----~~~~~~~~~~~~~~~~i~~~l~~lH~~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~ 153 (308)
T cd06615 81 MDGGSLDQVLK----KAGRIPENILGKISIAVLRGLTYLREKH---KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS 153 (308)
T ss_pred cCCCcHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHhhC---CEEECCCChHHEEEecCCcEEEccCCCccccccc
Confidence 99999999985 33668899999999999999999997 5 8999999999999999999999999998755332
Q ss_pred CCcccccccccccccCccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCCCchhcHHHHHHHHhccccc--------
Q 010519 343 ESHITTRVMGTFGYVAPEYANTGMLNEKSDIYSFGVLLLEAVTGRDPVDYGRPANEVNLVEWLKMMVGTRRA-------- 414 (508)
Q Consensus 343 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~-------- 414 (508)
. .....++..|+|||.+.+..++.++|+|||||++|+|++|+.||...... ....++.........
T Consensus 154 ~---~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~ 227 (308)
T cd06615 154 M---ANSFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIPPPDAK---ELEAMFGRPVSEGEAKESHRPVS 227 (308)
T ss_pred c---cccCCCCcCccChhHhcCCCCCccchHHHHHHHHHHHHhCCCCCCCcchh---hHHHhhcCccccccccCCccccc
Confidence 1 23456889999999998888999999999999999999999998643311 111111100000000
Q ss_pred ----------------ccccCCCCCCChhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhhc
Q 010519 415 ----------------EEVVDPNLEVKPATRALKRSLLVALRCVDPDSEKRPKMSQVVRMLEA 461 (508)
Q Consensus 415 ----------------~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~ 461 (508)
...........+.......+.+++.+||..||++|||+.+++++..-
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~~ 290 (308)
T cd06615 228 GHPPDSPRPMAIFELLDYIVNEPPPKLPSGAFSDEFQDFVDKCLKKNPKERADLKELTKHPFI 290 (308)
T ss_pred CCCCCccchhhHHHHHHHHhcCCCccCcCcccCHHHHHHHHHHccCChhhCcCHHHHhcChhh
Confidence 00000000000001123456789999999999999999999987654
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down |
| >PTZ00266 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-39 Score=351.77 Aligned_cols=262 Identities=22% Similarity=0.384 Sum_probs=202.9
Q ss_pred HHHHHhhCCcccceeEeeeCceEEEEEEEc-CCCEEEEEEEcccc--hhhHHHHHHHHHHHhcCCCCCceeEEEEEEeC-
Q 010519 179 RDLEIATNRFSAENVLGEGGYGVVYKGRLI-NGSEVAVKKLLNNL--GQAEKEFRVEVEAIGHVRHKNLVRLLGYCIEG- 254 (508)
Q Consensus 179 ~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~ei~~l~~l~h~niv~~~~~~~~~- 254 (508)
.+.+...++|.+.+.||.|+||+||++++. .+..+|+|.+.... ......+..|+.++..++|||||+++++|.+.
T Consensus 6 ~~ge~~l~~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l~e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~de~ 85 (1021)
T PTZ00266 6 DDGESRLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIVRYIDRFLNKA 85 (1021)
T ss_pred cCCccccCCEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEeccccCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEecC
Confidence 344556679999999999999999999875 46678888775432 23346788899999999999999999988654
Q ss_pred -ceeeEEEeecCCCCHHHHHhhhhccCCCccHHHHHHHHHHHHHHHHHHHhcCC----CCeEeecCCCCCEEEcC-----
Q 010519 255 -VHRMLVYEYVNNGNLEQWLHGAMRNQGNLTWEARMKVIIGTAKALAYLHEAIE----PKVVHRDIKSSNILIDD----- 324 (508)
Q Consensus 255 -~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~----~~iiH~Dlk~~NIll~~----- 324 (508)
..+||||||+++|+|.++|.........+++..++.|+.||+.||.|||+... .+||||||||+||||+.
T Consensus 86 ~~~lyIVMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~l 165 (1021)
T PTZ00266 86 NQKLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHI 165 (1021)
T ss_pred CCEEEEEEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCcccc
Confidence 56889999999999999997654555679999999999999999999998411 25999999999999964
Q ss_pred ------------CCcEEEEecCCccccCCCCCcccccccccccccCccccCC--CCCCChhhHHHHHHHHHHHHhCCCCC
Q 010519 325 ------------EFNAKVSDFGLAKLLDSGESHITTRVMGTFGYVAPEYANT--GMLNEKSDIYSFGVLLLEAVTGRDPV 390 (508)
Q Consensus 325 ------------~~~~kl~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~DvwS~Gvvl~elltG~~Pf 390 (508)
.+.+||+|||++....... ......||+.|+|||++.+ ..++.++||||||||||||++|..||
T Consensus 166 g~i~~~~~n~ng~~iVKLsDFGlAr~l~~~s--~~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYELLTGk~PF 243 (1021)
T PTZ00266 166 GKITAQANNLNGRPIAKIGDFGLSKNIGIES--MAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPF 243 (1021)
T ss_pred ccccccccccCCCCceEEccCCccccccccc--cccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHHHHCCCCC
Confidence 2348999999998664322 2334578999999999854 45889999999999999999999999
Q ss_pred CCCCCCchhcHHHHHHHHhcccccccccCCCCCCChhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 010519 391 DYGRPANEVNLVEWLKMMVGTRRAEEVVDPNLEVKPATRALKRSLLVALRCVDPDSEKRPKMSQVVRM 458 (508)
Q Consensus 391 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 458 (508)
..... ....+..+... +.+... .....+.+||..||..+|.+||++.|+|.+
T Consensus 244 ~~~~~-----~~qli~~lk~~--------p~lpi~---~~S~eL~dLI~~~L~~dPeeRPSa~QlL~h 295 (1021)
T PTZ00266 244 HKANN-----FSQLISELKRG--------PDLPIK---GKSKELNILIKNLLNLSAKERPSALQCLGY 295 (1021)
T ss_pred CcCCc-----HHHHHHHHhcC--------CCCCcC---CCCHHHHHHHHHHhcCChhHCcCHHHHhcc
Confidence 64322 11222222111 111111 123456779999999999999999999954
|
|
| >cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-38 Score=308.13 Aligned_cols=255 Identities=27% Similarity=0.413 Sum_probs=205.7
Q ss_pred hCCcccceeEeeeCceEEEEEEEc-CCCEEEEEEEcccchhhHHHHHHHHHHHhcCCCCCceeEEEEEEeCceeeEEEee
Q 010519 185 TNRFSAENVLGEGGYGVVYKGRLI-NGSEVAVKKLLNNLGQAEKEFRVEVEAIGHVRHKNLVRLLGYCIEGVHRMLVYEY 263 (508)
Q Consensus 185 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~ei~~l~~l~h~niv~~~~~~~~~~~~~lv~E~ 263 (508)
.++|++.+.||.|+||.||+|... ++..+++|.+..........+..|+.++++++||||+++++++.+....+++|||
T Consensus 2 ~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~l~~e~ 81 (262)
T cd06613 2 QEDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVAYFGSYLRRDKLWIVMEY 81 (262)
T ss_pred ccceEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCchhhHHHHHHHHHHHHhCCCCChhceEEEEEeCCEEEEEEeC
Confidence 368999999999999999999875 5788999988765555567888999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhhhhccCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCEEEcCCCcEEEEecCCccccCCCC
Q 010519 264 VNNGNLEQWLHGAMRNQGNLTWEARMKVIIGTAKALAYLHEAIEPKVVHRDIKSSNILIDDEFNAKVSDFGLAKLLDSGE 343 (508)
Q Consensus 264 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~~~ 343 (508)
+++++|.+++.. ....+++..++.++.|++.||.|||+. +++|+||+|+||++++++.+||+|||++.......
T Consensus 82 ~~~~~l~~~~~~---~~~~l~~~~~~~~~~ql~~~l~~lh~~---~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~ 155 (262)
T cd06613 82 CGGGSLQDIYQV---TRGPLSELQIAYVCRETLKGLAYLHET---GKIHRDIKGANILLTEDGDVKLADFGVSAQLTATI 155 (262)
T ss_pred CCCCcHHHHHHh---hccCCCHHHHHHHHHHHHHHHHHHHhC---CceecCCChhhEEECCCCCEEECccccchhhhhhh
Confidence 999999998853 335789999999999999999999998 99999999999999999999999999998654322
Q ss_pred CcccccccccccccCccccCCC---CCCChhhHHHHHHHHHHHHhCCCCCCCCCCCchhcHHHHHHHHhcccccccccCC
Q 010519 344 SHITTRVMGTFGYVAPEYANTG---MLNEKSDIYSFGVLLLEAVTGRDPVDYGRPANEVNLVEWLKMMVGTRRAEEVVDP 420 (508)
Q Consensus 344 ~~~~~~~~gt~~y~aPE~~~~~---~~~~~~DvwS~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 420 (508)
. ......++..|+|||.+.+. .++.++|+|||||++|+|++|..||....+.... ...... ....+
T Consensus 156 ~-~~~~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~~~~~~------~~~~~~----~~~~~ 224 (262)
T cd06613 156 A-KRKSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLHPMRAL------FLISKS----NFPPP 224 (262)
T ss_pred h-ccccccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHH------HHHHhc----cCCCc
Confidence 1 12335678899999999776 8899999999999999999999998643321111 111000 00001
Q ss_pred CCCCChhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 010519 421 NLEVKPATRALKRSLLVALRCVDPDSEKRPKMSQVVRM 458 (508)
Q Consensus 421 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 458 (508)
. ..........+.+++.+||..||.+|||+.+|+.+
T Consensus 225 ~--~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~ 260 (262)
T cd06613 225 K--LKDKEKWSPVFHDFIKKCLTKDPKKRPTATKLLQH 260 (262)
T ss_pred c--ccchhhhhHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 1 11122345567789999999999999999999864
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ |
| >cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-38 Score=315.53 Aligned_cols=265 Identities=25% Similarity=0.428 Sum_probs=200.4
Q ss_pred hhCCcccceeEeeeCceEEEEEEEcC---------------CCEEEEEEEcccc-hhhHHHHHHHHHHHhcCCCCCceeE
Q 010519 184 ATNRFSAENVLGEGGYGVVYKGRLIN---------------GSEVAVKKLLNNL-GQAEKEFRVEVEAIGHVRHKNLVRL 247 (508)
Q Consensus 184 ~~~~~~~~~~lg~G~~g~Vy~~~~~~---------------~~~vavK~~~~~~-~~~~~~~~~ei~~l~~l~h~niv~~ 247 (508)
..++|.+.+.||+|+||.||++...+ ...||+|.+.... ......+.+|++++++++|+|++++
T Consensus 3 ~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~ 82 (295)
T cd05097 3 PRQQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIMSRLKNPNIIRL 82 (295)
T ss_pred chHhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCcCeE
Confidence 34689999999999999999987532 1248899886543 3334578899999999999999999
Q ss_pred EEEEEeCceeeEEEeecCCCCHHHHHhhhhc--------cCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCC
Q 010519 248 LGYCIEGVHRMLVYEYVNNGNLEQWLHGAMR--------NQGNLTWEARMKVIIGTAKALAYLHEAIEPKVVHRDIKSSN 319 (508)
Q Consensus 248 ~~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~--------~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiH~Dlk~~N 319 (508)
++++......++||||+++++|.+++..... ....+++..++.++.|++.||.|||+. +++|+||||+|
T Consensus 83 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~---~i~H~dlkp~N 159 (295)
T cd05097 83 LGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASL---NFVHRDLATRN 159 (295)
T ss_pred EEEEcCCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHhc---CeeccccChhh
Confidence 9999999999999999999999999854210 112467889999999999999999999 99999999999
Q ss_pred EEEcCCCcEEEEecCCccccCCCCC-cccccccccccccCccccCCCCCCChhhHHHHHHHHHHHHh--CCCCCCCCCCC
Q 010519 320 ILIDDEFNAKVSDFGLAKLLDSGES-HITTRVMGTFGYVAPEYANTGMLNEKSDIYSFGVLLLEAVT--GRDPVDYGRPA 396 (508)
Q Consensus 320 Ill~~~~~~kl~Dfgla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~ellt--G~~Pf~~~~~~ 396 (508)
|++++++.+||+|||++........ .......++..|+|||++.+..++.++|||||||++|+|++ |..||......
T Consensus 160 ill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~~l~el~~~~~~~p~~~~~~~ 239 (295)
T cd05097 160 CLVGNHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTLCKEQPYSLLSDE 239 (295)
T ss_pred EEEcCCCcEEecccccccccccCcceeccCcCcCceeecChhhhccCCcCchhhHHHHHHHHHHHHHcCCCCCCcccChH
Confidence 9999999999999999976543221 11223345678999999998899999999999999999998 56677533221
Q ss_pred chhcHHHHHHHHhcccccccccCCCCCCChhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhh
Q 010519 397 NEVNLVEWLKMMVGTRRAEEVVDPNLEVKPATRALKRSLLVALRCVDPDSEKRPKMSQVVRMLE 460 (508)
Q Consensus 397 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 460 (508)
............... ... .......+..+.+|+.+||+.||.+|||+.+|++.|+
T Consensus 240 ---~~~~~~~~~~~~~~~-~~~-----~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~~l~ 294 (295)
T cd05097 240 ---QVIENTGEFFRNQGR-QIY-----LSQTPLCPSPVFKLMMRCWSRDIKDRPTFNKIHHFLR 294 (295)
T ss_pred ---HHHHHHHHhhhhccc-ccc-----CCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHh
Confidence 111111111111000 000 0001112346778999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including |
| >cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-39 Score=323.88 Aligned_cols=258 Identities=20% Similarity=0.252 Sum_probs=200.2
Q ss_pred CCcccceeEeeeCceEEEEEEEc-CCCEEEEEEEcccc---hhhHHHHHHHHHHHhcCCCCCceeEEEEEEeCceeeEEE
Q 010519 186 NRFSAENVLGEGGYGVVYKGRLI-NGSEVAVKKLLNNL---GQAEKEFRVEVEAIGHVRHKNLVRLLGYCIEGVHRMLVY 261 (508)
Q Consensus 186 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~ei~~l~~l~h~niv~~~~~~~~~~~~~lv~ 261 (508)
++|.+.+.||+|+||+||++++. ++..+|+|.+.... ......+..|+.++..++|+||+.+++++.+.+..|+||
T Consensus 1 d~y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~~~~~~lv~ 80 (331)
T cd05624 1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAFQDENYLYLVM 80 (331)
T ss_pred CCceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence 47999999999999999999875 57789999885422 222345788999999999999999999999999999999
Q ss_pred eecCCCCHHHHHhhhhccCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCEEEcCCCcEEEEecCCccccCC
Q 010519 262 EYVNNGNLEQWLHGAMRNQGNLTWEARMKVIIGTAKALAYLHEAIEPKVVHRDIKSSNILIDDEFNAKVSDFGLAKLLDS 341 (508)
Q Consensus 262 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~ 341 (508)
||+++|+|.+++.. ....+++..+..++.|++.||.|||+. +|+||||||+|||++.++.+||+|||++.....
T Consensus 81 Ey~~gg~L~~~l~~---~~~~l~~~~~~~~~~qi~~~L~~lH~~---~iiHrDlkp~Nill~~~~~~kl~DfG~a~~~~~ 154 (331)
T cd05624 81 DYYVGGDLLTLLSK---FEDRLPEDMARFYIAEMVLAIHSIHQL---HYVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQ 154 (331)
T ss_pred eCCCCCcHHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCchHHEEEcCCCCEEEEeccceeeccC
Confidence 99999999999963 345788999999999999999999998 999999999999999999999999999986654
Q ss_pred CCCcccccccccccccCccccCC-----CCCCChhhHHHHHHHHHHHHhCCCCCCCCCCCchhcHHHHHHHHhccccccc
Q 010519 342 GESHITTRVMGTFGYVAPEYANT-----GMLNEKSDIYSFGVLLLEAVTGRDPVDYGRPANEVNLVEWLKMMVGTRRAEE 416 (508)
Q Consensus 342 ~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~DvwS~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 416 (508)
..........|++.|+|||++.+ ..++.++|||||||+||||++|+.||..... .+..........
T Consensus 155 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~------~~~~~~i~~~~~--- 225 (331)
T cd05624 155 DGTVQSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESL------VETYGKIMNHEE--- 225 (331)
T ss_pred CCceeeccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccCCCH------HHHHHHHHcCCC---
Confidence 33322334579999999999875 5688999999999999999999999964321 111222211110
Q ss_pred ccCCCCCCCh-hHHHHHHHHHHHHHhcCCCCCC--CCCHHHHHHHhhcC
Q 010519 417 VVDPNLEVKP-ATRALKRSLLVALRCVDPDSEK--RPKMSQVVRMLEAD 462 (508)
Q Consensus 417 ~~~~~~~~~~-~~~~~~~l~~li~~cl~~dP~~--RPs~~evl~~L~~~ 462 (508)
.+..+. .......+.+++.+|+..++.+ |+++++++++..-.
T Consensus 226 ----~~~~p~~~~~~~~~~~~li~~ll~~~~~~~~~~~~~~~~~h~~f~ 270 (331)
T cd05624 226 ----RFQFPSHITDVSEEAKDLIQRLICSRERRLGQNGIEDFKKHAFFE 270 (331)
T ss_pred ----cccCCCccccCCHHHHHHHHHHccCchhhcCCCCHHHHhcCCCcC
Confidence 001000 0112455667888888866544 56899998875433
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. |
| >cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-39 Score=312.22 Aligned_cols=254 Identities=28% Similarity=0.496 Sum_probs=200.7
Q ss_pred CCcccceeEeeeCceEEEEEEEcC-C---CEEEEEEEcccc-hhhHHHHHHHHHHHhcCCCCCceeEEEEEEeCceeeEE
Q 010519 186 NRFSAENVLGEGGYGVVYKGRLIN-G---SEVAVKKLLNNL-GQAEKEFRVEVEAIGHVRHKNLVRLLGYCIEGVHRMLV 260 (508)
Q Consensus 186 ~~~~~~~~lg~G~~g~Vy~~~~~~-~---~~vavK~~~~~~-~~~~~~~~~ei~~l~~l~h~niv~~~~~~~~~~~~~lv 260 (508)
.+|.+.+.||+|+||.||+|.+.. + ..||+|.+.... ......|..|+.+++.++||||+++++++.++...++|
T Consensus 4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv 83 (269)
T cd05065 4 SCVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSRPVMII 83 (269)
T ss_pred HHeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCcCcceEEEEECCCCceEEE
Confidence 467889999999999999998753 3 359999886542 33456789999999999999999999999999999999
Q ss_pred EeecCCCCHHHHHhhhhccCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCEEEcCCCcEEEEecCCccccC
Q 010519 261 YEYVNNGNLEQWLHGAMRNQGNLTWEARMKVIIGTAKALAYLHEAIEPKVVHRDIKSSNILIDDEFNAKVSDFGLAKLLD 340 (508)
Q Consensus 261 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~Dfgla~~~~ 340 (508)
|||+++|+|.+++.. ..+.+++..++.++.|++.||.|||++ +++|+||||+||+++.++.+||+|||++....
T Consensus 84 ~e~~~~~~L~~~l~~---~~~~~~~~~~~~i~~~l~~al~~lH~~---g~~H~dl~p~nili~~~~~~kl~dfg~~~~~~ 157 (269)
T cd05065 84 TEFMENGALDSFLRQ---NDGQFTVIQLVGMLRGIAAGMKYLSEM---NYVHRDLAARNILVNSNLVCKVSDFGLSRFLE 157 (269)
T ss_pred EecCCCCcHHHHHhh---CCCCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccChheEEEcCCCcEEECCCccccccc
Confidence 999999999999863 345689999999999999999999998 99999999999999999999999999987654
Q ss_pred CCCCcc--cccc--cccccccCccccCCCCCCChhhHHHHHHHHHHHHh-CCCCCCCCCCCchhcHHHHHHHHhcccccc
Q 010519 341 SGESHI--TTRV--MGTFGYVAPEYANTGMLNEKSDIYSFGVLLLEAVT-GRDPVDYGRPANEVNLVEWLKMMVGTRRAE 415 (508)
Q Consensus 341 ~~~~~~--~~~~--~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~ 415 (508)
...... .... ..+..|+|||.+.+..++.++|||||||++|||++ |..||..... .....++ ....
T Consensus 158 ~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~e~l~~g~~p~~~~~~---~~~~~~i---~~~~--- 228 (269)
T cd05065 158 DDTSDPTYTSSLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSN---QDVINAI---EQDY--- 228 (269)
T ss_pred cCccccccccccCCCcceeecCHhHhccCcccchhhhhhhHHHHHHHhcCCCCCCCCCCH---HHHHHHH---HcCC---
Confidence 322111 1111 12457999999999999999999999999999886 9999864322 1122222 1110
Q ss_pred cccCCCCCCChhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhhc
Q 010519 416 EVVDPNLEVKPATRALKRSLLVALRCVDPDSEKRPKMSQVVRMLEA 461 (508)
Q Consensus 416 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~ 461 (508)
..+.....+..+.+++.+||..+|.+||++.+|+..|+.
T Consensus 229 -------~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 267 (269)
T cd05065 229 -------RLPPPMDCPTALHQLMLDCWQKDRNARPKFGQIVSTLDK 267 (269)
T ss_pred -------cCCCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHh
Confidence 111111223456679999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr |
| >cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-39 Score=331.22 Aligned_cols=255 Identities=25% Similarity=0.339 Sum_probs=198.3
Q ss_pred CCcccceeEeeeCceEEEEEEEc-CCCEEEEEEEcccc---hhhHHHHHHHHHHHhcCCCCCceeEEEEEEeCceeeEEE
Q 010519 186 NRFSAENVLGEGGYGVVYKGRLI-NGSEVAVKKLLNNL---GQAEKEFRVEVEAIGHVRHKNLVRLLGYCIEGVHRMLVY 261 (508)
Q Consensus 186 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~ei~~l~~l~h~niv~~~~~~~~~~~~~lv~ 261 (508)
++|++.+.||+|+||+||++... ++..||+|.+.... ......+..|+.++..++||||+++++.+.+....++||
T Consensus 1 ~~f~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~ 80 (360)
T cd05627 1 DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQDKRNLYLIM 80 (360)
T ss_pred CCceEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence 36888999999999999999875 68899999886432 223356788999999999999999999999999999999
Q ss_pred eecCCCCHHHHHhhhhccCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCEEEcCCCcEEEEecCCccccCC
Q 010519 262 EYVNNGNLEQWLHGAMRNQGNLTWEARMKVIIGTAKALAYLHEAIEPKVVHRDIKSSNILIDDEFNAKVSDFGLAKLLDS 341 (508)
Q Consensus 262 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~ 341 (508)
||+++|+|.+++. ....+++..+..++.|++.||.|||+. +|+||||||+|||++.++.+||+|||++.....
T Consensus 81 E~~~gg~L~~~l~----~~~~l~~~~~~~~~~qi~~~L~~lH~~---givHrDLkp~NIli~~~~~vkL~DfG~~~~~~~ 153 (360)
T cd05627 81 EFLPGGDMMTLLM----KKDTLSEEATQFYIAETVLAIDAIHQL---GFIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKK 153 (360)
T ss_pred eCCCCccHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEccCCCHHHEEECCCCCEEEeeccCCccccc
Confidence 9999999999984 456789999999999999999999999 999999999999999999999999999875432
Q ss_pred CCC----------------------------------cccccccccccccCccccCCCCCCChhhHHHHHHHHHHHHhCC
Q 010519 342 GES----------------------------------HITTRVMGTFGYVAPEYANTGMLNEKSDIYSFGVLLLEAVTGR 387 (508)
Q Consensus 342 ~~~----------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltG~ 387 (508)
... ......+||+.|+|||++.+..++.++|||||||+||||++|+
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvilyel~tG~ 233 (360)
T cd05627 154 AHRTEFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGY 233 (360)
T ss_pred ccccccccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCCCCCCcceeccccceeeecccCC
Confidence 110 0112357999999999999999999999999999999999999
Q ss_pred CCCCCCCCCchhcHHHHHHHHhcccccccccCCCCCCChhHHHHHHHHHHHHHhcCCCCCCCCC---HHHHHHHhhc
Q 010519 388 DPVDYGRPANEVNLVEWLKMMVGTRRAEEVVDPNLEVKPATRALKRSLLVALRCVDPDSEKRPK---MSQVVRMLEA 461 (508)
Q Consensus 388 ~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs---~~evl~~L~~ 461 (508)
.||....+. .......... ..+..+........+.+++.+|+ .||.+|++ +.++++|-.-
T Consensus 234 ~Pf~~~~~~------~~~~~i~~~~-------~~~~~p~~~~~s~~~~~li~~l~-~~p~~R~~~~~~~ei~~hp~f 296 (360)
T cd05627 234 PPFCSETPQ------ETYRKVMNWK-------ETLVFPPEVPISEKAKDLILRFC-TDSENRIGSNGVEEIKSHPFF 296 (360)
T ss_pred CCCCCCCHH------HHHHHHHcCC-------CceecCCCCCCCHHHHHHHHHhc-cChhhcCCCCCHHHHhcCCCC
Confidence 999644321 1111111110 00111111112334555777766 49999985 7788877543
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul |
| >cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-38 Score=306.62 Aligned_cols=248 Identities=27% Similarity=0.459 Sum_probs=198.5
Q ss_pred eeEeeeCceEEEEEEEcCCCEEEEEEEcccchh-hHHHHHHHHHHHhcCCCCCceeEEEEEEeCceeeEEEeecCCCCHH
Q 010519 192 NVLGEGGYGVVYKGRLINGSEVAVKKLLNNLGQ-AEKEFRVEVEAIGHVRHKNLVRLLGYCIEGVHRMLVYEYVNNGNLE 270 (508)
Q Consensus 192 ~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~-~~~~~~~ei~~l~~l~h~niv~~~~~~~~~~~~~lv~E~~~~gsL~ 270 (508)
++||+|+||.||++.+.+++.|++|.+...... ....+..|++++++++|+||+++++++.+....++||||+++++|.
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~l~ 80 (251)
T cd05041 1 EKIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVCVQKQPIYIVMELVPGGSLL 80 (251)
T ss_pred CccccCCCceEEEEEEeCCCcEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeEEEEEEEecCCCeEEEEEcCCCCcHH
Confidence 368999999999999877999999988654433 4567889999999999999999999999999999999999999999
Q ss_pred HHHhhhhccCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCEEEcCCCcEEEEecCCccccCCCCCccc-cc
Q 010519 271 QWLHGAMRNQGNLTWEARMKVIIGTAKALAYLHEAIEPKVVHRDIKSSNILIDDEFNAKVSDFGLAKLLDSGESHIT-TR 349 (508)
Q Consensus 271 ~~l~~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~~-~~ 349 (508)
+++.. ....+++..++.++.+++.||.|||++ +++||||+|+|||++.++.+||+|||++........... ..
T Consensus 81 ~~l~~---~~~~~~~~~~~~~~~~~~~~l~~lH~~---~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~ 154 (251)
T cd05041 81 TFLRK---KKNRLTVKKLLQMSLDAAAGMEYLESK---NCIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGL 154 (251)
T ss_pred HHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHhC---CEehhhcCcceEEEcCCCcEEEeeccccccccCCcceecccc
Confidence 99853 344688999999999999999999999 999999999999999999999999999986543221111 11
Q ss_pred ccccccccCccccCCCCCCChhhHHHHHHHHHHHHh-CCCCCCCCCCCchhcHHHHHHHHhcccccccccCCCCCCChhH
Q 010519 350 VMGTFGYVAPEYANTGMLNEKSDIYSFGVLLLEAVT-GRDPVDYGRPANEVNLVEWLKMMVGTRRAEEVVDPNLEVKPAT 428 (508)
Q Consensus 350 ~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 428 (508)
..++..|+|||.+.+..++.++|+|||||++|||++ |..||....... ........ .....+.
T Consensus 155 ~~~~~~y~~PE~~~~~~~~~~~Di~slG~i~~~l~t~~~~p~~~~~~~~------~~~~~~~~----------~~~~~~~ 218 (251)
T cd05041 155 KQIPIKWTAPEALNYGRYTSESDVWSYGILLWETFSLGDTPYPGMSNQQ------TRERIESG----------YRMPAPQ 218 (251)
T ss_pred CcceeccCChHhhccCCCCcchhHHHHHHHHHHHHhccCCCCccCCHHH------HHHHHhcC----------CCCCCCc
Confidence 233567999999998899999999999999999999 888885443211 11111100 0111112
Q ss_pred HHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhhc
Q 010519 429 RALKRSLLVALRCVDPDSEKRPKMSQVVRMLEA 461 (508)
Q Consensus 429 ~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~ 461 (508)
..+..+.+++.+||..+|.+|||+.|+++.|+.
T Consensus 219 ~~~~~~~~li~~~l~~~p~~Rp~~~ell~~l~~ 251 (251)
T cd05041 219 LCPEEIYRLMLQCWAYDPENRPSFSEIYNELQI 251 (251)
T ss_pred cCCHHHHHHHHHHhccChhhCcCHHHHHHHhhC
Confidence 234567789999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k |
| >cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-39 Score=318.54 Aligned_cols=262 Identities=26% Similarity=0.437 Sum_probs=205.1
Q ss_pred HHhhCCcccceeEeeeCceEEEEEEEc--------CCCEEEEEEEcccc-hhhHHHHHHHHHHHhcC-CCCCceeEEEEE
Q 010519 182 EIATNRFSAENVLGEGGYGVVYKGRLI--------NGSEVAVKKLLNNL-GQAEKEFRVEVEAIGHV-RHKNLVRLLGYC 251 (508)
Q Consensus 182 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~--------~~~~vavK~~~~~~-~~~~~~~~~ei~~l~~l-~h~niv~~~~~~ 251 (508)
.+...+|.+.+.||+|+||.||++++. ++..+|+|.+.... ......+..|+.+++.+ +||||+++++++
T Consensus 11 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~ 90 (304)
T cd05101 11 EFSRDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGAC 90 (304)
T ss_pred cccHHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeecccccchHHHHHHHHHHHHHHhhccCCCchheeEEE
Confidence 345568899999999999999999742 23468999876443 33346788899999999 899999999999
Q ss_pred EeCceeeEEEeecCCCCHHHHHhhhhc------------cCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCC
Q 010519 252 IEGVHRMLVYEYVNNGNLEQWLHGAMR------------NQGNLTWEARMKVIIGTAKALAYLHEAIEPKVVHRDIKSSN 319 (508)
Q Consensus 252 ~~~~~~~lv~E~~~~gsL~~~l~~~~~------------~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiH~Dlk~~N 319 (508)
......++||||+++|+|.+++..... ....+++..++.++.||+.||.|||++ +++||||||+|
T Consensus 91 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~---givH~dlkp~N 167 (304)
T cd05101 91 TQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQ---KCIHRDLAARN 167 (304)
T ss_pred ecCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHHC---Ceeecccccce
Confidence 999999999999999999999964311 123578889999999999999999999 99999999999
Q ss_pred EEEcCCCcEEEEecCCccccCCCCCc-ccccccccccccCccccCCCCCCChhhHHHHHHHHHHHHh-CCCCCCCCCCCc
Q 010519 320 ILIDDEFNAKVSDFGLAKLLDSGESH-ITTRVMGTFGYVAPEYANTGMLNEKSDIYSFGVLLLEAVT-GRDPVDYGRPAN 397 (508)
Q Consensus 320 Ill~~~~~~kl~Dfgla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~ellt-G~~Pf~~~~~~~ 397 (508)
||+++++.+||+|||+++........ ......+++.|+|||++.+..++.++||||||+++|+|++ |..||....
T Consensus 168 ili~~~~~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~--- 244 (304)
T cd05101 168 VLVTENNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIP--- 244 (304)
T ss_pred EEEcCCCcEEECCCccceecccccccccccCCCCCceeeCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCC---
Confidence 99999999999999999866433221 1222345678999999998889999999999999999998 778875321
Q ss_pred hhcHHHHHHHHhcccccccccCCCCCCChhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhhcC
Q 010519 398 EVNLVEWLKMMVGTRRAEEVVDPNLEVKPATRALKRSLLVALRCVDPDSEKRPKMSQVVRMLEAD 462 (508)
Q Consensus 398 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~ 462 (508)
..++.......... ..+......+..++.+||+.+|.+|||+.++++.|+..
T Consensus 245 ---~~~~~~~~~~~~~~----------~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~l~~l~~~ 296 (304)
T cd05101 245 ---VEELFKLLKEGHRM----------DKPANCTNELYMMMRDCWHAIPSHRPTFKQLVEDLDRI 296 (304)
T ss_pred ---HHHHHHHHHcCCcC----------CCCCCCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHH
Confidence 22222222211110 01112345566799999999999999999999999764
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-38 Score=308.15 Aligned_cols=250 Identities=34% Similarity=0.522 Sum_probs=202.2
Q ss_pred eeEeeeCceEEEEEEEcC----CCEEEEEEEcccchhh-HHHHHHHHHHHhcCCCCCceeEEEEEEeCceeeEEEeecCC
Q 010519 192 NVLGEGGYGVVYKGRLIN----GSEVAVKKLLNNLGQA-EKEFRVEVEAIGHVRHKNLVRLLGYCIEGVHRMLVYEYVNN 266 (508)
Q Consensus 192 ~~lg~G~~g~Vy~~~~~~----~~~vavK~~~~~~~~~-~~~~~~ei~~l~~l~h~niv~~~~~~~~~~~~~lv~E~~~~ 266 (508)
+.||+|+||.||+|.... +..+++|.+....... ...+..|++.+..++|+||+++++++......++||||+++
T Consensus 1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (262)
T cd00192 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVRLLGVCTEEEPLYLVLEYMEG 80 (262)
T ss_pred CccccCCceEEEEEEEecCCCCCceEEeEeeccccchhHHHHHHHHHHHHhhcCCCChheeeeeecCCCceEEEEEeccC
Confidence 469999999999998754 7889999886554332 56788999999999999999999999998999999999999
Q ss_pred CCHHHHHhhhhcc-----CCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCEEEcCCCcEEEEecCCccccCC
Q 010519 267 GNLEQWLHGAMRN-----QGNLTWEARMKVIIGTAKALAYLHEAIEPKVVHRDIKSSNILIDDEFNAKVSDFGLAKLLDS 341 (508)
Q Consensus 267 gsL~~~l~~~~~~-----~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~ 341 (508)
++|.+++...... ...+++..++.++.|++.||.|||++ +++|+||+|+||++++++.+||+|||.+.....
T Consensus 81 ~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~---~i~H~di~p~nili~~~~~~~l~dfg~~~~~~~ 157 (262)
T cd00192 81 GDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASK---KFVHRDLAARNCLVGEDLVVKISDFGLSRDVYD 157 (262)
T ss_pred CcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHcC---CcccCccCcceEEECCCCcEEEccccccccccc
Confidence 9999999643111 47799999999999999999999998 999999999999999999999999999987654
Q ss_pred CCC-cccccccccccccCccccCCCCCCChhhHHHHHHHHHHHHh-CCCCCCCCCCCchhcHHHHHHHHhcccccccccC
Q 010519 342 GES-HITTRVMGTFGYVAPEYANTGMLNEKSDIYSFGVLLLEAVT-GRDPVDYGRPANEVNLVEWLKMMVGTRRAEEVVD 419 (508)
Q Consensus 342 ~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 419 (508)
... .......++..|+|||.+.+..++.++|||||||++|+|++ |..||..... .+.........
T Consensus 158 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~------~~~~~~~~~~~------- 224 (262)
T cd00192 158 DDYYRKKTGGKLPIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSN------EEVLEYLRKGY------- 224 (262)
T ss_pred ccccccccCCCcCccccCHHHhccCCcchhhccHHHHHHHHHHHhcCCCCCCCCCH------HHHHHHHHcCC-------
Confidence 321 12333457889999999988889999999999999999999 6999865421 12222222110
Q ss_pred CCCCCChhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhh
Q 010519 420 PNLEVKPATRALKRSLLVALRCVDPDSEKRPKMSQVVRMLE 460 (508)
Q Consensus 420 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 460 (508)
....+......+.+++.+||+.||.+|||+.+++++|+
T Consensus 225 ---~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~ 262 (262)
T cd00192 225 ---RLPKPEYCPDELYELMLSCWQLDPEDRPTFSELVERLE 262 (262)
T ss_pred ---CCCCCccCChHHHHHHHHHccCCcccCcCHHHHHHhhC
Confidence 11111222456778999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan |
| >cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-39 Score=325.07 Aligned_cols=243 Identities=25% Similarity=0.295 Sum_probs=188.4
Q ss_pred eeEeeeCceEEEEEEEc-CCCEEEEEEEcccch---hhHHHHHHHH-HHHhcCCCCCceeEEEEEEeCceeeEEEeecCC
Q 010519 192 NVLGEGGYGVVYKGRLI-NGSEVAVKKLLNNLG---QAEKEFRVEV-EAIGHVRHKNLVRLLGYCIEGVHRMLVYEYVNN 266 (508)
Q Consensus 192 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~ei-~~l~~l~h~niv~~~~~~~~~~~~~lv~E~~~~ 266 (508)
+.||+|+||+||+|++. +++.+|+|.+..... .....+..|. .+++.++||||+++++++......++||||+++
T Consensus 1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~~~~~lv~e~~~~ 80 (325)
T cd05602 1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYING 80 (325)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEcCCeEEEEEeCCCC
Confidence 46999999999999876 567899998864321 1222333344 456788999999999999999999999999999
Q ss_pred CCHHHHHhhhhccCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCEEEcCCCcEEEEecCCccccCCCCCcc
Q 010519 267 GNLEQWLHGAMRNQGNLTWEARMKVIIGTAKALAYLHEAIEPKVVHRDIKSSNILIDDEFNAKVSDFGLAKLLDSGESHI 346 (508)
Q Consensus 267 gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~ 346 (508)
|+|.+++. ....+.+..+..++.||+.||.|||+. +|+||||||+|||++.++.+||+|||++....... ..
T Consensus 81 ~~L~~~~~----~~~~~~~~~~~~~~~qi~~~L~~lH~~---giiHrDlkp~Nili~~~~~~kl~DfG~a~~~~~~~-~~ 152 (325)
T cd05602 81 GELFYHLQ----RERCFLEPRARFYAAEIASALGYLHSL---NIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHN-GT 152 (325)
T ss_pred CcHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHeEECCCCCEEEccCCCCcccccCC-CC
Confidence 99999984 345678888889999999999999999 99999999999999999999999999997543222 12
Q ss_pred cccccccccccCccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCCCchhcHHHHHHHHhcccccccccCCCCCCCh
Q 010519 347 TTRVMGTFGYVAPEYANTGMLNEKSDIYSFGVLLLEAVTGRDPVDYGRPANEVNLVEWLKMMVGTRRAEEVVDPNLEVKP 426 (508)
Q Consensus 347 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 426 (508)
....+||+.|+|||++.+..++.++|||||||++|+|++|..||..... .+........ ....
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~------~~~~~~i~~~---------~~~~-- 215 (325)
T cd05602 153 TSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNT------AEMYDNILNK---------PLQL-- 215 (325)
T ss_pred cccccCCccccCHHHHcCCCCCCccccccccHHHHHHhcCCCCCCCCCH------HHHHHHHHhC---------CcCC--
Confidence 3445799999999999999999999999999999999999999964321 1111121111 0111
Q ss_pred hHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHh
Q 010519 427 ATRALKRSLLVALRCVDPDSEKRPKMSQVVRML 459 (508)
Q Consensus 427 ~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L 459 (508)
.......+.+++.+||+.||.+||++.+.+..+
T Consensus 216 ~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~i 248 (325)
T cd05602 216 KPNITNSARHLLEGLLQKDRTKRLGAKDDFMEI 248 (325)
T ss_pred CCCCCHHHHHHHHHHcccCHHHCCCCCCCHHHH
Confidence 111234556688999999999999987544333
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt |
| >cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-39 Score=319.74 Aligned_cols=265 Identities=23% Similarity=0.344 Sum_probs=200.4
Q ss_pred CCcccceeEeeeCceEEEEEEEc-CCCEEEEEEEcccc-hhhHHHHHHHHHHHhcCCCCCceeEEEEEEeCceeeEEEee
Q 010519 186 NRFSAENVLGEGGYGVVYKGRLI-NGSEVAVKKLLNNL-GQAEKEFRVEVEAIGHVRHKNLVRLLGYCIEGVHRMLVYEY 263 (508)
Q Consensus 186 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~ei~~l~~l~h~niv~~~~~~~~~~~~~lv~E~ 263 (508)
++|.+.+.||+|+||+||+|++. ++..||+|.+.... ......+.+|+.++++++||||+++++++..+...++||||
T Consensus 6 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 85 (309)
T cd07872 6 ETYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIVHTDKSLTLVFEY 85 (309)
T ss_pred CceEEEEEecccCCEEEEEEEecCCCCeEEEEEeeccccCCcchhHHHHHHHHHhCCCCCcceEEEEEeeCCeEEEEEeC
Confidence 57999999999999999999875 67889999886433 22234567799999999999999999999999999999999
Q ss_pred cCCCCHHHHHhhhhccCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCEEEcCCCcEEEEecCCccccCCCC
Q 010519 264 VNNGNLEQWLHGAMRNQGNLTWEARMKVIIGTAKALAYLHEAIEPKVVHRDIKSSNILIDDEFNAKVSDFGLAKLLDSGE 343 (508)
Q Consensus 264 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~~~ 343 (508)
+++ +|.+++.. ....+++..+..++.||+.||.|||+. +|+||||||+|||++.++.+||+|||++.......
T Consensus 86 ~~~-~l~~~~~~---~~~~~~~~~~~~~~~qi~~aL~~lH~~---~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~ 158 (309)
T cd07872 86 LDK-DLKQYMDD---CGNIMSMHNVKIFLYQILRGLAYCHRR---KVLHRDLKPQNLLINERGELKLADFGLARAKSVPT 158 (309)
T ss_pred CCC-CHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEECccccceecCCCc
Confidence 975 88888752 345688899999999999999999998 99999999999999999999999999997653322
Q ss_pred CcccccccccccccCccccCC-CCCCChhhHHHHHHHHHHHHhCCCCCCCCCCCchhcHHHHHHHHhcccc---------
Q 010519 344 SHITTRVMGTFGYVAPEYANT-GMLNEKSDIYSFGVLLLEAVTGRDPVDYGRPANEVNLVEWLKMMVGTRR--------- 413 (508)
Q Consensus 344 ~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwS~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~--------- 413 (508)
. ......+++.|+|||++.+ ..++.++|||||||++|+|++|+.||......+.... +....+...
T Consensus 159 ~-~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~ 234 (309)
T cd07872 159 K-TYSNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHL---IFRLLGTPTEETWPGISS 234 (309)
T ss_pred c-ccccccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHH---HHHHhCCCCHHHHhhhcc
Confidence 1 1233467899999998865 5688999999999999999999999965433221111 111111000
Q ss_pred ---cccccCCCCCC----ChhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhhc
Q 010519 414 ---AEEVVDPNLEV----KPATRALKRSLLVALRCVDPDSEKRPKMSQVVRMLEA 461 (508)
Q Consensus 414 ---~~~~~~~~~~~----~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~ 461 (508)
......+.... .........+.+|+.+||+.||.+|||+.|++++-+-
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~~~ 289 (309)
T cd07872 235 NDEFKNYNFPKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRISAEEAMKHAYF 289 (309)
T ss_pred hhhhhhhhcCccCCCchhhhccCCCHHHHHHHHHhccCChhhCCCHHHHhcChhh
Confidence 00000000000 0001123456789999999999999999999986544
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play |
| >cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-39 Score=318.76 Aligned_cols=257 Identities=26% Similarity=0.408 Sum_probs=199.4
Q ss_pred hCCcccceeEeeeCceEEEEEEEc-CCC--EEEEEEEcccc-hhhHHHHHHHHHHHhcC-CCCCceeEEEEEEeCceeeE
Q 010519 185 TNRFSAENVLGEGGYGVVYKGRLI-NGS--EVAVKKLLNNL-GQAEKEFRVEVEAIGHV-RHKNLVRLLGYCIEGVHRML 259 (508)
Q Consensus 185 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~--~vavK~~~~~~-~~~~~~~~~ei~~l~~l-~h~niv~~~~~~~~~~~~~l 259 (508)
.++|++.+.||+|+||.||+|.+. ++. .+++|.+.... ......+..|++++.++ +||||+++++++..+...++
T Consensus 6 ~~~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~~~~~~l 85 (303)
T cd05088 6 WNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYL 85 (303)
T ss_pred hhhceeeeeecCCCCceEEEEEEccCCceeeEEEEEecccCCHHHHHHHHHHHHHHHHhcCCCCcceEEEEECCCCCceE
Confidence 358899999999999999999875 444 35777765432 33446788899999999 89999999999999999999
Q ss_pred EEeecCCCCHHHHHhhhhc------------cCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCEEEcCCCc
Q 010519 260 VYEYVNNGNLEQWLHGAMR------------NQGNLTWEARMKVIIGTAKALAYLHEAIEPKVVHRDIKSSNILIDDEFN 327 (508)
Q Consensus 260 v~E~~~~gsL~~~l~~~~~------------~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiH~Dlk~~NIll~~~~~ 327 (508)
||||+++|+|.++++.... ....+++..++.++.|++.||+|||+. +++||||||+|||+++++.
T Consensus 86 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~---gi~H~dlkp~Nili~~~~~ 162 (303)
T cd05088 86 AIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK---QFIHRDLAARNILVGENYV 162 (303)
T ss_pred EEEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHhC---CccccccchheEEecCCCc
Confidence 9999999999999964311 123578999999999999999999998 9999999999999999999
Q ss_pred EEEEecCCccccCCCCCcccccccccccccCccccCCCCCCChhhHHHHHHHHHHHHh-CCCCCCCCCCCchhcHHHHHH
Q 010519 328 AKVSDFGLAKLLDSGESHITTRVMGTFGYVAPEYANTGMLNEKSDIYSFGVLLLEAVT-GRDPVDYGRPANEVNLVEWLK 406 (508)
Q Consensus 328 ~kl~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~ellt-G~~Pf~~~~~~~~~~~~~~~~ 406 (508)
+||+|||++....... ......++..|+|||++.+..++.++|||||||++|||++ |..||..... .+...
T Consensus 163 ~kl~dfg~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~------~~~~~ 234 (303)
T cd05088 163 AKIADFGLSRGQEVYV--KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTC------AELYE 234 (303)
T ss_pred EEeCccccCcccchhh--hcccCCCcccccCHHHHhccCCcccccchhhhhHHHHHHhcCCCCcccCCh------HHHHH
Confidence 9999999986432111 1111234567999999988889999999999999999998 9999853322 11122
Q ss_pred HHhcccccccccCCCCCCChhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhhcC
Q 010519 407 MMVGTRRAEEVVDPNLEVKPATRALKRSLLVALRCVDPDSEKRPKMSQVVRMLEAD 462 (508)
Q Consensus 407 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~ 462 (508)
....... .. .+......+.+|+.+||+.+|.+||++.+++.+|+..
T Consensus 235 ~~~~~~~------~~----~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~l~~~ 280 (303)
T cd05088 235 KLPQGYR------LE----KPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRM 280 (303)
T ss_pred HHhcCCc------CC----CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence 2111100 00 0111234567799999999999999999999998754
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A |
| >cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-38 Score=323.66 Aligned_cols=265 Identities=25% Similarity=0.296 Sum_probs=197.7
Q ss_pred hCCcccceeEeeeCceEEEEEEEc-CCCEEEEEEEcccc--hhhHHHHHHHHHHHhcCCCCCceeEEEEEEeCc------
Q 010519 185 TNRFSAENVLGEGGYGVVYKGRLI-NGSEVAVKKLLNNL--GQAEKEFRVEVEAIGHVRHKNLVRLLGYCIEGV------ 255 (508)
Q Consensus 185 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~ei~~l~~l~h~niv~~~~~~~~~~------ 255 (508)
.++|.+.+.||+|+||.||++.+. .|..||+|++.... ......+.+|+.+++.++||||+++++++....
T Consensus 20 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 99 (359)
T cd07876 20 LKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEEFQ 99 (359)
T ss_pred hhceEEEEEeecCCCEEEEEEEEcCCCceeEEEEecccccchhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCccccc
Confidence 468999999999999999999875 68899999985432 233456778999999999999999999986543
Q ss_pred eeeEEEeecCCCCHHHHHhhhhccCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCEEEcCCCcEEEEecCC
Q 010519 256 HRMLVYEYVNNGNLEQWLHGAMRNQGNLTWEARMKVIIGTAKALAYLHEAIEPKVVHRDIKSSNILIDDEFNAKVSDFGL 335 (508)
Q Consensus 256 ~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~Dfgl 335 (508)
..|+||||+++ +|.++++ ..+++..+..++.||+.||.|||++ +|+||||||+|||++.++.+||+|||+
T Consensus 100 ~~~lv~e~~~~-~l~~~~~------~~~~~~~~~~~~~qi~~~L~~LH~~---~ivHrDlkp~NIl~~~~~~~kl~Dfg~ 169 (359)
T cd07876 100 DVYLVMELMDA-NLCQVIH------MELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGL 169 (359)
T ss_pred eeEEEEeCCCc-CHHHHHh------ccCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEECCCCCEEEecCCC
Confidence 46899999965 6777663 2377888999999999999999999 999999999999999999999999999
Q ss_pred ccccCCCCCcccccccccccccCccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCCCchh------------cHHH
Q 010519 336 AKLLDSGESHITTRVMGTFGYVAPEYANTGMLNEKSDIYSFGVLLLEAVTGRDPVDYGRPANEV------------NLVE 403 (508)
Q Consensus 336 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltG~~Pf~~~~~~~~~------------~~~~ 403 (508)
++...... ......||+.|+|||++.+..++.++|||||||++|+|++|+.||......... ....
T Consensus 170 a~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 247 (359)
T cd07876 170 ARTACTNF--MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIEQLGTPSAEFMN 247 (359)
T ss_pred ccccccCc--cCCCCcccCCCCCchhccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCcHHHHH
Confidence 97643322 233457899999999999999999999999999999999999999744321100 0000
Q ss_pred ----HHHHHhccc-ccc-----cccCCCCCC----ChhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhhcC
Q 010519 404 ----WLKMMVGTR-RAE-----EVVDPNLEV----KPATRALKRSLLVALRCVDPDSEKRPKMSQVVRMLEAD 462 (508)
Q Consensus 404 ----~~~~~~~~~-~~~-----~~~~~~~~~----~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~ 462 (508)
......... ... ... +.... .........+.+|+.+||..||.+|||+.|++++-+-.
T Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~~~ 319 (359)
T cd07876 248 RLQPTVRNYVENRPQYPGISFEELF-PDWIFPSESERDKLKTSQARDLLSKMLVIDPDKRISVDEALRHPYIT 319 (359)
T ss_pred HHHHHHHHHHhhCCCCCCcchhhhc-cccccccccccccccchhHHHHHHHHhccCcccCCCHHHHhcCchhh
Confidence 000000000 000 000 00000 00011134567899999999999999999999976543
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-38 Score=308.26 Aligned_cols=247 Identities=30% Similarity=0.479 Sum_probs=195.3
Q ss_pred eeEeeeCceEEEEEEEcC----CCEEEEEEEcccch-hhHHHHHHHHHHHhcCCCCCceeEEEEEEeCceeeEEEeecCC
Q 010519 192 NVLGEGGYGVVYKGRLIN----GSEVAVKKLLNNLG-QAEKEFRVEVEAIGHVRHKNLVRLLGYCIEGVHRMLVYEYVNN 266 (508)
Q Consensus 192 ~~lg~G~~g~Vy~~~~~~----~~~vavK~~~~~~~-~~~~~~~~ei~~l~~l~h~niv~~~~~~~~~~~~~lv~E~~~~ 266 (508)
+.||+|+||.||+|.+.. +..+|+|.+..... .....+..|+.+++.++||||+++++++. ....++||||+++
T Consensus 1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~v~e~~~~ 79 (257)
T cd05060 1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLIGVCK-GEPLMLVMELAPL 79 (257)
T ss_pred CccCccCceeEEEeEeeccCCCcceEEEEecccccchHHHHHHHHHHHHHHhcCCCCeeeEEEEEc-CCceEEEEEeCCC
Confidence 469999999999997632 26899998865543 34567888999999999999999999876 4567899999999
Q ss_pred CCHHHHHhhhhccCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCEEEcCCCcEEEEecCCccccCCCCCcc
Q 010519 267 GNLEQWLHGAMRNQGNLTWEARMKVIIGTAKALAYLHEAIEPKVVHRDIKSSNILIDDEFNAKVSDFGLAKLLDSGESHI 346 (508)
Q Consensus 267 gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~ 346 (508)
|+|.+++. ....+++..++.++.|++.||.|||.. +++|+||||+|||++.++.+||+|||+++.........
T Consensus 80 ~~L~~~l~----~~~~~~~~~~~~~~~qi~~~l~~lh~~---~i~H~di~p~nili~~~~~~kl~df~~~~~~~~~~~~~ 152 (257)
T cd05060 80 GPLLKYLK----KRREIPVSDLKELAHQVAMGMAYLESK---HFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYY 152 (257)
T ss_pred CcHHHHHH----hCCCCCHHHHHHHHHHHHHHHHHHhhc---CeeccCcccceEEEcCCCcEEeccccccceeecCCccc
Confidence 99999995 334789999999999999999999998 99999999999999999999999999998664433221
Q ss_pred c--ccccccccccCccccCCCCCCChhhHHHHHHHHHHHHh-CCCCCCCCCCCchhcHHHHHHHHhcccccccccCCCCC
Q 010519 347 T--TRVMGTFGYVAPEYANTGMLNEKSDIYSFGVLLLEAVT-GRDPVDYGRPANEVNLVEWLKMMVGTRRAEEVVDPNLE 423 (508)
Q Consensus 347 ~--~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 423 (508)
. ....++..|+|||.+.+..++.++|||||||++|+|++ |..||..... ..+..++ .....
T Consensus 153 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~~g~~p~~~~~~---~~~~~~~---~~~~~---------- 216 (257)
T cd05060 153 RATTAGRWPLKWYAPECINYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEMKG---AEVIAML---ESGER---------- 216 (257)
T ss_pred ccccCccccccccCHHHhcCCCCCccchHHHHHHHHHHHHcCCCCCcccCCH---HHHHHHH---HcCCc----------
Confidence 1 11223467999999999899999999999999999998 9999864322 1222221 11111
Q ss_pred CChhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhhcC
Q 010519 424 VKPATRALKRSLLVALRCVDPDSEKRPKMSQVVRMLEAD 462 (508)
Q Consensus 424 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~ 462 (508)
...+......+.+++.+||+.||.+||++.++++.|+..
T Consensus 217 ~~~~~~~~~~l~~li~~cl~~~p~~Rp~~~~l~~~l~~~ 255 (257)
T cd05060 217 LPRPEECPQEIYSIMLSCWKYRPEDRPTFSELESTFRRD 255 (257)
T ss_pred CCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHhc
Confidence 011112234667799999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi |
| >cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-38 Score=308.35 Aligned_cols=251 Identities=28% Similarity=0.426 Sum_probs=204.7
Q ss_pred hCCcccceeEeeeCceEEEEEEEcC-CCEEEEEEEcccchhhHHHHHHHHHHHhcCCCCCceeEEEEEEeCceeeEEEee
Q 010519 185 TNRFSAENVLGEGGYGVVYKGRLIN-GSEVAVKKLLNNLGQAEKEFRVEVEAIGHVRHKNLVRLLGYCIEGVHRMLVYEY 263 (508)
Q Consensus 185 ~~~~~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~ei~~l~~l~h~niv~~~~~~~~~~~~~lv~E~ 263 (508)
.++|++.+.||.|+||.||+|.+.. +..+++|.+..... ...+.+|+++++.++||||+++++++.+....++++||
T Consensus 2 ~~~y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~--~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~ 79 (256)
T cd06612 2 EEVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEED--LQEIIKEISILKQCDSPYIVKYYGSYFKNTDLWIVMEY 79 (256)
T ss_pred cccchhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHHH--HHHHHHHHHHHHhCCCCcEeeeeeeeecCCcEEEEEec
Confidence 3579999999999999999998864 78899998865433 56788999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhhhhccCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCEEEcCCCcEEEEecCCccccCCCC
Q 010519 264 VNNGNLEQWLHGAMRNQGNLTWEARMKVIIGTAKALAYLHEAIEPKVVHRDIKSSNILIDDEFNAKVSDFGLAKLLDSGE 343 (508)
Q Consensus 264 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~~~ 343 (508)
+++++|.+++.. ....+++..++.++.|++.||.|||+. +++|+||+|+||++++++.+||+|||++.......
T Consensus 80 ~~~~~L~~~l~~---~~~~l~~~~~~~~~~~l~~~l~~lh~~---~i~H~dl~~~ni~~~~~~~~~l~dfg~~~~~~~~~ 153 (256)
T cd06612 80 CGAGSVSDIMKI---TNKTLTEEEIAAILYQTLKGLEYLHSN---KKIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTM 153 (256)
T ss_pred CCCCcHHHHHHh---CccCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCcceEEECCCCcEEEcccccchhcccCc
Confidence 999999999852 346789999999999999999999999 99999999999999999999999999998665432
Q ss_pred CcccccccccccccCccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCCCchhcHHHHHHHHhcccccccccCCCCC
Q 010519 344 SHITTRVMGTFGYVAPEYANTGMLNEKSDIYSFGVLLLEAVTGRDPVDYGRPANEVNLVEWLKMMVGTRRAEEVVDPNLE 423 (508)
Q Consensus 344 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 423 (508)
. ......++..|+|||++.+..++.++||||||+++|+|++|+.||....+.... . .. .. ...+.
T Consensus 154 ~-~~~~~~~~~~y~~PE~~~~~~~~~~~Di~s~G~il~~l~~g~~p~~~~~~~~~~-----~-~~-~~-----~~~~~-- 218 (256)
T cd06612 154 A-KRNTVIGTPFWMAPEVIQEIGYNNKADIWSLGITAIEMAEGKPPYSDIHPMRAI-----F-MI-PN-----KPPPT-- 218 (256)
T ss_pred c-ccccccCCccccCHHHHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCcchhhhh-----h-hh-cc-----CCCCC--
Confidence 1 223345788999999999989999999999999999999999999743321110 0 00 00 00011
Q ss_pred CChhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 010519 424 VKPATRALKRSLLVALRCVDPDSEKRPKMSQVVRM 458 (508)
Q Consensus 424 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 458 (508)
..........+.+++.+||+.||.+|||+.|++++
T Consensus 219 ~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~il~~ 253 (256)
T cd06612 219 LSDPEKWSPEFNDFVKKCLVKDPEERPSAIQLLQH 253 (256)
T ss_pred CCchhhcCHHHHHHHHHHHhcChhhCcCHHHHhcC
Confidence 11122234567779999999999999999999974
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a |
| >cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-39 Score=322.14 Aligned_cols=237 Identities=24% Similarity=0.311 Sum_probs=186.6
Q ss_pred eeEeeeCceEEEEEEEc-CCCEEEEEEEcccch---hhHHHHHHHH-HHHhcCCCCCceeEEEEEEeCceeeEEEeecCC
Q 010519 192 NVLGEGGYGVVYKGRLI-NGSEVAVKKLLNNLG---QAEKEFRVEV-EAIGHVRHKNLVRLLGYCIEGVHRMLVYEYVNN 266 (508)
Q Consensus 192 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~ei-~~l~~l~h~niv~~~~~~~~~~~~~lv~E~~~~ 266 (508)
+.||+|+||.||+|++. ++..+|+|.+..... .....+..|. .+++.++||||+++++++.+.+..++||||+++
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~~ 80 (321)
T cd05603 1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTAEKLYFVLDYVNG 80 (321)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 46999999999999875 678899998864321 2223344454 467889999999999999999999999999999
Q ss_pred CCHHHHHhhhhccCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCEEEcCCCcEEEEecCCccccCCCCCcc
Q 010519 267 GNLEQWLHGAMRNQGNLTWEARMKVIIGTAKALAYLHEAIEPKVVHRDIKSSNILIDDEFNAKVSDFGLAKLLDSGESHI 346 (508)
Q Consensus 267 gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~ 346 (508)
|+|..++. ....+++..+..++.||+.||.|||+. +|+||||||+|||++.++.+||+|||++....... ..
T Consensus 81 ~~L~~~l~----~~~~~~~~~~~~~~~qi~~~L~~lH~~---~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~-~~ 152 (321)
T cd05603 81 GELFFHLQ----RERCFLEPRARFYAAEVASAIGYLHSL---NIIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPE-ET 152 (321)
T ss_pred CCHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCCHHHeEECCCCCEEEccCCCCccCCCCC-Cc
Confidence 99998884 345688889999999999999999998 99999999999999999999999999987532222 12
Q ss_pred cccccccccccCccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCCCchhcHHHHHHHHhcccccccccCCCCCCCh
Q 010519 347 TTRVMGTFGYVAPEYANTGMLNEKSDIYSFGVLLLEAVTGRDPVDYGRPANEVNLVEWLKMMVGTRRAEEVVDPNLEVKP 426 (508)
Q Consensus 347 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 426 (508)
....+||+.|+|||++.+..++.++|||||||++|||++|..||.... ........... ....
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~------~~~~~~~i~~~---------~~~~-- 215 (321)
T cd05603 153 TSTFCGTPEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYGLPPFYSRD------VSQMYDNILHK---------PLQL-- 215 (321)
T ss_pred cccccCCcccCCHHHhcCCCCCCcCcccccchhhhhhhcCCCCCCCCC------HHHHHHHHhcC---------CCCC--
Confidence 344578999999999999999999999999999999999999996432 11222222211 1111
Q ss_pred hHHHHHHHHHHHHHhcCCCCCCCCCHH
Q 010519 427 ATRALKRSLLVALRCVDPDSEKRPKMS 453 (508)
Q Consensus 427 ~~~~~~~l~~li~~cl~~dP~~RPs~~ 453 (508)
+......+.+++.+||+.||.+||++.
T Consensus 216 ~~~~~~~~~~li~~~l~~~p~~R~~~~ 242 (321)
T cd05603 216 PGGKTVAACDLLVGLLHKDQRRRLGAK 242 (321)
T ss_pred CCCCCHHHHHHHHHHccCCHhhcCCCC
Confidence 111234566799999999999999764
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. |
| >PHA03209 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-38 Score=323.42 Aligned_cols=193 Identities=23% Similarity=0.346 Sum_probs=165.2
Q ss_pred HhhCCcccceeEeeeCceEEEEEEEc-CCCEEEEEEEcccchhhHHHHHHHHHHHhcCCCCCceeEEEEEEeCceeeEEE
Q 010519 183 IATNRFSAENVLGEGGYGVVYKGRLI-NGSEVAVKKLLNNLGQAEKEFRVEVEAIGHVRHKNLVRLLGYCIEGVHRMLVY 261 (508)
Q Consensus 183 ~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~ei~~l~~l~h~niv~~~~~~~~~~~~~lv~ 261 (508)
....+|.+.+.||+|+||.||+|++. ++..||+|..... ....|+.++++++||||+++++++......++||
T Consensus 63 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~~------~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 136 (357)
T PHA03209 63 VASLGYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKG------TTLIEAMLLQNVNHPSVIRMKDTLVSGAITCMVL 136 (357)
T ss_pred hhhcCcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCcc------ccHHHHHHHHhCCCCCCcChhheEEeCCeeEEEE
Confidence 34468999999999999999999875 4677888864322 2345899999999999999999999999999999
Q ss_pred eecCCCCHHHHHhhhhccCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCEEEcCCCcEEEEecCCccccCC
Q 010519 262 EYVNNGNLEQWLHGAMRNQGNLTWEARMKVIIGTAKALAYLHEAIEPKVVHRDIKSSNILIDDEFNAKVSDFGLAKLLDS 341 (508)
Q Consensus 262 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~ 341 (508)
||+. ++|.+++. .....+++..++.++.||+.||.|||+. +|+||||||+|||++.++.+||+|||++.....
T Consensus 137 e~~~-~~l~~~l~---~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~ 209 (357)
T PHA03209 137 PHYS-SDLYTYLT---KRSRPLPIDQALIIEKQILEGLRYLHAQ---RIIHRDVKTENIFINDVDQVCIGDLGAAQFPVV 209 (357)
T ss_pred EccC-CcHHHHHH---hccCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEEecCcccccccc
Confidence 9995 68999885 3456789999999999999999999999 999999999999999999999999999975432
Q ss_pred CCCcccccccccccccCccccCCCCCCChhhHHHHHHHHHHHHhCCCCC
Q 010519 342 GESHITTRVMGTFGYVAPEYANTGMLNEKSDIYSFGVLLLEAVTGRDPV 390 (508)
Q Consensus 342 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltG~~Pf 390 (508)
.. ......||+.|+|||++.+..++.++|||||||++|||+++..|+
T Consensus 210 ~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvvl~ell~~~~~~ 256 (357)
T PHA03209 210 AP--AFLGLAGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTI 256 (357)
T ss_pred Cc--ccccccccccccCCeecCCCCCCchhhHHHHHHHHHHHHHcCCcc
Confidence 21 123456899999999999999999999999999999999966554
|
|
| >cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-38 Score=308.72 Aligned_cols=257 Identities=27% Similarity=0.431 Sum_probs=201.3
Q ss_pred HHHhhCCcccceeEeeeCceEEEEEEEc-CCCEEEEEEEcccchhhHHHHHHHHHHHhcCCCCCceeEEEEEEeCceeeE
Q 010519 181 LEIATNRFSAENVLGEGGYGVVYKGRLI-NGSEVAVKKLLNNLGQAEKEFRVEVEAIGHVRHKNLVRLLGYCIEGVHRML 259 (508)
Q Consensus 181 ~~~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~ei~~l~~l~h~niv~~~~~~~~~~~~~l 259 (508)
++.+++++.....||+|+||.||+|.+. ++..|++|.+........+.+.+|+.+++.++|+||+++++++..+...++
T Consensus 3 ~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l 82 (268)
T cd06624 3 YEYEYDENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYLGSDSENGFFKI 82 (268)
T ss_pred cccccccCCceEEEecCCceEEEEeEecCCCcEEEEEEecCCCHHHHHHHHHHHHHHHhcCCCCeeeeeeeeccCCEEEE
Confidence 3456667777789999999999999865 577899998876655566788999999999999999999999999999999
Q ss_pred EEeecCCCCHHHHHhhhhccCCCc--cHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCEEEcC-CCcEEEEecCCc
Q 010519 260 VYEYVNNGNLEQWLHGAMRNQGNL--TWEARMKVIIGTAKALAYLHEAIEPKVVHRDIKSSNILIDD-EFNAKVSDFGLA 336 (508)
Q Consensus 260 v~E~~~~gsL~~~l~~~~~~~~~l--~~~~~~~i~~~i~~al~yLH~~~~~~iiH~Dlk~~NIll~~-~~~~kl~Dfgla 336 (508)
|+||+++++|.+++.. ....+ ++..+..++.||+.||.|||+. +|+||||||+||+++. ++.++|+|||++
T Consensus 83 v~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~i~h~dl~p~nil~~~~~~~~~l~dfg~~ 156 (268)
T cd06624 83 FMEQVPGGSLSALLRS---KWGPLKDNEQTIIFYTKQILEGLKYLHDN---QIVHRDIKGDNVLVNTYSGVVKISDFGTS 156 (268)
T ss_pred EEecCCCCCHHHHHHH---hcccCCCcHHHHHHHHHHHHHHHHHHHHC---CEeecCCCHHHEEEcCCCCeEEEecchhh
Confidence 9999999999999963 22334 7788889999999999999998 9999999999999976 678999999999
Q ss_pred cccCCCCCcccccccccccccCccccCCCC--CCChhhHHHHHHHHHHHHhCCCCCCCCCCCchhcHHHHHHHHhccccc
Q 010519 337 KLLDSGESHITTRVMGTFGYVAPEYANTGM--LNEKSDIYSFGVLLLEAVTGRDPVDYGRPANEVNLVEWLKMMVGTRRA 414 (508)
Q Consensus 337 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~~DvwS~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~ 414 (508)
........ ......+++.|+|||++.+.. ++.++||||||+++|+|++|+.||........ ..+......
T Consensus 157 ~~~~~~~~-~~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~~~~---~~~~~~~~~---- 228 (268)
T cd06624 157 KRLAGINP-CTETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQA---AMFKVGMFK---- 228 (268)
T ss_pred eecccCCC-ccccCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCccccChhh---hHhhhhhhc----
Confidence 76543222 122345789999999986643 78999999999999999999999864322111 111100000
Q ss_pred ccccCCCCCCChhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 010519 415 EEVVDPNLEVKPATRALKRSLLVALRCVDPDSEKRPKMSQVVRM 458 (508)
Q Consensus 415 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 458 (508)
..+.+ +......+.+++.+||+.+|.+|||+.+++.+
T Consensus 229 ---~~~~~----~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~ 265 (268)
T cd06624 229 ---IHPEI----PESLSAEAKNFILRCFEPDPDKRASAHDLLQD 265 (268)
T ss_pred ---cCCCC----CcccCHHHHHHHHHHcCCCchhCCCHHHHHhC
Confidence 00111 11234456779999999999999999999975
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina |
| >cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-39 Score=312.69 Aligned_cols=254 Identities=25% Similarity=0.373 Sum_probs=201.3
Q ss_pred hCCcccceeEeeeCceEEEEEEEc-CCCEEEEEEEcccchhhHHHHHHHHHHHhcCCCCCceeEEEEEEeCceeeEEEee
Q 010519 185 TNRFSAENVLGEGGYGVVYKGRLI-NGSEVAVKKLLNNLGQAEKEFRVEVEAIGHVRHKNLVRLLGYCIEGVHRMLVYEY 263 (508)
Q Consensus 185 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~ei~~l~~l~h~niv~~~~~~~~~~~~~lv~E~ 263 (508)
.++|.+.+.||+|+||.||+|++. ++..+|+|.+..........+.+|+.+++.++||||+++++++......++||||
T Consensus 8 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~~~~l~h~~ii~~~~~~~~~~~~~lv~e~ 87 (267)
T cd06645 8 QEDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIVAYFGSYLRRDKLWICMEF 87 (267)
T ss_pred HHHHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEEEec
Confidence 357888899999999999999865 6888999988665544455678899999999999999999999999999999999
Q ss_pred cCCCCHHHHHhhhhccCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCEEEcCCCcEEEEecCCccccCCCC
Q 010519 264 VNNGNLEQWLHGAMRNQGNLTWEARMKVIIGTAKALAYLHEAIEPKVVHRDIKSSNILIDDEFNAKVSDFGLAKLLDSGE 343 (508)
Q Consensus 264 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~~~ 343 (508)
+++++|.+++. ..+.+++..++.++.|++.||.|||+. +++|+||||+||+++.++.+||+|||++.......
T Consensus 88 ~~~~~L~~~~~----~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~~~ 160 (267)
T cd06645 88 CGGGSLQDIYH----VTGPLSESQIAYVSRETLQGLYYLHSK---GKMHRDIKGANILLTDNGHVKLADFGVSAQITATI 160 (267)
T ss_pred cCCCcHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEECcceeeeEccCcc
Confidence 99999999884 445789999999999999999999999 99999999999999999999999999987654322
Q ss_pred CcccccccccccccCccccC---CCCCCChhhHHHHHHHHHHHHhCCCCCCCCCCCchhcHHHHHHHHhcccccccccCC
Q 010519 344 SHITTRVMGTFGYVAPEYAN---TGMLNEKSDIYSFGVLLLEAVTGRDPVDYGRPANEVNLVEWLKMMVGTRRAEEVVDP 420 (508)
Q Consensus 344 ~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DvwS~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 420 (508)
.......|++.|+|||++. ...++.++|+|||||++|+|++|..||....+.... ....... ...+
T Consensus 161 -~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~~~~~~------~~~~~~~----~~~~ 229 (267)
T cd06645 161 -AKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRAL------FLMTKSN----FQPP 229 (267)
T ss_pred -cccccccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCcccccchhhH------HhhhccC----CCCC
Confidence 1223456899999999874 456889999999999999999999998543321111 0110000 0001
Q ss_pred CCCCChhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 010519 421 NLEVKPATRALKRSLLVALRCVDPDSEKRPKMSQVVRM 458 (508)
Q Consensus 421 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 458 (508)
.... .......+.+++.+||..||++|||+.+++++
T Consensus 230 ~~~~--~~~~~~~~~~li~~~l~~~P~~R~~~~~ll~~ 265 (267)
T cd06645 230 KLKD--KMKWSNSFHHFVKMALTKNPKKRPTAEKLLQH 265 (267)
T ss_pred cccc--cCCCCHHHHHHHHHHccCCchhCcCHHHHhcC
Confidence 1100 01123346679999999999999999999875
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-38 Score=314.94 Aligned_cols=258 Identities=24% Similarity=0.389 Sum_probs=202.9
Q ss_pred hhCCcccceeEeeeCceEEEEEEEc------CCCEEEEEEEcccc-hhhHHHHHHHHHHHhcCCCCCceeEEEEEEeCce
Q 010519 184 ATNRFSAENVLGEGGYGVVYKGRLI------NGSEVAVKKLLNNL-GQAEKEFRVEVEAIGHVRHKNLVRLLGYCIEGVH 256 (508)
Q Consensus 184 ~~~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~-~~~~~~~~~ei~~l~~l~h~niv~~~~~~~~~~~ 256 (508)
..++|++.+.||+|+||.||++.+. .+..+|+|.+.... ......+..|+.++++++||||+++++++.+...
T Consensus 3 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~~~~ 82 (288)
T cd05050 3 PRNNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVKLLGVCAVGKP 82 (288)
T ss_pred ChHhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCcCHHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCc
Confidence 4568999999999999999999863 46789999886543 3344678889999999999999999999999999
Q ss_pred eeEEEeecCCCCHHHHHhhhhc------------------cCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCC
Q 010519 257 RMLVYEYVNNGNLEQWLHGAMR------------------NQGNLTWEARMKVIIGTAKALAYLHEAIEPKVVHRDIKSS 318 (508)
Q Consensus 257 ~~lv~E~~~~gsL~~~l~~~~~------------------~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiH~Dlk~~ 318 (508)
.+++|||+++|+|.+++..... ....+++..++.++.|++.||.|||+. +++||||||+
T Consensus 83 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~~---~i~H~dl~p~ 159 (288)
T cd05050 83 MCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSER---KFVHRDLATR 159 (288)
T ss_pred cEEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhC---CeecccccHh
Confidence 9999999999999999964211 123477888999999999999999998 9999999999
Q ss_pred CEEEcCCCcEEEEecCCccccCCCCCc-ccccccccccccCccccCCCCCCChhhHHHHHHHHHHHHh-CCCCCCCCCCC
Q 010519 319 NILIDDEFNAKVSDFGLAKLLDSGESH-ITTRVMGTFGYVAPEYANTGMLNEKSDIYSFGVLLLEAVT-GRDPVDYGRPA 396 (508)
Q Consensus 319 NIll~~~~~~kl~Dfgla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~ellt-G~~Pf~~~~~~ 396 (508)
|||+++++.++|+|||++......... .......+..|+|||.+.+..++.++|||||||++|||++ |..||.....
T Consensus 160 nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~~~~p~~~~~~- 238 (288)
T cd05050 160 NCLVGENMVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQPYYGMAH- 238 (288)
T ss_pred heEecCCCceEECccccceecccCccccccCCCccChhhcCHHHHhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCH-
Confidence 999999999999999998755332211 1122234667999999998899999999999999999998 8888853221
Q ss_pred chhcHHHHHHHHhcccccccccCCCCCCChhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhh
Q 010519 397 NEVNLVEWLKMMVGTRRAEEVVDPNLEVKPATRALKRSLLVALRCVDPDSEKRPKMSQVVRMLE 460 (508)
Q Consensus 397 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 460 (508)
.+........ ... ..+......+.+++.+||+.||.+|||+.|+++.|+
T Consensus 239 -----~~~~~~~~~~-~~~---------~~~~~~~~~l~~li~~~l~~~p~~Rpt~~el~~~l~ 287 (288)
T cd05050 239 -----EEVIYYVRDG-NVL---------SCPDNCPLELYNLMRLCWSKLPSDRPSFASINRILQ 287 (288)
T ss_pred -----HHHHHHHhcC-CCC---------CCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHhh
Confidence 1222222111 100 011123456777999999999999999999999987
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M |
| >cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-38 Score=318.68 Aligned_cols=263 Identities=25% Similarity=0.431 Sum_probs=203.9
Q ss_pred HHhhCCcccceeEeeeCceEEEEEEEc--------CCCEEEEEEEcccc-hhhHHHHHHHHHHHhcC-CCCCceeEEEEE
Q 010519 182 EIATNRFSAENVLGEGGYGVVYKGRLI--------NGSEVAVKKLLNNL-GQAEKEFRVEVEAIGHV-RHKNLVRLLGYC 251 (508)
Q Consensus 182 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~--------~~~~vavK~~~~~~-~~~~~~~~~ei~~l~~l-~h~niv~~~~~~ 251 (508)
.+..++|.+.+.||+|+||.||+++.. ....+|+|.+.... ......+..|+.+++.+ +||||+++++++
T Consensus 8 ~~~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~ 87 (314)
T cd05099 8 EFPRDRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKNIINLLGVC 87 (314)
T ss_pred cccHHHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCCChHHHHHHHHHHHHHHhccCCCCeeeEEEEE
Confidence 455568999999999999999999752 24468888876443 23345688899999999 699999999999
Q ss_pred EeCceeeEEEeecCCCCHHHHHhhhhc------------cCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCC
Q 010519 252 IEGVHRMLVYEYVNNGNLEQWLHGAMR------------NQGNLTWEARMKVIIGTAKALAYLHEAIEPKVVHRDIKSSN 319 (508)
Q Consensus 252 ~~~~~~~lv~E~~~~gsL~~~l~~~~~------------~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiH~Dlk~~N 319 (508)
......+++|||+++|+|.+++..... ....+++..+..++.||+.||.|||++ +++||||||+|
T Consensus 88 ~~~~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~---gi~H~dlkp~N 164 (314)
T cd05099 88 TQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESR---RCIHRDLAARN 164 (314)
T ss_pred ccCCceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHHC---Ceeecccccee
Confidence 998899999999999999999965311 124588999999999999999999998 99999999999
Q ss_pred EEEcCCCcEEEEecCCccccCCCCCcc-cccccccccccCccccCCCCCCChhhHHHHHHHHHHHHh-CCCCCCCCCCCc
Q 010519 320 ILIDDEFNAKVSDFGLAKLLDSGESHI-TTRVMGTFGYVAPEYANTGMLNEKSDIYSFGVLLLEAVT-GRDPVDYGRPAN 397 (508)
Q Consensus 320 Ill~~~~~~kl~Dfgla~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~ellt-G~~Pf~~~~~~~ 397 (508)
||+++++.+||+|||+++......... .....++..|+|||.+.+..++.++|||||||++|+|++ |..||.....
T Consensus 165 ill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~-- 242 (314)
T cd05099 165 VLVTEDNVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPYPGIPV-- 242 (314)
T ss_pred EEEcCCCcEEEccccccccccccccccccccCCCCccccCHHHHccCCcCccchhhHHHHHHHHHHhCCCCCCCCCCH--
Confidence 999999999999999998654322111 112234467999999998899999999999999999999 8888853321
Q ss_pred hhcHHHHHHHHhcccccccccCCCCCCChhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhhcCC
Q 010519 398 EVNLVEWLKMMVGTRRAEEVVDPNLEVKPATRALKRSLLVALRCVDPDSEKRPKMSQVVRMLEADD 463 (508)
Q Consensus 398 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~ 463 (508)
.+.+........ ...+......+.+++.+||+.||.+|||+.++++.|+...
T Consensus 243 ----~~~~~~~~~~~~----------~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~l~~~~ 294 (314)
T cd05099 243 ----EELFKLLREGHR----------MDKPSNCTHELYMLMRECWHAVPTQRPTFKQLVEALDKVL 294 (314)
T ss_pred ----HHHHHHHHcCCC----------CCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHH
Confidence 111211111110 0111122345667999999999999999999999998653
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-38 Score=313.40 Aligned_cols=254 Identities=24% Similarity=0.310 Sum_probs=200.3
Q ss_pred cccceeEeeeCceEEEEEEEc-CCCEEEEEEEcccc---hhhHHHHHHHHHHHhcCCCCCceeEEEEEEeCceeeEEEee
Q 010519 188 FSAENVLGEGGYGVVYKGRLI-NGSEVAVKKLLNNL---GQAEKEFRVEVEAIGHVRHKNLVRLLGYCIEGVHRMLVYEY 263 (508)
Q Consensus 188 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~ei~~l~~l~h~niv~~~~~~~~~~~~~lv~E~ 263 (508)
|+..+.||+|+||+||++.+. +++.+|+|.+.... ......+..|+.++++++|+|++++++.+.+....++||||
T Consensus 2 f~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~ 81 (285)
T cd05630 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTL 81 (285)
T ss_pred ceeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEEecCCEEEEEEEe
Confidence 677789999999999999875 68899999885432 22234567799999999999999999999999999999999
Q ss_pred cCCCCHHHHHhhhhccCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCEEEcCCCcEEEEecCCccccCCCC
Q 010519 264 VNNGNLEQWLHGAMRNQGNLTWEARMKVIIGTAKALAYLHEAIEPKVVHRDIKSSNILIDDEFNAKVSDFGLAKLLDSGE 343 (508)
Q Consensus 264 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~~~ 343 (508)
+++++|.+++.. .....+++..+..++.|++.||.|||+. +|+||||||+||++++++.++|+|||++.......
T Consensus 82 ~~g~~L~~~l~~--~~~~~l~~~~~~~~~~qi~~~l~~lH~~---~iiH~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~ 156 (285)
T cd05630 82 MNGGDLKFHIYH--MGEAGFEEGRAVFYAAEICCGLEDLHQE---RIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQ 156 (285)
T ss_pred cCCCcHHHHHHH--hcccCCCHHHHHHHHHHHHHHHHHHHhC---CEEeCCCCHHHEEECCCCCEEEeeccceeecCCCc
Confidence 999999999853 2334688999999999999999999998 99999999999999999999999999997654332
Q ss_pred CcccccccccccccCccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCCCchhcHHHHHHHHhcccccccccCCCCC
Q 010519 344 SHITTRVMGTFGYVAPEYANTGMLNEKSDIYSFGVLLLEAVTGRDPVDYGRPANEVNLVEWLKMMVGTRRAEEVVDPNLE 423 (508)
Q Consensus 344 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 423 (508)
. .....|+..|+|||++.+..++.++|||||||++|+|++|..||.......... . ......... ...
T Consensus 157 ~--~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~~--~-~~~~~~~~~------~~~- 224 (285)
T cd05630 157 T--IKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKRE--E-VERLVKEVQ------EEY- 224 (285)
T ss_pred c--ccCCCCCccccChHHHcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCccchHH--H-HHhhhhhhh------hhc-
Confidence 1 223468999999999999999999999999999999999999997533211110 0 111110000 000
Q ss_pred CChhHHHHHHHHHHHHHhcCCCCCCCCC-----HHHHHHHhhc
Q 010519 424 VKPATRALKRSLLVALRCVDPDSEKRPK-----MSQVVRMLEA 461 (508)
Q Consensus 424 ~~~~~~~~~~l~~li~~cl~~dP~~RPs-----~~evl~~L~~ 461 (508)
.......+.+|+.+||+.||.+||| +.|++++-+-
T Consensus 225 ---~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~~~~~h~~~ 264 (285)
T cd05630 225 ---SEKFSPDARSLCKMLLCKDPKERLGCQGGGAREVKEHPLF 264 (285)
T ss_pred ---CccCCHHHHHHHHHHhhcCHHHccCCCCCchHHHHcChhh
Confidence 1112334667999999999999999 8899986543
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as |
| >cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-38 Score=315.02 Aligned_cols=264 Identities=26% Similarity=0.409 Sum_probs=203.8
Q ss_pred hCCcccceeEeeeCceEEEEEEEcC-----------------CCEEEEEEEcccc-hhhHHHHHHHHHHHhcCCCCCcee
Q 010519 185 TNRFSAENVLGEGGYGVVYKGRLIN-----------------GSEVAVKKLLNNL-GQAEKEFRVEVEAIGHVRHKNLVR 246 (508)
Q Consensus 185 ~~~~~~~~~lg~G~~g~Vy~~~~~~-----------------~~~vavK~~~~~~-~~~~~~~~~ei~~l~~l~h~niv~ 246 (508)
.++|.+.+.||+|+||.||++.+.. +..||+|.+.... ......+..|+.++++++||||++
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~ 83 (296)
T cd05051 4 RQPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEVKILSRLSDPNIAR 83 (296)
T ss_pred hhhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccCHHHHHHHHHHHHHHHhcCCCCEeE
Confidence 4589999999999999999997642 2458899886543 334567889999999999999999
Q ss_pred EEEEEEeCceeeEEEeecCCCCHHHHHhhhhc-------cCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCC
Q 010519 247 LLGYCIEGVHRMLVYEYVNNGNLEQWLHGAMR-------NQGNLTWEARMKVIIGTAKALAYLHEAIEPKVVHRDIKSSN 319 (508)
Q Consensus 247 ~~~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~-------~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiH~Dlk~~N 319 (508)
+++++..+...+++|||+++++|.+++..... ....+++..++.++.|++.||.|||+. +++|+||||+|
T Consensus 84 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~---~i~H~dlkp~N 160 (296)
T cd05051 84 LLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESL---NFVHRDLATRN 160 (296)
T ss_pred EEEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHHc---Cccccccchhc
Confidence 99999999999999999999999999964321 123689999999999999999999998 99999999999
Q ss_pred EEEcCCCcEEEEecCCccccCCCCC-cccccccccccccCccccCCCCCCChhhHHHHHHHHHHHHh--CCCCCCCCCCC
Q 010519 320 ILIDDEFNAKVSDFGLAKLLDSGES-HITTRVMGTFGYVAPEYANTGMLNEKSDIYSFGVLLLEAVT--GRDPVDYGRPA 396 (508)
Q Consensus 320 Ill~~~~~~kl~Dfgla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~ellt--G~~Pf~~~~~~ 396 (508)
|++++++.++|+|||++........ .......++..|+|||.+.+..++.++|||||||++|||++ |..||.....
T Consensus 161 ili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p~~~~~~- 239 (296)
T cd05051 161 CLVGKNYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCREQPYEHLTD- 239 (296)
T ss_pred eeecCCCceEEccccceeecccCcceeecCcCCCCceecCHHHhhcCCCCccchhhhhHHHHHHHHhcCCCCCCCCcCh-
Confidence 9999999999999999986543221 12233456778999999988889999999999999999998 6677753321
Q ss_pred chhcHHHHHHHHhcccccccccCCCCCCChhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhh
Q 010519 397 NEVNLVEWLKMMVGTRRAEEVVDPNLEVKPATRALKRSLLVALRCVDPDSEKRPKMSQVVRMLE 460 (508)
Q Consensus 397 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 460 (508)
............... ...........+..+.+++.+||+.||.+|||+.+|++.|+
T Consensus 240 --~~~~~~~~~~~~~~~------~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~el~~~L~ 295 (296)
T cd05051 240 --QQVIENAGHFFRDDG------RQIYLPRPPNCPKDIYELMLECWRRDEEDRPTFREIHLFLQ 295 (296)
T ss_pred --HHHHHHHHhcccccc------ccccCCCccCCCHHHHHHHHHHhccChhcCCCHHHHHHHhc
Confidence 111111111111000 00001111122356788999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke |
| >cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-38 Score=308.99 Aligned_cols=240 Identities=28% Similarity=0.396 Sum_probs=187.8
Q ss_pred eeEeeeCceEEEEEEEcC-------------CCEEEEEEEcccchhhHHHHHHHHHHHhcCCCCCceeEEEEEEeCceee
Q 010519 192 NVLGEGGYGVVYKGRLIN-------------GSEVAVKKLLNNLGQAEKEFRVEVEAIGHVRHKNLVRLLGYCIEGVHRM 258 (508)
Q Consensus 192 ~~lg~G~~g~Vy~~~~~~-------------~~~vavK~~~~~~~~~~~~~~~ei~~l~~l~h~niv~~~~~~~~~~~~~ 258 (508)
+.||+|+||.||+|++.. ...|++|.+..........+.+|+.++..++||||+++++++......+
T Consensus 1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~~~~~~ 80 (262)
T cd05077 1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHRDISLAFFETASMMRQVSHKHIVLLYGVCVRDVENI 80 (262)
T ss_pred CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhhhhHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCE
Confidence 368999999999997532 2257888775554444567888999999999999999999999988999
Q ss_pred EEEeecCCCCHHHHHhhhhccCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCEEEcCCCc-------EEEE
Q 010519 259 LVYEYVNNGNLEQWLHGAMRNQGNLTWEARMKVIIGTAKALAYLHEAIEPKVVHRDIKSSNILIDDEFN-------AKVS 331 (508)
Q Consensus 259 lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiH~Dlk~~NIll~~~~~-------~kl~ 331 (508)
+||||+++|+|..++. .....+++..++.++.||++||.|||+. +|+||||||+|||++.++. ++++
T Consensus 81 lv~e~~~~~~l~~~~~---~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~dlkp~Nill~~~~~~~~~~~~~~l~ 154 (262)
T cd05077 81 MVEEFVEFGPLDLFMH---RKSDVLTTPWKFKVAKQLASALSYLEDK---DLVHGNVCTKNILLAREGIDGECGPFIKLS 154 (262)
T ss_pred EEEecccCCCHHHHHH---hcCCCCCHHHHHHHHHHHHHHHHHhhhC---CeECCCCCcccEEEecCCccCCCCceeEeC
Confidence 9999999999998875 3345689999999999999999999998 9999999999999987664 8999
Q ss_pred ecCCccccCCCCCcccccccccccccCccccC-CCCCCChhhHHHHHHHHHHHH-hCCCCCCCCCCCchhcHHHHHHHHh
Q 010519 332 DFGLAKLLDSGESHITTRVMGTFGYVAPEYAN-TGMLNEKSDIYSFGVLLLEAV-TGRDPVDYGRPANEVNLVEWLKMMV 409 (508)
Q Consensus 332 Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~DvwS~Gvvl~ell-tG~~Pf~~~~~~~~~~~~~~~~~~~ 409 (508)
|||++...... ....++..|+|||.+. +..++.++|||||||+||||+ .|..||...... +.. ...
T Consensus 155 d~g~~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~------~~~-~~~ 222 (262)
T cd05077 155 DPGIPITVLSR-----QECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKTLA------EKE-RFY 222 (262)
T ss_pred CCCCCccccCc-----ccccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCcchh------HHH-HHH
Confidence 99998755322 2235788899999886 567899999999999999998 588887533211 111 111
Q ss_pred cccccccccCCCCCCChhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhh
Q 010519 410 GTRRAEEVVDPNLEVKPATRALKRSLLVALRCVDPDSEKRPKMSQVVRMLE 460 (508)
Q Consensus 410 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 460 (508)
.. .. .... + ....+.+|+.+||+.||.+||++.+|++.|+
T Consensus 223 ~~-~~------~~~~-~---~~~~~~~li~~cl~~dp~~Rp~~~~il~~~~ 262 (262)
T cd05077 223 EG-QC------MLVT-P---SCKELADLMTHCMNYDPNQRPFFRAIMRDIN 262 (262)
T ss_pred hc-Cc------cCCC-C---ChHHHHHHHHHHcCCChhhCcCHHHHHHhcC
Confidence 00 00 0000 1 1245677999999999999999999998874
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom |
| >PHA03211 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-38 Score=328.30 Aligned_cols=262 Identities=19% Similarity=0.238 Sum_probs=196.9
Q ss_pred hCCcccceeEeeeCceEEEEEEEc-CCCEEEEEEEcccchhhHHHHHHHHHHHhcCCCCCceeEEEEEEeCceeeEEEee
Q 010519 185 TNRFSAENVLGEGGYGVVYKGRLI-NGSEVAVKKLLNNLGQAEKEFRVEVEAIGHVRHKNLVRLLGYCIEGVHRMLVYEY 263 (508)
Q Consensus 185 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~ei~~l~~l~h~niv~~~~~~~~~~~~~lv~E~ 263 (508)
...|.+.+.||+|+||.||++.+. .++.||||.... ..+.+|+.+|++++|+|||++++++..+...++|||+
T Consensus 168 ~~gy~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~~------~~~~~E~~iL~~L~HpnIv~l~~~~~~~~~~~lv~e~ 241 (461)
T PHA03211 168 GLGFAIHRALTPGSEGCVFESSHPDYPQRVVVKAGWY------ASSVHEARLLRRLSHPAVLALLDVRVVGGLTCLVLPK 241 (461)
T ss_pred cCCeEEEEEEccCCCeEEEEEEECCCCCEEEEecccc------cCHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEEc
Confidence 457999999999999999999875 478899996422 2355799999999999999999999999999999999
Q ss_pred cCCCCHHHHHhhhhccCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCEEEcCCCcEEEEecCCccccCCCC
Q 010519 264 VNNGNLEQWLHGAMRNQGNLTWEARMKVIIGTAKALAYLHEAIEPKVVHRDIKSSNILIDDEFNAKVSDFGLAKLLDSGE 343 (508)
Q Consensus 264 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~~~ 343 (508)
+. ++|.+++.. ....+++..++.++.||+.||.|||++ +|+||||||+|||++.++.+||+|||+++......
T Consensus 242 ~~-~~L~~~l~~---~~~~l~~~~~~~i~~qi~~aL~yLH~~---gIvHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~ 314 (461)
T PHA03211 242 YR-SDLYTYLGA---RLRPLGLAQVTAVARQLLSAIDYIHGE---GIIHRDIKTENVLVNGPEDICLGDFGAACFARGSW 314 (461)
T ss_pred cC-CCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHC---CEEECcCCHHHEEECCCCCEEEcccCCceeccccc
Confidence 94 699998852 345799999999999999999999999 99999999999999999999999999998654322
Q ss_pred C-cccccccccccccCccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCCC-ch----hcHHHHHHHHhcc-ccccc
Q 010519 344 S-HITTRVMGTFGYVAPEYANTGMLNEKSDIYSFGVLLLEAVTGRDPVDYGRPA-NE----VNLVEWLKMMVGT-RRAEE 416 (508)
Q Consensus 344 ~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltG~~Pf~~~~~~-~~----~~~~~~~~~~~~~-~~~~~ 416 (508)
. .......||+.|+|||++.+..++.++|||||||+||||++|..|+...... .. ..+...+...... .....
T Consensus 315 ~~~~~~~~~GT~~Y~APE~~~~~~~~~~sDvwSlGviL~El~~g~~~lf~~~~~~~~~~~~~~l~~~i~~~~~~~~~~~~ 394 (461)
T PHA03211 315 STPFHYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFEAAVHTASLFSASRGDERRPYDAQILRIIRQAQVHVDEFPQ 394 (461)
T ss_pred ccccccccCCCcCCcCHHHHcCCCCCchHHHHHHHHHHHHHHHcCCCcccCCcccccCCcHHHHHHHHHhhccccccCCC
Confidence 1 1223457999999999999999999999999999999999988765332211 11 1111111111000 00000
Q ss_pred ----------------ccCCCCCCC---hhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHh
Q 010519 417 ----------------VVDPNLEVK---PATRALKRSLLVALRCVDPDSEKRPKMSQVVRML 459 (508)
Q Consensus 417 ----------------~~~~~~~~~---~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L 459 (508)
...+..... ........+.+|+.+||+.||.+|||+.|+|++-
T Consensus 395 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~DP~~RPsa~elL~hp 456 (461)
T PHA03211 395 HAGSRLVSQYRHRAARNRRPAYTRPAWTRYYKLDLDVEYLVCRALTFDGARRPSAAELLRLP 456 (461)
T ss_pred CcchHHHHHHHhhhhcccCCccCCcchhhhccccchHHHHHHHHcccChhhCcCHHHHhhCc
Confidence 000000000 0011223567799999999999999999999863
|
|
| >cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-38 Score=311.23 Aligned_cols=252 Identities=24% Similarity=0.344 Sum_probs=199.7
Q ss_pred cccceeEeeeCceEEEEEEEc-CCCEEEEEEEcccchhhHHHHHHHHHHHhcCCCCCceeEEEEEEeCceeeEEEeecCC
Q 010519 188 FSAENVLGEGGYGVVYKGRLI-NGSEVAVKKLLNNLGQAEKEFRVEVEAIGHVRHKNLVRLLGYCIEGVHRMLVYEYVNN 266 (508)
Q Consensus 188 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~ei~~l~~l~h~niv~~~~~~~~~~~~~lv~E~~~~ 266 (508)
|++.+.||.|+||.||+|.+. ++..+++|.+..........+..|+++++.++||||+++++++......++||||+++
T Consensus 7 ~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~~v~e~~~~ 86 (282)
T cd06643 7 WEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCAG 86 (282)
T ss_pred HHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCCCHHHHHHHHHHHHHHHHCCCCCeeeEEEEEeeCCEEEEEEEecCC
Confidence 677889999999999999876 4677888887655555566788899999999999999999999999999999999999
Q ss_pred CCHHHHHhhhhccCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCEEEcCCCcEEEEecCCccccCCCCCcc
Q 010519 267 GNLEQWLHGAMRNQGNLTWEARMKVIIGTAKALAYLHEAIEPKVVHRDIKSSNILIDDEFNAKVSDFGLAKLLDSGESHI 346 (508)
Q Consensus 267 gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~ 346 (508)
++|..++.. ....+++..++.++.|++.||.|||+. +++|+||||+|||++.++.+||+|||++........ .
T Consensus 87 ~~l~~~~~~---~~~~l~~~~~~~~~~qi~~~L~~LH~~---~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~~-~ 159 (282)
T cd06643 87 GAVDAVMLE---LERPLTEPQIRVVCKQTLEALNYLHEN---KIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQ-R 159 (282)
T ss_pred CcHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCcccEEEccCCCEEEcccccccccccccc-c
Confidence 999998752 345789999999999999999999998 999999999999999999999999999976533221 2
Q ss_pred cccccccccccCccccC-----CCCCCChhhHHHHHHHHHHHHhCCCCCCCCCCCchhcHHHHHHHHhcccccccccCCC
Q 010519 347 TTRVMGTFGYVAPEYAN-----TGMLNEKSDIYSFGVLLLEAVTGRDPVDYGRPANEVNLVEWLKMMVGTRRAEEVVDPN 421 (508)
Q Consensus 347 ~~~~~gt~~y~aPE~~~-----~~~~~~~~DvwS~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 421 (508)
.....++..|+|||++. +..++.++|||||||++|||++|+.||....+. ........... +.
T Consensus 160 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~------~~~~~~~~~~~------~~ 227 (282)
T cd06643 160 RDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNPM------RVLLKIAKSEP------PT 227 (282)
T ss_pred cccccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccccCHH------HHHHHHhhcCC------CC
Confidence 23356889999999983 456788999999999999999999998643211 11111111100 01
Q ss_pred CCCChhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhh
Q 010519 422 LEVKPATRALKRSLLVALRCVDPDSEKRPKMSQVVRMLE 460 (508)
Q Consensus 422 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 460 (508)
.. .+......+.+++.+||+.||.+||++.+++++-.
T Consensus 228 ~~--~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~ 264 (282)
T cd06643 228 LA--QPSRWSSEFKDFLKKCLEKNVDARWTTTQLLQHPF 264 (282)
T ss_pred CC--CccccCHHHHHHHHHHccCChhhCcCHHHHhcCCC
Confidence 00 11122345677999999999999999999987654
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. |
| >cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-38 Score=311.54 Aligned_cols=254 Identities=25% Similarity=0.295 Sum_probs=199.4
Q ss_pred cccceeEeeeCceEEEEEEEc-CCCEEEEEEEcccch---hhHHHHHHHHHHHhcCCCCCceeEEEEEEeCceeeEEEee
Q 010519 188 FSAENVLGEGGYGVVYKGRLI-NGSEVAVKKLLNNLG---QAEKEFRVEVEAIGHVRHKNLVRLLGYCIEGVHRMLVYEY 263 (508)
Q Consensus 188 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~ei~~l~~l~h~niv~~~~~~~~~~~~~lv~E~ 263 (508)
|+..+.||+|+||+||++.+. +++.+|+|.+..... .....+..|+.+++.++|+|++.+++.+..++..+++|||
T Consensus 2 ~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~ 81 (285)
T cd05632 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYETKDALCLVLTI 81 (285)
T ss_pred ceEEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEEecCCEEEEEEEe
Confidence 667789999999999999875 688999998854432 2234567799999999999999999999999999999999
Q ss_pred cCCCCHHHHHhhhhccCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCEEEcCCCcEEEEecCCccccCCCC
Q 010519 264 VNNGNLEQWLHGAMRNQGNLTWEARMKVIIGTAKALAYLHEAIEPKVVHRDIKSSNILIDDEFNAKVSDFGLAKLLDSGE 343 (508)
Q Consensus 264 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~~~ 343 (508)
+++++|.+++.. .....+++..+..++.|++.||.|||+. +|+||||||+||++++++.+||+|||++.......
T Consensus 82 ~~~~~L~~~~~~--~~~~~~~~~~~~~~~~ql~~~l~~lH~~---~iiH~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~ 156 (285)
T cd05632 82 MNGGDLKFHIYN--MGNPGFEEERALFYAAEILCGLEDLHRE---NTVYRDLKPENILLDDYGHIRISDLGLAVKIPEGE 156 (285)
T ss_pred ccCccHHHHHHH--hcCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecCCCHHHEEECCCCCEEEecCCcceecCCCC
Confidence 999999998853 2344699999999999999999999998 99999999999999999999999999997654322
Q ss_pred CcccccccccccccCccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCCCchhcHHHHHHHHhcccccccccCCCCC
Q 010519 344 SHITTRVMGTFGYVAPEYANTGMLNEKSDIYSFGVLLLEAVTGRDPVDYGRPANEVNLVEWLKMMVGTRRAEEVVDPNLE 423 (508)
Q Consensus 344 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 423 (508)
. .....|+..|+|||++.+..++.++|+|||||++|+|++|..||........ ...+........ ...
T Consensus 157 ~--~~~~~g~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~P~~~~~~~~~--~~~~~~~~~~~~-------~~~- 224 (285)
T cd05632 157 S--IRGRVGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRGRKEKVK--REEVDRRVLETE-------EVY- 224 (285)
T ss_pred c--ccCCCCCcCccChHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCCHHHH--HHHHHHhhhccc-------ccc-
Confidence 1 2334689999999999998999999999999999999999999964322111 111111111000 001
Q ss_pred CChhHHHHHHHHHHHHHhcCCCCCCCCC-----HHHHHHHhhc
Q 010519 424 VKPATRALKRSLLVALRCVDPDSEKRPK-----MSQVVRMLEA 461 (508)
Q Consensus 424 ~~~~~~~~~~l~~li~~cl~~dP~~RPs-----~~evl~~L~~ 461 (508)
.......+.+|+..||+.||.+||+ +.+++.+-.-
T Consensus 225 ---~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~~~~ 264 (285)
T cd05632 225 ---SAKFSEEAKSICKMLLTKDPKQRLGCQEEGAGEVKRHPFF 264 (285)
T ss_pred ---CccCCHHHHHHHHHHccCCHhHcCCCcccChHHHHcChhh
Confidence 1112334567899999999999999 6777775433
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with |
| >cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-38 Score=314.19 Aligned_cols=252 Identities=25% Similarity=0.401 Sum_probs=204.1
Q ss_pred CCcccceeEeeeCceEEEEEEEc-CCCEEEEEEEcccchhhHHHHHHHHHHHhcCCCCCceeEEEEEEeCceeeEEEeec
Q 010519 186 NRFSAENVLGEGGYGVVYKGRLI-NGSEVAVKKLLNNLGQAEKEFRVEVEAIGHVRHKNLVRLLGYCIEGVHRMLVYEYV 264 (508)
Q Consensus 186 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~ei~~l~~l~h~niv~~~~~~~~~~~~~lv~E~~ 264 (508)
.+|++.+.||.|++|.||+|... +++.|++|.+..........+.+|+.+++.++||||+++++++......++|+||+
T Consensus 19 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 98 (296)
T cd06655 19 KKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKELKNPNIVNFLDSFLVGDELFVVMEYL 98 (296)
T ss_pred ceEEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEecccCchHHHHHHHHHHHHhcCCCceeeeeeeEecCceEEEEEEec
Confidence 47999999999999999999864 78899999886555445567888999999999999999999999999999999999
Q ss_pred CCCCHHHHHhhhhccCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCEEEcCCCcEEEEecCCccccCCCCC
Q 010519 265 NNGNLEQWLHGAMRNQGNLTWEARMKVIIGTAKALAYLHEAIEPKVVHRDIKSSNILIDDEFNAKVSDFGLAKLLDSGES 344 (508)
Q Consensus 265 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~ 344 (508)
++++|.+++. ...+++..+..++.+++.||.|||+. +++|+||+|+||+++.++.+||+|||++........
T Consensus 99 ~~~~L~~~~~-----~~~l~~~~~~~i~~~l~~al~~LH~~---~i~H~dL~p~Nili~~~~~~kl~dfg~~~~~~~~~~ 170 (296)
T cd06655 99 AGGSLTDVVT-----ETCMDEAQIAAVCRECLQALEFLHAN---QVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQS 170 (296)
T ss_pred CCCcHHHHHH-----hcCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEccCccchhcccccc
Confidence 9999999884 23588999999999999999999999 999999999999999999999999999886543322
Q ss_pred cccccccccccccCccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCCCchhcHHHHHHHHhcccccccccCCCCCC
Q 010519 345 HITTRVMGTFGYVAPEYANTGMLNEKSDIYSFGVLLLEAVTGRDPVDYGRPANEVNLVEWLKMMVGTRRAEEVVDPNLEV 424 (508)
Q Consensus 345 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 424 (508)
......+++.|+|||.+.+..++.++|||||||++|+|++|+.||....+... ........ . +.+
T Consensus 171 -~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~~lltg~~pf~~~~~~~~------~~~~~~~~-~-----~~~-- 235 (296)
T cd06655 171 -KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRA------LYLIATNG-T-----PEL-- 235 (296)
T ss_pred -cCCCcCCCccccCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH------HHHHHhcC-C-----ccc--
Confidence 12334688899999999988899999999999999999999999965432111 11111000 0 001
Q ss_pred ChhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhh
Q 010519 425 KPATRALKRSLLVALRCVDPDSEKRPKMSQVVRMLE 460 (508)
Q Consensus 425 ~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 460 (508)
..+......+.+++.+||..||.+|||+.+++++=.
T Consensus 236 ~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~il~~~~ 271 (296)
T cd06655 236 QNPEKLSPIFRDFLNRCLEMDVEKRGSAKELLQHPF 271 (296)
T ss_pred CCcccCCHHHHHHHHHHhhcChhhCCCHHHHhhChH
Confidence 111122345667899999999999999999997543
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-38 Score=313.55 Aligned_cols=250 Identities=25% Similarity=0.392 Sum_probs=203.6
Q ss_pred CCcccceeEeeeCceEEEEEEEc-CCCEEEEEEEcccchhhHHHHHHHHHHHhcCCCCCceeEEEEEEeCceeeEEEeec
Q 010519 186 NRFSAENVLGEGGYGVVYKGRLI-NGSEVAVKKLLNNLGQAEKEFRVEVEAIGHVRHKNLVRLLGYCIEGVHRMLVYEYV 264 (508)
Q Consensus 186 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~ei~~l~~l~h~niv~~~~~~~~~~~~~lv~E~~ 264 (508)
.+|++.+.||.|+||.||++... +++.||+|.+..........+..|+.+++.++|+||+++++++..+...++||||+
T Consensus 19 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~ 98 (297)
T cd06656 19 KKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYL 98 (297)
T ss_pred hhceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCEEEEeeccc
Confidence 58999999999999999999864 78999999987655555567888999999999999999999999999999999999
Q ss_pred CCCCHHHHHhhhhccCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCEEEcCCCcEEEEecCCccccCCCCC
Q 010519 265 NNGNLEQWLHGAMRNQGNLTWEARMKVIIGTAKALAYLHEAIEPKVVHRDIKSSNILIDDEFNAKVSDFGLAKLLDSGES 344 (508)
Q Consensus 265 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~ 344 (508)
++++|.+++.. ..+++..+..++.+++.||.|||+. +++|+||||+|||++.++.++|+|||++........
T Consensus 99 ~~~~L~~~~~~-----~~~~~~~~~~~~~~l~~~L~~LH~~---~i~H~dL~p~Nili~~~~~~~l~Dfg~~~~~~~~~~ 170 (297)
T cd06656 99 AGGSLTDVVTE-----TCMDEGQIAAVCRECLQALDFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS 170 (297)
T ss_pred CCCCHHHHHHh-----CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEECcCccceEccCCcc
Confidence 99999998842 3578889999999999999999998 999999999999999999999999999976543322
Q ss_pred cccccccccccccCccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCCCchhcHHHHHHHHhcccccccccCCCCCC
Q 010519 345 HITTRVMGTFGYVAPEYANTGMLNEKSDIYSFGVLLLEAVTGRDPVDYGRPANEVNLVEWLKMMVGTRRAEEVVDPNLEV 424 (508)
Q Consensus 345 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 424 (508)
......+++.|+|||.+.+..++.++|+|||||++|+|++|..||....+..... ... .......
T Consensus 171 -~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slGvil~~l~tg~~pf~~~~~~~~~~------~~~--------~~~~~~~ 235 (297)
T cd06656 171 -KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALY------LIA--------TNGTPEL 235 (297)
T ss_pred -CcCcccCCccccCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcchhee------eec--------cCCCCCC
Confidence 1233468899999999999889999999999999999999999996443211100 000 0001111
Q ss_pred ChhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 010519 425 KPATRALKRSLLVALRCVDPDSEKRPKMSQVVRM 458 (508)
Q Consensus 425 ~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 458 (508)
..+......+.+++.+||..||.+||++.+++++
T Consensus 236 ~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 269 (297)
T cd06656 236 QNPERLSAVFRDFLNRCLEMDVDRRGSAKELLQH 269 (297)
T ss_pred CCccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 1122234456679999999999999999999985
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-38 Score=313.87 Aligned_cols=261 Identities=24% Similarity=0.349 Sum_probs=192.9
Q ss_pred CcccceeEeeeCceEEEEEEEc-CCCEEEEEEEcccchh--hHHHHHHHHHHHhcC---CCCCceeEEEEEEeC-----c
Q 010519 187 RFSAENVLGEGGYGVVYKGRLI-NGSEVAVKKLLNNLGQ--AEKEFRVEVEAIGHV---RHKNLVRLLGYCIEG-----V 255 (508)
Q Consensus 187 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~--~~~~~~~ei~~l~~l---~h~niv~~~~~~~~~-----~ 255 (508)
+|++.+.||+|+||+||+|.+. +++.||+|.+...... ....+..|+.+++.+ +||||+++++++... .
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~~ 80 (288)
T cd07863 1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRET 80 (288)
T ss_pred CceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCCCCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCCc
Confidence 5888999999999999999875 6888999988643211 123345566666554 799999999988642 4
Q ss_pred eeeEEEeecCCCCHHHHHhhhhccCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCEEEcCCCcEEEEecCC
Q 010519 256 HRMLVYEYVNNGNLEQWLHGAMRNQGNLTWEARMKVIIGTAKALAYLHEAIEPKVVHRDIKSSNILIDDEFNAKVSDFGL 335 (508)
Q Consensus 256 ~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~Dfgl 335 (508)
..+++|||++ ++|.+++.. .....+++..+..++.||+.||.|||+. +++||||||+|||++.++.+||+|||+
T Consensus 81 ~~~lv~e~~~-~~l~~~~~~--~~~~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dikp~Nili~~~~~~kl~dfg~ 154 (288)
T cd07863 81 KVTLVFEHVD-QDLRTYLDK--VPPPGLPAETIKDLMRQFLRGLDFLHAN---CIVHRDLKPENILVTSGGQVKLADFGL 154 (288)
T ss_pred eEEEEEcccc-cCHHHHHHh--cCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCEEECccCc
Confidence 5789999997 489998863 2334589999999999999999999999 999999999999999999999999999
Q ss_pred ccccCCCCCcccccccccccccCccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCCCchhcHHHHHHHHhcccccc
Q 010519 336 AKLLDSGESHITTRVMGTFGYVAPEYANTGMLNEKSDIYSFGVLLLEAVTGRDPVDYGRPANEVNLVEWLKMMVGTRRAE 415 (508)
Q Consensus 336 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~ 415 (508)
+....... ......++..|+|||++.+..++.++|||||||++|+|++|+.||....... .+...... .+.....
T Consensus 155 ~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~~f~~~~~~~--~~~~~~~~-~~~~~~~ 229 (288)
T cd07863 155 ARIYSCQM--ALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEAD--QLGKIFDL-IGLPPED 229 (288)
T ss_pred cccccCcc--cCCCccccccccCchHhhCCCCCCcchhhhHHHHHHHHHhCCcCcCCCCHHH--HHHHHHHH-hCCCChh
Confidence 98664322 1234567999999999998899999999999999999999999986432211 11111111 1100000
Q ss_pred c----------ccCCCCCC---ChhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 010519 416 E----------VVDPNLEV---KPATRALKRSLLVALRCVDPDSEKRPKMSQVVRM 458 (508)
Q Consensus 416 ~----------~~~~~~~~---~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 458 (508)
. ...+.... .........+.+++.+||+.||.+|||+.|++.+
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~l~h 285 (288)
T cd07863 230 DWPRDVTLPRGAFSPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRALQH 285 (288)
T ss_pred hCcccccccccccCCCCCCchHHhCcCcCHHHHHHHHHHhccCcccCCCHHHHhcC
Confidence 0 00000000 0011223456789999999999999999999975
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou |
| >cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-38 Score=317.89 Aligned_cols=257 Identities=21% Similarity=0.249 Sum_probs=197.4
Q ss_pred CCcccceeEeeeCceEEEEEEEc-CCCEEEEEEEcccc---hhhHHHHHHHHHHHhcCCCCCceeEEEEEEeCceeeEEE
Q 010519 186 NRFSAENVLGEGGYGVVYKGRLI-NGSEVAVKKLLNNL---GQAEKEFRVEVEAIGHVRHKNLVRLLGYCIEGVHRMLVY 261 (508)
Q Consensus 186 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~ei~~l~~l~h~niv~~~~~~~~~~~~~lv~ 261 (508)
++|.+.+.||+|+||+||++++. ++..+|+|.+.... ......+..|+.++..++|+||+++++++.+....++||
T Consensus 1 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (332)
T cd05623 1 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAFQDENNLYLVM 80 (332)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCEEEEEE
Confidence 47899999999999999999876 46779999875422 222345788999999999999999999999999999999
Q ss_pred eecCCCCHHHHHhhhhccCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCEEEcCCCcEEEEecCCccccCC
Q 010519 262 EYVNNGNLEQWLHGAMRNQGNLTWEARMKVIIGTAKALAYLHEAIEPKVVHRDIKSSNILIDDEFNAKVSDFGLAKLLDS 341 (508)
Q Consensus 262 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~ 341 (508)
||+++|+|.+++.. ....+++..+..++.||+.||.|||+. +|+||||||+|||++.++.+||+|||++.....
T Consensus 81 ey~~~g~L~~~l~~---~~~~l~~~~~~~~~~qi~~al~~lH~~---~iiHrDlkp~Nili~~~~~~kL~DfG~a~~~~~ 154 (332)
T cd05623 81 DYYVGGDLLTLLSK---FEDRLPEDMARFYLAEMVIAIDSVHQL---HYVHRDIKPDNILMDMNGHIRLADFGSCLKLME 154 (332)
T ss_pred eccCCCcHHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHEEECCCCCEEEeecchheeccc
Confidence 99999999999963 345689999999999999999999998 999999999999999999999999999976543
Q ss_pred CCCcccccccccccccCccccC-----CCCCCChhhHHHHHHHHHHHHhCCCCCCCCCCCchhcHHHHHHHHhccccccc
Q 010519 342 GESHITTRVMGTFGYVAPEYAN-----TGMLNEKSDIYSFGVLLLEAVTGRDPVDYGRPANEVNLVEWLKMMVGTRRAEE 416 (508)
Q Consensus 342 ~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DvwS~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 416 (508)
.........+||+.|+|||++. ...++.++|||||||+||||++|+.||.... ..+............
T Consensus 155 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~~------~~~~~~~i~~~~~~~- 227 (332)
T cd05623 155 DGTVQSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAES------LVETYGKIMNHKERF- 227 (332)
T ss_pred CCcceecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCCCC------HHHHHHHHhCCCccc-
Confidence 3322233457999999999986 3468899999999999999999999996432 112222222111000
Q ss_pred ccCCCCCCChhHHHHHHHHHHHHHhcCCCC--CCCCCHHHHHHHhh
Q 010519 417 VVDPNLEVKPATRALKRSLLVALRCVDPDS--EKRPKMSQVVRMLE 460 (508)
Q Consensus 417 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP--~~RPs~~evl~~L~ 460 (508)
.+.. ........+.+|+.+|+..++ ..|+++.++++|-.
T Consensus 228 ----~~p~-~~~~~s~~~~~li~~ll~~~~~r~~r~~~~~~~~h~~ 268 (332)
T cd05623 228 ----QFPA-QVTDVSEDAKDLIRRLICSREHRLGQNGIEDFKQHPF 268 (332)
T ss_pred ----cCCC-ccccCCHHHHHHHHHHccChhhhcCCCCHHHHhCCCC
Confidence 0000 011123455667888775544 44789999998843
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw |
| >cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-38 Score=312.88 Aligned_cols=255 Identities=24% Similarity=0.354 Sum_probs=204.2
Q ss_pred hCCcccceeEeeeCceEEEEEEEc-CCCEEEEEEEcccchhhHHHHHHHHHHHhcCCCCCceeEEEEEEeCceeeEEEee
Q 010519 185 TNRFSAENVLGEGGYGVVYKGRLI-NGSEVAVKKLLNNLGQAEKEFRVEVEAIGHVRHKNLVRLLGYCIEGVHRMLVYEY 263 (508)
Q Consensus 185 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~ei~~l~~l~h~niv~~~~~~~~~~~~~lv~E~ 263 (508)
.++|++.+.||.|+||.||++.+. ++..+|+|.+..........+..|++++++++||||+++++++......++||||
T Consensus 4 ~~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 83 (280)
T cd06611 4 NDIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYFYENKLWILIEF 83 (280)
T ss_pred hhHHHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeCCHHHHHHHHHHHHHHHhCCCCceeEEEEEEecCCeEEEEeec
Confidence 457999999999999999999875 6888999988765555566788899999999999999999999999999999999
Q ss_pred cCCCCHHHHHhhhhccCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCEEEcCCCcEEEEecCCccccCCCC
Q 010519 264 VNNGNLEQWLHGAMRNQGNLTWEARMKVIIGTAKALAYLHEAIEPKVVHRDIKSSNILIDDEFNAKVSDFGLAKLLDSGE 343 (508)
Q Consensus 264 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~~~ 343 (508)
+++++|.+++.. ....+++..++.++.|++.||.|||+. +++|+||+|+||+++.++.++|+|||++.......
T Consensus 84 ~~~~~L~~~~~~---~~~~l~~~~~~~~~~ql~~~l~~lh~~---~i~h~dl~p~nili~~~~~~~l~d~g~~~~~~~~~ 157 (280)
T cd06611 84 CDGGALDSIMLE---LERGLTEPQIRYVCRQMLEALNFLHSH---KVIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTL 157 (280)
T ss_pred cCCCcHHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChhhEEECCCCCEEEccCccchhhcccc
Confidence 999999999853 345689999999999999999999999 99999999999999999999999999987654322
Q ss_pred CcccccccccccccCccccC-----CCCCCChhhHHHHHHHHHHHHhCCCCCCCCCCCchhcHHHHHHHHhccccccccc
Q 010519 344 SHITTRVMGTFGYVAPEYAN-----TGMLNEKSDIYSFGVLLLEAVTGRDPVDYGRPANEVNLVEWLKMMVGTRRAEEVV 418 (508)
Q Consensus 344 ~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DvwS~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 418 (508)
. ......+++.|+|||.+. +..++.++|+||||+++|+|++|+.||...... ..+.......
T Consensus 158 ~-~~~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~~~------~~~~~~~~~~------ 224 (280)
T cd06611 158 Q-KRDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNPM------RVLLKILKSE------ 224 (280)
T ss_pred c-ccceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccCCHH------HHHHHHhcCC------
Confidence 1 223356899999999874 345778999999999999999999999643211 1111111110
Q ss_pred CCCCCCChhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhh
Q 010519 419 DPNLEVKPATRALKRSLLVALRCVDPDSEKRPKMSQVVRMLE 460 (508)
Q Consensus 419 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 460 (508)
.+.+ ..+......+.+++.+||+.||.+||++.+++++-.
T Consensus 225 ~~~~--~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~ 264 (280)
T cd06611 225 PPTL--DQPSKWSSSFNDFLKSCLVKDPDDRPTAAELLKHPF 264 (280)
T ss_pred CCCc--CCcccCCHHHHHHHHHHhccChhhCcCHHHHhcChh
Confidence 0111 111223345667999999999999999999998644
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti |
| >cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-38 Score=307.99 Aligned_cols=249 Identities=26% Similarity=0.445 Sum_probs=199.0
Q ss_pred CcccceeEeeeCceEEEEEEEc-CCCEEEEEEEcccch---------hhHHHHHHHHHHHhcCCCCCceeEEEEEEeCce
Q 010519 187 RFSAENVLGEGGYGVVYKGRLI-NGSEVAVKKLLNNLG---------QAEKEFRVEVEAIGHVRHKNLVRLLGYCIEGVH 256 (508)
Q Consensus 187 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---------~~~~~~~~ei~~l~~l~h~niv~~~~~~~~~~~ 256 (508)
+|.+.+.||.|++|.||+|.+. ++..+|+|.+..... ...+.+..|+.++++++||||+++++++.....
T Consensus 1 ~~~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 80 (267)
T cd06628 1 KWIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLDADH 80 (267)
T ss_pred CccccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCc
Confidence 4677889999999999999864 678899998854321 122568889999999999999999999999999
Q ss_pred eeEEEeecCCCCHHHHHhhhhccCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCEEEcCCCcEEEEecCCc
Q 010519 257 RMLVYEYVNNGNLEQWLHGAMRNQGNLTWEARMKVIIGTAKALAYLHEAIEPKVVHRDIKSSNILIDDEFNAKVSDFGLA 336 (508)
Q Consensus 257 ~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~Dfgla 336 (508)
.+++|||+++++|.+++. ....+++..+..++.|++.||.|||+. +++|+||+|+||++++++.++|+|||++
T Consensus 81 ~~lv~e~~~~~~L~~~l~----~~~~l~~~~~~~~~~~l~~~l~~lH~~---~ivH~di~p~nil~~~~~~~~l~dfg~~ 153 (267)
T cd06628 81 LNIFLEYVPGGSVAALLN----NYGAFEETLVRNFVRQILKGLNYLHNR---GIIHRDIKGANILVDNKGGIKISDFGIS 153 (267)
T ss_pred cEEEEEecCCCCHHHHHH----hccCccHHHHHHHHHHHHHHHHHHHhc---CcccccCCHHHEEEcCCCCEEecccCCC
Confidence 999999999999999984 345688899999999999999999998 9999999999999999999999999999
Q ss_pred cccCCCCC-----cccccccccccccCccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCCCchhcHHHHHHHHhcc
Q 010519 337 KLLDSGES-----HITTRVMGTFGYVAPEYANTGMLNEKSDIYSFGVLLLEAVTGRDPVDYGRPANEVNLVEWLKMMVGT 411 (508)
Q Consensus 337 ~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~ 411 (508)
+....... .......|+..|+|||.+.+..++.++|+|||||++|+|++|+.||...... .. ......
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~-----~~-~~~~~~- 226 (267)
T cd06628 154 KKLEANSLSTKTNGARPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDCTQL-----QA-IFKIGE- 226 (267)
T ss_pred cccccccccCCccccccccCCCcCccChhHhccCCCCchhhhHHHHHHHHHHhhCCCCCCCccHH-----HH-HHHHhc-
Confidence 86642211 1112345788999999999888999999999999999999999999643211 11 111111
Q ss_pred cccccccCCCCCCChhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 010519 412 RRAEEVVDPNLEVKPATRALKRSLLVALRCVDPDSEKRPKMSQVVRM 458 (508)
Q Consensus 412 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 458 (508)
...+.+. ......+.+++.+||++||.+||++.+++++
T Consensus 227 -----~~~~~~~----~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 264 (267)
T cd06628 227 -----NASPEIP----SNISSEAIDFLEKTFEIDHNKRPTAAELLKH 264 (267)
T ss_pred -----cCCCcCC----cccCHHHHHHHHHHccCCchhCcCHHHHhhC
Confidence 0111111 1234556779999999999999999999874
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate |
| >cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-38 Score=322.52 Aligned_cols=263 Identities=26% Similarity=0.394 Sum_probs=200.8
Q ss_pred HHhhCCcccceeEeeeCceEEEEEEE------cCCCEEEEEEEcccch-hhHHHHHHHHHHHhcC-CCCCceeEEEEEEe
Q 010519 182 EIATNRFSAENVLGEGGYGVVYKGRL------INGSEVAVKKLLNNLG-QAEKEFRVEVEAIGHV-RHKNLVRLLGYCIE 253 (508)
Q Consensus 182 ~~~~~~~~~~~~lg~G~~g~Vy~~~~------~~~~~vavK~~~~~~~-~~~~~~~~ei~~l~~l-~h~niv~~~~~~~~ 253 (508)
....++|.+.+.||+|+||.||+|.+ ..++.||||++..... .....+..|+.++.++ +||||+++++++..
T Consensus 3 ~~~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~ 82 (343)
T cd05103 3 EFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTK 82 (343)
T ss_pred ccchhHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCCChHHHHHHHHHHHHHHhccCCccHhhhcceeec
Confidence 34567899999999999999999974 2467899999865432 2345678899999999 68999999998865
Q ss_pred C-ceeeEEEeecCCCCHHHHHhhhhc------------------------------------------------------
Q 010519 254 G-VHRMLVYEYVNNGNLEQWLHGAMR------------------------------------------------------ 278 (508)
Q Consensus 254 ~-~~~~lv~E~~~~gsL~~~l~~~~~------------------------------------------------------ 278 (508)
. ...+++|||+++|+|.++++....
T Consensus 83 ~~~~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 162 (343)
T cd05103 83 PGGPLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDVE 162 (343)
T ss_pred CCCceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccch
Confidence 4 457899999999999999864210
Q ss_pred ---------cCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCEEEcCCCcEEEEecCCccccCCCCC-cccc
Q 010519 279 ---------NQGNLTWEARMKVIIGTAKALAYLHEAIEPKVVHRDIKSSNILIDDEFNAKVSDFGLAKLLDSGES-HITT 348 (508)
Q Consensus 279 ---------~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~-~~~~ 348 (508)
....+++..+..++.||+.||.|||++ +|+||||||+|||+++++.+||+|||++........ ....
T Consensus 163 ~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~ 239 (343)
T cd05103 163 EEEAEQEDLYKKVLTLEDLICYSFQVAKGMEFLASR---KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKG 239 (343)
T ss_pred hhhhhhhhhhhccCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCccCeEEEcCCCcEEEEecccccccccCcchhhcC
Confidence 012467888899999999999999999 999999999999999999999999999986533221 1122
Q ss_pred cccccccccCccccCCCCCCChhhHHHHHHHHHHHHh-CCCCCCCCCCCchhcHHHHHHHHhcccccccccCCCCCCChh
Q 010519 349 RVMGTFGYVAPEYANTGMLNEKSDIYSFGVLLLEAVT-GRDPVDYGRPANEVNLVEWLKMMVGTRRAEEVVDPNLEVKPA 427 (508)
Q Consensus 349 ~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 427 (508)
...+++.|+|||.+.+..++.++||||||+++|+|++ |..||....... ........... ....
T Consensus 240 ~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~-----~~~~~~~~~~~------~~~~---- 304 (343)
T cd05103 240 DARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDE-----EFCRRLKEGTR------MRAP---- 304 (343)
T ss_pred CCCCCcceECcHHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCccccH-----HHHHHHhccCC------CCCC----
Confidence 2335678999999988899999999999999999997 899986432211 11111111110 0000
Q ss_pred HHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhhcC
Q 010519 428 TRALKRSLLVALRCVDPDSEKRPKMSQVVRMLEAD 462 (508)
Q Consensus 428 ~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~ 462 (508)
......+.+++.+||+.||.+|||+.+|+++|+..
T Consensus 305 ~~~~~~~~~~~~~cl~~~p~~Rps~~eil~~l~~~ 339 (343)
T cd05103 305 DYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNL 339 (343)
T ss_pred CCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence 01123567789999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp |
| >KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-38 Score=307.47 Aligned_cols=268 Identities=25% Similarity=0.410 Sum_probs=204.7
Q ss_pred HHhhCCcccceeEeeeCceEEEEEEEcCCCEEEEEEEcccchhhHHHHHHHHHHHh--cCCCCCceeEEEEEEeC----c
Q 010519 182 EIATNRFSAENVLGEGGYGVVYKGRLINGSEVAVKKLLNNLGQAEKEFRVEVEAIG--HVRHKNLVRLLGYCIEG----V 255 (508)
Q Consensus 182 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~ei~~l~--~l~h~niv~~~~~~~~~----~ 255 (508)
.....+..+.+.||+|.||+||+|.| .|..||||++.... +..+.+|.+++. .|+|+||+.|++.-..+ .
T Consensus 207 RTiarqI~L~e~IGkGRyGEVwrG~w-rGe~VAVKiF~srd---E~SWfrEtEIYqTvmLRHENILgFIaaD~~~~gs~T 282 (513)
T KOG2052|consen 207 RTIARQIVLQEIIGKGRFGEVWRGRW-RGEDVAVKIFSSRD---ERSWFRETEIYQTVMLRHENILGFIAADNKDNGSWT 282 (513)
T ss_pred HhhhheeEEEEEecCccccceeeccc-cCCceEEEEecccc---hhhhhhHHHHHHHHHhccchhhhhhhccccCCCceE
Confidence 45567899999999999999999998 88999999985432 334455555554 46999999999976543 3
Q ss_pred eeeEEEeecCCCCHHHHHhhhhccCCCccHHHHHHHHHHHHHHHHHHHhc-----CCCCeEeecCCCCCEEEcCCCcEEE
Q 010519 256 HRMLVYEYVNNGNLEQWLHGAMRNQGNLTWEARMKVIIGTAKALAYLHEA-----IEPKVVHRDIKSSNILIDDEFNAKV 330 (508)
Q Consensus 256 ~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~-----~~~~iiH~Dlk~~NIll~~~~~~kl 330 (508)
+++||.+|.+.|+|+|||. ...++....++++..+|.||++||.. .+|.|.|||||+.||||..++.+.|
T Consensus 283 QLwLvTdYHe~GSL~DyL~-----r~tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKkn~~C~I 357 (513)
T KOG2052|consen 283 QLWLVTDYHEHGSLYDYLN-----RNTVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCI 357 (513)
T ss_pred EEEEeeecccCCcHHHHHh-----hccCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEccCCcEEE
Confidence 6789999999999999994 36788999999999999999999964 3899999999999999999999999
Q ss_pred EecCCccccCCCCCc---ccccccccccccCccccCCCC----CC--ChhhHHHHHHHHHHHHh----------CCCCCC
Q 010519 331 SDFGLAKLLDSGESH---ITTRVMGTFGYVAPEYANTGM----LN--EKSDIYSFGVLLLEAVT----------GRDPVD 391 (508)
Q Consensus 331 ~Dfgla~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~----~~--~~~DvwS~Gvvl~ellt----------G~~Pf~ 391 (508)
+|+|||......... ..+..+||.+|||||++...- +. ..+||||||+|+||+.. .++||.
T Consensus 358 ADLGLAv~h~~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiarRc~~ggi~eey~~Pyy 437 (513)
T KOG2052|consen 358 ADLGLAVRHDSDTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIARRCESGGIVEEYQLPYY 437 (513)
T ss_pred eeceeeEEecccCCcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHHHhhcCCEehhhcCCcc
Confidence 999999866544221 244568999999999986532 11 47999999999999976 256776
Q ss_pred CCCCCchhcHHHHHHHHhcccccccccCCCCCCChhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhhcCC
Q 010519 392 YGRPANEVNLVEWLKMMVGTRRAEEVVDPNLEVKPATRALKRSLLVALRCVDPDSEKRPKMSQVVRMLEADD 463 (508)
Q Consensus 392 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~ 463 (508)
...+.+. .+.+ ++.+....++...++..... ...+..+..++..||..||.-|.|+-.+-+.|....
T Consensus 438 d~Vp~DP-s~ee-MrkVVCv~~~RP~ipnrW~s---~~~l~~m~klMkeCW~~Np~aRltALriKKtl~~l~ 504 (513)
T KOG2052|consen 438 DVVPSDP-SFEE-MRKVVCVQKLRPNIPNRWKS---DPALRVMAKLMKECWYANPAARLTALRIKKTLAKLS 504 (513)
T ss_pred cCCCCCC-CHHH-HhcceeecccCCCCCccccc---CHHHHHHHHHHHHhhcCCchhhhHHHHHHHHHHHHh
Confidence 4444332 2222 23333333333333333333 345667777999999999999999999888876544
|
|
| >cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-38 Score=307.55 Aligned_cols=251 Identities=28% Similarity=0.424 Sum_probs=199.7
Q ss_pred CcccceeEeeeCceEEEEEEEcCCCEEEEEEEcccc------hhhHHHHHHHHHHHhcCCCCCceeEEEEEEeCceeeEE
Q 010519 187 RFSAENVLGEGGYGVVYKGRLINGSEVAVKKLLNNL------GQAEKEFRVEVEAIGHVRHKNLVRLLGYCIEGVHRMLV 260 (508)
Q Consensus 187 ~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~------~~~~~~~~~ei~~l~~l~h~niv~~~~~~~~~~~~~lv 260 (508)
+|...+.||.|+||+||+|...++..+|+|.+.... ......+.+|+++++.++|+||+++++++.+....+++
T Consensus 1 ~~~~~~~ig~g~~~~v~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv 80 (265)
T cd06631 1 EWTKGEVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDDNTISIF 80 (265)
T ss_pred CccccceEeccCCeEEEEEEEcCCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeecCCeEEEE
Confidence 477889999999999999988788999999885432 12234688899999999999999999999999999999
Q ss_pred EeecCCCCHHHHHhhhhccCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCEEEcCCCcEEEEecCCccccC
Q 010519 261 YEYVNNGNLEQWLHGAMRNQGNLTWEARMKVIIGTAKALAYLHEAIEPKVVHRDIKSSNILIDDEFNAKVSDFGLAKLLD 340 (508)
Q Consensus 261 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~Dfgla~~~~ 340 (508)
|||+++++|.+++. ....+++..+..++.|++.||.|||+. +++|+||+|+||++++++.++|+|||++....
T Consensus 81 ~e~~~~~~L~~~l~----~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~ 153 (265)
T cd06631 81 MEFVPGGSISSILN----RFGPLPEPVFCKYTKQILDGVAYLHNN---CVVHRDIKGNNVMLMPNGIIKLIDFGCARRLA 153 (265)
T ss_pred EecCCCCcHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCcCHHhEEECCCCeEEeccchhhHhhh
Confidence 99999999999984 335688999999999999999999998 99999999999999999999999999987543
Q ss_pred CCC-----CcccccccccccccCccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCCCchhcHHHHHHHHhcccccc
Q 010519 341 SGE-----SHITTRVMGTFGYVAPEYANTGMLNEKSDIYSFGVLLLEAVTGRDPVDYGRPANEVNLVEWLKMMVGTRRAE 415 (508)
Q Consensus 341 ~~~-----~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~ 415 (508)
... ........++..|+|||++.+..++.++|||||||++|+|++|..||....... ............
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~-----~~~~~~~~~~~~- 227 (265)
T cd06631 154 WVGLHGTHSNMLKSMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPLASMDRLA-----AMFYIGAHRGLM- 227 (265)
T ss_pred hccccccccccccccCCCccccChhhhcCCCCcchhhHHHHHHHHHHHHhCCCccccCChHH-----HHHHhhhccCCC-
Confidence 211 111223468889999999999889999999999999999999999996432111 111110000000
Q ss_pred cccCCCCCCChhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 010519 416 EVVDPNLEVKPATRALKRSLLVALRCVDPDSEKRPKMSQVVRM 458 (508)
Q Consensus 416 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 458 (508)
+.+. ......+.+++.+||+.+|.+||++.+++++
T Consensus 228 ----~~~~----~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~~ 262 (265)
T cd06631 228 ----PRLP----DSFSAAAIDFVTSCLTRDQHERPSALQLLRH 262 (265)
T ss_pred ----CCCC----CCCCHHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence 1111 1234456779999999999999999999864
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. |
| >cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-38 Score=308.83 Aligned_cols=250 Identities=26% Similarity=0.420 Sum_probs=193.3
Q ss_pred eeEeeeCceEEEEEEEcC-CC--EEEEEEEcccc-hhhHHHHHHHHHHHhcC-CCCCceeEEEEEEeCceeeEEEeecCC
Q 010519 192 NVLGEGGYGVVYKGRLIN-GS--EVAVKKLLNNL-GQAEKEFRVEVEAIGHV-RHKNLVRLLGYCIEGVHRMLVYEYVNN 266 (508)
Q Consensus 192 ~~lg~G~~g~Vy~~~~~~-~~--~vavK~~~~~~-~~~~~~~~~ei~~l~~l-~h~niv~~~~~~~~~~~~~lv~E~~~~ 266 (508)
+.||+|+||.||+|++.+ +. .+++|.+.... ......+..|+.++.++ +||||+++++++......++||||+++
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~ 80 (270)
T cd05047 1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPH 80 (270)
T ss_pred CcCCCCCCceEEEEEEcCCCCeeEEEEEEccccCCHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecCCCceEEEEeCCC
Confidence 368999999999998753 33 46788776432 33446788899999999 899999999999999999999999999
Q ss_pred CCHHHHHhhhhc------------cCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCEEEcCCCcEEEEecC
Q 010519 267 GNLEQWLHGAMR------------NQGNLTWEARMKVIIGTAKALAYLHEAIEPKVVHRDIKSSNILIDDEFNAKVSDFG 334 (508)
Q Consensus 267 gsL~~~l~~~~~------------~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~Dfg 334 (508)
|+|.+++..... ....+++..++.++.|++.||+|||+. +++|+||||+|||+++++.+||+|||
T Consensus 81 ~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~~---~i~H~dikp~nili~~~~~~kl~dfg 157 (270)
T cd05047 81 GNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK---QFIHRDLAARNILVGENYVAKIADFG 157 (270)
T ss_pred CcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccccceEEEcCCCeEEECCCC
Confidence 999999964211 123578999999999999999999998 99999999999999999999999999
Q ss_pred CccccCCCCCcccccccccccccCccccCCCCCCChhhHHHHHHHHHHHHh-CCCCCCCCCCCchhcHHHHHHHHhcccc
Q 010519 335 LAKLLDSGESHITTRVMGTFGYVAPEYANTGMLNEKSDIYSFGVLLLEAVT-GRDPVDYGRPANEVNLVEWLKMMVGTRR 413 (508)
Q Consensus 335 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~ 413 (508)
++........ ......+..|+|||++.+..++.++|||||||++|||++ |..||..... ...........
T Consensus 158 l~~~~~~~~~--~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~------~~~~~~~~~~~- 228 (270)
T cd05047 158 LSRGQEVYVK--KTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTC------AELYEKLPQGY- 228 (270)
T ss_pred Cccccchhhh--ccCCCCccccCChHHHccCCCCchhhHHHHHHHHHHHHcCCCCCccccCH------HHHHHHHhCCC-
Confidence 9863321111 111223567999999998899999999999999999997 9999854321 11122211110
Q ss_pred cccccCCCCCCChhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhhcC
Q 010519 414 AEEVVDPNLEVKPATRALKRSLLVALRCVDPDSEKRPKMSQVVRMLEAD 462 (508)
Q Consensus 414 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~ 462 (508)
...........+.+++.+||+.||.+|||+.+++..|+..
T Consensus 229 ---------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~~~ 268 (270)
T cd05047 229 ---------RLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRM 268 (270)
T ss_pred ---------CCCCCCcCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHh
Confidence 0011112234567899999999999999999999999764
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l |
| >cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-38 Score=311.84 Aligned_cols=255 Identities=24% Similarity=0.343 Sum_probs=202.8
Q ss_pred hhCCcccceeEeeeCceEEEEEEEc-CCCEEEEEEEcccchhhHHHHHHHHHHHhcCCCCCceeEEEEEEeCceeeEEEe
Q 010519 184 ATNRFSAENVLGEGGYGVVYKGRLI-NGSEVAVKKLLNNLGQAEKEFRVEVEAIGHVRHKNLVRLLGYCIEGVHRMLVYE 262 (508)
Q Consensus 184 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~ei~~l~~l~h~niv~~~~~~~~~~~~~lv~E 262 (508)
+.+.|++.+.||.|+||.||+|++. ++..+++|.+..........+..|+.+++.++||||+++++++..+...++|||
T Consensus 10 ~~~~y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 89 (292)
T cd06644 10 PNEVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAFYWDGKLWIMIE 89 (292)
T ss_pred cchhhhhhheecCCCCeEEEEEEECCCCceEEEEEeccCCHHHHHHHHHHHHHHHhCCCCcEeeeEEEEEeCCeEEEEEe
Confidence 3467999999999999999999875 578899999876655556778889999999999999999999999999999999
Q ss_pred ecCCCCHHHHHhhhhccCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCEEEcCCCcEEEEecCCccccCCC
Q 010519 263 YVNNGNLEQWLHGAMRNQGNLTWEARMKVIIGTAKALAYLHEAIEPKVVHRDIKSSNILIDDEFNAKVSDFGLAKLLDSG 342 (508)
Q Consensus 263 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~~ 342 (508)
|+++++|..++. .....+++..+..++.|++.||.|||+. +++||||||+||+++.++.+||+|||++......
T Consensus 90 ~~~~~~l~~~~~---~~~~~l~~~~~~~~~~ql~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~ 163 (292)
T cd06644 90 FCPGGAVDAIML---ELDRGLTEPQIQVICRQMLEALQYLHSM---KIIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKT 163 (292)
T ss_pred cCCCCcHHHHHH---hhcCCCCHHHHHHHHHHHHHHHHHHhcC---CeeecCCCcceEEEcCCCCEEEccCccceecccc
Confidence 999999998875 2345689999999999999999999998 9999999999999999999999999998754322
Q ss_pred CCcccccccccccccCccccC-----CCCCCChhhHHHHHHHHHHHHhCCCCCCCCCCCchhcHHHHHHHHhcccccccc
Q 010519 343 ESHITTRVMGTFGYVAPEYAN-----TGMLNEKSDIYSFGVLLLEAVTGRDPVDYGRPANEVNLVEWLKMMVGTRRAEEV 417 (508)
Q Consensus 343 ~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DvwS~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 417 (508)
. .......+++.|+|||++. ...++.++|||||||++|||++|..||....+ ............
T Consensus 164 ~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~------~~~~~~~~~~~~---- 232 (292)
T cd06644 164 L-QRRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNP------MRVLLKIAKSEP---- 232 (292)
T ss_pred c-cccceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCccccH------HHHHHHHhcCCC----
Confidence 1 1223446788999999884 34578899999999999999999999864321 111111111100
Q ss_pred cCCCCCCChhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHh
Q 010519 418 VDPNLEVKPATRALKRSLLVALRCVDPDSEKRPKMSQVVRML 459 (508)
Q Consensus 418 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L 459 (508)
+.. .........+.+++.+||..||++||++.+++++-
T Consensus 233 --~~~--~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~ 270 (292)
T cd06644 233 --PTL--SQPSKWSMEFRDFLKTALDKHPETRPSAAQLLEHP 270 (292)
T ss_pred --ccC--CCCcccCHHHHHHHHHHhcCCcccCcCHHHHhcCc
Confidence 111 11112234567799999999999999999998753
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. |
| >cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-38 Score=310.71 Aligned_cols=260 Identities=24% Similarity=0.421 Sum_probs=201.2
Q ss_pred CcccceeEeeeCceEEEEEEE-----cCCCEEEEEEEcccc-hhhHHHHHHHHHHHhcCCCCCceeEEEEEEeC--ceee
Q 010519 187 RFSAENVLGEGGYGVVYKGRL-----INGSEVAVKKLLNNL-GQAEKEFRVEVEAIGHVRHKNLVRLLGYCIEG--VHRM 258 (508)
Q Consensus 187 ~~~~~~~lg~G~~g~Vy~~~~-----~~~~~vavK~~~~~~-~~~~~~~~~ei~~l~~l~h~niv~~~~~~~~~--~~~~ 258 (508)
.|.+.+.||+|+||.||++++ .++..||+|.+.... ......+..|+.+++.++||||+++++++... ...+
T Consensus 5 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 84 (284)
T cd05079 5 FLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGIK 84 (284)
T ss_pred hhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccccHHHHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCCceE
Confidence 478889999999999999974 257789999886443 33346788999999999999999999998875 5678
Q ss_pred EEEeecCCCCHHHHHhhhhccCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCEEEcCCCcEEEEecCCccc
Q 010519 259 LVYEYVNNGNLEQWLHGAMRNQGNLTWEARMKVIIGTAKALAYLHEAIEPKVVHRDIKSSNILIDDEFNAKVSDFGLAKL 338 (508)
Q Consensus 259 lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~Dfgla~~ 338 (508)
+||||+++++|.+++.. ....+++..+..++.|++.||+|||++ +++||||||+||+++.++.++|+|||++..
T Consensus 85 lv~e~~~g~~L~~~l~~---~~~~~~~~~~~~i~~~i~~aL~~lH~~---gi~H~dlkp~Nil~~~~~~~~l~dfg~~~~ 158 (284)
T cd05079 85 LIMEFLPSGSLKEYLPR---NKNKINLKQQLKYAVQICKGMDYLGSR---QYVHRDLAARNVLVESEHQVKIGDFGLTKA 158 (284)
T ss_pred EEEEccCCCCHHHHHHh---ccCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecccchheEEEcCCCCEEECCCccccc
Confidence 99999999999999853 334689999999999999999999999 999999999999999999999999999986
Q ss_pred cCCCCCc--ccccccccccccCccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCC---------CchhcHHHHHHH
Q 010519 339 LDSGESH--ITTRVMGTFGYVAPEYANTGMLNEKSDIYSFGVLLLEAVTGRDPVDYGRP---------ANEVNLVEWLKM 407 (508)
Q Consensus 339 ~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltG~~Pf~~~~~---------~~~~~~~~~~~~ 407 (508)
....... ......++..|+|||++.+..++.++|||||||++|||++++.|+..... ........+...
T Consensus 159 ~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~ellt~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (284)
T cd05079 159 IETDKEYYTVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLTYCDSESSPMTLFLKMIGPTHGQMTVTRLVRV 238 (284)
T ss_pred cccCccceeecCCCCCCccccCHHHhccCCCCccccchhhhhhhhhhhcCCCCCccccchhhhhcccccccccHHHHHHH
Confidence 6433221 12234567789999999888899999999999999999998776432110 011111111111
Q ss_pred HhcccccccccCCCCCCChhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhhcC
Q 010519 408 MVGTRRAEEVVDPNLEVKPATRALKRSLLVALRCVDPDSEKRPKMSQVVRMLEAD 462 (508)
Q Consensus 408 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~ 462 (508)
..... ..+........+.+|+.+||+.||.+|||+.++++.|++.
T Consensus 239 ~~~~~----------~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~~~ 283 (284)
T cd05079 239 LEEGK----------RLPRPPNCPEEVYQLMRKCWEFQPSKRTTFQNLIEGFEAI 283 (284)
T ss_pred HHcCc----------cCCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHHhh
Confidence 11110 0111112345677899999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a |
| >cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-38 Score=310.82 Aligned_cols=257 Identities=28% Similarity=0.429 Sum_probs=202.2
Q ss_pred CCcccceeEeeeCceEEEEEEEc------CCCEEEEEEEcccchh-hHHHHHHHHHHHhcCCCCCceeEEEEEEeCceee
Q 010519 186 NRFSAENVLGEGGYGVVYKGRLI------NGSEVAVKKLLNNLGQ-AEKEFRVEVEAIGHVRHKNLVRLLGYCIEGVHRM 258 (508)
Q Consensus 186 ~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~-~~~~~~~ei~~l~~l~h~niv~~~~~~~~~~~~~ 258 (508)
++|.+.+.||+|+||.||+|+.. ....+++|.+...... ....+..|+.++++++|+||+++++++.+....+
T Consensus 5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 84 (275)
T cd05046 5 SNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVVRLLGLCREAEPHY 84 (275)
T ss_pred HhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCccchHHHHHHHHHHHHHHhcCCcceeeeEEEECCCCcce
Confidence 57889999999999999999864 2456888887554433 3467889999999999999999999999988999
Q ss_pred EEEeecCCCCHHHHHhhhhcc-----CCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCEEEcCCCcEEEEec
Q 010519 259 LVYEYVNNGNLEQWLHGAMRN-----QGNLTWEARMKVIIGTAKALAYLHEAIEPKVVHRDIKSSNILIDDEFNAKVSDF 333 (508)
Q Consensus 259 lv~E~~~~gsL~~~l~~~~~~-----~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~Df 333 (508)
+||||+++|+|.+++...... ...+++..+..++.|++.||.|||+. +|+|+||||+||+++.++.++|+||
T Consensus 85 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~---~i~H~dlkp~Nili~~~~~~~l~~~ 161 (275)
T cd05046 85 MILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNA---RFVHRDLAARNCLVSSQREVKVSLL 161 (275)
T ss_pred EEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhhc---CcccCcCccceEEEeCCCcEEEccc
Confidence 999999999999999642211 12689999999999999999999999 9999999999999999999999999
Q ss_pred CCccccCCCCCcccccccccccccCccccCCCCCCChhhHHHHHHHHHHHHh-CCCCCCCCCCCchhcHHHHHHHHhccc
Q 010519 334 GLAKLLDSGESHITTRVMGTFGYVAPEYANTGMLNEKSDIYSFGVLLLEAVT-GRDPVDYGRPANEVNLVEWLKMMVGTR 412 (508)
Q Consensus 334 gla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~ 412 (508)
|++...............++..|+|||.+.+..++.++||||||+++|+|++ |..||..... ... ...... .
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~~~~~p~~~~~~---~~~---~~~~~~-~ 234 (275)
T cd05046 162 SLSKDVYNSEYYKLRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLSD---EEV---LNRLQA-G 234 (275)
T ss_pred ccccccCcccccccCCceeEEeecChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCccccch---HHH---HHHHHc-C
Confidence 9987543332222333456778999999988888999999999999999999 7888853321 111 111110 0
Q ss_pred ccccccCCCCCCChhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhh
Q 010519 413 RAEEVVDPNLEVKPATRALKRSLLVALRCVDPDSEKRPKMSQVVRMLE 460 (508)
Q Consensus 413 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 460 (508)
. ............+.+++.+||+.||.+|||+.+++..|+
T Consensus 235 ~--------~~~~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~~l~~l~ 274 (275)
T cd05046 235 K--------LELPVPEGCPSRLYKLMTRCWAVNPKDRPSFSELVSALG 274 (275)
T ss_pred C--------cCCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhc
Confidence 1 001111122346777999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s |
| >KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-38 Score=309.20 Aligned_cols=267 Identities=26% Similarity=0.457 Sum_probs=196.2
Q ss_pred cccceeEeeeCceEEEEEEEcCCCEEEEEEEcccchhhHHHHHHHHHHHh--cCCCCCceeEEEEEEeCc----eeeEEE
Q 010519 188 FSAENVLGEGGYGVVYKGRLINGSEVAVKKLLNNLGQAEKEFRVEVEAIG--HVRHKNLVRLLGYCIEGV----HRMLVY 261 (508)
Q Consensus 188 ~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~ei~~l~--~l~h~niv~~~~~~~~~~----~~~lv~ 261 (508)
..+.++||+|.||.||+|++ +++.||||++.. +..+.|..|-++.+ .+.|+||++|++.-.... .++||+
T Consensus 212 l~l~eli~~Grfg~V~KaqL-~~~~VAVKifp~---~~kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~~~eywLVt 287 (534)
T KOG3653|consen 212 LQLLELIGRGRFGCVWKAQL-DNRLVAVKIFPE---QEKQSFQNEKNIYSLPGMKHENILQFIGAEKRGTADRMEYWLVT 287 (534)
T ss_pred hhhHHHhhcCccceeehhhc-cCceeEEEecCH---HHHHHHHhHHHHHhccCccchhHHHhhchhccCCccccceeEEe
Confidence 44567899999999999998 679999999753 33455666666654 468999999999766544 678999
Q ss_pred eecCCCCHHHHHhhhhccCCCccHHHHHHHHHHHHHHHHHHHhcC------CCCeEeecCCCCCEEEcCCCcEEEEecCC
Q 010519 262 EYVNNGNLEQWLHGAMRNQGNLTWEARMKVIIGTAKALAYLHEAI------EPKVVHRDIKSSNILIDDEFNAKVSDFGL 335 (508)
Q Consensus 262 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~------~~~iiH~Dlk~~NIll~~~~~~kl~Dfgl 335 (508)
+|.+.|+|.+||. ...++|....+|+..+++||+|||+.. +|+|+|||||++||||.+|+++.|+|||+
T Consensus 288 ~fh~kGsL~dyL~-----~ntisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlTccIaDFGL 362 (534)
T KOG3653|consen 288 EFHPKGSLCDYLK-----ANTISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLTCCIADFGL 362 (534)
T ss_pred eeccCCcHHHHHH-----hccccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCCcEEeeccce
Confidence 9999999999995 346899999999999999999999654 78999999999999999999999999999
Q ss_pred ccccCCCCCc-ccccccccccccCccccCCCC-CC-----ChhhHHHHHHHHHHHHhCCCCCC-CCCCCchhcH------
Q 010519 336 AKLLDSGESH-ITTRVMGTFGYVAPEYANTGM-LN-----EKSDIYSFGVLLLEAVTGRDPVD-YGRPANEVNL------ 401 (508)
Q Consensus 336 a~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~-~~-----~~~DvwS~Gvvl~elltG~~Pf~-~~~~~~~~~~------ 401 (508)
|..+..+... .....+||.+|||||++.+.- +. .+.||||+|.|||||++...-++ ...+.-...+
T Consensus 363 Al~~~p~~~~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~~~~~~vp~Yqlpfe~evG~ 442 (534)
T KOG3653|consen 363 ALRLEPGKPQGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTDADPGPVPEYQLPFEAEVGN 442 (534)
T ss_pred eEEecCCCCCcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhcccccCCCCCcccCchhHHhcC
Confidence 9987644332 233468999999999997632 22 37899999999999998543332 1111111111
Q ss_pred ---HHHHHHH-hcccccccccCCCCCCChhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhhcCCCCCc
Q 010519 402 ---VEWLKMM-VGTRRAEEVVDPNLEVKPATRALKRSLLVALRCVDPDSEKRPKMSQVVRMLEADDYPFR 467 (508)
Q Consensus 402 ---~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~~~ 467 (508)
.+.++.. ...+.-..+.+..... .....+.+.+..||+.||+-|.|+.=+-+.+.+.....+
T Consensus 443 hPt~e~mq~~VV~kK~RP~~p~~W~~h----~~~~~l~et~EeCWDhDaeARLTA~Cv~eR~~~l~~~~~ 508 (534)
T KOG3653|consen 443 HPTLEEMQELVVRKKQRPKIPDAWRKH----AGMAVLCETIEECWDHDAEARLTAGCVEERMAELMMLWE 508 (534)
T ss_pred CCCHHHHHHHHHhhccCCCChhhhhcC----ccHHHHHHHHHHHcCCchhhhhhhHHHHHHHHHHhccCC
Confidence 1111111 1111111121111111 345567778899999999999999999888887665543
|
|
| >cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-38 Score=312.53 Aligned_cols=265 Identities=25% Similarity=0.371 Sum_probs=204.8
Q ss_pred eHHHHHHhhCCcccceeEeeeCceEEEEEEEc-CCCEEEEEEEcccchhhHHHHHHHHHHHhcC-CCCCceeEEEEEE--
Q 010519 177 TLRDLEIATNRFSAENVLGEGGYGVVYKGRLI-NGSEVAVKKLLNNLGQAEKEFRVEVEAIGHV-RHKNLVRLLGYCI-- 252 (508)
Q Consensus 177 ~~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~ei~~l~~l-~h~niv~~~~~~~-- 252 (508)
.++.+..+.++|++.+.||+|+||.||++.+. ++..+|+|.+.... .....+..|+.++..+ +||||+++++++.
T Consensus 9 ~~~~~~~~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~-~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~ 87 (286)
T cd06638 9 IFDSFPDPSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIH-DIDEEIEAEYNILKALSDHPNVVKFYGMYYKK 87 (286)
T ss_pred EeecCCCcccceeeeeeeccCCCcEEEEEEECCCCceeEEEeecccc-chHHHHHHHHHHHHHHhcCCCeeeeeeeeeec
Confidence 34555667789999999999999999999875 57889999765432 2235677899999999 6999999999884
Q ss_pred ---eCceeeEEEeecCCCCHHHHHhhhhccCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCEEEcCCCcEE
Q 010519 253 ---EGVHRMLVYEYVNNGNLEQWLHGAMRNQGNLTWEARMKVIIGTAKALAYLHEAIEPKVVHRDIKSSNILIDDEFNAK 329 (508)
Q Consensus 253 ---~~~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiH~Dlk~~NIll~~~~~~k 329 (508)
.+...++||||+++++|.+++.........+++..+..++.|++.||.|||+. +++||||||+||++++++.+|
T Consensus 88 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~nili~~~~~~k 164 (286)
T cd06638 88 DVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHVN---KTIHRDVKGNNILLTTEGGVK 164 (286)
T ss_pred ccCCCCeEEEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHHhC---CccccCCCHHhEEECCCCCEE
Confidence 34568999999999999999875444556788999999999999999999998 999999999999999999999
Q ss_pred EEecCCccccCCCCCcccccccccccccCccccCC-----CCCCChhhHHHHHHHHHHHHhCCCCCCCCCCCchhcHHHH
Q 010519 330 VSDFGLAKLLDSGESHITTRVMGTFGYVAPEYANT-----GMLNEKSDIYSFGVLLLEAVTGRDPVDYGRPANEVNLVEW 404 (508)
Q Consensus 330 l~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~DvwS~Gvvl~elltG~~Pf~~~~~~~~~~~~~~ 404 (508)
|+|||++........ ......|++.|+|||++.. ..++.++|||||||++|||++|+.||....+.. ..
T Consensus 165 l~dfg~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~~~~~-----~~ 238 (286)
T cd06638 165 LVDFGVSAQLTSTRL-RRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPMR-----AL 238 (286)
T ss_pred EccCCceeecccCCC-ccccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCCCchhH-----HH
Confidence 999999986543221 1233468999999998853 457889999999999999999999986443211 11
Q ss_pred HHHHhcccccccccCCCCCCChhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhh
Q 010519 405 LKMMVGTRRAEEVVDPNLEVKPATRALKRSLLVALRCVDPDSEKRPKMSQVVRMLE 460 (508)
Q Consensus 405 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 460 (508)
. ..... . .+... .+......+.+++.+||+.||.+|||+.|+++++.
T Consensus 239 ~-~~~~~-~-----~~~~~--~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~~~ 285 (286)
T cd06638 239 F-KIPRN-P-----PPTLH--QPELWSNEFNDFIRKCLTKDYEKRPTVSDLLQHVF 285 (286)
T ss_pred h-hcccc-C-----CCccc--CCCCcCHHHHHHHHHHccCCcccCCCHHHHhhccc
Confidence 1 11000 0 01110 01112345667999999999999999999998753
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear |
| >cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-38 Score=311.38 Aligned_cols=259 Identities=24% Similarity=0.398 Sum_probs=205.5
Q ss_pred hCCcccceeEeeeCceEEEEEEEc-CCCEEEEEEEcccc-hhhHHHHHHHHHHHhcCCCCCceeEEEEEEeCceeeEEEe
Q 010519 185 TNRFSAENVLGEGGYGVVYKGRLI-NGSEVAVKKLLNNL-GQAEKEFRVEVEAIGHVRHKNLVRLLGYCIEGVHRMLVYE 262 (508)
Q Consensus 185 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~ei~~l~~l~h~niv~~~~~~~~~~~~~lv~E 262 (508)
.++|++.+.||+|+||+||++.+. ++..+|+|.+.... ......+..|+++++.++||||+++++++......++|||
T Consensus 4 ~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 83 (284)
T cd06620 4 NEDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYGAFLNENNICMCME 83 (284)
T ss_pred HHHHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecCcchHHHHHHHHHHHHHHcCCCCcceEeeeEecCCEEEEEEe
Confidence 457888999999999999999875 58889999876443 3345678899999999999999999999999999999999
Q ss_pred ecCCCCHHHHHhhhhccCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCEEEcCCCcEEEEecCCccccCCC
Q 010519 263 YVNNGNLEQWLHGAMRNQGNLTWEARMKVIIGTAKALAYLHEAIEPKVVHRDIKSSNILIDDEFNAKVSDFGLAKLLDSG 342 (508)
Q Consensus 263 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~~ 342 (508)
|+++++|.+++. ..+.+++..+..++.+++.||.|||+.. +++|+||+|+||++++++.++|+|||++......
T Consensus 84 ~~~~~~L~~~~~----~~~~~~~~~~~~~~~~i~~~l~~LH~~~--~i~H~dl~p~nil~~~~~~~~l~d~gl~~~~~~~ 157 (284)
T cd06620 84 FMDCGSLDRIYK----KGGPIPVEILGKIAVAVVEGLTYLYNVH--RIMHRDIKPSNILVNSRGQIKLCDFGVSGELINS 157 (284)
T ss_pred cCCCCCHHHHHH----hccCCCHHHHHHHHHHHHHHHHHHHHhc--CeeccCCCHHHEEECCCCcEEEccCCcccchhhh
Confidence 999999999884 3457899999999999999999999632 8999999999999999999999999998754322
Q ss_pred CCcccccccccccccCccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCCCc-----hhcHHHHHHHHhcccccccc
Q 010519 343 ESHITTRVMGTFGYVAPEYANTGMLNEKSDIYSFGVLLLEAVTGRDPVDYGRPAN-----EVNLVEWLKMMVGTRRAEEV 417 (508)
Q Consensus 343 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltG~~Pf~~~~~~~-----~~~~~~~~~~~~~~~~~~~~ 417 (508)
. .....|+..|+|||++.+..++.++|||||||++|+|++|..||....... .....++........
T Consensus 158 ~---~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~----- 229 (284)
T cd06620 158 I---ADTFVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDLLQQIVQEP----- 229 (284)
T ss_pred c---cCccccCcccCCHHHHccCCCCccchHHHHHHHHHHHHhCCCCCcccchhhhhhhhhhHHHHHHHHHhhcc-----
Confidence 1 223568999999999988899999999999999999999999997443211 111122222221110
Q ss_pred cCCCCCCChhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhhc
Q 010519 418 VDPNLEVKPATRALKRSLLVALRCVDPDSEKRPKMSQVVRMLEA 461 (508)
Q Consensus 418 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~ 461 (508)
.+.+ +.......+.+|+.+||+.||.+|||+.|++++..-
T Consensus 230 -~~~~---~~~~~~~~~~~li~~~l~~dp~~Rpt~~e~~~~~~~ 269 (284)
T cd06620 230 -PPRL---PSSDFPEDLRDFVDACLLKDPTERPTPQQLCAMPPF 269 (284)
T ss_pred -CCCC---CchhcCHHHHHHHHHHhcCCcccCcCHHHHhcCccc
Confidence 0111 111234567779999999999999999999987543
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-38 Score=319.78 Aligned_cols=265 Identities=27% Similarity=0.437 Sum_probs=206.4
Q ss_pred HHHhhCCcccceeEeeeCceEEEEEEEcC--------CCEEEEEEEcccc-hhhHHHHHHHHHHHhcC-CCCCceeEEEE
Q 010519 181 LEIATNRFSAENVLGEGGYGVVYKGRLIN--------GSEVAVKKLLNNL-GQAEKEFRVEVEAIGHV-RHKNLVRLLGY 250 (508)
Q Consensus 181 ~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~--------~~~vavK~~~~~~-~~~~~~~~~ei~~l~~l-~h~niv~~~~~ 250 (508)
+++...+|.+.+.||+|+||.||++.+.. +..+|+|.+.... ......+..|+.+++++ +||||++++++
T Consensus 7 ~~~~~~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~ 86 (334)
T cd05100 7 WELSRTRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKNIINLLGA 86 (334)
T ss_pred cccCHhHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccccCHHHHHHHHHHHHHHHhhcCCCCeeeeeEE
Confidence 45556689999999999999999997531 2368999776433 33346788899999999 79999999999
Q ss_pred EEeCceeeEEEeecCCCCHHHHHhhhhc------------cCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCC
Q 010519 251 CIEGVHRMLVYEYVNNGNLEQWLHGAMR------------NQGNLTWEARMKVIIGTAKALAYLHEAIEPKVVHRDIKSS 318 (508)
Q Consensus 251 ~~~~~~~~lv~E~~~~gsL~~~l~~~~~------------~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiH~Dlk~~ 318 (508)
|......+++|||+++|+|.+++..... ....+++..++.++.|++.||.|||++ +++||||||+
T Consensus 87 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~---givH~dlkp~ 163 (334)
T cd05100 87 CTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQ---KCIHRDLAAR 163 (334)
T ss_pred EccCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHC---Ceeccccccc
Confidence 9999999999999999999999964211 223578899999999999999999998 9999999999
Q ss_pred CEEEcCCCcEEEEecCCccccCCCCCc-ccccccccccccCccccCCCCCCChhhHHHHHHHHHHHHh-CCCCCCCCCCC
Q 010519 319 NILIDDEFNAKVSDFGLAKLLDSGESH-ITTRVMGTFGYVAPEYANTGMLNEKSDIYSFGVLLLEAVT-GRDPVDYGRPA 396 (508)
Q Consensus 319 NIll~~~~~~kl~Dfgla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~ellt-G~~Pf~~~~~~ 396 (508)
|||+++++.+||+|||+++........ ......++..|+|||++.+..++.++|||||||+||||++ |..||....
T Consensus 164 Nill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~-- 241 (334)
T cd05100 164 NVLVTEDNVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIP-- 241 (334)
T ss_pred eEEEcCCCcEEECCcccceecccccccccccCCCcCceEcCHHHhccCCcCchhhhHHHHHHHHHHHhcCCCCCCCCC--
Confidence 999999999999999999865432211 1122234567999999999999999999999999999998 888885332
Q ss_pred chhcHHHHHHHHhcccccccccCCCCCCChhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhhcCCC
Q 010519 397 NEVNLVEWLKMMVGTRRAEEVVDPNLEVKPATRALKRSLLVALRCVDPDSEKRPKMSQVVRMLEADDY 464 (508)
Q Consensus 397 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~ 464 (508)
..++......... ...+......+.+++.+||+.+|.+|||+.++++.|+....
T Consensus 242 ----~~~~~~~~~~~~~----------~~~~~~~~~~l~~li~~cl~~~p~~Rps~~ell~~l~~~~~ 295 (334)
T cd05100 242 ----VEELFKLLKEGHR----------MDKPANCTHELYMIMRECWHAVPSQRPTFKQLVEDLDRVLT 295 (334)
T ss_pred ----HHHHHHHHHcCCC----------CCCCCCCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHhh
Confidence 2222222221111 01111223456679999999999999999999999987653
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >PRK13184 pknD serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-38 Score=342.62 Aligned_cols=260 Identities=24% Similarity=0.369 Sum_probs=201.8
Q ss_pred CCcccceeEeeeCceEEEEEEEc-CCCEEEEEEEcccc---hhhHHHHHHHHHHHhcCCCCCceeEEEEEEeCceeeEEE
Q 010519 186 NRFSAENVLGEGGYGVVYKGRLI-NGSEVAVKKLLNNL---GQAEKEFRVEVEAIGHVRHKNLVRLLGYCIEGVHRMLVY 261 (508)
Q Consensus 186 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~ei~~l~~l~h~niv~~~~~~~~~~~~~lv~ 261 (508)
++|.+.+.||+|+||.||+|++. +|+.||+|++.... ......+.+|+.++++++||||+++++++.+.+..++||
T Consensus 2 grYeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d~~~lyLVM 81 (932)
T PRK13184 2 QRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICSDGDPVYYTM 81 (932)
T ss_pred CCeEEEEEEecCCCEEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEeeCCEEEEEE
Confidence 47999999999999999999875 58899999986532 233457888999999999999999999999999999999
Q ss_pred eecCCCCHHHHHhhhhcc-------CCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCEEEcCCCcEEEEecC
Q 010519 262 EYVNNGNLEQWLHGAMRN-------QGNLTWEARMKVIIGTAKALAYLHEAIEPKVVHRDIKSSNILIDDEFNAKVSDFG 334 (508)
Q Consensus 262 E~~~~gsL~~~l~~~~~~-------~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~Dfg 334 (508)
||++||+|.+++...... ...+++..++.++.||+.||.|||+. +|+||||||+|||++.++.+||+|||
T Consensus 82 EY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~---GIIHRDLKPeNILLd~dg~vKLiDFG 158 (932)
T PRK13184 82 PYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSK---GVLHRDLKPDNILLGLFGEVVILDWG 158 (932)
T ss_pred EcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHC---CccccCCchheEEEcCCCCEEEEecC
Confidence 999999999998643211 23456677899999999999999999 99999999999999999999999999
Q ss_pred CccccCCCC-----------------CcccccccccccccCccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCCCc
Q 010519 335 LAKLLDSGE-----------------SHITTRVMGTFGYVAPEYANTGMLNEKSDIYSFGVLLLEAVTGRDPVDYGRPAN 397 (508)
Q Consensus 335 la~~~~~~~-----------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltG~~Pf~~~~~~~ 397 (508)
++....... .......+||+.|+|||++.+..++.++|||||||++|||++|..||.......
T Consensus 159 LAk~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~~~S~kSDIWSLGVILyELLTG~~PF~~~~~~k 238 (932)
T PRK13184 159 AAIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPYRRKKGRK 238 (932)
T ss_pred cceecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCCCCCcHhHHHHHHHHHHHHHHCCCCCCCcchhh
Confidence 998652110 001123579999999999999999999999999999999999999996432111
Q ss_pred hhcHHHHHHHHhcccccccccCCCCCCChhHHHHHHHHHHHHHhcCCCCCCCC-CHHHHHHHhhcC
Q 010519 398 EVNLVEWLKMMVGTRRAEEVVDPNLEVKPATRALKRSLLVALRCVDPDSEKRP-KMSQVVRMLEAD 462 (508)
Q Consensus 398 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-s~~evl~~L~~~ 462 (508)
.. .... ...+ ....+....+..+.+++.+||+.||.+|| +++++++.|+..
T Consensus 239 ---i~--~~~~--------i~~P-~~~~p~~~iP~~L~~LI~rcL~~DP~kR~ss~eeLl~~Le~~ 290 (932)
T PRK13184 239 ---IS--YRDV--------ILSP-IEVAPYREIPPFLSQIAMKALAVDPAERYSSVQELKQDLEPH 290 (932)
T ss_pred ---hh--hhhh--------ccCh-hhccccccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence 00 0000 0000 00111112334566789999999999996 567777766653
|
|
| >cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-38 Score=303.05 Aligned_cols=251 Identities=24% Similarity=0.348 Sum_probs=203.1
Q ss_pred CcccceeEeeeCceEEEEEEEc-CCCEEEEEEEcccc--hhhHHHHHHHHHHHhcCCCCCceeEEEEEEeCceeeEEEee
Q 010519 187 RFSAENVLGEGGYGVVYKGRLI-NGSEVAVKKLLNNL--GQAEKEFRVEVEAIGHVRHKNLVRLLGYCIEGVHRMLVYEY 263 (508)
Q Consensus 187 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~ei~~l~~l~h~niv~~~~~~~~~~~~~lv~E~ 263 (508)
+|+..+.||.|+||.||.++.. ++..+++|++.... ......+.+|+.++++++|+||+++++++.+....+++|||
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~~~e~ 80 (256)
T cd08221 1 HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNHFMDDNTLLIEMEY 80 (256)
T ss_pred CceEeeEecccCCceEEEEEEcCCCcEEEEEEEeecccchhHHHHHHHHHHHHHhCCCCCeeEEEeEEecCCeEEEEEEe
Confidence 5888999999999999998764 68889999875432 33445688899999999999999999999999999999999
Q ss_pred cCCCCHHHHHhhhhccCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCEEEcCCCcEEEEecCCccccCCCC
Q 010519 264 VNNGNLEQWLHGAMRNQGNLTWEARMKVIIGTAKALAYLHEAIEPKVVHRDIKSSNILIDDEFNAKVSDFGLAKLLDSGE 343 (508)
Q Consensus 264 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~~~ 343 (508)
+++++|.+++... ....+++..+..++.|++.||.|||+. +++|+||+|+||++++++.+||+|||++.......
T Consensus 81 ~~~~~L~~~~~~~--~~~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~dl~p~ni~~~~~~~~kl~d~~~~~~~~~~~ 155 (256)
T cd08221 81 ANGGTLYDKIVRQ--KGQLFEEEMVLWYLFQIVSAVSYIHKA---GILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEY 155 (256)
T ss_pred cCCCcHHHHHHhc--cccCCCHHHHHHHHHHHHHHHHHHHhC---CccccCCChHhEEEeCCCCEEECcCcceEEccccc
Confidence 9999999998642 245689999999999999999999998 99999999999999999999999999998664333
Q ss_pred CcccccccccccccCccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCCCchhcHHHHHHHHhcccccccccCCCCC
Q 010519 344 SHITTRVMGTFGYVAPEYANTGMLNEKSDIYSFGVLLLEAVTGRDPVDYGRPANEVNLVEWLKMMVGTRRAEEVVDPNLE 423 (508)
Q Consensus 344 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 423 (508)
. ......+++.|+|||++.+..++.++||||||+++|+|++|..||..... .+....... .. ..
T Consensus 156 ~-~~~~~~~~~~y~ape~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~------~~~~~~~~~-~~--------~~ 219 (256)
T cd08221 156 S-MAETVVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKRTFDATNP------LNLVVKIVQ-GN--------YT 219 (256)
T ss_pred c-cccccCCCccccCHhhcCCCCCCCcchhHHHHHHHHHHHHCCCCCCCCCH------HHHHHHHHc-CC--------CC
Confidence 2 23345689999999999888899999999999999999999999864322 111111111 10 00
Q ss_pred CChhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHh
Q 010519 424 VKPATRALKRSLLVALRCVDPDSEKRPKMSQVVRML 459 (508)
Q Consensus 424 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L 459 (508)
. ........+.+++.+||..+|.+||++.++++++
T Consensus 220 ~-~~~~~~~~~~~~i~~~l~~~p~~R~s~~~ll~~~ 254 (256)
T cd08221 220 P-VVSVYSSELISLVHSLLQQDPEKRPTADEVLDQP 254 (256)
T ss_pred C-CccccCHHHHHHHHHHcccCcccCCCHHHHhhCc
Confidence 0 0122244566799999999999999999999865
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa |
| >cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-38 Score=310.30 Aligned_cols=253 Identities=26% Similarity=0.421 Sum_probs=197.9
Q ss_pred hhCCcccceeEeeeCceEEEEEEEc-CCCEEEEEEEcccchhhHHHHHHHHHHHhcC-CCCCceeEEEEEEeC------c
Q 010519 184 ATNRFSAENVLGEGGYGVVYKGRLI-NGSEVAVKKLLNNLGQAEKEFRVEVEAIGHV-RHKNLVRLLGYCIEG------V 255 (508)
Q Consensus 184 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~ei~~l~~l-~h~niv~~~~~~~~~------~ 255 (508)
+.+.|++.+.||+|+||.||+|.+. .++.+|+|.+.... .....+..|+.++.++ +|+||+++++++... .
T Consensus 4 ~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~-~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~ 82 (272)
T cd06637 4 PAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG-DEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDD 82 (272)
T ss_pred hhhhhhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcCC-ccHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCCCCc
Confidence 4567888999999999999999875 57789999875443 3345678899999998 799999999998753 4
Q ss_pred eeeEEEeecCCCCHHHHHhhhhccCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCEEEcCCCcEEEEecCC
Q 010519 256 HRMLVYEYVNNGNLEQWLHGAMRNQGNLTWEARMKVIIGTAKALAYLHEAIEPKVVHRDIKSSNILIDDEFNAKVSDFGL 335 (508)
Q Consensus 256 ~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~Dfgl 335 (508)
..+++|||+++++|.+++.. .....+++..+..++.|++.||.|||+. +|+|+||||+||++++++.+||+|||+
T Consensus 83 ~~~iv~e~~~~~~L~~~l~~--~~~~~l~~~~~~~~~~qi~~~l~~LH~~---~ivh~dl~~~nili~~~~~~~l~Dfg~ 157 (272)
T cd06637 83 QLWLVMEFCGAGSVTDLIKN--TKGNTLKEEWIAYICREILRGLSHLHQH---KVIHRDIKGQNVLLTENAEVKLVDFGV 157 (272)
T ss_pred EEEEEEEcCCCCcHHHHHHh--ccCCCCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCCHHHEEECCCCCEEEccCCC
Confidence 57899999999999999864 2345688999999999999999999998 999999999999999999999999999
Q ss_pred ccccCCCCCcccccccccccccCccccC-----CCCCCChhhHHHHHHHHHHHHhCCCCCCCCCCCchhcHHHHHHHHhc
Q 010519 336 AKLLDSGESHITTRVMGTFGYVAPEYAN-----TGMLNEKSDIYSFGVLLLEAVTGRDPVDYGRPANEVNLVEWLKMMVG 410 (508)
Q Consensus 336 a~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DvwS~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~ 410 (508)
+........ ......|++.|+|||++. +..++.++|||||||++|||++|..||....+. .......
T Consensus 158 ~~~~~~~~~-~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~~~~-----~~~~~~~-- 229 (272)
T cd06637 158 SAQLDRTVG-RRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPM-----RALFLIP-- 229 (272)
T ss_pred ceecccccc-cCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCccccCHH-----HHHHHHh--
Confidence 986543221 233456899999999986 346888999999999999999999999633211 1111110
Q ss_pred ccccccccCCCCCCChhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 010519 411 TRRAEEVVDPNLEVKPATRALKRSLLVALRCVDPDSEKRPKMSQVVRM 458 (508)
Q Consensus 411 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 458 (508)
... ..... .......+.+|+.+||..||.+|||+.+++++
T Consensus 230 ~~~-----~~~~~---~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~ 269 (272)
T cd06637 230 RNP-----APRLK---SKKWSKKFQSFIESCLVKNHSQRPTTEQLMKH 269 (272)
T ss_pred cCC-----CCCCC---CCCcCHHHHHHHHHHcCCChhhCCCHHHHhhC
Confidence 000 01111 11123456779999999999999999999875
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ |
| >cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-38 Score=309.18 Aligned_cols=239 Identities=26% Similarity=0.397 Sum_probs=187.0
Q ss_pred eEeeeCceEEEEEEEcC-------------------------CCEEEEEEEcccchhhHHHHHHHHHHHhcCCCCCceeE
Q 010519 193 VLGEGGYGVVYKGRLIN-------------------------GSEVAVKKLLNNLGQAEKEFRVEVEAIGHVRHKNLVRL 247 (508)
Q Consensus 193 ~lg~G~~g~Vy~~~~~~-------------------------~~~vavK~~~~~~~~~~~~~~~ei~~l~~l~h~niv~~ 247 (508)
.||+|+||.||+|.+.. ...|++|.+..........+.+|+.+++.++||||+++
T Consensus 2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~~~~l~h~niv~~ 81 (274)
T cd05076 2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSHRDIALAFFETASLMSQVSHIHLAFV 81 (274)
T ss_pred CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHHHHHHHHHHHHHHHHhcCCCCCeeeE
Confidence 59999999999997521 13588888765444445678889999999999999999
Q ss_pred EEEEEeCceeeEEEeecCCCCHHHHHhhhhccCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCEEEcCCC-
Q 010519 248 LGYCIEGVHRMLVYEYVNNGNLEQWLHGAMRNQGNLTWEARMKVIIGTAKALAYLHEAIEPKVVHRDIKSSNILIDDEF- 326 (508)
Q Consensus 248 ~~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiH~Dlk~~NIll~~~~- 326 (508)
+++|......++||||+++|+|..++. ...+.+++..+..++.||+.||.|||++ +|+||||||+|||++..+
T Consensus 82 ~~~~~~~~~~~lv~ey~~~g~L~~~l~---~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~iiH~dlkp~Nill~~~~~ 155 (274)
T cd05076 82 HGVCVRGSENIMVEEFVEHGPLDVCLR---KEKGRVPVAWKITVAQQLASALSYLEDK---NLVHGNVCAKNILLARLGL 155 (274)
T ss_pred EEEEEeCCceEEEEecCCCCcHHHHHH---hcCCCCCHHHHHHHHHHHHHHHHHHHcC---CccCCCCCcccEEEeccCc
Confidence 999999999999999999999999885 3456788999999999999999999998 999999999999997654
Q ss_pred ------cEEEEecCCccccCCCCCcccccccccccccCccccCC-CCCCChhhHHHHHHHHHHHH-hCCCCCCCCCCCch
Q 010519 327 ------NAKVSDFGLAKLLDSGESHITTRVMGTFGYVAPEYANT-GMLNEKSDIYSFGVLLLEAV-TGRDPVDYGRPANE 398 (508)
Q Consensus 327 ------~~kl~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwS~Gvvl~ell-tG~~Pf~~~~~~~~ 398 (508)
.+|++|||++...... ....++..|+|||.+.+ ..++.++|||||||++|||+ +|..||....+...
T Consensus 156 ~~~~~~~~kl~d~g~~~~~~~~-----~~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~ 230 (274)
T cd05076 156 AEGTSPFIKLSDPGVSFTALSR-----EERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKERTPSEK 230 (274)
T ss_pred ccCccceeeecCCccccccccc-----cccccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCccccChHHH
Confidence 3899999988644322 12346788999998865 56899999999999999995 68999864432211
Q ss_pred hcHHHHHHHHhcccccccccCCCCCCChhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhh
Q 010519 399 VNLVEWLKMMVGTRRAEEVVDPNLEVKPATRALKRSLLVALRCVDPDSEKRPKMSQVVRMLE 460 (508)
Q Consensus 399 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 460 (508)
..+... . ...... ....+.+++.+||+.+|.+|||+.++++.|.
T Consensus 231 ---~~~~~~---~--------~~~~~~----~~~~~~~li~~cl~~~p~~Rps~~~il~~L~ 274 (274)
T cd05076 231 ---ERFYEK---K--------HRLPEP----SCKELATLISQCLTYEPTQRPSFRTILRDLT 274 (274)
T ss_pred ---HHHHHh---c--------cCCCCC----CChHHHHHHHHHcccChhhCcCHHHHHHhhC
Confidence 111110 0 000000 1235677999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt |
| >KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-38 Score=325.88 Aligned_cols=274 Identities=24% Similarity=0.288 Sum_probs=207.5
Q ss_pred eeHHHHHHhhCCcccceeEeeeCceEEEEEEEc-CCCEEEEEEEcccchhhHHHHHHHHHHHhcCC-C-----CCceeEE
Q 010519 176 FTLRDLEIATNRFSAENVLGEGGYGVVYKGRLI-NGSEVAVKKLLNNLGQAEKEFRVEVEAIGHVR-H-----KNLVRLL 248 (508)
Q Consensus 176 ~~~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~ei~~l~~l~-h-----~niv~~~ 248 (508)
|.+..-+...-+|.+.+.||+|+||.|.+|.+. +++.||||++.++..- ..+-..|+.+|..|+ | -|+|+++
T Consensus 176 Y~~v~~d~i~~rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~k~f-~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~ 254 (586)
T KOG0667|consen 176 YQLVVNDHIAYRYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNKKRF-LRQAQIEIRILELLNKHDPDDKYNIVRML 254 (586)
T ss_pred eeEEecceeEEEEEEEEEecccccceeEEEEecCCCcEEEEEeeccChHH-HHHHHHHHHHHHHHhccCCCCCeeEEEee
Confidence 333334444558999999999999999999864 6899999998766543 344556999999997 4 3899999
Q ss_pred EEEEeCceeeEEEeecCCCCHHHHHhhhhccCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCEEEcCCC--
Q 010519 249 GYCIEGVHRMLVYEYVNNGNLEQWLHGAMRNQGNLTWEARMKVIIGTAKALAYLHEAIEPKVVHRDIKSSNILIDDEF-- 326 (508)
Q Consensus 249 ~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiH~Dlk~~NIll~~~~-- 326 (508)
++|...+++|||+|.+. -+|+++|+. .+...++...++.++.||+.||.+||+. +|||+||||+||||.+.+
T Consensus 255 d~F~fr~HlciVfELL~-~NLYellK~--n~f~Glsl~~ir~~~~Qil~~L~~L~~l---~IIHcDLKPENILL~~~~r~ 328 (586)
T KOG0667|consen 255 DYFYFRNHLCIVFELLS-TNLYELLKN--NKFRGLSLPLVRKFAQQILTALLFLHEL---GIIHCDLKPENILLKDPKRS 328 (586)
T ss_pred eccccccceeeeehhhh-hhHHHHHHh--cCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeccCChhheeeccCCcC
Confidence 99999999999999995 599999975 4566799999999999999999999998 999999999999997544
Q ss_pred cEEEEecCCccccCCCCCcccccccccccccCccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCCCchhcHHHHHH
Q 010519 327 NAKVSDFGLAKLLDSGESHITTRVMGTFGYVAPEYANTGMLNEKSDIYSFGVLLLEAVTGRDPVDYGRPANEVNLVEWLK 406 (508)
Q Consensus 327 ~~kl~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~ 406 (508)
.+||+|||.++...... . ..+-+..|.|||++.|.+|+.+.||||||||+.||++|.+-|......+.. ..+.
T Consensus 329 ~vKVIDFGSSc~~~q~v---y-tYiQSRfYRAPEVILGlpY~~~IDmWSLGCIlAEL~tG~PLfpG~ne~DQl---~~I~ 401 (586)
T KOG0667|consen 329 RIKVIDFGSSCFESQRV---Y-TYIQSRFYRAPEVILGLPYDTAIDMWSLGCILAELFTGEPLFPGDNEYDQL---ARII 401 (586)
T ss_pred ceeEEecccccccCCcc---e-eeeeccccccchhhccCCCCCccceeehhhhHHhHhcCccccCCCCHHHHH---HHHH
Confidence 59999999999765432 2 345688999999999999999999999999999999997767544332222 1111
Q ss_pred HHhccc---------ccccccCC---------------------------------CCC-------CChhHHHHHHHHHH
Q 010519 407 MMVGTR---------RAEEVVDP---------------------------------NLE-------VKPATRALKRSLLV 437 (508)
Q Consensus 407 ~~~~~~---------~~~~~~~~---------------------------------~~~-------~~~~~~~~~~l~~l 437 (508)
.+++.. ......+. ... .......-..++++
T Consensus 402 e~lG~Pp~~mL~~~~~~~kff~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~P~~~~~l~~~~~~~~~~~F~df 481 (586)
T KOG0667|consen 402 EVLGLPPPKMLDTAKKAHKFFTSLKGFPRLCVETSAPRGTKSPEVRKYYRKARLERRGPPGSRSLESGLPKADDKLFIDF 481 (586)
T ss_pred HHhCCCCHHHHHhccccceehhccCCceeeeeeecccccccchhhhhhhhhhcccccCCCCCcccchhcccccHHHHHHH
Confidence 111110 00000000 000 00011223456789
Q ss_pred HHHhcCCCCCCCCCHHHHHHHhhcCC
Q 010519 438 ALRCVDPDSEKRPKMSQVVRMLEADD 463 (508)
Q Consensus 438 i~~cl~~dP~~RPs~~evl~~L~~~~ 463 (508)
+.+||..||.+|+|+.|+++|-.-..
T Consensus 482 lk~~L~~dP~~R~tp~qal~Hpfl~~ 507 (586)
T KOG0667|consen 482 LKRCLEWDPAERITPAQALNHPFLTG 507 (586)
T ss_pred HHHHhccCchhcCCHHHHhcCccccc
Confidence 99999999999999999999876553
|
|
| >cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-38 Score=303.24 Aligned_cols=250 Identities=23% Similarity=0.336 Sum_probs=200.4
Q ss_pred CcccceeEeeeCceEEEEEEEc-CCCEEEEEEEcccc--hhhHHHHHHHHHHHhcCCCCCceeEEEEEEe-CceeeEEEe
Q 010519 187 RFSAENVLGEGGYGVVYKGRLI-NGSEVAVKKLLNNL--GQAEKEFRVEVEAIGHVRHKNLVRLLGYCIE-GVHRMLVYE 262 (508)
Q Consensus 187 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~ei~~l~~l~h~niv~~~~~~~~-~~~~~lv~E 262 (508)
+|++.+.||+|++|.||++... +++.+++|++.... ....+.+..|++++++++|+|++++++.+.. ....+++||
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e 80 (257)
T cd08223 1 AYCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRESWEGEDGLLYIVMG 80 (257)
T ss_pred CceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhcCHHHHHHHHHHHHHHHhCCCCCeeeeeeeecCCCCEEEEEec
Confidence 4888999999999999999875 57889999985432 2334568889999999999999999998764 446789999
Q ss_pred ecCCCCHHHHHhhhhccCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCEEEcCCCcEEEEecCCccccCCC
Q 010519 263 YVNNGNLEQWLHGAMRNQGNLTWEARMKVIIGTAKALAYLHEAIEPKVVHRDIKSSNILIDDEFNAKVSDFGLAKLLDSG 342 (508)
Q Consensus 263 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~~ 342 (508)
|+++++|.+++.. .....+++..++.++.+++.||.|||+. +++|+||+|+||+++.++.++|+|||++......
T Consensus 81 ~~~~~~l~~~l~~--~~~~~l~~~~~~~~~~~l~~~l~~lH~~---~i~H~di~p~nil~~~~~~~~l~df~~~~~~~~~ 155 (257)
T cd08223 81 FCEGGDLYHKLKE--QKGKLLPENQVVEWFVQIAMALQYLHEK---HILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQ 155 (257)
T ss_pred ccCCCcHHHHHHH--hcCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCchhEEEecCCcEEEecccceEEeccc
Confidence 9999999999964 2345689999999999999999999999 9999999999999999999999999999866433
Q ss_pred CCcccccccccccccCccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCCCchhcHHHHHHHHhcccccccccCCCC
Q 010519 343 ESHITTRVMGTFGYVAPEYANTGMLNEKSDIYSFGVLLLEAVTGRDPVDYGRPANEVNLVEWLKMMVGTRRAEEVVDPNL 422 (508)
Q Consensus 343 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 422 (508)
.. ......+++.|+|||++.+..++.++||||||+++|+|++|+.||..... ........... . +.
T Consensus 156 ~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~------~~~~~~~~~~~-~-----~~- 221 (257)
T cd08223 156 CD-MASTLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFNAKDM------NSLVYRIIEGK-L-----PP- 221 (257)
T ss_pred CC-ccccccCCcCccChhHhcCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCH------HHHHHHHHhcC-C-----CC-
Confidence 22 23345688999999999999999999999999999999999999863321 11111111110 0 11
Q ss_pred CCChhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 010519 423 EVKPATRALKRSLLVALRCVDPDSEKRPKMSQVVRM 458 (508)
Q Consensus 423 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 458 (508)
.+......+.+++.+||+.||.+|||+.+++++
T Consensus 222 ---~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~ 254 (257)
T cd08223 222 ---MPKDYSPELGELIATMLSKRPEKRPSVKSILRQ 254 (257)
T ss_pred ---CccccCHHHHHHHHHHhccCcccCCCHHHHhcC
Confidence 112234567789999999999999999999975
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. |
| >cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-38 Score=314.56 Aligned_cols=265 Identities=23% Similarity=0.319 Sum_probs=200.6
Q ss_pred CCcccceeEeeeCceEEEEEEEc-CCCEEEEEEEcccc-hhhHHHHHHHHHHHhcCCCCCceeEEEEEEeCceeeEEEee
Q 010519 186 NRFSAENVLGEGGYGVVYKGRLI-NGSEVAVKKLLNNL-GQAEKEFRVEVEAIGHVRHKNLVRLLGYCIEGVHRMLVYEY 263 (508)
Q Consensus 186 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~ei~~l~~l~h~niv~~~~~~~~~~~~~lv~E~ 263 (508)
++|.+.+.||.|+||.||+|++. ++..||+|.+.... ......+..|+.+++.++||||+++++++......++||||
T Consensus 6 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv~e~ 85 (301)
T cd07873 6 ETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEY 85 (301)
T ss_pred cceEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEecccccCchhHHHHHHHHHHhcCCCCcceEEEEEecCCeEEEEEec
Confidence 57999999999999999999875 67889999885433 22334567799999999999999999999999999999999
Q ss_pred cCCCCHHHHHhhhhccCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCEEEcCCCcEEEEecCCccccCCCC
Q 010519 264 VNNGNLEQWLHGAMRNQGNLTWEARMKVIIGTAKALAYLHEAIEPKVVHRDIKSSNILIDDEFNAKVSDFGLAKLLDSGE 343 (508)
Q Consensus 264 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~~~ 343 (508)
++ ++|.+++.. ....+++..+..++.||+.||.|||+. +++|+||||+|||+++++.+||+|||++.......
T Consensus 86 ~~-~~l~~~l~~---~~~~~~~~~~~~~~~qi~~aL~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~ 158 (301)
T cd07873 86 LD-KDLKQYLDD---CGNSINMHNVKLFLFQLLRGLNYCHRR---KVLHRDLKPQNLLINERGELKLADFGLARAKSIPT 158 (301)
T ss_pred cc-cCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCCHHHEEECCCCcEEECcCcchhccCCCC
Confidence 96 599998853 345688999999999999999999998 99999999999999999999999999997654322
Q ss_pred CcccccccccccccCccccCC-CCCCChhhHHHHHHHHHHHHhCCCCCCCCCCCchhcHHHHHHHHhccc----------
Q 010519 344 SHITTRVMGTFGYVAPEYANT-GMLNEKSDIYSFGVLLLEAVTGRDPVDYGRPANEVNLVEWLKMMVGTR---------- 412 (508)
Q Consensus 344 ~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwS~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~---------- 412 (508)
. ......+++.|+|||++.+ ..++.++|||||||++|||++|+.||....... ....+.......
T Consensus 159 ~-~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~ 234 (301)
T cd07873 159 K-TYSNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEE---QLHFIFRILGTPTEETWPGILS 234 (301)
T ss_pred C-cccccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCCCHHH---HHHHHHHHcCCCChhhchhhhc
Confidence 1 1233457889999998865 457889999999999999999999996543211 111111111100
Q ss_pred --ccccccCCCCCCCh----hHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhhc
Q 010519 413 --RAEEVVDPNLEVKP----ATRALKRSLLVALRCVDPDSEKRPKMSQVVRMLEA 461 (508)
Q Consensus 413 --~~~~~~~~~~~~~~----~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~ 461 (508)
.......+...... .......+.+|+.+||+.||.+|||+.|++++-+-
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~eil~h~~f 289 (301)
T cd07873 235 NEEFKSYNYPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMKHPYF 289 (301)
T ss_pred cccccccccCccccccHHhhcCCCCHHHHHHHHHHhcCCcccCcCHHHHhcCccc
Confidence 00000001110000 11223456779999999999999999999986554
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl |
| >cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-38 Score=308.41 Aligned_cols=250 Identities=26% Similarity=0.406 Sum_probs=202.8
Q ss_pred CCcccceeEeeeCceEEEEEEEc-CCCEEEEEEEcccc-hhhHHHHHHHHHHHhcCCCCCceeEEEEEEeCceeeEEEee
Q 010519 186 NRFSAENVLGEGGYGVVYKGRLI-NGSEVAVKKLLNNL-GQAEKEFRVEVEAIGHVRHKNLVRLLGYCIEGVHRMLVYEY 263 (508)
Q Consensus 186 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~ei~~l~~l~h~niv~~~~~~~~~~~~~lv~E~ 263 (508)
++|++.+.||.|++|.||+|.+. +++.+++|.+.... ......+..|+.+++.++|+||+++++++.++...++|+||
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (274)
T cd06609 1 ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYITKYYGSFLKGSKLWIIMEY 80 (274)
T ss_pred ChhhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeeccccchHHHHHHHHHHHHHHcCCCCeeeeeEEEEECCeEEEEEEe
Confidence 36888899999999999999875 68899999886543 33345688899999999999999999999999999999999
Q ss_pred cCCCCHHHHHhhhhccCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCEEEcCCCcEEEEecCCccccCCCC
Q 010519 264 VNNGNLEQWLHGAMRNQGNLTWEARMKVIIGTAKALAYLHEAIEPKVVHRDIKSSNILIDDEFNAKVSDFGLAKLLDSGE 343 (508)
Q Consensus 264 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~~~ 343 (508)
+++++|.+++.. ..+++..++.++.|++.||.|||+. +++|+||+|+||++++++.++|+|||++.......
T Consensus 81 ~~~~~L~~~~~~-----~~~~~~~~~~~~~ql~~~l~~lh~~---~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~ 152 (274)
T cd06609 81 CGGGSCLDLLKP-----GKLDETYIAFILREVLLGLEYLHEE---GKIHRDIKAANILLSEEGDVKLADFGVSGQLTSTM 152 (274)
T ss_pred eCCCcHHHHHhh-----cCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEECCCCCEEEcccccceeecccc
Confidence 999999999853 2789999999999999999999998 99999999999999999999999999998765432
Q ss_pred CcccccccccccccCccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCCCchhcHHHHHHHHhcccccccccCCCCC
Q 010519 344 SHITTRVMGTFGYVAPEYANTGMLNEKSDIYSFGVLLLEAVTGRDPVDYGRPANEVNLVEWLKMMVGTRRAEEVVDPNLE 423 (508)
Q Consensus 344 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 423 (508)
. ......+++.|+|||++.+..++.++|||||||++|+|++|..||....+. ........ . ..+.+.
T Consensus 153 ~-~~~~~~~~~~y~~PE~~~~~~~~~~sDv~slG~il~~l~tg~~p~~~~~~~------~~~~~~~~-~-----~~~~~~ 219 (274)
T cd06609 153 S-KRNTFVGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKGEPPLSDLHPM------RVLFLIPK-N-----NPPSLE 219 (274)
T ss_pred c-ccccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccCchH------HHHHHhhh-c-----CCCCCc
Confidence 1 233456788999999999988999999999999999999999999643321 11111110 0 011111
Q ss_pred CChhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHh
Q 010519 424 VKPATRALKRSLLVALRCVDPDSEKRPKMSQVVRML 459 (508)
Q Consensus 424 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L 459 (508)
.. .....+.+++.+||..||++|||+++++++-
T Consensus 220 ~~---~~~~~~~~~l~~~l~~~p~~Rpt~~~il~~~ 252 (274)
T cd06609 220 GN---KFSKPFKDFVSLCLNKDPKERPSAKELLKHK 252 (274)
T ss_pred cc---ccCHHHHHHHHHHhhCChhhCcCHHHHhhCh
Confidence 11 0334567799999999999999999999853
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) |
| >cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-38 Score=310.41 Aligned_cols=263 Identities=23% Similarity=0.322 Sum_probs=197.6
Q ss_pred CcccceeEeeeCceEEEEEEEc-CCCEEEEEEEcccc--hhhHHHHHHHHHHHhcCCCCCceeEEEEEEeCceeeEEEee
Q 010519 187 RFSAENVLGEGGYGVVYKGRLI-NGSEVAVKKLLNNL--GQAEKEFRVEVEAIGHVRHKNLVRLLGYCIEGVHRMLVYEY 263 (508)
Q Consensus 187 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~ei~~l~~l~h~niv~~~~~~~~~~~~~lv~E~ 263 (508)
+|++.+.||+|++|.||+|+.. ++..||+|++.... ......+..|+.+++.++||||+++++++.++...++||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (285)
T cd07861 1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDVLMQESRLYLIFEF 80 (285)
T ss_pred CceEeeEecccCceEEEEEEECCCCcEEEEEEeccccccCCchHHHHHHHHHHHhcCCCCEeeeEEEEeeCCeEEEEEec
Confidence 4788899999999999999875 68899999885432 22335678899999999999999999999999999999999
Q ss_pred cCCCCHHHHHhhhhccCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCEEEcCCCcEEEEecCCccccCCCC
Q 010519 264 VNNGNLEQWLHGAMRNQGNLTWEARMKVIIGTAKALAYLHEAIEPKVVHRDIKSSNILIDDEFNAKVSDFGLAKLLDSGE 343 (508)
Q Consensus 264 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~~~ 343 (508)
+. ++|.+++... .....+++..++.++.||+.||.|||+. +++|+||+|+||++++++.+||+|||++.......
T Consensus 81 ~~-~~l~~~~~~~-~~~~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~ 155 (285)
T cd07861 81 LS-MDLKKYLDSL-PKGQYMDAELVKSYLYQILQGILFCHSR---RVLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPV 155 (285)
T ss_pred CC-CCHHHHHhcC-CCCCcCCHHHHHHHHHHHHHHHHHHHhC---CeeecCCCHHHEEEcCCCcEEECcccceeecCCCc
Confidence 97 6899988542 2335789999999999999999999998 99999999999999999999999999997654322
Q ss_pred CcccccccccccccCccccCC-CCCCChhhHHHHHHHHHHHHhCCCCCCCCCCCchhcHHHHHHHHhccc----------
Q 010519 344 SHITTRVMGTFGYVAPEYANT-GMLNEKSDIYSFGVLLLEAVTGRDPVDYGRPANEVNLVEWLKMMVGTR---------- 412 (508)
Q Consensus 344 ~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwS~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~---------- 412 (508)
.......+++.|+|||++.+ ..++.++|||||||++|+|++|+.||....... .............
T Consensus 156 -~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~ 232 (285)
T cd07861 156 -RVYTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEID--QLFRIFRILGTPTEDVWPGVTSL 232 (285)
T ss_pred -ccccCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCCCCHHH--HHHHHHHHhCCCChhhhhcchhh
Confidence 12233457889999998865 457899999999999999999999996432211 1111110000000
Q ss_pred -----ccccccCCCCCCChhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 010519 413 -----RAEEVVDPNLEVKPATRALKRSLLVALRCVDPDSEKRPKMSQVVRM 458 (508)
Q Consensus 413 -----~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 458 (508)
.......... ..........+.+++.+||+.||.+|||+.+|+.+
T Consensus 233 ~~~~~~~~~~~~~~~-~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~ll~~ 282 (285)
T cd07861 233 PDYKNTFPKWKKGSL-RSAVKNLDEDGLDLLEKMLIYDPAKRISAKKALNH 282 (285)
T ss_pred HHHHhhccccCcchh-HHhcCCCCHHHHHHHHHHhcCChhhCCCHHHHhcC
Confidence 0000000000 00001123456679999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 |
| >cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-38 Score=304.95 Aligned_cols=247 Identities=30% Similarity=0.502 Sum_probs=198.2
Q ss_pred CCcccceeEeeeCceEEEEEEEcCCCEEEEEEEcccchhhHHHHHHHHHHHhcCCCCCceeEEEEEEeCceeeEEEeecC
Q 010519 186 NRFSAENVLGEGGYGVVYKGRLINGSEVAVKKLLNNLGQAEKEFRVEVEAIGHVRHKNLVRLLGYCIEGVHRMLVYEYVN 265 (508)
Q Consensus 186 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~ei~~l~~l~h~niv~~~~~~~~~~~~~lv~E~~~ 265 (508)
++|++.+.||+|+||.||++.. .+..+|+|.+.... ....+..|+.+++.++|||++++++++... ..+++|||++
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~~-~~~~~~iK~~~~~~--~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~~~v~e~~~ 81 (254)
T cd05083 6 QKLTLGEIIGEGEFGAVLQGEY-TGQKVAVKNIKCDV--TAQAFLEETAVMTKLHHKNLVRLLGVILHN-GLYIVMELMS 81 (254)
T ss_pred HHceeeeeeccCCCCceEeccc-CCCceEEEeecCcc--hHHHHHHHHHHHHhCCCCCcCeEEEEEcCC-CcEEEEECCC
Confidence 4688899999999999999975 78889999886532 235688899999999999999999988654 4789999999
Q ss_pred CCCHHHHHhhhhccCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCEEEcCCCcEEEEecCCccccCCCCCc
Q 010519 266 NGNLEQWLHGAMRNQGNLTWEARMKVIIGTAKALAYLHEAIEPKVVHRDIKSSNILIDDEFNAKVSDFGLAKLLDSGESH 345 (508)
Q Consensus 266 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~ 345 (508)
+++|.+++.. .....+++..++.++.|++.||.|||+. +++||||||+||+++.++.+||+|||++.......
T Consensus 82 ~~~L~~~l~~--~~~~~~~~~~~~~~~~qi~~al~~lH~~---~~~H~dl~p~nili~~~~~~kl~Dfg~~~~~~~~~-- 154 (254)
T cd05083 82 KGNLVNFLRT--RGRALVSVIQLLQFSLDVAEGMEYLESK---KLVHRDLAARNILVSEDGVAKVSDFGLARVGSMGV-- 154 (254)
T ss_pred CCCHHHHHHh--cCcCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccccCcceEEEcCCCcEEECCCccceeccccC--
Confidence 9999999964 2334688999999999999999999998 99999999999999999999999999997643321
Q ss_pred ccccccccccccCccccCCCCCCChhhHHHHHHHHHHHHh-CCCCCCCCCCCchhcHHHHHHHHhcccccccccCCCCCC
Q 010519 346 ITTRVMGTFGYVAPEYANTGMLNEKSDIYSFGVLLLEAVT-GRDPVDYGRPANEVNLVEWLKMMVGTRRAEEVVDPNLEV 424 (508)
Q Consensus 346 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 424 (508)
.....+..|+|||.+.+..++.++|+|||||++|+|++ |+.||..... .+........ ...
T Consensus 155 --~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~------~~~~~~~~~~----------~~~ 216 (254)
T cd05083 155 --DNSKLPVKWTAPEALKHKKFSSKSDVWSYGVLLWEVFSYGRAPYPKMSL------KEVKECVEKG----------YRM 216 (254)
T ss_pred --CCCCCCceecCHHHhccCCcCchhhHHHHHHHHHHHHhCCCCCCccCCH------HHHHHHHhCC----------CCC
Confidence 12234568999999998899999999999999999998 9999864322 1111111111 111
Q ss_pred ChhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhhc
Q 010519 425 KPATRALKRSLLVALRCVDPDSEKRPKMSQVVRMLEA 461 (508)
Q Consensus 425 ~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~ 461 (508)
.........+.+++.+||+.+|.+||++.+++..|+.
T Consensus 217 ~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~ 253 (254)
T cd05083 217 EPPEGCPADVYVLMTSCWETEPKKRPSFHKLREKLEK 253 (254)
T ss_pred CCCCcCCHHHHHHHHHHcCCChhhCcCHHHHHHHHcc
Confidence 1112234566779999999999999999999998874
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki |
| >cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-38 Score=304.95 Aligned_cols=249 Identities=31% Similarity=0.455 Sum_probs=190.1
Q ss_pred eeEeeeCceEEEEEEEcC----CCEEEEEEEcccc-hhhHHHHHHHHHHHhcCCCCCceeEEEEEEe-CceeeEEEeecC
Q 010519 192 NVLGEGGYGVVYKGRLIN----GSEVAVKKLLNNL-GQAEKEFRVEVEAIGHVRHKNLVRLLGYCIE-GVHRMLVYEYVN 265 (508)
Q Consensus 192 ~~lg~G~~g~Vy~~~~~~----~~~vavK~~~~~~-~~~~~~~~~ei~~l~~l~h~niv~~~~~~~~-~~~~~lv~E~~~ 265 (508)
+.||+|+||.||+|.+.+ ...+|+|++.... ......+..|+.+++.++||||+++++++.. +...+++|||+.
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~~ 80 (262)
T cd05058 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSEGSPLVVLPYMK 80 (262)
T ss_pred CcccccCCceEEEEEEecCCCceEEEEEEecCccCCHHHHHHHHHHHHHHccCCCCCcceEEEEeecCCCCcEEEEecCC
Confidence 368999999999998642 3468999875432 3344678889999999999999999998764 456789999999
Q ss_pred CCCHHHHHhhhhccCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCEEEcCCCcEEEEecCCccccCCCCC-
Q 010519 266 NGNLEQWLHGAMRNQGNLTWEARMKVIIGTAKALAYLHEAIEPKVVHRDIKSSNILIDDEFNAKVSDFGLAKLLDSGES- 344 (508)
Q Consensus 266 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~- 344 (508)
+|+|.+++.. ....+.+..+..++.||+.||.|||+. +++||||||+|||+++++.+||+|||+++.......
T Consensus 81 ~~~L~~~~~~---~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlk~~nili~~~~~~kl~dfg~~~~~~~~~~~ 154 (262)
T cd05058 81 HGDLRNFIRS---ETHNPTVKDLIGFGLQVAKGMEYLASK---KFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYY 154 (262)
T ss_pred CCCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHhC---CccccccCcceEEEcCCCcEEECCccccccccCCcce
Confidence 9999999863 334567788889999999999999998 999999999999999999999999999975533211
Q ss_pred --cccccccccccccCccccCCCCCCChhhHHHHHHHHHHHHhCC-CCCCCCCCCchhcHHHHHHHHhcccccccccCCC
Q 010519 345 --HITTRVMGTFGYVAPEYANTGMLNEKSDIYSFGVLLLEAVTGR-DPVDYGRPANEVNLVEWLKMMVGTRRAEEVVDPN 421 (508)
Q Consensus 345 --~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltG~-~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 421 (508)
.......+++.|+|||.+.+..++.++|||||||++|||++|. .||.... . .+.......... .
T Consensus 155 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~---~---~~~~~~~~~~~~------~- 221 (262)
T cd05058 155 SVHNHTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVD---S---FDITVYLLQGRR------L- 221 (262)
T ss_pred eecccccCcCCccccChhHhccCccchHHHHHHHHHHHHHHHcCCCCCCCCCC---H---HHHHHHHhcCCC------C-
Confidence 1112334577899999998889999999999999999999954 5554221 1 111222211110 0
Q ss_pred CCCChhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhhcC
Q 010519 422 LEVKPATRALKRSLLVALRCVDPDSEKRPKMSQVVRMLEAD 462 (508)
Q Consensus 422 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~ 462 (508)
..+...+..+.+++.+||+.+|.+||++.++++.|+..
T Consensus 222 ---~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~il~~l~~~ 259 (262)
T cd05058 222 ---LQPEYCPDPLYEVMLSCWHPKPEMRPTFSELVSRIEQI 259 (262)
T ss_pred ---CCCCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHH
Confidence 00111234567799999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca |
| >cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-38 Score=320.54 Aligned_cols=263 Identities=23% Similarity=0.266 Sum_probs=197.7
Q ss_pred hCCcccceeEeeeCceEEEEEEEc-CCCEEEEEEEcccc--hhhHHHHHHHHHHHhcCCCCCceeEEEEEEeC------c
Q 010519 185 TNRFSAENVLGEGGYGVVYKGRLI-NGSEVAVKKLLNNL--GQAEKEFRVEVEAIGHVRHKNLVRLLGYCIEG------V 255 (508)
Q Consensus 185 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~ei~~l~~l~h~niv~~~~~~~~~------~ 255 (508)
.++|.+.+.||+|+||.||++.+. .++.||||++.... ......+.+|+.+++.++||||+++++++... .
T Consensus 23 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~~~~ 102 (364)
T cd07875 23 LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQ 102 (364)
T ss_pred hcceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCccccCchhHHHHHHHHHHHHhcCCCCccccceeecccccccccC
Confidence 468999999999999999999864 68889999986432 23345677899999999999999999987643 3
Q ss_pred eeeEEEeecCCCCHHHHHhhhhccCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCEEEcCCCcEEEEecCC
Q 010519 256 HRMLVYEYVNNGNLEQWLHGAMRNQGNLTWEARMKVIIGTAKALAYLHEAIEPKVVHRDIKSSNILIDDEFNAKVSDFGL 335 (508)
Q Consensus 256 ~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~Dfgl 335 (508)
..|+||||+++ +|.+++. ..+++..+..++.|++.||.|||++ +|+||||||+|||++.++.+||+|||+
T Consensus 103 ~~~lv~e~~~~-~l~~~~~------~~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~DfG~ 172 (364)
T cd07875 103 DVYIVMELMDA-NLCQVIQ------MELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGL 172 (364)
T ss_pred eEEEEEeCCCC-CHHHHHH------hcCCHHHHHHHHHHHHHHHHHHhhC---CeecCCCCHHHEEECCCCcEEEEeCCC
Confidence 56899999965 7877763 2377888999999999999999999 999999999999999999999999999
Q ss_pred ccccCCCCCcccccccccccccCccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCCCchhcHHHHHHH--------
Q 010519 336 AKLLDSGESHITTRVMGTFGYVAPEYANTGMLNEKSDIYSFGVLLLEAVTGRDPVDYGRPANEVNLVEWLKM-------- 407 (508)
Q Consensus 336 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~-------- 407 (508)
++...... ......+|+.|+|||++.+..++.++|||||||+||+|++|+.||........ ....+..
T Consensus 173 a~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~--~~~~~~~~~~~~~~~ 248 (364)
T cd07875 173 ARTAGTSF--MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQ--WNKVIEQLGTPCPEF 248 (364)
T ss_pred ccccCCCC--cccCCcccCCcCCHHHHhCCCCCchhhHHhHHHHHHHHHhCCCCCCCCCHHHH--HHHHHHhcCCCCHHH
Confidence 98654322 23345689999999999999999999999999999999999999964432111 1111100
Q ss_pred ----------Hhcccc-cccc----cCCCC--CC--ChhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhhc
Q 010519 408 ----------MVGTRR-AEEV----VDPNL--EV--KPATRALKRSLLVALRCVDPDSEKRPKMSQVVRMLEA 461 (508)
Q Consensus 408 ----------~~~~~~-~~~~----~~~~~--~~--~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~ 461 (508)
...... .... ..+.. .. .........+.+|+.+||+.||.+|||+.++++|-+-
T Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~R~t~~e~L~hp~~ 321 (364)
T cd07875 249 MKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPYI 321 (364)
T ss_pred HHhhhHHHHHHHhhCCCcCCCChHhhCccccccccccccccccHHHHHHHHHhcCcCcccCCCHHHHhcCccc
Confidence 000000 0000 00000 00 0001122456789999999999999999999997554
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-38 Score=306.11 Aligned_cols=255 Identities=27% Similarity=0.433 Sum_probs=202.1
Q ss_pred CcccceeEeeeCceEEEEEEEcC--CCEEEEEEEcccc----------hhhHHHHHHHHHHHhc-CCCCCceeEEEEEEe
Q 010519 187 RFSAENVLGEGGYGVVYKGRLIN--GSEVAVKKLLNNL----------GQAEKEFRVEVEAIGH-VRHKNLVRLLGYCIE 253 (508)
Q Consensus 187 ~~~~~~~lg~G~~g~Vy~~~~~~--~~~vavK~~~~~~----------~~~~~~~~~ei~~l~~-l~h~niv~~~~~~~~ 253 (508)
.|++.+.||+|+||.||+|.+.. +..+|+|.+.... ......+..|+.++.+ ++||||+++++++..
T Consensus 1 ~y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~ 80 (269)
T cd08528 1 EYAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLE 80 (269)
T ss_pred CchhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEcc
Confidence 47788899999999999999764 6789999875321 2223456678887765 799999999999999
Q ss_pred CceeeEEEeecCCCCHHHHHhhhhccCCCccHHHHHHHHHHHHHHHHHHHh-cCCCCeEeecCCCCCEEEcCCCcEEEEe
Q 010519 254 GVHRMLVYEYVNNGNLEQWLHGAMRNQGNLTWEARMKVIIGTAKALAYLHE-AIEPKVVHRDIKSSNILIDDEFNAKVSD 332 (508)
Q Consensus 254 ~~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~yLH~-~~~~~iiH~Dlk~~NIll~~~~~~kl~D 332 (508)
+...+++|||+++++|.+++.........+++..++.++.|++.||.|||+ . +++|+||+|+|||++.++.+||+|
T Consensus 81 ~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~---~i~H~dl~~~nil~~~~~~~~l~d 157 (269)
T cd08528 81 NDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHKEK---RIVHRDLTPNNIMLGEDDKVTITD 157 (269)
T ss_pred CCeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhccCC---ceeecCCCHHHEEECCCCcEEEec
Confidence 999999999999999999986544456678999999999999999999996 5 899999999999999999999999
Q ss_pred cCCccccCCCCCcccccccccccccCccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCCCchhcHHHHHHHHhccc
Q 010519 333 FGLAKLLDSGESHITTRVMGTFGYVAPEYANTGMLNEKSDIYSFGVLLLEAVTGRDPVDYGRPANEVNLVEWLKMMVGTR 412 (508)
Q Consensus 333 fgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~ 412 (508)
||++....... ......++..|+|||.+.+..++.++||||||+++|+|++|..||...... ........ .
T Consensus 158 fg~~~~~~~~~--~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~ll~~l~~g~~p~~~~~~~------~~~~~~~~-~ 228 (269)
T cd08528 158 FGLAKQKQPES--KLTSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYSTNML------SLATKIVE-A 228 (269)
T ss_pred ccceeeccccc--ccccccCcccCcChhhhcCCCCchHHHHHHHHHHHHHHHhCCCcccccCHH------HHHHHHhh-c
Confidence 99998765433 234456888999999999988999999999999999999999998643211 11111111 1
Q ss_pred ccccccCCCCCCChhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhhc
Q 010519 413 RAEEVVDPNLEVKPATRALKRSLLVALRCVDPDSEKRPKMSQVVRMLEA 461 (508)
Q Consensus 413 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~ 461 (508)
... + .........+.+++.+||+.||++||++.|+..++++
T Consensus 229 ~~~----~----~~~~~~~~~l~~li~~cl~~~p~~Rp~~~e~~~~~~~ 269 (269)
T cd08528 229 VYE----P----LPEGMYSEDVTDVITSCLTPDAEARPDIIQVSAMISD 269 (269)
T ss_pred cCC----c----CCcccCCHHHHHHHHHHCCCCCccCCCHHHHHHHhcC
Confidence 100 0 0011123456779999999999999999999998863
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. |
| >cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-37 Score=305.16 Aligned_cols=264 Identities=25% Similarity=0.342 Sum_probs=205.0
Q ss_pred CCcccceeEeeeCceEEEEEEEc-CCCEEEEEEEcccch-hhHHHHHHHHHHHhcCCCCCceeEEEEEEeC--ceeeEEE
Q 010519 186 NRFSAENVLGEGGYGVVYKGRLI-NGSEVAVKKLLNNLG-QAEKEFRVEVEAIGHVRHKNLVRLLGYCIEG--VHRMLVY 261 (508)
Q Consensus 186 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~ei~~l~~l~h~niv~~~~~~~~~--~~~~lv~ 261 (508)
++|...+.||.|++|.||++.+. +++.+|+|.+..... .....+.+|++++++++||||++++++|.+. ...++||
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~ 80 (287)
T cd06621 1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYIVKYYGAFLDESSSSIGIAM 80 (287)
T ss_pred CceEEEEEeccCCceEEEEEEECCCCeEEEEEEEecCCchHHHHHHHHHHHHHHhCCCCCeeeeeeEEEccCCCeEEEEE
Confidence 36888899999999999999875 578899998864432 3456788899999999999999999998654 4678999
Q ss_pred eecCCCCHHHHHhhhhccCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCEEEcCCCcEEEEecCCccccCC
Q 010519 262 EYVNNGNLEQWLHGAMRNQGNLTWEARMKVIIGTAKALAYLHEAIEPKVVHRDIKSSNILIDDEFNAKVSDFGLAKLLDS 341 (508)
Q Consensus 262 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~ 341 (508)
||+++++|.+++.........+++..+..++.||+.||.|||+. +++|+||+|+||++++++.++|+|||++.....
T Consensus 81 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~---~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~ 157 (287)
T cd06621 81 EYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSR---KIIHRDIKPSNILLTRKGQVKLCDFGVSGELVN 157 (287)
T ss_pred EecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEecCCeEEEeeccccccccc
Confidence 99999999998865444556789999999999999999999998 999999999999999999999999999875543
Q ss_pred CCCcccccccccccccCccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCCCchhcHHHHHHHHhcccccccccCCC
Q 010519 342 GESHITTRVMGTFGYVAPEYANTGMLNEKSDIYSFGVLLLEAVTGRDPVDYGRPANEVNLVEWLKMMVGTRRAEEVVDPN 421 (508)
Q Consensus 342 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 421 (508)
.. .....++..|+|||.+.+..++.++|||||||++|+|++|..||....... ....+.......... ..+. ..
T Consensus 158 ~~---~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~-~~~~~~~~~~~~~~~-~~~~-~~ 231 (287)
T cd06621 158 SL---AGTFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPP-LGPIELLSYIVNMPN-PELK-DE 231 (287)
T ss_pred cc---cccccCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCcccCCC-CChHHHHHHHhcCCc-hhhc-cC
Confidence 22 123457889999999999899999999999999999999999997553211 111122221111110 0000 00
Q ss_pred CCCChhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhh
Q 010519 422 LEVKPATRALKRSLLVALRCVDPDSEKRPKMSQVVRMLE 460 (508)
Q Consensus 422 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 460 (508)
..........+.+++.+||..||.+|||+.|++++-+
T Consensus 232 --~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~eil~~~~ 268 (287)
T cd06621 232 --PGNGIKWSEEFKDFIKQCLEKDPTRRPTPWDMLEHPW 268 (287)
T ss_pred --CCCCCchHHHHHHHHHHHcCCCcccCCCHHHHHhCcc
Confidence 0000123456778999999999999999999998654
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-38 Score=320.19 Aligned_cols=264 Identities=23% Similarity=0.252 Sum_probs=198.2
Q ss_pred hhCCcccceeEeeeCceEEEEEEEc-CCCEEEEEEEcccc--hhhHHHHHHHHHHHhcCCCCCceeEEEEEEeC------
Q 010519 184 ATNRFSAENVLGEGGYGVVYKGRLI-NGSEVAVKKLLNNL--GQAEKEFRVEVEAIGHVRHKNLVRLLGYCIEG------ 254 (508)
Q Consensus 184 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~ei~~l~~l~h~niv~~~~~~~~~------ 254 (508)
..++|.+.+.||+|+||.||++.+. .++.+|+|++.... ......+.+|+.+++.++||||+++++++...
T Consensus 15 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 94 (355)
T cd07874 15 VLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEEF 94 (355)
T ss_pred hhhceeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCcccChHHHHHHHHHHHHHHHhCCCchhceeeeeecccccccc
Confidence 4578999999999999999999864 68899999886432 23345677899999999999999999988643
Q ss_pred ceeeEEEeecCCCCHHHHHhhhhccCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCEEEcCCCcEEEEecC
Q 010519 255 VHRMLVYEYVNNGNLEQWLHGAMRNQGNLTWEARMKVIIGTAKALAYLHEAIEPKVVHRDIKSSNILIDDEFNAKVSDFG 334 (508)
Q Consensus 255 ~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~Dfg 334 (508)
...++||||+++ +|.+++. ..+++..+..++.|++.||.|||+. +|+||||||+|||++.++.+||+|||
T Consensus 95 ~~~~lv~e~~~~-~l~~~~~------~~l~~~~~~~~~~qi~~aL~~LH~~---givHrDikp~Nill~~~~~~kl~Dfg 164 (355)
T cd07874 95 QDVYLVMELMDA-NLCQVIQ------MELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFG 164 (355)
T ss_pred ceeEEEhhhhcc-cHHHHHh------hcCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCChHHEEECCCCCEEEeeCc
Confidence 346899999965 7777663 2478888999999999999999999 99999999999999999999999999
Q ss_pred CccccCCCCCcccccccccccccCccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCCCchhcHHHHHH--------
Q 010519 335 LAKLLDSGESHITTRVMGTFGYVAPEYANTGMLNEKSDIYSFGVLLLEAVTGRDPVDYGRPANEVNLVEWLK-------- 406 (508)
Q Consensus 335 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~-------- 406 (508)
+++...... ......||+.|+|||++.+..++.++|||||||++|+|++|+.||........ ....+.
T Consensus 165 ~~~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~--~~~~~~~~~~~~~~ 240 (355)
T cd07874 165 LARTAGTSF--MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQ--WNKVIEQLGTPCPE 240 (355)
T ss_pred ccccCCCcc--ccCCccccCCccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH--HHHHHHHhCCCCHH
Confidence 998654322 23345789999999999999999999999999999999999999964331111 000000
Q ss_pred ----------HHhcc-ccccccc------CCCCCC--ChhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhhc
Q 010519 407 ----------MMVGT-RRAEEVV------DPNLEV--KPATRALKRSLLVALRCVDPDSEKRPKMSQVVRMLEA 461 (508)
Q Consensus 407 ----------~~~~~-~~~~~~~------~~~~~~--~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~ 461 (508)
..... .....+. +..... .........+.+|+.+||+.||.+|||+.|++++-+-
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rps~~ell~hp~~ 314 (355)
T cd07874 241 FMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDEALQHPYI 314 (355)
T ss_pred HHHhhcHHHHHHHhcCCccccccchhhccccccccccccccccchHHHHHHHHHhcCCchhcCCHHHHhcCcch
Confidence 00000 0000000 000000 0011123456789999999999999999999997544
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok |
| >cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-38 Score=307.55 Aligned_cols=251 Identities=27% Similarity=0.475 Sum_probs=196.0
Q ss_pred eeEeeeCceEEEEEEEcC-------CCEEEEEEEcccc-hhhHHHHHHHHHHHhcCCCCCceeEEEEEEeCceeeEEEee
Q 010519 192 NVLGEGGYGVVYKGRLIN-------GSEVAVKKLLNNL-GQAEKEFRVEVEAIGHVRHKNLVRLLGYCIEGVHRMLVYEY 263 (508)
Q Consensus 192 ~~lg~G~~g~Vy~~~~~~-------~~~vavK~~~~~~-~~~~~~~~~ei~~l~~l~h~niv~~~~~~~~~~~~~lv~E~ 263 (508)
+.||+|+||.||+|++.+ +..+++|.+.... ......+.+|+.+++.++||||+++++++......++||||
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (269)
T cd05044 1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIVKLLGVCLLNEPQYIIMEL 80 (269)
T ss_pred CccccccceeEEeeeecccccCcccceeehhhhhhcccchhhHHHHHHHHHHHHhcCCCCeeeEeeeecCCCCeEEEEec
Confidence 368999999999998642 2568889875443 23456788899999999999999999999999999999999
Q ss_pred cCCCCHHHHHhhhhc---cCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCEEEcCCC-----cEEEEecCC
Q 010519 264 VNNGNLEQWLHGAMR---NQGNLTWEARMKVIIGTAKALAYLHEAIEPKVVHRDIKSSNILIDDEF-----NAKVSDFGL 335 (508)
Q Consensus 264 ~~~gsL~~~l~~~~~---~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiH~Dlk~~NIll~~~~-----~~kl~Dfgl 335 (508)
+++++|.+++..... ....+++..++.++.|++.||.|||+. +++|+||+|+||+++.++ .++|+|||+
T Consensus 81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~~~~~~~l~dfg~ 157 (269)
T cd05044 81 MEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQM---HFIHRDLAARNCLVSEKGYDADRVVKIGDFGL 157 (269)
T ss_pred cCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHhC---CcccCCCChheEEEecCCCCCCcceEECCccc
Confidence 999999999965322 223478899999999999999999998 999999999999999887 899999999
Q ss_pred ccccCCCCC-cccccccccccccCccccCCCCCCChhhHHHHHHHHHHHHh-CCCCCCCCCCCchhcHHHHHHHHhcccc
Q 010519 336 AKLLDSGES-HITTRVMGTFGYVAPEYANTGMLNEKSDIYSFGVLLLEAVT-GRDPVDYGRPANEVNLVEWLKMMVGTRR 413 (508)
Q Consensus 336 a~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~ 413 (508)
+........ .......++..|+|||++.+..++.++|||||||++|||++ |..||..... ..... ......
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt~g~~p~~~~~~---~~~~~---~~~~~~- 230 (269)
T cd05044 158 ARDIYKSDYYRKEGEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPALNN---QEVLQ---HVTAGG- 230 (269)
T ss_pred ccccccccccccCcccCCCccccCHHHHccCCcccchhHHHHHHHHHHHHHcCCCCCcccCH---HHHHH---HHhcCC-
Confidence 975533221 11222345678999999999999999999999999999998 9999863321 11111 111100
Q ss_pred cccccCCCCCCChhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhhc
Q 010519 414 AEEVVDPNLEVKPATRALKRSLLVALRCVDPDSEKRPKMSQVVRMLEA 461 (508)
Q Consensus 414 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~ 461 (508)
........+..+.+++.+||..+|.+||++.++++.|++
T Consensus 231 ---------~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 269 (269)
T cd05044 231 ---------RLQKPENCPDKIYQLMTNCWAQDPSERPTFDRIQEILQN 269 (269)
T ss_pred ---------ccCCcccchHHHHHHHHHHcCCCcccCCCHHHHHHHHhC
Confidence 111112234567789999999999999999999999863
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male |
| >smart00219 TyrKc Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-38 Score=302.61 Aligned_cols=251 Identities=31% Similarity=0.508 Sum_probs=199.4
Q ss_pred cccceeEeeeCceEEEEEEEcC-----CCEEEEEEEcccchh-hHHHHHHHHHHHhcCCCCCceeEEEEEEeCceeeEEE
Q 010519 188 FSAENVLGEGGYGVVYKGRLIN-----GSEVAVKKLLNNLGQ-AEKEFRVEVEAIGHVRHKNLVRLLGYCIEGVHRMLVY 261 (508)
Q Consensus 188 ~~~~~~lg~G~~g~Vy~~~~~~-----~~~vavK~~~~~~~~-~~~~~~~ei~~l~~l~h~niv~~~~~~~~~~~~~lv~ 261 (508)
|++.+.||.|+||.||++++.. +..+|+|.+...... ....+..|+..+..++|+||+++++++.+....+++|
T Consensus 1 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~i~ 80 (258)
T smart00219 1 LTLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDADEQQIEEFLREARIMRKLDHPNIVKLLGVCTEEEPLMIVM 80 (258)
T ss_pred CcccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCCChHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCeeEEEE
Confidence 3567889999999999998753 378999998655433 4568889999999999999999999999999999999
Q ss_pred eecCCCCHHHHHhhhhccCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCEEEcCCCcEEEEecCCccccCC
Q 010519 262 EYVNNGNLEQWLHGAMRNQGNLTWEARMKVIIGTAKALAYLHEAIEPKVVHRDIKSSNILIDDEFNAKVSDFGLAKLLDS 341 (508)
Q Consensus 262 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~ 341 (508)
||+++++|.+++... ....+++..++.++.|++.||+|||+. +++|+||+|+||++++++.++|+|||++.....
T Consensus 81 e~~~~~~l~~~~~~~--~~~~~~~~~~~~~~~ql~~~l~~lh~~---~~~h~dl~~~nil~~~~~~~~l~dfg~~~~~~~ 155 (258)
T smart00219 81 EYMEGGDLLDYLRKN--RPKELSLSDLLSFALQIARGMEYLESK---NFIHRDLAARNCLVGENLVVKISDFGLSRDLYD 155 (258)
T ss_pred eccCCCCHHHHHHhh--hhccCCHHHHHHHHHHHHHHHHHHhcC---CeeecccccceEEEccCCeEEEcccCCceeccc
Confidence 999999999998631 122289999999999999999999999 999999999999999999999999999986654
Q ss_pred CCCcccccccccccccCccccCCCCCCChhhHHHHHHHHHHHHh-CCCCCCCCCCCchhcHHHHHHHHhcccccccccCC
Q 010519 342 GESHITTRVMGTFGYVAPEYANTGMLNEKSDIYSFGVLLLEAVT-GRDPVDYGRPANEVNLVEWLKMMVGTRRAEEVVDP 420 (508)
Q Consensus 342 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 420 (508)
..........+++.|+|||.+.+..++.++||||||+++|+|++ |..||.... . ............ .
T Consensus 156 ~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~i~~~l~~~g~~p~~~~~---~---~~~~~~~~~~~~------~ 223 (258)
T smart00219 156 DDYYKKKGGKLPIRWMAPESLKDGKFTSKSDVWSFGVLLWEIFTLGESPYPGMS---N---EEVLEYLKKGYR------L 223 (258)
T ss_pred ccccccccCCCcccccChHHhccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCC---H---HHHHHHHhcCCC------C
Confidence 42222212336789999999988889999999999999999998 788875421 1 111111111111 0
Q ss_pred CCCCChhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHh
Q 010519 421 NLEVKPATRALKRSLLVALRCVDPDSEKRPKMSQVVRML 459 (508)
Q Consensus 421 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L 459 (508)
.........+.+++.+||+.||.+|||+.++++.|
T Consensus 224 ----~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~l 258 (258)
T smart00219 224 ----PKPENCPPEIYKLMLQCWAEDPEDRPTFSELVEIL 258 (258)
T ss_pred ----CCCCcCCHHHHHHHHHHCcCChhhCcCHHHHHhhC
Confidence 01111345677799999999999999999999865
|
Phosphotransferases. Tyrosine-specific kinase subfamily. |
| >cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-37 Score=305.50 Aligned_cols=252 Identities=23% Similarity=0.355 Sum_probs=204.0
Q ss_pred CCcccceeEeeeCceEEEEEEEc-CCCEEEEEEEcccc-hhhHHHHHHHHHHHhcCCCCCceeEEEEEEeCceeeEEEee
Q 010519 186 NRFSAENVLGEGGYGVVYKGRLI-NGSEVAVKKLLNNL-GQAEKEFRVEVEAIGHVRHKNLVRLLGYCIEGVHRMLVYEY 263 (508)
Q Consensus 186 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~ei~~l~~l~h~niv~~~~~~~~~~~~~lv~E~ 263 (508)
..|+..+.||.|+||.||+|.+. ++..||+|.+.... ......+..|+.+++.++||||+++++++.+....++||||
T Consensus 4 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 83 (277)
T cd06640 4 ELFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKGTKLWIIMEY 83 (277)
T ss_pred HhhhhhhhcccCCCeEEEEEEEccCCEEEEEEEEeccccHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEEec
Confidence 35777889999999999999875 57889999876443 34456788899999999999999999999999999999999
Q ss_pred cCCCCHHHHHhhhhccCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCEEEcCCCcEEEEecCCccccCCCC
Q 010519 264 VNNGNLEQWLHGAMRNQGNLTWEARMKVIIGTAKALAYLHEAIEPKVVHRDIKSSNILIDDEFNAKVSDFGLAKLLDSGE 343 (508)
Q Consensus 264 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~~~ 343 (508)
+++|+|.+++. ...+++..+..++.+++.||.|||+. +++|+||+|+||+++.++.++|+|||++.......
T Consensus 84 ~~~~~L~~~i~-----~~~l~~~~~~~~~~~l~~~l~~lh~~---~ivH~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~ 155 (277)
T cd06640 84 LGGGSALDLLR-----AGPFDEFQIATMLKEILKGLDYLHSE---KKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQ 155 (277)
T ss_pred CCCCcHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHhC---CccCcCCChhhEEEcCCCCEEEcccccceeccCCc
Confidence 99999999884 24578889999999999999999998 99999999999999999999999999997654332
Q ss_pred CcccccccccccccCccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCCCchhcHHHHHHHHhcccccccccCCCCC
Q 010519 344 SHITTRVMGTFGYVAPEYANTGMLNEKSDIYSFGVLLLEAVTGRDPVDYGRPANEVNLVEWLKMMVGTRRAEEVVDPNLE 423 (508)
Q Consensus 344 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 423 (508)
. ......++..|+|||++.+..++.++|+|||||++|||++|..||....+.. ...... ....
T Consensus 156 ~-~~~~~~~~~~y~apE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~------~~~~~~----------~~~~ 218 (277)
T cd06640 156 I-KRNTFVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNSDMHPMR------VLFLIP----------KNNP 218 (277)
T ss_pred c-ccccccCcccccCHhHhccCCCccHHHHHHHHHHHHHHHHCCCCCCCcChHh------Hhhhhh----------cCCC
Confidence 2 1233467889999999998889999999999999999999999986433211 111100 0001
Q ss_pred CChhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhhcC
Q 010519 424 VKPATRALKRSLLVALRCVDPDSEKRPKMSQVVRMLEAD 462 (508)
Q Consensus 424 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~ 462 (508)
..........+.+++.+||+.+|.+||++.+++++-.-.
T Consensus 219 ~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~~ 257 (277)
T cd06640 219 PTLTGEFSKPFKEFIDACLNKDPSFRPTAKELLKHKFIV 257 (277)
T ss_pred CCCchhhhHHHHHHHHHHcccCcccCcCHHHHHhChHhh
Confidence 111223455677899999999999999999999875543
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter |
| >cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-38 Score=303.32 Aligned_cols=248 Identities=28% Similarity=0.444 Sum_probs=197.3
Q ss_pred eeEeeeCceEEEEEEEcC--C--CEEEEEEEcccch-hhHHHHHHHHHHHhcCCCCCceeEEEEEEeCceeeEEEeecCC
Q 010519 192 NVLGEGGYGVVYKGRLIN--G--SEVAVKKLLNNLG-QAEKEFRVEVEAIGHVRHKNLVRLLGYCIEGVHRMLVYEYVNN 266 (508)
Q Consensus 192 ~~lg~G~~g~Vy~~~~~~--~--~~vavK~~~~~~~-~~~~~~~~ei~~l~~l~h~niv~~~~~~~~~~~~~lv~E~~~~ 266 (508)
+.||+|++|.||+|.+.+ + ..+|+|.+..... ...+.+..|+..+++++||||+++++++.. ...++||||+++
T Consensus 1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v~e~~~~ 79 (257)
T cd05040 1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRLYGVVLT-HPLMMVTELAPL 79 (257)
T ss_pred CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccHHHHHHHHHHHHHHhhcCCCCccceeEEEcC-CeEEEEEEecCC
Confidence 368999999999998743 2 2689998876655 556788899999999999999999999988 888999999999
Q ss_pred CCHHHHHhhhhccCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCEEEcCCCcEEEEecCCccccCCCCCc-
Q 010519 267 GNLEQWLHGAMRNQGNLTWEARMKVIIGTAKALAYLHEAIEPKVVHRDIKSSNILIDDEFNAKVSDFGLAKLLDSGESH- 345 (508)
Q Consensus 267 gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~- 345 (508)
|+|.+++... ....+++..++.++.|++.||.|||+. +++|+||+|+||+++.++.+||+|||++.........
T Consensus 80 ~~L~~~l~~~--~~~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~di~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~ 154 (257)
T cd05040 80 GSLLDRLRKD--ALGHFLISTLCDYAVQIANGMRYLESK---RFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHY 154 (257)
T ss_pred CcHHHHHHhc--ccccCcHHHHHHHHHHHHHHHHHHHhC---CccccccCcccEEEecCCEEEeccccccccccccccce
Confidence 9999999642 115689999999999999999999998 9999999999999999999999999999876442211
Q ss_pred -ccccccccccccCccccCCCCCCChhhHHHHHHHHHHHHh-CCCCCCCCCCCchhcHHHHHHHHhcccccccccCCCCC
Q 010519 346 -ITTRVMGTFGYVAPEYANTGMLNEKSDIYSFGVLLLEAVT-GRDPVDYGRPANEVNLVEWLKMMVGTRRAEEVVDPNLE 423 (508)
Q Consensus 346 -~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 423 (508)
......++..|+|||.+.+..++.++|||||||++|||++ |..||...... +......... ....
T Consensus 155 ~~~~~~~~~~~y~~pE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~------~~~~~~~~~~-------~~~~ 221 (257)
T cd05040 155 VMEEHLKVPFAWCAPESLRTRTFSHASDVWMFGVTLWEMFTYGEEPWAGLSGS------QILKKIDKEG-------ERLE 221 (257)
T ss_pred ecccCCCCCceecCHHHhcccCcCchhhhHHHHHHHHHHHhCCCCCCCCCCHH------HHHHHHHhcC-------CcCC
Confidence 1122456788999999999899999999999999999998 99998643221 1111111100 0000
Q ss_pred CChhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhh
Q 010519 424 VKPATRALKRSLLVALRCVDPDSEKRPKMSQVVRMLE 460 (508)
Q Consensus 424 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 460 (508)
.+...+..+.+++.+||+.+|.+|||+.++++.|.
T Consensus 222 --~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~ 256 (257)
T cd05040 222 --RPEACPQDIYNVMLQCWAHNPADRPTFAALREFLP 256 (257)
T ss_pred --CCccCCHHHHHHHHHHCCCCcccCCCHHHHHHHhc
Confidence 11122356777999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and |
| >cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-38 Score=303.07 Aligned_cols=250 Identities=22% Similarity=0.372 Sum_probs=202.2
Q ss_pred CcccceeEeeeCceEEEEEEEc-CCCEEEEEEEcccc--hhhHHHHHHHHHHHhcCCCCCceeEEEEEEeCceeeEEEee
Q 010519 187 RFSAENVLGEGGYGVVYKGRLI-NGSEVAVKKLLNNL--GQAEKEFRVEVEAIGHVRHKNLVRLLGYCIEGVHRMLVYEY 263 (508)
Q Consensus 187 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~ei~~l~~l~h~niv~~~~~~~~~~~~~lv~E~ 263 (508)
+|++.+.||+|+||.+|++... +|+.+++|.+.... ......+..|+.++++++||||+++++++...+..++||||
T Consensus 1 ~y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08218 1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQESFEENGNLYIVMDY 80 (256)
T ss_pred CceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhCChHHHHHHHHHHHHHHhCCCCCeeeeEeeecCCCeEEEEEec
Confidence 5888999999999999999864 68899999885432 23345788899999999999999999999999999999999
Q ss_pred cCCCCHHHHHhhhhccCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCEEEcCCCcEEEEecCCccccCCCC
Q 010519 264 VNNGNLEQWLHGAMRNQGNLTWEARMKVIIGTAKALAYLHEAIEPKVVHRDIKSSNILIDDEFNAKVSDFGLAKLLDSGE 343 (508)
Q Consensus 264 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~~~ 343 (508)
+++++|.+++.. .....+++..++.++.|++.||.|||++ +++|+||+|+|||++.++.++|+|||++.......
T Consensus 81 ~~~~~l~~~~~~--~~~~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~~l~~~nil~~~~~~~~l~d~~~~~~~~~~~ 155 (256)
T cd08218 81 CEGGDLYKKINA--QRGVLFPEDQILDWFVQICLALKHVHDR---KILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTV 155 (256)
T ss_pred CCCCcHHHHHHh--ccCCCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEcCCCCEEEeeccceeecCcch
Confidence 999999999863 2234578899999999999999999998 99999999999999999999999999998664432
Q ss_pred CcccccccccccccCccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCCCchhcHHHHHHHHhcccccccccCCCCC
Q 010519 344 SHITTRVMGTFGYVAPEYANTGMLNEKSDIYSFGVLLLEAVTGRDPVDYGRPANEVNLVEWLKMMVGTRRAEEVVDPNLE 423 (508)
Q Consensus 344 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 423 (508)
. ......|++.|+|||++.+..++.++|+|||||++|+|++|+.||..... .+.......... +
T Consensus 156 ~-~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~------~~~~~~~~~~~~------~--- 219 (256)
T cd08218 156 E-LARTCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLKHAFEAGNM------KNLVLKIIRGSY------P--- 219 (256)
T ss_pred h-hhhhccCCccccCHHHhCCCCCCCccchhHHHHHHHHHHcCCCCccCCCH------HHHHHHHhcCCC------C---
Confidence 1 12234578899999999998999999999999999999999999864321 111211111110 0
Q ss_pred CChhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 010519 424 VKPATRALKRSLLVALRCVDPDSEKRPKMSQVVRM 458 (508)
Q Consensus 424 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 458 (508)
..+......+.+++.+||+.+|.+||++.+|+++
T Consensus 220 -~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~vl~~ 253 (256)
T cd08218 220 -PVSSHYSYDLRNLVSQLFKRNPRDRPSVNSILEK 253 (256)
T ss_pred -CCcccCCHHHHHHHHHHhhCChhhCcCHHHHhhC
Confidence 0112234567779999999999999999999985
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti |
| >cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=312.36 Aligned_cols=197 Identities=23% Similarity=0.344 Sum_probs=160.6
Q ss_pred ceeEeeeCceEEEEEEEc---CCCEEEEEEEcccchhhHHHHHHHHHHHhcCCCCCceeEEEEEEe--CceeeEEEeecC
Q 010519 191 ENVLGEGGYGVVYKGRLI---NGSEVAVKKLLNNLGQAEKEFRVEVEAIGHVRHKNLVRLLGYCIE--GVHRMLVYEYVN 265 (508)
Q Consensus 191 ~~~lg~G~~g~Vy~~~~~---~~~~vavK~~~~~~~~~~~~~~~ei~~l~~l~h~niv~~~~~~~~--~~~~~lv~E~~~ 265 (508)
.++||+|+||+||+|++. ++..+|+|.+..... ...+.+|+.++++++||||+++++++.. +...+++|||+.
T Consensus 6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~~--~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~ 83 (317)
T cd07868 6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGI--SMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDYAE 83 (317)
T ss_pred ccccccCCCeEEEEEEEccCCCCceEEEEEECCCCC--cHHHHHHHHHHHhcCCCCCcceeeeEecCCCcEEEEEEeccC
Confidence 468999999999999864 467899998854322 2346679999999999999999998864 456789999995
Q ss_pred CCCHHHHHhhhhc-----cCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCEEE----cCCCcEEEEecCCc
Q 010519 266 NGNLEQWLHGAMR-----NQGNLTWEARMKVIIGTAKALAYLHEAIEPKVVHRDIKSSNILI----DDEFNAKVSDFGLA 336 (508)
Q Consensus 266 ~gsL~~~l~~~~~-----~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiH~Dlk~~NIll----~~~~~~kl~Dfgla 336 (508)
++|.+++..... ....+++..+..++.||+.||.|||++ +|+||||||+|||+ +.++.+||+|||++
T Consensus 84 -~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~---~ivHrDlkp~Nil~~~~~~~~~~~kl~DfG~a 159 (317)
T cd07868 84 -HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHAN---WVLHRDLKPANILVMGEGPERGRVKIADMGFA 159 (317)
T ss_pred -CCHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHhC---CEEcCCCCHHHEEEecCCCCcCcEEEeecCce
Confidence 589888753211 123588899999999999999999999 99999999999999 45678999999999
Q ss_pred cccCCCCC--cccccccccccccCccccCC-CCCCChhhHHHHHHHHHHHHhCCCCCCCC
Q 010519 337 KLLDSGES--HITTRVMGTFGYVAPEYANT-GMLNEKSDIYSFGVLLLEAVTGRDPVDYG 393 (508)
Q Consensus 337 ~~~~~~~~--~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwS~Gvvl~elltG~~Pf~~~ 393 (508)
+....... .......||+.|+|||++.+ ..++.++|||||||++|||++|+.||...
T Consensus 160 ~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~ 219 (317)
T cd07868 160 RLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCR 219 (317)
T ss_pred eccCCCCccccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCccCC
Confidence 87643321 12334578999999999876 46899999999999999999999999643
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p |
| >cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-37 Score=302.29 Aligned_cols=254 Identities=23% Similarity=0.363 Sum_probs=190.4
Q ss_pred eeEeeeCceEEEEEEEcC---CCEEEEEEEcccch-hhHHHHHHHHHHHhcCCCCCceeEEEEEEeCceeeEEEeecCCC
Q 010519 192 NVLGEGGYGVVYKGRLIN---GSEVAVKKLLNNLG-QAEKEFRVEVEAIGHVRHKNLVRLLGYCIEGVHRMLVYEYVNNG 267 (508)
Q Consensus 192 ~~lg~G~~g~Vy~~~~~~---~~~vavK~~~~~~~-~~~~~~~~ei~~l~~l~h~niv~~~~~~~~~~~~~lv~E~~~~g 267 (508)
+.||+|+||.||+|.+.+ +..+++|++..... .....+.+|+.++++++||||+++++++.+....++||||+++|
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g 80 (269)
T cd05087 1 KEIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLGQCTEVTPYLLVMEFCPLG 80 (269)
T ss_pred CcccccCCceEEEEEEcCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCCcEEEEECCCCC
Confidence 358999999999998643 35789998765432 33456888999999999999999999999988899999999999
Q ss_pred CHHHHHhhhhc-cCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCEEEcCCCcEEEEecCCccccCCCCCc-
Q 010519 268 NLEQWLHGAMR-NQGNLTWEARMKVIIGTAKALAYLHEAIEPKVVHRDIKSSNILIDDEFNAKVSDFGLAKLLDSGESH- 345 (508)
Q Consensus 268 sL~~~l~~~~~-~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~- 345 (508)
+|.++++.... ....+++..+..++.|++.||.|||+. +++|+||||+||+++.++.+||+|||++.........
T Consensus 81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~~~~~ 157 (269)
T cd05087 81 DLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKN---NFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYV 157 (269)
T ss_pred cHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHC---CEeccccCcceEEEcCCCcEEECCccccccccCcceee
Confidence 99999965322 223466778889999999999999998 9999999999999999999999999999754332211
Q ss_pred ccccccccccccCccccCCC-------CCCChhhHHHHHHHHHHHHh-CCCCCCCCCCCchhcHHHHHHHHhcccccccc
Q 010519 346 ITTRVMGTFGYVAPEYANTG-------MLNEKSDIYSFGVLLLEAVT-GRDPVDYGRPANEVNLVEWLKMMVGTRRAEEV 417 (508)
Q Consensus 346 ~~~~~~gt~~y~aPE~~~~~-------~~~~~~DvwS~Gvvl~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 417 (508)
......++..|+|||++.+. .++.++||||||+++|||++ |..||........ ... .. .......
T Consensus 158 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~---~~~---~~-~~~~~~~ 230 (269)
T cd05087 158 TPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQV---LTY---TV-REQQLKL 230 (269)
T ss_pred cCCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCChHHH---HHH---Hh-hcccCCC
Confidence 12234567889999998642 35789999999999999996 9999965432211 110 00 0111111
Q ss_pred cCCCCCCChhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhh
Q 010519 418 VDPNLEVKPATRALKRSLLVALRCVDPDSEKRPKMSQVVRMLE 460 (508)
Q Consensus 418 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 460 (508)
..+.+... ....+.+++..|| .+|.+|||+.+|+..|+
T Consensus 231 ~~~~~~~~----~~~~~~~l~~~c~-~~P~~Rpt~~~l~~~l~ 268 (269)
T cd05087 231 PKPRLKLP----LSDRWYEVMQFCW-LQPEQRPSAEEVHLLLS 268 (269)
T ss_pred CCCccCCC----CChHHHHHHHHHh-cCcccCCCHHHHHHHhc
Confidence 12222211 1233555888998 68999999999998875
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells |
| >cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-38 Score=312.78 Aligned_cols=253 Identities=24% Similarity=0.284 Sum_probs=202.9
Q ss_pred CCcccceeEeeeCceEEEEEEEc-CCCEEEEEEEcccch---hhHHHHHHHHHHHhcCCCCCceeEEEEEEeCceeeEEE
Q 010519 186 NRFSAENVLGEGGYGVVYKGRLI-NGSEVAVKKLLNNLG---QAEKEFRVEVEAIGHVRHKNLVRLLGYCIEGVHRMLVY 261 (508)
Q Consensus 186 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~ei~~l~~l~h~niv~~~~~~~~~~~~~lv~ 261 (508)
++|.+.+.||+|++|+||+|... ++..+|+|.+..... .....+..|+++++.++||||+++++++.+....++||
T Consensus 1 ~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 80 (316)
T cd05574 1 KHFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASFQTETYLCLVM 80 (316)
T ss_pred CceEEeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeeeecCCEEEEEE
Confidence 36888999999999999999875 488999999865432 23456888999999999999999999999999999999
Q ss_pred eecCCCCHHHHHhhhhccCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCEEEcCCCcEEEEecCCccccCC
Q 010519 262 EYVNNGNLEQWLHGAMRNQGNLTWEARMKVIIGTAKALAYLHEAIEPKVVHRDIKSSNILIDDEFNAKVSDFGLAKLLDS 341 (508)
Q Consensus 262 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~ 341 (508)
||+.+++|.+++.. .....+++..+..++.|+++||.|||+. +++|+||||+||+++.++.++|+|||++.....
T Consensus 81 e~~~~~~L~~~~~~--~~~~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~ 155 (316)
T cd05574 81 DYCPGGELFRLLQR--QPGKCLSEEVARFYAAEVLLALEYLHLL---GIVYRDLKPENILLHESGHIMLSDFDLSKQSDV 155 (316)
T ss_pred EecCCCCHHHHHHh--CCCCccCHHHHHHHHHHHHHHHHHHHHC---CeeccCCChHHeEEcCCCCEEEeecchhhcccc
Confidence 99999999999863 2346789999999999999999999998 999999999999999999999999999875432
Q ss_pred CCCc----------------------------ccccccccccccCccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCC
Q 010519 342 GESH----------------------------ITTRVMGTFGYVAPEYANTGMLNEKSDIYSFGVLLLEAVTGRDPVDYG 393 (508)
Q Consensus 342 ~~~~----------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltG~~Pf~~~ 393 (508)
.... ......|+..|+|||++.+..++.++||||||+++|+|++|..||...
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~ 235 (316)
T cd05574 156 EPPPVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGTTPFKGS 235 (316)
T ss_pred cccccccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCCCCCchHHHHHHHHHHHHHhhCCCCCCCC
Confidence 2110 112346788999999999988999999999999999999999999643
Q ss_pred CCCchhcHHHHHHHHhcccccccccCCCCCCChhHHHHHHHHHHHHHhcCCCCCCCCC----HHHHHHH
Q 010519 394 RPANEVNLVEWLKMMVGTRRAEEVVDPNLEVKPATRALKRSLLVALRCVDPDSEKRPK----MSQVVRM 458 (508)
Q Consensus 394 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs----~~evl~~ 458 (508)
... .. +..... ..............+.+++.+||..||.+||| +++++.+
T Consensus 236 ~~~--~~----~~~~~~---------~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~ll~~ 289 (316)
T cd05574 236 NRD--ET----FSNILK---------KEVTFPGSPPVSSSARDLIRKLLVKDPSKRLGSKRGAAEIKQH 289 (316)
T ss_pred chH--HH----HHHHhc---------CCccCCCccccCHHHHHHHHHHccCCHhHCCCchhhHHHHHcC
Confidence 321 11 111111 11111111124566778999999999999999 8888775
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin |
| >cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-38 Score=306.97 Aligned_cols=261 Identities=25% Similarity=0.413 Sum_probs=203.6
Q ss_pred CCcccceeEeeeCceEEEEEEEc-----CCCEEEEEEEcccchh-hHHHHHHHHHHHhcCCCCCceeEEEEEEe--Ccee
Q 010519 186 NRFSAENVLGEGGYGVVYKGRLI-----NGSEVAVKKLLNNLGQ-AEKEFRVEVEAIGHVRHKNLVRLLGYCIE--GVHR 257 (508)
Q Consensus 186 ~~~~~~~~lg~G~~g~Vy~~~~~-----~~~~vavK~~~~~~~~-~~~~~~~ei~~l~~l~h~niv~~~~~~~~--~~~~ 257 (508)
..|.+.+.||+|+||.||++++. .+..+|+|.+...... ....+..|++.++.++|+||+++++++.. ....
T Consensus 4 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~~~~~~ 83 (284)
T cd05038 4 RHLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIVKYKGVCEKPGGRSL 83 (284)
T ss_pred hhchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccchHHHHHHHHHHHHHHhCCCCChheEEeeeecCCCCce
Confidence 36777899999999999999864 3678999988655443 45678999999999999999999999887 5578
Q ss_pred eEEEeecCCCCHHHHHhhhhccCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCEEEcCCCcEEEEecCCcc
Q 010519 258 MLVYEYVNNGNLEQWLHGAMRNQGNLTWEARMKVIIGTAKALAYLHEAIEPKVVHRDIKSSNILIDDEFNAKVSDFGLAK 337 (508)
Q Consensus 258 ~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~Dfgla~ 337 (508)
+++|||+++++|.+++.. ....+++..++.++.|++.||.|||+. +++|+||||+||+++.++.++|+|||++.
T Consensus 84 ~lv~e~~~~~~l~~~l~~---~~~~~~~~~~~~~~~~l~~aL~~lH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~~ 157 (284)
T cd05038 84 RLIMEYLPSGSLRDYLQR---HRDQINLKRLLLFSSQICKGMDYLGSQ---RYIHRDLAARNILVESEDLVKISDFGLAK 157 (284)
T ss_pred EEEEecCCCCCHHHHHHh---CccccCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHhEEEcCCCCEEEccccccc
Confidence 999999999999999963 334689999999999999999999998 99999999999999999999999999998
Q ss_pred ccCCCCCc--ccccccccccccCccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCCCch---------hcHHHHHH
Q 010519 338 LLDSGESH--ITTRVMGTFGYVAPEYANTGMLNEKSDIYSFGVLLLEAVTGRDPVDYGRPANE---------VNLVEWLK 406 (508)
Q Consensus 338 ~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltG~~Pf~~~~~~~~---------~~~~~~~~ 406 (508)
........ ......++..|+|||.+.+..++.++||||||+++|||++|..|+........ .....+..
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (284)
T cd05038 158 VLPEDKDYYYVKEPGESPIFWYAPECLRTSKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGIAQGQMIVTRLLE 237 (284)
T ss_pred ccccCCcceeccCCCCCcccccCcHHHccCCCCcccchHHHhhhhheeeccCCCcccccchhccccccccccccHHHHHH
Confidence 76532211 11122345679999999888999999999999999999999999854322110 00111111
Q ss_pred HHhcccccccccCCCCCCChhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhhcC
Q 010519 407 MMVGTRRAEEVVDPNLEVKPATRALKRSLLVALRCVDPDSEKRPKMSQVVRMLEAD 462 (508)
Q Consensus 407 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~ 462 (508)
.+... .....+......+.+++.+||+.+|.+|||+.||+++|+..
T Consensus 238 ~~~~~----------~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~i 283 (284)
T cd05038 238 LLKEG----------ERLPRPPSCPDEVYDLMKLCWEAEPQDRPSFADLILIVDRL 283 (284)
T ss_pred HHHcC----------CcCCCCccCCHHHHHHHHHHhccChhhCCCHHHHHHHHhhc
Confidence 11111 11111122235677899999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut |
| >cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-38 Score=306.77 Aligned_cols=255 Identities=29% Similarity=0.466 Sum_probs=201.4
Q ss_pred hCCcccceeEeeeCceEEEEEEEcC-CC----EEEEEEEcccc-hhhHHHHHHHHHHHhcCCCCCceeEEEEEEeCceee
Q 010519 185 TNRFSAENVLGEGGYGVVYKGRLIN-GS----EVAVKKLLNNL-GQAEKEFRVEVEAIGHVRHKNLVRLLGYCIEGVHRM 258 (508)
Q Consensus 185 ~~~~~~~~~lg~G~~g~Vy~~~~~~-~~----~vavK~~~~~~-~~~~~~~~~ei~~l~~l~h~niv~~~~~~~~~~~~~ 258 (508)
..+|.+.+.||+|+||.||+|.+.+ |. .+|+|.+.... ......+.+|+..+++++||||+++++++.. ...+
T Consensus 6 ~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~ 84 (279)
T cd05057 6 ETELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRLLGICLS-SQVQ 84 (279)
T ss_pred HHHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEec-CceE
Confidence 3578889999999999999998643 33 58888776544 3344678889999999999999999999987 7788
Q ss_pred EEEeecCCCCHHHHHhhhhccCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCEEEcCCCcEEEEecCCccc
Q 010519 259 LVYEYVNNGNLEQWLHGAMRNQGNLTWEARMKVIIGTAKALAYLHEAIEPKVVHRDIKSSNILIDDEFNAKVSDFGLAKL 338 (508)
Q Consensus 259 lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~Dfgla~~ 338 (508)
+||||+++|+|.+++. .....+++..+..++.|++.||.|||+. +++|+||||+||++++++.+||+|||+++.
T Consensus 85 ~v~e~~~~g~L~~~l~---~~~~~~~~~~~~~~~~qi~~~l~~LH~~---~i~H~di~p~nil~~~~~~~kL~dfg~~~~ 158 (279)
T cd05057 85 LITQLMPLGCLLDYVR---NHKDNIGSQYLLNWCVQIAKGMSYLEEK---RLVHRDLAARNVLVKTPQHVKITDFGLAKL 158 (279)
T ss_pred EEEecCCCCcHHHHHH---hccCCCCHHHHHHHHHHHHHHHHHHHhC---CEEecccCcceEEEcCCCeEEECCCccccc
Confidence 9999999999999986 3345689999999999999999999998 999999999999999999999999999987
Q ss_pred cCCCCCccc-ccccccccccCccccCCCCCCChhhHHHHHHHHHHHHh-CCCCCCCCCCCchhcHHHHHHHHhccccccc
Q 010519 339 LDSGESHIT-TRVMGTFGYVAPEYANTGMLNEKSDIYSFGVLLLEAVT-GRDPVDYGRPANEVNLVEWLKMMVGTRRAEE 416 (508)
Q Consensus 339 ~~~~~~~~~-~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 416 (508)
......... ....++..|+|||.+.+..++.++|+|||||++|||++ |..||..... .++.........
T Consensus 159 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~------~~~~~~~~~~~~--- 229 (279)
T cd05057 159 LDVDEKEYHAEGGKVPIKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGIPA------VEIPDLLEKGER--- 229 (279)
T ss_pred ccCcccceecCCCcccccccCHHHhhcCCcCchhhHHHHHHHHHHHhcCCCCCCCCCCH------HHHHHHHhCCCC---
Confidence 653332211 11223568999999988889999999999999999998 9999864322 111111111110
Q ss_pred ccCCCCCCChhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhhcC
Q 010519 417 VVDPNLEVKPATRALKRSLLVALRCVDPDSEKRPKMSQVVRMLEAD 462 (508)
Q Consensus 417 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~ 462 (508)
...+......+.+++.+||..||.+|||+.++++.|...
T Consensus 230 -------~~~~~~~~~~~~~~~~~~l~~~p~~Rp~~~~l~~~l~~~ 268 (279)
T cd05057 230 -------LPQPPICTIDVYMVLVKCWMIDAESRPTFKELINEFSKM 268 (279)
T ss_pred -------CCCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHH
Confidence 011111224566789999999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea |
| >cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-37 Score=302.06 Aligned_cols=252 Identities=26% Similarity=0.391 Sum_probs=202.7
Q ss_pred CcccceeEeeeCceEEEEEEEc-CCCEEEEEEEcccc--hhhHHHHHHHHHHHhcCCCCCceeEEEEEEe--CceeeEEE
Q 010519 187 RFSAENVLGEGGYGVVYKGRLI-NGSEVAVKKLLNNL--GQAEKEFRVEVEAIGHVRHKNLVRLLGYCIE--GVHRMLVY 261 (508)
Q Consensus 187 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~ei~~l~~l~h~niv~~~~~~~~--~~~~~lv~ 261 (508)
+|++.+.||.|+||.||++.+. ++..+|+|.+.... ......+..|+.+++.++||||+++++++.. ....+++|
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~ 80 (265)
T cd08217 1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQTLYIVM 80 (265)
T ss_pred CceeeeeeccCCCeEEEEeeecCCCCEEEEEEEecccCCHHHHHHHHHHHHHHHhcCCCccceeeeeeecCCCCEEEEEe
Confidence 4788899999999999999864 67889999875432 3334568889999999999999999998764 35678999
Q ss_pred eecCCCCHHHHHhhhhccCCCccHHHHHHHHHHHHHHHHHHH-----hcCCCCeEeecCCCCCEEEcCCCcEEEEecCCc
Q 010519 262 EYVNNGNLEQWLHGAMRNQGNLTWEARMKVIIGTAKALAYLH-----EAIEPKVVHRDIKSSNILIDDEFNAKVSDFGLA 336 (508)
Q Consensus 262 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~yLH-----~~~~~~iiH~Dlk~~NIll~~~~~~kl~Dfgla 336 (508)
||+++++|.+++.........+++..++.++.+|+.||.||| +. +++|+||+|+||++++++.+||+|||++
T Consensus 81 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~---~i~h~dl~p~nili~~~~~~kl~d~g~~ 157 (265)
T cd08217 81 EYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGN---TVLHRDLKPANIFLDANNNVKLGDFGLA 157 (265)
T ss_pred hhccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccC---cceecCCCHHHEEEecCCCEEEeccccc
Confidence 999999999999765455678999999999999999999999 66 9999999999999999999999999999
Q ss_pred cccCCCCCcccccccccccccCccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCCCchhcHHHHHHHHhccccccc
Q 010519 337 KLLDSGESHITTRVMGTFGYVAPEYANTGMLNEKSDIYSFGVLLLEAVTGRDPVDYGRPANEVNLVEWLKMMVGTRRAEE 416 (508)
Q Consensus 337 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 416 (508)
......... .....+++.|+|||.+.+..++.++|+||||+++|+|++|+.||..... . ....... ....
T Consensus 158 ~~~~~~~~~-~~~~~~~~~~~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~---~---~~~~~~~-~~~~-- 227 (265)
T cd08217 158 KILGHDSSF-AKTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTARNQ---L---QLASKIK-EGKF-- 227 (265)
T ss_pred ccccCCccc-ccccccCCCccChhhhcCCCCCchhHHHHHHHHHHHHHHCCCcccCcCH---H---HHHHHHh-cCCC--
Confidence 876543321 2334689999999999988899999999999999999999999974431 1 1111111 1111
Q ss_pred ccCCCCCCChhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 010519 417 VVDPNLEVKPATRALKRSLLVALRCVDPDSEKRPKMSQVVRM 458 (508)
Q Consensus 417 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 458 (508)
+. .+......+.+++.+||+.+|.+|||+.+|+++
T Consensus 228 ---~~----~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~il~~ 262 (265)
T cd08217 228 ---RR----IPYRYSSELNEVIKSMLNVDPDKRPSTEELLQL 262 (265)
T ss_pred ---CC----CccccCHHHHHHHHHHccCCcccCCCHHHHhhC
Confidence 11 111234567779999999999999999999975
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi |
| >cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-38 Score=307.77 Aligned_cols=256 Identities=23% Similarity=0.384 Sum_probs=200.6
Q ss_pred CCcccceeEeeeCceEEEEEEEc-CCCEEEEEEEcccc-hhhHHHHHHHHHHHhcCCCCCceeEEEEEEeCceeeEEEee
Q 010519 186 NRFSAENVLGEGGYGVVYKGRLI-NGSEVAVKKLLNNL-GQAEKEFRVEVEAIGHVRHKNLVRLLGYCIEGVHRMLVYEY 263 (508)
Q Consensus 186 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~ei~~l~~l~h~niv~~~~~~~~~~~~~lv~E~ 263 (508)
++|++.+.||+|+||.||++.+. ++..+|+|.+.... ......+.+|+.++++++||||+++++.+......++||||
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~ 80 (286)
T cd06622 1 DEIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFYGAFFIEGAVYMCMEY 80 (286)
T ss_pred ChhhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeecccCHHHHHHHHHHHHHHHhcCCCcHHhhhhheecCCeEEEEEee
Confidence 36888999999999999999875 68999999886542 23346788899999999999999999999999999999999
Q ss_pred cCCCCHHHHHhhhhccCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCEEEcCCCcEEEEecCCccccCCCC
Q 010519 264 VNNGNLEQWLHGAMRNQGNLTWEARMKVIIGTAKALAYLHEAIEPKVVHRDIKSSNILIDDEFNAKVSDFGLAKLLDSGE 343 (508)
Q Consensus 264 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~~~ 343 (508)
+++++|..++... .....+++..+..++.+++.||.|||+.. +++|+||||+||+++.++.+||+|||++.......
T Consensus 81 ~~~~~l~~~~~~~-~~~~~~~~~~~~~~~~~i~~~l~~LH~~~--~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~ 157 (286)
T cd06622 81 MDAGSLDKLYAGG-VATEGIPEDVLRRITYAVVKGLKFLKEEH--NIIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVASL 157 (286)
T ss_pred cCCCCHHHHHHhc-cccCCCCHHHHHHHHHHHHHHHHHHHhcC--CEeeCCCCHHHEEECCCCCEEEeecCCcccccCCc
Confidence 9999999988532 12347899999999999999999999622 89999999999999999999999999997653322
Q ss_pred CcccccccccccccCccccCCC------CCCChhhHHHHHHHHHHHHhCCCCCCCCCCCchhcHHHHHHHHhcccccccc
Q 010519 344 SHITTRVMGTFGYVAPEYANTG------MLNEKSDIYSFGVLLLEAVTGRDPVDYGRPANEVNLVEWLKMMVGTRRAEEV 417 (508)
Q Consensus 344 ~~~~~~~~gt~~y~aPE~~~~~------~~~~~~DvwS~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 417 (508)
.....+++.|+|||.+.+. .++.++|+|||||++|+|++|..||........ ...+.......
T Consensus 158 ---~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~---~~~~~~~~~~~----- 226 (286)
T cd06622 158 ---AKTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYANI---FAQLSAIVDGD----- 226 (286)
T ss_pred ---cccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcchhhH---HHHHHHHhhcC-----
Confidence 2334578899999998553 357899999999999999999999964322111 11111111100
Q ss_pred cCCCCCCChhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhh
Q 010519 418 VDPNLEVKPATRALKRSLLVALRCVDPDSEKRPKMSQVVRMLE 460 (508)
Q Consensus 418 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 460 (508)
.+. .+......+.+++.+||..+|.+||++.+++.+-+
T Consensus 227 -~~~----~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~~~ 264 (286)
T cd06622 227 -PPT----LPSGYSDDAQDFVAKCLNKIPNRRPTYAQLLEHPW 264 (286)
T ss_pred -CCC----CCcccCHHHHHHHHHHcccCcccCCCHHHHhcChh
Confidence 011 11124456677999999999999999999997543
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-37 Score=312.66 Aligned_cols=264 Identities=20% Similarity=0.230 Sum_probs=193.8
Q ss_pred cceeEeee--CceEEEEEEEc-CCCEEEEEEEcccc--hhhHHHHHHHHHHHhcCCCCCceeEEEEEEeCceeeEEEeec
Q 010519 190 AENVLGEG--GYGVVYKGRLI-NGSEVAVKKLLNNL--GQAEKEFRVEVEAIGHVRHKNLVRLLGYCIEGVHRMLVYEYV 264 (508)
Q Consensus 190 ~~~~lg~G--~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~ei~~l~~l~h~niv~~~~~~~~~~~~~lv~E~~ 264 (508)
++++||+| +|++||++... +|..||+|++.... ......+.+|+.+++.++||||++++++|..++..++||||+
T Consensus 2 ~~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~ 81 (327)
T cd08227 2 LLTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFM 81 (327)
T ss_pred hhhhccccccceEEEEEEeecccCcEEEEEEechhhccHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEECCEEEEEEecc
Confidence 45789999 68899999874 78899999986432 233456788999999999999999999999999999999999
Q ss_pred CCCCHHHHHhhhhccCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCEEEcCCCcEEEEecCCccccCCCCC
Q 010519 265 NNGNLEQWLHGAMRNQGNLTWEARMKVIIGTAKALAYLHEAIEPKVVHRDIKSSNILIDDEFNAKVSDFGLAKLLDSGES 344 (508)
Q Consensus 265 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~ 344 (508)
++|+|.+++... ....+++..++.++.|++.||.|||++ +|+||||||+|||++.++.++++||+..........
T Consensus 82 ~~~~l~~~~~~~--~~~~l~~~~~~~i~~qi~~~L~~LH~~---~iiH~dlkp~Nil~~~~~~~~l~~~~~~~~~~~~~~ 156 (327)
T cd08227 82 AYGSAKDLICTH--FMDGMSELAIAYILQGVLKALDYIHHM---GYVHRSVKASHILISVDGKVYLSGLRSNLSMINHGQ 156 (327)
T ss_pred CCCcHHHHHHhh--ccCCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCChhhEEEecCCcEEEcccchhhccccccc
Confidence 999999998542 234588999999999999999999998 999999999999999999999999987543321110
Q ss_pred c------ccccccccccccCccccCC--CCCCChhhHHHHHHHHHHHHhCCCCCCCCCCCchhcHHHHHHHHhcc-----
Q 010519 345 H------ITTRVMGTFGYVAPEYANT--GMLNEKSDIYSFGVLLLEAVTGRDPVDYGRPANEVNLVEWLKMMVGT----- 411 (508)
Q Consensus 345 ~------~~~~~~gt~~y~aPE~~~~--~~~~~~~DvwS~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~----- 411 (508)
. ......++..|+|||++.+ ..++.++|||||||++|||++|+.||....... ............
T Consensus 157 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~--~~~~~~~~~~~~~~~~~ 234 (327)
T cd08227 157 RLRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQ--MLLEKLNGTVPCLLDTT 234 (327)
T ss_pred cccccccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCCcchhH--HHHHHhcCCcccccccc
Confidence 0 1122346778999999976 468999999999999999999999996432111 000000000000
Q ss_pred ---------cccccccCCCC-----------------CCChhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhh
Q 010519 412 ---------RRAEEVVDPNL-----------------EVKPATRALKRSLLVALRCVDPDSEKRPKMSQVVRMLE 460 (508)
Q Consensus 412 ---------~~~~~~~~~~~-----------------~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 460 (508)
.......+... ...........+.+|+.+||+.||.+|||++|++++-.
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~ell~~p~ 309 (327)
T cd08227 235 TIPAEELTMKPSRSGANSGLGESTTVSTPRPSNGESSSHPYNRTFSPHFHHFVEQCLQRNPDARPSASTLLNHSF 309 (327)
T ss_pred chhhhhcccCCcccCCcCCCCcccccCCcCccccCCcccccccccCHHHHHHHHHHHhhCchhcCCHHHHhcChh
Confidence 00000000000 00011122346778999999999999999999998643
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype |
| >cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-38 Score=308.84 Aligned_cols=263 Identities=25% Similarity=0.381 Sum_probs=204.6
Q ss_pred eHHHHHHhhCCcccceeEeeeCceEEEEEEEc-CCCEEEEEEEcccchhhHHHHHHHHHHHhcC-CCCCceeEEEEEEeC
Q 010519 177 TLRDLEIATNRFSAENVLGEGGYGVVYKGRLI-NGSEVAVKKLLNNLGQAEKEFRVEVEAIGHV-RHKNLVRLLGYCIEG 254 (508)
Q Consensus 177 ~~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~ei~~l~~l-~h~niv~~~~~~~~~ 254 (508)
++.++..+.++|.+.+.||+|+||.||++... +++.+|+|.+.... .....+..|+.++.++ +|||++++++++...
T Consensus 13 ~~~~~~~~~~~y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~~-~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~~ 91 (291)
T cd06639 13 GLESLGDPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPIS-DVDEEIEAEYNILQSLPNHPNVVKFYGMFYKA 91 (291)
T ss_pred hcccCCCCCCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEecccc-cHHHHHHHHHHHHHHhcCCCCeEEEEEEEEec
Confidence 34555566789999999999999999999874 67889999875432 2245677899999998 899999999998754
Q ss_pred -----ceeeEEEeecCCCCHHHHHhhhhccCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCEEEcCCCcEE
Q 010519 255 -----VHRMLVYEYVNNGNLEQWLHGAMRNQGNLTWEARMKVIIGTAKALAYLHEAIEPKVVHRDIKSSNILIDDEFNAK 329 (508)
Q Consensus 255 -----~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiH~Dlk~~NIll~~~~~~k 329 (508)
...++||||+++++|.++++........+++..++.++.|++.||.|||+. +++|+||||+||++++++.+|
T Consensus 92 ~~~~~~~~~lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dlkp~nili~~~~~~k 168 (291)
T cd06639 92 DKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHNN---RIIHRDVKGNNILLTTEGGVK 168 (291)
T ss_pred cccCCCeeEEEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHEEEcCCCCEE
Confidence 357899999999999999875444566789999999999999999999998 999999999999999999999
Q ss_pred EEecCCccccCCCCCcccccccccccccCccccCCC-----CCCChhhHHHHHHHHHHHHhCCCCCCCCCCCchhcHHHH
Q 010519 330 VSDFGLAKLLDSGESHITTRVMGTFGYVAPEYANTG-----MLNEKSDIYSFGVLLLEAVTGRDPVDYGRPANEVNLVEW 404 (508)
Q Consensus 330 l~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----~~~~~~DvwS~Gvvl~elltG~~Pf~~~~~~~~~~~~~~ 404 (508)
|+|||++........ ......|+..|+|||.+... .++.++|||||||++|||++|+.||....... .+.
T Consensus 169 l~dfg~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~~~~--~~~-- 243 (291)
T cd06639 169 LVDFGVSAQLTSTRL-RRNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPVK--TLF-- 243 (291)
T ss_pred Eeecccchhcccccc-cccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCCcHHH--HHH--
Confidence 999999986543221 12234678899999988543 36889999999999999999999986432211 111
Q ss_pred HHHHhcccccccccCCCCCCChhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 010519 405 LKMMVGTRRAEEVVDPNLEVKPATRALKRSLLVALRCVDPDSEKRPKMSQVVRM 458 (508)
Q Consensus 405 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 458 (508)
..... .. +.+ .........+.+++.+||+.||.+||++.+++++
T Consensus 244 --~~~~~-~~-----~~~--~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~~ 287 (291)
T cd06639 244 --KIPRN-PP-----PTL--LHPEKWCRSFNHFISQCLIKDFEARPSVTHLLEH 287 (291)
T ss_pred --HHhcC-CC-----CCC--CcccccCHHHHHHHHHHhhcChhhCcCHHHHhcC
Confidence 11111 00 111 1112233457789999999999999999999976
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre |
| >cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-37 Score=303.33 Aligned_cols=253 Identities=23% Similarity=0.432 Sum_probs=201.1
Q ss_pred CcccceeEeeeCceEEEEEEE-cCCCEEEEEEEcccc------hhhHHHHHHHHHHHhcCCCCCceeEEEEEEeCceeeE
Q 010519 187 RFSAENVLGEGGYGVVYKGRL-INGSEVAVKKLLNNL------GQAEKEFRVEVEAIGHVRHKNLVRLLGYCIEGVHRML 259 (508)
Q Consensus 187 ~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~------~~~~~~~~~ei~~l~~l~h~niv~~~~~~~~~~~~~l 259 (508)
+|+..+.||+|++|.||++.. .++..+|+|.+.... ......+..|+..+++++|+||+++++++.+.+..++
T Consensus 1 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~ 80 (268)
T cd06630 1 EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCEDSHFNL 80 (268)
T ss_pred CccccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceeccCCeEEE
Confidence 477889999999999999986 478899999885432 1234678889999999999999999999999999999
Q ss_pred EEeecCCCCHHHHHhhhhccCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCEEEcCCC-cEEEEecCCccc
Q 010519 260 VYEYVNNGNLEQWLHGAMRNQGNLTWEARMKVIIGTAKALAYLHEAIEPKVVHRDIKSSNILIDDEF-NAKVSDFGLAKL 338 (508)
Q Consensus 260 v~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiH~Dlk~~NIll~~~~-~~kl~Dfgla~~ 338 (508)
||||+++++|.+++. ....+++..+..++.||+.||.|||++ +++|+||+|+||+++.++ .+||+|||++..
T Consensus 81 v~e~~~~~~L~~~l~----~~~~~~~~~~~~~~~ql~~al~~LH~~---~i~H~~i~~~nil~~~~~~~~~l~dfg~~~~ 153 (268)
T cd06630 81 FVEWMAGGSVSHLLS----KYGAFKEAVIINYTEQLLRGLSYLHEN---QIIHRDVKGANLLIDSTGQRLRIADFGAAAR 153 (268)
T ss_pred EEeccCCCcHHHHHH----HhCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEEcccccccc
Confidence 999999999999984 345788999999999999999999999 999999999999998776 599999999986
Q ss_pred cCCCCCc---ccccccccccccCccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCCCchhcHHHHHHHHhcccccc
Q 010519 339 LDSGESH---ITTRVMGTFGYVAPEYANTGMLNEKSDIYSFGVLLLEAVTGRDPVDYGRPANEVNLVEWLKMMVGTRRAE 415 (508)
Q Consensus 339 ~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~ 415 (508)
....... ......++..|+|||.+.+..++.++|+||||+++|+|++|..||......... ........
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~---~~~~~~~~----- 225 (268)
T cd06630 154 LAAKGTGAGEFQGQLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNHL---ALIFKIAS----- 225 (268)
T ss_pred cccccccCCccccccccccceeCHhHhccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcchH---HHHHHHhc-----
Confidence 6533211 122346788999999998888999999999999999999999999644322211 11111100
Q ss_pred cccCCCCCCChhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 010519 416 EVVDPNLEVKPATRALKRSLLVALRCVDPDSEKRPKMSQVVRM 458 (508)
Q Consensus 416 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 458 (508)
.......+......+.+++.+||..+|.+|||+.+++++
T Consensus 226 ----~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~ll~~ 264 (268)
T cd06630 226 ----ATTAPSIPEHLSPGLRDVTLRCLELQPEDRPPSRELLKH 264 (268)
T ss_pred ----cCCCCCCchhhCHHHHHHHHHHcCCCcccCcCHHHHhcC
Confidence 000111222344567779999999999999999999964
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their |
| >cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-38 Score=307.83 Aligned_cols=249 Identities=24% Similarity=0.393 Sum_probs=200.4
Q ss_pred CcccceeEeeeCceEEEEEEEc-CCCEEEEEEEcccc-hhhHHHHHHHHHHHhcCCCCCceeEEEEEEeCceeeEEEeec
Q 010519 187 RFSAENVLGEGGYGVVYKGRLI-NGSEVAVKKLLNNL-GQAEKEFRVEVEAIGHVRHKNLVRLLGYCIEGVHRMLVYEYV 264 (508)
Q Consensus 187 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~ei~~l~~l~h~niv~~~~~~~~~~~~~lv~E~~ 264 (508)
.|+..+.||+|+||.||+|.+. ++..||+|.+.... ......+..|+.++++++||||+++++++......++||||+
T Consensus 5 ~y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 84 (277)
T cd06642 5 LFTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYGSYLKGTKLWIIMEYL 84 (277)
T ss_pred HHHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEeccccchHHHHHHHHHHHHHHcCCCCccHhhhcccccCCceEEEEEcc
Confidence 5677788999999999999865 57789999876443 334467889999999999999999999999999999999999
Q ss_pred CCCCHHHHHhhhhccCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCEEEcCCCcEEEEecCCccccCCCCC
Q 010519 265 NNGNLEQWLHGAMRNQGNLTWEARMKVIIGTAKALAYLHEAIEPKVVHRDIKSSNILIDDEFNAKVSDFGLAKLLDSGES 344 (508)
Q Consensus 265 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~ 344 (508)
++++|.+++. ...+++..++.++.+++.|+.|||+. +++|+||+|+||++++++.++|+|||++........
T Consensus 85 ~~~~L~~~~~-----~~~~~~~~~~~~~~~i~~~l~~lH~~---~ivH~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~ 156 (277)
T cd06642 85 GGGSALDLLK-----PGPLEETYIATILREILKGLDYLHSE---RKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQI 156 (277)
T ss_pred CCCcHHHHhh-----cCCCCHHHHHHHHHHHHHHHHHHhcC---CeeccCCChheEEEeCCCCEEEccccccccccCcch
Confidence 9999999874 24688999999999999999999998 999999999999999999999999999976543221
Q ss_pred cccccccccccccCccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCCCchhcHHHHHHHHhcccccccccCCCCCC
Q 010519 345 HITTRVMGTFGYVAPEYANTGMLNEKSDIYSFGVLLLEAVTGRDPVDYGRPANEVNLVEWLKMMVGTRRAEEVVDPNLEV 424 (508)
Q Consensus 345 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 424 (508)
......++..|+|||.+.+..++.++|||||||++|||++|+.||....+.. ........ ..+.+
T Consensus 157 -~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~------~~~~~~~~------~~~~~-- 221 (277)
T cd06642 157 -KRNTFVGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPPNSDLHPMR------VLFLIPKN------SPPTL-- 221 (277)
T ss_pred -hhhcccCcccccCHHHhCcCCCchhhhHHHHHHHHHHHHhCCCCCcccchhh------HHhhhhcC------CCCCC--
Confidence 1223457889999999999899999999999999999999999986432211 11111000 00111
Q ss_pred ChhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhh
Q 010519 425 KPATRALKRSLLVALRCVDPDSEKRPKMSQVVRMLE 460 (508)
Q Consensus 425 ~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 460 (508)
.......+.+++.+||+.+|.+||++.+++++-.
T Consensus 222 --~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~ 255 (277)
T cd06642 222 --EGQYSKPFKEFVEACLNKDPRFRPTAKELLKHKF 255 (277)
T ss_pred --CcccCHHHHHHHHHHccCCcccCcCHHHHHHhHH
Confidence 1123445677999999999999999999999754
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 |
| >cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=306.61 Aligned_cols=262 Identities=24% Similarity=0.355 Sum_probs=200.6
Q ss_pred CCcccceeEeeeCceEEEEEEEc-CCCEEEEEEEcccc--hhhHHHHHHHHHHHhcCCCCCceeEEEEEEeCceeeEEEe
Q 010519 186 NRFSAENVLGEGGYGVVYKGRLI-NGSEVAVKKLLNNL--GQAEKEFRVEVEAIGHVRHKNLVRLLGYCIEGVHRMLVYE 262 (508)
Q Consensus 186 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~ei~~l~~l~h~niv~~~~~~~~~~~~~lv~E 262 (508)
++|++.+.||+|+||.||+|++. +|+.||+|++.... ....+.+..|+.+++.++|||++++++++......++|||
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~e 80 (286)
T cd07847 1 EKYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEVFRRKRKLHLVFE 80 (286)
T ss_pred CceeeeeeecccCCeEEEEEEECCCCcEEEEEEEeecccCccccHHHHHHHHHHHhCCCCCEeeeeeEEeeCCEEEEEEe
Confidence 47888999999999999999876 58899999885432 2233567889999999999999999999999999999999
Q ss_pred ecCCCCHHHHHhhhhccCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCEEEcCCCcEEEEecCCccccCCC
Q 010519 263 YVNNGNLEQWLHGAMRNQGNLTWEARMKVIIGTAKALAYLHEAIEPKVVHRDIKSSNILIDDEFNAKVSDFGLAKLLDSG 342 (508)
Q Consensus 263 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~~ 342 (508)
|++++.|..++. ....+++..++.++.||+.||.|||+. +++|+||||+||+++.++.+||+|||++......
T Consensus 81 ~~~~~~l~~~~~----~~~~~~~~~~~~~~~ql~~~l~~LH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~ 153 (286)
T cd07847 81 YCDHTVLNELEK----NPRGVPEHLIKKIIWQTLQAVNFCHKH---NCIHRDVKPENILITKQGQIKLCDFGFARILTGP 153 (286)
T ss_pred ccCccHHHHHHh----CCCCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCChhhEEEcCCCcEEECccccceecCCC
Confidence 999988887763 445689999999999999999999998 9999999999999999999999999999876543
Q ss_pred CCcccccccccccccCccccCC-CCCCChhhHHHHHHHHHHHHhCCCCCCCCCCCchhcHHHHHHHHhccc---------
Q 010519 343 ESHITTRVMGTFGYVAPEYANT-GMLNEKSDIYSFGVLLLEAVTGRDPVDYGRPANEVNLVEWLKMMVGTR--------- 412 (508)
Q Consensus 343 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwS~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~--------- 412 (508)
.. ......++..|+|||++.+ ..++.++|||||||++|+|++|..||......+.. ..........
T Consensus 154 ~~-~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~ 229 (286)
T cd07847 154 GD-DYTDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQL---YLIRKTLGDLIPRHQQIFS 229 (286)
T ss_pred cc-cccCcccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCCCChHHHH---HHHHHHhCCCChHHhhhcc
Confidence 21 1223457889999999876 56889999999999999999999999644322111 1111111000
Q ss_pred ---ccccccCCCCCCCh-----hHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 010519 413 ---RAEEVVDPNLEVKP-----ATRALKRSLLVALRCVDPDSEKRPKMSQVVRM 458 (508)
Q Consensus 413 ---~~~~~~~~~~~~~~-----~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 458 (508)
.......+...... .......+.+|+.+||+.||.+|||+.|++.+
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~ 283 (286)
T cd07847 230 TNQFFKGLSIPEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELLEH 283 (286)
T ss_pred cccccccccCCCcccccCHHHHhccCCHHHHHHHHHHhcCCccccCCHHHHhcC
Confidence 00000001100000 01224567789999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio |
| >cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-37 Score=301.74 Aligned_cols=238 Identities=28% Similarity=0.440 Sum_probs=188.1
Q ss_pred eeEeeeCceEEEEEEEcCCC-----------EEEEEEEcccchhhHHHHHHHHHHHhcCCCCCceeEEEEEEeCceeeEE
Q 010519 192 NVLGEGGYGVVYKGRLINGS-----------EVAVKKLLNNLGQAEKEFRVEVEAIGHVRHKNLVRLLGYCIEGVHRMLV 260 (508)
Q Consensus 192 ~~lg~G~~g~Vy~~~~~~~~-----------~vavK~~~~~~~~~~~~~~~ei~~l~~l~h~niv~~~~~~~~~~~~~lv 260 (508)
+.||+|+||.||+|.+.+.. .+++|.+...... ...+.+|+.+++.++||||+++++++.. ...++|
T Consensus 1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~-~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~lv 78 (259)
T cd05037 1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRD-SLAFFETASLMSQLSHKHLVKLYGVCVR-DENIMV 78 (259)
T ss_pred CcccccccceEEEEEEeccCCccccCCccceeeeeeccccchhh-HHHHHHHHHHHHcCCCcchhheeeEEec-CCcEEE
Confidence 36899999999999886433 4677765443333 5678889999999999999999999988 778999
Q ss_pred EeecCCCCHHHHHhhhhccCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCEEEcCCC-------cEEEEec
Q 010519 261 YEYVNNGNLEQWLHGAMRNQGNLTWEARMKVIIGTAKALAYLHEAIEPKVVHRDIKSSNILIDDEF-------NAKVSDF 333 (508)
Q Consensus 261 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiH~Dlk~~NIll~~~~-------~~kl~Df 333 (508)
|||+++|+|.+++.. ....+++..++.++.||+.||.|||++ +|+||||||+|||++.++ .+||+||
T Consensus 79 ~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dlkp~Nill~~~~~~~~~~~~~kl~Df 152 (259)
T cd05037 79 EEYVKFGPLDVFLHR---EKNNVSLHWKLDVAKQLASALHYLEDK---KLVHGNVCGKNILVARYGLNEGYVPFIKLSDP 152 (259)
T ss_pred EEcCCCCcHHHHHHh---hccCCCHHHHHHHHHHHHHHHHHHhhC---CeecccCccceEEEecCccccCCceeEEeCCC
Confidence 999999999999863 233788999999999999999999998 999999999999999888 7999999
Q ss_pred CCccccCCCCCcccccccccccccCccccCCC--CCCChhhHHHHHHHHHHHHh-CCCCCCCCCCCchhcHHHHHHHHhc
Q 010519 334 GLAKLLDSGESHITTRVMGTFGYVAPEYANTG--MLNEKSDIYSFGVLLLEAVT-GRDPVDYGRPANEVNLVEWLKMMVG 410 (508)
Q Consensus 334 gla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~DvwS~Gvvl~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~ 410 (508)
|++..... .....++..|+|||++.+. .++.++|||||||++|+|++ |..||....... ...+.. .
T Consensus 153 g~a~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~~~~---~~~~~~---~ 221 (259)
T cd05037 153 GIPITVLS-----REERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSSE---KERFYQ---D 221 (259)
T ss_pred Cccccccc-----ccccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccCCchh---HHHHHh---c
Confidence 99986543 1223467789999999876 78999999999999999999 577775443211 111111 0
Q ss_pred ccccccccCCCCCCChhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhh
Q 010519 411 TRRAEEVVDPNLEVKPATRALKRSLLVALRCVDPDSEKRPKMSQVVRMLE 460 (508)
Q Consensus 411 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 460 (508)
.. ...... ...+.+++.+||..+|.+|||+.++++.|+
T Consensus 222 ~~--------~~~~~~----~~~~~~li~~~l~~~p~~Rpt~~~il~~l~ 259 (259)
T cd05037 222 QH--------RLPMPD----CAELANLINQCWTYDPTKRPSFRAILRDLN 259 (259)
T ss_pred CC--------CCCCCC----chHHHHHHHHHhccChhhCCCHHHHHHhcC
Confidence 00 000100 156677999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki |
| >cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-38 Score=311.25 Aligned_cols=256 Identities=29% Similarity=0.472 Sum_probs=199.0
Q ss_pred hCCcccceeEeeeCceEEEEEEEc-CCC----EEEEEEEcccch-hhHHHHHHHHHHHhcCCCCCceeEEEEEEeCceee
Q 010519 185 TNRFSAENVLGEGGYGVVYKGRLI-NGS----EVAVKKLLNNLG-QAEKEFRVEVEAIGHVRHKNLVRLLGYCIEGVHRM 258 (508)
Q Consensus 185 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~----~vavK~~~~~~~-~~~~~~~~ei~~l~~l~h~niv~~~~~~~~~~~~~ 258 (508)
.++|...+.||+|+||.||+|.+. +|. .+|+|.+..... .....+..|+.+++.++||||+++++++... ..+
T Consensus 6 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~-~~~ 84 (303)
T cd05110 6 ETELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRLLGVCLSP-TIQ 84 (303)
T ss_pred hhhceeccccccCCCccEEEEEEecCCCcceeeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEcCC-Cce
Confidence 457888899999999999999864 344 468887754432 3334688899999999999999999998754 467
Q ss_pred EEEeecCCCCHHHHHhhhhccCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCEEEcCCCcEEEEecCCccc
Q 010519 259 LVYEYVNNGNLEQWLHGAMRNQGNLTWEARMKVIIGTAKALAYLHEAIEPKVVHRDIKSSNILIDDEFNAKVSDFGLAKL 338 (508)
Q Consensus 259 lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~Dfgla~~ 338 (508)
+++||+++|+|.+++.. ....+++..+..++.|++.||.|||++ +|+|+||||+|||+++++.+||+|||+++.
T Consensus 85 ~v~e~~~~g~l~~~~~~---~~~~~~~~~~~~~~~qi~~~L~~LH~~---~ivH~dikp~Nill~~~~~~kL~Dfg~~~~ 158 (303)
T cd05110 85 LVTQLMPHGCLLDYVHE---HKDNIGSQLLLNWCVQIAKGMMYLEER---RLVHRDLAARNVLVKSPNHVKITDFGLARL 158 (303)
T ss_pred eeehhcCCCCHHHHHHh---cccCCCHHHHHHHHHHHHHHHHHHhhc---CeeccccccceeeecCCCceEEcccccccc
Confidence 99999999999999853 344688999999999999999999998 999999999999999999999999999986
Q ss_pred cCCCCCc-ccccccccccccCccccCCCCCCChhhHHHHHHHHHHHHh-CCCCCCCCCCCchhcHHHHHHHHhccccccc
Q 010519 339 LDSGESH-ITTRVMGTFGYVAPEYANTGMLNEKSDIYSFGVLLLEAVT-GRDPVDYGRPANEVNLVEWLKMMVGTRRAEE 416 (508)
Q Consensus 339 ~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 416 (508)
....... ......++..|+|||.+.+..++.++|||||||++|||++ |..||..... .....++ ......
T Consensus 159 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~el~t~g~~p~~~~~~---~~~~~~~---~~~~~~-- 230 (303)
T cd05110 159 LEGDEKEYNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIPT---REIPDLL---EKGERL-- 230 (303)
T ss_pred ccCcccccccCCCccccccCCHHHhccCCCChHHHHHHHHHHHHHHHhCCCCCCCCCCH---HHHHHHH---HCCCCC--
Confidence 6433221 1222345678999999999899999999999999999997 8999853321 1111211 111110
Q ss_pred ccCCCCCCChhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhhcCC
Q 010519 417 VVDPNLEVKPATRALKRSLLVALRCVDPDSEKRPKMSQVVRMLEADD 463 (508)
Q Consensus 417 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~ 463 (508)
.........+.+++.+||..+|.+||++.++++.|+...
T Consensus 231 --------~~~~~~~~~~~~li~~c~~~~p~~Rp~~~~l~~~l~~~~ 269 (303)
T cd05110 231 --------PQPPICTIDVYMVMVKCWMIDADSRPKFKELAAEFSRMA 269 (303)
T ss_pred --------CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence 001112345667899999999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin |
| >cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-37 Score=301.69 Aligned_cols=252 Identities=28% Similarity=0.421 Sum_probs=201.6
Q ss_pred CcccceeEeeeCceEEEEEEEc-CCCEEEEEEEcccch--hhHHHHHHHHHHHhcCCCCCceeEEEEEEeCceeeEEEee
Q 010519 187 RFSAENVLGEGGYGVVYKGRLI-NGSEVAVKKLLNNLG--QAEKEFRVEVEAIGHVRHKNLVRLLGYCIEGVHRMLVYEY 263 (508)
Q Consensus 187 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~ei~~l~~l~h~niv~~~~~~~~~~~~~lv~E~ 263 (508)
+|.+.+.||+|+||.||+|... ++..+++|.+..... .....+..|+.+++.++|+||+++++++......++|+||
T Consensus 1 ~y~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (264)
T cd06626 1 RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGVEVHREKVYIFMEY 80 (264)
T ss_pred CceeeeEeecCCCcEEEEEEECCCCcEEEEEEEECcccchHHHHHHHHHHHHHHhCCCCChhheeeeEecCCEEEEEEec
Confidence 5788899999999999999865 688999999865544 2557789999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhhhhccCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCEEEcCCCcEEEEecCCccccCCCC
Q 010519 264 VNNGNLEQWLHGAMRNQGNLTWEARMKVIIGTAKALAYLHEAIEPKVVHRDIKSSNILIDDEFNAKVSDFGLAKLLDSGE 343 (508)
Q Consensus 264 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~~~ 343 (508)
+++++|.+++. ....+++..++.++.+++.||.|||+. +++|+||+|+||++++++.+||+|||++.......
T Consensus 81 ~~~~~L~~~~~----~~~~~~~~~~~~i~~~i~~~l~~lh~~---~i~H~dl~~~nil~~~~~~~kl~d~g~~~~~~~~~ 153 (264)
T cd06626 81 CSGGTLEELLE----HGRILDEHVIRVYTLQLLEGLAYLHSH---GIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNT 153 (264)
T ss_pred CCCCcHHHHHh----hcCCCChHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEcccccccccCCCC
Confidence 99999999985 345578899999999999999999998 99999999999999999999999999998765433
Q ss_pred Cccc---ccccccccccCccccCCCC---CCChhhHHHHHHHHHHHHhCCCCCCCCCCCchhcHHHHHHHHhcccccccc
Q 010519 344 SHIT---TRVMGTFGYVAPEYANTGM---LNEKSDIYSFGVLLLEAVTGRDPVDYGRPANEVNLVEWLKMMVGTRRAEEV 417 (508)
Q Consensus 344 ~~~~---~~~~gt~~y~aPE~~~~~~---~~~~~DvwS~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 417 (508)
.... ....++..|+|||++.+.. ++.++||||||+++|+|++|+.||..... ... ...... ..
T Consensus 154 ~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~~--~~~---~~~~~~-~~----- 222 (264)
T cd06626 154 TTMGEEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDN--EFQ---IMFHVG-AG----- 222 (264)
T ss_pred CcccccccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCCcc--hHH---HHHHHh-cC-----
Confidence 2211 1346788999999998766 88999999999999999999999964321 111 111111 00
Q ss_pred cCCCCCCChhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 010519 418 VDPNLEVKPATRALKRSLLVALRCVDPDSEKRPKMSQVVRM 458 (508)
Q Consensus 418 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 458 (508)
.....+........+.+++.+||+.+|.+|||+.+++.+
T Consensus 223 --~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~i~~~ 261 (264)
T cd06626 223 --HKPPIPDSLQLSPEGKDFLDRCLESDPKKRPTASELLQH 261 (264)
T ss_pred --CCCCCCcccccCHHHHHHHHHHccCCcccCCCHHHHhcC
Confidence 111111111224456679999999999999999999864
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4 |
| >cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-38 Score=320.93 Aligned_cols=243 Identities=22% Similarity=0.240 Sum_probs=186.8
Q ss_pred EeeeCceEEEEEEEc-CCCEEEEEEEcccch---hhHHHHHHHHHHHhcC---CCCCceeEEEEEEeCceeeEEEeecCC
Q 010519 194 LGEGGYGVVYKGRLI-NGSEVAVKKLLNNLG---QAEKEFRVEVEAIGHV---RHKNLVRLLGYCIEGVHRMLVYEYVNN 266 (508)
Q Consensus 194 lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~ei~~l~~l---~h~niv~~~~~~~~~~~~~lv~E~~~~ 266 (508)
||+|+||+||+|++. ++..||+|++..... .....+..|..++..+ +||||+.+++++.+....|+||||+++
T Consensus 1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~~~lv~e~~~~ 80 (330)
T cd05586 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSDLYLVTDYMSG 80 (330)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCCeEEEEEcCCCC
Confidence 699999999999875 688999999854321 1122344466666554 699999999999999999999999999
Q ss_pred CCHHHHHhhhhccCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCEEEcCCCcEEEEecCCccccCCCCCcc
Q 010519 267 GNLEQWLHGAMRNQGNLTWEARMKVIIGTAKALAYLHEAIEPKVVHRDIKSSNILIDDEFNAKVSDFGLAKLLDSGESHI 346 (508)
Q Consensus 267 gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~ 346 (508)
|+|.+++. ....+++..+..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||++....... ..
T Consensus 81 g~L~~~l~----~~~~~~~~~~~~~~~qil~al~~LH~~---~ivHrDlkp~Nili~~~~~~kl~Dfg~a~~~~~~~-~~ 152 (330)
T cd05586 81 GELFWHLQ----KEGRFSEDRAKFYIAELVLALEHLHKY---DIVYRDLKPENILLDATGHIALCDFGLSKANLTDN-KT 152 (330)
T ss_pred ChHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCCHHHeEECCCCCEEEecCCcCcCCCCCC-CC
Confidence 99999884 456789999999999999999999999 99999999999999999999999999987543222 12
Q ss_pred cccccccccccCccccCCC-CCCChhhHHHHHHHHHHHHhCCCCCCCCCCCchhcHHHHHHHHhcccccccccCCCCCCC
Q 010519 347 TTRVMGTFGYVAPEYANTG-MLNEKSDIYSFGVLLLEAVTGRDPVDYGRPANEVNLVEWLKMMVGTRRAEEVVDPNLEVK 425 (508)
Q Consensus 347 ~~~~~gt~~y~aPE~~~~~-~~~~~~DvwS~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 425 (508)
....+||+.|+|||++.+. .++.++|||||||+||+|++|+.||..... .+........ . ..+..
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~~~~------~~~~~~i~~~-~------~~~~~- 218 (330)
T cd05586 153 TNTFCGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAEDT------QQMYRNIAFG-K------VRFPK- 218 (330)
T ss_pred ccCccCCccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCCCCH------HHHHHHHHcC-C------CCCCC-
Confidence 3345799999999998764 489999999999999999999999964321 1111111110 0 00110
Q ss_pred hhHHHHHHHHHHHHHhcCCCCCCCC----CHHHHHHHhh
Q 010519 426 PATRALKRSLLVALRCVDPDSEKRP----KMSQVVRMLE 460 (508)
Q Consensus 426 ~~~~~~~~l~~li~~cl~~dP~~RP----s~~evl~~L~ 460 (508)
......+.+++.+||+.||.+|| ++.+++++-.
T Consensus 219 --~~~~~~~~~li~~~L~~~P~~R~~~~~~~~~ll~h~~ 255 (330)
T cd05586 219 --NVLSDEGRQFVKGLLNRNPQHRLGAHRDAVELKEHPF 255 (330)
T ss_pred --ccCCHHHHHHHHHHcCCCHHHCCCCCCCHHHHhcCcc
Confidence 11234556689999999999998 5777776543
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of |
| >cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-37 Score=301.13 Aligned_cols=248 Identities=27% Similarity=0.401 Sum_probs=199.9
Q ss_pred CcccceeEeeeCceEEEEEEEc-CCCEEEEEEEcccc-----hhhHHHHHHHHHHHhcCCCCCceeEEEEEEeCceeeEE
Q 010519 187 RFSAENVLGEGGYGVVYKGRLI-NGSEVAVKKLLNNL-----GQAEKEFRVEVEAIGHVRHKNLVRLLGYCIEGVHRMLV 260 (508)
Q Consensus 187 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-----~~~~~~~~~ei~~l~~l~h~niv~~~~~~~~~~~~~lv 260 (508)
+|...+.||+|++|.||+|... ++..|++|.+.... ......+..|+.+++.++|+||+++++++.+....+++
T Consensus 1 ~~~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv 80 (258)
T cd06632 1 RWRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTEREEDNLYIF 80 (258)
T ss_pred CccccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEecCCeEEEE
Confidence 4677889999999999999876 78999999875432 23446788899999999999999999999999999999
Q ss_pred EeecCCCCHHHHHhhhhccCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCEEEcCCCcEEEEecCCccccC
Q 010519 261 YEYVNNGNLEQWLHGAMRNQGNLTWEARMKVIIGTAKALAYLHEAIEPKVVHRDIKSSNILIDDEFNAKVSDFGLAKLLD 340 (508)
Q Consensus 261 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~Dfgla~~~~ 340 (508)
+||+++++|.+++. ....+++..+..++.||+.||.|||+. +++|+||+|+||+++.++.+||+|||++....
T Consensus 81 ~e~~~~~~L~~~~~----~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~~~ni~~~~~~~~kl~d~~~~~~~~ 153 (258)
T cd06632 81 LELVPGGSLAKLLK----KYGSFPEPVIRLYTRQILLGLEYLHDR---NTVHRDIKGANILVDTNGVVKLADFGMAKQVV 153 (258)
T ss_pred EEecCCCcHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEccCccceecc
Confidence 99999999999985 345688999999999999999999998 99999999999999999999999999988654
Q ss_pred CCCCcccccccccccccCccccCCCC-CCChhhHHHHHHHHHHHHhCCCCCCCCCCCchhcHHHHHHHHhcccccccccC
Q 010519 341 SGESHITTRVMGTFGYVAPEYANTGM-LNEKSDIYSFGVLLLEAVTGRDPVDYGRPANEVNLVEWLKMMVGTRRAEEVVD 419 (508)
Q Consensus 341 ~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DvwS~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 419 (508)
... ......++..|+|||.+.... ++.++|+|||||++|+|++|..||...... ............
T Consensus 154 ~~~--~~~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~~~------~~~~~~~~~~~~----- 220 (258)
T cd06632 154 EFS--FAKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLEGV------AAVFKIGRSKEL----- 220 (258)
T ss_pred ccc--cccccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccCcHH------HHHHHHHhcccC-----
Confidence 332 223456889999999987766 899999999999999999999999643311 111111110000
Q ss_pred CCCCCChhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 010519 420 PNLEVKPATRALKRSLLVALRCVDPDSEKRPKMSQVVRM 458 (508)
Q Consensus 420 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 458 (508)
+.+ +......+.+++.+||+.+|.+||++.+++.+
T Consensus 221 ~~~----~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~ 255 (258)
T cd06632 221 PPI----PDHLSDEAKDFILKCLQRDPSLRPTAAELLEH 255 (258)
T ss_pred CCc----CCCcCHHHHHHHHHHhhcCcccCcCHHHHhcC
Confidence 111 11223556679999999999999999999875
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops |
| >cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=307.98 Aligned_cols=247 Identities=25% Similarity=0.330 Sum_probs=201.3
Q ss_pred CCcccceeEeeeCceEEEEEEEc-CCCEEEEEEEcccc---hhhHHHHHHHHHHHhcCCCCCceeEEEEEEeCceeeEEE
Q 010519 186 NRFSAENVLGEGGYGVVYKGRLI-NGSEVAVKKLLNNL---GQAEKEFRVEVEAIGHVRHKNLVRLLGYCIEGVHRMLVY 261 (508)
Q Consensus 186 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~ei~~l~~l~h~niv~~~~~~~~~~~~~lv~ 261 (508)
++|++.+.||+|+||.||++.+. +++.+|+|.+.... ......+..|++++++++||||+++++++.++...++||
T Consensus 1 ~~y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 80 (290)
T cd05580 1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQDDSNLYLVM 80 (290)
T ss_pred CceEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEEEcCCeEEEEE
Confidence 47899999999999999999875 68899999885432 223456888999999999999999999999999999999
Q ss_pred eecCCCCHHHHHhhhhccCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCEEEcCCCcEEEEecCCccccCC
Q 010519 262 EYVNNGNLEQWLHGAMRNQGNLTWEARMKVIIGTAKALAYLHEAIEPKVVHRDIKSSNILIDDEFNAKVSDFGLAKLLDS 341 (508)
Q Consensus 262 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~ 341 (508)
||+++++|.+++. ....+++..+..++.|++.||.|||+. +++|+||+|+|||+++++.+||+|||++.....
T Consensus 81 e~~~~~~L~~~~~----~~~~l~~~~~~~~~~qil~~l~~lH~~---~i~H~dl~p~nili~~~~~~kl~dfg~~~~~~~ 153 (290)
T cd05580 81 EYVPGGELFSHLR----KSGRFPEPVARFYAAQVVLALEYLHSL---DIVYRDLKPENLLLDSDGYIKITDFGFAKRVKG 153 (290)
T ss_pred ecCCCCCHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHEEECCCCCEEEeeCCCccccCC
Confidence 9999999999984 346789999999999999999999998 999999999999999999999999999987654
Q ss_pred CCCcccccccccccccCccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCCCchhcHHHHHHHHhcccccccccCCC
Q 010519 342 GESHITTRVMGTFGYVAPEYANTGMLNEKSDIYSFGVLLLEAVTGRDPVDYGRPANEVNLVEWLKMMVGTRRAEEVVDPN 421 (508)
Q Consensus 342 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 421 (508)
. .....+++.|+|||.+.+..++.++||||||+++|+|++|..||..... . ......... .
T Consensus 154 ~----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~---~---~~~~~~~~~---------~ 214 (290)
T cd05580 154 R----TYTLCGTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAGYPPFFDDNP---I---QIYEKILEG---------K 214 (290)
T ss_pred C----CCCCCCCccccChhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCH---H---HHHHHHhcC---------C
Confidence 3 2334688999999999888889999999999999999999999964331 1 111111111 0
Q ss_pred CCCChhHHHHHHHHHHHHHhcCCCCCCCC-----CHHHHHHHhh
Q 010519 422 LEVKPATRALKRSLLVALRCVDPDSEKRP-----KMSQVVRMLE 460 (508)
Q Consensus 422 ~~~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~evl~~L~ 460 (508)
... +......+.+++.+||..||.+|+ ++++++++-.
T Consensus 215 ~~~--~~~~~~~l~~li~~~l~~~p~~R~~~~~~~~~~l~~~~~ 256 (290)
T cd05580 215 VRF--PSFFSPDAKDLIRNLLQVDLTKRLGNLKNGVNDIKNHPW 256 (290)
T ss_pred ccC--CccCCHHHHHHHHHHccCCHHHccCcccCCHHHHHcCcc
Confidence 111 111234566799999999999999 8888887643
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi |
| >cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-38 Score=311.34 Aligned_cols=250 Identities=23% Similarity=0.339 Sum_probs=199.6
Q ss_pred CcccceeEeeeCceEEEEEEEc-CCCEEEEEEEcccchhhHHHHHHHHHHHhcCCCCCceeEEEEEEeCceeeEEEeecC
Q 010519 187 RFSAENVLGEGGYGVVYKGRLI-NGSEVAVKKLLNNLGQAEKEFRVEVEAIGHVRHKNLVRLLGYCIEGVHRMLVYEYVN 265 (508)
Q Consensus 187 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~ei~~l~~l~h~niv~~~~~~~~~~~~~lv~E~~~ 265 (508)
.|.....||+|+||.||++... ++..||||++..........+..|+..++.++|+||+++++.+...+..++||||++
T Consensus 23 ~~~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~lv~e~~~ 102 (292)
T cd06658 23 YLDSFIKIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELWVVMEFLE 102 (292)
T ss_pred HHhhhhcccCCCCeEEEEEEECCCCCEEEEEEEecchHHHHHHHHHHHHHHHhCCCCcHHHHHHheecCCeEEEEEeCCC
Confidence 3444567999999999999864 688999998866555556678899999999999999999999999999999999999
Q ss_pred CCCHHHHHhhhhccCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCEEEcCCCcEEEEecCCccccCCCCCc
Q 010519 266 NGNLEQWLHGAMRNQGNLTWEARMKVIIGTAKALAYLHEAIEPKVVHRDIKSSNILIDDEFNAKVSDFGLAKLLDSGESH 345 (508)
Q Consensus 266 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~ 345 (508)
+++|.+++. ...+++..++.++.||+.||.|||+. +++||||||+||++++++.++|+|||++........
T Consensus 103 ~~~L~~~~~-----~~~l~~~~~~~~~~qi~~~l~~LH~~---~ivH~dlkp~Nill~~~~~~kL~dfg~~~~~~~~~~- 173 (292)
T cd06658 103 GGALTDIVT-----HTRMNEEQIATVCLSVLRALSYLHNQ---GVIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEVP- 173 (292)
T ss_pred CCcHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHHC---CEeecCCCHHHEEEcCCCCEEEccCcchhhcccccc-
Confidence 999999873 23588999999999999999999999 999999999999999999999999999875533221
Q ss_pred ccccccccccccCccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCCCchhcHHHHHHHHhcccccccccCCCCCCC
Q 010519 346 ITTRVMGTFGYVAPEYANTGMLNEKSDIYSFGVLLLEAVTGRDPVDYGRPANEVNLVEWLKMMVGTRRAEEVVDPNLEVK 425 (508)
Q Consensus 346 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 425 (508)
......|+..|+|||.+.+..++.++||||||+++|||++|+.||....... . +..... ...+.+..
T Consensus 174 ~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~---~---~~~~~~------~~~~~~~~- 240 (292)
T cd06658 174 KRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPPYFNEPPLQ---A---MRRIRD------NLPPRVKD- 240 (292)
T ss_pred cCceeecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH---H---HHHHHh------cCCCcccc-
Confidence 2233568899999999998889999999999999999999999996433211 1 111110 01111111
Q ss_pred hhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHh
Q 010519 426 PATRALKRSLLVALRCVDPDSEKRPKMSQVVRML 459 (508)
Q Consensus 426 ~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L 459 (508)
.......+..++.+||..||.+|||+++++++-
T Consensus 241 -~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~~ 273 (292)
T cd06658 241 -SHKVSSVLRGFLDLMLVREPSQRATAQELLQHP 273 (292)
T ss_pred -ccccCHHHHHHHHHHccCChhHCcCHHHHhhCh
Confidence 111233456688999999999999999999863
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express |
| >PHA03210 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-38 Score=331.49 Aligned_cols=271 Identities=18% Similarity=0.262 Sum_probs=192.0
Q ss_pred hhCCcccceeEeeeCceEEEEEEEcC--CCEEEEEE--------------Ec---ccchhhHHHHHHHHHHHhcCCCCCc
Q 010519 184 ATNRFSAENVLGEGGYGVVYKGRLIN--GSEVAVKK--------------LL---NNLGQAEKEFRVEVEAIGHVRHKNL 244 (508)
Q Consensus 184 ~~~~~~~~~~lg~G~~g~Vy~~~~~~--~~~vavK~--------------~~---~~~~~~~~~~~~ei~~l~~l~h~ni 244 (508)
..++|.+.+.||+|+||+||+|.+.. +...+.|. +. .........+.+|+.+|++++||||
T Consensus 146 ~~~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~Ei~il~~l~HpnI 225 (501)
T PHA03210 146 FLAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQLENEILALGRLNHENI 225 (501)
T ss_pred hhhccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhhcchHHHHHHHHHHHHHHhCCCCCc
Confidence 45789999999999999999987532 21122110 10 1112234567889999999999999
Q ss_pred eeEEEEEEeCceeeEEEeecCCCCHHHHHhhhh-ccCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCEEEc
Q 010519 245 VRLLGYCIEGVHRMLVYEYVNNGNLEQWLHGAM-RNQGNLTWEARMKVIIGTAKALAYLHEAIEPKVVHRDIKSSNILID 323 (508)
Q Consensus 245 v~~~~~~~~~~~~~lv~E~~~~gsL~~~l~~~~-~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiH~Dlk~~NIll~ 323 (508)
+++++++......|+|++++. ++|.+++.... ..........+..++.||+.||.|||++ +|+||||||+|||++
T Consensus 226 v~l~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~~---gIiHrDLKP~NILl~ 301 (501)
T PHA03210 226 LKIEEILRSEANTYMITQKYD-FDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDK---KLIHRDIKLENIFLN 301 (501)
T ss_pred CcEeEEEEECCeeEEEEeccc-cCHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEC
Confidence 999999999999999999994 58888774321 1122344566788999999999999998 999999999999999
Q ss_pred CCCcEEEEecCCccccCCCCCcccccccccccccCccccCCCCCCChhhHHHHHHHHHHHHhCCCC-CCCCCCCchhcHH
Q 010519 324 DEFNAKVSDFGLAKLLDSGESHITTRVMGTFGYVAPEYANTGMLNEKSDIYSFGVLLLEAVTGRDP-VDYGRPANEVNLV 402 (508)
Q Consensus 324 ~~~~~kl~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltG~~P-f~~~~~~~~~~~~ 402 (508)
.++.+||+|||++..+............||..|+|||++.+..++.++|||||||+||||++|..+ |..........+.
T Consensus 302 ~~~~vkL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~~~~~p~~~~~~~~~~~~~ 381 (501)
T PHA03210 302 CDGKIVLGDFGTAMPFEKEREAFDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLSHDFCPIGDGGGKPGKQLL 381 (501)
T ss_pred CCCCEEEEeCCCceecCcccccccccccCCcCCCCchhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCccCCCCCHHHHHH
Confidence 999999999999987755433334456799999999999999999999999999999999998754 4333222222222
Q ss_pred HHHHHHhcccccccccCC-----------CC-----CCCh---hHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhh
Q 010519 403 EWLKMMVGTRRAEEVVDP-----------NL-----EVKP---ATRALKRSLLVALRCVDPDSEKRPKMSQVVRMLE 460 (508)
Q Consensus 403 ~~~~~~~~~~~~~~~~~~-----------~~-----~~~~---~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 460 (508)
+.+...... ...+.+. .+ .... .......+.+++.+||+.||.+|||+.|++.+-.
T Consensus 382 ~~~~~~~~~--~~~~p~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~li~kmL~~DP~~Rpsa~elL~hp~ 456 (501)
T PHA03210 382 KIIDSLSVC--DEEFPDPPCKLFDYIDSAEIDHAGHSVPPLIRNLGLPADFEYPLVKMLTFDWHLRPGAAELLALPL 456 (501)
T ss_pred HHHHhcccC--hhhcCCcHHHHHHHhhhhhcccCccchhhHHHhcCCChHHHHHHHHHhccCcccCcCHHHHhhChh
Confidence 211111000 0000000 00 0000 0011234556788999999999999999998654
|
|
| >cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-37 Score=304.71 Aligned_cols=263 Identities=24% Similarity=0.344 Sum_probs=201.9
Q ss_pred CcccceeEeeeCceEEEEEEEc-CCCEEEEEEEcccc--hhhHHHHHHHHHHHhcCCCCCceeEEEEEEeCceeeEEEee
Q 010519 187 RFSAENVLGEGGYGVVYKGRLI-NGSEVAVKKLLNNL--GQAEKEFRVEVEAIGHVRHKNLVRLLGYCIEGVHRMLVYEY 263 (508)
Q Consensus 187 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~ei~~l~~l~h~niv~~~~~~~~~~~~~lv~E~ 263 (508)
+|++.+.||.|+||.||+|.+. +|..|++|++.... ......+..|+.++++++||||+++++++......++||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~ 80 (286)
T cd07832 1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDVFPHGSGFVLVMEY 80 (286)
T ss_pred CceEEeecccCCCcEEEEEEECCCCceEEEEEEEcccccchhhHHHHHHHHHHHhCCCCCCcceeeEEecCCeeEEEecc
Confidence 5788999999999999999875 68899999986543 23346788899999999999999999999999999999999
Q ss_pred cCCCCHHHHHhhhhccCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCEEEcCCCcEEEEecCCccccCCCC
Q 010519 264 VNNGNLEQWLHGAMRNQGNLTWEARMKVIIGTAKALAYLHEAIEPKVVHRDIKSSNILIDDEFNAKVSDFGLAKLLDSGE 343 (508)
Q Consensus 264 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~~~ 343 (508)
+ +++|.+++.. ....+++..++.++.||+.||.|||+. +++|+||||+||+++.++.++|+|||++.......
T Consensus 81 ~-~~~L~~~~~~---~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~ni~~~~~~~~~l~dfg~~~~~~~~~ 153 (286)
T cd07832 81 M-PSDLSEVLRD---EERPLPEAQVKSYMRMLLKGVAYMHAN---GIMHRDLKPANLLISADGVLKIADFGLARLFSEEE 153 (286)
T ss_pred c-CCCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCcCHHHEEEcCCCcEEEeeeeecccccCCC
Confidence 9 9999999863 336789999999999999999999998 99999999999999999999999999998765443
Q ss_pred CcccccccccccccCccccCCC-CCCChhhHHHHHHHHHHHHhCCCCCCCCCCCchhcHHHHHHHHhccccc--------
Q 010519 344 SHITTRVMGTFGYVAPEYANTG-MLNEKSDIYSFGVLLLEAVTGRDPVDYGRPANEVNLVEWLKMMVGTRRA-------- 414 (508)
Q Consensus 344 ~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwS~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~-------- 414 (508)
........++..|+|||++.+. .++.++|||||||++|||++|..||..... ...........+....
T Consensus 154 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~ 230 (286)
T cd07832 154 PRLYSHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGEND---IEQLAIVFRTLGTPNEETWPGLTS 230 (286)
T ss_pred CCccccccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCCCCH---HHHHHHHHHHcCCCChHHHhhccC
Confidence 2223345689999999988654 468999999999999999999777753321 1111111111110000
Q ss_pred ----ccccCCCCCCC----hhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHh
Q 010519 415 ----EEVVDPNLEVK----PATRALKRSLLVALRCVDPDSEKRPKMSQVVRML 459 (508)
Q Consensus 415 ----~~~~~~~~~~~----~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L 459 (508)
..+..+..... ........+.+++.+||+.||.+|||+++++.+-
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~l~h~ 283 (286)
T cd07832 231 LPDYNKITFPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALRHP 283 (286)
T ss_pred cchhhcccCCCCCcchHHHhCCCccHHHHHHHHHHhccChhhCCCHHHHhhCc
Confidence 00000000000 0012236778899999999999999999999863
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea |
| >cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-37 Score=299.67 Aligned_cols=249 Identities=24% Similarity=0.394 Sum_probs=200.0
Q ss_pred CcccceeEeeeCceEEEEEEEc-CCCEEEEEEEcccc--hhhHHHHHHHHHHHhcCCCCCceeEEEEEEeCceeeEEEee
Q 010519 187 RFSAENVLGEGGYGVVYKGRLI-NGSEVAVKKLLNNL--GQAEKEFRVEVEAIGHVRHKNLVRLLGYCIEGVHRMLVYEY 263 (508)
Q Consensus 187 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~ei~~l~~l~h~niv~~~~~~~~~~~~~lv~E~ 263 (508)
+|+..+.||+|+||.||++... +++.+|+|.+.... ......+..|+.+++.++|||++++++.+..+...++||||
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08220 1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYENFLEDKALMIVMEY 80 (256)
T ss_pred CceEEEEecccCceEEEEEEEcCCCcEEEEEEEeccccccHHHHHHHHHHHHHhhCCCCchhheeeeEecCCEEEEEEec
Confidence 5888999999999999999864 68889999885432 23346788899999999999999999999999999999999
Q ss_pred cCCCCHHHHHhhhhccCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCEEEcCCC-cEEEEecCCccccCCC
Q 010519 264 VNNGNLEQWLHGAMRNQGNLTWEARMKVIIGTAKALAYLHEAIEPKVVHRDIKSSNILIDDEF-NAKVSDFGLAKLLDSG 342 (508)
Q Consensus 264 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiH~Dlk~~NIll~~~~-~~kl~Dfgla~~~~~~ 342 (508)
+++++|.+++.. .....+++..++.++.+++.||.|||++ +++|+||+|+||++++++ .+||+|||++......
T Consensus 81 ~~~~~L~~~~~~--~~~~~~~~~~~~~~~~~i~~~l~~lh~~---~i~h~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~ 155 (256)
T cd08220 81 APGGTLAEYIQK--RCNSLLDEDTILHFFVQILLALHHVHTK---LILHRDLKTQNILLDKHKMVVKIGDFGISKILSSK 155 (256)
T ss_pred CCCCCHHHHHHH--hcccCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEEccCCCceecCCC
Confidence 999999999964 2344588999999999999999999999 999999999999998654 5899999999876543
Q ss_pred CCcccccccccccccCccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCCCchhcHHHHHHHHhcccccccccCCCC
Q 010519 343 ESHITTRVMGTFGYVAPEYANTGMLNEKSDIYSFGVLLLEAVTGRDPVDYGRPANEVNLVEWLKMMVGTRRAEEVVDPNL 422 (508)
Q Consensus 343 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 422 (508)
.. .....++..|+|||.+.+..++.++||||||+++|+|++|..||...... ......... ...
T Consensus 156 ~~--~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~------~~~~~~~~~-~~~------- 219 (256)
T cd08220 156 SK--AYTVVGTPCYISPELCEGKPYNQKSDIWALGCVLYELASLKRAFEAANLP------ALVLKIMSG-TFA------- 219 (256)
T ss_pred cc--ccccccCCcccCchhccCCCCCcccchHHHHHHHHHHHhCCCCcccCchH------HHHHHHHhc-CCC-------
Confidence 22 22346788999999999888999999999999999999999998643321 111111110 000
Q ss_pred CCChhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 010519 423 EVKPATRALKRSLLVALRCVDPDSEKRPKMSQVVRM 458 (508)
Q Consensus 423 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 458 (508)
.........+.+++.+||+.||.+|||+.|++++
T Consensus 220 --~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~ll~~ 253 (256)
T cd08220 220 --PISDRYSPDLRQLILSMLNLDPSKRPQLSQIMAQ 253 (256)
T ss_pred --CCCCCcCHHHHHHHHHHccCChhhCCCHHHHhhC
Confidence 0111234456679999999999999999999975
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with |
| >cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-38 Score=306.92 Aligned_cols=240 Identities=24% Similarity=0.384 Sum_probs=187.9
Q ss_pred eeEeeeCceEEEEEEEcC--------CCEEEEEEEcccchhhHHHHHHHHHHHhcCCCCCceeEEEEEEeCceeeEEEee
Q 010519 192 NVLGEGGYGVVYKGRLIN--------GSEVAVKKLLNNLGQAEKEFRVEVEAIGHVRHKNLVRLLGYCIEGVHRMLVYEY 263 (508)
Q Consensus 192 ~~lg~G~~g~Vy~~~~~~--------~~~vavK~~~~~~~~~~~~~~~ei~~l~~l~h~niv~~~~~~~~~~~~~lv~E~ 263 (508)
+.||.|+||.||+|.... ...+++|.+........+.+.+|+.+++.++||||+++++++..+...++||||
T Consensus 1 ~~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~ 80 (258)
T cd05078 1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLVLNYGVCVCGDESIMVQEY 80 (258)
T ss_pred CCCCcccchhheeeeecccccccccccchhhHHhhcchhHHHHHHHHHHHHHHHhCCCCChhheeeEEEeCCCcEEEEec
Confidence 368999999999997642 234778877554444456788899999999999999999999998899999999
Q ss_pred cCCCCHHHHHhhhhccCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCEEEcCCCc--------EEEEecCC
Q 010519 264 VNNGNLEQWLHGAMRNQGNLTWEARMKVIIGTAKALAYLHEAIEPKVVHRDIKSSNILIDDEFN--------AKVSDFGL 335 (508)
Q Consensus 264 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiH~Dlk~~NIll~~~~~--------~kl~Dfgl 335 (508)
+++|+|.+++.. ....+++..++.++.||+.||.|||+. +|+||||||+|||++.++. ++++|||+
T Consensus 81 ~~~g~L~~~l~~---~~~~~~~~~~~~~~~qi~~~l~~lH~~---~iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~g~ 154 (258)
T cd05078 81 VKFGSLDTYLKK---NKNLINISWKLEVAKQLAWALHFLEDK---GLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGI 154 (258)
T ss_pred CCCCcHHHHHhc---CCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCccceEEEecccccccCCCceEEeccccc
Confidence 999999999863 344688999999999999999999999 9999999999999987765 69999999
Q ss_pred ccccCCCCCcccccccccccccCccccCC-CCCCChhhHHHHHHHHHHHHhCC-CCCCCCCCCchhcHHHHHHHHhcccc
Q 010519 336 AKLLDSGESHITTRVMGTFGYVAPEYANT-GMLNEKSDIYSFGVLLLEAVTGR-DPVDYGRPANEVNLVEWLKMMVGTRR 413 (508)
Q Consensus 336 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwS~Gvvl~elltG~-~Pf~~~~~~~~~~~~~~~~~~~~~~~ 413 (508)
+...... ....++..|+|||++.+ ..++.++|||||||++|||++|. .||....+. .........
T Consensus 155 ~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~~~~~------~~~~~~~~~-- 221 (258)
T cd05078 155 SITVLPK-----EILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDSQ------KKLQFYEDR-- 221 (258)
T ss_pred ccccCCc-----hhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChhhccHH------HHHHHHHcc--
Confidence 8755432 22457889999999976 45889999999999999999985 555422211 111111100
Q ss_pred cccccCCCCCCChhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhh
Q 010519 414 AEEVVDPNLEVKPATRALKRSLLVALRCVDPDSEKRPKMSQVVRMLE 460 (508)
Q Consensus 414 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 460 (508)
..+.. .....+.+++.+||+.||.+|||++++++.|+
T Consensus 222 ------~~~~~----~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~ 258 (258)
T cd05078 222 ------HQLPA----PKWTELANLINQCMDYEPDFRPSFRAIIRDLN 258 (258)
T ss_pred ------ccCCC----CCcHHHHHHHHHHhccChhhCCCHHHHHHhcC
Confidence 01111 11245677999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity |
| >cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-37 Score=302.68 Aligned_cols=255 Identities=28% Similarity=0.408 Sum_probs=204.6
Q ss_pred CCcccceeEeeeCceEEEEEEEc-CCCEEEEEEEcccc-hhhHHHHHHHHHHHhcCCCCCceeEEEEEEeCceeeEEEee
Q 010519 186 NRFSAENVLGEGGYGVVYKGRLI-NGSEVAVKKLLNNL-GQAEKEFRVEVEAIGHVRHKNLVRLLGYCIEGVHRMLVYEY 263 (508)
Q Consensus 186 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~ei~~l~~l~h~niv~~~~~~~~~~~~~lv~E~ 263 (508)
++|+..+.||.|+||.||++.+. +++.+++|.+.... ......+.+|++++++++||||+++++++......++++||
T Consensus 1 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~ 80 (265)
T cd06605 1 DDLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYGAFYNNGDISICMEY 80 (265)
T ss_pred CcchHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEecccChHHHHHHHHHHHHHHHCCCCchhhhheeeecCCEEEEEEEe
Confidence 36778889999999999999876 58889999886553 34456788899999999999999999999999999999999
Q ss_pred cCCCCHHHHHhhhhccCCCccHHHHHHHHHHHHHHHHHHHh-cCCCCeEeecCCCCCEEEcCCCcEEEEecCCccccCCC
Q 010519 264 VNNGNLEQWLHGAMRNQGNLTWEARMKVIIGTAKALAYLHE-AIEPKVVHRDIKSSNILIDDEFNAKVSDFGLAKLLDSG 342 (508)
Q Consensus 264 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~yLH~-~~~~~iiH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~~ 342 (508)
+++++|.+++.. ....+++..+..++.|++.||.|||+ . +++|+||+|+||++++++.++|+|||.+......
T Consensus 81 ~~~~~L~~~~~~---~~~~~~~~~~~~~~~~l~~~l~~lH~~~---~i~H~dl~~~ni~~~~~~~~~l~d~g~~~~~~~~ 154 (265)
T cd06605 81 MDGGSLDKILKE---VQGRIPERILGKIAVAVLKGLTYLHEKH---KIIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNS 154 (265)
T ss_pred cCCCcHHHHHHH---ccCCCCHHHHHHHHHHHHHHHHHHcCCC---CeecCCCCHHHEEECCCCCEEEeecccchhhHHH
Confidence 999999999863 22678899999999999999999999 7 9999999999999999999999999998765432
Q ss_pred CCcccccccccccccCccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCCCchhcHHHHHHHHhcccccccccCCCC
Q 010519 343 ESHITTRVMGTFGYVAPEYANTGMLNEKSDIYSFGVLLLEAVTGRDPVDYGRPANEVNLVEWLKMMVGTRRAEEVVDPNL 422 (508)
Q Consensus 343 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 422 (508)
.. ....++..|+|||.+.+..++.++||||||+++|+|++|..||....... ....+.+........ +.+
T Consensus 155 ~~---~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~-~~~~~~~~~~~~~~~------~~~ 224 (265)
T cd06605 155 LA---KTFVGTSSYMAPERIQGNDYSVKSDIWSLGLSLIELATGRFPYPPENDPP-DGIFELLQYIVNEPP------PRL 224 (265)
T ss_pred Hh---hcccCChhccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCcccccc-ccHHHHHHHHhcCCC------CCC
Confidence 21 12568889999999999999999999999999999999999986442211 122222222221110 111
Q ss_pred CCChhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHh
Q 010519 423 EVKPATRALKRSLLVALRCVDPDSEKRPKMSQVVRML 459 (508)
Q Consensus 423 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L 459 (508)
+.......+.+++.+||..||.+|||+.+++.+-
T Consensus 225 ---~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~~ 258 (265)
T cd06605 225 ---PSGKFSPDFQDFVNLCLIKDPRERPSYKELLEHP 258 (265)
T ss_pred ---ChhhcCHHHHHHHHHHcCCCchhCcCHHHHhhCc
Confidence 1111345577799999999999999999998753
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity |
| >cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=315.62 Aligned_cols=261 Identities=25% Similarity=0.345 Sum_probs=195.7
Q ss_pred hhCCcccceeEeeeCceEEEEEEEc-CCCEEEEEEEcccch--hhHHHHHHHHHHHhcCCCCCceeEEEEEEeC------
Q 010519 184 ATNRFSAENVLGEGGYGVVYKGRLI-NGSEVAVKKLLNNLG--QAEKEFRVEVEAIGHVRHKNLVRLLGYCIEG------ 254 (508)
Q Consensus 184 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~ei~~l~~l~h~niv~~~~~~~~~------ 254 (508)
..++|.+.+.||.|+||+||+|.+. ++..||||++..... .....+.+|+.+++.++||||+++++++...
T Consensus 13 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 92 (343)
T cd07878 13 VPERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDVFTPATSIENF 92 (343)
T ss_pred hhhhhhhheecccCCCeEEEEEEECCCCCEEEEEEeCchhhhhHHHHHHHHHHHHHHhcCCCchhhhhhhhccccccccc
Confidence 4578999999999999999999864 678899998864322 2334577899999999999999999987543
Q ss_pred ceeeEEEeecCCCCHHHHHhhhhccCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCEEEcCCCcEEEEecC
Q 010519 255 VHRMLVYEYVNNGNLEQWLHGAMRNQGNLTWEARMKVIIGTAKALAYLHEAIEPKVVHRDIKSSNILIDDEFNAKVSDFG 334 (508)
Q Consensus 255 ~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~Dfg 334 (508)
...+++++++ +++|.+++. ...+++..+..++.||+.||.|||+. +|+||||||+|||+++++.+||+|||
T Consensus 93 ~~~~~~~~~~-~~~l~~~~~-----~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivHrdikp~Nil~~~~~~~kl~Dfg 163 (343)
T cd07878 93 NEVYLVTNLM-GADLNNIVK-----CQKLSDEHVQFLIYQLLRGLKYIHSA---GIIHRDLKPSNVAVNEDCELRILDFG 163 (343)
T ss_pred CcEEEEeecC-CCCHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeecccCChhhEEECCCCCEEEcCCc
Confidence 3468999998 779988773 34689999999999999999999999 99999999999999999999999999
Q ss_pred CccccCCCCCcccccccccccccCccccCC-CCCCChhhHHHHHHHHHHHHhCCCCCCCCCCCchhcHHHHHHHHhcccc
Q 010519 335 LAKLLDSGESHITTRVMGTFGYVAPEYANT-GMLNEKSDIYSFGVLLLEAVTGRDPVDYGRPANEVNLVEWLKMMVGTRR 413 (508)
Q Consensus 335 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwS~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~ 413 (508)
++...... .....||+.|+|||++.+ ..++.++|||||||++|+|++|+.||....... .+..+. ...+...
T Consensus 164 ~~~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~--~~~~~~-~~~~~~~ 236 (343)
T cd07878 164 LARQADDE----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYID--QLKRIM-EVVGTPS 236 (343)
T ss_pred cceecCCC----cCCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCCCCCHHH--HHHHHH-HHhCCCC
Confidence 99865432 234568999999999876 578999999999999999999999996432211 111111 1000000
Q ss_pred c-----------ccccC--CCCCCChh----HHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhh
Q 010519 414 A-----------EEVVD--PNLEVKPA----TRALKRSLLVALRCVDPDSEKRPKMSQVVRMLE 460 (508)
Q Consensus 414 ~-----------~~~~~--~~~~~~~~----~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 460 (508)
. ..... +....... ......+.+|+.+||..||.+|||+.|++.|-.
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dp~~R~s~~ell~hp~ 300 (343)
T cd07878 237 PEVLKKISSEHARKYIQSLPHMPQQDLKKIFRGANPLAIDLLEKMLVLDSDKRISASEALAHPY 300 (343)
T ss_pred HHHHHhcchhhHHHHhhccccccchhHHHhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcCcc
Confidence 0 00000 00000000 001223567999999999999999999998643
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is |
| >cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-37 Score=301.82 Aligned_cols=250 Identities=24% Similarity=0.385 Sum_probs=194.3
Q ss_pred CCcccceeEeeeCceEEEEEEEc-CCCEEEEEEEcccc-----hhhHHHHHHHHHHHhcCCCCCceeEEEEEEeC--cee
Q 010519 186 NRFSAENVLGEGGYGVVYKGRLI-NGSEVAVKKLLNNL-----GQAEKEFRVEVEAIGHVRHKNLVRLLGYCIEG--VHR 257 (508)
Q Consensus 186 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-----~~~~~~~~~ei~~l~~l~h~niv~~~~~~~~~--~~~ 257 (508)
.+|...+.||+|+||.||++... .+..+++|++.... ......+.+|+.+++.++||||+++++++.+. ...
T Consensus 2 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (266)
T cd06651 2 INWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRAEKTL 81 (266)
T ss_pred CCccccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcCCCCEE
Confidence 47888999999999999999874 68899999875332 12335688899999999999999999988753 567
Q ss_pred eEEEeecCCCCHHHHHhhhhccCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCEEEcCCCcEEEEecCCcc
Q 010519 258 MLVYEYVNNGNLEQWLHGAMRNQGNLTWEARMKVIIGTAKALAYLHEAIEPKVVHRDIKSSNILIDDEFNAKVSDFGLAK 337 (508)
Q Consensus 258 ~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~Dfgla~ 337 (508)
++++||+++++|.+++. ....+++...+.++.|++.||.|||+. +++|+||+|+||+++.++.+||+|||++.
T Consensus 82 ~l~~e~~~~~~L~~~l~----~~~~l~~~~~~~~~~qi~~~l~~LH~~---~i~H~~l~p~nil~~~~~~~~l~dfg~~~ 154 (266)
T cd06651 82 TIFMEYMPGGSVKDQLK----AYGALTESVTRKYTRQILEGMSYLHSN---MIVHRDIKGANILRDSAGNVKLGDFGASK 154 (266)
T ss_pred EEEEeCCCCCcHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEECCCCCEEEccCCCcc
Confidence 89999999999999985 344688899999999999999999998 99999999999999999999999999997
Q ss_pred ccCCCC--CcccccccccccccCccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCCCchhcHHHHHHHHhcccccc
Q 010519 338 LLDSGE--SHITTRVMGTFGYVAPEYANTGMLNEKSDIYSFGVLLLEAVTGRDPVDYGRPANEVNLVEWLKMMVGTRRAE 415 (508)
Q Consensus 338 ~~~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~ 415 (508)
...... ........++..|+|||.+.+..++.++|||||||++|||++|+.||..... ...........
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~el~~g~~pf~~~~~------~~~~~~~~~~~--- 225 (266)
T cd06651 155 RLQTICMSGTGIRSVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPPWAEYEA------MAAIFKIATQP--- 225 (266)
T ss_pred ccccccccCCccccCCccccccCHHHhCCCCCCchhhhHHHHHHHHHHHHCCCCccccch------HHHHHHHhcCC---
Confidence 653211 1112234578899999999998899999999999999999999999964321 11111111110
Q ss_pred cccCCCCCCChhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 010519 416 EVVDPNLEVKPATRALKRSLLVALRCVDPDSEKRPKMSQVVRM 458 (508)
Q Consensus 416 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 458 (508)
..+.+ +......+.+++ +||..+|.+||+++||++|
T Consensus 226 --~~~~~----~~~~~~~~~~li-~~~~~~p~~Rp~~~eil~h 261 (266)
T cd06651 226 --TNPQL----PSHISEHARDFL-GCIFVEARHRPSAEELLRH 261 (266)
T ss_pred --CCCCC----chhcCHHHHHHH-HHhcCChhhCcCHHHHhcC
Confidence 01111 111223344455 7888999999999999875
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development |
| >cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-37 Score=306.19 Aligned_cols=260 Identities=26% Similarity=0.427 Sum_probs=201.6
Q ss_pred eHHHHHHhhCCcccceeEeeeCceEEEEEEEc-CCCEEEEEEEcccchhhHHHHHHHHHHHhcC-CCCCceeEEEEEEe-
Q 010519 177 TLRDLEIATNRFSAENVLGEGGYGVVYKGRLI-NGSEVAVKKLLNNLGQAEKEFRVEVEAIGHV-RHKNLVRLLGYCIE- 253 (508)
Q Consensus 177 ~~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~ei~~l~~l-~h~niv~~~~~~~~- 253 (508)
++.++..+.+.|++.+.||.|+||.||+|.+. +++.+|+|.+.... .....+..|+.++.++ +|+||+++++++..
T Consensus 7 ~~~~~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~~-~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~ 85 (282)
T cd06636 7 DLSALRDPAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTE-DEEEEIKLEINMLKKYSHHRNIATYYGAFIKK 85 (282)
T ss_pred hhhhhcChhhhhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecCh-HHHHHHHHHHHHHHHhcCCCcEEEEeeehhcc
Confidence 34555667789999999999999999999874 67889999875443 3345678899999988 79999999999853
Q ss_pred -----CceeeEEEeecCCCCHHHHHhhhhccCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCEEEcCCCcE
Q 010519 254 -----GVHRMLVYEYVNNGNLEQWLHGAMRNQGNLTWEARMKVIIGTAKALAYLHEAIEPKVVHRDIKSSNILIDDEFNA 328 (508)
Q Consensus 254 -----~~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiH~Dlk~~NIll~~~~~~ 328 (508)
....+++|||+++|+|.+++.. .....+++..++.++.||+.||.|||+. +++|+||+|+||++++++.+
T Consensus 86 ~~~~~~~~~~iv~e~~~~~~L~~~~~~--~~~~~~~~~~~~~~~~qi~~al~~LH~~---~ivH~dl~~~nili~~~~~~ 160 (282)
T cd06636 86 SPPGHDDQLWLVMEFCGAGSVTDLVKN--TKGNALKEDWIAYICREILRGLAHLHAH---KVIHRDIKGQNVLLTENAEV 160 (282)
T ss_pred cccCCCCEEEEEEEeCCCCcHHHHHHH--ccCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCE
Confidence 4577899999999999999864 2344578888999999999999999998 99999999999999999999
Q ss_pred EEEecCCccccCCCCCcccccccccccccCccccC-----CCCCCChhhHHHHHHHHHHHHhCCCCCCCCCCCchhcHHH
Q 010519 329 KVSDFGLAKLLDSGESHITTRVMGTFGYVAPEYAN-----TGMLNEKSDIYSFGVLLLEAVTGRDPVDYGRPANEVNLVE 403 (508)
Q Consensus 329 kl~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DvwS~Gvvl~elltG~~Pf~~~~~~~~~~~~~ 403 (508)
+|+|||++........ ......|++.|+|||.+. +..++.++|||||||++|||++|..||....+....
T Consensus 161 ~l~dfg~~~~~~~~~~-~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~---- 235 (282)
T cd06636 161 KLVDFGVSAQLDRTVG-RRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPMRAL---- 235 (282)
T ss_pred EEeeCcchhhhhcccc-CCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCccccCHHhhh----
Confidence 9999999875532211 123356889999999875 356888999999999999999999999643221111
Q ss_pred HHHHHhcccccccccCCCCCCChhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 010519 404 WLKMMVGTRRAEEVVDPNLEVKPATRALKRSLLVALRCVDPDSEKRPKMSQVVRM 458 (508)
Q Consensus 404 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 458 (508)
. ... . ...+... .......+.+++.+||+.||.+|||+.|++++
T Consensus 236 -~-~~~-~-----~~~~~~~---~~~~~~~~~~li~~cl~~~p~~Rp~~~ell~~ 279 (282)
T cd06636 236 -F-LIP-R-----NPPPKLK---SKKWSKKFIDFIEGCLVKNYLSRPSTEQLLKH 279 (282)
T ss_pred -h-hHh-h-----CCCCCCc---ccccCHHHHHHHHHHhCCChhhCcCHHHHhcC
Confidence 0 000 0 0001111 11234567789999999999999999999864
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea |
| >cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-37 Score=299.21 Aligned_cols=253 Identities=26% Similarity=0.419 Sum_probs=206.3
Q ss_pred CCcccceeEeeeCceEEEEEEEc-CCCEEEEEEEcccch-hhHHHHHHHHHHHhcCCCCCceeEEEEEEeCceeeEEEee
Q 010519 186 NRFSAENVLGEGGYGVVYKGRLI-NGSEVAVKKLLNNLG-QAEKEFRVEVEAIGHVRHKNLVRLLGYCIEGVHRMLVYEY 263 (508)
Q Consensus 186 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~ei~~l~~l~h~niv~~~~~~~~~~~~~lv~E~ 263 (508)
++|++.+.||+|++|.||++++. ++..+++|++..... .....+..|+..+.+++|+|++++++++......++||||
T Consensus 1 ~~~~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (264)
T cd06623 1 SDLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGAFYKEGEISIVLEY 80 (264)
T ss_pred CcceeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCeeeEEEEEccCCeEEEEEEe
Confidence 36888999999999999999886 489999998866543 4456788999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhhhhccCCCccHHHHHHHHHHHHHHHHHHHh-cCCCCeEeecCCCCCEEEcCCCcEEEEecCCccccCCC
Q 010519 264 VNNGNLEQWLHGAMRNQGNLTWEARMKVIIGTAKALAYLHE-AIEPKVVHRDIKSSNILIDDEFNAKVSDFGLAKLLDSG 342 (508)
Q Consensus 264 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~yLH~-~~~~~iiH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~~ 342 (508)
+++++|.+++.. ...+++..++.++.|+++|+.|||+ . +++|+||+|+||+++.++.++|+|||++......
T Consensus 81 ~~~~~L~~~l~~----~~~l~~~~~~~~~~~l~~~l~~lh~~~---~~~H~~l~~~ni~~~~~~~~~l~df~~~~~~~~~ 153 (264)
T cd06623 81 MDGGSLADLLKK----VGKIPEPVLAYIARQILKGLDYLHTKR---HIIHRDIKPSNLLINSKGEVKIADFGISKVLENT 153 (264)
T ss_pred cCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHhccC---CCccCCCCHHHEEECCCCCEEEccCccceecccC
Confidence 999999999853 3678999999999999999999999 8 9999999999999999999999999999866543
Q ss_pred CCcccccccccccccCccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCCCchhcHHHHHHHHhcccccccccCCCC
Q 010519 343 ESHITTRVMGTFGYVAPEYANTGMLNEKSDIYSFGVLLLEAVTGRDPVDYGRPANEVNLVEWLKMMVGTRRAEEVVDPNL 422 (508)
Q Consensus 343 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 422 (508)
... .....++..|+|||.+.+..++.++|+||||+++|+|++|..||........... ......... +..
T Consensus 154 ~~~-~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~---~~~~~~~~~------~~~ 223 (264)
T cd06623 154 LDQ-CNTFVGTVTYMSPERIQGESYSYAADIWSLGLTLLECALGKFPFLPPGQPSFFEL---MQAICDGPP------PSL 223 (264)
T ss_pred CCc-ccceeecccccCHhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCccccccCHHHH---HHHHhcCCC------CCC
Confidence 322 2244678899999999998999999999999999999999999965442121211 222111110 111
Q ss_pred CCChhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 010519 423 EVKPATRALKRSLLVALRCVDPDSEKRPKMSQVVRM 458 (508)
Q Consensus 423 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 458 (508)
... .....+.+++.+||.++|.+|||+.+++++
T Consensus 224 ~~~---~~~~~l~~li~~~l~~~p~~R~~~~~ll~~ 256 (264)
T cd06623 224 PAE---EFSPEFRDFISACLQKDPKKRPSAAELLQH 256 (264)
T ss_pred Ccc---cCCHHHHHHHHHHccCChhhCCCHHHHHhC
Confidence 111 034567779999999999999999999985
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of |
| >cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-37 Score=307.56 Aligned_cols=263 Identities=27% Similarity=0.373 Sum_probs=201.9
Q ss_pred CCcccceeEeeeCceEEEEEEEc-CCCEEEEEEEcccc--hhhHHHHHHHHHHHhcCCCCCceeEEEEEEeCceeeEEEe
Q 010519 186 NRFSAENVLGEGGYGVVYKGRLI-NGSEVAVKKLLNNL--GQAEKEFRVEVEAIGHVRHKNLVRLLGYCIEGVHRMLVYE 262 (508)
Q Consensus 186 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~ei~~l~~l~h~niv~~~~~~~~~~~~~lv~E 262 (508)
++|++.+.||+|+||.||+|.+. +++.|++|.+.... ......+..|++++++++|+||+++++++...+..+++||
T Consensus 1 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e 80 (288)
T cd07833 1 NKYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKEAFRRKGRLYLVFE 80 (288)
T ss_pred CceeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhcccccchhHHHHHHHHHHhcCCCCeeehhheEEECCEEEEEEe
Confidence 37889999999999999999876 57889999875432 2334678889999999999999999999999999999999
Q ss_pred ecCCCCHHHHHhhhhccCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCEEEcCCCcEEEEecCCccccCCC
Q 010519 263 YVNNGNLEQWLHGAMRNQGNLTWEARMKVIIGTAKALAYLHEAIEPKVVHRDIKSSNILIDDEFNAKVSDFGLAKLLDSG 342 (508)
Q Consensus 263 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~~ 342 (508)
|++++.+..++ .....+++..++.++.+|+.||.|||+. +++|+||+|+||++++++.+||+|||++......
T Consensus 81 ~~~~~~l~~~~----~~~~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dl~~~ni~~~~~~~~kl~d~g~~~~~~~~ 153 (288)
T cd07833 81 YVERTLLELLE----ASPGGLPPDAVRSYIWQLLQAIAYCHSH---NIIHRDIKPENILVSESGVLKLCDFGFARALRAR 153 (288)
T ss_pred cCCCCHHHHHH----hcCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCCEEEEeeecccccCCC
Confidence 99987666655 3445689999999999999999999999 9999999999999999999999999999876554
Q ss_pred CCcccccccccccccCccccCCC-CCCChhhHHHHHHHHHHHHhCCCCCCCCCCCchhcHHHHHHHHhccc---------
Q 010519 343 ESHITTRVMGTFGYVAPEYANTG-MLNEKSDIYSFGVLLLEAVTGRDPVDYGRPANEVNLVEWLKMMVGTR--------- 412 (508)
Q Consensus 343 ~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwS~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~--------- 412 (508)
.........++..|+|||++.+. .++.++||||||+++|+|++|+.||...... ..........+..
T Consensus 154 ~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~ 230 (288)
T cd07833 154 PASPLTDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDI---DQLYLIQKCLGPLPPSHQELFS 230 (288)
T ss_pred ccccccCcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCHH---HHHHHHHHHhCCCCHHHhhhcc
Confidence 33233445678899999999887 8899999999999999999999998643221 1111111111100
Q ss_pred ---ccc--cccCCCCCC----ChhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 010519 413 ---RAE--EVVDPNLEV----KPATRALKRSLLVALRCVDPDSEKRPKMSQVVRM 458 (508)
Q Consensus 413 ---~~~--~~~~~~~~~----~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 458 (508)
... ......... ..+......+.+++.+||+.+|++|||+++++++
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 285 (288)
T cd07833 231 SNPRFAGVAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQH 285 (288)
T ss_pred cCccccccccCCCCCcHHHHHhcCCccchHHHHHHHHHhccCchhcccHHHHhcC
Confidence 000 000000000 0011124667889999999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning |
| >KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-39 Score=319.28 Aligned_cols=247 Identities=25% Similarity=0.382 Sum_probs=201.7
Q ss_pred CCcccceeEeeeCceEEEEEEEc-CCCEEEEEEEcccch---hhHHHHHHHHHHHhcCCCCCceeEEEEEEeCceeeEEE
Q 010519 186 NRFSAENVLGEGGYGVVYKGRLI-NGSEVAVKKLLNNLG---QAEKEFRVEVEAIGHVRHKNLVRLLGYCIEGVHRMLVY 261 (508)
Q Consensus 186 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~ei~~l~~l~h~niv~~~~~~~~~~~~~lv~ 261 (508)
..|+-++.||.|+||.||.+++. +...||||++.-... .....+..|+..|.+++|||+|.+.|+|..+...++||
T Consensus 26 klf~dLrEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyLre~TaWLVM 105 (948)
T KOG0577|consen 26 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLREHTAWLVM 105 (948)
T ss_pred HHHHHHHHhcCCccceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccceeeccchHHHHH
Confidence 34677788999999999999874 678899999854333 33457888999999999999999999999999999999
Q ss_pred eecCCCCHHHHHhhhhccCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCEEEcCCCcEEEEecCCccccCC
Q 010519 262 EYVNNGNLEQWLHGAMRNQGNLTWEARMKVIIGTAKALAYLHEAIEPKVVHRDIKSSNILIDDEFNAKVSDFGLAKLLDS 341 (508)
Q Consensus 262 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~ 341 (508)
|||- |+-.|+|. ...+++.+..+..|+.+.++||+|||+. +.||||||..|||+++.|.|||+|||.+.....
T Consensus 106 EYCl-GSAsDlle---VhkKplqEvEIAAi~~gaL~gLaYLHS~---~~IHRDiKAGNILLse~g~VKLaDFGSAsi~~P 178 (948)
T KOG0577|consen 106 EYCL-GSASDLLE---VHKKPLQEVEIAAITHGALQGLAYLHSH---NRIHRDIKAGNILLSEPGLVKLADFGSASIMAP 178 (948)
T ss_pred HHHh-ccHHHHHH---HHhccchHHHHHHHHHHHHHHHHHHHHh---hHHhhhccccceEecCCCeeeeccccchhhcCc
Confidence 9994 58888885 4567899999999999999999999999 999999999999999999999999999987654
Q ss_pred CCCcccccccccccccCccccC---CCCCCChhhHHHHHHHHHHHHhCCCCCCCCCCCchhcHHHHHHHHhccccccccc
Q 010519 342 GESHITTRVMGTFGYVAPEYAN---TGMLNEKSDIYSFGVLLLEAVTGRDPVDYGRPANEVNLVEWLKMMVGTRRAEEVV 418 (508)
Q Consensus 342 ~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DvwS~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 418 (508)
...++|||.|||||++. .+.|+-++||||||++-.||.-.++|+... ..+..... +..+ -
T Consensus 179 -----AnsFvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlFnM-----NAMSALYH-IAQN------e 241 (948)
T KOG0577|consen 179 -----ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNM-----NAMSALYH-IAQN------E 241 (948)
T ss_pred -----hhcccCCccccchhHheeccccccCCccceeeccchhhhhhhcCCCccCc-----hHHHHHHH-HHhc------C
Confidence 45678999999999874 478999999999999999999999996422 11111111 1111 1
Q ss_pred CCCCCCChhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHh
Q 010519 419 DPNLEVKPATRALKRSLLVALRCVDPDSEKRPKMSQVVRML 459 (508)
Q Consensus 419 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L 459 (508)
.|.+. ...+...++.++..||++-|.+|||.+++++|-
T Consensus 242 sPtLq---s~eWS~~F~~Fvd~CLqKipqeRptse~ll~H~ 279 (948)
T KOG0577|consen 242 SPTLQ---SNEWSDYFRNFVDSCLQKIPQERPTSEELLKHR 279 (948)
T ss_pred CCCCC---CchhHHHHHHHHHHHHhhCcccCCcHHHHhhcc
Confidence 13333 344555666788899999999999999999864
|
|
| >cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-37 Score=298.85 Aligned_cols=257 Identities=28% Similarity=0.444 Sum_probs=204.3
Q ss_pred CCcccceeEeeeCceEEEEEEEc-CCCEEEEEEEcccc-hhhHHHHHHHHHHHhcCCCCCceeEEEEEEeCceeeEEEee
Q 010519 186 NRFSAENVLGEGGYGVVYKGRLI-NGSEVAVKKLLNNL-GQAEKEFRVEVEAIGHVRHKNLVRLLGYCIEGVHRMLVYEY 263 (508)
Q Consensus 186 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~ei~~l~~l~h~niv~~~~~~~~~~~~~lv~E~ 263 (508)
++|++.+.||.|+||+||+|... ++..+++|++.... ......+.+|++.++.++|+|++++++.+......++||||
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~ 80 (267)
T cd06610 1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYTSFVVGDELWLVMPY 80 (267)
T ss_pred CcceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcchHHHHHHHHHHHHHhcCCCCEEEEEEEEeeCCEEEEEEec
Confidence 47899999999999999999864 67889999885433 33456788999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhhhhccCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCEEEcCCCcEEEEecCCccccCCCC
Q 010519 264 VNNGNLEQWLHGAMRNQGNLTWEARMKVIIGTAKALAYLHEAIEPKVVHRDIKSSNILIDDEFNAKVSDFGLAKLLDSGE 343 (508)
Q Consensus 264 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~~~ 343 (508)
+++++|.+++.... ....+++..+..++.|++.||.|||+. +++|+||+|+||++++++.++|+|||++..+....
T Consensus 81 ~~~~~l~~~~~~~~-~~~~~~~~~~~~~~~ql~~al~~lh~~---~i~h~~l~p~ni~~~~~~~~~l~df~~~~~~~~~~ 156 (267)
T cd06610 81 LSGGSLLDIMKSSY-PRGGLDEAIIATVLKEVLKGLEYLHSN---GQIHRDIKAGNILLGEDGSVKIADFGVSASLADGG 156 (267)
T ss_pred cCCCcHHHHHHHhc-ccCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHhEEEcCCCCEEEcccchHHHhccCc
Confidence 99999999996421 135689999999999999999999998 99999999999999999999999999997665432
Q ss_pred Cc---ccccccccccccCccccCCC-CCCChhhHHHHHHHHHHHHhCCCCCCCCCCCchhcHHHHHHHHhcccccccccC
Q 010519 344 SH---ITTRVMGTFGYVAPEYANTG-MLNEKSDIYSFGVLLLEAVTGRDPVDYGRPANEVNLVEWLKMMVGTRRAEEVVD 419 (508)
Q Consensus 344 ~~---~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwS~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 419 (508)
.. ......|+..|+|||++... .++.++|+|||||++|+|++|+.||....... .+.. .... ..
T Consensus 157 ~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~--~~~~----~~~~------~~ 224 (267)
T cd06610 157 DRTRKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPMK--VLML----TLQN------DP 224 (267)
T ss_pred cccccccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCccccChhh--hHHH----HhcC------CC
Confidence 21 22334688999999998776 78899999999999999999999996432211 1111 1111 00
Q ss_pred CCCCCCh-hHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 010519 420 PNLEVKP-ATRALKRSLLVALRCVDPDSEKRPKMSQVVRM 458 (508)
Q Consensus 420 ~~~~~~~-~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 458 (508)
+.+.... .......+.+++.+||..||.+|||+.+++++
T Consensus 225 ~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~ll~~ 264 (267)
T cd06610 225 PSLETGADYKKYSKSFRKMISLCLQKDPSKRPTAEELLKH 264 (267)
T ss_pred CCcCCccccccccHHHHHHHHHHcCCChhhCcCHHHHhhC
Confidence 1111111 12334566789999999999999999999975
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 |
| >KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-38 Score=323.42 Aligned_cols=255 Identities=27% Similarity=0.422 Sum_probs=209.8
Q ss_pred HhhCCcccceeEeeeCceEEEEEEEcC--CC--EEEEEEEcccchh-hHHHHHHHHHHHhcCCCCCceeEEEEEEeCcee
Q 010519 183 IATNRFSAENVLGEGGYGVVYKGRLIN--GS--EVAVKKLLNNLGQ-AEKEFRVEVEAIGHVRHKNLVRLLGYCIEGVHR 257 (508)
Q Consensus 183 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~--~~--~vavK~~~~~~~~-~~~~~~~ei~~l~~l~h~niv~~~~~~~~~~~~ 257 (508)
|..++..+.++||+|.||.|++|.|.. |+ .||||.+...... ....|.+|+..|.+|+|+|++++||+..+ ...
T Consensus 107 Ipee~i~l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~~mddflrEas~M~~L~H~hliRLyGvVl~-qp~ 185 (1039)
T KOG0199|consen 107 IPEEQIKLYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNAIMDDFLREASHMLKLQHPHLIRLYGVVLD-QPA 185 (1039)
T ss_pred ccHHHHHHHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccchhHHHHHHHHHHHHhccCcceeEEeeeecc-chh
Confidence 344566777899999999999999863 33 5899998765533 55789999999999999999999999887 677
Q ss_pred eEEEeecCCCCHHHHHhhhhccCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCEEEcCCCcEEEEecCCcc
Q 010519 258 MLVYEYVNNGNLEQWLHGAMRNQGNLTWEARMKVIIGTAKALAYLHEAIEPKVVHRDIKSSNILIDDEFNAKVSDFGLAK 337 (508)
Q Consensus 258 ~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~Dfgla~ 337 (508)
+||||+++.|+|.+.|++ .....|.......++.|||.|+.||.++ ++|||||..+|+||-..-.|||+||||.+
T Consensus 186 mMV~ELaplGSLldrLrk--a~~~~llv~~Lcdya~QiA~aM~YLesk---rlvHRDLAARNlllasprtVKI~DFGLmR 260 (1039)
T KOG0199|consen 186 MMVFELAPLGSLLDRLRK--AKKAILLVSRLCDYAMQIAKAMQYLESK---RLVHRDLAARNLLLASPRTVKICDFGLMR 260 (1039)
T ss_pred hHHhhhcccchHHHHHhh--ccccceeHHHHHHHHHHHHHHHHHHhhh---hhhhhhhhhhhheecccceeeeeccccee
Confidence 899999999999999986 4667788899999999999999999999 99999999999999998899999999999
Q ss_pred ccCCCCCcc-c-ccccccccccCccccCCCCCCChhhHHHHHHHHHHHHh-CCCCCCCCCCCchhcHHHHHHHHhccccc
Q 010519 338 LLDSGESHI-T-TRVMGTFGYVAPEYANTGMLNEKSDIYSFGVLLLEAVT-GRDPVDYGRPANEVNLVEWLKMMVGTRRA 414 (508)
Q Consensus 338 ~~~~~~~~~-~-~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~ 414 (508)
.+...+... + ....-...|+|||.+....++.++|||+|||.||||++ |..||...... +.+.
T Consensus 261 aLg~ned~Yvm~p~rkvPfAWCaPEsLrh~kFShaSDvWmyGVTiWEMFtyGEePW~G~~g~------qIL~-------- 326 (1039)
T KOG0199|consen 261 ALGENEDMYVMAPQRKVPFAWCAPESLRHRKFSHASDVWMYGVTIWEMFTYGEEPWVGCRGI------QILK-------- 326 (1039)
T ss_pred ccCCCCcceEecCCCcCcccccCHhHhccccccccchhhhhhhhHHhhhccCCCCCCCCCHH------HHHH--------
Confidence 886554432 2 12233568999999999999999999999999999999 88898643321 1121
Q ss_pred ccccCCCCCCChhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHh
Q 010519 415 EEVVDPNLEVKPATRALKRSLLVALRCVDPDSEKRPKMSQVVRML 459 (508)
Q Consensus 415 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L 459 (508)
.+|..-....+..+.+++++++.+||..+|.+|||+..|...+
T Consensus 327 --~iD~~erLpRPk~csedIY~imk~cWah~paDRptFsair~~~ 369 (1039)
T KOG0199|consen 327 --NIDAGERLPRPKYCSEDIYQIMKNCWAHNPADRPTFSAIREDL 369 (1039)
T ss_pred --hccccccCCCCCCChHHHHHHHHHhccCCccccccHHHHHHhH
Confidence 1223334445556788999999999999999999999997433
|
|
| >KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-39 Score=302.69 Aligned_cols=253 Identities=26% Similarity=0.349 Sum_probs=214.6
Q ss_pred CcccceeEeeeCceEEEEEEEc-CCCEEEEEEEcccchhhHHHHHHHHHHHhcCCCCCceeEEEEEEeCceeeEEEeecC
Q 010519 187 RFSAENVLGEGGYGVVYKGRLI-NGSEVAVKKLLNNLGQAEKEFRVEVEAIGHVRHKNLVRLLGYCIEGVHRMLVYEYVN 265 (508)
Q Consensus 187 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~ei~~l~~l~h~niv~~~~~~~~~~~~~lv~E~~~ 265 (508)
-|.+..+||+|+||.||++.++ .|+.+|||++... ...+++..|+.+|.+++.|++|++||.+.....++||||||.
T Consensus 34 VFDi~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV~--sDLQEIIKEISIMQQC~S~yVVKYYGSYFK~sDLWIVMEYCG 111 (502)
T KOG0574|consen 34 VFDIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPVD--TDLQEIIKEISIMQQCKSKYVVKYYGSYFKHSDLWIVMEYCG 111 (502)
T ss_pred HHHHHHHhcCCcchHHHHHHHhccCcEEEEEecCcc--chHHHHHHHHHHHHHcCCchhhhhhhhhccCCceEeehhhcC
Confidence 3667789999999999999875 7899999988654 445678889999999999999999999999999999999999
Q ss_pred CCCHHHHHhhhhccCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCEEEcCCCcEEEEecCCccccCCCCCc
Q 010519 266 NGNLEQWLHGAMRNQGNLTWEARMKVIIGTAKALAYLHEAIEPKVVHRDIKSSNILIDDEFNAKVSDFGLAKLLDSGESH 345 (508)
Q Consensus 266 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~ 345 (508)
.|++.+.++ ..+++|++..+..++...++||+|||.. .-||||||..|||++.+|++||+|||.+..+.+.. .
T Consensus 112 AGSiSDI~R---~R~K~L~E~EIs~iL~~TLKGL~YLH~~---~KIHRDIKAGNILLNT~G~AKLADFGVAGQLTDTM-A 184 (502)
T KOG0574|consen 112 AGSISDIMR---ARRKPLSEQEISAVLRDTLKGLQYLHDL---KKIHRDIKAGNILLNTDGIAKLADFGVAGQLTDTM-A 184 (502)
T ss_pred CCcHHHHHH---HhcCCccHHHHHHHHHHHHhHHHHHHHH---HHHHhhcccccEEEcccchhhhhhccccchhhhhH-H
Confidence 999999986 4677899999999999999999999998 88999999999999999999999999998765432 2
Q ss_pred ccccccccccccCccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCCCchhcHHHHHHHHhcccccccccCCCCCCC
Q 010519 346 ITTRVMGTFGYVAPEYANTGMLNEKSDIYSFGVLLLEAVTGRDPVDYGRPANEVNLVEWLKMMVGTRRAEEVVDPNLEVK 425 (508)
Q Consensus 346 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 425 (508)
....+.|||.|||||++..-.|+.++||||||+...||.-|+.||..-.+-.. ...-...|.....
T Consensus 185 KRNTVIGTPFWMAPEVI~EIGY~~~ADIWSLGITaIEMAEG~PPYsDIHPMRA--------------IFMIPT~PPPTF~ 250 (502)
T KOG0574|consen 185 KRNTVIGTPFWMAPEVIEEIGYDTKADIWSLGITAIEMAEGRPPYSDIHPMRA--------------IFMIPTKPPPTFK 250 (502)
T ss_pred hhCccccCcccccHHHHHHhccchhhhHhhhcchhhhhhcCCCCcccccccce--------------eEeccCCCCCCCC
Confidence 34557899999999999999999999999999999999999999964332110 1111222344455
Q ss_pred hhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhhcC
Q 010519 426 PATRALKRSLLVALRCVDPDSEKRPKMSQVVRMLEAD 462 (508)
Q Consensus 426 ~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~ 462 (508)
.+......+-+++++||-++|++|-|+-++++|--..
T Consensus 251 KPE~WS~~F~DFi~~CLiK~PE~R~TA~~L~~H~Fik 287 (502)
T KOG0574|consen 251 KPEEWSSEFNDFIRSCLIKKPEERKTALRLCEHTFIK 287 (502)
T ss_pred ChHhhhhHHHHHHHHHhcCCHHHHHHHHHHhhhhhhc
Confidence 5677788888999999999999999999999986443
|
|
| >cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-37 Score=300.40 Aligned_cols=251 Identities=24% Similarity=0.322 Sum_probs=196.4
Q ss_pred CCcccceeEeeeCceEEEEEEEc-CCCEEEEEEEcccc-----hhhHHHHHHHHHHHhcCCCCCceeEEEEEEeC--cee
Q 010519 186 NRFSAENVLGEGGYGVVYKGRLI-NGSEVAVKKLLNNL-----GQAEKEFRVEVEAIGHVRHKNLVRLLGYCIEG--VHR 257 (508)
Q Consensus 186 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-----~~~~~~~~~ei~~l~~l~h~niv~~~~~~~~~--~~~ 257 (508)
++|.+.+.||+|+||.||+|.+. ++..|++|.+.... ......+.+|+.++++++||||+++++++.+. ...
T Consensus 2 ~~~~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (265)
T cd06652 2 TNWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPMERTL 81 (265)
T ss_pred CcceEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccCCCceE
Confidence 57899999999999999999874 58899999875322 22335788899999999999999999988764 467
Q ss_pred eEEEeecCCCCHHHHHhhhhccCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCEEEcCCCcEEEEecCCcc
Q 010519 258 MLVYEYVNNGNLEQWLHGAMRNQGNLTWEARMKVIIGTAKALAYLHEAIEPKVVHRDIKSSNILIDDEFNAKVSDFGLAK 337 (508)
Q Consensus 258 ~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~Dfgla~ 337 (508)
+++|||+++++|.+++. ....+++.....++.|++.||.|||+. +++|+||+|+||+++.++.++|+|||++.
T Consensus 82 ~~v~e~~~~~~L~~~l~----~~~~~~~~~~~~~~~~l~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~~l~Dfg~~~ 154 (265)
T cd06652 82 SIFMEHMPGGSIKDQLK----SYGALTENVTRKYTRQILEGVSYLHSN---MIVHRDIKGANILRDSVGNVKLGDFGASK 154 (265)
T ss_pred EEEEEecCCCcHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEecCCCCEEECcCcccc
Confidence 89999999999999985 334578888999999999999999999 99999999999999999999999999998
Q ss_pred ccCCCCC--cccccccccccccCccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCCCchhcHHHHHHHHhcccccc
Q 010519 338 LLDSGES--HITTRVMGTFGYVAPEYANTGMLNEKSDIYSFGVLLLEAVTGRDPVDYGRPANEVNLVEWLKMMVGTRRAE 415 (508)
Q Consensus 338 ~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~ 415 (508)
....... .......++..|+|||.+.+..++.++|||||||++|+|++|+.||..... ... ........
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~-----~~~-~~~~~~~~--- 225 (265)
T cd06652 155 RLQTICLSGTGMKSVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPPWAEFEA-----MAA-IFKIATQP--- 225 (265)
T ss_pred ccccccccccccccCCCCccccChhhhcCCCCCcchhHHHHHHHHHHHhhCCCCCCccch-----HHH-HHHHhcCC---
Confidence 5532111 112334588899999999888899999999999999999999999863211 111 11111110
Q ss_pred cccCCCCCCChhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHh
Q 010519 416 EVVDPNLEVKPATRALKRSLLVALRCVDPDSEKRPKMSQVVRML 459 (508)
Q Consensus 416 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L 459 (508)
.....+......+.+++.+|+. +|.+||++++++++-
T Consensus 226 ------~~~~~~~~~~~~~~~~i~~~l~-~p~~Rp~~~~il~~~ 262 (265)
T cd06652 226 ------TNPVLPPHVSDHCRDFLKRIFV-EAKLRPSADELLRHT 262 (265)
T ss_pred ------CCCCCchhhCHHHHHHHHHHhc-ChhhCCCHHHHhcCc
Confidence 0111122334556678889984 999999999999764
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re |
| >cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-38 Score=308.93 Aligned_cols=262 Identities=25% Similarity=0.370 Sum_probs=199.6
Q ss_pred CCcccceeEeeeCceEEEEEEEc-CCCEEEEEEEcccch--hhHHHHHHHHHHHhcCCCCCceeEEEEEEeCceeeEEEe
Q 010519 186 NRFSAENVLGEGGYGVVYKGRLI-NGSEVAVKKLLNNLG--QAEKEFRVEVEAIGHVRHKNLVRLLGYCIEGVHRMLVYE 262 (508)
Q Consensus 186 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~ei~~l~~l~h~niv~~~~~~~~~~~~~lv~E 262 (508)
++|++.+.||+|+||.||+|.+. +++.+|+|++..... ...+.+..|+++++.++||||+++++++......++|||
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 80 (286)
T cd07846 1 EKYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIEVFRRKKRLYLVFE 80 (286)
T ss_pred CceeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCcchhhHHHHHHHHHHHhcCCcchhhHHHhcccCCeEEEEEe
Confidence 47888999999999999999885 588999998754332 234567889999999999999999999999999999999
Q ss_pred ecCCCCHHHHHhhhhccCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCEEEcCCCcEEEEecCCccccCCC
Q 010519 263 YVNNGNLEQWLHGAMRNQGNLTWEARMKVIIGTAKALAYLHEAIEPKVVHRDIKSSNILIDDEFNAKVSDFGLAKLLDSG 342 (508)
Q Consensus 263 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~~ 342 (508)
|+++++|.++.. ....+++..++.++.||+.||.|||+. +++|+||+|+||++++++.++|+|||++......
T Consensus 81 ~~~~~~l~~~~~----~~~~~~~~~~~~~~~~i~~~l~~LH~~---~i~h~~l~p~ni~~~~~~~~~l~dfg~~~~~~~~ 153 (286)
T cd07846 81 FVDHTVLDDLEK----YPNGLDESRVRKYLFQILRGIEFCHSH---NIIHRDIKPENILVSQSGVVKLCDFGFARTLAAP 153 (286)
T ss_pred cCCccHHHHHHh----ccCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEECCCCcEEEEeeeeeeeccCC
Confidence 999988888763 344589999999999999999999998 9999999999999999999999999999865433
Q ss_pred CCcccccccccccccCccccCC-CCCCChhhHHHHHHHHHHHHhCCCCCCCCCCCchhcHHHHHHHHhcc----------
Q 010519 343 ESHITTRVMGTFGYVAPEYANT-GMLNEKSDIYSFGVLLLEAVTGRDPVDYGRPANEVNLVEWLKMMVGT---------- 411 (508)
Q Consensus 343 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwS~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~---------- 411 (508)
. .......++..|+|||++.+ ..++.++|||||||++|||++|..||....... ...-+......
T Consensus 154 ~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~ 229 (286)
T cd07846 154 G-EVYTDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDID---QLYHIIKCLGNLIPRHQEIFQ 229 (286)
T ss_pred c-cccCcccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCCCchHH---HHHHHHHHhCCCchhhHHHhc
Confidence 2 22333467889999998875 457889999999999999999999886432211 00000000000
Q ss_pred --cccccccCCCCCCCh-----hHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 010519 412 --RRAEEVVDPNLEVKP-----ATRALKRSLLVALRCVDPDSEKRPKMSQVVRM 458 (508)
Q Consensus 412 --~~~~~~~~~~~~~~~-----~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 458 (508)
........+...... .......+.+++.+||+.+|.+||++.+++++
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~ 283 (286)
T cd07846 230 KNPLFAGMRLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLHH 283 (286)
T ss_pred cchHhhccccccccCcchHHHhCCCcCHHHHHHHHHHhcCCcccchhHHHHhcC
Confidence 000000001111000 11234567789999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI |
| >cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-37 Score=301.39 Aligned_cols=254 Identities=25% Similarity=0.412 Sum_probs=198.0
Q ss_pred CcccceeEeeeCceEEEEEEEc-CCCEEEEEEEcccch----------hhHHHHHHHHHHHhcCCCCCceeEEEEEEeCc
Q 010519 187 RFSAENVLGEGGYGVVYKGRLI-NGSEVAVKKLLNNLG----------QAEKEFRVEVEAIGHVRHKNLVRLLGYCIEGV 255 (508)
Q Consensus 187 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~----------~~~~~~~~ei~~l~~l~h~niv~~~~~~~~~~ 255 (508)
+|...+.||.|+||.||+|... +|+.+|+|.+..... ...+.+..|+.+++.++|||++++++++....
T Consensus 2 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 81 (272)
T cd06629 2 KWVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETTEE 81 (272)
T ss_pred ceeecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEeccCC
Confidence 5777899999999999999864 688999998753211 11246788999999999999999999999999
Q ss_pred eeeEEEeecCCCCHHHHHhhhhccCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCEEEcCCCcEEEEecCC
Q 010519 256 HRMLVYEYVNNGNLEQWLHGAMRNQGNLTWEARMKVIIGTAKALAYLHEAIEPKVVHRDIKSSNILIDDEFNAKVSDFGL 335 (508)
Q Consensus 256 ~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~Dfgl 335 (508)
..++||||+++++|.+++.. ...+++..+..++.||+.||.|||+. +++|+||+|+||++++++.++|+|||+
T Consensus 82 ~~~lv~e~~~~~~L~~~l~~----~~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~~~nil~~~~~~~~l~d~~~ 154 (272)
T cd06629 82 YLSIFLEYVPGGSIGSCLRT----YGRFEEQLVRFFTEQVLEGLAYLHSK---GILHRDLKADNLLVDADGICKISDFGI 154 (272)
T ss_pred ceEEEEecCCCCcHHHHHhh----ccCCCHHHHHHHHHHHHHHHHHHhhC---CeeecCCChhhEEEcCCCeEEEeeccc
Confidence 99999999999999999853 36788999999999999999999998 999999999999999999999999999
Q ss_pred ccccCCCCCc-ccccccccccccCccccCCCC--CCChhhHHHHHHHHHHHHhCCCCCCCCCCCchhcHHHHHHHHhccc
Q 010519 336 AKLLDSGESH-ITTRVMGTFGYVAPEYANTGM--LNEKSDIYSFGVLLLEAVTGRDPVDYGRPANEVNLVEWLKMMVGTR 412 (508)
Q Consensus 336 a~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~--~~~~~DvwS~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~ 412 (508)
+......... ......++..|+|||.+.+.. ++.++|+||||+++|+|++|..||..... ..... ......
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~-----~~~~~-~~~~~~ 228 (272)
T cd06629 155 SKKSDDIYDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEA-----IAAMF-KLGNKR 228 (272)
T ss_pred cccccccccccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCcch-----HHHHH-Hhhccc
Confidence 9865432211 123345788999999987654 88999999999999999999999853221 11111 111110
Q ss_pred ccccccCCCCCCChhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 010519 413 RAEEVVDPNLEVKPATRALKRSLLVALRCVDPDSEKRPKMSQVVRM 458 (508)
Q Consensus 413 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 458 (508)
. . ..+...........+.+++.+||++||.+|||+.+++++
T Consensus 229 ~-~----~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 269 (272)
T cd06629 229 S-A----PPIPPDVSMNLSPVALDFLNACFTINPDNRPTARELLQH 269 (272)
T ss_pred c-C----CcCCccccccCCHHHHHHHHHHhcCChhhCCCHHHHhhC
Confidence 0 0 111111111234567779999999999999999999986
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte |
| >cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-37 Score=307.15 Aligned_cols=262 Identities=22% Similarity=0.337 Sum_probs=197.4
Q ss_pred CcccceeEeeeCceEEEEEEEc-CCCEEEEEEEcccch--hhHHHHHHHHHHHhcCCCCCceeEEEEEEeCceeeEEEee
Q 010519 187 RFSAENVLGEGGYGVVYKGRLI-NGSEVAVKKLLNNLG--QAEKEFRVEVEAIGHVRHKNLVRLLGYCIEGVHRMLVYEY 263 (508)
Q Consensus 187 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~ei~~l~~l~h~niv~~~~~~~~~~~~~lv~E~ 263 (508)
+|++.+.||+|+||.||+|++. +|..+|+|++..... .....+..|+.+++.++||||+++++++.+....++|+||
T Consensus 1 ~y~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 80 (284)
T cd07839 1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDVLHSDKKLTLVFEY 80 (284)
T ss_pred CceeEEEecccCCeEEEEEEECCCCcEEEEEEeecccccccCccchhHHHHHHHhcCCCCeeeHHHHhccCCceEEEEec
Confidence 5788899999999999999875 688999998854321 2234577799999999999999999999999999999999
Q ss_pred cCCCCHHHHHhhhhccCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCEEEcCCCcEEEEecCCccccCCCC
Q 010519 264 VNNGNLEQWLHGAMRNQGNLTWEARMKVIIGTAKALAYLHEAIEPKVVHRDIKSSNILIDDEFNAKVSDFGLAKLLDSGE 343 (508)
Q Consensus 264 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~~~ 343 (508)
+. ++|.+++.. ....+++..++.++.||++||.|||+. +++|+||||+||+++.++.+||+|||++.......
T Consensus 81 ~~-~~l~~~~~~---~~~~~~~~~~~~~~~qi~~al~~LH~~---~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~ 153 (284)
T cd07839 81 CD-QDLKKYFDS---CNGDIDPEIVKSFMFQLLKGLAFCHSH---NVLHRDLKPQNLLINKNGELKLADFGLARAFGIPV 153 (284)
T ss_pred CC-CCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHEEEcCCCcEEECccchhhccCCCC
Confidence 96 588888752 345689999999999999999999999 99999999999999999999999999998654332
Q ss_pred CcccccccccccccCccccCCC-CCCChhhHHHHHHHHHHHHhCCCCCCCCCCCchhcHHHHHHHHhccccc------cc
Q 010519 344 SHITTRVMGTFGYVAPEYANTG-MLNEKSDIYSFGVLLLEAVTGRDPVDYGRPANEVNLVEWLKMMVGTRRA------EE 416 (508)
Q Consensus 344 ~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwS~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~------~~ 416 (508)
. ......+++.|+|||++.+. .++.++|||||||++|+|++|..||...... ...+ ..+....+.... ..
T Consensus 154 ~-~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~-~~~~-~~~~~~~~~~~~~~~~~~~~ 230 (284)
T cd07839 154 R-CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDV-DDQL-KRIFRLLGTPTEESWPGVSK 230 (284)
T ss_pred C-CcCCCccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCcCCCCH-HHHH-HHHHHHhCCCChHHhHHhhh
Confidence 2 12334578899999988764 4789999999999999999999996533221 1111 111111110000 00
Q ss_pred ccC----CCCCCC-----hhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 010519 417 VVD----PNLEVK-----PATRALKRSLLVALRCVDPDSEKRPKMSQVVRM 458 (508)
Q Consensus 417 ~~~----~~~~~~-----~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 458 (508)
..+ +..... ........+.+++.+||+.||.+|||+++++++
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~il~h 281 (284)
T cd07839 231 LPDYKPYPMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQH 281 (284)
T ss_pred cccccccCCCCCcchhhhhcccCCHHHHHHHHHHhcCChhhcCCHHHHhcC
Confidence 000 000000 011234566789999999999999999999975
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also |
| >cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-37 Score=301.58 Aligned_cols=253 Identities=25% Similarity=0.373 Sum_probs=186.5
Q ss_pred eEeeeCceEEEEEEEcC---CCEEEEEEEcccc-hhhHHHHHHHHHHHhcCCCCCceeEEEEEEeCceeeEEEeecCCCC
Q 010519 193 VLGEGGYGVVYKGRLIN---GSEVAVKKLLNNL-GQAEKEFRVEVEAIGHVRHKNLVRLLGYCIEGVHRMLVYEYVNNGN 268 (508)
Q Consensus 193 ~lg~G~~g~Vy~~~~~~---~~~vavK~~~~~~-~~~~~~~~~ei~~l~~l~h~niv~~~~~~~~~~~~~lv~E~~~~gs 268 (508)
.||+|+||.||+|...+ ...+++|.+.... ......+.+|+..++.++||||+++++++......++||||+++|+
T Consensus 2 ~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~~~~~~lv~e~~~~g~ 81 (269)
T cd05042 2 EIGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLGQCIESIPYLLVLEFCPLGD 81 (269)
T ss_pred cCCccCCceEEEEEEecCCCCeEEEEeecCccCChHHHHHHHHHHHHHHhCCCCCcceEEEEECCCCceEEEEEeCCCCc
Confidence 58999999999997543 3467888765433 2334567889999999999999999999999999999999999999
Q ss_pred HHHHHhhhhcc-CCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCEEEcCCCcEEEEecCCccccCCCCC-cc
Q 010519 269 LEQWLHGAMRN-QGNLTWEARMKVIIGTAKALAYLHEAIEPKVVHRDIKSSNILIDDEFNAKVSDFGLAKLLDSGES-HI 346 (508)
Q Consensus 269 L~~~l~~~~~~-~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~-~~ 346 (508)
|.+++...... .....+.....++.||+.||+|||+. +|+||||||+|||+++++.+||+|||++........ ..
T Consensus 82 L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~ 158 (269)
T cd05042 82 LKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQA---DFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYIT 158 (269)
T ss_pred HHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHhc---CEecccccHhheEecCCCcEEEeccccccccccchheec
Confidence 99999653221 23356778899999999999999999 999999999999999999999999999875432211 11
Q ss_pred cccccccccccCccccC-------CCCCCChhhHHHHHHHHHHHHh-CCCCCCCCCCCchhcHHHHHHHHhccccccccc
Q 010519 347 TTRVMGTFGYVAPEYAN-------TGMLNEKSDIYSFGVLLLEAVT-GRDPVDYGRPANEVNLVEWLKMMVGTRRAEEVV 418 (508)
Q Consensus 347 ~~~~~gt~~y~aPE~~~-------~~~~~~~~DvwS~Gvvl~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 418 (508)
.....++..|+|||++. ...++.++|||||||++|||++ |..||....+. +.+........ ..+.
T Consensus 159 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~------~~~~~~~~~~~-~~~~ 231 (269)
T cd05042 159 KDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDE------QVLKQVVREQD-IKLP 231 (269)
T ss_pred cCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCCHH------HHHHHHhhccC-ccCC
Confidence 22234567899999874 3456789999999999999999 78888533211 11111111111 1111
Q ss_pred CCCCCCChhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhh
Q 010519 419 DPNLEVKPATRALKRSLLVALRCVDPDSEKRPKMSQVVRMLE 460 (508)
Q Consensus 419 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 460 (508)
.+.+. ......+.+++..|| .||.+|||+++|++.|.
T Consensus 232 ~~~~~----~~~~~~~~~~~~~~~-~dp~~Rpt~~~v~~~l~ 268 (269)
T cd05042 232 KPQLD----LKYSDRWYEVMQFCW-LDPETRPTAEEVHELLT 268 (269)
T ss_pred CCccc----ccCCHHHHHHHHHHh-cCcccccCHHHHHHHhc
Confidence 12111 122344455777888 59999999999998873
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina |
| >cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-37 Score=299.40 Aligned_cols=253 Identities=23% Similarity=0.381 Sum_probs=187.8
Q ss_pred eEeeeCceEEEEEEEcCCC---EEEEEEEcccc-hhhHHHHHHHHHHHhcCCCCCceeEEEEEEeCceeeEEEeecCCCC
Q 010519 193 VLGEGGYGVVYKGRLINGS---EVAVKKLLNNL-GQAEKEFRVEVEAIGHVRHKNLVRLLGYCIEGVHRMLVYEYVNNGN 268 (508)
Q Consensus 193 ~lg~G~~g~Vy~~~~~~~~---~vavK~~~~~~-~~~~~~~~~ei~~l~~l~h~niv~~~~~~~~~~~~~lv~E~~~~gs 268 (508)
.||+|+||.||+|...++. .+++|.+.... ......+.+|+..++.++||||++++++|......++||||+++|+
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~ 81 (268)
T cd05086 2 EIGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCLGQCVEAIPYLLVFEYCELGD 81 (268)
T ss_pred cCCCCcCceEEEEEEEcCCCcceEEEEEecCCCChHHHHHHHHHHHHHhccCCcchhheEEEecCCCccEEEEecCCCCc
Confidence 5999999999999765443 45566654433 3345678889999999999999999999999999999999999999
Q ss_pred HHHHHhhhhccCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCEEEcCCCcEEEEecCCccccCCCC-Cccc
Q 010519 269 LEQWLHGAMRNQGNLTWEARMKVIIGTAKALAYLHEAIEPKVVHRDIKSSNILIDDEFNAKVSDFGLAKLLDSGE-SHIT 347 (508)
Q Consensus 269 L~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~~~-~~~~ 347 (508)
|.++++........+.+..+..++.||+.||.|||+. +++||||||+|||++.++.+||+|||++....... ....
T Consensus 82 L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~---~i~H~dikp~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~ 158 (268)
T cd05086 82 LKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKH---NFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIETE 158 (268)
T ss_pred HHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHC---CeeccCCccceEEEcCCccEEecccccccccCcchhhhcc
Confidence 9999975333334567778889999999999999998 99999999999999999999999999986432111 1112
Q ss_pred ccccccccccCccccCC-------CCCCChhhHHHHHHHHHHHHh-CCCCCCCCCCCchhcHHHHHHHHhcccccccccC
Q 010519 348 TRVMGTFGYVAPEYANT-------GMLNEKSDIYSFGVLLLEAVT-GRDPVDYGRPANEVNLVEWLKMMVGTRRAEEVVD 419 (508)
Q Consensus 348 ~~~~gt~~y~aPE~~~~-------~~~~~~~DvwS~Gvvl~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 419 (508)
....++..|+|||++.. ..++.++|||||||++|||++ |..||..... .+.+...... ....+.+
T Consensus 159 ~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~------~~~~~~~~~~-~~~~~~~ 231 (268)
T cd05086 159 DDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSD------REVLNHVIKD-QQVKLFK 231 (268)
T ss_pred cCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCH------HHHHHHHHhh-cccccCC
Confidence 34567889999998743 245789999999999999997 5667753321 1112111111 1112222
Q ss_pred CCCCCChhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhh
Q 010519 420 PNLEVKPATRALKRSLLVALRCVDPDSEKRPKMSQVVRMLE 460 (508)
Q Consensus 420 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 460 (508)
+.+... ....+.+++..|| .+|.+||++.+|++.|.
T Consensus 232 ~~~~~~----~~~~~~~l~~~c~-~~P~~Rp~~~~i~~~l~ 267 (268)
T cd05086 232 PQLELP----YSERWYEVLQFCW-LSPEKRATAEEVHRLLT 267 (268)
T ss_pred CccCCC----CcHHHHHHHHHHh-hCcccCCCHHHHHHHhc
Confidence 332222 2234555888899 67999999999999875
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage |
| >cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-37 Score=302.49 Aligned_cols=256 Identities=30% Similarity=0.424 Sum_probs=201.7
Q ss_pred hhCCcccceeEeeeCceEEEEEEEc-CCCEEEEEEEcccchhhHHHHHHHHHHHhcC-CCCCceeEEEEEEeCc------
Q 010519 184 ATNRFSAENVLGEGGYGVVYKGRLI-NGSEVAVKKLLNNLGQAEKEFRVEVEAIGHV-RHKNLVRLLGYCIEGV------ 255 (508)
Q Consensus 184 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~ei~~l~~l-~h~niv~~~~~~~~~~------ 255 (508)
+.++|++.+.||+|++|.||+|.+. +++.+++|.+..... ....+..|+.+++++ +|+||+++++++....
T Consensus 4 ~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~ 82 (275)
T cd06608 4 PTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIED-EEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPGNDD 82 (275)
T ss_pred chhheeheeeecCCCCeEEEEEEECCCCcEEEEEEEecCch-hHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCCcce
Confidence 4578999999999999999999875 577899998765433 346788999999999 7999999999997644
Q ss_pred eeeEEEeecCCCCHHHHHhhhhccCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCEEEcCCCcEEEEecCC
Q 010519 256 HRMLVYEYVNNGNLEQWLHGAMRNQGNLTWEARMKVIIGTAKALAYLHEAIEPKVVHRDIKSSNILIDDEFNAKVSDFGL 335 (508)
Q Consensus 256 ~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~Dfgl 335 (508)
..++||||+++++|.+++.........+++..++.++.|++.||.|||+. +++|+||+|+||++++++.+||+|||+
T Consensus 83 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~---~i~H~~l~p~ni~~~~~~~~~l~d~~~ 159 (275)
T cd06608 83 QLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHEN---KVIHRDIKGQNILLTKNAEVKLVDFGV 159 (275)
T ss_pred EEEEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcC---CcccCCCCHHHEEEccCCeEEECCCcc
Confidence 47899999999999999875433457889999999999999999999998 999999999999999999999999999
Q ss_pred ccccCCCCCcccccccccccccCccccCC-----CCCCChhhHHHHHHHHHHHHhCCCCCCCCCCCchhcHHHHHHHHhc
Q 010519 336 AKLLDSGESHITTRVMGTFGYVAPEYANT-----GMLNEKSDIYSFGVLLLEAVTGRDPVDYGRPANEVNLVEWLKMMVG 410 (508)
Q Consensus 336 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~DvwS~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~ 410 (508)
+........ ......++..|+|||++.. ..++.++|||||||+||+|++|+.||...... ........
T Consensus 160 ~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~------~~~~~~~~ 232 (275)
T cd06608 160 SAQLDSTLG-RRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPM------RALFKIPR 232 (275)
T ss_pred ceecccchh-hhcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCccccchH------HHHHHhhc
Confidence 876543221 2233468899999998753 34678999999999999999999999633211 11111111
Q ss_pred ccccccccCCCCCCChhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 010519 411 TRRAEEVVDPNLEVKPATRALKRSLLVALRCVDPDSEKRPKMSQVVRM 458 (508)
Q Consensus 411 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 458 (508)
. ..............+.+++.+||..||.+|||+.+++++
T Consensus 233 ~--------~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~ll~~ 272 (275)
T cd06608 233 N--------PPPTLKSPENWSKKFNDFISECLIKNYEQRPFMEELLEH 272 (275)
T ss_pred c--------CCCCCCchhhcCHHHHHHHHHHhhcChhhCcCHHHHhcC
Confidence 0 011111122234567789999999999999999999875
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I |
| >cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-37 Score=302.27 Aligned_cols=254 Identities=27% Similarity=0.428 Sum_probs=196.1
Q ss_pred CCcccceeEeeeCceEEEEEEEc-CCCEEEEEEEcccc-hhhHHHHHHHHHH-HhcCCCCCceeEEEEEEeCceeeEEEe
Q 010519 186 NRFSAENVLGEGGYGVVYKGRLI-NGSEVAVKKLLNNL-GQAEKEFRVEVEA-IGHVRHKNLVRLLGYCIEGVHRMLVYE 262 (508)
Q Consensus 186 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~ei~~-l~~l~h~niv~~~~~~~~~~~~~lv~E 262 (508)
++|++.+.||+|+||.||++.+. +|..||+|++.... ......+..|+.. ++.++||||+++++++..+...+++||
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~iv~~~~~~~~~~~~~lv~e 80 (283)
T cd06617 1 DDLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDCPYTVTFYGALFREGDVWICME 80 (283)
T ss_pred CCceEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCCcHHHHHHHHHHHHHHHHcCCCCeeeeeEEEecCCcEEEEhh
Confidence 47889999999999999999875 68999999886543 2233445556664 666799999999999999999999999
Q ss_pred ecCCCCHHHHHhhhhccCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCEEEcCCCcEEEEecCCccccCCC
Q 010519 263 YVNNGNLEQWLHGAMRNQGNLTWEARMKVIIGTAKALAYLHEAIEPKVVHRDIKSSNILIDDEFNAKVSDFGLAKLLDSG 342 (508)
Q Consensus 263 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~~ 342 (508)
|++ |+|.+++.........+++..++.++.||+.||.|||++. +++||||||+|||++.++.+||+|||++......
T Consensus 81 ~~~-~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--~i~h~dlkp~nil~~~~~~~kl~dfg~~~~~~~~ 157 (283)
T cd06617 81 VMD-TSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKL--SVIHRDVKPSNVLINRNGQVKLCDFGISGYLVDS 157 (283)
T ss_pred hhc-ccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhcC--CeecCCCCHHHEEECCCCCEEEeecccccccccc
Confidence 996 6999988754445567999999999999999999999742 7999999999999999999999999999865432
Q ss_pred CCcccccccccccccCccccCC----CCCCChhhHHHHHHHHHHHHhCCCCCCCCCCCchhcHHHHHHHHhccccccccc
Q 010519 343 ESHITTRVMGTFGYVAPEYANT----GMLNEKSDIYSFGVLLLEAVTGRDPVDYGRPANEVNLVEWLKMMVGTRRAEEVV 418 (508)
Q Consensus 343 ~~~~~~~~~gt~~y~aPE~~~~----~~~~~~~DvwS~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 418 (508)
. ......++..|+|||.+.+ ..++.++|+|||||++|+|++|+.||...... ... +.......
T Consensus 158 ~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~----~~~-~~~~~~~~------ 224 (283)
T cd06617 158 V--AKTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTP----FQQ-LKQVVEEP------ 224 (283)
T ss_pred c--ccccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCccccC----HHH-HHHHHhcC------
Confidence 2 1233467889999998865 45688999999999999999999998632211 111 11111100
Q ss_pred CCCCCCChhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 010519 419 DPNLEVKPATRALKRSLLVALRCVDPDSEKRPKMSQVVRM 458 (508)
Q Consensus 419 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 458 (508)
.+.+. .......+.+++.+||..+|.+||++.+++++
T Consensus 225 ~~~~~---~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~ 261 (283)
T cd06617 225 SPQLP---AEKFSPEFQDFVNKCLKKNYKERPNYPELLQH 261 (283)
T ss_pred CCCCC---ccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 01111 11234557779999999999999999999975
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs |
| >cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-37 Score=308.90 Aligned_cols=197 Identities=24% Similarity=0.351 Sum_probs=160.0
Q ss_pred ceeEeeeCceEEEEEEEc---CCCEEEEEEEcccchhhHHHHHHHHHHHhcCCCCCceeEEEEEEe--CceeeEEEeecC
Q 010519 191 ENVLGEGGYGVVYKGRLI---NGSEVAVKKLLNNLGQAEKEFRVEVEAIGHVRHKNLVRLLGYCIE--GVHRMLVYEYVN 265 (508)
Q Consensus 191 ~~~lg~G~~g~Vy~~~~~---~~~~vavK~~~~~~~~~~~~~~~ei~~l~~l~h~niv~~~~~~~~--~~~~~lv~E~~~ 265 (508)
..+||+|+||+||+|+.. .+..+|+|.+.... ....+.+|+.+++.++||||+++++++.. +...++||||+.
T Consensus 6 g~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~ 83 (317)
T cd07867 6 GCKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTG--ISMSACREIALLRELKHPNVIALQKVFLSHSDRKVWLLFDYAE 83 (317)
T ss_pred ceEeccCCCeeEEEEEecCCCccceEEEEEecCCC--CcHHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEEEEEeeeC
Confidence 367999999999999865 34689999875432 22356779999999999999999998854 456789999986
Q ss_pred CCCHHHHHhhhhc-----cCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCEEE----cCCCcEEEEecCCc
Q 010519 266 NGNLEQWLHGAMR-----NQGNLTWEARMKVIIGTAKALAYLHEAIEPKVVHRDIKSSNILI----DDEFNAKVSDFGLA 336 (508)
Q Consensus 266 ~gsL~~~l~~~~~-----~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiH~Dlk~~NIll----~~~~~~kl~Dfgla 336 (508)
++|.+++..... ....+++..+..++.||+.||.|||+. +|+||||||+|||+ +.++.+||+|||++
T Consensus 84 -~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG~a 159 (317)
T cd07867 84 -HDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHAN---WVLHRDLKPANILVMGEGPERGRVKIADMGFA 159 (317)
T ss_pred -CcHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhC---CEEcCCCCHHHEEEccCCCCCCcEEEeeccce
Confidence 588888753211 123588899999999999999999998 99999999999999 56678999999999
Q ss_pred cccCCCCC--cccccccccccccCccccCC-CCCCChhhHHHHHHHHHHHHhCCCCCCCC
Q 010519 337 KLLDSGES--HITTRVMGTFGYVAPEYANT-GMLNEKSDIYSFGVLLLEAVTGRDPVDYG 393 (508)
Q Consensus 337 ~~~~~~~~--~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwS~Gvvl~elltG~~Pf~~~ 393 (508)
+....... .......+|+.|+|||++.+ ..++.++|||||||++|||++|+.||...
T Consensus 160 ~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~~~ 219 (317)
T cd07867 160 RLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCR 219 (317)
T ss_pred eccCCCcccccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCcccc
Confidence 86643322 12234568999999999876 45899999999999999999999999643
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as |
| >cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-37 Score=306.06 Aligned_cols=255 Identities=24% Similarity=0.323 Sum_probs=198.1
Q ss_pred CCcccceeEeeeCceEEEEEEEc-CCCEEEEEEEcccc---hhhHHHHHHHHHHHhcCCCCCceeEEEEEEeCceeeEEE
Q 010519 186 NRFSAENVLGEGGYGVVYKGRLI-NGSEVAVKKLLNNL---GQAEKEFRVEVEAIGHVRHKNLVRLLGYCIEGVHRMLVY 261 (508)
Q Consensus 186 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~ei~~l~~l~h~niv~~~~~~~~~~~~~lv~ 261 (508)
++|.+.+.||+|+||.||++.+. .++.|++|.+.... ......+..|+++++.++||||+++++.+..+...++||
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (305)
T cd05609 1 EDFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSFETKRHLCMVM 80 (305)
T ss_pred CCceEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEecCCEEEEEE
Confidence 46888999999999999999875 57889999886543 223356778999999999999999999999999999999
Q ss_pred eecCCCCHHHHHhhhhccCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCEEEcCCCcEEEEecCCccccCC
Q 010519 262 EYVNNGNLEQWLHGAMRNQGNLTWEARMKVIIGTAKALAYLHEAIEPKVVHRDIKSSNILIDDEFNAKVSDFGLAKLLDS 341 (508)
Q Consensus 262 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~ 341 (508)
||+++++|.+++. ..+.+++..+..++.+++.||.|||+. +++|+||||+||+++.++.+||+|||+++....
T Consensus 81 e~~~g~~L~~~l~----~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~NIll~~~~~~~l~dfg~~~~~~~ 153 (305)
T cd05609 81 EYVEGGDCATLLK----NIGALPVDMARMYFAETVLALEYLHNY---GIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLM 153 (305)
T ss_pred ecCCCCcHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCchHHEEECCCCCEEEeeCCCccccCc
Confidence 9999999999984 345689999999999999999999998 999999999999999999999999999864211
Q ss_pred CC--------------CcccccccccccccCccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCCCchhcHHHHHHH
Q 010519 342 GE--------------SHITTRVMGTFGYVAPEYANTGMLNEKSDIYSFGVLLLEAVTGRDPVDYGRPANEVNLVEWLKM 407 (508)
Q Consensus 342 ~~--------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~ 407 (508)
.. ........++..|+|||.+.+..++.++|+|||||++|||++|..||..... .++...
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~vl~el~~g~~pf~~~~~------~~~~~~ 227 (305)
T cd05609 154 SLTTNLYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTP------EELFGQ 227 (305)
T ss_pred CccccccccccccchhhccccCCccCccccCchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH------HHHHHH
Confidence 00 0011224578899999999888899999999999999999999999963321 122222
Q ss_pred HhcccccccccCCCCCCChhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhhc
Q 010519 408 MVGTRRAEEVVDPNLEVKPATRALKRSLLVALRCVDPDSEKRPKMSQVVRMLEA 461 (508)
Q Consensus 408 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~ 461 (508)
..... ...+... ......+.+++.+||+.||.+||++.++++.|+.
T Consensus 228 ~~~~~----~~~~~~~----~~~~~~~~~li~~~l~~~P~~R~~~~~~~~ll~~ 273 (305)
T cd05609 228 VISDD----IEWPEGD----EALPADAQDLISRLLRQNPLERLGTGGAFEVKQH 273 (305)
T ss_pred HHhcc----cCCCCcc----ccCCHHHHHHHHHHhccChhhccCccCHHHHHhC
Confidence 11110 0001100 1223456679999999999999996555555544
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a |
| >KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-39 Score=323.17 Aligned_cols=258 Identities=22% Similarity=0.312 Sum_probs=206.1
Q ss_pred CcccceeEeeeCceEEEEEEEcCC-CEEEEEEEcccchhhHHHHHHHHHHHhcCCCCCceeEEEEEEeCceeeEEEeecC
Q 010519 187 RFSAENVLGEGGYGVVYKGRLING-SEVAVKKLLNNLGQAEKEFRVEVEAIGHVRHKNLVRLLGYCIEGVHRMLVYEYVN 265 (508)
Q Consensus 187 ~~~~~~~lg~G~~g~Vy~~~~~~~-~~vavK~~~~~~~~~~~~~~~ei~~l~~l~h~niv~~~~~~~~~~~~~lv~E~~~ 265 (508)
-|.++..||-|+||.||++..+.. --.|.|.+........+.+..||++|..++||+||.+++.|+.++.++|+.|||.
T Consensus 33 ~WeIiGELGDGAFGKVyKA~nket~~lAAaKvIetkseEELEDylVEIeILa~CdHP~ivkLl~ayy~enkLwiliEFC~ 112 (1187)
T KOG0579|consen 33 HWEIIGELGDGAFGKVYKAVNKETKLLAAAKVIETKSEEELEDYLVEIEILAECDHPVIVKLLSAYYFENKLWILIEFCG 112 (1187)
T ss_pred HHHHHhhhcCccchhhhhhhcccchhhhhhhhhcccchhHHhhhhhhhhhhhcCCChHHHHHHHHHhccCceEEEEeecC
Confidence 355666799999999999987643 3455777766666667889999999999999999999999999999999999999
Q ss_pred CCCHHHHHhhhhccCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCEEEcCCCcEEEEecCCccccCCCCCc
Q 010519 266 NGNLEQWLHGAMRNQGNLTWEARMKVIIGTAKALAYLHEAIEPKVVHRDIKSSNILIDDEFNAKVSDFGLAKLLDSGESH 345 (508)
Q Consensus 266 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~ 345 (508)
||-+...+- .-+..|++.++.-++.+++.||.|||++ +|||||||..|||++-+|.++|+|||.+-...... .
T Consensus 113 GGAVDaiml---EL~r~LtE~QIqvvc~q~ldALn~LHs~---~iIHRDLKAGNiL~TldGdirLADFGVSAKn~~t~-q 185 (1187)
T KOG0579|consen 113 GGAVDAIML---ELGRVLTEDQIQVVCYQVLDALNWLHSQ---NIIHRDLKAGNILLTLDGDIRLADFGVSAKNKSTR-Q 185 (1187)
T ss_pred CchHhHHHH---HhccccchHHHHHHHHHHHHHHHHHhhc---chhhhhccccceEEEecCcEeeecccccccchhHH-h
Confidence 999988774 3466799999999999999999999999 99999999999999999999999999986543221 2
Q ss_pred ccccccccccccCccccC-----CCCCCChhhHHHHHHHHHHHHhCCCCCCCCCCCchhcHHHHHHHHhcccccccccCC
Q 010519 346 ITTRVMGTFGYVAPEYAN-----TGMLNEKSDIYSFGVLLLEAVTGRDPVDYGRPANEVNLVEWLKMMVGTRRAEEVVDP 420 (508)
Q Consensus 346 ~~~~~~gt~~y~aPE~~~-----~~~~~~~~DvwS~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 420 (508)
....+.|||.|||||+.. ..+|+.++||||||+.|.||..+.+|-... +....+..+....
T Consensus 186 kRDsFIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHhel------npMRVllKiaKSe-------- 251 (1187)
T KOG0579|consen 186 KRDSFIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHHEL------NPMRVLLKIAKSE-------- 251 (1187)
T ss_pred hhccccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCcccc------chHHHHHHHhhcC--------
Confidence 345678999999999764 568999999999999999999999886422 2222222221111
Q ss_pred CCCCChhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhhcCCCC
Q 010519 421 NLEVKPATRALKRSLLVALRCVDPDSEKRPKMSQVVRMLEADDYP 465 (508)
Q Consensus 421 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~ 465 (508)
....-.+..+...+.+++.+||.+||..||+++++++|-.-...+
T Consensus 252 PPTLlqPS~Ws~~F~DfLk~cL~Knp~~Rp~aaqll~Hpfv~~~~ 296 (1187)
T KOG0579|consen 252 PPTLLQPSHWSRSFSDFLKRCLVKNPRNRPPAAQLLKHPFVQNAP 296 (1187)
T ss_pred CCcccCcchhhhHHHHHHHHHHhcCCccCCCHHHHhhCcccccCC
Confidence 111223445566777799999999999999999999987654433
|
|
| >cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-37 Score=308.63 Aligned_cols=249 Identities=26% Similarity=0.361 Sum_probs=198.8
Q ss_pred cccceeEeeeCceEEEEEEEc-CCCEEEEEEEcccchhhHHHHHHHHHHHhcCCCCCceeEEEEEEeCceeeEEEeecCC
Q 010519 188 FSAENVLGEGGYGVVYKGRLI-NGSEVAVKKLLNNLGQAEKEFRVEVEAIGHVRHKNLVRLLGYCIEGVHRMLVYEYVNN 266 (508)
Q Consensus 188 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~ei~~l~~l~h~niv~~~~~~~~~~~~~lv~E~~~~ 266 (508)
|.....||+|+||.||++... ++..||+|.+..........+.+|+.++..++||||+++++++..+...++||||+++
T Consensus 23 ~~~~~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~iv~e~~~~ 102 (297)
T cd06659 23 LENYIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLMEFLQG 102 (297)
T ss_pred HHhhhhcCCCCceeEEEEEEcCCCCEEEEEEEEecccchHHHHHHHHHHHHhCCCCchhhhhhheeeCCeEEEEEecCCC
Confidence 334457999999999999875 6889999998654444456788899999999999999999999999999999999999
Q ss_pred CCHHHHHhhhhccCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCEEEcCCCcEEEEecCCccccCCCCCcc
Q 010519 267 GNLEQWLHGAMRNQGNLTWEARMKVIIGTAKALAYLHEAIEPKVVHRDIKSSNILIDDEFNAKVSDFGLAKLLDSGESHI 346 (508)
Q Consensus 267 gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~ 346 (508)
++|.+++. ...+++..++.++.|++.||.|||+. +++|+||+|+||+++.++.+||+|||++........ .
T Consensus 103 ~~L~~~~~-----~~~~~~~~~~~~~~qi~~~L~~LH~~---~ivH~dl~p~Nill~~~~~~kL~dfg~~~~~~~~~~-~ 173 (297)
T cd06659 103 GALTDIVS-----QTRLNEEQIATVCESVLQALCYLHSQ---GVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVP-K 173 (297)
T ss_pred CCHHHHHh-----hcCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHeEEccCCcEEEeechhHhhcccccc-c
Confidence 99998763 24588999999999999999999999 999999999999999999999999999875543221 1
Q ss_pred cccccccccccCccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCCCchhcHHHHHHHHhcccccccccCCCCCCCh
Q 010519 347 TTRVMGTFGYVAPEYANTGMLNEKSDIYSFGVLLLEAVTGRDPVDYGRPANEVNLVEWLKMMVGTRRAEEVVDPNLEVKP 426 (508)
Q Consensus 347 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 426 (508)
.....++..|+|||++.+..++.++|||||||++|||++|+.||....+. ..+........ +... .
T Consensus 174 ~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~------~~~~~~~~~~~------~~~~--~ 239 (297)
T cd06659 174 RKSLVGTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPPYFSDSPV------QAMKRLRDSPP------PKLK--N 239 (297)
T ss_pred ccceecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH------HHHHHHhccCC------CCcc--c
Confidence 23356889999999999888999999999999999999999999643321 11111111100 0000 0
Q ss_pred hHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHh
Q 010519 427 ATRALKRSLLVALRCVDPDSEKRPKMSQVVRML 459 (508)
Q Consensus 427 ~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L 459 (508)
.......+.+++.+||+.+|.+||++.+++++-
T Consensus 240 ~~~~~~~l~~~i~~~l~~~P~~Rps~~~ll~~~ 272 (297)
T cd06659 240 AHKISPVLRDFLERMLTREPQERATAQELLDHP 272 (297)
T ss_pred cCCCCHHHHHHHHHHhcCCcccCcCHHHHhhCh
Confidence 111234566799999999999999999999963
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i |
| >cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-37 Score=300.14 Aligned_cols=256 Identities=23% Similarity=0.414 Sum_probs=197.0
Q ss_pred cccceeEeeeCceEEEEEEEc----CCCEEEEEEEcccc--hhhHHHHHHHHHHHhcCCCCCceeEEEEEEeCc------
Q 010519 188 FSAENVLGEGGYGVVYKGRLI----NGSEVAVKKLLNNL--GQAEKEFRVEVEAIGHVRHKNLVRLLGYCIEGV------ 255 (508)
Q Consensus 188 ~~~~~~lg~G~~g~Vy~~~~~----~~~~vavK~~~~~~--~~~~~~~~~ei~~l~~l~h~niv~~~~~~~~~~------ 255 (508)
|.+.+.||+|+||.||+|.+. .+..+|||.+.... ....+.+..|+.+++.++||||+++++++....
T Consensus 1 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 80 (273)
T cd05074 1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRLP 80 (273)
T ss_pred CcchhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccCChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCccc
Confidence 566789999999999999763 36789999886543 333456888999999999999999999886532
Q ss_pred eeeEEEeecCCCCHHHHHhhhhc--cCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCEEEcCCCcEEEEec
Q 010519 256 HRMLVYEYVNNGNLEQWLHGAMR--NQGNLTWEARMKVIIGTAKALAYLHEAIEPKVVHRDIKSSNILIDDEFNAKVSDF 333 (508)
Q Consensus 256 ~~~lv~E~~~~gsL~~~l~~~~~--~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~Df 333 (508)
..++++||+.+|+|.+++..... ....+++...+.++.|++.||+|||+. +|+||||||+||++++++.+||+||
T Consensus 81 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~---~i~H~dikp~nili~~~~~~kl~df 157 (273)
T cd05074 81 IPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSK---NFIHRDLAARNCMLNENMTVCVADF 157 (273)
T ss_pred ceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CEeecccchhhEEEcCCCCEEECcc
Confidence 23689999999999998753221 123578889999999999999999998 9999999999999999999999999
Q ss_pred CCccccCCCCCc-ccccccccccccCccccCCCCCCChhhHHHHHHHHHHHHh-CCCCCCCCCCCchhcHHHHHHHHhcc
Q 010519 334 GLAKLLDSGESH-ITTRVMGTFGYVAPEYANTGMLNEKSDIYSFGVLLLEAVT-GRDPVDYGRPANEVNLVEWLKMMVGT 411 (508)
Q Consensus 334 gla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~ 411 (508)
|+++........ ......+++.|++||.+.+..++.++|||||||++|+|++ |+.||..... ..... .....
T Consensus 158 g~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~sDi~slG~il~el~~~g~~p~~~~~~---~~~~~---~~~~~ 231 (273)
T cd05074 158 GLSKKIYSGDYYRQGCASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVEN---SEIYN---YLIKG 231 (273)
T ss_pred cccccccCCcceecCCCccCchhhcCHhHHhcCccchhhhhHHHHHHHHHHhhCCCCCCCCCCH---HHHHH---HHHcC
Confidence 999865433211 1222345678999999998889999999999999999999 8888853321 11111 11111
Q ss_pred cccccccCCCCCCChhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhhcC
Q 010519 412 RRAEEVVDPNLEVKPATRALKRSLLVALRCVDPDSEKRPKMSQVVRMLEAD 462 (508)
Q Consensus 412 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~ 462 (508)
... .. .......+.+++.+||+.+|++|||+.++++.|+..
T Consensus 232 ~~~--------~~--~~~~~~~~~~l~~~~l~~~p~~Rps~~~~~~~l~~~ 272 (273)
T cd05074 232 NRL--------KQ--PPDCLEDVYELMCQCWSPEPKCRPSFQHLRDQLELI 272 (273)
T ss_pred CcC--------CC--CCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 110 00 112345677799999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac |
| >cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-37 Score=304.32 Aligned_cols=251 Identities=25% Similarity=0.392 Sum_probs=203.0
Q ss_pred CCcccceeEeeeCceEEEEEEEc-CCCEEEEEEEcccchhhHHHHHHHHHHHhcCCCCCceeEEEEEEeCceeeEEEeec
Q 010519 186 NRFSAENVLGEGGYGVVYKGRLI-NGSEVAVKKLLNNLGQAEKEFRVEVEAIGHVRHKNLVRLLGYCIEGVHRMLVYEYV 264 (508)
Q Consensus 186 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~ei~~l~~l~h~niv~~~~~~~~~~~~~lv~E~~ 264 (508)
.+|.+.+.||.|+||.||++... ++..+++|.+..........+..|+.+++.++||||+++++++...+..++|+||+
T Consensus 19 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~ 98 (293)
T cd06647 19 KKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRENKHPNIVNYLDSYLVGDELWVVMEYL 98 (293)
T ss_pred hhceeeeEecCCCCeEEEEEEEcCCCCEEEEEEeccccchHHHHHHHHHHHHhhcCCCCeeehhheeeeCCcEEEEEecC
Confidence 58899999999999999999864 67889999886544444567888999999999999999999999999999999999
Q ss_pred CCCCHHHHHhhhhccCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCEEEcCCCcEEEEecCCccccCCCCC
Q 010519 265 NNGNLEQWLHGAMRNQGNLTWEARMKVIIGTAKALAYLHEAIEPKVVHRDIKSSNILIDDEFNAKVSDFGLAKLLDSGES 344 (508)
Q Consensus 265 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~ 344 (508)
++++|.+++.. ..+++..+..++.+++.||.|||++ +++|+||+|+||+++.++.+||+|||++........
T Consensus 99 ~~~~L~~~~~~-----~~l~~~~~~~i~~~l~~al~~LH~~---gi~H~dL~p~Nili~~~~~~kL~dfg~~~~~~~~~~ 170 (293)
T cd06647 99 AGGSLTDVVTE-----TCMDEGQIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS 170 (293)
T ss_pred CCCcHHHHHhh-----cCCCHHHHHHHHHHHHHHHHHHHhC---CEeeccCCHHHEEEcCCCCEEEccCcceeccccccc
Confidence 99999999842 3478889999999999999999999 999999999999999999999999999875543322
Q ss_pred cccccccccccccCccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCCCchhcHHHHHHHHhcccccccccCCCCCC
Q 010519 345 HITTRVMGTFGYVAPEYANTGMLNEKSDIYSFGVLLLEAVTGRDPVDYGRPANEVNLVEWLKMMVGTRRAEEVVDPNLEV 424 (508)
Q Consensus 345 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 424 (508)
......+++.|+|||.+.+..++.++|+|||||++|++++|+.||.......... ... .......
T Consensus 171 -~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~ll~~ll~g~~pf~~~~~~~~~~------~~~--------~~~~~~~ 235 (293)
T cd06647 171 -KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALY------LIA--------TNGTPEL 235 (293)
T ss_pred -ccccccCChhhcCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhhhee------ehh--------cCCCCCC
Confidence 2233468889999999988889999999999999999999999996443211110 000 0011111
Q ss_pred ChhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHh
Q 010519 425 KPATRALKRSLLVALRCVDPDSEKRPKMSQVVRML 459 (508)
Q Consensus 425 ~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L 459 (508)
.........+.+++.+||+.+|.+||++.+++.+-
T Consensus 236 ~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~h~ 270 (293)
T cd06647 236 QNPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQHP 270 (293)
T ss_pred CCccccCHHHHHHHHHHccCChhhCcCHHHHhcCH
Confidence 11222344567799999999999999999999874
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi |
| >cd05122 PKc_STE Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-37 Score=293.57 Aligned_cols=250 Identities=28% Similarity=0.451 Sum_probs=204.1
Q ss_pred CcccceeEeeeCceEEEEEEEc-CCCEEEEEEEcccchhhHHHHHHHHHHHhcCCCCCceeEEEEEEeCceeeEEEeecC
Q 010519 187 RFSAENVLGEGGYGVVYKGRLI-NGSEVAVKKLLNNLGQAEKEFRVEVEAIGHVRHKNLVRLLGYCIEGVHRMLVYEYVN 265 (508)
Q Consensus 187 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~ei~~l~~l~h~niv~~~~~~~~~~~~~lv~E~~~ 265 (508)
+|+..+.||+|++|.||++.+. ++..+++|++..........+.+|+..++.++|+|++++++++......++++||++
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l~~e~~~ 80 (253)
T cd05122 1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVKYYGSYLKKDELWIVMEFCS 80 (253)
T ss_pred CceeeeeeccCCceEEEEEEECCCCcEEEEEEecccchhHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEecCC
Confidence 4778899999999999999875 688899999876655456788899999999999999999999999999999999999
Q ss_pred CCCHHHHHhhhhccCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCEEEcCCCcEEEEecCCccccCCCCCc
Q 010519 266 NGNLEQWLHGAMRNQGNLTWEARMKVIIGTAKALAYLHEAIEPKVVHRDIKSSNILIDDEFNAKVSDFGLAKLLDSGESH 345 (508)
Q Consensus 266 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~ 345 (508)
+++|.+++.. ....+++..+..++.+++.||.|||.. +++|+||+|+||++++++.++|+|||.+........
T Consensus 81 ~~~L~~~~~~---~~~~~~~~~~~~i~~~i~~~l~~lh~~---~i~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~- 153 (253)
T cd05122 81 GGSLKDLLKS---TNQTLTESQIAYVCKELLKGLEYLHSN---GIIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKA- 153 (253)
T ss_pred CCcHHHHHhh---cCCCCCHHHHHHHHHHHHHHHHHhhcC---CEecCCCCHHHEEEccCCeEEEeecccccccccccc-
Confidence 9999999853 225789999999999999999999998 999999999999999999999999999987654432
Q ss_pred ccccccccccccCccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCCCchhcHHHHHHHHhcccccccccCCCCCCC
Q 010519 346 ITTRVMGTFGYVAPEYANTGMLNEKSDIYSFGVLLLEAVTGRDPVDYGRPANEVNLVEWLKMMVGTRRAEEVVDPNLEVK 425 (508)
Q Consensus 346 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 425 (508)
.....++..|+|||.+.+..++.++|+||||+++|+|++|+.||....... ....... ... +.+.
T Consensus 154 -~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~------~~~~~~~-~~~-----~~~~-- 218 (253)
T cd05122 154 -RNTMVGTPYWMAPEVINGKPYDYKADIWSLGITAIELAEGKPPYSELPPMK------ALFKIAT-NGP-----PGLR-- 218 (253)
T ss_pred -ccceecCCcccCHHHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCchHH------HHHHHHh-cCC-----CCcC--
Confidence 234568889999999998889999999999999999999999986432211 1111110 000 1111
Q ss_pred hhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 010519 426 PATRALKRSLLVALRCVDPDSEKRPKMSQVVRM 458 (508)
Q Consensus 426 ~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 458 (508)
........+.+++.+||+.||.+|||+.+++++
T Consensus 219 ~~~~~~~~~~~~i~~~l~~~p~~R~t~~~~l~~ 251 (253)
T cd05122 219 NPEKWSDEFKDFLKKCLQKNPEKRPTAEQLLKH 251 (253)
T ss_pred cccccCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 111123456779999999999999999999975
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core |
| >cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-37 Score=301.82 Aligned_cols=263 Identities=24% Similarity=0.365 Sum_probs=196.1
Q ss_pred CCcccceeEeeeCceEEEEEEEc-CCCEEEEEEEcccch-hhHHHHHHHHHHHhcCCCCCceeEEEEEEeCceeeEEEee
Q 010519 186 NRFSAENVLGEGGYGVVYKGRLI-NGSEVAVKKLLNNLG-QAEKEFRVEVEAIGHVRHKNLVRLLGYCIEGVHRMLVYEY 263 (508)
Q Consensus 186 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~ei~~l~~l~h~niv~~~~~~~~~~~~~lv~E~ 263 (508)
++|++.+.||+|++|.||+|... ++..||+|.+..... .....+.+|+++++.++|+||+++++++.+....++||||
T Consensus 5 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 84 (291)
T cd07844 5 ETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIREASLLKDLKHANIVTLHDIIHTKKTLTLVFEY 84 (291)
T ss_pred cceeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEecccccCCchhHHHHHHHHhhCCCcceeeEEEEEecCCeEEEEEec
Confidence 57999999999999999999875 688999998864432 2223466799999999999999999999999999999999
Q ss_pred cCCCCHHHHHhhhhccCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCEEEcCCCcEEEEecCCccccCCCC
Q 010519 264 VNNGNLEQWLHGAMRNQGNLTWEARMKVIIGTAKALAYLHEAIEPKVVHRDIKSSNILIDDEFNAKVSDFGLAKLLDSGE 343 (508)
Q Consensus 264 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~~~ 343 (508)
+.+ +|.+++.. ....+++..+..++.|+++||.|||+. +++|+||||+||+++.++.+||+|||+++......
T Consensus 85 ~~~-~L~~~~~~---~~~~~~~~~~~~~~~ql~~al~~lH~~---~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~ 157 (291)
T cd07844 85 LDT-DLKQYMDD---CGGGLSMHNVRLFLFQLLRGLAYCHQR---RVLHRDLKPQNLLISERGELKLADFGLARAKSVPS 157 (291)
T ss_pred CCC-CHHHHHHh---CCCCCCHHHHHHHHHHHHHHHHHHHhC---CeecccCCHHHEEEcCCCCEEECccccccccCCCC
Confidence 975 99998863 344788999999999999999999998 99999999999999999999999999987543221
Q ss_pred CcccccccccccccCccccCC-CCCCChhhHHHHHHHHHHHHhCCCCCCCCCCCchhcHHHHHHHHhccccc--------
Q 010519 344 SHITTRVMGTFGYVAPEYANT-GMLNEKSDIYSFGVLLLEAVTGRDPVDYGRPANEVNLVEWLKMMVGTRRA-------- 414 (508)
Q Consensus 344 ~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwS~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~-------- 414 (508)
. ......++..|+|||++.+ ..++.++|||||||++|+|++|+.||....... ..........+....
T Consensus 158 ~-~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~ 234 (291)
T cd07844 158 K-TYSNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVE--DQLHKIFRVLGTPTEETWPGVSS 234 (291)
T ss_pred c-cccccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCCCccHH--HHHHHHHHhcCCCChhhhhhhhh
Confidence 1 1222346889999998865 458899999999999999999999996433111 111101010000000
Q ss_pred ----ccccCCCCCCCh------hHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 010519 415 ----EEVVDPNLEVKP------ATRALKRSLLVALRCVDPDSEKRPKMSQVVRM 458 (508)
Q Consensus 415 ----~~~~~~~~~~~~------~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 458 (508)
............ .......+.+++.+||+.||.+|||+.+++.+
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~Rps~~e~l~~ 288 (291)
T cd07844 235 NPEFKPYSFPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRISAAEAMKH 288 (291)
T ss_pred ccccccccccccCChhHHHhCcCCCCchhHHHHHHHHhccCcccccCHHHHhcC
Confidence 000000000000 00011455679999999999999999999864
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the |
| >cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-37 Score=303.28 Aligned_cols=264 Identities=22% Similarity=0.268 Sum_probs=195.9
Q ss_pred hCCcccceeEeeeCceEEEEEEEc-CCCEEEEEEEcccch-hhHHHHHHHHHHHhcCCCCCceeEEEEEEeCceeeEEEe
Q 010519 185 TNRFSAENVLGEGGYGVVYKGRLI-NGSEVAVKKLLNNLG-QAEKEFRVEVEAIGHVRHKNLVRLLGYCIEGVHRMLVYE 262 (508)
Q Consensus 185 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~ei~~l~~l~h~niv~~~~~~~~~~~~~lv~E 262 (508)
.++|.+.+.||+|+||.||+|... ++..+++|.+..... .....+.+|+.+++.++|+||+++++++..+...++|||
T Consensus 4 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e 83 (291)
T cd07870 4 ATSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLKHANIVLLHDIIHTKETLTFVFE 83 (291)
T ss_pred cceeEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCcCCCcHHHHHHHHHHHhcCCCCEeEEEEEEecCCeEEEEEe
Confidence 468999999999999999999864 688999999865432 223456779999999999999999999999999999999
Q ss_pred ecCCCCHHHHHhhhhccCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCEEEcCCCcEEEEecCCccccCCC
Q 010519 263 YVNNGNLEQWLHGAMRNQGNLTWEARMKVIIGTAKALAYLHEAIEPKVVHRDIKSSNILIDDEFNAKVSDFGLAKLLDSG 342 (508)
Q Consensus 263 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~~ 342 (508)
|+. ++|.+++. .....+.+..+..++.||+.||.|||+. +++|+||||+|||++.++.+||+|||++......
T Consensus 84 ~~~-~~l~~~~~---~~~~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~ 156 (291)
T cd07870 84 YMH-TDLAQYMI---QHPGGLHPYNVRLFMFQLLRGLAYIHGQ---HILHRDLKPQNLLISYLGELKLADFGLARAKSIP 156 (291)
T ss_pred ccc-CCHHHHHH---hCCCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCChHHEEEcCCCcEEEeccccccccCCC
Confidence 995 68888774 2345678888899999999999999998 9999999999999999999999999999754332
Q ss_pred CCcccccccccccccCccccCC-CCCCChhhHHHHHHHHHHHHhCCCCCCCCCCCchhcHHHHHHHHhccc---------
Q 010519 343 ESHITTRVMGTFGYVAPEYANT-GMLNEKSDIYSFGVLLLEAVTGRDPVDYGRPANEVNLVEWLKMMVGTR--------- 412 (508)
Q Consensus 343 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwS~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~--------- 412 (508)
.. ......+++.|+|||.+.+ ..++.++|||||||+||+|++|..||.......+ .+.+ .....+..
T Consensus 157 ~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~~~~~-~~~~-~~~~~~~~~~~~~~~~~ 233 (291)
T cd07870 157 SQ-TYSSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDVFE-QLEK-IWTVLGVPTEDTWPGVS 233 (291)
T ss_pred CC-CCCCccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCchhHHH-HHHH-HHHHcCCCChhhhhhhh
Confidence 21 1233457889999999875 4578899999999999999999999964432111 1111 00000000
Q ss_pred cc----ccccCCCCCCC-----hhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 010519 413 RA----EEVVDPNLEVK-----PATRALKRSLLVALRCVDPDSEKRPKMSQVVRM 458 (508)
Q Consensus 413 ~~----~~~~~~~~~~~-----~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 458 (508)
.. ........... ........+.+++.+|+..||.+|||+.|++.+
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dp~~R~t~~~~l~h 288 (291)
T cd07870 234 KLPNYKPEWFLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQDALLH 288 (291)
T ss_pred hcccccchhccccCCcchhhhccccCCChHHHHHHHHHhCcCcccCcCHHHHhcC
Confidence 00 00000000000 000113455678999999999999999999864
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess |
| >KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-38 Score=319.33 Aligned_cols=244 Identities=31% Similarity=0.454 Sum_probs=200.5
Q ss_pred eEeeeCceEEEEEEEc-CCCEEEEEEEcccchhhHHHHHHHHHHHhcCCCCCceeEEEEEEeCceeeEEEeecCCCCHHH
Q 010519 193 VLGEGGYGVVYKGRLI-NGSEVAVKKLLNNLGQAEKEFRVEVEAIGHVRHKNLVRLLGYCIEGVHRMLVYEYVNNGNLEQ 271 (508)
Q Consensus 193 ~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~ei~~l~~l~h~niv~~~~~~~~~~~~~lv~E~~~~gsL~~ 271 (508)
+||+|.||+||.|++. +...+|||-+........+-+.+||.+-++|+|.|||+++|.|.++++.-|.||-++||+|.+
T Consensus 582 VLGKGTYG~VYA~RD~~tqvrIaIKEIpekdsr~~QPLhEEIaLH~~LrHkNIVrYLGs~senGf~kIFMEqVPGGSLSs 661 (1226)
T KOG4279|consen 582 VLGKGTYGTVYAARDMDTQVRIAIKEIPEKDSREVQPLHEEIALHSTLRHKNIVRYLGSVSENGFFKIFMEQVPGGSLSS 661 (1226)
T ss_pred EeecCceeEEEeeccccceeEEEeeecccccchhhccHHHHHHHHHHHhhHhHHHHhhccCCCCeEEEEeecCCCCcHHH
Confidence 5999999999999975 456799999877766666778899999999999999999999999998889999999999999
Q ss_pred HHhhhhccCCCc--cHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCEEEc-CCCcEEEEecCCccccCCCCCcccc
Q 010519 272 WLHGAMRNQGNL--TWEARMKVIIGTAKALAYLHEAIEPKVVHRDIKSSNILID-DEFNAKVSDFGLAKLLDSGESHITT 348 (508)
Q Consensus 272 ~l~~~~~~~~~l--~~~~~~~i~~~i~~al~yLH~~~~~~iiH~Dlk~~NIll~-~~~~~kl~Dfgla~~~~~~~~~~~~ 348 (508)
+|+. .-+++ ++...-.+..||++||.|||++ .|||||||-+|||++ -.|.+||+|||-++++..-. ....
T Consensus 662 LLrs---kWGPlKDNEstm~fYtkQILeGLkYLHen---~IVHRDIKGDNVLvNTySGvlKISDFGTsKRLAgin-P~TE 734 (1226)
T KOG4279|consen 662 LLRS---KWGPLKDNESTMNFYTKQILEGLKYLHEN---KIVHRDIKGDNVLVNTYSGVLKISDFGTSKRLAGIN-PCTE 734 (1226)
T ss_pred HHHh---ccCCCccchhHHHHHHHHHHHHhhhhhhc---ceeeccccCCcEEEeeccceEEecccccchhhccCC-cccc
Confidence 9973 45666 7788888999999999999999 999999999999995 67889999999998775333 3455
Q ss_pred cccccccccCccccCCC--CCCChhhHHHHHHHHHHHHhCCCCCCCCCCCchhcHHHHHHHHhcccccccccCCCCCCCh
Q 010519 349 RVMGTFGYVAPEYANTG--MLNEKSDIYSFGVLLLEAVTGRDPVDYGRPANEVNLVEWLKMMVGTRRAEEVVDPNLEVKP 426 (508)
Q Consensus 349 ~~~gt~~y~aPE~~~~~--~~~~~~DvwS~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 426 (508)
.+.||..|||||++..+ .|+.++|||||||.+.||.||++||....... ...++. +. -..-.+.
T Consensus 735 TFTGTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~Elgspq----AAMFkV----Gm------yKvHP~i 800 (1226)
T KOG4279|consen 735 TFTGTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELGSPQ----AAMFKV----GM------YKVHPPI 800 (1226)
T ss_pred ccccchhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecCChh----Hhhhhh----cc------eecCCCC
Confidence 67899999999999765 58899999999999999999999996432211 111111 10 1111223
Q ss_pred hHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 010519 427 ATRALKRSLLVALRCVDPDSEKRPKMSQVVR 457 (508)
Q Consensus 427 ~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 457 (508)
+.........+|++|+.+||.+||++.++|.
T Consensus 801 Peelsaeak~FilrcFepd~~~R~sA~~LL~ 831 (1226)
T KOG4279|consen 801 PEELSAEAKNFILRCFEPDPCDRPSAKDLLQ 831 (1226)
T ss_pred cHHHHHHHHHHHHHHcCCCcccCccHHHhcc
Confidence 4455666777999999999999999999997
|
|
| >cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-36 Score=303.99 Aligned_cols=250 Identities=25% Similarity=0.367 Sum_probs=198.7
Q ss_pred hCCcccceeEeeeCceEEEEEEEc-CCCEEEEEEEcccc---hhhHHHHHHHHHHHhcCCCCCceeEEEEEEeCceeeEE
Q 010519 185 TNRFSAENVLGEGGYGVVYKGRLI-NGSEVAVKKLLNNL---GQAEKEFRVEVEAIGHVRHKNLVRLLGYCIEGVHRMLV 260 (508)
Q Consensus 185 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~ei~~l~~l~h~niv~~~~~~~~~~~~~lv 260 (508)
.+.|...+.||+|+||+||+|+.. +++.||+|.+.... ......+.+|+.+++.++||||++++++|.+....++|
T Consensus 14 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~lv 93 (307)
T cd06607 14 EKLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLREHTAWLV 93 (307)
T ss_pred chhhhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEeCCeEEEE
Confidence 457889999999999999999875 68899999885332 23335688899999999999999999999999999999
Q ss_pred EeecCCCCHHHHHhhhhccCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCEEEcCCCcEEEEecCCccccC
Q 010519 261 YEYVNNGNLEQWLHGAMRNQGNLTWEARMKVIIGTAKALAYLHEAIEPKVVHRDIKSSNILIDDEFNAKVSDFGLAKLLD 340 (508)
Q Consensus 261 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~Dfgla~~~~ 340 (508)
|||+. |+|.+++. .....+++..+..++.|++.||.|||+. +++|+||+|+||++++++.+||+|||++....
T Consensus 94 ~e~~~-g~l~~~~~---~~~~~l~~~~~~~~~~ql~~~L~~LH~~---~i~H~dl~p~nIl~~~~~~~kL~dfg~~~~~~ 166 (307)
T cd06607 94 MEYCL-GSASDILE---VHKKPLQEVEIAAICHGALQGLAYLHSH---ERIHRDIKAGNILLTEPGTVKLADFGSASLVS 166 (307)
T ss_pred HHhhC-CCHHHHHH---HcccCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCcccEEECCCCCEEEeecCcceecC
Confidence 99996 58888774 2345689999999999999999999998 99999999999999999999999999997654
Q ss_pred CCCCcccccccccccccCccccC---CCCCCChhhHHHHHHHHHHHHhCCCCCCCCCCCchhcHHHHHHHHhcccccccc
Q 010519 341 SGESHITTRVMGTFGYVAPEYAN---TGMLNEKSDIYSFGVLLLEAVTGRDPVDYGRPANEVNLVEWLKMMVGTRRAEEV 417 (508)
Q Consensus 341 ~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DvwS~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 417 (508)
.. ....+++.|+|||++. ...++.++||||||+++|||++|..||...... ...........
T Consensus 167 ~~-----~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~~~------~~~~~~~~~~~---- 231 (307)
T cd06607 167 PA-----NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAM------SALYHIAQNDS---- 231 (307)
T ss_pred CC-----CCccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCccHH------HHHHHHhcCCC----
Confidence 32 2345788999999874 456889999999999999999999998643211 11111110000
Q ss_pred cCCCCCCChhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhhc
Q 010519 418 VDPNLEVKPATRALKRSLLVALRCVDPDSEKRPKMSQVVRMLEA 461 (508)
Q Consensus 418 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~ 461 (508)
+.+ ........+.+++.+||+.||.+||++.+++.+..-
T Consensus 232 --~~~---~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~ 270 (307)
T cd06607 232 --PTL---SSNDWSDYFRNFVDSCLQKIPQDRPSSEELLKHRFV 270 (307)
T ss_pred --CCC---CchhhCHHHHHHHHHHhcCChhhCcCHHHHhcChhh
Confidence 111 112234567789999999999999999999987543
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily |
| >cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-37 Score=303.08 Aligned_cols=261 Identities=26% Similarity=0.309 Sum_probs=198.3
Q ss_pred CcccceeEeeeCceEEEEEEEc-CCCEEEEEEEcccchh-----hHHHHHHHHHHHhcCCCCCceeEEEEEEeCceeeEE
Q 010519 187 RFSAENVLGEGGYGVVYKGRLI-NGSEVAVKKLLNNLGQ-----AEKEFRVEVEAIGHVRHKNLVRLLGYCIEGVHRMLV 260 (508)
Q Consensus 187 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-----~~~~~~~ei~~l~~l~h~niv~~~~~~~~~~~~~lv 260 (508)
+|.+.+.||+|+||.||+|.+. +++.|++|++...... ....+..|+++++.++|+||+++++++.+....++|
T Consensus 1 ~y~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv 80 (298)
T cd07841 1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGHKSNINLV 80 (298)
T ss_pred CceeeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeecCCEEEEE
Confidence 4788899999999999999875 6889999998654322 234567799999999999999999999999999999
Q ss_pred EeecCCCCHHHHHhhhhccCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCEEEcCCCcEEEEecCCccccC
Q 010519 261 YEYVNNGNLEQWLHGAMRNQGNLTWEARMKVIIGTAKALAYLHEAIEPKVVHRDIKSSNILIDDEFNAKVSDFGLAKLLD 340 (508)
Q Consensus 261 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~Dfgla~~~~ 340 (508)
|||+ +|+|.+++.. ....+++..++.++.||++||.|||++ +++|+||+|+||+++.++.++|+|||++....
T Consensus 81 ~e~~-~~~L~~~i~~---~~~~~~~~~~~~~~~qi~~al~~lH~~---~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~ 153 (298)
T cd07841 81 FEFM-ETDLEKVIKD---KSIVLTPADIKSYMLMTLRGLEYLHSN---WILHRDLKPNNLLIASDGVLKLADFGLARSFG 153 (298)
T ss_pred Eccc-CCCHHHHHhc---cCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecCCChhhEEEcCCCCEEEccceeeeecc
Confidence 9999 8999999853 223789999999999999999999999 99999999999999999999999999998765
Q ss_pred CCCCcccccccccccccCccccCC-CCCCChhhHHHHHHHHHHHHhCCCCCCCCCCCchhcHHHHHHHHhccc-------
Q 010519 341 SGESHITTRVMGTFGYVAPEYANT-GMLNEKSDIYSFGVLLLEAVTGRDPVDYGRPANEVNLVEWLKMMVGTR------- 412 (508)
Q Consensus 341 ~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwS~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~------- 412 (508)
..... .....+++.|+|||.+.+ ..++.++|||||||++|||++|..||....... .+..... .....
T Consensus 154 ~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~~~~--~~~~~~~-~~~~~~~~~~~~ 229 (298)
T cd07841 154 SPNRK-MTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDID--QLGKIFE-ALGTPTEENWPG 229 (298)
T ss_pred CCCcc-ccccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccCCccHH--HHHHHHH-HcCCCchhhhhh
Confidence 43221 223356788999998854 567899999999999999999977775332211 1111111 10000
Q ss_pred --ccccccCCCCCCC-----hhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 010519 413 --RAEEVVDPNLEVK-----PATRALKRSLLVALRCVDPDSEKRPKMSQVVRM 458 (508)
Q Consensus 413 --~~~~~~~~~~~~~-----~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 458 (508)
............. ........+.+++.+||+.||.+|||+.|++.+
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~e~l~~ 282 (298)
T cd07841 230 VTSLPDYVEFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALEH 282 (298)
T ss_pred cccccccccccccCCcchhhhcccccHHHHHHHHHHhcCCcccCcCHHHHhhC
Confidence 0000000000000 011224567789999999999999999999986
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is |
| >cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=298.53 Aligned_cols=248 Identities=23% Similarity=0.393 Sum_probs=199.6
Q ss_pred CcccceeEeeeCceEEEEEEEc-CCCEEEEEEEcccc-hhhHHHHHHHHHHHhcCCCCCceeEEEEEEeCceeeEEEeec
Q 010519 187 RFSAENVLGEGGYGVVYKGRLI-NGSEVAVKKLLNNL-GQAEKEFRVEVEAIGHVRHKNLVRLLGYCIEGVHRMLVYEYV 264 (508)
Q Consensus 187 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~ei~~l~~l~h~niv~~~~~~~~~~~~~lv~E~~ 264 (508)
-|...+.||.|+||.||+|.+. ++..+|+|.+.... ......+.+|+..+.+++||||+++++++..+...++||||+
T Consensus 5 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 84 (277)
T cd06641 5 LFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYL 84 (277)
T ss_pred hhhhheeEeecCCeEEEEEEECCCCcEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCEeEEEEEEEeCCeEEEEEEeC
Confidence 4677889999999999999864 67889999875433 333467888999999999999999999999999999999999
Q ss_pred CCCCHHHHHhhhhccCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCEEEcCCCcEEEEecCCccccCCCCC
Q 010519 265 NNGNLEQWLHGAMRNQGNLTWEARMKVIIGTAKALAYLHEAIEPKVVHRDIKSSNILIDDEFNAKVSDFGLAKLLDSGES 344 (508)
Q Consensus 265 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~ 344 (508)
++++|.+++. ...+++..+..++.+++.|+.|||+. +++|+||+|+||+++.++.++|+|||++........
T Consensus 85 ~~~~l~~~i~-----~~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~dl~p~Ni~i~~~~~~~l~dfg~~~~~~~~~~ 156 (277)
T cd06641 85 GGGSALDLLE-----PGPLDETQIATILREILKGLDYLHSE---KKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQI 156 (277)
T ss_pred CCCcHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHccC---CeecCCCCHHhEEECCCCCEEEeecccceecccchh
Confidence 9999999884 24588999999999999999999998 999999999999999999999999999876543221
Q ss_pred cccccccccccccCccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCCCchhcHHHHHHHHhcccccccccCCCCCC
Q 010519 345 HITTRVMGTFGYVAPEYANTGMLNEKSDIYSFGVLLLEAVTGRDPVDYGRPANEVNLVEWLKMMVGTRRAEEVVDPNLEV 424 (508)
Q Consensus 345 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 424 (508)
......++..|+|||.+.+..++.++|+|||||++|+|++|..||..... .......... .. +.+
T Consensus 157 -~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~------~~~~~~~~~~-~~-----~~~-- 221 (277)
T cd06641 157 -KRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPHSELHP------MKVLFLIPKN-NP-----PTL-- 221 (277)
T ss_pred -hhccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCccch------HHHHHHHhcC-CC-----CCC--
Confidence 12334678899999999888899999999999999999999999863321 1111111111 00 111
Q ss_pred ChhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHh
Q 010519 425 KPATRALKRSLLVALRCVDPDSEKRPKMSQVVRML 459 (508)
Q Consensus 425 ~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L 459 (508)
.......+.+++.+||+.+|.+||++.+++++-
T Consensus 222 --~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~~~ 254 (277)
T cd06641 222 --EGNYSKPLKEFVEACLNKEPSFRPTAKELLKHK 254 (277)
T ss_pred --CcccCHHHHHHHHHHccCChhhCcCHHHHHhCH
Confidence 112234566799999999999999999999963
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int |
| >cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-37 Score=301.82 Aligned_cols=250 Identities=26% Similarity=0.355 Sum_probs=200.2
Q ss_pred CcccceeEeeeCceEEEEEEEc-CCCEEEEEEEcccchhhHHHHHHHHHHHhcCCCCCceeEEEEEEeCceeeEEEeecC
Q 010519 187 RFSAENVLGEGGYGVVYKGRLI-NGSEVAVKKLLNNLGQAEKEFRVEVEAIGHVRHKNLVRLLGYCIEGVHRMLVYEYVN 265 (508)
Q Consensus 187 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~ei~~l~~l~h~niv~~~~~~~~~~~~~lv~E~~~ 265 (508)
+|...+.||+|++|.||++... ++..+++|++........+.+.+|+.+++.++||||+++++++...+..++++||++
T Consensus 20 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~~~~~~~v~e~~~ 99 (285)
T cd06648 20 YLDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNIVEMYSSYLVGDELWVVMEFLE 99 (285)
T ss_pred hhhcceEeccCCCeEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHHcCCCChheEEEEEEcCCeEEEEEeccC
Confidence 3444579999999999999864 678899998865544445668889999999999999999999999999999999999
Q ss_pred CCCHHHHHhhhhccCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCEEEcCCCcEEEEecCCccccCCCCCc
Q 010519 266 NGNLEQWLHGAMRNQGNLTWEARMKVIIGTAKALAYLHEAIEPKVVHRDIKSSNILIDDEFNAKVSDFGLAKLLDSGESH 345 (508)
Q Consensus 266 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~ 345 (508)
+++|.+++.. ..+++..++.++.|++.||.|||++ +++||||+|+||+++.++.++|+|||++........
T Consensus 100 ~~~L~~~~~~-----~~~~~~~~~~~~~ql~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~l~d~g~~~~~~~~~~- 170 (285)
T cd06648 100 GGALTDIVTH-----TRMNEEQIATVCLAVLKALSFLHAQ---GVIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEVP- 170 (285)
T ss_pred CCCHHHHHHh-----CCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCChhhEEEcCCCcEEEcccccchhhccCCc-
Confidence 9999999842 4688999999999999999999999 999999999999999999999999998875543222
Q ss_pred ccccccccccccCccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCCCchhcHHHHHHHHhcccccccccCCCCCCC
Q 010519 346 ITTRVMGTFGYVAPEYANTGMLNEKSDIYSFGVLLLEAVTGRDPVDYGRPANEVNLVEWLKMMVGTRRAEEVVDPNLEVK 425 (508)
Q Consensus 346 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 425 (508)
......|++.|+|||.+.+..++.++|||||||++|+|++|..||....+ .......... . .+....
T Consensus 171 ~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ell~g~~p~~~~~~------~~~~~~~~~~-~-----~~~~~~- 237 (285)
T cd06648 171 RRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPPYFNEPP------LQAMKRIRDN-L-----PPKLKN- 237 (285)
T ss_pred ccccccCCccccCHHHhcCCCCCCcccHHHHHHHHHHHHhCCCCCcCCCH------HHHHHHHHhc-C-----CCCCcc-
Confidence 12334688999999999988899999999999999999999999864322 1111111111 0 011111
Q ss_pred hhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHh
Q 010519 426 PATRALKRSLLVALRCVDPDSEKRPKMSQVVRML 459 (508)
Q Consensus 426 ~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L 459 (508)
.......+.+++.+||+.+|.+|||+.+++++-
T Consensus 238 -~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~ 270 (285)
T cd06648 238 -LHKVSPRLRSFLDRMLVRDPAQRATAAELLNHP 270 (285)
T ss_pred -cccCCHHHHHHHHHHcccChhhCcCHHHHccCc
Confidence 111234677799999999999999999999753
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun |
| >KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-38 Score=335.98 Aligned_cols=291 Identities=22% Similarity=0.257 Sum_probs=225.5
Q ss_pred HHHHHHhhCCcccceeEeeeCceEEEEEEEc-CCCEEEEEEEcccc---hhhHHHHHHHHHHHhcCCCCCceeEEEEEEe
Q 010519 178 LRDLEIATNRFSAENVLGEGGYGVVYKGRLI-NGSEVAVKKLLNNL---GQAEKEFRVEVEAIGHVRHKNLVRLLGYCIE 253 (508)
Q Consensus 178 ~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~ei~~l~~l~h~niv~~~~~~~~ 253 (508)
+.+++...++|.+.++||+|+||.|.+++++ .++.+|+|++.+.. ......|..|-++|..-+.+=|++++-.|++
T Consensus 67 v~~lrl~~~DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv~LhyAFQD 146 (1317)
T KOG0612|consen 67 VKELRLKAEDFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIVQLHYAFQD 146 (1317)
T ss_pred HHHHhCCHHhhHHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHHHHHHHhcC
Confidence 5778888999999999999999999999986 57778999875522 2334578999999999999999999999999
Q ss_pred CceeeEEEeecCCCCHHHHHhhhhccCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCEEEcCCCcEEEEec
Q 010519 254 GVHRMLVYEYVNNGNLEQWLHGAMRNQGNLTWEARMKVIIGTAKALAYLHEAIEPKVVHRDIKSSNILIDDEFNAKVSDF 333 (508)
Q Consensus 254 ~~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~Df 333 (508)
..++|||||||+||+|..++. +..++++..++.++..|+.||.-||+. |+|||||||+|||||..|++||+||
T Consensus 147 ~~~LYlVMdY~pGGDlltLlS----k~~~~pE~~ArFY~aEiVlAldslH~m---gyVHRDiKPDNvLld~~GHikLADF 219 (1317)
T KOG0612|consen 147 ERYLYLVMDYMPGGDLLTLLS----KFDRLPEDWARFYTAEIVLALDSLHSM---GYVHRDIKPDNVLLDKSGHIKLADF 219 (1317)
T ss_pred ccceEEEEecccCchHHHHHh----hcCCChHHHHHHHHHHHHHHHHHHHhc---cceeccCCcceeEecccCcEeeccc
Confidence 999999999999999999994 445899999999999999999999999 9999999999999999999999999
Q ss_pred CCccccCCCCCcccccccccccccCccccC----C-CCCCChhhHHHHHHHHHHHHhCCCCCCCCCCCchhcHHHHHHHH
Q 010519 334 GLAKLLDSGESHITTRVMGTFGYVAPEYAN----T-GMLNEKSDIYSFGVLLLEAVTGRDPVDYGRPANEVNLVEWLKMM 408 (508)
Q Consensus 334 gla~~~~~~~~~~~~~~~gt~~y~aPE~~~----~-~~~~~~~DvwS~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~ 408 (508)
|.+..+..+..-.....+|||.|++||++. + +.|++.+|+||+||++|||+.|..||... .+.+-....
T Consensus 220 GsClkm~~dG~V~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYad------slveTY~KI 293 (1317)
T KOG0612|consen 220 GSCLKMDADGTVRSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYAD------SLVETYGKI 293 (1317)
T ss_pred hhHHhcCCCCcEEeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchHH------HHHHHHHHH
Confidence 999988866655566779999999999984 3 67999999999999999999999999522 222222222
Q ss_pred hcccccccccCCCCCCChhHHHHHHHHHHHHHhcCCCCCCCCC---HHHHHHHhhcCCCCCchhhccccCCCcchhhhcc
Q 010519 409 VGTRRAEEVVDPNLEVKPATRALKRSLLVALRCVDPDSEKRPK---MSQVVRMLEADDYPFREDRRNRKSRTTSMEIESL 485 (508)
Q Consensus 409 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs---~~evl~~L~~~~~~~~~~~~~~~~~~~~~~~~~~ 485 (508)
.... ..+.++.....+....+||.+.+. +|..|.. ++++-.|..-....|..-+...-+-......+..
T Consensus 294 m~hk-------~~l~FP~~~~VSeeakdLI~~ll~-~~e~RLgrngiedik~HpFF~g~~W~~iR~~~pP~vPevssd~D 365 (1317)
T KOG0612|consen 294 MNHK-------ESLSFPDETDVSEEAKDLIEALLC-DREVRLGRNGIEDIKNHPFFEGIDWDNIRESVPPVVPEVSSDDD 365 (1317)
T ss_pred hchh-------hhcCCCcccccCHHHHHHHHHHhc-ChhhhcccccHHHHHhCccccCCChhhhhhcCCCCCCcCCCCCc
Confidence 1111 123333333455666678777664 6888888 9999887654444443333333333333333333
Q ss_pred cccc
Q 010519 486 KEST 489 (508)
Q Consensus 486 ~~~~ 489 (508)
....
T Consensus 366 TsnF 369 (1317)
T KOG0612|consen 366 TSNF 369 (1317)
T ss_pred cccc
Confidence 3333
|
|
| >KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-38 Score=310.82 Aligned_cols=256 Identities=21% Similarity=0.324 Sum_probs=200.3
Q ss_pred HHhhCCcccceeEeeeCceEEEEEEEcCCCEEEEEEEccc--chhhHHHHHHHHHHHhcC-CCCCceeEEEEEEeCceee
Q 010519 182 EIATNRFSAENVLGEGGYGVVYKGRLINGSEVAVKKLLNN--LGQAEKEFRVEVEAIGHV-RHKNLVRLLGYCIEGVHRM 258 (508)
Q Consensus 182 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~--~~~~~~~~~~ei~~l~~l-~h~niv~~~~~~~~~~~~~ 258 (508)
.+....|++++.||.||.+.||++...+.+.+|+|++... ..+...-|..|+..|.+| .|.+||++++|-..+..+|
T Consensus 357 ~Vkg~~Yeilk~iG~GGSSkV~kV~~s~~~iyalkkv~~~~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~d~~lY 436 (677)
T KOG0596|consen 357 KVKGREYEILKQIGSGGSSKVFKVLNSDKQIYALKKVVLLEADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVTDGYLY 436 (677)
T ss_pred EECcchhhHHHhhcCCCcceeeeeecCCCcchhhhHHHHhhcCHHHHHHHHHHHHHHHHhcCCceEEEEeeeeccCceEE
Confidence 3455689999999999999999998777788898877433 345567899999999999 5999999999999999999
Q ss_pred EEEeecCCCCHHHHHhhhhccCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCEEEcCCCcEEEEecCCccc
Q 010519 259 LVYEYVNNGNLEQWLHGAMRNQGNLTWEARMKVIIGTAKALAYLHEAIEPKVVHRDIKSSNILIDDEFNAKVSDFGLAKL 338 (508)
Q Consensus 259 lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~Dfgla~~ 338 (508)
|||||- ..+|..+|.. ....++.-.++.+..|+++|+.++|.. ||||.||||.|+|+-. |.+||+|||+|..
T Consensus 437 mvmE~G-d~DL~kiL~k---~~~~~~~~~lk~ywkqML~aV~~IH~~---gIVHSDLKPANFLlVk-G~LKLIDFGIA~a 508 (677)
T KOG0596|consen 437 MVMECG-DIDLNKILKK---KKSIDPDWFLKFYWKQMLLAVKTIHQH---GIVHSDLKPANFLLVK-GRLKLIDFGIANA 508 (677)
T ss_pred EEeecc-cccHHHHHHh---ccCCCchHHHHHHHHHHHHHHHHHHHh---ceeecCCCcccEEEEe-eeEEeeeechhcc
Confidence 999987 5599999964 223333237788999999999999999 9999999999999975 5999999999998
Q ss_pred cCCCCCcc-cccccccccccCccccCCCC-----------CCChhhHHHHHHHHHHHHhCCCCCCCCCCCchhcHHHHHH
Q 010519 339 LDSGESHI-TTRVMGTFGYVAPEYANTGM-----------LNEKSDIYSFGVLLLEAVTGRDPVDYGRPANEVNLVEWLK 406 (508)
Q Consensus 339 ~~~~~~~~-~~~~~gt~~y~aPE~~~~~~-----------~~~~~DvwS~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~ 406 (508)
+..+.... ....+||+.||+||.+.... .+.++||||+|||||+|+.|+.||.. +.....
T Consensus 509 I~~DTTsI~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~--------~~n~~a 580 (677)
T KOG0596|consen 509 IQPDTTSIVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQ--------IINQIA 580 (677)
T ss_pred cCccccceeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHH--------HHHHHH
Confidence 76654433 34568999999999885432 45799999999999999999999962 221111
Q ss_pred HHhcccccccccCCCCCCChhHH-HHHHHHHHHHHhcCCCCCCCCCHHHHHHHh
Q 010519 407 MMVGTRRAEEVVDPNLEVKPATR-ALKRSLLVALRCVDPDSEKRPKMSQVVRML 459 (508)
Q Consensus 407 ~~~~~~~~~~~~~~~~~~~~~~~-~~~~l~~li~~cl~~dP~~RPs~~evl~~L 459 (508)
.+..+.+|...++.+.- ....+++++..||..||.+|||..++|++-
T Consensus 581 ------Kl~aI~~P~~~Iefp~~~~~~~li~~mK~CL~rdPkkR~si~eLLqhp 628 (677)
T KOG0596|consen 581 ------KLHAITDPNHEIEFPDIPENDELIDVMKCCLARDPKKRWSIPELLQHP 628 (677)
T ss_pred ------HHHhhcCCCccccccCCCCchHHHHHHHHHHhcCcccCCCcHHHhcCc
Confidence 12233444332222111 112277899999999999999999999864
|
|
| >cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-37 Score=299.73 Aligned_cols=248 Identities=23% Similarity=0.288 Sum_probs=201.6
Q ss_pred CcccceeEeeeCceEEEEEEEc-CCCEEEEEEEcccc---hhhHHHHHHHHHHHhcCCCCCceeEEEEEEeCceeeEEEe
Q 010519 187 RFSAENVLGEGGYGVVYKGRLI-NGSEVAVKKLLNNL---GQAEKEFRVEVEAIGHVRHKNLVRLLGYCIEGVHRMLVYE 262 (508)
Q Consensus 187 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~ei~~l~~l~h~niv~~~~~~~~~~~~~lv~E 262 (508)
+|++.+.||.|+||.||+|.+. ++..+|+|.+.... ....+.+.+|++++++++||||+++++++.+....++|+|
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 80 (258)
T cd05578 1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSFQDEENMYLVVD 80 (258)
T ss_pred CceEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhhcCCCeEEEEEe
Confidence 4888999999999999999875 58899999886433 2345678889999999999999999999999999999999
Q ss_pred ecCCCCHHHHHhhhhccCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCEEEcCCCcEEEEecCCccccCCC
Q 010519 263 YVNNGNLEQWLHGAMRNQGNLTWEARMKVIIGTAKALAYLHEAIEPKVVHRDIKSSNILIDDEFNAKVSDFGLAKLLDSG 342 (508)
Q Consensus 263 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~~ 342 (508)
|+.+++|.+++.. ...+++..+..++.||++||.|||+. +++|+||+|+||++++++.++|+|||++......
T Consensus 81 ~~~~~~L~~~l~~----~~~l~~~~~~~~~~~i~~~l~~lh~~---~i~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~ 153 (258)
T cd05578 81 LLLGGDLRYHLSQ----KVKFSEEQVKFWICEIVLALEYLHSK---GIIHRDIKPDNILLDEQGHVHITDFNIATKVTPD 153 (258)
T ss_pred CCCCCCHHHHHHh----cCCcCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHeEEcCCCCEEEeecccccccCCC
Confidence 9999999999853 35788999999999999999999998 9999999999999999999999999999866443
Q ss_pred CCcccccccccccccCccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCCCchhcHHHHHHHHhcccccccccCCCC
Q 010519 343 ESHITTRVMGTFGYVAPEYANTGMLNEKSDIYSFGVLLLEAVTGRDPVDYGRPANEVNLVEWLKMMVGTRRAEEVVDPNL 422 (508)
Q Consensus 343 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 422 (508)
. ......|+..|+|||++.+..++.++|+||||+++|+|++|..||....... ..++...... .. +
T Consensus 154 ~--~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~----~~~~~~~~~~--~~----~-- 219 (258)
T cd05578 154 T--LTTSTSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHSRTI----RDQIRAKQET--AD----V-- 219 (258)
T ss_pred c--cccccCCChhhcCHHHHcccCCCCcccchhhHHHHHHHHhCCCCCCCCCccH----HHHHHHHhcc--cc----c--
Confidence 2 2233567889999999998889999999999999999999999997554321 1111111111 00 0
Q ss_pred CCChhHHHHHHHHHHHHHhcCCCCCCCCCH--HHHHH
Q 010519 423 EVKPATRALKRSLLVALRCVDPDSEKRPKM--SQVVR 457 (508)
Q Consensus 423 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~--~evl~ 457 (508)
..+......+.+++.+||+.||.+||++ .|+++
T Consensus 220 --~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~l~~ 254 (258)
T cd05578 220 --LYPATWSTEAIDAINKLLERDPQKRLGDNLKDLKN 254 (258)
T ss_pred --cCcccCcHHHHHHHHHHccCChhHcCCccHHHHhc
Confidence 1111223567779999999999999999 66654
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. |
| >cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-37 Score=305.06 Aligned_cols=268 Identities=21% Similarity=0.299 Sum_probs=198.7
Q ss_pred CcccceeEeeeCceEEEEEEEcC---CCEEEEEEEcccc---hhhHHHHHHHHHHHhcCCCCCceeEEEEEEeC--ceee
Q 010519 187 RFSAENVLGEGGYGVVYKGRLIN---GSEVAVKKLLNNL---GQAEKEFRVEVEAIGHVRHKNLVRLLGYCIEG--VHRM 258 (508)
Q Consensus 187 ~~~~~~~lg~G~~g~Vy~~~~~~---~~~vavK~~~~~~---~~~~~~~~~ei~~l~~l~h~niv~~~~~~~~~--~~~~ 258 (508)
+|.+.+.||+|+||.||+|.... +..+|+|.+.... ......+..|+.++..++||||+++++++.+. ...+
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 80 (316)
T cd07842 1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLEHADKSVY 80 (316)
T ss_pred CceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeCCCCceEE
Confidence 47888999999999999998754 7899999987633 23335677799999999999999999999988 7889
Q ss_pred EEEeecCCCCHHHHHhhhhccC-CCccHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCEEEcC----CCcEEEEec
Q 010519 259 LVYEYVNNGNLEQWLHGAMRNQ-GNLTWEARMKVIIGTAKALAYLHEAIEPKVVHRDIKSSNILIDD----EFNAKVSDF 333 (508)
Q Consensus 259 lv~E~~~~gsL~~~l~~~~~~~-~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiH~Dlk~~NIll~~----~~~~kl~Df 333 (508)
+||||+++ +|.+++....... ..+++..++.++.||+.||.|||+. +++||||||+|||++. ++.+||+||
T Consensus 81 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~h~dlkp~Nil~~~~~~~~~~~kl~Df 156 (316)
T cd07842 81 LLFDYAEH-DLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHSN---WVLHRDLKPANILVMGEGPERGVVKIGDL 156 (316)
T ss_pred EEEeCCCc-CHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHhC---CEeeCCCCHHHEEEcCCCCccceEEECCC
Confidence 99999964 7888775443333 3788999999999999999999999 9999999999999999 999999999
Q ss_pred CCccccCCCCC--cccccccccccccCccccCC-CCCCChhhHHHHHHHHHHHHhCCCCCCCCCCCch-------hcHHH
Q 010519 334 GLAKLLDSGES--HITTRVMGTFGYVAPEYANT-GMLNEKSDIYSFGVLLLEAVTGRDPVDYGRPANE-------VNLVE 403 (508)
Q Consensus 334 gla~~~~~~~~--~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwS~Gvvl~elltG~~Pf~~~~~~~~-------~~~~~ 403 (508)
|++........ .......+++.|+|||++.+ ..++.++|||||||+||+|++|+.||........ ..+..
T Consensus 157 g~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (316)
T cd07842 157 GLARLFNAPLKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKSNPFQRDQLER 236 (316)
T ss_pred ccccccCCCcccccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCCcCCcccccccchhHHHHHHH
Confidence 99986543322 12233467889999998866 4588999999999999999999999964433220 01111
Q ss_pred HHHHHhccc-----------cccc----ccCCCCCCChh-H------HHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 010519 404 WLKMMVGTR-----------RAEE----VVDPNLEVKPA-T------RALKRSLLVALRCVDPDSEKRPKMSQVVRM 458 (508)
Q Consensus 404 ~~~~~~~~~-----------~~~~----~~~~~~~~~~~-~------~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 458 (508)
.+..+.... .... ........... . .....+.+++.+||+.||.+|||+.|++++
T Consensus 237 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~eil~~ 313 (316)
T cd07842 237 IFEVLGTPTEKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQGFDLLRKLLEYDPTKRITAEEALEH 313 (316)
T ss_pred HHHHhCCCchhHHHHHhhcccchhhhhhccCCCCCCccHHHHHHhccCCCHHHHHHHHHHhcCCcccCcCHHHHhcC
Confidence 111110000 0000 00000000000 0 123457789999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the |
| >cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-37 Score=300.90 Aligned_cols=256 Identities=27% Similarity=0.375 Sum_probs=205.6
Q ss_pred hhCCcccceeEeeeCceEEEEEEEc-CCCEEEEEEEcccchhhHHHHHHHHHHHhcCCCCCceeEEEEEEeCceeeEEEe
Q 010519 184 ATNRFSAENVLGEGGYGVVYKGRLI-NGSEVAVKKLLNNLGQAEKEFRVEVEAIGHVRHKNLVRLLGYCIEGVHRMLVYE 262 (508)
Q Consensus 184 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~ei~~l~~l~h~niv~~~~~~~~~~~~~lv~E 262 (508)
.++.|+..+.||+|++|.||+|.+. ++..+++|.+..... ....+..|++.++.++|+|++++++++......++++|
T Consensus 17 ~~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e 95 (286)
T cd06614 17 PRELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQ-NKELIINEILIMKDCKHPNIVDYYDSYLVGDELWVVME 95 (286)
T ss_pred ccccchHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCch-hHHHHHHHHHHHHHCCCCCeeEEEEEEEECCEEEEEEe
Confidence 4567888899999999999999886 688999999865544 45678889999999999999999999999999999999
Q ss_pred ecCCCCHHHHHhhhhccCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCEEEcCCCcEEEEecCCccccCCC
Q 010519 263 YVNNGNLEQWLHGAMRNQGNLTWEARMKVIIGTAKALAYLHEAIEPKVVHRDIKSSNILIDDEFNAKVSDFGLAKLLDSG 342 (508)
Q Consensus 263 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~~ 342 (508)
|+++++|.+++... ...+++..+..++.+++.||.|||+. +++|+||+|+||+++.++.++|+|||++......
T Consensus 96 ~~~~~~L~~~l~~~---~~~l~~~~~~~i~~~i~~~L~~lH~~---gi~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~ 169 (286)
T cd06614 96 YMDGGSLTDIITQN---FVRMNEPQIAYVCREVLQGLEYLHSQ---NVIHRDIKSDNILLSKDGSVKLADFGFAAQLTKE 169 (286)
T ss_pred ccCCCcHHHHHHHh---ccCCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCChhhEEEcCCCCEEECccchhhhhccc
Confidence 99999999999642 24789999999999999999999998 9999999999999999999999999998755432
Q ss_pred CCcccccccccccccCccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCCCchhcHHHHHHHHhcccccccccCCCC
Q 010519 343 ESHITTRVMGTFGYVAPEYANTGMLNEKSDIYSFGVLLLEAVTGRDPVDYGRPANEVNLVEWLKMMVGTRRAEEVVDPNL 422 (508)
Q Consensus 343 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 422 (508)
.. ......+++.|+|||++.+..++.++|+|||||++|+|++|+.||....+.. ........ .. +
T Consensus 170 ~~-~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slGvil~~l~~g~~p~~~~~~~~------~~~~~~~~-~~-----~-- 234 (286)
T cd06614 170 KS-KRNSVVGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPPYLREPPLR------ALFLITTK-GI-----P-- 234 (286)
T ss_pred hh-hhccccCCcccCCHhHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCHHH------HHHHHHhc-CC-----C--
Confidence 21 1233457889999999998889999999999999999999999986432211 11111100 00 0
Q ss_pred CCChhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhhc
Q 010519 423 EVKPATRALKRSLLVALRCVDPDSEKRPKMSQVVRMLEA 461 (508)
Q Consensus 423 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~ 461 (508)
...........+.+++.+||+.+|.+|||+.+++.+..-
T Consensus 235 ~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~~ 273 (286)
T cd06614 235 PLKNPEKWSPEFKDFLNKCLVKDPEKRPSAEELLQHPFL 273 (286)
T ss_pred CCcchhhCCHHHHHHHHHHhccChhhCcCHHHHhhChHh
Confidence 111111134566779999999999999999999975543
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou |
| >cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=299.63 Aligned_cols=262 Identities=24% Similarity=0.328 Sum_probs=197.0
Q ss_pred CcccceeEeeeCceEEEEEEEc-CCCEEEEEEEcccc--hhhHHHHHHHHHHHhcCCCCCceeEEEEEEeCceeeEEEee
Q 010519 187 RFSAENVLGEGGYGVVYKGRLI-NGSEVAVKKLLNNL--GQAEKEFRVEVEAIGHVRHKNLVRLLGYCIEGVHRMLVYEY 263 (508)
Q Consensus 187 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~ei~~l~~l~h~niv~~~~~~~~~~~~~lv~E~ 263 (508)
+|+..+.||.|++|.||+|++. ++..+|+|++.... ......+..|++++++++||||+++++++.+....++||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (284)
T cd07860 1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEF 80 (284)
T ss_pred CceeeeeecCCCceEEEEEEECCCCCEEEEEEccccccccccchHHHHHHHHHHhcCCCCCcchhhhcccCCcEEEEeec
Confidence 4788899999999999999875 68899999885433 22235688899999999999999999999999999999999
Q ss_pred cCCCCHHHHHhhhhccCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCEEEcCCCcEEEEecCCccccCCCC
Q 010519 264 VNNGNLEQWLHGAMRNQGNLTWEARMKVIIGTAKALAYLHEAIEPKVVHRDIKSSNILIDDEFNAKVSDFGLAKLLDSGE 343 (508)
Q Consensus 264 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~~~ 343 (508)
+. ++|.+++.. .....+++..++.++.|++.||+|||+. +++|+||+|+||++++++.+||+|||++.......
T Consensus 81 ~~-~~l~~~~~~--~~~~~l~~~~~~~~~~~i~~~l~~lh~~---~i~H~~l~p~nill~~~~~~~l~dfg~~~~~~~~~ 154 (284)
T cd07860 81 LH-QDLKKFMDA--SPLSGIPLPLIKSYLFQLLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPV 154 (284)
T ss_pred cc-cCHHHHHHh--CCCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEEeeccchhhcccCc
Confidence 95 689998864 2345789999999999999999999998 99999999999999999999999999987654322
Q ss_pred CcccccccccccccCccccCCC-CCCChhhHHHHHHHHHHHHhCCCCCCCCCCCchhcHHHHHHHHhccc----------
Q 010519 344 SHITTRVMGTFGYVAPEYANTG-MLNEKSDIYSFGVLLLEAVTGRDPVDYGRPANEVNLVEWLKMMVGTR---------- 412 (508)
Q Consensus 344 ~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwS~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~---------- 412 (508)
. ......+++.|+|||++.+. .++.++|||||||++|+|++|+.||...... ..............
T Consensus 155 ~-~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~ 231 (284)
T cd07860 155 R-TYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEI--DQLFRIFRTLGTPDEVVWPGVTSL 231 (284)
T ss_pred c-ccccccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHH--HHHHHHHHHhCCCChhhhhhhhHH
Confidence 1 12333568899999988664 4688999999999999999999999643221 11111111100000
Q ss_pred -----ccccccCCCCCCChhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 010519 413 -----RAEEVVDPNLEVKPATRALKRSLLVALRCVDPDSEKRPKMSQVVRM 458 (508)
Q Consensus 413 -----~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 458 (508)
.........+. .........+.+++.+||+.||.+|||+++++++
T Consensus 232 ~~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~ 281 (284)
T cd07860 232 PDYKPSFPKWARQDFS-KVVPPLDEDGRDLLSQMLHYDPNKRISAKAALAH 281 (284)
T ss_pred HHHHhhcccccccCHH-HHcccCCHHHHHHHHHhcCCCcccCCCHHHHhcC
Confidence 00000000000 0001122445679999999999999999999975
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex |
| >cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-37 Score=296.24 Aligned_cols=250 Identities=22% Similarity=0.382 Sum_probs=200.1
Q ss_pred CcccceeEeeeCceEEEEEEEc-CCCEEEEEEEcccc--hhhHHHHHHHHHHHhcCCCCCceeEEEEEEeCceeeEEEee
Q 010519 187 RFSAENVLGEGGYGVVYKGRLI-NGSEVAVKKLLNNL--GQAEKEFRVEVEAIGHVRHKNLVRLLGYCIEGVHRMLVYEY 263 (508)
Q Consensus 187 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~ei~~l~~l~h~niv~~~~~~~~~~~~~lv~E~ 263 (508)
+|++.+.||.|+||.||+|... +|..+|+|.+.... ......+..|+.+++.++|+||+++++.+......++|+||
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~ 80 (257)
T cd08225 1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFASFQENGRLFIVMEY 80 (257)
T ss_pred CceEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhccchhhHHHHHHHHHHHhCCCCChhhhhheeccCCeEEEEEec
Confidence 5788899999999999999875 57889999885432 22345678899999999999999999999999999999999
Q ss_pred cCCCCHHHHHhhhhccCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCEEEcCCCc-EEEEecCCccccCCC
Q 010519 264 VNNGNLEQWLHGAMRNQGNLTWEARMKVIIGTAKALAYLHEAIEPKVVHRDIKSSNILIDDEFN-AKVSDFGLAKLLDSG 342 (508)
Q Consensus 264 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiH~Dlk~~NIll~~~~~-~kl~Dfgla~~~~~~ 342 (508)
+++++|.+++.. .....+++..+..++.+++.||.|||+. +++|+||+|+||++++++. +||+|||.+......
T Consensus 81 ~~~~~L~~~~~~--~~~~~~~~~~~~~~~~~l~~~l~~lh~~---~i~H~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~ 155 (257)
T cd08225 81 CDGGDLMKRINR--QRGVLFSEDQILSWFVQISLGLKHIHDR---KILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDS 155 (257)
T ss_pred CCCCcHHHHHHh--ccCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccccCCHHHEEEcCCCCeEEecccccchhccCC
Confidence 999999999863 2334578999999999999999999998 9999999999999998865 699999999866543
Q ss_pred CCcccccccccccccCccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCCCchhcHHHHHHHHhcccccccccCCCC
Q 010519 343 ESHITTRVMGTFGYVAPEYANTGMLNEKSDIYSFGVLLLEAVTGRDPVDYGRPANEVNLVEWLKMMVGTRRAEEVVDPNL 422 (508)
Q Consensus 343 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 422 (508)
.. ......|++.|+|||++.+..++.++|+||||+++|+|++|..||.... ..++........ . .+
T Consensus 156 ~~-~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~------~~~~~~~~~~~~-~----~~-- 221 (257)
T cd08225 156 ME-LAYTCVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFEGNN------LHQLVLKICQGY-F----AP-- 221 (257)
T ss_pred cc-cccccCCCccccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCcc------HHHHHHHHhccc-C----CC--
Confidence 22 1223458889999999988889999999999999999999999986332 122222221111 0 00
Q ss_pred CCChhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 010519 423 EVKPATRALKRSLLVALRCVDPDSEKRPKMSQVVRM 458 (508)
Q Consensus 423 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 458 (508)
........+.+++.+||..+|.+|||+.+++++
T Consensus 222 ---~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~ 254 (257)
T cd08225 222 ---ISPNFSRDLRSLISQLFKVSPRDRPSITSILKR 254 (257)
T ss_pred ---CCCCCCHHHHHHHHHHhccChhhCcCHHHHhhC
Confidence 011223457779999999999999999999976
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. |
| >cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-36 Score=297.90 Aligned_cols=249 Identities=26% Similarity=0.456 Sum_probs=198.3
Q ss_pred CcccceeEeeeCceEEEEEEEc-CCCEEEEEEEcccc-hhhHHHHHHHHHHHhcCC---CCCceeEEEEEEeCceeeEEE
Q 010519 187 RFSAENVLGEGGYGVVYKGRLI-NGSEVAVKKLLNNL-GQAEKEFRVEVEAIGHVR---HKNLVRLLGYCIEGVHRMLVY 261 (508)
Q Consensus 187 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~ei~~l~~l~---h~niv~~~~~~~~~~~~~lv~ 261 (508)
.|+..+.||.|+||.||+|.+. ++..+++|.+.... ......+..|+.+++.++ |||++++++++..+...++||
T Consensus 2 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~~~~~lv~ 81 (277)
T cd06917 2 LYQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYYGSYLKGPRLWIIM 81 (277)
T ss_pred hhhhhhheeccCCceEEEEEEcCCCcEEEEEEecCCCCchhHHHHHHHHHHHHHhccCCCCCeeeEeeeeeeCCEEEEEE
Confidence 4777889999999999999874 68899999886443 333456788999998886 999999999999999999999
Q ss_pred eecCCCCHHHHHhhhhccCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCEEEcCCCcEEEEecCCccccCC
Q 010519 262 EYVNNGNLEQWLHGAMRNQGNLTWEARMKVIIGTAKALAYLHEAIEPKVVHRDIKSSNILIDDEFNAKVSDFGLAKLLDS 341 (508)
Q Consensus 262 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~ 341 (508)
||+++++|.+++.. ..+++..++.++.+++.||.|||+. +++|+||+|+||++++++.++|+|||++.....
T Consensus 82 e~~~~~~L~~~~~~-----~~l~~~~~~~i~~~i~~~l~~lh~~---~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~ 153 (277)
T cd06917 82 EYAEGGSVRTLMKA-----GPIAEKYISVIIREVLVALKYIHKV---GVIHRDIKAANILVTNTGNVKLCDFGVAALLNQ 153 (277)
T ss_pred ecCCCCcHHHHHHc-----cCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCcCHHHEEEcCCCCEEEccCCceeecCC
Confidence 99999999998742 3688999999999999999999998 999999999999999999999999999987654
Q ss_pred CCCcccccccccccccCccccCC-CCCCChhhHHHHHHHHHHHHhCCCCCCCCCCCchhcHHHHHHHHhcccccccccCC
Q 010519 342 GESHITTRVMGTFGYVAPEYANT-GMLNEKSDIYSFGVLLLEAVTGRDPVDYGRPANEVNLVEWLKMMVGTRRAEEVVDP 420 (508)
Q Consensus 342 ~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwS~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 420 (508)
... ......|+..|+|||.+.+ ..++.++|+|||||++|+|++|..||...... ...... ... ..+
T Consensus 154 ~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~------~~~~~~-~~~-----~~~ 220 (277)
T cd06917 154 NSS-KRSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAF------RAMMLI-PKS-----KPP 220 (277)
T ss_pred Ccc-ccccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCCChh------hhhhcc-ccC-----CCC
Confidence 332 2233468889999998865 45789999999999999999999999643221 111100 000 111
Q ss_pred CCCCChhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHh
Q 010519 421 NLEVKPATRALKRSLLVALRCVDPDSEKRPKMSQVVRML 459 (508)
Q Consensus 421 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L 459 (508)
.+... .....+.+++.+||+.||.+||++.+++.+-
T Consensus 221 ~~~~~---~~~~~~~~~i~~~l~~~p~~R~~~~~il~~~ 256 (277)
T cd06917 221 RLEDN---GYSKLLREFVAACLDEEPKERLSAEELLKSK 256 (277)
T ss_pred CCCcc---cCCHHHHHHHHHHcCCCcccCcCHHHHhhCh
Confidence 11111 1334667799999999999999999998753
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent |
| >cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-36 Score=292.69 Aligned_cols=252 Identities=25% Similarity=0.395 Sum_probs=205.9
Q ss_pred CcccceeEeeeCceEEEEEEEc-CCCEEEEEEEcccch--hhHHHHHHHHHHHhcCCCCCceeEEEEEEeCceeeEEEee
Q 010519 187 RFSAENVLGEGGYGVVYKGRLI-NGSEVAVKKLLNNLG--QAEKEFRVEVEAIGHVRHKNLVRLLGYCIEGVHRMLVYEY 263 (508)
Q Consensus 187 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~ei~~l~~l~h~niv~~~~~~~~~~~~~lv~E~ 263 (508)
+|.+.+.||.|+||.||++.+. ++..+++|++..... .....+..|+++++.++|||++++++.+......++|+||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~lv~e~ 80 (258)
T cd08215 1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYESFEEKGKLCIVMEY 80 (258)
T ss_pred CceEEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccCChHHHHHHHHHHHHHHhcCCCChhheEEEEecCCEEEEEEEe
Confidence 5788899999999999999875 588999999865432 4456788899999999999999999999999999999999
Q ss_pred cCCCCHHHHHhhhhccCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCEEEcCCCcEEEEecCCccccCCCC
Q 010519 264 VNNGNLEQWLHGAMRNQGNLTWEARMKVIIGTAKALAYLHEAIEPKVVHRDIKSSNILIDDEFNAKVSDFGLAKLLDSGE 343 (508)
Q Consensus 264 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~~~ 343 (508)
+++++|.+++.........+++..+..++.+++.||.|||+. +++|+||+|+||++++++.++|+|||++.......
T Consensus 81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~---~~~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~ 157 (258)
T cd08215 81 ADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSR---KILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTV 157 (258)
T ss_pred cCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHHhC---CEecccCChHHeEEcCCCcEEECCccceeecccCc
Confidence 999999999975433357899999999999999999999998 99999999999999999999999999998665433
Q ss_pred CcccccccccccccCccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCCCchhcHHHHHHHHhcccccccccCCCCC
Q 010519 344 SHITTRVMGTFGYVAPEYANTGMLNEKSDIYSFGVLLLEAVTGRDPVDYGRPANEVNLVEWLKMMVGTRRAEEVVDPNLE 423 (508)
Q Consensus 344 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 423 (508)
.......|++.|+|||.+.+..++.++|+||||+++|+|++|..||..... .......... .. +.+.
T Consensus 158 -~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~------~~~~~~~~~~-~~-----~~~~ 224 (258)
T cd08215 158 -DLAKTVVGTPYYLSPELCQNKPYNYKSDIWSLGCVLYELCTLKHPFEGENL------LELALKILKG-QY-----PPIP 224 (258)
T ss_pred -ceecceeeeecccChhHhccCCCCccccHHHHHHHHHHHHcCCCCCCCCcH------HHHHHHHhcC-CC-----CCCC
Confidence 123345688999999999988899999999999999999999999864431 1112221111 11 1111
Q ss_pred CChhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 010519 424 VKPATRALKRSLLVALRCVDPDSEKRPKMSQVVRM 458 (508)
Q Consensus 424 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 458 (508)
......+.+++.+||+.+|.+|||+.+++++
T Consensus 225 ----~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~ 255 (258)
T cd08215 225 ----SQYSSELRNLVSSLLQKDPEERPSIAQILQS 255 (258)
T ss_pred ----CCCCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 1223456779999999999999999999975
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They |
| >cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-36 Score=300.75 Aligned_cols=258 Identities=25% Similarity=0.363 Sum_probs=197.3
Q ss_pred CcccceeEeeeCceEEEEEEEc-CCCEEEEEEEcccc-hhhHHHHHHHHHHHhcCC-CCCceeEEEEEEeCceeeEEEee
Q 010519 187 RFSAENVLGEGGYGVVYKGRLI-NGSEVAVKKLLNNL-GQAEKEFRVEVEAIGHVR-HKNLVRLLGYCIEGVHRMLVYEY 263 (508)
Q Consensus 187 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~ei~~l~~l~-h~niv~~~~~~~~~~~~~lv~E~ 263 (508)
+|...+.||+|+||.||++.+. ++..+|+|.+.... ......+..|+.++.++. |+||+++++++..+...+++|||
T Consensus 5 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~~~~~~~~e~ 84 (288)
T cd06616 5 DLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFYGALFREGDCWICMEL 84 (288)
T ss_pred HhHHHHHhCCCCceEEEEEEECCCCCEEEEEEehhccChHHHHHHHHHHHHHHHhcCCCCEeeeeeEEecCCcEEEEEec
Confidence 5566788999999999999875 68899999886443 334457888999999996 99999999999998899999999
Q ss_pred cCCCCHHHHHhhh-hccCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCEEEcCCCcEEEEecCCccccCCC
Q 010519 264 VNNGNLEQWLHGA-MRNQGNLTWEARMKVIIGTAKALAYLHEAIEPKVVHRDIKSSNILIDDEFNAKVSDFGLAKLLDSG 342 (508)
Q Consensus 264 ~~~gsL~~~l~~~-~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~~ 342 (508)
+. ++|.++.... ......+++..+..++.+++.||.|||+.. +++||||||+||+++.++.+||+|||++......
T Consensus 85 ~~-~~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~--~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~ 161 (288)
T cd06616 85 MD-ISLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEEL--KIIHRDVKPSNILLDRNGNIKLCDFGISGQLVDS 161 (288)
T ss_pred cc-CCHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhcC--CeeccCCCHHHEEEccCCcEEEeecchhHHhccC
Confidence 85 4766654321 123467899999999999999999999632 8999999999999999999999999999765433
Q ss_pred CCcccccccccccccCccccCCC---CCCChhhHHHHHHHHHHHHhCCCCCCCCCCCchhcHHHHHHHHhcccccccccC
Q 010519 343 ESHITTRVMGTFGYVAPEYANTG---MLNEKSDIYSFGVLLLEAVTGRDPVDYGRPANEVNLVEWLKMMVGTRRAEEVVD 419 (508)
Q Consensus 343 ~~~~~~~~~gt~~y~aPE~~~~~---~~~~~~DvwS~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 419 (508)
.. .....|+..|+|||.+.+. .++.++|||||||++|+|++|+.||.... ...+.+...... ..
T Consensus 162 ~~--~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~-----~~~~~~~~~~~~------~~ 228 (288)
T cd06616 162 IA--KTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWN-----SVFDQLTQVVKG------DP 228 (288)
T ss_pred Cc--cccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhcc-----hHHHHHhhhcCC------CC
Confidence 21 2233578899999998776 68999999999999999999999996432 111111111110 01
Q ss_pred CCCCCChhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhh
Q 010519 420 PNLEVKPATRALKRSLLVALRCVDPDSEKRPKMSQVVRMLE 460 (508)
Q Consensus 420 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 460 (508)
+.+...........+.+|+.+||+.||.+|||+.+|+.+-.
T Consensus 229 ~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~i~~~~~ 269 (288)
T cd06616 229 PILSNSEEREFSPSFVNFINLCLIKDESKRPKYKELLEHPF 269 (288)
T ss_pred CcCCCcCCCccCHHHHHHHHHHccCChhhCcCHHHHhcChh
Confidence 11111111234456778999999999999999999998644
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates |
| >KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-37 Score=283.62 Aligned_cols=253 Identities=26% Similarity=0.407 Sum_probs=198.0
Q ss_pred CCcccceeEeeeCceEEEEEEEc-CCCEEEEEEEcccc-hhhHHHHHHHHHHHhcCC-CCCceeEEEEEEeCceeeEEEe
Q 010519 186 NRFSAENVLGEGGYGVVYKGRLI-NGSEVAVKKLLNNL-GQAEKEFRVEVEAIGHVR-HKNLVRLLGYCIEGVHRMLVYE 262 (508)
Q Consensus 186 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~ei~~l~~l~-h~niv~~~~~~~~~~~~~lv~E 262 (508)
++...+..||.|+.|.||++++. .|..+|||.+..+. .+..+.+...++++...+ .|+||+.+|+|..+...++.||
T Consensus 92 ndl~~l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt~Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi~n~dV~IcMe 171 (391)
T KOG0983|consen 92 NDLENLGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVQCFGYFITNTDVFICME 171 (391)
T ss_pred HHhhhHHhhcCCCccceEEEEEcccceEEEEEeecccCCHHHHHHHHHhhhHHhhccCCCeeeeeeeEEeeCchHHHHHH
Confidence 45556677999999999999875 58899999997654 344467777888776654 8999999999999999999999
Q ss_pred ecCCCCHHHHHhhhhccCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCEEEcCCCcEEEEecCCccccCCC
Q 010519 263 YVNNGNLEQWLHGAMRNQGNLTWEARMKVIIGTAKALAYLHEAIEPKVVHRDIKSSNILIDDEFNAKVSDFGLAKLLDSG 342 (508)
Q Consensus 263 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~~ 342 (508)
.|. .-+..+|. +-.+++++..+-++...++.||.||.+++ +|+|||+||+|||+|+.|++||||||++-++-+.
T Consensus 172 lMs-~C~ekLlk---rik~piPE~ilGk~tva~v~AL~YLKeKH--~viHRDvKPSNILlDe~GniKlCDFGIsGrlvdS 245 (391)
T KOG0983|consen 172 LMS-TCAEKLLK---RIKGPIPERILGKMTVAIVKALYYLKEKH--GVIHRDVKPSNILLDERGNIKLCDFGISGRLVDS 245 (391)
T ss_pred HHH-HHHHHHHH---HhcCCchHHhhhhhHHHHHHHHHHHHHhc--ceeecccCccceEEccCCCEEeecccccceeecc
Confidence 994 35566664 45667999999999999999999999877 9999999999999999999999999999876544
Q ss_pred CCcccccccccccccCccccCC---CCCCChhhHHHHHHHHHHHHhCCCCCCCCCCCchhcHHHHHHHHhcccccccccC
Q 010519 343 ESHITTRVMGTFGYVAPEYANT---GMLNEKSDIYSFGVLLLEAVTGRDPVDYGRPANEVNLVEWLKMMVGTRRAEEVVD 419 (508)
Q Consensus 343 ~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~DvwS~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 419 (508)
. ..+...|.+.|||||.+.- ..|+.++||||||+.|+||.||+.||...... .. .+....... ...++
T Consensus 246 k--AhtrsAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~td--Fe---~ltkvln~e--PP~L~ 316 (391)
T KOG0983|consen 246 K--AHTRSAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKGCKTD--FE---VLTKVLNEE--PPLLP 316 (391)
T ss_pred c--ccccccCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCCCCcc--HH---HHHHHHhcC--CCCCC
Confidence 3 3455679999999998854 46899999999999999999999999754322 11 111222111 11111
Q ss_pred CCCCCChhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHh
Q 010519 420 PNLEVKPATRALKRSLLVALRCVDPDSEKRPKMSQVVRML 459 (508)
Q Consensus 420 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L 459 (508)
+. ......+.+++..||.+|+.+||...++++|-
T Consensus 317 ~~------~gFSp~F~~fv~~CL~kd~r~RP~Y~~Ll~h~ 350 (391)
T KOG0983|consen 317 GH------MGFSPDFQSFVKDCLTKDHRKRPKYNKLLEHP 350 (391)
T ss_pred cc------cCcCHHHHHHHHHHhhcCcccCcchHHHhcCc
Confidence 11 11344566688899999999999999999864
|
|
| >cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-36 Score=293.48 Aligned_cols=250 Identities=25% Similarity=0.349 Sum_probs=204.0
Q ss_pred CcccceeEeeeCceEEEEEEEc-CCCEEEEEEEcccc--hhhHHHHHHHHHHHhcCCCCCceeEEEEEEeCceeeEEEee
Q 010519 187 RFSAENVLGEGGYGVVYKGRLI-NGSEVAVKKLLNNL--GQAEKEFRVEVEAIGHVRHKNLVRLLGYCIEGVHRMLVYEY 263 (508)
Q Consensus 187 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~ei~~l~~l~h~niv~~~~~~~~~~~~~lv~E~ 263 (508)
+|++.+.||+|+||.||+++.. ++..+++|.+.... ......+..|+.+++.++|+||+++++++.+....++||||
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~ 80 (256)
T cd08530 1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEAFLDGNKLCIVMEY 80 (256)
T ss_pred CceEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhccHHHHHHHHHHHHHHHhCCCCCchhhhhhhccCCEEEEEehh
Confidence 4788899999999999999865 67889999886432 23345677899999999999999999999999999999999
Q ss_pred cCCCCHHHHHhhhhccCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCEEEcCCCcEEEEecCCccccCCCC
Q 010519 264 VNNGNLEQWLHGAMRNQGNLTWEARMKVIIGTAKALAYLHEAIEPKVVHRDIKSSNILIDDEFNAKVSDFGLAKLLDSGE 343 (508)
Q Consensus 264 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~~~ 343 (508)
+++++|.+++.........+++..++.++.+++.||.|||+. +++|+||+|.||++++++.+||+|||++.......
T Consensus 81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh~~---~i~h~~l~~~ni~~~~~~~~kl~d~g~~~~~~~~~ 157 (256)
T cd08530 81 APFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQ---KILHRDLKSANILLVANDLVKIGDLGISKVLKKNM 157 (256)
T ss_pred cCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhC---CcccCCCCcceEEEecCCcEEEeeccchhhhccCC
Confidence 999999999975444456789999999999999999999999 99999999999999999999999999998765431
Q ss_pred CcccccccccccccCccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCCCchhcHHHHHHHHhcccccccccCCCCC
Q 010519 344 SHITTRVMGTFGYVAPEYANTGMLNEKSDIYSFGVLLLEAVTGRDPVDYGRPANEVNLVEWLKMMVGTRRAEEVVDPNLE 423 (508)
Q Consensus 344 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 423 (508)
.....+++.|++||.+.+..++.++|+||||+++|+|++|+.||...... .+.. . ...... +
T Consensus 158 ---~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~---~~~~---~-~~~~~~-----~--- 219 (256)
T cd08530 158 ---AKTQIGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEARSMQ---DLRY---K-VQRGKY-----P--- 219 (256)
T ss_pred ---cccccCCccccCHHHHCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH---HHHH---H-HhcCCC-----C---
Confidence 22345788999999999989999999999999999999999999643321 1111 1 111111 1
Q ss_pred CChhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 010519 424 VKPATRALKRSLLVALRCVDPDSEKRPKMSQVVRM 458 (508)
Q Consensus 424 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 458 (508)
.........+.+++.+||..+|.+|||+.+++++
T Consensus 220 -~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~ 253 (256)
T cd08530 220 -PIPPIYSQDLQNFIRSMLQVKPKLRPNCDKILAS 253 (256)
T ss_pred -CCchhhCHHHHHHHHHHcCCCcccCCCHHHHhcC
Confidence 1112345667889999999999999999999975
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an |
| >cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-36 Score=297.13 Aligned_cols=249 Identities=22% Similarity=0.281 Sum_probs=190.3
Q ss_pred eEeeeCceEEEEEEEc-CCCEEEEEEEcccc---hhhHHHHHHHHH---HHhcCCCCCceeEEEEEEeCceeeEEEeecC
Q 010519 193 VLGEGGYGVVYKGRLI-NGSEVAVKKLLNNL---GQAEKEFRVEVE---AIGHVRHKNLVRLLGYCIEGVHRMLVYEYVN 265 (508)
Q Consensus 193 ~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~ei~---~l~~l~h~niv~~~~~~~~~~~~~lv~E~~~ 265 (508)
.||+|+||.||++... ++..+|+|.+.... ......+..|.. ++...+||||+.+++++...+..++||||++
T Consensus 1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~ 80 (279)
T cd05633 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTPDKLCFILDLMN 80 (279)
T ss_pred CcccCCCeEEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecCCeEEEEEecCC
Confidence 4899999999999875 58899999885432 111222333433 3334579999999999999899999999999
Q ss_pred CCCHHHHHhhhhccCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCEEEcCCCcEEEEecCCccccCCCCCc
Q 010519 266 NGNLEQWLHGAMRNQGNLTWEARMKVIIGTAKALAYLHEAIEPKVVHRDIKSSNILIDDEFNAKVSDFGLAKLLDSGESH 345 (508)
Q Consensus 266 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~ 345 (508)
+|+|.+++. ..+.+++..+..++.|++.||.|||+. +++|+||||+|||+++++.++|+|||++.......
T Consensus 81 ~~~L~~~i~----~~~~l~~~~~~~i~~qi~~al~~lH~~---~ivH~dikp~Nil~~~~~~~~l~dfg~~~~~~~~~-- 151 (279)
T cd05633 81 GGDLHYHLS----QHGVFSEKEMRFYATEIILGLEHMHNR---FVVYRDLKPANILLDEHGHVRISDLGLACDFSKKK-- 151 (279)
T ss_pred CCCHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHHC---CcCCCCCCHHHEEECCCCCEEEccCCcceeccccC--
Confidence 999999884 445799999999999999999999999 99999999999999999999999999997554322
Q ss_pred ccccccccccccCccccC-CCCCCChhhHHHHHHHHHHHHhCCCCCCCCCCCchhcHHHHHHHHhcccccccccCCCCCC
Q 010519 346 ITTRVMGTFGYVAPEYAN-TGMLNEKSDIYSFGVLLLEAVTGRDPVDYGRPANEVNLVEWLKMMVGTRRAEEVVDPNLEV 424 (508)
Q Consensus 346 ~~~~~~gt~~y~aPE~~~-~~~~~~~~DvwS~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 424 (508)
.....|+..|+|||.+. +..++.++|||||||++|+|++|..||.......... +...... ...
T Consensus 152 -~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~----~~~~~~~----------~~~ 216 (279)
T cd05633 152 -PHASVGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHE----IDRMTLT----------VNV 216 (279)
T ss_pred -ccCcCCCcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCCCCcCHHH----HHHHhhc----------CCc
Confidence 22346899999999886 4568999999999999999999999996443322111 1111100 001
Q ss_pred ChhHHHHHHHHHHHHHhcCCCCCCCC-----CHHHHHHHhhcCCCC
Q 010519 425 KPATRALKRSLLVALRCVDPDSEKRP-----KMSQVVRMLEADDYP 465 (508)
Q Consensus 425 ~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~evl~~L~~~~~~ 465 (508)
..+......+.+++.+||+.||.+|| |++++++|..-....
T Consensus 217 ~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~~~~h~~~~~~~ 262 (279)
T cd05633 217 ELPDSFSPELKSLLEGLLQRDVSKRLGCLGRGAQEVKEHVFFKGID 262 (279)
T ss_pred CCccccCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHhCccccCCC
Confidence 11122345667799999999999999 699999986555443
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi |
| >cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-36 Score=293.65 Aligned_cols=245 Identities=25% Similarity=0.304 Sum_probs=197.1
Q ss_pred EeeeCceEEEEEEEc-CCCEEEEEEEcccch---hhHHHHHHHHHHHhcCCCCCceeEEEEEEeCceeeEEEeecCCCCH
Q 010519 194 LGEGGYGVVYKGRLI-NGSEVAVKKLLNNLG---QAEKEFRVEVEAIGHVRHKNLVRLLGYCIEGVHRMLVYEYVNNGNL 269 (508)
Q Consensus 194 lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~ei~~l~~l~h~niv~~~~~~~~~~~~~lv~E~~~~gsL 269 (508)
||.|++|.||++++. ++..+++|.+..... ...+.+..|+.+++.++||||+++++++.++...+++|||+++++|
T Consensus 1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (262)
T cd05572 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFKDKKYIYMLMEYCLGGEL 80 (262)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEcCCccEEEEecCCCCcH
Confidence 689999999999975 488999998864332 3346788999999999999999999999999999999999999999
Q ss_pred HHHHhhhhccCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCEEEcCCCcEEEEecCCccccCCCCCccccc
Q 010519 270 EQWLHGAMRNQGNLTWEARMKVIIGTAKALAYLHEAIEPKVVHRDIKSSNILIDDEFNAKVSDFGLAKLLDSGESHITTR 349 (508)
Q Consensus 270 ~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~ 349 (508)
.+++. ....+++..+..++.||+.||.|||+. +++|+||+|+||+++.++.++|+|||++....... ....
T Consensus 81 ~~~l~----~~~~l~~~~~~~~~~~i~~~l~~lH~~---~~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~~~--~~~~ 151 (262)
T cd05572 81 WTILR----DRGLFDEYTARFYIACVVLAFEYLHNR---GIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQ--KTWT 151 (262)
T ss_pred HHHHh----hcCCCCHHHHHHHHHHHHHHHHHHhhC---CcccCCCCHHHEEEcCCCCEEEeeCCcccccCccc--cccc
Confidence 99995 334588999999999999999999998 99999999999999999999999999998765432 2233
Q ss_pred ccccccccCccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCCCchhcHHHHHHHHhcccccccccCCCCCCChhHH
Q 010519 350 VMGTFGYVAPEYANTGMLNEKSDIYSFGVLLLEAVTGRDPVDYGRPANEVNLVEWLKMMVGTRRAEEVVDPNLEVKPATR 429 (508)
Q Consensus 350 ~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 429 (508)
..+++.|++||.+.+..++.++|+||||+++|+|++|..||...... ..+........ ......+..
T Consensus 152 ~~~~~~~~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~----~~~~~~~~~~~---------~~~~~~~~~ 218 (262)
T cd05572 152 FCGTPEYVAPEIILNKGYDFSVDYWSLGILLYELLTGRPPFGEDDED----PMEIYNDILKG---------NGKLEFPNY 218 (262)
T ss_pred ccCCcCccChhHhcCCCCCChhhhhhhHHHHHHHHhCCCCcCCCCCC----HHHHHHHHhcc---------CCCCCCCcc
Confidence 46789999999998888999999999999999999999999654321 11222221110 001111111
Q ss_pred HHHHHHHHHHHhcCCCCCCCCC-----HHHHHHHhh
Q 010519 430 ALKRSLLVALRCVDPDSEKRPK-----MSQVVRMLE 460 (508)
Q Consensus 430 ~~~~l~~li~~cl~~dP~~RPs-----~~evl~~L~ 460 (508)
....+.+++.+||+.||.+||+ +.|++++-.
T Consensus 219 ~~~~~~~~i~~~l~~~p~~R~~~~~~~~~~l~~~~~ 254 (262)
T cd05572 219 IDKAAKDLIKQLLRRNPEERLGNLKGGIKDIKKHKW 254 (262)
T ss_pred cCHHHHHHHHHHccCChhhCcCCcccCHHHHhcChh
Confidence 2456778999999999999999 888887544
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi |
| >KOG0584 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-37 Score=314.23 Aligned_cols=245 Identities=25% Similarity=0.399 Sum_probs=192.8
Q ss_pred cceeEeeeCceEEEEEEEc-CCCEEEEEE--Ecc--cchhhHHHHHHHHHHHhcCCCCCceeEEEEEEeCce--eeEEEe
Q 010519 190 AENVLGEGGYGVVYKGRLI-NGSEVAVKK--LLN--NLGQAEKEFRVEVEAIGHVRHKNLVRLLGYCIEGVH--RMLVYE 262 (508)
Q Consensus 190 ~~~~lg~G~~g~Vy~~~~~-~~~~vavK~--~~~--~~~~~~~~~~~ei~~l~~l~h~niv~~~~~~~~~~~--~~lv~E 262 (508)
+..+||+|+|-+||+|.+. .|.+||=-. +.. ......+.|..|+.+|+.|+||||+++|.++.+... ..+|.|
T Consensus 44 ~~evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~n~~in~iTE 123 (632)
T KOG0584|consen 44 FDEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTDNKTINFITE 123 (632)
T ss_pred hhhhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheecCCCceeeeeee
Confidence 3467999999999999874 577776222 211 123334789999999999999999999999987654 668999
Q ss_pred ecCCCCHHHHHhhhhccCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCEEEc-CCCcEEEEecCCccccCC
Q 010519 263 YVNNGNLEQWLHGAMRNQGNLTWEARMKVIIGTAKALAYLHEAIEPKVVHRDIKSSNILID-DEFNAKVSDFGLAKLLDS 341 (508)
Q Consensus 263 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiH~Dlk~~NIll~-~~~~~kl~Dfgla~~~~~ 341 (508)
.|..|+|..|+. ..+.++...+..|+.||++||.|||+ ..|+|||||||-+||||+ ..|.|||+|+|||.....
T Consensus 124 L~TSGtLr~Y~k----k~~~vn~kaik~W~RQILkGL~yLHs-~~PPIIHRDLKCDNIFinG~~G~VKIGDLGLAtl~r~ 198 (632)
T KOG0584|consen 124 LFTSGTLREYRK----KHRRVNIKAIKSWCRQILKGLVYLHS-QDPPIIHRDLKCDNIFVNGNLGEVKIGDLGLATLLRK 198 (632)
T ss_pred cccCCcHHHHHH----HhccCCHHHHHHHHHHHHHHhhhhhc-CCCCccccccccceEEEcCCcCceeecchhHHHHhhc
Confidence 999999999984 55678889999999999999999998 588999999999999997 468899999999997754
Q ss_pred CCCcccccccccccccCccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCCCchhcHHHHHHHHhcccccccccCCC
Q 010519 342 GESHITTRVMGTFGYVAPEYANTGMLNEKSDIYSFGVLLLEAVTGRDPVDYGRPANEVNLVEWLKMMVGTRRAEEVVDPN 421 (508)
Q Consensus 342 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 421 (508)
.. .....|||.|||||+.. +.|++.+||||||++++||+|+..||..-. +..+..+.+...... ..
T Consensus 199 s~---aksvIGTPEFMAPEmYE-E~YnE~VDVYaFGMCmLEMvT~eYPYsEC~-----n~AQIYKKV~SGiKP-----~s 264 (632)
T KOG0584|consen 199 SH---AKSVIGTPEFMAPEMYE-ENYNELVDVYAFGMCMLEMVTSEYPYSECT-----NPAQIYKKVTSGIKP-----AA 264 (632)
T ss_pred cc---cceeccCccccChHHHh-hhcchhhhhhhhhHHHHHHHhccCChhhhC-----CHHHHHHHHHcCCCH-----HH
Confidence 32 34478999999999997 689999999999999999999999996332 333333443322211 11
Q ss_pred CCCChhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 010519 422 LEVKPATRALKRSLLVALRCVDPDSEKRPKMSQVVRM 458 (508)
Q Consensus 422 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 458 (508)
+..-. ...+.++|.+||.. ..+|||+.|+|.+
T Consensus 265 l~kV~----dPevr~fIekCl~~-~~~R~sa~eLL~d 296 (632)
T KOG0584|consen 265 LSKVK----DPEVREFIEKCLAT-KSERLSAKELLKD 296 (632)
T ss_pred hhccC----CHHHHHHHHHHhcC-chhccCHHHHhhC
Confidence 11111 12345589999999 9999999999984
|
|
| >cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-36 Score=299.71 Aligned_cols=262 Identities=23% Similarity=0.299 Sum_probs=196.9
Q ss_pred CCcccceeEeeeCceEEEEEEEc-CCCEEEEEEEcccchh--hHHHHHHHHHHHhcCCCCCceeEEEEEEeC--ceeeEE
Q 010519 186 NRFSAENVLGEGGYGVVYKGRLI-NGSEVAVKKLLNNLGQ--AEKEFRVEVEAIGHVRHKNLVRLLGYCIEG--VHRMLV 260 (508)
Q Consensus 186 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~--~~~~~~~ei~~l~~l~h~niv~~~~~~~~~--~~~~lv 260 (508)
++|++.+.||.|+||.||+|.+. ++..+++|.+...... ....+.+|+.++++++||||+++++++... ...++|
T Consensus 5 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~lv 84 (293)
T cd07843 5 DEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQHPNIVTVKEVVVGSNLDKIYMV 84 (293)
T ss_pred hhhhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeeccccccchhhHHHHHHHHHhcCCCCEEEEEEEEEecCCCcEEEE
Confidence 47888999999999999999886 5788999988644322 223466799999999999999999999877 889999
Q ss_pred EeecCCCCHHHHHhhhhccCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCEEEcCCCcEEEEecCCccccC
Q 010519 261 YEYVNNGNLEQWLHGAMRNQGNLTWEARMKVIIGTAKALAYLHEAIEPKVVHRDIKSSNILIDDEFNAKVSDFGLAKLLD 340 (508)
Q Consensus 261 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~Dfgla~~~~ 340 (508)
|||++ ++|.+++.. ....+++..++.++.||+.||.|||+. +++|+||||+|||+++++.+||+|||++....
T Consensus 85 ~e~~~-~~L~~~~~~---~~~~l~~~~~~~i~~qi~~aL~~LH~~---~i~H~dl~p~nili~~~~~~~l~d~g~~~~~~ 157 (293)
T cd07843 85 MEYVE-HDLKSLMET---MKQPFLQSEVKCLMLQLLSGVAHLHDN---WILHRDLKTSNLLLNNRGILKICDFGLAREYG 157 (293)
T ss_pred ehhcC-cCHHHHHHh---ccCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCCHHHEEECCCCcEEEeecCceeecc
Confidence 99997 499998863 234689999999999999999999999 99999999999999999999999999998765
Q ss_pred CCCCcccccccccccccCccccCCC-CCCChhhHHHHHHHHHHHHhCCCCCCCCCCCchhcHHHHHHHHhcc--------
Q 010519 341 SGESHITTRVMGTFGYVAPEYANTG-MLNEKSDIYSFGVLLLEAVTGRDPVDYGRPANEVNLVEWLKMMVGT-------- 411 (508)
Q Consensus 341 ~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwS~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~-------- 411 (508)
.... ......+++.|+|||.+.+. .++.++|+||||+++|+|++|..||........ ... +....+.
T Consensus 158 ~~~~-~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~~~~~~~--~~~-~~~~~~~~~~~~~~~ 233 (293)
T cd07843 158 SPLK-PYTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQ--LNK-IFKLLGTPTEKIWPG 233 (293)
T ss_pred CCcc-ccccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCCCChHHH--HHH-HHHHhCCCchHHHHH
Confidence 4321 12334578899999988654 468999999999999999999999964332111 111 1111000
Q ss_pred ---------cccccccCCCCCCChhHH-HHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 010519 412 ---------RRAEEVVDPNLEVKPATR-ALKRSLLVALRCVDPDSEKRPKMSQVVRM 458 (508)
Q Consensus 412 ---------~~~~~~~~~~~~~~~~~~-~~~~l~~li~~cl~~dP~~RPs~~evl~~ 458 (508)
..........+....+.. ....+.+++.+||+.||++|||+.|++.+
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~ell~~ 290 (293)
T cd07843 234 FSELPGAKKKTFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISAEDALKH 290 (293)
T ss_pred hhccchhcccccccccchhhhccccccCCChHHHHHHHHHhccCccccCCHHHHhcC
Confidence 000000000000001111 24456679999999999999999999975
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the |
| >cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-36 Score=297.05 Aligned_cols=265 Identities=23% Similarity=0.303 Sum_probs=195.8
Q ss_pred CCcccceeEeeeCceEEEEEEEc-CCCEEEEEEEcccchh--hHHHHHHHHHHHhcCC-CCCceeEEEEEEeCce-----
Q 010519 186 NRFSAENVLGEGGYGVVYKGRLI-NGSEVAVKKLLNNLGQ--AEKEFRVEVEAIGHVR-HKNLVRLLGYCIEGVH----- 256 (508)
Q Consensus 186 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~--~~~~~~~ei~~l~~l~-h~niv~~~~~~~~~~~----- 256 (508)
++|++.+.||+|+||.||+|.+. ++..||+|++...... ....+..|+.+++.+. ||||+++++++.....
T Consensus 1 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~~ 80 (295)
T cd07837 1 DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKPS 80 (295)
T ss_pred CCceEeeEecccCCeEEEEEEECCCCcEEEEEeehhhccccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCce
Confidence 46889999999999999999875 6889999987543321 2356777999999995 6999999999987665
Q ss_pred eeEEEeecCCCCHHHHHhhhhcc-CCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCEEEcC-CCcEEEEecC
Q 010519 257 RMLVYEYVNNGNLEQWLHGAMRN-QGNLTWEARMKVIIGTAKALAYLHEAIEPKVVHRDIKSSNILIDD-EFNAKVSDFG 334 (508)
Q Consensus 257 ~~lv~E~~~~gsL~~~l~~~~~~-~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiH~Dlk~~NIll~~-~~~~kl~Dfg 334 (508)
.|+||||+++ +|.+++...... ...+++..++.++.||+.||.|||+. +++||||+|+||+++. ++.+||+|||
T Consensus 81 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~---~i~H~dl~~~nil~~~~~~~~kl~dfg 156 (295)
T cd07837 81 LYLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHKH---GVMHRDLKPQNLLVDKQKGLLKIADLG 156 (295)
T ss_pred EEEEeeccCc-CHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCChHHEEEecCCCeEEEeecc
Confidence 7999999975 899988643222 35689999999999999999999999 9999999999999998 8899999999
Q ss_pred CccccCCCCCcccccccccccccCccccCC-CCCCChhhHHHHHHHHHHHHhCCCCCCCCCCCchhcHHHHHHHHhcccc
Q 010519 335 LAKLLDSGESHITTRVMGTFGYVAPEYANT-GMLNEKSDIYSFGVLLLEAVTGRDPVDYGRPANEVNLVEWLKMMVGTRR 413 (508)
Q Consensus 335 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwS~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~ 413 (508)
++........ ......+++.|+|||++.+ ..++.++||||||+++|+|++|..||....... .+...... .....
T Consensus 157 ~~~~~~~~~~-~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~--~~~~~~~~-~~~~~ 232 (295)
T cd07837 157 LGRAFSIPVK-SYTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQ--QLLHIFKL-LGTPT 232 (295)
T ss_pred cceecCCCcc-ccCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHH--HHHHHHHH-hCCCC
Confidence 9986533211 1223356889999998865 457899999999999999999999986432211 11111110 00000
Q ss_pred cc------ccc----CCCCCCC----hhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 010519 414 AE------EVV----DPNLEVK----PATRALKRSLLVALRCVDPDSEKRPKMSQVVRM 458 (508)
Q Consensus 414 ~~------~~~----~~~~~~~----~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 458 (508)
.. ... -+..... ........+.+++.+||++||.+||++.|++.+
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~R~~~~eil~~ 291 (295)
T cd07837 233 EQVWPGVSKLRDWHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISAKAALTH 291 (295)
T ss_pred hhhCcchhhccchhhcCcccchhHHHhccccCHHHHHHHHHHccCChhhcCCHHHHhcC
Confidence 00 000 0000000 001234557789999999999999999999875
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm |
| >cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-36 Score=296.39 Aligned_cols=258 Identities=24% Similarity=0.308 Sum_probs=193.7
Q ss_pred cccceeEeeeCceEEEEEEEc-CCCEEEEEEEcccch-hhHHHHHHHHHHHhcCC-CCCceeEEEEEEeC--ceeeEEEe
Q 010519 188 FSAENVLGEGGYGVVYKGRLI-NGSEVAVKKLLNNLG-QAEKEFRVEVEAIGHVR-HKNLVRLLGYCIEG--VHRMLVYE 262 (508)
Q Consensus 188 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~ei~~l~~l~-h~niv~~~~~~~~~--~~~~lv~E 262 (508)
|.+.+.||+|+||.||+|... ++..+|+|++..... ........|+..+.++. |+|++++++++.+. +..++|||
T Consensus 1 y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv~e 80 (282)
T cd07831 1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNLREIQALRRLSPHPNILRLIEVLFDRKTGRLALVFE 80 (282)
T ss_pred CceEeeccccccceEEEEEEcCCCcEEEEEEehhccCCchhhhHHHHHHHHhhcCCCCCccceEEEEecCCCCcEEEEEe
Confidence 567889999999999999865 688999998865422 22233446888888885 99999999999987 88899999
Q ss_pred ecCCCCHHHHHhhhhccCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCEEEcCCCcEEEEecCCccccCCC
Q 010519 263 YVNNGNLEQWLHGAMRNQGNLTWEARMKVIIGTAKALAYLHEAIEPKVVHRDIKSSNILIDDEFNAKVSDFGLAKLLDSG 342 (508)
Q Consensus 263 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~~ 342 (508)
|+. |+|.+++.. ....+++..++.++.|++.||.|||+. +++|+||+|+||+++. +.+||+|||++......
T Consensus 81 ~~~-~~l~~~l~~---~~~~~~~~~~~~~~~qi~~~L~~LH~~---~i~H~dl~p~ni~l~~-~~~kl~dfg~~~~~~~~ 152 (282)
T cd07831 81 LMD-MNLYELIKG---RKRPLPEKRVKSYMYQLLKSLDHMHRN---GIFHRDIKPENILIKD-DILKLADFGSCRGIYSK 152 (282)
T ss_pred cCC-ccHHHHHHh---ccCCCCHHHHHHHHHHHHHHHHHHHHC---CceecccCHHHEEEcC-CCeEEEecccccccccC
Confidence 996 588888753 335789999999999999999999999 9999999999999999 99999999999866433
Q ss_pred CCcccccccccccccCccccC-CCCCCChhhHHHHHHHHHHHHhCCCCCCCCCCCchhcHHHHHHHHhccccc-------
Q 010519 343 ESHITTRVMGTFGYVAPEYAN-TGMLNEKSDIYSFGVLLLEAVTGRDPVDYGRPANEVNLVEWLKMMVGTRRA------- 414 (508)
Q Consensus 343 ~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~DvwS~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~------- 414 (508)
.. .....++..|+|||.+. +..++.++|||||||++|||++|..||...... ....+.....+....
T Consensus 153 ~~--~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~ 227 (282)
T cd07831 153 PP--YTEYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNEL---DQIAKIHDVLGTPDAEVLKKFR 227 (282)
T ss_pred CC--cCCCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCCCCHH---HHHHHHHHHcCCCCHHHHHhhc
Confidence 22 22345788999999764 456789999999999999999999999644321 111222111111000
Q ss_pred -ccccCCCCCC-------ChhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 010519 415 -EEVVDPNLEV-------KPATRALKRSLLVALRCVDPDSEKRPKMSQVVRM 458 (508)
Q Consensus 415 -~~~~~~~~~~-------~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 458 (508)
....+..... .........+.+++.+||++||.+|||+.+++++
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~~ 279 (282)
T cd07831 228 KSRHMNYNFPSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALRH 279 (282)
T ss_pred ccccccccCcccccccHHHHcccccHHHHHHHHHHhccCcccccCHHHHhhC
Confidence 0000000000 0011235678889999999999999999999975
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. |
| >cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-36 Score=300.75 Aligned_cols=251 Identities=24% Similarity=0.359 Sum_probs=198.2
Q ss_pred CCcccceeEeeeCceEEEEEEEc-CCCEEEEEEEcccc---hhhHHHHHHHHHHHhcCCCCCceeEEEEEEeCceeeEEE
Q 010519 186 NRFSAENVLGEGGYGVVYKGRLI-NGSEVAVKKLLNNL---GQAEKEFRVEVEAIGHVRHKNLVRLLGYCIEGVHRMLVY 261 (508)
Q Consensus 186 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~ei~~l~~l~h~niv~~~~~~~~~~~~~lv~ 261 (508)
+.|...+.||+|+||.||++++. ++..+|+|++.... ......+..|+.+++.++|||++++++++.++...++||
T Consensus 25 ~~f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 104 (317)
T cd06635 25 KLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAWLVM 104 (317)
T ss_pred hhhhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCeEEEEE
Confidence 34778889999999999999865 68899999885432 233356888999999999999999999999999999999
Q ss_pred eecCCCCHHHHHhhhhccCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCEEEcCCCcEEEEecCCccccCC
Q 010519 262 EYVNNGNLEQWLHGAMRNQGNLTWEARMKVIIGTAKALAYLHEAIEPKVVHRDIKSSNILIDDEFNAKVSDFGLAKLLDS 341 (508)
Q Consensus 262 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~ 341 (508)
||+. |+|.+++. .....+++..+..++.+++.||.|||+. +++|+||+|+||+++.++.+||+|||++.....
T Consensus 105 e~~~-g~l~~~~~---~~~~~l~~~~~~~i~~~i~~~l~~lH~~---~i~H~dL~p~Nil~~~~~~~kl~dfg~~~~~~~ 177 (317)
T cd06635 105 EYCL-GSASDLLE---VHKKPLQEVEIAAITHGALQGLAYLHSH---NMIHRDIKAGNILLTEPGQVKLADFGSASIASP 177 (317)
T ss_pred eCCC-CCHHHHHH---HhcCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCcccEEECCCCCEEEecCCCccccCC
Confidence 9996 58888775 2345689999999999999999999999 999999999999999999999999999875443
Q ss_pred CCCcccccccccccccCccccC---CCCCCChhhHHHHHHHHHHHHhCCCCCCCCCCCchhcHHHHHHHHhccccccccc
Q 010519 342 GESHITTRVMGTFGYVAPEYAN---TGMLNEKSDIYSFGVLLLEAVTGRDPVDYGRPANEVNLVEWLKMMVGTRRAEEVV 418 (508)
Q Consensus 342 ~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DvwS~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 418 (508)
. ....+++.|+|||++. ++.++.++|||||||++|||++|..||...... ...........
T Consensus 178 ~-----~~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~------~~~~~~~~~~~----- 241 (317)
T cd06635 178 A-----NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAM------SALYHIAQNES----- 241 (317)
T ss_pred c-----ccccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCccHH------HHHHHHHhccC-----
Confidence 2 2345788999999873 456889999999999999999999998643211 11111111100
Q ss_pred CCCCCCChhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhhcCC
Q 010519 419 DPNLEVKPATRALKRSLLVALRCVDPDSEKRPKMSQVVRMLEADD 463 (508)
Q Consensus 419 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~ 463 (508)
+. .........+.+++.+||+.+|.+||++.++++++....
T Consensus 242 -~~---~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~~~~ 282 (317)
T cd06635 242 -PT---LQSNEWSDYFRNFVDSCLQKIPQDRPTSEELLKHMFVLR 282 (317)
T ss_pred -CC---CCCccccHHHHHHHHHHccCCcccCcCHHHHHhChhhhc
Confidence 11 111123345677999999999999999999999876543
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron |
| >cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-36 Score=287.77 Aligned_cols=251 Identities=27% Similarity=0.371 Sum_probs=203.4
Q ss_pred CcccceeEeeeCceEEEEEEEc-CCCEEEEEEEcccch--hhHHHHHHHHHHHhcCCCCCceeEEEEEEeC--ceeeEEE
Q 010519 187 RFSAENVLGEGGYGVVYKGRLI-NGSEVAVKKLLNNLG--QAEKEFRVEVEAIGHVRHKNLVRLLGYCIEG--VHRMLVY 261 (508)
Q Consensus 187 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~ei~~l~~l~h~niv~~~~~~~~~--~~~~lv~ 261 (508)
+|...+.||+|++|.||+|... ++..+++|.+..... .....+..|+..+++++||||+++++++... ...++++
T Consensus 1 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~ 80 (260)
T cd06606 1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYGSERDEEKNTLNIFL 80 (260)
T ss_pred CceeeeEeeecCceEEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCCCCeEEEEE
Confidence 4777899999999999999886 688999998865442 4456788999999999999999999999988 8899999
Q ss_pred eecCCCCHHHHHhhhhccCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCEEEcCCCcEEEEecCCccccCC
Q 010519 262 EYVNNGNLEQWLHGAMRNQGNLTWEARMKVIIGTAKALAYLHEAIEPKVVHRDIKSSNILIDDEFNAKVSDFGLAKLLDS 341 (508)
Q Consensus 262 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~ 341 (508)
||+++++|.+++.. ...+++..++.++.+++.||.|||+. +++|+||+|+||+++.++.++|+|||.+.....
T Consensus 81 e~~~~~~L~~~~~~----~~~~~~~~~~~~~~~l~~~l~~lh~~---~~~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~ 153 (260)
T cd06606 81 EYVSGGSLSSLLKK----FGKLPEPVIRKYTRQILEGLAYLHSN---GIVHRDIKGANILVDSDGVVKLADFGCAKRLGD 153 (260)
T ss_pred EecCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEEcCCCCEEEcccccEEeccc
Confidence 99999999999853 33889999999999999999999998 999999999999999999999999999987654
Q ss_pred CCCc-ccccccccccccCccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCCCchhcHHHHHHHHhcccccccccCC
Q 010519 342 GESH-ITTRVMGTFGYVAPEYANTGMLNEKSDIYSFGVLLLEAVTGRDPVDYGRPANEVNLVEWLKMMVGTRRAEEVVDP 420 (508)
Q Consensus 342 ~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 420 (508)
.... ......++..|+|||.+.+..++.++||||||+++|+|++|..||..... .......... .
T Consensus 154 ~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~-----~~~~~~~~~~---------~ 219 (260)
T cd06606 154 IETGEGTGSVRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPPWSELGN-----PMAALYKIGS---------S 219 (260)
T ss_pred ccccccccCCCCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCc-----hHHHHHhccc---------c
Confidence 4321 12335678899999999888899999999999999999999999965431 1111111110 0
Q ss_pred CCCCChhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 010519 421 NLEVKPATRALKRSLLVALRCVDPDSEKRPKMSQVVRM 458 (508)
Q Consensus 421 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 458 (508)
......+......+.+++.+||+.||.+||++.+++.+
T Consensus 220 ~~~~~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~ll~~ 257 (260)
T cd06606 220 GEPPEIPEHLSEEAKDFLRKCLRRDPKKRPTADELLQH 257 (260)
T ss_pred CCCcCCCcccCHHHHHHHHHhCcCChhhCCCHHHHhhC
Confidence 01111112225567779999999999999999999975
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK |
| >cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-36 Score=297.94 Aligned_cols=261 Identities=26% Similarity=0.327 Sum_probs=198.3
Q ss_pred cccceeEeeeCceEEEEEEEc-CCCEEEEEEEcccc--hhhHHHHHHHHHHHhcCCCCCceeEEEEEEeC--ceeeEEEe
Q 010519 188 FSAENVLGEGGYGVVYKGRLI-NGSEVAVKKLLNNL--GQAEKEFRVEVEAIGHVRHKNLVRLLGYCIEG--VHRMLVYE 262 (508)
Q Consensus 188 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~ei~~l~~l~h~niv~~~~~~~~~--~~~~lv~E 262 (508)
|++.+.||.|+||.||+|+.. ++..+|+|++.... ......+..|+.+++.++|+|++++++++.+. ...++|||
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e 80 (287)
T cd07840 1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGSIYMVFE 80 (287)
T ss_pred CeeeEEeccCCCeEEEEEEECCCCeEEEEEEEecccccccchHHHHHHHHHHHhccCCCeeeheeeEecCCCCcEEEEec
Confidence 567889999999999999876 57899999987653 23345677899999999999999999999988 78999999
Q ss_pred ecCCCCHHHHHhhhhccCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCEEEcCCCcEEEEecCCccccCCC
Q 010519 263 YVNNGNLEQWLHGAMRNQGNLTWEARMKVIIGTAKALAYLHEAIEPKVVHRDIKSSNILIDDEFNAKVSDFGLAKLLDSG 342 (508)
Q Consensus 263 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~~ 342 (508)
|+++ +|.+++.. ....+++..++.++.||+.||.|||+. +++|+||+|+||++++++.+||+|||++......
T Consensus 81 ~~~~-~l~~~~~~---~~~~~~~~~~~~i~~~i~~al~~LH~~---~~~h~dl~p~nil~~~~~~~~l~d~g~~~~~~~~ 153 (287)
T cd07840 81 YMDH-DLTGLLDS---PEVKFTESQIKCYMKQLLEGLQYLHSN---GILHRDIKGSNILINNDGVLKLADFGLARPYTKR 153 (287)
T ss_pred cccc-cHHHHHhc---cCCCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCcHHHeEEcCCCCEEEccccceeeccCC
Confidence 9975 89888852 235789999999999999999999998 9999999999999999999999999999876544
Q ss_pred CCcccccccccccccCccccCC-CCCCChhhHHHHHHHHHHHHhCCCCCCCCCCCchhcHHHHHHHHhccccccc-----
Q 010519 343 ESHITTRVMGTFGYVAPEYANT-GMLNEKSDIYSFGVLLLEAVTGRDPVDYGRPANEVNLVEWLKMMVGTRRAEE----- 416 (508)
Q Consensus 343 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwS~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~----- 416 (508)
.........++..|+|||.+.+ ..++.++||||||+++|||++|+.||....... ....+...........
T Consensus 154 ~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~ 230 (287)
T cd07840 154 NSADYTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTELE---QLEKIFELCGSPTDENWPGVS 230 (287)
T ss_pred CcccccccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCCCChHH---HHHHHHHHhCCCchhhccccc
Confidence 3222333456889999997765 467899999999999999999999996443211 1111111111100000
Q ss_pred ------ccCCCCCCC-----hhHH-HHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 010519 417 ------VVDPNLEVK-----PATR-ALKRSLLVALRCVDPDSEKRPKMSQVVRM 458 (508)
Q Consensus 417 ------~~~~~~~~~-----~~~~-~~~~l~~li~~cl~~dP~~RPs~~evl~~ 458 (508)
...+..... .... ....+.+++.+||+.||.+||++.+++++
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~ 284 (287)
T cd07840 231 KLPWFENLKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQH 284 (287)
T ss_pred cchhhhhccccccchhHHHHHhcccCCHHHHHHHHHHcCCChhhCcCHHHHhhC
Confidence 000000000 0001 14567889999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po |
| >cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-36 Score=297.95 Aligned_cols=262 Identities=25% Similarity=0.337 Sum_probs=196.3
Q ss_pred cccceeEeeeCceEEEEEEEc-CCCEEEEEEEcccc--hhhHHHHHHHHHHHhcCCCCCceeEEEEEEeCceeeEEEeec
Q 010519 188 FSAENVLGEGGYGVVYKGRLI-NGSEVAVKKLLNNL--GQAEKEFRVEVEAIGHVRHKNLVRLLGYCIEGVHRMLVYEYV 264 (508)
Q Consensus 188 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~ei~~l~~l~h~niv~~~~~~~~~~~~~lv~E~~ 264 (508)
|++.+.||.|++|.||+|.+. +|..|++|++.... ......+..|++.++.++|||++++++++.+....+++|||+
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~~~~~~iv~e~~ 80 (283)
T cd07835 1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDVVHSENKLYLVFEFL 80 (283)
T ss_pred CchheEecCCCCeEEEEEEEcCCCCEEEEEEeecccccccchhHHHHHHHHHHhcCCCCccCHhheeccCCeEEEEEecc
Confidence 567789999999999999875 78999999886443 222356778999999999999999999999999999999999
Q ss_pred CCCCHHHHHhhhhccCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCEEEcCCCcEEEEecCCccccCCCCC
Q 010519 265 NNGNLEQWLHGAMRNQGNLTWEARMKVIIGTAKALAYLHEAIEPKVVHRDIKSSNILIDDEFNAKVSDFGLAKLLDSGES 344 (508)
Q Consensus 265 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~ 344 (508)
+ ++|.+++... ....+++..++.++.|++.||.|||+. +++|+||+|+||+++.++.++|+|||++........
T Consensus 81 ~-~~l~~~~~~~--~~~~~~~~~~~~~~~~i~~~L~~lH~~---~~~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~ 154 (283)
T cd07835 81 D-LDLKKYMDSS--PLTGLDPPLIKSYLYQLLQGIAYCHSH---RVLHRDLKPQNLLIDREGALKLADFGLARAFGVPVR 154 (283)
T ss_pred C-cCHHHHHhhC--CCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeCCCCCHHHEEEcCCCcEEEeecccccccCCCcc
Confidence 5 6999998532 224689999999999999999999998 999999999999999999999999999976543221
Q ss_pred cccccccccccccCccccCCC-CCCChhhHHHHHHHHHHHHhCCCCCCCCCCCchhcHHHHHHHHhccc--------ccc
Q 010519 345 HITTRVMGTFGYVAPEYANTG-MLNEKSDIYSFGVLLLEAVTGRDPVDYGRPANEVNLVEWLKMMVGTR--------RAE 415 (508)
Q Consensus 345 ~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwS~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~--------~~~ 415 (508)
......+++.|+|||++.+. .++.++||||||+++|+|++|+.||....... .+.+......... ...
T Consensus 155 -~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~ 231 (283)
T cd07835 155 -TYTHEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEID--QLFRIFRTLGTPDEDVWPGVTSLP 231 (283)
T ss_pred -ccCccccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH--HHHHHHHHhCCCChHHhhhhhhch
Confidence 12223568899999987654 57899999999999999999999996443211 1111111100000 000
Q ss_pred cccC--CCCCC----ChhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 010519 416 EVVD--PNLEV----KPATRALKRSLLVALRCVDPDSEKRPKMSQVVRM 458 (508)
Q Consensus 416 ~~~~--~~~~~----~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 458 (508)
.... +.... .........+.+++.+||++||.+|||+.|++.+
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~ 280 (283)
T cd07835 232 DYKPTFPKWARQDLSKVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQH 280 (283)
T ss_pred hhhhhcccccccchhhhcCCCCHHHHHHHHHHhcCChhhCcCHHHHhcC
Confidence 0000 00000 0011123567789999999999999999999865
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc |
| >cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-36 Score=289.39 Aligned_cols=248 Identities=29% Similarity=0.469 Sum_probs=202.0
Q ss_pred CcccceeEeeeCceEEEEEEEc-CCCEEEEEEEcccch--hhHHHHHHHHHHHhcCCCCCceeEEEEEEeCceeeEEEee
Q 010519 187 RFSAENVLGEGGYGVVYKGRLI-NGSEVAVKKLLNNLG--QAEKEFRVEVEAIGHVRHKNLVRLLGYCIEGVHRMLVYEY 263 (508)
Q Consensus 187 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~ei~~l~~l~h~niv~~~~~~~~~~~~~lv~E~ 263 (508)
+|++.+.||+|++|.||+++.. ++..+++|.+..... .....+..|++++.+++|+|++++++++.+....+++|||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~ 80 (254)
T cd06627 1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIGSIETSDSLYIILEY 80 (254)
T ss_pred CceeeeEEcccCCeEEEEEEEcCCCcEEEEEEecccccCHHHHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEEEec
Confidence 4788899999999999999875 678899999866543 3456788999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhhhhccCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCEEEcCCCcEEEEecCCccccCCCC
Q 010519 264 VNNGNLEQWLHGAMRNQGNLTWEARMKVIIGTAKALAYLHEAIEPKVVHRDIKSSNILIDDEFNAKVSDFGLAKLLDSGE 343 (508)
Q Consensus 264 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~~~ 343 (508)
+++++|.+++. ....+++..+..++.|++.||.|||+. +++|+||+|+||+++.++.++|+|||++.......
T Consensus 81 ~~~~~L~~~~~----~~~~l~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~ 153 (254)
T cd06627 81 AENGSLRQIIK----KFGPFPESLVAVYVYQVLQGLAYLHEQ---GVIHRDIKAANILTTKDGVVKLADFGVATKLNDVS 153 (254)
T ss_pred CCCCcHHHHHH----hccCCCHHHHHHHHHHHHHHHHHHhhC---CcccCCCCHHHEEECCCCCEEEeccccceecCCCc
Confidence 99999999985 336789999999999999999999998 99999999999999999999999999998765433
Q ss_pred CcccccccccccccCccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCCCchhcHHHHHHHHhcccccccccCCCCC
Q 010519 344 SHITTRVMGTFGYVAPEYANTGMLNEKSDIYSFGVLLLEAVTGRDPVDYGRPANEVNLVEWLKMMVGTRRAEEVVDPNLE 423 (508)
Q Consensus 344 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 423 (508)
.. .....++..|+|||...+..++.++|||+||+++|+|++|..||..... ...... .... .. +.+
T Consensus 154 ~~-~~~~~~~~~y~~pe~~~~~~~~~~~Dv~~lG~~l~~l~~g~~p~~~~~~-----~~~~~~-~~~~-~~-----~~~- 219 (254)
T cd06627 154 KD-DASVVGTPYWMAPEVIEMSGASTASDIWSLGCTVIELLTGNPPYYDLNP-----MAALFR-IVQD-DH-----PPL- 219 (254)
T ss_pred cc-ccccccchhhcCHhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCccH-----HHHHHH-Hhcc-CC-----CCC-
Confidence 21 2334678899999999888889999999999999999999999864321 111111 1100 00 111
Q ss_pred CChhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 010519 424 VKPATRALKRSLLVALRCVDPDSEKRPKMSQVVRM 458 (508)
Q Consensus 424 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 458 (508)
+......+.+++.+||..+|++|||+.+++.+
T Consensus 220 ---~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~~ 251 (254)
T cd06627 220 ---PEGISPELKDFLMQCFQKDPNLRPTAKQLLKH 251 (254)
T ss_pred ---CCCCCHHHHHHHHHHHhCChhhCcCHHHHhcC
Confidence 11123456679999999999999999999864
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast |
| >cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-36 Score=303.96 Aligned_cols=264 Identities=25% Similarity=0.280 Sum_probs=198.8
Q ss_pred hhCCcccceeEeeeCceEEEEEEEc-CCCEEEEEEEcccc--hhhHHHHHHHHHHHhcCCCCCceeEEEEEEeC------
Q 010519 184 ATNRFSAENVLGEGGYGVVYKGRLI-NGSEVAVKKLLNNL--GQAEKEFRVEVEAIGHVRHKNLVRLLGYCIEG------ 254 (508)
Q Consensus 184 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~ei~~l~~l~h~niv~~~~~~~~~------ 254 (508)
..++|+..+.||+|+||.||+|... ++..||+|.+.... ......+..|+.+++.++||||+++++++...
T Consensus 14 ~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 93 (353)
T cd07850 14 VLKRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEEF 93 (353)
T ss_pred hhcceEEEEEeccCCCEEEEEEEECCCCCEEEEEecCccccChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCcccc
Confidence 4578999999999999999999875 68899999885432 23345677799999999999999999988643
Q ss_pred ceeeEEEeecCCCCHHHHHhhhhccCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCEEEcCCCcEEEEecC
Q 010519 255 VHRMLVYEYVNNGNLEQWLHGAMRNQGNLTWEARMKVIIGTAKALAYLHEAIEPKVVHRDIKSSNILIDDEFNAKVSDFG 334 (508)
Q Consensus 255 ~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~Dfg 334 (508)
...|+||||+. ++|.+++.. .+++..+..++.|++.||.|||+. +++||||||+||+++.++.+||+|||
T Consensus 94 ~~~~lv~e~~~-~~l~~~~~~------~l~~~~~~~~~~ql~~aL~~LH~~---gi~H~dlkp~Nil~~~~~~~kL~Dfg 163 (353)
T cd07850 94 QDVYLVMELMD-ANLCQVIQM------DLDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFG 163 (353)
T ss_pred CcEEEEEeccC-CCHHHHHhh------cCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEECCCCCEEEccCc
Confidence 35689999995 588887742 278889999999999999999998 99999999999999999999999999
Q ss_pred CccccCCCCCcccccccccccccCccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCCCchhcHHHHHH--------
Q 010519 335 LAKLLDSGESHITTRVMGTFGYVAPEYANTGMLNEKSDIYSFGVLLLEAVTGRDPVDYGRPANEVNLVEWLK-------- 406 (508)
Q Consensus 335 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~-------- 406 (508)
++........ .....+++.|+|||.+.+..++.++|||||||++|+|++|+.||........ ......
T Consensus 164 ~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~--~~~~~~~~~~~~~~ 239 (353)
T cd07850 164 LARTAGTSFM--MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGTVLFPGTDHIDQ--WNKIIEQLGTPSDE 239 (353)
T ss_pred cceeCCCCCC--CCCCcccccccCHHHHhCCCCCCchhhHhHHHHHHHHHHCCCCCCCCCHHHH--HHHHHHhcCCCCHH
Confidence 9987654321 2334678899999999999999999999999999999999999964432110 000000
Q ss_pred ----------HHhcccc------cccccC----CCCCCChhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhhc
Q 010519 407 ----------MMVGTRR------AEEVVD----PNLEVKPATRALKRSLLVALRCVDPDSEKRPKMSQVVRMLEA 461 (508)
Q Consensus 407 ----------~~~~~~~------~~~~~~----~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~ 461 (508)
....... ...... +.............+.+++.+||+.||.+|||+.|+|.+-.-
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eiL~~~~~ 314 (353)
T cd07850 240 FMSRLQPTVRNYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPEKRISVDDALQHPYI 314 (353)
T ss_pred HHHHhhhhhhHHhhcCCCCCCcchhhhCcccccCcccccccccchhHHHHHHHHHcCCChhhCcCHHHHhcChhH
Confidence 0000000 000000 000000011234456789999999999999999999987543
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK |
| >KOG0586 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-37 Score=309.72 Aligned_cols=253 Identities=25% Similarity=0.382 Sum_probs=208.7
Q ss_pred hCCcccceeEeeeCceEEEEEEEc-CCCEEEEEEEcccc--hhhHHHHHHHHHHHhcCCCCCceeEEEEEEeCceeeEEE
Q 010519 185 TNRFSAENVLGEGGYGVVYKGRLI-NGSEVAVKKLLNNL--GQAEKEFRVEVEAIGHVRHKNLVRLLGYCIEGVHRMLVY 261 (508)
Q Consensus 185 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~ei~~l~~l~h~niv~~~~~~~~~~~~~lv~ 261 (508)
...|.+.+.||+|.|+.|.++++. .+..||||.+.+.. ......+.+|+++|+.++|||||+++.+......+|+||
T Consensus 55 vg~y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln~~~~~k~~rev~imk~l~HPnIvkl~~v~~t~~~lylV~ 134 (596)
T KOG0586|consen 55 VGLYVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLNPSKRQKLGREVDIMKSLNHPNIVKLFSVIETEATLYLVM 134 (596)
T ss_pred ccceeeeeeeccceeEEEEeeEecCCCceEEEEEehhcccChHHHHHHHHHHHHHHhcCCcceeeeeeeeeecceeEEEE
Confidence 357899999999999999999875 78999999886543 223345788999999999999999999999999999999
Q ss_pred eecCCCCHHHHHhhhhccCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCEEEcCCCcEEEEecCCccccCC
Q 010519 262 EYVNNGNLEQWLHGAMRNQGNLTWEARMKVIIGTAKALAYLHEAIEPKVVHRDIKSSNILIDDEFNAKVSDFGLAKLLDS 341 (508)
Q Consensus 262 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~ 341 (508)
||+.+|.++++|. +.++..+..+..++.|+..|++|||++ .|+|||||.+||||+.+.++||+|||++..+..
T Consensus 135 eya~~ge~~~yl~----~~gr~~e~~ar~~F~q~vsaveYcH~k---~ivHrdLk~eNilL~~~mnikIaDfgfS~~~~~ 207 (596)
T KOG0586|consen 135 EYASGGELFDYLV----KHGRMKEKEARAKFRQIVSAVEYCHSK---NIVHRDLKAENILLDENMNIKIADFGFSTFFDY 207 (596)
T ss_pred EeccCchhHHHHH----hcccchhhhhhhhhHHHHHHHHHHhhc---ceeccccchhhcccccccceeeeccccceeecc
Confidence 9999999999994 566777788999999999999999999 999999999999999999999999999998874
Q ss_pred CCCcccccccccccccCccccCCCCCC-ChhhHHHHHHHHHHHHhCCCCCCCCCCCchhcHHHHHHHHhcccccccccCC
Q 010519 342 GESHITTRVMGTFGYVAPEYANTGMLN-EKSDIYSFGVLLLEAVTGRDPVDYGRPANEVNLVEWLKMMVGTRRAEEVVDP 420 (508)
Q Consensus 342 ~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DvwS~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 420 (508)
.. ....++|++.|.|||++.+..|+ +.+|+||+|++||-|+.|.+||+...-..-. ...+..
T Consensus 208 ~~--~lqt~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG~~lk~Lr---------------~rvl~g 270 (596)
T KOG0586|consen 208 GL--MLQTFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDGQNLKELR---------------PRVLRG 270 (596)
T ss_pred cc--cccccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccCCccccccc---------------chheee
Confidence 43 45678999999999999997765 7999999999999999999999754321110 111112
Q ss_pred CCCCChhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhhcCC
Q 010519 421 NLEVKPATRALKRSLLVALRCVDPDSEKRPKMSQVVRMLEADD 463 (508)
Q Consensus 421 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~ 463 (508)
.+..+.. ...++-++++++|-++|.+|++++++-++-+...
T Consensus 271 k~rIp~~--ms~dce~lLrk~lvl~Pskr~~~dqim~~~W~n~ 311 (596)
T KOG0586|consen 271 KYRIPFY--MSCDCEDLLRKFLVLNPSKRGPCDQIMKDRWRND 311 (596)
T ss_pred eecccce--eechhHHHHHHhhccCccccCCHHHhhhhcccch
Confidence 2222221 2233445888999999999999999998776654
|
|
| >cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-36 Score=300.50 Aligned_cols=267 Identities=25% Similarity=0.343 Sum_probs=199.7
Q ss_pred HHhhCCcccceeEeeeCceEEEEEEEc-CCCEEEEEEEcccc--hhhHHHHHHHHHHHhcCCCCCceeEEEEEEeCc---
Q 010519 182 EIATNRFSAENVLGEGGYGVVYKGRLI-NGSEVAVKKLLNNL--GQAEKEFRVEVEAIGHVRHKNLVRLLGYCIEGV--- 255 (508)
Q Consensus 182 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~ei~~l~~l~h~niv~~~~~~~~~~--- 255 (508)
+...++|++.+.||+|+||.||+|.+. +|+.||+|.+.... ......+..|+.+++.++||||+++++++.+..
T Consensus 3 ~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~ 82 (302)
T cd07864 3 KRCVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLKEIVTDKQDAL 82 (302)
T ss_pred hhhhhhhheeeeecccCCEEEEEEEECCCCcEEEEEEEeecccccCchHHHHHHHHHHHhCCCCCeeeeeheecCcchhh
Confidence 345678999999999999999999985 58899999885432 222345677999999999999999999987654
Q ss_pred -------eeeEEEeecCCCCHHHHHhhhhccCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCEEEcCCCcE
Q 010519 256 -------HRMLVYEYVNNGNLEQWLHGAMRNQGNLTWEARMKVIIGTAKALAYLHEAIEPKVVHRDIKSSNILIDDEFNA 328 (508)
Q Consensus 256 -------~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiH~Dlk~~NIll~~~~~~ 328 (508)
..++|+||+++ +|.+++.. ....+++..++.++.||+.||+|||+. +|+|+||+|+||++++++.+
T Consensus 83 ~~~~~~~~~~lv~e~~~~-~l~~~l~~---~~~~~~~~~~~~i~~qi~~aL~~LH~~---~i~H~dl~p~nili~~~~~~ 155 (302)
T cd07864 83 DFKKDKGAFYLVFEYMDH-DLMGLLES---GLVHFSEDHIKSFMKQLLEGLNYCHKK---NFLHRDIKCSNILLNNKGQI 155 (302)
T ss_pred hccccCCcEEEEEcccCc-cHHHHHhc---CCCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCcE
Confidence 78899999976 77777742 345689999999999999999999999 99999999999999999999
Q ss_pred EEEecCCccccCCCCCcccccccccccccCccccCC-CCCCChhhHHHHHHHHHHHHhCCCCCCCCCCCchhcHHHHHHH
Q 010519 329 KVSDFGLAKLLDSGESHITTRVMGTFGYVAPEYANT-GMLNEKSDIYSFGVLLLEAVTGRDPVDYGRPANEVNLVEWLKM 407 (508)
Q Consensus 329 kl~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwS~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~ 407 (508)
||+|||++...............++..|+|||.+.+ ..++.++|||||||++|+|++|+.||..... ......+..
T Consensus 156 kl~dfg~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~~~~~---~~~~~~~~~ 232 (302)
T cd07864 156 KLADFGLARLYNSEESRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQE---LAQLELISR 232 (302)
T ss_pred EeCcccccccccCCcccccccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCh---HHHHHHHHH
Confidence 999999998665433222233356788999998865 4578999999999999999999999964332 111111222
Q ss_pred Hhcccccc---cc--------cCCCCCC-----ChhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 010519 408 MVGTRRAE---EV--------VDPNLEV-----KPATRALKRSLLVALRCVDPDSEKRPKMSQVVRM 458 (508)
Q Consensus 408 ~~~~~~~~---~~--------~~~~~~~-----~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 458 (508)
..+..... .+ .+..... .........+.+++.+||+.||.+|||+.+++.+
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~ 299 (302)
T cd07864 233 LCGSPCPAVWPDVIKLPYFNTMKPKKQYRRRLREEFSFIPTPALDLLDHMLTLDPSKRCTAEEALNS 299 (302)
T ss_pred HhCCCChhhcccccccccccccccccccccchhhhcCCCCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 21111000 00 0000000 0001124567789999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely |
| >cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-36 Score=292.23 Aligned_cols=251 Identities=22% Similarity=0.312 Sum_probs=197.1
Q ss_pred CCcccceeEeeeCceEEEEEEEc-CCCEEEEEEEccc-----chhhHHHHHHHHHHHhcCCCCCceeEEEEEEeC--cee
Q 010519 186 NRFSAENVLGEGGYGVVYKGRLI-NGSEVAVKKLLNN-----LGQAEKEFRVEVEAIGHVRHKNLVRLLGYCIEG--VHR 257 (508)
Q Consensus 186 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~-----~~~~~~~~~~ei~~l~~l~h~niv~~~~~~~~~--~~~ 257 (508)
.+|.+.+.||+|+||.||+|.+. ++..+++|.+... .......+.+|+.++++++|+||+++++++.+. ...
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (264)
T cd06653 2 VNWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPEEKKL 81 (264)
T ss_pred CceeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCCCCEE
Confidence 47899999999999999999864 6889999987432 123345788899999999999999999998764 457
Q ss_pred eEEEeecCCCCHHHHHhhhhccCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCEEEcCCCcEEEEecCCcc
Q 010519 258 MLVYEYVNNGNLEQWLHGAMRNQGNLTWEARMKVIIGTAKALAYLHEAIEPKVVHRDIKSSNILIDDEFNAKVSDFGLAK 337 (508)
Q Consensus 258 ~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~Dfgla~ 337 (508)
++++||+++++|.+++. ....+++.....++.|++.||.|||+. +++|+||+|+||+++.++.++|+|||++.
T Consensus 82 ~~v~e~~~~~~L~~~~~----~~~~l~~~~~~~~~~~i~~al~~LH~~---~i~H~dl~p~ni~i~~~~~~~l~dfg~~~ 154 (264)
T cd06653 82 SIFVEYMPGGSIKDQLK----AYGALTENVTRRYTRQILQGVSYLHSN---MIVHRDIKGANILRDSAGNVKLGDFGASK 154 (264)
T ss_pred EEEEEeCCCCcHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEcCCCCEEECcccccc
Confidence 89999999999999984 345688899999999999999999999 99999999999999999999999999998
Q ss_pred ccCCCCC--cccccccccccccCccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCCCchhcHHHHHHHHhcccccc
Q 010519 338 LLDSGES--HITTRVMGTFGYVAPEYANTGMLNEKSDIYSFGVLLLEAVTGRDPVDYGRPANEVNLVEWLKMMVGTRRAE 415 (508)
Q Consensus 338 ~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~ 415 (508)
....... .......++..|+|||++.+..++.++|+|||||++|+|++|+.||...... ..+.......
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~------~~~~~~~~~~--- 225 (264)
T cd06653 155 RIQTICMSGTGIKSVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPPWAEYEAM------AAIFKIATQP--- 225 (264)
T ss_pred ccccccccCccccccCCcccccCHhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCccCHH------HHHHHHHcCC---
Confidence 6532111 1122346889999999999888999999999999999999999999633211 1111111100
Q ss_pred cccCCCCCCChhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHh
Q 010519 416 EVVDPNLEVKPATRALKRSLLVALRCVDPDSEKRPKMSQVVRML 459 (508)
Q Consensus 416 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L 459 (508)
.....+......+.+++.+||. +|..||++.+++.|.
T Consensus 226 ------~~~~~p~~~~~~~~~~i~~~l~-~~~~r~~~~~~~~~~ 262 (264)
T cd06653 226 ------TKPMLPDGVSDACRDFLKQIFV-EEKRRPTAEFLLRHP 262 (264)
T ss_pred ------CCCCCCcccCHHHHHHHHHHhc-CcccCccHHHHhcCC
Confidence 0011122234567779999999 579999999998753
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho |
| >cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-36 Score=300.81 Aligned_cols=270 Identities=24% Similarity=0.310 Sum_probs=200.5
Q ss_pred hCCcccceeEeeeCceEEEEEEEc-CCCEEEEEEEcccch--hhHHHHHHHHHHHhcCCCCCceeEEEEEEeC--ceeeE
Q 010519 185 TNRFSAENVLGEGGYGVVYKGRLI-NGSEVAVKKLLNNLG--QAEKEFRVEVEAIGHVRHKNLVRLLGYCIEG--VHRML 259 (508)
Q Consensus 185 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~ei~~l~~l~h~niv~~~~~~~~~--~~~~l 259 (508)
.++|++.+.||+|+||.||+|.+. +|..||+|++..... .....+.+|+.++++++|+||+++++++... ...++
T Consensus 6 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~l 85 (309)
T cd07845 6 VTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELKEVVVGKHLDSIFL 85 (309)
T ss_pred ccceeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCCCCCcchhhHHHHHHHhCCCCCCcceEEEEecCCCCeEEE
Confidence 358999999999999999999875 689999998854322 1123456799999999999999999998765 46789
Q ss_pred EEeecCCCCHHHHHhhhhccCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCEEEcCCCcEEEEecCCcccc
Q 010519 260 VYEYVNNGNLEQWLHGAMRNQGNLTWEARMKVIIGTAKALAYLHEAIEPKVVHRDIKSSNILIDDEFNAKVSDFGLAKLL 339 (508)
Q Consensus 260 v~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~Dfgla~~~ 339 (508)
||||+. ++|.+++.. ....+++..++.++.||+.||.|||+. +++|+||||+||++++++.+||+|||++...
T Consensus 86 v~e~~~-~~l~~~l~~---~~~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~kL~dfg~~~~~ 158 (309)
T cd07845 86 VMEYCE-QDLASLLDN---MPTPFSESQVKCLMLQLLRGLQYLHEN---FIIHRDLKVSNLLLTDKGCLKIADFGLARTY 158 (309)
T ss_pred EEecCC-CCHHHHHHh---cccCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCEEECccceeeec
Confidence 999996 589998853 236789999999999999999999999 9999999999999999999999999999876
Q ss_pred CCCCCcccccccccccccCccccCC-CCCCChhhHHHHHHHHHHHHhCCCCCCCCCCCchhcHHHHHHHHhccccc----
Q 010519 340 DSGESHITTRVMGTFGYVAPEYANT-GMLNEKSDIYSFGVLLLEAVTGRDPVDYGRPANEVNLVEWLKMMVGTRRA---- 414 (508)
Q Consensus 340 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwS~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~---- 414 (508)
..... ......+++.|+|||.+.+ ..++.++|||||||++|||++|..||...... .....+....+....
T Consensus 159 ~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~~~~~---~~~~~~~~~~~~~~~~~~~ 234 (309)
T cd07845 159 GLPAK-PMTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSEI---EQLDLIIQLLGTPNESIWP 234 (309)
T ss_pred CCccC-CCCcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCCCCHH---HHHHHHHHhcCCCChhhch
Confidence 54321 1223345788999998865 56889999999999999999999999644321 111111111110000
Q ss_pred --------ccccCCCCCCCh----hHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhhcCCCC
Q 010519 415 --------EEVVDPNLEVKP----ATRALKRSLLVALRCVDPDSEKRPKMSQVVRMLEADDYP 465 (508)
Q Consensus 415 --------~~~~~~~~~~~~----~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~ 465 (508)
.....+...... .......+.+++.+||+.||++|||+.+++.+-+-...+
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~~il~h~~f~~~~ 297 (309)
T cd07845 235 GFSDLPLVGKFTLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEALESSYFKEKP 297 (309)
T ss_pred hhhcccccccccccCCCCCchHHhccccCHHHHHHHHHHhcCChhhCcCHHHHhcChhhccCC
Confidence 000000000000 011244567799999999999999999999876554433
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing |
| >cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-36 Score=298.34 Aligned_cols=245 Identities=25% Similarity=0.355 Sum_probs=196.5
Q ss_pred ceeEeeeCceEEEEEEEc-CCCEEEEEEEcccchhhHHHHHHHHHHHhcCCCCCceeEEEEEEeCceeeEEEeecCCCCH
Q 010519 191 ENVLGEGGYGVVYKGRLI-NGSEVAVKKLLNNLGQAEKEFRVEVEAIGHVRHKNLVRLLGYCIEGVHRMLVYEYVNNGNL 269 (508)
Q Consensus 191 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~ei~~l~~l~h~niv~~~~~~~~~~~~~lv~E~~~~gsL 269 (508)
...||+|+||.||++... ++..||+|++..........+..|+.+++.++|+|++++++++...+..++||||+++++|
T Consensus 25 ~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L 104 (292)
T cd06657 25 FIKIGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGAL 104 (292)
T ss_pred HHHcCCCCCeEEEEEEEcCCCeEEEEEEecccchhHHHHHHHHHHHHHhcCCcchhheeeEEEeCCEEEEEEecCCCCcH
Confidence 367999999999999874 6889999988655555556788899999999999999999999999999999999999999
Q ss_pred HHHHhhhhccCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCEEEcCCCcEEEEecCCccccCCCCCccccc
Q 010519 270 EQWLHGAMRNQGNLTWEARMKVIIGTAKALAYLHEAIEPKVVHRDIKSSNILIDDEFNAKVSDFGLAKLLDSGESHITTR 349 (508)
Q Consensus 270 ~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~ 349 (508)
.+++. ...+++..+..++.|++.||.|||+. +++|+||+|+||++++++.++|+|||++........ ....
T Consensus 105 ~~~~~-----~~~~~~~~~~~~~~ql~~~l~~lH~~---givH~dl~p~Nilv~~~~~~~l~dfg~~~~~~~~~~-~~~~ 175 (292)
T cd06657 105 TDIVT-----HTRMNEEQIAAVCLAVLKALSVLHAQ---GVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVP-RRKS 175 (292)
T ss_pred HHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEEcccccceecccccc-cccc
Confidence 99773 23578999999999999999999999 999999999999999999999999999876543221 1233
Q ss_pred ccccccccCccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCCCchhcHHHHHHHHhcccccccccCCCCCCChhHH
Q 010519 350 VMGTFGYVAPEYANTGMLNEKSDIYSFGVLLLEAVTGRDPVDYGRPANEVNLVEWLKMMVGTRRAEEVVDPNLEVKPATR 429 (508)
Q Consensus 350 ~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 429 (508)
..+++.|+|||.+.+..++.++|+||||+++|+|++|..||...... .....+... ..+.+.. ...
T Consensus 176 ~~~~~~y~~pE~~~~~~~~~~~Dv~slGvil~el~tg~~p~~~~~~~---~~~~~~~~~---------~~~~~~~--~~~ 241 (292)
T cd06657 176 LVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPL---KAMKMIRDN---------LPPKLKN--LHK 241 (292)
T ss_pred cccCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH---HHHHHHHhh---------CCcccCC--ccc
Confidence 46789999999998888999999999999999999999998643221 111111110 0011110 111
Q ss_pred HHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 010519 430 ALKRSLLVALRCVDPDSEKRPKMSQVVRM 458 (508)
Q Consensus 430 ~~~~l~~li~~cl~~dP~~RPs~~evl~~ 458 (508)
....+.+++.+||+.||.+||++.+++.+
T Consensus 242 ~~~~l~~li~~~l~~~P~~R~~~~~ll~~ 270 (292)
T cd06657 242 VSPSLKGFLDRLLVRDPAQRATAAELLKH 270 (292)
T ss_pred CCHHHHHHHHHHHhCCcccCcCHHHHhcC
Confidence 23345668999999999999999999985
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo |
| >KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-38 Score=293.59 Aligned_cols=251 Identities=25% Similarity=0.303 Sum_probs=200.4
Q ss_pred HhhCCcccceeEeeeCceEEEEEEEc-CCCEEEEEEEcccchhhH---HHHHHHHHHHhcCCCCCceeEEEEEEeCceee
Q 010519 183 IATNRFSAENVLGEGGYGVVYKGRLI-NGSEVAVKKLLNNLGQAE---KEFRVEVEAIGHVRHKNLVRLLGYCIEGVHRM 258 (508)
Q Consensus 183 ~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~---~~~~~ei~~l~~l~h~niv~~~~~~~~~~~~~ 258 (508)
+.-++|..+++||+|.||.|.+++-+ .++.+|+|++.+..-... ..-..|-.+|...+||.+..+.-.|+..+.++
T Consensus 165 vTm~dFdfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYsFQt~drlC 244 (516)
T KOG0690|consen 165 VTMEDFDFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYSFQTQDRLC 244 (516)
T ss_pred eccchhhHHHHhcCCccceEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhhhccCceEE
Confidence 34578899999999999999999865 788999998876543222 33455889999999999999999999999999
Q ss_pred EEEeecCCCCHHHHHhhhhccCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCEEEcCCCcEEEEecCCccc
Q 010519 259 LVYEYVNNGNLEQWLHGAMRNQGNLTWEARMKVIIGTAKALAYLHEAIEPKVVHRDIKSSNILIDDEFNAKVSDFGLAKL 338 (508)
Q Consensus 259 lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~Dfgla~~ 338 (508)
+||||..||.|+-+| .....+++...+.+-..|+.||.|||++ +||+||||.+|+|+|.||++||+|||+++.
T Consensus 245 FVMeyanGGeLf~HL----srer~FsE~RtRFYGaEIvsAL~YLHs~---~ivYRDlKLENLlLDkDGHIKitDFGLCKE 317 (516)
T KOG0690|consen 245 FVMEYANGGELFFHL----SRERVFSEDRTRFYGAEIVSALGYLHSR---NIVYRDLKLENLLLDKDGHIKITDFGLCKE 317 (516)
T ss_pred EEEEEccCceEeeeh----hhhhcccchhhhhhhHHHHHHhhhhhhC---CeeeeechhhhheeccCCceEeeecccchh
Confidence 999999999999888 4456788888889999999999999999 999999999999999999999999999985
Q ss_pred cCCCCCcccccccccccccCccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCCCchhcHHHHHHHHhccccccccc
Q 010519 339 LDSGESHITTRVMGTFGYVAPEYANTGMLNEKSDIYSFGVLLLEAVTGRDPVDYGRPANEVNLVEWLKMMVGTRRAEEVV 418 (508)
Q Consensus 339 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 418 (508)
--... ..+..+||||.|+|||++....|+.++|+|.+||++|||++|++||...+-.. +.+.+. .
T Consensus 318 ~I~~g-~t~kTFCGTPEYLAPEVleDnDYgraVDWWG~GVVMYEMmCGRLPFyn~dh~k---LFeLIl--~--------- 382 (516)
T KOG0690|consen 318 EIKYG-DTTKTFCGTPEYLAPEVLEDNDYGRAVDWWGVGVVMYEMMCGRLPFYNKDHEK---LFELIL--M--------- 382 (516)
T ss_pred ccccc-ceeccccCChhhcCchhhccccccceeehhhhhHHHHHHHhccCcccccchhH---HHHHHH--h---------
Confidence 43222 24677899999999999999999999999999999999999999996443221 111111 1
Q ss_pred CCCCCCChhHHHHHHHHHHHHHhcCCCCCCCC-----CHHHHHHH
Q 010519 419 DPNLEVKPATRALKRSLLVALRCVDPDSEKRP-----KMSQVVRM 458 (508)
Q Consensus 419 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~evl~~ 458 (508)
..++ .+.....+...|+...|.+||.+|. .+.||.++
T Consensus 383 -ed~k--FPr~ls~eAktLLsGLL~kdP~kRLGgGpdDakEi~~h 424 (516)
T KOG0690|consen 383 -EDLK--FPRTLSPEAKTLLSGLLKKDPKKRLGGGPDDAKEIMRH 424 (516)
T ss_pred -hhcc--CCccCCHHHHHHHHHHhhcChHhhcCCCchhHHHHHhh
Confidence 1111 1122233344477788999999996 35565554
|
|
| >cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-36 Score=295.16 Aligned_cols=263 Identities=25% Similarity=0.369 Sum_probs=198.4
Q ss_pred CcccceeEeeeCceEEEEEEEc-CCCEEEEEEEcccch-hhHHHHHHHHHHHhcCCCCCceeEEEEEEeCceeeEEEeec
Q 010519 187 RFSAENVLGEGGYGVVYKGRLI-NGSEVAVKKLLNNLG-QAEKEFRVEVEAIGHVRHKNLVRLLGYCIEGVHRMLVYEYV 264 (508)
Q Consensus 187 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~ei~~l~~l~h~niv~~~~~~~~~~~~~lv~E~~ 264 (508)
+|+..+.||.|++|.||+|++. +|..||+|.+..... .....+..|+.+++.++||||+++++++.+.+..++||||+
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 80 (284)
T cd07836 1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIVRLHDVIHTENKLMLVFEYM 80 (284)
T ss_pred CceEeeeeccCCceEEEEEEECCCCeEEEEEEecccccccchHHHHHHHHHHHhhcCCCEeeeeeeEeeCCcEEEEEecC
Confidence 5888999999999999999975 688899998865432 22355677999999999999999999999999999999999
Q ss_pred CCCCHHHHHhhhhccCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCEEEcCCCcEEEEecCCccccCCCCC
Q 010519 265 NNGNLEQWLHGAMRNQGNLTWEARMKVIIGTAKALAYLHEAIEPKVVHRDIKSSNILIDDEFNAKVSDFGLAKLLDSGES 344 (508)
Q Consensus 265 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~ 344 (508)
++ +|.+++... .....+++..+..++.|++.||.|||+. +++|+||+|+||++++++.++|+|||++........
T Consensus 81 ~~-~l~~~~~~~-~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~h~dl~p~ni~~~~~~~~~l~d~g~~~~~~~~~~ 155 (284)
T cd07836 81 DK-DLKKYMDTH-GVRGALDPNTVKSFTYQLLKGIAFCHEN---RVLHRDLKPQNLLINKRGELKLADFGLARAFGIPVN 155 (284)
T ss_pred Cc-cHHHHHHhc-CCCCCcCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHHHEEECCCCcEEEeecchhhhhcCCcc
Confidence 75 899988542 1235689999999999999999999998 999999999999999999999999999976543221
Q ss_pred cccccccccccccCccccCC-CCCCChhhHHHHHHHHHHHHhCCCCCCCCCCCchhcHHHHHHHHhccc--------ccc
Q 010519 345 HITTRVMGTFGYVAPEYANT-GMLNEKSDIYSFGVLLLEAVTGRDPVDYGRPANEVNLVEWLKMMVGTR--------RAE 415 (508)
Q Consensus 345 ~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwS~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~--------~~~ 415 (508)
......++..|++||.+.+ ..++.++|||||||++|+|++|+.||........ ............ ...
T Consensus 156 -~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~ 232 (284)
T cd07836 156 -TFSNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQ--LLKIFRIMGTPTESTWPGISQLP 232 (284)
T ss_pred -ccccccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcHHH--HHHHHHHhCCCChhhHHHHhcCc
Confidence 1223456889999998865 4578999999999999999999999975432211 111111100000 000
Q ss_pred cccCCCCCCC-------hhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 010519 416 EVVDPNLEVK-------PATRALKRSLLVALRCVDPDSEKRPKMSQVVRM 458 (508)
Q Consensus 416 ~~~~~~~~~~-------~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 458 (508)
... ...... ........+.+++.+||+.||.+||++.+++++
T Consensus 233 ~~~-~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~~ 281 (284)
T cd07836 233 EYK-PTFPRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHDALQH 281 (284)
T ss_pred hhc-ccccCCChHHHHHHhhhcCcHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence 000 000000 011224556789999999999999999999864
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. |
| >PHA02882 putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-35 Score=295.01 Aligned_cols=258 Identities=17% Similarity=0.244 Sum_probs=185.2
Q ss_pred HhhCCcccceeEeeeCceEEEEEEEcCC----CEEEEEEEcccchhh--H---------HHHHHHHHHHhcCCCCCceeE
Q 010519 183 IATNRFSAENVLGEGGYGVVYKGRLING----SEVAVKKLLNNLGQA--E---------KEFRVEVEAIGHVRHKNLVRL 247 (508)
Q Consensus 183 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~----~~vavK~~~~~~~~~--~---------~~~~~ei~~l~~l~h~niv~~ 247 (508)
+..++|.+.+.||+|+||+||+|.+.++ ..+++|......... + .....+...+..+.|+|++++
T Consensus 9 i~~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~ 88 (294)
T PHA02882 9 ITGKEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIPKY 88 (294)
T ss_pred cCCCceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCCcE
Confidence 4457899999999999999999987543 345555432211110 0 111223445667789999999
Q ss_pred EEEEEeCc----eeeEEEeecCCCCHHHHHhhhhccCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCEEEc
Q 010519 248 LGYCIEGV----HRMLVYEYVNNGNLEQWLHGAMRNQGNLTWEARMKVIIGTAKALAYLHEAIEPKVVHRDIKSSNILID 323 (508)
Q Consensus 248 ~~~~~~~~----~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiH~Dlk~~NIll~ 323 (508)
++++.... ..++++|++. .++.+.+. .....++..+..++.|++.||.|||+. +|+||||||+|||++
T Consensus 89 ~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~----~~~~~~~~~~~~i~~qi~~~l~~lH~~---~iiHrDiKp~Nill~ 160 (294)
T PHA02882 89 YGCGSFKRCRMYYRFILLEKLV-ENTKEIFK----RIKCKNKKLIKNIMKDMLTTLEYIHEH---GISHGDIKPENIMVD 160 (294)
T ss_pred EEeeeEecCCceEEEEEEehhc-cCHHHHHH----hhccCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEc
Confidence 99766543 3468888874 47777663 223456788899999999999999998 999999999999999
Q ss_pred CCCcEEEEecCCccccCCCCC------cccccccccccccCccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCCCc
Q 010519 324 DEFNAKVSDFGLAKLLDSGES------HITTRVMGTFGYVAPEYANTGMLNEKSDIYSFGVLLLEAVTGRDPVDYGRPAN 397 (508)
Q Consensus 324 ~~~~~kl~Dfgla~~~~~~~~------~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltG~~Pf~~~~~~~ 397 (508)
.++.++|+|||+++.+..... .......||+.|+|||++.+..++.++|||||||+||||++|+.||.......
T Consensus 161 ~~~~~~l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~~~~~~~DiwSlG~~l~el~~g~~P~~~~~~~~ 240 (294)
T PHA02882 161 GNNRGYIIDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGACVTRRGDLESLGYCMLKWAGIKLPWKGFGHNG 240 (294)
T ss_pred CCCcEEEEEcCCceeeccCCcccccccccccccCCCccccCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCccccch
Confidence 999999999999986532211 11223468999999999999999999999999999999999999997542221
Q ss_pred hh-cH--HHHHHHHhcccccccccCCCCCCChhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhh
Q 010519 398 EV-NL--VEWLKMMVGTRRAEEVVDPNLEVKPATRALKRSLLVALRCVDPDSEKRPKMSQVVRMLE 460 (508)
Q Consensus 398 ~~-~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 460 (508)
.. .. .++...+. .+...... ....+.+++..|++.+|.+||++.++++.|+
T Consensus 241 ~~~~~~~~~~~~~~~---------~~~~~~~~---~~~~~~~~~~~~~~~~~~~rp~~~~l~~~~~ 294 (294)
T PHA02882 241 NLIHAAKCDFIKRLH---------EGKIKIKN---ANKFIYDFIECVTKLSYEEKPDYDALIKIFD 294 (294)
T ss_pred HHHHHhHHHHHHHhh---------hhhhccCC---CCHHHHHHHHHHHhCCCCCCCCHHHHHHhhC
Confidence 11 10 11111111 11111111 2355677999999999999999999998763
|
|
| >cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-36 Score=294.59 Aligned_cols=247 Identities=25% Similarity=0.309 Sum_probs=192.5
Q ss_pred EeeeCceEEEEEEEc-CCCEEEEEEEcccc---hhhHHHHHHHHHHHhcCCCCCceeEEEEEEeCceeeEEEeecCCCCH
Q 010519 194 LGEGGYGVVYKGRLI-NGSEVAVKKLLNNL---GQAEKEFRVEVEAIGHVRHKNLVRLLGYCIEGVHRMLVYEYVNNGNL 269 (508)
Q Consensus 194 lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~ei~~l~~l~h~niv~~~~~~~~~~~~~lv~E~~~~gsL 269 (508)
||+|+||+||++... +|..+|+|.+.... ......+..|+++++.++||||+++++++......++||||+++++|
T Consensus 1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (277)
T cd05577 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFETKDDLCLVMTLMNGGDL 80 (277)
T ss_pred CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEecCCeEEEEEecCCCCcH
Confidence 689999999999764 68899999885432 12234567799999999999999999999999999999999999999
Q ss_pred HHHHhhhhccCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCEEEcCCCcEEEEecCCccccCCCCCccccc
Q 010519 270 EQWLHGAMRNQGNLTWEARMKVIIGTAKALAYLHEAIEPKVVHRDIKSSNILIDDEFNAKVSDFGLAKLLDSGESHITTR 349 (508)
Q Consensus 270 ~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~ 349 (508)
.+++... ....+++..+..++.|++.||.|||+. +++|+||+|+||++++++.++|+|||++....... ....
T Consensus 81 ~~~l~~~--~~~~~~~~~~~~~~~ql~~~l~~lH~~---~i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~~~~--~~~~ 153 (277)
T cd05577 81 KYHIYNV--GEPGFPEARAIFYAAQIICGLEHLHQR---RIVYRDLKPENVLLDDHGNVRISDLGLAVELKGGK--KIKG 153 (277)
T ss_pred HHHHHHc--CcCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEECCCCCEEEccCcchhhhccCC--cccc
Confidence 9998642 234689999999999999999999998 99999999999999999999999999998654322 1233
Q ss_pred ccccccccCccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCCCchhcHHHHHHHHhcccccccccCCCCCCChhHH
Q 010519 350 VMGTFGYVAPEYANTGMLNEKSDIYSFGVLLLEAVTGRDPVDYGRPANEVNLVEWLKMMVGTRRAEEVVDPNLEVKPATR 429 (508)
Q Consensus 350 ~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 429 (508)
..++..|+|||++.+..++.++|||||||++|+|++|+.||......... ........ . . ....+..
T Consensus 154 ~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~--~~~~~~~~-~--------~--~~~~~~~ 220 (277)
T cd05577 154 RAGTPGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSPFRQRKEKVEK--EELKRRTL-E--------M--AVEYPDK 220 (277)
T ss_pred ccCCCCcCCHHHhcCCCCCchhhhHHHHHHHHHHhhCCCCCCCCcccccH--HHHHhccc-c--------c--cccCCcc
Confidence 45788999999998888999999999999999999999999644321111 11111000 0 0 0001111
Q ss_pred HHHHHHHHHHHhcCCCCCCCC-----CHHHHHHHhh
Q 010519 430 ALKRSLLVALRCVDPDSEKRP-----KMSQVVRMLE 460 (508)
Q Consensus 430 ~~~~l~~li~~cl~~dP~~RP-----s~~evl~~L~ 460 (508)
....+.+++.+||+.||.+|| ++.+++.+-.
T Consensus 221 ~~~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~h~~ 256 (277)
T cd05577 221 FSPEAKDLCEALLQKDPEKRLGCRGGSADEVREHPL 256 (277)
T ss_pred CCHHHHHHHHHHccCChhHccCCCcccHHHHHhChh
Confidence 244566799999999999999 7777776543
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of |
| >cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-36 Score=300.09 Aligned_cols=263 Identities=22% Similarity=0.306 Sum_probs=194.4
Q ss_pred CCcccceeEeeeCceEEEEEEEc-CCCEEEEEEEcccc--hhhHHHHHHHHHHHhcCCCCCceeEEEEEEeCc-------
Q 010519 186 NRFSAENVLGEGGYGVVYKGRLI-NGSEVAVKKLLNNL--GQAEKEFRVEVEAIGHVRHKNLVRLLGYCIEGV------- 255 (508)
Q Consensus 186 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~ei~~l~~l~h~niv~~~~~~~~~~------- 255 (508)
++|++.+.||+|+||.||+|... ++..||+|.+.... ......+..|+.++++++||||+++++++....
T Consensus 12 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 91 (310)
T cd07865 12 SKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPYNRYK 91 (310)
T ss_pred hheEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCCcCCchhHHHHHHHHHHhCCCCCccceEEEEecccccccCCC
Confidence 47999999999999999999875 68899999885432 222234567999999999999999999987653
Q ss_pred -eeeEEEeecCCCCHHHHHhhhhccCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCEEEcCCCcEEEEecC
Q 010519 256 -HRMLVYEYVNNGNLEQWLHGAMRNQGNLTWEARMKVIIGTAKALAYLHEAIEPKVVHRDIKSSNILIDDEFNAKVSDFG 334 (508)
Q Consensus 256 -~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~Dfg 334 (508)
..++||||+. ++|.+++. .....+++..++.++.||+.||.|||++ +++|+||||+||+++.++.+||+|||
T Consensus 92 ~~~~lv~e~~~-~~l~~~l~---~~~~~~~~~~~~~i~~qi~~al~~lH~~---~i~H~dl~p~nil~~~~~~~kl~dfg 164 (310)
T cd07865 92 GSFYLVFEFCE-HDLAGLLS---NKNVKFTLSEIKKVMKMLLNGLYYIHRN---KILHRDMKAANILITKDGILKLADFG 164 (310)
T ss_pred ceEEEEEcCCC-cCHHHHHH---hcccCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHEEECCCCcEEECcCC
Confidence 3489999996 58888875 2334689999999999999999999999 99999999999999999999999999
Q ss_pred CccccCCCCCc---ccccccccccccCccccCCC-CCCChhhHHHHHHHHHHHHhCCCCCCCCCCCchhcHHHHHHHHhc
Q 010519 335 LAKLLDSGESH---ITTRVMGTFGYVAPEYANTG-MLNEKSDIYSFGVLLLEAVTGRDPVDYGRPANEVNLVEWLKMMVG 410 (508)
Q Consensus 335 la~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwS~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~ 410 (508)
++......... ......++..|+|||.+.+. .++.++||||||+++|||++|..||....... ....+..+.+
T Consensus 165 ~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~~~~~~~~---~~~~~~~~~~ 241 (310)
T cd07865 165 LARAFSLSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQH---QLTLISQLCG 241 (310)
T ss_pred CcccccCCcccCCCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCCCCCCHHH---HHHHHHHHhC
Confidence 99865432211 12234578899999988664 47889999999999999999999986443221 1112222211
Q ss_pred ccccc---c---------ccCCCCCCChhH------HHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 010519 411 TRRAE---E---------VVDPNLEVKPAT------RALKRSLLVALRCVDPDSEKRPKMSQVVRM 458 (508)
Q Consensus 411 ~~~~~---~---------~~~~~~~~~~~~------~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 458 (508)
..... . ...+........ .....+.+++.+||..||.+|||+++++++
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~dli~~~l~~~P~~R~t~~e~l~h 307 (310)
T cd07865 242 SITPEVWPGVDKLELFKKMELPQGQKRKVKERLKPYVKDPHALDLIDKLLVLDPAKRIDADTALNH 307 (310)
T ss_pred CCChhhcccccchhhhhhccCCCccchhhHHhcccccCCHHHHHHHHHHhcCChhhccCHHHHhcC
Confidence 10000 0 000000000000 012345679999999999999999999975
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl |
| >cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-36 Score=306.81 Aligned_cols=262 Identities=23% Similarity=0.329 Sum_probs=195.7
Q ss_pred hCCcccceeEeeeCceEEEEEEEc-CCCEEEEEEEcccc-hhhHHHHHHHHHHHhcCCCCCceeEEEEEEeC-----cee
Q 010519 185 TNRFSAENVLGEGGYGVVYKGRLI-NGSEVAVKKLLNNL-GQAEKEFRVEVEAIGHVRHKNLVRLLGYCIEG-----VHR 257 (508)
Q Consensus 185 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~ei~~l~~l~h~niv~~~~~~~~~-----~~~ 257 (508)
.++|.+.+.||+|+||.||+|.+. +|+.||+|++.... ......+..|+.+++.++||||+++++++... ...
T Consensus 4 ~~~y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 83 (336)
T cd07849 4 GPRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLREIKILRRFKHENIIGILDIIRPPSFESFNDV 83 (336)
T ss_pred ccceEEEEEEEecCCeEEEEEEEcCCCCeEEEEEecccccchhHHHHHHHHHHHHhCCCCCcCchhheeecccccccceE
Confidence 368999999999999999999864 68899999885422 23345677899999999999999999987654 357
Q ss_pred eEEEeecCCCCHHHHHhhhhccCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCEEEcCCCcEEEEecCCcc
Q 010519 258 MLVYEYVNNGNLEQWLHGAMRNQGNLTWEARMKVIIGTAKALAYLHEAIEPKVVHRDIKSSNILIDDEFNAKVSDFGLAK 337 (508)
Q Consensus 258 ~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~Dfgla~ 337 (508)
++|+||+.+ +|.+++. ...+++..++.++.|++.||.|||+. +|+||||||+|||++.++.+||+|||++.
T Consensus 84 ~lv~e~~~~-~l~~~~~-----~~~l~~~~~~~i~~ql~~aL~~LH~~---~ivH~dlkp~Nill~~~~~~kl~dfg~~~ 154 (336)
T cd07849 84 YIVQELMET-DLYKLIK-----TQHLSNDHIQYFLYQILRGLKYIHSA---NVLHRDLKPSNLLLNTNCDLKICDFGLAR 154 (336)
T ss_pred EEEehhccc-CHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHEEECCCCCEEECccccee
Confidence 899999964 8887763 34689999999999999999999999 99999999999999999999999999998
Q ss_pred ccCCCCCc--ccccccccccccCccccCC-CCCCChhhHHHHHHHHHHHHhCCCCCCCCCCCchhcHHHHHHHHhccccc
Q 010519 338 LLDSGESH--ITTRVMGTFGYVAPEYANT-GMLNEKSDIYSFGVLLLEAVTGRDPVDYGRPANEVNLVEWLKMMVGTRRA 414 (508)
Q Consensus 338 ~~~~~~~~--~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwS~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~ 414 (508)
........ ......|++.|+|||.+.+ ..++.++|||||||++|+|++|+.||...... .....+....+....
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~~~~~---~~~~~~~~~~~~~~~ 231 (336)
T cd07849 155 IADPEHDHTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYL---HQLNLILGVLGTPSQ 231 (336)
T ss_pred eccccccccCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHH---HHHHHHHHHcCCCCH
Confidence 65432211 1233468899999998754 56899999999999999999999999643211 111111111110000
Q ss_pred ---ccc-----------cCCCCCCC---hhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 010519 415 ---EEV-----------VDPNLEVK---PATRALKRSLLVALRCVDPDSEKRPKMSQVVRM 458 (508)
Q Consensus 415 ---~~~-----------~~~~~~~~---~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 458 (508)
..+ ........ ........+.+++.+||+.||.+|||+.|++++
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~e~l~h 292 (336)
T cd07849 232 EDLNCIISLRARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEEALAH 292 (336)
T ss_pred HHHHHhhchhhhhHHhhcCcCCcccHHHHhcccCcHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 000 00000000 001224567789999999999999999999997
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase |
| >KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-37 Score=315.55 Aligned_cols=251 Identities=28% Similarity=0.467 Sum_probs=208.1
Q ss_pred cccceeEeeeCceEEEEEEEc-CC----CEEEEEEEcccc-hhhHHHHHHHHHHHhcCCCCCceeEEEEEEeCceeeEEE
Q 010519 188 FSAENVLGEGGYGVVYKGRLI-NG----SEVAVKKLLNNL-GQAEKEFRVEVEAIGHVRHKNLVRLLGYCIEGVHRMLVY 261 (508)
Q Consensus 188 ~~~~~~lg~G~~g~Vy~~~~~-~~----~~vavK~~~~~~-~~~~~~~~~ei~~l~~l~h~niv~~~~~~~~~~~~~lv~ 261 (508)
....++||.|+||+||+|.|. .| -+||||++.... .+...++..|+..|.+++|||+++++|+|..+. ..||.
T Consensus 698 lkk~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t~~~~s~e~LdeAl~masldHpnl~RLLgvc~~s~-~qlvt 776 (1177)
T KOG1025|consen 698 LKKDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFTSPKASIELLDEALRMASLDHPNLLRLLGVCMLST-LQLVT 776 (1177)
T ss_pred hhhhceeccccceeEEeeeEecCCceecceeEEEEeeccCCchhhHHHHHHHHHHhcCCCchHHHHhhhcccch-HHHHH
Confidence 445689999999999999874 33 368999886554 445678999999999999999999999998766 78999
Q ss_pred eecCCCCHHHHHhhhhccCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCEEEcCCCcEEEEecCCccccCC
Q 010519 262 EYVNNGNLEQWLHGAMRNQGNLTWEARMKVIIGTAKALAYLHEAIEPKVVHRDIKSSNILIDDEFNAKVSDFGLAKLLDS 341 (508)
Q Consensus 262 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~ 341 (508)
+||+.|.|.+|++ .++..+-....+.|..||++|+.|||.+ .++||||..+||||.+..++||+|||+++.+..
T Consensus 777 q~mP~G~LlDyvr---~hr~~igsq~lLnw~~QIAkgM~YLe~q---rlVHrdLaaRNVLVksP~hvkitdfgla~ll~~ 850 (1177)
T KOG1025|consen 777 QLMPLGCLLDYVR---EHRDNIGSQDLLNWCYQIAKGMKYLEEQ---RLVHRDLAARNVLVKSPNHVKITDFGLAKLLAP 850 (1177)
T ss_pred HhcccchHHHHHH---HhhccccHHHHHHHHHHHHHHHHHHHhc---chhhhhhhhhheeecCCCeEEEEecchhhccCc
Confidence 9999999999997 4667788899999999999999999999 999999999999999999999999999998866
Q ss_pred CCCccccc-ccccccccCccccCCCCCCChhhHHHHHHHHHHHHh-CCCCCCCCCCCchhcHHHHHHHHhcccccccccC
Q 010519 342 GESHITTR-VMGTFGYVAPEYANTGMLNEKSDIYSFGVLLLEAVT-GRDPVDYGRPANEVNLVEWLKMMVGTRRAEEVVD 419 (508)
Q Consensus 342 ~~~~~~~~-~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 419 (508)
+....... ..-.+.|||-|.+....|+.++|||||||.+||++| |..||+.... .+ +..++.
T Consensus 851 d~~ey~~~~gK~pikwmale~i~~~~~thqSDVWsfGVtiWElmTFGa~Py~gi~~-~e---------------I~dlle 914 (1177)
T KOG1025|consen 851 DEKEYSAPGGKVPIKWMALESIRIRKYTHQSDVWSFGVTIWELMTFGAKPYDGIPA-EE---------------IPDLLE 914 (1177)
T ss_pred ccccccccccccCcHHHHHHHhhccCCCchhhhhhhhhhHHHHHhcCCCccCCCCH-HH---------------hhHHHh
Confidence 55443322 223568999999999999999999999999999999 9999864332 11 122222
Q ss_pred CCCCCChhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhhc
Q 010519 420 PNLEVKPATRALKRSLLVALRCVDPDSEKRPKMSQVVRMLEA 461 (508)
Q Consensus 420 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~ 461 (508)
...+...++....++..++.+||..|+..||+++++...+..
T Consensus 915 ~geRLsqPpiCtiDVy~~mvkCwmid~~~rp~fkel~~~fs~ 956 (1177)
T KOG1025|consen 915 KGERLSQPPICTIDVYMVMVKCWMIDADSRPTFKELAEEFSR 956 (1177)
T ss_pred ccccCCCCCCccHHHHHHHHHHhccCcccCccHHHHHHHHHH
Confidence 333455666677788889999999999999999999887754
|
|
| >cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-36 Score=297.47 Aligned_cols=249 Identities=24% Similarity=0.386 Sum_probs=201.6
Q ss_pred CCcccceeEeeeCceEEEEEEEc-CCCEEEEEEEcccc---hhhHHHHHHHHHHHhcCC-CCCceeEEEEEEeCceeeEE
Q 010519 186 NRFSAENVLGEGGYGVVYKGRLI-NGSEVAVKKLLNNL---GQAEKEFRVEVEAIGHVR-HKNLVRLLGYCIEGVHRMLV 260 (508)
Q Consensus 186 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~ei~~l~~l~-h~niv~~~~~~~~~~~~~lv 260 (508)
++|.+.+.||.|+||.||+++.. +++.+++|.+.... ......+..|+.++.+++ ||||+++++++......++|
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv 80 (280)
T cd05581 1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDEENLYFV 80 (280)
T ss_pred CCceEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhcCCceEEEE
Confidence 47889999999999999999875 78999999875422 233466788999999998 99999999999999999999
Q ss_pred EeecCCCCHHHHHhhhhccCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCEEEcCCCcEEEEecCCccccC
Q 010519 261 YEYVNNGNLEQWLHGAMRNQGNLTWEARMKVIIGTAKALAYLHEAIEPKVVHRDIKSSNILIDDEFNAKVSDFGLAKLLD 340 (508)
Q Consensus 261 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~Dfgla~~~~ 340 (508)
|||+.+++|.+++. ....+++..++.++.|++.||.|||+. +++|+||+|+||+++.++.++|+|||++....
T Consensus 81 ~e~~~~~~L~~~l~----~~~~l~~~~~~~i~~ql~~~l~~Lh~~---~~~H~dl~~~ni~i~~~~~~~l~df~~~~~~~ 153 (280)
T cd05581 81 LEYAPNGELLQYIR----KYGSLDEKCTRFYAAEILLALEYLHSK---GIIHRDLKPENILLDKDMHIKITDFGTAKVLD 153 (280)
T ss_pred EcCCCCCcHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHeEECCCCCEEecCCccccccC
Confidence 99999999999985 345799999999999999999999998 99999999999999999999999999998654
Q ss_pred CCCC-------------------cccccccccccccCccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCCCchhcH
Q 010519 341 SGES-------------------HITTRVMGTFGYVAPEYANTGMLNEKSDIYSFGVLLLEAVTGRDPVDYGRPANEVNL 401 (508)
Q Consensus 341 ~~~~-------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltG~~Pf~~~~~~~~~~~ 401 (508)
.... .......++..|+|||.+.+..++.++|+||||++++++++|..||..... ...
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~---~~~ 230 (280)
T cd05581 154 PNSSPESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRGSNE---YLT 230 (280)
T ss_pred CccccccCCCCCccccccccccccccccccCCccccCHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCccH---HHH
Confidence 3221 122334678899999999888899999999999999999999999974431 111
Q ss_pred HHHHHHHhcccccccccCCCCCCChhHHHHHHHHHHHHHhcCCCCCCCCCH----HHHHHH
Q 010519 402 VEWLKMMVGTRRAEEVVDPNLEVKPATRALKRSLLVALRCVDPDSEKRPKM----SQVVRM 458 (508)
Q Consensus 402 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~----~evl~~ 458 (508)
+..... . ....+......+.+++.+||+.||.+|||+ ++++++
T Consensus 231 ---~~~~~~---------~--~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~ll~~ 277 (280)
T cd05581 231 ---FQKILK---------L--EYSFPPNFPPDAKDLIEKLLVLDPQDRLGVNEGYDELKAH 277 (280)
T ss_pred ---HHHHHh---------c--CCCCCCccCHHHHHHHHHHhcCCHhhCCCcccCHHHHhcC
Confidence 111110 0 001111224556779999999999999999 888765
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto |
| >cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-36 Score=295.06 Aligned_cols=252 Identities=25% Similarity=0.348 Sum_probs=196.8
Q ss_pred CcccceeEeeeCceEEEEEEEc----CCCEEEEEEEcccch----hhHHHHHHHHHHHhcC-CCCCceeEEEEEEeCcee
Q 010519 187 RFSAENVLGEGGYGVVYKGRLI----NGSEVAVKKLLNNLG----QAEKEFRVEVEAIGHV-RHKNLVRLLGYCIEGVHR 257 (508)
Q Consensus 187 ~~~~~~~lg~G~~g~Vy~~~~~----~~~~vavK~~~~~~~----~~~~~~~~ei~~l~~l-~h~niv~~~~~~~~~~~~ 257 (508)
+|++.+.||.|+||.||+++.. +|..||+|.+..... ...+.+..|+.++.++ +|+||+++++++..+...
T Consensus 1 ~y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~ 80 (290)
T cd05613 1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTDTKL 80 (290)
T ss_pred CceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeecCCeE
Confidence 4778899999999999999863 688999998864322 2335678899999999 599999999999999999
Q ss_pred eEEEeecCCCCHHHHHhhhhccCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCEEEcCCCcEEEEecCCcc
Q 010519 258 MLVYEYVNNGNLEQWLHGAMRNQGNLTWEARMKVIIGTAKALAYLHEAIEPKVVHRDIKSSNILIDDEFNAKVSDFGLAK 337 (508)
Q Consensus 258 ~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~Dfgla~ 337 (508)
++||||+++++|.+++. ....+++..+..++.|++.||.|||+. +++||||+|+|||++.++.+||+|||++.
T Consensus 81 ~lv~e~~~~~~L~~~l~----~~~~l~~~~~~~~~~qi~~al~~lH~~---~i~H~dl~p~nil~~~~~~~kl~dfg~~~ 153 (290)
T cd05613 81 HLILDYINGGELFTHLS----QRERFKEQEVQIYSGEIVLALEHLHKL---GIIYRDIKLENILLDSNGHVVLTDFGLSK 153 (290)
T ss_pred EEEEecCCCCcHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHeEECCCCCEEEeeCccce
Confidence 99999999999999984 345688899999999999999999998 99999999999999999999999999998
Q ss_pred ccCCCCCcccccccccccccCccccCCC--CCCChhhHHHHHHHHHHHHhCCCCCCCCCCCchhcHHHHHHHHhcccccc
Q 010519 338 LLDSGESHITTRVMGTFGYVAPEYANTG--MLNEKSDIYSFGVLLLEAVTGRDPVDYGRPANEVNLVEWLKMMVGTRRAE 415 (508)
Q Consensus 338 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~DvwS~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~ 415 (508)
..............|+..|+|||.+.+. .++.++||||||+++|+|++|..||...... .....+........
T Consensus 154 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~--~~~~~~~~~~~~~~--- 228 (290)
T cd05613 154 EFHEDEVERAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEK--NSQAEISRRILKSE--- 228 (290)
T ss_pred ecccccccccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCcCCcc--ccHHHHHHHhhccC---
Confidence 6644332223345688999999998653 4678999999999999999999998643221 11122222211110
Q ss_pred cccCCCCCCChhHHHHHHHHHHHHHhcCCCCCCCC-----CHHHHHHH
Q 010519 416 EVVDPNLEVKPATRALKRSLLVALRCVDPDSEKRP-----KMSQVVRM 458 (508)
Q Consensus 416 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~evl~~ 458 (508)
+.. +......+.+++.+||+.||.+|| ++.+++.+
T Consensus 229 ----~~~----~~~~~~~~~~ll~~~l~~~p~~R~~~~~~~~~~l~~~ 268 (290)
T cd05613 229 ----PPY----PQEMSALAKDIIQRLLMKDPKKRLGCGPSDADEIKKH 268 (290)
T ss_pred ----CCC----CccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHcC
Confidence 111 111234556799999999999997 67777765
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-35 Score=298.31 Aligned_cols=259 Identities=22% Similarity=0.276 Sum_probs=193.2
Q ss_pred eeEeee--CceEEEEEEEc-CCCEEEEEEEcccc--hhhHHHHHHHHHHHhcCCCCCceeEEEEEEeCceeeEEEeecCC
Q 010519 192 NVLGEG--GYGVVYKGRLI-NGSEVAVKKLLNNL--GQAEKEFRVEVEAIGHVRHKNLVRLLGYCIEGVHRMLVYEYVNN 266 (508)
Q Consensus 192 ~~lg~G--~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~ei~~l~~l~h~niv~~~~~~~~~~~~~lv~E~~~~ 266 (508)
..||+| +||+||++++. .|+.||+|.+.... ....+.+.+|+.+++.++||||++++++|..+...++||||+.+
T Consensus 4 ~~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~~v~e~~~~ 83 (328)
T cd08226 4 VEIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMAY 83 (328)
T ss_pred HHhCCcccCceeEEEEEEcCCCcEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEeeeEecCCceEEEEecccC
Confidence 456666 99999999875 78999999886432 23346788899999999999999999999999999999999999
Q ss_pred CCHHHHHhhhhccCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCEEEcCCCcEEEEecCCccccCCCCCcc
Q 010519 267 GNLEQWLHGAMRNQGNLTWEARMKVIIGTAKALAYLHEAIEPKVVHRDIKSSNILIDDEFNAKVSDFGLAKLLDSGESHI 346 (508)
Q Consensus 267 gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~ 346 (508)
++|.+++... ....+++..+..++.|++.||.|||+. +++||||||+|||++.++.++++||+.+..........
T Consensus 84 ~~l~~~l~~~--~~~~~~~~~~~~~~~qi~~aL~~lH~~---~ivHrDlkp~Nill~~~~~~~~~~~~~~~~~~~~~~~~ 158 (328)
T cd08226 84 GSANSLLKTY--FPEGMSEALIGNILFGALRGLNYLHQN---GYIHRNIKASHILISGDGLVSLSGLSHLYSLVRNGQKA 158 (328)
T ss_pred CCHHHHHHhh--cccCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEeCCCcEEEechHHHhhhhccCccc
Confidence 9999998642 234588999999999999999999998 99999999999999999999999998654322111000
Q ss_pred ------cccccccccccCccccCCC--CCCChhhHHHHHHHHHHHHhCCCCCCCCCCCchhcHHHHHHHHhccc------
Q 010519 347 ------TTRVMGTFGYVAPEYANTG--MLNEKSDIYSFGVLLLEAVTGRDPVDYGRPANEVNLVEWLKMMVGTR------ 412 (508)
Q Consensus 347 ------~~~~~gt~~y~aPE~~~~~--~~~~~~DvwS~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~------ 412 (508)
.....++..|+|||++.+. .++.++|||||||++|||++|..||....... .... ......
T Consensus 159 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~--~~~~---~~~~~~~~~~~~ 233 (328)
T cd08226 159 KVVYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRTQ--MLLQ---KLKGPPYSPLDI 233 (328)
T ss_pred cccccccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcChHH--HHHH---HhcCCCCCCccc
Confidence 0112345679999999764 47899999999999999999999996433211 1100 000000
Q ss_pred -----------------------------ccccccCCCCCCChhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhh
Q 010519 413 -----------------------------RAEEVVDPNLEVKPATRALKRSLLVALRCVDPDSEKRPKMSQVVRMLE 460 (508)
Q Consensus 413 -----------------------------~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 460 (508)
....+....+...........+.+|+.+||+.||.+|||+.|++++-.
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpta~e~l~~~~ 310 (328)
T cd08226 234 TTFPCEESRMKNSQSGVDSGIGESVVAAGMTQTMTSERLRTPSSKTFSPAFQNLVELCLQQDPEKRPSASSLLSHAF 310 (328)
T ss_pred cccchhhhhhccchhhhhcccccchhccccccccccccccchhhhhhhHHHHHHHHHHccCCcccCCCHHHHhhCHH
Confidence 000111111222223345567888999999999999999999998654
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig |
| >PHA03390 pk1 serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-35 Score=289.32 Aligned_cols=245 Identities=22% Similarity=0.275 Sum_probs=189.0
Q ss_pred hhCCcccceeE--eeeCceEEEEEEEc-CCCEEEEEEEcccchhhHHHHHHHHHHHhcC-CCCCceeEEEEEEeCceeeE
Q 010519 184 ATNRFSAENVL--GEGGYGVVYKGRLI-NGSEVAVKKLLNNLGQAEKEFRVEVEAIGHV-RHKNLVRLLGYCIEGVHRML 259 (508)
Q Consensus 184 ~~~~~~~~~~l--g~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~ei~~l~~l-~h~niv~~~~~~~~~~~~~l 259 (508)
..++|.+.+.+ |.|+||.||++... ++..+|+|.+........ |+.....+ +||||+++++++...+..++
T Consensus 12 ~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~-----e~~~~~~~~~h~~iv~~~~~~~~~~~~~i 86 (267)
T PHA03390 12 FLKNCEIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFNAI-----EPMVHQLMKDNPNFIKLYYSVTTLKGHVL 86 (267)
T ss_pred HHHhhccccceeecCCCceEEEEEEEcCCCcEEEEEEEehhhcchh-----hHHHHHHhhcCCCEEEEEEEEecCCeeEE
Confidence 34567776666 99999999999864 677888888754321111 22222212 79999999999999999999
Q ss_pred EEeecCCCCHHHHHhhhhccCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCEEEcCCC-cEEEEecCCccc
Q 010519 260 VYEYVNNGNLEQWLHGAMRNQGNLTWEARMKVIIGTAKALAYLHEAIEPKVVHRDIKSSNILIDDEF-NAKVSDFGLAKL 338 (508)
Q Consensus 260 v~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiH~Dlk~~NIll~~~~-~~kl~Dfgla~~ 338 (508)
||||+++++|.+++. ....+++..+..++.|+++||.|||+. +++||||||+||+++.++ .++|+|||++..
T Consensus 87 v~e~~~~~~L~~~l~----~~~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~~~l~dfg~~~~ 159 (267)
T PHA03390 87 IMDYIKDGDLFDLLK----KEGKLSEAEVKKIIRQLVEALNDLHKH---NIIHNDIKLENVLYDRAKDRIYLCDYGLCKI 159 (267)
T ss_pred EEEcCCCCcHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEEeCCCCeEEEecCcccee
Confidence 999999999999985 334889999999999999999999998 999999999999999998 999999999886
Q ss_pred cCCCCCcccccccccccccCccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCCCchhcHHHHHHHHhccccccccc
Q 010519 339 LDSGESHITTRVMGTFGYVAPEYANTGMLNEKSDIYSFGVLLLEAVTGRDPVDYGRPANEVNLVEWLKMMVGTRRAEEVV 418 (508)
Q Consensus 339 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 418 (508)
.... ....++..|+|||++.+..++.++|||||||++|+|++|+.||..... .......+.....
T Consensus 160 ~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~-~~~~~~~~~~~~~--------- 224 (267)
T PHA03390 160 IGTP-----SCYDGTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFKEDED-EELDLESLLKRQQ--------- 224 (267)
T ss_pred cCCC-----ccCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCc-chhhHHHHHHhhc---------
Confidence 5432 123578999999999998999999999999999999999999973322 2222222222211
Q ss_pred CCCCCCChhHHHHHHHHHHHHHhcCCCCCCCCC-HHHHHHH
Q 010519 419 DPNLEVKPATRALKRSLLVALRCVDPDSEKRPK-MSQVVRM 458 (508)
Q Consensus 419 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs-~~evl~~ 458 (508)
... .........+.+++.+||+.||.+||+ +++++++
T Consensus 225 -~~~--~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~l~h 262 (267)
T PHA03390 225 -KKL--PFIKNVSKNANDFVQSMLKYNINYRLTNYNEIIKH 262 (267)
T ss_pred -ccC--CcccccCHHHHHHHHHHhccChhhCCchHHHHhcC
Confidence 000 011123455677999999999999996 6999864
|
|
| >cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-36 Score=306.25 Aligned_cols=262 Identities=21% Similarity=0.324 Sum_probs=198.1
Q ss_pred hCCcccceeEeeeCceEEEEEEEc-CCCEEEEEEEcccc--hhhHHHHHHHHHHHhcCCCCCceeEEEEEEeC-----ce
Q 010519 185 TNRFSAENVLGEGGYGVVYKGRLI-NGSEVAVKKLLNNL--GQAEKEFRVEVEAIGHVRHKNLVRLLGYCIEG-----VH 256 (508)
Q Consensus 185 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~ei~~l~~l~h~niv~~~~~~~~~-----~~ 256 (508)
.++|.+.+.||+|+||+||+++.. ++..||||.+.... ......+..|+.+++.++|+||+++++++... ..
T Consensus 4 ~~~y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~~~ 83 (337)
T cd07858 4 DTKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAFND 83 (337)
T ss_pred ccceeEEEEeccCCCeEEEEEEecCCCCeEEEEEecccccccchhHHHHHHHHHHHhcCCCCccchHHheecccccccCc
Confidence 357999999999999999999864 68899999886432 22334567799999999999999999988654 34
Q ss_pred eeEEEeecCCCCHHHHHhhhhccCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCEEEcCCCcEEEEecCCc
Q 010519 257 RMLVYEYVNNGNLEQWLHGAMRNQGNLTWEARMKVIIGTAKALAYLHEAIEPKVVHRDIKSSNILIDDEFNAKVSDFGLA 336 (508)
Q Consensus 257 ~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~Dfgla 336 (508)
.++|+||+. ++|.+++. ....+++..+..++.|++.||.|||+. +++|+||||+||+++.++.+||+|||++
T Consensus 84 ~~lv~e~~~-~~L~~~~~----~~~~l~~~~~~~i~~qi~~aL~~LH~~---~i~H~dlkp~Nil~~~~~~~kL~Dfg~~ 155 (337)
T cd07858 84 VYIVYELMD-TDLHQIIR----SSQTLSDDHCQYFLYQLLRGLKYIHSA---NVLHRDLKPSNLLLNANCDLKICDFGLA 155 (337)
T ss_pred EEEEEeCCC-CCHHHHHh----cCCCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEcCCCCEEECcCccc
Confidence 789999995 68988884 456799999999999999999999999 9999999999999999999999999999
Q ss_pred cccCCCCCcccccccccccccCccccCC-CCCCChhhHHHHHHHHHHHHhCCCCCCCCCCCchhcHHHHHHHHhcccccc
Q 010519 337 KLLDSGESHITTRVMGTFGYVAPEYANT-GMLNEKSDIYSFGVLLLEAVTGRDPVDYGRPANEVNLVEWLKMMVGTRRAE 415 (508)
Q Consensus 337 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwS~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~ 415 (508)
....... .......++..|+|||.+.+ ..++.++|||||||++|+|++|+.||...... .....+....+.....
T Consensus 156 ~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~---~~~~~~~~~~~~~~~~ 231 (337)
T cd07858 156 RTTSEKG-DFMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDYV---HQLKLITELLGSPSEE 231 (337)
T ss_pred cccCCCc-ccccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCCCChH---HHHHHHHHHhCCCChH
Confidence 8664332 12233457889999998764 56889999999999999999999999643211 1111111111110000
Q ss_pred ------------------cccCCCCCCChhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHh
Q 010519 416 ------------------EVVDPNLEVKPATRALKRSLLVALRCVDPDSEKRPKMSQVVRML 459 (508)
Q Consensus 416 ------------------~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L 459 (508)
....+.+. .........+.+++.+||+.||.+|||+.+++++-
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~l~~~P~~Rps~~ell~h~ 292 (337)
T cd07858 232 DLGFIRNEKARRYIRSLPYTPRQSFA-RLFPHANPLAIDLLEKMLVFDPSKRITVEEALAHP 292 (337)
T ss_pred HhhhcCchhhhHHHHhcCcccccCHH-HHcccCCHHHHHHHHHHhcCChhhccCHHHHHcCc
Confidence 00000000 00112345677899999999999999999999983
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati |
| >cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-36 Score=294.63 Aligned_cols=260 Identities=26% Similarity=0.337 Sum_probs=199.5
Q ss_pred cccceeEeeeCceEEEEEEEc-CCCEEEEEEEcccch--hhHHHHHHHHHHHhcCCCCCceeEEEEEEeCceeeEEEeec
Q 010519 188 FSAENVLGEGGYGVVYKGRLI-NGSEVAVKKLLNNLG--QAEKEFRVEVEAIGHVRHKNLVRLLGYCIEGVHRMLVYEYV 264 (508)
Q Consensus 188 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~ei~~l~~l~h~niv~~~~~~~~~~~~~lv~E~~ 264 (508)
|.+.+.||.|++|.||+|... +++.+++|++..... .....+..|+.++++++|+||+++++++..+...++||||+
T Consensus 1 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~ 80 (283)
T cd05118 1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDVFRHKGDLYLVFEFM 80 (283)
T ss_pred CccceeeecCCCceEEEEEcCCCCcEEEEEEeccccccchhHHHHHHHHHHHHHhcCCCcchHHHhhccCCCEEEEEecc
Confidence 566789999999999999875 688899998865432 23456778999999999999999999999999999999999
Q ss_pred CCCCHHHHHhhhhccCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCEEEcCCCcEEEEecCCccccCCCCC
Q 010519 265 NNGNLEQWLHGAMRNQGNLTWEARMKVIIGTAKALAYLHEAIEPKVVHRDIKSSNILIDDEFNAKVSDFGLAKLLDSGES 344 (508)
Q Consensus 265 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~ 344 (508)
++ +|.+++.. ....+++..++.++.+|+.||.|||+. +++|+||+|+||++++++.++|+|||.+.......
T Consensus 81 ~~-~l~~~l~~---~~~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dl~p~nili~~~~~~~l~df~~~~~~~~~~- 152 (283)
T cd05118 81 DT-DLYKLIKD---RQRGLPESLIKSYLYQLLQGLAFCHSH---GILHRDLKPENLLINTEGVLKLADFGLARSFGSPV- 152 (283)
T ss_pred CC-CHHHHHHh---hcccCCHHHHHHHHHHHHHHHHHHHHC---CeeecCcCHHHEEECCCCcEEEeeeeeeEecCCCc-
Confidence 75 89888853 336789999999999999999999999 99999999999999999999999999998765433
Q ss_pred cccccccccccccCccccCCC-CCCChhhHHHHHHHHHHHHhCCCCCCCCCCCchhcHHHHHHHHhcccc---cccccC-
Q 010519 345 HITTRVMGTFGYVAPEYANTG-MLNEKSDIYSFGVLLLEAVTGRDPVDYGRPANEVNLVEWLKMMVGTRR---AEEVVD- 419 (508)
Q Consensus 345 ~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwS~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~- 419 (508)
.......++..|+|||.+.+. .++.++|+||||+++|+|++|+.||......+. ... .....+... ...+..
T Consensus 153 ~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~--~~~-~~~~~~~~~~~~~~~~~~~ 229 (283)
T cd05118 153 RPYTHYVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQ--LFK-IFRTLGTPDPEVWPKFTSL 229 (283)
T ss_pred ccccCccCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHH--HHH-HHHHcCCCchHhcccchhh
Confidence 122334578899999998776 789999999999999999999999864432111 111 000000000 000000
Q ss_pred --------CCCCC----ChhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 010519 420 --------PNLEV----KPATRALKRSLLVALRCVDPDSEKRPKMSQVVRM 458 (508)
Q Consensus 420 --------~~~~~----~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 458 (508)
+.... .........+.+++.+||++||.+||++.+++.+
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~ll~~ 280 (283)
T cd05118 230 ARNYKFSFPKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALAH 280 (283)
T ss_pred hhhhhhhhccccccCHHHhhhhhCHHHHHHHHHHhccCcccCcCHHHHhhC
Confidence 00000 0112345678889999999999999999999975
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They |
| >KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=291.10 Aligned_cols=266 Identities=26% Similarity=0.343 Sum_probs=213.1
Q ss_pred HHHHHHhhCCcccceeEeeeCceEEEEEEEc------CCCEEEEEEEcccchh-hHHHHHHHHHHHhcCCCCCceeEEEE
Q 010519 178 LRDLEIATNRFSAENVLGEGGYGVVYKGRLI------NGSEVAVKKLLNNLGQ-AEKEFRVEVEAIGHVRHKNLVRLLGY 250 (508)
Q Consensus 178 ~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~-~~~~~~~ei~~l~~l~h~niv~~~~~ 250 (508)
..++.+-..++++...+.+|.||.||.|.|. +.+.|.+|.+.....+ ....+..|--.+..+.|||+.++.++
T Consensus 276 ~~~l~v~r~Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~AS~iQv~~~L~es~lly~~sH~nll~V~~V 355 (563)
T KOG1024|consen 276 LQELTVQRCRVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQHASQIQVNLLLQESMLLYGASHPNLLSVLGV 355 (563)
T ss_pred HHhhhhhhhheechhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhcccHHHHHHHHHHHHHHhcCcCCCccceeEE
Confidence 5677778888999999999999999999654 3456778877655433 33567778888889999999999999
Q ss_pred EEeC-ceeeEEEeecCCCCHHHHHhhhh----ccCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCEEEcCC
Q 010519 251 CIEG-VHRMLVYEYVNNGNLEQWLHGAM----RNQGNLTWEARMKVIIGTAKALAYLHEAIEPKVVHRDIKSSNILIDDE 325 (508)
Q Consensus 251 ~~~~-~~~~lv~E~~~~gsL~~~l~~~~----~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiH~Dlk~~NIll~~~ 325 (508)
+.+. ...++++.++.-|+|..||...+ .....++-.+...++.|++.|+.|||+. ++||.||..+|.++++.
T Consensus 356 ~ie~~~~P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~~---~ViHkDiAaRNCvIdd~ 432 (563)
T KOG1024|consen 356 SIEDYATPFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHNH---GVIHKDIAARNCVIDDQ 432 (563)
T ss_pred EeeccCcceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHhc---Ccccchhhhhcceehhh
Confidence 8765 56789999999999999997322 1223466778899999999999999999 99999999999999999
Q ss_pred CcEEEEecCCccccCCCCCccccc-ccccccccCccccCCCCCCChhhHHHHHHHHHHHHh-CCCCCCCCCCCchhcHHH
Q 010519 326 FNAKVSDFGLAKLLDSGESHITTR-VMGTFGYVAPEYANTGMLNEKSDIYSFGVLLLEAVT-GRDPVDYGRPANEVNLVE 403 (508)
Q Consensus 326 ~~~kl~Dfgla~~~~~~~~~~~~~-~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~ellt-G~~Pf~~~~~~~~~~~~~ 403 (508)
..+||+|=.+++.+-....+.... -.....||+||.+.+..|+.++|||||||+||||+| |+.||..-+|.+...+
T Consensus 433 LqVkltDsaLSRDLFP~DYhcLGDnEnRPvkWMslEal~n~~yssasDvWsfGVllWELmtlg~~PyaeIDPfEm~~y-- 510 (563)
T KOG1024|consen 433 LQVKLTDSALSRDLFPGDYHCLGDNENRPVKWMSLEALQNSHYSSASDVWSFGVLLWELMTLGKLPYAEIDPFEMEHY-- 510 (563)
T ss_pred eeEEeccchhccccCcccccccCCCCCCcccccCHHHHhhhhhcchhhhHHHHHHHHHHHhcCCCCccccCHHHHHHH--
Confidence 999999999999665544433322 234568999999999999999999999999999999 9999975544332221
Q ss_pred HHHHHhcccccccccCCCCCCChhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhhcC
Q 010519 404 WLKMMVGTRRAEEVVDPNLEVKPATRALKRSLLVALRCVDPDSEKRPKMSQVVRMLEAD 462 (508)
Q Consensus 404 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~ 462 (508)
.. ...+...+..++.+++.++.-||..+|++||+++|+..-|.+.
T Consensus 511 ----lk----------dGyRlaQP~NCPDeLf~vMacCWallpeeRPsf~Qlv~cLseF 555 (563)
T KOG1024|consen 511 ----LK----------DGYRLAQPFNCPDELFTVMACCWALLPEERPSFSQLVICLSEF 555 (563)
T ss_pred ----Hh----------ccceecCCCCCcHHHHHHHHHHHhcCcccCCCHHHHHHHHHHH
Confidence 11 3334445556677888899999999999999999999988653
|
|
| >cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-36 Score=292.29 Aligned_cols=245 Identities=25% Similarity=0.370 Sum_probs=194.1
Q ss_pred EeeeCceEEEEEEEc-CCCEEEEEEEcccch---hhHHHHHHHHHHHhcCCCCCceeEEEEEEeCceeeEEEeecCCCCH
Q 010519 194 LGEGGYGVVYKGRLI-NGSEVAVKKLLNNLG---QAEKEFRVEVEAIGHVRHKNLVRLLGYCIEGVHRMLVYEYVNNGNL 269 (508)
Q Consensus 194 lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~ei~~l~~l~h~niv~~~~~~~~~~~~~lv~E~~~~gsL 269 (508)
||.|+||.||++.+. +|+.+++|.+..... .....+..|++++++++||||+++++.+......|++|||+++++|
T Consensus 1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (265)
T cd05579 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQGKKNLYLVMEYLPGGDL 80 (265)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHheecCcEEEEEEecCCCCcH
Confidence 689999999999986 489999998865432 3446788899999999999999999999999999999999999999
Q ss_pred HHHHhhhhccCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCEEEcCCCcEEEEecCCccccCCCCC-----
Q 010519 270 EQWLHGAMRNQGNLTWEARMKVIIGTAKALAYLHEAIEPKVVHRDIKSSNILIDDEFNAKVSDFGLAKLLDSGES----- 344 (508)
Q Consensus 270 ~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~----- 344 (508)
.+++.. ...+++..+..++.||+.||.|||+. +++|+||+|+||++++++.++|+|||++........
T Consensus 81 ~~~l~~----~~~~~~~~~~~i~~qi~~~L~~lH~~---~i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~ 153 (265)
T cd05579 81 ASLLEN----VGSLDEDVARIYIAEIVLALEYLHSN---GIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLND 153 (265)
T ss_pred HHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHc---CeecCCCCHHHeEEcCCCCEEEEecccchhcccCccccccc
Confidence 999853 34789999999999999999999998 999999999999999999999999999875433211
Q ss_pred --cccccccccccccCccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCCCchhcHHHHHHHHhcccccccccCCCC
Q 010519 345 --HITTRVMGTFGYVAPEYANTGMLNEKSDIYSFGVLLLEAVTGRDPVDYGRPANEVNLVEWLKMMVGTRRAEEVVDPNL 422 (508)
Q Consensus 345 --~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 422 (508)
.......++..|+|||.+.+..++.++||||||+++|+|++|..||...... ......... ..
T Consensus 154 ~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~------~~~~~~~~~---------~~ 218 (265)
T cd05579 154 DEKEDKRIVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPPFHGETPE------EIFQNILNG---------KI 218 (265)
T ss_pred ccccccCcccCccccCHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHH------HHHHHHhcC---------Cc
Confidence 1223356788999999998888999999999999999999999999644321 122222110 01
Q ss_pred CCChhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhh
Q 010519 423 EVKPATRALKRSLLVALRCVDPDSEKRPKMSQVVRMLE 460 (508)
Q Consensus 423 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 460 (508)
...........+..++.+||+.+|.+|||+..+.+.|+
T Consensus 219 ~~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~~~~~l~ 256 (265)
T cd05579 219 EWPEDVEVSDEAIDLISKLLVPDPEKRLGAKSIEEIKN 256 (265)
T ss_pred CCCccccCCHHHHHHHHHHhcCCHhhcCCCccHHHHhc
Confidence 11111112456677999999999999999955444444
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re |
| >PLN00009 cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-36 Score=295.10 Aligned_cols=263 Identities=24% Similarity=0.327 Sum_probs=195.1
Q ss_pred CCcccceeEeeeCceEEEEEEEc-CCCEEEEEEEcccc--hhhHHHHHHHHHHHhcCCCCCceeEEEEEEeCceeeEEEe
Q 010519 186 NRFSAENVLGEGGYGVVYKGRLI-NGSEVAVKKLLNNL--GQAEKEFRVEVEAIGHVRHKNLVRLLGYCIEGVHRMLVYE 262 (508)
Q Consensus 186 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~ei~~l~~l~h~niv~~~~~~~~~~~~~lv~E 262 (508)
++|++.+.||+|++|+||+|.+. +|+.||+|++.... ......+..|++++++++||||+++++++.+....++|||
T Consensus 2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 81 (294)
T PLN00009 2 DQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKRLYLVFE 81 (294)
T ss_pred CceEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhccccccchHHHHHHHHHHHhccCCCEeeEEEEEecCCeEEEEEe
Confidence 47899999999999999999875 68899999875432 2223567789999999999999999999999999999999
Q ss_pred ecCCCCHHHHHhhhhccCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCEEEcC-CCcEEEEecCCccccCC
Q 010519 263 YVNNGNLEQWLHGAMRNQGNLTWEARMKVIIGTAKALAYLHEAIEPKVVHRDIKSSNILIDD-EFNAKVSDFGLAKLLDS 341 (508)
Q Consensus 263 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiH~Dlk~~NIll~~-~~~~kl~Dfgla~~~~~ 341 (508)
|++ ++|.+++.. .....+++..+..++.||+.||+|||++ +++|+||+|+||+++. ++.+||+|||++.....
T Consensus 82 ~~~-~~l~~~~~~--~~~~~~~~~~~~~~~~qi~~aL~~LH~~---~i~H~dl~p~nill~~~~~~~kl~dfg~~~~~~~ 155 (294)
T PLN00009 82 YLD-LDLKKHMDS--SPDFAKNPRLIKTYLYQILRGIAYCHSH---RVLHRDLKPQNLLIDRRTNALKLADFGLARAFGI 155 (294)
T ss_pred ccc-ccHHHHHHh--CCCCCcCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCCcceEEEECCCCEEEEcccccccccCC
Confidence 995 588888743 2233467888899999999999999998 9999999999999985 55799999999976543
Q ss_pred CCCcccccccccccccCccccCC-CCCCChhhHHHHHHHHHHHHhCCCCCCCCCCCchhcHHHHHHHHhcccccc-----
Q 010519 342 GESHITTRVMGTFGYVAPEYANT-GMLNEKSDIYSFGVLLLEAVTGRDPVDYGRPANEVNLVEWLKMMVGTRRAE----- 415 (508)
Q Consensus 342 ~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwS~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~----- 415 (508)
... ......+++.|+|||++.+ ..++.++|||||||++|+|++|..||......+. +.+.+ ...+.....
T Consensus 156 ~~~-~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~~~~--~~~~~-~~~~~~~~~~~~~~ 231 (294)
T PLN00009 156 PVR-TFTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEIDE--LFKIF-RILGTPNEETWPGV 231 (294)
T ss_pred Ccc-ccccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHH--HHHHH-HHhCCCChhhcccc
Confidence 221 1233457889999998866 4578999999999999999999999964432111 11111 110000000
Q ss_pred ----ccc--CCCCCCC----hhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 010519 416 ----EVV--DPNLEVK----PATRALKRSLLVALRCVDPDSEKRPKMSQVVRM 458 (508)
Q Consensus 416 ----~~~--~~~~~~~----~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 458 (508)
... -+..... ........+.+++.+|++.||.+||++.+++++
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~~l~~ 284 (294)
T PLN00009 232 TSLPDYKSAFPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAALEH 284 (294)
T ss_pred ccchhhhhhcccCCCCCHHHhCcCCChHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 000 0000000 001123456779999999999999999999975
|
|
| >cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=288.78 Aligned_cols=242 Identities=23% Similarity=0.285 Sum_probs=186.0
Q ss_pred eeEeeeCceEEEEEEEc-CCCEEEEEEEcccch---hhHHHHHHHHHH-HhcCCCCCceeEEEEEEeCceeeEEEeecCC
Q 010519 192 NVLGEGGYGVVYKGRLI-NGSEVAVKKLLNNLG---QAEKEFRVEVEA-IGHVRHKNLVRLLGYCIEGVHRMLVYEYVNN 266 (508)
Q Consensus 192 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~ei~~-l~~l~h~niv~~~~~~~~~~~~~lv~E~~~~ 266 (508)
+.||.|+||.||+|... +++.||+|.+..... .....+..|..+ ....+|+|++++++++..++..++|+||+++
T Consensus 2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 81 (260)
T cd05611 2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKDYLYLVMEYLNG 81 (260)
T ss_pred ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcCCeEEEEEeccCC
Confidence 56899999999999874 688999998864321 112233445444 4455899999999999999999999999999
Q ss_pred CCHHHHHhhhhccCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCEEEcCCCcEEEEecCCccccCCCCCcc
Q 010519 267 GNLEQWLHGAMRNQGNLTWEARMKVIIGTAKALAYLHEAIEPKVVHRDIKSSNILIDDEFNAKVSDFGLAKLLDSGESHI 346 (508)
Q Consensus 267 gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~ 346 (508)
++|.+++. ....+++..+..++.|++.||.|||+. +++|+||+|+||++++++.+||+|||++.....
T Consensus 82 ~~L~~~l~----~~~~~~~~~~~~i~~qi~~aL~~lH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~----- 149 (260)
T cd05611 82 GDCASLIK----TLGGLPEDWAKQYIAEVVLGVEDLHQR---GIIHRDIKPENLLIDQTGHLKLTDFGLSRNGLE----- 149 (260)
T ss_pred CCHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCcEEEeecccceeccc-----
Confidence 99999984 345688999999999999999999998 999999999999999999999999999875433
Q ss_pred cccccccccccCccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCCCchhcHHHHHHHHhcccccccccCCCCCCCh
Q 010519 347 TTRVMGTFGYVAPEYANTGMLNEKSDIYSFGVLLLEAVTGRDPVDYGRPANEVNLVEWLKMMVGTRRAEEVVDPNLEVKP 426 (508)
Q Consensus 347 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 426 (508)
.....++..|+|||.+.+..++.++||||||+++|+|++|..||..... ............ ......
T Consensus 150 ~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~------~~~~~~~~~~~~-------~~~~~~ 216 (260)
T cd05611 150 NKKFVGTPDYLAPETILGVGDDKMSDWWSLGCVIFEFLFGYPPFHAETP------DAVFDNILSRRI-------NWPEEV 216 (260)
T ss_pred cccCCCCcCccChhhhcCCCCcchhhhHHHHHHHHHHHHCCCCCCCCCH------HHHHHHHHhccc-------CCCCcc
Confidence 2234578899999999888899999999999999999999999964322 111111111100 001111
Q ss_pred hHHHHHHHHHHHHHhcCCCCCCCCCHH---HHHHH
Q 010519 427 ATRALKRSLLVALRCVDPDSEKRPKMS---QVVRM 458 (508)
Q Consensus 427 ~~~~~~~l~~li~~cl~~dP~~RPs~~---evl~~ 458 (508)
.......+.+++.+||+.||++||++. |++.+
T Consensus 217 ~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~l~~ 251 (260)
T cd05611 217 KEFCSPEAVDLINRLLCMDPAKRLGANGYQEIKSH 251 (260)
T ss_pred cccCCHHHHHHHHHHccCCHHHccCCCcHHHHHcC
Confidence 112345667799999999999999664 55544
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do |
| >cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-35 Score=292.62 Aligned_cols=256 Identities=27% Similarity=0.356 Sum_probs=198.4
Q ss_pred CcccceeEeeeCceEEEEEEEc----CCCEEEEEEEcccc----hhhHHHHHHHHHHHhcC-CCCCceeEEEEEEeCcee
Q 010519 187 RFSAENVLGEGGYGVVYKGRLI----NGSEVAVKKLLNNL----GQAEKEFRVEVEAIGHV-RHKNLVRLLGYCIEGVHR 257 (508)
Q Consensus 187 ~~~~~~~lg~G~~g~Vy~~~~~----~~~~vavK~~~~~~----~~~~~~~~~ei~~l~~l-~h~niv~~~~~~~~~~~~ 257 (508)
+|++.+.||+|++|.||+++.. ++..+|||.+.... ......+..|+.++.++ +||||+++++.+..+...
T Consensus 1 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~~~~~ 80 (288)
T cd05583 1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQTDTKL 80 (288)
T ss_pred CceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeecCCEE
Confidence 4778899999999999999753 56789999886432 12235677899999999 699999999999999999
Q ss_pred eEEEeecCCCCHHHHHhhhhccCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCEEEcCCCcEEEEecCCcc
Q 010519 258 MLVYEYVNNGNLEQWLHGAMRNQGNLTWEARMKVIIGTAKALAYLHEAIEPKVVHRDIKSSNILIDDEFNAKVSDFGLAK 337 (508)
Q Consensus 258 ~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~Dfgla~ 337 (508)
++||||+++|+|.+++. ....+++..+..++.|+++||.|||+. +++|+||+|+||+++.++.++|+|||++.
T Consensus 81 ~lv~e~~~~~~L~~~~~----~~~~~~~~~~~~~~~ql~~~l~~lH~~---~~~H~dl~p~nil~~~~~~~~l~dfg~~~ 153 (288)
T cd05583 81 HLILDYVNGGELFTHLY----QREHFTESEVRVYIAEIVLALDHLHQL---GIIYRDIKLENILLDSEGHVVLTDFGLSK 153 (288)
T ss_pred EEEEecCCCCcHHHHHh----hcCCcCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHeEECCCCCEEEEECcccc
Confidence 99999999999999984 345688999999999999999999998 99999999999999999999999999988
Q ss_pred ccCCCCCcccccccccccccCccccCCCC--CCChhhHHHHHHHHHHHHhCCCCCCCCCCCchhcHHHHHHHHhcccccc
Q 010519 338 LLDSGESHITTRVMGTFGYVAPEYANTGM--LNEKSDIYSFGVLLLEAVTGRDPVDYGRPANEVNLVEWLKMMVGTRRAE 415 (508)
Q Consensus 338 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~~DvwS~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~ 415 (508)
..............|+..|+|||.+.+.. ++.++||||||+++|+|++|..||....... .............
T Consensus 154 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~--~~~~~~~~~~~~~--- 228 (288)
T cd05583 154 EFLAEEEERAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQN--SQSEISRRILKSK--- 228 (288)
T ss_pred ccccccccccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcccCcccc--hHHHHHHHHHccC---
Confidence 65433322223346789999999987655 7889999999999999999999986332211 1112122221110
Q ss_pred cccCCCCCCChhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhhcC
Q 010519 416 EVVDPNLEVKPATRALKRSLLVALRCVDPDSEKRPKMSQVVRMLEAD 462 (508)
Q Consensus 416 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~ 462 (508)
+.. +......+.+++.+||+.||++|||+.++...|+..
T Consensus 229 ----~~~----~~~~~~~l~~li~~~l~~~p~~R~t~~~~~~~l~~~ 267 (288)
T cd05583 229 ----PPF----PKTMSAEARDFIQKLLEKDPKKRLGANGADEIKNHP 267 (288)
T ss_pred ----CCC----CcccCHHHHHHHHHHhcCCHhhccCcchHHHHhcCc
Confidence 111 111234566789999999999999988777666543
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines |
| >cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=300.24 Aligned_cols=265 Identities=24% Similarity=0.334 Sum_probs=195.6
Q ss_pred hCCcccceeEeeeCceEEEEEEEc-CCCEEEEEEEcccc--hhhHHHHHHHHHHHhcC-CCCCceeEEEEEEeC--ceee
Q 010519 185 TNRFSAENVLGEGGYGVVYKGRLI-NGSEVAVKKLLNNL--GQAEKEFRVEVEAIGHV-RHKNLVRLLGYCIEG--VHRM 258 (508)
Q Consensus 185 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~ei~~l~~l-~h~niv~~~~~~~~~--~~~~ 258 (508)
.++|++.+.||+|+||.||+|.+. ++..+|+|++.... ......+..|+.++.++ +||||++++++|... ...+
T Consensus 6 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~~~~~ 85 (337)
T cd07852 6 LRKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGDHPNIVKLLNVIKAENDKDIY 85 (337)
T ss_pred hhHHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeeccccCcchhhhhhhHHHHHHHHhcCCCCccceeeeeccCCCceEE
Confidence 468999999999999999999875 57889999885422 22334567799999999 999999999998654 4678
Q ss_pred EEEeecCCCCHHHHHhhhhccCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCEEEcCCCcEEEEecCCccc
Q 010519 259 LVYEYVNNGNLEQWLHGAMRNQGNLTWEARMKVIIGTAKALAYLHEAIEPKVVHRDIKSSNILIDDEFNAKVSDFGLAKL 338 (508)
Q Consensus 259 lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~Dfgla~~ 338 (508)
+||||++ ++|.+++.. . .+.+..++.++.||+.||.|||+. +|+|+||||+||+++.++.+||+|||++..
T Consensus 86 lv~e~~~-~~L~~~~~~----~-~~~~~~~~~i~~qi~~~L~~LH~~---~i~H~dl~p~nill~~~~~~kl~d~g~~~~ 156 (337)
T cd07852 86 LVFEYME-TDLHAVIRA----N-ILEDVHKRYIMYQLLKALKYIHSG---NVIHRDLKPSNILLNSDCRVKLADFGLARS 156 (337)
T ss_pred EEecccc-cCHHHHHhc----C-CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCcEEEeeccchhc
Confidence 9999996 599988742 2 678889999999999999999998 999999999999999999999999999986
Q ss_pred cCCCCC----cccccccccccccCccccCC-CCCCChhhHHHHHHHHHHHHhCCCCCCCCCCCchhcHHH----------
Q 010519 339 LDSGES----HITTRVMGTFGYVAPEYANT-GMLNEKSDIYSFGVLLLEAVTGRDPVDYGRPANEVNLVE---------- 403 (508)
Q Consensus 339 ~~~~~~----~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwS~Gvvl~elltG~~Pf~~~~~~~~~~~~~---------- 403 (508)
...... .......|+..|+|||.+.+ ..++.++||||||+++|+|++|+.||....+........
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~ 236 (337)
T cd07852 157 LSELEENPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQLEKIIEVIGPPSAED 236 (337)
T ss_pred cccccccccCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHH
Confidence 543321 12334568899999998754 567899999999999999999999996433221110000
Q ss_pred --HHHHHhcccccccccCCCCC--CChhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 010519 404 --WLKMMVGTRRAEEVVDPNLE--VKPATRALKRSLLVALRCVDPDSEKRPKMSQVVRM 458 (508)
Q Consensus 404 --~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 458 (508)
.+.................. ..........+.+++.+||+.||.+|||+.+++++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rps~~~il~~ 295 (337)
T cd07852 237 IESIKSPFAATMLDSLPSRPRKPLDELLPKASDDALDLLKKLLVFNPNKRLTAEEALEH 295 (337)
T ss_pred HHHHHhhhHHHhhhhcccccccchhhhccCCCHHHHHHHHHhccCCcccccCHHHHhhC
Confidence 00000000000000000000 00001124567789999999999999999999986
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul |
| >cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-35 Score=294.47 Aligned_cols=261 Identities=21% Similarity=0.234 Sum_probs=193.7
Q ss_pred ccceeEeeeCceEEEEEEEcCCCEEEEEEEccc--chhhHHHHHHHHHHHhcCCCCCceeEEEEEEeCceeeEEEeecCC
Q 010519 189 SAENVLGEGGYGVVYKGRLINGSEVAVKKLLNN--LGQAEKEFRVEVEAIGHVRHKNLVRLLGYCIEGVHRMLVYEYVNN 266 (508)
Q Consensus 189 ~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~--~~~~~~~~~~ei~~l~~l~h~niv~~~~~~~~~~~~~lv~E~~~~ 266 (508)
.+.+.+|.|+++.||++.. ++..||+|++... .......+..|+.+++.++|+||+++++++.+....+++|||+++
T Consensus 5 ~i~~~~~~~~~v~~~~~~~-~~~~~avK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~e~~~~ 83 (314)
T cd08216 5 LIGKCFEDLMIVHLAKHKP-TNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSPLMAY 83 (314)
T ss_pred hhhHhhcCCceEEEEEecC-CCCEEEEEEEeccccchhHHHHHHHHHHHHHhcCCcchhhhhheeecCCeEEEEEeccCC
Confidence 3445556666666666654 7899999998654 234456788999999999999999999999999999999999999
Q ss_pred CCHHHHHhhhhccCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCEEEcCCCcEEEEecCCccccCCCCC--
Q 010519 267 GNLEQWLHGAMRNQGNLTWEARMKVIIGTAKALAYLHEAIEPKVVHRDIKSSNILIDDEFNAKVSDFGLAKLLDSGES-- 344 (508)
Q Consensus 267 gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~-- 344 (508)
|+|.+++... ....+++..+..++.|++.||.|||++ +|+||||||+||+++.++.+||+|||.+........
T Consensus 84 ~~l~~~l~~~--~~~~~~~~~~~~~~~~l~~~L~~LH~~---~ivH~dlk~~Nili~~~~~~kl~d~~~~~~~~~~~~~~ 158 (314)
T cd08216 84 GSCEDLLKTH--FPEGLPELAIAFILKDVLNALDYIHSK---GFIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQ 158 (314)
T ss_pred CCHHHHHHHh--cccCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCcceEEEecCCceEEecCccceeeccccccc
Confidence 9999999642 234688899999999999999999999 999999999999999999999999998875532211
Q ss_pred ----cccccccccccccCccccCC--CCCCChhhHHHHHHHHHHHHhCCCCCCCCCCCchhcHHHHHHHHhccc------
Q 010519 345 ----HITTRVMGTFGYVAPEYANT--GMLNEKSDIYSFGVLLLEAVTGRDPVDYGRPANEVNLVEWLKMMVGTR------ 412 (508)
Q Consensus 345 ----~~~~~~~gt~~y~aPE~~~~--~~~~~~~DvwS~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~------ 412 (508)
.......++..|+|||++.+ ..++.++|+|||||++|||++|..||....... .. .....+..
T Consensus 159 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~~~~~~--~~---~~~~~~~~~~~~~~ 233 (314)
T cd08216 159 RVVHDFPKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPATQ--ML---LEKVRGTVPCLLDK 233 (314)
T ss_pred cccccccccccccccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHH--HH---HHHHhccCcccccc
Confidence 11223456778999999876 358899999999999999999999997433211 11 11110000
Q ss_pred --------cccc----ccCCC----CCCChhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhh
Q 010519 413 --------RAEE----VVDPN----LEVKPATRALKRSLLVALRCVDPDSEKRPKMSQVVRMLE 460 (508)
Q Consensus 413 --------~~~~----~~~~~----~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 460 (508)
.... ..++. ............+.+++.+||..||.+|||+.+++++-.
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~p~ 297 (314)
T cd08216 234 STYPLYEDSMSQSRSSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQLLNHSF 297 (314)
T ss_pred CchhhhcCCcCcccccccccchhhhhhcchhhHHHHHHHHHHHHHhhcCCCcCcCHHHHhcCch
Confidence 0000 00000 011111223346778999999999999999999998654
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc |
| >cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-35 Score=290.05 Aligned_cols=247 Identities=23% Similarity=0.299 Sum_probs=189.0
Q ss_pred eEeeeCceEEEEEEEc-CCCEEEEEEEcccch---hhHHHHHHH---HHHHhcCCCCCceeEEEEEEeCceeeEEEeecC
Q 010519 193 VLGEGGYGVVYKGRLI-NGSEVAVKKLLNNLG---QAEKEFRVE---VEAIGHVRHKNLVRLLGYCIEGVHRMLVYEYVN 265 (508)
Q Consensus 193 ~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~e---i~~l~~l~h~niv~~~~~~~~~~~~~lv~E~~~ 265 (508)
.||+|+||.||++... +++.||+|.+..... .....+..| +..+....||||+.+++++......++||||++
T Consensus 1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~ 80 (278)
T cd05606 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMN 80 (278)
T ss_pred CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCEEEEEEecCC
Confidence 4899999999999864 588999998864321 111223333 334555689999999999999999999999999
Q ss_pred CCCHHHHHhhhhccCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCEEEcCCCcEEEEecCCccccCCCCCc
Q 010519 266 NGNLEQWLHGAMRNQGNLTWEARMKVIIGTAKALAYLHEAIEPKVVHRDIKSSNILIDDEFNAKVSDFGLAKLLDSGESH 345 (508)
Q Consensus 266 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~ 345 (508)
+|+|.+++. ..+.+++..+..++.|++.||.|||+. +++||||||+||++++++.+||+|||++.......
T Consensus 81 g~~L~~~l~----~~~~l~~~~~~~~~~ql~~~l~~lH~~---~i~H~di~p~nili~~~~~~kl~dfg~~~~~~~~~-- 151 (278)
T cd05606 81 GGDLHYHLS----QHGVFSEAEMRFYAAEIILGLEHMHNR---FVVYRDLKPANILLDEHGHVRISDLGLACDFSKKK-- 151 (278)
T ss_pred CCcHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHHC---CEEcCCCCHHHEEECCCCCEEEccCcCccccCccC--
Confidence 999999884 456799999999999999999999998 99999999999999999999999999987554322
Q ss_pred ccccccccccccCccccCCC-CCCChhhHHHHHHHHHHHHhCCCCCCCCCCCchhcHHHHHHHHhcccccccccCCCCCC
Q 010519 346 ITTRVMGTFGYVAPEYANTG-MLNEKSDIYSFGVLLLEAVTGRDPVDYGRPANEVNLVEWLKMMVGTRRAEEVVDPNLEV 424 (508)
Q Consensus 346 ~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwS~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 424 (508)
.....|+..|+|||++.++ .++.++|||||||++|+|++|+.||............ .... . ....+.
T Consensus 152 -~~~~~~~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~~~~~~~---~~~~-~------~~~~~~- 219 (278)
T cd05606 152 -PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEID---RMTL-T------MAVELP- 219 (278)
T ss_pred -CcCcCCCcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCccchHHHH---HHhh-c------cCCCCC-
Confidence 2234689999999998754 6899999999999999999999999754322211111 0100 0 011111
Q ss_pred ChhHHHHHHHHHHHHHhcCCCCCCCC-----CHHHHHHHhhcCC
Q 010519 425 KPATRALKRSLLVALRCVDPDSEKRP-----KMSQVVRMLEADD 463 (508)
Q Consensus 425 ~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~evl~~L~~~~ 463 (508)
......+.+++.+||..||.+|| ++.+++++-+-.+
T Consensus 220 ---~~~s~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~~~~~~~ 260 (278)
T cd05606 220 ---DSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKEHPFFRS 260 (278)
T ss_pred ---CcCCHHHHHHHHHHhhcCHHhccCCCCCCHHHHHhCccccC
Confidence 11245667799999999999999 9999997554433
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co |
| >cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-36 Score=304.48 Aligned_cols=267 Identities=22% Similarity=0.336 Sum_probs=201.0
Q ss_pred CCcccceeEeeeCceEEEEEEEc-CCCEEEEEEEcccc--hhhHHHHHHHHHHHhcCCCCCceeEEEEEEe----Cceee
Q 010519 186 NRFSAENVLGEGGYGVVYKGRLI-NGSEVAVKKLLNNL--GQAEKEFRVEVEAIGHVRHKNLVRLLGYCIE----GVHRM 258 (508)
Q Consensus 186 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~ei~~l~~l~h~niv~~~~~~~~----~~~~~ 258 (508)
++|++.+.||.|+||.||+|... +|..||+|++.... ......+..|+.+++.++||||+++++++.. ....+
T Consensus 5 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 84 (334)
T cd07855 5 SRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIRDILRPPGADFKDVY 84 (334)
T ss_pred hceeeeeeeecCCCeEEEEEEEcCCCCEEEEEEeccccccccchHHHHHHHHHHHhcCCCCccCHHHhccccCCCCceEE
Confidence 68999999999999999999875 68999999886542 2234567779999999999999999998763 35678
Q ss_pred EEEeecCCCCHHHHHhhhhccCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCEEEcCCCcEEEEecCCccc
Q 010519 259 LVYEYVNNGNLEQWLHGAMRNQGNLTWEARMKVIIGTAKALAYLHEAIEPKVVHRDIKSSNILIDDEFNAKVSDFGLAKL 338 (508)
Q Consensus 259 lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~Dfgla~~ 338 (508)
+||||+. |+|.+++. ....+++..+..++.||+.||.|||+. +++||||||+||++++++.+||+|||++..
T Consensus 85 lv~e~~~-~~l~~~~~----~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~Nil~~~~~~~kl~dfg~~~~ 156 (334)
T cd07855 85 VVMDLME-SDLHHIIH----SDQPLTEEHIRYFLYQLLRGLKYIHSA---NVIHRDLKPSNLLVNEDCELRIGDFGMARG 156 (334)
T ss_pred EEEehhh-hhHHHHhc----cCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCcEEeccccccee
Confidence 9999995 68998884 445689999999999999999999998 999999999999999999999999999976
Q ss_pred cCCCCC---cccccccccccccCccccCC-CCCCChhhHHHHHHHHHHHHhCCCCCCCCCCCchhcHHHHHHHHhcccc-
Q 010519 339 LDSGES---HITTRVMGTFGYVAPEYANT-GMLNEKSDIYSFGVLLLEAVTGRDPVDYGRPANEVNLVEWLKMMVGTRR- 413 (508)
Q Consensus 339 ~~~~~~---~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwS~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~- 413 (508)
...... .......++..|+|||++.+ ..++.++|||||||++|||++|+.||........ ...+..+.+...
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~~~~~~---~~~~~~~~g~~~~ 233 (334)
T cd07855 157 LSSSPTEHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQ---LKLILSVLGSPSE 233 (334)
T ss_pred ecccCcCCCcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCccCCCChHHH---HHHHHHHhCCChh
Confidence 543221 11234568899999998865 5688999999999999999999999964332111 111111111100
Q ss_pred ----------ccc---ccCCCCCCCh---hHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhhcCC
Q 010519 414 ----------AEE---VVDPNLEVKP---ATRALKRSLLVALRCVDPDSEKRPKMSQVVRMLEADD 463 (508)
Q Consensus 414 ----------~~~---~~~~~~~~~~---~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~ 463 (508)
... .......... .......+.+++.+||+.||.+|||+.+++.+.+-..
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~~~~~~ 299 (334)
T cd07855 234 EVLNRIGSDRVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQALQHPFLAQ 299 (334)
T ss_pred HhhhhhchhhHHHHHhhcccCCCCCHHHHcccCCHHHHHHHHHHccCChhhCcCHHHHHhChhhhh
Confidence 000 0000000000 0123566788999999999999999999998765543
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the |
| >cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-36 Score=295.69 Aligned_cols=257 Identities=27% Similarity=0.406 Sum_probs=196.5
Q ss_pred HhhCCcccceeEeeeCceEEEEEEEcC-CCEEEEEEEcccc-hhhHHHHHHHHHHHhcC-CCCCceeEEEEEEeCceeeE
Q 010519 183 IATNRFSAENVLGEGGYGVVYKGRLIN-GSEVAVKKLLNNL-GQAEKEFRVEVEAIGHV-RHKNLVRLLGYCIEGVHRML 259 (508)
Q Consensus 183 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~-~~~~~~~~~ei~~l~~l-~h~niv~~~~~~~~~~~~~l 259 (508)
+..++|.+.+.||+|+||.||+|.+.. +..+|||.+.... ......+..|+.++..+ .||||+++++++.+....++
T Consensus 12 ~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~ 91 (296)
T cd06618 12 ADLNDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVKCYGYFITDSDVFI 91 (296)
T ss_pred CCcchheeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCChHHHHHHHHHHHHHHhccCCCchHhhheeeecCCeEEE
Confidence 344688999999999999999999864 8899999986433 22334556677766666 59999999999999999999
Q ss_pred EEeecCCCCHHHHHhhhhccCCCccHHHHHHHHHHHHHHHHHHHh-cCCCCeEeecCCCCCEEEcCCCcEEEEecCCccc
Q 010519 260 VYEYVNNGNLEQWLHGAMRNQGNLTWEARMKVIIGTAKALAYLHE-AIEPKVVHRDIKSSNILIDDEFNAKVSDFGLAKL 338 (508)
Q Consensus 260 v~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~yLH~-~~~~~iiH~Dlk~~NIll~~~~~~kl~Dfgla~~ 338 (508)
+|||+. ++|.+++.. ....+++..+..++.+|+.||+|||+ . +|+||||+|+||++++++.+||+|||++..
T Consensus 92 v~e~~~-~~l~~l~~~---~~~~l~~~~~~~i~~~i~~~l~~lH~~~---~i~H~dl~p~nill~~~~~~kL~dfg~~~~ 164 (296)
T cd06618 92 CMELMS-TCLDKLLKR---IQGPIPEDILGKMTVAIVKALHYLKEKH---GVIHRDVKPSNILLDASGNVKLCDFGISGR 164 (296)
T ss_pred EeeccC-cCHHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHhhC---CEecCCCcHHHEEEcCCCCEEECccccchh
Confidence 999985 578877642 34578999999999999999999996 5 899999999999999999999999999986
Q ss_pred cCCCCCcccccccccccccCccccCCCC----CCChhhHHHHHHHHHHHHhCCCCCCCCCCCchhcHHHHHHHHhccccc
Q 010519 339 LDSGESHITTRVMGTFGYVAPEYANTGM----LNEKSDIYSFGVLLLEAVTGRDPVDYGRPANEVNLVEWLKMMVGTRRA 414 (508)
Q Consensus 339 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~----~~~~~DvwS~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~ 414 (508)
...... .....++..|+|||.+.+.. ++.++||||||+++|+|++|+.||...... . +.+........
T Consensus 165 ~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~--~---~~~~~~~~~~~- 236 (296)
T cd06618 165 LVDSKA--KTRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTE--F---EVLTKILQEEP- 236 (296)
T ss_pred ccCCCc--ccCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCcchhH--H---HHHHHHhcCCC-
Confidence 543322 22335788999999987654 788999999999999999999999642211 1 11111111110
Q ss_pred ccccCCCCCCChhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhhc
Q 010519 415 EEVVDPNLEVKPATRALKRSLLVALRCVDPDSEKRPKMSQVVRMLEA 461 (508)
Q Consensus 415 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~ 461 (508)
+.... .......+.+++.+||+.||.+||++.+++++..-
T Consensus 237 -----~~~~~--~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~~~~ 276 (296)
T cd06618 237 -----PSLPP--NEGFSPDFCSFVDLCLTKDHRKRPKYRELLQHPFI 276 (296)
T ss_pred -----CCCCC--CCCCCHHHHHHHHHHccCChhhCCCHHHHhcChhh
Confidence 11111 11123456779999999999999999999987553
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it |
| >cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-35 Score=293.07 Aligned_cols=245 Identities=25% Similarity=0.366 Sum_probs=193.3
Q ss_pred cccceeEeeeCceEEEEEEEc-CCCEEEEEEEcccc---hhhHHHHHHHHHHHhcCCCCCceeEEEEEEeCceeeEEEee
Q 010519 188 FSAENVLGEGGYGVVYKGRLI-NGSEVAVKKLLNNL---GQAEKEFRVEVEAIGHVRHKNLVRLLGYCIEGVHRMLVYEY 263 (508)
Q Consensus 188 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~ei~~l~~l~h~niv~~~~~~~~~~~~~lv~E~ 263 (508)
|...+.||+|+||+||+|+.. ++..+++|++.... ......+..|+.+++.++|||++++++++.+....++||||
T Consensus 23 ~~~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 102 (313)
T cd06633 23 FVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKEHTAWLVMEY 102 (313)
T ss_pred hhcceeeccCCCeEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEEec
Confidence 666778999999999999874 68889999885432 22335677899999999999999999999999999999999
Q ss_pred cCCCCHHHHHhhhhccCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCEEEcCCCcEEEEecCCccccCCCC
Q 010519 264 VNNGNLEQWLHGAMRNQGNLTWEARMKVIIGTAKALAYLHEAIEPKVVHRDIKSSNILIDDEFNAKVSDFGLAKLLDSGE 343 (508)
Q Consensus 264 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~~~ 343 (508)
+. |+|.+++. .....+++..++.++.||+.||.|||+. +++|+||+|+||+++.++.+||+|||++.....
T Consensus 103 ~~-~~l~~~l~---~~~~~l~~~~~~~~~~qi~~al~~LH~~---gi~H~dl~p~nili~~~~~~kL~dfg~~~~~~~-- 173 (313)
T cd06633 103 CL-GSASDLLE---VHKKPLQEVEIAAITHGALQGLAYLHSH---NMIHRDIKAGNILLTEPGQVKLADFGSASKSSP-- 173 (313)
T ss_pred CC-CCHHHHHH---hcCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCChhhEEECCCCCEEEeecCCCcccCC--
Confidence 95 58888775 3345689999999999999999999998 999999999999999999999999999864322
Q ss_pred CcccccccccccccCccccC---CCCCCChhhHHHHHHHHHHHHhCCCCCCCCCCCchhcHHHHHHHHhcccccccccCC
Q 010519 344 SHITTRVMGTFGYVAPEYAN---TGMLNEKSDIYSFGVLLLEAVTGRDPVDYGRPANEVNLVEWLKMMVGTRRAEEVVDP 420 (508)
Q Consensus 344 ~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DvwS~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 420 (508)
.....|+..|+|||++. +..++.++|||||||++|+|++|..||....... .......... +
T Consensus 174 ---~~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~~~~------~~~~~~~~~~------~ 238 (313)
T cd06633 174 ---ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMS------ALYHIAQNDS------P 238 (313)
T ss_pred ---CCCccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHH------HHHHHHhcCC------C
Confidence 22346888999999974 4568899999999999999999999986432211 1111111100 1
Q ss_pred CCCCChhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHh
Q 010519 421 NLEVKPATRALKRSLLVALRCVDPDSEKRPKMSQVVRML 459 (508)
Q Consensus 421 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L 459 (508)
... .......+.+++.+||+.+|.+||++.+++.+-
T Consensus 239 ~~~---~~~~~~~l~~li~~~l~~~P~~Rp~~~~~l~~~ 274 (313)
T cd06633 239 TLQ---SNEWTDSFRGFVDYCLQKIPQERPASAELLRHD 274 (313)
T ss_pred CCC---ccccCHHHHHHHHHHccCChhhCcCHHHHhcCc
Confidence 111 111223466799999999999999999999763
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co |
| >cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=296.11 Aligned_cols=251 Identities=25% Similarity=0.363 Sum_probs=197.4
Q ss_pred CCcccceeEeeeCceEEEEEEEc-CCCEEEEEEEccc---chhhHHHHHHHHHHHhcCCCCCceeEEEEEEeCceeeEEE
Q 010519 186 NRFSAENVLGEGGYGVVYKGRLI-NGSEVAVKKLLNN---LGQAEKEFRVEVEAIGHVRHKNLVRLLGYCIEGVHRMLVY 261 (508)
Q Consensus 186 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~ei~~l~~l~h~niv~~~~~~~~~~~~~lv~ 261 (508)
+.|...+.||+|+||.||+|+.. ++..+++|.+... .......+..|+++++.++|+|++++++++......++||
T Consensus 15 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 94 (308)
T cd06634 15 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM 94 (308)
T ss_pred HHHHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEEcCCeeEEEE
Confidence 45777889999999999999875 6788999987532 2233456778999999999999999999999999999999
Q ss_pred eecCCCCHHHHHhhhhccCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCEEEcCCCcEEEEecCCccccCC
Q 010519 262 EYVNNGNLEQWLHGAMRNQGNLTWEARMKVIIGTAKALAYLHEAIEPKVVHRDIKSSNILIDDEFNAKVSDFGLAKLLDS 341 (508)
Q Consensus 262 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~ 341 (508)
||+. |+|.+++. .....+++..+..++.+++.||.|||+. +++|+||+|+||+++.++.++|+|||++.....
T Consensus 95 e~~~-~~l~~~~~---~~~~~l~~~~~~~~~~~l~~~l~~LH~~---~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~ 167 (308)
T cd06634 95 EYCL-GSASDLLE---VHKKPLQEVEIAAVTHGALQGLAYLHSH---NMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP 167 (308)
T ss_pred EccC-CCHHHHHH---HcCCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHhEEECCCCcEEECCcccceeecC
Confidence 9996 68888775 2345688999999999999999999998 999999999999999999999999999876543
Q ss_pred CCCcccccccccccccCccccC---CCCCCChhhHHHHHHHHHHHHhCCCCCCCCCCCchhcHHHHHHHHhccccccccc
Q 010519 342 GESHITTRVMGTFGYVAPEYAN---TGMLNEKSDIYSFGVLLLEAVTGRDPVDYGRPANEVNLVEWLKMMVGTRRAEEVV 418 (508)
Q Consensus 342 ~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DvwS~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 418 (508)
. ....+++.|+|||.+. ...++.++|||||||++|+|++|..||...... ...........
T Consensus 168 ~-----~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~------~~~~~~~~~~~----- 231 (308)
T cd06634 168 A-----NXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAM------SALYHIAQNES----- 231 (308)
T ss_pred c-----ccccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCccccHH------HHHHHHhhcCC-----
Confidence 2 2345788999999874 356788999999999999999999998543211 11111111000
Q ss_pred CCCCCCChhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhhcCC
Q 010519 419 DPNLEVKPATRALKRSLLVALRCVDPDSEKRPKMSQVVRMLEADD 463 (508)
Q Consensus 419 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~ 463 (508)
+.. ........+.+++.+||+.+|.+||++.+++++.+...
T Consensus 232 -~~~---~~~~~~~~~~~li~~cl~~~P~~Rp~~~~ll~~~~~~~ 272 (308)
T cd06634 232 -PAL---QSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRFVLR 272 (308)
T ss_pred -CCc---CcccccHHHHHHHHHHhhCCcccCCCHHHHhhCccccc
Confidence 111 11123455677999999999999999999998866554
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin |
| >cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-36 Score=302.33 Aligned_cols=263 Identities=25% Similarity=0.340 Sum_probs=201.1
Q ss_pred CcccceeEeeeCceEEEEEEEc-CCCEEEEEEEcccc--hhhHHHHHHHHHHHhcCCCCCceeEEEEEEeCc-----eee
Q 010519 187 RFSAENVLGEGGYGVVYKGRLI-NGSEVAVKKLLNNL--GQAEKEFRVEVEAIGHVRHKNLVRLLGYCIEGV-----HRM 258 (508)
Q Consensus 187 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~ei~~l~~l~h~niv~~~~~~~~~~-----~~~ 258 (508)
+|.+.+.||.|++|.||+|+.. ++..+++|++.... ....+.+..|+.+++.++|+||+++++++.... ..|
T Consensus 1 ~y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~ 80 (330)
T cd07834 1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDVY 80 (330)
T ss_pred CceeeeeecCCCCeEEEEEEeCCCCcEEEEEeeccccccchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccceE
Confidence 5888899999999999999875 48899999886543 334467888999999999999999999988765 789
Q ss_pred EEEeecCCCCHHHHHhhhhccCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCEEEcCCCcEEEEecCCccc
Q 010519 259 LVYEYVNNGNLEQWLHGAMRNQGNLTWEARMKVIIGTAKALAYLHEAIEPKVVHRDIKSSNILIDDEFNAKVSDFGLAKL 338 (508)
Q Consensus 259 lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~Dfgla~~ 338 (508)
++|||+. ++|.+++. ....+++..++.++.+|+.||.|||+. +++|+||||.|||++.++.++|+|||++..
T Consensus 81 lv~e~~~-~~l~~~l~----~~~~l~~~~~~~i~~~l~~~l~~LH~~---gi~H~dlkp~nili~~~~~~~L~dfg~~~~ 152 (330)
T cd07834 81 IVTELME-TDLHKVIK----SPQPLTDDHIQYFLYQILRGLKYLHSA---NVIHRDLKPSNILVNSNCDLKICDFGLARG 152 (330)
T ss_pred EEecchh-hhHHHHHh----CCCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEcccCceEe
Confidence 9999997 58888884 344899999999999999999999999 999999999999999999999999999987
Q ss_pred cCCCCC--cccccccccccccCccccCCC-CCCChhhHHHHHHHHHHHHhCCCCCCCCCCCchhcHHHHHHHHhcccccc
Q 010519 339 LDSGES--HITTRVMGTFGYVAPEYANTG-MLNEKSDIYSFGVLLLEAVTGRDPVDYGRPANEVNLVEWLKMMVGTRRAE 415 (508)
Q Consensus 339 ~~~~~~--~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwS~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~ 415 (508)
...... .......++..|+|||++.+. .++.++|+||||+++|+|++|..||....... ....+....+.....
T Consensus 153 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~~~~~~---~~~~i~~~~~~~~~~ 229 (330)
T cd07834 153 VDPDEDEKGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYID---QLNLIVEVLGTPSEE 229 (330)
T ss_pred ecccccccccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcCCCCHHH---HHHHHHHhcCCCChh
Confidence 654321 123344678899999999887 88999999999999999999999996443211 111111111100000
Q ss_pred c-----------cc---CCCCCCC---hhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhh
Q 010519 416 E-----------VV---DPNLEVK---PATRALKRSLLVALRCVDPDSEKRPKMSQVVRMLE 460 (508)
Q Consensus 416 ~-----------~~---~~~~~~~---~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 460 (508)
. .+ ....... ........+.+++.+||+.||.+|||+.+++.+-.
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~ 291 (330)
T cd07834 230 DLKFITSEKARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEALAHPY 291 (330)
T ss_pred HhhhccccchhhHHhhcccCCcchhHHhcccCCHHHHHHHHHHccCChhhCCCHHHHHhCcc
Confidence 0 00 0000000 00112456778999999999999999999998643
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and |
| >KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-36 Score=283.14 Aligned_cols=256 Identities=24% Similarity=0.338 Sum_probs=201.8
Q ss_pred eeEeeeCceEEEEEE-EcCCCEEEEEEEcccchhhHHHHHHHHHHHhcC-CCCCceeEEEEEEeCceeeEEEeecCCCCH
Q 010519 192 NVLGEGGYGVVYKGR-LINGSEVAVKKLLNNLGQAEKEFRVEVEAIGHV-RHKNLVRLLGYCIEGVHRMLVYEYVNNGNL 269 (508)
Q Consensus 192 ~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~ei~~l~~l-~h~niv~~~~~~~~~~~~~lv~E~~~~gsL 269 (508)
+.||+|+|+.|.-+. ..+|.++|||++.+........+.+|++++.++ .|+||++++++|+++...|+|||.|.||+|
T Consensus 84 e~LGeGAyasVqtcv~i~t~~EYAVKiidKq~gHsR~RvfREVe~f~~Cqgh~nilqLiefFEdd~~FYLVfEKm~GGpl 163 (463)
T KOG0607|consen 84 ELLGEGAYASVQTCVSIQTGKEYAVKIIDKQPGHSRSRVFREVETFYQCQGHKNILQLIEFFEDDTRFYLVFEKMRGGPL 163 (463)
T ss_pred HHhcCccceeeeeeeeeccchhhhhhhhhcCCchHHHHHHHHHHHHHHhcCCccHHHHHHHhcccceEEEEEecccCchH
Confidence 579999999999987 458999999999888888888889999999998 599999999999999999999999999999
Q ss_pred HHHHhhhhccCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCEEEcCCCc---EEEEecCCccccCC--CCC
Q 010519 270 EQWLHGAMRNQGNLTWEARMKVIIGTAKALAYLHEAIEPKVVHRDIKSSNILIDDEFN---AKVSDFGLAKLLDS--GES 344 (508)
Q Consensus 270 ~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiH~Dlk~~NIll~~~~~---~kl~Dfgla~~~~~--~~~ 344 (508)
..+|+ +...+++..+.++..+|+.||.|||.+ ||.||||||+|||-.+... +|||||.+..-... +..
T Consensus 164 LshI~----~~~~F~E~EAs~vvkdia~aLdFlH~k---gIAHRDlKPENiLC~~pn~vsPvKiCDfDLgSg~k~~~~~s 236 (463)
T KOG0607|consen 164 LSHIQ----KRKHFNEREASRVVKDIASALDFLHTK---GIAHRDLKPENILCESPNKVSPVKICDFDLGSGIKLNNDCS 236 (463)
T ss_pred HHHHH----HhhhccHHHHHHHHHHHHHHHHHHhhc---CcccccCCccceeecCCCCcCceeeeccccccccccCCCCC
Confidence 99994 566799999999999999999999999 9999999999999987665 79999988753321 111
Q ss_pred ----cccccccccccccCccccC-----CCCCCChhhHHHHHHHHHHHHhCCCCCCCCCCCc------hh--cHHHHHHH
Q 010519 345 ----HITTRVMGTFGYVAPEYAN-----TGMLNEKSDIYSFGVLLLEAVTGRDPVDYGRPAN------EV--NLVEWLKM 407 (508)
Q Consensus 345 ----~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DvwS~Gvvl~elltG~~Pf~~~~~~~------~~--~~~~~~~~ 407 (508)
......+|+..|||||+.. ...|+.+.|.||||||||-|++|..||......+ +. .-.+.+..
T Consensus 237 pastP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~Cg~dCGWdrGe~Cr~CQ~~LFe 316 (463)
T KOG0607|consen 237 PASTPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFE 316 (463)
T ss_pred CCCCccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCccCCcCCccCCCccHHHHHHHHH
Confidence 1133467899999999763 3568999999999999999999999996443221 11 11111111
Q ss_pred HhcccccccccCCCCCCC--hhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhhcC
Q 010519 408 MVGTRRAEEVVDPNLEVK--PATRALKRSLLVALRCVDPDSEKRPKMSQVVRMLEAD 462 (508)
Q Consensus 408 ~~~~~~~~~~~~~~~~~~--~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~ 462 (508)
-+ -+..+..+ ..........+|+...|..|+.+|.++.+++++-+..
T Consensus 317 sI--------QEGkYeFPdkdWahIS~eakdlisnLlvrda~~rlsa~~vlnhPw~~ 365 (463)
T KOG0607|consen 317 SI--------QEGKYEFPDKDWAHISSEAKDLISNLLVRDAKQRLSAAQVLNHPWVQ 365 (463)
T ss_pred HH--------hccCCcCChhhhHHhhHHHHHHHHHHHhccHHhhhhhhhccCCcccc
Confidence 11 11222222 2233455566788999999999999999999865543
|
|
| >cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-35 Score=286.99 Aligned_cols=261 Identities=25% Similarity=0.331 Sum_probs=194.5
Q ss_pred cccceeEeeeCceEEEEEEEc-CCCEEEEEEEcccch--hhHHHHHHHHHHHhcC---CCCCceeEEEEEEeCce-----
Q 010519 188 FSAENVLGEGGYGVVYKGRLI-NGSEVAVKKLLNNLG--QAEKEFRVEVEAIGHV---RHKNLVRLLGYCIEGVH----- 256 (508)
Q Consensus 188 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~ei~~l~~l---~h~niv~~~~~~~~~~~----- 256 (508)
|++.+.||.|+||.||+|++. ++..+|+|++..... .....+..|+.++.++ +|||++++++++.....
T Consensus 1 y~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~ 80 (287)
T cd07838 1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDRELK 80 (287)
T ss_pred CeEEEEecccCceEEEEEEECCCCCEEEEEEeccccccchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCce
Confidence 567889999999999999986 489999999864322 1223455677766655 69999999999988776
Q ss_pred eeEEEeecCCCCHHHHHhhhhccCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCEEEcCCCcEEEEecCCc
Q 010519 257 RMLVYEYVNNGNLEQWLHGAMRNQGNLTWEARMKVIIGTAKALAYLHEAIEPKVVHRDIKSSNILIDDEFNAKVSDFGLA 336 (508)
Q Consensus 257 ~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~Dfgla 336 (508)
.+++|||+. ++|.+++.. .....+++..++.++.|++.||.|||+. +++|+||+|+||++++++.+||+|||++
T Consensus 81 ~~l~~e~~~-~~l~~~l~~--~~~~~l~~~~~~~~~~~i~~al~~LH~~---~i~h~~l~~~nili~~~~~~~l~dfg~~ 154 (287)
T cd07838 81 LTLVFEHVD-QDLATYLSK--CPKPGLPPETIKDLMRQLLRGVDFLHSH---RIVHRDLKPQNILVTSDGQVKIADFGLA 154 (287)
T ss_pred eEEEehhcc-cCHHHHHHH--ccCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCChhhEEEccCCCEEEeccCcc
Confidence 899999996 489998863 2234689999999999999999999998 9999999999999999999999999999
Q ss_pred cccCCCCCcccccccccccccCccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCCCchhcHHHHHHHHhcccccc-
Q 010519 337 KLLDSGESHITTRVMGTFGYVAPEYANTGMLNEKSDIYSFGVLLLEAVTGRDPVDYGRPANEVNLVEWLKMMVGTRRAE- 415 (508)
Q Consensus 337 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~- 415 (508)
........ .....++..|+|||++.+..++.++|+|||||++|||++|..||..... ..................
T Consensus 155 ~~~~~~~~--~~~~~~~~~~~~PE~~~~~~~~~~~Di~s~G~~l~~l~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~ 230 (287)
T cd07838 155 RIYSFEMA--LTSVVVTLWYRAPEVLLQSSYATPVDMWSVGCIFAELFRRRPLFRGTSE--ADQLDKIFDVIGLPSEEEW 230 (287)
T ss_pred eeccCCcc--cccccccccccChHHhccCCCCCcchhhhHHHHHHHHHhCCCcccCCCh--HHHHHHHHHHcCCCChHhc
Confidence 87643322 2233578899999999998999999999999999999999988864322 111222221111000000
Q ss_pred --------cccCCCCCC---ChhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 010519 416 --------EVVDPNLEV---KPATRALKRSLLVALRCVDPDSEKRPKMSQVVRM 458 (508)
Q Consensus 416 --------~~~~~~~~~---~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 458 (508)
......... .........+.+++.+||+.||.+||++.+++.+
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~il~~ 284 (287)
T cd07838 231 PRNVSLPRSSFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQH 284 (287)
T ss_pred CCCcccchhhcccccccchhhhhhhhhHHHHHHHHHHhccCCccCCCHHHHhcC
Confidence 000000000 0111234566789999999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both |
| >cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=288.47 Aligned_cols=251 Identities=22% Similarity=0.329 Sum_probs=196.0
Q ss_pred CcccceeEeeeCceEEEEEEEcC-CCEEEEEEEccc-----chhhHHHHHHHHHHHhcCCCCCceeEEEEEEeCceeeEE
Q 010519 187 RFSAENVLGEGGYGVVYKGRLIN-GSEVAVKKLLNN-----LGQAEKEFRVEVEAIGHVRHKNLVRLLGYCIEGVHRMLV 260 (508)
Q Consensus 187 ~~~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~-----~~~~~~~~~~ei~~l~~l~h~niv~~~~~~~~~~~~~lv 260 (508)
+|.+.+.||+|+||.||++.+.. +..+++|.+... .......+..|+.+++.++||||+++++++.+....++|
T Consensus 1 ~y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 80 (260)
T cd08222 1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFLERDAFCII 80 (260)
T ss_pred CceeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHhcCCceEEE
Confidence 58888999999999999998753 444555554321 122234566789999999999999999999988899999
Q ss_pred EeecCCCCHHHHHhhhhccCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCEEEcCCCcEEEEecCCccccC
Q 010519 261 YEYVNNGNLEQWLHGAMRNQGNLTWEARMKVIIGTAKALAYLHEAIEPKVVHRDIKSSNILIDDEFNAKVSDFGLAKLLD 340 (508)
Q Consensus 261 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~Dfgla~~~~ 340 (508)
|||+++++|.+++.........+++..++.++.|++.||.|||+. +++|+||+|+||++++ +.+||+|||++....
T Consensus 81 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~i~h~~l~~~nili~~-~~~~l~d~g~~~~~~ 156 (260)
T cd08222 81 TEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQR---RILHRDLKAKNIFLKN-NLLKIGDFGVSRLLM 156 (260)
T ss_pred EEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHc---CccccCCChhheEeec-CCEeecccCceeecC
Confidence 999999999999976544566799999999999999999999998 9999999999999975 569999999997654
Q ss_pred CCCCcccccccccccccCccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCCCchhcHHHHHHHHhcccccccccCC
Q 010519 341 SGESHITTRVMGTFGYVAPEYANTGMLNEKSDIYSFGVLLLEAVTGRDPVDYGRPANEVNLVEWLKMMVGTRRAEEVVDP 420 (508)
Q Consensus 341 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 420 (508)
.... ......|++.|+|||.+.+..++.++|+||||+++|+|++|..||.... ........... . .+
T Consensus 157 ~~~~-~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~------~~~~~~~~~~~-~-----~~ 223 (260)
T cd08222 157 GSCD-LATTFTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEMCCLAHAFEGQN------FLSVVLRIVEG-P-----TP 223 (260)
T ss_pred CCcc-cccCCCCCcCccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCcc------HHHHHHHHHcC-C-----CC
Confidence 3322 2233457889999999988889999999999999999999999985321 11111111111 0 01
Q ss_pred CCCCChhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 010519 421 NLEVKPATRALKRSLLVALRCVDPDSEKRPKMSQVVRM 458 (508)
Q Consensus 421 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 458 (508)
. .+......+.+++.+||+.||.+||++.+++++
T Consensus 224 ~----~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 257 (260)
T cd08222 224 S----LPETYSRQLNSIMQSMLNKDPSLRPSAAEILRN 257 (260)
T ss_pred C----CcchhcHHHHHHHHHHhcCChhhCcCHHHHhhC
Confidence 1 112334567779999999999999999999975
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check |
| >cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-35 Score=294.08 Aligned_cols=264 Identities=26% Similarity=0.328 Sum_probs=194.7
Q ss_pred hCCcccceeEeeeCceEEEEEEEc-CCCEEEEEEEcccchh--hHHHHHHHHHHHhcCCCCCceeEEEEEEeCc------
Q 010519 185 TNRFSAENVLGEGGYGVVYKGRLI-NGSEVAVKKLLNNLGQ--AEKEFRVEVEAIGHVRHKNLVRLLGYCIEGV------ 255 (508)
Q Consensus 185 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~--~~~~~~~ei~~l~~l~h~niv~~~~~~~~~~------ 255 (508)
.++|++.+.||.|+||.||+|++. +++.+++|++...... ....+.+|+++++.++||||+++++++....
T Consensus 7 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 86 (311)
T cd07866 7 LRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLKHPNVVPLIDMAVERPDKSKRK 86 (311)
T ss_pred cccEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCCCcchhHHHHHHHHHhcCCCCccchhhheeccccccccc
Confidence 468999999999999999999875 6889999988543322 2235677999999999999999999875433
Q ss_pred --eeeEEEeecCCCCHHHHHhhhhccCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCEEEcCCCcEEEEec
Q 010519 256 --HRMLVYEYVNNGNLEQWLHGAMRNQGNLTWEARMKVIIGTAKALAYLHEAIEPKVVHRDIKSSNILIDDEFNAKVSDF 333 (508)
Q Consensus 256 --~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~Df 333 (508)
..++||||+.+ +|..++. .....+++..+..++.|+++||.|||+. +++|+||||+||++++++.++|+||
T Consensus 87 ~~~~~lv~~~~~~-~l~~~~~---~~~~~~~~~~~~~i~~~l~~al~~lH~~---~i~H~dl~p~nil~~~~~~~~l~df 159 (311)
T cd07866 87 RGSVYMVTPYMDH-DLSGLLE---NPSVKLTESQIKCYMLQLLEGINYLHEN---HILHRDIKAANILIDNQGILKIADF 159 (311)
T ss_pred CceEEEEEecCCc-CHHHHHh---ccccCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCEEECcC
Confidence 45899999965 7877775 2345799999999999999999999999 9999999999999999999999999
Q ss_pred CCccccCCCCCc----------ccccccccccccCccccCC-CCCCChhhHHHHHHHHHHHHhCCCCCCCCCCCchhcHH
Q 010519 334 GLAKLLDSGESH----------ITTRVMGTFGYVAPEYANT-GMLNEKSDIYSFGVLLLEAVTGRDPVDYGRPANEVNLV 402 (508)
Q Consensus 334 gla~~~~~~~~~----------~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwS~Gvvl~elltG~~Pf~~~~~~~~~~~~ 402 (508)
|++......... ..+...+++.|+|||.+.+ ..++.++|||||||++|||++|+.||....... ..
T Consensus 160 g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~~~~~~~~---~~ 236 (311)
T cd07866 160 GLARPYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDID---QL 236 (311)
T ss_pred ccchhccCCCcccccCCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCCCCCCHHH---HH
Confidence 999865432211 1123456888999998765 458899999999999999999999986433211 11
Q ss_pred HHHHHHhcccc---------ccccc----CCCCCCCh---hHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 010519 403 EWLKMMVGTRR---------AEEVV----DPNLEVKP---ATRALKRSLLVALRCVDPDSEKRPKMSQVVRM 458 (508)
Q Consensus 403 ~~~~~~~~~~~---------~~~~~----~~~~~~~~---~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 458 (508)
..+....+... ..... ........ .......+.+++.+||+.||.+|||+.+++.+
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~t~~ell~~ 308 (311)
T cd07866 237 HLIFKLCGTPTEETWPGWRSLPGCEGVHSFTNYPRTLEERFGKLGPEGLDLLSKLLSLDPYKRLTASDALEH 308 (311)
T ss_pred HHHHHHhCCCChhhchhhhhcccccccccCCCCCccHHHHcccCChhHHHHHHHHcccCcccCcCHHHHhcC
Confidence 11111111000 00000 00000000 01122467789999999999999999999875
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic |
| >cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-35 Score=287.92 Aligned_cols=263 Identities=25% Similarity=0.322 Sum_probs=195.5
Q ss_pred cccceeEeeeCceEEEEEEEc-CCCEEEEEEEcccch-hhHHHHHHHHHHHhcCC-CCCceeEEEEEEeCceeeEEEeec
Q 010519 188 FSAENVLGEGGYGVVYKGRLI-NGSEVAVKKLLNNLG-QAEKEFRVEVEAIGHVR-HKNLVRLLGYCIEGVHRMLVYEYV 264 (508)
Q Consensus 188 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~ei~~l~~l~-h~niv~~~~~~~~~~~~~lv~E~~ 264 (508)
|.+.+.||.|++|+||+|+.. ++..|++|++..... ........|+..+++++ |+|++++++++.++...++||||+
T Consensus 1 y~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e~~ 80 (283)
T cd07830 1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNEHPNIVKLKEVFRENDELYFVFEYM 80 (283)
T ss_pred CeeheeeccCCceEEEEEEECCCCcEEEEEEehhhccchhHHHHHHHHHHHHhccCCCCchhHHHHhhcCCcEEEEEecC
Confidence 567889999999999999975 578899998865432 22233456899999998 999999999999999999999999
Q ss_pred CCCCHHHHHhhhhccCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCEEEcCCCcEEEEecCCccccCCCCC
Q 010519 265 NNGNLEQWLHGAMRNQGNLTWEARMKVIIGTAKALAYLHEAIEPKVVHRDIKSSNILIDDEFNAKVSDFGLAKLLDSGES 344 (508)
Q Consensus 265 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~ 344 (508)
+|+|.+++.. .....+++..++.++.|++.||.|||++ +++|+||+|+||++++++.++|+|||++........
T Consensus 81 -~~~l~~~~~~--~~~~~~~~~~~~~~~~~l~~~l~~Lh~~---~i~H~dl~~~ni~i~~~~~~~l~d~~~~~~~~~~~~ 154 (283)
T cd07830 81 -EGNLYQLMKD--RKGKPFSESVIRSIIYQILQGLAHIHKH---GFFHRDLKPENLLVSGPEVVKIADFGLAREIRSRPP 154 (283)
T ss_pred -CCCHHHHHHh--cccccCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChhhEEEcCCCCEEEeecccceeccCCCC
Confidence 7899998863 2235789999999999999999999998 999999999999999999999999999986644322
Q ss_pred cccccccccccccCccccC-CCCCCChhhHHHHHHHHHHHHhCCCCCCCCCCCchhcHH----------HHHHHHhcccc
Q 010519 345 HITTRVMGTFGYVAPEYAN-TGMLNEKSDIYSFGVLLLEAVTGRDPVDYGRPANEVNLV----------EWLKMMVGTRR 413 (508)
Q Consensus 345 ~~~~~~~gt~~y~aPE~~~-~~~~~~~~DvwS~Gvvl~elltG~~Pf~~~~~~~~~~~~----------~~~~~~~~~~~ 413 (508)
.....++..|+|||++. +..++.++|+||||+++++|++|+.||............ .|.........
T Consensus 155 --~~~~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (283)
T cd07830 155 --YTDYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVLGTPTKQDWPEGYKLASK 232 (283)
T ss_pred --cCCCCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCCCChHHHHHHHHHhcCCCChhhhhhHhhhhcc
Confidence 23345788999999874 456789999999999999999999998644322111000 00000000000
Q ss_pred cccccCCCCCCCh---hHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 010519 414 AEEVVDPNLEVKP---ATRALKRSLLVALRCVDPDSEKRPKMSQVVRM 458 (508)
Q Consensus 414 ~~~~~~~~~~~~~---~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 458 (508)
............. .......+.+++.+||+.||.+|||+.|++.+
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~ 280 (283)
T cd07830 233 LGFRFPQFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPTASQALQH 280 (283)
T ss_pred ccccccccccccHHHHcccCCHHHHHHHHHhcccCcccCCCHHHHhhC
Confidence 0000000000000 00113567789999999999999999999875
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili |
| >KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-37 Score=333.92 Aligned_cols=253 Identities=28% Similarity=0.343 Sum_probs=201.2
Q ss_pred hCCcccceeEeeeCceEEEEEEE-cCCCEEEEEEEcccc--hhhHHHHHHHHHHHhcCCCCCceeEEEEEEeCceeeEEE
Q 010519 185 TNRFSAENVLGEGGYGVVYKGRL-INGSEVAVKKLLNNL--GQAEKEFRVEVEAIGHVRHKNLVRLLGYCIEGVHRMLVY 261 (508)
Q Consensus 185 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~ei~~l~~l~h~niv~~~~~~~~~~~~~lv~ 261 (508)
+-++.....||.|.||.||.|.. .+|.-.|+|-+.... ......+.+|..++..++|||+|+++|+-.+.+..+|.|
T Consensus 1234 ~~rWqrg~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvHRekv~IFM 1313 (1509)
T KOG4645|consen 1234 TFRWQRGNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSDHKTFKLIAEEMKVLEGLNHPNLVRYYGVEVHREKVYIFM 1313 (1509)
T ss_pred eeeeccccccCCcceeeeEEeecCCccchhhhhhhhcCccccccCcchHHHHHHHHhccCccccccCceeecHHHHHHHH
Confidence 34667778899999999999975 478889999775433 233356788999999999999999999999999999999
Q ss_pred eecCCCCHHHHHhhhhccCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCEEEcCCCcEEEEecCCccccCC
Q 010519 262 EYVNNGNLEQWLHGAMRNQGNLTWEARMKVIIGTAKALAYLHEAIEPKVVHRDIKSSNILIDDEFNAKVSDFGLAKLLDS 341 (508)
Q Consensus 262 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~ 341 (508)
|||.+|+|.+++ ..+...++.....+..|++.|+.|||++ |||||||||.||||+.+|.+|++|||.|..+..
T Consensus 1314 EyC~~GsLa~ll----~~gri~dE~vt~vyt~qll~gla~LH~~---gIVHRDIK~aNI~Ld~~g~iK~~DFGsa~ki~~ 1386 (1509)
T KOG4645|consen 1314 EYCEGGSLASLL----EHGRIEDEMVTRVYTKQLLEGLAYLHEH---GIVHRDIKPANILLDFNGLIKYGDFGSAVKIKN 1386 (1509)
T ss_pred HHhccCcHHHHH----HhcchhhhhHHHHHHHHHHHHHHHHHhc---CceecCCCccceeeecCCcEEeecccceeEecC
Confidence 999999999998 3455567777788889999999999999 999999999999999999999999999987754
Q ss_pred CCC---cccccccccccccCccccCCC---CCCChhhHHHHHHHHHHHHhCCCCCCCCCCCchhcHHHHHHHHhcccccc
Q 010519 342 GES---HITTRVMGTFGYVAPEYANTG---MLNEKSDIYSFGVLLLEAVTGRDPVDYGRPANEVNLVEWLKMMVGTRRAE 415 (508)
Q Consensus 342 ~~~---~~~~~~~gt~~y~aPE~~~~~---~~~~~~DvwS~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~ 415 (508)
... ......+||+.|||||++.+. ...-++||||+|||+.||+||+.||..-+ ++.++. ... +.+.
T Consensus 1387 ~~~~~~~el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~d--ne~aIM--y~V--~~gh-- 1458 (1509)
T KOG4645|consen 1387 NAQTMPGELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELD--NEWAIM--YHV--AAGH-- 1458 (1509)
T ss_pred chhcCCHHHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhcc--chhHHH--hHH--hccC--
Confidence 421 223456899999999999653 35579999999999999999999996332 222111 111 1111
Q ss_pred cccCCCCCCChhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHh
Q 010519 416 EVVDPNLEVKPATRALKRSLLVALRCVDPDSEKRPKMSQVVRML 459 (508)
Q Consensus 416 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L 459 (508)
....+.+....-.+++.+||..||.+|.++.|++++=
T Consensus 1459 -------~Pq~P~~ls~~g~dFle~Cl~~dP~~Rw~~~qlle~~ 1495 (1509)
T KOG4645|consen 1459 -------KPQIPERLSSEGRDFLEHCLEQDPKMRWTASQLLEHA 1495 (1509)
T ss_pred -------CCCCchhhhHhHHHHHHHHHhcCchhhhHHHHHHHhh
Confidence 1122333556667799999999999999999988753
|
|
| >KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-36 Score=277.82 Aligned_cols=260 Identities=22% Similarity=0.280 Sum_probs=200.1
Q ss_pred hhCCcccc-eeEeeeCceEEEEEEEc-CCCEEEEEEEcccchhhHHHHHHHHHHHhcC-CCCCceeEEEEEEeC----ce
Q 010519 184 ATNRFSAE-NVLGEGGYGVVYKGRLI-NGSEVAVKKLLNNLGQAEKEFRVEVEAIGHV-RHKNLVRLLGYCIEG----VH 256 (508)
Q Consensus 184 ~~~~~~~~-~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~ei~~l~~l-~h~niv~~~~~~~~~----~~ 256 (508)
.+++|++. ++||-|-.|.|..+.++ .|+.+|+|++... ...++|+++--.. .|||||.++++|.+. ..
T Consensus 59 itedY~is~qvLG~GinGkV~~C~~k~T~ekfALKvL~Ds-----~KARrEVeLHw~~s~h~~iV~IidVyeNs~~~rkc 133 (400)
T KOG0604|consen 59 ITEDYSISWQVLGAGINGKVVQCVHKRTQEKFALKVLLDS-----PKARREVELHWMASGHPHIVSIIDVYENSYQGRKC 133 (400)
T ss_pred chhhheehhhhhccccCCceEEEEeccchhhhHHHHHhcC-----HHHHhHhhhhhhhcCCCceEEeehhhhhhccCcee
Confidence 45566654 56999999999999875 6888999987543 2344577664444 699999999998754 45
Q ss_pred eeEEEeecCCCCHHHHHhhhhccCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCEEEcC---CCcEEEEec
Q 010519 257 RMLVYEYVNNGNLEQWLHGAMRNQGNLTWEARMKVIIGTAKALAYLHEAIEPKVVHRDIKSSNILIDD---EFNAKVSDF 333 (508)
Q Consensus 257 ~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiH~Dlk~~NIll~~---~~~~kl~Df 333 (508)
+.+|||.|+||.|+..+.. +....+++..+..|+.||+.|+.|||+. +|.||||||+|+|.+. |..+||+||
T Consensus 134 LLiVmE~meGGeLfsriq~--~g~~afTErea~eI~~qI~~Av~~lH~~---nIAHRDlKpENLLyt~t~~na~lKLtDf 208 (400)
T KOG0604|consen 134 LLIVMECMEGGELFSRIQD--RGDQAFTEREASEIMKQIGLAVRYLHSM---NIAHRDLKPENLLYTTTSPNAPLKLTDF 208 (400)
T ss_pred eEeeeecccchHHHHHHHH--cccccchHHHHHHHHHHHHHHHHHHHhc---chhhccCChhheeeecCCCCcceEeccc
Confidence 6799999999999999965 4456799999999999999999999999 9999999999999964 445999999
Q ss_pred CCccccCCCCCcccccccccccccCccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCCCchhcHHHHHHHHhcccc
Q 010519 334 GLAKLLDSGESHITTRVMGTFGYVAPEYANTGMLNEKSDIYSFGVLLLEAVTGRDPVDYGRPANEVNLVEWLKMMVGTRR 413 (508)
Q Consensus 334 gla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~ 413 (508)
|+++..... ......+-||.|.|||++..+.|+...|+||+||++|-|++|..||..... ..+..-++..+..+.
T Consensus 209 GFAK~t~~~--~~L~TPc~TPyYvaPevlg~eKydkscdmwSlgVimYIlLCGyPPFYS~hg---~aispgMk~rI~~gq 283 (400)
T KOG0604|consen 209 GFAKETQEP--GDLMTPCFTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHG---LAISPGMKRRIRTGQ 283 (400)
T ss_pred ccccccCCC--ccccCCcccccccCHHHhCchhcCCCCCccchhHHHHHhhcCCCcccccCC---ccCChhHHhHhhccC
Confidence 999976543 335556789999999999999999999999999999999999999953322 111111111111111
Q ss_pred cccccCCCCCCChhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhhcCCC
Q 010519 414 AEEVVDPNLEVKPATRALKRSLLVALRCVDPDSEKRPKMSQVVRMLEADDY 464 (508)
Q Consensus 414 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~ 464 (508)
-.+..+......+...++|+.+|..+|.+|.|+.+++.+-+....
T Consensus 284 ------y~FP~pEWs~VSe~aKdlIR~LLkt~PteRlTI~~~m~hpwi~~~ 328 (400)
T KOG0604|consen 284 ------YEFPEPEWSCVSEAAKDLIRKLLKTEPTERLTIEEVMDHPWINQY 328 (400)
T ss_pred ------ccCCChhHhHHHHHHHHHHHHHhcCCchhheeHHHhhcCchhccc
Confidence 112222233456667789999999999999999999998776544
|
|
| >cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-35 Score=299.23 Aligned_cols=268 Identities=26% Similarity=0.327 Sum_probs=200.0
Q ss_pred eHHHHHHhhCCcccceeEeeeCceEEEEEEEc-CCCEEEEEEEcccc--hhhHHHHHHHHHHHhcCCCCCceeEEEEEEe
Q 010519 177 TLRDLEIATNRFSAENVLGEGGYGVVYKGRLI-NGSEVAVKKLLNNL--GQAEKEFRVEVEAIGHVRHKNLVRLLGYCIE 253 (508)
Q Consensus 177 ~~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~ei~~l~~l~h~niv~~~~~~~~ 253 (508)
...++....++|.+.+.||+|+||.||+|... ++..||+|++.... ......+.+|+.++++++||||+++++++..
T Consensus 8 ~~~~~~~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~iv~~~~~~~~ 87 (345)
T cd07877 8 LNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTP 87 (345)
T ss_pred HHHHHhhccCceEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHHHHHHcCCCcccceeeeeee
Confidence 34566677899999999999999999999864 68899999886432 2234567789999999999999999998864
Q ss_pred C------ceeeEEEeecCCCCHHHHHhhhhccCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCEEEcCCCc
Q 010519 254 G------VHRMLVYEYVNNGNLEQWLHGAMRNQGNLTWEARMKVIIGTAKALAYLHEAIEPKVVHRDIKSSNILIDDEFN 327 (508)
Q Consensus 254 ~------~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiH~Dlk~~NIll~~~~~ 327 (508)
. ...+++++++ +++|.+++. ...+++..++.++.|++.||.|||+. +++||||||+||++++++.
T Consensus 88 ~~~~~~~~~~~lv~~~~-~~~L~~~~~-----~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIll~~~~~ 158 (345)
T cd07877 88 ARSLEEFNDVYLVTHLM-GADLNNIVK-----CQKLTDDHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCE 158 (345)
T ss_pred cccccccccEEEEehhc-ccCHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCChHHEEEcCCCC
Confidence 3 3357888887 789988774 23588999999999999999999999 9999999999999999999
Q ss_pred EEEEecCCccccCCCCCcccccccccccccCccccCC-CCCCChhhHHHHHHHHHHHHhCCCCCCCCCCCchhcHHHHHH
Q 010519 328 AKVSDFGLAKLLDSGESHITTRVMGTFGYVAPEYANT-GMLNEKSDIYSFGVLLLEAVTGRDPVDYGRPANEVNLVEWLK 406 (508)
Q Consensus 328 ~kl~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwS~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~ 406 (508)
+||+|||++...... .....++..|+|||.+.+ ..++.++|||||||++|+|++|+.||....... .+.....
T Consensus 159 ~kl~dfg~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~--~~~~~~~ 232 (345)
T cd07877 159 LKILDFGLARHTDDE----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHID--QLKLILR 232 (345)
T ss_pred EEEeccccccccccc----ccccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH--HHHHHHH
Confidence 999999999865332 233467889999998866 568899999999999999999999996433211 1111110
Q ss_pred HHhcccc---cccc-----------cCCCCCCCh---hHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhh
Q 010519 407 MMVGTRR---AEEV-----------VDPNLEVKP---ATRALKRSLLVALRCVDPDSEKRPKMSQVVRMLE 460 (508)
Q Consensus 407 ~~~~~~~---~~~~-----------~~~~~~~~~---~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 460 (508)
...... ...+ +........ .......+.+++.+||+.||.+|||+.+++.+-.
T Consensus 233 -~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~~ 302 (345)
T cd07877 233 -LVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAY 302 (345)
T ss_pred -HhCCCCHHHHhhcccHhHHHHHHHhcccCCcchhhhcCCCCHHHHHHHHHHcCCChhhcCCHHHHhcChh
Confidence 000000 0000 000000000 0012345678999999999999999999998753
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14 |
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-36 Score=319.57 Aligned_cols=249 Identities=27% Similarity=0.404 Sum_probs=185.6
Q ss_pred hCCcccceeEeeeCceEEEEEEEc-CCCEEEEEEEcccc-hhhHHHHHHHHHHHhcCCCCCceeEEEEEEe---------
Q 010519 185 TNRFSAENVLGEGGYGVVYKGRLI-NGSEVAVKKLLNNL-GQAEKEFRVEVEAIGHVRHKNLVRLLGYCIE--------- 253 (508)
Q Consensus 185 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~ei~~l~~l~h~niv~~~~~~~~--------- 253 (508)
.++|+.++.||+||||.||+++.+ +|+.+|||++..+. .+....+.+|+..|.+|+|||||+++..+.+
T Consensus 478 ~~DFEEL~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~~~~~~e 557 (1351)
T KOG1035|consen 478 LNDFEELELLGKGGFGSVVKVRNKLDGREYAIKKIPLKASDKLYSKILREVKLLARLNHPNVVRYYSAWVESTAELTVLE 557 (1351)
T ss_pred hhhhHHHHHhcCCCCceEEEEeecccchhhhhhhccCchHHHHHHHHHHHHHHHhhcCCcceeeeehhhhccCCcccccc
Confidence 357888899999999999999876 89999999997664 3334567889999999999999998753100
Q ss_pred --------------------------------------------------------C-----------------------
Q 010519 254 --------------------------------------------------------G----------------------- 254 (508)
Q Consensus 254 --------------------------------------------------------~----------------------- 254 (508)
+
T Consensus 558 i~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~tS~~e 637 (1351)
T KOG1035|consen 558 IVASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNTSDSE 637 (1351)
T ss_pred ccccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCcccccccccccccccccccC
Confidence 0
Q ss_pred -------------------------------ceeeEEEeecCCCCHHHHHhhhhccCCCc-cHHHHHHHHHHHHHHHHHH
Q 010519 255 -------------------------------VHRMLVYEYVNNGNLEQWLHGAMRNQGNL-TWEARMKVIIGTAKALAYL 302 (508)
Q Consensus 255 -------------------------------~~~~lv~E~~~~gsL~~~l~~~~~~~~~l-~~~~~~~i~~~i~~al~yL 302 (508)
..+||=||||+...|.++++. +... .....++++.+|++||.|+
T Consensus 638 ~~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~----N~~~~~~d~~wrLFreIlEGLaYI 713 (1351)
T KOG1035|consen 638 GSVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRR----NHFNSQRDEAWRLFREILEGLAYI 713 (1351)
T ss_pred CccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHh----cccchhhHHHHHHHHHHHHHHHHH
Confidence 124678999988777776642 1111 3577899999999999999
Q ss_pred HhcCCCCeEeecCCCCCEEEcCCCcEEEEecCCccccC-----------------CCCCcccccccccccccCccccCCC
Q 010519 303 HEAIEPKVVHRDIKSSNILIDDEFNAKVSDFGLAKLLD-----------------SGESHITTRVMGTFGYVAPEYANTG 365 (508)
Q Consensus 303 H~~~~~~iiH~Dlk~~NIll~~~~~~kl~Dfgla~~~~-----------------~~~~~~~~~~~gt~~y~aPE~~~~~ 365 (508)
|++ |||||||||.||+++++..|||+|||++.... .......+..+||..|+|||++.+.
T Consensus 714 H~~---giIHRDLKP~NIFLd~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll~~~ 790 (1351)
T KOG1035|consen 714 HDQ---GIIHRDLKPRNIFLDSRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELLSDT 790 (1351)
T ss_pred HhC---ceeeccCCcceeEEcCCCCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHHhccc
Confidence 999 99999999999999999999999999998621 0111235667899999999999765
Q ss_pred ---CCCChhhHHHHHHHHHHHHhCCCCCCCCCCCchhcHHHHHHHHhcccccccccCCCCCCC--hhHHHHHHHHHHHHH
Q 010519 366 ---MLNEKSDIYSFGVLLLEAVTGRDPVDYGRPANEVNLVEWLKMMVGTRRAEEVVDPNLEVK--PATRALKRSLLVALR 440 (508)
Q Consensus 366 ---~~~~~~DvwS~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~l~~li~~ 440 (508)
.|+.|+|+||+||||+||+. ||.... +.+..+..-+ ++.++.+ ........-..+|.+
T Consensus 791 ~~~~Yn~KiDmYSLGIVlFEM~y---PF~TsM--------ERa~iL~~LR------~g~iP~~~~f~~~~~~~e~slI~~ 853 (1351)
T KOG1035|consen 791 SSNKYNSKIDMYSLGIVLFEMLY---PFGTSM--------ERASILTNLR------KGSIPEPADFFDPEHPEEASLIRW 853 (1351)
T ss_pred ccccccchhhhHHHHHHHHHHhc---cCCchH--------HHHHHHHhcc------cCCCCCCcccccccchHHHHHHHH
Confidence 49999999999999999986 565332 1111111111 1222222 111122233448899
Q ss_pred hcCCCCCCCCCHHHHHH
Q 010519 441 CVDPDSEKRPKMSQVVR 457 (508)
Q Consensus 441 cl~~dP~~RPs~~evl~ 457 (508)
+++.||.+||||.|+|+
T Consensus 854 Ll~hdP~kRPtA~eLL~ 870 (1351)
T KOG1035|consen 854 LLSHDPSKRPTATELLN 870 (1351)
T ss_pred HhcCCCccCCCHHHHhh
Confidence 99999999999999986
|
|
| >PTZ00024 cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-35 Score=296.13 Aligned_cols=268 Identities=21% Similarity=0.256 Sum_probs=198.2
Q ss_pred CCcc-cceeEeeeCceEEEEEEEc-CCCEEEEEEEcccchhh--------------HHHHHHHHHHHhcCCCCCceeEEE
Q 010519 186 NRFS-AENVLGEGGYGVVYKGRLI-NGSEVAVKKLLNNLGQA--------------EKEFRVEVEAIGHVRHKNLVRLLG 249 (508)
Q Consensus 186 ~~~~-~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~--------------~~~~~~ei~~l~~l~h~niv~~~~ 249 (508)
++|. +.+.||.|+||+||+|.+. .++.||+|++....... ...+..|+++++.++|+||+++++
T Consensus 8 ~ry~~~~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~ 87 (335)
T PTZ00024 8 ERYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGLVD 87 (335)
T ss_pred cchhhhhhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceeeeeE
Confidence 4564 4577999999999999865 68899999885432211 124677999999999999999999
Q ss_pred EEEeCceeeEEEeecCCCCHHHHHhhhhccCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCEEEcCCCcEE
Q 010519 250 YCIEGVHRMLVYEYVNNGNLEQWLHGAMRNQGNLTWEARMKVIIGTAKALAYLHEAIEPKVVHRDIKSSNILIDDEFNAK 329 (508)
Q Consensus 250 ~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiH~Dlk~~NIll~~~~~~k 329 (508)
++......++||||+. |+|.+++. ....+++.....++.|++.||.|||+. +++|+||+|+||+++.++.++
T Consensus 88 ~~~~~~~~~lv~e~~~-~~l~~~l~----~~~~~~~~~~~~~~~ql~~aL~~LH~~---~i~H~dl~~~nill~~~~~~k 159 (335)
T PTZ00024 88 VYVEGDFINLVMDIMA-SDLKKVVD----RKIRLTESQVKCILLQILNGLNVLHKW---YFMHRDLSPANIFINSKGICK 159 (335)
T ss_pred EEecCCcEEEEEeccc-cCHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHhC---CeecccccHHHeEECCCCCEE
Confidence 9999999999999996 69999884 345688999999999999999999998 999999999999999999999
Q ss_pred EEecCCccccCCCC-------------CcccccccccccccCccccCCC-CCCChhhHHHHHHHHHHHHhCCCCCCCCCC
Q 010519 330 VSDFGLAKLLDSGE-------------SHITTRVMGTFGYVAPEYANTG-MLNEKSDIYSFGVLLLEAVTGRDPVDYGRP 395 (508)
Q Consensus 330 l~Dfgla~~~~~~~-------------~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwS~Gvvl~elltG~~Pf~~~~~ 395 (508)
|+|||++....... ........+++.|+|||.+.+. .++.++|||||||++|+|++|..||.....
T Consensus 160 l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~ 239 (335)
T PTZ00024 160 IADFGLARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGENE 239 (335)
T ss_pred ECCccceeecccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCH
Confidence 99999997654111 1112223467889999998764 478999999999999999999999964432
Q ss_pred CchhcHHHHHHHHhcccccccc-----------cCCCCCCC---hhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhhc
Q 010519 396 ANEVNLVEWLKMMVGTRRAEEV-----------VDPNLEVK---PATRALKRSLLVALRCVDPDSEKRPKMSQVVRMLEA 461 (508)
Q Consensus 396 ~~~~~~~~~~~~~~~~~~~~~~-----------~~~~~~~~---~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~ 461 (508)
.. ....+....+....... ........ ........+.+++.+||+.+|.+|||+++++.+-+-
T Consensus 240 ~~---~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~~~~~ 316 (335)
T PTZ00024 240 ID---QLGRIFELLGTPNEDNWPQAKKLPLYTEFTPRKPKDLKTIFPNASDDAIDLLQSLLKLNPLERISAKEALKHEYF 316 (335)
T ss_pred HH---HHHHHHHHhCCCchhhCcchhhcccccccCcCCcccHHHhCcCCChHHHHHHHHHcCCCchhccCHHHHhcCccc
Confidence 11 11111111111100000 00000000 001124567789999999999999999999986655
Q ss_pred CCC
Q 010519 462 DDY 464 (508)
Q Consensus 462 ~~~ 464 (508)
...
T Consensus 317 ~~~ 319 (335)
T PTZ00024 317 KSD 319 (335)
T ss_pred CCC
Confidence 443
|
|
| >KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-36 Score=293.68 Aligned_cols=255 Identities=25% Similarity=0.307 Sum_probs=202.3
Q ss_pred hhCCcccceeEeeeCceEEEEEEEc-CCCEEEEEEEcccc---hhhHHHHHHHHHHHhcCCCCCceeEEEEEEeCceeeE
Q 010519 184 ATNRFSAENVLGEGGYGVVYKGRLI-NGSEVAVKKLLNNL---GQAEKEFRVEVEAIGHVRHKNLVRLLGYCIEGVHRML 259 (508)
Q Consensus 184 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~ei~~l~~l~h~niv~~~~~~~~~~~~~l 259 (508)
..+.|..-++||+|+||.||-++.. +|+-+|.|++.++. .+.+....+|-.+|.+++.++||.+--.|+..+.+++
T Consensus 183 t~n~F~~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVslaYAfeTkd~LCl 262 (591)
T KOG0986|consen 183 TKNTFRVYRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSLAYAFETKDALCL 262 (591)
T ss_pred cccceeeeEEEecccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEEeeeecCCCceEE
Confidence 4467888899999999999999865 68889999885443 3334556779999999999999999888999999999
Q ss_pred EEeecCCCCHHHHHhhhhccCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCEEEcCCCcEEEEecCCcccc
Q 010519 260 VYEYVNNGNLEQWLHGAMRNQGNLTWEARMKVIIGTAKALAYLHEAIEPKVVHRDIKSSNILIDDEFNAKVSDFGLAKLL 339 (508)
Q Consensus 260 v~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~Dfgla~~~ 339 (508)
|+..|.||+|.-+|.. -....+++..++.++.+|+.||.+||+. +||+|||||+|||||+.|+++|+|+|+|..+
T Consensus 263 VLtlMNGGDLkfHiyn--~g~~gF~e~ra~FYAAEi~cGLehlH~~---~iVYRDLKPeNILLDd~GhvRISDLGLAvei 337 (591)
T KOG0986|consen 263 VLTLMNGGDLKFHIYN--HGNPGFDEQRARFYAAEIICGLEHLHRR---RIVYRDLKPENILLDDHGHVRISDLGLAVEI 337 (591)
T ss_pred EEEeecCCceeEEeec--cCCCCCchHHHHHHHHHHHhhHHHHHhc---ceeeccCChhheeeccCCCeEeeccceEEec
Confidence 9999999999988854 2335799999999999999999999999 9999999999999999999999999999988
Q ss_pred CCCCCcccccccccccccCccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCCCchhcHHHHHHHHhcccccccccC
Q 010519 340 DSGESHITTRVMGTFGYVAPEYANTGMLNEKSDIYSFGVLLLEAVTGRDPVDYGRPANEVNLVEWLKMMVGTRRAEEVVD 419 (508)
Q Consensus 340 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 419 (508)
..+.. ....+||.+|||||++.++.|+...|+|||||+||||+.|+.||........ .+-+..+.....
T Consensus 338 ~~g~~--~~~rvGT~GYMAPEvl~ne~Y~~s~Dwf~lGCllYemi~G~sPFr~~KeKvk---~eEvdrr~~~~~------ 406 (591)
T KOG0986|consen 338 PEGKP--IRGRVGTVGYMAPEVLQNEVYDFSPDWFSLGCLLYEMIAGHSPFRQRKEKVK---REEVDRRTLEDP------ 406 (591)
T ss_pred CCCCc--cccccCcccccCHHHHcCCcccCCccHHHHHhHHHHHHcccCchhhhhhhhh---HHHHHHHHhcch------
Confidence 76654 3444899999999999999999999999999999999999999964432111 111222211110
Q ss_pred CCCCCChhHHHHHHHHHHHHHhcCCCCCCCCC-----HHHHHHH
Q 010519 420 PNLEVKPATRALKRSLLVALRCVDPDSEKRPK-----MSQVVRM 458 (508)
Q Consensus 420 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs-----~~evl~~ 458 (508)
. ..+.....+..+|....|.+||.+|.- +.+|-+|
T Consensus 407 ~----ey~~kFS~eakslc~~LL~Kdp~~RLGcrg~ga~evk~H 446 (591)
T KOG0986|consen 407 E----EYSDKFSEEAKSLCEGLLTKDPEKRLGCRGEGAQEVKEH 446 (591)
T ss_pred h----hcccccCHHHHHHHHHHHccCHHHhccCCCcCcchhhhC
Confidence 0 111223344555777889999999974 4555543
|
|
| >cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-35 Score=294.20 Aligned_cols=261 Identities=27% Similarity=0.352 Sum_probs=196.9
Q ss_pred HhhCCcccceeEeeeCceEEEEEEEc-CCCEEEEEEEcccc--hhhHHHHHHHHHHHhcCCCCCceeEEEEEEe-Cceee
Q 010519 183 IATNRFSAENVLGEGGYGVVYKGRLI-NGSEVAVKKLLNNL--GQAEKEFRVEVEAIGHVRHKNLVRLLGYCIE-GVHRM 258 (508)
Q Consensus 183 ~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~ei~~l~~l~h~niv~~~~~~~~-~~~~~ 258 (508)
..+++|++.+.||.|+||.||++... ++..+|+|++.... ......+..|+.+++.++||||++++++|.. ....+
T Consensus 7 ~~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~ 86 (328)
T cd07856 7 EITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSDIFISPLEDIY 86 (328)
T ss_pred ccccceEEEEeecccCCeEEEEEEECCCCCEEEEEEecccccccchhHHHHHHHHHHHhcCCCCeeeEeeeEecCCCcEE
Confidence 46778999999999999999999865 78899999875432 2234567789999999999999999999876 46788
Q ss_pred EEEeecCCCCHHHHHhhhhccCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCEEEcCCCcEEEEecCCccc
Q 010519 259 LVYEYVNNGNLEQWLHGAMRNQGNLTWEARMKVIIGTAKALAYLHEAIEPKVVHRDIKSSNILIDDEFNAKVSDFGLAKL 338 (508)
Q Consensus 259 lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~Dfgla~~ 338 (508)
+++||+ +++|.+++. ...+++..+..++.|+++||.|||+. +++|+||+|+|||+++++.++|+|||++..
T Consensus 87 lv~e~~-~~~L~~~~~-----~~~~~~~~~~~~~~ql~~aL~~LH~~---~iiH~dl~p~Nili~~~~~~~l~dfg~~~~ 157 (328)
T cd07856 87 FVTELL-GTDLHRLLT-----SRPLEKQFIQYFLYQILRGLKYVHSA---GVVHRDLKPSNILINENCDLKICDFGLARI 157 (328)
T ss_pred EEeehh-ccCHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEeECCCCCEEeCccccccc
Confidence 999999 568988874 34578888889999999999999999 999999999999999999999999999985
Q ss_pred cCCCCCcccccccccccccCccccCC-CCCCChhhHHHHHHHHHHHHhCCCCCCCCCCCchhcHHHHHHHHhcc------
Q 010519 339 LDSGESHITTRVMGTFGYVAPEYANT-GMLNEKSDIYSFGVLLLEAVTGRDPVDYGRPANEVNLVEWLKMMVGT------ 411 (508)
Q Consensus 339 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwS~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~------ 411 (508)
.... .....+++.|+|||.+.+ ..++.++|||||||++|+|++|+.||......... ..+....+.
T Consensus 158 ~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~~~~~~~~---~~~~~~~~~~~~~~~ 230 (328)
T cd07856 158 QDPQ----MTGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQF---SIITDLLGTPPDDVI 230 (328)
T ss_pred cCCC----cCCCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHH---HHHHHHhCCCCHHHH
Confidence 4322 123457889999998765 57899999999999999999999999644321111 111111100
Q ss_pred ------cccccccCC--CCCCChh---HHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHh
Q 010519 412 ------RRAEEVVDP--NLEVKPA---TRALKRSLLVALRCVDPDSEKRPKMSQVVRML 459 (508)
Q Consensus 412 ------~~~~~~~~~--~~~~~~~---~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L 459 (508)
......... ....... ......+.+++.+||+.+|.+|||+.+++.+-
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~ell~~~ 289 (328)
T cd07856 231 NTICSENTLRFVQSLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALAHP 289 (328)
T ss_pred HhccchhhHHHHhhccccCCCcHHHHcCCCCHHHHHHHHHHcCCChhhCCCHHHHhcCC
Confidence 000000000 0000000 11235677899999999999999999998763
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U |
| >cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-36 Score=301.57 Aligned_cols=265 Identities=23% Similarity=0.296 Sum_probs=195.0
Q ss_pred CCcccceeEeeeCceEEEEEEEc-CCCEEEEEEEcccchhhHHHHHHHHHHHhcCCCCCceeEEEEEEeC----------
Q 010519 186 NRFSAENVLGEGGYGVVYKGRLI-NGSEVAVKKLLNNLGQAEKEFRVEVEAIGHVRHKNLVRLLGYCIEG---------- 254 (508)
Q Consensus 186 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~ei~~l~~l~h~niv~~~~~~~~~---------- 254 (508)
.+|.+.+.||.|+||.||+|... +|..||+|++........+.+.+|+++++.++||||+++++++...
T Consensus 5 ~~y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~ 84 (342)
T cd07854 5 SRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTEDVGS 84 (342)
T ss_pred cceEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCCCchHHHHHHHHHHHHhcCCCcchhhHhhhccccccccccccc
Confidence 58999999999999999999875 6889999998665555556788899999999999999999876543
Q ss_pred ----ceeeEEEeecCCCCHHHHHhhhhccCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCEEEc-CCCcEE
Q 010519 255 ----VHRMLVYEYVNNGNLEQWLHGAMRNQGNLTWEARMKVIIGTAKALAYLHEAIEPKVVHRDIKSSNILID-DEFNAK 329 (508)
Q Consensus 255 ----~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiH~Dlk~~NIll~-~~~~~k 329 (508)
...++||||++ ++|.+++. ...+++..++.++.||+.||.|||+. +++||||||+||+++ +++.+|
T Consensus 85 ~~~~~~~~lv~e~~~-~~L~~~~~-----~~~l~~~~~~~~~~qi~~aL~~LH~~---givH~dikp~Nili~~~~~~~k 155 (342)
T cd07854 85 LTELNSVYIVQEYME-TDLANVLE-----QGPLSEEHARLFMYQLLRGLKYIHSA---NVLHRDLKPANVFINTEDLVLK 155 (342)
T ss_pred ccccceEEEEeeccc-ccHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEEcCCCceEE
Confidence 35689999996 58988773 34688999999999999999999998 999999999999997 456789
Q ss_pred EEecCCccccCCCCCc--ccccccccccccCccccCC-CCCCChhhHHHHHHHHHHHHhCCCCCCCCCCCchhcHHHHHH
Q 010519 330 VSDFGLAKLLDSGESH--ITTRVMGTFGYVAPEYANT-GMLNEKSDIYSFGVLLLEAVTGRDPVDYGRPANEVNLVEWLK 406 (508)
Q Consensus 330 l~Dfgla~~~~~~~~~--~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwS~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~ 406 (508)
|+|||++......... ......++..|+|||.+.+ ..++.++|||||||++|+|++|+.||....+..... ..+.
T Consensus 156 l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~~~--~~~~ 233 (342)
T cd07854 156 IGDFGLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQMQ--LILE 233 (342)
T ss_pred ECCcccceecCCccccccccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHH--HHHH
Confidence 9999999865432111 1123357889999997654 568899999999999999999999996443211111 0000
Q ss_pred HHhcc----------ccccccc-CCCCCCChh----HHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhhc
Q 010519 407 MMVGT----------RRAEEVV-DPNLEVKPA----TRALKRSLLVALRCVDPDSEKRPKMSQVVRMLEA 461 (508)
Q Consensus 407 ~~~~~----------~~~~~~~-~~~~~~~~~----~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~ 461 (508)
..... ....... .......+. ......+.+++.+||+.||.+|||+.+++.+-.-
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~h~~~ 303 (342)
T cd07854 234 SVPVVREEDRNELLNVIPSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLTAEEALMHPYM 303 (342)
T ss_pred hcCCCChHHhhhhhhhhhhhhhhcccccCCCHHHHccCCCHHHHHHHHHHhCCCchhccCHHHHhCCCcc
Confidence 00000 0000000 000000000 1123567789999999999999999999976443
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi |
| >KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-35 Score=317.15 Aligned_cols=265 Identities=29% Similarity=0.459 Sum_probs=214.2
Q ss_pred HHHHhhCCcccceeEeeeCceEEEEEEEc----C----CCEEEEEEEcccch-hhHHHHHHHHHHHhcC-CCCCceeEEE
Q 010519 180 DLEIATNRFSAENVLGEGGYGVVYKGRLI----N----GSEVAVKKLLNNLG-QAEKEFRVEVEAIGHV-RHKNLVRLLG 249 (508)
Q Consensus 180 ~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~----~----~~~vavK~~~~~~~-~~~~~~~~ei~~l~~l-~h~niv~~~~ 249 (508)
.+++..++..+.+.||+|.||.|++|... . ...||||++..... ...+.+..|+++|+.+ .|+||+.++|
T Consensus 290 ~~e~~~~~l~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~~~~~~~~~El~~m~~~g~H~niv~llG 369 (609)
T KOG0200|consen 290 KWEIPRENLKLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASSSEKKDLMSELNVLKELGKHPNIVNLLG 369 (609)
T ss_pred ceeechhhccccceeecccccceEeEEEeecccccccceEEEEEEecccccCcHHHHHHHHHHHHHHHhcCCcchhhhee
Confidence 56777888888889999999999999743 1 45799999876543 3456788999999999 5999999999
Q ss_pred EEEeCceeeEEEeecCCCCHHHHHhhhh---c-------cC--CCccHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCC
Q 010519 250 YCIEGVHRMLVYEYVNNGNLEQWLHGAM---R-------NQ--GNLTWEARMKVIIGTAKALAYLHEAIEPKVVHRDIKS 317 (508)
Q Consensus 250 ~~~~~~~~~lv~E~~~~gsL~~~l~~~~---~-------~~--~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiH~Dlk~ 317 (508)
+|..+...++|+||+..|+|.++|+... . .. ..++..+.+.++.|||.|+.||++. +++||||..
T Consensus 370 ~~t~~~~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~---~~vHRDLAa 446 (609)
T KOG0200|consen 370 ACTQDGPLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLASV---PCVHRDLAA 446 (609)
T ss_pred eeccCCceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhhC---Cccchhhhh
Confidence 9999999999999999999999997543 0 01 2488999999999999999999999 999999999
Q ss_pred CCEEEcCCCcEEEEecCCccccCCCCCcccccccc--cccccCccccCCCCCCChhhHHHHHHHHHHHHh-CCCCCCCCC
Q 010519 318 SNILIDDEFNAKVSDFGLAKLLDSGESHITTRVMG--TFGYVAPEYANTGMLNEKSDIYSFGVLLLEAVT-GRDPVDYGR 394 (508)
Q Consensus 318 ~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~~~g--t~~y~aPE~~~~~~~~~~~DvwS~Gvvl~ellt-G~~Pf~~~~ 394 (508)
+|||++++..+||+|||+++..............+ ...|||||.+....|+.++|||||||+||||++ |..||..-.
T Consensus 447 RNVLi~~~~~~kIaDFGlar~~~~~~~y~~~~~~~~LP~kWmApEsl~~~~ft~kSDVWSfGI~L~EifsLG~~PYp~~~ 526 (609)
T KOG0200|consen 447 RNVLITKNKVIKIADFGLARDHYNKDYYRTKSSAGTLPVKWMAPESLFDRVFTSKSDVWSFGILLWEIFTLGGTPYPGIP 526 (609)
T ss_pred hhEEecCCCEEEEccccceeccCCCCceEecCCCCccceeecCHHHhccCcccccchhhHHHHHHHHHhhCCCCCCCCCC
Confidence 99999999999999999999665544333222222 446999999999999999999999999999999 889986421
Q ss_pred CCchhcHHHHHHHHhcccccccccCCCCCCChhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhhcC
Q 010519 395 PANEVNLVEWLKMMVGTRRAEEVVDPNLEVKPATRALKRSLLVALRCVDPDSEKRPKMSQVVRMLEAD 462 (508)
Q Consensus 395 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~ 462 (508)
.. ..+.++++ ...+...+..+..++.++++.||+.+|.+||++.++.+.++..
T Consensus 527 ~~--~~l~~~l~-------------~G~r~~~P~~c~~eiY~iM~~CW~~~p~~RP~F~~~~~~~~~~ 579 (609)
T KOG0200|consen 527 PT--EELLEFLK-------------EGNRMEQPEHCSDEIYDLMKSCWNADPEDRPTFSECVEFFEKH 579 (609)
T ss_pred cH--HHHHHHHh-------------cCCCCCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHHHHH
Confidence 11 11222222 3334444455567788899999999999999999999999883
|
|
| >cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-35 Score=297.95 Aligned_cols=257 Identities=25% Similarity=0.388 Sum_probs=192.1
Q ss_pred hCCcccceeEeeeCceEEEEEEEc-CCCEEEEEEEcccc--hhhHHHHHHHHHHHhcCCCCCceeEEEEEEeCc------
Q 010519 185 TNRFSAENVLGEGGYGVVYKGRLI-NGSEVAVKKLLNNL--GQAEKEFRVEVEAIGHVRHKNLVRLLGYCIEGV------ 255 (508)
Q Consensus 185 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~ei~~l~~l~h~niv~~~~~~~~~~------ 255 (508)
.++|...+.||+|+||.||+|.+. +|..||+|++.... ......+..|+.+++.++||||+++++++....
T Consensus 14 ~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 93 (342)
T cd07879 14 PERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGDEFQ 93 (342)
T ss_pred ccceEEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCccccccchhHHHHHHHHHHhcCCCCccchhheecccccCCCCc
Confidence 468999999999999999999865 68999999886432 222345778999999999999999999987542
Q ss_pred eeeEEEeecCCCCHHHHHhhhhccCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCEEEcCCCcEEEEecCC
Q 010519 256 HRMLVYEYVNNGNLEQWLHGAMRNQGNLTWEARMKVIIGTAKALAYLHEAIEPKVVHRDIKSSNILIDDEFNAKVSDFGL 335 (508)
Q Consensus 256 ~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~Dfgl 335 (508)
..++|+||+.. +|..++ ...+++..+..++.|++.||.|||+. +++||||||+|||++.++.+||+|||+
T Consensus 94 ~~~lv~e~~~~-~l~~~~------~~~~~~~~~~~~~~qi~~aL~~LH~~---~i~H~dlkp~NIll~~~~~~kL~dfg~ 163 (342)
T cd07879 94 DFYLVMPYMQT-DLQKIM------GHPLSEDKVQYLVYQMLCGLKYIHSA---GIIHRDLKPGNLAVNEDCELKILDFGL 163 (342)
T ss_pred eEEEEeccccc-CHHHHH------cCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEeeCCC
Confidence 45899999964 777654 23588899999999999999999999 999999999999999999999999999
Q ss_pred ccccCCCCCcccccccccccccCccccCC-CCCCChhhHHHHHHHHHHHHhCCCCCCCCCCCchhcHHHHHHHHhccc--
Q 010519 336 AKLLDSGESHITTRVMGTFGYVAPEYANT-GMLNEKSDIYSFGVLLLEAVTGRDPVDYGRPANEVNLVEWLKMMVGTR-- 412 (508)
Q Consensus 336 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwS~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~-- 412 (508)
+...... .....+++.|+|||.+.+ ..++.++|||||||++|||++|+.||........ +.. +....+..
T Consensus 164 ~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~~~~~~~--~~~-~~~~~~~~~~ 236 (342)
T cd07879 164 ARHADAE----MTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQ--LTQ-ILKVTGVPGP 236 (342)
T ss_pred CcCCCCC----CCCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCCCCCHHHH--HHH-HHHhcCCCCH
Confidence 9865322 223467889999999876 5688999999999999999999999974332111 111 00000000
Q ss_pred ---------ccccccC--CCCCCCh----hHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 010519 413 ---------RAEEVVD--PNLEVKP----ATRALKRSLLVALRCVDPDSEKRPKMSQVVRM 458 (508)
Q Consensus 413 ---------~~~~~~~--~~~~~~~----~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 458 (508)
....... +...... .......+.+++.+||+.||.+||++.+++.+
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~~~~e~l~h 297 (342)
T cd07879 237 EFVQKLEDKAAKSYIKSLPKYPRKDFSTLFPKASPQAVDLLEKMLELDVDKRLTATEALEH 297 (342)
T ss_pred HHHHHhcccchHHHHhhcCCcccchHHHHhcCCCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 0000000 0000000 01123456789999999999999999999976
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13 |
| >cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-34 Score=292.12 Aligned_cols=260 Identities=25% Similarity=0.376 Sum_probs=194.9
Q ss_pred hhCCcccceeEeeeCceEEEEEEEc-CCCEEEEEEEcccc--hhhHHHHHHHHHHHhcCCCCCceeEEEEEEeCc-----
Q 010519 184 ATNRFSAENVLGEGGYGVVYKGRLI-NGSEVAVKKLLNNL--GQAEKEFRVEVEAIGHVRHKNLVRLLGYCIEGV----- 255 (508)
Q Consensus 184 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~ei~~l~~l~h~niv~~~~~~~~~~----- 255 (508)
..++|.+.+.||+|+||.||++... ++..||||++.... ......+..|+.+++.++||||+++++++....
T Consensus 13 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 92 (343)
T cd07880 13 VPDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLSLDRF 92 (343)
T ss_pred cccceEEEEEeeecCCeEEEEEEECCCCcEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCccceeeeecCCcccccc
Confidence 4578999999999999999999864 68899999885432 223356778999999999999999999987653
Q ss_pred -eeeEEEeecCCCCHHHHHhhhhccCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCEEEcCCCcEEEEecC
Q 010519 256 -HRMLVYEYVNNGNLEQWLHGAMRNQGNLTWEARMKVIIGTAKALAYLHEAIEPKVVHRDIKSSNILIDDEFNAKVSDFG 334 (508)
Q Consensus 256 -~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~Dfg 334 (508)
..++||||+ +++|.+++. ...+++..++.++.||+.||.|||+. +|+||||||+||+++.++.+||+|||
T Consensus 93 ~~~~lv~e~~-~~~l~~~~~-----~~~l~~~~~~~i~~qi~~al~~LH~~---gi~H~dlkp~Nill~~~~~~kl~dfg 163 (343)
T cd07880 93 HDFYLVMPFM-GTDLGKLMK-----HEKLSEDRIQFLVYQMLKGLKYIHAA---GIIHRDLKPGNLAVNEDCELKILDFG 163 (343)
T ss_pred ceEEEEEecC-CCCHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEeecc
Confidence 358999999 779988873 34689999999999999999999998 99999999999999999999999999
Q ss_pred CccccCCCCCcccccccccccccCccccCC-CCCCChhhHHHHHHHHHHHHhCCCCCCCCCCCchhcHHHHHHHH-----
Q 010519 335 LAKLLDSGESHITTRVMGTFGYVAPEYANT-GMLNEKSDIYSFGVLLLEAVTGRDPVDYGRPANEVNLVEWLKMM----- 408 (508)
Q Consensus 335 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwS~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~----- 408 (508)
++...... .....+++.|+|||.+.+ ..++.++|+|||||++|+|++|..||...... ..........
T Consensus 164 ~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~--~~~~~~~~~~~~~~~ 237 (343)
T cd07880 164 LARQTDSE----MTGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHL--DQLMEIMKVTGTPSK 237 (343)
T ss_pred cccccccC----ccccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHH--HHHHHHHHhcCCCCH
Confidence 99865432 223457889999998876 45889999999999999999999999643221 1111110000
Q ss_pred -----hcccccccccC--CCCCCC----hhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 010519 409 -----VGTRRAEEVVD--PNLEVK----PATRALKRSLLVALRCVDPDSEKRPKMSQVVRM 458 (508)
Q Consensus 409 -----~~~~~~~~~~~--~~~~~~----~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 458 (508)
........... +..... ........+.+++.+|++.||.+|||+.+++.+
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~t~~~~l~~ 298 (343)
T cd07880 238 EFVQKLQSEDAKNYVKKLPRFRKKDFRSLLPNANPLAVNVLEKMLVLDAESRITAAEALAH 298 (343)
T ss_pred HHHHhhcchhHHHHHHhccccCcchHHHhccCCChHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 00000000000 000000 001123356789999999999999999999964
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12 |
| >KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-36 Score=297.36 Aligned_cols=253 Identities=24% Similarity=0.370 Sum_probs=209.1
Q ss_pred ceeEeeeCceEEEEEEEc-CCCEEEEEEEcccc--hhhHHHHHHHHHHHhcCCCCCceeEEEEEEeCceeeEEEeecCCC
Q 010519 191 ENVLGEGGYGVVYKGRLI-NGSEVAVKKLLNNL--GQAEKEFRVEVEAIGHVRHKNLVRLLGYCIEGVHRMLVYEYVNNG 267 (508)
Q Consensus 191 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~ei~~l~~l~h~niv~~~~~~~~~~~~~lv~E~~~~g 267 (508)
.++||.|.||+||-|+++ +|+.||||.+.+-. .+.+..+++|+.+|..++||.||.+...|+..+..++|||.+ +|
T Consensus 569 devLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~kqesqlR~EVaILq~l~HPGiV~le~M~ET~ervFVVMEKl-~G 647 (888)
T KOG4236|consen 569 DEVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTKQESQLRNEVAILQNLHHPGIVNLECMFETPERVFVVMEKL-HG 647 (888)
T ss_pred HhhccCCcceeeecceecccCceeeeeeeecccCCCchHHHHHHHHHHHHhcCCCCeeEEEEeecCCceEEEEehhh-cc
Confidence 578999999999999875 89999999985432 444578999999999999999999999999999999999999 55
Q ss_pred CHHHHHhhhhccCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCEEEcCCC---cEEEEecCCccccCCCCC
Q 010519 268 NLEQWLHGAMRNQGNLTWEARMKVIIGTAKALAYLHEAIEPKVVHRDIKSSNILIDDEF---NAKVSDFGLAKLLDSGES 344 (508)
Q Consensus 268 sL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiH~Dlk~~NIll~~~~---~~kl~Dfgla~~~~~~~~ 344 (508)
+..+.|.. .+.++|++.....++.||+.||.|||.+ +|+|+||||+|||+.+.. .+||||||+++.+++..
T Consensus 648 DMLEMILS--sEkgRL~er~TkFlvtQIL~ALr~LH~k---nIvHCDLKPENVLLas~~~FPQvKlCDFGfARiIgEks- 721 (888)
T KOG4236|consen 648 DMLEMILS--SEKGRLPERITKFLVTQILVALRYLHFK---NIVHCDLKPENVLLASASPFPQVKLCDFGFARIIGEKS- 721 (888)
T ss_pred hHHHHHHH--hhcccchHHHHHHHHHHHHHHHHHhhhc---ceeeccCCchheeeccCCCCCceeeccccceeecchhh-
Confidence 77777654 5678899999999999999999999999 999999999999997543 48999999999987543
Q ss_pred cccccccccccccCccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCCCchhcHHHHHHHHhcccccccccCCCCCC
Q 010519 345 HITTRVMGTFGYVAPEYANTGMLNEKSDIYSFGVLLLEAVTGRDPVDYGRPANEVNLVEWLKMMVGTRRAEEVVDPNLEV 424 (508)
Q Consensus 345 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 424 (508)
....++|||.|+|||++.++.|...-|+||.|||+|--++|..||..... +.+.++. .. --+..
T Consensus 722 -FRrsVVGTPAYLaPEVLrnkGyNrSLDMWSVGVIiYVsLSGTFPFNEdEd-----IndQIQN----Aa------FMyPp 785 (888)
T KOG4236|consen 722 -FRRSVVGTPAYLAPEVLRNKGYNRSLDMWSVGVIIYVSLSGTFPFNEDED-----INDQIQN----AA------FMYPP 785 (888)
T ss_pred -hhhhhcCCccccCHHHHhhccccccccceeeeEEEEEEecccccCCCccc-----hhHHhhc----cc------cccCC
Confidence 35668999999999999999999999999999999999999999974432 2222211 11 11122
Q ss_pred ChhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhhcCCCCC
Q 010519 425 KPATRALKRSLLVALRCVDPDSEKRPKMSQVVRMLEADDYPF 466 (508)
Q Consensus 425 ~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~~ 466 (508)
.+........++||...|+..-.+|.|...-+.+.+..++..
T Consensus 786 ~PW~eis~~AidlIn~LLqVkm~kRysvdk~lsh~Wlq~yq~ 827 (888)
T KOG4236|consen 786 NPWSEISPEAIDLINNLLQVKMRKRYSVDKSLSHPWLQDYQT 827 (888)
T ss_pred CchhhcCHHHHHHHHHHHHHHHHHhcchHhhccchhhhcchH
Confidence 333445566788999999999999999999999888776543
|
|
| >cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-35 Score=286.45 Aligned_cols=260 Identities=26% Similarity=0.361 Sum_probs=197.6
Q ss_pred cccceeEeeeCceEEEEEEEc-CCCEEEEEEEcccc--hhhHHHHHHHHHHHhcCCCCCceeEEEEEEeCceeeEEEeec
Q 010519 188 FSAENVLGEGGYGVVYKGRLI-NGSEVAVKKLLNNL--GQAEKEFRVEVEAIGHVRHKNLVRLLGYCIEGVHRMLVYEYV 264 (508)
Q Consensus 188 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~ei~~l~~l~h~niv~~~~~~~~~~~~~lv~E~~ 264 (508)
|+..+.||+|++|.||+|+.. +++.+++|.+.... ......+..|+.+++.++|+|++++++++.+....++||||+
T Consensus 1 y~~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~~ 80 (282)
T cd07829 1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKLLDVIHTERKLYLVFEYC 80 (282)
T ss_pred CeeehcccccCcceEEEeeecCCCcEEEEEEeccccccccccHHHHHHHHHHHhcCCCCHHHHHhhhhcCCceEEEecCc
Confidence 556788999999999999876 58999999886543 223356778999999999999999999999999999999999
Q ss_pred CCCCHHHHHhhhhccCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCEEEcCCCcEEEEecCCccccCCCCC
Q 010519 265 NNGNLEQWLHGAMRNQGNLTWEARMKVIIGTAKALAYLHEAIEPKVVHRDIKSSNILIDDEFNAKVSDFGLAKLLDSGES 344 (508)
Q Consensus 265 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~ 344 (508)
+ ++|.+++.. ....+++..+..++.+++.||.|||+. +++|+||+|+||++++++.++|+|||++........
T Consensus 81 ~-~~l~~~i~~---~~~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~~l~~~ni~~~~~~~~~l~d~g~~~~~~~~~~ 153 (282)
T cd07829 81 D-MDLKKYLDK---RPGPLSPNLIKSIMYQLLRGLAYCHSH---RILHRDLKPQNILINRDGVLKLADFGLARAFGIPLR 153 (282)
T ss_pred C-cCHHHHHHh---hccCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChheEEEcCCCCEEEecCCcccccCCCcc
Confidence 7 599999863 225689999999999999999999999 999999999999999999999999999986643322
Q ss_pred cccccccccccccCccccCCC-CCCChhhHHHHHHHHHHHHhCCCCCCCCCCCchhcHHHHHHHHhcccc---------c
Q 010519 345 HITTRVMGTFGYVAPEYANTG-MLNEKSDIYSFGVLLLEAVTGRDPVDYGRPANEVNLVEWLKMMVGTRR---------A 414 (508)
Q Consensus 345 ~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwS~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~---------~ 414 (508)
......++..|+|||.+.+. .++.++|||||||++|||++|..||....... ....+....+... .
T Consensus 154 -~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~ 229 (282)
T cd07829 154 -TYTHEVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEID---QLFKIFQILGTPTEESWPGVTKL 229 (282)
T ss_pred -ccCccccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCCccHHH---HHHHHHHHhCCCcHHHHHhhccc
Confidence 12233457789999998776 88999999999999999999999986433211 1111111110000 0
Q ss_pred --ccccCCCCCCC----hhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 010519 415 --EEVVDPNLEVK----PATRALKRSLLVALRCVDPDSEKRPKMSQVVRM 458 (508)
Q Consensus 415 --~~~~~~~~~~~----~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 458 (508)
....-+..... ........+.+++.+||..||.+||++.+++.+
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~ 279 (282)
T cd07829 230 PDYKPTFPKFPPKDLEKVLPRLDPEGIDLLSKMLQYNPAKRISAKEALKH 279 (282)
T ss_pred ccccccccccCccchHHhcccccHHHHHHHHHhhccCcccCCCHHHHhhC
Confidence 00000000000 011124567889999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the |
| >cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-35 Score=280.80 Aligned_cols=240 Identities=28% Similarity=0.319 Sum_probs=193.1
Q ss_pred EeeeCceEEEEEEEc-CCCEEEEEEEcccch---hhHHHHHHHHHHHhcCCCCCceeEEEEEEeCceeeEEEeecCCCCH
Q 010519 194 LGEGGYGVVYKGRLI-NGSEVAVKKLLNNLG---QAEKEFRVEVEAIGHVRHKNLVRLLGYCIEGVHRMLVYEYVNNGNL 269 (508)
Q Consensus 194 lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~ei~~l~~l~h~niv~~~~~~~~~~~~~lv~E~~~~gsL 269 (508)
||.|+||.||++.+. +++.+++|.+..... .....+..|+.+++.++||||+++++.+..+...++||||+++++|
T Consensus 1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L 80 (250)
T cd05123 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQTEEKLYLVLEYAPGGEL 80 (250)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHeecCCeeEEEEecCCCCcH
Confidence 689999999999875 588999998865432 2345788899999999999999999999999999999999999999
Q ss_pred HHHHhhhhccCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCEEEcCCCcEEEEecCCccccCCCCCccccc
Q 010519 270 EQWLHGAMRNQGNLTWEARMKVIIGTAKALAYLHEAIEPKVVHRDIKSSNILIDDEFNAKVSDFGLAKLLDSGESHITTR 349 (508)
Q Consensus 270 ~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~ 349 (508)
.+++. ....+++..+..++.|++.||.|||+. +++|+||+|+||+++.++.++|+|||++........ ....
T Consensus 81 ~~~l~----~~~~l~~~~~~~~~~qi~~~l~~lh~~---~~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~~-~~~~ 152 (250)
T cd05123 81 FSHLS----KEGRFSEERARFYAAEIVLALEYLHSL---GIIYRDLKPENILLDADGHIKLTDFGLAKELSSEGS-RTNT 152 (250)
T ss_pred HHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCcceEEEcCCCcEEEeecCcceecccCCC-cccC
Confidence 99984 334689999999999999999999998 999999999999999999999999999986644321 2334
Q ss_pred ccccccccCccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCCCchhcHHHHHHHHhcccccccccCCCCCCChhHH
Q 010519 350 VMGTFGYVAPEYANTGMLNEKSDIYSFGVLLLEAVTGRDPVDYGRPANEVNLVEWLKMMVGTRRAEEVVDPNLEVKPATR 429 (508)
Q Consensus 350 ~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 429 (508)
..++..|+|||...+..++.++|+||||+++|+|++|..||..... . ........ ..+ ..+..
T Consensus 153 ~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~---~---~~~~~~~~---------~~~--~~~~~ 215 (250)
T cd05123 153 FCGTPEYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPPFYAEDR---K---EIYEKILK---------DPL--RFPEF 215 (250)
T ss_pred CcCCccccChHHhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCH---H---HHHHHHhc---------CCC--CCCCC
Confidence 5678899999999888889999999999999999999999964432 1 11111111 011 11111
Q ss_pred HHHHHHHHHHHhcCCCCCCCCCH---HHHHHH
Q 010519 430 ALKRSLLVALRCVDPDSEKRPKM---SQVVRM 458 (508)
Q Consensus 430 ~~~~l~~li~~cl~~dP~~RPs~---~evl~~ 458 (508)
....+.+++.+||..||++||++ .+++.+
T Consensus 216 ~~~~l~~~i~~~l~~~p~~R~~~~~~~~l~~~ 247 (250)
T cd05123 216 LSPEARDLISGLLQKDPTKRLGSGGAEEIKAH 247 (250)
T ss_pred CCHHHHHHHHHHhcCCHhhCCCcccHHHHHhC
Confidence 24556679999999999999999 565543
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the |
| >KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-36 Score=288.34 Aligned_cols=269 Identities=20% Similarity=0.271 Sum_probs=207.1
Q ss_pred eHHHHHHhhCCcccceeEeeeCceEEEEEEEc-CCCEEEEEEEcccchhhHHHHHHHHHHHhcCCC--C----CceeEEE
Q 010519 177 TLRDLEIATNRFSAENVLGEGGYGVVYKGRLI-NGSEVAVKKLLNNLGQAEKEFRVEVEAIGHVRH--K----NLVRLLG 249 (508)
Q Consensus 177 ~~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~ei~~l~~l~h--~----niv~~~~ 249 (508)
.+.......++|.+.+.+|+|.||.|-.+.+. .+..||+|++..- ....+..+.|+++|.++.+ | -+|.+.+
T Consensus 80 v~~~gD~l~~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~V-~kYreAa~iEi~vLqki~~~DP~g~~rcv~m~~ 158 (415)
T KOG0671|consen 80 VYQVGDILTNRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKNV-DKYREAALIEIEVLQKINESDPNGKFRCVQMRD 158 (415)
T ss_pred EEEeccccccceehhhhhcCCcccceEEEeecCCCceehHHHHHHH-HHHhhHHHHHHHHHHHHHhcCCCCceEEEeeeh
Confidence 34444556889999999999999999999764 4678999976543 3334555669999999942 2 3788889
Q ss_pred EEEeCceeeEEEeecCCCCHHHHHhhhhccCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCEEEc------
Q 010519 250 YCIEGVHRMLVYEYVNNGNLEQWLHGAMRNQGNLTWEARMKVIIGTAKALAYLHEAIEPKVVHRDIKSSNILID------ 323 (508)
Q Consensus 250 ~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiH~Dlk~~NIll~------ 323 (508)
||...++.+||+|.+ |-+++++|.. ++..+++...+..++.|++++++|||+. +++|.||||+|||+.
T Consensus 159 wFdyrghiCivfell-G~S~~dFlk~--N~y~~fpi~~ir~m~~QL~~sv~fLh~~---kl~HTDLKPENILfvss~~~~ 232 (415)
T KOG0671|consen 159 WFDYRGHICIVFELL-GLSTFDFLKE--NNYIPFPIDHIRHMGYQLLESVAFLHDL---KLTHTDLKPENILFVSSEYFK 232 (415)
T ss_pred hhhccCceEEEEecc-ChhHHHHhcc--CCccccchHHHHHHHHHHHHHHHHHHhc---ceeecCCChheEEEeccceEE
Confidence 999999999999998 6699999964 4556789999999999999999999999 999999999999993
Q ss_pred --------------CCCcEEEEecCCccccCCCCCcccccccccccccCccccCCCCCCChhhHHHHHHHHHHHHhCCCC
Q 010519 324 --------------DEFNAKVSDFGLAKLLDSGESHITTRVMGTFGYVAPEYANTGMLNEKSDIYSFGVLLLEAVTGRDP 389 (508)
Q Consensus 324 --------------~~~~~kl~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltG~~P 389 (508)
.+..+||+|||.|...... ....+.|..|.|||++.+-.++.++||||+||||+||.+|...
T Consensus 233 ~~~~k~~~~~~r~~ks~~I~vIDFGsAtf~~e~----hs~iVsTRHYRAPEViLgLGwS~pCDvWSiGCIL~ElytG~~L 308 (415)
T KOG0671|consen 233 TYNPKKKVCFIRPLKSTAIKVIDFGSATFDHEH----HSTIVSTRHYRAPEVILGLGWSQPCDVWSIGCILVELYTGETL 308 (415)
T ss_pred EeccCCccceeccCCCcceEEEecCCcceeccC----cceeeeccccCCchheeccCcCCccCceeeeeEEEEeecccee
Confidence 2345899999999875443 3556889999999999999999999999999999999999999
Q ss_pred CCCCCCCchhcHHHHHHHHhcccccccccCC---------CCC-----------------------CChhHHHHHHHHHH
Q 010519 390 VDYGRPANEVNLVEWLKMMVGTRRAEEVVDP---------NLE-----------------------VKPATRALKRSLLV 437 (508)
Q Consensus 390 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---------~~~-----------------------~~~~~~~~~~l~~l 437 (508)
|......+... .+...++.....-+... .+. ..........+++|
T Consensus 309 FqtHen~EHLa---MMerIlGp~P~~mi~r~~~~Kyf~~~rldw~e~~~~~~~k~v~~~ckpl~~~~~~~d~e~~~LfDL 385 (415)
T KOG0671|consen 309 FQTHENLEHLA---MMERILGPIPSRMIKKTRKEKYFRRGRLDWPEVSSKGKSKYVFEPCKPLKKYMLQDDLEHVQLFDL 385 (415)
T ss_pred cccCCcHHHHH---HHHHhhCCCcHHHhhhhhhHhhhhcccccCccccccccchhhhcCCccHHHHhccCcHHHhHHHHH
Confidence 97665333222 22222221110000000 000 11223445678999
Q ss_pred HHHhcCCCCCCCCCHHHHHHHh
Q 010519 438 ALRCVDPDSEKRPKMSQVVRML 459 (508)
Q Consensus 438 i~~cl~~dP~~RPs~~evl~~L 459 (508)
+.+||..||.+|+|+.|+|.|-
T Consensus 386 l~~mL~fDP~~RiTl~EAL~Hp 407 (415)
T KOG0671|consen 386 LRRMLEFDPARRITLREALSHP 407 (415)
T ss_pred HHHHHccCccccccHHHHhcCH
Confidence 9999999999999999999763
|
|
| >cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-34 Score=290.52 Aligned_cols=262 Identities=25% Similarity=0.314 Sum_probs=191.8
Q ss_pred CcccceeEeeeCceEEEEEEEc-C--CCEEEEEEEcccc--hhhHHHHHHHHHHHhcC-CCCCceeEEEEEEeC----ce
Q 010519 187 RFSAENVLGEGGYGVVYKGRLI-N--GSEVAVKKLLNNL--GQAEKEFRVEVEAIGHV-RHKNLVRLLGYCIEG----VH 256 (508)
Q Consensus 187 ~~~~~~~lg~G~~g~Vy~~~~~-~--~~~vavK~~~~~~--~~~~~~~~~ei~~l~~l-~h~niv~~~~~~~~~----~~ 256 (508)
+|.+.+.||+|+||.||++.+. . +..+|+|++.... ....+.+..|+.+++++ +||||+++++++... ..
T Consensus 1 ~y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~ 80 (332)
T cd07857 1 RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGNFNE 80 (332)
T ss_pred CceEEEEccccCCeEEEEEEeCCCCcCceEEEEEeccccccchhHHHHHHHHHHHHHhcCCCChheeeeeeeeccccCCc
Confidence 4788899999999999999875 3 6789999886432 22345677799999999 599999999975432 45
Q ss_pred eeEEEeecCCCCHHHHHhhhhccCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCEEEcCCCcEEEEecCCc
Q 010519 257 RMLVYEYVNNGNLEQWLHGAMRNQGNLTWEARMKVIIGTAKALAYLHEAIEPKVVHRDIKSSNILIDDEFNAKVSDFGLA 336 (508)
Q Consensus 257 ~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~Dfgla 336 (508)
.++++||+. ++|.+++. ....+++..++.++.||+.||.|||+. +++||||||+|||+++++.+||+|||++
T Consensus 81 ~~~~~e~~~-~~L~~~l~----~~~~~~~~~~~~~~~qi~~aL~~LH~~---givH~dlkp~Nili~~~~~~kl~Dfg~a 152 (332)
T cd07857 81 LYLYEELME-ADLHQIIR----SGQPLTDAHFQSFIYQILCGLKYIHSA---NVLHRDLKPGNLLVNADCELKICDFGLA 152 (332)
T ss_pred EEEEEeccc-CCHHHHHh----cCCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHeEEcCCCCEEeCcCCCc
Confidence 678899985 69999884 456789999999999999999999999 9999999999999999999999999999
Q ss_pred cccCCCCC---cccccccccccccCccccCC-CCCCChhhHHHHHHHHHHHHhCCCCCCCCCCCchhcHHHHHHHHhccc
Q 010519 337 KLLDSGES---HITTRVMGTFGYVAPEYANT-GMLNEKSDIYSFGVLLLEAVTGRDPVDYGRPANEVNLVEWLKMMVGTR 412 (508)
Q Consensus 337 ~~~~~~~~---~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwS~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~ 412 (508)
........ .......|++.|+|||.+.+ ..++.++|||||||++|+|++|..||....... .........+..
T Consensus 153 ~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~~~~~~---~~~~~~~~~~~~ 229 (332)
T cd07857 153 RGFSENPGENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYVD---QLNQILQVLGTP 229 (332)
T ss_pred eecccccccccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCCCCCHHH---HHHHHHHHhCCC
Confidence 86543221 11233568999999998765 568999999999999999999999986543211 111000000000
Q ss_pred -----------cc----ccc-cCCCCCCC-hhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHh
Q 010519 413 -----------RA----EEV-VDPNLEVK-PATRALKRSLLVALRCVDPDSEKRPKMSQVVRML 459 (508)
Q Consensus 413 -----------~~----~~~-~~~~~~~~-~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L 459 (508)
.. ... ..+..... ........+.+++.+||+.||.+|||+.+++.+=
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~ll~~~ 293 (332)
T cd07857 230 DEETLSRIGSPKAQNYIRSLPNIPKKPFESIFPNANPLALDLLEKLLAFDPTKRISVEEALEHP 293 (332)
T ss_pred CHHHHHhhhhhhHHHHHHhccccCCcchHhhCCCCCHHHHHHHHHHccCCcccCCCHHHHhcCh
Confidence 00 000 00000000 0001134577799999999999999999998654
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co |
| >KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-37 Score=280.86 Aligned_cols=256 Identities=25% Similarity=0.340 Sum_probs=197.8
Q ss_pred CcccceeEeeeCceEEEEEEEc-CCCEEEEEEEcccch-hhHHHHHHHHHHHhc-CCCCCceeEEEEEEeCceeeEEEee
Q 010519 187 RFSAENVLGEGGYGVVYKGRLI-NGSEVAVKKLLNNLG-QAEKEFRVEVEAIGH-VRHKNLVRLLGYCIEGVHRMLVYEY 263 (508)
Q Consensus 187 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~ei~~l~~-l~h~niv~~~~~~~~~~~~~lv~E~ 263 (508)
+.+-+..||.|+||+|++-.++ .|+.+|||++..+.. ...+++..|.+...+ -+.||||++||.+..+..++|.||+
T Consensus 65 ~Lqdlg~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~~keq~rll~e~d~~mks~~cp~IVkfyGa~F~EGdcWiCMEL 144 (361)
T KOG1006|consen 65 NLQDLGEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNIEKEQKRLLMEHDTVMKSSNCPNIVKFYGALFSEGDCWICMEL 144 (361)
T ss_pred hHHHHHHhcCCcchhhhhhhcCccCcEEEEEEeeeccchHHHHHHHHHHHHHHhhcCCcHHHHHhhhhhcCCceeeeHHH
Confidence 3444567999999999998875 689999999976553 556788889887554 4799999999999999999999999
Q ss_pred cCCCCHHHHHhh-hhccCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCEEEcCCCcEEEEecCCccccCCC
Q 010519 264 VNNGNLEQWLHG-AMRNQGNLTWEARMKVIIGTAKALAYLHEAIEPKVVHRDIKSSNILIDDEFNAKVSDFGLAKLLDSG 342 (508)
Q Consensus 264 ~~~gsL~~~l~~-~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~~ 342 (508)
|+ -+|..+... +......+++...-+|....+.||.||...+ .|||||+||+|||++..|.+||||||++-.+.+.
T Consensus 145 Md-~SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~~l--kiIHRDvKPSNILldr~G~vKLCDFGIcGqLv~S 221 (361)
T KOG1006|consen 145 MD-ISLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKEEL--KIIHRDVKPSNILLDRHGDVKLCDFGICGQLVDS 221 (361)
T ss_pred Hh-hhHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHHHh--hhhhccCChhheEEecCCCEeeecccchHhHHHH
Confidence 95 477655432 1234567899999999999999999998765 8999999999999999999999999999866543
Q ss_pred CCcccccccccccccCccccCC--CCCCChhhHHHHHHHHHHHHhCCCCCCCCCCCchhcHHHHHHHHhcccccccccCC
Q 010519 343 ESHITTRVMGTFGYVAPEYANT--GMLNEKSDIYSFGVLLLEAVTGRDPVDYGRPANEVNLVEWLKMMVGTRRAEEVVDP 420 (508)
Q Consensus 343 ~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~DvwS~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 420 (508)
. ..+.-.|...|||||.+.. ..|+.++||||||+.|||+.||..||..... +.+.+.+...... |
T Consensus 222 i--AkT~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr~w~s-----vfeql~~Vv~gdp------p 288 (361)
T KOG1006|consen 222 I--AKTVDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYRKWDS-----VFEQLCQVVIGDP------P 288 (361)
T ss_pred H--HhhhccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCcchHHH-----HHHHHHHHHcCCC------C
Confidence 2 2344568889999998853 4589999999999999999999999974432 2233333222111 1
Q ss_pred CCCCCh-hHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 010519 421 NLEVKP-ATRALKRSLLVALRCVDPDSEKRPKMSQVVRM 458 (508)
Q Consensus 421 ~~~~~~-~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 458 (508)
.+..+. .......++.++.-||.+|-+.||+..+++++
T Consensus 289 ~l~~~~~~~~~s~~~~~fintCl~Kd~~~Rpky~~Lk~~ 327 (361)
T KOG1006|consen 289 ILLFDKECVHYSFSMVRFINTCLIKDRSDRPKYDDLKKF 327 (361)
T ss_pred eecCcccccccCHHHHHHHHHHhhcccccCcchhhhhcC
Confidence 111111 12345567779999999999999999998874
|
|
| >cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-34 Score=292.75 Aligned_cols=262 Identities=24% Similarity=0.333 Sum_probs=197.4
Q ss_pred hhCCcccceeEeeeCceEEEEEEEc-CCCEEEEEEEcccc--hhhHHHHHHHHHHHhcCCCCCceeEEEEEEeCce----
Q 010519 184 ATNRFSAENVLGEGGYGVVYKGRLI-NGSEVAVKKLLNNL--GQAEKEFRVEVEAIGHVRHKNLVRLLGYCIEGVH---- 256 (508)
Q Consensus 184 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~ei~~l~~l~h~niv~~~~~~~~~~~---- 256 (508)
..++|.+.+.||+|++|.||+|++. ++..||+|++.... ......+..|+.+++.++|||++++++++.....
T Consensus 13 ~~~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 92 (343)
T cd07851 13 VPDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLLDVFTPASSLEDF 92 (343)
T ss_pred ccCceEEEEEeccCCceEEEEEEECCCCcEEEEEecccccchhhHHHHHHHHHHHHHhccCCCHHHHHHHhhcccccccc
Confidence 3568999999999999999999875 57889999875432 2233556779999999999999999998766544
Q ss_pred --eeEEEeecCCCCHHHHHhhhhccCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCEEEcCCCcEEEEecC
Q 010519 257 --RMLVYEYVNNGNLEQWLHGAMRNQGNLTWEARMKVIIGTAKALAYLHEAIEPKVVHRDIKSSNILIDDEFNAKVSDFG 334 (508)
Q Consensus 257 --~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~Dfg 334 (508)
.++|+||+ +++|.+++. ...+++..++.++.|++.||.|||+. +++|+||+|+||++++++.+||+|||
T Consensus 93 ~~~~lv~e~~-~~~L~~~~~-----~~~l~~~~~~~~~~ql~~aL~~LH~~---gi~H~dlkp~Nill~~~~~~kL~dfg 163 (343)
T cd07851 93 QDVYLVTHLM-GADLNNIVK-----CQKLSDDHIQFLVYQILRGLKYIHSA---GIIHRDLKPSNIAVNEDCELKILDFG 163 (343)
T ss_pred ccEEEEEecC-CCCHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCCEEEcccc
Confidence 78999999 669999874 24689999999999999999999998 99999999999999999999999999
Q ss_pred CccccCCCCCcccccccccccccCccccCC-CCCCChhhHHHHHHHHHHHHhCCCCCCCCCCCchhcHHHHHHHHhcccc
Q 010519 335 LAKLLDSGESHITTRVMGTFGYVAPEYANT-GMLNEKSDIYSFGVLLLEAVTGRDPVDYGRPANEVNLVEWLKMMVGTRR 413 (508)
Q Consensus 335 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwS~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~ 413 (508)
++...... .....++..|+|||.+.+ ..++.++|||||||++|+|++|+.||......... ..+....+...
T Consensus 164 ~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~---~~i~~~~~~~~ 236 (343)
T cd07851 164 LARHTDDE----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHIDQL---KRIMNLVGTPD 236 (343)
T ss_pred cccccccc----ccCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHH---HHHHHhcCCCC
Confidence 99865432 233457889999998865 46789999999999999999999999644321111 11111000000
Q ss_pred -----------cccc---cCCCCCCCh---hHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhhc
Q 010519 414 -----------AEEV---VDPNLEVKP---ATRALKRSLLVALRCVDPDSEKRPKMSQVVRMLEA 461 (508)
Q Consensus 414 -----------~~~~---~~~~~~~~~---~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~ 461 (508)
.... +........ .......+.+++.+||+.||.+|||+.+|+++-.-
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dli~~~l~~~P~~Rpt~~ell~h~~~ 301 (343)
T cd07851 237 EELLQKISSESARNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAAEALAHPYL 301 (343)
T ss_pred HHHHhhccchhHHHHHHhccccCCCCHHHHhccCCHHHHHHHHHhCCCChhhCCCHHHHhcCCCc
Confidence 0000 000000000 01124567889999999999999999999986443
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK |
| >KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-35 Score=302.08 Aligned_cols=201 Identities=31% Similarity=0.475 Sum_probs=171.3
Q ss_pred cccceeEeeeCceEEEEEEE-cCCCEEEEEEEcccc-hhhHHHHHHHHHHHhcCCCCCceeEEEEEEeCc------eeeE
Q 010519 188 FSAENVLGEGGYGVVYKGRL-INGSEVAVKKLLNNL-GQAEKEFRVEVEAIGHVRHKNLVRLLGYCIEGV------HRML 259 (508)
Q Consensus 188 ~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~-~~~~~~~~~ei~~l~~l~h~niv~~~~~~~~~~------~~~l 259 (508)
+...+.||+|+||.||+|++ ..|..||||.+.... ....+..-+|+++|++++|+|||+++++-++.. ...+
T Consensus 15 W~~~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~~~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~~~~vl 94 (732)
T KOG4250|consen 15 WEMDERLGKGAFGNVYRGRNKETGRLVAVKTFNKESSLRPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLVTRLPVL 94 (732)
T ss_pred eeehhhhcCCccceeeeecccccccchhHHhhhhhcccchHHHHHHHHHHHHHcCchhhhhhcccCCccccCcccccceE
Confidence 34457799999999999995 479999999886543 223355667999999999999999999766544 3479
Q ss_pred EEeecCCCCHHHHHhhhhccCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCEEEc--CCCc--EEEEecCC
Q 010519 260 VYEYVNNGNLEQWLHGAMRNQGNLTWEARMKVIIGTAKALAYLHEAIEPKVVHRDIKSSNILID--DEFN--AKVSDFGL 335 (508)
Q Consensus 260 v~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiH~Dlk~~NIll~--~~~~--~kl~Dfgl 335 (508)
|||||.+|||...|... .+...|++.+.+.++.+++.||.|||++ +|+||||||.||++- ++|. .||+|||.
T Consensus 95 vmEyC~gGsL~~~L~~P-EN~~GLpE~e~l~lL~d~~~al~~LrEn---~IvHRDlKP~NIvl~~Gedgq~IyKLtDfG~ 170 (732)
T KOG4250|consen 95 VMEYCSGGSLRKVLNSP-ENAYGLPESEFLDLLSDLVSALRHLREN---GIVHRDLKPGNIVLQIGEDGQSIYKLTDFGA 170 (732)
T ss_pred EEeecCCCcHHHHhcCc-ccccCCCHHHHHHHHHHHHHHHHHHHHc---CceeccCCCCcEEEeecCCCceEEeeecccc
Confidence 99999999999999754 3456799999999999999999999999 999999999999993 4344 79999999
Q ss_pred ccccCCCCCcccccccccccccCccccC-CCCCCChhhHHHHHHHHHHHHhCCCCCCCCC
Q 010519 336 AKLLDSGESHITTRVMGTFGYVAPEYAN-TGMLNEKSDIYSFGVLLLEAVTGRDPVDYGR 394 (508)
Q Consensus 336 a~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~DvwS~Gvvl~elltG~~Pf~~~~ 394 (508)
|+.+.++. ....++||..|++||+.. .+.|+..+|.|||||++|+.+||..||....
T Consensus 171 Arel~d~s--~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~p~~ 228 (732)
T KOG4250|consen 171 ARELDDNS--LFTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELPFIPFG 228 (732)
T ss_pred cccCCCCC--eeeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCCCCcCC
Confidence 99887665 577889999999999998 4889999999999999999999999996443
|
|
| >cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-33 Score=308.13 Aligned_cols=145 Identities=32% Similarity=0.450 Sum_probs=130.1
Q ss_pred CCcccceeEeeeCceEEEEEEEc-CCCEEEEEEEcccc---hhhHHHHHHHHHHHhcCCCCCceeEEEEEEeCceeeEEE
Q 010519 186 NRFSAENVLGEGGYGVVYKGRLI-NGSEVAVKKLLNNL---GQAEKEFRVEVEAIGHVRHKNLVRLLGYCIEGVHRMLVY 261 (508)
Q Consensus 186 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~ei~~l~~l~h~niv~~~~~~~~~~~~~lv~ 261 (508)
++|.+.+.||+|+||+||+|.+. .+..||||++.... ......+..|+.++..++||||+++++++......||||
T Consensus 4 ~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lVm 83 (669)
T cd05610 4 EEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQSANNVYLVM 83 (669)
T ss_pred CCEEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEEECCEEEEEE
Confidence 57999999999999999999876 68899999986432 223356888999999999999999999999999999999
Q ss_pred eecCCCCHHHHHhhhhccCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCEEEcCCCcEEEEecCCcc
Q 010519 262 EYVNNGNLEQWLHGAMRNQGNLTWEARMKVIIGTAKALAYLHEAIEPKVVHRDIKSSNILIDDEFNAKVSDFGLAK 337 (508)
Q Consensus 262 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~Dfgla~ 337 (508)
||+.+++|.+++. ..+.+++..++.++.||+.||.|||.. +|+||||||+||||+.++.+||+|||+++
T Consensus 84 Ey~~g~~L~~li~----~~~~l~~~~~~~i~~qil~aL~yLH~~---gIiHrDLKP~NILl~~~g~vkL~DFGls~ 152 (669)
T cd05610 84 EYLIGGDVKSLLH----IYGYFDEEMAVKYISEVALALDYLHRH---GIIHRDLKPDNMLISNEGHIKLTDFGLSK 152 (669)
T ss_pred eCCCCCCHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHhC---CEEeCCccHHHEEEcCCCCEEEEeCCCCc
Confidence 9999999999985 345688899999999999999999998 99999999999999999999999999985
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481 |
| >KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-35 Score=272.30 Aligned_cols=270 Identities=21% Similarity=0.282 Sum_probs=196.6
Q ss_pred CCcccceeEeeeCceEEEEEEEcC-----CCEEEEEEEcccchhh--HHHHHHHHHHHhcCCCCCceeEEEEEEe-Ccee
Q 010519 186 NRFSAENVLGEGGYGVVYKGRLIN-----GSEVAVKKLLNNLGQA--EKEFRVEVEAIGHVRHKNLVRLLGYCIE-GVHR 257 (508)
Q Consensus 186 ~~~~~~~~lg~G~~g~Vy~~~~~~-----~~~vavK~~~~~~~~~--~~~~~~ei~~l~~l~h~niv~~~~~~~~-~~~~ 257 (508)
..|+....||+|+||.||++.-.+ ...+|+|++....... ....-+|+.+++.++|||++.+..+|.. +...
T Consensus 24 ~~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~tGiS~SAcREiaL~REl~h~nvi~Lv~Vfl~~d~~v 103 (438)
T KOG0666|consen 24 FEYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGTGISMSACREIALLRELKHPNVISLVKVFLSHDKKV 103 (438)
T ss_pred HHhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCCCCCcCHHHHHHHHHHHHhcCCcchhHHHHHhccCceE
Confidence 378889999999999999995432 3368999886542111 1234459999999999999999999987 7788
Q ss_pred eEEEeecCCCCHHHHHhhhhc-cCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCEEEcCC----CcEEEEe
Q 010519 258 MLVYEYVNNGNLEQWLHGAMR-NQGNLTWEARMKVIIGTAKALAYLHEAIEPKVVHRDIKSSNILIDDE----FNAKVSD 332 (508)
Q Consensus 258 ~lv~E~~~~gsL~~~l~~~~~-~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiH~Dlk~~NIll~~~----~~~kl~D 332 (508)
+|++||.+. +|...|+-+.. ....++......|+.||+.|++|||++ -|+||||||.||||..+ |.|||+|
T Consensus 104 ~l~fdYAEh-DL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~N---WvlHRDLKPaNIlvmgdgperG~VKIaD 179 (438)
T KOG0666|consen 104 WLLFDYAEH-DLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHSN---WVLHRDLKPANILVMGDGPERGRVKIAD 179 (438)
T ss_pred EEEehhhhh-hHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhhh---heeeccCCcceEEEeccCCccCeeEeec
Confidence 999999976 99998865433 235688899999999999999999999 89999999999999887 8999999
Q ss_pred cCCccccCCCCCc--ccccccccccccCccccCC-CCCCChhhHHHHHHHHHHHHhCCCCCCCCCCC----chhcHH--H
Q 010519 333 FGLAKLLDSGESH--ITTRVMGTFGYVAPEYANT-GMLNEKSDIYSFGVLLLEAVTGRDPVDYGRPA----NEVNLV--E 403 (508)
Q Consensus 333 fgla~~~~~~~~~--~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwS~Gvvl~elltG~~Pf~~~~~~----~~~~~~--~ 403 (508)
||+++.+.+.-.. ....++-|.+|.|||++.| ..|+.+.|||++|||+.||++-.+-|...... +..... +
T Consensus 180 lGlaR~~~~plkpl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl~PlF~g~E~k~~~~~Pfq~dQl~ 259 (438)
T KOG0666|consen 180 LGLARLFNNPLKPLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTLEPLFKGREEKIKTKNPFQHDQLD 259 (438)
T ss_pred ccHHHHhhccccccccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHccCccccchhhhcccCCCchHHHHH
Confidence 9999988654322 2345677999999999877 56999999999999999999987777433211 111111 1
Q ss_pred HHHHHhcccccccccC----CCC-----------CCCh-hHH-------HHHHHHHHHHHhcCCCCCCCCCHHHHHHHh
Q 010519 404 WLKMMVGTRRAEEVVD----PNL-----------EVKP-ATR-------ALKRSLLVALRCVDPDSEKRPKMSQVVRML 459 (508)
Q Consensus 404 ~~~~~~~~~~~~~~~~----~~~-----------~~~~-~~~-------~~~~l~~li~~cl~~dP~~RPs~~evl~~L 459 (508)
.+..+++........+ |.. .... ... .....++|+.++|..||.+|.|+++.+++.
T Consensus 260 rIf~vLG~Pt~~~Wp~lkk~Pe~q~~ls~f~~~~~~n~sL~~~~~~~k~k~~~a~~LL~klL~yDP~kRIta~qAleh~ 338 (438)
T KOG0666|consen 260 RIFEVLGTPTDKDWPDLKKMPEYQTLLSDFRRHYYDNVSLHKYYHKHKVKDPSALDLLQKLLTYDPIKRITAEQALEHP 338 (438)
T ss_pred HHHHHcCCCccccchhhhhCcchHHHHHHhHHhhcCcchHHHHHHHhcCCCchHHHHHHHHhccCchhhccHHHHhccc
Confidence 1222222211111000 000 0000 000 011256788899999999999999999864
|
|
| >cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-34 Score=275.88 Aligned_cols=219 Identities=20% Similarity=0.186 Sum_probs=173.8
Q ss_pred eCceEEEEEEEc-CCCEEEEEEEcccchhhHHHHHHHHHHHhcCCCCCceeEEEEEEeCceeeEEEeecCCCCHHHHHhh
Q 010519 197 GGYGVVYKGRLI-NGSEVAVKKLLNNLGQAEKEFRVEVEAIGHVRHKNLVRLLGYCIEGVHRMLVYEYVNNGNLEQWLHG 275 (508)
Q Consensus 197 G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~ei~~l~~l~h~niv~~~~~~~~~~~~~lv~E~~~~gsL~~~l~~ 275 (508)
|.+|.||++.+. +++.+|+|++.... .+..|...+....||||+++++++.+....++||||+++|+|.+++..
T Consensus 4 g~~~~v~~~~~~~~~~~~~~K~i~~~~-----~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~ 78 (237)
T cd05576 4 GVIDKVLLVMDTRTQQTFILKGLRKSS-----EYSRERLTIIPHCVPNMVCLHKYIVSEDSVFLVLQHAEGGKLWSHISK 78 (237)
T ss_pred cccceEEEEEEccCCcEEEEEeecchh-----hhhhHHHHHHhcCCCceeehhhheecCCeEEEEEecCCCCCHHHHHHH
Confidence 889999999875 78899999986542 223344445556799999999999999999999999999999999853
Q ss_pred hhccCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCEEEcCCCcEEEEecCCccccCCCCCccccccccccc
Q 010519 276 AMRNQGNLTWEARMKVIIGTAKALAYLHEAIEPKVVHRDIKSSNILIDDEFNAKVSDFGLAKLLDSGESHITTRVMGTFG 355 (508)
Q Consensus 276 ~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~~~gt~~ 355 (508)
...+++..+..++.|++.||.|||+. +++||||||+||+++.++.++++|||.+...... .....++..
T Consensus 79 ----~~~l~~~~~~~~~~ql~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~~----~~~~~~~~~ 147 (237)
T cd05576 79 ----FLNIPEECVKRWAAEMVVALDALHRE---GIVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDS----CDGEAVENM 147 (237)
T ss_pred ----hcCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHEEEcCCCCEEEecccchhccccc----cccCCcCcc
Confidence 34589999999999999999999998 9999999999999999999999999988755432 122345778
Q ss_pred ccCccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCCCchhcHHHHHHHHhcccccccccCCCCCCChhHHHHHHHH
Q 010519 356 YVAPEYANTGMLNEKSDIYSFGVLLLEAVTGRDPVDYGRPANEVNLVEWLKMMVGTRRAEEVVDPNLEVKPATRALKRSL 435 (508)
Q Consensus 356 y~aPE~~~~~~~~~~~DvwS~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 435 (508)
|+|||.+.+..++.++|+||+|+++|||++|..|+....... . .......+......+.
T Consensus 148 y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~~~~~~~~~~-----------------~----~~~~~~~~~~~~~~~~ 206 (237)
T cd05576 148 YCAPEVGGISEETEACDWWSLGAILFELLTGKTLVECHPSGI-----------------N----THTTLNIPEWVSEEAR 206 (237)
T ss_pred ccCCcccCCCCCCchhhHHHHHHHHHHHHHCcchhhcCchhc-----------------c----cccccCCcccCCHHHH
Confidence 999999988889999999999999999999998875321100 0 0000001111234566
Q ss_pred HHHHHhcCCCCCCCCCH
Q 010519 436 LVALRCVDPDSEKRPKM 452 (508)
Q Consensus 436 ~li~~cl~~dP~~RPs~ 452 (508)
+++.+||+.||.+||++
T Consensus 207 ~li~~~l~~dp~~R~~~ 223 (237)
T cd05576 207 SLLQQLLQFNPTERLGA 223 (237)
T ss_pred HHHHHHccCCHHHhcCC
Confidence 79999999999999996
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha |
| >KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-34 Score=298.40 Aligned_cols=266 Identities=27% Similarity=0.417 Sum_probs=217.6
Q ss_pred HHHHHhhCCcccceeEeeeCceEEEEEEEc-CCCEEEEEEEcccchhhHHHHHHHHHHHhcC-CCCCceeEEEEEEe---
Q 010519 179 RDLEIATNRFSAENVLGEGGYGVVYKGRLI-NGSEVAVKKLLNNLGQAEKEFRVEVEAIGHV-RHKNLVRLLGYCIE--- 253 (508)
Q Consensus 179 ~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~ei~~l~~l-~h~niv~~~~~~~~--- 253 (508)
+.+..++.-|++..+||.|.+|.||+++.. +++.+|+|++..... ..+++..|.++|+.+ +|||++.++|++..
T Consensus 12 ~~lpdp~d~~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~~d-~deEiE~eynil~~~~~hpnv~~fyg~~~k~~~ 90 (953)
T KOG0587|consen 12 SSLPDPADIFEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPTED-EEEEIELEYNMLKKYSHHPNVATFYGAFIKKDP 90 (953)
T ss_pred hhCCCCCCccEEEEEEeeccceeEEEEeeeecCceeeeEeecCCcc-ccHHHHHHHHHHHhccCCCCcceEEEEEEEecC
Confidence 334455678999999999999999999854 788888887654433 345677789998887 79999999999864
Q ss_pred --CceeeEEEeecCCCCHHHHHhhhhccCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCEEEcCCCcEEEE
Q 010519 254 --GVHRMLVYEYVNNGNLEQWLHGAMRNQGNLTWEARMKVIIGTAKALAYLHEAIEPKVVHRDIKSSNILIDDEFNAKVS 331 (508)
Q Consensus 254 --~~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~ 331 (508)
++.++||||||.+|+..|++++.+ +.++.|..+.-|+..++.|+.+||.+ .++|||||-.|||++.++.+||+
T Consensus 91 ~~~DqLWLVMEfC~gGSVTDLVKn~~--g~rl~E~~IaYI~re~lrgl~HLH~n---kviHRDikG~NiLLT~e~~VKLv 165 (953)
T KOG0587|consen 91 GNGDQLWLVMEFCGGGSVTDLVKNTK--GNRLKEEWIAYILREILRGLAHLHNN---KVIHRDIKGQNVLLTENAEVKLV 165 (953)
T ss_pred CCCCeEEEEeeccCCccHHHHHhhhc--ccchhhHHHHHHHHHHHHHHHHHhhc---ceeeecccCceEEEeccCcEEEe
Confidence 468899999999999999998754 78899999999999999999999999 99999999999999999999999
Q ss_pred ecCCccccCCCCCcccccccccccccCccccCCC-----CCCChhhHHHHHHHHHHHHhCCCCCCCCCCCchhcHHHHHH
Q 010519 332 DFGLAKLLDSGESHITTRVMGTFGYVAPEYANTG-----MLNEKSDIYSFGVLLLEAVTGRDPVDYGRPANEVNLVEWLK 406 (508)
Q Consensus 332 Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----~~~~~~DvwS~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~ 406 (508)
|||++..+..... .....+|||.|||||++... .|+..+|+||||++..||.-|.+|+.+..+. +
T Consensus 166 DFGvSaQldsT~g-rRnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~DmHPm---------r 235 (953)
T KOG0587|consen 166 DFGVSAQLDSTVG-RRNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLCDMHPM---------R 235 (953)
T ss_pred eeeeeeeeecccc-cccCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCccCcchh---------h
Confidence 9999987765433 34456899999999998543 4778999999999999999999998644321 1
Q ss_pred HHhcccccccccCCCCCCChhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhhcCCCC
Q 010519 407 MMVGTRRAEEVVDPNLEVKPATRALKRSLLVALRCVDPDSEKRPKMSQVVRMLEADDYP 465 (508)
Q Consensus 407 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~ 465 (508)
.++ .-.-+|..+...+....+++.++|..||.+|..+||++.++|+|--.-..+
T Consensus 236 aLF-----~IpRNPPPkLkrp~kWs~~FndFIs~cL~Kd~e~RP~~~~ll~hpFi~e~~ 289 (953)
T KOG0587|consen 236 ALF-----LIPRNPPPKLKRPKKWSKKFNDFISTCLVKDYEQRPSTEELLKHPFITEQP 289 (953)
T ss_pred hhc-----cCCCCCCccccchhhHHHHHHHHHHHHHhhccccCcchhhhccCCcccccc
Confidence 111 112235556666778899999999999999999999999999875444333
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-34 Score=294.21 Aligned_cols=243 Identities=24% Similarity=0.293 Sum_probs=194.1
Q ss_pred hCCcccceeEeeeCceEEEEEEEc-CCCEEEEEEEcccchhhHHHHHHHHHHHhcC-CCCCceeEEEEEEeCceeeEEEe
Q 010519 185 TNRFSAENVLGEGGYGVVYKGRLI-NGSEVAVKKLLNNLGQAEKEFRVEVEAIGHV-RHKNLVRLLGYCIEGVHRMLVYE 262 (508)
Q Consensus 185 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~ei~~l~~l-~h~niv~~~~~~~~~~~~~lv~E 262 (508)
++.|.+...+|.|+|+.|-.+.+. .++..++|.+...... ..+|+.++... +||||+++++++.+..+.|+|||
T Consensus 321 ~~~y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~~~~----~~~e~~~~~~~~~h~niv~~~~v~~~~~~~~~v~e 396 (612)
T KOG0603|consen 321 TESYEFREELGEGSFSAVKYCESSPTDQEPAVKIISKRADD----NQDEIPISLLVRDHPNIVKSHDVYEDGKEIYLVME 396 (612)
T ss_pred chhhccccccCCCCccceeeeeccccccchhheeccccccc----cccccchhhhhcCCCcceeecceecCCceeeeeeh
Confidence 567888888999999999999765 6888999988655222 33366555554 79999999999999999999999
Q ss_pred ecCCCCHHHHHhhhhccCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCEEE-cCCCcEEEEecCCccccCC
Q 010519 263 YVNNGNLEQWLHGAMRNQGNLTWEARMKVIIGTAKALAYLHEAIEPKVVHRDIKSSNILI-DDEFNAKVSDFGLAKLLDS 341 (508)
Q Consensus 263 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiH~Dlk~~NIll-~~~~~~kl~Dfgla~~~~~ 341 (508)
++.++-|.+.+. ...... ..+..|+.+|+.|+.|||.+ ++|||||||+|||+ ++.++++|+|||.++....
T Consensus 397 ~l~g~ell~ri~----~~~~~~-~e~~~w~~~lv~Av~~LH~~---gvvhRDLkp~NIL~~~~~g~lrltyFG~a~~~~~ 468 (612)
T KOG0603|consen 397 LLDGGELLRRIR----SKPEFC-SEASQWAAELVSAVDYLHEQ---GVVHRDLKPGNILLDGSAGHLRLTYFGFWSELER 468 (612)
T ss_pred hccccHHHHHHH----hcchhH-HHHHHHHHHHHHHHHHHHhc---CeeecCCChhheeecCCCCcEEEEEechhhhCch
Confidence 999998888774 222333 67778999999999999999 99999999999999 6999999999999997765
Q ss_pred CCCcccccccccccccCccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCCCchhcHHHHHHHHhcccccccccCCC
Q 010519 342 GESHITTRVMGTFGYVAPEYANTGMLNEKSDIYSFGVLLLEAVTGRDPVDYGRPANEVNLVEWLKMMVGTRRAEEVVDPN 421 (508)
Q Consensus 342 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 421 (508)
. ....+-|..|.|||++....|++++||||||++||+|++|+.||...... . + +...++.. .
T Consensus 469 ~----~~tp~~t~~y~APEvl~~~~yt~acD~WSLGvlLy~ML~G~tp~~~~P~~--~---e-i~~~i~~~--------~ 530 (612)
T KOG0603|consen 469 S----CDTPALTLQYVAPEVLAIQEYTEACDWWSLGVLLYEMLTGRTLFAAHPAG--I---E-IHTRIQMP--------K 530 (612)
T ss_pred h----hcccchhhcccChhhhccCCCCcchhhHHHHHHHHHHHhCCCccccCCch--H---H-HHHhhcCC--------c
Confidence 4 22234588999999999999999999999999999999999999755433 1 1 11222111 1
Q ss_pred CCCChhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhhc
Q 010519 422 LEVKPATRALKRSLLVALRCVDPDSEKRPKMSQVVRMLEA 461 (508)
Q Consensus 422 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~ 461 (508)
+. ........+|+.+||+.||.+||++.+++.+-+-
T Consensus 531 ~s----~~vS~~AKdLl~~LL~~dP~~Rl~~~~i~~h~w~ 566 (612)
T KOG0603|consen 531 FS----ECVSDEAKDLLQQLLQVDPALRLGADEIGAHPWF 566 (612)
T ss_pred cc----cccCHHHHHHHHHhccCChhhCcChhhhccCcch
Confidence 11 2234455668999999999999999999987665
|
|
| >KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-34 Score=278.26 Aligned_cols=245 Identities=25% Similarity=0.318 Sum_probs=193.2
Q ss_pred HHhhCCcccceeEeeeCceEEEEEEEc-CCCEEEEEEEcccchhh---HHHHHHHHHHHhcC-CCCCceeEEEEEEeCce
Q 010519 182 EIATNRFSAENVLGEGGYGVVYKGRLI-NGSEVAVKKLLNNLGQA---EKEFRVEVEAIGHV-RHKNLVRLLGYCIEGVH 256 (508)
Q Consensus 182 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~---~~~~~~ei~~l~~l-~h~niv~~~~~~~~~~~ 256 (508)
.+...+|.++.+||+|+||.|.++..+ ..+.+|||++.++.-.. .+--..|-.+|.-. +-|.+++++.+|+.-+.
T Consensus 345 ~i~~tDFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScFQTmDR 424 (683)
T KOG0696|consen 345 RIKATDFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCFQTMDR 424 (683)
T ss_pred ceeecccceEEEeccCccceeeeecccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHhhhhhh
Confidence 456678999999999999999999765 34568999886554211 11123355556554 56899999999999999
Q ss_pred eeEEEeecCCCCHHHHHhhhhccCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCEEEcCCCcEEEEecCCc
Q 010519 257 RMLVYEYVNNGNLEQWLHGAMRNQGNLTWEARMKVIIGTAKALAYLHEAIEPKVVHRDIKSSNILIDDEFNAKVSDFGLA 336 (508)
Q Consensus 257 ~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~Dfgla 336 (508)
+|+||||+.||+|--.+ +.-+.+.+..+..++..|+-||-|||++ +||+||||.+||||+.+|++||+|||++
T Consensus 425 LyFVMEyvnGGDLMyhi----QQ~GkFKEp~AvFYAaEiaigLFFLh~k---gIiYRDLKLDNvmLd~eGHiKi~DFGmc 497 (683)
T KOG0696|consen 425 LYFVMEYVNGGDLMYHI----QQVGKFKEPVAVFYAAEIAIGLFFLHSK---GIIYRDLKLDNVMLDSEGHIKIADFGMC 497 (683)
T ss_pred eeeEEEEecCchhhhHH----HHhcccCCchhhhhhHHHHHHhhhhhcC---CeeeeeccccceEeccCCceEeeecccc
Confidence 99999999999998887 4567788888999999999999999999 9999999999999999999999999999
Q ss_pred cccCCCCCcccccccccccccCccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCCCchhcHHHHHHHHhccccccc
Q 010519 337 KLLDSGESHITTRVMGTFGYVAPEYANTGMLNEKSDIYSFGVLLLEAVTGRDPVDYGRPANEVNLVEWLKMMVGTRRAEE 416 (508)
Q Consensus 337 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 416 (508)
+.---+. .....++|||.|+|||++.-.+|+..+|+|||||+||||+.|+.||+..+.. +.+.....
T Consensus 498 KEni~~~-~TTkTFCGTPdYiAPEIi~YqPYgksvDWWa~GVLLyEmlaGQpPFdGeDE~------elF~aI~e------ 564 (683)
T KOG0696|consen 498 KENIFDG-VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDED------ELFQAIME------ 564 (683)
T ss_pred cccccCC-cceeeecCCCcccccceEEecccccchhHHHHHHHHHHHHcCCCCCCCCCHH------HHHHHHHH------
Confidence 8543222 2356689999999999999999999999999999999999999999754322 12222211
Q ss_pred ccCCCCCCChhHHHHHHHHHHHHHhcCCCCCCCCC
Q 010519 417 VVDPNLEVKPATRALKRSLLVALRCVDPDSEKRPK 451 (508)
Q Consensus 417 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs 451 (508)
.. ...+....++...++...|.+.|.+|.-
T Consensus 565 ---hn--vsyPKslSkEAv~ickg~ltK~P~kRLG 594 (683)
T KOG0696|consen 565 ---HN--VSYPKSLSKEAVAICKGLLTKHPGKRLG 594 (683)
T ss_pred ---cc--CcCcccccHHHHHHHHHHhhcCCccccC
Confidence 11 1122234556677888899999999963
|
|
| >KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-34 Score=280.99 Aligned_cols=257 Identities=25% Similarity=0.429 Sum_probs=194.6
Q ss_pred hhCCcccceeEeeeCceEEEEEEEc-CCCEEEEEEEcccc--hhh-----HHHHHHHHHHHhcCCCCCceeEEEEEEeC-
Q 010519 184 ATNRFSAENVLGEGGYGVVYKGRLI-NGSEVAVKKLLNNL--GQA-----EKEFRVEVEAIGHVRHKNLVRLLGYCIEG- 254 (508)
Q Consensus 184 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~-----~~~~~~ei~~l~~l~h~niv~~~~~~~~~- 254 (508)
..++|-++.+||+|+|+.||++.+. ..+.||||+-..+. ... .+..-+|..+-+.|+||.||++|++|.-+
T Consensus 461 Ln~RYLlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDyfslDt 540 (775)
T KOG1151|consen 461 LNDRYLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDYFSLDT 540 (775)
T ss_pred hHHHHHHHHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeeeeeeecc
Confidence 3467888899999999999999864 56678888653222 111 12345699999999999999999999755
Q ss_pred ceeeEEEeecCCCCHHHHHhhhhccCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCEEEc---CCCcEEEE
Q 010519 255 VHRMLVYEYVNNGNLEQWLHGAMRNQGNLTWEARMKVIIGTAKALAYLHEAIEPKVVHRDIKSSNILID---DEFNAKVS 331 (508)
Q Consensus 255 ~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiH~Dlk~~NIll~---~~~~~kl~ 331 (508)
...+-|+|||+|.+|.-|| .....+++..++.|++||+.||.||.+ .+|+|||-||||.||||- .-|.+||+
T Consensus 541 dsFCTVLEYceGNDLDFYL----KQhklmSEKEARSIiMQiVnAL~YLNE-ikpPIIHYDLKPgNILLv~GtacGeIKIT 615 (775)
T KOG1151|consen 541 DSFCTVLEYCEGNDLDFYL----KQHKLMSEKEARSIIMQIVNALKYLNE-IKPPIIHYDLKPGNILLVNGTACGEIKIT 615 (775)
T ss_pred ccceeeeeecCCCchhHHH----HhhhhhhHHHHHHHHHHHHHHHHHHhc-cCCCeeeeccCCccEEEecCcccceeEee
Confidence 5667899999999999998 456678999999999999999999987 688999999999999994 45779999
Q ss_pred ecCCccccCCCCCc------ccccccccccccCccccCC----CCCCChhhHHHHHHHHHHHHhCCCCCCCCCCCchhcH
Q 010519 332 DFGLAKLLDSGESH------ITTRVMGTFGYVAPEYANT----GMLNEKSDIYSFGVLLLEAVTGRDPVDYGRPANEVNL 401 (508)
Q Consensus 332 Dfgla~~~~~~~~~------~~~~~~gt~~y~aPE~~~~----~~~~~~~DvwS~Gvvl~elltG~~Pf~~~~~~~~~~~ 401 (508)
|||+++.++++... ......||.+|++||.+.- ..++.|+||||+|||+|+.+.|+.||....... ++
T Consensus 616 DFGLSKIMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGhnqsQQ--dI 693 (775)
T KOG1151|consen 616 DFGLSKIMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGHNQSQQ--DI 693 (775)
T ss_pred ecchhhhccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCCchhHH--HH
Confidence 99999988654432 2345789999999998743 356789999999999999999999997443211 11
Q ss_pred HHHHHHHhcccccccccC-CCCCCChhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 010519 402 VEWLKMMVGTRRAEEVVD-PNLEVKPATRALKRSLLVALRCVDPDSEKRPKMSQVVR 457 (508)
Q Consensus 402 ~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 457 (508)
.+ . ..++. ....+++.+-...+...+|++||+.--++|....++..
T Consensus 694 Lq---e-------NTIlkAtEVqFP~KPvVsseAkaFIRRCLaYRKeDR~DV~qLA~ 740 (775)
T KOG1151|consen 694 LQ---E-------NTILKATEVQFPPKPVVSSEAKAFIRRCLAYRKEDRIDVQQLAC 740 (775)
T ss_pred Hh---h-------hchhcceeccCCCCCccCHHHHHHHHHHHHhhhhhhhhHHHHcc
Confidence 11 0 01111 11222222233344556999999999999988777654
|
|
| >PLN03225 Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-33 Score=298.72 Aligned_cols=265 Identities=20% Similarity=0.225 Sum_probs=172.5
Q ss_pred hhCCcccceeEeeeCceEEEEEEEc-C----CCEEEEEEEcccchhhHHHHHHHHHHHhcCCCCCceeEEEE------EE
Q 010519 184 ATNRFSAENVLGEGGYGVVYKGRLI-N----GSEVAVKKLLNNLGQAEKEFRVEVEAIGHVRHKNLVRLLGY------CI 252 (508)
Q Consensus 184 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~----~~~vavK~~~~~~~~~~~~~~~ei~~l~~l~h~niv~~~~~------~~ 252 (508)
..++|.+.+.||+|+||.||+|++. + +..||+|++...... +....+ .+....+.+++.++.. +.
T Consensus 130 ~~~~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~~~--e~~~~e--~l~~~~~~~~~~~~~~~~~~~~~~ 205 (566)
T PLN03225 130 KKDDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGAV--EIWMNE--RVRRACPNSCADFVYGFLEPVSSK 205 (566)
T ss_pred ccCCeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccchh--HHHHHH--HHHhhchhhHHHHHHhhhcccccc
Confidence 5679999999999999999999875 4 689999987543211 111111 1222222333322221 23
Q ss_pred eCceeeEEEeecCCCCHHHHHhhhhc----------------cCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCC
Q 010519 253 EGVHRMLVYEYVNNGNLEQWLHGAMR----------------NQGNLTWEARMKVIIGTAKALAYLHEAIEPKVVHRDIK 316 (508)
Q Consensus 253 ~~~~~~lv~E~~~~gsL~~~l~~~~~----------------~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiH~Dlk 316 (508)
.....++||||+.+++|.+++..... .........+..++.||+.||.|||+. +|+|||||
T Consensus 206 ~~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~---gIiHRDLK 282 (566)
T PLN03225 206 KEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHST---GIVHRDVK 282 (566)
T ss_pred cCCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHC---CEEeCcCC
Confidence 45678999999999999999853210 001112344668999999999999998 99999999
Q ss_pred CCCEEEcC-CCcEEEEecCCccccCCCCCcccccccccccccCccccCCC----------------------CCCChhhH
Q 010519 317 SSNILIDD-EFNAKVSDFGLAKLLDSGESHITTRVMGTFGYVAPEYANTG----------------------MLNEKSDI 373 (508)
Q Consensus 317 ~~NIll~~-~~~~kl~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----------------------~~~~~~Dv 373 (508)
|+|||+++ ++.+||+|||+++.+............+++.|+|||.+... .++.++||
T Consensus 283 P~NILl~~~~~~~KL~DFGlA~~l~~~~~~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~~k~DV 362 (566)
T PLN03225 283 PQNIIFSEGSGSFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDI 362 (566)
T ss_pred HHHEEEeCCCCcEEEEeCCCccccccccccCCcccccCCCccChHHhhccCCCCCCccccccccccchhccccCCCCccc
Confidence 99999985 57899999999986654444444566789999999965322 23456799
Q ss_pred HHHHHHHHHHHhCCCCCCCCCCCchhcHHHHHHHHhcccc----cccccCCCCCCC------hhHHHHHHHHHHHHHhcC
Q 010519 374 YSFGVLLLEAVTGRDPVDYGRPANEVNLVEWLKMMVGTRR----AEEVVDPNLEVK------PATRALKRSLLVALRCVD 443 (508)
Q Consensus 374 wS~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~~------~~~~~~~~l~~li~~cl~ 443 (508)
|||||+||||+++..|++.. ...+...+..... ......+..... ..........+|+.+||+
T Consensus 363 wSlGviL~el~~~~~~~~~~-------~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~dLi~~mL~ 435 (566)
T PLN03225 363 YSAGLIFLQMAFPNLRSDSN-------LIQFNRQLKRNDYDLVAWRKLVEPRASPDLRRGFEVLDLDGGAGWELLKSMMR 435 (566)
T ss_pred HHHHHHHHHHHhCcCCCchH-------HHHHHHHHHhcCCcHHHHHHhhccccchhhhhhhhhccccchHHHHHHHHHcc
Confidence 99999999999987765311 1111111100000 000001110000 000011233479999999
Q ss_pred CCCCCCCCHHHHHHHhhcC
Q 010519 444 PDSEKRPKMSQVVRMLEAD 462 (508)
Q Consensus 444 ~dP~~RPs~~evl~~L~~~ 462 (508)
.||.+|||+.++++|-.-.
T Consensus 436 ~dP~kR~ta~e~L~Hpff~ 454 (566)
T PLN03225 436 FKGRQRISAKAALAHPYFD 454 (566)
T ss_pred CCcccCCCHHHHhCCcCcC
Confidence 9999999999999975443
|
|
| >KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-35 Score=286.81 Aligned_cols=258 Identities=22% Similarity=0.289 Sum_probs=209.9
Q ss_pred hCCcccceeEeeeCceEEEEEEEcCCC-EEEEEEEcccc---hhhHHHHHHHHHHHhcCCCCCceeEEEEEEeCceeeEE
Q 010519 185 TNRFSAENVLGEGGYGVVYKGRLINGS-EVAVKKLLNNL---GQAEKEFRVEVEAIGHVRHKNLVRLLGYCIEGVHRMLV 260 (508)
Q Consensus 185 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~-~vavK~~~~~~---~~~~~~~~~ei~~l~~l~h~niv~~~~~~~~~~~~~lv 260 (508)
..++.....||-|+||.|=++...+.. .+|+|.+.+.. ....+.+..|-++|..++.|+||++|--|.++.+.||+
T Consensus 419 l~dl~~iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrTfrd~kyvYmL 498 (732)
T KOG0614|consen 419 LSDLKRIATLGVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRTFRDSKYVYML 498 (732)
T ss_pred hhhhhhhhhcccCccceEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHHhccchhhhhh
Confidence 356667788999999999999874333 37777765433 23345677799999999999999999999999999999
Q ss_pred EeecCCCCHHHHHhhhhccCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCEEEcCCCcEEEEecCCccccC
Q 010519 261 YEYVNNGNLEQWLHGAMRNQGNLTWEARMKVIIGTAKALAYLHEAIEPKVVHRDIKSSNILIDDEFNAKVSDFGLAKLLD 340 (508)
Q Consensus 261 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~Dfgla~~~~ 340 (508)
||-|-||.|+..| +.++.+.......++..+++|+.|||.+ +||+|||||+|++|+.+|-+||.|||+++.+.
T Consensus 499 mEaClGGElWTiL----rdRg~Fdd~tarF~~acv~EAfeYLH~k---~iIYRDLKPENllLd~~Gy~KLVDFGFAKki~ 571 (732)
T KOG0614|consen 499 MEACLGGELWTIL----RDRGSFDDYTARFYVACVLEAFEYLHRK---GIIYRDLKPENLLLDNRGYLKLVDFGFAKKIG 571 (732)
T ss_pred HHhhcCchhhhhh----hhcCCcccchhhhhHHHHHHHHHHHHhc---CceeccCChhheeeccCCceEEeehhhHHHhc
Confidence 9999999999999 5678899999999999999999999999 99999999999999999999999999999887
Q ss_pred CCCCcccccccccccccCccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCCCchhcHHHHHHHHhcccccccccCC
Q 010519 341 SGESHITTRVMGTFGYVAPEYANTGMLNEKSDIYSFGVLLLEAVTGRDPVDYGRPANEVNLVEWLKMMVGTRRAEEVVDP 420 (508)
Q Consensus 341 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 420 (508)
.+. .+-.++|||.|.|||++.++..+.++|.||||+++|||++|.+||...++-..- +.+-. .
T Consensus 572 ~g~--KTwTFcGTpEYVAPEIILnKGHD~avDyWaLGIli~ELL~G~pPFs~~dpmktY---n~ILk------------G 634 (732)
T KOG0614|consen 572 SGR--KTWTFCGTPEYVAPEIILNKGHDRAVDYWALGILIYELLTGSPPFSGVDPMKTY---NLILK------------G 634 (732)
T ss_pred cCC--ceeeecCCcccccchhhhccCcchhhHHHHHHHHHHHHHcCCCCCCCCchHHHH---HHHHh------------h
Confidence 654 356789999999999999999999999999999999999999999765432211 11111 1
Q ss_pred CCCCChhHHHHHHHHHHHHHhcCCCCCCCCC-----HHHHHHHhhcCCCCC
Q 010519 421 NLEVKPATRALKRSLLVALRCVDPDSEKRPK-----MSQVVRMLEADDYPF 466 (508)
Q Consensus 421 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs-----~~evl~~L~~~~~~~ 466 (508)
--.+..+....+...+|+++....+|.+|.- +.+|-+|-+-..+.|
T Consensus 635 id~i~~Pr~I~k~a~~Lik~LCr~~P~ERLG~~~~gI~DIkkH~Wf~gfdw 685 (732)
T KOG0614|consen 635 IDKIEFPRRITKTATDLIKKLCRDNPTERLGYQKGGINDIKKHRWFEGFDW 685 (732)
T ss_pred hhhhhcccccchhHHHHHHHHHhcCcHhhhccccCChHHHHhhhhhhcCCh
Confidence 1112223344556667889999999999985 788888877655544
|
|
| >KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-34 Score=250.92 Aligned_cols=213 Identities=28% Similarity=0.446 Sum_probs=180.9
Q ss_pred eHHHHHHhhCCcccceeEeeeCceEEEEEEEc-CCCEEEEEEEcccc-hhhHHHHHHHHHHHhc-CCCCCceeEEEEEEe
Q 010519 177 TLRDLEIATNRFSAENVLGEGGYGVVYKGRLI-NGSEVAVKKLLNNL-GQAEKEFRVEVEAIGH-VRHKNLVRLLGYCIE 253 (508)
Q Consensus 177 ~~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~ei~~l~~-l~h~niv~~~~~~~~ 253 (508)
..+.+++..++..-+..||+|++|.|-+-++. +|..+|+|.+.... .+..+.+.+|+++..+ ..+|++|.|||....
T Consensus 37 ~~~~~eV~ad~L~~i~elGrGayG~vekmrh~~sg~imAvKri~~tvn~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~r 116 (282)
T KOG0984|consen 37 GDRNFEVPADDLVGIEELGRGAYGVVEKMRHIQSGTIMAVKRIRATVNSQEQKRLLMDLDIIMRTVDCPFTVHFYGALFR 116 (282)
T ss_pred ecCccccchhhhhhhhhhcCCccchhhheeeccCCeEEEEeeehhhcChHHHHHHHHhhhhhccCCCCCeEEEeehhhhc
Confidence 34456778888888889999999999887764 79999999986543 3445667778887655 479999999999988
Q ss_pred CceeeEEEeecCCCCHHHHHhhhhccCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCEEEcCCCcEEEEec
Q 010519 254 GVHRMLVYEYVNNGNLEQWLHGAMRNQGNLTWEARMKVIIGTAKALAYLHEAIEPKVVHRDIKSSNILIDDEFNAKVSDF 333 (508)
Q Consensus 254 ~~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~Df 333 (508)
....++.||.|+- +|..|-...+..++.+++..+-+|+..+++||.|||+++ .+||||+||+|||++.+|++|+|||
T Consensus 117 egdvwIcME~M~t-Sldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~kL--~vIHRDvKPsNiLIn~~GqVKiCDF 193 (282)
T KOG0984|consen 117 EGDVWICMELMDT-SLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHSKL--SVIHRDVKPSNILINYDGQVKICDF 193 (282)
T ss_pred cccEEEeHHHhhh-hHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHHHh--hhhhccCCcceEEEccCCcEEEccc
Confidence 9999999999954 999988777788899999999999999999999999987 8999999999999999999999999
Q ss_pred CCccccCCCCCcccccccccccccCccccCC----CCCCChhhHHHHHHHHHHHHhCCCCCCCCC
Q 010519 334 GLAKLLDSGESHITTRVMGTFGYVAPEYANT----GMLNEKSDIYSFGVLLLEAVTGRDPVDYGR 394 (508)
Q Consensus 334 gla~~~~~~~~~~~~~~~gt~~y~aPE~~~~----~~~~~~~DvwS~Gvvl~elltG~~Pf~~~~ 394 (508)
|++-.+.+... .+...|...|||||.+.. ..|+.++||||||+.+.||.+++.||+.+.
T Consensus 194 GIsG~L~dSiA--kt~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~~w~ 256 (282)
T KOG0984|consen 194 GISGYLVDSIA--KTMDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYESWG 256 (282)
T ss_pred ccceeehhhhH--HHHhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhccccccccC
Confidence 99987755432 222357889999998853 468999999999999999999999997554
|
|
| >KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-33 Score=262.80 Aligned_cols=251 Identities=25% Similarity=0.327 Sum_probs=198.1
Q ss_pred HhhCCcccceeEeeeCceEEEEEEEc-CCCEEEEEEEcccc---hhhHHHHHHHHHHHhcC-CCCCceeEEEEEEeCcee
Q 010519 183 IATNRFSAENVLGEGGYGVVYKGRLI-NGSEVAVKKLLNNL---GQAEKEFRVEVEAIGHV-RHKNLVRLLGYCIEGVHR 257 (508)
Q Consensus 183 ~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~ei~~l~~l-~h~niv~~~~~~~~~~~~ 257 (508)
+..++|.++.+||+|+|..|.++++. ..+.+|+|++.+.. .+...-++.|-.+.... +||.+|.++.+|+.+..+
T Consensus 247 l~l~df~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscfqtesrl 326 (593)
T KOG0695|consen 247 LGLQDFDLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCFQTESRL 326 (593)
T ss_pred cccccceeeeeecCcchhhhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhhcccceE
Confidence 44578999999999999999999875 56778998875432 23334455566666655 799999999999999999
Q ss_pred eEEEeecCCCCHHHHHhhhhccCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCEEEcCCCcEEEEecCCcc
Q 010519 258 MLVYEYVNNGNLEQWLHGAMRNQGNLTWEARMKVIIGTAKALAYLHEAIEPKVVHRDIKSSNILIDDEFNAKVSDFGLAK 337 (508)
Q Consensus 258 ~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~Dfgla~ 337 (508)
++|.||++||+|--++ +.+..++++.++.+...|+.||.|||+. |||+||||..|||++..|++||+|+|+++
T Consensus 327 ffvieyv~ggdlmfhm----qrqrklpeeharfys~ei~lal~flh~r---giiyrdlkldnvlldaeghikltdygmck 399 (593)
T KOG0695|consen 327 FFVIEYVNGGDLMFHM----QRQRKLPEEHARFYSAEICLALNFLHER---GIIYRDLKLDNVLLDAEGHIKLTDYGMCK 399 (593)
T ss_pred EEEEEEecCcceeeeh----hhhhcCcHHHhhhhhHHHHHHHHHHhhc---CeeeeeccccceEEccCCceeecccchhh
Confidence 9999999999987666 5667899999999999999999999999 99999999999999999999999999998
Q ss_pred ccCCCCCcccccccccccccCccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCCC-chhcHHHHHHHHhccccccc
Q 010519 338 LLDSGESHITTRVMGTFGYVAPEYANTGMLNEKSDIYSFGVLLLEAVTGRDPVDYGRPA-NEVNLVEWLKMMVGTRRAEE 416 (508)
Q Consensus 338 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltG~~Pf~~~~~~-~~~~~~~~~~~~~~~~~~~~ 416 (508)
.--.+. .....++|||.|+|||++.+..|+..+|+|++||+++||+.|+.||+-.... .+.+..+++.+.+-...+
T Consensus 400 e~l~~g-d~tstfcgtpnyiapeilrgeeygfsvdwwalgvlmfemmagrspfdivgm~n~d~ntedylfqvilekqi-- 476 (593)
T KOG0695|consen 400 EGLGPG-DTTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIVGMDNPDMNTEDYLFQVILEKQI-- 476 (593)
T ss_pred cCCCCC-cccccccCCCcccchhhhcccccCceehHHHHHHHHHHHHcCCCCcceecCCCcccchhHHHHHHHhhhcc--
Confidence 543332 2356689999999999999999999999999999999999999999754433 334445555554433221
Q ss_pred ccCCCCCCChhHHHHHHHHHHHHHhcCCCCCCCCC
Q 010519 417 VVDPNLEVKPATRALKRSLLVALRCVDPDSEKRPK 451 (508)
Q Consensus 417 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs 451 (508)
+++. ....+..-++..-|++||.+|.-
T Consensus 477 ------ripr--slsvkas~vlkgflnkdp~erlg 503 (593)
T KOG0695|consen 477 ------RIPR--SLSVKASHVLKGFLNKDPKERLG 503 (593)
T ss_pred ------cccc--eeehhhHHHHHHhhcCCcHHhcC
Confidence 1111 11122233566788999999863
|
|
| >smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-32 Score=261.93 Aligned_cols=237 Identities=29% Similarity=0.432 Sum_probs=191.8
Q ss_pred CceEEEEEEEc-CCCEEEEEEEcccchhh-HHHHHHHHHHHhcCCCCCceeEEEEEEeCceeeEEEeecCCCCHHHHHhh
Q 010519 198 GYGVVYKGRLI-NGSEVAVKKLLNNLGQA-EKEFRVEVEAIGHVRHKNLVRLLGYCIEGVHRMLVYEYVNNGNLEQWLHG 275 (508)
Q Consensus 198 ~~g~Vy~~~~~-~~~~vavK~~~~~~~~~-~~~~~~ei~~l~~l~h~niv~~~~~~~~~~~~~lv~E~~~~gsL~~~l~~ 275 (508)
+||.||+|.+. ++..+++|++....... ...+..|+..+++++|+|++++++++......+++|||+++++|.+++..
T Consensus 1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~~~~ 80 (244)
T smart00220 1 SFGKVYLARDKKTGKLVAIKVIKKEKIKKKRERILREISILKKLKHPNIVRLYDVFEDEDKLYLVMEYCDGGDLFDLLKK 80 (244)
T ss_pred CceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHhCCCCcHHHHHhheeeCCEEEEEEeCCCCCCHHHHHHh
Confidence 58999999986 48999999987654433 57888999999999999999999999999999999999999999999853
Q ss_pred hhccCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCEEEcCCCcEEEEecCCccccCCCCCccccccccccc
Q 010519 276 AMRNQGNLTWEARMKVIIGTAKALAYLHEAIEPKVVHRDIKSSNILIDDEFNAKVSDFGLAKLLDSGESHITTRVMGTFG 355 (508)
Q Consensus 276 ~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~~~gt~~ 355 (508)
...+++..++.++.+++.++.|||.. +++|+||+|.||++++++.++|+|||.+....... ......++..
T Consensus 81 ----~~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~--~~~~~~~~~~ 151 (244)
T smart00220 81 ----RGRLSEDEARFYARQILSALEYLHSN---GIIHRDLKPENILLDEDGHVKLADFGLARQLDPGG--LLTTFVGTPE 151 (244)
T ss_pred ----ccCCCHHHHHHHHHHHHHHHHHHHHc---CeecCCcCHHHeEECCCCcEEEccccceeeecccc--ccccccCCcC
Confidence 23388999999999999999999998 99999999999999999999999999998765432 2334567889
Q ss_pred ccCccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCCCchhcHHHHHHHHhcccccccccCCCCCCChhHH-HHHHH
Q 010519 356 YVAPEYANTGMLNEKSDIYSFGVLLLEAVTGRDPVDYGRPANEVNLVEWLKMMVGTRRAEEVVDPNLEVKPATR-ALKRS 434 (508)
Q Consensus 356 y~aPE~~~~~~~~~~~DvwS~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~l 434 (508)
|++||.+.+..++.++|||+||+++++|++|..||..... .....+++.. .......... ....+
T Consensus 152 ~~~pE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~--~~~~~~~~~~------------~~~~~~~~~~~~~~~~ 217 (244)
T smart00220 152 YMAPEVLLGKGYGKAVDVWSLGVILYELLTGKPPFPGDDQ--LLELFKKIGK------------PKPPFPPPEWKISPEA 217 (244)
T ss_pred CCCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCc--HHHHHHHHhc------------cCCCCccccccCCHHH
Confidence 9999999988899999999999999999999999864321 1111111111 0001000000 33567
Q ss_pred HHHHHHhcCCCCCCCCCHHHHHH
Q 010519 435 LLVALRCVDPDSEKRPKMSQVVR 457 (508)
Q Consensus 435 ~~li~~cl~~dP~~RPs~~evl~ 457 (508)
.+++.+||..+|++||++.++++
T Consensus 218 ~~~i~~~l~~~p~~Rp~~~~~~~ 240 (244)
T smart00220 218 KDLIRKLLVKDPEKRLTAEEALQ 240 (244)
T ss_pred HHHHHHHccCCchhccCHHHHhh
Confidence 77999999999999999999997
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. |
| >PLN03224 probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-32 Score=287.21 Aligned_cols=265 Identities=22% Similarity=0.284 Sum_probs=183.9
Q ss_pred HhhCCcccceeEeeeCceEEEEEEE-----------------cCCCEEEEEEEcccchhhHHH--------------HHH
Q 010519 183 IATNRFSAENVLGEGGYGVVYKGRL-----------------INGSEVAVKKLLNNLGQAEKE--------------FRV 231 (508)
Q Consensus 183 ~~~~~~~~~~~lg~G~~g~Vy~~~~-----------------~~~~~vavK~~~~~~~~~~~~--------------~~~ 231 (508)
...++|.+.++||+|+||+||+|.+ ..++.||||++.......... ...
T Consensus 142 ~~~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~v 221 (507)
T PLN03224 142 WSSDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMV 221 (507)
T ss_pred ccccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHH
Confidence 4567999999999999999999964 235679999986443222222 334
Q ss_pred HHHHHhcCCCCCc-----eeEEEEEEe--------CceeeEEEeecCCCCHHHHHhhhhc--------------------
Q 010519 232 EVEAIGHVRHKNL-----VRLLGYCIE--------GVHRMLVYEYVNNGNLEQWLHGAMR-------------------- 278 (508)
Q Consensus 232 ei~~l~~l~h~ni-----v~~~~~~~~--------~~~~~lv~E~~~~gsL~~~l~~~~~-------------------- 278 (508)
|+.++.+++|.++ +.++++|.. ....++||||+++|+|.++|+....
T Consensus 222 E~~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~ 301 (507)
T PLN03224 222 EAYMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNM 301 (507)
T ss_pred HHHHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhc
Confidence 6777777766554 677777653 3467899999999999999974211
Q ss_pred cCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCEEEcCCCcEEEEecCCccccCCCCCcccccccccccccC
Q 010519 279 NQGNLTWEARMKVIIGTAKALAYLHEAIEPKVVHRDIKSSNILIDDEFNAKVSDFGLAKLLDSGESHITTRVMGTFGYVA 358 (508)
Q Consensus 279 ~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~~~gt~~y~a 358 (508)
....+++..+..++.|++.||.|||+. +|+||||||+|||++.++.+||+|||++...............+++.|+|
T Consensus 302 ~~~~~~~~~~~~i~~ql~~aL~~lH~~---~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~g~~tp~Y~a 378 (507)
T PLN03224 302 PQDKRDINVIKGVMRQVLTGLRKLHRI---GIVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGINFNPLYGMLDPRYSP 378 (507)
T ss_pred ccccCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCchHhEEECCCCcEEEEeCcCccccccCCccCccccCCCcceeC
Confidence 012346778899999999999999998 99999999999999999999999999997654332222222345889999
Q ss_pred ccccCCCC--------------------CC--ChhhHHHHHHHHHHHHhCCC-CCCCCCCCch------hcHHHHHHHHh
Q 010519 359 PEYANTGM--------------------LN--EKSDIYSFGVLLLEAVTGRD-PVDYGRPANE------VNLVEWLKMMV 409 (508)
Q Consensus 359 PE~~~~~~--------------------~~--~~~DvwS~Gvvl~elltG~~-Pf~~~~~~~~------~~~~~~~~~~~ 409 (508)
||.+.... |+ .+.||||+||+||+|++|.. ||......+. .....|..
T Consensus 379 PE~l~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~~~~f~~~~~~~~~~~~~~r~--- 455 (507)
T PLN03224 379 PEELVMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVANIRLFNTELRQYDNDLNRWRM--- 455 (507)
T ss_pred hhhhcCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccchhhhhhHHhhccchHHHHHh---
Confidence 99875432 11 34799999999999999886 6642211110 00111111
Q ss_pred cccccccccCCCCCCChhHHHHHHHHHHHHHhcCCCC---CCCCCHHHHHHHhh
Q 010519 410 GTRRAEEVVDPNLEVKPATRALKRSLLVALRCVDPDS---EKRPKMSQVVRMLE 460 (508)
Q Consensus 410 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP---~~RPs~~evl~~L~ 460 (508)
...................+|+.+||..+| .+|+|++|+|+|-+
T Consensus 456 -------~~~~~~~~~~~d~~s~~~~dLi~~LL~~~~~~~~~RlSa~eaL~Hp~ 502 (507)
T PLN03224 456 -------YKGQKYDFSLLDRNKEAGWDLACKLITKRDQANRGRLSVGQALSHRF 502 (507)
T ss_pred -------hcccCCCcccccccChHHHHHHHHHhccCCCCcccCCCHHHHhCCCC
Confidence 001111222222234556678889998765 78999999998754
|
|
| >KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-33 Score=281.80 Aligned_cols=205 Identities=26% Similarity=0.395 Sum_probs=173.4
Q ss_pred CCcccceeEeeeCceEEEEEEEc-CCCEEEEEEEcccc---hhhHHHHHHHHHHHhcCCCCCceeEEEEEEeCceeeEEE
Q 010519 186 NRFSAENVLGEGGYGVVYKGRLI-NGSEVAVKKLLNNL---GQAEKEFRVEVEAIGHVRHKNLVRLLGYCIEGVHRMLVY 261 (508)
Q Consensus 186 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~ei~~l~~l~h~niv~~~~~~~~~~~~~lv~ 261 (508)
.-|..++.||-|+||+|.++... ....+|+|.+.+.. ......++.|-++|...+.+-||++|-.|++++.+|+||
T Consensus 629 SmFvkik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrLyySFQDkdnLYFVM 708 (1034)
T KOG0608|consen 629 SMFVKIKTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVM 708 (1034)
T ss_pred cceEEEeeecccccceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEEEEEeccCCceEEEE
Confidence 44667788999999999999643 45678999886543 233356788999999999999999999999999999999
Q ss_pred eecCCCCHHHHHhhhhccCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCEEEcCCCcEEEEecCCcccc--
Q 010519 262 EYVNNGNLEQWLHGAMRNQGNLTWEARMKVIIGTAKALAYLHEAIEPKVVHRDIKSSNILIDDEFNAKVSDFGLAKLL-- 339 (508)
Q Consensus 262 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~Dfgla~~~-- 339 (508)
+|++||++-.+|. ..+.+.+..++.++..+..|+.+.|.. |+|||||||+|||||.+|++||+||||+.-+
T Consensus 709 dYIPGGDmMSLLI----rmgIFeE~LARFYIAEltcAiesVHkm---GFIHRDiKPDNILIDrdGHIKLTDFGLCTGfRW 781 (1034)
T KOG0608|consen 709 DYIPGGDMMSLLI----RMGIFEEDLARFYIAELTCAIESVHKM---GFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRW 781 (1034)
T ss_pred eccCCccHHHHHH----HhccCHHHHHHHHHHHHHHHHHHHHhc---cceecccCccceEEccCCceeeeecccccccee
Confidence 9999999999984 456788899999999999999999999 9999999999999999999999999998422
Q ss_pred -------CCCCCc--------------------------------ccccccccccccCccccCCCCCCChhhHHHHHHHH
Q 010519 340 -------DSGESH--------------------------------ITTRVMGTFGYVAPEYANTGMLNEKSDIYSFGVLL 380 (508)
Q Consensus 340 -------~~~~~~--------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl 380 (508)
..+... .....+||+.|+|||++....|+..+|+||.||||
T Consensus 782 THdskYYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~g~~q~cdwws~gvil 861 (1034)
T KOG0608|consen 782 THDSKYYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLARTGYTQLCDWWSVGVIL 861 (1034)
T ss_pred ccccccccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcccCccccchhhHhhHHH
Confidence 111000 01126899999999999999999999999999999
Q ss_pred HHHHhCCCCCCCCCCCc
Q 010519 381 LEAVTGRDPVDYGRPAN 397 (508)
Q Consensus 381 ~elltG~~Pf~~~~~~~ 397 (508)
|||+.|+.||....+..
T Consensus 862 ~em~~g~~pf~~~tp~~ 878 (1034)
T KOG0608|consen 862 YEMLVGQPPFLADTPGE 878 (1034)
T ss_pred HHHhhCCCCccCCCCCc
Confidence 99999999997666543
|
|
| >KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-33 Score=240.72 Aligned_cols=261 Identities=21% Similarity=0.340 Sum_probs=196.2
Q ss_pred CcccceeEeeeCceEEEEEEEc-CCCEEEEEEEcccc--hhhHHHHHHHHHHHhcCCCCCceeEEEEEEeCceeeEEEee
Q 010519 187 RFSAENVLGEGGYGVVYKGRLI-NGSEVAVKKLLNNL--GQAEKEFRVEVEAIGHVRHKNLVRLLGYCIEGVHRMLVYEY 263 (508)
Q Consensus 187 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~ei~~l~~l~h~niv~~~~~~~~~~~~~lv~E~ 263 (508)
+|...++||+|.||+||+|+.. .++.||+|++..+. ..-.....+||-+++.++|.|||+++++...+..+-+|+||
T Consensus 3 ~ydkmekigegtygtvfkarn~~t~eivalkrvrlddddegvpssalreicllkelkhknivrl~dvlhsdkkltlvfe~ 82 (292)
T KOG0662|consen 3 KYDKMEKIGEGTYGTVFKARNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEF 82 (292)
T ss_pred chHHHHhhcCCcceeeEecccCCccceEEEEEEeccCCCCCCcHHHHHHHHHHHHhhhcceeehhhhhccCceeEEeHHH
Confidence 4666788999999999999864 57789999886433 22234566799999999999999999999999999999999
Q ss_pred cCCCCHHHHHhhhhccCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCEEEcCCCcEEEEecCCccccCCCC
Q 010519 264 VNNGNLEQWLHGAMRNQGNLTWEARMKVIIGTAKALAYLHEAIEPKVVHRDIKSSNILIDDEFNAKVSDFGLAKLLDSGE 343 (508)
Q Consensus 264 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~~~ 343 (508)
|+. +|..|.. .-++.++...+..++.|+++||.|+|++ ++.||||||.|+|++.+|++||+|||+++.++-..
T Consensus 83 cdq-dlkkyfd---slng~~d~~~~rsfmlqllrgl~fchsh---nvlhrdlkpqnllin~ngelkladfglarafgipv 155 (292)
T KOG0662|consen 83 CDQ-DLKKYFD---SLNGDLDPEIVRSFMLQLLRGLGFCHSH---NVLHRDLKPQNLLINRNGELKLADFGLARAFGIPV 155 (292)
T ss_pred hhH-HHHHHHH---hcCCcCCHHHHHHHHHHHHhhhhhhhhh---hhhhccCCcceEEeccCCcEEecccchhhhcCCce
Confidence 965 8888886 3467788999999999999999999999 99999999999999999999999999999877554
Q ss_pred CcccccccccccccCccccCC-CCCCChhhHHHHHHHHHHHHhCCCC-CCCCCCCchhcHHHHHHHHhcccc------cc
Q 010519 344 SHITTRVMGTFGYVAPEYANT-GMLNEKSDIYSFGVLLLEAVTGRDP-VDYGRPANEVNLVEWLKMMVGTRR------AE 415 (508)
Q Consensus 344 ~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwS~Gvvl~elltG~~P-f~~~~~~~~~~~~~~~~~~~~~~~------~~ 415 (508)
.+. ...+-|.+|.+|.++.+ +-|+...|+||-|||+.|+.....| |...+- ..++...++ ..+... +.
T Consensus 156 rcy-saevvtlwyrppdvlfgakly~tsidmwsagcifaelanagrplfpg~dv--ddqlkrif~-~lg~p~ed~wps~t 231 (292)
T KOG0662|consen 156 RCY-SAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDV--DDQLKRIFR-LLGTPTEDQWPSMT 231 (292)
T ss_pred Eee-eceeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCCCCCCcH--HHHHHHHHH-HhCCCccccCCccc
Confidence 333 33456999999998876 5689999999999999999984444 543321 122222222 222211 11
Q ss_pred cccCCCC-CCChh--------HHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 010519 416 EVVDPNL-EVKPA--------TRALKRSLLVALRCVDPDSEKRPKMSQVVRM 458 (508)
Q Consensus 416 ~~~~~~~-~~~~~--------~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 458 (508)
.+.|-.. ...+. ++....-.+|..+.+.-+|.+|.++++.+++
T Consensus 232 ~lpdyk~yp~ypattswsqivp~lns~grdllqkll~cnp~qrisaeaalqh 283 (292)
T KOG0662|consen 232 KLPDYKPYPIYPATTSWSQIVPKLNSTGRDLLQKLLKCNPAQRISAEAALQH 283 (292)
T ss_pred cCCCCcccCCccccchHHHHhhhhcchhHHHHHHHhccCcccccCHHHHhcC
Confidence 1111110 11111 1122233567888999999999999999875
|
|
| >KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-33 Score=292.76 Aligned_cols=248 Identities=28% Similarity=0.421 Sum_probs=189.4
Q ss_pred cccceeEeeeCceE-EEEEEEcCCCEEEEEEEcccchhhHHHHHHHHHHHhcC-CCCCceeEEEEEEeCceeeEEEeecC
Q 010519 188 FSAENVLGEGGYGV-VYKGRLINGSEVAVKKLLNNLGQAEKEFRVEVEAIGHV-RHKNLVRLLGYCIEGVHRMLVYEYVN 265 (508)
Q Consensus 188 ~~~~~~lg~G~~g~-Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~ei~~l~~l-~h~niv~~~~~~~~~~~~~lv~E~~~ 265 (508)
|.-.+++|.|+.|+ ||+|.+ .|+.||||++... ......+|+..|+.- .|||||++++.-.+...+||..|.|
T Consensus 511 ~~~~eilG~Gs~Gt~Vf~G~y-e~R~VAVKrll~e---~~~~A~rEi~lL~eSD~H~NviRyyc~E~d~qF~YIalELC- 585 (903)
T KOG1027|consen 511 FSPKEILGYGSNGTVVFRGVY-EGREVAVKRLLEE---FFDFAQREIQLLQESDEHPNVIRYYCSEQDRQFLYIALELC- 585 (903)
T ss_pred eccHHHcccCCCCcEEEEEee-CCceehHHHHhhH---hHHHHHHHHHHHHhccCCCceEEEEeeccCCceEEEEehHh-
Confidence 44557799999886 799987 8899999998643 234566799999887 6999999999999999999999999
Q ss_pred CCCHHHHHhhhhccCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCEEEcC---C--CcEEEEecCCccccC
Q 010519 266 NGNLEQWLHGAMRNQGNLTWEARMKVIIGTAKALAYLHEAIEPKVVHRDIKSSNILIDD---E--FNAKVSDFGLAKLLD 340 (508)
Q Consensus 266 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiH~Dlk~~NIll~~---~--~~~kl~Dfgla~~~~ 340 (508)
..+|.+++...............+.+..|++.||++||+. +||||||||.||||+. + .+++|+|||+++.+.
T Consensus 586 ~~sL~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLHsl---~iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsKkl~ 662 (903)
T KOG1027|consen 586 ACSLQDLIESSGLDVEMQSDIDPISVLSQIASGLAHLHSL---KIVHRDLKPQNILISVPSADGTLRAKISDFGLSKKLA 662 (903)
T ss_pred hhhHHHHHhccccchhhcccccHHHHHHHHHHHHHHHHhc---ccccccCCCceEEEEccCCCcceeEEecccccccccC
Confidence 5699999965311111122245678889999999999998 9999999999999975 3 468999999999887
Q ss_pred CCCCcc--cccccccccccCccccCCCCCCChhhHHHHHHHHHHHHhC-CCCCCCCCCCchhcHHHHHHHHhcccccccc
Q 010519 341 SGESHI--TTRVMGTFGYVAPEYANTGMLNEKSDIYSFGVLLLEAVTG-RDPVDYGRPANEVNLVEWLKMMVGTRRAEEV 417 (508)
Q Consensus 341 ~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltG-~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 417 (508)
.+.... .....||.+|+|||++....-+.++||||||||+|+.++| .+||...-.. ......++..+.
T Consensus 663 ~~~sS~~r~s~~sGt~GW~APE~L~~~~~~~avDiFslGCvfyYvltgG~HpFGd~~~R-------~~NIl~~~~~L~-- 733 (903)
T KOG1027|consen 663 GGKSSFSRLSGGSGTSGWQAPEQLREDRKTQAVDIFSLGCVFYYVLTGGSHPFGDSLER-------QANILTGNYTLV-- 733 (903)
T ss_pred CCcchhhcccCCCCcccccCHHHHhccccCcccchhhcCceEEEEecCCccCCCchHHh-------hhhhhcCcccee--
Confidence 554432 3456799999999999998888899999999999999995 8999633211 111111111111
Q ss_pred cCCCCCCChhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHh
Q 010519 418 VDPNLEVKPATRALKRSLLVALRCVDPDSEKRPKMSQVVRML 459 (508)
Q Consensus 418 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L 459 (508)
...+..+. ...+||.+|+++||..||++.+||.|-
T Consensus 734 -----~L~~~~d~--eA~dLI~~ml~~dP~~RPsa~~VL~HP 768 (903)
T KOG1027|consen 734 -----HLEPLPDC--EAKDLISRMLNPDPQLRPSATDVLNHP 768 (903)
T ss_pred -----eeccCchH--HHHHHHHHhcCCCcccCCCHHHHhCCC
Confidence 11111111 566799999999999999999999764
|
|
| >KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.6e-33 Score=254.55 Aligned_cols=272 Identities=24% Similarity=0.349 Sum_probs=200.7
Q ss_pred CCcccceeEeeeCceEEEEEEEc-CCCEEEEEEEcccchh--hHHHHHHHHHHHhcCCCCCceeEEEEEEeC--------
Q 010519 186 NRFSAENVLGEGGYGVVYKGRLI-NGSEVAVKKLLNNLGQ--AEKEFRVEVEAIGHVRHKNLVRLLGYCIEG-------- 254 (508)
Q Consensus 186 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~--~~~~~~~ei~~l~~l~h~niv~~~~~~~~~-------- 254 (508)
+.|....+||+|.||+||+++.. .|+.||+|++.-...+ -.....+|+++|..+.|+|++.++.+|...
T Consensus 17 ~~yek~~kigqGtfgeVFkAr~~n~~kkvalkkvlmeneKeGfpitalreikiL~~lkHenv~nliEic~tk~Tp~~r~r 96 (376)
T KOG0669|consen 17 SKYEKLAKIGQGTFGEVFKARSKNTGKKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPTNRDR 96 (376)
T ss_pred hHHHHHHhcCCchHHHHHHHhhcCccchhHHHHHHHhccccCCcHHHHHHHHHHHHhcchhHHHHHHHHhhccCCccccc
Confidence 45677788999999999999875 5677898876532211 112345599999999999999999988532
Q ss_pred ceeeEEEeecCCCCHHHHHhhhhccCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCEEEcCCCcEEEEecC
Q 010519 255 VHRMLVYEYVNNGNLEQWLHGAMRNQGNLTWEARMKVIIGTAKALAYLHEAIEPKVVHRDIKSSNILIDDEFNAKVSDFG 334 (508)
Q Consensus 255 ~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~Dfg 334 (508)
...|+||.+|.. +|..+|. ....+++...+.+++.++..||.|+|.. .|+|||+|+.|+|++.+|.+||+|||
T Consensus 97 ~t~ylVf~~ceh-DLaGlLs---n~~vr~sls~Ikk~Mk~Lm~GL~~iHr~---kilHRDmKaaNvLIt~dgilklADFG 169 (376)
T KOG0669|consen 97 ATFYLVFDFCEH-DLAGLLS---NRKVRFSLSEIKKVMKGLMNGLYYIHRN---KILHRDMKAANVLITKDGILKLADFG 169 (376)
T ss_pred ceeeeeHHHhhh-hHHHHhc---CccccccHHHHHHHHHHHHHHHHHHHHh---hHHhhcccHhhEEEcCCceEEeeccc
Confidence 347899999976 9999884 2335788999999999999999999999 99999999999999999999999999
Q ss_pred CccccCCCCC---cccccccccccccCccccCC-CCCCChhhHHHHHHHHHHHHhCCCCCCCCCCCchhcHHHHHHHHhc
Q 010519 335 LAKLLDSGES---HITTRVMGTFGYVAPEYANT-GMLNEKSDIYSFGVLLLEAVTGRDPVDYGRPANEVNLVEWLKMMVG 410 (508)
Q Consensus 335 la~~~~~~~~---~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwS~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~ 410 (508)
+++.+..... ...+..+-|.+|.+||.+.| ..|+++.|||.-|||+.||+++.+-+.... +.+....+..+.+
T Consensus 170 lar~fs~~~n~~kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrspimqgnt---eqqql~~Is~LcG 246 (376)
T KOG0669|consen 170 LARAFSTSKNVVKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPIMQGNT---EQQQLHLISQLCG 246 (376)
T ss_pred cccceecccccCCCCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCccccCCh---HHHHHHHHHHHhc
Confidence 9976532221 12334456999999998876 569999999999999999999988775433 2333344444444
Q ss_pred cccccc--c-----cCCCCC--------CChhHHHHH------HHHHHHHHhcCCCCCCCCCHHHHHHHhhcCCCCCc
Q 010519 411 TRRAEE--V-----VDPNLE--------VKPATRALK------RSLLVALRCVDPDSEKRPKMSQVVRMLEADDYPFR 467 (508)
Q Consensus 411 ~~~~~~--~-----~~~~~~--------~~~~~~~~~------~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~~~ 467 (508)
...-.. - +-..+. ........+ ..++|+..++..||.+|+++.+++.+-.-...+..
T Consensus 247 s~tkevWP~~d~lpL~~sie~ePl~~~~~rkv~n~~kp~~kd~~a~dLle~ll~~DP~kR~~ad~alnh~~F~kdp~p 324 (376)
T KOG0669|consen 247 SITKEVWPNVDNLPLYQSIELEPLPKGQKRKVKNRLKPYVKDDEALDLLEKLLKLDPTKRIDADQALNHDFFWKDPMP 324 (376)
T ss_pred cCCcccCCCcccchHHHhccCCCCCcchhhhhhhhcccccCChhHHHHHHHHhccCcccCcchHhhhchhhhhcCCcc
Confidence 321100 0 000000 001111222 56779999999999999999999988765555544
|
|
| >KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.3e-32 Score=271.89 Aligned_cols=278 Identities=24% Similarity=0.231 Sum_probs=212.9
Q ss_pred CcceeHHHHHHhhCCcccceeEeeeCceEEEEEEEc-CCCEEEEEEEcccchhhHHHHHHHHHHHhcCC------CCCce
Q 010519 173 GHWFTLRDLEIATNRFSAENVLGEGGYGVVYKGRLI-NGSEVAVKKLLNNLGQAEKEFRVEVEAIGHVR------HKNLV 245 (508)
Q Consensus 173 ~~~~~~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~ei~~l~~l~------h~niv 245 (508)
..+|.+.-.++.-.+|.+....|+|-|++|..|.+. .|+.||||+|.++..... .=..|+++|++|+ --|++
T Consensus 419 EGYYrv~igE~LD~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnNE~M~K-tGl~EleiLkKL~~AD~Edk~Hcl 497 (752)
T KOG0670|consen 419 EGYYRVRIGELLDSRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRNNEVMHK-TGLKELEILKKLNDADPEDKFHCL 497 (752)
T ss_pred cceEEEehhhhhcceeEEEeccccceeeeeeeccccCCCCeeEEEEeecchHHhh-hhhHHHHHHHHhhccCchhhhHHH
Confidence 346788888899999999999999999999999865 578999999987754433 3344999999995 34899
Q ss_pred eEEEEEEeCceeeEEEeecCCCCHHHHHhhhhccCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCEEEcCC
Q 010519 246 RLLGYCIEGVHRMLVYEYVNNGNLEQWLHGAMRNQGNLTWEARMKVIIGTAKALAYLHEAIEPKVVHRDIKSSNILIDDE 325 (508)
Q Consensus 246 ~~~~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiH~Dlk~~NIll~~~ 325 (508)
+++-.|...+++|||||-+ ..+|.+.|..+ ...-.|...++..++.|+..||..|... +|+|.||||.||||++.
T Consensus 498 rl~r~F~hknHLClVFE~L-slNLRevLKKy-G~nvGL~ikaVRsYaqQLflALklLK~c---~vlHaDIKPDNiLVNE~ 572 (752)
T KOG0670|consen 498 RLFRHFKHKNHLCLVFEPL-SLNLREVLKKY-GRNVGLHIKAVRSYAQQLFLALKLLKKC---GVLHADIKPDNILVNES 572 (752)
T ss_pred HHHHHhhhcceeEEEehhh-hchHHHHHHHh-CcccceeehHHHHHHHHHHHHHHHHHhc---CeeecccCccceEeccC
Confidence 9999999999999999988 45999999765 3455688899999999999999999987 99999999999999876
Q ss_pred C-cEEEEecCCccccCCCCCcccccccccccccCccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCCCchhcHHHH
Q 010519 326 F-NAKVSDFGLAKLLDSGESHITTRVMGTFGYVAPEYANTGMLNEKSDIYSFGVLLLEAVTGRDPVDYGRPANEVNLVEW 404 (508)
Q Consensus 326 ~-~~kl~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltG~~Pf~~~~~~~~~~~~~~ 404 (508)
- .+||||||.|......+. +...-+..|.|||++.|.+|+...|+||.||.||||.||+..|.......++.+.--
T Consensus 573 k~iLKLCDfGSA~~~~enei---tPYLVSRFYRaPEIiLG~~yd~~iD~WSvgctLYElYtGkIlFpG~TNN~MLrl~me 649 (752)
T KOG0670|consen 573 KNILKLCDFGSASFASENEI---TPYLVSRFYRAPEIILGLPYDYPIDTWSVGCTLYELYTGKILFPGRTNNQMLRLFME 649 (752)
T ss_pred cceeeeccCccccccccccc---cHHHHHHhccCcceeecCcccCCccceeeceeeEEeeccceecCCCCcHHHHHHHHH
Confidence 5 479999999987765432 222235679999999999999999999999999999999999975544333221100
Q ss_pred H-----HHHhcccc---------------------------cccccCCCC-----------CCChhHHHHHHHHHHHHHh
Q 010519 405 L-----KMMVGTRR---------------------------AEEVVDPNL-----------EVKPATRALKRSLLVALRC 441 (508)
Q Consensus 405 ~-----~~~~~~~~---------------------------~~~~~~~~~-----------~~~~~~~~~~~l~~li~~c 441 (508)
+ ..|+.... +...+.|.- ...........+.+|+..|
T Consensus 650 ~KGk~p~KmlRKgqF~dqHFD~d~nf~~~e~D~vT~r~~~~vm~~vkPtkdl~s~l~~~q~~~deq~~~~~~~rdLLdkm 729 (752)
T KOG0670|consen 650 LKGKFPNKMLRKGQFKDQHFDQDLNFLYIEVDKVTEREKRTVMVNVKPTKDLGSELIAVQRLPDEQPKIVQQLRDLLDKM 729 (752)
T ss_pred hcCCCcHHHhhhcchhhhhcccccceEEEeccccccceeEEEecccCcchhHHHHHhccCCCCchhHHHHHHHHHHHHHH
Confidence 0 00110000 000111100 0112234566778899999
Q ss_pred cCCCCCCCCCHHHHHHHh
Q 010519 442 VDPDSEKRPKMSQVVRML 459 (508)
Q Consensus 442 l~~dP~~RPs~~evl~~L 459 (508)
|..||.+|.|..|+|.|-
T Consensus 730 l~LdP~KRit~nqAL~Hp 747 (752)
T KOG0670|consen 730 LILDPEKRITVNQALKHP 747 (752)
T ss_pred hccChhhcCCHHHHhcCC
Confidence 999999999999999863
|
|
| >KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.8e-33 Score=253.98 Aligned_cols=266 Identities=23% Similarity=0.351 Sum_probs=202.8
Q ss_pred CcccceeEeeeCceEEEEEEEc-CCCEEEEEEEcccc--hhhHHHHHHHHHHHhcCCCCCceeEEEEEEeCc-----eee
Q 010519 187 RFSAENVLGEGGYGVVYKGRLI-NGSEVAVKKLLNNL--GQAEKEFRVEVEAIGHVRHKNLVRLLGYCIEGV-----HRM 258 (508)
Q Consensus 187 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~ei~~l~~l~h~niv~~~~~~~~~~-----~~~ 258 (508)
+.+..+-||.|+||.||.+++. +|+.||.|++.+-. -...+.+.+|+++|..++|.|++..+++.+-.. .+|
T Consensus 54 Di~PDRPIGYGAFGVVWsVTDPRdgrrvalkK~pnvfq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqEiY 133 (449)
T KOG0664|consen 54 DIQPDRPIGYGAFGVVWSVTDPRSGKRVALKKMPNVFQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQELY 133 (449)
T ss_pred cCCCCCcccccceeEEEeccCCCCccchhHhhcchHHHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHHHH
Confidence 4566788999999999999874 79999999986432 233466778999999999999999999876542 457
Q ss_pred EEEeecCCCCHHHHHhhhhccCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCEEEcCCCcEEEEecCCccc
Q 010519 259 LVYEYVNNGNLEQWLHGAMRNQGNLTWEARMKVIIGTAKALAYLHEAIEPKVVHRDIKSSNILIDDEFNAKVSDFGLAKL 338 (508)
Q Consensus 259 lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~Dfgla~~ 338 (508)
++.|+|.. +|...+ .....++.+.+.-++.||++||.|||+. +|.||||||.|+|++.+..+||||||+++.
T Consensus 134 V~TELmQS-DLHKII----VSPQ~Ls~DHvKVFlYQILRGLKYLHsA---~ILHRDIKPGNLLVNSNCvLKICDFGLARv 205 (449)
T KOG0664|consen 134 VLTELMQS-DLHKII----VSPQALTPDHVKVFVYQILRGLKYLHTA---NILHRDIKPGNLLVNSNCILKICDFGLART 205 (449)
T ss_pred HHHHHHHh-hhhhee----ccCCCCCcchhhhhHHHHHhhhHHHhhc---chhhccCCCccEEeccCceEEecccccccc
Confidence 88888854 666655 5677899899999999999999999999 999999999999999999999999999997
Q ss_pred cCCCCCcccccccccccccCccccCC-CCCCChhhHHHHHHHHHHHHhCCCCCCCCCCCchhcHHHHHHHHhcccccc--
Q 010519 339 LDSGESHITTRVMGTFGYVAPEYANT-GMLNEKSDIYSFGVLLLEAVTGRDPVDYGRPANEVNLVEWLKMMVGTRRAE-- 415 (508)
Q Consensus 339 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwS~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~-- 415 (508)
-+.++...++..+-|..|.|||+++| ..|+.+.||||.|||+.||+..+..|....+....++ +..+++.....
T Consensus 206 ee~d~~~hMTqEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQAq~PiqQL~l---ItdLLGTPs~EaM 282 (449)
T KOG0664|consen 206 WDQRDRLNMTHEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILFQAAGPIEQLQM---IIDLLGTPSQEAM 282 (449)
T ss_pred cchhhhhhhHHHHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhhhccChHHHHHH---HHHHhCCCcHHHH
Confidence 76666666777777999999999987 5699999999999999999998888876555443332 22222221110
Q ss_pred ---------cccC-----CCCC----CChhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhhcCC
Q 010519 416 ---------EVVD-----PNLE----VKPATRALKRSLLVALRCVDPDSEKRPKMSQVVRMLEADD 463 (508)
Q Consensus 416 ---------~~~~-----~~~~----~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~ 463 (508)
.++. |.+. .......-...+.+...++..||+.|.+..+.+.++-...
T Consensus 283 r~ACEGAk~H~LR~~~k~Ps~~vLYtlsS~~~~~heav~~~~~~l~~d~dkris~~~A~~~~~~~e 348 (449)
T KOG0664|consen 283 KYACEGAKNHVLRAGLRAPDTQRLYKIASPDDKNHEAVDLLQKLLHFDPDKRISVEEALQHRYLEE 348 (449)
T ss_pred HHHhhhhHHHhhccCCCCCCccceeeecCCcccchHHHHHHHHHhCCCCcccccHhhhcccccccc
Confidence 0111 1111 1111122334556778899999999999999998875543
|
|
| >KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.4e-29 Score=249.21 Aligned_cols=285 Identities=21% Similarity=0.277 Sum_probs=204.3
Q ss_pred CcceeHHHHHHhh-CCcccceeEeeeCceEEEEEEEc-CCCEEEEEEEcccchhhHHHHHHHHHHHhcCC-----C---C
Q 010519 173 GHWFTLRDLEIAT-NRFSAENVLGEGGYGVVYKGRLI-NGSEVAVKKLLNNLGQAEKEFRVEVEAIGHVR-----H---K 242 (508)
Q Consensus 173 ~~~~~~~~~~~~~-~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~ei~~l~~l~-----h---~ 242 (508)
|.+-++...+... .+|.+.++||-|-|++||++.+. +.+.||+|+++.. ..-.+....||++|++++ | .
T Consensus 64 GGYHpV~IGD~F~~gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKSA-qhYtEaAlDEIklL~~v~~~Dp~~~~~~ 142 (590)
T KOG1290|consen 64 GGYHPVRIGDVFNGGRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKSA-QHYTEAALDEIKLLQQVREGDPNDPGKK 142 (590)
T ss_pred CCCceeeccccccCceEEEEEeccccccceeEEEeeccCCeEEEEEEEehh-hHHHHHHHHHHHHHHHHHhcCCCCCCCc
Confidence 3333444445444 89999999999999999999865 4567888876543 333345566999999883 3 3
Q ss_pred CceeEEEEEEe----CceeeEEEeecCCCCHHHHHhhhhccCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCC
Q 010519 243 NLVRLLGYCIE----GVHRMLVYEYVNNGNLEQWLHGAMRNQGNLTWEARMKVIIGTAKALAYLHEAIEPKVVHRDIKSS 318 (508)
Q Consensus 243 niv~~~~~~~~----~~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiH~Dlk~~ 318 (508)
+||+++++|.. +.+.+||+|++ |.+|..+|.. .....++...+.+|+.||+.||.|||..+ +|||.||||+
T Consensus 143 ~VV~LlD~FkhsGpNG~HVCMVfEvL-GdnLLklI~~--s~YrGlpl~~VK~I~~qvL~GLdYLH~ec--gIIHTDlKPE 217 (590)
T KOG1290|consen 143 CVVQLLDHFKHSGPNGQHVCMVFEVL-GDNLLKLIKY--SNYRGLPLSCVKEICRQVLTGLDYLHREC--GIIHTDLKPE 217 (590)
T ss_pred eeeeeeccceecCCCCcEEEEEehhh-hhHHHHHHHH--hCCCCCcHHHHHHHHHHHHHHHHHHHHhc--CccccCCCcc
Confidence 69999999975 46889999999 7799999975 45567889999999999999999999887 9999999999
Q ss_pred CEEEcCC-------------------------------------------------------------------------
Q 010519 319 NILIDDE------------------------------------------------------------------------- 325 (508)
Q Consensus 319 NIll~~~------------------------------------------------------------------------- 325 (508)
|||+..+
T Consensus 218 NvLl~~~e~~~~~~~~~a~e~~~~~p~~s~s~~~t~~d~~~~~~~~~~s~~~~k~~~kk~~r~~~~~~~~l~~~~~~~~~ 297 (590)
T KOG1290|consen 218 NVLLCSTEIDPAKDAREAGEATTSLPKMSPSAVSTRPDALQRMAAEPMSKSKFKKMKKKLKRQAKKLEASLAGLEGIEEE 297 (590)
T ss_pred eeeeeccccchhhhhhhhccccccCCCCCcccccccccccchhhccccchhhHHHHHHHHhhhhhhhhhhhccccccccc
Confidence 9998300
Q ss_pred --------------------------------------------------------------------------------
Q 010519 326 -------------------------------------------------------------------------------- 325 (508)
Q Consensus 326 -------------------------------------------------------------------------------- 325 (508)
T Consensus 298 ~~~~s~n~~~~~n~~~~~v~~~~~~~~~~~~~~~~n~~~k~~e~~~~~~~sl~~~~~~~~~t~~~~~~~s~~s~~~~~~n 377 (590)
T KOG1290|consen 298 PNQESYNNEPRINGNESTVERSTLEEDSNENGNRENLPIKSPENFRGNNTSLPESQLRDSATPSDGSLSSPSSPGTIASN 377 (590)
T ss_pred ccccccccccCCCccccchhhcccccccccccCCccccccCccccccccccccchhcccccccccccccCcCCccccccc
Confidence
Q ss_pred -------------CcEEEEecCCccccCCCCCcccccccccccccCccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCC
Q 010519 326 -------------FNAKVSDFGLAKLLDSGESHITTRVMGTFGYVAPEYANTGMLNEKSDIYSFGVLLLEAVTGRDPVDY 392 (508)
Q Consensus 326 -------------~~~kl~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltG~~Pf~~ 392 (508)
-.+||+|||-|+.+... .+.-..|..|.|||++.+..|+..+|||||+|+++||+||-..|+.
T Consensus 378 ~~v~p~~~~~~~di~vKIaDlGNACW~~kh----FT~DIQTRQYRapEVllGsgY~~~ADiWS~AC~~FELaTGDyLFeP 453 (590)
T KOG1290|consen 378 PLVNPDIPLPECDIRVKIADLGNACWVHKH----FTEDIQTRQYRAPEVLLGSGYSTSADIWSTACMAFELATGDYLFEP 453 (590)
T ss_pred cccCCCCCCCccceeEEEeeccchhhhhhh----hchhhhhhhccCcceeecCCCCCchhHHHHHHHHHHhhcCceeecC
Confidence 01345555555443321 2223458889999999999999999999999999999999998864
Q ss_pred CCCC----chhcHHHHHHHH--------hcccccccccCCC--------CC-----------CChhHHHHHHHHHHHHHh
Q 010519 393 GRPA----NEVNLVEWLKMM--------VGTRRAEEVVDPN--------LE-----------VKPATRALKRSLLVALRC 441 (508)
Q Consensus 393 ~~~~----~~~~~~~~~~~~--------~~~~~~~~~~~~~--------~~-----------~~~~~~~~~~l~~li~~c 441 (508)
.... ++..+...+..+ .+.....++++.. ++ ...+.+...++.+++.-|
T Consensus 454 hsG~~Y~rDEDHiA~i~ELLG~iPr~ia~~Gk~SRdFFnr~G~LrhI~~LK~WpL~~VL~eKY~~s~e~A~~fsdFL~Pm 533 (590)
T KOG1290|consen 454 HSGENYSRDEDHIALIMELLGKIPRKIALGGKYSRDFFNRRGELRHIRRLKPWPLYEVLIEKYEWSEEDAQQFSDFLSPM 533 (590)
T ss_pred CCCCCCCccHHHHHHHHHHHhhccHHHHhcCcchHhhhccccceecccccCCCcHHHHHHHHhCCCHHHHHHHHHHHHHH
Confidence 3322 222222211111 1111111222111 11 234556677888899999
Q ss_pred cCCCCCCCCCHHHHHHHhhcCCCCCc
Q 010519 442 VDPDSEKRPKMSQVVRMLEADDYPFR 467 (508)
Q Consensus 442 l~~dP~~RPs~~evl~~L~~~~~~~~ 467 (508)
|+.+|.+||||.+.|+|-+-...+.+
T Consensus 534 Lef~PeKR~tA~~cl~hPwLn~~~~~ 559 (590)
T KOG1290|consen 534 LEFDPEKRPTAAQCLKHPWLNPVAGP 559 (590)
T ss_pred HhcCccccccHHHHhcCccccCCCCC
Confidence 99999999999999998777655443
|
|
| >cd00180 PKc Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.5e-29 Score=233.95 Aligned_cols=211 Identities=36% Similarity=0.603 Sum_probs=181.8
Q ss_pred EeeeCceEEEEEEEcC-CCEEEEEEEcccchh-hHHHHHHHHHHHhcCCCCCceeEEEEEEeCceeeEEEeecCCCCHHH
Q 010519 194 LGEGGYGVVYKGRLIN-GSEVAVKKLLNNLGQ-AEKEFRVEVEAIGHVRHKNLVRLLGYCIEGVHRMLVYEYVNNGNLEQ 271 (508)
Q Consensus 194 lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~-~~~~~~~ei~~l~~l~h~niv~~~~~~~~~~~~~lv~E~~~~gsL~~ 271 (508)
||+|.+|.||++...+ +..+++|++...... ....+.+|+..++.+.|++++++++++......+++|||+++++|.+
T Consensus 1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~~~e~~~~~~l~~ 80 (215)
T cd00180 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVFEDENHLYLVMEYCEGGSLKD 80 (215)
T ss_pred CCcCCceEEEEEEecCCCcEEEEEEeccccchhHHHHHHHHHHHHHhcCCCCeeeEeeeeecCCeEEEEEecCCCCcHHH
Confidence 6899999999998854 889999998655432 34678889999999999999999999999889999999999999999
Q ss_pred HHhhhhccCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCEEEcC-CCcEEEEecCCccccCCCCCcccccc
Q 010519 272 WLHGAMRNQGNLTWEARMKVIIGTAKALAYLHEAIEPKVVHRDIKSSNILIDD-EFNAKVSDFGLAKLLDSGESHITTRV 350 (508)
Q Consensus 272 ~l~~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiH~Dlk~~NIll~~-~~~~kl~Dfgla~~~~~~~~~~~~~~ 350 (508)
++.. ....+++..++.++.+++.++.|||+. +++|+||+|.||+++. ++.++|+|||.+........ .....
T Consensus 81 ~~~~---~~~~~~~~~~~~~~~~l~~~l~~lh~~---~~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~~~-~~~~~ 153 (215)
T cd00180 81 LLKE---NEGKLSEDEILRILLQILEGLEYLHSN---GIIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKS-LLKTI 153 (215)
T ss_pred HHHh---ccCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHhhEEEeCCCCcEEEecCCceEEccCCcc-hhhcc
Confidence 9853 225688999999999999999999999 9999999999999999 89999999999986654321 12334
Q ss_pred cccccccCccccCCC-CCCChhhHHHHHHHHHHHHhCCCCCCCCCCCchhcHHHHHHHHhcccccccccCCCCCCChhHH
Q 010519 351 MGTFGYVAPEYANTG-MLNEKSDIYSFGVLLLEAVTGRDPVDYGRPANEVNLVEWLKMMVGTRRAEEVVDPNLEVKPATR 429 (508)
Q Consensus 351 ~gt~~y~aPE~~~~~-~~~~~~DvwS~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 429 (508)
.+...|++||.+... .++.+.|+|++|+++++|
T Consensus 154 ~~~~~~~~pe~~~~~~~~~~~~D~~~lg~~~~~l---------------------------------------------- 187 (215)
T cd00180 154 VGTPAYMAPEVLLGKGYYSEKSDIWSLGVILYEL---------------------------------------------- 187 (215)
T ss_pred cCCCCccChhHhcccCCCCchhhhHHHHHHHHHH----------------------------------------------
Confidence 578899999999887 888999999999999999
Q ss_pred HHHHHHHHHHHhcCCCCCCCCCHHHHHHHh
Q 010519 430 ALKRSLLVALRCVDPDSEKRPKMSQVVRML 459 (508)
Q Consensus 430 ~~~~l~~li~~cl~~dP~~RPs~~evl~~L 459 (508)
..+.+++..|++.||.+||++.++++++
T Consensus 188 --~~~~~~l~~~l~~~p~~R~~~~~l~~~~ 215 (215)
T cd00180 188 --PELKDLIRKMLQKDPEKRPSAKEILEHL 215 (215)
T ss_pred --HHHHHHHHHHhhCCcccCcCHHHHhhCC
Confidence 2445588899999999999999999764
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which |
| >KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.1e-30 Score=259.25 Aligned_cols=196 Identities=25% Similarity=0.374 Sum_probs=169.7
Q ss_pred CCcccceeEeeeCceEEEEEEEc-CCCEEEEEEEcccchh--------hHHHHHHHHHHHhcCC---CCCceeEEEEEEe
Q 010519 186 NRFSAENVLGEGGYGVVYKGRLI-NGSEVAVKKLLNNLGQ--------AEKEFRVEVEAIGHVR---HKNLVRLLGYCIE 253 (508)
Q Consensus 186 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~--------~~~~~~~ei~~l~~l~---h~niv~~~~~~~~ 253 (508)
.+|+..+.+|+|+||.|++|.++ +...|+||.+.+..-- ....+-.||.+|..++ |+||++++++|++
T Consensus 561 s~yttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLdfFEd 640 (772)
T KOG1152|consen 561 SDYTTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLDFFED 640 (772)
T ss_pred ccceeeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhheeec
Confidence 46899999999999999999986 5678889987544310 1123556999999997 9999999999999
Q ss_pred CceeeEEEeec-CCCCHHHHHhhhhccCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCEEEcCCCcEEEEe
Q 010519 254 GVHRMLVYEYV-NNGNLEQWLHGAMRNQGNLTWEARMKVIIGTAKALAYLHEAIEPKVVHRDIKSSNILIDDEFNAKVSD 332 (508)
Q Consensus 254 ~~~~~lv~E~~-~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~D 332 (508)
++++||+||-- ++-+|+++| .-...+++..+..|+.||+.|+++||+. +|||||||-+||.++.+|-+||+|
T Consensus 641 dd~yyl~te~hg~gIDLFd~I----E~kp~m~E~eAk~IFkQV~agi~hlh~~---~ivhrdikdenvivd~~g~~klid 713 (772)
T KOG1152|consen 641 DDYYYLETEVHGEGIDLFDFI----EFKPRMDEPEAKLIFKQVVAGIKHLHDQ---GIVHRDIKDENVIVDSNGFVKLID 713 (772)
T ss_pred CCeeEEEecCCCCCcchhhhh----hccCccchHHHHHHHHHHHhcccccccc---CceecccccccEEEecCCeEEEee
Confidence 99999999975 355899998 4567899999999999999999999999 999999999999999999999999
Q ss_pred cCCccccCCCCCcccccccccccccCccccCCCCC-CChhhHHHHHHHHHHHHhCCCCCC
Q 010519 333 FGLAKLLDSGESHITTRVMGTFGYVAPEYANTGML-NEKSDIYSFGVLLLEAVTGRDPVD 391 (508)
Q Consensus 333 fgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DvwS~Gvvl~elltG~~Pf~ 391 (508)
||.+.....+. ...++||..|.|||++.|..| +..-|||++|++||.++....||.
T Consensus 714 fgsaa~~ksgp---fd~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenpyy 770 (772)
T KOG1152|consen 714 FGSAAYTKSGP---FDVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPYY 770 (772)
T ss_pred ccchhhhcCCC---cceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCCCc
Confidence 99998876654 345789999999999999876 467899999999999999888874
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1e-30 Score=265.40 Aligned_cols=255 Identities=26% Similarity=0.358 Sum_probs=205.8
Q ss_pred hhCCcccceeEeeeCceEEEEEEEc-CCCEEEEEEEcccchhhHHHHHHHHHHHhcCCCCCceeEEEEEEeCceeeEEEe
Q 010519 184 ATNRFSAENVLGEGGYGVVYKGRLI-NGSEVAVKKLLNNLGQAEKEFRVEVEAIGHVRHKNLVRLLGYCIEGVHRMLVYE 262 (508)
Q Consensus 184 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~ei~~l~~l~h~niv~~~~~~~~~~~~~lv~E 262 (508)
+..+|.+...+|.|+||.||++++. .+...|+|.+.-.......-+..|+-+++..+|||||.++|.+.....++++||
T Consensus 13 P~ddyellqrvgsgTygdvyKaRd~~s~elaavkvVkLep~dd~~~iqqei~~~~dc~h~nivay~gsylr~dklwicME 92 (829)
T KOG0576|consen 13 PQDDYELLQRVGSGTYGDVYKARDKRSGELAAVKVVKLEPGDDFSGIQQEIGMLRDCRHPNIVAYFGSYLRRDKLWICME 92 (829)
T ss_pred CccchhheeeecCCcccchhhhcccccCchhhheeeeccCCccccccccceeeeecCCCcChHHHHhhhhhhcCcEEEEE
Confidence 4568999999999999999999875 688899999877766666778889999999999999999999999999999999
Q ss_pred ecCCCCHHHHHhhhhccCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCEEEcCCCcEEEEecCCccccCCC
Q 010519 263 YVNNGNLEQWLHGAMRNQGNLTWEARMKVIIGTAKALAYLHEAIEPKVVHRDIKSSNILIDDEFNAKVSDFGLAKLLDSG 342 (508)
Q Consensus 263 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~~ 342 (508)
||.+|+|.+.- .-.+++++.++..++...+++++|||+. +=+|||||-.|||+++.|.+|++|||.+-.+...
T Consensus 93 ycgggslQdiy----~~TgplselqiayvcRetl~gl~ylhs~---gk~hRdiKGanilltd~gDvklaDfgvsaqitat 165 (829)
T KOG0576|consen 93 YCGGGSLQDIY----HVTGPLSELQIAYVCRETLQGLKYLHSQ---GKIHRDIKGANILLTDEGDVKLADFGVSAQITAT 165 (829)
T ss_pred ecCCCccccee----eecccchhHHHHHHHhhhhccchhhhcC---CcccccccccceeecccCceeecccCchhhhhhh
Confidence 99999999865 3567899999999999999999999999 8999999999999999999999999999876543
Q ss_pred CCcccccccccccccCcccc---CCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCCCchhcHHHHHHHHhcccccccccC
Q 010519 343 ESHITTRVMGTFGYVAPEYA---NTGMLNEKSDIYSFGVLLLEAVTGRDPVDYGRPANEVNLVEWLKMMVGTRRAEEVVD 419 (508)
Q Consensus 343 ~~~~~~~~~gt~~y~aPE~~---~~~~~~~~~DvwS~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 419 (508)
.. ....+.||+.|||||+. ..+.|...+|||++|+...|+---+.|.....+ ...+..|.....
T Consensus 166 i~-KrksfiGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqpplfdlhp------mr~l~LmTkS~~------ 232 (829)
T KOG0576|consen 166 IA-KRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPLFDLHP------MRALFLMTKSGF------ 232 (829)
T ss_pred hh-hhhcccCCccccchhHHHHHhcccccccccccccccchhhhhhcCCcccccch------HHHHHHhhccCC------
Confidence 32 35567899999999976 566799999999999999999776666432211 122222221110
Q ss_pred CCCCCChhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 010519 420 PNLEVKPATRALKRSLLVALRCVDPDSEKRPKMSQVVRM 458 (508)
Q Consensus 420 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 458 (508)
.........+....+.+|++.|+..+|++|||++.+|.|
T Consensus 233 qpp~lkDk~kws~~fh~fvK~altknpKkRptaeklL~h 271 (829)
T KOG0576|consen 233 QPPTLKDKTKWSEFFHNFVKGALTKNPKKRPTAEKLLQH 271 (829)
T ss_pred CCCcccCCccchHHHHHHHHHHhcCCCccCCChhhheec
Confidence 111112223445566679999999999999999887763
|
|
| >smart00221 STYKc Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.96 E-value=2e-28 Score=231.51 Aligned_cols=198 Identities=34% Similarity=0.513 Sum_probs=171.9
Q ss_pred cccceeEeeeCceEEEEEEEcC-CCEEEEEEEcccchh-hHHHHHHHHHHHhcCCCCCceeEEEEEEeCceeeEEEeecC
Q 010519 188 FSAENVLGEGGYGVVYKGRLIN-GSEVAVKKLLNNLGQ-AEKEFRVEVEAIGHVRHKNLVRLLGYCIEGVHRMLVYEYVN 265 (508)
Q Consensus 188 ~~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~-~~~~~~~ei~~l~~l~h~niv~~~~~~~~~~~~~lv~E~~~ 265 (508)
|.+.+.||.|++|.||++...+ +..+++|.+...... ....+..|++.++.++|+|++++++++......++++||++
T Consensus 1 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~ 80 (225)
T smart00221 1 YELGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTEKQREEFLREIRILKKLKHPNIVKLYGVFEDPEPLYLVMEYCE 80 (225)
T ss_pred CceeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccchHHHHHHHHHHHHHHhCCCCChhhheeeeecCCceEEEEeccC
Confidence 5567899999999999998864 889999998765544 56788889999999999999999999998889999999999
Q ss_pred CCCHHHHHhhhhccCCC-ccHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCEEEcCCCcEEEEecCCccccCCCCC
Q 010519 266 NGNLEQWLHGAMRNQGN-LTWEARMKVIIGTAKALAYLHEAIEPKVVHRDIKSSNILIDDEFNAKVSDFGLAKLLDSGES 344 (508)
Q Consensus 266 ~gsL~~~l~~~~~~~~~-l~~~~~~~i~~~i~~al~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~ 344 (508)
+++|.+++.. ... +++.....++.+++.++.|||.. +++|+||+|.||+++.++.++|+|||++........
T Consensus 81 ~~~L~~~~~~----~~~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~di~~~ni~v~~~~~~~l~d~g~~~~~~~~~~ 153 (225)
T smart00221 81 GGDLFDYLRK----KGGKLSEEEARFYLRQILEALEYLHSL---GIVHRDLKPENILLGMDGLVKLADFGLARFIHRDLA 153 (225)
T ss_pred CCCHHHHHHh----cccCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEeeCceeeEecCccc
Confidence 9999999853 223 78999999999999999999998 999999999999999999999999999987654321
Q ss_pred cccccccccccccCcccc-CCCCCCChhhHHHHHHHHHHHHhCCCCCCC
Q 010519 345 HITTRVMGTFGYVAPEYA-NTGMLNEKSDIYSFGVLLLEAVTGRDPVDY 392 (508)
Q Consensus 345 ~~~~~~~gt~~y~aPE~~-~~~~~~~~~DvwS~Gvvl~elltG~~Pf~~ 392 (508)
.......++..|++||.+ ....++.++|+|+||+++++|++|+.||..
T Consensus 154 ~~~~~~~~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~~ 202 (225)
T smart00221 154 ALLKTVKGTPFYLAPEVLLGGKGYGEAVDIWSLGVILYELLWGPEPFSG 202 (225)
T ss_pred ccccceeccCCcCCHhHhcCCCCCCchhhHHHHHHHHHHHHHCCCCccc
Confidence 122334678899999998 677788899999999999999999999953
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. |
| >KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.2e-29 Score=227.65 Aligned_cols=257 Identities=24% Similarity=0.379 Sum_probs=194.4
Q ss_pred hCCcccceeEeeeCceEEEEEEE-cCCCEEEEEEEcccchhhHHHHHHHHHHHhcCC-CCCceeEEEEEEeC--ceeeEE
Q 010519 185 TNRFSAENVLGEGGYGVVYKGRL-INGSEVAVKKLLNNLGQAEKEFRVEVEAIGHVR-HKNLVRLLGYCIEG--VHRMLV 260 (508)
Q Consensus 185 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~ei~~l~~l~-h~niv~~~~~~~~~--~~~~lv 260 (508)
.++|++.+++|+|-|++||.|.. .+++.++||.+..- ..+.+.+|+.+|..|. ||||+.++++..+. ....+|
T Consensus 37 ~ddYeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLKPV---kkkKIkREikIL~nL~gg~NIi~L~DiV~Dp~SktpaLi 113 (338)
T KOG0668|consen 37 QDDYEIVRKVGRGKYSEVFEGINITNNEKCVIKILKPV---KKKKIKREIKILQNLRGGPNIIKLLDIVKDPESKTPSLI 113 (338)
T ss_pred cchHHHHHHHcCccHhhHhcccccCCCceEEEeeechH---HHHHHHHHHHHHHhccCCCCeeehhhhhcCccccCchhH
Confidence 46899999999999999999974 47788889987542 3456888999999996 99999999998865 455799
Q ss_pred EeecCCCCHHHHHhhhhccCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCEEEcCCC-cEEEEecCCcccc
Q 010519 261 YEYVNNGNLEQWLHGAMRNQGNLTWEARMKVIIGTAKALAYLHEAIEPKVVHRDIKSSNILIDDEF-NAKVSDFGLAKLL 339 (508)
Q Consensus 261 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiH~Dlk~~NIll~~~~-~~kl~Dfgla~~~ 339 (508)
+||..+.+...+. ..++...+..++.+++.||.|+|+. ||.|||+||.|++++... .++|+|+|+|.++
T Consensus 114 FE~v~n~Dfk~ly-------~tl~d~dIryY~~elLkALdyCHS~---GImHRDVKPhNvmIdh~~rkLrlIDWGLAEFY 183 (338)
T KOG0668|consen 114 FEYVNNTDFKQLY-------PTLTDYDIRYYIYELLKALDYCHSM---GIMHRDVKPHNVMIDHELRKLRLIDWGLAEFY 183 (338)
T ss_pred hhhhccccHHHHh-------hhhchhhHHHHHHHHHHHHhHHHhc---CcccccCCcceeeechhhceeeeeecchHhhc
Confidence 9999998877654 3477788899999999999999999 999999999999998654 5999999999988
Q ss_pred CCCCCcccccccccccccCccccCC-CCCCChhhHHHHHHHHHHHHhCCCCCCCCCCCchhcHHHHHHHHhcccc-----
Q 010519 340 DSGESHITTRVMGTFGYVAPEYANT-GMLNEKSDIYSFGVLLLEAVTGRDPVDYGRPANEVNLVEWLKMMVGTRR----- 413 (508)
Q Consensus 340 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwS~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~----- 413 (508)
..+.. ..-.+.+..|--||++-. ..|+..-|+|||||+|..|+..+.||..+... ..++....+.+ +...
T Consensus 184 Hp~~e--YnVRVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepFFhG~dN-~DQLVkIakVL-Gt~el~~Yl 259 (338)
T KOG0668|consen 184 HPGKE--YNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDN-YDQLVKIAKVL-GTDELYAYL 259 (338)
T ss_pred CCCce--eeeeeehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCcccCCCCC-HHHHHHHHHHh-ChHHHHHHH
Confidence 76543 223356778899998865 56889999999999999999999999766543 23333222211 1110
Q ss_pred --cccccCCCCCC--------C------hhH--HHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 010519 414 --AEEVVDPNLEV--------K------PAT--RALKRSLLVALRCVDPDSEKRPKMSQVVRM 458 (508)
Q Consensus 414 --~~~~~~~~~~~--------~------~~~--~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 458 (508)
..--+++.+.. . ... -...+.++|+.+.|..|-.+|||+.|...|
T Consensus 260 ~KY~i~Ldp~~~~i~~~~~rk~w~~Fi~~~n~hl~~peaiDlldklLrYDHqeRlTakEam~H 322 (338)
T KOG0668|consen 260 NKYQIDLDPQFEDILGRHSRKPWSRFINSENQHLVSPEAIDLLDKLLRYDHQERLTAKEAMAH 322 (338)
T ss_pred HHHccCCChhHhhHhhccccccHHHhCCccccccCChHHHHHHHHHHhhccccccchHHHhcC
Confidence 00011221110 0 000 112467789999999999999999998754
|
|
| >KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.8e-29 Score=237.18 Aligned_cols=256 Identities=27% Similarity=0.322 Sum_probs=192.2
Q ss_pred CCcccceeEeeeCceEEEEEEE-cCCCEEEEEEEcccc--hhhHHHHHHHHHHHhcCCCCCceeEEEEEEeC------ce
Q 010519 186 NRFSAENVLGEGGYGVVYKGRL-INGSEVAVKKLLNNL--GQAEKEFRVEVEAIGHVRHKNLVRLLGYCIEG------VH 256 (508)
Q Consensus 186 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~ei~~l~~l~h~niv~~~~~~~~~------~~ 256 (508)
.+|.-++.+|.|.- .|..+.+ -.+++||+|++.... ....+...+|...+..++|+||++++.+|.-. ..
T Consensus 17 ~Ry~nL~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~pf~n~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~l~~~~e 95 (369)
T KOG0665|consen 17 KRYVNLKPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRPFQNQTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKTLEEFQE 95 (369)
T ss_pred eeeeeecccCCCCc-eEEecchhhccCceehhhhcCccccCccchhhhhhhhhhhhhcccceeeeeeccCccccHHHHHh
Confidence 47777788898887 5555543 268999999884332 23345566799999999999999999988643 34
Q ss_pred eeEEEeecCCCCHHHHHhhhhccCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCEEEcCCCcEEEEecCCc
Q 010519 257 RMLVYEYVNNGNLEQWLHGAMRNQGNLTWEARMKVIIGTAKALAYLHEAIEPKVVHRDIKSSNILIDDEFNAKVSDFGLA 336 (508)
Q Consensus 257 ~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~Dfgla 336 (508)
.|+|||||. ++|...++ ..++-.....++.|++.|++|||+. +|+||||||+||++..+..+||.|||++
T Consensus 96 ~y~v~e~m~-~nl~~vi~------~elDH~tis~i~yq~~~~ik~lhs~---~IihRdLkPsnivv~~~~~lKi~dfg~a 165 (369)
T KOG0665|consen 96 VYLVMELMD-ANLCQVIL------MELDHETISYILYQMLCGIKHLHSA---GIIHRDLKPSNIVVNSDCTLKILDFGLA 165 (369)
T ss_pred HHHHHHhhh-hHHHHHHH------HhcchHHHHHHHHHHHHHHHHHHhc---ceeecccCcccceecchhheeeccchhh
Confidence 689999995 59999885 2366678889999999999999999 9999999999999999999999999999
Q ss_pred cccCCCCCcccccccccccccCccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCCCchhcHHHHHHHH--------
Q 010519 337 KLLDSGESHITTRVMGTFGYVAPEYANTGMLNEKSDIYSFGVLLLEAVTGRDPVDYGRPANEVNLVEWLKMM-------- 408 (508)
Q Consensus 337 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~-------- 408 (508)
+.-+.. ..++..+.|..|.|||++.+..|.+.+||||+||++.||++|..-|.... .+.+|.+..
T Consensus 166 r~e~~~--~~mtpyVvtRyyrapevil~~~~ke~vdiwSvGci~gEli~~~Vlf~g~d-----~idQ~~ki~~~lgtpd~ 238 (369)
T KOG0665|consen 166 RTEDTD--FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELILGTVLFPGKD-----HIDQWNKIIEQLGTPDP 238 (369)
T ss_pred cccCcc--cccCchhheeeccCchheeccCCcccchhhhhhhHHHHHhhceEEecCch-----HHHHHHHHHHHhcCCCH
Confidence 865443 35667788999999999999889999999999999999999999886222 222222111
Q ss_pred -------------hccc-------ccccccCCCCCCC--hhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHh
Q 010519 409 -------------VGTR-------RAEEVVDPNLEVK--PATRALKRSLLVALRCVDPDSEKRPKMSQVVRML 459 (508)
Q Consensus 409 -------------~~~~-------~~~~~~~~~~~~~--~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L 459 (508)
..+. ....+.|..+... ..........+++.+||-.||++|.++.++|+|-
T Consensus 239 ~F~~qL~~~~r~yv~~~~~y~~~~f~~~fpD~~f~~~~e~~~~~~~~ardll~~MLvi~pe~Risv~daL~HP 311 (369)
T KOG0665|consen 239 SFMKQLQPTVRNYVENRPQYQAISFSELFPDSLFPVVLEGSKLDCSLARDLLSKMLVIDPEKRISVDDALRHP 311 (369)
T ss_pred HHHHHhhHHHHHHhhcChHhhccchhhhCCcccccccccCCccchHHHHHHHHHhhccChhhcccHHHHhcCC
Confidence 1000 0011111111111 1112233456688899999999999999999875
|
|
| >KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=1e-28 Score=226.93 Aligned_cols=253 Identities=22% Similarity=0.368 Sum_probs=184.9
Q ss_pred hCCcccceeEeeeCceEEEEEEEcC-CCEEEEEEEcccchhhHHHHHHHHHHHhcC-CCCCceeEEEEE-EeCceeeEEE
Q 010519 185 TNRFSAENVLGEGGYGVVYKGRLIN-GSEVAVKKLLNNLGQAEKEFRVEVEAIGHV-RHKNLVRLLGYC-IEGVHRMLVY 261 (508)
Q Consensus 185 ~~~~~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~ei~~l~~l-~h~niv~~~~~~-~~~~~~~lv~ 261 (508)
.+.|.+.+.||+|.||.+-++.++. .+.+++|.+... .....+|.+|..---.| .|.||+..|++. +..+..++++
T Consensus 23 ~d~y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~p-~tt~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt~d~YvF~q 101 (378)
T KOG1345|consen 23 EDVYTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPRP-QTTQADFVREFHYSFFLSPHQHIIDTYEVAFQTSDAYVFVQ 101 (378)
T ss_pred hhhhhHHHHhcccceeeEEeeeccCCceEEEeeccCcc-hhhHHHHHHHhccceeeccchhhhHHHHHHhhcCceEEEee
Confidence 3579999999999999999999874 566777866443 34456788888765555 589999988864 5556677999
Q ss_pred eecCCCCHHHHHhhhhccCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCEEEc--CCCcEEEEecCCcccc
Q 010519 262 EYVNNGNLEQWLHGAMRNQGNLTWEARMKVIIGTAKALAYLHEAIEPKVVHRDIKSSNILID--DEFNAKVSDFGLAKLL 339 (508)
Q Consensus 262 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiH~Dlk~~NIll~--~~~~~kl~Dfgla~~~ 339 (508)
||++.|+|.+-+ ....+.+....+++.|++.||.|||++ ++||||||.+||||- +..++||||||+.+..
T Consensus 102 E~aP~gdL~snv-----~~~GigE~~~K~v~~ql~SAi~fMHsk---nlVHRdlK~eNiLif~~df~rvKlcDFG~t~k~ 173 (378)
T KOG1345|consen 102 EFAPRGDLRSNV-----EAAGIGEANTKKVFAQLLSAIEFMHSK---NLVHRDLKAENILIFDADFYRVKLCDFGLTRKV 173 (378)
T ss_pred ccCccchhhhhc-----CcccccHHHHHHHHHHHHHHHHHhhcc---chhhcccccceEEEecCCccEEEeeeccccccc
Confidence 999999999876 335678888999999999999999999 999999999999993 4457999999999876
Q ss_pred CCCCCcccccccccccccCccccCC---C--CCCChhhHHHHHHHHHHHHhCCCCCCCCCCCchhcHHHHHHHHhccccc
Q 010519 340 DSGESHITTRVMGTFGYVAPEYANT---G--MLNEKSDIYSFGVLLLEAVTGRDPVDYGRPANEVNLVEWLKMMVGTRRA 414 (508)
Q Consensus 340 ~~~~~~~~~~~~gt~~y~aPE~~~~---~--~~~~~~DvwS~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~ 414 (508)
+.. ......+..|.+||.... + ...+.+|+|.||+++|.+++|..||. .....+..+.+|..-..+..
T Consensus 174 g~t----V~~~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQ-ka~~~d~~Y~~~~~w~~rk~-- 246 (378)
T KOG1345|consen 174 GTT----VKYLEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQ-KASIMDKPYWEWEQWLKRKN-- 246 (378)
T ss_pred Cce----ehhhhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcch-hhhccCchHHHHHHHhcccC--
Confidence 532 222334667999997643 2 24578999999999999999999997 33344445555554332211
Q ss_pred ccccCCCCCCChhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHh
Q 010519 415 EEVVDPNLEVKPATRALKRSLLVALRCVDPDSEKRPKMSQVVRML 459 (508)
Q Consensus 415 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L 459 (508)
+.+.... ......++.+.++-|.++|++|-...++.++-
T Consensus 247 -----~~~P~~F-~~fs~~a~r~Fkk~lt~~~~drcki~~~kk~r 285 (378)
T KOG1345|consen 247 -----PALPKKF-NPFSEKALRLFKKSLTPRFKDRCKIWTAKKMR 285 (378)
T ss_pred -----ccCchhh-cccCHHHHHHHHHhcCCcccccchhHHHHHHH
Confidence 1111110 11123344467788999999996666655544
|
|
| >PLN00181 protein SPA1-RELATED; Provisional | Back alignment and domain information |
|---|
Probab=99.95 E-value=4.8e-28 Score=270.86 Aligned_cols=199 Identities=19% Similarity=0.240 Sum_probs=140.2
Q ss_pred cCCC-CCceeEEEEE-------EeCceeeEEEeecCCCCHHHHHhhhhccCCCccHHHHHHHHHHHHHHHHHHHhcCCCC
Q 010519 238 HVRH-KNLVRLLGYC-------IEGVHRMLVYEYVNNGNLEQWLHGAMRNQGNLTWEARMKVIIGTAKALAYLHEAIEPK 309 (508)
Q Consensus 238 ~l~h-~niv~~~~~~-------~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~ 309 (508)
.++| +||++++++| ......++++||+ +++|.++|.. ....+++..++.++.||++||.|||++ +
T Consensus 28 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~---~~~~~~~~~~~~i~~qi~~al~~lH~~---g 100 (793)
T PLN00181 28 SLSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDN---PDRSVDAFECFHVFRQIVEIVNAAHSQ---G 100 (793)
T ss_pred hhhHHHHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhc---ccccccHHHHHHHHHHHHHHHHHHHhC---C
Confidence 4455 5888888877 2234566789988 6699999962 345689999999999999999999999 9
Q ss_pred eEeecCCCCCEEEcCCCc-------------------EEEEecCCccccCCCCC---------------ccccccccccc
Q 010519 310 VVHRDIKSSNILIDDEFN-------------------AKVSDFGLAKLLDSGES---------------HITTRVMGTFG 355 (508)
Q Consensus 310 iiH~Dlk~~NIll~~~~~-------------------~kl~Dfgla~~~~~~~~---------------~~~~~~~gt~~ 355 (508)
|+||||||+||||+..+. +|++|||+++....... ......+||+.
T Consensus 101 IvHrDlKP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~ 180 (793)
T PLN00181 101 IVVHNVRPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSW 180 (793)
T ss_pred eeeccCCchhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcc
Confidence 999999999999965444 55556665543211000 00112457889
Q ss_pred ccCccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCCCchhcHHHHHHHHhcccccccccCCCCCCChhHHHHHHHH
Q 010519 356 YVAPEYANTGMLNEKSDIYSFGVLLLEAVTGRDPVDYGRPANEVNLVEWLKMMVGTRRAEEVVDPNLEVKPATRALKRSL 435 (508)
Q Consensus 356 y~aPE~~~~~~~~~~~DvwS~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 435 (508)
|+|||++.+..|+.++|||||||+||||++|..|+.... ..+...... ...+.. ........
T Consensus 181 Y~APE~~~~~~~~~~sDVwSlGviL~ELl~~~~~~~~~~--------~~~~~~~~~-----~~~~~~-----~~~~~~~~ 242 (793)
T PLN00181 181 YTSPEEDNGSSSNCASDVYRLGVLLFELFCPVSSREEKS--------RTMSSLRHR-----VLPPQI-----LLNWPKEA 242 (793)
T ss_pred eEChhhhccCCCCchhhhhhHHHHHHHHhhCCCchhhHH--------HHHHHHHHh-----hcChhh-----hhcCHHHH
Confidence 999999999999999999999999999999888764211 111111000 011110 01122345
Q ss_pred HHHHHhcCCCCCCCCCHHHHHHHhhc
Q 010519 436 LVALRCVDPDSEKRPKMSQVVRMLEA 461 (508)
Q Consensus 436 ~li~~cl~~dP~~RPs~~evl~~L~~ 461 (508)
.++.+||++||.+|||+.|++++-.-
T Consensus 243 ~~~~~~L~~~P~~Rps~~eil~h~~~ 268 (793)
T PLN00181 243 SFCLWLLHPEPSCRPSMSELLQSEFI 268 (793)
T ss_pred HHHHHhCCCChhhCcChHHHhhchhh
Confidence 67889999999999999999987643
|
|
| >smart00750 KIND kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Probab=99.94 E-value=2.8e-26 Score=209.48 Aligned_cols=167 Identities=23% Similarity=0.188 Sum_probs=126.7
Q ss_pred CCHHHHHhhhhccCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCEEEcCCCcEEEEecCCccccCCCCCcc
Q 010519 267 GNLEQWLHGAMRNQGNLTWEARMKVIIGTAKALAYLHEAIEPKVVHRDIKSSNILIDDEFNAKVSDFGLAKLLDSGESHI 346 (508)
Q Consensus 267 gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~ 346 (508)
|+|.+++.. .+..+++..++.++.||+.||.|||+. + ||+|||++.++.+|+ ||++.......
T Consensus 1 GsL~~~l~~---~~~~l~~~~~~~i~~qi~~~L~~lH~~---~------kp~Nil~~~~~~~~~--fG~~~~~~~~~--- 63 (176)
T smart00750 1 VSLADILEV---RGRPLNEEEIWAVCLQCLRALRELHRQ---A------KSGNILLTWDGLLKL--DGSVAFKTPEQ--- 63 (176)
T ss_pred CcHHHHHHH---hCCCCCHHHHHHHHHHHHHHHHHHHhc---C------CcccEeEcCccceee--ccceEeecccc---
Confidence 689999863 355799999999999999999999998 6 999999999999999 99998664322
Q ss_pred cccccccccccCccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCCCchhcHHHHHHHHhcccccccccCCCCCCCh
Q 010519 347 TTRVMGTFGYVAPEYANTGMLNEKSDIYSFGVLLLEAVTGRDPVDYGRPANEVNLVEWLKMMVGTRRAEEVVDPNLEVKP 426 (508)
Q Consensus 347 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 426 (508)
..|++.|+|||++.+..++.++|||||||++|||++|+.||....... ..+..+...+... .+. ....
T Consensus 64 ---~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~-~~~~~~~~~~~~~-------~~~-~~~~ 131 (176)
T smart00750 64 ---SRVDPYFMAPEVIQGQSYTEKADIYSLGITLYEALDYELPYNEERELS-AILEILLNGMPAD-------DPR-DRSN 131 (176)
T ss_pred ---CCCcccccChHHhcCCCCcchhhHHHHHHHHHHHHhCCCCccccchhc-HHHHHHHHHhccC-------Ccc-cccc
Confidence 258899999999999999999999999999999999999986432211 1111111111100 000 0011
Q ss_pred hHHHHH--HHHHHHHHhcCCCCCCCCCHHHHHHHhhcC
Q 010519 427 ATRALK--RSLLVALRCVDPDSEKRPKMSQVVRMLEAD 462 (508)
Q Consensus 427 ~~~~~~--~l~~li~~cl~~dP~~RPs~~evl~~L~~~ 462 (508)
...... .+.+++.+||+.||.+|||+.|+++++...
T Consensus 132 ~~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~ll~~~~~~ 169 (176)
T smart00750 132 LESVSAARSFADFMRVCASRLPQRREAANHYLAHCRAL 169 (176)
T ss_pred HHHHHhhhhHHHHHHHHHhcccccccCHHHHHHHHHHH
Confidence 122222 578899999999999999999999998754
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features |
| >KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=99.94 E-value=2e-27 Score=231.36 Aligned_cols=266 Identities=24% Similarity=0.316 Sum_probs=195.0
Q ss_pred HHHhhCCcccceeEeeeCceEEEEEEEc----CCCEEEEEEEcccchhhHHHHHHHHHHHhcC-CCCCceeEEEEEEeCc
Q 010519 181 LEIATNRFSAENVLGEGGYGVVYKGRLI----NGSEVAVKKLLNNLGQAEKEFRVEVEAIGHV-RHKNLVRLLGYCIEGV 255 (508)
Q Consensus 181 ~~~~~~~~~~~~~lg~G~~g~Vy~~~~~----~~~~vavK~~~~~~~~~~~~~~~ei~~l~~l-~h~niv~~~~~~~~~~ 255 (508)
+....+.|...++||+|.|++||++++. .+..||+|.+..... ...+..|+++|..+ .+.||+++.+++..++
T Consensus 31 ~p~~~~~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~ts~--p~ri~~El~~L~~~gG~~ni~~~~~~~rnnd 108 (418)
T KOG1167|consen 31 IPFISNAYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRTSS--PSRILNELEMLYRLGGSDNIIKLNGCFRNND 108 (418)
T ss_pred hhhhhhhhhhhccccccchhhhhhhhHhhhccccceEeeeecccccC--chHHHHHHHHHHHhccchhhhcchhhhccCC
Confidence 3445578999999999999999999764 367899998865432 34578899999998 5999999999999999
Q ss_pred eeeEEEeecCCCCHHHHHhhhhccCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCEEEc-CCCcEEEEecC
Q 010519 256 HRMLVYEYVNNGNLEQWLHGAMRNQGNLTWEARMKVIIGTAKALAYLHEAIEPKVVHRDIKSSNILID-DEFNAKVSDFG 334 (508)
Q Consensus 256 ~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiH~Dlk~~NIll~-~~~~~kl~Dfg 334 (508)
...+|+||++.....+++.. ++...+..++..++.||.++|.+ |||||||||.|+|.+ ..+.-.|.|||
T Consensus 109 ~v~ivlp~~~H~~f~~l~~~-------l~~~~i~~Yl~~ll~Al~~~h~~---GIvHRDiKpsNFL~n~~t~rg~LvDFg 178 (418)
T KOG1167|consen 109 QVAIVLPYFEHDRFRDLYRS-------LSLAEIRWYLRNLLKALAHLHKN---GIVHRDIKPSNFLYNRRTQRGVLVDFG 178 (418)
T ss_pred eeEEEecccCccCHHHHHhc-------CCHHHHHHHHHHHHHHhhhhhcc---CccccCCCccccccccccCCceEEech
Confidence 99999999999999988742 56788899999999999999999 999999999999997 45678999999
Q ss_pred CccccCCCC------C-------------------------------------cccccccccccccCccccCC-CCCCCh
Q 010519 335 LAKLLDSGE------S-------------------------------------HITTRVMGTFGYVAPEYANT-GMLNEK 370 (508)
Q Consensus 335 la~~~~~~~------~-------------------------------------~~~~~~~gt~~y~aPE~~~~-~~~~~~ 370 (508)
++...+... . .......||++|.|||++.. ..-+++
T Consensus 179 LA~~~d~~~~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~~Qtta 258 (418)
T KOG1167|consen 179 LAQRYDGYQQTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRCPRQTTA 258 (418)
T ss_pred hHHHHHhhhhhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhccCcCCc
Confidence 997221000 0 00112568999999998865 456789
Q ss_pred hhHHHHHHHHHHHHhCCCCCCCCCCCchhcHHHHH--------HHH-hcccc--ccc----------------c----cC
Q 010519 371 SDIYSFGVLLLEAVTGRDPVDYGRPANEVNLVEWL--------KMM-VGTRR--AEE----------------V----VD 419 (508)
Q Consensus 371 ~DvwS~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~--------~~~-~~~~~--~~~----------------~----~~ 419 (508)
+||||.|||++-+++++.||.....+-+ .+.+.+ +.+ .-.+. +.+ + +.
T Consensus 259 iDiws~GVI~Lslls~~~PFf~a~dd~~-al~ei~tifG~~~mrk~A~l~g~~~l~~ksn~~~~~e~~~~f~s~~~~~~~ 337 (418)
T KOG1167|consen 259 IDIWSAGVILLSLLSRRYPFFKAKDDAD-ALAEIATIFGSAEMRKCAALPGRILLWQKSNIPTIPELRVNFETLHIESIY 337 (418)
T ss_pred cceeeccceeehhhccccccccCccccc-hHHHHHHHhChHHHHHHhhcCCceeeeccccccccHHHHhchhccChhhcc
Confidence 9999999999999999999865443221 111111 110 00011 000 0 00
Q ss_pred C--C--CCCCh-hHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHh
Q 010519 420 P--N--LEVKP-ATRALKRSLLVALRCVDPDSEKRPKMSQVVRML 459 (508)
Q Consensus 420 ~--~--~~~~~-~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L 459 (508)
+ . ..... ..-....+++|..+|+..||.+|.|+++.|+|-
T Consensus 338 ~~~q~n~~~~~~~d~~~~~~~dlLdk~le~np~kRitAEeALkHp 382 (418)
T KOG1167|consen 338 KSRQPNTEREIGSDVFPALLLDLLDKCLELNPQKRITAEDALKHP 382 (418)
T ss_pred cccccceeeccccccccHHHHHHHHHHccCChhhcccHHHHhcCc
Confidence 0 0 00000 111123567899999999999999999999864
|
|
| >KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.92 E-value=5.2e-24 Score=201.23 Aligned_cols=201 Identities=20% Similarity=0.302 Sum_probs=173.4
Q ss_pred CcccceeEeeeCceEEEEEEE-cCCCEEEEEEEcccchhhHHHHHHHHHHHhcCC-CCCceeEEEEEEeCceeeEEEeec
Q 010519 187 RFSAENVLGEGGYGVVYKGRL-INGSEVAVKKLLNNLGQAEKEFRVEVEAIGHVR-HKNLVRLLGYCIEGVHRMLVYEYV 264 (508)
Q Consensus 187 ~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~ei~~l~~l~-h~niv~~~~~~~~~~~~~lv~E~~ 264 (508)
.|.++++||+|+||+++.|+. .++++||||.= .......+++.|....+.|. .+.|..+|-+-+++.+..||+|++
T Consensus 29 hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfE--PrkS~APQLrdEYr~YKlL~g~~GIP~vYYFGqeG~~NiLVidLL 106 (449)
T KOG1165|consen 29 HYRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFE--PRKSEAPQLRDEYRTYKLLGGTEGIPQVYYFGQEGKYNILVIDLL 106 (449)
T ss_pred cceeccccccCcceeeecccccccCceEEEEec--cccCCcchHHHHHHHHHHHcCCCCCCceeeeccccchhhhhhhhh
Confidence 799999999999999999974 58999999943 33344567888988888884 689999998888888889999998
Q ss_pred CCCCHHHHHhhhhccCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCEEEcCCC-----cEEEEecCCcccc
Q 010519 265 NNGNLEQWLHGAMRNQGNLTWEARMKVIIGTAKALAYLHEAIEPKVVHRDIKSSNILIDDEF-----NAKVSDFGLAKLL 339 (508)
Q Consensus 265 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiH~Dlk~~NIll~~~~-----~~kl~Dfgla~~~ 339 (508)
|-+|+|++. ..+..++.+..+.++.|++.-++|+|++ .+|+|||||+|+||...+ .+.++|||+++.+
T Consensus 107 -GPSLEDLFD---~CgR~FSvKTV~miA~Qmi~rie~vH~k---~LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGmAK~Y 179 (449)
T KOG1165|consen 107 -GPSLEDLFD---LCGRRFSVKTVAMIAKQMITRIEYVHEK---DLIYRDIKPDNFLIGRPGTKDANVIHIIDFGMAKEY 179 (449)
T ss_pred -CcCHHHHHH---HhcCcccHHhHHHHHHHHHHHHHHHHhc---ceeecccCccceeecCCCCCCCceEEEEeccchhhh
Confidence 779999886 5678899999999999999999999999 999999999999996443 4899999999988
Q ss_pred CCCCCc------ccccccccccccCccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCCC
Q 010519 340 DSGESH------ITTRVMGTFGYVAPEYANTGMLNEKSDIYSFGVLLLEAVTGRDPVDYGRPA 396 (508)
Q Consensus 340 ~~~~~~------~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltG~~Pf~~~~~~ 396 (508)
.+.... .....-||.+||+-....|..-+.+.|+-|||.+++++|-|.+||......
T Consensus 180 rDp~TkqHIPYrE~KSLsGTARYMSINTHlGrEQSRRDDLEaLGHvFmYFLRGsLPWQGLKA~ 242 (449)
T KOG1165|consen 180 RDPKTKQHIPYREHKSLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAD 242 (449)
T ss_pred cCccccccCccccccccccceeeeEeeccccchhhhhhhHHHhhhhhhhhccCCCccccccCc
Confidence 665432 234567999999999999999999999999999999999999999765543
|
|
| >KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.92 E-value=8.2e-26 Score=207.81 Aligned_cols=249 Identities=22% Similarity=0.377 Sum_probs=189.8
Q ss_pred CcccceeEeeeCceEEEEEEEcCCCEEEEEEEcccc--hhhHHHHHHHHHHHhcCCCCCceeEEEEEEeCceeeEEEeec
Q 010519 187 RFSAENVLGEGGYGVVYKGRLINGSEVAVKKLLNNL--GQAEKEFRVEVEAIGHVRHKNLVRLLGYCIEGVHRMLVYEYV 264 (508)
Q Consensus 187 ~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~--~~~~~~~~~ei~~l~~l~h~niv~~~~~~~~~~~~~lv~E~~ 264 (508)
+..+..+|.+...|+.|+|+| .|..+++|++.... ......|.+|.-.|+-+.||||+++++.|....++.++..||
T Consensus 191 ~lnl~tkl~e~hsgelwrgrw-qgndivakil~vr~~t~risrdfneefp~lrifshpnilpvlgacnsppnlv~isq~m 269 (448)
T KOG0195|consen 191 SLNLITKLAESHSGELWRGRW-QGNDIVAKILNVREVTARISRDFNEEFPALRIFSHPNILPVLGACNSPPNLVIISQYM 269 (448)
T ss_pred hhhhhhhhccCCCcccccccc-cCcchhhhhhhhhhcchhhcchhhhhCcceeeecCCchhhhhhhccCCCCceEeeeec
Confidence 344556789999999999999 55666677664322 222357888999999999999999999999999999999999
Q ss_pred CCCCHHHHHhhhhccCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCEEEcCCCcEEEE--ecCCccccCCC
Q 010519 265 NNGNLEQWLHGAMRNQGNLTWEARMKVIIGTAKALAYLHEAIEPKVVHRDIKSSNILIDDEFNAKVS--DFGLAKLLDSG 342 (508)
Q Consensus 265 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~--Dfgla~~~~~~ 342 (508)
+.|+|+..|+. ...-..+..++.+++.+++.|++|||+ ++|-|.--.|++..+++|++.+++|+ |--++..
T Consensus 270 p~gslynvlhe--~t~vvvd~sqav~faldiargmaflhs-lep~ipr~~lns~hvmidedltarismad~kfsfq---- 342 (448)
T KOG0195|consen 270 PFGSLYNVLHE--QTSVVVDHSQAVRFALDIARGMAFLHS-LEPMIPRFYLNSKHVMIDEDLTARISMADTKFSFQ---- 342 (448)
T ss_pred cchHHHHHHhc--CccEEEecchHHHHHHHHHhhHHHHhh-cchhhhhhhcccceEEecchhhhheecccceeeee----
Confidence 99999999985 344456778999999999999999998 57767777899999999999988874 3222221
Q ss_pred CCcccccccccccccCccccCCCCCC---ChhhHHHHHHHHHHHHhCCCCCCCCCCCchhcHHHHHHHHhcccccccccC
Q 010519 343 ESHITTRVMGTFGYVAPEYANTGMLN---EKSDIYSFGVLLLEAVTGRDPVDYGRPANEVNLVEWLKMMVGTRRAEEVVD 419 (508)
Q Consensus 343 ~~~~~~~~~gt~~y~aPE~~~~~~~~---~~~DvwS~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 419 (508)
.....-.|.||+||.+...+-+ .++|+|||+++||||.|...||....+-+- +.. +.-
T Consensus 343 ----e~gr~y~pawmspealqrkped~n~raadmwsfaillwel~trevpfadlspmec-----------gmk----ial 403 (448)
T KOG0195|consen 343 ----EVGRAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADLSPMEC-----------GMK----IAL 403 (448)
T ss_pred ----ccccccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccCCchhh-----------hhh----hhh
Confidence 1112347899999999776544 589999999999999999999975543211 100 111
Q ss_pred CCCCCChhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhhcC
Q 010519 420 PNLEVKPATRALKRSLLVALRCVDPDSEKRPKMSQVVRMLEAD 462 (508)
Q Consensus 420 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~ 462 (508)
..++...++.....+..|+.-|++.||.+||.+..|+-.|+..
T Consensus 404 eglrv~ippgis~hm~klm~icmnedpgkrpkfdmivpilekm 446 (448)
T KOG0195|consen 404 EGLRVHIPPGISRHMNKLMNICMNEDPGKRPKFDMIVPILEKM 446 (448)
T ss_pred ccccccCCCCccHHHHHHHHHHhcCCCCcCCCcceehhhHHHh
Confidence 2333333444455666788999999999999999999888753
|
|
| >PRK09188 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.92 E-value=2.2e-24 Score=216.56 Aligned_cols=166 Identities=23% Similarity=0.248 Sum_probs=129.1
Q ss_pred HhhCCcccceeEeeeCceEEEEEEEc--CCCEEEEEEEccc-----chhhHHHHHHHHHHHhcCCCCCceeEEEEEEeCc
Q 010519 183 IATNRFSAENVLGEGGYGVVYKGRLI--NGSEVAVKKLLNN-----LGQAEKEFRVEVEAIGHVRHKNLVRLLGYCIEGV 255 (508)
Q Consensus 183 ~~~~~~~~~~~lg~G~~g~Vy~~~~~--~~~~vavK~~~~~-----~~~~~~~~~~ei~~l~~l~h~niv~~~~~~~~~~ 255 (508)
...++|.+.+.||+|+||+||+|.+. +++.+|||++... .......+.+|+++|++++|+|+++.+.. ..
T Consensus 15 ~~~~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~---~~ 91 (365)
T PRK09188 15 ALSARFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLA---TG 91 (365)
T ss_pred cccCCceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEE---cC
Confidence 34568999999999999999999874 5777899987533 12234568999999999999999863322 24
Q ss_pred eeeEEEeecCCCCHHHHHhhhhccCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEeecC-CCCCEEEcCCCcEEEEecC
Q 010519 256 HRMLVYEYVNNGNLEQWLHGAMRNQGNLTWEARMKVIIGTAKALAYLHEAIEPKVVHRDI-KSSNILIDDEFNAKVSDFG 334 (508)
Q Consensus 256 ~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiH~Dl-k~~NIll~~~~~~kl~Dfg 334 (508)
..|+||||++|++|.. + .... ...++.++++||.|||+. +|+|||| ||+|||++.++.+||+|||
T Consensus 92 ~~~LVmE~~~G~~L~~-~----~~~~------~~~~~~~i~~aL~~lH~~---gIiHrDL~KP~NILv~~~~~ikLiDFG 157 (365)
T PRK09188 92 KDGLVRGWTEGVPLHL-A----RPHG------DPAWFRSAHRALRDLHRA---GITHNDLAKPQNWLMGPDGEAAVIDFQ 157 (365)
T ss_pred CcEEEEEccCCCCHHH-h----Cccc------hHHHHHHHHHHHHHHHHC---CCeeCCCCCcceEEEcCCCCEEEEECc
Confidence 5799999999999963 2 1111 146788999999999999 9999999 9999999999999999999
Q ss_pred CccccCCCCCc-------ccccccccccccCccccCCC
Q 010519 335 LAKLLDSGESH-------ITTRVMGTFGYVAPEYANTG 365 (508)
Q Consensus 335 la~~~~~~~~~-------~~~~~~gt~~y~aPE~~~~~ 365 (508)
+++.+...... ......+++.|+|||++...
T Consensus 158 lA~~~~~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~~~ 195 (365)
T PRK09188 158 LASVFRRRGALYRIAAYEDLRHLLKHKRTYAPDALTPR 195 (365)
T ss_pred cceecccCcchhhhhhhhhhhhhhccCccCCcccCChh
Confidence 99866433211 11356788899999998653
|
|
| >KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.91 E-value=2e-23 Score=209.40 Aligned_cols=258 Identities=20% Similarity=0.257 Sum_probs=189.5
Q ss_pred CcccceeEeeeCceEEEEEEEcCC--CEEEEEEEcccchhhHHHHHHHHHHHhcCCC----CCceeEEEEE-EeCceeeE
Q 010519 187 RFSAENVLGEGGYGVVYKGRLING--SEVAVKKLLNNLGQAEKEFRVEVEAIGHVRH----KNLVRLLGYC-IEGVHRML 259 (508)
Q Consensus 187 ~~~~~~~lg~G~~g~Vy~~~~~~~--~~vavK~~~~~~~~~~~~~~~ei~~l~~l~h----~niv~~~~~~-~~~~~~~l 259 (508)
+|.+.+.||+|+||.||.+..... ..+|+|.-..........+..|+.++..+.. +++..+++.. ......||
T Consensus 19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~~~~~~~i 98 (322)
T KOG1164|consen 19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSKPSVLKIEIQVLKKLEKKNGPSHFPKLLDHGRSTEDFNFI 98 (322)
T ss_pred ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCCCccchhHHHHHHHHhhhcCCCCCCEEEEeccCCCceeEE
Confidence 899999999999999999987554 3677776654433322367778888888863 5899999988 47778899
Q ss_pred EEeecCCCCHHHHHhhhhccCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCEEEcCC-----CcEEEEecC
Q 010519 260 VYEYVNNGNLEQWLHGAMRNQGNLTWEARMKVIIGTAKALAYLHEAIEPKVVHRDIKSSNILIDDE-----FNAKVSDFG 334 (508)
Q Consensus 260 v~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiH~Dlk~~NIll~~~-----~~~kl~Dfg 334 (508)
||+.+ |-+|.++.... ..+.++......|+.|++.+|.+||+. |++||||||.|+++... ..+.|.|||
T Consensus 99 VM~l~-G~sL~dl~~~~--~~~~fs~~T~l~ia~q~l~~l~~lH~~---G~iHRDiKp~N~~~g~~~~~~~~~~~llDfG 172 (322)
T KOG1164|consen 99 VMSLL-GPSLEDLRKRN--PPGRFSRKTVLRIAIQNLNALEDLHSK---GFIHRDIKPENFVVGQSSRSEVRTLYLLDFG 172 (322)
T ss_pred EEecc-CccHHHHHHhC--CCCCcCHhHHHHHHHHHHHHHHHHHhc---CcccCCcCHHHeeecCCCCcccceEEEEecC
Confidence 99998 77999977532 257899999999999999999999999 99999999999999765 358999999
Q ss_pred Ccc--ccCCCCC------cc-cccccccccccCccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCCCchhcHHHHH
Q 010519 335 LAK--LLDSGES------HI-TTRVMGTFGYVAPEYANTGMLNEKSDIYSFGVLLLEAVTGRDPVDYGRPANEVNLVEWL 405 (508)
Q Consensus 335 la~--~~~~~~~------~~-~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~ 405 (508)
+++ .+..... .. .....||..|+++....+...+.+.|+||++.++.+++.|.+||.......... . +
T Consensus 173 lar~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~e~~r~DDles~~Y~l~el~~g~LPW~~~~~~~~~~--~-~ 249 (322)
T KOG1164|consen 173 LARRFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGIEQGRRDDLESLFYMLLELLKGSLPWEALEMTDLKS--K-F 249 (322)
T ss_pred CCccccccCCCCcccccCCCCccCCCCccccccHHHhCCCccCCchhhhhHHHHHHHHhcCCCCCccccccchHH--H-H
Confidence 998 3321111 01 123559999999999999999999999999999999999999996444322211 1 1
Q ss_pred HHHhcccccccccCCCCCCChhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhhcC
Q 010519 406 KMMVGTRRAEEVVDPNLEVKPATRALKRSLLVALRCVDPDSEKRPKMSQVVRMLEAD 462 (508)
Q Consensus 406 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~ 462 (508)
......... .. .....+ ..+..+...+-..+...+|....+...|+..
T Consensus 250 ~~~~~~~~~----~~--~~~~~~---~~~~~~~~~~~~~~~~~~Pdy~~~~~~l~~~ 297 (322)
T KOG1164|consen 250 EKDPRKLLT----DR--FGDLKP---EEFAKILEYIDSLDYEDKPDYEKLAELLKDV 297 (322)
T ss_pred HHHhhhhcc----cc--ccCCCh---HHHHHHHHHhhccCCcCCCCHHHHHHHHHHH
Confidence 111100000 00 111122 2333344445558999999999998886553
|
|
| >COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Probab=99.90 E-value=3.9e-22 Score=197.61 Aligned_cols=260 Identities=30% Similarity=0.427 Sum_probs=196.1
Q ss_pred cccceeEeeeCceEEEEEEEcCCCEEEEEEEcccchh---hHHHHHHHHHHHhcCCCC-CceeEEEEEEeCceeeEEEee
Q 010519 188 FSAENVLGEGGYGVVYKGRLINGSEVAVKKLLNNLGQ---AEKEFRVEVEAIGHVRHK-NLVRLLGYCIEGVHRMLVYEY 263 (508)
Q Consensus 188 ~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~---~~~~~~~ei~~l~~l~h~-niv~~~~~~~~~~~~~lv~E~ 263 (508)
|.+.+.||.|+||.||++.+. ..+++|.+...... ....+.+|+..+..+.|+ +++++++++......+++++|
T Consensus 2 ~~~~~~l~~g~~~~v~~~~~~--~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 79 (384)
T COG0515 2 YRILRKLGEGSFGEVYLARDR--KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQDEGSLYLVMEY 79 (384)
T ss_pred ceeEEeecCCCCeEEEEEEec--cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEecCCEEEEEEec
Confidence 667789999999999999875 78899988654432 356788899999999988 799999999777778999999
Q ss_pred cCCCCHHHHHhhhhccCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCEEEcCCC-cEEEEecCCccccCCC
Q 010519 264 VNNGNLEQWLHGAMRNQGNLTWEARMKVIIGTAKALAYLHEAIEPKVVHRDIKSSNILIDDEF-NAKVSDFGLAKLLDSG 342 (508)
Q Consensus 264 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiH~Dlk~~NIll~~~~-~~kl~Dfgla~~~~~~ 342 (508)
+.+++|.+++...... ..+.......++.+++.++.|+|.. +++|||+||+||+++..+ .++++|||++......
T Consensus 80 ~~~~~l~~~~~~~~~~-~~~~~~~~~~~~~~~~~~l~~~H~~---~~~hrd~kp~nil~~~~~~~~~l~dfg~~~~~~~~ 155 (384)
T COG0515 80 VDGGSLEDLLKKIGRK-GPLSESEALFILAQILSALEYLHSK---GIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDP 155 (384)
T ss_pred CCCCcHHHHHHhcccc-cCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHeeecCCCCeEEEeccCcceecCCC
Confidence 9999999776421111 3688899999999999999999999 999999999999999998 7999999999855443
Q ss_pred CCc-----ccccccccccccCccccCC---CCCCChhhHHHHHHHHHHHHhCCCCCCCCCCC-chhcHHHHHHHHhcccc
Q 010519 343 ESH-----ITTRVMGTFGYVAPEYANT---GMLNEKSDIYSFGVLLLEAVTGRDPVDYGRPA-NEVNLVEWLKMMVGTRR 413 (508)
Q Consensus 343 ~~~-----~~~~~~gt~~y~aPE~~~~---~~~~~~~DvwS~Gvvl~elltG~~Pf~~~~~~-~~~~~~~~~~~~~~~~~ 413 (508)
... ......|+..|+|||.+.+ ..+....|+|++|++++++++|..||...... ........+......
T Consensus 156 ~~~~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~-- 233 (384)
T COG0515 156 GSTSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILELPTP-- 233 (384)
T ss_pred CccccccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccccHHHHHHHHHhcCCc--
Confidence 321 2356689999999999987 57889999999999999999999997544321 011111111111100
Q ss_pred cccccCCCCCCChhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 010519 414 AEEVVDPNLEVKPATRALKRSLLVALRCVDPDSEKRPKMSQVVRM 458 (508)
Q Consensus 414 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 458 (508)
.................+.+++..|+..+|..|.+..+....
T Consensus 234 ---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~~~~~ 275 (384)
T COG0515 234 ---SLASPLSPSNPELISKAASDLLKKLLAKDPKNRLSSSSDLSH 275 (384)
T ss_pred ---ccccccCccccchhhHHHHHHHHHHHhcCchhcCCHHHHhhc
Confidence 000001100002223456668889999999999998887765
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.89 E-value=5.3e-24 Score=227.31 Aligned_cols=255 Identities=20% Similarity=0.247 Sum_probs=186.9
Q ss_pred ccceeEeeeCceEEEEEEEc-CCCEEEEEEEc----ccc--hhhHHHHHHHHHHHhcCCCCCceeEEEEEEeCceeeEEE
Q 010519 189 SAENVLGEGGYGVVYKGRLI-NGSEVAVKKLL----NNL--GQAEKEFRVEVEAIGHVRHKNLVRLLGYCIEGVHRMLVY 261 (508)
Q Consensus 189 ~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~----~~~--~~~~~~~~~ei~~l~~l~h~niv~~~~~~~~~~~~~lv~ 261 (508)
.....+|.|++|.|+..... .....+.|... ... ......+..|+.+-..+.|||++..+..+.+....+-+|
T Consensus 321 ~~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~~~~~~~m 400 (601)
T KOG0590|consen 321 KPGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEIDGILQSM 400 (601)
T ss_pred CccceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhhcccchhhh
Confidence 35678999999977777543 23333333322 111 111122666888888899999988888777766666569
Q ss_pred eecCCCCHHHHHhhhhccCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCEEEcCCCcEEEEecCCccccCC
Q 010519 262 EYVNNGNLEQWLHGAMRNQGNLTWEARMKVIIGTAKALAYLHEAIEPKVVHRDIKSSNILIDDEFNAKVSDFGLAKLLDS 341 (508)
Q Consensus 262 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~ 341 (508)
|||++ +|+.++. ....+....+..++.|++.|+.|||+. ||.|||||++|++++.+|.+||+|||.+.....
T Consensus 401 E~~~~-Dlf~~~~----~~~~~~~~e~~c~fKqL~~Gv~y~h~~---GiahrdlK~enll~~~~g~lki~Dfg~~~vf~~ 472 (601)
T KOG0590|consen 401 EYCPY-DLFSLVM----SNGKLTPLEADCFFKQLLRGVKYLHSM---GLAHRDLKLENLLVTENGILKIIDFGAASVFRY 472 (601)
T ss_pred hcccH-HHHHHHh----cccccchhhhhHHHHHHHHHHHHHHhc---CceeccCccccEEEecCCceEEeecCcceeecc
Confidence 99999 9999984 345788889999999999999999999 999999999999999999999999999976543
Q ss_pred CCC---cccccccccccccCccccCCCCCCC-hhhHHHHHHHHHHHHhCCCCCCCCCCCchhcHHHHHHHHhcccccccc
Q 010519 342 GES---HITTRVMGTFGYVAPEYANTGMLNE-KSDIYSFGVLLLEAVTGRDPVDYGRPANEVNLVEWLKMMVGTRRAEEV 417 (508)
Q Consensus 342 ~~~---~~~~~~~gt~~y~aPE~~~~~~~~~-~~DvwS~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 417 (508)
... ......+|+..|+|||++.+..|++ ..||||.|+++..|++|+.||......+... .... .....
T Consensus 473 ~~e~~~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~~~~~-----~~~~---~~~~~ 544 (601)
T KOG0590|consen 473 PWEKNIHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFPWKVAKKSDNSF-----KTNN---YSDQR 544 (601)
T ss_pred CcchhhhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCCccccccccccch-----hhhc---ccccc
Confidence 322 4566788999999999999999986 7899999999999999999997665543321 0000 00000
Q ss_pred cCCCCCCChhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHh
Q 010519 418 VDPNLEVKPATRALKRSLLVALRCVDPDSEKRPKMSQVVRML 459 (508)
Q Consensus 418 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L 459 (508)
....-..............++.++|++||.+|.|+++|++.=
T Consensus 545 ~~~~~~~~~~~~lp~~~~~~~~~~l~~~P~~R~ti~~i~~d~ 586 (601)
T KOG0590|consen 545 NIFEGPNRLLSLLPRETRIIIYRMLQLDPTKRITIEQILNDE 586 (601)
T ss_pred ccccChHHHHHhchhhHHHHHHHHccCChhheecHHHHhhCh
Confidence 001111111223344456688999999999999999999743
|
|
| >KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.89 E-value=1.2e-22 Score=184.16 Aligned_cols=208 Identities=21% Similarity=0.271 Sum_probs=171.7
Q ss_pred HhhCCcccceeEeeeCceEEEEEEE-cCCCEEEEEEEcccchhhHHHHHHHHHHHhcCCC-CCceeEEEEEEeCceeeEE
Q 010519 183 IATNRFSAENVLGEGGYGVVYKGRL-INGSEVAVKKLLNNLGQAEKEFRVEVEAIGHVRH-KNLVRLLGYCIEGVHRMLV 260 (508)
Q Consensus 183 ~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~ei~~l~~l~h-~niv~~~~~~~~~~~~~lv 260 (508)
+...+|.+.+.||.|+||.+|.|.. .+|.+||||.=..+... ..+.-|..+.+.|++ ..|..+..+..+..+..+|
T Consensus 12 iv~gky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~a~h--pqL~yEskvY~iL~~g~GiP~i~~y~~e~~ynvlV 89 (341)
T KOG1163|consen 12 IVGGKYKLVRKIGSGSFGDIYLGISITSGEEVAIKLESSKAKH--PQLLYESKVYRILQGGVGIPHIRHYGTEKDYNVLV 89 (341)
T ss_pred eeccceEEEEeecCCchhheeeeeeccCCceEEEEeecccCCC--cchhHHHHHHHHhccCCCCchhhhhccccccceee
Confidence 4567899999999999999999975 48999999975443332 356668888888865 5777788888888899999
Q ss_pred EeecCCCCHHHHHhhhhccCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCEEEcCC---CcEEEEecCCcc
Q 010519 261 YEYVNNGNLEQWLHGAMRNQGNLTWEARMKVIIGTAKALAYLHEAIEPKVVHRDIKSSNILIDDE---FNAKVSDFGLAK 337 (508)
Q Consensus 261 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiH~Dlk~~NIll~~~---~~~kl~Dfgla~ 337 (508)
|+.+ |-+|.+++. -....++..+.+.++-|++.-++|+|.+ ++|||||||+|+|+.-+ ..+.|+|||+++
T Consensus 90 MdLL-GPsLEdLfn---fC~R~ftmkTvLMLaDQml~RiEyvH~r---~fiHRDIKPdNFLMGlgrh~~kl~LIDFGLaK 162 (341)
T KOG1163|consen 90 MDLL-GPSLEDLFN---FCSRRFTMKTVLMLADQMLSRIEYVHLR---NFIHRDIKPDNFLMGLGRHCNKLYLIDFGLAK 162 (341)
T ss_pred eecc-CccHHHHHH---HHhhhhhHHhHHHHHHHHHHHHHHHHhh---ccccccCCccceeeccccccceEEEEeccchh
Confidence 9998 779999886 3456788999999999999999999999 99999999999999643 358899999999
Q ss_pred ccCCCCCc------ccccccccccccCccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCCCchh
Q 010519 338 LLDSGESH------ITTRVMGTFGYVAPEYANTGMLNEKSDIYSFGVLLLEAVTGRDPVDYGRPANEV 399 (508)
Q Consensus 338 ~~~~~~~~------~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltG~~Pf~~~~~~~~~ 399 (508)
.+.+.... ......||.+|.+-....+..-+...|+-|+|.+|.++..|.+||..-......
T Consensus 163 ky~d~~t~~HIpyre~r~ltGTaRYASinAh~g~eqSRRDDmeSvgYvLmYfnrG~LPWQglka~tk~ 230 (341)
T KOG1163|consen 163 KYRDIRTRQHIPYREDRNLTGTARYASINAHLGIEQSRRDDMESVGYVLMYFNRGSLPWQGLKAATKK 230 (341)
T ss_pred hhccccccccCccccCCccceeeeehhhhhhhhhhhhhhhhhhhhcceeeeeecCCCcccccchhhHH
Confidence 77544322 234567999999998888888889999999999999999999999866554433
|
|
| >KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.89 E-value=7.5e-24 Score=226.12 Aligned_cols=252 Identities=23% Similarity=0.228 Sum_probs=184.4
Q ss_pred CcccceeEeeeCceEEEEEEEcCCCEEEEEEEcccc-hhhHHHHHH---HHHHHhcCCCCCceeEEEEEEeCceeeEEEe
Q 010519 187 RFSAENVLGEGGYGVVYKGRLINGSEVAVKKLLNNL-GQAEKEFRV---EVEAIGHVRHKNLVRLLGYCIEGVHRMLVYE 262 (508)
Q Consensus 187 ~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~~---ei~~l~~l~h~niv~~~~~~~~~~~~~lv~E 262 (508)
+|...+.||.+.|=.|.+|++..|. |+||++.+.. ......|.+ |++ ...++|||++++.-+-......|||-+
T Consensus 24 e~~~~~~LGstRFlKv~r~k~~eG~-vVvKVFvk~~p~~sL~~~~qrL~~ik-~~l~~~pn~lPfqk~~~t~kAAylvRq 101 (1431)
T KOG1240|consen 24 ECHYVENLGSTRFLKVARAKDREGL-VVVKVFVKQDPTISLRPFKQRLEEIK-FALMKAPNCLPFQKVLVTDKAAYLVRQ 101 (1431)
T ss_pred ceeeecccCchhhhhhhhccCCCce-EEEEEEeccCCCCCchHHHHHHHHHH-HHhhcCCcccchHHHHHhhHHHHHHHH
Confidence 6777889999999999999987777 8899886554 222233333 444 555689999999998777788899999
Q ss_pred ecCCCCHHHHHhhhhccCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCEEEcCCCcEEEEecCCcccc--C
Q 010519 263 YVNNGNLEQWLHGAMRNQGNLTWEARMKVIIGTAKALAYLHEAIEPKVVHRDIKSSNILIDDEFNAKVSDFGLAKLL--D 340 (508)
Q Consensus 263 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~Dfgla~~~--~ 340 (508)
|..+ +|+|.| ..+..+...+.+.|+.|++.||..+|.. ||+|||||.+||||+.-+-+.|+||..-+.. .
T Consensus 102 yvkh-nLyDRl----STRPFL~~iEKkWiaFQLL~al~qcH~~---gVcHGDIKsENILiTSWNW~~LtDFAsFKPtYLP 173 (1431)
T KOG1240|consen 102 YVKH-NLYDRL----STRPFLVLIEKKWIAFQLLKALSQCHKL---GVCHGDIKSENILITSWNWLYLTDFASFKPTYLP 173 (1431)
T ss_pred HHhh-hhhhhh----ccchHHHHHHHHHHHHHHHHHHHHHHHc---CccccccccceEEEeeechhhhhcccccCCccCC
Confidence 9966 999988 5666788888999999999999999999 9999999999999999999999999887633 3
Q ss_pred CCCCcccccccc----cccccCccccCCC----------C-CCChhhHHHHHHHHHHHHh-CCCCCCCCCCCchhcHHHH
Q 010519 341 SGESHITTRVMG----TFGYVAPEYANTG----------M-LNEKSDIYSFGVLLLEAVT-GRDPVDYGRPANEVNLVEW 404 (508)
Q Consensus 341 ~~~~~~~~~~~g----t~~y~aPE~~~~~----------~-~~~~~DvwS~Gvvl~ellt-G~~Pf~~~~~~~~~~~~~~ 404 (508)
.+.....+-+.. ...|+|||.+... . .+++.||||+||++.||++ |++||. +.+.
T Consensus 174 eDNPadf~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~---------LSQL 244 (1431)
T KOG1240|consen 174 EDNPADFTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFT---------LSQL 244 (1431)
T ss_pred CCCcccceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCccc---------HHHH
Confidence 333322222223 3369999977431 1 5689999999999999999 788884 2222
Q ss_pred HHHHhcccccccccCCCCCCChhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhhcCCC
Q 010519 405 LKMMVGTRRAEEVVDPNLEVKPATRALKRSLLVALRCVDPDSEKRPKMSQVVRMLEADDY 464 (508)
Q Consensus 405 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~ 464 (508)
+....++....+.+-..+. ...+..++..|++.||++|.++++.|+.-.+..+
T Consensus 245 ~aYr~~~~~~~e~~Le~Ie-------d~~~Rnlil~Mi~rdPs~RlSAedyL~~yrG~~F 297 (1431)
T KOG1240|consen 245 LAYRSGNADDPEQLLEKIE-------DVSLRNLILSMIQRDPSKRLSAEDYLQKYRGLVF 297 (1431)
T ss_pred HhHhccCccCHHHHHHhCc-------CccHHHHHHHHHccCchhccCHHHHHHhhhcccc
Confidence 2222111111111111111 1245568899999999999999999998655443
|
|
| >PRK10359 lipopolysaccharide core biosynthesis protein; Provisional | Back alignment and domain information |
|---|
Probab=99.87 E-value=3.4e-22 Score=187.09 Aligned_cols=174 Identities=13% Similarity=0.155 Sum_probs=136.2
Q ss_pred HHhhCCcccceeEeeeCceEEEEEEEcCCCEEEEEEEcccchhhHH---------HHHHHHHHHhcCCCCCceeEEEEEE
Q 010519 182 EIATNRFSAENVLGEGGYGVVYKGRLINGSEVAVKKLLNNLGQAEK---------EFRVEVEAIGHVRHKNLVRLLGYCI 252 (508)
Q Consensus 182 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~---------~~~~ei~~l~~l~h~niv~~~~~~~ 252 (508)
.+..++|...++||.|+||.||+... ++..+|+|.+......... .+.+|+..+.++.|++|..+.+++.
T Consensus 27 ~~l~~~y~~~~~l~~~~f~~v~l~~~-~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d~~~ 105 (232)
T PRK10359 27 DFLSYNIKTIKVFRNIDDTKVSLIDT-DYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGLASLNDFYL 105 (232)
T ss_pred HHhhCceEEEEEecCCCceEEEEEec-CCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcceEeee
Confidence 45678999999999999999999755 6778999998654332222 2678999999999999999999866
Q ss_pred eC--------ceeeEEEeecCCCCHHHHHhhhhccCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCEEEcC
Q 010519 253 EG--------VHRMLVYEYVNNGNLEQWLHGAMRNQGNLTWEARMKVIIGTAKALAYLHEAIEPKVVHRDIKSSNILIDD 324 (508)
Q Consensus 253 ~~--------~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiH~Dlk~~NIll~~ 324 (508)
.. ...+|+|||++|.+|.++.. ++. ....+++.+|..||.. +++|||++|.||+++.
T Consensus 106 ~~~~~~~~~~~~~~lvmEyi~G~tL~~~~~--------~~~----~~~~~i~~~l~~lH~~---gi~H~Dikp~Nili~~ 170 (232)
T PRK10359 106 LAERKTLRYAHTYIMLIEYIEGVELNDMPE--------ISE----DVKAKIKASIESLHQH---GMVSGDPHKGNFIVSK 170 (232)
T ss_pred ecccccccccCCeEEEEEEECCccHHHhhh--------ccH----HHHHHHHHHHHHHHHc---CCccCCCChHHEEEeC
Confidence 43 24689999999999988742 222 2455899999999999 9999999999999999
Q ss_pred CCcEEEEecCCccccCCCCCcccccccccccccCccccCCCCCCChhhHHHHHHHHHHHHh
Q 010519 325 EFNAKVSDFGLAKLLDSGESHITTRVMGTFGYVAPEYANTGMLNEKSDIYSFGVLLLEAVT 385 (508)
Q Consensus 325 ~~~~kl~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~ellt 385 (508)
++ ++|+|||.......... . ..+.....|+.++|+|+||+.|..+..
T Consensus 171 ~g-i~liDfg~~~~~~e~~a--~-----------d~~vler~y~~~~di~~lg~~~~~~~~ 217 (232)
T PRK10359 171 NG-LRIIDLSGKRCTAQRKA--K-----------DRIDLERHYGIKNEIKDLGYYLLIYKK 217 (232)
T ss_pred CC-EEEEECCCcccccchhh--H-----------HHHHHHhHhcccccccceeEeehHHHH
Confidence 98 99999998875532211 0 113444567789999999999877653
|
|
| >cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain | Back alignment and domain information |
|---|
Probab=99.86 E-value=1.6e-21 Score=180.10 Aligned_cols=140 Identities=15% Similarity=0.194 Sum_probs=109.0
Q ss_pred ceeEeeeCceEEEEEEEcCCCEEEEEEEcccchh--h------------------------HHHHHHHHHHHhcCCCCCc
Q 010519 191 ENVLGEGGYGVVYKGRLINGSEVAVKKLLNNLGQ--A------------------------EKEFRVEVEAIGHVRHKNL 244 (508)
Q Consensus 191 ~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~--~------------------------~~~~~~ei~~l~~l~h~ni 244 (508)
...||+|+||.||+|.+.+|+.||||++...... . ......|+..+.++.++++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~v 81 (190)
T cd05147 2 NGCISTGKEANVYHATTANGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAGI 81 (190)
T ss_pred CCccccccceEEEEEECCCCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCCC
Confidence 4679999999999999878999999998643211 0 1122348999999988776
Q ss_pred eeEEEEEEeCceeeEEEeecCCCCHHHHHhhhhccCCCccHHHHHHHHHHHHHHHHHH-HhcCCCCeEeecCCCCCEEEc
Q 010519 245 VRLLGYCIEGVHRMLVYEYVNNGNLEQWLHGAMRNQGNLTWEARMKVIIGTAKALAYL-HEAIEPKVVHRDIKSSNILID 323 (508)
Q Consensus 245 v~~~~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~yL-H~~~~~~iiH~Dlk~~NIll~ 323 (508)
.....+... ..+|||||++++++...+. ....++...+..++.|++.+|.|| |+. +|+||||||+|||++
T Consensus 82 ~~p~~~~~~--~~~iVmE~i~g~~l~~~~~----~~~~~~~~~~~~i~~qi~~~L~~l~H~~---giiHrDlkP~NIli~ 152 (190)
T cd05147 82 PCPEPILLK--SHVLVMEFIGDDGWAAPRL----KDAPLSESKARELYLQVIQIMRILYQDC---RLVHADLSEYNLLYH 152 (190)
T ss_pred CCCcEEEec--CCEEEEEEeCCCCCcchhh----hcCCCCHHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEEE
Confidence 443333222 2389999999887765432 335688899999999999999999 688 999999999999998
Q ss_pred CCCcEEEEecCCccccC
Q 010519 324 DEFNAKVSDFGLAKLLD 340 (508)
Q Consensus 324 ~~~~~kl~Dfgla~~~~ 340 (508)
++.++|+|||++....
T Consensus 153 -~~~v~LiDFG~a~~~~ 168 (190)
T cd05147 153 -DGKLYIIDVSQSVEHD 168 (190)
T ss_pred -CCcEEEEEccccccCC
Confidence 4789999999998553
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c |
| >cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain | Back alignment and domain information |
|---|
Probab=99.85 E-value=2.1e-20 Score=173.02 Aligned_cols=141 Identities=19% Similarity=0.168 Sum_probs=111.4
Q ss_pred ceeEeeeCceEEEEEEEcCCCEEEEEEEcccchh--------------------------hHHHHHHHHHHHhcCCCCCc
Q 010519 191 ENVLGEGGYGVVYKGRLINGSEVAVKKLLNNLGQ--------------------------AEKEFRVEVEAIGHVRHKNL 244 (508)
Q Consensus 191 ~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~--------------------------~~~~~~~ei~~l~~l~h~ni 244 (508)
...||+|++|.||+|.+.+|+.||||.+...... ....+..|...+.++.|+++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i 81 (190)
T cd05145 2 NGCISTGKEANVYHARTGDGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEAGV 81 (190)
T ss_pred CceeecCCCcEEEEEEcCCCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhCCC
Confidence 4689999999999999878999999998654210 01224578999999999987
Q ss_pred eeEEEEEEeCceeeEEEeecCCCCHHHHHhhhhccCCCccHHHHHHHHHHHHHHHHHHHh-cCCCCeEeecCCCCCEEEc
Q 010519 245 VRLLGYCIEGVHRMLVYEYVNNGNLEQWLHGAMRNQGNLTWEARMKVIIGTAKALAYLHE-AIEPKVVHRDIKSSNILID 323 (508)
Q Consensus 245 v~~~~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~yLH~-~~~~~iiH~Dlk~~NIll~ 323 (508)
.....+... ..+|||||++++++..... ....++......++.+++.++.+||+ . +|+||||||+|||++
T Consensus 82 ~~p~~~~~~--~~~lVmE~~~g~~~~~~~l----~~~~~~~~~~~~i~~~l~~~l~~lH~~~---givHrDlkP~NIll~ 152 (190)
T cd05145 82 PVPEPILLK--KNVLVMEFIGDDGSPAPRL----KDVPLEEEEAEELYEQVVEQMRRLYQEA---GLVHGDLSEYNILYH 152 (190)
T ss_pred CCceEEEec--CCEEEEEEecCCCchhhhh----hhccCCHHHHHHHHHHHHHHHHHHHHhC---CEecCCCChhhEEEE
Confidence 555444333 2489999999886544321 23457788899999999999999999 8 999999999999999
Q ss_pred CCCcEEEEecCCccccCC
Q 010519 324 DEFNAKVSDFGLAKLLDS 341 (508)
Q Consensus 324 ~~~~~kl~Dfgla~~~~~ 341 (508)
++.++|+|||++.....
T Consensus 153 -~~~~~liDFG~a~~~~~ 169 (190)
T cd05145 153 -DGKPYIIDVSQAVELDH 169 (190)
T ss_pred -CCCEEEEEcccceecCC
Confidence 78999999999986643
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro |
| >KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.84 E-value=1.3e-20 Score=192.67 Aligned_cols=217 Identities=28% Similarity=0.473 Sum_probs=163.6
Q ss_pred HhcCCCCCceeEEEEEEeCceeeEEEeecCCCCHHHHHhhhhccCCCccHHHHHHHHHHHHHHHHHHHhcCCCCe-Eeec
Q 010519 236 IGHVRHKNLVRLLGYCIEGVHRMLVYEYVNNGNLEQWLHGAMRNQGNLTWEARMKVIIGTAKALAYLHEAIEPKV-VHRD 314 (508)
Q Consensus 236 l~~l~h~niv~~~~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~i-iH~D 314 (508)
|+.+.|.|+.+++|.+.++...++|.+||..|+|.|.+. .....+++.-...++.+|+.||.|||+. +| .|+.
T Consensus 1 l~~l~h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~---~~~~~~d~~F~~s~~rdi~~Gl~ylh~s---~i~~hg~ 74 (484)
T KOG1023|consen 1 LRQLDHDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILS---NEDIKLDYFFILSFIRDISKGLAYLHNS---PIGYHGA 74 (484)
T ss_pred CcccchhhhhhheeeEecCCceEEEEeeecCccHHhHHh---ccccCccHHHHHHHHHHHHHHHHHHhcC---cceeeee
Confidence 467899999999999999999999999999999999996 3456788889999999999999999976 44 9999
Q ss_pred CCCCCEEEcCCCcEEEEecCCccccCCC-CCcccccccccccccCccccCCCC-------CCChhhHHHHHHHHHHHHhC
Q 010519 315 IKSSNILIDDEFNAKVSDFGLAKLLDSG-ESHITTRVMGTFGYVAPEYANTGM-------LNEKSDIYSFGVLLLEAVTG 386 (508)
Q Consensus 315 lk~~NIll~~~~~~kl~Dfgla~~~~~~-~~~~~~~~~gt~~y~aPE~~~~~~-------~~~~~DvwS~Gvvl~elltG 386 (508)
|++.|++++..+.+||+|||+....... .........-...|.|||.+.+.. .+.+.||||||++++|+++.
T Consensus 75 l~s~nClvd~~w~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei~~r 154 (484)
T KOG1023|consen 75 LKSSNCLVDSRWVLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEILFR 154 (484)
T ss_pred eccccceeeeeEEEEechhhhcccccccccccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHHHhc
Confidence 9999999999999999999999876421 111111222355799999987632 46689999999999999999
Q ss_pred CCCCCCCCCCchhcHHHHHHHHhcccccccccCCCCCCChhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhhcCCC
Q 010519 387 RDPVDYGRPANEVNLVEWLKMMVGTRRAEEVVDPNLEVKPATRALKRSLLVALRCVDPDSEKRPKMSQVVRMLEADDY 464 (508)
Q Consensus 387 ~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~ 464 (508)
+.||+........ .+.+..... .......|.+.... .....+..++.+||..+|.+||++.++-..++....
T Consensus 155 ~~~~~~~~~~~~~--~eii~~~~~--~~~~~~rP~i~~~~--e~~~~l~~l~~~cw~e~P~~rPs~~~i~~~~~~~~~ 226 (484)
T KOG1023|consen 155 SGPFDLRNLVEDP--DEIILRVKK--GGSNPFRPSIELLN--ELPPELLLLVARCWEEIPEKRPSIEQIRSKLLTINK 226 (484)
T ss_pred cCccccccccCCh--HHHHHHHHh--cCCCCcCcchhhhh--hcchHHHHHHHHhcccChhhCccHHHHHhhhhhhcc
Confidence 9999764433322 122222111 11112222222111 233367779999999999999999999998887654
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.84 E-value=4.4e-22 Score=203.46 Aligned_cols=225 Identities=26% Similarity=0.276 Sum_probs=177.2
Q ss_pred eEeeeCceEEEEEEE----cCCCEEEEEEEcccchh--hHHHHHHHHHHHhcCC-CCCceeEEEEEEeCceeeEEEeecC
Q 010519 193 VLGEGGYGVVYKGRL----INGSEVAVKKLLNNLGQ--AEKEFRVEVEAIGHVR-HKNLVRLLGYCIEGVHRMLVYEYVN 265 (508)
Q Consensus 193 ~lg~G~~g~Vy~~~~----~~~~~vavK~~~~~~~~--~~~~~~~ei~~l~~l~-h~niv~~~~~~~~~~~~~lv~E~~~ 265 (508)
++|+|+||.|+++.. +.|.-+|+|.+.+.... .......|..++..++ ||.+|.++-.++.+...+++++|..
T Consensus 1 vlg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~~t~~er~il~~~~~~~f~v~lhyafqt~~kl~l~ld~~r 80 (612)
T KOG0603|consen 1 VLGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRTHTKQERIILAFVHNTPFLVKLHYAFQTDGKLYLILDFLR 80 (612)
T ss_pred CCCcCCCcchHHHHHhccccccchhhhhcccccccccccccccccHHHHHhhccCCCceeeeeeeeccccchhHhhhhcc
Confidence 378999999998742 35667888876543311 1113444777888886 9999999999999999999999999
Q ss_pred CCCHHHHHhhhhccCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCEEEcCCCcEEEEecCCccccCCCCCc
Q 010519 266 NGNLEQWLHGAMRNQGNLTWEARMKVIIGTAKALAYLHEAIEPKVVHRDIKSSNILIDDEFNAKVSDFGLAKLLDSGESH 345 (508)
Q Consensus 266 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~ 345 (508)
+|+|...+ .....+.+.....+...++-|+.++|.. +++|||+|++||+++.+|++++.|||+++..-+...
T Consensus 81 gg~lft~l----~~~~~f~~~~~~~~~aelaLald~lh~l---~iiyrd~k~enilld~~Ghi~~tdfglske~v~~~~- 152 (612)
T KOG0603|consen 81 GGDLFTRL----SKEVMFDELDVAFYLAELALALDHLHKL---GIAYRDYKLENVLLLLEGHIKLTDFGLSKEAVKEKI- 152 (612)
T ss_pred cchhhhcc----ccCCchHHHHHHHHHHHHHHHHhhcchh---HHHHhcccccceeecccCccccCCchhhhHhHhhhh-
Confidence 99999987 4556677888888888999999999999 999999999999999999999999999986644322
Q ss_pred ccccccccccccCccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCCCchhcHHHHHHHHhcccccccccCCCCCCC
Q 010519 346 ITTRVMGTFGYVAPEYANTGMLNEKSDIYSFGVLLLEAVTGRDPVDYGRPANEVNLVEWLKMMVGTRRAEEVVDPNLEVK 425 (508)
Q Consensus 346 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 425 (508)
.|||..|||||++. ....++|.||||++++||++|..||.. +....+ ...+..
T Consensus 153 ----~cgt~eymApEI~~--gh~~a~D~ws~gvl~felltg~~pf~~----------~~~~~I-----------l~~~~~ 205 (612)
T KOG0603|consen 153 ----ACGTYEYRAPEIIN--GHLSAADWWSFGVLAFELLTGTLPFGG----------DTMKRI-----------LKAELE 205 (612)
T ss_pred ----cccchhhhhhHhhh--ccCCcccchhhhhhHHHHhhCCCCCch----------HHHHHH-----------hhhccC
Confidence 18999999999998 457899999999999999999999963 111111 122223
Q ss_pred hhHHHHHHHHHHHHHhcCCCCCCCCCH
Q 010519 426 PATRALKRSLLVALRCVDPDSEKRPKM 452 (508)
Q Consensus 426 ~~~~~~~~l~~li~~cl~~dP~~RPs~ 452 (508)
.+......+..++..++..+|.+|.-.
T Consensus 206 ~p~~l~~~a~~~~~~l~~r~p~nrLg~ 232 (612)
T KOG0603|consen 206 MPRELSAEARSLFRQLFKRNPENRLGA 232 (612)
T ss_pred CchhhhHHHHHHHHHHHhhCHHHHhcc
Confidence 344445556668889999999999855
|
|
| >PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A | Back alignment and domain information |
|---|
Probab=99.84 E-value=3.4e-20 Score=178.73 Aligned_cols=234 Identities=20% Similarity=0.316 Sum_probs=149.0
Q ss_pred CcccceeEeeeCceEEEEEEEc-CCCEEEEEEEcccc---hhhHHHHHHHHHHHhcCCC----------CCceeEEEEEE
Q 010519 187 RFSAENVLGEGGYGVVYKGRLI-NGSEVAVKKLLNNL---GQAEKEFRVEVEAIGHVRH----------KNLVRLLGYCI 252 (508)
Q Consensus 187 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~ei~~l~~l~h----------~niv~~~~~~~ 252 (508)
.+.....||.|+++.||.+++. .|+++|+|...... ....+.+++|.-....+.+ -.++-.++...
T Consensus 13 ~l~~~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~~~ 92 (288)
T PF14531_consen 13 TLVRGRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDLLR 92 (288)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEEEE
T ss_pred EEEEccccccCCceEEEEEEEccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEEEE
Confidence 4566788999999999999986 58999999885333 2234566666554444322 12222222221
Q ss_pred ---------eC---c-----eeeEEEeecCCCCHHHHHhhhhccC---CCccHHHHHHHHHHHHHHHHHHHhcCCCCeEe
Q 010519 253 ---------EG---V-----HRMLVYEYVNNGNLEQWLHGAMRNQ---GNLTWEARMKVIIGTAKALAYLHEAIEPKVVH 312 (508)
Q Consensus 253 ---------~~---~-----~~~lv~E~~~~gsL~~~l~~~~~~~---~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiH 312 (508)
.. . ..+++|+-+ .++|.+++....... ..+....++.+..|+++.+++||.. |++|
T Consensus 93 i~~~~~~~~~~~~~~~~~v~n~~~l~P~~-~~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~~---GlVH 168 (288)
T PF14531_consen 93 IPGKPPFFERGPGQSIYWVLNRFLLMPRA-QGDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHSY---GLVH 168 (288)
T ss_dssp ETTS-SEEEECETTEEEEEESEEEEEE---SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHT---TEEE
T ss_pred EcCCCcceecCCCCccceeehhhhccchh-hhcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhhc---ceEe
Confidence 11 1 236788888 559988864322221 2344566677888999999999999 9999
Q ss_pred ecCCCCCEEEcCCCcEEEEecCCccccCCCCCcccccccccccccCccccCC--------CCCCChhhHHHHHHHHHHHH
Q 010519 313 RDIKSSNILIDDEFNAKVSDFGLAKLLDSGESHITTRVMGTFGYVAPEYANT--------GMLNEKSDIYSFGVLLLEAV 384 (508)
Q Consensus 313 ~Dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~~~~~DvwS~Gvvl~ell 384 (508)
+||+|+|+|++.+|.++|+||+.....+..... ...+..|.+||.... -.++.+.|.|++|+++|.|+
T Consensus 169 gdi~~~nfll~~~G~v~Lg~F~~~~r~g~~~~~----~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~ly~lW 244 (288)
T PF14531_consen 169 GDIKPENFLLDQDGGVFLGDFSSLVRAGTRYRC----SEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGITLYSLW 244 (288)
T ss_dssp ST-SGGGEEE-TTS-EEE--GGGEEETTEEEEG----GGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHHHHHHH
T ss_pred cccceeeEEEcCCCCEEEcChHHHeecCceeec----cCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHHHHHHH
Confidence 999999999999999999999988765542211 234577999997633 24788999999999999999
Q ss_pred hCCCCCCCCCCCchhcHHHHHHHHhcccccccccCCCCCCChhHHHHHHHHHHHHHhcCCCCCCC
Q 010519 385 TGRDPVDYGRPANEVNLVEWLKMMVGTRRAEEVVDPNLEVKPATRALKRSLLVALRCVDPDSEKR 449 (508)
Q Consensus 385 tG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~R 449 (508)
+|..||+...+.... ......+.+.+..+..||..+|++||.+|
T Consensus 245 C~~lPf~~~~~~~~~---------------------~~~f~~C~~~Pe~v~~LI~~lL~~~~~~R 288 (288)
T PF14531_consen 245 CGRLPFGLSSPEADP---------------------EWDFSRCRDMPEPVQFLIRGLLQRNPEDR 288 (288)
T ss_dssp HSS-STCCCGGGSTS---------------------GGGGTTSS---HHHHHHHHHHT-SSGGGS
T ss_pred HccCCCCCCCccccc---------------------cccchhcCCcCHHHHHHHHHHccCCcccC
Confidence 999999744322111 00111122566777789999999999988
|
|
| >PRK12274 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.83 E-value=1.1e-19 Score=166.72 Aligned_cols=183 Identities=20% Similarity=0.140 Sum_probs=137.6
Q ss_pred cceeEeeeCceEEEEEEEcCCCEEEEEEEcccchh----hHHHHHHHHHHHhcCC-CCCceeEEEEEEeCceeeEEEeec
Q 010519 190 AENVLGEGGYGVVYKGRLINGSEVAVKKLLNNLGQ----AEKEFRVEVEAIGHVR-HKNLVRLLGYCIEGVHRMLVYEYV 264 (508)
Q Consensus 190 ~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~----~~~~~~~ei~~l~~l~-h~niv~~~~~~~~~~~~~lv~E~~ 264 (508)
....|++|+||+||.+.. .+.+++.+.+.....- ....+.+|+++|++|. |+++++++++ ...+++|||+
T Consensus 6 ~~~~l~~~~f~~v~~~~~-~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~----~~~~lvmeyI 80 (218)
T PRK12274 6 VNEPLKSDTFGRILLVRG-GERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHW----DGRHLDRSYL 80 (218)
T ss_pred cceeecCCCcceEEEeec-CCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE----cCEEEEEeee
Confidence 457899999999998765 7788887776544321 1235788999999995 5889999886 3468999999
Q ss_pred CCCCHHHHHhhhhccCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEeecC-CCCCEEEcCCCcEEEEecCCccccCCCC
Q 010519 265 NNGNLEQWLHGAMRNQGNLTWEARMKVIIGTAKALAYLHEAIEPKVVHRDI-KSSNILIDDEFNAKVSDFGLAKLLDSGE 343 (508)
Q Consensus 265 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiH~Dl-k~~NIll~~~~~~kl~Dfgla~~~~~~~ 343 (508)
.|.+|...+. . . ...++.+++.+|.++|.+ ||+|||| ||+|||++.++.++|+|||++.......
T Consensus 81 ~G~~L~~~~~----~-~------~~~~~~qi~~~L~~lH~~---GIvHrDL~kp~NILv~~~g~i~LIDFG~A~~~~~~~ 146 (218)
T PRK12274 81 AGAAMYQRPP----R-G------DLAYFRAARRLLQQLHRC---GVAHNDLAKEANWLVQEDGSPAVIDFQLAVRGNPRA 146 (218)
T ss_pred cCccHHhhhh----h-h------hHHHHHHHHHHHHHHHHC---cCccCCCCCcceEEEcCCCCEEEEECCCceecCCcc
Confidence 9999876431 1 1 134678899999999999 9999999 7999999999999999999998554322
Q ss_pred Cc----c--------cccccccccccCccccCCC-CCC-ChhhHHHHHHHHHHHHhCCCCCC
Q 010519 344 SH----I--------TTRVMGTFGYVAPEYANTG-MLN-EKSDIYSFGVLLLEAVTGRDPVD 391 (508)
Q Consensus 344 ~~----~--------~~~~~gt~~y~aPE~~~~~-~~~-~~~DvwS~Gvvl~elltG~~Pf~ 391 (508)
.. . ..-...++.|++|+...-- ..+ ...++++.|+-+|.++|+..+..
T Consensus 147 ~~~r~L~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~~ 208 (218)
T PRK12274 147 RWMRLLAREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLHW 208 (218)
T ss_pred hHHHHHHHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCcc
Confidence 10 0 0112357788888754221 223 67899999999999999998853
|
|
| >KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.83 E-value=1.6e-20 Score=181.47 Aligned_cols=204 Identities=24% Similarity=0.283 Sum_probs=139.3
Q ss_pred CCCCceeEEEEEEe---------------------------CceeeEEEeecCCCCHHHHHhhhhccCCCccHHHHHHHH
Q 010519 240 RHKNLVRLLGYCIE---------------------------GVHRMLVYEYVNNGNLEQWLHGAMRNQGNLTWEARMKVI 292 (508)
Q Consensus 240 ~h~niv~~~~~~~~---------------------------~~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~ 292 (508)
+|||||++.++|.+ ...+|+||..++. +|.+++. ....+.....-++
T Consensus 274 ~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY~~-tLr~yl~-----~~~~s~r~~~~~l 347 (598)
T KOG4158|consen 274 KHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRYRQ-TLREYLW-----TRHRSYRTGRVIL 347 (598)
T ss_pred CCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcchh-hHHHHHh-----cCCCchHHHHHHH
Confidence 59999999987743 2346899998865 9999984 2335566677788
Q ss_pred HHHHHHHHHHHhcCCCCeEeecCCCCCEEE--cCCCc--EEEEecCCccccCCCC-----CcccccccccccccCccccC
Q 010519 293 IGTAKALAYLHEAIEPKVVHRDIKSSNILI--DDEFN--AKVSDFGLAKLLDSGE-----SHITTRVMGTFGYVAPEYAN 363 (508)
Q Consensus 293 ~~i~~al~yLH~~~~~~iiH~Dlk~~NIll--~~~~~--~kl~Dfgla~~~~~~~-----~~~~~~~~gt~~y~aPE~~~ 363 (508)
.|+++|+.|||.+ +|.|||||++|||+ ++|+. +.|+|||.+...+... ....-..-|...-||||+..
T Consensus 348 aQlLEav~hL~~h---gvAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi~t 424 (598)
T KOG4158|consen 348 AQLLEAVTHLHKH---GVAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDNHGLQLPYESDEVDLGGNAKLMAPEIAT 424 (598)
T ss_pred HHHHHHHHHHHHc---cchhhcccccceEEEecCCCCcEEEEcccceeeeccccccccccccccccCCCcceecchhhhh
Confidence 9999999999999 99999999999999 34443 7899999886432210 01111234777899999885
Q ss_pred CCC--C----CChhhHHHHHHHHHHHHhCCCCCCCCCCCchhcHHHHHHHHhcccccccccCCCCCCChhHHHHHHHHHH
Q 010519 364 TGM--L----NEKSDIYSFGVLLLEAVTGRDPVDYGRPANEVNLVEWLKMMVGTRRAEEVVDPNLEVKPATRALKRSLLV 437 (508)
Q Consensus 364 ~~~--~----~~~~DvwS~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 437 (508)
..+ . -.|+|.|+.|.+.||++....||.. ...-...... .++---|.+... ....+.+|
T Consensus 425 a~PGp~avvny~kAD~WA~GalaYEIfg~~NPFY~-rGem~L~~r~----------Yqe~qLPalp~~----vpp~~rql 489 (598)
T KOG4158|consen 425 AVPGPNAVVNYEKADTWAAGALAYEIFGRSNPFYK-RGEMLLDTRT----------YQESQLPALPSR----VPPVARQL 489 (598)
T ss_pred cCCCCceeeccchhhhhhhhhhHHHHhccCCcccc-cchheechhh----------hhhhhCCCCccc----CChHHHHH
Confidence 432 1 1589999999999999999999853 1111111111 111111222222 23344558
Q ss_pred HHHhcCCCCCCCCCHHHHHHHhhcCCCCCc
Q 010519 438 ALRCVDPDSEKRPKMSQVVRMLEADDYPFR 467 (508)
Q Consensus 438 i~~cl~~dP~~RPs~~evl~~L~~~~~~~~ 467 (508)
+...|++||++|++..-....|+-..+...
T Consensus 490 V~~lL~r~pskRvsp~iAANvl~LsLw~~~ 519 (598)
T KOG4158|consen 490 VFDLLKRDPSKRVSPNIAANVLNLSLWRMG 519 (598)
T ss_pred HHHHhcCCccccCCccHHHhHHHHHHhcCc
Confidence 889999999999998777766665544433
|
|
| >KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.81 E-value=1.6e-19 Score=196.79 Aligned_cols=201 Identities=20% Similarity=0.230 Sum_probs=160.9
Q ss_pred HHHHHHhhCCcccceeEeeeCceEEEEEEEcCCCEEEEEEEcccchhhHHHHHHHHHHHhcCC---CCCceeEEEEEEeC
Q 010519 178 LRDLEIATNRFSAENVLGEGGYGVVYKGRLINGSEVAVKKLLNNLGQAEKEFRVEVEAIGHVR---HKNLVRLLGYCIEG 254 (508)
Q Consensus 178 ~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~ei~~l~~l~---h~niv~~~~~~~~~ 254 (508)
..++++..+.|.+.+.||+|+||.||+|...+|+.||+|.-..... .+|---.+++.+|+ -+.|..+...+.-.
T Consensus 690 ~~~~~~~~~~~~I~~e~G~g~y~~vy~a~~~~~~~~alK~e~P~~~---WEfYI~~q~~~RLk~~~~~~~~~~~~a~~~~ 766 (974)
T KOG1166|consen 690 NTEFEVGGEKFCISKEIGEGSYGSVYVATHSNGKLVALKVEKPPNP---WEFYICLQVMERLKPQMLPSIMHISSAHVFQ 766 (974)
T ss_pred cceeeecceeEEEEeeeccccceEEEEeecCCCcEEEEEeecCCCc---eeeeehHHHHHhhchhhhcchHHHHHHHccC
Confidence 3456667788999999999999999999988899999997543321 22222333444444 23455555555666
Q ss_pred ceeeEEEeecCCCCHHHHHhhhhccCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCEEEc-------CCCc
Q 010519 255 VHRMLVYEYVNNGNLEQWLHGAMRNQGNLTWEARMKVIIGTAKALAYLHEAIEPKVVHRDIKSSNILID-------DEFN 327 (508)
Q Consensus 255 ~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiH~Dlk~~NIll~-------~~~~ 327 (508)
+..++|+||.+.|+|.++++ ..+.++|...+.++.|++.-+..||.. +|||+||||+|+||. +..-
T Consensus 767 ~~S~lv~ey~~~Gtlld~~N----~~~~m~e~lv~~~~~qml~ive~lH~~---~IIHgDiKPDNfll~~~~~~~~~~~~ 839 (974)
T KOG1166|consen 767 NASVLVSEYSPYGTLLDLIN----TNKVMDEYLVMFFSCQMLRIVEHLHAM---GIIHGDIKPDNFLLRREICADSDSKG 839 (974)
T ss_pred CcceeeeeccccccHHHhhc----cCCCCCchhhhHHHHHHHHHHHHHHhc---ceecccCCcceeEeecccCCCCcccc
Confidence 77789999999999999984 677899999999999999999999999 999999999999994 2334
Q ss_pred EEEEecCCccccCCCCC-cccccccccccccCccccCCCCCCChhhHHHHHHHHHHHHhCCC
Q 010519 328 AKVSDFGLAKLLDSGES-HITTRVMGTFGYVAPEYANTGMLNEKSDIYSFGVLLLEAVTGRD 388 (508)
Q Consensus 328 ~kl~Dfgla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltG~~ 388 (508)
++|+|||.+..+.--.. ......++|-.+-.+|+..|..++..+|.|.|+.+++-|+.|+.
T Consensus 840 l~lIDfG~siDm~lfp~~~~F~~~~~td~f~C~EM~~grpWtYq~DyfGlAa~~h~mLFG~y 901 (974)
T KOG1166|consen 840 LYLIDFGRSIDMKLFPDGTKFKAVWHTDLFDCIEMREGRPWTYQIDYFGLAATVHVMLFGKY 901 (974)
T ss_pred eEEEecccceeeeEcCCCcEEeeeeccccchhHHHhcCCCCchhhhhHHHHHHHHHHHHHHH
Confidence 89999999975432111 24566788999999999999999999999999999999999974
|
|
| >PRK10345 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.80 E-value=5.3e-19 Score=164.99 Aligned_cols=137 Identities=19% Similarity=0.239 Sum_probs=105.5
Q ss_pred ccceeEeeeCceEEEEEEEcCCCEEEEEEEcccchhhHHHHHHHHHHHhcC-----CCCCceeEEEEEEeCc---eee-E
Q 010519 189 SAENVLGEGGYGVVYKGRLINGSEVAVKKLLNNLGQAEKEFRVEVEAIGHV-----RHKNLVRLLGYCIEGV---HRM-L 259 (508)
Q Consensus 189 ~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~ei~~l~~l-----~h~niv~~~~~~~~~~---~~~-l 259 (508)
.-.+.||+|+||.||. +......+||++..........+.+|+..++.+ +||||+++++++.++. ..+ +
T Consensus 5 ~~~~~LG~G~~~~Vy~--hp~~~~k~IKv~~~~~~~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~v~~~ 82 (210)
T PRK10345 5 SEQSPLGTGRHRKCYA--HPEDAQRCIKIVYHRGDGGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTGYVYDV 82 (210)
T ss_pred CCcceecCCCceEEEE--CCCCcCeEEEEEeccccchHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCeEEEEE
Confidence 3357899999999996 443343479988655444556789999999999 5799999999998873 334 7
Q ss_pred EEee--cCCCCHHHHHhhhhccCCCccHHHHHHHHHHHHHHH-HHHHhcCCCCeEeecCCCCCEEEcC----CCcEEEEe
Q 010519 260 VYEY--VNNGNLEQWLHGAMRNQGNLTWEARMKVIIGTAKAL-AYLHEAIEPKVVHRDIKSSNILIDD----EFNAKVSD 332 (508)
Q Consensus 260 v~E~--~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al-~yLH~~~~~~iiH~Dlk~~NIll~~----~~~~kl~D 332 (508)
|+|| +.+|+|.+++.. ..+++. ..++.+++.++ .|||++ +|+||||||+|||++. ++.++|+|
T Consensus 83 I~e~~G~~~~tL~~~l~~-----~~~~e~--~~~~~~~L~~l~~yLh~~---~IvhrDlKp~NILl~~~~~~~~~~~LiD 152 (210)
T PRK10345 83 IADFDGKPSITLTEFAEQ-----CRYEED--VAQLRQLLKKLKRYLLDN---RIVTMELKPQNILCQRISESEVIPVVCD 152 (210)
T ss_pred EecCCCCcchhHHHHHHc-----ccccHh--HHHHHHHHHHHHHHHHHC---CEeecCCCHHHEEEeccCCCCCcEEEEE
Confidence 8999 557999999942 235544 35567777777 999999 9999999999999974 34799999
Q ss_pred cCCcc
Q 010519 333 FGLAK 337 (508)
Q Consensus 333 fgla~ 337 (508)
|+.+.
T Consensus 153 g~G~~ 157 (210)
T PRK10345 153 NIGES 157 (210)
T ss_pred CCCCc
Confidence 55443
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.78 E-value=3.2e-19 Score=190.96 Aligned_cols=207 Identities=24% Similarity=0.313 Sum_probs=144.5
Q ss_pred CCcccceeEeeeCceEEEEEEEc-CCCEEEEEEEcccchhhHHHHHHHHHHHhcCCCCCceeEEEEEEeCceeeEEEeec
Q 010519 186 NRFSAENVLGEGGYGVVYKGRLI-NGSEVAVKKLLNNLGQAEKEFRVEVEAIGHVRHKNLVRLLGYCIEGVHRMLVYEYV 264 (508)
Q Consensus 186 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~ei~~l~~l~h~niv~~~~~~~~~~~~~lv~E~~ 264 (508)
.+|..+++|..|+||.||.++++ ..+++|+| +.++.-. +++ ++.....|.+|
T Consensus 83 ~df~~IklisngAygavylvrh~~trqrfa~k-iNkq~li----lRn---ilt~a~npfvv------------------- 135 (1205)
T KOG0606|consen 83 SDFNTIKLISNGAYGAVYLVRHKETRQRFAMK-INKQNLI----LRN---ILTFAGNPFVV------------------- 135 (1205)
T ss_pred cccceeEeeccCCCCceeeeeccccccchhhc-ccccchh----hhc---cccccCCccee-------------------
Confidence 47888999999999999999876 46678884 3222111 111 33333444444
Q ss_pred CCCCHHHHHhhhhccCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCEEEcCCCcEEEEecCCccccCCCCC
Q 010519 265 NNGNLEQWLHGAMRNQGNLTWEARMKVIIGTAKALAYLHEAIEPKVVHRDIKSSNILIDDEFNAKVSDFGLAKLLDSGES 344 (508)
Q Consensus 265 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~ 344 (508)
|+-.+++ +.-++++... +.+++|||+. +|+|||+||+|.+|+.-|++|++|||+++.......
T Consensus 136 --gDc~tll----k~~g~lPvdm--------vla~Eylh~y---givhrdlkpdnllIT~mGhiKlTDfgLsk~GLms~a 198 (1205)
T KOG0606|consen 136 --GDCATLL----KNIGPLPVDM--------VLAVEYLHSY---GIVHRDLKPDNLLITSMGHIKLTDFGLSKKGLMSLA 198 (1205)
T ss_pred --chhhhhc----ccCCCCcchh--------hHHhHhhccC---CeecCCCCCCcceeeecccccccchhhhhhhhhhcc
Confidence 5656655 3445555443 6799999999 999999999999999999999999999874421110
Q ss_pred --------------cccccccccccccCccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCCCchhcHHHHHHHHhc
Q 010519 345 --------------HITTRVMGTFGYVAPEYANTGMLNEKSDIYSFGVLLLEAVTGRDPVDYGRPANEVNLVEWLKMMVG 410 (508)
Q Consensus 345 --------------~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~ 410 (508)
.....++|||.|+|||++....|+..+|+|++|+|+||++.|..||....+.. .+..++.
T Consensus 199 tnl~eg~I~k~t~Ef~dKqvcgTPeyiaPeVilrqgygkpvdwwamGiIlyeFLVgcvpffGdtpee------lfg~vis 272 (1205)
T KOG0606|consen 199 TNLKEGHIEKDTHEFQDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEE------LFGQVIS 272 (1205)
T ss_pred chhhhcchHHHHHHhhhccccCCccccChhhhhhhccCCCccHHHHHHHHHHHheeeeeccCCCHHH------HHhhhhh
Confidence 11234689999999999999999999999999999999999999997554432 2222222
Q ss_pred ccccccccCCCCCCChhHHHHHHHHHHHHHhcCCCCCCCC
Q 010519 411 TRRAEEVVDPNLEVKPATRALKRSLLVALRCVDPDSEKRP 450 (508)
Q Consensus 411 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP 450 (508)
..... .+. ......+..+++.+.|..+|..|.
T Consensus 273 d~i~w--pE~------dea~p~Ea~dli~~LL~qnp~~Rl 304 (1205)
T KOG0606|consen 273 DDIEW--PEE------DEALPPEAQDLIEQLLRQNPLCRL 304 (1205)
T ss_pred hhccc--ccc------CcCCCHHHHHHHHHHHHhChHhhc
Confidence 11110 001 111233455688899999999996
|
|
| >smart00090 RIO RIO-like kinase | Back alignment and domain information |
|---|
Probab=99.77 E-value=2.3e-18 Score=164.50 Aligned_cols=142 Identities=17% Similarity=0.161 Sum_probs=110.9
Q ss_pred CcccceeEeeeCceEEEEEE--EcCCCEEEEEEEcccchh------------------------hHHHHHHHHHHHhcCC
Q 010519 187 RFSAENVLGEGGYGVVYKGR--LINGSEVAVKKLLNNLGQ------------------------AEKEFRVEVEAIGHVR 240 (508)
Q Consensus 187 ~~~~~~~lg~G~~g~Vy~~~--~~~~~~vavK~~~~~~~~------------------------~~~~~~~ei~~l~~l~ 240 (508)
-|.+.+.||+|+||.||+|. ..+|+.||+|.+...... ....+..|+..+.++.
T Consensus 29 ~~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~~L~ 108 (237)
T smart00090 29 LSAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQRLY 108 (237)
T ss_pred hHHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHHHHH
Confidence 47888999999999999998 458999999988643210 1123567999999997
Q ss_pred CCC--ceeEEEEEEeCceeeEEEeecCCCCHHHHHhhhhccCCCccHHHHHHHHHHHHHHHHHHHhcCCCC-eEeecCCC
Q 010519 241 HKN--LVRLLGYCIEGVHRMLVYEYVNNGNLEQWLHGAMRNQGNLTWEARMKVIIGTAKALAYLHEAIEPK-VVHRDIKS 317 (508)
Q Consensus 241 h~n--iv~~~~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~-iiH~Dlk~ 317 (508)
+.. +..++++ ...++||||+++++|..++. ....+.......++.||+.++.+||.. + ++|+||||
T Consensus 109 ~~~i~~p~~~~~----~~~~lV~E~~~g~~L~~~~~----~~~~~~~~~~~~i~~qi~~~l~~LH~~---g~iiH~Dikp 177 (237)
T smart00090 109 EAGVPVPKPIAW----RRNVLVMEFIGGDGLPAPRL----KDVEPEEEEEFELYDDILEEMRKLYKE---GELVHGDLSE 177 (237)
T ss_pred hcCCCCCeeeEe----cCceEEEEEecCCccccccc----ccCCcchHHHHHHHHHHHHHHHHHHhc---CCEEeCCCCh
Confidence 532 3344442 23589999999988876542 233455666789999999999999999 9 99999999
Q ss_pred CCEEEcCCCcEEEEecCCccccC
Q 010519 318 SNILIDDEFNAKVSDFGLAKLLD 340 (508)
Q Consensus 318 ~NIll~~~~~~kl~Dfgla~~~~ 340 (508)
+||+++ ++.++|+|||.+....
T Consensus 178 ~NIli~-~~~i~LiDFg~a~~~~ 199 (237)
T smart00090 178 YNILVH-DGKVVIIDVSQSVELD 199 (237)
T ss_pred hhEEEE-CCCEEEEEChhhhccC
Confidence 999999 8899999999988544
|
|
| >PRK14879 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.75 E-value=9.7e-18 Score=157.75 Aligned_cols=134 Identities=19% Similarity=0.338 Sum_probs=113.2
Q ss_pred eeEeeeCceEEEEEEEcCCCEEEEEEEcccch--------hhHHHHHHHHHHHhcCCCCCceeEEEEEEeCceeeEEEee
Q 010519 192 NVLGEGGYGVVYKGRLINGSEVAVKKLLNNLG--------QAEKEFRVEVEAIGHVRHKNLVRLLGYCIEGVHRMLVYEY 263 (508)
Q Consensus 192 ~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~--------~~~~~~~~ei~~l~~l~h~niv~~~~~~~~~~~~~lv~E~ 263 (508)
+.||+|++|.||+|.+ .|..+++|+...... .....+..|+.++..+.|+++.....++......+++|||
T Consensus 2 ~~l~~G~~~~vy~~~~-~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~ 80 (211)
T PRK14879 2 KLIKRGAEAEIYLGDF-LGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVDPENFIIVMEY 80 (211)
T ss_pred cccccCceEEEEEEee-CCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeCCCCEEEEEE
Confidence 5799999999999987 788899997653321 1123577899999999999998888887777888999999
Q ss_pred cCCCCHHHHHhhhhccCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCEEEcCCCcEEEEecCCccc
Q 010519 264 VNNGNLEQWLHGAMRNQGNLTWEARMKVIIGTAKALAYLHEAIEPKVVHRDIKSSNILIDDEFNAKVSDFGLAKL 338 (508)
Q Consensus 264 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~Dfgla~~ 338 (508)
++|++|.+++.. . .. .+..++.+++.+|.+||+. +++|+|++|.|||++ ++.++|+|||++..
T Consensus 81 ~~G~~L~~~~~~----~---~~-~~~~i~~~i~~~l~~lH~~---~i~H~Dl~p~Nil~~-~~~~~liDf~~a~~ 143 (211)
T PRK14879 81 IEGEPLKDLINS----N---GM-EELELSREIGRLVGKLHSA---GIIHGDLTTSNMILS-GGKIYLIDFGLAEF 143 (211)
T ss_pred eCCcCHHHHHHh----c---cH-HHHHHHHHHHHHHHHHHhC---CcccCCCCcccEEEE-CCCEEEEECCcccC
Confidence 999999998852 1 11 7788999999999999999 999999999999999 78999999998875
|
|
| >TIGR03724 arch_bud32 Kae1-associated kinase Bud32 | Back alignment and domain information |
|---|
Probab=99.75 E-value=1.2e-17 Score=155.61 Aligned_cols=131 Identities=21% Similarity=0.391 Sum_probs=107.3
Q ss_pred eEeeeCceEEEEEEEcCCCEEEEEEEcccch--------hhHHHHHHHHHHHhcCCCCCceeEEEEEEeCceeeEEEeec
Q 010519 193 VLGEGGYGVVYKGRLINGSEVAVKKLLNNLG--------QAEKEFRVEVEAIGHVRHKNLVRLLGYCIEGVHRMLVYEYV 264 (508)
Q Consensus 193 ~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~--------~~~~~~~~ei~~l~~l~h~niv~~~~~~~~~~~~~lv~E~~ 264 (508)
.||+|+||.||+|.+ ++..+++|....... .....+..|++++..+.|+++.....++......++||||+
T Consensus 1 ~ig~G~~~~vy~~~~-~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~~ 79 (199)
T TIGR03724 1 LIAKGAEAIIYLGDF-LGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDPDNKTIVMEYI 79 (199)
T ss_pred CCCCCceEEEEEeec-CCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEECCCCEEEEEEE
Confidence 389999999999986 778899998654321 11245778999999999887666666666667778999999
Q ss_pred CCCCHHHHHhhhhccCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCEEEcCCCcEEEEecCCcccc
Q 010519 265 NNGNLEQWLHGAMRNQGNLTWEARMKVIIGTAKALAYLHEAIEPKVVHRDIKSSNILIDDEFNAKVSDFGLAKLL 339 (508)
Q Consensus 265 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~Dfgla~~~ 339 (508)
+|++|.+++... .. .++.+++.+|.+||+. +++|+|++|.||+++ ++.++++|||++...
T Consensus 80 ~g~~l~~~~~~~----~~-------~~~~~i~~~l~~lH~~---gi~H~Dl~~~Nil~~-~~~~~liDfg~a~~~ 139 (199)
T TIGR03724 80 EGKPLKDVIEEG----ND-------ELLREIGRLVGKLHKA---GIVHGDLTTSNIIVR-DDKLYLIDFGLGKYS 139 (199)
T ss_pred CCccHHHHHhhc----HH-------HHHHHHHHHHHHHHHC---CeecCCCCcceEEEE-CCcEEEEECCCCcCC
Confidence 999999987421 10 7889999999999999 999999999999999 789999999998754
|
Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine. |
| >KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.75 E-value=4.9e-19 Score=177.97 Aligned_cols=124 Identities=31% Similarity=0.512 Sum_probs=109.6
Q ss_pred ceeeEEEeecCCCCHHHHHhhhhccCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCEEEcCCCcEEEEecC
Q 010519 255 VHRMLVYEYVNNGNLEQWLHGAMRNQGNLTWEARMKVIIGTAKALAYLHEAIEPKVVHRDIKSSNILIDDEFNAKVSDFG 334 (508)
Q Consensus 255 ~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~Dfg 334 (508)
.++||.|++|...+|.+||... ......++.....++.|++.|+.| + +.+|+|+||.||++..+..+||.|||
T Consensus 329 ~~lyI~Mn~c~~~tledWl~rr-~~~e~~s~s~~~~~~~q~~~~~~y---k---~~ihrdlkp~nif~~~d~q~kIgDFg 401 (516)
T KOG1033|consen 329 VYLYIQMNLCEKETLEDWLRRR-RTGEERSLSLMLDIFKQIAPAVEY---K---GLIHRDLKPSNIFFSDDDQLKIGDFG 401 (516)
T ss_pred cchhhhhhhhhhhhHHHHhhCC-CcccccchhHHHHHHHhhccchhh---c---cchhhhccccccccccchhhhhhhhh
Confidence 3578999999999999999643 345567888899999999999999 6 89999999999999999999999999
Q ss_pred CccccCCCC-----CcccccccccccccCccccCCCCCCChhhHHHHHHHHHHHHh
Q 010519 335 LAKLLDSGE-----SHITTRVMGTFGYVAPEYANTGMLNEKSDIYSFGVLLLEAVT 385 (508)
Q Consensus 335 la~~~~~~~-----~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~ellt 385 (508)
+........ ....+..+||..||+||.+.+..|+.++||||||+||+||+.
T Consensus 402 l~ts~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g~~y~~kvdIyaLGlil~EL~~ 457 (516)
T KOG1033|consen 402 LVTSQDKDETVAPAAASHTQQVGTLLYMSPEQIRGQQYSEKVDIYALGLILAELLI 457 (516)
T ss_pred heeecccCCcccchhhhhhhcccccccCCHHHHhhhhhhhhcchhhHHHHHHHHHH
Confidence 998765544 234566789999999999999999999999999999999998
|
|
| >PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated | Back alignment and domain information |
|---|
Probab=99.74 E-value=1.9e-17 Score=177.33 Aligned_cols=141 Identities=21% Similarity=0.369 Sum_probs=114.1
Q ss_pred HHhhCCcccceeEeeeCceEEEEEEEcCCCEEEEEEEcccc--------hhhHHHHHHHHHHHhcCCCCCceeEEEEEEe
Q 010519 182 EIATNRFSAENVLGEGGYGVVYKGRLINGSEVAVKKLLNNL--------GQAEKEFRVEVEAIGHVRHKNLVRLLGYCIE 253 (508)
Q Consensus 182 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~--------~~~~~~~~~ei~~l~~l~h~niv~~~~~~~~ 253 (508)
......|...+.||+|+||+||+|.+.. ..+++|+..... ......+..|++++..++|++++..+.++..
T Consensus 329 ~~~~~~~~~~~~iG~G~~g~Vy~~~~~~-~~~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~ 407 (535)
T PRK09605 329 EEVKRRKIPDHLIGKGAEADIKKGEYLG-RDAVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVIYDVD 407 (535)
T ss_pred cccccccCccceeccCCcEEEEEEeecC-ccceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEEEEEe
Confidence 3334456778999999999999998744 445555432211 1123467889999999999999988888887
Q ss_pred CceeeEEEeecCCCCHHHHHhhhhccCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCEEEcCCCcEEEEec
Q 010519 254 GVHRMLVYEYVNNGNLEQWLHGAMRNQGNLTWEARMKVIIGTAKALAYLHEAIEPKVVHRDIKSSNILIDDEFNAKVSDF 333 (508)
Q Consensus 254 ~~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~Df 333 (508)
....++||||+++++|.+++. ....++.+++++|.|||+. +++||||||+|||+ +++.++|+||
T Consensus 408 ~~~~~lv~E~~~g~~L~~~l~------------~~~~~~~~i~~~L~~lH~~---giiHrDlkp~NILl-~~~~~~liDF 471 (535)
T PRK09605 408 PEEKTIVMEYIGGKDLKDVLE------------GNPELVRKVGEIVAKLHKA---GIVHGDLTTSNFIV-RDDRLYLIDF 471 (535)
T ss_pred CCCCEEEEEecCCCcHHHHHH------------HHHHHHHHHHHHHHHHHhC---CCccCCCChHHEEE-ECCcEEEEeC
Confidence 778899999999999999874 3467899999999999999 99999999999999 6779999999
Q ss_pred CCcccc
Q 010519 334 GLAKLL 339 (508)
Q Consensus 334 gla~~~ 339 (508)
|+++..
T Consensus 472 Gla~~~ 477 (535)
T PRK09605 472 GLGKYS 477 (535)
T ss_pred cccccC
Confidence 999853
|
|
| >cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain | Back alignment and domain information |
|---|
Probab=99.72 E-value=4.4e-17 Score=151.82 Aligned_cols=139 Identities=19% Similarity=0.166 Sum_probs=109.1
Q ss_pred CCcccceeEeeeCceEEEEEEEcCCCEEEEEEEcccch----------------------hhHHHHHHHHHHHhcCCCCC
Q 010519 186 NRFSAENVLGEGGYGVVYKGRLINGSEVAVKKLLNNLG----------------------QAEKEFRVEVEAIGHVRHKN 243 (508)
Q Consensus 186 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~----------------------~~~~~~~~ei~~l~~l~h~n 243 (508)
..|.+.+.||+|+||.||++...+|+.||||++..... .....+..|+..+..+.|++
T Consensus 15 ~~~~~~~~i~~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~ 94 (198)
T cd05144 15 VVESLGNQIGVGKESDVYLALDPDGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALKALYEEG 94 (198)
T ss_pred chhhcCCccccCcceEEEEEEcCCCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHHHHHHcC
Confidence 34888899999999999999887899999998653221 01123567888888887774
Q ss_pred --ceeEEEEEEeCceeeEEEeecCCCCHHHHHhhhhccCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCEE
Q 010519 244 --LVRLLGYCIEGVHRMLVYEYVNNGNLEQWLHGAMRNQGNLTWEARMKVIIGTAKALAYLHEAIEPKVVHRDIKSSNIL 321 (508)
Q Consensus 244 --iv~~~~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiH~Dlk~~NIl 321 (508)
+...++ ....++||||+++++|..+.. ......++.+++.++.++|+. +++|+||+|.||+
T Consensus 95 i~v~~~~~----~~~~~lv~e~~~g~~L~~~~~----------~~~~~~~~~~i~~~l~~lh~~---gi~H~Dl~p~Nil 157 (198)
T cd05144 95 FPVPKPID----WNRHAVVMEYIDGVELYRVRV----------LEDPEEVLDEILEEIVKAYKH---GIIHGDLSEFNIL 157 (198)
T ss_pred CCCCceee----cCCceEEEEEeCCcchhhccc----------cccHHHHHHHHHHHHHHHHHC---CCCcCCCCcccEE
Confidence 444444 234589999999999876531 023467888999999999998 9999999999999
Q ss_pred EcCCCcEEEEecCCccccCC
Q 010519 322 IDDEFNAKVSDFGLAKLLDS 341 (508)
Q Consensus 322 l~~~~~~kl~Dfgla~~~~~ 341 (508)
+++++.++|+|||++.....
T Consensus 158 l~~~~~~~liDfg~~~~~~~ 177 (198)
T cd05144 158 VDDDEKIYIIDWPQMVSTDH 177 (198)
T ss_pred EcCCCcEEEEECCccccCCC
Confidence 99999999999999975543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom |
| >cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Probab=99.64 E-value=1.5e-15 Score=133.83 Aligned_cols=135 Identities=19% Similarity=0.182 Sum_probs=112.3
Q ss_pred cceeEeeeCceEEEEEEEcCCCEEEEEEEcccchhhHHHHHHHHHHHhcCCC--CCceeEEEEEEeCceeeEEEeecCCC
Q 010519 190 AENVLGEGGYGVVYKGRLINGSEVAVKKLLNNLGQAEKEFRVEVEAIGHVRH--KNLVRLLGYCIEGVHRMLVYEYVNNG 267 (508)
Q Consensus 190 ~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~ei~~l~~l~h--~niv~~~~~~~~~~~~~lv~E~~~~g 267 (508)
+.+.||.|.++.||++.. ++..+++|....... ...+..|+..+..+.| .+++++++++...+..+++|||++++
T Consensus 2 ~~~~i~~g~~~~v~~~~~-~~~~~~iK~~~~~~~--~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~~~~~~v~e~~~g~ 78 (155)
T cd05120 2 SIKLLKGGLTNRVYLLGT-KDEDYVLKINPSREK--GADREREVAILQLLARKGLPVPKVLASGESDGWSYLLMEWIEGE 78 (155)
T ss_pred cceecccccccceEEEEe-cCCeEEEEecCCCCc--hhHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCccEEEEEecCCe
Confidence 357899999999999987 447899998755433 4568889999999976 58999999888778889999999887
Q ss_pred CHHHHHhhhhccCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCEEEcCCCcEEEEecCCccc
Q 010519 268 NLEQWLHGAMRNQGNLTWEARMKVIIGTAKALAYLHEAIEPKVVHRDIKSSNILIDDEFNAKVSDFGLAKL 338 (508)
Q Consensus 268 sL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~Dfgla~~ 338 (508)
.+..+ +......++.++++++.+||....++++|+||+|+||+++..+.++++|||.+..
T Consensus 79 ~~~~~-----------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~~ 138 (155)
T cd05120 79 TLDEV-----------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAGY 138 (155)
T ss_pred ecccC-----------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEEEecccccC
Confidence 66543 4456677889999999999986445799999999999999989999999998874
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves |
| >cd05119 RIO RIO kinase family, catalytic domain | Back alignment and domain information |
|---|
Probab=99.64 E-value=1.4e-15 Score=140.26 Aligned_cols=137 Identities=21% Similarity=0.232 Sum_probs=98.1
Q ss_pred ceeEeeeCceEEEEEEEcCCCEEEEEEEcccchhh---HHH---------------------HHHHHHHHhcCCCC--Cc
Q 010519 191 ENVLGEGGYGVVYKGRLINGSEVAVKKLLNNLGQA---EKE---------------------FRVEVEAIGHVRHK--NL 244 (508)
Q Consensus 191 ~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~---~~~---------------------~~~ei~~l~~l~h~--ni 244 (508)
.+.||+|+||+||+|.+.+|+.||||.+....... ... ...|...+..+.+. .+
T Consensus 2 ~~~lg~G~~g~Vy~a~~~~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~ 81 (187)
T cd05119 2 GGPIGTGKEADVYLALDGDGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGVPV 81 (187)
T ss_pred CcccccccceeEEEEECCCCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCCCC
Confidence 46799999999999998789999999876432111 111 13455556555433 24
Q ss_pred eeEEEEEEeCceeeEEEeecCCCCHHHH-HhhhhccCCCccHHHHHHHHHHHHHHHHHHHh-cCCCCeEeecCCCCCEEE
Q 010519 245 VRLLGYCIEGVHRMLVYEYVNNGNLEQW-LHGAMRNQGNLTWEARMKVIIGTAKALAYLHE-AIEPKVVHRDIKSSNILI 322 (508)
Q Consensus 245 v~~~~~~~~~~~~~lv~E~~~~gsL~~~-l~~~~~~~~~l~~~~~~~i~~~i~~al~yLH~-~~~~~iiH~Dlk~~NIll 322 (508)
...+++ ...++||||++++.+... +... . .. .....++.+++.++.++|. . +|+|+||||+||++
T Consensus 82 ~~~~~~----~~~~lv~e~~~g~~~~~~~l~~~-~----~~-~~~~~~~~~~~~~l~~lh~~~---~ivH~Dl~p~Nili 148 (187)
T cd05119 82 PKPIDL----NRHVLVMEFIGGDGIPAPRLKDV-R----LL-EDPEELYDQILELMRKLYREA---GLVHGDLSEYNILV 148 (187)
T ss_pred CceEec----CCCEEEEEEeCCCCccChhhhhh-h----hc-ccHHHHHHHHHHHHHHHhhcc---CcCcCCCChhhEEE
Confidence 444443 245899999998543321 1110 0 11 5678899999999999998 7 99999999999999
Q ss_pred cCCCcEEEEecCCccccCC
Q 010519 323 DDEFNAKVSDFGLAKLLDS 341 (508)
Q Consensus 323 ~~~~~~kl~Dfgla~~~~~ 341 (508)
+ ++.++|+|||.+.....
T Consensus 149 ~-~~~~~liDfg~a~~~~~ 166 (187)
T cd05119 149 D-DGKVYIIDVPQAVEIDH 166 (187)
T ss_pred E-CCcEEEEECcccccccC
Confidence 9 88999999999975543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct |
| >PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.62 E-value=6.1e-15 Score=141.15 Aligned_cols=135 Identities=20% Similarity=0.255 Sum_probs=104.4
Q ss_pred eeEe-eeCceEEEEEEEcCCCEEEEEEEcccc-------------hhhHHHHHHHHHHHhcCCCCCc--eeEEEEEEeCc
Q 010519 192 NVLG-EGGYGVVYKGRLINGSEVAVKKLLNNL-------------GQAEKEFRVEVEAIGHVRHKNL--VRLLGYCIEGV 255 (508)
Q Consensus 192 ~~lg-~G~~g~Vy~~~~~~~~~vavK~~~~~~-------------~~~~~~~~~ei~~l~~l~h~ni--v~~~~~~~~~~ 255 (508)
..|| .|+.|+||.+.. ++..+++|.+.... ......+.+|+.++.++.|++| +..+++.....
T Consensus 37 ~~lg~~~g~gtv~~v~~-~~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~~~ 115 (239)
T PRK01723 37 RVVGSAKGRGTTWFVQT-PGVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARVVRH 115 (239)
T ss_pred ceeecCCCCccEEEEEe-CCceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeeeeec
Confidence 4687 889999999977 57889998774311 1223457789999999998775 67777654432
Q ss_pred ----eeeEEEeecCC-CCHHHHHhhhhccCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCEEEcCCCcEEE
Q 010519 256 ----HRMLVYEYVNN-GNLEQWLHGAMRNQGNLTWEARMKVIIGTAKALAYLHEAIEPKVVHRDIKSSNILIDDEFNAKV 330 (508)
Q Consensus 256 ----~~~lv~E~~~~-gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl 330 (508)
..++||||++| .+|.+++.. ..++.. .+.+|+.+|.+||+. ||+|+||||.|||++.++.++|
T Consensus 116 ~~~~~~~lV~e~l~G~~~L~~~l~~-----~~l~~~----~~~~i~~~l~~lH~~---GI~HrDlkp~NILv~~~~~v~L 183 (239)
T PRK01723 116 GLFYRADILIERIEGARDLVALLQE-----APLSEE----QWQAIGQLIARFHDA---GVYHADLNAHNILLDPDGKFWL 183 (239)
T ss_pred CcceeeeEEEEecCCCCCHHHHHhc-----CCCCHH----HHHHHHHHHHHHHHC---CCCCCCCCchhEEEcCCCCEEE
Confidence 22599999997 699988742 234443 356889999999999 9999999999999999899999
Q ss_pred EecCCcccc
Q 010519 331 SDFGLAKLL 339 (508)
Q Consensus 331 ~Dfgla~~~ 339 (508)
+|||.+...
T Consensus 184 IDfg~~~~~ 192 (239)
T PRK01723 184 IDFDRGELR 192 (239)
T ss_pred EECCCcccC
Confidence 999988753
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.60 E-value=4.7e-17 Score=174.15 Aligned_cols=256 Identities=20% Similarity=0.281 Sum_probs=188.2
Q ss_pred CcccceeEeeeCceEEEEEEEcCCC--EEEEEEEcccc--hhhHHHHHHHHHHHhcCC-CCCceeEEEEEEeCceeeEEE
Q 010519 187 RFSAENVLGEGGYGVVYKGRLINGS--EVAVKKLLNNL--GQAEKEFRVEVEAIGHVR-HKNLVRLLGYCIEGVHRMLVY 261 (508)
Q Consensus 187 ~~~~~~~lg~G~~g~Vy~~~~~~~~--~vavK~~~~~~--~~~~~~~~~ei~~l~~l~-h~niv~~~~~~~~~~~~~lv~ 261 (508)
.|.+.+.||+|+|+.|-......+. .+|+|.+.... .........|..+-..+. |+|++.+++...+....+++.
T Consensus 21 ~~~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~~~~~~~~~ 100 (601)
T KOG0590|consen 21 QYKLSRSIGKGSFSSSALASNSRDPESSSATKPISIPPKSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSSPRSYLLSL 100 (601)
T ss_pred cccccccccccccchhhhhhhcCCCcceeeccCCCCCCCccchhhhcCccccccccccccccccccCCccCCCccccccc
Confidence 5666777999999999888654333 45555443332 222234455777777776 999999999999999999999
Q ss_pred eecCCCCHHHHHhhhhccCCCccHHHHHHHHHHHHHHHHHHH-hcCCCCeEeecCCCCCEEEcCCC-cEEEEecCCcccc
Q 010519 262 EYVNNGNLEQWLHGAMRNQGNLTWEARMKVIIGTAKALAYLH-EAIEPKVVHRDIKSSNILIDDEF-NAKVSDFGLAKLL 339 (508)
Q Consensus 262 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~yLH-~~~~~~iiH~Dlk~~NIll~~~~-~~kl~Dfgla~~~ 339 (508)
+|..++++++.+.. ......+...+-.++.|+..++.|+| .. ++.|+||||+|.+++..+ .++++|||++..+
T Consensus 101 ~~s~g~~~f~~i~~--~~~~~~~~~~~~~~~~ql~s~l~~~H~~~---~~~h~~ikP~n~~l~~s~~~l~~~df~~At~~ 175 (601)
T KOG0590|consen 101 SYSDGGSLFSKISH--PDSTGTSSSSASRYLPQLNSGLSYLHPEN---GVTHRDIKPSNSLLDESGSALKIADFGLATAY 175 (601)
T ss_pred Cccccccccccccc--CCccCCCCcchhhhhhhhccCccccCccc---ccccCCCCCccchhccCCCcccCCCchhhccc
Confidence 99999999987720 22224566677789999999999999 77 999999999999999999 9999999999866
Q ss_pred CC--CCCcccccccc-cccccCccccCCC-CCCChhhHHHHHHHHHHHHhCCCCCCCCCCCchhcHHHHHHHHhcccccc
Q 010519 340 DS--GESHITTRVMG-TFGYVAPEYANTG-MLNEKSDIYSFGVLLLEAVTGRDPVDYGRPANEVNLVEWLKMMVGTRRAE 415 (508)
Q Consensus 340 ~~--~~~~~~~~~~g-t~~y~aPE~~~~~-~~~~~~DvwS~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~ 415 (508)
.. +........+| ++.|+|||...+. ...+..|+||.|+++.-+++|..|+......... +..|....
T Consensus 176 ~~~~g~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~~~~-~~~~~~~~------- 247 (601)
T KOG0590|consen 176 RNKNGAERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFPSRKDGR-YSSWKSNK------- 247 (601)
T ss_pred cccCCcceeeecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCCcccccccccc-ceeecccc-------
Confidence 54 44444556678 9999999999884 5568899999999999999999998765543311 11111110
Q ss_pred cccCCCCCCChhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHh
Q 010519 416 EVVDPNLEVKPATRALKRSLLVALRCVDPDSEKRPKMSQVVRML 459 (508)
Q Consensus 416 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L 459 (508)
..+...+..........+..+++..+|..|.+.+++-..=
T Consensus 248 ----~~~~~~~~~~~~~~~~~~l~k~l~~~~~~r~s~~~~~~d~ 287 (601)
T KOG0590|consen 248 ----GRFTQLPWNSISDQAHDLLHKILKENPSNRLSIEELKLDN 287 (601)
T ss_pred ----cccccCccccCChhhhhcccccccCCchhccccccccccc
Confidence 1111222223334455577789999999999998876543
|
|
| >KOG1266 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.56 E-value=6.9e-15 Score=139.67 Aligned_cols=209 Identities=22% Similarity=0.290 Sum_probs=147.1
Q ss_pred HHHHHhcCCCCCceeEEEEEEeCc-----eeeEEEeecCCCCHHHHHhhhhccCCCccHHHHHHHHHHHHHHHHHHHhcC
Q 010519 232 EVEAIGHVRHKNLVRLLGYCIEGV-----HRMLVYEYVNNGNLEQWLHGAMRNQGNLTWEARMKVIIGTAKALAYLHEAI 306 (508)
Q Consensus 232 ei~~l~~l~h~niv~~~~~~~~~~-----~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~ 306 (508)
-+..+-++-|.|||+++.|+.+.. ...++.|||..|+|..+|+.....+..+......+++.||+.||.|||+ +
T Consensus 117 vFdnllqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs-~ 195 (458)
T KOG1266|consen 117 VFDNLLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKNQKALFQKAWKKWCTQILSALSYLHS-C 195 (458)
T ss_pred HHHHHHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhc-c
Confidence 344455667999999999886543 3578999999999999999887888889999999999999999999998 6
Q ss_pred CCCeEeecCCCCCEEEcCCCcEEEEecCCccccCCCC----CcccccccccccccCccccCCCCCCChhhHHHHHHHHHH
Q 010519 307 EPKVVHRDIKSSNILIDDEFNAKVSDFGLAKLLDSGE----SHITTRVMGTFGYVAPEYANTGMLNEKSDIYSFGVLLLE 382 (508)
Q Consensus 307 ~~~iiH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~~~----~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~e 382 (508)
.|+|+|+++.-+.|++..+|-+|+.- +.-....... ........+.++|.|||.=.....+-++|||+||+...+
T Consensus 196 ~PpiihgnlTc~tifiq~ngLIkig~-~ap~s~h~s~~~~~~~Ek~~~~~~~g~~a~~sg~~tn~~~a~dIy~fgmcAle 274 (458)
T KOG1266|consen 196 DPPIIHGNLTCDTIFIQHNGLIKIGS-VAPDSTHPSVNSTREAEKSVNTSLPGFSAPESGTTTNTTGASDIYKFGMCALE 274 (458)
T ss_pred CCccccCCcchhheeecCCceEEecc-cCccccchhhhhhhHhhhhccccCCccccCCcCcccccccchhhhhhhHHHHH
Confidence 89999999999999999998888752 2111111000 011122346788999998666666789999999999999
Q ss_pred HHhCCCCCCCCCCCchhcHHHHHHHHhcccccccccCCCCCCChhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhhc
Q 010519 383 AVTGRDPVDYGRPANEVNLVEWLKMMVGTRRAEEVVDPNLEVKPATRALKRSLLVALRCVDPDSEKRPKMSQVVRMLEA 461 (508)
Q Consensus 383 lltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~ 461 (508)
|..+..--..+...-. ..+.+.... ..+- ..+ -..++..|++..|..||+|.+++.|.-.
T Consensus 275 mailEiq~tnseS~~~--~ee~ia~~i-----~~le-n~l-----------qr~~i~kcl~~eP~~rp~ar~llfHpll 334 (458)
T KOG1266|consen 275 MAILEIQSTNSESKVE--VEENIANVI-----IGLE-NGL-----------QRGSITKCLEGEPNGRPDARLLLFHPLL 334 (458)
T ss_pred HHHheeccCCCcceee--hhhhhhhhe-----eecc-Ccc-----------ccCcCcccccCCCCCCcchhhhhcCcee
Confidence 9887654222211110 011010000 0000 000 1126779999999999999999887544
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.49 E-value=1.5e-13 Score=141.22 Aligned_cols=248 Identities=24% Similarity=0.300 Sum_probs=181.6
Q ss_pred CCcccceeEee--eCceEEEEEEE---cCCCEEEEEEEcccch--hhHHHHHHHHHHHhcC-CCCCceeEEEEEEeCcee
Q 010519 186 NRFSAENVLGE--GGYGVVYKGRL---INGSEVAVKKLLNNLG--QAEKEFRVEVEAIGHV-RHKNLVRLLGYCIEGVHR 257 (508)
Q Consensus 186 ~~~~~~~~lg~--G~~g~Vy~~~~---~~~~~vavK~~~~~~~--~~~~~~~~ei~~l~~l-~h~niv~~~~~~~~~~~~ 257 (508)
..|.+.+.+|. |.+|.||.+.. .++..+|+|+-..... .....=.+|+...+.+ .|+|.++.+..+..++..
T Consensus 114 ~~~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~s~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~~e~~~~l 193 (524)
T KOG0601|consen 114 QRFPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPFSPPLDSKRKLREFLSHHKIDSHENPVRDSPAWEGSGIL 193 (524)
T ss_pred hhcccccccccCCCCCceeecccCCcccCCcccccccccCCCCCccccccccchhhcccccCccccccccCcccccCCcc
Confidence 45677788999 99999999976 3678899887433222 2222233466666666 499999999988889999
Q ss_pred eEEEeecCCCCHHHHHhhhhccCCCccHHHHHHHHHHHHH----HHHHHHhcCCCCeEeecCCCCCEEEcCC-CcEEEEe
Q 010519 258 MLVYEYVNNGNLEQWLHGAMRNQGNLTWEARMKVIIGTAK----ALAYLHEAIEPKVVHRDIKSSNILIDDE-FNAKVSD 332 (508)
Q Consensus 258 ~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~----al~yLH~~~~~~iiH~Dlk~~NIll~~~-~~~kl~D 332 (508)
|+-.|++. .+|.++.+. ....++....+....+..+ ||.++|.. +++|-|+||.||++..+ ...+++|
T Consensus 194 fiqtE~~~-~sl~~~~~~---~~~~~p~~~l~~~~~~~~~~~~~al~~~hs~---~~~~~~~kp~~i~~~~~~~s~~~~d 266 (524)
T KOG0601|consen 194 FIQTELCG-ESLQSYCHT---PCNFLPDNLLWNSLRDWLSRDVTALSHLHSN---NIVHDDLKPANIFTTSDWTSCKLTD 266 (524)
T ss_pred eeeecccc-chhHHhhhc---ccccCCchhhhhHHhhhhhcccccccccCCC---cccccccchhheecccccceeecCC
Confidence 99999994 688888763 3344777788888888888 99999999 99999999999999999 8899999
Q ss_pred cCCccccCCCCCc----ccccccccccccCccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCCCchhcHHHHHHHH
Q 010519 333 FGLAKLLDSGESH----ITTRVMGTFGYVAPEYANTGMLNEKSDIYSFGVLLLEAVTGRDPVDYGRPANEVNLVEWLKMM 408 (508)
Q Consensus 333 fgla~~~~~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~ 408 (508)
||+...+.+.... ......|...|++||..++ .++...|+|++|.++.+..++..++..+... .|...
T Consensus 267 f~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~-l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~------~W~~~- 338 (524)
T KOG0601|consen 267 FGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNG-LATFASDIFSLGEVILEAILGSHLPSVGKNS------SWSQL- 338 (524)
T ss_pred cceeEEccCCccccceeeeecCCCCceEeChhhhcc-ccchHhhhcchhhhhHhhHhhcccccCCCCC------Ccccc-
Confidence 9999887665421 1233467889999999876 6789999999999999999988776544211 12111
Q ss_pred hcccccccccCCCCCCChhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 010519 409 VGTRRAEEVVDPNLEVKPATRALKRSLLVALRCVDPDSEKRPKMSQVVR 457 (508)
Q Consensus 409 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 457 (508)
+... +..........++...+..+++.+|..|++.+.+..
T Consensus 339 ------r~~~---ip~e~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~ 378 (524)
T KOG0601|consen 339 ------RQGY---IPLEFCEGGSSSLRSVTSQMLDEDPRLRLTAQILTA 378 (524)
T ss_pred ------cccc---CchhhhcCcchhhhhHHHHhcCcchhhhhHHHHHhc
Confidence 0000 111111122233344778899999999999887764
|
|
| >TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase | Back alignment and domain information |
|---|
Probab=99.47 E-value=3.6e-13 Score=139.97 Aligned_cols=142 Identities=22% Similarity=0.285 Sum_probs=99.8
Q ss_pred ceeEeeeCceEEEEEEEcCCCEEEEEEEcccchhhH----------------------------------------HHHH
Q 010519 191 ENVLGEGGYGVVYKGRLINGSEVAVKKLLNNLGQAE----------------------------------------KEFR 230 (508)
Q Consensus 191 ~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~----------------------------------------~~~~ 230 (508)
.+.||.|++|.||+|++.+|+.||||+......... -.|.
T Consensus 122 ~~plasaSigQVh~A~l~~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~Eldf~ 201 (437)
T TIGR01982 122 EKPLAAASIAQVHRARLVDGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRELDLR 201 (437)
T ss_pred CcceeeeehhheEEEEecCCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHHHCHH
Confidence 357999999999999999999999999865431110 0133
Q ss_pred HHHHHHhcC----CCCCceeEEEEEEe-CceeeEEEeecCCCCHHHHHhhhhccCCCccHHHHHHHHHHHHH-HHHHHHh
Q 010519 231 VEVEAIGHV----RHKNLVRLLGYCIE-GVHRMLVYEYVNNGNLEQWLHGAMRNQGNLTWEARMKVIIGTAK-ALAYLHE 304 (508)
Q Consensus 231 ~ei~~l~~l----~h~niv~~~~~~~~-~~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~-al~yLH~ 304 (508)
.|...+.++ .|.+-+.+-.++.+ ....++||||++|++|.+++... .... ....++..++. .+..+|.
T Consensus 202 ~Ea~n~~~~~~~~~~~~~v~vP~v~~~~~~~~vLvmE~i~G~~L~~~~~~~---~~~~---~~~~ia~~~~~~~l~ql~~ 275 (437)
T TIGR01982 202 REAANASELGENFKNDPGVYVPEVYWDRTSERVLTMEWIDGIPLSDIAALD---EAGL---DRKALAENLARSFLNQVLR 275 (437)
T ss_pred HHHHHHHHHHHhcCCCCCEEeCCEehhhcCCceEEEEeECCcccccHHHHH---hcCC---CHHHHHHHHHHHHHHHHHh
Confidence 444444444 23333444444432 44578999999999999876421 1112 23345555555 4678888
Q ss_pred cCCCCeEeecCCCCCEEEcCCCcEEEEecCCccccCC
Q 010519 305 AIEPKVVHRDIKSSNILIDDEFNAKVSDFGLAKLLDS 341 (508)
Q Consensus 305 ~~~~~iiH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~ 341 (508)
. |++|+|++|.||++++++.++|+|||++..+..
T Consensus 276 ~---g~~H~D~hPgNilv~~~g~i~liDfG~~~~l~~ 309 (437)
T TIGR01982 276 D---GFFHADLHPGNIFVLKDGKIIALDFGIVGRLSE 309 (437)
T ss_pred C---CceeCCCCcccEEECCCCcEEEEeCCCeeECCH
Confidence 8 999999999999999999999999999987653
|
This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species. |
| >PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed | Back alignment and domain information |
|---|
Probab=99.36 E-value=7.1e-13 Score=139.44 Aligned_cols=144 Identities=19% Similarity=0.212 Sum_probs=97.0
Q ss_pred hCCcccceeEeeeCceEEEEEEEcC-CCEEEEEEEcccchhh----------------------------------HHH-
Q 010519 185 TNRFSAENVLGEGGYGVVYKGRLIN-GSEVAVKKLLNNLGQA----------------------------------EKE- 228 (508)
Q Consensus 185 ~~~~~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~----------------------------------~~~- 228 (508)
...|.. +.||.|++|.||+|++.+ |+.||||++....... .+.
T Consensus 119 F~~fd~-~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~~l 197 (537)
T PRK04750 119 FDDFDI-KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEKTL 197 (537)
T ss_pred HHhcCh-hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHHHH
Confidence 345765 689999999999999877 9999999986543110 111
Q ss_pred -----HHHHHHHHhcC----CCCCceeEEEEEEe-CceeeEEEeecCCCCHHHHHhhhhccCC----CccHHHHHHHHHH
Q 010519 229 -----FRVEVEAIGHV----RHKNLVRLLGYCIE-GVHRMLVYEYVNNGNLEQWLHGAMRNQG----NLTWEARMKVIIG 294 (508)
Q Consensus 229 -----~~~ei~~l~~l----~h~niv~~~~~~~~-~~~~~lv~E~~~~gsL~~~l~~~~~~~~----~l~~~~~~~i~~~ 294 (508)
+..|...+.++ .+.+.+.+-.++++ ....+|||||++|++|.++-.- ...+ .+....+..++.|
T Consensus 198 ~~ElD~~~Ea~N~~~~~~~f~~~~~v~VP~v~~d~st~~VLvmE~i~G~~l~d~~~l--~~~g~d~~~la~~~v~~~~~Q 275 (537)
T PRK04750 198 HDELDLMREAANASQLRRNFEDSDMLYVPEVYWDYCSETVMVMERMYGIPVSDVAAL--RAAGTDMKLLAERGVEVFFTQ 275 (537)
T ss_pred HHhhCHHHHHHHHHHHHHHccCCCCeecceeecccCCCceEEEeeecCccHHhHHHH--HhcCCCHHHHHHHHHHHHHHH
Confidence 33344444333 24445555555554 4567899999999999875311 1111 2333333333333
Q ss_pred HHHHHHHHHhcCCCCeEeecCCCCCEEEcCCC----cEEEEecCCccccCC
Q 010519 295 TAKALAYLHEAIEPKVVHRDIKSSNILIDDEF----NAKVSDFGLAKLLDS 341 (508)
Q Consensus 295 i~~al~yLH~~~~~~iiH~Dlk~~NIll~~~~----~~kl~Dfgla~~~~~ 341 (508)
+ ... |++|+|++|.||+++.++ .++++|||++..+..
T Consensus 276 i-------f~~---GffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l~~ 316 (537)
T PRK04750 276 V-------FRD---GFFHADMHPGNIFVSYDPPENPRYIALDFGIVGSLNK 316 (537)
T ss_pred H-------HhC---CeeeCCCChHHeEEecCCCCCCeEEEEecceEEECCH
Confidence 3 345 999999999999999988 999999999987643
|
|
| >cd05151 ChoK Choline Kinase (ChoK) | Back alignment and domain information |
|---|
Probab=99.32 E-value=5.1e-12 Score=114.33 Aligned_cols=130 Identities=18% Similarity=0.122 Sum_probs=94.3
Q ss_pred eeEeeeCceEEEEEEEcCCCEEEEEEEcccchhhHHHHHHHHHHHhcCCCCCcee-EEEEEEeCceeeEEEeecCCCCHH
Q 010519 192 NVLGEGGYGVVYKGRLINGSEVAVKKLLNNLGQAEKEFRVEVEAIGHVRHKNLVR-LLGYCIEGVHRMLVYEYVNNGNLE 270 (508)
Q Consensus 192 ~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~ei~~l~~l~h~niv~-~~~~~~~~~~~~lv~E~~~~gsL~ 270 (508)
+.|+.|.++.||+++. .+..+++|....... ....+..|+..+..+.+.++++ ++.+. ....++||||++|.++.
T Consensus 4 ~~l~~G~~~~vy~~~~-~~~~~~lK~~~~~~~-~~~~~~~E~~~l~~l~~~~~~P~~~~~~--~~~~~lv~e~i~G~~l~ 79 (170)
T cd05151 4 SPLKGGMTNKNYRVEV-ANKKYVVRIPGNGTE-LLINRENEAENSKLAAEAGIGPKLYYFD--PETGVLITEFIEGSELL 79 (170)
T ss_pred eecCCcccCceEEEEE-CCeEEEEEeCCCCcc-cccCHHHHHHHHHHHHHhCCCCceEEEe--CCCCeEEEEecCCCccc
Confidence 5688999999999987 578899998644322 1234567888888886555544 44432 33457999999998765
Q ss_pred HHHhhhhccCCCccHHHHHHHHHHHHHHHHHHHhcC--CCCeEeecCCCCCEEEcCCCcEEEEecCCccc
Q 010519 271 QWLHGAMRNQGNLTWEARMKVIIGTAKALAYLHEAI--EPKVVHRDIKSSNILIDDEFNAKVSDFGLAKL 338 (508)
Q Consensus 271 ~~l~~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~--~~~iiH~Dlk~~NIll~~~~~~kl~Dfgla~~ 338 (508)
+.. .....++.+++++|..||... ...++|+|++|.||+++ ++.++++||+.+..
T Consensus 80 ~~~------------~~~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~-~~~~~liDf~~a~~ 136 (170)
T cd05151 80 TED------------FSDPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD-DGRLWLIDWEYAGM 136 (170)
T ss_pred ccc------------ccCHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE-CCeEEEEecccccC
Confidence 420 011345678999999999872 12369999999999999 66899999998763
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph |
| >KOG1243 consensus Protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.32 E-value=3.3e-11 Score=125.27 Aligned_cols=167 Identities=20% Similarity=0.227 Sum_probs=126.0
Q ss_pred cCCCEEEEEEEcccchhhHHHHHHHHHHHhcCCCCCceeEEEEEEeCceeeEEEeecCCCCHHHHHhhhhccCCCccHHH
Q 010519 208 INGSEVAVKKLLNNLGQAEKEFRVEVEAIGHVRHKNLVRLLGYCIEGVHRMLVYEYVNNGNLEQWLHGAMRNQGNLTWEA 287 (508)
Q Consensus 208 ~~~~~vavK~~~~~~~~~~~~~~~ei~~l~~l~h~niv~~~~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~ 287 (508)
.++.+|.|...............+-++.|+.++||||++++..++.+...|+|+|-+. .|..++.. +....
T Consensus 35 ~~~~~vsVF~~~~~~~~~~~~~~~A~k~lKtlRHP~Il~yL~t~e~~~~~ylvTErV~--Pl~~~lk~-------l~~~~ 105 (690)
T KOG1243|consen 35 ADGGPVSVFVYKRSNGEVTELAKRAVKRLKTLRHPNILSYLDTTEEEGTLYLVTERVR--PLETVLKE-------LGKEE 105 (690)
T ss_pred ccCCceEEEEEeCCCchhhHHHHHHHHHhhhccCchhhhhhhhhcccCceEEEeeccc--cHHHHHHH-------hHHHH
Confidence 4788888888766555334556778889999999999999999999999999999984 78887753 23556
Q ss_pred HHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCEEEcCCCcEEEEecCCccccCCCCCcccccccccccccCccccCCCCC
Q 010519 288 RMKVIIGTAKALAYLHEAIEPKVVHRDIKSSNILIDDEFNAKVSDFGLAKLLDSGESHITTRVMGTFGYVAPEYANTGML 367 (508)
Q Consensus 288 ~~~i~~~i~~al~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~ 367 (508)
..--+.||+.||.|||+.+ +++|++|.-..|+|+..|+.||++|-++........ ......---.|..|+.+....
T Consensus 106 v~~Gl~qIl~AL~FL~~d~--~lvHgNv~~~SVfVn~~GeWkLggle~v~~~~~~~~-~~~~~~~~~s~~~P~~~~~s~- 181 (690)
T KOG1243|consen 106 VCLGLFQILAALSFLNDDC--NLVHGNVCKDSVFVNESGEWKLGGLELVSKASGFNA-PAKSLYLIESFDDPEEIDPSE- 181 (690)
T ss_pred HHHHHHHHHHHHHHHhccC--CeeeccEeeeeEEEcCCCcEEEeeeEEEeccccCCc-ccccchhhhcccChhhcCccc-
Confidence 6667889999999998544 899999999999999999999999998865432111 001111122456666554332
Q ss_pred CChhhHHHHHHHHHHHHhCCC
Q 010519 368 NEKSDIYSFGVLLLEAVTGRD 388 (508)
Q Consensus 368 ~~~~DvwS~Gvvl~elltG~~ 388 (508)
-..|.|-|||++++++.|..
T Consensus 182 -~s~D~~~Lg~li~el~ng~~ 201 (690)
T KOG1243|consen 182 -WSIDSWGLGCLIEELFNGSL 201 (690)
T ss_pred -cchhhhhHHHHHHHHhCccc
Confidence 34799999999999999943
|
|
| >KOG3087 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.22 E-value=3e-10 Score=100.55 Aligned_cols=144 Identities=17% Similarity=0.310 Sum_probs=107.7
Q ss_pred cceeEeeeCceEEEEEEEcCCCEEEEEEEcccc--------hhhHHHHHHHHHHHhcCCCCCceeEEEEEEeCceeeEEE
Q 010519 190 AENVLGEGGYGVVYKGRLINGSEVAVKKLLNNL--------GQAEKEFRVEVEAIGHVRHKNLVRLLGYCIEGVHRMLVY 261 (508)
Q Consensus 190 ~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~--------~~~~~~~~~ei~~l~~l~h~niv~~~~~~~~~~~~~lv~ 261 (508)
....|-+|+-+.|+++.+ .|+...||.-..+. .-......+|+..|.++.--.|.-..-++.+...-.|+|
T Consensus 11 ~l~likQGAEArv~~~~~-~Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D~~~~~i~M 89 (229)
T KOG3087|consen 11 SLELIKQGAEARVPRGSF-SGEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFIDTYGGQIYM 89 (229)
T ss_pred cceeeeccceeeEeeecc-CCceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEEecCCCeEEE
Confidence 456899999999999987 78877777443221 122356777999999887656665556677777778999
Q ss_pred eecCC-CCHHHHHhhhhccCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCEEEcCCCc---EEEEecCCcc
Q 010519 262 EYVNN-GNLEQWLHGAMRNQGNLTWEARMKVIIGTAKALAYLHEAIEPKVVHRDIKSSNILIDDEFN---AKVSDFGLAK 337 (508)
Q Consensus 262 E~~~~-gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiH~Dlk~~NIll~~~~~---~kl~Dfgla~ 337 (508)
||++| -++.+++.... ...........++..|-+.+.-||.+ +|||+||..+||++..++. +.++|||++.
T Consensus 90 E~~~g~~~vk~~i~~~~--~~~~~d~~~~~~~~~iG~~igklH~n---diiHGDLTTSNill~~~~~~~~~~lIdfgls~ 164 (229)
T KOG3087|consen 90 EFIDGASTVKDFILSTM--EDESEDEGLAELARRIGELIGKLHDN---DIIHGDLTTSNILLRSDGNQITPILIDFGLSS 164 (229)
T ss_pred EeccchhHHHHHHHHHc--cCcccchhHHHHHHHHHHHHHHhhhC---CeecccccccceEEecCCCcCceEEEeecchh
Confidence 99976 37888886432 22223333477888999999999999 9999999999999976554 5899999987
Q ss_pred cc
Q 010519 338 LL 339 (508)
Q Consensus 338 ~~ 339 (508)
.-
T Consensus 165 ~s 166 (229)
T KOG3087|consen 165 VS 166 (229)
T ss_pred cc
Confidence 53
|
|
| >cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain | Back alignment and domain information |
|---|
Probab=99.21 E-value=2.4e-10 Score=105.03 Aligned_cols=137 Identities=17% Similarity=0.171 Sum_probs=97.3
Q ss_pred eeEeeeCceEEEEEEEcC-------CCEEEEEEEcccc----------------------hhhHHHHH----HHHHHHhc
Q 010519 192 NVLGEGGYGVVYKGRLIN-------GSEVAVKKLLNNL----------------------GQAEKEFR----VEVEAIGH 238 (508)
Q Consensus 192 ~~lg~G~~g~Vy~~~~~~-------~~~vavK~~~~~~----------------------~~~~~~~~----~ei~~l~~ 238 (508)
..||.|--+.||.|...+ +..+|||...... ......+. .|+..|.+
T Consensus 3 g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~r 82 (197)
T cd05146 3 GCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLKR 82 (197)
T ss_pred CccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHHH
Confidence 468999999999997543 4789999774211 00012233 78999988
Q ss_pred CCC--CCceeEEEEEEeCceeeEEEeecCCCCHHHHHhhhhccCCCccHHHHHHHHHHHHHHHHHH-HhcCCCCeEeecC
Q 010519 239 VRH--KNLVRLLGYCIEGVHRMLVYEYVNNGNLEQWLHGAMRNQGNLTWEARMKVIIGTAKALAYL-HEAIEPKVVHRDI 315 (508)
Q Consensus 239 l~h--~niv~~~~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~yL-H~~~~~~iiH~Dl 315 (508)
+.. -++..++++ ...+|||||+.+..+..-. .....++......+..+++.+|..| |.. +++|+||
T Consensus 83 l~~~Gv~vP~pi~~----~~~~lvME~Ig~~~~~~~~----Lkd~~~~~~~~~~i~~~i~~~l~~l~H~~---glVHGDL 151 (197)
T cd05146 83 MQKAGIPCPEVVVL----KKHVLVMSFIGDDQVPAPK----LKDAKLNDEEMKNAYYQVLSMMKQLYKEC---NLVHADL 151 (197)
T ss_pred HHHcCCCCCeEEEe----cCCEEEEEEcCCCCccchh----hhccccCHHHHHHHHHHHHHHHHHHHHhC---CeecCCC
Confidence 853 456666654 4567999999765442211 1122344556677888999999998 888 9999999
Q ss_pred CCCCEEEcCCCcEEEEecCCccccC
Q 010519 316 KSSNILIDDEFNAKVSDFGLAKLLD 340 (508)
Q Consensus 316 k~~NIll~~~~~~kl~Dfgla~~~~ 340 (508)
++.|||+++ +.+.|+|||.+....
T Consensus 152 s~~NIL~~~-~~v~iIDF~qav~~~ 175 (197)
T cd05146 152 SEYNMLWHD-GKVWFIDVSQSVEPT 175 (197)
T ss_pred CHHHEEEEC-CcEEEEECCCceeCC
Confidence 999999974 689999999987654
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown. |
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.17 E-value=1.6e-11 Score=126.44 Aligned_cols=249 Identities=23% Similarity=0.232 Sum_probs=171.8
Q ss_pred HHhhCCcccceeEeeeCceEEEEEEEc--CCCEEEEEEEcccchhhHHH--HHHHHHHHhcC-CCCCceeEEEEEEeCce
Q 010519 182 EIATNRFSAENVLGEGGYGVVYKGRLI--NGSEVAVKKLLNNLGQAEKE--FRVEVEAIGHV-RHKNLVRLLGYCIEGVH 256 (508)
Q Consensus 182 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~--~~~~vavK~~~~~~~~~~~~--~~~ei~~l~~l-~h~niv~~~~~~~~~~~ 256 (508)
-....+|..+..||.|.|+.|+..... ++..+++|.+.+.......+ -..|+.+...+ .|.++++.+..+..-..
T Consensus 261 s~~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~r~ 340 (524)
T KOG0601|consen 261 SCKLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQLRQ 340 (524)
T ss_pred eeecCCcceeEEccCCccccceeeeecCCCCceEeChhhhccccchHhhhcchhhhhHhhHhhcccccCCCCCCcccccc
Confidence 344567889999999999999998643 67889999876655332221 12255555555 48888888777777777
Q ss_pred eeEEEeecCCCCHHHHHhhhhccCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCEEEcCC-CcEEEEecCC
Q 010519 257 RMLVYEYVNNGNLEQWLHGAMRNQGNLTWEARMKVIIGTAKALAYLHEAIEPKVVHRDIKSSNILIDDE-FNAKVSDFGL 335 (508)
Q Consensus 257 ~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiH~Dlk~~NIll~~~-~~~kl~Dfgl 335 (508)
.|+=-|||.++++...+ .....+.+...+++..+++.++.++|+. .++|+|++|+||++..+ +..+++|||.
T Consensus 341 ~~ip~e~~~~~s~~l~~----~~~~~~d~~~~~~~~~q~~~~l~~i~s~---~~~~~d~~psni~i~~~~~~~~~~~~~~ 413 (524)
T KOG0601|consen 341 GYIPLEFCEGGSSSLRS----VTSQMLDEDPRLRLTAQILTALNVIHSK---LFVHLDVKPSNILISNDGFFSKLGDFGC 413 (524)
T ss_pred ccCchhhhcCcchhhhh----HHHHhcCcchhhhhHHHHHhccccccch---hhhcccccccceeeccchhhhhcccccc
Confidence 78999999999988766 2334466778889999999999999998 99999999999999886 7789999999
Q ss_pred ccccCCCCCccccccccccccc--CccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCCCchhcHHHHHHHHhcccc
Q 010519 336 AKLLDSGESHITTRVMGTFGYV--APEYANTGMLNEKSDIYSFGVLLLEAVTGRDPVDYGRPANEVNLVEWLKMMVGTRR 413 (508)
Q Consensus 336 a~~~~~~~~~~~~~~~gt~~y~--aPE~~~~~~~~~~~DvwS~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~ 413 (508)
+..+.-.. ....+..++. ++.......+-.++|+||||.-+.+.++|..--... .+|.....
T Consensus 414 ~t~~~~~~----~~~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~ls~~~--------~~~~~i~~---- 477 (524)
T KOG0601|consen 414 WTRLAFSS----GVFHHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGSPLSESG--------VQSLTIRS---- 477 (524)
T ss_pred ccccceec----ccccccccccccchhhccccccccccccccccccccccccCcccCccc--------ccceeeec----
Confidence 86432111 1111233334 555556677888999999999999999987432211 11111100
Q ss_pred cccccCCCCCCChhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhhc
Q 010519 414 AEEVVDPNLEVKPATRALKRSLLVALRCVDPDSEKRPKMSQVVRMLEA 461 (508)
Q Consensus 414 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~ 461 (508)
-.-+.... ....+..+...+..+++..||.+.++..+.+-
T Consensus 478 ---~~~p~~~~-----~~~~~q~~~kv~~~~~~~~~~l~~~l~~~~~~ 517 (524)
T KOG0601|consen 478 ---GDTPNLPG-----LKLQLQVLLKVMINPDRKRRPSAVELSLHSEF 517 (524)
T ss_pred ---ccccCCCc-----hHHhhhhhhhhhcCCccccchhhhhhcccchh
Confidence 00011111 11344446667889999999999888766543
|
|
| >COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.14 E-value=5.7e-10 Score=99.28 Aligned_cols=132 Identities=22% Similarity=0.368 Sum_probs=99.6
Q ss_pred eeEeeeCceEEEEEEEcCCCEEEEEEEcccc--------hhhHHHHHHHHHHHhcCCCCCceeEEEEEEeCceeeEEEee
Q 010519 192 NVLGEGGYGVVYKGRLINGSEVAVKKLLNNL--------GQAEKEFRVEVEAIGHVRHKNLVRLLGYCIEGVHRMLVYEY 263 (508)
Q Consensus 192 ~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~--------~~~~~~~~~ei~~l~~l~h~niv~~~~~~~~~~~~~lv~E~ 263 (508)
..+++|+-+.+|.+.+ -|.++++|.-..+. .-......+|..++.++.--.|...+-++.+.....|+|||
T Consensus 2 ~~i~~GAEa~i~~~~~-~g~~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dvD~~~~~I~me~ 80 (204)
T COG3642 2 DLIKQGAEAIIYLTDF-LGLPAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDVDPDNGLIVMEY 80 (204)
T ss_pred chhhCCcceeEEeeec-cCcceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCEEEEEE
Confidence 3578999999999976 44456666432222 11123466789998888765665555566677777899999
Q ss_pred cCCCCHHHHHhhhhccCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCEEEcCCCcEEEEecCCcccc
Q 010519 264 VNNGNLEQWLHGAMRNQGNLTWEARMKVIIGTAKALAYLHEAIEPKVVHRDIKSSNILIDDEFNAKVSDFGLAKLL 339 (508)
Q Consensus 264 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~Dfgla~~~ 339 (508)
.+|-.|.+++... ...++..+-.-+.-||.. +|+|+||.++||.+..+. +.++|||++...
T Consensus 81 I~G~~lkd~l~~~-----------~~~~~r~vG~~vg~lH~~---givHGDLTtsNiIl~~~~-i~~IDfGLg~~s 141 (204)
T COG3642 81 IEGELLKDALEEA-----------RPDLLREVGRLVGKLHKA---GIVHGDLTTSNIILSGGR-IYFIDFGLGEFS 141 (204)
T ss_pred eCChhHHHHHHhc-----------chHHHHHHHHHHHHHHhc---CeecCCCccceEEEeCCc-EEEEECCccccc
Confidence 9999999888531 245667777888999999 999999999999999875 999999999854
|
|
| >cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins | Back alignment and domain information |
|---|
Probab=99.13 E-value=3.5e-10 Score=106.81 Aligned_cols=142 Identities=22% Similarity=0.261 Sum_probs=106.0
Q ss_pred eeEeeeCceEEEEEEEcCCCEEEEEEEcccch-hhHHHHHHHHHHHhcCCC--CCceeEEEEEEeCc---eeeEEEeecC
Q 010519 192 NVLGEGGYGVVYKGRLINGSEVAVKKLLNNLG-QAEKEFRVEVEAIGHVRH--KNLVRLLGYCIEGV---HRMLVYEYVN 265 (508)
Q Consensus 192 ~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~-~~~~~~~~ei~~l~~l~h--~niv~~~~~~~~~~---~~~lv~E~~~ 265 (508)
+.|+.|..+.||++...+|..+++|....... .....+..|+.++..+.+ .++.+++.+..... ..++||||++
T Consensus 4 ~~l~~G~~n~~~~v~~~~g~~~ilK~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~~v~e~i~ 83 (223)
T cd05154 4 RQLSGGQSNLTYLLTAGGGRRLVLRRPPPGALLPSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPFYVMERVD 83 (223)
T ss_pred eecCCCccceEEEEEecCCcceEEEeCCCcccCcccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCceEEEEEeC
Confidence 56899999999999886668899998654322 134567889999999865 34567777766532 5689999999
Q ss_pred CCCHHHHHhhhhccCCCccHHHHHHHHHHHHHHHHHHHhcC---------------------------------------
Q 010519 266 NGNLEQWLHGAMRNQGNLTWEARMKVIIGTAKALAYLHEAI--------------------------------------- 306 (508)
Q Consensus 266 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~--------------------------------------- 306 (508)
|.++.+.+. ...++......++.+++++|.+||+..
T Consensus 84 G~~l~~~~~-----~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 158 (223)
T cd05154 84 GRVLRDRLL-----RPELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEPPAME 158 (223)
T ss_pred CEecCCCCC-----CCCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccccHHHH
Confidence 988776441 134566677777777888887777421
Q ss_pred --------------CCCeEeecCCCCCEEEcC--CCcEEEEecCCccc
Q 010519 307 --------------EPKVVHRDIKSSNILIDD--EFNAKVSDFGLAKL 338 (508)
Q Consensus 307 --------------~~~iiH~Dlk~~NIll~~--~~~~kl~Dfgla~~ 338 (508)
...++|+|+.+.||+++. ++.+.|+||+.+..
T Consensus 159 ~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~~ 206 (223)
T cd05154 159 RLLRWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELATL 206 (223)
T ss_pred HHHHHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEecccccc
Confidence 246799999999999998 66689999998864
|
This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain |
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.11 E-value=1.6e-11 Score=132.64 Aligned_cols=248 Identities=21% Similarity=0.238 Sum_probs=165.2
Q ss_pred hhCCcccceeEeeeCceEEEEEEEc-CCCEEEEEEEcccc---hhhHHHHHHHHHHHhcCCCCCceeEEEEEEeCceeeE
Q 010519 184 ATNRFSAENVLGEGGYGVVYKGRLI-NGSEVAVKKLLNNL---GQAEKEFRVEVEAIGHVRHKNLVRLLGYCIEGVHRML 259 (508)
Q Consensus 184 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~ei~~l~~l~h~niv~~~~~~~~~~~~~l 259 (508)
..+.+.+.+-+..|.++.++.+.-. .|...++|...... ....+....+-.++-..++|.++...--+......++
T Consensus 802 S~d~~~i~~p~qS~sp~ss~p~~pa~sgh~~~~~v~~~ap~i~~~~~~s~r~~s~~~i~p~~P~v~~~~~s~~~rsP~~L 881 (1205)
T KOG0606|consen 802 SPDGFEITKPSQSGSPSSSFPASPAGSGHTRPSKVHGLAPKIRTNDYESIRSKSNILITPRSPAVVRSFPSFPCRSPLPL 881 (1205)
T ss_pred CCccceecccccCCCCcccccCCccccccccchhhhccchhhccccccccCCccCccccCCCCceecccCCCCCCCCcch
Confidence 3456667777888999998887532 23333333221111 1111222223333333455666655554555677899
Q ss_pred EEeecCCCCHHHHHhhhhccCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCEEEcCCCcEEEEecCCcccc
Q 010519 260 VYEYVNNGNLEQWLHGAMRNQGNLTWEARMKVIIGTAKALAYLHEAIEPKVVHRDIKSSNILIDDEFNAKVSDFGLAKLL 339 (508)
Q Consensus 260 v~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~Dfgla~~~ 339 (508)
+++|+.+++|...|+. -+..+.......+..+.++++|||.. .+.|+|++|.|+|...+++.+++|||.....
T Consensus 882 ~~~~~~~~~~~Skl~~----~~~~saepaRs~i~~~vqs~e~L~s~---~r~h~~~~p~~~l~~~~gh~~l~~~~t~~~v 954 (1205)
T KOG0606|consen 882 VGHYLNGGDLPSKLHN----SGCLSAEPARSPILERVQSLESLHSS---LRKHRDLKPDSLLIAYDGHRPLTDFGTLSKV 954 (1205)
T ss_pred hhHHhccCCchhhhhc----CCCcccccccchhHHHHhhhhccccc---hhhcccccccchhhcccCCcccCcccccccc
Confidence 9999999999999863 33566666777788899999999998 7999999999999999999999999843221
Q ss_pred CCC------------------------------CCcccccccccccccCccccCCCCCCChhhHHHHHHHHHHHHhCCCC
Q 010519 340 DSG------------------------------ESHITTRVMGTFGYVAPEYANTGMLNEKSDIYSFGVLLLEAVTGRDP 389 (508)
Q Consensus 340 ~~~------------------------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltG~~P 389 (508)
... +........+|+.|.+||.+.+......+|+|++|++++|.++|..|
T Consensus 955 g~~~p~~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~hgs~ad~~~~g~~l~e~l~g~pp 1034 (1205)
T KOG0606|consen 955 GLIPPTTDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRRHGSAADWWSSGVCLFEVLTGIPP 1034 (1205)
T ss_pred ccccCcCCcccccccCccccccccccccccccchhhccccccCCCcccCCcccccccCCCcchhhhhhhhhhhhhcCCCC
Confidence 100 00112346789999999999999999999999999999999999999
Q ss_pred CCCCCCCchhcHHHHHHHHhcccccccccCCCCCCCh-hHHHHHHHHHHHHHhcCCCCCCCCCHH
Q 010519 390 VDYGRPANEVNLVEWLKMMVGTRRAEEVVDPNLEVKP-ATRALKRSLLVALRCVDPDSEKRPKMS 453 (508)
Q Consensus 390 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~l~~li~~cl~~dP~~RPs~~ 453 (508)
|....+...+ ..+. .....+.. +........+++...+..+|.+|..+.
T Consensus 1035 ~na~tpq~~f------~ni~---------~~~~~~p~g~~~~s~~aq~~~~~ll~~~~~qr~~a~ 1084 (1205)
T KOG0606|consen 1035 FNAETPQQIF------ENIL---------NRDIPWPEGPEEGSYEAQDLINRLLTEEPTQRLGAK 1084 (1205)
T ss_pred CCCcchhhhh------hccc---------cCCCCCCCCccccChhhhhhhhhhhccCchhccCcc
Confidence 9765543221 1111 11111111 112233344577788889999998776
|
|
| >COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.09 E-value=4.1e-09 Score=104.15 Aligned_cols=264 Identities=16% Similarity=0.151 Sum_probs=158.4
Q ss_pred ccceeEeeeCceEEEEEEEcCCCEEEEEEEcccchhhHHHHHHHHHHHhcC-CCCCceeEEEEE----E--eC-ceeeEE
Q 010519 189 SAENVLGEGGYGVVYKGRLINGSEVAVKKLLNNLGQAEKEFRVEVEAIGHV-RHKNLVRLLGYC----I--EG-VHRMLV 260 (508)
Q Consensus 189 ~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~ei~~l~~l-~h~niv~~~~~~----~--~~-~~~~lv 260 (508)
.....||+|+-+.+|-.-- -+. .+.|++.........+ .+..|... .||-+-.-+.|= + +. ...-++
T Consensus 14 ~~gr~LgqGgea~ly~l~e-~~d-~VAKIYh~Pppa~~aq---k~a~la~~p~~p~~~~rvaWPqa~L~G~~~~~~iGfl 88 (637)
T COG4248 14 PPGRPLGQGGEADLYTLGE-VRD-QVAKIYHAPPPAAQAQ---KVAELAATPDAPLLNYRVAWPQATLHGGRRGKVIGFL 88 (637)
T ss_pred CCCccccCCccceeeecch-hhc-hhheeecCCCchHHHH---HHHHhccCCCCcchhhhhcccHHHhhCCCccceeEEe
Confidence 4457799999999997532 122 3446665544333322 22333333 566433212211 1 12 224578
Q ss_pred EeecCCC-CHHHHHh--hhhccCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCEEEcCCCcEEEEecCCcc
Q 010519 261 YEYVNNG-NLEQWLH--GAMRNQGNLTWEARMKVIIGTAKALAYLHEAIEPKVVHRDIKSSNILIDDEFNAKVSDFGLAK 337 (508)
Q Consensus 261 ~E~~~~g-sL~~~l~--~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~Dfgla~ 337 (508)
|+.+++. .+.+++. .+.+......|.-.++++..++.+.+-||+. |.+-+|++++|+|+++++.+.|.|-....
T Consensus 89 mP~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~~---Gh~vGDVn~~~~lVsd~~~V~LVdsDsfq 165 (637)
T COG4248 89 MPKVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHEH---GHVVGDVNQNSFLVSDDSKVVLVDSDSFQ 165 (637)
T ss_pred cccCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHhc---CCcccccCccceeeecCceEEEEccccee
Confidence 8887764 2333331 1123445688999999999999999999999 99999999999999999999999866554
Q ss_pred ccCCCCCcccccccccccccCccccC-----CCCCCChhhHHHHHHHHHHHHhC-CCCCCCCCC------CchhcHHHHH
Q 010519 338 LLDSGESHITTRVMGTFGYVAPEYAN-----TGMLNEKSDIYSFGVLLLEAVTG-RDPVDYGRP------ANEVNLVEWL 405 (508)
Q Consensus 338 ~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DvwS~Gvvl~elltG-~~Pf~~~~~------~~~~~~~~~~ 405 (508)
...++. .....+|.+.|.+||.-. +..-+...|.|.|||++++++.| ++||..-.. ..+..+..-.
T Consensus 166 i~~ng~--~~~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysGI~~~~~ap~p~E~~Ia~g~ 243 (637)
T COG4248 166 INANGT--LHLCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSGIPLISDAPNPLETDIAHGR 243 (637)
T ss_pred eccCCc--eEecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhcCCCCCCcccccCCCCCcchhhhhcce
Confidence 433332 234457899999999654 44556789999999999999996 999853211 1111111000
Q ss_pred HHHhcccccccccCCCCCCChhHHHHHHHHHHHHHhcCC--CCCCCCCHHHHHHHhhcCCC
Q 010519 406 KMMVGTRRAEEVVDPNLEVKPATRALKRSLLVALRCVDP--DSEKRPKMSQVVRMLEADDY 464 (508)
Q Consensus 406 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~--dP~~RPs~~evl~~L~~~~~ 464 (508)
.... ... .....+.....+..-....+.-|..+|+.. ++.-|||++-.+..|.....
T Consensus 244 f~ya-~~~-~~g~~p~P~~~P~~~Lpp~vqAlF~qaF~~~~~~~~RP~a~aW~aAl~al~~ 302 (637)
T COG4248 244 FAYA-SDQ-RRGLKPPPRSIPLSMLPPDVQALFQQAFTESGVATPRPTAKAWVAALDALRQ 302 (637)
T ss_pred eeec-hhc-cCCCCCCCCCCChhhcCHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHHHH
Confidence 0000 000 001111111111122222333355678764 46789999998888866443
|
|
| >KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=99.07 E-value=6.5e-09 Score=105.23 Aligned_cols=170 Identities=21% Similarity=0.299 Sum_probs=128.3
Q ss_pred ceEEEEEEEc-CCCEEEEEEEcccchhhHHHHHHHHHHHhcCCCCCceeEEEEEEe----CceeeEEEeecCC-CCHHHH
Q 010519 199 YGVVYKGRLI-NGSEVAVKKLLNNLGQAEKEFRVEVEAIGHVRHKNLVRLLGYCIE----GVHRMLVYEYVNN-GNLEQW 272 (508)
Q Consensus 199 ~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~ei~~l~~l~h~niv~~~~~~~~----~~~~~lv~E~~~~-gsL~~~ 272 (508)
-.+.|++... +|..++.|++..+..+.......-+++++++.|+|+|++..+|.. +..+++||+|+++ ++|.++
T Consensus 289 ~~Ttyk~~s~~DG~~YvLkRlhg~r~~~~nk~t~lve~wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~TL~d~ 368 (655)
T KOG3741|consen 289 SITTYKATSNVDGNAYVLKRLHGDRDQSTNKDTSLVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYYPSSPTLYDL 368 (655)
T ss_pred cceeEeeeeccCCceeeeeeeccccccCcccchHHHHHHHHhccCceeehhhhhhhhccCcceEEEEEecCCCCchHHHH
Confidence 3578898753 889999999844433333233346788999999999999998873 4567899999885 366665
Q ss_pred Hhhhh-----------ccCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCEEEcCCCcEEEEecCCccccCC
Q 010519 273 LHGAM-----------RNQGNLTWEARMKVIIGTAKALAYLHEAIEPKVVHRDIKSSNILIDDEFNAKVSDFGLAKLLDS 341 (508)
Q Consensus 273 l~~~~-----------~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~ 341 (508)
-.... ..+..+++..+|.++.|+..||.++|+. |+.-+-|.+.+||++.+.+++|+..|....+..
T Consensus 369 ~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHss---GLAck~L~~~kIlv~G~~RIriS~C~i~Dvl~~ 445 (655)
T KOG3741|consen 369 YFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHSS---GLACKTLDLKKILVTGKMRIRISGCGIMDVLQE 445 (655)
T ss_pred HccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHhc---CceeecccHhHeEeeCcceEEEecccceeeecC
Confidence 42211 1233467899999999999999999999 999999999999999999999998888776554
Q ss_pred CCCcccccccccccccCccccCCCCCCChhhHHHHHHHHHHHHhCCCC
Q 010519 342 GESHITTRVMGTFGYVAPEYANTGMLNEKSDIYSFGVLLLEAVTGRDP 389 (508)
Q Consensus 342 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltG~~P 389 (508)
+.. |.+.+ -.+-|.=.||.+++.|.||..-
T Consensus 446 d~~---------------~~le~---~Qq~D~~~lG~ll~aLAt~~~n 475 (655)
T KOG3741|consen 446 DPT---------------EPLES---QQQNDLRDLGLLLLALATGTEN 475 (655)
T ss_pred CCC---------------cchhH---HhhhhHHHHHHHHHHHhhcccc
Confidence 320 11111 2567899999999999999653
|
|
| >PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional | Back alignment and domain information |
|---|
Probab=98.99 E-value=1.2e-08 Score=99.05 Aligned_cols=141 Identities=16% Similarity=0.085 Sum_probs=100.2
Q ss_pred eeEeeeCceEEEEEEEcCCCEEEEEEEcccchh-----------hHHHHHHHHHHHhcCCCCC--ceeEEEEEEe-----
Q 010519 192 NVLGEGGYGVVYKGRLINGSEVAVKKLLNNLGQ-----------AEKEFRVEVEAIGHVRHKN--LVRLLGYCIE----- 253 (508)
Q Consensus 192 ~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~-----------~~~~~~~ei~~l~~l~h~n--iv~~~~~~~~----- 253 (508)
+.+-......|+++.+ +|+.+.||........ ....+.+|...+.+|..-+ .+.++++...
T Consensus 28 e~v~~~~~rrvvr~~~-~g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~~ 106 (268)
T PRK15123 28 EVFRELEGRRTLRFEL-AGKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGSNPA 106 (268)
T ss_pred cEEecCCCceEEEEEE-CCEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecCCCc
Confidence 4555555556777765 7889999976433211 0113667888877774322 3344555543
Q ss_pred CceeeEEEeecCCC-CHHHHHhhhhccCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCEEEcC-------C
Q 010519 254 GVHRMLVYEYVNNG-NLEQWLHGAMRNQGNLTWEARMKVIIGTAKALAYLHEAIEPKVVHRDIKSSNILIDD-------E 325 (508)
Q Consensus 254 ~~~~~lv~E~~~~g-sL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiH~Dlk~~NIll~~-------~ 325 (508)
....++|+|++++. +|.+++... ............++.+++..+.-||.. ||+|+||++.|||++. +
T Consensus 107 ~~~s~LVte~l~~~~sL~~~~~~~--~~~~~~~~~~~~ll~~la~~i~~LH~~---Gi~HgDL~~~NiLl~~~~~~~~~~ 181 (268)
T PRK15123 107 TRTSFIITEDLAPTISLEDYCADW--ATNPPDPRLKRMLIKRVATMVRDMHAA---GINHRDCYICHFLLHLPFPGREED 181 (268)
T ss_pred cceeEEEEeeCCCCccHHHHHHhh--cccCCCHHHHHHHHHHHHHHHHHHHHC---cCccCCCChhhEEEeccccCCCCC
Confidence 23468999999876 899988532 123455667788999999999999999 9999999999999975 4
Q ss_pred CcEEEEecCCccc
Q 010519 326 FNAKVSDFGLAKL 338 (508)
Q Consensus 326 ~~~kl~Dfgla~~ 338 (508)
+.+.|+||+.+..
T Consensus 182 ~~~~LIDl~r~~~ 194 (268)
T PRK15123 182 LKLSVIDLHRAQI 194 (268)
T ss_pred ceEEEEECCcccc
Confidence 6799999998863
|
|
| >PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.88 E-value=1.6e-08 Score=92.63 Aligned_cols=126 Identities=25% Similarity=0.303 Sum_probs=82.4
Q ss_pred EEEEEEEcCCCEEEEEEEcccc--------------h------------hhHHHHHHHHHHHhcCCCC--CceeEEEEEE
Q 010519 201 VVYKGRLINGSEVAVKKLLNNL--------------G------------QAEKEFRVEVEAIGHVRHK--NLVRLLGYCI 252 (508)
Q Consensus 201 ~Vy~~~~~~~~~vavK~~~~~~--------------~------------~~~~~~~~ei~~l~~l~h~--niv~~~~~~~ 252 (508)
.||.|...+|..+|+|...... . ......+.|...|.++..- ++..++++-
T Consensus 1 ~Vy~~~~~~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~~- 79 (188)
T PF01163_consen 1 DVYHAIDPDGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDYN- 79 (188)
T ss_dssp EEEEEEECTTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEEE-
T ss_pred CEEEEECCCCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEEe-
Confidence 3899988889999999774211 0 0123467799999999765 455666442
Q ss_pred eCceeeEEEeecC--CCCHHHHHhhhhccCCCccHHHHHHHHHHHHHHHHH-HHhcCCCCeEeecCCCCCEEEcCCCcEE
Q 010519 253 EGVHRMLVYEYVN--NGNLEQWLHGAMRNQGNLTWEARMKVIIGTAKALAY-LHEAIEPKVVHRDIKSSNILIDDEFNAK 329 (508)
Q Consensus 253 ~~~~~~lv~E~~~--~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~y-LH~~~~~~iiH~Dlk~~NIll~~~~~~k 329 (508)
..+|||||++ |..+..+... .++......++.+++..+.. +|.. ||+|+||.+.|||++++ .+.
T Consensus 80 ---~~~ivME~I~~~G~~~~~l~~~------~~~~~~~~~~~~~il~~~~~~~~~~---givHGDLs~~NIlv~~~-~~~ 146 (188)
T PF01163_consen 80 ---RNVIVMEYIGEDGVPLPRLKDV------DLSPEEPKELLEEILEEIIKMLHKA---GIVHGDLSEYNILVDDG-KVY 146 (188)
T ss_dssp ---TTEEEEE--EETTEEGGCHHHC------GGGGSTHHHHHHHHHHHHHHHHHCT---TEEESS-STTSEEEETT-CEE
T ss_pred ---CCEEEEEecCCCccchhhHHhc------cccchhHHHHHHHHHHHHHHHHHhc---CceecCCChhhEEeecc-eEE
Confidence 3479999998 6555544321 11133445667777775555 5677 99999999999999988 999
Q ss_pred EEecCCccccC
Q 010519 330 VSDFGLAKLLD 340 (508)
Q Consensus 330 l~Dfgla~~~~ 340 (508)
|+|||.+....
T Consensus 147 iIDf~qav~~~ 157 (188)
T PF01163_consen 147 IIDFGQAVDSS 157 (188)
T ss_dssp E--GTTEEETT
T ss_pred EEecCcceecC
Confidence 99999887554
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A. |
| >COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.80 E-value=3.4e-08 Score=93.23 Aligned_cols=137 Identities=20% Similarity=0.196 Sum_probs=98.4
Q ss_pred cccceeEeeeCceEEEEEEEcCCCEEEEEEEcccc----------h------------hhHHHHHHHHHHHhcCCCC--C
Q 010519 188 FSAENVLGEGGYGVVYKGRLINGSEVAVKKLLNNL----------G------------QAEKEFRVEVEAIGHVRHK--N 243 (508)
Q Consensus 188 ~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~----------~------------~~~~~~~~ei~~l~~l~h~--n 243 (508)
..++..||.|--+.||.|....|.++|||.=.... . ......++|.++|.+|.-. .
T Consensus 93 e~iG~~IGvGKEsdVY~~~~~~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G~~ 172 (304)
T COG0478 93 EAIGTKIGVGKESDVYVAIDPKGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEGVK 172 (304)
T ss_pred HhhccccccCccceEEEEECCCCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcCCC
Confidence 45678999999999999999889999999432110 0 1123466799999998654 6
Q ss_pred ceeEEEEEEeCceeeEEEeecCCCCHHHHHhhhhccCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCEEEc
Q 010519 244 LVRLLGYCIEGVHRMLVYEYVNNGNLEQWLHGAMRNQGNLTWEARMKVIIGTAKALAYLHEAIEPKVVHRDIKSSNILID 323 (508)
Q Consensus 244 iv~~~~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiH~Dlk~~NIll~ 323 (508)
+...+++ +...+||||.+|-.|...- +.......++..|++-+.-+-.. ||||+|+++-||+++
T Consensus 173 VP~P~~~----nRHaVvMe~ieG~eL~~~r---------~~~en~~~il~~il~~~~~~~~~---GiVHGDlSefNIlV~ 236 (304)
T COG0478 173 VPKPIAW----NRHAVVMEYIEGVELYRLR---------LDVENPDEILDKILEEVRKAYRR---GIVHGDLSEFNILVT 236 (304)
T ss_pred CCCcccc----ccceeeeehcccceeeccc---------CcccCHHHHHHHHHHHHHHHHHc---CccccCCchheEEEe
Confidence 6667664 4557999999886655421 12233344444555555554456 999999999999999
Q ss_pred CCCcEEEEecCCccccC
Q 010519 324 DEFNAKVSDFGLAKLLD 340 (508)
Q Consensus 324 ~~~~~kl~Dfgla~~~~ 340 (508)
+||.+.++||-.+....
T Consensus 237 ~dg~~~vIDwPQ~v~~~ 253 (304)
T COG0478 237 EDGDIVVIDWPQAVPIS 253 (304)
T ss_pred cCCCEEEEeCcccccCC
Confidence 99999999999776543
|
|
| >PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.69 E-value=1.9e-07 Score=87.42 Aligned_cols=106 Identities=21% Similarity=0.268 Sum_probs=81.1
Q ss_pred HHHHHHHHHHhcCCC--CCceeEEEEEEeC----ceeeEEEeecCCC-CHHHHHhhhhccCCCccHHHHHHHHHHHHHHH
Q 010519 227 KEFRVEVEAIGHVRH--KNLVRLLGYCIEG----VHRMLVYEYVNNG-NLEQWLHGAMRNQGNLTWEARMKVIIGTAKAL 299 (508)
Q Consensus 227 ~~~~~ei~~l~~l~h--~niv~~~~~~~~~----~~~~lv~E~~~~g-sL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al 299 (508)
....+|...+..|.. -.....+++.... ...++|+|++++. +|.+++.. ...++......++.+++..+
T Consensus 56 ~ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~~----~~~~~~~~~~~ll~~l~~~i 131 (206)
T PF06293_consen 56 SRAKREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQQ----WEQLDPSQRRELLRALARLI 131 (206)
T ss_pred hHHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHHh----hcccchhhHHHHHHHHHHHH
Confidence 345667777666642 2355566666543 2347999999874 79998853 22256677889999999999
Q ss_pred HHHHhcCCCCeEeecCCCCCEEEcCCC---cEEEEecCCcccc
Q 010519 300 AYLHEAIEPKVVHRDIKSSNILIDDEF---NAKVSDFGLAKLL 339 (508)
Q Consensus 300 ~yLH~~~~~~iiH~Dlk~~NIll~~~~---~~kl~Dfgla~~~ 339 (508)
.-||.. ||+|+|+++.|||++.+. .+.|+||+-++..
T Consensus 132 ~~lH~~---gi~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~~ 171 (206)
T PF06293_consen 132 AKLHDA---GIYHGDLNPSNILVDPDDGQYRFYLIDLDRMRFR 171 (206)
T ss_pred HHHHHC---cCCCCCCCcccEEEeCCCCceeEEEEcchhceeC
Confidence 999999 999999999999999887 8999999987753
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane |
| >PRK09902 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=98.63 E-value=4.8e-07 Score=83.50 Aligned_cols=138 Identities=17% Similarity=0.193 Sum_probs=100.6
Q ss_pred EeeeCceEEEEEEEcCCCEEEEEEEcccc------hhhHHHHHHHHHHHhcCCCC--CceeEEEEEEe-----CceeeEE
Q 010519 194 LGEGGYGVVYKGRLINGSEVAVKKLLNNL------GQAEKEFRVEVEAIGHVRHK--NLVRLLGYCIE-----GVHRMLV 260 (508)
Q Consensus 194 lg~G~~g~Vy~~~~~~~~~vavK~~~~~~------~~~~~~~~~ei~~l~~l~h~--niv~~~~~~~~-----~~~~~lv 260 (508)
-|+||-+-|+...+ +|..+.+|+..+.. .-....|.+|+..+.+|..- .+.+++ ++.. ....+||
T Consensus 26 ~~rgG~SgV~r~~~-~g~~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pv-f~~~~k~~~~~rA~LV 103 (216)
T PRK09902 26 YRRNGMSGVQCVER-NGKKLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIV-FGEAVKIEGEWRALLV 103 (216)
T ss_pred cCCCCcceEEEEEe-CCcEEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccc-eeeeeccCCceEEEEE
Confidence 35678888888766 66689999875222 22346788899998888432 244444 3321 1235799
Q ss_pred EeecCC-CCHHHHHhhhhccCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCEEEcCCCc--EEEEecCCcc
Q 010519 261 YEYVNN-GNLEQWLHGAMRNQGNLTWEARMKVIIGTAKALAYLHEAIEPKVVHRDIKSSNILIDDEFN--AKVSDFGLAK 337 (508)
Q Consensus 261 ~E~~~~-gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiH~Dlk~~NIll~~~~~--~kl~Dfgla~ 337 (508)
+|-+++ -+|.+++.. ....+.+...+..++.+++.++.-||.. |+.|+|+.+.|||++.++. ++++||--++
T Consensus 104 Te~L~g~~~L~~~l~~--~~~~~~~~~~k~~il~~va~~ia~LH~~---Gv~Hgdly~khIll~~~g~~~v~lIDlEk~r 178 (216)
T PRK09902 104 TEDMAGFISIADWYAQ--HAVSPYSDEVRQAMLKAVALAFKKMHSV---NRQHGCCYVRHIYVKTEGKAEAGFLDLEKSR 178 (216)
T ss_pred EEeCCCCccHHHHHhc--CCcCCcchHHHHHHHHHHHHHHHHHHHC---CCcCCCCCHhheeecCCCCeeEEEEEhhccc
Confidence 997753 489888843 1234567777889999999999999999 9999999999999986667 9999998776
Q ss_pred c
Q 010519 338 L 338 (508)
Q Consensus 338 ~ 338 (508)
.
T Consensus 179 ~ 179 (216)
T PRK09902 179 R 179 (216)
T ss_pred h
Confidence 3
|
|
| >COG0661 AarF Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.62 E-value=1.5e-07 Score=98.81 Aligned_cols=142 Identities=20% Similarity=0.276 Sum_probs=94.5
Q ss_pred eeEeeeCceEEEEEEEcCCCEEEEEEEcccchhh----------------------------------HH------HHHH
Q 010519 192 NVLGEGGYGVVYKGRLINGSEVAVKKLLNNLGQA----------------------------------EK------EFRV 231 (508)
Q Consensus 192 ~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~----------------------------------~~------~~~~ 231 (508)
+-|+.++-|.||+|++.+|+.||||+...+.... .+ .+..
T Consensus 131 ~PiAsASIaQVH~A~L~sG~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~~~l~~ElDy~~ 210 (517)
T COG0661 131 EPIASASIAQVHRAVLKSGEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFEKRLREELDYRR 210 (517)
T ss_pred CchhhhhHhhheeEEecCCCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHHHHHHHHhCHHH
Confidence 5799999999999999999999999986544221 01 1333
Q ss_pred HHHHHhcC----CCCCceeEEEEEEe-CceeeEEEeecCCCCHHHHHhhhhccCCCccHHHHHHHHHHHHHHHHHHHhcC
Q 010519 232 EVEAIGHV----RHKNLVRLLGYCIE-GVHRMLVYEYVNNGNLEQWLHGAMRNQGNLTWEARMKVIIGTAKALAYLHEAI 306 (508)
Q Consensus 232 ei~~l~~l----~h~niv~~~~~~~~-~~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~ 306 (508)
|...+.++ ....-+.+=.++++ .....|+|||++|-.+.+...- ....++.+.+.....++. +..+=..
T Consensus 211 EA~n~~~~~~nf~~~~~v~VP~V~we~t~~~VLtmE~i~Gi~i~d~~~l---~~~g~d~k~ia~~~~~~f--~~q~~~d- 284 (517)
T COG0661 211 EAANAERFRENFKDDPDVYVPKVYWEYTTRRVLTMEWIDGIKISDIAAL---KSAGIDRKELAELLVRAF--LRQLLRD- 284 (517)
T ss_pred HHHHHHHHHHHcCCCCCeEeceeehhccCCcEEEEEeeCCEecccHHHH---HhcCCCHHHHHHHHHHHH--HHHHHhc-
Confidence 44444443 22233444445553 5677899999999999887531 123344333332222221 1222224
Q ss_pred CCCeEeecCCCCCEEEcCCCcEEEEecCCccccCC
Q 010519 307 EPKVVHRDIKSSNILIDDEFNAKVSDFGLAKLLDS 341 (508)
Q Consensus 307 ~~~iiH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~ 341 (508)
|++|.|..|.||+++.+|++.+.|||+...+..
T Consensus 285 --gffHaDpHpGNi~v~~~g~i~~lDfGi~g~l~~ 317 (517)
T COG0661 285 --GFFHADPHPGNILVRSDGRIVLLDFGIVGRLDP 317 (517)
T ss_pred --CccccCCCccceEEecCCcEEEEcCcceecCCH
Confidence 899999999999999999999999999986654
|
|
| >KOG2137 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.56 E-value=2.5e-08 Score=104.61 Aligned_cols=165 Identities=18% Similarity=0.213 Sum_probs=107.0
Q ss_pred HHHHHHHHHHhcCCCCeEeecCCCCCEEEcCCCcEEEEecCCccccCCCCCc--------ccccccccccccCccccCCC
Q 010519 294 GTAKALAYLHEAIEPKVVHRDIKSSNILIDDEFNAKVSDFGLAKLLDSGESH--------ITTRVMGTFGYVAPEYANTG 365 (508)
Q Consensus 294 ~i~~al~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~--------~~~~~~gt~~y~aPE~~~~~ 365 (508)
+++.|+.|+|.. +++||++|.|++|.++.++..||+.|+++......... ...-..-...|.|||++.+.
T Consensus 107 ~v~dgl~flh~s--Ak~VH~ni~p~~i~~na~~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~~~~ 184 (700)
T KOG2137|consen 107 NVADGLAFLHRS--AKVVHGNIQPEAIVVNANGDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYLLGT 184 (700)
T ss_pred cccchhhhhccC--cceeecccchhheeeccCcceeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhhccc
Confidence 344899999965 59999999999999999999999999988644331110 01112235579999999998
Q ss_pred CCCChhhHHHHHHHHHHHHhCCCCCCCCCCCchhcHHHHHHHHhcccccccccCCCCCCChhHHHHHHHHHHHHHhcCCC
Q 010519 366 MLNEKSDIYSFGVLLLEAVTGRDPVDYGRPANEVNLVEWLKMMVGTRRAEEVVDPNLEVKPATRALKRSLLVALRCVDPD 445 (508)
Q Consensus 366 ~~~~~~DvwS~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~d 445 (508)
..+.++|+||+||++|.+..|..+.-....... ...+.... .. .-........+.++.+=+.+++..+
T Consensus 185 ~~~~~sd~fSlG~li~~i~~~gk~i~~a~~~~~---~~~~~~~~--~~-------~~~~~~s~~~p~el~~~l~k~l~~~ 252 (700)
T KOG2137|consen 185 TNTPASDVFSLGVLIYTIYNGGKSIIAANGGLL---SYSFSRNL--LN-------AGAFGYSNNLPSELRESLKKLLNGD 252 (700)
T ss_pred cccccccceeeeeEEEEEecCCcchhhccCCcc---hhhhhhcc--cc-------cccccccccCcHHHHHHHHHHhcCC
Confidence 888999999999999999965554322211110 00000000 00 0001111333455556677899999
Q ss_pred CCCCCCHHHHHHHhhcCCCCCchhhcc
Q 010519 446 SEKRPKMSQVVRMLEADDYPFREDRRN 472 (508)
Q Consensus 446 P~~RPs~~evl~~L~~~~~~~~~~~~~ 472 (508)
+.-||++.+++...--.+..++.-+..
T Consensus 253 ~~~rp~~~~l~~~~ff~D~~~~aLrfL 279 (700)
T KOG2137|consen 253 SAVRPTLDLLLSIPFFSDPGLKALRFL 279 (700)
T ss_pred cccCcchhhhhcccccCCchhhhhhhc
Confidence 999998888877655555444444443
|
|
| >PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY) | Back alignment and domain information |
|---|
Probab=98.48 E-value=2.9e-06 Score=78.64 Aligned_cols=140 Identities=14% Similarity=0.177 Sum_probs=93.2
Q ss_pred HHhhCCcccceeEeeeCceEEEEEEEcCCCEEEEEEEcccchhhHH---------HHHHHHHHHhcC---CCCCceeEEE
Q 010519 182 EIATNRFSAENVLGEGGYGVVYKGRLINGSEVAVKKLLNNLGQAEK---------EFRVEVEAIGHV---RHKNLVRLLG 249 (508)
Q Consensus 182 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~---------~~~~ei~~l~~l---~h~niv~~~~ 249 (508)
.+..++|...+++-......|.+-.. +|..+++|.-.......++ ...+.+..+.++ .-..++.++.
T Consensus 27 ~i~~~~~~~~kv~k~~~r~~ValIei-~~~kyIlK~pr~~~~r~er~~~sf~kg~~~~~l~~~~~~i~~~g~~~~~~~yl 105 (229)
T PF06176_consen 27 KILDNNYKIIKVFKNTKRNYVALIEI-DGKKYILKEPREENRRPERRFKSFFKGSEYSRLINNTDKIRNEGFTEPADPYL 105 (229)
T ss_pred HHHhCCceEEEeecCCCccEEEEEEE-CCcEEEEeccchhhhhHHHHHHHHhccHHHHHHHHHHHHHHHcCcccccccee
Confidence 34667888888888777777777655 7888999976543322222 122334433333 3333444444
Q ss_pred EEEe-----CceeeEEEeecCCCCHHHHHhhhhccCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCEEEcC
Q 010519 250 YCIE-----GVHRMLVYEYVNNGNLEQWLHGAMRNQGNLTWEARMKVIIGTAKALAYLHEAIEPKVVHRDIKSSNILIDD 324 (508)
Q Consensus 250 ~~~~-----~~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiH~Dlk~~NIll~~ 324 (508)
++.. ....+|+|||++|..|.++.. +++ .++..+.+++.-||.. |+.|+|..|.|+++++
T Consensus 106 ~~ekk~~~~~~~~~ll~EYIeG~~l~d~~~--------i~e----~~~~ki~~~ikqlH~~---G~~HGD~hpgNFlv~~ 170 (229)
T PF06176_consen 106 AAEKKIFRYTSSYVLLMEYIEGVELNDIED--------IDE----DLAEKIVEAIKQLHKH---GFYHGDPHPGNFLVSN 170 (229)
T ss_pred eeeeeeccceeEEEEEEEEecCeecccchh--------cCH----HHHHHHHHHHHHHHHc---CCccCCCCcCcEEEEC
Confidence 4332 234468999999988876532 222 2445677889999999 9999999999999996
Q ss_pred CCcEEEEecCCccc
Q 010519 325 EFNAKVSDFGLAKL 338 (508)
Q Consensus 325 ~~~~kl~Dfgla~~ 338 (508)
++ ++++||+..+.
T Consensus 171 ~~-i~iID~~~k~~ 183 (229)
T PF06176_consen 171 NG-IRIIDTQGKRM 183 (229)
T ss_pred Cc-EEEEECccccc
Confidence 64 99999986653
|
The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process |
| >TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172 | Back alignment and domain information |
|---|
Probab=98.34 E-value=7.8e-06 Score=77.60 Aligned_cols=139 Identities=18% Similarity=0.223 Sum_probs=83.9
Q ss_pred eeEeeeCceEEEEEEEcCCCEEEEEEEcccchhhHHHHHHHHHHHhcCCCCC--ceeEEEEEEeCceeeEEEeecCCCC-
Q 010519 192 NVLGEGGYGVVYKGRLINGSEVAVKKLLNNLGQAEKEFRVEVEAIGHVRHKN--LVRLLGYCIEGVHRMLVYEYVNNGN- 268 (508)
Q Consensus 192 ~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~ei~~l~~l~h~n--iv~~~~~~~~~~~~~lv~E~~~~gs- 268 (508)
..||+|..+.||+. .|..+++|...... ......+|.+++..+..-. +.+.+++....+...+|||+++|.+
T Consensus 7 ~~i~~G~t~~~y~~---~~~~~VlR~~~~~~--~~~~i~~E~~~l~~l~~~glpvP~~~~~~~~~~~~glv~e~i~G~~~ 81 (226)
T TIGR02172 7 TQTGEGGNGESYTH---KTGKWMLKLYNPGF--DKETIKREFDASRKVFSLGIPTPHPFDLVEDGGRLGLIYELIVGKRS 81 (226)
T ss_pred eeecCCCCcceeEe---cCCCEEEEeCCCCC--CHHHHHHHHHHHHHHHHcCCCCCceEEEEecCCeeeeeeeecCCccc
Confidence 46899999999984 35567777664432 2345677999998885433 4667777777777789999998863
Q ss_pred HH--------------HH-------HhhhhccCCCccHHHHHHHHH----------HHHH-HHHHHHhc-CCCCeEeecC
Q 010519 269 LE--------------QW-------LHGAMRNQGNLTWEARMKVII----------GTAK-ALAYLHEA-IEPKVVHRDI 315 (508)
Q Consensus 269 L~--------------~~-------l~~~~~~~~~l~~~~~~~i~~----------~i~~-al~yLH~~-~~~~iiH~Dl 315 (508)
+. .. ||........+.. ....+.. .+.. ...+|... ..+.++|+|+
T Consensus 82 ~~~~~~~~~~~~~~l~~~la~~l~~lH~~~~~~~~l~~-~~~~~~~~l~~~~~~~~~~~~~l~~~l~~~~~~~~~~HgD~ 160 (226)
T TIGR02172 82 FSRIISDNPSRLEEIAKIFAEMAKKLHSTKCDTSTFQS-YKEKIRKFIEEKDFVPKDYKEKARAFIKEVPDTSTCLHGDF 160 (226)
T ss_pred hhhhhcCCHHHHHHHHHHHHHHHHHHhCCCCCCCcHHH-HHHHHHHHHHhccCCCHHHHHHHHHHHHhCCCCCceEecCC
Confidence 11 11 1110000111110 0000000 0111 12222211 2346899999
Q ss_pred CCCCEEEcCCCcEEEEecCCcc
Q 010519 316 KSSNILIDDEFNAKVSDFGLAK 337 (508)
Q Consensus 316 k~~NIll~~~~~~kl~Dfgla~ 337 (508)
.|.||++++++ +.|+||+.+.
T Consensus 161 ~~~Nii~~~~~-~~iIDwe~a~ 181 (226)
T TIGR02172 161 QIGNLITSGKG-TYWIDLGDFG 181 (226)
T ss_pred CCCcEEEcCCC-cEEEechhcC
Confidence 99999999988 9999999775
|
This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636. |
| >PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily | Back alignment and domain information |
|---|
Probab=98.29 E-value=1.3e-05 Score=76.00 Aligned_cols=145 Identities=19% Similarity=0.214 Sum_probs=84.4
Q ss_pred ceeEeeeCceEEEEEEEcCCCEEEEEEEcccchhhHHHHHHHHHHHhcCCCC--CceeEEEEEEeC---ceeeEEEeecC
Q 010519 191 ENVLGEGGYGVVYKGRLINGSEVAVKKLLNNLGQAEKEFRVEVEAIGHVRHK--NLVRLLGYCIEG---VHRMLVYEYVN 265 (508)
Q Consensus 191 ~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~ei~~l~~l~h~--niv~~~~~~~~~---~~~~lv~E~~~ 265 (508)
.+.|+.|..+.||+....+ ..+++|..... .....+..|..++..+... .+..++.++... ...+++|++++
T Consensus 2 i~~l~~G~~n~~~~v~~~~-~~~vlK~~~~~--~~~~~~~~e~~~~~~l~~~~~pvP~~~~~~~~~~~~~~~~~~~~~i~ 78 (239)
T PF01636_consen 2 IRPLSGGFSNRVYRVTTDD-GRYVLKFYRPP--DAAERLRREAAVLRQLAEHGIPVPRVLAFDTSDEFNGFPYLLMEYIP 78 (239)
T ss_dssp EEEEEESSSSEEEEEEETT-SEEEEEEESSH--HHHHHHHHHHHHHHHHHHTTSBS--EEEEEEETEETSEEEEEEEEES
T ss_pred CccCCCCCeeeEEEEEECC-cEEEEEEeCCC--CCHHHHHHHHHHHHHHHhcCCCCceEEeecccccccccceEEEEEec
Confidence 3578999999999998855 68999986544 3456677788888877433 355666654333 34689999999
Q ss_pred CCCHHH----------------HH---hhhhccCCCccHHH---------HHHH------------HHHHHH-HHHHHHh
Q 010519 266 NGNLEQ----------------WL---HGAMRNQGNLTWEA---------RMKV------------IIGTAK-ALAYLHE 304 (508)
Q Consensus 266 ~gsL~~----------------~l---~~~~~~~~~l~~~~---------~~~i------------~~~i~~-al~yLH~ 304 (508)
|..+.. .+ +........+.... .... ...+.+ .+..++.
T Consensus 79 g~~~~~~~~~~~~~~~~~~~~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 158 (239)
T PF01636_consen 79 GRPLDDELSPEQRPELLRQLGRALAQLHQVPPPFSPFADWPEWRLEFLRQLESWTARLRASELFDDLEELEERLLQELEA 158 (239)
T ss_dssp SEEHHHTSTHHHHHHHHHHHHHHHHHHHHSHTTCCCHTHHHHHHHHHHHHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHH
T ss_pred cccccccccccccccccccchhhhhhcccccccccccccccccccccccccccccccccchhhhhhhHHHHHHHHHHHHh
Confidence 988877 11 11100111111100 0000 111222 3333332
Q ss_pred c----CCCCeEeecCCCCCEEEc-CCCcEEEEecCCccc
Q 010519 305 A----IEPKVVHRDIKSSNILID-DEFNAKVSDFGLAKL 338 (508)
Q Consensus 305 ~----~~~~iiH~Dlk~~NIll~-~~~~~kl~Dfgla~~ 338 (508)
. ..+.++|+|+.|.|||++ +++.+-|+||+.+..
T Consensus 159 ~~~~~~~~~~~HgD~~~~Nil~~~~~~~i~iID~e~a~~ 197 (239)
T PF01636_consen 159 LLPKPLPPVLIHGDLHPGNILVDPSDGRIGIIDFEDAGW 197 (239)
T ss_dssp HHHCCSCEEEE-SS-SGGGEEEESSTTEEEE--GTT-EE
T ss_pred hhccCCCcEEEEeccccccceeeeccceeEEEecccceE
Confidence 2 234799999999999999 666778999987753
|
; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B .... |
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.21 E-value=8.1e-08 Score=99.72 Aligned_cols=187 Identities=20% Similarity=0.145 Sum_probs=131.4
Q ss_pred CCcccceeEeeeCceEEEEEEEcCCCEEEEEEEcccchhhHHHHHHHHHHHhcCCCCC-ceeEEEEEEeCceeeEEEeec
Q 010519 186 NRFSAENVLGEGGYGVVYKGRLINGSEVAVKKLLNNLGQAEKEFRVEVEAIGHVRHKN-LVRLLGYCIEGVHRMLVYEYV 264 (508)
Q Consensus 186 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~ei~~l~~l~h~n-iv~~~~~~~~~~~~~lv~E~~ 264 (508)
..+..-.-.++|+++.+|+.+....+....+.+... .....++++|.+++||| .+..++-+..+...+++++++
T Consensus 242 kws~~fh~fvK~altknpKkRptaeklL~h~fvs~~-----l~~rl~~eLLdK~n~P~~~v~~~~d~~~E~~~~i~~~i~ 316 (829)
T KOG0576|consen 242 KWSEFFHNFVKGALTKNPKKRPTAEKLLQHPFVSQT-----LSRRLAIELLDKVNNPNPVVRYLEDYDGEDYLWIPMRIC 316 (829)
T ss_pred cchHHHHHHHHHHhcCCCccCCChhhheeceeeccc-----hhhHHHHHHHHHccCCCCcccccccCCcccccchhhhhh
Confidence 334444567899999999986533333444443322 44556899999999999 677777677777888999999
Q ss_pred CCC-CHHHHHhhhhccCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCEEEcCCCcEEEEecCCccccCCCC
Q 010519 265 NNG-NLEQWLHGAMRNQGNLTWEARMKVIIGTAKALAYLHEAIEPKVVHRDIKSSNILIDDEFNAKVSDFGLAKLLDSGE 343 (508)
Q Consensus 265 ~~g-sL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~~~ 343 (508)
.++ +...... .....+..-+...+...-+++++|||+. .=+|+| ||+.++ +..+.+||+....+....
T Consensus 317 s~~rs~~~~~~---~se~~~~~~~~~~~~r~et~~l~~l~~~---~~~~~d----~~l~s~-~~~~~~~~~v~~~L~~~~ 385 (829)
T KOG0576|consen 317 STGRSSALEMT---VSEIALEQYQFAYPLRKETRPLAELHSS---YKVHRD----NILGSE-EEVKLLDFAVPPQLTRTM 385 (829)
T ss_pred cCCccccccCC---hhhHhhhhhhhhhhhhhhcccccccccc---cccCcc----cccccc-cccccccccCCcccCccc
Confidence 887 2211110 1111223333444555567889999986 558888 887776 588999999988765443
Q ss_pred CcccccccccccccCccccCCCCCCChhhHHHHHHHHHHHHhCCCCC
Q 010519 344 SHITTRVMGTFGYVAPEYANTGMLNEKSDIYSFGVLLLEAVTGRDPV 390 (508)
Q Consensus 344 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltG~~Pf 390 (508)
......+++.|+|||+.....++...|+|++|+--.++.-|-.|-
T Consensus 386 --~~~t~~~~~~~~~pev~~~~~~~~~p~~~~~~~~~~~~ap~~pPr 430 (829)
T KOG0576|consen 386 --KPRTAIGTPEPLAPEVIQENTIDGCPDSGSLAVSAIQMAPGLPPR 430 (829)
T ss_pred --ccccCCCCCCCCCchhhcccccccCCCccCCCcchhhcCCCCCCC
Confidence 244567899999999999999999999999998777776676663
|
|
| >KOG1235 consensus Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.20 E-value=8.1e-06 Score=85.66 Aligned_cols=141 Identities=21% Similarity=0.294 Sum_probs=91.0
Q ss_pred eeEeeeCceEEEEEEEcCCCEEEEEEEcccchhh-------------------------------HH------HHHHHHH
Q 010519 192 NVLGEGGYGVVYKGRLINGSEVAVKKLLNNLGQA-------------------------------EK------EFRVEVE 234 (508)
Q Consensus 192 ~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~-------------------------------~~------~~~~ei~ 234 (508)
+.||..+.|.||+|++++|+.||||+........ .+ .|..|.+
T Consensus 167 ~piaaASlaQVhrA~L~~G~~VaVKVQ~P~l~~~~~~Dl~~~~~~~~~l~k~~p~~~~~~lvdE~~~~L~~ELDF~~EA~ 246 (538)
T KOG1235|consen 167 EPIAAASLAQVHRARLKNGEDVAVKVQHPGLEKLIMLDLRNLRLLAKVLQKFFPDFDLVWLVDEIAKSLPQELDFTKEAK 246 (538)
T ss_pred chhhhcchhheEEEEecCCCEEEEEecCcChHHHHHHHHHHHHHHHHHHHHhCcCCchhhHHHHHHhhhHhhcchHHHHH
Confidence 5799999999999999999999999875443221 01 1233333
Q ss_pred HHhc----CCCCC---ceeEEEEEEe-CceeeEEEeecCCCCHHHHHhhhhccCCCccHHHHHHHHHHHHHHHHHHHhcC
Q 010519 235 AIGH----VRHKN---LVRLLGYCIE-GVHRMLVYEYVNNGNLEQWLHGAMRNQGNLTWEARMKVIIGTAKALAYLHEAI 306 (508)
Q Consensus 235 ~l~~----l~h~n---iv~~~~~~~~-~~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~ 306 (508)
-..+ +.|-+ -|.+-.++++ .....|+||||+|..+.|.-. -....++... ++..+.++. ++...
T Consensus 247 Nae~~~~~f~~~~~~~~V~VP~Vy~~~st~RVLtME~~~G~~i~Dl~~---i~~~gi~~~~---i~~~l~~~~--~~qIf 318 (538)
T KOG1235|consen 247 NAERFRENFKDFSLLTYVLVPKVYWDLSTKRVLTMEYVDGIKINDLDA---IDKRGISPHD---ILNKLVEAY--LEQIF 318 (538)
T ss_pred hHHHHHHHHHhcccccceeCCeehhhcCcceEEEEEecCCccCCCHHH---HHHcCCCHHH---HHHHHHHHH--HHHHH
Confidence 3322 23444 2234444444 356789999999998877532 1222344433 333333332 22223
Q ss_pred CCCeEeecCCCCCEEEcC----CCcEEEEecCCccccC
Q 010519 307 EPKVVHRDIKSSNILIDD----EFNAKVSDFGLAKLLD 340 (508)
Q Consensus 307 ~~~iiH~Dlk~~NIll~~----~~~~kl~Dfgla~~~~ 340 (508)
..|++|+|=.|.||+++. ++.+.+.|||+.....
T Consensus 319 ~~GffHaDPHPGNilv~~~~~~~~~ivllDhGl~~~is 356 (538)
T KOG1235|consen 319 KTGFFHADPHPGNILVRPNPEGDEEIVLLDHGLYAVIS 356 (538)
T ss_pred hcCCccCCCCCCcEEEecCCCCCccEEEEccccccccc
Confidence 338999999999999983 6789999999998654
|
|
| >COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=98.20 E-value=1.5e-05 Score=74.88 Aligned_cols=152 Identities=20% Similarity=0.223 Sum_probs=98.3
Q ss_pred eHHHHHHhhCCccccee---EeeeCceEEEEEEEcCCCEEEEEEEcccchhhH------------------------HHH
Q 010519 177 TLRDLEIATNRFSAENV---LGEGGYGVVYKGRLINGSEVAVKKLLNNLGQAE------------------------KEF 229 (508)
Q Consensus 177 ~~~~~~~~~~~~~~~~~---lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~------------------------~~~ 229 (508)
++..+.-..++..+... |+.|--+.||+|...++..+|+|++........ .-.
T Consensus 36 t~~~l~~L~~rg~i~~~~g~istGKEA~Vy~a~~~~~~~~avKiyr~~t~~fk~~~~Yi~gd~Rf~~~~~~rr~lv~~W~ 115 (268)
T COG1718 36 TLETLRRLLSRGVITELVGCISTGKEANVYLAETGDGRYVAVKIYRTSTSEFKRIRRYIQGDPRFRNSRSNRRKLVFAWA 115 (268)
T ss_pred HHHHHHHHhcCCceeeeEeeecCCcceEEEeeccCCCceEEEEEEehhhhhhhhHHHHHhcChhhhcCCCCHHHHHHHHH
Confidence 34444444455554444 556667789999877899999998854321110 113
Q ss_pred HHHHHHHhcCC--CCCceeEEEEEEeCceeeEEEeecCCCCHHHHHhhhhccCCCccHHHHHHHHHHHHHHHHHHHh-cC
Q 010519 230 RVEVEAIGHVR--HKNLVRLLGYCIEGVHRMLVYEYVNNGNLEQWLHGAMRNQGNLTWEARMKVIIGTAKALAYLHE-AI 306 (508)
Q Consensus 230 ~~ei~~l~~l~--h~niv~~~~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~yLH~-~~ 306 (508)
..|+.-|.++. +=.+.+.+++. ...+||||+....+ .......-.+.......+..++++.+.-|-. .
T Consensus 116 ~kEf~NL~R~~eAGVrvP~Pi~~~----~nVLvMEfIg~~g~----pAP~LkDv~~e~~e~~~~~~~~v~~~~~l~~~a- 186 (268)
T COG1718 116 RKEFRNLKRAYEAGVRVPEPIAFR----NNVLVMEFIGDDGL----PAPRLKDVPLELEEAEGLYEDVVEYMRRLYKEA- 186 (268)
T ss_pred HHHHHHHHHHHHcCCCCCCceeec----CCeEEEEeccCCCC----CCCCcccCCcCchhHHHHHHHHHHHHHHHHHhc-
Confidence 44777777763 34455556543 34699999965311 0000112223333567777888888888765 5
Q ss_pred CCCeEeecCCCCCEEEcCCCcEEEEecCCccccC
Q 010519 307 EPKVVHRDIKSSNILIDDEFNAKVSDFGLAKLLD 340 (508)
Q Consensus 307 ~~~iiH~Dlk~~NIll~~~~~~kl~Dfgla~~~~ 340 (508)
++||+||+.-|||+. ++.+.|+|||.+....
T Consensus 187 --~LVHgDLSEyNiL~~-~~~p~iID~~QaV~~~ 217 (268)
T COG1718 187 --GLVHGDLSEYNILVH-DGEPYIIDVSQAVTID 217 (268)
T ss_pred --CcccccchhhheEEE-CCeEEEEECccccccC
Confidence 999999999999999 7799999999887554
|
|
| >PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C) | Back alignment and domain information |
|---|
Probab=98.17 E-value=5.7e-05 Score=69.43 Aligned_cols=104 Identities=22% Similarity=0.249 Sum_probs=81.2
Q ss_pred HHHHHHhcCCC-CCceeEEEEEEeCceeeEEEeecCCCCHHHHHhhhhccCCCccHHHHHHHHHHHHHHHHHHHhcCCCC
Q 010519 231 VEVEAIGHVRH-KNLVRLLGYCIEGVHRMLVYEYVNNGNLEQWLHGAMRNQGNLTWEARMKVIIGTAKALAYLHEAIEPK 309 (508)
Q Consensus 231 ~ei~~l~~l~h-~niv~~~~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~ 309 (508)
.|.-++..+++ +++.+++|+|- .++|.||...+++... .......-..+|..+.+|+.++++.+.+|++...-.
T Consensus 8 ~E~lll~~l~~~~~~pk~lG~CG----~~~v~E~~~~~~~~~~-~~~l~~~~~~~w~~R~~iA~~lL~~l~~l~~~~~~~ 82 (188)
T PF12260_consen 8 NEPLLLQLLQGSEPFPKLLGSCG----RFYVVEYVGAGSLYGI-YRPLSQFLQSPWEQRAKIALQLLELLEELDHGPLGF 82 (188)
T ss_pred cHHHHHHHcCCCCCCCCeeeECC----CEEEEEeecCcccccc-ccccccccccCHHHHHHHHHHHHHHHHHHhcCCCCc
Confidence 37778888866 69999999993 4789999987765421 000012234689999999999999999999854336
Q ss_pred eEeecCCCCCEEEcCCCcEEEEecCCcccc
Q 010519 310 VVHRDIKSSNILIDDEFNAKVSDFGLAKLL 339 (508)
Q Consensus 310 iiH~Dlk~~NIll~~~~~~kl~Dfgla~~~ 339 (508)
+.-.|++++|+-+++++++|++|...+...
T Consensus 83 ~~lcDv~~~nfgv~~~~~lk~iDld~v~~~ 112 (188)
T PF12260_consen 83 FYLCDVSPDNFGVNDDGRLKLIDLDDVFVE 112 (188)
T ss_pred EEEeecchHHeEEeCCCcEEEEechhcchh
Confidence 888999999999999999999999877543
|
Proteins in this uncharacterised family are described as transmembrane proteins. |
| >PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP | Back alignment and domain information |
|---|
Probab=98.11 E-value=6.5e-05 Score=69.45 Aligned_cols=128 Identities=20% Similarity=0.319 Sum_probs=89.3
Q ss_pred ceeEeeeCceEEEEEEEcCCCEEEEEEEcccc----------------hhhHHHHHHHHHHHhcCC------CCCceeEE
Q 010519 191 ENVLGEGGYGVVYKGRLINGSEVAVKKLLNNL----------------GQAEKEFRVEVEAIGHVR------HKNLVRLL 248 (508)
Q Consensus 191 ~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~----------------~~~~~~~~~ei~~l~~l~------h~niv~~~ 248 (508)
...||+|+.-.||. +.++....||+..... .....+..+|+.....+. +.+|.+++
T Consensus 6 ~~~i~~G~~R~cy~--HP~dp~~cIKV~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~E~~~y~~l~~~~~~~~~~i~r~~ 83 (199)
T PF10707_consen 6 SDLIAQGGERDCYQ--HPDDPNLCIKVMRPDRGERRRPFKRWLKRLRPKSRYRQNRRELRYYKQLSLRRGVDWSHIPRFY 83 (199)
T ss_pred CcccccCCCceEEE--CCCCCCeEEEEEccccccccccchhHHHhhcccchhHHHHHHHHHHHHHhhccCCcccccccEe
Confidence 35799999999998 5667778888876554 112344555665555544 88999999
Q ss_pred EEEEeCceeeEEEeecCCC------CHHHHHhhhhccCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCEEE
Q 010519 249 GYCIEGVHRMLVYEYVNNG------NLEQWLHGAMRNQGNLTWEARMKVIIGTAKALAYLHEAIEPKVVHRDIKSSNILI 322 (508)
Q Consensus 249 ~~~~~~~~~~lv~E~~~~g------sL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiH~Dlk~~NIll 322 (508)
|+.+++...-+|+|...+. +|.+++. .+.++. .. ...+-+-..||-.. .|+.+||+|.||++
T Consensus 84 G~veT~~G~Glv~e~I~d~dG~~s~TL~~~l~-----~~~~~~-~~---~~~L~~f~~~l~~~---~Iv~~dl~~~NIv~ 151 (199)
T PF10707_consen 84 GFVETNLGLGLVVELIRDADGNISPTLEDYLK-----EGGLTE-EL---RQALDEFKRYLLDH---HIVIRDLNPHNIVV 151 (199)
T ss_pred EEEecCCceEEEEEEEECCCCCcCccHHHHHH-----cCCccH-HH---HHHHHHHHHHHHHc---CCeecCCCcccEEE
Confidence 9999998888999886543 5777763 233444 33 33344556677777 89999999999999
Q ss_pred cCCC----cEEEEe
Q 010519 323 DDEF----NAKVSD 332 (508)
Q Consensus 323 ~~~~----~~kl~D 332 (508)
.... .+.|+|
T Consensus 152 ~~~~~~~~~lvlID 165 (199)
T PF10707_consen 152 QRRDSGEFRLVLID 165 (199)
T ss_pred EecCCCceEEEEEe
Confidence 5332 467776
|
PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner []. |
| >cd05150 APH Aminoglycoside 3'-phosphotransferase (APH) | Back alignment and domain information |
|---|
Probab=98.10 E-value=3.6e-05 Score=73.98 Aligned_cols=140 Identities=16% Similarity=0.135 Sum_probs=82.1
Q ss_pred EeeeCc-eEEEEEEEcCCCEEEEEEEcccchhhHHHHHHHHHHHhcCC-CCCceeEEEEEEeCceeeEEEeecCCCCHHH
Q 010519 194 LGEGGY-GVVYKGRLINGSEVAVKKLLNNLGQAEKEFRVEVEAIGHVR-HKNLVRLLGYCIEGVHRMLVYEYVNNGNLEQ 271 (508)
Q Consensus 194 lg~G~~-g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~ei~~l~~l~-h~niv~~~~~~~~~~~~~lv~E~~~~gsL~~ 271 (508)
|..|.. ..||+... ++..+++|...... ...+..|+.+++.+. +--+.+++++.......++|||+++|.+|..
T Consensus 6 ~~~g~~~~~v~~~~~-~~~~~~vk~~~~~~---~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~i~G~~l~~ 81 (244)
T cd05150 6 VTEGQSGATVYRLDG-KNPGLYLKIAPSGP---TYELEREAERLRWLAGKLPVPEVIDYGSDDGRAWLLTSAVPGVPAAA 81 (244)
T ss_pred cCCCCCcCeEEEEcC-CCCcEEEEecCCCc---ccchHHHHHHHHHHHhcCCCCeEEEEEecCCccEEEEEeeCCccHhH
Confidence 444555 78899865 45677777654332 234566888887773 3445677777766666789999999987764
Q ss_pred HH-------------------hhhhccCCCccH--HHHHHHHH--------------------HHHHHHHHHHhc----C
Q 010519 272 WL-------------------HGAMRNQGNLTW--EARMKVII--------------------GTAKALAYLHEA----I 306 (508)
Q Consensus 272 ~l-------------------~~~~~~~~~l~~--~~~~~i~~--------------------~i~~al~yLH~~----~ 306 (508)
.. |..-.....+.. ........ .+...+..|-.. .
T Consensus 82 ~~~~~~~~~~~~~l~~~l~~lH~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~ 161 (244)
T cd05150 82 LWEELEPERLVDALAEALRRLHALPVADCPFDRRLDRRLAEARARVENGLVDEDDFDDERRGWSAEELYAELEATRPAEE 161 (244)
T ss_pred hhcccCHHHHHHHHHHHHHHHhcCCcccCCcchhHHHHHHHHHHHHhcCCcChhhCcHhhcCCCHHHHHHHHHhhCCCcC
Confidence 31 110000001110 00000000 011112222111 2
Q ss_pred CCCeEeecCCCCCEEEcCCCcEEEEecCCcc
Q 010519 307 EPKVVHRDIKSSNILIDDEFNAKVSDFGLAK 337 (508)
Q Consensus 307 ~~~iiH~Dlk~~NIll~~~~~~kl~Dfgla~ 337 (508)
.+.++|+|+.|.|||++++..+.|+||+.+.
T Consensus 162 ~~~l~HgD~~~~Nil~~~~~~~~iIDwe~a~ 192 (244)
T cd05150 162 DLVVTHGDACLPNIIVDPGKFSGFIDLGRLG 192 (244)
T ss_pred ceEEECCCCCCccEEEeCCcEEEEEEccccc
Confidence 3569999999999999998778899999775
|
The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio |
| >PLN02876 acyl-CoA dehydrogenase | Back alignment and domain information |
|---|
Probab=98.03 E-value=5.8e-05 Score=85.28 Aligned_cols=149 Identities=17% Similarity=0.246 Sum_probs=90.6
Q ss_pred ceeEeeeCceEEEEEEEcCC---CEEEEEEEcccc-hhhHHHHHHHHHHHhcCC-CCCc--eeEEEEEEeC---ceeeEE
Q 010519 191 ENVLGEGGYGVVYKGRLING---SEVAVKKLLNNL-GQAEKEFRVEVEAIGHVR-HKNL--VRLLGYCIEG---VHRMLV 260 (508)
Q Consensus 191 ~~~lg~G~~g~Vy~~~~~~~---~~vavK~~~~~~-~~~~~~~~~ei~~l~~l~-h~ni--v~~~~~~~~~---~~~~lv 260 (508)
.+.++.|.+..+|+....++ ..+++|+..... ......+.+|+.+|+.+. |.++ .+++.+|.+. ...|+|
T Consensus 43 v~~l~gG~sn~ty~l~~~~~~~~~~~VLR~~p~~~~~~~~~~~~rE~~~l~~L~~~~~vpVP~v~~~~~d~~v~G~~flV 122 (822)
T PLN02876 43 VSQFGHGQSNPTFLLEVGNGGSVKRYVLRKKPPGKLLQSAHAVEREYQVLRALGEHTDVPVPKVYCLCTDASVIGTAFYI 122 (822)
T ss_pred EEEeCCCCcCceEEEEECCCCcceeEEEEeCCCCccCccHHHHHHHHHHHHHHhhcCCCCCCcEEEEecCCCcCCCceEE
Confidence 46789999999999876544 366777653322 122346788999999985 6654 7778887664 457899
Q ss_pred EeecCCCCHHH--------------------H---Hhhhhcc-------CCCccH--HHHHHHH---------------H
Q 010519 261 YEYVNNGNLEQ--------------------W---LHGAMRN-------QGNLTW--EARMKVI---------------I 293 (508)
Q Consensus 261 ~E~~~~gsL~~--------------------~---l~~~~~~-------~~~l~~--~~~~~i~---------------~ 293 (508)
|||++|..+.+ . ||..-.. ..+..+ ..+..+. -
T Consensus 123 ME~v~G~~~~~~~~~~~~~~~r~~l~~~l~~~La~LH~vd~~~~gl~~~g~~~~~~~~~l~~w~~~~~~~~~~~~~~~~~ 202 (822)
T PLN02876 123 MEYLEGRIFVDPKLPGVAPERRRAIYRATAKVLAALHSADVDAIGLGKYGRRDNYCKRQVERWAKQYLASTGEGKPPRNP 202 (822)
T ss_pred EEecCCcccCCccCCCCCHHHHHHHHHHHHHHHHHHhCCCchhcChhhcCCCCchHHHHHHHHHHHHHHhhcccCCCCCh
Confidence 99998764321 1 1110000 001011 1111111 1
Q ss_pred HHHHHHHHHHhcCC--------CCeEeecCCCCCEEEcC-CCc-EEEEecCCcccc
Q 010519 294 GTAKALAYLHEAIE--------PKVVHRDIKSSNILIDD-EFN-AKVSDFGLAKLL 339 (508)
Q Consensus 294 ~i~~al~yLH~~~~--------~~iiH~Dlk~~NIll~~-~~~-~kl~Dfgla~~~ 339 (508)
.+...+.+|..+.. +.+||+|+++.||+++. ++. +-|.||.++..-
T Consensus 203 ~~~~l~~wL~~~~P~~~~~~~~~~LvHGD~~~~Nvl~~~~~~~v~aVLDWE~a~~G 258 (822)
T PLN02876 203 KMLELIDWLRENIPAEDSTGAGTGIVHGDFRIDNLVFHPTEDRVIGILDWELSTLG 258 (822)
T ss_pred hHHHHHHHHHhcCCCccccCCCcceEecCcccccEEEcCCCCeEEEEEeeeccccC
Confidence 13344667754331 35999999999999985 334 468999987643
|
|
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=97.98 E-value=3.1e-05 Score=86.12 Aligned_cols=198 Identities=23% Similarity=0.287 Sum_probs=140.8
Q ss_pred HHHHHHHHHhcCCCCCceeEEEEEEeCcee----eEEEeecCCCCHHHHHhhhhccCCCccHHHHHHHHHHHHHHHHHHH
Q 010519 228 EFRVEVEAIGHVRHKNLVRLLGYCIEGVHR----MLVYEYVNNGNLEQWLHGAMRNQGNLTWEARMKVIIGTAKALAYLH 303 (508)
Q Consensus 228 ~~~~ei~~l~~l~h~niv~~~~~~~~~~~~----~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~yLH 303 (508)
...-|++.+....|+|++.++.|-...... .+..+++..-++...+ ..-..++....+.+..++.+|+.|+|
T Consensus 228 ~~E~e~~~l~k~~~~n~~~~~~~~le~~~~g~~~~v~~~~~s~~~~~~~~----q~v~~i~~~~~r~~~~~~~~GL~~~h 303 (1351)
T KOG1035|consen 228 TTEIELESLSKIAHDNLGGYFVYGLERLFRGIVLDVLQEICSKVELRSLL----QSVGSIPLETLRILHQKLLEGLAYLH 303 (1351)
T ss_pred HHHHHHHHHHhhccccccceeEEeehhhcchHHHHHHHhhcCccchHHHH----hhccccCHHHHHHHHHHHhhhHHHHH
Confidence 344477788888999999999987765433 2556888888888887 45667888999999999999999999
Q ss_pred hcCCCCeEeecCCCC---CEEEcCCCcEEEE--ecCCccccCCCCCcccccccccccccCccccCCCCCCC--hhhHHHH
Q 010519 304 EAIEPKVVHRDIKSS---NILIDDEFNAKVS--DFGLAKLLDSGESHITTRVMGTFGYVAPEYANTGMLNE--KSDIYSF 376 (508)
Q Consensus 304 ~~~~~~iiH~Dlk~~---NIll~~~~~~kl~--Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~--~~DvwS~ 376 (508)
+. .+.|.-|... +.-.+..+.+.++ ||+.+..+.+.... ........|.+||......++. ..|+|.+
T Consensus 304 ~~---~l~~v~L~~s~~~~~~~~~e~~~~~sl~~~~ss~~l~d~~~~--~~~~~~~~~~~~e~~~~~~~~~~r~~dL~~l 378 (1351)
T KOG1035|consen 304 SL---SLEHVVLSASSSKESTVDGEGVVAISLSDFDSSKPLPDNEKS--FSDLLAEIRNADEDLKENTAKKSRLTDLWCL 378 (1351)
T ss_pred Hh---ccceeEEecccccccccCccceeecchhhhcccccCCCcccc--hhhcCccccccccccccccchhhhhhHHHHH
Confidence 98 6666666555 5555667777777 99988877654332 2223456788888887766654 4799999
Q ss_pred HHHHHHHHhCCCCCCCCCCCchhcHHHHHHHHhcccccccccCCCCCCChhHHHHHHHHHHHHHhcCCCCCCCCCHHHHH
Q 010519 377 GVLLLEAVTGRDPVDYGRPANEVNLVEWLKMMVGTRRAEEVVDPNLEVKPATRALKRSLLVALRCVDPDSEKRPKMSQVV 456 (508)
Q Consensus 377 Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl 456 (508)
|..+..+..|..+-...... . .+++. .. ...+.+...+|+..++++|+++.+++
T Consensus 379 gll~~~~~~~~~i~~~~~~~-----~-------------~~l~~----~~----~~~~~d~~~~~~~~~~~~Rl~~~~ll 432 (1351)
T KOG1035|consen 379 GLLLLQLSQGEDISEKSAVP-----V-------------SLLDV----LS----TSELLDALPKCLDEDSEERLSALELL 432 (1351)
T ss_pred HHHHhhhhhcCcccccccch-----h-------------hhhcc----cc----chhhhhhhhhhcchhhhhccchhhhh
Confidence 99999999987653221100 0 00000 00 01344566789999999999999999
Q ss_pred HHhh
Q 010519 457 RMLE 460 (508)
Q Consensus 457 ~~L~ 460 (508)
.+.-
T Consensus 433 ~~~f 436 (1351)
T KOG1035|consen 433 THPF 436 (1351)
T ss_pred hchh
Confidence 8653
|
|
| >COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=97.84 E-value=0.00016 Score=64.46 Aligned_cols=129 Identities=19% Similarity=0.276 Sum_probs=88.3
Q ss_pred ccceeEeeeCceEEEEEEEcCCCEEEEEEEcccchhhHHHHHHHHHHHhcCCCCCcee-EEEEEEeCceeeEEEeecCCC
Q 010519 189 SAENVLGEGGYGVVYKGRLINGSEVAVKKLLNNLGQAEKEFRVEVEAIGHVRHKNLVR-LLGYCIEGVHRMLVYEYVNNG 267 (508)
Q Consensus 189 ~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~ei~~l~~l~h~niv~-~~~~~~~~~~~~lv~E~~~~g 267 (508)
...+.|++|.+|.||+|.+ .|..+|+|+-..+. ....+..|.++|..+.--++.+ +|.|-. .++.|||..|-
T Consensus 25 ~v~~~L~KG~~s~Vyl~~~-~~~~~a~Kvrr~ds--~r~~l~kEakiLeil~g~~~~p~vy~yg~----~~i~me~i~G~ 97 (201)
T COG2112 25 RVEKELAKGTTSVVYLGEW-RGGEVALKVRRRDS--PRRNLEKEAKILEILAGEGVTPEVYFYGE----DFIRMEYIDGR 97 (201)
T ss_pred hhhhhhhcccccEEEEeec-cCceEEEEEecCCc--chhhHHHHHHHHHHhhhcCCCceEEEech----hhhhhhhhcCc
Confidence 3456799999999999988 66689999765543 3456788999998887655543 444332 24569999988
Q ss_pred CHHHHHhhhhccCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCC-CCCEEEcCCCcEEEEecCCccc
Q 010519 268 NLEQWLHGAMRNQGNLTWEARMKVIIGTAKALAYLHEAIEPKVVHRDIK-SSNILIDDEFNAKVSDFGLAKL 338 (508)
Q Consensus 268 sL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiH~Dlk-~~NIll~~~~~~kl~Dfgla~~ 338 (508)
+|.++-.. . + .+-+..++++---|... ||-|+.|. |..++|..++.+.|+||..|..
T Consensus 98 ~L~~~~~~----~---~----rk~l~~vlE~a~~LD~~---GI~H~El~~~~k~vlv~~~~~~iIDFd~At~ 155 (201)
T COG2112 98 PLGKLEIG----G---D----RKHLLRVLEKAYKLDRL---GIEHGELSRPWKNVLVNDRDVYIIDFDSATF 155 (201)
T ss_pred chhhhhhc----c---c----HHHHHHHHHHHHHHHHh---ccchhhhcCCceeEEecCCcEEEEEccchhh
Confidence 88876431 0 1 22333455554445555 99999996 4444444455999999998874
|
|
| >PRK10593 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=97.74 E-value=0.0003 Score=69.74 Aligned_cols=78 Identities=10% Similarity=0.038 Sum_probs=55.2
Q ss_pred ccceeEeeeCceEEEEEEEcCCCEEEEEEEcccchhhHHHHHHHHHHHhcCCC---CCceeEEEEEEeC---ceeeEEEe
Q 010519 189 SAENVLGEGGYGVVYKGRLINGSEVAVKKLLNNLGQAEKEFRVEVEAIGHVRH---KNLVRLLGYCIEG---VHRMLVYE 262 (508)
Q Consensus 189 ~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~ei~~l~~l~h---~niv~~~~~~~~~---~~~~lv~E 262 (508)
.-.+.||.|..+.||.....++ .+++|.... ......+..|...|+.|.- -.+.++++++... +..+||||
T Consensus 17 ~~~~~i~~G~~~~vy~~~~~~~-~~~~k~~~~--~~~~~~~~~Ea~~L~~L~~~~~vpVP~V~~~~~~~~~~g~~~LVmE 93 (297)
T PRK10593 17 SRVECISEQPYAALWALYDSQG-NPMPLMARS--FSTPGVAQQEAWKLSMLARSGTVRMPTVYGVMTHEQSPGPDVLLLE 93 (297)
T ss_pred heeeecCCccceeEEEEEcCCC-CEEEEEecc--cccchHHHHHHHHHHHHccCCCCCcCcEEEEeccCCcCCCeEEEEe
Confidence 3346799999999999865444 466665322 1123578889998888843 3677888877643 56799999
Q ss_pred ecCCCCH
Q 010519 263 YVNNGNL 269 (508)
Q Consensus 263 ~~~~gsL 269 (508)
+++++++
T Consensus 94 ~i~G~~~ 100 (297)
T PRK10593 94 RLRGVSV 100 (297)
T ss_pred ccCCEec
Confidence 9998754
|
|
| >cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes | Back alignment and domain information |
|---|
Probab=97.57 E-value=0.00063 Score=64.82 Aligned_cols=73 Identities=16% Similarity=0.112 Sum_probs=45.3
Q ss_pred eeEeeeCceEEEEEEEcC--CCEEEEEEEcccchhhHHHHHHHHHHHhcCCCCCc-eeEEEEEEeCceeeEEEeecCCCC
Q 010519 192 NVLGEGGYGVVYKGRLIN--GSEVAVKKLLNNLGQAEKEFRVEVEAIGHVRHKNL-VRLLGYCIEGVHRMLVYEYVNNGN 268 (508)
Q Consensus 192 ~~lg~G~~g~Vy~~~~~~--~~~vavK~~~~~~~~~~~~~~~ei~~l~~l~h~ni-v~~~~~~~~~~~~~lv~E~~~~gs 268 (508)
+.|..|-...+|+....+ +..+++|........ ......|+.++..+....+ .++++.+. ..++|||++|.+
T Consensus 4 ~~l~gG~tN~~~~v~~~~~~~~~~vlR~~~~~~~~-~~d~~~E~~~~~~l~~~gl~P~v~~~~~----~~~l~e~i~G~~ 78 (235)
T cd05157 4 KRFTGGITNKLVKVSNKEDNQDAVLVRVYGNKTEL-IIDRERELRIHKLLSKHGLAPKLYATFQ----NGLIYEFIPGRT 78 (235)
T ss_pred EEcCCcccceEEEEEcCCCCCCeEEEEEccCCccc-eecHHHHHHHHHHHHhCCCCCeEEEEeC----CcEEEEeeCCCc
Confidence 467778888999987653 567888865432211 1123357888887754333 44444332 248999998876
Q ss_pred H
Q 010519 269 L 269 (508)
Q Consensus 269 L 269 (508)
+
T Consensus 79 l 79 (235)
T cd05157 79 L 79 (235)
T ss_pred C
Confidence 5
|
ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo |
| >PF13095 FTA2: Kinetochore Sim4 complex subunit FTA2 | Back alignment and domain information |
|---|
Probab=97.57 E-value=0.00085 Score=61.71 Aligned_cols=125 Identities=26% Similarity=0.403 Sum_probs=88.3
Q ss_pred CCcccceeEeeeCc-eEEEEEEEcCCCEEEEEEEcc---cc--------h----------hhHHHHHHHHHHHhcCC---
Q 010519 186 NRFSAENVLGEGGY-GVVYKGRLINGSEVAVKKLLN---NL--------G----------QAEKEFRVEVEAIGHVR--- 240 (508)
Q Consensus 186 ~~~~~~~~lg~G~~-g~Vy~~~~~~~~~vavK~~~~---~~--------~----------~~~~~~~~ei~~l~~l~--- 240 (508)
.+++.++.||.|.- |.||+++. +|..+|+|.... .. . ....-|..|.....+|+
T Consensus 37 ~~I~flefLg~g~~~~~V~kv~I-~g~~YALKlf~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PF~~ECRAfgRLke~~ 115 (207)
T PF13095_consen 37 DDIEFLEFLGHGSHDGYVFKVEI-DGRIYALKLFRFWDYTEPDYTRERFAGHETSLSTPAHYADPFNCECRAFGRLKEAG 115 (207)
T ss_pred CcEeeeeecCCCCceeEEEEEEE-CCeEEEEEEeeccccCCCccccccccccccccchhhhhcChHHHHHHhhHHHHhcc
Confidence 68889999999999 99999987 888999998321 00 0 01124667888777764
Q ss_pred CCCc--eeEEEEEEeCc------------------eeeEEEeecCCCCHHHHHhhhhccCCCccHHHHHHHHHHHHHHHH
Q 010519 241 HKNL--VRLLGYCIEGV------------------HRMLVYEYVNNGNLEQWLHGAMRNQGNLTWEARMKVIIGTAKALA 300 (508)
Q Consensus 241 h~ni--v~~~~~~~~~~------------------~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~ 300 (508)
+.++ |+.+||..-.. ...||.||.+... .+.. .-+.++.+-+.
T Consensus 116 ~e~~~Avkc~Gyl~L~~~~q~~~~~~~~~~~~~~~~~aIVKD~v~~~~-------------~~~~----~~~~~~~~dl~ 178 (207)
T PF13095_consen 116 REGLWAVKCHGYLLLTEDQQFEQLRQRGSDHRPLPIRAIVKDFVPDDP-------------PLQI----RDIPQMLRDLK 178 (207)
T ss_pred ccCceEEEeeEEEEEchHHHHHHhhcccccCCCCccEEEEEeecCCcc-------------ccch----hHHHHHHHHHH
Confidence 5566 89999874321 1247888876533 1222 23345666788
Q ss_pred HHHhcCCCCeEeecCCCCCEEEcCCCcEEEEecCCc
Q 010519 301 YLHEAIEPKVVHRDIKSSNILIDDEFNAKVSDFGLA 336 (508)
Q Consensus 301 yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~Dfgla 336 (508)
.+|.. +|+-+|+++.|.. .-||+|||.+
T Consensus 179 ~~~k~---gI~~~Dv~~~ny~-----~G~lvDfs~~ 206 (207)
T PF13095_consen 179 ILHKL---GIVPRDVKPRNYR-----GGKLVDFSSS 206 (207)
T ss_pred HHHHC---CeeeccCcccccc-----CCEEEecccC
Confidence 89998 9999999999986 4589999865
|
|
| >cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members | Back alignment and domain information |
|---|
Probab=97.57 E-value=0.00063 Score=64.94 Aligned_cols=32 Identities=31% Similarity=0.487 Sum_probs=26.3
Q ss_pred CCCeEeecCCCCCEEEcCCCcEEEEecCCccc
Q 010519 307 EPKVVHRDIKSSNILIDDEFNAKVSDFGLAKL 338 (508)
Q Consensus 307 ~~~iiH~Dlk~~NIll~~~~~~kl~Dfgla~~ 338 (508)
.+.++|+|+.+.||+++++...-|+||+.+..
T Consensus 163 ~~~l~HGD~~~~Nvlv~~~~i~giIDw~~a~~ 194 (235)
T cd05155 163 PPVWFHGDLAPGNLLVQDGRLSAVIDFGCLGV 194 (235)
T ss_pred CceEEeCCCCCCcEEEECCCEEEEEeCcccCc
Confidence 34599999999999998765557999997753
|
The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista |
| >PRK09550 mtnK methylthioribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=97.54 E-value=0.0014 Score=67.23 Aligned_cols=75 Identities=20% Similarity=0.291 Sum_probs=52.2
Q ss_pred eeEeeeCceEEEEEEEcCC-CEEEEEEEcccc-------hhhHHHHHHHHHHHhcCC---CCCceeEEEEEEeCceeeEE
Q 010519 192 NVLGEGGYGVVYKGRLING-SEVAVKKLLNNL-------GQAEKEFRVEVEAIGHVR---HKNLVRLLGYCIEGVHRMLV 260 (508)
Q Consensus 192 ~~lg~G~~g~Vy~~~~~~~-~~vavK~~~~~~-------~~~~~~~~~ei~~l~~l~---h~niv~~~~~~~~~~~~~lv 260 (508)
+.||.|.+..||++...+| +.++||.-.... ......+..|.+.|..+. -.++.+++.+ +....++|
T Consensus 32 ~elggGn~N~VyrV~~~~g~~svIVKqa~p~~r~~g~~wpl~~eR~~~Eae~L~~l~~~~p~~VPkV~~~--D~~~~~lV 109 (401)
T PRK09550 32 REIGDGNLNLVFRVSDTEGGKSVIVKQALPYVRVVGESWPLTLDRARIEAEALKIQAKYVPDLVPKVYHY--DEELAVTV 109 (401)
T ss_pred eEcCCCceEEEEEEEeCCCCeEEEEEecCcccccccccccccHHHHHHHHHHHHHHHhhCCCCCCeEEEE--CCCCCEEE
Confidence 5789999999999998766 489999753211 123345666777777762 2456667765 44567899
Q ss_pred EeecCCCC
Q 010519 261 YEYVNNGN 268 (508)
Q Consensus 261 ~E~~~~gs 268 (508)
|||+++..
T Consensus 110 ME~L~~~~ 117 (401)
T PRK09550 110 MEDLSDHK 117 (401)
T ss_pred EecCCCcc
Confidence 99998744
|
|
| >TIGR02721 ycfN_thiK thiamine kinase | Back alignment and domain information |
|---|
Probab=97.41 E-value=0.0015 Score=63.30 Aligned_cols=139 Identities=14% Similarity=0.093 Sum_probs=76.6
Q ss_pred EeeeCceEEEEEEEcCCCEEEEEEEcccchhhHHHHHHHHHHHhcCCCCCc-eeEEEEEEeCceeeEEEeecCCCCHHH-
Q 010519 194 LGEGGYGVVYKGRLINGSEVAVKKLLNNLGQAEKEFRVEVEAIGHVRHKNL-VRLLGYCIEGVHRMLVYEYVNNGNLEQ- 271 (508)
Q Consensus 194 lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~ei~~l~~l~h~ni-v~~~~~~~~~~~~~lv~E~~~~gsL~~- 271 (508)
+..|-...+|+... ++..+++|..........-....|..+++.+....+ .+++..+. .++||||++|..+..
T Consensus 4 ~~~G~tn~~y~~~~-~~~~~vlR~~~~~~~~~~~~r~~E~~~l~~l~~~g~~P~~i~~~~----~~~v~e~i~G~~~~~~ 78 (256)
T TIGR02721 4 LSGGLTNRSWRIEH-PGISFVWRPQSPVCKALGVDRQREYQILQALSALGLAPKPILVNE----HWLLVEWLEGEVITLD 78 (256)
T ss_pred CCCcCcCCeEEEEe-CCccEEEeeCCcccccccCcHHHHHHHHHHHHhcCCCCceEEEeC----CEEEEEeccCcccccc
Confidence 45677788998864 677788886433221111124568888887754333 33444332 368999999876532
Q ss_pred -------------H---HhhhhccCCCccHHH-HHHHHHH---------HHHHHHHHHhc-----CCCCeEeecCCCCCE
Q 010519 272 -------------W---LHGAMRNQGNLTWEA-RMKVIIG---------TAKALAYLHEA-----IEPKVVHRDIKSSNI 320 (508)
Q Consensus 272 -------------~---l~~~~~~~~~l~~~~-~~~i~~~---------i~~al~yLH~~-----~~~~iiH~Dlk~~NI 320 (508)
. ||.......++.... ...+..+ +...+..+-.. ..+.++|+|+.|.||
T Consensus 79 ~~~~~~~~~~la~~l~~lH~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~H~Dl~~~Ni 158 (256)
T TIGR02721 79 QFVALDLLLELAALLHQLHSQPRFGYPLSLKARIAHYWLQIDPARRTPEWLRLYKQFRSAPEPAPLPLAPLHMDVHAYNL 158 (256)
T ss_pred cccCchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHhcccccCChHHHHHHHHHHhccCCCCCCCeeecCCCCcCcE
Confidence 1 121101111222111 1111111 11112222111 133689999999999
Q ss_pred EEcCCCcEEEEecCCccc
Q 010519 321 LIDDEFNAKVSDFGLAKL 338 (508)
Q Consensus 321 ll~~~~~~kl~Dfgla~~ 338 (508)
++++++ +.|+||..+..
T Consensus 159 l~~~~~-~~lIDwE~a~~ 175 (256)
T TIGR02721 159 VVTPQG-LKLIDWEYASD 175 (256)
T ss_pred EEeCCC-CEEEeccccCc
Confidence 999877 78999998864
|
Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function. |
| >PRK05231 homoserine kinase; Provisional | Back alignment and domain information |
|---|
Probab=97.40 E-value=0.0058 Score=61.14 Aligned_cols=143 Identities=16% Similarity=0.192 Sum_probs=75.2
Q ss_pred eeEeeeCceEEEEEEEcCCCEEEEEEEcccchhhHHHHHHHHHHHhcCCCC--CceeEEE------EEEeCceeeEEEee
Q 010519 192 NVLGEGGYGVVYKGRLINGSEVAVKKLLNNLGQAEKEFRVEVEAIGHVRHK--NLVRLLG------YCIEGVHRMLVYEY 263 (508)
Q Consensus 192 ~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~ei~~l~~l~h~--niv~~~~------~~~~~~~~~lv~E~ 263 (508)
+.|+.|....+|+....+| .+++|+.. . .....+..|+.++..|... .+.+++. +....+..++++||
T Consensus 28 ~~l~~G~~n~~y~v~t~~g-~~vLK~~~-~--~~~~~l~~~~~~l~~L~~~glpvP~~i~~~~G~~~~~~~g~~~~l~~~ 103 (319)
T PRK05231 28 KGIAEGIENSNFFLTTTQG-EYVLTLFE-R--LTAEDLPFFLGLMQHLAARGVPVPAPVARRDGAALGELAGKPAAIVTF 103 (319)
T ss_pred chhccccccceEEEEeCCC-cEEEEEec-c--CChHHhHHHHHHHHHHHHCCCCCCcceeCCCCCEeeeeCCEEEEEEEe
Confidence 4466777778999876444 68888764 1 1123333455555554211 1223332 12234567899999
Q ss_pred cCCCCHH-----------HH---HhhhhccC-------CCccH-HHHHH------------HHHH-HHHHHHHHHh----
Q 010519 264 VNNGNLE-----------QW---LHGAMRNQ-------GNLTW-EARMK------------VIIG-TAKALAYLHE---- 304 (508)
Q Consensus 264 ~~~gsL~-----------~~---l~~~~~~~-------~~l~~-~~~~~------------i~~~-i~~al~yLH~---- 304 (508)
++|..+. .. +|...... ..+.| ..... .+.+ +...+..+..
T Consensus 104 l~G~~~~~~~~~~~~~~G~~LA~lH~~~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 183 (319)
T PRK05231 104 LEGKWPRAPTAAHCAEVGEMLARMHLAGRDFPLERPNLRGLAWWRELAPRLLPFLADEQAALLEAELAAQLAFLASAAWP 183 (319)
T ss_pred cCCCCCCCCCHHHHHHHHHHHHHHHhhhhcCCccCCCCCChHHHHHHHHHHhhccChhHHHHHHHHHHHHHHhhhccccc
Confidence 9887431 11 12111110 01111 11111 1111 1122233321
Q ss_pred cCCCCeEeecCCCCCEEEcCCCcEEEEecCCccc
Q 010519 305 AIEPKVVHRDIKSSNILIDDEFNAKVSDFGLAKL 338 (508)
Q Consensus 305 ~~~~~iiH~Dlk~~NIll~~~~~~kl~Dfgla~~ 338 (508)
....++||+|+.+.||+++++...-|+||+.+..
T Consensus 184 ~lp~~liHgD~~~~Nil~~~~~~~~iIDf~~~~~ 217 (319)
T PRK05231 184 ALPRGVIHADLFRDNVLFEGDRLSGFIDFYFACN 217 (319)
T ss_pred cCCcccCCCCCCCCcEEEECCceEEEEecccccC
Confidence 1345899999999999999765557999998763
|
|
| >cd05153 HomoserineK_II Homoserine Kinase, type II | Back alignment and domain information |
|---|
Probab=97.31 E-value=0.0022 Score=63.39 Aligned_cols=144 Identities=17% Similarity=0.183 Sum_probs=83.5
Q ss_pred ceeEeeeCceEEEEEEEcCCCEEEEEEEcccchhhHHHHHHHHHHHhcCCCC--CceeEEEE------EEeCceeeEEEe
Q 010519 191 ENVLGEGGYGVVYKGRLINGSEVAVKKLLNNLGQAEKEFRVEVEAIGHVRHK--NLVRLLGY------CIEGVHRMLVYE 262 (508)
Q Consensus 191 ~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~ei~~l~~l~h~--niv~~~~~------~~~~~~~~lv~E 262 (508)
.+.|..|....+|+... ++..+++|.... .....+..|+.++..+.+. .+.+++.. ....+..++|++
T Consensus 19 i~~i~~G~~n~~y~v~~-~~~~~vLr~~~~---~~~~~~~~e~~~l~~L~~~g~~vp~~i~~~~g~~~~~~~~~~~~l~~ 94 (296)
T cd05153 19 FEGISAGIENTNYFVTT-DSGRYVLTLFEK---VSAEELPFFLALLDHLAERGLPVPRPIADRDGEYLSELAGKPAALVE 94 (296)
T ss_pred eecccCccccceEEEEe-CCCcEEEEEcCC---CChHhccHHHHHHHHHHHCCCCCCccccCCCCcEeeeeCCceEEEEE
Confidence 45577787789999866 445788887643 2234456677777777432 24444331 123345689999
Q ss_pred ecCCCCHHH--------------HHhhhhccC-------CCccHHHHH----------HHHHHHHHHHHHHHh----cCC
Q 010519 263 YVNNGNLEQ--------------WLHGAMRNQ-------GNLTWEARM----------KVIIGTAKALAYLHE----AIE 307 (508)
Q Consensus 263 ~~~~gsL~~--------------~l~~~~~~~-------~~l~~~~~~----------~i~~~i~~al~yLH~----~~~ 307 (508)
|++|..+.. .||...... ....|.... .....+..++.++.. ...
T Consensus 95 ~i~G~~~~~~~~~~~~~lg~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~~~~~~~ 174 (296)
T cd05153 95 FLAGEHLTRPTAAHCRQIGEALARLHLAAQSFPGERNNLRGLAWIRELGKDLLPLLSAEDRALLADELARQDAFDPSDLP 174 (296)
T ss_pred eCCCCCCCCCCHHHHHHHHHHHHHHHHHhccCCccCCCcCCcHHHHHHHHHhccccCHHHHHHHHHHHHHHHhhhhhcCC
Confidence 998876421 112111110 011111110 011123344555543 123
Q ss_pred CCeEeecCCCCCEEEcCCCcEEEEecCCccc
Q 010519 308 PKVVHRDIKSSNILIDDEFNAKVSDFGLAKL 338 (508)
Q Consensus 308 ~~iiH~Dlk~~NIll~~~~~~kl~Dfgla~~ 338 (508)
.+++|+|+.|.||++++++.+.|+||+.+..
T Consensus 175 ~~l~HgD~~~~Nil~~~~~~~~iIDfe~a~~ 205 (296)
T cd05153 175 RGVIHADLFRDNVLFDGDELSGVIDFYFACT 205 (296)
T ss_pred CcCCccCcCcccEEEeCCceEEEeehhhhcC
Confidence 4799999999999999987778999997763
|
Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine. |
| >KOG2268 consensus Serine/threonine protein kinase [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=97.18 E-value=0.0003 Score=68.53 Aligned_cols=135 Identities=18% Similarity=0.104 Sum_probs=91.3
Q ss_pred CcccceeEeeeCceEEEEEEEcCCCEEEEEEEc----------ccc------h------hhHHHHHHHHHHHhcCC-CCC
Q 010519 187 RFSAENVLGEGGYGVVYKGRLINGSEVAVKKLL----------NNL------G------QAEKEFRVEVEAIGHVR-HKN 243 (508)
Q Consensus 187 ~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~----------~~~------~------~~~~~~~~ei~~l~~l~-h~n 243 (508)
=+++++.||-|--+.+|.+-+.+|.+.++|.-. .+. . -+.-....|+..|+.|. |..
T Consensus 93 v~svGnqIGVGKESDIY~v~d~~G~~~~lK~HRLGRtSFR~Vk~kRDY~r~r~~~sWlyLSRlaa~kEfafmkaL~e~gf 172 (465)
T KOG2268|consen 93 VESVGNQIGVGKESDIYVVADEEGNPLILKLHRLGRTSFRNVKNKRDYLRKRKSGSWLYLSRLAATKEFAFMKALYERGF 172 (465)
T ss_pred hhhhccccccccccceEEEecCCCCchhHHHHhhhhhhHHHhhhhhhhHhcCCccchhhhHHHHHHHHHHHHHHHHHcCC
Confidence 467889999999999999998889999888321 000 0 00113445777787774 332
Q ss_pred -ceeEEEEEEeCceeeEEEeecCCCCHHHHHhhhhccCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCEEE
Q 010519 244 -LVRLLGYCIEGVHRMLVYEYVNNGNLEQWLHGAMRNQGNLTWEARMKVIIGTAKALAYLHEAIEPKVVHRDIKSSNILI 322 (508)
Q Consensus 244 -iv~~~~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiH~Dlk~~NIll 322 (508)
+...+++ +..++|||++.+-.|...-+ ..+. ..+...+..-+.-|-.+ |+||+|.+--||++
T Consensus 173 pVPkpiD~----~RH~Vvmelv~g~Pl~~v~~-------v~d~---~~ly~~lm~~Iv~la~~---GlIHgDFNEFNimv 235 (465)
T KOG2268|consen 173 PVPKPIDH----NRHCVVMELVDGYPLRQVRH-------VEDP---PTLYDDLMGLIVRLANH---GLIHGDFNEFNIMV 235 (465)
T ss_pred CCCCcccc----cceeeHHHhhcccceeeeee-------cCCh---HHHHHHHHHHHHHHHHc---CceecccchheeEE
Confidence 3334443 45679999998877765321 1122 23333344445556677 99999999999999
Q ss_pred cCCCcEEEEecCCccc
Q 010519 323 DDEFNAKVSDFGLAKL 338 (508)
Q Consensus 323 ~~~~~~kl~Dfgla~~ 338 (508)
++++.++++||--...
T Consensus 236 ~dd~~i~vIDFPQmvS 251 (465)
T KOG2268|consen 236 KDDDKIVVIDFPQMVS 251 (465)
T ss_pred ecCCCEEEeechHhhc
Confidence 9999999999986543
|
|
| >TIGR00938 thrB_alt homoserine kinase, Neisseria type | Back alignment and domain information |
|---|
Probab=97.16 E-value=0.0077 Score=59.97 Aligned_cols=144 Identities=17% Similarity=0.203 Sum_probs=79.4
Q ss_pred ceeEeeeCceEEEEEEEcCCCEEEEEEEcccchhhHHHHHHHHHHHhcCCCCC--ceeEEEE------EEeCceeeEEEe
Q 010519 191 ENVLGEGGYGVVYKGRLINGSEVAVKKLLNNLGQAEKEFRVEVEAIGHVRHKN--LVRLLGY------CIEGVHRMLVYE 262 (508)
Q Consensus 191 ~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~ei~~l~~l~h~n--iv~~~~~------~~~~~~~~lv~E 262 (508)
.+.++.|....+|+....+| .+++|....... ...+..|++++..|.... +.+++.. ....+..+++++
T Consensus 27 i~~~~~G~~n~~y~v~t~~~-~~vLK~~~~~~~--~~~i~~e~~~l~~L~~~g~pvp~~i~t~~g~~~~~~~g~~~~l~e 103 (307)
T TIGR00938 27 LKGIAEGVENSNYLLTTDVG-RYILTLYEKRVK--AEELPFFLALTTHLAARGLPVPKPVKSRDGRQLSTLAGKPACLVE 103 (307)
T ss_pred ccccCCccccceEEEEeCCC-cEEEEEecCCCC--HHHHHHHHHHHHHHHHCCCCCCccccCCCCCeehhcCCeEEEEEE
Confidence 34577777788999876444 577786543211 233445666666663221 3333331 122355689999
Q ss_pred ecCCCCHH-----------H---HHhhhhccC-----C---CccHHHHH------------HHHHHHHHHHHHHHh----
Q 010519 263 YVNNGNLE-----------Q---WLHGAMRNQ-----G---NLTWEARM------------KVIIGTAKALAYLHE---- 304 (508)
Q Consensus 263 ~~~~gsL~-----------~---~l~~~~~~~-----~---~l~~~~~~------------~i~~~i~~al~yLH~---- 304 (508)
|++|..+. . .+|...... . .-.|.... .....+...+.++..
T Consensus 104 ~i~G~~~~~~~~~~~~~~G~~LA~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~l~~~~~~~l~~~~~~l~~~~~~ 183 (307)
T TIGR00938 104 FLQGLSVGRPTAMHCRPVGEVLAWMHLAGAHFPENRKNSLRLEAWHILAEKCFEAAPQLEAHMGAELDKELDYLDKFWPR 183 (307)
T ss_pred eCCCCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCCCCCCChHHHHHHHHhhhhcccccCHHHHHHHHHHHHHHHhhhhh
Confidence 99885431 1 122111110 0 01111100 011123344555532
Q ss_pred cCCCCeEeecCCCCCEEEcCCCcEEEEecCCcc
Q 010519 305 AIEPKVVHRDIKSSNILIDDEFNAKVSDFGLAK 337 (508)
Q Consensus 305 ~~~~~iiH~Dlk~~NIll~~~~~~kl~Dfgla~ 337 (508)
...++++|+|+.+.||++++++...|+||+.+.
T Consensus 184 ~~~~~l~HgD~~~~Nvl~~~~~~~~vIDfd~~~ 216 (307)
T TIGR00938 184 DLPRGVIHADLFPDNVLFDGDSVKGVIDFYFAC 216 (307)
T ss_pred cCCCccCCCCCCcCcEEEECCceEEEeeccccc
Confidence 234589999999999999988767899999775
|
Homoserine kinase is required in the biosynthesis of threonine from aspartate.The member of this family from Pseudomonas aeruginosa was shown by direct assay and complementation to act specifically as a homoserine kinase. |
| >KOG1826 consensus Ras GTPase activating protein RasGAP/neurofibromin [Defense mechanisms] | Back alignment and domain information |
|---|
Probab=97.05 E-value=0.00012 Score=83.32 Aligned_cols=161 Identities=14% Similarity=0.048 Sum_probs=116.6
Q ss_pred HHHHHHHHhcCCCCCceeEEEEEEe--CceeeEEEeecCCCCHHHHHhhhhccCCCccHHHHHHHHHHHHHHHHHHHhcC
Q 010519 229 FRVEVEAIGHVRHKNLVRLLGYCIE--GVHRMLVYEYVNNGNLEQWLHGAMRNQGNLTWEARMKVIIGTAKALAYLHEAI 306 (508)
Q Consensus 229 ~~~ei~~l~~l~h~niv~~~~~~~~--~~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~ 306 (508)
...|.+.++...|+++...+.=... ....+..++|+.+|.+++.|.+...+...+....+...-.+.+.+..-+|+..
T Consensus 1276 ll~e~de~~~~~h~~~~~~p~rI~ps~s~ee~~r~~~~~~g~~f~iIikg~ee~~~ld~~~v~~~~kvsvl~~~~~ls~t 1355 (2724)
T KOG1826|consen 1276 LLSERDELREAKHYLTEVDPLRIPPSESTEEYIRSLYVEFGKLFSIIIKGLEESPDLDRSPVHLRHKVSVLNRNVILSLT 1355 (2724)
T ss_pred hhhhhhhhhhhhceeeecccccCCCCCChHHHHHHHHHHHhHHHHHHHhccccCCcchhchHHHHHHHHHhccchhhhcc
Confidence 4445666667789888776654433 24457899999999999999765444444544444333333355555555432
Q ss_pred --CCCeEeecCCCCCEEEcCCCcEEEEecCCccccCCCCCcccccccccccccCccccCCCCCCChhhHHHHHHHHHHHH
Q 010519 307 --EPKVVHRDIKSSNILIDDEFNAKVSDFGLAKLLDSGESHITTRVMGTFGYVAPEYANTGMLNEKSDIYSFGVLLLEAV 384 (508)
Q Consensus 307 --~~~iiH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~ell 384 (508)
..-.+|++||+-|.++..+.++|++++|+.+...... ...+..++++.|+.|++.+.-.++.++|+|..|+-+|+..
T Consensus 1356 nlg~T~v~~~Lkf~lpmIVtny~v~~gk~gLdKIknp~~-sf~Gl~l~sp~~v~qli~N~ik~t~rsdilr~s~~ly~rs 1434 (2724)
T KOG1826|consen 1356 NLGNTNVSKSLKFTLPMIVTNYNVKLGKGGLDKIKNPVL-SFFGLELCSPIYVLQLIKNEIKFTKRSDILRRSLSLYLRS 1434 (2724)
T ss_pred cCCccchhhhhhhhccceecCCcccccccccccccCchH-hhhhhhhCCHHHHHHHHHHHHhhhhHHHHHHHHHHHHHHh
Confidence 2236899999999999999999999999999433222 2344556788999999998888998999999999999998
Q ss_pred hCCCCC
Q 010519 385 TGRDPV 390 (508)
Q Consensus 385 tG~~Pf 390 (508)
-|..+|
T Consensus 1435 ~~n~~f 1440 (2724)
T KOG1826|consen 1435 DGNAYF 1440 (2724)
T ss_pred cccHHH
Confidence 887775
|
|
| >cd05156 ChoK_euk Choline Kinase (ChoK) in eukaryotes | Back alignment and domain information |
|---|
Probab=97.05 E-value=0.0062 Score=60.42 Aligned_cols=141 Identities=21% Similarity=0.249 Sum_probs=79.8
Q ss_pred eeEeeeCceEEEEEEEcC-------CCEEEEEEEcccchhhHHHHHHHHHHHhcCCCCCc-eeEEEEEEeCceeeEEEee
Q 010519 192 NVLGEGGYGVVYKGRLIN-------GSEVAVKKLLNNLGQAEKEFRVEVEAIGHVRHKNL-VRLLGYCIEGVHRMLVYEY 263 (508)
Q Consensus 192 ~~lg~G~~g~Vy~~~~~~-------~~~vavK~~~~~~~~~~~~~~~ei~~l~~l~h~ni-v~~~~~~~~~~~~~lv~E~ 263 (508)
+.|..|-...+|+....+ +..+++|....... .......|..++..+....+ .++++++.. .+|+||
T Consensus 4 ~~l~gGltN~~y~v~~~~~~~~~~~~~~~vlRi~~~~~~-~~~~r~~E~~~~~~l~~~g~~P~~~~~~~~----~~v~e~ 78 (302)
T cd05156 4 SKISGGLTNAVYKVSLPDEDALSDEPRKVLLRVYGQSVE-LLIDRERELVVFARLSERNLGPKLYGIFPN----GRIEEF 78 (302)
T ss_pred EEecCcccceeEEEEcCCcccccCCCCeEEEEEecCCCc-ceechHHHHHHHHHHHhCCCCCceEEEeCC----Cchhhe
Confidence 456667777899887644 47788887544322 22344567777777743333 345555432 368999
Q ss_pred cCCCCHHHH-----------------HhhhhccC-C----Cc--cHHHHHH--------------------------HHH
Q 010519 264 VNNGNLEQW-----------------LHGAMRNQ-G----NL--TWEARMK--------------------------VII 293 (508)
Q Consensus 264 ~~~gsL~~~-----------------l~~~~~~~-~----~l--~~~~~~~--------------------------i~~ 293 (508)
++|..+... ||...... . .. -+..... +..
T Consensus 79 i~G~~l~~~~~~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 158 (302)
T cd05156 79 IPSRTLTTEELRDPDISAEIARRMAKLHSIVVPLSPEERDLTPAIWKLLKQWLDLAETVIEIVDSDSEKLLEVELSLFLE 158 (302)
T ss_pred eCCCcCCHhHcCCcHHHHHHHHHHHHhhCCCCCCCCCcCcccchHHHHHHHHHHHhhhhhhhcccchhhhhhhhHHHHHH
Confidence 988765321 11111110 0 00 0111100 111
Q ss_pred HHHHHHHHHHh------cCCCCeEeecCCCCCEEEcCC----CcEEEEecCCcc
Q 010519 294 GTAKALAYLHE------AIEPKVVHRDIKSSNILIDDE----FNAKVSDFGLAK 337 (508)
Q Consensus 294 ~i~~al~yLH~------~~~~~iiH~Dlk~~NIll~~~----~~~kl~Dfgla~ 337 (508)
.+...+.+|-. .....++|+|+.+.||+++++ +.+.|+||..+.
T Consensus 159 ~~~~~~~~l~~~~~~~~~~~~~lcH~Dl~~~Nil~~~~~~~~~~i~lIDwEya~ 212 (302)
T cd05156 159 DEAKYLRFLLESTSEESGSPVVFCHNDLQEGNILLLNPSSETKKLVLIDFEYAS 212 (302)
T ss_pred HHHHHHHHHHhhccCCCCCCceEEecCCCcCeEEecCCCCCCCcEEEEeeCCCC
Confidence 22223334432 134579999999999999985 889999999876
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC) and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. ChoK plays an important role in cell signaling pathways and the regulation of cell growth. Along with PCho, it is involved in malignant transformation through Ras oncogenes in various human cancer |
| >PF03881 Fructosamin_kin: Fructosamine kinase; InterPro: IPR016477 Ketosamines derive from a non-enzymatic reaction between a sugar and a protein [] | Back alignment and domain information |
|---|
Probab=96.91 E-value=0.011 Score=58.11 Aligned_cols=75 Identities=15% Similarity=0.231 Sum_probs=47.1
Q ss_pred ccceeEeeeCceEEEEEEEcCCCEEEEEEEcccchhhHHHHHHHHHHHhcC---CCCCceeEEEEEEeCceeeEEEeecC
Q 010519 189 SAENVLGEGGYGVVYKGRLINGSEVAVKKLLNNLGQAEKEFRVEVEAIGHV---RHKNLVRLLGYCIEGVHRMLVYEYVN 265 (508)
Q Consensus 189 ~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~ei~~l~~l---~h~niv~~~~~~~~~~~~~lv~E~~~ 265 (508)
+-.+.|+.|....+|+.. .+++.+.||.-. ......|..|..-|+.| .--.+.+++++....+..++|+||++
T Consensus 20 ~~~~~v~GG~i~~a~~~~-~~~~~~FvK~~~---~~~~~~f~~Ea~gL~~L~~~~~~~vP~vi~~G~~~~~~fLlle~l~ 95 (288)
T PF03881_consen 20 TSIEPVSGGDINEAYRLD-TDGGSYFVKVNS---ESGRDMFEGEAEGLKALAEANPIRVPKVIAWGEYDDDAFLLLEFLE 95 (288)
T ss_dssp -EEEEE--SSSSEEEEEE-TTS-EEEEEEEE---GGGCCHHHHHHHHHHHHCHTTTSBS--EEEEEE-SSCCEEEEE---
T ss_pred eeeEecCCCChhheEEEE-CCCccEEEEecC---hhhHHHHHHHHHHHHHHHhcCCCCCCeEEEEEeecCCceEEEEeec
Confidence 345678989999999986 588899999765 22234566777777776 34567788998887778899999998
Q ss_pred CC
Q 010519 266 NG 267 (508)
Q Consensus 266 ~g 267 (508)
.+
T Consensus 96 ~~ 97 (288)
T PF03881_consen 96 MG 97 (288)
T ss_dssp --
T ss_pred CC
Confidence 77
|
Ketosamine-3-kinases (KT3K), of which fructosamine-3-kinase (FN3K) is the best-known example, catalyse the phosphorylation of the ketosamine moiety of glycated proteins. The instability of a phosphorylated ketosamine leads to its degradation, and KT3K is thus thought to be involved in protein repair []. The function of the prokaryotic members of this group has not been established. However, several lines of evidence indicate that they may function as fructosamine-3-kinases (FN3K). First, they are similar to characterised FN3K from mouse and human. Second, the Escherichia coli members are found in close proximity on the genome to fructose-6-phosphate kinase (PfkB). Last, FN3K activity has been found in a Anacystis montana (Gloeocapsa montana Kutzing 1843) [], indicating such activity-directly demonstrated in eukaryotes-is nonetheless not confined to eukaryotes. This family includes eukaryotic fructosamine-3-kinase enzymes [] which may initiate a process leading to the deglycation of fructoselysine and of glycated proteins and in the phosphorylation of 1-deoxy-1-morpholinofructose, fructoselysine, fructoseglycine, fructose and glycated lysozyme. The family also includes bacterial members that have not been characterised but probably have a similar or identical function. For additional information please see [].; PDB: 3JR1_B 3F7W_A. |
| >cd05152 MPH2' Macrolide 2'-Phosphotransferase (MPH2') | Back alignment and domain information |
|---|
Probab=96.84 E-value=0.011 Score=58.01 Aligned_cols=32 Identities=31% Similarity=0.522 Sum_probs=26.4
Q ss_pred CCCeEeecCCCCCEEEcCCCcE-EEEecCCccc
Q 010519 307 EPKVVHRDIKSSNILIDDEFNA-KVSDFGLAKL 338 (508)
Q Consensus 307 ~~~iiH~Dlk~~NIll~~~~~~-kl~Dfgla~~ 338 (508)
.+.++|+|+.+.|||+++++.+ -|+||+.+..
T Consensus 184 ~~~lvHGD~~~~Nilv~~~~~~~gviDWe~a~i 216 (276)
T cd05152 184 HTVLVHGDLHPGHILIDEDARVTGLIDWTEAKV 216 (276)
T ss_pred CCeeEeCCCCCCcEEEeCCCCEEEEECcHhccc
Confidence 3468999999999999976664 5999998764
|
MPH2' is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). MPH2' catalyzes the transfer of the gamma-phosphoryl group from ATP to the 2'-hydroxyl of macrolide antibiotics such as erythromycin, clarithromycin, and azithromycin, among others. Macrolides penetrate the bacterial cell and bind to ribosomes, where it interrupts protein elongation, leading ultimately to the demise of the bacterium. Phosphorylation of macrolides leads to their inactivation. Based on substrate specificity and amino acid sequence, MPH2' is divided into types I and II, encoded by mphA and mphB genes, respectively. MPH2'I inactivates 14-membered ring macrolides while MPH2'II inactivates both 14- and 16-membered ring macrolides. Enzymatic inactivation of macrolides has been reported |
| >KOG2270 consensus Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=96.73 E-value=0.014 Score=58.14 Aligned_cols=142 Identities=16% Similarity=0.207 Sum_probs=92.5
Q ss_pred cceeEeeeCceEEEEEEEcCCCEEEEEEEcccc------h----------------hhHH----HHHHHHHHHhcCCCCC
Q 010519 190 AENVLGEGGYGVVYKGRLINGSEVAVKKLLNNL------G----------------QAEK----EFRVEVEAIGHVRHKN 243 (508)
Q Consensus 190 ~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~------~----------------~~~~----~~~~ei~~l~~l~h~n 243 (508)
+...|..|--+-||.++-.+|..+|||++.... . ...+ -...|+.-|.+|+...
T Consensus 148 inGCiSTGKEANVYHat~~dG~~~AIKIYKTSILvFKDRdRYV~GEfRFRhgyck~NPRKMVk~WAEKE~RNLkRl~~aG 227 (520)
T KOG2270|consen 148 INGCISTGKEANVYHATEEDGSEFAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKHNPRKMVKTWAEKEMRNLKRLNNAG 227 (520)
T ss_pred cccccccCccceeEeeecCCCceEEEEEEeeeEEEEechhhhccceeeeecccccCCcHHHHHHHHHHHHHHHHHHHhcC
Confidence 345688888899999998899999999763211 0 0011 1234666677765443
Q ss_pred ceeEEEEEEeCceeeEEEeecCCCCHHHHHhhhhccCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCEEEc
Q 010519 244 LVRLLGYCIEGVHRMLVYEYVNNGNLEQWLHGAMRNQGNLTWEARMKVIIGTAKALAYLHEAIEPKVVHRDIKSSNILID 323 (508)
Q Consensus 244 iv~~~~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiH~Dlk~~NIll~ 323 (508)
|.-.--+.. ....|||+|+....... .....-.++...+..+-.+++.-+.-|-..+ ++||.||.--|+|+.
T Consensus 228 IP~PePIlL--k~hVLVM~FlGrdgw~a----PkLKd~~ls~~ka~~~Y~~~v~~MR~lY~~c--~LVHADLSEfN~Lyh 299 (520)
T KOG2270|consen 228 IPCPEPILL--KNHVLVMEFLGRDGWAA----PKLKDASLSTSKARELYQQCVRIMRRLYQKC--RLVHADLSEFNLLYH 299 (520)
T ss_pred CCCCCceee--ecceEeeeeccCCCCcC----cccccccCChHHHHHHHHHHHHHHHHHHHHh--ceeccchhhhhheEE
Confidence 322111111 12369999985322111 1123345666778888888888888776555 899999999999987
Q ss_pred CCCcEEEEecCCccccC
Q 010519 324 DEFNAKVSDFGLAKLLD 340 (508)
Q Consensus 324 ~~~~~kl~Dfgla~~~~ 340 (508)
+ |.+.|+|-+.+....
T Consensus 300 d-G~lyiIDVSQSVE~D 315 (520)
T KOG2270|consen 300 D-GKLYIIDVSQSVEHD 315 (520)
T ss_pred C-CEEEEEEccccccCC
Confidence 5 589999998886543
|
|
| >PLN02756 S-methyl-5-thioribose kinase | Back alignment and domain information |
|---|
Probab=96.58 E-value=0.03 Score=57.43 Aligned_cols=73 Identities=12% Similarity=0.200 Sum_probs=48.5
Q ss_pred ceeEeeeCceEEEEEEEcCCCEEEEEEEcccch-------hhHHHHHHHHHHHhcCC---CCCceeEEEEEEeCceeeEE
Q 010519 191 ENVLGEGGYGVVYKGRLINGSEVAVKKLLNNLG-------QAEKEFRVEVEAIGHVR---HKNLVRLLGYCIEGVHRMLV 260 (508)
Q Consensus 191 ~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~-------~~~~~~~~ei~~l~~l~---h~niv~~~~~~~~~~~~~lv 260 (508)
.+.||.|..-.||+... .+..++||+-..... .....-..|...|+.+. ..++.+++.++. ...+++
T Consensus 37 ~~eiggGn~N~VyrV~~-~~~svVVKqa~p~~r~vga~wpl~~~R~~~Ea~aL~~~~~~~p~~VPkVy~~de--d~~vlv 113 (418)
T PLN02756 37 IKEVGDGNLNFVYIVVS-SSGSFVIKQALPYIRCIGESWPMTKERAYFEATALREHGRLCPDHVPEVYHFDR--TMALIG 113 (418)
T ss_pred EEEcCCCceeeEEEEEc-CCccEEEEeCCccccCCCccccCCccHHHHHHHHHHHhhhcCCCCCCeEEEECC--CCCEEE
Confidence 46789999999999876 556788987642111 12222333566666553 247778888876 446789
Q ss_pred EeecCC
Q 010519 261 YEYVNN 266 (508)
Q Consensus 261 ~E~~~~ 266 (508)
|||+++
T Consensus 114 ME~L~~ 119 (418)
T PLN02756 114 MRYLEP 119 (418)
T ss_pred EeecCC
Confidence 999977
|
|
| >PF01102 Glycophorin_A: Glycophorin A; InterPro: IPR001195 Proteins in this group are responsible for the molecular basis of the blood group antigens, surface markers on the outside of the red blood cell membrane | Back alignment and domain information |
|---|
Probab=96.57 E-value=0.001 Score=55.63 Aligned_cols=36 Identities=28% Similarity=0.283 Sum_probs=19.7
Q ss_pred cchhHHHHHHHHHHHHHHHHHHHHhhhheecccccc
Q 010519 18 LGLKLWVLIGISVGAFIVLILCILSVWVSFRRKSRK 53 (508)
Q Consensus 18 ~~~~~~~~igi~~g~~~~~~l~~~~~~~~~rr~~~~ 53 (508)
-+|...+++||++|+++-++++|++++|+.||++||
T Consensus 59 h~fs~~~i~~Ii~gv~aGvIg~Illi~y~irR~~Kk 94 (122)
T PF01102_consen 59 HRFSEPAIIGIIFGVMAGVIGIILLISYCIRRLRKK 94 (122)
T ss_dssp SSSS-TCHHHHHHHHHHHHHHHHHHHHHHHHHHS--
T ss_pred cCccccceeehhHHHHHHHHHHHHHHHHHHHHHhcc
Confidence 355666778888877766555555544444444443
|
Most of these markers are proteins, but some are carbohydrates attached to lipids or proteins [Reid M.E., Lomas-Francis C. The Blood Group Antigen FactsBook Academic Press, London / San Diego, (1997)]. Glycophorin A (PAS-2) and glycophorin B (PAS-3) belong to the MNS blood group system and are associated with antigens that include M/N, S/s, U, He, Mi(a), M(c), Vw, Mur, M(g), Vr, M(e), Mt(a), St(a), Ri(a), Cl(a), Ny(a), Hut, Hil, M(v), Far, Mit, Dantu, Hop, Nob, En(a), ENKT, amongst others. Glycophorin A is the major sialoglycoprotein of the erythrocyte membrane []. Structurally, glycophorin A consists of an N-terminal extracellular domain, heavily glycosylated on serine and threonine residues, followed by a transmembrane region and a C-terminal cytoplasmic domain. Other glycophorins in this entry such as Glycophorin B and Glycophorin E represent minor sialoglycoproteins in the erythrocyte membrane.; GO: 0016021 integral to membrane; PDB: 2KPF_B 1AFO_B 2KPE_A. |
| >COG3173 Predicted aminoglycoside phosphotransferase [General function prediction only] | Back alignment and domain information |
|---|
Probab=96.53 E-value=0.022 Score=56.46 Aligned_cols=147 Identities=19% Similarity=0.262 Sum_probs=79.4
Q ss_pred eeEeeeCceEEEEEEEcCCCEEEEEEEcc--cchhhHHHHHHHHHHHhcCCC--CCceeEEEEEEeCc--eeeEEEeecC
Q 010519 192 NVLGEGGYGVVYKGRLINGSEVAVKKLLN--NLGQAEKEFRVEVEAIGHVRH--KNLVRLLGYCIEGV--HRMLVYEYVN 265 (508)
Q Consensus 192 ~~lg~G~~g~Vy~~~~~~~~~vavK~~~~--~~~~~~~~~~~ei~~l~~l~h--~niv~~~~~~~~~~--~~~lv~E~~~ 265 (508)
+.+..|..-.+|.... .++++++. ... ..........+|+.+++.+.- --+...+++|.++. ..+.||+|+.
T Consensus 31 ~~~~~G~sn~t~~~~~-~~~~~vlR-~P~~~~~~~~~~~~~re~~~i~~l~~~~vP~p~~~~~~~~~~~g~pf~v~~~ve 108 (321)
T COG3173 31 EEISGGWSNDTFRLGD-TGQKYVLR-KPPRGDPVESAHDEKREYRVIAALLDVDVPVPRAFGLCGEGYLGTPFYVMEWVE 108 (321)
T ss_pred eeccCCcccceEEEec-CCceEEEe-cCCccccchhhhHHHhHHHHHHHhcCCCCCCcccccccccCCCCCceEEEEEec
Confidence 3443343334454433 36777776 321 122333456667777777642 23445677777666 6689999998
Q ss_pred CCCHHHH------------------Hhhh---h----cc--------CCC-ccHHHHHHHH--------HHHHHHHHHHH
Q 010519 266 NGNLEQW------------------LHGA---M----RN--------QGN-LTWEARMKVI--------IGTAKALAYLH 303 (508)
Q Consensus 266 ~gsL~~~------------------l~~~---~----~~--------~~~-l~~~~~~~i~--------~~i~~al~yLH 303 (508)
|..+.+. |... - .. ..+ ..|......+ -.......+|+
T Consensus 109 Ge~~~~~~~~~~~~~~~~~~~l~~~La~LH~ida~~~~~~g~~~~~~~rql~~~~~~~~~~~~~~~~~~p~~~~~~~Wl~ 188 (321)
T COG3173 109 GEVVWSALPPESLGRQFALDALADFLAELHSIDAAGLPDPGKPNAYRGRQLARWDDEYRRAKKELGGRIPLADRLIKWLE 188 (321)
T ss_pred ceeccCcCCcccchHHHHHHHHHHHHHHHhCCCCcCCCCCCccCccccchhhHHHHHHHHHHHhccCCCchHHHHHHHHH
Confidence 8432221 1100 0 00 000 0011111000 00122234444
Q ss_pred hcC-----CCCeEeecCCCCCEEEcCCCcEEEEecCCccccC
Q 010519 304 EAI-----EPKVVHRDIKSSNILIDDEFNAKVSDFGLAKLLD 340 (508)
Q Consensus 304 ~~~-----~~~iiH~Dlk~~NIll~~~~~~kl~Dfgla~~~~ 340 (508)
.+. .+.++|+|+.+.||+++...-+=|.||+++..-+
T Consensus 189 ~~~p~~~~~~~lvHGD~~~gNlii~~~~~~gVlDwe~~~lGD 230 (321)
T COG3173 189 ANRPPWAGPPVLVHGDYRPGNLIIDPGRPTGVLDWELATLGD 230 (321)
T ss_pred hcCCCcCCCceeeeCCcccCCEEEeCCCeeEEEeccccccCC
Confidence 332 3479999999999999998889999999997544
|
|
| >TIGR02906 spore_CotS spore coat protein, CotS family | Back alignment and domain information |
|---|
Probab=96.33 E-value=0.05 Score=54.04 Aligned_cols=30 Identities=30% Similarity=0.379 Sum_probs=26.1
Q ss_pred CCCeEeecCCCCCEEEcCCCcEEEEecCCcc
Q 010519 307 EPKVVHRDIKSSNILIDDEFNAKVSDFGLAK 337 (508)
Q Consensus 307 ~~~iiH~Dlk~~NIll~~~~~~kl~Dfgla~ 337 (508)
.++++|+|+.+.||+++. +.+.|+||+.+.
T Consensus 186 ~~~liHgD~~~~Nil~~~-~~i~lIDfd~~~ 215 (313)
T TIGR02906 186 IRGFCHQDYAYHNILLKD-NEVYVIDFDYCT 215 (313)
T ss_pred cCceEcCCCCcccEEEeC-CcEEEEECcccc
Confidence 358999999999999988 678999999665
|
Members of this family include the spore coat proteins CotS and YtaA from Bacillus subtilis and, from other endospore-forming bacteria, homologs that are more closely related to these two than to the spore coat proteins YutH and YsxE. The CotS family is more broadly distributed than YutH or YsxE, but still is not universal among spore-formers. |
| >TIGR01767 MTRK 5-methylthioribose kinase | Back alignment and domain information |
|---|
Probab=96.24 E-value=0.039 Score=55.55 Aligned_cols=73 Identities=18% Similarity=0.223 Sum_probs=46.1
Q ss_pred eEeeeCceEEEEEEEcCC-CEEEEEEEcccc-------hhhHHHHHHHHHHHhcCC--CCC-ceeEEEEEEeCceeeEEE
Q 010519 193 VLGEGGYGVVYKGRLING-SEVAVKKLLNNL-------GQAEKEFRVEVEAIGHVR--HKN-LVRLLGYCIEGVHRMLVY 261 (508)
Q Consensus 193 ~lg~G~~g~Vy~~~~~~~-~~vavK~~~~~~-------~~~~~~~~~ei~~l~~l~--h~n-iv~~~~~~~~~~~~~lv~ 261 (508)
.||-|....||++...+| +.|+||.-.... .-.......|...|+... -|. +.++|. .+.....+||
T Consensus 2 EigdGnlN~VfrV~~~~g~~svIVKQAlp~vRv~g~~wpl~~~R~~~E~~~L~~~~~~~P~~vP~vy~--~D~e~~~~vM 79 (370)
T TIGR01767 2 EVGDGNLNLVFHVYDQEGDRAAIVKQALPYVRVVGESWPLTLDRARIESSALIRQGEHVPHLVPRIFH--FDTEMAVTVM 79 (370)
T ss_pred cCCCCceEEEEEEEcCCCCeeEEEEEcCHHHhhcCCCCCCCccHHHHHHHHHHHhhccCccccCeEEE--EccccceehH
Confidence 479999999999987544 579998653211 222234455777776653 343 444443 3455667999
Q ss_pred eecCCC
Q 010519 262 EYVNNG 267 (508)
Q Consensus 262 E~~~~g 267 (508)
|+++..
T Consensus 80 EdL~~~ 85 (370)
T TIGR01767 80 EDLSHH 85 (370)
T ss_pred hhCccc
Confidence 999654
|
This enzyme is involved in the methionine salvage pathway in certain bacteria. |
| >COG2334 Putative homoserine kinase type II (protein kinase fold) [General function prediction only] | Back alignment and domain information |
|---|
Probab=96.13 E-value=0.086 Score=52.81 Aligned_cols=137 Identities=22% Similarity=0.294 Sum_probs=78.5
Q ss_pred CceEEEEEEEcCCCEEEEEEEcccchhhHHHHHHHHHHHhcCC---CCCcee---EEE----EEEeCceeeEEEeecCCC
Q 010519 198 GYGVVYKGRLINGSEVAVKKLLNNLGQAEKEFRVEVEAIGHVR---HKNLVR---LLG----YCIEGVHRMLVYEYVNNG 267 (508)
Q Consensus 198 ~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~ei~~l~~l~---h~niv~---~~~----~~~~~~~~~lv~E~~~~g 267 (508)
.--.+|+....+|.. ++|..... ....++..|+..|..|. .+-.++ .=| ........+-+++|++|.
T Consensus 37 ~eN~~f~~~~~~g~~-iLki~~~~--~~~~~i~~el~~l~~La~~~i~v~~Pl~~~dG~~l~~~~~~~r~a~lf~~l~G~ 113 (331)
T COG2334 37 EENSNFRVQTEDGRY-ILKIYRPG--WTRAEIPFELALLQHLAERGIPVPAPLPSLDGELLEALSGGPRPAALFEYLPGR 113 (331)
T ss_pred ccCceEEEEecCCCe-EEEEecCC--CCHHHHHHHHHHHHHHHHcCCCCCCCccCCCcchhhhccCCceeEEEEEecCCc
Confidence 345689988766666 67765444 44556677888887773 222222 111 111122667899999998
Q ss_pred CHHH---------------HHhhhhccC--------CCccHHH-------------HHHHHHHHHHHHHHHHhcC----C
Q 010519 268 NLEQ---------------WLHGAMRNQ--------GNLTWEA-------------RMKVIIGTAKALAYLHEAI----E 307 (508)
Q Consensus 268 sL~~---------------~l~~~~~~~--------~~l~~~~-------------~~~i~~~i~~al~yLH~~~----~ 307 (508)
.+.. .||...+.. ....|.. ......++...+..+.... .
T Consensus 114 ~~~~~~~~~~~~~lG~~LgrlH~a~~~f~~~~p~~~~~~~w~~~~~~~~~~~~~~~~~~l~a~~~~~~~~~~~~~~~~lp 193 (331)
T COG2334 114 PLERDDNAEQLEELGRMLGRLHLALRGFPFERPNALRRLEWDILEPRALLRLDLVEPEDLRAALLAALDRLLARLPAHLP 193 (331)
T ss_pred CcCCCCcHHHHHHHHHHHHHHHHHhCcCCccCCCcccccchhhhcchhhhhhcccCchhhHHHHHHHHHHHHhhchhhCC
Confidence 7762 112111111 1123320 0112233344444444332 2
Q ss_pred CC---eEeecCCCCCEEEcCCCc-EEEEecCCcc
Q 010519 308 PK---VVHRDIKSSNILIDDEFN-AKVSDFGLAK 337 (508)
Q Consensus 308 ~~---iiH~Dlk~~NIll~~~~~-~kl~Dfgla~ 337 (508)
.. +||+|+.|.||+++++.. +-++||+-+.
T Consensus 194 ~~~~~iIH~D~~~~NVl~d~~~~~~g~iDFdDa~ 227 (331)
T COG2334 194 ALGDQIIHGDLHPDNVLFDDDTDVSGFIDFDDAG 227 (331)
T ss_pred cccceeeecCCCccceeEcCCCCeeeEEEccccc
Confidence 23 899999999999999885 8899999775
|
|
| >COG3001 Uncharacterized protein conserved in bacteria [Function unknown] | Back alignment and domain information |
|---|
Probab=96.09 E-value=0.041 Score=51.45 Aligned_cols=75 Identities=17% Similarity=0.236 Sum_probs=51.8
Q ss_pred eeEeeeCceEEEEEEEcCCCEEEEEEEcccchhhHHHHHHHHHHHhcC---CCCCceeEEEEEEeCceeeEEEeecCCCC
Q 010519 192 NVLGEGGYGVVYKGRLINGSEVAVKKLLNNLGQAEKEFRVEVEAIGHV---RHKNLVRLLGYCIEGVHRMLVYEYVNNGN 268 (508)
Q Consensus 192 ~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~ei~~l~~l---~h~niv~~~~~~~~~~~~~lv~E~~~~gs 268 (508)
+.+.-|..-..|...+ +..++.+|.= .......|..|+.-|..| +--++.+++.+-.+..+.|+|+||++-|.
T Consensus 22 ~~v~gG~inea~~v~d-g~~~~FvK~n---~~~~~~~f~AEa~gL~~la~s~ti~VP~vi~~G~~~~~sylVle~L~~~~ 97 (286)
T COG3001 22 EEVSGGDINEAWRLRD-GTDPFFVKCN---QREQLSMFTAEADGLELLARSNTITVPKVIAVGASRDHSYLVLEYLPTGP 97 (286)
T ss_pred cccCCccccceeEeec-CCcceEEEec---chhhHHHHHHHHHHHHHHHhcCCccccceEEecCCCCeeEEEEeeccCCC
Confidence 3455555555566544 6778888862 233345677777766665 44567788888888899999999999876
Q ss_pred HH
Q 010519 269 LE 270 (508)
Q Consensus 269 L~ 270 (508)
+.
T Consensus 98 ~d 99 (286)
T COG3001 98 LD 99 (286)
T ss_pred CC
Confidence 64
|
|
| >PLN02236 choline kinase | Back alignment and domain information |
|---|
Probab=96.09 E-value=0.072 Score=53.96 Aligned_cols=142 Identities=19% Similarity=0.225 Sum_probs=77.1
Q ss_pred eeEeeeCceEEEEEEEcC-----CCEEEEEEEcccchhhHHHHHHHHHHHhcCCCCCc-eeEEEEEEeCceeeEEEeecC
Q 010519 192 NVLGEGGYGVVYKGRLIN-----GSEVAVKKLLNNLGQAEKEFRVEVEAIGHVRHKNL-VRLLGYCIEGVHRMLVYEYVN 265 (508)
Q Consensus 192 ~~lg~G~~g~Vy~~~~~~-----~~~vavK~~~~~~~~~~~~~~~ei~~l~~l~h~ni-v~~~~~~~~~~~~~lv~E~~~ 265 (508)
+.|..|-.-.+|+....+ +..+++|..-....... .-..|..++..+..-++ .++++.+..+ .|.+|++
T Consensus 42 ~~l~gGlTN~~y~v~~~~~~~~~~~~~v~Ri~g~~t~~~i-dR~~E~~~~~~l~~~gl~P~~~~~~~~g----~v~efi~ 116 (344)
T PLN02236 42 IPLKGAMTNEVFQIKWPTKEGNLGRKVLVRIYGEGVELFF-DRDDEIRTFECMSRHGQGPRLLGRFPNG----RVEEFIH 116 (344)
T ss_pred EEcCCcccceeEEEEeCCCCCCCCCeEEEEEccCCCCeee-chHHHHHHHHHHHHcCCCCceEEEECCc----eEEEeeC
Confidence 345557777899987532 35678886644332111 12457777777754333 3456655332 5799987
Q ss_pred CCCHHHH-----------------HhhhhccCC--CccHHHHHHHHHH-----------------HHHHHHHHHh-----
Q 010519 266 NGNLEQW-----------------LHGAMRNQG--NLTWEARMKVIIG-----------------TAKALAYLHE----- 304 (508)
Q Consensus 266 ~gsL~~~-----------------l~~~~~~~~--~l~~~~~~~i~~~-----------------i~~al~yLH~----- 304 (508)
+.+|... +|....... ...+.....+..+ +...+..|..
T Consensus 117 g~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~~~~~~~~l~~~~~~~~~~~~~l~~~~~~L~~~~~~~ 196 (344)
T PLN02236 117 ARTLSAADLRDPEISALIAAKLREFHSLDMPGPKNVLLWDRLRNWLKEAKNLCSPEEAKEFRLDSLEDEINLLEKELSGD 196 (344)
T ss_pred CCCCCHHHcCChHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhhcCcchhhhcCHHHHHHHHHHHHHHhccc
Confidence 7665311 111100111 1112222222211 1112222221
Q ss_pred cCCCCeEeecCCCCCEEEcC-CCcEEEEecCCccc
Q 010519 305 AIEPKVVHRDIKSSNILIDD-EFNAKVSDFGLAKL 338 (508)
Q Consensus 305 ~~~~~iiH~Dlk~~NIll~~-~~~~kl~Dfgla~~ 338 (508)
.....++|+|+++.|||+++ ++.+.|+||..+..
T Consensus 197 ~~~~~~cH~Dl~~~Nil~~~~~~~~~lID~Eya~~ 231 (344)
T PLN02236 197 DQEIGFCHNDLQYGNIMIDEETRAITIIDYEYASY 231 (344)
T ss_pred CCCceEEeCCCCcCcEEEeCCCCcEEEEeehhccc
Confidence 12336899999999999986 46799999988763
|
|
| >TIGR02904 spore_ysxE spore coat protein YsxE | Back alignment and domain information |
|---|
Probab=95.85 E-value=0.16 Score=50.54 Aligned_cols=32 Identities=22% Similarity=0.314 Sum_probs=28.5
Q ss_pred CCCeEeecCCCCCEEEcCCCcEEEEecCCccc
Q 010519 307 EPKVVHRDIKSSNILIDDEFNAKVSDFGLAKL 338 (508)
Q Consensus 307 ~~~iiH~Dlk~~NIll~~~~~~kl~Dfgla~~ 338 (508)
..+++|+|+.+.|||+++++.+-++||..+..
T Consensus 195 ~~~lcHgD~~~~Nvl~~~~~~~~iIDfd~~~~ 226 (309)
T TIGR02904 195 RTVLVHGKLSLSHFLYDETRGGYFINFEKASF 226 (309)
T ss_pred ceeeeCCCCcHHhEEEcCCCCEEEEEhhhccc
Confidence 34799999999999999999999999998764
|
Members of this family are homologs of the Bacillus subtilis spore coat protein CotS. Members of this family, designated YsxE, are found only in the family Bacillaceae, from among the endospore-forming members of the Firmicutes branch of the Bacteria. As a rule, the ysxE gene is found immediately downstream of spoVID, a gene necessary for spore coat assembly. The protein has been shown to be part of the spore coat. |
| >PTZ00382 Variant-specific surface protein (VSP); Provisional | Back alignment and domain information |
|---|
Probab=95.79 E-value=0.0013 Score=52.96 Aligned_cols=36 Identities=28% Similarity=0.281 Sum_probs=23.3
Q ss_pred cccccchhHHHHHHHHHHHHHHHH-HHHHhhhheecc
Q 010519 14 KTSFLGLKLWVLIGISVGAFIVLI-LCILSVWVSFRR 49 (508)
Q Consensus 14 ~~~~~~~~~~~~igi~~g~~~~~~-l~~~~~~~~~rr 49 (508)
.+...|+....++||+||++++++ |+.+++|++++|
T Consensus 57 st~~~~ls~gaiagi~vg~~~~v~~lv~~l~w~f~~r 93 (96)
T PTZ00382 57 GANRSGLSTGAIAGISVAVVAVVGGLVGFLCWWFVCR 93 (96)
T ss_pred ccCCCCcccccEEEEEeehhhHHHHHHHHHhheeEEe
Confidence 345578899999999998776653 433444443333
|
|
| >KOG1093 consensus Predicted protein kinase (contains TBC and RHOD domains) [General function prediction only] | Back alignment and domain information |
|---|
Probab=95.71 E-value=0.0096 Score=61.62 Aligned_cols=46 Identities=20% Similarity=0.265 Sum_probs=36.2
Q ss_pred HHHHHHHHHhcCCCCCceeEEEEEEeCc-eeeEEEeecCCCCHHHHHh
Q 010519 228 EFRVEVEAIGHVRHKNLVRLLGYCIEGV-HRMLVYEYVNNGNLEQWLH 274 (508)
Q Consensus 228 ~~~~ei~~l~~l~h~niv~~~~~~~~~~-~~~lv~E~~~~gsL~~~l~ 274 (508)
.+.-...+++.+.|+|+..++++-.... ...+|||++ +.+|++.+.
T Consensus 28 ~ilgr~~~lktl~~~~l~~yl~~~r~~~~r~IVV~e~~-~~Sled~~~ 74 (725)
T KOG1093|consen 28 QILGRFQYLKSLQHDNLCQYLDFSRGKHERVIVVMEHY-TMSLEDILK 74 (725)
T ss_pred HHhhhhHHHHhhcCccceeeEeeecCccceEEEEehhh-ccchHHHHH
Confidence 4455677889999999999999876543 356899999 669999885
|
|
| >PRK12396 5-methylribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=95.37 E-value=0.078 Score=54.14 Aligned_cols=75 Identities=15% Similarity=0.210 Sum_probs=48.8
Q ss_pred ceeEeeeCceEEEEEEEcC-CCEEEEEEEcccc------hhhHHHHHHHHHHHhcCC--CCC-ceeEEEEEEeCceeeEE
Q 010519 191 ENVLGEGGYGVVYKGRLIN-GSEVAVKKLLNNL------GQAEKEFRVEVEAIGHVR--HKN-LVRLLGYCIEGVHRMLV 260 (508)
Q Consensus 191 ~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~------~~~~~~~~~ei~~l~~l~--h~n-iv~~~~~~~~~~~~~lv 260 (508)
.+.||-|.-..||++.+.+ +..|+||.-.... .-......-|.+.|+.+. -|. +.+++.+ +.....+|
T Consensus 34 ~~eigdGnlN~VfrV~~~~~~~svIVKQAlp~vRv~~swpL~~~R~~~E~~aL~~~~~~~P~~VP~vy~~--D~e~~~~v 111 (409)
T PRK12396 34 CKEIGDGNLNYVFRVWDEQKNISVIVKQAGDTARISDEFKLSTNRIRIESDVLQLEEELAPGLVPKVYLF--DSVMNCCV 111 (409)
T ss_pred eeEcCCCceEEEEEEeeCCCCceEEEEeccHhhccCCCCCCChHHHHHHHHHHHHHHhhCCCcCCeEEEE--CcHHhhHH
Confidence 4578999999999998743 5679998653221 223345556777777653 343 4445443 45566789
Q ss_pred EeecCCC
Q 010519 261 YEYVNNG 267 (508)
Q Consensus 261 ~E~~~~g 267 (508)
||+++..
T Consensus 112 MEdL~~~ 118 (409)
T PRK12396 112 MEDLSDH 118 (409)
T ss_pred HHhCccc
Confidence 9998653
|
|
| >PRK11768 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=95.31 E-value=0.5 Score=47.43 Aligned_cols=70 Identities=14% Similarity=0.036 Sum_probs=41.4
Q ss_pred CceEEEEEEEcCCCEEEEEEEcccchhhHHHHHHHHHHHhcCCCC--CceeEE---E--EEEeCceeeEEEeecCCCC
Q 010519 198 GYGVVYKGRLINGSEVAVKKLLNNLGQAEKEFRVEVEAIGHVRHK--NLVRLL---G--YCIEGVHRMLVYEYVNNGN 268 (508)
Q Consensus 198 ~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~ei~~l~~l~h~--niv~~~---~--~~~~~~~~~lv~E~~~~gs 268 (508)
.-..||+....++..+++|..... .....++..|+..+..|... .++... | +...+...+.++++++|..
T Consensus 37 ~eN~vy~v~~~~~~~~vlKv~r~~-~~~~~~i~~E~~~l~~L~~~gipv~~p~~~~G~~~~~~~g~~~~l~~~~~G~~ 113 (325)
T PRK11768 37 YENRVYQFGDEDGRRVVAKFYRPE-RWSDAQILEEHAFALELAEAEIPVVAPLAFNGQTLHEHQGFRFALFPRRGGRA 113 (325)
T ss_pred ccceEEEEecCCCCEEEEEEcCcc-cCCHHHHHHHHHHHHHHHHCCCCCCCCccCCCCEEEEECCEEEEEEeeeCCCC
Confidence 345789988777888888876422 22345566677777666311 122211 1 1223456778999998764
|
|
| >COG5072 ALK1 Serine/threonine kinase of the haspin family [Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=95.26 E-value=0.11 Score=51.89 Aligned_cols=116 Identities=22% Similarity=0.167 Sum_probs=73.4
Q ss_pred CCCceeEEEEE-EeCceeeEEEeecCCCCHHHHHhhhhccCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCC
Q 010519 241 HKNLVRLLGYC-IEGVHRMLVYEYVNNGNLEQWLHGAMRNQGNLTWEARMKVIIGTAKALAYLHEAIEPKVVHRDIKSSN 319 (508)
Q Consensus 241 h~niv~~~~~~-~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiH~Dlk~~N 319 (508)
-++..+.+-+- .+..+.|++|++- |++|.- -....+.+...++.+-+..+.-+..+. ++-|||+.-.|
T Consensus 284 ~~~~e~~~vv~~de~~y~yl~~kdh-gt~is~--------ik~~~~~e~lsff~s~~sil~~lekkf--~fehrnlt~~n 352 (488)
T COG5072 284 SVFLETLKVVSLDETLYLYLHFKDH-GTPISI--------IKADRSEEELSFFWSCISILDILEKKF--PFEHRNLTLDN 352 (488)
T ss_pred chhhhcceEEecCCceEEEEEEecC-Cceeee--------eecccHHHHHHHHHHHHHHHhhhhhcC--Ccccccccccc
Confidence 34444433333 2334567888875 555432 122457788888888777777776543 78999999999
Q ss_pred EEEcCCCcEEEEecCCccccCCCCCcccccccccccccCccccCCCCCCChhhHHH
Q 010519 320 ILIDDEFNAKVSDFGLAKLLDSGESHITTRVMGTFGYVAPEYANTGMLNEKSDIYS 375 (508)
Q Consensus 320 Ill~~~~~~kl~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS 375 (508)
||++ +|++-|+||-+++.-..+.. ..-...-.|-.+.|.. +..=+||-
T Consensus 353 iLId-~GnvtLIDfklsRl~~~q~~------isy~rldhp~lF~G~d-d~QFeIYr 400 (488)
T COG5072 353 ILID-EGNVTLIDFKLSRLSYSQGI------ISYNRLDHPDLFNGVD-DYQFEIYR 400 (488)
T ss_pred eeee-cCceEEEEeeeeecccCCce------eeccccCchhhhcCcc-ceeeeHHH
Confidence 9999 99999999999994332211 1122334555565433 55666765
|
|
| >PLN02421 phosphotransferase, alcohol group as acceptor/kinase | Back alignment and domain information |
|---|
Probab=94.96 E-value=0.14 Score=51.51 Aligned_cols=30 Identities=23% Similarity=0.397 Sum_probs=26.0
Q ss_pred CeEeecCCCCCEEEcC-CCcEEEEecCCccc
Q 010519 309 KVVHRDIKSSNILIDD-EFNAKVSDFGLAKL 338 (508)
Q Consensus 309 ~iiH~Dlk~~NIll~~-~~~~kl~Dfgla~~ 338 (508)
-++|+||.+.|||+++ ++.++++||..+..
T Consensus 183 v~CHnDl~~~NiL~~~~~~~l~lID~EYag~ 213 (330)
T PLN02421 183 VFAHNDLLSGNLMLNEDEGKLYFIDFEYGSY 213 (330)
T ss_pred EEEECCCCcccEEEeCCCCcEEEEcccccCC
Confidence 4799999999999975 56899999998864
|
|
| >PRK06148 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=94.88 E-value=0.4 Score=55.64 Aligned_cols=143 Identities=19% Similarity=0.272 Sum_probs=77.7
Q ss_pred eeEeeeCceEEEEEEEcCCCEEEEEEEcccchhhHHHHHHHHHHHhcC-------CCCCceeEE-----EEEEe-Cc--e
Q 010519 192 NVLGEGGYGVVYKGRLINGSEVAVKKLLNNLGQAEKEFRVEVEAIGHV-------RHKNLVRLL-----GYCIE-GV--H 256 (508)
Q Consensus 192 ~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~ei~~l~~l-------~h~niv~~~-----~~~~~-~~--~ 256 (508)
+.|+ |..-.+|+....+|..+++|...... ....+..|...|..| .-|.+++.. ..... +. .
T Consensus 31 ~~L~-s~~d~nf~v~~~~g~~yVLKi~~~~~--~~~~~~~q~~~L~hL~~~~~glpvP~~i~t~~G~~~~~v~~~~G~~~ 107 (1013)
T PRK06148 31 TPLD-GERDLNFRLTTDDGADYILKIVNPSE--PRVESDFQTAALDHLAAVAPDLPVPRLIPSLSGASLASAQDPDGEPR 107 (1013)
T ss_pred eecC-CcCCceEEEEeCCCCeEEEEEcCCcc--chhHHHHHHHHHHHHHhhCCCCCcCeeeecCCCCeEEEeecCCCceE
Confidence 3454 34567888877778888888875432 223344455555544 233333322 11111 12 4
Q ss_pred eeEEEeecCCCCHHHH-----------------HhhhhccC------CCccHHH-----------------HHHHHHHHH
Q 010519 257 RMLVYEYVNNGNLEQW-----------------LHGAMRNQ------GNLTWEA-----------------RMKVIIGTA 296 (508)
Q Consensus 257 ~~lv~E~~~~gsL~~~-----------------l~~~~~~~------~~l~~~~-----------------~~~i~~~i~ 296 (508)
.+-+++|++|..|.+. ++...... ..+.|.. ...++..++
T Consensus 108 ~vrLl~~l~G~~l~~~~~~t~~~~~~lG~~larlh~al~~F~~p~~~r~~~Wdl~~~~~l~~~l~~i~d~~~r~~l~~~~ 187 (1013)
T PRK06148 108 LLRLLSWLPGTPLAEAAPRTEALLDNLGRALGRLDRALQGFMHPGALRDLDWDLRHAGRARDRLHFIDDPEDRALVERFL 187 (1013)
T ss_pred EEEEEeccCCCcHHhccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccccccccccchhhhhhhhhcCCHHHHHHHHHHH
Confidence 5678999999877651 11111111 1122211 112222332
Q ss_pred HHHH-----HHHhcCCCCeEeecCCCCCEEEcCCC--cEE-EEecCCccc
Q 010519 297 KALA-----YLHEAIEPKVVHRDIKSSNILIDDEF--NAK-VSDFGLAKL 338 (508)
Q Consensus 297 ~al~-----yLH~~~~~~iiH~Dlk~~NIll~~~~--~~k-l~Dfgla~~ 338 (508)
..+. .|. .+...+||+|+++.|||++.++ .+. |+|||-+..
T Consensus 188 ~~~~~~v~p~l~-~Lp~~vIHgDln~~NiLv~~~~~~~isGiIDFgDa~~ 236 (1013)
T PRK06148 188 ARFERNVAPRLA-ALPAQVIHNDANDYNILVDADDGERISGLIDFGDAVH 236 (1013)
T ss_pred HHHHHHHHHHHh-cCCcceECCCCCcccEEEcCCCCcceEEEEECccccc
Confidence 2222 122 2345899999999999999876 565 999997763
|
|
| >PF14575 EphA2_TM: Ephrin type-A receptor 2 transmembrane domain; PDB: 3KUL_A 2XVD_A 2VX1_A 2VWV_A 2VX0_A 2VWY_A 2VWZ_A 2VWW_A 2VWU_A 2VWX_A | Back alignment and domain information |
|---|
Probab=94.68 E-value=0.033 Score=42.68 Aligned_cols=28 Identities=29% Similarity=0.487 Sum_probs=14.9
Q ss_pred HHHHHHHHHHHHHHHHHHHhhhheeccc
Q 010519 23 WVLIGISVGAFIVLILCILSVWVSFRRK 50 (508)
Q Consensus 23 ~~~igi~~g~~~~~~l~~~~~~~~~rr~ 50 (508)
|+++++++|++++++++++++++++|++
T Consensus 1 ~ii~~~~~g~~~ll~~v~~~~~~~rr~~ 28 (75)
T PF14575_consen 1 LIIASIIVGVLLLLVLVIIVIVCFRRCK 28 (75)
T ss_dssp -HHHHHHHHHHHHHHHHHHHHCCCTT--
T ss_pred CEEehHHHHHHHHHHhheeEEEEEeeEc
Confidence 5666676776666655555555544433
|
... |
| >PF12273 RCR: Chitin synthesis regulation, resistance to Congo red; InterPro: IPR020999 RCR proteins are ER membrane proteins that regulate chitin deposition in fungal cell walls | Back alignment and domain information |
|---|
Probab=94.42 E-value=0.016 Score=49.76 Aligned_cols=11 Identities=45% Similarity=0.863 Sum_probs=6.9
Q ss_pred HHHHHHHHHHH
Q 010519 23 WVLIGISVGAF 33 (508)
Q Consensus 23 ~~~igi~~g~~ 33 (508)
|++++|+|+++
T Consensus 2 W~l~~iii~~i 12 (130)
T PF12273_consen 2 WVLFAIIIVAI 12 (130)
T ss_pred eeeHHHHHHHH
Confidence 77777755543
|
Although chitin, a linear polymer of beta-1,4-linked N-acetylglucosamine, constitutes only 2% of the cell wall it plays a vital role in the overall protection of the cell wall against stress, noxious chemicals and osmotic pressure changes. Congo red is a cell wall-disrupting benzidine-type dye extensively used in many cell wall mutant studies that specifically targets chitin in yeast cells and inhibits growth. RCR proteins render the yeasts resistant to Congo red by diminishing the content of chitin in the cell wall []. RCR proteins are probably regulating chitin synthase III interact directly with ubiquitin ligase Rsp5, and the VPEY motif is necessary for this, via interaction with the WW domains of Rsp5 []. |
Homologous Structure Templates
Structure Templates Detected by BLAST
Original result of BLAST against Protein Data Bank
| ID | Alignment Graph | Length |
Definition |
E-value | |
| Query | 508 | ||||
| 3tl8_A | 349 | The Avrptob-Bak1 Complex Reveals Two Structurally S | 9e-73 | ||
| 3uim_A | 326 | Structural Basis For The Impact Of Phosphorylation | 3e-71 | ||
| 3hgk_A | 327 | Crystal Structure Of Effect Protein Avrptob Complex | 1e-53 | ||
| 2qkw_B | 321 | Structural Basis For Activation Of Plant Immunity B | 7e-53 | ||
| 2nry_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 4e-41 | ||
| 2nru_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 7e-41 | ||
| 2oib_A | 301 | Crystal Structure Of Irak4 Kinase Domain Apo Form L | 1e-40 | ||
| 2o8y_A | 298 | Apo Irak4 Kinase Domain Length = 298 | 2e-39 | ||
| 3ppz_A | 309 | Crystal Structure Of Ctr1 Kinase Domain In Complex | 9e-28 | ||
| 3p86_A | 309 | Crystal Structure Of Ctr1 Kinase Domain Mutant D676 | 2e-27 | ||
| 3dtc_A | 271 | Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp | 6e-25 | ||
| 4f0f_A | 287 | Crystal Structure Of The Roco4 Kinase Domain Bound | 2e-24 | ||
| 4gs6_A | 315 | Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz | 3e-24 | ||
| 2eva_A | 307 | Structural Basis For The Interaction Of Tak1 Kinase | 3e-24 | ||
| 4f1o_A | 287 | Crystal Structure Of The L1180t Mutant Roco4 Kinase | 7e-24 | ||
| 4f1m_A | 287 | Crystal Structure Of The G1179s Roco4 Kinase Domain | 9e-24 | ||
| 2qok_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 2e-22 | ||
| 2c6e_A | 283 | Aurora A Kinase Activated Mutant (T287d) In Complex | 2e-22 | ||
| 2qoo_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 3e-22 | ||
| 2wtw_A | 285 | Aurora-A Inhibitor Structure (2nd Crystal Form) Len | 3e-22 | ||
| 2qoi_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 4e-22 | ||
| 2qof_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f | 4e-22 | ||
| 2qod_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y602f | 4e-22 | ||
| 2qoc_A | 344 | Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp | 4e-22 | ||
| 3dzq_A | 361 | Human Epha3 Kinase Domain In Complex With Inhibitor | 4e-22 | ||
| 2gsf_A | 373 | The Human Epha3 Receptor Tyrosine Kinase And Juxtam | 5e-22 | ||
| 3fxx_A | 371 | Human Epha3 Kinase And Juxtamembrane Region Bound T | 5e-22 | ||
| 2qol_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596:y | 5e-22 | ||
| 3kul_A | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 6e-22 | ||
| 2j4z_A | 306 | Structure Of Aurora-2 In Complex With Pha-680626 Le | 7e-22 | ||
| 2xng_A | 283 | Structure Of Aurora-A Bound To A Selective Imidazop | 8e-22 | ||
| 1muo_A | 297 | Crystal Structure Of Aurora-2, An Oncogenic Serine- | 8e-22 | ||
| 2x6d_A | 285 | Aurora-A Bound To An Inhibitor Length = 285 | 8e-22 | ||
| 2xru_A | 280 | Aurora-A T288e Complexed With Pha-828300 Length = 2 | 8e-22 | ||
| 2j50_A | 280 | Structure Of Aurora-2 In Complex With Pha-739358 Le | 9e-22 | ||
| 3o50_A | 267 | Crystal Structure Of Benzamide 9 Bound To Auroraa L | 9e-22 | ||
| 2w1d_A | 275 | Structure Determination Of Aurora Kinase In Complex | 9e-22 | ||
| 3e5a_A | 268 | Crystal Structure Of Aurora A In Complex With Vx-68 | 1e-21 | ||
| 3q6w_A | 307 | Structure Of Dually-phosphorylated Met Receptor Kin | 1e-21 | ||
| 2wqe_A | 262 | Structure Of S155r Aurora-A Somatic Mutant Length = | 1e-21 | ||
| 3qbn_A | 281 | Structure Of Human Aurora A In Complex With A Diami | 1e-21 | ||
| 3kul_B | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 1e-21 | ||
| 3fdn_A | 279 | Structure-Based Drug Design Of Novel Aurora Kinase | 1e-21 | ||
| 2g15_A | 318 | Structural Characterization Of Autoinhibited C-Met | 1e-21 | ||
| 1mq4_A | 272 | Crystal Structure Of Aurora-A Protein Kinase Length | 1e-21 | ||
| 2c6d_A | 275 | Aurora A Kinase Activated Mutant (T287d) In Complex | 1e-21 | ||
| 4gg5_A | 319 | Crystal Structure Of Cmet In Complex With Novel Inh | 1e-21 | ||
| 3lau_A | 287 | Crystal Structure Of Aurora2 Kinase In Complex With | 1e-21 | ||
| 2wd1_A | 292 | Human C-Met Kinase In Complex With Azaindole Inhibi | 1e-21 | ||
| 3miy_A | 266 | X-Ray Crystal Structure Of Itk Complexed With Sunit | 2e-21 | ||
| 3i5n_A | 309 | Crystal Structure Of C-Met With Triazolopyridazine | 2e-21 | ||
| 3lq8_A | 302 | Structure Of The Kinase Domain Of C-Met Bound To Xl | 2e-21 | ||
| 3f66_A | 298 | Human C-Met Kinase In Complex With Quinoxaline Inhi | 2e-21 | ||
| 3q6u_A | 308 | Structure Of The Apo Met Receptor Kinase In The Dua | 2e-21 | ||
| 2rfn_A | 310 | X-ray Structure Of C-met With Inhibitor. Length = 3 | 2e-21 | ||
| 2wgj_A | 306 | X-Ray Structure Of Pf-02341066 Bound To The Kinase | 2e-21 | ||
| 2wtv_A | 285 | Aurora-A Inhibitor Structure Length = 285 | 2e-21 | ||
| 1sm2_A | 264 | Crystal Structure Of The Phosphorylated Interleukin | 2e-21 | ||
| 2clq_A | 295 | Structure Of Mitogen-Activated Protein Kinase Kinas | 2e-21 | ||
| 3v5j_A | 266 | Crystal Structure Of Interleukin-2 Inducible T-Cell | 3e-21 | ||
| 4hct_A | 269 | Crystal Structure Of Itk In Complex With Compound 5 | 3e-21 | ||
| 2qon_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 3e-21 | ||
| 1ol6_A | 282 | Structure Of Unphosphorylated D274n Mutant Of Auror | 3e-21 | ||
| 1ol5_A | 282 | Structure Of Aurora-A 122-403, Phosphorylated On Th | 4e-21 | ||
| 3r21_A | 271 | Design, Synthesis, And Biological Evaluation Of Pyr | 4e-21 | ||
| 3dkg_A | 317 | Sgx Clone 5698a109kfg1h1 Length = 317 | 4e-21 | ||
| 3nrm_A | 283 | Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito | 4e-21 | ||
| 2qo7_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Dephos | 4e-21 | ||
| 2xne_A | 272 | Structure Of Aurora-A Bound To An Imidazopyrazine I | 4e-21 | ||
| 2qob_A | 344 | Human Epha3 Kinase Domain, Base Structure Length = | 4e-21 | ||
| 3unz_A | 279 | Aurora A In Complex With Rpm1679 Length = 279 | 4e-21 | ||
| 2w1c_A | 275 | Structure Determination Of Aurora Kinase In Complex | 4e-21 | ||
| 3coh_A | 268 | Crystal Structure Of Aurora-A In Complex With A Pen | 4e-21 | ||
| 3c1x_A | 373 | Crystal Structure Of The Tyrosine Kinase Domain Of | 4e-21 | ||
| 3vw6_A | 269 | Crystal Structure Of Human Apoptosis Signal-Regulat | 5e-21 | ||
| 3h0y_A | 268 | Aurora A In Complex With A Bisanilinopyrimidine Len | 5e-21 | ||
| 3qti_A | 314 | C-Met Kinase In Complex With Nvp-Bvu972 Length = 31 | 5e-21 | ||
| 1r0p_A | 312 | Crystal Structure Of The Tyrosine Kinase Domain Of | 5e-21 | ||
| 3a4p_A | 319 | Human C-Met Kinase Domain Complexed With 6-Benzylox | 5e-21 | ||
| 3dkc_A | 317 | Sgx Clone 5698a65kfg1h1 Length = 317 | 5e-21 | ||
| 2bmc_A | 306 | Aurora-2 T287d T288d Complexed With Pha-680632 Leng | 5e-21 | ||
| 3ha6_A | 268 | Crystal Structure Of Aurora A In Complex With Tpx2 | 5e-21 | ||
| 3cth_A | 314 | Crystal Structure Of The Tyrosine Kinase Domain Of | 5e-21 | ||
| 2r2p_A | 295 | Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep | 5e-21 | ||
| 3qgw_A | 286 | Crystal Structure Of Itk Kinase Bound To An Inhibit | 6e-21 | ||
| 2dwb_A | 285 | Aurora-A Kinase Complexed With Amppnp Length = 285 | 1e-20 | ||
| 3t9t_A | 267 | Crystal Structure Of Btk Mutant (F435t,K596r) Compl | 1e-20 | ||
| 4aw5_A | 291 | Complex Of The Ephb4 Kinase Domain With An Oxindole | 2e-20 | ||
| 3d14_A | 272 | Crystal Structure Of Mouse Aurora A (Asn186->gly, L | 2e-20 | ||
| 3c4c_A | 280 | B-Raf Kinase In Complex With Plx4720 Length = 280 | 2e-20 | ||
| 3omv_A | 307 | Crystal Structure Of C-Raf (Raf-1) Length = 307 | 2e-20 | ||
| 3kmm_A | 288 | Structure Of Human Lck Kinase With A Small Molecule | 2e-20 | ||
| 1mqb_A | 333 | Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro | 3e-20 | ||
| 3lck_A | 271 | The Kinase Domain Of Human Lymphocyte Kinase (Lck), | 3e-20 | ||
| 2zm1_A | 285 | Crystal Structure Of Imidazo Pyrazin 1 Bound To The | 3e-20 | ||
| 2ofu_A | 273 | X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam | 3e-20 | ||
| 2vwu_A | 302 | Ephb4 Kinase Domain Inhibitor Complex Length = 302 | 3e-20 | ||
| 3kxz_A | 287 | The Complex Crystal Structure Of Lck With A Probe M | 3e-20 | ||
| 3bym_A | 272 | X-Ray Co-Crystal Structure Aminobenzimidazole Triaz | 3e-20 | ||
| 1qpe_A | 279 | Structural Analysis Of The Lymphocyte-Specific Kina | 3e-20 | ||
| 4fk3_A | 292 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 3e-20 | ||
| 2hel_A | 306 | Crystal Structure Of A Mutant Epha4 Kinase Domain ( | 3e-20 | ||
| 2ofv_A | 277 | Crystal Structure Of Aminoquinazoline 1 Bound To Lc | 3e-20 | ||
| 3bys_A | 277 | Co-Crystal Structure Of Lck And Aminopyrimidine Ami | 4e-20 | ||
| 2pl0_A | 289 | Lck Bound To Imatinib Length = 289 | 4e-20 | ||
| 2of2_A | 271 | Crystal Structure Of Furanopyrimidine 8 Bound To Lc | 4e-20 | ||
| 3og7_A | 289 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 4e-20 | ||
| 2xyu_A | 285 | Crystal Structure Of Epha4 Kinase Domain In Complex | 5e-20 | ||
| 1jpa_A | 312 | Crystal Structure Of Unphosphorylated Ephb2 Recepto | 5e-20 | ||
| 2og8_A | 265 | Crystal Structure Of Aminoquinazoline 36 Bound To L | 5e-20 | ||
| 2y6m_A | 291 | Crystal Structure Of Epha4 Kinase Domain Length = 2 | 6e-20 | ||
| 3oez_A | 286 | Crystal Structure Of The L317i Mutant Of The Chicke | 8e-20 | ||
| 1qpd_A | 279 | Structural Analysis Of The Lymphocyte-specific Kina | 9e-20 | ||
| 3dqw_A | 286 | C-Src Kinase Domain Thr338ile Mutant In Complex Wit | 9e-20 | ||
| 3u4w_A | 275 | Src In Complex With Dna-Templated Macrocyclic Inhib | 1e-19 | ||
| 3d7u_B | 277 | Structural Basis For The Recognition Of C-Src By It | 1e-19 | ||
| 3daj_A | 272 | Crystal Structure Of Aurora A Complexed With An Inh | 1e-19 | ||
| 3svv_A | 286 | Crystal Structure Of T338c C-Src Covalently Bound T | 1e-19 | ||
| 3f69_A | 311 | Crystal Structure Of The Mycobacterium Tuberculosis | 1e-19 | ||
| 3g6h_A | 286 | Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma | 1e-19 | ||
| 2oiq_A | 286 | Crystal Structure Of Chicken C-Src Kinase Domain In | 1e-19 | ||
| 1yol_A | 283 | Crystal Structure Of Src Kinase Domain In Complex W | 2e-19 | ||
| 1yoj_A | 283 | Crystal Structure Of Src Kinase Domain Length = 283 | 2e-19 | ||
| 3mpm_A | 267 | Lck Complexed With A Pyrazolopyrimidine Length = 26 | 2e-19 | ||
| 2qq7_A | 286 | Crystal Structure Of Drug Resistant Src Kinase Doma | 2e-19 | ||
| 3ori_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain L33d | 2e-19 | ||
| 3f61_A | 311 | Crystal Structure Of M. Tuberculosis Pknb Leu33aspV | 2e-19 | ||
| 2hwo_A | 286 | Crystal Structure Of Src Kinase Domain In Complex W | 2e-19 | ||
| 4eqm_A | 294 | Structural Analysis Of Staphylococcus Aureus Serine | 2e-19 | ||
| 3dk7_A | 277 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 3e-19 | ||
| 3geq_A | 286 | Structural Basis For The Chemical Rescue Of Src Kin | 3e-19 | ||
| 2fb8_A | 281 | Structure Of The B-Raf Kinase Domain Bound To Sb-59 | 3e-19 | ||
| 4dbn_A | 284 | Crystal Structure Of The Kinase Domain Of Human B-R | 3e-19 | ||
| 3ii5_A | 306 | The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi | 3e-19 | ||
| 3q96_A | 282 | B-Raf Kinase Domain In Complex With A Tetrahydronap | 3e-19 | ||
| 3d4q_A | 307 | Pyrazole-Based Inhibitors Of B-Raf Kinase Length = | 3e-19 | ||
| 4h58_A | 275 | Braf In Complex With Compound 3 Length = 275 | 4e-19 | ||
| 3dk3_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 4e-19 | ||
| 1yi6_A | 276 | C-Term Tail Segment Of Human Tyrosine Kinase (258-5 | 4e-19 | ||
| 3idp_A | 300 | B-Raf V600e Kinase Domain In Complex With An Aminoi | 5e-19 | ||
| 1uwh_A | 276 | The Complex Of Wild Type B-Raf And Bay439006 Length | 5e-19 | ||
| 2r4b_A | 321 | Erbb4 Kinase Domain Complexed With A Thienopyrimidi | 5e-19 | ||
| 4g9r_A | 307 | B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr | 5e-19 | ||
| 2hen_A | 286 | Crystal Structure Of The Ephb2 Receptor Kinase Doma | 5e-19 | ||
| 3bbt_B | 328 | Crystal Structure Of The Erbb4 Kinase In Complex Wi | 5e-19 | ||
| 1uwj_A | 276 | The Complex Of Mutant V599e B-raf And Bay439006 Len | 6e-19 | ||
| 2bdf_A | 279 | Src Kinase In Complex With Inhibitor Ap23451 Length | 6e-19 | ||
| 2rei_A | 318 | Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep | 6e-19 | ||
| 2v7a_A | 286 | Crystal Structure Of The T315i Abl Mutant In Comple | 7e-19 | ||
| 2gqg_A | 278 | X-Ray Crystal Structure Of Dasatinib (Bms-354825) B | 7e-19 | ||
| 2w5a_A | 279 | Human Nek2 Kinase Adp-Bound Length = 279 | 7e-19 | ||
| 3dk6_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 8e-19 | ||
| 3qri_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain I | 8e-19 | ||
| 3orm_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain D76a | 8e-19 | ||
| 2ptk_A | 453 | Chicken Src Tyrosine Kinase Length = 453 | 8e-19 | ||
| 3qrj_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain T | 8e-19 | ||
| 1fmk_A | 452 | Crystal Structure Of Human Tyrosine-Protein Kinase | 9e-19 | ||
| 2h8h_A | 535 | Src Kinase In Complex With A Quinazoline Inhibitor | 9e-19 | ||
| 1y57_A | 452 | Structure Of Unphosphorylated C-Src In Complex With | 1e-18 | ||
| 1mru_A | 311 | Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob | 1e-18 | ||
| 2e2b_A | 293 | Crystal Structure Of The C-Abl Kinase Domain In Com | 1e-18 | ||
| 2hyy_A | 273 | Human Abl Kinase Domain In Complex With Imatinib (S | 1e-18 | ||
| 2g1t_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 1e-18 | ||
| 2hiw_A | 287 | Crystal Structure Of Inactive Conformation Abl Kina | 1e-18 | ||
| 2hzi_A | 277 | Abl Kinase Domain In Complex With Pd180970 Length = | 1e-18 | ||
| 2wqm_A | 310 | Structure Of Apo Human Nek7 Length = 310 | 1e-18 | ||
| 2hz0_A | 270 | Abl Kinase Domain In Complex With Nvp-Aeg082 Length | 1e-18 | ||
| 3pyy_A | 298 | Discovery And Characterization Of A Cell-Permeable, | 1e-18 | ||
| 4a4x_A | 279 | Nek2-Ede Bound To Cct248662 Length = 279 | 1e-18 | ||
| 1ksw_A | 452 | Structure Of Human C-Src Tyrosine Kinase (Thr338gly | 1e-18 | ||
| 2f4j_A | 287 | Structure Of The Kinase Domain Of An Imatinib-Resis | 2e-18 | ||
| 2g2f_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 2e-18 | ||
| 1o6y_A | 299 | Catalytic Domain Of Pknb Kinase From Mycobacterium | 2e-18 | ||
| 3k54_A | 283 | Structures Of Human Bruton's Tyrosine Kinase In Act | 2e-18 | ||
| 2bfy_A | 284 | Complex Of Aurora-B With Incenp And Hesperidin. Len | 2e-18 | ||
| 2bfx_B | 284 | Mechanism Of Aurora-B Activation By Incenp And Inhi | 2e-18 | ||
| 3sxr_A | 268 | Crystal Structure Of Bmx Non-Receptor Tyrosine Kina | 2e-18 | ||
| 2vrx_A | 285 | Structure Of Aurora B Kinase In Complex With Zm4474 | 2e-18 | ||
| 1fpu_A | 293 | Crystal Structure Of Abl Kinase Domain In Complex W | 2e-18 | ||
| 2qoh_A | 288 | Crystal Structure Of Abl Kinase Bound With Ppy-a Le | 2e-18 | ||
| 2z60_A | 288 | Crystal Structure Of The T315i Mutant Of Abl Kinase | 3e-18 | ||
| 3gen_A | 283 | The 1.6 A Crystal Structure Of Human Bruton's Tyros | 3e-18 | ||
| 2jav_A | 279 | Human Kinase With Pyrrole-Indolinone Ligand Length | 3e-18 | ||
| 3oy3_A | 284 | Crystal Structure Of Abl T315i Mutant Kinase Domain | 3e-18 | ||
| 3oxz_A | 284 | Crystal Structure Of Abl Kinase Domain Bound With A | 3e-18 | ||
| 3pls_A | 298 | Ron In Complex With Ligand Amp-Pnp Length = 298 | 4e-18 | ||
| 3gvu_A | 292 | The Crystal Structure Of Human Abl2 In Complex With | 4e-18 | ||
| 4asz_A | 299 | Crystal Structure Of Apo Trkb Kinase Domain Length | 6e-18 | ||
| 3s95_A | 310 | Crystal Structure Of The Human Limk1 Kinase Domain | 7e-18 | ||
| 3cok_A | 278 | Crystal Structure Of Plk4 Kinase Length = 278 | 1e-17 | ||
| 1f3m_C | 297 | Crystal Structure Of Human SerineTHREONINE KINASE P | 1e-17 | ||
| 1opl_A | 537 | Structural Basis For The Auto-Inhibition Of C-Abl T | 2e-17 | ||
| 2fo0_A | 495 | Organization Of The Sh3-Sh2 Unit In Active And Inac | 2e-17 | ||
| 2p0c_A | 313 | Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro | 2e-17 | ||
| 3pix_A | 274 | Crystal Structure Of Btk Kinase Domain Complexed Wi | 2e-17 | ||
| 3pp0_A | 338 | Crystal Structure Of The Kinase Domain Of Human Her | 2e-17 | ||
| 1opk_A | 495 | Structural Basis For The Auto-Inhibition Of C-Abl T | 2e-17 | ||
| 3a4o_X | 286 | Lyn Kinase Domain Length = 286 | 3e-17 | ||
| 3v5q_A | 297 | Discovery Of A Selective Trk Inhibitor With Efficac | 4e-17 | ||
| 3d7t_A | 269 | Structural Basis For The Recognition Of C-Src By It | 4e-17 | ||
| 1yhv_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Two Po | 4e-17 | ||
| 2dq7_X | 283 | Crystal Structure Of Fyn Kinase Domain Complexed Wi | 4e-17 | ||
| 3d7u_A | 263 | Structural Basis For The Recognition Of C-Src By It | 6e-17 | ||
| 1byg_A | 278 | Kinase Domain Of Human C-Terminal Src Kinase (Csk) | 8e-17 | ||
| 1k9a_A | 450 | Crystal Structure Analysis Of Full-Length Carboxyl- | 1e-16 | ||
| 3q4z_A | 306 | Structure Of Unphosphorylated Pak1 Kinase Domain Le | 1e-16 | ||
| 3q52_A | 306 | Structure Of Phosphorylated Pak1 Kinase Domain Leng | 1e-16 | ||
| 4gt5_A | 306 | Crystal Structure Of The Inactive Trka Kinase Domai | 1e-16 | ||
| 4f0i_A | 300 | Crystal Structure Of Apo Trka Length = 300 | 1e-16 | ||
| 4af3_A | 292 | Human Aurora B Kinase In Complex With Incenp And Vx | 1e-16 | ||
| 3p08_A | 267 | Crystal Structure Of The Human Btk Kinase Domain Le | 1e-16 | ||
| 2jiv_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 1e-16 | ||
| 3ika_A | 331 | Crystal Structure Of Egfr 696-1022 T790m Mutant Cov | 2e-16 | ||
| 2jiu_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 2e-16 | ||
| 1k2p_A | 263 | Crystal Structure Of Bruton's Tyrosine Kinase Domai | 2e-16 | ||
| 2jit_A | 327 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 2e-16 | ||
| 3fxz_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Ruthen | 2e-16 | ||
| 3bel_A | 315 | X-Ray Structure Of Egfr In Complex With Oxime Inhib | 2e-16 | ||
| 4i24_A | 329 | Structure Of T790m Egfr Kinase Domain Co-crystalliz | 2e-16 | ||
| 4g5p_A | 330 | Crystal Structure Of Egfr Kinase T790m In Complex W | 2e-16 | ||
| 4aoj_A | 329 | Human Trka In Complex With The Inhibitor Az-23 Leng | 2e-16 | ||
| 1m14_A | 333 | Tyrosine Kinase Domain From Epidermal Growth Factor | 2e-16 | ||
| 2j5e_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 2e-16 | ||
| 4i23_A | 329 | Crystal Structure Of The Wild-type Egfr Kinase Doma | 2e-16 | ||
| 4g5j_A | 330 | Crystal Structure Of Egfr Kinase In Complex With Bi | 2e-16 | ||
| 1xkk_A | 352 | Egfr Kinase Domain Complexed With A Quinazoline Inh | 2e-16 | ||
| 3pjc_A | 315 | Crystal Structure Of Jak3 Complexed With A Potent A | 2e-16 | ||
| 2j5f_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 2e-16 | ||
| 3ocs_A | 271 | Crystal Structure Of Bruton's Tyrosine Kinase In Co | 2e-16 | ||
| 3vjo_A | 334 | Crystal Structure Of The Wild-Type Egfr Kinase Doma | 2e-16 | ||
| 4hvd_A | 314 | Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h | 2e-16 | ||
| 2gs2_A | 330 | Crystal Structure Of The Active Egfr Kinase Domain | 3e-16 | ||
| 2zv7_A | 279 | Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | 3e-16 | ||
| 3oct_A | 265 | Crystal Structure Of Bruton's Tyrosine Kinase Mutan | 3e-16 | ||
| 4e4l_A | 302 | Jak1 Kinase (Jh1 Domain) In Complex With Compound 3 | 3e-16 | ||
| 3lzb_A | 327 | Egfr Kinase Domain Complexed With An Imidazo[2,1-B] | 3e-16 | ||
| 4hjo_A | 337 | Crystal Structure Of The Inactive Egfr Tyrosine Kin | 3e-16 | ||
| 2gs7_A | 330 | Crystal Structure Of The Inactive Egfr Kinase Domai | 4e-16 | ||
| 1zy4_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 4e-16 | ||
| 3lxk_A | 327 | Structural And Thermodynamic Characterization Of Th | 4e-16 | ||
| 3eyg_A | 290 | Crystal Structures Of Jak1 And Jak2 Inhibitor Compl | 4e-16 | ||
| 2oo8_X | 317 | Synthesis, Structural Analysis, And Sar Studies Of | 5e-16 | ||
| 3ugc_A | 295 | Structural Basis Of Jak2 Inhibition By The Type Ii | 5e-16 | ||
| 3rzf_A | 677 | Crystal Structure Of Inhibitor Of Kappab Kinase Bet | 5e-16 | ||
| 1fvr_A | 327 | Tie2 Kinase Domain Length = 327 | 5e-16 | ||
| 3qa8_A | 676 | Crystal Structure Of Inhibitor Of Kappa B Kinase Be | 5e-16 | ||
| 1yvj_A | 290 | Crystal Structure Of The Jak3 Kinase Domain In Comp | 6e-16 | ||
| 2rfd_A | 324 | Crystal Structure Of The Complex Between The Egfr K | 6e-16 | ||
| 3rvg_A | 303 | Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido | 7e-16 | ||
| 3zgw_A | 347 | Crystal Structure Of Maternal Embryonic Leucine Zip | 7e-16 | ||
| 3e62_A | 293 | Fragment Based Discovery Of Jak-2 Inhibitors Length | 7e-16 | ||
| 2xa4_A | 298 | Inhibitors Of Jak2 Kinase Domain Length = 298 | 7e-16 | ||
| 3com_A | 314 | Crystal Structure Of Mst1 Kinase Length = 314 | 7e-16 | ||
| 3tjc_A | 298 | Co-Crystal Structure Of Jak2 With Thienopyridine 8 | 7e-16 | ||
| 2b7a_A | 293 | The Structural Basis Of Janus Kinase 2 Inhibition B | 8e-16 | ||
| 4hge_A | 300 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 | 8e-16 | ||
| 3q32_A | 301 | Structure Of Janus Kinase 2 With A Pyrrolotriazine | 8e-16 | ||
| 3lpb_A | 295 | Crystal Structure Of Jak2 Complexed With A Potent 2 | 8e-16 | ||
| 4aqc_A | 301 | Triazolopyridine-Based Inhibitor Of Janus Kinase 2 | 8e-16 | ||
| 2w1i_A | 326 | Structure Determination Of Aurora Kinase In Complex | 9e-16 | ||
| 3ug1_A | 334 | Crystal Structure Of The Mutated Egfr Kinase Domain | 9e-16 | ||
| 4e4m_A | 302 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 3 | 9e-16 | ||
| 3gop_A | 361 | Crystal Structure Of The Egf Receptor Juxtamembrane | 9e-16 | ||
| 2itn_A | 327 | Crystal Structure Of Egfr Kinase Domain G719s Mutat | 1e-15 | ||
| 3w2o_A | 331 | Egfr Kinase Domain T790m/l858r Mutant With Tak-285 | 1e-15 | ||
| 4i21_A | 329 | Crystal Structure Of L858r + T790m Egfr Kinase Doma | 1e-15 | ||
| 3jy9_A | 311 | Janus Kinase 2 Inhibitors Length = 311 | 1e-15 | ||
| 2eb2_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (G7 | 1e-15 | ||
| 4e6d_A | 298 | Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W | 1e-15 | ||
| 3io7_A | 313 | 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel | 1e-15 | ||
| 2itt_A | 327 | Crystal Structure Of Egfr Kinase Domain L858r Mutat | 1e-15 | ||
| 2eb3_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (L8 | 1e-15 | ||
| 4bbe_A | 298 | Aminoalkylpyrimidine Inhibitor Complexes With Jak2 | 1e-15 | ||
| 2hk5_A | 270 | Hck Kinase In Complex With Lck Targetted Inhibitor | 2e-15 | ||
| 4gt4_A | 308 | Structure Of Unliganded, Inactive Ror2 Kinase Domai | 2e-15 | ||
| 4i1z_A | 329 | Crystal Structure Of The Monomeric (v948r) Form Of | 2e-15 | ||
| 2z8c_A | 303 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 2e-15 | ||
| 1ir3_A | 306 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 2e-15 | ||
| 3zzw_A | 289 | Crystal Structure Of The Kinase Domain Of Ror2 Leng | 2e-15 | ||
| 2x7f_A | 326 | Crystal Structure Of The Kinase Domain Of Human Tra | 2e-15 | ||
| 4i20_A | 329 | Crystal Structure Of Monomeric (v948r) Primary Onco | 2e-15 | ||
| 2wqb_A | 324 | Structure Of The Tie2 Kinase Domain In Complex With | 2e-15 | ||
| 3cc6_A | 281 | Crystal Structure Of Kinase Domain Of Protein Tyros | 2e-15 | ||
| 4h1j_A | 293 | Crystal Structure Of Pyk2 With The Pyrazole 13a Len | 2e-15 | ||
| 1fot_A | 318 | Structure Of The Unliganded Camp-Dependent Protein | 2e-15 | ||
| 3fzo_A | 277 | Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin | 2e-15 | ||
| 1qcf_A | 454 | Crystal Structure Of Hck In Complex With A Src Fami | 3e-15 | ||
| 1i44_A | 306 | Crystallographic Studies Of An Activation Loop Muta | 3e-15 | ||
| 1u59_A | 287 | Crystal Structure Of The Zap-70 Kinase Domain In Co | 3e-15 | ||
| 1zyc_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 3e-15 | ||
| 1p4o_A | 322 | Structure Of Apo Unactivated Igf-1r Kinase Domain A | 4e-15 | ||
| 1rqq_A | 306 | Crystal Structure Of The Insulin Receptor Kinase In | 4e-15 | ||
| 3iec_A | 319 | Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K | 4e-15 | ||
| 1irk_A | 306 | Crystal Structure Of The Tyrosine Kinase Domain Of | 4e-15 | ||
| 3lw0_A | 304 | Igf-1rk In Complex With Ligand Msc1609119a-1 Length | 5e-15 | ||
| 2pwl_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 5e-15 | ||
| 3cd3_A | 377 | Crystal Structure Of Phosphorylated Human Feline Sa | 5e-15 | ||
| 4e7w_A | 394 | Structure Of Gsk3 From Ustilago Maydis Length = 394 | 6e-15 | ||
| 2h6d_A | 276 | Protein Kinase Domain Of The Human 5'-Amp-Activated | 6e-15 | ||
| 1k3a_A | 299 | Structure Of The Insulin-Like Growth Factor 1 Recep | 6e-15 | ||
| 1zmu_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 6e-15 | ||
| 2r0i_A | 327 | Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len | 6e-15 | ||
| 2ozo_A | 613 | Autoinhibited Intact Human Zap-70 Length = 613 | 6e-15 | ||
| 2hak_A | 328 | Catalytic And Ubiqutin-Associated Domains Of Mark1P | 6e-15 | ||
| 2pz5_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 7e-15 | ||
| 2pvy_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 7e-15 | ||
| 4ewh_B | 275 | Co-Crystal Structure Of Ack1 With Inhibitor Length | 7e-15 | ||
| 2pzp_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 7e-15 | ||
| 4hzs_A | 341 | Crystal Structure Of Ack1 Kinase Domain With C-term | 7e-15 | ||
| 3o23_A | 305 | Human Unphosphorylated Igf1-R Kinase Domain In Comp | 7e-15 | ||
| 3lmg_A | 344 | Crystal Structure Of The Erbb3 Kinase Domain In Com | 7e-15 | ||
| 3bkb_A | 377 | Crystal Structure Of Human Feline Sarcoma Viral Onc | 7e-15 | ||
| 2zm3_A | 308 | Complex Structure Of Insulin-Like Growth Factor Rec | 7e-15 | ||
| 3gqi_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 8e-15 | ||
| 2psq_A | 370 | Crystal Structure Of Unphosphorylated Unactivated W | 8e-15 | ||
| 3eqp_B | 276 | Crystal Structure Of Ack1 With Compound T95 Length | 8e-15 | ||
| 3b2t_A | 311 | Structure Of Phosphotransferase Length = 311 | 9e-15 | ||
| 3kex_A | 325 | Crystal Structure Of The Catalytically Inactive Kin | 9e-15 | ||
| 1u46_A | 291 | Crystal Structure Of The Unphosphorylated Kinase Do | 9e-15 | ||
| 2pvf_A | 334 | Crystal Structure Of Tyrosine Phosphorylated Activa | 9e-15 | ||
| 1u54_A | 291 | Crystal Structures Of The Phosphorylated And Unphos | 9e-15 | ||
| 4id7_A | 273 | Ack1 Kinase In Complex With The Inhibitor Cis-3-[8- | 9e-15 | ||
| 3ri1_A | 313 | Crystal Structure Of The Catalytic Domain Of Fgfr2 | 9e-15 | ||
| 1gjo_A | 316 | The Fgfr2 Tyrosine Kinase Domain Length = 316 | 1e-14 | ||
| 3cly_A | 334 | Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase | 1e-14 | ||
| 4hzr_A | 277 | Crystal Structure Of Ack1 Kinase Domain Length = 27 | 1e-14 | ||
| 4fl3_A | 635 | Structural And Biophysical Characterization Of The | 1e-14 | ||
| 3tub_A | 293 | Crystal Structure Of Syk Kinase Domain With 1-(5-(6 | 1e-14 | ||
| 3vf8_A | 299 | Crystal Structure Of Spleen Tyrosine Kinase Syk Cat | 1e-14 | ||
| 1m7n_A | 322 | Crystal Structure Of Unactivated Apo Insulin-Like G | 1e-14 | ||
| 3sls_A | 304 | Crystal Structure Of Human Mek-1 Kinase In Complex | 1e-14 | ||
| 3eta_A | 317 | Kinase Domain Of Insulin Receptor Complexed With A | 1e-14 | ||
| 1zmv_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 1e-14 | ||
| 3c4f_A | 302 | Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M | 1e-14 | ||
| 4fl2_A | 636 | Structural And Biophysical Characterization Of The | 1e-14 | ||
| 1vzo_A | 355 | The Structure Of The N-Terminal Kinase Domain Of Ms | 1e-14 | ||
| 2pzr_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-14 | ||
| 3emg_A | 291 | Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami | 1e-14 | ||
| 3q4t_A | 322 | Crystal Structure Of Activin Receptor Type-Iia (Acv | 1e-14 | ||
| 1jqh_A | 308 | Igf-1 Receptor Kinase Domain Length = 308 | 1e-14 | ||
| 1fgk_A | 310 | Crystal Structure Of The Tyrosine Kinase Domain Of | 1e-14 | ||
| 3gql_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 1e-14 | ||
| 3qqu_A | 301 | Cocrystal Structure Of Unphosphorylated Igf With Py | 1e-14 | ||
| 3js2_A | 317 | Crystal Structure Of Minimal Kinase Domain Of Fibro | 1e-14 | ||
| 3ggf_A | 301 | Crystal Structure Of Human SerineTHREONINE-Protein | 1e-14 | ||
| 2yza_A | 276 | Crystal Structure Of Kinase Domain Of Human 5'-Amp- | 2e-14 | ||
| 3rhx_B | 306 | Crystal Structure Of The Catalytic Domain Of Fgfr1 | 2e-14 | ||
| 4f63_A | 309 | Crystal Structure Of Human Fibroblast Growth Factor | 2e-14 | ||
| 3i81_A | 315 | Crystal Structure Of Insulin-Like Growth Factor 1 R | 2e-14 | ||
| 2oj9_A | 307 | Structure Of Igf-1r Kinase Domain Complexed With A | 2e-14 | ||
| 2a19_B | 284 | Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng | 2e-14 | ||
| 3srv_B | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 2e-14 | ||
| 1xba_A | 291 | Crystal Structure Of Apo Syk Tyrosine Kinase Domain | 2e-14 | ||
| 2y94_A | 476 | Structure Of An Active Form Of Mammalian Ampk Lengt | 2e-14 | ||
| 3orn_A | 307 | Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In | 2e-14 | ||
| 2wzj_A | 327 | Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82 | 2e-14 | ||
| 4dfl_A | 274 | Crystal Structure Of Spleen Tyrosine Kinase Complex | 2e-14 | ||
| 1zmw_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 2e-14 | ||
| 4g31_A | 299 | Crystal Structure Of Gsk6414 Bound To Perk (R587-R1 | 2e-14 | ||
| 4f4p_A | 273 | Syk In Complex With Ligand Lasw836 Length = 273 | 2e-14 | ||
| 2qnj_A | 328 | Kinase And Ubiquitin-Associated Domains Of Mark3PAR | 2e-14 | ||
| 3lvp_A | 336 | Crystal Structure Of Bisphosphorylated Igf1-R Kinas | 3e-14 | ||
| 1zxe_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 3e-14 | ||
| 3uiu_A | 306 | Crystal Structure Of Apo-Pkr Kinase Domain Length = | 3e-14 | ||
| 2q0b_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 3e-14 | ||
| 3kxx_A | 317 | Structure Of The Mutant Fibroblast Growth Factor Re | 3e-14 | ||
| 3tt0_A | 382 | Co-Structure Of Fibroblast Growth Factor Receptor 1 | 3e-14 | ||
| 2p55_A | 333 | X-Ray Structure Of The Human Mitogen-Activated Prot | 3e-14 | ||
| 3d94_A | 301 | Crystal Structure Of The Insulin-Like Growth Factor | 3e-14 | ||
| 2f9g_A | 353 | Crystal Structure Of Fus3 Phosphorylated On Tyr182 | 3e-14 | ||
| 1s9j_A | 341 | X-Ray Structure Of The Human Mitogen-Activated Prot | 4e-14 | ||
| 3mbl_A | 328 | Crystal Structure Of The Human Mitogen-Activated Pr | 4e-14 | ||
| 3dv3_A | 322 | Mek1 With Pf-04622664 Bound Length = 322 | 4e-14 | ||
| 2b9f_A | 353 | Crystal Structure Of Non-Phosphorylated Fus3 Length | 4e-14 | ||
| 3srv_A | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 4e-14 | ||
| 2i1m_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An | 4e-14 | ||
| 3bea_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P | 4e-14 | ||
| 4aaa_A | 331 | Crystal Structure Of The Human Cdkl2 Kinase Domain | 4e-14 | ||
| 1p14_A | 306 | Crystal Structure Of A Catalytic-Loop Mutant Of The | 4e-14 | ||
| 2qlu_A | 314 | Crystal Structure Of Activin Receptor Type Ii Kinas | 5e-14 | ||
| 4apc_A | 350 | Crystal Structure Of Human Nima-Related Kinase 1 (N | 5e-14 | ||
| 3ekk_A | 307 | Insulin Receptor Kinase Complexed With An Inhibitor | 5e-14 | ||
| 2py3_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 5e-14 | ||
| 4ic7_A | 442 | Crystal Structure Of The Erk5 Kinase Domain In Comp | 5e-14 | ||
| 2y4i_C | 395 | Ksr2-Mek1 Heterodimer Length = 395 | 5e-14 | ||
| 4b99_A | 398 | Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le | 7e-14 | ||
| 3eqc_A | 360 | X-Ray Structure Of The Human Mitogen-Activated Prot | 7e-14 | ||
| 3fe3_A | 328 | Crystal Structure Of The Kinase Mark3PAR-1: T211a-S | 7e-14 | ||
| 3lcd_A | 329 | Inhibitor Bound To A Dfg-In Structure Of The Kinase | 7e-14 | ||
| 3g51_A | 325 | Structural Diversity Of The Active Conformation Of | 8e-14 | ||
| 2zoq_A | 382 | Structural Dissection Of Human Mitogen-Activated Ki | 9e-14 | ||
| 4an2_A | 301 | Crystal Structures Of Human Mek1 With Carboxamide-B | 1e-13 | ||
| 4e5a_X | 360 | The W197a Mutant Of P38a Map Kinase Length = 360 | 1e-13 | ||
| 2puu_A | 348 | Crystal Structure Of P38 Complex With 1-(5-Tert-But | 1e-13 | ||
| 2b9h_A | 353 | Crystal Structure Of Fus3 With A Docking Motif From | 1e-13 | ||
| 3ubd_A | 304 | Structure Of N-Terminal Domain Of Rsk2 Kinase In Co | 1e-13 | ||
| 4el9_A | 305 | Structure Of N-Terminal Kinase Domain Of Rsk2 With | 1e-13 | ||
| 3oht_A | 389 | Crystal Structure Of Salmo Salar P38alpha Length = | 1e-13 | ||
| 3lct_A | 344 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 1e-13 | ||
| 2oza_B | 366 | Structure Of P38alpha Complex Length = 366 | 1e-13 | ||
| 3l9p_A | 367 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 1e-13 | ||
| 1s9i_A | 354 | X-Ray Structure Of The Human Mitogen-Activated Prot | 1e-13 | ||
| 1lew_A | 360 | Crystal Structure Of Map Kinase P38 Complexed To Th | 1e-13 | ||
| 2i0v_A | 335 | C-Fms Tyrosine Kinase In Complex With A Quinolone I | 1e-13 | ||
| 2baq_A | 365 | P38alpha Bound To Ro3201195 Length = 365 | 2e-13 | ||
| 2gtm_A | 348 | Mutated Mouse P38 Map Kinase Domain In Complex With | 2e-13 | ||
| 3tg1_A | 380 | Crystal Structure Of P38alpha In Complex With A Map | 2e-13 | ||
| 1bmk_A | 379 | The Complex Structure Of The Map Kinase P38SB218655 | 2e-13 | ||
| 4fv6_A | 360 | Crystal Structure Of The Erk2 Complexed With E57 Le | 2e-13 | ||
| 4fux_A | 360 | Crystal Structure Of The Erk2 Complexed With E75 Le | 2e-13 | ||
| 1ian_A | 366 | Human P38 Map Kinase Inhibitor Complex Length = 366 | 2e-13 | ||
| 2y9q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 2e-13 | ||
| 3ody_X | 360 | Crystal Structure Of P38alpha Y323q Active Mutant L | 2e-13 | ||
| 1m7q_A | 366 | Crystal Structure Of P38 Map Kinase In Complex With | 2e-13 | ||
| 3odz_X | 360 | Crystal Structure Of P38alpha Y323r Active Mutant L | 2e-13 | ||
| 3zsg_A | 362 | X-Ray Structure Of P38alpha Bound To Tak-715 Length | 2e-13 | ||
| 3od6_X | 360 | Crystal Structure Of P38alpha Y323t Active Mutant L | 2e-13 | ||
| 1ad5_A | 438 | Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | 2e-13 | ||
| 1wzy_A | 368 | Crystal Structure Of Human Erk2 Complexed With A Py | 2e-13 | ||
| 1tvo_A | 368 | The Structure Of Erk2 In Complex With A Small Molec | 2e-13 | ||
| 2lgc_A | 359 | Joint Nmr And X-Ray Refinement Reveals The Structur | 2e-13 | ||
| 2bal_A | 365 | P38alpha Map Kinase Bound To Pyrazoloamine Length = | 2e-13 | ||
| 2baj_A | 365 | P38alpha Bound To Pyrazolourea Length = 365 | 2e-13 | ||
| 3hrb_A | 359 | P38 Kinase Crystal Structure In Complex With Small | 2e-13 | ||
| 3nnu_A | 354 | Crystal Structure Of P38 Alpha In Complex With Dp13 | 2e-13 | ||
| 1di9_A | 360 | The Structure Of P38 Mitogen-Activated Protein Kina | 2e-13 | ||
| 4fv7_A | 360 | Crystal Structure Of The Erk2 Complexed With E94 Le | 2e-13 | ||
| 3hvc_A | 362 | Crystal Structure Of Human P38alpha Map Kinase Leng | 2e-13 | ||
| 3oef_X | 360 | Crystal Structure Of Y323f Inactive Mutant Of P38al | 2e-13 | ||
| 3nnx_A | 354 | Crystal Structure Of Phosphorylated P38 Alpha In Co | 2e-13 | ||
| 3d83_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 2e-13 | ||
| 2ojg_A | 380 | Crystal Structure Of Erk2 In Complex With N,n-dimet | 2e-13 | ||
| 1zzl_A | 351 | Crystal Structure Of P38 With Triazolopyridine Leng | 2e-13 | ||
| 2c30_A | 321 | Crystal Structure Of The Human P21-Activated Kinase | 2e-13 | ||
| 3k3j_A | 362 | P38alpha Bound To Novel Dfg-Out Compound Pf-0041612 | 2e-13 | ||
| 3d7z_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 2e-13 | ||
| 3s3i_A | 349 | P38 Kinase Crystal Structure In Complex With Small | 2e-13 | ||
| 3gcu_A | 360 | Human P38 Map Kinase In Complex With Rl48 Length = | 2e-13 | ||
| 2pk9_A | 317 | Structure Of The Pho85-pho80 Cdk-cyclin Complex Of | 2e-13 | ||
| 3p4k_A | 370 | The Third Conformation Of P38a Map Kinase Observed | 2e-13 | ||
| 3e92_A | 371 | Crystal Structure Of P38 Kinase In Complex With A B | 2e-13 | ||
| 2npq_A | 367 | A Novel Lipid Binding Site In The P38 Alpha Map Kin | 2e-13 | ||
| 1oz1_A | 372 | P38 Mitogen-Activated Kinase In Complex With 4-Azai | 2e-13 | ||
| 3nyx_A | 302 | Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T | 2e-13 | ||
| 2gfs_A | 372 | P38 Kinase Crystal Structure In Complex With Ro3201 | 2e-13 | ||
| 4e20_A | 290 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 3e-13 | ||
| 3hec_A | 348 | P38 In Complex With Imatinib Length = 348 | 3e-13 | ||
| 4e1z_A | 291 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 3e-13 | ||
| 1bl6_A | 379 | The Complex Structure Of The Map Kinase P38SB216995 | 3e-13 | ||
| 3tei_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 3e-13 | ||
| 3mpt_A | 371 | Crystal Structure Of P38 Kinase In Complex With A P | 3e-13 | ||
| 3fi4_A | 372 | P38 Kinase Crystal Structure In Complex With Ro4499 | 3e-13 | ||
| 3k3i_A | 350 | P38alpha Bound To Novel Dgf-Out Compound Pf-0021595 | 3e-13 | ||
| 3kq7_A | 380 | Structure Of Human P38alpha With N-[4-Methyl-3-(6-{ | 3e-13 | ||
| 3r63_A | 358 | Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | 3e-13 | ||
| 3o71_A | 358 | Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length | 3e-13 | ||
| 3zu7_A | 365 | Crystal Structure Of A Designed Selected Ankyrin Re | 3e-13 | ||
| 3a62_A | 327 | Crystal Structure Of Phosphorylated P70s6k1 Length | 3e-13 | ||
| 2z7l_A | 366 | Unphosphorylated Mitogen Activated Protein Kinase E | 3e-13 | ||
| 3c9w_A | 357 | Crystal Structure Of Erk-2 With Hypothemycin Covale | 3e-13 | ||
| 2fys_B | 364 | Crystal Structure Of Erk2 Complex With Kim Peptide | 3e-13 | ||
| 3sa0_A | 360 | Complex Of Erk2 With Norathyriol Length = 360 | 3e-13 | ||
| 3dt1_A | 383 | P38 Complexed With A Quinazoline Inhibitor Length = | 3e-13 | ||
| 3qyw_A | 364 | Crystal Structure Of Erk2 In Complex With An Inhibi | 3e-13 | ||
| 1ove_A | 366 | The Structure Of P38 Alpha In Complex With A Dihydr | 3e-13 | ||
| 3nz0_A | 302 | Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3 | 3e-13 | ||
| 3a60_A | 327 | Crystal Structure Of Unphosphorylated P70s6k1 (Form | 3e-13 | ||
| 2vwi_A | 303 | Structure Of The Osr1 Kinase, A Hypertension Drug T | 3e-13 | ||
| 2y8o_A | 362 | Crystal Structure Of Human P38alpha Complexed With | 3e-13 | ||
| 1y8g_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 3e-13 | ||
| 2fsl_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a+f3 | 4e-13 | ||
| 2fso_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a) A | 4e-13 | ||
| 2fst_X | 367 | Mitogen Activated Protein Kinase P38alpha (d176a+f3 | 4e-13 | ||
| 3h4j_B | 336 | Crystal Structure Of Pombe Ampk Kdaid Fragment Leng | 4e-13 | ||
| 3dak_A | 290 | Crystal Structure Of Domain-Swapped Osr1 Kinase Dom | 4e-13 | ||
| 3lxn_A | 318 | Structural And Thermodynamic Characterization Of Th | 4e-13 | ||
| 2gph_A | 364 | Docking Motif Interactions In The Map Kinase Erk2 L | 4e-13 | ||
| 1pme_A | 380 | Structure Of Penta Mutant Human Erk2 Map Kinase Com | 4e-13 | ||
| 4fnw_A | 327 | Crystal Structure Of The Apo F1174l Anaplastic Lymp | 4e-13 | ||
| 1ywr_A | 360 | Crystal Structure Analysis Of Inactive P38 Kinase D | 4e-13 | ||
| 4h3q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 4e-13 | ||
| 4gsb_A | 364 | Monoclinic Crystal Form Of The Apo-Erk2 Length = 36 | 5e-13 | ||
| 3ma6_A | 298 | Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr | 5e-13 | ||
| 2ghl_A | 348 | Mutant Mus Musculus P38 Kinase Domain In Complex Wi | 5e-13 | ||
| 1yw2_A | 360 | Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | 5e-13 | ||
| 1a06_A | 332 | Calmodulin-Dependent Protein Kinase From Rat Length | 5e-13 | ||
| 3zh8_A | 349 | A Novel Small Molecule Apkc Inhibitor Length = 349 | 5e-13 | ||
| 3ll6_A | 337 | Crystal Structure Of The Human Cyclin G Associated | 5e-13 | ||
| 2j51_A | 325 | Crystal Structure Of Human Ste20-Like Kinase Bound | 5e-13 | ||
| 1gol_A | 364 | Coordinates Of Rat Map Kinase Erk2 With An Arginine | 5e-13 | ||
| 2jfm_A | 325 | Crystal Structure Of Human Ste20-Like Kinase (Unlig | 6e-13 | ||
| 4fnz_A | 327 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 6e-13 | ||
| 1zrz_A | 364 | Crystal Structure Of The Catalytic Domain Of Atypic | 6e-13 | ||
| 2f57_A | 317 | Crystal Structure Of The Human P21-activated Kinase | 6e-13 | ||
| 1vyw_A | 309 | Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = | 6e-13 | ||
| 2yjr_A | 342 | Structure Of F1174l Mutant Anaplastic Lymphoma Kina | 6e-13 | ||
| 3a8w_A | 345 | Crystal Structure Of Pkciota Kinase Domain Length = | 6e-13 | ||
| 2jkm_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 6e-13 | ||
| 3mh2_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 6e-13 | ||
| 3vn9_A | 340 | Rifined Crystal Structure Of Non-Phosphorylated Map | 6e-13 | ||
| 3aox_A | 344 | X-Ray Crystal Structure Of Human Anaplastic Lymphom | 6e-13 | ||
| 2jam_A | 304 | Crystal Structure Of Human Calmodulin-Dependent Pro | 6e-13 | ||
| 4dce_A | 333 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 6e-13 | ||
| 3cjg_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 6e-13 | ||
| 4fnx_A | 327 | Crystal Structure Of The Apo R1275q Anaplastic Lymp | 6e-13 | ||
| 2ivs_A | 314 | Crystal Structure Of Non-Phosphorylated Ret Tyrosin | 6e-13 | ||
| 2xp2_A | 327 | Structure Of The Human Anaplastic Lymphoma Kinase I | 7e-13 | ||
| 1i09_A | 420 | Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len | 7e-13 | ||
| 2xb7_A | 315 | Structure Of Human Anaplastic Lymphoma Kinase In Co | 7e-13 | ||
| 3cjf_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 7e-13 | ||
| 2yfx_A | 327 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 7e-13 | ||
| 2jfl_A | 325 | Crystal Structure Of Human Ste20-Like Kinase ( Diph | 7e-13 | ||
| 4ewq_A | 383 | Human P38 Alpha Mapk In Complex With A Pyridazine B | 7e-13 | ||
| 1q5k_A | 414 | Crystal Structure Of Glycogen Synthase Kinase 3 In | 7e-13 | ||
| 2ow3_A | 352 | Glycogen Synthase Kinase-3 Beta In Complex With Bis | 7e-13 | ||
| 4fob_A | 353 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 7e-13 | ||
| 3i79_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 7e-13 | ||
| 3zrk_A | 371 | Identification Of 2-(4-Pyridyl)thienopyridinones As | 7e-13 | ||
| 3f88_A | 349 | Glycogen Synthase Kinase 3beta Inhibitor Complex Le | 8e-13 | ||
| 3f7z_A | 350 | X-ray Co-crystal Structure Of Glycogen Synthase Kin | 8e-13 | ||
| 2acx_A | 576 | Crystal Structure Of G Protein Coupled Receptor Kin | 8e-13 | ||
| 1pf8_A | 298 | Crystal Structure Of Human Cyclin-dependent Kinase | 8e-13 | ||
| 4fie_A | 423 | Full-Length Human Pak4 Length = 423 | 8e-13 | ||
| 4dc2_A | 396 | Structure Of Pkc In Complex With A Substrate Peptid | 8e-13 | ||
| 3zdi_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 8e-13 | ||
| 2w17_A | 299 | Cdk2 In Complex With The Imidazole Pyrimidine Amide | 8e-13 | ||
| 1gng_A | 378 | Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With | 8e-13 | ||
| 1fin_A | 298 | Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = | 8e-13 | ||
| 3py3_A | 380 | Crystal Structure Of Phosphorylated P38alpha Map Ki | 8e-13 | ||
| 3say_A | 430 | Crystal Structure Of Human Glycogen Synthase Kinase | 8e-13 | ||
| 1t46_A | 313 | Structural Basis For The Autoinhibition And Sti-571 | 8e-13 | ||
| 1pyx_A | 422 | Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | 8e-13 | ||
| 3krw_A | 688 | Human Grk2 In Complex With Gbetgamma Subunits And B | 8e-13 | ||
| 3ezr_A | 300 | Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ | 8e-13 | ||
| 1uv5_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With 6-Br | 8e-13 | ||
| 2o5k_A | 372 | Crystal Structure Of Gsk3beta In Complex With A Ben | 8e-13 | ||
| 3sd0_A | 350 | Identification Of A Glycogen Synthase Kinase-3b Inh | 8e-13 | ||
| 3pxf_A | 306 | Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N | 8e-13 | ||
| 4afj_A | 367 | 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec | 8e-13 | ||
| 1gz8_A | 299 | Human Cyclin Dependent Kinase 2 Complexed With The | 8e-13 | ||
| 1q3d_A | 424 | Gsk-3 Beta Complexed With Staurosporine Length = 42 | 8e-13 | ||
| 3gcp_A | 360 | Human P38 Map Kinase In Complex With Sb203580 Lengt | 8e-13 | ||
| 3g0f_A | 336 | Kit Kinase Domain Mutant D816h In Complex With Suni | 8e-13 | ||
| 2jkk_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 8e-13 | ||
| 4erw_A | 306 | Cdk2 In Complex With Staurosporine Length = 306 | 8e-13 | ||
| 3nyn_A | 576 | Crystal Structure Of G Protein-Coupled Receptor Kin | 8e-13 | ||
| 2j0m_B | 276 | Crystal Structure A Two-Chain Complex Between The F | 9e-13 | ||
| 1h8f_A | 352 | Glycogen Synthase Kinase 3 Beta. Length = 352 | 9e-13 | ||
| 3cik_A | 689 | Human Grk2 In Complex With Gbetagamma Subunits Leng | 9e-13 | ||
| 4dit_A | 382 | Crystal Structure Of Gsk3beta In Complex With A Imi | 9e-13 | ||
| 3pj8_A | 299 | Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D] | 9e-13 | ||
| 2yhv_A | 342 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 9e-13 | ||
| 1omw_A | 689 | Crystal Structure Of The Complex Between G Protein- | 9e-13 | ||
| 3psc_A | 695 | Bovine Grk2 In Complex With Gbetagamma Subunits Len | 9e-13 | ||
| 4acc_A | 465 | Gsk3b In Complex With Inhibitor Length = 465 | 9e-13 | ||
| 1gii_A | 298 | Human Cyclin Dependent Kinase 2 Complexed With The | 9e-13 | ||
| 2q0n_A | 301 | Structure Of Human P21 Activating Kinase 4 (Pak4) I | 1e-12 | ||
| 1r0e_A | 391 | Glycogen Synthase Kinase-3 Beta In Complex With 3-I | 1e-12 | ||
| 1mp8_A | 281 | Crystal Structure Of Focal Adhesion Kinase (Fak) Le | 1e-12 | ||
| 2etm_A | 281 | Crystal Structure Of Focal Adhesion Kinase Domain C | 1e-12 | ||
| 1t45_A | 331 | Structural Basis For The Autoinhibition And Sti-571 | 1e-12 | ||
| 3pxk_A | 282 | Focal Adhesion Kinase Catalytic Domain In Complex W | 1e-12 | ||
| 3txo_A | 353 | Pkc Eta Kinase In Complex With A Naphthyridine Leng | 1e-12 | ||
| 3ku2_A | 507 | Crystal Structure Of Inactivated Form Of Cdpk1 From | 1e-12 | ||
| 3gb2_A | 353 | Gsk3beta Inhibitor Complex Length = 353 | 1e-12 | ||
| 2j0l_A | 276 | Crystal Structure Of A The Active Conformation Of T | 1e-12 | ||
| 3c7q_A | 316 | Structure Of Vegfr2 Kinase Domain In Complex With B | 1e-12 | ||
| 2cdz_A | 303 | Crystal Structure Of The Human P21-Activated Kinase | 1e-12 | ||
| 2oh4_A | 316 | Crystal Structure Of Vegfr2 With A Benzimidazole-Ur | 1e-12 | ||
| 3kmw_A | 271 | Crystal Structure Of The IlkALPHA-Parvin Core Compl | 1e-12 | ||
| 4fg7_A | 293 | Crystal Structure Of Human Calcium/calmodulin-depen | 1e-12 | ||
| 1pkg_A | 329 | Structure Of A C-kit Kinase Product Complex Length | 1e-12 | ||
| 3hx4_A | 508 | Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg | 1e-12 | ||
| 3g0e_A | 336 | Kit Kinase Domain In Complex With Sunitinib Length | 1e-12 | ||
| 3mdy_A | 337 | Crystal Structure Of The Cytoplasmic Domain Of The | 1e-12 | ||
| 1o9u_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 1e-12 | ||
| 4ebw_A | 304 | Structure Of Focal Adhesion Kinase Catalytic Domain | 1e-12 | ||
| 3zuv_A | 364 | Crystal Structure Of A Designed Selected Ankyrin Re | 1e-12 | ||
| 2erk_A | 365 | Phosphorylated Map Kinase Erk2 Length = 365 | 1e-12 | ||
| 3vnt_A | 318 | Crystal Structure Of The Kinase Domain Of Human Veg | 1e-12 | ||
| 3gi3_A | 360 | Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana | 1e-12 | ||
| 2ogv_A | 317 | Crystal Structure Of The Autoinhibited Human C-Fms | 1e-12 | ||
| 2yjs_A | 342 | Structure Of C1156y Mutant Anaplastic Lymphoma Kina | 1e-12 | ||
| 3u6j_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 1e-12 | ||
| 3iw4_A | 360 | Crystal Structure Of Pkc Alpha In Complex With Nvp- | 1e-12 | ||
| 4fsy_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-12 | ||
| 2xir_A | 316 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 1e-12 | ||
| 4fg8_A | 315 | Crystal Structure Of Human Calcium/calmodulin-depen | 1e-12 | ||
| 2bva_A | 292 | Crystal Structure Of The Human P21-Activated Kinase | 1e-12 | ||
| 3aln_A | 327 | Crystal Structure Of Human Non-Phosphorylated Mkk4 | 1e-12 | ||
| 3ewh_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 1e-12 | ||
| 4fg9_A | 320 | Crystal Structure Of Human Calcium/calmodulin-depen | 1e-12 | ||
| 2xik_A | 294 | Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K | 1e-12 | ||
| 4fsz_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-12 | ||
| 4agu_A | 311 | Crystal Structure Of The Human Cdkl1 Kinase Domain | 1e-12 | ||
| 3kn5_A | 325 | Crystal Structure Of The C-Terminal Kinase Domain O | 1e-12 | ||
| 2ivt_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 1e-12 | ||
| 2x4z_A | 296 | Crystal Structure Of The Human P21-Activated Kinase | 2e-12 | ||
| 1b6c_B | 342 | Crystal Structure Of The Cytoplasmic Domain Of The | 2e-12 | ||
| 1ywn_A | 316 | Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p | 2e-12 | ||
| 2ydj_A | 276 | Discovery Of Checkpoint Kinase Inhibitor Azd7762 By | 2e-12 | ||
| 2hog_A | 322 | Crystal Structure Of Chek1 In Complex With Inhibito | 2e-12 | ||
| 2j0j_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 2e-12 | ||
| 4agc_A | 353 | Crystal Structure Of Vegfr2 (Juxtamembrane And Kina | 2e-12 | ||
| 2r0u_A | 323 | Crystal Structure Of Chek1 In Complex With Inhibito | 2e-12 | ||
| 1zys_A | 273 | Co-Crystal Structure Of Checkpoint Kinase Chk1 With | 2e-12 | ||
| 3i7c_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 2e-12 | ||
| 1vr2_A | 316 | Human Vascular Endothelial Growth Factor Receptor 2 | 2e-12 | ||
| 1rw8_A | 301 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 2e-12 | ||
| 2p2i_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 2e-12 | ||
| 4fif_A | 346 | Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid | 2e-12 | ||
| 2p2h_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 2e-12 | ||
| 3is5_A | 285 | Crystal Structure Of Cdpk Kinase Domain From Toxopl | 2e-12 | ||
| 1oit_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 2e-12 | ||
| 2br1_A | 297 | Structure-Based Design Of Novel Chk1 Inhibitors: In | 2e-12 | ||
| 1ia8_A | 289 | The 1.7 A Crystal Structure Of Human Cell Cycle Che | 2e-12 | ||
| 1zlt_A | 295 | Crystal Structure Of Chk1 Complexed With A Hymenald | 2e-12 | ||
| 4bc6_A | 293 | Crystal Structure Of Human Serine Threonine Kinase- | 2e-12 | ||
| 3tzm_A | 309 | Tgf-Beta Receptor Type 1 In Complex With Sb431542 L | 2e-12 | ||
| 1vjy_A | 303 | Crystal Structure Of A Naphthyridine Inhibitor Of H | 2e-12 | ||
| 1py5_A | 326 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 2e-12 | ||
| 3o8p_A | 360 | Conformational Plasticity Of P38 Map Kinase Dfg Mot | 2e-12 | ||
| 2j7t_A | 302 | Crystal Structure Of Human Serine Threonine Kinase- | 2e-12 | ||
| 2wot_A | 306 | Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl) | 2e-12 | ||
| 4fsn_A | 278 | Crystal Structure Of The Chk1 Length = 278 | 2e-12 | ||
| 4fsm_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-12 | ||
| 2x8e_A | 276 | Discovery Of A Novel Class Of Triazolones As Checkp | 2e-12 | ||
| 2iw8_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82 | 2e-12 | ||
| 3fme_A | 290 | Crystal Structure Of Human Mitogen-Activated Protei | 2e-12 | ||
| 4fsw_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-12 | ||
| 2ghg_A | 269 | H-Chk1 Complexed With A431994 Length = 269 | 2e-12 | ||
| 2j0k_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 2e-12 | ||
| 2e9v_A | 268 | Structure Of H-Chk1 Complexed With A859017 Length = | 3e-12 | ||
| 2ayp_A | 269 | Crystal Structure Of Chk1 With An Indol Inhibitor L | 3e-12 | ||
| 3ot3_A | 273 | X-Ray Crystal Structure Of Compound 22k Bound To Hu | 3e-12 | ||
| 4ft3_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 3e-12 | ||
| 3jvr_A | 271 | Characterization Of The Chk1 Allosteric Inhibitor B | 3e-12 | ||
| 2uv2_A | 287 | Crystal Structure Of Human Ste20-Like Kinase Bound | 3e-12 | ||
| 1luf_A | 343 | Crystal Structure Of The Musk Tyrosine Kinase: Insi | 3e-12 | ||
| 4fst_A | 269 | Crystal Structure Of The Chk1 Length = 269 | 3e-12 | ||
| 3mh0_A | 360 | Mutagenesis Of P38 Map Kinase Eshtablishes Key Role | 3e-12 | ||
| 1w98_A | 298 | The Structural Basis Of Cdk2 Activation By Cyclin E | 3e-12 | ||
| 4eoq_A | 301 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 3e-12 | ||
| 4bcq_A | 301 | Structure Of Cdk2 In Complex With Cyclin A And A 2- | 3e-12 | ||
| 1e9h_A | 297 | Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex | 3e-12 | ||
| 1jst_A | 298 | Phosphorylated Cyclin-Dependent Kinase-2 Bound To C | 3e-12 | ||
| 4eos_A | 300 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 3e-12 | ||
| 4i3z_A | 296 | Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES | 3e-12 | ||
| 1ogu_A | 302 | Structure Of Human Thr160-phospho Cdk2/cyclin A Com | 3e-12 | ||
| 3mh3_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 3e-12 | ||
| 1oir_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 3e-12 | ||
| 1h01_A | 298 | Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili | 3e-12 | ||
| 1qmz_A | 299 | Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com | 3e-12 | ||
| 1h1p_A | 303 | Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP | 4e-12 | ||
| 4eop_A | 300 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 4e-12 | ||
| 2rio_A | 434 | Structure Of The Dual Enzyme Ire1 Reveals The Basis | 4e-12 | ||
| 1v0o_A | 288 | Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho | 4e-12 | ||
| 3bht_A | 300 | Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN | 4e-12 | ||
| 1v0b_A | 288 | Crystal Structure Of The T198a Mutant Of Pfpk5 Leng | 4e-12 | ||
| 3qhr_A | 298 | Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic | 4e-12 | ||
| 4eoo_A | 299 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 4e-12 | ||
| 3orx_A | 316 | Pdk1 Mutant Bound To Allosteric Disulfide Fragment | 4e-12 | ||
| 3mh1_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 4e-12 | ||
| 2jgz_A | 289 | Crystal Structure Of Phospho-Cdk2 In Complex With C | 4e-12 | ||
| 3bz3_A | 276 | Crystal Structure Analysis Of Focal Adhesion Kinase | 4e-12 | ||
| 3lco_A | 324 | Inhibitor Bound To A Dfg-Out Structure Of The Kinas | 5e-12 | ||
| 1ob3_A | 288 | Structure Of P. Falciparum Pfpk5 Length = 288 | 5e-12 | ||
| 2iw6_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com | 5e-12 | ||
| 2ivv_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 5e-12 | ||
| 1rjb_A | 344 | Crystal Structure Of Flt3 Length = 344 | 6e-12 | ||
| 1bi8_A | 326 | Mechanism Of G1 Cyclin Dependent Kinase Inhibition | 6e-12 | ||
| 4eoi_A | 299 | Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc | 6e-12 | ||
| 1jow_B | 308 | Crystal Structure Of A Complex Of Human Cdk6 And A | 6e-12 | ||
| 3qc9_A | 543 | Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4 | 7e-12 | ||
| 3c4w_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 7e-12 | ||
| 4eom_A | 301 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 7e-12 | ||
| 3nup_A | 307 | Cdk6 (Monomeric) In Complex With Inhibitor Length = | 7e-12 | ||
| 3c4x_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 7e-12 | ||
| 4eon_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 8e-12 | ||
| 3t8o_A | 543 | Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu | 8e-12 | ||
| 1u5q_A | 348 | Crystal Structure Of The Tao2 Kinase Domain: Activa | 8e-12 | ||
| 3mn3_A | 271 | An Inhibited Conformation For The Protein Kinase Do | 8e-12 | ||
| 2jed_A | 352 | The Crystal Structure Of The Kinase Domain Of The P | 8e-12 | ||
| 2gcd_A | 309 | Tao2 Kinase Domain-Staurosporine Structure Length = | 8e-12 | ||
| 4eoj_A | 302 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 9e-12 | ||
| 3dae_A | 283 | Crystal Structure Of Phosphorylated Snf1 Kinase Dom | 9e-12 | ||
| 4eok_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 1e-11 | ||
| 2fh9_A | 274 | Structure And Dimerization Of The Kinase Domain Fro | 1e-11 | ||
| 1phk_A | 298 | Two Structures Of The Catalytic Domain Of Phosphory | 1e-11 | ||
| 3hyh_A | 275 | Crystal Structure Of The Protein Kinase Domain Of Y | 1e-11 | ||
| 1ql6_A | 298 | The Catalytic Mechanism Of Phosphorylase Kinase Pro | 1e-11 | ||
| 2phk_A | 277 | The Crystal Structure Of A Phosphorylase Kinase Pep | 1e-11 | ||
| 2z7q_A | 321 | Crystal Structure Of The N-Terminal Kinase Domain O | 1e-11 | ||
| 2y7j_A | 365 | Structure Of Human Phosphorylase Kinase, Gamma 2 Le | 1e-11 | ||
| 3niz_A | 311 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 1e-11 | ||
| 2w4o_A | 349 | Crystal Structure Of Human Camk4 In Complex With 4- | 2e-11 | ||
| 2qkr_A | 313 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 2e-11 | ||
| 3sdj_A | 448 | Structure Of Rnase-Inactive Point Mutant Of Oligome | 2e-11 | ||
| 3fbv_A | 448 | Crystal Structure Of The Oligomer Formed By The Kin | 2e-11 | ||
| 2dyl_A | 318 | Crystal Structure Of Human Mitogen-Activated Protei | 2e-11 | ||
| 2jc6_A | 334 | Crystal Structure Of Human Calmodulin-Dependent Pro | 2e-11 | ||
| 1xjd_A | 345 | Crystal Structure Of Pkc-Theta Complexed With Staur | 2e-11 | ||
| 4fsu_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-11 | ||
| 3ckw_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 2e-11 | ||
| 3gc9_A | 370 | The Structure Of P38beta C119s, C162s In Complex Wi | 2e-11 | ||
| 1h1w_A | 289 | High Resolution Crystal Structure Of The Human Pdk1 | 3e-11 | ||
| 1uu9_A | 286 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 3e-11 | ||
| 3g2f_A | 336 | Crystal Structure Of The Kinase Domain Of Bone Morp | 3e-11 | ||
| 3pwy_A | 311 | Crystal Structure Of An Extender (Spd28345)-Modifie | 3e-11 | ||
| 3gp0_A | 348 | Crystal Structure Of Human Mitogen Activated Protei | 3e-11 | ||
| 3igo_A | 486 | Crystal Structure Of Cryptosporidium Parvum Cdpk1, | 3e-11 | ||
| 3g33_A | 308 | Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | 3e-11 | ||
| 1z5m_A | 286 | Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr | 3e-11 | ||
| 2wei_A | 287 | Crystal Structure Of The Kinase Domain Of Cryptospo | 3e-11 | ||
| 3dfa_A | 286 | Crystal Structure Of Kinase Domain Of Calcium-depen | 3e-11 | ||
| 3p23_A | 432 | Crystal Structure Of The Human Kinase And Rnase Dom | 3e-11 | ||
| 3nus_A | 286 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra | 3e-11 | ||
| 3zhp_C | 294 | Human Mst3 (stk24) In Complex With Mo25beta Length | 4e-11 | ||
| 2r7b_A | 312 | Crystal Structure Of The Phosphoinositide-Dependent | 4e-11 | ||
| 2xch_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 4e-11 | ||
| 4a07_A | 311 | Human Pdk1 Kinase Domain In Complex With Allosteric | 4e-11 | ||
| 1uu3_A | 310 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 4e-11 | ||
| 3fi3_A | 364 | Crystal Structure Of Jnk3 With Indazole Inhibitor, | 4e-11 | ||
| 3nun_A | 292 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea | 5e-11 | ||
| 3h9o_A | 311 | Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) | 5e-11 | ||
| 3gc8_A | 370 | The Structure Of P38beta C162s In Complex With A Di | 5e-11 | ||
| 3rwp_A | 311 | Discovery Of A Novel, Potent And Selective Inhibito | 5e-11 | ||
| 3iop_A | 312 | Pdk-1 In Complex With The Inhibitor Compound-8i Len | 5e-11 | ||
| 3hrc_A | 311 | Crystal Structure Of A Mutant Of Human Pdk1 Kinase | 5e-11 | ||
| 2biy_A | 310 | Structure Of Pdk1-S241a Mutant Kinase Domain Length | 5e-11 | ||
| 3sc1_A | 311 | Novel Isoquinolone Pdk1 Inhibitors Discovered Throu | 5e-11 | ||
| 3qc4_A | 314 | Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = | 5e-11 | ||
| 3kvx_A | 364 | Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le | 5e-11 | ||
| 3lj0_A | 434 | Ire1 Complexed With Adp And Quercetin Length = 434 | 6e-11 | ||
| 3nax_A | 311 | Pdk1 In Complex With Inhibitor Mp7 Length = 311 | 6e-11 | ||
| 3nay_A | 311 | Pdk1 In Complex With Inhibitor Mp6 Length = 311 | 7e-11 | ||
| 4fvp_A | 289 | Crystal Structure Of The Jak2 Pseudokinase Domain ( | 7e-11 | ||
| 2r9s_A | 356 | C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu | 7e-11 | ||
| 3fv8_A | 355 | Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le | 7e-11 | ||
| 3q5i_A | 504 | Crystal Structure Of Pbanka_031420 Length = 504 | 7e-11 | ||
| 3a7f_A | 303 | Human Mst3 Kinase Length = 303 | 8e-11 | ||
| 3vum_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M7 | 8e-11 | ||
| 3my0_A | 305 | Crystal Structure Of The Acvrl1 (Alk1) Kinase Domai | 8e-11 | ||
| 4fvr_A | 289 | Crystal Structure Of The Jak2 Pseudokinase Domain M | 9e-11 | ||
| 3mtl_A | 324 | Crystal Structure Of The Pctaire1 Kinase In Complex | 9e-11 | ||
| 3ckx_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 9e-11 | ||
| 3vul_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 9e-11 | ||
| 3e7o_A | 360 | Crystal Structure Of Jnk2 Length = 360 | 1e-10 | ||
| 3oz6_A | 388 | Crystal Structure Of Mapk From Cryptosporidium Parv | 1e-10 | ||
| 3fpq_A | 290 | Crystal Structure Of The Kinase Domain Of Wnk1 Leng | 1e-10 | ||
| 3qup_A | 323 | Inhibitor Bound Structure Of The Kinase Domain Of T | 1e-10 | ||
| 3f3z_A | 277 | Crystal Structure Of Cryptosporidium Parvum Calcium | 1e-10 | ||
| 2qg5_A | 294 | Cryptosporidium Parvum Calcium Dependent Protein Ki | 1e-10 | ||
| 3enm_A | 316 | The Structure Of The Map2k Mek6 Reveals An Autoinhi | 1e-10 | ||
| 2o0u_A | 364 | Crystal Structure Of Human Jnk3 Complexed With N-{3 | 1e-10 | ||
| 2w99_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 1e-10 | ||
| 1pmn_A | 364 | Crystal Structure Of Jnk3 In Complex With An Imidaz | 1e-10 | ||
| 2w9f_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 1e-10 | ||
| 3fi2_A | 353 | Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib | 1e-10 | ||
| 1koa_A | 491 | Twitchin Kinase Fragment (C.Elegans), Autoregulated | 1e-10 | ||
| 3ptg_A | 363 | Design And Synthesis Of A Novel, Orally Efficacious | 1e-10 | ||
| 2ok1_A | 365 | Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3 | 1e-10 | ||
| 3oxi_A | 362 | Design And Synthesis Of Disubstituted Thiophene And | 1e-10 | ||
| 2xck_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 1e-10 | ||
| 3ttj_A | 464 | Crystal Structure Of Jnk3 Complexed With Cc-359, A | 1e-10 | ||
| 3uto_A | 573 | Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin- | 1e-10 | ||
| 2b1p_A | 355 | Inhibitor Complex Of Jnk3 Length = 355 | 1e-10 | ||
| 2exc_X | 356 | Inhibitor Complex Of Jnk3 Length = 356 | 1e-10 | ||
| 3vug_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 1e-10 | ||
| 2w96_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 1e-10 | ||
| 4h36_A | 356 | Crystal Structure Of Jnk3 In Complex With Atf2 Pept | 1e-10 | ||
| 1cm8_A | 367 | Phosphorylated Map Kinase P38-Gamma Length = 367 | 2e-10 | ||
| 3rny_A | 346 | Crystal Structure Of Human Rsk1 C-Terminal Kinase D | 2e-10 | ||
| 1jnk_A | 423 | The C-Jun N-Terminal Kinase (Jnk3s) Complexed With | 2e-10 | ||
| 2y4i_B | 319 | Ksr2-Mek1 Heterodimer Length = 319 | 2e-10 | ||
| 3vuh_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M3 | 2e-10 | ||
| 1ukh_A | 369 | Structural Basis For The Selective Inhibition Of Jn | 2e-10 | ||
| 2wnt_A | 330 | Crystal Structure Of The Human Ribosomal Protein S6 | 2e-10 | ||
| 4exu_A | 371 | Mapk13, Inactive Form Length = 371 | 2e-10 | ||
| 4aw2_A | 437 | Crystal Structure Of Cdc42 Binding Protein Kinase A | 2e-10 | ||
| 3elj_A | 369 | Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine | 2e-10 | ||
| 2hw6_A | 307 | Crystal Structure Of Mnk1 Catalytic Domain Length = | 2e-10 | ||
| 3pze_A | 358 | Jnk1 In Complex With Inhibitor Length = 358 | 2e-10 | ||
| 3h9r_A | 330 | Crystal Structure Of The Kinase Domain Of Type I Ac | 2e-10 | ||
| 1gzn_A | 335 | Structure Of Pkb Kinase Domain Length = 335 | 2e-10 | ||
| 3mtf_A | 301 | Crystal Structure Of The Acvr1 Kinase In Complex Wi | 2e-10 | ||
| 3vud_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 2e-10 | ||
| 2xrw_A | 371 | Linear Binding Motifs For Jnk And For Calcineurin A | 2e-10 | ||
| 1mrv_A | 339 | Crystal Structure Of An Inactive Akt2 Kinase Domain | 3e-10 | ||
| 4dym_A | 301 | Crystal Structure Of The Acvr1 Kinase Domain In Com | 3e-10 | ||
| 3vui_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 3e-10 | ||
| 3vuk_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M5 | 3e-10 | ||
| 3coi_A | 353 | Crystal Structure Of P38delta Kinase Length = 353 | 3e-10 | ||
| 3d5u_A | 317 | Crystal Structure Of A Wildtype Polo-Like Kinase 1 | 3e-10 | ||
| 1gzk_A | 315 | Molecular Mechanism For The Regulation Of Protein K | 3e-10 | ||
| 1h4l_A | 292 | Structure And Regulation Of The Cdk5-P25(Nck5a) Com | 3e-10 | ||
| 3v3v_A | 379 | Structural And Functional Analysis Of Quercetagetin | 3e-10 | ||
| 2jdo_A | 342 | Structure Of Pkb-Beta (Akt2) Complexed With Isoquin | 4e-10 | ||
| 1ua2_A | 346 | Crystal Structure Of Human Cdk7 Length = 346 | 4e-10 | ||
| 3pfq_A | 674 | Crystal Structure And Allosteric Activation Of Prot | 4e-10 | ||
| 2buj_A | 317 | Crystal Structure Of The Human Serine-Threonine Kin | 4e-10 | ||
| 2qr8_A | 342 | 2.0a X-ray Structure Of C-terminal Kinase Domain Of | 5e-10 | ||
| 4eut_A | 396 | Structure Of Bx-795 Complexed With Unphosphorylated | 5e-10 | ||
| 2qr7_A | 342 | 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of | 5e-10 | ||
| 3npc_A | 364 | Crystal Structure Of Jnk2 Complexed With Birb796 Le | 6e-10 | ||
| 2iwi_A | 312 | Crystal Structure Of The Human Pim2 In Complex With | 7e-10 | ||
| 2vz6_A | 313 | Structure Of Human Calcium Calmodulin Dependent Pro | 7e-10 | ||
| 1o6l_A | 337 | Crystal Structure Of An Activated Akt/protein Kinas | 7e-10 | ||
| 1yrp_A | 278 | Catalytic Domain Of Human Zip Kinase Phosphorylated | 7e-10 | ||
| 3kmu_A | 271 | Crystal Structure Of The IlkALPHA-Parvin Core Compl | 7e-10 | ||
| 3bhy_A | 283 | Crystal Structure Of Human Death Associated Protein | 7e-10 | ||
| 3d5w_A | 317 | Crystal Structure Of A Phosphorylated Polo-Like Kin | 8e-10 | ||
| 1o6k_A | 336 | Structure Of Activated Form Of Pkb Kinase Domain S4 | 8e-10 | ||
| 2i0e_A | 353 | Structure Of Catalytic Domain Of Human Protein Kina | 8e-10 | ||
| 3e87_A | 335 | Crystal Structures Of The Kinase Domain Of Akt2 In | 8e-10 | ||
| 2xs0_A | 386 | Linear Binding Motifs For Jnk And For Calcineurin A | 8e-10 | ||
| 3o17_A | 370 | Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3 | 9e-10 | ||
| 2x4f_A | 373 | The Crystal Structure Of The Human Myosin Light Cha | 9e-10 | ||
| 2bdw_A | 362 | Crystal Structure Of The Auto-Inhibited Kinase Doma | 1e-09 | ||
| 3db6_A | 301 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 1e-09 | ||
| 2j90_A | 304 | Crystal Structure Of Human Zip Kinase In Complex Wi | 1e-09 | ||
| 3d5v_A | 317 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 1e-09 | ||
| 2ya9_A | 361 | Crystal Structure Of The Autoinhibited Form Of Mous | 1e-09 | ||
| 4euu_A | 319 | Structure Of Bx-795 Complexed With Human Tbk1 Kinas | 1e-09 | ||
| 2xuu_A | 334 | Crystal Structure Of A Dap-Kinase 1 Mutant Length = | 1e-09 | ||
| 1na7_A | 329 | Crystal Structure Of The Catalytic Subunit Of Human | 1e-09 | ||
| 1ung_A | 292 | Structural Mechanism For The Inhibition Of Cdk5-P25 | 2e-09 | ||
| 4ejn_A | 446 | Crystal Structure Of Autoinhibited Form Of Akt1 In | 2e-09 | ||
| 3o96_A | 446 | Crystal Structure Of Human Akt1 With An Allosteric | 2e-09 | ||
| 2g01_A | 370 | Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit | 2e-09 | ||
| 3cqu_A | 342 | Crystal Structure Of Akt-1 Complexed With Substrate | 2e-09 | ||
| 2f2u_A | 402 | Crystal Structure Of The Rho-Kinase Kinase Domain L | 2e-09 | ||
| 3kk8_A | 284 | Camkii Substrate Complex A Length = 284 | 2e-09 | ||
| 3ujg_A | 361 | Crystal Structure Of Snrk2.6 In Complex With Hab1 L | 2e-09 | ||
| 2x0g_A | 334 | X-ray Structure Of A Dap-kinase Calmodulin Complex | 2e-09 | ||
| 2v5q_A | 315 | Crystal Structure Of Wild-type Plk-1 Kinase Domain | 2e-09 | ||
| 2yac_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 3e-09 | ||
| 3kl8_A | 269 | Camkiintide Inhibitor Complex Length = 269 | 3e-09 | ||
| 3kb7_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 3e-09 | ||
| 3kk9_A | 282 | Camkii Substrate Complex B Length = 282 | 3e-09 | ||
| 3dfc_B | 295 | Crystal Structure Of A Glycine-Rich Loop Mutant Of | 3e-09 | ||
| 2a2a_A | 321 | High-resolution Crystallographic Analysis Of The Au | 3e-09 | ||
| 2a27_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 3e-09 | ||
| 1zws_A | 288 | Crystal Structure Of The Catalytic Domain Of Human | 3e-09 | ||
| 1z9x_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 3e-09 | ||
| 3soa_A | 444 | Full-Length Human Camkii Length = 444 | 3e-09 | ||
| 1wmk_A | 321 | Human Death-Associated Kinase Drp-1, Mutant S308d D | 3e-09 | ||
| 1p4f_A | 293 | Death Associated Protein Kinase Catalytic Domain Wi | 3e-09 | ||
| 1ig1_A | 294 | 1.8a X-Ray Structure Of Ternary Complex Of A Cataly | 3e-09 | ||
| 3f5u_A | 295 | Crystal Structure Of The Death Associated Protein K | 3e-09 | ||
| 2r5t_A | 373 | Crystal Structure Of Inactive Serum And Glucocortic | 4e-09 | ||
| 4gv1_A | 340 | Pkb Alpha In Complex With Azd5363 Length = 340 | 4e-09 | ||
| 3udb_A | 317 | Crystal Structure Of Snrk2.6 Length = 317 | 4e-09 | ||
| 2xzs_A | 312 | Death Associated Protein Kinase 1 Residues 1-312 Le | 4e-09 | ||
| 2yak_A | 285 | Structure Of Death-Associated Protein Kinase 1 (Dap | 4e-09 | ||
| 3ocb_A | 341 | Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor | 4e-09 | ||
| 1wvw_A | 278 | Crystal Structures Of Kinase Domain Of Dap Kinase I | 4e-09 | ||
| 3bhh_A | 295 | Crystal Structure Of Human Calcium/calmodulin-depen | 5e-09 | ||
| 2w4j_A | 277 | X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | 5e-09 | ||
| 2w4k_A | 302 | X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | 5e-09 | ||
| 3uc4_A | 362 | The Crystal Structure Of Snf1-Related Kinase 2.6 Le | 5e-09 | ||
| 3qd2_B | 332 | Crsytal Structure Of Mouse Perk Kinase Domain Lengt | 5e-09 | ||
| 3hko_A | 345 | Crystal Structure Of A Cdpk Kinase Domain From Cryp | 5e-09 | ||
| 3gu4_A | 295 | Crystal Structure Of Dapkq23v-Amppnp Length = 295 | 5e-09 | ||
| 3uc3_A | 361 | The Crystal Structure Of Snf1-Related Kinase 2.3 Le | 6e-09 | ||
| 3gu8_A | 295 | Crystal Structure Of Dapkl93g With N6-Cyclopentylad | 7e-09 | ||
| 2y0a_A | 326 | Structure Of Dapk1 Construct Residues 1-304 Length | 7e-09 | ||
| 3jxw_A | 294 | Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4- | 8e-09 | ||
| 2ycf_A | 322 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 8e-09 | ||
| 2ycr_A | 323 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 9e-09 | ||
| 3thb_A | 333 | Structure Of Plk1 Kinase Domain In Complex With A B | 9e-09 | ||
| 2xk9_A | 322 | Structural Analysis Of Checkpoint Kinase 2 (Chk2) I | 9e-09 | ||
| 2w0j_A | 323 | Crystal Structure Of Chk2 In Complex With Nsc 10955 | 9e-09 | ||
| 3uix_A | 298 | Crystal Structure Of Pim1 Kinase In Complex With Sm | 9e-09 | ||
| 2cn5_A | 329 | Crystal Structure Of Human Chk2 In Complex With Adp | 9e-09 | ||
| 3i6u_A | 419 | Structure And Activation Mechanism Of The Chk2 Dna- | 1e-08 | ||
| 4g3d_A | 371 | Crystal Structure Of Human Nf-kappab Inducing Kinas | 1e-08 | ||
| 1yxs_A | 293 | Crystal Structure Of Kinase Pim1 With P123m Mutatio | 1e-08 | ||
| 3r00_A | 299 | The Discovery Of Novel Benzofuran-2-Carboxylic Acid | 1e-08 | ||
| 2ou7_A | 335 | Structure Of The Catalytic Domain Of Human Polo-Lik | 1e-08 | ||
| 3i6w_A | 443 | Structure And Activation Mechanism Of The Chk2 Dna- | 1e-08 | ||
| 2rku_A | 294 | Structure Of Plk1 In Complex With Bi2536 Length = 2 | 1e-08 | ||
| 4a7c_A | 308 | Crystal Structure Of Pim1 Kinase With Etp46546 Leng | 1e-08 | ||
| 1ywv_A | 293 | Crystal Structures Of Proto-Oncogene Kinase Pim1: A | 1e-08 | ||
| 2ac5_A | 316 | Structure Of Human Mnk2 Kinase Domain Mutant D228g | 1e-08 | ||
| 1xws_A | 313 | Crystal Structure Of The Human Pim1 Kinase Domain L | 1e-08 | ||
| 2pml_X | 348 | Crystal Structure Of Pfpk7 In Complex With An Atp A | 1e-08 | ||
| 3f2a_A | 300 | Crystal Structure Of Human Pim-1 In Complex With Da | 2e-08 | ||
| 1xqz_A | 300 | Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolut | 2e-08 | ||
| 2xj0_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-4 Fro | 2e-08 | ||
| 2obj_A | 333 | Crystal Structure Of Human Pim-1 Kinase In Complex | 2e-08 | ||
| 3a99_A | 320 | Structure Of Pim-1 Kinase Crystallized In The Prese | 2e-08 | ||
| 3jpv_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 2e-08 | ||
| 2bik_B | 313 | Human Pim1 Phosphorylated On Ser261 Length = 313 | 2e-08 | ||
| 2xix_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-1 Fro | 2e-08 | ||
| 3cxw_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 2e-08 | ||
| 3zut_A | 362 | The Structure Of Ost1 (D160a) Kinase Length = 362 | 2e-08 | ||
| 2bil_B | 313 | The Human Protein Kinase Pim1 In Complex With Its C | 2e-08 | ||
| 3cy3_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 2e-08 | ||
| 3dcv_A | 328 | Crystal Structure Of Human Pim1 Kinase Complexed Wi | 2e-08 | ||
| 3zuu_A | 362 | The Structure Of Ost1 (D160a, S175d) Kinase In Comp | 2e-08 | ||
| 2xiy_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-2 Fro | 2e-08 | ||
| 4bcf_A | 331 | Structure Of Cdk9 In Complex With Cyclin T And A 2- | 2e-08 | ||
| 3ma3_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 2e-08 | ||
| 2j2i_B | 312 | Crystal Structure Of The Humab Pim1 In Complex With | 2e-08 | ||
| 4alv_A | 328 | Benzofuropyrimidinone Inhibitors Of Pim-1 Length = | 2e-08 | ||
| 2zv2_A | 298 | Crystal Structure Of Human CalciumCALMODULIN-Depend | 2e-08 | ||
| 3e3p_A | 360 | Glycogen Synthase Kinase From Leishmania Major Leng | 2e-08 | ||
| 4dtk_A | 276 | Novel And Selective Pan-Pim Kinase Inhibitor Length | 2e-08 | ||
| 3qfv_A | 415 | Mrck Beta In Complex With Tpca-1 Length = 415 | 2e-08 | ||
| 3mfr_A | 351 | Cask-4m Cam Kinase Domain, Native Length = 351 | 2e-08 | ||
| 2v55_A | 406 | Mechanism Of Multi-site Phosphorylation From A Rock | 2e-08 | ||
| 3c4e_A | 273 | Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7 | 2e-08 | ||
| 2esm_A | 415 | Crystal Structure Of Rock 1 Bound To Fasudil Length | 3e-08 | ||
| 3v8s_A | 410 | Human Rho-Associated Protein Kinase 1 (Rock 1) In C | 3e-08 | ||
| 4as0_A | 273 | Cyclometalated Phthalimides As Protein Kinase Inhib | 3e-08 | ||
| 4ec8_A | 373 | Structure Of Full Length Cdk9 In Complex With Cycli | 3e-08 | ||
| 3tku_A | 433 | Mrck Beta In Complex With Fasudil Length = 433 | 3e-08 | ||
| 1yhs_A | 273 | Crystal Structure Of Pim-1 Bound To Staurosporine L | 4e-08 | ||
| 4dn5_A | 356 | Crystal Structure Of Nf-kb-inducing Kinase (nik) Le | 4e-08 | ||
| 2uzt_A | 336 | Pka Structures Of Akt, Indazole-Pyridine Inhibitors | 4e-08 | ||
| 3blh_A | 331 | Crystal Structure Of Human Cdk9CYCLINT1 Length = 33 | 4e-08 | ||
| 3mi9_A | 351 | Crystal Structure Of Hiv-1 Tat Complexed With Human | 5e-08 | ||
| 4g3g_A | 350 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 5e-08 | ||
| 2gnj_A | 350 | Pka Three Fold Mutant Model Of Rho-Kinase With Y-27 | 6e-08 | ||
| 4fr4_A | 384 | Crystal Structure Of Human SerineTHREONINE-Protein | 6e-08 | ||
| 3dnd_A | 350 | Camp-Dependent Protein Kinase Pka Catalytic Subunit | 6e-08 | ||
| 2c1a_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 7e-08 | ||
| 1svh_A | 350 | Crystal Structure Of Protein Kinase A In Complex Wi | 7e-08 | ||
| 1stc_E | 350 | Camp-Dependent Protein Kinase, Alpha-Catalytic Subu | 7e-08 | ||
| 1ydt_E | 350 | Structure Of Camp-Dependent Protein Kinase, Alpha-C | 7e-08 | ||
| 2f7e_E | 351 | Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu | 8e-08 | ||
| 2gnf_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 8e-08 | ||
| 2ac3_A | 316 | Structure Of Human Mnk2 Kinase Domain Length = 316 | 8e-08 | ||
| 3lij_A | 494 | Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) | 8e-08 | ||
| 1xh9_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 9e-08 | ||
| 4g3f_A | 336 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 9e-08 | ||
| 4g3c_A | 352 | Crystal Structure Of Apo Murine Nf-kappab Inducing | 9e-08 | ||
| 2gng_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 9e-08 | ||
| 2gu8_A | 337 | Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel | 1e-07 | ||
| 4dfy_A | 371 | Crystal Structure Of R194a Mutant Of Camp-Dependent | 1e-07 | ||
| 2jds_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 1e-07 | ||
| 1q8w_A | 350 | The Catalytic Subunit Of Camp-Dependent Protein Kin | 1e-07 | ||
| 1xh7_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 1e-07 | ||
| 3ama_A | 351 | Protein Kinase A Sixfold Mutant Model Of Aurora B W | 1e-07 | ||
| 2v7o_A | 336 | Crystal Structure Of Human Calcium-Calmodulin-Depen | 1e-07 | ||
| 2i6l_A | 320 | Crystal Structure Of Human Mitogen Activated Protei | 1e-07 | ||
| 1q61_A | 350 | Pka Triple Mutant Model Of Pkb Length = 350 | 1e-07 | ||
| 2vn9_A | 301 | Crystal Structure Of Human Calcium Calmodulin Depen | 2e-07 | ||
| 2wtk_C | 305 | Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2 | 2e-07 | ||
| 4ae6_A | 343 | Structure And Function Of The Human Sperm-specific | 2e-07 | ||
| 2wel_A | 327 | Crystal Structure Of Su6656-Bound CalciumCALMODULIN | 2e-07 | ||
| 1cdk_A | 350 | Camp-Dependent Protein Kinase Catalytic Subunit (E. | 2e-07 | ||
| 2qur_A | 350 | Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe | 2e-07 | ||
| 1ctp_E | 350 | Structure Of The Mammalian Catalytic Subunit Of Cam | 2e-07 | ||
| 1kob_A | 387 | Twitchin Kinase Fragment (Aplysia), Autoregulated P | 2e-07 | ||
| 1smh_A | 350 | Protein Kinase A Variant Complex With Completely Or | 2e-07 | ||
| 1cmk_E | 350 | Crystal Structures Of The Myristylated Catalytic Su | 2e-07 | ||
| 1fmo_E | 350 | Crystal Structure Of A Polyhistidine-Tagged Recombi | 2e-07 | ||
| 2erz_E | 351 | Crystal Structure Of C-amp Dependent Kinase (pka) B | 2e-07 | ||
| 1szm_A | 350 | Dual Binding Mode Of Bisindolylmaleimide 2 To Prote | 2e-07 | ||
| 3agl_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 2e-07 | ||
| 3hng_A | 360 | Crystal Structure Of Vegfr1 In Complex With N-(4-ch | 2e-07 | ||
| 1j3h_A | 350 | Crystal Structure Of Apoenzyme Camp-Dependent Prote | 2e-07 | ||
| 3nx8_A | 351 | Human Camp Dependent Protein Kinase In Complex With | 2e-07 | ||
| 3l9m_A | 351 | Crystal Structure Of Pkab3 (Pka Triple Mutant V123a | 2e-07 | ||
| 2vo0_A | 351 | Structure Of Pka-Pkb Chimera Complexed With C-(4-(4 | 2e-07 | ||
| 2uvy_A | 351 | Structure Of Pka-pkb Chimera Complexed With Methyl- | 2e-07 | ||
| 3agm_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 2e-07 | ||
| 2jdt_A | 351 | Structure Of Pka-Pkb Chimera Complexed With Isoquin | 2e-07 | ||
| 3qal_E | 350 | Crystal Structure Of Arg280ala Mutant Of Catalytic | 2e-07 | ||
| 1bkx_A | 350 | A Binary Complex Of The Catalytic Subunit Of Camp-D | 2e-07 | ||
| 3fhi_A | 350 | Crystal Structure Of A Complex Between The Catalyti | 2e-07 | ||
| 4ae9_A | 343 | Structure And Function Of The Human Sperm-specific | 3e-07 | ||
| 3mvj_A | 371 | Human Cyclic Amp-Dependent Protein Kinase Pka Inhib | 3e-07 | ||
| 3pvb_A | 345 | Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca | 3e-07 | ||
| 3juh_A | 335 | Crystal Structure Of A Mutant Of Human Protein Kina | 3e-07 | ||
| 4dfx_E | 350 | Crystal Structure Of Myristoylated K7c Catalytic Su | 3e-07 | ||
| 1l3r_E | 350 | Crystal Structure Of A Transition State Mimic Of Th | 3e-07 | ||
| 2qcs_A | 350 | A Complex Structure Between The Catalytic And Regul | 3e-07 | ||
| 1q24_A | 350 | Pka Double Mutant Model Of Pkb In Complex With Mgat | 4e-07 | ||
| 4dg3_E | 371 | Crystal Structure Of R336a Mutant Of Camp-dependent | 4e-07 | ||
| 1apm_E | 350 | 2.0 Angstrom Refined Crystal Structure Of The Catal | 4e-07 | ||
| 3dxn_A | 287 | Crystal Structure Of The Calcium-dependent Kinase F | 4e-07 | ||
| 1jbp_E | 350 | Crystal Structure Of The Catalytic Subunit Of Camp- | 4e-07 | ||
| 3o7l_B | 350 | Crystal Structure Of Phospholamban (1-19):pka C-Sub | 4e-07 | ||
| 2r7i_A | 335 | Crystal Structure Of Catalytic Subunit Of Protein K | 5e-07 | ||
| 1syk_A | 350 | Crystal Structure Of E230q Mutant Of Camp-Dependent | 5e-07 | ||
| 3nga_A | 333 | Human Ck2 Catalytic Domain In Complex With Cx-4945 | 5e-07 | ||
| 3uib_A | 362 | Map Kinase Lmampk10 From Leishmania Major In Comple | 5e-07 | ||
| 3q9w_A | 336 | Crystal Structure Of Human Ck2 Alpha In Complex Wit | 5e-07 | ||
| 3pg1_A | 362 | Map Kinase Lmampk10 From Leishmania Major (1.95 Ang | 5e-07 | ||
| 3h30_A | 334 | Crystal Structure Of The Catalytic Subunit Of Human | 5e-07 | ||
| 3u87_A | 349 | Structure Of A Chimeric Construct Of Human Ck2alpha | 5e-07 | ||
| 3nsz_A | 330 | Human Ck2 Catalytic Domain In Complex With Amppn Le | 5e-07 | ||
| 3mb6_A | 331 | Human Ck2 Catalytic Domain In Complex With A Difura | 5e-07 | ||
| 3bqc_A | 335 | High Ph-Value Crystal Structure Of Emodin In Comple | 5e-07 | ||
| 1pjk_A | 334 | Crystal Structure Of A C-terminal Deletion Mutant O | 5e-07 | ||
| 2zjw_A | 340 | Crystal Structure Of Human Ck2 Alpha Complexed With | 5e-07 | ||
| 1jwh_A | 337 | Crystal Structure Of Human Protein Kinase Ck2 Holoe | 5e-07 |
| >pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349 | Back alignment and structure |
|
| >pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326 | Back alignment and structure |
|
| >pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327 | Back alignment and structure |
|
| >pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321 | Back alignment and structure |
|
| >pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301 | Back alignment and structure |
|
| >pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271 | Back alignment and structure |
|
| >pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315 | Back alignment and structure |
|
| >pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307 | Back alignment and structure |
|
| >pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287 | Back alignment and structure |
|
| >pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285 | Back alignment and structure |
|
| >pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344 | Back alignment and structure |
|
| >pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361 | Back alignment and structure |
|
| >pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373 | Back alignment and structure |
|
| >pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371 | Back alignment and structure |
|
| >pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306 | Back alignment and structure |
|
| >pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297 | Back alignment and structure |
|
| >pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285 | Back alignment and structure |
|
| >pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280 | Back alignment and structure |
|
| >pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280 | Back alignment and structure |
|
| >pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267 | Back alignment and structure |
|
| >pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268 | Back alignment and structure |
|
| >pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307 | Back alignment and structure |
|
| >pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262 | Back alignment and structure |
|
| >pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281 | Back alignment and structure |
|
| >pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279 | Back alignment and structure |
|
| >pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318 | Back alignment and structure |
|
| >pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272 | Back alignment and structure |
|
| >pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275 | Back alignment and structure |
|
| >pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292 | Back alignment and structure |
|
| >pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266 | Back alignment and structure |
|
| >pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309 | Back alignment and structure |
|
| >pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302 | Back alignment and structure |
|
| >pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308 | Back alignment and structure |
|
| >pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310 | Back alignment and structure |
|
| >pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306 | Back alignment and structure |
|
| >pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285 | Back alignment and structure |
|
| >pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264 | Back alignment and structure |
|
| >pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295 | Back alignment and structure |
|
| >pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266 | Back alignment and structure |
|
| >pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269 | Back alignment and structure |
|
| >pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282 | Back alignment and structure |
|
| >pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282 | Back alignment and structure |
|
| >pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271 | Back alignment and structure |
|
| >pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283 | Back alignment and structure |
|
| >pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373 | Back alignment and structure |
|
| >pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272 | Back alignment and structure |
|
| >pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344 | Back alignment and structure |
|
| >pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279 | Back alignment and structure |
|
| >pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268 | Back alignment and structure |
|
| >pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373 | Back alignment and structure |
|
| >pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268 | Back alignment and structure |
|
| >pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314 | Back alignment and structure |
|
| >pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312 | Back alignment and structure |
|
| >pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306 | Back alignment and structure |
|
| >pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268 | Back alignment and structure |
|
| >pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295 | Back alignment and structure |
|
| >pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285 | Back alignment and structure |
|
| >pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267 | Back alignment and structure |
|
| >pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272 | Back alignment and structure |
|
| >pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280 | Back alignment and structure |
|
| >pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307 | Back alignment and structure |
|
| >pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288 | Back alignment and structure |
|
| >pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333 | Back alignment and structure |
|
| >pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271 | Back alignment and structure |
|
| >pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285 | Back alignment and structure |
|
| >pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273 | Back alignment and structure |
|
| >pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302 | Back alignment and structure |
|
| >pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287 | Back alignment and structure |
|
| >pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272 | Back alignment and structure |
|
| >pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292 | Back alignment and structure |
|
| >pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306 | Back alignment and structure |
|
| >pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277 | Back alignment and structure |
|
| >pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277 | Back alignment and structure |
|
| >pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289 | Back alignment and structure |
|
| >pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271 | Back alignment and structure |
|
| >pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289 | Back alignment and structure |
|
| >pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285 | Back alignment and structure |
|
| >pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312 | Back alignment and structure |
|
| >pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265 | Back alignment and structure |
|
| >pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286 | Back alignment and structure |
|
| >pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286 | Back alignment and structure |
|
| >pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275 | Back alignment and structure |
|
| >pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277 | Back alignment and structure |
|
| >pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272 | Back alignment and structure |
|
| >pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286 | Back alignment and structure |
|
| >pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311 | Back alignment and structure |
|
| >pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286 | Back alignment and structure |
|
| >pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286 | Back alignment and structure |
|
| >pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283 | Back alignment and structure |
|
| >pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267 | Back alignment and structure |
|
| >pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311 | Back alignment and structure |
|
| >pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311 | Back alignment and structure |
|
| >pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294 | Back alignment and structure |
|
| >pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277 | Back alignment and structure |
|
| >pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286 | Back alignment and structure |
|
| >pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281 | Back alignment and structure |
|
| >pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284 | Back alignment and structure |
|
| >pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306 | Back alignment and structure |
|
| >pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282 | Back alignment and structure |
|
| >pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307 | Back alignment and structure |
|
| >pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275 | Back alignment and structure |
|
| >pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276 | Back alignment and structure |
|
| >pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300 | Back alignment and structure |
|
| >pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321 | Back alignment and structure |
|
| >pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286 | Back alignment and structure |
|
| >pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328 | Back alignment and structure |
|
| >pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279 | Back alignment and structure |
|
| >pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318 | Back alignment and structure |
|
| >pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286 | Back alignment and structure |
|
| >pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278 | Back alignment and structure |
|
| >pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279 | Back alignment and structure |
|
| >pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277 | Back alignment and structure |
|
| >pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311 | Back alignment and structure |
|
| >pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453 | Back alignment and structure |
|
| >pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277 | Back alignment and structure |
|
| >pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452 | Back alignment and structure |
|
| >pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535 | Back alignment and structure |
|
| >pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452 | Back alignment and structure |
|
| >pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311 | Back alignment and structure |
|
| >pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293 | Back alignment and structure |
|
| >pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273 | Back alignment and structure |
|
| >pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277 | Back alignment and structure |
|
| >pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310 | Back alignment and structure |
|
| >pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270 | Back alignment and structure |
|
| >pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298 | Back alignment and structure |
|
| >pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279 | Back alignment and structure |
|
| >pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452 | Back alignment and structure |
|
| >pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287 | Back alignment and structure |
|
| >pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299 | Back alignment and structure |
|
| >pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283 | Back alignment and structure |
|
| >pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284 | Back alignment and structure |
|
| >pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268 | Back alignment and structure |
|
| >pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285 | Back alignment and structure |
|
| >pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288 | Back alignment and structure |
|
| >pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288 | Back alignment and structure |
|
| >pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283 | Back alignment and structure |
|
| >pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279 | Back alignment and structure |
|
| >pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284 | Back alignment and structure |
|
| >pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284 | Back alignment and structure |
|
| >pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298 | Back alignment and structure |
|
| >pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292 | Back alignment and structure |
|
| >pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299 | Back alignment and structure |
|
| >pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310 | Back alignment and structure |
|
| >pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278 | Back alignment and structure |
|
| >pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297 | Back alignment and structure |
|
| >pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537 | Back alignment and structure |
|
| >pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313 | Back alignment and structure |
|
| >pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274 | Back alignment and structure |
|
| >pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338 | Back alignment and structure |
|
| >pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495 | Back alignment and structure |
|
| >pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286 | Back alignment and structure |
|
| >pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297 | Back alignment and structure |
|
| >pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269 | Back alignment and structure |
|
| >pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297 | Back alignment and structure |
|
| >pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283 | Back alignment and structure |
|
| >pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263 | Back alignment and structure |
|
| >pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278 | Back alignment and structure |
|
| >pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450 | Back alignment and structure |
|
| >pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300 | Back alignment and structure |
|
| >pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292 | Back alignment and structure |
|
| >pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267 | Back alignment and structure |
|
| >pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328 | Back alignment and structure |
|
| >pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331 | Back alignment and structure |
|
| >pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328 | Back alignment and structure |
|
| >pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263 | Back alignment and structure |
|
| >pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327 | Back alignment and structure |
|
| >pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297 | Back alignment and structure |
|
| >pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315 | Back alignment and structure |
|
| >pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329 | Back alignment and structure |
|
| >pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329 | Back alignment and structure |
|
| >pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333 | Back alignment and structure |
|
| >pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327 | Back alignment and structure |
|
| >pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329 | Back alignment and structure |
|
| >pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352 | Back alignment and structure |
|
| >pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315 | Back alignment and structure |
|
| >pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327 | Back alignment and structure |
|
| >pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271 | Back alignment and structure |
|
| >pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314 | Back alignment and structure |
|
| >pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330 | Back alignment and structure |
|
| >pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | Back alignment and structure |
|
| >pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265 | Back alignment and structure |
|
| >pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327 | Back alignment and structure |
|
| >pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337 | Back alignment and structure |
|
| >pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330 | Back alignment and structure |
|
| >pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327 | Back alignment and structure |
|
| >pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290 | Back alignment and structure |
|
| >pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317 | Back alignment and structure |
|
| >pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295 | Back alignment and structure |
|
| >pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677 | Back alignment and structure |
|
| >pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327 | Back alignment and structure |
|
| >pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676 | Back alignment and structure |
|
| >pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290 | Back alignment and structure |
|
| >pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324 | Back alignment and structure |
|
| >pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303 | Back alignment and structure |
|
| >pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293 | Back alignment and structure |
|
| >pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314 | Back alignment and structure |
|
| >pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298 | Back alignment and structure |
|
| >pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300 | Back alignment and structure |
|
| >pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295 | Back alignment and structure |
|
| >pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301 | Back alignment and structure |
|
| >pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334 | Back alignment and structure |
|
| >pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361 | Back alignment and structure |
|
| >pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331 | Back alignment and structure |
|
| >pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329 | Back alignment and structure |
|
| >pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311 | Back alignment and structure |
|
| >pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334 | Back alignment and structure |
|
| >pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298 | Back alignment and structure |
|
| >pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313 | Back alignment and structure |
|
| >pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327 | Back alignment and structure |
|
| >pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298 | Back alignment and structure |
|
| >pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270 | Back alignment and structure |
|
| >pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329 | Back alignment and structure |
|
| >pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303 | Back alignment and structure |
|
| >pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306 | Back alignment and structure |
|
| >pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289 | Back alignment and structure |
|
| >pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329 | Back alignment and structure |
|
| >pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324 | Back alignment and structure |
|
| >pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281 | Back alignment and structure |
|
| >pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293 | Back alignment and structure |
|
| >pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318 | Back alignment and structure |
|
| >pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277 | Back alignment and structure |
|
| >pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454 | Back alignment and structure |
|
| >pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287 | Back alignment and structure |
|
| >pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322 | Back alignment and structure |
|
| >pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306 | Back alignment and structure |
|
| >pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319 | Back alignment and structure |
|
| >pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306 | Back alignment and structure |
|
| >pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304 | Back alignment and structure |
|
| >pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377 | Back alignment and structure |
|
| >pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394 | Back alignment and structure |
|
| >pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276 | Back alignment and structure |
|
| >pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299 | Back alignment and structure |
|
| >pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327 | Back alignment and structure |
|
| >pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327 | Back alignment and structure |
|
| >pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613 | Back alignment and structure |
|
| >pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341 | Back alignment and structure |
|
| >pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305 | Back alignment and structure |
|
| >pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344 | Back alignment and structure |
|
| >pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377 | Back alignment and structure |
|
| >pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308 | Back alignment and structure |
|
| >pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370 | Back alignment and structure |
|
| >pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276 | Back alignment and structure |
|
| >pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311 | Back alignment and structure |
|
| >pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325 | Back alignment and structure |
|
| >pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291 | Back alignment and structure |
|
| >pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334 | Back alignment and structure |
|
| >pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291 | Back alignment and structure |
|
| >pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273 | Back alignment and structure |
|
| >pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313 | Back alignment and structure |
|
| >pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334 | Back alignment and structure |
|
| >pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277 | Back alignment and structure |
|
| >pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635 | Back alignment and structure |
|
| >pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293 | Back alignment and structure |
|
| >pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299 | Back alignment and structure |
|
| >pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322 | Back alignment and structure |
|
| >pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304 | Back alignment and structure |
|
| >pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317 | Back alignment and structure |
|
| >pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327 | Back alignment and structure |
|
| >pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302 | Back alignment and structure |
|
| >pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636 | Back alignment and structure |
|
| >pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355 | Back alignment and structure |
|
| >pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291 | Back alignment and structure |
|
| >pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322 | Back alignment and structure |
|
| >pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310 | Back alignment and structure |
|
| >pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301 | Back alignment and structure |
|
| >pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317 | Back alignment and structure |
|
| >pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301 | Back alignment and structure |
|
| >pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276 | Back alignment and structure |
|
| >pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306 | Back alignment and structure |
|
| >pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309 | Back alignment and structure |
|
| >pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315 | Back alignment and structure |
|
| >pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284 | Back alignment and structure |
|
| >pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476 | Back alignment and structure |
|
| >pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307 | Back alignment and structure |
|
| >pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327 | Back alignment and structure |
|
| >pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274 | Back alignment and structure |
|
| >pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327 | Back alignment and structure |
|
| >pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299 | Back alignment and structure |
|
| >pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273 | Back alignment and structure |
|
| >pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336 | Back alignment and structure |
|
| >pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303 | Back alignment and structure |
|
| >pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317 | Back alignment and structure |
|
| >pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382 | Back alignment and structure |
|
| >pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333 | Back alignment and structure |
|
| >pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1 Receptor Kinase In Complex With Pqip Length = 301 | Back alignment and structure |
|
| >pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353 | Back alignment and structure |
|
| >pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341 | Back alignment and structure |
|
| >pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328 | Back alignment and structure |
|
| >pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322 | Back alignment and structure |
|
| >pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353 | Back alignment and structure |
|
| >pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331 | Back alignment and structure |
|
| >pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|2QLU|A Chain A, Crystal Structure Of Activin Receptor Type Ii Kinase Domain From Human Length = 314 | Back alignment and structure |
|
| >pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350 | Back alignment and structure |
|
| >pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442 | Back alignment and structure |
|
| >pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395 | Back alignment and structure |
|
| >pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398 | Back alignment and structure |
|
| >pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360 | Back alignment and structure |
|
| >pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328 | Back alignment and structure |
|
| >pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329 | Back alignment and structure |
|
| >pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325 | Back alignment and structure |
|
| >pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382 | Back alignment and structure |
|
| >pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301 | Back alignment and structure |
|
| >pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348 | Back alignment and structure |
|
| >pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353 | Back alignment and structure |
|
| >pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304 | Back alignment and structure |
|
| >pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305 | Back alignment and structure |
|
| >pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389 | Back alignment and structure |
|
| >pdb|3LCT|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 344 | Back alignment and structure |
|
| >pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366 | Back alignment and structure |
|
| >pdb|3L9P|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 367 | Back alignment and structure |
|
| >pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354 | Back alignment and structure |
|
| >pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360 | Back alignment and structure |
|
| >pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365 | Back alignment and structure |
|
| >pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348 | Back alignment and structure |
|
| >pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380 | Back alignment and structure |
|
| >pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379 | Back alignment and structure |
|
| >pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360 | Back alignment and structure |
|
| >pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360 | Back alignment and structure |
|
| >pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366 | Back alignment and structure |
|
| >pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362 | Back alignment and structure |
|
| >pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | Back alignment and structure |
|
| >pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368 | Back alignment and structure |
|
| >pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368 | Back alignment and structure |
|
| >pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359 | Back alignment and structure |
|
| >pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365 | Back alignment and structure |
|
| >pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365 | Back alignment and structure |
|
| >pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354 | Back alignment and structure |
|
| >pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360 | Back alignment and structure |
|
| >pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360 | Back alignment and structure |
|
| >pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362 | Back alignment and structure |
|
| >pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354 | Back alignment and structure |
|
| >pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351 | Back alignment and structure |
|
| >pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321 | Back alignment and structure |
|
| >pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362 | Back alignment and structure |
|
| >pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360 | Back alignment and structure |
|
| >pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317 | Back alignment and structure |
|
| >pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370 | Back alignment and structure |
|
| >pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367 | Back alignment and structure |
|
| >pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372 | Back alignment and structure |
|
| >pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290 | Back alignment and structure |
|
| >pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348 | Back alignment and structure |
|
| >pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379 | Back alignment and structure |
|
| >pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372 | Back alignment and structure |
|
| >pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350 | Back alignment and structure |
|
| >pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | Back alignment and structure |
|
| >pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358 | Back alignment and structure |
|
| >pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327 | Back alignment and structure |
|
| >pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366 | Back alignment and structure |
|
| >pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357 | Back alignment and structure |
|
| >pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364 | Back alignment and structure |
|
| >pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360 | Back alignment and structure |
|
| >pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366 | Back alignment and structure |
|
| >pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302 | Back alignment and structure |
|
| >pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327 | Back alignment and structure |
|
| >pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303 | Back alignment and structure |
|
| >pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327 | Back alignment and structure |
|
| >pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367 | Back alignment and structure |
|
| >pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336 | Back alignment and structure |
|
| >pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290 | Back alignment and structure |
|
| >pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318 | Back alignment and structure |
|
| >pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298 | Back alignment and structure |
|
| >pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348 | Back alignment and structure |
|
| >pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | Back alignment and structure |
|
| >pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332 | Back alignment and structure |
|
| >pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|3LL6|A Chain A, Crystal Structure Of The Human Cyclin G Associated Kinase (gak) Length = 337 | Back alignment and structure |
|
| >pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364 | Back alignment and structure |
|
| >pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325 | Back alignment and structure |
|
| >pdb|4FNZ|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Piperidine-Carboxamide Inhibitor 2 Length = 327 | Back alignment and structure |
|
| >pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364 | Back alignment and structure |
|
| >pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317 | Back alignment and structure |
|
| >pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309 | Back alignment and structure |
|
| >pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345 | Back alignment and structure |
|
| >pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340 | Back alignment and structure |
|
| >pdb|3AOX|A Chain A, X-Ray Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Ch5424802 Length = 344 | Back alignment and structure |
|
| >pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304 | Back alignment and structure |
|
| >pdb|4DCE|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With A Piperidine-Carboxamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|4FNX|A Chain A, Crystal Structure Of The Apo R1275q Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|2XP2|A Chain A, Structure Of The Human Anaplastic Lymphoma Kinase In Complex With Crizotinib (Pf-02341066) Length = 327 | Back alignment and structure |
|
| >pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420 | Back alignment and structure |
|
| >pdb|2XB7|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex With Nvp- Tae684 Length = 315 | Back alignment and structure |
|
| >pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|2YFX|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase In Complex With Crizotinib Length = 327 | Back alignment and structure |
|
| >pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414 | Back alignment and structure |
|
| >pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352 | Back alignment and structure |
|
| >pdb|4FOB|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Acyliminobenzimidazole Inhibitor 1 Length = 353 | Back alignment and structure |
|
| >pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484 | Back alignment and structure |
|
| >pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371 | Back alignment and structure |
|
| >pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349 | Back alignment and structure |
|
| >pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350 | Back alignment and structure |
|
| >pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576 | Back alignment and structure |
|
| >pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423 | Back alignment and structure |
|
| >pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396 | Back alignment and structure |
|
| >pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350 | Back alignment and structure |
|
| >pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299 | Back alignment and structure |
|
| >pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378 | Back alignment and structure |
|
| >pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298 | Back alignment and structure |
|
| >pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430 | Back alignment and structure |
|
| >pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313 | Back alignment and structure |
|
| >pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | Back alignment and structure |
|
| >pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688 | Back alignment and structure |
|
| >pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300 | Back alignment and structure |
|
| >pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350 | Back alignment and structure |
|
| >pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350 | Back alignment and structure |
|
| >pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306 | Back alignment and structure |
|
| >pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367 | Back alignment and structure |
|
| >pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299 | Back alignment and structure |
|
| >pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424 | Back alignment and structure |
|
| >pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360 | Back alignment and structure |
|
| >pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306 | Back alignment and structure |
|
| >pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576 | Back alignment and structure |
|
| >pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276 | Back alignment and structure |
|
| >pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352 | Back alignment and structure |
|
| >pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689 | Back alignment and structure |
|
| >pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382 | Back alignment and structure |
|
| >pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299 | Back alignment and structure |
|
| >pdb|2YHV|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695 | Back alignment and structure |
|
| >pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465 | Back alignment and structure |
|
| >pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301 | Back alignment and structure |
|
| >pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391 | Back alignment and structure |
|
| >pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281 | Back alignment and structure |
|
| >pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281 | Back alignment and structure |
|
| >pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331 | Back alignment and structure |
|
| >pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282 | Back alignment and structure |
|
| >pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353 | Back alignment and structure |
|
| >pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507 | Back alignment and structure |
|
| >pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353 | Back alignment and structure |
|
| >pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276 | Back alignment and structure |
|
| >pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316 | Back alignment and structure |
|
| >pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303 | Back alignment and structure |
|
| >pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316 | Back alignment and structure |
|
| >pdb|3KMW|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Mgatp) Length = 271 | Back alignment and structure |
|
| >pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293 | Back alignment and structure |
|
| >pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329 | Back alignment and structure |
|
| >pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508 | Back alignment and structure |
|
| >pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|3MDY|A Chain A, Crystal Structure Of The Cytoplasmic Domain Of The Bone Morp Protein Receptor Type-1b (Bmpr1b) In Complex With Fkbp12 An 193189 Length = 337 | Back alignment and structure |
|
| >pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350 | Back alignment and structure |
|
| >pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304 | Back alignment and structure |
|
| >pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318 | Back alignment and structure |
|
| >pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317 | Back alignment and structure |
|
| >pdb|2YJS|A Chain A, Structure Of C1156y Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360 | Back alignment and structure |
|
| >pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316 | Back alignment and structure |
|
| >pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315 | Back alignment and structure |
|
| >pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292 | Back alignment and structure |
|
| >pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320 | Back alignment and structure |
|
| >pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294 | Back alignment and structure |
|
| >pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311 | Back alignment and structure |
|
| >pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325 | Back alignment and structure |
|
| >pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296 | Back alignment and structure |
|
| >pdb|1B6C|B Chain B, Crystal Structure Of The Cytoplasmic Domain Of The Type I Tgf-Beta Receptor In Complex With Fkbp12 Length = 342 | Back alignment and structure |
|
| >pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316 | Back alignment and structure |
|
| >pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276 | Back alignment and structure |
|
| >pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322 | Back alignment and structure |
|
| >pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656 | Back alignment and structure |
|
| >pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353 | Back alignment and structure |
|
| >pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323 | Back alignment and structure |
|
| >pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273 | Back alignment and structure |
|
| >pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484 | Back alignment and structure |
|
| >pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|1RW8|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Atp Site Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346 | Back alignment and structure |
|
| >pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285 | Back alignment and structure |
|
| >pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297 | Back alignment and structure |
|
| >pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289 | Back alignment and structure |
|
| >pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295 | Back alignment and structure |
|
| >pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293 | Back alignment and structure |
|
| >pdb|3TZM|A Chain A, Tgf-Beta Receptor Type 1 In Complex With Sb431542 Length = 309 | Back alignment and structure |
|
| >pdb|1VJY|A Chain A, Crystal Structure Of A Naphthyridine Inhibitor Of Human Tgf- Beta Type I Receptor Length = 303 | Back alignment and structure |
|
| >pdb|1PY5|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360 | Back alignment and structure |
|
| >pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302 | Back alignment and structure |
|
| >pdb|2WOT|A Chain A, Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)-3- Pyridyl)oxy)-N-(3,4,5-Trimethoxyphenyl)pyridin-2-Amine Length = 306 | Back alignment and structure |
|
| >pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278 | Back alignment and structure |
|
| >pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276 | Back alignment and structure |
|
| >pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290 | Back alignment and structure |
|
| >pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269 | Back alignment and structure |
|
| >pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656 | Back alignment and structure |
|
| >pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268 | Back alignment and structure |
|
| >pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273 | Back alignment and structure |
|
| >pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271 | Back alignment and structure |
|
| >pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343 | Back alignment and structure |
|
| >pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269 | Back alignment and structure |
|
| >pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298 | Back alignment and structure |
|
| >pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297 | Back alignment and structure |
|
| >pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298 | Back alignment and structure |
|
| >pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296 | Back alignment and structure |
|
| >pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299 | Back alignment and structure |
|
| >pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303 | Back alignment and structure |
|
| >pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|2RIO|A Chain A, Structure Of The Dual Enzyme Ire1 Reveals The Basis For Catalysis And Regulation Of Non-conventional Splicing Length = 434 | Back alignment and structure |
|
| >pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288 | Back alignment and structure |
|
| >pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300 | Back alignment and structure |
|
| >pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298 | Back alignment and structure |
|
| >pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299 | Back alignment and structure |
|
| >pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316 | Back alignment and structure |
|
| >pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289 | Back alignment and structure |
|
| >pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324 | Back alignment and structure |
|
| >pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314 | Back alignment and structure |
|
| >pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344 | Back alignment and structure |
|
| >pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326 | Back alignment and structure |
|
| >pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299 | Back alignment and structure |
|
| >pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308 | Back alignment and structure |
|
| >pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543 | Back alignment and structure |
|
| >pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543 | Back alignment and structure |
|
| >pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543 | Back alignment and structure |
|
| >pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543 | Back alignment and structure |
|
| >pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348 | Back alignment and structure |
|
| >pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271 | Back alignment and structure |
|
| >pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352 | Back alignment and structure |
|
| >pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309 | Back alignment and structure |
|
| >pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302 | Back alignment and structure |
|
| >pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300 | Back alignment and structure |
|
| >pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274 | Back alignment and structure |
|
| >pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298 | Back alignment and structure |
|
| >pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275 | Back alignment and structure |
|
| >pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298 | Back alignment and structure |
|
| >pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277 | Back alignment and structure |
|
| >pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321 | Back alignment and structure |
|
| >pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365 | Back alignment and structure |
|
| >pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311 | Back alignment and structure |
|
| >pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349 | Back alignment and structure |
|
| >pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313 | Back alignment and structure |
|
| >pdb|3SDJ|A Chain A, Structure Of Rnase-Inactive Point Mutant Of Oligomeric KinaseRNASE Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|3FBV|A Chain A, Crystal Structure Of The Oligomer Formed By The Kinase-Ribonuclease Domain Of Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318 | Back alignment and structure |
|
| >pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334 | Back alignment and structure |
|
| >pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345 | Back alignment and structure |
|
| >pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304 | Back alignment and structure |
|
| >pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370 | Back alignment and structure |
|
| >pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289 | Back alignment and structure |
|
| >pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286 | Back alignment and structure |
|
| >pdb|3G2F|A Chain A, Crystal Structure Of The Kinase Domain Of Bone Morphogenetic Protein Receptor Type Ii (Bmpr2) At 2.35 A Resolution Length = 336 | Back alignment and structure |
|
| >pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311 | Back alignment and structure |
|
| >pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348 | Back alignment and structure |
|
| >pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486 | Back alignment and structure |
|
| >pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | Back alignment and structure |
|
| >pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286 | Back alignment and structure |
|
| >pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287 | Back alignment and structure |
|
| >pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286 | Back alignment and structure |
|
| >pdb|3P23|A Chain A, Crystal Structure Of The Human Kinase And Rnase Domains In Complex With Adp Length = 432 | Back alignment and structure |
|
| >pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286 | Back alignment and structure |
|
| >pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294 | Back alignment and structure |
|
| >pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312 | Back alignment and structure |
|
| >pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311 | Back alignment and structure |
|
| >pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310 | Back alignment and structure |
|
| >pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364 | Back alignment and structure |
|
| >pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292 | Back alignment and structure |
|
| >pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311 | Back alignment and structure |
|
| >pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370 | Back alignment and structure |
|
| >pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311 | Back alignment and structure |
|
| >pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312 | Back alignment and structure |
|
| >pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311 | Back alignment and structure |
|
| >pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310 | Back alignment and structure |
|
| >pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311 | Back alignment and structure |
|
| >pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314 | Back alignment and structure |
|
| >pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364 | Back alignment and structure |
|
| >pdb|3LJ0|A Chain A, Ire1 Complexed With Adp And Quercetin Length = 434 | Back alignment and structure |
|
| >pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311 | Back alignment and structure |
|
| >pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311 | Back alignment and structure |
|
| >pdb|4FVP|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain (Apo Form) Length = 289 | Back alignment and structure |
|
| >pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356 | Back alignment and structure |
|
| >pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355 | Back alignment and structure |
|
| >pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504 | Back alignment and structure |
|
| >pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303 | Back alignment and structure |
|
| >pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3MY0|A Chain A, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound To Ldn- 193189 Length = 305 | Back alignment and structure |
|
| >pdb|4FVR|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain Mutant V617f (Mg- Atp-Bound Form) Length = 289 | Back alignment and structure |
|
| >pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324 | Back alignment and structure |
|
| >pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304 | Back alignment and structure |
|
| >pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360 | Back alignment and structure |
|
| >pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388 | Back alignment and structure |
|
| >pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290 | Back alignment and structure |
|
| >pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323 | Back alignment and structure |
|
| >pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277 | Back alignment and structure |
|
| >pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294 | Back alignment and structure |
|
| >pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316 | Back alignment and structure |
|
| >pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364 | Back alignment and structure |
|
| >pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353 | Back alignment and structure |
|
| >pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491 | Back alignment and structure |
|
| >pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363 | Back alignment and structure |
|
| >pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365 | Back alignment and structure |
|
| >pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362 | Back alignment and structure |
|
| >pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464 | Back alignment and structure |
|
| >pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573 | Back alignment and structure |
|
| >pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355 | Back alignment and structure |
|
| >pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356 | Back alignment and structure |
|
| >pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356 | Back alignment and structure |
|
| >pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367 | Back alignment and structure |
|
| >pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346 | Back alignment and structure |
|
| >pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423 | Back alignment and structure |
|
| >pdb|2Y4I|B Chain B, Ksr2-Mek1 Heterodimer Length = 319 | Back alignment and structure |
|
| >pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369 | Back alignment and structure |
|
| >pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330 | Back alignment and structure |
|
| >pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371 | Back alignment and structure |
|
| >pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437 | Back alignment and structure |
|
| >pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369 | Back alignment and structure |
|
| >pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307 | Back alignment and structure |
|
| >pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358 | Back alignment and structure |
|
| >pdb|3H9R|A Chain A, Crystal Structure Of The Kinase Domain Of Type I Activin Receptor (Acvr1) In Complex With Fkbp12 And Dorsomorphin Length = 330 | Back alignment and structure |
|
| >pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335 | Back alignment and structure |
|
| >pdb|3MTF|A Chain A, Crystal Structure Of The Acvr1 Kinase In Complex With A 2- Aminopyridine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371 | Back alignment and structure |
|
| >pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339 | Back alignment and structure |
|
| >pdb|4DYM|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex With The Imidazo[1,2-B]pyridazine Inhibitor K00135 Length = 301 | Back alignment and structure |
|
| >pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353 | Back alignment and structure |
|
| >pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317 | Back alignment and structure |
|
| >pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315 | Back alignment and structure |
|
| >pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292 | Back alignment and structure |
|
| >pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379 | Back alignment and structure |
|
| >pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342 | Back alignment and structure |
|
| >pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346 | Back alignment and structure |
|
| >pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674 | Back alignment and structure |
|
| >pdb|2BUJ|A Chain A, Crystal Structure Of The Human Serine-Threonine Kinase 16 In Complex With Staurosporine Length = 317 | Back alignment and structure |
|
| >pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342 | Back alignment and structure |
|
| >pdb|4EUT|A Chain A, Structure Of Bx-795 Complexed With Unphosphorylated Human Tbk1 Kinase- Uld Domain Length = 396 | Back alignment and structure |
|
| >pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342 | Back alignment and structure |
|
| >pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364 | Back alignment and structure |
|
| >pdb|2IWI|A Chain A, Crystal Structure Of The Human Pim2 In Complex With A Ruthenium Organometallic Ligand Ru1 Length = 312 | Back alignment and structure |
|
| >pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313 | Back alignment and structure |
|
| >pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337 | Back alignment and structure |
|
| >pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278 | Back alignment and structure |
|
| >pdb|3KMU|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Apo) Length = 271 | Back alignment and structure |
|
| >pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283 | Back alignment and structure |
|
| >pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317 | Back alignment and structure |
|
| >pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336 | Back alignment and structure |
|
| >pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353 | Back alignment and structure |
|
| >pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335 | Back alignment and structure |
|
| >pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386 | Back alignment and structure |
|
| >pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370 | Back alignment and structure |
|
| >pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373 | Back alignment and structure |
|
| >pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362 | Back alignment and structure |
|
| >pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301 | Back alignment and structure |
|
| >pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304 | Back alignment and structure |
|
| >pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317 | Back alignment and structure |
|
| >pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361 | Back alignment and structure |
|
| >pdb|4EUU|A Chain A, Structure Of Bx-795 Complexed With Human Tbk1 Kinase Domain Phosphorylated On Ser172 Length = 319 | Back alignment and structure |
|
| >pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334 | Back alignment and structure |
|
| >pdb|1NA7|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human Protein Kinase Ck2 Length = 329 | Back alignment and structure |
|
| >pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292 | Back alignment and structure |
|
| >pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446 | Back alignment and structure |
|
| >pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446 | Back alignment and structure |
|
| >pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370 | Back alignment and structure |
|
| >pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342 | Back alignment and structure |
|
| >pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402 | Back alignment and structure |
|
| >pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284 | Back alignment and structure |
|
| >pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361 | Back alignment and structure |
|
| >pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334 | Back alignment and structure |
|
| >pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315 | Back alignment and structure |
|
| >pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311 | Back alignment and structure |
|
| >pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269 | Back alignment and structure |
|
| >pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311 | Back alignment and structure |
|
| >pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282 | Back alignment and structure |
|
| >pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321 | Back alignment and structure |
|
| >pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288 | Back alignment and structure |
|
| >pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444 | Back alignment and structure |
|
| >pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321 | Back alignment and structure |
|
| >pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293 | Back alignment and structure |
|
| >pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294 | Back alignment and structure |
|
| >pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295 | Back alignment and structure |
|
| >pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373 | Back alignment and structure |
|
| >pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340 | Back alignment and structure |
|
| >pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317 | Back alignment and structure |
|
| >pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312 | Back alignment and structure |
|
| >pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285 | Back alignment and structure |
|
| >pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341 | Back alignment and structure |
|
| >pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278 | Back alignment and structure |
|
| >pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295 | Back alignment and structure |
|
| >pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | Back alignment and structure |
|
| >pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | Back alignment and structure |
|
| >pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362 | Back alignment and structure |
|
| >pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332 | Back alignment and structure |
|
| >pdb|3HKO|A Chain A, Crystal Structure Of A Cdpk Kinase Domain From Cryptosporidium Parvum, Cgd7_40 Length = 345 | Back alignment and structure |
|
| >pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361 | Back alignment and structure |
|
| >pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295 | Back alignment and structure |
|
| >pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326 | Back alignment and structure |
|
| >pdb|3JXW|A Chain A, Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-Ones As Potent, Highly Selective And Orally Bioavailable Pim Kinases Inhibitors Length = 294 | Back alignment and structure |
|
| >pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322 | Back alignment and structure |
|
| >pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323 | Back alignment and structure |
|
| >pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322 | Back alignment and structure |
|
| >pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323 | Back alignment and structure |
|
| >pdb|3UIX|A Chain A, Crystal Structure Of Pim1 Kinase In Complex With Small Molecule Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329 | Back alignment and structure |
|
| >pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419 | Back alignment and structure |
|
| >pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371 | Back alignment and structure |
|
| >pdb|1YXS|A Chain A, Crystal Structure Of Kinase Pim1 With P123m Mutation Length = 293 | Back alignment and structure |
|
| >pdb|3R00|A Chain A, The Discovery Of Novel Benzofuran-2-Carboxylic Acids As Potent Pim-1 Inhibitors Length = 299 | Back alignment and structure |
|
| >pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335 | Back alignment and structure |
|
| >pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443 | Back alignment and structure |
|
| >pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294 | Back alignment and structure |
|
| >pdb|4A7C|A Chain A, Crystal Structure Of Pim1 Kinase With Etp46546 Length = 308 | Back alignment and structure |
|
| >pdb|1YWV|A Chain A, Crystal Structures Of Proto-Oncogene Kinase Pim1: A Target Of Aberrant Somatic Hypermutations In Diffuse Large Cell Lymphoma Length = 293 | Back alignment and structure |
|
| >pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316 | Back alignment and structure |
|
| >pdb|1XWS|A Chain A, Crystal Structure Of The Human Pim1 Kinase Domain Length = 313 | Back alignment and structure |
|
| >pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348 | Back alignment and structure |
|
| >pdb|3F2A|A Chain A, Crystal Structure Of Human Pim-1 In Complex With Dappa Length = 300 | Back alignment and structure |
|
| >pdb|1XQZ|A Chain A, Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolution Length = 300 | Back alignment and structure |
|
| >pdb|2XJ0|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-4 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|2OBJ|A Chain A, Crystal Structure Of Human Pim-1 Kinase In Complex With Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3A99|A Chain A, Structure Of Pim-1 Kinase Crystallized In The Presence Of P27kip1 Carboxy-Terminal Peptide Length = 320 | Back alignment and structure |
|
| >pdb|3JPV|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Pyrrolo[2,3- A]carbazole Ligand Length = 313 | Back alignment and structure |
|
| >pdb|2BIK|B Chain B, Human Pim1 Phosphorylated On Ser261 Length = 313 | Back alignment and structure |
|
| >pdb|2XIX|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-1 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|3CXW|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Beta Carboline Ligand I Length = 314 | Back alignment and structure |
|
| >pdb|3ZUT|A Chain A, The Structure Of Ost1 (D160a) Kinase Length = 362 | Back alignment and structure |
|
| >pdb|2BIL|B Chain B, The Human Protein Kinase Pim1 In Complex With Its Consensus Peptide Pimtide Length = 313 | Back alignment and structure |
|
| >pdb|3CY3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And The Jnk Inhibitor V Length = 314 | Back alignment and structure |
|
| >pdb|3DCV|A Chain A, Crystal Structure Of Human Pim1 Kinase Complexed With 4-(4- Hydroxy-3-Methyl-Phenyl)-6-Phenylpyrimidin-2(1h)-One Length = 328 | Back alignment and structure |
|
| >pdb|3ZUU|A Chain A, The Structure Of Ost1 (D160a, S175d) Kinase In Complex With Gold Length = 362 | Back alignment and structure |
|
| >pdb|2XIY|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-2 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331 | Back alignment and structure |
|
| >pdb|3MA3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Naphtho-Difuran Ligand Length = 313 | Back alignment and structure |
|
| >pdb|2J2I|B Chain B, Crystal Structure Of The Humab Pim1 In Complex With Ly333531 Length = 312 | Back alignment and structure |
|
| >pdb|4ALV|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328 | Back alignment and structure |
|
| >pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298 | Back alignment and structure |
|
| >pdb|3E3P|A Chain A, Glycogen Synthase Kinase From Leishmania Major Length = 360 | Back alignment and structure |
|
| >pdb|4DTK|A Chain A, Novel And Selective Pan-Pim Kinase Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415 | Back alignment and structure |
|
| >pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351 | Back alignment and structure |
|
| >pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406 | Back alignment and structure |
|
| >pdb|3C4E|A Chain A, Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7- Azaindole Length = 273 | Back alignment and structure |
|
| >pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415 | Back alignment and structure |
|
| >pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410 | Back alignment and structure |
|
| >pdb|4AS0|A Chain A, Cyclometalated Phthalimides As Protein Kinase Inhibitors Length = 273 | Back alignment and structure |
|
| >pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373 | Back alignment and structure |
|
| >pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433 | Back alignment and structure |
|
| >pdb|1YHS|A Chain A, Crystal Structure Of Pim-1 Bound To Staurosporine Length = 273 | Back alignment and structure |
|
| >pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356 | Back alignment and structure |
|
| >pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336 | Back alignment and structure |
|
| >pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331 | Back alignment and structure |
|
| >pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351 | Back alignment and structure |
|
| >pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350 | Back alignment and structure |
|
| >pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350 | Back alignment and structure |
|
| >pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384 | Back alignment and structure |
|
| >pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350 | Back alignment and structure |
|
| >pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351 | Back alignment and structure |
|
| >pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350 | Back alignment and structure |
|
| >pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350 | Back alignment and structure |
|
| >pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350 | Back alignment and structure |
|
| >pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351 | Back alignment and structure |
|
| >pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350 | Back alignment and structure |
|
| >pdb|2AC3|A Chain A, Structure Of Human Mnk2 Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494 | Back alignment and structure |
|
| >pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336 | Back alignment and structure |
|
| >pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352 | Back alignment and structure |
|
| >pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337 | Back alignment and structure |
|
| >pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371 | Back alignment and structure |
|
| >pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351 | Back alignment and structure |
|
| >pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350 | Back alignment and structure |
|
| >pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351 | Back alignment and structure |
|
| >pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336 | Back alignment and structure |
|
| >pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320 | Back alignment and structure |
|
| >pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350 | Back alignment and structure |
|
| >pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301 | Back alignment and structure |
|
| >pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305 | Back alignment and structure |
|
| >pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327 | Back alignment and structure |
|
| >pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350 | Back alignment and structure |
|
| >pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350 | Back alignment and structure |
|
| >pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387 | Back alignment and structure |
|
| >pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350 | Back alignment and structure |
|
| >pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350 | Back alignment and structure |
|
| >pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350 | Back alignment and structure |
|
| >pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351 | Back alignment and structure |
|
| >pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350 | Back alignment and structure |
|
| >pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351 | Back alignment and structure |
|
| >pdb|3HNG|A Chain A, Crystal Structure Of Vegfr1 In Complex With N-(4-chlorophenyl)-2- ((pyridin-4-ylmethyl)amino)benzamide Length = 360 | Back alignment and structure |
|
| >pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350 | Back alignment and structure |
|
| >pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351 | Back alignment and structure |
|
| >pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351 | Back alignment and structure |
|
| >pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351 | Back alignment and structure |
|
| >pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351 | Back alignment and structure |
|
| >pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351 | Back alignment and structure |
|
| >pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351 | Back alignment and structure |
|
| >pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350 | Back alignment and structure |
|
| >pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350 | Back alignment and structure |
|
| >pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371 | Back alignment and structure |
|
| >pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345 | Back alignment and structure |
|
| >pdb|3JUH|A Chain A, Crystal Structure Of A Mutant Of Human Protein Kinase Ck2alpha With Altered Cosubstrate Specificity Length = 335 | Back alignment and structure |
|
| >pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350 | Back alignment and structure |
|
| >pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350 | Back alignment and structure |
|
| >pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350 | Back alignment and structure |
|
| >pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371 | Back alignment and structure |
|
| >pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350 | Back alignment and structure |
|
| >pdb|2R7I|A Chain A, Crystal Structure Of Catalytic Subunit Of Protein Kinase Ck2 Length = 335 | Back alignment and structure |
|
| >pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350 | Back alignment and structure |
|
| >pdb|3NGA|A Chain A, Human Ck2 Catalytic Domain In Complex With Cx-4945 Length = 333 | Back alignment and structure |
|
| >pdb|3UIB|A Chain A, Map Kinase Lmampk10 From Leishmania Major In Complex With Sb203580 Length = 362 | Back alignment and structure |
|
| >pdb|3Q9W|A Chain A, Crystal Structure Of Human Ck2 Alpha In Complex With Emodin At Ph 8.5 Length = 336 | Back alignment and structure |
|
| >pdb|3PG1|A Chain A, Map Kinase Lmampk10 From Leishmania Major (1.95 Angs Resolution) Length = 362 | Back alignment and structure |
|
| >pdb|3H30|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human Protein Kinase Ck2 With 5,6-Dichloro-1-Beta-D- Ribofuranosylbenzimidazole Length = 334 | Back alignment and structure |
|
| >pdb|3U87|A Chain A, Structure Of A Chimeric Construct Of Human Ck2alpha And Human Ck2alpha' In Complex With A Non-hydrolysable Atp-analogue Length = 349 | Back alignment and structure |
|
| >pdb|3NSZ|A Chain A, Human Ck2 Catalytic Domain In Complex With Amppn Length = 330 | Back alignment and structure |
|
| >pdb|3MB6|A Chain A, Human Ck2 Catalytic Domain In Complex With A Difurane Derivative Inhibitor (Cpa) Length = 331 | Back alignment and structure |
|
| >pdb|3BQC|A Chain A, High Ph-Value Crystal Structure Of Emodin In Complex With The Catalytic Subunit Of Protein Kinase Ck2 Length = 335 | Back alignment and structure |
|
| >pdb|1PJK|A Chain A, Crystal Structure Of A C-terminal Deletion Mutant Of Human Protein Kinase Ck2 Catalytic Subunit Length = 334 | Back alignment and structure |
|
| >pdb|2ZJW|A Chain A, Crystal Structure Of Human Ck2 Alpha Complexed With Ellagic Acid Length = 340 | Back alignment and structure |
|
| >pdb|1JWH|A Chain A, Crystal Structure Of Human Protein Kinase Ck2 Holoenzyme Length = 337 | Back alignment and structure |
|
Structure Templates Detected by RPS-BLAST
Original result of RPS-BLAST against PDB70 database
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326 | Back alignment and structure |
|---|
Score = 524 bits (1352), Expect = 0.0
Identities = 137/314 (43%), Positives = 210/314 (66%), Gaps = 4/314 (1%)
Query: 164 LPEISHLGWGHWFTLRDLEIATNRFSAENVLGEGGYGVVYKGRLINGSEVAVKKLLNNLG 223
PE+ HLG F+LR+L++A++ FS +N+LG GG+G VYKGRL +G+ VAVK+L
Sbjct: 9 DPEV-HLGQLKRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERT 67
Query: 224 QA-EKEFRVEVEAIGHVRHKNLVRLLGYCIEGVHRMLVYEYVNNGNLEQWLHGAMRNQGN 282
Q E +F+ EVE I H+NL+RL G+C+ R+LVY Y+ NG++ L +Q
Sbjct: 68 QGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQPP 127
Query: 283 LTWEARMKVIIGTAKALAYLHEAIEPKVVHRDIKSSNILIDDEFNAKVSDFGLAKLLDSG 342
L W R ++ +G+A+ LAYLH+ +PK++HRD+K++NIL+D+EF A V DFGLAKL+D
Sbjct: 128 LDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYK 187
Query: 343 ESHITTRVMGTFGYVAPEYANTGMLNEKSDIYSFGVLLLEAVTGRDPVDYGRPANE--VN 400
++H+TT V GT G++APEY +TG +EK+D++ +GV+LLE +TG+ D R AN+ V
Sbjct: 188 DTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVM 247
Query: 401 LVEWLKMMVGTRRAEEVVDPNLEVKPATRALKRSLLVALRCVDPDSEKRPKMSQVVRMLE 460
L++W+K ++ ++ E +VD +L+ +++ + VAL C +RPKMS+VVRMLE
Sbjct: 248 LLDWVKGLLKEKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLE 307
Query: 461 ADDYPFREDRRNRK 474
D R + ++
Sbjct: 308 GDGLAERWEEWQKE 321
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321 | Back alignment and structure |
|---|
Score = 485 bits (1251), Expect = e-171
Identities = 120/318 (37%), Positives = 183/318 (57%), Gaps = 9/318 (2%)
Query: 144 GHKHSSLSYGGLVTASPLIGLPEISHLGWGHWFTLRDLEIATNRFSAENVLGEGGYGVVY 203
G K+S + S +P + L DLE ATN F + ++G G +G VY
Sbjct: 2 GSKYSKATNSINDALSSSYLVP-----FESYRVPLVDLEEATNNFDHKFLIGHGVFGKVY 56
Query: 204 KGRLINGSEVAVKKLLNNLGQAEKEFRVEVEAIGHVRHKNLVRLLGYCIEGVHRMLVYEY 263
KG L +G++VA+K+ Q +EF E+E + RH +LV L+G+C E +L+Y+Y
Sbjct: 57 KGVLRDGAKVALKRRTPESSQGIEEFETEIETLSFCRHPHLVSLIGFCDERNEMILIYKY 116
Query: 264 VNNGNLEQWLHGAMRNQGNLTWEARMKVIIGTAKALAYLHEAIEPKVVHRDIKSSNILID 323
+ NGNL++ L+G+ +++WE R+++ IG A+ L YLH ++HRD+KS NIL+D
Sbjct: 117 MENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLH---TRAIIHRDVKSINILLD 173
Query: 324 DEFNAKVSDFGLAKL-LDSGESHITTRVMGTFGYVAPEYANTGMLNEKSDIYSFGVLLLE 382
+ F K++DFG++K + ++H++T V GT GY+ PEY G L EKSD+YSFGV+L E
Sbjct: 174 ENFVPKITDFGISKKGTELDQTHLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFE 233
Query: 383 AVTGRDPVDYGRPANEVNLVEWLKMMVGTRRAEEVVDPNLEVKPATRALKRSLLVALRCV 442
+ R + P VNL EW + E++VDPNL K +L++ A++C+
Sbjct: 234 VLCARSAIVQSLPREMVNLAEWAVESHNNGQLEQIVDPNLADKIRPESLRKFGDTAVKCL 293
Query: 443 DPDSEKRPKMSQVVRMLE 460
SE RP M V+ LE
Sbjct: 294 ALSSEDRPSMGDVLWKLE 311
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307 | Back alignment and structure |
|---|
Score = 413 bits (1065), Expect = e-143
Identities = 107/299 (35%), Positives = 168/299 (56%), Gaps = 21/299 (7%)
Query: 174 HWFTLRDLEIATNRFSAE------NVLGEGGYGVVYKGRLINGSEVAVKKLLNNL----G 223
H F+ +L+ TN F N +GEGG+GVVYKG + N + VAVKKL +
Sbjct: 13 HSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV-NNTTVAVKKLAAMVDITTE 71
Query: 224 QAEKEFRVEVEAIGHVRHKNLVRLLGYCIEGVHRMLVYEYVNNGNLEQWLHGAMRNQGNL 283
+ +++F E++ + +H+NLV LLG+ +G LVY Y+ NG+L L + L
Sbjct: 72 ELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSC-LDGTPPL 130
Query: 284 TWEARMKVIIGTAKALAYLHEAIEPKVVHRDIKSSNILIDDEFNAKVSDFGLAKLLDSGE 343
+W R K+ G A + +LH E +HRDIKS+NIL+D+ F AK+SDFGLA+ +
Sbjct: 131 SWHMRCKIAQGAANGINFLH---ENHHIHRDIKSANILLDEAFTAKISDFGLARASEKFA 187
Query: 344 -SHITTRVMGTFGYVAPEYANTGMLNEKSDIYSFGVLLLEAVTGRDPVDYGRPANEVNLV 402
+ +T+R++GT Y+APE G + KSDIYSFGV+LLE +TG VD R L+
Sbjct: 188 QTVMTSRIVGTTAYMAPEAL-RGEITPKSDIYSFGVVLLEIITGLPAVDEHRE--PQLLL 244
Query: 403 EWLKMMVGTRRA-EEVVDPNLEVKPATRALKRSLLVALRCVDPDSEKRPKMSQVVRMLE 460
+ + + + E+ +D + + +++ VA +C+ KRP + +V ++L+
Sbjct: 245 DIKEEIEDEEKTIEDYIDKKMNDADS-TSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQ 302
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322 | Back alignment and structure |
|---|
Score = 292 bits (749), Expect = 9e-96
Identities = 74/309 (23%), Positives = 124/309 (40%), Gaps = 30/309 (9%)
Query: 176 FTLRDLEIATNRFSAENVLGEGGYGVVYKGRLINGSEVAVKKLLNNLGQAEKEFRVEVEA 235
+L + V G +G V+K + + VAVK + + EV +
Sbjct: 14 LGTENLYFQSMPLQLLEVKARGRFGCVWKAQ-LLNEYVAVKIFPIQ-DKQSWQNEYEVYS 71
Query: 236 IGHVRHKNLVRLLGYCIEG----VHRMLVYEYVNNGNLEQWLHGAMRNQGNLTWEARMKV 291
+ ++H+N+++ +G G V L+ + G+L +L ++W +
Sbjct: 72 LPGMKHENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFLKA-----NVVSWNELCHI 126
Query: 292 IIGTAKALAYLHEAI-------EPKVVHRDIKSSNILIDDEFNAKVSDFGLAKLLDSGES 344
A+ LAYLHE I +P + HRDIKS N+L+ + A ++DFGLA ++G+S
Sbjct: 127 AETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLALKFEAGKS 186
Query: 345 HI-TTRVMGTFGYVAPEYANTGMLNE-----KSDIYSFGVLLLEAVTGRDPVDYGRPANE 398
T +GT Y+APE + + + D+Y+ G++L E + D
Sbjct: 187 AGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYM 246
Query: 399 VNLVEWLKMMVGTRRAEEVV-----DPNLEVKPATRALKRSLL-VALRCVDPDSEKRPKM 452
+ E + +EVV P L A L C D D+E R
Sbjct: 247 LPFEEEIGQHPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEARLSA 306
Query: 453 SQVVRMLEA 461
V +
Sbjct: 307 GCVGERITQ 315
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336 | Back alignment and structure |
|---|
Score = 221 bits (564), Expect = 4e-68
Identities = 65/324 (20%), Positives = 116/324 (35%), Gaps = 49/324 (15%)
Query: 176 FTLRDLEIATNRFSAENVLGEGGYGVVYKGRLINGSEVAVKKLLNNLGQAEKEFRVEVE- 234
+ + + ++G G YG VYKG L + VAVK + F E
Sbjct: 3 AAASEPSLDLDNLKLLELIGRGRYGAVYKGSL-DERPVAVKVFSF---ANRQNFINEKNI 58
Query: 235 -AIGHVRHKNLVRLLGYCIEG-----VHRMLVYEYVNNGNLEQWLHGAMRNQGNLTWEAR 288
+ + H N+ R + + +LV EY NG+L ++L W +
Sbjct: 59 YRVPLMEHDNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYLS-----LHTSDWVSS 113
Query: 289 MKVIIGTAKALAYLHEAIE------PKVVHRDIKSSNILIDDEFNAKVSDFGLAKLLDSG 342
++ + LAYLH + P + HRD+ S N+L+ ++ +SDFGL+ L
Sbjct: 114 CRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGN 173
Query: 343 -------ESHITTRVMGTFGYVAPEYANTGM-------LNEKSDIYSFGVLLLEAVTGRD 388
E + +GT Y+APE + ++ D+Y+ G++ E
Sbjct: 174 RLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCT 233
Query: 389 PVDYGRPANEVNL-----------VEWLKMMVGTRRAEEVVDPNLEVKPATRALKRSLLV 437
+ G E + E ++++V + + + +
Sbjct: 234 DLFPGESVPEYQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKETI- 292
Query: 438 ALRCVDPDSEKRPKMSQVVRMLEA 461
C D D+E R +
Sbjct: 293 -EDCWDQDAEARLTAQXAEERMAE 315
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309 | Back alignment and structure |
|---|
Score = 217 bits (556), Expect = 3e-67
Identities = 81/287 (28%), Positives = 142/287 (49%), Gaps = 27/287 (9%)
Query: 180 DLEIATNRFSAENVLGEGGYGVVYKGRLINGSEVAVKKLL--NNLGQAEKEFRVEVEAIG 237
D++I + + +G G +G V++ +GS+VAVK L+ + + EF EV +
Sbjct: 31 DMDIPWCDLNIKEKIGAGSFGTVHRAEW-HGSDVAVKILMEQDFHAERVNEFLREVAIMK 89
Query: 238 HVRHKNLVRLLGYCIEGVHRMLVYEYVNNGNLEQWLHGAMRNQGNLTWEARMKVIIGTAK 297
+RH N+V +G + + +V EY++ G+L + LH + + L R+ + AK
Sbjct: 90 RLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKSGARE-QLDERRRLSMAYDVAK 148
Query: 298 ALAYLHEAIEPKVVHRDIKSSNILIDDEFNAKVSDFGLAKLLDSGESHITTRVMGTFGYV 357
+ YLH P +VHR++KS N+L+D ++ KV DFGL++L S + GT ++
Sbjct: 149 GMNYLH-NRNPPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLKASTFLSSKSAA-GTPEWM 206
Query: 358 APEYANTGMLNEKSDIYSFGVLLLEAVTGRDPVDYGRPANEVNLVEWLKMMV-GTRRAE- 415
APE NEKSD+YSFGV+L E T + P + +N + + + +R E
Sbjct: 207 APEVLRDEPSNEKSDVYSFGVILWELATLQQP--W----GNLNPAQVVAAVGFKCKRLEI 260
Query: 416 -EVVDPNLEVKPATRALKRSLLVALRCVDPDSEKRPKMSQVVRMLEA 461
++P + +++ C + KRP + ++ +L
Sbjct: 261 PRNLNPQV----------AAIIE--GCWTNEPWKRPSFATIMDLLRP 295
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307 | Back alignment and structure |
|---|
Score = 212 bits (541), Expect = 6e-65
Identities = 75/286 (26%), Positives = 122/286 (42%), Gaps = 37/286 (12%)
Query: 182 EIATNRFSAENVLGEGGYGVVYKGRLINGSEVAVKKLLNNLGQAEKEFRVEVEAIGHVRH 241
I E V+G G +GVV K + +VA+K++ + K F VE+ + V H
Sbjct: 4 MIDYKEIEVEEVVGRGAFGVVCKAKW-RAKDVAIKQIES--ESERKAFIVELRQLSRVNH 60
Query: 242 KNLVRLLGYCIEGVHRMLVYEYVNNGNLEQWLHGAMRNQGNLTWEARMKVIIGTAKALAY 301
N+V+L G C+ LV EY G+L LHGA T M + ++ +AY
Sbjct: 61 PNIVKLYGACLN--PVCLVMEYAEGGSLYNVLHGA-EPLPYYTAAHAMSWCLQCSQGVAY 117
Query: 302 LHEAIEPKVVHRDIKSSNILIDDEFN-AKVSDFGLAKLLDSGESHITTRVMGTFGYVAPE 360
LH ++HRD+K N+L+ K+ DFG A + + T G+ ++APE
Sbjct: 118 LHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQT----HMTNNKGSAAWMAPE 173
Query: 361 YANTGMLNEKSDIYSFGVLLLEAVTGRDPVDYGRPANEVNLVEWLKMMVGTRRAEEVVDP 420
+EK D++S+G++L E +T R P + ++ R V
Sbjct: 174 VFEGSNYSEKCDVFSWGIILWEVITRRKP--------------FDEIGGPAFRIMWAVHN 219
Query: 421 NL------EVKPATRALKRSLLVALRCVDPDSEKRPKMSQVVRMLE 460
+ +L RC D +RP M ++V+++
Sbjct: 220 GTRPPLIKNLPKPIESLMT------RCWSKDPSQRPSMEEIVKIMT 259
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287 | Back alignment and structure |
|---|
Score = 209 bits (534), Expect = 3e-64
Identities = 83/300 (27%), Positives = 139/300 (46%), Gaps = 42/300 (14%)
Query: 179 RDLEIATNRFSAENVLGEGGYGVVYKGRLI-NGSEVAVKKLLNNLGQAE-------KEFR 230
R +A N E +G+GG+G+V+KGRL+ + S VA+K L+ + E +EF+
Sbjct: 12 RLPTLADNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQ 71
Query: 231 VEVEAIGHVRHKNLVRLLGYCIEGVHRMLVYEYVNNGNLEQWLHGAMRNQGNLTWEARMK 290
EV + ++ H N+V+L G +V E+V G+L L + W +++
Sbjct: 72 REVFIMSNLNHPNIVKLYGLMHNPP--RMVMEFVPCGDLYHRLL---DKAHPIKWSVKLR 126
Query: 291 VIIGTAKALAYLHEAIEPKVVHRDIKSSNILID-----DEFNAKVSDFGLAKLLDSGESH 345
+++ A + Y+ P +VHRD++S NI + AKV+DFGL++ H
Sbjct: 127 LMLDIALGIEYMQ-NQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQQ----SVH 181
Query: 346 ITTRVMGTFGYVAPE--YANTGMLNEKSDIYSFGVLLLEAVTGRDPVDYGRPANEVNLVE 403
+ ++G F ++APE A EK+D YSF ++L +TG P D ++ +
Sbjct: 182 SVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFD-EYSYGKIKFIN 240
Query: 404 WLKMMVGTRRAE--EVVDPNLEVKPATRALKRSLLVALRCVDPDSEKRPKMSQVVRMLEA 461
+ R E P L R+++ C D +KRP S +V+ L
Sbjct: 241 M--IREEGLRPTIPEDCPPRL----------RNVIE--LCWSGDPKKRPHFSYIVKELSE 286
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310 | Back alignment and structure |
|---|
Score = 209 bits (535), Expect = 4e-64
Identities = 68/303 (22%), Positives = 118/303 (38%), Gaps = 44/303 (14%)
Query: 174 HWFTLRDLEIATNRFSAENVLGEGGYGVVYKGRL-INGSEVAVKKLLNNLGQAEKEFRVE 232
H + VLG+G +G K G + +K+L+ + ++ F E
Sbjct: 4 HR------IFRPSDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKE 57
Query: 233 VEAIGHVRHKNLVRLLGYCIEGVHRMLVYEYVNNGNLEQWLHGAMRNQGNLTWEARMKVI 292
V+ + + H N+++ +G + + EY+ G L + W R+
Sbjct: 58 VKVMRCLEHPNVLKFIGVLYKDKRLNFITEYIKGGTLRGIIK---SMDSQYPWSQRVSFA 114
Query: 293 IGTAKALAYLHEAIEPKVVHRDIKSSNILIDDEFNAKVSDFGLAKLLDSGESHITTR--- 349
A +AYLH ++HRD+ S N L+ + N V+DFGLA+L+ ++
Sbjct: 115 KDIASGMAYLHSM---NIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSL 171
Query: 350 ----------VMGTFGYVAPEYANTGMLNEKSDIYSFGVLLLEAVTGRDPVDYGRPANEV 399
V+G ++APE N +EK D++SFG++L E + + P
Sbjct: 172 KKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMD 231
Query: 400 NLVEWLKMMVGTRRAE--EVVDPNLEVKPATRALKRSLLVALRCVDPDSEKRPKMSQVVR 457
+ + G P+ + +RC D D EKRP ++
Sbjct: 232 FGLN----VRGFLDRYCPPNCPPSF------------FPITVRCCDLDPEKRPSFVKLEH 275
Query: 458 MLE 460
LE
Sbjct: 276 WLE 278
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271 | Back alignment and structure |
|---|
Score = 205 bits (523), Expect = 7e-63
Identities = 78/295 (26%), Positives = 128/295 (43%), Gaps = 40/295 (13%)
Query: 181 LEIATNRFSAENVLGEGGYGVVYKGRLINGSEVAVKKLL----NNLGQAEKEFRVEVEAI 236
LEI + E ++G GG+G VY+ G EVAVK ++ Q + R E +
Sbjct: 2 LEIDFAELTLEEIIGIGGFGKVYRAFW-IGDEVAVKAARHDPDEDISQTIENVRQEAKLF 60
Query: 237 GHVRHKNLVRLLGYCIEGVHRMLVYEYVNNGNLEQWLHGAMRNQGNLTWEARMKVIIGTA 296
++H N++ L G C++ + LV E+ G L + L G + + + + A
Sbjct: 61 AMLKHPNIIALRGVCLKEPNLCLVMEFARGGPLNRVLSGK-----RIPPDILVNWAVQIA 115
Query: 297 KALAYLHEAIEPKVVHRDIKSSNILIDDEF--------NAKVSDFGLAKLLDSGESHITT 348
+ + YLH+ ++HRD+KSSNILI + K++DFGLA+
Sbjct: 116 RGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAREWHRTT---KM 172
Query: 349 RVMGTFGYVAPEYANTGMLNEKSDIYSFGVLLLEAVTGRDPVDYGRPANEVNLVEWLKMM 408
G + ++APE M ++ SD++S+GVLL E +TG P + + +
Sbjct: 173 SAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVP--F-------------RGI 217
Query: 409 VGTRRAEEVVDPN--LEVKPATRALKRSLLVALRCVDPDSEKRPKMSQVVRMLEA 461
G A V L + L+ C +PD RP + ++ L
Sbjct: 218 DGLAVAYGVAMNKLALPIPSTCPEPFAKLM--EDCWNPDPHSRPSFTNILDQLTT 270
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271 | Back alignment and structure |
|---|
Score = 202 bits (516), Expect = 1e-61
Identities = 66/292 (22%), Positives = 119/292 (40%), Gaps = 36/292 (12%)
Query: 179 RDLEIATNRFSAENVLGEGGYGVVYKGRLINGSEVAVKKLL--NNLGQAEKEFRVEVEAI 236
+ I + + L E G ++KGR G+++ VK L + + ++F E +
Sbjct: 3 KHSGIDFKQLNFLTKLNENHSGELWKGRW-QGNDIVVKVLKVRDWSTRKSRDFNEECPRL 61
Query: 237 GHVRHKNLVRLLGYCIE--GVHRMLVYEYVNNGNLEQWLHGAMRNQGNLTWEARMKVIIG 294
H N++ +LG C H L+ ++ G+L LH + +K +
Sbjct: 62 RIFSHPNVLPVLGACQSPPAPHPTLITHWMPYGSLYNVLHE--GTNFVVDQSQAVKFALD 119
Query: 295 TAKALAYLHEAIEPKVVHRDIKSSNILIDDEFNAKVSDFGLAKLLDSGESHITTRVMGTF 354
A+ +A+LH +EP + + S +++ID++ A++S + S M
Sbjct: 120 MARGMAFLH-TLEPLIPRHALNSRSVMIDEDMTARISMADVKFSFQS------PGRMYAP 172
Query: 355 GYVAPE---YANTGMLNEKSDIYSFGVLLLEAVTGRDPVDYGRPANEVNLVEWLKMMV-- 409
+VAPE +D++SF VLL E VT P + +++ +E +
Sbjct: 173 AWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVP--F----ADLSNMEIGMKVALE 226
Query: 410 GTRRAEEVVDPNLEVKPATRALKRSLLVALRCVDPDSEKRPKMSQVVRMLEA 461
G R + P L+ C++ D KRPK +V +LE
Sbjct: 227 GLR---------PTIPPGISPHVSKLMK--ICMNEDPAKRPKFDMIVPILEK 267
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289 | Back alignment and structure |
|---|
Score = 196 bits (500), Expect = 4e-59
Identities = 70/304 (23%), Positives = 133/304 (43%), Gaps = 34/304 (11%)
Query: 165 PEISHLGWGHWFTLRDLEIATNRFSAENVLGEGGYGVVYKGRLINGSEVAVKKLL--NNL 222
S W EI + + +G G +G VYKG+ +G +VAVK L
Sbjct: 9 HHGSRDAADDW------EIPDGQITVGQRIGSGSFGTVYKGKW-HG-DVAVKMLNVTAPT 60
Query: 223 GQAEKEFRVEVEAIGHVRHKNLVRLLGYCIEGVHRMLVYEYVNNGNLEQWLHGAMRNQGN 282
Q + F+ EV + RH N++ +GY +V ++ +L LH ++
Sbjct: 61 PQQLQAFKNEVGVLRKTRHVNILLFMGYSTAP-QLAIVTQWCEGSSLYHHLH---ASETK 116
Query: 283 LTWEARMKVIIGTAKALAYLHEAIEPKVVHRDIKSSNILIDDEFNAKVSDFGLAKLLDS- 341
+ + + TA+ + YLH ++HRD+KS+NI + ++ K+ DFGLA
Sbjct: 117 FEMKKLIDIARQTARGMDYLHA---KSIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRW 173
Query: 342 GESHITTRVMGTFGYVAPE---YANTGMLNEKSDIYSFGVLLLEAVTGRDPVDYGRPANE 398
SH ++ G+ ++APE ++ + +SD+Y+FG++L E +TG+ P ++
Sbjct: 174 SGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQ 233
Query: 399 V-NLVEWLKMMVGTRRAEEVVDPNLEVKPATRALKRSLLVALRCVDPDSEKRPKMSQVVR 457
+ +V + + + + L+ C+ ++RP +++
Sbjct: 234 IIEMVGRGSLSPDLSKVRSNCPKRM----------KRLM--AECLKKKRDERPSFPRILA 281
Query: 458 MLEA 461
+E
Sbjct: 282 EIEE 285
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301 | Back alignment and structure |
|---|
Score = 196 bits (499), Expect = 5e-59
Identities = 70/310 (22%), Positives = 124/310 (40%), Gaps = 47/310 (15%)
Query: 179 RDLEIATNRFSAENVLGEGGYGVVYKGRLINGSEVAVKKLLNNLGQAEKEFRVEVE--AI 236
RD+ + +G+G YG V++G G VAVK + + EK + E E
Sbjct: 8 RDITL-------LECVGKGRYGEVWRGSW-QGENVAVKIFSS---RDEKSWFRETELYNT 56
Query: 237 GHVRHKNLVRLLGYCIEGVHR----MLVYEYVNNGNLEQWLHGAMRNQGNLTWEARMKVI 292
+RH+N++ + + H L+ Y G+L +L L + ++++
Sbjct: 57 VMLRHENILGFIASDMTSRHSSTQLWLITHYHEMGSLYDYLQ-----LTTLDTVSCLRIV 111
Query: 293 IGTAKALAYLHEAIE-----PKVVHRDIKSSNILIDDEFNAKVSDFGLAKLLDSGESHIT 347
+ A LA+LH I P + HRD+KS NIL+ ++D GLA + + +
Sbjct: 112 LSIASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLD 171
Query: 348 TRVM---GTFGYVAPE------YANTGMLNEKSDIYSFGVLLLEAVTGRDPV----DYGR 394
GT Y+APE + ++ DI++FG++L E DY
Sbjct: 172 VGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKP 231
Query: 395 PANEVN----LVEWLKMMVGTRRAEEVVDPNLEVKPATRALKRSLLVALRCVDPDSEKRP 450
P +V E ++ +V + + P +L + L+ C + R
Sbjct: 232 PFYDVVPNDPSFEDMRKVVCVDQQRPNIPNRWFSDPTLTSLAK-LMK--ECWYQNPSARL 288
Query: 451 KMSQVVRMLE 460
++ + L
Sbjct: 289 TALRIKKTLT 298
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 193 bits (491), Expect = 2e-57
Identities = 70/332 (21%), Positives = 127/332 (38%), Gaps = 52/332 (15%)
Query: 157 TASPLIGLPEISHLGWGHWFTLRDLEIATNRFSAENVLGEGGYGVVYKGRLINGSEVAVK 216
++ GLP + + +++ +G+G YG V+ G+ G +VAVK
Sbjct: 20 SSGSGSGLPLLVQ-----RTIAKQIQM-------VKQIGKGRYGEVWMGKW-RGEKVAVK 66
Query: 217 KLLNNLGQAEKEFRVEVE--AIGHVRHKNLVRLLGYCIEGVHR----MLVYEYVNNGNLE 270
E + E E +RH+N++ + I+G L+ +Y NG+L
Sbjct: 67 VFFT---TEEASWFRETEIYQTVLMRHENILGFIAADIKGTGSWTQLYLITDYHENGSLY 123
Query: 271 QWLHGAMRNQGNLTWEARMKVIIGTAKALAYLHEAIE-----PKVVHRDIKSSNILIDDE 325
+L L ++ +K+ + L +LH I P + HRD+KS NIL+
Sbjct: 124 DYLK-----STTLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKN 178
Query: 326 FNAKVSDFGLAKLLDSGESHI---TTRVMGTFGYVAPE------YANTGMLNEKSDIYSF 376
++D GLA S + + +GT Y+ PE N +D+YSF
Sbjct: 179 GTCCIADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSF 238
Query: 377 GVLLLEAVTGRDPV----DYGRPANEVN----LVEWLKMMVGTRRAEEVVDPNLEVKPAT 428
G++L E +Y P +++ E ++ +V ++
Sbjct: 239 GLILWEVARRCVSGGIVEEYQLPYHDLVPSDPSYEDMREIVCIKKLRPSFPNRWSSDECL 298
Query: 429 RALKRSLLVALRCVDPDSEKRPKMSQVVRMLE 460
R + + + C + R +V + L
Sbjct: 299 RQMGK---LMTECWAHNPASRLTALRVKKTLA 327
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 191 bits (488), Expect = 5e-57
Identities = 62/301 (20%), Positives = 117/301 (38%), Gaps = 41/301 (13%)
Query: 177 TLRDLEIATNRFSAENVLGEGGYGVVYKGRLINGSEVAVKKLL--NNLGQAEKEFRVEVE 234
L++ +I + ++G+G +G VY GR +G EVA++ + + K F+ EV
Sbjct: 24 FLQEWDIPFEQLEIGELIGKGRFGQVYHGRW-HG-EVAIRLIDIERDNEDQLKAFKREVM 81
Query: 235 AIGHVRHKNLVRLLGYCIEGVHRMLVYEYVNNGNLEQWLHGAMRNQGNLTWEARMKVIIG 294
A RH+N+V +G C+ H ++ L + + L ++
Sbjct: 82 AYRQTRHENVVLFMGACMSPPHLAIITSLCKGRTLYSVVR---DAKIVLDVNKTRQIAQE 138
Query: 295 TAKALAYLHEAIEPKVVHRDIKSSNILIDDEFNAKVSDFGLAKLLD----SGESHITTRV 350
K + YLH ++H+D+KS N+ D+ ++DFGL +
Sbjct: 139 IVKGMGYLH---AKGILHKDLKSKNVFYDN-GKVVITDFGLFSISGVLQAGRREDKLRIQ 194
Query: 351 MGTFGYVAPEYANTGML---------NEKSDIYSFGVLLLEAVTGRDPVDY-GRPANEVN 400
G ++APE ++ SD+++ G + E P + +PA +
Sbjct: 195 NGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWP--FKTQPAEAII 252
Query: 401 LVEWLKMMVGTRRAEEVVDPNLEVKPATRALKRSLLVALRCVDPDSEKRPKMSQVVRMLE 460
M G + + + + L C + E+RP ++++ MLE
Sbjct: 253 WQ----MGTGMKP----NLSQIGMGKEISDI------LLFCWAFEQEERPTFTKLMDMLE 298
Query: 461 A 461
Sbjct: 299 K 299
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342 | Back alignment and structure |
|---|
Score = 188 bits (480), Expect = 1e-55
Identities = 75/326 (23%), Positives = 135/326 (41%), Gaps = 52/326 (15%)
Query: 163 GLPEISHLGWGHWFTLRDLEIATNRFSAENVLGEGGYGVVYKGRLINGSEVAVKKLLNNL 222
GLP + R + + + +G+G +G V++G+ G EVAVK +
Sbjct: 31 GLPLLVQ-----RTIARTIVL-------QESIGKGRFGEVWRGKW-RGEEVAVKIFSS-- 75
Query: 223 GQAEKEFRVEVE--AIGHVRHKNLVRLLGYCI----EGVHRMLVYEYVNNGNLEQWLHGA 276
+ E+ + E E +RH+N++ + LV +Y +G+L +L+
Sbjct: 76 -REERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLN-- 132
Query: 277 MRNQGNLTWEARMKVIIGTAKALAYLHEAIE-----PKVVHRDIKSSNILIDDEFNAKVS 331
+ +T E +K+ + TA LA+LH I P + HRD+KS NIL+ ++
Sbjct: 133 ---RYTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIA 189
Query: 332 DFGLAKLLDSGESHIT---TRVMGTFGYVAPE------YANTGMLNEKSDIYSFGVLLLE 382
D GLA DS I +GT Y+APE +++DIY+ G++ E
Sbjct: 190 DLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWE 249
Query: 383 AVTGRDPV----DYGRPANEVN----LVEWLKMMVGTRRAEEVVDPNLEVKPATRALKRS 434
DY P ++ VE ++ +V ++ + + A R + +
Sbjct: 250 IARRCSIGGIHEDYQLPYYDLVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAK- 308
Query: 435 LLVALRCVDPDSEKRPKMSQVVRMLE 460
++ C + R ++ + L
Sbjct: 309 IMR--ECWYANGAARLTALRIKKTLS 332
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294 | Back alignment and structure |
|---|
Score = 156 bits (397), Expect = 4e-44
Identities = 64/208 (30%), Positives = 97/208 (46%), Gaps = 11/208 (5%)
Query: 186 NRFSAENVLGEGGYGVVYKGR-LINGSEVAVKKLLNNLGQAE---KEFRVEVEAIGHVRH 241
R+ + LG GG VY I +VA+K + + E K F EV + H
Sbjct: 11 ERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSH 70
Query: 242 KNLVRLLGYCIEGVHRMLVYEYVNNGNLEQWLHGAMRNQGNLTWEARMKVIIGTAKALAY 301
+N+V ++ E LV EY+ L +++ + G L+ + + + +
Sbjct: 71 QNIVSMIDVDEEDDCYYLVMEYIEGPTLSEYI----ESHGPLSVDTAINFTNQILDGIKH 126
Query: 302 LHEAIEPKVVHRDIKSSNILIDDEFNAKVSDFGLAKLLDSGESHITTRVMGTFGYVAPEY 361
H+ ++VHRDIK NILID K+ DFG+AK L T V+GT Y +PE
Sbjct: 127 AHDM---RIVHRDIKPQNILIDSNKTLKIFDFGIAKALSETSLTQTNHVLGTVQYFSPEQ 183
Query: 362 ANTGMLNEKSDIYSFGVLLLEAVTGRDP 389
A +E +DIYS G++L E + G P
Sbjct: 184 AKGEATDECTDIYSIGIVLYEMLVGEPP 211
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377 | Back alignment and structure |
|---|
Score = 155 bits (393), Expect = 1e-42
Identities = 70/330 (21%), Positives = 120/330 (36%), Gaps = 56/330 (16%)
Query: 145 HKHSSLSYGGLVTASPLIGLPEISHLGWGHWFTLRDLEIATNRFSAENVLGEGGYGVVYK 204
+ L S ++ + W + +G G +G V+
Sbjct: 85 LLSTQ---QPLTKKSGVVLHRAVPKDKW---------VLNHEDLVLGEQIGRGNFGEVFS 132
Query: 205 GRLINGS-EVAVKKL-LNNLGQAEKEFRVEVEAIGHVRHKNLVRLLGYCIEGVHRMLVYE 262
GRL + VAVK + +F E + H N+VRL+G C + +V E
Sbjct: 133 GRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVME 192
Query: 263 YVNNGNLEQWLHGAMRNQGNLTWEARMKVIIGTAKALAYLHEAIEPKVVHRDIKSSNILI 322
V G+ +L L + ++++ A + YL +HRD+ + N L+
Sbjct: 193 LVQGGDFLTFLR---TEGARLRVKTLLQMVGDAAAGMEYLESK---CCIHRDLAARNCLV 246
Query: 323 DDEFNAKVSDFGLAKLLDSGESHITTRVMGTFGYV-----APEYANTGMLNEKSDIYSFG 377
++ K+SDFG+++ G G V APE N G + +SD++SFG
Sbjct: 247 TEKNVLKISDFGMSREEADGVYA----ASGGLRQVPVKWTAPEALNYGRYSSESDVWSFG 302
Query: 378 VLLLEAVT-GRDPVDY-GRPANEV-NLVE---WLKMMVGTRRAEEVVDPNLEVKPATRAL 431
+LL E + G P Y + VE L + V
Sbjct: 303 ILLWETFSLGASP--YPNLSNQQTREFVEKGGRLPCPELC--PDAVFR------------ 346
Query: 432 KRSLLVALRCVDPDSEKRPKMSQVVRMLEA 461
+ +C + +RP S + + L++
Sbjct: 347 -----LMEQCWAYEPGQRPSFSTIYQELQS 371
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311 | Back alignment and structure |
|---|
Score = 152 bits (386), Expect = 2e-42
Identities = 63/214 (29%), Positives = 105/214 (49%), Gaps = 17/214 (7%)
Query: 186 NRFSAENVLGEGGYGVVYKGR-LINGSEVAVKKLLNNLGQAE---KEFRVEVEAIGHVRH 241
+R+ +LG GG V+ R L + +VAVK L +L + FR E + + H
Sbjct: 12 DRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNH 71
Query: 242 KNLVRLLGYCIE----GVHRMLVYEYVNNGNLEQWLHGAMRNQGNLTWEARMKVIIGTAK 297
+V + G +V EYV+ L + +G +T + ++VI +
Sbjct: 72 PAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIV----HTEGPMTPKRAIEVIADACQ 127
Query: 298 ALAYLHEAIEPKVVHRDIKSSNILIDDEFNAKVSDFGLAKLLDSGESHITT--RVMGTFG 355
AL + H+ ++HRD+K +NI+I KV DFG+A+ + + +T V+GT
Sbjct: 128 ALNFSHQN---GIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQ 184
Query: 356 YVAPEYANTGMLNEKSDIYSFGVLLLEAVTGRDP 389
Y++PE A ++ +SD+YS G +L E +TG P
Sbjct: 185 YLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPP 218
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327 | Back alignment and structure |
|---|
Score = 150 bits (380), Expect = 2e-41
Identities = 70/294 (23%), Positives = 126/294 (42%), Gaps = 26/294 (8%)
Query: 182 EIATNRFSAENVLGEGGYGVVYKGRLI-----NGSEVAVKKLLNNLGQAEKEFRVEVEAI 236
+ LG+G +G V R G+ VAVK+L ++ +++F+ E++ +
Sbjct: 19 IFEERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQIL 78
Query: 237 GHVRHKNLVRLLGYCIEGVHR--MLVYEYVNNGNLEQWLHGAMRNQGNLTWEARMKVIIG 294
+ +V+ G + LV EY+ +G L +L R++ L +
Sbjct: 79 KALHSDFIVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQ---RHRARLDASRLLLYSSQ 135
Query: 295 TAKALAYLHEAIEPKVVHRDIKSSNILIDDEFNAKVSDFGLAKLLDSGESHITTRVMGTF 354
K + YL + VHRD+ + NIL++ E + K++DFGLAKLL + + R G
Sbjct: 136 ICKGMEYLGSR---RCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQS 192
Query: 355 --GYVAPEYANTGMLNEKSDIYSFGVLLLEAVT-GRDPVDYGRPANEVNLVEWLKMMVGT 411
+ APE + + + +SD++SFGV+L E T A + ++ + +
Sbjct: 193 PIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKS--CSPSAEFLRMMGCERDVPAL 250
Query: 412 RRAEEVVDPN--LEVKPA--TRALKRSLLVALRCVDPDSEKRPKMSQVVRMLEA 461
R E+++ L P + + C P + RP S + L+
Sbjct: 251 SRLLELLEEGQRLP-APPACPAEVHE---LMKLCWAPSPQDRPSFSALGPQLDM 300
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327 | Back alignment and structure |
|---|
Score = 150 bits (380), Expect = 2e-41
Identities = 77/288 (26%), Positives = 130/288 (45%), Gaps = 51/288 (17%)
Query: 191 ENVLGEGGYGVVYKGRLINGSE-----VAVKKLLNNLG-QAEKEFRVEVEAIGHVRHKNL 244
VLG G +G VYKG I E VA+K+L +A KE E + V + ++
Sbjct: 20 IKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHV 79
Query: 245 VRLLGYCIEGVHRMLVYEYVNNGNLEQWLHGAMRNQGNLTWEARMKVIIGTAKALAYLHE 304
RLLG C+ L+ + + G L ++ ++ N+ + + + AK + YL +
Sbjct: 80 CRLLGICLTS-TVQLITQLMPFGCLLDYVR---EHKDNIGSQYLLNWCVQIAKGMNYLED 135
Query: 305 AIEPKVVHRDIKSSNILIDDEFNAKVSDFGLAKLLDSGESHITTRV-------MGTFGYV 357
++VHRD+ + N+L+ + K++DFGLAKLL + E M
Sbjct: 136 R---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWM------ 186
Query: 358 APEYANTGMLNEKSDIYSFGVLLLEAVT-GRDPVDY-GRPANEV-NLVEWLKMMVGTRRA 414
A E + +SD++S+GV + E +T G P Y G PA+E+ +++E G R
Sbjct: 187 ALESILHRIYTHQSDVWSYGVTVWELMTFGSKP--YDGIPASEISSILE-----KGER-- 237
Query: 415 EEVVDPNLEVKPA--TRALKRSLLVALRCVDPDSEKRPKMSQVVRMLE 460
L +P T + + +C D++ RPK +++
Sbjct: 238 -------LP-QPPICTIDVYM---IMRKCWMIDADSRPKFRELIIEFS 274
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317 | Back alignment and structure |
|---|
Score = 149 bits (377), Expect = 4e-41
Identities = 66/301 (21%), Positives = 117/301 (38%), Gaps = 37/301 (12%)
Query: 179 RDLEIATNRFSAENVLGEGGYGVVYKGR-LINGSEVAVKKLLNNLGQAEKEFRVEVEAIG 237
+ I + LGEGG+ V L +G A+K++L + Q +E + E +
Sbjct: 22 HMVIIDNKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHR 81
Query: 238 HVRHKNLVRLLGYCIEGVHRM----LVYEYVNNGNLEQWLHGAMRNQGNLTWEAR-MKVI 292
H N++RL+ YC+ L+ + G L + LT E + + ++
Sbjct: 82 LFNHPNILRLVAYCLRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLT-EDQILWLL 140
Query: 293 IGTAKALAYLHEAIEPKVVHRDIKSSNILIDDEFNAKVSDFGLAKLLDSGESHITTRVM- 351
+G + L +H HRD+K +NIL+ DE + D G +
Sbjct: 141 LGICRGLEAIHA---KGYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQALTL 197
Query: 352 -------GTFGYVAPE----YANTGMLNEKSDIYSFGVLLLEAVTGRDPVDYGRPANEVN 400
T Y APE ++ +++E++D++S G +L + G P D +
Sbjct: 198 QDWAAQRCTISYRAPELFSVQSHC-VIDERTDVWSLGCVLYAMMFGEGPYDM---VFQKG 253
Query: 401 LVEWLKMMVGTRRAEEVVDPNLEVKPATRALKRSLLVALRCVDPDSEKRPKMSQVVRMLE 460
L + + + A L S++ VDP +RP + ++ LE
Sbjct: 254 DSVALAVQNQLS-----IPQSPRHSSALWQLLNSMMT----VDP--HQRPHIPLLLSQLE 302
Query: 461 A 461
A
Sbjct: 303 A 303
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295 | Back alignment and structure |
|---|
Score = 146 bits (371), Expect = 2e-40
Identities = 67/304 (22%), Positives = 123/304 (40%), Gaps = 45/304 (14%)
Query: 182 EIATNRFSAENVLGEGGYGVVYKGRLI-----NGSEVAVKKLLNNLGQAEKEFRVEVEAI 236
+ LG+G +G V R G VAVKKL ++ + ++F E+E +
Sbjct: 6 QFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEIL 65
Query: 237 GHVRHKNLVRLLGYCIEGVHR--MLVYEYVNNGNLEQWLHGAMRNQGNLTWEARMKVIIG 294
++H N+V+ G C R L+ EY+ G+L +L +++ + ++
Sbjct: 66 KSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQ---KHKERIDHIKLLQYTSQ 122
Query: 295 TAKALAYLHEAIEPKVVHRDIKSSNILIDDEFNAKVSDFGLAKLLDSGESHITTRVMGTF 354
K + YL + +HRD+ + NIL+++E K+ DFGL K+L + + G
Sbjct: 123 ICKGMEYLGTK---RYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEFFKVKEPGES 179
Query: 355 --GYVAPEYANTGMLNEKSDIYSFGVLLLEAVTGRDPVDYGRPANEVNLVEWLKMMVGTR 412
+ APE + SD++SFGV+L E T Y + E+++M+ +
Sbjct: 180 PIFWYAPESLTESKFSVASDVWSFGVVLYELFT------YIEKSKS-PPAEFMRMIGNDK 232
Query: 413 RAEEVVDPNLEVKPATRALKR---------------SLLVALRCVDPDSEKRPKMSQVVR 457
+ V LK ++ C + + +RP +
Sbjct: 233 ------QGQMIVFHLIELLKNNGRLPRPDGCPDEIYMIM--TECWNNNVNQRPSFRDLAL 284
Query: 458 MLEA 461
++
Sbjct: 285 RVDQ 288
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267 | Back alignment and structure |
|---|
Score = 145 bits (369), Expect = 2e-40
Identities = 65/222 (29%), Positives = 111/222 (50%), Gaps = 15/222 (6%)
Query: 182 EIATNRFSAENVLGEGGYGVVYKGRLINGSEVAVKKLLNNLGQAEKEFRVEVEAIGHVRH 241
I + + +G G +G+V+ G +N +VA+K + +E++F E E + + H
Sbjct: 4 VIDPSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGA-MSEEDFIEEAEVMMKLSH 62
Query: 242 KNLVRLLGYCIEGVHRMLVYEYVNNGNLEQWLHGAMRNQGNLTWEARMKVIIGTAKALAY 301
LV+L G C+E LV E++ +G L +L +G E + + + + +AY
Sbjct: 63 PKLVQLYGVCLEQAPICLVTEFMEHGCLSDYLR---TQRGLFAAETLLGMCLDVCEGMAY 119
Query: 302 LHEAIEPKVVHRDIKSSNILIDDEFNAKVSDFGLAKLLDSGESHITTRVMGTFGY--VAP 359
L EA V+HRD+ + N L+ + KVSDFG+ + + + T+ F +P
Sbjct: 120 LEEA---CVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQY--TSSTGTKFPVKWASP 174
Query: 360 EYANTGMLNEKSDIYSFGVLLLEAVT-GRDPVDY-GRPANEV 399
E + + KSD++SFGVL+ E + G+ P Y R +EV
Sbjct: 175 EVFSFSRYSSKSDVWSFGVLMWEVFSEGKIP--YENRSNSEV 214
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283 | Back alignment and structure |
|---|
Score = 145 bits (369), Expect = 3e-40
Identities = 68/239 (28%), Positives = 113/239 (47%), Gaps = 21/239 (8%)
Query: 165 PEISHLGWGHWFTLRDLEIATNRFSAENVLGEGGYGVVYKGRLINGSEVAVKKLLNNLGQ 224
P + LG+G W EI + LG G +GVV G+ +VA+K +
Sbjct: 9 PSTAGLGYGSW------EIDPKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMI-KEGSM 61
Query: 225 AEKEFRVEVEAIGHVRHKNLVRLLGYCIEGVHRMLVYEYVNNGNLEQWLHGAMRNQGNLT 284
+E EF E + + ++ H+ LV+L G C + ++ EY+ NG L +L +
Sbjct: 62 SEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLR---EMRHRFQ 118
Query: 285 WEARMKVIIGTAKALAYLHEAIEPKVVHRDIKSSNILIDDEFNAKVSDFGLAKLLDSGES 344
+ +++ +A+ YL + +HRD+ + N L++D+ KVSDFGL++ + E
Sbjct: 119 TQQLLEMCKDVCEAMEYLESK---QFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEY 175
Query: 345 HITTRVMGTFGY--VAPEYANTGMLNEKSDIYSFGVLLLEAVT-GRDPVDY-GRPANEV 399
T+ V F PE + KSDI++FGVL+ E + G+ P Y +E
Sbjct: 176 --TSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMP--YERFTNSET 230
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 147 bits (372), Expect = 3e-40
Identities = 72/342 (21%), Positives = 131/342 (38%), Gaps = 52/342 (15%)
Query: 145 HKHSSLSYGGLVTASPLI-GLPEISHLGWGHWFTLRDLEIATNRFSAENVLGEGGYGVVY 203
H H Y T + G + + LG+G +G V
Sbjct: 5 HHHHHHDYDIPTTENLYFQGAMGSAFEDRDPT------QFEERHLKFLQQLGKGNFGSVE 58
Query: 204 KGRLI-----NGSEVAVKKLLNNLGQAEKEFRVEVEAIGHVRHKNLVRLLGYCIEGVHR- 257
R G VAVKKL ++ + ++F E+E + ++H N+V+ G C R
Sbjct: 59 MCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRN 118
Query: 258 -MLVYEYVNNGNLEQWLHGAMRNQGNLTWEARMKVIIGTAKALAYLHEAIEPKVVHRDIK 316
L+ EY+ G+L +L +++ + ++ K + YL + +HRD+
Sbjct: 119 LKLIMEYLPYGSLRDYLQ---KHKERIDHIKLLQYTSQICKGMEYLGTK---RYIHRDLA 172
Query: 317 SSNILIDDEFNAKVSDFGLAKLLDSGESHITTRVMGTF--GYVAPEYANTGMLNEKSDIY 374
+ NIL+++E K+ DFGL K+L + + + G + APE + SD++
Sbjct: 173 TRNILVENENRVKIGDFGLTKVLPQDKEYYKVKEPGESPIFWYAPESLTESKFSVASDVW 232
Query: 375 SFGVLLLEAVTGRDPVDYGRPANEVNLVEWLKMMVGTRRAEEVVDPNLEVKPATRALKR- 433
SFGV+L E T Y + E+++M+ + + V LK
Sbjct: 233 SFGVVLYELFT------YIEKSKS-PPAEFMRMIGNDK------QGQMIVFHLIELLKNN 279
Query: 434 --------------SLLVALRCVDPDSEKRPKMSQVVRMLEA 461
++ C + + +RP + ++
Sbjct: 280 GRLPRPDGCPDEIYMIM--TECWNNNVNQRPSFRDLALRVDQ 319
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302 | Back alignment and structure |
|---|
Score = 145 bits (369), Expect = 4e-40
Identities = 67/299 (22%), Positives = 124/299 (41%), Gaps = 35/299 (11%)
Query: 182 EIATNRFSAENVLGEGGYGVVYKGRLI-----NGSEVAVKKLLNNLGQAE-KEFRVEVEA 235
LGEG +G V R G +VAVK L G + + E+E
Sbjct: 17 HFEKRFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEI 76
Query: 236 IGHVRHKNLVRLLGYCIEGVHR--MLVYEYVNNGNLEQWLHGAMRNQGNLTWEARMKVII 293
+ ++ H+N+V+ G C E L+ E++ +G+L+++L +N+ + + ++K +
Sbjct: 77 LRNLYHENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLP---KNKNKINLKQQLKYAV 133
Query: 294 GTAKALAYLHEAIEPKVVHRDIKSSNILIDDEFNAKVSDFGLAKLLDSGESHITTRVMGT 353
K + YL + VHRD+ + N+L++ E K+ DFGL K +++ + + T +
Sbjct: 134 QICKGMDYLGSR---QYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDRD 190
Query: 354 F--GYVAPEYANTGMLNEKSDIYSFGVLLLEAVTGRDPVDYGRPANEVNLVEWLKMMV-- 409
+ APE SD++SFGV L E +T Y + + +
Sbjct: 191 SPVFWYAPECLMQSKFYIASDVWSFGVTLHELLT------YCDSDSSPMALFLKMIGPTH 244
Query: 410 GTRRAEEVVDPNLEV-----KPA--TRALKRSLLVALRCVDPDSEKRPKMSQVVRMLEA 461
G +V+ L+ P + + + +C + R ++ EA
Sbjct: 245 GQMTVTRLVN-TLKEGKRLPCPPNCPDEVYQ---LMRKCWEFQPSNRTSFQNLIEGFEA 299
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309 | Back alignment and structure |
|---|
Score = 145 bits (369), Expect = 5e-40
Identities = 50/207 (24%), Positives = 84/207 (40%), Gaps = 11/207 (5%)
Query: 187 RFSAENVLGEGGYGVVYKGR-LINGSEVAVKKLLNNLG---QAEKEFRVEVEAIGHVRHK 242
+ ++G GG G VY+ + VA+K + L + E G ++
Sbjct: 35 PYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEP 94
Query: 243 NLVRLLGYCIEGVHRMLVYEYVNNGNLEQWLHGAMRNQGNLTWEARMKVIIGTAKALAYL 302
++V + + + +N +L L R QG L + ++ AL
Sbjct: 95 HVVPIHDFGEIDGQLYVDMRLINGVDLAAML----RRQGPLAPPRAVAIVRQIGSALDAA 150
Query: 303 HEAIEPKVVHRDIKSSNILIDDEFNAKVSDFGLAKLLDSGESHITTRVMGTFGYVAPEYA 362
H A HRD+K NIL+ + A + DFG+A + +GT Y+APE
Sbjct: 151 HAA---GATHRDVKPENILVSADDFAYLVDFGIASATTDEKLTQLGNTVGTLYYMAPERF 207
Query: 363 NTGMLNEKSDIYSFGVLLLEAVTGRDP 389
+ ++DIY+ +L E +TG P
Sbjct: 208 SESHATYRADIYALTCVLYECLTGSPP 234
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287 | Back alignment and structure |
|---|
Score = 143 bits (363), Expect = 2e-39
Identities = 77/293 (26%), Positives = 128/293 (43%), Gaps = 35/293 (11%)
Query: 179 RDLEIATNRFS-AENVLGEGGYGVVYKGRLINGSE---VAVKKL-LNNLGQAEKEFRVEV 233
+ L + + A+ LG G +G V +G + VA+K L +E E
Sbjct: 2 KKLFLKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREA 61
Query: 234 EAIGHVRHKNLVRLLGYCIEGVHRMLVYEYVNNGNLEQWLHGAMRNQGNLTWEARMKVII 293
+ + + + +VRL+G C MLV E G L ++L G + + +++
Sbjct: 62 QIMHQLDNPYIVRLIGVCQAEAL-MLVMEMAGGGPLHKFLVG---KREEIPVSNVAELLH 117
Query: 294 GTAKALAYLHEAIEPKVVHRDIKSSNILIDDEFNAKVSDFGLAKLLDSGESHITTRVMGT 353
+ + YL E VHRD+ + N+L+ + AK+SDFGL+K L + +S+ T R G
Sbjct: 118 QVSMGMKYLEEK---NFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGK 174
Query: 354 F--GYVAPEYANTGMLNEKSDIYSFGVLLLEAVT-GRDPVDY-GRPANEV-NLVEWLKMM 408
+ + APE N + +SD++S+GV + EA++ G+ P Y EV +E
Sbjct: 175 WPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKP--YKKMKGPEVMAFIE----- 227
Query: 409 VGTRRAEEVVDPNLEVKPATRALKRSLLVALRCVDPDSEKRPKMSQVVRMLEA 461
G R +E P +L+ C E RP V + + A
Sbjct: 228 QGKR---------MECPPECPPELYALM--SDCWIYKWEDRPDFLTVEQRMRA 269
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327 | Back alignment and structure |
|---|
Score = 144 bits (366), Expect = 2e-39
Identities = 86/335 (25%), Positives = 151/335 (45%), Gaps = 50/335 (14%)
Query: 186 NRFSAENVLGEGGYGVVYKGRLINGSE-----VAVKKLLNNLG-QAEKEFRVEVEAIGHV 239
F VLG G +G VYKG I E VA+K+L +A KE E + V
Sbjct: 15 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 74
Query: 240 RHKNLVRLLGYCIEGVHRMLVYEYVNNGNLEQWLHGAMRNQGNLTWEARMKVIIGTAKAL 299
+ ++ RLLG C+ L+ + + G L ++ ++ N+ + + + AK +
Sbjct: 75 DNPHVCRLLGICLTS-TVQLITQLMPFGCLLDYVR---EHKDNIGSQYLLNWCVQIAKGM 130
Query: 300 AYLHEAIEPKVVHRDIKSSNILIDDEFNAKVSDFGLAKLLDSGESHITTRVMGT---FGY 356
YL + ++VHRD+ + N+L+ + K++DFGLAKLL + E G +
Sbjct: 131 NYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAE--GGKVPIKW 185
Query: 357 VAPEYANTGMLNEKSDIYSFGVLLLEAVT-GRDPVDY-GRPANEV-NLVEWLKMMVGTRR 413
+A E + +SD++S+GV + E +T G P Y G PA+E+ +++E G R
Sbjct: 186 MALESILHRIYTHQSDVWSYGVTVWELMTFGSKP--YDGIPASEISSILE-----KGER- 237
Query: 414 AEEVVDPNLEVKPA--TRALKRSLLVALRCVDPDSEKRPKMSQVVRMLEA-----DDY-- 464
L +P T + + ++C D++ RPK +++ Y
Sbjct: 238 --------LP-QPPICTIDVYM---IMVKCWMIDADSRPKFRELIIEFSKMARDPQRYLV 285
Query: 465 PFREDRRNRKSRTTSMEIESLKESTEIESKVEDSE 499
++R + S T S +L + +++ V+ E
Sbjct: 286 IQGDERMHLPSPTDSNFYRALMDEEDMDDVVDADE 320
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279 | Back alignment and structure |
|---|
Score = 143 bits (362), Expect = 3e-39
Identities = 67/211 (31%), Positives = 102/211 (48%), Gaps = 8/211 (3%)
Query: 186 NRFSAENVLGEGGYGVVYKGR-LINGSEVAVKKL-LNNLGQAEKEF-RVEVEAIGHVRHK 242
+ +G G YG K R +G + K+L ++ +AEK+ EV + ++H
Sbjct: 6 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHP 65
Query: 243 NLVRLLGYCIEGVHRML--VYEYVNNGNLEQWLHGAMRNQGNLTWEARMKVIIGTAKALA 300
N+VR I+ + L V EY G+L + + + L E ++V+ AL
Sbjct: 66 NIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALK 125
Query: 301 YLHE--AIEPKVVHRDIKSSNILIDDEFNAKVSDFGLAKLLDSGESHITTRVMGTFGYVA 358
H V+HRD+K +N+ +D + N K+ DFGLA++L+ S T V GT Y++
Sbjct: 126 ECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKTFV-GTPYYMS 184
Query: 359 PEYANTGMLNEKSDIYSFGVLLLEAVTGRDP 389
PE N NEKSDI+S G LL E P
Sbjct: 185 PEQMNRMSYNEKSDIWSLGCLLYELCALMPP 215
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495 | Back alignment and structure |
|---|
Score = 147 bits (373), Expect = 4e-39
Identities = 76/323 (23%), Positives = 128/323 (39%), Gaps = 41/323 (12%)
Query: 165 PEISHLGWGHWFTLRDLEIATNRFSAENVLGEGGYGVVYKGRLINGS-EVAVKKLLNNLG 223
+ W E+ + ++ LG G YG VY+G S VAVK L +
Sbjct: 205 IYGVSPNYDKW------EMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM 258
Query: 224 QAEKEFRVEVEAIGHVRHKNLVRLLGYCIEGVHRMLVYEYVNNGNLEQWLHGAMRNQGNL 283
+ E EF E + ++H NLV+LLG C ++ E++ GNL +L N+ +
Sbjct: 259 EVE-EFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRE--CNRQEV 315
Query: 284 TWEARMKVIIGTAKALAYLHEAIEPKVVHRDIKSSNILIDDEFNAKVSDFGLAKLLDSGE 343
+ + + + A+ YL + +HR++ + N L+ + KV+DFGL++L+
Sbjct: 316 SAVVLLYMATQISSAMEYLEKK---NFIHRNLAARNCLVGENHLVKVADFGLSRLMTGDT 372
Query: 344 SHITTRVMGTFGYVAPEYANTGMLNEKSDIYSFGVLLLEAVT-GRDPVDYGRPANE--VN 400
+ APE + KSD+++FGVLL E T G P Y
Sbjct: 373 YTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSP--YPGIDLSQVYE 430
Query: 401 LVEWLKMMVGTRRAEEVVDPNLEVKP--ATRALKRSLLVALRCVDPDSEKRPKMSQVVRM 458
L+E R +E +P + + C + RP +++ +
Sbjct: 431 LLE-----KDYR---------ME-RPEGCPEKVYE---LMRACWQWNPSDRPSFAEIHQA 472
Query: 459 LEA---DDYPFREDRRNRKSRTT 478
E + E + R T
Sbjct: 473 FETMFQESSISDEVEKELGKRGT 495
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325 | Back alignment and structure |
|---|
Score = 143 bits (363), Expect = 4e-39
Identities = 76/293 (25%), Positives = 127/293 (43%), Gaps = 43/293 (14%)
Query: 182 EIATNRFSAENVLGEGGYGVVYKGRLINGSE-----VAVKKLLNNLG-QAEKEFRVEVEA 235
VLG G +G V+KG I E V +K + + G Q+ + + A
Sbjct: 9 IFKETELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLA 68
Query: 236 IGHVRHKNLVRLLGYCIEGVHRMLVYEYVNNGNLEQWLHGAMRNQGNLTWEARMKVIIGT 295
IG + H ++VRLLG C LV +Y+ G+L + +++G L + + +
Sbjct: 69 IGSLDHAHIVRLLGLCPGS-SLQLVTQYLPLGSLLDHVR---QHRGALGPQLLLNWGVQI 124
Query: 296 AKALAYLHEAIEPKVVHRDIKSSNILIDDEFNAKVSDFGLAKLLDSGESHITTRVMGT-- 353
AK + YL E +VHR++ + N+L+ +V+DFG+A LL + +
Sbjct: 125 AKGMYYLEEH---GMVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYS--EAKT 179
Query: 354 -FGYVAPEYANTGMLNEKSDIYSFGVLLLEAVT-GRDPVDY-GRPANEV-NLVEWLKMMV 409
++A E + G +SD++S+GV + E +T G +P Y G EV +L+E
Sbjct: 180 PIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEP--YAGLRLAEVPDLLE-----K 232
Query: 410 GTRRAEEVVDPNLEVKPA--TRALKRSLLVALRCVDPDSEKRPKMSQVVRMLE 460
G R L +P T + V ++C D RP ++
Sbjct: 233 GER---------LA-QPQICTIDVYM---VMVKCWMIDENIRPTFKELANEFT 272
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452 | Back alignment and structure |
|---|
Score = 146 bits (370), Expect = 6e-39
Identities = 86/321 (26%), Positives = 133/321 (41%), Gaps = 38/321 (11%)
Query: 145 HKHSSLSYGGLVTASPLIGLPEISHLGWGHWFTLRDLEIATNRFSAENVLGEGGYGVVYK 204
+ + +T P+ L W EI E LG+G +G V+
Sbjct: 149 YSKHADGLCHRLTTVCPTSKPQTQGLAKDAW------EIPRESLRLEVKLGQGCFGEVWM 202
Query: 205 GRLINGSEVAVKKLLNNLGQAEKEFRVEVEAIGHVRHKNLVRLLGYCIEGVHRMLVYEYV 264
G + VA+K L + + F E + + +RH+ LV+L E +V EY+
Sbjct: 203 GTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSEE-PIYIVTEYM 260
Query: 265 NNGNLEQWLHGAMRNQGNLTWEARMKVIIGTAKALAYLHEAIEPKVVHRDIKSSNILIDD 324
+ G+L +L G L + + A +AY+ VHRD++++NIL+ +
Sbjct: 261 SKGSLLDFLKG--ETGKYLRLPQLVDMAAQIASGMAYVERM---NYVHRDLRAANILVGE 315
Query: 325 EFNAKVSDFGLAKLLDSGESHITTRVMGTFGYVAPEYANTGMLNEKSDIYSFGVLLLEAV 384
KV+DFGLA+L++ E + APE A G KSD++SFG+LL E
Sbjct: 316 NLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELT 375
Query: 385 T-GRDPVDY-GRPANEV-NLVEWLKMMVGTRRAEEVVDPNLEVKPAT--RALKRSLLVAL 439
T GR P Y G EV + VE G R + P +L +
Sbjct: 376 TKGRVP--YPGMVNREVLDQVER-----GYR---------MP-CPPECPESLHD---LMC 415
Query: 440 RCVDPDSEKRPKMSQVVRMLE 460
+C + E+RP + LE
Sbjct: 416 QCWRKEPEERPTFEYLQAFLE 436
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373 | Back alignment and structure |
|---|
Score = 143 bits (363), Expect = 1e-38
Identities = 81/291 (27%), Positives = 130/291 (44%), Gaps = 36/291 (12%)
Query: 182 EIATNRFSAENVLGEGGYGVVYKGRLINGSE----VAVKKLLNNLGQAEK-EFRVEVEAI 236
E+ S + V+G G +G V GRL S+ VA+K L + ++ +F E +
Sbjct: 41 ELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIM 100
Query: 237 GHVRHKNLVRLLGYCIEGVHRMLVYEYVNNGNLEQWLHGAMRNQGNLTWEARMKVIIGTA 296
G H N++RL G + M+V EY+ NG+L+ +L ++ T + ++ G A
Sbjct: 101 GQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLR---KHDAQFTVIQLVGMLRGIA 157
Query: 297 KALAYLHEAIEPKVVHRDIKSSNILIDDEFNAKVSDFGLAKLLDSGESHITTRVMGTFGY 356
+ YL + VHRD+ + NILI+ KVSDFGL ++L+ T G
Sbjct: 158 SGMKYLSDM---GYVHRDLAARNILINSNLVCKVSDFGLGRVLEDDPEAAYTTRGGKIPI 214
Query: 357 --VAPEYANTGMLNEKSDIYSFGVLLLEAVT-GRDPVDYGRPANE--VNLVEWLKMMVGT 411
+PE SD++S+G++L E ++ G P Y +N+ + V+ G
Sbjct: 215 RWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERP--YWEMSNQDVIKAVD-----EGY 267
Query: 412 RRAEEVVDPNLEVKPATRALKRSL-LVALRCVDPDSEKRPKMSQVVRMLEA 461
R L P +L + L C D RPK Q+V +L+
Sbjct: 268 R---------L---PPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDK 306
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268 | Back alignment and structure |
|---|
Score = 140 bits (355), Expect = 2e-38
Identities = 59/221 (26%), Positives = 103/221 (46%), Gaps = 20/221 (9%)
Query: 173 GHWFTLRDLEIATNRFSAENVLGEGGYGVVYKGRLINGSEVAVKKLLNNLGQAEKEFRVE 232
GH E+ + LG G +GVV G+ +VAVK + +E EF E
Sbjct: 1 GHM------ELKREEITLLKELGSGQFGVVKLGKWKGQYDVAVKMI-KEGSMSEDEFFQE 53
Query: 233 VEAIGHVRHKNLVRLLGYCIEGVHRMLVYEYVNNGNLEQWLHGAMRNQGNLTWEARMKVI 292
+ + + H LV+ G C + +V EY++NG L +L + L +++
Sbjct: 54 AQTMMKLSHPKLVKFYGVCSKEYPIYIVTEYISNGCLLNYLR---SHGKGLEPSQLLEMC 110
Query: 293 IGTAKALAYLHEAIEPKVVHRDIKSSNILIDDEFNAKVSDFGLAKLLDSGESHITTRVMG 352
+ +A+L + +HRD+ + N L+D + KVSDFG+ + + + +G
Sbjct: 111 YDVCEGMAFLESH---QFIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQ---YVSSVG 164
Query: 353 T---FGYVAPEYANTGMLNEKSDIYSFGVLLLEAVT-GRDP 389
T + APE + + KSD+++FG+L+ E + G+ P
Sbjct: 165 TKFPVKWSAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKMP 205
|
| >4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350 | Back alignment and structure |
|---|
Score = 142 bits (361), Expect = 2e-38
Identities = 54/208 (25%), Positives = 103/208 (49%), Gaps = 11/208 (5%)
Query: 186 NRFSAENVLGEGGYGVVYKGR-LINGSEVAVKKL-LNNLGQAEKEF-RVEVEAIGHVRHK 242
++ +GEG +G + +G + +K++ ++ + E+E R EV + +++H
Sbjct: 24 EKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHP 83
Query: 243 NLVRLLGYCIEGVHRMLVYEYVNNGNLEQWLHGAMRNQGNLTWEAR-MKVIIGTAKALAY 301
N+V+ E +V +Y G+L + + +G L E + + + AL +
Sbjct: 84 NIVQYRESFEENGSLYIVMDYCEGGDLFKRI---NAQKGVLFQEDQILDWFVQICLALKH 140
Query: 302 LHEAIEPKVVHRDIKSSNILIDDEFNAKVSDFGLAKLLDSGESHITTRVMGTFGYVAPEY 361
+H+ K++HRDIKS NI + + ++ DFG+A++L+S + GT Y++PE
Sbjct: 141 VHD---RKILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTVELARACI-GTPYYLSPEI 196
Query: 362 ANTGMLNEKSDIYSFGVLLLEAVTGRDP 389
N KSDI++ G +L E T +
Sbjct: 197 CENKPYNNKSDIWALGCVLYELCTLKHA 224
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325 | Back alignment and structure |
|---|
Score = 142 bits (359), Expect = 2e-38
Identities = 86/291 (29%), Positives = 132/291 (45%), Gaps = 36/291 (12%)
Query: 182 EIATNRFSAENVLGEGGYGVVYKGRLINGSE----VAVKKLLNNLGQAEK-EFRVEVEAI 236
EI +R E ++G G G V GRL + VA+K L + ++ +F E +
Sbjct: 45 EIEASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIM 104
Query: 237 GHVRHKNLVRLLGYCIEGVHRMLVYEYVNNGNLEQWLHGAMRNQGNLTWEARMKVIIGTA 296
G H N++RL G G M+V EY+ NG+L+ +L + G T + ++ G
Sbjct: 105 GQFDHPNIIRLEGVVTRGRLAMIVTEYMENGSLDTFLR---THDGQFTIMQLVGMLRGVG 161
Query: 297 KALAYLHEAIEPKVVHRDIKSSNILIDDEFNAKVSDFGLAKLLDSGESHITTRVMGTFGY 356
+ YL + VHRD+ + N+L+D KVSDFGL+++L+ T G
Sbjct: 162 AGMRYLSDL---GYVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAAYTTTGGKIPI 218
Query: 357 --VAPEYANTGMLNEKSDIYSFGVLLLEAVT-GRDPVDY-GRPANEV-NLVEWLKMMVGT 411
APE + SD++SFGV++ E + G P Y +V + VE G
Sbjct: 219 RWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERP--YWNMTNRDVISSVE-----EGY 271
Query: 412 RRAEEVVDPNLEVKPATRALKRSL-LVALRCVDPDSEKRPKMSQVVRMLEA 461
R L PA +L + L C D +RP+ SQ+V +L+A
Sbjct: 272 R---------L---PAPMGCPHALHQLMLDCWHKDRAQRPRFSQIVSVLDA 310
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278 | Back alignment and structure |
|---|
Score = 140 bits (355), Expect = 2e-38
Identities = 68/244 (27%), Positives = 108/244 (44%), Gaps = 31/244 (12%)
Query: 163 GLPEISHLGWGHWFTLRDLEIATNRFSAENVLGEGGYGVVYKGRLINGSEVAVKKLLNNL 222
+ W + +G+G +G V G G++VAVK +
Sbjct: 4 SVAAQDEFYRSGW------ALNMKELKLLQTIGKGEFGDVMLGDY-RGNKVAVKCI--KN 54
Query: 223 GQAEKEFRVEVEAIGHVRHKNLVRLLGYCIEGVHR-MLVYEYVNNGNLEQWLHGAMRNQG 281
+ F E + +RH NLV+LLG +E +V EY+ G+L +L R +
Sbjct: 55 DATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRS--RGRS 112
Query: 282 NLTWEARMKVIIGTAKALAYLHEAIEPKVVHRDIKSSNILIDDEFNAKVSDFGLAKLLDS 341
L + +K + +A+ YL VHRD+ + N+L+ ++ AKVSDFGL K ++
Sbjct: 113 VLGGDCLLKFSLDVCEAMEYLEGN---NFVHRDLAARNVLVSEDNVAKVSDFGLTK--EA 167
Query: 342 GESHITTRV----MGTFGYVAPEYANTGMLNEKSDIYSFGVLLLEAVT-GRDPVDY-GRP 395
+ T ++ APE + KSD++SFG+LL E + GR P Y P
Sbjct: 168 SSTQDTGKLPVKWT------APEALREKKFSTKSDVWSFGILLWEIYSFGRVP--YPRIP 219
Query: 396 ANEV 399
+V
Sbjct: 220 LKDV 223
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681 | Back alignment and structure |
|---|
Score = 147 bits (373), Expect = 3e-38
Identities = 56/273 (20%), Positives = 102/273 (37%), Gaps = 47/273 (17%)
Query: 186 NRFSAENVLGEGGYGVVYKGR--LINGSEVAVKKLLNNLGQAEKE-FRVEVEAIGHVRHK 242
++ + + GG G +Y +NG V +K L+++ + E + + V H
Sbjct: 80 GQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHP 139
Query: 243 NLVRLLGYCIEGVHRM-----LVYEYVNNGNLEQWLHGAMRNQGNLTWEARMKVIIGTAK 297
++V++ + +V EYV +L++ L + ++
Sbjct: 140 SIVQIFNFVEHTDRHGDPVGYIVMEYVGGQSLKRSKGQK------LPVAEAIAYLLEILP 193
Query: 298 ALAYLHEAIEPKVVHRDIKSSNILIDDEFNAKVSDFGLAKLLDSGESHITTRVMGTFGYV 357
AL+YLH +V+ D+K NI++ +E K+ D G ++S + GT G+
Sbjct: 194 ALSYLHSI---GLVYNDLKPENIMLTEE-QLKLIDLGAVSRINS-----FGYLYGTPGFQ 244
Query: 358 APEYANTGMLNEKSDIYSFGVLLLEAVTGRDPVDYGRPANEVNLVEWLKMMVGTRRAEEV 417
APE +DIY+ G L + GR + +
Sbjct: 245 APEIV-RTGPTVATDIYTVGRTLAALTLDLPTRN-GRYVDGLP----------------E 286
Query: 418 VDPNLEVKPATRALKRSLLVALRCVDPDSEKRP 450
DP L+ + L R +DPD +R
Sbjct: 287 DDPVLKTYDSYGRL------LRRAIDPDPRQRF 313
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333 | Back alignment and structure |
|---|
Score = 141 bits (358), Expect = 3e-38
Identities = 79/292 (27%), Positives = 132/292 (45%), Gaps = 39/292 (13%)
Query: 182 EIATNRFSAENVLGEGGYGVVYKGRLINGSE-----VAVKKLLNNLGQAEK-EFRVEVEA 235
EI + + + V+G G +G VYKG L S VA+K L + ++ +F E
Sbjct: 40 EIHPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGI 99
Query: 236 IGHVRHKNLVRLLGYCIEGVHRMLVYEYVNNGNLEQWLHGAMRNQGNLTWEARMKVIIGT 295
+G H N++RL G + M++ EY+ NG L+++L G + + ++ G
Sbjct: 100 MGQFSHHNIIRLEGVISKYKPMMIITEYMENGALDKFLR---EKDGEFSVLQLVGMLRGI 156
Query: 296 AKALAYLHEAIEPKVVHRDIKSSNILIDDEFNAKVSDFGLAKLLDSGESHITTRVMGTFG 355
A + YL VHRD+ + NIL++ KVSDFGL+++L+ T G
Sbjct: 157 AAGMKYLANM---NYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIP 213
Query: 356 Y--VAPEYANTGMLNEKSDIYSFGVLLLEAVT-GRDPVDY-GRPANEV-NLVEWLKMMVG 410
APE + SD++SFG+++ E +T G P Y +EV + G
Sbjct: 214 IRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERP--YWELSNHEVMKAIN-----DG 266
Query: 411 TRRAEEVVDPNLEVKP--ATRALKRSLLVALRCVDPDSEKRPKMSQVVRMLE 460
R L P A+ + + ++C + +RPK + +V +L+
Sbjct: 267 FR---------LP-TPMDCPSAIYQ---LMMQCWQQERARRPKFADIVSILD 305
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291 | Back alignment and structure |
|---|
Score = 140 bits (355), Expect = 3e-38
Identities = 72/293 (24%), Positives = 121/293 (41%), Gaps = 40/293 (13%)
Query: 182 EIATNRFSAENVLGEGGYGVVYKGRLINGS----EVAVKKLLNNL---GQAEKEFRVEVE 234
I LG+G +GVV +G S VAVK L ++ +A +F EV
Sbjct: 14 LIGEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVN 73
Query: 235 AIGHVRHKNLVRLLGYCIEGVHRMLVYEYVNNGNLEQWLHGAMRNQGNLTWEARMKVIIG 294
A+ + H+NL+RL G + +V E G+L L ++QG+ + +
Sbjct: 74 AMHSLDHRNLIRLYGVVLTP-PMKMVTELAPLGSLLDRLR---KHQGHFLLGTLSRYAVQ 129
Query: 295 TAKALAYLHEAIEPKVVHRDIKSSNILIDDEFNAKVSDFGLAKLLDSGESHITTRVMGTF 354
A+ + YL + +HRD+ + N+L+ K+ DFGL + L + H +
Sbjct: 130 VAEGMGYLESK---RFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKV 186
Query: 355 GY--VAPEYANTGMLNEKSDIYSFGVLLLEAVT-GRDPVDY-GRPANEV-NLVEWLKMMV 409
+ APE T + SD + FGV L E T G++P + G +++ + ++
Sbjct: 187 PFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEP--WIGLNGSQILHKID----KE 240
Query: 410 GTRRAEEVVDPNLEVKPA--TRALKRSLLVALRCVDPDSEKRPKMSQVVRMLE 460
G R L +P + + V ++C E RP + L
Sbjct: 241 GER---------LP-RPEDCPQDIYN---VMVQCWAHKPEDRPTFVALRDFLL 280
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450 | Back alignment and structure |
|---|
Score = 144 bits (365), Expect = 3e-38
Identities = 84/327 (25%), Positives = 132/327 (40%), Gaps = 51/327 (15%)
Query: 146 KHSSLSYGGLVTA-----SPLIGLPEISHLGWGHWFTLRDLEIATNRFSAENVLGEGGYG 200
+H + GL T + W + +G+G +G
Sbjct: 154 EHYTTDADGLCTRLIKPKVMEGTVAAQDEFYRSGW------ALNMKELKLLQTIGKGEFG 207
Query: 201 VVYKGRLINGSEVAVKKLLNNLGQAEKEFRVEVEAIGHVRHKNLVRLLGYCIEGVHR-ML 259
V G G++VAVK + + F E + +RH NLV+LLG +E +
Sbjct: 208 DVMLGDY-RGNKVAVKCI--KNDATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYI 264
Query: 260 VYEYVNNGNLEQWLHGAMRNQGNLTWEARMKVIIGTAKALAYLHEAIEPKVVHRDIKSSN 319
V EY+ G+L +L R + L + +K + +A+ YL VHRD+ + N
Sbjct: 265 VTEYMAKGSLVDYLRS--RGRSVLGGDCLLKFSLDVCEAMEYLEGN---NFVHRDLAARN 319
Query: 320 ILIDDEFNAKVSDFGLAKLLDSGESH--ITTRVMGTFGYVAPEYANTGMLNEKSDIYSFG 377
+L+ ++ AKVSDFGL K S + + + APE + KSD++SFG
Sbjct: 320 VLVSEDNVAKVSDFGLTKEASSTQDTGKLPVKWT------APEALREKKFSTKSDVWSFG 373
Query: 378 VLLLEAVT-GRDPVDY-GRPANEVNLVEWLKMMVGTRRAEEVVDPNLEVKPAT--RALKR 433
+LL E + GR P Y P +V V ++ G + ++ P A+
Sbjct: 374 ILLWEIYSFGRVP--YPRIPLKDV--VPRVEK--GYK---------MD-APDGCPPAVYD 417
Query: 434 SLLVALRCVDPDSEKRPKMSQVVRMLE 460
V C D+ RP Q+ LE
Sbjct: 418 ---VMKNCWHLDAATRPTFLQLREQLE 441
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535 | Back alignment and structure |
|---|
Score = 145 bits (368), Expect = 4e-38
Identities = 86/321 (26%), Positives = 133/321 (41%), Gaps = 38/321 (11%)
Query: 145 HKHSSLSYGGLVTASPLIGLPEISHLGWGHWFTLRDLEIATNRFSAENVLGEGGYGVVYK 204
+ + +T P+ L W EI E LG+G +G V+
Sbjct: 232 YSKHADGLCHRLTTVCPTSKPQTQGLAKDAW------EIPRESLRLEVKLGQGCFGEVWM 285
Query: 205 GRLINGSEVAVKKLLNNLGQAEKEFRVEVEAIGHVRHKNLVRLLGYCIEGVHRMLVYEYV 264
G + VA+K L + + F E + + +RH+ LV+L E +V EY+
Sbjct: 286 GTWNGTTRVAIK-TLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSEE-PIYIVTEYM 343
Query: 265 NNGNLEQWLHGAMRNQGNLTWEARMKVIIGTAKALAYLHEAIEPKVVHRDIKSSNILIDD 324
+ G+L +L G L + + A +AY+ VHRD++++NIL+ +
Sbjct: 344 SKGSLLDFLKG--ETGKYLRLPQLVDMAAQIASGMAYVERM---NYVHRDLRAANILVGE 398
Query: 325 EFNAKVSDFGLAKLLDSGESHITTRVMGTFGYVAPEYANTGMLNEKSDIYSFGVLLLEAV 384
KV+DFGLA+L++ E + APE A G KSD++SFG+LL E
Sbjct: 399 NLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELT 458
Query: 385 T-GRDPVDY-GRPANEV-NLVEWLKMMVGTRRAEEVVDPNLEVKP--ATRALKRSLLVAL 439
T GR P Y G EV + VE G R + P +L +
Sbjct: 459 TKGRVP--YPGMVNREVLDQVER-----GYR---------MP-CPPECPESLHD---LMC 498
Query: 440 RCVDPDSEKRPKMSQVVRMLE 460
+C + E+RP + LE
Sbjct: 499 QCWRKEPEERPTFEYLQAFLE 519
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291 | Back alignment and structure |
|---|
Score = 139 bits (353), Expect = 6e-38
Identities = 66/218 (30%), Positives = 108/218 (49%), Gaps = 19/218 (8%)
Query: 191 ENVLGEGGYGVVYKGRLINGS---EVAVKKLLNNL--GQAEKEFRVEVEAIGHVRHKNLV 245
+ LG G +G V KG VAVK L N + E E + + + +V
Sbjct: 22 DKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIV 81
Query: 246 RLLGYCIEGVHRMLVYEYVNNGNLEQWLHGAMRNQGNLTWEARMKVIIGTAKALAYLHEA 305
R++G C MLV E G L ++L + ++ + ++++ + + YL E+
Sbjct: 82 RMIGICEAESW-MLVMEMAELGPLNKYL----QQNRHVKDKNIIELVHQVSMGMKYLEES 136
Query: 306 IEPKVVHRDIKSSNILIDDEFNAKVSDFGLAKLLDSGESHITTRVMGTF--GYVAPEYAN 363
VHRD+ + N+L+ + AK+SDFGL+K L + E++ + G + + APE N
Sbjct: 137 ---NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECIN 193
Query: 364 TGMLNEKSDIYSFGVLLLEAVT-GRDPVDY-GRPANEV 399
+ KSD++SFGVL+ EA + G+ P Y G +EV
Sbjct: 194 YYKFSSKSDVWSFGVLMWEAFSYGQKP--YRGMKGSEV 229
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318 | Back alignment and structure |
|---|
Score = 140 bits (355), Expect = 7e-38
Identities = 71/340 (20%), Positives = 123/340 (36%), Gaps = 59/340 (17%)
Query: 145 HKHSSLSYGGLVTASPLIGLPEISHLGWGHWFTLRDLEIATNRFSAENVLGEGGYGVVYK 204
H H + G + L + LGEG +G V
Sbjct: 4 HHHHHHHHHGALEV-----LFQGPGDPT---------VFHKRYLKKIRDLGEGHFGKVSL 49
Query: 205 GRLIN-----GSEVAVKKLLNNLG-QAEKEFRVEVEAIGHVRHKNLVRLLGYCIEGVHR- 257
G VAVK L + G Q ++ E++ + + H+++++ G C +
Sbjct: 50 YCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAGAAS 109
Query: 258 -MLVYEYVNNGNLEQWLHGAMRNQGNLTWEARMKVIIGTAKALAYLHEAIEPKVVHRDIK 316
LV EYV G+L +L + ++ + + +AYLH +HRD+
Sbjct: 110 LQLVMEYVPLGSLRDYLP-----RHSIGLAQLLLFAQQICEGMAYLHAQ---HYIHRDLA 161
Query: 317 SSNILIDDEFNAKVSDFGLAKLLDSGESHITTRVMGTF--GYVAPEYANTGMLNEKSDIY 374
+ N+L+D++ K+ DFGLAK + G + R G + APE SD++
Sbjct: 162 ARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAPECLKEYKFYYASDVW 221
Query: 375 SFGVLLLEAVT-GRDPVDYGRPANEVNLVEWLKMMVGTRRAEEVVDPNLEVKPATRALKR 433
SFGV L E +T E+ + +M L + +R
Sbjct: 222 SFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQM------------TVLRLTELLERGER 269
Query: 434 ------------SLLVALRCVDPDSEKRPKMSQVVRMLEA 461
L+ C + ++ RP ++ +L+
Sbjct: 270 LPRPDKCPAEVYHLM--KNCWETEASFRPTFENLIPILKT 307
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290 | Back alignment and structure |
|---|
Score = 139 bits (353), Expect = 7e-38
Identities = 66/268 (24%), Positives = 117/268 (43%), Gaps = 35/268 (13%)
Query: 193 VLGEGGYGVVYKGR-LINGSEVAVKKL-LNNLGQAEKE-FRVEVEAIGHVRHKNLVRLLG 249
+G G + VYKG EVA +L L ++E++ F+ E E + ++H N+VR
Sbjct: 33 EIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYD 92
Query: 250 YCIEGVHRM----LVYEYVNNGNLEQWLHGAMRNQGNLTWEARMKVIIGTAKALAYLHEA 305
V LV E + +G L+ +L + + + K L +LH
Sbjct: 93 SWESTVKGKKCIVLVTELMTSGTLKTYL----KRFKVMKIKVLRSWCRQILKGLQFLHTR 148
Query: 306 IEPKVVHRDIKSSNILIDDEF-NAKVSDFGLAKLLDSGESHITTRVMGTFGYVAPEYANT 364
P ++HRD+K NI I + K+ D GLA L + V+GT ++APE
Sbjct: 149 -TPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLK---RASFAKAVIGTPEFMAPEMYEE 204
Query: 365 GMLNEKSDIYSFGVLLLEAVTGRDPVDYGRPANEVNLVEWLKMMVGTRRA--EEVVDPNL 422
+E D+Y+FG+ +LE T P + A ++ + ++ G + A ++V P +
Sbjct: 205 K-YDESVDVYAFGMCMLEMATSEYPYSECQNAAQI----YRRVTSGVKPASFDKVAIPEV 259
Query: 423 EVKPATRALKRSLLVALRCVDPDSEKRP 450
+ ++ C+ + ++R
Sbjct: 260 ----------KEII--EGCIRQNKDERY 275
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288 | Back alignment and structure |
|---|
Score = 138 bits (349), Expect = 2e-37
Identities = 68/223 (30%), Positives = 107/223 (47%), Gaps = 15/223 (6%)
Query: 182 EIATNRFSAENVLGEGGYGVVYKGRLINGS-EVAVKKLLNNLGQAEKEFRVEVEAIGHVR 240
E+ + ++ LG G YG VY+G S VAVK L + + E EF E + ++
Sbjct: 9 EMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE-EFLKEAAVMKEIK 67
Query: 241 HKNLVRLLGYCIEGVHRMLVYEYVNNGNLEQWLHGAMRNQGNLTWEARMKVIIGTAKALA 300
H NLV+LLG C ++ E++ GNL +L N+ ++ + + + A+
Sbjct: 68 HPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRE--CNRQEVSAVVLLYMATQISSAME 125
Query: 301 YLHEAIEPKVVHRDIKSSNILIDDEFNAKVSDFGLAKLLDSGESHITTRVMGTFGY--VA 358
YL + +HRD+ + N L+ + KV+DFGL++L+ T F A
Sbjct: 126 YLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTY--TAHAGAKFPIKWTA 180
Query: 359 PEYANTGMLNEKSDIYSFGVLLLEAVT-GRDPVDY-GRPANEV 399
PE + KSD+++FGVLL E T G P Y G ++V
Sbjct: 181 PESLAYNKFSIKSDVWAFGVLLWEIATYGMSP--YPGIDLSQV 221
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613 | Back alignment and structure |
|---|
Score = 144 bits (364), Expect = 2e-37
Identities = 74/326 (22%), Positives = 132/326 (40%), Gaps = 25/326 (7%)
Query: 77 GQNFNDHPESVFLSVHDKSSDKNSEKMHVHLGMSKSSD----PDNISQCSSVHHHERACS 132
G F+ + V K + ++ P + S++ H +R
Sbjct: 226 GTKFDTLWQLVEYLKLKADGLIYCLKEACPNSSASNASGAAAPTLPAHPSTLTHPQRRID 285
Query: 133 SQSGEEGSSGAGHKHSSLSYGGLVTASPLIGLPEI--SHLGWGHWFTLRDLEIATNRFSA 190
+ + + + S + + + P L F RD N A
Sbjct: 286 TLNSDGYTPEPARITSPDKPRPMPMDTSVFESPFSDPEELKDKKLFLKRD-----NLLIA 340
Query: 191 ENVLGEGGYGVVYKGRLINGSE---VAVKKL-LNNLGQAEKEFRVEVEAIGHVRHKNLVR 246
+ LG G +G V +G + VA+K L +E E + + + + +VR
Sbjct: 341 DIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVR 400
Query: 247 LLGYCIEGVHRMLVYEYVNNGNLEQWLHGAMRNQGNLTWEARMKVIIGTAKALAYLHEAI 306
L+G C MLV E G L ++L + + +++ + + YL E
Sbjct: 401 LIGVCQAEAL-MLVMEMAGGGPLHKFLV---GKREEIPVSNVAELLHQVSMGMKYLEEK- 455
Query: 307 EPKVVHRDIKSSNILIDDEFNAKVSDFGLAKLLDSGESHITTRVMGTFGY--VAPEYANT 364
VHR++ + N+L+ + AK+SDFGL+K L + +S+ T R G + APE N
Sbjct: 456 --NFVHRNLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINF 513
Query: 365 GMLNEKSDIYSFGVLLLEAVT-GRDP 389
+ +SD++S+GV + EA++ G+ P
Sbjct: 514 RKFSSRSDVWSYGVTMWEALSYGQKP 539
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284 | Back alignment and structure |
|---|
Score = 137 bits (346), Expect = 5e-37
Identities = 68/291 (23%), Positives = 121/291 (41%), Gaps = 49/291 (16%)
Query: 186 NRFSAENVLGEGGYGVVYKGR-LINGSEVAVKKLLNNLGQAEKEFRVEVEAIGHVRHKNL 244
F ++G GG+G V+K + I+G +K++ ++ EV+A+ + H N+
Sbjct: 11 MDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRV----KYNNEKAEREVKALAKLDHVNI 66
Query: 245 VRLLGYCIEGVHRM----------------LVYEYVNNGNLEQWLHGAMRNQGNLTWEAR 288
V G + + E+ + G LEQW+ R L
Sbjct: 67 VHYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIE--KRRGEKLDKVLA 124
Query: 289 MKVIIGTAKALAYLHEAIEPKVVHRDIKSSNILIDDEFNAKVSDFGLAKLLDSGESHITT 348
+++ K + Y+H K+++RD+K SNI + D K+ DFGL L + T
Sbjct: 125 LELFEQITKGVDYIHS---KKLINRDLKPSNIFLVDTKQVKIGDFGLVTSLKNDGKR--T 179
Query: 349 RVMGTFGYVAPEYANTGMLNEKSDIYSFGVLLLEAVTGRDPVDYGRPANEVNLVEWLKMM 408
R GT Y++PE ++ ++ D+Y+ G++L E + A E + + +
Sbjct: 180 RSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHV------CDTAFETSKF-FTDLR 232
Query: 409 VGTRRAEEVVDPNLEVKPATRALKRSLLVALRCVDPDSEKRPKMSQVVRML 459
G ++ D ++LL L P E RP S+++R L
Sbjct: 233 DGII--SDIFDKKE----------KTLLQKLLSKKP--EDRPNTSEILRTL 269
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299 | Back alignment and structure |
|---|
Score = 137 bits (347), Expect = 6e-37
Identities = 55/222 (24%), Positives = 94/222 (42%), Gaps = 29/222 (13%)
Query: 186 NRFSAENVLGEGGYGVVYKGR-LINGSEVAVKKL-LNNLGQAEKEFRVEVEAIGHVRHKN 243
F LG GG+GVV++ + ++ A+K++ L N A ++ EV+A+ + H
Sbjct: 5 TDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPG 64
Query: 244 LVRLLGYCIEGVHRM------------LVYEYVNNGNLEQWLHGAMRNQGNLTWEARMKV 291
+VR +E + + NL+ W++ + +
Sbjct: 65 IVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMN-GRCTIEERERSVCLHI 123
Query: 292 IIGTAKALAYLHEAIEPKVVHRDIKSSNILIDDEFNAKVSDFGLAKLLDSGESHITTRVM 351
+ A+A+ +LH ++HRD+K SNI + KV DFGL +D E T
Sbjct: 124 FLQIAEAVEFLHS---KGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTP 180
Query: 352 -----------GTFGYVAPEYANTGMLNEKSDIYSFGVLLLE 382
GT Y++PE + + K DI+S G++L E
Sbjct: 181 MPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFE 222
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303 | Back alignment and structure |
|---|
Score = 137 bits (346), Expect = 7e-37
Identities = 71/301 (23%), Positives = 118/301 (39%), Gaps = 54/301 (17%)
Query: 185 TNRFSAENVLGEGGYGVVYKGR-LINGSEVAVKKLLNNLGQAEKEFRVEVEAIGHVRHKN 243
+ F VLG+G +G V K R ++ A+KK+ + + EV + + H+
Sbjct: 5 ASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTEEKLSTILS-EVMLLASLNHQY 63
Query: 244 LVRLLGYCIEGVHRM-------------LVYEYVNNGNLEQWLHGAMRNQGNLTWEARMK 290
+VR +E + + + EY NG L + ++
Sbjct: 64 VVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLI----HSENLNQQRDEYW 119
Query: 291 VIIG-TAKALAYLHEAIEPKVVHRDIKSSNILIDDEFNAKVSDFGLAKLLDS-------- 341
+ +AL+Y+H ++HRD+K NI ID+ N K+ DFGLAK +
Sbjct: 120 RLFRQILEALSYIHS---QGIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLD 176
Query: 342 ------GESHITTRVMGTFGYVAPE-YANTGMLNEKSDIYSFGVLLLEAVTGRDPVDYGR 394
++T+ + GT YVA E TG NEK D+YS G++ E +
Sbjct: 177 SQNLPGSSDNLTSAI-GTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIYP-------- 227
Query: 395 PANEVNLVEWLKMMVGTRRAEEVVDPNLEVKPATRALKRSLLVALRCVDPDSEKRPKMSQ 454
+ + V LK + R P+ + + ++ L DP KRP
Sbjct: 228 FSTGMERVNILKKL---RSVSIEFPPDFDDNKMKVE--KKIIRLLIDHDP--NKRPGART 280
Query: 455 V 455
+
Sbjct: 281 L 281
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 136 bits (344), Expect = 1e-36
Identities = 70/222 (31%), Positives = 110/222 (49%), Gaps = 15/222 (6%)
Query: 182 EIATNRFSAENVLGEGGYGVVYKGRLINGSEVAVKKLLNNLGQAEKEFRVEVEAIGHVRH 241
E+ LG G +G V+ G ++VAVK L + F E + ++H
Sbjct: 9 EVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSL-KQGSMSPDAFLAEANLMKQLQH 67
Query: 242 KNLVRLLGYCIEGVHRMLVYEYVNNGNLEQWLHGAMRNQGNLTWEARMKVIIGTAKALAY 301
+ LVRL + ++ EY+ NG+L +L + LT + + A+ +A+
Sbjct: 68 QRLVRLYAVVTQE-PIYIITEYMENGSLVDFLKT--PSGIKLTINKLLDMAAQIAEGMAF 124
Query: 302 LHEAIEPKVVHRDIKSSNILIDDEFNAKVSDFGLAKLLDSGESHITTRVMGTFGY--VAP 359
+ E +HRD++++NIL+ D + K++DFGLA+L++ ++ T R F AP
Sbjct: 125 IEER---NYIHRDLRAANILVSDTLSCKIADFGLARLIE--DNEYTAREGAKFPIKWTAP 179
Query: 360 EYANTGMLNEKSDIYSFGVLLLEAVT-GRDPVDY-GRPANEV 399
E N G KSD++SFG+LL E VT GR P Y G EV
Sbjct: 180 EAINYGTFTIKSDVWSFGILLTEIVTHGRIP--YPGMTNPEV 219
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310 | Back alignment and structure |
|---|
Score = 137 bits (346), Expect = 1e-36
Identities = 73/277 (26%), Positives = 123/277 (44%), Gaps = 21/277 (7%)
Query: 186 NRFSAENVLGEGGYGVVYKGR-LINGSEVAVKK--LLNNLGQAEKEF-RVEVEAIGHVRH 241
F E +G G + VY+ L++G VA+KK + + + + E++ + + H
Sbjct: 32 ANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNH 91
Query: 242 KNLVRLLGYCIEGVHRMLVYEYVNNGNLEQWLHGAMRNQGNLTWEARMKVIIGTAKALAY 301
N+++ IE +V E + G+L + + + + + K + AL +
Sbjct: 92 PNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEH 151
Query: 302 LHEAIEPKVVHRDIKSSNILIDDEFNAKVSDFGLAKLLDSGESHITTRVMGTFGYVAPEY 361
+H +V+HRDIK +N+ I K+ D GL + S + + V GT Y++PE
Sbjct: 152 MHSR---RVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLV-GTPYYMSPER 207
Query: 362 ANTGMLNEKSDIYSFGVLLLEAVTGRDPVDYGRPANEVNLVEWLKMMVGTRRAEEVVDPN 421
+ N KSDI+S G LL E + P YG N +L K+ P
Sbjct: 208 IHENGYNFKSDIWSLGCLLYEMAALQSPF-YGDKMNLYSLC--KKIEQCDY-------PP 257
Query: 422 LEVKPATRALKRSLLVALRCVDPDSEKRPKMSQVVRM 458
L + L R L+ C++PD EKRP ++ V +
Sbjct: 258 LPSDHYSEEL-RQLV--NMCINPDPEKRPDVTYVYDV 291
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454 | Back alignment and structure |
|---|
Score = 140 bits (354), Expect = 1e-36
Identities = 74/286 (25%), Positives = 123/286 (43%), Gaps = 36/286 (12%)
Query: 182 EIATNRFSAENVLGEGGYGVVYKGRLINGSEVAVKKLLNNLGQAEKEFRVEVEAIGHVRH 241
EI E LG G +G V+ ++VAVK + + + F E + ++H
Sbjct: 184 EIPRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPG-SMSVEAFLAEANVMKTLQH 242
Query: 242 KNLVRLLGYCIEGVHRMLVYEYVNNGNLEQWLHGAMRNQGNLTWEARMKVIIGTAKALAY 301
LV+L + ++ E++ G+L +L + A+ +A+
Sbjct: 243 DKLVKLHAVVTKE-PIYIITEFMAKGSLLDFLKS--DEGSKQPLPKLIDFSAQIAEGMAF 299
Query: 302 LHEAIEPKVVHRDIKSSNILIDDEFNAKVSDFGLAKLLDSGESHITTRVMGTFGY--VAP 359
+ + +HRD++++NIL+ K++DFGLA++++ E T R F AP
Sbjct: 300 IEQR---NYIHRDLRAANILVSASLVCKIADFGLARVIEDNEY--TAREGAKFPIKWTAP 354
Query: 360 EYANTGMLNEKSDIYSFGVLLLEAVT-GRDPVDY-GRPANEV-NLVEWLKMMVGTRRAEE 416
E N G KSD++SFG+LL+E VT GR P Y G EV +E G R
Sbjct: 355 EAINFGSFTIKSDVWSFGILLMEIVTYGRIP--YPGMSNPEVIRALE-----RGYR---- 403
Query: 417 VVDPNLEVKPAT--RALKRSLLVALRCVDPDSEKRPKMSQVVRMLE 460
+ +P L + +RC E+RP + +L+
Sbjct: 404 -----MP-RPENCPEELYN---IMMRCWKNRPEERPTFEYIQSVLD 440
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313 | Back alignment and structure |
|---|
Score = 136 bits (344), Expect = 2e-36
Identities = 81/309 (26%), Positives = 130/309 (42%), Gaps = 52/309 (16%)
Query: 177 TLRDLEIATNRFSAENVLGEGGYGVVYKGRLINGSE----VAVK--KLLNNLGQAEKEFR 230
L D+ I N +LGEG +G V +G L VAVK KL N+ + +EF
Sbjct: 25 KLEDVVIDRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFL 84
Query: 231 VEVEAIGHVRHKNLVRLLGYCIEG-----VHRMLVYEYVNNGNLEQWL--HGAMRNQGNL 283
E + H N++RLLG CIE M++ ++ G+L +L ++
Sbjct: 85 SEAACMKDFSHPNVIRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHI 144
Query: 284 TWEARMKVIIGTAKALAYLHEAIEPKVVHRDIKSSNILIDDEFNAKVSDFGLAKLLDSGE 343
+ +K ++ A + YL +HRD+ + N ++ D+ V+DFGL+K + SG+
Sbjct: 145 PLQTLLKFMVDIALGMEYLSNR---NFLHRDLAARNCMLRDDMTVCVADFGLSKKIYSGD 201
Query: 344 SHITTRV-------MGTFGYVAPEYANTGMLNEKSDIYSFGVLLLEAVT-GRDPVDY-GR 394
+ R+ + A E + KSD+++FGV + E T G P Y G
Sbjct: 202 YYRQGRIAKMPVKWI------AIESLADRVYTSKSDVWAFGVTMWEIATRGMTP--YPGV 253
Query: 395 PANEVNLVEWLKMMVGTRRAEEVVDPNLEVKPA--TRALKRSLLVALRCVDPDSEKRPKM 452
+E+ ++L G R L+ +P L + C D RP
Sbjct: 254 QNHEM--YDYLLH--GHR---------LK-QPEDCLDELYE---IMYSCWRTDPLDRPTF 296
Query: 453 SQVVRMLEA 461
S + LE
Sbjct: 297 SVLRLQLEK 305
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323 | Back alignment and structure |
|---|
Score = 136 bits (344), Expect = 3e-36
Identities = 69/306 (22%), Positives = 130/306 (42%), Gaps = 45/306 (14%)
Query: 177 TLRDLEIATNRFSAENVLGEGGYGVVYKGRLINGSE----VAVKKL-LNNLGQAEKE-FR 230
L D+ I +F+ +LG+G +G V + +L VAVK L + + ++ E F
Sbjct: 14 KLEDVLIPEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFL 73
Query: 231 VEVEAIGHVRHKNLVRLLGYCIEG------VHRMLVYEYVNNGNLEQWL--HGAMRNQGN 282
E + H ++ +L+G + M++ ++ +G+L +L N N
Sbjct: 74 REAACMKEFDHPHVAKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFN 133
Query: 283 LTWEARMKVIIGTAKALAYLHEAIEPKVVHRDIKSSNILIDDEFNAKVSDFGLAKLLDSG 342
L + ++ ++ A + YL +HRD+ + N ++ ++ V+DFGL++ + SG
Sbjct: 134 LPLQTLVRFMVDIACGMEYLSSR---NFIHRDLAARNCMLAEDMTVCVADFGLSRKIYSG 190
Query: 343 ESHITTRVMGTFGYV-----APEYANTGMLNEKSDIYSFGVLLLEAVT-GRDPVDY-GRP 395
+ + G + A E + SD+++FGV + E +T G+ P Y G
Sbjct: 191 DYY----RQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTP--YAGIE 244
Query: 396 ANEVNLVEWLKMMVGTRRAEEVVDPNLEVKPATRALKRSLLVALRCVDPDSEKRPKMSQV 455
E+ +L G R L+ P L+ +C D ++RP + +
Sbjct: 245 NAEI--YNYLIG--GNR---------LKQPPECMEEVYDLM--YQCWSADPKQRPSFTCL 289
Query: 456 VRMLEA 461
LE
Sbjct: 290 RMELEN 295
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298 | Back alignment and structure |
|---|
Score = 135 bits (341), Expect = 4e-36
Identities = 82/297 (27%), Positives = 129/297 (43%), Gaps = 44/297 (14%)
Query: 181 LEIATNRFSAENVLGEGGYGVVYKGRLINGSE----VAVKKLLNNLGQAEK-EFRVEVEA 235
+ ++ V+G G +G VY G L++ AVK L E +F E
Sbjct: 20 IGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGII 79
Query: 236 IGHVRHKNLVRLLGYCIEGVH-RMLVYEYVNNGNLEQWLHGAMRNQGNLTWEARMKVIIG 294
+ H N++ LLG C+ ++V Y+ +G+L ++ N T + + +
Sbjct: 80 MKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIR---NETHNPTVKDLIGFGLQ 136
Query: 295 TAKALAYLHEAIEPKVVHRDIKSSNILIDDEFNAKVSDFGLAKLLDSGESHITTRVMGTF 354
AK + YL K VHRD+ + N ++D++F KV+DFGLA+ + E + V
Sbjct: 137 VAKGMKYLASK---KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYY---SVHNKT 190
Query: 355 G------YVAPEYANTGMLNEKSDIYSFGVLLLEAVT-GRDPVDY-GRPANEVNLVEWLK 406
G ++A E T KSD++SFGVLL E +T G P Y ++ +L
Sbjct: 191 GAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPP--YPDVNTFDI--TVYLL 246
Query: 407 MMVGTRRAEEVVDPNLEVKPA--TRALKRSLLVALRCVDPDSEKRPKMSQVVRMLEA 461
G R L +P L V L+C P +E RP S++V + A
Sbjct: 247 Q--GRR---------LL-QPEYCPDPLYE---VMLKCWHPKAEMRPSFSELVSRISA 288
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 134 bits (340), Expect = 4e-36
Identities = 78/300 (26%), Positives = 133/300 (44%), Gaps = 42/300 (14%)
Query: 178 LRDLEIATNRFS--AENVLGEGGYGVVYKGRLINGSE----VAVKKLLNNLGQAEK-EFR 230
++D+ I R ++ V+G+G +GVVY G I+ ++ A+K L + F
Sbjct: 11 VKDVLIPHERVVTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFL 70
Query: 231 VEVEAIGHVRHKNLVRLLGYCIEGV-HRMLVYEYVNNGNLEQWLHGAMRNQGNLTWEARM 289
E + + H N++ L+G + ++ Y+ +G+L Q++ Q N T + +
Sbjct: 71 REGLLMRGLNHPNVLALIGIMLPPEGLPHVLLPYMCHGDLLQFIR---SPQRNPTVKDLI 127
Query: 290 KVIIGTAKALAYLHEAIEPKVVHRDIKSSNILIDDEFNAKVSDFGLAKLLDSGESHITTR 349
+ A+ + YL E K VHRD+ + N ++D+ F KV+DFGLA+ + E + +
Sbjct: 128 SFGLQVARGMEYLAEQ---KFVHRDLAARNCMLDESFTVKVADFGLARDILDREYYSVQQ 184
Query: 350 VMGTFGYV---APEYANTGMLNEKSDIYSFGVLLLEAVT-GRDPVDY-GRPANEV-NLVE 403
V A E T KSD++SFGVLL E +T G P Y ++ + +
Sbjct: 185 HRHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPP--YRHIDPFDLTHFLA 242
Query: 404 WLKMMVGTRRAEEVVDPNLEVKPA--TRALKRSLLVALRCVDPDSEKRPKMSQVVRMLEA 461
G R L +P +L + V +C + D RP +V +E
Sbjct: 243 -----QGRR---------LP-QPEYCPDSLYQ---VMQQCWEADPAVRPTFRVLVGEVEQ 284
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281 | Back alignment and structure |
|---|
Score = 134 bits (339), Expect = 4e-36
Identities = 60/240 (25%), Positives = 103/240 (42%), Gaps = 28/240 (11%)
Query: 170 LGWGHWFTLRDLEIATNRFSAENVLGEGGYGVVYKGRLINGSE----VAVKKL-LNNLGQ 224
+G + IA +LGEG +G VY+G N VAVK +
Sbjct: 2 MGGPQY------GIAREDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLD 55
Query: 225 AEKEFRVEVEAIGHVRHKNLVRLLGYCIEGVHRMLVYEYVNNGNLEQWLHGAMRNQGNLT 284
+++F E + ++ H ++V+L+G E ++ E G L +L RN+ +L
Sbjct: 56 NKEKFMSEAVIMKNLDHPHIVKLIGIIEEE-PTWIIMELYPYGELGHYLE---RNKNSLK 111
Query: 285 WEARMKVIIGTAKALAYLHEAIEPKVVHRDIKSSNILIDDEFNAKVSDFGLAKLLDSGES 344
+ + KA+AYL VHRDI NIL+ K+ DFGL++ ++ +
Sbjct: 112 VLTLVLYSLQICKAMAYLESI---NCVHRDIAVRNILVASPECVKLGDFGLSRYIEDED- 167
Query: 345 HITTRVMGT---FGYVAPEYANTGMLNEKSDIYSFGVLLLEAVT-GRDPVDY-GRPANEV 399
+ T +++PE N SD++ F V + E ++ G+ P + +V
Sbjct: 168 --YYKASVTRLPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQP--FFWLENKDV 223
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281 | Back alignment and structure |
|---|
Score = 134 bits (339), Expect = 4e-36
Identities = 59/231 (25%), Positives = 103/231 (44%), Gaps = 16/231 (6%)
Query: 176 FTLRDLEIATNRFSAENVLGEGGYGVVYKGRLINGSE----VAVKKLLNNLGQAEK-EFR 230
+ RD EI R +GEG +G V++G ++ VA+K N + + +F
Sbjct: 5 SSTRDYEIQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFL 64
Query: 231 VEVEAIGHVRHKNLVRLLGYCIEGVHRMLVYEYVNNGNLEQWLHGAMRNQGNLTWEARMK 290
E + H ++V+L+G E ++ E G L +L + +L + +
Sbjct: 65 QEALTMRQFDHPHIVKLIGVITEN-PVWIIMELCTLGELRSFLQ---VRKYSLDLASLIL 120
Query: 291 VIIGTAKALAYLHEAIEPKVVHRDIKSSNILIDDEFNAKVSDFGLAKLLDSGESHITTRV 350
+ ALAYL + VHRDI + N+L+ K+ DFGL++ ++ + ++
Sbjct: 121 YAYQLSTALAYLESK---RFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKG 177
Query: 351 MGTFGYVAPEYANTGMLNEKSDIYSFGVLLLEAVT-GRDPVDY-GRPANEV 399
++APE N SD++ FGV + E + G P + G N+V
Sbjct: 178 KLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKP--FQGVKNNDV 226
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329 | Back alignment and structure |
|---|
Score = 134 bits (340), Expect = 9e-36
Identities = 82/348 (23%), Positives = 138/348 (39%), Gaps = 57/348 (16%)
Query: 139 GSSGAGHKHSSLSYGGLVTASPLIGLPEISHLGWGHWFTLRDL-EIATNRFSAENVLGEG 197
G+ G+G S G +I P+ +F+ + I + LGEG
Sbjct: 1 GAMGSGSSLSPTEGKGSGLQGHIIENPQ--------YFSDACVHHIKRRDIVLKWELGEG 52
Query: 198 GYGVVYKGRLINGSE------VAVKKLLNNLGQAEKEFRVEVEAIGHVRHKNLVRLLGYC 251
+G V+ N VAVK L A ++F+ E E + ++H+++VR G C
Sbjct: 53 AFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRFFGVC 112
Query: 252 IEGVHRMLVYEYVNNGNLEQWL-----------HGAMRNQGNLTWEARMKVIIGTAKALA 300
EG ++V+EY+ +G+L ++L G G L + V A +
Sbjct: 113 TEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMV 172
Query: 301 YLHEAIEPKVVHRDIKSSNILIDDEFNAKVSDFGLAKLLDSGESHITTRVMGTFGYV--- 357
YL VHRD+ + N L+ K+ DFG+++ + S + RV G +
Sbjct: 173 YLAGL---HFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTD---YYRVGGR-TMLPIR 225
Query: 358 --APEYANTGMLNEKSDIYSFGVLLLEAVT-GRDPVDY-GRPANEVNLVEWLKMMVGTRR 413
PE +SD++SFGV+L E T G+ P + E ++ + G
Sbjct: 226 WMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQP--WYQLSNTEA--IDCITQ--GRE- 278
Query: 414 AEEVVDPNLEVKPATRALKRSLLVALRCVDPDSEKRPKMSQVVRMLEA 461
LE A +++ C + ++R + V L+A
Sbjct: 279 --------LERPRACPPEVYAIM--RGCWQREPQQRHSIKDVHARLQA 316
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373 | Back alignment and structure |
|---|
Score = 136 bits (343), Expect = 9e-36
Identities = 78/296 (26%), Positives = 125/296 (42%), Gaps = 42/296 (14%)
Query: 181 LEIATNRFSAENVLGEGGYGVVYKGRLINGSE----VAVKKLLNNLGQAEK-EFRVEVEA 235
+ ++ V+G G +G VY G L++ AVK L E +F E
Sbjct: 84 IGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGII 143
Query: 236 IGHVRHKNLVRLLGYCIEGVH-RMLVYEYVNNGNLEQWLHGAMRNQGNLTWEARMKVIIG 294
+ H N++ LLG C+ ++V Y+ +G+L ++ N T + + +
Sbjct: 144 MKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIR---NETHNPTVKDLIGFGLQ 200
Query: 295 TAKALAYLHEAIEPKVVHRDIKSSNILIDDEFNAKVSDFGLAKLLDSGESHITTRVMGTF 354
AK + +L K VHRD+ + N ++D++F KV+DFGLA+ + E T
Sbjct: 201 VAKGMKFLASK---KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHN--KTG 255
Query: 355 GYV-----APEYANTGMLNEKSDIYSFGVLLLEAVT-GRDPVDY-GRPANEVNLVEWLKM 407
+ A E T KSD++SFGVLL E +T G P Y ++
Sbjct: 256 AKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPP--YPDVNTFDI-----TVY 308
Query: 408 MVGTRRAEEVVDPNLEVKPA--TRALKRSLLVALRCVDPDSEKRPKMSQVVRMLEA 461
++ RR +P L V L+C P +E RP S++V + A
Sbjct: 309 LLQGRRLL---------QPEYCPDPLYE---VMLKCWHPKAEMRPSFSELVSRISA 352
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371 | Back alignment and structure |
|---|
Score = 135 bits (342), Expect = 1e-35
Identities = 32/305 (10%), Positives = 70/305 (22%), Gaps = 49/305 (16%)
Query: 187 RFSAENVLGEGGYGVVYKGR-LINGSEVAVKKLL---NNLGQAEKEFRVEVEAIGHVRHK 242
+ L G VV+ R + + A+K N + A + +
Sbjct: 63 KLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGE 122
Query: 243 NLVRLLGYCIEGV--------------------------HRMLVYEYV--NNGNLEQWLH 274
+ + + +L+ + L L
Sbjct: 123 SPEEARDRRRLLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAASVDLELLFSTLD 182
Query: 275 GAMRNQGNLTWEARMKVIIGTAKALAYLHEAIEPKVVHRDIKSSNILIDDEFNAKVSDFG 334
+G+ A + + A L +VH N+ I + + D
Sbjct: 183 FVYVFRGDEGILALHILTAQLIRLAANLQSK---GLVHGHFTPDNLFIMPDGRLMLGDVS 239
Query: 335 LAKLLDSGESHITTRVMGTFGYVAPEY--ANTGMLNEKSDIYSFGVLLLEAVTGRDPVDY 392
+ + Y E+ A+T + + G+ + P +
Sbjct: 240 ALWKVGT----RGPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFLP--F 293
Query: 393 GRPANEVNLVEWLKMMVGTRRAEEVVDPNLEVKPATRALKRSLLVALRCVDPDSEKRPKM 452
G + + + + L L D +R
Sbjct: 294 GLVTPGIKGSWKRPSLRVPGTDSLAFGSCTPLPDFVKTLIGRFLN------FDRRRRLLP 347
Query: 453 SQVVR 457
+ +
Sbjct: 348 LEAME 352
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294 | Back alignment and structure |
|---|
Score = 133 bits (336), Expect = 2e-35
Identities = 60/273 (21%), Positives = 116/273 (42%), Gaps = 39/273 (14%)
Query: 194 LGEGGYGVVYKGR-LINGSEVAVK----KLLNNLGQAEKEFRVEVEAIGHVRHKNLVRLL 248
LG+GG+ ++ A K LL Q EK E+ + H+++V
Sbjct: 23 LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSM-EISIHRSLAHQHVVGFH 81
Query: 249 GYCIEGVHRM-LVYEYVNNGNLEQWLHGAMRNQGNLT-WEAR--MKVIIGTAKALAYLHE 304
G+ E + +V E +L + + + LT EAR ++ I+ YLH
Sbjct: 82 GF-FEDNDFVFVVLELCRRRSLLELH----KRRKALTEPEARYYLRQIVL---GCQYLHR 133
Query: 305 AIEPKVVHRDIKSSNILIDDEFNAKVSDFGLAKLLDSGESHITTRVMGTFGYVAPEYANT 364
+V+HRD+K N+ ++++ K+ DFGLA ++ + GT Y+APE +
Sbjct: 134 N---RVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKV-LCGTPNYIAPEVLSK 189
Query: 365 GMLNEKSDIYSFGVLLLEAVTGRDPVDYGRPANEVNLVEWLKMMVGTRRAEEVVDPNLEV 424
+ + D++S G ++ + G+ P + L E + ++ E + ++
Sbjct: 190 KGHSFEVDVWSIGCIMYTLLVGKPPFE------TSCLKETYLRI---KKNEYSIPKHIN- 239
Query: 425 KPATRALKRSLLVALRCVDPDSEKRPKMSQVVR 457
P +L + +L D RP +++++
Sbjct: 240 -PVAASLIQKML------QTDPTARPTINELLN 265
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656 | Back alignment and structure |
|---|
Score = 138 bits (350), Expect = 2e-35
Identities = 60/233 (25%), Positives = 104/233 (44%), Gaps = 17/233 (7%)
Query: 179 RDLEIATNRFSAENVLGEGGYGVVYKGRLINGSE----VAVKKLLNNLGQAEK-EFRVEV 233
RD EI R +GEG +G V++G ++ VA+K N + + +F E
Sbjct: 383 RDYEIQRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEA 442
Query: 234 EAIGHVRHKNLVRLLGYCIEGVHRMLVYEYVNNGNLEQWLHGAMRNQGNLTWEARMKVII 293
+ H ++V+L+G E ++ E G L +L + +L + +
Sbjct: 443 LTMRQFDHPHIVKLIGVITEN-PVWIIMELCTLGELRSFLQ---VRKFSLDLASLILYAY 498
Query: 294 GTAKALAYLHEAIEPKVVHRDIKSSNILIDDEFNAKVSDFGLAKLLDSGESHITTRVMGT 353
+ ALAYL + VHRDI + N+L+ K+ DFGL++ ++ + ++
Sbjct: 499 QLSTALAYLESK---RFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLP 555
Query: 354 FGYVAPEYANTGMLNEKSDIYSFGVLLLEAVT-GRDPVDY-GRPANEV-NLVE 403
++APE N SD++ FGV + E + G P + G N+V +E
Sbjct: 556 IKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKP--FQGVKNNDVIGRIE 606
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335 | Back alignment and structure |
|---|
Score = 133 bits (338), Expect = 2e-35
Identities = 61/280 (21%), Positives = 118/280 (42%), Gaps = 39/280 (13%)
Query: 187 RFSAENVLGEGGYGVVYKGR-LINGSEVAVK----KLLNNLGQAEKEFRVEVEAIGHVRH 241
R+ LG+GG+ ++ A K LL Q EK E+ + H
Sbjct: 42 RYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSM-EISIHRSLAH 100
Query: 242 KNLVRLLGYCIEGVHRM-LVYEYVNNGNLEQWLHGAMRNQGNLT-WEAR--MKVIIGTAK 297
+++V G+ E + +V E +L + + + LT EAR ++ I+
Sbjct: 101 QHVVGFHGF-FEDNDFVFVVLELCRRRSLLELH----KRRKALTEPEARYYLRQIVL--- 152
Query: 298 ALAYLHEAIEPKVVHRDIKSSNILIDDEFNAKVSDFGLAKLLDSGESHITTRVMGTFGYV 357
YLH +V+HRD+K N+ ++++ K+ DFGLA ++ + GT Y+
Sbjct: 153 GCQYLHRN---RVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKV-LCGTPNYI 208
Query: 358 APEYANTGMLNEKSDIYSFGVLLLEAVTGRDPVDYGRPANEVNLVEWLKMMVGTRRAEEV 417
APE + + + D++S G ++ + G+ P + L E + ++ E
Sbjct: 209 APEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFE------TSCLKETYLRI---KKNEYS 259
Query: 418 VDPNLEVKPATRALKRSLLVALRCVDPDSEKRPKMSQVVR 457
+ + + P +L + +L D RP +++++
Sbjct: 260 IPKH--INPVAASLIQKML------QTDPTARPTINELLN 291
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413 | Back alignment and structure |
|---|
Score = 135 bits (340), Expect = 4e-35
Identities = 40/303 (13%), Positives = 78/303 (25%), Gaps = 62/303 (20%)
Query: 193 VLGEGGYGVVYKGR-LINGSEVAVK---KLLNNLGQAEKEFRVEVEAIGHVR-------- 240
VLG+ + G V A K+ + EV + +R
Sbjct: 85 VLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQA 144
Query: 241 -----------------HKNLVRLLG----YCIEGVHRMLVYEYVNNGNLEQWLHGAMRN 279
K ++R+ + + N + L
Sbjct: 145 KVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSST 204
Query: 280 QGNLTWEARMKVIIGTAKALAYLHEAIEPKVVHRDIKSSNILIDDEFNAKVSDFGLAKLL 339
+L AR+++ + + LA LH +VH ++ +I++D ++ F
Sbjct: 205 HKSLVHHARLQLTLQVIRLLASLHHY---GLVHTYLRPVDIVLDQRGGVFLTGFEHLVRD 261
Query: 340 DSGESHITTRVMGTFGYVAPE-----YANTGMLNEKSDIYSFGVLLLEAVTGRDPVDYGR 394
+ R A + ++ D ++ G+ + P
Sbjct: 262 GASAVSPIGRGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWCADLP--NTD 319
Query: 395 PANEVNLVEWLKMMVGTRRAEEVVDPNLEVKPATRALKRSLLVALRCVDPDSEKRPKMSQ 454
+ EW + + RAL L E R Q
Sbjct: 320 D-AALGGSEW------------IFRSCKNIPQPVRALLEGFL------RYPKEDRLLPLQ 360
Query: 455 VVR 457
+
Sbjct: 361 AME 363
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 132 bits (335), Expect = 4e-35
Identities = 64/305 (20%), Positives = 107/305 (35%), Gaps = 42/305 (13%)
Query: 183 IATNRFSAENVLGEGGYGVVYKGR-LINGSEVAVKKL-LNNLGQAEKEFRVEVEAIGHVR 240
+ + + ++LG+G V++GR G A+K + + E E + +
Sbjct: 6 TSNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLN 65
Query: 241 HKNLVRLLGYCIEGVHRMLVY---EYVNNGNLEQWLHGAMRNQGNLT-WEARMKVIIGTA 296
HKN+V+L E E+ G+L L N L E V+
Sbjct: 66 HKNIVKLFA-IEEETTTRHKVLIMEFCPCGSLYTVLE-EPSNAYGLPESEFL-IVLRDVV 122
Query: 297 KALAYLHEAIEPKVVHRDIKSSNILI----DDEFNAKVSDFGLAKLLDSGESHITTRVMG 352
+ +L E +VHR+IK NI+ D + K++DFG A+ L+ E + G
Sbjct: 123 GGMNHLREN---GIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDE-QFVSLY-G 177
Query: 353 TFGYVAPEYANTGML--------NEKSDIYSFGVLLLEAVTGRDP-VDYGRPANEVNLVE 403
T Y+ P+ +L D++S GV A TG P + P ++
Sbjct: 178 TEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMY 237
Query: 404 -------------WLKMMVGTRRAEEVVDPNLEVKPATRALKRSLLVALRCVDPDSEKRP 450
K G + + + + L +L + D EK
Sbjct: 238 KIITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQ--EKCW 295
Query: 451 KMSQV 455
Q
Sbjct: 296 GFDQF 300
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396 | Back alignment and structure |
|---|
Score = 133 bits (337), Expect = 7e-35
Identities = 64/310 (20%), Positives = 107/310 (34%), Gaps = 42/310 (13%)
Query: 183 IATNRFSAENVLGEGGYGVVYKGR-LINGSEVAVKKL-LNNLGQAEKEFRVEVEAIGHVR 240
+ + + ++LG+G V++GR G A+K + + E E + +
Sbjct: 6 TSNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLN 65
Query: 241 HKNLVRLLGYCIEGVHRMLVY---EYVNNGNLEQWLHGAMRNQGNLT-WEARMKVIIGTA 296
HKN+V+L E E+ G+L L N L E V+
Sbjct: 66 HKNIVKLFA-IEEETTTRHKVLIMEFCPCGSLYTVLE-EPSNAYGLPESEFL-IVLRDVV 122
Query: 297 KALAYLHEAIEPKVVHRDIKSSNILI----DDEFNAKVSDFGLAKLLDSGESHITTRVMG 352
+ +L E +VHR+IK NI+ D + K++DFG A+ L+ E + G
Sbjct: 123 GGMNHLREN---GIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDE-QFVSLY-G 177
Query: 353 TFGYVAPEYANTGML--------NEKSDIYSFGVLLLEAVTGRDP-VDYGRPANEVNLVE 403
T Y+ P+ +L D++S GV A TG P + P ++
Sbjct: 178 TEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMY 237
Query: 404 -------------WLKMMVGTRRAEEVVDPNLEVKPATRALKRSLLVALRCVDPDSEKRP 450
K G + + + + L +L + D EK
Sbjct: 238 KIITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQ--EKCW 295
Query: 451 KMSQVVRMLE 460
Q
Sbjct: 296 GFDQFFAETS 305
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322 | Back alignment and structure |
|---|
Score = 132 bits (333), Expect = 8e-35
Identities = 58/239 (24%), Positives = 106/239 (44%), Gaps = 27/239 (11%)
Query: 180 DLEIATNRFSAENVLGEGGYGVVYKGRLINGSE------VAVKKLLNNLGQAEK-EFRVE 232
+ E+A + + LG+G +G+VY+G + VA+K + E+ EF E
Sbjct: 19 EWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNE 78
Query: 233 VEAIGHVRHKNLVRLLGYCIEGVHRMLVYEYVNNGNLEQWL------HGAMRNQGNLTWE 286
+ ++VRLLG +G +++ E + G+L+ +L +
Sbjct: 79 ASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLS 138
Query: 287 ARMKVIIGTAKALAYLHEAIEPKVVHRDIKSSNILIDDEFNAKVSDFGLAKLLDSGESHI 346
+++ A +AYL+ K VHRD+ + N ++ ++F K+ DFG+ + + + +
Sbjct: 139 KMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYY- 194
Query: 347 TTRVMGTFGYV-----APEYANTGMLNEKSDIYSFGVLLLEAVT-GRDPVDYGRPANEV 399
G G + +PE G+ SD++SFGV+L E T P G +V
Sbjct: 195 ---RKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPY-QGLSNEQV 249
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 130 bits (330), Expect = 9e-35
Identities = 65/210 (30%), Positives = 93/210 (44%), Gaps = 18/210 (8%)
Query: 186 NRFSAENVLGEGGYGVVYKGR-LINGSEVAVKKL----LNNLGQAEKEFRVEVEAIGHVR 240
F LG+G +G VY R + +A+K L L G + R EVE H+R
Sbjct: 9 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQ-LRREVEIQSHLR 67
Query: 241 HKNLVRLLGYCIEGVHRMLVYEYVNNGNLEQWLHGAMRNQGNLT-WEARMKVIIGTAKAL 299
H N++RL GY + L+ EY G + + L + I A AL
Sbjct: 68 HPNILRLYGYFHDATRVYLILEYAPLGTVYREL----QKLSKFDEQRTA-TYITELANAL 122
Query: 300 AYLHEAIEPKVVHRDIKSSNILIDDEFNAKVSDFGLAKLLDSGESHITTRVMGTFGYVAP 359
+Y H +V+HRDIK N+L+ K++DFG + S GT Y+ P
Sbjct: 123 SYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAPS-SRRTDL--CGTLDYLPP 176
Query: 360 EYANTGMLNEKSDIYSFGVLLLEAVTGRDP 389
E M +EK D++S GVL E + G+ P
Sbjct: 177 EMIEGRMHDEKVDLWSLGVLCYEFLVGKPP 206
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313 | Back alignment and structure |
|---|
Score = 131 bits (332), Expect = 9e-35
Identities = 62/297 (20%), Positives = 124/297 (41%), Gaps = 45/297 (15%)
Query: 178 LRDLEIATNRFSAENVLGEGGYGVVYKGRLINGSEVAVKKL-LNNLGQAEKE-FRVEVEA 235
+ + + +S +G GG V++ A+K + L + +R E+
Sbjct: 20 FQSMSVKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAY 79
Query: 236 IGHVRHKNL--VRLLGYCIEGVHRMLVYEYVNNGNLEQWLHGAMRNQGNLT-WEAR--MK 290
+ ++ + +RL Y I + +V E N +L WL + + ++ WE + K
Sbjct: 80 LNKLQQHSDKIIRLYDYEITDQYIYMVMECG-NIDLNSWL----KKKKSIDPWERKSYWK 134
Query: 291 VIIGTAKALAYLHEAIEPKVVHRDIKSSNILIDDEFNAKVSDFGLAKLLDSGESHITTR- 349
++ +A+ +H+ +VH D+K +N LI D K+ DFG+A + + +
Sbjct: 135 NML---EAVHTIHQH---GIVHSDLKPANFLIVDG-MLKLIDFGIANQMQPDTTSVVKDS 187
Query: 350 VMGTFGYVAPE-----------YANTGMLNEKSDIYSFGVLLLEAVTGRDPVDYGRPANE 398
+GT Y+ PE + ++ KSD++S G +L G+ P + + N+
Sbjct: 188 QVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTP--FQQIINQ 245
Query: 399 VNLVEWLKMMVGTRRAEEVVDPNLEVKPATRALKRSLLVALRCVDPDSEKRPKMSQV 455
++ K+ E+ P++ K LK L DP ++R + ++
Sbjct: 246 IS-----KLHAIIDPNHEIEFPDIPEKDLQDVLKCCL-----KRDP--KQRISIPEL 290
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 131 bits (332), Expect = 9e-35
Identities = 69/277 (24%), Positives = 109/277 (39%), Gaps = 34/277 (12%)
Query: 187 RFSAENVLGEGGYGVVYKGR-LINGSEVAVKKL-LNNLGQAEKE-FRVEVEAIGHV-RHK 242
F + LG G YG V+K R +G AVK+ G ++ EV + V +H
Sbjct: 58 SFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHP 117
Query: 243 NLVRLLGYCIEGVHRMLVYEYVNNGNLEQWLHGAMRNQGNLTWEARMKVIIG-TAKALAY 301
VRL EG L E +L+Q G EA++ + T ALA+
Sbjct: 118 CCVRLEQAWEEGGILYLQTELCG-PSLQQHC----EAWGASLPEAQVWGYLRDTLLALAH 172
Query: 302 LHEAIEPKVVHRDIKSSNILIDDEFNAKVSDFGLAKLLDSGESHITTRVMGTFGYVAPEY 361
LH +VH D+K +NI + K+ DFGL L + + G Y+APE
Sbjct: 173 LHSQ---GLVHLDVKPANIFLGPRGRCKLGDFGLLVELGTAGAGEV--QEGDPRYMAPEL 227
Query: 362 ANTGMLNEKSDIYSFGVLLLEAVTGRDPVDYGRPANEVNLVEWLKMMVGTRRAEEVVDPN 421
+D++S G+ +LE + G W ++ G + P
Sbjct: 228 LQGS-YGTAADVFSLGLTILEVACNMELPHGGEG--------WQQLRQG------YLPPE 272
Query: 422 LEVKPATRALKRSLLVALRCVDPDSEKRPKMSQVVRM 458
+ L RS+L + ++PD + R ++ +
Sbjct: 273 FT-AGLSSEL-RSVL--VMMLEPDPKLRATAEALLAL 305
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327 | Back alignment and structure |
|---|
Score = 130 bits (330), Expect = 2e-34
Identities = 76/304 (25%), Positives = 128/304 (42%), Gaps = 53/304 (17%)
Query: 182 EIATNRFSAENVLGEGGYGVVYKGRLINGSE---VAVKKLLNNLGQAEK-EFRVEVEAIG 237
+ N ++V+GEG +G V K R+ A+K++ + + +F E+E +
Sbjct: 21 VLDWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLC 80
Query: 238 HV-RHKNLVRLLGYCIEGVHRMLVYEYVNNGNLEQWL------------HGAMRNQGNLT 284
+ H N++ LLG C + L EY +GNL +L A L+
Sbjct: 81 KLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLS 140
Query: 285 WEARMKVIIGTAKALAYLHEAIEPKVVHRDIKSSNILIDDEFNAKVSDFGLAKLLDSGES 344
+ + A+ + YL + + +HRD+ + NIL+ + + AK++DFGL++ +
Sbjct: 141 SQQLLHFAADVARGMDYLSQK---QFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVK 197
Query: 345 HITTRV----MGTFGYVAPEYANTGMLNEKSDIYSFGVLLLEAVT-GRDPVDY-GRPANE 398
R+ M A E N + SD++S+GVLL E V+ G P Y G E
Sbjct: 198 KTMGRLPVRWM------AIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTP--YCGMTCAE 249
Query: 399 VNLVEWLKMMVGTRRAEEVVDPNLEVKPA--TRALKRSLLVALRCVDPDSEKRPKMSQVV 456
+ E L G R LE KP + + +C +RP +Q++
Sbjct: 250 L--YEKLPQ--GYR---------LE-KPLNCDDEVYD---LMRQCWREKPYERPSFAQIL 292
Query: 457 RMLE 460
L
Sbjct: 293 VSLN 296
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343 | Back alignment and structure |
|---|
Score = 130 bits (330), Expect = 3e-34
Identities = 59/289 (20%), Positives = 122/289 (42%), Gaps = 45/289 (15%)
Query: 186 NRFSAENVLGEGGYGVVYKGRLINGSEVAVKKL-LNNLGQAEKE-FRVEVEAIGHVRHKN 243
+S +G GG V++ A+K + L + +R E+ + ++ +
Sbjct: 9 RIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHS 68
Query: 244 L--VRLLGYCIEGVHRMLVYEYVNNGNLEQWLHGAMRNQGNLT-WEAR--MKVIIGTAKA 298
+RL Y I + +V E N +L WL + + ++ WE + K ++ +A
Sbjct: 69 DKIIRLYDYEITDQYIYMVMECG-NIDLNSWL----KKKKSIDPWERKSYWKNML---EA 120
Query: 299 LAYLHEAIEPKVVHRDIKSSNILIDDEFNAKVSDFGLAKLLDSGESHITTR-VMGTFGYV 357
+ +H+ +VH D+K +N LI D K+ DFG+A + + + +GT Y+
Sbjct: 121 VHTIHQH---GIVHSDLKPANFLIVDG-MLKLIDFGIANQMQPDTTSVVKDSQVGTVNYM 176
Query: 358 APE-----------YANTGMLNEKSDIYSFGVLLLEAVTGRDPVDYGRPANEVNLVEWLK 406
PE + ++ KSD++S G +L G+ P + + N+++ K
Sbjct: 177 PPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTP--FQQIINQIS-----K 229
Query: 407 MMVGTRRAEEVVDPNLEVKPATRALKRSLLVALRCVDPDSEKRPKMSQV 455
+ E+ P++ + + + + L DP ++R + ++
Sbjct: 230 LHAIIDPNHEIEFPDI-PEKDLQDVLKCCLK----RDP--KQRISIPEL 271
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289 | Back alignment and structure |
|---|
Score = 129 bits (326), Expect = 3e-34
Identities = 54/243 (22%), Positives = 94/243 (38%), Gaps = 44/243 (18%)
Query: 182 EIATNRFSAENVLGEGGYGVVYKGRLINGS--------EVAVKKLLNNLGQAEKEFRVEV 233
+I LG+G + ++KG EV +K L + F
Sbjct: 4 KIRNEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAA 63
Query: 234 EAIGHVRHKNLVRLLGYCIEGVHRMLVYEYVNNGNLEQWLHGAMRNQGNLTWEARMKVII 293
+ + HK+LV G C+ G +LV E+V G+L+ +L +N+ + +++V
Sbjct: 64 SMMSKLSHKHLVLNYGVCVCGDENILVQEFVKFGSLDTYLK---KNKNCINILWKLEVAK 120
Query: 294 GTAKALAYLHEAIEPKVVHRDIKSSNILIDDEFN--------AKVSDFGLAKLLDSGESH 345
A A+ +L E ++H ++ + NIL+ E + K+SD G++ + +
Sbjct: 121 QLAAAMHFLEEN---TLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLPKD-- 175
Query: 346 ITTRVMGTFGY------VAPE-YANTGMLNEKSDIYSFGVLLLEAVT-GRDPVDY-GRPA 396
V PE N LN +D +SFG L E + G P +
Sbjct: 176 ---------ILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKP--LSALDS 224
Query: 397 NEV 399
Sbjct: 225 QRK 227
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 130 bits (329), Expect = 3e-34
Identities = 72/307 (23%), Positives = 136/307 (44%), Gaps = 46/307 (14%)
Query: 179 RDLEIATNRFSAENVLGEGGYGVVYKGR-LINGSEVAVKKLLNNLGQAEKEFRVEVEAIG 237
+ +E+ R VL EGG+ VY+ + + +G E A+K+LL+N + + EV +
Sbjct: 21 QTVELGELRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMK 80
Query: 238 HVR-HKNLVRLLGYCIEGVHRM-------LVYEYVNNGNLEQWLHGAMRNQGNLTWEARM 289
+ H N+V+ G L+ + G L ++L M ++G L+ + +
Sbjct: 81 KLSGHPNIVQFCSAASIGKEESDTGQAEFLLLTELCKGQLVEFLK-KMESRGPLSCDTVL 139
Query: 290 KVIIGTAKALAYLHEAIEPKVVHRDIKSSNILIDDEFNAKVSDFGLAKLLDSGESHITTR 349
K+ T +A+ ++H +P ++HRD+K N+L+ ++ K+ DFG A + + +
Sbjct: 140 KIFYQTCRAVQHMHRQ-KPPIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYSWSA 198
Query: 350 VM-----------GTFGYVAPE----YANTGMLNEKSDIYSFGVLLLEAVTGRDPVDYGR 394
T Y PE Y+N + EK DI++ G +L + P + G
Sbjct: 199 QRRALVEEEITRNTTPMYRTPEIIDLYSN-FPIGEKQDIWALGCILYLLCFRQHPFEDGA 257
Query: 395 PANEVNLVEWLKMMVGTRRAEEVVDPNLEVKPATRALKRSLLVALRCVDPDSEKRPKMSQ 454
L+++ G + P+ +L R++L V+P E+R +++
Sbjct: 258 K---------LRIVNGKYS----IPPHDTQYTVFHSLIRAMLQ----VNP--EERLSIAE 298
Query: 455 VVRMLEA 461
VV L+
Sbjct: 299 VVHQLQE 305
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278 | Back alignment and structure |
|---|
Score = 128 bits (325), Expect = 4e-34
Identities = 72/281 (25%), Positives = 119/281 (42%), Gaps = 38/281 (13%)
Query: 186 NRFSAENVLGEGGYGVVYKGR-LINGSEVAVK----KLLNNLGQAEKEFRVEVEAIGHVR 240
F N+LG+G + VY+ + G EVA+K K + G ++ EV+ ++
Sbjct: 11 EDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQN-EVKIHCQLK 69
Query: 241 HKNLVRLLGYCIEGVHRM-LVYEYVNNGNLEQWLHGAMRNQGNLT-WEAR--MKVIIGTA 296
H +++ L Y E + + LV E +NG + ++L + EAR M II
Sbjct: 70 HPSILELYNY-FEDSNYVYLVLEMCHNGEMNRYLK---NRVKPFSENEARHFMHQIIT-- 123
Query: 297 KALAYLHEAIEPKVVHRDIKSSNILIDDEFNAKVSDFGLAKLLDSGESHITTRVMGTFGY 356
+ YLH ++HRD+ SN+L+ N K++DFGLA L T + GT Y
Sbjct: 124 -GMLYLHSH---GILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHEKHYT-LCGTPNY 178
Query: 357 VAPEYANTGMLNEKSDIYSFGVLLLEAVTGRDPVDYGRPANEVNLVEWLKMMVGTRRAEE 416
++PE A +SD++S G + + GR P D + L + +
Sbjct: 179 ISPEIATRSAHGLESDVWSLGCMFYTLLIGRPPFD------TDTVKNTLNKV----VLAD 228
Query: 417 VVDPNLEVKPATRALKRSLLVALRCVDPDSEKRPKMSQVVR 457
P+ + + L LL + R +S V+
Sbjct: 229 YEMPS-FLSIEAKDLIHQLL------RRNPADRLSLSSVLD 262
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327 | Back alignment and structure |
|---|
Score = 130 bits (328), Expect = 4e-34
Identities = 68/299 (22%), Positives = 117/299 (39%), Gaps = 42/299 (14%)
Query: 182 EIATNRFSAENVLGEGGYGVVYKGRLINGS------EVAVKKLLNNLGQAEK-EFRVEVE 234
E+ + LG G +G VY+G++ +VAVK L + ++ +F +E
Sbjct: 26 EVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEAL 85
Query: 235 AIGHVRHKNLVRLLGYCIEGVHRMLVYEYVNNGNLEQWLHGAMRNQGN---LTWEARMKV 291
I H+N+VR +G ++ + R ++ E + G+L+ +L L + V
Sbjct: 86 IISKFNHQNIVRCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHV 145
Query: 292 IIGTAKALAYLHEAIEPKVVHRDIKSSNILID---DEFNAKVSDFGLAKLLDSGESHITT 348
A YL E +HRDI + N L+ AK+ DFG+A+ +
Sbjct: 146 ARDIACGCQYLEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAS----Y 198
Query: 349 RVMGTFGYV-----APEYANTGMLNEKSDIYSFGVLLLEAVT-GRDPVDYGRPANEVNLV 402
G + PE G+ K+D +SFGVLL E + G P + EV
Sbjct: 199 YRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPY-PSKSNQEV--- 254
Query: 403 EWLKMMVGTRRAEEVVDPNLEVKPATRALKRSLLVALRCVDPDSEKRPKMSQVVRMLEA 461
L+ + R ++ ++ +C E RP + ++ +E
Sbjct: 255 --LEFVTSGGR--------MDPPKNCPGPVYRIM--TQCWQHQPEDRPNFAIILERIEY 301
|
| >3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297 | Back alignment and structure |
|---|
Score = 129 bits (326), Expect = 4e-34
Identities = 64/242 (26%), Positives = 108/242 (44%), Gaps = 32/242 (13%)
Query: 182 EIATNRFSAENVLGEGGYGVVYKGRLINGSE------VAVKKLLNNLGQAEKEFRVEVEA 235
I + LGEG +G V+ N S VAVK L + A K+F+ E E
Sbjct: 11 HIKRRDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAEL 70
Query: 236 IGHVRHKNLVRLLGYCIEGVHRMLVYEYVNNGNLEQWL------------HGAMRNQGNL 283
+ +++H+++V+ G C +G ++V+EY+ +G+L ++L + +G L
Sbjct: 71 LTNLQHEHIVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGEL 130
Query: 284 TWEARMKVIIGTAKALAYLHEAIEPKVVHRDIKSSNILIDDEFNAKVSDFGLAKLLDSGE 343
+ + A + YL VHRD+ + N L+ K+ DFG+++ + S +
Sbjct: 131 GLSQMLHIASQIASGMVYLASQ---HFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTD 187
Query: 344 SHITTRVMGTFGYV-----APEYANTGMLNEKSDIYSFGVLLLEAVT-GRDPVDYGRPAN 397
RV G + PE +SD++SFGV+L E T G+ P +
Sbjct: 188 ---YYRVGGH-TMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPW-FQLSNT 242
Query: 398 EV 399
EV
Sbjct: 243 EV 244
|
| >3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289 | Back alignment and structure |
|---|
Score = 128 bits (323), Expect = 1e-33
Identities = 76/307 (24%), Positives = 128/307 (41%), Gaps = 52/307 (16%)
Query: 182 EIATNRFSAENVLGEGGYGVVYKGRLINGSE------VAVKKLLNNL-GQAEKEFRVEVE 234
EI+ + LGE +G VYKG L + VA+K L + G +EFR E
Sbjct: 5 EISLSAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAM 64
Query: 235 AIGHVRHKNLVRLLGYCIEGVHRMLVYEYVNNGNLEQWL------------HGAMRNQGN 282
++H N+V LLG + +++ Y ++G+L ++L +
Sbjct: 65 LRARLQHPNVVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSA 124
Query: 283 LTWEARMKVIIGTAKALAYLHEAIEPKVVHRDIKSSNILIDDEFNAKVSDFGLAKLLDS- 341
L + ++ A + YL VVH+D+ + N+L+ D+ N K+SD GL + + +
Sbjct: 125 LEPPDFVHLVAQIAAGMEYLSSH---HVVHKDLATRNVLVYDKLNVKISDLGLFREVYAA 181
Query: 342 ------GESHITTRVMGTFGYVAPEYANTGMLNEKSDIYSFGVLLLEAVT-GRDPVDYGR 394
G S + R M APE G + SDI+S+GV+L E + G P G
Sbjct: 182 DYYKLLGNSLLPIRWM------APEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPY-CGY 234
Query: 395 PANEVNLVEWLKMMVGTRRAEEVVDPNLEVKPATRALKRSLLVALRCVDPDSEKRPKMSQ 454
+V ++M+ + L A +L+ + C + +RP+
Sbjct: 235 SNQDV-----VEMIRNRQV--------LPCPDDCPAWVYALM--IECWNEFPSRRPRFKD 279
Query: 455 VVRMLEA 461
+ L A
Sbjct: 280 IHSRLRA 286
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367 | Back alignment and structure |
|---|
Score = 129 bits (327), Expect = 1e-33
Identities = 80/364 (21%), Positives = 137/364 (37%), Gaps = 47/364 (12%)
Query: 122 SSVHHHERACSSQSGEEGSSGAGHKHSSLSYGGL----VTASPLIGLPEISHLGWGHWFT 177
S HHH E G S L + S ++ ++ G +
Sbjct: 2 SYYHHHHHHDYDIPTTENLYFQGAMGSELQSPEYKLSKLRTSTIMTDYNPNYCFAGKTSS 61
Query: 178 LRDL-EIATNRFSAENVLGEGGYGVVYKGRLINGS------EVAVKKLLNNLGQAEK-EF 229
+ DL E+ + LG G +G VY+G++ +VAVK L + ++ +F
Sbjct: 62 ISDLKEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDF 121
Query: 230 RVEVEAIGHVRHKNLVRLLGYCIEGVHRMLVYEYVNNGNLEQWLH---GAMRNQGNLTWE 286
+E I H+N+VR +G ++ + R ++ E + G+L+ +L +L
Sbjct: 122 LMEALIISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAML 181
Query: 287 ARMKVIIGTAKALAYLHEAIEPKVVHRDIKSSNILID---DEFNAKVSDFGLAKLLDSGE 343
+ V A YL E +HRDI + N L+ AK+ DFG+A+ +
Sbjct: 182 DLLHVARDIACGCQYLEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAG 238
Query: 344 SHITTRVMGTFGYV-----APEYANTGMLNEKSDIYSFGVLLLEAVT-GRDPVDYGRPAN 397
G + PE G+ K+D +SFGVLL E + G P +
Sbjct: 239 ----YYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPY-PSKSNQ 293
Query: 398 EVNLVEWLKMMVGTRRAEEVVDPNLEVKPATRALKRSLLVALRCVDPDSEKRPKMSQVVR 457
EV L+ + R ++ ++ +C E RP + ++
Sbjct: 294 EV-----LEFVTSGGR--------MDPPKNCPGPVYRIM--TQCWQHQPEDRPNFAIILE 338
Query: 458 MLEA 461
+E
Sbjct: 339 RIEY 342
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284 | Back alignment and structure |
|---|
Score = 127 bits (322), Expect = 1e-33
Identities = 64/210 (30%), Positives = 94/210 (44%), Gaps = 18/210 (8%)
Query: 186 NRFSAENVLGEGGYGVVYKGR-LINGSEVAVKKL----LNNLGQAEKEFRVEVEAIGHVR 240
+ F LG+G +G VY R N +A+K L L G + R E+E H+R
Sbjct: 14 DDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRR-EIEIQSHLR 72
Query: 241 HKNLVRLLGYCIEGVHRMLVYEYVNNGNLEQWLHGAMRNQGNLT-WEARMKVIIGTAKAL 299
H N++R+ Y + L+ E+ G L + L + G + + A AL
Sbjct: 73 HPNILRMYNYFHDRKRIYLMLEFAPRGELYKEL----QKHGRFDEQRSA-TFMEELADAL 127
Query: 300 AYLHEAIEPKVVHRDIKSSNILIDDEFNAKVSDFGLAKLLDSGESHITTRVMGTFGYVAP 359
Y HE KV+HRDIK N+L+ + K++DFG + S T GT Y+ P
Sbjct: 128 HYCHER---KVIHRDIKPENLLMGYKGELKIADFGWSVHAPSLRRR-TM--CGTLDYLPP 181
Query: 360 EYANTGMLNEKSDIYSFGVLLLEAVTGRDP 389
E +EK D++ GVL E + G P
Sbjct: 182 EMIEGKTHDEKVDLWCAGVLCYEFLVGMPP 211
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390 | Back alignment and structure |
|---|
Score = 129 bits (326), Expect = 3e-33
Identities = 67/350 (19%), Positives = 135/350 (38%), Gaps = 51/350 (14%)
Query: 125 HHHERACSSQSGEEGSSGAGHKHSSLSYGGLVTASPLIGLPEISHLGWGHWFTLRDLEIA 184
HHH SS GS + + + + + +++
Sbjct: 1 HHHHHH-SSGLVPRGSGMKETAAAKFERQHMDSPDLGTDDDDKASSSANECISVKG---- 55
Query: 185 TNRFSAENVLGEGGYGVVYKGRLINGSEVAVKKL-LNNLGQAEKE-FRVEVEAIGHVRHK 242
+S +G GG V++ A+K + L + +R E+ + ++
Sbjct: 56 -RIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQH 114
Query: 243 NL--VRLLGYCIEGVHRMLVYEYVNNGNLEQWLHGAMRNQGNLT-WEAR--MKVIIGTAK 297
+ +RL Y I + +V E N +L WL + + ++ WE + K ++ +
Sbjct: 115 SDKIIRLYDYEITDQYIYMVMECG-NIDLNSWL----KKKKSIDPWERKSYWKNML---E 166
Query: 298 ALAYLHEAIEPKVVHRDIKSSNILIDDEFNAKVSDFGLAKLLDSGESHITTR-VMGTFGY 356
A+ +H+ +VH D+K +N LI D K+ DFG+A + + + +G Y
Sbjct: 167 AVHTIHQH---GIVHSDLKPANFLIVDG-MLKLIDFGIANQMQPDTTSVVKDSQVGAVNY 222
Query: 357 VAPE-----------YANTGMLNEKSDIYSFGVLLLEAVTGRDPVDYGRPANEVNLVEWL 405
+ PE + ++ KSD++S G +L G+ P + + N+++
Sbjct: 223 MPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTP--FQQIINQIS----- 275
Query: 406 KMMVGTRRAEEVVDPNLEVKPATRALKRSLLVALRCVDPDSEKRPKMSQV 455
K+ E+ P++ K LK C+ D ++R + ++
Sbjct: 276 KLHAIIDPNHEIEFPDIPEKDLQDVLK-------CCLKRDPKQRISIPEL 318
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676 | Back alignment and structure |
|---|
Score = 131 bits (331), Expect = 7e-33
Identities = 70/287 (24%), Positives = 110/287 (38%), Gaps = 36/287 (12%)
Query: 193 VLGEGGYGVVYKGR-LINGSEVAVKKLLNNLGQAEKE-FRVEVEAIGHVRHKNLVRLL-- 248
LG GG+G V + G +VA+K+ L +E + +E++ + + H N+V
Sbjct: 21 RLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREV 80
Query: 249 ----GYCIEGVHRMLVYEYVNNGNLEQWLHGAMRNQGNLT-WEAR--MKVIIGTAKALAY 301
+L EY G+L ++L+ N L R + I AL Y
Sbjct: 81 PDGLQKLAPNDLPLLAMEYCEGGDLRKYLN-QFENCCGLKEGPIRTLLSDIS---SALRY 136
Query: 302 LHEAIEPKVVHRDIKSSNILIDDEFNA---KVSDFGLAKLLDSGESHITTRVMGTFGYVA 358
LHE +++HRD+K NI++ K+ D G AK LD GE T V GT Y+A
Sbjct: 137 LHEN---RIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGE-LCTEFV-GTLQYLA 191
Query: 359 PEYANTGMLNEKSDIYSFGVLLLEAVTGRDPVDYGRPANE----------VNLVEWLKMM 408
PE D +SFG L E +TG P + ++V + +
Sbjct: 192 PELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQPVQWHGKVREKSNEHIVVYDDLT 251
Query: 409 VGTRRAEEVVDPNLEVKPATRALKRSLLVALRCVDPDSEKRPKMSQV 455
+ + + PN + L + +R Q
Sbjct: 252 GAVKFSSVLPTPN-HLSGILAGKLERWLQCMLMWHQ--RQRGTDPQN 295
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432 | Back alignment and structure |
|---|
Score = 128 bits (323), Expect = 1e-32
Identities = 66/281 (23%), Positives = 113/281 (40%), Gaps = 36/281 (12%)
Query: 187 RFSAENVLGEGGYGVVYKGRLINGSEVAVKKLL-NNLGQAEKEFRVEVEAIGHV-RHKNL 244
F ++VLG G G + + + +VAVK++L A++ EV+ + H N+
Sbjct: 25 SFCPKDVLGHGAEGTIVYRGMFDNRDVAVKRILPECFSFADR----EVQLLRESDEHPNV 80
Query: 245 VRLLGYCIEGVHRMLVYEYVNNGNLEQWLHGAMRNQGNLTWEARMKVIIGTAKALAYLHE 304
+R + + + E L++++ + + ++ T LA+LH
Sbjct: 81 IRYFCTEKDRQFQYIAIELC-AATLQEYVE---QKDFAHLGLEPITLLQQTTSGLAHLHS 136
Query: 305 AIEPKVVHRDIKSSNILI-----DDEFNAKVSDFGLAKLLDSGESHITTR--VMGTFGYV 357
+VHRD+K NILI + A +SDFGL K L G + R V GT G++
Sbjct: 137 L---NIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTEGWI 193
Query: 358 APEY---ANTGMLNEKSDIYSFGVLLLEAVTGRDPVDYGRPANEVNLVEWLKMMVGTRRA 414
APE DI+S G + ++ G +L +++G
Sbjct: 194 APEMLSEDCKENPTYTVDIFSAGCVFYYVISE------GSHPFGKSLQRQANILLGACSL 247
Query: 415 EEVVDPNLEVKPATRALKRSLLVALRCVDPDSEKRPKMSQV 455
+ + P R L ++ +DP +KRP V
Sbjct: 248 DC-LHPEKHEDVIARELIEKMI----AMDP--QKRPSAKHV 281
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289 | Back alignment and structure |
|---|
Score = 124 bits (314), Expect = 2e-32
Identities = 62/298 (20%), Positives = 109/298 (36%), Gaps = 53/298 (17%)
Query: 185 TNRFSAENVLGEGGYGVVYKGR-LINGSEVAVKKL-LNNLGQAEKEFRV-EVEAIGHV-R 240
T F +G G +G V+K ++G A+K+ G +++ + EV A + +
Sbjct: 10 TTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQ 69
Query: 241 HKNLVRLLGYCIEGVHRMLVYEYVNNGNLEQWLHGAMRNQGNLTWEARMKVIIG-TAKAL 299
H ++VR E H ++ EY N G+L + R EA +K ++ + L
Sbjct: 70 HSHVVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFK-EAELKDLLLQVGRGL 128
Query: 300 AYLHEAIEPKVVHRDIKSSNILIDDE-------------------FNAKVSDFGLAKLLD 340
Y+H +VH DIK SNI I K+ D G +
Sbjct: 129 RYIHSM---SLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTRIS 185
Query: 341 SGESHITTRVMGTFGYVAPE-YANTGMLNEKSDIYSFGVLLLEAVTGRDPVDYGRPANEV 399
S + G ++A E K+DI++ + ++ A G
Sbjct: 186 SPQVEE-----GDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNGDQ---- 236
Query: 400 NLVEWLKMMVGTRRAEEVVDPNLEVKPATRALKRSLLVALRCVDPDSEKRPKMSQVVR 457
W ++ G P + ++ L+ + + PD E+RP +V+
Sbjct: 237 ----WHEIRQGRL-------PRIPQV-LSQEFTE--LLKV-MIHPDPERRPSAMALVK 279
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334 | Back alignment and structure |
|---|
Score = 125 bits (317), Expect = 2e-32
Identities = 71/289 (24%), Positives = 123/289 (42%), Gaps = 53/289 (18%)
Query: 142 GAGHKHSSLSYGGLVTASPLIGLPEISHLGWGHWFTLRDLEIATNRFSAENVLGEGGYGV 201
G+ H H S ++ LPE W E ++ + LGEG +G
Sbjct: 2 GSSHHHHHHSQDPMLAGVSEYELPEDPK-----W------EFPRDKLTLGKPLGEGAFGQ 50
Query: 202 VYKGRLI--------NGSEVAVKKLLNNLGQAEK-EFRVEVEAIGHV-RHKNLVRLLGYC 251
V + VAVK L ++ + + + E+E + + +HKN++ LLG C
Sbjct: 51 VVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGAC 110
Query: 252 IEGVHRMLVYEYVNNGNLEQWL------------HGAMRNQGNLTWEARMKVIIGTAKAL 299
+ ++ EY + GNL ++L + +T++ + A+ +
Sbjct: 111 TQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGM 170
Query: 300 AYLHEAIEPKVVHRDIKSSNILIDDEFNAKVSDFGLAKLLDSGESHITTRV-------MG 352
YL K +HRD+ + N+L+ + K++DFGLA+ +++ + + T M
Sbjct: 171 EYLASQ---KCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWM- 226
Query: 353 TFGYVAPEYANTGMLNEKSDIYSFGVLLLEAVT-GRDPVDY-GRPANEV 399
APE + +SD++SFGVL+ E T G P Y G P E+
Sbjct: 227 -----APEALFDRVYTHQSDVWSFGVLMWEIFTLGGSP--YPGIPVEEL 268
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343 | Back alignment and structure |
|---|
Score = 124 bits (314), Expect = 5e-32
Identities = 63/256 (24%), Positives = 105/256 (41%), Gaps = 43/256 (16%)
Query: 178 LRDLEIATNRFSAENVLGEGGYGVVYKGRLINGSE------VAVKKLLNNLGQAEK-EFR 230
L LE N +GEG +G V++ R VAVK L + +F+
Sbjct: 39 LLSLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQ 98
Query: 231 VEVEAIGHVRHKNLVRLLGYCIEGVHRMLVYEYVNNGNLEQWL----------------- 273
E + + N+V+LLG C G L++EY+ G+L ++L
Sbjct: 99 REAALMAEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLS 158
Query: 274 ---HGAMRNQGNLTWEARMKVIIGTAKALAYLHEAIEPKVVHRDIKSSNILIDDEFNAKV 330
+ L+ ++ + A +AYL E K VHRD+ + N L+ + K+
Sbjct: 159 TRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSER---KFVHRDLATRNCLVGENMVVKI 215
Query: 331 SDFGLAKLLDSGESHITTRVMGTFGYV-----APEYANTGMLNEKSDIYSFGVLLLEAVT 385
+DFGL++ + S + + + PE +SD++++GV+L E +
Sbjct: 216 ADFGLSRNIYSADYY----KADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFS 271
Query: 386 -GRDPVDY-GRPANEV 399
G P Y G EV
Sbjct: 272 YGLQP--YYGMAHEEV 285
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314 | Back alignment and structure |
|---|
Score = 123 bits (311), Expect = 8e-32
Identities = 65/254 (25%), Positives = 103/254 (40%), Gaps = 47/254 (18%)
Query: 182 EIATNRFSAENVLGEGGYGVVYKGRLINGSE------VAVKKLLNNLGQAEK-EFRVEVE 234
E LGEG +G V K + VAVK L N +E + E
Sbjct: 19 EFPRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFN 78
Query: 235 AIGHVRHKNLVRLLGYCIEGVHRMLVYEYVNNGNLEQWL----HGAMRNQGNLTWEARMK 290
+ V H ++++L G C + +L+ EY G+L +L G+
Sbjct: 79 VLKQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSS 138
Query: 291 VIIGT----------------AKALAYLHEAIEPKVVHRDIKSSNILIDDEFNAKVSDFG 334
+ ++ + YL E K+VHRD+ + NIL+ + K+SDFG
Sbjct: 139 LDHPDERALTMGDLISFAWQISQGMQYLAEM---KLVHRDLAARNILVAEGRKMKISDFG 195
Query: 335 LAKLLDSGESHITT-------RVMGTFGYVAPEYANTGMLNEKSDIYSFGVLLLEAVT-G 386
L++ + +S++ + M A E + +SD++SFGVLL E VT G
Sbjct: 196 LSRDVYEEDSYVKRSQGRIPVKWM------AIESLFDHIYTTQSDVWSFGVLLWEIVTLG 249
Query: 387 RDPVDY-GRPANEV 399
+P Y G P +
Sbjct: 250 GNP--YPGIPPERL 261
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316 | Back alignment and structure |
|---|
Score = 123 bits (311), Expect = 9e-32
Identities = 80/312 (25%), Positives = 124/312 (39%), Gaps = 61/312 (19%)
Query: 182 EIATNRFSAENVLGEGGYGVVYKGRLINGSE------VAVKKLLNNLGQAEK-EFRVEVE 234
E +R LG G +G V + + VAVK L +E E++
Sbjct: 23 EFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELK 82
Query: 235 AIGHV-RHKNLVRLLGYC-IEGVHRMLVYEYVNNGNLEQWLHGAMRNQGNLTWEARMKVI 292
+ H+ H N+V LLG C G M++ E+ GNL +L + RN+ A +
Sbjct: 83 ILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLR-SKRNEFVPYKVAPEDLY 141
Query: 293 IGT-------------AKALAYLHEAIEPKVVHRDIKSSNILIDDEFNAKVSDFGLAKLL 339
AK + +L K +HRD+ + NIL+ ++ K+ DFGLA+ +
Sbjct: 142 KDFLTLEHLICYSFQVAKGMEFLASR---KCIHRDLAARNILLSEKNVVKICDFGLARDI 198
Query: 340 DSGESHITT-------RVMGTFGYVAPEYANTGMLNEKSDIYSFGVLLLEAVT-GRDPVD 391
++ + M APE + +SD++SFGVLL E + G P
Sbjct: 199 YKDPDYVRKGDARLPLKWM------APETIFDRVYTIQSDVWSFGVLLWEIFSLGASP-- 250
Query: 392 Y-GRPANEVNLVEWLKMMVGTRRAEEVVDPNLEVKP--ATRALKRSLLVALRCVDPDSEK 448
Y G +E LK GTR + P T + + L C + +
Sbjct: 251 YPGVKIDE-EFCRRLKE--GTR---------MR-APDYTTPEMYQ---TMLDCWHGEPSQ 294
Query: 449 RPKMSQVVRMLE 460
RP S++V L
Sbjct: 295 RPTFSELVEHLG 306
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434 | Back alignment and structure |
|---|
Score = 125 bits (316), Expect = 1e-31
Identities = 69/298 (23%), Positives = 110/298 (36%), Gaps = 47/298 (15%)
Query: 186 NRFSAENVLGEGGYGVVYKGRLINGSEVAVKKLLNNLGQAEKEFRVEVEAIGHV-RHKNL 244
N +E +LG G G V G VAVK++L +E++ + H N+
Sbjct: 15 NLVVSEKILGYGSSGTVVFQGSFQGRPVAVKRMLI---DFCDIALMEIKLLTESDDHPNV 71
Query: 245 VRLLGYCIEGVHRMLVYEYVNNGNLEQWL--HGAMRNQGNLTWEARMKVII-GTAKALAY 301
+R + E N NL+ + L E ++ A +A+
Sbjct: 72 IRYYCSETTDRFLYIALELC-NLNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAH 130
Query: 302 LHEAIEPKVVHRDIKSSNILID-------------DEFNAKVSDFGLAKLLDSGESHITT 348
LH K++HRD+K NIL+ + +SDFGL K LDSG+S T
Sbjct: 131 LHSL---KIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQSSFRT 187
Query: 349 RVM---GTFGYVAPE-------YANTGMLNEKSDIYSFGVLLLEAVTGRDPVDYGRPANE 398
+ GT G+ APE L DI+S G + ++ + + E
Sbjct: 188 NLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYSRE 247
Query: 399 VNLVEWLKMMVGTRRAEEVVDPN-LEVKPATRALKRSLLVALRCVDPDSEKRPKMSQV 455
N ++ G +E+ + + L ++ DP KRP +V
Sbjct: 248 SN------IIRGIFSLDEMKCLHDRSLIAEATDLISQMI----DHDP--LKRPTAMKV 293
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313 | Back alignment and structure |
|---|
Score = 122 bits (308), Expect = 2e-31
Identities = 77/314 (24%), Positives = 128/314 (40%), Gaps = 60/314 (19%)
Query: 180 DLEIATNRFSAENVLGEGGYGVVYKGRL--INGSE----VAVKKLLNNLGQAEK-EFRVE 232
E NR S LG G +G V + + S+ VAVK L + E+ E
Sbjct: 17 KWEFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSE 76
Query: 233 VEAIGHV-RHKNLVRLLGYCIEGVHRMLVYEYVNNGNLEQWL--------------HGAM 277
++ + ++ H N+V LLG C G +++ EY G+L +L
Sbjct: 77 LKVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIME 136
Query: 278 RNQGNLTWEARMKVIIGTAKALAYLHEAIEPKVVHRDIKSSNILIDDEFNAKVSDFGLAK 337
++ L E + AK +A+L +HRD+ + NIL+ K+ DFGLA+
Sbjct: 137 DDELALDLEDLLSFSYQVAKGMAFLASK---NCIHRDLAARNILLTHGRITKICDFGLAR 193
Query: 338 LLDSGESHITT-------RVMGTFGYVAPEYANTGMLNEKSDIYSFGVLLLEAVT-GRDP 389
+ + +++ + M APE + +SD++S+G+ L E + G P
Sbjct: 194 DIKNDSNYVVKGNARLPVKWM------APESIFNCVYTFESDVWSYGIFLWELFSLGSSP 247
Query: 390 VDY-GRPANEVNLVEWLKMMVGTRRAEEVVDPNLEVKP--ATRALKRSLLVALRCVDPDS 446
Y G P + + +K G R + P A + + C D D
Sbjct: 248 --YPGMPVDS-KFYKMIKE--GFR---------ML-SPEHAPAEMYD---IMKTCWDADP 289
Query: 447 EKRPKMSQVVRMLE 460
KRP Q+V+++E
Sbjct: 290 LKRPTFKQIVQLIE 303
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333 | Back alignment and structure |
|---|
Score = 122 bits (309), Expect = 3e-31
Identities = 70/308 (22%), Positives = 123/308 (39%), Gaps = 56/308 (18%)
Query: 182 EIATNRFSAENVLGEGGYGVVYKGRLINGSE------VAVKKLLNNLGQAEK-EFRVEVE 234
E N LG G +G V + + VAVK L + EK E++
Sbjct: 42 EFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELK 101
Query: 235 AIGHV-RHKNLVRLLGYCIEGVHRMLVYEYVNNGNLEQWL----------HGAMRNQGNL 283
+ H+ +H+N+V LLG C G +++ EY G+L +L
Sbjct: 102 IMSHLGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTA 161
Query: 284 TWEARMKVIIGTAKALAYLHEAIEPKVVHRDIKSSNILIDDEFNAKVSDFGLAKLLDS-- 341
+ + A+ +A+L +HRD+ + N+L+ + AK+ DFGLA+ + +
Sbjct: 162 STRDLLHFSSQVAQGMAFLASK---NCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDS 218
Query: 342 -----GESHITTRVMGTFGYVAPEYANTGMLNEKSDIYSFGVLLLEAVT-GRDPVDY-GR 394
G + + + M APE + +SD++S+G+LL E + G +P Y G
Sbjct: 219 NYIVKGNARLPVKWM------APESIFDCVYTVQSDVWSYGILLWEIFSLGLNP--YPGI 270
Query: 395 PANEVNLVEWLKMMVGTRRAEEVVDPNLEVKP--ATRALKRSLLVALRCVDPDSEKRPKM 452
N + +K G + + +P A + + + C + RP
Sbjct: 271 LVNS-KFYKLVKD--GYQ---------MA-QPAFAPKNIYS---IMQACWALEPTHRPTF 314
Query: 453 SQVVRMLE 460
Q+ L+
Sbjct: 315 QQICSFLQ 322
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336 | Back alignment and structure |
|---|
Score = 122 bits (308), Expect = 3e-31
Identities = 56/223 (25%), Positives = 92/223 (41%), Gaps = 32/223 (14%)
Query: 174 HWFTLRDLEIATNRFSAENVLGEGGYGVVYKGR-LINGSEVAVKKLLNNLGQAEKEFRVE 232
HW T + +G G +G V++ + G + AVKK+ L E E
Sbjct: 58 HWMTHQPR------------VGRGSFGEVHRMKDKQTGFQCAVKKV--RLEVFRVE---E 100
Query: 233 VEAIGHVRHKNLVRLLGYCIEGVHRMLVYEYVNNGNLEQWLHGAMRNQGNLTWEARMKVI 292
+ A + +V L G EG + E + G+L ++ G L E R
Sbjct: 101 LVACAGLSSPRIVPLYGAVREGPWVNIFMELLEGGSL----GQLIKQMGCLP-EDRALYY 155
Query: 293 IG-TAKALAYLHEAIEPKVVHRDIKSSNILIDDE-FNAKVSDFGLAKLLDSGESHITTR- 349
+G + L YLH +++H D+K+ N+L+ + A + DFG A L +
Sbjct: 156 LGQALEGLEYLHTR---RILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLT 212
Query: 350 ---VMGTFGYVAPEYANTGMLNEKSDIYSFGVLLLEAVTGRDP 389
+ GT ++APE + K DI+S ++L + G P
Sbjct: 213 GDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHP 255
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344 | Back alignment and structure |
|---|
Score = 121 bits (306), Expect = 7e-31
Identities = 75/317 (23%), Positives = 128/317 (40%), Gaps = 65/317 (20%)
Query: 182 EIATNRFSAENVLGEGGYGVVYKGRL--INGSE----VAVKKLLNNLGQAEK-EFRVEVE 234
E VLG G +G V I+ + VAVK L +E+ E++
Sbjct: 41 EFPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELK 100
Query: 235 AIGHV-RHKNLVRLLGYCIEGVHRMLVYEYVNNGNLEQWL--HGAMRNQGNLTWEARMKV 291
+ + H+N+V LLG C L++EY G+L +L ++ + +E + ++
Sbjct: 101 MMTQLGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRL 160
Query: 292 IIGT-----------------AKALAYLHEAIEPKVVHRDIKSSNILIDDEFNAKVSDFG 334
AK + +L VHRD+ + N+L+ K+ DFG
Sbjct: 161 EEEEDLNVLTFEDLLCFAYQVAKGMEFLEFK---SCVHRDLAARNVLVTHGKVVKICDFG 217
Query: 335 LAKLLDSGESHITT-------RVMGTFGYVAPEYANTGMLNEKSDIYSFGVLLLEAVT-G 386
LA+ + S +++ + M APE G+ KSD++S+G+LL E + G
Sbjct: 218 LARDIMSDSNYVVRGNARLPVKWM------APESLFEGIYTIKSDVWSYGILLWEIFSLG 271
Query: 387 RDPVDY-GRPANEVNLVEWLKMMVGTRRAEEVVDPNLEVKP--ATRALKRSLLVALRCVD 443
+P Y G P + N + ++ G + ++ +P AT + + C
Sbjct: 272 VNP--YPGIPVDA-NFYKLIQN--GFK---------MD-QPFYATEEIYI---IMQSCWA 313
Query: 444 PDSEKRPKMSQVVRMLE 460
DS KRP + L
Sbjct: 314 FDSRKRPSFPNLTSFLG 330
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377 | Back alignment and structure |
|---|
Score = 122 bits (306), Expect = 8e-31
Identities = 42/309 (13%), Positives = 83/309 (26%), Gaps = 73/309 (23%)
Query: 193 VLGEGGYGVVYKGR-LINGSEVAVK---KLLNNLGQAEKEFRVEVEAIGHVR-------- 240
VLG+ + G V A K+ + EV + +R
Sbjct: 80 VLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQA 139
Query: 241 -----------------HKNLVRLLGYCIEGVHRMLVYEY----VNNGNLEQWLHGAMRN 279
K ++R+ + + Y N + L
Sbjct: 140 KVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSST 199
Query: 280 QGNLTWEARMKVIIGTAKALAYLHEAIEPKVVHRDIKSSNILIDDEFNAKVSDFGLAKLL 339
+L AR+++ + + LA LH +VH ++ +I++D ++ F
Sbjct: 200 HKSLVHHARLQLTLQVIRLLASLHHY---GLVHTYLRPVDIVLDQRGGVFLTGFEHLVRD 256
Query: 340 DSGESHITTRVMGTFGYVAPEY-----------ANTGMLNEKSDIYSFGVLLLEAVTGRD 388
+ + G+ PE ++ D ++ G+++
Sbjct: 257 GA-----RVVSSVSRGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYWIWCADL 311
Query: 389 PVDYGRPANEVNLVEWLKMMVGTRRAEEVVDPNLEVKPATRALKRSLLVALRCVDPDSEK 448
P+ + EW + + RAL L E
Sbjct: 312 PIT---KDAALGGSEW------------IFRSCKNIPQPVRALLEGFL------RYPKED 350
Query: 449 RPKMSQVVR 457
R Q +
Sbjct: 351 RLLPLQAME 359
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370 | Back alignment and structure |
|---|
Score = 121 bits (306), Expect = 1e-30
Identities = 86/383 (22%), Positives = 149/383 (38%), Gaps = 65/383 (16%)
Query: 111 KSSDPDNISQCSSVHHHERACSSQSGEEGSSGAGHKHSSLSYGGLVTASPLIGLPEISHL 170
S DP + + + R Q S + ++ S P ++ +
Sbjct: 10 HSQDPPAVHKLTKRIPLRR----QVTVSAESSSSMNSNTPLVRITTRLSSTADTPMLAGV 65
Query: 171 GWGHWFTLRDLEIATNRFSAENVLGEGGYGVVYKGRLI--------NGSEVAVKKLLNNL 222
E ++ + LGEG +G V + VAVK L ++
Sbjct: 66 SEYELPEDPKWEFPRDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDA 125
Query: 223 GQAEK-EFRVEVEAIGHV-RHKNLVRLLGYCIEGVHRMLVYEYVNNGNL----------- 269
+ + + E+E + + +HKN++ LLG C + ++ EY + GNL
Sbjct: 126 TEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPG 185
Query: 270 -EQWLHGAMRNQGNLTWEARMKVIIGTAKALAYLHEAIEPKVVHRDIKSSNILIDDEFNA 328
E + +T++ + A+ + YL K +HRD+ + N+L+ +
Sbjct: 186 MEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLAS---QKCIHRDLAARNVLVTENNVM 242
Query: 329 KVSDFGLAKLLDSGESHITTRV-------MGTFGYVAPEYANTGMLNEKSDIYSFGVLLL 381
K++DFGLA+ +++ + + T M APE + +SD++SFGVL+
Sbjct: 243 KIADFGLARDINNIDYYKKTTNGRLPVKWM------APEALFDRVYTHQSDVWSFGVLMW 296
Query: 382 EAVT-GRDPVDY-GRPANEVNLVEWLKMMVGTRRAEEVVDPNLEVKPA--TRALKRSLLV 437
E T G P Y G P E+ + LK G R ++ KPA T L +
Sbjct: 297 EIFTLGGSP--YPGIPVEEL--FKLLKE--GHR---------MD-KPANCTNELYM---M 337
Query: 438 ALRCVDPDSEKRPKMSQVVRMLE 460
C +RP Q+V L+
Sbjct: 338 MRDCWHAVPSQRPTFKQLVEDLD 360
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382 | Back alignment and structure |
|---|
Score = 120 bits (304), Expect = 2e-30
Identities = 66/249 (26%), Positives = 115/249 (46%), Gaps = 42/249 (16%)
Query: 182 EIATNRFSAENVLGEGGYGVVYKGRLIN--------GSEVAVKKLLNNLGQAEK-EFRVE 232
E+ +R LGEG +G V I ++VAVK L ++ + + + E
Sbjct: 65 ELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISE 124
Query: 233 VEAIGHV-RHKNLVRLLGYCIEGVHRMLVYEYVNNGNLEQWL------------HGAMRN 279
+E + + +HKN++ LLG C + ++ EY + GNL ++L + +
Sbjct: 125 MEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNP 184
Query: 280 QGNLTWEARMKVIIGTAKALAYLHEAIEPKVVHRDIKSSNILIDDEFNAKVSDFGLAKLL 339
+ L+ + + A+ + YL K +HRD+ + N+L+ ++ K++DFGLA+ +
Sbjct: 185 EEQLSSKDLVSCAYQVARGMEYLASK---KCIHRDLAARNVLVTEDNVMKIADFGLARDI 241
Query: 340 DSGESHITT-------RVMGTFGYVAPEYANTGMLNEKSDIYSFGVLLLEAVT-GRDPVD 391
+ + T + M APE + +SD++SFGVLL E T G P
Sbjct: 242 HHIDYYKKTTNGRLPVKWM------APEALFDRIYTHQSDVWSFGVLLWEIFTLGGSP-- 293
Query: 392 Y-GRPANEV 399
Y G P E+
Sbjct: 294 YPGVPVEEL 302
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295 | Back alignment and structure |
|---|
Score = 118 bits (299), Expect = 3e-30
Identities = 67/222 (30%), Positives = 104/222 (46%), Gaps = 19/222 (8%)
Query: 177 TLRDLEIATNRFSAENVLGEGGYGVVYKGR-LINGSEVAVKKLLNNLGQAEKEFRVEVEA 235
L + + + VLG+G YG+VY GR L N +A+K++ + + E+
Sbjct: 13 DLLEYDYEYDENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIAL 72
Query: 236 IGHVRHKNLVRLLGYCIEGVHRMLVYEYVNNGNLEQWL---HGAMRNQGNLTWEARMKVI 292
H++HKN+V+ LG E + E V G+L L G +++ E +
Sbjct: 73 HKHLKHKNIVQYLGSFSENGFIKIFMEQVPGGSLSALLRSKWGPLKDN-----EQTIGFY 127
Query: 293 IG-TAKALAYLHEAIEPKVVHRDIKSSNILIDDEF-NAKVSDFGLAKLLDSGESHITTRV 350
+ L YLH+ ++VHRDIK N+LI+ K+SDFG +K L T
Sbjct: 128 TKQILEGLKYLHDN---QIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINPCTET-F 183
Query: 351 MGTFGYVAPE---YANTGMLNEKSDIYSFGVLLLEAVTGRDP 389
GT Y+APE G + +DI+S G ++E TG+ P
Sbjct: 184 TGTLQYMAPEIIDKGPRG-YGKAADIWSLGCTIIEMATGKPP 224
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348 | Back alignment and structure |
|---|
Score = 118 bits (298), Expect = 8e-30
Identities = 45/222 (20%), Positives = 89/222 (40%), Gaps = 33/222 (14%)
Query: 193 VLGEGGYGVVYKGRLINGSEVAVKKL-----------------LNNLGQAEKEFRVEVEA 235
L +G + + + A+KK ++ +F+ E++
Sbjct: 38 TLNQGKFNKIILCE-KDNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQI 96
Query: 236 IGHVRHKNLVRLLGYCIEGVHRM-LVYEYVNNGNLEQWLHGAMRNQGNLT-----WEARM 289
I ++++ + G I + ++YEY+ N ++ ++ N T +
Sbjct: 97 ITDIKNEYCLTCEGI-ITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIK- 154
Query: 290 KVIIGTAKALAYLHEAIEPKVVHRDIKSSNILIDDEFNAKVSDFGLAKLLDSGESHITTR 349
+I + +Y+H E + HRD+K SNIL+D K+SDFG ++ + + +
Sbjct: 155 CIIKSVLNSFSYIHN--EKNICHRDVKPSNILMDKNGRVKLSDFGESEYMVDKKIK-GS- 210
Query: 350 VMGTFGYVAPE--YANTGMLNEKSDIYSFGVLLLEAVTGRDP 389
GT+ ++ PE + K DI+S G+ L P
Sbjct: 211 -RGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVP 251
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365 | Back alignment and structure |
|---|
Score = 117 bits (294), Expect = 3e-29
Identities = 44/320 (13%), Positives = 90/320 (28%), Gaps = 36/320 (11%)
Query: 179 RDLEIATNRFSAENVLGEGGYGVVYKGR------LINGSEVAVKKLLNNLGQAEKEFRVE 232
+ ++ + ++LGEG + VY+ N + +K
Sbjct: 58 TEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQL 117
Query: 233 VEAIGHVRHKNLVRLLGYCIEGVHRMLVYEYVNNGNLEQWL-HGAMRNQGNLTWEARMKV 291
+E + ++ + +LV E + G L + + + +
Sbjct: 118 MERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISF 177
Query: 292 IIGTAKALAYLHEAIEPKVVHRDIKSSNILI-----------DDEFNAKVSDFGLAKLLD 340
+ + +H+ +++H DIK N ++ D + D G + +
Sbjct: 178 AMRMLYMIEQVHDC---EIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMK 234
Query: 341 S-GESHITTRVMGTFGYVAPEYANTGMLNEKS-----DIYSFGVLLLEAVTGRDPVDYGR 394
+ I T T G+ E ML+ K D + + + G
Sbjct: 235 LFPKGTIFTAKCETSGFQCVE-----MLSNKPWNYQIDYFGVAATVYCMLFGTYM-KVKN 288
Query: 395 PANEVNLVEWLKMMVGTRRAEEVVDPNLEVKPATRALKRSLLVALRCVDPDSEKRPKMSQ 454
E + + E L + LL K+
Sbjct: 289 EGGECKPEGLFRRLPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQHYTNKIRA 348
Query: 455 VVRMLEADDYPFREDRRNRK 474
+ L E +R+RK
Sbjct: 349 LRNRLIVLLL---ECKRSRK 365
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394 | Back alignment and structure |
|---|
Score = 116 bits (293), Expect = 9e-29
Identities = 61/225 (27%), Positives = 106/225 (47%), Gaps = 34/225 (15%)
Query: 179 RDLEIATNRFSAENVLGEGGYGVVYKGRLINGSEVAVKKLLNNLGQAEKEFRVEVEAIGH 238
+ E ++ V+G G +GVV++ +L+ EVA+KK+L + R E++ +
Sbjct: 33 KTGEQREIAYTNCKVIGNGSFGVVFQAKLVESDEVAIKKVLQ---DKRFKNR-ELQIMRI 88
Query: 239 VRHKNLVRLLGYCIEGVHRM------LVYEYVNNGNLEQWLHGAMRNQGNLTWEARMKVI 292
V+H N+V L + + LV EYV + + + + + +K+
Sbjct: 89 VKHPNVVDLKAFFYSNGDKKDEVFLNLVLEYVPE-TVYRASRHYAKLKQTMP-MLLIKLY 146
Query: 293 I-GTAKALAYLHEAIEPKVVHRDIKSSNILIDDEFNA-KVSDFGLAKLLDSGE---SHIT 347
+ ++LAY+H + HRDIK N+L+D K+ DFG AK+L +GE S+I
Sbjct: 147 MYQLLRSLAYIHSI---GICHRDIKPQNLLLDPPSGVLKLIDFGSAKILIAGEPNVSYIC 203
Query: 348 TRVMGTFGYVAPEYANTGMLNEKS-----DIYSFGVLLLEAVTGR 387
+R Y APE + + DI+S G ++ E + G+
Sbjct: 204 SRY-----YRAPEL----IFGATNYTTNIDIWSTGCVMAELMQGQ 239
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494 | Back alignment and structure |
|---|
Score = 116 bits (293), Expect = 2e-28
Identities = 55/222 (24%), Positives = 95/222 (42%), Gaps = 18/222 (8%)
Query: 175 WFTLRDLEIATNRFSAENVLGEGGYGVVYKGR-LINGSEVAVKKL-LNNLGQAEKE-FRV 231
F + + LG G YG V R + E A+K + ++ +
Sbjct: 26 MFITSKKGHLSEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLE 85
Query: 232 EVEAIGHVRHKNLVRLLGYCIEGVHRMLVYEYVNNGNLEQWLHGAMRNQGNLTWEARMKV 291
EV + + H N+++L + + + LV E G L + ++ E V
Sbjct: 86 EVAVLKLLDHPNIMKLYDFFEDKRNYYLVMECYKGGELFDE----IIHRMKFN-EVDAAV 140
Query: 292 IIGT-AKALAYLHEAIEPKVVHRDIKSSNILI---DDEFNAKVSDFGLAKLLDSGESHIT 347
II + YLH+ +VHRD+K N+L+ + + K+ DFGL+ + ++ +
Sbjct: 141 IIKQVLSGVTYLHKH---NIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQKKM-- 195
Query: 348 TRVMGTFGYVAPEYANTGMLNEKSDIYSFGVLLLEAVTGRDP 389
+GT Y+APE +EK D++S GV+L + G P
Sbjct: 196 KERLGTAYYIAPEVLR-KKYDEKCDVWSIGVILFILLAGYPP 236
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286 | Back alignment and structure |
|---|
Score = 112 bits (283), Expect = 3e-28
Identities = 38/283 (13%), Positives = 81/283 (28%), Gaps = 52/283 (18%)
Query: 183 IATNRFSAENVLGEGGYGVVYKGR-LINGSEVAVKKLLNNLGQAE---KEFRVEVEAIGH 238
IA R+ G ++ +VA+ + + +E +
Sbjct: 28 IANGRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSR 87
Query: 239 VRHKNLVRLLGYCIEGVHRMLVYEYVNNGNLEQWLHGAMRNQGNLTWEARMKVIIGTAKA 298
+ + R+L ++V E++ G+L++ + + ++ + A A
Sbjct: 88 IDKPGVARVLDVVHTRAGGLVVAEWIRGGSLQEVADTS------PSPVGAIRAMQSLAAA 141
Query: 299 LAYLHEAIEPKVVHRDIKSSNILIDDEFNAKVSDFGLAKLLDSGESHITTRVMGTFGYVA 358
H A V S + + + G L +
Sbjct: 142 ADAAHRA---GVALSIDHPSRVRVSID--------GDVVL-------------AYPATMP 177
Query: 359 PEYANTGMLNEKSDIYSFGVLLLEAVTGRDPVDYGRPANEVNLVEWLKMMVGTRRAEEVV 418
N + DI G L + R P+ + + E A + +
Sbjct: 178 DA-------NPQDDIRGIGASLYALLVNRWPLPEAGVRSGLAPAE-------RDTAGQPI 223
Query: 419 DPNLEVKPATRALKRSLLVALRCVDPDSEKRPKMSQVVRMLEA 461
+P + + VA R V D R S ++ +++
Sbjct: 224 EPADIDRDIPFQISA---VAARSVQGDGGIRSA-STLLNLMQQ 262
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285 | Back alignment and structure |
|---|
Score = 112 bits (283), Expect = 3e-28
Identities = 57/204 (27%), Positives = 91/204 (44%), Gaps = 17/204 (8%)
Query: 185 TNRFSAENVLGEGGYGVVYKGRLI-NGSEVAVKKLL-NNLGQAEKEFRVEVEAIGHVRHK 242
+ F + LG G +G V+ +G E +K + + ++ E+E + + H
Sbjct: 21 DDLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHP 80
Query: 243 NLVRLLGYCIEGVHRMLVYEYVNNGNLEQWLHGAMRNQGNLT-WEAR--MKVIIGTAKAL 299
N++++ + + +V E G L + + A L+ MK ++ AL
Sbjct: 81 NIIKIFEVFEDYHNMYIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMN---AL 137
Query: 300 AYLHEAIEPKVVHRDIKSSNILI---DDEFNAKVSDFGLAKLLDSGESHITTRVMGTFGY 356
AY H VVH+D+K NIL K+ DFGLA+L S E H T GT Y
Sbjct: 138 AYFHSQ---HVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSDE-HSTNAA-GTALY 192
Query: 357 VAPEYANTGMLNEKSDIYSFGVLL 380
+APE + K DI+S GV++
Sbjct: 193 MAPEVFK-RDVTFKCDIWSAGVVM 215
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303 | Back alignment and structure |
|---|
Score = 112 bits (283), Expect = 5e-28
Identities = 56/208 (26%), Positives = 99/208 (47%), Gaps = 17/208 (8%)
Query: 187 RFSAENVLGEGGYGVVYKGR-LINGSEVAVKKLLNNLGQAE---KEFRVEVEAIGHVRHK 242
F+ +G+G +G V+KG VA+K + +L +AE ++ + E+ +
Sbjct: 23 LFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKII--DLEEAEDEIEDIQQEITVLSQCDSP 80
Query: 243 NLVRLLGYCIEGVHRMLVYEYVNNGNLEQWLHGAMRNQGNLTWEARMKVII-GTAKALAY 301
+ + G ++ ++ EY+ G+ L G L E ++ I+ K L Y
Sbjct: 81 YVTKYYGSYLKDTKLWIIMEYLGGGSALDLLE-----PGPLD-ETQIATILREILKGLDY 134
Query: 302 LHEAIEPKVVHRDIKSSNILIDDEFNAKVSDFGLAKLLDSGESHITTRVMGTFGYVAPEY 361
LH K +HRDIK++N+L+ + K++DFG+A L + T +GT ++APE
Sbjct: 135 LHSE---KKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNT-FVGTPFWMAPEV 190
Query: 362 ANTGMLNEKSDIYSFGVLLLEAVTGRDP 389
+ K+DI+S G+ +E G P
Sbjct: 191 IKQSAYDSKADIWSLGITAIELARGEPP 218
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304 | Back alignment and structure |
|---|
Score = 112 bits (283), Expect = 5e-28
Identities = 55/201 (27%), Positives = 91/201 (45%), Gaps = 16/201 (7%)
Query: 185 TNRFSAENVLGEGGYGVVYKGRLIN-GSEVAVKKLLNNLGQAEKEFRVEVEAIGHVRHKN 243
F VLG G + V+ + G A+K + + + E+ + ++H+N
Sbjct: 8 RKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHEN 67
Query: 244 LVRLLGYCIEGVHRMLVYEYVNNGNLEQWLHGAMRNQGNLTWEARMKVIIGT-AKALAYL 302
+V L H LV + V+ G L + +G T E ++I A+ YL
Sbjct: 68 IVTLEDIYESTTHYYLVMQLVSGGELFDRI----LERGVYT-EKDASLVIQQVLSAVKYL 122
Query: 303 HEAIEPKVVHRDIKSSNILI---DDEFNAKVSDFGLAKLLDSGESHITTRVMGTFGYVAP 359
HE +VHRD+K N+L ++ ++DFGL+K+ +G ++T GT GYVAP
Sbjct: 123 HEN---GIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQNGI--MSTAC-GTPGYVAP 176
Query: 360 EYANTGMLNEKSDIYSFGVLL 380
E ++ D +S GV+
Sbjct: 177 EVLAQKPYSKAVDCWSIGVIT 197
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290 | Back alignment and structure |
|---|
Score = 111 bits (281), Expect = 6e-28
Identities = 56/216 (25%), Positives = 96/216 (44%), Gaps = 12/216 (5%)
Query: 181 LEIATNRFSAENVLGEGGYGVVYKGRLI-NGSEVAVKKLLNNLGQAE-KEFRVEVEAIGH 238
+E+ + LG G YGVV K R + +G +AVK++ + E K ++++
Sbjct: 2 MEVKADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMR 61
Query: 239 -VRHKNLVRLLGYCIEGVHRMLVYEYVNNGNLEQWLHGAMRNQGNLTWEARMKVIIGTAK 297
V V G + E ++ +L+++ + + + K+ + K
Sbjct: 62 TVDCPFTVTFYGALFREGDVWICMELMD-TSLDKFYKQVIDKGQTIPEDILGKIAVSIVK 120
Query: 298 ALAYLHEAIEPKVVHRDIKSSNILIDDEFNAKVSDFGLAKLLDSGESHITTRVMGTFGYV 357
AL +LH + V+HRD+K SN+LI+ K+ DFG++ L G Y+
Sbjct: 121 ALEHLHS--KLSVIHRDVKPSNVLINALGQVKMCDFGISGYLVD--DVAKDIDAGCKPYM 176
Query: 358 APE----YANTGMLNEKSDIYSFGVLLLEAVTGRDP 389
APE N + KSDI+S G+ ++E R P
Sbjct: 177 APERINPELNQKGYSVKSDIWSLGITMIELAILRFP 212
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420 | Back alignment and structure |
|---|
Score = 113 bits (285), Expect = 1e-27
Identities = 62/220 (28%), Positives = 102/220 (46%), Gaps = 35/220 (15%)
Query: 185 TNRFSAENVLGEGGYGVVYKGRLI-NGSEVAVKKLLNNLGQAEKEFRVEVEAIGHVRHKN 243
++ V+G G +GVVY+ +L +G VA+KK+L + R E++ + + H N
Sbjct: 53 EVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQ---DKRFKNR-ELQIMRKLDHCN 108
Query: 244 LVRLLGYCIEGVHRM------LVYEYVNNGNLEQWLHGAMRNQGNLTWEARMKVII-GTA 296
+VRL + + LV +YV + + R + L +K+ +
Sbjct: 109 IVRLRYFFYSSGEKKDEVYLNLVLDYVPE-TVYRVARHYSRAKQTLP-VIYVKLYMYQLF 166
Query: 297 KALAYLHEAIEPKVVHRDIKSSNILIDDEFNA-KVSDFGLAKLLDSGE---SHITTRVMG 352
++LAY+H + HRDIK N+L+D + K+ DFG AK L GE S+I +R
Sbjct: 167 RSLAYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRY-- 221
Query: 353 TFGYVAPEYANTGMLNEKS-----DIYSFGVLLLEAVTGR 387
Y APE + D++S G +L E + G+
Sbjct: 222 ---YRAPEL----IFGATDYTSSIDVWSAGCVLAELLLGQ 254
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504 | Back alignment and structure |
|---|
Score = 114 bits (288), Expect = 1e-27
Identities = 56/224 (25%), Positives = 92/224 (41%), Gaps = 29/224 (12%)
Query: 175 WFTLRDLEIATNRFSAENVLGEGGYGVVYKGR-LINGSEVAVKKL-------------LN 220
+ + + LG G YG V + SE A+K +
Sbjct: 25 MYVRKKEGKIGESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNK 84
Query: 221 NLGQAEKEFRVEVEAIGHVRHKNLVRLLGYCIEGVHRMLVYEYVNNGNLEQWLHGAMRNQ 280
N+ + +E E+ + + H N+++L + + LV E+ G L + + N+
Sbjct: 85 NIEKFHEEIYNEISLLKSLDHPNIIKLFDVFEDKKYFYLVTEFYEGGELFEQI----INR 140
Query: 281 GNLTWEARMKVIIGT-AKALAYLHEAIEPKVVHRDIKSSNILI---DDEFNAKVSDFGLA 336
E I+ + YLH+ +VHRDIK NIL+ + N K+ DFGL+
Sbjct: 141 HKFD-ECDAANIMKQILSGICYLHKH---NIVHRDIKPENILLENKNSLLNIKIVDFGLS 196
Query: 337 KLLDSGESHITTRVMGTFGYVAPEYANTGMLNEKSDIYSFGVLL 380
+ R+ GT Y+APE NEK D++S GV++
Sbjct: 197 SFFSKDYK-LRDRL-GTAYYIAPE-VLKKKYNEKCDVWSCGVIM 237
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327 | Back alignment and structure |
|---|
Score = 112 bits (281), Expect = 1e-27
Identities = 59/219 (26%), Positives = 103/219 (47%), Gaps = 13/219 (5%)
Query: 179 RDLEIATNRFSAENVLGEGGYGVVYKGRLI-NGSEVAVKKLLNNLGQAE-KEFRVEVEAI 236
+ + +G G YG V K +G +AVK++ + + + E K+ ++++ +
Sbjct: 15 QHWDFTAEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVV 74
Query: 237 GH-VRHKNLVRLLGYCIEGVHRMLVYEYVNNGNLEQWLHGAMRNQGNLTWEARM-KVIIG 294
+V+ G + E ++ + +++ ++ E + K+ +
Sbjct: 75 MRSSDCPYIVQFYGALFREGDCWICMELMS-TSFDKFYKYVYSVLDDVIPEEILGKITLA 133
Query: 295 TAKALAYLHEAIEPKVVHRDIKSSNILIDDEFNAKVSDFGLAKLLDSGESHITTRVMGTF 354
T KAL +L E K++HRDIK SNIL+D N K+ DFG++ L S TR G
Sbjct: 134 TVKALNHLKE--NLKIIHRDIKPSNILLDRSGNIKLCDFGISGQLVD--SIAKTRDAGCR 189
Query: 355 GYVAPE----YANTGMLNEKSDIYSFGVLLLEAVTGRDP 389
Y+APE A+ + +SD++S G+ L E TGR P
Sbjct: 190 PYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFP 228
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276 | Back alignment and structure |
|---|
Score = 110 bits (277), Expect = 2e-27
Identities = 69/277 (24%), Positives = 112/277 (40%), Gaps = 43/277 (15%)
Query: 194 LGEGGYGVVYKGR-LINGSEVAVK-----KLLNNLGQAEKEFRVEVEAIGHVRHKNLVRL 247
LGEG YG V + VAVK + ++ +KE + + H+N+V+
Sbjct: 15 LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKE----ICINKMLNHENVVKF 70
Query: 248 LGYCIEGVHRMLVYEYVNNGNLEQWL--HGAMRNQGNLTWEARMKV--IIGTAKALAYLH 303
G+ EG + L EY + G L + M +A+ ++ + YLH
Sbjct: 71 YGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEP-----DAQRFFHQLMA---GVVYLH 122
Query: 304 EAIEPKVVHRDIKSSNILIDDEFNAKVSDFGLAKLLDSG--ESHITTRVMGTFGYVAPE- 360
+ HRDIK N+L+D+ N K+SDFGLA + E + GT YVAPE
Sbjct: 123 GI---GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMC-GTLPYVAPEL 178
Query: 361 YANTGMLNEKSDIYSFGVLLLEAVTGRDPVDYGRPANEVNLVEWLKMMVGTRRAEEVVDP 420
E D++S G++L + G P D + + + ++P
Sbjct: 179 LKRREFHAEPVDVWSCGIVLTAMLAGELPWD-----QPSDSCQEYSDWK---EKKTYLNP 230
Query: 421 NLEVKPATRALKRSLLVALRCVDPDSEKRPKMSQVVR 457
++ A AL +LV +P R + + +
Sbjct: 231 WKKIDSAPLALLHKILV----ENP--SARITIPDIKK 261
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484 | Back alignment and structure |
|---|
Score = 114 bits (287), Expect = 2e-27
Identities = 58/213 (27%), Positives = 105/213 (49%), Gaps = 19/213 (8%)
Query: 185 TNRFSAENVLGEGGYGVVYKGR-LINGSEVAVKKLL-NNLGQAEKEFRV--EVEAIGHVR 240
++R+ + VLG+G +G V + I G E AVK + + Q + + EV+ + +
Sbjct: 25 SDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLD 84
Query: 241 HKNLVRLLGYCIEGVHRMLVYEYVNNGNLEQWLHGAMRNQGNLTWEARMKVIIGT-AKAL 299
H N+++L + + + LV E G L + ++ + E II +
Sbjct: 85 HPNIMKLYEFFEDKGYFYLVGEVYTGGELFDE----IISRKRFS-EVDAARIIRQVLSGI 139
Query: 300 AYLHEAIEPKVVHRDIKSSNILI---DDEFNAKVSDFGLAKLLDSGESHITTRVMGTFGY 356
Y+H+ K+VHRD+K N+L+ + N ++ DFGL+ ++ + +GT Y
Sbjct: 140 TYMHKN---KIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKM--KDKIGTAYY 194
Query: 357 VAPEYANTGMLNEKSDIYSFGVLLLEAVTGRDP 389
+APE + G +EK D++S GV+L ++G P
Sbjct: 195 IAPEVLH-GTYDEKCDVWSTGVILYILLSGCPP 226
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486 | Back alignment and structure |
|---|
Score = 114 bits (286), Expect = 2e-27
Identities = 55/208 (26%), Positives = 92/208 (44%), Gaps = 28/208 (13%)
Query: 185 TNRFSAENVLGEGGYGVVYKGR-LINGSEVAVKKL-LNNLGQAEKE-FRVEVEAIGHVRH 241
R++ +LG+G +G V K + I E AVK + + + EVE + + H
Sbjct: 21 AERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDH 80
Query: 242 KNLVRLLGYCIEGVHRMLVYEYVNNGNLEQWLHGAMRNQGNLTWEARMKVIIGT-AKALA 300
N+++L + +V E G L + + + E II +
Sbjct: 81 PNIMKLFEILEDSSSFYIVGELYTGGELFDEI----IKRKRFS-EHDAARIIKQVFSGIT 135
Query: 301 YLHEAIEPKVVHRDIKSSNILI---DDEFNAKVSDFGLAKLLDSGESHITTRVMGTFGYV 357
Y+H+ +VHRD+K NIL+ + + + K+ DFGL+ + R+ GT Y+
Sbjct: 136 YMHKH---NIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTK-MKDRI-GTAYYI 190
Query: 358 APE-----YANTGMLNEKSDIYSFGVLL 380
APE Y +EK D++S GV+L
Sbjct: 191 APEVLRGTY------DEKCDVWSAGVIL 212
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314 | Back alignment and structure |
|---|
Score = 110 bits (278), Expect = 2e-27
Identities = 62/207 (29%), Positives = 97/207 (46%), Gaps = 12/207 (5%)
Query: 185 TNRFSAENVLGEGGYGVVYKGR-LINGSEVAVKKLLNNLGQAEKEFRVEVEAIGHVRHKN 243
F LGEG YG VYK G VA+K++ + +E E+ + +
Sbjct: 28 EEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQV--PVESDLQEIIKEISIMQQCDSPH 85
Query: 244 LVRLLGYCIEGVHRMLVYEYVNNGNLEQWLHGAMRNQGNLTWEARMKVII-GTAKALAYL 302
+V+ G + +V EY G++ + LT E + I+ T K L YL
Sbjct: 86 VVKYYGSYFKNTDLWIVMEYCGAGSVSDIIR---LRNKTLT-EDEIATILQSTLKGLEYL 141
Query: 303 HEAIEPKVVHRDIKSSNILIDDEFNAKVSDFGLAKLLDSGESHITTRVMGTFGYVAPEYA 362
H + +HRDIK+ NIL++ E +AK++DFG+A L + T + GT ++APE
Sbjct: 142 HFM---RKIHRDIKAGNILLNTEGHAKLADFGVAGQLTDTMAKRNTVI-GTPFWMAPEVI 197
Query: 363 NTGMLNEKSDIYSFGVLLLEAVTGRDP 389
N +DI+S G+ +E G+ P
Sbjct: 198 QEIGYNCVADIWSLGITAIEMAEGKPP 224
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360 | Back alignment and structure |
|---|
Score = 111 bits (280), Expect = 3e-27
Identities = 60/210 (28%), Positives = 101/210 (48%), Gaps = 11/210 (5%)
Query: 182 EIATNRFSAENVLGEGGYGVVYKGRLI-NGSEVAVKKLLNNLGQAE-KEFRVEVEAIGHV 239
E+ + F + LG G GVV+K +G +A K + + A + E++ +
Sbjct: 29 ELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHEC 88
Query: 240 RHKNLVRLLGYCIEGVHRMLVYEYVNNGNLEQWLHGAMRNQGNLTWEARMKVIIGTAKAL 299
+V G + E+++ G+L+Q ++ G + + KV I K L
Sbjct: 89 NSPYIVGFYGAFYSDGEISICMEHMDGGSLDQ----VLKKAGRIPEQILGKVSIAVIKGL 144
Query: 300 AYLHEAIEPKVVHRDIKSSNILIDDEFNAKVSDFGLAKLLDSGESHITTRVMGTFGYVAP 359
YL E + K++HRD+K SNIL++ K+ DFG++ L +S + V GT Y++P
Sbjct: 145 TYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLI--DSMANSFV-GTRSYMSP 199
Query: 360 EYANTGMLNEKSDIYSFGVLLLEAVTGRDP 389
E + +SDI+S G+ L+E GR P
Sbjct: 200 ERLQGTHYSVQSDIWSMGLSLVEMAVGRYP 229
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297 | Back alignment and structure |
|---|
Score = 110 bits (277), Expect = 3e-27
Identities = 54/207 (26%), Positives = 100/207 (48%), Gaps = 12/207 (5%)
Query: 185 TNRFSAENVLGEGGYGVVYKGR-LINGSEVAVKKLLNNLGQAEKEFRVEVEAIGHVRHKN 243
+++ +G+G G VY + G EVA++++ ++ E+ + ++ N
Sbjct: 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPN 78
Query: 244 LVRLLGYCIEGVHRMLVYEYVNNGNLEQWLHGAMRNQGNLTWEARMKVII-GTAKALAYL 302
+V L + G +V EY+ G+L + + + E ++ + +AL +L
Sbjct: 79 IVNYLDSYLVGDELWVVMEYLAGGSLTDVVT-----ETCMD-EGQIAAVCRECLQALEFL 132
Query: 303 HEAIEPKVVHRDIKSSNILIDDEFNAKVSDFGLAKLLDSGESHITTRVMGTFGYVAPEYA 362
H +V+HRDIKS NIL+ + + K++DFG + +S +T V GT ++APE
Sbjct: 133 HSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMV-GTPYWMAPEVV 188
Query: 363 NTGMLNEKSDIYSFGVLLLEAVTGRDP 389
K DI+S G++ +E + G P
Sbjct: 189 TRKAYGPKVDIWSLGIMAIEMIEGEPP 215
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321 | Back alignment and structure |
|---|
Score = 110 bits (277), Expect = 4e-27
Identities = 58/207 (28%), Positives = 96/207 (46%), Gaps = 12/207 (5%)
Query: 185 TNRFSAENVLGEGGYGVVYKGR-LINGSEVAVKKLLNNLGQAEKEFRVEVEAIGHVRHKN 243
+ +GEG G+V R +G +VAVK + Q + EV + +H N
Sbjct: 44 RLLLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHFN 103
Query: 244 LVRLLGYCIEGVHRMLVYEYVNNGNLEQWLHGAMRNQGNLTWEARMKVII-GTAKALAYL 302
+V + + G ++ E++ G L + Q L E ++ + +ALAYL
Sbjct: 104 VVEMYKSYLVGEELWVLMEFLQGGALTDIVS-----QVRLN-EEQIATVCEAVLQALAYL 157
Query: 303 HEAIEPKVVHRDIKSSNILIDDEFNAKVSDFGLAKLLDSGESHITTRVMGTFGYVAPEYA 362
H V+HRDIKS +IL+ + K+SDFG + + V GT ++APE
Sbjct: 158 HA---QGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKSLV-GTPYWMAPEVI 213
Query: 363 NTGMLNEKSDIYSFGVLLLEAVTGRDP 389
+ + + DI+S G++++E V G P
Sbjct: 214 SRSLYATEVDIWSLGIMVIEMVDGEPP 240
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365 | Back alignment and structure |
|---|
Score = 110 bits (277), Expect = 7e-27
Identities = 64/306 (20%), Positives = 118/306 (38%), Gaps = 31/306 (10%)
Query: 94 KSSDKNSEKMHVHLGMSKSSDPDNISQCSSVHHHERACSSQSGEEGSSGAGHKHSSLSYG 153
+S + + I +++ +R +S + S + + +
Sbjct: 2 HHHHHHSSGVDNKFNKERRRARREIRHLPNLNREQRRAFIRSLRDDPSQSANLLAEAKKL 61
Query: 154 GLVTASPLIGLPEISHLGWGHWFTLRDLEIATNRFSAENVLGEGGYGVVYKGRLI-NGSE 212
L S + ++ ++V+G G VV + G E
Sbjct: 62 NDAQPKGTENLYFQSMGPEDELPDWAAAKEFYQKYDPKDVIGRGVSSVVRRCVHRATGHE 121
Query: 213 VAVK-----KLLNNLGQAEKE---FRVEVEAIGHVR-HKNLVRLLGYCIEGVHRMLVYEY 263
AVK + Q E+ R E + V H +++ L+ LV++
Sbjct: 122 FAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSYESSSFMFLVFDL 181
Query: 264 VNNGNLEQWLHGAMRNQGNLT-WEAR--MKVIIGTAKALAYLHEAIEPKVVHRDIKSSNI 320
+ G L +L + L+ E R M+ ++ +A+++LH +VHRD+K NI
Sbjct: 182 MRKGELFDYL----TEKVALSEKETRSIMRSLL---EAVSFLHAN---NIVHRDLKPENI 231
Query: 321 LIDDEFNAKVSDFGLAKLLDSGESHITTRVMGTFGYVAPE------YANTGMLNEKSDIY 374
L+DD ++SDFG + L+ GE + GT GY+APE ++ D++
Sbjct: 232 LLDDNMQIRLSDFGFSCHLEPGEK-LRELC-GTPGYLAPEILKCSMDETHPGYGKEVDLW 289
Query: 375 SFGVLL 380
+ GV+L
Sbjct: 290 ACGVIL 295
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298 | Back alignment and structure |
|---|
Score = 108 bits (273), Expect = 1e-26
Identities = 56/216 (25%), Positives = 95/216 (43%), Gaps = 32/216 (14%)
Query: 185 TNRFSAENVLGEGGYGVVYKGRLIN-GSEVAVK---------KLLNNLGQAEKEFRVEVE 234
+ + +LG G VV + E AVK + + + EV+
Sbjct: 16 YENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVD 75
Query: 235 AIGHV-RHKNLVRLLGYCIEGVHRMLVYEYVNNGNLEQWLHGAMRNQGNLT-WEAR--MK 290
+ V H N+++L LV++ + G L +L + L+ E R M+
Sbjct: 76 ILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYL----TEKVTLSEKETRKIMR 131
Query: 291 VIIGTAKALAYLHEAIEPKVVHRDIKSSNILIDDEFNAKVSDFGLAKLLDSGESHITTRV 350
++ + + LH+ +VHRD+K NIL+DD+ N K++DFG + LD GE +
Sbjct: 132 ALL---EVICALHKL---NIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEK-LREVC 184
Query: 351 MGTFGYVAPE------YANTGMLNEKSDIYSFGVLL 380
GT Y+APE N ++ D++S GV++
Sbjct: 185 -GTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIM 219
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360 | Back alignment and structure |
|---|
Score = 110 bits (276), Expect = 1e-26
Identities = 58/226 (25%), Positives = 96/226 (42%), Gaps = 41/226 (18%)
Query: 185 TNRFSAENVLGEGGYGVVYKGRLI-NGSEVAVKKLLNNLGQAEKEFRVEVEAIGHVRHKN 243
+RF E + G+G +G V G+ G VA+KK++ + +E + ++ + + H N
Sbjct: 22 MDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRFRNRELQ-IMQDLAVLHHPN 80
Query: 244 LVRLLGYCI--------EGVHRMLVYEYVNNGNLEQWLHGAMRNQGN----LTWEARMKV 291
+V+L ++ +V EYV LH RN +KV
Sbjct: 81 IVQLQ-SYFYTLGERDRRDIYLNVVMEYV-----PDTLHRCCRNYYRRQVAPPPI-LIKV 133
Query: 292 II-GTAKALAYLHEAIEPKVVHRDIKSSNILIDDEFNA-KVSDFGLAKLLDSGE---SHI 346
+ +++ LH V HRDIK N+L+++ K+ DFG AK L E ++I
Sbjct: 134 FLFQLIRSIGCLHLP-SVNVCHRDIKPHNVLVNEADGTLKLCDFGSAKKLSPSEPNVAYI 192
Query: 347 TTRVMGTFGYVAPEYANTGMLNEKS-----DIYSFGVLLLEAVTGR 387
+R Y APE + + DI+S G + E + G
Sbjct: 193 CSRY-----YRAPEL----IFGNQHYTTAVDIWSVGCIFAEMMLGE 229
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351 | Back alignment and structure |
|---|
Score = 109 bits (274), Expect = 2e-26
Identities = 53/228 (23%), Positives = 97/228 (42%), Gaps = 15/228 (6%)
Query: 163 GLPEISHLGWGHWFTLRDLEIATNRFSAENVLGEGGYGVVYKGRLIN-GSEVAVK----- 216
G P IS G G D + + + V+G+G + VV + G + AVK
Sbjct: 1 GSPGISGGGGGILDMADDDVLFEDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVA 60
Query: 217 KLLNNLGQAEKEFRVEVEAIGHVRHKNLVRLLGYCIEGVHRMLVYEYVNNGNLEQWLHGA 276
K ++ G + ++ + E ++H ++V LL +V+E+++ +L +
Sbjct: 61 KFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSSDGMLYMVFEFMDGADLCFEIVKR 120
Query: 277 MRNQGNLTWEARMKVIIGT-AKALAYLHEAIEPKVVHRDIKSSNILI---DDEFNAKVSD 332
+ EA + +AL Y H+ ++HRD+K +L+ ++ K+
Sbjct: 121 ADAGFVYS-EAVASHYMRQILEALRYCHDN---NIIHRDVKPHCVLLASKENSAPVKLGG 176
Query: 333 FGLAKLLDSGESHITTRVMGTFGYVAPEYANTGMLNEKSDIYSFGVLL 380
FG+A L RV GT ++APE + D++ GV+L
Sbjct: 177 FGVAIQLGESGLVAGGRV-GTPHFMAPEVVKREPYGKPVDVWGCGVIL 223
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323 | Back alignment and structure |
|---|
Score = 108 bits (272), Expect = 2e-26
Identities = 70/277 (25%), Positives = 114/277 (41%), Gaps = 43/277 (15%)
Query: 194 LGEGGYGVVYKGR-LINGSEVAVK-----KLLNNLGQAEKEFRVEVEAIGHVRHKNLVRL 247
LGEG YG V + VAVK + ++ +KE + + H+N+V+
Sbjct: 15 LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKE----ICINKMLNHENVVKF 70
Query: 248 LGYCIEGVHRMLVYEYVNNGNLEQWL--HGAMRNQGNLTWEARMKV--IIGTAKALAYLH 303
G+ EG + L EY + G L + M +A+ ++ + YLH
Sbjct: 71 YGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEP-----DAQRFFHQLMA---GVVYLH 122
Query: 304 EAIEPKVVHRDIKSSNILIDDEFNAKVSDFGLAKLLDSG--ESHITTRVMGTFGYVAPE- 360
+ HRDIK N+L+D+ N K+SDFGLA + E + GT YVAPE
Sbjct: 123 GI---GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMC-GTLPYVAPEL 178
Query: 361 YANTGMLNEKSDIYSFGVLLLEAVTGRDPVDYGRPANEVNLVEWLKMMVGTRRAEEVVDP 420
E D++S G++L + G P D + +W + + ++P
Sbjct: 179 LKRREFHAEPVDVWSCGIVLTAMLAGELPWD-QPSDSCQEYSDWKE-------KKTYLNP 230
Query: 421 NLEVKPATRALKRSLLVALRCVDPDSEKRPKMSQVVR 457
++ A AL +LV +P R + + +
Sbjct: 231 WKKIDSAPLALLHKILV----ENP--SARITIPDIKK 261
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287 | Back alignment and structure |
|---|
Score = 107 bits (269), Expect = 3e-26
Identities = 55/208 (26%), Positives = 92/208 (44%), Gaps = 28/208 (13%)
Query: 185 TNRFSAENVLGEGGYGVVYKGR-LINGSEVAVKKLL-NNLGQAEKE-FRVEVEAIGHVRH 241
R++ +LG+G +G V K + I E AVK + + + EVE + + H
Sbjct: 21 AERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDH 80
Query: 242 KNLVRLLGYCIEGVHRMLVYEYVNNGNLEQWLHGAMRNQGNLTWEARMKVIIGT-AKALA 300
N+++L + +V E G L + + + E II +
Sbjct: 81 PNIMKLFEILEDSSSFYIVGELYTGGELFDE----IIKRKRFS-EHDAARIIKQVFSGIT 135
Query: 301 YLHEAIEPKVVHRDIKSSNILI---DDEFNAKVSDFGLAKLLDSGESHITTRVMGTFGYV 357
Y+H+ +VHRD+K NIL+ + + + K+ DFGL+ + R+ GT Y+
Sbjct: 136 YMHKH---NIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTK-MKDRI-GTAYYI 190
Query: 358 APE-----YANTGMLNEKSDIYSFGVLL 380
APE Y +EK D++S GV+L
Sbjct: 191 APEVLRGTY------DEKCDVWSAGVIL 212
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349 | Back alignment and structure |
|---|
Score = 108 bits (272), Expect = 3e-26
Identities = 63/262 (24%), Positives = 107/262 (40%), Gaps = 27/262 (10%)
Query: 124 VHHHERACSSQSGEEGSSGAGHKHSSLSYGGLVTASPLIGLPEISHLGWGHWFTLRDLEI 183
+HHH SG + + + S S +P+ G + +
Sbjct: 1 MHHHH---HHSSGVDLGTENLYFQSMSSVTASAAPGTASLVPDYWIDG-------SNRDA 50
Query: 184 ATNRFSAENVLGEGGYGVVYKGRLIN-GSEVAVKKLLNNLGQAEKEFRVEVEAIGHVRHK 242
++ F E+ LG G +VY+ + A+K L +K R E+ + + H
Sbjct: 51 LSDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKT--VDKKIVRTEIGVLLRLSHP 108
Query: 243 NLVRLLGYCIEGVHRMLVYEYVNNGNLEQWLHGAMRNQGNLTWEARMKVIIGT-AKALAY 301
N+++L LV E V G L + +G + E + +A+AY
Sbjct: 109 NIIKLKEIFETPTEISLVLELVTGGELFDRI----VEKGYYS-ERDAADAVKQILEAVAY 163
Query: 302 LHEAIEPKVVHRDIKSSNILI---DDEFNAKVSDFGLAKLLDSGESHITTRVMGTFGYVA 358
LHE +VHRD+K N+L + K++DFGL+K+++ + T GT GY A
Sbjct: 164 LHEN---GIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQVL-MKTVC-GTPGYCA 218
Query: 359 PEYANTGMLNEKSDIYSFGVLL 380
PE + D++S G++
Sbjct: 219 PEILRGCAYGPEVDMWSVGIIT 240
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419 | Back alignment and structure |
|---|
Score = 109 bits (274), Expect = 4e-26
Identities = 49/204 (24%), Positives = 84/204 (41%), Gaps = 27/204 (13%)
Query: 193 VLGEGGYGVVYKGRLIN-GSEVAVK-----KLLNNLGQAEKE---FRVEVEAIGHVRHKN 243
LG G G V +VA++ K + E+E + + H
Sbjct: 142 TLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPC 201
Query: 244 LVRLLGYCIEGVHRMLVYEYVNNGNLEQWLHGAMRNQGNLTWEARMKVIIGT-AKALAYL 302
++++ + + +V E + G L + L EA K+ A+ YL
Sbjct: 202 IIKIKNF-FDAEDYYIVLELMEGGELFDKV----VGNKRLK-EATCKLYFYQMLLAVQYL 255
Query: 303 HEAIEPKVVHRDIKSSNILI---DDEFNAKVSDFGLAKLLDSGESHITTRVMGTFGYVAP 359
HE ++HRD+K N+L+ +++ K++DFG +K+L + + GT Y+AP
Sbjct: 256 HEN---GIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETS--LMRTLCGTPTYLAP 310
Query: 360 E---YANTGMLNEKSDIYSFGVLL 380
E T N D +S GV+L
Sbjct: 311 EVLVSVGTAGYNRAVDCWSLGVIL 334
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322 | Back alignment and structure |
|---|
Score = 107 bits (270), Expect = 4e-26
Identities = 48/206 (23%), Positives = 84/206 (40%), Gaps = 31/206 (15%)
Query: 193 VLGEGGYGVVYKGRLIN-GSEVAVK----KLLNNLGQAEKE----FRVEVEAIGHVRHKN 243
LG G G V +VA+K + E + E+E + + H
Sbjct: 17 TLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPC 76
Query: 244 LVRLLGYCIEGVHRMLVYEYVNNGNLEQWLHGAMRNQGNLT-WEAR--MKVIIGTAKALA 300
++++ + + +V E + G L + L + ++ A+
Sbjct: 77 IIKIKNF-FDAEDYYIVLELMEGGELFDKV----VGNKRLKEATCKLYFYQMLL---AVQ 128
Query: 301 YLHEAIEPKVVHRDIKSSNILI---DDEFNAKVSDFGLAKLLDSGESHITTRVMGTFGYV 357
YLHE ++HRD+K N+L+ +++ K++DFG +K+L + T GT Y+
Sbjct: 129 YLHEN---GIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSL-MRTLC-GTPTYL 183
Query: 358 APE---YANTGMLNEKSDIYSFGVLL 380
APE T N D +S GV+L
Sbjct: 184 APEVLVSVGTAGYNRAVDCWSLGVIL 209
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277 | Back alignment and structure |
|---|
Score = 106 bits (267), Expect = 4e-26
Identities = 54/208 (25%), Positives = 88/208 (42%), Gaps = 30/208 (14%)
Query: 185 TNRFSAENVLGEGGYGVVYKGRLIN-GSEVAVKKLLNNLGQAEKEFRVEVEAIGHVRHKN 243
++ EN +G G +G V A KK+ + F+ E+E + + H N
Sbjct: 8 NQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPN 67
Query: 244 LVRLLGYCIEGVHRMLVYEYVNNGNLEQWLHGAMRNQGNLT-WEAR--MKVIIGTAKALA 300
++RL + LV E G L + + ++ +A MK ++ A+A
Sbjct: 68 IIRLYETFEDNTDIYLVMELCTGGELFERV----VHKRVFRESDAARIMKDVL---SAVA 120
Query: 301 YLHEAIEPKVVHRDIKSSNILI---DDEFNAKVSDFGLAKLLDSGESHITTRVMGTFGYV 357
Y H+ V HRD+K N L + K+ DFGLA G+ + T+V GT YV
Sbjct: 121 YCHKL---NVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKM-MRTKV-GTPYYV 175
Query: 358 APE-----YANTGMLNEKSDIYSFGVLL 380
+P+ Y + D +S GV++
Sbjct: 176 SPQVLEGLY------GPECDEWSAGVMM 197
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303 | Back alignment and structure |
|---|
Score = 107 bits (268), Expect = 4e-26
Identities = 54/223 (24%), Positives = 105/223 (47%), Gaps = 30/223 (13%)
Query: 186 NRFSAENVLGEGGYGVVYKGR-LINGSEVAVKKLLNNLGQAEKEF---RVEVEAIGHVRH 241
+ + + V+G G VV +VA+K++ NL + + E++A+ H
Sbjct: 15 DDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRI--NLEKCQTSMDELLKEIQAMSQCHH 72
Query: 242 KNLVRLLGYCIEGVHRMLVYEYVNNG---NLEQWLHGAMRNQGNLTWEARMKVII-GTAK 297
N+V + LV + ++ G ++ + + ++ + E+ + I+ +
Sbjct: 73 PNIVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLE 132
Query: 298 ALAYLHEAIEPKVVHRDIKSSNILIDDEFNAKVSDFGLAKLLDSGESHITTRVMGTF-G- 355
L YLH+ +HRD+K+ NIL+ ++ + +++DFG++ L +G +V TF G
Sbjct: 133 GLEYLHKN---GQIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFVGT 189
Query: 356 --YVAPE-------YANTGMLNEKSDIYSFGVLLLEAVTGRDP 389
++APE Y + K+DI+SFG+ +E TG P
Sbjct: 190 PCWMAPEVMEQVRGY------DFKADIWSFGITAIELATGAAP 226
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342 | Back alignment and structure |
|---|
Score = 107 bits (270), Expect = 5e-26
Identities = 56/205 (27%), Positives = 90/205 (43%), Gaps = 24/205 (11%)
Query: 185 TNRFSAENVLGEGGYGVVYKGR-LINGSEVAVKKLLNNLGQAEKEFRVEVEAIGH-VRHK 242
T+ + + +G G Y V + E AVK + +++++ E+E + +H
Sbjct: 21 TDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIID----KSKRDPTEEIEILLRYGQHP 76
Query: 243 NLVRLLGYCIEGVHRMLVYEYVNNGNLEQWLHGAMRNQGNLT-WEAR--MKVIIGTAKAL 299
N++ L +G + +V E + G L + Q + EA + I K +
Sbjct: 77 NIITLKDVYDDGKYVYVVTELMKGGELLDKIL----RQKFFSEREASAVLFTI---TKTV 129
Query: 300 AYLHEAIEPKVVHRDIKSSNILI----DDEFNAKVSDFGLAKLLDSGESHITTRVMGTFG 355
YLH VVHRD+K SNIL + + ++ DFG AK L + + T T
Sbjct: 130 EYLHAQ---GVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENGLLMTPC-YTAN 185
Query: 356 YVAPEYANTGMLNEKSDIYSFGVLL 380
+VAPE + DI+S GVLL
Sbjct: 186 FVAPEVLERQGYDAACDIWSLGVLL 210
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328 | Back alignment and structure |
|---|
Score = 107 bits (269), Expect = 5e-26
Identities = 77/275 (28%), Positives = 128/275 (46%), Gaps = 44/275 (16%)
Query: 194 LGEGGYGVVYKGR-LINGSEVAVK---KLLNNLGQAEKEFRVEVEAIGHVRHKNLVRLLG 249
+G+G + V R ++ G EVA+K K N +K FR EV + + H N+V+L
Sbjct: 23 IGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFR-EVRIMKILNHPNIVKL-- 79
Query: 250 Y-CIEGVHRM-LVYEYVNNGNLEQWL--HGAMRNQGNLTWEARMKV--IIGTAKALAYLH 303
+ IE + L+ EY + G + +L HG M+ + EAR K I+ A+ Y H
Sbjct: 80 FEVIETEKTLYLIMEYASGGEVFDYLVAHGRMKEK-----EARSKFRQIV---SAVQYCH 131
Query: 304 EAIEPKVVHRDIKSSNILIDDEFNAKVSDFGLAKLLDSGESHITTRVMGTFGYVAPE-YA 362
+ ++VHRD+K+ N+L+D + N K++DFG + G + G Y APE +
Sbjct: 132 QK---RIVHRDLKAENLLLDADMNIKIADFGFSNEFTVGG-KLDAFC-GAPPYAAPELFQ 186
Query: 363 NTGMLNEKSDIYSFGVLLLEAVTGRDPVDYGRPANEVNLVEWLKMMVGTRRAEEVVDPNL 422
+ D++S GV+L V+G P D N L E +++ G R + +
Sbjct: 187 GKKYDGPEVDVWSLGVILYTLVSGSLPFD---GQNLKELRE--RVLRGKYRIPFYMSTDC 241
Query: 423 EVKPATRALKRSLLVALRCVDPDSEKRPKMSQVVR 457
+LL ++P KR + Q+++
Sbjct: 242 ----------ENLLKRFLVLNP--IKRGTLEQIMK 264
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302 | Back alignment and structure |
|---|
Score = 106 bits (266), Expect = 8e-26
Identities = 50/212 (23%), Positives = 98/212 (46%), Gaps = 15/212 (7%)
Query: 185 TNRFSAENVLGEGGYGVVYKGR-LINGSEVAVKKLLNNLGQAEKEFRVEVEAIGHVRHKN 243
+ LG+G +G VYK + G+ A K + + +++ VE+E + H
Sbjct: 18 NEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPY 77
Query: 244 LVRLLGYCIEGVHRMLVYEYVNNGNLEQWLHGAMRNQGNLTWEARMKVII-GTAKALAYL 302
+V+LLG ++ E+ G ++ M E +++V+ +AL +L
Sbjct: 78 IVKLLGAYYHDGKLWIMIEFCPGGAVDA----IMLELDRGLTEPQIQVVCRQMLEALNFL 133
Query: 303 HEAIEPKVVHRDIKSSNILIDDEFNAKVSDFGLAKLLDSGESHITTRVMGTFGYVAPEYA 362
H +++HRD+K+ N+L+ E + +++DFG++ + +GT ++APE
Sbjct: 134 HSK---RIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQKRDS-FIGTPYWMAPEVV 189
Query: 363 NTGML-----NEKSDIYSFGVLLLEAVTGRDP 389
+ + K+DI+S G+ L+E P
Sbjct: 190 MCETMKDTPYDYKADIWSLGITLIEMAQIEPP 221
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389 | Back alignment and structure |
|---|
Score = 107 bits (269), Expect = 1e-25
Identities = 50/221 (22%), Positives = 79/221 (35%), Gaps = 24/221 (10%)
Query: 185 TNRFSAENVLGEG--GYGVVYKGR-LINGSEVAVKKLLNNLGQAEKEF----RVEVEAIG 237
+ V+G+G V R G V V+++ NL E + E+
Sbjct: 24 GGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRI--NLEACSNEMVTFLQGELHVSK 81
Query: 238 HVRHKNLVRLLGYCIEGVHRMLVYEYVNNGNLEQWLHGAMRNQGNLTWEARMKVII-GTA 296
H N+V I +V ++ G+ + + + N E + I+ G
Sbjct: 82 LFNHPNIVPYRATFIADNELWVVTSFMAYGSAKDLICTHFMDGMN---ELAIAYILQGVL 138
Query: 297 KALAYLHEAIEPKVVHRDIKSSNILIDDEFNAKVSDFGLAKLLDSGESHITTRVMGTFGY 356
KAL Y+H VHR +K+S+ILI + +S + S
Sbjct: 139 KALDYIHHM---GYVHRSVKASHILISVDGKVYLSGLRSNLSMISHGQRQRVVHDFPKYS 195
Query: 357 V------APEYANTGML--NEKSDIYSFGVLLLEAVTGRDP 389
V +PE + + KSDIYS G+ E G P
Sbjct: 196 VKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVP 236
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276 | Back alignment and structure |
|---|
Score = 104 bits (263), Expect = 2e-25
Identities = 68/210 (32%), Positives = 103/210 (49%), Gaps = 28/210 (13%)
Query: 194 LGEGGYGVVYKGR-LINGSEVAVK----KLLNNLGQAEKEFRVEVEAIGHVRHKNLVRLL 248
LG G +G V G + G +VAVK + + +L K R E++ + RH ++++L
Sbjct: 19 LGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKR-EIQNLKLFRHPHIIKL- 76
Query: 249 GY-CIEGVHRM-LVYEYVNNGNLEQWL--HGAMRNQGNLTWEARMKV--IIGTAKALAYL 302
Y I +V EYV+ G L ++ HG + EAR I+ A+ Y
Sbjct: 77 -YQVISTPTDFFMVMEYVSGGELFDYICKHGRVEEM-----EARRLFQQILS---AVDYC 127
Query: 303 HEAIEPKVVHRDIKSSNILIDDEFNAKVSDFGLAKLLDSGESHITTRVMGTFGYVAPE-Y 361
H VVHRD+K N+L+D NAK++DFGL+ ++ GE T+ G+ Y APE
Sbjct: 128 HRH---MVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRTS--CGSPNYAAPEVI 182
Query: 362 ANTGMLNEKSDIYSFGVLLLEAVTGRDPVD 391
+ + DI+S GV+L + G P D
Sbjct: 183 SGRLYAGPEVDIWSCGVILYALLCGTLPFD 212
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305 | Back alignment and structure |
|---|
Score = 105 bits (264), Expect = 2e-25
Identities = 59/212 (27%), Positives = 87/212 (41%), Gaps = 22/212 (10%)
Query: 193 VLGEGGYGVVYKGR-LINGSEVAVK----KLLNNLGQAEKEFRVEVEAIGHVRHKNLVRL 247
+LGEG YG V + AVK K L + E + E++ + +RHKN+++L
Sbjct: 12 LLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQL 71
Query: 248 LG-YCIEGVHRM-LVYEYVNNGNLEQWLHGAMRNQGNLT-WEARMKV--IIGTAKALAYL 302
+ E +M +V EY G E + +A +I L YL
Sbjct: 72 VDVLYNEEKQKMYMVMEYCVCGMQEMLDSVP---EKRFPVCQAHGYFCQLID---GLEYL 125
Query: 303 HEAIEPKVVHRDIKSSNILIDDEFNAKVSDFGLAKLLDSG-ESHITTRVMGTFGYVAPEY 361
H +VH+DIK N+L+ K+S G+A+ L G+ + PE
Sbjct: 126 HSQ---GIVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAADDTCRTSQGSPAFQPPEI 182
Query: 362 ANTGMLNE--KSDIYSFGVLLLEAVTGRDPVD 391
AN K DI+S GV L TG P +
Sbjct: 183 ANGLDTFSGFKVDIWSAGVTLYNITTGLYPFE 214
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320 | Back alignment and structure |
|---|
Score = 105 bits (265), Expect = 2e-25
Identities = 66/266 (24%), Positives = 113/266 (42%), Gaps = 33/266 (12%)
Query: 142 GAGHKHSSLSYGGLVTASPLIGLPEISHLGWGHWFTLRDLEIATNRFSAENVLGEGGYGV 201
G+ H H S G + S + ++ ++ E +++ +LG GG+G
Sbjct: 2 GSSHHHHHHSSGLVPRGSHMAPCNDLHATKLA---PGKEKEPLESQYQVGPLLGSGGFGS 58
Query: 202 VYKGR-LINGSEVAVKKL----LNNLGQAEKEFRV--EVEAIGHVRHK--NLVRLLGYCI 252
VY G + + VA+K + +++ G+ RV EV + V ++RLL +
Sbjct: 59 VYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFE 118
Query: 253 EGVHRMLVYEYVNN-GNLEQWL--HGAMRNQGNLTWEAR--MKVIIGTAKALAYLHEAIE 307
+L+ E +L ++ GA++ + AR ++ +A+ + H
Sbjct: 119 RPDSFVLILERPEPVQDLFDFITERGALQEE-----LARSFFWQVL---EAVRHCHNC-- 168
Query: 308 PKVVHRDIKSSNILID-DEFNAKVSDFGLAKLLDSGESHITTRVMGTFGYVAPEY-ANTG 365
V+HRDIK NILID + K+ DFG LL T GT Y PE+
Sbjct: 169 -GVLHRDIKDENILIDLNRGELKLIDFGSGALLKDT--VYTDFD-GTRVYSPPEWIRYHR 224
Query: 366 MLNEKSDIYSFGVLLLEAVTGRDPVD 391
+ ++S G+LL + V G P +
Sbjct: 225 YHGRSAAVWSLGILLYDMVCGDIPFE 250
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321 | Back alignment and structure |
|---|
Score = 105 bits (265), Expect = 2e-25
Identities = 56/210 (26%), Positives = 91/210 (43%), Gaps = 26/210 (12%)
Query: 185 TNRFSAENVLGEGGYGVVYKGRLI-NGSEVAVK-----KLLNNLGQAEKE-FRVEVEAIG 237
+ + LG G + +V K R G E A K + + +E EV +
Sbjct: 11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILR 70
Query: 238 HVRHKNLVRLLGYCIEGVHRMLVYEYVNNGNLEQWLHGAMRNQGNLT-WEAR--MKVIIG 294
V H N++ L +L+ E V+ G E L + + +L+ EA +K I+
Sbjct: 71 QVLHHNVITLHDVYENRTDVVLILELVSGG--E--LFDFLAQKESLSEEEATSFIKQILD 126
Query: 295 TAKALAYLHEAIEPKVVHRDIKSSNILI----DDEFNAKVSDFGLAKLLDSGESHITTRV 350
+ YLH K+ H D+K NI++ + K+ DFGLA ++ G +
Sbjct: 127 ---GVNYLHTK---KIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGV--EFKNI 178
Query: 351 MGTFGYVAPEYANTGMLNEKSDIYSFGVLL 380
GT +VAPE N L ++D++S GV+
Sbjct: 179 FGTPEFVAPEIVNYEPLGLEADMWSIGVIT 208
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325 | Back alignment and structure |
|---|
Score = 105 bits (264), Expect = 3e-25
Identities = 55/198 (27%), Positives = 92/198 (46%), Gaps = 22/198 (11%)
Query: 191 ENVLGEGGYGVVYKGR-LINGSEVAVKKLLNNLGQAEKEFRVEVEAIGHVR-HKNLVRLL 248
+ LGEG + + K + AVK + + E + E+ A+ H N+V+L
Sbjct: 16 DKPLGEGSFSICRKCVHKKSNQAFAVKIISK---RMEANTQKEITALKLCEGHPNIVKLH 72
Query: 249 GYCIEGVHRMLVYEYVNNGNLEQWLHGAMRNQGNLT-WEAR--MKVIIGTAKALAYLHEA 305
+ +H LV E +N G L + ++ + + + EA M+ + A++++H+
Sbjct: 73 EVFHDQLHTFLVMELLNGGELFE----RIKKKKHFSETEASYIMRKL---VSAVSHMHDV 125
Query: 306 IEPKVVHRDIKSSNILI---DDEFNAKVSDFGLAKLLDSGESHITTRVMGTFGYVAPEYA 362
VVHRD+K N+L +D K+ DFG A+L + T T Y APE
Sbjct: 126 ---GVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQPLKTPC-FTLHYAAPELL 181
Query: 363 NTGMLNEKSDIYSFGVLL 380
N +E D++S GV+L
Sbjct: 182 NQNGYDESCDLWSLGVIL 199
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284 | Back alignment and structure |
|---|
Score = 104 bits (261), Expect = 3e-25
Identities = 51/205 (24%), Positives = 95/205 (46%), Gaps = 21/205 (10%)
Query: 185 TNRFSAENVLGEGGYGVVYKGRLIN-GSEVAVKKLL-NNLGQAEKE-FRVEVEAIGHVRH 241
++ + + LG+G + VV + G E A K + L + + E ++H
Sbjct: 5 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQH 64
Query: 242 KNLVRLLGYCIEGVHRMLVYEYVNNGNLEQWLHGAMRNQGNLT-WEAR--MKVIIGTAKA 298
N+VRL E LV++ V G L + + + + +A ++ I+ ++
Sbjct: 65 PNIVRLHDSIQEESFHYLVFDLVTGGELFEDI----VAREFYSEADASHCIQQIL---ES 117
Query: 299 LAYLHEAIEPKVVHRDIKSSNILIDDEFNA---KVSDFGLAKLLDSGESHITTRVMGTFG 355
+AY H +VHR++K N+L+ + K++DFGLA ++ E+ GT G
Sbjct: 118 IAYCHSN---GIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEA-WHGFA-GTPG 172
Query: 356 YVAPEYANTGMLNEKSDIYSFGVLL 380
Y++PE ++ DI++ GV+L
Sbjct: 173 YLSPEVLKKDPYSKPVDIWACGVIL 197
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573 | Back alignment and structure |
|---|
Score = 108 bits (271), Expect = 3e-25
Identities = 62/276 (22%), Positives = 108/276 (39%), Gaps = 21/276 (7%)
Query: 108 GMSKSSDPDNISQCSSVHHHERACSSQSGEEGSSGAGHKHSSLSYGGLVTASPLIGLPEI 167
G SK +P +R E+G G S +Y V P+
Sbjct: 89 GQSKPCEPTAPVLIPG-DERKRRRGYDVDEQGKIVRGKGTVSSNYDNYVFDIWKQYYPQP 147
Query: 168 SHLGWGHWFTLRDLEIATNRFSAENVLGEGGYGVVYKGRLIN-GSEVAVKKLLNNLGQAE 226
+ H + + LG G +GVV++ G+ A K ++ +
Sbjct: 148 VEIKHDH---------VLDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDK 198
Query: 227 KEFRVEVEAIGHVRHKNLVRLLGYCIEGVHRMLVYEYVNNGNLEQWLHGAMRNQGNLTWE 286
+ R E++ + +RH LV L + +++YE+++ G L + + ++ +
Sbjct: 199 ETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFMSGGELFEKV---ADEHNKMSED 255
Query: 287 ARMKVIIGTAKALAYLHEAIEPKVVHRDIKSSNILI--DDEFNAKVSDFGLAKLLDSGES 344
++ + K L ++HE VH D+K NI+ K+ DFGL LD +S
Sbjct: 256 EAVEYMRQVCKGLCHMHEN---NYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQS 312
Query: 345 HITTRVMGTFGYVAPEYANTGMLNEKSDIYSFGVLL 380
GT + APE A + +D++S GVL
Sbjct: 313 --VKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLS 346
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 104 bits (262), Expect = 4e-25
Identities = 60/221 (27%), Positives = 92/221 (41%), Gaps = 42/221 (19%)
Query: 186 NRFSAENVLGEGGYGVVYKGR-LINGSEVAVKKLLNNLGQAEKE------FRVEVEAIGH 238
++ +GEG YGVV+K R G VA+KK L + R E+ +
Sbjct: 3 EKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLE---SEDDPVIKKIALR-EIRMLKQ 58
Query: 239 VRHKNLVRLLGYCIEGVHR----MLVYEYVNNGNLEQWLHGAMRNQGNLTWEARMKVIIG 294
++H NLV LL E R LV+EY + + + E +K I
Sbjct: 59 LKHPNLVNLL----EVFRRKRRLHLVFEY-----CDHTVLHELDRYQRGVPEHLVKSITW 109
Query: 295 -TAKALAYLHEAIEPKVVHRDIKSSNILIDDEFNAKVSDFGLAKLLDSGESHITTRVMGT 353
T +A+ + H+ +HRD+K NILI K+ DFG A+LL + V T
Sbjct: 110 QTLQAVNFCHKH---NCIHRDVKPENILITKHSVIKLCDFGFARLLTGPSDYYDDEVA-T 165
Query: 354 FGYVAPE-------YANTGMLNEKSDIYSFGVLLLEAVTGR 387
Y +PE Y + D+++ G + E ++G
Sbjct: 166 RWYRSPELLVGDTQY-GPPV-----DVWAIGCVFAELLSGV 200
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444 | Back alignment and structure |
|---|
Score = 106 bits (267), Expect = 5e-25
Identities = 50/203 (24%), Positives = 88/203 (43%), Gaps = 16/203 (7%)
Query: 185 TNRFSAENVLGEGGYGVVYKGRLIN-GSEVAVKKLL-NNLGQAEKE-FRVEVEAIGHVRH 241
T + LG+G + VV + + G E A + L + + E ++H
Sbjct: 10 TEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKH 69
Query: 242 KNLVRLLGYCIEGVHRMLVYEYVNNGNLEQWLHGAMRNQGNLTWEARMKVIIGT-AKALA 300
N+VRL E H L+++ V G L + + + + EA I +A+
Sbjct: 70 PNIVRLHDSISEEGHHYLIFDLVTGGELFEDI----VAREYYS-EADASHCIQQILEAVL 124
Query: 301 YLHEAIEPKVVHRDIKSSNILI---DDEFNAKVSDFGLAKLLDSGESHITTRVMGTFGYV 357
+ H+ VVHR++K N+L+ K++DFGLA ++ + GT GY+
Sbjct: 125 HCHQM---GVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQAWFGFA-GTPGYL 180
Query: 358 APEYANTGMLNEKSDIYSFGVLL 380
+PE + D+++ GV+L
Sbjct: 181 SPEVLRKDPYGKPVDLWACGVIL 203
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283 | Back alignment and structure |
|---|
Score = 103 bits (259), Expect = 5e-25
Identities = 56/210 (26%), Positives = 94/210 (44%), Gaps = 26/210 (12%)
Query: 185 TNRFSAENVLGEGGYGVVYKGRLI-NGSEVAVK-----KLLNNLGQAEKE-FRVEVEAIG 237
+ + LG G + +V K R G E A K +L ++ +E EV +
Sbjct: 4 EDHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILR 63
Query: 238 HVRHKNLVRLLGYCIEGVHRMLVYEYVNNGNLEQWLHGAMRNQGNLT-WEAR--MKVIIG 294
+RH N++ L +L+ E V+ G E L + + +LT EA +K I+
Sbjct: 64 EIRHPNIITLHDIFENKTDVVLILELVSGG--E--LFDFLAEKESLTEDEATQFLKQILD 119
Query: 295 TAKALAYLHEAIEPKVVHRDIKSSNILI----DDEFNAKVSDFGLAKLLDSGESHITTRV 350
+ YLH ++ H D+K NI++ K+ DFG+A +++G +
Sbjct: 120 ---GVHYLHSK---RIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEFKN--I 171
Query: 351 MGTFGYVAPEYANTGMLNEKSDIYSFGVLL 380
GT +VAPE N L ++D++S GV+
Sbjct: 172 FGTPEFVAPEIVNYEPLGLEADMWSIGVIT 201
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361 | Back alignment and structure |
|---|
Score = 104 bits (262), Expect = 8e-25
Identities = 54/208 (25%), Positives = 87/208 (41%), Gaps = 22/208 (10%)
Query: 185 TNRFSAENVLGEGGYGVVYKGRLI-NGSEVAVK-----KLLNNLGQAEKE-FRVEVEAIG 237
+ + LG G + +V K R G E A K + + +E EV +
Sbjct: 11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILR 70
Query: 238 HVRHKNLVRLLGYCIEGVHRMLVYEYVNNGNLEQWLHGAMRNQGNLTWEARMKVIIGT-A 296
V H N++ L +L+ E V+ G L +L + +L+ E I
Sbjct: 71 QVLHPNIITLHDVYENRTDVVLILELVSGGELFDFL----AQKESLS-EEEATSFIKQIL 125
Query: 297 KALAYLHEAIEPKVVHRDIKSSNILI----DDEFNAKVSDFGLAKLLDSGESHITTRVMG 352
+ YLH K+ H D+K NI++ + K+ DFGLA ++ G + G
Sbjct: 126 DGVNYLHTK---KIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKN--IFG 180
Query: 353 TFGYVAPEYANTGMLNEKSDIYSFGVLL 380
T +VAPE N L ++D++S GV+
Sbjct: 181 TPEFVAPEIVNYEPLGLEADMWSIGVIT 208
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331 | Back alignment and structure |
|---|
Score = 103 bits (260), Expect = 9e-25
Identities = 55/215 (25%), Positives = 91/215 (42%), Gaps = 30/215 (13%)
Query: 186 NRFSAENVLGEGGYGVVYKGR-LINGSEVAVKKLLNNLGQAEKEFRV----EVEAIGHVR 240
++ ++GEG YG+V K R G VA+KK L +K + E++ + +R
Sbjct: 25 EKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFL--ESDDDKMVKKIAMREIKLLKQLR 82
Query: 241 HKNLVRLLGYCIEGVHRMLVYEYVNNGNLEQWLHGAMRNQGNLTWEARMKVIIG-TAKAL 299
H+NLV LL C + LV+E+ ++ + + N ++ + +
Sbjct: 83 HENLVNLLEVCKKKKRWYLVFEF-----VDHTILDDLELFPNGLDYQVVQKYLFQIINGI 137
Query: 300 AYLHEAIEPKVVHRDIKSSNILIDDEFNAKVSDFGLAKLLDSGESHITTRVMGTFGYVAP 359
+ H ++HRDIK NIL+ K+ DFG A+ L + V T Y AP
Sbjct: 138 GFCHSH---NIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYDDEVA-TRWYRAP 193
Query: 360 E-------YANTGMLNEKSDIYSFGVLLLEAVTGR 387
E Y + D+++ G L+ E G
Sbjct: 194 ELLVGDVKY-GKAV-----DVWAIGCLVTEMFMGE 222
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 103 bits (260), Expect = 1e-24
Identities = 56/210 (26%), Positives = 92/210 (43%), Gaps = 26/210 (12%)
Query: 185 TNRFSAENVLGEGGYGVVYKGRLI-NGSEVAVK-----KLLNNLGQAEKE-FRVEVEAIG 237
+ + LG G + VV K R G + A K + ++ +E EV +
Sbjct: 10 DDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILK 69
Query: 238 HVRHKNLVRLLGYCIEGVHRMLVYEYVNNGNLEQWLHGAMRNQGNLT-WEAR--MKVIIG 294
++H N++ L +L+ E V G E L + + +LT EA +K I+
Sbjct: 70 EIQHPNVITLHEVYENKTDVILILELVAGG--E--LFDFLAEKESLTEEEATEFLKQILN 125
Query: 295 TAKALAYLHEAIEPKVVHRDIKSSNILI----DDEFNAKVSDFGLAKLLDSGESHITTRV 350
+ YLH ++ H D+K NI++ + K+ DFGLA +D G +
Sbjct: 126 ---GVYYLHSL---QIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEF--KNI 177
Query: 351 MGTFGYVAPEYANTGMLNEKSDIYSFGVLL 380
GT +VAPE N L ++D++S GV+
Sbjct: 178 FGTPEFVAPEIVNYEPLGLEADMWSIGVIT 207
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316 | Back alignment and structure |
|---|
Score = 103 bits (259), Expect = 1e-24
Identities = 56/209 (26%), Positives = 93/209 (44%), Gaps = 29/209 (13%)
Query: 191 ENVLGEGGYGVVYKGR-LINGSEVAVKKLLNNLGQAEKEFRVEVEAIGHVR-HKNLVRLL 248
E+VLGEG + V LI E AVK + G EVE + + H+N++ L+
Sbjct: 18 EDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELI 77
Query: 249 GYCIEGVHRMLVYEYVNNGNLEQWLHGAMRNQGNLT-WEAR--MKVIIGTAKALAYLHEA 305
+ E LV+E + G++ L + + + EA ++ + A AL +LH
Sbjct: 78 EFFEEEDRFYLVFEKMRGGSI---LS-HIHKRRHFNELEASVVVQDV---ASALDFLHN- 129
Query: 306 IEPKVVHRDIKSSNILI---DDEFNAKVSDFGLAKLLDSGESH--ITTRVM----GTFGY 356
+ HRD+K NIL + K+ DF L + I+T + G+ Y
Sbjct: 130 --KGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEY 187
Query: 357 VAPE-----YANTGMLNEKSDIYSFGVLL 380
+APE + +++ D++S GV+L
Sbjct: 188 MAPEVVEAFSEEASIYDKRCDLWSLGVIL 216
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 103 bits (259), Expect = 1e-24
Identities = 60/219 (27%), Positives = 98/219 (44%), Gaps = 22/219 (10%)
Query: 185 TNRFSAENVLGEGGYGVVYKGR-LINGSEVAVKKLLNNLGQAEKEFRVEVEAIGHV-RHK 242
F ++G G YG VYKGR + G A+K + + G E+E + E+ + H+
Sbjct: 23 AGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVM-DVTGDEEEEIKQEINMLKKYSHHR 81
Query: 243 NLVRLLG-YCIEGVHRM-----LVYEYVNNGNLEQWLHGAMRNQGNLTWEARMKVII-GT 295
N+ G + + M LV E+ G++ + L E + I
Sbjct: 82 NIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIK--NTKGNTLK-EEWIAYICREI 138
Query: 296 AKALAYLHEAIEPKVVHRDIKSSNILIDDEFNAKVSDFGLAKLLDSGESHITTRVMGTFG 355
+ L++LH+ KV+HRDIK N+L+ + K+ DFG++ LD T +GT
Sbjct: 139 LRGLSHLHQ---HKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNT-FIGTPY 194
Query: 356 YVAPE-----YANTGMLNEKSDIYSFGVLLLEAVTGRDP 389
++APE + KSD++S G+ +E G P
Sbjct: 195 WMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPP 233
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318 | Back alignment and structure |
|---|
Score = 102 bits (257), Expect = 2e-24
Identities = 54/220 (24%), Positives = 92/220 (41%), Gaps = 18/220 (8%)
Query: 179 RDLEIATNRFSAENVLGEGGYGVVYKGRLINGSEV-AVKKLLNNLGQAE-KEFRVEVEAI 236
+ + N +G G G V+K R V AVK++ + + E K ++++ +
Sbjct: 18 QRYQAEINDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVV 77
Query: 237 GH-VRHKNLVRLLGYCIEGVHRMLVYEYVNNGNLEQWLHGAMRNQGNLTWEARM-KVIIG 294
+V+ G I + E + + E + K+ +
Sbjct: 78 LKSHDCPYIVQCFGTFITNTDVFIAMELMGTC-----AEKLKKRMQGPIPERILGKMTVA 132
Query: 295 TAKALAYLHEAIEPKVVHRDIKSSNILIDDEFNAKVSDFGLAKLLDSGESHITTRVMGTF 354
KAL YL E + V+HRD+K SNIL+D+ K+ DFG++ L R G
Sbjct: 133 IVKALYYLKE--KHGVIHRDVKPSNILLDERGQIKLCDFGISGRLVD--DKAKDRSAGCA 188
Query: 355 GYVAPE-----YANTGMLNEKSDIYSFGVLLLEAVTGRDP 389
Y+APE + ++D++S G+ L+E TG+ P
Sbjct: 189 AYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFP 228
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387 | Back alignment and structure |
|---|
Score = 104 bits (260), Expect = 2e-24
Identities = 42/199 (21%), Positives = 82/199 (41%), Gaps = 11/199 (5%)
Query: 185 TNRFSAENVLGEGGYGVVYKGRLI-NGSEVAVKKLLNNLGQAEKEFRVEVEAIGHVRHKN 243
+ + LG G +GVV++ G K + + + E+ + + H
Sbjct: 50 YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPK 109
Query: 244 LVRLLGYCIEGVHRMLVYEYVNNGNLEQWLHGAMRNQGNLTWEARMKVIIGTAKALAYLH 303
L+ L + +L+ E+++ G L + ++ + + + L ++H
Sbjct: 110 LINLHDAFEDKYEMVLILEFLSGGELFDRI---AAEDYKMSEAEVINYMRQACEGLKHMH 166
Query: 304 EAIEPKVVHRDIKSSNILIDDEFNA--KVSDFGLAKLLDSGESHITTRVMGTFGYVAPEY 361
E +VH DIK NI+ + + + K+ DFGLA L+ E T + APE
Sbjct: 167 EH---SIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVKV--TTATAEFAAPEI 221
Query: 362 ANTGMLNEKSDIYSFGVLL 380
+ + +D+++ GVL
Sbjct: 222 VDREPVGFYTDMWAIGVLG 240
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362 | Back alignment and structure |
|---|
Score = 103 bits (258), Expect = 3e-24
Identities = 51/205 (24%), Positives = 94/205 (45%), Gaps = 21/205 (10%)
Query: 185 TNRFSAENVLGEGGYGVVYKGRLIN-GSEVAVKKLL-NNLGQAEKE-FRVEVEAIGHVRH 241
++ + + LG+G + VV + G E A K + L + + E ++H
Sbjct: 28 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQH 87
Query: 242 KNLVRLLGYCIEGVHRMLVYEYVNNGNLEQWLHGAMRNQGNLT-WEAR--MKVIIGTAKA 298
N+VRL E LV++ V G L + + + + +A ++ I+ ++
Sbjct: 88 PNIVRLHDSIQEESFHYLVFDLVTGGELFEDI----VAREFYSEADASHCIQQIL---ES 140
Query: 299 LAYLHEAIEPKVVHRDIKSSNILI---DDEFNAKVSDFGLAKLLDSGESHITTRVMGTFG 355
+AY H +VHR++K N+L+ K++DFGLA ++ E+ GT G
Sbjct: 141 IAYCHSN---GIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEA-WHGFA-GTPG 195
Query: 356 YVAPEYANTGMLNEKSDIYSFGVLL 380
Y++PE ++ DI++ GV+L
Sbjct: 196 YLSPEVLKKDPYSKPVDIWACGVIL 220
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346 | Back alignment and structure |
|---|
Score = 102 bits (257), Expect = 3e-24
Identities = 58/216 (26%), Positives = 103/216 (47%), Gaps = 29/216 (13%)
Query: 186 NRFSAENVLGEGGYGVVYKGR-LINGSEVAVKKL-LNNLGQAEKEFRV----EVEAIGHV 239
R+ + LGEG + VYK R VA+KK+ L + +A+ E++ + +
Sbjct: 10 KRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQEL 69
Query: 240 RHKNLVRLLGYCIEGVHRMLVYEYVNNGNLEQWLHGAMRNQGNLTWEARMKVIIG-TAKA 298
H N++ LL + LV+++ +E L +++ + + +K + T +
Sbjct: 70 SHPNIIGLLDAFGHKSNISLVFDF-----METDLEVIIKDNSLVLTPSHIKAYMLMTLQG 124
Query: 299 LAYLHEAIEPKVVHRDIKSSNILIDDEFNAKVSDFGLAKLLDSGESHITTRVMGTFGYVA 358
L YLH+ ++HRD+K +N+L+D+ K++DFGLAK S T +V+ T Y A
Sbjct: 125 LEYLHQH---WILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYTHQVV-TRWYRA 180
Query: 359 PE-------YANTGMLNEKSDIYSFGVLLLEAVTGR 387
PE Y G+ D+++ G +L E +
Sbjct: 181 PELLFGARMY-GVGV-----DMWAVGCILAELLLRV 210
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292 | Back alignment and structure |
|---|
Score = 101 bits (254), Expect = 3e-24
Identities = 52/218 (23%), Positives = 90/218 (41%), Gaps = 32/218 (14%)
Query: 186 NRFSAENVLGEGGYGVVYKGR-LINGSEVAVKKL-LNNLGQAEKE------FRVEVEAIG 237
++ +GEG YG V+K + VA+K++ L++ + E R E+ +
Sbjct: 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDD----DDEGVPSSALR-EICLLK 56
Query: 238 HVRHKNLVRLLGYCIEGVHRMLVYEYVNNGNLEQWLHGAMRNQGNLTWEARMKVIIG-TA 296
++HKN+VRL LV+E+ +Q L + +K +
Sbjct: 57 ELKHKNIVRLHDVLHSDKKLTLVFEF-----CDQDLKKYFDSCNGDLDPEIVKSFLFQLL 111
Query: 297 KALAYLHEAIEPKVVHRDIKSSNILIDDEFNAKVSDFGLAKLLDSGESHITTRVMGTFGY 356
K L + H V+HRD+K N+LI+ K+++FGLA+ + V+ T Y
Sbjct: 112 KGLGFCHSR---NVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSAEVV-TLWY 167
Query: 357 VAPEYANTGMLNEKS-----DIYSFGVLLLEAVTGRDP 389
P+ + K D++S G + E P
Sbjct: 168 RPPDV----LFGAKLYSTSIDMWSAGCIFAELANAGRP 201
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312 | Back alignment and structure |
|---|
Score = 101 bits (254), Expect = 4e-24
Identities = 67/281 (23%), Positives = 107/281 (38%), Gaps = 51/281 (18%)
Query: 193 VLGEGGYGVVYKGR-LINGSEVAVKKL----LNNLGQAEKEFRVEVE------AIGHVRH 241
+LG+GG+G V+ G L + +VA+K + + +E H
Sbjct: 38 LLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGH 97
Query: 242 KNLVRLLGYCIEGVHRMLVYEYVNNGNLEQWLHGAMRNQGNLT-WEAR--MKVIIGTAKA 298
++RLL + MLV E Q L + +G L +R ++ A
Sbjct: 98 PGVIRLLDWFETQEGFMLVLERPLPA---QDLFDYITEKGPLGEGPSRCFFGQVV---AA 151
Query: 299 LAYLHEAIEPKVVHRDIKSSNILIDDEFNA-KVSDFGLAKLLDSGESHITTRVMGTFGYV 357
+ + H VVHRDIK NILID K+ DFG LL T GT Y
Sbjct: 152 IQHCHSR---GVVHRDIKDENILIDLRRGCAKLIDFGSGALLHDE--PYTDFD-GTRVYS 205
Query: 358 APEY-ANTGMLNEKSDIYSFGVLLLEAVTGRDPVDYGRPANEVNLVEWLKMMVGTRRAEE 416
PE+ + + ++S G+LL + V G P + R +E
Sbjct: 206 PPEWISRHQYHALPATVWSLGILLYDMVCGDIPFE---------------------RDQE 244
Query: 417 VVDPNLEVKPATRALKRSLLVALRCVDPDSEKRPKMSQVVR 457
+++ L +L+ RC+ P RP + +++
Sbjct: 245 ILEAELHFPAHVSPDCCALIR--RCLAPKPSSRPSLEEILL 283
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311 | Back alignment and structure |
|---|
Score = 101 bits (253), Expect = 6e-24
Identities = 57/214 (26%), Positives = 102/214 (47%), Gaps = 29/214 (13%)
Query: 186 NRFSAENVLGEGGYGVVYKGRLINGSEVAVKKLLNNLGQAEKE------FRVEVEAIGHV 239
++ +GEG YGVVYK + G VA+K++ L E E R E+ + +
Sbjct: 21 EKYQKLEKVGEGTYGVVYKAKDSQGRIVALKRI--RLDA-EDEGIPSTAIR-EISLLKEL 76
Query: 240 RHKNLVRLLGYCIEGVHRMLVYEYVNNGNLEQWLHGAMRNQGNLTWEARMKVIIG-TAKA 298
H N+V L+ LV+E+ +E+ L + ++++K+ + +
Sbjct: 77 HHPNIVSLIDVIHSERCLTLVFEF-----MEKDLKKVLDENKTGLQDSQIKIYLYQLLRG 131
Query: 299 LAYLHEAIEPKVVHRDIKSSNILIDDEFNAKVSDFGLAKLLDSGESHITTRVMGTFGYVA 358
+A+ H+ +++HRD+K N+LI+ + K++DFGLA+ T V+ T Y A
Sbjct: 132 VAHCHQH---RILHRDLKPQNLLINSDGALKLADFGLARAFGIPVRSYTHEVV-TLWYRA 187
Query: 359 PEYANTGMLNEKS-----DIYSFGVLLLEAVTGR 387
P+ ++ K DI+S G + E +TG+
Sbjct: 188 PDV----LMGSKKYSTSVDIWSIGCIFAEMITGK 217
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543 | Back alignment and structure |
|---|
Score = 103 bits (259), Expect = 8e-24
Identities = 58/237 (24%), Positives = 101/237 (42%), Gaps = 44/237 (18%)
Query: 175 WFTLRDLEIATNRFSAENVLGEGGYGVVYKGRLINGSEV-AVKKLLNNLGQAEKEFRVEV 233
W L + + F VLG GG+G V+ ++ ++ A KKL K+ +
Sbjct: 174 WKWLEAQPMGEDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKL-------NKKRLKKR 226
Query: 234 EAIGH----------VRHKNLVRLLGYCIEGVHRM-LVYEYVNNGNLEQWLHGAMRNQGN 282
+ V + +V L Y E + LV +N G++ ++ +
Sbjct: 227 KGYQGAMVEKKILAKVHSRFIVSLA-YAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPG 285
Query: 283 LTWEARMK-----VIIGTAKALAYLHEAIEPKVVHRDIKSSNILIDDEFNAKVSDFGLAK 337
E R ++ L +LH+ +++RD+K N+L+DD+ N ++SD GLA
Sbjct: 286 FQ-EPRAIFYTAQIVS----GLEHLHQR---NIIYRDLKPENVLLDDDGNVRISDLGLAV 337
Query: 338 LLDSGESHITTRVMGTFGYVAPEYANTGMLNEKS-----DIYSFGVLLLEAVTGRDP 389
L +G++ GT G++APE +L + D ++ GV L E + R P
Sbjct: 338 ELKAGQTKTKGYA-GTPGFMAPE-----LLLGEEYDFSVDYFALGVTLYEMIAARGP 388
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476 | Back alignment and structure |
|---|
Score = 103 bits (258), Expect = 8e-24
Identities = 65/210 (30%), Positives = 105/210 (50%), Gaps = 28/210 (13%)
Query: 194 LGEGGYGVVYKGR-LINGSEVAVK----KLLNNLGQAEKEFRVEVEAIGHVRHKNLVRLL 248
LG G +G V G+ + G +VAVK + + +L K R E++ + RH ++++L
Sbjct: 24 LGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRR-EIQNLKLFRHPHIIKL- 81
Query: 249 GY-CIEGVHRM-LVYEYVNNGNLEQWL--HGAMRNQGNLTWEARMKV--IIGTAKALAYL 302
Y I + +V EYV+ G L ++ +G + + E+R I+ + Y
Sbjct: 82 -YQVISTPSDIFMVMEYVSGGELFDYICKNGRLDEK-----ESRRLFQQILS---GVDYC 132
Query: 303 HEAIEPKVVHRDIKSSNILIDDEFNAKVSDFGLAKLLDSGESHITTRVMGTFGYVAPE-Y 361
H VVHRD+K N+L+D NAK++DFGL+ ++ GE T+ G+ Y APE
Sbjct: 133 HRH---MVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRTS--CGSPNYAAPEVI 187
Query: 362 ANTGMLNEKSDIYSFGVLLLEAVTGRDPVD 391
+ + DI+S GV+L + G P D
Sbjct: 188 SGRLYAGPEVDIWSSGVILYALLCGTLPFD 217
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335 | Back alignment and structure |
|---|
Score = 101 bits (253), Expect = 9e-24
Identities = 79/342 (23%), Positives = 127/342 (37%), Gaps = 57/342 (16%)
Query: 187 RFSAENVLGEGGYGVVYKGR-LINGSEVAVK-----KLLN----NLGQAEKEFRVEVEAI 236
++S + LG G +G V+ EV VK K+L + K E+ +
Sbjct: 25 KYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTL-EIAIL 83
Query: 237 GHVRHKNLVRLLGYCIEGVHRM-LVYEYVNNGNLEQWLHGAMRNQGNLT-WEARMKV--I 292
V H N++++L E LV E +G L+ L + L A +
Sbjct: 84 SRVEHANIIKVLDI-FENQGFFQLVMEKHGSG-LD--LFAFIDRHPRLDEPLASYIFRQL 139
Query: 293 IGTAKALAYLHEAIEPKVVHRDIKSSNILIDDEFNAKVSDFGLAKLLDSGESHITTRVMG 352
+ A+ YL ++HRDIK NI+I ++F K+ DFG A L+ G+ T G
Sbjct: 140 VS---AVGYLRLK---DIIHRDIKDENIVIAEDFTIKLIDFGSAAYLERGK-LFYTFC-G 191
Query: 353 TFGYVAPE-YANTGMLNEKSDIYSFGVLLLEAVTGRDPVDYGRPANEVNLVEWLKMMVGT 411
T Y APE + +++S GV L V +P E + +
Sbjct: 192 TIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFC-----------ELEETVEA- 239
Query: 412 RRAEEVVDPNLEVKPATRALKRSLLVALRCVDPDSEKRPKMSQVVR------MLEADDYP 465
+ P V +L LL P E+R + ++V + DY
Sbjct: 240 ----AIHPPY-LVSKELMSLVSGLLQ----PVP--ERRTTLEKLVTDPWVTQPVNLADYT 288
Query: 466 FREDRRNRKSRTTSMEIESLKESTEIESKVEDSEGRISEKTH 507
+ E R K + + SL+ S V ++ + H
Sbjct: 289 WEEVFRVNKPESGVLSAASLEMGNRSLSDVAQAQELCGGEGH 330
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348 | Back alignment and structure |
|---|
Score = 101 bits (253), Expect = 9e-24
Identities = 56/215 (26%), Positives = 93/215 (43%), Gaps = 25/215 (11%)
Query: 185 TNRFSAENVLGEGGYGVVYKGR-LINGSEVAVKKLLNNLGQAE---KEFRVEVEAIGHVR 240
FS +G G +G VY R + N VA+KK+ + Q+ ++ EV + +R
Sbjct: 53 EKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLR 112
Query: 241 HKNLVRLLGYCIEGVHRMLVYEYVNNGNLEQWLHGAMRNQGNLTWEARMKVII-GTAKAL 299
H N ++ G + LV EY + + E + + G + L
Sbjct: 113 HPNTIQYRGCYLREHTAWLVMEYCLGSASD-----LLEVHKKPLQEVEIAAVTHGALQGL 167
Query: 300 AYLHEAIEPKVVHRDIKSSNILIDDEFNAKVSDFGLAKLLDSGESHITTR--VMGTFGYV 357
AYLH ++HRD+K+ NIL+ + K+ DFG A S + +GT ++
Sbjct: 168 AYLHSH---NMIHRDVKAGNILLSEPGLVKLGDFGSA-------SIMAPANSFVGTPYWM 217
Query: 358 APE---YANTGMLNEKSDIYSFGVLLLEAVTGRDP 389
APE + G + K D++S G+ +E + P
Sbjct: 218 APEVILAMDEGQYDGKVDVWSLGITCIELAERKPP 252
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 101 bits (252), Expect = 9e-24
Identities = 38/147 (25%), Positives = 65/147 (44%), Gaps = 18/147 (12%)
Query: 250 YCIEGVHRMLVY---EYVNNGNLEQWLHGAMRNQGNLTWEARMKVIIGTAKALAYLHEAI 306
++ +Y + NL+ W++ + + + + I A+A+ +LH
Sbjct: 126 QLQPSSPKVYLYIQMQLCRKENLKDWMN-RRCSLEDREHGVCLHIFIQIAEAVEFLHSK- 183
Query: 307 EPKVVHRDIKSSNILIDDEFNAKVSDFGLAKLLDSGESHIT-----------TRVMGTFG 355
++HRD+K SNI + KV DFGL +D E T T +GT
Sbjct: 184 --GLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKL 241
Query: 356 YVAPEYANTGMLNEKSDIYSFGVLLLE 382
Y++PE + + K DI+S G++L E
Sbjct: 242 YMSPEQIHGNNYSHKVDIFSLGLILFE 268
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321 | Back alignment and structure |
|---|
Score = 100 bits (251), Expect = 1e-23
Identities = 37/199 (18%), Positives = 86/199 (43%), Gaps = 12/199 (6%)
Query: 185 TNRFSAENVLGEGGYGVVYKGRLI-NGSEVAVKKLLNNLGQAEKEFRVEVEAIGHVRHKN 243
++ LG G +G+V++ + K + G + + E+ + RH+N
Sbjct: 4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAK-FVKVKGTDQVLVKKEISILNIARHRN 62
Query: 244 LVRLLGYCIEGVHRMLVYEYVNNGNLEQWLHGAMRNQGNLTWEARMKVIIGTAKALAYLH 303
++ L ++++E+++ ++ + + + L + + +AL +LH
Sbjct: 63 ILHLHESFESMEELVMIFEFISGLDIFERI---NTSAFELNEREIVSYVHQVCEALQFLH 119
Query: 304 EAIEPKVVHRDIKSSNILIDDEFNA--KVSDFGLAKLLDSGESHITTRVMGTFGYVAPEY 361
+ H DI+ NI+ ++ K+ +FG A+ L G++ + Y APE
Sbjct: 120 SH---NIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRL--LFTAPEYYAPEV 174
Query: 362 ANTGMLNEKSDIYSFGVLL 380
+++ +D++S G L+
Sbjct: 175 HQHDVVSTATDMWSLGTLV 193
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329 | Back alignment and structure |
|---|
Score = 100 bits (251), Expect = 2e-23
Identities = 52/220 (23%), Positives = 89/220 (40%), Gaps = 36/220 (16%)
Query: 186 NRFSAENVLGEGGYGVVYKGR-LINGSEVAVKKLLNNLGQAEKE------FRVEVEAIGH 238
+R+ LGEG YG VYK + VA+K++ L E+E R EV +
Sbjct: 34 DRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRI--RLEH-EEEGVPGTAIR-EVSLLKE 89
Query: 239 VRHKNLVRLLGYCIEGVHRMLVYEYVNNGNLEQWLHGAMRNQGNLTWEARMKVIIG-TAK 297
++H+N++ L L++EY E L M +++ +K +
Sbjct: 90 LQHRNIIELKSVIHHNHRLHLIFEY-----AENDLKKYMDKNPDVS-MRVIKSFLYQLIN 143
Query: 298 ALAYLHEAIEPKVVHRDIKSSNILIDDEFNA-----KVSDFGLAKLLDSGESHITTRVMG 352
+ + H + +HRD+K N+L+ + K+ DFGLA+ T ++
Sbjct: 144 GVNFCHS---RRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFGIPIRQFTHEII- 199
Query: 353 TFGYVAPEYANTGMLNEKS-----DIYSFGVLLLEAVTGR 387
T Y PE +L + DI+S + E +
Sbjct: 200 TLWYRPPEI----LLGSRHYSTSVDIWSIACIWAEMLMKT 235
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345 | Back alignment and structure |
|---|
Score = 99.5 bits (248), Expect = 3e-23
Identities = 61/260 (23%), Positives = 92/260 (35%), Gaps = 58/260 (22%)
Query: 173 GHWFTLRDLEIATNRFSAENVLGEGGYGVVYKGR-LINGSEVAVK-----KLLNNLGQAE 226
+F L ++ + +G+G YGVV + A+K K+ +
Sbjct: 13 NLYFQGGSLLELQKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDV 72
Query: 227 KEFRVEVEAIGHVRHKNLVRLLGYCIEGVHRMLVYEYVNNGNL----------------- 269
+ + EV + + H N+ RL + + LV E + G+L
Sbjct: 73 ERIKTEVRLMKKLHHPNIARLYEVYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAM 132
Query: 270 ---------EQWLHGAMRNQGNLTW-----------EAR--MKVIIGTAKALAYLHEAIE 307
+ N + M+ I AL YLH
Sbjct: 133 DVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFS---ALHYLHNQ-- 187
Query: 308 PKVVHRDIKSSNILIDDEFNA--KVSDFGLAKLL---DSGESHITTRVMGTFGYVAPEYA 362
+ HRDIK N L + K+ DFGL+K ++GE + T GT +VAPE
Sbjct: 188 -GICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVL 246
Query: 363 NTGML--NEKSDIYSFGVLL 380
NT K D +S GVLL
Sbjct: 247 NTTNESYGPKCDAWSAGVLL 266
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373 | Back alignment and structure |
|---|
Score = 100 bits (250), Expect = 3e-23
Identities = 53/199 (26%), Positives = 91/199 (45%), Gaps = 17/199 (8%)
Query: 188 FSAENVLGEGGYGVVYKGRLIN-GSEVAVKKLLNNLGQAEKEFRVEVEAIGHVRHKNLVR 246
S +LG G +G V+K G ++A K + + ++E + E+ + + H NL++
Sbjct: 91 VSKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQ 150
Query: 247 LLGYCIEGVHRMLVYEYVNNGNLEQWLHGAMRNQGNLT-WEAR--MKVIIGTAKALAYLH 303
L +LV EYV+ G L + + NLT + MK I + ++H
Sbjct: 151 LYDAFESKNDIVLVMEYVDGGELFDRI---IDESYNLTELDTILFMKQICE---GIRHMH 204
Query: 304 EAIEPKVVHRDIKSSNILIDDEFNA--KVSDFGLAKLLDSGESHITTRVMGTFGYVAPEY 361
+ ++H D+K NIL + K+ DFGLA+ E GT ++APE
Sbjct: 205 QM---YILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPREKLKV--NFGTPEFLAPEV 259
Query: 362 ANTGMLNEKSDIYSFGVLL 380
N ++ +D++S GV+
Sbjct: 260 VNYDFVSFPTDMWSVGVIA 278
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327 | Back alignment and structure |
|---|
Score = 99.3 bits (248), Expect = 4e-23
Identities = 44/198 (22%), Positives = 80/198 (40%), Gaps = 20/198 (10%)
Query: 193 VLGEGGYGVVYKGRLI-NGSEVAVKKLL-NNLGQAEKE-FRVEVEAIGHVRH-KNLVRLL 248
LG G + VV + G E A K L GQ + E+ + + ++ L
Sbjct: 36 ELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLH 95
Query: 249 GYCIEGVHRMLVYEYVNNGNLEQWLHGAMRNQGNLT-WEAR--MKVIIGTAKALAYLHEA 305
+L+ EY G + ++ + +K I+ + YLH+
Sbjct: 96 EVYENTSEIILILEYAAGGEIFSLC--LPELAEMVSENDVIRLIKQILE---GVYYLHQN 150
Query: 306 IEPKVVHRDIKSSNILI---DDEFNAKVSDFGLAKLLDSGESHITTRVMGTFGYVAPEYA 362
+VH D+K NIL+ + K+ DFG+++ + +MGT Y+APE
Sbjct: 151 ---NIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGHACELRE--IMGTPEYLAPEIL 205
Query: 363 NTGMLNEKSDIYSFGVLL 380
N + +D+++ G++
Sbjct: 206 NYDPITTATDMWNIGIIA 223
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361 | Back alignment and structure |
|---|
Score = 99.4 bits (248), Expect = 6e-23
Identities = 70/326 (21%), Positives = 118/326 (36%), Gaps = 47/326 (14%)
Query: 194 LGEGGYGVVYKGR-LINGSEVAVKKLLNNLGQAEKEFRVEVEAIGHVRHKNLVRLLGYCI 252
+G G +GV R + VAVK + E R E+ +RH N+VR +
Sbjct: 28 IGSGNFGVARLMRDKLTKELVAVKYIERGAAIDENVQR-EIINHRSLRHPNIVRFKEVIL 86
Query: 253 EGVHRMLVYEYVNNGNLEQWL--HGAMRNQGNLTWEARMKV--IIGTAKALAYLHEAIEP 308
H ++ EY + G L + + G EAR ++ ++Y H
Sbjct: 87 TPTHLAIIMEYASGGELYERICNAGRFSED-----EARFFFQQLLS---GVSYCHSM--- 135
Query: 309 KVVHRDIKSSNILIDDEF--NAKVSDFGLAKLLDSGESHITTRVMGTFGYVAPE-YANTG 365
++ HRD+K N L+D K+ DFG +K S + V GT Y+APE
Sbjct: 136 QICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH-SQPKSTV-GTPAYIAPEVLLRQE 193
Query: 366 MLNEKSDIYSFGVLLLEAVTGRDPVDYGRPANEVNLVEWL-KMMVGTRRAEEVVDPNLEV 424
+ +D++S GV L + G P + + K + + + ++ +
Sbjct: 194 YDGKIADVWSCGVTLYVMLVGAYPFE------DPEEPRDYRKTIQRILSVKYSIPDDIRI 247
Query: 425 KPATRALKRSLLVALRCVDPDSEKRPKMSQVVR---MLEADDYPFREDRRNRKSRTTSME 481
P L + V DP R + ++ L+ + P S
Sbjct: 248 SPECCHLISRIFV----ADP--ATRISIPEIKTHSWFLK--NLP-------ADLMNESNT 292
Query: 482 IESLKESTEIESKVEDSEGRISEKTH 507
+E + ++ ISE T
Sbjct: 293 GSQFQEPEQPMQSLDTIMQIISEATI 318
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288 | Back alignment and structure |
|---|
Score = 97.6 bits (244), Expect = 6e-23
Identities = 60/215 (27%), Positives = 95/215 (44%), Gaps = 31/215 (14%)
Query: 186 NRFSAENVLGEGGYGVVYKGRLINGSEVAVKKL-LNNLGQAEKE------FRVEVEAIGH 238
++ +GEG YGVVYK + G A+KK+ L E E R E+ +
Sbjct: 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEK----EDEGIPSTTIR-EISILKE 56
Query: 239 VRHKNLVRLLGYCIEGVHRMLVYEYVNNGNLEQWLHGAMRNQGNLTWEARMKVIIG-TAK 297
++H N+V+L +LV+E+ L+Q L + K +
Sbjct: 57 LKHSNIVKLYDVIHTKKRLVLVFEH-----LDQDLKKLLDVCEGGLESVTAKSFLLQLLN 111
Query: 298 ALAYLHEAIEPKVVHRDIKSSNILIDDEFNAKVSDFGLAKLLDSGESHITTRVMGTFGYV 357
+AY H+ +V+HRD+K N+LI+ E K++DFGLA+ T ++ T Y
Sbjct: 112 GIAYCHDR---RVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEIV-TLWYR 167
Query: 358 APEYANTGMLNEKS-----DIYSFGVLLLEAVTGR 387
AP+ ++ K DI+S G + E V G
Sbjct: 168 APDV----LMGSKKYSTTIDIWSVGCIFAEMVNGT 198
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 97.7 bits (244), Expect = 7e-23
Identities = 63/304 (20%), Positives = 118/304 (38%), Gaps = 76/304 (25%)
Query: 194 LGEGGYGVVYKGR-LINGSEVAVK-----KLLNNLGQAEKEFRV---------------- 231
+G+G YGVV + + A+K KL+ G +
Sbjct: 21 IGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPI 80
Query: 232 -----EVEAIGHVRHKNLVRLLGYCI----EGVHRMLVYEYVNNGNL-EQWLHGAMRNQG 281
E+ + + H N+V+L + H +V+E VN G + E +
Sbjct: 81 EQVYQEIAILKKLDHPNVVKL--VEVLDDPNEDHLYMVFELVNQGPVMEVPTLKPLSED- 137
Query: 282 NLTWEARMKV--IIGTAKALAYLHEAIEPKVVHRDIKSSNILIDDEFNAKVSDFGLAKLL 339
+AR +I K + YLH K++HRDIK SN+L+ ++ + K++DFG++
Sbjct: 138 ----QARFYFQDLI---KGIEYLHYQ---KIIHRDIKPSNLLVGEDGHIKIADFGVSNEF 187
Query: 340 DSGESHITTRVMGTFGYVAPEYANTGMLNE--------KSDIYSFGVLLLEAVTGRDPVD 391
++ ++ V GT ++APE L+E D+++ GV L V G+ P
Sbjct: 188 KGSDALLSNTV-GTPAFMAPE-----SLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFM 241
Query: 392 YGRPANEVNLVEWLKMMVGTRRAEEVVDPNLEVKPATRALKRSLLVALRCVDPDSEKRPK 451
+ ++ + + ++ + L +L +P E R
Sbjct: 242 ------DERIMCLHSKI---KSQALEFPDQPDIAEDLKDLITRMLD----KNP--ESRIV 286
Query: 452 MSQV 455
+ ++
Sbjct: 287 VPEI 290
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324 | Back alignment and structure |
|---|
Score = 98.1 bits (245), Expect = 8e-23
Identities = 61/221 (27%), Positives = 96/221 (43%), Gaps = 43/221 (19%)
Query: 186 NRFSAENVLGEGGYGVVYKGR-LINGSEVAVKKLLNNLGQAEKEFRVEVE------AIGH 238
+ + LGEG Y VYKG+ + + VA+K++ R+E E AI
Sbjct: 2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEI-----------RLEHEEGAPCTAIRE 50
Query: 239 V------RHKNLVRLLGYCIEGVHRMLVYEYVNNGNLEQWLHGAMRNQGNLTWEARMKVI 292
V +H N+V L LV+EY L++ L + + GN+ +K+
Sbjct: 51 VSLLKDLKHANIVTLHDIIHTEKSLTLVFEY-----LDKDLKQYLDDCGNIINMHNVKLF 105
Query: 293 IG-TAKALAYLHEAIEPKVVHRDIKSSNILIDDEFNAKVSDFGLAKLLDSGESHITTRVM 351
+ + LAY H KV+HRD+K N+LI++ K++DFGLA+ V+
Sbjct: 106 LFQLLRGLAYCHRQ---KVLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTYDNEVV 162
Query: 352 GTFGYVAPEYANTGMLNEKS-----DIYSFGVLLLEAVTGR 387
T Y P+ +L D++ G + E TGR
Sbjct: 163 -TLWYRPPDI----LLGSTDYSTQIDMWGVGCIFYEMATGR 198
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336 | Back alignment and structure |
|---|
Score = 98.5 bits (246), Expect = 8e-23
Identities = 62/210 (29%), Positives = 96/210 (45%), Gaps = 29/210 (13%)
Query: 194 LGEGGYGVVYKGR-LINGSEVAVK----KLLNNLGQAEKEFRVEVEAIGHVRHKNLVRLL 248
LGEG +G V +VA+K +LL + R E+ + +RH ++++L
Sbjct: 17 LGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVER-EISYLKLLRHPHIIKL- 74
Query: 249 GY-CIEGVHRM-LVYEYVNNGNLEQWL--HGAMRNQGNLTWEARMKV--IIGTAKALAYL 302
Y I + +V EY G L ++ M E R II A+ Y
Sbjct: 75 -YDVITTPTDIVMVIEYAG-GELFDYIVEKKRMTED-----EGRRFFQQIIC---AIEYC 124
Query: 303 HEAIEPKVVHRDIKSSNILIDDEFNAKVSDFGLAKLLDSGESHITTRVMGTFGYVAPE-Y 361
H K+VHRD+K N+L+DD N K++DFGL+ ++ G T+ G+ Y APE
Sbjct: 125 HRH---KIVHRDLKPENLLLDDNLNVKIADFGLSNIMTDGNFLKTS--CGSPNYAAPEVI 179
Query: 362 ANTGMLNEKSDIYSFGVLLLEAVTGRDPVD 391
+ D++S G++L + GR P D
Sbjct: 180 NGKLYAGPEVDVWSCGIVLYVMLVGRLPFD 209
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383 | Back alignment and structure |
|---|
Score = 99.0 bits (247), Expect = 9e-23
Identities = 58/256 (22%), Positives = 105/256 (41%), Gaps = 67/256 (26%)
Query: 181 LEIATNRFSAENVLGEGGYGVVYKGRLI-NGSEVAVKKLLNNLGQAEKEFRVEVEAIGHV 239
LE ++ ++S LG G +G+V + I +G A+KK+L + R E++ + +
Sbjct: 2 LETSSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQ---DPRYKNR-ELDIMKVL 57
Query: 240 RHKNLVRLLGYCIEGVHRM--------------------------------------LVY 261
H N+++L+ Y ++
Sbjct: 58 DHVNIIKLVDYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIM 117
Query: 262 EYVNNGNLEQWLHGAMRNQGNLTWEARMKVII-GTAKALAYLHEAIEPKVVHRDIKSSNI 320
EYV + L + L +R+ ++ + + I +A+ ++H + HRDIK N+
Sbjct: 118 EYVPD-TLHKVLKSFIRSGRSIP-MNLISIYIYQLFRAVGFIHSL---GICHRDIKPQNL 172
Query: 321 LIDDEFNA-KVSDFGLAKLLDSGE---SHITTRVMGTFGYVAPEYANTGMLNEKS----- 371
L++ + N K+ DFG AK L E ++I +R Y APE ML
Sbjct: 173 LVNSKDNTLKLCDFGSAKKLIPSEPSVAYICSRF-----YRAPEL----MLGATEYTPSI 223
Query: 372 DIYSFGVLLLEAVTGR 387
D++S G + E + G+
Sbjct: 224 DLWSIGCVFGELILGK 239
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336 | Back alignment and structure |
|---|
Score = 97.4 bits (243), Expect = 2e-22
Identities = 53/231 (22%), Positives = 91/231 (39%), Gaps = 37/231 (16%)
Query: 169 HLGWGHWFTLRDLEIATNRFSA-----ENVLGEGGYGVVYKGR-LINGSEVAVKKLLNNL 222
H G + E + + VLG G G V + G + A+K L ++
Sbjct: 7 HHSSGLEVLFQGPEPKKYAVTDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDS- 65
Query: 223 GQAEKEFRVEVEAIGHV-RHKNLVRLLGYCIEGVHRM----LVYEYVNNGNLEQWLHGAM 277
+ R EV+ ++V +L H ++ E + G L +
Sbjct: 66 ----PKARQEVDHHWQASGGPHIVCILDVYENMHHGKRCLLIIMECMEGGELFS----RI 117
Query: 278 RNQGNLTW---EAR--MKVIIGTAKALAYLHEAIEPKVVHRDIKSSNILI---DDEFNAK 329
+ +G+ + EA M+ I A+ +LH + HRD+K N+L + + K
Sbjct: 118 QERGDQAFTEREAAEIMRDI---GTAIQFLHSH---NIAHRDVKPENLLYTSKEKDAVLK 171
Query: 330 VSDFGLAKLLDSGESHITTRVMGTFGYVAPEYANTGMLNEKSDIYSFGVLL 380
++DFG AK + T T YVAPE ++ D++S GV++
Sbjct: 172 LTDFGFAKETTQNA--LQTPC-YTPYYVAPEVLGPEKYDKSCDMWSLGVIM 219
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351 | Back alignment and structure |
|---|
Score = 97.7 bits (244), Expect = 2e-22
Identities = 60/221 (27%), Positives = 105/221 (47%), Gaps = 42/221 (19%)
Query: 192 NVLGEGGYGVVYKGR-LINGSEVAVKKL-LNNLGQAEKE-FRV----EVEAIGHVRHKNL 244
+G+G +G V+K R G +VA+KK+ + N EKE F + E++ + ++H+N+
Sbjct: 23 AKIGQGTFGEVFKARHRKTGQKVALKKVLMEN----EKEGFPITALREIKILQLLKHENV 78
Query: 245 VRLLGYCIEGVHRM--------LVYEYVNNGNLEQWLHGAMRNQGNLTWEARMKVIIG-T 295
V L+ C LV+++ E L G + N + +K ++
Sbjct: 79 VNLIEICRTKASPYNRCKGSIYLVFDF-----CEHDLAGLLSNVLVKFTLSEIKRVMQML 133
Query: 296 AKALAYLHEAIEPKVVHRDIKSSNILIDDEFNAKVSDFGLAKL----LDSGESHITTRVM 351
L Y+H K++HRD+K++N+LI + K++DFGLA+ +S + T RV+
Sbjct: 134 LNGLYYIHRN---KILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVV 190
Query: 352 GTFGYVAPEYANTGMLNEKS-----DIYSFGVLLLEAVTGR 387
T Y PE +L E+ D++ G ++ E T
Sbjct: 191 -TLWYRPPEL----LLGERDYGPPIDLWGAGCIMAEMWTRS 226
|
| >3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695 | Back alignment and structure |
|---|
Score = 98.8 bits (246), Expect = 5e-22
Identities = 57/213 (26%), Positives = 95/213 (44%), Gaps = 24/213 (11%)
Query: 188 FSAENVLGEGGYGVVYKGRLINGSEV-AVKKL-------LNNLGQAEKEFRVEVEAIGHV 239
FS ++G GG+G VY R + ++ A+K L A E + + +
Sbjct: 191 FSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIM-LSLVSTG 249
Query: 240 RHKNLVRLLGYCIEGVHRM-LVYEYVNNGNLEQWLHGAMRNQGNLTWEARMKVIIG-TAK 297
+V + Y ++ + + +N G+L L G + EA M+
Sbjct: 250 DCPFIVCM-SYAFHTPDKLSFILDLMNGGDLHYHL----SQHGVFS-EADMRFYAAEIIL 303
Query: 298 ALAYLHEAIEPKVVHRDIKSSNILIDDEFNAKVSDFGLAKLLDSGESHITTRVMGTFGYV 357
L ++H VV+RD+K +NIL+D+ + ++SD GLA + H V GT GY+
Sbjct: 304 GLEHMHNR---FVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPH--ASV-GTHGYM 357
Query: 358 APEYANTGMLNEKS-DIYSFGVLLLEAVTGRDP 389
APE G+ + S D +S G +L + + G P
Sbjct: 358 APEVLQKGVAYDSSADWFSLGCMLFKLLRGHSP 390
|
| >1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310 | Back alignment and structure |
|---|
Score = 95.4 bits (238), Expect = 6e-22
Identities = 56/217 (25%), Positives = 93/217 (42%), Gaps = 32/217 (14%)
Query: 188 FSAENVLGEGGYGVVYKGRLI-NGSEVAVKKLLNNLGQAEKEF---RVEVEAIGHVRHKN 243
F +LGEG + V R + E A+K L E + E + + + H
Sbjct: 32 FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPF 91
Query: 244 LVRLLGYCIEGVHRMLVYEYVNNGNLEQWLHGAMRNQGNLTWEARMK-----VIIGTAKA 298
V+L + Y NG L +++ R G+ E + ++ A
Sbjct: 92 FVKLYFTFQDDEKLYFGLSYAKNGELLKYI----RKIGSFD-ETCTRFYTAEIVS----A 142
Query: 299 LAYLHEAIEPKVVHRDIKSSNILIDDEFNAKVSDFGLAKLLDSGESHITTRVM-GTFGYV 357
L YLH ++HRD+K NIL++++ + +++DFG AK+L GT YV
Sbjct: 143 LEYLHGK---GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYV 199
Query: 358 APEYANTGMLNEK-----SDIYSFGVLLLEAVTGRDP 389
+PE +L EK SD+++ G ++ + V G P
Sbjct: 200 SPE-----LLTEKSACKSSDLWALGCIIYQLVAGLPP 231
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317 | Back alignment and structure |
|---|
Score = 95.3 bits (238), Expect = 7e-22
Identities = 58/219 (26%), Positives = 104/219 (47%), Gaps = 30/219 (13%)
Query: 184 ATNRFSAENVLGEGGYGVVYKGR-LINGSEVAVKKLLNNLGQAEKE-------FRVEVEA 235
++++F LG G Y VYKG G VA+K++ + + E R E+
Sbjct: 3 SSSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEV-----KLDSEEGTPSTAIR-EISL 56
Query: 236 IGHVRHKNLVRLLGYCIEGVHRMLVYEYVNNGNLEQWL--HGAMRNQGNLTWEARMKVII 293
+ ++H+N+VRL LV+E+++N +L++++ L
Sbjct: 57 MKELKHENIVRLYDVIHTENKLTLVFEFMDN-DLKKYMDSRTVGNTPRGLELNLVKYFQW 115
Query: 294 GTAKALAYLHEAIEPKVVHRDIKSSNILIDDEFNAKVSDFGLAKLLDSGESHITTRVMGT 353
+ LA+ HE K++HRD+K N+LI+ K+ DFGLA+ + ++ V+ T
Sbjct: 116 QLLQGLAFCHEN---KILHRDLKPQNLLINKRGQLKLGDFGLARAFGIPVNTFSSEVV-T 171
Query: 354 FGYVAPEYANTGMLNEKS-----DIYSFGVLLLEAVTGR 387
Y AP+ ++ ++ DI+S G +L E +TG+
Sbjct: 172 LWYRAPDV----LMGSRTYSTSIDIWSCGCILAEMITGK 206
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576 | Back alignment and structure |
|---|
Score = 97.6 bits (243), Expect = 1e-21
Identities = 66/234 (28%), Positives = 105/234 (44%), Gaps = 41/234 (17%)
Query: 175 WFTLRDLEIATNRFSAENVLGEGGYGVVYKGRLINGSEV-AVKKLLNNLGQAEKEFRVEV 233
W L + N F VLG+GG+G V ++ ++ A KKL EK+ +
Sbjct: 173 WKWLERQPVTKNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKL-------EKKRIKKR 225
Query: 234 EAIGH----------VRHKNLVRLLGYCIEGVHRM-LVYEYVNNGNLEQWLHGAMRNQGN 282
+ V + +V L Y E + LV +N G+L+ ++ + G
Sbjct: 226 KGEAMALNEKQILEKVNSRFVVSL-AYAYETKDALCLVLTLMNGGDLKFHIY----HMGQ 280
Query: 283 LTW-EARMKVIIG-TAKALAYLHEAIEPKVVHRDIKSSNILIDDEFNAKVSDFGLAKLLD 340
+ EAR L LH ++V+RD+K NIL+DD + ++SD GLA +
Sbjct: 281 AGFPEARAVFYAAEICCGLEDLHRE---RIVYRDLKPENILLDDHGHIRISDLGLAVHVP 337
Query: 341 SGESHITTRVMGTFGYVAPEYANTGMLNEKS-----DIYSFGVLLLEAVTGRDP 389
G++ I RV GT GY+APE ++ + D ++ G LL E + G+ P
Sbjct: 338 EGQT-IKGRV-GTVGYMAPE-----VVKNERYTFSPDWWALGCLLYEMIAGQSP 384
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458 | Back alignment and structure |
|---|
Score = 96.0 bits (239), Expect = 2e-21
Identities = 62/308 (20%), Positives = 117/308 (37%), Gaps = 65/308 (21%)
Query: 133 SQSGEEGSSGAGHKHSSLSYGGLVTASPLIGLPEISHLGWGHWFTLRDLEIATNRFSAEN 192
+ + ++ +SG H S G P S + + +R+ +
Sbjct: 6 AAAAQQHNSGTQHTVSGSQQEGQQRKQHHSSKPTASMPRPHSDWQI------PDRYEIRH 59
Query: 193 VLGEGGYGVVYKGR-LINGSEVAVKKLLN---NLGQAEKEFRVEVEAIGHVRHKNLVRLL 248
++G G YG V + + VA+KK+L +L ++ R E+ + + H ++V++L
Sbjct: 60 LIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILR-EIAILNRLNHDHVVKVL 118
Query: 249 G-YCIEGVHRM----LVYEYVNNGNLEQWLHGAMRNQGNLTWEARMKVII-GTAKALAYL 302
+ V + +V E + R LT E +K ++ + Y+
Sbjct: 119 DIVIPKDVEKFDELYVVLEI-----ADSDFKKLFRTPVYLT-ELHIKTLLYNLLVGVKYV 172
Query: 303 HEAIEPKVVHRDIKSSNILIDDEFNAKVSDFGLAKLLDSGESHITTRVMGTF-------- 354
H A ++HRD+K +N L++ + + KV DFGLA+ +D E+ + +
Sbjct: 173 HSA---GILHRDLKPANCLVNQDCSVKVCDFGLARTVDYPENGNSQLPISPREDDMNLVT 229
Query: 355 ------------GYV------APEYANTGMLNEKS-----DIYS----FGVLLLEAVTGR 387
G+V APE +L +++ D++S F LL
Sbjct: 230 FPHTKNLKRQLTGHVVTRWYRAPEL----ILLQENYTEAIDVWSIGCIFAELLNMIKENV 285
Query: 388 DPVDYGRP 395
P
Sbjct: 286 AYHADRGP 293
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308 | Back alignment and structure |
|---|
Score = 93.0 bits (232), Expect = 3e-21
Identities = 58/228 (25%), Positives = 94/228 (41%), Gaps = 42/228 (18%)
Query: 184 ATNRFSAENVLGEGGYGVVYKGR-LINGSEVAVKKL-LNNLGQAEKEFRVEVEAI----- 236
AT+R+ +G G YG VYK R +G VA+K + + N + + +
Sbjct: 7 ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPN--GGGGGGGLPISTVREVAL 64
Query: 237 ----GHVRHKNLVRLLGYCIEGVHR-----MLVYEYVNNGNLEQWLHGAMRNQGNLTWEA 287
H N+VRL+ C LV+E+ ++Q L + A
Sbjct: 65 LRRLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEH-----VDQDLRTYLDKAPPPGLPA 119
Query: 288 RM--KVIIGTAKALAYLHEAIEPKVVHRDIKSSNILIDDEFNAKVSDFGLAKLLDSGESH 345
++ + L +LH +VHRD+K NIL+ K++DFGLA++ +
Sbjct: 120 ETIKDLMRQFLRGLDFLHAN---CIVHRDLKPENILVTSGGTVKLADFGLARIYSY-QMA 175
Query: 346 ITTRVMGTFGYVAPE------YANTGMLNEKSDIYSFGVLLLEAVTGR 387
+T V+ T Y APE Y T + D++S G + E +
Sbjct: 176 LTPVVV-TLWYRAPEVLLQSTY-ATPV-----DMWSVGCIFAEMFRRK 216
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405 | Back alignment and structure |
|---|
Score = 93.7 bits (233), Expect = 6e-21
Identities = 51/226 (22%), Positives = 91/226 (40%), Gaps = 53/226 (23%)
Query: 194 LGEGGYGVVYKGR---LINGSEVAVKKLLNNLGQAEKEFRVEVEAIGHV------RHKNL 244
+G G YG VYK + + + A+K++ + + + A + +H N+
Sbjct: 29 VGRGTYGHVYKAKRKDGKDDKDYALKQI--------EGTGISMSACREIALLRELKHPNV 80
Query: 245 VRLLGYCIEGVHR--MLVYEYVNNGNLEQWLHGAMRNQGNLTWEARMKVI-IGTAK---- 297
+ L + R L+++Y E L ++ + + G K
Sbjct: 81 ISLQKVFLSHADRKVWLLFDY-----AEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLY 135
Query: 298 ----ALAYLHEAIEPKVVHRDIKSSNILIDDEFNA----KVSDFGLAKLLDS---GESHI 346
+ YLH V+HRD+K +NIL+ E K++D G A+L +S + +
Sbjct: 136 QILDGIHYLHAN---WVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADL 192
Query: 347 TTRVMGTFGYVAPEYANTGMLNEKS-----DIYSFGVLLLEAVTGR 387
V+ TF Y APE +L + DI++ G + E +T
Sbjct: 193 DPVVV-TFWYRAPEL----LLGARHYTKAIDIWAIGCIFAELLTSE 233
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400 | Back alignment and structure |
|---|
Score = 93.3 bits (232), Expect = 8e-21
Identities = 58/204 (28%), Positives = 91/204 (44%), Gaps = 31/204 (15%)
Query: 191 ENVLGEGGYGVVYKGR-LINGSEVAVKKLLNNLGQAEKEFRVEVEAIGHV-RHKNLVRLL 248
VLG G G V + + A+K L Q + R EVE + ++VR++
Sbjct: 67 SQVLGLGINGKVLQIFNKRTQEKFALKML-----QDCPKARREVELHWRASQCPHIVRIV 121
Query: 249 GYCIEGVHRM----LVYEYVNNGNLEQWLHGAMRNQGNLTW---EAR--MKVIIGTAKAL 299
+V E ++ G L ++++G+ + EA MK I +A+
Sbjct: 122 DVYENLYAGRKCLLIVMECLDGGELFS----RIQDRGDQAFTEREASEIMKSI---GEAI 174
Query: 300 AYLHEAIEPKVVHRDIKSSNILIDDEF-NA--KVSDFGLAKLLDSGESHITTRVMGTFGY 356
YLH + HRD+K N+L + NA K++DFG AK S S +TT T Y
Sbjct: 175 QYLHSI---NIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNS-LTTPC-YTPYY 229
Query: 357 VAPEYANTGMLNEKSDIYSFGVLL 380
VAPE ++ D++S GV++
Sbjct: 230 VAPEVLGPEKYDKSCDMWSLGVIM 253
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353 | Back alignment and structure |
|---|
Score = 91.5 bits (228), Expect = 2e-20
Identities = 59/226 (26%), Positives = 103/226 (45%), Gaps = 38/226 (16%)
Query: 185 TNRFSAENVLGEGGYGVVYKGR-LINGSEVAVKKL--LNNLGQAEKEFRVEVEAIGHVRH 241
++ F +++LGEG YGVV G VA+KK+ + A + R E++ + H +H
Sbjct: 10 SSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLR-EIKILKHFKH 68
Query: 242 KNLVRLLG-YCIEGVHRM----LVYEYVNNGNLEQWLHGAMRNQGNLTWEARMKVII-GT 295
+N++ + + ++ E ++ LH + Q L+ + ++ I T
Sbjct: 69 ENIITIFNIQRPDSFENFNEVYIIQEL-----MQTDLHRVISTQ-MLS-DDHIQYFIYQT 121
Query: 296 AKALAYLHEAIEPKVVHRDIKSSNILIDDEFNAKVSDFGLAKLLDSGESHITTRVMGTF- 354
+A+ LH + V+HRD+K SN+LI+ + KV DFGLA+++D + +
Sbjct: 122 LRAVKVLHGS---NVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSG 178
Query: 355 --GYV------APEYANTGMLNEKS-----DIYSFGVLLLEAVTGR 387
+V APE ML D++S G +L E R
Sbjct: 179 MVEFVATRWYRAPEV----MLTSAKYSRAMDVWSCGCILAELFLRR 220
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330 | Back alignment and structure |
|---|
Score = 91.2 bits (227), Expect = 2e-20
Identities = 53/220 (24%), Positives = 97/220 (44%), Gaps = 29/220 (13%)
Query: 185 TNRFSAENVLGEGGYGVVYKGR-LINGSEVAVKKLLNNLGQAEKEFRVEVEAIGHVR-HK 242
+ + LG G Y V++ + N +V VK L + +K R E++ + ++R
Sbjct: 35 QDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKIL--KPVKKKKIKR-EIKILENLRGGP 91
Query: 243 NLVRLLGYCIEGVHRMLVY--EYVNNGNLEQWLHGAMRNQGNLTWEARMKVIIGTAKALA 300
N++ L + V R E+VNN + +Q LT + KAL
Sbjct: 92 NIITLADIVKDPVSRTPALVFEHVNNTDFKQLYQ-------TLTDYDIRFYMYEILKALD 144
Query: 301 YLHEAIEPKVVHRDIKSSNILIDDEFNA-KVSDFGLAKLLDSGESHITTRVMGTFGYVAP 359
Y H ++HRD+K N++ID E ++ D+GLA+ G+ + RV + + P
Sbjct: 145 YCHSM---GIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEY-NVRV-ASRYFKGP 199
Query: 360 EYANTGMLNEKS-----DIYSFGVLLLEAVTGRDPVDYGR 394
E +++ + D++S G +L + ++P +G
Sbjct: 200 EL----LVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGH 235
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320 | Back alignment and structure |
|---|
Score = 90.8 bits (226), Expect = 2e-20
Identities = 55/233 (23%), Positives = 101/233 (43%), Gaps = 50/233 (21%)
Query: 185 TNRFSAENVLGEGGYGVVYKGR-LINGSEVAVKKL-LNNLGQAEKEFRVEVEAIGHVRHK 242
+R+ LG GG G+V+ VA+KK+ L + + R E++ I + H
Sbjct: 10 GSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALR-EIKIIRRLDHD 68
Query: 243 NLVRLL----------GYCIEGVHRM----LVYEYVNNGNLEQWLHGAMRNQGNLTWEAR 288
N+V++ + + + +V EY +E L + L E
Sbjct: 69 NIVKVFEILGPSGSQLTDDVGSLTELNSVYIVQEY-----METDLANVLEQG-PLL-EEH 121
Query: 289 MKVII-GTAKALAYLHEAIEPKVVHRDIKSSNILIDDEF-NAKVSDFGLAKLLDSGESH- 345
++ + + L Y+H A V+HRD+K +N+ I+ E K+ DFGLA+++D SH
Sbjct: 122 ARLFMYQLLRGLKYIHSA---NVLHRDLKPANLFINTEDLVLKIGDFGLARIMDPHYSHK 178
Query: 346 ------ITTRVMGTFGYVAPEYANTGMLNEKS-----DIYSFGVLLLEAVTGR 387
+ T+ Y +P +L+ + D+++ G + E +TG+
Sbjct: 179 GHLSEGLVTK-----WYRSPRL----LLSPNNYTKAIDMWAAGCIFAEMLTGK 222
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362 | Back alignment and structure |
|---|
Score = 91.2 bits (227), Expect = 3e-20
Identities = 48/229 (20%), Positives = 88/229 (38%), Gaps = 44/229 (19%)
Query: 185 TNRFSAENVLGEGGYGVVYKGRLINGSEVAVKKLLNNLGQAEKE--FRVEVEA------- 235
+ ++ + + G YG V G G VA+K++ N +
Sbjct: 21 QSPYTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREI 80
Query: 236 --IGHVRHKNLVRLLG----YCIEGVHRM-LVYEYVNNGNLEQWLHGAMR-NQGNLTWEA 287
+ H H N++ L + +H++ LV E + L + + ++
Sbjct: 81 RLLNHFHHPNILGLRDIFVHFEEPAMHKLYLVTEL-----MRTDLAQVIHDQRIVIS-PQ 134
Query: 288 RMKVII-GTAKALAYLHEAIEPKVVHRDIKSSNILIDDEFNAKVSDFGLAKLLDSGES-- 344
++ + L LHEA VVHRD+ NIL+ D + + DF LA+ + +
Sbjct: 135 HIQYFMYHILLGLHVLHEA---GVVHRDLHPGNILLADNNDITICDFNLAREDTADANKT 191
Query: 345 -HITTRVMGTFGYVAPEYANTGMLNEKS-----DIYSFGVLLLEAVTGR 387
++T R Y APE ++ K D++S G ++ E +
Sbjct: 192 HYVTHRW-----YRAPEL----VMQFKGFTKLVDMWSAGCVMAEMFNRK 231
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326 | Back alignment and structure |
|---|
Score = 90.7 bits (226), Expect = 3e-20
Identities = 57/236 (24%), Positives = 94/236 (39%), Gaps = 64/236 (27%)
Query: 186 NRFSAENVLGEGGYGVVYKGR--LINGSEVAVKKLLNNLGQAEKEFRVEVEAIG------ 237
++ +GEG YG V+K R G VA+K++ RV+ G
Sbjct: 11 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRV-----------RVQTGEEGMPLSTI 59
Query: 238 ----------HVRHKNLVRLL----GYCIEGVHRM-LVYEYVNNGNLEQWLHGAMRNQGN 282
H N+VRL + ++ LV+E+ ++Q L +
Sbjct: 60 REVAVLRHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEH-----VDQDLTTYLDKVPE 114
Query: 283 LTWEAR-----MKVIIGTAKALAYLHEAIEPKVVHRDIKSSNILIDDEFNAKVSDFGLAK 337
M ++ + L +LH +VVHRD+K NIL+ K++DFGLA+
Sbjct: 115 PGVPTETIKDMMFQLL---RGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGLAR 168
Query: 338 LLDSGESHITTRVMGTFGYVAPE------YANTGMLNEKSDIYSFGVLLLEAVTGR 387
+ + +T+ V+ T Y APE Y T + D++S G + E +
Sbjct: 169 IYSF-QMALTSVVV-TLWYRAPEVLLQSSY-ATPV-----DLWSVGCIFAEMFRRK 216
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 90.8 bits (226), Expect = 3e-20
Identities = 58/220 (26%), Positives = 104/220 (47%), Gaps = 38/220 (17%)
Query: 185 TNRFSAENVLGEGGYGVVYKGR-LINGSEVAVKKLLN---NLGQAEKEFRVEVEAIGHVR 240
+ + +G G YG V +G +VA+KKL + A++ +R E+ + H++
Sbjct: 23 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYR-ELLLLKHMQ 81
Query: 241 HKNLVRLLGYCIEGVHRM-------LVYEYVNNGNLEQWLHGAMRNQGNLTWEARMKVII 293
H+N++ LL + LV + ++ L M + E +++ ++
Sbjct: 82 HENVIGLL-DVFTPASSLRNFYDFYLVMPF-----MQTDLQKIMGL--KFS-EEKIQYLV 132
Query: 294 -GTAKALAYLHEAIEPKVVHRDIKSSNILIDDEFNAKVSDFGLAKLLDSGESHITTRVMG 352
K L Y+H A VVHRD+K N+ ++++ K+ DFGLA+ D + +T V+
Sbjct: 133 YQMLKGLKYIHSA---GVVHRDLKPGNLAVNEDCELKILDFGLARHAD---AEMTGYVV- 185
Query: 353 TFGYVAPEYANTGMLNEKS-----DIYSFGVLLLEAVTGR 387
T Y APE +L+ DI+S G ++ E +TG+
Sbjct: 186 TRWYRAPEV----ILSWMHYNQTVDIWSVGCIMAEMLTGK 221
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367 | Back alignment and structure |
|---|
Score = 91.2 bits (227), Expect = 3e-20
Identities = 61/219 (27%), Positives = 106/219 (48%), Gaps = 35/219 (15%)
Query: 185 TNRFSAENVLGEGGYGVVYKGR-LINGSEVAVKKLLN---NLGQAEKEFRVEVEAIGHVR 240
+ +G G YG V G++VA+KKL + A++ +R E+ + H+R
Sbjct: 24 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYR-ELRLLKHMR 82
Query: 241 HKNLVRLL-----GYCIEGVHRM-LVYEYVNNGNLEQWLHGAMRNQGNLTWEARMKVII- 293
H+N++ LL ++ LV + + L M+++ L E R++ ++
Sbjct: 83 HENVIGLLDVFTPDETLDDFTDFYLVMPF-----MGTDLGKLMKHE-KLG-EDRIQFLVY 135
Query: 294 GTAKALAYLHEAIEPKVVHRDIKSSNILIDDEFNAKVSDFGLAKLLDSGESHITTRVMGT 353
K L Y+H A ++HRD+K N+ ++++ K+ DFGLA+ D S +T V+ T
Sbjct: 136 QMLKGLRYIHAA---GIIHRDLKPGNLAVNEDCELKILDFGLARQAD---SEMTGYVV-T 188
Query: 354 FGYVAPEYANTGMLNEKS-----DIYSFGVLLLEAVTGR 387
Y APE +LN DI+S G ++ E +TG+
Sbjct: 189 RWYRAPEV----ILNWMRYTQTVDIWSVGCIMAEMITGK 223
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432 | Back alignment and structure |
|---|
Score = 91.7 bits (228), Expect = 4e-20
Identities = 52/251 (20%), Positives = 101/251 (40%), Gaps = 54/251 (21%)
Query: 185 TNRFSAENVLGEGGYGVVYKGR-LINGSEVAVKKLLN---NLGQAEKEFRVEVEAIGHVR 240
+ + ++++G G YG VY VA+KK+ +L ++ R E+ + ++
Sbjct: 25 PDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILR-EITILNRLK 83
Query: 241 HKNLVRLLGYCI-EGVHRM----LVYEYVNNGNLEQWLHGAMRNQGNLTWEARMKVIIG- 294
++RL I + + + +V E + L + LT E +K I+
Sbjct: 84 SDYIIRLYDLIIPDDLLKFDELYIVLEI-----ADSDLKKLFKTPIFLT-EEHIKTILYN 137
Query: 295 TAKALAYLHEAIEPKVVHRDIKSSNILIDDEFNAKVSDFGLAKLLDSGESHITTRVMGTF 354
++HE+ ++HRD+K +N L++ + + KV DFGLA+ ++S + +
Sbjct: 138 LLLGENFIHES---GIIHRDLKPANCLLNQDCSVKVCDFGLARTINSEKDTNIVNDLEEN 194
Query: 355 ---------------GYV------APEYANTGMLNEKS-----DIYS----FGVLLLEAV 384
+V APE +L +++ DI+S F LL
Sbjct: 195 EEPGPHNKNLKKQLTSHVVTRWYRAPEL----ILLQENYTKSIDIWSTGCIFAELLNMLQ 250
Query: 385 TGRDPVDYGRP 395
+ + P
Sbjct: 251 SHINDPTNRFP 261
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371 | Back alignment and structure |
|---|
Score = 90.5 bits (225), Expect = 6e-20
Identities = 58/218 (26%), Positives = 94/218 (43%), Gaps = 33/218 (15%)
Query: 185 TNRFSAENVLGEGGYGVVYKGR-LINGSEVAVKKLLN---NLGQAEKEFRVEVEAIGHVR 240
R+ +G G G+V I VA+KKL N A++ +R E+ + V
Sbjct: 24 LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYR-ELVLMKCVN 82
Query: 241 HKNLVRLLGYCIEGVHRM------LVYEYVNNGNLEQWLHGAMRNQGNLTWEARMKVII- 293
HKN++ LL +V E ++ L ++ + L RM ++
Sbjct: 83 HKNIIGLLNVFTPQKSLEEFQDVYIVMEL-----MDANLCQVIQME--LD-HERMSYLLY 134
Query: 294 GTAKALAYLHEAIEPKVVHRDIKSSNILIDDEFNAKVSDFGLAKLLDSGESHITTRVMGT 353
+ +LH A ++HRD+K SNI++ + K+ DFGLA+ S + T + T
Sbjct: 135 QMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLARTAG--TSFMMTPYVVT 189
Query: 354 FGYVAPEYANTGMLN----EKSDIYSFGVLLLEAVTGR 387
Y APE +L E DI+S G ++ E + G
Sbjct: 190 RYYRAPEV----ILGMGYKENVDIWSVGCIMGEMIKGG 223
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364 | Back alignment and structure |
|---|
Score = 90.0 bits (224), Expect = 8e-20
Identities = 61/220 (27%), Positives = 107/220 (48%), Gaps = 33/220 (15%)
Query: 185 TNRFSAENVLGEGGYGVVYKGR-LINGSEVAVKKLLN--NLGQAEKEFRVEVEAIGHVRH 241
R++ + +GEG YG+V +N VA+KK+ + ++ R E++ + RH
Sbjct: 26 GPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLR-EIKILLRFRH 84
Query: 242 KNLVRLLG-YCIEGVHRM----LVYEYVNNGNLEQWLHGAMRNQGNLTWEARMKVII-GT 295
+N++ + + +M +V + +E L+ ++ Q +L+ + +
Sbjct: 85 ENIIGINDIIRAPTIEQMKDVYIVQDL-----METDLYKLLKTQ-HLS-NDHICYFLYQI 137
Query: 296 AKALAYLHEAIEPKVVHRDIKSSNILIDDEFNAKVSDFGLAKLLDSGESH---ITTRVMG 352
+ L Y+H A V+HRD+K SN+L++ + K+ DFGLA++ D H +T V
Sbjct: 138 LRGLKYIHSA---NVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVA- 193
Query: 353 TFGYVAPEYANTGMLNEKS-----DIYSFGVLLLEAVTGR 387
T Y APE MLN K DI+S G +L E ++ R
Sbjct: 194 TRWYRAPEI----MLNSKGYTKSIDIWSVGCILAEMLSNR 229
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367 | Back alignment and structure |
|---|
Score = 88.5 bits (220), Expect = 2e-19
Identities = 62/219 (28%), Positives = 102/219 (46%), Gaps = 35/219 (15%)
Query: 185 TNRFSAENVLGEGGYGVVYKGR-LINGSEVAVKKLLN---NLGQAEKEFRVEVEAIGHVR 240
R+ + +G G YG V G VAVKKL ++ A++ +R E+ + H++
Sbjct: 28 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMK 86
Query: 241 HKNLVRLLGYCIEGVHRM------LVYEYVNNGNLEQWLHGAMRNQGNLTWEARMKVII- 293
H+N++ LL LV + L+ ++ Q LT + ++ +I
Sbjct: 87 HENVIGLLDVFTPARSLEEFNDVYLVTHL-----MGADLNNIVKCQ-KLT-DDHVQFLIY 139
Query: 294 GTAKALAYLHEAIEPKVVHRDIKSSNILIDDEFNAKVSDFGLAKLLDSGESHITTRVMGT 353
+ L Y+H A ++HRD+K SN+ ++++ K+ DFGLA+ +T V T
Sbjct: 140 QILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLARHTA---DEMTGYVA-T 192
Query: 354 FGYVAPEYANTGMLNEKS-----DIYSFGVLLLEAVTGR 387
Y APE MLN DI+S G ++ E +TGR
Sbjct: 193 RWYRAPEI----MLNWMHYNQTVDIWSVGCIMAELLTGR 227
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464 | Back alignment and structure |
|---|
Score = 89.5 bits (222), Expect = 3e-19
Identities = 58/217 (26%), Positives = 95/217 (43%), Gaps = 31/217 (14%)
Query: 185 TNRFSAENVLGEGGYGVVYKGR-LINGSEVAVKKLLN---NLGQAEKEFRVEVEAIGHVR 240
R+ +G G G+V + VA+KKL N A++ +R E+ + V
Sbjct: 61 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYR-ELVLMKCVN 119
Query: 241 HKNLVRLL-----GYCIEGVHRM-LVYEYVNNGNLEQWLHGAMRNQGNLTWEARMKVIIG 294
HKN++ LL +E + LV E ++ L ++ L E ++
Sbjct: 120 HKNIISLLNVFTPQKTLEEFQDVYLVMEL-----MDANLCQVIQM--ELDHERMSYLLYQ 172
Query: 295 TAKALAYLHEAIEPKVVHRDIKSSNILIDDEFNAKVSDFGLAKLLDSGESHITTRVMGTF 354
+ +LH A ++HRD+K SNI++ + K+ DFGLA+ S + T + T
Sbjct: 173 MLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLARTAG--TSFMMTPYVVTR 227
Query: 355 GYVAPEYANTGMLN----EKSDIYSFGVLLLEAVTGR 387
Y APE +L E DI+S G ++ E V +
Sbjct: 228 YYRAPEV----ILGMGYKENVDIWSVGCIMGEMVRHK 260
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384 | Back alignment and structure |
|---|
Score = 84.3 bits (209), Expect = 7e-18
Identities = 55/223 (24%), Positives = 94/223 (42%), Gaps = 44/223 (19%)
Query: 188 FSAENVLGEGGYGVVYKGRLINGSEV-AVKKLLNNLGQAEKEFRVEVEAIGH-------- 238
F +G+G +G V + + ++ A+K + K+ VE + +
Sbjct: 17 FEILRAIGKGSFGKVCIVQKNDTKKMYAMKYM-------NKQKCVERNEVRNVFKELQIM 69
Query: 239 --VRHKNLVRLLGYCIEGVHRM-LVYEYVNNGNLEQWLHGAMRNQGNLTWEARMKVIIG- 294
+ H LV L Y + M +V + + G+L L + + E +K+ I
Sbjct: 70 QGLEHPFLVNLW-YSFQDEEDMFMVVDLLLGGDLRYHL----QQNVHFK-EETVKLFICE 123
Query: 295 TAKALAYLHEAIEPKVVHRDIKSSNILIDDEFNAKVSDFGLAKLLDSGESHITTRVMGTF 354
AL YL +++HRD+K NIL+D+ + ++DF +A +L T + GT
Sbjct: 124 LVMALDYLQNQ---RIIHRDMKPDNILLDEHGHVHITDFNIAAMLPRETQITT--MAGTK 178
Query: 355 GYVAPEYANTGMLNEKS--------DIYSFGVLLLEAVTGRDP 389
Y+APE M + + D +S GV E + GR P
Sbjct: 179 PYMAPE-----MFSSRKGAGYSFAVDWWSLGVTAYELLRGRRP 216
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412 | Back alignment and structure |
|---|
Score = 84.4 bits (209), Expect = 9e-18
Identities = 50/225 (22%), Positives = 93/225 (41%), Gaps = 21/225 (9%)
Query: 178 LRDLEIATNRFSAENVLGEGGYGVVYKGRLINGSEV-AVKKL--LNNLGQAEKE-FRVEV 233
L+++ + + F V+G G + V ++ +V A+K + + L + E FR E
Sbjct: 53 LKEVRLQRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREER 112
Query: 234 EAIGHVRHKNLVRLLGYCIEGVHRM-LVYEYVNNGNLEQWLHGAMRNQGNLTWEARMKVI 292
+ + + + + +L + + + + LV EY G+L L G +
Sbjct: 113 DVLVNGDRRWITQLH-FAFQDENYLYLVMEYYVGGDLLTLL----SKFGERIPAEMARFY 167
Query: 293 IG-TAKALAYLHEAIEPKVVHRDIKSSNILIDDEFNAKVSDFGLAKLLDSGESHITTRVM 351
+ A+ +H VHRDIK NIL+D + +++DFG L + + + +
Sbjct: 168 LAEIVMAIDSVHRL---GYVHRDIKPDNILLDRCGHIRLADFGSCLKLRADGTVRSLVAV 224
Query: 352 GTFGYVAPEYANTGMLNEKSDIY-------SFGVLLLEAVTGRDP 389
GT Y++PE + Y + GV E G+ P
Sbjct: 225 GTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTP 269
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388 | Back alignment and structure |
|---|
Score = 84.0 bits (208), Expect = 1e-17
Identities = 64/241 (26%), Positives = 103/241 (42%), Gaps = 58/241 (24%)
Query: 185 TNRFSAENVLGEGGYGVVYKGR-LINGSEVAVKKLLN---NLGQAEKEFRVEVEAIGHVR 240
++ LG+G YG+V+K G VAVKK+ + N A++ FR E+ + +
Sbjct: 8 LRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFR-EIMILTELS 66
Query: 241 -HKNLVRLLGYCIEGVHRM-------LVYEYVNNGNLEQWLHGAMRNQGNLTWEARMKVI 292
H+N+V LL V R LV++Y +E LH +R L + +
Sbjct: 67 GHENIVNLLN-----VLRADNDRDVYLVFDY-----METDLHAVIRAN-ILE-PVHKQYV 114
Query: 293 I-GTAKALAYLHEAIEPKVVHRDIKSSNILIDDEFNAKVSDFGLAKLLDSGESHITTRVM 351
+ K + YLH ++HRD+K SNIL++ E + KV+DFGL++ + +
Sbjct: 115 VYQLIKVIKYLHSG---GLLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNIPL 171
Query: 352 GTF--------------GYV------APEYANTGMLNEKS-----DIYSFGVLLLEAVTG 386
YV APE +L D++S G +L E + G
Sbjct: 172 SINENTENFDDDQPILTDYVATRWYRAPEI----LLGSTKYTKGIDMWSLGCILGEILCG 227
Query: 387 R 387
+
Sbjct: 228 K 228
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437 | Back alignment and structure |
|---|
Score = 82.9 bits (205), Expect = 3e-17
Identities = 56/223 (25%), Positives = 96/223 (43%), Gaps = 19/223 (8%)
Query: 178 LRDLEIATNRFSAENVLGEGGYGVVYKGRLINGSEV-AVKKLLNNLGQAEKE---FRVEV 233
++ + + F V+G G +G V +L N +V A+K L E FR E
Sbjct: 66 VKQMRLHREDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREER 125
Query: 234 EAIGHVRHKNLVRLLGYCIEGVHRM-LVYEYVNNGNLEQWLHGAMRNQGNLTWEARMKVI 292
+ + + K + L Y + + + LV +Y G+L L + + L E +
Sbjct: 126 DVLVNGDSKWITTLH-YAFQDDNNLYLVMDYYVGGDLLTLL---SKFEDRLP-EEMARFY 180
Query: 293 IG-TAKALAYLHEAIEPKVVHRDIKSSNILIDDEFNAKVSDFGLAKLLDSGESHITTRVM 351
+ A+ +H+ VHRDIK NIL+D + +++DFG L + ++ +
Sbjct: 181 LAEMVIAIDSVHQL---HYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVAV 237
Query: 352 GTFGYVAPE-----YANTGMLNEKSDIYSFGVLLLEAVTGRDP 389
GT Y++PE G + D +S GV + E + G P
Sbjct: 238 GTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETP 280
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350 | Back alignment and structure |
|---|
Score = 81.6 bits (202), Expect = 4e-17
Identities = 57/231 (24%), Positives = 90/231 (38%), Gaps = 48/231 (20%)
Query: 176 FTLRDLEIATNRFSAENVLGEGGYGVVYKGRLINGSEV-AVKKLLNNLGQAEKEFRVEVE 234
L + LG G +G V + A+K L +K+ V+++
Sbjct: 38 AQLDQFDRIK-------TLGTGSFGRVMLVKHKESGNHYAMKIL-------DKQKVVKLK 83
Query: 235 AIGH----------VRHKNLVRLLGYCIEGVHRMLVYEYVNNGNLEQWLHGAMRNQGNLT 284
I H V LV+L + + +V EYV G E + H +R G +
Sbjct: 84 QIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGG--EMFSH--LRRIGRFS 139
Query: 285 WEARMKVIIG-TAKALAYLHEAIEPKVVHRDIKSSNILIDDEFNAKVSDFGLAKLLDSGE 343
E + YLH +++RD+K N+LID + +V+DFG AK +
Sbjct: 140 -EPHARFYAAQIVLTFEYLHSL---DLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG-- 193
Query: 344 SHITTRVMGTFGYVAPEYANTGMLNEKS-----DIYSFGVLLLEAVTGRDP 389
T + GT +APE ++ K D ++ GVL+ E G P
Sbjct: 194 --RTWTLCGTPEALAPE-----IILSKGYNKAVDWWALGVLIYEMAAGYPP 237
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446 | Back alignment and structure |
|---|
Score = 82.5 bits (204), Expect = 4e-17
Identities = 59/208 (28%), Positives = 90/208 (43%), Gaps = 25/208 (12%)
Query: 193 VLGEGGYGVVYKGRLINGSEV-AVKKLLNNLGQAEKEF---RVEVEAIGHVRHKNLVRLL 248
+LG+G +G V + A+K L + A+ E E + + RH L L
Sbjct: 155 LLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALK 214
Query: 249 GYCIEGVHRM-LVYEYVNNGNLEQWLHGAMRNQGNLTWEARMKVIIG-TAKALAYLHEAI 306
Y + R+ V EY N G L L + + E R + AL YLH
Sbjct: 215 -YSFQTHDRLCFVMEYANGGELFFHLS----RERVFS-EDRARFYGAEIVSALDYLHS-- 266
Query: 307 EPKVVHRDIKSSNILIDDEFNAKVSDFGLAKLLDSGESHITTRVMGTFGYVAPEYANTGM 366
E VV+RD+K N+++D + + K++DFGL K + GT Y+APE +
Sbjct: 267 EKNVVYRDLKLENLMLDKDGHIKITDFGLCK-EGIKDGATMKTFCGTPEYLAPE-----V 320
Query: 367 LNEKS-----DIYSFGVLLLEAVTGRDP 389
L + D + GV++ E + GR P
Sbjct: 321 LEDNDYGRAVDWWGLGVVMYEMMCGRLP 348
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337 | Back alignment and structure |
|---|
Score = 81.1 bits (201), Expect = 5e-17
Identities = 61/215 (28%), Positives = 90/215 (41%), Gaps = 40/215 (18%)
Query: 193 VLGEGGYGVVYKGRLINGSEV-AVKKLLNNLGQAEKEFRVEVEAIGH----------VRH 241
+LG+G +G V R A+K L KE + + + H RH
Sbjct: 12 LLGKGTFGKVILVREKATGRYYAMKIL-------RKEVIIAKDEVAHTVTESRVLQNTRH 64
Query: 242 KNLVRLLGYCIEGVHRM-LVYEYVNNGNLEQWLHGAMRNQGNLTWEARMKVIIG-TAKAL 299
L L Y + R+ V EY N G L + H + + T E R + AL
Sbjct: 65 PFLTALK-YAFQTHDRLCFVMEYANGGEL--FFH--LSRERVFT-EERARFYGAEIVSAL 118
Query: 300 AYLHEAIEPKVVHRDIKSSNILIDDEFNAKVSDFGLAKLLDSGESHITTRVMGTFGYVAP 359
YLH VV+RDIK N+++D + + K++DFGL K + GT Y+AP
Sbjct: 119 EYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCK-EGISDGATMKTFCGTPEYLAP 174
Query: 360 EYANTGMLNEKS-----DIYSFGVLLLEAVTGRDP 389
E +L + D + GV++ E + GR P
Sbjct: 175 E-----VLEDNDYGRAVDWWGLGVVMYEMMCGRLP 204
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355 | Back alignment and structure |
|---|
Score = 80.4 bits (199), Expect = 1e-16
Identities = 74/287 (25%), Positives = 121/287 (42%), Gaps = 47/287 (16%)
Query: 124 VHHHERACSSQSGEEGSSGAGHKHSSLSYGGLVTASPLIGLPEISHLGWGHWFTLRDLEI 183
+ HH + G G GA + GG + L + G + + E+
Sbjct: 1 MAHHHHHHEEEGGSSG--GAAGTSADGGDGGEQLLTVKHELRTANLTGHAEKVGIENFEL 58
Query: 184 ATNRFSAENVLGEGGYGVVYKGRLINGSEV----AVKKL-----LNNLGQAE---KEFRV 231
VLG G YG V+ R I+G + A+K L + E E +V
Sbjct: 59 LK-------VLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQV 111
Query: 232 EVEAIGHVRHKNLVRLLGYCIEGVHRM-LVYEYVNNGNLEQWLHGAMRNQGNLTWEARMK 290
+E I LV L Y + ++ L+ +Y+N G L + H + + T E ++
Sbjct: 112 -LEHIRQ--SPFLVTLH-YAFQTETKLHLILDYINGGEL--FTH--LSQRERFT-EHEVQ 162
Query: 291 VIIG-TAKALAYLHEAIEPKVVHRDIKSSNILIDDEFNAKVSDFGLAKLLDSGESHITTR 349
+ +G AL +LH+ +++RDIK NIL+D + ++DFGL+K + E+
Sbjct: 163 IYVGEIVLALEHLHKL---GIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYD 219
Query: 350 VMGTFGYVAPEYANTGMLNEKS-------DIYSFGVLLLEAVTGRDP 389
GT Y+AP+ ++ D +S GVL+ E +TG P
Sbjct: 220 FCGTIEYMAPD-----IVRGGDSGHDKAVDWWSLGVLMYELLTGASP 261
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373 | Back alignment and structure |
|---|
Score = 80.0 bits (198), Expect = 2e-16
Identities = 57/220 (25%), Positives = 97/220 (44%), Gaps = 49/220 (22%)
Query: 193 VLGEGGYGVVYKGRLINGSEV-AVKKLLNNLGQAEKEFRVEVEAIGH-----------VR 240
V+G+G +G V R AVK L +K+ ++ + H V+
Sbjct: 45 VIGKGSFGKVLLARHKAEEVFYAVKVL-------QKKAILKKKEEKHIMSERNVLLKNVK 97
Query: 241 HKNLVRLLGYCIEGVHRM-LVYEYVNNGNLEQWLHGAMRNQGNLTWEARMK-----VIIG 294
H LV L + + ++ V +Y+N G L + H ++ + E R + +
Sbjct: 98 HPFLVGLH-FSFQTADKLYFVLDYINGGEL--FYH--LQRERCFL-EPRARFYAAEIAS- 150
Query: 295 TAKALAYLHEAIEPKVVHRDIKSSNILIDDEFNAKVSDFGLAKLLDSGESHITTRVMGTF 354
AL YLH +V+RD+K NIL+D + + ++DFGL K + + T+ GT
Sbjct: 151 ---ALGYLHSL---NIVYRDLKPENILLDSQGHIVLTDFGLCK-ENIEHNSTTSTFCGTP 203
Query: 355 GYVAPEYANTGMLNEKS-----DIYSFGVLLLEAVTGRDP 389
Y+APE +L+++ D + G +L E + G P
Sbjct: 204 EYLAPE-----VLHKQPYDRTVDWWCLGAVLYEMLYGLPP 238
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 79.6 bits (196), Expect = 2e-16
Identities = 75/355 (21%), Positives = 115/355 (32%), Gaps = 97/355 (27%)
Query: 182 EIATNRFSAENVLGEGGYGVVYKGRLIN------GSEVAVKKLLNNLGQAE-KEFRVE-- 232
E +R LG G +G V + VAVK L +E + E
Sbjct: 18 EFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELK 77
Query: 233 -----------VEAIGHV--------------RHKNLVRLL--------GYCIEGVHRML 259
V +G + NL L Y +G
Sbjct: 78 ILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQ 137
Query: 260 VYEYVNNGN----------------------LEQWLHGAMRNQGN-------LTWEARMK 290
+YV E+ L + LT E +
Sbjct: 138 GKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEEAPEDLYKDFLTLEHLIC 197
Query: 291 VIIGTAKALAYLHEAIEPKVVHRDIKSSNILIDDEFNAKVSDFGLAKLLDSGESHI-TTR 349
AK + +L K +HRD+ + NIL+ ++ K+ DFGLA+ + ++
Sbjct: 198 YSFQVAKGMEFLASR---KCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGD 254
Query: 350 VMGTFGYVAPEYANTGMLNEKSDIYSFGVLLLEAVT-GRDPVDY-GRPANEVNLVEWLKM 407
++APE + +SD++SFGVLL E + G P Y G +E LK
Sbjct: 255 ARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASP--YPGVKIDE-EFCRRLKE 311
Query: 408 MVGTRRAEEVVDPNLEVKP--ATRALKRSLLVALRCVDPDSEKRPKMSQVVRMLE 460
GTR + P T + + L C + +RP S++V L
Sbjct: 312 --GTR---------MR-APDYTTPEMYQ---TMLDCWHGEPSQRPTFSELVEHLG 351
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674 | Back alignment and structure |
|---|
Score = 80.5 bits (198), Expect = 4e-16
Identities = 72/341 (21%), Positives = 121/341 (35%), Gaps = 58/341 (17%)
Query: 76 VGQNFNDHPESVFLSVHDKSSDKN---SEKMHVHLGMSKSSDPDNISQCSSVHHHERACS 132
+ ++ D SV + D +S + S + D +
Sbjct: 232 LKESDKDRRLSVEIWDWDLTSRNDFMGSLSFGISELQKAGVDGWFKLLSQEEGEYFNVPV 291
Query: 133 SQSGEEGSSGAGHKHSSLSYGGLVTASPLIGLPEISHLGWGHWFTLRDLEIATNRFSAEN 192
G EG+ K G A IS D +R +
Sbjct: 292 PPEGSEGNEELRQKFERAKIGQGTKAPEEKTANTISK---------FDNNGNRDRMKLTD 342
Query: 193 -----VLGEGGYGVVYKGRLINGSEV-AVKKLLNNLGQAEKEFRVEVEAIGHV------- 239
VLG+G +G V E+ AVK L +K+ ++ + +
Sbjct: 343 FNFLMVLGKGSFGKVMLSERKGTDELYAVKIL-------KKDVVIQDDDVECTMVEKRVL 395
Query: 240 ----RHKNLVRLLGYCIEGVHRM-LVYEYVNNGNLEQWLHGAMRNQGNLTWEARMKVIIG 294
+ L +L C + + R+ V EYVN G+L + G E
Sbjct: 396 ALPGKPPFLTQLH-SCFQTMDRLYFVMEYVNGGDLMYHIQ----QVGRFK-EPHAVFYAA 449
Query: 295 -TAKALAYLHEAIEPKVVHRDIKSSNILIDDEFNAKVSDFGLAKLLDSGESHITTRVMGT 353
A L +L +++RD+K N+++D E + K++DFG+ K + + T GT
Sbjct: 450 EIAIGLFFLQSK---GIIYRDLKLDNVMLDSEGHIKIADFGMCK-ENIWDGVTTKTFCGT 505
Query: 354 FGYVAPEYANTGMLNEKS-----DIYSFGVLLLEAVTGRDP 389
Y+APE ++ + D ++FGVLL E + G+ P
Sbjct: 506 PDYIAPE-----IIAYQPYGKSVDWWAFGVLLYEMLAGQAP 541
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345 | Back alignment and structure |
|---|
Score = 78.4 bits (194), Expect = 4e-16
Identities = 68/218 (31%), Positives = 99/218 (45%), Gaps = 45/218 (20%)
Query: 193 VLGEGGYGVVYKGRLINGSEV-AVKKLLNNLGQAEKEFRVEVEAIGHV-----------R 240
V+G G Y V RL + A+K + +KE + E I V
Sbjct: 16 VIGRGSYAKVLLVRLKKTDRIYAMKVV-------KKELVNDDEDIDWVQTEKHVFEQASN 68
Query: 241 HKNLVRLLGYCIEGVHRM-LVYEYVNNGNLEQWLHGAMRNQGNLTWEARMKVIIGT-AKA 298
H LV L C + R+ V EYVN G+L H M+ Q L E + + A
Sbjct: 69 HPFLVGLH-SCFQTESRLFFVIEYVNGGDL--MFH--MQRQRKLP-EEHARFYSAEISLA 122
Query: 299 LAYLHEAIEPKVVHRDIKSSNILIDDEFNAKVSDFGLAKL-LDSGESHITTRVM-GTFGY 356
L YLHE +++RD+K N+L+D E + K++D+G+ K L G+ TT GT Y
Sbjct: 123 LNYLHER---GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGD---TTSTFCGTPNY 176
Query: 357 VAPEYANTGMLNEKS-----DIYSFGVLLLEAVTGRDP 389
+APE +L + D ++ GVL+ E + GR P
Sbjct: 177 IAPE-----ILRGEDYGFSVDWWALGVLMFEMMAGRSP 209
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 78.4 bits (194), Expect = 5e-16
Identities = 60/216 (27%), Positives = 96/216 (44%), Gaps = 41/216 (18%)
Query: 193 VLGEGGYGVVYKGRLINGSEV-AVKKLLNNLGQAEKEFRVEVEAIGHVR----------- 240
VLG+G +G V R+ ++ AVK L +K+ ++ + +
Sbjct: 30 VLGKGSFGKVMLARVKETGDLYAVKVL-------KKDVILQDDDVECTMTEKRILSLARN 82
Query: 241 HKNLVRLLGYCIEGVHRM-LVYEYVNNGNLEQWLHGAMRNQGNLTWEARMKVIIG-TAKA 298
H L +L C + R+ V E+VN G+L H ++ EAR + A
Sbjct: 83 HPFLTQLF-CCFQTPDRLFFVMEFVNGGDL--MFH--IQKSRRFD-EARARFYAAEIISA 136
Query: 299 LAYLHEAIEPKVVHRDIKSSNILIDDEFNAKVSDFGLAKLLDSGESHITTRVMGTFGYVA 358
L +LH+ +++RD+K N+L+D E + K++DFG+ K T GT Y+A
Sbjct: 137 LMFLHDK---GIIYRDLKLDNVLLDHEGHCKLADFGMCK-EGICNGVTTATFCGTPDYIA 192
Query: 359 PEYANTGMLNEKS-----DIYSFGVLLLEAVTGRDP 389
PE +L E D ++ GVLL E + G P
Sbjct: 193 PE-----ILQEMLYGPAVDWWAMGVLLYEMLCGHAP 223
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345 | Back alignment and structure |
|---|
Score = 78.0 bits (193), Expect = 7e-16
Identities = 52/216 (24%), Positives = 89/216 (41%), Gaps = 41/216 (18%)
Query: 193 VLGEGGYGVVYKGRLINGSEV-AVKKLLNNLGQAEKEFRVEVEAIGH-----------VR 240
+LG+G +G V+ ++ A+K L +K+ + + +
Sbjct: 24 MLGKGSFGKVFLAEFKKTNQFFAIKAL-------KKDVVLMDDDVECTMVEKRVLSLAWE 76
Query: 241 HKNLVRLLGYCIEGVHRM-LVYEYVNNGNLEQWLHGAMRNQGNLTWEARMKVIIG-TAKA 298
H L + + + V EY+N G+L + + +R
Sbjct: 77 HPFLTHMF-CTFQTKENLFFVMEYLNGGDLMYHIQ----SCHKFD-LSRATFYAAEIILG 130
Query: 299 LAYLHEAIEPKVVHRDIKSSNILIDDEFNAKVSDFGLAKLLDSGESHITTRVMGTFGYVA 358
L +LH +V+RD+K NIL+D + + K++DFG+ K + T GT Y+A
Sbjct: 131 LQFLHSK---GIVYRDLKLDNILLDKDGHIKIADFGMCK-ENMLGDAKTNTFCGTPDYIA 186
Query: 359 PEYANTGMLNEKS-----DIYSFGVLLLEAVTGRDP 389
PE +L + D +SFGVLL E + G+ P
Sbjct: 187 PE-----ILLGQKYNHSVDWWSFGVLLYEMLIGQSP 217
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396 | Back alignment and structure |
|---|
Score = 77.8 bits (192), Expect = 1e-15
Identities = 67/218 (30%), Positives = 99/218 (45%), Gaps = 45/218 (20%)
Query: 193 VLGEGGYGVVYKGRLINGSEV-AVKKLLNNLGQAEKEFRVEVEAIGHV-----------R 240
V+G G Y V RL + A++ + +KE + E I V
Sbjct: 59 VIGRGSYAKVLLVRLKKTDRIYAMRVV-------KKELVNDDEDIDWVQTEKHVFEQASN 111
Query: 241 HKNLVRLLGYCIEGVHRM-LVYEYVNNGNLEQWLHGAMRNQGNLTWEARMKVIIGT-AKA 298
H LV L C + R+ V EYVN G+L H M+ Q L E + + A
Sbjct: 112 HPFLVGLH-SCFQTESRLFFVIEYVNGGDL--MFH--MQRQRKLP-EEHARFYSAEISLA 165
Query: 299 LAYLHEAIEPKVVHRDIKSSNILIDDEFNAKVSDFGLAKL-LDSGESHITTRVM-GTFGY 356
L YLHE +++RD+K N+L+D E + K++D+G+ K L G+ TT GT Y
Sbjct: 166 LNYLHER---GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGD---TTSTFCGTPNY 219
Query: 357 VAPEYANTGMLNEKS-----DIYSFGVLLLEAVTGRDP 389
+APE +L + D ++ GVL+ E + GR P
Sbjct: 220 IAPE-----ILRGEDYGFSVDWWALGVLMFEMMAGRSP 252
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353 | Back alignment and structure |
|---|
Score = 77.3 bits (191), Expect = 1e-15
Identities = 55/216 (25%), Positives = 93/216 (43%), Gaps = 41/216 (18%)
Query: 193 VLGEGGYGVVYKGRLINGSEV-AVKKLLNNLGQAEKEFRVEVEAIGHV-----------R 240
VLG+G +G V E+ AVK L +K+ ++ + + +
Sbjct: 27 VLGKGSFGKVMLSERKGTDELYAVKIL-------KKDVVIQDDDVECTMVEKRVLALPGK 79
Query: 241 HKNLVRLLGYCIEGVHRM-LVYEYVNNGNLEQWLHGAMRNQGNLTWEARMKVIIG-TAKA 298
L +L C + + R+ V EYVN G+L + G E A
Sbjct: 80 PPFLTQLH-SCFQTMDRLYFVMEYVNGGDLMYHIQ----QVGRFK-EPHAVFYAAEIAIG 133
Query: 299 LAYLHEAIEPKVVHRDIKSSNILIDDEFNAKVSDFGLAKLLDSGESHITTRVMGTFGYVA 358
L +L +++RD+K N+++D E + K++DFG+ K + + T GT Y+A
Sbjct: 134 LFFLQSK---GIIYRDLKLDNVMLDSEGHIKIADFGMCK-ENIWDGVTTKTFCGTPDYIA 189
Query: 359 PEYANTGMLNEKS-----DIYSFGVLLLEAVTGRDP 389
PE ++ + D ++FGVLL E + G+ P
Sbjct: 190 PE-----IIAYQPYGKSVDWWAFGVLLYEMLAGQAP 220
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318 | Back alignment and structure |
|---|
Score = 76.8 bits (190), Expect = 1e-15
Identities = 59/224 (26%), Positives = 94/224 (41%), Gaps = 51/224 (22%)
Query: 188 FSAENVLGEGGYGVVYKGRLINGSEV-AVKKLLNNLGQAEKEFRVEVEAIGH-------- 238
F LG G +G V+ R + A+K L +KE V ++ + H
Sbjct: 8 FQILRTLGTGSFGRVHLIRSRHNGRYYAMKVL-------KKEIVVRLKQVEHTNDERLML 60
Query: 239 --VRHKNLVRLLGYCIEGVHRMLVYEYVNNGNLEQWLHGAMRNQGNLTWEARMK-----V 291
V H ++R+ G + ++ +Y+ G L L R K V
Sbjct: 61 SIVTHPFIIRMWGTFQDAQQIFMIMDYIEGGELFSLL----RKSQRFP-NPVAKFYAAEV 115
Query: 292 IIGTAKALAYLHEAIEPKVVHRDIKSSNILIDDEFNAKVSDFGLAKLLDSGESHITTRVM 351
+ AL YLH +++RD+K NIL+D + K++DFG AK + T +
Sbjct: 116 CL----ALEYLHSK---DIIYRDLKPENILLDKNGHIKITDFGFAKYVPD-----VTYTL 163
Query: 352 -GTFGYVAPEYANTGMLNEKS-----DIYSFGVLLLEAVTGRDP 389
GT Y+APE +++ K D +SFG+L+ E + G P
Sbjct: 164 CGTPDYIAPE-----VVSTKPYNKSIDWWSFGILIYEMLAGYTP 202
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410 | Back alignment and structure |
|---|
Score = 77.4 bits (191), Expect = 2e-15
Identities = 52/222 (23%), Positives = 91/222 (40%), Gaps = 20/222 (9%)
Query: 178 LRDLEIATNRFSAENVLGEGGYGVVYKGRLINGSEV-AVKKLLNNLGQAEKE---FRVEV 233
+RDL + + V+G G +G V R + +V A+K L + F E
Sbjct: 61 IRDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEER 120
Query: 234 EAIGHVRHKNLVRLLGYCIEGVHRM-LVYEYVNNGNLEQWLHGAMRNQGNLTWEARMKVI 292
+ + +V+L Y + + +V EY+ G+L + + ++ E +
Sbjct: 121 DIMAFANSPWVVQLF-YAFQDDRYLYMVMEYMPGGDLVNLM-----SNYDVP-EKWARFY 173
Query: 293 IG-TAKALAYLHEAIEPKVVHRDIKSSNILIDDEFNAKVSDFGLAKLLDSGESHITTRVM 351
AL +H +HRD+K N+L+D + K++DFG ++ +
Sbjct: 174 TAEVVLALDAIHSM---GFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAV 230
Query: 352 GTFGYVAPE----YANTGMLNEKSDIYSFGVLLLEAVTGRDP 389
GT Y++PE G + D +S GV L E + G P
Sbjct: 231 GTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTP 272
|
| >3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325 | Back alignment and structure |
|---|
Score = 76.0 bits (188), Expect = 2e-15
Identities = 61/210 (29%), Positives = 105/210 (50%), Gaps = 28/210 (13%)
Query: 193 VLGEGGYGVVYKGRLINGSEV----AVKKLLNNLGQAEKEFRVEVE--AIGHVRHKNLVR 246
VLG+G +G V+ + I+GS+ A+K L + R ++E + V H +V+
Sbjct: 31 VLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVK 90
Query: 247 LLGYCIEGVHRM-LVYEYVNNGNLEQWLHGAMRNQGNLTWEARMKVIIG-TAKALAYLHE 304
L Y + ++ L+ +++ G+L + + + T E +K + A AL +LH
Sbjct: 91 LH-YAFQTEGKLYLILDFLRGGDL--FTR--LSKEVMFT-EEDVKFYLAELALALDHLHS 144
Query: 305 AIEPKVVHRDIKSSNILIDDEFNAKVSDFGLAKLLDSGESHITTRVMGTFGYVAPEYANT 364
+++RD+K NIL+D+E + K++DFGL+K GT Y+APE
Sbjct: 145 L---GIIYRDLKPENILLDEEGHIKLTDFGLSK-ESIDHEKKAYSFCGTVEYMAPE---- 196
Query: 365 GMLNEKS-----DIYSFGVLLLEAVTGRDP 389
++N + D +SFGVL+ E +TG P
Sbjct: 197 -VVNRRGHTQSADWWSFGVLMFEMLTGTLP 225
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327 | Back alignment and structure |
|---|
Score = 76.0 bits (188), Expect = 2e-15
Identities = 58/216 (26%), Positives = 102/216 (47%), Gaps = 38/216 (17%)
Query: 193 VLGEGGYGVVYKGRLINGSEV----AVKKLL-NNLGQAEKEF---RVEVEAIGHVRHKNL 244
VLG+GGYG V++ R + G+ A+K L + + K+ + E + V+H +
Sbjct: 24 VLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFI 83
Query: 245 VRLLGYCIEGVHRM-LVYEYVNNGNLEQWLHGAMRNQGNLTWEARMK-----VIIGTAKA 298
V L+ Y + ++ L+ EY++ G L L +G E + + A
Sbjct: 84 VDLI-YAFQTGGKLYLILEYLSGGELFMQLE----REGIFM-EDTACFYLAEISM----A 133
Query: 299 LAYLHEAIEPKVVHRDIKSSNILIDDEFNAKVSDFGLAKLLDSGESHITTRVMGTFGYVA 358
L +LH+ +++RD+K NI+++ + + K++DFGL K + +T GT Y+A
Sbjct: 134 LGHLHQK---GIIYRDLKPENIMLNHQGHVKLTDFGLCK-ESIHDGTVTHTFCGTIEYMA 189
Query: 359 PEYANTGMLNEKS-----DIYSFGVLLLEAVTGRDP 389
PE +L D +S G L+ + +TG P
Sbjct: 190 PE-----ILMRSGHNRAVDWWSLGALMYDMLTGAPP 220
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299 | Back alignment and structure |
|---|
Score = 69.2 bits (170), Expect = 3e-13
Identities = 47/219 (21%), Positives = 82/219 (37%), Gaps = 52/219 (23%)
Query: 176 FTLRDLEIATNRFSAENVLGEGGYGVVYKGRLI-NGSEVAVKKLLNNLGQAEKEFRVEVE 234
++ I + VLG G G V + + A+K L + + R EVE
Sbjct: 8 LQIKKNAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-----PKARREVE 62
Query: 235 AIGHV-RHKNLVRLLGYCIEGVHRM----LVYEYVNNGNLEQWLHGAMRNQGNLTW---E 286
+ ++VR++ +V E ++ G L ++++G+ + E
Sbjct: 63 LHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFS----RIQDRGDQAFTERE 118
Query: 287 AR--MKVIIGTAKALAYLHEAIEPKVVHRDIKSSNILI---DDEFNAKVSDFGLAKLLDS 341
A MK I +A+ YLH + HRD+K N+L K++DFG AK
Sbjct: 119 ASEIMKSI---GEAIQYLHSI---NIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTG 172
Query: 342 GESHITTRVMGTFGYVAPEYANTGMLNEKSDIYSFGVLL 380
Y ++ D++S GV++
Sbjct: 173 E------------KY-----------DKSCDMWSLGVIM 188
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373 | Back alignment and structure |
|---|
Score = 68.2 bits (167), Expect = 1e-12
Identities = 51/312 (16%), Positives = 111/312 (35%), Gaps = 64/312 (20%)
Query: 183 IATNRFSAENVLGEGGYGVVYKGR-LINGSEVAVKKLLNN---LGQAEKEFRV------- 231
R+ LG G + V+ + ++N + VA+K + + AE E ++
Sbjct: 16 YKDARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVNDA 75
Query: 232 EVEAIGHVRHKNLVRLLGY----CIEGVHRMLVYEYVNNGNLEQWLHGAMRNQGNLTWEA 287
+ + ++++LL + GVH ++V+E V NL + +
Sbjct: 76 DNTKEDSMGANHILKLLDHFNHKGPNGVHVVMVFE-VLGENLLALIK--KYEHRGIPLIY 132
Query: 288 RMKVIIGTAKALAYLHEAIEPKVVHRDIKSSNILIDDE------FNAKVSDFGLAKLLDS 341
++ L Y+H ++H DIK N+L++ K++D G A D
Sbjct: 133 VKQISKQLLLGLDYMHR--RCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYD- 189
Query: 342 GESHITTRVMGTFGYVAPE------YANTGMLNEKSDIYSFGVLLLEAVTGR---DPVDY 392
H T + Y +PE + +DI+S L+ E +TG +P +
Sbjct: 190 --EHYTNSIQTRE-YRSPEVLLGAPW------GCGADIWSTACLIFELITGDFLFEPDEG 240
Query: 393 GRPANEVNLVEWLKMMVGT------------RRAEEVVDPNLEVKPATRA----LKRSLL 436
+ + + ++ + + ++ ++ L+ L
Sbjct: 241 HSYTKDDDH---IAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLT 297
Query: 437 VALRCVDPDSEK 448
+ ++++
Sbjct: 298 EKYKFSKDEAKE 309
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336 | Back alignment and structure |
|---|
Score = 64.9 bits (157), Expect = 1e-11
Identities = 28/216 (12%), Positives = 58/216 (26%), Gaps = 57/216 (26%)
Query: 183 IATNRFSAENVLGEGGYGVVYKGRLINGSEVAVKKLL--------NNLGQAEKEFRVEVE 234
+ T + +GEG +G V++ + + VA+K + + + +E E+
Sbjct: 17 LPTEKLQRCEKIGEGVFGEVFQTIA-DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEII 75
Query: 235 ---------AIGHVRHKNLVRLLGYCI------------------------------EGV 255
R + + L +
Sbjct: 76 ISKELSLLSGEVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDD 135
Query: 256 HRMLVYEYVNNGN-LEQWLHGAMRNQGNLTWEARMKVIIGTAKALAYLHEAIEPKVVHRD 314
+V E+ G LEQ + ++ +LA + HRD
Sbjct: 136 QLFIVLEFEFGGIDLEQM------RTKLSSLATAKSILHQLTASLAVAEA--SLRFEHRD 187
Query: 315 IKSSNILIDDEFNAKVSDFGLAKLLDSGESHITTRV 350
+ N+L+ K+ K + +
Sbjct: 188 LHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSI 223
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330 | Back alignment and structure |
|---|
Score = 62.4 bits (152), Expect = 8e-11
Identities = 48/226 (21%), Positives = 88/226 (38%), Gaps = 40/226 (17%)
Query: 186 NRFSAENVLGEGGYGVVYKGR-LINGSEVAVK--KLLNNLGQAEKEFRVEVEAIGHVRHK 242
F +G G +G + G+ L VA+K + + Q E+R +
Sbjct: 9 PNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSRAPQLHLEYRFYKQLGSGD--- 65
Query: 243 NLVRLLGYCIEGVHRMLVYEYVNNG-NLEQWLHGAMRNQGNLTWEARMKVIIGT--AKAL 299
+ ++ + G + +V E + G +LE + + + T+ + ++I +
Sbjct: 66 GIPQVYYFGPCGKYNAMVLELL--GPSLED-----LFDLCDRTFSLKTVLMIAIQLISRM 118
Query: 300 AYLHEAIEPKVVHRDIKSSNILIDDEFNAKVS-----DFGLAK--LLDSGESHITTR--- 349
Y+H +++RD+K N LI N DF LAK + + HI R
Sbjct: 119 EYVHSK---NLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEYIDPETKKHIPYREHK 175
Query: 350 -VMGTFGYVAPEYA--NTGMLNEKS---DIYSFGVLLLEAVTGRDP 389
+ GT Y NT + E+S D+ + G + + + G P
Sbjct: 176 SLTGT-----ARYMSINTHLGKEQSRRDDLEALGHMFMYFLRGSLP 216
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382 | Back alignment and structure |
|---|
Score = 62.0 bits (151), Expect = 1e-10
Identities = 55/222 (24%), Positives = 93/222 (41%), Gaps = 32/222 (14%)
Query: 182 EIATNRFSAENVLGEGGYGVVYKGR-LINGSEVAVKKLLNN---LGQAEKEFRV--EVEA 235
E +R+ ++++G+G +G V K + VA+K + N L QA+ E R+ +
Sbjct: 50 EKWMDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKKAFLNQAQIEVRLLELMNK 109
Query: 236 IGHVRHKNLVRLLGYCIEGVHRMLVYEYVNNGNLEQWLHGAMRNQGN--LTWEARMKVII 293
+V L + + H LV+E L L+ +RN ++ K
Sbjct: 110 HDTEMKYYIVHLKRHFMFRNHLCLVFE-----MLSYNLYDLLRNTNFRGVSLNLTRKFAQ 164
Query: 294 GTAKALAYLHEAIEPKVVHRDIKSSNILIDDEFNA--KVSDFGLAKLLDSGESHITTRVM 351
AL +L E ++H D+K NIL+ + + K+ DFG + L I +
Sbjct: 165 QMCTALLFLATP-ELSIIHCDLKPENILLCNPKRSAIKIVDFGSSCQLG---QRIYQYIQ 220
Query: 352 GTFGYVAPE------YANTGMLNEKSDIYSFGVLLLEAVTGR 387
F Y +PE Y + D++S G +L+E TG
Sbjct: 221 SRF-YRSPEVLLGMPY------DLAIDMWSLGCILVEMHTGE 255
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298 | Back alignment and structure |
|---|
Score = 58.9 bits (143), Expect = 7e-10
Identities = 53/226 (23%), Positives = 93/226 (41%), Gaps = 40/226 (17%)
Query: 186 NRFSAENVLGEGGYGVVYKGR-LINGSEVAVK--KLLNNLGQAEKEFRVEVEAIGHVRHK 242
+ +GEG +GV+++G L+N +VA+K ++ Q E+R G
Sbjct: 10 VHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDAPQLRDEYRTYKLLAGCT--- 66
Query: 243 NLVRLLGYCIEGVHRMLVYEYVNNG-NLEQWLHGAMRNQGNLTWEARMKVIIGT--AKAL 299
+ + + EG+H +LV + + G +LE + + + + + +
Sbjct: 67 GIPNVYYFGQEGLHNVLVIDLL--GPSLED-----LLDLCGRKFSVKTVAMAAKQMLARV 119
Query: 300 AYLHEAIEPKVVHRDIKSSNILIDDEFNAK-----VSDFGLAKL-LDS-GESHITTR--- 349
+HE +V+RDIK N LI + V DFG+ K D + HI R
Sbjct: 120 QSIHEK---SLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKK 176
Query: 350 -VMGTFGYVAPEYA--NTGMLNEKS---DIYSFGVLLLEAVTGRDP 389
+ GT Y NT + E+S D+ + G + + + G P
Sbjct: 177 NLSGT-----ARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLP 217
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429 | Back alignment and structure |
|---|
Score = 59.0 bits (143), Expect = 1e-09
Identities = 57/255 (22%), Positives = 95/255 (37%), Gaps = 56/255 (21%)
Query: 182 EIATNRFSAENVLGEGGYGVVYKGR-LINGSEVAVKKLLNN---LGQAEKEFRV--EVEA 235
+ R+ V+G+G +G V K VA+K + N QA +E R+ +
Sbjct: 93 DHVAYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNEKRFHRQAAEEIRILEHLRK 152
Query: 236 IGHVRHKNLVRLLGY-------CIEGVHRML---VYEYVNNGNLEQWLHGAMRNQGNLTW 285
N++ +L C+ +L +YE + QG +
Sbjct: 153 QDKDNTMNVIHMLENFTFRNHICM--TFELLSMNLYELIKKNK----------FQG-FSL 199
Query: 286 EARMKVIIGTAKALAYLHEAIEPKVVHRDIKSSNILIDDEFNA--KVSDFGLAKLLDSGE 343
K + L LH+ +++H D+K NIL+ + + KV DFG +
Sbjct: 200 PLVRKFAHSILQCLDALHKN---RIIHCDLKPENILLKQQGRSGIKVIDFGSSCYEH--- 253
Query: 344 SHITTRVMGTFGYVAPE------YANTGMLNEKSDIYSFGVLLLEAVTGRDPVDYGRPAN 397
+ T + F Y APE Y D++S G +L E +TG P+ G +
Sbjct: 254 QRVYTYIQSRF-YRAPEVILGARY------GMPIDMWSLGCILAELLTGY-PLLPGE--D 303
Query: 398 EVNLVEWLKMMVGTR 412
E + L M+
Sbjct: 304 EGDQ---LACMIELL 315
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397 | Back alignment and structure |
|---|
Score = 56.1 bits (135), Expect = 1e-08
Identities = 61/357 (17%), Positives = 115/357 (32%), Gaps = 86/357 (24%)
Query: 182 EIATNRFSAENVLGEGGYGVVYKGR-LINGSEVAVKKLLNN---LGQAEKEFRVEVEAI- 236
++ R+ LG G + V+ + VA+K + + A E R+ +++
Sbjct: 33 DLFNGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSAEHYTETALDEIRLL-KSVR 91
Query: 237 ----GHVRHKNLVRLLGY----CIEGVHRMLVYEYVNNGNLEQWLHGAMRNQGNLTWEAR 288
+ +V+LL + G H +V+E V +L +W+ N L
Sbjct: 92 NSDPNDPNREMVVQLLDDFKISGVNGTHICMVFE-VLGHHLLKWII--KSNYQGLPLPCV 148
Query: 289 MKVIIGTAKALAYLHEAIEPKVVHRDIKSSNILI-------------------------- 322
K+I + L YLH + +++H DIK NIL+
Sbjct: 149 KKIIQQVLQGLDYLHT--KCRIIHTDIKPENILLSVNEQYIRRLAAEATEWQRSGAPPPS 206
Query: 323 -----------------------DDEFNAKVSDFGLAKLLDSGESHITTRVMGTFGYVAP 359
++ K++D G A + H T + T Y +
Sbjct: 207 GSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVH---KHFTEDIQ-TRQYRSL 262
Query: 360 EYANTGMLNEKSDIYSFGVLLLEAVTGRDPVDYGRPANEVNLVEWLKMMVGT-------- 411
E N +DI+S + E TG + + + +++
Sbjct: 263 EVLIGSGYNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKL 322
Query: 412 ----RRAEEVVDPNLEVKPATRALKRSLLVAL--RCVDPDSEKRPKMSQVVRMLEAD 462
+ ++E ++K T+ L L + E ++ MLE
Sbjct: 323 IVAGKYSKEFFTKKGDLKHITKLKPWGLFEVLVEKYEWSQEEAAGFTDFLLPMLELI 379
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296 | Back alignment and structure |
|---|
Score = 54.3 bits (131), Expect = 2e-08
Identities = 53/224 (23%), Positives = 90/224 (40%), Gaps = 38/224 (16%)
Query: 186 NRFSAENVLGEGGYGVVYKGR-LINGSEVAVK--KLLNNLGQAEKEFRVEVEAIGHVRHK 242
NR+ +G G +G +Y G + G EVA+K + Q E ++ + +
Sbjct: 9 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKI-YKMMQGGVG- 66
Query: 243 NLVRLLGYCIEGVHRMLVYEYVNNG-NLEQWLHGAMRNQGNLTWEARMKVIIGT--AKAL 299
+ + EG + ++V E + G +LE + N + + + +++ +
Sbjct: 67 -IPTIRWCGAEGDYNVMVMELL--GPSLED-----LFNFCSRKFSLKTVLLLADQMISRI 118
Query: 300 AYLHEAIEPKVVHRDIKSSNILI---DDEFNAKVSDFGLAK--LLDSGESHITTR----V 350
Y+H +HRD+K N L+ + DFGLAK HI R +
Sbjct: 119 EYIHSK---NFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNL 175
Query: 351 MGTFGYVAPEYA--NTGMLNEKS---DIYSFGVLLLEAVTGRDP 389
GT YA NT + E+S D+ S G +L+ G P
Sbjct: 176 TGT-----ARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLP 214
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345 | Back alignment and structure |
|---|
Score = 52.4 bits (126), Expect = 1e-07
Identities = 34/186 (18%), Positives = 61/186 (32%), Gaps = 37/186 (19%)
Query: 186 NRFSAENVLGEGGYGVVYKG-RLINGSEVAVK--KLLN-NLGQAEKEFRVEVEAIGHVRH 241
N++ +G GG+G++Y + A K+ G E +
Sbjct: 37 NQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCI 96
Query: 242 KNLVRLLGYCIEGV---------------HRMLVYEYVNNGNLEQWLHGAMRNQGNLTWE 286
K + G+ +R +V E L L G
Sbjct: 97 KKWIERKQLDYLGIPLFYGSGLTEFKGRSYRFMVMER-----LGIDLQKISGQNGTFK-- 149
Query: 287 ARMKVIIGTA----KALAYLHEAIEPKVVHRDIKSSNILIDDEFNAKV--SDFGLAKLLD 340
++ L Y+HE + VH DIK++N+L+ + +V +D+GL+
Sbjct: 150 --KSTVLQLGIRMLDVLEYIHEN---EYVHGDIKAANLLLGYKNPDQVYLADYGLSYRYC 204
Query: 341 SGESHI 346
+H
Sbjct: 205 PNGNHK 210
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483 | Back alignment and structure |
|---|
Score = 51.5 bits (123), Expect = 4e-07
Identities = 54/223 (24%), Positives = 91/223 (40%), Gaps = 36/223 (16%)
Query: 186 NRFSAENVLGEGGYGVVYKGR-LINGSEVAVK--KLLNNLGQAEKEFRVEVEAIGHVRHK 242
N+F +G G +G +Y G + EVA+K + Q E ++ G
Sbjct: 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLLYESKIYRILQGGT--- 63
Query: 243 NLVRLLGYCIEGVHRMLVYEYVNNGNLEQWLHGAMRNQGNLTWEARMKVIIGT--AKALA 300
+ + + +EG + +LV + + +LE + N + + +++ +
Sbjct: 64 GIPNVRWFGVEGDYNVLVMDLLGP-SLED-----LFNFCSRKLSLKTVLMLADQMINRVE 117
Query: 301 YLHEAIEPKVVHRDIKSSNILIDDEFNAK---VSDFGLAKLL--DSGESHITTR----VM 351
++H +HRDIK N L+ A + DFGLAK S HI R +
Sbjct: 118 FVHSK---SFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLT 174
Query: 352 GTFGYVAPEYA--NTGMLNEKS---DIYSFGVLLLEAVTGRDP 389
GT YA NT + E+S D+ S G +L+ + G P
Sbjct: 175 GT-----ARYASVNTHLGIEQSRRDDLESLGYVLMYFLRGSLP 212
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352 | Back alignment and structure |
|---|
Score = 50.1 bits (120), Expect = 7e-07
Identities = 31/188 (16%), Positives = 69/188 (36%), Gaps = 38/188 (20%)
Query: 186 NRFSAENVLGEGGYGVVYKGR---------LINGSEVAVK---------KLLNNLGQAEK 227
++ ++ G++Y+ + ++K N +A K
Sbjct: 42 RQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKDGRLFNEQNFFQRAAK 101
Query: 228 EFRVEVEAIGH-VRHKNLVRLLGY-CIEGVHRMLVYEYVNNG-NLEQWLHGAMRNQGNLT 284
+V + + +G+ + +R LV + G +L+ L + + L+
Sbjct: 102 PLQVNKWKKLYSTPLLAIPTCMGFGVHQDKYRFLVLPSL--GRSLQSALD--VSPKHVLS 157
Query: 285 WEARMKVIIGTAK----ALAYLHEAIEPKVVHRDIKSSNILIDDEFNAKV--SDFGLAKL 338
+ ++ A AL +LHE + VH ++ + NI +D E ++V + +G A
Sbjct: 158 ----ERSVLQVACRLLDALEFLHEN---EYVHGNVTAENIFVDPEDQSQVTLAGYGFAFR 210
Query: 339 LDSGESHI 346
H+
Sbjct: 211 YCPSGKHV 218
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364 | Back alignment and structure |
|---|
Score = 49.4 bits (118), Expect = 1e-06
Identities = 35/180 (19%), Positives = 68/180 (37%), Gaps = 40/180 (22%)
Query: 186 NRFSAENVLGEGGYGVVYKGRLINGS------EVAVKKLLNNLGQAEKEFRVEVEAIGHV 239
+ +G+GG+G +Y + + VK ++ G E + A
Sbjct: 35 AAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPE 94
Query: 240 RHKNLVRLLGYCIEGV---------------HRMLVYEYVNNG-NLEQWLHGAMRNQGNL 283
+ + +R GV +R ++ + G +L++ N
Sbjct: 95 QIQKWIRTRKLKYLGVPKYWGSGLHDKNGKSYRFMIMDRF--GSDLQKIY---EANAKRF 149
Query: 284 TWEARMKVIIGTA----KALAYLHEAIEPKVVHRDIKSSNILIDDEFNAKV--SDFGLAK 337
+ K ++ + L Y+HE + VH DIK+SN+L++ + +V D+GLA
Sbjct: 150 S----RKTVLQLSLRILDILEYIHEH---EYVHGDIKASNLLLNYKNPDQVYLVDYGLAY 202
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355 | Back alignment and structure |
|---|
Score = 48.1 bits (115), Expect = 3e-06
Identities = 51/256 (19%), Positives = 86/256 (33%), Gaps = 69/256 (26%)
Query: 173 GHWFTLRDLEIATNRFSAENVLGEGGYGVVYKG--RLINGSEVAVKKLLNNLGQAEKEFR 230
GH R + R+ LGEG +G V + S+VA+K + N ++R
Sbjct: 7 GH-LVCRIGDWLQERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNV-----GKYR 60
Query: 231 ----VEVEAIGHVRHK------NLVRLLGYCIEGVHRMLVYEYVNNGNLEQWLHGAMRNQ 280
+E+ + ++ K V + + H + +E L + ++
Sbjct: 61 EAARLEINVLKKIKEKDKENKFLCVLMSDWFNFHGHMCIAFE-----LLGKNTFEFLKEN 115
Query: 281 GN--LTWEARMKVIIGTAKALAYLHEAIEPKVVHRDIKSSNILIDDEFNA---------- 328
+ AL +LHE ++ H D+K NIL +
Sbjct: 116 NFQPYPLPHVRHMAYQLCHALRFLHEN---QLTHTDLKPENILFVNSEFETLYNEHKSCE 172
Query: 329 ---------KVSDFGLAKLLDSGESH---ITTRVMGTFGYVAPE------YANTGMLNEK 370
+V+DFG A E H + TR Y PE + +
Sbjct: 173 EKSVKNTSIRVADFGSA--TFDHEHHTTIVATRH-----YRPPEVILELGW------AQP 219
Query: 371 SDIYSFGVLLLEAVTG 386
D++S G +L E G
Sbjct: 220 CDVWSIGCILFEYYRG 235
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339 | Back alignment and structure |
|---|
Score = 46.5 bits (111), Expect = 1e-05
Identities = 56/251 (22%), Positives = 89/251 (35%), Gaps = 59/251 (23%)
Query: 173 GHWFTLRDLEIATNRFSAENVLGEGGYGVVYKG--RLINGSEVAVKKLLNN---LGQAEK 227
H + ++ + R+ + LGEG +G V + G VAVK + N A
Sbjct: 2 MH-LICQSGDVLSARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNVDRYCEAARS 60
Query: 228 EFRV--EVEAIGHVRHKNLVRLLGYCIEGVHRMLVYEYVNNGNLEQWLHGAMRNQGN--L 283
E +V + V++L + H +V+E L + ++ G
Sbjct: 61 EIQVLEHLNTTDPNSTFRCVQMLEWFEHHGHICIVFE-----LLGLSTYDFIKENGFLPF 115
Query: 284 TWEARMKVIIGTAKALAYLHEAIEPKVVHRDIKSSNILIDDEFNA--------------- 328
+ K+ K++ +LH K+ H D+K NIL
Sbjct: 116 RLDHIRKMAYQICKSVNFLHSN---KLTHTDLKPENILFVQSDYTEAYNPKIKRDERTLI 172
Query: 329 ----KVSDFGLAKLLDSGESHIT---TRVMGTFGYVAPE------YANTGMLNEKSDIYS 375
KV DFG A E H T TR Y APE + ++ D++S
Sbjct: 173 NPDIKVVDFGSA--TYDDEHHSTLVSTRH-----YRAPEVILALGW------SQPCDVWS 219
Query: 376 FGVLLLEAVTG 386
G +L+E G
Sbjct: 220 IGCILIEYYLG 230
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360 | Back alignment and structure |
|---|
Score = 45.4 bits (108), Expect = 2e-05
Identities = 60/260 (23%), Positives = 96/260 (36%), Gaps = 73/260 (28%)
Query: 173 GHWFTLRDLEIATNRFSAENVLGEGGYGVVYKGR-LINGSEVAVKKLLNNLGQAEKEFR- 230
H F+ + + N F +G+G +G V + + N AVK + N K++
Sbjct: 23 VH-FSWKKGMLLNNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNI-----KKYTR 76
Query: 231 ---VEVEAIGHVRH-----KNLVRLLGYCIEGVHRMLVYEYVNNGNLEQWLHGAMRNQGN 282
+E + + +++ N+V+ G + H L++E L L+ +
Sbjct: 77 SAKIEADILKKIQNDDINNNNIVKYHGKFMYYDHMCLIFE-----PLGPSLYEIITRNNY 131
Query: 283 --LTWEARMKVIIGTAKALAYLHEAIEPKVVHRDIKSSNILIDDEFNA------------ 328
E I KAL YL + + H D+K NIL+DD +
Sbjct: 132 NGFHIEDIKLYCIEILKALNYLRKM---SLTHTDLKPENILLDDPYFEKSLITVRRVTDG 188
Query: 329 -------------KVSDFGLAKLLDSGESH---ITTRVMGTFGYVAPE------YANTGM 366
K+ DFG A + H I TR Y APE +
Sbjct: 189 KKIQIYRTKSTGIKLIDFGCA--TFKSDYHGSIINTR----Q-YRAPEVILNLGW----- 236
Query: 367 LNEKSDIYSFGVLLLEAVTG 386
+ SD++SFG +L E TG
Sbjct: 237 -DVSSDMWSFGCVLAELYTG 255
|
| >3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A* Length = 540 | Back alignment and structure |
|---|
Score = 43.1 bits (102), Expect = 2e-04
Identities = 32/172 (18%), Positives = 69/172 (40%), Gaps = 20/172 (11%)
Query: 179 RDLEIATNRFSAENVLGEGGYGVVYKGRLINGSEVAVKKLLNNLGQAEKEFRVEV--EAI 236
R E+++G+G + + + +V +K+ + +K +R E E I
Sbjct: 329 IKEIKGKKRKIPEHLIGKGAEADIKRDSYL-DFDVIIKE------RVKKGYRDERLDENI 381
Query: 237 GHVRHKNLVRLLGYC-IEGVHRMLVYEY-VNNGNLE-QWLHGAMRNQGNLTWEARMKVII 293
R R L G+ +++ ++N + +++G + E + +
Sbjct: 382 RKSRTAREARYLALVKDFGIPAPYIFDVDLDNKRIMMSYINGKLAKDVI---EDNLDIAY 438
Query: 294 GTAKALAYLHEAIEPKVVHRDIKSSNILIDDEFNAKVSDFGLAKLLDSGESH 345
+ + LH+ V+H D+ +SN + D + + DFGL K+ + E
Sbjct: 439 KIGEIVGKLHKN---DVIHNDLTTSNFIFDKD--LYIIDFGLGKISNLDEDK 485
|
Structure Templates Detected by HHsearch
Original result of HHsearch against PDB70 database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 508 | |||
| 4aoj_A | 329 | High affinity nerve growth factor receptor; transf | 100.0 | |
| 4asz_A | 299 | BDNF/NT-3 growth factors receptor; transferase, TR | 100.0 | |
| 3omv_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 4gt4_A | 308 | Tyrosine-protein kinase transmembrane receptor RO; | 100.0 | |
| 4fih_A | 346 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 4b9d_A | 350 | Serine/threonine-protein kinase NEK1; transferase, | 100.0 | |
| 4aw0_A | 311 | HPDK1, 3-phosphoinositide-dependent protein kinase | 100.0 | |
| 3fpq_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 4fie_A | 423 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 4g3f_A | 336 | NF-kappa-beta-inducing kinase; non-RD kinase, prot | 100.0 | |
| 4ase_A | 353 | Vascular endothelial growth factor receptor 2; tra | 100.0 | |
| 3hyh_A | 275 | Carbon catabolite-derepressing protein kinase; kin | 100.0 | |
| 3hmm_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 3ubd_A | 304 | Ribosomal protein S6 kinase alpha-3; kinase-inhibi | 100.0 | |
| 4g31_A | 299 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 4b99_A | 398 | Mitogen-activated protein kinase 7; transferase, i | 100.0 | |
| 4f9c_A | 361 | Cell division cycle 7-related protein kinase; Ser/ | 100.0 | |
| 3uim_A | 326 | Brassinosteroid insensitive 1-associated receptor; | 100.0 | |
| 3uto_A | 573 | Twitchin; kinase, muscle sarcomere, transferase; H | 100.0 | |
| 3v5w_A | 689 | G-protein coupled receptor kinase 2; inhibitor com | 100.0 | |
| 2qkw_B | 321 | Protein kinase; three-helix bundle motif, AVRPTO-P | 100.0 | |
| 3fxz_A | 297 | Serine/threonine-protein kinase PAK 1; transferase | 100.0 | |
| 3zgw_A | 347 | Maternal embryonic leucine zipper kinase; transfer | 100.0 | |
| 3s95_A | 310 | LIMK-1, LIM domain kinase 1; structural genomics, | 100.0 | |
| 3fe3_A | 328 | MAP/microtubule affinity-regulating kinase 3; seri | 100.0 | |
| 2psq_A | 370 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 3p86_A | 309 | Serine/threonine-protein kinase CTR1; ETR1, ERS1, | 100.0 | |
| 3sxs_A | 268 | Cytoplasmic tyrosine-protein kinase BMX; transfera | 100.0 | |
| 4hcu_A | 269 | Tyrosine-protein kinase ITK/TSK; transferase-trans | 100.0 | |
| 3kul_A | 325 | Ephrin type-A receptor 8; ATP-binding, kinase, nuc | 100.0 | |
| 2c30_A | 321 | Serine/threonine-protein kinase PAK 6; CRIB domain | 100.0 | |
| 2yab_A | 361 | Death-associated protein kinase 2; apoptosis, tran | 100.0 | |
| 4eqm_A | 294 | Protein kinase; transferase; HET: ANP; 3.00A {Stap | 100.0 | |
| 1o6l_A | 337 | RAC-beta serine/threonine protein kinase; protein | 100.0 | |
| 3gen_A | 283 | Tyrosine-protein kinase BTK; bruton'S tyrosine kin | 100.0 | |
| 3cbl_A | 377 | C-FES, proto-oncogene tyrosine-protein kinase FES/ | 100.0 | |
| 1qcf_A | 454 | Haematopoetic cell kinase (HCK); tyrosine kinase-i | 100.0 | |
| 3c0i_A | 351 | Peripheral plasma membrane protein CASK; neurexin, | 100.0 | |
| 2nru_A | 307 | Interleukin-1 receptor-associated kinase 4; inhibi | 100.0 | |
| 4euu_A | 319 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 3ugc_A | 295 | Tyrosine-protein kinase JAK2; small molecule inhib | 100.0 | |
| 3tki_A | 323 | Serine/threonine-protein kinase CHK1; cell checkpo | 100.0 | |
| 3soc_A | 322 | Activin receptor type-2A; structural genomics cons | 100.0 | |
| 2y0a_A | 326 | Death-associated protein kinase 1; transferase, ca | 100.0 | |
| 4aw2_A | 437 | Serine/threonine-protein kinase MRCK alpha; transf | 100.0 | |
| 3txo_A | 353 | PKC-L, NPKC-ETA, protein kinase C ETA type; phosph | 100.0 | |
| 1mp8_A | 281 | Focal adhesion kinase 1; tyrosine protein kinase, | 100.0 | |
| 3niz_A | 311 | Rhodanese family protein; structural genomics, str | 100.0 | |
| 3v8s_A | 410 | RHO-associated protein kinase 1; dimerization, myo | 100.0 | |
| 3t9t_A | 267 | Tyrosine-protein kinase ITK/TSK; kinase domain, al | 100.0 | |
| 2qol_A | 373 | Ephrin receptor; receptor tyrosine kinase, juxtame | 100.0 | |
| 2bdw_A | 362 | Hypothetical protein K11E8.1D; kinase, calmodulin | 100.0 | |
| 1k9a_A | 450 | Carboxyl-terminal SRC kinase; COOH-terminal SRC ki | 100.0 | |
| 3q4u_A | 301 | Activin receptor type-1; structural genomics conso | 100.0 | |
| 1tki_A | 321 | Titin; serine kinase, muscle, autoinhibition; 2.00 | 100.0 | |
| 3lb7_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 3h4j_B | 336 | AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin | 100.0 | |
| 1opk_A | 495 | P150, C-ABL, proto-oncogene tyrosine-protein kinas | 100.0 | |
| 3soa_A | 444 | Calcium/calmodulin-dependent protein kinase type a | 100.0 | |
| 1fmk_A | 452 | C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros | 100.0 | |
| 1fot_A | 318 | TPK1 delta, CAMP-dependent protein kinase type 1; | 100.0 | |
| 4fr4_A | 384 | YANK1, serine/threonine-protein kinase 32A; struct | 100.0 | |
| 1luf_A | 343 | Muscle-specific tyrosine kinase receptor MUSK; pho | 100.0 | |
| 2ivs_A | 314 | Proto-oncogene tyrosine-protein kinase receptor RE | 100.0 | |
| 3tt0_A | 382 | Basic fibroblast growth factor receptor 1; kinase | 100.0 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 100.0 | |
| 4dc2_A | 396 | Protein kinase C IOTA type; kinase, substrate, cel | 100.0 | |
| 1kob_A | 387 | Twitchin; kinase, intrasteric regulation; 2.30A {A | 100.0 | |
| 1p4o_A | 322 | Insulin-like growth factor I receptor protein; IGF | 100.0 | |
| 3dtc_A | 271 | Mitogen-activated protein kinase kinase kinase 9; | 100.0 | |
| 1xjd_A | 345 | Protein kinase C, theta type; PKC-theta, ATP, AMP, | 100.0 | |
| 3l9p_A | 367 | Anaplastic lymphoma kinase; kinase domain, ATP-bin | 100.0 | |
| 3a8x_A | 345 | Protein kinase C IOTA type; transferase; HET: TPO; | 100.0 | |
| 1qpc_A | 279 | LCK kinase; alpha beta fold, transferase; HET: PTR | 100.0 | |
| 3qup_A | 323 | Tyrosine-protein kinase receptor TYRO3; protein ki | 100.0 | |
| 2izr_A | 330 | Casein kinase I isoform gamma-3; serine/threonine- | 100.0 | |
| 3o0g_A | 292 | Cell division protein kinase 5; kinase activator c | 100.0 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 3poz_A | 327 | Epidermal growth factor receptor; kinase domain, a | 100.0 | |
| 1rdq_E | 350 | PKA C-alpha, CAMP-dependent protein kinase, alpha- | 100.0 | |
| 1ob3_A | 288 | PFPK5, cell division control protein 2 homolog; tr | 100.0 | |
| 3a62_A | 327 | Ribosomal protein S6 kinase beta-1; kinase domain, | 100.0 | |
| 2vd5_A | 412 | DMPK protein; serine/threonine-protein kinase, kin | 100.0 | |
| 1csn_A | 298 | Casein kinase-1; phosphotransferase; HET: ATP; 2.0 | 100.0 | |
| 3uc3_A | 361 | Serine/threonine-protein kinase SRK2I; SNRK2, ABA | 100.0 | |
| 4fvq_A | 289 | Tyrosine-protein kinase JAK2; janus protein kinase | 100.0 | |
| 3kfa_A | 288 | Tyrosine-protein kinase ABL1; CML, drug resistance | 100.0 | |
| 1rjb_A | 344 | FL cytokine receptor; kinase, structure, autoinhib | 100.0 | |
| 2zv2_A | 298 | Calcium/calmodulin-dependent protein kinase kinas; | 100.0 | |
| 2buj_A | 317 | Serine/threonine-protein kinase 16; transferase, A | 100.0 | |
| 2w4o_A | 349 | Calcium/calmodulin-dependent protein kinase type I | 100.0 | |
| 2i0e_A | 353 | Protein kinase C-beta II; serine/threonine protein | 100.0 | |
| 4f0f_A | 287 | Serine/threonine-protein kinase ROCO4; LRRK2, ATP- | 100.0 | |
| 3llt_A | 360 | Serine/threonine kinase-1, pflammer; lammer kinase | 100.0 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 100.0 | |
| 3cc6_A | 281 | Protein tyrosine kinase 2 beta; focal adhesion kin | 100.0 | |
| 3gni_B | 389 | Strad alpha; kinase fold, pseudokinase, alpha heli | 100.0 | |
| 2x4f_A | 373 | Myosin light chain kinase family member 4; LUNG, b | 100.0 | |
| 3p1a_A | 311 | MYT1 kinase, membrane-associated tyrosine- and thr | 100.0 | |
| 3kn6_A | 325 | Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1 | 100.0 | |
| 3f3z_A | 277 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 1t46_A | 313 | HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom | 100.0 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 100.0 | |
| 3kk8_A | 284 | Calcium/calmodulin dependent protein kinase II; AT | 100.0 | |
| 4ejn_A | 446 | RAC-alpha serine/threonine-protein kinase; AKT1, a | 100.0 | |
| 1nxk_A | 400 | MAP kinase-activated protein kinase 2; MK2, phosph | 100.0 | |
| 4e5w_A | 302 | Tyrosine-protein kinase JAK1; kinase domain, trans | 100.0 | |
| 2y94_A | 476 | 5'-AMP-activated protein kinase catalytic subunit; | 100.0 | |
| 3kex_A | 325 | Receptor tyrosine-protein kinase ERBB-3; kinase do | 100.0 | |
| 3is5_A | 285 | Calcium-dependent protein kinase; CDPK, structural | 100.0 | |
| 2wqm_A | 310 | Serine/threonine-protein kinase NEK7; ATP-binding, | 100.0 | |
| 3hko_A | 345 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 3lxl_A | 327 | Tyrosine-protein kinase JAK3; TYK2, inflammation, | 100.0 | |
| 3kmu_A | 271 | ILK, integrin-linked kinase; cell adhesion, ANK re | 100.0 | |
| 3cok_A | 278 | Serine/threonine-protein kinase PLK4; POLO-like ki | 100.0 | |
| 2a2a_A | 321 | Death-associated protein kinase 2; autoinhibition, | 100.0 | |
| 1u59_A | 287 | Tyrosine-protein kinase ZAP-70; transferase; HET: | 100.0 | |
| 2qr7_A | 342 | Ribosomal protein S6 kinase alpha-3; kinase domain | 100.0 | |
| 3lzb_A | 327 | Epidermal growth factor receptor; epidermal growth | 100.0 | |
| 3mdy_A | 337 | Bone morphogenetic protein receptor type-1B; compl | 100.0 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 100.0 | |
| 1mqb_A | 333 | Ephrin type-A receptor 2; tyrosine protein kinase, | 100.0 | |
| 3op5_A | 364 | Serine/threonine-protein kinase VRK1; adenosine tr | 100.0 | |
| 3og7_A | 289 | AKAP9-BRAF fusion protein; proto-oncogene, V600E, | 100.0 | |
| 4agu_A | 311 | Cyclin-dependent kinase-like 1; transferase, phosp | 100.0 | |
| 2pmi_A | 317 | Negative RE, cyclin-dependent protein kinase PHO85 | 100.0 | |
| 2v62_A | 345 | Serine/threonine-protein kinase VRK2; transferase, | 100.0 | |
| 3ork_A | 311 | Serine/threonine protein kinase; structural genomi | 100.0 | |
| 2pvf_A | 334 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 2h34_A | 309 | Serine/threonine-protein kinase PKNE; apoenzyme, t | 100.0 | |
| 2ac3_A | 316 | MAP kinase-interacting serine/threonine kinase 2; | 100.0 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 100.0 | |
| 2eva_A | 307 | TAK1 kinase - TAB1 chimera fusion protein; transfe | 100.0 | |
| 2i1m_A | 333 | Macrophage colony-stimulating factor 1 receptor; k | 100.0 | |
| 2eue_A | 275 | Carbon catabolite derepressing protein kinase; kin | 100.0 | |
| 2xir_A | 316 | Vascular endothelial growth factor receptor 2; ang | 100.0 | |
| 2r5t_A | 373 | Serine/threonine-protein kinase SGK1; AGC protein | 100.0 | |
| 1u5q_A | 348 | Serine/threonine protein kinase TAO2; transferase; | 100.0 | |
| 3g33_A | 308 | Cell division protein kinase 4; Ser/Thr protein ki | 100.0 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 100.0 | |
| 2acx_A | 576 | G protein-coupled receptor kinase 6; GRK, G transf | 100.0 | |
| 1vzo_A | 355 | Ribosomal protein S6 kinase alpha 5; protein kinas | 100.0 | |
| 3uzp_A | 296 | CKI-delta, CKID, casein kinase I isoform delta; CK | 100.0 | |
| 3brb_A | 313 | Proto-oncogene tyrosine-protein kinase MER; ATP-bi | 100.0 | |
| 2yex_A | 276 | Serine/threonine-protein kinase CHK1; transferase, | 100.0 | |
| 4hgt_A | 296 | Casein kinase I isoform delta; CK1D, inhibitor, tr | 100.0 | |
| 3oz6_A | 388 | Mitogen-activated protein kinase 1, serine/threon | 100.0 | |
| 3dls_A | 335 | PAS domain-containing serine/threonine-protein KI; | 100.0 | |
| 3c1x_A | 373 | Hepatocyte growth factor receptor; receptor tyrosi | 100.0 | |
| 1b6c_B | 342 | TGF-B superfamily receptor type I; complex (isomer | 100.0 | |
| 3rp9_A | 458 | Mitogen-activated protein kinase; structural genom | 100.0 | |
| 2vgo_A | 284 | Serine/threonine-protein kinase 12-A; nucleotide-b | 100.0 | |
| 2jam_A | 304 | Calcium/calmodulin-dependent protein kinase type 1 | 100.0 | |
| 3c4z_A | 543 | Rhodopsin kinase; Ser/Thr kinase, RGS homology dom | 100.0 | |
| 1xbb_A | 291 | Tyrosine-protein kinase SYK; gleevec, STI-571, ima | 100.0 | |
| 3pls_A | 298 | Macrophage-stimulating protein receptor; protein k | 100.0 | |
| 2rku_A | 294 | Serine/threonine-protein kinase PLK1; structure of | 100.0 | |
| 3bhy_A | 283 | Death-associated protein kinase 3; death associate | 100.0 | |
| 3f66_A | 298 | Hepatocyte growth factor receptor; C-Met, protein | 100.0 | |
| 3mtl_A | 324 | Cell division protein kinase 16; pctaire1, indirub | 100.0 | |
| 2ozo_A | 613 | Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t | 100.0 | |
| 1t4h_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 3ll6_A | 337 | Cyclin G-associated kinase; transferase, protein k | 100.0 | |
| 1byg_A | 278 | CSK, protein (C-terminal SRC kinase); protein kina | 100.0 | |
| 3lxp_A | 318 | Non-receptor tyrosine-protein kinase TYK2; JAK3, i | 100.0 | |
| 3ttj_A | 464 | Mitogen-activated protein kinase 10; JNK3, protein | 100.0 | |
| 1x8b_A | 289 | WEE1HU, WEE1-like protein kinase; cell cycle, tran | 100.0 | |
| 3lm5_A | 327 | Serine/threonine-protein kinase 17B; STK17B, serin | 100.0 | |
| 2owb_A | 335 | Serine/threonine-protein kinase PLK1; catalytic do | 100.0 | |
| 3eqc_A | 360 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3eb0_A | 383 | Putative uncharacterized protein; kinase cryptospo | 100.0 | |
| 3a7i_A | 303 | MST3 kinase, serine/threonine kinase 24 (STE20 hom | 100.0 | |
| 2w1i_A | 326 | JAK2; chromosomal rearrangement, nucleotide-bindin | 100.0 | |
| 2a19_B | 284 | Interferon-induced, double-stranded RNA-activated | 100.0 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 1fvr_A | 327 | Tyrosine-protein kinase TIE-2; tyrosine kinase, tr | 100.0 | |
| 2h6d_A | 276 | 5'-AMP-activated protein kinase catalytic subunit | 100.0 | |
| 2y7j_A | 365 | Phosphorylase B kinase gamma catalytic chain, test | 100.0 | |
| 3g2f_A | 336 | Bone morphogenetic protein receptor type-2; kinase | 100.0 | |
| 3an0_A | 340 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3e7e_A | 365 | HBUB1, BUB1A, mitotic checkpoint serine/threonine- | 100.0 | |
| 2jii_A | 352 | Serine/threonine-protein kinase VRK3 molecule: VA | 100.0 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 3n9x_A | 432 | Phosphotransferase; malaria kinase, structural gen | 100.0 | |
| 4aaa_A | 331 | Cyclin-dependent kinase-like 2; transferase, phosp | 100.0 | |
| 3fme_A | 290 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 4eut_A | 396 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 3com_A | 314 | Serine/threonine-protein kinase 4; MST1, STE20-lik | 100.0 | |
| 3i6u_A | 419 | CDS1, serine/threonine-protein kinase CHK2; Ser/Th | 100.0 | |
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 100.0 | |
| 2yfx_A | 327 | Tyrosine-protein kinase receptor; nucleotide-bindi | 100.0 | |
| 3gbz_A | 329 | Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide- | 100.0 | |
| 3gxj_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 100.0 | |
| 2clq_A | 295 | Mitogen-activated protein kinase kinase kinase 5; | 100.0 | |
| 1ua2_A | 346 | CAK, cell division protein kinase 7; cell cycle, p | 100.0 | |
| 3byv_A | 377 | Rhoptry kinase; malaria, transferase, structural g | 100.0 | |
| 2j7t_A | 302 | Serine/threonine-protein kinase 10; transferase, A | 100.0 | |
| 2xrw_A | 371 | Mitogen-activated protein kinase 8; transcription, | 100.0 | |
| 3pg1_A | 362 | Mitogen-activated protein kinase, putative (MAP K | 100.0 | |
| 3pfq_A | 674 | PKC-B, PKC-beta, protein kinase C beta type; phosp | 100.0 | |
| 4fl3_A | 635 | Tyrosine-protein kinase SYK; transferase; HET: ANP | 100.0 | |
| 3mi9_A | 351 | Cell division protein kinase 9; P-TEFB, HIV-1, pro | 100.0 | |
| 2vwi_A | 303 | Serine/threonine-protein kinase OSR1; STE kinase, | 100.0 | |
| 1phk_A | 298 | Phosphorylase kinase; glycogen metabolism, transfe | 100.0 | |
| 3nsz_A | 330 | CK II alpha, casein kinase II subunit alpha; inhib | 100.0 | |
| 1wak_A | 397 | Serine/threonine-protein kinase SPRK1; SRPK, trans | 100.0 | |
| 4e7w_A | 394 | Glycogen synthase kinase 3; GSK3, PTyr195, transfe | 100.0 | |
| 1j1b_A | 420 | Glycogen synthase kinase-3 beta; complex, TAU, AMP | 100.0 | |
| 2r3i_A | 299 | Cell division protein kinase 2; serine/threonine-p | 100.0 | |
| 2x7f_A | 326 | TRAF2 and NCK-interacting protein kinase; serine/t | 100.0 | |
| 3q60_A | 371 | ROP5B; pseudokinase, transferase; HET: ATP; 1.72A | 100.0 | |
| 1u46_A | 291 | ACK-1, activated CDC42 kinase 1; tyrosine kinase, | 100.0 | |
| 3rgf_A | 405 | Cyclin-dependent kinase 8; protein kinase complex, | 100.0 | |
| 1cm8_A | 367 | Phosphorylated MAP kinase P38-gamma; phosphorylati | 100.0 | |
| 2wtk_C | 305 | Serine/threonine-protein kinase 11; transferase-me | 100.0 | |
| 2ycf_A | 322 | Serine/threonine-protein kinase CHK2; transferase, | 100.0 | |
| 1zy4_A | 303 | Serine/threonine-protein kinase GCN2; translation | 100.0 | |
| 3sv0_A | 483 | Casein kinase I-like; typical kinase domain fold, | 100.0 | |
| 3e3p_A | 360 | Protein kinase, putative glycogen synthase kinase; | 100.0 | |
| 2pml_X | 348 | PFPK7, Ser/Thr protein kinase; phosphorylati trans | 100.0 | |
| 1z57_A | 339 | Dual specificity protein kinase CLK1; protein tyro | 100.0 | |
| 2j0j_A | 656 | Focal adhesion kinase 1; cell migration, FERM, tra | 100.0 | |
| 3cek_A | 313 | Dual specificity protein kinase TTK; HMPS1, PYT, E | 100.0 | |
| 3qyz_A | 364 | Mitogen-activated protein kinase 1; transferase, s | 100.0 | |
| 2vx3_A | 382 | Dual specificity tyrosine-phosphorylation- regula | 100.0 | |
| 2wei_A | 287 | Calmodulin-domain protein kinase 1, putative; nucl | 100.0 | |
| 3kvw_A | 429 | DYRK2, dual specificity tyrosine-phosphorylation-r | 100.0 | |
| 1blx_A | 326 | Cyclin-dependent kinase 6; inhibitor protein, cycl | 100.0 | |
| 3fhr_A | 336 | MAP kinase-activated protein kinase 3; kinase-inhi | 100.0 | |
| 2i6l_A | 320 | Mitogen-activated protein kinase 6; MAPK6, ERK3, e | 100.0 | |
| 2fst_X | 367 | Mitogen-activated protein kinase 14; active mutant | 100.0 | |
| 2y4i_B | 319 | KSR2, HKSR2, kinase suppressor of RAS 2; transfera | 100.0 | |
| 2b9h_A | 353 | MAP kinase FUS3, mitogen-activated protein kinase | 100.0 | |
| 4exu_A | 371 | Mitogen-activated protein kinase 13; P38 kinase, t | 100.0 | |
| 2rio_A | 434 | Serine/threonine-protein kinase/endoribonuclease I | 100.0 | |
| 3aln_A | 327 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 1q8y_A | 373 | SR protein kinase; transferase; HET: ADP ADE; 2.05 | 100.0 | |
| 3a99_A | 320 | Proto-oncogene serine/threonine-protein kinase PI; | 100.0 | |
| 2eu9_A | 355 | Dual specificity protein kinase CLK3; kinase domai | 100.0 | |
| 2iwi_A | 312 | Serine/threonine-protein kinase PIM-2; nucleotide- | 100.0 | |
| 2dyl_A | 318 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| 3coi_A | 353 | Mitogen-activated protein kinase 13; P38D, P38delt | 100.0 | |
| 3p23_A | 432 | Serine/threonine-protein kinase/endoribonuclease; | 100.0 | |
| 3qa8_A | 676 | MGC80376 protein; kinase ubiquitin-like domain, ph | 100.0 | |
| 2pzi_A | 681 | Probable serine/threonine-protein kinase PKNG; ATP | 100.0 | |
| 3m2w_A | 299 | MAP kinase-activated protein kinase 2; small molec | 100.0 | |
| 3uqc_A | 286 | Probable conserved transmembrane protein; structur | 100.0 | |
| 3dzo_A | 413 | Rhoptry kinase domain; parasitic disease, transfer | 100.0 | |
| 2vuw_A | 336 | Serine/threonine-protein kinase haspin; cell cycle | 100.0 | |
| 4azs_A | 569 | Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15 | 99.97 | |
| 3en9_A | 540 | Glycoprotease, O-sialoglycoprotein endopeptidase/p | 99.94 | |
| 1zar_A | 282 | RIO2 kinase; serine kinase, winged-helix, RIO doma | 99.9 | |
| 1zth_A | 258 | RIO1 serine protein kinase; ribosome biogenesis, r | 99.8 | |
| 4gyi_A | 397 | RIO2 kinase; protein kinase, ADP complex, phosphoa | 99.66 | |
| 3tm0_A | 263 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.33 | |
| 1nd4_A | 264 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.14 | |
| 3dxp_A | 359 | Putative acyl-COA dehydrogenase; protein kinase-li | 99.03 | |
| 3sg8_A | 304 | APH(2'')-ID; antibiotic resistance enzyme, transfe | 98.93 | |
| 3r70_A | 320 | Aminoglycoside phosphotransferase; structural geno | 98.59 | |
| 3d1u_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 98.47 | |
| 4gkh_A | 272 | Aminoglycoside 3'-phosphotransferase APHA1-IAB; py | 98.4 | |
| 3tdw_A | 306 | Gentamicin resistance protein; kinase, phosphoryl | 98.37 | |
| 3ovc_A | 362 | Hygromycin-B 4-O-kinase; aminoglycoside phosphotra | 98.25 | |
| 3ats_A | 357 | Putative uncharacterized protein; hypothetical pro | 98.07 | |
| 2q83_A | 346 | YTAA protein; 2635576, structural genomics, joint | 97.95 | |
| 3f7w_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 97.93 | |
| 2olc_A | 397 | MTR kinase, methylthioribose kinase; kinase ADP-2H | 97.89 | |
| 2pyw_A | 420 | Uncharacterized protein; 5-methylthioribose kinase | 97.78 | |
| 3jr1_A | 312 | Putative fructosamine-3-kinase; YP_719053.1, struc | 97.72 | |
| 2ppq_A | 322 | HSK, HK, homoserine kinase; structural genomics, M | 97.19 | |
| 2k1k_A | 38 | Ephrin type-A receptor 1; EPHA1, receptor tyrosine | 97.11 | |
| 2yle_A | 229 | Protein spire homolog 1; actin-binding protein, ac | 97.07 | |
| 3dxq_A | 301 | Choline/ethanolamine kinase family protein; NP_106 | 96.99 | |
| 2l2t_A | 44 | Receptor tyrosine-protein kinase ERBB-4; transmemb | 96.99 | |
| 3csv_A | 333 | Aminoglycoside phosphotransferase; YP_614837.1, ph | 96.97 | |
| 1zyl_A | 328 | Hypothetical protein YIHE; putative protein kinase | 96.92 | |
| 2jwa_A | 44 | Receptor tyrosine-protein kinase ERBB-2; transmemb | 96.86 | |
| 1nw1_A | 429 | Choline kinase (49.2 KD); phospholipid synthesis, | 96.72 | |
| 2ks1_B | 44 | Epidermal growth factor receptor; ERBB1, ERBB2, tr | 96.42 | |
| 3feg_A | 379 | Choline/ethanolamine kinase; non-protein kinase, c | 96.39 | |
| 2qg7_A | 458 | Ethanolamine kinase PV091845; malaria, SGC, struct | 96.23 | |
| 3c5i_A | 369 | Choline kinase; choline, kinase, malaria, transfer | 96.19 | |
| 3i1a_A | 339 | Spectinomycin phosphotransferase; protein kinase, | 96.06 | |
| 2l34_A | 33 | TYRO protein tyrosine kinase-binding protein; immu | 95.52 | |
| 3f2s_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 95.51 | |
| 2k9y_A | 41 | Ephrin type-A receptor 2; receptor tyrosine kinase | 94.9 | |
| 2l8s_A | 54 | Integrin alpha-1; transmembrane region, detergent | 94.87 | |
| 3mes_A | 424 | Choline kinase; malaria, structural genomics, stru | 93.93 | |
| 2knc_A | 54 | Integrin alpha-IIB; transmembrane signaling, prote | 93.77 | |
| 1iij_A | 35 | ERBB-2 receptor protein-tyrosine kinase; alpha-hel | 92.89 | |
| 2k1a_A | 42 | Integrin alpha-IIB; single-PASS transmembrane segm | 92.49 | |
| 4ann_A | 215 | ESSB; membrane protein, membrane secretion, ESS ty | 89.83 | |
| 1q55_A | 880 | EP-cadherin, C-cadherin; trans interaction, desmos | 89.16 | |
| 2knc_B | 79 | Integrin beta-3; transmembrane signaling, protein | 86.48 | |
| 4ano_A | 219 | ESSB; membrane protein, membrane secretion, ESS ty | 86.35 | |
| 2klu_A | 70 | T-cell surface glycoprotein CD4; cell membrane, di | 86.16 | |
| 2k9j_B | 43 | Integrin beta-3; transmembrane complex, cell adhes | 85.5 | |
| 2llm_A | 43 | Amyloid beta A4 protein; alzheimer'S disease, prot | 84.8 |
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-56 Score=445.32 Aligned_cols=262 Identities=26% Similarity=0.423 Sum_probs=208.1
Q ss_pred HhhCCcccceeEeeeCceEEEEEEEc------CCCEEEEEEEcccchhhHHHHHHHHHHHhcCCCCCceeEEEEEEeCce
Q 010519 183 IATNRFSAENVLGEGGYGVVYKGRLI------NGSEVAVKKLLNNLGQAEKEFRVEVEAIGHVRHKNLVRLLGYCIEGVH 256 (508)
Q Consensus 183 ~~~~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~ei~~l~~l~h~niv~~~~~~~~~~~ 256 (508)
+..++|.+.+.||+|+||+||+|++. ++..||||++........+.|.+|+++|++++|||||+++|+|.+...
T Consensus 38 i~~~d~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~ 117 (329)
T 4aoj_A 38 IKRRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRFFGVCTEGRP 117 (329)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESCCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSS
T ss_pred cCHHHeEEEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCE
Confidence 34467889999999999999999874 467899999987666667889999999999999999999999999999
Q ss_pred eeEEEeecCCCCHHHHHhhhhc-----------cCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCEEEcCC
Q 010519 257 RMLVYEYVNNGNLEQWLHGAMR-----------NQGNLTWEARMKVIIGTAKALAYLHEAIEPKVVHRDIKSSNILIDDE 325 (508)
Q Consensus 257 ~~lv~E~~~~gsL~~~l~~~~~-----------~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiH~Dlk~~NIll~~~ 325 (508)
.|||||||++|+|.++|+.... ...+++|..++.++.||+.||.|||++ +||||||||+||||+++
T Consensus 118 ~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~---~iiHRDLKp~NILl~~~ 194 (329)
T 4aoj_A 118 LLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGL---HFVHRDLATRNCLVGQG 194 (329)
T ss_dssp EEEEEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEETT
T ss_pred EEEEEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhcC---CeecccccHhhEEECCC
Confidence 9999999999999999975321 234699999999999999999999998 99999999999999999
Q ss_pred CcEEEEecCCccccCCCCC-cccccccccccccCccccCCCCCCChhhHHHHHHHHHHHHh-CCCCCCCCCCCchhcHHH
Q 010519 326 FNAKVSDFGLAKLLDSGES-HITTRVMGTFGYVAPEYANTGMLNEKSDIYSFGVLLLEAVT-GRDPVDYGRPANEVNLVE 403 (508)
Q Consensus 326 ~~~kl~Dfgla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~ellt-G~~Pf~~~~~~~~~~~~~ 403 (508)
+.+||+|||+++....... ......+||+.|||||++.+..|+.++|||||||+||||+| |+.||..... . +
T Consensus 195 ~~~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~~sDvwS~Gvvl~Ellt~G~~Pf~~~~~---~---~ 268 (329)
T 4aoj_A 195 LVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSN---T---E 268 (329)
T ss_dssp TEEEECCCC----------------CCCCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSSCH---H---H
T ss_pred CcEEEcccccceeccCCCcceecCcccccccccChhhhcCCCCCccccccchHHHHHHHHcCCCCCCCCCCH---H---H
Confidence 9999999999986643322 23445679999999999999999999999999999999999 8999964321 1 2
Q ss_pred HHHHHhcccccccccCCCCCCChhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhhcCC
Q 010519 404 WLKMMVGTRRAEEVVDPNLEVKPATRALKRSLLVALRCVDPDSEKRPKMSQVVRMLEADD 463 (508)
Q Consensus 404 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~ 463 (508)
.+........ +. .+...+..+.+|+.+||+.||.+||||.||+++|+...
T Consensus 269 ~~~~i~~g~~------~~----~p~~~~~~~~~li~~cl~~dP~~RPs~~ei~~~L~~l~ 318 (329)
T 4aoj_A 269 AIDCITQGRE------LE----RPRACPPEVYAIMRGCWQREPQQRHSIKDVHARLQALA 318 (329)
T ss_dssp HHHHHHHTCC------CC----CCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHHHHHHHH
T ss_pred HHHHHHcCCC------CC----CcccccHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHh
Confidence 2222221111 11 11123456677999999999999999999999998753
|
| >4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-56 Score=442.33 Aligned_cols=261 Identities=25% Similarity=0.428 Sum_probs=213.2
Q ss_pred HhhCCcccceeEeeeCceEEEEEEEc------CCCEEEEEEEcccchhhHHHHHHHHHHHhcCCCCCceeEEEEEEeCce
Q 010519 183 IATNRFSAENVLGEGGYGVVYKGRLI------NGSEVAVKKLLNNLGQAEKEFRVEVEAIGHVRHKNLVRLLGYCIEGVH 256 (508)
Q Consensus 183 ~~~~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~ei~~l~~l~h~niv~~~~~~~~~~~ 256 (508)
+..++|.+.+.||+|+||+||+|++. ++..||||++........++|.+|+++|++++|||||+++|+|.+++.
T Consensus 10 I~r~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~ 89 (299)
T 4asz_A 10 IKRHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDP 89 (299)
T ss_dssp CCGGGEEEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSS
T ss_pred cCHHHeEEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCCChHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCE
Confidence 34568999999999999999999874 367899999977666667889999999999999999999999999999
Q ss_pred eeEEEeecCCCCHHHHHhhhh---------ccCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCEEEcCCCc
Q 010519 257 RMLVYEYVNNGNLEQWLHGAM---------RNQGNLTWEARMKVIIGTAKALAYLHEAIEPKVVHRDIKSSNILIDDEFN 327 (508)
Q Consensus 257 ~~lv~E~~~~gsL~~~l~~~~---------~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiH~Dlk~~NIll~~~~~ 327 (508)
.+||||||++|+|.++|+... .....++|..++.++.||+.||.|||++ +|+||||||+||||++++.
T Consensus 90 ~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~---~iiHRDlKp~NILl~~~~~ 166 (299)
T 4asz_A 90 LIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLASQ---HFVHRDLATRNCLVGENLL 166 (299)
T ss_dssp EEEEEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGC
T ss_pred EEEEEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCccCHhhEEECCCCc
Confidence 999999999999999997531 1235799999999999999999999999 9999999999999999999
Q ss_pred EEEEecCCccccCCCCCc-ccccccccccccCccccCCCCCCChhhHHHHHHHHHHHHh-CCCCCCCCCCCchhcHHHHH
Q 010519 328 AKVSDFGLAKLLDSGESH-ITTRVMGTFGYVAPEYANTGMLNEKSDIYSFGVLLLEAVT-GRDPVDYGRPANEVNLVEWL 405 (508)
Q Consensus 328 ~kl~Dfgla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~ellt-G~~Pf~~~~~~~~~~~~~~~ 405 (508)
+||+|||+++........ ......||+.|||||++.+..|+.++|||||||+||||+| |+.||..... .+.+
T Consensus 167 ~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~k~DVwS~Gvvl~Ellt~G~~Pf~~~~~------~~~~ 240 (299)
T 4asz_A 167 VKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSN------NEVI 240 (299)
T ss_dssp EEECCCSCHHHHTGGGCEEETTTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCH------HHHH
T ss_pred EEECCcccceecCCCCceeecCceecChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCH------HHHH
Confidence 999999999866443222 2334579999999999999999999999999999999999 8999964321 1222
Q ss_pred HHHhcccccccccCCCCCCChhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhhcC
Q 010519 406 KMMVGTRRAEEVVDPNLEVKPATRALKRSLLVALRCVDPDSEKRPKMSQVVRMLEAD 462 (508)
Q Consensus 406 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~ 462 (508)
........ +. .+...+..+.+|+.+||+.||.+|||+.||++.|+..
T Consensus 241 ~~i~~~~~------~~----~p~~~~~~~~~li~~cl~~dP~~RPs~~~i~~~L~~~ 287 (299)
T 4asz_A 241 ECITQGRV------LQ----RPRTCPQEVYELMLGCWQREPHMRKNIKGIHTLLQNL 287 (299)
T ss_dssp HHHHHTCC------CC----CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred HHHHcCCC------CC----CCccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHH
Confidence 22221111 01 1112345677799999999999999999999999864
|
| >3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.6e-56 Score=436.55 Aligned_cols=267 Identities=28% Similarity=0.453 Sum_probs=208.0
Q ss_pred HHHhhCCcccceeEeeeCceEEEEEEEcCCCEEEEEEEccc--chhhHHHHHHHHHHHhcCCCCCceeEEEEEEeCceee
Q 010519 181 LEIATNRFSAENVLGEGGYGVVYKGRLINGSEVAVKKLLNN--LGQAEKEFRVEVEAIGHVRHKNLVRLLGYCIEGVHRM 258 (508)
Q Consensus 181 ~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~--~~~~~~~~~~ei~~l~~l~h~niv~~~~~~~~~~~~~ 258 (508)
|++..++|.+.+.||+|+||+||+|++. ..||||++... .....+.|.+|+.+|++++|||||++++++.+ +..+
T Consensus 31 Wei~~~~l~l~~~iG~G~fG~Vy~~~~~--~~vAvK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~-~~~~ 107 (307)
T 3omv_A 31 WEIEASEVMLSTRIGSGSFGTVYKGKWH--GDVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTK-DNLA 107 (307)
T ss_dssp CBCCTTSCCEEEECCCCSSSEEEEEESS--SEEEEEECCCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCE
T ss_pred cEEcHHHeEEeeEEeeCCCcEEEEEEEC--CcEEEEEEEecCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEC-CeEE
Confidence 4677789999999999999999999863 36999988533 23445789999999999999999999998754 5689
Q ss_pred EEEeecCCCCHHHHHhhhhccCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCEEEcCCCcEEEEecCCccc
Q 010519 259 LVYEYVNNGNLEQWLHGAMRNQGNLTWEARMKVIIGTAKALAYLHEAIEPKVVHRDIKSSNILIDDEFNAKVSDFGLAKL 338 (508)
Q Consensus 259 lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~Dfgla~~ 338 (508)
||||||++|+|.++|+ .....+++..++.|+.|||.||+|||++ +||||||||+||||++++.+||+|||+|+.
T Consensus 108 iVmEy~~gGsL~~~l~---~~~~~l~~~~~~~i~~qia~gL~yLH~~---~IiHRDlKp~NILl~~~~~~Ki~DFGla~~ 181 (307)
T 3omv_A 108 IVTQWCEGSSLYKHLH---VQETKFQMFQLIDIARQTAQGMDYLHAK---NIIHRDMKSNNIFLHEGLTVKIGDFGLATV 181 (307)
T ss_dssp EEEECCSSCBHHHHHH---TSCCCCCHHHHHHHHHHHHHHHHHHHHT---TCBCSCCCSSSEEEETTEEEEECCCSSCBC
T ss_pred EEEEcCCCCCHHHHHh---hcCCCCCHHHHHHHHHHHHHHHHHHHHC---CccCCccCHHHEEECCCCcEEEeeccCcee
Confidence 9999999999999996 3456799999999999999999999998 999999999999999999999999999986
Q ss_pred cCCCC-CcccccccccccccCccccCC---CCCCChhhHHHHHHHHHHHHhCCCCCCCCCCCchhcHHHHHHHHhccccc
Q 010519 339 LDSGE-SHITTRVMGTFGYVAPEYANT---GMLNEKSDIYSFGVLLLEAVTGRDPVDYGRPANEVNLVEWLKMMVGTRRA 414 (508)
Q Consensus 339 ~~~~~-~~~~~~~~gt~~y~aPE~~~~---~~~~~~~DvwS~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~ 414 (508)
..... .......+||+.|||||++.+ +.|+.++|||||||+||||+||+.||....... .+........
T Consensus 182 ~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~~Pf~~~~~~~------~~~~~~~~~~- 254 (307)
T 3omv_A 182 KSRWSGSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRD------QIIFMVGRGY- 254 (307)
T ss_dssp ------------CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHH------HHHHHHHTTC-
T ss_pred cccCCcceeecccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHHCCCCCCCCChHH------HHHHHHhcCC-
Confidence 64322 223455689999999999853 468999999999999999999999996433211 1111111111
Q ss_pred ccccCCCCCCChhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhhcCCCCCc
Q 010519 415 EEVVDPNLEVKPATRALKRSLLVALRCVDPDSEKRPKMSQVVRMLEADDYPFR 467 (508)
Q Consensus 415 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~~~ 467 (508)
..+.+. ......+..+.+|+.+||+.||.+||||.||+++|+....++.
T Consensus 255 ---~~p~~~-~~~~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~Le~l~~~lp 303 (307)
T 3omv_A 255 ---ASPDLS-KLYKNCPKAMKRLVADCVKKVKEERPLFPQILSSIELLQHSLP 303 (307)
T ss_dssp ---CCCCST-TSCTTSCHHHHHHHHHHTCSSSTTSCCHHHHHHHHHHHHTTCC
T ss_pred ---CCCCcc-cccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhccCC
Confidence 111111 1111234556679999999999999999999999987655543
|
| >4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-56 Score=439.98 Aligned_cols=261 Identities=25% Similarity=0.407 Sum_probs=211.7
Q ss_pred hhCCcccceeEeeeCceEEEEEEEc------CCCEEEEEEEcccc-hhhHHHHHHHHHHHhcCCCCCceeEEEEEEeCce
Q 010519 184 ATNRFSAENVLGEGGYGVVYKGRLI------NGSEVAVKKLLNNL-GQAEKEFRVEVEAIGHVRHKNLVRLLGYCIEGVH 256 (508)
Q Consensus 184 ~~~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~-~~~~~~~~~ei~~l~~l~h~niv~~~~~~~~~~~ 256 (508)
..+++.+.+.||+|+||+||+|++. +++.||||++.... ....++|.+|+.+|++++|||||+++|+|.++..
T Consensus 24 ~~~~~~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~~~~ 103 (308)
T 4gt4_A 24 SLSAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVCLLGVVTKDQP 103 (308)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEEC-------CEEEEEEECCC-CCC-CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred CHHHCeEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECcccChHHHHHHHHHHHHHHhCCCCCCCCcceEEEECCE
Confidence 3456778899999999999999863 46789999986543 3345789999999999999999999999999999
Q ss_pred eeEEEeecCCCCHHHHHhhhh------------ccCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCEEEcC
Q 010519 257 RMLVYEYVNNGNLEQWLHGAM------------RNQGNLTWEARMKVIIGTAKALAYLHEAIEPKVVHRDIKSSNILIDD 324 (508)
Q Consensus 257 ~~lv~E~~~~gsL~~~l~~~~------------~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiH~Dlk~~NIll~~ 324 (508)
.+||||||++|+|.++|+... .....+++..++.++.|||.||.|||++ +||||||||+||||++
T Consensus 104 ~~lV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~---~iiHRDLK~~NILl~~ 180 (308)
T 4gt4_A 104 LSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSH---HVVHKDLATRNVLVYD 180 (308)
T ss_dssp CEEEEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECG
T ss_pred EEEEEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhC---CCCCCCccccceEECC
Confidence 999999999999999996431 1134689999999999999999999999 9999999999999999
Q ss_pred CCcEEEEecCCccccCCCC-CcccccccccccccCccccCCCCCCChhhHHHHHHHHHHHHh-CCCCCCCCCCCchhcHH
Q 010519 325 EFNAKVSDFGLAKLLDSGE-SHITTRVMGTFGYVAPEYANTGMLNEKSDIYSFGVLLLEAVT-GRDPVDYGRPANEVNLV 402 (508)
Q Consensus 325 ~~~~kl~Dfgla~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~ellt-G~~Pf~~~~~~~~~~~~ 402 (508)
++.+||+|||+++...... ....+..+||+.|||||++.++.|+.++|||||||+||||+| |..||.... ..
T Consensus 181 ~~~~Ki~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~~s~ksDVwSfGvvl~El~t~g~~Pf~~~~---~~--- 254 (308)
T 4gt4_A 181 KLNVKISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYS---NQ--- 254 (308)
T ss_dssp GGCEEECCSCCBCGGGGGGCBCSSSSSCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTCC---HH---
T ss_pred CCCEEECCcccceeccCCCceeEecccccCCcccCHHHHhCCCCCccchhhhHHHHHHHHHhCCCCCCCCCC---HH---
Confidence 9999999999998664322 223455689999999999999999999999999999999998 899996432 11
Q ss_pred HHHHHHhcccccccccCCCCCCChhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhhcCC
Q 010519 403 EWLKMMVGTRRAEEVVDPNLEVKPATRALKRSLLVALRCVDPDSEKRPKMSQVVRMLEADD 463 (508)
Q Consensus 403 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~ 463 (508)
+.+........ .+.+...+..+.+|+.+||+.||.+||||.||+++|++..
T Consensus 255 ~~~~~i~~~~~----------~~~p~~~~~~~~~li~~C~~~dP~~RPs~~ei~~~L~a~~ 305 (308)
T 4gt4_A 255 DVVEMIRNRQV----------LPCPDDCPAWVYALMIECWNEFPSRRPRFKDIHSRLRAWG 305 (308)
T ss_dssp HHHHHHHTTCC----------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSC
T ss_pred HHHHHHHcCCC----------CCCcccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHhcc
Confidence 22222221111 1112223456777999999999999999999999999754
|
| >4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-55 Score=439.98 Aligned_cols=252 Identities=25% Similarity=0.334 Sum_probs=210.7
Q ss_pred CCcccceeEeeeCceEEEEEEEc-CCCEEEEEEEcccchhhHHHHHHHHHHHhcCCCCCceeEEEEEEeCceeeEEEeec
Q 010519 186 NRFSAENVLGEGGYGVVYKGRLI-NGSEVAVKKLLNNLGQAEKEFRVEVEAIGHVRHKNLVRLLGYCIEGVHRMLVYEYV 264 (508)
Q Consensus 186 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~ei~~l~~l~h~niv~~~~~~~~~~~~~lv~E~~ 264 (508)
+.|++.+.||+|+||+||+|++. +|+.||||++........+.+.+|+.+|+.++|||||+++++|.+++.+|||||||
T Consensus 74 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~ivmEy~ 153 (346)
T 4fih_A 74 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFL 153 (346)
T ss_dssp GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCSSGGGGHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEECCC
T ss_pred HhcEEeEEeecCcCeEEEEEEECCCCCEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeCC
Confidence 56999999999999999999986 68999999996555444566888999999999999999999999999999999999
Q ss_pred CCCCHHHHHhhhhccCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCEEEcCCCcEEEEecCCccccCCCCC
Q 010519 265 NNGNLEQWLHGAMRNQGNLTWEARMKVIIGTAKALAYLHEAIEPKVVHRDIKSSNILIDDEFNAKVSDFGLAKLLDSGES 344 (508)
Q Consensus 265 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~ 344 (508)
+||+|.+++.. ..+++..++.++.||+.||.|||++ +||||||||+||||+.++.+||+|||+|+.+.....
T Consensus 154 ~gg~L~~~l~~-----~~l~e~~~~~~~~qi~~aL~ylH~~---~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~~ 225 (346)
T 4fih_A 154 EGGALTDIVTH-----TRMNEEQIAAVCLAVLQALSVLHAQ---GVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVP 225 (346)
T ss_dssp TTEEHHHHHHH-----SCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTTCEECCSSSC
T ss_pred CCCcHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHHC---CcccccCCHHHEEECCCCCEEEecCcCceecCCCCC
Confidence 99999998852 4699999999999999999999999 999999999999999999999999999997754332
Q ss_pred cccccccccccccCccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCCCchhcHHHHHHHHhcccccccccCCCCCC
Q 010519 345 HITTRVMGTFGYVAPEYANTGMLNEKSDIYSFGVLLLEAVTGRDPVDYGRPANEVNLVEWLKMMVGTRRAEEVVDPNLEV 424 (508)
Q Consensus 345 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 424 (508)
.....+||+.|||||++.+..|+.++|||||||+||||++|+.||.... .. +.+....... .+.+
T Consensus 226 -~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~---~~---~~~~~i~~~~------~~~~-- 290 (346)
T 4fih_A 226 -RRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEP---PL---KAMKMIRDNL------PPRL-- 290 (346)
T ss_dssp -CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSC---HH---HHHHHHHHSS------CCCC--
T ss_pred -cccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcC---HH---HHHHHHHcCC------CCCC--
Confidence 3456789999999999999999999999999999999999999996432 11 2222221111 1111
Q ss_pred ChhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhh
Q 010519 425 KPATRALKRSLLVALRCVDPDSEKRPKMSQVVRMLE 460 (508)
Q Consensus 425 ~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 460 (508)
.........+.+|+.+||..||.+|||+.|+++|-+
T Consensus 291 ~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~l~Hp~ 326 (346)
T 4fih_A 291 KNLHKVSPSLKGFLDRLLVRDPAQRATAAELLKHPF 326 (346)
T ss_dssp SCGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTCGG
T ss_pred CccccCCHHHHHHHHHHcCCChhHCcCHHHHhcCHh
Confidence 112233456677999999999999999999998643
|
| >4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-55 Score=440.10 Aligned_cols=251 Identities=22% Similarity=0.378 Sum_probs=203.2
Q ss_pred CCcccceeEeeeCceEEEEEEEc-CCCEEEEEEEcccc--hhhHHHHHHHHHHHhcCCCCCceeEEEEEEeCceeeEEEe
Q 010519 186 NRFSAENVLGEGGYGVVYKGRLI-NGSEVAVKKLLNNL--GQAEKEFRVEVEAIGHVRHKNLVRLLGYCIEGVHRMLVYE 262 (508)
Q Consensus 186 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~ei~~l~~l~h~niv~~~~~~~~~~~~~lv~E 262 (508)
++|++++.||+|+||+||+|++. +|+.||||++.... ....+.+.+|+.+|++++|||||++++++.++...|||||
T Consensus 24 e~Y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~yiVmE 103 (350)
T 4b9d_A 24 EKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRESFEENGSLYIVMD 103 (350)
T ss_dssp CCEEEEEEC------CEEEEEETTTCCEEEEEEEECTTSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred cceEEeEEEecCCCeEEEEEEECCCCCEEEEEEEehHHCCHHHHHHHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEe
Confidence 58999999999999999999975 68999999986442 3345678999999999999999999999999999999999
Q ss_pred ecCCCCHHHHHhhhhccCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCEEEcCCCcEEEEecCCccccCCC
Q 010519 263 YVNNGNLEQWLHGAMRNQGNLTWEARMKVIIGTAKALAYLHEAIEPKVVHRDIKSSNILIDDEFNAKVSDFGLAKLLDSG 342 (508)
Q Consensus 263 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~~ 342 (508)
||+||+|.++|.. .....+++..++.++.||+.||.|||++ +|+||||||+||||+.++.+||+|||+++.....
T Consensus 104 y~~gg~L~~~i~~--~~~~~~~e~~~~~~~~qi~~aL~ylH~~---~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~ 178 (350)
T 4b9d_A 104 YCEGGDLFKRINA--QKGVLFQEDQILDWFVQICLALKHVHDR---KILHRDIKSQNIFLTKDGTVQLGDFGIARVLNST 178 (350)
T ss_dssp CCTTCBHHHHHHH--TTTCCCCHHHHHHHHHHHHHHHHHHHHT---TCEETTCCGGGEEECTTCCEEECSTTEESCCCHH
T ss_pred CCCCCcHHHHHHH--cCCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCCHHHEEECCCCCEEEcccccceeecCC
Confidence 9999999999964 3445678999999999999999999999 9999999999999999999999999999876432
Q ss_pred CCcccccccccccccCccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCCCchhcHHHHHHHHhcccccccccCCCC
Q 010519 343 ESHITTRVMGTFGYVAPEYANTGMLNEKSDIYSFGVLLLEAVTGRDPVDYGRPANEVNLVEWLKMMVGTRRAEEVVDPNL 422 (508)
Q Consensus 343 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 422 (508)
. ......+||+.|||||++.+..|+.++|||||||+||||++|+.||.... ..+.+........ +.+
T Consensus 179 ~-~~~~~~~GT~~YmAPE~l~~~~y~~~~DiwSlGvilyemltG~~PF~~~~------~~~~~~~i~~~~~------~~~ 245 (350)
T 4b9d_A 179 V-ELARACIGTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKHAFEAGS------MKNLVLKIISGSF------PPV 245 (350)
T ss_dssp H-HHHHHHHSCCTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSS------HHHHHHHHHHTCC------CCC
T ss_pred c-ccccccCCCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcC------HHHHHHHHHcCCC------CCC
Confidence 1 12345689999999999999999999999999999999999999996432 1222222221111 111
Q ss_pred CCChhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 010519 423 EVKPATRALKRSLLVALRCVDPDSEKRPKMSQVVRM 458 (508)
Q Consensus 423 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 458 (508)
. ......+.+|+.+||+.||.+|||+.|+++|
T Consensus 246 ~----~~~s~~~~~li~~~L~~dP~~R~s~~e~l~h 277 (350)
T 4b9d_A 246 S----LHYSYDLRSLVSQLFKRNPRDRPSVNSILEK 277 (350)
T ss_dssp C----TTSCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred C----ccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 1 1123456779999999999999999999986
|
| >4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-55 Score=432.87 Aligned_cols=250 Identities=22% Similarity=0.354 Sum_probs=208.2
Q ss_pred CCcccceeEeeeCceEEEEEEEc-CCCEEEEEEEcccc---hhhHHHHHHHHHHHhcCCCCCceeEEEEEEeCceeeEEE
Q 010519 186 NRFSAENVLGEGGYGVVYKGRLI-NGSEVAVKKLLNNL---GQAEKEFRVEVEAIGHVRHKNLVRLLGYCIEGVHRMLVY 261 (508)
Q Consensus 186 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~ei~~l~~l~h~niv~~~~~~~~~~~~~lv~ 261 (508)
++|++.+.||+|+||+||+|++. +|+.||||++.... ....+.+.+|+++|++++|||||++++++++++..||||
T Consensus 32 ~dy~i~~~lG~G~fg~V~~a~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~yivm 111 (311)
T 4aw0_A 32 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGL 111 (311)
T ss_dssp GGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cccEEEEEEecccCeEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence 57999999999999999999975 68999999986432 233467889999999999999999999999999999999
Q ss_pred eecCCCCHHHHHhhhhccCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCEEEcCCCcEEEEecCCccccCC
Q 010519 262 EYVNNGNLEQWLHGAMRNQGNLTWEARMKVIIGTAKALAYLHEAIEPKVVHRDIKSSNILIDDEFNAKVSDFGLAKLLDS 341 (508)
Q Consensus 262 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~ 341 (508)
|||+||+|.++|. ..+.+++..+..++.||+.||.|||++ +|+||||||+||||+.++++||+|||+|+.+..
T Consensus 112 Ey~~gG~L~~~i~----~~~~l~e~~~~~~~~qi~~al~ylH~~---~IiHRDlKPeNILl~~~g~vKl~DFGla~~~~~ 184 (311)
T 4aw0_A 112 SYAKNGELLKYIR----KIGSFDETCTRFYTAEIVSALEYLHGK---GIIHRDLKPENILLNEDMHIQITDFGTAKVLSP 184 (311)
T ss_dssp CCCTTEEHHHHHH----HHSSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEECCCTTCEECCT
T ss_pred ecCCCCCHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCCHHHeEEcCCCCEEEEEcCCceecCC
Confidence 9999999999995 456799999999999999999999999 999999999999999999999999999997754
Q ss_pred CC-CcccccccccccccCccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCCCchhcHHHHHHHHhcccccccccCC
Q 010519 342 GE-SHITTRVMGTFGYVAPEYANTGMLNEKSDIYSFGVLLLEAVTGRDPVDYGRPANEVNLVEWLKMMVGTRRAEEVVDP 420 (508)
Q Consensus 342 ~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 420 (508)
.. .......+||+.|||||++.+..|+.++|||||||+||||++|+.||.... .. +.+....... .
T Consensus 185 ~~~~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~---~~---~~~~~i~~~~-------~ 251 (311)
T 4aw0_A 185 ESKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGN---EG---LIFAKIIKLE-------Y 251 (311)
T ss_dssp TTTCCCBCCCCSCGGGCCHHHHHHSCBCHHHHHHHHHHHHHHHHHSSCSSCCSS---HH---HHHHHHHHTC-------C
T ss_pred CCCcccccCcccCcccCCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC---HH---HHHHHHHcCC-------C
Confidence 32 233556789999999999999999999999999999999999999996432 11 2222222111 0
Q ss_pred CCCCChhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHh
Q 010519 421 NLEVKPATRALKRSLLVALRCVDPDSEKRPKMSQVVRML 459 (508)
Q Consensus 421 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L 459 (508)
.+. ......+.+|+.+||.+||.+|||++|++.+-
T Consensus 252 ~~p----~~~s~~~~dli~~lL~~dp~~R~t~~e~~~~~ 286 (311)
T 4aw0_A 252 DFP----EKFFPKARDLVEKLLVLDATKRLGCEEMEGYG 286 (311)
T ss_dssp CCC----TTCCHHHHHHHHHHSCSSGGGSTTSGGGTCHH
T ss_pred CCC----cccCHHHHHHHHHHccCCHhHCcChHHHcCCH
Confidence 111 11234567799999999999999999975443
|
| >3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-54 Score=420.26 Aligned_cols=250 Identities=24% Similarity=0.369 Sum_probs=199.5
Q ss_pred cccceeEeeeCceEEEEEEEc-CCCEEEEEEEcccc--hhhHHHHHHHHHHHhcCCCCCceeEEEEEEe----CceeeEE
Q 010519 188 FSAENVLGEGGYGVVYKGRLI-NGSEVAVKKLLNNL--GQAEKEFRVEVEAIGHVRHKNLVRLLGYCIE----GVHRMLV 260 (508)
Q Consensus 188 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~ei~~l~~l~h~niv~~~~~~~~----~~~~~lv 260 (508)
|.+.+.||+|+||+||+|.+. ++..||+|++.... ....+.|.+|+.+|++++|||||+++++|.+ +...|||
T Consensus 28 ~~~~~~iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~lv 107 (290)
T 3fpq_A 28 LKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLV 107 (290)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEETTEEEEEEE
T ss_pred EEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEeeccCCCcEEEEE
Confidence 366788999999999999885 68899999986433 3345678999999999999999999999875 3557899
Q ss_pred EeecCCCCHHHHHhhhhccCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCEEEc-CCCcEEEEecCCcccc
Q 010519 261 YEYVNNGNLEQWLHGAMRNQGNLTWEARMKVIIGTAKALAYLHEAIEPKVVHRDIKSSNILID-DEFNAKVSDFGLAKLL 339 (508)
Q Consensus 261 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiH~Dlk~~NIll~-~~~~~kl~Dfgla~~~ 339 (508)
||||++|+|.++|. ....+++..+..++.||+.||+|||++ .++|+||||||+||||+ .++.+||+|||+|+..
T Consensus 108 mEy~~gg~L~~~l~----~~~~l~~~~~~~~~~qi~~aL~ylH~~-~~~IiHRDlKp~NILl~~~~g~vKl~DFGla~~~ 182 (290)
T 3fpq_A 108 TELMTSGTLKTYLK----RFKVMKIKVLRSWCRQILKGLQFLHTR-TPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLK 182 (290)
T ss_dssp EECCCSCBHHHHHH----HHSSCCHHHHHHHHHHHHHHHHHHHTS-SSCCCCCCCCGGGEEESSTTSCEEECCTTGGGGC
T ss_pred EeCCCCCCHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHHC-CCCEEecccChhheeEECCCCCEEEEeCcCCEeC
Confidence 99999999999995 346799999999999999999999997 22399999999999998 4799999999999865
Q ss_pred CCCCCcccccccccccccCccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCCCchhcHHHHHHHHhcccccccccC
Q 010519 340 DSGESHITTRVMGTFGYVAPEYANTGMLNEKSDIYSFGVLLLEAVTGRDPVDYGRPANEVNLVEWLKMMVGTRRAEEVVD 419 (508)
Q Consensus 340 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 419 (508)
... .....+||+.|||||++.+ .|+.++|||||||+||||+||+.||..... .............
T Consensus 183 ~~~---~~~~~~GTp~YmAPE~~~~-~y~~~~DiwSlGvilyelltg~~Pf~~~~~-----~~~~~~~i~~~~~------ 247 (290)
T 3fpq_A 183 RAS---FAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQN-----AAQIYRRVTSGVK------ 247 (290)
T ss_dssp CTT---SBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSS-----HHHHHHHHTTTCC------
T ss_pred CCC---ccCCcccCccccCHHHcCC-CCCcHHHHHHHHHHHHHHHHCCCCCCCCCc-----HHHHHHHHHcCCC------
Confidence 432 3455789999999999876 699999999999999999999999964322 1122222221111
Q ss_pred CCCCCChhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhh
Q 010519 420 PNLEVKPATRALKRSLLVALRCVDPDSEKRPKMSQVVRMLE 460 (508)
Q Consensus 420 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 460 (508)
....+......+.+|+.+||+.||.+|||+.|+++|-+
T Consensus 248 ---~~~~~~~~~~~~~~li~~~L~~dP~~R~s~~e~l~Hp~ 285 (290)
T 3fpq_A 248 ---PASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLNHAF 285 (290)
T ss_dssp ---CGGGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGG
T ss_pred ---CCCCCccCCHHHHHHHHHHccCChhHCcCHHHHhcCcc
Confidence 00111112335667999999999999999999998643
|
| >4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-54 Score=440.47 Aligned_cols=253 Identities=25% Similarity=0.333 Sum_probs=210.7
Q ss_pred hCCcccceeEeeeCceEEEEEEEc-CCCEEEEEEEcccchhhHHHHHHHHHHHhcCCCCCceeEEEEEEeCceeeEEEee
Q 010519 185 TNRFSAENVLGEGGYGVVYKGRLI-NGSEVAVKKLLNNLGQAEKEFRVEVEAIGHVRHKNLVRLLGYCIEGVHRMLVYEY 263 (508)
Q Consensus 185 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~ei~~l~~l~h~niv~~~~~~~~~~~~~lv~E~ 263 (508)
.+.|++.+.||+|+||+||+|++. +|+.||||++........+.+.+|+.+|+.++|||||+++++|.+++.+||||||
T Consensus 150 ~~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~iVmEy 229 (423)
T 4fie_A 150 RSYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEF 229 (423)
T ss_dssp GGTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEESTTCSSGGGHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred hHhcEeeeEeccCcCcEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHhCCCCCCCceEEEEEECCEEEEEEeC
Confidence 357999999999999999999985 6899999999765545556788999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhhhhccCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCEEEcCCCcEEEEecCCccccCCCC
Q 010519 264 VNNGNLEQWLHGAMRNQGNLTWEARMKVIIGTAKALAYLHEAIEPKVVHRDIKSSNILIDDEFNAKVSDFGLAKLLDSGE 343 (508)
Q Consensus 264 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~~~ 343 (508)
|+||+|.+++. ...+++..+..++.||+.||.|||++ +||||||||+||||+.+|.+||+|||+|+.+....
T Consensus 230 ~~gG~L~~~i~-----~~~l~e~~~~~~~~qil~aL~ylH~~---~IiHRDiKp~NILl~~~g~vKl~DFGla~~~~~~~ 301 (423)
T 4fie_A 230 LEGGALTDIVT-----HTRMNEEQIAAVCLAVLQALSVLHAQ---GVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEV 301 (423)
T ss_dssp CTTEEHHHHHH-----HSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSTTTEEECTTCCEEECCCTTCEECCSSC
T ss_pred CCCCcHHHHHh-----ccCCCHHHHHHHHHHHHHHHHHHHHC---CeecccCCHHHEEEcCCCCEEEecCccceECCCCC
Confidence 99999999884 24589999999999999999999999 99999999999999999999999999998765433
Q ss_pred CcccccccccccccCccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCCCchhcHHHHHHHHhcccccccccCCCCC
Q 010519 344 SHITTRVMGTFGYVAPEYANTGMLNEKSDIYSFGVLLLEAVTGRDPVDYGRPANEVNLVEWLKMMVGTRRAEEVVDPNLE 423 (508)
Q Consensus 344 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 423 (508)
. .....+||+.|||||++.+..|+.++|||||||+||||++|+.||.... .. +.+....... .+.+.
T Consensus 302 ~-~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~---~~---~~~~~i~~~~------~~~~~ 368 (423)
T 4fie_A 302 P-RRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEP---PL---KAMKMIRDNL------PPRLK 368 (423)
T ss_dssp C-CBCCCEECTTTCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSC---HH---HHHHHHHHSC------CCCCS
T ss_pred c-cccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcC---HH---HHHHHHHcCC------CCCCc
Confidence 2 3456789999999999999999999999999999999999999996432 12 2222221111 11111
Q ss_pred CChhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhh
Q 010519 424 VKPATRALKRSLLVALRCVDPDSEKRPKMSQVVRMLE 460 (508)
Q Consensus 424 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 460 (508)
........+.+|+.+||..||.+|||+.|+|+|-+
T Consensus 369 --~~~~~s~~~~dli~~~L~~dP~~R~ta~ell~Hp~ 403 (423)
T 4fie_A 369 --NLHKVSPSLKGFLDRLLVRDPAQRATAAELLKHPF 403 (423)
T ss_dssp --CTTSSCHHHHHHHHHHSCSSTTTSCCHHHHTTCGG
T ss_pred --ccccCCHHHHHHHHHHcCCChhHCcCHHHHhcCHH
Confidence 11122345667999999999999999999998643
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-54 Score=427.30 Aligned_cols=251 Identities=21% Similarity=0.241 Sum_probs=203.0
Q ss_pred hCCcccceeEeeeCceEEEEEEEc-CCCEEEEEEEcccchhhHHHHHHHHHHHhcCCCCCceeEEEEEEeCceeeEEEee
Q 010519 185 TNRFSAENVLGEGGYGVVYKGRLI-NGSEVAVKKLLNNLGQAEKEFRVEVEAIGHVRHKNLVRLLGYCIEGVHRMLVYEY 263 (508)
Q Consensus 185 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~ei~~l~~l~h~niv~~~~~~~~~~~~~lv~E~ 263 (508)
.+.|.+.++||+|+||+||+|++. +|+.||||++..... ..+|+.+|+.++|||||++++++.++...||||||
T Consensus 57 ~~~~~~~~~lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~~~-----~~~E~~il~~l~HpnIV~l~~~~~~~~~~~ivmEy 131 (336)
T 4g3f_A 57 VHWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVF-----RVEELVACAGLSSPRIVPLYGAVREGPWVNIFMEL 131 (336)
T ss_dssp TTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTC-----CTHHHHTTTTCCCTTBCCEEEEEEETTEEEEEECC
T ss_pred hhheEeCcEeccCCCeEEEEEEECCCCCEEEEEEECHHHh-----HHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEec
Confidence 356888999999999999999985 689999999865422 23599999999999999999999999999999999
Q ss_pred cCCCCHHHHHhhhhccCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCEEEcCCC-cEEEEecCCccccCCC
Q 010519 264 VNNGNLEQWLHGAMRNQGNLTWEARMKVIIGTAKALAYLHEAIEPKVVHRDIKSSNILIDDEF-NAKVSDFGLAKLLDSG 342 (508)
Q Consensus 264 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiH~Dlk~~NIll~~~~-~~kl~Dfgla~~~~~~ 342 (508)
|+||+|.++|. ..+.+++..++.++.||+.||.|||++ +||||||||+||||+.++ ++||+|||+|+.+...
T Consensus 132 ~~gg~L~~~l~----~~~~l~e~~~~~~~~qi~~aL~ylH~~---~IiHRDlKp~NILl~~~g~~vKl~DFGla~~~~~~ 204 (336)
T 4g3f_A 132 LEGGSLGQLIK----QMGCLPEDRALYYLGQALEGLEYLHTR---RILHGDVKADNVLLSSDGSRAALCDFGHALCLQPD 204 (336)
T ss_dssp CTTCBHHHHHH----HHSSCCHHHHHHHHHHHHHHHHHHHTT---TEECSCCCGGGEEECTTSCCEEECCCTTCEEC---
T ss_pred cCCCcHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHHC---CceecccCHHHEEEeCCCCEEEEeeCCCCeEccCC
Confidence 99999999995 346799999999999999999999999 999999999999999988 6999999999876543
Q ss_pred CCc----ccccccccccccCccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCCCchhcHHHHHHHHhccccccccc
Q 010519 343 ESH----ITTRVMGTFGYVAPEYANTGMLNEKSDIYSFGVLLLEAVTGRDPVDYGRPANEVNLVEWLKMMVGTRRAEEVV 418 (508)
Q Consensus 343 ~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 418 (508)
... .....+||+.|||||++.+..|+.++|||||||+||||++|+.||......... ..+ .........
T Consensus 205 ~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~---~~i--~~~~~~~~~-- 277 (336)
T 4g3f_A 205 GLGKSLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPWTQYFRGPLC---LKI--ASEPPPIRE-- 277 (336)
T ss_dssp ---------CCCCCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSTTTCCSCCH---HHH--HHSCCGGGG--
T ss_pred CcccceecCCccccCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHH---HHH--HcCCCCchh--
Confidence 211 123467999999999999999999999999999999999999999754332211 111 111111100
Q ss_pred CCCCCCChhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhhc
Q 010519 419 DPNLEVKPATRALKRSLLVALRCVDPDSEKRPKMSQVVRMLEA 461 (508)
Q Consensus 419 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~ 461 (508)
.+......+.+|+.+||+.||.+|||+.|++++|..
T Consensus 278 -------~~~~~s~~~~~li~~~L~~dP~~R~sa~el~~~l~~ 313 (336)
T 4g3f_A 278 -------IPPSCAPLTAQAIQEGLRKEPVHRASAMELRRKVGK 313 (336)
T ss_dssp -------SCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred -------cCccCCHHHHHHHHHHccCCHhHCcCHHHHHHHHHH
Confidence 011223456679999999999999999999998864
|
| >4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-54 Score=433.38 Aligned_cols=268 Identities=26% Similarity=0.386 Sum_probs=216.8
Q ss_pred eHHHHHHhhCCcccceeEeeeCceEEEEEEEcC------CCEEEEEEEcccch-hhHHHHHHHHHHHhcCCC-CCceeEE
Q 010519 177 TLRDLEIATNRFSAENVLGEGGYGVVYKGRLIN------GSEVAVKKLLNNLG-QAEKEFRVEVEAIGHVRH-KNLVRLL 248 (508)
Q Consensus 177 ~~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~------~~~vavK~~~~~~~-~~~~~~~~ei~~l~~l~h-~niv~~~ 248 (508)
...+|++..++|++.+.||+|+||+||+|++.. ++.||||++..... ...+.|.+|+.+|.+++| ||||+++
T Consensus 55 ~~~~wEi~~~~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~~~~~~~~~~~E~~il~~l~hhpnIV~l~ 134 (353)
T 4ase_A 55 DASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLL 134 (353)
T ss_dssp CHHHHBCCGGGEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred CCcccEecHHHeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEccccChHHHHHHHHHHHHHHHcCCCCcEEEEE
Confidence 457789999999999999999999999998753 25799999865543 344678999999999965 8999999
Q ss_pred EEEEeC-ceeeEEEeecCCCCHHHHHhhhhc------------cCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEeecC
Q 010519 249 GYCIEG-VHRMLVYEYVNNGNLEQWLHGAMR------------NQGNLTWEARMKVIIGTAKALAYLHEAIEPKVVHRDI 315 (508)
Q Consensus 249 ~~~~~~-~~~~lv~E~~~~gsL~~~l~~~~~------------~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiH~Dl 315 (508)
|+|.+. ..++||||||++|+|.++|+.... ....+++..++.++.|||.||.|||++ +||||||
T Consensus 135 g~~~~~~~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~~---~iiHRDL 211 (353)
T 4ase_A 135 GACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR---KCIHRDL 211 (353)
T ss_dssp EEECCTTSCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHHT---TCCCSCC
T ss_pred EEEEecCCEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhhC---CeecCcc
Confidence 999764 568999999999999999975322 134589999999999999999999999 9999999
Q ss_pred CCCCEEEcCCCcEEEEecCCccccCCCCC-cccccccccccccCccccCCCCCCChhhHHHHHHHHHHHHh-CCCCCCCC
Q 010519 316 KSSNILIDDEFNAKVSDFGLAKLLDSGES-HITTRVMGTFGYVAPEYANTGMLNEKSDIYSFGVLLLEAVT-GRDPVDYG 393 (508)
Q Consensus 316 k~~NIll~~~~~~kl~Dfgla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~ellt-G~~Pf~~~ 393 (508)
||+|||+++++.+||+|||+|+....... ......+||+.|||||++.+..|+.++|||||||+||||+| |+.||...
T Consensus 212 K~~NILl~~~~~vKi~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~y~~ksDVwS~Gv~l~El~t~G~~Pf~~~ 291 (353)
T 4ase_A 212 AARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGV 291 (353)
T ss_dssp SGGGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTC
T ss_pred CccceeeCCCCCEEECcchhhhhcccCCCceeeccccccccccCHHHHhcCCCCCcccEeehHHHHHHHHhCCCCCCCCC
Confidence 99999999999999999999987654433 23445679999999999999999999999999999999998 99999754
Q ss_pred CCCchhcHHHHHHHHhcccccccccCCCCCCChhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhhcC
Q 010519 394 RPANEVNLVEWLKMMVGTRRAEEVVDPNLEVKPATRALKRSLLVALRCVDPDSEKRPKMSQVVRMLEAD 462 (508)
Q Consensus 394 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~ 462 (508)
..... +. ..+....+ +.. +......+.+|+.+||+.||.+|||+.||+++|+..
T Consensus 292 ~~~~~--~~---~~i~~g~~------~~~----p~~~~~~~~~li~~c~~~dP~~RPt~~eil~~L~~l 345 (353)
T 4ase_A 292 KIDEE--FC---RRLKEGTR------MRA----PDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNL 345 (353)
T ss_dssp CCSHH--HH---HHHHHTCC------CCC----CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred CHHHH--HH---HHHHcCCC------CCC----CccCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHHH
Confidence 32211 11 11111111 111 112234567799999999999999999999999754
|
| >3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-53 Score=415.09 Aligned_cols=248 Identities=22% Similarity=0.366 Sum_probs=192.2
Q ss_pred CCcccceeEeeeCceEEEEEEEc-CCCEEEEEEEcccc---hhhHHHHHHHHHHHhcCCCCCceeEEEEEEeCceeeEEE
Q 010519 186 NRFSAENVLGEGGYGVVYKGRLI-NGSEVAVKKLLNNL---GQAEKEFRVEVEAIGHVRHKNLVRLLGYCIEGVHRMLVY 261 (508)
Q Consensus 186 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~ei~~l~~l~h~niv~~~~~~~~~~~~~lv~ 261 (508)
++|++.+.||+|+||+||+|++. +|+.||||++.... ......+.+|+.+|++++|||||++++++.+.+..||||
T Consensus 13 g~Y~i~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivm 92 (275)
T 3hyh_A 13 GNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVIKSKDEIIMVI 92 (275)
T ss_dssp -CCEEEEEEEC---CCEEEEECTTTCCEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred eCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEE
Confidence 58999999999999999999875 68999999986443 223457889999999999999999999999999999999
Q ss_pred eecCCCCHHHHHhhhhccCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCEEEcCCCcEEEEecCCccccCC
Q 010519 262 EYVNNGNLEQWLHGAMRNQGNLTWEARMKVIIGTAKALAYLHEAIEPKVVHRDIKSSNILIDDEFNAKVSDFGLAKLLDS 341 (508)
Q Consensus 262 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~ 341 (508)
||+ +|+|.+++. ..+.+++..+..++.||+.||+|||++ +|+||||||+|||+++++++||+|||+|+....
T Consensus 93 Ey~-~g~L~~~l~----~~~~l~e~~~~~~~~qi~~al~ylH~~---~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~ 164 (275)
T 3hyh_A 93 EYA-GNELFDYIV----QRDKMSEQEARRFFQQIISAVEYCHRH---KIVHRDLKPENLLLDEHLNVKIADFGLSNIMTD 164 (275)
T ss_dssp ECC-CEEHHHHHH----HSCSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCTTTEEECTTCCEEECCSSCC-----
T ss_pred eCC-CCCHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHHC---CcccccCChHHeEECCCCCEEEeecCCCeecCC
Confidence 999 689999984 456799999999999999999999999 999999999999999999999999999987654
Q ss_pred CCCcccccccccccccCccccCCCCC-CChhhHHHHHHHHHHHHhCCCCCCCCCCCchhcHHHHHHHHhcccccccccCC
Q 010519 342 GESHITTRVMGTFGYVAPEYANTGML-NEKSDIYSFGVLLLEAVTGRDPVDYGRPANEVNLVEWLKMMVGTRRAEEVVDP 420 (508)
Q Consensus 342 ~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DvwS~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 420 (508)
.. .....+||+.|||||++.+..| +.++|||||||+||||++|+.||.... ....+....... .
T Consensus 165 ~~--~~~~~~GT~~Y~APE~~~~~~y~~~~~DiwSlGvily~lltg~~PF~~~~------~~~~~~~i~~~~-------~ 229 (275)
T 3hyh_A 165 GN--FLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDES------IPVLFKNISNGV-------Y 229 (275)
T ss_dssp ------------CTTSCHHHHSSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCSS------HHHHHHHHHHTC-------C
T ss_pred CC--ccCCeeECcccCChhhhcCCCCCCChhhhHHHHHHHHHHHHCCCCCCCCC------HHHHHHHHHcCC-------C
Confidence 32 2445689999999999998876 579999999999999999999996432 122222222111 1
Q ss_pred CCCCChhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhh
Q 010519 421 NLEVKPATRALKRSLLVALRCVDPDSEKRPKMSQVVRMLE 460 (508)
Q Consensus 421 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 460 (508)
.+. ......+.+|+.+||+.||.+|||++|+++|-+
T Consensus 230 ~~p----~~~s~~~~~li~~~L~~dP~~R~s~~eil~hpw 265 (275)
T 3hyh_A 230 TLP----KFLSPGAAGLIKRMLIVNPLNRISIHEIMQDDW 265 (275)
T ss_dssp CCC----TTSCHHHHHHHHHHSCSSGGGSCCHHHHHHCHH
T ss_pred CCC----CCCCHHHHHHHHHHccCChhHCcCHHHHHcCcc
Confidence 111 112345667999999999999999999998643
|
| >3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-52 Score=414.93 Aligned_cols=265 Identities=25% Similarity=0.350 Sum_probs=201.5
Q ss_pred CCcccceeEeeeCceEEEEEEEcCCCEEEEEEEcccchhhHHHHHHHHHHHhcCCCCCceeEEEEEEeCc----eeeEEE
Q 010519 186 NRFSAENVLGEGGYGVVYKGRLINGSEVAVKKLLNNLGQAEKEFRVEVEAIGHVRHKNLVRLLGYCIEGV----HRMLVY 261 (508)
Q Consensus 186 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~ei~~l~~l~h~niv~~~~~~~~~~----~~~lv~ 261 (508)
++|.+.+.||+|+||+||+|++ +|+.||||++..... ....+..|+..+.+++|||||+++++|.+++ .+||||
T Consensus 3 r~i~L~~~iG~G~fG~Vy~~~~-~g~~VAvK~l~~~~~-~~~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~~~~~~~~lV~ 80 (303)
T 3hmm_A 3 RTIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSREE-RSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVS 80 (303)
T ss_dssp GGEEEEEEEEECSSSEEEEEEE-TTEEEEEEEECGGGH-HHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEE
T ss_pred cEEEEEEEEeeCCCeEEEEEEE-CCEEEEEEEECccch-hhHHHHHHHHHHhcCCCCCCCcEEEEEEecCCCceEEEEEe
Confidence 4688899999999999999988 789999999854432 2223445677778899999999999998653 578999
Q ss_pred eecCCCCHHHHHhhhhccCCCccHHHHHHHHHHHHHHHHHHHhc-----CCCCeEeecCCCCCEEEcCCCcEEEEecCCc
Q 010519 262 EYVNNGNLEQWLHGAMRNQGNLTWEARMKVIIGTAKALAYLHEA-----IEPKVVHRDIKSSNILIDDEFNAKVSDFGLA 336 (508)
Q Consensus 262 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~-----~~~~iiH~Dlk~~NIll~~~~~~kl~Dfgla 336 (508)
|||++|+|.++|+. ..+++..+++++.|++.||+|||++ ..++|+||||||+||||++++++||+|||++
T Consensus 81 Ey~~~gsL~~~l~~-----~~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~~~~Ki~DFGla 155 (303)
T 3hmm_A 81 DYHEHGSLFDYLNR-----YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLA 155 (303)
T ss_dssp ECCTTCBHHHHHHH-----CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCCTTC
T ss_pred cCCCCCcHHHHHHh-----CCCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCCCCEEEEeCCCC
Confidence 99999999999953 3589999999999999999999975 2568999999999999999999999999999
Q ss_pred cccCCCCCc---ccccccccccccCccccCCC------CCCChhhHHHHHHHHHHHHhCCCCCCCCCCC---------ch
Q 010519 337 KLLDSGESH---ITTRVMGTFGYVAPEYANTG------MLNEKSDIYSFGVLLLEAVTGRDPVDYGRPA---------NE 398 (508)
Q Consensus 337 ~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~------~~~~~~DvwS~Gvvl~elltG~~Pf~~~~~~---------~~ 398 (508)
+........ .....+||+.|||||++.+. .|+.++|||||||+||||+||..||...... ..
T Consensus 156 ~~~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg~~~~~~~~~~~~p~~~~~~~~ 235 (303)
T 3hmm_A 156 VRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSD 235 (303)
T ss_dssp EEEETTTTEESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSS
T ss_pred ccccCCCCceeeecccccccccccCHHHhcccccccCCccChhHhhhhHHHHHHHHHHCCCCCCccccccccchhccccc
Confidence 876543322 12346799999999999764 3678999999999999999998776432211 01
Q ss_pred hcHHHHHHHHhcccccccccCCCCCCCh-hHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhhcC
Q 010519 399 VNLVEWLKMMVGTRRAEEVVDPNLEVKP-ATRALKRSLLVALRCVDPDSEKRPKMSQVVRMLEAD 462 (508)
Q Consensus 399 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~ 462 (508)
............ ...++.+.... ....+..+.+|+.+||+.||.+||||.||++.|+..
T Consensus 236 ~~~~~~~~~~~~-----~~~rp~~p~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~~l 295 (303)
T 3hmm_A 236 PSVEEMRKVVCE-----QKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQL 295 (303)
T ss_dssp CCHHHHHHHHTT-----SCCCCCCCGGGGSSHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHH
T ss_pred chHHHHHHHHhc-----ccCCCCCCccccchHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHH
Confidence 111222222211 12223322221 234566788899999999999999999999999753
|
| >3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-54 Score=421.95 Aligned_cols=251 Identities=25% Similarity=0.307 Sum_probs=198.5
Q ss_pred CCcccceeEeeeCceEEEEEEEc----CCCEEEEEEEcccc--hhhHHHHHHHHHHHhcCCCCCceeEEEEEEeCceeeE
Q 010519 186 NRFSAENVLGEGGYGVVYKGRLI----NGSEVAVKKLLNNL--GQAEKEFRVEVEAIGHVRHKNLVRLLGYCIEGVHRML 259 (508)
Q Consensus 186 ~~~~~~~~lg~G~~g~Vy~~~~~----~~~~vavK~~~~~~--~~~~~~~~~ei~~l~~l~h~niv~~~~~~~~~~~~~l 259 (508)
++|++.+.||+|+||+||+|+.. .++.||||++.... ......+.+|+.+|++++|||||++++++.+++..||
T Consensus 24 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~i 103 (304)
T 3ubd_A 24 SQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKLHYAFQTEGKLYL 103 (304)
T ss_dssp GGEEEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEEEECC------CCCCCCCCTTEECEEEEEEETTEEEE
T ss_pred cccEEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcChHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEE
Confidence 57999999999999999999863 46789999986432 1223457789999999999999999999999999999
Q ss_pred EEeecCCCCHHHHHhhhhccCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCEEEcCCCcEEEEecCCcccc
Q 010519 260 VYEYVNNGNLEQWLHGAMRNQGNLTWEARMKVIIGTAKALAYLHEAIEPKVVHRDIKSSNILIDDEFNAKVSDFGLAKLL 339 (508)
Q Consensus 260 v~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~Dfgla~~~ 339 (508)
|||||+||+|.++|. ..+.+++..+..++.||+.||.|||++ +|+||||||+|||++.++++||+|||+|+..
T Consensus 104 vmEy~~gg~L~~~l~----~~~~l~e~~~~~~~~qi~~aL~ylH~~---~IiHRDlKp~NILl~~~g~vKl~DFGla~~~ 176 (304)
T 3ubd_A 104 ILDFLRGGDLFTRLS----KEVMFTEEDVKFYLAELALALDHLHSL---GIIYRDLKPENILLDEEGHIKLTDFGLSKES 176 (304)
T ss_dssp EECCCTTCEEHHHHH----HHCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCCGGGEEECTTSCEEEESSEEEEC-
T ss_pred EEEcCCCCCHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHHC---CCcCCCCCHHHeEEcCCCCEEecccccceec
Confidence 999999999999995 456799999999999999999999999 9999999999999999999999999999865
Q ss_pred CCCCCcccccccccccccCccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCCCchhcHHHHHHHHhcccccccccC
Q 010519 340 DSGESHITTRVMGTFGYVAPEYANTGMLNEKSDIYSFGVLLLEAVTGRDPVDYGRPANEVNLVEWLKMMVGTRRAEEVVD 419 (508)
Q Consensus 340 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 419 (508)
..... .....+||+.|||||++.+..|+.++|||||||+||||++|+.||.... . .+.+.......
T Consensus 177 ~~~~~-~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~PF~~~~---~---~~~~~~i~~~~------- 242 (304)
T 3ubd_A 177 IDHEK-KAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKD---R---KETMTMILKAK------- 242 (304)
T ss_dssp ----C-CCCSCCCCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSS---H---HHHHHHHHHCC-------
T ss_pred cCCCc-cccccccCcccCCHHHhccCCCCCCCcccchHHHHHHHHhCCCCCCCcC---H---HHHHHHHHcCC-------
Confidence 43322 2445789999999999999999999999999999999999999996432 1 12222222111
Q ss_pred CCCCCChhHHHHHHHHHHHHHhcCCCCCCCCCH-----HHHHHHhhc
Q 010519 420 PNLEVKPATRALKRSLLVALRCVDPDSEKRPKM-----SQVVRMLEA 461 (508)
Q Consensus 420 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~-----~evl~~L~~ 461 (508)
..+ +......+.+|+.+||+.||.+|||+ +|+++|-+-
T Consensus 243 ~~~----p~~~s~~~~~li~~~L~~dP~~R~ta~~~~~~eil~Hp~f 285 (304)
T 3ubd_A 243 LGM----PQFLSPEAQSLLRMLFKRNPANRLGAGPDGVEEIKRHSFF 285 (304)
T ss_dssp CCC----CTTSCHHHHHHHHHHTCSSGGGSTTCSTTTHHHHHTSGGG
T ss_pred CCC----CCcCCHHHHHHHHHHcccCHHHCCCCCcCCHHHHHcCccc
Confidence 011 11123456779999999999999984 688876543
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-51 Score=403.37 Aligned_cols=252 Identities=25% Similarity=0.422 Sum_probs=190.3
Q ss_pred CCcccceeEeeeCceEEEEEEEc-CCCEEEEEEEcccc-hhhHHHHHHHHHHHhcCCCCCceeEEEEEEeCc--------
Q 010519 186 NRFSAENVLGEGGYGVVYKGRLI-NGSEVAVKKLLNNL-GQAEKEFRVEVEAIGHVRHKNLVRLLGYCIEGV-------- 255 (508)
Q Consensus 186 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~ei~~l~~l~h~niv~~~~~~~~~~-------- 255 (508)
++|++.+.||+|+||+||+|++. +|+.||||++.... ....+.+.+|+.+|++++|||||++++++.+.+
T Consensus 5 ~dy~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~~ 84 (299)
T 4g31_A 5 TDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKLQPS 84 (299)
T ss_dssp HHEEEEEEEEECC--EEEEEEETTTCCEEEEEEEEECSSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC--------
T ss_pred hhCEEeeEEecCCCeEEEEEEECCCCCEEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEecCcccccccc
Confidence 36899999999999999999875 68999999986443 334467889999999999999999999987543
Q ss_pred ----eeeEEEeecCCCCHHHHHhhhhccCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCEEEcCCCcEEEE
Q 010519 256 ----HRMLVYEYVNNGNLEQWLHGAMRNQGNLTWEARMKVIIGTAKALAYLHEAIEPKVVHRDIKSSNILIDDEFNAKVS 331 (508)
Q Consensus 256 ----~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~ 331 (508)
.+|||||||++|+|.+++... .......+..++.++.||+.||+|||++ +|+||||||+||||+.++.+||+
T Consensus 85 ~~~~~l~ivmE~~~gg~L~~~l~~~-~~~~~~~~~~~~~i~~qi~~al~ylH~~---~IiHRDlKp~NILl~~~~~vKl~ 160 (299)
T 4g31_A 85 SPKVYLYIQMQLCRKENLKDWMNGR-CTIEERERSVCLHIFLQIAEAVEFLHSK---GLMHRDLKPSNIFFTMDDVVKVG 160 (299)
T ss_dssp --CEEEEEEEECCCSCCHHHHHHTC-CSGGGSCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEEC
T ss_pred CCCcEEEEEEecCCCCcHHHHHHhc-CCCChhHHHHHHHHHHHHHHHHHHHHHC---cCccccCcHHHeEECCCCcEEEc
Confidence 368999999999999999642 1223355677889999999999999999 99999999999999999999999
Q ss_pred ecCCccccCCCCCc-----------ccccccccccccCccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCCCchhc
Q 010519 332 DFGLAKLLDSGESH-----------ITTRVMGTFGYVAPEYANTGMLNEKSDIYSFGVLLLEAVTGRDPVDYGRPANEVN 400 (508)
Q Consensus 332 Dfgla~~~~~~~~~-----------~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltG~~Pf~~~~~~~~~~ 400 (508)
|||+|+........ ..+..+||+.|||||++.+..|+.++|||||||+||||++ ||.. ...
T Consensus 161 DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyell~---Pf~~-----~~~ 232 (299)
T 4g31_A 161 DFGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY---PFST-----QME 232 (299)
T ss_dssp CCCCC--------------------------CCCTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHS---CCSS-----HHH
T ss_pred cCccceecCCCccccccccccccccccCCcccCccccCHHHHcCCCCCCHHHHHHHHHHHHHHcc---CCCC-----ccH
Confidence 99999876543221 1234689999999999999999999999999999999996 7742 111
Q ss_pred HHHHHHHHhcccccccccCCCCCCCh-hHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhh
Q 010519 401 LVEWLKMMVGTRRAEEVVDPNLEVKP-ATRALKRSLLVALRCVDPDSEKRPKMSQVVRMLE 460 (508)
Q Consensus 401 ~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 460 (508)
....+..... . ..++ .........+|+.+||++||.+|||+.|++++-.
T Consensus 233 ~~~~~~~~~~---------~--~~p~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~h~~ 282 (299)
T 4g31_A 233 RVRTLTDVRN---------L--KFPPLFTQKYPCEYVMVQDMLSPSPMERPEAINIIENAV 282 (299)
T ss_dssp HHHHHHHHHT---------T--CCCHHHHHHCHHHHHHHHHHTCSSGGGSCCHHHHHTSGG
T ss_pred HHHHHHHHhc---------C--CCCCCCcccCHHHHHHHHHHcCCChhHCcCHHHHhcCHh
Confidence 1111111110 1 1111 2233345667999999999999999999998643
|
| >4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-49 Score=402.24 Aligned_cols=267 Identities=24% Similarity=0.354 Sum_probs=206.1
Q ss_pred CCcccceeEeeeCceEEEEEEEc-CCCEEEEEEEcccc--hhhHHHHHHHHHHHhcCCCCCceeEEEEEEeC------ce
Q 010519 186 NRFSAENVLGEGGYGVVYKGRLI-NGSEVAVKKLLNNL--GQAEKEFRVEVEAIGHVRHKNLVRLLGYCIEG------VH 256 (508)
Q Consensus 186 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~ei~~l~~l~h~niv~~~~~~~~~------~~ 256 (508)
++|.+++.||+|+||+||+|++. +|+.||||++.... ....+.+.+|+.+|+.++|||||++++++... ..
T Consensus 54 ~~Y~~~~~lG~G~fG~V~~a~~~~t~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~~ 133 (398)
T 4b99_A 54 DEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAIKDILRPTVPYGEFKS 133 (398)
T ss_dssp SSEEEEEEEEECSSCEEEEEEETTTCCEEEEEEETTTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSSCTTTCCC
T ss_pred CCeEEEEEEecccCeEEEEEEECCCCCEEEEEEECccccchHHHHHHHHHHHHHHhcCCCCcceEeeeeecccccccCCE
Confidence 58999999999999999999985 79999999996443 33346688899999999999999999987643 56
Q ss_pred eeEEEeecCCCCHHHHHhhhhccCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCEEEcCCCcEEEEecCCc
Q 010519 257 RMLVYEYVNNGNLEQWLHGAMRNQGNLTWEARMKVIIGTAKALAYLHEAIEPKVVHRDIKSSNILIDDEFNAKVSDFGLA 336 (508)
Q Consensus 257 ~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~Dfgla 336 (508)
.|||||||+ |+|.+++ ...+.+++..+..++.||+.||.|||++ +||||||||+|||++.++.+||+|||++
T Consensus 134 ~~ivmE~~~-g~L~~~i----~~~~~l~~~~~~~~~~qil~al~ylH~~---~iiHRDlKP~NIl~~~~~~~Ki~DFGla 205 (398)
T 4b99_A 134 VYVVLDLME-SDLHQII----HSSQPLTLEHVRYFLYQLLRGLKYMHSA---QVIHRDLKPSNLLVNENCELKIGDFGMA 205 (398)
T ss_dssp EEEEEECCS-EEHHHHH----TSSSCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTCCEEECCCTTC
T ss_pred EEEEEeCCC-CCHHHHH----HhcCCCCHHHHHHHHHHHHHHHHHHHHC---cCcCCCcCccccccCCCCCEEEeeccee
Confidence 899999995 6899998 4567899999999999999999999999 9999999999999999999999999999
Q ss_pred cccCCCC---CcccccccccccccCccccCCC-CCCChhhHHHHHHHHHHHHhCCCCCCCCCCCchhcHHHHHHHHhccc
Q 010519 337 KLLDSGE---SHITTRVMGTFGYVAPEYANTG-MLNEKSDIYSFGVLLLEAVTGRDPVDYGRPANEVNLVEWLKMMVGTR 412 (508)
Q Consensus 337 ~~~~~~~---~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwS~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~ 412 (508)
+.+.... .......+||+.|+|||++.+. .|+.++||||+||+||||++|+.||.... .......+....+..
T Consensus 206 ~~~~~~~~~~~~~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWSlG~il~ell~G~~pF~g~~---~~~~l~~I~~~~g~p 282 (398)
T 4b99_A 206 RGLCTSPAEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKN---YVHQLQLIMMVLGTP 282 (398)
T ss_dssp BCC-------CCCCCSSCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTSCSSCCSS---HHHHHHHHHHHHCCC
T ss_pred eecccCccccccccccceeChHhcCHHHhcCCCCCCChhheehhHHHHHHHHHCCCCCCCCC---HHHHHHHHHHhcCCC
Confidence 8664321 2234567899999999998875 57999999999999999999999996432 222222222222211
Q ss_pred ccccc--------------cCCCCCCChh---HHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhhcCC
Q 010519 413 RAEEV--------------VDPNLEVKPA---TRALKRSLLVALRCVDPDSEKRPKMSQVVRMLEADD 463 (508)
Q Consensus 413 ~~~~~--------------~~~~~~~~~~---~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~ 463 (508)
..... ..+....... ......+.+|+.+||..||.+|||+.|+|+|-+-..
T Consensus 283 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~ 350 (398)
T 4b99_A 283 SPAVIQAVGAERVRAYIQSLPPRQPVPWETVYPGADRQALSLLGRMLRFEPSARISAAAALRHPFLAK 350 (398)
T ss_dssp CGGGTC-----CHHHHHHSSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSTTTSCCHHHHTTSGGGTT
T ss_pred ChHHhhhhhhhhhhhhhhcCCCcCCCCHHHhCCCCCHHHHHHHHHHCcCChhHCcCHHHHhcCHhhCc
Confidence 11000 0000000000 012345678999999999999999999999765544
|
| >4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-48 Score=392.46 Aligned_cols=199 Identities=24% Similarity=0.375 Sum_probs=170.7
Q ss_pred hhCCcccceeEeeeCceEEEEEEEc----CCCEEEEEEEcccchhhHHHHHHHHHHHhcC-CCCCceeEEEEEEeCceee
Q 010519 184 ATNRFSAENVLGEGGYGVVYKGRLI----NGSEVAVKKLLNNLGQAEKEFRVEVEAIGHV-RHKNLVRLLGYCIEGVHRM 258 (508)
Q Consensus 184 ~~~~~~~~~~lg~G~~g~Vy~~~~~----~~~~vavK~~~~~~~~~~~~~~~ei~~l~~l-~h~niv~~~~~~~~~~~~~ 258 (508)
..++|.+.+.||+|+||+||+|+++ .++.||+|++.... ....+.+|+++|+.+ +|||||++++++.+.++.|
T Consensus 19 l~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~--~~~~~~~E~~~l~~~~~h~nIv~l~~~~~~~~~~~ 96 (361)
T 4f9c_A 19 LSNVFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPTS--HPIRIAAELQCLTVAGGQDNVMGVKYCFRKNDHVV 96 (361)
T ss_dssp GGGTCEEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTTS--CHHHHHHHHHHHHHTCSBTTBCCCSEEEEETTEEE
T ss_pred ccCcEEEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEcccc--CHHHHHHHHHHHHHhcCCCCCceEEEEEEECCEEE
Confidence 4578999999999999999999864 36789999986543 234577899999988 6999999999999999999
Q ss_pred EEEeecCCCCHHHHHhhhhccCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCEEEcCC-CcEEEEecCCcc
Q 010519 259 LVYEYVNNGNLEQWLHGAMRNQGNLTWEARMKVIIGTAKALAYLHEAIEPKVVHRDIKSSNILIDDE-FNAKVSDFGLAK 337 (508)
Q Consensus 259 lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiH~Dlk~~NIll~~~-~~~kl~Dfgla~ 337 (508)
|||||+++|+|.+++. .+++..+..++.||+.||.|||++ +|+||||||+|||++.+ +.+||+|||+|+
T Consensus 97 lvmE~~~g~~L~~~~~-------~l~~~~~~~~~~qll~al~ylH~~---gIiHRDiKPeNiLl~~~~~~~kl~DFGla~ 166 (361)
T 4f9c_A 97 IAMPYLEHESFLDILN-------SLSFQEVREYMLNLFKALKRIHQF---GIVHRDVKPSNFLYNRRLKKYALVDFGLAQ 166 (361)
T ss_dssp EEEECCCCCCHHHHHT-------TCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEETTTTEEEECCCTTCE
T ss_pred EEEeCCCcccHHHHHc-------CCCHHHHHHHHHHHHHHHHHHHHC---CeEeCcCCHHHeEEeCCCCeEEECcCCCCc
Confidence 9999999999999883 388999999999999999999999 99999999999999876 799999999998
Q ss_pred ccCCCCC---------------------------cccccccccccccCccccCCC-CCCChhhHHHHHHHHHHHHhCCCC
Q 010519 338 LLDSGES---------------------------HITTRVMGTFGYVAPEYANTG-MLNEKSDIYSFGVLLLEAVTGRDP 389 (508)
Q Consensus 338 ~~~~~~~---------------------------~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwS~Gvvl~elltG~~P 389 (508)
....... ......+||+.|+|||++.+. .|+.++||||+||+||||++|+.|
T Consensus 167 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~y~~~~DiWSlG~il~ell~G~~P 246 (361)
T 4f9c_A 167 GTHDTKIELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFLSLLSGRYP 246 (361)
T ss_dssp ECTTCSCGGGGGC--------------------------CCCCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTCSS
T ss_pred ccCCccccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCCccchhhhHHHHHHHHHCCCC
Confidence 6543221 112345799999999999775 589999999999999999999999
Q ss_pred CCCCC
Q 010519 390 VDYGR 394 (508)
Q Consensus 390 f~~~~ 394 (508)
|..+.
T Consensus 247 f~~~~ 251 (361)
T 4f9c_A 247 FYKAS 251 (361)
T ss_dssp SSCCS
T ss_pred CCCCC
Confidence 96543
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-48 Score=390.25 Aligned_cols=291 Identities=44% Similarity=0.812 Sum_probs=248.4
Q ss_pred cceeHHHHHHhhCCcccceeEeeeCceEEEEEEEcCCCEEEEEEEcccchh-hHHHHHHHHHHHhcCCCCCceeEEEEEE
Q 010519 174 HWFTLRDLEIATNRFSAENVLGEGGYGVVYKGRLINGSEVAVKKLLNNLGQ-AEKEFRVEVEAIGHVRHKNLVRLLGYCI 252 (508)
Q Consensus 174 ~~~~~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~-~~~~~~~ei~~l~~l~h~niv~~~~~~~ 252 (508)
..|++.+++...++|.+.+.||+|+||+||+|++.+|..||||++...... ....+.+|+.+++.++||||+++++++.
T Consensus 18 ~~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~ 97 (326)
T 3uim_A 18 KRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCM 97 (326)
T ss_dssp EECCTHHHHTTTTSSCSTTEEECCSSSEEEEECCSSSCCEEEEECCC-----CCCHHHHHHHGGGTCCCTTBCCCCEEEC
T ss_pred ceecHHHHHHHhhccccceeEecCCCcEEEEEEecCCCEEEEEEeccccCchHHHHHHHHHHHHHhccCCCccceEEEEe
Confidence 456889999999999999999999999999998878999999998654322 2236888999999999999999999999
Q ss_pred eCceeeEEEeecCCCCHHHHHhhhhccCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCEEEcCCCcEEEEe
Q 010519 253 EGVHRMLVYEYVNNGNLEQWLHGAMRNQGNLTWEARMKVIIGTAKALAYLHEAIEPKVVHRDIKSSNILIDDEFNAKVSD 332 (508)
Q Consensus 253 ~~~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~D 332 (508)
+....++||||+++|+|.+++.........+++..+..++.|++.||.|||+...++|+||||||+|||++.++.+||+|
T Consensus 98 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nil~~~~~~~kl~D 177 (326)
T 3uim_A 98 TPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGD 177 (326)
T ss_dssp CSSCCEEEEECCTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHHSSSSCEECCCCSGGGEEECTTCCEEECC
T ss_pred cCCceEEEEEeccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCchhhEEECCCCCEEecc
Confidence 99999999999999999999976544555699999999999999999999998777999999999999999999999999
Q ss_pred cCCccccCCCCCcccccccccccccCccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCC--CCchhcHHHHHHHHhc
Q 010519 333 FGLAKLLDSGESHITTRVMGTFGYVAPEYANTGMLNEKSDIYSFGVLLLEAVTGRDPVDYGR--PANEVNLVEWLKMMVG 410 (508)
Q Consensus 333 fgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltG~~Pf~~~~--~~~~~~~~~~~~~~~~ 410 (508)
||++...............||+.|+|||++.+..++.++|||||||++|+|++|+.||.... .........|......
T Consensus 178 fg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 257 (326)
T 3uim_A 178 FGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLK 257 (326)
T ss_dssp CSSCEECCSSSSCEECCCCSCGGGCCHHHHHHSEECHHHHHHHHHHHHHHHHHCCCSBCHHHHTTTSCSBHHHHHTTTTS
T ss_pred CccccccCcccccccccccCCcCccCHHHhccCCCCccccchhHHHHHHHHHhCCCcccccccccccchhHHHHHHHHhh
Confidence 99998776554444555679999999999988889999999999999999999999995221 2233445566666666
Q ss_pred ccccccccCCCCCCChhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhhcCCC
Q 010519 411 TRRAEEVVDPNLEVKPATRALKRSLLVALRCVDPDSEKRPKMSQVVRMLEADDY 464 (508)
Q Consensus 411 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~ 464 (508)
......+.+..+...........+.+++.+||+.||.+|||+.||+++|+....
T Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~~~~ 311 (326)
T 3uim_A 258 EKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLEGDGL 311 (326)
T ss_dssp SCCSTTSSCTTCTTSCCHHHHHHHHHHHHHHTCSCGGGSCCHHHHHHHHHTSSC
T ss_pred chhhhhhcChhhccccCHHHHHHHHHHHHHHhCcCCccCCCHHHHHHHhcCcch
Confidence 666677777777777777888899999999999999999999999999997644
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-48 Score=415.00 Aligned_cols=255 Identities=22% Similarity=0.321 Sum_probs=212.9
Q ss_pred hCCcccceeEeeeCceEEEEEEEc-CCCEEEEEEEcccchhhHHHHHHHHHHHhcCCCCCceeEEEEEEeCceeeEEEee
Q 010519 185 TNRFSAENVLGEGGYGVVYKGRLI-NGSEVAVKKLLNNLGQAEKEFRVEVEAIGHVRHKNLVRLLGYCIEGVHRMLVYEY 263 (508)
Q Consensus 185 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~ei~~l~~l~h~niv~~~~~~~~~~~~~lv~E~ 263 (508)
.++|.+.+.||+|+||+||+|++. +|+.||+|++........+.+.+|+.+|+.++|||||+++++|.+...+||||||
T Consensus 156 l~~Y~i~~~lG~G~fg~V~~~~~~~tg~~~AiK~i~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iv~E~ 235 (573)
T 3uto_A 156 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEF 235 (573)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred ccccEEEEEEeeccCeEEEEEEECCCCCEEEEEEEeccchhhHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEee
Confidence 368999999999999999999885 6899999999776666667888999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhhhhccCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCEEEcCC--CcEEEEecCCccccCC
Q 010519 264 VNNGNLEQWLHGAMRNQGNLTWEARMKVIIGTAKALAYLHEAIEPKVVHRDIKSSNILIDDE--FNAKVSDFGLAKLLDS 341 (508)
Q Consensus 264 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiH~Dlk~~NIll~~~--~~~kl~Dfgla~~~~~ 341 (508)
|+||+|.++|. .....+++..+..++.||+.||.|||++ +|+||||||+|||++.+ +.+||+|||+++.+..
T Consensus 236 ~~gg~L~~~i~---~~~~~l~e~~~~~~~~qi~~al~ylH~~---~iiHRDlKp~Nill~~~~~~~vKl~DFG~a~~~~~ 309 (573)
T 3uto_A 236 MSGGELFEKVA---DEHNKMSEDEAVEYMRQVCKGLCHMHEN---NYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDP 309 (573)
T ss_dssp CCCCBHHHHHT---CTTSCEEHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSSSCCCEEECCCSSCEECCT
T ss_pred cCCCcHHHHHH---HhCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCChhhccccCCCCCCEEEeeccceeEccC
Confidence 99999999985 3456799999999999999999999999 99999999999999854 8999999999998764
Q ss_pred CCCcccccccccccccCccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCCCchhcHHHHHHHHhcccccccccCCC
Q 010519 342 GESHITTRVMGTFGYVAPEYANTGMLNEKSDIYSFGVLLLEAVTGRDPVDYGRPANEVNLVEWLKMMVGTRRAEEVVDPN 421 (508)
Q Consensus 342 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 421 (508)
.. .....+||+.|||||++.+..|+.++|||||||+||||++|..||..... .+.+....... ..
T Consensus 310 ~~--~~~~~~GT~~y~APEv~~~~~y~~~~DiWSlGvilyeml~G~~Pf~~~~~------~~~~~~i~~~~-------~~ 374 (573)
T 3uto_A 310 KQ--SVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGEND------DETLRNVKSCD-------WN 374 (573)
T ss_dssp TS--EEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSH------HHHHHHHHTTC-------CC
T ss_pred CC--ceeeeEECccccCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCH------HHHHHHHHhCC-------CC
Confidence 43 24456899999999999999999999999999999999999999964321 12222221110 11
Q ss_pred CCCChhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhh
Q 010519 422 LEVKPATRALKRSLLVALRCVDPDSEKRPKMSQVVRMLE 460 (508)
Q Consensus 422 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 460 (508)
+...........+.+|+.+||..||.+|||+.|+|+|-+
T Consensus 375 ~~~~~~~~~s~~~~dli~~~L~~dp~~R~t~~e~l~Hpw 413 (573)
T 3uto_A 375 MDDSAFSGISEDGKDFIRKLLLADPNTRMTIHQALEHPW 413 (573)
T ss_dssp CCSGGGTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSTT
T ss_pred CCcccccCCCHHHHHHHHHHccCChhHCcCHHHHhcCcC
Confidence 111111223456677999999999999999999999754
|
| >3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-48 Score=414.77 Aligned_cols=253 Identities=23% Similarity=0.304 Sum_probs=203.8
Q ss_pred hCCcccceeEeeeCceEEEEEEEc-CCCEEEEEEEcccc---hhhHH---HHHHHHHHHhcCCCCCceeEEEEEEeCcee
Q 010519 185 TNRFSAENVLGEGGYGVVYKGRLI-NGSEVAVKKLLNNL---GQAEK---EFRVEVEAIGHVRHKNLVRLLGYCIEGVHR 257 (508)
Q Consensus 185 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~---~~~~ei~~l~~l~h~niv~~~~~~~~~~~~ 257 (508)
-++|.+.++||+|+||+||+|++. +|+.||||++.+.. ..... ..+.++.+++.++|||||+++++|++...+
T Consensus 188 lddf~i~k~LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~f~~~~~l 267 (689)
T 3v5w_A 188 MNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKL 267 (689)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEE
T ss_pred hHHeEEEEEEecccCeEEEEEEECCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEEEEEEECCEE
Confidence 368999999999999999999986 68999999985432 11122 233456778888999999999999999999
Q ss_pred eEEEeecCCCCHHHHHhhhhccCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCEEEcCCCcEEEEecCCcc
Q 010519 258 MLVYEYVNNGNLEQWLHGAMRNQGNLTWEARMKVIIGTAKALAYLHEAIEPKVVHRDIKSSNILIDDEFNAKVSDFGLAK 337 (508)
Q Consensus 258 ~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~Dfgla~ 337 (508)
|||||||+||+|.++|. ..+.+++..+..++.||+.||.|||++ +||||||||+||||+.+|++||+|||+|+
T Consensus 268 ylVmEy~~GGdL~~~l~----~~~~l~E~~a~~y~~qIl~aL~yLH~~---gIiHRDLKPeNILld~~G~vKL~DFGlA~ 340 (689)
T 3v5w_A 268 SFILDLMNGGDLHYHLS----QHGVFSEADMRFYAAEIILGLEHMHNR---FVVYRDLKPANILLDEHGHVRISDLGLAC 340 (689)
T ss_dssp EEEECCCCSCBHHHHHH----HHCCCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCSGGGEEECTTSCEEECCCTTCE
T ss_pred EEEEecCCCCcHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCchHHeEEeCCCCEEecccceee
Confidence 99999999999999995 456799999999999999999999999 99999999999999999999999999998
Q ss_pred ccCCCCCcccccccccccccCccccC-CCCCCChhhHHHHHHHHHHHHhCCCCCCCCCCCchhcHHHHHHHHhccccccc
Q 010519 338 LLDSGESHITTRVMGTFGYVAPEYAN-TGMLNEKSDIYSFGVLLLEAVTGRDPVDYGRPANEVNLVEWLKMMVGTRRAEE 416 (508)
Q Consensus 338 ~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~DvwS~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 416 (508)
...... ....+||+.|||||++. +..|+.++|||||||+||||++|+.||......+.. .........
T Consensus 341 ~~~~~~---~~t~~GTp~YmAPEvl~~~~~y~~~vDiWSLGvilYEmLtG~~PF~~~~~~~~~---~i~~~i~~~----- 409 (689)
T 3v5w_A 341 DFSKKK---PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKH---EIDRMTLTM----- 409 (689)
T ss_dssp ECSSCC---CCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCTTCGGGCCCHH---HHHHHHHHC-----
T ss_pred ecCCCC---CCCccCCcCccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHH---HHHHhhcCC-----
Confidence 765432 34568999999999996 457999999999999999999999999644332221 111111111
Q ss_pred ccCCCCCCChhHHHHHHHHHHHHHhcCCCCCCCCC-----HHHHHHHhhc
Q 010519 417 VVDPNLEVKPATRALKRSLLVALRCVDPDSEKRPK-----MSQVVRMLEA 461 (508)
Q Consensus 417 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs-----~~evl~~L~~ 461 (508)
.... +......+.+|+.+||..||.+|++ ++||++|-+-
T Consensus 410 ----~~~~--p~~~S~~a~dLI~~lL~~dP~~Rl~~~~~ga~ei~~HpfF 453 (689)
T 3v5w_A 410 ----AVEL--PDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKESPFF 453 (689)
T ss_dssp ----CCCC--CTTSCHHHHHHHHHHTCSCGGGCTTCSSSTHHHHTTSGGG
T ss_pred ----CCCC--CccCCHHHHHHHHHHccCCHhHCCCCCCCCHHHHhcCccc
Confidence 1111 1112345667999999999999998 7899887643
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-48 Score=387.21 Aligned_cols=282 Identities=41% Similarity=0.700 Sum_probs=243.4
Q ss_pred HHHHHHhhCCcccceeEeeeCceEEEEEEEcCCCEEEEEEEcccchhhHHHHHHHHHHHhcCCCCCceeEEEEEEeCcee
Q 010519 178 LRDLEIATNRFSAENVLGEGGYGVVYKGRLINGSEVAVKKLLNNLGQAEKEFRVEVEAIGHVRHKNLVRLLGYCIEGVHR 257 (508)
Q Consensus 178 ~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~ei~~l~~l~h~niv~~~~~~~~~~~~ 257 (508)
+.+++...++|.+.+.||+|+||+||+|++.++..||+|++..........+.+|+.+++.++||||+++++++.+....
T Consensus 31 ~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 110 (321)
T 2qkw_B 31 LVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESSQGIEEFETEIETLSFCRHPHLVSLIGFCDERNEM 110 (321)
T ss_dssp CSCCCCCCCCCSCCCCSCBCSSSEEEEEECTTCCEEEEEECCSCCSSHHHHHHHHHHGGGSCCCTTBCCEEEECCCTTCC
T ss_pred HHHHHHHHhccCccceeecCCCeeEEEEEECCCCEEEEEEecccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCeE
Confidence 34445567899999999999999999999888999999998766666667899999999999999999999999999999
Q ss_pred eEEEeecCCCCHHHHHhhhhccCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCEEEcCCCcEEEEecCCcc
Q 010519 258 MLVYEYVNNGNLEQWLHGAMRNQGNLTWEARMKVIIGTAKALAYLHEAIEPKVVHRDIKSSNILIDDEFNAKVSDFGLAK 337 (508)
Q Consensus 258 ~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~Dfgla~ 337 (508)
++||||+++|+|.+++.........+++..++.++.||+.||.|||++ +|+||||||+|||++.++.+||+|||++.
T Consensus 111 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~ 187 (321)
T 2qkw_B 111 ILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTR---AIIHRDVKSINILLDENFVPKITDFGISK 187 (321)
T ss_dssp EEEEECCTTCBTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCSTTEEECTTCCEEECCCTTCE
T ss_pred EEEEEcCCCCcHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhcCC---CeecCCCCHHHEEECCCCCEEEeeccccc
Confidence 999999999999999864323334689999999999999999999999 99999999999999999999999999998
Q ss_pred ccCCCC-CcccccccccccccCccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCCCchhcHHHHHHHHhccccccc
Q 010519 338 LLDSGE-SHITTRVMGTFGYVAPEYANTGMLNEKSDIYSFGVLLLEAVTGRDPVDYGRPANEVNLVEWLKMMVGTRRAEE 416 (508)
Q Consensus 338 ~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 416 (508)
...... ........||+.|+|||++.+..++.++|||||||++|||++|+.||....+........|............
T Consensus 188 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 267 (321)
T 2qkw_B 188 KGTELDQTHLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESHNNGQLEQ 267 (321)
T ss_dssp ECSSSSCCCCBCCCEEETTTCCHHHHHHCBCCTHHHHHHHHHHHHHHHHCCTTCSCSSSSSCCCHHHHTHHHHTTTCCCS
T ss_pred ccccccccccccccCCCccccCHHHhcCCCCCcccchHhHHHHHHHHHhCCCcccccCcHHHHHHHHHhhhccccccHHH
Confidence 654322 2223445689999999999888999999999999999999999999987777666777777666666666667
Q ss_pred ccCCCCCCChhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhhcC
Q 010519 417 VVDPNLEVKPATRALKRSLLVALRCVDPDSEKRPKMSQVVRMLEAD 462 (508)
Q Consensus 417 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~ 462 (508)
.+++.+...........+.+++.+||+.||.+|||+.|++++|+..
T Consensus 268 ~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~ 313 (321)
T 2qkw_B 268 IVDPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKLEYA 313 (321)
T ss_dssp SSSSSCTTCSCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred hcChhhccccCHHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHH
Confidence 7777776666777888899999999999999999999999999864
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-45 Score=363.57 Aligned_cols=253 Identities=24% Similarity=0.367 Sum_probs=209.4
Q ss_pred hCCcccceeEeeeCceEEEEEEE-cCCCEEEEEEEcccchhhHHHHHHHHHHHhcCCCCCceeEEEEEEeCceeeEEEee
Q 010519 185 TNRFSAENVLGEGGYGVVYKGRL-INGSEVAVKKLLNNLGQAEKEFRVEVEAIGHVRHKNLVRLLGYCIEGVHRMLVYEY 263 (508)
Q Consensus 185 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~ei~~l~~l~h~niv~~~~~~~~~~~~~lv~E~ 263 (508)
.++|.+.+.||+|+||+||+|.+ .+++.||+|++........+.+.+|+.+++.++||||+++++++......++||||
T Consensus 19 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~ 98 (297)
T 3fxz_A 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEY 98 (297)
T ss_dssp GGTBCCCEEEEEETTEEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred hhceeeeeeeccCCCeEEEEEEECCCCcEEEEEEeecccccHHHHHHHHHHHHhcCCCCCCCeEeEEEEECCEEEEEEEC
Confidence 35899999999999999999986 47899999998765555567788999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhhhhccCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCEEEcCCCcEEEEecCCccccCCCC
Q 010519 264 VNNGNLEQWLHGAMRNQGNLTWEARMKVIIGTAKALAYLHEAIEPKVVHRDIKSSNILIDDEFNAKVSDFGLAKLLDSGE 343 (508)
Q Consensus 264 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~~~ 343 (508)
+++|+|.+++.. ..+++..++.++.|++.||.|||++ +|+||||||+|||++.++.+||+|||++.......
T Consensus 99 ~~~~~L~~~~~~-----~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 170 (297)
T 3fxz_A 99 LAGGSLTDVVTE-----TCMDEGQIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ 170 (297)
T ss_dssp CTTCBHHHHHHH-----SCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTTCEECCSTT
T ss_pred CCCCCHHHHHhh-----cCCCHHHHHHHHHHHHHHHHHHHhC---CceeCCCCHHHEEECCCCCEEEeeCCCceecCCcc
Confidence 999999999853 3588999999999999999999999 99999999999999999999999999998765433
Q ss_pred CcccccccccccccCccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCCCchhcHHHHHHHHhcccccccccCCCCC
Q 010519 344 SHITTRVMGTFGYVAPEYANTGMLNEKSDIYSFGVLLLEAVTGRDPVDYGRPANEVNLVEWLKMMVGTRRAEEVVDPNLE 423 (508)
Q Consensus 344 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 423 (508)
. ......||+.|+|||++.+..++.++|||||||++|||++|..||...... .......... ...
T Consensus 171 ~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~------~~~~~~~~~~--------~~~ 235 (297)
T 3fxz_A 171 S-KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPL------RALYLIATNG--------TPE 235 (297)
T ss_dssp C-CBCCCCSCGGGCCHHHHHCSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHH------HHHHHHHHHC--------SCC
T ss_pred c-ccCCccCCcCccChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHH------HHHHHHHhCC--------CCC
Confidence 2 234467999999999999999999999999999999999999999643211 1111111110 111
Q ss_pred CChhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhh
Q 010519 424 VKPATRALKRSLLVALRCVDPDSEKRPKMSQVVRMLE 460 (508)
Q Consensus 424 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 460 (508)
...+......+.+|+.+||+.||.+|||+.|++++-.
T Consensus 236 ~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~h~~ 272 (297)
T 3fxz_A 236 LQNPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQHQF 272 (297)
T ss_dssp CSCGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTCGG
T ss_pred CCCccccCHHHHHHHHHHccCChhHCcCHHHHhhChh
Confidence 1112233455677999999999999999999998654
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-44 Score=358.92 Aligned_cols=256 Identities=27% Similarity=0.459 Sum_probs=211.3
Q ss_pred hCCcccceeEeeeCceEEEEEEEc-CCCEEEEEEEcccchhhHHHHHHHHHHHhcCCCCCceeEEEEEEeCceeeEEEee
Q 010519 185 TNRFSAENVLGEGGYGVVYKGRLI-NGSEVAVKKLLNNLGQAEKEFRVEVEAIGHVRHKNLVRLLGYCIEGVHRMLVYEY 263 (508)
Q Consensus 185 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~ei~~l~~l~h~niv~~~~~~~~~~~~~lv~E~ 263 (508)
.++|.+.+.||+|+||+||+|.+. ++..||+|++..........+.+|+.++++++||||+++++++.++...++||||
T Consensus 9 ~~~~~~~~~lG~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~ 88 (310)
T 3s95_A 9 PSDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGVLYKDKRLNFITEY 88 (310)
T ss_dssp GGGEEEEEEEECCSSEEEEEEEETTTCCEEEEEEESCCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred hhHeeccceecCCCCEEEEEEEECCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCcCcccEEEEEecCCeeEEEEEe
Confidence 458999999999999999999985 6889999998776666678899999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhhhhccCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCEEEcCCCcEEEEecCCccccCCCC
Q 010519 264 VNNGNLEQWLHGAMRNQGNLTWEARMKVIIGTAKALAYLHEAIEPKVVHRDIKSSNILIDDEFNAKVSDFGLAKLLDSGE 343 (508)
Q Consensus 264 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~~~ 343 (508)
+++|+|.+++.. ....+++..++.++.|++.||.|||+. +|+||||||+|||++.++.+||+|||++.......
T Consensus 89 ~~~~~L~~~l~~---~~~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 162 (310)
T 3s95_A 89 IKGGTLRGIIKS---MDSQYPWSQRVSFAKDIASGMAYLHSM---NIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEK 162 (310)
T ss_dssp CTTCBHHHHHHH---CCTTSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSTTSEEECTTSCEEECCCTTCEECC---
T ss_pred cCCCcHHHHHHh---ccCCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCCcCeEEECCCCCEEEeecccceeccccc
Confidence 999999999963 356799999999999999999999999 99999999999999999999999999998764332
Q ss_pred Ccc-------------cccccccccccCccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCCCchh---cHHHHHHH
Q 010519 344 SHI-------------TTRVMGTFGYVAPEYANTGMLNEKSDIYSFGVLLLEAVTGRDPVDYGRPANEV---NLVEWLKM 407 (508)
Q Consensus 344 ~~~-------------~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltG~~Pf~~~~~~~~~---~~~~~~~~ 407 (508)
... .....||+.|+|||++.+..++.++|||||||++|||++|..||......... ........
T Consensus 163 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~ 242 (310)
T 3s95_A 163 TQPEGLRSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFGLNVRGFLDR 242 (310)
T ss_dssp -----------------CCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHTCCSSTTTSCBCTTSSBCHHHHHHH
T ss_pred ccccccccccccccccccccCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHhcCCCCCcchhhhHHHHhhhhhccccc
Confidence 211 11457999999999999999999999999999999999999998644332211 11111111
Q ss_pred HhcccccccccCCCCCCChhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhhcCC
Q 010519 408 MVGTRRAEEVVDPNLEVKPATRALKRSLLVALRCVDPDSEKRPKMSQVVRMLEADD 463 (508)
Q Consensus 408 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~ 463 (508)
. ..+ .....+.+++.+||+.||.+|||+.++++.|+...
T Consensus 243 ~---------~~~--------~~~~~l~~li~~~l~~dP~~Rps~~~l~~~L~~l~ 281 (310)
T 3s95_A 243 Y---------CPP--------NCPPSFFPITVRCCDLDPEKRPSFVKLEHWLETLR 281 (310)
T ss_dssp T---------CCT--------TCCTTHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred c---------CCC--------CCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence 0 000 11234566999999999999999999999998653
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-45 Score=367.63 Aligned_cols=251 Identities=23% Similarity=0.361 Sum_probs=207.7
Q ss_pred hCCcccceeEeeeCceEEEEEEE-cCCCEEEEEEEcccc--hhhHHHHHHHHHHHhcCCCCCceeEEEEEEeCceeeEEE
Q 010519 185 TNRFSAENVLGEGGYGVVYKGRL-INGSEVAVKKLLNNL--GQAEKEFRVEVEAIGHVRHKNLVRLLGYCIEGVHRMLVY 261 (508)
Q Consensus 185 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~ei~~l~~l~h~niv~~~~~~~~~~~~~lv~ 261 (508)
.++|.+.+.||+|+||.||+|++ .+|+.||||++.... ......+.+|+.+++.++||||+++++++......++||
T Consensus 14 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~ 93 (328)
T 3fe3_A 14 IGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVIETEKTLYLIM 93 (328)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cCCEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhhcCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEE
Confidence 46899999999999999999998 478999999986542 334567888999999999999999999999999999999
Q ss_pred eecCCCCHHHHHhhhhccCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCEEEcCCCcEEEEecCCccccCC
Q 010519 262 EYVNNGNLEQWLHGAMRNQGNLTWEARMKVIIGTAKALAYLHEAIEPKVVHRDIKSSNILIDDEFNAKVSDFGLAKLLDS 341 (508)
Q Consensus 262 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~ 341 (508)
||+++|+|.+++. ..+.+++..++.++.||+.||.|||++ +|+||||||+|||++.++.+||+|||++.....
T Consensus 94 e~~~~~~L~~~l~----~~~~l~~~~~~~~~~qi~~al~~lH~~---~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~ 166 (328)
T 3fe3_A 94 EYASGGEVFDYLV----AHGRMKEKEARSKFRQIVSAVQYCHQK---RIVHRDLKAENLLLDADMNIKIADFGFSNEFTV 166 (328)
T ss_dssp CCCTTCBHHHHHH----HHCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECSTTCCGGGSS
T ss_pred ECCCCCcHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHHC---CEeccCCCHHHEEEcCCCCEEEeeccCceecCC
Confidence 9999999999995 345699999999999999999999999 999999999999999999999999999987654
Q ss_pred CCCcccccccccccccCccccCCCCCC-ChhhHHHHHHHHHHHHhCCCCCCCCCCCchhcHHHHHHHHhcccccccccCC
Q 010519 342 GESHITTRVMGTFGYVAPEYANTGMLN-EKSDIYSFGVLLLEAVTGRDPVDYGRPANEVNLVEWLKMMVGTRRAEEVVDP 420 (508)
Q Consensus 342 ~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DvwS~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 420 (508)
.. .....+||+.|+|||++.+..++ .++|||||||+||+|++|+.||.... ...........
T Consensus 167 ~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~------~~~~~~~i~~~--------- 229 (328)
T 3fe3_A 167 GG--KLDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQN------LKELRERVLRG--------- 229 (328)
T ss_dssp SC--GGGTTSSSGGGCCHHHHHTCCCCSHHHHHHHHHHHHHHHHHSSCSSCCSS------HHHHHHHHHHC---------
T ss_pred CC--ccccccCCcceeCcccccCCCcCCchhhhhhhHHHHHHHHhCCCCCCCCC------HHHHHHHHHhC---------
Confidence 33 24556899999999999888775 79999999999999999999996432 12222222111
Q ss_pred CCCCChhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhhc
Q 010519 421 NLEVKPATRALKRSLLVALRCVDPDSEKRPKMSQVVRMLEA 461 (508)
Q Consensus 421 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~ 461 (508)
....+ ......+.+|+.+||..||.+|||+.|++++-+-
T Consensus 230 ~~~~p--~~~s~~~~~li~~~L~~dP~~R~t~~eil~h~~~ 268 (328)
T 3fe3_A 230 KYRIP--FYMSTDCENLLKRFLVLNPIKRGTLEQIMKDRWI 268 (328)
T ss_dssp CCCCC--TTSCHHHHHHHHHHCCSSTTTSCCHHHHTTCTTT
T ss_pred CCCCC--CCCCHHHHHHHHHHCCCChhHCcCHHHHhcCHhh
Confidence 01111 1123456679999999999999999999987543
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-45 Score=373.12 Aligned_cols=262 Identities=26% Similarity=0.436 Sum_probs=210.6
Q ss_pred HHhhCCcccceeEeeeCceEEEEEEEc--------CCCEEEEEEEcccc-hhhHHHHHHHHHHHhcC-CCCCceeEEEEE
Q 010519 182 EIATNRFSAENVLGEGGYGVVYKGRLI--------NGSEVAVKKLLNNL-GQAEKEFRVEVEAIGHV-RHKNLVRLLGYC 251 (508)
Q Consensus 182 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~--------~~~~vavK~~~~~~-~~~~~~~~~ei~~l~~l-~h~niv~~~~~~ 251 (508)
++..++|.+.+.||+|+||+||+|++. ++..||||++.... ......+.+|+.+++.+ +||||++++++|
T Consensus 77 ~~~~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~ 156 (370)
T 2psq_A 77 EFPRDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGAC 156 (370)
T ss_dssp BCCGGGEEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTTCBHHHHHHHHHHHHHHHHSCCCTTBCCEEEEE
T ss_pred cccHHHCEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCCcCHHHHHHHHHHHHHHHHhcCCCCEeeEEEEE
Confidence 345578999999999999999999863 34579999986543 33446788999999999 899999999999
Q ss_pred EeCceeeEEEeecCCCCHHHHHhhhhc------------cCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCC
Q 010519 252 IEGVHRMLVYEYVNNGNLEQWLHGAMR------------NQGNLTWEARMKVIIGTAKALAYLHEAIEPKVVHRDIKSSN 319 (508)
Q Consensus 252 ~~~~~~~lv~E~~~~gsL~~~l~~~~~------------~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiH~Dlk~~N 319 (508)
.+....|+||||+++|+|.+++..... ....+++..++.++.||+.||.|||++ +|+||||||+|
T Consensus 157 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~N 233 (370)
T 2psq_A 157 TQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQ---KCIHRDLAARN 233 (370)
T ss_dssp CSSSSCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGG
T ss_pred ccCCCEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhC---Ceeccccchhh
Confidence 999999999999999999999975321 124588999999999999999999999 99999999999
Q ss_pred EEEcCCCcEEEEecCCccccCCCCC-cccccccccccccCccccCCCCCCChhhHHHHHHHHHHHHh-CCCCCCCCCCCc
Q 010519 320 ILIDDEFNAKVSDFGLAKLLDSGES-HITTRVMGTFGYVAPEYANTGMLNEKSDIYSFGVLLLEAVT-GRDPVDYGRPAN 397 (508)
Q Consensus 320 Ill~~~~~~kl~Dfgla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~ellt-G~~Pf~~~~~~~ 397 (508)
||++.++.+||+|||+++....... .......+|+.|+|||++.+..++.++|||||||+||||++ |..||......
T Consensus 234 Ill~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~p~~~~~~~- 312 (370)
T 2psq_A 234 VLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVE- 312 (370)
T ss_dssp EEECTTCCEEECCCSSCEETTCCCTTCTTTTTTSCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGG-
T ss_pred EEECCCCCEEEccccCCcccCcccceecccCCCcccceECHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCCCCCCHH-
Confidence 9999999999999999986654322 22334567889999999999999999999999999999999 99999643321
Q ss_pred hhcHHHHHHHHhcccccccccCCCCCCChhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhhcC
Q 010519 398 EVNLVEWLKMMVGTRRAEEVVDPNLEVKPATRALKRSLLVALRCVDPDSEKRPKMSQVVRMLEAD 462 (508)
Q Consensus 398 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~ 462 (508)
.+.. ....... . ..+......+.+++.+||+.||.+|||+.|++++|+..
T Consensus 313 --~~~~---~~~~~~~------~----~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~L~~i 362 (370)
T 2psq_A 313 --ELFK---LLKEGHR------M----DKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRI 362 (370)
T ss_dssp --GHHH---HHHTTCC------C----CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred --HHHH---HHhcCCC------C----CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence 1111 1111111 1 11112334567799999999999999999999999864
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-45 Score=364.52 Aligned_cols=266 Identities=29% Similarity=0.445 Sum_probs=203.7
Q ss_pred HHHHHHhhCCcccceeEeeeCceEEEEEEEcCCCEEEEEEEcccc--hhhHHHHHHHHHHHhcCCCCCceeEEEEEEeCc
Q 010519 178 LRDLEIATNRFSAENVLGEGGYGVVYKGRLINGSEVAVKKLLNNL--GQAEKEFRVEVEAIGHVRHKNLVRLLGYCIEGV 255 (508)
Q Consensus 178 ~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~--~~~~~~~~~ei~~l~~l~h~niv~~~~~~~~~~ 255 (508)
..++++..++|.+.+.||+|+||+||+|++ +|..||||++.... ......+.+|+.++++++||||+++++++.+..
T Consensus 29 ~~~~~i~~~~y~i~~~lG~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~ 107 (309)
T 3p86_A 29 GDDMDIPWCDLNIKEKIGAGSFGTVHRAEW-HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPP 107 (309)
T ss_dssp ---CBCCGGGEEEEEEEEECSSEEEEEEEE-TTEEEEEEEECCCCCSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTT
T ss_pred cccccCChhHceeeeEeecCCCeEEEEEEE-CCCcEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECC
Confidence 344566678999999999999999999987 78899999986543 333467889999999999999999999999999
Q ss_pred eeeEEEeecCCCCHHHHHhhhhccCCCccHHHHHHHHHHHHHHHHHHHhcCCCC--eEeecCCCCCEEEcCCCcEEEEec
Q 010519 256 HRMLVYEYVNNGNLEQWLHGAMRNQGNLTWEARMKVIIGTAKALAYLHEAIEPK--VVHRDIKSSNILIDDEFNAKVSDF 333 (508)
Q Consensus 256 ~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~--iiH~Dlk~~NIll~~~~~~kl~Df 333 (508)
..++||||+++|+|.+++... .....+++..++.++.||+.||.|||+. + |+||||||+|||++.++.+||+||
T Consensus 108 ~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~~~ivH~Dikp~NIll~~~~~~kL~Df 183 (309)
T 3p86_A 108 NLSIVTEYLSRGSLYRLLHKS-GAREQLDERRRLSMAYDVAKGMNYLHNR---NPPIVHRNLKSPNLLVDKKYTVKVCDF 183 (309)
T ss_dssp CCEEEEECCTTCBHHHHHHST-THHHHSCHHHHHHHHHHHHHHHHHHHTS---SSCCCCTTCCGGGEEECTTCCEEECCC
T ss_pred ceEEEEecCCCCcHHHHHhhc-CCCCCCCHHHHHHHHHHHHHHHHHHHcC---CCCEECCCCChhhEEEeCCCcEEECCC
Confidence 999999999999999999632 1123489999999999999999999998 8 999999999999999999999999
Q ss_pred CCccccCCCCCcccccccccccccCccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCCCchhcHHHHHHHHhcccc
Q 010519 334 GLAKLLDSGESHITTRVMGTFGYVAPEYANTGMLNEKSDIYSFGVLLLEAVTGRDPVDYGRPANEVNLVEWLKMMVGTRR 413 (508)
Q Consensus 334 gla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~ 413 (508)
|+++...... .......||+.|+|||++.+..++.++|||||||++|+|++|+.||..... . +.........
T Consensus 184 g~a~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~~~~---~---~~~~~~~~~~- 255 (309)
T 3p86_A 184 GLSRLKASTF-LSSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWGNLNP---A---QVVAAVGFKC- 255 (309)
T ss_dssp C------------------CCTTSCHHHHTTCCCCTTHHHHHHHHHHHHHHHCCCTTTTSCH---H---HHHHHHHHSC-
T ss_pred CCCccccccc-cccccCCCCccccChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH---H---HHHHHHHhcC-
Confidence 9998654332 123445789999999999999999999999999999999999999964322 1 1111111000
Q ss_pred cccccCCCCCCChhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhhcCCC
Q 010519 414 AEEVVDPNLEVKPATRALKRSLLVALRCVDPDSEKRPKMSQVVRMLEADDY 464 (508)
Q Consensus 414 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~ 464 (508)
... ..+......+.+|+.+||+.||.+|||+.++++.|+....
T Consensus 256 ------~~~--~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~L~~~~~ 298 (309)
T 3p86_A 256 ------KRL--EIPRNLNPQVAAIIEGCWTNEPWKRPSFATIMDLLRPLIK 298 (309)
T ss_dssp ------CCC--CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHC
T ss_pred ------CCC--CCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHH
Confidence 000 1111223456679999999999999999999999986543
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-45 Score=356.63 Aligned_cols=260 Identities=26% Similarity=0.410 Sum_probs=213.4
Q ss_pred HHhhCCcccceeEeeeCceEEEEEEEcCCCEEEEEEEcccchhhHHHHHHHHHHHhcCCCCCceeEEEEEEeCceeeEEE
Q 010519 182 EIATNRFSAENVLGEGGYGVVYKGRLINGSEVAVKKLLNNLGQAEKEFRVEVEAIGHVRHKNLVRLLGYCIEGVHRMLVY 261 (508)
Q Consensus 182 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~ei~~l~~l~h~niv~~~~~~~~~~~~~lv~ 261 (508)
++..++|.+.+.||+|+||+||+|.+.++..||+|++..... ....+.+|+.++.+++||||+++++++.+....++||
T Consensus 4 ~l~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 82 (268)
T 3sxs_A 4 ELKREEITLLKELGSGQFGVVKLGKWKGQYDVAVKMIKEGSM-SEDEFFQEAQTMMKLSHPKLVKFYGVCSKEYPIYIVT 82 (268)
T ss_dssp BCCGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECBTTB-CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEE
T ss_pred EechhheeeeeeeccCCCceEEEEEecCceeEEEEEeccCCC-cHHHHHHHHHHHHhCCCCCEeeEEEEEccCCceEEEE
Confidence 345678999999999999999999988888999999865432 3466888999999999999999999999999999999
Q ss_pred eecCCCCHHHHHhhhhccCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCEEEcCCCcEEEEecCCccccCC
Q 010519 262 EYVNNGNLEQWLHGAMRNQGNLTWEARMKVIIGTAKALAYLHEAIEPKVVHRDIKSSNILIDDEFNAKVSDFGLAKLLDS 341 (508)
Q Consensus 262 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~ 341 (508)
||+++++|.+++.. ....+++..++.++.|++.||.|||+. +|+||||||+|||++.++.+||+|||++.....
T Consensus 83 e~~~~~~L~~~l~~---~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~ 156 (268)
T 3sxs_A 83 EYISNGCLLNYLRS---HGKGLEPSQLLEMCYDVCEGMAFLESH---QFIHRDLAARNCLVDRDLCVKVSDFGMTRYVLD 156 (268)
T ss_dssp ECCTTCBHHHHHHH---HGGGCCHHHHHHHHHHHHHHHHHHHHT---TEEESSCSGGGEEECTTCCEEECCTTCEEECCT
T ss_pred EccCCCcHHHHHHH---cCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCcCcceEEECCCCCEEEccCccceecch
Confidence 99999999999963 345689999999999999999999999 999999999999999999999999999987765
Q ss_pred CCCcccccccccccccCccccCCCCCCChhhHHHHHHHHHHHHh-CCCCCCCCCCCchhcHHHHHHHHhcccccccccCC
Q 010519 342 GESHITTRVMGTFGYVAPEYANTGMLNEKSDIYSFGVLLLEAVT-GRDPVDYGRPANEVNLVEWLKMMVGTRRAEEVVDP 420 (508)
Q Consensus 342 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 420 (508)
..........+|+.|+|||++.+..++.++||||||+++|+|++ |..||...... ........... ...+
T Consensus 157 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~------~~~~~~~~~~~---~~~~ 227 (268)
T 3sxs_A 157 DQYVSSVGTKFPVKWSAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKMPYDLYTNS------EVVLKVSQGHR---LYRP 227 (268)
T ss_dssp TCEEECCSCCCCGGGCCHHHHHHSEEETTHHHHHHHHHHHHHHTTTCCTTTTSCHH------HHHHHHHTTCC---CCCC
T ss_pred hhhhcccCCCcCcccCCHHHHhccCCchhhhhHHHHHHHHHHHcCCCCCccccChH------HHHHHHHcCCC---CCCC
Confidence 54433444556778999999998889999999999999999999 99999643221 11111111110 0001
Q ss_pred CCCCChhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhhcCCC
Q 010519 421 NLEVKPATRALKRSLLVALRCVDPDSEKRPKMSQVVRMLEADDY 464 (508)
Q Consensus 421 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~ 464 (508)
......+.+++.+||+.||.+|||+.+++++|+....
T Consensus 228 -------~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l~~ 264 (268)
T 3sxs_A 228 -------HLASDTIYQIMYSCWHELPEKRPTFQQLLSSIEPLRE 264 (268)
T ss_dssp -------TTSCHHHHHHHHHTTCSSGGGSCCHHHHHHHHGGGCC
T ss_pred -------CcChHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhh
Confidence 1113456679999999999999999999999987653
|
| >4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-45 Score=358.65 Aligned_cols=258 Identities=27% Similarity=0.452 Sum_probs=212.1
Q ss_pred HHhhCCcccceeEeeeCceEEEEEEEcCCCEEEEEEEcccchhhHHHHHHHHHHHhcCCCCCceeEEEEEEeCceeeEEE
Q 010519 182 EIATNRFSAENVLGEGGYGVVYKGRLINGSEVAVKKLLNNLGQAEKEFRVEVEAIGHVRHKNLVRLLGYCIEGVHRMLVY 261 (508)
Q Consensus 182 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~ei~~l~~l~h~niv~~~~~~~~~~~~~lv~ 261 (508)
.+..++|.+.+.||+|+||+||+|.+.++..||+|++..... ..+.+.+|+.++++++||||+++++++.+....++||
T Consensus 6 ~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 84 (269)
T 4hcu_A 6 VIDPSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAM-SEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVF 84 (269)
T ss_dssp BCCGGGEEEEEEEEECSSCEEEEEEETTTEEEEEEEECTTSB-CHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEE
T ss_pred EeChhhceeeheecCCCccEEEEEEecCCCeEEEEEeccccc-CHHHHHHHHHHHHhCCCCCEeeEEEEEecCCceEEEE
Confidence 345578999999999999999999998889999999865433 3456889999999999999999999999999999999
Q ss_pred eecCCCCHHHHHhhhhccCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCEEEcCCCcEEEEecCCccccCC
Q 010519 262 EYVNNGNLEQWLHGAMRNQGNLTWEARMKVIIGTAKALAYLHEAIEPKVVHRDIKSSNILIDDEFNAKVSDFGLAKLLDS 341 (508)
Q Consensus 262 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~ 341 (508)
||+++++|.+++. .....+++..++.++.|++.||.|||+. +|+||||||+|||++.++.+||+|||++.....
T Consensus 85 e~~~~~~L~~~l~---~~~~~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~ 158 (269)
T 4hcu_A 85 EFMEHGCLSDYLR---TQRGLFAAETLLGMCLDVCEGMAYLEEA---CVIHRDLAARNCLVGENQVIKVSDFGMTRFVLD 158 (269)
T ss_dssp ECCTTCBHHHHHH---TTTTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECGGGCEEECCTTGGGGBCC
T ss_pred EeCCCCcHHHHHH---hcCcccCHHHHHHHHHHHHHHHHHHHhC---CeecCCcchheEEEcCCCCEEeccccccccccc
Confidence 9999999999996 3455789999999999999999999999 999999999999999999999999999987654
Q ss_pred CCCcccccccccccccCccccCCCCCCChhhHHHHHHHHHHHHh-CCCCCCCCCCCchhcHHHHHHHHhcccccccccCC
Q 010519 342 GESHITTRVMGTFGYVAPEYANTGMLNEKSDIYSFGVLLLEAVT-GRDPVDYGRPANEVNLVEWLKMMVGTRRAEEVVDP 420 (508)
Q Consensus 342 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 420 (508)
..........+++.|+|||++.+..++.++||||||+++|+|++ |..||..... ............
T Consensus 159 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~~g~~p~~~~~~------~~~~~~~~~~~~------- 225 (269)
T 4hcu_A 159 DQYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSN------SEVVEDISTGFR------- 225 (269)
T ss_dssp HHHHSTTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCH------HHHHHHHHTTCC-------
T ss_pred cccccccCcccccccCCHHHhcCCCCCchhhhHHHHHHHHHHhcCCCCCCCCCCH------HHHHHHHhcCcc-------
Confidence 33333344556788999999998999999999999999999999 9999964321 122222211110
Q ss_pred CCCCChhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhhcC
Q 010519 421 NLEVKPATRALKRSLLVALRCVDPDSEKRPKMSQVVRMLEAD 462 (508)
Q Consensus 421 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~ 462 (508)
...+......+.+++.+||+.||.+|||+.+++++|+..
T Consensus 226 ---~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~l 264 (269)
T 4hcu_A 226 ---LYKPRLASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEI 264 (269)
T ss_dssp ---CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred ---CCCCCcCCHHHHHHHHHHccCCcccCcCHHHHHHHHHHH
Confidence 011111234566799999999999999999999999864
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-45 Score=364.71 Aligned_cols=259 Identities=29% Similarity=0.484 Sum_probs=208.3
Q ss_pred HhhCCcccceeEeeeCceEEEEEEEc----CCCEEEEEEEcccc-hhhHHHHHHHHHHHhcCCCCCceeEEEEEEeCcee
Q 010519 183 IATNRFSAENVLGEGGYGVVYKGRLI----NGSEVAVKKLLNNL-GQAEKEFRVEVEAIGHVRHKNLVRLLGYCIEGVHR 257 (508)
Q Consensus 183 ~~~~~~~~~~~lg~G~~g~Vy~~~~~----~~~~vavK~~~~~~-~~~~~~~~~ei~~l~~l~h~niv~~~~~~~~~~~~ 257 (508)
+..++|.+.+.||+|+||+||+|.+. .+..||||++.... ......+.+|+.+++.++||||+++++++.+....
T Consensus 46 ~~~~~y~i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 125 (325)
T 3kul_A 46 IEASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLEGVVTRGRLA 125 (325)
T ss_dssp CCGGGEEEEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECGGGCC
T ss_pred cChhHeEEeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCcc
Confidence 44568999999999999999999884 34459999986543 34456789999999999999999999999999999
Q ss_pred eEEEeecCCCCHHHHHhhhhccCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCEEEcCCCcEEEEecCCcc
Q 010519 258 MLVYEYVNNGNLEQWLHGAMRNQGNLTWEARMKVIIGTAKALAYLHEAIEPKVVHRDIKSSNILIDDEFNAKVSDFGLAK 337 (508)
Q Consensus 258 ~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~Dfgla~ 337 (508)
++||||+++|+|.+++. .....+++..++.++.||+.||.|||+. +|+||||||+|||++.++.+||+|||+++
T Consensus 126 ~lv~e~~~~~~L~~~l~---~~~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~ 199 (325)
T 3kul_A 126 MIVTEYMENGSLDTFLR---THDGQFTIMQLVGMLRGVGAGMRYLSDL---GYVHRDLAARNVLVDSNLVCKVSDFGLSR 199 (325)
T ss_dssp EEEEECCTTCBHHHHHH---TTTTCSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCSSCE
T ss_pred EEEeeCCCCCcHHHHHH---hcccCCCHHHHHHHHHHHHHHHHHHHHC---CeeCCCCCcceEEECCCCCEEECCCCccc
Confidence 99999999999999995 3446799999999999999999999999 99999999999999999999999999998
Q ss_pred ccCCCCCc--ccccccccccccCccccCCCCCCChhhHHHHHHHHHHHHh-CCCCCCCCCCCchhcHHHHHHHHhccccc
Q 010519 338 LLDSGESH--ITTRVMGTFGYVAPEYANTGMLNEKSDIYSFGVLLLEAVT-GRDPVDYGRPANEVNLVEWLKMMVGTRRA 414 (508)
Q Consensus 338 ~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~ 414 (508)
........ ......+|+.|+|||++.+..++.++|||||||++|||++ |..||..... ............
T Consensus 200 ~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~------~~~~~~~~~~~~- 272 (325)
T 3kul_A 200 VLEDDPDAAYTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNMTN------RDVISSVEEGYR- 272 (325)
T ss_dssp ECC----CCEECC---CCGGGSCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTSCH------HHHHHHHHTTCC-
T ss_pred ccccCccceeeccCCCCcccccCHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCcccCCH------HHHHHHHHcCCC-
Confidence 76543221 2233456778999999998899999999999999999999 9999964321 112222221111
Q ss_pred ccccCCCCCCChhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhhcCC
Q 010519 415 EEVVDPNLEVKPATRALKRSLLVALRCVDPDSEKRPKMSQVVRMLEADD 463 (508)
Q Consensus 415 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~ 463 (508)
...+......+.+|+.+||+.||.+|||+.+|++.|+...
T Consensus 273 ---------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~L~~l~ 312 (325)
T 3kul_A 273 ---------LPAPMGCPHALHQLMLDCWHKDRAQRPRFSQIVSVLDALI 312 (325)
T ss_dssp ---------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred ---------CCCCCCcCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence 1111123456677999999999999999999999998754
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-44 Score=357.61 Aligned_cols=263 Identities=26% Similarity=0.349 Sum_probs=214.3
Q ss_pred eeHHHHHHhhCC----------cccceeEeeeCceEEEEEEEc-CCCEEEEEEEcccchhhHHHHHHHHHHHhcCCCCCc
Q 010519 176 FTLRDLEIATNR----------FSAENVLGEGGYGVVYKGRLI-NGSEVAVKKLLNNLGQAEKEFRVEVEAIGHVRHKNL 244 (508)
Q Consensus 176 ~~~~~~~~~~~~----------~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~ei~~l~~l~h~ni 244 (508)
|+..++..+.+. |...+.||+|+||.||+|++. +|+.||||++........+.+.+|+.+++.++||||
T Consensus 25 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~lg~G~~g~V~~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~ni 104 (321)
T 2c30_A 25 VTHEQFKAALRMVVDQGDPRLLLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHFNV 104 (321)
T ss_dssp CCHHHHHHHHHTTSCSSCHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCSHHHHHHHHHHHTTCCCTTB
T ss_pred CcHHHHHHHHhhccCCCCchhhhhccEEeccCCCeEEEEEEECCCCcEEEEEEEeccchhHHHHHHHHHHHHHhCCCCCc
Confidence 355666555543 777889999999999999986 799999999876655566778899999999999999
Q ss_pred eeEEEEEEeCceeeEEEeecCCCCHHHHHhhhhccCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCEEEcC
Q 010519 245 VRLLGYCIEGVHRMLVYEYVNNGNLEQWLHGAMRNQGNLTWEARMKVIIGTAKALAYLHEAIEPKVVHRDIKSSNILIDD 324 (508)
Q Consensus 245 v~~~~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiH~Dlk~~NIll~~ 324 (508)
+++++++......++||||+++|+|.+++. ...+++..+..++.|++.||.|||+. +|+||||||+|||++.
T Consensus 105 v~~~~~~~~~~~~~lv~e~~~~~~L~~~l~-----~~~l~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~ 176 (321)
T 2c30_A 105 VEMYKSYLVGEELWVLMEFLQGGALTDIVS-----QVRLNEEQIATVCEAVLQALAYLHAQ---GVIHRDIKSDSILLTL 176 (321)
T ss_dssp CCEEEEEEETTEEEEEECCCCSCBHHHHHT-----TCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECT
T ss_pred ceEEEEEEECCEEEEEEecCCCCCHHHHHH-----hcCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECC
Confidence 999999999999999999999999999884 34689999999999999999999999 9999999999999999
Q ss_pred CCcEEEEecCCccccCCCCCcccccccccccccCccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCCCchhcHHHH
Q 010519 325 EFNAKVSDFGLAKLLDSGESHITTRVMGTFGYVAPEYANTGMLNEKSDIYSFGVLLLEAVTGRDPVDYGRPANEVNLVEW 404 (508)
Q Consensus 325 ~~~~kl~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltG~~Pf~~~~~~~~~~~~~~ 404 (508)
++.+||+|||++........ ......||+.|+|||++.+..++.++|||||||++|||++|+.||..... .. .
T Consensus 177 ~~~~kl~Dfg~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~pf~~~~~---~~---~ 249 (321)
T 2c30_A 177 DGRVKLSDFGFCAQISKDVP-KRKSLVGTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGEPPYFSDSP---VQ---A 249 (321)
T ss_dssp TCCEEECCCTTCEECCSSSC-CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCH---HH---H
T ss_pred CCcEEEeeeeeeeecccCcc-ccccccCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH---HH---H
Confidence 99999999999987654322 23456799999999999999999999999999999999999999964321 11 1
Q ss_pred HHHHhcccccccccCCCCCCChhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhhc
Q 010519 405 LKMMVGTRRAEEVVDPNLEVKPATRALKRSLLVALRCVDPDSEKRPKMSQVVRMLEA 461 (508)
Q Consensus 405 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~ 461 (508)
........ .+.+ .........+.+++.+||+.||.+|||+.+++++..-
T Consensus 250 ~~~~~~~~------~~~~--~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~hp~~ 298 (321)
T 2c30_A 250 MKRLRDSP------PPKL--KNSHKVSPVLRDFLERMLVRDPQERATAQELLDHPFL 298 (321)
T ss_dssp HHHHHHSS------CCCC--TTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGG
T ss_pred HHHHhcCC------CCCc--CccccCCHHHHHHHHHHccCChhhCcCHHHHhcChhh
Confidence 11111111 1111 1112233456779999999999999999999986544
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-44 Score=362.80 Aligned_cols=254 Identities=24% Similarity=0.345 Sum_probs=209.5
Q ss_pred hCCcccceeEeeeCceEEEEEEEc-CCCEEEEEEEcccchh------hHHHHHHHHHHHhcCCCCCceeEEEEEEeCcee
Q 010519 185 TNRFSAENVLGEGGYGVVYKGRLI-NGSEVAVKKLLNNLGQ------AEKEFRVEVEAIGHVRHKNLVRLLGYCIEGVHR 257 (508)
Q Consensus 185 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~------~~~~~~~ei~~l~~l~h~niv~~~~~~~~~~~~ 257 (508)
.++|.+.+.||+|+||+||+|++. +|..||+|.+...... ....+.+|+.+++.++||||+++++++.+....
T Consensus 11 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~ 90 (361)
T 2yab_A 11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVYENRTDV 90 (361)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEE
T ss_pred hhceEEeeEEeeCcCEEEEEEEECCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCCCcEEEEEEeCCEE
Confidence 457999999999999999999886 6889999998654321 346788999999999999999999999999999
Q ss_pred eEEEeecCCCCHHHHHhhhhccCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCEEEcCCC----cEEEEec
Q 010519 258 MLVYEYVNNGNLEQWLHGAMRNQGNLTWEARMKVIIGTAKALAYLHEAIEPKVVHRDIKSSNILIDDEF----NAKVSDF 333 (508)
Q Consensus 258 ~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiH~Dlk~~NIll~~~~----~~kl~Df 333 (508)
++||||+++|+|.+++. ....+++..++.++.||+.||.|||+. +|+||||||+|||+++++ .+||+||
T Consensus 91 ~lv~e~~~gg~L~~~l~----~~~~l~~~~~~~i~~qi~~aL~~LH~~---givHrDlkp~NIll~~~~~~~~~vkl~DF 163 (361)
T 2yab_A 91 VLILELVSGGELFDFLA----QKESLSEEEATSFIKQILDGVNYLHTK---KIAHFDLKPENIMLLDKNIPIPHIKLIDF 163 (361)
T ss_dssp EEEEECCCSCBHHHHHT----TCSCCBHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESCTTSSSCCEEECCC
T ss_pred EEEEEcCCCCcHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEeCCCCCccCEEEEec
Confidence 99999999999999984 456799999999999999999999999 999999999999998877 7999999
Q ss_pred CCccccCCCCCcccccccccccccCccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCCCchhcHHHHHHHHhcccc
Q 010519 334 GLAKLLDSGESHITTRVMGTFGYVAPEYANTGMLNEKSDIYSFGVLLLEAVTGRDPVDYGRPANEVNLVEWLKMMVGTRR 413 (508)
Q Consensus 334 gla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~ 413 (508)
|++....... .....+||+.|+|||++.+..|+.++|||||||++|+|++|..||..... .+.+.....
T Consensus 164 G~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~~ll~g~~Pf~~~~~------~~~~~~i~~--- 232 (361)
T 2yab_A 164 GLAHEIEDGV--EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTK------QETLANITA--- 232 (361)
T ss_dssp SSCEECCTTC--CCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSH------HHHHHHHHT---
T ss_pred CCceEcCCCC--ccccCCCCccEECchHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCH------HHHHHHHHh---
Confidence 9998765432 23456799999999999999999999999999999999999999964321 112222211
Q ss_pred cccccCCCCCCCh--hHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhhcC
Q 010519 414 AEEVVDPNLEVKP--ATRALKRSLLVALRCVDPDSEKRPKMSQVVRMLEAD 462 (508)
Q Consensus 414 ~~~~~~~~~~~~~--~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~ 462 (508)
....... .......+.+|+.+||..||.+|||+.|+++|-+-.
T Consensus 233 ------~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~hp~~~ 277 (361)
T 2yab_A 233 ------VSYDFDEEFFSQTSELAKDFIRKLLVKETRKRLTIQEALRHPWIT 277 (361)
T ss_dssp ------TCCCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSTTTS
T ss_pred ------cCCCCCchhccCCCHHHHHHHHHHCCCChhHCcCHHHHhcCcCcC
Confidence 1111111 112345567799999999999999999999876543
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-44 Score=354.28 Aligned_cols=262 Identities=27% Similarity=0.402 Sum_probs=206.1
Q ss_pred hhCCcccceeEeeeCceEEEEEEEc-CCCEEEEEEEcccc---hhhHHHHHHHHHHHhcCCCCCceeEEEEEEeCceeeE
Q 010519 184 ATNRFSAENVLGEGGYGVVYKGRLI-NGSEVAVKKLLNNL---GQAEKEFRVEVEAIGHVRHKNLVRLLGYCIEGVHRML 259 (508)
Q Consensus 184 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~ei~~l~~l~h~niv~~~~~~~~~~~~~l 259 (508)
..++|.+.+.||+|+||.||+|++. ++..||+|.+.... ......+.+|+.++.+++||||+++++++.+....++
T Consensus 9 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~l 88 (294)
T 4eqm_A 9 INERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVDEEDDCYYL 88 (294)
T ss_dssp EETTEEEEEEEEEETTEEEEEEEETTTCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCBTTBCCEEEEEECSSEEEE
T ss_pred hhccEEEEEEEccCCCEEEEEEEECCCCCeEEEEEeccCccccHHHHHHHHHHHHHHhcCCCCCCceEEEeeeeCCeEEE
Confidence 4578999999999999999999875 68899999985432 3344678899999999999999999999999999999
Q ss_pred EEeecCCCCHHHHHhhhhccCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCEEEcCCCcEEEEecCCcccc
Q 010519 260 VYEYVNNGNLEQWLHGAMRNQGNLTWEARMKVIIGTAKALAYLHEAIEPKVVHRDIKSSNILIDDEFNAKVSDFGLAKLL 339 (508)
Q Consensus 260 v~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~Dfgla~~~ 339 (508)
||||+++++|.+++. ....+++..++.++.|++.||.|||++ +|+||||||+|||++.++.+||+|||++...
T Consensus 89 v~e~~~g~~L~~~l~----~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~ 161 (294)
T 4eqm_A 89 VMEYIEGPTLSEYIE----SHGPLSVDTAINFTNQILDGIKHAHDM---RIVHRDIKPQNILIDSNKTLKIFDFGIAKAL 161 (294)
T ss_dssp EEECCCSCBHHHHHH----HHCSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCCSSSTTC
T ss_pred EEeCCCCCCHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEEeCCCcccc
Confidence 999999999999995 345799999999999999999999999 9999999999999999999999999999876
Q ss_pred CCCCCcccccccccccccCccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCCCchhcHHHHHHHHhcccccccccC
Q 010519 340 DSGESHITTRVMGTFGYVAPEYANTGMLNEKSDIYSFGVLLLEAVTGRDPVDYGRPANEVNLVEWLKMMVGTRRAEEVVD 419 (508)
Q Consensus 340 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 419 (508)
............||+.|+|||++.+..++.++|||||||++|+|++|+.||...... ........ ...
T Consensus 162 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~-----~~~~~~~~-~~~------ 229 (294)
T 4eqm_A 162 SETSLTQTNHVLGTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPPFNGETAV-----SIAIKHIQ-DSV------ 229 (294)
T ss_dssp -------------CCSSCCHHHHHTCCCCTTHHHHHHHHHHHHHHHSSCSSCSSCHH-----HHHHHHHS-SCC------
T ss_pred ccccccccCccccCccccCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChH-----HHHHHHhh-ccC------
Confidence 544433344567999999999999999999999999999999999999999643211 11111111 110
Q ss_pred CCCCCChhHHHHHHHHHHHHHhcCCCCCCCC-CHHHHHHHhhcCCC
Q 010519 420 PNLEVKPATRALKRSLLVALRCVDPDSEKRP-KMSQVVRMLEADDY 464 (508)
Q Consensus 420 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-s~~evl~~L~~~~~ 464 (508)
+..........+..+.+++.+||+.||.+|| +++++.+.|+....
T Consensus 230 ~~~~~~~~~~~~~~l~~li~~~l~~dp~~R~~~~~~l~~~l~~~~~ 275 (294)
T 4eqm_A 230 PNVTTDVRKDIPQSLSNVILRATEKDKANRYKTIQEMKDDLSSVLH 275 (294)
T ss_dssp CCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCSSHHHHHHHHHTSSS
T ss_pred CCcchhcccCCCHHHHHHHHHHhcCCHhHccccHHHHHHHHHHHHh
Confidence 0000000111234566799999999999999 89999999987654
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-44 Score=363.11 Aligned_cols=252 Identities=25% Similarity=0.276 Sum_probs=207.2
Q ss_pred hCCcccceeEeeeCceEEEEEEEc-CCCEEEEEEEcccc---hhhHHHHHHHHHHHhcCCCCCceeEEEEEEeCceeeEE
Q 010519 185 TNRFSAENVLGEGGYGVVYKGRLI-NGSEVAVKKLLNNL---GQAEKEFRVEVEAIGHVRHKNLVRLLGYCIEGVHRMLV 260 (508)
Q Consensus 185 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~ei~~l~~l~h~niv~~~~~~~~~~~~~lv 260 (508)
.++|.+.+.||+|+||+||+|+.. +|+.||+|.+.... ......+..|+.+++.++||||+++++++.+....|+|
T Consensus 4 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lv 83 (337)
T 1o6l_A 4 MNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFV 83 (337)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEE
T ss_pred hHHeEEEEEEecCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhCCCCcCcceEEEEEeCCEEEEE
Confidence 358999999999999999999886 68999999986532 22345678899999999999999999999999999999
Q ss_pred EeecCCCCHHHHHhhhhccCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCEEEcCCCcEEEEecCCccccC
Q 010519 261 YEYVNNGNLEQWLHGAMRNQGNLTWEARMKVIIGTAKALAYLHEAIEPKVVHRDIKSSNILIDDEFNAKVSDFGLAKLLD 340 (508)
Q Consensus 261 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~Dfgla~~~~ 340 (508)
|||+++|+|.+++. ....+++..++.++.||+.||.|||++ +|+||||||+|||++.++++||+|||+++...
T Consensus 84 ~E~~~gg~L~~~l~----~~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~ 156 (337)
T 1o6l_A 84 MEYANGGELFFHLS----RERVFTEERARFYGAEIVSALEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCKEGI 156 (337)
T ss_dssp EECCTTCBHHHHHH----HHSCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBCSC
T ss_pred EeCCCCCcHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCcCCHHHEEECCCCCEEEeeccchhhcc
Confidence 99999999999985 345789999999999999999999999 99999999999999999999999999998643
Q ss_pred CCCCcccccccccccccCccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCCCchhcHHHHHHHHhcccccccccCC
Q 010519 341 SGESHITTRVMGTFGYVAPEYANTGMLNEKSDIYSFGVLLLEAVTGRDPVDYGRPANEVNLVEWLKMMVGTRRAEEVVDP 420 (508)
Q Consensus 341 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 420 (508)
... ......+||+.|+|||++.+..++.++|||||||++|||++|..||..... ..........
T Consensus 157 ~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~------~~~~~~i~~~--------- 220 (337)
T 1o6l_A 157 SDG-ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH------ERLFELILME--------- 220 (337)
T ss_dssp CTT-CCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSH------HHHHHHHHHC---------
T ss_pred cCC-CcccccccChhhCChhhhcCCCCCchhhcccchhHHHHHhcCCCCCCCCCH------HHHHHHHHcC---------
Confidence 322 224456899999999999999999999999999999999999999964321 1112121111
Q ss_pred CCCCChhHHHHHHHHHHHHHhcCCCCCCCC-----CHHHHHHHhhc
Q 010519 421 NLEVKPATRALKRSLLVALRCVDPDSEKRP-----KMSQVVRMLEA 461 (508)
Q Consensus 421 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~evl~~L~~ 461 (508)
.... +......+.+|+.+||+.||.+|| ++.|+++|-.-
T Consensus 221 ~~~~--p~~~s~~~~~li~~lL~~dP~~R~g~~~~~~~ei~~h~~f 264 (337)
T 1o6l_A 221 EIRF--PRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFF 264 (337)
T ss_dssp CCCC--CTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTSGGG
T ss_pred CCCC--CCCCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHHcCCCc
Confidence 0111 111234566799999999999999 99999987543
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-45 Score=357.58 Aligned_cols=258 Identities=25% Similarity=0.385 Sum_probs=208.7
Q ss_pred HHhhCCcccceeEeeeCceEEEEEEEcCCCEEEEEEEcccchhhHHHHHHHHHHHhcCCCCCceeEEEEEEeCceeeEEE
Q 010519 182 EIATNRFSAENVLGEGGYGVVYKGRLINGSEVAVKKLLNNLGQAEKEFRVEVEAIGHVRHKNLVRLLGYCIEGVHRMLVY 261 (508)
Q Consensus 182 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~ei~~l~~l~h~niv~~~~~~~~~~~~~lv~ 261 (508)
++..++|.+.+.||+|+||+||+|.+.++..||+|++..... ....+.+|+.++..++||||+++++++.+....++||
T Consensus 20 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 98 (283)
T 3gen_A 20 EIDPKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSM-SEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIIT 98 (283)
T ss_dssp BCCGGGEEEEEECC---CEEEEEEEETTTEEEEEEEECTTSB-CHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEE
T ss_pred cCCHHHHHhHhhcCCCCCceEEEEEEcCCCeEEEEEecCCCC-CHHHHHHHHHHHhcCCCCCEeeEEEEEecCCCeEEEE
Confidence 455679999999999999999999998888999999865432 3466888999999999999999999999999999999
Q ss_pred eecCCCCHHHHHhhhhccCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCEEEcCCCcEEEEecCCccccCC
Q 010519 262 EYVNNGNLEQWLHGAMRNQGNLTWEARMKVIIGTAKALAYLHEAIEPKVVHRDIKSSNILIDDEFNAKVSDFGLAKLLDS 341 (508)
Q Consensus 262 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~ 341 (508)
||+++|+|.+++.. ....+++..++.++.|++.||.|||++ +|+||||||+|||++.++.+||+|||++.....
T Consensus 99 e~~~~~~L~~~l~~---~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~ 172 (283)
T 3gen_A 99 EYMANGCLLNYLRE---MRHRFQTQQLLEMCKDVCEAMEYLESK---QFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLD 172 (283)
T ss_dssp CCCTTCBHHHHHHC---GGGCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCSGGGEEECTTSCEEECSTTGGGGBCC
T ss_pred eccCCCcHHHHHHH---hccCCCHHHHHHHHHHHHHHHHHHHHC---CccCCCCccceEEEcCCCCEEEccccccccccc
Confidence 99999999999963 345699999999999999999999999 999999999999999999999999999987654
Q ss_pred CCCcccccccccccccCccccCCCCCCChhhHHHHHHHHHHHHh-CCCCCCCCCCCchhcHHHHHHHHhcccccccccCC
Q 010519 342 GESHITTRVMGTFGYVAPEYANTGMLNEKSDIYSFGVLLLEAVT-GRDPVDYGRPANEVNLVEWLKMMVGTRRAEEVVDP 420 (508)
Q Consensus 342 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 420 (508)
..........+|+.|+|||++.+..++.++||||||+++|+|++ |+.||..... ............ .
T Consensus 173 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~t~g~~p~~~~~~------~~~~~~~~~~~~------~ 240 (283)
T 3gen_A 173 DEYTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTN------SETAEHIAQGLR------L 240 (283)
T ss_dssp HHHHSTTSTTSCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTTCCTTTTSCH------HHHHHHHHTTCC------C
T ss_pred cccccccCCccCcccCCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCccccCh------hHHHHHHhcccC------C
Confidence 33223334456788999999998899999999999999999998 9999964321 111112211110 0
Q ss_pred CCCCChhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhhcC
Q 010519 421 NLEVKPATRALKRSLLVALRCVDPDSEKRPKMSQVVRMLEAD 462 (508)
Q Consensus 421 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~ 462 (508)
..+......+.+++.+||+.||.+|||+.+++++|+..
T Consensus 241 ----~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~~ 278 (283)
T 3gen_A 241 ----YRPHLASEKVYTIMYSCWHEKADERPTFKILLSNILDV 278 (283)
T ss_dssp ----CCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHH
T ss_pred ----CCCCcCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHH
Confidence 01111134566799999999999999999999999764
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-45 Score=374.07 Aligned_cols=260 Identities=24% Similarity=0.397 Sum_probs=210.0
Q ss_pred HHHhhCCcccceeEeeeCceEEEEEEEc-CCCEEEEEEEcccc-hhhHHHHHHHHHHHhcCCCCCceeEEEEEEeCceee
Q 010519 181 LEIATNRFSAENVLGEGGYGVVYKGRLI-NGSEVAVKKLLNNL-GQAEKEFRVEVEAIGHVRHKNLVRLLGYCIEGVHRM 258 (508)
Q Consensus 181 ~~~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~ei~~l~~l~h~niv~~~~~~~~~~~~~ 258 (508)
+.+..++|.+.+.||+|+||+||+|++. ++..||||.+.... ......+.+|+.+|++++||||+++++++......+
T Consensus 109 ~~~~~~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~ 188 (377)
T 3cbl_A 109 WVLNHEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIY 188 (377)
T ss_dssp TBCCGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEECCTTSCHHHHTTTTHHHHHHTTCCCTTBCCEEEEECSSSSCE
T ss_pred cEEchHHeEEeeEeccCCCCeEEEEEEecCCeEEEEEEccccCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEecCCCcE
Confidence 4566779999999999999999999986 78899999986543 233456888999999999999999999999989999
Q ss_pred EEEeecCCCCHHHHHhhhhccCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCEEEcCCCcEEEEecCCccc
Q 010519 259 LVYEYVNNGNLEQWLHGAMRNQGNLTWEARMKVIIGTAKALAYLHEAIEPKVVHRDIKSSNILIDDEFNAKVSDFGLAKL 338 (508)
Q Consensus 259 lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~Dfgla~~ 338 (508)
+||||+++|+|.+++.. ....+++..++.++.||+.||.|||++ +|+||||||+|||++.++.+||+|||+++.
T Consensus 189 lv~e~~~~g~L~~~l~~---~~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivHrDlkp~Nil~~~~~~~kl~DfG~s~~ 262 (377)
T 3cbl_A 189 IVMELVQGGDFLTFLRT---EGARLRVKTLLQMVGDAAAGMEYLESK---CCIHRDLAARNCLVTEKNVLKISDFGMSRE 262 (377)
T ss_dssp EEEECCTTCBHHHHHHH---HGGGCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCGGGCEE
T ss_pred EEEEcCCCCCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHC---CcCCcccCHHHEEEcCCCcEEECcCCCcee
Confidence 99999999999999963 345689999999999999999999999 999999999999999999999999999986
Q ss_pred cCCCCCccc-ccccccccccCccccCCCCCCChhhHHHHHHHHHHHHh-CCCCCCCCCCCchhcHHHHHHHHhccccccc
Q 010519 339 LDSGESHIT-TRVMGTFGYVAPEYANTGMLNEKSDIYSFGVLLLEAVT-GRDPVDYGRPANEVNLVEWLKMMVGTRRAEE 416 (508)
Q Consensus 339 ~~~~~~~~~-~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 416 (508)
......... ....+++.|+|||++.+..++.++|||||||+||||++ |..||..... ..... .......
T Consensus 263 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~t~g~~p~~~~~~---~~~~~---~~~~~~~--- 333 (377)
T 3cbl_A 263 EADGVYAASGGLRQVPVKWTAPEALNYGRYSSESDVWSFGILLWETFSLGASPYPNLSN---QQTRE---FVEKGGR--- 333 (377)
T ss_dssp CTTSEEECCSSCCEEEGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCSSTTSCH---HHHHH---HHHTTCC---
T ss_pred cCCCceeecCCCCCCCcCcCCHhHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCH---HHHHH---HHHcCCC---
Confidence 543221111 12235778999999998899999999999999999998 9999864321 11111 1111111
Q ss_pred ccCCCCCCChhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhhcC
Q 010519 417 VVDPNLEVKPATRALKRSLLVALRCVDPDSEKRPKMSQVVRMLEAD 462 (508)
Q Consensus 417 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~ 462 (508)
...+......+.+|+.+||+.||.+|||+.++++.|+..
T Consensus 334 -------~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~i 372 (377)
T 3cbl_A 334 -------LPCPELCPDAVFRLMEQCWAYEPGQRPSFSTIYQELQSI 372 (377)
T ss_dssp -------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred -------CCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHH
Confidence 111112234567799999999999999999999999864
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-45 Score=383.07 Aligned_cols=263 Identities=24% Similarity=0.407 Sum_probs=214.1
Q ss_pred HHHHHhhCCcccceeEeeeCceEEEEEEEcCCCEEEEEEEcccchhhHHHHHHHHHHHhcCCCCCceeEEEEEEeCceee
Q 010519 179 RDLEIATNRFSAENVLGEGGYGVVYKGRLINGSEVAVKKLLNNLGQAEKEFRVEVEAIGHVRHKNLVRLLGYCIEGVHRM 258 (508)
Q Consensus 179 ~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~ei~~l~~l~h~niv~~~~~~~~~~~~~ 258 (508)
..+++..++|.+.+.||+|+||+||+|.+.++..||||++.... ...+.+.+|+.+|+.++||||+++++++. ....+
T Consensus 181 ~~~~i~~~~~~~~~~lG~G~fg~V~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~iv~l~~~~~-~~~~~ 258 (454)
T 1qcf_A 181 DAWEIPRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGS-MSVEAFLAEANVMKTLQHDKLVKLHAVVT-KEPIY 258 (454)
T ss_dssp TCSBCCGGGEEEEEEEECCSSEEEEEEEETTTEEEEEEEECTTS-BCHHHHHHHHHHHTTCCCTTBCCEEEEEC-SSSCE
T ss_pred cceeechHHeEEEEEcccCCceEEEEEEECCccEEEEEEecCCC-ccHHHHHHHHHHHhhCCCCCEeeEEEEEe-CCccE
Confidence 44567788999999999999999999999888899999987543 34567899999999999999999999886 66789
Q ss_pred EEEeecCCCCHHHHHhhhhccCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCEEEcCCCcEEEEecCCccc
Q 010519 259 LVYEYVNNGNLEQWLHGAMRNQGNLTWEARMKVIIGTAKALAYLHEAIEPKVVHRDIKSSNILIDDEFNAKVSDFGLAKL 338 (508)
Q Consensus 259 lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~Dfgla~~ 338 (508)
+||||+++|+|.+++... ....+++..++.++.||+.||.|||++ +|+||||||+|||++.++.+||+|||+++.
T Consensus 259 lv~e~~~~g~L~~~l~~~--~~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivHrDlkp~Nill~~~~~~kl~DFG~a~~ 333 (454)
T 1qcf_A 259 IITEFMAKGSLLDFLKSD--EGSKQPLPKLIDFSAQIAEGMAFIEQR---NYIHRDLRAANILVSASLVCKIADFGLARV 333 (454)
T ss_dssp EEECCCTTCBHHHHHHSH--HHHTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCSGGGEEECTTCCEEECSTTGGGG
T ss_pred EEEeecCCCcHHHHHHhc--cCCCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCCHHHEEECCCCcEEEeeCCCceE
Confidence 999999999999999642 234678899999999999999999999 999999999999999999999999999987
Q ss_pred cCCCCCcccccccccccccCccccCCCCCCChhhHHHHHHHHHHHHh-CCCCCCCCCCCchhcHHHHHHHHhcccccccc
Q 010519 339 LDSGESHITTRVMGTFGYVAPEYANTGMLNEKSDIYSFGVLLLEAVT-GRDPVDYGRPANEVNLVEWLKMMVGTRRAEEV 417 (508)
Q Consensus 339 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 417 (508)
.............++..|+|||++.+..++.++|||||||+||||++ |+.||..... . +..........
T Consensus 334 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t~g~~P~~~~~~---~---~~~~~i~~~~~---- 403 (454)
T 1qcf_A 334 IEDNEYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSN---P---EVIRALERGYR---- 403 (454)
T ss_dssp BCCHHHHTTCSSSSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCH---H---HHHHHHHHTCC----
T ss_pred cCCCceeccCCCcccccccCHHHhccCCCCcHHHHHhHHHHHHHHHhCCCCCCCCCCH---H---HHHHHHHcCCC----
Confidence 65432222233456788999999998899999999999999999999 9999964321 1 11222211111
Q ss_pred cCCCCCCChhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhhcCCC
Q 010519 418 VDPNLEVKPATRALKRSLLVALRCVDPDSEKRPKMSQVVRMLEADDY 464 (508)
Q Consensus 418 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~ 464 (508)
...+......+.+|+.+||+.||.+|||+.+|++.|+....
T Consensus 404 ------~~~~~~~~~~l~~li~~cl~~dp~~RPt~~~i~~~L~~~~~ 444 (454)
T 1qcf_A 404 ------MPRPENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDDFYT 444 (454)
T ss_dssp ------CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSSS
T ss_pred ------CCCCCCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHHh
Confidence 11112234567779999999999999999999999998754
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-44 Score=362.61 Aligned_cols=256 Identities=19% Similarity=0.274 Sum_probs=208.4
Q ss_pred hCCcccceeEeeeCceEEEEEEEc-CCCEEEEEEEcccc-----hhhHHHHHHHHHHHhcCCCCCceeEEEEEEeCceee
Q 010519 185 TNRFSAENVLGEGGYGVVYKGRLI-NGSEVAVKKLLNNL-----GQAEKEFRVEVEAIGHVRHKNLVRLLGYCIEGVHRM 258 (508)
Q Consensus 185 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-----~~~~~~~~~ei~~l~~l~h~niv~~~~~~~~~~~~~ 258 (508)
.++|.+.+.||+|+||+||+|.+. +|+.||||++.... ......+.+|+.+++.++||||+++++++.+....|
T Consensus 23 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~ 102 (351)
T 3c0i_A 23 EDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSSDGMLY 102 (351)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEE
T ss_pred ccceEEeeEEeeCCCEEEEEEEECCCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEE
Confidence 457999999999999999999875 68999999985322 123567889999999999999999999999999999
Q ss_pred EEEeecCCCCHHHHHhhhhccCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCEEEcCCCc---EEEEecCC
Q 010519 259 LVYEYVNNGNLEQWLHGAMRNQGNLTWEARMKVIIGTAKALAYLHEAIEPKVVHRDIKSSNILIDDEFN---AKVSDFGL 335 (508)
Q Consensus 259 lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiH~Dlk~~NIll~~~~~---~kl~Dfgl 335 (508)
+||||+++|+|.+++.........+++..++.++.||+.||.|||++ +|+||||||+|||++.++. +||+|||+
T Consensus 103 lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~---~ivHrDlkp~NIl~~~~~~~~~vkl~Dfg~ 179 (351)
T 3c0i_A 103 MVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDN---NIIHRDVKPHCVLLASKENSAPVKLGGFGV 179 (351)
T ss_dssp EEEECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECSSSTTCCEEECCCTT
T ss_pred EEEeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCChHHeEEecCCCCCcEEEecCcc
Confidence 99999999999998876544555789999999999999999999999 9999999999999987655 99999999
Q ss_pred ccccCCCCCcccccccccccccCccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCCCchhcHHHHHHHHhcccccc
Q 010519 336 AKLLDSGESHITTRVMGTFGYVAPEYANTGMLNEKSDIYSFGVLLLEAVTGRDPVDYGRPANEVNLVEWLKMMVGTRRAE 415 (508)
Q Consensus 336 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~ 415 (508)
+........ .....+||+.|+|||++.+..++.++|||||||+||+|++|..||.... . ........
T Consensus 180 a~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~----~---~~~~~i~~----- 246 (351)
T 3c0i_A 180 AIQLGESGL-VAGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPFYGTK----E---RLFEGIIK----- 246 (351)
T ss_dssp CEECCTTSC-BCCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCSSH----H---HHHHHHHH-----
T ss_pred eeEecCCCe-eecCCcCCcCccCHHHHcCCCCCchHhhHHHHHHHHHHHHCCCCCCCcH----H---HHHHHHHc-----
Confidence 987654322 2344679999999999999999999999999999999999999996421 1 11111111
Q ss_pred cccCCCCCCChh--HHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhh
Q 010519 416 EVVDPNLEVKPA--TRALKRSLLVALRCVDPDSEKRPKMSQVVRMLE 460 (508)
Q Consensus 416 ~~~~~~~~~~~~--~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 460 (508)
......+. ......+.+|+.+||+.||.+|||+.|++++-+
T Consensus 247 ----~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~hp~ 289 (351)
T 3c0i_A 247 ----GKYKMNPRQWSHISESAKDLVRRMLMLDPAERITVYEALNHPW 289 (351)
T ss_dssp ----TCCCCCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHH
T ss_pred ----CCCCCCccccccCCHHHHHHHHHHCCCChhHCcCHHHHhcChh
Confidence 11111111 122456777999999999999999999998653
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-43 Score=348.80 Aligned_cols=280 Identities=37% Similarity=0.643 Sum_probs=225.0
Q ss_pred ceeHHHHHHhhCCcccc------eeEeeeCceEEEEEEEcCCCEEEEEEEcccc----hhhHHHHHHHHHHHhcCCCCCc
Q 010519 175 WFTLRDLEIATNRFSAE------NVLGEGGYGVVYKGRLINGSEVAVKKLLNNL----GQAEKEFRVEVEAIGHVRHKNL 244 (508)
Q Consensus 175 ~~~~~~~~~~~~~~~~~------~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~----~~~~~~~~~ei~~l~~l~h~ni 244 (508)
.|++.++..++++|... +.||+|+||.||+|.+ ++..||+|++.... ......+.+|+.+++.++||||
T Consensus 14 ~~~~~~l~~~~~~f~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i 92 (307)
T 2nru_A 14 SFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV-NNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENL 92 (307)
T ss_dssp ECCHHHHHHHTTTTCCSBTTTTCCEEEECSSEEEEEEES-SSCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHHCCCTTB
T ss_pred cccHHHHHHHHcccccccccccCCccccCCCeEEEEEEE-CCceEEEEEEecccCcchHHHHHHHHHHHHHHHhcCCCCe
Confidence 35788888888888776 8999999999999986 78999999986432 3345678899999999999999
Q ss_pred eeEEEEEEeCceeeEEEeecCCCCHHHHHhhhhccCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCEEEcC
Q 010519 245 VRLLGYCIEGVHRMLVYEYVNNGNLEQWLHGAMRNQGNLTWEARMKVIIGTAKALAYLHEAIEPKVVHRDIKSSNILIDD 324 (508)
Q Consensus 245 v~~~~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiH~Dlk~~NIll~~ 324 (508)
+++++++.+....++||||+++|+|.+++... .....+++..++.++.||+.||.|||+. +|+||||||+|||++.
T Consensus 93 ~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dlkp~Nili~~ 168 (307)
T 2nru_A 93 VELLGFSSDGDDLCLVYVYMPNGSLLDRLSCL-DGTPPLSWHMRCKIAQGAANGINFLHEN---HHIHRDIKSANILLDE 168 (307)
T ss_dssp CCEEEEECSSSSCEEEEECCTTCBHHHHHHTG-GGCCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECT
T ss_pred EEEEEEEecCCceEEEEEecCCCcHHHHHHhc-cCCCCCCHHHHHHHHHHHHHHHHHHhcC---CeecCCCCHHHEEEcC
Confidence 99999999999999999999999999999642 3345799999999999999999999999 9999999999999999
Q ss_pred CCcEEEEecCCccccCCCCCc-ccccccccccccCccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCCCchhcHHH
Q 010519 325 EFNAKVSDFGLAKLLDSGESH-ITTRVMGTFGYVAPEYANTGMLNEKSDIYSFGVLLLEAVTGRDPVDYGRPANEVNLVE 403 (508)
Q Consensus 325 ~~~~kl~Dfgla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltG~~Pf~~~~~~~~~~~~~ 403 (508)
++.+||+|||++......... ......||+.|+|||++.+ .++.++||||||+++|+|++|..||......... ..
T Consensus 169 ~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~--~~ 245 (307)
T 2nru_A 169 AFTAKISDFGLARASEKFAQTVMTSRIVGTTAYMAPEALRG-EITPKSDIYSFGVVLLEIITGLPAVDEHREPQLL--LD 245 (307)
T ss_dssp TCCEEECCCTTCEECCSCSSCEECSSCCSCGGGCCHHHHTT-EECTHHHHHHHHHHHHHHHHCCCSBCTTBSSSBT--TH
T ss_pred CCcEEEeecccccccccccccccccccCCCcCcCChHHhcC-CCCccchhHHHHHHHHHHHHCCCCcccCcchHHH--HH
Confidence 999999999999876543222 2334578999999999876 4889999999999999999999999755433221 12
Q ss_pred HHHHHhc-ccccccccCCCCCCChhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhhcCC
Q 010519 404 WLKMMVG-TRRAEEVVDPNLEVKPATRALKRSLLVALRCVDPDSEKRPKMSQVVRMLEADD 463 (508)
Q Consensus 404 ~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~ 463 (508)
+...... .......++..+. .........+.+++.+||+.||.+|||+.+++++|+...
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~l~~li~~cl~~~p~~Rps~~~l~~~L~~l~ 305 (307)
T 2nru_A 246 IKEEIEDEEKTIEDYIDKKMN-DADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQEMT 305 (307)
T ss_dssp HHHHHHTTSCCHHHHSCSSCS-CCCHHHHHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHC
T ss_pred HHHHhhhhhhhhhhhcccccc-ccchHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHh
Confidence 2222211 1222233333332 233455677888999999999999999999999998653
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-43 Score=350.68 Aligned_cols=276 Identities=23% Similarity=0.270 Sum_probs=214.0
Q ss_pred hCCcccceeEeeeCceEEEEEEEc-CCCEEEEEEEcccc-hhhHHHHHHHHHHHhcCCCCCceeEEEEEEeCc--eeeEE
Q 010519 185 TNRFSAENVLGEGGYGVVYKGRLI-NGSEVAVKKLLNNL-GQAEKEFRVEVEAIGHVRHKNLVRLLGYCIEGV--HRMLV 260 (508)
Q Consensus 185 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~ei~~l~~l~h~niv~~~~~~~~~~--~~~lv 260 (508)
.++|.+.+.||+|+||+||+|++. +++.||||++.... ......+.+|+.++++++||||+++++++.... ..++|
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv 87 (319)
T 4euu_A 8 NHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLI 87 (319)
T ss_dssp SEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEE
T ss_pred CCCEEEEEEecCCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCcceEEEEeecCCCceEEEE
Confidence 357999999999999999999986 48899999986543 233466788999999999999999999998765 67899
Q ss_pred EeecCCCCHHHHHhhhhccCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCEEE----cCCCcEEEEecCCc
Q 010519 261 YEYVNNGNLEQWLHGAMRNQGNLTWEARMKVIIGTAKALAYLHEAIEPKVVHRDIKSSNILI----DDEFNAKVSDFGLA 336 (508)
Q Consensus 261 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiH~Dlk~~NIll----~~~~~~kl~Dfgla 336 (508)
|||+++|+|.+++... .....+++..++.++.||+.||.|||+. +|+||||||+|||+ +.++.+||+|||++
T Consensus 88 ~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~~kL~Dfg~a 163 (319)
T 4euu_A 88 MEFCPCGSLYTVLEEP-SNAYGLPESEFLIVLRDVVGGMNHLREN---GIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAA 163 (319)
T ss_dssp EECCTTCBHHHHHHSG-GGTTCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEECTTSCEEEEECCCTTC
T ss_pred EeCCCCCCHHHHHHHh-ccccCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHEEEeccCCCCceEEEccCCCc
Confidence 9999999999999643 2233489999999999999999999999 99999999999999 78888999999999
Q ss_pred cccCCCCCcccccccccccccCccccC--------CCCCCChhhHHHHHHHHHHHHhCCCCCCCCCCCchhcHHHHHHHH
Q 010519 337 KLLDSGESHITTRVMGTFGYVAPEYAN--------TGMLNEKSDIYSFGVLLLEAVTGRDPVDYGRPANEVNLVEWLKMM 408 (508)
Q Consensus 337 ~~~~~~~~~~~~~~~gt~~y~aPE~~~--------~~~~~~~~DvwS~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~ 408 (508)
+....... .....||+.|+|||++. +..++.++|||||||++|||++|+.||........ ..+.+...
T Consensus 164 ~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~--~~~~~~~~ 239 (319)
T 4euu_A 164 RELEDDEQ--FVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRR--NKEVMYKI 239 (319)
T ss_dssp EECCTTCC--BCCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHHHSSCSEECTTCGGG--CHHHHHHH
T ss_pred eecCCCCc--eeecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCccch--hHHHHHHH
Confidence 87654432 33457899999999886 57889999999999999999999999964332221 11222222
Q ss_pred hccccc---ccc---c--------CCCCCCChhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhhcCCCCCch
Q 010519 409 VGTRRA---EEV---V--------DPNLEVKPATRALKRSLLVALRCVDPDSEKRPKMSQVVRMLEADDYPFRE 468 (508)
Q Consensus 409 ~~~~~~---~~~---~--------~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~~~~ 468 (508)
...... ..+ . ...............+.+++.+||+.||.+|||+.|++++..+...+-..
T Consensus 240 ~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~R~s~~ell~h~~d~~~~~~~ 313 (319)
T 4euu_A 240 ITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDILHRGNS 313 (319)
T ss_dssp HHHCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHHTC----
T ss_pred hcCCCcccchhhhcccCCccccCccCCcccccchhHHHHhHHHHHHhccCChhhhccHHHhhhccHHHhhcCCc
Confidence 211110 000 0 01111123355666778899999999999999999999999987765433
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-44 Score=354.28 Aligned_cols=264 Identities=22% Similarity=0.402 Sum_probs=205.7
Q ss_pred HhhCCcccceeEeeeCceEEEEEEEc-----CCCEEEEEEEcccchhhHHHHHHHHHHHhcCCCCCceeEEEEEEeC--c
Q 010519 183 IATNRFSAENVLGEGGYGVVYKGRLI-----NGSEVAVKKLLNNLGQAEKEFRVEVEAIGHVRHKNLVRLLGYCIEG--V 255 (508)
Q Consensus 183 ~~~~~~~~~~~lg~G~~g~Vy~~~~~-----~~~~vavK~~~~~~~~~~~~~~~ei~~l~~l~h~niv~~~~~~~~~--~ 255 (508)
+..++|++.+.||+|+||+||+|++. ++..||||++..........+.+|+.++++++||||+++++++... .
T Consensus 7 ~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 86 (295)
T 3ugc_A 7 FEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRR 86 (295)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECHHHHT
T ss_pred CCHHHhhhhheeeccCCEEEEEEEEecccCCCCcEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCC
Confidence 34568999999999999999999852 6789999999876666667899999999999999999999998654 4
Q ss_pred eeeEEEeecCCCCHHHHHhhhhccCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCEEEcCCCcEEEEecCC
Q 010519 256 HRMLVYEYVNNGNLEQWLHGAMRNQGNLTWEARMKVIIGTAKALAYLHEAIEPKVVHRDIKSSNILIDDEFNAKVSDFGL 335 (508)
Q Consensus 256 ~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~Dfgl 335 (508)
..++||||+++|+|.+++.. ....+++..++.++.|++.||.|||+. +|+||||||+|||++.++.+||+|||+
T Consensus 87 ~~~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dikp~Nil~~~~~~~kl~Dfg~ 160 (295)
T 3ugc_A 87 NLKLIMEYLPYGSLRDYLQK---HKERIDHIKLLQYTSQICKGMEYLGTK---RYIHRDLATRNILVENENRVKIGDFGL 160 (295)
T ss_dssp SCEEEEECCTTCBHHHHHHH---CGGGCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECCCCS
T ss_pred ceEEEEEeCCCCCHHHHHHh---cccccCHHHHHHHHHHHHHHHHHHhcC---CcccCCCCHhhEEEcCCCeEEEccCcc
Confidence 57899999999999999963 344689999999999999999999999 999999999999999999999999999
Q ss_pred ccccCCCCC--cccccccccccccCccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCC----------CchhcHHH
Q 010519 336 AKLLDSGES--HITTRVMGTFGYVAPEYANTGMLNEKSDIYSFGVLLLEAVTGRDPVDYGRP----------ANEVNLVE 403 (508)
Q Consensus 336 a~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltG~~Pf~~~~~----------~~~~~~~~ 403 (508)
+........ .......++..|+|||++.+..++.++|||||||++|||++|..||..... ........
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (295)
T 3ugc_A 161 TKVLPQDKEFFKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFH 240 (295)
T ss_dssp CC-------------CTTCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTTCTTCSHHHHHHHHHCTTCCTHHHHHH
T ss_pred cccccCCcceeeeccCCCCccceeCcHHhcCCCCChHHHHHHHHHHHHHHHhcccccCCChHHHHhhhcCccccchhHHH
Confidence 987643322 122334577789999999999999999999999999999999999853210 00000001
Q ss_pred HHHHHhcccccccccCCCCCCChhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhhcC
Q 010519 404 WLKMMVGTRRAEEVVDPNLEVKPATRALKRSLLVALRCVDPDSEKRPKMSQVVRMLEAD 462 (508)
Q Consensus 404 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~ 462 (508)
........ .....+......+.+++.+||+.||.+|||+.|+++.|+..
T Consensus 241 ~~~~~~~~----------~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~el~~~L~~l 289 (295)
T 3ugc_A 241 LIELLKNN----------GRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQI 289 (295)
T ss_dssp HHHHHHTT----------CCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHH
T ss_pred HHHHHhcc----------CcCCCCcCcCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHH
Confidence 11111111 11111222345677799999999999999999999999864
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-44 Score=358.35 Aligned_cols=257 Identities=24% Similarity=0.363 Sum_probs=206.1
Q ss_pred CCcccceeEeeeCceEEEEEEEc-CCCEEEEEEEcccch-hhHHHHHHHHHHHhcCCCCCceeEEEEEEeCceeeEEEee
Q 010519 186 NRFSAENVLGEGGYGVVYKGRLI-NGSEVAVKKLLNNLG-QAEKEFRVEVEAIGHVRHKNLVRLLGYCIEGVHRMLVYEY 263 (508)
Q Consensus 186 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~ei~~l~~l~h~niv~~~~~~~~~~~~~lv~E~ 263 (508)
++|.+.+.||+|+||+||+|.+. +++.||+|++..... ...+.+.+|+.+++.++||||+++++++.+....++||||
T Consensus 7 ~~y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~ 86 (323)
T 3tki_A 7 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEY 86 (323)
T ss_dssp TCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred hhceeeeEEecCCCEEEEEEEECCCCcEEEEEEEEcccccchHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEEEEc
Confidence 58999999999999999999886 788999999854432 2345688899999999999999999999999999999999
Q ss_pred cCCCCHHHHHhhhhccCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCEEEcCCCcEEEEecCCccccCCCC
Q 010519 264 VNNGNLEQWLHGAMRNQGNLTWEARMKVIIGTAKALAYLHEAIEPKVVHRDIKSSNILIDDEFNAKVSDFGLAKLLDSGE 343 (508)
Q Consensus 264 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~~~ 343 (508)
+++|+|.+++ .....+++..++.++.||+.||.|||+. +|+||||||+|||++.++.+||+|||++.......
T Consensus 87 ~~~~~L~~~l----~~~~~~~~~~~~~i~~qi~~aL~~LH~~---givH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~ 159 (323)
T 3tki_A 87 CSGGELFDRI----EPDIGMPEPDAQRFFHQLMAGVVYLHGI---GITHRDIKPENLLLDERDNLKISDFGLATVFRYNN 159 (323)
T ss_dssp CTTEEGGGGS----BTTTBCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCTTCEECEETT
T ss_pred CCCCcHHHHH----hhcCCCCHHHHHHHHHHHHHHHHHHHHC---CccccccchHHEEEeCCCCEEEEEeeccceeccCC
Confidence 9999999987 4556799999999999999999999999 99999999999999999999999999998654222
Q ss_pred -CcccccccccccccCccccCCCCC-CChhhHHHHHHHHHHHHhCCCCCCCCCCCchhcHHHHHHHHhcccccccccCCC
Q 010519 344 -SHITTRVMGTFGYVAPEYANTGML-NEKSDIYSFGVLLLEAVTGRDPVDYGRPANEVNLVEWLKMMVGTRRAEEVVDPN 421 (508)
Q Consensus 344 -~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DvwS~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 421 (508)
........||+.|+|||++.+..+ +.++|||||||+||+|++|+.||....... .....+. . ..
T Consensus 160 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~-~~~~~~~----~---------~~ 225 (323)
T 3tki_A 160 RERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSC-QEYSDWK----E---------KK 225 (323)
T ss_dssp EECCBCSCCSCGGGSCHHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSCTTS-HHHHHHH----T---------TC
T ss_pred cccccCCCccCcCccCcHHhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCchHH-HHHHHHh----c---------cc
Confidence 122345679999999999987765 779999999999999999999997543321 1111111 1 11
Q ss_pred CCCChhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhhcCC
Q 010519 422 LEVKPATRALKRSLLVALRCVDPDSEKRPKMSQVVRMLEADD 463 (508)
Q Consensus 422 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~ 463 (508)
............+.+|+.+||+.||.+|||+.|++++-+-..
T Consensus 226 ~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eil~h~~~~~ 267 (323)
T 3tki_A 226 TYLNPWKKIDSAPLALLHKILVENPSARITIPDIKKDRWYNK 267 (323)
T ss_dssp TTSTTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTCTTTTC
T ss_pred ccCCccccCCHHHHHHHHHHccCChhhCcCHHHHhhChhhcc
Confidence 111112223455667999999999999999999998765543
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-44 Score=359.75 Aligned_cols=268 Identities=25% Similarity=0.359 Sum_probs=207.5
Q ss_pred HhhCCcccceeEeeeCceEEEEEEEcCCCEEEEEEEcccchhhHHHHHHHHHHHhcCCCCCceeEEEEEEeCc----eee
Q 010519 183 IATNRFSAENVLGEGGYGVVYKGRLINGSEVAVKKLLNNLGQAEKEFRVEVEAIGHVRHKNLVRLLGYCIEGV----HRM 258 (508)
Q Consensus 183 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~ei~~l~~l~h~niv~~~~~~~~~~----~~~ 258 (508)
+..++|.+.+.||+|+||+||+|++ .++.||||++..... ....+..|+.++.+++||||+++++++.... ..+
T Consensus 21 ~~~~~y~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~ 98 (322)
T 3soc_A 21 FQSMPLQLLEVKARGRFGCVWKAQL-LNEYVAVKIFPIQDK-QSWQNEYEVYSLPGMKHENILQFIGAEKRGTSVDVDLW 98 (322)
T ss_dssp ETTEEEEEEEEEECSTTCEEEEEEE-TTEEEEEEEECGGGH-HHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEE
T ss_pred cchhhchhhheecccCceEEEEEEE-CCCEEEEEEeecCch-HHHHHHHHHHHHhcCCCCCchhhcceeccCCCCCceEE
Confidence 4456899999999999999999987 589999999865433 2345566899999999999999999998753 468
Q ss_pred EEEeecCCCCHHHHHhhhhccCCCccHHHHHHHHHHHHHHHHHHHhc-------CCCCeEeecCCCCCEEEcCCCcEEEE
Q 010519 259 LVYEYVNNGNLEQWLHGAMRNQGNLTWEARMKVIIGTAKALAYLHEA-------IEPKVVHRDIKSSNILIDDEFNAKVS 331 (508)
Q Consensus 259 lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~-------~~~~iiH~Dlk~~NIll~~~~~~kl~ 331 (508)
+||||+++|+|.+++.. ..+++..++.++.|++.||.|||+. ..++|+||||||+|||++.++.+||+
T Consensus 99 lv~e~~~~g~L~~~l~~-----~~~~~~~~~~i~~qi~~al~~LH~~~~~l~~~~~~~ivH~Dlkp~Nill~~~~~~kL~ 173 (322)
T 3soc_A 99 LITAFHEKGSLSDFLKA-----NVVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIA 173 (322)
T ss_dssp EEEECCTTCBHHHHHHH-----CCBCHHHHHHHHHHHHHHHHHHTCCEEEETTEEECEEECSCCSGGGEEECTTCCEEEC
T ss_pred EEEecCCCCCHHHHHHh-----cCCCHHHHHHHHHHHHHHHHHHHhhccccccccCCCEEeCCCChHhEEECCCCeEEEc
Confidence 99999999999999953 3489999999999999999999975 13489999999999999999999999
Q ss_pred ecCCccccCCCCC-cccccccccccccCccccCCC-----CCCChhhHHHHHHHHHHHHhCCCCCCCCCCCchhcH----
Q 010519 332 DFGLAKLLDSGES-HITTRVMGTFGYVAPEYANTG-----MLNEKSDIYSFGVLLLEAVTGRDPVDYGRPANEVNL---- 401 (508)
Q Consensus 332 Dfgla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~-----~~~~~~DvwS~Gvvl~elltG~~Pf~~~~~~~~~~~---- 401 (508)
|||+++....... .......||+.|+|||++.+. .++.++|||||||++|||++|+.||...........
T Consensus 174 DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~ 253 (322)
T 3soc_A 174 DFGLALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLPFEEEI 253 (322)
T ss_dssp CCTTCEEECTTSCCCCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHTTBTTSSSCCCCCCCTTHHHH
T ss_pred cCCcccccccccCccccccCccCccccCHhhcccccccCcCCCccchhHHHHHHHHHHHhCCCCCCCCcchhccchhhhh
Confidence 9999986654332 223345799999999999873 455688999999999999999999975443222211
Q ss_pred ------HHHHHHHhcccccccccCCCCCCC-hhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhhcC
Q 010519 402 ------VEWLKMMVGTRRAEEVVDPNLEVK-PATRALKRSLLVALRCVDPDSEKRPKMSQVVRMLEAD 462 (508)
Q Consensus 402 ------~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~ 462 (508)
..+....... ...+.+... ........+.+|+.+||+.||.+|||+.||++.|+..
T Consensus 254 ~~~~~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~l 316 (322)
T 3soc_A 254 GQHPSLEDMQEVVVHK-----KKRPVLRDYWQKHAGMAMLCETIEECWDHDAEARLSAGCVGERITQM 316 (322)
T ss_dssp CSSCCHHHHHHHHTTS-----CCCCCCCGGGGSSHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred ccCCchhhhhhhhhcc-----cCCCCccccccccchHHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence 1111111111 111111111 1223456688899999999999999999999999864
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-44 Score=357.52 Aligned_cols=255 Identities=24% Similarity=0.326 Sum_probs=207.9
Q ss_pred CCcccceeEeeeCceEEEEEEEc-CCCEEEEEEEcccch------hhHHHHHHHHHHHhcCCCCCceeEEEEEEeCceee
Q 010519 186 NRFSAENVLGEGGYGVVYKGRLI-NGSEVAVKKLLNNLG------QAEKEFRVEVEAIGHVRHKNLVRLLGYCIEGVHRM 258 (508)
Q Consensus 186 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~------~~~~~~~~ei~~l~~l~h~niv~~~~~~~~~~~~~ 258 (508)
++|.+.+.||+|+||.||+|.+. +|..||+|.+..... .....+.+|+.+++.++||||+++++++.+....+
T Consensus 11 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~ 90 (326)
T 2y0a_A 11 DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVI 90 (326)
T ss_dssp HHEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred cceEeceEEeeCCCeEEEEEEECCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEE
Confidence 57999999999999999999985 688999999865432 13567889999999999999999999999999999
Q ss_pred EEEeecCCCCHHHHHhhhhccCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCEEEcCCC----cEEEEecC
Q 010519 259 LVYEYVNNGNLEQWLHGAMRNQGNLTWEARMKVIIGTAKALAYLHEAIEPKVVHRDIKSSNILIDDEF----NAKVSDFG 334 (508)
Q Consensus 259 lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiH~Dlk~~NIll~~~~----~~kl~Dfg 334 (508)
+||||+++|+|.+++. ....+++..++.++.||+.||.|||+. +|+||||||+|||++.++ .+||+|||
T Consensus 91 lv~e~~~~~~L~~~l~----~~~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg 163 (326)
T 2y0a_A 91 LILELVAGGELFDFLA----EKESLTEEEATEFLKQILNGVYYLHSL---QIAHFDLKPENIMLLDRNVPKPRIKIIDFG 163 (326)
T ss_dssp EEEECCCSCBHHHHHT----TSSCCBHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESCSSSSSCCEEECCCT
T ss_pred EEEEcCCCCCHHHHHH----hcCCcCHHHHHHHHHHHHHHHHHHHHC---CeEcCCCCHHHEEEecCCCCCCCEEEEECC
Confidence 9999999999999984 456799999999999999999999999 999999999999999887 79999999
Q ss_pred CccccCCCCCcccccccccccccCccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCCCchhcHHHHHHHHhccccc
Q 010519 335 LAKLLDSGESHITTRVMGTFGYVAPEYANTGMLNEKSDIYSFGVLLLEAVTGRDPVDYGRPANEVNLVEWLKMMVGTRRA 414 (508)
Q Consensus 335 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~ 414 (508)
++....... ......||+.|+|||++.+..++.++|||||||++|+|++|..||..... . +.+.......
T Consensus 164 ~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~---~---~~~~~~~~~~-- 233 (326)
T 2y0a_A 164 LAHKIDFGN--EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTK---Q---ETLANVSAVN-- 233 (326)
T ss_dssp TCEECCTTS--CCCCCCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSH---H---HHHHHHHHTC--
T ss_pred CCeECCCCC--ccccccCCcCcCCceeecCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCH---H---HHHHHHHhcC--
Confidence 998765332 23445799999999999999999999999999999999999999964321 1 1111111100
Q ss_pred ccccCCCCCCChhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhhcC
Q 010519 415 EEVVDPNLEVKPATRALKRSLLVALRCVDPDSEKRPKMSQVVRMLEAD 462 (508)
Q Consensus 415 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~ 462 (508)
..+...........+.+|+.+||+.||.+|||+.|++++-.-.
T Consensus 234 -----~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~ 276 (326)
T 2y0a_A 234 -----YEFEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQHPWIK 276 (326)
T ss_dssp -----CCCCHHHHTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHSTTTS
T ss_pred -----CCcCccccccCCHHHHHHHHHHccCChhhCCCHHHHhcCCCcc
Confidence 0111011112234567799999999999999999999976543
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-44 Score=370.23 Aligned_cols=272 Identities=21% Similarity=0.253 Sum_probs=215.2
Q ss_pred eHHHHHHhhCCcccceeEeeeCceEEEEEEEc-CCCEEEEEEEcccch---hhHHHHHHHHHHHhcCCCCCceeEEEEEE
Q 010519 177 TLRDLEIATNRFSAENVLGEGGYGVVYKGRLI-NGSEVAVKKLLNNLG---QAEKEFRVEVEAIGHVRHKNLVRLLGYCI 252 (508)
Q Consensus 177 ~~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~ei~~l~~l~h~niv~~~~~~~ 252 (508)
.+.++.+..++|.+.++||+|+||+||+|++. +++.||+|++..... .....+.+|+.++..++||||++++++|.
T Consensus 65 ~~~~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~ 144 (437)
T 4aw2_A 65 KVKQMRLHREDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHYAFQ 144 (437)
T ss_dssp HHHHHSCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHSCTTTBCCEEEEEE
T ss_pred hhhcccCChhheEEEEEEEeCCCEEEEEEEEcCCCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhCCCCCEEEEEEEEe
Confidence 35667778899999999999999999999986 477899999854321 11234788999999999999999999999
Q ss_pred eCceeeEEEeecCCCCHHHHHhhhhccCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCEEEcCCCcEEEEe
Q 010519 253 EGVHRMLVYEYVNNGNLEQWLHGAMRNQGNLTWEARMKVIIGTAKALAYLHEAIEPKVVHRDIKSSNILIDDEFNAKVSD 332 (508)
Q Consensus 253 ~~~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~D 332 (508)
+....|+||||+++|+|.+++.. ....+++..++.++.||+.||.|||+. +|+||||||+||||+.++.+||+|
T Consensus 145 ~~~~~~lV~Ey~~gg~L~~~l~~---~~~~l~e~~~~~~~~qi~~aL~~LH~~---giiHrDLKp~NILl~~~g~vkL~D 218 (437)
T 4aw2_A 145 DDNNLYLVMDYYVGGDLLTLLSK---FEDRLPEEMARFYLAEMVIAIDSVHQL---HYVHRDIKPDNILMDMNGHIRLAD 218 (437)
T ss_dssp CSSEEEEEECCCTTCBHHHHHHT---TTTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECC
T ss_pred eCCEEEEEEecCCCCcHHHHHHH---ccCCCCHHHHHHHHHHHHHHHHHHHhC---CeEecccCHHHeeEcCCCCEEEcc
Confidence 99999999999999999999963 356799999999999999999999999 999999999999999999999999
Q ss_pred cCCccccCCCCCcccccccccccccCccccC-----CCCCCChhhHHHHHHHHHHHHhCCCCCCCCCCCchhcHHHHHHH
Q 010519 333 FGLAKLLDSGESHITTRVMGTFGYVAPEYAN-----TGMLNEKSDIYSFGVLLLEAVTGRDPVDYGRPANEVNLVEWLKM 407 (508)
Q Consensus 333 fgla~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DvwS~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~ 407 (508)
||+++.............+||+.|+|||++. +..|+.++|||||||+||||++|+.||..... . +....
T Consensus 219 FGla~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~---~---~~~~~ 292 (437)
T 4aw2_A 219 FGSCLKLMEDGTVQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESL---V---ETYGK 292 (437)
T ss_dssp CTTCEECCTTSCEECCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHSSCTTCCSSH---H---HHHHH
T ss_pred hhhhhhcccCCCcccccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhCCCCCCCCCh---h---HHHHh
Confidence 9999876554444445568999999999986 56789999999999999999999999964321 1 11111
Q ss_pred HhcccccccccCCCCCCChhHHHHHHHHHHHHHhcCCCCCC--CCCHHHHHHHhhcCCCCC
Q 010519 408 MVGTRRAEEVVDPNLEVKPATRALKRSLLVALRCVDPDSEK--RPKMSQVVRMLEADDYPF 466 (508)
Q Consensus 408 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~--RPs~~evl~~L~~~~~~~ 466 (508)
...... .+.-+... ......+.+|+.+||..+|.+ ||+++|+++|-.-....+
T Consensus 293 i~~~~~--~~~~p~~~----~~~s~~~~dLi~~lL~~~~~r~~r~~~~eil~Hpff~~i~w 347 (437)
T 4aw2_A 293 IMNHKE--RFQFPTQV----TDVSENAKDLIRRLICSREHRLGQNGIEDFKKHPFFSGIDW 347 (437)
T ss_dssp HHTHHH--HCCCCSSC----CCSCHHHHHHHHTTSSCGGGCTTTTTTHHHHTSGGGTTCCT
T ss_pred hhhccc--cccCCccc----ccCCHHHHHHHHHHhcccccccCCCCHHHHhCCCccCCCCH
Confidence 111100 00001110 112345667999999888888 999999999876544433
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-44 Score=365.77 Aligned_cols=256 Identities=22% Similarity=0.310 Sum_probs=202.8
Q ss_pred HhhCCcccceeEeeeCceEEEEEEEc-CCCEEEEEEEcccc---hhhHHHHHHHHHHHhcC-CCCCceeEEEEEEeCcee
Q 010519 183 IATNRFSAENVLGEGGYGVVYKGRLI-NGSEVAVKKLLNNL---GQAEKEFRVEVEAIGHV-RHKNLVRLLGYCIEGVHR 257 (508)
Q Consensus 183 ~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~ei~~l~~l-~h~niv~~~~~~~~~~~~ 257 (508)
+..++|.+.+.||+|+||+||+|++. +|+.||||++.... ......+..|..++..+ +||||+++++++.+....
T Consensus 20 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~ 99 (353)
T 3txo_A 20 LGIDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQTPDRL 99 (353)
T ss_dssp ---CCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEE
T ss_pred CchhheEEEEEEeeCCCEEEEEEEEcCCCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEEEEeCCEE
Confidence 44579999999999999999999876 58899999986542 22345677899999988 799999999999999999
Q ss_pred eEEEeecCCCCHHHHHhhhhccCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCEEEcCCCcEEEEecCCcc
Q 010519 258 MLVYEYVNNGNLEQWLHGAMRNQGNLTWEARMKVIIGTAKALAYLHEAIEPKVVHRDIKSSNILIDDEFNAKVSDFGLAK 337 (508)
Q Consensus 258 ~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~Dfgla~ 337 (508)
|+||||+++|+|.+++. ....+++..++.++.||+.||.|||++ +|+||||||+|||++.++++||+|||+++
T Consensus 100 ~lv~E~~~gg~L~~~l~----~~~~~~~~~~~~~~~qi~~aL~~LH~~---givHrDlkp~NILl~~~g~ikL~DFG~a~ 172 (353)
T 3txo_A 100 FFVMEFVNGGDLMFHIQ----KSRRFDEARARFYAAEIISALMFLHDK---GIIYRDLKLDNVLLDHEGHCKLADFGMCK 172 (353)
T ss_dssp EEEEECCCSCBHHHHHH----HHSSCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCB
T ss_pred EEEEeCCCCCcHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHHC---CCcccCCCHHHEEECCCCCEEEcccccee
Confidence 99999999999999985 346799999999999999999999999 99999999999999999999999999998
Q ss_pred ccCCCCCcccccccccccccCccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCCCchhcHHHHHHHHhcccccccc
Q 010519 338 LLDSGESHITTRVMGTFGYVAPEYANTGMLNEKSDIYSFGVLLLEAVTGRDPVDYGRPANEVNLVEWLKMMVGTRRAEEV 417 (508)
Q Consensus 338 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 417 (508)
...... ......+||+.|+|||++.+..|+.++|||||||++|||++|+.||..... .+.........
T Consensus 173 ~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~------~~~~~~i~~~~----- 240 (353)
T 3txo_A 173 EGICNG-VTTATFCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEAENE------DDLFEAILNDE----- 240 (353)
T ss_dssp CSCC----------CCGGGCCHHHHHHHHCTTHHHHHHHHHHHHHHHHSSCSSCCSSH------HHHHHHHHHCC-----
T ss_pred ecccCC-ccccccCCCcCeEChhhcCCCCcCCccCCCcchHHHHHHHhCCCCCCCCCH------HHHHHHHHcCC-----
Confidence 543322 224456899999999999998999999999999999999999999964321 12222222111
Q ss_pred cCCCCCCChhHHHHHHHHHHHHHhcCCCCCCCCCH------HHHHHHhhcCC
Q 010519 418 VDPNLEVKPATRALKRSLLVALRCVDPDSEKRPKM------SQVVRMLEADD 463 (508)
Q Consensus 418 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~------~evl~~L~~~~ 463 (508)
... +......+.+|+.+||+.||.+||++ .++++|-.-..
T Consensus 241 ----~~~--p~~~~~~~~~li~~lL~~dP~~R~~~~~~~~~~~il~hp~f~~ 286 (353)
T 3txo_A 241 ----VVY--PTWLHEDATGILKSFMTKNPTMRLGSLTQGGEHAILRHPFFKE 286 (353)
T ss_dssp ----CCC--CTTSCHHHHHHHHHHTCSSGGGSTTSGGGTCTHHHHTSGGGTT
T ss_pred ----CCC--CCCCCHHHHHHHHHHhhhCHHHccCCcccCCHHHHhhCCcccC
Confidence 111 11123456679999999999999998 88888665433
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-44 Score=352.77 Aligned_cols=259 Identities=23% Similarity=0.371 Sum_probs=196.8
Q ss_pred HHHhhCCcccceeEeeeCceEEEEEEEcC----CCEEEEEEEcccc-hhhHHHHHHHHHHHhcCCCCCceeEEEEEEeCc
Q 010519 181 LEIATNRFSAENVLGEGGYGVVYKGRLIN----GSEVAVKKLLNNL-GQAEKEFRVEVEAIGHVRHKNLVRLLGYCIEGV 255 (508)
Q Consensus 181 ~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~----~~~vavK~~~~~~-~~~~~~~~~ei~~l~~l~h~niv~~~~~~~~~~ 255 (508)
+++..++|.+.+.||+|+||+||+|.+.. +..||+|.+.... ......+.+|+.++++++||||+++++++ ..+
T Consensus 10 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~-~~~ 88 (281)
T 1mp8_A 10 YEIQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVI-TEN 88 (281)
T ss_dssp CBCCGGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEE-CSS
T ss_pred eEEehHHeEEEeEeeecCCeeEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCccceEEEEE-ccC
Confidence 34566799999999999999999998743 4469999876533 34456788999999999999999999987 456
Q ss_pred eeeEEEeecCCCCHHHHHhhhhccCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCEEEcCCCcEEEEecCC
Q 010519 256 HRMLVYEYVNNGNLEQWLHGAMRNQGNLTWEARMKVIIGTAKALAYLHEAIEPKVVHRDIKSSNILIDDEFNAKVSDFGL 335 (508)
Q Consensus 256 ~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~Dfgl 335 (508)
..++||||+++|+|.+++.. ....+++..++.++.|++.||.|||+. +|+||||||+|||++.++.+||+|||+
T Consensus 89 ~~~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~Dfg~ 162 (281)
T 1mp8_A 89 PVWIIMELCTLGELRSFLQV---RKYSLDLASLILYAYQLSTALAYLESK---RFVHRDIAARNVLVSSNDCVKLGDFGL 162 (281)
T ss_dssp SCEEEEECCTTEEHHHHHHH---TTTTSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECC---
T ss_pred ccEEEEecCCCCCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHhC---CeecccccHHHEEECCCCCEEECcccc
Confidence 78899999999999999963 345689999999999999999999999 999999999999999999999999999
Q ss_pred ccccCCCCCcccccccccccccCccccCCCCCCChhhHHHHHHHHHHHHh-CCCCCCCCCCCchhcHHHHHHHHhccccc
Q 010519 336 AKLLDSGESHITTRVMGTFGYVAPEYANTGMLNEKSDIYSFGVLLLEAVT-GRDPVDYGRPANEVNLVEWLKMMVGTRRA 414 (508)
Q Consensus 336 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~ 414 (508)
+...............+++.|+|||++.+..++.++|||||||++|||++ |..||...... .... .......
T Consensus 163 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~pf~~~~~~---~~~~---~i~~~~~- 235 (281)
T 1mp8_A 163 SRYMEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNN---DVIG---RIENGER- 235 (281)
T ss_dssp ----------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGG---GHHH---HHHTTCC-
T ss_pred ccccCcccccccccCCCcccccChhhcccCCCCCccCchHHHHHHHHHHhcCCCCCCcCCHH---HHHH---HHHcCCC-
Confidence 98765443333344457889999999998899999999999999999997 99999654322 1111 1111110
Q ss_pred ccccCCCCCCChhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhhcC
Q 010519 415 EEVVDPNLEVKPATRALKRSLLVALRCVDPDSEKRPKMSQVVRMLEAD 462 (508)
Q Consensus 415 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~ 462 (508)
. ..+......+.+++.+||+.||.+|||+.+++++|+..
T Consensus 236 -----~----~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~ 274 (281)
T 1mp8_A 236 -----L----PMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTI 274 (281)
T ss_dssp -----C----CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred -----C----CCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence 0 01112234566799999999999999999999999864
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.3e-44 Score=354.00 Aligned_cols=266 Identities=23% Similarity=0.309 Sum_probs=205.7
Q ss_pred hhCCcccceeEeeeCceEEEEEEEcCCCEEEEEEEcccch--hhHHHHHHHHHHHhcCCCCCceeEEEEEEeCceeeEEE
Q 010519 184 ATNRFSAENVLGEGGYGVVYKGRLINGSEVAVKKLLNNLG--QAEKEFRVEVEAIGHVRHKNLVRLLGYCIEGVHRMLVY 261 (508)
Q Consensus 184 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~--~~~~~~~~ei~~l~~l~h~niv~~~~~~~~~~~~~lv~ 261 (508)
..++|.+.+.||+|+||+||+|++.+|+.||+|++..... .....+.+|+.++++++||||+++++++.+....++||
T Consensus 19 l~~~y~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 98 (311)
T 3niz_A 19 LMEKYQKLEKVGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDVIHSERCLTLVF 98 (311)
T ss_dssp SSCEEEEEEEEEECSSCEEEEEEETTSCEEEEEEEC------CHHHHHHHHHHHHHHCCCTTBCCEEEEECCSSCEEEEE
T ss_pred hHhhhHhhhhccCCCCeEEEEEEECCCCEEEEEEEecccccchhhHHHHHHHHHHHHcCCCCEeeeeeEEccCCEEEEEE
Confidence 3468999999999999999999998899999999864432 22456888999999999999999999999999999999
Q ss_pred eecCCCCHHHHHhhhhccCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCEEEcCCCcEEEEecCCccccCC
Q 010519 262 EYVNNGNLEQWLHGAMRNQGNLTWEARMKVIIGTAKALAYLHEAIEPKVVHRDIKSSNILIDDEFNAKVSDFGLAKLLDS 341 (508)
Q Consensus 262 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~ 341 (508)
||+++ +|.+++. .....+++..++.++.||+.||.|||+. +|+||||||+|||++.++.+||+|||++.....
T Consensus 99 e~~~~-~l~~~~~---~~~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~ 171 (311)
T 3niz_A 99 EFMEK-DLKKVLD---ENKTGLQDSQIKIYLYQLLRGVAHCHQH---RILHRDLKPQNLLINSDGALKLADFGLARAFGI 171 (311)
T ss_dssp ECCSE-EHHHHHH---TCTTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEETTS
T ss_pred cCCCC-CHHHHHH---hccCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCchHhEEECCCCCEEEccCcCceecCC
Confidence 99974 8888885 3455699999999999999999999999 999999999999999999999999999987653
Q ss_pred CCCcccccccccccccCccccCC-CCCCChhhHHHHHHHHHHHHhCCCCCCCCCCCchhcHHHHHHHHhccccccccc--
Q 010519 342 GESHITTRVMGTFGYVAPEYANT-GMLNEKSDIYSFGVLLLEAVTGRDPVDYGRPANEVNLVEWLKMMVGTRRAEEVV-- 418 (508)
Q Consensus 342 ~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwS~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~-- 418 (508)
... ......||+.|+|||++.+ ..++.++|||||||++|+|++|+.||........ ...+....+........
T Consensus 172 ~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~---~~~i~~~~~~~~~~~~~~~ 247 (311)
T 3niz_A 172 PVR-SYTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQ---LPKIFSILGTPNPREWPQV 247 (311)
T ss_dssp CCC----CCCCCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSTTTH---HHHHHHHHCCCCTTTSGGG
T ss_pred Ccc-cccCCcccCCcCCHHHhcCCCCCCchHHhHHHHHHHHHHHhCCCCCCCCChHHH---HHHHHHHHCCCChHHhhhh
Confidence 322 2344578999999999876 5689999999999999999999999975443322 12222222211110000
Q ss_pred ----------CCCCCCCh----hHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhh
Q 010519 419 ----------DPNLEVKP----ATRALKRSLLVALRCVDPDSEKRPKMSQVVRMLE 460 (508)
Q Consensus 419 ----------~~~~~~~~----~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 460 (508)
........ .......+.+|+.+||+.||.+|||+.|+++|-+
T Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~ 303 (311)
T 3niz_A 248 QELPLWKQRTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMNHPY 303 (311)
T ss_dssp TTSHHHHSCCCCCCCCCCHHHHSTTCCHHHHHHHHHHSCSCTTTSCCHHHHHTSGG
T ss_pred hccchhhhcccccccCCcHHHhCcccCHHHHHHHHHHcCCChhHCCCHHHHhcCcc
Confidence 00000000 0112346678999999999999999999998644
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-44 Score=371.15 Aligned_cols=265 Identities=20% Similarity=0.268 Sum_probs=212.4
Q ss_pred HHHHHHhhCCcccceeEeeeCceEEEEEEEc-CCCEEEEEEEcccch---hhHHHHHHHHHHHhcCCCCCceeEEEEEEe
Q 010519 178 LRDLEIATNRFSAENVLGEGGYGVVYKGRLI-NGSEVAVKKLLNNLG---QAEKEFRVEVEAIGHVRHKNLVRLLGYCIE 253 (508)
Q Consensus 178 ~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~ei~~l~~l~h~niv~~~~~~~~ 253 (508)
+.++++..++|.+.+.||+|+||+||+|++. +++.||+|++..... .....+.+|+.++..++||||++++++|.+
T Consensus 61 ~~~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~ 140 (410)
T 3v8s_A 61 IRDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQD 140 (410)
T ss_dssp HHHHSCCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHCCCTTBCCEEEEEEC
T ss_pred HHhcccCccccEEEEEEEcCCCEEEEEEEECCCCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEE
Confidence 4566677889999999999999999999986 588899999854321 112347789999999999999999999999
Q ss_pred CceeeEEEeecCCCCHHHHHhhhhccCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCEEEcCCCcEEEEec
Q 010519 254 GVHRMLVYEYVNNGNLEQWLHGAMRNQGNLTWEARMKVIIGTAKALAYLHEAIEPKVVHRDIKSSNILIDDEFNAKVSDF 333 (508)
Q Consensus 254 ~~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~Df 333 (508)
....|+||||+++|+|.+++.. ..+++..++.++.||+.||.|||++ +|+||||||+|||++.++++||+||
T Consensus 141 ~~~~~lV~E~~~gg~L~~~l~~-----~~~~e~~~~~~~~qi~~aL~~LH~~---givHrDLKp~NILl~~~g~ikL~DF 212 (410)
T 3v8s_A 141 DRYLYMVMEYMPGGDLVNLMSN-----YDVPEKWARFYTAEVVLALDAIHSM---GFIHRDVKPDNMLLDKSGHLKLADF 212 (410)
T ss_dssp SSEEEEEECCCTTEEHHHHHHH-----CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCC
T ss_pred CCEEEEEEeCCCCCcHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCCHHHeeECCCCCEEEecc
Confidence 9999999999999999999853 3588999999999999999999999 9999999999999999999999999
Q ss_pred CCccccCCCCCcccccccccccccCccccCCCC----CCChhhHHHHHHHHHHHHhCCCCCCCCCCCchhcHHHHHHHHh
Q 010519 334 GLAKLLDSGESHITTRVMGTFGYVAPEYANTGM----LNEKSDIYSFGVLLLEAVTGRDPVDYGRPANEVNLVEWLKMMV 409 (508)
Q Consensus 334 gla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~----~~~~~DvwS~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~ 409 (508)
|+++.............+||+.|+|||++.+.. |+.++|||||||+||||++|+.||..... ........
T Consensus 213 G~a~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~------~~~~~~i~ 286 (410)
T 3v8s_A 213 GTCMKMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSL------VGTYSKIM 286 (410)
T ss_dssp TTCEECCTTSEEECCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCTTCCSSH------HHHHHHHH
T ss_pred ceeEeeccCCcccccCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCCCCCCCCh------hhHHHHHH
Confidence 999877654433345678999999999997665 88999999999999999999999964321 11122221
Q ss_pred cccccccccCCCCCCChhHHHHHHHHHHHHHhcCCCCCC--CCCHHHHHHHhhcCC
Q 010519 410 GTRRAEEVVDPNLEVKPATRALKRSLLVALRCVDPDSEK--RPKMSQVVRMLEADD 463 (508)
Q Consensus 410 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~--RPs~~evl~~L~~~~ 463 (508)
..... +..+........+.+|+.+||..+|.+ ||+++||++|-+-..
T Consensus 287 ~~~~~-------~~~p~~~~~s~~~~~li~~lL~~~~~rlgR~~~~ei~~Hp~f~~ 335 (410)
T 3v8s_A 287 NHKNS-------LTFPDDNDISKEAKNLICAFLTDREVRLGRNGVEEIKRHLFFKN 335 (410)
T ss_dssp THHHH-------CCCCTTCCCCHHHHHHHHHHSSCGGGCTTSSCHHHHHTSGGGCC
T ss_pred hcccc-------ccCCCcccccHHHHHHHHHHccChhhhCCCCCHHHHhcCccccC
Confidence 11000 001111112345667999999999988 999999999876543
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-44 Score=349.92 Aligned_cols=257 Identities=27% Similarity=0.440 Sum_probs=210.7
Q ss_pred HhhCCcccceeEeeeCceEEEEEEEcCCCEEEEEEEcccchhhHHHHHHHHHHHhcCCCCCceeEEEEEEeCceeeEEEe
Q 010519 183 IATNRFSAENVLGEGGYGVVYKGRLINGSEVAVKKLLNNLGQAEKEFRVEVEAIGHVRHKNLVRLLGYCIEGVHRMLVYE 262 (508)
Q Consensus 183 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~ei~~l~~l~h~niv~~~~~~~~~~~~~lv~E 262 (508)
+..++|.+.+.||+|+||.||+|.+.++..||+|++..... ..+.+.+|+.+++.++||||+++++++.+....++|||
T Consensus 5 i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 83 (267)
T 3t9t_A 5 IDPSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAM-SEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVTE 83 (267)
T ss_dssp CCGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTTB-CHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCEEEEC
T ss_pred EchhheeeeeEecCCCceeEEEEEecCCCeEEEEEccccCC-CHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCeEEEEe
Confidence 44568999999999999999999998888999999865443 34678889999999999999999999999999999999
Q ss_pred ecCCCCHHHHHhhhhccCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCEEEcCCCcEEEEecCCccccCCC
Q 010519 263 YVNNGNLEQWLHGAMRNQGNLTWEARMKVIIGTAKALAYLHEAIEPKVVHRDIKSSNILIDDEFNAKVSDFGLAKLLDSG 342 (508)
Q Consensus 263 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~~ 342 (508)
|+++++|.+++.. ....+++..++.++.|++.||.|||+. +++|+||||+||+++.++.+||+|||++......
T Consensus 84 ~~~~~~L~~~~~~---~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~ 157 (267)
T 3t9t_A 84 FMEHGCLSDYLRT---QRGLFAAETLLGMCLDVCEGMAYLEEA---CVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDD 157 (267)
T ss_dssp CCTTCBHHHHHHH---TTTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCCGGGEEECGGGCEEECCTTGGGGBCCH
T ss_pred CCCCCcHHHHHhh---CcccCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCchheEEECCCCCEEEcccccccccccc
Confidence 9999999999963 345789999999999999999999999 9999999999999999999999999999876443
Q ss_pred CCcccccccccccccCccccCCCCCCChhhHHHHHHHHHHHHh-CCCCCCCCCCCchhcHHHHHHHHhcccccccccCCC
Q 010519 343 ESHITTRVMGTFGYVAPEYANTGMLNEKSDIYSFGVLLLEAVT-GRDPVDYGRPANEVNLVEWLKMMVGTRRAEEVVDPN 421 (508)
Q Consensus 343 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 421 (508)
.........+++.|+|||++.+..++.++||||||+++|+|++ |..||..... ............ .
T Consensus 158 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~------~~~~~~i~~~~~------~- 224 (267)
T 3t9t_A 158 QYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSN------SEVVEDISTGFR------L- 224 (267)
T ss_dssp HHHSTTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCH------HHHHHHHHTTCC------C-
T ss_pred cccccccccccccccChhhhcCCCccchhchhhhHHHHHHHhccCCCCCCCCCH------HHHHHHHhcCCc------C-
Confidence 2222334457789999999998899999999999999999999 8999864321 122222211110 0
Q ss_pred CCCChhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhhcC
Q 010519 422 LEVKPATRALKRSLLVALRCVDPDSEKRPKMSQVVRMLEAD 462 (508)
Q Consensus 422 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~ 462 (508)
..+......+.+++.+||+.||.+|||+.+++++|+..
T Consensus 225 ---~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l 262 (267)
T 3t9t_A 225 ---YKPRLASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEI 262 (267)
T ss_dssp ---CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred ---CCCccCcHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence 01111234566799999999999999999999999864
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-44 Score=368.88 Aligned_cols=259 Identities=28% Similarity=0.475 Sum_probs=198.4
Q ss_pred HhhCCcccceeEeeeCceEEEEEEEc----CCCEEEEEEEcccc-hhhHHHHHHHHHHHhcCCCCCceeEEEEEEeCcee
Q 010519 183 IATNRFSAENVLGEGGYGVVYKGRLI----NGSEVAVKKLLNNL-GQAEKEFRVEVEAIGHVRHKNLVRLLGYCIEGVHR 257 (508)
Q Consensus 183 ~~~~~~~~~~~lg~G~~g~Vy~~~~~----~~~~vavK~~~~~~-~~~~~~~~~ei~~l~~l~h~niv~~~~~~~~~~~~ 257 (508)
+..++|.+.+.||+|+||+||+|++. ++..||||++.... ......+.+|+.++++++||||+++++++.+....
T Consensus 42 ~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~ 121 (373)
T 2qol_A 42 LDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPV 121 (373)
T ss_dssp CCGGGCCCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSC
T ss_pred cCHhhceeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCce
Confidence 34568999999999999999999875 46789999986543 34456789999999999999999999999999999
Q ss_pred eEEEeecCCCCHHHHHhhhhccCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCEEEcCCCcEEEEecCCcc
Q 010519 258 MLVYEYVNNGNLEQWLHGAMRNQGNLTWEARMKVIIGTAKALAYLHEAIEPKVVHRDIKSSNILIDDEFNAKVSDFGLAK 337 (508)
Q Consensus 258 ~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~Dfgla~ 337 (508)
++||||+++|+|.+++. .....+++..++.++.||+.||.|||+. +|+||||||+|||++.++.+||+|||+++
T Consensus 122 ~lv~e~~~~~sL~~~l~---~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~ 195 (373)
T 2qol_A 122 MIVTEYMENGSLDSFLR---KHDAQFTVIQLVGMLRGIASGMKYLSDM---GYVHRDLAARNILINSNLVCKVSDFGLGR 195 (373)
T ss_dssp EEEEECCTTCBHHHHHH---TTTTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCC----
T ss_pred EEEEeCCCCCcHHHHHH---hCCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeCCCCCcceEEEcCCCCEEECcCcccc
Confidence 99999999999999996 3445799999999999999999999999 99999999999999999999999999998
Q ss_pred ccCCCCCc--ccccccccccccCccccCCCCCCChhhHHHHHHHHHHHHh-CCCCCCCCCCCchhcHHHHHHHHhccccc
Q 010519 338 LLDSGESH--ITTRVMGTFGYVAPEYANTGMLNEKSDIYSFGVLLLEAVT-GRDPVDYGRPANEVNLVEWLKMMVGTRRA 414 (508)
Q Consensus 338 ~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~ 414 (508)
........ ......+++.|+|||++.+..++.++|||||||+||||++ |+.||..... .+..........
T Consensus 196 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~SlG~il~ellt~g~~P~~~~~~------~~~~~~i~~~~~- 268 (373)
T 2qol_A 196 VLEDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSN------QDVIKAVDEGYR- 268 (373)
T ss_dssp ------------------CTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTC-CTTTTCCH------HHHHHHHHTTEE-
T ss_pred ccccCCccceeccCCCcCCCccChhhhccCCcCchhcHHHHHHHHHHHHhCCCCCCCCCCH------HHHHHHHHcCCC-
Confidence 76543221 1222345778999999999999999999999999999998 9999964321 122222211111
Q ss_pred ccccCCCCCCChhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhhcCC
Q 010519 415 EEVVDPNLEVKPATRALKRSLLVALRCVDPDSEKRPKMSQVVRMLEADD 463 (508)
Q Consensus 415 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~ 463 (508)
...+......+.+++.+||+.||.+|||+.+|++.|+...
T Consensus 269 ---------~~~~~~~~~~l~~li~~cl~~dp~~RPs~~~i~~~L~~~~ 308 (373)
T 2qol_A 269 ---------LPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKLI 308 (373)
T ss_dssp ---------CCCCTTCBHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred ---------CCCCccccHHHHHHHHHHhCcChhhCcCHHHHHHHHHHHH
Confidence 1111123456677999999999999999999999998753
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-43 Score=360.40 Aligned_cols=255 Identities=21% Similarity=0.295 Sum_probs=207.3
Q ss_pred hhCCcccceeEeeeCceEEEEEEEc-CCCEEEEEEEcccc--hhhHHHHHHHHHHHhcCCCCCceeEEEEEEeCceeeEE
Q 010519 184 ATNRFSAENVLGEGGYGVVYKGRLI-NGSEVAVKKLLNNL--GQAEKEFRVEVEAIGHVRHKNLVRLLGYCIEGVHRMLV 260 (508)
Q Consensus 184 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~ei~~l~~l~h~niv~~~~~~~~~~~~~lv 260 (508)
..++|.+.+.||+|+||.||+|.+. +|..||+|++.... ......+.+|+.+++.++||||+++++++.+....|+|
T Consensus 27 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv 106 (362)
T 2bdw_A 27 FSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLV 106 (362)
T ss_dssp HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred cccCeEEeeEEecCCCeEEEEEEECCCCCEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEE
Confidence 3468999999999999999999875 68899999986543 23346788999999999999999999999999999999
Q ss_pred EeecCCCCHHHHHhhhhccCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCEEEcCCC---cEEEEecCCcc
Q 010519 261 YEYVNNGNLEQWLHGAMRNQGNLTWEARMKVIIGTAKALAYLHEAIEPKVVHRDIKSSNILIDDEF---NAKVSDFGLAK 337 (508)
Q Consensus 261 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiH~Dlk~~NIll~~~~---~~kl~Dfgla~ 337 (508)
|||+++|+|.+++. ....+++..++.++.||+.||.|||++ +|+||||||+|||++.++ .+||+|||++.
T Consensus 107 ~e~~~gg~L~~~l~----~~~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~Dlkp~NIll~~~~~~~~~kl~DfG~a~ 179 (362)
T 2bdw_A 107 FDLVTGGELFEDIV----AREFYSEADASHCIQQILESIAYCHSN---GIVHRNLKPENLLLASKAKGAAVKLADFGLAI 179 (362)
T ss_dssp ECCCCSCBHHHHHT----TCSCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSGGGEEESCSSTTCCEEECCCTTCB
T ss_pred EecCCCCCHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCchHHEEEecCCCCCCEEEeecCcce
Confidence 99999999999984 456789999999999999999999999 999999999999998654 59999999998
Q ss_pred ccCCCCCcccccccccccccCccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCCCchhcHHHHHHHHhcccccccc
Q 010519 338 LLDSGESHITTRVMGTFGYVAPEYANTGMLNEKSDIYSFGVLLLEAVTGRDPVDYGRPANEVNLVEWLKMMVGTRRAEEV 417 (508)
Q Consensus 338 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 417 (508)
...... ......||+.|+|||++.+..|+.++|||||||++|+|++|..||.... .. ......... .
T Consensus 180 ~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~---~~---~~~~~i~~~-~---- 246 (362)
T 2bdw_A 180 EVNDSE--AWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDED---QH---RLYAQIKAG-A---- 246 (362)
T ss_dssp CCTTCC--SCCCSCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSS---HH---HHHHHHHHT-C----
T ss_pred EecCCc--ccccCCCCccccCHHHHccCCCCchhhHHHHHHHHHHHHHCCCCCCCCC---HH---HHHHHHHhC-C----
Confidence 765432 2344679999999999999999999999999999999999999996432 11 111111111 0
Q ss_pred cCCCCCCChhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhh
Q 010519 418 VDPNLEVKPATRALKRSLLVALRCVDPDSEKRPKMSQVVRMLE 460 (508)
Q Consensus 418 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 460 (508)
..+...........+.+|+.+||+.||.+|||+.+++++-+
T Consensus 247 --~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~ 287 (362)
T 2bdw_A 247 --YDYPSPEWDTVTPEAKSLIDSMLTVNPKKRITADQALKVPW 287 (362)
T ss_dssp --CCCCTTGGGGSCHHHHHHHHHHSCSSGGGSCCHHHHTTSHH
T ss_pred --CCCCcccccCCCHHHHHHHHHHcCCChhhCcCHHHHhcCcc
Confidence 01111111223455677999999999999999999998743
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-44 Score=373.30 Aligned_cols=255 Identities=29% Similarity=0.434 Sum_probs=207.7
Q ss_pred HHHHhhCCcccceeEeeeCceEEEEEEEcCCCEEEEEEEcccchhhHHHHHHHHHHHhcCCCCCceeEEEEEEeCc-eee
Q 010519 180 DLEIATNRFSAENVLGEGGYGVVYKGRLINGSEVAVKKLLNNLGQAEKEFRVEVEAIGHVRHKNLVRLLGYCIEGV-HRM 258 (508)
Q Consensus 180 ~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~ei~~l~~l~h~niv~~~~~~~~~~-~~~ 258 (508)
.+++..++|.+.+.||+|+||.||+|.+ .|..||||++.... ..+.|.+|+.+|++++||||+++++++.... ..+
T Consensus 187 ~~~i~~~~~~~~~~lG~G~fg~V~~~~~-~~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 263 (450)
T 1k9a_A 187 GWALNMKELKLLQTIGKGEFGDVMLGDY-RGNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLY 263 (450)
T ss_dssp TCBCCGGGEEEEEEEEECSSEEEEEEEE-TTEEEEEEEESSCT--TSHHHHHHHHHHHTCCCTTBCCEEEEEECTTSCEE
T ss_pred ccccChHHeEEEeeecCcCCeeEEEEEe-cCCeEEEEEeCCch--HHHHHHHHHHHHHhccCCCEEEEEEEEEcCCCceE
Confidence 3456678899999999999999999988 57899999986543 3467889999999999999999999988765 789
Q ss_pred EEEeecCCCCHHHHHhhhhccCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCEEEcCCCcEEEEecCCccc
Q 010519 259 LVYEYVNNGNLEQWLHGAMRNQGNLTWEARMKVIIGTAKALAYLHEAIEPKVVHRDIKSSNILIDDEFNAKVSDFGLAKL 338 (508)
Q Consensus 259 lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~Dfgla~~ 338 (508)
+||||+++|+|.+++.. .....+++..++.++.||+.||.|||++ +|+||||||+|||++.++.+||+|||+++.
T Consensus 264 iv~e~~~~g~L~~~l~~--~~~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivHrDlkp~Nill~~~~~~kl~DfG~a~~ 338 (450)
T 1k9a_A 264 IVTEYMAKGSLVDYLRS--RGRSVLGGDCLLKFSLDVCEAMEYLEGN---NFVHRDLAARNVLVSEDNVAKVSDFGLTKE 338 (450)
T ss_dssp EEEECCTTCBHHHHHHH--HCTTTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECTTSCEEECCCTTCEE
T ss_pred EEEEecCCCcHHHHHHh--cCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCCHhhEEECCCCCEEEeeCCCccc
Confidence 99999999999999974 2334578999999999999999999999 999999999999999999999999999986
Q ss_pred cCCCCCcccccccccccccCccccCCCCCCChhhHHHHHHHHHHHHh-CCCCCCCCCCCchhcHHHHHHHHhcccccccc
Q 010519 339 LDSGESHITTRVMGTFGYVAPEYANTGMLNEKSDIYSFGVLLLEAVT-GRDPVDYGRPANEVNLVEWLKMMVGTRRAEEV 417 (508)
Q Consensus 339 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 417 (508)
.... .....+++.|+|||++.+..++.++|||||||+||||++ |..||....... ... ......
T Consensus 339 ~~~~----~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~---~~~---~i~~~~----- 403 (450)
T 1k9a_A 339 ASST----QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKD---VVP---RVEKGY----- 403 (450)
T ss_dssp CC----------CCCTTTSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTTCCSSTTSCTTT---HHH---HHHTTC-----
T ss_pred cccc----ccCCCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHH---HHH---HHHcCC-----
Confidence 5432 122356889999999999999999999999999999998 999997543322 111 111111
Q ss_pred cCCCCCCChhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhhcC
Q 010519 418 VDPNLEVKPATRALKRSLLVALRCVDPDSEKRPKMSQVVRMLEAD 462 (508)
Q Consensus 418 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~ 462 (508)
....+......+.+|+.+||+.||.+|||+.++++.|+..
T Consensus 404 -----~~~~p~~~~~~l~~li~~cl~~dp~~Rpt~~~l~~~L~~i 443 (450)
T 1k9a_A 404 -----KMDAPDGCPPAVYDVMKNCWHLDAATRPTFLQLREQLEHI 443 (450)
T ss_dssp -----CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred -----CCCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHH
Confidence 1111222345667799999999999999999999999764
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-43 Score=349.77 Aligned_cols=261 Identities=24% Similarity=0.386 Sum_probs=201.4
Q ss_pred hhCCcccceeEeeeCceEEEEEEEcCCCEEEEEEEcccchhhHHHHHHHHHHHhc--CCCCCceeEEEEEEeC----cee
Q 010519 184 ATNRFSAENVLGEGGYGVVYKGRLINGSEVAVKKLLNNLGQAEKEFRVEVEAIGH--VRHKNLVRLLGYCIEG----VHR 257 (508)
Q Consensus 184 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~ei~~l~~--l~h~niv~~~~~~~~~----~~~ 257 (508)
..++|.+.+.||+|+||+||+|++ +++.||||++.... ...+..|.+++.. ++||||+++++++... ...
T Consensus 6 ~~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~---~~~~~~e~~~~~~~~l~h~niv~~~~~~~~~~~~~~~~ 81 (301)
T 3q4u_A 6 VARDITLLECVGKGRYGEVWRGSW-QGENVAVKIFSSRD---EKSWFRETELYNTVMLRHENILGFIASDMTSRHSSTQL 81 (301)
T ss_dssp CGGGCEEEEEEEECSSEEEEEEEE-TTEEEEEEEECGGG---HHHHHHHHHHHHHTCCCCTTBCCEEEEEEEEETTEEEE
T ss_pred ccCcEEEEEeeccCCCcEEEEEEE-CCEEEEEEEecccc---chhhHHHHHHHHHhhccCcCeeeEEEeeccccCCCcee
Confidence 356899999999999999999988 78999999985432 3344455665555 8999999999987653 457
Q ss_pred eEEEeecCCCCHHHHHhhhhccCCCccHHHHHHHHHHHHHHHHHHH--------hcCCCCeEeecCCCCCEEEcCCCcEE
Q 010519 258 MLVYEYVNNGNLEQWLHGAMRNQGNLTWEARMKVIIGTAKALAYLH--------EAIEPKVVHRDIKSSNILIDDEFNAK 329 (508)
Q Consensus 258 ~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~yLH--------~~~~~~iiH~Dlk~~NIll~~~~~~k 329 (508)
++||||+++|+|.+++. ...+++..++.++.||+.||.||| +. +|+||||||+|||++.++.+|
T Consensus 82 ~lv~e~~~~g~L~~~l~-----~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~---~ivH~Dlkp~Nill~~~~~~k 153 (301)
T 3q4u_A 82 WLITHYHEMGSLYDYLQ-----LTTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKP---AIAHRDLKSKNILVKKNGQCC 153 (301)
T ss_dssp EEEECCCTTCBHHHHHT-----TCCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBC---EEECSCCCGGGEEECTTSCEE
T ss_pred EEehhhccCCCHHHHHh-----hcccCHHHHHHHHHHHHHHHHHHHHhhhhccCCC---CeecCCCChHhEEEcCCCCEE
Confidence 89999999999999984 346899999999999999999999 77 999999999999999999999
Q ss_pred EEecCCccccCCCCCcc---cccccccccccCccccCCC------CCCChhhHHHHHHHHHHHHhC----------CCCC
Q 010519 330 VSDFGLAKLLDSGESHI---TTRVMGTFGYVAPEYANTG------MLNEKSDIYSFGVLLLEAVTG----------RDPV 390 (508)
Q Consensus 330 l~Dfgla~~~~~~~~~~---~~~~~gt~~y~aPE~~~~~------~~~~~~DvwS~Gvvl~elltG----------~~Pf 390 (508)
|+|||++.......... .....||+.|+|||++.+. .++.++|||||||++|||++| ..||
T Consensus 154 l~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~pf 233 (301)
T 3q4u_A 154 IADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPF 233 (301)
T ss_dssp ECCCTTCEEEETTTTEEECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTT
T ss_pred EeeCCCeeecccccccccccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHHhhhcCccccccccccc
Confidence 99999998654433221 2334799999999999876 455799999999999999999 8887
Q ss_pred CCCCCCchhcHHHHHHHHhcccccccccCCCCCC-ChhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhhcC
Q 010519 391 DYGRPANEVNLVEWLKMMVGTRRAEEVVDPNLEV-KPATRALKRSLLVALRCVDPDSEKRPKMSQVVRMLEAD 462 (508)
Q Consensus 391 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~ 462 (508)
....+... ............. ..+.+.. .........+.+|+.+||+.||.+|||+.+|++.|+..
T Consensus 234 ~~~~~~~~-~~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~i 300 (301)
T 3q4u_A 234 YDVVPNDP-SFEDMRKVVCVDQ-----QRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKKTLTKI 300 (301)
T ss_dssp TTTSCSSC-CHHHHHHHHTTSC-----CCCCCCGGGGGSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHHHH
T ss_pred cccCCCCc-chhhhhHHHhccC-----CCCCCChhhccCccHHHHHHHHHHHhhcChhhCCCHHHHHHHHhcc
Confidence 54433222 1222222111111 1111111 11234567788899999999999999999999999864
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-43 Score=354.10 Aligned_cols=253 Identities=17% Similarity=0.271 Sum_probs=208.7
Q ss_pred hCCcccceeEeeeCceEEEEEEEc-CCCEEEEEEEcccchhhHHHHHHHHHHHhcCCCCCceeEEEEEEeCceeeEEEee
Q 010519 185 TNRFSAENVLGEGGYGVVYKGRLI-NGSEVAVKKLLNNLGQAEKEFRVEVEAIGHVRHKNLVRLLGYCIEGVHRMLVYEY 263 (508)
Q Consensus 185 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~ei~~l~~l~h~niv~~~~~~~~~~~~~lv~E~ 263 (508)
.++|.+.+.||+|+||+||+|.+. ++..+|+|.+... ......+.+|+.+++.++||||+++++++.+....++||||
T Consensus 4 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~a~K~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~ 82 (321)
T 1tki_A 4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVK-GTDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFEF 82 (321)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCC-THHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEECC
T ss_pred hhceEeeeEEecCCCeEEEEEEECCCCcEEEEEEEecC-cccHHHHHHHHHHHHhCCCCCCCeEeEEEecCCEEEEEEEe
Confidence 468999999999999999999886 5778999988644 33456688999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhhhhccCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCEEEcC--CCcEEEEecCCccccCC
Q 010519 264 VNNGNLEQWLHGAMRNQGNLTWEARMKVIIGTAKALAYLHEAIEPKVVHRDIKSSNILIDD--EFNAKVSDFGLAKLLDS 341 (508)
Q Consensus 264 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiH~Dlk~~NIll~~--~~~~kl~Dfgla~~~~~ 341 (508)
+++|+|.+++. .....+++..++.++.||+.||.|||++ +|+||||||+|||++. ++.+||+|||++.....
T Consensus 83 ~~g~~L~~~l~---~~~~~~~~~~~~~i~~qi~~al~~lH~~---givH~Dlkp~NIl~~~~~~~~~kl~Dfg~a~~~~~ 156 (321)
T 1tki_A 83 ISGLDIFERIN---TSAFELNEREIVSYVHQVCEALQFLHSH---NIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKP 156 (321)
T ss_dssp CCCCBHHHHHT---SSSCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSSSCCCEEECCCTTCEECCT
T ss_pred CCCCCHHHHHH---hcCCCCCHHHHHHHHHHHHHHHHHHHHC---CCCcCCCCHHHEEEccCCCCCEEEEECCCCeECCC
Confidence 99999999985 3345799999999999999999999999 9999999999999987 78999999999987754
Q ss_pred CCCcccccccccccccCccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCCCchhcHHHHHHHHhcccccccccCCC
Q 010519 342 GESHITTRVMGTFGYVAPEYANTGMLNEKSDIYSFGVLLLEAVTGRDPVDYGRPANEVNLVEWLKMMVGTRRAEEVVDPN 421 (508)
Q Consensus 342 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 421 (508)
.. ......||+.|+|||++.+..++.++|||||||++|+|++|..||..... . ..+...... .
T Consensus 157 ~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~---~---~~~~~i~~~---------~ 219 (321)
T 1tki_A 157 GD--NFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETN---Q---QIIENIMNA---------E 219 (321)
T ss_dssp TC--EEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSH---H---HHHHHHHHT---------C
T ss_pred CC--ccccccCChhhcCcHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCcCCCH---H---HHHHHHHcC---------C
Confidence 33 23446789999999999998899999999999999999999999964321 1 112221111 1
Q ss_pred CCCCh--hHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhhc
Q 010519 422 LEVKP--ATRALKRSLLVALRCVDPDSEKRPKMSQVVRMLEA 461 (508)
Q Consensus 422 ~~~~~--~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~ 461 (508)
..... .......+.+|+.+||..||.+|||+.|++++-+-
T Consensus 220 ~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~e~l~hp~~ 261 (321)
T 1tki_A 220 YTFDEEAFKEISIEAMDFVDRLLVKERKSRMTASEALQHPWL 261 (321)
T ss_dssp CCCCHHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSHHH
T ss_pred CCCChhhhccCCHHHHHHHHHHcCCChhHCcCHHHHhcChhh
Confidence 11111 11234567789999999999999999999997654
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-44 Score=359.33 Aligned_cols=249 Identities=24% Similarity=0.370 Sum_probs=204.3
Q ss_pred CCcccceeEeeeCceEEEEEEE-cCCCEEEEEEEcccch---hhHHHHHHHHHHHhcCCCCCceeEEEEEEeCceeeEEE
Q 010519 186 NRFSAENVLGEGGYGVVYKGRL-INGSEVAVKKLLNNLG---QAEKEFRVEVEAIGHVRHKNLVRLLGYCIEGVHRMLVY 261 (508)
Q Consensus 186 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~---~~~~~~~~ei~~l~~l~h~niv~~~~~~~~~~~~~lv~ 261 (508)
++|.+.+.||+|+||+||+|.+ .+++.||+|++..... .....+.+|+.+++.++||||+++++++.+....++||
T Consensus 9 ~~Y~i~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~ 88 (336)
T 3h4j_B 9 GPYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVITTPTDIVMVI 88 (336)
T ss_dssp TTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred CCEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEehHHccchhHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence 5899999999999999999997 4788999999864321 22356888999999999999999999999999999999
Q ss_pred eecCCCCHHHHHhhhhccCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCEEEcCCCcEEEEecCCccccCC
Q 010519 262 EYVNNGNLEQWLHGAMRNQGNLTWEARMKVIIGTAKALAYLHEAIEPKVVHRDIKSSNILIDDEFNAKVSDFGLAKLLDS 341 (508)
Q Consensus 262 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~ 341 (508)
||+ +|+|.+++. ....+++..++.++.||+.||.|||+. +|+||||||+|||+++++.+||+|||++.....
T Consensus 89 E~~-~g~l~~~l~----~~~~l~~~~~~~i~~qi~~aL~~LH~~---givH~Dlkp~NIll~~~~~~kl~DFG~s~~~~~ 160 (336)
T 3h4j_B 89 EYA-GGELFDYIV----EKKRMTEDEGRRFFQQIICAIEYCHRH---KIVHRDLKPENLLLDDNLNVKIADFGLSNIMTD 160 (336)
T ss_dssp CCC-CEEHHHHHH----HHCSCCHHHHHHHHHHHHHHHHHHHHH---TCCCCCCSTTTEEECTTCCEEECCSSCTBTTTT
T ss_pred ECC-CCcHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCchhhEEEcCCCCEEEEEeccceeccC
Confidence 999 789999985 345799999999999999999999999 999999999999999999999999999987654
Q ss_pred CCCcccccccccccccCccccCCCCC-CChhhHHHHHHHHHHHHhCCCCCCCCCCCchhcHHHHHHHHhcccccccccCC
Q 010519 342 GESHITTRVMGTFGYVAPEYANTGML-NEKSDIYSFGVLLLEAVTGRDPVDYGRPANEVNLVEWLKMMVGTRRAEEVVDP 420 (508)
Q Consensus 342 ~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DvwS~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 420 (508)
.. .....+||+.|+|||++.+..+ +.++|||||||+||+|++|+.||......... ..+...
T Consensus 161 ~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~---------------~~i~~~ 223 (336)
T 3h4j_B 161 GN--FLKTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPNLF---------------KKVNSC 223 (336)
T ss_dssp SB--TTCCCTTSTTTSCGGGSCCSGGGCHHHHHHHHHHHHHHHHHSSCSSBCSSSTTCB---------------CCCCSS
T ss_pred Cc--ccccccCCcCcCCHHHHcCCCCCCCccchhHHHHHHHHHHhCCCCCCCccHHHHH---------------HHHHcC
Confidence 32 2345579999999999988776 68999999999999999999999643321110 111111
Q ss_pred CCCCChhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhhc
Q 010519 421 NLEVKPATRALKRSLLVALRCVDPDSEKRPKMSQVVRMLEA 461 (508)
Q Consensus 421 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~ 461 (508)
... .+......+.+|+.+||+.||.+|||+.|++++-+-
T Consensus 224 ~~~--~p~~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp~~ 262 (336)
T 3h4j_B 224 VYV--MPDFLSPGAQSLIRRMIVADPMQRITIQEIRRDPWF 262 (336)
T ss_dssp CCC--CCTTSCHHHHHHHHTTSCSSGGGSCCHHHHTTCHHH
T ss_pred CCC--CcccCCHHHHHHHHHHcCCChhHCcCHHHHHhChhh
Confidence 111 111223456679999999999999999999987654
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-44 Score=381.71 Aligned_cols=263 Identities=25% Similarity=0.404 Sum_probs=216.4
Q ss_pred HHHHHhhCCcccceeEeeeCceEEEEEEEcC-CCEEEEEEEcccchhhHHHHHHHHHHHhcCCCCCceeEEEEEEeCcee
Q 010519 179 RDLEIATNRFSAENVLGEGGYGVVYKGRLIN-GSEVAVKKLLNNLGQAEKEFRVEVEAIGHVRHKNLVRLLGYCIEGVHR 257 (508)
Q Consensus 179 ~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~ei~~l~~l~h~niv~~~~~~~~~~~~ 257 (508)
..+++..++|.+.+.||+|+||.||+|.+.. +..||||.+..... ..+.|.+|+.+|++++||||++++++|.+....
T Consensus 213 ~~~~~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~ 291 (495)
T 1opk_A 213 DKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM-EVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPF 291 (495)
T ss_dssp SCCBCCGGGEEEEEESGGGTTSSEEEEEEGGGTEEEEEEECCSSSS-CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred cccccCHHHceeeeEecCCCCeEEEEEEEcCCCeEEEEEEecCccc-chHHHHHHHHHHHhcCCCCEeeEEEEEecCCcE
Confidence 3456677889999999999999999999864 78899999865433 356788999999999999999999999999999
Q ss_pred eEEEeecCCCCHHHHHhhhhccCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCEEEcCCCcEEEEecCCcc
Q 010519 258 MLVYEYVNNGNLEQWLHGAMRNQGNLTWEARMKVIIGTAKALAYLHEAIEPKVVHRDIKSSNILIDDEFNAKVSDFGLAK 337 (508)
Q Consensus 258 ~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~Dfgla~ 337 (508)
++||||+++|+|.+++.. .....+++..++.++.||+.||.|||++ +|+||||||+|||++.++.+||+|||+++
T Consensus 292 ~lv~E~~~~g~L~~~l~~--~~~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivHrDlkp~NIll~~~~~~kl~DFG~a~ 366 (495)
T 1opk_A 292 YIITEFMTYGNLLDYLRE--CNRQEVSAVVLLYMATQISSAMEYLEKK---NFIHRNLAARNCLVGENHLVKVADFGLSR 366 (495)
T ss_dssp EEEEECCTTCBHHHHHHH--SCTTTSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECGGGCEEECCTTCEE
T ss_pred EEEEEccCCCCHHHHHHh--cCcCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCChhhEEECCCCcEEEeecccce
Confidence 999999999999999964 2345689999999999999999999999 99999999999999999999999999998
Q ss_pred ccCCCCCcccccccccccccCccccCCCCCCChhhHHHHHHHHHHHHh-CCCCCCCCCCCchhcHHHHHHHHhccccccc
Q 010519 338 LLDSGESHITTRVMGTFGYVAPEYANTGMLNEKSDIYSFGVLLLEAVT-GRDPVDYGRPANEVNLVEWLKMMVGTRRAEE 416 (508)
Q Consensus 338 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 416 (508)
..............++..|+|||++.+..++.++|||||||+||||++ |..||...... .+...+ ...
T Consensus 367 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlG~~l~el~t~g~~p~~~~~~~---~~~~~~---~~~----- 435 (495)
T 1opk_A 367 LMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLS---QVYELL---EKD----- 435 (495)
T ss_dssp CCTTCCEECCTTCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCGG---GHHHHH---HTT-----
T ss_pred eccCCceeecCCCcCCcceeCHhHHhcCCCCcHHhHHhHHHHHHHHHhCCCCCCCCCCHH---HHHHHH---HcC-----
Confidence 765443333334456789999999998899999999999999999999 99999644322 222211 111
Q ss_pred ccCCCCCCChhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhhcCC
Q 010519 417 VVDPNLEVKPATRALKRSLLVALRCVDPDSEKRPKMSQVVRMLEADD 463 (508)
Q Consensus 417 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~ 463 (508)
.....+......+.+|+.+||+.||.+|||+.+|++.|+...
T Consensus 436 -----~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~el~~~L~~~~ 477 (495)
T 1opk_A 436 -----YRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMF 477 (495)
T ss_dssp -----CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSC
T ss_pred -----CCCCCCCCCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHH
Confidence 111112223456677999999999999999999999999764
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-43 Score=367.61 Aligned_cols=255 Identities=20% Similarity=0.276 Sum_probs=205.4
Q ss_pred hCCcccceeEeeeCceEEEEEEEc-CCCEEEEEEEcccc--hhhHHHHHHHHHHHhcCCCCCceeEEEEEEeCceeeEEE
Q 010519 185 TNRFSAENVLGEGGYGVVYKGRLI-NGSEVAVKKLLNNL--GQAEKEFRVEVEAIGHVRHKNLVRLLGYCIEGVHRMLVY 261 (508)
Q Consensus 185 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~ei~~l~~l~h~niv~~~~~~~~~~~~~lv~ 261 (508)
.++|.+.+.||+|+||+||+|.+. +|+.+|+|++.... ......+.+|+.+++.++||||+++++++.+....++||
T Consensus 10 ~~~Y~i~~~LG~G~fg~V~~~~~~~~~~~~a~K~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lv~ 89 (444)
T 3soa_A 10 TEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSISEEGHHYLIF 89 (444)
T ss_dssp HHHEEEEEEEEEC--CEEEEEEETTTTEEEEEEEEESCSCHHHHHHHHHHHHHHHHHCCBTTBCCEEEEEECSSEEEEEE
T ss_pred cCCeEEEEEeccCCCeEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCcCCCeEEEEEEECCEEEEEE
Confidence 468999999999999999999875 68899999986543 233467889999999999999999999999999999999
Q ss_pred eecCCCCHHHHHhhhhccCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCEEEc---CCCcEEEEecCCccc
Q 010519 262 EYVNNGNLEQWLHGAMRNQGNLTWEARMKVIIGTAKALAYLHEAIEPKVVHRDIKSSNILID---DEFNAKVSDFGLAKL 338 (508)
Q Consensus 262 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiH~Dlk~~NIll~---~~~~~kl~Dfgla~~ 338 (508)
||+.+|+|.+++. ....+++..+..++.||+.||.|||++ +|+||||||+|||++ .++.+||+|||++..
T Consensus 90 E~~~gg~L~~~i~----~~~~~~e~~~~~i~~qil~aL~~lH~~---givHrDlKp~NIll~~~~~~~~vkL~DFG~a~~ 162 (444)
T 3soa_A 90 DLVTGGELFEDIV----AREYYSEADASHCIQQILEAVLHCHQM---GVVHRNLKPENLLLASKLKGAAVKLADFGLAIE 162 (444)
T ss_dssp CCCBCCBHHHHHH----HCSCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSSTTEEESBSSTTCCEEECCCSSCBC
T ss_pred EeCCCCCHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEEeccCCCCcEEEccCceeEE
Confidence 9999999999985 456799999999999999999999999 999999999999998 567899999999987
Q ss_pred cCCCCCcccccccccccccCccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCCCchhcHHHHHHHHhccccccccc
Q 010519 339 LDSGESHITTRVMGTFGYVAPEYANTGMLNEKSDIYSFGVLLLEAVTGRDPVDYGRPANEVNLVEWLKMMVGTRRAEEVV 418 (508)
Q Consensus 339 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 418 (508)
...... ......||+.|+|||++.+..|+.++|||||||+||+|++|..||.... .. ......... ..
T Consensus 163 ~~~~~~-~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyell~G~~Pf~~~~---~~---~~~~~i~~~-~~---- 230 (444)
T 3soa_A 163 VEGEQQ-AWFGFAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPPFWDED---QH---RLYQQIKAG-AY---- 230 (444)
T ss_dssp CCTTCC-BCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSCCCSS---HH---HHHHHHHHT-CC----
T ss_pred ecCCCc-eeecccCCcccCCHHHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCcc---HH---HHHHHHHhC-CC----
Confidence 654332 2345679999999999999999999999999999999999999996432 11 111111111 00
Q ss_pred CCCCCCChhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhh
Q 010519 419 DPNLEVKPATRALKRSLLVALRCVDPDSEKRPKMSQVVRMLE 460 (508)
Q Consensus 419 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 460 (508)
.+...........+.+|+.+||+.||.+|||+.|++++-+
T Consensus 231 --~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~e~L~hp~ 270 (444)
T 3soa_A 231 --DFPSPEWDTVTPEAKDLINKMLTINPSKRITAAEALKHPW 270 (444)
T ss_dssp --CCCTTTTTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSCT
T ss_pred --CCCccccccCCHHHHHHHHHHcCCChhHCCCHHHHhcCcc
Confidence 0011111122345667999999999999999999998643
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-44 Score=377.96 Aligned_cols=263 Identities=28% Similarity=0.408 Sum_probs=208.3
Q ss_pred HHHHHhhCCcccceeEeeeCceEEEEEEEcCCCEEEEEEEcccchhhHHHHHHHHHHHhcCCCCCceeEEEEEEeCceee
Q 010519 179 RDLEIATNRFSAENVLGEGGYGVVYKGRLINGSEVAVKKLLNNLGQAEKEFRVEVEAIGHVRHKNLVRLLGYCIEGVHRM 258 (508)
Q Consensus 179 ~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~ei~~l~~l~h~niv~~~~~~~~~~~~~ 258 (508)
..+++..++|.+.+.||+|+||+||+|.+.++..||||++.... ...+.|.+|+.+|++++||||+++++++.+ ...+
T Consensus 177 ~~~~i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-~~~~ 254 (452)
T 1fmk_A 177 DAWEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIY 254 (452)
T ss_dssp TCSBCCGGGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCE
T ss_pred cccccChhHceeeeeecCCCCeEEEEEEECCCceEEEEEeccCC-CCHHHHHHHHHHHHhCCCCCEeeEEEEEcC-CceE
Confidence 34567778999999999999999999999877889999986543 234678899999999999999999999865 6789
Q ss_pred EEEeecCCCCHHHHHhhhhccCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCEEEcCCCcEEEEecCCccc
Q 010519 259 LVYEYVNNGNLEQWLHGAMRNQGNLTWEARMKVIIGTAKALAYLHEAIEPKVVHRDIKSSNILIDDEFNAKVSDFGLAKL 338 (508)
Q Consensus 259 lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~Dfgla~~ 338 (508)
+||||+++|+|.+++.. .....+++..++.++.||+.||.|||++ +|+||||||+|||+++++.+||+|||+++.
T Consensus 255 iv~e~~~~gsL~~~l~~--~~~~~~~~~~~~~i~~qi~~~l~~LH~~---~ivHrDlkp~Nill~~~~~~kl~DfG~a~~ 329 (452)
T 1fmk_A 255 IVTEYMSKGSLLDFLKG--ETGKYLRLPQLVDMAAQIASGMAYVERM---NYVHRDLRAANILVGENLVCKVADFGLARL 329 (452)
T ss_dssp EEECCCTTCBHHHHHSH--HHHTTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCCCTTC-
T ss_pred EEehhhcCCCHHHHHHh--cCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChhhEEECCCCCEEECCCcccee
Confidence 99999999999999964 2335689999999999999999999999 999999999999999999999999999987
Q ss_pred cCCCCCcccccccccccccCccccCCCCCCChhhHHHHHHHHHHHHh-CCCCCCCCCCCchhcHHHHHHHHhcccccccc
Q 010519 339 LDSGESHITTRVMGTFGYVAPEYANTGMLNEKSDIYSFGVLLLEAVT-GRDPVDYGRPANEVNLVEWLKMMVGTRRAEEV 417 (508)
Q Consensus 339 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 417 (508)
.............++..|+|||++.+..++.++|||||||+||||++ |..||..... .+.........
T Consensus 330 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~------~~~~~~i~~~~----- 398 (452)
T 1fmk_A 330 IEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVN------REVLDQVERGY----- 398 (452)
T ss_dssp -------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCH------HHHHHHHHTTC-----
T ss_pred cCCCceecccCCcccccccCHhHHhcCCCCccccHHhHHHHHHHHHhCCCCCCCCCCH------HHHHHHHHcCC-----
Confidence 65433333334456789999999998899999999999999999999 9999964321 12222222111
Q ss_pred cCCCCCCChhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhhcCCC
Q 010519 418 VDPNLEVKPATRALKRSLLVALRCVDPDSEKRPKMSQVVRMLEADDY 464 (508)
Q Consensus 418 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~ 464 (508)
....+......+.+|+.+||+.||.+|||+.+|++.|+....
T Consensus 399 -----~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~l~~~L~~~~~ 440 (452)
T 1fmk_A 399 -----RMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFT 440 (452)
T ss_dssp -----CCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTS
T ss_pred -----CCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHhc
Confidence 111112234566779999999999999999999999998654
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-43 Score=354.74 Aligned_cols=250 Identities=24% Similarity=0.334 Sum_probs=207.1
Q ss_pred CCcccceeEeeeCceEEEEEEEc-CCCEEEEEEEcccc---hhhHHHHHHHHHHHhcCCCCCceeEEEEEEeCceeeEEE
Q 010519 186 NRFSAENVLGEGGYGVVYKGRLI-NGSEVAVKKLLNNL---GQAEKEFRVEVEAIGHVRHKNLVRLLGYCIEGVHRMLVY 261 (508)
Q Consensus 186 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~ei~~l~~l~h~niv~~~~~~~~~~~~~lv~ 261 (508)
++|.+.+.||+|+||+||+++.. +|+.||+|++.... ......+.+|+.+++.++||||+++++++.+....|+||
T Consensus 6 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lv~ 85 (318)
T 1fot_A 6 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIM 85 (318)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEEE
T ss_pred HHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhCCCCCCceEeEEEEeCCEEEEEE
Confidence 57999999999999999999885 68999999986532 123456788999999999999999999999999999999
Q ss_pred eecCCCCHHHHHhhhhccCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCEEEcCCCcEEEEecCCccccCC
Q 010519 262 EYVNNGNLEQWLHGAMRNQGNLTWEARMKVIIGTAKALAYLHEAIEPKVVHRDIKSSNILIDDEFNAKVSDFGLAKLLDS 341 (508)
Q Consensus 262 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~ 341 (508)
||+++|+|.+++. ....+++..++.++.||+.||.|||++ +|+||||||+|||++.++.+||+|||++.....
T Consensus 86 e~~~gg~L~~~l~----~~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~~kL~Dfg~a~~~~~ 158 (318)
T 1fot_A 86 DYIEGGELFSLLR----KSQRFPNPVAKFYAAEVCLALEYLHSK---DIIYRDLKPENILLDKNGHIKITDFGFAKYVPD 158 (318)
T ss_dssp CCCCSCBHHHHHH----HTSSCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECTTSCEEECCCSSCEECSS
T ss_pred eCCCCCCHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCChheEEEcCCCCEEEeecCcceecCC
Confidence 9999999999995 345789999999999999999999999 999999999999999999999999999987643
Q ss_pred CCCcccccccccccccCccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCCCchhcHHHHHHHHhcccccccccCCC
Q 010519 342 GESHITTRVMGTFGYVAPEYANTGMLNEKSDIYSFGVLLLEAVTGRDPVDYGRPANEVNLVEWLKMMVGTRRAEEVVDPN 421 (508)
Q Consensus 342 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 421 (508)
. ....+||+.|+|||++.+..++.++|||||||++|||++|..||..... .......... .
T Consensus 159 ~----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~------~~~~~~i~~~---------~ 219 (318)
T 1fot_A 159 V----TYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNT------MKTYEKILNA---------E 219 (318)
T ss_dssp C----BCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSH------HHHHHHHHHC---------C
T ss_pred c----cccccCCccccCHhHhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCH------HHHHHHHHhC---------C
Confidence 2 3346799999999999999999999999999999999999999964321 1112222111 1
Q ss_pred CCCChhHHHHHHHHHHHHHhcCCCCCCCC-----CHHHHHHHhhcCC
Q 010519 422 LEVKPATRALKRSLLVALRCVDPDSEKRP-----KMSQVVRMLEADD 463 (508)
Q Consensus 422 ~~~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~evl~~L~~~~ 463 (508)
+..+ ......+.+++.+||..||.+|| +++++++|-.-..
T Consensus 220 ~~~p--~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~~i~~hp~f~~ 264 (318)
T 1fot_A 220 LRFP--PFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNHPWFKE 264 (318)
T ss_dssp CCCC--TTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHTSGGGSS
T ss_pred CCCC--CCCCHHHHHHHHHHhccCHHHcCCCcCCCHHHHhcCccccC
Confidence 1111 11234566799999999999999 8999998765443
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-43 Score=361.97 Aligned_cols=255 Identities=22% Similarity=0.309 Sum_probs=207.3
Q ss_pred hhCCcccceeEeeeCceEEEEEEEc-CCCEEEEEEEcccc---hhhHHHHHHHHHHHhcCCCCCceeEEEEEEeCceeeE
Q 010519 184 ATNRFSAENVLGEGGYGVVYKGRLI-NGSEVAVKKLLNNL---GQAEKEFRVEVEAIGHVRHKNLVRLLGYCIEGVHRML 259 (508)
Q Consensus 184 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~ei~~l~~l~h~niv~~~~~~~~~~~~~l 259 (508)
..++|.+.+.||+|+||.||++.+. +++.||+|.+.... ......+.+|+.+|+.++|||||+++++|.+....|+
T Consensus 13 ~~~~y~i~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~l 92 (384)
T 4fr4_A 13 NFDHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWYSFQDEEDMFM 92 (384)
T ss_dssp CGGGEEEEEEEECCTTCCEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEE
T ss_pred ChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEE
Confidence 3468999999999999999999876 57889999985432 2234578889999999999999999999999999999
Q ss_pred EEeecCCCCHHHHHhhhhccCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCEEEcCCCcEEEEecCCcccc
Q 010519 260 VYEYVNNGNLEQWLHGAMRNQGNLTWEARMKVIIGTAKALAYLHEAIEPKVVHRDIKSSNILIDDEFNAKVSDFGLAKLL 339 (508)
Q Consensus 260 v~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~Dfgla~~~ 339 (508)
||||+.+|+|.+++. ....+++..++.++.||+.||.|||+. +|+||||||+|||++.++.+||+|||++...
T Consensus 93 v~e~~~gg~L~~~l~----~~~~l~~~~~~~~~~qi~~aL~~LH~~---givHrDlkp~NIll~~~g~vkL~DFG~a~~~ 165 (384)
T 4fr4_A 93 VVDLLLGGDLRYHLQ----QNVHFKEETVKLFICELVMALDYLQNQ---RIIHRDMKPDNILLDEHGHVHITDFNIAAML 165 (384)
T ss_dssp EECCCTTEEHHHHHH----TTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEEC
T ss_pred EEecCCCCcHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCcHHHeEECCCCCEEEeccceeeec
Confidence 999999999999984 456799999999999999999999999 9999999999999999999999999999876
Q ss_pred CCCCCcccccccccccccCccccCC---CCCCChhhHHHHHHHHHHHHhCCCCCCCCCCCchhcHHHHHHHHhccccccc
Q 010519 340 DSGESHITTRVMGTFGYVAPEYANT---GMLNEKSDIYSFGVLLLEAVTGRDPVDYGRPANEVNLVEWLKMMVGTRRAEE 416 (508)
Q Consensus 340 ~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~DvwS~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 416 (508)
.... .....+||+.|+|||++.+ ..|+.++|||||||+||||++|+.||............. ......
T Consensus 166 ~~~~--~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~---~~~~~~---- 236 (384)
T 4fr4_A 166 PRET--QITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKEIVH---TFETTV---- 236 (384)
T ss_dssp CTTC--CBCCCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHHSSCSSCCCTTSCHHHHHH---HHHHCC----
T ss_pred cCCC--ceeccCCCccccCCeeeccCCCCCCCccceeechHHHHHHHHhCCCCCCCCCCccHHHHHH---HHhhcc----
Confidence 5432 2455689999999999964 458999999999999999999999997544333222222 111110
Q ss_pred ccCCCCCCChhHHHHHHHHHHHHHhcCCCCCCCCC-HHHHHHHhhc
Q 010519 417 VVDPNLEVKPATRALKRSLLVALRCVDPDSEKRPK-MSQVVRMLEA 461 (508)
Q Consensus 417 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs-~~evl~~L~~ 461 (508)
..+ +......+.+|+.+||+.||.+||+ +++++++-.-
T Consensus 237 ---~~~----p~~~s~~~~~li~~lL~~dP~~R~s~~~~l~~hp~f 275 (384)
T 4fr4_A 237 ---VTY----PSAWSQEMVSLLKKLLEPNPDQRFSQLSDVQNFPYM 275 (384)
T ss_dssp ---CCC----CTTSCHHHHHHHHHHSCSSGGGSCCSHHHHHTSGGG
T ss_pred ---cCC----CCcCCHHHHHHHHHHhcCCHhHhcccHHHHHcChhh
Confidence 000 1112345677999999999999998 8888875443
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-44 Score=360.70 Aligned_cols=269 Identities=24% Similarity=0.370 Sum_probs=214.1
Q ss_pred HHHHHHhhCCcccceeEeeeCceEEEEEEEcC------CCEEEEEEEcccc-hhhHHHHHHHHHHHhcCCCCCceeEEEE
Q 010519 178 LRDLEIATNRFSAENVLGEGGYGVVYKGRLIN------GSEVAVKKLLNNL-GQAEKEFRVEVEAIGHVRHKNLVRLLGY 250 (508)
Q Consensus 178 ~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~------~~~vavK~~~~~~-~~~~~~~~~ei~~l~~l~h~niv~~~~~ 250 (508)
+..+++..++|.+.+.||+|+||.||+|++.+ +..||+|.+.... ......+.+|+.+++.++||||++++++
T Consensus 39 ~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~ 118 (343)
T 1luf_A 39 LLSLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGV 118 (343)
T ss_dssp HHHTBCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEE
T ss_pred cceeEecHHHCeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEE
Confidence 34556677899999999999999999998753 3789999986543 3345678999999999999999999999
Q ss_pred EEeCceeeEEEeecCCCCHHHHHhhhhcc--------------------CCCccHHHHHHHHHHHHHHHHHHHhcCCCCe
Q 010519 251 CIEGVHRMLVYEYVNNGNLEQWLHGAMRN--------------------QGNLTWEARMKVIIGTAKALAYLHEAIEPKV 310 (508)
Q Consensus 251 ~~~~~~~~lv~E~~~~gsL~~~l~~~~~~--------------------~~~l~~~~~~~i~~~i~~al~yLH~~~~~~i 310 (508)
+.+....++||||+++|+|.+++...... ...+++..++.++.||+.||.|||++ +|
T Consensus 119 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~---~i 195 (343)
T 1luf_A 119 CAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSER---KF 195 (343)
T ss_dssp ECSSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHT---TC
T ss_pred EccCCceEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhC---Ce
Confidence 99999999999999999999999753111 25789999999999999999999999 99
Q ss_pred EeecCCCCCEEEcCCCcEEEEecCCccccCCCCC-cccccccccccccCccccCCCCCCChhhHHHHHHHHHHHHh-CCC
Q 010519 311 VHRDIKSSNILIDDEFNAKVSDFGLAKLLDSGES-HITTRVMGTFGYVAPEYANTGMLNEKSDIYSFGVLLLEAVT-GRD 388 (508)
Q Consensus 311 iH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~ellt-G~~ 388 (508)
+||||||+|||++.++.+||+|||++........ .......+|+.|+|||++.+..++.++|||||||++|||++ |..
T Consensus 196 vH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~ 275 (343)
T 1luf_A 196 VHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQ 275 (343)
T ss_dssp CCSCCSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCC
T ss_pred ecCCCCcceEEECCCCeEEEeecCCCcccccCccccccCCCcccceecChhhhccCCcCcccccHHHHHHHHHHHhcCCC
Confidence 9999999999999999999999999986543221 12334567899999999998899999999999999999999 999
Q ss_pred CCCCCCCCchhcHHHHHHHHhcccccccccCCCCCCChhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhhcCCCC
Q 010519 389 PVDYGRPANEVNLVEWLKMMVGTRRAEEVVDPNLEVKPATRALKRSLLVALRCVDPDSEKRPKMSQVVRMLEADDYP 465 (508)
Q Consensus 389 Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~ 465 (508)
||..... .+.......... ... +......+.+++.+||+.||.+|||+.+++++|+.....
T Consensus 276 p~~~~~~------~~~~~~~~~~~~------~~~----~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~L~~~~~~ 336 (343)
T 1luf_A 276 PYYGMAH------EEVIYYVRDGNI------LAC----PENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRMCER 336 (343)
T ss_dssp TTTTSCH------HHHHHHHHTTCC------CCC----CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTC-
T ss_pred cCCCCCh------HHHHHHHhCCCc------CCC----CCCCCHHHHHHHHHHcccCcccCCCHHHHHHHHHHHHhh
Confidence 9964321 122222221111 001 112234567799999999999999999999999987543
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-44 Score=354.85 Aligned_cols=263 Identities=27% Similarity=0.425 Sum_probs=211.2
Q ss_pred HHHhhCCcccceeEeeeCceEEEEEEEc------CCCEEEEEEEcccc-hhhHHHHHHHHHHHhcCCCCCceeEEEEEEe
Q 010519 181 LEIATNRFSAENVLGEGGYGVVYKGRLI------NGSEVAVKKLLNNL-GQAEKEFRVEVEAIGHVRHKNLVRLLGYCIE 253 (508)
Q Consensus 181 ~~~~~~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~-~~~~~~~~~ei~~l~~l~h~niv~~~~~~~~ 253 (508)
+++..++|.+.+.||+|+||.||+|++. ++..||+|.+.... ......+.+|+.+++.++||||+++++++.+
T Consensus 18 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~ 97 (314)
T 2ivs_A 18 WEFPRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIKLYGACSQ 97 (314)
T ss_dssp TBCCGGGEEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS
T ss_pred cccchhheeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCceeeEEEEEec
Confidence 3456678999999999999999999862 34789999986543 3444678899999999999999999999999
Q ss_pred CceeeEEEeecCCCCHHHHHhhhhc--------------------cCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEee
Q 010519 254 GVHRMLVYEYVNNGNLEQWLHGAMR--------------------NQGNLTWEARMKVIIGTAKALAYLHEAIEPKVVHR 313 (508)
Q Consensus 254 ~~~~~lv~E~~~~gsL~~~l~~~~~--------------------~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiH~ 313 (508)
....++||||+++|+|.+++..... ....+++..++.++.||+.||.|||++ +|+||
T Consensus 98 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~ 174 (314)
T 2ivs_A 98 DGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEM---KLVHR 174 (314)
T ss_dssp SSSCEEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHHHT---TEECC
T ss_pred CCceEEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHHHC---CCccc
Confidence 9999999999999999999975322 123488999999999999999999999 99999
Q ss_pred cCCCCCEEEcCCCcEEEEecCCccccCCCCCc-ccccccccccccCccccCCCCCCChhhHHHHHHHHHHHHh-CCCCCC
Q 010519 314 DIKSSNILIDDEFNAKVSDFGLAKLLDSGESH-ITTRVMGTFGYVAPEYANTGMLNEKSDIYSFGVLLLEAVT-GRDPVD 391 (508)
Q Consensus 314 Dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~ellt-G~~Pf~ 391 (508)
||||+|||++.++.+||+|||++......... ......+++.|+|||++.+..++.++|||||||++|||++ |..||.
T Consensus 175 dikp~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~ 254 (314)
T 2ivs_A 175 DLAARNILVAEGRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYP 254 (314)
T ss_dssp CCSGGGEEEETTTEEEECCCTTCEECTTTSCEECSSCCCSCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSST
T ss_pred ccchheEEEcCCCCEEEccccccccccccccceeccCCCCcccccChhhhcCCCcCchhhHHHHHHHHHHHHhCCCCCCC
Confidence 99999999999999999999999866543322 2233457889999999999899999999999999999999 999996
Q ss_pred CCCCCchhcHHHHHHHHhcccccccccCCCCCCChhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhhcC
Q 010519 392 YGRPANEVNLVEWLKMMVGTRRAEEVVDPNLEVKPATRALKRSLLVALRCVDPDSEKRPKMSQVVRMLEAD 462 (508)
Q Consensus 392 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~ 462 (508)
...... .... ...... . ..+......+.+++.+||+.||.+|||+.+++++|+..
T Consensus 255 ~~~~~~---~~~~---~~~~~~------~----~~~~~~~~~~~~li~~~l~~dp~~Rps~~~l~~~l~~~ 309 (314)
T 2ivs_A 255 GIPPER---LFNL---LKTGHR------M----ERPDNCSEEMYRLMLQCWKQEPDKRPVFADISKDLEKM 309 (314)
T ss_dssp TCCGGG---HHHH---HHTTCC------C----CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred CCCHHH---HHHH---hhcCCc------C----CCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence 543221 1111 111110 0 11112234567799999999999999999999999864
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-44 Score=365.09 Aligned_cols=263 Identities=27% Similarity=0.439 Sum_probs=212.5
Q ss_pred HHhhCCcccceeEeeeCceEEEEEEEc--------CCCEEEEEEEcccc-hhhHHHHHHHHHHHhcC-CCCCceeEEEEE
Q 010519 182 EIATNRFSAENVLGEGGYGVVYKGRLI--------NGSEVAVKKLLNNL-GQAEKEFRVEVEAIGHV-RHKNLVRLLGYC 251 (508)
Q Consensus 182 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~--------~~~~vavK~~~~~~-~~~~~~~~~ei~~l~~l-~h~niv~~~~~~ 251 (508)
++..++|.+.+.||+|+||+||+|++. .+..||+|++.... ......+.+|+.+++++ +||||+++++++
T Consensus 65 ~i~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~ 144 (382)
T 3tt0_A 65 ELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGAC 144 (382)
T ss_dssp BCCGGGEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred ccchhheEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeeccccCHHHHHHHHHHHHHHHHhcCCchhhhheeee
Confidence 556679999999999999999999863 23579999986543 33446788999999999 999999999999
Q ss_pred EeCceeeEEEeecCCCCHHHHHhhhhc------------cCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCC
Q 010519 252 IEGVHRMLVYEYVNNGNLEQWLHGAMR------------NQGNLTWEARMKVIIGTAKALAYLHEAIEPKVVHRDIKSSN 319 (508)
Q Consensus 252 ~~~~~~~lv~E~~~~gsL~~~l~~~~~------------~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiH~Dlk~~N 319 (508)
......++||||+++|+|.+++..... ....+++..++.++.||+.||.|||+. +|+||||||+|
T Consensus 145 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~N 221 (382)
T 3tt0_A 145 TQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASK---KCIHRDLAARN 221 (382)
T ss_dssp CSSSSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGG
T ss_pred ccCCceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCcce
Confidence 999999999999999999999975321 124589999999999999999999999 99999999999
Q ss_pred EEEcCCCcEEEEecCCccccCCCCC-cccccccccccccCccccCCCCCCChhhHHHHHHHHHHHHh-CCCCCCCCCCCc
Q 010519 320 ILIDDEFNAKVSDFGLAKLLDSGES-HITTRVMGTFGYVAPEYANTGMLNEKSDIYSFGVLLLEAVT-GRDPVDYGRPAN 397 (508)
Q Consensus 320 Ill~~~~~~kl~Dfgla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~ellt-G~~Pf~~~~~~~ 397 (508)
||++.++.+||+|||+++....... .......+|+.|+|||++.+..++.++|||||||++|+|++ |..||....
T Consensus 222 Ill~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~ellt~g~~p~~~~~--- 298 (382)
T 3tt0_A 222 VLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVP--- 298 (382)
T ss_dssp EEECTTCCEEECSCSCCCCSSCCCTTCCCTTCCCGGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCC---
T ss_pred EEEcCCCcEEEcccCcccccccccccccccCCCCCcceeCHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCC---
Confidence 9999999999999999986654322 22334567889999999999999999999999999999999 999986432
Q ss_pred hhcHHHHHHHHhcccccccccCCCCCCChhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhhcCC
Q 010519 398 EVNLVEWLKMMVGTRRAEEVVDPNLEVKPATRALKRSLLVALRCVDPDSEKRPKMSQVVRMLEADD 463 (508)
Q Consensus 398 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~ 463 (508)
..+........... . .+......+.+|+.+||+.||.+|||+.||+++|+...
T Consensus 299 ---~~~~~~~~~~~~~~------~----~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~ 351 (382)
T 3tt0_A 299 ---VEELFKLLKEGHRM------D----KPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIV 351 (382)
T ss_dssp ---HHHHHHHHHTTCCC------C----CCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred ---HHHHHHHHHcCCCC------C----CCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence 12222222211111 1 11122345677999999999999999999999998754
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-44 Score=366.35 Aligned_cols=268 Identities=26% Similarity=0.388 Sum_probs=213.0
Q ss_pred eHHHHHHhhCCcccceeEeeeCceEEEEEEEc------CCCEEEEEEEcccc-hhhHHHHHHHHHHHhcC-CCCCceeEE
Q 010519 177 TLRDLEIATNRFSAENVLGEGGYGVVYKGRLI------NGSEVAVKKLLNNL-GQAEKEFRVEVEAIGHV-RHKNLVRLL 248 (508)
Q Consensus 177 ~~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~-~~~~~~~~~ei~~l~~l-~h~niv~~~ 248 (508)
....+++..++|.+.+.||+|+||.||+|++. +++.||||++.... ......+.+|+.++.++ +||||++++
T Consensus 13 ~~~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~~ 92 (359)
T 3vhe_A 13 DASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLL 92 (359)
T ss_dssp CHHHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred CcccccccccceeeceeecCCCCceEEEEEeccccccccceEEEEEEecCcCCHHHHHHHHHHHHHHHhhcCCcceeeee
Confidence 46778889999999999999999999999753 35789999986543 33346788999999999 799999999
Q ss_pred EEEEeCce-eeEEEeecCCCCHHHHHhhhhcc------------------------------------------------
Q 010519 249 GYCIEGVH-RMLVYEYVNNGNLEQWLHGAMRN------------------------------------------------ 279 (508)
Q Consensus 249 ~~~~~~~~-~~lv~E~~~~gsL~~~l~~~~~~------------------------------------------------ 279 (508)
+++.+... .++||||+++|+|.+++......
T Consensus 93 ~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 172 (359)
T 3vhe_A 93 GACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEKS 172 (359)
T ss_dssp EEECSTTSCCEEEEECCTTEEHHHHHHTTTTSBCSCC-------------------------------------------
T ss_pred eeeecCCCceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCccccccccccccccc
Confidence 99987654 88999999999999999753211
Q ss_pred --------------CCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCEEEcCCCcEEEEecCCccccCCCCC-
Q 010519 280 --------------QGNLTWEARMKVIIGTAKALAYLHEAIEPKVVHRDIKSSNILIDDEFNAKVSDFGLAKLLDSGES- 344 (508)
Q Consensus 280 --------------~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~- 344 (508)
...+++..++.++.||+.||.|||++ +|+||||||+|||++.++.+||+|||++........
T Consensus 173 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~---~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~ 249 (359)
T 3vhe_A 173 LSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR---KCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDY 249 (359)
T ss_dssp -----------CTTTTCBCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCCGGGSCTTSCTTC
T ss_pred cchhhhcccccchhccccCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChhhEEEcCCCcEEEEeccceeeecccccc
Confidence 12288999999999999999999999 999999999999999999999999999986543322
Q ss_pred cccccccccccccCccccCCCCCCChhhHHHHHHHHHHHHh-CCCCCCCCCCCchhcHHHHHHHHhcccccccccCCCCC
Q 010519 345 HITTRVMGTFGYVAPEYANTGMLNEKSDIYSFGVLLLEAVT-GRDPVDYGRPANEVNLVEWLKMMVGTRRAEEVVDPNLE 423 (508)
Q Consensus 345 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 423 (508)
.......||+.|+|||++.+..++.++|||||||++|||++ |..||........ ... ....... ...
T Consensus 250 ~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~--~~~---~~~~~~~------~~~- 317 (359)
T 3vhe_A 250 VRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEE--FCR---RLKEGTR------MRA- 317 (359)
T ss_dssp EEC--CEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHH--HHH---HHHHTCC------CCC-
T ss_pred hhccccCCCceeEChhhhcCCCCCchhhhhhHHHHHHHHHhcCCCCCCccchhHH--HHH---HHHcCCC------CCC-
Confidence 23344578999999999999999999999999999999998 9999965433221 111 1111110 001
Q ss_pred CChhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhhcC
Q 010519 424 VKPATRALKRSLLVALRCVDPDSEKRPKMSQVVRMLEAD 462 (508)
Q Consensus 424 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~ 462 (508)
+......+.+++.+||+.||.+|||+.|++++|+..
T Consensus 318 ---~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~ 353 (359)
T 3vhe_A 318 ---PDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNL 353 (359)
T ss_dssp ---CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred ---CCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHH
Confidence 111234566799999999999999999999999864
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-43 Score=364.45 Aligned_cols=259 Identities=24% Similarity=0.316 Sum_probs=203.8
Q ss_pred hCCcccceeEeeeCceEEEEEEEc-CCCEEEEEEEcccch---hhHHHHHHHHHHHhcC-CCCCceeEEEEEEeCceeeE
Q 010519 185 TNRFSAENVLGEGGYGVVYKGRLI-NGSEVAVKKLLNNLG---QAEKEFRVEVEAIGHV-RHKNLVRLLGYCIEGVHRML 259 (508)
Q Consensus 185 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~ei~~l~~l-~h~niv~~~~~~~~~~~~~l 259 (508)
.++|.+.+.||+|+||+||+|++. +++.||+|++..... .....+..|..++.++ +||||+++++++.+....|+
T Consensus 51 ~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~l 130 (396)
T 4dc2_A 51 LQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFF 130 (396)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEE
T ss_pred hhHcEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEEEECCEEEE
Confidence 468999999999999999999986 577899999865432 2224577799998876 89999999999999999999
Q ss_pred EEeecCCCCHHHHHhhhhccCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCEEEcCCCcEEEEecCCcccc
Q 010519 260 VYEYVNNGNLEQWLHGAMRNQGNLTWEARMKVIIGTAKALAYLHEAIEPKVVHRDIKSSNILIDDEFNAKVSDFGLAKLL 339 (508)
Q Consensus 260 v~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~Dfgla~~~ 339 (508)
||||+++|+|.+++. ....+++..++.++.||+.||.|||++ +|+||||||+|||++.++++||+|||+++..
T Consensus 131 V~E~~~gg~L~~~l~----~~~~l~~~~~~~~~~qi~~aL~~LH~~---givHrDLKp~NILl~~~g~ikL~DFGla~~~ 203 (396)
T 4dc2_A 131 VIEYVNGGDLMFHMQ----RQRKLPEEHARFYSAEISLALNYLHER---GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEG 203 (396)
T ss_dssp EEECCTTCBHHHHHH----HHSSCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBCC
T ss_pred EEEcCCCCcHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHHC---CEEeccCCHHHEEECCCCCEEEeecceeeec
Confidence 999999999999985 346799999999999999999999999 9999999999999999999999999999853
Q ss_pred CCCCCcccccccccccccCccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCCCch--hcHHHHHHHHhcccccccc
Q 010519 340 DSGESHITTRVMGTFGYVAPEYANTGMLNEKSDIYSFGVLLLEAVTGRDPVDYGRPANE--VNLVEWLKMMVGTRRAEEV 417 (508)
Q Consensus 340 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltG~~Pf~~~~~~~~--~~~~~~~~~~~~~~~~~~~ 417 (508)
.... ......+||+.|+|||++.+..|+.++|||||||+||||++|+.||........ ......+.......
T Consensus 204 ~~~~-~~~~~~~gt~~Y~aPE~l~~~~~~~~~DiwslGvllyell~G~~Pf~~~~~~~~~~~~~~~~~~~~i~~~----- 277 (396)
T 4dc2_A 204 LRPG-DTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEK----- 277 (396)
T ss_dssp CCTT-CCBCCCCBCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSTTTTC------CCHHHHHHHHHHC-----
T ss_pred ccCC-CccccccCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCcccccccccchhhHHHHHHHHhcc-----
Confidence 3222 234557899999999999999999999999999999999999999964322111 11111111111111
Q ss_pred cCCCCCCChhHHHHHHHHHHHHHhcCCCCCCCCCH------HHHHHHhhc
Q 010519 418 VDPNLEVKPATRALKRSLLVALRCVDPDSEKRPKM------SQVVRMLEA 461 (508)
Q Consensus 418 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~------~evl~~L~~ 461 (508)
.+.. +......+.+|+.+||+.||.+||++ .|+++|-.-
T Consensus 278 ---~~~~--p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~ei~~Hpff 322 (396)
T 4dc2_A 278 ---QIRI--PRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFF 322 (396)
T ss_dssp ---CCCC--CTTSCHHHHHHHHHHTCSCTTTSTTCSTTTHHHHHHHSTTT
T ss_pred ---ccCC--CCcCCHHHHHHHHHHhcCCHhHcCCCCCCCCHHHHhcCccc
Confidence 1111 11123456679999999999999995 688776543
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-43 Score=360.32 Aligned_cols=256 Identities=19% Similarity=0.268 Sum_probs=208.8
Q ss_pred hCCcccceeEeeeCceEEEEEEEc-CCCEEEEEEEcccchhhHHHHHHHHHHHhcCCCCCceeEEEEEEeCceeeEEEee
Q 010519 185 TNRFSAENVLGEGGYGVVYKGRLI-NGSEVAVKKLLNNLGQAEKEFRVEVEAIGHVRHKNLVRLLGYCIEGVHRMLVYEY 263 (508)
Q Consensus 185 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~ei~~l~~l~h~niv~~~~~~~~~~~~~lv~E~ 263 (508)
.++|.+.+.||+|+||+||+|.+. +|..+|+|.+..........+.+|+.+|+.++||||+++++++.+....++||||
T Consensus 50 ~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv~E~ 129 (387)
T 1kob_A 50 YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEF 129 (387)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEEC
T ss_pred ccceEEEEEEecCCCEEEEEEEECCCCCEEEEEEecccchhhHHHHHHHHHHHHhCCCcCCCeEEEEEEeCCEEEEEEEc
Confidence 358999999999999999999885 6888999998766555566789999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhhhhccCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCEEEcC--CCcEEEEecCCccccCC
Q 010519 264 VNNGNLEQWLHGAMRNQGNLTWEARMKVIIGTAKALAYLHEAIEPKVVHRDIKSSNILIDD--EFNAKVSDFGLAKLLDS 341 (508)
Q Consensus 264 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiH~Dlk~~NIll~~--~~~~kl~Dfgla~~~~~ 341 (508)
+++|+|.+++. .....+++..++.++.||+.||.|||++ +|+||||||+|||++. ++.+||+|||++.....
T Consensus 130 ~~gg~L~~~l~---~~~~~l~~~~~~~i~~qi~~aL~~LH~~---givHrDlkp~NIll~~~~~~~vkL~DFG~a~~~~~ 203 (387)
T 1kob_A 130 LSGGELFDRIA---AEDYKMSEAEVINYMRQACEGLKHMHEH---SIVHLDIKPENIMCETKKASSVKIIDFGLATKLNP 203 (387)
T ss_dssp CCCCBHHHHTT---CTTCCBCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSTTCCCEEECCCTTCEECCT
T ss_pred CCCCcHHHHHH---hhcCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecccchHHeEEecCCCCceEEEecccceecCC
Confidence 99999999985 2345799999999999999999999999 9999999999999974 57799999999987654
Q ss_pred CCCcccccccccccccCccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCCCchhcHHHHHHHHhcccccccccCCC
Q 010519 342 GESHITTRVMGTFGYVAPEYANTGMLNEKSDIYSFGVLLLEAVTGRDPVDYGRPANEVNLVEWLKMMVGTRRAEEVVDPN 421 (508)
Q Consensus 342 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 421 (508)
... .....||+.|+|||++.+..++.++|||||||+||||++|..||.... .. ..+....... ..
T Consensus 204 ~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~---~~---~~~~~i~~~~-------~~ 268 (387)
T 1kob_A 204 DEI--VKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGED---DL---ETLQNVKRCD-------WE 268 (387)
T ss_dssp TSC--EEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSS---HH---HHHHHHHHCC-------CC
T ss_pred Ccc--eeeeccCCCccCchhccCCCCCCcccEeeHhHHHHHHHhCCCCCCCCC---HH---HHHHHHHhCC-------CC
Confidence 332 334579999999999999999999999999999999999999996432 11 1111111110 00
Q ss_pred CCCChhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhhc
Q 010519 422 LEVKPATRALKRSLLVALRCVDPDSEKRPKMSQVVRMLEA 461 (508)
Q Consensus 422 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~ 461 (508)
+...........+.+|+.+||+.||.+|||+.|++++-.-
T Consensus 269 ~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~hp~~ 308 (387)
T 1kob_A 269 FDEDAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALEHPWL 308 (387)
T ss_dssp CCSSTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHTSTTT
T ss_pred CCccccccCCHHHHHHHHHHcCCChhHCcCHHHHhhCccc
Confidence 1111111223456779999999999999999999987543
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=9.2e-44 Score=355.11 Aligned_cols=275 Identities=21% Similarity=0.381 Sum_probs=218.9
Q ss_pred ceeHHHHHHhhCCcccceeEeeeCceEEEEEEEc------CCCEEEEEEEcccc-hhhHHHHHHHHHHHhcCCCCCceeE
Q 010519 175 WFTLRDLEIATNRFSAENVLGEGGYGVVYKGRLI------NGSEVAVKKLLNNL-GQAEKEFRVEVEAIGHVRHKNLVRL 247 (508)
Q Consensus 175 ~~~~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~-~~~~~~~~~ei~~l~~l~h~niv~~ 247 (508)
.+...++++..++|.+.+.||+|+||.||+|++. .+..||+|.+.... ......+.+|+.+++.++||||+++
T Consensus 14 ~~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~ 93 (322)
T 1p4o_A 14 VYVPDEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRL 93 (322)
T ss_dssp CCCCCTTBCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCE
T ss_pred ccChhhhcchhhheeeeeEeccCCceEEEeeeecCccCCCCceEEEEEecccccCHHHHHHHHHHHHHHHhcCCCCEeee
Confidence 3455667788899999999999999999999864 36789999986543 2344578899999999999999999
Q ss_pred EEEEEeCceeeEEEeecCCCCHHHHHhhhhcc------CCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCEE
Q 010519 248 LGYCIEGVHRMLVYEYVNNGNLEQWLHGAMRN------QGNLTWEARMKVIIGTAKALAYLHEAIEPKVVHRDIKSSNIL 321 (508)
Q Consensus 248 ~~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~------~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiH~Dlk~~NIl 321 (508)
++++.+....++||||+++|+|.+++...... ...+++..++.++.||+.||.|||++ +|+||||||+|||
T Consensus 94 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dikp~NIl 170 (322)
T 1p4o_A 94 LGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCM 170 (322)
T ss_dssp EEEECSSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHT---TCBCSCCSGGGEE
T ss_pred EEEEccCCccEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHHC---CCccCCCccceEE
Confidence 99999999999999999999999999653211 24578999999999999999999999 9999999999999
Q ss_pred EcCCCcEEEEecCCccccCCCCC-cccccccccccccCccccCCCCCCChhhHHHHHHHHHHHHh-CCCCCCCCCCCchh
Q 010519 322 IDDEFNAKVSDFGLAKLLDSGES-HITTRVMGTFGYVAPEYANTGMLNEKSDIYSFGVLLLEAVT-GRDPVDYGRPANEV 399 (508)
Q Consensus 322 l~~~~~~kl~Dfgla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~ellt-G~~Pf~~~~~~~~~ 399 (508)
++.++.+||+|||++........ .......+|+.|+|||++.+..++.++|||||||++|+|++ |..||.....
T Consensus 171 i~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~---- 246 (322)
T 1p4o_A 171 VAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSN---- 246 (322)
T ss_dssp ECTTCCEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCH----
T ss_pred EcCCCeEEECcCccccccccccccccccCCCCCCCccChhhhccCCCCchhhHHHHHHHHHHHHhcCCCccccCCH----
Confidence 99999999999999986543221 12233467889999999999899999999999999999999 8899864321
Q ss_pred cHHHHHHHHhcccccccccCCCCCCChhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhhcCCCCCch
Q 010519 400 NLVEWLKMMVGTRRAEEVVDPNLEVKPATRALKRSLLVALRCVDPDSEKRPKMSQVVRMLEADDYPFRE 468 (508)
Q Consensus 400 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~~~~ 468 (508)
............ .. ........+.+++.+||+.||.+|||+.|++++|+....+...
T Consensus 247 --~~~~~~~~~~~~------~~----~~~~~~~~l~~li~~~l~~dp~~Rps~~e~l~~L~~~~~~~~~ 303 (322)
T 1p4o_A 247 --EQVLRFVMEGGL------LD----KPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEMEPGFR 303 (322)
T ss_dssp --HHHHHHHHTTCC------CC----CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSCTTHH
T ss_pred --HHHHHHHHcCCc------CC----CCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHhhccCCc
Confidence 122222221111 00 1112234566799999999999999999999999987665443
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0 | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-44 Score=347.29 Aligned_cols=251 Identities=28% Similarity=0.475 Sum_probs=194.6
Q ss_pred hhCCcccceeEeeeCceEEEEEEEcCCCEEEEEEEcccch----hhHHHHHHHHHHHhcCCCCCceeEEEEEEeCceeeE
Q 010519 184 ATNRFSAENVLGEGGYGVVYKGRLINGSEVAVKKLLNNLG----QAEKEFRVEVEAIGHVRHKNLVRLLGYCIEGVHRML 259 (508)
Q Consensus 184 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~----~~~~~~~~ei~~l~~l~h~niv~~~~~~~~~~~~~l 259 (508)
..++|.+.+.||+|+||+||+|.+ .+..||+|++..... ...+.+.+|+.+++.++||||+++++++.+....++
T Consensus 5 ~~~~~~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 83 (271)
T 3dtc_A 5 DFAELTLEEIIGIGGFGKVYRAFW-IGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCLKEPNLCL 83 (271)
T ss_dssp CTTSEEEEEEEEEETTEEEEEEEE-TTEEEEEEEC----------CHHHHHHHHHHHHHCCCTTBCCEEEEECCC--CEE
T ss_pred chhheeeeeeeccCCCeEEEEEEE-cCCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCCceEE
Confidence 456899999999999999999987 589999998865432 224678889999999999999999999999999999
Q ss_pred EEeecCCCCHHHHHhhhhccCCCccHHHHHHHHHHHHHHHHHHHhcCCCC---eEeecCCCCCEEEcC--------CCcE
Q 010519 260 VYEYVNNGNLEQWLHGAMRNQGNLTWEARMKVIIGTAKALAYLHEAIEPK---VVHRDIKSSNILIDD--------EFNA 328 (508)
Q Consensus 260 v~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~---iiH~Dlk~~NIll~~--------~~~~ 328 (508)
||||+++++|.+++. ...+++..++.++.|++.||.|||++ + |+||||||+|||++. ++.+
T Consensus 84 v~e~~~~~~L~~~~~-----~~~~~~~~~~~i~~~l~~~l~~lH~~---~~~~i~H~dikp~Nil~~~~~~~~~~~~~~~ 155 (271)
T 3dtc_A 84 VMEFARGGPLNRVLS-----GKRIPPDILVNWAVQIARGMNYLHDE---AIVPIIHRDLKSSNILILQKVENGDLSNKIL 155 (271)
T ss_dssp EEECCTTEEHHHHHT-----SSCCCHHHHHHHHHHHHHHHHHHHHS---SSSCCCCSCCSGGGEEESSCCSSSCCSSCCE
T ss_pred EEEcCCCCCHHHHhh-----cCCCCHHHHHHHHHHHHHHHHHHHhC---CCCceeecCCchHHEEEecccccccccCcce
Confidence 999999999999883 45789999999999999999999998 7 999999999999986 7789
Q ss_pred EEEecCCccccCCCCCcccccccccccccCccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCCCchhcHHHHHHHH
Q 010519 329 KVSDFGLAKLLDSGESHITTRVMGTFGYVAPEYANTGMLNEKSDIYSFGVLLLEAVTGRDPVDYGRPANEVNLVEWLKMM 408 (508)
Q Consensus 329 kl~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~ 408 (508)
||+|||++....... .....||+.|+|||++.+..++.++||||||+++|+|++|+.||..... . ......
T Consensus 156 kl~Dfg~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~---~---~~~~~~ 226 (271)
T 3dtc_A 156 KITDFGLAREWHRTT---KMSAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGIDG---L---AVAYGV 226 (271)
T ss_dssp EECCCCC----------------CCGGGSCHHHHHHCCCSHHHHHHHHHHHHHHHHHCCCTTTTSCH---H---HHHHHH
T ss_pred EEccCCccccccccc---ccCCCCccceeCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH---H---HHHHhh
Confidence 999999998665432 2245689999999999999999999999999999999999999964321 1 111111
Q ss_pred hcccccccccCCCCCCChhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhhc
Q 010519 409 VGTRRAEEVVDPNLEVKPATRALKRSLLVALRCVDPDSEKRPKMSQVVRMLEA 461 (508)
Q Consensus 409 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~ 461 (508)
.... .....+......+.+++.+||+.||.+|||+.|++++|+.
T Consensus 227 ~~~~---------~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~L~~ 270 (271)
T 3dtc_A 227 AMNK---------LALPIPSTCPEPFAKLMEDCWNPDPHSRPSFTNILDQLTT 270 (271)
T ss_dssp HTSC---------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHC
T ss_pred hcCC---------CCCCCCcccCHHHHHHHHHHhcCCcccCcCHHHHHHHHhc
Confidence 1111 1111112223456779999999999999999999999975
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-44 Score=361.41 Aligned_cols=255 Identities=24% Similarity=0.322 Sum_probs=205.3
Q ss_pred HHhhCCcccceeEeeeCceEEEEEEEc-CCCEEEEEEEcccc---hhhHHHHHHHHHHHhcC-CCCCceeEEEEEEeCce
Q 010519 182 EIATNRFSAENVLGEGGYGVVYKGRLI-NGSEVAVKKLLNNL---GQAEKEFRVEVEAIGHV-RHKNLVRLLGYCIEGVH 256 (508)
Q Consensus 182 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~ei~~l~~l-~h~niv~~~~~~~~~~~ 256 (508)
.+..++|.+.+.||+|+||.||+|++. +|+.||+|++.... ......+..|..++..+ +||||+++++++.+...
T Consensus 13 ~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~~~~~~ 92 (345)
T 1xjd_A 13 KLKIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKEN 92 (345)
T ss_dssp ---CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSE
T ss_pred CCChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEEEeCCE
Confidence 456689999999999999999999986 58889999986542 22345677788888876 99999999999999999
Q ss_pred eeEEEeecCCCCHHHHHhhhhccCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCEEEcCCCcEEEEecCCc
Q 010519 257 RMLVYEYVNNGNLEQWLHGAMRNQGNLTWEARMKVIIGTAKALAYLHEAIEPKVVHRDIKSSNILIDDEFNAKVSDFGLA 336 (508)
Q Consensus 257 ~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~Dfgla 336 (508)
.|+||||+++|+|.+++. ....+++..+..++.||+.||.|||++ +|+||||||+|||++.++++||+|||++
T Consensus 93 ~~lv~E~~~gg~L~~~l~----~~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~vkL~DFG~a 165 (345)
T 1xjd_A 93 LFFVMEYLNGGDLMYHIQ----SCHKFDLSRATFYAAEIILGLQFLHSK---GIVYRDLKLDNILLDKDGHIKIADFGMC 165 (345)
T ss_dssp EEEEEECCTTCBHHHHHH----HHSSCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTC
T ss_pred EEEEEeCCCCCcHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCChhhEEECCCCCEEEeEChhh
Confidence 999999999999999995 345689999999999999999999999 9999999999999999999999999999
Q ss_pred cccCCCCCcccccccccccccCccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCCCchhcHHHHHHHHhccccccc
Q 010519 337 KLLDSGESHITTRVMGTFGYVAPEYANTGMLNEKSDIYSFGVLLLEAVTGRDPVDYGRPANEVNLVEWLKMMVGTRRAEE 416 (508)
Q Consensus 337 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 416 (508)
+...... ......+||+.|+|||++.+..++.++|||||||++|||++|..||..... . ..........
T Consensus 166 ~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~---~---~~~~~i~~~~---- 234 (345)
T 1xjd_A 166 KENMLGD-AKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDE---E---ELFHSIRMDN---- 234 (345)
T ss_dssp BCCCCTT-CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH---H---HHHHHHHHCC----
T ss_pred hhcccCC-CcccCCCCCcccCChhhhcCCCCCChhhhHHHHHHHHHHhcCCCCCCCCCH---H---HHHHHHHhCC----
Confidence 8643322 224456899999999999999999999999999999999999999964321 1 1121211110
Q ss_pred ccCCCCCCChhHHHHHHHHHHHHHhcCCCCCCCCCHH-HHHHHhhc
Q 010519 417 VVDPNLEVKPATRALKRSLLVALRCVDPDSEKRPKMS-QVVRMLEA 461 (508)
Q Consensus 417 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~-evl~~L~~ 461 (508)
+.+. ......+.+|+.+||..||.+||++. ++++|-.-
T Consensus 235 ---~~~p----~~~s~~~~~li~~lL~~dp~~R~~~~~~i~~hp~f 273 (345)
T 1xjd_A 235 ---PFYP----RWLEKEAKDLLVKLFVREPEKRLGVRGDIRQHPLF 273 (345)
T ss_dssp ---CCCC----TTSCHHHHHHHHHHSCSSGGGSBTTBSCGGGSGGG
T ss_pred ---CCCC----cccCHHHHHHHHHHhcCCHhHcCCChHHHHcCccc
Confidence 1111 11234566799999999999999998 78765543
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-44 Score=366.15 Aligned_cols=262 Identities=26% Similarity=0.415 Sum_probs=208.2
Q ss_pred HhhCCcccceeEeeeCceEEEEEEEc------CCCEEEEEEEcccc-hhhHHHHHHHHHHHhcCCCCCceeEEEEEEeCc
Q 010519 183 IATNRFSAENVLGEGGYGVVYKGRLI------NGSEVAVKKLLNNL-GQAEKEFRVEVEAIGHVRHKNLVRLLGYCIEGV 255 (508)
Q Consensus 183 ~~~~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~-~~~~~~~~~ei~~l~~l~h~niv~~~~~~~~~~ 255 (508)
+..++|.+.+.||+|+||+||+|++. ++..||||++.... ......+.+|+.++++++||||+++++++.+..
T Consensus 68 ~~~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~ 147 (367)
T 3l9p_A 68 VPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSL 147 (367)
T ss_dssp CCGGGEEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred cCHhHeEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEecccccChhhHHHHHHHHHHHHhCCCCCCCeEEEEEecCC
Confidence 34568999999999999999999853 45689999986442 344567888999999999999999999999999
Q ss_pred eeeEEEeecCCCCHHHHHhhhhc---cCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCEEEcCCC---cEE
Q 010519 256 HRMLVYEYVNNGNLEQWLHGAMR---NQGNLTWEARMKVIIGTAKALAYLHEAIEPKVVHRDIKSSNILIDDEF---NAK 329 (508)
Q Consensus 256 ~~~lv~E~~~~gsL~~~l~~~~~---~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiH~Dlk~~NIll~~~~---~~k 329 (508)
..++||||+++|+|.+++..... ....+++..++.++.||+.||.|||++ +|+||||||+|||++.++ .+|
T Consensus 148 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~~~~~~~k 224 (367)
T 3l9p_A 148 PRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEEN---HFIHRDIAARNCLLTCPGPGRVAK 224 (367)
T ss_dssp SCEEEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESCSSTTCCEE
T ss_pred CCEEEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChhhEEEecCCCCceEE
Confidence 99999999999999999975321 124589999999999999999999999 999999999999999555 499
Q ss_pred EEecCCccccCCC-CCcccccccccccccCccccCCCCCCChhhHHHHHHHHHHHHh-CCCCCCCCCCCchhcHHHHHHH
Q 010519 330 VSDFGLAKLLDSG-ESHITTRVMGTFGYVAPEYANTGMLNEKSDIYSFGVLLLEAVT-GRDPVDYGRPANEVNLVEWLKM 407 (508)
Q Consensus 330 l~Dfgla~~~~~~-~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~ellt-G~~Pf~~~~~~~~~~~~~~~~~ 407 (508)
|+|||+++..... .........||+.|+|||++.+..++.++|||||||+||||++ |..||..... .+....
T Consensus 225 L~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~pf~~~~~------~~~~~~ 298 (367)
T 3l9p_A 225 IGDFGMARDIYRAGYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSN------QEVLEF 298 (367)
T ss_dssp ECCCHHHHHHHHHSSCTTCCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCH------HHHHHH
T ss_pred ECCCccccccccccccccCCCcCCcccEECHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCH------HHHHHH
Confidence 9999999754221 1122334567999999999999999999999999999999998 9999964321 122222
Q ss_pred HhcccccccccCCCCCCChhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhhcCC
Q 010519 408 MVGTRRAEEVVDPNLEVKPATRALKRSLLVALRCVDPDSEKRPKMSQVVRMLEADD 463 (508)
Q Consensus 408 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~ 463 (508)
...... ...+......+.+|+.+||+.||.+|||+.+|+++|+...
T Consensus 299 i~~~~~----------~~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~l~~~~ 344 (367)
T 3l9p_A 299 VTSGGR----------MDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCT 344 (367)
T ss_dssp HHTTCC----------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred HHcCCC----------CCCCccCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHh
Confidence 221111 0111122345667999999999999999999999998753
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-43 Score=355.80 Aligned_cols=257 Identities=24% Similarity=0.316 Sum_probs=205.0
Q ss_pred CCcccceeEeeeCceEEEEEEEc-CCCEEEEEEEcccc---hhhHHHHHHHHHHHhcC-CCCCceeEEEEEEeCceeeEE
Q 010519 186 NRFSAENVLGEGGYGVVYKGRLI-NGSEVAVKKLLNNL---GQAEKEFRVEVEAIGHV-RHKNLVRLLGYCIEGVHRMLV 260 (508)
Q Consensus 186 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~ei~~l~~l-~h~niv~~~~~~~~~~~~~lv 260 (508)
++|.+.+.||+|+||.||+|++. +++.||+|++.... ......+..|+.++.++ +||||+++++++.+....|+|
T Consensus 9 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~lv 88 (345)
T 3a8x_A 9 QDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFV 88 (345)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEE
T ss_pred hheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEEEeCCEEEEE
Confidence 57999999999999999999986 57889999986543 23345678899999887 899999999999999999999
Q ss_pred EeecCCCCHHHHHhhhhccCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCEEEcCCCcEEEEecCCccccC
Q 010519 261 YEYVNNGNLEQWLHGAMRNQGNLTWEARMKVIIGTAKALAYLHEAIEPKVVHRDIKSSNILIDDEFNAKVSDFGLAKLLD 340 (508)
Q Consensus 261 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~Dfgla~~~~ 340 (508)
|||+++|+|.+++. ....+++..++.++.||+.||.|||++ +|+||||||+|||++.++++||+|||+++...
T Consensus 89 ~e~~~gg~L~~~l~----~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~~kL~DFG~a~~~~ 161 (345)
T 3a8x_A 89 IEYVNGGDLMFHMQ----RQRKLPEEHARFYSAEISLALNYLHER---GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGL 161 (345)
T ss_dssp ECCCCSCBHHHHHH----HHSSCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCGGGCBCSC
T ss_pred EeCCCCCcHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCHHHEEECCCCCEEEEecccccccc
Confidence 99999999999985 345799999999999999999999999 99999999999999999999999999998643
Q ss_pred CCCCcccccccccccccCccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCCCch---hcHHHHHHHHhcccccccc
Q 010519 341 SGESHITTRVMGTFGYVAPEYANTGMLNEKSDIYSFGVLLLEAVTGRDPVDYGRPANE---VNLVEWLKMMVGTRRAEEV 417 (508)
Q Consensus 341 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltG~~Pf~~~~~~~~---~~~~~~~~~~~~~~~~~~~ 417 (508)
... ......+||+.|+|||++.+..++.++|||||||++|||++|+.||........ ............ ..
T Consensus 162 ~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~i~~-~~---- 235 (345)
T 3a8x_A 162 RPG-DTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILE-KQ---- 235 (345)
T ss_dssp CTT-CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTTTC-------CHHHHHHHHHH-CC----
T ss_pred CCC-CcccccCCCccccCccccCCCCCChHHhHHHHHHHHHHHHhCCCCcCCcccccccccccHHHHHHHHHc-CC----
Confidence 222 224456899999999999999999999999999999999999999964322111 011111111111 11
Q ss_pred cCCCCCCChhHHHHHHHHHHHHHhcCCCCCCCCCH------HHHHHHhhc
Q 010519 418 VDPNLEVKPATRALKRSLLVALRCVDPDSEKRPKM------SQVVRMLEA 461 (508)
Q Consensus 418 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~------~evl~~L~~ 461 (508)
... +......+.+|+.+||+.||.+||++ .++++|-.-
T Consensus 236 ----~~~--p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~~i~~hp~f 279 (345)
T 3a8x_A 236 ----IRI--PRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFF 279 (345)
T ss_dssp ----CCC--CTTSCHHHHHHHHHHTCSSTTTSTTCCTTTHHHHHHTSGGG
T ss_pred ----CCC--CCCCCHHHHHHHHHHhcCCHhHCCCCCCcCCHHHHhcCCcc
Confidence 111 11123456679999999999999995 788876544
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-44 Score=349.21 Aligned_cols=261 Identities=28% Similarity=0.429 Sum_probs=211.6
Q ss_pred HHHHHhhCCcccceeEeeeCceEEEEEEEcCCCEEEEEEEcccchhhHHHHHHHHHHHhcCCCCCceeEEEEEEeCceee
Q 010519 179 RDLEIATNRFSAENVLGEGGYGVVYKGRLINGSEVAVKKLLNNLGQAEKEFRVEVEAIGHVRHKNLVRLLGYCIEGVHRM 258 (508)
Q Consensus 179 ~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~ei~~l~~l~h~niv~~~~~~~~~~~~~ 258 (508)
.++++..++|.+.+.||+|+||.||+|.+.++..||+|.+.... .....+.+|+++++.++||||+++++++. ....+
T Consensus 6 ~~~~v~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~ 83 (279)
T 1qpc_A 6 DEWEVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLVRLYAVVT-QEPIY 83 (279)
T ss_dssp CTTBCCGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEEC-SSSCE
T ss_pred hhcccCHHhhhheeeecCCCCeEEEEEEEcCCcEEEEEEecCCc-ccHHHHHHHHHHHHhCCCcCcceEEEEEc-CCCcE
Confidence 34567778999999999999999999998888899999986543 23567889999999999999999999876 45688
Q ss_pred EEEeecCCCCHHHHHhhhhccCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCEEEcCCCcEEEEecCCccc
Q 010519 259 LVYEYVNNGNLEQWLHGAMRNQGNLTWEARMKVIIGTAKALAYLHEAIEPKVVHRDIKSSNILIDDEFNAKVSDFGLAKL 338 (508)
Q Consensus 259 lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~Dfgla~~ 338 (508)
+||||+++++|.+++... ....+++..++.++.|++.||.|||++ +|+||||||+|||+++++.+||+|||++..
T Consensus 84 ~v~e~~~~~~L~~~l~~~--~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~ 158 (279)
T 1qpc_A 84 IITEYMENGSLVDFLKTP--SGIKLTINKLLDMAAQIAEGMAFIEER---NYIHRDLRAANILVSDTLSCKIADFGLARL 158 (279)
T ss_dssp EEEECCTTCBHHHHTTSH--HHHTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEECCCTTCEE
T ss_pred EEEecCCCCCHHHHHhcC--CCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHhhEEEcCCCCEEECCCccccc
Confidence 999999999999998531 223689999999999999999999999 999999999999999999999999999987
Q ss_pred cCCCCCcccccccccccccCccccCCCCCCChhhHHHHHHHHHHHHh-CCCCCCCCCCCchhcHHHHHHHHhcccccccc
Q 010519 339 LDSGESHITTRVMGTFGYVAPEYANTGMLNEKSDIYSFGVLLLEAVT-GRDPVDYGRPANEVNLVEWLKMMVGTRRAEEV 417 (508)
Q Consensus 339 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 417 (508)
.............+++.|+|||++.+..++.++||||||+++|||++ |..||..... .+..........
T Consensus 159 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~------~~~~~~~~~~~~---- 228 (279)
T 1qpc_A 159 IEDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTN------PEVIQNLERGYR---- 228 (279)
T ss_dssp CSSSCEECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCH------HHHHHHHHTTCC----
T ss_pred ccCcccccccCCCCccCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCcccCH------HHHHHHHhcccC----
Confidence 76544333344557889999999998889999999999999999999 9999864321 112222211110
Q ss_pred cCCCCCCChhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhhcC
Q 010519 418 VDPNLEVKPATRALKRSLLVALRCVDPDSEKRPKMSQVVRMLEAD 462 (508)
Q Consensus 418 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~ 462 (508)
. ..+......+.+++.+||+.||.+|||+.++++.|+..
T Consensus 229 --~----~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~ 267 (279)
T 1qpc_A 229 --M----VRPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDF 267 (279)
T ss_dssp --C----CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred --C----CCcccccHHHHHHHHHHhccChhhCCCHHHHHHHHHHH
Confidence 0 01112234667799999999999999999999999864
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-43 Score=355.05 Aligned_cols=266 Identities=23% Similarity=0.425 Sum_probs=196.1
Q ss_pred HHHHHhhCCcccceeEeeeCceEEEEEEEcCCC----EEEEEEEccc--chhhHHHHHHHHHHHhcCCCCCceeEEEEEE
Q 010519 179 RDLEIATNRFSAENVLGEGGYGVVYKGRLINGS----EVAVKKLLNN--LGQAEKEFRVEVEAIGHVRHKNLVRLLGYCI 252 (508)
Q Consensus 179 ~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~----~vavK~~~~~--~~~~~~~~~~ei~~l~~l~h~niv~~~~~~~ 252 (508)
.++.+..++|.+.+.||+|+||+||+|++.... .||||.+... .......+.+|+.++++++||||+++++++.
T Consensus 16 ~~~~i~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~ 95 (323)
T 3qup_A 16 EDVLIPEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKLVGVSL 95 (323)
T ss_dssp CTTBCC---CEEEEEEEEETTEEEEEEEC-------CEEEEEEC------CHHHHHHHHHHHHHTTCCCTTBCCCCEEEE
T ss_pred hhcccChhHeEEeceecccCCeEEEEEEEcccCCcceeEEEEEecccccCHHHHHHHHHHHHHHHHCCCCceehhhceee
Confidence 344566789999999999999999999865332 7999988654 2344567889999999999999999999998
Q ss_pred eCcee------eEEEeecCCCCHHHHHhhhhcc--CCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCEEEcC
Q 010519 253 EGVHR------MLVYEYVNNGNLEQWLHGAMRN--QGNLTWEARMKVIIGTAKALAYLHEAIEPKVVHRDIKSSNILIDD 324 (508)
Q Consensus 253 ~~~~~------~lv~E~~~~gsL~~~l~~~~~~--~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiH~Dlk~~NIll~~ 324 (508)
..... ++||||+.+|+|.+++...... ...+++..++.++.||+.||.|||+. +|+||||||+|||+++
T Consensus 96 ~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~---~ivH~Dikp~NIli~~ 172 (323)
T 3qup_A 96 RSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSSR---NFIHRDLAARNCMLAE 172 (323)
T ss_dssp CC-------CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECT
T ss_pred ccccccCCCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHcC---CcccCCCCcceEEEcC
Confidence 77655 8999999999999999653322 22589999999999999999999999 9999999999999999
Q ss_pred CCcEEEEecCCccccCCCCC-cccccccccccccCccccCCCCCCChhhHHHHHHHHHHHHh-CCCCCCCCCCCchhcHH
Q 010519 325 EFNAKVSDFGLAKLLDSGES-HITTRVMGTFGYVAPEYANTGMLNEKSDIYSFGVLLLEAVT-GRDPVDYGRPANEVNLV 402 (508)
Q Consensus 325 ~~~~kl~Dfgla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~ellt-G~~Pf~~~~~~~~~~~~ 402 (508)
++.+||+|||++........ .......+++.|+|||.+.+..++.++|||||||++|||++ |..||....... ..
T Consensus 173 ~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~---~~ 249 (323)
T 3qup_A 173 DMTVCVADFGLSRKIYSGDYYRQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIENAE---IY 249 (323)
T ss_dssp TSCEEECCCCC-----------------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGG---HH
T ss_pred CCCEEEeeccccccccccccccccccccCcccccCchhhcCCCCCCccchhhHHHHHHHHHhCCCCCccccChHH---HH
Confidence 99999999999986643322 12233456789999999999999999999999999999999 899996543221 11
Q ss_pred HHHHHHhcccccccccCCCCCCChhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhhcCC
Q 010519 403 EWLKMMVGTRRAEEVVDPNLEVKPATRALKRSLLVALRCVDPDSEKRPKMSQVVRMLEADD 463 (508)
Q Consensus 403 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~ 463 (508)
........ ...+......+.+|+.+||+.||.+|||+.++++.|+...
T Consensus 250 ---~~~~~~~~----------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~l 297 (323)
T 3qup_A 250 ---NYLIGGNR----------LKQPPECMEEVYDLMYQCWSADPKQRPSFTCLRMELENIL 297 (323)
T ss_dssp ---HHHHTTCC----------CCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHH
T ss_pred ---HHHhcCCC----------CCCCCccCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence 11111111 0111122345677999999999999999999999998753
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-43 Score=351.62 Aligned_cols=258 Identities=16% Similarity=0.177 Sum_probs=207.4
Q ss_pred hCCcccceeEeeeCceEEEEEEE-cCCCEEEEEEEcccchhhHHHHHHHHHHHhcC-CCCCceeEEEEEEeCceeeEEEe
Q 010519 185 TNRFSAENVLGEGGYGVVYKGRL-INGSEVAVKKLLNNLGQAEKEFRVEVEAIGHV-RHKNLVRLLGYCIEGVHRMLVYE 262 (508)
Q Consensus 185 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~ei~~l~~l-~h~niv~~~~~~~~~~~~~lv~E 262 (508)
.++|.+.+.||+|+||+||+|++ .+++.||||.+..... ...+..|+.+++.+ +||||+++++++.+....++|||
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e 85 (330)
T 2izr_A 8 GPNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSR--APQLHLEYRFYKQLGSGDGIPQVYYFGPCGKYNAMVLE 85 (330)
T ss_dssp TTTEEEEEECCC-CTTSEEEEEETTTTEEEEEEEEETTCS--SCCHHHHHHHHHHHCSCTTSCCEEEEEEETTEEEEEEE
T ss_pred cCCeEEEEEeeccCCceEEEEEECCCCcEEEEEEeccccc--hHHHHHHHHHHHHhhCCCCCCEEEEEEecCCccEEEEE
Confidence 46899999999999999999987 4788999998864432 23577899999999 99999999999999999999999
Q ss_pred ecCCCCHHHHHhhhhccCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCEEEcCCCc-----EEEEecCCcc
Q 010519 263 YVNNGNLEQWLHGAMRNQGNLTWEARMKVIIGTAKALAYLHEAIEPKVVHRDIKSSNILIDDEFN-----AKVSDFGLAK 337 (508)
Q Consensus 263 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiH~Dlk~~NIll~~~~~-----~kl~Dfgla~ 337 (508)
|+ +++|.+++.. ....+++..++.++.||+.||.|||+. +|+||||||+|||++.++. +||+|||++.
T Consensus 86 ~~-~~~L~~~~~~---~~~~~~~~~~~~i~~qi~~~l~~LH~~---~iiHrDlkp~Nill~~~~~~~~~~~kl~DFg~a~ 158 (330)
T 2izr_A 86 LL-GPSLEDLFDL---CDRTFSLKTVLMIAIQLISRMEYVHSK---NLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAK 158 (330)
T ss_dssp CC-CCBHHHHHHH---TTTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECCGGGTCTTSEEECCCTTCE
T ss_pred eC-CCCHHHHHHH---cCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHeeeccCCCCCCceEEEEEcccce
Confidence 99 9999999963 356799999999999999999999999 9999999999999999887 9999999998
Q ss_pred ccCCCCCc------ccccccccccccCccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCCCchhcHHHHHHHHhcc
Q 010519 338 LLDSGESH------ITTRVMGTFGYVAPEYANTGMLNEKSDIYSFGVLLLEAVTGRDPVDYGRPANEVNLVEWLKMMVGT 411 (508)
Q Consensus 338 ~~~~~~~~------~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~ 411 (508)
........ ......||+.|+|||++.+..++.++|||||||+||||++|..||..............+......
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~Pf~~~~~~~~~~~~~~i~~~~~~ 238 (330)
T 2izr_A 159 EYIDPETKKHIPYREHKSLTGTARYMSINTHLGKEQSRRDDLEALGHMFMYFLRGSLPWQGLKADTLKERYQKIGDTKRA 238 (330)
T ss_dssp ESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCSSHHHHHHHHHHHHHH
T ss_pred eeecCCCCccccccccCCcCCCccccChHHHcCCCCCchhHHHHHHHHHHHHhcCCCCccccccccHHHHHHHHHhhhcc
Confidence 76443321 124567999999999999999999999999999999999999999765433332222221111100
Q ss_pred cccccccCCCCCCChhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhhc
Q 010519 412 RRAEEVVDPNLEVKPATRALKRSLLVALRCVDPDSEKRPKMSQVVRMLEA 461 (508)
Q Consensus 412 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~ 461 (508)
...... . ...+ .+.+++..||+.||.+||++.+|++.|+.
T Consensus 239 ~~~~~~-----~----~~~p-~~~~li~~~l~~~p~~RP~~~~l~~~l~~ 278 (330)
T 2izr_A 239 TPIEVL-----C----ENFP-EMATYLRYVRRLDFFEKPDYDYLRKLFTD 278 (330)
T ss_dssp SCHHHH-----T----TTCH-HHHHHHHHHHHCCTTCCCCHHHHHHHHHH
T ss_pred CCHHHH-----h----ccCh-HHHHHHHHHHhCCCCCCCCHHHHHHHHHH
Confidence 000000 0 0012 67779999999999999999999998865
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-42 Score=342.80 Aligned_cols=266 Identities=21% Similarity=0.302 Sum_probs=205.2
Q ss_pred CCcccceeEeeeCceEEEEEEEc-CCCEEEEEEEcccc--hhhHHHHHHHHHHHhcCCCCCceeEEEEEEeCceeeEEEe
Q 010519 186 NRFSAENVLGEGGYGVVYKGRLI-NGSEVAVKKLLNNL--GQAEKEFRVEVEAIGHVRHKNLVRLLGYCIEGVHRMLVYE 262 (508)
Q Consensus 186 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~ei~~l~~l~h~niv~~~~~~~~~~~~~lv~E 262 (508)
++|++.+.||+|+||+||+|++. +++.||+|++.... ......+.+|+.++++++||||+++++++.++...++|||
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 81 (292)
T 3o0g_A 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE 81 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred CCceeeeEecCCCCeEEEEEEECCCCceEEEEeeeccCCcCCcchHHHHHHHHHhcCCCCCEeeEEeEEEeCCEEEEEEe
Confidence 57999999999999999999985 68899999986443 2334678889999999999999999999999999999999
Q ss_pred ecCCCCHHHHHhhhhccCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCEEEcCCCcEEEEecCCccccCCC
Q 010519 263 YVNNGNLEQWLHGAMRNQGNLTWEARMKVIIGTAKALAYLHEAIEPKVVHRDIKSSNILIDDEFNAKVSDFGLAKLLDSG 342 (508)
Q Consensus 263 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~~ 342 (508)
|+++ +|.+++. .....+++..++.++.||+.||.|||++ +|+||||||+|||++.++.+||+|||++......
T Consensus 82 ~~~~-~l~~~~~---~~~~~l~~~~~~~~~~ql~~~l~~lH~~---~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~ 154 (292)
T 3o0g_A 82 FCDQ-DLKKYFD---SCNGDLDPEIVKSFLFQLLKGLGFCHSR---NVLHRDLKPQNLLINRNGELKLANFGLARAFGIP 154 (292)
T ss_dssp CCSE-EHHHHHH---HTTTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECCSC
T ss_pred cCCC-CHHHHHH---hCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEeecccceecCCc
Confidence 9975 6766664 3456799999999999999999999999 9999999999999999999999999999876533
Q ss_pred CCcccccccccccccCccccCCCC-CCChhhHHHHHHHHHHHHhCCCCCCCCCCCchhcHHHHHHHHhccccccc-----
Q 010519 343 ESHITTRVMGTFGYVAPEYANTGM-LNEKSDIYSFGVLLLEAVTGRDPVDYGRPANEVNLVEWLKMMVGTRRAEE----- 416 (508)
Q Consensus 343 ~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DvwS~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~----- 416 (508)
.. ......||+.|+|||++.+.. ++.++|||||||++|+|++|..||..... .......+....+......
T Consensus 155 ~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~~~~p~~~~~~--~~~~~~~i~~~~~~~~~~~~~~~~ 231 (292)
T 3o0g_A 155 VR-CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGND--VDDQLKRIFRLLGTPTEEQWPSMT 231 (292)
T ss_dssp CS-CCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSS--HHHHHHHHHHHHCCCCTTTCTTGG
T ss_pred cc-cccCCccccCCcChHHHcCCCCcCchHHHHHHHHHHHHHHHcCCCCcCCCC--HHHHHHHHHHHhCCCChhhhhhhc
Confidence 22 234457899999999997765 89999999999999999999988654332 1112222222221111000
Q ss_pred -ccC---------CCCCCChhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhhc
Q 010519 417 -VVD---------PNLEVKPATRALKRSLLVALRCVDPDSEKRPKMSQVVRMLEA 461 (508)
Q Consensus 417 -~~~---------~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~ 461 (508)
..+ ..............+.+|+.+||+.||.+|||++|+++|-+-
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f 286 (292)
T 3o0g_A 232 KLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYF 286 (292)
T ss_dssp GSTTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGG
T ss_pred ccccccccccccCCcchhhcccccChHHHHHHHHHhccChhhCCCHHHHhcCccc
Confidence 000 000000111234456679999999999999999999986543
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-43 Score=350.03 Aligned_cols=252 Identities=23% Similarity=0.391 Sum_probs=199.5
Q ss_pred CCcccceeEeeeCceEEEEEEEc-CCCEEEEEEEcccc-hhhHHHHHHHHHHHhcCCCCCceeEEEEEEeCc--------
Q 010519 186 NRFSAENVLGEGGYGVVYKGRLI-NGSEVAVKKLLNNL-GQAEKEFRVEVEAIGHVRHKNLVRLLGYCIEGV-------- 255 (508)
Q Consensus 186 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~ei~~l~~l~h~niv~~~~~~~~~~-------- 255 (508)
++|++.+.||+|+||.||+|++. +|+.||||++.... ....+.+.+|+.++++++||||++++++|.+..
T Consensus 6 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~ 85 (332)
T 3qd2_B 6 TDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLETPPEKWQEEM 85 (332)
T ss_dssp HHEEEEEEEECC-CSEEEEEEETTTCCEEEEEEEECCSTTTHHHHHHHHHHHHTSCCCTTBCCEEEEEEECCSCHHHHHH
T ss_pred hcCceeeEecCCCCeEEEEEEEcCCCcEEEEEEeecCCchhHHHHHHHHHHHHHhCCCCCEeeEEEEEEEeccchhhhhh
Confidence 47999999999999999999986 78999999986433 344577899999999999999999999986643
Q ss_pred -------------------------------------------------eeeEEEeecCCCCHHHHHhhhhccCCCccHH
Q 010519 256 -------------------------------------------------HRMLVYEYVNNGNLEQWLHGAMRNQGNLTWE 286 (508)
Q Consensus 256 -------------------------------------------------~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~ 286 (508)
..++||||+++|+|.+++... .......+.
T Consensus 86 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~-~~~~~~~~~ 164 (332)
T 3qd2_B 86 DEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRR-CSLEDREHG 164 (332)
T ss_dssp HC--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTC-CSGGGSCHH
T ss_pred hhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhcc-cCccchhhH
Confidence 378999999999999999643 223345677
Q ss_pred HHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCEEEcCCCcEEEEecCCccccCCCCC-----------ccccccccccc
Q 010519 287 ARMKVIIGTAKALAYLHEAIEPKVVHRDIKSSNILIDDEFNAKVSDFGLAKLLDSGES-----------HITTRVMGTFG 355 (508)
Q Consensus 287 ~~~~i~~~i~~al~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~-----------~~~~~~~gt~~ 355 (508)
.++.++.||+.||.|||++ +|+||||||+|||++.++.+||+|||++........ .......||+.
T Consensus 165 ~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~ 241 (332)
T 3qd2_B 165 VCLHIFIQIAEAVEFLHSK---GLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKL 241 (332)
T ss_dssp HHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEECSCC--------------CCCSCC-CGG
T ss_pred HHHHHHHHHHHHHHHHHhC---CeeecCCCcccEEEeCCCCEEEeecCcccccccchhhccccccccccccccccCCCcC
Confidence 8899999999999999999 999999999999999999999999999987654321 12334579999
Q ss_pred ccCccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCCCchhcHHHHHHHHhcccccccccCCCCCCChhHHHHHHHH
Q 010519 356 YVAPEYANTGMLNEKSDIYSFGVLLLEAVTGRDPVDYGRPANEVNLVEWLKMMVGTRRAEEVVDPNLEVKPATRALKRSL 435 (508)
Q Consensus 356 y~aPE~~~~~~~~~~~DvwS~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 435 (508)
|+|||++.+..++.++|||||||++|||++|..|+. ........... ... ..........+.
T Consensus 242 y~aPE~~~~~~~~~~~Di~slG~il~el~~~~~~~~--------~~~~~~~~~~~---------~~~-~~~~~~~~~~~~ 303 (332)
T 3qd2_B 242 YMSPEQIHGNNYSHKVDIFSLGLILFELLYSFSTQM--------ERVRIITDVRN---------LKF-PLLFTQKYPQEH 303 (332)
T ss_dssp GSCHHHHHCCCCCTHHHHHHHHHHHHHHHSCCCCHH--------HHHHHHHHHHT---------TCC-CHHHHHHCHHHH
T ss_pred ccChHHhcCCCCcchhhHHHHHHHHHHHHHcCCChh--------HHHHHHHHhhc---------cCC-CcccccCChhHH
Confidence 999999999999999999999999999999876642 11111111110 111 111233345667
Q ss_pred HHHHHhcCCCCCCCCCHHHHHHHh
Q 010519 436 LVALRCVDPDSEKRPKMSQVVRML 459 (508)
Q Consensus 436 ~li~~cl~~dP~~RPs~~evl~~L 459 (508)
+|+.+||+.||.+|||+.|++++-
T Consensus 304 ~li~~~l~~~p~~Rps~~~~l~~~ 327 (332)
T 3qd2_B 304 MMVQDMLSPSPTERPEATDIIENA 327 (332)
T ss_dssp HHHHHHHCSSGGGSCCHHHHHHST
T ss_pred HHHHHHccCCCCcCCCHHHHhhch
Confidence 899999999999999999999864
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-43 Score=354.50 Aligned_cols=256 Identities=27% Similarity=0.450 Sum_probs=199.4
Q ss_pred hCCcccceeEeeeCceEEEEEEEc-CCCE----EEEEEEcccc-hhhHHHHHHHHHHHhcCCCCCceeEEEEEEeCceee
Q 010519 185 TNRFSAENVLGEGGYGVVYKGRLI-NGSE----VAVKKLLNNL-GQAEKEFRVEVEAIGHVRHKNLVRLLGYCIEGVHRM 258 (508)
Q Consensus 185 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~----vavK~~~~~~-~~~~~~~~~ei~~l~~l~h~niv~~~~~~~~~~~~~ 258 (508)
.++|.+.+.||+|+||+||+|++. ++.. ||+|.+.... ......+.+|+.++++++||||++++++|.+.. .+
T Consensus 14 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-~~ 92 (327)
T 3poz_A 14 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST-VQ 92 (327)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEECC----CCEEEEEEEC-------CHHHHHHHHHHHHHCCBTTBCCEEEEEESSS-EE
T ss_pred HHHcccceEEeeCCCeEEEEEEEcCCCceEEEEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCC-eE
Confidence 458999999999999999999874 3443 5777764332 344567889999999999999999999998754 67
Q ss_pred EEEeecCCCCHHHHHhhhhccCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCEEEcCCCcEEEEecCCccc
Q 010519 259 LVYEYVNNGNLEQWLHGAMRNQGNLTWEARMKVIIGTAKALAYLHEAIEPKVVHRDIKSSNILIDDEFNAKVSDFGLAKL 338 (508)
Q Consensus 259 lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~Dfgla~~ 338 (508)
+|+||+.+|+|.+++.. ....+++..++.++.||+.||.|||++ +|+||||||+|||++.++.+||+|||+++.
T Consensus 93 ~v~e~~~~g~L~~~l~~---~~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~ 166 (327)
T 3poz_A 93 LITQLMPFGCLLDYVRE---HKDNIGSQYLLNWCVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKL 166 (327)
T ss_dssp EEEECCTTCBHHHHHHH---STTSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEEETTEEEECCTTHHHH
T ss_pred EEEEecCCCcHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHhhC---CeeCCCCChheEEECCCCCEEEccCcceeE
Confidence 99999999999999963 456799999999999999999999999 999999999999999999999999999987
Q ss_pred cCCCCCc-ccccccccccccCccccCCCCCCChhhHHHHHHHHHHHHh-CCCCCCCCCCCchhcHHHHHHHHhccccccc
Q 010519 339 LDSGESH-ITTRVMGTFGYVAPEYANTGMLNEKSDIYSFGVLLLEAVT-GRDPVDYGRPANEVNLVEWLKMMVGTRRAEE 416 (508)
Q Consensus 339 ~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 416 (508)
....... ......+|+.|+|||++.+..++.++|||||||++|||++ |+.||...... .+...+. ...
T Consensus 167 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~---~~~~~~~---~~~---- 236 (327)
T 3poz_A 167 LGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPAS---EISSILE---KGE---- 236 (327)
T ss_dssp HTTTCC-------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGG---GHHHHHH---TTC----
T ss_pred ccCCcccccccCCCccccccChHHhccCCCCchhhhhhhHHHHHHHHhcCCCCccCCCHH---HHHHHHH---cCC----
Confidence 6543322 2333456889999999999999999999999999999999 99999644322 1222111 111
Q ss_pred ccCCCCCCChhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhhcCC
Q 010519 417 VVDPNLEVKPATRALKRSLLVALRCVDPDSEKRPKMSQVVRMLEADD 463 (508)
Q Consensus 417 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~ 463 (508)
....+......+..++.+||+.||.+|||+.+++++|+...
T Consensus 237 ------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~l~~~~ 277 (327)
T 3poz_A 237 ------RLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMA 277 (327)
T ss_dssp ------CCCCCTTBCHHHHHHHHHHTCSCGGGSCCHHHHHHHHHHHH
T ss_pred ------CCCCCccCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHH
Confidence 11111122345677999999999999999999999997654
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-43 Score=357.80 Aligned_cols=249 Identities=23% Similarity=0.274 Sum_probs=206.8
Q ss_pred CCcccceeEeeeCceEEEEEEEc-CCCEEEEEEEcccc---hhhHHHHHHHHHHHhcCCCCCceeEEEEEEeCceeeEEE
Q 010519 186 NRFSAENVLGEGGYGVVYKGRLI-NGSEVAVKKLLNNL---GQAEKEFRVEVEAIGHVRHKNLVRLLGYCIEGVHRMLVY 261 (508)
Q Consensus 186 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~ei~~l~~l~h~niv~~~~~~~~~~~~~lv~ 261 (508)
++|.+.+.||+|+||.||++++. +|+.||+|++.... ......+.+|+.+++.++||||+++++++.+....|+||
T Consensus 41 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 120 (350)
T 1rdq_E 41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVM 120 (350)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred HHCEEEEEeecCcCcEEEEEEECCCCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEEEEE
Confidence 58999999999999999999986 68999999985432 123456888999999999999999999999999999999
Q ss_pred eecCCCCHHHHHhhhhccCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCEEEcCCCcEEEEecCCccccCC
Q 010519 262 EYVNNGNLEQWLHGAMRNQGNLTWEARMKVIIGTAKALAYLHEAIEPKVVHRDIKSSNILIDDEFNAKVSDFGLAKLLDS 341 (508)
Q Consensus 262 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~ 341 (508)
||+++|+|.+++.. ...+++..++.++.||+.||.|||++ +|+||||||+|||++.++.+||+|||+++....
T Consensus 121 e~~~gg~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~~kL~DFg~a~~~~~ 193 (350)
T 1rdq_E 121 EYVAGGEMFSHLRR----IGRFSEPHARFYAAQIVLTFEYLHSL---DLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG 193 (350)
T ss_dssp ECCTTCBHHHHHHH----HCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECSS
T ss_pred cCCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CcccccCccceEEECCCCCEEEcccccceeccC
Confidence 99999999999953 35689999999999999999999999 999999999999999999999999999987643
Q ss_pred CCCcccccccccccccCccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCCCchhcHHHHHHHHhcccccccccCCC
Q 010519 342 GESHITTRVMGTFGYVAPEYANTGMLNEKSDIYSFGVLLLEAVTGRDPVDYGRPANEVNLVEWLKMMVGTRRAEEVVDPN 421 (508)
Q Consensus 342 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 421 (508)
. ....+||+.|+|||++.+..++.++|||||||+||||++|..||..... ...........
T Consensus 194 ~----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~------~~~~~~i~~~~--------- 254 (350)
T 1rdq_E 194 R----TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQP------IQIYEKIVSGK--------- 254 (350)
T ss_dssp C----BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH------HHHHHHHHHCC---------
T ss_pred C----cccccCCccccCHHHhcCCCCCCcCCEecccHhHhHHhhCCCCCCCCCH------HHHHHHHHcCC---------
Confidence 2 2345799999999999999999999999999999999999999964321 12222221111
Q ss_pred CCCChhHHHHHHHHHHHHHhcCCCCCCCCC-----HHHHHHHhhcC
Q 010519 422 LEVKPATRALKRSLLVALRCVDPDSEKRPK-----MSQVVRMLEAD 462 (508)
Q Consensus 422 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPs-----~~evl~~L~~~ 462 (508)
... +......+.+|+.+||+.||.+||+ ++++++|-.-.
T Consensus 255 ~~~--p~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~ei~~h~~f~ 298 (350)
T 1rdq_E 255 VRF--PSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHKWFA 298 (350)
T ss_dssp CCC--CTTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHTSGGGT
T ss_pred CCC--CCCCCHHHHHHHHHHhhcCHHhccCCccCCHHHHHhCcCcC
Confidence 111 1112345667999999999999998 99999876543
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-43 Score=344.26 Aligned_cols=264 Identities=24% Similarity=0.349 Sum_probs=201.5
Q ss_pred CCcccceeEeeeCceEEEEEEEcCCCEEEEEEEcccch--hhHHHHHHHHHHHhcCCCCCceeEEEEEEeCceeeEEEee
Q 010519 186 NRFSAENVLGEGGYGVVYKGRLINGSEVAVKKLLNNLG--QAEKEFRVEVEAIGHVRHKNLVRLLGYCIEGVHRMLVYEY 263 (508)
Q Consensus 186 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~--~~~~~~~~ei~~l~~l~h~niv~~~~~~~~~~~~~lv~E~ 263 (508)
++|.+.+.||+|+||+||+|++.+|+.||+|++..... .....+.+|+.+++.++||||+++++++.+....++||||
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 81 (288)
T 1ob3_A 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEH 81 (288)
T ss_dssp CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred ccchhhhhcccCCCEEEEEEEcCCCCEEEEEEEeccccccccchhHHHHHHHHHhcCCCCEeeeeeEEccCCeEEEEEEe
Confidence 57999999999999999999987899999999864432 2235678899999999999999999999999999999999
Q ss_pred cCCCCHHHHHhhhhccCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCEEEcCCCcEEEEecCCccccCCCC
Q 010519 264 VNNGNLEQWLHGAMRNQGNLTWEARMKVIIGTAKALAYLHEAIEPKVVHRDIKSSNILIDDEFNAKVSDFGLAKLLDSGE 343 (508)
Q Consensus 264 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~~~ 343 (508)
+++ +|.+++. .....+++..+..++.||+.||.|||++ +|+||||||+|||++.++.+||+|||++.......
T Consensus 82 ~~~-~l~~~~~---~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 154 (288)
T 1ob3_A 82 LDQ-DLKKLLD---VCEGGLESVTAKSFLLQLLNGIAYCHDR---RVLHRDLKPQNLLINREGELKIADFGLARAFGIPV 154 (288)
T ss_dssp CSE-EHHHHHH---TSTTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC--
T ss_pred cCC-CHHHHHH---hcccCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCCEEEeECccccccCccc
Confidence 975 9999885 3346789999999999999999999999 99999999999999999999999999998764332
Q ss_pred CcccccccccccccCccccCC-CCCCChhhHHHHHHHHHHHHhCCCCCCCCCCCchhcHHHHHHHHhccccccc------
Q 010519 344 SHITTRVMGTFGYVAPEYANT-GMLNEKSDIYSFGVLLLEAVTGRDPVDYGRPANEVNLVEWLKMMVGTRRAEE------ 416 (508)
Q Consensus 344 ~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwS~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~------ 416 (508)
. ......||+.|+|||++.+ ..++.++|||||||++|||++|..||..... ......+....+......
T Consensus 155 ~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~ 230 (288)
T 1ob3_A 155 R-KYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSE---ADQLMRIFRILGTPNSKNWPNVTE 230 (288)
T ss_dssp --------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSH---HHHHHHHHHHHCCCCTTTSTTGGG
T ss_pred c-ccccccccccccCchheeCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCH---HHHHHHHHHHHCCCChhhchhhhc
Confidence 2 2334568999999999976 4589999999999999999999999964321 111111111111110000
Q ss_pred --ccCCCCCCC-------hhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhh
Q 010519 417 --VVDPNLEVK-------PATRALKRSLLVALRCVDPDSEKRPKMSQVVRMLE 460 (508)
Q Consensus 417 --~~~~~~~~~-------~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 460 (508)
..++.+... ........+.+|+.+||+.||.+|||+.|++++-.
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~ 283 (288)
T 1ob3_A 231 LPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAY 283 (288)
T ss_dssp STTCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGG
T ss_pred ccccccccccccCccHHHHhhhcCHHHHHHHHHHcCCCcccCCCHHHHhcCcc
Confidence 001111000 00112345667999999999999999999998643
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-43 Score=353.92 Aligned_cols=256 Identities=23% Similarity=0.337 Sum_probs=199.1
Q ss_pred hhCCcccceeEeeeCceEEEEEEE----cCCCEEEEEEEcccc----hhhHHHHHHHHHHHhcCCCCCceeEEEEEEeCc
Q 010519 184 ATNRFSAENVLGEGGYGVVYKGRL----INGSEVAVKKLLNNL----GQAEKEFRVEVEAIGHVRHKNLVRLLGYCIEGV 255 (508)
Q Consensus 184 ~~~~~~~~~~lg~G~~g~Vy~~~~----~~~~~vavK~~~~~~----~~~~~~~~~ei~~l~~l~h~niv~~~~~~~~~~ 255 (508)
..++|.+.+.||+|+||.||+++. .+++.||+|++.... ......+.+|+.+++.++||||+++++++.+..
T Consensus 15 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~ 94 (327)
T 3a62_A 15 RPECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAFQTGG 94 (327)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC--------------HHHHHHHCCCTTBCCEEEEEECSS
T ss_pred CHHHeEEEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCCCCCccceeEEEEcCC
Confidence 346899999999999999999987 478899999986542 223356778999999999999999999999999
Q ss_pred eeeEEEeecCCCCHHHHHhhhhccCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCEEEcCCCcEEEEecCC
Q 010519 256 HRMLVYEYVNNGNLEQWLHGAMRNQGNLTWEARMKVIIGTAKALAYLHEAIEPKVVHRDIKSSNILIDDEFNAKVSDFGL 335 (508)
Q Consensus 256 ~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~Dfgl 335 (508)
..|+||||+++|+|.+++. ....+++..++.++.||+.||.|||++ +|+||||||+|||++.++.+||+|||+
T Consensus 95 ~~~lv~e~~~~~~L~~~l~----~~~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~Dlkp~Nill~~~~~~kl~Dfg~ 167 (327)
T 3a62_A 95 KLYLILEYLSGGELFMQLE----REGIFMEDTACFYLAEISMALGHLHQK---GIIYRDLKPENIMLNHQGHVKLTDFGL 167 (327)
T ss_dssp CEEEEEECCTTEEHHHHHH----HHSSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCTTTEEECTTSCEEECCCSC
T ss_pred EEEEEEeCCCCCcHHHHHH----hCCCCCHHHHHHHHHHHHHHHHHHHhC---CEEcccCCHHHeEECCCCcEEEEeCCc
Confidence 9999999999999999985 345688999999999999999999999 999999999999999999999999999
Q ss_pred ccccCCCCCcccccccccccccCccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCCCchhcHHHHHHHHhcccccc
Q 010519 336 AKLLDSGESHITTRVMGTFGYVAPEYANTGMLNEKSDIYSFGVLLLEAVTGRDPVDYGRPANEVNLVEWLKMMVGTRRAE 415 (508)
Q Consensus 336 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~ 415 (508)
+....... ......+||+.|+|||++.+..++.++|||||||++|+|++|..||..... ...........
T Consensus 168 ~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~------~~~~~~i~~~~--- 237 (327)
T 3a62_A 168 CKESIHDG-TVTHTFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGENR------KKTIDKILKCK--- 237 (327)
T ss_dssp C-----------CTTSSCCTTSCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSH------HHHHHHHHHTC---
T ss_pred ccccccCC-ccccccCCCcCccCHhhCcCCCCCCcccchhHHHHHHHHHHCCCCCCCCCH------HHHHHHHHhCC---
Confidence 98543322 123446799999999999999999999999999999999999999964321 11122221110
Q ss_pred cccCCCCCCChhHHHHHHHHHHHHHhcCCCCCCCC-----CHHHHHHHhhcCCC
Q 010519 416 EVVDPNLEVKPATRALKRSLLVALRCVDPDSEKRP-----KMSQVVRMLEADDY 464 (508)
Q Consensus 416 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~evl~~L~~~~~ 464 (508)
... +......+.+|+.+||..||.+|| ++.|+++|-.-...
T Consensus 238 ------~~~--p~~~~~~~~~li~~~L~~dp~~R~~~~~~~~~e~l~hp~f~~~ 283 (327)
T 3a62_A 238 ------LNL--PPYLTQEARDLLKKLLKRNAASRLGAGPGDAGEVQAHPFFRHI 283 (327)
T ss_dssp ------CCC--CTTSCHHHHHHHHHHSCSCGGGSTTSSTTTHHHHHHSGGGSSC
T ss_pred ------CCC--CCCCCHHHHHHHHHHHhcCHhhccCCCCCCHHHHHcCCcccCC
Confidence 111 111234566799999999999999 88899987665443
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-43 Score=362.21 Aligned_cols=267 Identities=21% Similarity=0.225 Sum_probs=211.9
Q ss_pred eHHHHHHhhCCcccceeEeeeCceEEEEEEEc-CCCEEEEEEEcccch---hhHHHHHHHHHHHhcCCCCCceeEEEEEE
Q 010519 177 TLRDLEIATNRFSAENVLGEGGYGVVYKGRLI-NGSEVAVKKLLNNLG---QAEKEFRVEVEAIGHVRHKNLVRLLGYCI 252 (508)
Q Consensus 177 ~~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~ei~~l~~l~h~niv~~~~~~~ 252 (508)
.+.+..+..++|.+.+.||+|+||+||++++. +|+.||+|++..... .....+.+|..++..++||||+++++++.
T Consensus 52 ~~~~~~~~~~~f~~~~~lG~G~fG~V~~~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~ 131 (412)
T 2vd5_A 52 RLKEVRLQRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHFAFQ 131 (412)
T ss_dssp HHHHHSCCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHSCTTTBCCEEEEEE
T ss_pred hhhhccCChhhEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhcCCCCeeeEEEEEe
Confidence 35566677899999999999999999999985 689999999864321 12234788999999999999999999999
Q ss_pred eCceeeEEEeecCCCCHHHHHhhhhccCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCEEEcCCCcEEEEe
Q 010519 253 EGVHRMLVYEYVNNGNLEQWLHGAMRNQGNLTWEARMKVIIGTAKALAYLHEAIEPKVVHRDIKSSNILIDDEFNAKVSD 332 (508)
Q Consensus 253 ~~~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~D 332 (508)
+....|+||||+++|+|.+++.. ....+++..++.++.||+.||.|||++ +|+||||||+|||++.++++||+|
T Consensus 132 ~~~~~~lVmE~~~gg~L~~~l~~---~~~~l~~~~~~~~~~qi~~aL~~LH~~---giiHrDLKp~NILld~~g~vkL~D 205 (412)
T 2vd5_A 132 DENYLYLVMEYYVGGDLLTLLSK---FGERIPAEMARFYLAEIVMAIDSVHRL---GYVHRDIKPDNILLDRCGHIRLAD 205 (412)
T ss_dssp CSSEEEEEECCCCSCBHHHHHHH---HSSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECC
T ss_pred eCCEEEEEEcCCCCCcHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecccCHHHeeecCCCCEEEee
Confidence 99999999999999999999963 345799999999999999999999999 999999999999999999999999
Q ss_pred cCCccccCCCCCcccccccccccccCccccC-------CCCCCChhhHHHHHHHHHHHHhCCCCCCCCCCCchhcHHHHH
Q 010519 333 FGLAKLLDSGESHITTRVMGTFGYVAPEYAN-------TGMLNEKSDIYSFGVLLLEAVTGRDPVDYGRPANEVNLVEWL 405 (508)
Q Consensus 333 fgla~~~~~~~~~~~~~~~gt~~y~aPE~~~-------~~~~~~~~DvwS~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~ 405 (508)
||+++.............+||+.|+|||++. +..|+.++|||||||++|||++|+.||..... . +..
T Consensus 206 FGla~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~---~---~~~ 279 (412)
T 2vd5_A 206 FGSCLKLRADGTVRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADST---A---ETY 279 (412)
T ss_dssp CTTCEECCTTSCEECSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHHSSCTTCCSSH---H---HHH
T ss_pred chhheeccCCCccccceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHhCCCCCCCCCH---H---HHH
Confidence 9999877554433344568999999999987 45789999999999999999999999964321 1 111
Q ss_pred HHHhcccccccccCCCCCCChhHHHHHHHHHHHHHhcCCCCCCC---CCHHHHHHHhhcC
Q 010519 406 KMMVGTRRAEEVVDPNLEVKPATRALKRSLLVALRCVDPDSEKR---PKMSQVVRMLEAD 462 (508)
Q Consensus 406 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~R---Ps~~evl~~L~~~ 462 (508)
........ ...-+.. .......+.+|+.+||. +|.+| |+++|+++|-.-.
T Consensus 280 ~~i~~~~~--~~~~p~~----~~~~s~~~~dli~~lL~-~p~~Rlgr~~~~ei~~Hpff~ 332 (412)
T 2vd5_A 280 GKIVHYKE--HLSLPLV----DEGVPEEARDFIQRLLC-PPETRLGRGGAGDFRTHPFFF 332 (412)
T ss_dssp HHHHTHHH--HCCCC--------CCCHHHHHHHHTTSS-CGGGCTTTTTHHHHHTSGGGT
T ss_pred HHHHhccc--CcCCCcc----ccCCCHHHHHHHHHHcC-ChhhcCCCCCHHHHhcCCCcC
Confidence 11111000 0000110 11123456779999999 99998 5999999886543
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.3e-43 Score=343.61 Aligned_cols=263 Identities=17% Similarity=0.224 Sum_probs=210.7
Q ss_pred HhhCCcccceeEeeeCceEEEEEEE-cCCCEEEEEEEcccchhhHHHHHHHHHHHhcC-CCCCceeEEEEEEeCceeeEE
Q 010519 183 IATNRFSAENVLGEGGYGVVYKGRL-INGSEVAVKKLLNNLGQAEKEFRVEVEAIGHV-RHKNLVRLLGYCIEGVHRMLV 260 (508)
Q Consensus 183 ~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~ei~~l~~l-~h~niv~~~~~~~~~~~~~lv 260 (508)
+..++|.+.+.||+|+||+||+|.+ .+++.||+|.+.... ....+.+|+..+..+ +|+|++++++++.+....++|
T Consensus 7 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv 84 (298)
T 1csn_A 7 VVGVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRS--DAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLV 84 (298)
T ss_dssp EETTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCT--TSCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEE
T ss_pred ccccceEEEEEEeecCCEEEEEEEECCCCcEEEEEEeccCC--ccHHHHHHHHHHHHHhcCCCCCeEEeecCCCceeEEE
Confidence 3457899999999999999999987 478899999885432 224577799999999 799999999999999999999
Q ss_pred EeecCCCCHHHHHhhhhccCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCEEEcCCCc-----EEEEecCC
Q 010519 261 YEYVNNGNLEQWLHGAMRNQGNLTWEARMKVIIGTAKALAYLHEAIEPKVVHRDIKSSNILIDDEFN-----AKVSDFGL 335 (508)
Q Consensus 261 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiH~Dlk~~NIll~~~~~-----~kl~Dfgl 335 (508)
|||+ +++|.+++.. ....+++..++.++.||+.||.|||++ +|+||||||+|||++.++. +||+|||+
T Consensus 85 ~e~~-~~~L~~~l~~---~~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dlkp~NIl~~~~~~~~~~~~kl~Dfg~ 157 (298)
T 1csn_A 85 IDLL-GPSLEDLLDL---CGRKFSVKTVAMAAKQMLARVQSIHEK---SLVYRDIKPDNFLIGRPNSKNANMIYVVDFGM 157 (298)
T ss_dssp EECC-CCBHHHHHHH---TTTCCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECCSSSTTTTCEEECCCTT
T ss_pred EEec-CCCHHHHHHH---hccCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEeccCCCCCCCeEEEEECcc
Confidence 9999 9999999963 345699999999999999999999999 9999999999999987776 99999999
Q ss_pred ccccCCCCCc------ccccccccccccCccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCCCchhcHHHHHHHHh
Q 010519 336 AKLLDSGESH------ITTRVMGTFGYVAPEYANTGMLNEKSDIYSFGVLLLEAVTGRDPVDYGRPANEVNLVEWLKMMV 409 (508)
Q Consensus 336 a~~~~~~~~~------~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~ 409 (508)
+......... ......||+.|+|||++.+..++.++|||||||++|||++|+.||..............+....
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~ 237 (298)
T 1csn_A 158 VKFYRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKK 237 (298)
T ss_dssp CEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHH
T ss_pred ccccccccccccccccCccCCCCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHcCCCCcchhhccccHHHHHHHHhhc
Confidence 9876543221 2345679999999999999999999999999999999999999997654433332222221111
Q ss_pred cccccccccCCCCCCChhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhhcCC
Q 010519 410 GTRRAEEVVDPNLEVKPATRALKRSLLVALRCVDPDSEKRPKMSQVVRMLEADD 463 (508)
Q Consensus 410 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~ 463 (508)
......... ......+.+++.+||+.||.+|||+.+|++.|+...
T Consensus 238 ~~~~~~~~~---------~~~~~~l~~li~~~l~~dp~~RP~~~~l~~~l~~~~ 282 (298)
T 1csn_A 238 QSTPLRELC---------AGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVL 282 (298)
T ss_dssp HHSCHHHHT---------TTSCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHH
T ss_pred cCccHHHHH---------hhCcHHHHHHHHHHhcCCcccCCCHHHHHHHHHHHH
Confidence 111100000 012346677999999999999999999999998653
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-43 Score=358.72 Aligned_cols=255 Identities=22% Similarity=0.316 Sum_probs=196.8
Q ss_pred hCCcccceeEeeeCceEEEEEEEc-CCCEEEEEEEcccchhhHHHHHHHHHHHhcCCCCCceeEEEEEEeCceeeEEEee
Q 010519 185 TNRFSAENVLGEGGYGVVYKGRLI-NGSEVAVKKLLNNLGQAEKEFRVEVEAIGHVRHKNLVRLLGYCIEGVHRMLVYEY 263 (508)
Q Consensus 185 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~ei~~l~~l~h~niv~~~~~~~~~~~~~lv~E~ 263 (508)
.++|.+.+.||+|+||+||++++. +++.||+|++...... ...+.+|+.+++.++||||+++++++.+....++||||
T Consensus 19 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~ 97 (361)
T 3uc3_A 19 SDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAAI-DENVQREIINHRSLRHPNIVRFKEVILTPTHLAIIMEY 97 (361)
T ss_dssp TTTEEEEEEESSSTTSSEEEEEETTTCCEEEEEEEESSTTS-CHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred CCcEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEecCccc-cHHHHHHHHHHHhCCCCCCCcEEEEEeeCCEEEEEEEe
Confidence 468999999999999999999986 7889999998654322 35678899999999999999999999999999999999
Q ss_pred cCCCCHHHHHhhhhccCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCEEEcCCCc--EEEEecCCccccCC
Q 010519 264 VNNGNLEQWLHGAMRNQGNLTWEARMKVIIGTAKALAYLHEAIEPKVVHRDIKSSNILIDDEFN--AKVSDFGLAKLLDS 341 (508)
Q Consensus 264 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiH~Dlk~~NIll~~~~~--~kl~Dfgla~~~~~ 341 (508)
+++|+|.+++. ..+.+++..++.++.||+.||.|||++ +|+||||||+|||++.++. +||+|||+++....
T Consensus 98 ~~~~~L~~~l~----~~~~~~~~~~~~i~~ql~~~L~~LH~~---~ivH~Dlkp~Nill~~~~~~~~kl~Dfg~a~~~~~ 170 (361)
T 3uc3_A 98 ASGGELYERIC----NAGRFSEDEARFFFQQLLSGVSYCHSM---QICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL 170 (361)
T ss_dssp CCSCBHHHHHH----HHSSCCHHHHHHHHHHHHHHHHHHHHT---TCCSCCCCGGGEEECSSSSCCEEECCCCCC-----
T ss_pred CCCCCHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEcCCCCceEEEeecCccccccc
Confidence 99999999984 345799999999999999999999999 9999999999999987766 99999999974432
Q ss_pred CCCcccccccccccccCccccCCCCCCCh-hhHHHHHHHHHHHHhCCCCCCCCCCCchhcHHHHHHHHhcccccccccCC
Q 010519 342 GESHITTRVMGTFGYVAPEYANTGMLNEK-SDIYSFGVLLLEAVTGRDPVDYGRPANEVNLVEWLKMMVGTRRAEEVVDP 420 (508)
Q Consensus 342 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~-~DvwS~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 420 (508)
.. ......||+.|+|||++.+..++.+ +|||||||++|+|++|+.||....... .....+......
T Consensus 171 ~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~--~~~~~~~~~~~~--------- 237 (361)
T 3uc3_A 171 HS--QPKSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPR--DYRKTIQRILSV--------- 237 (361)
T ss_dssp ------------CTTSCHHHHHCSSCCHHHHHHHHHHHHHHHHHHSSCSCC----CC--CHHHHHHHHHTT---------
T ss_pred cC--CCCCCcCCCCcCChhhhcCCCCCCCeeeeehhHHHHHHHHhCCCCCCCCccHH--HHHHHHHHHhcC---------
Confidence 21 2344579999999999988877665 899999999999999999997543322 222222222211
Q ss_pred CCCCChhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhh
Q 010519 421 NLEVKPATRALKRSLLVALRCVDPDSEKRPKMSQVVRMLE 460 (508)
Q Consensus 421 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 460 (508)
....+........+.+|+.+||+.||.+|||+.|+++|-+
T Consensus 238 ~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~ell~hp~ 277 (361)
T 3uc3_A 238 KYSIPDDIRISPECCHLISRIFVADPATRISIPEIKTHSW 277 (361)
T ss_dssp CCCCCTTSCCCHHHHHHHHHHSCSCTTTSCCHHHHHTSHH
T ss_pred CCCCCCcCCCCHHHHHHHHHHccCChhHCcCHHHHHhCcc
Confidence 1111111122345667999999999999999999999754
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-43 Score=345.25 Aligned_cols=258 Identities=24% Similarity=0.342 Sum_probs=204.6
Q ss_pred hhCCcccceeEeeeCceEEEEEEEcC-C-------CEEEEEEEcccchhhHHHHHHHHHHHhcCCCCCceeEEEEEEeCc
Q 010519 184 ATNRFSAENVLGEGGYGVVYKGRLIN-G-------SEVAVKKLLNNLGQAEKEFRVEVEAIGHVRHKNLVRLLGYCIEGV 255 (508)
Q Consensus 184 ~~~~~~~~~~lg~G~~g~Vy~~~~~~-~-------~~vavK~~~~~~~~~~~~~~~ei~~l~~l~h~niv~~~~~~~~~~ 255 (508)
..++|.+.+.||+|+||+||+|.+.. + ..||+|.+........+.+.+|+.++++++||||+++++++.+..
T Consensus 6 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 85 (289)
T 4fvq_A 6 RNEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHLVLNYGVCVCGD 85 (289)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGGGGGGHHHHHHHHHHHHTSCCTTBCCEEEEECCTT
T ss_pred chhHeeeeeeeccCCCceEEEEEEecccccccccchhhhhhhcccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEeCC
Confidence 45689999999999999999998753 3 469999987666666678999999999999999999999999999
Q ss_pred eeeEEEeecCCCCHHHHHhhhhccCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCEEEcCCCc--------
Q 010519 256 HRMLVYEYVNNGNLEQWLHGAMRNQGNLTWEARMKVIIGTAKALAYLHEAIEPKVVHRDIKSSNILIDDEFN-------- 327 (508)
Q Consensus 256 ~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiH~Dlk~~NIll~~~~~-------- 327 (508)
..++||||+++|+|.+++.. ....+++..++.++.||+.||.|||++ +|+||||||+|||++.++.
T Consensus 86 ~~~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~~~~~ 159 (289)
T 4fvq_A 86 ENILVQEFVKFGSLDTYLKK---NKNCINILWKLEVAKQLAAAMHFLEEN---TLIHGNVCAKNILLIREEDRKTGNPPF 159 (289)
T ss_dssp CCEEEEECCTTCBHHHHHHH---TGGGCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEEEECCBGGGTBCCE
T ss_pred CCEEEEECCCCCCHHHHHHh---CCCCCCHHHHHHHHHHHHHHHHHHhhC---CeECCCcCcceEEEecCCcccccccce
Confidence 99999999999999999963 344589999999999999999999999 9999999999999998887
Q ss_pred EEEEecCCccccCCCCCcccccccccccccCccccCC-CCCCChhhHHHHHHHHHHHHhCCCCCCCCCCCchhcHHHHHH
Q 010519 328 AKVSDFGLAKLLDSGESHITTRVMGTFGYVAPEYANT-GMLNEKSDIYSFGVLLLEAVTGRDPVDYGRPANEVNLVEWLK 406 (508)
Q Consensus 328 ~kl~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwS~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~ 406 (508)
+||+|||++..... .....|++.|+|||++.+ ..++.++|||||||++|||++|..|+...... .....
T Consensus 160 ~kl~Dfg~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~~~~~~~~-----~~~~~ 229 (289)
T 4fvq_A 160 IKLSDPGISITVLP-----KDILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDS-----QRKLQ 229 (289)
T ss_dssp EEECCCCSCTTTSC-----HHHHHHTTTTSCHHHHHCGGGCCHHHHHHHHHHHHHHHHTTTCCTTTTSCH-----HHHHH
T ss_pred eeeccCcccccccC-----ccccCCcCcccCHHHhCCCCCCCchhHHHHHHHHHHHHHcCCCCCccccch-----HHHHH
Confidence 99999999975532 223457899999999987 77999999999999999999966554322211 11111
Q ss_pred HHhcccccccccCCCCCCChhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhhcCCCCCchh
Q 010519 407 MMVGTRRAEEVVDPNLEVKPATRALKRSLLVALRCVDPDSEKRPKMSQVVRMLEADDYPFRED 469 (508)
Q Consensus 407 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~~~~~ 469 (508)
......... ... ...+.+|+.+||+.||.+|||+.+++++|+....+....
T Consensus 230 ~~~~~~~~~--------~~~----~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~l~~p~~~~ 280 (289)
T 4fvq_A 230 FYEDRHQLP--------APK----AAELANLINNCMDYEPDHRPSFRAIIRDLNSLFTPDLVP 280 (289)
T ss_dssp HHHTTCCCC--------CCS----SCTTHHHHHHHSCSSGGGSCCHHHHHHHHHTCC------
T ss_pred HhhccCCCC--------CCC----CHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcCCCCCC
Confidence 111111111 000 224556899999999999999999999999887654443
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-44 Score=349.56 Aligned_cols=262 Identities=26% Similarity=0.414 Sum_probs=216.5
Q ss_pred HHHHHhhCCcccceeEeeeCceEEEEEEEc-CCCEEEEEEEcccchhhHHHHHHHHHHHhcCCCCCceeEEEEEEeCcee
Q 010519 179 RDLEIATNRFSAENVLGEGGYGVVYKGRLI-NGSEVAVKKLLNNLGQAEKEFRVEVEAIGHVRHKNLVRLLGYCIEGVHR 257 (508)
Q Consensus 179 ~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~ei~~l~~l~h~niv~~~~~~~~~~~~ 257 (508)
.++++..++|.+.+.||+|+||+||+|.+. ++..||+|.+.... ...+.+.+|+.+++.++||||+++++++.+....
T Consensus 6 ~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~ 84 (288)
T 3kfa_A 6 DKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPF 84 (288)
T ss_dssp CTTBCCGGGEEEEEESGGGTTCSEEEEEEGGGTEEEEEEEECSCS-THHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSE
T ss_pred hcccccccceeEEeecCCCCceeEEEeEecCCCEEEEEEecCcCH-HHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCE
Confidence 445667789999999999999999999986 47889999986543 3456788899999999999999999999999999
Q ss_pred eEEEeecCCCCHHHHHhhhhccCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCEEEcCCCcEEEEecCCcc
Q 010519 258 MLVYEYVNNGNLEQWLHGAMRNQGNLTWEARMKVIIGTAKALAYLHEAIEPKVVHRDIKSSNILIDDEFNAKVSDFGLAK 337 (508)
Q Consensus 258 ~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~Dfgla~ 337 (508)
++||||+++++|.+++.. .....+++..++.++.|++.||.|||+. +|+|+||||+||+++.++.+||+|||++.
T Consensus 85 ~~v~e~~~~~~L~~~~~~--~~~~~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~~l~Dfg~~~ 159 (288)
T 3kfa_A 85 YIITEFMTYGNLLDYLRE--CNRQEVSAVVLLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSR 159 (288)
T ss_dssp EEEEECCTTEEHHHHHHH--CCTTTSCHHHHHHHHHHHHHHHHHHHHH---TCCCSCCSGGGEEECGGGCEEECCCCGGG
T ss_pred EEEEEcCCCCcHHHHHHh--cccCCccHhHHHHHHHHHHHHHHHHHHC---CccCCCCCcceEEEcCCCCEEEccCccce
Confidence 999999999999999964 3445689999999999999999999999 99999999999999999999999999998
Q ss_pred ccCCCCCcccccccccccccCccccCCCCCCChhhHHHHHHHHHHHHh-CCCCCCCCCCCchhcHHHHHHHHhccccccc
Q 010519 338 LLDSGESHITTRVMGTFGYVAPEYANTGMLNEKSDIYSFGVLLLEAVT-GRDPVDYGRPANEVNLVEWLKMMVGTRRAEE 416 (508)
Q Consensus 338 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 416 (508)
..............+++.|+|||++.+..++.++||||||+++|+|++ |..||...... .....+ ...
T Consensus 160 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~~g~~p~~~~~~~---~~~~~~---~~~----- 228 (288)
T 3kfa_A 160 LMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLS---QVYELL---EKD----- 228 (288)
T ss_dssp TSCSSSSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGG---GHHHHH---HTT-----
T ss_pred eccCCccccccCCccccCcCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHH---HHHHHH---hcc-----
Confidence 776554444455567889999999998899999999999999999999 99998654322 122211 111
Q ss_pred ccCCCCCCChhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhhcC
Q 010519 417 VVDPNLEVKPATRALKRSLLVALRCVDPDSEKRPKMSQVVRMLEAD 462 (508)
Q Consensus 417 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~ 462 (508)
.....+......+.+|+.+||+.||.+|||+.++++.|+..
T Consensus 229 -----~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~~~~l~~~ 269 (288)
T 3kfa_A 229 -----YRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETM 269 (288)
T ss_dssp -----CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred -----CCCCCCCCCCHHHHHHHHHHhCCChhhCcCHHHHHHHHHHH
Confidence 11111112235567799999999999999999999999764
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=9.1e-44 Score=358.61 Aligned_cols=269 Identities=25% Similarity=0.389 Sum_probs=210.2
Q ss_pred HHHHhhCCcccceeEeeeCceEEEEEEEc------CCCEEEEEEEcccc-hhhHHHHHHHHHHHhcC-CCCCceeEEEEE
Q 010519 180 DLEIATNRFSAENVLGEGGYGVVYKGRLI------NGSEVAVKKLLNNL-GQAEKEFRVEVEAIGHV-RHKNLVRLLGYC 251 (508)
Q Consensus 180 ~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~-~~~~~~~~~ei~~l~~l-~h~niv~~~~~~ 251 (508)
++++..++|.+.+.||+|+||+||+|++. .+..||+|.+.... ......+.+|+.++.++ +||||+++++++
T Consensus 39 ~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~ 118 (344)
T 1rjb_A 39 KWEFPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGAC 118 (344)
T ss_dssp GGBCCGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred CcccCHHHceeeeeecCCCCceeEEeeeeccccCCcceEEEEEecccccCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEE
Confidence 34566789999999999999999999862 35579999986543 23346788999999999 899999999999
Q ss_pred EeCceeeEEEeecCCCCHHHHHhhhhcc-------------------CCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEe
Q 010519 252 IEGVHRMLVYEYVNNGNLEQWLHGAMRN-------------------QGNLTWEARMKVIIGTAKALAYLHEAIEPKVVH 312 (508)
Q Consensus 252 ~~~~~~~lv~E~~~~gsL~~~l~~~~~~-------------------~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiH 312 (508)
......++||||+++|+|.+++...... ...+++..++.++.||+.||.|||+. +|+|
T Consensus 119 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH 195 (344)
T 1rjb_A 119 TLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFK---SCVH 195 (344)
T ss_dssp CSSSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHT---TEEE
T ss_pred eeCCccEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHhC---Cccc
Confidence 9999999999999999999999643111 13478999999999999999999999 9999
Q ss_pred ecCCCCCEEEcCCCcEEEEecCCccccCCCCC-cccccccccccccCccccCCCCCCChhhHHHHHHHHHHHHh-CCCCC
Q 010519 313 RDIKSSNILIDDEFNAKVSDFGLAKLLDSGES-HITTRVMGTFGYVAPEYANTGMLNEKSDIYSFGVLLLEAVT-GRDPV 390 (508)
Q Consensus 313 ~Dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~ellt-G~~Pf 390 (508)
|||||+|||++.++.+||+|||++........ .......+|+.|+|||++.+..++.++|||||||+||+|++ |..||
T Consensus 196 ~Dikp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~ 275 (344)
T 1rjb_A 196 RDLAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPY 275 (344)
T ss_dssp TTCSGGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSS
T ss_pred CCCChhhEEEcCCCcEEeCCCccCcccccCccceeccCccCccCccCHHHhccCCCChhHhHHHHHHHHHHHHcCCCCCc
Confidence 99999999999999999999999986643322 22334567889999999998999999999999999999998 99999
Q ss_pred CCCCCCchhcHHHHHHHHhcccccccccCCCCCCChhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhhcCCCCC
Q 010519 391 DYGRPANEVNLVEWLKMMVGTRRAEEVVDPNLEVKPATRALKRSLLVALRCVDPDSEKRPKMSQVVRMLEADDYPF 466 (508)
Q Consensus 391 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~~ 466 (508)
........ .... .... .....+......+.+|+.+||+.||.+|||+.+++++|+......
T Consensus 276 ~~~~~~~~--~~~~---~~~~----------~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~~ 336 (344)
T 1rjb_A 276 PGIPVDAN--FYKL---IQNG----------FKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLGCQLADA 336 (344)
T ss_dssp TTCCCSHH--HHHH---HHTT----------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC---
T ss_pred ccCCcHHH--HHHH---HhcC----------CCCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHHHH
Confidence 65433211 1111 1111 011111122455677999999999999999999999999865543
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-43 Score=348.84 Aligned_cols=251 Identities=23% Similarity=0.336 Sum_probs=197.2
Q ss_pred hCCcccceeEeeeCceEEEEEEEc-CCCEEEEEEEcccchh--------------------------hHHHHHHHHHHHh
Q 010519 185 TNRFSAENVLGEGGYGVVYKGRLI-NGSEVAVKKLLNNLGQ--------------------------AEKEFRVEVEAIG 237 (508)
Q Consensus 185 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~--------------------------~~~~~~~ei~~l~ 237 (508)
.++|.+.+.||+|+||.||+|++. +++.||||++...... ..+.+.+|+.+++
T Consensus 12 ~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~ 91 (298)
T 2zv2_A 12 LNQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAILK 91 (298)
T ss_dssp ETTEEEEEEEEC--CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHHHHHHH
T ss_pred ecceEEEeEEeecCCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHHHHH
Confidence 468999999999999999999875 6788999998644211 1245788999999
Q ss_pred cCCCCCceeEEEEEEe--CceeeEEEeecCCCCHHHHHhhhhccCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEeecC
Q 010519 238 HVRHKNLVRLLGYCIE--GVHRMLVYEYVNNGNLEQWLHGAMRNQGNLTWEARMKVIIGTAKALAYLHEAIEPKVVHRDI 315 (508)
Q Consensus 238 ~l~h~niv~~~~~~~~--~~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiH~Dl 315 (508)
+++||||+++++++.+ ....++||||+++++|.+++ ....+++..++.++.||+.||.|||++ +|+||||
T Consensus 92 ~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~-----~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dl 163 (298)
T 2zv2_A 92 KLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVP-----TLKPLSEDQARFYFQDLIKGIEYLHYQ---KIIHRDI 163 (298)
T ss_dssp TCCCTTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSS-----CSSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCC
T ss_pred hCCCCCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHh-----hcCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCC
Confidence 9999999999999987 56789999999999988754 345799999999999999999999999 9999999
Q ss_pred CCCCEEEcCCCcEEEEecCCccccCCCCCcccccccccccccCccccCCCC---CCChhhHHHHHHHHHHHHhCCCCCCC
Q 010519 316 KSSNILIDDEFNAKVSDFGLAKLLDSGESHITTRVMGTFGYVAPEYANTGM---LNEKSDIYSFGVLLLEAVTGRDPVDY 392 (508)
Q Consensus 316 k~~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~---~~~~~DvwS~Gvvl~elltG~~Pf~~ 392 (508)
||+|||++.++.+||+|||++........ ......||+.|+|||++.+.. ++.++|||||||++|+|++|+.||..
T Consensus 164 kp~Nil~~~~~~~kl~Dfg~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~ 242 (298)
T 2zv2_A 164 KPSNLLVGEDGHIKIADFGVSNEFKGSDA-LLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMD 242 (298)
T ss_dssp CGGGEEECTTSCEEECCCTTCEECSSSSC-EECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHHHHHSSCSSCC
T ss_pred CHHHEEECCCCCEEEecCCCccccccccc-cccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHHHHHCCCCCCC
Confidence 99999999999999999999987654322 234457999999999998765 37899999999999999999999964
Q ss_pred CCCCchhcHHHHHHHHhcccccccccCCCCCCChhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHh
Q 010519 393 GRPANEVNLVEWLKMMVGTRRAEEVVDPNLEVKPATRALKRSLLVALRCVDPDSEKRPKMSQVVRML 459 (508)
Q Consensus 393 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L 459 (508)
.. ...+....... . ............+.+|+.+||+.||.+|||+.|+++|-
T Consensus 243 ~~------~~~~~~~~~~~-~--------~~~~~~~~~~~~l~~li~~~l~~dp~~R~s~~e~l~hp 294 (298)
T 2zv2_A 243 ER------IMCLHSKIKSQ-A--------LEFPDQPDIAEDLKDLITRMLDKNPESRIVVPEIKLHP 294 (298)
T ss_dssp SS------HHHHHHHHHHC-C--------CCCCSSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTTCH
T ss_pred cc------HHHHHHHHhcc-c--------CCCCCccccCHHHHHHHHHHhhcChhhCCCHHHHhcCc
Confidence 32 11111111111 0 01111111234566799999999999999999998753
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-43 Score=350.37 Aligned_cols=268 Identities=23% Similarity=0.318 Sum_probs=210.6
Q ss_pred HhhCCcccceeEeeeCceEEEEEEE-cCCCEEEEEEEcccchhhHHHHHHHHHHHhcCCCCCceeEEEEEEe----Ccee
Q 010519 183 IATNRFSAENVLGEGGYGVVYKGRL-INGSEVAVKKLLNNLGQAEKEFRVEVEAIGHVRHKNLVRLLGYCIE----GVHR 257 (508)
Q Consensus 183 ~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~ei~~l~~l~h~niv~~~~~~~~----~~~~ 257 (508)
+..++|.+.+.||+|+||.||++.. .+++.||+|++..........+.+|+.+++.++||||+++++++.. ....
T Consensus 26 i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 105 (317)
T 2buj_A 26 IDNKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILRLVAYCLRERGAKHEA 105 (317)
T ss_dssp ETTEEEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEEEETTEEEE
T ss_pred ECCeEEEEEEEecCCCCeEEEEEEecCCCcEEEEEEEecCCHHHHHHHHHHHHHHhhcCCCCeeeEEEEEEeccCCCcee
Confidence 4456899999999999999999987 4789999999876666666788999999999999999999999873 3467
Q ss_pred eEEEeecCCCCHHHHHhhhhccCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCEEEcCCCcEEEEecCCcc
Q 010519 258 MLVYEYVNNGNLEQWLHGAMRNQGNLTWEARMKVIIGTAKALAYLHEAIEPKVVHRDIKSSNILIDDEFNAKVSDFGLAK 337 (508)
Q Consensus 258 ~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~Dfgla~ 337 (508)
++||||+++|+|.+++.........+++..++.++.||+.||.|||+. +|+||||||+|||++.++.+||+|||++.
T Consensus 106 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~dlkp~NIl~~~~~~~kl~dfg~~~ 182 (317)
T 2buj_A 106 WLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAK---GYAHRDLKPTNILLGDEGQPVLMDLGSMN 182 (317)
T ss_dssp EEEEECCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTSCEEECCCSSCE
T ss_pred EEEEEeCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEEcCCCCEEEEecCcch
Confidence 899999999999999976555667899999999999999999999999 99999999999999999999999999987
Q ss_pred ccCCCCCc--------ccccccccccccCccccCCCC---CCChhhHHHHHHHHHHHHhCCCCCCCCCCCchhcHHHHHH
Q 010519 338 LLDSGESH--------ITTRVMGTFGYVAPEYANTGM---LNEKSDIYSFGVLLLEAVTGRDPVDYGRPANEVNLVEWLK 406 (508)
Q Consensus 338 ~~~~~~~~--------~~~~~~gt~~y~aPE~~~~~~---~~~~~DvwS~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~ 406 (508)
........ ......||+.|+|||++.+.. ++.++|||||||++|+|++|+.||....... .....
T Consensus 183 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~-~~~~~--- 258 (317)
T 2buj_A 183 QACIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKG-DSVAL--- 258 (317)
T ss_dssp ESCEEEESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHHHHHSSCTTHHHHHTT-SCHHH---
T ss_pred hcccccccccccccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHHHHHHhCCCChhhhhccc-chhhH---
Confidence 65321110 012345799999999997654 6899999999999999999999985211000 01111
Q ss_pred HHhcccccccccCCCCCCChhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhhcCCCCCc
Q 010519 407 MMVGTRRAEEVVDPNLEVKPATRALKRSLLVALRCVDPDSEKRPKMSQVVRMLEADDYPFR 467 (508)
Q Consensus 407 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~~~ 467 (508)
.... .............+.+++.+||+.||.+|||+.+++++|+....+..
T Consensus 259 ~~~~----------~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~~~~~~ 309 (317)
T 2buj_A 259 AVQN----------QLSIPQSPRHSSALWQLLNSMMTVDPHQRPHIPLLLSQLEALQPPAP 309 (317)
T ss_dssp HHHC----------C--CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTCCCCC
T ss_pred Hhhc----------cCCCCccccCCHHHHHHHHHHhhcChhhCCCHHHHHHHhhhcCCCCC
Confidence 1111 00111111223457779999999999999999999999998765443
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-43 Score=355.89 Aligned_cols=256 Identities=23% Similarity=0.322 Sum_probs=192.4
Q ss_pred HhhCCcccceeEeeeCceEEEEEEEc-CCCEEEEEEEcccchhhHHHHHHHHHHHhcCCCCCceeEEEEEEeCceeeEEE
Q 010519 183 IATNRFSAENVLGEGGYGVVYKGRLI-NGSEVAVKKLLNNLGQAEKEFRVEVEAIGHVRHKNLVRLLGYCIEGVHRMLVY 261 (508)
Q Consensus 183 ~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~ei~~l~~l~h~niv~~~~~~~~~~~~~lv~ 261 (508)
...++|.+.+.||+|+||+||+|++. +++.||||++.... ..+.+.+|+.++++++||||+++++++.+....++||
T Consensus 50 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 127 (349)
T 2w4o_A 50 ALSDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTV--DKKIVRTEIGVLLRLSHPNIIKLKEIFETPTEISLVL 127 (349)
T ss_dssp CGGGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEC------------CHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cccCcEEEeeEEeeCCCEEEEEEEECCCCcEEEEEEeccch--hHHHHHHHHHHHHhCCCCCCcceeeeEecCCeEEEEE
Confidence 34568999999999999999999986 57889999986543 3456788999999999999999999999999999999
Q ss_pred eecCCCCHHHHHhhhhccCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCEEEcC---CCcEEEEecCCccc
Q 010519 262 EYVNNGNLEQWLHGAMRNQGNLTWEARMKVIIGTAKALAYLHEAIEPKVVHRDIKSSNILIDD---EFNAKVSDFGLAKL 338 (508)
Q Consensus 262 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiH~Dlk~~NIll~~---~~~~kl~Dfgla~~ 338 (508)
||+++|+|.+++. ....+++..++.++.||+.||.|||+. +|+||||||+|||++. ++.+||+|||++..
T Consensus 128 e~~~~~~L~~~l~----~~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dikp~NIll~~~~~~~~~kl~Dfg~a~~ 200 (349)
T 2w4o_A 128 ELVTGGELFDRIV----EKGYYSERDAADAVKQILEAVAYLHEN---GIVHRDLKPENLLYATPAPDAPLKIADFGLSKI 200 (349)
T ss_dssp CCCCSCBHHHHHT----TCSSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEESSSSTTCCEEECCCC----
T ss_pred EeCCCCCHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCcccEEEecCCCCCCEEEccCccccc
Confidence 9999999999984 456789999999999999999999999 9999999999999975 88999999999986
Q ss_pred cCCCCCcccccccccccccCccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCCCchhcHHHHHHHHhccccccccc
Q 010519 339 LDSGESHITTRVMGTFGYVAPEYANTGMLNEKSDIYSFGVLLLEAVTGRDPVDYGRPANEVNLVEWLKMMVGTRRAEEVV 418 (508)
Q Consensus 339 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 418 (508)
..... ......||+.|+|||++.+..++.++|||||||+||||++|..||....... ........... ..
T Consensus 201 ~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~-----~~~~~i~~~~~--~~- 270 (349)
T 2w4o_A 201 VEHQV--LMKTVCGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCGFEPFYDERGDQ-----FMFRRILNCEY--YF- 270 (349)
T ss_dssp --------------CGGGSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCTTCHH-----HHHHHHHTTCC--CC-
T ss_pred cCccc--ccccccCCCCccCHHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCcccH-----HHHHHHHhCCC--cc-
Confidence 64332 2344578999999999999999999999999999999999999996443211 11112211110 00
Q ss_pred CCCCCCChhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhhc
Q 010519 419 DPNLEVKPATRALKRSLLVALRCVDPDSEKRPKMSQVVRMLEA 461 (508)
Q Consensus 419 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~ 461 (508)
...........+.+|+.+||+.||.+|||+.|++++-.-
T Consensus 271 ----~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~ 309 (349)
T 2w4o_A 271 ----ISPWWDEVSLNAKDLVRKLIVLDPKKRLTTFQALQHPWV 309 (349)
T ss_dssp ----CTTTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSTTT
T ss_pred ----CCchhhhCCHHHHHHHHHHccCChhhCcCHHHHhcCccc
Confidence 011111234456779999999999999999999986443
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-43 Score=356.93 Aligned_cols=254 Identities=23% Similarity=0.283 Sum_probs=205.4
Q ss_pred HhhCCcccceeEeeeCceEEEEEEEc-CCCEEEEEEEcccc---hhhHHHHHHHHHHHhcC-CCCCceeEEEEEEeCcee
Q 010519 183 IATNRFSAENVLGEGGYGVVYKGRLI-NGSEVAVKKLLNNL---GQAEKEFRVEVEAIGHV-RHKNLVRLLGYCIEGVHR 257 (508)
Q Consensus 183 ~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~ei~~l~~l-~h~niv~~~~~~~~~~~~ 257 (508)
+..++|.+.+.||+|+||+||+|++. +++.||+|++.... ......+..|..++..+ +||||+++++++.+....
T Consensus 17 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~ 96 (353)
T 2i0e_A 17 MKLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRL 96 (353)
T ss_dssp --CTTEEEEEEEEEETTEEEEEEEETTEEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEEECSSEE
T ss_pred CchHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEEEEEcCCEE
Confidence 44578999999999999999999986 47889999986542 22345677899999988 899999999999999999
Q ss_pred eEEEeecCCCCHHHHHhhhhccCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCEEEcCCCcEEEEecCCcc
Q 010519 258 MLVYEYVNNGNLEQWLHGAMRNQGNLTWEARMKVIIGTAKALAYLHEAIEPKVVHRDIKSSNILIDDEFNAKVSDFGLAK 337 (508)
Q Consensus 258 ~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~Dfgla~ 337 (508)
|+||||+++|+|.+++. ..+.+++..++.++.||+.||.|||++ +|+||||||+|||++.++++||+|||+++
T Consensus 97 ~lv~E~~~gg~L~~~l~----~~~~~~~~~~~~~~~qi~~aL~~LH~~---givHrDlkp~NIll~~~g~vkL~DFG~a~ 169 (353)
T 2i0e_A 97 YFVMEYVNGGDLMYHIQ----QVGRFKEPHAVFYAAEIAIGLFFLQSK---GIIYRDLKLDNVMLDSEGHIKIADFGMCK 169 (353)
T ss_dssp EEEEECCCSCBHHHHHH----HHSSCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCB
T ss_pred EEEEeCCCCCcHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHHC---CEEeccCCHHHEEEcCCCcEEEEeCCccc
Confidence 99999999999999995 345699999999999999999999999 99999999999999999999999999998
Q ss_pred ccCCCCCcccccccccccccCccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCCCchhcHHHHHHHHhcccccccc
Q 010519 338 LLDSGESHITTRVMGTFGYVAPEYANTGMLNEKSDIYSFGVLLLEAVTGRDPVDYGRPANEVNLVEWLKMMVGTRRAEEV 417 (508)
Q Consensus 338 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 417 (508)
...... ......+||+.|+|||++.+..++.++|||||||++|||++|+.||.... . ...........
T Consensus 170 ~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~---~---~~~~~~i~~~~----- 237 (353)
T 2i0e_A 170 ENIWDG-VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGED---E---DELFQSIMEHN----- 237 (353)
T ss_dssp CCCCTT-CCBCCCCSCGGGCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCSSCCSS---H---HHHHHHHHHCC-----
T ss_pred ccccCC-cccccccCCccccChhhhcCCCcCCcccccchHHHHHHHHcCCCCCCCCC---H---HHHHHHHHhCC-----
Confidence 643222 22445689999999999999999999999999999999999999996432 1 12222222111
Q ss_pred cCCCCCCChhHHHHHHHHHHHHHhcCCCCCCCCC-----HHHHHHHhhc
Q 010519 418 VDPNLEVKPATRALKRSLLVALRCVDPDSEKRPK-----MSQVVRMLEA 461 (508)
Q Consensus 418 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs-----~~evl~~L~~ 461 (508)
+.. +......+.+|+.+||..||.+||+ +.++++|-.-
T Consensus 238 ----~~~--p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~i~~h~~f 280 (353)
T 2i0e_A 238 ----VAY--PKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEHAFF 280 (353)
T ss_dssp ----CCC--CTTSCHHHHHHHHHHTCSCTTSCTTCSTTHHHHHHTSGGG
T ss_pred ----CCC--CCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcCccc
Confidence 111 1122345677999999999999995 6888877543
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-43 Score=343.53 Aligned_cols=253 Identities=30% Similarity=0.533 Sum_probs=202.1
Q ss_pred hhCCcccceeEeeeCceEEEEEEEc-CCCEEEEEEEcccchhh-------HHHHHHHHHHHhcCCCCCceeEEEEEEeCc
Q 010519 184 ATNRFSAENVLGEGGYGVVYKGRLI-NGSEVAVKKLLNNLGQA-------EKEFRVEVEAIGHVRHKNLVRLLGYCIEGV 255 (508)
Q Consensus 184 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~-------~~~~~~ei~~l~~l~h~niv~~~~~~~~~~ 255 (508)
..++|.+.+.||+|+||+||+|++. +++.||+|++....... ...+.+|+.++++++||||+++++++.+..
T Consensus 17 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~ 96 (287)
T 4f0f_A 17 ADNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMHNPP 96 (287)
T ss_dssp CSTTEEEEEECCCCSSSCEEEEEETTTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTTBCCEEEEETTTT
T ss_pred hhccceehhccccCCceeEEEEEEcCCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCCCCchhhheeecCCC
Confidence 3468999999999999999999885 78899999985433211 157889999999999999999999986554
Q ss_pred eeeEEEeecCCCCHHHHHhhhhccCCCccHHHHHHHHHHHHHHHHHHHhcCCCC--eEeecCCCCCEEEcCCCc-----E
Q 010519 256 HRMLVYEYVNNGNLEQWLHGAMRNQGNLTWEARMKVIIGTAKALAYLHEAIEPK--VVHRDIKSSNILIDDEFN-----A 328 (508)
Q Consensus 256 ~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~--iiH~Dlk~~NIll~~~~~-----~ 328 (508)
++||||+++|+|.+++. .....+++..++.++.|++.||.|||+. + |+||||||+|||++.++. +
T Consensus 97 --~lv~e~~~~~~L~~~l~---~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~~~ivH~dikp~Nil~~~~~~~~~~~~ 168 (287)
T 4f0f_A 97 --RMVMEFVPCGDLYHRLL---DKAHPIKWSVKLRLMLDIALGIEYMQNQ---NPPIVHRDLRSPNIFLQSLDENAPVCA 168 (287)
T ss_dssp --EEEEECCTTCBHHHHHH---CTTSCCCHHHHHHHHHHHHHHHHHHHTS---SSCCBCSCCSGGGEEESCCCTTCSCCE
T ss_pred --eEEEEecCCCCHHHHHh---cccCCccHHHHHHHHHHHHHHHHHHHhC---CCCeecCCCCcceEEEeccCCCCceeE
Confidence 69999999999999885 3456799999999999999999999998 8 999999999999988876 9
Q ss_pred EEEecCCccccCCCCCcccccccccccccCcccc--CCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCCCchhcHHHHHH
Q 010519 329 KVSDFGLAKLLDSGESHITTRVMGTFGYVAPEYA--NTGMLNEKSDIYSFGVLLLEAVTGRDPVDYGRPANEVNLVEWLK 406 (508)
Q Consensus 329 kl~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~--~~~~~~~~~DvwS~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~ 406 (508)
||+|||++..... ......||+.|+|||++ ....++.++|||||||++|+|++|+.||....... .... .
T Consensus 169 kl~Dfg~~~~~~~----~~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~-~~~~---~ 240 (287)
T 4f0f_A 169 KVADFGLSQQSVH----SVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGK-IKFI---N 240 (287)
T ss_dssp EECCCTTCBCCSS----CEECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHHHSSCTTTTCCCCH-HHHH---H
T ss_pred EeCCCCccccccc----cccccCCCccccCchhhccCCCCcCchhhHHHHHHHHHHHHcCCCCCccccccH-HHHH---H
Confidence 9999999985433 23446789999999998 45567899999999999999999999997543322 1111 1
Q ss_pred HHhcccccccccCCCCCCChhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhhc
Q 010519 407 MMVGTRRAEEVVDPNLEVKPATRALKRSLLVALRCVDPDSEKRPKMSQVVRMLEA 461 (508)
Q Consensus 407 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~ 461 (508)
....... .+.+ +......+.+++.+||+.||.+|||+.++++.|+.
T Consensus 241 ~~~~~~~-----~~~~----~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~ 286 (287)
T 4f0f_A 241 MIREEGL-----RPTI----PEDCPPRLRNVIELCWSGDPKKRPHFSYIVKELSE 286 (287)
T ss_dssp HHHHSCC-----CCCC----CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHT
T ss_pred HHhccCC-----CCCC----CcccCHHHHHHHHHHhcCChhhCcCHHHHHHHHHh
Confidence 1111111 0111 11223456779999999999999999999999975
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-43 Score=355.66 Aligned_cols=269 Identities=22% Similarity=0.275 Sum_probs=208.3
Q ss_pred eHHHHHHhhCCcccceeEeeeCceEEEEEEEc-CCCEEEEEEEcccchhhHHHHHHHHHHHhcCC-----CCCceeEEEE
Q 010519 177 TLRDLEIATNRFSAENVLGEGGYGVVYKGRLI-NGSEVAVKKLLNNLGQAEKEFRVEVEAIGHVR-----HKNLVRLLGY 250 (508)
Q Consensus 177 ~~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~ei~~l~~l~-----h~niv~~~~~ 250 (508)
++.+..+..++|.+.+.||+|+||+||+|++. ++..||||++... ......+..|+.+++.+. ||||++++++
T Consensus 26 ~~~~g~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~h~~iv~~~~~ 104 (360)
T 3llt_A 26 SWKKGMLLNNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNI-KKYTRSAKIEADILKKIQNDDINNNNIVKYHGK 104 (360)
T ss_dssp CCCTTCEETTTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSC-HHHHHHHHHHHHHHHHTCCCSTTGGGBCCEEEE
T ss_pred eeecceEecCEEEEEEEEcccCCeEEEEEEECCCCeEEEEEEeccc-hhhhhhhHHHHHHHHHhcccCCCCCCeecccce
Confidence 44556677889999999999999999999984 6889999988643 333456777999999886 9999999999
Q ss_pred EEeCceeeEEEeecCCCCHHHHHhhhhccCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCEEEcC------
Q 010519 251 CIEGVHRMLVYEYVNNGNLEQWLHGAMRNQGNLTWEARMKVIIGTAKALAYLHEAIEPKVVHRDIKSSNILIDD------ 324 (508)
Q Consensus 251 ~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiH~Dlk~~NIll~~------ 324 (508)
+......++||||+ +++|.+++.. .....+++..++.++.||+.||.|||+. +|+||||||+|||++.
T Consensus 105 ~~~~~~~~lv~e~~-~~~L~~~~~~--~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~~~~~~ 178 (360)
T 3llt_A 105 FMYYDHMCLIFEPL-GPSLYEIITR--NNYNGFHIEDIKLYCIEILKALNYLRKM---SLTHTDLKPENILLDDPYFEKS 178 (360)
T ss_dssp EEETTEEEEEECCC-CCBHHHHHHH--TTTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEESCTTCCEE
T ss_pred eeECCeeEEEEcCC-CCCHHHHHHh--cCCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCcccEEEcccccccc
Confidence 99999999999999 8999999964 2334689999999999999999999999 9999999999999975
Q ss_pred -------------------CCcEEEEecCCccccCCCCCcccccccccccccCccccCCCCCCChhhHHHHHHHHHHHHh
Q 010519 325 -------------------EFNAKVSDFGLAKLLDSGESHITTRVMGTFGYVAPEYANTGMLNEKSDIYSFGVLLLEAVT 385 (508)
Q Consensus 325 -------------------~~~~kl~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~ellt 385 (508)
++.+||+|||++...... .....||+.|+|||++.+..++.++|||||||+||+|++
T Consensus 179 ~~~~~~~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~ 254 (360)
T 3llt_A 179 LITVRRVTDGKKIQIYRTKSTGIKLIDFGCATFKSDY----HGSIINTRQYRAPEVILNLGWDVSSDMWSFGCVLAELYT 254 (360)
T ss_dssp EEEEECTTTCCEEEEEEESCCCEEECCCTTCEETTSC----CCSCCSCGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHH
T ss_pred ccchhcccccccccccccCCCCEEEEeccCceecCCC----CcCccCcccccCcHHHcCCCCCCccchHHHHHHHHHHHH
Confidence 788999999999865432 234578999999999999999999999999999999999
Q ss_pred CCCCCCCCCCCchhcHHHHHHHHhcccc------------cccccC-------CCCCCChh-------------HHHHHH
Q 010519 386 GRDPVDYGRPANEVNLVEWLKMMVGTRR------------AEEVVD-------PNLEVKPA-------------TRALKR 433 (508)
Q Consensus 386 G~~Pf~~~~~~~~~~~~~~~~~~~~~~~------------~~~~~~-------~~~~~~~~-------------~~~~~~ 433 (508)
|+.||...... .....+........ ...... +....... ......
T Consensus 255 g~~pf~~~~~~---~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 331 (360)
T 3llt_A 255 GSLLFRTHEHM---EHLAMMESIIQPIPKNMLYEATKTNGSKYVNKDELKLAWPENASSINSIKHVKKCLPLYKIIKHEL 331 (360)
T ss_dssp SSCSCCCSSHH---HHHHHHHHHTCCCCHHHHHHHTTSGGGGGEETTTTEECTTTTCSCHHHHHHHHTCCCHHHHCCCHH
T ss_pred CCCCCCCCcHH---HHHHHHHHhcCCCCHHHHhhhhhccCccccCcccceecCcccccchhhhhhhhhcccccccchHHH
Confidence 99999643321 11111111111100 000000 00000000 000145
Q ss_pred HHHHHHHhcCCCCCCCCCHHHHHHHh
Q 010519 434 SLLVALRCVDPDSEKRPKMSQVVRML 459 (508)
Q Consensus 434 l~~li~~cl~~dP~~RPs~~evl~~L 459 (508)
+.+|+.+||+.||.+|||+.|+|++-
T Consensus 332 l~~li~~~L~~dP~~Rpta~elL~hp 357 (360)
T 3llt_A 332 FCDFLYSILQIDPTLRPSPAELLKHK 357 (360)
T ss_dssp HHHHHHHHCCSSGGGSCCHHHHTTSG
T ss_pred HHHHHHHHhcCChhhCCCHHHHhcCc
Confidence 66899999999999999999999753
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-44 Score=381.98 Aligned_cols=263 Identities=29% Similarity=0.413 Sum_probs=213.9
Q ss_pred HHHHHhhCCcccceeEeeeCceEEEEEEEcCCCEEEEEEEcccchhhHHHHHHHHHHHhcCCCCCceeEEEEEEeCceee
Q 010519 179 RDLEIATNRFSAENVLGEGGYGVVYKGRLINGSEVAVKKLLNNLGQAEKEFRVEVEAIGHVRHKNLVRLLGYCIEGVHRM 258 (508)
Q Consensus 179 ~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~ei~~l~~l~h~niv~~~~~~~~~~~~~ 258 (508)
..+++..++|.+.+.||+|+||+||+|.+.++..||||++.... ...+.|.+|+.+|++++||||+++++++.+ ...+
T Consensus 260 ~~~~i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~-~~~~ 337 (535)
T 2h8h_A 260 DAWEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIY 337 (535)
T ss_dssp TCSBCCGGGEEEEEEEEECSSEEEEEEEETTTEEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCE
T ss_pred cceecchhhhhhheecccCCCeEEEEEEECCCceEEEEEeCCCC-CCHHHHHHHHHHHHhCCCCCEeeEEEEEee-ccce
Confidence 44567788999999999999999999999878889999986543 234678899999999999999999999865 6789
Q ss_pred EEEeecCCCCHHHHHhhhhccCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCEEEcCCCcEEEEecCCccc
Q 010519 259 LVYEYVNNGNLEQWLHGAMRNQGNLTWEARMKVIIGTAKALAYLHEAIEPKVVHRDIKSSNILIDDEFNAKVSDFGLAKL 338 (508)
Q Consensus 259 lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~Dfgla~~ 338 (508)
|||||+.+|+|.++|.. .....+++..++.++.||+.||.|||++ +|+||||||+||||++++.+||+|||+++.
T Consensus 338 lv~e~~~~gsL~~~l~~--~~~~~l~~~~~~~i~~qi~~~L~~LH~~---~ivHrDlkp~NIll~~~~~~kl~DFG~a~~ 412 (535)
T 2h8h_A 338 IVTEYMSKGSLLDFLKG--ETGKYLRLPQLVDMAAQIASGMAYVERM---NYVHRDLRAANILVGENLVCKVADFGLARL 412 (535)
T ss_dssp EEECCCTTEEHHHHHSH--HHHTTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCTTSTTT
T ss_pred EeeehhcCCcHHHHHhh--cCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCCHhhEEEcCCCcEEEccccccee
Confidence 99999999999999964 2335689999999999999999999999 999999999999999999999999999987
Q ss_pred cCCCCCcccccccccccccCccccCCCCCCChhhHHHHHHHHHHHHh-CCCCCCCCCCCchhcHHHHHHHHhcccccccc
Q 010519 339 LDSGESHITTRVMGTFGYVAPEYANTGMLNEKSDIYSFGVLLLEAVT-GRDPVDYGRPANEVNLVEWLKMMVGTRRAEEV 417 (508)
Q Consensus 339 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 417 (508)
.............++..|+|||++.+..++.++|||||||+||||++ |+.||..... .+.+..+.....
T Consensus 413 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~t~g~~P~~~~~~------~~~~~~i~~~~~---- 482 (535)
T 2h8h_A 413 IEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVN------REVLDQVERGYR---- 482 (535)
T ss_dssp CCCHHHHTTCSTTSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTTCCSSTTCCH------HHHHHHHHTTCC----
T ss_pred cCCCceecccCCcCcccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCH------HHHHHHHHcCCC----
Confidence 65332222233456788999999998899999999999999999999 9999964321 122222221111
Q ss_pred cCCCCCCChhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhhcCCC
Q 010519 418 VDPNLEVKPATRALKRSLLVALRCVDPDSEKRPKMSQVVRMLEADDY 464 (508)
Q Consensus 418 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~ 464 (508)
...+......+.+|+.+||+.||.+|||+.+|++.|+....
T Consensus 483 ------~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~L~~~~~ 523 (535)
T 2h8h_A 483 ------MPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFT 523 (535)
T ss_dssp ------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSSC
T ss_pred ------CCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHhh
Confidence 11112234566779999999999999999999999998654
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-43 Score=344.95 Aligned_cols=257 Identities=26% Similarity=0.394 Sum_probs=202.9
Q ss_pred HhhCCcccceeEeeeCceEEEEEEEcCC----CEEEEEEEcccc-hhhHHHHHHHHHHHhcCCCCCceeEEEEEEeCcee
Q 010519 183 IATNRFSAENVLGEGGYGVVYKGRLING----SEVAVKKLLNNL-GQAEKEFRVEVEAIGHVRHKNLVRLLGYCIEGVHR 257 (508)
Q Consensus 183 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~----~~vavK~~~~~~-~~~~~~~~~ei~~l~~l~h~niv~~~~~~~~~~~~ 257 (508)
+..++|.+.+.||+|+||+||+|++.+. ..||+|.+.... ......+.+|+.+++.++||||+++++++.+ ...
T Consensus 9 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~ 87 (281)
T 3cc6_A 9 IAREDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLIGIIEE-EPT 87 (281)
T ss_dssp CCGGGEEEEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTTSCHHHHHHHHHHHHHHHHHCCTTBCCEEEEECS-SSC
T ss_pred ecccceEEEEEEEecCCeeEEEeEEcCCCCCcceEEEEecccccCchHHHHHHHHHHHHHhCCCCCcceEEEEEcC-CCC
Confidence 3456899999999999999999987532 359999886543 3445678899999999999999999998764 456
Q ss_pred eEEEeecCCCCHHHHHhhhhccCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCEEEcCCCcEEEEecCCcc
Q 010519 258 MLVYEYVNNGNLEQWLHGAMRNQGNLTWEARMKVIIGTAKALAYLHEAIEPKVVHRDIKSSNILIDDEFNAKVSDFGLAK 337 (508)
Q Consensus 258 ~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~Dfgla~ 337 (508)
++||||+++++|.+++.. ....+++..++.++.|++.||.|||++ +|+||||||+|||++.++.+||+|||++.
T Consensus 88 ~~v~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~ 161 (281)
T 3cc6_A 88 WIIMELYPYGELGHYLER---NKNSLKVLTLVLYSLQICKAMAYLESI---NCVHRDIAVRNILVASPECVKLGDFGLSR 161 (281)
T ss_dssp EEEEECCTTCBHHHHHHH---HTTTCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEEEETTEEEECCCCGGG
T ss_pred EEEEecCCCCCHHHHHHh---ccccCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCccceEEECCCCcEEeCccCCCc
Confidence 899999999999999963 345689999999999999999999999 99999999999999999999999999998
Q ss_pred ccCCCCCcccccccccccccCccccCCCCCCChhhHHHHHHHHHHHHh-CCCCCCCCCCCchhcHHHHHHHHhccccccc
Q 010519 338 LLDSGESHITTRVMGTFGYVAPEYANTGMLNEKSDIYSFGVLLLEAVT-GRDPVDYGRPANEVNLVEWLKMMVGTRRAEE 416 (508)
Q Consensus 338 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 416 (508)
..............+++.|+|||++.+..++.++||||||+++|+|++ |+.||....... ....+.. ...
T Consensus 162 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~llt~g~~p~~~~~~~~---~~~~~~~---~~~--- 232 (281)
T 3cc6_A 162 YIEDEDYYKASVTRLPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLENKD---VIGVLEK---GDR--- 232 (281)
T ss_dssp CC---------CCCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCGGG---HHHHHHH---TCC---
T ss_pred ccccccccccccCCCCcceeCchhhccCCCCchhccHHHHHHHHHHHhCCCCCcccCChHH---HHHHHhc---CCC---
Confidence 765443333344567889999999998899999999999999999998 999996443222 2221111 110
Q ss_pred ccCCCCCCChhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhhcC
Q 010519 417 VVDPNLEVKPATRALKRSLLVALRCVDPDSEKRPKMSQVVRMLEAD 462 (508)
Q Consensus 417 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~ 462 (508)
.. .+......+.+++.+||+.||.+|||+.+++++|+..
T Consensus 233 ---~~----~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~ 271 (281)
T 3cc6_A 233 ---LP----KPDLCPPVLYTLMTRCWDYDPSDRPRFTELVCSLSDV 271 (281)
T ss_dssp ---CC----CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred ---CC----CCCCCCHHHHHHHHHHccCCchhCcCHHHHHHHHHHH
Confidence 00 0111234566799999999999999999999999864
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-42 Score=355.64 Aligned_cols=267 Identities=19% Similarity=0.233 Sum_probs=204.5
Q ss_pred CCcccceeEeee--CceEEEEEEEc-CCCEEEEEEEcccc--hhhHHHHHHHHHHHhcCCCCCceeEEEEEEeCceeeEE
Q 010519 186 NRFSAENVLGEG--GYGVVYKGRLI-NGSEVAVKKLLNNL--GQAEKEFRVEVEAIGHVRHKNLVRLLGYCIEGVHRMLV 260 (508)
Q Consensus 186 ~~~~~~~~lg~G--~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~ei~~l~~l~h~niv~~~~~~~~~~~~~lv 260 (508)
++|++.+.||+| +||+||+|++. +|+.||||++.... ......+.+|+.+++.++|||||++++++.+....++|
T Consensus 25 ~~y~~~~~lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv 104 (389)
T 3gni_B 25 GCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVV 104 (389)
T ss_dssp GGEEEEEEEEEETTTTEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred CcEEEEecccCCcCCceEEEEEEEcCCCCEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCCCcEeEEEEECCEEEEE
Confidence 589999999999 99999999986 68999999986543 33446788899999999999999999999999999999
Q ss_pred EeecCCCCHHHHHhhhhccCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCEEEcCCCcEEEEecCCccccC
Q 010519 261 YEYVNNGNLEQWLHGAMRNQGNLTWEARMKVIIGTAKALAYLHEAIEPKVVHRDIKSSNILIDDEFNAKVSDFGLAKLLD 340 (508)
Q Consensus 261 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~Dfgla~~~~ 340 (508)
|||+++|+|.+++.. .....+++..++.++.||+.||.|||++ +|+||||||+|||++.++.+||+|||++....
T Consensus 105 ~e~~~~~~L~~~l~~--~~~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivHrDlkp~NIll~~~~~~kl~dfg~~~~~~ 179 (389)
T 3gni_B 105 TSFMAYGSAKDLICT--HFMDGMNELAIAYILQGVLKALDYIHHM---GYVHRSVKASHILISVDGKVYLSGLRSNLSMI 179 (389)
T ss_dssp EECCTTCBHHHHHHH--TCTTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCGGGCEECE
T ss_pred EEccCCCCHHHHHhh--hcccCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEcccccceeec
Confidence 999999999999964 2345699999999999999999999999 99999999999999999999999999986442
Q ss_pred CCCC------cccccccccccccCccccCC--CCCCChhhHHHHHHHHHHHHhCCCCCCCCCCCchhcHHHHHHHHh---
Q 010519 341 SGES------HITTRVMGTFGYVAPEYANT--GMLNEKSDIYSFGVLLLEAVTGRDPVDYGRPANEVNLVEWLKMMV--- 409 (508)
Q Consensus 341 ~~~~------~~~~~~~gt~~y~aPE~~~~--~~~~~~~DvwS~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~--- 409 (508)
.... .......||+.|+|||++.+ ..++.++|||||||++|||++|+.||......... ........
T Consensus 180 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~--~~~~~~~~~~~ 257 (389)
T 3gni_B 180 SHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQML--LEKLNGTVPCL 257 (389)
T ss_dssp ETTEECSCBCCCCTTCTTTGGGSCHHHHSTTSSCBCTHHHHHHHHHHHHHHHHSSCTTTTCCSTTHH--HHC--------
T ss_pred cccccccccccccccccccccccCHHHHhccCCCCCcHhHHHHHHHHHHHHHHCCCCCCCCCHHHHH--HHHhcCCCCcc
Confidence 2111 11223478999999999987 67999999999999999999999999654332211 10000000
Q ss_pred -cccc------------------cccccC---------CCCCCChhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHh
Q 010519 410 -GTRR------------------AEEVVD---------PNLEVKPATRALKRSLLVALRCVDPDSEKRPKMSQVVRML 459 (508)
Q Consensus 410 -~~~~------------------~~~~~~---------~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L 459 (508)
.... ...... ..............+.+|+.+||+.||.+|||+.|++++-
T Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~ell~hp 335 (389)
T 3gni_B 258 LDTSTIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQCLQRNPDARPSASTLLNHS 335 (389)
T ss_dssp ------------------------------------------------CCHHHHHHHHHHTCSCTTTSCCHHHHTTSG
T ss_pred ccccccccccccccccccccccccccccccCccccccCCCCCCccccccCHHHHHHHHHHhhcCcccCCCHHHHhcCH
Confidence 0000 000000 0000001122345677899999999999999999999873
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-43 Score=356.08 Aligned_cols=252 Identities=24% Similarity=0.312 Sum_probs=200.6
Q ss_pred ccceeEeeeCceEEEEEEEc-CCCEEEEEEEcccchhhHHHHHHHHHHHhcCCCCCceeEEEEEEeCceeeEEEeecCCC
Q 010519 189 SAENVLGEGGYGVVYKGRLI-NGSEVAVKKLLNNLGQAEKEFRVEVEAIGHVRHKNLVRLLGYCIEGVHRMLVYEYVNNG 267 (508)
Q Consensus 189 ~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~ei~~l~~l~h~niv~~~~~~~~~~~~~lv~E~~~~g 267 (508)
...+.||+|+||.||+|.+. +|..||+|++..........+.+|+.++++++||||+++++++.+....++||||+++|
T Consensus 92 ~~~~~lG~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E~~~~~ 171 (373)
T 2x4f_A 92 SKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQLYDAFESKNDIVLVMEYVDGG 171 (373)
T ss_dssp EEEEECC-----CEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCTTC
T ss_pred ecceEEecCcCEEEEEEEEcCCCcEEEEEEEcccccccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeCCCCC
Confidence 33678999999999999875 68899999987766566678999999999999999999999999999999999999999
Q ss_pred CHHHHHhhhhccCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCEEE--cCCCcEEEEecCCccccCCCCCc
Q 010519 268 NLEQWLHGAMRNQGNLTWEARMKVIIGTAKALAYLHEAIEPKVVHRDIKSSNILI--DDEFNAKVSDFGLAKLLDSGESH 345 (508)
Q Consensus 268 sL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiH~Dlk~~NIll--~~~~~~kl~Dfgla~~~~~~~~~ 345 (508)
+|.+++.. ....+++..++.++.||+.||.|||+. +|+||||||+|||+ ++++.+||+|||++........
T Consensus 172 ~L~~~l~~---~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~~~~~~~~- 244 (373)
T 2x4f_A 172 ELFDRIID---ESYNLTELDTILFMKQICEGIRHMHQM---YILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPREK- 244 (373)
T ss_dssp EEHHHHHH---TGGGCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEEEETTTTEEEECCCSSCEECCTTCB-
T ss_pred cHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccccCCHHHEEEecCCCCcEEEEeCCCceecCCccc-
Confidence 99999853 345689999999999999999999999 99999999999999 5678899999999987654332
Q ss_pred ccccccccccccCccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCCCchhcHHHHHHHHhcccccccccCCCCCCC
Q 010519 346 ITTRVMGTFGYVAPEYANTGMLNEKSDIYSFGVLLLEAVTGRDPVDYGRPANEVNLVEWLKMMVGTRRAEEVVDPNLEVK 425 (508)
Q Consensus 346 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 425 (508)
....+||+.|+|||++.+..++.++|||||||+||||++|..||..... . +.+........ .+...
T Consensus 245 -~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~---~---~~~~~i~~~~~-------~~~~~ 310 (373)
T 2x4f_A 245 -LKVNFGTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLSPFLGDND---A---ETLNNILACRW-------DLEDE 310 (373)
T ss_dssp -CCCCCSSCTTCCHHHHTTCBCCHHHHHHHHHHHHHHHHHSSCTTCCSSH---H---HHHHHHHHTCC-------CSCSG
T ss_pred -cccccCCCcEeChhhccCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCH---H---HHHHHHHhccC-------CCChh
Confidence 3345699999999999999999999999999999999999999964321 1 11222211110 01111
Q ss_pred hhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhhc
Q 010519 426 PATRALKRSLLVALRCVDPDSEKRPKMSQVVRMLEA 461 (508)
Q Consensus 426 ~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~ 461 (508)
........+.+|+.+||+.||.+|||+.|++++-.-
T Consensus 311 ~~~~~~~~~~~li~~~L~~dp~~Rps~~e~l~hp~~ 346 (373)
T 2x4f_A 311 EFQDISEEAKEFISKLLIKEKSWRISASEALKHPWL 346 (373)
T ss_dssp GGTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSHHH
T ss_pred hhccCCHHHHHHHHHHcCCChhhCCCHHHHhcCcCc
Confidence 111234567779999999999999999999986543
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-43 Score=349.38 Aligned_cols=250 Identities=25% Similarity=0.292 Sum_probs=195.8
Q ss_pred HhhCCcccceeEeeeCceEEEEEEEc-CCCEEEEEEEcccc--hhhHHHHHHHHHHHhcC-CCCCceeEEEEEEeCceee
Q 010519 183 IATNRFSAENVLGEGGYGVVYKGRLI-NGSEVAVKKLLNNL--GQAEKEFRVEVEAIGHV-RHKNLVRLLGYCIEGVHRM 258 (508)
Q Consensus 183 ~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~ei~~l~~l-~h~niv~~~~~~~~~~~~~ 258 (508)
+..++|++.+.||+|+||+||+|++. +|+.||||++.... ......+..|+..+..+ +||||++++++|.++...+
T Consensus 54 ~~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~~~~~~~h~~iv~l~~~~~~~~~~~ 133 (311)
T 3p1a_A 54 FFQQSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEEGGILY 133 (311)
T ss_dssp HHHHHEEEEEEEEEETTEEEEEEEETTTSCEEEEEEESSSCCSHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEE
T ss_pred hhhhheeeeheeccCCCeEEEEEEECCCCeEEEEEEecccccChHHHHHHHHHHHHHHHhcCCCcEEEEEEEEEeCCEEE
Confidence 34468999999999999999999986 78999999886433 22233444455555444 9999999999999999999
Q ss_pred EEEeecCCCCHHHHHhhhhccCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCEEEcCCCcEEEEecCCccc
Q 010519 259 LVYEYVNNGNLEQWLHGAMRNQGNLTWEARMKVIIGTAKALAYLHEAIEPKVVHRDIKSSNILIDDEFNAKVSDFGLAKL 338 (508)
Q Consensus 259 lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~Dfgla~~ 338 (508)
+||||+ +++|.+++.. ....+++..++.++.||+.||.|||+. +|+||||||+|||++.++.+||+|||++..
T Consensus 134 lv~e~~-~~~L~~~~~~---~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIll~~~~~~kl~DFG~a~~ 206 (311)
T 3p1a_A 134 LQTELC-GPSLQQHCEA---WGASLPEAQVWGYLRDTLLALAHLHSQ---GLVHLDVKPANIFLGPRGRCKLGDFGLLVE 206 (311)
T ss_dssp EEEECC-CCBHHHHHHH---HCSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECGGGCEEECCCTTCEE
T ss_pred EEEecc-CCCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHEEECCCCCEEEccceeeee
Confidence 999999 6799999863 356799999999999999999999999 999999999999999999999999999987
Q ss_pred cCCCCCcccccccccccccCccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCCCchhcHHHHHHHHhccccccccc
Q 010519 339 LDSGESHITTRVMGTFGYVAPEYANTGMLNEKSDIYSFGVLLLEAVTGRDPVDYGRPANEVNLVEWLKMMVGTRRAEEVV 418 (508)
Q Consensus 339 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 418 (508)
..... ......||+.|+|||++.+ .++.++|||||||++|||++|..||... . .+ ..+..
T Consensus 207 ~~~~~--~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~el~~g~~~~~~~-----~---~~-~~~~~-------- 266 (311)
T 3p1a_A 207 LGTAG--AGEVQEGDPRYMAPELLQG-SYGTAADVFSLGLTILEVACNMELPHGG-----E---GW-QQLRQ-------- 266 (311)
T ss_dssp CC--------CCCCCGGGCCGGGGGT-CCSTHHHHHHHHHHHHHHHHTCCCCSSH-----H---HH-HHHTT--------
T ss_pred cccCC--CCcccCCCccccCHhHhcC-CCCchhhHHHHHHHHHHHHhCCCCCCCc-----c---HH-HHHhc--------
Confidence 65432 2344568999999999886 7899999999999999999997766421 1 11 11111
Q ss_pred CCCCCCChhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhh
Q 010519 419 DPNLEVKPATRALKRSLLVALRCVDPDSEKRPKMSQVVRMLE 460 (508)
Q Consensus 419 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 460 (508)
..............+.+++.+||+.||.+|||+.|++++-+
T Consensus 267 -~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~hp~ 307 (311)
T 3p1a_A 267 -GYLPPEFTAGLSSELRSVLVMMLEPDPKLRATAEALLALPV 307 (311)
T ss_dssp -TCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGG
T ss_pred -cCCCcccccCCCHHHHHHHHHHcCCChhhCcCHHHHHhCcc
Confidence 11111111223456778999999999999999999998644
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-43 Score=351.24 Aligned_cols=254 Identities=25% Similarity=0.338 Sum_probs=183.3
Q ss_pred ceeEeeeCceEEEEEEEc-CCCEEEEEEEcccchhhHHHHHHHHHHHhcCC-CCCceeEEEEEEeCceeeEEEeecCCCC
Q 010519 191 ENVLGEGGYGVVYKGRLI-NGSEVAVKKLLNNLGQAEKEFRVEVEAIGHVR-HKNLVRLLGYCIEGVHRMLVYEYVNNGN 268 (508)
Q Consensus 191 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~ei~~l~~l~-h~niv~~~~~~~~~~~~~lv~E~~~~gs 268 (508)
.+.||+|+||+||+|.+. +++.||||++... ....+.+|+.+++.+. ||||+++++++.+....++||||+++|+
T Consensus 16 ~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~e~~~l~~l~~h~niv~~~~~~~~~~~~~lv~e~~~~~~ 92 (325)
T 3kn6_A 16 DKPLGEGSFSICRKCVHKKSNQAFAVKIISKR---MEANTQKEITALKLCEGHPNIVKLHEVFHDQLHTFLVMELLNGGE 92 (325)
T ss_dssp SCCSEEETTEEEEEEEETTTCCEEEEEEEEGG---GHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEECCCCSCB
T ss_pred CCccccCCCeEEEEEEECCCCCEEEEEEEChh---hhhhHHHHHHHHHHhcCCCCeeEEEEEEEcCCEEEEEEEccCCCc
Confidence 378999999999999985 6889999998543 3456778999999997 9999999999999999999999999999
Q ss_pred HHHHHhhhhccCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCEEEcCCC---cEEEEecCCccccCCCCCc
Q 010519 269 LEQWLHGAMRNQGNLTWEARMKVIIGTAKALAYLHEAIEPKVVHRDIKSSNILIDDEF---NAKVSDFGLAKLLDSGESH 345 (508)
Q Consensus 269 L~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiH~Dlk~~NIll~~~~---~~kl~Dfgla~~~~~~~~~ 345 (508)
|.+++. ....+++..+..++.||+.||.|||++ +|+||||||+|||++.++ .+||+|||++........
T Consensus 93 L~~~l~----~~~~~~~~~~~~i~~qi~~~l~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~~~~~~~~- 164 (325)
T 3kn6_A 93 LFERIK----KKKHFSETEASYIMRKLVSAVSHMHDV---GVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQ- 164 (325)
T ss_dssp HHHHHH----HCSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEEEC----CEEEECCCTTCEECCC----
T ss_pred HHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHHC---CCeecCCCHHHEEEecCCCcccEEEeccccceecCCCCC-
Confidence 999995 456799999999999999999999999 999999999999998766 799999999986654322
Q ss_pred ccccccccccccCccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCCCch-hcHHHHHHHHhcccccccccCCCCCC
Q 010519 346 ITTRVMGTFGYVAPEYANTGMLNEKSDIYSFGVLLLEAVTGRDPVDYGRPANE-VNLVEWLKMMVGTRRAEEVVDPNLEV 424 (508)
Q Consensus 346 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltG~~Pf~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~ 424 (508)
.....+||+.|+|||++.+..++.++|||||||++|+|++|..||........ ....+.+...... . ..+..
T Consensus 165 ~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~i~~~-~------~~~~~ 237 (325)
T 3kn6_A 165 PLKTPCFTLHYAAPELLNQNGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIMKKIKKG-D------FSFEG 237 (325)
T ss_dssp -------------------CCCCHHHHHHHHHHHHHHHHHSSCTTC-------CCCHHHHHHHHTTT-C------CCCCS
T ss_pred cccccCCCcCccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCccccccccHHHHHHHHHcC-C------CCCCc
Confidence 23445789999999999999999999999999999999999999975432211 1112222222111 0 11111
Q ss_pred ChhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhhcC
Q 010519 425 KPATRALKRSLLVALRCVDPDSEKRPKMSQVVRMLEAD 462 (508)
Q Consensus 425 ~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~ 462 (508)
.........+.+|+.+||+.||.+|||+.|++++-+-.
T Consensus 238 ~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~h~w~~ 275 (325)
T 3kn6_A 238 EAWKNVSQEAKDLIQGLLTVDPNKRLKMSGLRYNEWLQ 275 (325)
T ss_dssp HHHHTSCHHHHHHHHHHHCCCTTTCCCTTTSTTCGGGC
T ss_pred ccccCCCHHHHHHHHHHCCCChhHCCCHHHHhcChhhc
Confidence 11123355677899999999999999999999775543
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-42 Score=338.63 Aligned_cols=250 Identities=22% Similarity=0.306 Sum_probs=205.6
Q ss_pred hCCcccceeEeeeCceEEEEEEEc-CCCEEEEEEEcccchhhHHHHHHHHHHHhcCCCCCceeEEEEEEeCceeeEEEee
Q 010519 185 TNRFSAENVLGEGGYGVVYKGRLI-NGSEVAVKKLLNNLGQAEKEFRVEVEAIGHVRHKNLVRLLGYCIEGVHRMLVYEY 263 (508)
Q Consensus 185 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~ei~~l~~l~h~niv~~~~~~~~~~~~~lv~E~ 263 (508)
.++|.+.+.||+|+||+||+|.+. ++..+|+|++..........+.+|+.++++++||||+++++++.+....++||||
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 87 (277)
T 3f3z_A 8 NQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYETFEDNTDIYLVMEL 87 (277)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred hhhEEeeeEEeecCCEEEEEEEeCCCCcEEEEEeehhhccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCeEEEEEec
Confidence 357999999999999999999886 4678999998766555667889999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhhhhccCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCEEE---cCCCcEEEEecCCccccC
Q 010519 264 VNNGNLEQWLHGAMRNQGNLTWEARMKVIIGTAKALAYLHEAIEPKVVHRDIKSSNILI---DDEFNAKVSDFGLAKLLD 340 (508)
Q Consensus 264 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiH~Dlk~~NIll---~~~~~~kl~Dfgla~~~~ 340 (508)
+++++|.+++. ....+++..++.++.|++.||.|||++ +|+||||||+|||+ +.++.+||+|||++....
T Consensus 88 ~~~~~L~~~~~----~~~~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~~~~l~Dfg~~~~~~ 160 (277)
T 3f3z_A 88 CTGGELFERVV----HKRVFRESDAARIMKDVLSAVAYCHKL---NVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFK 160 (277)
T ss_dssp CCSCBHHHHHH----HHCSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESSSSTTCCEEECCCTTCEECC
T ss_pred cCCCcHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHHC---CccCCCCCHHHEEEecCCCCCcEEEEecccceecc
Confidence 99999999985 345689999999999999999999999 99999999999999 788999999999998765
Q ss_pred CCCCcccccccccccccCccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCCCchhcHHHHHHHHhcccccccccCC
Q 010519 341 SGESHITTRVMGTFGYVAPEYANTGMLNEKSDIYSFGVLLLEAVTGRDPVDYGRPANEVNLVEWLKMMVGTRRAEEVVDP 420 (508)
Q Consensus 341 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 420 (508)
... ......||+.|+|||++.+. ++.++||||||+++|+|++|+.||..... . ........ .
T Consensus 161 ~~~--~~~~~~~t~~y~aPE~~~~~-~~~~~Di~slG~~l~~l~~g~~p~~~~~~---~---~~~~~~~~---------~ 222 (277)
T 3f3z_A 161 PGK--MMRTKVGTPYYVSPQVLEGL-YGPECDEWSAGVMMYVLLCGYPPFSAPTD---S---EVMLKIRE---------G 222 (277)
T ss_dssp TTS--CBCCCCSCTTTCCHHHHTTC-BCTTHHHHHHHHHHHHHHHSSCSSCCSSH---H---HHHHHHHH---------C
T ss_pred Ccc--chhccCCCCCccChHHhccc-CCchhhehhHHHHHHHHHHCCCCCCCCCH---H---HHHHHHHh---------C
Confidence 433 23445789999999998765 89999999999999999999999964321 1 11111111 1
Q ss_pred CCCCChh--HHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHh
Q 010519 421 NLEVKPA--TRALKRSLLVALRCVDPDSEKRPKMSQVVRML 459 (508)
Q Consensus 421 ~~~~~~~--~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L 459 (508)
....... ......+.+++.+||+.||.+|||+.+++++-
T Consensus 223 ~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~s~~~~l~h~ 263 (277)
T 3f3z_A 223 TFTFPEKDWLNVSPQAESLIRRLLTKSPKQRITSLQALEHE 263 (277)
T ss_dssp CCCCCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHTTSH
T ss_pred CCCCCchhhhcCCHHHHHHHHHHccCChhhCcCHHHHhcCH
Confidence 1111111 12245677799999999999999999998753
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-43 Score=351.28 Aligned_cols=265 Identities=26% Similarity=0.400 Sum_probs=212.2
Q ss_pred HHHHhhCCcccceeEeeeCceEEEEEEE------cCCCEEEEEEEcccch-hhHHHHHHHHHHHhcC-CCCCceeEEEEE
Q 010519 180 DLEIATNRFSAENVLGEGGYGVVYKGRL------INGSEVAVKKLLNNLG-QAEKEFRVEVEAIGHV-RHKNLVRLLGYC 251 (508)
Q Consensus 180 ~~~~~~~~~~~~~~lg~G~~g~Vy~~~~------~~~~~vavK~~~~~~~-~~~~~~~~ei~~l~~l-~h~niv~~~~~~ 251 (508)
.+++..++|.+.+.||+|+||.||+|++ .++..||+|.+..... ...+.+.+|+.++.++ +||||+++++++
T Consensus 17 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~ 96 (313)
T 1t46_A 17 KWEFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGAC 96 (313)
T ss_dssp GGBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred ccccChhhhhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcchhHHHHHHHHHHHHHHhhcccCCCeeeEEEEE
Confidence 3456678999999999999999999986 2467899999865433 3456788999999999 999999999999
Q ss_pred EeCceeeEEEeecCCCCHHHHHhhhhc--------------cCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCC
Q 010519 252 IEGVHRMLVYEYVNNGNLEQWLHGAMR--------------NQGNLTWEARMKVIIGTAKALAYLHEAIEPKVVHRDIKS 317 (508)
Q Consensus 252 ~~~~~~~lv~E~~~~gsL~~~l~~~~~--------------~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiH~Dlk~ 317 (508)
.+....++||||+++|+|.+++..... ....+++..++.++.||+.||.|||++ +|+||||||
T Consensus 97 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp 173 (313)
T 1t46_A 97 TIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASK---NCIHRDLAA 173 (313)
T ss_dssp CSSSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSG
T ss_pred ecCCCcEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCcc
Confidence 999999999999999999999975321 122589999999999999999999999 999999999
Q ss_pred CCEEEcCCCcEEEEecCCccccCCCCCc-ccccccccccccCccccCCCCCCChhhHHHHHHHHHHHHh-CCCCCCCCCC
Q 010519 318 SNILIDDEFNAKVSDFGLAKLLDSGESH-ITTRVMGTFGYVAPEYANTGMLNEKSDIYSFGVLLLEAVT-GRDPVDYGRP 395 (508)
Q Consensus 318 ~NIll~~~~~~kl~Dfgla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~ellt-G~~Pf~~~~~ 395 (508)
+|||++.++.+||+|||++......... ......+|+.|+|||++.+..++.++|||||||++|+|++ |..||.....
T Consensus 174 ~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~ 253 (313)
T 1t46_A 174 RNILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPV 253 (313)
T ss_dssp GGEEEETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCS
T ss_pred ceEEEcCCCCEEEccccccccccccccceeccCCCCcceeeChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCCcccc
Confidence 9999999999999999999876544322 2334557889999999999999999999999999999999 9999965432
Q ss_pred CchhcHHHHHHHHhcccccccccCCCCCCChhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhhcC
Q 010519 396 ANEVNLVEWLKMMVGTRRAEEVVDPNLEVKPATRALKRSLLVALRCVDPDSEKRPKMSQVVRMLEAD 462 (508)
Q Consensus 396 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~ 462 (508)
.. .....+.. ... . ..+......+.+++.+||+.||.+|||+.|++++|+..
T Consensus 254 ~~--~~~~~~~~---~~~------~----~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~ 305 (313)
T 1t46_A 254 DS--KFYKMIKE---GFR------M----LSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQ 305 (313)
T ss_dssp SH--HHHHHHHH---TCC------C----CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred hh--HHHHHhcc---CCC------C----CCcccCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHH
Confidence 21 11111111 100 0 00111234567799999999999999999999999864
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-43 Score=342.91 Aligned_cols=250 Identities=29% Similarity=0.433 Sum_probs=201.8
Q ss_pred hhCCcccceeEeeeCceEEEEEEEc-CCCEEEEEEEcccc---hhhHHHHHHHHHHHhcCCCCCceeEEEEEEeCceeeE
Q 010519 184 ATNRFSAENVLGEGGYGVVYKGRLI-NGSEVAVKKLLNNL---GQAEKEFRVEVEAIGHVRHKNLVRLLGYCIEGVHRML 259 (508)
Q Consensus 184 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~ei~~l~~l~h~niv~~~~~~~~~~~~~l 259 (508)
..++|.+.+.||+|+||+||+|.+. ++..||+|++.... ......+.+|+.+++.++||||+++++++.+....++
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 86 (279)
T 3fdn_A 7 ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYL 86 (279)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEE
T ss_pred ecccEEEeeEEecCCCeEEEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHcCCCCCCcchhheEecCCEEEE
Confidence 3468999999999999999999876 56789999985433 1224568889999999999999999999999999999
Q ss_pred EEeecCCCCHHHHHhhhhccCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCEEEcCCCcEEEEecCCcccc
Q 010519 260 VYEYVNNGNLEQWLHGAMRNQGNLTWEARMKVIIGTAKALAYLHEAIEPKVVHRDIKSSNILIDDEFNAKVSDFGLAKLL 339 (508)
Q Consensus 260 v~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~Dfgla~~~ 339 (508)
||||+++|+|.+++. ....+++..++.++.||+.||.|||+. +|+||||||+|||++.++.+||+|||++...
T Consensus 87 v~e~~~~~~l~~~l~----~~~~~~~~~~~~~~~qi~~~l~~LH~~---~i~H~dlkp~Nili~~~~~~~l~Dfg~~~~~ 159 (279)
T 3fdn_A 87 ILEYAPLGTVYRELQ----KLSKFDEQRTATYITELANALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHA 159 (279)
T ss_dssp EECCCTTEEHHHHHH----HHSSCCHHHHHHHHHHHHHHHHHHHTT---TCEECCCCGGGEEECTTSCEEECSCCEESCC
T ss_pred EEecCCCCcHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHhC---CEecccCChHhEEEcCCCCEEEEeccccccC
Confidence 999999999999985 345689999999999999999999998 9999999999999999999999999998654
Q ss_pred CCCCCcccccccccccccCccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCCCchhcHHHHHHHHhcccccccccC
Q 010519 340 DSGESHITTRVMGTFGYVAPEYANTGMLNEKSDIYSFGVLLLEAVTGRDPVDYGRPANEVNLVEWLKMMVGTRRAEEVVD 419 (508)
Q Consensus 340 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 419 (508)
.... .....|++.|+|||++.+..++.++||||||+++|+|++|..||..... ...........
T Consensus 160 ~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~------~~~~~~~~~~~------- 223 (279)
T 3fdn_A 160 PSSR---RTDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTY------QETYKRISRVE------- 223 (279)
T ss_dssp -----------CCCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSH------HHHHHHHHHTC-------
T ss_pred Cccc---ccccCCCCCccCHhHhccCCCCccchhHhHHHHHHHHHHCCCCCCCCcH------HHHHHHHHhCC-------
Confidence 4322 3345789999999999999999999999999999999999999964321 11111111100
Q ss_pred CCCCCChhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhh
Q 010519 420 PNLEVKPATRALKRSLLVALRCVDPDSEKRPKMSQVVRMLE 460 (508)
Q Consensus 420 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 460 (508)
..+ +......+.+|+.+||+.||.+|||+.|++++-+
T Consensus 224 ~~~----~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~h~~ 260 (279)
T 3fdn_A 224 FTF----PDFVTEGARDLISRLLKHNPSQRPMLREVLEHPW 260 (279)
T ss_dssp CCC----CTTSCHHHHHHHHHHCCSSGGGSCCHHHHHHCHH
T ss_pred CCC----CCcCCHHHHHHHHHHhccChhhCCCHHHHhhCcc
Confidence 011 1112345667999999999999999999998754
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-42 Score=339.46 Aligned_cols=254 Identities=22% Similarity=0.308 Sum_probs=205.5
Q ss_pred hCCcccceeEeeeCceEEEEEEEc-CCCEEEEEEEcccc--hhhHHHHHHHHHHHhcCCCCCceeEEEEEEeCceeeEEE
Q 010519 185 TNRFSAENVLGEGGYGVVYKGRLI-NGSEVAVKKLLNNL--GQAEKEFRVEVEAIGHVRHKNLVRLLGYCIEGVHRMLVY 261 (508)
Q Consensus 185 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~ei~~l~~l~h~niv~~~~~~~~~~~~~lv~ 261 (508)
.++|.+.+.||+|+||.||+|.+. ++..||+|++.... ......+.+|+.++++++||||+++++++.+....++||
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 84 (284)
T 3kk8_A 5 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVF 84 (284)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hhhhhhhhhhcCcCCeEEEEEEEcCCCceEEEEEeecccCCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEcCCEEEEEE
Confidence 468999999999999999999875 58899999986543 333467888999999999999999999999999999999
Q ss_pred eecCCCCHHHHHhhhhccCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCEEEcCCCc---EEEEecCCccc
Q 010519 262 EYVNNGNLEQWLHGAMRNQGNLTWEARMKVIIGTAKALAYLHEAIEPKVVHRDIKSSNILIDDEFN---AKVSDFGLAKL 338 (508)
Q Consensus 262 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiH~Dlk~~NIll~~~~~---~kl~Dfgla~~ 338 (508)
||+++++|.+++. ....+++..+..++.|++.||.|||+. +|+||||||+|||++.++. +||+|||++..
T Consensus 85 e~~~~~~l~~~~~----~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~~~~kl~Dfg~~~~ 157 (284)
T 3kk8_A 85 DLVTGGELFEDIV----AREFYSEADASHCIQQILESIAYCHSN---GIVHRNLKPENLLLASKAKGAAVKLADFGLAIE 157 (284)
T ss_dssp CCCCSCBHHHHHH----HHSSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEESSSSTTCCEEECCCTTCEE
T ss_pred ecCCCCCHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHHC---CcCcCCCCHHHEEEecCCCCCcEEEeeceeeEE
Confidence 9999999999885 345689999999999999999999999 9999999999999987665 99999999987
Q ss_pred cCCCCCcccccccccccccCccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCCCchhcHHHHHHHHhccccccccc
Q 010519 339 LDSGESHITTRVMGTFGYVAPEYANTGMLNEKSDIYSFGVLLLEAVTGRDPVDYGRPANEVNLVEWLKMMVGTRRAEEVV 418 (508)
Q Consensus 339 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 418 (508)
...... .....||+.|+|||++.+..++.++||||||+++|+|++|..||..... ... ....... .. .
T Consensus 158 ~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~---~~~---~~~~~~~-~~-~-- 225 (284)
T 3kk8_A 158 VNDSEA--WHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQ---HRL---YAQIKAG-AY-D-- 225 (284)
T ss_dssp CCSSCB--CCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH---HHH---HHHHHHT-CC-C--
T ss_pred cccCcc--ccCCCCCcCCcCchhhcCCCCCcccchHHHHHHHHHHHHCCCCCCCCch---hHH---HHHHHhc-cc-c--
Confidence 654332 3445789999999999999999999999999999999999999964321 111 1111111 00 0
Q ss_pred CCCCCCChhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhh
Q 010519 419 DPNLEVKPATRALKRSLLVALRCVDPDSEKRPKMSQVVRMLE 460 (508)
Q Consensus 419 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 460 (508)
............+.+|+.+||+.||.+|||+.|++++-+
T Consensus 226 ---~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~ 264 (284)
T 3kk8_A 226 ---YPSPEWDTVTPEAKSLIDSMLTVNPKKRITADQALKVPW 264 (284)
T ss_dssp ---CCTTTTTTSCHHHHHHHHHHSCSSTTTSCCHHHHTTSHH
T ss_pred ---CCchhhcccCHHHHHHHHHHcccChhhCCCHHHHhcCcc
Confidence 000011112345667999999999999999999998654
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-43 Score=369.38 Aligned_cols=257 Identities=22% Similarity=0.255 Sum_probs=200.1
Q ss_pred HhhCCcccceeEeeeCceEEEEEEEc-CCCEEEEEEEcccc---hhhHHHHHHHHHHHhcCCCCCceeEEEEEEeCceee
Q 010519 183 IATNRFSAENVLGEGGYGVVYKGRLI-NGSEVAVKKLLNNL---GQAEKEFRVEVEAIGHVRHKNLVRLLGYCIEGVHRM 258 (508)
Q Consensus 183 ~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~ei~~l~~l~h~niv~~~~~~~~~~~~~ 258 (508)
+..++|.+.+.||+|+||.||+|++. +|..||||++.... ......+..|+.+++.++||||+++++++.+....+
T Consensus 145 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~ 224 (446)
T 4ejn_A 145 VTMNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLC 224 (446)
T ss_dssp CCGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHC-------------CCCCCSCTTSCCEEEEEEETTEEE
T ss_pred CChHHcEEeEEEeeCcCEEEEEEEEcCCCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhCCCCeEeeEEEEEeeCCEEE
Confidence 34568999999999999999999875 68899999986432 223356778999999999999999999999999999
Q ss_pred EEEeecCCCCHHHHHhhhhccCCCccHHHHHHHHHHHHHHHHHHHh-cCCCCeEeecCCCCCEEEcCCCcEEEEecCCcc
Q 010519 259 LVYEYVNNGNLEQWLHGAMRNQGNLTWEARMKVIIGTAKALAYLHE-AIEPKVVHRDIKSSNILIDDEFNAKVSDFGLAK 337 (508)
Q Consensus 259 lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~yLH~-~~~~~iiH~Dlk~~NIll~~~~~~kl~Dfgla~ 337 (508)
+||||+++|+|.+++. ....+++..+..++.||+.||.|||+ . +|+||||||+||||+.++.+||+|||+++
T Consensus 225 lv~e~~~~~~L~~~l~----~~~~~~~~~~~~~~~qi~~aL~~LH~~~---giiHrDlkp~NIll~~~~~~kl~DFG~a~ 297 (446)
T 4ejn_A 225 FVMEYANGGELFFHLS----RERVFSEDRARFYGAEIVSALDYLHSEK---NVVYRDLKLENLMLDKDGHIKITDFGLCK 297 (446)
T ss_dssp EEECCCSSCBHHHHHH----HHSCCCHHHHHHHHHHHHHHHHHHHHHT---CCCCCCCCGGGEEECSSSCEEECCCCCCC
T ss_pred EEEeeCCCCcHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHhhcC---CEEECCCCHHHEEECCCCCEEEccCCCce
Confidence 9999999999999985 34578999999999999999999998 7 99999999999999999999999999998
Q ss_pred ccCCCCCcccccccccccccCccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCCCchhcHHHHHHHHhcccccccc
Q 010519 338 LLDSGESHITTRVMGTFGYVAPEYANTGMLNEKSDIYSFGVLLLEAVTGRDPVDYGRPANEVNLVEWLKMMVGTRRAEEV 417 (508)
Q Consensus 338 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 417 (508)
...... ......+||+.|+|||++.+..|+.++|||||||+||||++|+.||..... . ..........
T Consensus 298 ~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~---~---~~~~~i~~~~----- 365 (446)
T 4ejn_A 298 EGIKDG-ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH---E---KLFELILMEE----- 365 (446)
T ss_dssp TTCC------CCSSSCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSH---H---HHHHHHHHCC-----
T ss_pred eccCCC-cccccccCCccccCHhhcCCCCCCCccchhhhHHHHHHHhhCCCCCCCCCH---H---HHHHHHHhCC-----
Confidence 643322 224456899999999999999999999999999999999999999964321 1 1111111110
Q ss_pred cCCCCCCChhHHHHHHHHHHHHHhcCCCCCCCC-----CHHHHHHHhhcCCC
Q 010519 418 VDPNLEVKPATRALKRSLLVALRCVDPDSEKRP-----KMSQVVRMLEADDY 464 (508)
Q Consensus 418 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~evl~~L~~~~~ 464 (508)
..+. ......+.+|+.+||+.||.+|| |+.|+++|-.-...
T Consensus 366 --~~~p----~~~~~~~~~li~~~L~~dP~~R~~~~~~t~~ell~hp~f~~~ 411 (446)
T 4ejn_A 366 --IRFP----RTLGPEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQHRFFAGI 411 (446)
T ss_dssp --CCCC----TTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTSGGGTTC
T ss_pred --CCCC----ccCCHHHHHHHHHHcccCHHHhCCCCCCCHHHHHhCccccCC
Confidence 0011 11234566799999999999999 99999987665443
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-42 Score=358.35 Aligned_cols=254 Identities=21% Similarity=0.282 Sum_probs=192.2
Q ss_pred CCcccc-eeEeeeCceEEEEEEEc-CCCEEEEEEEcccchhhHHHHHHHHHHH-hcCCCCCceeEEEEEEe----Cceee
Q 010519 186 NRFSAE-NVLGEGGYGVVYKGRLI-NGSEVAVKKLLNNLGQAEKEFRVEVEAI-GHVRHKNLVRLLGYCIE----GVHRM 258 (508)
Q Consensus 186 ~~~~~~-~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~ei~~l-~~l~h~niv~~~~~~~~----~~~~~ 258 (508)
++|.+. +.||+|+||+||+|.+. ++..||||++... ..+.+|+.++ +..+||||+++++++.. ....|
T Consensus 61 ~~y~~~~~~LG~G~~g~V~~~~~~~~~~~vAiK~~~~~-----~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~~~~~~~~ 135 (400)
T 1nxk_A 61 DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-----PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLL 135 (400)
T ss_dssp GTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS-----HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEE
T ss_pred ccceeccceeeeccCeEEEEEEECCCCCEEEEEEeCcc-----hhHHHHHHHHHHhcCCCCcceEeEEEeecccCCcEEE
Confidence 456665 78999999999999876 6889999998532 3456688876 44589999999999876 56789
Q ss_pred EEEeecCCCCHHHHHhhhhccCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCEEEcC---CCcEEEEecCC
Q 010519 259 LVYEYVNNGNLEQWLHGAMRNQGNLTWEARMKVIIGTAKALAYLHEAIEPKVVHRDIKSSNILIDD---EFNAKVSDFGL 335 (508)
Q Consensus 259 lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiH~Dlk~~NIll~~---~~~~kl~Dfgl 335 (508)
|||||+++|+|.+++.. .....+++..++.++.||+.||.|||+. +|+||||||+|||++. ++.+||+|||+
T Consensus 136 lv~E~~~gg~L~~~l~~--~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~Nill~~~~~~~~~kl~DFG~ 210 (400)
T 1nxk_A 136 IVMECLDGGELFSRIQD--RGDQAFTEREASEIMKSIGEAIQYLHSI---NIAHRDVKPENLLYTSKRPNAILKLTDFGF 210 (400)
T ss_dssp EEEECCCSEEHHHHHHC--C---CCBHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSSSTTCCEEECCCTT
T ss_pred EEEEeCCCCcHHHHHHH--hCCCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCcCcceEEEecCCCCccEEEEeccc
Confidence 99999999999999963 2234699999999999999999999999 9999999999999997 78899999999
Q ss_pred ccccCCCCCcccccccccccccCccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCCCchh-cHHHHHHHHhccccc
Q 010519 336 AKLLDSGESHITTRVMGTFGYVAPEYANTGMLNEKSDIYSFGVLLLEAVTGRDPVDYGRPANEV-NLVEWLKMMVGTRRA 414 (508)
Q Consensus 336 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltG~~Pf~~~~~~~~~-~~~~~~~~~~~~~~~ 414 (508)
++...... .....+||+.|+|||++.+..|+.++|||||||+||||++|..||......... .....+. .+...
T Consensus 211 a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~i~--~~~~~- 285 (400)
T 1nxk_A 211 AKETTSHN--SLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIR--MGQYE- 285 (400)
T ss_dssp CEECC-------------CTTCCGGGSCCCCSSSHHHHHHHHHHHHHHHHSSCSCCCCTTCSSCCSHHHHHH--HTCCC-
T ss_pred ccccCCCC--ccccCCCCCCccCHhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCccccccHHHHHHHH--cCccc-
Confidence 98664332 234567899999999999999999999999999999999999999754332211 1111111 11100
Q ss_pred ccccCCCCCCChhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhhc
Q 010519 415 EEVVDPNLEVKPATRALKRSLLVALRCVDPDSEKRPKMSQVVRMLEA 461 (508)
Q Consensus 415 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~ 461 (508)
+...........+.+|+.+||+.||.+|||+.|+++|-+-
T Consensus 286 -------~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp~~ 325 (400)
T 1nxk_A 286 -------FPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWI 325 (400)
T ss_dssp -------CCTTTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSHHH
T ss_pred -------CCCcccccCCHHHHHHHHHHCCCChhHCcCHHHHhcCccc
Confidence 0000111233456779999999999999999999997654
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-43 Score=345.90 Aligned_cols=261 Identities=24% Similarity=0.408 Sum_probs=205.3
Q ss_pred hCCcccceeEeeeCceEEEEEEE-----cCCCEEEEEEEcccc-hhhHHHHHHHHHHHhcCCCCCceeEEEEEEeC--ce
Q 010519 185 TNRFSAENVLGEGGYGVVYKGRL-----INGSEVAVKKLLNNL-GQAEKEFRVEVEAIGHVRHKNLVRLLGYCIEG--VH 256 (508)
Q Consensus 185 ~~~~~~~~~lg~G~~g~Vy~~~~-----~~~~~vavK~~~~~~-~~~~~~~~~ei~~l~~l~h~niv~~~~~~~~~--~~ 256 (508)
.++|++.+.||+|+||.||+|++ .+++.||+|++.... ......+.+|+.+++.++||||+++++++.+. ..
T Consensus 20 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 99 (302)
T 4e5w_A 20 KRFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNG 99 (302)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC-----CCHHHHHHHHHHHHTCCCTTBCCEEEEEEC---CC
T ss_pred hhhhhhhhccCCCCceEEEEEEEccccCccCeEEEEEEecccccchhHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCce
Confidence 35689999999999999999984 368899999986443 23346788999999999999999999999876 66
Q ss_pred eeEEEeecCCCCHHHHHhhhhccCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCEEEcCCCcEEEEecCCc
Q 010519 257 RMLVYEYVNNGNLEQWLHGAMRNQGNLTWEARMKVIIGTAKALAYLHEAIEPKVVHRDIKSSNILIDDEFNAKVSDFGLA 336 (508)
Q Consensus 257 ~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~Dfgla 336 (508)
.++||||+++|+|.+++.. ....+++..++.++.|++.||.|||+. +|+||||||+|||++.++.+||+|||++
T Consensus 100 ~~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~kl~Dfg~~ 173 (302)
T 4e5w_A 100 IKLIMEFLPSGSLKEYLPK---NKNKINLKQQLKYAVQICKGMDYLGSR---QYVHRDLAARNVLVESEHQVKIGDFGLT 173 (302)
T ss_dssp EEEEEECCTTCBHHHHHHH---HTTTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEETTEEEECCCTTC
T ss_pred EEEEEEeCCCCcHHHHHHh---ccccCCHHHHHHHHHHHHHHHHHhhcC---CcccCCCchheEEEcCCCCEEECccccc
Confidence 7899999999999999963 345689999999999999999999999 9999999999999999999999999999
Q ss_pred cccCCCCC--cccccccccccccCccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCC---------CCchhcHHHHH
Q 010519 337 KLLDSGES--HITTRVMGTFGYVAPEYANTGMLNEKSDIYSFGVLLLEAVTGRDPVDYGR---------PANEVNLVEWL 405 (508)
Q Consensus 337 ~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltG~~Pf~~~~---------~~~~~~~~~~~ 405 (508)
........ .......||..|+|||++.+..++.++|||||||++|+|++|..|+.... ...........
T Consensus 174 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 253 (302)
T 4e5w_A 174 KAIETDKEYYTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHGQMTVTRLV 253 (302)
T ss_dssp EECCTTCCEEECCCCTTCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCGGGHHHHHH
T ss_pred ccccCCCcceeccCCCCCCccccCCeeecCCCCCcchhHHHHHHHHHHHHHccCCCcchhhHHhhccCCcccccCHHHHH
Confidence 87654432 22334567888999999999899999999999999999999999864211 01111111111
Q ss_pred HHHhcccccccccCCCCCCChhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhhc
Q 010519 406 KMMVGTRRAEEVVDPNLEVKPATRALKRSLLVALRCVDPDSEKRPKMSQVVRMLEA 461 (508)
Q Consensus 406 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~ 461 (508)
....... ....+......+.+|+.+||+.||.+|||+.++++.|+.
T Consensus 254 ~~~~~~~----------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~ 299 (302)
T 4e5w_A 254 NTLKEGK----------RLPCPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIEGFEA 299 (302)
T ss_dssp HHHHTTC----------CCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHH
T ss_pred HHHhccC----------CCCCCCCCCHHHHHHHHHHcCCCCCCCCCHHHHHHHHHH
Confidence 1111111 111112234567779999999999999999999999975
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-43 Score=366.08 Aligned_cols=250 Identities=25% Similarity=0.400 Sum_probs=206.8
Q ss_pred hCCcccceeEeeeCceEEEEEEEc-CCCEEEEEEEcccch---hhHHHHHHHHHHHhcCCCCCceeEEEEEEeCceeeEE
Q 010519 185 TNRFSAENVLGEGGYGVVYKGRLI-NGSEVAVKKLLNNLG---QAEKEFRVEVEAIGHVRHKNLVRLLGYCIEGVHRMLV 260 (508)
Q Consensus 185 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~ei~~l~~l~h~niv~~~~~~~~~~~~~lv 260 (508)
.++|.+.+.||+|+||.||+|++. +|+.||||++..... .....+.+|+.+++.++||||+++++++.+....++|
T Consensus 15 ~~~Y~l~~~LG~G~fg~V~~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lv 94 (476)
T 2y94_A 15 IGHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVISTPSDIFMV 94 (476)
T ss_dssp ETTEEEEEEEECCSSSCEEEEEETTTCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred ecCEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEE
Confidence 468999999999999999999986 789999999864321 2345788999999999999999999999999999999
Q ss_pred EeecCCCCHHHHHhhhhccCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCEEEcCCCcEEEEecCCccccC
Q 010519 261 YEYVNNGNLEQWLHGAMRNQGNLTWEARMKVIIGTAKALAYLHEAIEPKVVHRDIKSSNILIDDEFNAKVSDFGLAKLLD 340 (508)
Q Consensus 261 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~Dfgla~~~~ 340 (508)
|||+++|+|.+++. ..+.+++..++.++.||+.||.|||++ +|+||||||+|||++.++.+||+|||++....
T Consensus 95 ~E~~~gg~L~~~l~----~~~~l~~~~~~~i~~qi~~aL~~LH~~---givHrDLkp~NIll~~~~~vkL~DFG~a~~~~ 167 (476)
T 2y94_A 95 MEYVSGGELFDYIC----KNGRLDEKESRRLFQQILSGVDYCHRH---MVVHRDLKPENVLLDAHMNAKIADFGLSNMMS 167 (476)
T ss_dssp EECCSSEEHHHHTT----SSSSCCHHHHHHHHHHHHHHHHHHHTT---TEECSCCSGGGEEECTTCCEEECCCSSCEECC
T ss_pred EeCCCCCcHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHHC---CCCcccccHHHEEEecCCCeEEEeccchhhcc
Confidence 99999999999983 456799999999999999999999999 99999999999999999999999999998765
Q ss_pred CCCCcccccccccccccCccccCCCCC-CChhhHHHHHHHHHHHHhCCCCCCCCCCCchhcHHHHHHHHhcccccccccC
Q 010519 341 SGESHITTRVMGTFGYVAPEYANTGML-NEKSDIYSFGVLLLEAVTGRDPVDYGRPANEVNLVEWLKMMVGTRRAEEVVD 419 (508)
Q Consensus 341 ~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DvwS~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 419 (508)
... .....+||+.|+|||++.+..+ +.++|||||||++|+|++|..||...... ..........
T Consensus 168 ~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~------~~~~~i~~~~------- 232 (476)
T 2y94_A 168 DGE--FLRTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDHVP------TLFKKICDGI------- 232 (476)
T ss_dssp TTC--CBCCCCSCSTTCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSSCCSSSH------HHHHHHHTTC-------
T ss_pred ccc--cccccCCCcCeEChhhccCCCCCCCcceehhhHHHHHHHhhCCCCCCCCCHH------HHHHHHhcCC-------
Confidence 433 2344679999999999988765 68999999999999999999999743221 1122222111
Q ss_pred CCCCCChhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhh
Q 010519 420 PNLEVKPATRALKRSLLVALRCVDPDSEKRPKMSQVVRMLE 460 (508)
Q Consensus 420 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 460 (508)
... +......+.+|+.+||+.||.+|||+.|+++|-+
T Consensus 233 --~~~--p~~~s~~~~~Li~~~L~~dP~~Rpt~~eil~hp~ 269 (476)
T 2y94_A 233 --FYT--PQYLNPSVISLLKHMLQVDPMKRATIKDIREHEW 269 (476)
T ss_dssp --CCC--CTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTCHH
T ss_pred --cCC--CccCCHHHHHHHHHHcCCCchhCcCHHHHHhCHH
Confidence 010 1112345667999999999999999999998643
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-43 Score=352.40 Aligned_cols=257 Identities=27% Similarity=0.439 Sum_probs=200.6
Q ss_pred hCCcccceeEeeeCceEEEEEEEc-CCCE----EEEEEEcccc-hhhHHHHHHHHHHHhcCCCCCceeEEEEEEeCceee
Q 010519 185 TNRFSAENVLGEGGYGVVYKGRLI-NGSE----VAVKKLLNNL-GQAEKEFRVEVEAIGHVRHKNLVRLLGYCIEGVHRM 258 (508)
Q Consensus 185 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~----vavK~~~~~~-~~~~~~~~~ei~~l~~l~h~niv~~~~~~~~~~~~~ 258 (508)
.++|.+.+.||+|+||+||+|++. ++.. ||+|.+.... ......+.+|+.+++.++||||+++++++. +...+
T Consensus 12 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~ 90 (325)
T 3kex_A 12 ETELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRLLGLCP-GSSLQ 90 (325)
T ss_dssp TTTEEEEEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTTSCSCBCSCCHHHHHHHTCCCTTBCCEEEEEC-BSSEE
T ss_pred HhHceeeeeeeecCCceEEEEEEcCCCceEEEEEEEEeccccccHHHHHHHHHHHHHHhcCCCCCcCeEEEEEc-CCccE
Confidence 468999999999999999999875 3443 7777764332 222245677999999999999999999886 45688
Q ss_pred EEEeecCCCCHHHHHhhhhccCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCEEEcCCCcEEEEecCCccc
Q 010519 259 LVYEYVNNGNLEQWLHGAMRNQGNLTWEARMKVIIGTAKALAYLHEAIEPKVVHRDIKSSNILIDDEFNAKVSDFGLAKL 338 (508)
Q Consensus 259 lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~Dfgla~~ 338 (508)
+||||+.+|+|.+++.. ....+++..++.++.||+.||.|||+. +|+||||||+|||++.++.+||+|||+++.
T Consensus 91 ~v~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~ 164 (325)
T 3kex_A 91 LVTQYLPLGSLLDHVRQ---HRGALGPQLLLNWGVQIAKGMYYLEEH---GMVHRNLAARNVLLKSPSQVQVADFGVADL 164 (325)
T ss_dssp EEEECCTTCBSHHHHHS---SGGGSCTTHHHHHHHHHHHHHHHHHHT---TCCCSCCSSTTEEESSSSCEEECSCSGGGG
T ss_pred EEEEeCCCCCHHHHHHH---ccccCCHHHHHHHHHHHHHHHHHHHhC---CCCCCccchheEEECCCCeEEECCCCcccc
Confidence 99999999999999963 345788999999999999999999999 999999999999999999999999999997
Q ss_pred cCCCCCc-ccccccccccccCccccCCCCCCChhhHHHHHHHHHHHHh-CCCCCCCCCCCchhcHHHHHHHHhccccccc
Q 010519 339 LDSGESH-ITTRVMGTFGYVAPEYANTGMLNEKSDIYSFGVLLLEAVT-GRDPVDYGRPANEVNLVEWLKMMVGTRRAEE 416 (508)
Q Consensus 339 ~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 416 (508)
....... ......+++.|+|||++.+..++.++|||||||++|+|++ |..||....... .... ......
T Consensus 165 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~---~~~~---~~~~~~--- 235 (325)
T 3kex_A 165 LPPDDKQLLYSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRLAE---VPDL---LEKGER--- 235 (325)
T ss_dssp SCCCTTCCC-----CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCTTH---HHHH---HHTTCB---
T ss_pred cCcccccccccCCCCcccccChHHhccCCCChhhHhHHhHHHHHHHHhCCCCCccccCHHH---HHHH---HHcCCC---
Confidence 7543322 2344567889999999998999999999999999999999 999997543321 1111 111111
Q ss_pred ccCCCCCCChhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhhcCCC
Q 010519 417 VVDPNLEVKPATRALKRSLLVALRCVDPDSEKRPKMSQVVRMLEADDY 464 (508)
Q Consensus 417 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~ 464 (508)
...+. .....+.+++.+||+.||.+|||+.+++++|+....
T Consensus 236 ~~~~~-------~~~~~~~~li~~~l~~dp~~Rps~~el~~~l~~~~~ 276 (325)
T 3kex_A 236 LAQPQ-------ICTIDVYMVMVKCWMIDENIRPTFKELANEFTRMAR 276 (325)
T ss_dssp CCCCT-------TBCTTTTHHHHHHTCSCTTTSCCHHHHHHHHHHHTT
T ss_pred CCCCC-------cCcHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHh
Confidence 00010 112245568999999999999999999999987643
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.1e-43 Score=342.27 Aligned_cols=254 Identities=26% Similarity=0.348 Sum_probs=200.3
Q ss_pred CCcccceeEeeeCceEEEEEEEc-CCCEEEEEEEcccc-hhhHHHHHHHHHHHhcCCCCCceeEEEEEEeCceeeEEEee
Q 010519 186 NRFSAENVLGEGGYGVVYKGRLI-NGSEVAVKKLLNNL-GQAEKEFRVEVEAIGHVRHKNLVRLLGYCIEGVHRMLVYEY 263 (508)
Q Consensus 186 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~ei~~l~~l~h~niv~~~~~~~~~~~~~lv~E~ 263 (508)
++|.+.+.||+|+||+||++... ++..+|+|++.... ......+.+|+.+++.++||||+++++++.+....++||||
T Consensus 22 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~ 101 (285)
T 3is5_A 22 DLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEVFEDYHNMYIVMET 101 (285)
T ss_dssp HHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEECC
T ss_pred hheeecceeccCCCeEEEEEEEccCCceEEEEEeeccccchhHHHHHHHHHHHHhCCCchHHhHHHheecCCeEEEEEEe
Confidence 57999999999999999999875 68899999986543 33456788999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhhhhccCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCEEE---cCCCcEEEEecCCccccC
Q 010519 264 VNNGNLEQWLHGAMRNQGNLTWEARMKVIIGTAKALAYLHEAIEPKVVHRDIKSSNILI---DDEFNAKVSDFGLAKLLD 340 (508)
Q Consensus 264 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiH~Dlk~~NIll---~~~~~~kl~Dfgla~~~~ 340 (508)
+++|+|.+++.........+++..++.++.||+.||.|||+. +|+||||||+|||+ +.++.+||+|||++....
T Consensus 102 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~dikp~NIl~~~~~~~~~~kl~Dfg~a~~~~ 178 (285)
T 3is5_A 102 CEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQ---HVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFK 178 (285)
T ss_dssp CSCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEESSSSTTCCEEECCCCCCCC--
T ss_pred CCCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHHhC---CEEECCCCHHHEEEecCCCCCCEEEEeeecceecC
Confidence 999999999976555567899999999999999999999999 99999999999999 556789999999998665
Q ss_pred CCCCcccccccccccccCccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCCCchhcHHHHHHHHhcccccccccCC
Q 010519 341 SGESHITTRVMGTFGYVAPEYANTGMLNEKSDIYSFGVLLLEAVTGRDPVDYGRPANEVNLVEWLKMMVGTRRAEEVVDP 420 (508)
Q Consensus 341 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 420 (508)
... ......||+.|+|||++.+ .++.++|||||||++|+|++|+.||..... ........... +
T Consensus 179 ~~~--~~~~~~~t~~y~aPE~~~~-~~~~~~Di~slG~il~~ll~g~~pf~~~~~------~~~~~~~~~~~-------~ 242 (285)
T 3is5_A 179 SDE--HSTNAAGTALYMAPEVFKR-DVTFKCDIWSAGVVMYFLLTGCLPFTGTSL------EEVQQKATYKE-------P 242 (285)
T ss_dssp ----------CTTGGGCCHHHHTT-CCCHHHHHHHHHHHHHHHHHSSCSSCCSSH------HHHHHHHHHCC-------C
T ss_pred Ccc--cCcCcccccCcCChHHhcc-CCCcccCeehHHHHHHHHHhCCCCCCCCCH------HHHHhhhccCC-------c
Confidence 432 2344578999999999864 689999999999999999999999964321 11111111000 0
Q ss_pred CCCCChhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHh
Q 010519 421 NLEVKPATRALKRSLLVALRCVDPDSEKRPKMSQVVRML 459 (508)
Q Consensus 421 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L 459 (508)
..... .......+.+|+.+||+.||.+|||+.|++++-
T Consensus 243 ~~~~~-~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~hp 280 (285)
T 3is5_A 243 NYAVE-CRPLTPQAVDLLKQMLTKDPERRPSAAQVLHHE 280 (285)
T ss_dssp CCCC---CCCCHHHHHHHHHHTCSCTTTSCCHHHHHTSG
T ss_pred ccccc-cCcCCHHHHHHHHHHccCChhhCcCHHHHhcCH
Confidence 00000 000134566799999999999999999999753
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-42 Score=343.51 Aligned_cols=261 Identities=26% Similarity=0.394 Sum_probs=200.1
Q ss_pred hCCcccceeEeeeCceEEEEEEEc-CCCEEEEEEEccc---chhhHHHHHHHHHHHhcCCCCCceeEEEEEEeCceeeEE
Q 010519 185 TNRFSAENVLGEGGYGVVYKGRLI-NGSEVAVKKLLNN---LGQAEKEFRVEVEAIGHVRHKNLVRLLGYCIEGVHRMLV 260 (508)
Q Consensus 185 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~ei~~l~~l~h~niv~~~~~~~~~~~~~lv 260 (508)
.++|.+.+.||+|+||.||+|.+. +|..||+|++... .......+.+|+.+++.++||||+++++++......++|
T Consensus 31 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv 110 (310)
T 2wqm_A 31 LANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIV 110 (310)
T ss_dssp GGGEEEEEEEECC--CEEEEEEETTTCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEE
T ss_pred ccceEEEEeecCCCCceEEEEEEcCCCceEEEEeeehhhccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCcEEEE
Confidence 357999999999999999999874 7899999998642 234456788899999999999999999999999999999
Q ss_pred EeecCCCCHHHHHhhhhccCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCEEEcCCCcEEEEecCCccccC
Q 010519 261 YEYVNNGNLEQWLHGAMRNQGNLTWEARMKVIIGTAKALAYLHEAIEPKVVHRDIKSSNILIDDEFNAKVSDFGLAKLLD 340 (508)
Q Consensus 261 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~Dfgla~~~~ 340 (508)
|||+++|+|.+++.........+++..++.++.||+.||.|||+. +++|+||||+|||++.++.+||+|||++....
T Consensus 111 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dl~p~NIl~~~~~~~kl~Dfg~~~~~~ 187 (310)
T 2wqm_A 111 LELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSR---RVMHRDIKPANVFITATGVVKLGDLGLGRFFS 187 (310)
T ss_dssp EECCCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCC-------
T ss_pred EecCCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHhhC---CeeCCCCcHHHEEEcCCCCEEEEeccceeeec
Confidence 999999999999976555567799999999999999999999999 99999999999999999999999999998664
Q ss_pred CCCCcccccccccccccCccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCCCchhcHHHHHHHHhcccccccccCC
Q 010519 341 SGESHITTRVMGTFGYVAPEYANTGMLNEKSDIYSFGVLLLEAVTGRDPVDYGRPANEVNLVEWLKMMVGTRRAEEVVDP 420 (508)
Q Consensus 341 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 420 (508)
.... ......|++.|+|||++.+..++.++||||||+++|+|++|..||..... ............ .. +
T Consensus 188 ~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~----~~~~~~~~~~~~-~~-----~ 256 (310)
T 2wqm_A 188 SKTT-AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKM----NLYSLCKKIEQC-DY-----P 256 (310)
T ss_dssp ------------CCSSCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTC---C----CHHHHHHHHHTT-CS-----C
T ss_pred CCCc-cccccCCCeeEeChHHhCCCCCCchhhHHHHHHHHHHHHhCCCCCcccch----hHHHHHHHhhcc-cC-----C
Confidence 3322 23345689999999999999999999999999999999999999964322 112222222111 11 1
Q ss_pred CCCCChhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhhcC
Q 010519 421 NLEVKPATRALKRSLLVALRCVDPDSEKRPKMSQVVRMLEAD 462 (508)
Q Consensus 421 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~ 462 (508)
... .......+.+++.+||+.||.+|||+.+|+++|+..
T Consensus 257 ~~~---~~~~~~~l~~li~~~l~~dp~~Rps~~~il~~l~~l 295 (310)
T 2wqm_A 257 PLP---SDHYSEELRQLVNMCINPDPEKRPDVTYVYDVAKRM 295 (310)
T ss_dssp CCC---TTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred CCc---ccccCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHH
Confidence 111 112234566799999999999999999999999764
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-42 Score=350.88 Aligned_cols=262 Identities=23% Similarity=0.240 Sum_probs=202.2
Q ss_pred HhhCCcccceeEeeeCceEEEEEEEc-CCCEEEEEEEcccc-----hhhHHHHHHHHHHHhcCCCCCceeEEEEEEeCce
Q 010519 183 IATNRFSAENVLGEGGYGVVYKGRLI-NGSEVAVKKLLNNL-----GQAEKEFRVEVEAIGHVRHKNLVRLLGYCIEGVH 256 (508)
Q Consensus 183 ~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-----~~~~~~~~~ei~~l~~l~h~niv~~~~~~~~~~~ 256 (508)
...++|.+.+.||+|+||+||+|.+. ++..||+|++.... ......+.+|+.++++++||||+++++++.+...
T Consensus 23 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~ 102 (345)
T 3hko_A 23 ELQKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYEDEQY 102 (345)
T ss_dssp HHHHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSE
T ss_pred hhhhheeecceeeecCCeEEEEEEECCCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCCCCcceeehhhccCCe
Confidence 34568999999999999999999875 67889999885432 2344678899999999999999999999999999
Q ss_pred eeEEEeecCCCCHHHHHhhhhcc------------------------------------CCCccHHHHHHHHHHHHHHHH
Q 010519 257 RMLVYEYVNNGNLEQWLHGAMRN------------------------------------QGNLTWEARMKVIIGTAKALA 300 (508)
Q Consensus 257 ~~lv~E~~~~gsL~~~l~~~~~~------------------------------------~~~l~~~~~~~i~~~i~~al~ 300 (508)
.++||||+++|+|.+++...... ...+++..++.++.||+.||.
T Consensus 103 ~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~ 182 (345)
T 3hko_A 103 ICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALH 182 (345)
T ss_dssp EEEEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHHHHHHHH
T ss_pred EEEEEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHHHHH
Confidence 99999999999999998521111 122467788999999999999
Q ss_pred HHHhcCCCCeEeecCCCCCEEEcCCC--cEEEEecCCccccCCCC---CcccccccccccccCccccCC--CCCCChhhH
Q 010519 301 YLHEAIEPKVVHRDIKSSNILIDDEF--NAKVSDFGLAKLLDSGE---SHITTRVMGTFGYVAPEYANT--GMLNEKSDI 373 (508)
Q Consensus 301 yLH~~~~~~iiH~Dlk~~NIll~~~~--~~kl~Dfgla~~~~~~~---~~~~~~~~gt~~y~aPE~~~~--~~~~~~~Dv 373 (508)
|||+. +|+||||||+|||++.++ .+||+|||++....... ........||+.|+|||++.+ ..++.++||
T Consensus 183 ~LH~~---~ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Di 259 (345)
T 3hko_A 183 YLHNQ---GICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCDA 259 (345)
T ss_dssp HHHHT---TEECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC--------CCCGGGCCHHHHTCSSSCCCTHHHH
T ss_pred HHHHC---CccccCCChhhEEEecCCCceEEEeeccccccccccCccccccccccCCCccccCchhhccCCCCCCcHHHH
Confidence 99999 999999999999998776 89999999998653321 112345679999999999965 678999999
Q ss_pred HHHHHHHHHHHhCCCCCCCCCCCchhcHHHHHHHHhcccccccccCCCCCCChhHHHHHHHHHHHHHhcCCCCCCCCCHH
Q 010519 374 YSFGVLLLEAVTGRDPVDYGRPANEVNLVEWLKMMVGTRRAEEVVDPNLEVKPATRALKRSLLVALRCVDPDSEKRPKMS 453 (508)
Q Consensus 374 wS~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ 453 (508)
|||||+||||++|+.||...... +......... ..+...........+.+|+.+||+.||.+|||+.
T Consensus 260 wslG~il~el~~g~~pf~~~~~~------~~~~~~~~~~-------~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ 326 (345)
T 3hko_A 260 WSAGVLLHLLLMGAVPFPGVNDA------DTISQVLNKK-------LCFENPNYNVLSPLARDLLSNLLNRNVDERFDAM 326 (345)
T ss_dssp HHHHHHHHHHHHSSCSSCCSSHH------HHHHHHHHCC-------CCTTSGGGGGSCHHHHHHHHHHSCSCTTTSCCHH
T ss_pred HHHHHHHHHHHHCCCCCCCCChH------HHHHHHHhcc-------cccCCcccccCCHHHHHHHHHHcCCChhHCCCHH
Confidence 99999999999999999643211 1111221111 0111111122345677799999999999999999
Q ss_pred HHHHHhh
Q 010519 454 QVVRMLE 460 (508)
Q Consensus 454 evl~~L~ 460 (508)
+++++-+
T Consensus 327 ~~l~hp~ 333 (345)
T 3hko_A 327 RALQHPW 333 (345)
T ss_dssp HHHHSHH
T ss_pred HHhcChh
Confidence 9998654
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-43 Score=351.70 Aligned_cols=266 Identities=24% Similarity=0.350 Sum_probs=210.2
Q ss_pred hCCcccceeEeeeCceEEEEEEE-----cCCCEEEEEEEcccchhhHHHHHHHHHHHhcCCCCCceeEEEEEEe--Ccee
Q 010519 185 TNRFSAENVLGEGGYGVVYKGRL-----INGSEVAVKKLLNNLGQAEKEFRVEVEAIGHVRHKNLVRLLGYCIE--GVHR 257 (508)
Q Consensus 185 ~~~~~~~~~lg~G~~g~Vy~~~~-----~~~~~vavK~~~~~~~~~~~~~~~ei~~l~~l~h~niv~~~~~~~~--~~~~ 257 (508)
.++|.+.+.||+|+||.||+|++ .++..||||++........+.+.+|+.++++++||||+++++++.. ....
T Consensus 22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 101 (327)
T 3lxl_A 22 ERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYRGVSYGPGRQSL 101 (327)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSSCEE
T ss_pred hhhhhhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccCCHHHHHHHHHHHHHHHhcCCCceeEEEEEEecCCCceE
Confidence 46899999999999999999985 3678899999977766666789999999999999999999999874 4668
Q ss_pred eEEEeecCCCCHHHHHhhhhccCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCEEEcCCCcEEEEecCCcc
Q 010519 258 MLVYEYVNNGNLEQWLHGAMRNQGNLTWEARMKVIIGTAKALAYLHEAIEPKVVHRDIKSSNILIDDEFNAKVSDFGLAK 337 (508)
Q Consensus 258 ~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~Dfgla~ 337 (508)
++||||+++++|.+++.. ....+++..++.++.||+.||.|||+. +|+||||||+|||++.++.+||+|||++.
T Consensus 102 ~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~ 175 (327)
T 3lxl_A 102 RLVMEYLPSGCLRDFLQR---HRARLDASRLLLYSSQICKGMEYLGSR---RCVHRDLAARNILVESEAHVKIADFGLAK 175 (327)
T ss_dssp EEEEECCTTCBHHHHHHH---HGGGCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEETTEEEECCGGGCE
T ss_pred EEEEeecCCCCHHHHHHh---cccCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCChhhEEECCCCCEEEcccccce
Confidence 899999999999999963 234689999999999999999999999 99999999999999999999999999998
Q ss_pred ccCCCCCc--ccccccccccccCccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCCC---------chhcHHHHHH
Q 010519 338 LLDSGESH--ITTRVMGTFGYVAPEYANTGMLNEKSDIYSFGVLLLEAVTGRDPVDYGRPA---------NEVNLVEWLK 406 (508)
Q Consensus 338 ~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltG~~Pf~~~~~~---------~~~~~~~~~~ 406 (508)
........ ......+|+.|+|||++.+..++.++|||||||++|+|++|..||...... ..........
T Consensus 176 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 255 (327)
T 3lxl_A 176 LLPLDKDYYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCERDVPALSRLLE 255 (327)
T ss_dssp ECCTTCSEEECSSCCCSCGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHCC----CCHHHHHHH
T ss_pred ecccCCccceeeccCCccccccCHHHhccCCCChHHhHHHHHHHHHHHHhCCCCCccccchhhhhcccccccccHHHHHH
Confidence 76543321 223346788899999999988999999999999999999999998532110 0000011111
Q ss_pred HHhcccccccccCCCCCCChhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhhcCCCCC
Q 010519 407 MMVGTRRAEEVVDPNLEVKPATRALKRSLLVALRCVDPDSEKRPKMSQVVRMLEADDYPF 466 (508)
Q Consensus 407 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~~ 466 (508)
... .......+......+.+|+.+||+.||.+|||+.+++++|+......
T Consensus 256 ~~~----------~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~~ 305 (327)
T 3lxl_A 256 LLE----------EGQRLPAPPACPAEVHELMKLCWAPSPQDRPSFSALGPQLDMLWSGS 305 (327)
T ss_dssp HHH----------TTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHC----
T ss_pred Hhh----------cccCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhhh
Confidence 111 11111112223456677999999999999999999999999876543
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-43 Score=339.60 Aligned_cols=252 Identities=24% Similarity=0.344 Sum_probs=203.1
Q ss_pred hhCCcccceeEeeeCceEEEEEEEcCCCEEEEEEEcccc--hhhHHHHHHHHHHHhcCCCCCceeEEEEEEeC--ceeeE
Q 010519 184 ATNRFSAENVLGEGGYGVVYKGRLINGSEVAVKKLLNNL--GQAEKEFRVEVEAIGHVRHKNLVRLLGYCIEG--VHRML 259 (508)
Q Consensus 184 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~--~~~~~~~~~ei~~l~~l~h~niv~~~~~~~~~--~~~~l 259 (508)
..++|.+.+.||+|+||+||+|++ ++..||+|++.... ....+.+.+|+.++++++||||+++++++.+. ...++
T Consensus 8 ~~~~y~~~~~lg~G~~g~V~~~~~-~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~l 86 (271)
T 3kmu_A 8 DFKQLNFLTKLNENHSGELWKGRW-QGNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPAPHPTL 86 (271)
T ss_dssp CGGGCEEEEEEEEETTEEEEEEEE-TTEEEEEEEECCTTCCHHHHHHHHHHGGGGCCCSCTTEECEEEEECTTTSSSCEE
T ss_pred CHHHhHHHHHhcCCCcceEEEEEE-CCeeEEEEEecccccCHHHHHHHHHHHHHHHhcCCCchhheEEEEccCCCCCeEe
Confidence 346899999999999999999998 58899999986543 34456789999999999999999999999877 77899
Q ss_pred EEeecCCCCHHHHHhhhhccCCCccHHHHHHHHHHHHHHHHHHHhcCCCC--eEeecCCCCCEEEcCCCcEEEEecCCcc
Q 010519 260 VYEYVNNGNLEQWLHGAMRNQGNLTWEARMKVIIGTAKALAYLHEAIEPK--VVHRDIKSSNILIDDEFNAKVSDFGLAK 337 (508)
Q Consensus 260 v~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~--iiH~Dlk~~NIll~~~~~~kl~Dfgla~ 337 (508)
||||+++|+|.+++.. .....+++..++.++.||+.||.|||+. + ++||||||+|||++.++.++|+|||++.
T Consensus 87 v~e~~~~~~L~~~l~~--~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~~~i~H~dikp~Nil~~~~~~~~l~~~~~~~ 161 (271)
T 3kmu_A 87 ITHWMPYGSLYNVLHE--GTNFVVDQSQAVKFALDMARGMAFLHTL---EPLIPRHALNSRSVMIDEDMTARISMADVKF 161 (271)
T ss_dssp EEECCTTCBHHHHHHS--CSSCCCCHHHHHHHHHHHHHHHHHHTTS---SSCCTTCCCSGGGEEECTTSCEEEEGGGSCC
T ss_pred eecccCCCcHHHHHhh--cccCCCCHHHHHHHHHHHHHHHHHHhcC---CCceecCCCccceEEEcCCcceeEEecccee
Confidence 9999999999999963 2233689999999999999999999997 7 9999999999999999999999999876
Q ss_pred ccCCCCCcccccccccccccCccccCCCCCCC---hhhHHHHHHHHHHHHhCCCCCCCCCCCchhcHHHHHHHHhccccc
Q 010519 338 LLDSGESHITTRVMGTFGYVAPEYANTGMLNE---KSDIYSFGVLLLEAVTGRDPVDYGRPANEVNLVEWLKMMVGTRRA 414 (508)
Q Consensus 338 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~---~~DvwS~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~ 414 (508)
.... ....||+.|+|||++.+..++. ++|||||||++|||++|+.||..... ............
T Consensus 162 ~~~~------~~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~------~~~~~~~~~~~~- 228 (271)
T 3kmu_A 162 SFQS------PGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSN------MEIGMKVALEGL- 228 (271)
T ss_dssp TTSC------TTCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSCTTTTSCH------HHHHHHHHHSCC-
T ss_pred eecc------cCccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCccccCh------HHHHHHHHhcCC-
Confidence 5332 2346899999999998765554 89999999999999999999964321 111111111110
Q ss_pred ccccCCCCCCChhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhhcC
Q 010519 415 EEVVDPNLEVKPATRALKRSLLVALRCVDPDSEKRPKMSQVVRMLEAD 462 (508)
Q Consensus 415 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~ 462 (508)
.+.. +......+.+++.+||+.||.+|||+.++++.|+..
T Consensus 229 ----~~~~----~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~L~~l 268 (271)
T 3kmu_A 229 ----RPTI----PPGISPHVSKLMKICMNEDPAKRPKFDMIVPILEKM 268 (271)
T ss_dssp ----CCCC----CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred ----CCCC----CCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHh
Confidence 0111 112234567799999999999999999999999864
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.9e-43 Score=340.59 Aligned_cols=251 Identities=25% Similarity=0.395 Sum_probs=184.3
Q ss_pred CCcccceeEeeeCceEEEEEEEc-CCCEEEEEEEcccch---hhHHHHHHHHHHHhcCCCCCceeEEEEEEeCceeeEEE
Q 010519 186 NRFSAENVLGEGGYGVVYKGRLI-NGSEVAVKKLLNNLG---QAEKEFRVEVEAIGHVRHKNLVRLLGYCIEGVHRMLVY 261 (508)
Q Consensus 186 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~ei~~l~~l~h~niv~~~~~~~~~~~~~lv~ 261 (508)
++|.+.+.||+|+||.||+|++. +|+.||+|.+..... .....+.+|+.+++.++||||+++++++.+....++||
T Consensus 11 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 90 (278)
T 3cok_A 11 EDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYFEDSNYVYLVL 90 (278)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTBCCTTBCCEEEEEECSSEEEEEE
T ss_pred ccceeeeeecCCCceEEEEEEEccCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhCCCCCeEeEEEEEccCCeEEEEE
Confidence 57999999999999999999874 789999999854321 22367888999999999999999999999999999999
Q ss_pred eecCCCCHHHHHhhhhccCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCEEEcCCCcEEEEecCCccccCC
Q 010519 262 EYVNNGNLEQWLHGAMRNQGNLTWEARMKVIIGTAKALAYLHEAIEPKVVHRDIKSSNILIDDEFNAKVSDFGLAKLLDS 341 (508)
Q Consensus 262 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~ 341 (508)
||+++++|.+++. .....+++..++.++.|++.||.|||+. +++|+||||+|||++.++.+||+|||++.....
T Consensus 91 e~~~~~~L~~~l~---~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~ 164 (278)
T 3cok_A 91 EMCHNGEMNRYLK---NRVKPFSENEARHFMHQIITGMLYLHSH---GILHRDLTLSNLLLTRNMNIKIADFGLATQLKM 164 (278)
T ss_dssp ECCTTEEHHHHHH---TCSSCCCHHHHHHHHHHHHHHHHHHHHT---TEECSSCCGGGEEECTTCCEEECCCTTCEECC-
T ss_pred ecCCCCcHHHHHh---hccCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCCEEEEeecceeeccC
Confidence 9999999999986 3346789999999999999999999999 999999999999999999999999999987653
Q ss_pred CCCcccccccccccccCccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCCCchhcHHHHHHHHhcccccccccCCC
Q 010519 342 GESHITTRVMGTFGYVAPEYANTGMLNEKSDIYSFGVLLLEAVTGRDPVDYGRPANEVNLVEWLKMMVGTRRAEEVVDPN 421 (508)
Q Consensus 342 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 421 (508)
... ......||+.|+|||++.+..++.++||||||+++|+|++|+.||......... .. .....
T Consensus 165 ~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~------~~---------~~~~~ 228 (278)
T 3cok_A 165 PHE-KHYTLCGTPNYISPEIATRSAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKNTL------NK---------VVLAD 228 (278)
T ss_dssp ----------------------------CTHHHHHHHHHHHHHHSSCSSCCCSCC--------------------CCSSC
T ss_pred CCC-cceeccCCCCcCCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCChhHHHHH------HH---------Hhhcc
Confidence 322 123456899999999999999999999999999999999999999754322111 00 00011
Q ss_pred CCCChhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhh
Q 010519 422 LEVKPATRALKRSLLVALRCVDPDSEKRPKMSQVVRMLE 460 (508)
Q Consensus 422 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 460 (508)
... +......+.+++.+||+.||.+|||+.+++++-.
T Consensus 229 ~~~--~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~ 265 (278)
T 3cok_A 229 YEM--PSFLSIEAKDLIHQLLRRNPADRLSLSSVLDHPF 265 (278)
T ss_dssp CCC--CTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTSTT
T ss_pred cCC--ccccCHHHHHHHHHHcccCHhhCCCHHHHhcCcc
Confidence 111 1112345667999999999999999999997543
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-42 Score=344.38 Aligned_cols=255 Identities=24% Similarity=0.336 Sum_probs=207.9
Q ss_pred hCCcccceeEeeeCceEEEEEEEc-CCCEEEEEEEcccch------hhHHHHHHHHHHHhcCCCCCceeEEEEEEeCcee
Q 010519 185 TNRFSAENVLGEGGYGVVYKGRLI-NGSEVAVKKLLNNLG------QAEKEFRVEVEAIGHVRHKNLVRLLGYCIEGVHR 257 (508)
Q Consensus 185 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~------~~~~~~~~ei~~l~~l~h~niv~~~~~~~~~~~~ 257 (508)
.++|.+.+.||+|+||.||+|++. +|..||+|.+..... .....+.+|+.+++.++||||+++++++.+....
T Consensus 11 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 90 (321)
T 2a2a_A 11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYENRTDV 90 (321)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred hccEEEeeEeeecCCEEEEEEEECCCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEE
Confidence 357999999999999999999986 688999999865432 1356788999999999999999999999999999
Q ss_pred eEEEeecCCCCHHHHHhhhhccCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCEEEcCCC----cEEEEec
Q 010519 258 MLVYEYVNNGNLEQWLHGAMRNQGNLTWEARMKVIIGTAKALAYLHEAIEPKVVHRDIKSSNILIDDEF----NAKVSDF 333 (508)
Q Consensus 258 ~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiH~Dlk~~NIll~~~~----~~kl~Df 333 (508)
++||||+++++|.+++. ....+++..++.++.|++.||.|||+. +|+||||||+|||++.++ .+||+||
T Consensus 91 ~lv~e~~~~~~L~~~l~----~~~~~~~~~~~~i~~qi~~aL~~lH~~---~ivH~dikp~NIl~~~~~~~~~~~kl~Df 163 (321)
T 2a2a_A 91 VLILELVSGGELFDFLA----QKESLSEEEATSFIKQILDGVNYLHTK---KIAHFDLKPENIMLLDKNIPIPHIKLIDF 163 (321)
T ss_dssp EEEECCCCSCBHHHHHH----TCSCEEHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESCTTSSSCCEEECCC
T ss_pred EEEEEcCCCCcHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCChHHEEEecCCCCcCCEEEccC
Confidence 99999999999999994 456799999999999999999999999 999999999999999888 7999999
Q ss_pred CCccccCCCCCcccccccccccccCccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCCCchhcHHHHHHHHhcccc
Q 010519 334 GLAKLLDSGESHITTRVMGTFGYVAPEYANTGMLNEKSDIYSFGVLLLEAVTGRDPVDYGRPANEVNLVEWLKMMVGTRR 413 (508)
Q Consensus 334 gla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~ 413 (508)
|++....... ......||+.|+|||++.+..++.++|||||||++|+|++|..||..... .+.+.......
T Consensus 164 g~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~------~~~~~~i~~~~- 234 (321)
T 2a2a_A 164 GLAHEIEDGV--EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTK------QETLANITSVS- 234 (321)
T ss_dssp TTCEECCTTC--CCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSH------HHHHHHHHTTC-
T ss_pred ccceecCccc--cccccCCCCCccCcccccCCCCCCccccHHHHHHHHHHHHCCCCCCCCCH------HHHHHHHHhcc-
Confidence 9998765432 23445789999999999999999999999999999999999999964321 11122211110
Q ss_pred cccccCCCCCCChhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhhc
Q 010519 414 AEEVVDPNLEVKPATRALKRSLLVALRCVDPDSEKRPKMSQVVRMLEA 461 (508)
Q Consensus 414 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~ 461 (508)
..+...........+.+|+.+||+.||.+|||+.|++++-.-
T Consensus 235 ------~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~hp~~ 276 (321)
T 2a2a_A 235 ------YDFDEEFFSHTSELAKDFIRKLLVKETRKRLTIQEALRHPWI 276 (321)
T ss_dssp ------CCCCHHHHTTCCHHHHHHHHTTSCSSTTTSCCHHHHHHSTTT
T ss_pred ------cccChhhhcccCHHHHHHHHHHcCCChhhCcCHHHHhcCccc
Confidence 000000011223456779999999999999999999986543
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-43 Score=343.21 Aligned_cols=257 Identities=25% Similarity=0.394 Sum_probs=206.7
Q ss_pred hhCCcccce-eEeeeCceEEEEEEEc---CCCEEEEEEEcccc-hhhHHHHHHHHHHHhcCCCCCceeEEEEEEeCceee
Q 010519 184 ATNRFSAEN-VLGEGGYGVVYKGRLI---NGSEVAVKKLLNNL-GQAEKEFRVEVEAIGHVRHKNLVRLLGYCIEGVHRM 258 (508)
Q Consensus 184 ~~~~~~~~~-~lg~G~~g~Vy~~~~~---~~~~vavK~~~~~~-~~~~~~~~~ei~~l~~l~h~niv~~~~~~~~~~~~~ 258 (508)
..++|.+.+ .||+|+||.||+|.+. ++..||+|.+.... ......+.+|+.+++.++||||+++++++ .....+
T Consensus 7 ~~~~~~i~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~-~~~~~~ 85 (287)
T 1u59_A 7 KRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVC-QAEALM 85 (287)
T ss_dssp CGGGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEE-ESSSEE
T ss_pred cHHHhhhhhccccccCceeEEEeEeccCCCcceEEEEecCCccchhHHHHHHHHHHHHHhCCCCCEeEEEEEe-cCCCcE
Confidence 345677776 9999999999999863 57789999987643 34456788999999999999999999999 556689
Q ss_pred EEEeecCCCCHHHHHhhhhccCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCEEEcCCCcEEEEecCCccc
Q 010519 259 LVYEYVNNGNLEQWLHGAMRNQGNLTWEARMKVIIGTAKALAYLHEAIEPKVVHRDIKSSNILIDDEFNAKVSDFGLAKL 338 (508)
Q Consensus 259 lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~Dfgla~~ 338 (508)
+||||+++++|.+++. .....+++..++.++.|++.||.|||+. +|+||||||+|||++.++.+||+|||++..
T Consensus 86 lv~e~~~~~~L~~~l~---~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~kl~Dfg~~~~ 159 (287)
T 1u59_A 86 LVMEMAGGGPLHKFLV---GKREEIPVSNVAELLHQVSMGMKYLEEK---NFVHRDLAARNVLLVNRHYAKISDFGLSKA 159 (287)
T ss_dssp EEEECCTTEEHHHHHT---TCTTTSCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEEETTEEEECCCTTCEE
T ss_pred EEEEeCCCCCHHHHHH---hCCccCCHHHHHHHHHHHHHHHHHHHHC---CEeeCCCchheEEEcCCCCEEECcccceee
Confidence 9999999999999985 3456799999999999999999999999 999999999999999999999999999987
Q ss_pred cCCCCCcc--cccccccccccCccccCCCCCCChhhHHHHHHHHHHHHh-CCCCCCCCCCCchhcHHHHHHHHhcccccc
Q 010519 339 LDSGESHI--TTRVMGTFGYVAPEYANTGMLNEKSDIYSFGVLLLEAVT-GRDPVDYGRPANEVNLVEWLKMMVGTRRAE 415 (508)
Q Consensus 339 ~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~ 415 (508)
........ .....+|+.|+|||++.+..++.++|||||||++|+|++ |+.||...... .. .........
T Consensus 160 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~---~~---~~~i~~~~~-- 231 (287)
T 1u59_A 160 LGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGP---EV---MAFIEQGKR-- 231 (287)
T ss_dssp CTTCSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTH---HH---HHHHHTTCC--
T ss_pred eccCcceeeccccccccccccCHHHhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCHH---HH---HHHHhcCCc--
Confidence 65433221 223456889999999988889999999999999999998 99999654321 11 111111110
Q ss_pred cccCCCCCCChhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhhcCC
Q 010519 416 EVVDPNLEVKPATRALKRSLLVALRCVDPDSEKRPKMSQVVRMLEADD 463 (508)
Q Consensus 416 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~ 463 (508)
+.. +......+.+++.+||+.||.+|||+.+++++|+...
T Consensus 232 ----~~~----~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~ 271 (287)
T 1u59_A 232 ----MEC----PPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACY 271 (287)
T ss_dssp ----CCC----CTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHH
T ss_pred ----CCC----CCCcCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence 111 1123446677999999999999999999999998753
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-43 Score=353.97 Aligned_cols=255 Identities=26% Similarity=0.314 Sum_probs=202.2
Q ss_pred hCCcccceeEeeeCceEEEEEEEc-CCCEEEEEEEcccchhhHHHHHHHHHHHhcC-CCCCceeEEEEEEeCceeeEEEe
Q 010519 185 TNRFSAENVLGEGGYGVVYKGRLI-NGSEVAVKKLLNNLGQAEKEFRVEVEAIGHV-RHKNLVRLLGYCIEGVHRMLVYE 262 (508)
Q Consensus 185 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~ei~~l~~l-~h~niv~~~~~~~~~~~~~lv~E 262 (508)
.++|.+.+.||+|+||.||+|.+. +|+.||+|.+...... ..+|++++.++ +||||+++++++.+....|+|||
T Consensus 21 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~----~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E 96 (342)
T 2qr7_A 21 TDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKRD----PTEEIEILLRYGQHPNIITLKDVYDDGKYVYVVTE 96 (342)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTTCC----CHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEEC
T ss_pred cccEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEcccCC----hHHHHHHHHHhcCCCCcCeEEEEEEcCCEEEEEEe
Confidence 457999999999999999999886 5888999998654322 33577788777 79999999999999999999999
Q ss_pred ecCCCCHHHHHhhhhccCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCEEEcCC----CcEEEEecCCccc
Q 010519 263 YVNNGNLEQWLHGAMRNQGNLTWEARMKVIIGTAKALAYLHEAIEPKVVHRDIKSSNILIDDE----FNAKVSDFGLAKL 338 (508)
Q Consensus 263 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiH~Dlk~~NIll~~~----~~~kl~Dfgla~~ 338 (508)
|+++|+|.+++. ....+++..+..++.||+.||.|||++ +|+||||||+|||+.++ +.+||+|||++..
T Consensus 97 ~~~gg~L~~~i~----~~~~~~~~~~~~~~~qi~~al~~lH~~---givHrDlkp~NIl~~~~~~~~~~~kl~Dfg~a~~ 169 (342)
T 2qr7_A 97 LMKGGELLDKIL----RQKFFSEREASAVLFTITKTVEYLHAQ---GVVHRDLKPSNILYVDESGNPESIRICDFGFAKQ 169 (342)
T ss_dssp CCCSCBHHHHHH----TCTTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEESSSSCSGGGEEECCCTTCEE
T ss_pred CCCCCcHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHHC---CcEeccCCHHHEEEecCCCCcCeEEEEECCCccc
Confidence 999999999984 456799999999999999999999999 99999999999998543 3599999999987
Q ss_pred cCCCCCcccccccccccccCccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCCCchhcHHHHHHHHhccccccccc
Q 010519 339 LDSGESHITTRVMGTFGYVAPEYANTGMLNEKSDIYSFGVLLLEAVTGRDPVDYGRPANEVNLVEWLKMMVGTRRAEEVV 418 (508)
Q Consensus 339 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 418 (508)
...... .....+||+.|+|||++.+..|+.++|||||||+||||++|..||......... +.+...... ..
T Consensus 170 ~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~---~~~~~i~~~-~~---- 240 (342)
T 2qr7_A 170 LRAENG-LLMTPCYTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTPFANGPDDTPE---EILARIGSG-KF---- 240 (342)
T ss_dssp CBCTTC-CBCCSSCCSSCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHSSCSSCSSTTSCHH---HHHHHHHHC-CC----
T ss_pred CcCCCC-ceeccCCCccccCHHHhcCCCCCCccCeeeHhHHHHHHhcCCCCCCCCCcCCHH---HHHHHHccC-Cc----
Confidence 654332 234467899999999998888999999999999999999999999754322222 222222111 10
Q ss_pred CCCCCCChhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhhc
Q 010519 419 DPNLEVKPATRALKRSLLVALRCVDPDSEKRPKMSQVVRMLEA 461 (508)
Q Consensus 419 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~ 461 (508)
.+...........+.+|+.+||..||.+|||+.++++|-+-
T Consensus 241 --~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~il~hp~~ 281 (342)
T 2qr7_A 241 --SLSGGYWNSVSDTAKDLVSKMLHVDPHQRLTAALVLRHPWI 281 (342)
T ss_dssp --CCCSTTTTTSCHHHHHHHHHHTCSSTTTSCCHHHHTTSHHH
T ss_pred --ccCccccccCCHHHHHHHHHHCCCChhHCcCHHHHhcCCee
Confidence 01111111234456679999999999999999999987654
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-43 Score=350.63 Aligned_cols=257 Identities=26% Similarity=0.434 Sum_probs=198.7
Q ss_pred hCCcccceeEeeeCceEEEEEEEc-CCCE----EEEEEEcccc-hhhHHHHHHHHHHHhcCCCCCceeEEEEEEeCceee
Q 010519 185 TNRFSAENVLGEGGYGVVYKGRLI-NGSE----VAVKKLLNNL-GQAEKEFRVEVEAIGHVRHKNLVRLLGYCIEGVHRM 258 (508)
Q Consensus 185 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~----vavK~~~~~~-~~~~~~~~~ei~~l~~l~h~niv~~~~~~~~~~~~~ 258 (508)
.++|.+.+.||+|+||+||+|.+. ++.. |++|.+.... ......+.+|+.+++.++||||+++++++.... .+
T Consensus 14 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~-~~ 92 (327)
T 3lzb_A 14 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST-VQ 92 (327)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCCSSCCCHHHHHHHHHHHTTCCBTTBCCCCEEEESSS-EE
T ss_pred HhHceEEEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeeccccCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEecCC-ce
Confidence 468999999999999999999875 4443 5777664332 344577889999999999999999999998765 78
Q ss_pred EEEeecCCCCHHHHHhhhhccCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCEEEcCCCcEEEEecCCccc
Q 010519 259 LVYEYVNNGNLEQWLHGAMRNQGNLTWEARMKVIIGTAKALAYLHEAIEPKVVHRDIKSSNILIDDEFNAKVSDFGLAKL 338 (508)
Q Consensus 259 lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~Dfgla~~ 338 (508)
+|+||+.+|+|.+++.. ....+++..++.++.||+.||.|||++ +|+||||||+|||++.++.+||+|||++..
T Consensus 93 ~v~~~~~~g~L~~~l~~---~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIl~~~~~~~kL~DfG~a~~ 166 (327)
T 3lzb_A 93 LITQLMPFGCLLDYVRE---HKDNIGSQYLLNWCVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKL 166 (327)
T ss_dssp EEECCCSSCBHHHHHHH---TTTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEEETTEEEECCTTC---
T ss_pred EEEEecCCCcHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHhhC---CCcCCCCCHHHEEEcCCCCEEEccCcceeE
Confidence 99999999999999963 456799999999999999999999999 999999999999999999999999999987
Q ss_pred cCCCCC-cccccccccccccCccccCCCCCCChhhHHHHHHHHHHHHh-CCCCCCCCCCCchhcHHHHHHHHhccccccc
Q 010519 339 LDSGES-HITTRVMGTFGYVAPEYANTGMLNEKSDIYSFGVLLLEAVT-GRDPVDYGRPANEVNLVEWLKMMVGTRRAEE 416 (508)
Q Consensus 339 ~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 416 (508)
...... .......+|+.|+|||++.+..++.++|||||||++|||++ |..||...... .+...+ ....
T Consensus 167 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~---~~~~~~---~~~~---- 236 (327)
T 3lzb_A 167 LGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPAS---EISSIL---EKGE---- 236 (327)
T ss_dssp -------------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGG---GHHHHH---HTTC----
T ss_pred ccCccccccccCCCccccccCHHHHcCCCCChHHHHHHHHHHHHHHHHCCCCCCCCCCHH---HHHHHH---HcCC----
Confidence 643322 12233456889999999999999999999999999999999 99999654322 122111 1111
Q ss_pred ccCCCCCCChhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhhcCCC
Q 010519 417 VVDPNLEVKPATRALKRSLLVALRCVDPDSEKRPKMSQVVRMLEADDY 464 (508)
Q Consensus 417 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~ 464 (508)
....+......+.+++.+||+.||.+|||+.|+++.|+....
T Consensus 237 ------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~ 278 (327)
T 3lzb_A 237 ------RLPQPPICTIDVYMIMRKCWMIDADSRPKFRELIIEFSKMAR 278 (327)
T ss_dssp ------CCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHT
T ss_pred ------CCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHh
Confidence 111111123456679999999999999999999999987643
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-42 Score=343.17 Aligned_cols=269 Identities=25% Similarity=0.422 Sum_probs=203.5
Q ss_pred HHHHHhhCCcccceeEeeeCceEEEEEEEcCCCEEEEEEEcccchhhHHHHHHHHHHHhc--CCCCCceeEEEEEEeC--
Q 010519 179 RDLEIATNRFSAENVLGEGGYGVVYKGRLINGSEVAVKKLLNNLGQAEKEFRVEVEAIGH--VRHKNLVRLLGYCIEG-- 254 (508)
Q Consensus 179 ~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~ei~~l~~--l~h~niv~~~~~~~~~-- 254 (508)
.......++|.+.+.||+|+||.||+|++ .+..||||++.... ...+..|.+++.. ++||||+++++++...
T Consensus 30 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~---~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~ 105 (337)
T 3mdy_A 30 LVQRTIAKQIQMVKQIGKGRYGEVWMGKW-RGEKVAVKVFFTTE---EASWFRETEIYQTVLMRHENILGFIAADIKGTG 105 (337)
T ss_dssp HHHTTHHHHCEEEEEEEEETTEEEEEEEE-TTEEEEEEEEEGGG---HHHHHHHHHHHTSTTCCCTTBCCEEEEEEESCG
T ss_pred ccccccccceEEEeEeecCCCeEEEEEEE-CCceEEEEEEeccc---cchhhhHHHHHHHHhhcCCCeeeEEEEEccCCC
Confidence 34455667999999999999999999987 58999999985432 2333445555544 4999999999999887
Q ss_pred --ceeeEEEeecCCCCHHHHHhhhhccCCCccHHHHHHHHHHHHHHHHHHHhcC-----CCCeEeecCCCCCEEEcCCCc
Q 010519 255 --VHRMLVYEYVNNGNLEQWLHGAMRNQGNLTWEARMKVIIGTAKALAYLHEAI-----EPKVVHRDIKSSNILIDDEFN 327 (508)
Q Consensus 255 --~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~-----~~~iiH~Dlk~~NIll~~~~~ 327 (508)
...++||||+++|+|.+++.. ..+++..++.++.|++.||.|||+.. .++|+||||||+|||++.++.
T Consensus 106 ~~~~~~lv~e~~~~g~L~~~l~~-----~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dikp~Nill~~~~~ 180 (337)
T 3mdy_A 106 SWTQLYLITDYHENGSLYDYLKS-----TTLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGT 180 (337)
T ss_dssp GGCEEEEEECCCTTCBHHHHHHH-----CCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCCEECSCCCGGGEEECTTSC
T ss_pred CCCceEEEEeccCCCcHHHHhhc-----cCCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCEEecccchHHEEECCCCC
Confidence 678999999999999999953 35899999999999999999999741 448999999999999999999
Q ss_pred EEEEecCCccccCCCCCcc---cccccccccccCccccCCCCCCCh------hhHHHHHHHHHHHHhC----------CC
Q 010519 328 AKVSDFGLAKLLDSGESHI---TTRVMGTFGYVAPEYANTGMLNEK------SDIYSFGVLLLEAVTG----------RD 388 (508)
Q Consensus 328 ~kl~Dfgla~~~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~------~DvwS~Gvvl~elltG----------~~ 388 (508)
+||+|||++.......... .....||+.|+|||++.+..++.+ +|||||||++|||++| ..
T Consensus 181 ~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~~~~~~~~~~~ 260 (337)
T 3mdy_A 181 CCIADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQL 260 (337)
T ss_dssp EEECCCTTCEECC---------CCSSCSCGGGCCHHHHTTCCCTTCTHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCC
T ss_pred EEEEeCCCceeeccccccccCCCCCCccCcceeChhhcccccCCccccCccccchHHHHHHHHHHHhccCcccccccccc
Confidence 9999999998664332221 224579999999999988776665 9999999999999999 66
Q ss_pred CCCCCCCCchhcHHHHHHHHhcccccccccCCCCCCC-hhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhhcC
Q 010519 389 PVDYGRPANEVNLVEWLKMMVGTRRAEEVVDPNLEVK-PATRALKRSLLVALRCVDPDSEKRPKMSQVVRMLEAD 462 (508)
Q Consensus 389 Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~ 462 (508)
||....+... ...... ....... ..+.+... ........+.+|+.+||+.||.+|||+.+|+++|+..
T Consensus 261 p~~~~~~~~~-~~~~~~-~~~~~~~----~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l 329 (337)
T 3mdy_A 261 PYHDLVPSDP-SYEDMR-EIVCIKK----LRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALRVKKTLAKM 329 (337)
T ss_dssp TTTTTSCSSC-CHHHHH-HHHTTSC----CCCCCCGGGGGSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHH
T ss_pred cHhhhcCCCC-chhhhH-HHHhhhc----cCccccccchhhHHHHHHHHHHHHhhhhChhhCCCHHHHHHHHHHH
Confidence 7654333221 111111 1111111 11211111 1235667788899999999999999999999999864
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-43 Score=354.71 Aligned_cols=256 Identities=22% Similarity=0.333 Sum_probs=199.2
Q ss_pred HhhCCcccceeEeeeCceEEEEEEEcCCCEEEEEEEcccc--hhhHHHHHHHHHHHhcCCC--CCceeEEEEEEeCceee
Q 010519 183 IATNRFSAENVLGEGGYGVVYKGRLINGSEVAVKKLLNNL--GQAEKEFRVEVEAIGHVRH--KNLVRLLGYCIEGVHRM 258 (508)
Q Consensus 183 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~--~~~~~~~~~ei~~l~~l~h--~niv~~~~~~~~~~~~~ 258 (508)
+..++|.+.+.||+|+||+||++.+.+++.||||++.... ......+.+|+.++..++| |||+++++++.+....+
T Consensus 6 ~~~~~y~i~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~~ 85 (343)
T 3dbq_A 6 VKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIY 85 (343)
T ss_dssp SSSCEEEEEEEESCCSSEEEEEEECTTSCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEE
T ss_pred eecCEEEEEEEEecCCCeEEEEEEeCCCCEEEEEEeeccccchHHHHHHHHHHHHHHhhhhcCCceEEEeeeEeeCCEEE
Confidence 3456899999999999999999998889999999986433 3344678899999999976 99999999999999999
Q ss_pred EEEeecCCCCHHHHHhhhhccCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCEEEcCCCcEEEEecCCccc
Q 010519 259 LVYEYVNNGNLEQWLHGAMRNQGNLTWEARMKVIIGTAKALAYLHEAIEPKVVHRDIKSSNILIDDEFNAKVSDFGLAKL 338 (508)
Q Consensus 259 lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~Dfgla~~ 338 (508)
+|||+ .+|+|.+++. ....+++..+..++.||+.||.|||+. +|+||||||+|||++ ++.+||+|||++..
T Consensus 86 lv~e~-~~~~L~~~l~----~~~~~~~~~~~~i~~qi~~al~~lH~~---~iiHrDikp~NIll~-~~~~kl~DFG~a~~ 156 (343)
T 3dbq_A 86 MVMEC-GNIDLNSWLK----KKKSIDPWERKSYWKNMLEAVHTIHQH---GIVHSDLKPANFLIV-DGMLKLIDFGIANQ 156 (343)
T ss_dssp EEECC-CSEEHHHHHH----HSCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEEE-TTEEEECCCSSSCC
T ss_pred EEEeC-CCCCHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCcceEEEE-CCcEEEeecccccc
Confidence 99995 5889999995 456789999999999999999999999 999999999999997 57899999999987
Q ss_pred cCCCCCc-ccccccccccccCccccCC-----------CCCCChhhHHHHHHHHHHHHhCCCCCCCCCCCchhcHHHHHH
Q 010519 339 LDSGESH-ITTRVMGTFGYVAPEYANT-----------GMLNEKSDIYSFGVLLLEAVTGRDPVDYGRPANEVNLVEWLK 406 (508)
Q Consensus 339 ~~~~~~~-~~~~~~gt~~y~aPE~~~~-----------~~~~~~~DvwS~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~ 406 (508)
....... .....+||+.|+|||++.+ ..++.++|||||||+||||++|+.||..... ....+.
T Consensus 157 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~-----~~~~~~ 231 (343)
T 3dbq_A 157 MQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIIN-----QISKLH 231 (343)
T ss_dssp C------------CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHHHSSCTTTTCCS-----HHHHHH
T ss_pred cCcccccccCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHHhCCCcchhhhh-----HHHHHH
Confidence 6543322 2345679999999999864 6789999999999999999999999964321 111122
Q ss_pred HHhcccccccccCCCCCCChhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhhc
Q 010519 407 MMVGTRRAEEVVDPNLEVKPATRALKRSLLVALRCVDPDSEKRPKMSQVVRMLEA 461 (508)
Q Consensus 407 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~ 461 (508)
..... ......+......+.+|+.+||+.||.+|||+.|++++.+-
T Consensus 232 ~~~~~---------~~~~~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~hp~~ 277 (343)
T 3dbq_A 232 AIIDP---------NHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYV 277 (343)
T ss_dssp HHHCT---------TSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHH
T ss_pred HHhcC---------CcccCCcccCCHHHHHHHHHHcCCChhHCCCHHHHHhCccc
Confidence 22111 11111111112456679999999999999999999998654
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-42 Score=349.09 Aligned_cols=260 Identities=28% Similarity=0.467 Sum_probs=202.9
Q ss_pred HHhhCCcccceeEeeeCceEEEEEEEcC-----CCEEEEEEEcccc-hhhHHHHHHHHHHHhcCCCCCceeEEEEEEeCc
Q 010519 182 EIATNRFSAENVLGEGGYGVVYKGRLIN-----GSEVAVKKLLNNL-GQAEKEFRVEVEAIGHVRHKNLVRLLGYCIEGV 255 (508)
Q Consensus 182 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~~-----~~~vavK~~~~~~-~~~~~~~~~ei~~l~~l~h~niv~~~~~~~~~~ 255 (508)
++..++|.+.+.||+|+||+||+|.+.. +..||+|.+.... ......+.+|+.+++.++||||+++++++.+..
T Consensus 40 ~i~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 119 (333)
T 1mqb_A 40 EIHPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYK 119 (333)
T ss_dssp BCCTTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSS
T ss_pred cCChHHhhcccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCC
Confidence 3455789999999999999999998753 2359999986543 334457889999999999999999999999999
Q ss_pred eeeEEEeecCCCCHHHHHhhhhccCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCEEEcCCCcEEEEecCC
Q 010519 256 HRMLVYEYVNNGNLEQWLHGAMRNQGNLTWEARMKVIIGTAKALAYLHEAIEPKVVHRDIKSSNILIDDEFNAKVSDFGL 335 (508)
Q Consensus 256 ~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~Dfgl 335 (508)
..++||||+++|+|.+++.. ....+++..++.++.||+.||.|||+. +|+||||||+|||++.++.+||+|||+
T Consensus 120 ~~~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIl~~~~~~~kl~Dfg~ 193 (333)
T 1mqb_A 120 PMMIITEYMENGALDKFLRE---KDGEFSVLQLVGMLRGIAAGMKYLANM---NYVHRDLAARNILVNSNLVCKVSDFGL 193 (333)
T ss_dssp SEEEEEECCTTEEHHHHHHH---TTTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCCCC
T ss_pred CcEEEEeCCCCCcHHHHHHh---CCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChheEEECCCCcEEECCCCc
Confidence 99999999999999999963 456799999999999999999999999 999999999999999999999999999
Q ss_pred ccccCCCCCc--ccccccccccccCccccCCCCCCChhhHHHHHHHHHHHHh-CCCCCCCCCCCchhcHHHHHHHHhccc
Q 010519 336 AKLLDSGESH--ITTRVMGTFGYVAPEYANTGMLNEKSDIYSFGVLLLEAVT-GRDPVDYGRPANEVNLVEWLKMMVGTR 412 (508)
Q Consensus 336 a~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~ 412 (508)
+......... ......+++.|+|||++.+..++.++|||||||++|||++ |..||..... .+.........
T Consensus 194 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~------~~~~~~~~~~~ 267 (333)
T 1mqb_A 194 SRVLEDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSN------HEVMKAINDGF 267 (333)
T ss_dssp -----------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCH------HHHHHHHHTTC
T ss_pred chhhccccccccccCCCCccccccCchhcccCCCCchhhhHHHHHHHHHHHcCCCCCcccCCH------HHHHHHHHCCC
Confidence 9876543221 1223346788999999999999999999999999999999 9999964321 12222222111
Q ss_pred ccccccCCCCCCChhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhhcCC
Q 010519 413 RAEEVVDPNLEVKPATRALKRSLLVALRCVDPDSEKRPKMSQVVRMLEADD 463 (508)
Q Consensus 413 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~ 463 (508)
. ...+......+.+++.+||+.||.+||++.+++++|+...
T Consensus 268 ~----------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~~ 308 (333)
T 1mqb_A 268 R----------LPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLI 308 (333)
T ss_dssp C----------CCCCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHH
T ss_pred c----------CCCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence 1 0111122345667999999999999999999999998654
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-42 Score=353.61 Aligned_cols=267 Identities=17% Similarity=0.235 Sum_probs=202.4
Q ss_pred HhhCCcccceeEeeeCceEEEEEEEcC------CCEEEEEEEcccchhhH-----------HHHHHHHHHHhcCCCCCce
Q 010519 183 IATNRFSAENVLGEGGYGVVYKGRLIN------GSEVAVKKLLNNLGQAE-----------KEFRVEVEAIGHVRHKNLV 245 (508)
Q Consensus 183 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~------~~~vavK~~~~~~~~~~-----------~~~~~ei~~l~~l~h~niv 245 (508)
+..++|.+.+.||+|+||+||+|.+.. +..||||.+........ ..+..|+..+..++||||+
T Consensus 32 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~iv 111 (364)
T 3op5_A 32 MAAAAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVP 111 (364)
T ss_dssp TTCCEEEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCCSC
T ss_pred cCCCeEEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhccCCCCC
Confidence 445689999999999999999998864 47899999865442211 1234466678888999999
Q ss_pred eEEEEEEeC----ceeeEEEeecCCCCHHHHHhhhhccCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCEE
Q 010519 246 RLLGYCIEG----VHRMLVYEYVNNGNLEQWLHGAMRNQGNLTWEARMKVIIGTAKALAYLHEAIEPKVVHRDIKSSNIL 321 (508)
Q Consensus 246 ~~~~~~~~~----~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiH~Dlk~~NIl 321 (508)
++++++... ...+|||||+ +++|.+++.. ....+++..++.++.||+.||.|||+. +|+||||||+|||
T Consensus 112 ~~~~~~~~~~~~~~~~~lv~e~~-g~~L~~~~~~---~~~~l~~~~~~~i~~qi~~~l~~lH~~---~iiHrDlkp~Nil 184 (364)
T 3op5_A 112 KYWGSGLHDKNGKSYRFMIMDRF-GSDLQKIYEA---NAKRFSRKTVLQLSLRILDILEYIHEH---EYVHGDIKASNLL 184 (364)
T ss_dssp CEEEEEEEEETTEEEEEEEEECE-EEEHHHHHHH---TTSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEE
T ss_pred eEEeeeeeccCCcceEEEEEeCC-CCCHHHHHHh---ccCCCCHHHHHHHHHHHHHHHHHHHHC---CeEEecCCHHHEE
Confidence 999999875 4578999999 9999999963 446799999999999999999999999 9999999999999
Q ss_pred Ec--CCCcEEEEecCCccccCCCCCc------ccccccccccccCccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCC
Q 010519 322 ID--DEFNAKVSDFGLAKLLDSGESH------ITTRVMGTFGYVAPEYANTGMLNEKSDIYSFGVLLLEAVTGRDPVDYG 393 (508)
Q Consensus 322 l~--~~~~~kl~Dfgla~~~~~~~~~------~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltG~~Pf~~~ 393 (508)
++ .++.+||+|||+++.+...... ......||+.|+|||++.+..++.++|||||||+||||++|+.||...
T Consensus 185 l~~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~Pf~~~ 264 (364)
T 3op5_A 185 LNYKNPDQVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGVAPSRRGDLEILGYCMIQWLTGHLPWEDN 264 (364)
T ss_dssp EESSCTTCEEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGG
T ss_pred EecCCCCeEEEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCCCCCCchhhHHHHHHHHHHHHhCCCCcccc
Confidence 99 8899999999999865432111 123345999999999999999999999999999999999999999743
Q ss_pred CCCchhcHHHHHHHHhcccccccccCCCCCCChhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhhcC
Q 010519 394 RPANEVNLVEWLKMMVGTRRAEEVVDPNLEVKPATRALKRSLLVALRCVDPDSEKRPKMSQVVRMLEAD 462 (508)
Q Consensus 394 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~ 462 (508)
..... .......... .....++++.+.. ...+..+.+++..||+.||.+||++.+|++.|+..
T Consensus 265 ~~~~~--~~~~~~~~~~-~~~~~~~~~~~~~---~~~~~~~~~li~~cl~~~p~~RP~~~~l~~~l~~~ 327 (364)
T 3op5_A 265 LKDPK--YVRDSKIRYR-ENIASLMDKCFPA---ANAPGEIAKYMETVKLLDYTEKPLYENLRDILLQG 327 (364)
T ss_dssp TTCHH--HHHHHHHHHH-HCHHHHHHHHSCT---TCCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHH
T ss_pred ccCHH--HHHHHHHHhh-hhHHHHHHHhccc---ccCHHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHH
Confidence 32211 1111111100 0111111111110 11134566799999999999999999999998763
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-43 Score=343.66 Aligned_cols=263 Identities=27% Similarity=0.485 Sum_probs=196.8
Q ss_pred HHHhhCCcccceeEeeeCceEEEEEEEcCCCEEEEEEEcccc--hhhHHHHHHHHHHHhcCCCCCceeEEEEEEeCceee
Q 010519 181 LEIATNRFSAENVLGEGGYGVVYKGRLINGSEVAVKKLLNNL--GQAEKEFRVEVEAIGHVRHKNLVRLLGYCIEGVHRM 258 (508)
Q Consensus 181 ~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~--~~~~~~~~~ei~~l~~l~h~niv~~~~~~~~~~~~~ 258 (508)
.++..++|.+.+.||+|+||+||+|++ ...+|+|++.... ......+.+|+.+++.++||||+++++++ .....+
T Consensus 19 ~ei~~~~y~~~~~lG~G~~g~Vy~~~~--~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-~~~~~~ 95 (289)
T 3og7_A 19 WEIPDGQITVGQRIGSGSFGTVYKGKW--HGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS-TAPQLA 95 (289)
T ss_dssp CBCCTTSCEEEEEEEECSSEEEEEEES--SSEEEEEEESCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEE-CSSSCE
T ss_pred CccCccceeeeeEecCCCCeEEEEEEE--cCceEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCcEEEEEeec-cCCccE
Confidence 356678999999999999999999975 3469999986443 34456789999999999999999999965 556689
Q ss_pred EEEeecCCCCHHHHHhhhhccCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCEEEcCCCcEEEEecCCccc
Q 010519 259 LVYEYVNNGNLEQWLHGAMRNQGNLTWEARMKVIIGTAKALAYLHEAIEPKVVHRDIKSSNILIDDEFNAKVSDFGLAKL 338 (508)
Q Consensus 259 lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~Dfgla~~ 338 (508)
+||||+++++|.+++. .....+++..++.++.|++.||.|||+. +|+||||||+|||++.++.+||+|||++..
T Consensus 96 lv~e~~~~~~L~~~l~---~~~~~~~~~~~~~i~~qi~~~L~~lH~~---~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~ 169 (289)
T 3og7_A 96 IVTQWCEGSSLYHHLH---ASETKFEMKKLIDIARQTARGMDYLHAK---SIIHRDLKSNNIFLHEDNTVKIGDFGLATE 169 (289)
T ss_dssp EEEECCCEEEHHHHHT---TC---CCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEETTTEEEECCCC----
T ss_pred EEEEecCCCcHHHHHh---hccCCCCHHHHHHHHHHHHHHHHHHHhC---CcccccCccceEEECCCCCEEEccceeccc
Confidence 9999999999999985 3456799999999999999999999999 999999999999999999999999999986
Q ss_pred cCCCC-CcccccccccccccCccccC---CCCCCChhhHHHHHHHHHHHHhCCCCCCCCCCCchhcHHHHHHHHhccccc
Q 010519 339 LDSGE-SHITTRVMGTFGYVAPEYAN---TGMLNEKSDIYSFGVLLLEAVTGRDPVDYGRPANEVNLVEWLKMMVGTRRA 414 (508)
Q Consensus 339 ~~~~~-~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DvwS~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~ 414 (508)
..... ........||+.|+|||++. +..++.++|||||||++|+|++|+.||...... ........ ....
T Consensus 170 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~--~~~~~~~~----~~~~ 243 (289)
T 3og7_A 170 KSRWSGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNR--DQIIEMVG----RGSL 243 (289)
T ss_dssp --------------CCCTTCCHHHHC----CCSCHHHHHHHHHHHHHHHHHSSCTTSSCCCH--HHHHHHHH----HTSC
T ss_pred cccccccccccccCCCccccCchhhcccCCCCCCcccchHHHHHHHHHHHHCCCCccccchH--HHHHHHhc----cccc
Confidence 54321 12234457899999999986 667889999999999999999999999644321 11111111 1111
Q ss_pred ccccCCCCCCChhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhhcCC
Q 010519 415 EEVVDPNLEVKPATRALKRSLLVALRCVDPDSEKRPKMSQVVRMLEADD 463 (508)
Q Consensus 415 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~ 463 (508)
. +.+. .........+.+|+.+||+.||.+|||+.++++.|+...
T Consensus 244 ~----~~~~-~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~l~ 287 (289)
T 3og7_A 244 S----PDLS-KVRSNCPKRMKRLMAECLKKKRDERPSFPRILAEIEELA 287 (289)
T ss_dssp C----CCTT-SSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTT
T ss_pred C----cchh-hccccCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHh
Confidence 1 1100 001122356677999999999999999999999998764
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-42 Score=344.62 Aligned_cols=265 Identities=24% Similarity=0.316 Sum_probs=201.4
Q ss_pred CCcccceeEeeeCceEEEEEEEc-CCCEEEEEEEcccch--hhHHHHHHHHHHHhcCCCCCceeEEEEEEeCceeeEEEe
Q 010519 186 NRFSAENVLGEGGYGVVYKGRLI-NGSEVAVKKLLNNLG--QAEKEFRVEVEAIGHVRHKNLVRLLGYCIEGVHRMLVYE 262 (508)
Q Consensus 186 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~ei~~l~~l~h~niv~~~~~~~~~~~~~lv~E 262 (508)
++|.+.+.||+|+||+||+|++. +|+.||+|++..... .....+.+|+.++++++||||+++++++.+....++|||
T Consensus 3 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 82 (311)
T 4agu_A 3 EKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEVFRRKRRLHLVFE 82 (311)
T ss_dssp CCEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCCCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred ccceEeeEEeecCCeEEEEEEeCCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhCCCCCccchhheeecCCeEEEEEE
Confidence 58999999999999999999985 589999999865432 334668889999999999999999999999999999999
Q ss_pred ecCCCCHHHHHhhhhccCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCEEEcCCCcEEEEecCCccccCCC
Q 010519 263 YVNNGNLEQWLHGAMRNQGNLTWEARMKVIIGTAKALAYLHEAIEPKVVHRDIKSSNILIDDEFNAKVSDFGLAKLLDSG 342 (508)
Q Consensus 263 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~~ 342 (508)
|+++++|.+++. ....+++..+..++.|++.||.|||+. +|+||||||+|||++.++.+||+|||++......
T Consensus 83 ~~~~~~l~~~~~----~~~~~~~~~~~~i~~~l~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~ 155 (311)
T 4agu_A 83 YCDHTVLHELDR----YQRGVPEHLVKSITWQTLQAVNFCHKH---NCIHRDVKPENILITKHSVIKLCDFGFARLLTGP 155 (311)
T ss_dssp CCSEEHHHHHHH----TSSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECC--
T ss_pred eCCCchHHHHHh----hhcCCCHHHHHHHHHHHHHHHHHHHHC---CCcCCCCChhhEEEcCCCCEEEeeCCCchhccCc
Confidence 999999998873 456799999999999999999999999 9999999999999999999999999999876533
Q ss_pred CCcccccccccccccCccccCC-CCCCChhhHHHHHHHHHHHHhCCCCCCCCCCCchhcHHHHHHHHhccc---------
Q 010519 343 ESHITTRVMGTFGYVAPEYANT-GMLNEKSDIYSFGVLLLEAVTGRDPVDYGRPANEVNLVEWLKMMVGTR--------- 412 (508)
Q Consensus 343 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwS~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~--------- 412 (508)
.. ......||+.|+|||++.+ ..++.++|||||||++|+|++|..||....... ....+....+..
T Consensus 156 ~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~ 231 (311)
T 4agu_A 156 SD-YYDDEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVD---QLYLIRKTLGDLIPRHQQVFS 231 (311)
T ss_dssp -----------GGGCCHHHHHTCSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH---HHHHHHHHHCSCCHHHHHHHH
T ss_pred cc-ccCCCcCCccccChHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHH---HHHHHHHHhcccccccccccc
Confidence 22 2344578999999999876 678999999999999999999999996543221 111111111110
Q ss_pred ---ccc--cccCCCCCCCh---hHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhhc
Q 010519 413 ---RAE--EVVDPNLEVKP---ATRALKRSLLVALRCVDPDSEKRPKMSQVVRMLEA 461 (508)
Q Consensus 413 ---~~~--~~~~~~~~~~~---~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~ 461 (508)
... ...++...... .......+.+|+.+||+.||.+|||++|++++-+-
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f 288 (311)
T 4agu_A 232 TNQYFSGVKIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLHHPYF 288 (311)
T ss_dssp TCGGGTTCCCCCCSSCCCHHHHCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHTSGGG
T ss_pred cccccccCcCCCccccchhhhhcccccHHHHHHHHHHccCChhhcCCHHHHhcChHH
Confidence 000 00011000000 01223456779999999999999999999986543
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-42 Score=346.91 Aligned_cols=267 Identities=22% Similarity=0.319 Sum_probs=192.1
Q ss_pred CCcccceeEeeeCceEEEEEEEc-CCCEEEEEEEcccch-hhHHHHHHHHHHHhcCCCCCceeEEEEEEeCceeeEEEee
Q 010519 186 NRFSAENVLGEGGYGVVYKGRLI-NGSEVAVKKLLNNLG-QAEKEFRVEVEAIGHVRHKNLVRLLGYCIEGVHRMLVYEY 263 (508)
Q Consensus 186 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~ei~~l~~l~h~niv~~~~~~~~~~~~~lv~E~ 263 (508)
++|.+.+.||+|+||+||+|.+. +|..||+|++..... .....+.+|+.+++.++||||+++++++.+....++||||
T Consensus 5 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~ 84 (317)
T 2pmi_A 5 SQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKELKHENIVRLYDVIHTENKLTLVFEF 84 (317)
T ss_dssp --------------CEEEEEECSSSCCEEEEEEEECCSTTCSCHHHHHHHHHHTTCCBTTBCCEEEEECCTTEEEEEEEC
T ss_pred cceeEeeEECCCCCEEEEEEEECCCCcEEEEEEeecccccccHHHHHHHHHHHHhcCCCCcceEEEEEEECCeEEEEEEe
Confidence 57999999999999999999875 688999999865432 2335678899999999999999999999999999999999
Q ss_pred cCCCCHHHHHhhhhc--cCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCEEEcCCCcEEEEecCCccccCC
Q 010519 264 VNNGNLEQWLHGAMR--NQGNLTWEARMKVIIGTAKALAYLHEAIEPKVVHRDIKSSNILIDDEFNAKVSDFGLAKLLDS 341 (508)
Q Consensus 264 ~~~gsL~~~l~~~~~--~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~ 341 (508)
++ |+|.+++..... ....+++..+..++.||+.||.|||+. +|+||||||+|||++.++.+||+|||++.....
T Consensus 85 ~~-~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~---~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~ 160 (317)
T 2pmi_A 85 MD-NDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHEN---KILHRDLKPQNLLINKRGQLKLGDFGLARAFGI 160 (317)
T ss_dssp CC-CBHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCSSCEETTS
T ss_pred cC-CCHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCChHHeEEcCCCCEEECcCccceecCC
Confidence 97 599999865322 124589999999999999999999999 999999999999999999999999999987653
Q ss_pred CCCcccccccccccccCccccCC-CCCCChhhHHHHHHHHHHHHhCCCCCCCCCCCchhcHHHHHHHHhcccccc-----
Q 010519 342 GESHITTRVMGTFGYVAPEYANT-GMLNEKSDIYSFGVLLLEAVTGRDPVDYGRPANEVNLVEWLKMMVGTRRAE----- 415 (508)
Q Consensus 342 ~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwS~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~----- 415 (508)
... ......||+.|+|||++.+ ..++.++|||||||++|||++|+.||..... ......+....+.....
T Consensus 161 ~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~---~~~~~~i~~~~~~~~~~~~~~~ 236 (317)
T 2pmi_A 161 PVN-TFSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTND---EEQLKLIFDIMGTPNESLWPSV 236 (317)
T ss_dssp CCC-CCCCCCSCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSH---HHHHHHHHHHHCSCCTTTCGGG
T ss_pred Ccc-cCCCCcccccccCchHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCh---HHHHHHHHHHhCCCChhHhhhh
Confidence 322 2334578999999999976 4689999999999999999999999964322 11122222222111000
Q ss_pred -cc--cCCCCCC----C--------hhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhh
Q 010519 416 -EV--VDPNLEV----K--------PATRALKRSLLVALRCVDPDSEKRPKMSQVVRMLE 460 (508)
Q Consensus 416 -~~--~~~~~~~----~--------~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 460 (508)
.. ..+.+.. . ........+.+|+.+||+.||.+|||+.|++++-+
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~e~l~hp~ 296 (317)
T 2pmi_A 237 TKLPKYNPNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLSAKQALHHPW 296 (317)
T ss_dssp GGCTTCCTTCCCCCCCCSHHHHGGGCSSCCCHHHHHHHHHHSCSSGGGSCCHHHHTTSGG
T ss_pred hhhhhcccccccccchhHHHhhcccccccCCHHHHHHHHHHCCCCcccCCCHHHHhCChh
Confidence 00 0000000 0 00012346778999999999999999999998644
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-42 Score=349.61 Aligned_cols=273 Identities=16% Similarity=0.226 Sum_probs=203.3
Q ss_pred hhCCcccceeEeeeCceEEEEEEEc----CCCEEEEEEEcccchhh-----------HHHHHHHHHHHhcCCCCCceeEE
Q 010519 184 ATNRFSAENVLGEGGYGVVYKGRLI----NGSEVAVKKLLNNLGQA-----------EKEFRVEVEAIGHVRHKNLVRLL 248 (508)
Q Consensus 184 ~~~~~~~~~~lg~G~~g~Vy~~~~~----~~~~vavK~~~~~~~~~-----------~~~~~~ei~~l~~l~h~niv~~~ 248 (508)
..++|.+.+.||+|+||+||+|.+. .+..+|+|++....... ...+..|+..+..++||||++++
T Consensus 35 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ni~~~~ 114 (345)
T 2v62_A 35 EGNQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPLFY 114 (345)
T ss_dssp TSCEEEEEEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCCCCCEE
T ss_pred cCceEEEEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccCcceee
Confidence 4568999999999999999999985 57789999886543211 12356788899999999999999
Q ss_pred EEEEe----CceeeEEEeecCCCCHHHHHhhhhccCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCEEEcC
Q 010519 249 GYCIE----GVHRMLVYEYVNNGNLEQWLHGAMRNQGNLTWEARMKVIIGTAKALAYLHEAIEPKVVHRDIKSSNILIDD 324 (508)
Q Consensus 249 ~~~~~----~~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiH~Dlk~~NIll~~ 324 (508)
+++.. ....++||||+ +++|.+++. ....+++..++.++.||+.||.|||+. +|+||||||+|||++.
T Consensus 115 ~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~----~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~ 186 (345)
T 2v62_A 115 GSGLTEFKGRSYRFMVMERL-GIDLQKISG----QNGTFKKSTVLQLGIRMLDVLEYIHEN---EYVHGDIKAANLLLGY 186 (345)
T ss_dssp EEEEEESSSCEEEEEEEECE-EEEHHHHCB----GGGBCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEES
T ss_pred cccccccCCCcEEEEEEecc-CCCHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCcCHHHEEEcc
Confidence 99988 67889999999 999999984 334799999999999999999999999 9999999999999998
Q ss_pred CC--cEEEEecCCccccCCCCC------cccccccccccccCccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCCC
Q 010519 325 EF--NAKVSDFGLAKLLDSGES------HITTRVMGTFGYVAPEYANTGMLNEKSDIYSFGVLLLEAVTGRDPVDYGRPA 396 (508)
Q Consensus 325 ~~--~~kl~Dfgla~~~~~~~~------~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltG~~Pf~~~~~~ 396 (508)
++ .+||+|||+++.+..... .......||+.|+|||++.+..++.++|||||||+||||++|+.||......
T Consensus 187 ~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~ 266 (345)
T 2v62_A 187 KNPDQVYLADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKGVALSRRSDVEILGYCMLRWLCGKLPWEQNLKD 266 (345)
T ss_dssp SSTTSEEECCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCTTGGGTTC
T ss_pred CCCCcEEEEeCCCceecccccccccchhccccccCCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCccccccc
Confidence 87 999999999986642211 1124457999999999999999999999999999999999999999532221
Q ss_pred chhcHHHHHHHHhcccccccccCCCCCCChhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhhcCCCCCchhh
Q 010519 397 NEVNLVEWLKMMVGTRRAEEVVDPNLEVKPATRALKRSLLVALRCVDPDSEKRPKMSQVVRMLEADDYPFREDR 470 (508)
Q Consensus 397 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~~~~~~ 470 (508)
.............. .......... .......+.+++.+||+.||.+|||+.+|++.|+....+.....
T Consensus 267 -~~~~~~~~~~~~~~--~~~~~~~~~~---~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~~~~~~d 334 (345)
T 2v62_A 267 -PVAVQTAKTNLLDE--LPQSVLKWAP---SGSSCCEIAQFLVCAHSLAYDEKPNYQALKKILNPHGIPLGPLD 334 (345)
T ss_dssp -HHHHHHHHHHHHHT--TTHHHHHHSC---TTSCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHCTTCCCCCCCC
T ss_pred -cHHHHHHHHhhccc--ccHHHHhhcc---ccccHHHHHHHHHHHhhcCcccCCCHHHHHHHHhccCCcccCCC
Confidence 11111111111100 0000000000 00223467779999999999999999999999998776544433
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-43 Score=347.81 Aligned_cols=255 Identities=27% Similarity=0.398 Sum_probs=194.3
Q ss_pred hCCcccceeEeeeCceEEEEEEE-cCCCEEEEEEEcccc---hhhHHHHHHHHHHHhcCCCCCceeEEEEEEeCce----
Q 010519 185 TNRFSAENVLGEGGYGVVYKGRL-INGSEVAVKKLLNNL---GQAEKEFRVEVEAIGHVRHKNLVRLLGYCIEGVH---- 256 (508)
Q Consensus 185 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~ei~~l~~l~h~niv~~~~~~~~~~~---- 256 (508)
.++|.+.+.||+|+||.||+|++ .+++.||||++.... ......+.+|+.++++++||||+++++++.....
T Consensus 11 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~ 90 (311)
T 3ork_A 11 SDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPL 90 (311)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCCCCTTBCCEEEEEEEEETTEEE
T ss_pred cCcEEEEEEEccCCCEEEEEEEECCCCceEEEEEeCccccCCHHHHHHHHHHHHHHHcCCCCCcceEEEeeeccCCCCcc
Confidence 46899999999999999999997 478899999986543 2334578899999999999999999999886543
Q ss_pred eeEEEeecCCCCHHHHHhhhhccCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCEEEcCCCcEEEEecCCc
Q 010519 257 RMLVYEYVNNGNLEQWLHGAMRNQGNLTWEARMKVIIGTAKALAYLHEAIEPKVVHRDIKSSNILIDDEFNAKVSDFGLA 336 (508)
Q Consensus 257 ~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~Dfgla 336 (508)
.|+||||+++|+|.+++. ....+++..++.++.||+.||.|||++ +|+||||||+|||++.++.+||+|||++
T Consensus 91 ~~lv~e~~~g~~L~~~l~----~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~a 163 (311)
T 3ork_A 91 PYIVMEYVDGVTLRDIVH----TEGPMTPKRAIEVIADACQALNFSHQN---GIIHRDVKPANIMISATNAVKVMDFGIA 163 (311)
T ss_dssp EEEEEECCCEEEHHHHHH----HHCSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEEETTSCEEECCCSCC
T ss_pred cEEEEecCCCCCHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHHC---CCCcCCCCHHHEEEcCCCCEEEeeccCc
Confidence 389999999999999995 345789999999999999999999999 9999999999999999999999999999
Q ss_pred cccCCCCC--cccccccccccccCccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCCCchhcHHHHHHHHhccccc
Q 010519 337 KLLDSGES--HITTRVMGTFGYVAPEYANTGMLNEKSDIYSFGVLLLEAVTGRDPVDYGRPANEVNLVEWLKMMVGTRRA 414 (508)
Q Consensus 337 ~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~ 414 (508)
........ .......||+.|+|||++.+..++.++|||||||++|+|++|+.||...... ............
T Consensus 164 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~------~~~~~~~~~~~~ 237 (311)
T 3ork_A 164 RAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPV------SVAYQHVREDPI 237 (311)
T ss_dssp ------------------CCTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHH------HHHHHHHHCCCC
T ss_pred ccccccccccccccccCcCcccCCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChH------HHHHHHhcCCCC
Confidence 86643322 1233456899999999999999999999999999999999999999643211 111111111100
Q ss_pred ccccCCCCCCChhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHh
Q 010519 415 EEVVDPNLEVKPATRALKRSLLVALRCVDPDSEKRPKMSQVVRML 459 (508)
Q Consensus 415 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L 459 (508)
. ...........+.+++.+||+.||.+||++.+++.+-
T Consensus 238 ~-------~~~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~ 275 (311)
T 3ork_A 238 P-------PSARHEGLSADLDAVVLKALAKNPENRYQTAAEMRAD 275 (311)
T ss_dssp C-------HHHHSTTCCHHHHHHHHHHTCSSGGGSCSSHHHHHHH
T ss_pred C-------cccccCCCCHHHHHHHHHHHhcCHhhChhhHHHHHHH
Confidence 0 0000011234566799999999999999877766543
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-43 Score=351.36 Aligned_cols=263 Identities=26% Similarity=0.429 Sum_probs=209.2
Q ss_pred HHhhCCcccceeEeeeCceEEEEEEEc--------CCCEEEEEEEcccc-hhhHHHHHHHHHHHhcC-CCCCceeEEEEE
Q 010519 182 EIATNRFSAENVLGEGGYGVVYKGRLI--------NGSEVAVKKLLNNL-GQAEKEFRVEVEAIGHV-RHKNLVRLLGYC 251 (508)
Q Consensus 182 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~--------~~~~vavK~~~~~~-~~~~~~~~~ei~~l~~l-~h~niv~~~~~~ 251 (508)
++..++|.+.+.||+|+||+||+|++. ++..||+|++.... ......+.+|+.+++++ +||||+++++++
T Consensus 31 ~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~ 110 (334)
T 2pvf_A 31 EFPRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGAC 110 (334)
T ss_dssp BCCGGGEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred cCCHhHeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccCCcHHHHHHHHHHHHHHHHhhcCCCEeeEEEEE
Confidence 455679999999999999999999873 46789999986543 33446788999999999 899999999999
Q ss_pred EeCceeeEEEeecCCCCHHHHHhhhhc------------cCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCC
Q 010519 252 IEGVHRMLVYEYVNNGNLEQWLHGAMR------------NQGNLTWEARMKVIIGTAKALAYLHEAIEPKVVHRDIKSSN 319 (508)
Q Consensus 252 ~~~~~~~lv~E~~~~gsL~~~l~~~~~------------~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiH~Dlk~~N 319 (508)
.+....++||||+++|+|.+++..... ....+++..++.++.||+.||.|||+. +|+||||||+|
T Consensus 111 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~N 187 (334)
T 2pvf_A 111 TQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQ---KCIHRDLAARN 187 (334)
T ss_dssp CSSSCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGG
T ss_pred ccCCceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCccce
Confidence 999999999999999999999964321 123488999999999999999999999 99999999999
Q ss_pred EEEcCCCcEEEEecCCccccCCCCCc-ccccccccccccCccccCCCCCCChhhHHHHHHHHHHHHh-CCCCCCCCCCCc
Q 010519 320 ILIDDEFNAKVSDFGLAKLLDSGESH-ITTRVMGTFGYVAPEYANTGMLNEKSDIYSFGVLLLEAVT-GRDPVDYGRPAN 397 (508)
Q Consensus 320 Ill~~~~~~kl~Dfgla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~ellt-G~~Pf~~~~~~~ 397 (508)
||++.++.+||+|||++......... ......+++.|+|||++.+..++.++|||||||++|+|++ |..||.....
T Consensus 188 Ill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~-- 265 (334)
T 2pvf_A 188 VLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPV-- 265 (334)
T ss_dssp EEECTTCCEEECCCTTCEECTTTSSEECCSCCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCH--
T ss_pred EEEcCCCCEEEccccccccccccccccccCCCCcccceeChHHhcCCCcChHHHHHHHHHHHHHHHhCCCCCcCcCCH--
Confidence 99999999999999999876543321 2233457889999999988889999999999999999999 9999964321
Q ss_pred hhcHHHHHHHHhcccccccccCCCCCCChhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhhcCC
Q 010519 398 EVNLVEWLKMMVGTRRAEEVVDPNLEVKPATRALKRSLLVALRCVDPDSEKRPKMSQVVRMLEADD 463 (508)
Q Consensus 398 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~ 463 (508)
.+.......... ... +......+.+++.+||+.||.+|||+.+++++|+...
T Consensus 266 ----~~~~~~~~~~~~------~~~----~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~l~ 317 (334)
T 2pvf_A 266 ----EELFKLLKEGHR------MDK----PANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIL 317 (334)
T ss_dssp ----HHHHHHHHHTCC------CCC----CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred ----HHHHHHHhcCCC------CCC----CccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence 122222211111 111 1112345667999999999999999999999998753
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.8e-42 Score=339.29 Aligned_cols=261 Identities=21% Similarity=0.247 Sum_probs=198.6
Q ss_pred hCCcccceeEeeeCceEEEEEEEc-CCCEEEEEEEcccch---hhHHHHHHHHHHHhcCCCCCceeEEEEEEeCceeeEE
Q 010519 185 TNRFSAENVLGEGGYGVVYKGRLI-NGSEVAVKKLLNNLG---QAEKEFRVEVEAIGHVRHKNLVRLLGYCIEGVHRMLV 260 (508)
Q Consensus 185 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~ei~~l~~l~h~niv~~~~~~~~~~~~~lv 260 (508)
.++|.+.+.||+|+||.||+|.+. +++.||+|.+..... .....+.+|+.++++++||||+++++++......++|
T Consensus 33 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv 112 (309)
T 2h34_A 33 FGPYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHDFGEIDGQLYVD 112 (309)
T ss_dssp -CCEEEEEEEEECSSSEEEEEEETTTTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEE
T ss_pred eccEEEEEEEcCCCCeeEEEEEEcCCCeEEEEEecCcccccCHHHHHHHHHHHHHHhhcCCCCeeEEEEEEeeCCeEEEE
Confidence 468999999999999999999975 688899999865432 2346788999999999999999999999999999999
Q ss_pred EeecCCCCHHHHHhhhhccCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCEEEcCCCcEEEEecCCccccC
Q 010519 261 YEYVNNGNLEQWLHGAMRNQGNLTWEARMKVIIGTAKALAYLHEAIEPKVVHRDIKSSNILIDDEFNAKVSDFGLAKLLD 340 (508)
Q Consensus 261 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~Dfgla~~~~ 340 (508)
|||+++++|.+++.. ...+++..++.++.|++.||.|||+. +|+||||||+|||++.++.+||+|||++....
T Consensus 113 ~e~~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dlkp~NIl~~~~~~~kl~Dfg~~~~~~ 185 (309)
T 2h34_A 113 MRLINGVDLAAMLRR----QGPLAPPRAVAIVRQIGSALDAAHAA---GATHRDVKPENILVSADDFAYLVDFGIASATT 185 (309)
T ss_dssp EECCCCEEHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECSCCC-----
T ss_pred EEecCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC---cCCcCCCChHHEEEcCCCCEEEecCccCcccc
Confidence 999999999999953 45689999999999999999999999 99999999999999999999999999998765
Q ss_pred CCCCcccccccccccccCccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCCCchhcHHHHHHHHhcccccccccCC
Q 010519 341 SGESHITTRVMGTFGYVAPEYANTGMLNEKSDIYSFGVLLLEAVTGRDPVDYGRPANEVNLVEWLKMMVGTRRAEEVVDP 420 (508)
Q Consensus 341 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 420 (508)
...........|++.|+|||++.+..++.++||||||+++|+|++|+.||..... .................
T Consensus 186 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~------~~~~~~~~~~~~~~~~~-- 257 (309)
T 2h34_A 186 DEKLTQLGNTVGTLYYMAPERFSESHATYRADIYALTCVLYECLTGSPPYQGDQL------SVMGAHINQAIPRPSTV-- 257 (309)
T ss_dssp -----------CCGGGCCGGGTCC----CCCHHHHHHHHHHHHHHSSCSSCSCHH------HHHHHHHHSCCCCGGGT--
T ss_pred ccccccccccCCCcCccCHHHHcCCCCCchHhHHHHHHHHHHHHHCCCCCCCchH------HHHHHHhccCCCCcccc--
Confidence 4433334456789999999999999999999999999999999999999964321 11111111111100000
Q ss_pred CCCCChhHHHHHHHHHHHHHhcCCCCCCCC-CHHHHHHHhhcCCCCC
Q 010519 421 NLEVKPATRALKRSLLVALRCVDPDSEKRP-KMSQVVRMLEADDYPF 466 (508)
Q Consensus 421 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-s~~evl~~L~~~~~~~ 466 (508)
.......+.+++.+||+.||.+|| |++++++.|+......
T Consensus 258 ------~~~~~~~l~~li~~~l~~dP~~Rp~s~~~l~~~l~~~l~~~ 298 (309)
T 2h34_A 258 ------RPGIPVAFDAVIARGMAKNPEDRYVTCGDLSAAAHAALATA 298 (309)
T ss_dssp ------STTCCTHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHTCC--
T ss_pred ------CCCCCHHHHHHHHHhccCCHHHHHHhHHHHHHHHHHHHHhh
Confidence 111233566699999999999999 9999999999876543
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-42 Score=346.37 Aligned_cols=260 Identities=22% Similarity=0.297 Sum_probs=200.3
Q ss_pred CCcccc-eeEeeeCceEEEEEEEc-CCCEEEEEEEcccchhhHHHHHHHHHHHhcC-CCCCceeEEEEEEeCceeeEEEe
Q 010519 186 NRFSAE-NVLGEGGYGVVYKGRLI-NGSEVAVKKLLNNLGQAEKEFRVEVEAIGHV-RHKNLVRLLGYCIEGVHRMLVYE 262 (508)
Q Consensus 186 ~~~~~~-~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~ei~~l~~l-~h~niv~~~~~~~~~~~~~lv~E 262 (508)
++|.+. +.||+|+||+||+|++. +++.||||++..........+.+|+.++.++ +||||+++++++.+....++|||
T Consensus 12 ~~y~i~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e 91 (316)
T 2ac3_A 12 DVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVFE 91 (316)
T ss_dssp TSCEECCCCCCCCSSEEEEEEECSSSCCEEEEEEEECCSSCCHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred eeEEecCceecCCceEEEEEEEEcCCCcEEEEEEEeeCcchhHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEEEEEE
Confidence 578874 78999999999999864 7899999999766555567788899999885 79999999999999999999999
Q ss_pred ecCCCCHHHHHhhhhccCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCEEEcCCCc---EEEEecCCcccc
Q 010519 263 YVNNGNLEQWLHGAMRNQGNLTWEARMKVIIGTAKALAYLHEAIEPKVVHRDIKSSNILIDDEFN---AKVSDFGLAKLL 339 (508)
Q Consensus 263 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiH~Dlk~~NIll~~~~~---~kl~Dfgla~~~ 339 (508)
|+++|+|.+++.. ...+++..++.++.||+.||.|||++ +|+||||||+|||++.++. +||+|||++...
T Consensus 92 ~~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~~~~kl~Dfg~~~~~ 164 (316)
T 2ac3_A 92 KMRGGSILSHIHK----RRHFNELEASVVVQDVASALDFLHNK---GIAHRDLKPENILCEHPNQVSPVKICDFDLGSGI 164 (316)
T ss_dssp CCTTCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEESCSSSSCSEEECCTTCCC--
T ss_pred cCCCCcHHHHHhc----cCCCCHHHHHHHHHHHHHHHHHHHhC---CceeCCCCHHHEEEccCCCcCceEEEEccCcccc
Confidence 9999999999953 35689999999999999999999999 9999999999999998776 999999999765
Q ss_pred CCCCC------cccccccccccccCccccCC-----CCCCChhhHHHHHHHHHHHHhCCCCCCCCCCCchh---------
Q 010519 340 DSGES------HITTRVMGTFGYVAPEYANT-----GMLNEKSDIYSFGVLLLEAVTGRDPVDYGRPANEV--------- 399 (508)
Q Consensus 340 ~~~~~------~~~~~~~gt~~y~aPE~~~~-----~~~~~~~DvwS~Gvvl~elltG~~Pf~~~~~~~~~--------- 399 (508)
..... ......+||+.|+|||++.+ ..++.++|||||||++|||++|+.||.........
T Consensus 165 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~ 244 (316)
T 2ac3_A 165 KLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPA 244 (316)
T ss_dssp -----------------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHHHHHHHHHSSCSCCCCCCSCSCC----CCHH
T ss_pred ccCCccccccccccccccCCcCccChHHhhcccccccCCCcccccHhHHHHHHHHHHCCCCCcccccccccccccccchh
Confidence 32211 11223468999999999875 56889999999999999999999999754332200
Q ss_pred cHHHHHHHHhcccccccccCCCCCCChh--HHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhhc
Q 010519 400 NLVEWLKMMVGTRRAEEVVDPNLEVKPA--TRALKRSLLVALRCVDPDSEKRPKMSQVVRMLEA 461 (508)
Q Consensus 400 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~ 461 (508)
........... .....+.. ......+.+|+.+||+.||.+|||+.|++++-.-
T Consensus 245 ~~~~~~~~i~~---------~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~hp~~ 299 (316)
T 2ac3_A 245 CQNMLFESIQE---------GKYEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQHPWV 299 (316)
T ss_dssp HHHHHHHHHHH---------CCCCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSTTC
T ss_pred HHHHHHHHHhc---------cCcccCchhcccCCHHHHHHHHHHhhCChhhCCCHHHHhcChhh
Confidence 00111111111 11111111 1224567789999999999999999999986543
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-43 Score=341.36 Aligned_cols=258 Identities=26% Similarity=0.365 Sum_probs=206.5
Q ss_pred CCcccceeEeeeCceEEEEEEEc-CCCEEEEEEEcccc--hhhHHHHHHHHHHHhcCCCCCceeEEEEEEe--CceeeEE
Q 010519 186 NRFSAENVLGEGGYGVVYKGRLI-NGSEVAVKKLLNNL--GQAEKEFRVEVEAIGHVRHKNLVRLLGYCIE--GVHRMLV 260 (508)
Q Consensus 186 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~ei~~l~~l~h~niv~~~~~~~~--~~~~~lv 260 (508)
++|.+.+.||+|+||.||++.+. +++.||+|.+.... ....+.+.+|+.++++++||||+++++++.+ ....++|
T Consensus 6 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv 85 (279)
T 2w5a_A 6 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIV 85 (279)
T ss_dssp GGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEEGGGTEEEEE
T ss_pred hheeeehhccCCCCcEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhcCCCCCCeEEEEEecCCCceEEEE
Confidence 58999999999999999999886 68899999986433 3445678899999999999999999998865 4678999
Q ss_pred EeecCCCCHHHHHhhhhccCCCccHHHHHHHHHHHHHHHHHHHhcCCCC-----eEeecCCCCCEEEcCCCcEEEEecCC
Q 010519 261 YEYVNNGNLEQWLHGAMRNQGNLTWEARMKVIIGTAKALAYLHEAIEPK-----VVHRDIKSSNILIDDEFNAKVSDFGL 335 (508)
Q Consensus 261 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~-----iiH~Dlk~~NIll~~~~~~kl~Dfgl 335 (508)
|||+++++|.+++.........+++..++.++.|++.||.|||+. + |+||||||+|||++.++.+||+|||+
T Consensus 86 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~---~~~~~~ivH~dl~p~NIl~~~~~~~kl~dfg~ 162 (279)
T 2w5a_A 86 MEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRR---SDGGHTVLHRDLKPANVFLDGKQNVKLGDFGL 162 (279)
T ss_dssp EECCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHH---C------CCCCCSGGGEEECSSSCEEECCCCH
T ss_pred EeCCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcc---cCCCCeeEEeccchhhEEEcCCCCEEEecCch
Confidence 999999999999976545556799999999999999999999998 7 99999999999999999999999999
Q ss_pred ccccCCCCCcccccccccccccCccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCCCchhcHHHHHHHHhcccccc
Q 010519 336 AKLLDSGESHITTRVMGTFGYVAPEYANTGMLNEKSDIYSFGVLLLEAVTGRDPVDYGRPANEVNLVEWLKMMVGTRRAE 415 (508)
Q Consensus 336 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~ 415 (508)
+........ ......|++.|+|||++.+..++.++||||||+++|+|++|..||.... ...+.. ..... ..
T Consensus 163 ~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~---~~~~~~---~i~~~-~~- 233 (279)
T 2w5a_A 163 ARILNHDTS-FAKTFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFS---QKELAG---KIREG-KF- 233 (279)
T ss_dssp HHHC---CH-HHHHHHSCCTTCCHHHHHCC-CCHHHHHHHHHHHHHHHHHSSCSSCCSS---HHHHHH---HHHHT-CC-
T ss_pred heeeccccc-cccccCCCccccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCcccC---HHHHHH---HHhhc-cc-
Confidence 987654322 2234568999999999999999999999999999999999999996432 111111 11111 11
Q ss_pred cccCCCCCCChhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhhcCC
Q 010519 416 EVVDPNLEVKPATRALKRSLLVALRCVDPDSEKRPKMSQVVRMLEADD 463 (508)
Q Consensus 416 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~ 463 (508)
+.+. ......+.+++.+||+.||.+|||+.|++++++...
T Consensus 234 ----~~~~----~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~~~~~~ 273 (279)
T 2w5a_A 234 ----RRIP----YRYSDELNEIITRMLNLKDYHRPSVEEILENPLILE 273 (279)
T ss_dssp ----CCCC----TTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSTTCCG
T ss_pred ----ccCC----cccCHHHHHHHHHHcCCCcccCCCHHHHHhChhhhh
Confidence 1111 112345667999999999999999999999876543
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.3e-43 Score=346.07 Aligned_cols=256 Identities=30% Similarity=0.481 Sum_probs=196.2
Q ss_pred hCCcccceeEeeeCceEEEEEEEcCCCEEEEEEEcccchhhHHHHHHHHHHHhcCCCCCceeEEEEEEeCceeeEEEeec
Q 010519 185 TNRFSAENVLGEGGYGVVYKGRLINGSEVAVKKLLNNLGQAEKEFRVEVEAIGHVRHKNLVRLLGYCIEGVHRMLVYEYV 264 (508)
Q Consensus 185 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~ei~~l~~l~h~niv~~~~~~~~~~~~~lv~E~~ 264 (508)
.++|.+.+.||+|+||+||+|++ .++.||+|++... ...+.+.+|+.++++++||||+++++++.+ ..++||||+
T Consensus 7 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~--~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~--~~~lv~e~~ 81 (307)
T 2eva_A 7 YKEIEVEEVVGRGAFGVVCKAKW-RAKDVAIKQIESE--SERKAFIVELRQLSRVNHPNIVKLYGACLN--PVCLVMEYA 81 (307)
T ss_dssp GGGEEEEEEEECCSSSEEEEEEE-TTEEEEEEECSST--THHHHHHHHHHHHHHCCCTTBCCEEEBCTT--TTEEEEECC
T ss_pred HhHeeeeeEeecCCCceEEEEEE-CCeeEEEEEecCh--hHHHHHHHHHHHHhcCCCCCcCeEEEEEcC--CcEEEEEcC
Confidence 45899999999999999999987 6789999988543 345678899999999999999999998763 478999999
Q ss_pred CCCCHHHHHhhhhccCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCEEEcCCCc-EEEEecCCccccCCCC
Q 010519 265 NNGNLEQWLHGAMRNQGNLTWEARMKVIIGTAKALAYLHEAIEPKVVHRDIKSSNILIDDEFN-AKVSDFGLAKLLDSGE 343 (508)
Q Consensus 265 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiH~Dlk~~NIll~~~~~-~kl~Dfgla~~~~~~~ 343 (508)
++|+|.+++... .....+++..++.++.|+++||.|||+....+|+||||||+|||++.++. +||+|||++......
T Consensus 82 ~~~~L~~~l~~~-~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~~kl~Dfg~~~~~~~~- 159 (307)
T 2eva_A 82 EGGSLYNVLHGA-EPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQTH- 159 (307)
T ss_dssp TTCBHHHHHHCS-SSEECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEEETTTTEEEECCCCC--------
T ss_pred CCCCHHHHHhcc-CCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHEEEeCCCCEEEEcccccccccccc-
Confidence 999999999632 11234788999999999999999999921128999999999999998887 799999999865432
Q ss_pred CcccccccccccccCccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCCCchhcHHHHHHHHhcccccccccCCCCC
Q 010519 344 SHITTRVMGTFGYVAPEYANTGMLNEKSDIYSFGVLLLEAVTGRDPVDYGRPANEVNLVEWLKMMVGTRRAEEVVDPNLE 423 (508)
Q Consensus 344 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 423 (508)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||....... . ........... +..
T Consensus 160 ---~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~-~---~~~~~~~~~~~------~~~- 225 (307)
T 2eva_A 160 ---MTNNKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGPA-F---RIMWAVHNGTR------PPL- 225 (307)
T ss_dssp --------CCTTSSCHHHHTCCCCCTHHHHHHHHHHHHHHHHTCCTTTTTCSSH-H---HHHHHHHTTCC------CCC-
T ss_pred ---cccCCCCCceEChhhhCCCCCCcHHHHHHHHHHHHHHHHCCCCchhhCccH-H---HHHHHHhcCCC------CCc-
Confidence 233468999999999999999999999999999999999999996433211 1 11111111111 111
Q ss_pred CChhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhhcCCC
Q 010519 424 VKPATRALKRSLLVALRCVDPDSEKRPKMSQVVRMLEADDY 464 (508)
Q Consensus 424 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~ 464 (508)
.......+.+++.+||+.||.+|||+.+++++|+....
T Consensus 226 ---~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~ 263 (307)
T 2eva_A 226 ---IKNLPKPIESLMTRCWSKDPSQRPSMEEIVKIMTHLMR 263 (307)
T ss_dssp ---BTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHGG
T ss_pred ---ccccCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHH
Confidence 11123456679999999999999999999999987543
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-43 Score=353.00 Aligned_cols=266 Identities=24% Similarity=0.408 Sum_probs=211.3
Q ss_pred HHHHhhCCcccceeEeeeCceEEEEEEEcC-C-----CEEEEEEEcccc-hhhHHHHHHHHHHHhcC-CCCCceeEEEEE
Q 010519 180 DLEIATNRFSAENVLGEGGYGVVYKGRLIN-G-----SEVAVKKLLNNL-GQAEKEFRVEVEAIGHV-RHKNLVRLLGYC 251 (508)
Q Consensus 180 ~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~-~-----~~vavK~~~~~~-~~~~~~~~~ei~~l~~l-~h~niv~~~~~~ 251 (508)
.+++..++|.+.+.||+|+||+||+|.+.. + ..||+|.+.... ......+.+|+.+++.+ +||||+++++++
T Consensus 40 ~~~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~ 119 (333)
T 2i1m_A 40 KWEFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGAC 119 (333)
T ss_dssp GGBCCTTSEEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred cccCCHHHceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhcccccChHHHHHHHHHHHHHHhhcCCCCeeeEEEEE
Confidence 345667899999999999999999998743 2 479999986543 33456788999999999 899999999999
Q ss_pred EeCceeeEEEeecCCCCHHHHHhhhhc----------cCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCEE
Q 010519 252 IEGVHRMLVYEYVNNGNLEQWLHGAMR----------NQGNLTWEARMKVIIGTAKALAYLHEAIEPKVVHRDIKSSNIL 321 (508)
Q Consensus 252 ~~~~~~~lv~E~~~~gsL~~~l~~~~~----------~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiH~Dlk~~NIl 321 (508)
.+....++||||+++|+|.+++..... ....+++..++.++.||+.||.|||+. +|+||||||+|||
T Consensus 120 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~NIl 196 (333)
T 2i1m_A 120 THGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASK---NCIHRDVAARNVL 196 (333)
T ss_dssp CSSSSCEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGCE
T ss_pred ecCCceEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhcC---CcccCCcccceEE
Confidence 999999999999999999999965321 134678999999999999999999999 9999999999999
Q ss_pred EcCCCcEEEEecCCccccCCCCC-cccccccccccccCccccCCCCCCChhhHHHHHHHHHHHHh-CCCCCCCCCCCchh
Q 010519 322 IDDEFNAKVSDFGLAKLLDSGES-HITTRVMGTFGYVAPEYANTGMLNEKSDIYSFGVLLLEAVT-GRDPVDYGRPANEV 399 (508)
Q Consensus 322 l~~~~~~kl~Dfgla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~ellt-G~~Pf~~~~~~~~~ 399 (508)
++.++.+||+|||++........ .......+|+.|+|||++.+..++.++|||||||++|||++ |..||........
T Consensus 197 ~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~- 275 (333)
T 2i1m_A 197 LTNGHVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILVNSK- 275 (333)
T ss_dssp EEGGGEEEBCCCGGGCCGGGCTTSEECSSCEECGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCSSHH-
T ss_pred ECCCCeEEECccccccccccccceeecCCCCCCccccCHHHhccCCCChHHHHHHHHHHHHHHHcCCCCCCcccchhHH-
Confidence 99999999999999986543322 22334557889999999999899999999999999999998 9999965432221
Q ss_pred cHHHHHHHHhcccccccccCCCCCCChhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhhcCC
Q 010519 400 NLVEWLKMMVGTRRAEEVVDPNLEVKPATRALKRSLLVALRCVDPDSEKRPKMSQVVRMLEADD 463 (508)
Q Consensus 400 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~ 463 (508)
....... ... .. .+......+.+++.+||+.||.+|||+.+++++|+...
T Consensus 276 -~~~~~~~---~~~------~~----~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~~ 325 (333)
T 2i1m_A 276 -FYKLVKD---GYQ------MA----QPAFAPKNIYSIMQACWALEPTHRPTFQQICSFLQEQA 325 (333)
T ss_dssp -HHHHHHH---TCC------CC----CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred -HHHHHhc---CCC------CC----CCCCCCHHHHHHHHHHhccChhhCcCHHHHHHHHHHHH
Confidence 1111111 000 00 01112345667999999999999999999999998653
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-43 Score=346.79 Aligned_cols=268 Identities=26% Similarity=0.388 Sum_probs=212.7
Q ss_pred eHHHHHHhhCCcccceeEeeeCceEEEEEEEc------CCCEEEEEEEcccch-hhHHHHHHHHHHHhcC-CCCCceeEE
Q 010519 177 TLRDLEIATNRFSAENVLGEGGYGVVYKGRLI------NGSEVAVKKLLNNLG-QAEKEFRVEVEAIGHV-RHKNLVRLL 248 (508)
Q Consensus 177 ~~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~-~~~~~~~~ei~~l~~l-~h~niv~~~ 248 (508)
....+++..++|.+.+.||+|+||+||+|++. +++.||+|.+..... .....+.+|+.++.++ +||||++++
T Consensus 18 ~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~ 97 (316)
T 2xir_A 18 DASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLL 97 (316)
T ss_dssp CHHHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred cccceecchhheeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccCCCcHHHHHHHHHHHHHHhcccCCCeeeEE
Confidence 45677788899999999999999999999852 457899999865443 3346788999999999 799999999
Q ss_pred EEEEeCc-eeeEEEeecCCCCHHHHHhhhhcc------------CCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEeecC
Q 010519 249 GYCIEGV-HRMLVYEYVNNGNLEQWLHGAMRN------------QGNLTWEARMKVIIGTAKALAYLHEAIEPKVVHRDI 315 (508)
Q Consensus 249 ~~~~~~~-~~~lv~E~~~~gsL~~~l~~~~~~------------~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiH~Dl 315 (508)
+++.... ..++||||+++|+|.+++...... ...+++..++.++.||+.||.|||+. +|+||||
T Consensus 98 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~i~H~di 174 (316)
T 2xir_A 98 GACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR---KCIHRDL 174 (316)
T ss_dssp EEECCTTSCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHHT---TCCCSCC
T ss_pred EEEecCCCceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHhC---CcccccC
Confidence 9988754 488999999999999999643211 12389999999999999999999999 9999999
Q ss_pred CCCCEEEcCCCcEEEEecCCccccCCCCC-cccccccccccccCccccCCCCCCChhhHHHHHHHHHHHHh-CCCCCCCC
Q 010519 316 KSSNILIDDEFNAKVSDFGLAKLLDSGES-HITTRVMGTFGYVAPEYANTGMLNEKSDIYSFGVLLLEAVT-GRDPVDYG 393 (508)
Q Consensus 316 k~~NIll~~~~~~kl~Dfgla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~ellt-G~~Pf~~~ 393 (508)
||+|||++.++.+||+|||++........ .......+|+.|+|||++.+..++.++|||||||++|+|++ |..||...
T Consensus 175 kp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~ 254 (316)
T 2xir_A 175 AARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGV 254 (316)
T ss_dssp SGGGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTC
T ss_pred ccceEEECCCCCEEECCCccccccccCccceeccCCCcceeecCchhhccccccchhHHHHHHHHHHHHHhCCCCCCccc
Confidence 99999999999999999999986644332 22344567899999999999999999999999999999998 99999654
Q ss_pred CCCchhcHHHHHHHHhcccccccccCCCCCCChhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhhcC
Q 010519 394 RPANEVNLVEWLKMMVGTRRAEEVVDPNLEVKPATRALKRSLLVALRCVDPDSEKRPKMSQVVRMLEAD 462 (508)
Q Consensus 394 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~ 462 (508)
..... +.. ....... ... +......+.+++.+||+.||.+|||+.+++++|+..
T Consensus 255 ~~~~~--~~~---~~~~~~~------~~~----~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~ 308 (316)
T 2xir_A 255 KIDEE--FCR---RLKEGTR------MRA----PDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNL 308 (316)
T ss_dssp CCSHH--HHH---HHHHTCC------CCC----CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred chhHH--HHH---HhccCcc------CCC----CCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence 32221 111 1111110 001 111234566799999999999999999999999864
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-43 Score=356.87 Aligned_cols=245 Identities=26% Similarity=0.309 Sum_probs=191.8
Q ss_pred hCCcccceeEeeeCceEEEEEEEc-CCCEEEEEEEcccch---hhHHHHHHHHHH-HhcCCCCCceeEEEEEEeCceeeE
Q 010519 185 TNRFSAENVLGEGGYGVVYKGRLI-NGSEVAVKKLLNNLG---QAEKEFRVEVEA-IGHVRHKNLVRLLGYCIEGVHRML 259 (508)
Q Consensus 185 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~ei~~-l~~l~h~niv~~~~~~~~~~~~~l 259 (508)
.++|.+.+.||+|+||.||+|++. ++..||+|++..... .....+..|..+ ++.++||||+++++++.+....|+
T Consensus 37 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~~~~~~~~l 116 (373)
T 2r5t_A 37 PSDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYF 116 (373)
T ss_dssp GGGEEEEEEEECCTTCEEEEEEETTTCCEEEEEEEEGGGBC-------------CCBCCCCCTTBCCEEEEEECSSEEEE
T ss_pred hhheEEEEEEeeCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhCCCCCCCCEEEEEEeCCEEEE
Confidence 358999999999999999999986 578899999865432 223445667666 577899999999999999999999
Q ss_pred EEeecCCCCHHHHHhhhhccCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCEEEcCCCcEEEEecCCcccc
Q 010519 260 VYEYVNNGNLEQWLHGAMRNQGNLTWEARMKVIIGTAKALAYLHEAIEPKVVHRDIKSSNILIDDEFNAKVSDFGLAKLL 339 (508)
Q Consensus 260 v~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~Dfgla~~~ 339 (508)
||||+++|+|.+++. ....+++..++.++.||+.||.|||++ +|+||||||+|||++.++++||+|||+++..
T Consensus 117 v~E~~~gg~L~~~l~----~~~~~~~~~~~~~~~qi~~aL~~LH~~---givHrDlkp~NIll~~~g~ikL~DFG~a~~~ 189 (373)
T 2r5t_A 117 VLDYINGGELFYHLQ----RERCFLEPRARFYAAEIASALGYLHSL---NIVYRDLKPENILLDSQGHIVLTDFGLCKEN 189 (373)
T ss_dssp EEECCCSCBHHHHHH----HHSSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCCCBCGGG
T ss_pred EEeCCCCCcHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCHHHEEECCCCCEEEeeCcccccc
Confidence 999999999999985 345688999999999999999999999 9999999999999999999999999999864
Q ss_pred CCCCCcccccccccccccCccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCCCchhcHHHHHHHHhcccccccccC
Q 010519 340 DSGESHITTRVMGTFGYVAPEYANTGMLNEKSDIYSFGVLLLEAVTGRDPVDYGRPANEVNLVEWLKMMVGTRRAEEVVD 419 (508)
Q Consensus 340 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 419 (508)
.... ......+||+.|+|||++.+..|+.++|||||||++|||++|..||.... ..+.........
T Consensus 190 ~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~------~~~~~~~i~~~~------- 255 (373)
T 2r5t_A 190 IEHN-STTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRN------TAEMYDNILNKP------- 255 (373)
T ss_dssp BCCC-CCCCSBSCCCCCCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSB------HHHHHHHHHHSC-------
T ss_pred ccCC-CccccccCCccccCHHHhCCCCCCchhhhHHHHHHHHHHHcCCCCCCCCC------HHHHHHHHHhcc-------
Confidence 3322 22445689999999999999999999999999999999999999996432 112222222110
Q ss_pred CCCCCChhHHHHHHHHHHHHHhcCCCCCCCCCHHH
Q 010519 420 PNLEVKPATRALKRSLLVALRCVDPDSEKRPKMSQ 454 (508)
Q Consensus 420 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~e 454 (508)
+... ......+.+|+.+||+.||.+||++.+
T Consensus 256 --~~~~--~~~~~~~~~li~~lL~~dp~~R~~~~~ 286 (373)
T 2r5t_A 256 --LQLK--PNITNSARHLLEGLLQKDRTKRLGAKD 286 (373)
T ss_dssp --CCCC--SSSCHHHHHHHHHHTCSSGGGSTTTTT
T ss_pred --cCCC--CCCCHHHHHHHHHHcccCHHhCCCCCC
Confidence 1111 112345667999999999999999753
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-42 Score=350.51 Aligned_cols=250 Identities=25% Similarity=0.363 Sum_probs=202.5
Q ss_pred CCcccceeEeeeCceEEEEEEEc-CCCEEEEEEEcccc---hhhHHHHHHHHHHHhcCCCCCceeEEEEEEeCceeeEEE
Q 010519 186 NRFSAENVLGEGGYGVVYKGRLI-NGSEVAVKKLLNNL---GQAEKEFRVEVEAIGHVRHKNLVRLLGYCIEGVHRMLVY 261 (508)
Q Consensus 186 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~ei~~l~~l~h~niv~~~~~~~~~~~~~lv~ 261 (508)
++|...+.||+|+||+||+|++. ++..||||++.... ......+.+|+.++++++||||+++++++......++||
T Consensus 54 ~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 133 (348)
T 1u5q_A 54 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM 133 (348)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred hheeeeeEEccCCCEEEEEEEEccCCeEEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCeEEEEE
Confidence 46899999999999999999874 78899999986432 233457889999999999999999999999999999999
Q ss_pred eecCCCCHHHHHhhhhccCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCEEEcCCCcEEEEecCCccccCC
Q 010519 262 EYVNNGNLEQWLHGAMRNQGNLTWEARMKVIIGTAKALAYLHEAIEPKVVHRDIKSSNILIDDEFNAKVSDFGLAKLLDS 341 (508)
Q Consensus 262 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~ 341 (508)
||+. |+|.+++.. ....+++..++.++.|++.||.|||++ +|+||||||+|||++.++.+||+|||++.....
T Consensus 134 e~~~-g~l~~~l~~---~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~ 206 (348)
T 1u5q_A 134 EYCL-GSASDLLEV---HKKPLQEVEIAAVTHGALQGLAYLHSH---NMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP 206 (348)
T ss_dssp ECCS-EEHHHHHHH---HTSCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSGGGEEEETTTEEEECCCTTCBSSSS
T ss_pred ecCC-CCHHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEECCCCCEEEeeccCceecCC
Confidence 9997 689888853 356799999999999999999999999 999999999999999999999999999986543
Q ss_pred CCCcccccccccccccCccccC---CCCCCChhhHHHHHHHHHHHHhCCCCCCCCCCCchhcHHHHHHHHhccccccccc
Q 010519 342 GESHITTRVMGTFGYVAPEYAN---TGMLNEKSDIYSFGVLLLEAVTGRDPVDYGRPANEVNLVEWLKMMVGTRRAEEVV 418 (508)
Q Consensus 342 ~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DvwS~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 418 (508)
. ....||+.|+|||++. +..++.++|||||||+||||++|+.||..... ...+........
T Consensus 207 ~-----~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~------~~~~~~~~~~~~----- 270 (348)
T 1u5q_A 207 A-----NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNA------MSALYHIAQNES----- 270 (348)
T ss_dssp B-----CCCCSCGGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCH------HHHHHHHHHSCC-----
T ss_pred C-----CcccCCcceeCHhhhccccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCh------HHHHHHHHhcCC-----
Confidence 2 3357899999999984 56789999999999999999999999864321 111112211111
Q ss_pred CCCCCCChhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhhcC
Q 010519 419 DPNLEVKPATRALKRSLLVALRCVDPDSEKRPKMSQVVRMLEAD 462 (508)
Q Consensus 419 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~ 462 (508)
+..... .....+.+|+.+||+.||.+|||+.+++++..-.
T Consensus 271 -~~~~~~---~~~~~l~~li~~~l~~dP~~Rps~~~ll~h~~~~ 310 (348)
T 1u5q_A 271 -PALQSG---HWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRFVL 310 (348)
T ss_dssp -CCCCCT---TSCHHHHHHHHHHTCSSGGGSCCHHHHTTCHHHH
T ss_pred -CCCCCC---CCCHHHHHHHHHHcccChhhCcCHHHHhhChhhh
Confidence 111111 1234456799999999999999999999876543
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-42 Score=342.99 Aligned_cols=267 Identities=24% Similarity=0.322 Sum_probs=199.5
Q ss_pred HhhCCcccceeEeeeCceEEEEEEE-cCCCEEEEEEEcccch-----hhHHHHHHHHHHHhcC---CCCCceeEEEEEEe
Q 010519 183 IATNRFSAENVLGEGGYGVVYKGRL-INGSEVAVKKLLNNLG-----QAEKEFRVEVEAIGHV---RHKNLVRLLGYCIE 253 (508)
Q Consensus 183 ~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~-----~~~~~~~~ei~~l~~l---~h~niv~~~~~~~~ 253 (508)
+..++|.+.+.||+|+||+||+|++ .+++.||+|++..... .....+.+|+.+++.+ +||||+++++++..
T Consensus 6 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~~~~ 85 (308)
T 3g33_A 6 MATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVCAT 85 (308)
T ss_dssp ----CCEEEEEECCSSSCCEEEEECTTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEEEEE
T ss_pred ccccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeeeeec
Confidence 4567999999999999999999986 4788999999864321 1123455677776665 59999999999987
Q ss_pred Cc-----eeeEEEeecCCCCHHHHHhhhhccCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCEEEcCCCcE
Q 010519 254 GV-----HRMLVYEYVNNGNLEQWLHGAMRNQGNLTWEARMKVIIGTAKALAYLHEAIEPKVVHRDIKSSNILIDDEFNA 328 (508)
Q Consensus 254 ~~-----~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiH~Dlk~~NIll~~~~~~ 328 (508)
.. ..++||||+. |+|.+++.. .....+++..++.++.||+.||.|||++ +|+||||||+|||++.++.+
T Consensus 86 ~~~~~~~~~~lv~e~~~-~~L~~~~~~--~~~~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dlkp~Nil~~~~~~~ 159 (308)
T 3g33_A 86 SRTDREIKVTLVFEHVD-QDLRTYLDK--APPPGLPAETIKDLMRQFLRGLDFLHAN---CIVHRDLKPENILVTSGGTV 159 (308)
T ss_dssp CCSSSEEEEEEEEECCC-CBHHHHHHT--CCTTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCTTTEEECTTSCE
T ss_pred cCCCCceeEEEEehhhh-cCHHHHHhh--ccCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEcCCCCE
Confidence 64 4789999996 599999964 2334599999999999999999999999 99999999999999999999
Q ss_pred EEEecCCccccCCCCCcccccccccccccCccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCCCchhcHHHHHHHH
Q 010519 329 KVSDFGLAKLLDSGESHITTRVMGTFGYVAPEYANTGMLNEKSDIYSFGVLLLEAVTGRDPVDYGRPANEVNLVEWLKMM 408 (508)
Q Consensus 329 kl~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~ 408 (508)
||+|||++....... ......||+.|+|||++.+..++.++|||||||++|+|++|+.||..... ......+...
T Consensus 160 kl~Dfg~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~---~~~~~~i~~~ 234 (308)
T 3g33_A 160 KLADFGLARIYSYQM--ALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSE---ADQLGKIFDL 234 (308)
T ss_dssp EECSCSCTTTSTTCC--CSGGGGCCCSSCCHHHHHTSCCCSTHHHHHHHHHHHHTTTSSCSCCCSSH---HHHHHHHHHH
T ss_pred EEeeCccccccCCCc--ccCCccccccccCchHHcCCCCCchHHHHHHHHHHHHHHhCCCCCCCCCH---HHHHHHHHHH
Confidence 999999998765432 23456789999999999999999999999999999999999999964321 1222222222
Q ss_pred hccccccccc----------CCCCCCC---hhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhh
Q 010519 409 VGTRRAEEVV----------DPNLEVK---PATRALKRSLLVALRCVDPDSEKRPKMSQVVRMLE 460 (508)
Q Consensus 409 ~~~~~~~~~~----------~~~~~~~---~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 460 (508)
.+........ .+..... ........+.+|+.+||+.||.+|||+.|+++|-+
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h~~ 299 (308)
T 3g33_A 235 IGLPPEDDWPRDVSLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQHSY 299 (308)
T ss_dssp HCCCCTTTSCSSCSSCGGGSCCCCCCCHHHHSCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTSTT
T ss_pred hCCCChhhccchhhccccccCCCCCCcHHHhCccccHHHHHHHHHHhcCCCccCCCHHHHhcCcc
Confidence 2111110000 0000000 00122356677999999999999999999998643
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-42 Score=357.33 Aligned_cols=253 Identities=21% Similarity=0.327 Sum_probs=198.5
Q ss_pred CCcccceeEeeeCceEEEEEEEcCCCEEEEEEEcccc--hhhHHHHHHHHHHHhcCC--CCCceeEEEEEEeCceeeEEE
Q 010519 186 NRFSAENVLGEGGYGVVYKGRLINGSEVAVKKLLNNL--GQAEKEFRVEVEAIGHVR--HKNLVRLLGYCIEGVHRMLVY 261 (508)
Q Consensus 186 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~--~~~~~~~~~ei~~l~~l~--h~niv~~~~~~~~~~~~~lv~ 261 (508)
.+|.+.+.||+|+||+||++.+.+++.||||++.... ......+.+|+.+|..+. ||||+++++++......|+||
T Consensus 56 ~~y~~~~~LG~G~fg~Vy~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~~~~~~lv~ 135 (390)
T 2zmd_A 56 RIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVM 135 (390)
T ss_dssp EEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEE
T ss_pred CceEEEEEEccCCCeEEEEEEcCCCCEEEEEEEecccccHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEecCCEEEEEE
Confidence 4699999999999999999998889999999986432 344567899999999996 599999999999999999999
Q ss_pred eecCCCCHHHHHhhhhccCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCEEEcCCCcEEEEecCCccccCC
Q 010519 262 EYVNNGNLEQWLHGAMRNQGNLTWEARMKVIIGTAKALAYLHEAIEPKVVHRDIKSSNILIDDEFNAKVSDFGLAKLLDS 341 (508)
Q Consensus 262 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~ 341 (508)
| +.+++|.+++. ....+++..++.++.||+.||.|||+. +|+||||||+|||++ ++.+||+|||+++....
T Consensus 136 E-~~~~~L~~~l~----~~~~~~~~~~~~i~~qi~~aL~~lH~~---~ivHrDlkp~NIll~-~~~~kl~DFG~a~~~~~ 206 (390)
T 2zmd_A 136 E-CGNIDLNSWLK----KKKSIDPWERKSYWKNMLEAVHTIHQH---GIVHSDLKPANFLIV-DGMLKLIDFGIANQMQP 206 (390)
T ss_dssp E-CCSEEHHHHHH----HCSSCCHHHHHHHHHHHHHHHHHHHTT---TCCCCCCCGGGEEES-SSCEEECCCSSSCCC--
T ss_pred e-cCCCCHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHEEEE-CCeEEEEecCccccccC
Confidence 9 56889999995 345788999999999999999999999 999999999999996 57999999999987654
Q ss_pred CCCc-ccccccccccccCccccCC-----------CCCCChhhHHHHHHHHHHHHhCCCCCCCCCCCchhcHHHHHHHHh
Q 010519 342 GESH-ITTRVMGTFGYVAPEYANT-----------GMLNEKSDIYSFGVLLLEAVTGRDPVDYGRPANEVNLVEWLKMMV 409 (508)
Q Consensus 342 ~~~~-~~~~~~gt~~y~aPE~~~~-----------~~~~~~~DvwS~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~ 409 (508)
.... .....+||+.|+|||++.+ ..++.++|||||||+||||++|+.||..... ....+....
T Consensus 207 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~-----~~~~~~~~~ 281 (390)
T 2zmd_A 207 DTTSVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIIN-----QISKLHAII 281 (390)
T ss_dssp -------CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHHSSCTTTTCCC-----HHHHHHHHH
T ss_pred CCccccCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHCCCcchhhhH-----HHHHHHHHh
Confidence 3221 2345679999999999865 4689999999999999999999999964321 111222222
Q ss_pred cccccccccCCCCCCChhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhhc
Q 010519 410 GTRRAEEVVDPNLEVKPATRALKRSLLVALRCVDPDSEKRPKMSQVVRMLEA 461 (508)
Q Consensus 410 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~ 461 (508)
... .....+......+.+|+.+||+.||.+|||+.|++++.+-
T Consensus 282 ~~~---------~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~hp~~ 324 (390)
T 2zmd_A 282 DPN---------HEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYV 324 (390)
T ss_dssp CTT---------SCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHH
T ss_pred Ccc---------ccCCCCccchHHHHHHHHHHcccChhhCCCHHHHhhCcCc
Confidence 111 1111111113456679999999999999999999987644
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-42 Score=369.87 Aligned_cols=260 Identities=24% Similarity=0.307 Sum_probs=210.8
Q ss_pred HhhCCcccceeEeeeCceEEEEEEEc-CCCEEEEEEEcccc---hhhHHHHHHHHHHHhcCCCCCceeEEEEEEeCceee
Q 010519 183 IATNRFSAENVLGEGGYGVVYKGRLI-NGSEVAVKKLLNNL---GQAEKEFRVEVEAIGHVRHKNLVRLLGYCIEGVHRM 258 (508)
Q Consensus 183 ~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~ei~~l~~l~h~niv~~~~~~~~~~~~~ 258 (508)
+..++|.+.+.||+|+||.||+|++. +|+.||+|++.... ......+.+|+.+|+.++||||+++++++.+....|
T Consensus 181 ~~~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~ 260 (576)
T 2acx_A 181 VTKNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALC 260 (576)
T ss_dssp CCGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred ccccceEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHcCCCCEeeEEEEEeeCCEEE
Confidence 45578999999999999999999985 68999999985432 223456788999999999999999999999999999
Q ss_pred EEEeecCCCCHHHHHhhhhccCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCEEEcCCCcEEEEecCCccc
Q 010519 259 LVYEYVNNGNLEQWLHGAMRNQGNLTWEARMKVIIGTAKALAYLHEAIEPKVVHRDIKSSNILIDDEFNAKVSDFGLAKL 338 (508)
Q Consensus 259 lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~Dfgla~~ 338 (508)
+||||+++|+|.+++.. .....+++..++.++.||+.||.|||++ +|+||||||+|||++.++++||+|||++..
T Consensus 261 lVmEy~~gg~L~~~l~~--~~~~~l~e~~~~~i~~qIl~aL~yLH~~---gIvHrDLKPeNILld~~g~vKL~DFGla~~ 335 (576)
T 2acx_A 261 LVLTLMNGGDLKFHIYH--MGQAGFPEARAVFYAAEICCGLEDLHRE---RIVYRDLKPENILLDDHGHIRISDLGLAVH 335 (576)
T ss_dssp EEECCCCSCBHHHHHHS--SSSCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTSCEEECCCTTCEE
T ss_pred EEEEcCCCCcHHHHHHh--cCCCCCCHHHHHHHHHHHHHHHHHHHHC---CEeccCCchheEEEeCCCCeEEEeccccee
Confidence 99999999999999863 2234589999999999999999999999 999999999999999999999999999987
Q ss_pred cCCCCCcccccccccccccCccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCCCchhcHHHHHHHHhccccccccc
Q 010519 339 LDSGESHITTRVMGTFGYVAPEYANTGMLNEKSDIYSFGVLLLEAVTGRDPVDYGRPANEVNLVEWLKMMVGTRRAEEVV 418 (508)
Q Consensus 339 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 418 (508)
...... ....+||+.|+|||++.+..|+.++|||||||+||||++|+.||........ ........... .
T Consensus 336 ~~~~~~--~~~~~GT~~Y~APEvl~~~~~~~~~DiwSLGvilyeLltG~~PF~~~~~~~~--~~~i~~~i~~~-~----- 405 (576)
T 2acx_A 336 VPEGQT--IKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIK--REEVERLVKEV-P----- 405 (576)
T ss_dssp CCTTCC--EECCCSCGGGCCHHHHTTCEESSHHHHHHHHHHHHHHHHSSCSSSCSSSCCC--HHHHHHHHHHC-C-----
T ss_pred cccCcc--ccccCCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCcccccchh--HHHHHHHhhcc-c-----
Confidence 654332 3445899999999999999999999999999999999999999975432211 11111111111 0
Q ss_pred CCCCCCChhHHHHHHHHHHHHHhcCCCCCCCC-----CHHHHHHHhhcC
Q 010519 419 DPNLEVKPATRALKRSLLVALRCVDPDSEKRP-----KMSQVVRMLEAD 462 (508)
Q Consensus 419 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~evl~~L~~~ 462 (508)
..+. ......+.+|+.+||+.||.+|| ++.|+++|-.-.
T Consensus 406 -~~~p----~~~s~~~~dLI~~lL~~dP~~R~g~~~~sa~eil~HpfF~ 449 (576)
T 2acx_A 406 -EEYS----ERFSPQARSLCSQLLCKDPAERLGCRGGSAREVKEHPLFK 449 (576)
T ss_dssp -CCCC----TTSCHHHHHHHHHHTCSSGGGSTTCSSSHHHHHHTSGGGT
T ss_pred -ccCC----ccCCHHHHHHHHHhccCCHHHcCCCCCCCHHHHHhChhhc
Confidence 1111 11234567799999999999999 789999875443
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-43 Score=355.01 Aligned_cols=260 Identities=25% Similarity=0.331 Sum_probs=206.8
Q ss_pred hCCcccceeEeeeCceEEEEEEE----cCCCEEEEEEEcccc----hhhHHHHHHHHHHHhcC-CCCCceeEEEEEEeCc
Q 010519 185 TNRFSAENVLGEGGYGVVYKGRL----INGSEVAVKKLLNNL----GQAEKEFRVEVEAIGHV-RHKNLVRLLGYCIEGV 255 (508)
Q Consensus 185 ~~~~~~~~~lg~G~~g~Vy~~~~----~~~~~vavK~~~~~~----~~~~~~~~~ei~~l~~l-~h~niv~~~~~~~~~~ 255 (508)
.++|.+.+.||+|+||+||+++. .+++.||||++.... ......+..|+.++..+ +||||+++++++....
T Consensus 53 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~ 132 (355)
T 1vzo_A 53 IENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTET 132 (355)
T ss_dssp GGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETT
T ss_pred ccceEEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEEEeeCc
Confidence 46899999999999999999987 378999999985432 12234566799999999 6999999999999999
Q ss_pred eeeEEEeecCCCCHHHHHhhhhccCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCEEEcCCCcEEEEecCC
Q 010519 256 HRMLVYEYVNNGNLEQWLHGAMRNQGNLTWEARMKVIIGTAKALAYLHEAIEPKVVHRDIKSSNILIDDEFNAKVSDFGL 335 (508)
Q Consensus 256 ~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~Dfgl 335 (508)
..++||||+++|+|.+++.. ...+++..++.++.||+.||.|||++ +|+||||||+|||++.++.+||+|||+
T Consensus 133 ~~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kl~DfG~ 205 (355)
T 1vzo_A 133 KLHLILDYINGGELFTHLSQ----RERFTEHEVQIYVGEIVLALEHLHKL---GIIYRDIKLENILLDSNGHVVLTDFGL 205 (355)
T ss_dssp EEEEEECCCCSCBHHHHHHH----HSCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEESCSSE
T ss_pred eEEEEeecCCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCcEEEeeCCC
Confidence 99999999999999999953 45689999999999999999999999 999999999999999999999999999
Q ss_pred ccccCCCCCcccccccccccccCccccCC--CCCCChhhHHHHHHHHHHHHhCCCCCCCCCCCchhcHHHHHHHHhcccc
Q 010519 336 AKLLDSGESHITTRVMGTFGYVAPEYANT--GMLNEKSDIYSFGVLLLEAVTGRDPVDYGRPANEVNLVEWLKMMVGTRR 413 (508)
Q Consensus 336 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~DvwS~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~ 413 (508)
++.............+||+.|+|||++.+ ..++.++|||||||+||||++|+.||........ ............
T Consensus 206 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~--~~~~~~~~~~~~- 282 (355)
T 1vzo_A 206 SKEFVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNS--QAEISRRILKSE- 282 (355)
T ss_dssp EEECCGGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCC--HHHHHHHHHHCC-
T ss_pred CeecccCCCCcccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCCCCCccCCccch--HHHHHHHHhccC-
Confidence 98765443333445679999999999986 3478999999999999999999999964433221 122222221110
Q ss_pred cccccCCCCCCChhHHHHHHHHHHHHHhcCCCCCCCC-----CHHHHHHHhhcCCC
Q 010519 414 AEEVVDPNLEVKPATRALKRSLLVALRCVDPDSEKRP-----KMSQVVRMLEADDY 464 (508)
Q Consensus 414 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~evl~~L~~~~~ 464 (508)
+.+. ......+.+|+.+||..||.+|| |+.|++++..-...
T Consensus 283 ------~~~~----~~~~~~~~~li~~~L~~dP~~R~~~~~~s~~ell~h~~f~~~ 328 (355)
T 1vzo_A 283 ------PPYP----QEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLFFQKI 328 (355)
T ss_dssp ------CCCC----TTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSGGGTTC
T ss_pred ------CCCC----cccCHHHHHHHHHHhhhCHHHhcCCCCCCHHHHHcCcchhcC
Confidence 1111 11234566799999999999999 99999998876544
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-41 Score=334.44 Aligned_cols=260 Identities=19% Similarity=0.260 Sum_probs=205.2
Q ss_pred hCCcccceeEeeeCceEEEEEEE-cCCCEEEEEEEcccchhhHHHHHHHHHHHhcCCCCCceeEEEEE-EeCceeeEEEe
Q 010519 185 TNRFSAENVLGEGGYGVVYKGRL-INGSEVAVKKLLNNLGQAEKEFRVEVEAIGHVRHKNLVRLLGYC-IEGVHRMLVYE 262 (508)
Q Consensus 185 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~ei~~l~~l~h~niv~~~~~~-~~~~~~~lv~E 262 (508)
.++|.+.+.||+|+||.||+|++ .+++.||+|++..... ...+..|+.+++.++|++++..+.++ ......++|||
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e 85 (296)
T 3uzp_A 8 GNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK--HPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVME 85 (296)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEESCSS--CCHHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEEE
T ss_pred ccEEEEEEEEccCCCeEEEEEEEcCCCcEEEEEEecCCcc--hhHHHHHHHHHHHhhcCCCCCccccccCCCCceEEEEE
Confidence 46899999999999999999987 4788999998865432 23578899999999988877666655 56677899999
Q ss_pred ecCCCCHHHHHhhhhccCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCEEE---cCCCcEEEEecCCcccc
Q 010519 263 YVNNGNLEQWLHGAMRNQGNLTWEARMKVIIGTAKALAYLHEAIEPKVVHRDIKSSNILI---DDEFNAKVSDFGLAKLL 339 (508)
Q Consensus 263 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiH~Dlk~~NIll---~~~~~~kl~Dfgla~~~ 339 (508)
|+ +++|.+++.. ....+++..++.++.||+.||.|||++ +|+||||||+|||+ +.++.+||+|||++...
T Consensus 86 ~~-~~~L~~~~~~---~~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~~ 158 (296)
T 3uzp_A 86 LL-GPSLEDLFNF---CSRKFSLKTVLLLADQMISRIEYIHSK---NFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKY 158 (296)
T ss_dssp CC-CCBHHHHHHH---TTTCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECCGGGTTCEEECCCTTCEEC
T ss_pred ec-CCCHHHHHHh---hccCCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHeEEecCCCCCeEEEeeCCCcccc
Confidence 99 8999999962 345799999999999999999999999 99999999999999 48889999999999876
Q ss_pred CCCCCc------ccccccccccccCccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCCCchhcHHHHHHHHhcccc
Q 010519 340 DSGESH------ITTRVMGTFGYVAPEYANTGMLNEKSDIYSFGVLLLEAVTGRDPVDYGRPANEVNLVEWLKMMVGTRR 413 (508)
Q Consensus 340 ~~~~~~------~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~ 413 (508)
...... ......||+.|+|||++.+..++.++|||||||+||||++|+.||..............+........
T Consensus 159 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 238 (296)
T 3uzp_A 159 RDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTP 238 (296)
T ss_dssp BCTTTCCBCCCCCSCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHHSC
T ss_pred cccccccccccccccccccccccCChhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCcCchhhhhhhhhhcccccCCc
Confidence 543321 12445799999999999999999999999999999999999999976543333322222211110000
Q ss_pred cccccCCCCCCChhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhhcC
Q 010519 414 AEEVVDPNLEVKPATRALKRSLLVALRCVDPDSEKRPKMSQVVRMLEAD 462 (508)
Q Consensus 414 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~ 462 (508)
.... .......+.+++.+||+.||.+|||+.++++.|+..
T Consensus 239 ~~~~---------~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~ 278 (296)
T 3uzp_A 239 IEVL---------CKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNL 278 (296)
T ss_dssp HHHH---------TTTSCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHH
T ss_pred hHHH---------HhhCCHHHHHHHHHHHhcCcCcCCCHHHHHHHHHHH
Confidence 0000 011234577799999999999999999999999864
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-42 Score=344.93 Aligned_cols=265 Identities=26% Similarity=0.437 Sum_probs=200.2
Q ss_pred HHHHHhhCCcccceeEeeeCceEEEEEEEcC----CCEEEEEEEcccc--hhhHHHHHHHHHHHhcCCCCCceeEEEEEE
Q 010519 179 RDLEIATNRFSAENVLGEGGYGVVYKGRLIN----GSEVAVKKLLNNL--GQAEKEFRVEVEAIGHVRHKNLVRLLGYCI 252 (508)
Q Consensus 179 ~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~----~~~vavK~~~~~~--~~~~~~~~~ei~~l~~l~h~niv~~~~~~~ 252 (508)
.++.+..++|.+.+.||+|+||+||+|.+.. +..||+|.+.... ......+.+|+.++++++||||+++++++.
T Consensus 27 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~ 106 (313)
T 3brb_A 27 EDVVIDRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRLLGVCI 106 (313)
T ss_dssp TTTBCCGGGEEEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---CCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEE
T ss_pred HhcccCHHHeeeccceeecCCeEEEEEEEeccCCceeEEEEEEEeccccchhHHHHHHHHHHHHhcCCCCCeeeeeEEEe
Confidence 4445667799999999999999999998652 3479999886442 333467889999999999999999999998
Q ss_pred eCc-----eeeEEEeecCCCCHHHHHhhhh--ccCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCEEEcCC
Q 010519 253 EGV-----HRMLVYEYVNNGNLEQWLHGAM--RNQGNLTWEARMKVIIGTAKALAYLHEAIEPKVVHRDIKSSNILIDDE 325 (508)
Q Consensus 253 ~~~-----~~~lv~E~~~~gsL~~~l~~~~--~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiH~Dlk~~NIll~~~ 325 (508)
+.. ..++||||+++|+|.+++.... .....+++..++.++.||+.||.|||++ +|+||||||+|||++.+
T Consensus 107 ~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dikp~NIli~~~ 183 (313)
T 3brb_A 107 EMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNR---NFLHRDLAARNCMLRDD 183 (313)
T ss_dssp C-------CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHHTT---TCCCCCCSGGGEEECTT
T ss_pred eccccCCcccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCcceEEEcCC
Confidence 754 3489999999999999985432 2345699999999999999999999999 99999999999999999
Q ss_pred CcEEEEecCCccccCCCCC-cccccccccccccCccccCCCCCCChhhHHHHHHHHHHHHh-CCCCCCCCCCCchhcHHH
Q 010519 326 FNAKVSDFGLAKLLDSGES-HITTRVMGTFGYVAPEYANTGMLNEKSDIYSFGVLLLEAVT-GRDPVDYGRPANEVNLVE 403 (508)
Q Consensus 326 ~~~kl~Dfgla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~ellt-G~~Pf~~~~~~~~~~~~~ 403 (508)
+.+||+|||++........ .......+++.|+|||.+.+..++.++|||||||++|+|++ |..||...... ....
T Consensus 184 ~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~---~~~~ 260 (313)
T 3brb_A 184 MTVCVADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQNH---EMYD 260 (313)
T ss_dssp SCEEECSCSCC----------------CCGGGSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGG---GHHH
T ss_pred CcEEEeecCcceecccccccCcccccCCCccccCchhhcCCCccchhhhHHHHHHHHHHHhcCCCCCccCCHH---HHHH
Confidence 9999999999986643322 12233456889999999999999999999999999999999 88898644322 1111
Q ss_pred HHHHHhcccccccccCCCCCCChhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhhcC
Q 010519 404 WLKMMVGTRRAEEVVDPNLEVKPATRALKRSLLVALRCVDPDSEKRPKMSQVVRMLEAD 462 (508)
Q Consensus 404 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~ 462 (508)
....... ...+......+.+++.+||+.||.+|||+.+++++|+..
T Consensus 261 ---~~~~~~~----------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~l 306 (313)
T 3brb_A 261 ---YLLHGHR----------LKQPEDCLDELYEIMYSCWRTDPLDRPTFSVLRLQLEKL 306 (313)
T ss_dssp ---HHHTTCC----------CCCBTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHH
T ss_pred ---HHHcCCC----------CCCCccccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence 1111111 011112334677799999999999999999999999864
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-42 Score=336.37 Aligned_cols=254 Identities=24% Similarity=0.364 Sum_probs=205.8
Q ss_pred CCcccceeEeeeCceEEEEEEEc-CCCEEEEEEEcccc-hhhHHHHHHHHHHHhcCCCCCceeEEEEEEeCceeeEEEee
Q 010519 186 NRFSAENVLGEGGYGVVYKGRLI-NGSEVAVKKLLNNL-GQAEKEFRVEVEAIGHVRHKNLVRLLGYCIEGVHRMLVYEY 263 (508)
Q Consensus 186 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~ei~~l~~l~h~niv~~~~~~~~~~~~~lv~E~ 263 (508)
++|.+.+.||+|+||.||+|.+. +++.||+|.+.... ......+.+|+.+++.++||||+++++++.+....++||||
T Consensus 7 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 86 (276)
T 2yex_A 7 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEY 86 (276)
T ss_dssp HHEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGCTTHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred cceEEEEEeecCCCcEEEEEEECCCCcEEEEEEeeeccchhhhHHHHHHHHHHHhcCCCCceeeeeEEEcCCEEEEEEEe
Confidence 57999999999999999999886 68899999986433 34456788999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhhhhccCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCEEEcCCCcEEEEecCCccccCCCC
Q 010519 264 VNNGNLEQWLHGAMRNQGNLTWEARMKVIIGTAKALAYLHEAIEPKVVHRDIKSSNILIDDEFNAKVSDFGLAKLLDSGE 343 (508)
Q Consensus 264 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~~~ 343 (508)
+++++|.+++ .....+++..++.++.|++.||.|||+. +++|+||||+||+++.++.+||+|||++.......
T Consensus 87 ~~~~~L~~~l----~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~ 159 (276)
T 2yex_A 87 CSGGELFDRI----EPDIGMPEPDAQRFFHQLMAGVVYLHGI---GITHRDIKPENLLLDERDNLKISDFGLATVFRYNN 159 (276)
T ss_dssp CTTEEGGGGS----BTTTBCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCTTCEECEETT
T ss_pred cCCCcHHHHH----hhccCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCChHHEEEccCCCEEEeeCCCccccCCCc
Confidence 9999999987 3456789999999999999999999999 99999999999999999999999999998654322
Q ss_pred C-cccccccccccccCccccCCCCC-CChhhHHHHHHHHHHHHhCCCCCCCCCCCchhcHHHHHHHHhcccccccccCCC
Q 010519 344 S-HITTRVMGTFGYVAPEYANTGML-NEKSDIYSFGVLLLEAVTGRDPVDYGRPANEVNLVEWLKMMVGTRRAEEVVDPN 421 (508)
Q Consensus 344 ~-~~~~~~~gt~~y~aPE~~~~~~~-~~~~DvwS~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 421 (508)
. .......|++.|+|||++.+..+ +.++||||||+++|+|++|..||....... .....+. ...
T Consensus 160 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~-~~~~~~~----~~~--------- 225 (276)
T 2yex_A 160 RERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSC-QEYSDWK----EKK--------- 225 (276)
T ss_dssp EECCBCCCCSCGGGCCGGGGTCSSBCHHHHHHHHHHHHHHHHHHSSCCCSCSCTTS-HHHHHHH----TTC---------
T ss_pred chhcccCCccccCccChHHHhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCchHH-HHHHHhh----hcc---------
Confidence 1 12344578999999999987665 779999999999999999999997543321 1111111 110
Q ss_pred CCCChhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhh
Q 010519 422 LEVKPATRALKRSLLVALRCVDPDSEKRPKMSQVVRMLE 460 (508)
Q Consensus 422 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 460 (508)
............+.+|+.+||+.||.+|||+.|++++.+
T Consensus 226 ~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~ 264 (276)
T 2yex_A 226 TYLNPWKKIDSAPLALLHKILVENPSARITIPDIKKDRW 264 (276)
T ss_dssp TTSTTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTCTT
T ss_pred cccCchhhcCHHHHHHHHHHCCCCchhCCCHHHHhcCcc
Confidence 011111223445667999999999999999999998644
|
| >4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-41 Score=335.40 Aligned_cols=261 Identities=19% Similarity=0.252 Sum_probs=201.9
Q ss_pred hhCCcccceeEeeeCceEEEEEEE-cCCCEEEEEEEcccchhhHHHHHHHHHHHhcCCCCCceeEEEEE-EeCceeeEEE
Q 010519 184 ATNRFSAENVLGEGGYGVVYKGRL-INGSEVAVKKLLNNLGQAEKEFRVEVEAIGHVRHKNLVRLLGYC-IEGVHRMLVY 261 (508)
Q Consensus 184 ~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~ei~~l~~l~h~niv~~~~~~-~~~~~~~lv~ 261 (508)
..++|.+.+.||+|+||+||+|++ .+++.||||++..... ...+..|+.+++.++|++++..+.++ ......++||
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~ 84 (296)
T 4hgt_A 7 VGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK--HPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVM 84 (296)
T ss_dssp ----CEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEC-----CCCHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEE
T ss_pred cCCceEEeeeecCCCCeEEEEEEEcCCCceEEEEeeccccc--chHHHHHHHHHHHhcCCCCCCeeeeecCCCCceEEEE
Confidence 346899999999999999999987 4788999998654322 23477799999999988877776665 5667789999
Q ss_pred eecCCCCHHHHHhhhhccCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCEEE---cCCCcEEEEecCCccc
Q 010519 262 EYVNNGNLEQWLHGAMRNQGNLTWEARMKVIIGTAKALAYLHEAIEPKVVHRDIKSSNILI---DDEFNAKVSDFGLAKL 338 (508)
Q Consensus 262 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiH~Dlk~~NIll---~~~~~~kl~Dfgla~~ 338 (508)
||+ +++|.+++.. ....+++..++.++.||+.||.|||++ +|+||||||+|||+ ++++.+||+|||++..
T Consensus 85 e~~-~~~L~~~~~~---~~~~~~~~~~~~i~~qi~~~l~~LH~~---~ivH~Dlkp~NIl~~~~~~~~~~kL~Dfg~a~~ 157 (296)
T 4hgt_A 85 ELL-GPSLEDLFNF---CSRKFSLKTVLLLADQMISRIEYIHSK---NFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKK 157 (296)
T ss_dssp ECC-CCBHHHHHHH---TTSCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECCGGGTTCEEECCCTTCEE
T ss_pred Ecc-CCCHHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeeeeccCCCCeEEEecCcccee
Confidence 999 9999999862 355699999999999999999999999 99999999999999 7899999999999987
Q ss_pred cCCCCC------cccccccccccccCccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCCCchhcHHHHHHHHhccc
Q 010519 339 LDSGES------HITTRVMGTFGYVAPEYANTGMLNEKSDIYSFGVLLLEAVTGRDPVDYGRPANEVNLVEWLKMMVGTR 412 (508)
Q Consensus 339 ~~~~~~------~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~ 412 (508)
...... .......||+.|+|||++.+..++.++|||||||++|+|++|+.||......................
T Consensus 158 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 237 (296)
T 4hgt_A 158 YRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMST 237 (296)
T ss_dssp CBCTTTCCBCCCCCSCCCCSCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHHS
T ss_pred ccCcccCccCCCCcccccCCCccccchHHhcCCCCCchhHHHHHHHHHHHHhcCCCCCcccchhhhhhhhhhhhcccccc
Confidence 654332 12234678999999999999999999999999999999999999997654443333322211111000
Q ss_pred ccccccCCCCCCChhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhhcC
Q 010519 413 RAEEVVDPNLEVKPATRALKRSLLVALRCVDPDSEKRPKMSQVVRMLEAD 462 (508)
Q Consensus 413 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~ 462 (508)
..... .......+.+++.+||+.||.+|||+.++++.|+..
T Consensus 238 ~~~~~---------~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~~ 278 (296)
T 4hgt_A 238 PIEVL---------CKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNL 278 (296)
T ss_dssp CHHHH---------TTTSCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHH
T ss_pred hhhhh---------hccCCHHHHHHHHHHHhcCCCCCCCHHHHHHHHHHH
Confidence 00000 001134677799999999999999999999999764
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-42 Score=353.07 Aligned_cols=266 Identities=24% Similarity=0.335 Sum_probs=193.7
Q ss_pred HhhCCcccceeEeeeCceEEEEEEEc-CCCEEEEEEEccc--chhhHHHHHHHHHHHhcCC-CCCceeEEEEEEeCc--e
Q 010519 183 IATNRFSAENVLGEGGYGVVYKGRLI-NGSEVAVKKLLNN--LGQAEKEFRVEVEAIGHVR-HKNLVRLLGYCIEGV--H 256 (508)
Q Consensus 183 ~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~ei~~l~~l~-h~niv~~~~~~~~~~--~ 256 (508)
...++|.+.+.||+|+||+||+|.+. +|+.||||++... .......+.+|+.++..+. ||||+++++++...+ .
T Consensus 6 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~ 85 (388)
T 3oz6_A 6 HVLRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLLNVLRADNDRD 85 (388)
T ss_dssp HHHTTEEEEEC-------CEEEEEETTTCCEEEEEEECC--CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECTTSSC
T ss_pred cccCceEEEEEeeeCCCeEEEEEEECCCCCEEEEEEecccccChHHHHHHHHHHHHHHhccCCCCCCeeeeEEecCCCCE
Confidence 34579999999999999999999875 6899999998543 2344456778999999997 999999999998654 6
Q ss_pred eeEEEeecCCCCHHHHHhhhhccCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCEEEcCCCcEEEEecCCc
Q 010519 257 RMLVYEYVNNGNLEQWLHGAMRNQGNLTWEARMKVIIGTAKALAYLHEAIEPKVVHRDIKSSNILIDDEFNAKVSDFGLA 336 (508)
Q Consensus 257 ~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~Dfgla 336 (508)
.|+||||++ |+|.+++.. ..+++..+..++.||+.||.|||+. +|+||||||+|||++.++.+||+|||++
T Consensus 86 ~~lv~e~~~-~~L~~~~~~-----~~~~~~~~~~i~~qi~~~L~~LH~~---~ivHrDlkp~NIll~~~~~~kl~DFG~a 156 (388)
T 3oz6_A 86 VYLVFDYME-TDLHAVIRA-----NILEPVHKQYVVYQLIKVIKYLHSG---GLLHRDMKPSNILLNAECHVKVADFGLS 156 (388)
T ss_dssp EEEEEECCS-EEHHHHHHH-----TCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTC
T ss_pred EEEEecccC-cCHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHhC---CEEeCCCCHHHeEEcCCCCEEecCCccc
Confidence 799999997 599998853 4688999999999999999999999 9999999999999999999999999999
Q ss_pred cccCCC--------------------CCcccccccccccccCccccCC-CCCCChhhHHHHHHHHHHHHhCCCCCCCCCC
Q 010519 337 KLLDSG--------------------ESHITTRVMGTFGYVAPEYANT-GMLNEKSDIYSFGVLLLEAVTGRDPVDYGRP 395 (508)
Q Consensus 337 ~~~~~~--------------------~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwS~Gvvl~elltG~~Pf~~~~~ 395 (508)
+..... .....+..+||+.|+|||++.+ ..|+.++|||||||+||||++|+.||.....
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~ 236 (388)
T 3oz6_A 157 RSFVNIRRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPGSST 236 (388)
T ss_dssp EESSSCCCCCCCGGGCCC---------------CCCGGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSH
T ss_pred ccccccccccccccccccccccccccccccccCCcccCCcCCHHHhcCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCH
Confidence 865321 1112344689999999999976 6799999999999999999999999964321
Q ss_pred CchhcHHHHHHHHhccccccccc---------------------CCCCCCChh------------HHHHHHHHHHHHHhc
Q 010519 396 ANEVNLVEWLKMMVGTRRAEEVV---------------------DPNLEVKPA------------TRALKRSLLVALRCV 442 (508)
Q Consensus 396 ~~~~~~~~~~~~~~~~~~~~~~~---------------------~~~~~~~~~------------~~~~~~l~~li~~cl 442 (508)
......+....+......+. ......... ......+.+|+.+||
T Consensus 237 ---~~~~~~i~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L 313 (388)
T 3oz6_A 237 ---MNQLERIIGVIDFPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLKINPKADCNEEALDLLDKLL 313 (388)
T ss_dssp ---HHHHHHHHHHHCCCCHHHHHTSCCSSHHHHHHHHHHHCC-----CCCCHHHHHHHHHHHCTTCCCCHHHHHHHHHHC
T ss_pred ---HHHHHHHHHhcCCCCHHHHHhccCHHHHHHHHhCcccccccCCCHHHhCcchhhhcccccccccCCHHHHHHHHHhh
Confidence 11111111111111100000 000000000 012345778999999
Q ss_pred CCCCCCCCCHHHHHHHhh
Q 010519 443 DPDSEKRPKMSQVVRMLE 460 (508)
Q Consensus 443 ~~dP~~RPs~~evl~~L~ 460 (508)
..||.+|||+.|+++|-.
T Consensus 314 ~~dP~~R~t~~e~l~Hp~ 331 (388)
T 3oz6_A 314 QFNPNKRISANDALKHPF 331 (388)
T ss_dssp CSSGGGSCCHHHHTTSTT
T ss_pred ccCcccCCCHHHHhCCHH
Confidence 999999999999998754
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-43 Score=351.95 Aligned_cols=246 Identities=24% Similarity=0.356 Sum_probs=203.2
Q ss_pred hCCcccceeEeeeCceEEEEEEEc-CCCEEEEEEEcccch--------hhHHHHHHHHHHHhcCCCCCceeEEEEEEeCc
Q 010519 185 TNRFSAENVLGEGGYGVVYKGRLI-NGSEVAVKKLLNNLG--------QAEKEFRVEVEAIGHVRHKNLVRLLGYCIEGV 255 (508)
Q Consensus 185 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--------~~~~~~~~ei~~l~~l~h~niv~~~~~~~~~~ 255 (508)
.++|.+.+.||+|+||+||+|++. ++..||||.+..... .....+..|+.++++++||||+++++++.+..
T Consensus 23 ~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~ 102 (335)
T 3dls_A 23 SQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIFENQG 102 (335)
T ss_dssp HHHEEEEEECSSSSSCSEEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBCCEEEEEECSS
T ss_pred ccceEEEeEEEecCCEEEEEEEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEeeCC
Confidence 468999999999999999999875 688899999865421 12235677999999999999999999999999
Q ss_pred eeeEEEeecCCC-CHHHHHhhhhccCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCEEEcCCCcEEEEecC
Q 010519 256 HRMLVYEYVNNG-NLEQWLHGAMRNQGNLTWEARMKVIIGTAKALAYLHEAIEPKVVHRDIKSSNILIDDEFNAKVSDFG 334 (508)
Q Consensus 256 ~~~lv~E~~~~g-sL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~Dfg 334 (508)
..++||||+.+| +|.+++. ....+++..++.++.||+.||.|||+. +|+||||||+|||++.++.+||+|||
T Consensus 103 ~~~lv~e~~~~g~~l~~~~~----~~~~l~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~Dfg 175 (335)
T 3dls_A 103 FFQLVMEKHGSGLDLFAFID----RHPRLDEPLASYIFRQLVSAVGYLRLK---DIIHRDIKDENIVIAEDFTIKLIDFG 175 (335)
T ss_dssp EEEEEEECCTTSCBHHHHHH----TCCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEECCCT
T ss_pred EEEEEEEeCCCCccHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHhC---CeEEeccCHHHEEEcCCCcEEEeecc
Confidence 999999999777 9999984 456799999999999999999999999 99999999999999999999999999
Q ss_pred CccccCCCCCcccccccccccccCccccCCCCC-CChhhHHHHHHHHHHHHhCCCCCCCCCCCchhcHHHHHHHHhcccc
Q 010519 335 LAKLLDSGESHITTRVMGTFGYVAPEYANTGML-NEKSDIYSFGVLLLEAVTGRDPVDYGRPANEVNLVEWLKMMVGTRR 413 (508)
Q Consensus 335 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DvwS~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~ 413 (508)
++........ .....||+.|+|||++.+..+ +.++|||||||++|+|++|..||..... .
T Consensus 176 ~a~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~-----------------~ 236 (335)
T 3dls_A 176 SAAYLERGKL--FYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCELEE-----------------T 236 (335)
T ss_dssp TCEECCTTCC--BCEECSCGGGCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSCSSGGG-----------------G
T ss_pred cceECCCCCc--eeccCCCccccChhhhcCCCCCCCcccchhHHHHHHHHHhCCCchhhHHH-----------------H
Confidence 9987654432 334579999999999988776 7899999999999999999999963210 0
Q ss_pred cccccCCCCCCChhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhhcC
Q 010519 414 AEEVVDPNLEVKPATRALKRSLLVALRCVDPDSEKRPKMSQVVRMLEAD 462 (508)
Q Consensus 414 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~ 462 (508)
....... +......+.+|+.+||+.||.+|||+.+++++-+-.
T Consensus 237 ~~~~~~~------~~~~~~~l~~li~~~L~~dP~~Rps~~ell~hp~~~ 279 (335)
T 3dls_A 237 VEAAIHP------PYLVSKELMSLVSGLLQPVPERRTTLEKLVTDPWVT 279 (335)
T ss_dssp TTTCCCC------SSCCCHHHHHHHHHHTCSSGGGSCCHHHHHHCTTTT
T ss_pred HhhccCC------CcccCHHHHHHHHHHccCChhhCcCHHHHhcCcccc
Confidence 0000111 111234566799999999999999999999976543
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-42 Score=354.55 Aligned_cols=259 Identities=30% Similarity=0.462 Sum_probs=195.0
Q ss_pred CcccceeEeeeCceEEEEEEEcC--C--CEEEEEEEcccc-hhhHHHHHHHHHHHhcCCCCCceeEEEEEEe-CceeeEE
Q 010519 187 RFSAENVLGEGGYGVVYKGRLIN--G--SEVAVKKLLNNL-GQAEKEFRVEVEAIGHVRHKNLVRLLGYCIE-GVHRMLV 260 (508)
Q Consensus 187 ~~~~~~~lg~G~~g~Vy~~~~~~--~--~~vavK~~~~~~-~~~~~~~~~ei~~l~~l~h~niv~~~~~~~~-~~~~~lv 260 (508)
.|.+.+.||+|+||+||+|++.+ + ..||+|.+.... ......+.+|+.++++++||||+++++++.. +...++|
T Consensus 90 ~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~lv 169 (373)
T 3c1x_A 90 IVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVV 169 (373)
T ss_dssp EEEEEEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSCSCSHHHHHHHHHHTTSTTCCCTTBCCCCEEECCCSSCCEEE
T ss_pred eeecCcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCCCeEEE
Confidence 57788999999999999998642 2 358899875433 3445678999999999999999999998764 4577899
Q ss_pred EeecCCCCHHHHHhhhhccCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCEEEcCCCcEEEEecCCccccC
Q 010519 261 YEYVNNGNLEQWLHGAMRNQGNLTWEARMKVIIGTAKALAYLHEAIEPKVVHRDIKSSNILIDDEFNAKVSDFGLAKLLD 340 (508)
Q Consensus 261 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~Dfgla~~~~ 340 (508)
|||+++|+|.+++. .....+++..++.++.||+.||.|||++ +|+||||||+|||++.++.+||+|||+++...
T Consensus 170 ~e~~~~g~L~~~l~---~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~ 243 (373)
T 3c1x_A 170 LPYMKHGDLRNFIR---NETHNPTVKDLIGFGLQVAKGMKFLASK---KFVHRDLAARNCMLDEKFTVKVADFGLARDMY 243 (373)
T ss_dssp EECCTTCBHHHHHH---CTTCCCBHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCC-------
T ss_pred EECCCCCCHHHHHh---hcccCCCHHHHHHHHHHHHHHHHHHHHC---CEecCccchheEEECCCCCEEEeecccccccc
Confidence 99999999999995 3455688999999999999999999999 99999999999999999999999999998654
Q ss_pred CCCCc---ccccccccccccCccccCCCCCCChhhHHHHHHHHHHHHh-CCCCCCCCCCCchhcHHHHHHHHhccccccc
Q 010519 341 SGESH---ITTRVMGTFGYVAPEYANTGMLNEKSDIYSFGVLLLEAVT-GRDPVDYGRPANEVNLVEWLKMMVGTRRAEE 416 (508)
Q Consensus 341 ~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 416 (508)
..... ......+++.|+|||++.+..++.++|||||||+||||++ |..||....... ....+ .....
T Consensus 244 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt~~~~p~~~~~~~~---~~~~~---~~~~~--- 314 (373)
T 3c1x_A 244 DKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFD---ITVYL---LQGRR--- 314 (373)
T ss_dssp --------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCSSC---HHHHH---HTTCC---
T ss_pred ccccccccccCCCCCcccccChHHhcCCCCCcHHHHHHHHHHHHHHHhCcCCCCCCCCHHH---HHHHH---HcCCC---
Confidence 33211 1233457889999999999999999999999999999999 667775443322 11111 11111
Q ss_pred ccCCCCCCChhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhhcCCCCCc
Q 010519 417 VVDPNLEVKPATRALKRSLLVALRCVDPDSEKRPKMSQVVRMLEADDYPFR 467 (508)
Q Consensus 417 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~~~ 467 (508)
... +......+.+++.+||+.||.+|||+.+++++|+.....+.
T Consensus 315 ~~~-------p~~~~~~l~~li~~cl~~dp~~RPs~~ell~~L~~i~~~~~ 358 (373)
T 3c1x_A 315 LLQ-------PEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFI 358 (373)
T ss_dssp CCC-------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTCC
T ss_pred CCC-------CCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhcc
Confidence 000 11123456779999999999999999999999988654443
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-42 Score=343.76 Aligned_cols=267 Identities=26% Similarity=0.397 Sum_probs=210.0
Q ss_pred HHHHHHhhCCcccceeEeeeCceEEEEEEEcCCCEEEEEEEcccchhhHHHHHHHHHHHhc--CCCCCceeEEEEEEeCc
Q 010519 178 LRDLEIATNRFSAENVLGEGGYGVVYKGRLINGSEVAVKKLLNNLGQAEKEFRVEVEAIGH--VRHKNLVRLLGYCIEGV 255 (508)
Q Consensus 178 ~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~ei~~l~~--l~h~niv~~~~~~~~~~ 255 (508)
+.......++|.+.+.||+|+||.||+|++ +|+.||||.+... ....+..|++++.. ++||||+++++++....
T Consensus 34 ~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~---~~~~~~~e~~~~~~~~l~h~ni~~~~~~~~~~~ 109 (342)
T 1b6c_B 34 LLVQRTIARTIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSR---EERSWFREAEIYQTVMLRHENILGFIAADNKDN 109 (342)
T ss_dssp HHHHHHHHHHCEEEEEEEEETTEEEEEEEE-TTEEEEEEEECGG---GHHHHHHHHHHHHHSCCCCTTBCCEEEEEECCC
T ss_pred eeecccccccEEEEeeecCCCCcEEEEEEE-cCccEEEEEeCch---hHHHHHHHHHHHHHhhcCCCcEEEEEeeecccC
Confidence 444566678999999999999999999988 6899999998543 23456678888877 79999999999998875
Q ss_pred ----eeeEEEeecCCCCHHHHHhhhhccCCCccHHHHHHHHHHHHHHHHHHH--------hcCCCCeEeecCCCCCEEEc
Q 010519 256 ----HRMLVYEYVNNGNLEQWLHGAMRNQGNLTWEARMKVIIGTAKALAYLH--------EAIEPKVVHRDIKSSNILID 323 (508)
Q Consensus 256 ----~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~yLH--------~~~~~~iiH~Dlk~~NIll~ 323 (508)
..++||||+++|+|.+++.. ..+++..++.++.|++.||.||| +. +|+||||||+|||++
T Consensus 110 ~~~~~~~lv~e~~~~g~L~~~l~~-----~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~---~ivH~Dlkp~NIll~ 181 (342)
T 1b6c_B 110 GTWTQLWLVSDYHEHGSLFDYLNR-----YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKP---AIAHRDLKSKNILVK 181 (342)
T ss_dssp SSCCCEEEEECCCTTCBHHHHHHH-----CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBC---EEECSCCSGGGEEEC
T ss_pred CccceeEEEEeecCCCcHHHHHhc-----cCccHHHHHHHHHHHHHHHHHHHHHHhhhcccC---CeeeCCCCHHHEEEC
Confidence 78999999999999999953 35899999999999999999999 77 999999999999999
Q ss_pred CCCcEEEEecCCccccCCCCCc---ccccccccccccCccccCCCC------CCChhhHHHHHHHHHHHHhC--------
Q 010519 324 DEFNAKVSDFGLAKLLDSGESH---ITTRVMGTFGYVAPEYANTGM------LNEKSDIYSFGVLLLEAVTG-------- 386 (508)
Q Consensus 324 ~~~~~kl~Dfgla~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~------~~~~~DvwS~Gvvl~elltG-------- 386 (508)
.++.+||+|||++......... ......||+.|+|||++.+.. ++.++|||||||+||||++|
T Consensus 182 ~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~ 261 (342)
T 1b6c_B 182 KNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHE 261 (342)
T ss_dssp TTSCEEECCCTTCEEEETTTTEEEECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCC
T ss_pred CCCCEEEEECCCceeccccccccccccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHHHHHHhccCcCCccc
Confidence 9999999999999876543322 234457899999999998753 33689999999999999999
Q ss_pred --CCCCCCCCCCchhcHHHHHHHHhcccccccccCCCCCCC-hhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhhcC
Q 010519 387 --RDPVDYGRPANEVNLVEWLKMMVGTRRAEEVVDPNLEVK-PATRALKRSLLVALRCVDPDSEKRPKMSQVVRMLEAD 462 (508)
Q Consensus 387 --~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~ 462 (508)
..||....... .....+....... ...+.+... ........+.+|+.+||+.||.+|||+.+|+++|+..
T Consensus 262 ~~~~p~~~~~~~~-~~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~i~~~L~~i 334 (342)
T 1b6c_B 262 DYQLPYYDLVPSD-PSVEEMRKVVCEQ-----KLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQL 334 (342)
T ss_dssp CCCCTTTTTSCSS-CCHHHHHHHHTTS-----CCCCCCCGGGGTSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHHHH
T ss_pred ccccCccccCcCc-ccHHHHHHHHHHH-----HhCCCCcccccchhHHHHHHHHHHHHhccChhhCCCHHHHHHHHHHH
Confidence 78886443322 1222222222211 111221111 1235566788899999999999999999999999864
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-42 Score=359.56 Aligned_cols=272 Identities=21% Similarity=0.284 Sum_probs=190.3
Q ss_pred hCCcccceeEeeeCceEEEEEEEc-CCCEEEEEEEcccc--hhhHHHHHHHHHHHhcCCCCCceeEEEEEEeC-----ce
Q 010519 185 TNRFSAENVLGEGGYGVVYKGRLI-NGSEVAVKKLLNNL--GQAEKEFRVEVEAIGHVRHKNLVRLLGYCIEG-----VH 256 (508)
Q Consensus 185 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~ei~~l~~l~h~niv~~~~~~~~~-----~~ 256 (508)
.++|.+.+.||+|+||+||+|++. +++.||||++.... ....+.+.+|+.+|+.++||||+++++++... ..
T Consensus 52 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~ 131 (458)
T 3rp9_A 52 PDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKFDE 131 (458)
T ss_dssp CTTEEECCC-------CEEEEEECC--CEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCC
T ss_pred CCCeEEeeEeeecCCeEEEEEEECCCCcEEEEEEechhhcCHHHHHHHHHHHHHHHhCCCCCCCceEEEEecCCcccCce
Confidence 368999999999999999999875 68899999986532 33456788999999999999999999998543 56
Q ss_pred eeEEEeecCCCCHHHHHhhhhccCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCEEEcCCCcEEEEecCCc
Q 010519 257 RMLVYEYVNNGNLEQWLHGAMRNQGNLTWEARMKVIIGTAKALAYLHEAIEPKVVHRDIKSSNILIDDEFNAKVSDFGLA 336 (508)
Q Consensus 257 ~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~Dfgla 336 (508)
.|+||||+ +|+|.+++. ....+++..++.++.||+.||.|||+. +|+||||||+||||+.++.+||+|||++
T Consensus 132 ~~lv~e~~-~~~L~~~~~----~~~~l~~~~~~~~~~qi~~aL~~LH~~---~iiHrDlKp~NILl~~~~~~kl~DFGla 203 (458)
T 3rp9_A 132 LYVVLEIA-DSDFKKLFR----TPVYLTELHIKTLLYNLLVGVKYVHSA---GILHRDLKPANCLVNQDCSVKVCDFGLA 203 (458)
T ss_dssp EEEEECCC-SEEHHHHHH----SSCCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTCCEEECCCTTC
T ss_pred EEEEEecc-ccchhhhcc----cCCCCCHHHHHHHHHHHHHHHHHHHhC---CcCCCCCChhhEEECCCCCEeecccccc
Confidence 89999998 579999884 456799999999999999999999999 9999999999999999999999999999
Q ss_pred cccCCCCC--------------------------cccccccccccccCcccc-CCCCCCChhhHHHHHHHHHHHHh----
Q 010519 337 KLLDSGES--------------------------HITTRVMGTFGYVAPEYA-NTGMLNEKSDIYSFGVLLLEAVT---- 385 (508)
Q Consensus 337 ~~~~~~~~--------------------------~~~~~~~gt~~y~aPE~~-~~~~~~~~~DvwS~Gvvl~ellt---- 385 (508)
+....... ...+..+||+.|+|||++ .+..|+.++|||||||+||||++
T Consensus 204 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~DiwSlG~il~elltg~~~ 283 (458)
T 3rp9_A 204 RTVDYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNMIKE 283 (458)
T ss_dssp BCTTSCTTCCCCCC---------------------------CCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHTTSTT
T ss_pred hhccCccccccccccCccccccccccccccccccccccCCcccccccChHHhhCCCCCCcHhHHHHHHHHHHHHHHhccc
Confidence 87643221 123456789999999976 56679999999999999999999
Q ss_pred -------CCCCCCCCCCCc-----------------hhcHHHHHHHHhccccccc--------------ccCCCCCC---
Q 010519 386 -------GRDPVDYGRPAN-----------------EVNLVEWLKMMVGTRRAEE--------------VVDPNLEV--- 424 (508)
Q Consensus 386 -------G~~Pf~~~~~~~-----------------~~~~~~~~~~~~~~~~~~~--------------~~~~~~~~--- 424 (508)
|+.+|....... ..+....+....+...... ........
T Consensus 284 ~~~~~~~~~p~f~g~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 363 (458)
T 3rp9_A 284 NVAYHADRGPLFPGSSCFPLSPDQKAGNDFKFHTRGNRDQLNVIFNILGTPSEEDIEALEKEDAKRYIRIFPKREGTDLA 363 (458)
T ss_dssp TCSSGGGCCCSCC--------------------CHHHHHHHHHHHHHHCCCCHHHHHTSSCHHHHHHHTTSCCCCCCCGG
T ss_pred cccccccccccCCCCccccccccccccccccccccCCHHHHHHHHHHcCCCCHHHHhhcCCHHHHHHHHhcCCCCCCCHH
Confidence 555553322100 0011111111111111000 00000000
Q ss_pred ChhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhhcCCC
Q 010519 425 KPATRALKRSLLVALRCVDPDSEKRPKMSQVVRMLEADDY 464 (508)
Q Consensus 425 ~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~ 464 (508)
.........+.+|+.+||..||.+|||++|+|+|-.-...
T Consensus 364 ~~~~~~s~~~~dLl~~mL~~dP~~R~t~~e~L~Hp~f~~~ 403 (458)
T 3rp9_A 364 ERFPASSADAIHLLKRMLVFNPNKRITINECLAHPFFKEV 403 (458)
T ss_dssp GGSTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTT
T ss_pred HHCCCCCHHHHHHHHHHhccCccccCCHHHHhcCHhhhhc
Confidence 0011124566789999999999999999999998765544
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-42 Score=338.21 Aligned_cols=248 Identities=27% Similarity=0.389 Sum_probs=204.0
Q ss_pred hCCcccceeEeeeCceEEEEEEEc-CCCEEEEEEEcccc---hhhHHHHHHHHHHHhcCCCCCceeEEEEEEeCceeeEE
Q 010519 185 TNRFSAENVLGEGGYGVVYKGRLI-NGSEVAVKKLLNNL---GQAEKEFRVEVEAIGHVRHKNLVRLLGYCIEGVHRMLV 260 (508)
Q Consensus 185 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~ei~~l~~l~h~niv~~~~~~~~~~~~~lv 260 (508)
.++|.+.+.||+|+||.||+|++. ++..||+|.+.... ......+.+|+.+++.++||||+++++++.+....++|
T Consensus 13 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 92 (284)
T 2vgo_A 13 IDDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYFHDRKRIYLM 92 (284)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred hhhceeeheecCCCCeEEEEEEEcCCCcEEEEEEEcccccchHHHHHHHHHHHHHHhcCCCCCEeeEEEEEEcCCEEEEE
Confidence 358999999999999999999886 57789999885432 22246788899999999999999999999999999999
Q ss_pred EeecCCCCHHHHHhhhhccCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCEEEcCCCcEEEEecCCccccC
Q 010519 261 YEYVNNGNLEQWLHGAMRNQGNLTWEARMKVIIGTAKALAYLHEAIEPKVVHRDIKSSNILIDDEFNAKVSDFGLAKLLD 340 (508)
Q Consensus 261 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~Dfgla~~~~ 340 (508)
|||+++|+|.+++.. ...+++..++.++.||+.||.|||+. +++||||||+||+++.++.+||+|||++....
T Consensus 93 ~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~ 165 (284)
T 2vgo_A 93 LEFAPRGELYKELQK----HGRFDEQRSATFMEELADALHYCHER---KVIHRDIKPENLLMGYKGELKIADFGWSVHAP 165 (284)
T ss_dssp ECCCTTEEHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCSGGGEEECTTCCEEECCCTTCEECS
T ss_pred EEeCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCHHHEEEcCCCCEEEecccccccCc
Confidence 999999999999853 35689999999999999999999999 99999999999999999999999999997654
Q ss_pred CCCCcccccccccccccCccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCCCchhcHHHHHHHHhcccccccccCC
Q 010519 341 SGESHITTRVMGTFGYVAPEYANTGMLNEKSDIYSFGVLLLEAVTGRDPVDYGRPANEVNLVEWLKMMVGTRRAEEVVDP 420 (508)
Q Consensus 341 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 420 (508)
... .....|++.|+|||++.+..++.++||||||+++|+|++|..||..... ........... .
T Consensus 166 ~~~---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~------~~~~~~~~~~~-------~ 229 (284)
T 2vgo_A 166 SLR---RRTMCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSPSH------TETHRRIVNVD-------L 229 (284)
T ss_dssp SSC---BCCCCSCGGGCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSH------HHHHHHHHTTC-------C
T ss_pred ccc---cccccCCCCcCCHHHhccCCCCcccchhhHHHHHHHHHHCCCCCCCCCH------hHHHHHHhccc-------c
Confidence 322 2345689999999999999999999999999999999999999964321 11111111110 1
Q ss_pred CCCCChhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHh
Q 010519 421 NLEVKPATRALKRSLLVALRCVDPDSEKRPKMSQVVRML 459 (508)
Q Consensus 421 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L 459 (508)
.+. ......+.+++.+||+.||.+|||+.+++++-
T Consensus 230 ~~~----~~~~~~~~~li~~~l~~~p~~Rps~~~ll~h~ 264 (284)
T 2vgo_A 230 KFP----PFLSDGSKDLISKLLRYHPPQRLPLKGVMEHP 264 (284)
T ss_dssp CCC----TTSCHHHHHHHHHHSCSSGGGSCCHHHHHTCH
T ss_pred CCC----CcCCHHHHHHHHHHhhcCHhhCCCHHHHhhCH
Confidence 111 11234566799999999999999999999854
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-42 Score=340.26 Aligned_cols=254 Identities=24% Similarity=0.332 Sum_probs=204.2
Q ss_pred hCCcccceeEeeeCceEEEEEEEc-CCCEEEEEEEcccchhhHHHHHHHHHHHhcCCCCCceeEEEEEEeCceeeEEEee
Q 010519 185 TNRFSAENVLGEGGYGVVYKGRLI-NGSEVAVKKLLNNLGQAEKEFRVEVEAIGHVRHKNLVRLLGYCIEGVHRMLVYEY 263 (508)
Q Consensus 185 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~ei~~l~~l~h~niv~~~~~~~~~~~~~lv~E~ 263 (508)
.++|.+.+.||+|+||+||++++. +|+.||+|.+..........+.+|+.+++.++||||+++++++.+....++||||
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 87 (304)
T 2jam_A 8 RKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLEDIYESTTHYYLVMQL 87 (304)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECC------HHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECC
T ss_pred hccceeeeeccCCCCceEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHhCCCCCeeehhhhcccCCEEEEEEEc
Confidence 357999999999999999999885 6899999998765544556788999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhhhhccCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCEEE---cCCCcEEEEecCCccccC
Q 010519 264 VNNGNLEQWLHGAMRNQGNLTWEARMKVIIGTAKALAYLHEAIEPKVVHRDIKSSNILI---DDEFNAKVSDFGLAKLLD 340 (508)
Q Consensus 264 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiH~Dlk~~NIll---~~~~~~kl~Dfgla~~~~ 340 (508)
+++++|.+++. ..+.+++..++.++.|++.||.|||+. +|+||||||+|||+ ++++.+||+|||++....
T Consensus 88 ~~~~~L~~~l~----~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dikp~NIl~~~~~~~~~~kl~Dfg~~~~~~ 160 (304)
T 2jam_A 88 VSGGELFDRIL----ERGVYTEKDASLVIQQVLSAVKYLHEN---GIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQ 160 (304)
T ss_dssp CCSCBHHHHHH----HHSCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCSCCGGGCEESSSSTTCCEEBCSCSTTCCCC
T ss_pred CCCccHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEEecCCCCCCEEEccCCcceecC
Confidence 99999999985 345689999999999999999999999 99999999999999 788999999999997644
Q ss_pred CCCCcccccccccccccCccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCCCchhcHHHHHHHHhcccccccccCC
Q 010519 341 SGESHITTRVMGTFGYVAPEYANTGMLNEKSDIYSFGVLLLEAVTGRDPVDYGRPANEVNLVEWLKMMVGTRRAEEVVDP 420 (508)
Q Consensus 341 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 420 (508)
.. ......|++.|+|||++.+..++.++|||||||++|+|++|..||..... . ...........
T Consensus 161 ~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~---~---~~~~~i~~~~~------- 224 (304)
T 2jam_A 161 NG---IMSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCGYPPFYEETE---S---KLFEKIKEGYY------- 224 (304)
T ss_dssp CB---TTHHHHSCCCBCCTTTBSSCSCCHHHHHHHHHHHHHHHHHSSCTTTTSCH---H---HHHHHHHHCCC-------
T ss_pred CC---ccccccCCCCccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCH---H---HHHHHHHcCCC-------
Confidence 32 23345689999999999999999999999999999999999999964321 1 11112111110
Q ss_pred CCCCChhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhhc
Q 010519 421 NLEVKPATRALKRSLLVALRCVDPDSEKRPKMSQVVRMLEA 461 (508)
Q Consensus 421 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~ 461 (508)
.+...........+.+++.+||+.||.+|||+.|++++-.-
T Consensus 225 ~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~ 265 (304)
T 2jam_A 225 EFESPFWDDISESAKDFICHLLEKDPNERYTCEKALSHPWI 265 (304)
T ss_dssp CCCTTTTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHTSHHH
T ss_pred CCCccccccCCHHHHHHHHHHcCCChhHCcCHHHHhcCccc
Confidence 00111111223456779999999999999999999986543
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-42 Score=364.77 Aligned_cols=261 Identities=23% Similarity=0.286 Sum_probs=210.2
Q ss_pred hhCCcccceeEeeeCceEEEEEEEc-CCCEEEEEEEcccch---hhHHHHHHHHHHHhcCCCCCceeEEEEEEeCceeeE
Q 010519 184 ATNRFSAENVLGEGGYGVVYKGRLI-NGSEVAVKKLLNNLG---QAEKEFRVEVEAIGHVRHKNLVRLLGYCIEGVHRML 259 (508)
Q Consensus 184 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~ei~~l~~l~h~niv~~~~~~~~~~~~~l 259 (508)
..++|.+.+.||+|+||.||+|++. +|+.||+|++..... .....+..|+.+++.++||||+++++++.+....|+
T Consensus 183 ~~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~l 262 (543)
T 3c4z_A 183 GEDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAFETKTDLCL 262 (543)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEE
T ss_pred ChhheEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhcCCCCEeeEEEEEeeCCEEEE
Confidence 3468999999999999999999985 689999999864331 234568889999999999999999999999999999
Q ss_pred EEeecCCCCHHHHHhhhhccCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCEEEcCCCcEEEEecCCcccc
Q 010519 260 VYEYVNNGNLEQWLHGAMRNQGNLTWEARMKVIIGTAKALAYLHEAIEPKVVHRDIKSSNILIDDEFNAKVSDFGLAKLL 339 (508)
Q Consensus 260 v~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~Dfgla~~~ 339 (508)
||||++||+|.+++.........+++..++.++.||+.||.|||++ +|+||||||+|||++.++++||+|||+++..
T Consensus 263 VmE~~~gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH~~---gIvHrDLKP~NILl~~~g~vkL~DFGla~~~ 339 (543)
T 3c4z_A 263 VMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQR---NIIYRDLKPENVLLDDDGNVRISDLGLAVEL 339 (543)
T ss_dssp EECCCTTCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTSCEEECCCTTCEEC
T ss_pred EEEeccCCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHHHc---CCcccCCChHHEEEeCCCCEEEeecceeeec
Confidence 9999999999999975433355799999999999999999999999 9999999999999999999999999999876
Q ss_pred CCCCCcccccccccccccCccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCCCchhcHHHHHHHHhcccccccccC
Q 010519 340 DSGESHITTRVMGTFGYVAPEYANTGMLNEKSDIYSFGVLLLEAVTGRDPVDYGRPANEVNLVEWLKMMVGTRRAEEVVD 419 (508)
Q Consensus 340 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 419 (508)
..... .....+||+.|+|||++.+..|+.++|||||||+||||++|+.||....... .............
T Consensus 340 ~~~~~-~~~~~~GT~~Y~APE~l~~~~~~~~~DiwSlGvilyelltG~~PF~~~~~~~--~~~~~~~~i~~~~------- 409 (543)
T 3c4z_A 340 KAGQT-KTKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKV--ENKELKQRVLEQA------- 409 (543)
T ss_dssp CTTCC-CBCCCCSCTTTSCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCTTCCC--CHHHHHHHHHHCC-------
T ss_pred cCCCc-ccccccCCccccChhhhcCCCCChHHhcCcchHHHHHHHhCCCCCCCCccch--hHHHHHHHHhhcc-------
Confidence 54332 2344589999999999999999999999999999999999999997543221 1122222222111
Q ss_pred CCCCCChhHHHHHHHHHHHHHhcCCCCCCCCCH-----HHHHHHhhc
Q 010519 420 PNLEVKPATRALKRSLLVALRCVDPDSEKRPKM-----SQVVRMLEA 461 (508)
Q Consensus 420 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~-----~evl~~L~~ 461 (508)
... +......+.+|+.+||+.||.+||++ .++++|-.-
T Consensus 410 --~~~--p~~~s~~~~~li~~lL~~dP~~R~~~~~~~a~ei~~Hpff 452 (543)
T 3c4z_A 410 --VTY--PDKFSPASKDFCEALLQKDPEKRLGFRDGSCDGLRTHPLF 452 (543)
T ss_dssp --CCC--CTTSCHHHHHHHHHHSCSSGGGSCCCBTTBSHHHHTSGGG
T ss_pred --cCC--CcccCHHHHHHHHHhccCCHhHCCCCcccCHHHHHcCccc
Confidence 011 11223456679999999999999964 778876543
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-42 Score=340.97 Aligned_cols=259 Identities=29% Similarity=0.413 Sum_probs=205.0
Q ss_pred HHhhCCcccce-eEeeeCceEEEEEEEc---CCCEEEEEEEcccc--hhhHHHHHHHHHHHhcCCCCCceeEEEEEEeCc
Q 010519 182 EIATNRFSAEN-VLGEGGYGVVYKGRLI---NGSEVAVKKLLNNL--GQAEKEFRVEVEAIGHVRHKNLVRLLGYCIEGV 255 (508)
Q Consensus 182 ~~~~~~~~~~~-~lg~G~~g~Vy~~~~~---~~~~vavK~~~~~~--~~~~~~~~~ei~~l~~l~h~niv~~~~~~~~~~ 255 (508)
.+..++|.+.+ .||+|+||+||+|.+. .+..||||.+.... ......+.+|+.+++.++||||+++++++ ...
T Consensus 12 ~~~~~~y~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-~~~ 90 (291)
T 1xbb_A 12 YLDRKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGIC-EAE 90 (291)
T ss_dssp BCCGGGEEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEE-ESS
T ss_pred eecchhhhhccCccccccCeeeEeeeecCCCceeeEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEE-CCC
Confidence 44556888888 9999999999999653 46789999986543 23356788999999999999999999998 566
Q ss_pred eeeEEEeecCCCCHHHHHhhhhccCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCEEEcCCCcEEEEecCC
Q 010519 256 HRMLVYEYVNNGNLEQWLHGAMRNQGNLTWEARMKVIIGTAKALAYLHEAIEPKVVHRDIKSSNILIDDEFNAKVSDFGL 335 (508)
Q Consensus 256 ~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~Dfgl 335 (508)
..++||||+++++|.+++. ....+++..++.++.||+.||.|||+. +|+||||||+|||++.++.+||+|||+
T Consensus 91 ~~~lv~e~~~~~~L~~~l~----~~~~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dikp~Nil~~~~~~~kl~Dfg~ 163 (291)
T 1xbb_A 91 SWMLVMEMAELGPLNKYLQ----QNRHVKDKNIIELVHQVSMGMKYLEES---NFVHRDLAARNVLLVTQHYAKISDFGL 163 (291)
T ss_dssp SEEEEEECCTTEEHHHHHH----HCTTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEETTEEEECCCTT
T ss_pred CcEEEEEeCCCCCHHHHHH----hCcCCCHHHHHHHHHHHHHHHHHHHhC---CeEcCCCCcceEEEeCCCcEEEccCCc
Confidence 7889999999999999995 345689999999999999999999999 999999999999999999999999999
Q ss_pred ccccCCCCCcc--cccccccccccCccccCCCCCCChhhHHHHHHHHHHHHh-CCCCCCCCCCCchhcHHHHHHHHhccc
Q 010519 336 AKLLDSGESHI--TTRVMGTFGYVAPEYANTGMLNEKSDIYSFGVLLLEAVT-GRDPVDYGRPANEVNLVEWLKMMVGTR 412 (508)
Q Consensus 336 a~~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~ 412 (508)
+.......... .....+++.|+|||++.+..++.++||||||+++|+|++ |..||..... . ..........
T Consensus 164 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~---~---~~~~~~~~~~ 237 (291)
T 1xbb_A 164 SKALRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKG---S---EVTAMLEKGE 237 (291)
T ss_dssp CEECCTTCSEEEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCH---H---HHHHHHHTTC
T ss_pred ceeeccCCCcccccccCCCCceeeChHHhccCCCChhhhHHHHHHHHHHHHhcCCCCCCCCCH---H---HHHHHHHcCC
Confidence 98765443321 222346788999999988889999999999999999999 9999964322 1 1111111111
Q ss_pred ccccccCCCCCCChhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhhcCCC
Q 010519 413 RAEEVVDPNLEVKPATRALKRSLLVALRCVDPDSEKRPKMSQVVRMLEADDY 464 (508)
Q Consensus 413 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~ 464 (508)
. +. .+......+.+++.+||+.||.+|||+.++++.|+..-.
T Consensus 238 ~------~~----~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~ 279 (291)
T 1xbb_A 238 R------MG----CPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYY 279 (291)
T ss_dssp C------CC----CCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHH
T ss_pred C------CC----CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHH
Confidence 0 11 111234456779999999999999999999999987543
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=8.8e-42 Score=336.64 Aligned_cols=257 Identities=28% Similarity=0.400 Sum_probs=202.7
Q ss_pred CcccceeEeeeCceEEEEEEEcC-CC---EEEEEEEcccc-hhhHHHHHHHHHHHhcCCCCCceeEEEEEEeCcee-eEE
Q 010519 187 RFSAENVLGEGGYGVVYKGRLIN-GS---EVAVKKLLNNL-GQAEKEFRVEVEAIGHVRHKNLVRLLGYCIEGVHR-MLV 260 (508)
Q Consensus 187 ~~~~~~~lg~G~~g~Vy~~~~~~-~~---~vavK~~~~~~-~~~~~~~~~ei~~l~~l~h~niv~~~~~~~~~~~~-~lv 260 (508)
.|...+.||+|+||+||+|.+.+ +. .+|+|.+.... ....+.+.+|+.+++.++||||+++++++.+.... ++|
T Consensus 22 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~v 101 (298)
T 3pls_A 22 VTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLALIGIMLPPEGLPHVL 101 (298)
T ss_dssp EEEEEEEEEEETTEEEEEEEEECSSSCEEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEEE
T ss_pred EEccCceeccCCCceEEEEEEecCCCceeeeeeeeccccccHHHHHHHHHHHHHHHhCCCCCeeeEEEEEecCCCCcEEE
Confidence 56677999999999999998643 22 69999886543 33456788999999999999999999999876655 899
Q ss_pred EeecCCCCHHHHHhhhhccCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCEEEcCCCcEEEEecCCccccC
Q 010519 261 YEYVNNGNLEQWLHGAMRNQGNLTWEARMKVIIGTAKALAYLHEAIEPKVVHRDIKSSNILIDDEFNAKVSDFGLAKLLD 340 (508)
Q Consensus 261 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~Dfgla~~~~ 340 (508)
|||+.+|+|.+++. .....+++..++.++.|++.||.|||+. +++||||||+|||++.++.+||+|||++....
T Consensus 102 ~e~~~~~~L~~~~~---~~~~~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~ 175 (298)
T 3pls_A 102 LPYMCHGDLLQFIR---SPQRNPTVKDLISFGLQVARGMEYLAEQ---KFVHRDLAARNCMLDESFTVKVADFGLARDIL 175 (298)
T ss_dssp ECCCTTCBHHHHHH---CTTCCCBHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTCCEEECCTTSSCTTT
T ss_pred EecccCCCHHHHHh---ccccCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCcceEEEcCCCcEEeCcCCCccccc
Confidence 99999999999995 3456789999999999999999999999 99999999999999999999999999998654
Q ss_pred CCC---CcccccccccccccCccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCCCchhcHHHHHHHHhcccccccc
Q 010519 341 SGE---SHITTRVMGTFGYVAPEYANTGMLNEKSDIYSFGVLLLEAVTGRDPVDYGRPANEVNLVEWLKMMVGTRRAEEV 417 (508)
Q Consensus 341 ~~~---~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 417 (508)
... ........+++.|+|||.+.+..++.++|||||||++|+|++|..|+..... .......+.. ...
T Consensus 176 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~~~~~~~~--~~~~~~~~~~---~~~---- 246 (298)
T 3pls_A 176 DREYYSVQQHRHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPPYRHID--PFDLTHFLAQ---GRR---- 246 (298)
T ss_dssp TGGGGCSCCSSCTTCGGGGSCHHHHTTCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSC--GGGHHHHHHT---TCC----
T ss_pred CCcccccccCcCCCCCccccChhhhccCCCChhhchhhHHHHHHHHhhCCCCCCccCC--HHHHHHHhhc---CCC----
Confidence 322 1123345678899999999999999999999999999999996666543322 2222221111 110
Q ss_pred cCCCCCCChhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhhcCCC
Q 010519 418 VDPNLEVKPATRALKRSLLVALRCVDPDSEKRPKMSQVVRMLEADDY 464 (508)
Q Consensus 418 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~ 464 (508)
...+......+.+++.+||+.||.+|||+.++++.|+....
T Consensus 247 ------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~l~~~~~ 287 (298)
T 3pls_A 247 ------LPQPEYCPDSLYQVMQQCWEADPAVRPTFRVLVGEVEQIVS 287 (298)
T ss_dssp ------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred ------CCCCccchHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHH
Confidence 00111123456779999999999999999999999987543
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-42 Score=338.60 Aligned_cols=252 Identities=19% Similarity=0.313 Sum_probs=206.0
Q ss_pred hCCcccceeEeeeCceEEEEEEEc-CCCEEEEEEEcccc---hhhHHHHHHHHHHHhcCCCCCceeEEEEEEeCceeeEE
Q 010519 185 TNRFSAENVLGEGGYGVVYKGRLI-NGSEVAVKKLLNNL---GQAEKEFRVEVEAIGHVRHKNLVRLLGYCIEGVHRMLV 260 (508)
Q Consensus 185 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~ei~~l~~l~h~niv~~~~~~~~~~~~~lv 260 (508)
.++|.+.+.||+|+||.||++.+. +++.+|+|.+.... ......+.+|+.+++.++||||+++++++.+....++|
T Consensus 14 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 93 (294)
T 2rku_A 14 RRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVV 93 (294)
T ss_dssp TEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred ccceEEEEEEeecCCEEEEEEEECCCCceEEEEEechhhccCHHHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCEEEEE
Confidence 358999999999999999999986 57889999885442 33456788899999999999999999999999999999
Q ss_pred EeecCCCCHHHHHhhhhccCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCEEEcCCCcEEEEecCCccccC
Q 010519 261 YEYVNNGNLEQWLHGAMRNQGNLTWEARMKVIIGTAKALAYLHEAIEPKVVHRDIKSSNILIDDEFNAKVSDFGLAKLLD 340 (508)
Q Consensus 261 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~Dfgla~~~~ 340 (508)
|||+++++|.+++. ....+++..++.++.|++.||.|||+. +++||||||+|||++.++.+||+|||++....
T Consensus 94 ~e~~~~~~L~~~~~----~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~ 166 (294)
T 2rku_A 94 LELCRRRSLLELHK----RRKALTEPEARYYLRQIVLGCQYLHRN---RVIHRDLKLGNLFLNEDLEVKIGDFGLATKVE 166 (294)
T ss_dssp EECCTTCBHHHHHH----HHCSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEECC
T ss_pred EecCCCCCHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCChHhEEEcCCCCEEEEeccCceecc
Confidence 99999999999884 345789999999999999999999999 99999999999999999999999999998764
Q ss_pred CCCCcccccccccccccCccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCCCchhcHHHHHHHHhcccccccccCC
Q 010519 341 SGESHITTRVMGTFGYVAPEYANTGMLNEKSDIYSFGVLLLEAVTGRDPVDYGRPANEVNLVEWLKMMVGTRRAEEVVDP 420 (508)
Q Consensus 341 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 420 (508)
.... ......||+.|+|||++.+..++.++||||||+++|+|++|+.||..... .+.........
T Consensus 167 ~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~------~~~~~~~~~~~-------- 231 (294)
T 2rku_A 167 YDGE-RKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCL------KETYLRIKKNE-------- 231 (294)
T ss_dssp STTC-CBCCCCSCCSSCCHHHHTTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSH------HHHHHHHHTTC--------
T ss_pred cCcc-ccccccCCCCcCCcchhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH------HHHHHHHhhcc--------
Confidence 3222 23345789999999999999999999999999999999999999964321 11111111110
Q ss_pred CCCCChhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhhc
Q 010519 421 NLEVKPATRALKRSLLVALRCVDPDSEKRPKMSQVVRMLEA 461 (508)
Q Consensus 421 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~ 461 (508)
... +......+.+++.+||+.||.+|||+.+++++..-
T Consensus 232 -~~~--~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~~~~ 269 (294)
T 2rku_A 232 -YSI--PKHINPVAASLIQKMLQTDPTARPTINELLNDEFF 269 (294)
T ss_dssp -CCC--CTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGSHHH
T ss_pred -CCC--ccccCHHHHHHHHHHcccChhhCcCHHHHhhChhe
Confidence 010 01122456679999999999999999999986543
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-42 Score=338.03 Aligned_cols=252 Identities=24% Similarity=0.359 Sum_probs=202.4
Q ss_pred CCcccceeEeeeCceEEEEEEEc-CCCEEEEEEEcccch------hhHHHHHHHHHHHhcCCCCCceeEEEEEEeCceee
Q 010519 186 NRFSAENVLGEGGYGVVYKGRLI-NGSEVAVKKLLNNLG------QAEKEFRVEVEAIGHVRHKNLVRLLGYCIEGVHRM 258 (508)
Q Consensus 186 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~------~~~~~~~~ei~~l~~l~h~niv~~~~~~~~~~~~~ 258 (508)
++|.+.+.||+|+||.||+|++. +++.||+|.+..... .....+.+|+.++++++||||+++++++.+....+
T Consensus 5 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 84 (283)
T 3bhy_A 5 DHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFENKTDVV 84 (283)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred hhhhhHHhhcccCceEEEEEEEcCCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCCCCCeeehhheecCCCeEE
Confidence 57999999999999999999986 689999998864431 13567889999999999999999999999999999
Q ss_pred EEEeecCCCCHHHHHhhhhccCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCEEEcCCC----cEEEEecC
Q 010519 259 LVYEYVNNGNLEQWLHGAMRNQGNLTWEARMKVIIGTAKALAYLHEAIEPKVVHRDIKSSNILIDDEF----NAKVSDFG 334 (508)
Q Consensus 259 lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiH~Dlk~~NIll~~~~----~~kl~Dfg 334 (508)
+||||+++++|.+++. ....+++..++.++.||+.||.|||+. +++||||||+||+++.++ .+||+|||
T Consensus 85 lv~e~~~~~~L~~~l~----~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~~~~kl~dfg 157 (283)
T 3bhy_A 85 LILELVSGGELFDFLA----EKESLTEDEATQFLKQILDGVHYLHSK---RIAHFDLKPENIMLLDKNVPNPRIKLIDFG 157 (283)
T ss_dssp EEEECCCSCBHHHHHH----HHSSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEESCSSSSSCCEEECCCT
T ss_pred EEEeecCCCcHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCChHHEEEecCCCCCCceEEEecc
Confidence 9999999999999995 345789999999999999999999999 999999999999999877 89999999
Q ss_pred CccccCCCCCcccccccccccccCccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCCCchhcHHHHHHHHhccccc
Q 010519 335 LAKLLDSGESHITTRVMGTFGYVAPEYANTGMLNEKSDIYSFGVLLLEAVTGRDPVDYGRPANEVNLVEWLKMMVGTRRA 414 (508)
Q Consensus 335 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~ 414 (508)
++....... ......|++.|+|||++.+..++.++||||||+++|+|++|..||..... ...........
T Consensus 158 ~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~------~~~~~~~~~~~-- 227 (283)
T 3bhy_A 158 IAHKIEAGN--EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGETK------QETLTNISAVN-- 227 (283)
T ss_dssp TCEECC----------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSSH------HHHHHHHHTTC--
T ss_pred cceeccCCC--cccccCCCcCccCcceecCCCCCcchhhhhHHHHHHHHHHCCCCCCCcch------HHHHHHhHhcc--
Confidence 998765432 23345689999999999999999999999999999999999999964321 11111111100
Q ss_pred ccccCCCCCCChhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHh
Q 010519 415 EEVVDPNLEVKPATRALKRSLLVALRCVDPDSEKRPKMSQVVRML 459 (508)
Q Consensus 415 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L 459 (508)
..............+.+++.+||+.||.+|||+.+++++-
T Consensus 228 -----~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~ 267 (283)
T 3bhy_A 228 -----YDFDEEYFSNTSELAKDFIRRLLVKDPKRRMTIAQSLEHS 267 (283)
T ss_dssp -----CCCCHHHHTTCCHHHHHHHHTTSCSSGGGSCCHHHHHHCH
T ss_pred -----cCCcchhcccCCHHHHHHHHHHccCCHhHCcCHHHHHhCH
Confidence 0011011112244567799999999999999999999853
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-42 Score=338.73 Aligned_cols=257 Identities=29% Similarity=0.442 Sum_probs=199.6
Q ss_pred CCcccceeEeeeCceEEEEEEEcCC----CEEEEEEEcccc-hhhHHHHHHHHHHHhcCCCCCceeEEEEEEe-CceeeE
Q 010519 186 NRFSAENVLGEGGYGVVYKGRLING----SEVAVKKLLNNL-GQAEKEFRVEVEAIGHVRHKNLVRLLGYCIE-GVHRML 259 (508)
Q Consensus 186 ~~~~~~~~lg~G~~g~Vy~~~~~~~----~~vavK~~~~~~-~~~~~~~~~ei~~l~~l~h~niv~~~~~~~~-~~~~~l 259 (508)
.+|.+.+.||+|+||+||+|++.++ ..+|+|.+.... ......+.+|+.++++++||||+++++++.. +...++
T Consensus 25 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 104 (298)
T 3f66_A 25 LIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLV 104 (298)
T ss_dssp EEEEEEEEEEEETTEEEEEEEEC-----CEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEE
T ss_pred eehhhcceeeecCCceEEEEEEecCCCceeEEEEEecccCCCHHHHHHHHHHHHHHHhCCCCCEeeeeeEEEcCCCceEE
Confidence 4688999999999999999986432 258899886533 3344678899999999999999999998654 467789
Q ss_pred EEeecCCCCHHHHHhhhhccCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCEEEcCCCcEEEEecCCcccc
Q 010519 260 VYEYVNNGNLEQWLHGAMRNQGNLTWEARMKVIIGTAKALAYLHEAIEPKVVHRDIKSSNILIDDEFNAKVSDFGLAKLL 339 (508)
Q Consensus 260 v~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~Dfgla~~~ 339 (508)
||||+++|+|.+++. .....+++..++.++.|++.||.|||++ +|+||||||+|||++.++.+||+|||++...
T Consensus 105 v~e~~~~~~L~~~l~---~~~~~~~~~~~~~i~~ql~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~kl~Dfg~a~~~ 178 (298)
T 3f66_A 105 VLPYMKHGDLRNFIR---NETHNPTVKDLIGFGLQVAKGMKYLASK---KFVHRDLAARNCMLDEKFTVKVADFGLARDM 178 (298)
T ss_dssp EEECCTTCBHHHHHH---CTTCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTCCEEECSCGGGCCC
T ss_pred EEeCCCCCCHHHHHH---hcccCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCchheEEECCCCCEEECcccccccc
Confidence 999999999999995 3456689999999999999999999999 9999999999999999999999999999866
Q ss_pred CCCCC---cccccccccccccCccccCCCCCCChhhHHHHHHHHHHHHhC-CCCCCCCCCCchhcHHHHHHHHhcccccc
Q 010519 340 DSGES---HITTRVMGTFGYVAPEYANTGMLNEKSDIYSFGVLLLEAVTG-RDPVDYGRPANEVNLVEWLKMMVGTRRAE 415 (508)
Q Consensus 340 ~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltG-~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~ 415 (508)
..... .......+|+.|+|||.+.+..++.++||||||+++|+|++| ..||...... .... .......
T Consensus 179 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~~~---~~~~---~~~~~~~-- 250 (298)
T 3f66_A 179 YDKEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTF---DITV---YLLQGRR-- 250 (298)
T ss_dssp SCGGGCBC-----CCBCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTSCTT---THHH---HHHTTCC--
T ss_pred cccchhccccccCCCCCccccChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCccCCHH---HHHH---HHhcCCC--
Confidence 43321 123334678899999999999999999999999999999995 4555433222 1111 1111110
Q ss_pred cccCCCCCCChhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhhcCCC
Q 010519 416 EVVDPNLEVKPATRALKRSLLVALRCVDPDSEKRPKMSQVVRMLEADDY 464 (508)
Q Consensus 416 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~ 464 (508)
.. .+......+.+++.+||+.||.+|||+.++++.|+....
T Consensus 251 -~~-------~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~ 291 (298)
T 3f66_A 251 -LL-------QPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFS 291 (298)
T ss_dssp -CC-------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred -CC-------CCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHH
Confidence 00 011123456679999999999999999999999987543
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-42 Score=345.86 Aligned_cols=265 Identities=23% Similarity=0.315 Sum_probs=197.5
Q ss_pred CCcccceeEeeeCceEEEEEEEc-CCCEEEEEEEcccchhhH-HHHHHHHHHHhcCCCCCceeEEEEEEeCceeeEEEee
Q 010519 186 NRFSAENVLGEGGYGVVYKGRLI-NGSEVAVKKLLNNLGQAE-KEFRVEVEAIGHVRHKNLVRLLGYCIEGVHRMLVYEY 263 (508)
Q Consensus 186 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~-~~~~~ei~~l~~l~h~niv~~~~~~~~~~~~~lv~E~ 263 (508)
++|.+.+.||+|+||+||+|++. +++.||+|++........ ..+.+|+.+++.++||||+++++++.+....++||||
T Consensus 2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 81 (324)
T 3mtl_A 2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEY 81 (324)
T ss_dssp CSEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECC------CCCCCCCHHHHSCCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred CceEEEEEEcCCCCEEEEEEEECCCCcEEEEEEEecccccccchhHHHHHHHHHhcCCCCCCeeeeEEeeCCEEEEEecc
Confidence 57999999999999999999986 688999999864432211 2345699999999999999999999999999999999
Q ss_pred cCCCCHHHHHhhhhccCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCEEEcCCCcEEEEecCCccccCCCC
Q 010519 264 VNNGNLEQWLHGAMRNQGNLTWEARMKVIIGTAKALAYLHEAIEPKVVHRDIKSSNILIDDEFNAKVSDFGLAKLLDSGE 343 (508)
Q Consensus 264 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~~~ 343 (508)
++ |+|.+++.. ....+++..++.++.||+.||.|||+. +|+||||||+|||++.++.+||+|||++.......
T Consensus 82 ~~-~~l~~~~~~---~~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~ 154 (324)
T 3mtl_A 82 LD-KDLKQYLDD---CGNIINMHNVKLFLFQLLRGLAYCHRQ---KVLHRDLKPQNLLINERGELKLADFGLARAKSIPT 154 (324)
T ss_dssp CS-EEHHHHHHH---TTTCCCHHHHHHHHHHHHHHHHHHHHT---TEEESSCCGGGEEECTTCCEEECSSSEEECC----
T ss_pred cc-cCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHC---CccCCCcCHHHEEECCCCCEEEccCcccccccCCc
Confidence 97 599999863 455789999999999999999999999 99999999999999999999999999998654332
Q ss_pred CcccccccccccccCccccCC-CCCCChhhHHHHHHHHHHHHhCCCCCCCCCCCchhcHHHHHHHHhccccccccc----
Q 010519 344 SHITTRVMGTFGYVAPEYANT-GMLNEKSDIYSFGVLLLEAVTGRDPVDYGRPANEVNLVEWLKMMVGTRRAEEVV---- 418 (508)
Q Consensus 344 ~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwS~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~---- 418 (508)
. ......||+.|+|||++.+ ..++.++|||||||++|+|++|+.||..... ......+....+........
T Consensus 155 ~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~---~~~~~~i~~~~~~~~~~~~~~~~~ 230 (324)
T 3mtl_A 155 K-TYDNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTV---EEQLHFIFRILGTPTEETWPGILS 230 (324)
T ss_dssp ---------CGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSH---HHHHHHHHHHHCCCCTTTSTTGGG
T ss_pred c-ccccccCcccccChhhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCH---HHHHHHHHHHhCCCChHhchhhhc
Confidence 2 2334568999999999876 6789999999999999999999999964322 22222222222211110000
Q ss_pred --------CCCCCCC----hhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhhc
Q 010519 419 --------DPNLEVK----PATRALKRSLLVALRCVDPDSEKRPKMSQVVRMLEA 461 (508)
Q Consensus 419 --------~~~~~~~----~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~ 461 (508)
.+..... ........+.+|+.+||+.||.+|||+.|++++-+-
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f 285 (324)
T 3mtl_A 231 NEEFKTYNYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMKHPFF 285 (324)
T ss_dssp CHHHHHTCCCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGG
T ss_pred chhhcccccccccchhhhhhcCCCCHHHHHHHHHHcCcCcccCCCHHHHhcChhh
Confidence 0000000 001123456789999999999999999999986543
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-42 Score=373.46 Aligned_cols=257 Identities=24% Similarity=0.389 Sum_probs=202.4
Q ss_pred HhhCCcccce-eEeeeCceEEEEEEEc---CCCEEEEEEEcccc-hhhHHHHHHHHHHHhcCCCCCceeEEEEEEeCcee
Q 010519 183 IATNRFSAEN-VLGEGGYGVVYKGRLI---NGSEVAVKKLLNNL-GQAEKEFRVEVEAIGHVRHKNLVRLLGYCIEGVHR 257 (508)
Q Consensus 183 ~~~~~~~~~~-~lg~G~~g~Vy~~~~~---~~~~vavK~~~~~~-~~~~~~~~~ei~~l~~l~h~niv~~~~~~~~~~~~ 257 (508)
+..+++.+.+ .||+|+||.||+|.+. ++..||||++.... ....+.+.+|+.+|++++|||||+++++|.. ...
T Consensus 332 ~~~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~-~~~ 410 (613)
T 2ozo_A 332 LKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EAL 410 (613)
T ss_dssp CCTTSEEEEEEEEEECSSSEEEEEEEECSSCEEEEEEEECCCCCSSTTHHHHHHHHHHHTTCCCTTBCCEEEEEES-SSE
T ss_pred ccccceeEcCcEEecCCCcEEEEEEEecCCCcEEEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEecc-CCe
Confidence 3445666666 7999999999999874 45679999986543 3345789999999999999999999999976 568
Q ss_pred eEEEeecCCCCHHHHHhhhhccCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCEEEcCCCcEEEEecCCcc
Q 010519 258 MLVYEYVNNGNLEQWLHGAMRNQGNLTWEARMKVIIGTAKALAYLHEAIEPKVVHRDIKSSNILIDDEFNAKVSDFGLAK 337 (508)
Q Consensus 258 ~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~Dfgla~ 337 (508)
++||||+++|+|.+++. .....+++..++.++.||+.||.|||++ +|+||||||+||||++++.+||+|||+++
T Consensus 411 ~lv~E~~~~g~L~~~l~---~~~~~l~~~~~~~i~~qi~~~L~~LH~~---~iiHrDlkp~NILl~~~~~vkL~DFGla~ 484 (613)
T 2ozo_A 411 MLVMEMAGGGPLHKFLV---GKREEIPVSNVAELLHQVSMGMKYLEEK---NFVHRNLAARNVLLVNRHYAKISDFGLSK 484 (613)
T ss_dssp EEEEECCTTCBHHHHHT---TCTTTSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECCCSTTT
T ss_pred EEEEEeCCCCcHHHHHh---hccCCCCHHHHHHHHHHHHHHHHHHHHC---CEEcCcCCHHHEEEcCCCcEEEeeccCcc
Confidence 99999999999999995 3456799999999999999999999999 99999999999999999999999999998
Q ss_pred ccCCCCCcc--cccccccccccCccccCCCCCCChhhHHHHHHHHHHHHh-CCCCCCCCCCCchhcHHHHHHHHhccccc
Q 010519 338 LLDSGESHI--TTRVMGTFGYVAPEYANTGMLNEKSDIYSFGVLLLEAVT-GRDPVDYGRPANEVNLVEWLKMMVGTRRA 414 (508)
Q Consensus 338 ~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~ 414 (508)
......... .....+++.|+|||++.+..++.++|||||||+||||++ |+.||...... .+. .......
T Consensus 485 ~~~~~~~~~~~~~~~~~~~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~---~~~---~~i~~~~-- 556 (613)
T 2ozo_A 485 ALGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGP---EVM---AFIEQGK-- 556 (613)
T ss_dssp TCC--------------CCTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCSH---HHH---HHHHTTC--
T ss_pred cccCCCceeeeccCCCCccceeCHhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCCHH---HHH---HHHHcCC--
Confidence 765432211 222345689999999998999999999999999999998 99999754321 111 1111111
Q ss_pred ccccCCCCCCChhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhhcC
Q 010519 415 EEVVDPNLEVKPATRALKRSLLVALRCVDPDSEKRPKMSQVVRMLEAD 462 (508)
Q Consensus 415 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~ 462 (508)
....+......+.+|+.+||+.||.+|||+.+|++.|+..
T Consensus 557 --------~~~~p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~ 596 (613)
T 2ozo_A 557 --------RMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRAC 596 (613)
T ss_dssp --------CCCCCTTCCHHHHHHHHHTTCSSTTTSCCHHHHHHHHHHH
T ss_pred --------CCCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHH
Confidence 1111122345677799999999999999999999999864
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-41 Score=335.35 Aligned_cols=250 Identities=24% Similarity=0.355 Sum_probs=200.1
Q ss_pred CCcccceeEeeeCceEEEEEEEc-CCCEEEEEEEcccc--hhhHHHHHHHHHHHhcCCCCCceeEEEEEEe----Cceee
Q 010519 186 NRFSAENVLGEGGYGVVYKGRLI-NGSEVAVKKLLNNL--GQAEKEFRVEVEAIGHVRHKNLVRLLGYCIE----GVHRM 258 (508)
Q Consensus 186 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~ei~~l~~l~h~niv~~~~~~~~----~~~~~ 258 (508)
..|.+.+.||+|+||+||+|.+. ++..||+|.+.... ......+.+|+.+++.++||||+++++++.. ....+
T Consensus 26 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~va~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 105 (290)
T 1t4h_A 26 RFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIV 105 (290)
T ss_dssp CEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEE
T ss_pred eeEEeeeeccCCCCeEEEEeEecCCceEEEEEEecchhhCHHHHHHHHHHHHHHHhCCCCCeeeeeeeeccccCCCceEE
Confidence 45888899999999999999875 67789999886433 3445678899999999999999999999876 35678
Q ss_pred EEEeecCCCCHHHHHhhhhccCCCccHHHHHHHHHHHHHHHHHHHhcCCCC--eEeecCCCCCEEEc-CCCcEEEEecCC
Q 010519 259 LVYEYVNNGNLEQWLHGAMRNQGNLTWEARMKVIIGTAKALAYLHEAIEPK--VVHRDIKSSNILID-DEFNAKVSDFGL 335 (508)
Q Consensus 259 lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~--iiH~Dlk~~NIll~-~~~~~kl~Dfgl 335 (508)
+||||+++|+|.+++. ....+++..++.++.||+.||.|||+. + |+||||||+|||++ +++.+||+|||+
T Consensus 106 lv~e~~~~~~L~~~l~----~~~~~~~~~~~~~~~qi~~~l~~lH~~---~~~i~H~dikp~Nil~~~~~~~~kl~Dfg~ 178 (290)
T 1t4h_A 106 LVTELMTSGTLKTYLK----RFKVMKIKVLRSWCRQILKGLQFLHTR---TPPIIHRDLKCDNIFITGPTGSVKIGDLGL 178 (290)
T ss_dssp EEEECCCSCBHHHHHH----HHSSCCHHHHHHHHHHHHHHHHHHHTS---SSCCCCSCCCGGGEEESSTTSCEEECCTTG
T ss_pred EEEEecCCCCHHHHHH----HccCCCHHHHHHHHHHHHHHHHHHHcC---CCCEEECCCCHHHEEEECCCCCEEEeeCCC
Confidence 9999999999999995 346689999999999999999999998 7 99999999999998 889999999999
Q ss_pred ccccCCCCCcccccccccccccCccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCCCchhcHHHHHHHHhcccccc
Q 010519 336 AKLLDSGESHITTRVMGTFGYVAPEYANTGMLNEKSDIYSFGVLLLEAVTGRDPVDYGRPANEVNLVEWLKMMVGTRRAE 415 (508)
Q Consensus 336 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~ 415 (508)
+....... .....||+.|+|||++.+ .++.++|||||||++|+|++|+.||...... ............
T Consensus 179 ~~~~~~~~---~~~~~~t~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~-----~~~~~~~~~~~~-- 247 (290)
T 1t4h_A 179 ATLKRASF---AKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNA-----AQIYRRVTSGVK-- 247 (290)
T ss_dssp GGGCCTTS---BEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSH-----HHHHHHHTTTCC--
T ss_pred cccccccc---cccccCCcCcCCHHHHhc-cCCCcchHHHHHHHHHHHHhCCCCCCCcCcH-----HHHHHHHhccCC--
Confidence 97654332 334578999999998875 5899999999999999999999999643321 122222211111
Q ss_pred cccCCCCCCChhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhh
Q 010519 416 EVVDPNLEVKPATRALKRSLLVALRCVDPDSEKRPKMSQVVRMLE 460 (508)
Q Consensus 416 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 460 (508)
...........+.+++.+||+.||.+|||+.+++++-.
T Consensus 248 -------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h~~ 285 (290)
T 1t4h_A 248 -------PASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLNHAF 285 (290)
T ss_dssp -------CGGGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGG
T ss_pred -------ccccCCCCCHHHHHHHHHHccCChhhCCCHHHHhhCcc
Confidence 00111112245677999999999999999999998643
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-42 Score=347.85 Aligned_cols=258 Identities=24% Similarity=0.381 Sum_probs=190.9
Q ss_pred HHhhCCcccceeEeeeCceEEEEEEEc-CCCEEEEEEEcccchhhHHHHHHHHHHHhcCC-CCCceeEEEEEEe------
Q 010519 182 EIATNRFSAENVLGEGGYGVVYKGRLI-NGSEVAVKKLLNNLGQAEKEFRVEVEAIGHVR-HKNLVRLLGYCIE------ 253 (508)
Q Consensus 182 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~ei~~l~~l~-h~niv~~~~~~~~------ 253 (508)
++...+|.+.+.||+|+||.||+|++. +++.||+|++..........+.+|+.++.++. ||||+++++++..
T Consensus 24 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~~ 103 (337)
T 3ll6_A 24 ELGELRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEESD 103 (337)
T ss_dssp EETTEEEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEECTTTST
T ss_pred eccCceEEEEEEEccCCceEEEEEEECCCCcEEEEEEecCCchHHHHHHHHHHHHHHHhccCCChhhccccccccccccc
Confidence 344568999999999999999999975 78899999987666666678889999999995 9999999999952
Q ss_pred --CceeeEEEeecCCCCHHHHHhhhhccCCCccHHHHHHHHHHHHHHHHHHHhcCCCC--eEeecCCCCCEEEcCCCcEE
Q 010519 254 --GVHRMLVYEYVNNGNLEQWLHGAMRNQGNLTWEARMKVIIGTAKALAYLHEAIEPK--VVHRDIKSSNILIDDEFNAK 329 (508)
Q Consensus 254 --~~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~--iiH~Dlk~~NIll~~~~~~k 329 (508)
....++||||+. |+|.+++... .....+++..++.++.||+.||.|||+. + |+||||||+|||++.++.+|
T Consensus 104 ~~~~~~~lv~e~~~-g~L~~~l~~~-~~~~~~~~~~~~~i~~qi~~~l~~LH~~---~~~ivH~Dikp~NIl~~~~~~~k 178 (337)
T 3ll6_A 104 TGQAEFLLLTELCK-GQLVEFLKKM-ESRGPLSCDTVLKIFYQTCRAVQHMHRQ---KPPIIHRDLKVENLLLSNQGTIK 178 (337)
T ss_dssp TSSEEEEEEEECCS-EEHHHHHHHH-HTTCSCCHHHHHHHHHHHHHHHHHHHTS---SSCCBCCCCCGGGCEECTTSCEE
T ss_pred cCCceEEEEEEecC-CCHHHHHHHh-hccCCCCHHHHHHHHHHHHHHHHHHHhC---CCCEEEccCCcccEEECCCCCEE
Confidence 345789999995 7999998643 3456799999999999999999999998 7 99999999999999999999
Q ss_pred EEecCCccccCCCCCcc-----------cccccccccccCcccc---CCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCC
Q 010519 330 VSDFGLAKLLDSGESHI-----------TTRVMGTFGYVAPEYA---NTGMLNEKSDIYSFGVLLLEAVTGRDPVDYGRP 395 (508)
Q Consensus 330 l~Dfgla~~~~~~~~~~-----------~~~~~gt~~y~aPE~~---~~~~~~~~~DvwS~Gvvl~elltG~~Pf~~~~~ 395 (508)
|+|||++.......... .....||+.|+|||++ .+..++.++|||||||++|+|++|+.||.....
T Consensus 179 l~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~ 258 (337)
T 3ll6_A 179 LCDFGSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDGAK 258 (337)
T ss_dssp BCCCTTCBCCSSCC-------------------------------CCTTSCSSHHHHHHHHHHHHHHHHHSSCCC-----
T ss_pred EecCccceeccccCcccccccccccchhhccccCCCCcCChhhhhccccCCCChHHhHHHHHHHHHHHHhCCCCCcchhH
Confidence 99999998765432211 1134689999999998 567789999999999999999999999964321
Q ss_pred CchhcHHHHHHHHhcccccccccCCCCCCChhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhhcCC
Q 010519 396 ANEVNLVEWLKMMVGTRRAEEVVDPNLEVKPATRALKRSLLVALRCVDPDSEKRPKMSQVVRMLEADD 463 (508)
Q Consensus 396 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~ 463 (508)
.. ... ..............+.+|+.+||+.||.+|||+.|++++|+...
T Consensus 259 ~~------~~~-------------~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~~~~ 307 (337)
T 3ll6_A 259 LR------IVN-------------GKYSIPPHDTQYTVFHSLIRAMLQVNPEERLSIAEVVHQLQEIA 307 (337)
T ss_dssp --------------------------CCCCTTCCSSGGGHHHHHHHSCSSGGGSCCHHHHHHHHHHHH
T ss_pred HH------hhc-------------CcccCCcccccchHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence 10 000 01111111111223556899999999999999999999998754
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.7e-43 Score=340.82 Aligned_cols=253 Identities=29% Similarity=0.431 Sum_probs=197.8
Q ss_pred HHhhCCcccceeEeeeCceEEEEEEEcCCCEEEEEEEcccchhhHHHHHHHHHHHhcCCCCCceeEEEEEEeC-ceeeEE
Q 010519 182 EIATNRFSAENVLGEGGYGVVYKGRLINGSEVAVKKLLNNLGQAEKEFRVEVEAIGHVRHKNLVRLLGYCIEG-VHRMLV 260 (508)
Q Consensus 182 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~ei~~l~~l~h~niv~~~~~~~~~-~~~~lv 260 (508)
.+..++|.+.+.||+|+||+||++.+ .|..||+|.+.... ..+.+.+|+.++++++||||+++++++.+. ...++|
T Consensus 17 ~~~~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~lv 93 (278)
T 1byg_A 17 ALNMKELKLLQTIGKGEFGDVMLGDY-RGNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIV 93 (278)
T ss_dssp BCCGGGEEEEEEEEECSSCEEEEEEE-TTEEEEEEECCCCC----HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEE
T ss_pred cCChhhceEEeEEecCCCceEEEEEE-cCCEEEEEEecchh--HHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCCceEEE
Confidence 34457899999999999999999987 68899999886543 346788899999999999999999997655 468999
Q ss_pred EeecCCCCHHHHHhhhhccCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCEEEcCCCcEEEEecCCccccC
Q 010519 261 YEYVNNGNLEQWLHGAMRNQGNLTWEARMKVIIGTAKALAYLHEAIEPKVVHRDIKSSNILIDDEFNAKVSDFGLAKLLD 340 (508)
Q Consensus 261 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~Dfgla~~~~ 340 (508)
|||+++|+|.+++... ....+++..++.++.|++.||.|||++ +++||||||+|||++.++.+||+|||++....
T Consensus 94 ~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~ 168 (278)
T 1byg_A 94 TEYMAKGSLVDYLRSR--GRSVLGGDCLLKFSLDVCEAMEYLEGN---NFVHRDLAARNVLVSEDNVAKVSDFGLTKEAS 168 (278)
T ss_dssp ECCCTTEEHHHHHHHH--HHHHCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTSCEEECCCCC-----
T ss_pred EecCCCCCHHHHHHhc--ccccCCHHHHHHHHHHHHHHHHHHHhC---CccccCCCcceEEEeCCCcEEEeecccccccc
Confidence 9999999999999642 223478899999999999999999999 99999999999999999999999999998654
Q ss_pred CCCCcccccccccccccCccccCCCCCCChhhHHHHHHHHHHHHh-CCCCCCCCCCCchhcHHHHHHHHhcccccccccC
Q 010519 341 SGESHITTRVMGTFGYVAPEYANTGMLNEKSDIYSFGVLLLEAVT-GRDPVDYGRPANEVNLVEWLKMMVGTRRAEEVVD 419 (508)
Q Consensus 341 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 419 (508)
... ....+++.|+|||++.+..++.++||||||+++|+|++ |..||...... ... .......
T Consensus 169 ~~~----~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~---~~~---~~~~~~~------- 231 (278)
T 1byg_A 169 STQ----DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLK---DVV---PRVEKGY------- 231 (278)
T ss_dssp -----------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGG---GHH---HHHTTTC-------
T ss_pred ccc----cCCCccccccCHHHhCCCCCCchhcHHHHHHHHHHHHhCCCCCCCCCCHH---HHH---HHHhcCC-------
Confidence 322 22357889999999998899999999999999999998 99999644321 111 1111110
Q ss_pred CCCCCChhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhhcC
Q 010519 420 PNLEVKPATRALKRSLLVALRCVDPDSEKRPKMSQVVRMLEAD 462 (508)
Q Consensus 420 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~ 462 (508)
....+......+.+++.+||+.||.+|||+.++++.|+..
T Consensus 232 ---~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~i 271 (278)
T 1byg_A 232 ---KMDAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHI 271 (278)
T ss_dssp ---CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred ---CCCCcccCCHHHHHHHHHHhcCChhhCCCHHHHHHHHHHH
Confidence 1111122344567799999999999999999999999764
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.5e-42 Score=340.79 Aligned_cols=257 Identities=23% Similarity=0.385 Sum_probs=203.7
Q ss_pred cccceeEeeeCceEEEEEEEc-----CCCEEEEEEEcccc-hhhHHHHHHHHHHHhcCCCCCceeEEEEEEeC--ceeeE
Q 010519 188 FSAENVLGEGGYGVVYKGRLI-----NGSEVAVKKLLNNL-GQAEKEFRVEVEAIGHVRHKNLVRLLGYCIEG--VHRML 259 (508)
Q Consensus 188 ~~~~~~lg~G~~g~Vy~~~~~-----~~~~vavK~~~~~~-~~~~~~~~~ei~~l~~l~h~niv~~~~~~~~~--~~~~l 259 (508)
|.+.+.||+|+||+||++.+. +++.||||++.... ......+.+|+.++++++||||+++++++.+. ...++
T Consensus 33 ~~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~l 112 (318)
T 3lxp_A 33 LKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAGAASLQL 112 (318)
T ss_dssp EEEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTTTEEEE
T ss_pred HhhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEeccccChHHHHHHHHHHHHHHhCCCcchhhEEEEEecCCCceEEE
Confidence 499999999999999998753 67889999987554 34456789999999999999999999999884 67889
Q ss_pred EEeecCCCCHHHHHhhhhccCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCEEEcCCCcEEEEecCCcccc
Q 010519 260 VYEYVNNGNLEQWLHGAMRNQGNLTWEARMKVIIGTAKALAYLHEAIEPKVVHRDIKSSNILIDDEFNAKVSDFGLAKLL 339 (508)
Q Consensus 260 v~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~Dfgla~~~ 339 (508)
||||+++|+|.+++.. ..+++..++.++.||+.||.|||+. +|+||||||+|||++.++.+||+|||++...
T Consensus 113 v~e~~~~~~L~~~l~~-----~~~~~~~~~~i~~~l~~~l~~LH~~---~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~ 184 (318)
T 3lxp_A 113 VMEYVPLGSLRDYLPR-----HSIGLAQLLLFAQQICEGMAYLHAQ---HYIHRDLAARNVLLDNDRLVKIGDFGLAKAV 184 (318)
T ss_dssp EECCCTTCBHHHHGGG-----SCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCGGGCEEC
T ss_pred EEecccCCcHHHHHhh-----CCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCchheEEEcCCCCEEECCccccccc
Confidence 9999999999999842 3489999999999999999999999 9999999999999999999999999999877
Q ss_pred CCCCCc--ccccccccccccCccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCCC---------chhcHHHHHHHH
Q 010519 340 DSGESH--ITTRVMGTFGYVAPEYANTGMLNEKSDIYSFGVLLLEAVTGRDPVDYGRPA---------NEVNLVEWLKMM 408 (508)
Q Consensus 340 ~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltG~~Pf~~~~~~---------~~~~~~~~~~~~ 408 (508)
...... ......+++.|+|||++.+..++.++|||||||++|+|++|..||...... ............
T Consensus 185 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 264 (318)
T 3lxp_A 185 PEGHEYYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQMTVLRLTELL 264 (318)
T ss_dssp CTTCSEEEC---CCCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCHHHHHHHHHHHH
T ss_pred cccccccccccCCCCCceeeChHHhcCCCCCcHHHHHHHHHHHHHHHhCCCcccccchhhhhhhcccccchhHHHHHHHH
Confidence 544321 233456788899999999988999999999999999999999998532110 000111111111
Q ss_pred hcccccccccCCCCCCChhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhhcC
Q 010519 409 VGTRRAEEVVDPNLEVKPATRALKRSLLVALRCVDPDSEKRPKMSQVVRMLEAD 462 (508)
Q Consensus 409 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~ 462 (508)
. .......+......+.+|+.+||+.||.+|||+.|+++.|+..
T Consensus 265 ~----------~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l 308 (318)
T 3lxp_A 265 E----------RGERLPRPDKCPAEVYHLMKNCWETEASFRPTFENLIPILKTV 308 (318)
T ss_dssp H----------TTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred h----------cccCCCCCccccHHHHHHHHHHcCCCcccCcCHHHHHHHHHHH
Confidence 1 1111111222345677799999999999999999999999864
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-42 Score=360.61 Aligned_cols=262 Identities=24% Similarity=0.265 Sum_probs=197.3
Q ss_pred hCCcccceeEeeeCceEEEEEEEc-CCCEEEEEEEccc--chhhHHHHHHHHHHHhcCCCCCceeEEEEEEeC------c
Q 010519 185 TNRFSAENVLGEGGYGVVYKGRLI-NGSEVAVKKLLNN--LGQAEKEFRVEVEAIGHVRHKNLVRLLGYCIEG------V 255 (508)
Q Consensus 185 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~ei~~l~~l~h~niv~~~~~~~~~------~ 255 (508)
.++|.+.+.||+|+||+||+|.+. +++.||||++... .......+.+|+.+++.++||||+++++++... .
T Consensus 61 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~ 140 (464)
T 3ttj_A 61 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQ 140 (464)
T ss_dssp ETTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEESGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCC
T ss_pred cCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEECccccChHHHHHHHHHHHHHHhCCCCCCCcEEEEEccCCccccCC
Confidence 478999999999999999999875 6889999998654 234456788899999999999999999999754 3
Q ss_pred eeeEEEeecCCCCHHHHHhhhhccCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCEEEcCCCcEEEEecCC
Q 010519 256 HRMLVYEYVNNGNLEQWLHGAMRNQGNLTWEARMKVIIGTAKALAYLHEAIEPKVVHRDIKSSNILIDDEFNAKVSDFGL 335 (508)
Q Consensus 256 ~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~Dfgl 335 (508)
..|+||||+++ +|.+.+. ..+++..+..++.||+.||.|||+. +|+||||||+|||++.++.+||+|||+
T Consensus 141 ~~~lv~E~~~~-~l~~~~~------~~l~~~~~~~~~~qil~aL~~lH~~---~iiHrDlkp~NIll~~~~~~kl~DFG~ 210 (464)
T 3ttj_A 141 DVYLVMELMDA-NLCQVIQ------MELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGL 210 (464)
T ss_dssp EEEEEEECCSE-EHHHHHT------SCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCCCC
T ss_pred eEEEEEeCCCC-CHHHHHh------hcCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChHhEEEeCCCCEEEEEEEe
Confidence 56999999975 5777663 2488999999999999999999999 999999999999999999999999999
Q ss_pred ccccCCCCCcccccccccccccCccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCCCchhcHHHHHHHHhcccccc
Q 010519 336 AKLLDSGESHITTRVMGTFGYVAPEYANTGMLNEKSDIYSFGVLLLEAVTGRDPVDYGRPANEVNLVEWLKMMVGTRRAE 415 (508)
Q Consensus 336 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~ 415 (508)
++...... .....+||+.|+|||++.+..|+.++|||||||+||||++|+.||..... ......+....+.....
T Consensus 211 a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pF~g~~~---~~~~~~i~~~lg~p~~~ 285 (464)
T 3ttj_A 211 ARTAGTSF--MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDY---IDQWNKVIEQLGTPCPE 285 (464)
T ss_dssp C-----CC--CC----CCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSH---HHHHHHHHHHHCSCCHH
T ss_pred eeecCCCc--ccCCCcccccccCHHHHcCCCCCHHHHHHHHHHHHHHHHhCCCCCCCCCH---HHHHHHHHHhcCCCCHH
Confidence 98765432 24556899999999999999999999999999999999999999964321 11111111111110000
Q ss_pred ----------cccC--CC--------------CCCC--hhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhhc
Q 010519 416 ----------EVVD--PN--------------LEVK--PATRALKRSLLVALRCVDPDSEKRPKMSQVVRMLEA 461 (508)
Q Consensus 416 ----------~~~~--~~--------------~~~~--~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~ 461 (508)
..+. +. +... ........+.+|+.+||..||.+|||++|+++|-+-
T Consensus 286 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~~ 359 (464)
T 3ttj_A 286 FMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYI 359 (464)
T ss_dssp HHTTSCHHHHHHHTTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTSTTT
T ss_pred HHHHcchhhhhHhhcccccCCCChHHhCcccccccccccccccCHHHHHHHHHHcCCChhhCCCHHHHhcChhh
Confidence 0000 00 0000 011124567889999999999999999999987654
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-42 Score=336.79 Aligned_cols=249 Identities=24% Similarity=0.343 Sum_probs=200.9
Q ss_pred hCCcccceeEeeeCceEEEEEEEc-CCCEEEEEEEcccc--hhhHHHHHHHHHHHhcC-CCCCceeEEEEEEeCceeeEE
Q 010519 185 TNRFSAENVLGEGGYGVVYKGRLI-NGSEVAVKKLLNNL--GQAEKEFRVEVEAIGHV-RHKNLVRLLGYCIEGVHRMLV 260 (508)
Q Consensus 185 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~ei~~l~~l-~h~niv~~~~~~~~~~~~~lv 260 (508)
.++|.+.+.||+|+||+||+|.+. +++.||+|++.... ......+.+|+..+..+ +||||+++++++.+....++|
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~~~~~~lv 89 (289)
T 1x8b_A 10 TTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYFSAWAEDDHMLIQ 89 (289)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCCTTSHHHHHHHHHHHHHHHSCSCTTBCCEEEEEEETTEEEEE
T ss_pred cchhhhhhhhcCCCceEEEEEEEcCCCceEEEEEecccccccHHHHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEE
Confidence 357999999999999999999986 78999999986532 33456778899999998 999999999999999999999
Q ss_pred EeecCCCCHHHHHhhhhccCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCEEEcCC---------------
Q 010519 261 YEYVNNGNLEQWLHGAMRNQGNLTWEARMKVIIGTAKALAYLHEAIEPKVVHRDIKSSNILIDDE--------------- 325 (508)
Q Consensus 261 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiH~Dlk~~NIll~~~--------------- 325 (508)
|||+++|+|.+++.........+++..++.++.||+.||.|||++ +|+||||||+|||++.+
T Consensus 90 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dikp~NIl~~~~~~~~~~~~~~~~~~~ 166 (289)
T 1x8b_A 90 NEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSM---SLVHMDIKPSNIFISRTSIPNAASEEGDEDDW 166 (289)
T ss_dssp EECCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEC-----------------
T ss_pred EEecCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHHhC---CEeecCCCHHHEEEcCCCCCcccccccccccc
Confidence 999999999999976544457799999999999999999999999 99999999999999844
Q ss_pred ----CcEEEEecCCccccCCCCCcccccccccccccCccccCCC-CCCChhhHHHHHHHHHHHHhCCCCCCCCCCCchhc
Q 010519 326 ----FNAKVSDFGLAKLLDSGESHITTRVMGTFGYVAPEYANTG-MLNEKSDIYSFGVLLLEAVTGRDPVDYGRPANEVN 400 (508)
Q Consensus 326 ----~~~kl~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwS~Gvvl~elltG~~Pf~~~~~~~~~~ 400 (508)
..+||+|||++....... ...||+.|+|||++.+. .++.++|||||||++|+|++|..|+.... .
T Consensus 167 ~~~~~~~kl~Dfg~~~~~~~~~-----~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~-----~ 236 (289)
T 1x8b_A 167 ASNKVMFKIGDLGHVTRISSPQ-----VEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNGD-----Q 236 (289)
T ss_dssp ---CCCEEECCCTTCEETTCSC-----CCCCCGGGCCHHHHTTCCTTHHHHHHHHHHHHHHHHTTCCCCCSSSH-----H
T ss_pred cCCceEEEEcccccccccCCcc-----ccCCCccccChhHhcCCCCCCchhhHHHHHHHHHHHhcCCCCCcchh-----H
Confidence 479999999998765432 23589999999999876 56689999999999999999987764221 1
Q ss_pred HHHHHHHHhcccccccccCCCCCCChhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhh
Q 010519 401 LVEWLKMMVGTRRAEEVVDPNLEVKPATRALKRSLLVALRCVDPDSEKRPKMSQVVRMLE 460 (508)
Q Consensus 401 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 460 (508)
+. ..... .. +.+. ......+.+++.+||+.||.+|||+.+++++-.
T Consensus 237 ---~~-~~~~~-~~-----~~~~----~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~ 282 (289)
T 1x8b_A 237 ---WH-EIRQG-RL-----PRIP----QVLSQEFTELLKVMIHPDPERRPSAMALVKHSV 282 (289)
T ss_dssp ---HH-HHHTT-CC-----CCCS----SCCCHHHHHHHHHHTCSSGGGSCCHHHHHTCTT
T ss_pred ---HH-HHHcC-CC-----CCCC----cccCHHHHHHHHHHhCCCcccCCCHHHHhhChH
Confidence 11 11111 11 1111 112345667999999999999999999998654
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-42 Score=346.78 Aligned_cols=267 Identities=19% Similarity=0.250 Sum_probs=207.3
Q ss_pred HHHHhhCCcccc-eeEeeeCceEEEEEEEc-CCCEEEEEEEcccc--hhhHHHHHHHHHHHhcC-CCCCceeEEEEEEeC
Q 010519 180 DLEIATNRFSAE-NVLGEGGYGVVYKGRLI-NGSEVAVKKLLNNL--GQAEKEFRVEVEAIGHV-RHKNLVRLLGYCIEG 254 (508)
Q Consensus 180 ~~~~~~~~~~~~-~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~ei~~l~~l-~h~niv~~~~~~~~~ 254 (508)
..+...++|.+. +.||+|+||+||+|.+. +++.||+|++.... ......+.+|+.++..+ +||||+++++++.+.
T Consensus 22 ~~~~~~~~y~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~iv~~~~~~~~~ 101 (327)
T 3lm5_A 22 SMENFNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHEVYENT 101 (327)
T ss_dssp CHHHHHHHEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESEETTEECHHHHHHHHHHHHHTTTCTTBCCEEEEEECS
T ss_pred HHHhhhhEEeeccceeCCCCCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHhccCCCCEEEEEEEEEeC
Confidence 334556678877 88999999999999876 68999999986543 23356788899999999 569999999999999
Q ss_pred ceeeEEEeecCCCCHHHHHhhhhccCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCEEEcC---CCcEEEE
Q 010519 255 VHRMLVYEYVNNGNLEQWLHGAMRNQGNLTWEARMKVIIGTAKALAYLHEAIEPKVVHRDIKSSNILIDD---EFNAKVS 331 (508)
Q Consensus 255 ~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiH~Dlk~~NIll~~---~~~~kl~ 331 (508)
...++||||+++|+|.+++.. .....+++..++.++.||+.||.|||+. +|+||||||+|||++. ++.+||+
T Consensus 102 ~~~~lv~e~~~~~~L~~~~~~--~~~~~~~~~~~~~i~~ql~~~L~~LH~~---givH~Dikp~NIl~~~~~~~~~~kL~ 176 (327)
T 3lm5_A 102 SEIILILEYAAGGEIFSLCLP--ELAEMVSENDVIRLIKQILEGVYYLHQN---NIVHLDLKPQNILLSSIYPLGDIKIV 176 (327)
T ss_dssp SEEEEEEECCTTEEGGGGGSS--CC-CCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEESCBTTBCCEEEC
T ss_pred CeEEEEEEecCCCcHHHHHHH--hcccCCCHHHHHHHHHHHHHHHHHHHHC---CeecCcCChHHEEEecCCCCCcEEEe
Confidence 999999999999999998743 2346799999999999999999999999 9999999999999998 7899999
Q ss_pred ecCCccccCCCCCcccccccccccccCccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCCCchhcHHHHHHHHhcc
Q 010519 332 DFGLAKLLDSGESHITTRVMGTFGYVAPEYANTGMLNEKSDIYSFGVLLLEAVTGRDPVDYGRPANEVNLVEWLKMMVGT 411 (508)
Q Consensus 332 Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~ 411 (508)
|||++....... ......||+.|+|||++.+..++.++|||||||++|+|++|+.||..... ......+.. ..
T Consensus 177 Dfg~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~---~~~~~~i~~--~~ 249 (327)
T 3lm5_A 177 DFGMSRKIGHAC--ELREIMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTHTSPFVGEDN---QETYLNISQ--VN 249 (327)
T ss_dssp CGGGCEEC-----------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSH---HHHHHHHHH--TC
T ss_pred eCccccccCCcc--ccccccCCcCccCCeeecCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCc---hHHHHHHHh--cc
Confidence 999998765432 23345799999999999999999999999999999999999999964321 111111111 00
Q ss_pred cccccccCCCCCCChhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhhcCCCCC
Q 010519 412 RRAEEVVDPNLEVKPATRALKRSLLVALRCVDPDSEKRPKMSQVVRMLEADDYPF 466 (508)
Q Consensus 412 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~~ 466 (508)
..............+.+|+.+||+.||.+|||+.+++++-+-....+
T Consensus 250 --------~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~~ll~h~~~~~~~~ 296 (327)
T 3lm5_A 250 --------VDYSEETFSSVSQLATDFIQSLLVKNPEKRPTAEICLSHSWLQQWDF 296 (327)
T ss_dssp --------CCCCTTTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTCGGGCCCCT
T ss_pred --------cccCchhhcccCHHHHHHHHHHcCCChhhCcCHHHHhCCHhhccccc
Confidence 01111111223445667999999999999999999998866544433
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-42 Score=345.98 Aligned_cols=251 Identities=19% Similarity=0.310 Sum_probs=205.5
Q ss_pred hCCcccceeEeeeCceEEEEEEEc-CCCEEEEEEEcccc---hhhHHHHHHHHHHHhcCCCCCceeEEEEEEeCceeeEE
Q 010519 185 TNRFSAENVLGEGGYGVVYKGRLI-NGSEVAVKKLLNNL---GQAEKEFRVEVEAIGHVRHKNLVRLLGYCIEGVHRMLV 260 (508)
Q Consensus 185 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~ei~~l~~l~h~niv~~~~~~~~~~~~~lv 260 (508)
.++|.+.+.||+|+||.||++.+. +++.+|+|.+.... ......+.+|+.+++.++||||+++++++.+....++|
T Consensus 40 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 119 (335)
T 2owb_A 40 RRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVV 119 (335)
T ss_dssp TEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred CCceEEEEEEeeCCCeEEEEEEECCCCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEE
Confidence 358999999999999999999986 57789999886442 33456788899999999999999999999999999999
Q ss_pred EeecCCCCHHHHHhhhhccCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCEEEcCCCcEEEEecCCccccC
Q 010519 261 YEYVNNGNLEQWLHGAMRNQGNLTWEARMKVIIGTAKALAYLHEAIEPKVVHRDIKSSNILIDDEFNAKVSDFGLAKLLD 340 (508)
Q Consensus 261 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~Dfgla~~~~ 340 (508)
|||+++++|.+++. ....+++..++.++.||+.||.|||++ +|+||||||+|||++.++.+||+|||++....
T Consensus 120 ~e~~~~~~L~~~~~----~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~ 192 (335)
T 2owb_A 120 LELCRRRSLLELHK----RRKALTEPEARYYLRQIVLGCQYLHRN---RVIHRDLKLGNLFLNEDLEVKIGDFGLATKVE 192 (335)
T ss_dssp ECCCTTCBHHHHHH----HHCSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECTTCCEEECCCTTCEECC
T ss_pred EecCCCCCHHHHHh----ccCCCCHHHHHHHHHHHHHHHHHHHHC---CCEecCCCchhEEEcCCCCEEEeeccCceecc
Confidence 99999999999884 345789999999999999999999999 99999999999999999999999999998764
Q ss_pred CCCCcccccccccccccCccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCCCchhcHHHHHHHHhcccccccccCC
Q 010519 341 SGESHITTRVMGTFGYVAPEYANTGMLNEKSDIYSFGVLLLEAVTGRDPVDYGRPANEVNLVEWLKMMVGTRRAEEVVDP 420 (508)
Q Consensus 341 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 420 (508)
.... ......||+.|+|||++.+..++.++|||||||++|+|++|+.||..... .+......... .
T Consensus 193 ~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~------~~~~~~~~~~~-------~ 258 (335)
T 2owb_A 193 YDGE-RKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCL------KETYLRIKKNE-------Y 258 (335)
T ss_dssp STTC-CBCCCCSCCSSCCHHHHHTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSH------HHHHHHHHHTC-------C
T ss_pred cCcc-cccccCCCccccCHHHhccCCCCchhhHHHHHHHHHHHHHCcCCCCCCCH------HHHHHHHhcCC-------C
Confidence 3322 23445789999999999999999999999999999999999999964321 11111111110 0
Q ss_pred CCCCChhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhh
Q 010519 421 NLEVKPATRALKRSLLVALRCVDPDSEKRPKMSQVVRMLE 460 (508)
Q Consensus 421 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 460 (508)
.+.. .....+.+|+.+||+.||.+|||+.|++++-.
T Consensus 259 ~~~~----~~~~~~~~li~~~l~~dp~~Rps~~ell~~~~ 294 (335)
T 2owb_A 259 SIPK----HINPVAASLIQKMLQTDPTARPTINELLNDEF 294 (335)
T ss_dssp CCCT----TSCHHHHHHHHHHTCSSGGGSCCGGGGGGSHH
T ss_pred CCCc----cCCHHHHHHHHHHccCChhHCcCHHHHhcCcc
Confidence 0111 12235667999999999999999999998643
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-42 Score=349.14 Aligned_cols=258 Identities=25% Similarity=0.344 Sum_probs=204.3
Q ss_pred hhCCcccceeEeeeCceEEEEEEEc-CCCEEEEEEEcccc-hhhHHHHHHHHHHHhcCCCCCceeEEEEEEeCceeeEEE
Q 010519 184 ATNRFSAENVLGEGGYGVVYKGRLI-NGSEVAVKKLLNNL-GQAEKEFRVEVEAIGHVRHKNLVRLLGYCIEGVHRMLVY 261 (508)
Q Consensus 184 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~ei~~l~~l~h~niv~~~~~~~~~~~~~lv~ 261 (508)
..++|.+.+.||+|+||+||+|.+. ++..||+|++.... ......+.+|+.+++.++||||+++++++.+....++||
T Consensus 31 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 110 (360)
T 3eqc_A 31 KDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICM 110 (360)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECCCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEETTEEEEEE
T ss_pred ccccceeeeeecCCCCeEEEEEEECCCCcEEEEEEeccccCHHHHHHHHHHHHHHHHCCCCCEEEEeEEEEECCEEEEEE
Confidence 4568999999999999999999986 68899999986543 344567889999999999999999999999999999999
Q ss_pred eecCCCCHHHHHhhhhccCCCccHHHHHHHHHHHHHHHHHHHh-cCCCCeEeecCCCCCEEEcCCCcEEEEecCCccccC
Q 010519 262 EYVNNGNLEQWLHGAMRNQGNLTWEARMKVIIGTAKALAYLHE-AIEPKVVHRDIKSSNILIDDEFNAKVSDFGLAKLLD 340 (508)
Q Consensus 262 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~yLH~-~~~~~iiH~Dlk~~NIll~~~~~~kl~Dfgla~~~~ 340 (508)
||+++|+|.+++. ....+++..+..++.+++.||.|||+ . +|+||||||+|||++.++.+||+|||++....
T Consensus 111 e~~~~~~L~~~l~----~~~~~~~~~~~~i~~~i~~~l~~lh~~~---~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~ 183 (360)
T 3eqc_A 111 EHMDGGSLDQVLK----KAGRIPEQILGKVSIAVIKGLTYLREKH---KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLI 183 (360)
T ss_dssp CCCTTCBHHHHHH----HHSSCCHHHHHHHHHHHHHHHHHHHHHH---CCCCSCCSGGGEEECTTCCEEECCCCCCHHHH
T ss_pred ECCCCCCHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHHhC---CEEcCCccHHHEEECCCCCEEEEECCCCcccc
Confidence 9999999999995 34568999999999999999999998 5 79999999999999999999999999997553
Q ss_pred CCCCcccccccccccccCccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCCCchhcH-------------------
Q 010519 341 SGESHITTRVMGTFGYVAPEYANTGMLNEKSDIYSFGVLLLEAVTGRDPVDYGRPANEVNL------------------- 401 (508)
Q Consensus 341 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltG~~Pf~~~~~~~~~~~------------------- 401 (508)
.. ......||+.|+|||++.+..++.++|||||||++|+|++|+.||...........
T Consensus 184 ~~---~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 260 (360)
T 3eqc_A 184 DS---MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTP 260 (360)
T ss_dssp HH---C----CCCCTTCCHHHHTTCCCSHHHHHHHHHHHHHHHHHTSCCSSCCCHHHHHHHHC-----------------
T ss_pred cc---cccCCCCCCCeECHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccCCCCCCCcccC
Confidence 22 13345789999999999999999999999999999999999999964332110000
Q ss_pred -----------------HHHHHHHhcccccccccCCCCCCChhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhh
Q 010519 402 -----------------VEWLKMMVGTRRAEEVVDPNLEVKPATRALKRSLLVALRCVDPDSEKRPKMSQVVRMLE 460 (508)
Q Consensus 402 -----------------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 460 (508)
.+.+..... ......+.......+.+|+.+||+.||.+|||+.|+++|-+
T Consensus 261 ~~~~~~~~~~~~~~~~~~~~~~~~~~---------~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~ 327 (360)
T 3eqc_A 261 GRPLNKFGMDSRPPMAIFELLDYIVN---------EPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAF 327 (360)
T ss_dssp -------------CCCHHHHHHHHHH---------SCCCCCCTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHTSHH
T ss_pred CCcccccccCCCCcccchhhhhHHhc---------cCCCCCCcccccHHHHHHHHHHhhcChhhCCCHHHHhhChH
Confidence 000000000 00000111112345677999999999999999999998654
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-42 Score=350.84 Aligned_cols=265 Identities=23% Similarity=0.334 Sum_probs=201.4
Q ss_pred HHhhCCcccceeEeeeCceEEEEEEEc-CCCEEEEEEEcccchhhHHHHHHHHHHHhcCCCCCceeEEEEEEeC------
Q 010519 182 EIATNRFSAENVLGEGGYGVVYKGRLI-NGSEVAVKKLLNNLGQAEKEFRVEVEAIGHVRHKNLVRLLGYCIEG------ 254 (508)
Q Consensus 182 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~ei~~l~~l~h~niv~~~~~~~~~------ 254 (508)
+...++|.+.+.||+|+||+||+|++. +|+.||||++...... ..+|+.+++.++||||+++++++...
T Consensus 3 ~~~~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~~----~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~ 78 (383)
T 3eb0_A 3 ETSSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPRY----KNRELDIMKVLDHVNIIKLVDYFYTTGDEEPK 78 (383)
T ss_dssp ---CTTEEEEEEEECC-CEEEEEEEETTTCCEEEEEEEECCTTS----CCHHHHHHTTCCCTTBCCEEEEEEEC------
T ss_pred ccccceEEEEEEEEeccCEEEEEEEECCCCCEEEEEEEecCcch----HHHHHHHHHHcCCCCccchhheeeecCccccc
Confidence 456689999999999999999999874 7899999998654322 23599999999999999999998543
Q ss_pred --------------------------------ceeeEEEeecCCCCHHHHHhhhhccCCCccHHHHHHHHHHHHHHHHHH
Q 010519 255 --------------------------------VHRMLVYEYVNNGNLEQWLHGAMRNQGNLTWEARMKVIIGTAKALAYL 302 (508)
Q Consensus 255 --------------------------------~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~yL 302 (508)
...++||||++ |+|.+.+.........+++..++.++.||+.||.||
T Consensus 79 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~L 157 (383)
T 3eb0_A 79 PPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVP-DTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFI 157 (383)
T ss_dssp -------------------------------CCEEEEEECCCS-EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHH
T ss_pred ccccccccccccccccccccccccccccCCCceEEEEEEecCC-ccHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHH
Confidence 34789999997 599998877666778899999999999999999999
Q ss_pred HhcCCCCeEeecCCCCCEEEc-CCCcEEEEecCCccccCCCCCcccccccccccccCccccCCC-CCCChhhHHHHHHHH
Q 010519 303 HEAIEPKVVHRDIKSSNILID-DEFNAKVSDFGLAKLLDSGESHITTRVMGTFGYVAPEYANTG-MLNEKSDIYSFGVLL 380 (508)
Q Consensus 303 H~~~~~~iiH~Dlk~~NIll~-~~~~~kl~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwS~Gvvl 380 (508)
|+. +|+||||||+|||++ .++.+||+|||++........ .....||+.|+|||++.+. .++.++|||||||++
T Consensus 158 H~~---gi~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il 232 (383)
T 3eb0_A 158 HSL---GICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSEP--SVAYICSRFYRAPELMLGATEYTPSIDLWSIGCVF 232 (383)
T ss_dssp HTT---TEECSCCCGGGEEEETTTTEEEECCCTTCEECCTTSC--CCCCCCCSSCCCHHHHTTCSSCCTHHHHHHHHHHH
T ss_pred HHC---cCccCccCHHHEEEcCCCCcEEEEECCCCcccCCCCC--CcCcccCCCccCHHHhcCCCCCCcchhhhhHHHHH
Confidence 999 999999999999997 688999999999987654332 3345689999999998775 489999999999999
Q ss_pred HHHHhCCCCCCCCCCCchhcHHHHHHHHhccc----------ccccccCCCCCCCh-----hHHHHHHHHHHHHHhcCCC
Q 010519 381 LEAVTGRDPVDYGRPANEVNLVEWLKMMVGTR----------RAEEVVDPNLEVKP-----ATRALKRSLLVALRCVDPD 445 (508)
Q Consensus 381 ~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~----------~~~~~~~~~~~~~~-----~~~~~~~l~~li~~cl~~d 445 (508)
|||++|+.||..... ...+...+. ..+.. ......-+...... +......+.+|+.+||+.|
T Consensus 233 ~ell~g~~pf~~~~~--~~~~~~i~~-~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~d 309 (383)
T 3eb0_A 233 GELILGKPLFSGETS--IDQLVRIIQ-IMGTPTKEQMIRMNPHYTEVRFPTLKAKDWRKILPEGTPSLAIDLLEQILRYE 309 (383)
T ss_dssp HHHHHSSCSSCCSSH--HHHHHHHHH-HHCCCCHHHHHHHCTTC--CCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSS
T ss_pred HHHHhCCCCCCCCCh--HHHHHHHHH-HhCCCCHHHHHHhCcccccccCCccCcccHHhhCCCCCCHHHHHHHHHHccCC
Confidence 999999999964322 111111111 11111 00011111111111 1112345778999999999
Q ss_pred CCCCCCHHHHHHHh
Q 010519 446 SEKRPKMSQVVRML 459 (508)
Q Consensus 446 P~~RPs~~evl~~L 459 (508)
|.+|||+.|+++|-
T Consensus 310 P~~R~t~~e~l~hp 323 (383)
T 3eb0_A 310 PDLRINPYEAMAHP 323 (383)
T ss_dssp GGGSCCHHHHHTSG
T ss_pred hhhCCCHHHHhcCH
Confidence 99999999999754
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.9e-42 Score=337.88 Aligned_cols=251 Identities=24% Similarity=0.383 Sum_probs=206.2
Q ss_pred CCcccceeEeeeCceEEEEEEEc-CCCEEEEEEEcccc-hhhHHHHHHHHHHHhcCCCCCceeEEEEEEeCceeeEEEee
Q 010519 186 NRFSAENVLGEGGYGVVYKGRLI-NGSEVAVKKLLNNL-GQAEKEFRVEVEAIGHVRHKNLVRLLGYCIEGVHRMLVYEY 263 (508)
Q Consensus 186 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~ei~~l~~l~h~niv~~~~~~~~~~~~~lv~E~ 263 (508)
+.|.+.+.||+|+||.||+|++. +++.||+|.+.... ......+.+|+.+++.++||||+++++++.+....++||||
T Consensus 22 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 101 (303)
T 3a7i_A 22 ELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEY 101 (303)
T ss_dssp GTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEETTTCSTTHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred HHHHHhhhhcccCCeEEEEEEECCCCcEEEEEEecccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEEe
Confidence 57999999999999999999875 68899999986443 33456788999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhhhhccCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCEEEcCCCcEEEEecCCccccCCCC
Q 010519 264 VNNGNLEQWLHGAMRNQGNLTWEARMKVIIGTAKALAYLHEAIEPKVVHRDIKSSNILIDDEFNAKVSDFGLAKLLDSGE 343 (508)
Q Consensus 264 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~~~ 343 (508)
+++++|.+++. ...+++..++.++.||+.||.|||+. +|+|+||||+|||++.++.+||+|||++.......
T Consensus 102 ~~~~~L~~~~~-----~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~~ 173 (303)
T 3a7i_A 102 LGGGSALDLLE-----PGPLDETQIATILREILKGLDYLHSE---KKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQ 173 (303)
T ss_dssp CTTEEHHHHHT-----TSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECBTTB
T ss_pred CCCCcHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCChheEEECCCCCEEEeecccceecCccc
Confidence 99999999984 35689999999999999999999999 99999999999999999999999999998765432
Q ss_pred CcccccccccccccCccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCCCchhcHHHHHHHHhcccccccccCCCCC
Q 010519 344 SHITTRVMGTFGYVAPEYANTGMLNEKSDIYSFGVLLLEAVTGRDPVDYGRPANEVNLVEWLKMMVGTRRAEEVVDPNLE 423 (508)
Q Consensus 344 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 423 (508)
. ......|++.|+|||++.+..++.++||||||+++|+|++|..||..... . .......... .+.+.
T Consensus 174 ~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~---~---~~~~~~~~~~------~~~~~ 240 (303)
T 3a7i_A 174 I-KRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSELHP---M---KVLFLIPKNN------PPTLE 240 (303)
T ss_dssp C-CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCH---H---HHHHHHHHSC------CCCCC
T ss_pred c-ccCccCCCcCccCHHHHhcCCCCchhhhHHHHHHHHHHccCCCCCCCcCH---H---HHHHHhhcCC------CCCCc
Confidence 2 23445789999999999999999999999999999999999999964321 1 1111111111 01111
Q ss_pred CChhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhhc
Q 010519 424 VKPATRALKRSLLVALRCVDPDSEKRPKMSQVVRMLEA 461 (508)
Q Consensus 424 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~ 461 (508)
. .....+.+|+.+||+.||.+|||+.+++++..-
T Consensus 241 ~----~~~~~l~~li~~~l~~dp~~Rps~~~ll~~~~~ 274 (303)
T 3a7i_A 241 G----NYSKPLKEFVEACLNKEPSFRPTAKELLKHKFI 274 (303)
T ss_dssp S----SCCHHHHHHHHHHCCSSGGGSCCHHHHTTCHHH
T ss_pred c----ccCHHHHHHHHHHcCCChhhCcCHHHHhhChhh
Confidence 1 123456679999999999999999999987543
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-42 Score=343.10 Aligned_cols=264 Identities=23% Similarity=0.388 Sum_probs=207.5
Q ss_pred hhCCcccceeEeeeCceEEEEEEE-----cCCCEEEEEEEcccchhhHHHHHHHHHHHhcCCCCCceeEEEEEEeCc--e
Q 010519 184 ATNRFSAENVLGEGGYGVVYKGRL-----INGSEVAVKKLLNNLGQAEKEFRVEVEAIGHVRHKNLVRLLGYCIEGV--H 256 (508)
Q Consensus 184 ~~~~~~~~~~lg~G~~g~Vy~~~~-----~~~~~vavK~~~~~~~~~~~~~~~ei~~l~~l~h~niv~~~~~~~~~~--~ 256 (508)
..++|.+.+.||+|+||.||+|++ .++..||+|++..........+.+|+.+++.++||||+++++++.... .
T Consensus 39 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 118 (326)
T 2w1i_A 39 EERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRN 118 (326)
T ss_dssp CGGGEEEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSCCSHHHHHHHHHHHHHHTCCCTTBCCEEEEECC----C
T ss_pred CHHHceeeeeeccCCCeEEEEEEeccccCCCceEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEecCCCc
Confidence 346799999999999999999984 368899999997766666678999999999999999999999987653 6
Q ss_pred eeEEEeecCCCCHHHHHhhhhccCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCEEEcCCCcEEEEecCCc
Q 010519 257 RMLVYEYVNNGNLEQWLHGAMRNQGNLTWEARMKVIIGTAKALAYLHEAIEPKVVHRDIKSSNILIDDEFNAKVSDFGLA 336 (508)
Q Consensus 257 ~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~Dfgla 336 (508)
.++||||+++++|.+++.. ....+++..++.++.||+.||.|||+. +|+||||||+|||++.++.+||+|||++
T Consensus 119 ~~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dikp~NIli~~~~~~kL~Dfg~~ 192 (326)
T 2w1i_A 119 LKLIMEYLPYGSLRDYLQK---HKERIDHIKLLQYTSQICKGMEYLGTK---RYIHRDLATRNILVENENRVKIGDFGLT 192 (326)
T ss_dssp CEEEECCCTTCBHHHHHHH---STTSSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEEEETTEEEECCCTTC
T ss_pred eEEEEECCCCCCHHHHHHh---cccCCCHHHHHHHHHHHHHHHHHHHhC---CEeccCCCcceEEEcCCCcEEEecCcch
Confidence 7899999999999999963 345689999999999999999999999 9999999999999999999999999999
Q ss_pred cccCCCCCc--ccccccccccccCccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCC---------CCchhcHHHHH
Q 010519 337 KLLDSGESH--ITTRVMGTFGYVAPEYANTGMLNEKSDIYSFGVLLLEAVTGRDPVDYGR---------PANEVNLVEWL 405 (508)
Q Consensus 337 ~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltG~~Pf~~~~---------~~~~~~~~~~~ 405 (508)
......... ......++..|+|||++.+..++.++|||||||++|||++|..||.... ..........+
T Consensus 193 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 272 (326)
T 2w1i_A 193 KVLPQDKEYYKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHL 272 (326)
T ss_dssp EECCSSCSEEECSSCCSCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHHTTCGGGSHHHHHHHHHCTTCCTHHHHHHH
T ss_pred hhccccccccccccCCCCceeEECchhhcCCCCCchhhHHHHHHHHHHHHhcCCCCCCCHHHHHHhhccccchhhhHHHH
Confidence 876543321 1223456778999999998889999999999999999999999875221 00000000011
Q ss_pred HHHhcccccccccCCCCCCChhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhhcC
Q 010519 406 KMMVGTRRAEEVVDPNLEVKPATRALKRSLLVALRCVDPDSEKRPKMSQVVRMLEAD 462 (508)
Q Consensus 406 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~ 462 (508)
...... ......+......+.+++.+||+.||.+|||+.++++.|+..
T Consensus 273 ~~~~~~---------~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~el~~~L~~l 320 (326)
T 2w1i_A 273 IELLKN---------NGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQI 320 (326)
T ss_dssp HHHHHT---------TCCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHH
T ss_pred HHHhhc---------CCCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence 111110 001111122345677799999999999999999999999864
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-41 Score=333.08 Aligned_cols=253 Identities=25% Similarity=0.409 Sum_probs=204.6
Q ss_pred hhCCcccceeEeeeCceEEEEEEEc-CCCEEEEEEEcccchhhHHHHHHHHHHHhcCCCCCceeEEEEEEe---------
Q 010519 184 ATNRFSAENVLGEGGYGVVYKGRLI-NGSEVAVKKLLNNLGQAEKEFRVEVEAIGHVRHKNLVRLLGYCIE--------- 253 (508)
Q Consensus 184 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~ei~~l~~l~h~niv~~~~~~~~--------- 253 (508)
..++|.+.+.||+|+||.||+|.+. +++.||+|++.... ..+.+|+.+++.++||||+++++++..
T Consensus 9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~----~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~ 84 (284)
T 2a19_B 9 FGMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN----EKAEREVKALAKLDHVNIVHYNGCWDGFDYDPETSS 84 (284)
T ss_dssp HHHHEEEEEEEECSSSCCEEEEEETTTCCEEEEEEEECCS----GGGHHHHHHHHHCCCTTBCCEEEEEEEEEEC-----
T ss_pred hccccceeeeeccCCceEEEEEEEcCCCeEEEEEEecccc----HHHHHHHHHHHhCCCCCEEEEeeeEeccccCccccc
Confidence 3457999999999999999999986 78999999986543 245679999999999999999998865
Q ss_pred -------CceeeEEEeecCCCCHHHHHhhhhccCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCEEEcCCC
Q 010519 254 -------GVHRMLVYEYVNNGNLEQWLHGAMRNQGNLTWEARMKVIIGTAKALAYLHEAIEPKVVHRDIKSSNILIDDEF 326 (508)
Q Consensus 254 -------~~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiH~Dlk~~NIll~~~~ 326 (508)
....++||||+++|+|.+++.. .....+++..++.++.||+.||.|||+. +|+|+||||+|||+++++
T Consensus 85 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~--~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~ 159 (284)
T 2a19_B 85 KNSSRSKTKCLFIQMEFCDKGTLEQWIEK--RRGEKLDKVLALELFEQITKGVDYIHSK---KLINRDLKPSNIFLVDTK 159 (284)
T ss_dssp ----CCEEEEEEEEECCCCSCBHHHHHHH--GGGSCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEETT
T ss_pred ccccccCcceEEEEEeccCCCCHHHHHhh--ccCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeccCCHHHEEEcCCC
Confidence 3457899999999999999964 2346789999999999999999999999 999999999999999999
Q ss_pred cEEEEecCCccccCCCCCcccccccccccccCccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCCCchhcHHHHHH
Q 010519 327 NAKVSDFGLAKLLDSGESHITTRVMGTFGYVAPEYANTGMLNEKSDIYSFGVLLLEAVTGRDPVDYGRPANEVNLVEWLK 406 (508)
Q Consensus 327 ~~kl~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~ 406 (508)
.+||+|||++........ .....|++.|+|||++.+..++.++||||||+++|+|++|..||.. ......
T Consensus 160 ~~kl~Dfg~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~--------~~~~~~ 229 (284)
T 2a19_B 160 QVKIGDFGLVTSLKNDGK--RTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFE--------TSKFFT 229 (284)
T ss_dssp EEEECCCTTCEESSCCSC--CCCCCSCCTTSCHHHHHCSCCCTHHHHHHHHHHHHHHHSCCSSHHH--------HHHHHH
T ss_pred CEEECcchhheecccccc--ccccCCcccccChhhhccCCCcchhhhHHHHHHHHHHHhcCCcchh--------HHHHHH
Confidence 999999999987654332 3345689999999999999999999999999999999999988631 111111
Q ss_pred HHhcccccccccCCCCCCChhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhhcCCCCCch
Q 010519 407 MMVGTRRAEEVVDPNLEVKPATRALKRSLLVALRCVDPDSEKRPKMSQVVRMLEADDYPFRE 468 (508)
Q Consensus 407 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~~~~ 468 (508)
.... .. +... ....+.+++.+||+.||.+|||+.|++++|+........
T Consensus 230 ~~~~-~~--------~~~~----~~~~~~~li~~~l~~dp~~Rps~~e~l~~l~~~~~~~~~ 278 (284)
T 2a19_B 230 DLRD-GI--------ISDI----FDKKEKTLLQKLLSKKPEDRPNTSEILRTLTVWKKSPEK 278 (284)
T ss_dssp HHHT-TC--------CCTT----SCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHTC----
T ss_pred Hhhc-cc--------cccc----CCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHhhCCCc
Confidence 1111 11 1111 123456689999999999999999999999987655443
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-42 Score=361.44 Aligned_cols=255 Identities=22% Similarity=0.352 Sum_probs=208.6
Q ss_pred hhCCcccceeEeeeCceEEEEEEEc-CCCEEEEEEEcccc---hhhHHHHHHHHHHHhcCCCCCceeEEEEEEeCceeeE
Q 010519 184 ATNRFSAENVLGEGGYGVVYKGRLI-NGSEVAVKKLLNNL---GQAEKEFRVEVEAIGHVRHKNLVRLLGYCIEGVHRML 259 (508)
Q Consensus 184 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~ei~~l~~l~h~niv~~~~~~~~~~~~~l 259 (508)
..++|.+.+.||+|+||+||+|++. +|+.||||++.... ......+.+|+.++++++||||+++++++.+....++
T Consensus 24 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~l 103 (484)
T 3nyv_A 24 FSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYL 103 (484)
T ss_dssp HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEE
T ss_pred ccCceEEeeEEecCCCEEEEEEEECCCCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEE
Confidence 3458999999999999999999986 78999999985432 3345678899999999999999999999999999999
Q ss_pred EEeecCCCCHHHHHhhhhccCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCEEE---cCCCcEEEEecCCc
Q 010519 260 VYEYVNNGNLEQWLHGAMRNQGNLTWEARMKVIIGTAKALAYLHEAIEPKVVHRDIKSSNILI---DDEFNAKVSDFGLA 336 (508)
Q Consensus 260 v~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiH~Dlk~~NIll---~~~~~~kl~Dfgla 336 (508)
||||+.+|+|.+++. ....+++..++.++.||+.||.|||++ +|+||||||+|||+ +.++.+||+|||++
T Consensus 104 v~e~~~~~~L~~~~~----~~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a 176 (484)
T 3nyv_A 104 VGEVYTGGELFDEII----SRKRFSEVDAARIIRQVLSGITYMHKN---KIVHRDLKPENLLLESKSKDANIRIIDFGLS 176 (484)
T ss_dssp EECCCCSCBHHHHHH----TCSCCBHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESSSSTTCCEEECCTTHH
T ss_pred EEecCCCCCHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHHHEEEecCCCCCcEEEEeeeee
Confidence 999999999999984 456799999999999999999999999 99999999999999 56789999999999
Q ss_pred cccCCCCCcccccccccccccCccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCCCchhcHHHHHHHHhccccccc
Q 010519 337 KLLDSGESHITTRVMGTFGYVAPEYANTGMLNEKSDIYSFGVLLLEAVTGRDPVDYGRPANEVNLVEWLKMMVGTRRAEE 416 (508)
Q Consensus 337 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 416 (508)
....... .....+||+.|+|||++.+ .|+.++|||||||++|+|++|..||..... ... +.......
T Consensus 177 ~~~~~~~--~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~---~~~---~~~i~~~~---- 243 (484)
T 3nyv_A 177 THFEASK--KMKDKIGTAYYIAPEVLHG-TYDEKCDVWSTGVILYILLSGCPPFNGANE---YDI---LKKVEKGK---- 243 (484)
T ss_dssp HHBCCCC--SHHHHTTGGGTCCHHHHHT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSH---HHH---HHHHHHCC----
T ss_pred EEccccc--ccccCCCCccccCceeecC-CCCCcceeHHHHHHHHHHHHCCCCCCCCCH---HHH---HHHHHcCC----
Confidence 8765443 2344579999999999976 699999999999999999999999964321 111 11211110
Q ss_pred ccCCCCCCChhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhhc
Q 010519 417 VVDPNLEVKPATRALKRSLLVALRCVDPDSEKRPKMSQVVRMLEA 461 (508)
Q Consensus 417 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~ 461 (508)
..+..+........+.+|+.+||+.||.+|||+.|+++|-+-
T Consensus 244 ---~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~h~~~ 285 (484)
T 3nyv_A 244 ---YTFELPQWKKVSESAKDLIRKMLTYVPSMRISARDALDHEWI 285 (484)
T ss_dssp ---CCCCSGGGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHTSHHH
T ss_pred ---CCCCCcccccCCHHHHHHHHHHCCCChhHCcCHHHHhhChhh
Confidence 111112222334567789999999999999999999987653
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-42 Score=345.69 Aligned_cols=257 Identities=26% Similarity=0.407 Sum_probs=202.0
Q ss_pred CCcccceeEeeeCceEEEEEEEc-CCCE--EEEEEEcccc-hhhHHHHHHHHHHHhcC-CCCCceeEEEEEEeCceeeEE
Q 010519 186 NRFSAENVLGEGGYGVVYKGRLI-NGSE--VAVKKLLNNL-GQAEKEFRVEVEAIGHV-RHKNLVRLLGYCIEGVHRMLV 260 (508)
Q Consensus 186 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~--vavK~~~~~~-~~~~~~~~~ei~~l~~l-~h~niv~~~~~~~~~~~~~lv 260 (508)
++|.+.+.||+|+||.||+|++. ++.. +|+|.+.... ......+.+|+.++.++ +||||+++++++.+....++|
T Consensus 25 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv 104 (327)
T 1fvr_A 25 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLA 104 (327)
T ss_dssp GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEE
T ss_pred HHccceeeeecCCCceEEEEEEccCCcccceeeeeeccccchHHHHHHHHHHHHHHhccCCCchhhhceeeeeCCceEEE
Confidence 58999999999999999999875 4554 4889886432 23345688899999999 899999999999999999999
Q ss_pred EeecCCCCHHHHHhhhh------------ccCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCEEEcCCCcE
Q 010519 261 YEYVNNGNLEQWLHGAM------------RNQGNLTWEARMKVIIGTAKALAYLHEAIEPKVVHRDIKSSNILIDDEFNA 328 (508)
Q Consensus 261 ~E~~~~gsL~~~l~~~~------------~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiH~Dlk~~NIll~~~~~~ 328 (508)
|||+++|+|.+++.... .....+++..++.++.||+.||.|||++ +|+||||||+|||++.++.+
T Consensus 105 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIl~~~~~~~ 181 (327)
T 1fvr_A 105 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK---QFIHRDLAARNILVGENYVA 181 (327)
T ss_dssp ECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECGGGCE
T ss_pred EecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCccceEEEcCCCeE
Confidence 99999999999996432 1235789999999999999999999999 99999999999999999999
Q ss_pred EEEecCCccccCCCCCcccccccccccccCccccCCCCCCChhhHHHHHHHHHHHHh-CCCCCCCCCCCchhcHHHHHHH
Q 010519 329 KVSDFGLAKLLDSGESHITTRVMGTFGYVAPEYANTGMLNEKSDIYSFGVLLLEAVT-GRDPVDYGRPANEVNLVEWLKM 407 (508)
Q Consensus 329 kl~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~ellt-G~~Pf~~~~~~~~~~~~~~~~~ 407 (508)
||+|||++....... ......+++.|+|||++.+..++.++|||||||++|||++ |..||..... ......
T Consensus 182 kL~Dfg~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~------~~~~~~ 253 (327)
T 1fvr_A 182 KIADFGLSRGQEVYV--KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTC------AELYEK 253 (327)
T ss_dssp EECCTTCEESSCEEC--CC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCH------HHHHHH
T ss_pred EEcccCcCccccccc--cccCCCCCccccChhhhccccCCchhcchHHHHHHHHHHcCCCCCCCCCcH------HHHHHH
Confidence 999999997433211 1233456889999999998889999999999999999998 9999964321 122222
Q ss_pred HhcccccccccCCCCCCChhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhhcCC
Q 010519 408 MVGTRRAEEVVDPNLEVKPATRALKRSLLVALRCVDPDSEKRPKMSQVVRMLEADD 463 (508)
Q Consensus 408 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~ 463 (508)
...... . ..+......+.+|+.+||+.||.+|||+.+++++|+...
T Consensus 254 ~~~~~~------~----~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~ 299 (327)
T 1fvr_A 254 LPQGYR------L----EKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRML 299 (327)
T ss_dssp GGGTCC------C----CCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred hhcCCC------C----CCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence 111100 1 111122345677999999999999999999999998643
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-42 Score=335.39 Aligned_cols=253 Identities=25% Similarity=0.395 Sum_probs=198.0
Q ss_pred HHhhCCcccceeEeeeCceEEEEEEEc-CCCEEEEEEEcccc---hhhHHHHHHHHHHHhcCCCCCceeEEEEEEeCcee
Q 010519 182 EIATNRFSAENVLGEGGYGVVYKGRLI-NGSEVAVKKLLNNL---GQAEKEFRVEVEAIGHVRHKNLVRLLGYCIEGVHR 257 (508)
Q Consensus 182 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~ei~~l~~l~h~niv~~~~~~~~~~~~ 257 (508)
.+..++|.+.+.||+|+||.||+|++. +|+.||+|.+.... ......+.+|+.+++.++||||+++++++.+....
T Consensus 7 ~~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 86 (276)
T 2h6d_A 7 RVKIGHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVISTPTDF 86 (276)
T ss_dssp CCEETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEE
T ss_pred cceeccEEEEeeecCCCCeEEEEEEECCCCceEEEEEeccccccchhHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCeE
Confidence 345578999999999999999999986 78999999985432 22345788899999999999999999999999999
Q ss_pred eEEEeecCCCCHHHHHhhhhccCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCEEEcCCCcEEEEecCCcc
Q 010519 258 MLVYEYVNNGNLEQWLHGAMRNQGNLTWEARMKVIIGTAKALAYLHEAIEPKVVHRDIKSSNILIDDEFNAKVSDFGLAK 337 (508)
Q Consensus 258 ~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~Dfgla~ 337 (508)
++||||+++++|.+++.. ...+++..++.++.||+.||.|||++ +++|+||||+|||++.++.+||+|||++.
T Consensus 87 ~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~l~dfg~~~ 159 (276)
T 2h6d_A 87 FMVMEYVSGGELFDYICK----HGRVEEMEARRLFQQILSAVDYCHRH---MVVHRDLKPENVLLDAHMNAKIADFGLSN 159 (276)
T ss_dssp EEEEECCCSCBHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHHHHH---CSSCCCCCGGGEEECTTSCEEECCCCGGG
T ss_pred EEEEeccCCCcHHHHHhc----cCCCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCChhhEEECCCCCEEEeeccccc
Confidence 999999999999999953 35689999999999999999999999 99999999999999999999999999998
Q ss_pred ccCCCCCcccccccccccccCccccCCCCC-CChhhHHHHHHHHHHHHhCCCCCCCCCCCchhcHHHHHHHHhccccccc
Q 010519 338 LLDSGESHITTRVMGTFGYVAPEYANTGML-NEKSDIYSFGVLLLEAVTGRDPVDYGRPANEVNLVEWLKMMVGTRRAEE 416 (508)
Q Consensus 338 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DvwS~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 416 (508)
...... ......|++.|+|||++.+..+ +.++||||||+++|+|++|..||..... ...........
T Consensus 160 ~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~------~~~~~~~~~~~---- 227 (276)
T 2h6d_A 160 MMSDGE--FLRTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEHV------PTLFKKIRGGV---- 227 (276)
T ss_dssp CCCC---------------CCTGGGTTSCCCHHHHHHHHHHHHHHHHHHSSCSSCCSSH------HHHHHHHHHCC----
T ss_pred ccCCCc--ceecccCCccccCHHHHcCCCCCCccchHHHHHHHHHHHHhCCCCCCCCcH------HHHHHHhhcCc----
Confidence 765432 2334568999999999988765 5899999999999999999999964321 11121111110
Q ss_pred ccCCCCCCChhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhh
Q 010519 417 VVDPNLEVKPATRALKRSLLVALRCVDPDSEKRPKMSQVVRMLE 460 (508)
Q Consensus 417 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 460 (508)
..+. ......+.+++.+||+.||.+|||+.+++++-.
T Consensus 228 ---~~~~----~~~~~~l~~li~~~l~~~p~~Rps~~~~l~h~~ 264 (276)
T 2h6d_A 228 ---FYIP----EYLNRSVATLLMHMLQVDPLKRATIKDIREHEW 264 (276)
T ss_dssp ---CCCC----TTSCHHHHHHHHHHTCSSGGGSCCHHHHHHSHH
T ss_pred ---ccCc----hhcCHHHHHHHHHHccCChhhCCCHHHHHhChh
Confidence 0000 112345667999999999999999999998643
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-41 Score=345.06 Aligned_cols=259 Identities=24% Similarity=0.386 Sum_probs=207.8
Q ss_pred HHHHHHhhCCcccceeEeeeCceEEEEEEEc-CCCEEEEEEEcccch--------hhHHHHHHHHHHHhcC-CCCCceeE
Q 010519 178 LRDLEIATNRFSAENVLGEGGYGVVYKGRLI-NGSEVAVKKLLNNLG--------QAEKEFRVEVEAIGHV-RHKNLVRL 247 (508)
Q Consensus 178 ~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--------~~~~~~~~ei~~l~~l-~h~niv~~ 247 (508)
+.......++|.+.+.||+|+||.||+|++. +|+.||||++..... .....+..|+.+++++ +||||+++
T Consensus 86 ~~~~~~~~~~y~~~~~lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~ 165 (365)
T 2y7j_A 86 WAAAKEFYQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITL 165 (365)
T ss_dssp HHHHHHHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCE
T ss_pred chhhhhhhhhcccceEEecCCCEEEEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEE
Confidence 3444555678999999999999999999985 699999999864431 1235678899999998 89999999
Q ss_pred EEEEEeCceeeEEEeecCCCCHHHHHhhhhccCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCEEEcCCCc
Q 010519 248 LGYCIEGVHRMLVYEYVNNGNLEQWLHGAMRNQGNLTWEARMKVIIGTAKALAYLHEAIEPKVVHRDIKSSNILIDDEFN 327 (508)
Q Consensus 248 ~~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiH~Dlk~~NIll~~~~~ 327 (508)
++++......++||||+++++|.+++. ....+++..+..++.||+.||.|||+. +|+|+||||+|||++.++.
T Consensus 166 ~~~~~~~~~~~lv~e~~~g~~L~~~l~----~~~~l~~~~~~~i~~qi~~~L~~LH~~---gi~H~Dlkp~NIl~~~~~~ 238 (365)
T 2y7j_A 166 IDSYESSSFMFLVFDLMRKGELFDYLT----EKVALSEKETRSIMRSLLEAVSFLHAN---NIVHRDLKPENILLDDNMQ 238 (365)
T ss_dssp EEEEEBSSEEEEEECCCTTCBHHHHHH----HHSSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCC
T ss_pred EEEEeeCCEEEEEEEeCCCCcHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCC
Confidence 999999999999999999999999985 345789999999999999999999999 9999999999999999999
Q ss_pred EEEEecCCccccCCCCCcccccccccccccCccccCC------CCCCChhhHHHHHHHHHHHHhCCCCCCCCCCCchhcH
Q 010519 328 AKVSDFGLAKLLDSGESHITTRVMGTFGYVAPEYANT------GMLNEKSDIYSFGVLLLEAVTGRDPVDYGRPANEVNL 401 (508)
Q Consensus 328 ~kl~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~------~~~~~~~DvwS~Gvvl~elltG~~Pf~~~~~~~~~~~ 401 (508)
+||+|||++....... ......||+.|+|||++.+ ..++.++|||||||++|+|++|..||.... ..
T Consensus 239 ikl~DfG~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~---~~-- 311 (365)
T 2y7j_A 239 IRLSDFGFSCHLEPGE--KLRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRR---QI-- 311 (365)
T ss_dssp EEECCCTTCEECCTTC--CBCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSSCSSCCSS---HH--
T ss_pred EEEEecCcccccCCCc--ccccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHHCCCCCCCCC---HH--
Confidence 9999999998765433 2344679999999999853 358899999999999999999999996432 11
Q ss_pred HHHHHHHhcccccccccCCCCCCChh--HHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhh
Q 010519 402 VEWLKMMVGTRRAEEVVDPNLEVKPA--TRALKRSLLVALRCVDPDSEKRPKMSQVVRMLE 460 (508)
Q Consensus 402 ~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 460 (508)
........ .......+ ......+.+++.+||+.||.+|||+.+++++-+
T Consensus 312 -~~~~~i~~---------~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~hp~ 362 (365)
T 2y7j_A 312 -LMLRMIME---------GQYQFSSPEWDDRSSTVKDLISRLLQVDPEARLTAEQALQHPF 362 (365)
T ss_dssp -HHHHHHHH---------TCCCCCHHHHSSSCHHHHHHHHHHSCSSTTTSCCHHHHHHSGG
T ss_pred -HHHHHHHh---------CCCCCCCcccccCCHHHHHHHHHHcCCChhHCcCHHHHhcCcc
Confidence 11111111 11111111 112345677999999999999999999998643
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.8e-42 Score=342.47 Aligned_cols=279 Identities=23% Similarity=0.375 Sum_probs=201.3
Q ss_pred HhhCCcccceeEeeeCceEEEEEEEcCCCEEEEEEEcccchhhHHHHHHHHHHHhcCCCCCceeEEEEEEe-----Ccee
Q 010519 183 IATNRFSAENVLGEGGYGVVYKGRLINGSEVAVKKLLNNLGQAEKEFRVEVEAIGHVRHKNLVRLLGYCIE-----GVHR 257 (508)
Q Consensus 183 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~ei~~l~~l~h~niv~~~~~~~~-----~~~~ 257 (508)
+..++|.+.+.||+|+||+||+|++ +++.||||++...... ......++..+..++||||+++++++.. ....
T Consensus 10 ~~~~~y~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~~~-~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~ 87 (336)
T 3g2f_A 10 LDLDNLKLLELIGRGRYGAVYKGSL-DERPVAVKVFSFANRQ-NFINEKNIYRVPLMEHDNIARFIVGDERVTADGRMEY 87 (336)
T ss_dssp CCTTSEEEEEEEEECSSEEEEEEEE-TTEEEEEEEEEGGGHH-HHHHHHHHHTSTTCCCTTBCCEEEEEEEECTTSCEEE
T ss_pred cChHHhheeeecccCCCeEEEEEEE-CCeEEEEEEeeccchh-hHHHHHHHHHHHhccCcchhhheecccccccCCCceE
Confidence 3446899999999999999999977 7899999998643322 1122234444556899999999986643 2356
Q ss_pred eEEEeecCCCCHHHHHhhhhccCCCccHHHHHHHHHHHHHHHHHHHhcC------CCCeEeecCCCCCEEEcCCCcEEEE
Q 010519 258 MLVYEYVNNGNLEQWLHGAMRNQGNLTWEARMKVIIGTAKALAYLHEAI------EPKVVHRDIKSSNILIDDEFNAKVS 331 (508)
Q Consensus 258 ~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~------~~~iiH~Dlk~~NIll~~~~~~kl~ 331 (508)
++||||+++|+|.+++.. ...++..++.++.||+.||.|||+.. .++|+||||||+|||++.++.+||+
T Consensus 88 ~lv~e~~~~g~L~~~l~~-----~~~~~~~~~~i~~qi~~~L~~LH~~~~~~~~~~~~ivH~Dikp~Nill~~~~~~kL~ 162 (336)
T 3g2f_A 88 LLVMEYYPNGSLXKYLSL-----HTSDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVIS 162 (336)
T ss_dssp EEEECCCTTCBHHHHHHH-----CCBCHHHHHHHHHHHHHHHHHHHCCBCCGGGCBCCEECSSCSGGGEEECTTSCEEEC
T ss_pred EEEEecCCCCcHHHHHhh-----cccchhHHHHHHHHHHHHHHHHHhhhccccccccceeecccccceEEEcCCCcEEEe
Confidence 899999999999999853 23488899999999999999999752 3489999999999999999999999
Q ss_pred ecCCccccCCCC-------CcccccccccccccCccccCC-------CCCCChhhHHHHHHHHHHHHhCCCCCCCCCCCc
Q 010519 332 DFGLAKLLDSGE-------SHITTRVMGTFGYVAPEYANT-------GMLNEKSDIYSFGVLLLEAVTGRDPVDYGRPAN 397 (508)
Q Consensus 332 Dfgla~~~~~~~-------~~~~~~~~gt~~y~aPE~~~~-------~~~~~~~DvwS~Gvvl~elltG~~Pf~~~~~~~ 397 (508)
|||++....... ........||+.|+|||++.+ ..++.++|||||||+||||++|..||.......
T Consensus 163 DFG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~ 242 (336)
T 3g2f_A 163 DFGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPGESVP 242 (336)
T ss_dssp CCTTCEECSSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHHHHHHHTTBGGGSTTSCCC
T ss_pred eccceeecccccccCccccccccccCCCccceeCchhhcCCcccccccccccccchHHHHHHHHHHHhcCCcCCCccchh
Confidence 999998664321 112234579999999999987 456679999999999999999988765443322
Q ss_pred hhcH-----------HHHHHHHhcccccccccCCCCCCChhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhhcCCCCC
Q 010519 398 EVNL-----------VEWLKMMVGTRRAEEVVDPNLEVKPATRALKRSLLVALRCVDPDSEKRPKMSQVVRMLEADDYPF 466 (508)
Q Consensus 398 ~~~~-----------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~~ 466 (508)
.... ................+... ..........+.+|+.+||+.||.+|||+.|+++.|+.....+
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~l~~li~~cl~~dP~~Rps~~e~l~~L~~ll~~~ 320 (336)
T 3g2f_A 243 EYQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEA--WKENSLAVRSLKETIEDCWDQDAEARLTAQXAEERMAELMMIW 320 (336)
T ss_dssp CCCCTTHHHHCSSCCHHHHHHHHTTSCCCCCCCTT--CCCCSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHCC
T ss_pred HHHHhhhcccCCCchHHHHHhhhcccccCCCCCcc--cccccchHHHHHHHHHHHhcCChhhCcchHHHHHHHHHHHHHH
Confidence 1110 01111111111111111111 1112335567888999999999999999999999999876655
Q ss_pred chhh
Q 010519 467 REDR 470 (508)
Q Consensus 467 ~~~~ 470 (508)
....
T Consensus 321 ~~~~ 324 (336)
T 3g2f_A 321 ERNK 324 (336)
T ss_dssp CC--
T ss_pred Hhcc
Confidence 5443
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-41 Score=346.50 Aligned_cols=256 Identities=13% Similarity=0.151 Sum_probs=204.3
Q ss_pred HHHHhhCCcccceeEeeeCceEEEEEE------EcCCCEEEEEEEcccchhhHHHHHHHHHHHhcCC---CCCceeEEEE
Q 010519 180 DLEIATNRFSAENVLGEGGYGVVYKGR------LINGSEVAVKKLLNNLGQAEKEFRVEVEAIGHVR---HKNLVRLLGY 250 (508)
Q Consensus 180 ~~~~~~~~~~~~~~lg~G~~g~Vy~~~------~~~~~~vavK~~~~~~~~~~~~~~~ei~~l~~l~---h~niv~~~~~ 250 (508)
++++..++|.+.+.||+|+||+||+|. ...++.||+|++.... ..++..|+.++..++ |+||+.++++
T Consensus 59 ~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~e~~~~~~l~~~~~~~iv~~~~~ 135 (365)
T 3e7e_A 59 EFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPAN---PWEFYIGTQLMERLKPSMQHMFMKFYSA 135 (365)
T ss_dssp EEECSSSEEEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESSCC---HHHHHHHHHHHHHSCGGGGGGBCCEEEE
T ss_pred eEEECCEEEEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCCC---hhHHHHHHHHHHHhhhhhhhhhhhhhee
Confidence 345566889999999999999999994 3468899999986543 345667777777776 9999999999
Q ss_pred EEeCceeeEEEeecCCCCHHHHHhhhhc-cCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCEEEcC-----
Q 010519 251 CIEGVHRMLVYEYVNNGNLEQWLHGAMR-NQGNLTWEARMKVIIGTAKALAYLHEAIEPKVVHRDIKSSNILIDD----- 324 (508)
Q Consensus 251 ~~~~~~~~lv~E~~~~gsL~~~l~~~~~-~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiH~Dlk~~NIll~~----- 324 (508)
+...+..++||||+++|+|.+++..... ....+++..++.++.||+.||.|||+. +|+||||||+||||+.
T Consensus 136 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH~~---~ivHrDiKp~NIll~~~~~~~ 212 (365)
T 3e7e_A 136 HLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDC---EIIHGDIKPDNFILGNGFLEQ 212 (365)
T ss_dssp EECSSCEEEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCSGGGEEECGGGTCC
T ss_pred eecCCCcEEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHhhC---CeecCCCCHHHEEecccccCc
Confidence 9999999999999999999999975432 356799999999999999999999998 9999999999999998
Q ss_pred ------CCcEEEEecCCccccCC-CCCcccccccccccccCccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCCCc
Q 010519 325 ------EFNAKVSDFGLAKLLDS-GESHITTRVMGTFGYVAPEYANTGMLNEKSDIYSFGVLLLEAVTGRDPVDYGRPAN 397 (508)
Q Consensus 325 ------~~~~kl~Dfgla~~~~~-~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltG~~Pf~~~~~~~ 397 (508)
++.+||+|||+++.... .........+||+.|+|||++.+..|+.++|||||||+||||++|+.||.......
T Consensus 213 ~~~~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~ 292 (365)
T 3e7e_A 213 DDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGE 292 (365)
T ss_dssp ------CTTEEECCCTTCEEGGGSCTTEEECCSSCTTSCCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCCCEEEETTE
T ss_pred cccccccCCEEEeeCchhhhhhccCCCceeeeecCCCCCCChHHhcCCCCCccccHHHHHHHHHHHHhCCCccccCCCCc
Confidence 89999999999975432 22233455689999999999999999999999999999999999999985332110
Q ss_pred hhcHHHHHHHHhcccccccccCCCCCCChhHHHHHHHHHHHHHhcCCCCCCC-CCHHHHHHHhhcC
Q 010519 398 EVNLVEWLKMMVGTRRAEEVVDPNLEVKPATRALKRSLLVALRCVDPDSEKR-PKMSQVVRMLEAD 462 (508)
Q Consensus 398 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~R-Ps~~evl~~L~~~ 462 (508)
......+...+.. ..+.+++..|++.+|.+| |++.++.+.|+..
T Consensus 293 ------------------~~~~~~~~~~~~~---~~~~~~~~~~l~~~p~~r~~~~~~l~~~l~~~ 337 (365)
T 3e7e_A 293 ------------------CKPEGLFRRLPHL---DMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKV 337 (365)
T ss_dssp ------------------EEECSCCTTCSSH---HHHHHHHHHHHCCCCTTCCCCHHHHHHHHHHH
T ss_pred ------------------eeechhccccCcH---HHHHHHHHHHcCCCCCCcchHHHHHHHHHHHH
Confidence 0011112222222 334457889999999999 5788888777654
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-42 Score=347.21 Aligned_cols=262 Identities=17% Similarity=0.202 Sum_probs=204.0
Q ss_pred hCCcccceeEeeeCceEEEEEEEcC---------CCEEEEEEEcccchhhHHHHHHHHHHHhcCCCCCcee---------
Q 010519 185 TNRFSAENVLGEGGYGVVYKGRLIN---------GSEVAVKKLLNNLGQAEKEFRVEVEAIGHVRHKNLVR--------- 246 (508)
Q Consensus 185 ~~~~~~~~~lg~G~~g~Vy~~~~~~---------~~~vavK~~~~~~~~~~~~~~~ei~~l~~l~h~niv~--------- 246 (508)
.++|.+.+.||+|+||.||+|++.. ++.||+|.+... ..+.+|+.++++++||||++
T Consensus 41 ~~~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~-----~~~~~E~~~l~~l~h~niv~~~~~~~~~~ 115 (352)
T 2jii_A 41 GRQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD-----GRLFNEQNFFQRAAKPLQVNKWKKLYSTP 115 (352)
T ss_dssp SCEEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETT-----STHHHHHHHHHHHCCHHHHHHHHHHTTCT
T ss_pred CCeEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc-----chHHHHHHHHHHhcccchhhhhhhhccCC
Confidence 4689999999999999999998763 789999998644 35777999999999999887
Q ss_pred ------EEEEEEe-CceeeEEEeecCCCCHHHHHhhhhccCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCC
Q 010519 247 ------LLGYCIE-GVHRMLVYEYVNNGNLEQWLHGAMRNQGNLTWEARMKVIIGTAKALAYLHEAIEPKVVHRDIKSSN 319 (508)
Q Consensus 247 ------~~~~~~~-~~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiH~Dlk~~N 319 (508)
+++++.. +...++||||+ +++|.+++.. .....+++..++.++.||+.||.|||++ +|+||||||+|
T Consensus 116 ~~~i~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~--~~~~~l~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dikp~N 189 (352)
T 2jii_A 116 LLAIPTCMGFGVHQDKYRFLVLPSL-GRSLQSALDV--SPKHVLSERSVLQVACRLLDALEFLHEN---EYVHGNVTAEN 189 (352)
T ss_dssp TCSCCCCCEEEEETTTEEEEEEECC-CEEHHHHHHH--SGGGCCCHHHHHHHHHHHHHHHHHHHHT---TCBCSCCCGGG
T ss_pred ccCccchhhccccCCcEEEEEecCC-CcCHHHHHHh--CCcCCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCCHHH
Confidence 6778876 67889999999 9999999964 2246799999999999999999999999 99999999999
Q ss_pred EEEcCCC--cEEEEecCCccccCCCCC------cccccccccccccCccccCCCCCCChhhHHHHHHHHHHHHhCCCCCC
Q 010519 320 ILIDDEF--NAKVSDFGLAKLLDSGES------HITTRVMGTFGYVAPEYANTGMLNEKSDIYSFGVLLLEAVTGRDPVD 391 (508)
Q Consensus 320 Ill~~~~--~~kl~Dfgla~~~~~~~~------~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltG~~Pf~ 391 (508)
||++.++ .+||+|||+++....... .......||+.|+|||++.+..++.++|||||||+||||++|+.||.
T Consensus 190 Il~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~ 269 (352)
T 2jii_A 190 IFVDPEDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKGCGPSRRSDLQSLGYCMLKWLYGFLPWT 269 (352)
T ss_dssp EEEETTEEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTG
T ss_pred EEEcCCCCceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCcc
Confidence 9999998 899999999986643221 11234579999999999999999999999999999999999999997
Q ss_pred CCCCCchhcHHHHHHHHhcccccccccCCCCCCChhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhhcCC
Q 010519 392 YGRPANEVNLVEWLKMMVGTRRAEEVVDPNLEVKPATRALKRSLLVALRCVDPDSEKRPKMSQVVRMLEADD 463 (508)
Q Consensus 392 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~ 463 (508)
...... ............. ...+....... ......+.+|+.+||+.||.+|||+.++++.|+...
T Consensus 270 ~~~~~~-~~~~~~~~~~~~~--~~~~~~~~~~~---~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~ 335 (352)
T 2jii_A 270 NCLPNT-EDIMKQKQKFVDK--PGPFVGPCGHW---IRPSETLQKYLKVVMALTYEEKPPYAMLRNNLEALL 335 (352)
T ss_dssp GGTTCH-HHHHHHHHHHHHS--CCCEECTTSCE---ECCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHH
T ss_pred cCCcCH-HHHHHHHHhccCC--hhhhhhhcccc---CCCcHHHHHHHHHHHhCChhhCCCHHHHHHHHHHHH
Confidence 543222 1222222211111 11111111110 112345667999999999999999999999998643
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-42 Score=361.35 Aligned_cols=254 Identities=22% Similarity=0.323 Sum_probs=204.4
Q ss_pred hCCcccceeEeeeCceEEEEEEEc-CCCEEEEEEEcccc--hhhHHHHHHHHHHHhcCCCCCceeEEEEEEeCceeeEEE
Q 010519 185 TNRFSAENVLGEGGYGVVYKGRLI-NGSEVAVKKLLNNL--GQAEKEFRVEVEAIGHVRHKNLVRLLGYCIEGVHRMLVY 261 (508)
Q Consensus 185 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~ei~~l~~l~h~niv~~~~~~~~~~~~~lv~ 261 (508)
.++|.+.+.||+|+||+||+|++. +++.||||++.... ......+.+|+.++++++||||+++++++.+....++||
T Consensus 21 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 100 (486)
T 3mwu_A 21 AERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIVG 100 (486)
T ss_dssp HHHEEEEEEEECCSSSEEEEEEETTTCCEEEEEEEEHHHHBCSCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hcceEEeEEEeecCCEEEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHHHhCCCCCcCeEEEEEEcCCEEEEEE
Confidence 457999999999999999999985 78999999985432 233567888999999999999999999999999999999
Q ss_pred eecCCCCHHHHHhhhhccCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCEEEc---CCCcEEEEecCCccc
Q 010519 262 EYVNNGNLEQWLHGAMRNQGNLTWEARMKVIIGTAKALAYLHEAIEPKVVHRDIKSSNILID---DEFNAKVSDFGLAKL 338 (508)
Q Consensus 262 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiH~Dlk~~NIll~---~~~~~kl~Dfgla~~ 338 (508)
||+.+|+|.+++. ....+++..++.++.||+.||.|||++ +|+||||||+|||++ .++.+||+|||++..
T Consensus 101 e~~~~~~L~~~~~----~~~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~ 173 (486)
T 3mwu_A 101 ELYTGGELFDEII----KRKRFSEHDAARIIKQVFSGITYMHKH---NIVHRDLKPENILLESKEKDCDIKIIDFGLSTC 173 (486)
T ss_dssp CCCCSCBHHHHHH----HHSSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEESSSSTTCCEEECSCSCTTT
T ss_pred EcCCCCcHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCchHHEEEecCCCCCCEEEEECCcCeE
Confidence 9999999999985 345799999999999999999999999 999999999999995 566799999999986
Q ss_pred cCCCCCcccccccccccccCccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCCCchhcHHHHHHHHhccccccccc
Q 010519 339 LDSGESHITTRVMGTFGYVAPEYANTGMLNEKSDIYSFGVLLLEAVTGRDPVDYGRPANEVNLVEWLKMMVGTRRAEEVV 418 (508)
Q Consensus 339 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 418 (508)
..... .....+||+.|+|||++.+ .|+.++|||||||++|+|++|..||..... . +.+.......
T Consensus 174 ~~~~~--~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~---~---~~~~~i~~~~------ 238 (486)
T 3mwu_A 174 FQQNT--KMKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNE---Y---DILKRVETGK------ 238 (486)
T ss_dssp BCCC------CCTTGGGGCCGGGGGS-CCCHHHHHHHHHHHHHHHHHSSCSSCCSSH---H---HHHHHHHHTC------
T ss_pred CCCCC--ccCCCcCCCCCCCHHHhCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCH---H---HHHHHHHhCC------
Confidence 65432 2344579999999999976 599999999999999999999999964321 1 1122211110
Q ss_pred CCCCCCChhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhhc
Q 010519 419 DPNLEVKPATRALKRSLLVALRCVDPDSEKRPKMSQVVRMLEA 461 (508)
Q Consensus 419 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~ 461 (508)
..+..+........+.+|+.+||+.||.+|||+.+++++-+-
T Consensus 239 -~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~~~l~hp~~ 280 (486)
T 3mwu_A 239 -YAFDLPQWRTISDDAKDLIRKMLTFHPSLRITATQCLEHPWI 280 (486)
T ss_dssp -CCSCSGGGGGSCHHHHHHHHHHTCSSTTTSCCHHHHHHCHHH
T ss_pred -CCCCCcccCCCCHHHHHHHHHHcCCChhhCcCHHHHhcCHhh
Confidence 111111222334567779999999999999999999997543
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-41 Score=353.54 Aligned_cols=198 Identities=24% Similarity=0.364 Sum_probs=166.9
Q ss_pred hCCcccceeEeeeCceEEEEEEEc-CCCEEEEEEEcccc--hhhHHHHHHHHHHHhcCCCCCceeEEEEEEeC-----ce
Q 010519 185 TNRFSAENVLGEGGYGVVYKGRLI-NGSEVAVKKLLNNL--GQAEKEFRVEVEAIGHVRHKNLVRLLGYCIEG-----VH 256 (508)
Q Consensus 185 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~ei~~l~~l~h~niv~~~~~~~~~-----~~ 256 (508)
.++|.+.+.||+|+||+||+|++. +++.||||++.... ....+.+.+|+.+|+.++||||+++++++... ..
T Consensus 25 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~ 104 (432)
T 3n9x_A 25 PDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYIIRLYDLIIPDDLLKFDE 104 (432)
T ss_dssp CTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSTTTSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCC
T ss_pred cCCEEEEEEEeecCCEEEEEEEECCCCcEEEEEEeCchhcChHHHHHHHHHHHHHHHcCCCCcceEEEEEecCCCCcCCe
Confidence 468999999999999999999875 57889999986532 33446788999999999999999999999776 56
Q ss_pred eeEEEeecCCCCHHHHHhhhhccCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCEEEcCCCcEEEEecCCc
Q 010519 257 RMLVYEYVNNGNLEQWLHGAMRNQGNLTWEARMKVIIGTAKALAYLHEAIEPKVVHRDIKSSNILIDDEFNAKVSDFGLA 336 (508)
Q Consensus 257 ~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~Dfgla 336 (508)
.|+||||+. |+|.+++. ....+++..++.++.||+.||.|||+. +|+||||||+|||++.++.+||+|||++
T Consensus 105 ~~lv~e~~~-~~L~~~~~----~~~~l~~~~~~~i~~qil~aL~~LH~~---givHrDlkp~NILl~~~~~~kL~DFGla 176 (432)
T 3n9x_A 105 LYIVLEIAD-SDLKKLFK----TPIFLTEEHIKTILYNLLLGENFIHES---GIIHRDLKPANCLLNQDCSVKVCDFGLA 176 (432)
T ss_dssp EEEEEECCS-EEHHHHHH----SSCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTC
T ss_pred EEEEEecCC-cCHHHHHh----ccCCCCHHHHHHHHHHHHHHHHHHHHC---CCCCCCCCHHHeEECCCCCEEEccCCCc
Confidence 899999996 59999984 456799999999999999999999999 9999999999999999999999999999
Q ss_pred cccCCCCC---------------------cccccccccccccCcccc-CCCCCCChhhHHHHHHHHHHHHhCCCCC
Q 010519 337 KLLDSGES---------------------HITTRVMGTFGYVAPEYA-NTGMLNEKSDIYSFGVLLLEAVTGRDPV 390 (508)
Q Consensus 337 ~~~~~~~~---------------------~~~~~~~gt~~y~aPE~~-~~~~~~~~~DvwS~Gvvl~elltG~~Pf 390 (508)
+....... ...+..+||+.|+|||++ .+..|+.++|||||||+||||++|..||
T Consensus 177 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~~DiwSlG~il~ell~g~~p~ 252 (432)
T 3n9x_A 177 RTINSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSH 252 (432)
T ss_dssp EEC-------------------------------CCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHTTCTTT
T ss_pred ccccccccccccccccccccccccccchhccccCCCCCccccCHHHHhcCCCCCcccccchHHHHHHHHHhccccc
Confidence 87653321 123556899999999986 5667999999999999999999865554
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-42 Score=346.33 Aligned_cols=264 Identities=25% Similarity=0.401 Sum_probs=201.0
Q ss_pred CCcccceeEeeeCceEEEEEEEc-CCCEEEEEEEcccc--hhhHHHHHHHHHHHhcCCCCCceeEEEEEEeCceeeEEEe
Q 010519 186 NRFSAENVLGEGGYGVVYKGRLI-NGSEVAVKKLLNNL--GQAEKEFRVEVEAIGHVRHKNLVRLLGYCIEGVHRMLVYE 262 (508)
Q Consensus 186 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~ei~~l~~l~h~niv~~~~~~~~~~~~~lv~E 262 (508)
++|.+.+.||+|+||.||+|++. +|..||+|++.... ......+.+|+.+++.++||||+++++++.+....++|||
T Consensus 25 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 104 (331)
T 4aaa_A 25 EKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEVCKKKKRWYLVFE 104 (331)
T ss_dssp GGEEEEEEGGGGTTSSEEEEEETTTCCEEEEEEEESCSSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred hhheeeeEEeecCCEEEEEEEECCCCceEEEEEEecCCCchHHHHHHHHHHHHHhhCCCCCEeeEEEEeecCCEEEEEEe
Confidence 58999999999999999999986 58899999985443 2334567889999999999999999999999999999999
Q ss_pred ecCCCCHHHHHhhhhccCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCEEEcCCCcEEEEecCCccccCCC
Q 010519 263 YVNNGNLEQWLHGAMRNQGNLTWEARMKVIIGTAKALAYLHEAIEPKVVHRDIKSSNILIDDEFNAKVSDFGLAKLLDSG 342 (508)
Q Consensus 263 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~~ 342 (508)
|+++++|.+++ .....+++..++.++.||+.||.|||+. +|+||||||+|||++.++.+||+|||++......
T Consensus 105 ~~~~~~l~~~~----~~~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~ 177 (331)
T 4aaa_A 105 FVDHTILDDLE----LFPNGLDYQVVQKYLFQIINGIGFCHSH---NIIHRDIKPENILVSQSGVVKLCDFGFARTLAAP 177 (331)
T ss_dssp CCSEEHHHHHH----HSTTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCCTTC------
T ss_pred cCCcchHHHHH----hhccCCCHHHHHHHHHHHHHHHHHHHHC---CEEccCcChheEEEcCCCcEEEEeCCCceeecCC
Confidence 99999888876 3456799999999999999999999999 9999999999999999999999999999865433
Q ss_pred CCcccccccccccccCccccCCC-CCCChhhHHHHHHHHHHHHhCCCCCCCCCCCchhcHHHHHHHHhcc----------
Q 010519 343 ESHITTRVMGTFGYVAPEYANTG-MLNEKSDIYSFGVLLLEAVTGRDPVDYGRPANEVNLVEWLKMMVGT---------- 411 (508)
Q Consensus 343 ~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwS~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~---------- 411 (508)
.. ......||+.|+|||++.+. .++.++|||||||++|+|++|+.||....... .+.... ...+.
T Consensus 178 ~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~--~~~~~~-~~~~~~~~~~~~~~~ 253 (331)
T 4aaa_A 178 GE-VYDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDID--QLYHIM-MCLGNLIPRHQELFN 253 (331)
T ss_dssp -------CCCCCTTCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH--HHHHHH-HHHCSCCHHHHHHHH
T ss_pred cc-ccCCCcCCccccCcccccCCCCcchHHHHHHHHHHHHHHHhCCCCCCCCCcHH--HHHHHH-HHhCCCChhhhhHhh
Confidence 22 23345689999999999875 78999999999999999999999996443211 111111 11110
Q ss_pred --cccccccCCCCCCCh-----hHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhh
Q 010519 412 --RRAEEVVDPNLEVKP-----ATRALKRSLLVALRCVDPDSEKRPKMSQVVRMLE 460 (508)
Q Consensus 412 --~~~~~~~~~~~~~~~-----~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 460 (508)
........+...... .......+.+|+.+||+.||.+|||+.|++++-.
T Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~hp~ 309 (331)
T 4aaa_A 254 KNPVFAGVRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLHHDF 309 (331)
T ss_dssp HCGGGTTCCCCCCSSCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGSHH
T ss_pred hccccccccCccccccchhhhcccchhHHHHHHHHHHhccCcccCCCHHHHhcCch
Confidence 000111111111111 1123456778999999999999999999998543
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-42 Score=336.06 Aligned_cols=258 Identities=25% Similarity=0.361 Sum_probs=192.2
Q ss_pred HhhCCcccceeEeeeCceEEEEEEEc-CCCEEEEEEEcccch--hhHHHHHHHHHHHhcCCCCCceeEEEEEEeCceeeE
Q 010519 183 IATNRFSAENVLGEGGYGVVYKGRLI-NGSEVAVKKLLNNLG--QAEKEFRVEVEAIGHVRHKNLVRLLGYCIEGVHRML 259 (508)
Q Consensus 183 ~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~ei~~l~~l~h~niv~~~~~~~~~~~~~l 259 (508)
+..++|++.+.||+|+||+||+|++. +|+.||+|++..... .....+.++...++.++||||+++++++.+....++
T Consensus 4 i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~~~~~~l 83 (290)
T 3fme_A 4 VKADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGALFREGDVWI 83 (290)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEC---CHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSSEEE
T ss_pred ccHHhhhhHHhcCCCCCeEEEEEEecCCCeEEEEEEeecccCcHHHHHHHHHHHHHHHhCCCCeEEEEeeeeeccCCEEE
Confidence 45578999999999999999999874 788999999865432 222345555566888999999999999999999999
Q ss_pred EEeecCCCCHHHHHhhhhccCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCEEEcCCCcEEEEecCCcccc
Q 010519 260 VYEYVNNGNLEQWLHGAMRNQGNLTWEARMKVIIGTAKALAYLHEAIEPKVVHRDIKSSNILIDDEFNAKVSDFGLAKLL 339 (508)
Q Consensus 260 v~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~Dfgla~~~ 339 (508)
||||++ |+|.+++.........+++..++.++.|++.||.|||++. +|+||||||+|||++.++.+||+|||++...
T Consensus 84 v~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~--~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~ 160 (290)
T 3fme_A 84 CMELMD-TSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKL--SVIHRDVKPSNVLINALGQVKMCDFGISGYL 160 (290)
T ss_dssp EEECCS-EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHS--CCCCCCCSGGGCEECTTCCEEBCCC------
T ss_pred EEehhc-cchHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhcC--CeecCCCCHHHEEECCCCCEEEeecCCcccc
Confidence 999997 5999988766566778999999999999999999999842 8999999999999999999999999999866
Q ss_pred CCCCCcccccccccccccCcccc----CCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCCCchhcHHHHHHHHhcccccc
Q 010519 340 DSGESHITTRVMGTFGYVAPEYA----NTGMLNEKSDIYSFGVLLLEAVTGRDPVDYGRPANEVNLVEWLKMMVGTRRAE 415 (508)
Q Consensus 340 ~~~~~~~~~~~~gt~~y~aPE~~----~~~~~~~~~DvwS~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~ 415 (508)
..... .....||+.|+|||++ .+..++.++|||||||++|+|++|+.||...... ... +........
T Consensus 161 ~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~----~~~-~~~~~~~~~-- 231 (290)
T 3fme_A 161 VDDVA--KDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTP----FQQ-LKQVVEEPS-- 231 (290)
T ss_dssp -----------CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHHTSCSSCCCSCH----HHH-HHHHHHSCC--
T ss_pred ccccc--ccccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHHCCCCccccCch----HHH-HHHHhccCC--
Confidence 54322 2334689999999996 5667899999999999999999999999643221 111 111111111
Q ss_pred cccCCCCCCChhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHh
Q 010519 416 EVVDPNLEVKPATRALKRSLLVALRCVDPDSEKRPKMSQVVRML 459 (508)
Q Consensus 416 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L 459 (508)
+... .......+.+++.+||+.||.+|||+.|++++-
T Consensus 232 ----~~~~---~~~~~~~~~~li~~~l~~~p~~Rpt~~e~l~hp 268 (290)
T 3fme_A 232 ----PQLP---ADKFSAEFVDFTSQCLKKNSKERPTYPELMQHP 268 (290)
T ss_dssp ----CCCC---TTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTSH
T ss_pred ----CCcc---cccCCHHHHHHHHHHhhcChhhCcCHHHHHhCc
Confidence 1111 112234567799999999999999999998743
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-41 Score=349.69 Aligned_cols=272 Identities=24% Similarity=0.283 Sum_probs=211.1
Q ss_pred hCCcccceeEeeeCceEEEEEEEc-CCCEEEEEEEcccc-hhhHHHHHHHHHHHhcCCCCCceeEEEEEEeCc--eeeEE
Q 010519 185 TNRFSAENVLGEGGYGVVYKGRLI-NGSEVAVKKLLNNL-GQAEKEFRVEVEAIGHVRHKNLVRLLGYCIEGV--HRMLV 260 (508)
Q Consensus 185 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~ei~~l~~l~h~niv~~~~~~~~~~--~~~lv 260 (508)
.++|.+.+.||+|+||+||+|++. +|+.||||++.... ......+.+|++++++++||||+++++++.... ..++|
T Consensus 8 ~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~lv 87 (396)
T 4eut_A 8 NHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLI 87 (396)
T ss_dssp SEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEE
T ss_pred CCceEEEEEEEcCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCCCeEEEeeccCCCCeeEEE
Confidence 358999999999999999999986 48999999986533 233466778999999999999999999998765 67899
Q ss_pred EeecCCCCHHHHHhhhhccCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCEEE----cCCCcEEEEecCCc
Q 010519 261 YEYVNNGNLEQWLHGAMRNQGNLTWEARMKVIIGTAKALAYLHEAIEPKVVHRDIKSSNILI----DDEFNAKVSDFGLA 336 (508)
Q Consensus 261 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiH~Dlk~~NIll----~~~~~~kl~Dfgla 336 (508)
|||+++|+|.+++... .....+++..++.++.||+.||.|||+. +|+||||||+|||+ +.++.+||+|||++
T Consensus 88 ~e~~~~g~L~~~l~~~-~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~~kL~DFG~a 163 (396)
T 4eut_A 88 MEFCPCGSLYTVLEEP-SNAYGLPESEFLIVLRDVVGGMNHLREN---GIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAA 163 (396)
T ss_dssp ECCCTTEEHHHHTTSG-GGTTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEEEECTTSCEEEEECCGGGC
T ss_pred EecCCCCCHHHHHHhh-hcccCCCHHHHHHHHHHHHHHHHHHHHC---CEEECCcCHHHEEEeecCCCceeEEEecCCCc
Confidence 9999999999998642 2233489999999999999999999999 99999999999999 77888999999999
Q ss_pred cccCCCCCcccccccccccccCccccCC--------CCCCChhhHHHHHHHHHHHHhCCCCCCCCCCCchhcHHHHHHHH
Q 010519 337 KLLDSGESHITTRVMGTFGYVAPEYANT--------GMLNEKSDIYSFGVLLLEAVTGRDPVDYGRPANEVNLVEWLKMM 408 (508)
Q Consensus 337 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~~~~~DvwS~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~ 408 (508)
+...... ......||+.|+|||++.+ ..++.++|||||||++|||++|+.||........ . .+.+...
T Consensus 164 ~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~tg~~Pf~~~~~~~~-~-~~~~~~~ 239 (396)
T 4eut_A 164 RELEDDE--QFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRR-N-KEVMYKI 239 (396)
T ss_dssp EECCCGG--GSSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHHSSCSEECTTCTTT-C-HHHHHHH
T ss_pred eEccCCC--ccccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHHHHHCCCCCCCCCcccc-h-HHHHHHH
Confidence 8765432 2334579999999999865 5677899999999999999999999964332211 1 1222222
Q ss_pred hcccccc------ccc--------CCCCCCChhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhhcCCC
Q 010519 409 VGTRRAE------EVV--------DPNLEVKPATRALKRSLLVALRCVDPDSEKRPKMSQVVRMLEADDY 464 (508)
Q Consensus 409 ~~~~~~~------~~~--------~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~ 464 (508)
....... ... +..............+.+++.+||+.||.+|||+.++++.++....
T Consensus 240 ~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~ll~~~L~~dP~~R~s~~e~l~~l~~il~ 309 (396)
T 4eut_A 240 ITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDILH 309 (396)
T ss_dssp HHSCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHHHT
T ss_pred hcCCCcccchhheeccCCCcccCccCCcccccchHHHhhchHHHHHhhccChhhhccHHHHHHHHHHHhh
Confidence 2211100 000 0011112235566777889999999999999999999999977543
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-41 Score=337.27 Aligned_cols=256 Identities=26% Similarity=0.375 Sum_probs=202.5
Q ss_pred HhhCCcccceeEeeeCceEEEEEEEc-CCCEEEEEEEcccchhhHHHHHHHHHHHhcCCCCCceeEEEEEEeCceeeEEE
Q 010519 183 IATNRFSAENVLGEGGYGVVYKGRLI-NGSEVAVKKLLNNLGQAEKEFRVEVEAIGHVRHKNLVRLLGYCIEGVHRMLVY 261 (508)
Q Consensus 183 ~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~ei~~l~~l~h~niv~~~~~~~~~~~~~lv~ 261 (508)
...++|.+.+.||+|+||.||+|.+. +|..||+|.+.... ....+.+|+.++..++||||+++++++......++||
T Consensus 26 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 103 (314)
T 3com_A 26 QPEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVES--DLQEIIKEISIMQQCDSPHVVKYYGSYFKNTDLWIVM 103 (314)
T ss_dssp ----CEEEEEECC----CEEEEEEETTTCCEEEEEEEETTS--CCHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred cchhhhhhheeeccCCCeEEEEEEECCCCCEEEEEecCchH--HHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEe
Confidence 34578999999999999999999886 58999999986543 2356788999999999999999999999999999999
Q ss_pred eecCCCCHHHHHhhhhccCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCEEEcCCCcEEEEecCCccccCC
Q 010519 262 EYVNNGNLEQWLHGAMRNQGNLTWEARMKVIIGTAKALAYLHEAIEPKVVHRDIKSSNILIDDEFNAKVSDFGLAKLLDS 341 (508)
Q Consensus 262 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~ 341 (508)
||+++++|.+++. .....+++..++.++.+|+.||.|||+. +++|+||||+||+++.++.+||+|||++.....
T Consensus 104 e~~~~~~L~~~~~---~~~~~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~ 177 (314)
T 3com_A 104 EYCGAGSVSDIIR---LRNKTLTEDEIATILQSTLKGLEYLHFM---RKIHRDIKAGNILLNTEGHAKLADFGVAGQLTD 177 (314)
T ss_dssp ECCTTEEHHHHHH---HHTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTTCEECBT
T ss_pred ecCCCCCHHHHHH---hcCCCCCHHHHHHHHHHHHHHHHHHHhC---CCcCCCcCHHHEEECCCCCEEEeecccchhhhh
Confidence 9999999999985 2456789999999999999999999999 999999999999999999999999999986654
Q ss_pred CCCcccccccccccccCccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCCCchhcHHHHHHHHhcccccccccCCC
Q 010519 342 GESHITTRVMGTFGYVAPEYANTGMLNEKSDIYSFGVLLLEAVTGRDPVDYGRPANEVNLVEWLKMMVGTRRAEEVVDPN 421 (508)
Q Consensus 342 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 421 (508)
... ......|++.|+|||++.+..++.++||||||+++|+|++|..||..... . .......... .+.
T Consensus 178 ~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~---~---~~~~~~~~~~------~~~ 244 (314)
T 3com_A 178 TMA-KRNTVIGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPPYADIHP---M---RAIFMIPTNP------PPT 244 (314)
T ss_dssp TBS-CBCCCCSCGGGCCHHHHSSSCBCTTHHHHHHHHHHHHHHHSSCTTTTSCH---H---HHHHHHHHSC------CCC
T ss_pred hcc-ccCccCCCCCccChhhcCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCh---H---HHHHHHhcCC------Ccc
Confidence 322 23345689999999999999999999999999999999999999964321 1 1111111110 011
Q ss_pred CCCChhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhhc
Q 010519 422 LEVKPATRALKRSLLVALRCVDPDSEKRPKMSQVVRMLEA 461 (508)
Q Consensus 422 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~ 461 (508)
...+......+.+|+.+||+.||.+|||+.+++++-.-
T Consensus 245 --~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~~~~~ 282 (314)
T 3com_A 245 --FRKPELWSDNFTDFVKQCLVKSPEQRATATQLLQHPFV 282 (314)
T ss_dssp --CSSGGGSCHHHHHHHHHHTCSCTTTSCCHHHHTTSHHH
T ss_pred --cCCcccCCHHHHHHHHHHccCChhhCcCHHHHHhCHHH
Confidence 11122234566779999999999999999999986543
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-42 Score=355.92 Aligned_cols=256 Identities=21% Similarity=0.306 Sum_probs=195.9
Q ss_pred HhhCCcccceeEeeeCceEEEEEEEc-CCCEEEEEEEcccch--------hhHHHHHHHHHHHhcCCCCCceeEEEEEEe
Q 010519 183 IATNRFSAENVLGEGGYGVVYKGRLI-NGSEVAVKKLLNNLG--------QAEKEFRVEVEAIGHVRHKNLVRLLGYCIE 253 (508)
Q Consensus 183 ~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--------~~~~~~~~ei~~l~~l~h~niv~~~~~~~~ 253 (508)
...++|.+.+.||+|+||+||+|.+. +++.||||++..... .....+.+|+.+|++++||||+++++++.
T Consensus 132 ~~~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~- 210 (419)
T 3i6u_A 132 ALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFD- 210 (419)
T ss_dssp HHHTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTBCCCCEEEE-
T ss_pred hhhccEEEEeEEeeCCCeEEEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCEeeEEEEEe-
Confidence 44689999999999999999999875 578999999864321 11224788999999999999999999875
Q ss_pred CceeeEEEeecCCCCHHHHHhhhhccCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCEEEcCCC---cEEE
Q 010519 254 GVHRMLVYEYVNNGNLEQWLHGAMRNQGNLTWEARMKVIIGTAKALAYLHEAIEPKVVHRDIKSSNILIDDEF---NAKV 330 (508)
Q Consensus 254 ~~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiH~Dlk~~NIll~~~~---~~kl 330 (508)
....++||||+++|+|.+++ .....+++..++.++.||+.||.|||++ +|+||||||+|||++.++ .+||
T Consensus 211 ~~~~~lv~e~~~~g~L~~~l----~~~~~~~~~~~~~i~~qi~~~l~~LH~~---~ivHrDlkp~NIll~~~~~~~~~kl 283 (419)
T 3i6u_A 211 AEDYYIVLELMEGGELFDKV----VGNKRLKEATCKLYFYQMLLAVQYLHEN---GIIHRDLKPENVLLSSQEEDCLIKI 283 (419)
T ss_dssp SSEEEEEEECCTTCBGGGGT----SSSCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESSSSSSCCEEE
T ss_pred cCceEEEEEcCCCCcHHHHH----hccCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCChHhEEEecCCCcceEEE
Confidence 45578999999999999887 4556799999999999999999999999 999999999999997544 5999
Q ss_pred EecCCccccCCCCCcccccccccccccCccccCC---CCCCChhhHHHHHHHHHHHHhCCCCCCCCCCCchhcHHHHHHH
Q 010519 331 SDFGLAKLLDSGESHITTRVMGTFGYVAPEYANT---GMLNEKSDIYSFGVLLLEAVTGRDPVDYGRPANEVNLVEWLKM 407 (508)
Q Consensus 331 ~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~DvwS~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~ 407 (508)
+|||+++...... .....+||+.|+|||++.+ ..|+.++|||||||+||+|++|..||....... .+...+..
T Consensus 284 ~DFG~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~--~~~~~i~~ 359 (419)
T 3i6u_A 284 TDFGHSKILGETS--LMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQV--SLKDQITS 359 (419)
T ss_dssp CCSSTTTSCC-------------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHHSSCSSCCCSSSC--CHHHHHHT
T ss_pred eecccceecCCCc--cccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCcchH--HHHHHHhc
Confidence 9999998765432 2345679999999999853 678889999999999999999999997543222 12211111
Q ss_pred HhcccccccccCCCCCCCh--hHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhhcC
Q 010519 408 MVGTRRAEEVVDPNLEVKP--ATRALKRSLLVALRCVDPDSEKRPKMSQVVRMLEAD 462 (508)
Q Consensus 408 ~~~~~~~~~~~~~~~~~~~--~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~ 462 (508)
......+ .......+.+|+.+||+.||.+|||+.|+++|-+-.
T Consensus 360 ------------~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~hp~~~ 404 (419)
T 3i6u_A 360 ------------GKYNFIPEVWAEVSEKALDLVKKLLVVDPKARFTTEEALRHPWLQ 404 (419)
T ss_dssp ------------TCCCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGC
T ss_pred ------------CCCCCCchhhcccCHHHHHHHHHHccCChhHCcCHHHHhCCcccC
Confidence 1111111 112345677899999999999999999999976543
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.4e-42 Score=361.09 Aligned_cols=252 Identities=23% Similarity=0.338 Sum_probs=199.3
Q ss_pred hCCcccceeEeeeCceEEEEEEEc-CCCEEEEEEEcccc--hhhHHHHHHHHHHHhcCCCCCceeEEEEEEeCceeeEEE
Q 010519 185 TNRFSAENVLGEGGYGVVYKGRLI-NGSEVAVKKLLNNL--GQAEKEFRVEVEAIGHVRHKNLVRLLGYCIEGVHRMLVY 261 (508)
Q Consensus 185 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~ei~~l~~l~h~niv~~~~~~~~~~~~~lv~ 261 (508)
.++|.+.+.||+|+||+||+|++. ++..||+|++.... ......+.+|+.+++.++||||++++++|.+....++||
T Consensus 36 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 115 (494)
T 3lij_A 36 SEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLVM 115 (494)
T ss_dssp HHHEEEEEEEECC---EEEEEEETTTCCEEEEEEEEC-----CTTHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hcCeEEeeEEecCCCEEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence 357999999999999999999986 68899999986543 223467888999999999999999999999999999999
Q ss_pred eecCCCCHHHHHhhhhccCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCEEEcCC---CcEEEEecCCccc
Q 010519 262 EYVNNGNLEQWLHGAMRNQGNLTWEARMKVIIGTAKALAYLHEAIEPKVVHRDIKSSNILIDDE---FNAKVSDFGLAKL 338 (508)
Q Consensus 262 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiH~Dlk~~NIll~~~---~~~kl~Dfgla~~ 338 (508)
||+++|+|.+++. ....+++..++.++.||+.||.|||++ +|+||||||+|||++.. +.+||+|||++..
T Consensus 116 e~~~~g~L~~~~~----~~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~kl~DfG~a~~ 188 (494)
T 3lij_A 116 ECYKGGELFDEII----HRMKFNEVDAAVIIKQVLSGVTYLHKH---NIVHRDLKPENLLLESKEKDALIKIVDFGLSAV 188 (494)
T ss_dssp ECCCSCBHHHHHH----HHSSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEESCSSTTCCEEECCCTTCEE
T ss_pred ecCCCCcHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCChhhEEEeCCCCCCcEEEEECCCCeE
Confidence 9999999999884 345689999999999999999999999 99999999999999764 4599999999987
Q ss_pred cCCCCCcccccccccccccCccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCCCchhcHHHHHHHHhccccccccc
Q 010519 339 LDSGESHITTRVMGTFGYVAPEYANTGMLNEKSDIYSFGVLLLEAVTGRDPVDYGRPANEVNLVEWLKMMVGTRRAEEVV 418 (508)
Q Consensus 339 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 418 (508)
..... .....+||+.|+|||++.+ .|+.++|||||||++|+|++|..||..... . +.+.......
T Consensus 189 ~~~~~--~~~~~~gt~~y~aPE~l~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~---~---~~~~~i~~~~------ 253 (494)
T 3lij_A 189 FENQK--KMKERLGTAYYIAPEVLRK-KYDEKCDVWSIGVILFILLAGYPPFGGQTD---Q---EILRKVEKGK------ 253 (494)
T ss_dssp CBTTB--CBCCCCSCTTTCCHHHHTT-CBCTHHHHHHHHHHHHHHHHSSCSSCCSSH---H---HHHHHHHHTC------
T ss_pred CCCCc--cccccCCCcCeeCHHHHcc-cCCCchhHHHHHHHHHHHHhCCCCCCCCCH---H---HHHHHHHhCC------
Confidence 65432 2345679999999999874 699999999999999999999999964321 1 1122211110
Q ss_pred CCCCCCChhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHh
Q 010519 419 DPNLEVKPATRALKRSLLVALRCVDPDSEKRPKMSQVVRML 459 (508)
Q Consensus 419 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L 459 (508)
..+...........+.+|+.+||+.||.+|||+.|+++|-
T Consensus 254 -~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~hp 293 (494)
T 3lij_A 254 -YTFDSPEWKNVSEGAKDLIKQMLQFDSQRRISAQQALEHP 293 (494)
T ss_dssp -CCCCSGGGTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTCH
T ss_pred -CCCCchhcccCCHHHHHHHHHHCCCChhhCccHHHHhcCc
Confidence 0011111112344567799999999999999999999764
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-42 Score=344.73 Aligned_cols=262 Identities=26% Similarity=0.416 Sum_probs=203.8
Q ss_pred HhhCCcccceeEeeeCceEEEEEEE------cCCCEEEEEEEcccc-hhhHHHHHHHHHHHhcCCCCCceeEEEEEEeCc
Q 010519 183 IATNRFSAENVLGEGGYGVVYKGRL------INGSEVAVKKLLNNL-GQAEKEFRVEVEAIGHVRHKNLVRLLGYCIEGV 255 (508)
Q Consensus 183 ~~~~~~~~~~~lg~G~~g~Vy~~~~------~~~~~vavK~~~~~~-~~~~~~~~~ei~~l~~l~h~niv~~~~~~~~~~ 255 (508)
+..++|.+.+.||+|+||.||+|++ .++..||||.+.... ......+.+|+.++++++||||+++++++.+..
T Consensus 27 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 106 (327)
T 2yfx_A 27 VPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSL 106 (327)
T ss_dssp CCGGGCEEEEECC--CSSCEEEEEC--------CCEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred CChhheEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEeccccchhhHHHHHHHHHHHhhCCCCCCCeEEEEEcCCC
Confidence 3456899999999999999999973 256789999986443 344567888999999999999999999999999
Q ss_pred eeeEEEeecCCCCHHHHHhhhhcc---CCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCEEEcC---CCcEE
Q 010519 256 HRMLVYEYVNNGNLEQWLHGAMRN---QGNLTWEARMKVIIGTAKALAYLHEAIEPKVVHRDIKSSNILIDD---EFNAK 329 (508)
Q Consensus 256 ~~~lv~E~~~~gsL~~~l~~~~~~---~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiH~Dlk~~NIll~~---~~~~k 329 (508)
..++||||+++|+|.+++...... ...+++..++.++.||+.||.|||+. +|+||||||+|||++. +..+|
T Consensus 107 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~---~i~H~dlkp~NIli~~~~~~~~~k 183 (327)
T 2yfx_A 107 PRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEEN---HFIHRDIAARNCLLTCPGPGRVAK 183 (327)
T ss_dssp SCEEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESCSSTTCCEE
T ss_pred CcEEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhhC---CeecCcCCHhHEEEecCCCcceEE
Confidence 999999999999999999753211 14588999999999999999999999 9999999999999984 44699
Q ss_pred EEecCCccccCCCCC-cccccccccccccCccccCCCCCCChhhHHHHHHHHHHHHh-CCCCCCCCCCCchhcHHHHHHH
Q 010519 330 VSDFGLAKLLDSGES-HITTRVMGTFGYVAPEYANTGMLNEKSDIYSFGVLLLEAVT-GRDPVDYGRPANEVNLVEWLKM 407 (508)
Q Consensus 330 l~Dfgla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~ellt-G~~Pf~~~~~~~~~~~~~~~~~ 407 (508)
|+|||++........ .......+++.|+|||++.+..++.++|||||||++|+|++ |..||..... ......
T Consensus 184 l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~------~~~~~~ 257 (327)
T 2yfx_A 184 IGDFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSN------QEVLEF 257 (327)
T ss_dssp ECCCHHHHHHHC------CCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCH------HHHHHH
T ss_pred ECccccccccccccccccCCCcCCCcceeCHhHhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCcCH------HHHHHH
Confidence 999999975533221 22334567899999999998899999999999999999998 9999864321 112222
Q ss_pred HhcccccccccCCCCCCChhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhhcCC
Q 010519 408 MVGTRRAEEVVDPNLEVKPATRALKRSLLVALRCVDPDSEKRPKMSQVVRMLEADD 463 (508)
Q Consensus 408 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~ 463 (508)
...... .. ........+.+++.+||+.||.+|||+.+++++|+...
T Consensus 258 ~~~~~~------~~----~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~ 303 (327)
T 2yfx_A 258 VTSGGR------MD----PPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCT 303 (327)
T ss_dssp HHTTCC------CC----CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred HhcCCC------CC----CCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHh
Confidence 221111 00 11122345667999999999999999999999998653
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-42 Score=344.36 Aligned_cols=265 Identities=20% Similarity=0.273 Sum_probs=194.8
Q ss_pred hCCcccceeEeeeCceEEEEEEEc-CCCEEEEEEEcccch--hhHHHHHHHHHHHhcCCCCCceeEEEEEEeCceeeEEE
Q 010519 185 TNRFSAENVLGEGGYGVVYKGRLI-NGSEVAVKKLLNNLG--QAEKEFRVEVEAIGHVRHKNLVRLLGYCIEGVHRMLVY 261 (508)
Q Consensus 185 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~ei~~l~~l~h~niv~~~~~~~~~~~~~lv~ 261 (508)
.++|.+.+.||+|+||+||+|++. +++.||||++..... .....+.+|+.++++++||||+++++++.+....++||
T Consensus 33 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 112 (329)
T 3gbz_A 33 IDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELKSVIHHNHRLHLIF 112 (329)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTTEEEEEEECCCCC--------CHHHHHHGGGCCCTTBCCEEEEEEETTEEEEEE
T ss_pred hhhEEEEEEEEecCCeEEEEEEECCCCceEEEEEEcccccccccchhHHHHHHHHHHcCCCCcceEEEEEecCCEEEEEE
Confidence 458999999999999999999875 688999999864432 22356778999999999999999999999999999999
Q ss_pred eecCCCCHHHHHhhhhccCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCEEE-----cCCCcEEEEecCCc
Q 010519 262 EYVNNGNLEQWLHGAMRNQGNLTWEARMKVIIGTAKALAYLHEAIEPKVVHRDIKSSNILI-----DDEFNAKVSDFGLA 336 (508)
Q Consensus 262 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiH~Dlk~~NIll-----~~~~~~kl~Dfgla 336 (508)
||++ |+|.+++. ....+++..++.++.||+.||.|||++ +|+||||||+|||+ ++++.+||+|||++
T Consensus 113 e~~~-~~L~~~~~----~~~~~~~~~~~~i~~ql~~~l~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~~~kl~Dfg~a 184 (329)
T 3gbz_A 113 EYAE-NDLKKYMD----KNPDVSMRVIKSFLYQLINGVNFCHSR---RCLHRDLKPQNLLLSVSDASETPVLKIGDFGLA 184 (329)
T ss_dssp ECCS-EEHHHHHH----HCTTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEEC-----CCEEEECCTTHH
T ss_pred ecCC-CCHHHHHh----hcCCCCHHHHHHHHHHHHHHHHHHHhC---CEECCCCCHHHEEEecCCCCccceEEECcCCCc
Confidence 9997 59999984 445689999999999999999999999 99999999999999 45556999999999
Q ss_pred cccCCCCCcccccccccccccCccccCCC-CCCChhhHHHHHHHHHHHHhCCCCCCCCCCCchhcHHHHHHHHhcccccc
Q 010519 337 KLLDSGESHITTRVMGTFGYVAPEYANTG-MLNEKSDIYSFGVLLLEAVTGRDPVDYGRPANEVNLVEWLKMMVGTRRAE 415 (508)
Q Consensus 337 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwS~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~ 415 (508)
........ ......||+.|+|||++.+. .++.++|||||||++|||++|..||..... ...+..... ..+.....
T Consensus 185 ~~~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~--~~~~~~~~~-~~~~~~~~ 260 (329)
T 3gbz_A 185 RAFGIPIR-QFTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSE--IDQLFKIFE-VLGLPDDT 260 (329)
T ss_dssp HHHC------------CCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSH--HHHHHHHHH-HHCCCCTT
T ss_pred cccCCccc-ccCCCcCCccccCHHHhcCCCCCCcHHHHHHHHHHHHHHHHCCCCcCCCCH--HHHHHHHHH-HhCCCchh
Confidence 87653322 23445689999999999874 589999999999999999999999964321 111111111 11111000
Q ss_pred cc-----------cCCCCCCChhH-----HHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhhc
Q 010519 416 EV-----------VDPNLEVKPAT-----RALKRSLLVALRCVDPDSEKRPKMSQVVRMLEA 461 (508)
Q Consensus 416 ~~-----------~~~~~~~~~~~-----~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~ 461 (508)
.. ..+........ .....+.+|+.+||+.||.+|||+.|+++|-+-
T Consensus 261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f 322 (329)
T 3gbz_A 261 TWPGVTALPDWKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNALEHPYF 322 (329)
T ss_dssp TSTTGGGSTTCCTTCCCCCCCCHHHHHGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGG
T ss_pred hhhhhhhhhhhhhhhhhhccccHhhhcccccCHHHHHHHHHHccCChhhCCCHHHHhCCccc
Confidence 00 00000000001 123566789999999999999999999986543
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-41 Score=360.24 Aligned_cols=255 Identities=23% Similarity=0.312 Sum_probs=203.6
Q ss_pred hhCCcccceeEeeeCceEEEEEEEc-CCCEEEEEEEcccch-------------hhHHHHHHHHHHHhcCCCCCceeEEE
Q 010519 184 ATNRFSAENVLGEGGYGVVYKGRLI-NGSEVAVKKLLNNLG-------------QAEKEFRVEVEAIGHVRHKNLVRLLG 249 (508)
Q Consensus 184 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-------------~~~~~~~~ei~~l~~l~h~niv~~~~ 249 (508)
..++|.+.+.||+|+||+||+|++. ++..||+|++..... .....+.+|+.++++++||||+++++
T Consensus 34 i~~~Y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~ 113 (504)
T 3q5i_A 34 IGESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFD 113 (504)
T ss_dssp GGGTEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCCCTTBCCEEE
T ss_pred cccceEEEeEecccCCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCCCCCCeEEE
Confidence 4568999999999999999999986 578999999864321 23467889999999999999999999
Q ss_pred EEEeCceeeEEEeecCCCCHHHHHhhhhccCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCEEEcCCC---
Q 010519 250 YCIEGVHRMLVYEYVNNGNLEQWLHGAMRNQGNLTWEARMKVIIGTAKALAYLHEAIEPKVVHRDIKSSNILIDDEF--- 326 (508)
Q Consensus 250 ~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiH~Dlk~~NIll~~~~--- 326 (508)
++.+....++||||+++|+|.+++. ....+++..++.++.||+.||.|||+. +|+||||||+|||++.++
T Consensus 114 ~~~~~~~~~lv~e~~~gg~L~~~l~----~~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~~~~~ 186 (504)
T 3q5i_A 114 VFEDKKYFYLVTEFYEGGELFEQII----NRHKFDECDAANIMKQILSGICYLHKH---NIVHRDIKPENILLENKNSLL 186 (504)
T ss_dssp EEECSSEEEEEEECCTTCBHHHHHH----HHSCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEESSTTCCS
T ss_pred EEEcCCEEEEEEecCCCCcHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCcHHHEEEecCCCCc
Confidence 9999999999999999999999985 345699999999999999999999999 999999999999998776
Q ss_pred cEEEEecCCccccCCCCCcccccccccccccCccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCCCchhcHHHHHH
Q 010519 327 NAKVSDFGLAKLLDSGESHITTRVMGTFGYVAPEYANTGMLNEKSDIYSFGVLLLEAVTGRDPVDYGRPANEVNLVEWLK 406 (508)
Q Consensus 327 ~~kl~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~ 406 (508)
.+||+|||++....... ......||+.|+|||++.+ .|+.++|||||||++|+|++|..||..... .+.+.
T Consensus 187 ~~kl~Dfg~a~~~~~~~--~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~------~~~~~ 257 (504)
T 3q5i_A 187 NIKIVDFGLSSFFSKDY--KLRDRLGTAYYIAPEVLKK-KYNEKCDVWSCGVIMYILLCGYPPFGGQND------QDIIK 257 (504)
T ss_dssp SEEECCCTTCEECCTTS--CBCCCCSCTTTCCHHHHTT-CBCTHHHHHHHHHHHHHHHHSSCSSCCSSH------HHHHH
T ss_pred cEEEEECCCCEEcCCCC--ccccccCCcCCCCHHHhcc-CCCchHHHHHHHHHHHHHHhCCCCCCCCCH------HHHHH
Confidence 69999999998765432 2345579999999999875 689999999999999999999999964321 11222
Q ss_pred HHhcccccccccCCCCCCChhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhhc
Q 010519 407 MMVGTRRAEEVVDPNLEVKPATRALKRSLLVALRCVDPDSEKRPKMSQVVRMLEA 461 (508)
Q Consensus 407 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~ 461 (508)
...... ..+...........+.+|+.+||..||.+|||+.|++++-+-
T Consensus 258 ~i~~~~-------~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~e~l~h~~~ 305 (504)
T 3q5i_A 258 KVEKGK-------YYFDFNDWKNISDEAKELIKLMLTYDYNKRCTAEEALNSRWI 305 (504)
T ss_dssp HHHHCC-------CCCCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHH
T ss_pred HHHcCC-------CCCCccccCCCCHHHHHHHHHHcCCChhHCCCHHHHhcCHhh
Confidence 221110 000101111234567789999999999999999999987543
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-41 Score=333.40 Aligned_cols=257 Identities=28% Similarity=0.416 Sum_probs=199.9
Q ss_pred CCcccceeEeeeCceEEEEEEEc-CCCEEEEEEEcccchhhHHHHHHHHHHHhcCCCCCceeEEEEEEeCceeeEEEeec
Q 010519 186 NRFSAENVLGEGGYGVVYKGRLI-NGSEVAVKKLLNNLGQAEKEFRVEVEAIGHVRHKNLVRLLGYCIEGVHRMLVYEYV 264 (508)
Q Consensus 186 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~ei~~l~~l~h~niv~~~~~~~~~~~~~lv~E~~ 264 (508)
++|.....||+|+||.||+|.+. ++..||+|.+..........+.+|+.+++.++||||+++++++.+....++||||+
T Consensus 22 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 101 (295)
T 2clq_A 22 DENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSFSENGFIKIFMEQV 101 (295)
T ss_dssp CTTSSBCEEEECSSSEEEEEEETTTCCEEEEEEEECCCC---HHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred cCCCCcEEEeecCcEEEEEEEECCCCeEEEEEEccCCchHHHHHHHHHHHHHHhCCCCCEeeEeeEEEeCCcEEEEEEeC
Confidence 45555669999999999999875 67899999987665555677899999999999999999999999999999999999
Q ss_pred CCCCHHHHHhhhhccCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCEEEcC-CCcEEEEecCCccccCCCC
Q 010519 265 NNGNLEQWLHGAMRNQGNLTWEARMKVIIGTAKALAYLHEAIEPKVVHRDIKSSNILIDD-EFNAKVSDFGLAKLLDSGE 343 (508)
Q Consensus 265 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiH~Dlk~~NIll~~-~~~~kl~Dfgla~~~~~~~ 343 (508)
++++|.+++... .....+++..+..++.||+.||.|||+. +++|+||||+|||++. ++.+||+|||++.......
T Consensus 102 ~~~~L~~~l~~~-~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~kl~Dfg~~~~~~~~~ 177 (295)
T 2clq_A 102 PGGSLSALLRSK-WGPLKDNEQTIGFYTKQILEGLKYLHDN---QIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGIN 177 (295)
T ss_dssp SEEEHHHHHHHT-TCCCTTCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTTCCEEECCTTTCEESCC--
T ss_pred CCCCHHHHHHhh-ccCCCccHHHHHHHHHHHHHHHHHHHhC---CEEccCCChhhEEEECCCCCEEEeecccccccCCCC
Confidence 999999999642 1234567889999999999999999999 9999999999999987 8999999999998765332
Q ss_pred CcccccccccccccCccccCCCC--CCChhhHHHHHHHHHHHHhCCCCCCCCCCCchhcHHHHHHHHhcccccccccCCC
Q 010519 344 SHITTRVMGTFGYVAPEYANTGM--LNEKSDIYSFGVLLLEAVTGRDPVDYGRPANEVNLVEWLKMMVGTRRAEEVVDPN 421 (508)
Q Consensus 344 ~~~~~~~~gt~~y~aPE~~~~~~--~~~~~DvwS~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 421 (508)
. ......|++.|+|||++.+.. ++.++||||||+++|+|++|+.||....... . ......... ..+.
T Consensus 178 ~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~-~---~~~~~~~~~------~~~~ 246 (295)
T 2clq_A 178 P-CTETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQ-A---AMFKVGMFK------VHPE 246 (295)
T ss_dssp ----CCCCCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCTTGGGSSHH-H---HHHHHHHHC------CCCC
T ss_pred C-cccccCCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCCccCCCchh-H---HHHhhcccc------cccc
Confidence 2 233456899999999987643 8899999999999999999999996332111 1 111111000 0111
Q ss_pred CCCChhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhhc
Q 010519 422 LEVKPATRALKRSLLVALRCVDPDSEKRPKMSQVVRMLEA 461 (508)
Q Consensus 422 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~ 461 (508)
+. ......+.+++.+||+.||.+|||+.+++++-.-
T Consensus 247 ~~----~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~~~~ 282 (295)
T 2clq_A 247 IP----ESMSAEAKAFILKCFEPDPDKRACANDLLVDEFL 282 (295)
T ss_dssp CC----TTSCHHHHHHHHHTTCSSTTTSCCHHHHHTSGGG
T ss_pred cc----ccCCHHHHHHHHHHccCChhhCCCHHHHhcChhh
Confidence 11 1123456679999999999999999999976443
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-41 Score=341.76 Aligned_cols=270 Identities=25% Similarity=0.290 Sum_probs=201.4
Q ss_pred hhCCcccceeEeeeCceEEEEEEEc-CCCEEEEEEEcccchhh-----HHHHHHHHHHHhcCCCCCceeEEEEEEeCcee
Q 010519 184 ATNRFSAENVLGEGGYGVVYKGRLI-NGSEVAVKKLLNNLGQA-----EKEFRVEVEAIGHVRHKNLVRLLGYCIEGVHR 257 (508)
Q Consensus 184 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~-----~~~~~~ei~~l~~l~h~niv~~~~~~~~~~~~ 257 (508)
..++|.+.+.||+|+||.||+|++. +|+.||+|++....... ...+.+|+.+++.++||||+++++++.+....
T Consensus 8 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 87 (346)
T 1ua2_A 8 RAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNI 87 (346)
T ss_dssp -----CEEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCC
T ss_pred HhcccEEEeEEeecCCEEEEEEEECCCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCCCCCCeEEEEEeeCCce
Confidence 3468999999999999999999875 58899999986432211 23577899999999999999999999999999
Q ss_pred eEEEeecCCCCHHHHHhhhhccCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCEEEcCCCcEEEEecCCcc
Q 010519 258 MLVYEYVNNGNLEQWLHGAMRNQGNLTWEARMKVIIGTAKALAYLHEAIEPKVVHRDIKSSNILIDDEFNAKVSDFGLAK 337 (508)
Q Consensus 258 ~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~Dfgla~ 337 (508)
++||||+++ +|.+++. .....+++..++.++.|++.||.|||+. +|+||||||+|||++.++.+||+|||++.
T Consensus 88 ~lv~e~~~~-~l~~~~~---~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~ 160 (346)
T 1ua2_A 88 SLVFDFMET-DLEVIIK---DNSLVLTPSHIKAYMLMTLQGLEYLHQH---WILHRDLKPNNLLLDENGVLKLADFGLAK 160 (346)
T ss_dssp EEEEECCSE-EHHHHHT---TCCSSCCSSHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECCCGGGS
T ss_pred EEEEEcCCC-CHHHHHH---hcCcCCCHHHHHHHHHHHHHHHHHHHHC---CEECCCCCHHHEEEcCCCCEEEEecccce
Confidence 999999975 8998885 3445688899999999999999999999 99999999999999999999999999998
Q ss_pred ccCCCCCcccccccccccccCccccCC-CCCCChhhHHHHHHHHHHHHhCCCCCCCCCCCchhcHHHHHHHHhccccccc
Q 010519 338 LLDSGESHITTRVMGTFGYVAPEYANT-GMLNEKSDIYSFGVLLLEAVTGRDPVDYGRPANEVNLVEWLKMMVGTRRAEE 416 (508)
Q Consensus 338 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwS~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 416 (508)
....... ......||+.|+|||++.+ ..++.++|||||||++|||++|..||..... ...+...+ ...+......
T Consensus 161 ~~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~~~~~~~~--~~~~~~i~-~~~~~~~~~~ 236 (346)
T 1ua2_A 161 SFGSPNR-AYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSD--LDQLTRIF-ETLGTPTEEQ 236 (346)
T ss_dssp TTTSCCC-CCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSH--HHHHHHHH-HHHCCCCTTT
T ss_pred eccCCcc-cCCcccccccccCchHhhCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCCH--HHHHHHHH-HHcCCCChhh
Confidence 7654322 2344578999999999976 4589999999999999999999999864321 11111111 1111111000
Q ss_pred ccC----------CCCCCChh----HHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhhcCCC
Q 010519 417 VVD----------PNLEVKPA----TRALKRSLLVALRCVDPDSEKRPKMSQVVRMLEADDY 464 (508)
Q Consensus 417 ~~~----------~~~~~~~~----~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~ 464 (508)
..+ ......+. ......+.+|+.+||+.||.+|||+.|++++-.-...
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h~~f~~~ 298 (346)
T 1ua2_A 237 WPDMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYFSNR 298 (346)
T ss_dssp SSSTTSSTTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTSGGGTSS
T ss_pred hhhhccCcccccccccCCCChHHhhccCCHHHHHHHHHHhccChhhCCCHHHHhcChhhhcC
Confidence 000 00000000 1223567789999999999999999999998765443
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.7e-43 Score=356.36 Aligned_cols=244 Identities=14% Similarity=0.182 Sum_probs=191.0
Q ss_pred hCCcccceeEeeeCceEEEEEEE-cCCCEEEEEEEccc---chhhHHHHHHHH---HHHhcCCCCCceeEE-------EE
Q 010519 185 TNRFSAENVLGEGGYGVVYKGRL-INGSEVAVKKLLNN---LGQAEKEFRVEV---EAIGHVRHKNLVRLL-------GY 250 (508)
Q Consensus 185 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~---~~~~~~~~~~ei---~~l~~l~h~niv~~~-------~~ 250 (508)
.++|.+.+.||+|+||+||+|++ .+|+.||||++... .....+.+.+|+ ..++.++|||||+++ ++
T Consensus 72 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~~~~ 151 (377)
T 3byv_A 72 PRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDL 151 (377)
T ss_dssp CEEEEEEEEEEEETTEEEEEEEC-CCCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCCCSEE
T ss_pred CceEEEcceeecCCCEEEEEEEECCCCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhhhhhh
Confidence 46799999999999999999986 46899999998632 234456788999 556666899999998 66
Q ss_pred EEeCc-----------------eeeEEEeecCCCCHHHHHhhhhcc---CCCccHHHHHHHHHHHHHHHHHHHhcCCCCe
Q 010519 251 CIEGV-----------------HRMLVYEYVNNGNLEQWLHGAMRN---QGNLTWEARMKVIIGTAKALAYLHEAIEPKV 310 (508)
Q Consensus 251 ~~~~~-----------------~~~lv~E~~~~gsL~~~l~~~~~~---~~~l~~~~~~~i~~~i~~al~yLH~~~~~~i 310 (508)
+.+.+ ..||||||+ +|+|.+++.....- ...+++..++.++.||+.||.|||++ +|
T Consensus 152 ~~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~i 227 (377)
T 3byv_A 152 VKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHY---GL 227 (377)
T ss_dssp EECTTSCSEEEC------CEEESEEEEEECC-SEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHHHHHT---TE
T ss_pred hhccCCccccccccCCCceEEEEEEEEEecc-CCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHHHHhC---Ce
Confidence 66553 278999999 68999999643211 12355688899999999999999999 99
Q ss_pred EeecCCCCCEEEcCCCcEEEEecCCccccCCCCCcccccccccccccCccccCCC-----------CCCChhhHHHHHHH
Q 010519 311 VHRDIKSSNILIDDEFNAKVSDFGLAKLLDSGESHITTRVMGTFGYVAPEYANTG-----------MLNEKSDIYSFGVL 379 (508)
Q Consensus 311 iH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----------~~~~~~DvwS~Gvv 379 (508)
+||||||+|||++.++.+||+|||+++.... ......| +.|+|||++.+. .++.++|||||||+
T Consensus 228 vHrDikp~NIll~~~~~~kL~DFG~a~~~~~----~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DvwSlG~i 302 (377)
T 3byv_A 228 VHTYLRPVDIVLDQRGGVFLTGFEHLVRDGA----RVVSSVS-RGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLV 302 (377)
T ss_dssp ECSCCCGGGEEECTTCCEEECCGGGCEETTC----EEECCCC-TTCCCHHHHHHHTSTHHHHCCEEECCHHHHHHHHHHH
T ss_pred ecCCCCHHHEEEcCCCCEEEEechhheecCC----cccCCCC-cCccChhhhcccccccccccccccCChhhhHHHHHHH
Confidence 9999999999999999999999999986432 2344567 999999999887 89999999999999
Q ss_pred HHHHHhCCCCCCCCCCCchhcHHHHHHHHhcccccccccCCCCCCChhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 010519 380 LLEAVTGRDPVDYGRPANEVNLVEWLKMMVGTRRAEEVVDPNLEVKPATRALKRSLLVALRCVDPDSEKRPKMSQVVRM 458 (508)
Q Consensus 380 l~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 458 (508)
||||++|+.||......... ..+.... ......+.+|+.+||+.||.+|||+.|++++
T Consensus 303 l~elltg~~Pf~~~~~~~~~---------------~~~~~~~------~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~h 360 (377)
T 3byv_A 303 IYWIWCADLPITKDAALGGS---------------EWIFRSC------KNIPQPVRALLEGFLRYPKEDRLLPLQAMET 360 (377)
T ss_dssp HHHHHHSSCCC------CCS---------------GGGGSSC------CCCCHHHHHHHHHHTCSSGGGCCCHHHHHTS
T ss_pred HHHHHHCCCCCcccccccch---------------hhhhhhc------cCCCHHHHHHHHHHcCCCchhCCCHHHHhhC
Confidence 99999999999643321111 1111110 1123456679999999999999999999975
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-42 Score=339.13 Aligned_cols=256 Identities=23% Similarity=0.332 Sum_probs=200.7
Q ss_pred hhCCcccceeEeeeCceEEEEEEEc-CCCEEEEEEEcccchhhHHHHHHHHHHHhcCCCCCceeEEEEEEeCceeeEEEe
Q 010519 184 ATNRFSAENVLGEGGYGVVYKGRLI-NGSEVAVKKLLNNLGQAEKEFRVEVEAIGHVRHKNLVRLLGYCIEGVHRMLVYE 262 (508)
Q Consensus 184 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~ei~~l~~l~h~niv~~~~~~~~~~~~~lv~E 262 (508)
..++|++.+.||+|+||.||+|.+. ++..||+|.+..........+..|+.+++.++||||+++++++......++|||
T Consensus 17 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 96 (302)
T 2j7t_A 17 PNEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAYYHDGKLWIMIE 96 (302)
T ss_dssp GGGTEEEEEEEECSTTCCEEEEEETTTCCEEEEEEEC----CCHHHHHHHHHHHHHCCCTTBCCEEEEEECC-CEEEEEE
T ss_pred CccceeecceeccCCCeEEEEEEEcCCCcEEEEEEecCCCHHHHHHHHHHHHHHhcCCCCCEeeeeeeeeeCCeEEEEEE
Confidence 3468999999999999999999986 588999999876555556788899999999999999999999999999999999
Q ss_pred ecCCCCHHHHHhhhhccCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCEEEcCCCcEEEEecCCccccCCC
Q 010519 263 YVNNGNLEQWLHGAMRNQGNLTWEARMKVIIGTAKALAYLHEAIEPKVVHRDIKSSNILIDDEFNAKVSDFGLAKLLDSG 342 (508)
Q Consensus 263 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~~ 342 (508)
|+++++|.+++.. ....+++..++.++.||+.||.|||+. +++||||||+|||++.++.+||+|||++......
T Consensus 97 ~~~~~~l~~~~~~---~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~ 170 (302)
T 2j7t_A 97 FCPGGAVDAIMLE---LDRGLTEPQIQVVCRQMLEALNFLHSK---RIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKT 170 (302)
T ss_dssp CCTTEEHHHHHHH---HTSCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEECTTSCEEECCCHHHHHHHHH
T ss_pred eCCCCcHHHHHHh---hccCCCHHHHHHHHHHHHHHHHHHhcC---CcccCCCCHHHEEECCCCCEEEEECCCCcccccc
Confidence 9999999999853 346689999999999999999999999 9999999999999999999999999987543211
Q ss_pred CCcccccccccccccCcccc-----CCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCCCchhcHHHHHHHHhcccccccc
Q 010519 343 ESHITTRVMGTFGYVAPEYA-----NTGMLNEKSDIYSFGVLLLEAVTGRDPVDYGRPANEVNLVEWLKMMVGTRRAEEV 417 (508)
Q Consensus 343 ~~~~~~~~~gt~~y~aPE~~-----~~~~~~~~~DvwS~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 417 (508)
. .......|++.|+|||++ .+..++.++|||||||++|+|++|..||..... ............
T Consensus 171 ~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~------~~~~~~~~~~~~---- 239 (302)
T 2j7t_A 171 L-QKRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNP------MRVLLKIAKSDP---- 239 (302)
T ss_dssp H-HC-----CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHHSSCTTTTSCH------HHHHHHHHHSCC----
T ss_pred c-cccccccCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHHHhcCCCCCccCCH------HHHHHHHhccCC----
Confidence 0 112334689999999998 467789999999999999999999999964321 111111111110
Q ss_pred cCCCCCCChhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhh
Q 010519 418 VDPNLEVKPATRALKRSLLVALRCVDPDSEKRPKMSQVVRMLE 460 (508)
Q Consensus 418 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 460 (508)
+ ....+......+.+++.+||+.||.+|||+.+++++-.
T Consensus 240 --~--~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~ 278 (302)
T 2j7t_A 240 --P--TLLTPSKWSVEFRDFLKIALDKNPETRPSAAQLLEHPF 278 (302)
T ss_dssp --C--CCSSGGGSCHHHHHHHHHHSCSCTTTSCCHHHHTTSTT
T ss_pred --c--ccCCccccCHHHHHHHHHHcccChhhCCCHHHHhcChH
Confidence 0 11112223445677999999999999999999998644
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-41 Score=341.90 Aligned_cols=260 Identities=23% Similarity=0.264 Sum_probs=194.4
Q ss_pred hCCcccceeEeeeCceEEEEEEEc-CCCEEEEEEEcccc--hhhHHHHHHHHHHHhcCCCCCceeEEEEEEeCc------
Q 010519 185 TNRFSAENVLGEGGYGVVYKGRLI-NGSEVAVKKLLNNL--GQAEKEFRVEVEAIGHVRHKNLVRLLGYCIEGV------ 255 (508)
Q Consensus 185 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~ei~~l~~l~h~niv~~~~~~~~~~------ 255 (508)
.++|.+.+.||+|+||.||+|.+. ++..||||++.... ......+.+|+.+++.++||||+++++++....
T Consensus 24 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~ 103 (371)
T 2xrw_A 24 LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQ 103 (371)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSCCSTTTCC
T ss_pred hhheeEeeeeEecCCEEEEEEEECCCCceEEEEEeccccCChHHHHHHHHHHHHHHhcCCCCccceEEeecccccccccc
Confidence 468999999999999999999875 68889999986532 334467888999999999999999999997654
Q ss_pred eeeEEEeecCCCCHHHHHhhhhccCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCEEEcCCCcEEEEecCC
Q 010519 256 HRMLVYEYVNNGNLEQWLHGAMRNQGNLTWEARMKVIIGTAKALAYLHEAIEPKVVHRDIKSSNILIDDEFNAKVSDFGL 335 (508)
Q Consensus 256 ~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~Dfgl 335 (508)
..++||||+++ +|.+++. ..+++..+..++.||+.||.|||++ +|+||||||+|||++.++.+||+|||+
T Consensus 104 ~~~lv~e~~~~-~l~~~~~------~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dlkp~NIl~~~~~~~kl~Dfg~ 173 (371)
T 2xrw_A 104 DVYIVMELMDA-NLCQVIQ------MELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGL 173 (371)
T ss_dssp EEEEEEECCSE-EHHHHHH------SCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECCCCC
T ss_pred ceEEEEEcCCC-CHHHHHh------hccCHHHHHHHHHHHHHHHHHHHHC---CeecccCCHHHEEEcCCCCEEEEEeec
Confidence 67999999964 8888874 2488999999999999999999999 999999999999999999999999999
Q ss_pred ccccCCCCCcccccccccccccCccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCCCchhcHHHHHHHHhcccc--
Q 010519 336 AKLLDSGESHITTRVMGTFGYVAPEYANTGMLNEKSDIYSFGVLLLEAVTGRDPVDYGRPANEVNLVEWLKMMVGTRR-- 413 (508)
Q Consensus 336 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~-- 413 (508)
+....... ......||+.|+|||++.+..++.++|||||||++|+|++|+.||...... ...........
T Consensus 174 a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~------~~~~~i~~~~~~~ 245 (371)
T 2xrw_A 174 ARTAGTSF--MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHI------DQWNKVIEQLGTP 245 (371)
T ss_dssp ------------------CTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHH------HHHHHHHC-CCCC
T ss_pred cccccccc--ccCCceecCCccCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHH------HHHHHHHHHhCCC
Confidence 98664322 234457899999999999999999999999999999999999999643211 11111111000
Q ss_pred cccc-------------cCCCC--------------C--CChhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhhcC
Q 010519 414 AEEV-------------VDPNL--------------E--VKPATRALKRSLLVALRCVDPDSEKRPKMSQVVRMLEAD 462 (508)
Q Consensus 414 ~~~~-------------~~~~~--------------~--~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~ 462 (508)
.... ..+.. . ..........+.+|+.+||..||.+|||+.|+++|-.-.
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~~~ 323 (371)
T 2xrw_A 246 CPEFMKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPYIN 323 (371)
T ss_dssp CHHHHTTSCHHHHHHHHSSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSGGGSCCHHHHHHSHHHH
T ss_pred CHHHHHHhhhHHHHHHhhCccccccchhhhcccccCcccccccccccHHHHHHHHHHCcCChhhCCCHHHHhCCcchh
Confidence 0000 00000 0 001122356778899999999999999999999977543
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-41 Score=344.56 Aligned_cols=275 Identities=22% Similarity=0.291 Sum_probs=203.8
Q ss_pred eHHHHHHhhCCcccceeEeeeCceEEEEEEEcCCCEEEEEEEcccch-----------hhHHHHHHHHHHHhcCCCCCce
Q 010519 177 TLRDLEIATNRFSAENVLGEGGYGVVYKGRLINGSEVAVKKLLNNLG-----------QAEKEFRVEVEAIGHVRHKNLV 245 (508)
Q Consensus 177 ~~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~-----------~~~~~~~~ei~~l~~l~h~niv 245 (508)
.+.++....++|.+.+.||+|+||.||+|.+.+|..||||++..... ...+.+.+|+.++++++||||+
T Consensus 13 ~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv 92 (362)
T 3pg1_A 13 LIAELHAMQSPYTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNIL 92 (362)
T ss_dssp HHHHHHHTTCSCEEEEEEEEETTEEEEEEECTTSCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCCCTTBC
T ss_pred HHHHHHHhccceEEeEEeccCCCEEEEEEECCCCCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCCCcCcc
Confidence 35778888999999999999999999999988899999999854321 1236788999999999999999
Q ss_pred eEEEEEEeC-----ceeeEEEeecCCCCHHHHHhhhhccCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCE
Q 010519 246 RLLGYCIEG-----VHRMLVYEYVNNGNLEQWLHGAMRNQGNLTWEARMKVIIGTAKALAYLHEAIEPKVVHRDIKSSNI 320 (508)
Q Consensus 246 ~~~~~~~~~-----~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiH~Dlk~~NI 320 (508)
++++++... ...++||||+. |+|.+++. .....+++..++.++.||+.||.|||+. +|+||||||+||
T Consensus 93 ~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~---~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~NI 165 (362)
T 3pg1_A 93 GLRDIFVHFEEPAMHKLYLVTELMR-TDLAQVIH---DQRIVISPQHIQYFMYHILLGLHVLHEA---GVVHRDLHPGNI 165 (362)
T ss_dssp CCSEEEEECCTTTCCEEEEEEECCS-EEHHHHHH---CTTSCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGE
T ss_pred ceeeeEEeccCCCcceEEEEEccCC-CCHHHHHH---hcccCCCHHHHHHHHHHHHHHHHHHHHC---cCEecCCChHHE
Confidence 999998643 35789999997 68998885 3455799999999999999999999999 999999999999
Q ss_pred EEcCCCcEEEEecCCccccCCCCCcccccccccccccCccccCC-CCCCChhhHHHHHHHHHHHHhCCCCCCCCCCCchh
Q 010519 321 LIDDEFNAKVSDFGLAKLLDSGESHITTRVMGTFGYVAPEYANT-GMLNEKSDIYSFGVLLLEAVTGRDPVDYGRPANEV 399 (508)
Q Consensus 321 ll~~~~~~kl~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwS~Gvvl~elltG~~Pf~~~~~~~~~ 399 (508)
|++.++.+||+|||++....... ......||+.|+|||++.+ ..++.++|||||||++|+|++|+.||......
T Consensus 166 l~~~~~~~kl~Dfg~~~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~--- 240 (362)
T 3pg1_A 166 LLADNNDITICDFNLAREDTADA--NKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFY--- 240 (362)
T ss_dssp EECTTCCEEECCTTC-----------------CGGGCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH---
T ss_pred EEcCCCCEEEEecCccccccccc--ccceecccceecCcHHhcCCCCCCcHhHHHhHHHHHHHHHhCCCCCCCCCHH---
Confidence 99999999999999998544332 2344578999999999877 77999999999999999999999999744321
Q ss_pred cHHHHHHHHhcccccc-----------cccCCC---CCCCh----hHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhhc
Q 010519 400 NLVEWLKMMVGTRRAE-----------EVVDPN---LEVKP----ATRALKRSLLVALRCVDPDSEKRPKMSQVVRMLEA 461 (508)
Q Consensus 400 ~~~~~~~~~~~~~~~~-----------~~~~~~---~~~~~----~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~ 461 (508)
.....+....+..... ...... ..... .......+.+|+.+||+.||.+|||+.|++++-.-
T Consensus 241 ~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f 320 (362)
T 3pg1_A 241 NQLNKIVEVVGTPKIEDVVMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQRRISTEQALRHPYF 320 (362)
T ss_dssp HHHHHHHHHHCCCCHHHHHHTSCHHHHHHTTTCCCCCCCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGG
T ss_pred HHHHHHHHHcCCCChHHhhhccchhhhHHHHhhcccCChhhHHhhCCCCCHHHHHHHHHHhcCChhhCCCHHHHHcCchh
Confidence 1111111111111000 000000 00000 01123456779999999999999999999987654
Q ss_pred CC
Q 010519 462 DD 463 (508)
Q Consensus 462 ~~ 463 (508)
..
T Consensus 321 ~~ 322 (362)
T 3pg1_A 321 ES 322 (362)
T ss_dssp TT
T ss_pred hh
Confidence 43
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-41 Score=372.28 Aligned_cols=254 Identities=23% Similarity=0.293 Sum_probs=206.1
Q ss_pred HHhhCCcccceeEeeeCceEEEEEEEc-CCCEEEEEEEcccc---hhhHHHHHHHHHHHhcC-CCCCceeEEEEEEeCce
Q 010519 182 EIATNRFSAENVLGEGGYGVVYKGRLI-NGSEVAVKKLLNNL---GQAEKEFRVEVEAIGHV-RHKNLVRLLGYCIEGVH 256 (508)
Q Consensus 182 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~ei~~l~~l-~h~niv~~~~~~~~~~~ 256 (508)
.+..++|.+.+.||+|+||+||+|++. +++.||||++.... ......+..|..++..+ +||||+.+++++.+...
T Consensus 337 ~~~~~~f~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~~~~~~ 416 (674)
T 3pfq_A 337 RMKLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDR 416 (674)
T ss_dssp ---CTTEEEEEESSBTTTBCEEEEEESSSCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEECBCSSE
T ss_pred cccccceEEEEEEccCCCEEEEEEEECCCCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEEEeCCE
Confidence 345678999999999999999999976 57889999986432 22335677799999887 79999999999999999
Q ss_pred eeEEEeecCCCCHHHHHhhhhccCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCEEEcCCCcEEEEecCCc
Q 010519 257 RMLVYEYVNNGNLEQWLHGAMRNQGNLTWEARMKVIIGTAKALAYLHEAIEPKVVHRDIKSSNILIDDEFNAKVSDFGLA 336 (508)
Q Consensus 257 ~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~Dfgla 336 (508)
.||||||+++|+|.+++. ..+.+++..++.++.||+.||.|||++ +|+||||||+||||+.++++||+|||++
T Consensus 417 ~~lV~E~~~gg~L~~~l~----~~~~~~~~~~~~~~~qi~~aL~~LH~~---gIiHrDLKp~NILl~~~g~ikL~DFGla 489 (674)
T 3pfq_A 417 LYFVMEYVNGGDLMYHIQ----QVGRFKEPHAVFYAAEIAIGLFFLQSK---GIIYRDLKLDNVMLDSEGHIKIADFGMC 489 (674)
T ss_dssp EEEEEECCCSCBHHHHHH----HHSSCCHHHHHHHHHHHHHHHHHHHHT---SEECCCCCSTTEEECSSSCEEECCCTTC
T ss_pred EEEEEeCcCCCcHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHhC---CeEeccCChhhEEEcCCCcEEEeeccee
Confidence 999999999999999995 345799999999999999999999999 9999999999999999999999999999
Q ss_pred cccCCCCCcccccccccccccCccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCCCchhcHHHHHHHHhccccccc
Q 010519 337 KLLDSGESHITTRVMGTFGYVAPEYANTGMLNEKSDIYSFGVLLLEAVTGRDPVDYGRPANEVNLVEWLKMMVGTRRAEE 416 (508)
Q Consensus 337 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 416 (508)
+...... ......+||+.|+|||++.+..|+.++|||||||+||||++|+.||.... . .+.+......
T Consensus 490 ~~~~~~~-~~~~~~~GT~~Y~APE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~~~---~---~~~~~~i~~~----- 557 (674)
T 3pfq_A 490 KENIWDG-VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGED---E---DELFQSIMEH----- 557 (674)
T ss_dssp EECCCTT-CCBCCCCSCSSSCCHHHHTCCCBSTHHHHHHHHHHHHHHHHSSCSSCCSS---H---HHHHHHHHSS-----
T ss_pred eccccCC-cccccccCCCcccCHhhhcCCCCCccceEechHHHHHHHHcCCCCCCCCC---H---HHHHHHHHhC-----
Confidence 8643322 23455789999999999999999999999999999999999999996432 1 1222222211
Q ss_pred ccCCCCCCChhHHHHHHHHHHHHHhcCCCCCCCCCH-----HHHHHHhh
Q 010519 417 VVDPNLEVKPATRALKRSLLVALRCVDPDSEKRPKM-----SQVVRMLE 460 (508)
Q Consensus 417 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~-----~evl~~L~ 460 (508)
.+.. +......+.+|+.+||+.||.+||++ +||++|-.
T Consensus 558 ----~~~~--p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~ei~~h~f 600 (674)
T 3pfq_A 558 ----NVAY--PKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEHAF 600 (674)
T ss_dssp ----CCCC--CTTSCHHHHHHHHHHSCSSSTTCTTCSTTHHHHHHSSGG
T ss_pred ----CCCC--CccCCHHHHHHHHHHccCCHHHCCCCCCCcHHHHhcCcc
Confidence 1111 11234566779999999999999997 78887643
|
| >4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.8e-42 Score=370.50 Aligned_cols=247 Identities=29% Similarity=0.417 Sum_probs=196.0
Q ss_pred eeEeeeCceEEEEEEEc---CCCEEEEEEEcccc--hhhHHHHHHHHHHHhcCCCCCceeEEEEEEeCceeeEEEeecCC
Q 010519 192 NVLGEGGYGVVYKGRLI---NGSEVAVKKLLNNL--GQAEKEFRVEVEAIGHVRHKNLVRLLGYCIEGVHRMLVYEYVNN 266 (508)
Q Consensus 192 ~~lg~G~~g~Vy~~~~~---~~~~vavK~~~~~~--~~~~~~~~~ei~~l~~l~h~niv~~~~~~~~~~~~~lv~E~~~~ 266 (508)
+.||+|+||+||+|.+. .+..||||++.... ......+.+|+.+|++++|||||++++++.. ...++||||+++
T Consensus 375 ~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~-~~~~lv~E~~~~ 453 (635)
T 4fl3_A 375 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAEL 453 (635)
T ss_dssp EEEEECSSEEEEEEEEECSSCEEEEEEEEECGGGGCGGGHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEEEEECCTT
T ss_pred CEeccCCCEEEEEEEEcCCCcceEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec-CCEEEEEEccCC
Confidence 47999999999999763 45789999986543 2335789999999999999999999999864 557899999999
Q ss_pred CCHHHHHhhhhccCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCEEEcCCCcEEEEecCCccccCCCCC--
Q 010519 267 GNLEQWLHGAMRNQGNLTWEARMKVIIGTAKALAYLHEAIEPKVVHRDIKSSNILIDDEFNAKVSDFGLAKLLDSGES-- 344 (508)
Q Consensus 267 gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~-- 344 (508)
|+|.+++. ....+++..++.++.||+.||.|||++ +|+||||||+||||+.++.+||+|||+++.......
T Consensus 454 g~L~~~l~----~~~~l~~~~~~~i~~qi~~~L~yLH~~---~iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~~~~~ 526 (635)
T 4fl3_A 454 GPLNKYLQ----QNRHVKDKNIIELVHQVSMGMKYLEES---NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYY 526 (635)
T ss_dssp EEHHHHHH----HCTTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECCTTHHHHTTC-----
T ss_pred CCHHHHHh----hCCCCCHHHHHHHHHHHHHHHHHHHHC---CEeCCCCChHhEEEeCCCCEEEEEcCCccccccCcccc
Confidence 99999994 456789999999999999999999999 999999999999999999999999999987654332
Q ss_pred cccccccccccccCccccCCCCCCChhhHHHHHHHHHHHHh-CCCCCCCCCCCchhcHHHHHHHHhcccccccccCCCCC
Q 010519 345 HITTRVMGTFGYVAPEYANTGMLNEKSDIYSFGVLLLEAVT-GRDPVDYGRPANEVNLVEWLKMMVGTRRAEEVVDPNLE 423 (508)
Q Consensus 345 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 423 (508)
.......+|+.|+|||++.+..++.++|||||||+||||++ |+.||..... . +..........
T Consensus 527 ~~~~~~~~t~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~---~---~~~~~i~~~~~---------- 590 (635)
T 4fl3_A 527 KAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKG---S---EVTAMLEKGER---------- 590 (635)
T ss_dssp --------CGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCH---H---HHHHHHHTTCC----------
T ss_pred ccccCCCCceeeeChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCH---H---HHHHHHHcCCC----------
Confidence 12333456789999999999999999999999999999998 9999964322 1 11222211111
Q ss_pred CChhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhhcC
Q 010519 424 VKPATRALKRSLLVALRCVDPDSEKRPKMSQVVRMLEAD 462 (508)
Q Consensus 424 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~ 462 (508)
...+......+.+|+.+||+.||.+|||+.+|++.|+..
T Consensus 591 ~~~p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~ 629 (635)
T 4fl3_A 591 MGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNY 629 (635)
T ss_dssp CCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHH
T ss_pred CCCCCCCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHH
Confidence 111122345677799999999999999999999999853
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-41 Score=341.22 Aligned_cols=268 Identities=21% Similarity=0.265 Sum_probs=204.1
Q ss_pred CCcccceeEeeeCceEEEEEEEc-CCCEEEEEEEcccch--hhHHHHHHHHHHHhcCCCCCceeEEEEEEeC--------
Q 010519 186 NRFSAENVLGEGGYGVVYKGRLI-NGSEVAVKKLLNNLG--QAEKEFRVEVEAIGHVRHKNLVRLLGYCIEG-------- 254 (508)
Q Consensus 186 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~ei~~l~~l~h~niv~~~~~~~~~-------- 254 (508)
++|.+.+.||+|+||+||+|++. +|+.||+|++..... .....+.+|+.+++.++||||+++++++...
T Consensus 17 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 96 (351)
T 3mi9_A 17 SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRCK 96 (351)
T ss_dssp GGEEEEEECSSCSTTSEEEEEETTTCCEEEEEECCCSSCSSSSCHHHHHHHHHHHHCCCTTBCCEEEEEEEC--------
T ss_pred cceeEEEEEecCCCcEEEEEEECCCCCEEEEEEEecccccccchHHHHHHHHHHHhccCCCcccHhheeeccccccccCC
Confidence 58999999999999999999984 789999998854432 2235677899999999999999999999873
Q ss_pred ceeeEEEeecCCCCHHHHHhhhhccCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCEEEcCCCcEEEEecC
Q 010519 255 VHRMLVYEYVNNGNLEQWLHGAMRNQGNLTWEARMKVIIGTAKALAYLHEAIEPKVVHRDIKSSNILIDDEFNAKVSDFG 334 (508)
Q Consensus 255 ~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~Dfg 334 (508)
...++||||+.+ +|.+++. .....+++..++.++.||+.||.|||++ +|+||||||+|||++.++.+||+|||
T Consensus 97 ~~~~lv~e~~~~-~l~~~l~---~~~~~~~~~~~~~i~~qi~~~l~~LH~~---~ivH~Dlkp~NIl~~~~~~~kl~Dfg 169 (351)
T 3mi9_A 97 GSIYLVFDFCEH-DLAGLLS---NVLVKFTLSEIKRVMQMLLNGLYYIHRN---KILHRDMKAANVLITRDGVLKLADFG 169 (351)
T ss_dssp CEEEEEEECCSE-EHHHHHH---CTTSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCT
T ss_pred ceEEEEEeccCC-CHHHHHh---hccCCCCHHHHHHHHHHHHHHHHHHHHC---CeeCCCCCHHHEEEcCCCCEEEccch
Confidence 467899999975 8888775 3445699999999999999999999999 99999999999999999999999999
Q ss_pred CccccCCCC---CcccccccccccccCccccCC-CCCCChhhHHHHHHHHHHHHhCCCCCCCCCCCchhcHHHHHHHHhc
Q 010519 335 LAKLLDSGE---SHITTRVMGTFGYVAPEYANT-GMLNEKSDIYSFGVLLLEAVTGRDPVDYGRPANEVNLVEWLKMMVG 410 (508)
Q Consensus 335 la~~~~~~~---~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwS~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~ 410 (508)
++....... ........||+.|+|||++.+ ..++.++|||||||++|+|++|..||..... ......+....+
T Consensus 170 ~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~---~~~~~~i~~~~~ 246 (351)
T 3mi9_A 170 LARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTE---QHQLALISQLCG 246 (351)
T ss_dssp TCEECCCCSSSSCCCCCSSCSCGGGCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSH---HHHHHHHHHHHC
T ss_pred hcccccccccccccccCCcccccCccCchhhcCCCCCCcHhHHHHHHHHHHHHHhCCCCCCCCCh---HHHHHHHHHHhC
Confidence 998664222 122344578999999999876 5689999999999999999999999974322 222222222222
Q ss_pred ccccccc------------cCCCCCCChhHHH------HHHHHHHHHHhcCCCCCCCCCHHHHHHHhhcCC
Q 010519 411 TRRAEEV------------VDPNLEVKPATRA------LKRSLLVALRCVDPDSEKRPKMSQVVRMLEADD 463 (508)
Q Consensus 411 ~~~~~~~------------~~~~~~~~~~~~~------~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~ 463 (508)
....... ............. ...+.+|+.+||+.||.+|||+.|++++-+-..
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~ 317 (351)
T 3mi9_A 247 SITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHDFFWS 317 (351)
T ss_dssp CCCTTTSTTGGGCGGGTSSCCCSSCCCCHHHHHHHHHCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGS
T ss_pred CCChhhccccccchhhcccccccccccCHHHHhhhccCChHHHHHHHHHhcCChhhCCCHHHHhCCCCcCC
Confidence 1110000 0000000011111 234678999999999999999999999765543
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-42 Score=340.40 Aligned_cols=269 Identities=22% Similarity=0.371 Sum_probs=188.2
Q ss_pred HHHhhCCcccceeEeeeCceEEEEEEEc-CCCEEEEEEEcccc-hhhHHHHHHHHHHHhcCCCCCceeEEEEEEeCceee
Q 010519 181 LEIATNRFSAENVLGEGGYGVVYKGRLI-NGSEVAVKKLLNNL-GQAEKEFRVEVEAIGHVRHKNLVRLLGYCIEGVHRM 258 (508)
Q Consensus 181 ~~~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~ei~~l~~l~h~niv~~~~~~~~~~~~~ 258 (508)
+.+..++|.+.+.||+|+||.||+|.+. ++..||||.+.... ......+.+|+.+++.++||||+++++++......+
T Consensus 10 ~~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 89 (303)
T 2vwi_A 10 WSINRDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTSFVVKDELW 89 (303)
T ss_dssp ---CCCCCEEEEECC---CCCEEEEEC----CEEEEECCC----------------CCCCCCCTTBCCEEEEEESSSCEE
T ss_pred cccchhhhhhhheeccccceEEEEEEECCCCcEEEEEEEEhhhcchhHHHHHHHHHHHhhcCCCCEeeEEEEEeecCCcE
Confidence 4566789999999999999999999864 68899999875432 233466888999999999999999999999999999
Q ss_pred EEEeecCCCCHHHHHhhhhc----cCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCEEEcCCCcEEEEecC
Q 010519 259 LVYEYVNNGNLEQWLHGAMR----NQGNLTWEARMKVIIGTAKALAYLHEAIEPKVVHRDIKSSNILIDDEFNAKVSDFG 334 (508)
Q Consensus 259 lv~E~~~~gsL~~~l~~~~~----~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~Dfg 334 (508)
+||||+++++|.+++..... ....+++..++.++.||+.||.|||+. +++||||||+|||++.++.+||+|||
T Consensus 90 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~dfg 166 (303)
T 2vwi_A 90 LVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKN---GQIHRDVKAGNILLGEDGSVQIADFG 166 (303)
T ss_dssp EEEECCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEECTTCCEEECCCH
T ss_pred EEehhccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhC---CCCCCCCChhhEEEcCCCCEEEEecc
Confidence 99999999999999864322 245689999999999999999999999 99999999999999999999999999
Q ss_pred CccccCCCCC----cccccccccccccCccccCC-CCCCChhhHHHHHHHHHHHHhCCCCCCCCCCCchhcHHHHHHHHh
Q 010519 335 LAKLLDSGES----HITTRVMGTFGYVAPEYANT-GMLNEKSDIYSFGVLLLEAVTGRDPVDYGRPANEVNLVEWLKMMV 409 (508)
Q Consensus 335 la~~~~~~~~----~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwS~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~ 409 (508)
++........ .......||+.|+|||++.+ ..++.++|||||||++|+|++|+.||........ . . ...
T Consensus 167 ~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~---~--~-~~~ 240 (303)
T 2vwi_A 167 VSAFLATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKV---L--M-LTL 240 (303)
T ss_dssp HHHHCC---------------CCCTTCCHHHHHHHHCCCTHHHHHHHHHHHHHHHHSSCTTTTSCGGGH---H--H-HHH
T ss_pred chheeccCCCccchhhhcccCCCccccCHHHhccccCCCchhhHHHHHHHHHHHHhCCCCCccCchhhH---H--H-HHh
Confidence 9986543221 11234578999999999865 5689999999999999999999999975432211 1 1 111
Q ss_pred cccccccccCCCCCCChhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHh
Q 010519 410 GTRRAEEVVDPNLEVKPATRALKRSLLVALRCVDPDSEKRPKMSQVVRML 459 (508)
Q Consensus 410 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L 459 (508)
.... ...................+.+++.+||+.||.+|||+.+++++-
T Consensus 241 ~~~~-~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~ 289 (303)
T 2vwi_A 241 QNDP-PSLETGVQDKEMLKKYGKSFRKMISLCLQKDPEKRPTAAELLRHK 289 (303)
T ss_dssp TSSC-CCTTC-----CCCCCCCHHHHHHHHHHCCSSGGGSCCHHHHHTST
T ss_pred ccCC-CccccccccchhhhhhhHHHHHHHHHHccCChhhCcCHHHHhhCh
Confidence 1110 000000000000011234566799999999999999999999753
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-41 Score=331.50 Aligned_cols=256 Identities=24% Similarity=0.334 Sum_probs=205.6
Q ss_pred hCCcccceeEeeeCceEEEEEEEc-CCCEEEEEEEcccc---------hhhHHHHHHHHHHHhcCC-CCCceeEEEEEEe
Q 010519 185 TNRFSAENVLGEGGYGVVYKGRLI-NGSEVAVKKLLNNL---------GQAEKEFRVEVEAIGHVR-HKNLVRLLGYCIE 253 (508)
Q Consensus 185 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---------~~~~~~~~~ei~~l~~l~-h~niv~~~~~~~~ 253 (508)
.++|.+.+.||+|+||.||+|.+. +|+.||||.+.... ......+.+|+.+++++. ||||+++++++..
T Consensus 16 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~ 95 (298)
T 1phk_A 16 YENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYET 95 (298)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEC
T ss_pred hhccceeeeecCCCceEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeeeeecc
Confidence 468999999999999999999985 67899999985432 122356788999999995 9999999999999
Q ss_pred CceeeEEEeecCCCCHHHHHhhhhccCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCEEEcCCCcEEEEec
Q 010519 254 GVHRMLVYEYVNNGNLEQWLHGAMRNQGNLTWEARMKVIIGTAKALAYLHEAIEPKVVHRDIKSSNILIDDEFNAKVSDF 333 (508)
Q Consensus 254 ~~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~Df 333 (508)
....++||||+++++|.+++. ....+++..++.++.||+.||.|||+. +++|+||||+||+++.++.+||+||
T Consensus 96 ~~~~~lv~e~~~~~~L~~~l~----~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~df 168 (298)
T 1phk_A 96 NTFFFLVFDLMKKGELFDYLT----EKVTLSEKETRKIMRALLEVICALHKL---NIVHRDLKPENILLDDDMNIKLTDF 168 (298)
T ss_dssp SSEEEEEEECCTTCBHHHHHH----HHSSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCC
T ss_pred CCeEEEEEeccCCCcHHHHHh----ccCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCcceEEEcCCCcEEEecc
Confidence 999999999999999999995 345789999999999999999999999 9999999999999999999999999
Q ss_pred CCccccCCCCCcccccccccccccCccccC------CCCCCChhhHHHHHHHHHHHHhCCCCCCCCCCCchhcHHHHHHH
Q 010519 334 GLAKLLDSGESHITTRVMGTFGYVAPEYAN------TGMLNEKSDIYSFGVLLLEAVTGRDPVDYGRPANEVNLVEWLKM 407 (508)
Q Consensus 334 gla~~~~~~~~~~~~~~~gt~~y~aPE~~~------~~~~~~~~DvwS~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~ 407 (508)
|++....... ......|++.|+|||++. ...++.++||||||+++|+|++|..||..... . .....
T Consensus 169 g~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~---~---~~~~~ 240 (298)
T 1phk_A 169 GFSCQLDPGE--KLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQ---M---LMLRM 240 (298)
T ss_dssp TTCEECCTTC--CBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH---H---HHHHH
T ss_pred cchhhcCCCc--ccccccCCccccCHHHhccccccccccCCcccccHhHHHHHHHHHHCCCCCcCccH---H---HHHHH
Confidence 9998765433 234457899999999884 45688999999999999999999999964321 1 11111
Q ss_pred HhcccccccccCCCCCCChhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhhcC
Q 010519 408 MVGTRRAEEVVDPNLEVKPATRALKRSLLVALRCVDPDSEKRPKMSQVVRMLEAD 462 (508)
Q Consensus 408 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~ 462 (508)
..... ..............+.+++.+||+.||.+|||+.|++++-.-.
T Consensus 241 ~~~~~-------~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~ 288 (298)
T 1phk_A 241 IMSGN-------YQFGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAHPFFQ 288 (298)
T ss_dssp HHHTC-------CCCCTTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTTSGGGC
T ss_pred HhcCC-------cccCcccccccCHHHHHHHHHHccCCcccCCCHHHHHhChHhh
Confidence 11110 0111111122345677799999999999999999999865433
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-41 Score=337.29 Aligned_cols=259 Identities=23% Similarity=0.316 Sum_probs=201.0
Q ss_pred CCcccceeEeeeCceEEEEEEEc-CCCEEEEEEEcccchhhHHHHHHHHHHHhcCC-CCCceeEEEEEEe--CceeeEEE
Q 010519 186 NRFSAENVLGEGGYGVVYKGRLI-NGSEVAVKKLLNNLGQAEKEFRVEVEAIGHVR-HKNLVRLLGYCIE--GVHRMLVY 261 (508)
Q Consensus 186 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~ei~~l~~l~-h~niv~~~~~~~~--~~~~~lv~ 261 (508)
++|++.+.||+|+||+||+|++. +++.||+|++.... ...+.+|+.+++.++ ||||+++++++.+ ....++||
T Consensus 36 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~lv~ 112 (330)
T 3nsz_A 36 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK---KKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVF 112 (330)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSCC---HHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCCEEEEE
T ss_pred CceEEEEEecccCCeEEEEEEECCCCcEEEEEEecccc---hHHHHHHHHHHHHcCCCCCEEEeeeeeccCCCCceEEEE
Confidence 58999999999999999999874 78899999986432 456888999999997 9999999999988 56789999
Q ss_pred eecCCCCHHHHHhhhhccCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCEEEcCCC-cEEEEecCCccccC
Q 010519 262 EYVNNGNLEQWLHGAMRNQGNLTWEARMKVIIGTAKALAYLHEAIEPKVVHRDIKSSNILIDDEF-NAKVSDFGLAKLLD 340 (508)
Q Consensus 262 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiH~Dlk~~NIll~~~~-~~kl~Dfgla~~~~ 340 (508)
||+.+++|.+++. .+++..++.++.||+.||.|||+. +|+||||||+|||++.++ .+||+|||++....
T Consensus 113 e~~~~~~l~~~~~-------~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~ 182 (330)
T 3nsz_A 113 EHVNNTDFKQLYQ-------TLTDYDIRFYMYEILKALDYCHSM---GIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYH 182 (330)
T ss_dssp ECCCCCCHHHHGG-------GCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTTTEEEECCCTTCEECC
T ss_pred eccCchhHHHHHH-------hCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEEcCCCCEEEEEeCCCceEcC
Confidence 9999999999873 378899999999999999999999 999999999999999776 89999999998765
Q ss_pred CCCCcccccccccccccCccccCC-CCCCChhhHHHHHHHHHHHHhCCCCCCCCCCCchhcHHHHHHHHhcccccc----
Q 010519 341 SGESHITTRVMGTFGYVAPEYANT-GMLNEKSDIYSFGVLLLEAVTGRDPVDYGRPANEVNLVEWLKMMVGTRRAE---- 415 (508)
Q Consensus 341 ~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwS~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~---- 415 (508)
.... .....|++.|+|||++.+ ..++.++|||||||+||+|++|+.||....... ..+.... ...+.....
T Consensus 183 ~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~-~~l~~~~-~~~~~~~~~~~~~ 258 (330)
T 3nsz_A 183 PGQE--YNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNY-DQLVRIA-KVLGTEDLYDYID 258 (330)
T ss_dssp TTCC--CCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHH-HHHHHHH-HHHCHHHHHHHHH
T ss_pred CCCc--cccccccccccChhhhcCCCcCCchhhHHHHHHHHHHHHhCCCCcccCCchH-HHHHHHH-HhcCCchhhhHHH
Confidence 4332 334578999999999977 679999999999999999999999996443221 1111111 111000000
Q ss_pred -------------------cccCCCCCCChhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhhc
Q 010519 416 -------------------EVVDPNLEVKPATRALKRSLLVALRCVDPDSEKRPKMSQVVRMLEA 461 (508)
Q Consensus 416 -------------------~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~ 461 (508)
..................+.+|+.+||+.||.+|||++|+++|-+-
T Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~e~l~hp~f 323 (330)
T 3nsz_A 259 KYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYF 323 (330)
T ss_dssp HTTCCCCTHHHHHHCCCCCCCGGGGCCTTTGGGCCHHHHHHHHTTSCSSGGGSCCHHHHHTSGGG
T ss_pred HhccccccchhhhhhhccccchhhhccccccccCCHHHHHHHHHHhcCCcccCCCHHHHhcCccH
Confidence 0000000111111234567789999999999999999999986543
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-41 Score=347.03 Aligned_cols=267 Identities=22% Similarity=0.269 Sum_probs=204.6
Q ss_pred HhhCCcccceeEeeeCceEEEEEEEc-CCCEEEEEEEcccchhhHHHHHHHHHHHhcCC--------CCCceeEEEEEE-
Q 010519 183 IATNRFSAENVLGEGGYGVVYKGRLI-NGSEVAVKKLLNNLGQAEKEFRVEVEAIGHVR--------HKNLVRLLGYCI- 252 (508)
Q Consensus 183 ~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~ei~~l~~l~--------h~niv~~~~~~~- 252 (508)
+..++|.+.+.||+|+||+||+|++. +++.||||++... ......+.+|+.+++.++ |+||+++++++.
T Consensus 34 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~~~~~~~~ 112 (397)
T 1wak_A 34 LFNGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSA-EHYTETALDEIRLLKSVRNSDPNDPNREMVVQLLDDFKI 112 (397)
T ss_dssp EETTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHSCTTCGGGGGBCCEEEEEEE
T ss_pred hcCCeEEEEEEeeecCCeeEEEEEecCCCeEEEEEEEecC-CcchHHHHHHHHHHHHHhhcCCCCCCcceeeeeecceee
Confidence 34578999999999999999999875 5788999998644 334466788999998885 788999999988
Q ss_pred ---eCceeeEEEeecCCCCHHHHHhhhhccCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCEEEcCCC---
Q 010519 253 ---EGVHRMLVYEYVNNGNLEQWLHGAMRNQGNLTWEARMKVIIGTAKALAYLHEAIEPKVVHRDIKSSNILIDDEF--- 326 (508)
Q Consensus 253 ---~~~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiH~Dlk~~NIll~~~~--- 326 (508)
+....++||||+ +++|.+++.. .....+++..++.++.||+.||.|||++. +|+||||||+|||++.++
T Consensus 113 ~~~~~~~~~lv~e~~-~~~l~~~~~~--~~~~~~~~~~~~~i~~qi~~aL~~lH~~~--givHrDikp~NIll~~~~~~~ 187 (397)
T 1wak_A 113 SGVNGTHICMVFEVL-GHHLLKWIIK--SNYQGLPLPCVKKIIQQVLQGLDYLHTKC--RIIHTDIKPENILLSVNEQYI 187 (397)
T ss_dssp EETTEEEEEEEECCC-CCBHHHHHHH--TTTSCCCHHHHHHHHHHHHHHHHHHHHTT--CEECCCCSGGGEEECCCHHHH
T ss_pred cCCCCceEEEEEecc-CccHHHHHHh--cccCCCCHHHHHHHHHHHHHHHHHHHHhC--CEecCCCCHHHeeEeccchhh
Confidence 456789999999 6678777753 23467999999999999999999999843 799999999999999775
Q ss_pred ----------------------------------------------cEEEEecCCccccCCCCCcccccccccccccCcc
Q 010519 327 ----------------------------------------------NAKVSDFGLAKLLDSGESHITTRVMGTFGYVAPE 360 (508)
Q Consensus 327 ----------------------------------------------~~kl~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE 360 (508)
.+||+|||++...... .....||+.|+|||
T Consensus 188 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~~----~~~~~gt~~y~aPE 263 (397)
T 1wak_A 188 RRLAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKH----FTEDIQTRQYRSLE 263 (397)
T ss_dssp HHHHHHHC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTBC----SCSCCSCGGGCCHH
T ss_pred hhhhhhhHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEecccccccccccc----CccCCCCCcccCCh
Confidence 7999999999876532 33457899999999
Q ss_pred ccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCCCchhc---HHHHHHHHhccccc---------ccccCCC-------
Q 010519 361 YANTGMLNEKSDIYSFGVLLLEAVTGRDPVDYGRPANEVN---LVEWLKMMVGTRRA---------EEVVDPN------- 421 (508)
Q Consensus 361 ~~~~~~~~~~~DvwS~Gvvl~elltG~~Pf~~~~~~~~~~---~~~~~~~~~~~~~~---------~~~~~~~------- 421 (508)
++.+..++.++|||||||+||||++|+.||.......... ....+....+.... .......
T Consensus 264 ~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~ 343 (397)
T 1wak_A 264 VLIGSGYNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGKYSKEFFTKKGDLKHIT 343 (397)
T ss_dssp HHHTSCCCTHHHHHHHHHHHHHHHHSSCSCCCCCCSSSCHHHHHHHHHHHHHCSCCHHHHHHCTTGGGTBCTTSSBSSCC
T ss_pred hhcCCCCCcHHHHHHHHHHHHHHhhCCCCCCCCcccccCchHHHHHHHHHhcCCCChHHhhcccccccccCCcccccccc
Confidence 9999999999999999999999999999997544332211 11112222111100 0000000
Q ss_pred -C-----------CCChhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHh
Q 010519 422 -L-----------EVKPATRALKRSLLVALRCVDPDSEKRPKMSQVVRML 459 (508)
Q Consensus 422 -~-----------~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L 459 (508)
. ...........+.+|+.+||+.||.+|||+.|+++|-
T Consensus 344 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp 393 (397)
T 1wak_A 344 KLKPWGLFEVLVEKYEWSQEEAAGFTDFLLPMLELIPEKRATAAECLRHP 393 (397)
T ss_dssp CCCCCCHHHHHHHTSCCCHHHHHHHHHHHGGGGCSSGGGSCCHHHHHTSG
T ss_pred ccCCcchhHhhhhhcccchhhHHHHHHHHHHHhccChhhcCCHHHHhhCc
Confidence 0 0112344566788899999999999999999999864
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-41 Score=348.60 Aligned_cols=263 Identities=25% Similarity=0.332 Sum_probs=199.6
Q ss_pred CCcccceeEeeeCceEEEEEEEcCCCEEEEEEEcccchhhHHHHHHHHHHHhcCCCCCceeEEEEEEeCc------eeeE
Q 010519 186 NRFSAENVLGEGGYGVVYKGRLINGSEVAVKKLLNNLGQAEKEFRVEVEAIGHVRHKNLVRLLGYCIEGV------HRML 259 (508)
Q Consensus 186 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~ei~~l~~l~h~niv~~~~~~~~~~------~~~l 259 (508)
.+|.+.+.||+|+||+||+|++..+..+|+|++...... ..+|+.+++.++||||+++++++.... ..++
T Consensus 40 ~~Y~~~~~lG~G~~g~V~~a~~~~~~~~aikk~~~~~~~----~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~~l 115 (394)
T 4e7w_A 40 IAYTNCKVIGNGSFGVVFQAKLVESDEVAIKKVLQDKRF----KNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFLNL 115 (394)
T ss_dssp EEEEEEEEEEEETTEEEEEEEETTTEEEEEEEEECCTTS----CCHHHHHHHTCCCTTBCCEEEEEEEESSSSSCEEEEE
T ss_pred ceEEEeEEEeeCCCeEEEEEEECCCCeEEEEEEecCcch----HHHHHHHHHhCCCCCcceEEEEEEecCCCCCceEEEE
Confidence 479999999999999999999987788999998654322 235999999999999999999996543 3789
Q ss_pred EEeecCCCCHHHHHhhhhccCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCEEEc-CCCcEEEEecCCccc
Q 010519 260 VYEYVNNGNLEQWLHGAMRNQGNLTWEARMKVIIGTAKALAYLHEAIEPKVVHRDIKSSNILID-DEFNAKVSDFGLAKL 338 (508)
Q Consensus 260 v~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiH~Dlk~~NIll~-~~~~~kl~Dfgla~~ 338 (508)
||||+++ ++...+.........+++..++.++.||+.||.|||++ +|+||||||+|||++ .++.+||+|||+++.
T Consensus 116 v~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~Nill~~~~~~~kL~DFG~a~~ 191 (394)
T 4e7w_A 116 VLEYVPE-TVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSI---GICHRDIKPQNLLLDPPSGVLKLIDFGSAKI 191 (394)
T ss_dssp EEECCSE-EHHHHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEETTTTEEEECCCTTCEE
T ss_pred EeeccCc-cHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHC---CccCCCCCHHHEEEcCCCCcEEEeeCCCccc
Confidence 9999976 55555544334567899999999999999999999999 999999999999999 899999999999987
Q ss_pred cCCCCCcccccccccccccCccccCCC-CCCChhhHHHHHHHHHHHHhCCCCCCCCCCCchhcHHHHHHHHhccc-----
Q 010519 339 LDSGESHITTRVMGTFGYVAPEYANTG-MLNEKSDIYSFGVLLLEAVTGRDPVDYGRPANEVNLVEWLKMMVGTR----- 412 (508)
Q Consensus 339 ~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwS~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~----- 412 (508)
...... .....||+.|+|||++.+. .|+.++|||||||+||||++|+.||..... ...+...+.. .+..
T Consensus 192 ~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~--~~~l~~i~~~-~g~p~~~~~ 266 (394)
T 4e7w_A 192 LIAGEP--NVSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGESG--IDQLVEIIKV-LGTPSREQI 266 (394)
T ss_dssp CCTTCC--CCSSCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSH--HHHHHHHHHH-HCCCCHHHH
T ss_pred ccCCCC--CcccccCcCccCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCH--HHHHHHHHHH-hCCCCHHHH
Confidence 654432 3345789999999998764 599999999999999999999999964321 1111121111 1110
Q ss_pred -----ccccccCCCCCCChh-----HHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhhc
Q 010519 413 -----RAEEVVDPNLEVKPA-----TRALKRSLLVALRCVDPDSEKRPKMSQVVRMLEA 461 (508)
Q Consensus 413 -----~~~~~~~~~~~~~~~-----~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~ 461 (508)
......-+.....+. ......+.+|+.+||+.||.+|||+.|+++|-.-
T Consensus 267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f 325 (394)
T 4e7w_A 267 KTMNPNYMEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEALCHPFF 325 (394)
T ss_dssp HHHCGGGSSSCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHHTSGGG
T ss_pred HhhChhhhhhccccccCCcHHHhccccCCHHHHHHHHHHhCCChhhCCCHHHHhcChhh
Confidence 000000111111111 1133467789999999999999999999987543
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-41 Score=347.15 Aligned_cols=263 Identities=27% Similarity=0.350 Sum_probs=200.2
Q ss_pred CCcccceeEeeeCceEEEEEEEc-CCCEEEEEEEcccchhhHHHHHHHHHHHhcCCCCCceeEEEEEEeC------ceee
Q 010519 186 NRFSAENVLGEGGYGVVYKGRLI-NGSEVAVKKLLNNLGQAEKEFRVEVEAIGHVRHKNLVRLLGYCIEG------VHRM 258 (508)
Q Consensus 186 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~ei~~l~~l~h~niv~~~~~~~~~------~~~~ 258 (508)
.+|.+.+.||+|+||+||+|++. +|+.||||++..... .+.+|+++|+.++|||||+++++|... ...+
T Consensus 54 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~----~~~~E~~il~~l~hpniv~l~~~~~~~~~~~~~~~~~ 129 (420)
T 1j1b_A 54 VSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR----FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLN 129 (420)
T ss_dssp EEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECCTT----SCCHHHHHHHTCCCTTBCCEEEEEEEEETTTTEEEEE
T ss_pred ceEEeeeEEeeCCCEEEEEEEECCCCcEEEEEEecccch----hHHHHHHHHHHcCCCCccceeeEEeccCCCCcceeEE
Confidence 36999999999999999999985 589999999865432 233599999999999999999998642 2367
Q ss_pred EEEeecCCCCHHHHHhhhhccCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCEEEcCC-CcEEEEecCCcc
Q 010519 259 LVYEYVNNGNLEQWLHGAMRNQGNLTWEARMKVIIGTAKALAYLHEAIEPKVVHRDIKSSNILIDDE-FNAKVSDFGLAK 337 (508)
Q Consensus 259 lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiH~Dlk~~NIll~~~-~~~kl~Dfgla~ 337 (508)
+||||+++ +|.+++.........+++..++.++.||+.||.|||++ +|+||||||+||||+.+ +.+||+|||+++
T Consensus 130 lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NILl~~~~~~~kl~DFG~a~ 205 (420)
T 1j1b_A 130 LVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAK 205 (420)
T ss_dssp EEEECCCE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTT---TEECSCCSGGGEEEETTTTEEEECCCTTCE
T ss_pred eehhcccc-cHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCChhhEEEeCCCCeEEeccchhhh
Confidence 99999975 78877765545667899999999999999999999998 99999999999999955 568999999998
Q ss_pred ccCCCCCcccccccccccccCccccCCC-CCCChhhHHHHHHHHHHHHhCCCCCCCCCCCchhcHHHHHHHHhcc-----
Q 010519 338 LLDSGESHITTRVMGTFGYVAPEYANTG-MLNEKSDIYSFGVLLLEAVTGRDPVDYGRPANEVNLVEWLKMMVGT----- 411 (508)
Q Consensus 338 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwS~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~----- 411 (508)
....... ....+||+.|+|||++.+. .|+.++|||||||+||||++|+.||..... ...+.+.+.. .+.
T Consensus 206 ~~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~--~~~l~~i~~~-lg~p~~~~ 280 (420)
T 1j1b_A 206 QLVRGEP--NVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSG--VDQLVEIIKV-LGTPTREQ 280 (420)
T ss_dssp ECCTTCC--CCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSH--HHHHHHHHHH-HCSCCHHH
T ss_pred hcccCCC--ceeeeeCCCcCCHHHHcCCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCH--HHHHHHHHHH-hCCCCHHH
Confidence 7654332 2345789999999999764 799999999999999999999999964321 1122222221 111
Q ss_pred -----cccccccCCCCCCChh-----HHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhhc
Q 010519 412 -----RRAEEVVDPNLEVKPA-----TRALKRSLLVALRCVDPDSEKRPKMSQVVRMLEA 461 (508)
Q Consensus 412 -----~~~~~~~~~~~~~~~~-----~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~ 461 (508)
........+.+...+. ......+.+|+.+||..||.+|||+.|+++|-.-
T Consensus 281 ~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~R~t~~e~l~hp~f 340 (420)
T 1j1b_A 281 IREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFF 340 (420)
T ss_dssp HHHHCSCCCCCCCCCCCCCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGG
T ss_pred HHhhChhhhhhccCccCCCCHHHhcCCCCCHHHHHHHHHhccCChhHCCCHHHHhCCHhh
Confidence 0111111111111111 1123567789999999999999999999987543
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-41 Score=339.89 Aligned_cols=258 Identities=26% Similarity=0.415 Sum_probs=198.0
Q ss_pred HHhhCCcccceeEeeeCceEEEEEEEc-CCCEEEEEEEcccchhhHHHHHHHHHHHhcC-CCCCceeEEEEEEe------
Q 010519 182 EIATNRFSAENVLGEGGYGVVYKGRLI-NGSEVAVKKLLNNLGQAEKEFRVEVEAIGHV-RHKNLVRLLGYCIE------ 253 (508)
Q Consensus 182 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~ei~~l~~l-~h~niv~~~~~~~~------ 253 (508)
....++|.+.+.||+|+||.||+|++. +++.||+|++..... ....+.+|+.+++++ +||||+++++++..
T Consensus 20 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~-~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~ 98 (326)
T 2x7f_A 20 RDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGD-EEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGM 98 (326)
T ss_dssp CCCTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSS-TTHHHHHHHHHHHHHCCSTTBCCEEEEEEECC--CC
T ss_pred cCCCCcEEEEEEeccCCCEEEEEEEECCCCCeEEEEEEecCcc-cHHHHHHHHHHHHhccCCCCeeeeeeEEeeccCccc
Confidence 445679999999999999999999884 788999999865432 345788899999998 89999999999987
Q ss_pred CceeeEEEeecCCCCHHHHHhhhhccCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCEEEcCCCcEEEEec
Q 010519 254 GVHRMLVYEYVNNGNLEQWLHGAMRNQGNLTWEARMKVIIGTAKALAYLHEAIEPKVVHRDIKSSNILIDDEFNAKVSDF 333 (508)
Q Consensus 254 ~~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~Df 333 (508)
....++||||+++|+|.+++... ....+++..++.++.||+.||.|||+. +|+|+||||+|||++.++.+||+||
T Consensus 99 ~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~dlkp~NIl~~~~~~~kl~Df 173 (326)
T 2x7f_A 99 DDQLWLVMEFCGAGSVTDLIKNT--KGNTLKEEWIAYICREILRGLSHLHQH---KVIHRDIKGQNVLLTENAEVKLVDF 173 (326)
T ss_dssp CCEEEEEEECCTTEEHHHHHHHS--GGGCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEECTTCCEEECCC
T ss_pred cceEEEEEEcCCCCcHHHHHHhc--ccCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCcHHHEEEcCCCCEEEeeC
Confidence 46789999999999999999642 345789999999999999999999999 9999999999999999999999999
Q ss_pred CCccccCCCCCcccccccccccccCccccC-----CCCCCChhhHHHHHHHHHHHHhCCCCCCCCCCCchhcHHHHHHHH
Q 010519 334 GLAKLLDSGESHITTRVMGTFGYVAPEYAN-----TGMLNEKSDIYSFGVLLLEAVTGRDPVDYGRPANEVNLVEWLKMM 408 (508)
Q Consensus 334 gla~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DvwS~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~ 408 (508)
|++........ ......|++.|+|||++. +..++.++|||||||++|+|++|..||..... ... ....
T Consensus 174 g~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~---~~~---~~~~ 246 (326)
T 2x7f_A 174 GVSAQLDRTVG-RRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHP---MRA---LFLI 246 (326)
T ss_dssp TTTC--------------CCGGGCCHHHHC--------CCTTHHHHHHHHHHHHHHHSSCTTTTSCH---HHH---HHHH
T ss_pred cCceecCcCcc-ccccccCCccccChhhhccccccCcCCCccchHHHHHHHHHHHHhCCCCCCCCcH---HHH---HHHh
Confidence 99986643221 233456899999999987 56789999999999999999999999964321 111 1111
Q ss_pred hcccccccccCCCCCCChhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhhc
Q 010519 409 VGTRRAEEVVDPNLEVKPATRALKRSLLVALRCVDPDSEKRPKMSQVVRMLEA 461 (508)
Q Consensus 409 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~ 461 (508)
.... . +..... .....+.+|+.+||+.||.+|||+.+++++-.-
T Consensus 247 ~~~~-~-----~~~~~~---~~~~~l~~li~~~l~~dp~~Rps~~~ll~hp~~ 290 (326)
T 2x7f_A 247 PRNP-A-----PRLKSK---KWSKKFQSFIESCLVKNHSQRPATEQLMKHPFI 290 (326)
T ss_dssp HHSC-C-----CCCSCS---CSCHHHHHHHHHHCCSSGGGSCCHHHHHTSHHH
T ss_pred hcCc-c-----ccCCcc---ccCHHHHHHHHHHhccChhhCCCHHHHhhChHH
Confidence 1111 0 111111 123456679999999999999999999986543
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.4e-42 Score=348.28 Aligned_cols=254 Identities=11% Similarity=0.056 Sum_probs=183.0
Q ss_pred CCcccceeEeeeCceEEEEEEEc-CCCEEEEEEEcccch---hhHHHHHHHH---HHHhcCCCCCceeEE-------EEE
Q 010519 186 NRFSAENVLGEGGYGVVYKGRLI-NGSEVAVKKLLNNLG---QAEKEFRVEV---EAIGHVRHKNLVRLL-------GYC 251 (508)
Q Consensus 186 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~ei---~~l~~l~h~niv~~~-------~~~ 251 (508)
.+|.+.+.||+|+||+||+|++. +|+.||||++..... .....+.+|+ ..|+. +||||++++ +++
T Consensus 62 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~-~hp~iv~~~~~~~~p~d~~ 140 (371)
T 3q60_A 62 RKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLG-ESPEEARDRRRLLLPSDAV 140 (371)
T ss_dssp EEEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC-----------CBCCCCEEE
T ss_pred eeeeeeeeccCCCCEEEEEEEECCCCceeEEEEEEecccccccHHHHHHHHHHHHHHhcc-cChhhhhhceeEEeeehhe
Confidence 36899999999999999999975 788999999976442 3345677774 55555 799988755 555
Q ss_pred EeC-----------------ceeeEEEeecCCCCHHHHHhhhhccCCCccHHHH------HHHHHHHHHHHHHHHhcCCC
Q 010519 252 IEG-----------------VHRMLVYEYVNNGNLEQWLHGAMRNQGNLTWEAR------MKVIIGTAKALAYLHEAIEP 308 (508)
Q Consensus 252 ~~~-----------------~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~------~~i~~~i~~al~yLH~~~~~ 308 (508)
... ...++||||++ |+|.+++... ...+.+..+ ..++.||+.||.|||++
T Consensus 141 ~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~---~~~~~~~~~~~~~vk~~i~~qi~~aL~~LH~~--- 213 (371)
T 3q60_A 141 AVQSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTL---DFVYVFRGDEGILALHILTAQLIRLAANLQSK--- 213 (371)
T ss_dssp EETTSCSSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHH---HHSCCCCHHHHHHHHHHHHHHHHHHHHHHHHT---
T ss_pred ecCCCCCeeeccCCcccceeeeEEEEecCCC-CCHHHHHHHh---ccccchhhhhhhhhHHHHHHHHHHHHHHHHHC---
Confidence 433 33789999998 8999999743 223344445 67789999999999999
Q ss_pred CeEeecCCCCCEEEcCCCcEEEEecCCccccCCCCCcccccccccccccCccccCC--CCCCChhhHHHHHHHHHHHHhC
Q 010519 309 KVVHRDIKSSNILIDDEFNAKVSDFGLAKLLDSGESHITTRVMGTFGYVAPEYANT--GMLNEKSDIYSFGVLLLEAVTG 386 (508)
Q Consensus 309 ~iiH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~DvwS~Gvvl~elltG 386 (508)
+|+||||||+|||++.++.+||+|||+++..... .....+|+.|+|||++.+ ..++.++|||||||+||||++|
T Consensus 214 ~ivHrDikp~NIll~~~~~~kL~DFG~a~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlG~il~elltg 289 (371)
T 3q60_A 214 GLVHGHFTPDNLFIMPDGRLMLGDVSALWKVGTR----GPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCL 289 (371)
T ss_dssp TEEETTCSGGGEEECTTSCEEECCGGGEEETTCE----EEGGGSCGGGCCHHHHTCSEEECCHHHHHHHHHHHHHHHHHS
T ss_pred CCccCcCCHHHEEECCCCCEEEEecceeeecCCC----ccCccCCcCCcChhhccCCCCCcCccccHHHHHHHHHHHHhC
Confidence 9999999999999999999999999999876432 223456799999999987 7899999999999999999999
Q ss_pred CCCCCCCCCCchhcHHHHHHHHhcccccccccCCCCCCChhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHh
Q 010519 387 RDPVDYGRPANEVNLVEWLKMMVGTRRAEEVVDPNLEVKPATRALKRSLLVALRCVDPDSEKRPKMSQVVRML 459 (508)
Q Consensus 387 ~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L 459 (508)
+.||....+..... .............+...........+.+|+.+||+.||.+|||+.+++++-
T Consensus 290 ~~Pf~~~~~~~~~~--------~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp 354 (371)
T 3q60_A 290 FLPFGLVTPGIKGS--------WKRPSLRVPGTDSLAFGSCTPLPDFVKTLIGRFLNFDRRRRLLPLEAMETP 354 (371)
T ss_dssp SCSTTBCCTTCTTC--------CCBCCTTSCCCCSCCCTTSSCCCHHHHHHHHHHTCSSTTTCCCHHHHTTSH
T ss_pred CCCCCCcCcccccc--------hhhhhhhhccccccchhhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcCH
Confidence 99997553321110 000000111111222222223345677799999999999999999998753
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-42 Score=336.76 Aligned_cols=258 Identities=26% Similarity=0.413 Sum_probs=197.2
Q ss_pred hhCCcccceeEeeeCceEEEEEEEc--CCC--EEEEEEEcccc---hhhHHHHHHHHHHHhcCCCCCceeEEEEEEeCce
Q 010519 184 ATNRFSAENVLGEGGYGVVYKGRLI--NGS--EVAVKKLLNNL---GQAEKEFRVEVEAIGHVRHKNLVRLLGYCIEGVH 256 (508)
Q Consensus 184 ~~~~~~~~~~lg~G~~g~Vy~~~~~--~~~--~vavK~~~~~~---~~~~~~~~~ei~~l~~l~h~niv~~~~~~~~~~~ 256 (508)
..++|.+.+.||+|+||+||+|++. ++. .||+|.+.... ....+.+.+|+.++++++||||+++++++....
T Consensus 16 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~- 94 (291)
T 1u46_A 16 GEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTPP- 94 (291)
T ss_dssp CGGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS-
T ss_pred chhHeeeeeeecCCCceeEEEEEeccCCCceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEccCC-
Confidence 3468999999999999999999864 233 58999876432 334567889999999999999999999987654
Q ss_pred eeEEEeecCCCCHHHHHhhhhccCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCEEEcCCCcEEEEecCCc
Q 010519 257 RMLVYEYVNNGNLEQWLHGAMRNQGNLTWEARMKVIIGTAKALAYLHEAIEPKVVHRDIKSSNILIDDEFNAKVSDFGLA 336 (508)
Q Consensus 257 ~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~Dfgla 336 (508)
.++||||+++|+|.+++.. ....+++..++.++.|++.||.|||++ +++|+||||+|||++.++.+||+|||++
T Consensus 95 ~~~v~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dikp~Nili~~~~~~kl~Dfg~~ 168 (291)
T 1u46_A 95 MKMVTELAPLGSLLDRLRK---HQGHFLLGTLSRYAVQVAEGMGYLESK---RFIHRDLAARNLLLATRDLVKIGDFGLM 168 (291)
T ss_dssp CEEEEECCTTCBHHHHHHH---HGGGSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEEEETTEEEECCCTTC
T ss_pred ceeeEecccCCCHHHHHHh---ccCCcCHHHHHHHHHHHHHHHHHHHhC---CcccCCCchheEEEcCCCCEEEcccccc
Confidence 7899999999999999963 345689999999999999999999999 9999999999999999999999999999
Q ss_pred cccCCCCCc--ccccccccccccCccccCCCCCCChhhHHHHHHHHHHHHh-CCCCCCCCCCCchhcHHHHHHHHhcccc
Q 010519 337 KLLDSGESH--ITTRVMGTFGYVAPEYANTGMLNEKSDIYSFGVLLLEAVT-GRDPVDYGRPANEVNLVEWLKMMVGTRR 413 (508)
Q Consensus 337 ~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~ 413 (508)
......... ......+++.|+|||++.+..++.++||||||+++|+|++ |..||..... .+..........
T Consensus 169 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~------~~~~~~~~~~~~ 242 (291)
T 1u46_A 169 RALPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNG------SQILHKIDKEGE 242 (291)
T ss_dssp EECCC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCH------HHHHHHHHTSCC
T ss_pred ccccccccchhhhccCCCCceeeCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCcccCCH------HHHHHHHHccCC
Confidence 876543321 1233457888999999998889999999999999999999 9999964321 122222221111
Q ss_pred cccccCCCCCCChhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhhcCC
Q 010519 414 AEEVVDPNLEVKPATRALKRSLLVALRCVDPDSEKRPKMSQVVRMLEADD 463 (508)
Q Consensus 414 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~ 463 (508)
...........+.+++.+||+.||.+|||+.+++++|+...
T Consensus 243 ---------~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~ 283 (291)
T 1u46_A 243 ---------RLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEAQ 283 (291)
T ss_dssp ---------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC
T ss_pred ---------CCCCCcCcCHHHHHHHHHHccCCcccCcCHHHHHHHHHHhC
Confidence 01111123456677999999999999999999999998654
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-41 Score=345.63 Aligned_cols=275 Identities=20% Similarity=0.256 Sum_probs=188.9
Q ss_pred CCccc-ceeEeeeCceEEEEEEEc---CCCEEEEEEEcccchhhHHHHHHHHHHHhcCCCCCceeEEEEEEe--CceeeE
Q 010519 186 NRFSA-ENVLGEGGYGVVYKGRLI---NGSEVAVKKLLNNLGQAEKEFRVEVEAIGHVRHKNLVRLLGYCIE--GVHRML 259 (508)
Q Consensus 186 ~~~~~-~~~lg~G~~g~Vy~~~~~---~~~~vavK~~~~~~~~~~~~~~~ei~~l~~l~h~niv~~~~~~~~--~~~~~l 259 (508)
+.|.+ +++||+|+||+||+|++. ++..||+|++..... ...+.+|+.+|+.++||||+++++++.. ....++
T Consensus 20 ~~y~~~g~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~~--~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~l 97 (405)
T 3rgf_A 20 DLFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGI--SMSACREIALLRELKHPNVISLQKVFLSHADRKVWL 97 (405)
T ss_dssp HHEECSSCCCC-----EEEEEEESSSSCCCCEEEEECSSSSC--CHHHHHHHHHHHHCCCTTBCCCCEEEEETTTTEEEE
T ss_pred hhhhhcCcEeeecCCeEEEEEEEccCCCCeEEEEEEECCCCC--CHHHHHHHHHHHhcCCCCeeeEeeEEecCCCCeEEE
Confidence 34665 458999999999999975 478899999864422 2457789999999999999999999965 578899
Q ss_pred EEeecCCCCHHHHHhhhhc-----cCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCEEE----cCCCcEEE
Q 010519 260 VYEYVNNGNLEQWLHGAMR-----NQGNLTWEARMKVIIGTAKALAYLHEAIEPKVVHRDIKSSNILI----DDEFNAKV 330 (508)
Q Consensus 260 v~E~~~~gsL~~~l~~~~~-----~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiH~Dlk~~NIll----~~~~~~kl 330 (508)
||||+. |+|.+++..... ....+++..++.++.||+.||.|||+. +|+||||||+|||| +.++.+||
T Consensus 98 v~e~~~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~~kl 173 (405)
T 3rgf_A 98 LFDYAE-HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHAN---WVLHRDLKPANILVMGEGPERGRVKI 173 (405)
T ss_dssp EEECCS-EEHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECCSSTTTTCEEE
T ss_pred EEeCCC-CCHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHhC---CEeCCCcCHHHeEEecCCCCCCcEEE
Confidence 999996 589888853321 122489999999999999999999999 99999999999999 77889999
Q ss_pred EecCCccccCCCCC--cccccccccccccCccccCC-CCCCChhhHHHHHHHHHHHHhCCCCCCCCCCCc-------hhc
Q 010519 331 SDFGLAKLLDSGES--HITTRVMGTFGYVAPEYANT-GMLNEKSDIYSFGVLLLEAVTGRDPVDYGRPAN-------EVN 400 (508)
Q Consensus 331 ~Dfgla~~~~~~~~--~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwS~Gvvl~elltG~~Pf~~~~~~~-------~~~ 400 (508)
+|||+++....... ......+||+.|+|||++.+ ..++.++|||||||+||||++|..||....... ...
T Consensus 174 ~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~ 253 (405)
T 3rgf_A 174 ADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQ 253 (405)
T ss_dssp CCTTCCC----------------CCCTTCCHHHHTTCCSCCHHHHHHHHHHHHHHHHHSSCTTCCCC------CCCCHHH
T ss_pred EECCCceecCCCCcccccCCCceecCcccCchhhcCCCcccchhhhHHHHHHHHHHHhCCCCCCCccccccccccchHHH
Confidence 99999987653221 22345678999999999987 458999999999999999999999996443210 111
Q ss_pred HHHHHHHHhccccccccc----------------CCCCCCChhHH--------HHHHHHHHHHHhcCCCCCCCCCHHHHH
Q 010519 401 LVEWLKMMVGTRRAEEVV----------------DPNLEVKPATR--------ALKRSLLVALRCVDPDSEKRPKMSQVV 456 (508)
Q Consensus 401 ~~~~~~~~~~~~~~~~~~----------------~~~~~~~~~~~--------~~~~l~~li~~cl~~dP~~RPs~~evl 456 (508)
+.. +....+........ ........... ....+.+|+.+||..||.+|||+.|+|
T Consensus 254 l~~-i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ll~~~L~~dP~~R~ta~e~L 332 (405)
T 3rgf_A 254 LDR-IFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQAM 332 (405)
T ss_dssp HHH-HHHHHCCCCTTTCGGGGGSTTHHHHHHHCCGGGGTTCCHHHHHHTTTCCTTSHHHHHHHHHSCSSGGGSCCHHHHH
T ss_pred HHH-HHHhhCCCChhhcchhhcCcchhhhhhhccccCCCcchhhhhHhhcCCCCCHHHHHHHHHHccCCcccCCCHHHHh
Confidence 111 11111111100000 00000000000 023567799999999999999999999
Q ss_pred HHhhcCCCCCc
Q 010519 457 RMLEADDYPFR 467 (508)
Q Consensus 457 ~~L~~~~~~~~ 467 (508)
+|-+-...++.
T Consensus 333 ~hp~f~~~~~~ 343 (405)
T 3rgf_A 333 QDPYFLEDPLP 343 (405)
T ss_dssp TSGGGTSSSCC
T ss_pred cChhhccCCCC
Confidence 98776554443
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-41 Score=343.11 Aligned_cols=260 Identities=24% Similarity=0.334 Sum_probs=196.6
Q ss_pred hCCcccceeEeeeCceEEEEEEEc-CCCEEEEEEEcccc--hhhHHHHHHHHHHHhcCCCCCceeEEEEEEeCc------
Q 010519 185 TNRFSAENVLGEGGYGVVYKGRLI-NGSEVAVKKLLNNL--GQAEKEFRVEVEAIGHVRHKNLVRLLGYCIEGV------ 255 (508)
Q Consensus 185 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~ei~~l~~l~h~niv~~~~~~~~~~------ 255 (508)
.++|.+.+.||+|+||.||+|.+. +|+.||||++.... ......+.+|+.+++.++||||+++++++....
T Consensus 24 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~ 103 (367)
T 1cm8_A 24 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFT 103 (367)
T ss_dssp BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCC
T ss_pred cceEEEeEEeeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCcCCCCceeeEecCCccccCc
Confidence 468999999999999999999874 68999999985432 333467888999999999999999999997653
Q ss_pred eeeEEEeecCCCCHHHHHhhhhccCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCEEEcCCCcEEEEecCC
Q 010519 256 HRMLVYEYVNNGNLEQWLHGAMRNQGNLTWEARMKVIIGTAKALAYLHEAIEPKVVHRDIKSSNILIDDEFNAKVSDFGL 335 (508)
Q Consensus 256 ~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~Dfgl 335 (508)
..|+||||+ +++|.+++.. ..+++..+..++.||+.||.|||++ +|+||||||+|||++.++.+||+|||+
T Consensus 104 ~~~lv~e~~-~~~L~~~~~~-----~~l~~~~~~~~~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~kl~Dfg~ 174 (367)
T 1cm8_A 104 DFYLVMPFM-GTDLGKLMKH-----EKLGEDRIQFLVYQMLKGLRYIHAA---GIIHRDLKPGNLAVNEDCELKILDFGL 174 (367)
T ss_dssp CCEEEEECC-SEEHHHHHHH-----CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTT
T ss_pred eEEEEEecC-CCCHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHC---CccccCcCHHHEEEcCCCCEEEEeeec
Confidence 458999999 8899999852 4689999999999999999999999 999999999999999999999999999
Q ss_pred ccccCCCCCcccccccccccccCccccCC-CCCCChhhHHHHHHHHHHHHhCCCCCCCCCCCchhcHHHHHHHHhccccc
Q 010519 336 AKLLDSGESHITTRVMGTFGYVAPEYANT-GMLNEKSDIYSFGVLLLEAVTGRDPVDYGRPANEVNLVEWLKMMVGTRRA 414 (508)
Q Consensus 336 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwS~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~ 414 (508)
++..... ....++|+.|+|||++.+ ..++.++|||||||++|||++|+.||..... ......+....+....
T Consensus 175 a~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~---~~~l~~i~~~~g~~~~ 247 (367)
T 1cm8_A 175 ARQADSE----MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDH---LDQLKEIMKVTGTPPA 247 (367)
T ss_dssp CEECCSS----CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSH---HHHHHHHHHHHCCCCH
T ss_pred ccccccc----cCcCcCCCCcCCHHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCCCH---HHHHHHHHHhcCCCCH
Confidence 9876432 344578999999999877 7899999999999999999999999964321 1111111111111000
Q ss_pred ------------------ccccCCCCCCChhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhhc
Q 010519 415 ------------------EEVVDPNLEVKPATRALKRSLLVALRCVDPDSEKRPKMSQVVRMLEA 461 (508)
Q Consensus 415 ------------------~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~ 461 (508)
.......+. .........+.+|+.+||..||.+|||+.|+++|-.-
T Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~ll~~mL~~dP~~R~t~~e~l~hp~f 311 (367)
T 1cm8_A 248 EFVQRLQSDEAKNYMKGLPELEKKDFA-SILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYF 311 (367)
T ss_dssp HHHHTCSCHHHHHHHHHSCCCCCCCGG-GTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGG
T ss_pred HHHHHhhhHHHHHHHHhCCCCCCCCHH-HHCCCCCHHHHHHHHHHccCChhHCCCHHHHhcChHH
Confidence 000000000 0001223456779999999999999999999997544
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-41 Score=332.18 Aligned_cols=253 Identities=23% Similarity=0.275 Sum_probs=199.4
Q ss_pred CCcccceeEeeeCceEEEEEEEc-CCCEEEEEEEcccc----hhhHHHHHHHHHHHhcCCCCCceeEEEEEE--eCceee
Q 010519 186 NRFSAENVLGEGGYGVVYKGRLI-NGSEVAVKKLLNNL----GQAEKEFRVEVEAIGHVRHKNLVRLLGYCI--EGVHRM 258 (508)
Q Consensus 186 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~----~~~~~~~~~ei~~l~~l~h~niv~~~~~~~--~~~~~~ 258 (508)
++|.+.+.||+|+||.||++.+. ++..||+|.+.... ......+.+|+.+++.++||||+++++++. +....+
T Consensus 5 ~~y~i~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 84 (305)
T 2wtk_C 5 GKYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYNEEKQKMY 84 (305)
T ss_dssp CCBCCCCEEEECSSCEEEEEEBTTTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECC---CEE
T ss_pred cceeEeeEEecCCCeEEEEEEECCCCcEEEEEEeccccccccchhHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCeEE
Confidence 68999999999999999999874 68899999986432 234567889999999999999999999985 345789
Q ss_pred EEEeecCCCCHHHHHhhhhccCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCEEEcCCCcEEEEecCCccc
Q 010519 259 LVYEYVNNGNLEQWLHGAMRNQGNLTWEARMKVIIGTAKALAYLHEAIEPKVVHRDIKSSNILIDDEFNAKVSDFGLAKL 338 (508)
Q Consensus 259 lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~Dfgla~~ 338 (508)
+||||+.++ |.+++.. .....+++..++.++.||+.||.|||++ +|+||||||+|||++.++.+||+|||++..
T Consensus 85 lv~e~~~~~-l~~~~~~--~~~~~~~~~~~~~~~~qi~~al~~LH~~---~i~H~dlkp~NIl~~~~~~~kl~dfg~~~~ 158 (305)
T 2wtk_C 85 MVMEYCVCG-MQEMLDS--VPEKRFPVCQAHGYFCQLIDGLEYLHSQ---GIVHKDIKPGNLLLTTGGTLKISALGVAEA 158 (305)
T ss_dssp EEEECCSEE-HHHHHHH--STTCSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCTTCEE
T ss_pred EEehhccCC-HHHHHHh--CcccccCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCcccEEEcCCCcEEeeccccccc
Confidence 999999876 8887754 2356799999999999999999999999 999999999999999999999999999987
Q ss_pred cCCCC-CcccccccccccccCccccCCCC--CCChhhHHHHHHHHHHHHhCCCCCCCCCCCchhcHHHHHHHHhcccccc
Q 010519 339 LDSGE-SHITTRVMGTFGYVAPEYANTGM--LNEKSDIYSFGVLLLEAVTGRDPVDYGRPANEVNLVEWLKMMVGTRRAE 415 (508)
Q Consensus 339 ~~~~~-~~~~~~~~gt~~y~aPE~~~~~~--~~~~~DvwS~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~ 415 (508)
..... ........||+.|+|||++.+.. ++.++|||||||++|+|++|..||.... ........... .
T Consensus 159 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~------~~~~~~~i~~~-~-- 229 (305)
T 2wtk_C 159 LHPFAADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDN------IYKLFENIGKG-S-- 229 (305)
T ss_dssp CCTTCSSCEECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSSCSCCCSS------HHHHHHHHHHC-C--
T ss_pred cCccccccccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhCCCCCCCch------HHHHHHHHhcC-C--
Confidence 64322 22234456899999999997644 3779999999999999999999996432 11222221111 0
Q ss_pred cccCCCCCCChhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhhc
Q 010519 416 EVVDPNLEVKPATRALKRSLLVALRCVDPDSEKRPKMSQVVRMLEA 461 (508)
Q Consensus 416 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~ 461 (508)
..+. ......+.+++.+||+.||.+|||+.|++++-.-
T Consensus 230 ----~~~~----~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~~~~ 267 (305)
T 2wtk_C 230 ----YAIP----GDCGPPLSDLLKGMLEYEPAKRFSIRQIRQHSWF 267 (305)
T ss_dssp ----CCCC----SSSCHHHHHHHHHHTCSSTTTSCCHHHHHHSHHH
T ss_pred ----CCCC----CccCHHHHHHHHHHccCChhhCCCHHHHhcCccc
Confidence 0111 1123456679999999999999999999987543
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-41 Score=337.66 Aligned_cols=254 Identities=22% Similarity=0.314 Sum_probs=199.9
Q ss_pred hCCcccceeEeeeCceEEEEEEEc-CCCEEEEEEEcccch--------hhHHHHHHHHHHHhcCCCCCceeEEEEEEeCc
Q 010519 185 TNRFSAENVLGEGGYGVVYKGRLI-NGSEVAVKKLLNNLG--------QAEKEFRVEVEAIGHVRHKNLVRLLGYCIEGV 255 (508)
Q Consensus 185 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--------~~~~~~~~ei~~l~~l~h~niv~~~~~~~~~~ 255 (508)
.++|.+.+.||+|+||.||+|.+. +++.||||.+..... .....+.+|+.+++.++||||+++++++....
T Consensus 9 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~ 88 (322)
T 2ycf_A 9 RDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDAED 88 (322)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECC---------------CHHHHHHHHHHCCCTTBCCEEEEEESSS
T ss_pred hhceeEeeEEecCCCEEEEEEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCceEeeEEcCCc
Confidence 468999999999999999999875 578899999854321 11235788999999999999999999987654
Q ss_pred eeeEEEeecCCCCHHHHHhhhhccCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCEEEcCCCc---EEEEe
Q 010519 256 HRMLVYEYVNNGNLEQWLHGAMRNQGNLTWEARMKVIIGTAKALAYLHEAIEPKVVHRDIKSSNILIDDEFN---AKVSD 332 (508)
Q Consensus 256 ~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiH~Dlk~~NIll~~~~~---~kl~D 332 (508)
.++||||+++|+|.+++. ....+++..++.++.||+.||.|||++ +|+||||||+|||++.++. +||+|
T Consensus 89 -~~lv~e~~~~~~L~~~~~----~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~NIl~~~~~~~~~~kl~D 160 (322)
T 2ycf_A 89 -YYIVLELMEGGELFDKVV----GNKRLKEATCKLYFYQMLLAVQYLHEN---GIIHRDLKPENVLLSSQEEDCLIKITD 160 (322)
T ss_dssp -EEEEEECCTTEETHHHHS----TTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESSSSSSCCEEECC
T ss_pred -eEEEEecCCCCcHHHHHh----ccCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHEEEecCCCCCeEEEcc
Confidence 799999999999999884 456799999999999999999999999 9999999999999987665 99999
Q ss_pred cCCccccCCCCCcccccccccccccCccccC---CCCCCChhhHHHHHHHHHHHHhCCCCCCCCCCCchhcHHHHHHHHh
Q 010519 333 FGLAKLLDSGESHITTRVMGTFGYVAPEYAN---TGMLNEKSDIYSFGVLLLEAVTGRDPVDYGRPANEVNLVEWLKMMV 409 (508)
Q Consensus 333 fgla~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DvwS~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~ 409 (508)
||++....... ......||+.|+|||++. +..++.++|||||||++|+|++|..||....... .+...+..
T Consensus 161 fg~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~--~~~~~~~~-- 234 (322)
T 2ycf_A 161 FGHSKILGETS--LMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQV--SLKDQITS-- 234 (322)
T ss_dssp CTTCEECCCCH--HHHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSSCSSCSTTCSS--CHHHHHHH--
T ss_pred Cccceeccccc--ccccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchHH--HHHHHHHh--
Confidence 99998765332 233457899999999973 5678999999999999999999999997543322 12221111
Q ss_pred cccccccccCCCCCCCh--hHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhhcC
Q 010519 410 GTRRAEEVVDPNLEVKP--ATRALKRSLLVALRCVDPDSEKRPKMSQVVRMLEAD 462 (508)
Q Consensus 410 ~~~~~~~~~~~~~~~~~--~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~ 462 (508)
......+ .......+.+|+.+||+.||.+|||+.+++++-.-.
T Consensus 235 ----------~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~~~l~h~~~~ 279 (322)
T 2ycf_A 235 ----------GKYNFIPEVWAEVSEKALDLVKKLLVVDPKARFTTEEALRHPWLQ 279 (322)
T ss_dssp ----------TCCCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGC
T ss_pred ----------CccccCchhhhhcCHHHHHHHHHHcccCHhhCCCHHHHhhCcCcC
Confidence 0011111 112345677899999999999999999999865443
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-40 Score=328.08 Aligned_cols=255 Identities=28% Similarity=0.416 Sum_probs=194.3
Q ss_pred hCCcccceeEeeeCceEEEEEEEc-CCCEEEEEEEcccchhhHHHHHHHHHHHhcCCCCCceeEEEEEEe----------
Q 010519 185 TNRFSAENVLGEGGYGVVYKGRLI-NGSEVAVKKLLNNLGQAEKEFRVEVEAIGHVRHKNLVRLLGYCIE---------- 253 (508)
Q Consensus 185 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~ei~~l~~l~h~niv~~~~~~~~---------- 253 (508)
.++|++.+.||+|+||.||+|++. ++..||+|++... ......+.+|+.+++.++||||+++++++.+
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~ 83 (303)
T 1zy4_A 5 ASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHT-EEKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFVKPMTA 83 (303)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEEE-HHHHHHHHHHHHHHTTCCCTTBCCEEEEEEECCCCCC----
T ss_pred cccchhhheeccCCcEEEEEEEEcCCCeEEEEEEEecc-HHHHHHHHHHHHHHHhcCchHHHHHHHHHHhhcchhhhhcc
Confidence 357999999999999999999975 7899999998543 3445678889999999999999999998865
Q ss_pred ---CceeeEEEeecCCCCHHHHHhhhhccCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCEEEcCCCcEEE
Q 010519 254 ---GVHRMLVYEYVNNGNLEQWLHGAMRNQGNLTWEARMKVIIGTAKALAYLHEAIEPKVVHRDIKSSNILIDDEFNAKV 330 (508)
Q Consensus 254 ---~~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl 330 (508)
....++||||+++|+|.+++.. ....+++..++.++.|++.||.|||++ +|+||||||+|||++.++.+||
T Consensus 84 ~~~~~~~~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dlkp~Nil~~~~~~~kl 157 (303)
T 1zy4_A 84 VKKKSTLFIQMEYCENGTLYDLIHS---ENLNQQRDEYWRLFRQILEALSYIHSQ---GIIHRDLKPMNIFIDESRNVKI 157 (303)
T ss_dssp --CEEEEEEEEECCCSCBHHHHHHH---SCGGGCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEE
T ss_pred cccCCceEEEEecCCCCCHHHhhhc---cccccchHHHHHHHHHHHHHHHHHHhC---CeecccCCHHhEEEcCCCCEEE
Confidence 3567899999999999999963 345678899999999999999999999 9999999999999999999999
Q ss_pred EecCCccccCCCC-------------CcccccccccccccCccccCCC-CCCChhhHHHHHHHHHHHHhCCCCCCCCCCC
Q 010519 331 SDFGLAKLLDSGE-------------SHITTRVMGTFGYVAPEYANTG-MLNEKSDIYSFGVLLLEAVTGRDPVDYGRPA 396 (508)
Q Consensus 331 ~Dfgla~~~~~~~-------------~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwS~Gvvl~elltG~~Pf~~~~~~ 396 (508)
+|||++....... ........|++.|+|||++.+. .++.++|||||||++|+|++ ||...
T Consensus 158 ~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~---p~~~~--- 231 (303)
T 1zy4_A 158 GDFGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY---PFSTG--- 231 (303)
T ss_dssp CCCCCCSCTTC-------------------------CTTSCHHHHTSCSCCCTHHHHHHHHHHHHHHHS---CCSSH---
T ss_pred eeCcchhhcccccchhccccccccccccccccCCCcccccCcccccCCCCCcchhhHHHHHHHHHHHHh---ccCCc---
Confidence 9999998654321 1123345689999999999764 78999999999999999998 55321
Q ss_pred chhcHHHHHHHHhcccccccccCCCCCCChhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhhc
Q 010519 397 NEVNLVEWLKMMVGTRRAEEVVDPNLEVKPATRALKRSLLVALRCVDPDSEKRPKMSQVVRMLEA 461 (508)
Q Consensus 397 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~ 461 (508)
.............. ..+...........+.+++.+||+.||.+|||+.+++++-+-
T Consensus 232 --~~~~~~~~~~~~~~-------~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~ 287 (303)
T 1zy4_A 232 --MERVNILKKLRSVS-------IEFPPDFDDNKMKVEKKIIRLLIDHDPNKRPGARTLLNSGWL 287 (303)
T ss_dssp --HHHHHHHHHHHSTT-------CCCCTTCCTTTSHHHHHHHHHHTCSSGGGSCCHHHHHHSSCS
T ss_pred --hhHHHHHHhccccc-------cccCccccccchHHHHHHHHHHHhcCcccCcCHHHHhCCCCc
Confidence 11122222221110 111111112223456679999999999999999999986443
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-40 Score=348.49 Aligned_cols=260 Identities=19% Similarity=0.251 Sum_probs=204.9
Q ss_pred hCCcccceeEeeeCceEEEEEEEc-CCCEEEEEEEcccchhhHHHHHHHHHHHhcCCC-CCceeEEEEEEeCceeeEEEe
Q 010519 185 TNRFSAENVLGEGGYGVVYKGRLI-NGSEVAVKKLLNNLGQAEKEFRVEVEAIGHVRH-KNLVRLLGYCIEGVHRMLVYE 262 (508)
Q Consensus 185 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~ei~~l~~l~h-~niv~~~~~~~~~~~~~lv~E 262 (508)
.++|.+.+.||+|+||.||+|++. ++..||||++...... ..+..|+++++.+.| +++..+..++......+||||
T Consensus 6 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~--~~~~~E~~il~~L~~~~~i~~i~~~~~~~~~~~lvme 83 (483)
T 3sv0_A 6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKH--PQLLYESKIYRILQGGTGIPNVRWFGVEGDYNVLVMD 83 (483)
T ss_dssp TTTEECCCCCEECSSCEEEEEEETTTCCEEEEEEEETTCSS--CCHHHHHHHHHHTTTSTTCCCEEEEEEETTEEEEEEE
T ss_pred CCcEEEEEEEeeCCCEEEEEEEECCCCcEEEEEEecccccc--HHHHHHHHHHHHhcCCCCCCeEEEEEeeCCEEEEEEE
Confidence 468999999999999999999874 6899999987544322 347779999999977 556666667777888899999
Q ss_pred ecCCCCHHHHHhhhhccCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCEEE---cCCCcEEEEecCCcccc
Q 010519 263 YVNNGNLEQWLHGAMRNQGNLTWEARMKVIIGTAKALAYLHEAIEPKVVHRDIKSSNILI---DDEFNAKVSDFGLAKLL 339 (508)
Q Consensus 263 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiH~Dlk~~NIll---~~~~~~kl~Dfgla~~~ 339 (508)
|+ +++|.+++.. ....+++..++.++.||+.||.|||++ +|+||||||+|||| +.++.+||+|||+++.+
T Consensus 84 ~~-g~sL~~ll~~---~~~~l~~~~~~~i~~qi~~aL~yLH~~---gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~ 156 (483)
T 3sv0_A 84 LL-GPSLEDLFNF---CSRKLSLKTVLMLADQMINRVEFVHSK---SFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKY 156 (483)
T ss_dssp CC-CCBHHHHHHH---TTTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECCGGGTTCEEECCCTTCEEC
T ss_pred CC-CCCHHHHHHh---hcCCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccCcceEEEecCCCCCeEEEEeCCcceec
Confidence 99 9999999963 356799999999999999999999999 99999999999999 68899999999999876
Q ss_pred CCCCCc------ccccccccccccCccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCCCchhcHHHHHHHHhcccc
Q 010519 340 DSGESH------ITTRVMGTFGYVAPEYANTGMLNEKSDIYSFGVLLLEAVTGRDPVDYGRPANEVNLVEWLKMMVGTRR 413 (508)
Q Consensus 340 ~~~~~~------~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~ 413 (508)
...... ......||+.|+|||++.+..++.++|||||||+||||++|+.||..............+........
T Consensus 157 ~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~ 236 (483)
T 3sv0_A 157 RDTSTHQHIPYRENKNLTGTARYASVNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVATS 236 (483)
T ss_dssp BCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSHHHHHHHHHHHHHHSC
T ss_pred cCCccccccccccccccCCCccccCHHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccchhHHHHHHHHhhcccccc
Confidence 543321 12356799999999999999999999999999999999999999976544333322222111110001
Q ss_pred cccccCCCCCCChhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhhcC
Q 010519 414 AEEVVDPNLEVKPATRALKRSLLVALRCVDPDSEKRPKMSQVVRMLEAD 462 (508)
Q Consensus 414 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~ 462 (508)
...+. ......+.+|+..||+.||.+||++.+|++.|+..
T Consensus 237 ~~~l~---------~~~p~~l~~li~~cl~~dP~~RPs~~el~~~L~~l 276 (483)
T 3sv0_A 237 IEALC---------RGYPTEFASYFHYCRSLRFDDKPDYSYLKRLFRDL 276 (483)
T ss_dssp HHHHH---------TTSCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHH
T ss_pred HHHHh---------cCCcHHHHHHHHHHhcCChhhCcCHHHHHHHHHHH
Confidence 00000 11234677799999999999999999999988653
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-40 Score=337.62 Aligned_cols=273 Identities=22% Similarity=0.285 Sum_probs=194.7
Q ss_pred HHHHHhhCCcccceeEeeeCceEEEEEEEc-CCCEEEEEEEcccchhhHHHHHHHHHHHhcCCCCCceeEEEEEEeCce-
Q 010519 179 RDLEIATNRFSAENVLGEGGYGVVYKGRLI-NGSEVAVKKLLNNLGQAEKEFRVEVEAIGHVRHKNLVRLLGYCIEGVH- 256 (508)
Q Consensus 179 ~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~ei~~l~~l~h~niv~~~~~~~~~~~- 256 (508)
.......++|.+.+.||+|+||+||+|++. +|..||||++...... ...+..++..+..++||||+++++++.....
T Consensus 16 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~ 94 (360)
T 3e3p_A 16 ERSRKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRF-RNRELQIMQDLAVLHHPNIVQLQSYFYTLGER 94 (360)
T ss_dssp HHHHHHHTTEEEC----------CEEEEETTTCCEEEEEEEECCTTC-CCHHHHHHHHHHHHCCTTBCCEEEEEEEECSS
T ss_pred hhchhhccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEecCccc-cHHHHHHHHHHHhcCCCCcccHHHhhhccccc
Confidence 344566789999999999999999999985 6889999988654322 2345567888888999999999999976433
Q ss_pred ------eeEEEeecCCCCHHHHHhhhhccCCCccHHHHHHHHHHHHHHHHHHH--hcCCCCeEeecCCCCCEEEcC-CCc
Q 010519 257 ------RMLVYEYVNNGNLEQWLHGAMRNQGNLTWEARMKVIIGTAKALAYLH--EAIEPKVVHRDIKSSNILIDD-EFN 327 (508)
Q Consensus 257 ------~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~yLH--~~~~~~iiH~Dlk~~NIll~~-~~~ 327 (508)
.++||||+++ +|.+.+.........+++..+..++.|++.||.||| +. +|+||||||+|||++. ++.
T Consensus 95 ~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~---~ivH~Dlkp~NIll~~~~~~ 170 (360)
T 3e3p_A 95 DRRDIYLNVVMEYVPD-TLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPSV---NVCHRDIKPHNVLVNEADGT 170 (360)
T ss_dssp CTTCEEEEEEEECCSC-BHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHTSTTT---CCBCSCCCGGGEEEETTTTE
T ss_pred cccceeEEEEeecccc-cHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhCCCC---CeecCcCCHHHEEEeCCCCc
Confidence 7899999975 777666655566778999999999999999999999 87 9999999999999996 899
Q ss_pred EEEEecCCccccCCCCCcccccccccccccCccccCCC-CCCChhhHHHHHHHHHHHHhCCCCCCCCCCCchhcHHHHHH
Q 010519 328 AKVSDFGLAKLLDSGESHITTRVMGTFGYVAPEYANTG-MLNEKSDIYSFGVLLLEAVTGRDPVDYGRPANEVNLVEWLK 406 (508)
Q Consensus 328 ~kl~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwS~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~ 406 (508)
+||+|||++........ .....||+.|+|||++.+. .++.++|||||||++|+|++|+.||...... ..+.....
T Consensus 171 ~kl~Dfg~a~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~--~~~~~~~~ 246 (360)
T 3e3p_A 171 LKLCDFGSAKKLSPSEP--NVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSA--GQLHEIVR 246 (360)
T ss_dssp EEECCCTTCBCCCTTSC--CCSTTSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH--HHHHHHHH
T ss_pred EEEeeCCCceecCCCCC--cccccCCcceeCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCcCCCChH--HHHHHHHH
Confidence 99999999987654332 3345689999999998664 4899999999999999999999999753321 11111111
Q ss_pred HHhcccc------------cccccC-CCCC-----CChhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhhc
Q 010519 407 MMVGTRR------------AEEVVD-PNLE-----VKPATRALKRSLLVALRCVDPDSEKRPKMSQVVRMLEA 461 (508)
Q Consensus 407 ~~~~~~~------------~~~~~~-~~~~-----~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~ 461 (508)
..+... .....+ .... ..........+.+|+.+||+.||.+|||+.|+++|-+-
T Consensus 247 -~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f 318 (360)
T 3e3p_A 247 -VLGCPSREVLRKLNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERMKPYEALCHPYF 318 (360)
T ss_dssp -HHCCCCHHHHHHHCTTCCCGGGGCCCCCCHHHHTTTCCCTTHHHHHHHHHHHTCSSGGGSCCHHHHTTSGGG
T ss_pred -HcCCCCHHHHHhcccchhhccccccccCCcccccchhhccccHHHHHHHHHHhccCccccCCHHHHhcCccc
Confidence 111100 000000 0000 00001134567789999999999999999999986543
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-41 Score=342.66 Aligned_cols=263 Identities=19% Similarity=0.278 Sum_probs=206.8
Q ss_pred hhCCcccceeEeeeCceEEEEEEEcCCCEEEEEEEcccchhh-----------------HHHHHHHHHHHhcCCCCCcee
Q 010519 184 ATNRFSAENVLGEGGYGVVYKGRLINGSEVAVKKLLNNLGQA-----------------EKEFRVEVEAIGHVRHKNLVR 246 (508)
Q Consensus 184 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~-----------------~~~~~~ei~~l~~l~h~niv~ 246 (508)
..++|.+.+.||+|+||.||+|.+ ++..||+|.+....... ...+.+|+.++++++||||++
T Consensus 29 ~~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~ 107 (348)
T 2pml_X 29 YINDYRIIRTLNQGKFNKIILCEK-DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCLT 107 (348)
T ss_dssp EETTEEEEEEEECCSSCCEEEEEE-TTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCCCTTBCC
T ss_pred ccCceEEEEEEcCCCCeEEEEEEc-CCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCCCCCcce
Confidence 346899999999999999999998 99999999986432211 167889999999999999999
Q ss_pred EEEEEEeCceeeEEEeecCCCCHHHH------HhhhhccCCCccHHHHHHHHHHHHHHHHHHHh-cCCCCeEeecCCCCC
Q 010519 247 LLGYCIEGVHRMLVYEYVNNGNLEQW------LHGAMRNQGNLTWEARMKVIIGTAKALAYLHE-AIEPKVVHRDIKSSN 319 (508)
Q Consensus 247 ~~~~~~~~~~~~lv~E~~~~gsL~~~------l~~~~~~~~~l~~~~~~~i~~~i~~al~yLH~-~~~~~iiH~Dlk~~N 319 (508)
+++++.+....++||||+++|+|.++ +.. .....+++..++.++.||+.||.|||+ . +|+|+||||+|
T Consensus 108 ~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~--~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---~i~H~dl~p~N 182 (348)
T 2pml_X 108 CEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDK--NYTCFIPIQVIKCIIKSVLNSFSYIHNEK---NICHRDVKPSN 182 (348)
T ss_dssp CSEEEESSSEEEEEEECCTTCBSSEESSSEESSCS--SSCCCCCHHHHHHHHHHHHHHHHHHHHTS---CEECCCCCGGG
T ss_pred EEEEEeeCCeEEEEEeccCCCcHHHHHHHhhhhhh--ccccCCCHHHHHHHHHHHHHHHHHHhccC---CEeecCCChHh
Confidence 99999999999999999999999998 431 125679999999999999999999998 8 99999999999
Q ss_pred EEEcCCCcEEEEecCCccccCCCCCcccccccccccccCccccCCC-CCCC-hhhHHHHHHHHHHHHhCCCCCCCCCCCc
Q 010519 320 ILIDDEFNAKVSDFGLAKLLDSGESHITTRVMGTFGYVAPEYANTG-MLNE-KSDIYSFGVLLLEAVTGRDPVDYGRPAN 397 (508)
Q Consensus 320 Ill~~~~~~kl~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~-~~DvwS~Gvvl~elltG~~Pf~~~~~~~ 397 (508)
||++.++.+||+|||++...... ......|++.|+|||++.+. .++. ++|||||||++|+|++|..||.......
T Consensus 183 il~~~~~~~kl~dfg~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~ 259 (348)
T 2pml_X 183 ILMDKNGRVKLSDFGESEYMVDK---KIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKISLV 259 (348)
T ss_dssp EEECTTSCEEECCCTTCEECBTT---EECSSCSCGGGCCGGGGSSCCCEEHHHHHHHHHHHHHHHHHHSSCSSCCSSCSH
T ss_pred EEEcCCCcEEEeccccccccccc---cccCCCCCcCccCchhhcCCCCCCcchhhHHHHHHHHHHHHhCCCCCCCCCcHH
Confidence 99999999999999999876443 23445789999999999887 6666 9999999999999999999997543311
Q ss_pred hhcHHHHHHHHhcccccccccC------CCCC---CChhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhhc
Q 010519 398 EVNLVEWLKMMVGTRRAEEVVD------PNLE---VKPATRALKRSLLVALRCVDPDSEKRPKMSQVVRMLEA 461 (508)
Q Consensus 398 ~~~~~~~~~~~~~~~~~~~~~~------~~~~---~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~ 461 (508)
......... ......+ +... ..........+.+|+.+||+.||.+|||+.|++++-.-
T Consensus 260 -----~~~~~i~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~e~l~hp~f 326 (348)
T 2pml_X 260 -----ELFNNIRTK-NIEYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSEDALKHEWL 326 (348)
T ss_dssp -----HHHHHHTSC-CCCCCCSSSSSTTTTCC--------CCCHHHHHHHHHHCCSSGGGSCCHHHHHTSGGG
T ss_pred -----HHHHHHhcc-CcCCccchhhhhccccccccccchhhcCHHHHHHHHHHccCChhhCCCHHHHhcCccc
Confidence 112222111 1100000 0000 00002234566779999999999999999999986543
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-40 Score=334.08 Aligned_cols=263 Identities=21% Similarity=0.301 Sum_probs=203.5
Q ss_pred HhhCCcccceeEeeeCceEEEEEEE-c-CCCEEEEEEEcccchhhHHHHHHHHHHHhcCCCC------CceeEEEEEEeC
Q 010519 183 IATNRFSAENVLGEGGYGVVYKGRL-I-NGSEVAVKKLLNNLGQAEKEFRVEVEAIGHVRHK------NLVRLLGYCIEG 254 (508)
Q Consensus 183 ~~~~~~~~~~~lg~G~~g~Vy~~~~-~-~~~~vavK~~~~~~~~~~~~~~~ei~~l~~l~h~------niv~~~~~~~~~ 254 (508)
+..++|.+.+.||+|+||+||+|.+ . ++..||+|++... ......+..|+.+++.++|+ +++++++++...
T Consensus 11 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~~~~~~~ 89 (339)
T 1z57_A 11 VLSARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNV-DRYCEAARSEIQVLEHLNTTDPNSTFRCVQMLEWFEHH 89 (339)
T ss_dssp EETTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSS-HHHHHHHHHHHHHHHHHHHHCTTCTTCBCCEEEEEEET
T ss_pred CccCceEEEEEEecCCCeEEEEEEecCCCCcEEEEEEEecC-CchhHHHHHHHHHHHHhhhcCCCCceeeEeeecccccC
Confidence 3456999999999999999999987 3 6788999988643 33346678899998888655 599999999999
Q ss_pred ceeeEEEeecCCCCHHHHHhhhhccCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCEEEcC----------
Q 010519 255 VHRMLVYEYVNNGNLEQWLHGAMRNQGNLTWEARMKVIIGTAKALAYLHEAIEPKVVHRDIKSSNILIDD---------- 324 (508)
Q Consensus 255 ~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiH~Dlk~~NIll~~---------- 324 (508)
...++||||+ +++|.+++.. .....+++..++.++.||+.||.|||++ +|+||||||+|||++.
T Consensus 90 ~~~~lv~e~~-~~~l~~~l~~--~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~~~~ 163 (339)
T 1z57_A 90 GHICIVFELL-GLSTYDFIKE--NGFLPFRLDHIRKMAYQICKSVNFLHSN---KLTHTDLKPENILFVQSDYTEAYNPK 163 (339)
T ss_dssp TEEEEEEECC-CCBHHHHHHH--TTTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESCCCEEEEEC--
T ss_pred CcEEEEEcCC-CCCHHHHHHh--cCCCCCcHHHHHHHHHHHHHHHHHHHHC---CCcCCCCCHHHEEEeccccccccCCc
Confidence 9999999999 8899999964 2334688999999999999999999999 9999999999999987
Q ss_pred ---------CCcEEEEecCCccccCCCCCcccccccccccccCccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCC
Q 010519 325 ---------EFNAKVSDFGLAKLLDSGESHITTRVMGTFGYVAPEYANTGMLNEKSDIYSFGVLLLEAVTGRDPVDYGRP 395 (508)
Q Consensus 325 ---------~~~~kl~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltG~~Pf~~~~~ 395 (508)
++.+||+|||++...... .....||+.|+|||++.+..++.++|||||||++|||++|..||.....
T Consensus 164 ~~~~~~~~~~~~~kl~Dfg~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~ 239 (339)
T 1z57_A 164 IKRDERTLINPDIKVVDFGSATYDDEH----HSTLVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYYLGFTVFPTHDS 239 (339)
T ss_dssp --CEEEEESCCCEEECCCSSCEETTSC----CCSSCSCGGGCCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSCH
T ss_pred cccccccccCCCceEeeCcccccCccc----cccccCCccccChHHhhCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCh
Confidence 668999999999865432 2345789999999999999999999999999999999999999974432
Q ss_pred CchhcHHHHHHHHhccccc---------ccccCCCCC---------------------CChhHHHHHHHHHHHHHhcCCC
Q 010519 396 ANEVNLVEWLKMMVGTRRA---------EEVVDPNLE---------------------VKPATRALKRSLLVALRCVDPD 445 (508)
Q Consensus 396 ~~~~~~~~~~~~~~~~~~~---------~~~~~~~~~---------------------~~~~~~~~~~l~~li~~cl~~d 445 (508)
. .....+....+.... ......... ..........+.+|+.+||+.|
T Consensus 240 ~---~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~d 316 (339)
T 1z57_A 240 K---EHLAMMERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVEHERLFDLIQKMLEYD 316 (339)
T ss_dssp H---HHHHHHHHHHCSCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSS
T ss_pred H---HHHHHHHHHhCCCCHHHHhhccchhHHhhccccccccccccchhhhcCcchhhhcccchhhHHHHHHHHHHHhCcC
Confidence 1 111112121111000 000000000 0111233566788999999999
Q ss_pred CCCCCCHHHHHHHh
Q 010519 446 SEKRPKMSQVVRML 459 (508)
Q Consensus 446 P~~RPs~~evl~~L 459 (508)
|.+|||+.|++++-
T Consensus 317 P~~Rpt~~ell~hp 330 (339)
T 1z57_A 317 PAKRITLREALKHP 330 (339)
T ss_dssp TTTSCCHHHHTTSG
T ss_pred cccccCHHHHhcCH
Confidence 99999999999753
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-41 Score=368.31 Aligned_cols=261 Identities=23% Similarity=0.377 Sum_probs=205.5
Q ss_pred HHHHHhhCCcccceeEeeeCceEEEEEEEcC----CCEEEEEEEcccc-hhhHHHHHHHHHHHhcCCCCCceeEEEEEEe
Q 010519 179 RDLEIATNRFSAENVLGEGGYGVVYKGRLIN----GSEVAVKKLLNNL-GQAEKEFRVEVEAIGHVRHKNLVRLLGYCIE 253 (508)
Q Consensus 179 ~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~----~~~vavK~~~~~~-~~~~~~~~~ei~~l~~l~h~niv~~~~~~~~ 253 (508)
.++++..++|.+.+.||+|+||+||+|.+.. +..||+|++.... ....+.+.+|+.++++++||||+++++++.
T Consensus 383 ~~~~i~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~- 461 (656)
T 2j0j_A 383 RDYEIQRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT- 461 (656)
T ss_dssp GGTBCCGGGEEEEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSSTTCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC-
T ss_pred cccccccccEEEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEe-
Confidence 4456667889999999999999999998743 4568999876533 334467889999999999999999999884
Q ss_pred CceeeEEEeecCCCCHHHHHhhhhccCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCEEEcCCCcEEEEec
Q 010519 254 GVHRMLVYEYVNNGNLEQWLHGAMRNQGNLTWEARMKVIIGTAKALAYLHEAIEPKVVHRDIKSSNILIDDEFNAKVSDF 333 (508)
Q Consensus 254 ~~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~Df 333 (508)
.+..++||||+++|+|.+++.. ....+++..++.++.||+.||.|||++ +|+||||||+|||++.++.+||+||
T Consensus 462 ~~~~~lv~E~~~~g~L~~~l~~---~~~~l~~~~~~~i~~qi~~aL~~LH~~---givHrDikp~NILl~~~~~vkL~DF 535 (656)
T 2j0j_A 462 ENPVWIIMELCTLGELRSFLQV---RKFSLDLASLILYAYQLSTALAYLESK---RFVHRDIAARNVLVSSNDCVKLGDF 535 (656)
T ss_dssp SSSCEEEEECCTTCBHHHHHHH---TTTTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECCC
T ss_pred cCceEEEEEcCCCCcHHHHHHh---ccCCCCHHHHHHHHHHHHHHHHHHHhC---CccccccchHhEEEeCCCCEEEEec
Confidence 5668999999999999999963 345689999999999999999999999 9999999999999999999999999
Q ss_pred CCccccCCCCCcccccccccccccCccccCCCCCCChhhHHHHHHHHHHHHh-CCCCCCCCCCCchhcHHHHHHHHhccc
Q 010519 334 GLAKLLDSGESHITTRVMGTFGYVAPEYANTGMLNEKSDIYSFGVLLLEAVT-GRDPVDYGRPANEVNLVEWLKMMVGTR 412 (508)
Q Consensus 334 gla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~ 412 (508)
|+++..............+++.|+|||++.+..++.++|||||||++|||++ |..||..... . +.........
T Consensus 536 G~a~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~---~---~~~~~i~~~~ 609 (656)
T 2j0j_A 536 GLSRYMEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKN---N---DVIGRIENGE 609 (656)
T ss_dssp CCCCSCCC----------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCH---H---HHHHHHHHTC
T ss_pred CCCeecCCCcceeccCCCCCcceeCHHHhcCCCCCchhhHHHHHHHHHHHHHcCCCCCCCCCH---H---HHHHHHHcCC
Confidence 9998775544333344567889999999998899999999999999999997 9999964321 1 1111211111
Q ss_pred ccccccCCCCCCChhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhhcC
Q 010519 413 RAEEVVDPNLEVKPATRALKRSLLVALRCVDPDSEKRPKMSQVVRMLEAD 462 (508)
Q Consensus 413 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~ 462 (508)
. ... +......+.+|+.+||+.||.+|||+.++++.|+..
T Consensus 610 ~------~~~----~~~~~~~l~~li~~~l~~dP~~RPs~~el~~~L~~i 649 (656)
T 2j0j_A 610 R------LPM----PPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTI 649 (656)
T ss_dssp C------CCC----CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred C------CCC----CccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHHH
Confidence 1 001 112234566799999999999999999999999864
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-41 Score=336.83 Aligned_cols=261 Identities=21% Similarity=0.335 Sum_probs=200.7
Q ss_pred HHHHHHhhCCcccceeEeeeCceEEEEEEEcCCCEEEEEEEcccc--hhhHHHHHHHHHHHhcCC--CCCceeEEEEEEe
Q 010519 178 LRDLEIATNRFSAENVLGEGGYGVVYKGRLINGSEVAVKKLLNNL--GQAEKEFRVEVEAIGHVR--HKNLVRLLGYCIE 253 (508)
Q Consensus 178 ~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~--~~~~~~~~~ei~~l~~l~--h~niv~~~~~~~~ 253 (508)
+..+.+..++|.+.+.||+|+||.||++.+.+++.||+|++.... ......+.+|+.++.+++ ||||+++++++.+
T Consensus 20 ~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~ 99 (313)
T 3cek_A 20 FQSMSVKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEIT 99 (313)
T ss_dssp CCEEEETTEEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECSSCCHHHHHHHHHHHHHHHHHGGGCTTBCCEEEEEEC
T ss_pred eeeeeeccceEEEEEEecCCCCEEEEEEEcCCCcEEEEEEeccccccccchHHHHHHHHHHHhccccCCceEEEEEEeec
Confidence 344456667899999999999999999998889999999985432 344567889999999997 5999999999999
Q ss_pred CceeeEEEeecCCCCHHHHHhhhhccCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCEEEcCCCcEEEEec
Q 010519 254 GVHRMLVYEYVNNGNLEQWLHGAMRNQGNLTWEARMKVIIGTAKALAYLHEAIEPKVVHRDIKSSNILIDDEFNAKVSDF 333 (508)
Q Consensus 254 ~~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~Df 333 (508)
....++||| +.+++|.+++. ....+++..++.++.||+.||.|||+. +|+||||||+|||+++ +.+||+||
T Consensus 100 ~~~~~lv~e-~~~~~L~~~l~----~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIl~~~-~~~kL~Df 170 (313)
T 3cek_A 100 DQYIYMVME-CGNIDLNSWLK----KKKSIDPWERKSYWKNMLEAVHTIHQH---GIVHSDLKPANFLIVD-GMLKLIDF 170 (313)
T ss_dssp SSEEEEEEC-CCSEEHHHHHH----HCSSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEEET-TEEEECCC
T ss_pred CCEEEEEEe-cCCCcHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCcccEEEEC-CeEEEeec
Confidence 999999999 55889999995 345789999999999999999999999 9999999999999965 89999999
Q ss_pred CCccccCCCCCc-ccccccccccccCccccCC-----------CCCCChhhHHHHHHHHHHHHhCCCCCCCCCCCchhcH
Q 010519 334 GLAKLLDSGESH-ITTRVMGTFGYVAPEYANT-----------GMLNEKSDIYSFGVLLLEAVTGRDPVDYGRPANEVNL 401 (508)
Q Consensus 334 gla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~-----------~~~~~~~DvwS~Gvvl~elltG~~Pf~~~~~~~~~~~ 401 (508)
|++......... ......|++.|+|||++.+ ..++.++|||||||++|+|++|..||......
T Consensus 171 g~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~----- 245 (313)
T 3cek_A 171 GIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQ----- 245 (313)
T ss_dssp SSSCC--------------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHHHHHSSCTTTTCCSH-----
T ss_pred cccccccCccccccccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHHHhCCCchhhHHHH-----
Confidence 999866443221 2234568999999999875 47888999999999999999999999643221
Q ss_pred HHHHHHHhcccccccccCCCCCCChhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhhc
Q 010519 402 VEWLKMMVGTRRAEEVVDPNLEVKPATRALKRSLLVALRCVDPDSEKRPKMSQVVRMLEA 461 (508)
Q Consensus 402 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~ 461 (508)
...+....... .....+......+.+++.+||+.||.+|||+.|++++..-
T Consensus 246 ~~~~~~~~~~~---------~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h~~~ 296 (313)
T 3cek_A 246 ISKLHAIIDPN---------HEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYV 296 (313)
T ss_dssp HHHHHHHHCTT---------SCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHH
T ss_pred HHHHHHHHhcc---------cccCCcccchHHHHHHHHHHccCCcccCcCHHHHhcCccc
Confidence 11122222111 1111111113456679999999999999999999986543
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-40 Score=338.39 Aligned_cols=268 Identities=23% Similarity=0.320 Sum_probs=204.2
Q ss_pred hCCcccceeEeeeCceEEEEEEEc-CCCEEEEEEEcccc-hhhHHHHHHHHHHHhcCCCCCceeEEEEEEeC-----cee
Q 010519 185 TNRFSAENVLGEGGYGVVYKGRLI-NGSEVAVKKLLNNL-GQAEKEFRVEVEAIGHVRHKNLVRLLGYCIEG-----VHR 257 (508)
Q Consensus 185 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~ei~~l~~l~h~niv~~~~~~~~~-----~~~ 257 (508)
.++|.+.+.||+|+||.||+|.+. ++..||||++.... ......+.+|+.++.+++||||+++++++... ...
T Consensus 26 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 105 (364)
T 3qyz_A 26 GPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDV 105 (364)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCE
T ss_pred cccEEEEEEeecCCCeEEEEEEECCCCeEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCccceeEEecCCccccceE
Confidence 358999999999999999999875 67889999986433 33346788899999999999999999999765 367
Q ss_pred eEEEeecCCCCHHHHHhhhhccCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCEEEcCCCcEEEEecCCcc
Q 010519 258 MLVYEYVNNGNLEQWLHGAMRNQGNLTWEARMKVIIGTAKALAYLHEAIEPKVVHRDIKSSNILIDDEFNAKVSDFGLAK 337 (508)
Q Consensus 258 ~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~Dfgla~ 337 (508)
++||||+. |+|.+++.. ..+++..++.++.||+.||.|||++ +|+||||||+|||++.++.+||+|||++.
T Consensus 106 ~iv~e~~~-~~L~~~l~~-----~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~ 176 (364)
T 3qyz_A 106 YIVQDLME-TDLYKLLKT-----QHLSNDHICYFLYQILRGLKYIHSA---NVLHRDLKPSNLLLNTTCDLKICDFGLAR 176 (364)
T ss_dssp EEEEECCS-EEHHHHHHH-----CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCE
T ss_pred EEEEcccC-cCHHHHHHh-----CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCChHhEEECCCCCEEEEeCcceE
Confidence 89999996 599998842 4589999999999999999999999 99999999999999999999999999998
Q ss_pred ccCCCCCc--ccccccccccccCccccC-CCCCCChhhHHHHHHHHHHHHhCCCCCCCCCCCchhcHHHHHHHHhccccc
Q 010519 338 LLDSGESH--ITTRVMGTFGYVAPEYAN-TGMLNEKSDIYSFGVLLLEAVTGRDPVDYGRPANEVNLVEWLKMMVGTRRA 414 (508)
Q Consensus 338 ~~~~~~~~--~~~~~~gt~~y~aPE~~~-~~~~~~~~DvwS~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~ 414 (508)
........ ......||+.|+|||++. +..++.++|||||||++|+|++|+.||....... ....+....+....
T Consensus 177 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~---~~~~i~~~~~~~~~ 253 (364)
T 3qyz_A 177 VADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLD---QLNHILGILGSPSQ 253 (364)
T ss_dssp ECCGGGCBCCTTCCCCSCGGGCCHHHHHTBCSCSTHHHHHHHHHHHHHHHHSSCSSCCSSGGG---HHHHHHHHHCSCCH
T ss_pred ecCCCCCccccccccccccCCCCCHHhcCCCCCCcchhHHHHHHHHHHHHHCCCCCCCCChHH---HHHHHHHHhCCCCH
Confidence 66432221 134457999999999865 4558999999999999999999999996543222 11111111111100
Q ss_pred ccc--------------cCCCCCCCh---hHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhhcCCC
Q 010519 415 EEV--------------VDPNLEVKP---ATRALKRSLLVALRCVDPDSEKRPKMSQVVRMLEADDY 464 (508)
Q Consensus 415 ~~~--------------~~~~~~~~~---~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~ 464 (508)
... ......... .......+.+|+.+||+.||.+|||+.|++++-.-...
T Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~~~~~ 320 (364)
T 3qyz_A 254 EDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQY 320 (364)
T ss_dssp HHHHTCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGTTT
T ss_pred HHHHHhhhhhHHHHHHhcCCccCCCHHHhCCCCCHHHHHHHHHHcCCChhhCCCHHHHhcCcchhhc
Confidence 000 000000000 01123456789999999999999999999997665443
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-40 Score=337.60 Aligned_cols=204 Identities=25% Similarity=0.301 Sum_probs=172.0
Q ss_pred HHHhhCCcccceeEeeeCceEEEEEEEc-CCCEEEEEEEcccchhhHHHHHHHHHHHhcCC-CC-----CceeEEEEEEe
Q 010519 181 LEIATNRFSAENVLGEGGYGVVYKGRLI-NGSEVAVKKLLNNLGQAEKEFRVEVEAIGHVR-HK-----NLVRLLGYCIE 253 (508)
Q Consensus 181 ~~~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~ei~~l~~l~-h~-----niv~~~~~~~~ 253 (508)
.+...++|.+.+.||+|+||+||+|.+. +++.||||++... ......+..|+.++..++ |+ +|+.+++++..
T Consensus 49 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~~~~~~ 127 (382)
T 2vx3_A 49 GEKWMDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNK-KAFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFMF 127 (382)
T ss_dssp TCEETTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSS-HHHHHHHHHHHHHHHHHHHCSSGGGGGBCCEEEEEEE
T ss_pred CCEeeeeEEEEEEEeecCCEEEEEEEEcCCCcEEEEEEEecc-HHHHHHHHHHHHHHHHHHhcccccceeEEEeeeeecc
Confidence 3445679999999999999999999876 5788999998643 233456777888888774 44 49999999999
Q ss_pred CceeeEEEeecCCCCHHHHHhhhhccCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCEEEc--CCCcEEEE
Q 010519 254 GVHRMLVYEYVNNGNLEQWLHGAMRNQGNLTWEARMKVIIGTAKALAYLHEAIEPKVVHRDIKSSNILID--DEFNAKVS 331 (508)
Q Consensus 254 ~~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiH~Dlk~~NIll~--~~~~~kl~ 331 (508)
....++||||+. |+|.+++.. .....+++..++.++.||+.||.|||.+ ..+|+||||||+|||++ .++.+||+
T Consensus 128 ~~~~~lv~e~~~-~~L~~~l~~--~~~~~~~~~~~~~i~~qi~~al~~lH~~-~~~ivHrDlkp~NIll~~~~~~~~kL~ 203 (382)
T 2vx3_A 128 RNHLCLVFEMLS-YNLYDLLRN--TNFRGVSLNLTRKFAQQMCTALLFLATP-ELSIIHCDLKPENILLCNPKRSAIKIV 203 (382)
T ss_dssp TTEEEEEEECCC-CBHHHHHHH--TTTSCCCHHHHHHHHHHHHHHHHHHTST-TTCEECCCCSGGGEEESSTTSCCEEEC
T ss_pred CCceEEEEecCC-CCHHHHHhh--cCcCCCCHHHHHHHHHHHHHHHHHhccC-CCCEEcCCCCcccEEEecCCCCcEEEE
Confidence 999999999995 599999964 2335689999999999999999999941 22899999999999995 47789999
Q ss_pred ecCCccccCCCCCcccccccccccccCccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCC
Q 010519 332 DFGLAKLLDSGESHITTRVMGTFGYVAPEYANTGMLNEKSDIYSFGVLLLEAVTGRDPVDYG 393 (508)
Q Consensus 332 Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltG~~Pf~~~ 393 (508)
|||++...... .....||+.|+|||++.+..++.++|||||||+||||++|+.||...
T Consensus 204 DFG~a~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~ 261 (382)
T 2vx3_A 204 DFGSSCQLGQR----IYQYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLFSGA 261 (382)
T ss_dssp CCTTCEETTCC----CCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred eccCceecccc----cccccCCccccChHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence 99999876532 23457899999999999999999999999999999999999999744
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-40 Score=324.11 Aligned_cols=254 Identities=22% Similarity=0.331 Sum_probs=203.4
Q ss_pred HhhCCcccceeEeeeCceEEEEEEEc-CCCEEEEEEEcccc--hhhHHHHHHHHHHHhcCCCCCceeEEEEEEeCceeeE
Q 010519 183 IATNRFSAENVLGEGGYGVVYKGRLI-NGSEVAVKKLLNNL--GQAEKEFRVEVEAIGHVRHKNLVRLLGYCIEGVHRML 259 (508)
Q Consensus 183 ~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~ei~~l~~l~h~niv~~~~~~~~~~~~~l 259 (508)
...++|.+.+.||+|+||.||+|++. +++.||+|++.... ......+.+|+.++++++||||+++++++.+....++
T Consensus 19 ~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 98 (287)
T 2wei_A 19 TFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYI 98 (287)
T ss_dssp HHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGBSSSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEE
T ss_pred HHhhcceeeEEEcCCCCEEEEEEEEcCCCcEEEEEEecccccchHHHHHHHHHHHHHHhccCCCccEEEEEEeCCCeEEE
Confidence 34568999999999999999999986 68899999985433 2345678889999999999999999999999999999
Q ss_pred EEeecCCCCHHHHHhhhhccCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCEEEcCC---CcEEEEecCCc
Q 010519 260 VYEYVNNGNLEQWLHGAMRNQGNLTWEARMKVIIGTAKALAYLHEAIEPKVVHRDIKSSNILIDDE---FNAKVSDFGLA 336 (508)
Q Consensus 260 v~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiH~Dlk~~NIll~~~---~~~kl~Dfgla 336 (508)
||||+++++|.+++.. ...+++..++.++.||+.||.|||+. +++|+||||+|||++.+ +.+||+|||++
T Consensus 99 v~e~~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dl~p~NIlv~~~~~~~~~kL~Dfg~~ 171 (287)
T 2wei_A 99 VGELYTGGELFDEIIK----RKRFSEHDAARIIKQVFSGITYMHKH---NIVHRDLKPENILLESKEKDCDIKIIDFGLS 171 (287)
T ss_dssp EECCCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESCSSTTCCEEECSTTGG
T ss_pred EEEccCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCChhhEEEecCCCcccEEEeccCcc
Confidence 9999999999998853 35689999999999999999999999 99999999999999754 46999999999
Q ss_pred cccCCCCCcccccccccccccCccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCCCchhcHHHHHHHHhccccccc
Q 010519 337 KLLDSGESHITTRVMGTFGYVAPEYANTGMLNEKSDIYSFGVLLLEAVTGRDPVDYGRPANEVNLVEWLKMMVGTRRAEE 416 (508)
Q Consensus 337 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 416 (508)
........ .....|++.|+|||++.+. ++.++||||||+++|+|++|..||.... .. ...........
T Consensus 172 ~~~~~~~~--~~~~~~~~~y~aPE~~~~~-~~~~~Di~slG~~l~~l~~g~~p~~~~~---~~---~~~~~~~~~~~--- 239 (287)
T 2wei_A 172 TCFQQNTK--MKDRIGTAYYIAPEVLRGT-YDEKCDVWSAGVILYILLSGTPPFYGKN---EY---DILKRVETGKY--- 239 (287)
T ss_dssp GTBCCCSS--CSCHHHHHTTCCHHHHTTC-CCTHHHHHHHHHHHHHHHHSSCSSCCSS---HH---HHHHHHHHCCC---
T ss_pred eeecCCCc--cccccCcccccChHHhcCC-CCCchhhHhHHHHHHHHHhCCCCCCCCC---HH---HHHHHHHcCCC---
Confidence 86654322 2334689999999998764 8999999999999999999999996432 11 11222111110
Q ss_pred ccCCCCCCChhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHh
Q 010519 417 VVDPNLEVKPATRALKRSLLVALRCVDPDSEKRPKMSQVVRML 459 (508)
Q Consensus 417 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L 459 (508)
.............+.+++.+||+.||.+|||+.|++++-
T Consensus 240 ----~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~hp 278 (287)
T 2wei_A 240 ----AFDLPQWRTISDDAKDLIRKMLTFHPSLRITATQCLEHP 278 (287)
T ss_dssp ----CCCSGGGTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHSH
T ss_pred ----CCCchhhhhcCHHHHHHHHHHcccChhhCcCHHHHhcCH
Confidence 011111112344567799999999999999999999854
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-40 Score=342.78 Aligned_cols=199 Identities=23% Similarity=0.301 Sum_probs=171.9
Q ss_pred hhCCcccceeEeeeCceEEEEEEEc-CCCEEEEEEEcccchhhHHHHHHHHHHHhcC------CCCCceeEEEEEEeCce
Q 010519 184 ATNRFSAENVLGEGGYGVVYKGRLI-NGSEVAVKKLLNNLGQAEKEFRVEVEAIGHV------RHKNLVRLLGYCIEGVH 256 (508)
Q Consensus 184 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~ei~~l~~l------~h~niv~~~~~~~~~~~ 256 (508)
...+|.+.+.||+|+||+||+|.+. +++.||||++.... .....+..|+.+++.+ +|+||+++++++.....
T Consensus 95 ~~~ry~~~~~LG~G~fg~V~~a~~~~~~~~vAvK~~~~~~-~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~~~~~~ 173 (429)
T 3kvw_A 95 VAYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNEK-RFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFTFRNH 173 (429)
T ss_dssp ETTTEEEEEEEEESSSEEEEEEEETTTTEEEEEEEECSCH-HHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEEEETTE
T ss_pred ccCcEEEEEEcccCccEEEEEEEECCCCcEEEEEEECCcc-chHHHHHHHHHHHHHHhhccccCCcCEEEEEeecccCCe
Confidence 4568999999999999999999875 57889999986542 3335566777777766 67899999999999999
Q ss_pred eeEEEeecCCCCHHHHHhhhhccCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCEEEcCCCc--EEEEecC
Q 010519 257 RMLVYEYVNNGNLEQWLHGAMRNQGNLTWEARMKVIIGTAKALAYLHEAIEPKVVHRDIKSSNILIDDEFN--AKVSDFG 334 (508)
Q Consensus 257 ~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiH~Dlk~~NIll~~~~~--~kl~Dfg 334 (508)
.++||||+. ++|.+++.. .....+++..++.++.||+.||.|||+. +|+||||||+|||++.++. +||+|||
T Consensus 174 ~~lv~e~~~-~~L~~~l~~--~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlKp~NILl~~~~~~~vkL~DFG 247 (429)
T 3kvw_A 174 ICMTFELLS-MNLYELIKK--NKFQGFSLPLVRKFAHSILQCLDALHKN---RIIHCDLKPENILLKQQGRSGIKVIDFG 247 (429)
T ss_dssp EEEEECCCC-CBHHHHHHH--TTTCCCCHHHHHHHHHHHHHHHHHHHHH---TEECSCCSGGGEEESSTTSCCEEECCCT
T ss_pred EEEEEeccC-CCHHHHHHh--ccCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEEccCCCcceEEeecc
Confidence 999999995 699999864 2334589999999999999999999999 9999999999999999987 9999999
Q ss_pred CccccCCCCCcccccccccccccCccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCC
Q 010519 335 LAKLLDSGESHITTRVMGTFGYVAPEYANTGMLNEKSDIYSFGVLLLEAVTGRDPVDYG 393 (508)
Q Consensus 335 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltG~~Pf~~~ 393 (508)
++...... ....+||+.|+|||++.+..++.++|||||||+||||++|..||...
T Consensus 248 ~a~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~~ 302 (429)
T 3kvw_A 248 SSCYEHQR----VYTYIQSRFYRAPEVILGARYGMPIDMWSLGCILAELLTGYPLLPGE 302 (429)
T ss_dssp TCEETTCC----CCSSCSCGGGCCHHHHHTBCCCTHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred cceecCCc----ccccCCCCCccChHHHhCCCCCchHHHHhHHHHHHHHHhCCCCCCCC
Confidence 99865432 23457899999999999999999999999999999999999999644
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-40 Score=329.08 Aligned_cols=266 Identities=26% Similarity=0.367 Sum_probs=199.3
Q ss_pred hhCCcccceeEeeeCceEEEEEEEc--CCCEEEEEEEcccchh--hHHHHHHHHHHHhcC---CCCCceeEEEEEE----
Q 010519 184 ATNRFSAENVLGEGGYGVVYKGRLI--NGSEVAVKKLLNNLGQ--AEKEFRVEVEAIGHV---RHKNLVRLLGYCI---- 252 (508)
Q Consensus 184 ~~~~~~~~~~lg~G~~g~Vy~~~~~--~~~~vavK~~~~~~~~--~~~~~~~ei~~l~~l---~h~niv~~~~~~~---- 252 (508)
..++|.+.+.||+|+||+||+|++. +|..||+|++...... ....+.+|+.+++.+ +||||+++++++.
T Consensus 9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~ 88 (326)
T 1blx_A 9 ADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRT 88 (326)
T ss_dssp GGGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEEC
T ss_pred chhceeeeeeecccccEEEEEEEecCCCCEEEEEEEeccCcccccCCchhhHHHHHHHhhhccCCCCeEeeeeeeeeccc
Confidence 3468999999999999999999983 6788999988543321 112345566666555 8999999999987
Q ss_pred -eCceeeEEEeecCCCCHHHHHhhhhccCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCEEEcCCCcEEEE
Q 010519 253 -EGVHRMLVYEYVNNGNLEQWLHGAMRNQGNLTWEARMKVIIGTAKALAYLHEAIEPKVVHRDIKSSNILIDDEFNAKVS 331 (508)
Q Consensus 253 -~~~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~ 331 (508)
.....++||||+. |+|.+++.. .....+++..++.++.||+.||.|||+. +|+||||||+|||++.++.+||+
T Consensus 89 ~~~~~~~lv~e~~~-~~L~~~l~~--~~~~~~~~~~~~~~~~qi~~~l~~lH~~---gi~H~dlkp~Nili~~~~~~kl~ 162 (326)
T 1blx_A 89 DRETKLTLVFEHVD-QDLTTYLDK--VPEPGVPTETIKDMMFQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLA 162 (326)
T ss_dssp SSEEEEEEEEECCS-CBHHHHHHH--SCTTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEEC
T ss_pred CCCceEEEEEecCC-CCHHHHHHh--cccCCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCCHHHeEEcCCCCEEEe
Confidence 4567889999997 699999964 2344589999999999999999999999 99999999999999999999999
Q ss_pred ecCCccccCCCCCcccccccccccccCccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCCCchhcHHHHHHHHhcc
Q 010519 332 DFGLAKLLDSGESHITTRVMGTFGYVAPEYANTGMLNEKSDIYSFGVLLLEAVTGRDPVDYGRPANEVNLVEWLKMMVGT 411 (508)
Q Consensus 332 Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~ 411 (508)
|||++....... ......||+.|+|||++.+..++.++|||||||++|+|++|+.||..... ......+....+.
T Consensus 163 Dfg~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~---~~~~~~i~~~~~~ 237 (326)
T 1blx_A 163 DFGLARIYSFQM--ALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSD---VDQLGKILDVIGL 237 (326)
T ss_dssp SCCSCCCCCGGG--GGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSH---HHHHHHHHHHHCC
T ss_pred cCcccccccCCC--CccccccccceeCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCH---HHHHHHHHHHcCC
Confidence 999998654321 23445789999999999999999999999999999999999999974432 1111111111111
Q ss_pred cccccc----------cCCCCC---CChhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhh
Q 010519 412 RRAEEV----------VDPNLE---VKPATRALKRSLLVALRCVDPDSEKRPKMSQVVRMLE 460 (508)
Q Consensus 412 ~~~~~~----------~~~~~~---~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 460 (508)
...... ...... ..........+.+|+.+||+.||.+|||+.+++++-.
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~ 299 (326)
T 1blx_A 238 PGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPY 299 (326)
T ss_dssp CCGGGSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTSGG
T ss_pred CCcccCccccccchhhhcccCcchhhhccccCCHHHHHHHHHHcCCCcccCCCHHHHhcCcc
Confidence 100000 000000 0001122345667999999999999999999997644
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-40 Score=333.23 Aligned_cols=256 Identities=19% Similarity=0.228 Sum_probs=174.4
Q ss_pred hCCcccce-eEeeeCceEEEEEEEc-CCCEEEEEEEcccchhhHHHHHHHHHHHhcCCCCCceeEEEEEEe----Cceee
Q 010519 185 TNRFSAEN-VLGEGGYGVVYKGRLI-NGSEVAVKKLLNNLGQAEKEFRVEVEAIGHVRHKNLVRLLGYCIE----GVHRM 258 (508)
Q Consensus 185 ~~~~~~~~-~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~ei~~l~~l~h~niv~~~~~~~~----~~~~~ 258 (508)
.++|.+.+ .||+|+||+||+|.+. +|+.||+|++..... ...+....++.+.||||+++++++.. ....+
T Consensus 27 ~~~y~i~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~----~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~ 102 (336)
T 3fhr_A 27 TDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDSPK----ARQEVDHHWQASGGPHIVCILDVYENMHHGKRCLL 102 (336)
T ss_dssp GGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESSHH----HHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEE
T ss_pred cceeEecceeeeeCCCeEEEEEEECCCCCEEEEEEecCcHH----HHHHHHHHHHhcCCCChHHHHHHHhhccCCCceEE
Confidence 45888854 6999999999999986 689999999865321 12222334566799999999999986 45578
Q ss_pred EEEeecCCCCHHHHHhhhhccCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCEEEcC---CCcEEEEecCC
Q 010519 259 LVYEYVNNGNLEQWLHGAMRNQGNLTWEARMKVIIGTAKALAYLHEAIEPKVVHRDIKSSNILIDD---EFNAKVSDFGL 335 (508)
Q Consensus 259 lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiH~Dlk~~NIll~~---~~~~kl~Dfgl 335 (508)
+||||+++|+|.+++.. .....+++..++.++.||+.||.|||++ +|+||||||+|||++. ++.+||+|||+
T Consensus 103 lv~e~~~gg~L~~~l~~--~~~~~l~~~~~~~i~~ql~~~l~~LH~~---~ivH~dlkp~NIll~~~~~~~~~kl~Dfg~ 177 (336)
T 3fhr_A 103 IIMECMEGGELFSRIQE--RGDQAFTEREAAEIMRDIGTAIQFLHSH---NIAHRDVKPENLLYTSKEKDAVLKLTDFGF 177 (336)
T ss_dssp EEEECCTTEEHHHHHHT--C-CCCCBHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEESCSSTTCCEEECCCTT
T ss_pred EEEeccCCCCHHHHHHh--cCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEEecCCCceEEEecccc
Confidence 99999999999999964 2335799999999999999999999999 9999999999999986 45599999999
Q ss_pred ccccCCCCCcccccccccccccCccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCCCchhcHHHHHHHHhcccccc
Q 010519 336 AKLLDSGESHITTRVMGTFGYVAPEYANTGMLNEKSDIYSFGVLLLEAVTGRDPVDYGRPANEVNLVEWLKMMVGTRRAE 415 (508)
Q Consensus 336 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~ 415 (508)
+....... .....||+.|+|||++.+..++.++|||||||++|+|++|..||.......... ...... .. .
T Consensus 178 ~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~--~~~~~~-~~---~ 248 (336)
T 3fhr_A 178 AKETTQNA---LQTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISP--GMKRRI-RL---G 248 (336)
T ss_dssp CEEC-------------------------CHHHHHHHHHHHHHHHHHHHHSSCCC-------------------------
T ss_pred ceeccccc---cccCCCCcCccChhhhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCccchhhhh--hHHHhh-hc---c
Confidence 98654322 334568999999999998889999999999999999999999996433211100 000000 00 0
Q ss_pred cccCCCCCCChhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhhc
Q 010519 416 EVVDPNLEVKPATRALKRSLLVALRCVDPDSEKRPKMSQVVRMLEA 461 (508)
Q Consensus 416 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~ 461 (508)
. ..+...........+.+|+.+||+.||.+|||+.|++++-+-
T Consensus 249 ~---~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~ 291 (336)
T 3fhr_A 249 Q---YGFPNPEWSEVSEDAKQLIRLLLKTDPTERLTITQFMNHPWI 291 (336)
T ss_dssp -----CCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHSHHH
T ss_pred c---cccCchhhccCCHHHHHHHHHHCCCChhHCcCHHHHhcCccc
Confidence 0 001111111234456679999999999999999999996654
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-40 Score=330.74 Aligned_cols=265 Identities=22% Similarity=0.303 Sum_probs=195.1
Q ss_pred hCCcccceeEeeeCceEEEEEEEc-CCCEEEEEEEcccchhhHHHHHHHHHHHhcCCCCCceeEEEEEE-----------
Q 010519 185 TNRFSAENVLGEGGYGVVYKGRLI-NGSEVAVKKLLNNLGQAEKEFRVEVEAIGHVRHKNLVRLLGYCI----------- 252 (508)
Q Consensus 185 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~ei~~l~~l~h~niv~~~~~~~----------- 252 (508)
.++|.+.+.||+|+||.||+|.+. +++.||+|++........+.+.+|+.+++.++||||+++++++.
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 89 (320)
T 2i6l_A 10 GSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVFEILGPSGSQLTDDVG 89 (320)
T ss_dssp TTTEEEEEECC-----CEEEEEETTTTEEEEEEEEECCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECTTSCBCCC---
T ss_pred CCceeEEEEeccCCCeEEEEEEECCCCeEEEEEEEecCChHHHHHHHHHHHHHHhcCCCCeeEEEEeccccccccccccc
Confidence 468999999999999999999986 48899999987666666678889999999999999999999874
Q ss_pred ---eCceeeEEEeecCCCCHHHHHhhhhccCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCEEEc-CCCcE
Q 010519 253 ---EGVHRMLVYEYVNNGNLEQWLHGAMRNQGNLTWEARMKVIIGTAKALAYLHEAIEPKVVHRDIKSSNILID-DEFNA 328 (508)
Q Consensus 253 ---~~~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiH~Dlk~~NIll~-~~~~~ 328 (508)
+....++||||+. |+|.+++. ...+++..++.++.||+.||.|||++ +|+||||||+|||++ +++.+
T Consensus 90 ~~~~~~~~~lv~e~~~-~~L~~~~~-----~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~ 160 (320)
T 2i6l_A 90 SLTELNSVYIVQEYME-TDLANVLE-----QGPLLEEHARLFMYQLLRGLKYIHSA---NVLHRDLKPANLFINTEDLVL 160 (320)
T ss_dssp -CCSCSEEEEEEECCS-EEHHHHHT-----TCCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSGGGEEEETTTTEE
T ss_pred cccccCceeEEeeccC-CCHHHHhh-----cCCccHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEcCCCCeE
Confidence 3467789999997 69999884 35688999999999999999999999 999999999999997 57799
Q ss_pred EEEecCCccccCCCCC--cccccccccccccCccccCC-CCCCChhhHHHHHHHHHHHHhCCCCCCCCCCCchhcHHHHH
Q 010519 329 KVSDFGLAKLLDSGES--HITTRVMGTFGYVAPEYANT-GMLNEKSDIYSFGVLLLEAVTGRDPVDYGRPANEVNLVEWL 405 (508)
Q Consensus 329 kl~Dfgla~~~~~~~~--~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwS~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~ 405 (508)
||+|||++........ .......+++.|+|||++.+ ..++.++|||||||++|||++|+.||...... .....+
T Consensus 161 kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~---~~~~~~ 237 (320)
T 2i6l_A 161 KIGDFGLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHEL---EQMQLI 237 (320)
T ss_dssp EECCCTTCBCC--------CCCGGGSCCTTCCHHHHHCTTCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHH---HHHHHH
T ss_pred EEccCccccccCCCcccccccccccccccccCcHHhcCcccCCchhhhHhHHHHHHHHHhCCCCCCCCCHH---HHHHHH
Confidence 9999999987643211 12334567999999998865 77899999999999999999999999744321 111111
Q ss_pred HHHhcccc----------c-----ccccCCCCCCC-hhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhhc
Q 010519 406 KMMVGTRR----------A-----EEVVDPNLEVK-PATRALKRSLLVALRCVDPDSEKRPKMSQVVRMLEA 461 (508)
Q Consensus 406 ~~~~~~~~----------~-----~~~~~~~~~~~-~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~ 461 (508)
........ . .....+..... ........+.+|+.+||+.||.+|||+.|++++-.-
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~ 309 (320)
T 2i6l_A 238 LESIPVVHEEDRQELLSVIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMDRLTAEEALSHPYM 309 (320)
T ss_dssp HHHSCCCCHHHHHHHHTTSCHHHHHHTTSCCCCHHHHSTTCCHHHHHHHHTTSCSSGGGSCCHHHHHTSHHH
T ss_pred HHhcCCCchhhhhhhhhcCcccccccccCCCCChhHhcchhhHHHHHHHHHHcCCCccccCCHHHHhCCccc
Confidence 10000000 0 00000000000 001124567789999999999999999999986543
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-40 Score=337.76 Aligned_cols=263 Identities=26% Similarity=0.333 Sum_probs=186.7
Q ss_pred hCCcccceeEeeeCceEEEEEEEc-CCCEEEEEEEcccc--hhhHHHHHHHHHHHhcCCCCCceeEEEEEEeC------c
Q 010519 185 TNRFSAENVLGEGGYGVVYKGRLI-NGSEVAVKKLLNNL--GQAEKEFRVEVEAIGHVRHKNLVRLLGYCIEG------V 255 (508)
Q Consensus 185 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~ei~~l~~l~h~niv~~~~~~~~~------~ 255 (508)
.++|.+.+.||+|+||.||+|.+. +|+.||||++.... ......+.+|+.+++.++||||+++++++... .
T Consensus 28 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~ 107 (367)
T 2fst_X 28 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN 107 (367)
T ss_dssp ETTEEEEEECC----CCEEEEEETTTTEEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCC
T ss_pred CCceEEeeEEeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCccccCC
Confidence 368999999999999999999875 68899999986432 33456788899999999999999999998754 4
Q ss_pred eeeEEEeecCCCCHHHHHhhhhccCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCEEEcCCCcEEEEecCC
Q 010519 256 HRMLVYEYVNNGNLEQWLHGAMRNQGNLTWEARMKVIIGTAKALAYLHEAIEPKVVHRDIKSSNILIDDEFNAKVSDFGL 335 (508)
Q Consensus 256 ~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~Dfgl 335 (508)
..++|+||+ +++|.+++. ...+++..+..++.||+.||.|||+. +|+||||||+|||++.++.+||+|||+
T Consensus 108 ~~~lv~e~~-~~~L~~~~~-----~~~l~~~~~~~i~~qi~~aL~~LH~~---givH~Dlkp~NIll~~~~~~kL~DFG~ 178 (367)
T 2fst_X 108 DVYLVTHLM-GADLNNIVK-----CQKLTDDHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGL 178 (367)
T ss_dssp CCEEEEECC-CEECC----------CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECC---
T ss_pred eEEEEeccc-CCCHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHhhEEECCCCCEEEeeccc
Confidence 578999999 789999874 25699999999999999999999999 999999999999999999999999999
Q ss_pred ccccCCCCCcccccccccccccCccccCC-CCCCChhhHHHHHHHHHHHHhCCCCCCCCCCCchhcHHHHHHHHhccccc
Q 010519 336 AKLLDSGESHITTRVMGTFGYVAPEYANT-GMLNEKSDIYSFGVLLLEAVTGRDPVDYGRPANEVNLVEWLKMMVGTRRA 414 (508)
Q Consensus 336 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwS~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~ 414 (508)
++..... .....||+.|+|||++.+ ..++.++|||||||++|||++|+.||..... ......+....+....
T Consensus 179 a~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~---~~~l~~i~~~~g~p~~ 251 (367)
T 2fst_X 179 ARHTADE----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDH---IDQLKLILRLVGTPGA 251 (367)
T ss_dssp ----------------CCCTTCCHHHHTTCCSCCTTHHHHHHHHHHHHHHHSSCSCCCSSH---HHHHHHHHHHHCSCCH
T ss_pred ccccccc----CCCcCcCcCccChHHHcCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCH---HHHHHHHHHHhCCCCH
Confidence 9865432 344578999999999877 6899999999999999999999999964322 1111212222211100
Q ss_pred cc--------------ccCCCCCCChh---HHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhhcCC
Q 010519 415 EE--------------VVDPNLEVKPA---TRALKRSLLVALRCVDPDSEKRPKMSQVVRMLEADD 463 (508)
Q Consensus 415 ~~--------------~~~~~~~~~~~---~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~ 463 (508)
.. .+......... ......+.+|+.+||..||.+|||+.|+++|-.-..
T Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~t~~e~L~hp~~~~ 317 (367)
T 2fst_X 252 ELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQ 317 (367)
T ss_dssp HHHTTCCCHHHHHHHHTSCCCCCCCHHHHTTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTT
T ss_pred HHHHHhhhHHHHHHHhccCCCCCCCHHHHCCCCCHHHHHHHHHhCCCCcccCcCHHHHhcChhhhh
Confidence 00 00000000000 012345678999999999999999999999765443
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.2e-42 Score=339.99 Aligned_cols=264 Identities=23% Similarity=0.350 Sum_probs=202.3
Q ss_pred HHHHHHhhCCcccceeEeeeCceEEEEEEEcCCCEEEEEEEcccc--hhhHHHHHHHHHHHhcCCCCCceeEEEEEEeCc
Q 010519 178 LRDLEIATNRFSAENVLGEGGYGVVYKGRLINGSEVAVKKLLNNL--GQAEKEFRVEVEAIGHVRHKNLVRLLGYCIEGV 255 (508)
Q Consensus 178 ~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~--~~~~~~~~~ei~~l~~l~h~niv~~~~~~~~~~ 255 (508)
..++++..++|.+.+.||+|+||.||+|.+.+ .+|+|++.... ....+.+.+|+.++++++||||+++++++.+..
T Consensus 25 ~~~~~i~~~~~~~~~~lg~G~~g~V~~~~~~~--~~avk~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~ 102 (319)
T 2y4i_B 25 LQEWDIPFEQLEIGELIGKGRFGQVYHGRWHG--EVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACMSPP 102 (319)
T ss_dssp GGGSSSCCSCEECCCBCCCSSSSEEEEEEESS--SEEEEECCCCSCCCCCCCCCCTTGGGGTTCCCTTBCCCCEEEECSS
T ss_pred cccccCCHHHeEEeeEeccCCceEEEEEEEcC--eEEEEEeecCCCCHHHHHHHHHHHHHHhcCCCCCEeEEEEEEecCC
Confidence 45667778899999999999999999998743 59999885432 222345677999999999999999999999999
Q ss_pred eeeEEEeecCCCCHHHHHhhhhccCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCEEEcCCCcEEEEecCC
Q 010519 256 HRMLVYEYVNNGNLEQWLHGAMRNQGNLTWEARMKVIIGTAKALAYLHEAIEPKVVHRDIKSSNILIDDEFNAKVSDFGL 335 (508)
Q Consensus 256 ~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~Dfgl 335 (508)
..++||||+++++|.+++. .....+++..++.++.||+.||.|||+. +++||||||+|||++ ++.+||+|||+
T Consensus 103 ~~~iv~e~~~~~~L~~~l~---~~~~~~~~~~~~~i~~qi~~al~~lH~~---~i~H~dlkp~NIl~~-~~~~~l~Dfg~ 175 (319)
T 2y4i_B 103 HLAIITSLCKGRTLYSVVR---DAKIVLDVNKTRQIAQEIVKGMGYLHAK---GILHKDLKSKNVFYD-NGKVVITDFGL 175 (319)
T ss_dssp CEEEECBCCCSEEHHHHTT---SSCCCCCSHHHHHHHHHHHHHHHHHHHT---TCCCCCCCSTTEEEC---CCEECCCSC
T ss_pred ceEEEeecccCCcHHHHHH---hcCCCCCHHHHHHHHHHHHHHHHHHHhC---CccccCCChhhEEEe-CCCEEEeecCC
Confidence 9999999999999999985 2345789999999999999999999999 999999999999998 67999999999
Q ss_pred ccccCCCC----CcccccccccccccCccccCC---------CCCCChhhHHHHHHHHHHHHhCCCCCCCCCCCchhcHH
Q 010519 336 AKLLDSGE----SHITTRVMGTFGYVAPEYANT---------GMLNEKSDIYSFGVLLLEAVTGRDPVDYGRPANEVNLV 402 (508)
Q Consensus 336 a~~~~~~~----~~~~~~~~gt~~y~aPE~~~~---------~~~~~~~DvwS~Gvvl~elltG~~Pf~~~~~~~~~~~~ 402 (508)
+....... ........|++.|+|||++.+ ..++.++|||||||++|||++|..||..... .
T Consensus 176 ~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~------~ 249 (319)
T 2y4i_B 176 FSISGVLQAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPA------E 249 (319)
T ss_dssp CC----------CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHSSCSSSSCCH------H
T ss_pred ccccccccccccccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCCH------H
Confidence 87543211 112333468999999999864 4578999999999999999999999964321 1
Q ss_pred HHHHHHhcccccccccCCCCCCChhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhhcCCCC
Q 010519 403 EWLKMMVGTRRAEEVVDPNLEVKPATRALKRSLLVALRCVDPDSEKRPKMSQVVRMLEADDYP 465 (508)
Q Consensus 403 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~ 465 (508)
........... +..... .....+.+++.+||+.||.+|||+.++++.|+.....
T Consensus 250 ~~~~~~~~~~~------~~~~~~---~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~l~~~ 303 (319)
T 2y4i_B 250 AIIWQMGTGMK------PNLSQI---GMGKEISDILLFCWAFEQEERPTFTKLMDMLEKLPKR 303 (319)
T ss_dssp HHHHHHHTTCC------CCCCCS---SCCTTHHHHHHHHHCSSTTTSCCHHHHHHHHTTC---
T ss_pred HHHHHhccCCC------CCCCcC---CCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHh
Confidence 11112211111 111110 1123456699999999999999999999999987654
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-39 Score=329.78 Aligned_cols=267 Identities=24% Similarity=0.323 Sum_probs=201.5
Q ss_pred hCCcccceeEeeeCceEEEEEEEc-CCCEEEEEEEcccc-hhhHHHHHHHHHHHhcCCCCCceeEEEEEEeC-----cee
Q 010519 185 TNRFSAENVLGEGGYGVVYKGRLI-NGSEVAVKKLLNNL-GQAEKEFRVEVEAIGHVRHKNLVRLLGYCIEG-----VHR 257 (508)
Q Consensus 185 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~ei~~l~~l~h~niv~~~~~~~~~-----~~~ 257 (508)
.++|.+.+.||+|+||.||+|++. +|+.||||++.... ......+.+|+.+++.++||||+++++++... ...
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 89 (353)
T 2b9h_A 10 SSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHENIITIFNIQRPDSFENFNEV 89 (353)
T ss_dssp CTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCSTTCCCE
T ss_pred ccceEEeeEEcCCCCeEEEEEEECCCCcEEEEEeecccccchHHHHHHHHHHHHHhCcCCCcCCeeeeecccccCccceE
Confidence 468999999999999999999986 68899999986433 33445678899999999999999999988764 567
Q ss_pred eEEEeecCCCCHHHHHhhhhccCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCEEEcCCCcEEEEecCCcc
Q 010519 258 MLVYEYVNNGNLEQWLHGAMRNQGNLTWEARMKVIIGTAKALAYLHEAIEPKVVHRDIKSSNILIDDEFNAKVSDFGLAK 337 (508)
Q Consensus 258 ~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~Dfgla~ 337 (508)
++||||+. |+|.+++.. ..+++..++.++.||+.||.|||++ +|+||||||+|||++.++.+||+|||++.
T Consensus 90 ~lv~e~~~-~~L~~~~~~-----~~~~~~~~~~~~~qi~~~L~~LH~~---~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~ 160 (353)
T 2b9h_A 90 YIIQELMQ-TDLHRVIST-----QMLSDDHIQYFIYQTLRAVKVLHGS---NVIHRDLKPSNLLINSNCDLKVCDFGLAR 160 (353)
T ss_dssp EEEECCCS-EEHHHHHHH-----CCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECTTCCEEECCCTTCE
T ss_pred EEEEeccC-ccHHHHHhh-----cCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEEcCCCcEEEEeccccc
Confidence 99999996 599998853 4689999999999999999999999 99999999999999999999999999998
Q ss_pred ccCCCCCc---------ccccccccccccCccccCC-CCCCChhhHHHHHHHHHHHHhCCCCCCCCCCCchhcHHHHHHH
Q 010519 338 LLDSGESH---------ITTRVMGTFGYVAPEYANT-GMLNEKSDIYSFGVLLLEAVTGRDPVDYGRPANEVNLVEWLKM 407 (508)
Q Consensus 338 ~~~~~~~~---------~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwS~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~ 407 (508)
........ ......||+.|+|||++.+ ..++.++|||||||++|+|++|+.||..... ......+..
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~---~~~~~~~~~ 237 (353)
T 2b9h_A 161 IIDESAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDY---RHQLLLIFG 237 (353)
T ss_dssp ECC----------------CCCCCCGGGCCHHHHHSCCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSH---HHHHHHHHH
T ss_pred ccccccccccCccccccchhhccccccccCCeeeccCCCccchhhHHHHHHHHHHHHhCCCCCCCCCc---HHHHHHHHH
Confidence 76432211 1223578999999998754 7789999999999999999999999964321 111111111
Q ss_pred HhcccccccccC--------------CCCCCCh----hHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhhcCC
Q 010519 408 MVGTRRAEEVVD--------------PNLEVKP----ATRALKRSLLVALRCVDPDSEKRPKMSQVVRMLEADD 463 (508)
Q Consensus 408 ~~~~~~~~~~~~--------------~~~~~~~----~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~ 463 (508)
..+......... +...... .......+.+|+.+||+.||.+|||+.|++++-.-..
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~ 311 (353)
T 2b9h_A 238 IIGTPHSDNDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAKEALEHPYLQT 311 (353)
T ss_dssp HHCCCCSTTTTTTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTT
T ss_pred HhCCCchhccccccccchhhHHhhcccCCCCcchhhhcccCCHHHHHHHHHhcCcCcccCCCHHHHhcCccccc
Confidence 111111000000 0000000 0122345678999999999999999999998765543
|
| >4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-40 Score=334.96 Aligned_cols=261 Identities=24% Similarity=0.329 Sum_probs=198.1
Q ss_pred hCCcccceeEeeeCceEEEEEEEc-CCCEEEEEEEcccc--hhhHHHHHHHHHHHhcCCCCCceeEEEEEEeCcee----
Q 010519 185 TNRFSAENVLGEGGYGVVYKGRLI-NGSEVAVKKLLNNL--GQAEKEFRVEVEAIGHVRHKNLVRLLGYCIEGVHR---- 257 (508)
Q Consensus 185 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~ei~~l~~l~h~niv~~~~~~~~~~~~---- 257 (508)
.++|.+.+.||+|+||+||+|.+. +|+.||||++.... ......+.+|+.+++.++||||+++++++......
T Consensus 41 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 120 (371)
T 4exu_A 41 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFY 120 (371)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSSTTCC
T ss_pred cccEEEEeEEecCCCeEEEEEEECCCCCEEEEEEecccccchhHHHHHHHHHHHHHhcCCCCchhhhhheeccCCcccce
Confidence 468999999999999999999875 68899999986543 33346788899999999999999999999877654
Q ss_pred --eEEEeecCCCCHHHHHhhhhccCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCEEEcCCCcEEEEecCC
Q 010519 258 --MLVYEYVNNGNLEQWLHGAMRNQGNLTWEARMKVIIGTAKALAYLHEAIEPKVVHRDIKSSNILIDDEFNAKVSDFGL 335 (508)
Q Consensus 258 --~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~Dfgl 335 (508)
++||||+. ++|.+++. ..+++..+..++.||+.||.|||+. +|+||||||+|||++.++.+||+|||+
T Consensus 121 ~~~lv~e~~~-~~l~~~~~------~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIll~~~~~~kL~Dfg~ 190 (371)
T 4exu_A 121 DFYLVMPFMQ-TDLQKIMG------MEFSEEKIQYLVYQMLKGLKYIHSA---GVVHRDLKPGNLAVNEDCELKILDFGL 190 (371)
T ss_dssp CCEEEEECCC-EEHHHHTT------SCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECSTTC
T ss_pred eEEEEEcccc-ccHHHHhh------cCCCHHHHHHHHHHHHHHHHHHHHC---CCcCCCcCHHHeEECCCCCEEEEecCc
Confidence 89999996 68888762 3489999999999999999999999 999999999999999999999999999
Q ss_pred ccccCCCCCcccccccccccccCccccCC-CCCCChhhHHHHHHHHHHHHhCCCCCCCCCCCchhcHHHHHHHHhccccc
Q 010519 336 AKLLDSGESHITTRVMGTFGYVAPEYANT-GMLNEKSDIYSFGVLLLEAVTGRDPVDYGRPANEVNLVEWLKMMVGTRRA 414 (508)
Q Consensus 336 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwS~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~ 414 (508)
+...... .....||+.|+|||++.+ ..++.++|||||||++|+|++|+.||..... ......+....+....
T Consensus 191 a~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~---~~~~~~i~~~~~~~~~ 263 (371)
T 4exu_A 191 ARHADAE----MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDY---LDQLTQILKVTGVPGT 263 (371)
T ss_dssp C------------CTTCCCTTSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSH---HHHHHHHHHHHCCCCH
T ss_pred ccccccC----cCCcccCccccCHHHhcCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCh---HHHHHHHHHHhCCCcH
Confidence 9865432 334578999999999987 7899999999999999999999999964321 1111111111111000
Q ss_pred c--------------cccCCCCCCCh---hHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhhcC
Q 010519 415 E--------------EVVDPNLEVKP---ATRALKRSLLVALRCVDPDSEKRPKMSQVVRMLEAD 462 (508)
Q Consensus 415 ~--------------~~~~~~~~~~~---~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~ 462 (508)
. ........... .......+.+|+.+||+.||.+|||+.|++++-.-.
T Consensus 264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~ 328 (371)
T 4exu_A 264 EFVQKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTHPFFE 328 (371)
T ss_dssp HHHTTCSCHHHHHHHHHSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTSGGGT
T ss_pred HHHHHhhhhhhhhhhhccCCCcchhHHHhccccChHHHHHHHHHCCCChhhcCCHHHHhcCcccc
Confidence 0 00000000000 011245677899999999999999999999876544
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-40 Score=342.20 Aligned_cols=256 Identities=26% Similarity=0.358 Sum_probs=189.2
Q ss_pred CCcccceeEeeeCceEEEEEEEcCCCEEEEEEEcccchhhHHHHHHHHHHHhcC-CCCCceeEEEEEEeCceeeEEEeec
Q 010519 186 NRFSAENVLGEGGYGVVYKGRLINGSEVAVKKLLNNLGQAEKEFRVEVEAIGHV-RHKNLVRLLGYCIEGVHRMLVYEYV 264 (508)
Q Consensus 186 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~ei~~l~~l-~h~niv~~~~~~~~~~~~~lv~E~~ 264 (508)
+.|...+.||+|+||+||.+...+|+.||||++.... ...+.+|+.++..+ +||||+++++++.+....++||||+
T Consensus 15 ~~~~~~~~LG~G~~g~V~~~~~~~g~~vAvK~~~~~~---~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~lv~E~~ 91 (434)
T 2rio_A 15 NLVVSEKILGYGSSGTVVFQGSFQGRPVAVKRMLIDF---CDIALMEIKLLTESDDHPNVIRYYCSETTDRFLYIALELC 91 (434)
T ss_dssp SCEEEEEEEEECSTTCEEEEEESSSSEEEEEEEEGGG---HHHHHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEECCC
T ss_pred heeeccCeEeeCCCeEEEEEEEECCeEEEEEEEcHHH---HHHHHHHHHHHHhccCCCCcCeEEEEEecCCeEEEEEecC
Confidence 4566678999999999987766789999999986532 34567799999876 8999999999999999999999999
Q ss_pred CCCCHHHHHhhhhccCCC---ccHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCEEEcCC-------------CcE
Q 010519 265 NNGNLEQWLHGAMRNQGN---LTWEARMKVIIGTAKALAYLHEAIEPKVVHRDIKSSNILIDDE-------------FNA 328 (508)
Q Consensus 265 ~~gsL~~~l~~~~~~~~~---l~~~~~~~i~~~i~~al~yLH~~~~~~iiH~Dlk~~NIll~~~-------------~~~ 328 (508)
. |+|.+++......... ..+..++.++.||+.||.|||++ +|+||||||+|||++.+ +.+
T Consensus 92 ~-gsL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDLkp~NILl~~~~~~~~~~~~~~~~~~~ 167 (434)
T 2rio_A 92 N-LNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSL---KIIHRDLKPQNILVSTSSRFTADQQTGAENLRI 167 (434)
T ss_dssp S-EEHHHHHHTC------------CCHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEECCHHHHSCCTTCCCSCEE
T ss_pred C-CCHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHHC---CccccCCChHhEEEecCcccccccccCCCceEE
Confidence 5 6999999642211111 12334678999999999999999 99999999999999754 489
Q ss_pred EEEecCCccccCCCCCc---ccccccccccccCccccCC-------CCCCChhhHHHHHHHHHHHHh-CCCCCCCCCCCc
Q 010519 329 KVSDFGLAKLLDSGESH---ITTRVMGTFGYVAPEYANT-------GMLNEKSDIYSFGVLLLEAVT-GRDPVDYGRPAN 397 (508)
Q Consensus 329 kl~Dfgla~~~~~~~~~---~~~~~~gt~~y~aPE~~~~-------~~~~~~~DvwS~Gvvl~ellt-G~~Pf~~~~~~~ 397 (508)
||+|||++......... ......||+.|+|||++.+ ..++.++|||||||++|||++ |..||......
T Consensus 168 kL~DFG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~- 246 (434)
T 2rio_A 168 LISDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYSR- 246 (434)
T ss_dssp EECCCTTCEECCC--------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHHHHHTTSCCTTCSTTTH-
T ss_pred EEcccccceecCCCCccceeeecCCCCCCCccCHHHhccccccccccCcchhhhhHhHHHHHHHHHhCCCCCCCCchhh-
Confidence 99999999877543321 1234579999999999976 678999999999999999999 99999643221
Q ss_pred hhcHHHHHHHHhcccccccccCCCCCCChhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhh
Q 010519 398 EVNLVEWLKMMVGTRRAEEVVDPNLEVKPATRALKRSLLVALRCVDPDSEKRPKMSQVVRMLE 460 (508)
Q Consensus 398 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 460 (508)
. .... ...... +.............+.+|+.+||+.||.+|||+.++++|-.
T Consensus 247 ~---~~i~---~~~~~~-----~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~hp~ 298 (434)
T 2rio_A 247 E---SNII---RGIFSL-----DEMKCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLRHPL 298 (434)
T ss_dssp H---HHHH---HTCCCC-----CCCTTCCCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHTSGG
T ss_pred H---HHHh---cCCCCc-----ccccccccccchHHHHHHHHHHhhCChhhCCCHHHHHhCCc
Confidence 1 1111 111111 11111223345567888999999999999999999998654
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-40 Score=328.56 Aligned_cols=262 Identities=25% Similarity=0.364 Sum_probs=181.9
Q ss_pred HHhhCCcccceeEeeeCceEEEEEEEc-CCCEEEEEEEcccc-hhhHHHHHHHHH-HHhcCCCCCceeEEEEEEeCceee
Q 010519 182 EIATNRFSAENVLGEGGYGVVYKGRLI-NGSEVAVKKLLNNL-GQAEKEFRVEVE-AIGHVRHKNLVRLLGYCIEGVHRM 258 (508)
Q Consensus 182 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~ei~-~l~~l~h~niv~~~~~~~~~~~~~ 258 (508)
.+..++|.+.+.||+|+||.||+|.+. +|+.||||++.... ......+..|+. +++.++||||+++++++.+....+
T Consensus 18 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~h~niv~~~~~~~~~~~~~ 97 (327)
T 3aln_A 18 DFTAEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYGALFREGDCW 97 (327)
T ss_dssp CCCSCSEEC-CEEEECSSEEEEEEEETTTTEEEEEEEEECCCCHHHHHHHHHHHHHHHSSCCCTTBCCEEEEEECSSEEE
T ss_pred ccCHHHhhehheeccCCCEEEEEEEEcCCCCEEEEEEeecccCchHHHHHHHHHHHHHHcCCCCcEeeeeeEEEeCCceE
Confidence 344578999999999999999999985 68899999986543 233344555665 777889999999999999999999
Q ss_pred EEEeecCCCCHHHHHhhhhc-cCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCEEEcCCCcEEEEecCCcc
Q 010519 259 LVYEYVNNGNLEQWLHGAMR-NQGNLTWEARMKVIIGTAKALAYLHEAIEPKVVHRDIKSSNILIDDEFNAKVSDFGLAK 337 (508)
Q Consensus 259 lv~E~~~~gsL~~~l~~~~~-~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~Dfgla~ 337 (508)
+||||+++ +|.+++..... ....+++..+..++.|++.||.|||+.. +|+||||||+|||++.++.+||+|||++.
T Consensus 98 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~--~ivH~dlkp~NIll~~~~~~kl~Dfg~~~ 174 (327)
T 3aln_A 98 ICMELMST-SFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKENL--KIIHRDIKPSNILLDRSGNIKLCDFGISG 174 (327)
T ss_dssp EEECCCSE-EHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHHH--SCCCSCCCGGGEEEETTTEEEECCCSSSC
T ss_pred EEEeecCC-ChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHhccC--CEeECCCCHHHEEEcCCCCEEEccCCCce
Confidence 99999975 88888753222 3567899999999999999999999842 79999999999999999999999999998
Q ss_pred ccCCCCCcccccccccccccCcccc----CCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCCCchhcHHHHHHHHhcccc
Q 010519 338 LLDSGESHITTRVMGTFGYVAPEYA----NTGMLNEKSDIYSFGVLLLEAVTGRDPVDYGRPANEVNLVEWLKMMVGTRR 413 (508)
Q Consensus 338 ~~~~~~~~~~~~~~gt~~y~aPE~~----~~~~~~~~~DvwS~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~ 413 (508)
....... .....||+.|+|||++ .+..++.++|||||||++|+|++|..||....... +.+. .
T Consensus 175 ~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~-----~~~~------~ 241 (327)
T 3aln_A 175 QLVDSIA--KTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVF-----DQLT------Q 241 (327)
T ss_dssp C--------------------------------CCSHHHHHHHHHHHHHHHHSCCCSSCC------------C------C
T ss_pred ecccccc--cccCCCCccccCceeeccccCcCCCCchhhHHHHHHHHHHHHHCCCCCCCcchHH-----HHHH------H
Confidence 6643322 2334689999999998 46678999999999999999999999996432110 0000 0
Q ss_pred cccccCCCCCCChhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHh
Q 010519 414 AEEVVDPNLEVKPATRALKRSLLVALRCVDPDSEKRPKMSQVVRML 459 (508)
Q Consensus 414 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L 459 (508)
......+.+...........+.+|+.+||+.||.+|||+.+++++-
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~hp 287 (327)
T 3aln_A 242 VVKGDPPQLSNSEEREFSPSFINFVNLCLTKDESKRPKYKELLKHP 287 (327)
T ss_dssp CCCSCCCCCCCCSSCCCCHHHHHHHHHHTCSSGGGSCCHHHHTTSH
T ss_pred HhcCCCCCCCCcccccCCHHHHHHHHHHhhCChhhCcCHHHHHhCh
Confidence 0000111111111112334567799999999999999999998754
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-39 Score=332.20 Aligned_cols=269 Identities=19% Similarity=0.237 Sum_probs=201.9
Q ss_pred hCCcccceeEeeeCceEEEEEEEc-CCCEEEEEEEcccchhhHHHHHHHHHHHhcCC-----------CCCceeEEEEEE
Q 010519 185 TNRFSAENVLGEGGYGVVYKGRLI-NGSEVAVKKLLNNLGQAEKEFRVEVEAIGHVR-----------HKNLVRLLGYCI 252 (508)
Q Consensus 185 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~ei~~l~~l~-----------h~niv~~~~~~~ 252 (508)
.++|.+.+.||+|+||+||+|++. +++.||||.+.... .....+..|+.++++++ ||||+++++++.
T Consensus 18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~~~~~~~ 96 (373)
T 1q8y_A 18 DARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDK-VYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFN 96 (373)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCH-HHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEE
T ss_pred CCeEEEEEeeeecCCeEEEEEEecCCCcEEEEEEecCCc-cchhhhhHHHHHHHHhhcccccchhccccchHHHHHHHhh
Confidence 468999999999999999999874 68899999986432 33456778999988876 899999999998
Q ss_pred eCc----eeeEEEeecCCCCHHHHHhhhhccCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCEEEc-----
Q 010519 253 EGV----HRMLVYEYVNNGNLEQWLHGAMRNQGNLTWEARMKVIIGTAKALAYLHEAIEPKVVHRDIKSSNILID----- 323 (508)
Q Consensus 253 ~~~----~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiH~Dlk~~NIll~----- 323 (508)
... ..++||||+ +++|.+++.. .....+++..++.++.||+.||.|||++. +|+||||||+|||++
T Consensus 97 ~~~~~~~~~~lv~e~~-~~~L~~~~~~--~~~~~~~~~~~~~i~~qi~~aL~~lH~~~--~ivH~Dikp~NIll~~~~~~ 171 (373)
T 1q8y_A 97 HKGPNGVHVVMVFEVL-GENLLALIKK--YEHRGIPLIYVKQISKQLLLGLDYMHRRC--GIIHTDIKPENVLMEIVDSP 171 (373)
T ss_dssp EEETTEEEEEEEECCC-CEEHHHHHHH--TTTSCCCHHHHHHHHHHHHHHHHHHHHTT--CEECSCCSGGGEEEEEEETT
T ss_pred ccCCCCceEEEEEecC-CCCHHHHHHH--hhccCCcHHHHHHHHHHHHHHHHHHHhcC--CEEecCCChHHeEEeccCCC
Confidence 654 778999999 8899999964 23456899999999999999999999842 899999999999994
Q ss_pred -CCCcEEEEecCCccccCCCCCcccccccccccccCccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCCCchhcHH
Q 010519 324 -DEFNAKVSDFGLAKLLDSGESHITTRVMGTFGYVAPEYANTGMLNEKSDIYSFGVLLLEAVTGRDPVDYGRPANEVNLV 402 (508)
Q Consensus 324 -~~~~~kl~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltG~~Pf~~~~~~~~~~~~ 402 (508)
..+.+||+|||++...... .....||+.|+|||++.+..++.++|||||||+||||++|..||............
T Consensus 172 ~~~~~~kl~Dfg~a~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~ 247 (373)
T 1q8y_A 172 ENLIQIKIADLGNACWYDEH----YTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDD 247 (373)
T ss_dssp TTEEEEEECCCTTCEETTBC----CCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CHH
T ss_pred cCcceEEEcccccccccCCC----CCCCCCCccccCcHHHhCCCCCchHhHHHHHHHHHHHHhCCCCCCCCcccccCChH
Confidence 4457999999999876532 23457899999999999999999999999999999999999999754322111111
Q ss_pred HH---HHHHhccccc-------------------ccccCCC---------CCCChhHHHHHHHHHHHHHhcCCCCCCCCC
Q 010519 403 EW---LKMMVGTRRA-------------------EEVVDPN---------LEVKPATRALKRSLLVALRCVDPDSEKRPK 451 (508)
Q Consensus 403 ~~---~~~~~~~~~~-------------------~~~~~~~---------~~~~~~~~~~~~l~~li~~cl~~dP~~RPs 451 (508)
.. +....+.... ..+.... .....+......+.+|+.+||+.||.+|||
T Consensus 248 ~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt 327 (373)
T 1q8y_A 248 DHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRAD 327 (373)
T ss_dssp HHHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBC
T ss_pred HHHHHHHHhcCCCCHHHHhccchhhhhcCCcchhcccccccccchhhhhhhcccCCcchHHHHHHHHHHHhccCccccCC
Confidence 11 1111111000 0000000 001123455677888999999999999999
Q ss_pred HHHHHHHhhcCC
Q 010519 452 MSQVVRMLEADD 463 (508)
Q Consensus 452 ~~evl~~L~~~~ 463 (508)
+.|++++-.-..
T Consensus 328 ~~ell~hp~f~~ 339 (373)
T 1q8y_A 328 AGGLVNHPWLKD 339 (373)
T ss_dssp HHHHHTCGGGTT
T ss_pred HHHHhhChhhhc
Confidence 999998765443
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-41 Score=336.79 Aligned_cols=256 Identities=25% Similarity=0.368 Sum_probs=202.6
Q ss_pred eHHHHHHhhCCcccceeEeeeCceEEEEEEEc-CCCEEEEEEEcccchh------hHHHHHHHHHHHhcCC--CCCceeE
Q 010519 177 TLRDLEIATNRFSAENVLGEGGYGVVYKGRLI-NGSEVAVKKLLNNLGQ------AEKEFRVEVEAIGHVR--HKNLVRL 247 (508)
Q Consensus 177 ~~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~------~~~~~~~ei~~l~~l~--h~niv~~ 247 (508)
+..+.+...++|.+.+.||+|+||.||+|++. +++.||||.+...... ....+..|+.++++++ ||||+++
T Consensus 34 ~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~~~ 113 (320)
T 3a99_A 34 PGKEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRL 113 (320)
T ss_dssp ------CCTTTEEEEEECSSSSSCEEEEEEETTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCE
T ss_pred cccccCCccCceEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCceEE
Confidence 34555667789999999999999999999874 6888999998654311 1234667899999986 5999999
Q ss_pred EEEEEeCceeeEEEeecCC-CCHHHHHhhhhccCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCEEEc-CC
Q 010519 248 LGYCIEGVHRMLVYEYVNN-GNLEQWLHGAMRNQGNLTWEARMKVIIGTAKALAYLHEAIEPKVVHRDIKSSNILID-DE 325 (508)
Q Consensus 248 ~~~~~~~~~~~lv~E~~~~-gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiH~Dlk~~NIll~-~~ 325 (508)
++++......++||||+.+ ++|.+++. ....+++..++.++.||+.||.|||+. +|+||||||+|||++ ++
T Consensus 114 ~~~~~~~~~~~lv~e~~~~~~~L~~~l~----~~~~l~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~ 186 (320)
T 3a99_A 114 LDWFERPDSFVLILERPEPVQDLFDFIT----ERGALQEELARSFFWQVLEAVRHCHNC---GVLHRDIKDENILIDLNR 186 (320)
T ss_dssp EEEEECSSEEEEEEECCSSEEEHHHHHH----HHCSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTT
T ss_pred EEEEecCCcEEEEEEcCCCCccHHHHHh----ccCCCCHHHHHHHHHHHHHHHHHHHHC---CcEeCCCCHHHEEEeCCC
Confidence 9999999999999999976 89999985 346789999999999999999999999 999999999999999 78
Q ss_pred CcEEEEecCCccccCCCCCcccccccccccccCccccCCCCC-CChhhHHHHHHHHHHHHhCCCCCCCCCCCchhcHHHH
Q 010519 326 FNAKVSDFGLAKLLDSGESHITTRVMGTFGYVAPEYANTGML-NEKSDIYSFGVLLLEAVTGRDPVDYGRPANEVNLVEW 404 (508)
Q Consensus 326 ~~~kl~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DvwS~Gvvl~elltG~~Pf~~~~~~~~~~~~~~ 404 (508)
+.+||+|||++....... .....||+.|+|||++.+..+ +.++|||||||++|||++|+.||.... ..
T Consensus 187 ~~~kL~Dfg~~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~--------~~ 255 (320)
T 3a99_A 187 GELKLIDFGSGALLKDTV---YTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE--------EI 255 (320)
T ss_dssp TEEEECCCTTCEECCSSC---BCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH--------HH
T ss_pred CCEEEeeCcccccccccc---ccCCCCCccCCChHHhccCCCCCccchHHhHHHHHHHHHHCCCCCCChh--------hh
Confidence 999999999998765432 334568999999999877665 688999999999999999999995321 10
Q ss_pred HHHHhcccccccccCCCCCCChhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhhcCCCC
Q 010519 405 LKMMVGTRRAEEVVDPNLEVKPATRALKRSLLVALRCVDPDSEKRPKMSQVVRMLEADDYP 465 (508)
Q Consensus 405 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~ 465 (508)
..... . +. ......+.+|+.+||+.||.+|||+.+++++-.-....
T Consensus 256 ---~~~~~----~----~~----~~~~~~~~~li~~~l~~dp~~Rps~~~ll~hp~~~~~~ 301 (320)
T 3a99_A 256 ---IRGQV----F----FR----QRVSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQDVL 301 (320)
T ss_dssp ---HHCCC----C----CS----SCCCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGSSCC
T ss_pred ---hcccc----c----cc----ccCCHHHHHHHHHHccCChhhCcCHHHHhcCHhhcCcc
Confidence 00000 0 00 11234566799999999999999999999876655443
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-39 Score=327.08 Aligned_cols=265 Identities=21% Similarity=0.269 Sum_probs=203.1
Q ss_pred HhhCCcccceeEeeeCceEEEEEEEc-CC-CEEEEEEEcccchhhHHHHHHHHHHHhcCCCCC------ceeEEEEEEeC
Q 010519 183 IATNRFSAENVLGEGGYGVVYKGRLI-NG-SEVAVKKLLNNLGQAEKEFRVEVEAIGHVRHKN------LVRLLGYCIEG 254 (508)
Q Consensus 183 ~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~-~~vavK~~~~~~~~~~~~~~~ei~~l~~l~h~n------iv~~~~~~~~~ 254 (508)
...++|.+.+.||+|+||+||+|.+. ++ ..||+|++... ......+..|+.+++.++|++ ++.+++++...
T Consensus 16 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~ 94 (355)
T 2eu9_A 16 WLQERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNV-GKYREAARLEINVLKKIKEKDKENKFLCVLMSDWFNFH 94 (355)
T ss_dssp EETTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHHCTTSCSCBCCEEEEEEET
T ss_pred eecccEEEEEEeeccCCeEEEEEEecCCCceEEEEEEEccc-ccchhHHHHHHHHHHHHhhcCCCCceeEEEeeeeeeeC
Confidence 34579999999999999999999875 34 68999988643 334566788999998887655 99999999999
Q ss_pred ceeeEEEeecCCCCHHHHHhhhhccCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCEEE------------
Q 010519 255 VHRMLVYEYVNNGNLEQWLHGAMRNQGNLTWEARMKVIIGTAKALAYLHEAIEPKVVHRDIKSSNILI------------ 322 (508)
Q Consensus 255 ~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiH~Dlk~~NIll------------ 322 (508)
...++||||+ +++|.+++.. .....+++..++.++.||+.||.|||++ +|+||||||+|||+
T Consensus 95 ~~~~lv~e~~-~~~l~~~l~~--~~~~~~~~~~~~~i~~qi~~~L~~lH~~---~ivH~Dlkp~NIll~~~~~~~~~~~~ 168 (355)
T 2eu9_A 95 GHMCIAFELL-GKNTFEFLKE--NNFQPYPLPHVRHMAYQLCHALRFLHEN---QLTHTDLKPENILFVNSEFETLYNEH 168 (355)
T ss_dssp TEEEEEEECC-CCBHHHHHHH--TTTCCCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEESCCCEEEEECCC
T ss_pred CeEEEEEecc-CCChHHHHHh--ccCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEeccccccccccc
Confidence 9999999999 6788888753 2335789999999999999999999999 99999999999999
Q ss_pred -------cCCCcEEEEecCCccccCCCCCcccccccccccccCccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCC
Q 010519 323 -------DDEFNAKVSDFGLAKLLDSGESHITTRVMGTFGYVAPEYANTGMLNEKSDIYSFGVLLLEAVTGRDPVDYGRP 395 (508)
Q Consensus 323 -------~~~~~~kl~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltG~~Pf~~~~~ 395 (508)
+.++.+||+|||++...... .....||+.|+|||++.+..++.++|||||||+||||++|..||.....
T Consensus 169 ~~~~~~~~~~~~~kl~Dfg~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~ 244 (355)
T 2eu9_A 169 KSCEEKSVKNTSIRVADFGSATFDHEH----HTTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYRGFTLFQTHEN 244 (355)
T ss_dssp -CCCEEEESCCCEEECCCTTCEETTSC----CCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSH
T ss_pred ccccccccCCCcEEEeecCcccccccc----ccCCcCCCcccCCeeeecCCCCCccchHHHHHHHHHHHhCCCCCCCCCH
Confidence 56789999999999865432 2345789999999999999999999999999999999999999974332
Q ss_pred CchhcHHHHHHHHhccccc---------ccccCCCCC---------------------CChhHHHHHHHHHHHHHhcCCC
Q 010519 396 ANEVNLVEWLKMMVGTRRA---------EEVVDPNLE---------------------VKPATRALKRSLLVALRCVDPD 445 (508)
Q Consensus 396 ~~~~~~~~~~~~~~~~~~~---------~~~~~~~~~---------------------~~~~~~~~~~l~~li~~cl~~d 445 (508)
......+....+.... ......... ..........+.+|+.+||+.|
T Consensus 245 ---~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~d 321 (355)
T 2eu9_A 245 ---REHLVMMEKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSLEHVQLFDLMRRMLEFD 321 (355)
T ss_dssp ---HHHHHHHHHHHCCCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSS
T ss_pred ---HHHHHHHHHHcCCCcHHHhhhccchhhhcccccccccccchhccccccCCcccccccccchhHHHHHHHHHHHhcCC
Confidence 1111222222111000 000000000 0111223456778999999999
Q ss_pred CCCCCCHHHHHHHhhc
Q 010519 446 SEKRPKMSQVVRMLEA 461 (508)
Q Consensus 446 P~~RPs~~evl~~L~~ 461 (508)
|.+|||+.|++++-.-
T Consensus 322 P~~Rpt~~e~l~hp~f 337 (355)
T 2eu9_A 322 PAQRITLAEALLHPFF 337 (355)
T ss_dssp TTTSCCHHHHTTSGGG
T ss_pred hhhCcCHHHHhcChhh
Confidence 9999999999976443
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-40 Score=331.25 Aligned_cols=249 Identities=27% Similarity=0.387 Sum_probs=191.3
Q ss_pred HHHHhhCCcccceeEeeeCceEEEEEEEc-CCCEEEEEEEcccchh------hHHHHHHHHHHHhcC----CCCCceeEE
Q 010519 180 DLEIATNRFSAENVLGEGGYGVVYKGRLI-NGSEVAVKKLLNNLGQ------AEKEFRVEVEAIGHV----RHKNLVRLL 248 (508)
Q Consensus 180 ~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~------~~~~~~~ei~~l~~l----~h~niv~~~ 248 (508)
+.+...++|.+.+.||+|+||.||+|++. +++.||+|.+...... ....+..|+.++.++ +||||++++
T Consensus 25 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~~ 104 (312)
T 2iwi_A 25 DREAFEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLL 104 (312)
T ss_dssp --------CEEEEEEEEETTEEEEEEECTTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCEE
T ss_pred chhhhhhceEEeeEEEcCCCEEEEEEEEccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeEE
Confidence 34556689999999999999999999864 6889999998654321 223455688888888 899999999
Q ss_pred EEEEeCceeeEEEee-cCCCCHHHHHhhhhccCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCEEEc-CCC
Q 010519 249 GYCIEGVHRMLVYEY-VNNGNLEQWLHGAMRNQGNLTWEARMKVIIGTAKALAYLHEAIEPKVVHRDIKSSNILID-DEF 326 (508)
Q Consensus 249 ~~~~~~~~~~lv~E~-~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiH~Dlk~~NIll~-~~~ 326 (508)
+++......++|||| +.+++|.+++.. ...+++..++.++.||+.||.|||+. +|+||||||+|||++ .++
T Consensus 105 ~~~~~~~~~~~v~e~~~~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~ 177 (312)
T 2iwi_A 105 DWFETQEGFMLVLERPLPAQDLFDYITE----KGPLGEGPSRCFFGQVVAAIQHCHSR---GVVHRDIKDENILIDLRRG 177 (312)
T ss_dssp EEC-----CEEEEECCSSEEEHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHHHHH---TEECCCCSGGGEEEETTTT
T ss_pred EEEecCCeEEEEEEecCCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCChhhEEEeCCCC
Confidence 999999999999999 789999999953 45689999999999999999999999 999999999999999 899
Q ss_pred cEEEEecCCccccCCCCCcccccccccccccCccccCCCCCC-ChhhHHHHHHHHHHHHhCCCCCCCCCCCchhcHHHHH
Q 010519 327 NAKVSDFGLAKLLDSGESHITTRVMGTFGYVAPEYANTGMLN-EKSDIYSFGVLLLEAVTGRDPVDYGRPANEVNLVEWL 405 (508)
Q Consensus 327 ~~kl~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DvwS~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~ 405 (508)
.+||+|||++....... .....|++.|+|||++.+..+. .++|||||||++|+|++|+.||.... ...
T Consensus 178 ~~kl~dfg~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~--------~~~ 246 (312)
T 2iwi_A 178 CAKLIDFGSGALLHDEP---YTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERDQ--------EIL 246 (312)
T ss_dssp EEEECCCSSCEECCSSC---BCCCCSCTTTSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH--------HHH
T ss_pred eEEEEEcchhhhcccCc---ccccCCcccccCceeeecCCCCCccchHHHHHHHHHHHHHCCCCCCChH--------HHh
Confidence 99999999998765432 3345689999999998776664 58999999999999999999996310 111
Q ss_pred HHHhcccccccccCCCCCCChhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhhc
Q 010519 406 KMMVGTRRAEEVVDPNLEVKPATRALKRSLLVALRCVDPDSEKRPKMSQVVRMLEA 461 (508)
Q Consensus 406 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~ 461 (508)
... ..+. ......+.+++.+||+.||.+|||+.|++++-.-
T Consensus 247 ---~~~--------~~~~----~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~~~~ 287 (312)
T 2iwi_A 247 ---EAE--------LHFP----AHVSPDCCALIRRCLAPKPSSRPSLEEILLDPWM 287 (312)
T ss_dssp ---HTC--------CCCC----TTSCHHHHHHHHHHTCSSTTTSCCHHHHHHSTTT
T ss_pred ---hhc--------cCCc----ccCCHHHHHHHHHHccCChhhCcCHHHHhcChhh
Confidence 000 0011 1123456679999999999999999999986543
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-39 Score=323.80 Aligned_cols=254 Identities=26% Similarity=0.358 Sum_probs=182.0
Q ss_pred hhCCcccceeEeeeCceEEEEEEEc-CCCEEEEEEEcccch--hhHHHHHHHHHHHhcCCCCCceeEEEEEEeCceeeEE
Q 010519 184 ATNRFSAENVLGEGGYGVVYKGRLI-NGSEVAVKKLLNNLG--QAEKEFRVEVEAIGHVRHKNLVRLLGYCIEGVHRMLV 260 (508)
Q Consensus 184 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~ei~~l~~l~h~niv~~~~~~~~~~~~~lv 260 (508)
..++|.+.+.||+|+||.||+|.+. +|+.||||++..... .....+.++..+++.++||||+++++++.+....++|
T Consensus 23 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~lv 102 (318)
T 2dyl_A 23 EINDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGTFITNTDVFIA 102 (318)
T ss_dssp CGGGEEEEEEC------CEEEEEETTTCCEEEEEEEETTSCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEE
T ss_pred hhccccccceeeecCCeeEEEEEEecCCeEEEEEEecccccchHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCcEEEE
Confidence 3468999999999999999999985 689999999865432 2223445555678888999999999999999999999
Q ss_pred EeecCCCCHHHHHhhhhccCCCccHHHHHHHHHHHHHHHHHHHh-cCCCCeEeecCCCCCEEEcCCCcEEEEecCCcccc
Q 010519 261 YEYVNNGNLEQWLHGAMRNQGNLTWEARMKVIIGTAKALAYLHE-AIEPKVVHRDIKSSNILIDDEFNAKVSDFGLAKLL 339 (508)
Q Consensus 261 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~yLH~-~~~~~iiH~Dlk~~NIll~~~~~~kl~Dfgla~~~ 339 (508)
|||+ ++.+..++. .....+++..++.++.||+.||.|||+ . +++|+||||+|||++.++.+||+|||++...
T Consensus 103 ~e~~-~~~~~~l~~---~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~ 175 (318)
T 2dyl_A 103 MELM-GTCAEKLKK---RMQGPIPERILGKMTVAIVKALYYLKEKH---GVIHRDVKPSNILLDERGQIKLCDFGISGRL 175 (318)
T ss_dssp ECCC-SEEHHHHHH---HHTSCCCHHHHHHHHHHHHHHHHHHHHHH---CCCCCCCCGGGEEECTTSCEEECCCTTC---
T ss_pred Eecc-CCcHHHHHH---HhccCCCHHHHHHHHHHHHHHHHHHHhhC---CEEeCCCCHHHEEECCCCCEEEEECCCchhc
Confidence 9999 556665553 235678999999999999999999998 6 8999999999999999999999999999765
Q ss_pred CCCCCcccccccccccccCccccC-----CCCCCChhhHHHHHHHHHHHHhCCCCCCCCCCCchhcHHHHHHHHhccccc
Q 010519 340 DSGESHITTRVMGTFGYVAPEYAN-----TGMLNEKSDIYSFGVLLLEAVTGRDPVDYGRPANEVNLVEWLKMMVGTRRA 414 (508)
Q Consensus 340 ~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DvwS~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~ 414 (508)
.... ......|++.|+|||++. +..++.++|||||||++|+|++|+.||...... ...+........
T Consensus 176 ~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~-----~~~~~~~~~~~~- 247 (318)
T 2dyl_A 176 VDDK--AKDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTD-----FEVLTKVLQEEP- 247 (318)
T ss_dssp -------------CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHHHSSCTTTTCCSH-----HHHHHHHHHSCC-
T ss_pred cCCc--cccccCCCccccChhhcccccccccCCccccchhhHHHHHHHHHhCCCCCCCCCcc-----HHHHHHHhccCC-
Confidence 4432 233456899999999994 567889999999999999999999999743221 111222221111
Q ss_pred ccccCCCCCCChhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHh
Q 010519 415 EEVVDPNLEVKPATRALKRSLLVALRCVDPDSEKRPKMSQVVRML 459 (508)
Q Consensus 415 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L 459 (508)
+.+.. .......+.+++.+||+.||.+|||+.+++++-
T Consensus 248 -----~~~~~--~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~ 285 (318)
T 2dyl_A 248 -----PLLPG--HMGFSGDFQSFVKDCLTKDHRKRPKYNKLLEHS 285 (318)
T ss_dssp -----CCCCS--SSCCCHHHHHHHHHHTCSCTTTSCCHHHHTTSH
T ss_pred -----CCCCc--cCCCCHHHHHHHHHHccCChhHCcCHHHHhhCH
Confidence 11110 011234566799999999999999999999754
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-39 Score=328.83 Aligned_cols=260 Identities=24% Similarity=0.330 Sum_probs=197.3
Q ss_pred hCCcccceeEeeeCceEEEEEEEc-CCCEEEEEEEcccc--hhhHHHHHHHHHHHhcCCCCCceeEEEEEEeCce-----
Q 010519 185 TNRFSAENVLGEGGYGVVYKGRLI-NGSEVAVKKLLNNL--GQAEKEFRVEVEAIGHVRHKNLVRLLGYCIEGVH----- 256 (508)
Q Consensus 185 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~ei~~l~~l~h~niv~~~~~~~~~~~----- 256 (508)
.++|.+.+.||+|+||.||+|.+. +|+.||||++.... ......+.+|+.+++.++||||+++++++.....
T Consensus 23 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 102 (353)
T 3coi_A 23 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFY 102 (353)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEESSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCC
T ss_pred CceEEEeeeEecCCCeEEEEEEECCCCCEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCcccHhheEecccccccce
Confidence 368999999999999999999875 68899999986533 2334678889999999999999999999987654
Q ss_pred -eeEEEeecCCCCHHHHHhhhhccCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCEEEcCCCcEEEEecCC
Q 010519 257 -RMLVYEYVNNGNLEQWLHGAMRNQGNLTWEARMKVIIGTAKALAYLHEAIEPKVVHRDIKSSNILIDDEFNAKVSDFGL 335 (508)
Q Consensus 257 -~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~Dfgl 335 (508)
.++||||+. ++|.+++. ..+++..++.++.||+.||.|||++ +|+||||||+|||++.++.+||+|||+
T Consensus 103 ~~~lv~e~~~-~~l~~~~~------~~~~~~~~~~i~~qi~~al~~LH~~---~ivH~dlkp~NIl~~~~~~~kl~Dfg~ 172 (353)
T 3coi_A 103 DFYLVMPFMQ-TDLQKIMG------LKFSEEKIQYLVYQMLKGLKYIHSA---GVVHRDLKPGNLAVNEDCELKILDFGL 172 (353)
T ss_dssp CCEEEEECCS-EEGGGTTT------SCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCCGGGEEECTTCCEEECSTTC
T ss_pred eEEEEecccc-CCHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEeECCCCcEEEeeccc
Confidence 489999997 58877652 3489999999999999999999999 999999999999999999999999999
Q ss_pred ccccCCCCCcccccccccccccCccccCC-CCCCChhhHHHHHHHHHHHHhCCCCCCCCCCCchhcHHHHHHHHhcccc-
Q 010519 336 AKLLDSGESHITTRVMGTFGYVAPEYANT-GMLNEKSDIYSFGVLLLEAVTGRDPVDYGRPANEVNLVEWLKMMVGTRR- 413 (508)
Q Consensus 336 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwS~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~- 413 (508)
+...... .....+|+.|+|||++.+ ..++.++|||||||++|+|++|+.||..... ......+....+...
T Consensus 173 ~~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~---~~~~~~i~~~~~~~~~ 245 (353)
T 3coi_A 173 ARHADAE----MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDY---LDQLTQILKVTGVPGT 245 (353)
T ss_dssp TTC------------CCSBCCSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSSBSSCH---HHHHHHHHHHHCBCCH
T ss_pred ccCCCCC----ccccccCcCcCCHHHHhCcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH---HHHHHHHHHHhCCCCH
Confidence 9865432 234578999999999877 6789999999999999999999999964331 111111111111100
Q ss_pred -----------------cccccCCCCCCChhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhhcC
Q 010519 414 -----------------AEEVVDPNLEVKPATRALKRSLLVALRCVDPDSEKRPKMSQVVRMLEAD 462 (508)
Q Consensus 414 -----------------~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~ 462 (508)
........+. .........+.+|+.+||+.||.+|||+.+++++-.-.
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~f~ 310 (353)
T 3coi_A 246 EFVQKLNDKAAKSYIQSLPQTPRKDFT-QLFPRASPQAADLLEKMLELDVDKRLTAAQALTHPFFE 310 (353)
T ss_dssp HHHTTCSCHHHHHHHHTSCBCSSCCTT-TTCTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTSGGGT
T ss_pred HHHHHHhhHHHHHHHHhCcCCCCccHH-HhcCCcCHHHHHHHHHHcCCCcccCCCHHHHhcCcchh
Confidence 0000000000 00112345677799999999999999999999876544
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9e-40 Score=339.71 Aligned_cols=254 Identities=24% Similarity=0.355 Sum_probs=188.8
Q ss_pred HhhCCcccceeEeeeCceEEEEEEEcCCCEEEEEEEcccchhhHHHHHHHHHHHhcC-CCCCceeEEEEEEeCceeeEEE
Q 010519 183 IATNRFSAENVLGEGGYGVVYKGRLINGSEVAVKKLLNNLGQAEKEFRVEVEAIGHV-RHKNLVRLLGYCIEGVHRMLVY 261 (508)
Q Consensus 183 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~ei~~l~~l-~h~niv~~~~~~~~~~~~~lv~ 261 (508)
+...+|.+.+.||+|+||+||.....+++.||||++...... .+.+|+.+|+.+ +|||||++++++.+....|+||
T Consensus 21 i~~~~y~~~~~LG~G~~G~V~~~~~~~~~~vAvK~~~~~~~~---~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~~lv~ 97 (432)
T 3p23_A 21 VGKISFCPKDVLGHGAEGTIVYRGMFDNRDVAVKRILPECFS---FADREVQLLRESDEHPNVIRYFCTEKDRQFQYIAI 97 (432)
T ss_dssp ETTEEEEEEEEEEECGGGCEEEEEESSSSEEEEEEECTTTEE---ECHHHHHHHHHSCCCTTBCCEEEEEEETTEEEEEE
T ss_pred EccEEEecCCeeecCcCEEEEEEEEeCCeEEEEEEECHHHHH---HHHHHHHHHHhccCCCCcCeEEEEEecCCEEEEEE
Confidence 334579999999999999976555668999999998653322 245699999998 7999999999999999999999
Q ss_pred eecCCCCHHHHHhhhhccCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCEEEcC-----CCcEEEEecCCc
Q 010519 262 EYVNNGNLEQWLHGAMRNQGNLTWEARMKVIIGTAKALAYLHEAIEPKVVHRDIKSSNILIDD-----EFNAKVSDFGLA 336 (508)
Q Consensus 262 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiH~Dlk~~NIll~~-----~~~~kl~Dfgla 336 (508)
||+. |+|.+++.. ....+.+..++.++.||+.||.|||+. +|+||||||+|||++. ...+||+|||++
T Consensus 98 E~~~-g~L~~~l~~---~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlKp~NIll~~~~~~~~~~~kL~DFG~a 170 (432)
T 3p23_A 98 ELCA-ATLQEYVEQ---KDFAHLGLEPITLLQQTTSGLAHLHSL---NIVHRDLKPHNILISMPNAHGKIKAMISDFGLC 170 (432)
T ss_dssp ECCS-EEHHHHHHS---SSCCCCSSCHHHHHHHHHHHHHHHHHT---TCCCCCCSTTSEEECCCBTTTBCCEEECCTTEE
T ss_pred ECCC-CCHHHHHHh---cCCCccchhHHHHHHHHHHHHHHHHHC---cCEeCCCCHHHEEEecCCCCCceeEEEecccce
Confidence 9996 699999963 333445556678999999999999999 9999999999999953 335889999999
Q ss_pred cccCCCCC--cccccccccccccCccccC---CCCCCChhhHHHHHHHHHHHHh-CCCCCCCCCCCchhcHHHHHHHHhc
Q 010519 337 KLLDSGES--HITTRVMGTFGYVAPEYAN---TGMLNEKSDIYSFGVLLLEAVT-GRDPVDYGRPANEVNLVEWLKMMVG 410 (508)
Q Consensus 337 ~~~~~~~~--~~~~~~~gt~~y~aPE~~~---~~~~~~~~DvwS~Gvvl~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~ 410 (508)
+....... .......||+.|+|||++. ...++.++|||||||++|||++ |..||..... ........
T Consensus 171 ~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~ellt~g~~pf~~~~~-------~~~~~~~~ 243 (432)
T 3p23_A 171 KKLAVGRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQ-------RQANILLG 243 (432)
T ss_dssp ECC------------CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHHHTTSCBTTBSTTT-------HHHHHHTT
T ss_pred eeccCCCcceeeccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHHHHHHcCCCCCcchhhH-------HHHHHHhc
Confidence 87653321 2234467999999999997 4567889999999999999999 9999853221 11111111
Q ss_pred ccccccccCCCCCCChhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhh
Q 010519 411 TRRAEEVVDPNLEVKPATRALKRSLLVALRCVDPDSEKRPKMSQVVRMLE 460 (508)
Q Consensus 411 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 460 (508)
.... . ...+.......+.+|+.+||+.||.+|||+.++++|-.
T Consensus 244 ~~~~-----~--~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~evl~hp~ 286 (432)
T 3p23_A 244 ACSL-----D--CLHPEKHEDVIARELIEKMIAMDPQKRPSAKHVLKHPF 286 (432)
T ss_dssp CCCC-----T--TSCTTCHHHHHHHHHHHHHSCSSGGGSCCHHHHHTSTT
T ss_pred cCCc-----c--ccCccccccHHHHHHHHHHHhCCHhhCCCHHHHHhCcc
Confidence 1111 0 11112233445677999999999999999999997643
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-39 Score=345.84 Aligned_cols=260 Identities=25% Similarity=0.345 Sum_probs=196.7
Q ss_pred CCcccceeEeeeCceEEEEEEEc-CCCEEEEEEEcccc-hhhHHHHHHHHHHHhcCCCCCceeEEEEEEe------Ccee
Q 010519 186 NRFSAENVLGEGGYGVVYKGRLI-NGSEVAVKKLLNNL-GQAEKEFRVEVEAIGHVRHKNLVRLLGYCIE------GVHR 257 (508)
Q Consensus 186 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~ei~~l~~l~h~niv~~~~~~~~------~~~~ 257 (508)
++|.+.+.||+|+||+||+|.+. +|..||||++.... ......+.+|+.++++++||||+++++++.. ....
T Consensus 14 grY~i~~~LG~G~fG~Vyla~~~~tg~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~~~~~~~~~ 93 (676)
T 3qa8_A 14 GPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLAPNDLP 93 (676)
T ss_dssp ---CCCCCCCBCSSSBCCCCCCTTTTCCEEECCCCSCCCHHHHHHHHHHHHHHHHCCBTTBCCEEECCTTTCCCCTTSSC
T ss_pred CCeEEEEEEeeCCCeEEEEEEECCCCcEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCceeeeecccccccCCCeE
Confidence 68999999999999999999874 68899999886543 3445678899999999999999999998765 5677
Q ss_pred eEEEeecCCCCHHHHHhhhhccCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCEEEcCCCc---EEEEecC
Q 010519 258 MLVYEYVNNGNLEQWLHGAMRNQGNLTWEARMKVIIGTAKALAYLHEAIEPKVVHRDIKSSNILIDDEFN---AKVSDFG 334 (508)
Q Consensus 258 ~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiH~Dlk~~NIll~~~~~---~kl~Dfg 334 (508)
++||||+++|+|.+++... .....+++..++.++.+++.||.|||+. +|+||||||+|||++.++. +||+|||
T Consensus 94 ~LVmEy~~ggsL~~~L~~~-~~~~~lse~~i~~I~~QLl~aL~yLHs~---gIVHrDLKP~NILl~~~g~~~~vKL~DFG 169 (676)
T 3qa8_A 94 LLAMEYCEGGDLRKYLNQF-ENCCGLKEGPIRTLLSDISSALRYLHEN---RIIHRDLKPENIVLQPGPQRLIHKIIDLG 169 (676)
T ss_dssp CCEEECCSSCBHHHHHHSS-SCTTCCCSSHHHHHHHHHHHHHHHHHHT---TBCCCCCCSTTEEEECCSSSCEEEECSCC
T ss_pred EEEEEeCCCCCHHHHHHhc-ccCCCCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCCHHHeEeecCCCceeEEEcccc
Confidence 8999999999999999642 2233688999999999999999999999 9999999999999997765 9999999
Q ss_pred CccccCCCCCcccccccccccccCccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCCCchhcHHHHHHHHhc----
Q 010519 335 LAKLLDSGESHITTRVMGTFGYVAPEYANTGMLNEKSDIYSFGVLLLEAVTGRDPVDYGRPANEVNLVEWLKMMVG---- 410 (508)
Q Consensus 335 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~---- 410 (508)
++....... ......||+.|+|||++.+..++.++|||||||++|+|++|..||..... ...|......
T Consensus 170 ~a~~~~~~~--~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSLGviLyeLltG~~Pf~~~~~-----~~~~~~~i~~~~~~ 242 (676)
T 3qa8_A 170 YAKELDQGE--LCTEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQ-----PVQWHGKVREKSNE 242 (676)
T ss_dssp CCCBTTSCC--CCCCCCSCCTTCSSCSSCCSCCSTTHHHHHHHHHHHHHHSSCSSCCSSCH-----HHHSSTTCC-----
T ss_pred ccccccccc--ccccccCCcccCChHHhccCCCCchhHHHHHHHHHHHHHHCCCCCCcccc-----hhhhhhhhhcccch
Confidence 998765443 23446789999999999999999999999999999999999999964321 0111000000
Q ss_pred ccccccccCCCC--------CCChhHHHHHHHHHHHHHhcCCCCCCCCCHHHHH
Q 010519 411 TRRAEEVVDPNL--------EVKPATRALKRSLLVALRCVDPDSEKRPKMSQVV 456 (508)
Q Consensus 411 ~~~~~~~~~~~~--------~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl 456 (508)
............ ...........+.+++.+||..||.+|||+.+++
T Consensus 243 ~~~~~~~l~g~~~~~~~lp~p~~l~~~ls~~L~dLI~~mL~~DP~kRPTa~elL 296 (676)
T 3qa8_A 243 HIVVYDDLTGAVKFSSVLPTPNHLSGILAGKLERWLQCMLMWHQRQRGTDPQNP 296 (676)
T ss_dssp -CCSCCCCSSSCCCCSSSCCSCCCCGGGHHHHHHHHHHHSCSSCC---CCTTCC
T ss_pred hhhhhhhhccccccccccCCchhhchhhhHHHHHHHHHHccCCHhhCcCHHHHh
Confidence 000000000000 1112233456778899999999999999998744
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-38 Score=346.01 Aligned_cols=239 Identities=24% Similarity=0.351 Sum_probs=192.8
Q ss_pred HhhCCcccceeEeeeCceEEEEEEEc--CCCEEEEEEEcccc-hhhHHHHHHHHHHHhcCCCCCceeEEEEEEeCce---
Q 010519 183 IATNRFSAENVLGEGGYGVVYKGRLI--NGSEVAVKKLLNNL-GQAEKEFRVEVEAIGHVRHKNLVRLLGYCIEGVH--- 256 (508)
Q Consensus 183 ~~~~~~~~~~~lg~G~~g~Vy~~~~~--~~~~vavK~~~~~~-~~~~~~~~~ei~~l~~l~h~niv~~~~~~~~~~~--- 256 (508)
+..++|.+.+.||+|+||+||+|.+. +|+.||||++.... ......+..|+.++.+++||||+++++++.....
T Consensus 77 ~~~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~ 156 (681)
T 2pzi_A 77 IVAGQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTDRHGD 156 (681)
T ss_dssp EETTTEEEEEEEEEETTEEEEEEEEGGGTTEEEEEEESCSSCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEEECTTSC
T ss_pred EeCCceEEEEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCccCCHHHHHHHHHHHHHHHhcCCCCcCeEeeeEeecCCCCC
Confidence 34579999999999999999999985 58899999886433 3444678889999999999999999999987655
Q ss_pred --eeEEEeecCCCCHHHHHhhhhccCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCEEEcCCCcEEEEecC
Q 010519 257 --RMLVYEYVNNGNLEQWLHGAMRNQGNLTWEARMKVIIGTAKALAYLHEAIEPKVVHRDIKSSNILIDDEFNAKVSDFG 334 (508)
Q Consensus 257 --~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~Dfg 334 (508)
.||||||+++++|.+++. . .+++..++.++.||+.||.|||++ +|+||||||+|||++.+ .+||+|||
T Consensus 157 ~~~~lv~E~~~g~~L~~~~~----~--~l~~~~~~~~~~qi~~aL~~lH~~---giiHrDlkp~NIll~~~-~~kl~DFG 226 (681)
T 2pzi_A 157 PVGYIVMEYVGGQSLKRSKG----Q--KLPVAEAIAYLLEILPALSYLHSI---GLVYNDLKPENIMLTEE-QLKLIDLG 226 (681)
T ss_dssp EEEEEEEECCCCEECC--------C--CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECSS-CEEECCCT
T ss_pred ceeEEEEEeCCCCcHHHHHh----C--CCCHHHHHHHHHHHHHHHHHHHHC---CCeecccChHHeEEeCC-cEEEEecc
Confidence 699999999999998763 2 689999999999999999999999 99999999999999986 99999999
Q ss_pred CccccCCCCCcccccccccccccCccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCCCchhcHHHHHHHHhccccc
Q 010519 335 LAKLLDSGESHITTRVMGTFGYVAPEYANTGMLNEKSDIYSFGVLLLEAVTGRDPVDYGRPANEVNLVEWLKMMVGTRRA 414 (508)
Q Consensus 335 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~ 414 (508)
+++..... ....||+.|+|||++.+. ++.++|||||||+||+|++|..||......
T Consensus 227 ~a~~~~~~-----~~~~gt~~y~aPE~~~~~-~~~~sDi~slG~~l~~l~~g~~~~~~~~~~------------------ 282 (681)
T 2pzi_A 227 AVSRINSF-----GYLYGTPGFQAPEIVRTG-PTVATDIYTVGRTLAALTLDLPTRNGRYVD------------------ 282 (681)
T ss_dssp TCEETTCC-----SCCCCCTTTSCTTHHHHC-SCHHHHHHHHHHHHHHHHSCCCEETTEECS------------------
T ss_pred cchhcccC-----CccCCCccccCHHHHcCC-CCCceehhhhHHHHHHHHhCCCCCcccccc------------------
Confidence 99876543 345799999999998765 489999999999999999998887521100
Q ss_pred ccccCCCCCCChhHHHHHHHHHHHHHhcCCCCCCCCC-HHHHHHHhh
Q 010519 415 EEVVDPNLEVKPATRALKRSLLVALRCVDPDSEKRPK-MSQVVRMLE 460 (508)
Q Consensus 415 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs-~~evl~~L~ 460 (508)
......+.......+.+|+.+||+.||.+||+ ++++.+.|.
T Consensus 283 -----~~~~~~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~ 324 (681)
T 2pzi_A 283 -----GLPEDDPVLKTYDSYGRLLRRAIDPDPRQRFTTAEEMSAQLT 324 (681)
T ss_dssp -----SCCTTCHHHHHCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHH
T ss_pred -----cccccccccccCHHHHHHHhhhccCChhhCCCHHHHHHHHHH
Confidence 00011222233456778999999999999995 555555554
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-37 Score=304.97 Aligned_cols=231 Identities=19% Similarity=0.280 Sum_probs=179.9
Q ss_pred CCcccc-eeEeeeCceEEEEEEEc-CCCEEEEEEEcccchhhHHHHHHHHHHH-hcCCCCCceeEEEEEEe----Cceee
Q 010519 186 NRFSAE-NVLGEGGYGVVYKGRLI-NGSEVAVKKLLNNLGQAEKEFRVEVEAI-GHVRHKNLVRLLGYCIE----GVHRM 258 (508)
Q Consensus 186 ~~~~~~-~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~ei~~l-~~l~h~niv~~~~~~~~----~~~~~ 258 (508)
++|.+. +.||+|+||.||++.+. ++..||+|++... ..+.+|+.++ +.++||||+++++++.. ....+
T Consensus 17 ~~y~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-----~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~ 91 (299)
T 3m2w_A 17 DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-----PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLL 91 (299)
T ss_dssp GTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS-----HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEE
T ss_pred cchhhcCcccccCCCeEEEEEEEcCCCcEEEEEEeccc-----HHHHHHHHHHHHhccCCCchhHHhhhhhhcCCCceEE
Confidence 467766 78999999999999874 6889999998542 3456688877 56699999999999987 67789
Q ss_pred EEEeecCCCCHHHHHhhhhccCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCEEEcC---CCcEEEEecCC
Q 010519 259 LVYEYVNNGNLEQWLHGAMRNQGNLTWEARMKVIIGTAKALAYLHEAIEPKVVHRDIKSSNILIDD---EFNAKVSDFGL 335 (508)
Q Consensus 259 lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiH~Dlk~~NIll~~---~~~~kl~Dfgl 335 (508)
+||||+++|+|.+++.. .....+++..++.++.||+.||.|||+. +|+||||||+|||++. ++.+||+|||+
T Consensus 92 lv~e~~~~~~L~~~l~~--~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~~~kl~Dfg~ 166 (299)
T 3m2w_A 92 IVMECLDGGELFSRIQD--RGDQAFTEREASEIMKSIGEAIQYLHSI---NIAHRDVKPENLLYTSKRPNAILKLTDFGF 166 (299)
T ss_dssp EEECCCCSCBHHHHHHH--CTTCCCBHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESSSSTTCCEEECCCTT
T ss_pred EEEeecCCCcHHHHHHh--ccCCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEEecCCCCCcEEEecccc
Confidence 99999999999999964 2345799999999999999999999999 9999999999999998 78899999999
Q ss_pred ccccCCCCCcccccccccccccCccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCCCchhcHHHHHHHHhcccccc
Q 010519 336 AKLLDSGESHITTRVMGTFGYVAPEYANTGMLNEKSDIYSFGVLLLEAVTGRDPVDYGRPANEVNLVEWLKMMVGTRRAE 415 (508)
Q Consensus 336 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~ 415 (508)
+.... +..++.++|||||||++|||++|..||........ ......
T Consensus 167 a~~~~-----------------------~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~-----------~~~~~~ 212 (299)
T 3m2w_A 167 AKETT-----------------------GEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAI-----------SPGMKT 212 (299)
T ss_dssp CEECT-----------------------TCGGGGHHHHHHHHHHHHHHHHSSCSCCC------------------CCSCC
T ss_pred ccccc-----------------------cccCCchhhHHHHHHHHHHHHHCCCCCCCCcchhh-----------hHHHHH
Confidence 87543 23467899999999999999999999964322110 000011
Q ss_pred cccCCCCCCChh--HHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhh
Q 010519 416 EVVDPNLEVKPA--TRALKRSLLVALRCVDPDSEKRPKMSQVVRMLE 460 (508)
Q Consensus 416 ~~~~~~~~~~~~--~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 460 (508)
.+.......... ......+.+|+.+||+.||.+|||+.|++++-.
T Consensus 213 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~e~l~hp~ 259 (299)
T 3m2w_A 213 RIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPW 259 (299)
T ss_dssp SSCTTCCSSCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHH
T ss_pred HHhhccccCCchhcccCCHHHHHHHHHHcccChhhCCCHHHHhcChh
Confidence 111111111111 223556778999999999999999999998654
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-37 Score=306.35 Aligned_cols=232 Identities=15% Similarity=0.091 Sum_probs=182.8
Q ss_pred HhhCCcccceeEeeeCceEEEEEEEc-CCCEEEEEEEcccc---hhhHHHHHHHHHHHhcCCCCCceeEEEEEEeCceee
Q 010519 183 IATNRFSAENVLGEGGYGVVYKGRLI-NGSEVAVKKLLNNL---GQAEKEFRVEVEAIGHVRHKNLVRLLGYCIEGVHRM 258 (508)
Q Consensus 183 ~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~ei~~l~~l~h~niv~~~~~~~~~~~~~ 258 (508)
+..++|.+.+.||+|+||.||+|++. +++.||+|.+.... ......+.+|+..+.+++||||+++++++.+.+..|
T Consensus 28 ~~~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~ 107 (286)
T 3uqc_A 28 IANGRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDVVHTRAGGL 107 (286)
T ss_dssp ETTTTEEEEEEEEBSTTCEEEEEEETTTTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEE
T ss_pred EecCcEEEEEEEcccCCeEEEEEEecCCCceEEEEEECcccccCHHHHHHHHHHHHHHhcCCCCCcceeeEEEEECCcEE
Confidence 34468999999999999999999986 48899999986543 233467888999999999999999999999999999
Q ss_pred EEEeecCCCCHHHHHhhhhccCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCEEEcCCCcEEEEecCCccc
Q 010519 259 LVYEYVNNGNLEQWLHGAMRNQGNLTWEARMKVIIGTAKALAYLHEAIEPKVVHRDIKSSNILIDDEFNAKVSDFGLAKL 338 (508)
Q Consensus 259 lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~Dfgla~~ 338 (508)
+||||+++++|.+++.. + .....+..++.||+.||.|||++ +|+||||||+|||++.++.+||++++
T Consensus 108 lv~e~~~g~~L~~~l~~-----~-~~~~~~~~i~~ql~~aL~~lH~~---givH~Dikp~NIll~~~g~~kl~~~~---- 174 (286)
T 3uqc_A 108 VVAEWIRGGSLQEVADT-----S-PSPVGAIRAMQSLAAAADAAHRA---GVALSIDHPSRVRVSIDGDVVLAYPA---- 174 (286)
T ss_dssp EEEECCCEEEHHHHHTT-----C-CCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEEETTSCEEECSCC----
T ss_pred EEEEecCCCCHHHHHhc-----C-CChHHHHHHHHHHHHHHHHHHHC---CCccCCCCcccEEEcCCCCEEEEecc----
Confidence 99999999999999842 2 34456888999999999999999 99999999999999999999997443
Q ss_pred cCCCCCcccccccccccccCccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCCCchhcHHHHHHHHhccccccccc
Q 010519 339 LDSGESHITTRVMGTFGYVAPEYANTGMLNEKSDIYSFGVLLLEAVTGRDPVDYGRPANEVNLVEWLKMMVGTRRAEEVV 418 (508)
Q Consensus 339 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 418 (508)
|++ .++.++|||||||+||||++|+.||........... .....
T Consensus 175 -----------------~~~-------~~~~~~Di~slG~il~elltg~~Pf~~~~~~~~~~~------------~~~~~ 218 (286)
T 3uqc_A 175 -----------------TMP-------DANPQDDIRGIGASLYALLVNRWPLPEAGVRSGLAP------------AERDT 218 (286)
T ss_dssp -----------------CCT-------TCCHHHHHHHHHHHHHHHHHSEECSCCCSBCCCSEE------------CCBCT
T ss_pred -----------------ccC-------CCCchhHHHHHHHHHHHHHHCCCCCCcCCcchhhHH------------HHHHh
Confidence 333 368999999999999999999999975443221100 00000
Q ss_pred CCCCCC--ChhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhhcCCC
Q 010519 419 DPNLEV--KPATRALKRSLLVALRCVDPDSEKRPKMSQVVRMLEADDY 464 (508)
Q Consensus 419 ~~~~~~--~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~ 464 (508)
...... .........+.+++.+||+.||.+| |+.|+++.|+....
T Consensus 219 ~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~R-s~~el~~~L~~~~~ 265 (286)
T 3uqc_A 219 AGQPIEPADIDRDIPFQISAVAARSVQGDGGIR-SASTLLNLMQQATA 265 (286)
T ss_dssp TSCBCCHHHHCTTSCHHHHHHHHHHHCTTSSCC-CHHHHHHHHHHHHC
T ss_pred ccCCCChhhcccCCCHHHHHHHHHHcccCCccC-CHHHHHHHHHHHhc
Confidence 010000 0011234557779999999999999 99999999987543
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-37 Score=321.21 Aligned_cols=244 Identities=16% Similarity=0.181 Sum_probs=181.7
Q ss_pred hCCcccceeEeeeCceEEEEEEEc-CCCEEEEEEEcccch---hhHHHHHHHHHHHhcCCC-CCce----------e---
Q 010519 185 TNRFSAENVLGEGGYGVVYKGRLI-NGSEVAVKKLLNNLG---QAEKEFRVEVEAIGHVRH-KNLV----------R--- 246 (508)
Q Consensus 185 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~ei~~l~~l~h-~niv----------~--- 246 (508)
..+|...+.||+|+||+||+|++. +|+.||||++..... ...+.+.+|+.+++.+.| +|.. .
T Consensus 77 ~~~~~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~~~~~~ 156 (413)
T 3dzo_A 77 PRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDL 156 (413)
T ss_dssp CEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEECCSCC----CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBCCCCEE
T ss_pred ceeEEEecccccCCCEEEEEEEecCCCCceEEEEEecCCCccHHHHHHHHHHHHHHHhhccCCCHHHHHHhcccccchhh
Confidence 346888899999999999999974 689999998863332 224678899999999987 2211 1
Q ss_pred --------EEEEEEe-----CceeeEEEeecCCCCHHHHHhhh---hccCCCccHHHHHHHHHHHHHHHHHHHhcCCCCe
Q 010519 247 --------LLGYCIE-----GVHRMLVYEYVNNGNLEQWLHGA---MRNQGNLTWEARMKVIIGTAKALAYLHEAIEPKV 310 (508)
Q Consensus 247 --------~~~~~~~-----~~~~~lv~E~~~~gsL~~~l~~~---~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~i 310 (508)
++.++.. ....+++|+++ +++|.+++... ......+++..++.++.||+.||.|||++ +|
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~i 232 (413)
T 3dzo_A 157 VKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHY---GL 232 (413)
T ss_dssp EECCC---------------CCSEEEEEECC-SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHT---TE
T ss_pred cccCCCCccccccCCCccccccceEEEeehh-cCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHHhC---Cc
Confidence 1111111 12346777776 67999988532 12345688889999999999999999999 99
Q ss_pred EeecCCCCCEEEcCCCcEEEEecCCccccCCCCCcccccccccccccCcccc----------CCCCCCChhhHHHHHHHH
Q 010519 311 VHRDIKSSNILIDDEFNAKVSDFGLAKLLDSGESHITTRVMGTFGYVAPEYA----------NTGMLNEKSDIYSFGVLL 380 (508)
Q Consensus 311 iH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~----------~~~~~~~~~DvwS~Gvvl 380 (508)
+||||||+||||+.++.+||+|||+++..... ....+| +.|+|||++ .+..++.++|||||||+|
T Consensus 233 iHrDiKp~NILl~~~~~~kL~DFG~a~~~~~~----~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~DvwSlGvil 307 (413)
T 3dzo_A 233 VHTYLRPVDIVLDQRGGVFLTGFEHLVRDGAS----AVSPIG-RGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAI 307 (413)
T ss_dssp ECSCCCGGGEEECTTCCEEECCGGGCEETTEE----ECCCCC-TTTCCHHHHHHHTSTTGGGCCEEECHHHHHHHHHHHH
T ss_pred ccCCcccceEEEecCCeEEEEeccceeecCCc----cccCCC-CceeCchhhhccccccccccCcCCCchhhHHHHHHHH
Confidence 99999999999999999999999999865432 344567 999999999 666788999999999999
Q ss_pred HHHHhCCCCCCCCCCCchhcHHHHHHHHhcccccccccCCCCCCChhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 010519 381 LEAVTGRDPVDYGRPANEVNLVEWLKMMVGTRRAEEVVDPNLEVKPATRALKRSLLVALRCVDPDSEKRPKMSQVVRM 458 (508)
Q Consensus 381 ~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 458 (508)
|||++|+.||........ ...++..... ....+.+|+.+||+.||.+|||+.+++++
T Consensus 308 ~elltg~~Pf~~~~~~~~---------------~~~~~~~~~~------~~~~~~~li~~~l~~dP~~Rpt~~~~l~~ 364 (413)
T 3dzo_A 308 YWIWCADLPNTDDAALGG---------------SEWIFRSCKN------IPQPVRALLEGFLRYPKEDRLLPLQAMET 364 (413)
T ss_dssp HHHHHSSCCCCTTGGGSC---------------SGGGGSSCCC------CCHHHHHHHHHHTCSSGGGSCCHHHHTTS
T ss_pred HHHHHCCCCCCCcchhhh---------------HHHHHhhccc------CCHHHHHHHHHHccCChhhCcCHHHHHhC
Confidence 999999999964322111 1111111111 12456779999999999999998888654
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-38 Score=318.14 Aligned_cols=246 Identities=14% Similarity=0.163 Sum_probs=187.6
Q ss_pred HhhCCcccceeEeeeCceEEEEEEEcCCCEEEEEEEcccc--------hhhHHHHHHHHHHHhcCC---------CCCce
Q 010519 183 IATNRFSAENVLGEGGYGVVYKGRLINGSEVAVKKLLNNL--------GQAEKEFRVEVEAIGHVR---------HKNLV 245 (508)
Q Consensus 183 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~--------~~~~~~~~~ei~~l~~l~---------h~niv 245 (508)
+..++|.+.+.||+|+||+||+|++ +|+.||||++.... ......+.+|+.+++.++ ||||+
T Consensus 17 ~~~~~y~~~~~lG~G~~g~V~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~niv 95 (336)
T 2vuw_A 17 LPTEKLQRCEKIGEGVFGEVFQTIA-DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFI 95 (336)
T ss_dssp SCHHHHHTCEEEEEETTEEEEEEEE-TTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCBC
T ss_pred cccccchheeeecccCceEEEEEEe-CCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCchh
Confidence 3446799999999999999999988 78999999986542 222356778888888775 88888
Q ss_pred eEEEEEE------------------------------eCceeeEEEeecCCCCHHHHHhhhhccCCCccHHHHHHHHHHH
Q 010519 246 RLLGYCI------------------------------EGVHRMLVYEYVNNGNLEQWLHGAMRNQGNLTWEARMKVIIGT 295 (508)
Q Consensus 246 ~~~~~~~------------------------------~~~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i 295 (508)
++++++. .....|+||||+++|++.+.+. ...+++..++.++.||
T Consensus 96 ~l~~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~-----~~~~~~~~~~~i~~qi 170 (336)
T 2vuw_A 96 GLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMR-----TKLSSLATAKSILHQL 170 (336)
T ss_dssp CEEEEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGT-----TTCCCHHHHHHHHHHH
T ss_pred hhcceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHH-----hcCCCHHHHHHHHHHH
Confidence 8887653 2678899999999997766652 2568999999999999
Q ss_pred HHHHHHHH-hcCCCCeEeecCCCCCEEEcCCC--------------------cEEEEecCCccccCCCCCcccccccccc
Q 010519 296 AKALAYLH-EAIEPKVVHRDIKSSNILIDDEF--------------------NAKVSDFGLAKLLDSGESHITTRVMGTF 354 (508)
Q Consensus 296 ~~al~yLH-~~~~~~iiH~Dlk~~NIll~~~~--------------------~~kl~Dfgla~~~~~~~~~~~~~~~gt~ 354 (508)
+.||.||| +. +|+||||||+|||++.++ .+||+|||+++..... ..+||+
T Consensus 171 ~~aL~~lH~~~---~ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~~------~~~gt~ 241 (336)
T 2vuw_A 171 TASLAVAEASL---RFEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERDG------IVVFCD 241 (336)
T ss_dssp HHHHHHHHHHH---CCBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEETT------EEECCC
T ss_pred HHHHHHHHHhC---CEeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCCC------cEEEee
Confidence 99999999 88 999999999999999887 8999999999876532 347999
Q ss_pred cccCccccCCCCCCChhhHHHHHHH-HHHHHhCCCCCCCCCCCchhcHHHHHHHHhcccccccccCCCCCCChhHHHHHH
Q 010519 355 GYVAPEYANTGMLNEKSDIYSFGVL-LLEAVTGRDPVDYGRPANEVNLVEWLKMMVGTRRAEEVVDPNLEVKPATRALKR 433 (508)
Q Consensus 355 ~y~aPE~~~~~~~~~~~DvwS~Gvv-l~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 433 (508)
.|+|||++.+.. +.++||||||++ .+++++|..||.. ..|.............................
T Consensus 242 ~y~aPE~~~g~~-~~~~Diwsl~~~~~~~~~~g~~p~~~---------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~ 311 (336)
T 2vuw_A 242 VSMDEDLFTGDG-DYQFDIYRLMKKENNNRWGEYHPYSN---------VLWLHYLTDKMLKQMTFKTKCNTPAMKQIKRK 311 (336)
T ss_dssp CTTCSGGGCCCS-SHHHHHHHHHHHHHTTCTTSCCTHHH---------HHHHHHHHHHHHHTCCCSSCCCSHHHHHHHHH
T ss_pred cccChhhhcCCC-ccceehhhhhCCCCcccccccCCCcc---------hhhhhHHHHhhhhhhccCcccchhhhhhcCHH
Confidence 999999998776 899999998777 7788889999831 11211111000000001111112224456778
Q ss_pred HHHHHHHhcCCCCCCCCCHHHHH-HH
Q 010519 434 SLLVALRCVDPDSEKRPKMSQVV-RM 458 (508)
Q Consensus 434 l~~li~~cl~~dP~~RPs~~evl-~~ 458 (508)
+.+|+.+||+.| |+.|++ +|
T Consensus 312 ~~dli~~~L~~d-----sa~e~l~~H 332 (336)
T 2vuw_A 312 IQEFHRTMLNFS-----SATDLLCQH 332 (336)
T ss_dssp HHHHHHHGGGSS-----SHHHHHHHC
T ss_pred HHHHHHHHhccC-----CHHHHHhcC
Confidence 899999999976 999999 65
|
| >4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=3e-31 Score=284.13 Aligned_cols=185 Identities=17% Similarity=0.125 Sum_probs=130.9
Q ss_pred eEeeeCceEEEEEE-EcCCCEEEEEEEcccc----------hhhHHHHHHHHHHHhcC-CCCCceeEEEEEEeCceeeEE
Q 010519 193 VLGEGGYGVVYKGR-LINGSEVAVKKLLNNL----------GQAEKEFRVEVEAIGHV-RHKNLVRLLGYCIEGVHRMLV 260 (508)
Q Consensus 193 ~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~----------~~~~~~~~~ei~~l~~l-~h~niv~~~~~~~~~~~~~lv 260 (508)
..+.|++|.+..++ +.-|+.+++|.+.... ....++|.+|+++|+++ .|+||++++++++++...|||
T Consensus 241 ~~~~~~~~~h~~~rr~~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed~~~~yLV 320 (569)
T 4azs_A 241 QPYAGAGLAHKRSRRYFFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGENAQSGWLV 320 (569)
T ss_dssp C-C--------CCEEEEECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEECSSEEEEE
T ss_pred ccccCCcccccccccccccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEECCEEEEE
Confidence 35566666665543 3368899999986432 22335799999999999 799999999999999999999
Q ss_pred EeecCCCCHHHHHhhhhccCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCEEEcCCCcEEEEecCCccccC
Q 010519 261 YEYVNNGNLEQWLHGAMRNQGNLTWEARMKVIIGTAKALAYLHEAIEPKVVHRDIKSSNILIDDEFNAKVSDFGLAKLLD 340 (508)
Q Consensus 261 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~Dfgla~~~~ 340 (508)
|||++|++|.++|. ..++++.. +|+.||+.||.|||++ |||||||||+||||+++|.+||+|||+++...
T Consensus 321 MEyv~G~~L~d~i~----~~~~l~~~---~I~~QIl~AL~ylH~~---GIIHRDIKPeNILL~~dg~vKL~DFGlAr~~~ 390 (569)
T 4azs_A 321 MEKLPGRLLSDMLA----AGEEIDRE---KILGSLLRSLAALEKQ---GFWHDDVRPWNVMVDARQHARLIDFGSIVTTP 390 (569)
T ss_dssp EECCCSEEHHHHHH----TTCCCCHH---HHHHHHHHHHHHHHHT---TCEESCCCGGGEEECTTSCEEECCCTTEESCC
T ss_pred EecCCCCcHHHHHH----hCCCCCHH---HHHHHHHHHHHHHHHC---CceeccCchHhEEECCCCCEEEeecccCeeCC
Confidence 99999999999994 45666654 5889999999999999 99999999999999999999999999998765
Q ss_pred CCCCcccccccccccccCccccCCCCCCChhhHHHHHHHHHHHHhCCCC
Q 010519 341 SGESHITTRVMGTFGYVAPEYANTGMLNEKSDIYSFGVLLLEAVTGRDP 389 (508)
Q Consensus 341 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltG~~P 389 (508)
.... .....+||+.|+|||++.+. +..++|+||+|++++++.++..|
T Consensus 391 ~~~~-~~~t~vGTp~YmAPE~l~g~-~~~~~d~~s~g~~~~~l~~~~~~ 437 (569)
T 4azs_A 391 QDCS-WPTNLVQSFFVFVNELFAEN-KSWNGFWRSAPVHPFNLPQPWSN 437 (569)
T ss_dssp ---C-CSHHHHHHHHHHHHHHC------------------CCCCTTHHH
T ss_pred CCCc-cccCceechhhccHHHhCCC-CCCcccccccccchhhhccccch
Confidence 4332 34557899999999999764 67789999999998887665443
|
| >3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=4.8e-28 Score=257.88 Aligned_cols=185 Identities=16% Similarity=0.227 Sum_probs=147.4
Q ss_pred ccceeEeeeCceEEEEEEEcCCCEEEEEEEcccch--------hhHHHHHHHHHHHhcCCCCCceeEEEEEEeCceeeEE
Q 010519 189 SAENVLGEGGYGVVYKGRLINGSEVAVKKLLNNLG--------QAEKEFRVEVEAIGHVRHKNLVRLLGYCIEGVHRMLV 260 (508)
Q Consensus 189 ~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~--------~~~~~~~~ei~~l~~l~h~niv~~~~~~~~~~~~~lv 260 (508)
...+.||+|+||+||+|.. .+..+++|+...... ...+.+.+|++++++++||||+.+..++......+||
T Consensus 339 ~~~~~LG~G~fg~Vy~~~~-~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lV 417 (540)
T 3en9_A 339 IPEHLIGKGAEADIKRDSY-LDFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPYIFDVDLDNKRIM 417 (540)
T ss_dssp ---------CCEEEEEEEC-SSCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEEEEETTTTEEE
T ss_pred CCCCEEeeCCCEEEEEEEE-CCCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEEEEeCCccEEE
Confidence 4467899999999999954 788999998754321 1134578999999999999999776666777888999
Q ss_pred EeecCCCCHHHHHhhhhccCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCEEEcCCCcEEEEecCCccccC
Q 010519 261 YEYVNNGNLEQWLHGAMRNQGNLTWEARMKVIIGTAKALAYLHEAIEPKVVHRDIKSSNILIDDEFNAKVSDFGLAKLLD 340 (508)
Q Consensus 261 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~Dfgla~~~~ 340 (508)
|||+++++|.+++.. +..++.|++.||.|||++ +|+||||||+|||+++ .+||+|||+++...
T Consensus 418 mE~~~ggsL~~~l~~------------~~~i~~qi~~aL~~LH~~---gIiHrDiKp~NILl~~--~~kL~DFGla~~~~ 480 (540)
T 3en9_A 418 MSYINGKLAKDVIED------------NLDIAYKIGEIVGKLHKN---DVIHNDLTTSNFIFDK--DLYIIDFGLGKISN 480 (540)
T ss_dssp EECCCSEEHHHHSTT------------CTHHHHHHHHHHHHHHHT---TEECTTCCTTSEEESS--SEEECCCTTCEECC
T ss_pred EECCCCCCHHHHHHH------------HHHHHHHHHHHHHHHHHC---cCccCCCCHHHEEECC--eEEEEECccCEECC
Confidence 999999999999852 568999999999999999 9999999999999999 99999999999875
Q ss_pred CCCCcc------cccccccccccCccccCC--CCCCChhhHHHHHHHHHHHHhCCCCCC
Q 010519 341 SGESHI------TTRVMGTFGYVAPEYANT--GMLNEKSDIYSFGVLLLEAVTGRDPVD 391 (508)
Q Consensus 341 ~~~~~~------~~~~~gt~~y~aPE~~~~--~~~~~~~DvwS~Gvvl~elltG~~Pf~ 391 (508)
...... .....||+.|+|||++.+ ..|+...|+|+..+-..+-+.++.+|.
T Consensus 481 ~~~~~~~~~~~~~~~~~GT~~y~APEv~~~~~~~Y~~~~d~ws~vl~~l~~v~~r~rY~ 539 (540)
T 3en9_A 481 LDEDKAVDLIVFKKAVLSTHHEKFDEIWERFLEGYKSVYDRWEIILELMKDVERRARYV 539 (540)
T ss_dssp CHHHHHHHHHHHHHHHHHHCGGGHHHHHHHHHHHHHHHCTTHHHHHHHHHHHHTCSCCC
T ss_pred CccccccchhhhhhhhcCCCCcCCHHHHHHHHHHHHHHHhHHHHHHHHHHHHHhccccC
Confidence 432211 235689999999999977 668889999999999998888877763
|
| >1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A* | Back alignment and structure |
|---|
Probab=99.90 E-value=3.7e-24 Score=209.31 Aligned_cols=152 Identities=17% Similarity=0.102 Sum_probs=121.3
Q ss_pred HHHHHhhCCcccceeEeeeCceEEEEEEEcCCCEEEEEEEcccch------------------hhHHHHHHHHHHHhcCC
Q 010519 179 RDLEIATNRFSAENVLGEGGYGVVYKGRLINGSEVAVKKLLNNLG------------------QAEKEFRVEVEAIGHVR 240 (508)
Q Consensus 179 ~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~------------------~~~~~~~~ei~~l~~l~ 240 (508)
..+......|.+.+.||+|+||.||+|.+.+|+.||+|.+..... .....+.+|+.++++++
T Consensus 83 ~~~~~~~~~~~~~~~iG~G~~g~Vy~~~~~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l~ 162 (282)
T 1zar_A 83 HRLVRSGKVDAIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQ 162 (282)
T ss_dssp HHHHHTTSCSEEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTT
T ss_pred HHHHhCCeEEEecCEeccCCCceEEEEEeCCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhcc
Confidence 334445567788899999999999999997789999999854321 13456889999999998
Q ss_pred CCCceeEEEEEEeCceeeEEEeecCCCCHHHHHhhhhccCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCE
Q 010519 241 HKNLVRLLGYCIEGVHRMLVYEYVNNGNLEQWLHGAMRNQGNLTWEARMKVIIGTAKALAYLHEAIEPKVVHRDIKSSNI 320 (508)
Q Consensus 241 h~niv~~~~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiH~Dlk~~NI 320 (508)
| +++++++. .+..++||||+++|+|.+ +. . .....++.|++.||.|||+. +|+||||||+||
T Consensus 163 --~-~~v~~~~~-~~~~~lvmE~~~g~~L~~-l~----~------~~~~~i~~qi~~~l~~lH~~---giiHrDlkp~NI 224 (282)
T 1zar_A 163 --G-LAVPKVYA-WEGNAVLMELIDAKELYR-VR----V------ENPDEVLDMILEEVAKFYHR---GIVHGDLSQYNV 224 (282)
T ss_dssp --T-SSSCCEEE-EETTEEEEECCCCEEGGG-CC----C------SCHHHHHHHHHHHHHHHHHT---TEECSCCSTTSE
T ss_pred --C-CCcCeEEe-ccceEEEEEecCCCcHHH-cc----h------hhHHHHHHHHHHHHHHHHHC---CCEeCCCCHHHE
Confidence 4 66666543 356699999999999987 41 1 22346999999999999999 999999999999
Q ss_pred EEcCCCcEEEEecCCccccCCCCCcccccccccccccCccccC
Q 010519 321 LIDDEFNAKVSDFGLAKLLDSGESHITTRVMGTFGYVAPEYAN 363 (508)
Q Consensus 321 ll~~~~~~kl~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~ 363 (508)
|++ ++.+||+|||+++. +..|+|||++.
T Consensus 225 Ll~-~~~vkl~DFG~a~~--------------~~~~~a~e~l~ 252 (282)
T 1zar_A 225 LVS-EEGIWIIDFPQSVE--------------VGEEGWREILE 252 (282)
T ss_dssp EEE-TTEEEECCCTTCEE--------------TTSTTHHHHHH
T ss_pred EEE-CCcEEEEECCCCeE--------------CCCCCHHHHHH
Confidence 999 99999999999973 34568898874
|
| >1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A* | Back alignment and structure |
|---|
Probab=99.80 E-value=1e-19 Score=175.46 Aligned_cols=137 Identities=19% Similarity=0.207 Sum_probs=107.1
Q ss_pred CcccceeEeeeCceEEEEEEE-cCCCE--EEEEEEcccch------------------------hhHHHHHHHHHHHhcC
Q 010519 187 RFSAENVLGEGGYGVVYKGRL-INGSE--VAVKKLLNNLG------------------------QAEKEFRVEVEAIGHV 239 (508)
Q Consensus 187 ~~~~~~~lg~G~~g~Vy~~~~-~~~~~--vavK~~~~~~~------------------------~~~~~~~~ei~~l~~l 239 (508)
-|.+.+.||+|+||.||+|.+ .+|.. ||||.+..... .....+..|+..|.++
T Consensus 48 ~~~i~~~ig~G~~g~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l 127 (258)
T 1zth_A 48 ITAMGGVISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLERA 127 (258)
T ss_dssp EEEEEEEEEECSSEEEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHHHH
T ss_pred chhhCCEEeecceEEEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHHHH
Confidence 467889999999999999988 68888 99998643211 1123578899999999
Q ss_pred CCCCc--eeEEEEEEeCceeeEEEeecCC-C----CHHHHHhhhhccCCCccHHHHHHHHHHHHHHHHHHH-hcCCCCeE
Q 010519 240 RHKNL--VRLLGYCIEGVHRMLVYEYVNN-G----NLEQWLHGAMRNQGNLTWEARMKVIIGTAKALAYLH-EAIEPKVV 311 (508)
Q Consensus 240 ~h~ni--v~~~~~~~~~~~~~lv~E~~~~-g----sL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~yLH-~~~~~~ii 311 (508)
.|+++ ..++++ ...+|||||+.+ | +|.++... .++..+..++.|++.||.||| +. +|+
T Consensus 128 ~~~~i~~p~~~~~----~~~~lVmE~~g~~g~~~~~L~~~~~~-------~~~~~~~~i~~qi~~~l~~lH~~~---giv 193 (258)
T 1zth_A 128 KEAGVSVPQPYTY----MKNVLLMEFIGEDELPAPTLVELGRE-------LKELDVEGIFNDVVENVKRLYQEA---ELV 193 (258)
T ss_dssp HHTTCCCCCEEEE----ETTEEEEECCEETTEECCBHHHHGGG-------GGGSCHHHHHHHHHHHHHHHHHTS---CEE
T ss_pred HhCCCCCCeEEEc----CCCEEEEEecCCCCCccccHHHHhhc-------cChHHHHHHHHHHHHHHHHHHHHC---CEE
Confidence 88754 344432 356899999942 4 77776421 234567789999999999999 88 999
Q ss_pred eecCCCCCEEEcCCCcEEEEecCCcccc
Q 010519 312 HRDIKSSNILIDDEFNAKVSDFGLAKLL 339 (508)
Q Consensus 312 H~Dlk~~NIll~~~~~~kl~Dfgla~~~ 339 (508)
||||||+|||+++ .++|+|||++...
T Consensus 194 HrDlkp~NILl~~--~~~liDFG~a~~~ 219 (258)
T 1zth_A 194 HADLSEYNIMYID--KVYFIDMGQAVTL 219 (258)
T ss_dssp CSSCSTTSEEESS--SEEECCCTTCEET
T ss_pred eCCCCHHHEEEcC--cEEEEECcccccC
Confidence 9999999999998 9999999999864
|
| >4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A | Back alignment and structure |
|---|
Probab=99.66 E-value=8e-17 Score=162.16 Aligned_cols=139 Identities=13% Similarity=0.060 Sum_probs=101.1
Q ss_pred CCcccceeEeeeCceEEEEEEEcCCCEEEEEEEcccch----------------h------hHHHHHHHHHHHhcCCCCC
Q 010519 186 NRFSAENVLGEGGYGVVYKGRLINGSEVAVKKLLNNLG----------------Q------AEKEFRVEVEAIGHVRHKN 243 (508)
Q Consensus 186 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~----------------~------~~~~~~~ei~~l~~l~h~n 243 (508)
.-|.+.+.||+|+||.||+|...+|+.||||.+..... . .......|...|.++.+.+
T Consensus 95 ~iY~I~~~IG~Gk~a~VY~a~d~~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~rL~~~g 174 (397)
T 4gyi_A 95 DVYSVGSRIGVGKESDIMIVADEKGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMKALYEEG 174 (397)
T ss_dssp SCSEEEEEEEECSSEEEEEEECTTCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHHHHHHTT
T ss_pred CEEEecCEeeeCCceEEEEEECCCCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHHhcC
Confidence 34999999999999999999988999999998742210 0 0011234677777775544
Q ss_pred ceeEEEEEEeCceeeEEEeecCCCCHHHHHhhhhccCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCEEEc
Q 010519 244 LVRLLGYCIEGVHRMLVYEYVNNGNLEQWLHGAMRNQGNLTWEARMKVIIGTAKALAYLHEAIEPKVVHRDIKSSNILID 323 (508)
Q Consensus 244 iv~~~~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiH~Dlk~~NIll~ 323 (508)
+.-..-+... ..+|||||++|++|..+.. ......++.||+.+|.|||.. +||||||||.|||++
T Consensus 175 v~vp~p~~~~--~~~LVME~i~G~~L~~l~~----------~~~~~~l~~qll~~l~~lH~~---gIVHrDLKp~NILl~ 239 (397)
T 4gyi_A 175 FPVPEPIAQS--RHTIVMSLVDALPMRQVSS----------VPDPASLYADLIALILRLAKH---GLIHGDFNEFNILIR 239 (397)
T ss_dssp CSCCCEEEEE--TTEEEEECCSCEEGGGCCC----------CSCHHHHHHHHHHHHHHHHHT---TEECSCCSTTSEEEE
T ss_pred CCCCeeeecc--CceEEEEecCCccHhhhcc----------cHHHHHHHHHHHHHHHHHHHC---CCcCCCCCHHHEEEe
Confidence 3222222222 3479999999988765321 123456889999999999998 999999999999998
Q ss_pred CCC----------cEEEEecCCcccc
Q 010519 324 DEF----------NAKVSDFGLAKLL 339 (508)
Q Consensus 324 ~~~----------~~kl~Dfgla~~~ 339 (508)
+++ .+.|+||+.+...
T Consensus 240 ~dgd~~d~~~~~~~~~iID~~Q~V~~ 265 (397)
T 4gyi_A 240 EEKDAEDPSSITLTPIIIXFPQMVSM 265 (397)
T ss_dssp EEECSSCTTSEEEEEEECCCTTCEET
T ss_pred CCCCcccccccccceEEEEeCCcccC
Confidence 876 3899999988654
|
| >3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A* | Back alignment and structure |
|---|
Probab=99.33 E-value=4.2e-12 Score=121.99 Aligned_cols=143 Identities=14% Similarity=0.085 Sum_probs=110.9
Q ss_pred hCCcccceeEeeeCceEEEEEEEcCCCEEEEEEEcccchhhHHHHHHHHHHHhcCC-CCCceeEEEEEEeCceeeEEEee
Q 010519 185 TNRFSAENVLGEGGYGVVYKGRLINGSEVAVKKLLNNLGQAEKEFRVEVEAIGHVR-HKNLVRLLGYCIEGVHRMLVYEY 263 (508)
Q Consensus 185 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~ei~~l~~l~-h~niv~~~~~~~~~~~~~lv~E~ 263 (508)
-..|.+...++.|+.+.||++.. ++..+++|............+..|+.+++.+. +..+.++++++.+....|+||||
T Consensus 13 l~~~~~~~~~~g~s~~~v~~~~~-~~~~~vlK~~~~~~~~~~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~ 91 (263)
T 3tm0_A 13 IEKYRCVKDTEGMSPAKVYKLVG-ENENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLLMSE 91 (263)
T ss_dssp HTTSEEEECCSCCSSSEEEEEEC-SSCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEEC
T ss_pred hccceeEeeccCCCCCeEEEEEC-CCCcEEEEeCCcccCCCHHHHHHHHHHHHHHhcCCCCCeEEEEEecCCceEEEEEe
Confidence 35788888899999999999965 57899999876432222345778999998884 67788899999988899999999
Q ss_pred cCCCCHHHHHhhhhccCCCccHHHHHHHHHHHHHHHHHHHhcC-------------------------------------
Q 010519 264 VNNGNLEQWLHGAMRNQGNLTWEARMKVIIGTAKALAYLHEAI------------------------------------- 306 (508)
Q Consensus 264 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~------------------------------------- 306 (508)
++|.+|.+.+. +......++.+++++|..||+..
T Consensus 92 i~G~~l~~~~~---------~~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 162 (263)
T 3tm0_A 92 ADGVLCSEEYE---------DEQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEEDT 162 (263)
T ss_dssp CSSEEHHHHCC---------TTTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCSGGGGSTTC
T ss_pred cCCeehhhccC---------CcccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhccccccccccccccc
Confidence 99999887531 11223467888999999999810
Q ss_pred -------------------CCCeEeecCCCCCEEEcCCCcEEEEecCCcc
Q 010519 307 -------------------EPKVVHRDIKSSNILIDDEFNAKVSDFGLAK 337 (508)
Q Consensus 307 -------------------~~~iiH~Dlk~~NIll~~~~~~kl~Dfgla~ 337 (508)
.+.++|+|+++.|||++++..+.|+||+.+.
T Consensus 163 ~~~~~~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~lIDwe~a~ 212 (263)
T 3tm0_A 163 PFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSG 212 (263)
T ss_dssp SSSSHHHHHHHHHHCCCCCCEEEECSSCCTTSEEEETTEEEEECCCTTCE
T ss_pred cCCCHHHHHHHHHhcCCCCCceEECCCCCcCcEEEECCcEEEEEEchhcc
Confidence 1369999999999999876556799999775
|
| >1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=99.14 E-value=5.4e-11 Score=113.60 Aligned_cols=137 Identities=18% Similarity=0.130 Sum_probs=96.5
Q ss_pred CcccceeEeeeCceEEEEEEEcCCCEEEEEEEcccchhhHHHHHHHHHHHhcCCCCC--ceeEEEEEEeCceeeEEEeec
Q 010519 187 RFSAENVLGEGGYGVVYKGRLINGSEVAVKKLLNNLGQAEKEFRVEVEAIGHVRHKN--LVRLLGYCIEGVHRMLVYEYV 264 (508)
Q Consensus 187 ~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~ei~~l~~l~h~n--iv~~~~~~~~~~~~~lv~E~~ 264 (508)
.|.+..+.+.|..+.||++...+|..+++|..... ....+..|+.+++.+.+.+ +.+++++...+...++||||+
T Consensus 21 ~~~~~~~~~gg~~~~v~~~~~~~g~~~vlK~~~~~---~~~~~~~E~~~l~~l~~~~~~vP~~~~~~~~~~~~~~v~e~i 97 (264)
T 1nd4_A 21 GYDWAQQTIGCSDAAVFRLSAQGRPVLFVKTDLSG---ALNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEV 97 (264)
T ss_dssp TCEEEECSCTTSSCEEEEEECTTSCCEEEEEECSC---TTSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECC
T ss_pred CCceEecccCCCCceEEEEecCCCCeEEEEeCCcc---cchhhhHHHHHHHHHHhCCCCCCeEEEeccCCCCCEEEEEec
Confidence 44444333456669999997666788999986543 1234667888888885444 456888888777889999999
Q ss_pred CCCCHHHHHhhhhccCCCccHHHHHHHHHHHHHHHHHHHhcC--------------------------------------
Q 010519 265 NNGNLEQWLHGAMRNQGNLTWEARMKVIIGTAKALAYLHEAI-------------------------------------- 306 (508)
Q Consensus 265 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~-------------------------------------- 306 (508)
+|.+|. .. . .. ...++.+++..|..||...
T Consensus 98 ~G~~l~--~~----~---~~---~~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 165 (264)
T 1nd4_A 98 PGQDLL--SS----H---LA---PAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGL 165 (264)
T ss_dssp SSEETT--TS----C---CC---HHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTC
T ss_pred CCcccC--cC----c---CC---HhHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccchhhhhhccCc
Confidence 998874 21 1 11 1245666677777777531
Q ss_pred -----------------CCCeEeecCCCCCEEEcCCCcEEEEecCCccc
Q 010519 307 -----------------EPKVVHRDIKSSNILIDDEFNAKVSDFGLAKL 338 (508)
Q Consensus 307 -----------------~~~iiH~Dlk~~NIll~~~~~~kl~Dfgla~~ 338 (508)
.+.++|+|++|.|||++++..+.|+||+.+..
T Consensus 166 ~~~~~~~~l~~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~liD~~~a~~ 214 (264)
T 1nd4_A 166 APAELFARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLGV 214 (264)
T ss_dssp CHHHHHHHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCEE
T ss_pred cHHHHHHHHHHhcCCCCCeEEECCCCCCCcEEEECCcEEEEEcchhccc
Confidence 12399999999999998776667999998763
|
| >3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134} | Back alignment and structure |
|---|
Probab=99.03 E-value=4.3e-10 Score=113.15 Aligned_cols=142 Identities=13% Similarity=0.185 Sum_probs=104.9
Q ss_pred cceeEeeeCceEEEEEEEcCCCEEEEEEEc--ccc-hhhHHHHHHHHHHHhcCC--CCCceeEEEEEEeC---ceeeEEE
Q 010519 190 AENVLGEGGYGVVYKGRLINGSEVAVKKLL--NNL-GQAEKEFRVEVEAIGHVR--HKNLVRLLGYCIEG---VHRMLVY 261 (508)
Q Consensus 190 ~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~--~~~-~~~~~~~~~ei~~l~~l~--h~niv~~~~~~~~~---~~~~lv~ 261 (508)
..+.|+.|.++.||+... .+..+++|+.. ... ......+..|+.+++.+. +..+.+++.++.+. ...|+||
T Consensus 42 ~~~~l~~G~sn~~y~v~~-~~~~~vlr~~~~p~~~~~~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~~~g~~~~vm 120 (359)
T 3dxp_A 42 SVEQFKGGQSNPTFKLVT-PGQTYVMRAKPGPKSKLLPSAHAIEREYRVMDALAGTDVPVAKMYALCEDESVIGRAFYIM 120 (359)
T ss_dssp EEEECCC-CCSCEEEEEC-SSCEEEEECCCC----------CHHHHHHHHHHHTTSSSCCCCEEEEECCTTTTSSCEEEE
T ss_pred eEEEcCCcccceEEEEEE-CCceEEEEeCCCCCCCCCCcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCCCccCCeEEEE
Confidence 356789999999999876 45678888764 221 122346778999998886 45678889888766 3478999
Q ss_pred eecCCCCHHHHHhhhhccCCCccHHHHHHHHHHHHHHHHHHHhcC-----------------------------------
Q 010519 262 EYVNNGNLEQWLHGAMRNQGNLTWEARMKVIIGTAKALAYLHEAI----------------------------------- 306 (508)
Q Consensus 262 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~----------------------------------- 306 (508)
||++|..+.+. ....++...+..++.+++.+|..||...
T Consensus 121 e~v~G~~l~~~------~~~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 194 (359)
T 3dxp_A 121 EFVSGRVLWDQ------SLPGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKLSETESI 194 (359)
T ss_dssp ECCCCBCCCCT------TCTTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHHCCSCC
T ss_pred EecCCeecCCC------ccccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHhcCCcCC
Confidence 99998776431 1234677888889999999999999731
Q ss_pred --------------------CCCeEeecCCCCCEEEcCCCc--EEEEecCCccc
Q 010519 307 --------------------EPKVVHRDIKSSNILIDDEFN--AKVSDFGLAKL 338 (508)
Q Consensus 307 --------------------~~~iiH~Dlk~~NIll~~~~~--~kl~Dfgla~~ 338 (508)
.+.++|+|+++.|||++.++. +.|+||+.+..
T Consensus 195 ~~~~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~ 248 (359)
T 3dxp_A 195 PAMDSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTL 248 (359)
T ss_dssp HHHHHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCEE
T ss_pred hHHHHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECcccccc
Confidence 247999999999999997753 68999998874
|
| >3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A | Back alignment and structure |
|---|
Probab=98.93 E-value=4.5e-10 Score=110.35 Aligned_cols=183 Identities=17% Similarity=0.215 Sum_probs=118.0
Q ss_pred ceeEeeeCceEEEEEEEcCCCEEEEEEEcccchhhHHHHHHHHHHHhcC-CCCC--ceeEEEEEEeCc---eeeEEEeec
Q 010519 191 ENVLGEGGYGVVYKGRLINGSEVAVKKLLNNLGQAEKEFRVEVEAIGHV-RHKN--LVRLLGYCIEGV---HRMLVYEYV 264 (508)
Q Consensus 191 ~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~ei~~l~~l-~h~n--iv~~~~~~~~~~---~~~lv~E~~ 264 (508)
.+.++.|....||+.. ..+++|..... .....+..|+.+|+.+ .+.. +..++....... ..|+||+++
T Consensus 25 i~~~~~G~~n~v~~v~----~~~vlR~~~~~--~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~~~~~~~~vm~~i 98 (304)
T 3sg8_A 25 IEISGEGNDCIAYEIN----RDFIFKFPKHS--RGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPSETYQMSFAGFTKI 98 (304)
T ss_dssp CCEEEECSSEEEEEST----TSEEEEEESSH--HHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCSSCSCSCEEEECC
T ss_pred eEecCCCCcceEEEEC----CEEEEEecCCc--chHHHHHHHHHHHHHHHhcCCCCCCceEeecCCCCCCCcceEEEccc
Confidence 3568999999999863 56888875322 3346788899999887 3332 334444433332 347899999
Q ss_pred CCCCHHHHHhhhhccCCCccHHHHHHHHHHHHHHHHHHHhc---------------------------------------
Q 010519 265 NNGNLEQWLHGAMRNQGNLTWEARMKVIIGTAKALAYLHEA--------------------------------------- 305 (508)
Q Consensus 265 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~--------------------------------------- 305 (508)
+|.+|.+... ..++...+..++.+++..+..||..
T Consensus 99 ~G~~l~~~~~------~~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 172 (304)
T 3sg8_A 99 KGVPLTPLLL------NNLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKGPQMKK 172 (304)
T ss_dssp CCEECCHHHH------HTSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCHHHHHH
T ss_pred CCeECCcccc------ccCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCcccHHH
Confidence 9988765331 2356666777777888888888751
Q ss_pred ----------------CCCCeEeecCCCCCEEEcC--CCcEEEEecCCccccCCCCCcccccccccccc---cCccccCC
Q 010519 306 ----------------IEPKVVHRDIKSSNILIDD--EFNAKVSDFGLAKLLDSGESHITTRVMGTFGY---VAPEYANT 364 (508)
Q Consensus 306 ----------------~~~~iiH~Dlk~~NIll~~--~~~~kl~Dfgla~~~~~~~~~~~~~~~gt~~y---~aPE~~~~ 364 (508)
..+.++|+|+++.||++++ ...+.|+||+.+......... . ....+ ..|+....
T Consensus 173 l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~~~~~Dl--~---~~~~~~~~~~~~~~~~ 247 (304)
T 3sg8_A 173 VDDFYRDILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAISDPDNDF--I---SLMEDDEEYGMEFVSK 247 (304)
T ss_dssp HHHHHHHHHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEEECTTHHH--H---TTCCTTTSCCHHHHHH
T ss_pred HHHHHHHHHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCccCChHHHH--H---HHHhhccccCHHHHHH
Confidence 1246899999999999998 455789999998754321110 0 00001 12221110
Q ss_pred -----CC---------CCChhhHHHHHHHHHHHHhCCCCC
Q 010519 365 -----GM---------LNEKSDIYSFGVLLLEAVTGRDPV 390 (508)
Q Consensus 365 -----~~---------~~~~~DvwS~Gvvl~elltG~~Pf 390 (508)
+. .....+.|++|.++|.+.+|..+|
T Consensus 248 ~l~~Y~~~~~~~~~~r~~~~~~~~~l~~~~~~~~~g~~~~ 287 (304)
T 3sg8_A 248 ILNHYKHKDIPTVLEKYRMKEKYWSFEKIIYGKEYGYMDW 287 (304)
T ss_dssp HHHHHTCSCHHHHHHHHHHHHHHHHHHHHHHHHHTTCHHH
T ss_pred HHHHcCCCCcHHHHHHHHHHHHHHHHHHHHHHHHcCCHHH
Confidence 00 112368999999999999998775
|
| >4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A* | Back alignment and structure |
|---|
Probab=98.40 E-value=2.2e-06 Score=82.05 Aligned_cols=135 Identities=16% Similarity=0.126 Sum_probs=92.7
Q ss_pred eEeeeCce-EEEEEEEc-CCCEEEEEEEcccchhhHHHHHHHHHHHhcCC-CCCceeEEEEEEeCceeeEEEeecCCCCH
Q 010519 193 VLGEGGYG-VVYKGRLI-NGSEVAVKKLLNNLGQAEKEFRVEVEAIGHVR-HKNLVRLLGYCIEGVHRMLVYEYVNNGNL 269 (508)
Q Consensus 193 ~lg~G~~g-~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~ei~~l~~l~-h~niv~~~~~~~~~~~~~lv~E~~~~gsL 269 (508)
.+..|..| .||+.... ++..+++|+-.. .....+..|...|+.+. +--+.++++++.+.+..++|||+++|.++
T Consensus 31 ~~~~G~S~~~v~rl~~~~~~~~~~lk~~~~---~~~~~~~~E~~~l~~l~~~vPVP~v~~~~~~~~~~~lvme~l~G~~~ 107 (272)
T 4gkh_A 31 RDNVGQSGATIYRLYGKPNAPELFLKHGKG---SVANDVTDEMVRLNWLTAFMPLPTIKHFIRTPDDAWLLTTAIPGKTA 107 (272)
T ss_dssp EEECSSSSCEEEEEECCTTCCCEEEEEEET---HHHHHHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCCSEEH
T ss_pred EccCCCcCCeEEEEEecCCCeEEEEEECCC---CCHhHHHHHHHHHHHhccCCCcCeEEEEEEECCeEEEEEEeeCCccc
Confidence 45556555 68987654 456788887533 23456778988888774 33367788999999999999999999888
Q ss_pred HHHHhhhhccCCCccHHHHHHHHHHHHHHHHHHHhc--------------------------------------------
Q 010519 270 EQWLHGAMRNQGNLTWEARMKVIIGTAKALAYLHEA-------------------------------------------- 305 (508)
Q Consensus 270 ~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~-------------------------------------------- 305 (508)
.+..... ......++.+++..|..||..
T Consensus 108 ~~~~~~~--------~~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 179 (272)
T 4gkh_A 108 FQVLEEY--------PDSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERNGWPVEQV 179 (272)
T ss_dssp HHHHHHC--------GGGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGGGTTCCHHHH
T ss_pred cccccCC--------HHHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhccccccchHHHHH
Confidence 7654210 112233445555555555532
Q ss_pred -----------CCCCeEeecCCCCCEEEcCCCcEEEEecCCccc
Q 010519 306 -----------IEPKVVHRDIKSSNILIDDEFNAKVSDFGLAKL 338 (508)
Q Consensus 306 -----------~~~~iiH~Dlk~~NIll~~~~~~kl~Dfgla~~ 338 (508)
..+.++|+|+.+.|||+++++.+-|+||+.+..
T Consensus 180 ~~~l~~~~~~~~~~~l~HGDl~~~Nil~~~~~~~~viDwe~a~~ 223 (272)
T 4gkh_A 180 WKEMHKLLPFSPDSVVTHGDFSLDNLIFDEGKLIGCIDVGRVGI 223 (272)
T ss_dssp HHHHHTTCCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEE
T ss_pred HHHHHhcccccCCcEEEcCCCCCCeEEEECCeEEEEEECccccc
Confidence 012379999999999999876677999998764
|
| >3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A* | Back alignment and structure |
|---|
Probab=98.37 E-value=2.3e-06 Score=83.85 Aligned_cols=137 Identities=17% Similarity=0.150 Sum_probs=89.9
Q ss_pred ceeEeeeCceEEEEEEEcCCCEEEEEEEcccchhhHHHHHHHHHHHhcCCCC---CceeEEEEEE-eCceeeEEEeecCC
Q 010519 191 ENVLGEGGYGVVYKGRLINGSEVAVKKLLNNLGQAEKEFRVEVEAIGHVRHK---NLVRLLGYCI-EGVHRMLVYEYVNN 266 (508)
Q Consensus 191 ~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~ei~~l~~l~h~---niv~~~~~~~-~~~~~~lv~E~~~~ 266 (508)
.+.++.|....||+. |..+++|.-. .......+..|..+|+.+.+. .+..++.++. .....++||||++|
T Consensus 24 v~~l~~G~~n~v~~v----g~~~VlR~~~--~~~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~~~g~~~~v~e~i~G 97 (306)
T 3tdw_A 24 VESLGEGFRNYAILV----NGDWVFRFPK--SQQGADELNKEIQLLPLLVGCVKVNIPQYVYIGKRSDGNPFVGYRKVQG 97 (306)
T ss_dssp EEEEEECSSEEEEEE----TTTEEEEEES--SHHHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEECTTSCEEEEEECCCS
T ss_pred eeecCCCcceeEEEE----CCEEEEEecC--CchHHHHHHHHHHHHHHHHhcCCCCCCCeEeecccCCCceEEEEeccCC
Confidence 456888888899987 5678888742 223346788899999998642 3556666664 34557899999999
Q ss_pred CCHHHHHhhhhccCCCccHHHHHHHHHHHHHHHHHHHhc-----------------------------------------
Q 010519 267 GNLEQWLHGAMRNQGNLTWEARMKVIIGTAKALAYLHEA----------------------------------------- 305 (508)
Q Consensus 267 gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~----------------------------------------- 305 (508)
.+|.+... ..++......++.+++..|..||..
T Consensus 98 ~~l~~~~~------~~l~~~~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~~~~~~~~~~~~~~~l~~~~~~~ 171 (306)
T 3tdw_A 98 QILGEDGM------AVLPDDAKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKNKILLLSEAVEDQVFPLLDESLRDY 171 (306)
T ss_dssp EECHHHHH------TTSCHHHHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHHHHHHHHHHHHTGGGSCHHHHHH
T ss_pred eECchhhh------hhCCHHHHHHHHHHHHHHHHHHhcCCcccccccCCChHHHHHHHHHHHHHHHHhcccccchhhHHH
Confidence 88765211 0122233333333333333333321
Q ss_pred ----------------CCCCeEeecCCCCCEEEcC---CCcE-EEEecCCcccc
Q 010519 306 ----------------IEPKVVHRDIKSSNILIDD---EFNA-KVSDFGLAKLL 339 (508)
Q Consensus 306 ----------------~~~~iiH~Dlk~~NIll~~---~~~~-kl~Dfgla~~~ 339 (508)
..+.++|+|+++.|||++. ++.+ .|+||+.+...
T Consensus 172 l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~~g 225 (306)
T 3tdw_A 172 LTLRFQSYMTHPVYTRYTPRLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAAIS 225 (306)
T ss_dssp HHHHHHHHHHCHHHHCCCCEEECSCCSGGGEEECTTCSSCCEEEECCCTTCEEE
T ss_pred HHHHHHHHHhCcccccCCCeeEeCCCCcccEEEecCCCCCceEEEEehhhcCCC
Confidence 2346799999999999987 4564 89999988643
|
| >3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A* | Back alignment and structure |
|---|
Probab=98.07 E-value=2e-06 Score=85.94 Aligned_cols=79 Identities=11% Similarity=-0.026 Sum_probs=51.9
Q ss_pred ceeE-eeeCceEEEEEEEc-------CCCEEEEEEEcccc---hhhHHHHHHHHHHHhcCC-C--CCceeEEEEEEeC--
Q 010519 191 ENVL-GEGGYGVVYKGRLI-------NGSEVAVKKLLNNL---GQAEKEFRVEVEAIGHVR-H--KNLVRLLGYCIEG-- 254 (508)
Q Consensus 191 ~~~l-g~G~~g~Vy~~~~~-------~~~~vavK~~~~~~---~~~~~~~~~ei~~l~~l~-h--~niv~~~~~~~~~-- 254 (508)
.+.| +.|....+|+.... ++..+++|...... ......+..|+.+++.+. + -.+.+++.++.+.
T Consensus 25 ~~~l~~~G~~n~~y~v~~~~~~~~~~~~~~~vlR~~~~~~~~~~~~~~~~~~E~~~l~~L~~~~~vpvP~v~~~~~~~~~ 104 (357)
T 3ats_A 25 ESGVDSTGMSSETIILTARWQQDGRSIQQKLVARVAPAAEDVPVFPTYRLDHQFEVIRLVGELTDVPVPRVRWIETTGDV 104 (357)
T ss_dssp EEEECTTSSEEEEEEEEEEEEETTEEEEEEEEEEECCCGGGCCSSSCCCHHHHHHHHHHHHHHCCSCCCCEEEEECSSTT
T ss_pred EEECCCCCccceEEEEEEecccCCCCCCceEEEEeCCCCCccccCchhHHHHHHHHHHHHhhcCCCCCCcEEEEccCCCc
Confidence 3567 88888999998764 26678888653322 001234666888877773 2 3466788877654
Q ss_pred -ceeeEEEeecCCCCH
Q 010519 255 -VHRMLVYEYVNNGNL 269 (508)
Q Consensus 255 -~~~~lv~E~~~~gsL 269 (508)
...++||||++|..+
T Consensus 105 ~g~~~~v~e~l~G~~l 120 (357)
T 3ats_A 105 LGTPFFLMDYVEGVVP 120 (357)
T ss_dssp TSSCEEEEECCCCBCC
T ss_pred cCCceEEEEecCCCCh
Confidence 346899999988654
|
| >2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis} | Back alignment and structure |
|---|
Probab=97.95 E-value=6.5e-05 Score=74.10 Aligned_cols=141 Identities=18% Similarity=0.225 Sum_probs=78.0
Q ss_pred eeEeeeCceEEEEEEEcCCCEEEEEEEcccchhhHHHHHHHHHHHhcC-----CCCCceeEE-E--EEEeCceeeEEEee
Q 010519 192 NVLGEGGYGVVYKGRLINGSEVAVKKLLNNLGQAEKEFRVEVEAIGHV-----RHKNLVRLL-G--YCIEGVHRMLVYEY 263 (508)
Q Consensus 192 ~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~ei~~l~~l-----~h~niv~~~-~--~~~~~~~~~lv~E~ 263 (508)
+.|+.|..+.||+....+ ..+++|+..... ..+..|+.++..| ..|.++... | +....+..+++|+|
T Consensus 38 ~~l~gG~~n~~~~v~~~~-~~~vlk~~~~~~----~~~~~e~~~l~~L~~~g~~vp~~~~~~~g~~~~~~~~~~~~l~~~ 112 (346)
T 2q83_A 38 DVIQGNQMALVWKVHTDS-GAVCLKRIHRPE----KKALFSIFAQDYLAKKGMNVPGILPNKKGSLYSKHGSFLFVVYDW 112 (346)
T ss_dssp EECC----CEEEEEEETT-EEEEEEEECSCH----HHHHHHHHHHHHHHHHTCSSCCBCCCTTSCSCEEETTEEEEEEEC
T ss_pred eeccccccCcEEEEEeCC-CCEEEEecCCCH----HHHHHHHHHHHHHHHcCCCCCceeecCCCCEEEEECCEEEEEEEe
Confidence 346667788999997744 458888875421 2233344444433 234444311 1 22346677899999
Q ss_pred cCCCCHH--------------HHHhhhhccC--C--------CccHHH-------------------------------H
Q 010519 264 VNNGNLE--------------QWLHGAMRNQ--G--------NLTWEA-------------------------------R 288 (508)
Q Consensus 264 ~~~gsL~--------------~~l~~~~~~~--~--------~l~~~~-------------------------------~ 288 (508)
++|..+. ..+|...... . ...|.. .
T Consensus 113 i~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ 192 (346)
T 2q83_A 113 IEGRPFELTVKQDLEFIMKGLADFHTASVGYQPPNGVPIFTKLGRWPNHYTKRCKQMETWKLMAEAEKEDPFSQLYLQEI 192 (346)
T ss_dssp CCCBCCCTTSHHHHHHHHHHHHHHHHHHTTCCCCTTCCCCBCTTCHHHHHHHHHHHHHHHHHHHHHCSSCHHHHHHHHHH
T ss_pred ecCccCCCCCHHHHHHHHHHHHHHHHhCCCCCCCccchhcccccchHHHHHHHHHHHHHHHHHHHhccCCcHHHHHHHHH
Confidence 9986431 1123211111 0 011211 0
Q ss_pred HHHHHHHHHHHHHHHh----------cCCCCeEeecCCCCCEEEcCCCcEEEEecCCcc
Q 010519 289 MKVIIGTAKALAYLHE----------AIEPKVVHRDIKSSNILIDDEFNAKVSDFGLAK 337 (508)
Q Consensus 289 ~~i~~~i~~al~yLH~----------~~~~~iiH~Dlk~~NIll~~~~~~kl~Dfgla~ 337 (508)
..+...+..++.+|+. ...+.++|+|+++.|||++.++.+.|+||+.+.
T Consensus 193 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDfe~a~ 251 (346)
T 2q83_A 193 DGFIEDGLRIKDRLLQSTYVPWTEQLKKSPNLCHQDYGTGNTLLGENEQIWVIDLDTVS 251 (346)
T ss_dssp HHHHHHHHHHHHHHHHTTHHHHHHHHHHSCCEECSSCSTTSEEECGGGCEEECCCTTCE
T ss_pred HHHHHHHHHHHHHHHhchHHHHHHhccccCceecCCCCcccEEEeCCCcEEEEehhhcc
Confidence 1111223445666653 124589999999999999888889999999775
|
| >3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX} | Back alignment and structure |
|---|
Probab=97.93 E-value=3.6e-05 Score=74.44 Aligned_cols=81 Identities=20% Similarity=0.317 Sum_probs=58.1
Q ss_pred hhCCcccceeEeeeCceEEEEEEEcCCCEEEEEEEcccchhhHHHHHHHHHHHhcCCCC---CceeEEEEEEeCceeeEE
Q 010519 184 ATNRFSAENVLGEGGYGVVYKGRLINGSEVAVKKLLNNLGQAEKEFRVEVEAIGHVRHK---NLVRLLGYCIEGVHRMLV 260 (508)
Q Consensus 184 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~ei~~l~~l~h~---niv~~~~~~~~~~~~~lv 260 (508)
......-.+.+|.|..+.||+.+..+|+.+++|+...........|..|...|+.|.-. .+.+++++ . ..++|
T Consensus 13 ~G~~v~~v~~~g~G~~~~vyrv~l~DG~~~~vK~~~~~~~~~~~~~~~Ea~~L~~L~~~~~vpvP~v~~~--~--~~~lv 88 (288)
T 3f7w_A 13 TGREVAAVAERGHSHRWHLYRVELADGTPLFVKALPDDAPALDGLFRAEALGLDWLGRSFGSPVPQVAGW--D--DRTLA 88 (288)
T ss_dssp HCCCEEEEEEEEEETTEEEEEEEETTSCEEEEEECCTTCCCCTTHHHHHHHHHHHHTCSTTCCSCCEEEE--E--TTEEE
T ss_pred cCCCeEEEEecCCCCCeEEEEEEECCCCEEEEEEeCCCCcchhhHHHHHHHHHHHHHhhCCCCcceEEec--c--CceEE
Confidence 34566667889999999999999989999999976544433345677888888777421 24445543 2 34789
Q ss_pred EeecCCCC
Q 010519 261 YEYVNNGN 268 (508)
Q Consensus 261 ~E~~~~gs 268 (508)
|||++++.
T Consensus 89 ~e~l~~~~ 96 (288)
T 3f7w_A 89 MEWVDERP 96 (288)
T ss_dssp EECCCCCC
T ss_pred EEeecccC
Confidence 99998765
|
| >2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A* | Back alignment and structure |
|---|
Probab=97.89 E-value=2.4e-05 Score=79.43 Aligned_cols=75 Identities=15% Similarity=0.130 Sum_probs=47.7
Q ss_pred ceeEeeeCceEEEEEEEc-CCCEEEEEEEcccch-------hhHHHHHHHHHHHhcCCC--CCc-eeEEEEEEeCceeeE
Q 010519 191 ENVLGEGGYGVVYKGRLI-NGSEVAVKKLLNNLG-------QAEKEFRVEVEAIGHVRH--KNL-VRLLGYCIEGVHRML 259 (508)
Q Consensus 191 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-------~~~~~~~~ei~~l~~l~h--~ni-v~~~~~~~~~~~~~l 259 (508)
.+.||.|.++.||++... ++..+++|....... .....+..|.++++.+.. +.. ..++.+ +....++
T Consensus 35 ~~~lg~G~~n~vyrv~~~~~~~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~~--d~~~~~l 112 (397)
T 2olc_A 35 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVT 112 (397)
T ss_dssp EEECCSSSSEEEEEEEC----CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEE
T ss_pred EEECCCCceEEEEEEEECCCCcEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhhhCCCCcCeEEEE--cCCccEE
Confidence 467999999999999653 568899997643221 112345668888877632 333 345543 4455689
Q ss_pred EEeecCCC
Q 010519 260 VYEYVNNG 267 (508)
Q Consensus 260 v~E~~~~g 267 (508)
||||+++.
T Consensus 113 vmE~l~g~ 120 (397)
T 2olc_A 113 VMEDLSHL 120 (397)
T ss_dssp EECCCTTS
T ss_pred EEEeCCCc
Confidence 99999764
|
| >2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana} | Back alignment and structure |
|---|
Probab=97.78 E-value=3.4e-05 Score=78.97 Aligned_cols=78 Identities=14% Similarity=0.141 Sum_probs=49.6
Q ss_pred CCCeEeecCCCCCEEEcCCCcEEEEecCCccccCCCCCcccccccc--cccccCccccCCCC---CCChhhHHHHHHHHH
Q 010519 307 EPKVVHRDIKSSNILIDDEFNAKVSDFGLAKLLDSGESHITTRVMG--TFGYVAPEYANTGM---LNEKSDIYSFGVLLL 381 (508)
Q Consensus 307 ~~~iiH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~~~g--t~~y~aPE~~~~~~---~~~~~DvwS~Gvvl~ 381 (508)
.+.++|+|+++.|||++.++ ++|+||+.+........ ...... ...|++|+...... -....++......+|
T Consensus 231 ~~~liHGDl~~~Nil~~~~~-~~lID~e~a~~G~p~~D--la~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 307 (420)
T 2pyw_A 231 AQALIHGDLHTGSVMVTQDS-TQVIDPEFSFYGPMGFD--IGAYLGNLILAFFAQDGHATQENDRKEYKQWILRTIEQTW 307 (420)
T ss_dssp CCEEECSCCSGGGEEECSSC-EEECCCTTCEEECHHHH--HHHHHHHHHHHHHHGGGGCCSSCCSHHHHHHHHHHHHHHH
T ss_pred CCeEEecCCCCCcEEEeCCC-CEEEeCcccccCchHHH--HHHHHHHHHHHHHhcccccccccchHHHHHHHHHHHHHHH
Confidence 44899999999999999876 99999998875432111 111111 23467776654211 112355667888888
Q ss_pred HHHhCC
Q 010519 382 EAVTGR 387 (508)
Q Consensus 382 elltG~ 387 (508)
+.+++.
T Consensus 308 ~~y~~~ 313 (420)
T 2pyw_A 308 NLFNKR 313 (420)
T ss_dssp HHHHHH
T ss_pred HHHHHH
Confidence 887753
|
| >3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT} | Back alignment and structure |
|---|
Probab=97.72 E-value=0.00014 Score=71.09 Aligned_cols=140 Identities=17% Similarity=0.186 Sum_probs=90.8
Q ss_pred cceeEeeeCceEEEEEEEcCCCEEEEEEEcccchhhHHHHHHHHHHHhcCC---CCCceeEEEEEEeCceeeEEEeecCC
Q 010519 190 AENVLGEGGYGVVYKGRLINGSEVAVKKLLNNLGQAEKEFRVEVEAIGHVR---HKNLVRLLGYCIEGVHRMLVYEYVNN 266 (508)
Q Consensus 190 ~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~ei~~l~~l~---h~niv~~~~~~~~~~~~~lv~E~~~~ 266 (508)
-.+.|+.|....+|+... ++..+++|..... ....+..|...|+.|. ...+.+++.++......++||||+++
T Consensus 40 ~~~~l~gG~~n~~y~v~~-~~~~~vlK~~~~~---~~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~~g~~~lvme~l~G 115 (312)
T 3jr1_A 40 HKEKLYSGEMNEIWLIND-EVQTVFVKINERS---YRSMFRAEADQLALLAKTNSINVPLVYGIGNSQGHSFLLLEALNK 115 (312)
T ss_dssp EEEEECCSSSSEEEEEES-SSCEEEEEEEEGG---GHHHHHHHHHHHHHHHHTTSSBCCCEEEEEECSSEEEEEEECCCC
T ss_pred eeEEeCCccceeeeEEEE-CCCeEEEEeCCcc---cHHHHHHHHHHHHHHHhhCCCCcceEEEEeecCCceEEEEEeccC
Confidence 346789999999999875 6778888876432 3456788888887773 35688888888877889999999998
Q ss_pred CCHH--------H---HHhhhhc-c-C--------C--------CccHHHHH---HHH----------------HHHHHH
Q 010519 267 GNLE--------Q---WLHGAMR-N-Q--------G--------NLTWEARM---KVI----------------IGTAKA 298 (508)
Q Consensus 267 gsL~--------~---~l~~~~~-~-~--------~--------~l~~~~~~---~i~----------------~~i~~a 298 (508)
..+. . .||..-. . . + .-+|.... ++. ..++..
T Consensus 116 ~~~~~~~~~~lG~~LA~LH~~~~~~~fG~~~~~~~G~~~q~n~w~~~W~~f~~~~Rl~~~l~~a~~~g~~~~~~~~l~~~ 195 (312)
T 3jr1_A 116 SKNKQSSFTIFAEKIAQLHQIQGPDKYGLDFDTWLGPIYQPNDWQTSWAKFFSENRIGWQLQICKEKGLIFGNIDLIVQI 195 (312)
T ss_dssp CCCCTTHHHHHHHHHHHHHHCCCCSSBBCSSCEEETTEEECCCCBSCHHHHHHHHTHHHHHHHHHHHTCCCSCHHHHHHH
T ss_pred CCCCchhHHHHHHHHHHHHcCCCCCCCCCCCCCCCCCcCCCCCCcCCHHHHHHHHHHHHHHHHHHHcCCChHHHHHHHHH
Confidence 7641 1 2332111 0 0 0 01343221 111 111212
Q ss_pred H-HHHHh-cCCCCeEeecCCCCCEEEcCCCcEEEEecC
Q 010519 299 L-AYLHE-AIEPKVVHRDIKSSNILIDDEFNAKVSDFG 334 (508)
Q Consensus 299 l-~yLH~-~~~~~iiH~Dlk~~NIll~~~~~~kl~Dfg 334 (508)
+ ..|.. ...|.++|+|+.+.|++++.++ +.|.||.
T Consensus 196 l~~~L~~~~~~~~l~HgD~~~~N~l~~~~~-~~~iD~~ 232 (312)
T 3jr1_A 196 VADTLSKHNPKPSILHGNLWIENCIQVDDK-IFVCNPA 232 (312)
T ss_dssp HHHHHTTCCCCCEEECSSCSGGGEEEETTE-EEECSCC
T ss_pred HHHHhccCCCCceeEeCCCCcCcEeecCCC-eEEEcCc
Confidence 2 23321 2357899999999999999887 8888874
|
| >2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=97.19 E-value=0.0016 Score=63.59 Aligned_cols=156 Identities=12% Similarity=0.113 Sum_probs=82.0
Q ss_pred HHHHHhhCCccc-----ceeEeeeCceEEEEEEEcCCCEEEEEEEcccchhhHHHHHHHHHHHhcCC-----CCCceeEE
Q 010519 179 RDLEIATNRFSA-----ENVLGEGGYGVVYKGRLINGSEVAVKKLLNNLGQAEKEFRVEVEAIGHVR-----HKNLVRLL 248 (508)
Q Consensus 179 ~~~~~~~~~~~~-----~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~ei~~l~~l~-----h~niv~~~ 248 (508)
.++.....+|.+ .+.|+.|....+|+....+| .+++|...... ....+..|+.++..+. -|.++...
T Consensus 10 ~~l~~~l~~~~~~~~~~~~~i~~G~~n~~~~v~~~~g-~~vlk~~~~~~--~~~~l~~e~~~l~~L~~~g~~vP~~~~~~ 86 (322)
T 2ppq_A 10 DELRNFLTQYDVGSLTSYKGIAEGVENSNFLLHTTKD-PLILTLYEKRV--EKNDLPFFLGLMQHLAAKGLSCPLPLPRK 86 (322)
T ss_dssp HHHHHHHTTBCCCCEEEEEEECC---EEEEEEEESSC-CEEEEEECC-----CCHHHHHHHHHHHHHHTTCCCCCBCCBT
T ss_pred HHHHHHHHhCCCCcceEeeccCCCcccceEEEEeCCc-cEEEEEeCCCC--CHHHHHHHHHHHHHHHHCCCCCCcccCCC
Confidence 344433444544 24466788889999977555 67888765421 1223445666665553 23333211
Q ss_pred -E--EEEeCceeeEEEeecCCCCHH-----H---------HHhhhhccCC-C-------ccHHHHHH------------H
Q 010519 249 -G--YCIEGVHRMLVYEYVNNGNLE-----Q---------WLHGAMRNQG-N-------LTWEARMK------------V 291 (508)
Q Consensus 249 -~--~~~~~~~~~lv~E~~~~gsL~-----~---------~l~~~~~~~~-~-------l~~~~~~~------------i 291 (508)
| +....+..+++|+|++|..+. . .+|....... . ..|..... +
T Consensus 87 ~g~~~~~~~g~~~~l~~~l~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~~~~~l 166 (322)
T 2ppq_A 87 DGELLGELSGRPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVEKGL 166 (322)
T ss_dssp TCCSCEEETTEEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTSTTH
T ss_pred CCCEEEEECCEEEEEEEeCCCcCCCCCCHHHHHHHHHHHHHHHHHhccCCCcccCccChHHHHHHHHHHHHHHHhhhhhh
Confidence 1 112345678999999886431 0 1222111100 0 11222110 0
Q ss_pred HHHHHHHHHHHHhc----CCCCeEeecCCCCCEEEcCCCcEEEEecCCcc
Q 010519 292 IIGTAKALAYLHEA----IEPKVVHRDIKSSNILIDDEFNAKVSDFGLAK 337 (508)
Q Consensus 292 ~~~i~~al~yLH~~----~~~~iiH~Dlk~~NIll~~~~~~kl~Dfgla~ 337 (508)
...+...+.+++.. ..+.++|+|+.+.|||++++..+.|+||+.+.
T Consensus 167 ~~~l~~~~~~l~~~~~~~~~~~liHgDl~~~Nil~~~~~~~~lIDf~~a~ 216 (322)
T 2ppq_A 167 REEIRPEIDYLAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFAC 216 (322)
T ss_dssp HHHHHHHHHHHHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred HHHHHHHHHHHHhhCcccCCcccCCCCCCccCEEEeCCceEEEecchhcc
Confidence 01134455555532 23479999999999999987556799999775
|
| >2k1k_A Ephrin type-A receptor 1; EPHA1, receptor tyrosine kinase, dimeric transmembrane domain, ATP-binding, glycoprotein, nucleotide-binding; NMR {Homo sapiens} PDB: 2k1l_A | Back alignment and structure |
|---|
Probab=97.11 E-value=0.00043 Score=44.22 Aligned_cols=33 Identities=18% Similarity=0.132 Sum_probs=22.0
Q ss_pred ccchhHHHHHHHHHHHHHHHHHHHHhhhheecc
Q 010519 17 FLGLKLWVLIGISVGAFIVLILCILSVWVSFRR 49 (508)
Q Consensus 17 ~~~~~~~~~igi~~g~~~~~~l~~~~~~~~~rr 49 (508)
..|+.-+.+.||++|+++.+++++.++|+++||
T Consensus 5 ~~~ls~GaIAGiVvG~v~gv~li~~l~~~~~rr 37 (38)
T 2k1k_A 5 SRGLTGGEIVAVIFGLLLGAALLLGILVFRSRR 37 (38)
T ss_dssp STTCCHHHHHHHHHHHHHHHHHHHHHHHHHHCC
T ss_pred CCCCCCCceeeeehHHHHHHHHHHHHHHHHeec
Confidence 457788999999999877665545444443333
|
| >2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A | Back alignment and structure |
|---|
Probab=97.07 E-value=0.0037 Score=56.95 Aligned_cols=103 Identities=17% Similarity=0.102 Sum_probs=67.6
Q ss_pred CCHHHHHhhhhccCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCEEEcCCCcEEEEecCCccccCCCCCcc
Q 010519 267 GNLEQWLHGAMRNQGNLTWEARMKVIIGTAKALAYLHEAIEPKVVHRDIKSSNILIDDEFNAKVSDFGLAKLLDSGESHI 346 (508)
Q Consensus 267 gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~ 346 (508)
-+|.+.|. ..+.+++++++|.++.|.+.+|.-+-....+ ..+=+.|..|+|..+|.|.+.+ ..+.
T Consensus 33 vSL~eIL~---~~~~PlsEEqaWALc~Qc~~~L~~~~~~~~~--~~~i~~~~~i~l~~dG~V~f~~-~~s~--------- 97 (229)
T 2yle_A 33 LSLEEILR---LYNQPINEEQAWAVCYQCCGSLRAAARRRQP--RHRVRSAAQIRVWRDGAVTLAP-AADD--------- 97 (229)
T ss_dssp EEHHHHHH---HHTSCCCHHHHHHHHHHHHHHHHHHHHTTCC--CCCCCSGGGEEEETTSCEEECC-C------------
T ss_pred ccHHHHHH---HcCCCcCHHHHHHHHHHHHHHHHhhhhcccC--CceecCCcceEEecCCceeccc-cccc---------
Confidence 37999986 4578899999999999999998776221111 1333456899999999998764 1111
Q ss_pred cccccccccccCccccCCCCCCChhhHHHHHHHHHHHHhCCCC
Q 010519 347 TTRVMGTFGYVAPEYANTGMLNEKSDIYSFGVLLLEAVTGRDP 389 (508)
Q Consensus 347 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltG~~P 389 (508)
.....+.+||... ...+.+.=|||||++||.-+--..|
T Consensus 98 ----~~~~~~~~pe~~~-~~~te~~~IysLG~tLY~ALDygL~ 135 (229)
T 2yle_A 98 ----AGEPPPVAGKLGY-SQCMETEVIESLGIIIYKALDYGLK 135 (229)
T ss_dssp -------------CCSS-SSSCHHHHHHHHHHHHHHHHTTTCC
T ss_pred ----ccccCCCChhhcc-ccchHHHHHHHHHHHHHHHhhcCCC
Confidence 0123456888763 2446788999999999999875544
|
| >3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti} | Back alignment and structure |
|---|
Probab=96.99 E-value=0.00092 Score=64.81 Aligned_cols=140 Identities=12% Similarity=0.097 Sum_probs=72.9
Q ss_pred ceeEeeeCceEEEEEEEcCCCEEEEEEEcccchhhHHHHHHHHHHHhcCCCCCc-eeEEEEEEeCceeeEEEeec-CCCC
Q 010519 191 ENVLGEGGYGVVYKGRLINGSEVAVKKLLNNLGQAEKEFRVEVEAIGHVRHKNL-VRLLGYCIEGVHRMLVYEYV-NNGN 268 (508)
Q Consensus 191 ~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~ei~~l~~l~h~ni-v~~~~~~~~~~~~~lv~E~~-~~gs 268 (508)
.+.|+.|....+|+. ..+++|......... .....|+..++.+....+ .+++++ +...-++++||+ ++.+
T Consensus 23 i~~l~gG~tN~~~~~-----~~~vlR~~~~~~~~~-~~r~~E~~~l~~l~~~g~~P~~~~~--~~~~~~~v~e~i~~g~~ 94 (301)
T 3dxq_A 23 PLERLGGLTNLVFRA-----GDLCLRIPGKGTEEY-INRANEAVAAREAAKAGVSPEVLHV--DPATGVMVTRYIAGAQT 94 (301)
T ss_dssp CEEEESCSSEEEEEE-----TTEEEEEECC----C-CCHHHHHHHHHHHHHTTSSCCEEEE--CTTTCCEEEECCTTCEE
T ss_pred eeEcCCcccccccee-----eeEEEECCCCCccce-eCHHHHHHHHHHHHHcCCCCceEEE--ECCCCEEEEeecCCCcc
Confidence 578999999999998 568888764322111 112346666665532222 455543 344457899999 5544
Q ss_pred HHH---------------H---HhhhhccC-CCcc-HHHHHHHHH--------------HHHHHHHH----HHh-cCCCC
Q 010519 269 LEQ---------------W---LHGAMRNQ-GNLT-WEARMKVII--------------GTAKALAY----LHE-AIEPK 309 (508)
Q Consensus 269 L~~---------------~---l~~~~~~~-~~l~-~~~~~~i~~--------------~i~~al~y----LH~-~~~~~ 309 (508)
|.. . ||...... .... +.....+.. .+...+.. |.. ...+.
T Consensus 95 l~~~~~~~~~~~~~~~~~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~l~~~l~~~~~~~~ 174 (301)
T 3dxq_A 95 MSPEKFKTRPGSPARAGEAFRKLHGSGAVFPFRFELFAMIDDYLKVLSTKNVTLPAGYHDVVREAGGVRSALAAHPLPLA 174 (301)
T ss_dssp CCHHHHHHSTTHHHHHHHHHHHHHTSCCCCSSBCCHHHHHHHHHHHHC--CCCCCTTHHHHHHHHHHHHHHHHSSCCCCE
T ss_pred CCHhhHhhhHHHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHhhcCCCchhhHHHHHHHHHHHHHHHHhcCCCce
Confidence 321 0 11100000 0011 111111110 01111111 111 12346
Q ss_pred eEeecCCCCCEEEcCCCcEEEEecCCcccc
Q 010519 310 VVHRDIKSSNILIDDEFNAKVSDFGLAKLL 339 (508)
Q Consensus 310 iiH~Dlk~~NIll~~~~~~kl~Dfgla~~~ 339 (508)
++|+|+.+.||+ ..++.+.|+||..+...
T Consensus 175 l~HgDl~~~Nil-~~~~~~~lID~e~a~~g 203 (301)
T 3dxq_A 175 ACHCDPLCENFL-DTGERMWIVDWEYSGMN 203 (301)
T ss_dssp EECSCCCGGGEE-ECSSCEEECCCTTCEEE
T ss_pred eeccCCCcCCEE-ECCCCEEEEecccccCC
Confidence 899999999999 55668899999988643
|
| >2l2t_A Receptor tyrosine-protein kinase ERBB-4; transmembrane dimer, membrane domain, membrane protei; NMR {Homo sapiens} | Back alignment and structure |
|---|
Probab=96.99 E-value=0.00054 Score=45.01 Aligned_cols=30 Identities=20% Similarity=0.320 Sum_probs=14.5
Q ss_pred hhHHHHHHHHHHHHHHHHHHHHhhhheecc
Q 010519 20 LKLWVLIGISVGAFIVLILCILSVWVSFRR 49 (508)
Q Consensus 20 ~~~~~~igi~~g~~~~~~l~~~~~~~~~rr 49 (508)
-+...+++.++|.+++++++++++|++.||
T Consensus 7 s~~~aIA~gVVgGv~~v~ii~~~~~~~~RR 36 (44)
T 2l2t_A 7 ARTPLIAAGVIGGLFILVIVGLTFAVYVRR 36 (44)
T ss_dssp CSSHHHHHHHHHHHHHHHHHHHHHHHHHHT
T ss_pred CCcceEEEeehHHHHHHHHHHHHHHHHhhh
Confidence 345556666665444444444444443333
|
| >3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP} | Back alignment and structure |
|---|
Probab=96.97 E-value=0.0029 Score=62.14 Aligned_cols=33 Identities=39% Similarity=0.391 Sum_probs=28.3
Q ss_pred CCCeEeecCCCCCEEEcCC----CcEEEEecCCcccc
Q 010519 307 EPKVVHRDIKSSNILIDDE----FNAKVSDFGLAKLL 339 (508)
Q Consensus 307 ~~~iiH~Dlk~~NIll~~~----~~~kl~Dfgla~~~ 339 (508)
.+.++|+|+.+.|||++.+ +.+.|+||+.+...
T Consensus 182 ~~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~G 218 (333)
T 3csv_A 182 DMVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKLG 218 (333)
T ss_dssp CCEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEEE
T ss_pred CCeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCcC
Confidence 4479999999999999875 67999999988754
|
| >1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=96.92 E-value=0.0038 Score=60.98 Aligned_cols=143 Identities=16% Similarity=0.136 Sum_probs=78.8
Q ss_pred eeEeeeCceEEEEEEEcCCCEEEEEEEcccchhhHHHHHHHHHHHhcCCCC--CceeEEEE-----EEeCceeeEEEeec
Q 010519 192 NVLGEGGYGVVYKGRLINGSEVAVKKLLNNLGQAEKEFRVEVEAIGHVRHK--NLVRLLGY-----CIEGVHRMLVYEYV 264 (508)
Q Consensus 192 ~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~ei~~l~~l~h~--niv~~~~~-----~~~~~~~~lv~E~~ 264 (508)
..++ |....||+....+|..+++|...... .....+..|..++..+... .+++++.. ....+..+++|+|+
T Consensus 32 ~~l~-g~~n~~y~v~~~~g~~~vlK~~~~~~-~~~~~~~~E~~~~~~L~~~g~~vp~~~~~~g~~~~~~~g~~~~l~~~i 109 (328)
T 1zyl_A 32 TPLN-SYENRVYQFQDEDRRRFVVKFYRPER-WTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSV 109 (328)
T ss_dssp EEEC-CSSSEEEEECCTTCCCEEEEEECTTT-SCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECC
T ss_pred Eeec-CcccceEEEEcCCCCEEEEEEcCCCC-CCHHHHHHHHHHHHHHHHcCCeecceeecCCcEEEEECCEEEEEEEec
Confidence 4566 77889999876667789999875321 1234555677776666311 13333332 22345567899999
Q ss_pred CCCCHH-----H------H---HhhhhccC-----CCccHHHH----HHH---------------HHHHHHHHHHHHhc-
Q 010519 265 NNGNLE-----Q------W---LHGAMRNQ-----GNLTWEAR----MKV---------------IIGTAKALAYLHEA- 305 (508)
Q Consensus 265 ~~gsL~-----~------~---l~~~~~~~-----~~l~~~~~----~~i---------------~~~i~~al~yLH~~- 305 (508)
+|..+. . . +|...... ....+... ..+ ...+...+..+...
T Consensus 110 ~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~ 189 (328)
T 1zyl_A 110 GGRQFEADNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAVTAHW 189 (328)
T ss_dssp CCEECCSSCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHHHHHC
T ss_pred CCCCCCCCCHHHHHHHHHHHHHHHHhhccCCCccCCCCCHHHHHhhHHHHHhhcCcCCHHHHHHHHHHHHHHHHHHHHHh
Confidence 875421 1 1 22211110 11121110 001 01111223333321
Q ss_pred ---CCCCeEeecCCCCCEEEcCCCcEEEEecCCccc
Q 010519 306 ---IEPKVVHRDIKSSNILIDDEFNAKVSDFGLAKL 338 (508)
Q Consensus 306 ---~~~~iiH~Dlk~~NIll~~~~~~kl~Dfgla~~ 338 (508)
..+.++|+|+++.|||++ + .+.|+||+.+..
T Consensus 190 ~~~~~~~l~HgD~~~~Nil~~-~-~~~lIDfe~a~~ 223 (328)
T 1zyl_A 190 REDFTVLRLHGDCHAGNILWR-D-GPMFVDLDDARN 223 (328)
T ss_dssp CSCSCCEECCSSCSGGGEEES-S-SEEECCCTTCCE
T ss_pred hhcCCeeeeeCCCCcccEeEc-C-CCEEEECCCCCc
Confidence 234689999999999999 4 899999988764
|
| >2jwa_A Receptor tyrosine-protein kinase ERBB-2; transmembrane helix dimer, protein kinase receptor membrane domain, ATP-binding, glycoprotein; NMR {Homo sapiens} PDB: 2ks1_A | Back alignment and structure |
|---|
Probab=96.86 E-value=0.00083 Score=44.01 Aligned_cols=29 Identities=28% Similarity=0.366 Sum_probs=15.2
Q ss_pred hHHHHHHHHHHHHHHHHHHHHhhhheecc
Q 010519 21 KLWVLIGISVGAFIVLILCILSVWVSFRR 49 (508)
Q Consensus 21 ~~~~~igi~~g~~~~~~l~~~~~~~~~rr 49 (508)
....++++++|+++++++.++++++.|||
T Consensus 10 ~~~~Ia~~vVGvll~vi~~l~~~~~~RRR 38 (44)
T 2jwa_A 10 PLTSIISAVVGILLVVVLGVVFGILIKRR 38 (44)
T ss_dssp SHHHHHHHHHHHHHHHHHHHHHHHHHHHH
T ss_pred cccchHHHHHHHHHHHHHHHHHHhheehh
Confidence 34567788888554444433333333333
|
| >1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8 | Back alignment and structure |
|---|
Probab=96.72 E-value=0.0028 Score=64.78 Aligned_cols=72 Identities=17% Similarity=0.229 Sum_probs=46.5
Q ss_pred ceeEeeeCceEEEEEEEcC--------CCEEEEEEEcccchhhHHHHHHHHHHHhcCCCCCc-eeEEEEEEeCceeeEEE
Q 010519 191 ENVLGEGGYGVVYKGRLIN--------GSEVAVKKLLNNLGQAEKEFRVEVEAIGHVRHKNL-VRLLGYCIEGVHRMLVY 261 (508)
Q Consensus 191 ~~~lg~G~~g~Vy~~~~~~--------~~~vavK~~~~~~~~~~~~~~~ei~~l~~l~h~ni-v~~~~~~~~~~~~~lv~ 261 (508)
.+.|+.|-...+|++...+ +..+++|+.... .....+..|..+++.+...++ .++++.+.+ .+|+
T Consensus 78 v~~l~gG~tN~~y~v~~~~~~~~~~~~~~~~vlRi~~~~--~~~~~li~E~~~l~~L~~~g~~P~l~~~~~~----g~v~ 151 (429)
T 1nw1_A 78 ISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNP--ETESHLVAESVIFTLLSERHLGPKLYGIFSG----GRLE 151 (429)
T ss_dssp EEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSC--CCHHHHHHHHHHHHHHHHTTSSSCEEEEETT----EEEE
T ss_pred EEEeCCCcccceEEEEeCCCccccCCCCceEEEEEeCCC--CcHHHHHHHHHHHHHHHhCCCCCcEEEEeCC----CEEE
Confidence 4568888889999998743 467888876331 111344468888877743333 566665432 3899
Q ss_pred eecCCCC
Q 010519 262 EYVNNGN 268 (508)
Q Consensus 262 E~~~~gs 268 (508)
||++|.+
T Consensus 152 e~l~G~~ 158 (429)
T 1nw1_A 152 EYIPSRP 158 (429)
T ss_dssp CCCCEEE
T ss_pred EEeCCcc
Confidence 9997633
|
| >2ks1_B Epidermal growth factor receptor; ERBB1, ERBB2, transmembrane, heterodimer, complex, tyrosine receptor, bicelles, transferase; NMR {Homo sapiens} | Back alignment and structure |
|---|
Probab=96.42 E-value=0.0022 Score=42.27 Aligned_cols=26 Identities=19% Similarity=0.231 Sum_probs=10.6
Q ss_pred HHHHHHH-HHHHHHHHHHhhhheeccc
Q 010519 25 LIGISVG-AFIVLILCILSVWVSFRRK 50 (508)
Q Consensus 25 ~igi~~g-~~~~~~l~~~~~~~~~rr~ 50 (508)
+++.++| ++++++++++++|++|||+
T Consensus 13 IA~gVVgGv~~~~ii~~~~~~~~RRr~ 39 (44)
T 2ks1_B 13 IATGMVGALLLLLVVALGIGLFMRRRH 39 (44)
T ss_dssp STHHHHHHHHHHHHHHHHHHHHHHTTT
T ss_pred EEeehhHHHHHHHHHHHHHHHHhhhhH
Confidence 3444444 4444444333344444433
|
| >3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A* | Back alignment and structure |
|---|
Probab=96.39 E-value=0.0043 Score=62.21 Aligned_cols=142 Identities=16% Similarity=0.164 Sum_probs=79.1
Q ss_pred eeEeeeCceEEEEEEEc--------CCCEEEEEEEcccchhhHHHHHHHHHHHhcCC-CCCceeEEEEEEeCceeeEEEe
Q 010519 192 NVLGEGGYGVVYKGRLI--------NGSEVAVKKLLNNLGQAEKEFRVEVEAIGHVR-HKNLVRLLGYCIEGVHRMLVYE 262 (508)
Q Consensus 192 ~~lg~G~~g~Vy~~~~~--------~~~~vavK~~~~~~~~~~~~~~~ei~~l~~l~-h~niv~~~~~~~~~~~~~lv~E 262 (508)
+.|..|-...+|++... ++..+++|+.-. .......+.+|..+++.+. +.-..++++++.+ .+|||
T Consensus 56 ~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlR~~g~-~~~~~~~~~rE~~vl~~L~~~gv~P~ll~~~~~----g~v~e 130 (379)
T 3feg_A 56 YPVSGGLSNLLFRCSLPDHLPSVGEEPREVLLRLYGA-ILQGVDSLVLESVMFAILAERSLGPQLYGVFPE----GRLEQ 130 (379)
T ss_dssp EEC-----CCEEEEECCTTSCCCSSCCSEEEEEECC----CCHHHHHHHHHHHHHHHHTTSSCCEEEEETT----EEEEE
T ss_pred EEcCCcccccEEEEEeCCCccccCCCCCeEEEEECCC-ccchHHHHHHHHHHHHHHHhcCCCCeEEEEcCC----ccEEE
Confidence 46777888889998763 246788887422 1122345567888887773 3223566665543 28999
Q ss_pred ecCCCCHH--------------HH---Hhhhhcc-CCCc--cHHHHHHHHHHHH-------------------HHHHHHH
Q 010519 263 YVNNGNLE--------------QW---LHGAMRN-QGNL--TWEARMKVIIGTA-------------------KALAYLH 303 (508)
Q Consensus 263 ~~~~gsL~--------------~~---l~~~~~~-~~~l--~~~~~~~i~~~i~-------------------~al~yLH 303 (508)
|++|..|. +. ||..... .... -+..+.++..++. ..+..|.
T Consensus 131 ~i~G~~l~~~~l~~p~~~~~ia~~La~LH~~~~~~~~~~~~l~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~~~~~~L~ 210 (379)
T 3feg_A 131 YIPSRPLKTQELREPVLSAAIATKMAQFHGMEMPFTKEPHWLFGTMERYLKQIQDLPPTGLPEMNLLEMYSLKDEMGNLR 210 (379)
T ss_dssp CCSEEECCGGGGGCHHHHHHHHHHHHHHHTCCCSSCCSCCHHHHHHHHHHHHHHHCCCCSCCSCCHHHHTTHHHHHHHHH
T ss_pred EecCccCChhHhCCHHHHHHHHHHHHHHhCCCCCCCCCcccHHHHHHHHHHHHHhccCcccchhhhhhhHHHHHHHHHHH
Confidence 99876542 11 1211000 1111 2344444443331 1233332
Q ss_pred hc-----CCCCeEeecCCCCCEEEcCC----CcEEEEecCCccc
Q 010519 304 EA-----IEPKVVHRDIKSSNILIDDE----FNAKVSDFGLAKL 338 (508)
Q Consensus 304 ~~-----~~~~iiH~Dlk~~NIll~~~----~~~kl~Dfgla~~ 338 (508)
.. ....++|+|+.+.||+++.+ +.+.|+||..+..
T Consensus 211 ~~L~~~~~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~~ 254 (379)
T 3feg_A 211 KLLESTPSPVVFCHNDIQEGNILLLSEPENADSLMLVDFEYSSY 254 (379)
T ss_dssp HHHHTSCCCEEEECSCCCGGGEEEESCC---CCEEECCCTTCEE
T ss_pred HHHhhcCCCcEEEcCCCCCCeEEEcCCCCccCcEEEEecccCCc
Confidence 21 13368999999999999876 7899999998763
|
| >2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax} | Back alignment and structure |
|---|
Probab=96.23 E-value=0.015 Score=59.91 Aligned_cols=74 Identities=9% Similarity=0.082 Sum_probs=44.5
Q ss_pred ceeEeeeCceEEEEEEEcC-CCEEEEEEEcccchhhHHHHHHHHHHHhcCCCCCc-eeEEEEEEeCceeeEEEeecCCCC
Q 010519 191 ENVLGEGGYGVVYKGRLIN-GSEVAVKKLLNNLGQAEKEFRVEVEAIGHVRHKNL-VRLLGYCIEGVHRMLVYEYVNNGN 268 (508)
Q Consensus 191 ~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~ei~~l~~l~h~ni-v~~~~~~~~~~~~~lv~E~~~~gs 268 (508)
.+.|+.|-...+|++...+ +..+++|+........ -....|..++..|...++ .++++++. + .+||||++|.+
T Consensus 113 i~~lsgG~tN~~y~v~~~~~~~~~vLRi~g~~~~~~-idR~~E~~vl~~L~~~gl~P~ll~~~~--~--G~v~e~I~G~~ 187 (458)
T 2qg7_A 113 FQIINGGITNILIKVKDMSKQAKYLIRLYGPKTDEI-INREREKKISCILYNKNIAKKIYVFFT--N--GRIEEFMDGYA 187 (458)
T ss_dssp EEEECC--CEEEEEEEETTTTEEEEEEEECC-CCSC-SCHHHHHHHHHHHTTSSSBCCEEEEET--T--EEEEECCCSEE
T ss_pred EEEcCCCeEeEEEEEEECCCCceEEEEECCCChhhh-cCHHHHHHHHHHHHhcCCCCCEEEEeC--C--eEEEEeeCCcc
Confidence 4568888889999998754 3678887653322111 011457888887754444 46777662 2 35999998744
Q ss_pred H
Q 010519 269 L 269 (508)
Q Consensus 269 L 269 (508)
|
T Consensus 188 l 188 (458)
T 2qg7_A 188 L 188 (458)
T ss_dssp C
T ss_pred C
Confidence 3
|
| >3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A* | Back alignment and structure |
|---|
Probab=96.19 E-value=0.0058 Score=60.94 Aligned_cols=73 Identities=11% Similarity=0.052 Sum_probs=40.6
Q ss_pred ceeEeeeCceEEEEEEEcC---------CCEEEEEEEcccchhhHHHHHHHHHHHhcCCCCC-ceeEEEEEEeCceeeEE
Q 010519 191 ENVLGEGGYGVVYKGRLIN---------GSEVAVKKLLNNLGQAEKEFRVEVEAIGHVRHKN-LVRLLGYCIEGVHRMLV 260 (508)
Q Consensus 191 ~~~lg~G~~g~Vy~~~~~~---------~~~vavK~~~~~~~~~~~~~~~ei~~l~~l~h~n-iv~~~~~~~~~~~~~lv 260 (508)
.+.|+.|..-.+|+....+ +..+++|......... .....|..+++.+...+ ..++++.+ . -++|
T Consensus 38 ~~~l~~G~~N~~y~v~~~~~~~~~~~~~~~~~vlRi~~~~~~~~-~~~~~E~~~l~~L~~~g~~P~~~~~~--~--~~~v 112 (369)
T 3c5i_A 38 VKQILSGLTNQLFEVGLKEETANNYNSIRTRVLFRIYGKHVDEL-YNTISEFEVYKTMSKYKIAPQLLNTF--N--GGRI 112 (369)
T ss_dssp EEEC----CCEEEEEEECHHHHTTCTTSCCEEEEEECCTTGGGT-SCHHHHHHHHHHHHHTTSSCCEEEEE--T--TEEE
T ss_pred EEEeCCcccceEEEEEeCCCCcccccCCCceEEEEecCCCccce-ecHHHHHHHHHHHHhcCCCCceEEec--C--CcEE
Confidence 3467778888999987643 2677777654322111 12345777777664223 34566543 2 3689
Q ss_pred EeecCCCC
Q 010519 261 YEYVNNGN 268 (508)
Q Consensus 261 ~E~~~~gs 268 (508)
|||++|..
T Consensus 113 ~e~i~G~~ 120 (369)
T 3c5i_A 113 EEWLYGDP 120 (369)
T ss_dssp EECCCSEE
T ss_pred EEEecCCc
Confidence 99998754
|
| >3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A* | Back alignment and structure |
|---|
Probab=96.06 E-value=0.033 Score=54.85 Aligned_cols=31 Identities=26% Similarity=0.403 Sum_probs=27.8
Q ss_pred CCeEeecCCCCCEEEcCCCcEEEEecCCccc
Q 010519 308 PKVVHRDIKSSNILIDDEFNAKVSDFGLAKL 338 (508)
Q Consensus 308 ~~iiH~Dlk~~NIll~~~~~~kl~Dfgla~~ 338 (508)
+.++|+|+.+.||++++++.+.|+||+.+..
T Consensus 206 ~~~~HgD~~~~N~l~~~~~~~~~iD~e~~~~ 236 (339)
T 3i1a_A 206 YVLCHSDIHAGNVLVGNEESIYIIDWDEPML 236 (339)
T ss_dssp CEEECSCCCGGGEEECGGGCEEECCCSSCEE
T ss_pred ceeEeCCCCcCCEEEeCCCeEEEEECCCCee
Confidence 4799999999999999888899999987764
|
| >2l34_A TYRO protein tyrosine kinase-binding protein; immunoreceptor, transmembrane assembly, DAP12, protein bindi; NMR {Homo sapiens} PDB: 2l35_B | Back alignment and structure |
|---|
Probab=95.52 E-value=0.011 Score=36.26 Aligned_cols=30 Identities=33% Similarity=0.460 Sum_probs=24.0
Q ss_pred chhHHHHHHHHHHHHHHHHHHHHhhhheec
Q 010519 19 GLKLWVLIGISVGAFIVLILCILSVWVSFR 48 (508)
Q Consensus 19 ~~~~~~~igi~~g~~~~~~l~~~~~~~~~r 48 (508)
+++.+.++||++|.++..+++++.+|++.|
T Consensus 3 ~L~~gaIaGIVvgdi~~t~~i~~~vy~~~r 32 (33)
T 2l34_A 3 TVSPGVLAGIVVGDLVLTVLIALAVYFLGR 32 (33)
T ss_dssp CCCTHHHHHHHHHHHHHHHHHHHHHHHHCC
T ss_pred ccCcceEEeEeHHHHHHHHHHHHHHhheec
Confidence 567889999999998888777777777654
|
| >2k9y_A Ephrin type-A receptor 2; receptor tyrosine kinase, membrane protein, dimeric transmembrane domain, ephrin receptor, ATP-binding, glycoprotein; NMR {Homo sapiens} | Back alignment and structure |
|---|
Probab=94.90 E-value=0.023 Score=36.98 Aligned_cols=14 Identities=36% Similarity=0.660 Sum_probs=6.9
Q ss_pred HHHHHHHHHHHHHH
Q 010519 22 LWVLIGISVGAFIV 35 (508)
Q Consensus 22 ~~~~igi~~g~~~~ 35 (508)
.++.+++++|++++
T Consensus 13 ~~I~~~vv~Gv~ll 26 (41)
T 2k9y_A 13 LAVIGGVAVGVVLL 26 (41)
T ss_dssp THHHHHHHHHHHHH
T ss_pred EEEEeehhHHHHHH
Confidence 44555555555443
|
| >2l8s_A Integrin alpha-1; transmembrane region, detergent micelle, CE adhesion; NMR {Homo sapiens} | Back alignment and structure |
|---|
Probab=94.87 E-value=0.026 Score=38.63 Aligned_cols=26 Identities=31% Similarity=0.821 Sum_probs=19.2
Q ss_pred chhHHHHHHHHHHHHHHHHHHHHhhh
Q 010519 19 GLKLWVLIGISVGAFIVLILCILSVW 44 (508)
Q Consensus 19 ~~~~~~~igi~~g~~~~~~l~~~~~~ 44 (508)
+..+|++++.++|++++++++++++|
T Consensus 6 ~vp~WiIi~svl~GLLLL~Lii~~Lw 31 (54)
T 2l8s_A 6 RVPLWVILLSAFAGLLLLMLLILALW 31 (54)
T ss_dssp CCCTHHHHHHHHHHHHHHHHHHHHHH
T ss_pred cCchHHHHHHHHHHHHHHHHHHHHHH
Confidence 56789999888877777666665555
|
| >3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum} | Back alignment and structure |
|---|
Probab=93.93 E-value=0.099 Score=53.05 Aligned_cols=73 Identities=8% Similarity=0.115 Sum_probs=43.8
Q ss_pred ceeEeeeCceEEEEEEEcC--------CCEEEEEEEcccchhhHHHHHHHHHHHhcCC-CCCceeEEEEEEeCceeeEEE
Q 010519 191 ENVLGEGGYGVVYKGRLIN--------GSEVAVKKLLNNLGQAEKEFRVEVEAIGHVR-HKNLVRLLGYCIEGVHRMLVY 261 (508)
Q Consensus 191 ~~~lg~G~~g~Vy~~~~~~--------~~~vavK~~~~~~~~~~~~~~~ei~~l~~l~-h~niv~~~~~~~~~~~~~lv~ 261 (508)
.+.|..|-...+|+....+ +..+++++.-..... .-...+|..+++.+. +.-..++++.+ . -++||
T Consensus 75 v~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlRi~g~~t~~-~idR~~E~~~l~~L~~~gi~P~l~~~~--~--~~~I~ 149 (424)
T 3mes_A 75 VKQIFSGLTNQLFVVSIVNESMSLSLKHPRILFRIYGKHVGK-FYDSKVELDVFRYLSNINIAPNIIADF--P--EGRIE 149 (424)
T ss_dssp EEEECCCSSSEEEEEEECCC-----CCCSEEEEEECCCCC-C-CCCHHHHHHHHHHHHHTTSSCCEEEEE--T--TEEEE
T ss_pred EEEcCCCcccceEEEEeCCCcccccCCCCeEEEEECCCCcch-hcCHHHHHHHHHHHHhcCCCCCEEEEc--C--CCEEE
Confidence 3567778888999998742 577888875332211 111234666666663 22234555533 2 36899
Q ss_pred eecCCCC
Q 010519 262 EYVNNGN 268 (508)
Q Consensus 262 E~~~~gs 268 (508)
||++|..
T Consensus 150 efI~G~~ 156 (424)
T 3mes_A 150 EFIDGEP 156 (424)
T ss_dssp ECCCSEE
T ss_pred EEeCCcc
Confidence 9998865
|
| >2knc_A Integrin alpha-IIB; transmembrane signaling, protein structure, cell A cleavage on PAIR of basic residues, disease mutation, disul bond, glycoprotein; NMR {Homo sapiens} | Back alignment and structure |
|---|
Probab=93.77 E-value=0.076 Score=36.47 Aligned_cols=26 Identities=19% Similarity=0.732 Sum_probs=19.2
Q ss_pred chhHHHHHHHHHHHHHHHHHHHHhhh
Q 010519 19 GLKLWVLIGISVGAFIVLILCILSVW 44 (508)
Q Consensus 19 ~~~~~~~igi~~g~~~~~~l~~~~~~ 44 (508)
+..+|++++.++|++++++++++++|
T Consensus 9 ~vp~wiIi~svl~GLllL~li~~~Lw 34 (54)
T 2knc_A 9 AIPIWWVLVGVLGGLLLLTILVLAMW 34 (54)
T ss_dssp TCCHHHHHHHHHHHHHHHHHHHHHHH
T ss_pred CcchHHHHHHHHHHHHHHHHHHHHHH
Confidence 56799999888877777666665555
|
| >1iij_A ERBB-2 receptor protein-tyrosine kinase; alpha-helix-PI-bulge-alpha-helix, signaling protein; NMR {Synthetic} SCOP: j.35.1.1 | Back alignment and structure |
|---|
Probab=92.89 E-value=0.053 Score=33.53 Aligned_cols=12 Identities=25% Similarity=0.578 Sum_probs=5.7
Q ss_pred HHHHHHHHHHHH
Q 010519 24 VLIGISVGAFIV 35 (508)
Q Consensus 24 ~~igi~~g~~~~ 35 (508)
.++..++|.+++
T Consensus 9 sIaagVvglll~ 20 (35)
T 1iij_A 9 FIIATVVGVLLF 20 (35)
T ss_dssp HHHHHHHHHHHH
T ss_pred EeHHHHHHHHHH
Confidence 445555563333
|
| >2k1a_A Integrin alpha-IIB; single-PASS transmembrane segment, alternative splicing, calcium, cell adhesion, cleavage on PAIR of basic residues; NMR {Homo sapiens} PDB: 2k9j_A | Back alignment and structure |
|---|
Probab=92.49 E-value=0.15 Score=33.04 Aligned_cols=27 Identities=19% Similarity=0.678 Sum_probs=19.6
Q ss_pred cchhHHHHHHHHHHHHHHHHHHHHhhh
Q 010519 18 LGLKLWVLIGISVGAFIVLILCILSVW 44 (508)
Q Consensus 18 ~~~~~~~~igi~~g~~~~~~l~~~~~~ 44 (508)
.+..+|++++-++|.+++++++++++|
T Consensus 6 ~~vp~wiIi~s~l~GLllL~li~~~Lw 32 (42)
T 2k1a_A 6 RAIPIWWVLVGVLGGLLLLTILVLAMW 32 (42)
T ss_dssp CCCCHHHHHHHHHHHHHHHHHHHHHHH
T ss_pred CCcchHHHHHHHHHHHHHHHHHHHHHH
Confidence 356799998888877777666565555
|
| >4ann_A ESSB; membrane protein, membrane secretion, ESS type VII secretion virulence; 1.05A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=89.83 E-value=0.57 Score=42.45 Aligned_cols=123 Identities=9% Similarity=0.105 Sum_probs=83.0
Q ss_pred HHHHHhcCCCCCceeEEEEEEeCceeeEEEeecCCCCHHHHHhhhhccCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeE
Q 010519 232 EVEAIGHVRHKNLVRLLGYCIEGVHRMLVYEYVNNGNLEQWLHGAMRNQGNLTWEARMKVIIGTAKALAYLHEAIEPKVV 311 (508)
Q Consensus 232 ei~~l~~l~h~niv~~~~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~ii 311 (508)
|+.+|. ..||++++. .+..+.+...+.++.-+ +...| ..-..++...+++++.+|+....+++.. +
T Consensus 36 el~LL~-~~~~~Fl~~-~I~e~eD~v~~~y~~~~--~~~~f-----~~ik~~~~~eKlr~l~ni~~l~~~~~~r-----~ 101 (215)
T 4ann_A 36 LMYLLE-QHSPYFIDA-ELTELRDSFQIHYDIND--NHTPF-----DNIKSFTKNEKLRYLLNIKNLEEVNRTR-----Y 101 (215)
T ss_dssp GGGGGG-SCCTTBCCE-EEEECSSEEEEEECCCT--TSEEG-----GGGGGSCHHHHHHHHHHGGGGGGGGGSS-----E
T ss_pred HHHHHh-ccCCcccce-EEEEcccEEEEEEEcCc--ccCCH-----HHHHhcCHHHHHHHHHHHHHHHHHhcCc-----e
Confidence 444443 368998877 56666666555555433 22222 2234577889999999999888766544 7
Q ss_pred eecCCCCCEEEcCCCcEEEEecCCccccCCCCCcccccccccccccCccccCCCCCCChhhHHHHHHHHHHHHhCCCCCC
Q 010519 312 HRDIKSSNILIDDEFNAKVSDFGLAKLLDSGESHITTRVMGTFGYVAPEYANTGMLNEKSDIYSFGVLLLEAVTGRDPVD 391 (508)
Q Consensus 312 H~Dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltG~~Pf~ 391 (508)
|--|.|+||+++.++.+++.-.|+-..+ +|. .++...=.-.+=|++..+++++..|+
T Consensus 102 tf~L~P~NL~f~~~~~p~i~~RGik~~l------------------~P~-----~~~ee~fL~qyKAliiall~~K~~Fe 158 (215)
T 4ann_A 102 TFVLAPDELFFTRDGLPIAKTRGLQNVV------------------DPL-----PVSEAEFLTRYKALVICAFNEKQSFD 158 (215)
T ss_dssp ECCCSGGGEEECTTSCEEESCCEETTTB------------------SCC-----CCCHHHHHHHHHHHHHHHHCTTCCHH
T ss_pred EEEEecceEEEcCCCCEEEEEccCccCC------------------CCC-----CCCHHHHHHHHHHHHHHHHcCCCCHH
Confidence 8899999999999999999866643322 221 12233334567788999999998874
|
| >1q55_A EP-cadherin, C-cadherin; trans interaction, desmosome, junction, adhesion, structural protein; HET: NAG NDG; 30.00A {Mus musculus} SCOP: i.20.1.1 PDB: 1q5a_A* 1q5b_A* 1q5c_A* | Back alignment and structure |
|---|
Probab=89.16 E-value=0.073 Score=59.31 Aligned_cols=38 Identities=26% Similarity=0.280 Sum_probs=0.0
Q ss_pred cccchhHHHHHHHHHHHHHHHHHHHHhhhheecccccc
Q 010519 16 SFLGLKLWVLIGISVGAFIVLILCILSVWVSFRRKSRK 53 (508)
Q Consensus 16 ~~~~~~~~~~igi~~g~~~~~~l~~~~~~~~~rr~~~~ 53 (508)
...|+.+|++|+|++|+++|+++++++++++|||++++
T Consensus 698 ~~~~l~~~aii~il~~~~~ll~~~ll~~~~~~~~~~~k 735 (880)
T 1q55_A 698 LVGGFDLPIILVILGSVLALLILFLLLLLFLKRKKVVK 735 (880)
T ss_dssp --------------------------------------
T ss_pred cccCccHHHHHHHHHHHHHHHHHHHHHHhhhhhccccc
Confidence 45789999999998888777766565556655544333
|
| >2knc_B Integrin beta-3; transmembrane signaling, protein structure, cell A cleavage on PAIR of basic residues, disease mutation, disul bond, glycoprotein; NMR {Homo sapiens} | Back alignment and structure |
|---|
Probab=86.48 E-value=0.49 Score=35.50 Aligned_cols=27 Identities=26% Similarity=0.537 Sum_probs=16.1
Q ss_pred chhHHHHHHHHHHHHHHHHHHHHhhhh
Q 010519 19 GLKLWVLIGISVGAFIVLILCILSVWV 45 (508)
Q Consensus 19 ~~~~~~~igi~~g~~~~~~l~~~~~~~ 45 (508)
..++|.+++.++|++++++++++++|.
T Consensus 7 ~~n~~~Iv~gvi~gilliGllllliwk 33 (79)
T 2knc_B 7 GPDILVVLLSVMGAILLIGLAALLIWK 33 (79)
T ss_dssp SSCSHHHHHHHHHHHHHHHHHHHHHHH
T ss_pred CCCchhhHHHHHHHHHHHHHHHHHHHH
Confidence 346667766666666666665555554
|
| >4ano_A ESSB; membrane protein, membrane secretion, ESS type V secretion S; HET: MSE; 1.70A {Geobacillus thermodenitrificans ng80-2organism_taxid} | Back alignment and structure |
|---|
Probab=86.35 E-value=1.2 Score=40.41 Aligned_cols=115 Identities=9% Similarity=0.051 Sum_probs=77.0
Q ss_pred CCCCceeEEEEEEeCceeeEEEeecCCCCHHHHHhhhhccCCCccHHHHHHHHHHHHHHHH-HHHhcCCCCeEeecCCCC
Q 010519 240 RHKNLVRLLGYCIEGVHRMLVYEYVNNGNLEQWLHGAMRNQGNLTWEARMKVIIGTAKALA-YLHEAIEPKVVHRDIKSS 318 (508)
Q Consensus 240 ~h~niv~~~~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~-yLH~~~~~~iiH~Dlk~~ 318 (508)
.||++ -..+-.+++.+.+.++.-+++.=+.-+ ..++...+++++.+|+.... +++. -+|--|.|+
T Consensus 48 ~~~~f--~~~I~~~eD~~~i~y~~~~~~~~f~~i-------~~~~~~eKlrll~nl~~L~~~~~~~-----r~tf~l~P~ 113 (219)
T 4ano_A 48 VDPCI--VRDIDVSEDEVKVVIKPPSSFLTFAAI-------RKTTLLSRIRAAIHLVSKVKHHSAR-----RLIFIVCPE 113 (219)
T ss_dssp SCSSS--EEEEEECSSEEEEEEECCTTCEEHHHH-------HTSCHHHHHHHHHHHHHHHSSCCSS-----SEECCCCGG
T ss_pred cCCCC--CeEEEEeCCEEEEEEEcCcccCcHHHH-------HhcCHHHHHHHHHHHHHHHHHhhhC-----ceeEEEeCc
Confidence 68888 444456667766767665343222233 23678889999999888877 6654 478899999
Q ss_pred CEEEcCCCcEEEEecCCccccCCCCCcccccccccccccCccccCCCCCCChhhHHHHHHHHHHHHhCCCCCC
Q 010519 319 NILIDDEFNAKVSDFGLAKLLDSGESHITTRVMGTFGYVAPEYANTGMLNEKSDIYSFGVLLLEAVTGRDPVD 391 (508)
Q Consensus 319 NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltG~~Pf~ 391 (508)
||+++.++.++|.-.|+-.. ++|.- +++.-=.-.+=|++..++.++..|+
T Consensus 114 NL~f~~~~~p~i~hRGi~~~------------------lpP~e-----~~ee~fl~qyKali~all~~K~~Fe 163 (219)
T 4ano_A 114 NLMFNRALEPFFLHVGVKES------------------LPPDE-----WDDERLLREVKATVLALTEGEYRFD 163 (219)
T ss_dssp GEEECTTCCEEESCCEETTT------------------BSSCS-----CCHHHHHHHHHHHHHHHTTCSSCHH
T ss_pred eEEEeCCCcEEEEEcCCccc------------------CCCCC-----CCHHHHHHHHHHHHHHHHcCCCCHH
Confidence 99999999999987665432 22221 1222223467788888888888774
|
| >2klu_A T-cell surface glycoprotein CD4; cell membrane, disulfide bond, HOST- virus interaction, immune response, immunoglobulin domain, lipoprotein; NMR {Homo sapiens} | Back alignment and structure |
|---|
Probab=86.16 E-value=0.69 Score=32.71 Aligned_cols=7 Identities=29% Similarity=0.591 Sum_probs=2.7
Q ss_pred HHHHHHH
Q 010519 25 LIGISVG 31 (508)
Q Consensus 25 ~igi~~g 31 (508)
++|.++|
T Consensus 13 vlGg~~~ 19 (70)
T 2klu_A 13 VLGGVAG 19 (70)
T ss_dssp HHHHHHH
T ss_pred HHhHHHH
Confidence 3443333
|
| >2k9j_B Integrin beta-3; transmembrane complex, cell adhesion, cleavage on basic residues, disease mutation, glycoprotein, pyrrolidone carboxylic acid; NMR {Homo sapiens} PDB: 2rmz_A 2rn0_A 2l91_A | Back alignment and structure |
|---|
Probab=85.50 E-value=0.94 Score=29.56 Aligned_cols=28 Identities=21% Similarity=0.438 Sum_probs=17.6
Q ss_pred hhHHHHHHHHHHHHHHHHHHHHhhhhee
Q 010519 20 LKLWVLIGISVGAFIVLILCILSVWVSF 47 (508)
Q Consensus 20 ~~~~~~igi~~g~~~~~~l~~~~~~~~~ 47 (508)
.+.+.+++.++|++++++++++.+|-.+
T Consensus 7 ~n~~~Iv~gvi~~ivliGl~lLliwk~~ 34 (43)
T 2k9j_B 7 PDILVVLLSVMGAILLIGLAALLIWKLL 34 (43)
T ss_dssp CHHHHHHHHHHHHHHHHHHHHHHHHHHH
T ss_pred CCEeehHHHHHHHHHHHHHHHHHHHHHH
Confidence 4677777666666666666666655433
|
| >2llm_A Amyloid beta A4 protein; alzheimer'S disease, protein fibril; NMR {Homo sapiens} PDB: 2loh_A | Back alignment and structure |
|---|
Probab=84.80 E-value=0.19 Score=32.28 Aligned_cols=31 Identities=16% Similarity=0.410 Sum_probs=19.7
Q ss_pred chhHHHHHHHHHHHHHHHHHHHHhhhheecc
Q 010519 19 GLKLWVLIGISVGAFIVLILCILSVWVSFRR 49 (508)
Q Consensus 19 ~~~~~~~igi~~g~~~~~~l~~~~~~~~~rr 49 (508)
|.+-.++||+.++++.+..++++.+++.|||
T Consensus 13 ~~srga~iGL~v~gVai~~vIVvsl~mlRrr 43 (43)
T 2llm_A 13 GSNKGAIIGLMVGGVVIATVIVITLVMLKKK 43 (43)
Confidence 4466778888877666555555566665543
|
Homologous Structure Domains
Structure Domains Detected by RPS-BLAST
Original result of RPS-BLAST against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
E-value |
| 508 | ||||
| d1uwha_ | 276 | d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) | 1e-75 | |
| d1qpca_ | 272 | d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom | 6e-73 | |
| d1sm2a_ | 263 | d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu | 8e-70 | |
| d1fmka3 | 285 | d.144.1.7 (A:249-533) c-src tyrosine kinase {Human | 6e-69 | |
| d1jpaa_ | 299 | d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou | 5e-68 | |
| d1vjya_ | 303 | d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human | 7e-68 | |
| d1k2pa_ | 258 | d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum | 1e-66 | |
| d1s9ja_ | 322 | d.144.1.7 (A:) Dual specificity mitogen-activated | 7e-66 | |
| d1opja_ | 287 | d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou | 1e-65 | |
| d1lufa_ | 301 | d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n | 5e-65 | |
| d1mqba_ | 283 | d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum | 2e-64 | |
| d1byga_ | 262 | d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) | 3e-64 | |
| d1u59a_ | 285 | d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum | 9e-64 | |
| d1r0pa_ | 311 | d.144.1.7 (A:) Hepatocyte growth factor receptor, | 5e-63 | |
| d2java1 | 269 | d.144.1.7 (A:3-271) Serine/threonine-protein kinas | 2e-62 | |
| d1t46a_ | 311 | d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens | 5e-62 | |
| d1rjba_ | 325 | d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s | 7e-62 | |
| d2j4za1 | 263 | d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur | 2e-60 | |
| d1t4ha_ | 270 | d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa | 3e-60 | |
| d1xbba_ | 277 | d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human | 3e-60 | |
| d1u5ra_ | 309 | d.144.1.7 (A:) Serine/threonine protein kinase TAO | 3e-60 | |
| d1fvra_ | 309 | d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [ | 3e-60 | |
| d1mp8a_ | 273 | d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma | 1e-59 | |
| d1xkka_ | 317 | d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb- | 9e-59 | |
| d1u46a_ | 273 | d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum | 3e-58 | |
| d1nvra_ | 271 | d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 { | 4e-58 | |
| d2jfla1 | 288 | d.144.1.7 (A:21-308) STE20-like serine/threonine-p | 4e-58 | |
| d1yhwa1 | 293 | d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [ | 8e-58 | |
| d1koaa2 | 350 | d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C | 2e-55 | |
| d1p4oa_ | 308 | d.144.1.7 (A:) Insulin-like growth factor 1 recept | 2e-55 | |
| d1fgka_ | 299 | d.144.1.7 (A:) Fibroblast growth factor receptor 1 | 7e-55 | |
| d1ywna1 | 299 | d.144.1.7 (A:818-1166) Vascular endothelial growth | 4e-53 | |
| d1uu3a_ | 288 | d.144.1.7 (A:) 3-phosphoinositide dependent protei | 1e-52 | |
| d1koba_ | 352 | d.144.1.7 (A:) Twitchin, kinase domain {California | 4e-52 | |
| d1o6ya_ | 277 | d.144.1.7 (A:) Mycobacterial protein kinase PknB, | 9e-51 | |
| d1tkia_ | 321 | d.144.1.7 (A:) Titin, kinase domain {Human (Homo s | 2e-49 | |
| d1a06a_ | 307 | d.144.1.7 (A:) Calmodulin-dependent protein kinase | 3e-49 | |
| d1omwa3 | 364 | d.144.1.7 (A:186-549) G-protein coupled receptor k | 5e-49 | |
| d1phka_ | 277 | d.144.1.7 (A:) gamma-subunit of glycogen phosphory | 2e-48 | |
| d1ckia_ | 299 | d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n | 5e-48 | |
| d1xjda_ | 320 | d.144.1.7 (A:) Protein kinase C, theta type {Human | 2e-47 | |
| d1q5ka_ | 350 | d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs | 2e-47 | |
| d1pmea_ | 345 | d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien | 3e-47 | |
| d1ob3a_ | 286 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod | 7e-47 | |
| d1blxa_ | 305 | d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H | 1e-46 | |
| d1fota_ | 316 | d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni | 3e-46 | |
| d1jksa_ | 293 | d.144.1.7 (A:) Death-associated protein kinase, Da | 5e-46 | |
| d1ua2a_ | 299 | d.144.1.7 (A:) Cell division protein kinase 7, CDK | 5e-45 | |
| d1gz8a_ | 298 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H | 9e-45 | |
| d1csna_ | 293 | d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast | 7e-44 | |
| d1unla_ | 292 | d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H | 9e-44 | |
| d2ozaa1 | 335 | d.144.1.7 (A:51-385) MAP kinase activated protein | 1e-43 | |
| d1xwsa_ | 273 | d.144.1.7 (A:) Proto-oncogene serine/threonine-pro | 9e-43 | |
| d1cm8a_ | 346 | d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s | 1e-40 | |
| d3blha1 | 318 | d.144.1.7 (A:8-325) Cell division protein kinase 9 | 2e-40 | |
| d1o6la_ | 337 | d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap | 1e-39 | |
| d1rdqe_ | 350 | d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni | 2e-36 | |
| d1vzoa_ | 322 | d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5 | 5e-36 | |
| d3bqca1 | 328 | d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu | 6e-36 | |
| d2gfsa1 | 348 | d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa | 3e-34 | |
| d2b1pa1 | 355 | d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3 | 3e-33 | |
| d1q8ya_ | 362 | d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces | 4e-30 | |
| d1zara2 | 191 | d.144.1.9 (A:91-281) Rio2 serine protein kinase C- | 5e-21 |
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 237 bits (607), Expect = 1e-75
Identities = 72/287 (25%), Positives = 133/287 (46%), Gaps = 26/287 (9%)
Query: 180 DLEIATNRFSAENVLGEGGYGVVYKGRLINGSEVAVKKLLNNLGQAEKEFRVEVEAIGHV 239
D EI + + +G G +G VYKG+ V + + Q + F+ EV +
Sbjct: 2 DWEIPDGQITVGQRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKT 61
Query: 240 RHKNLVRLLGYCIEGVHRMLVYEYVNNGNLEQWLHGAMRNQGNLTWEARMKVIIGTAKAL 299
RH N++ +GY +V ++ +L LH + + + TA+ +
Sbjct: 62 RHVNILLFMGYSTAP-QLAIVTQWCEGSSLYHHLH---IIETKFEMIKLIDIARQTAQGM 117
Query: 300 AYLHEAIEPKVVHRDIKSSNILIDDEFNAKVSDFGLAKLLDSGE-SHITTRVMGTFGYVA 358
YLH ++HRD+KS+NI + ++ K+ DFGLA + SH ++ G+ ++A
Sbjct: 118 DYLH---AKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMA 174
Query: 359 PEYA---NTGMLNEKSDIYSFGVLLLEAVTGRDPVDYGRPANEVNLVEWLKMMVGTRRAE 415
PE + + +SD+Y+FG++L E +TG+ P + +N + + MVG
Sbjct: 175 PEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQ------LPYSNINNRDQIIFMVG----R 224
Query: 416 EVVDPNLEVKPAT--RALKRSLLVALRCVDPDSEKRPKMSQVVRMLE 460
+ P+L + +A+KR + C+ ++RP Q++ +E
Sbjct: 225 GYLSPDLSKVRSNCPKAMKR---LMAECLKKKRDERPLFPQILASIE 268
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Score = 230 bits (588), Expect = 6e-73
Identities = 75/283 (26%), Positives = 121/283 (42%), Gaps = 26/283 (9%)
Query: 180 DLEIATNRFSAENVLGEGGYGVVYKGRLINGSEVAVKKLLNNLGQAEKEFRVEVEAIGHV 239
+ E+ LG G +G V+ G ++VAVK L + F E + +
Sbjct: 7 EWEVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSL-KQGSMSPDAFLAEANLMKQL 65
Query: 240 RHKNLVRLLGYCIEGVHRMLVYEYVNNGNLEQWLHGAMRNQGNLTWEARMKVIIGTAKAL 299
+H+ LVRL + ++ EY+ NG+L +L + LT + + A+ +
Sbjct: 66 QHQRLVRLYAVVTQE-PIYIITEYMENGSLVDFLKT--PSGIKLTINKLLDMAAQIAEGM 122
Query: 300 AYLHEAIEPKVVHRDIKSSNILIDDEFNAKVSDFGLAKLLDSGESHITTRVMGTFGYVAP 359
A++ E +HRD++++NIL+ D + K++DFGLA+L++ E + AP
Sbjct: 123 AFIEE---RNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAP 179
Query: 360 EYANTGMLNEKSDIYSFGVLLLEAVTGRDPVDYGRPANEV--NLVEWLKMMVGTRRAEEV 417
E N G KSD++SFG+LL E VT G EV NL +M+ EE+
Sbjct: 180 EAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRPDNCPEEL 239
Query: 418 VDPNLEVKPATRALKRSLLVALRCVDPDSEKRPKMSQVVRMLE 460
+ C E RP + +LE
Sbjct: 240 YQ-----------------LMRLCWKERPEDRPTFDYLRSVLE 265
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Score = 221 bits (565), Expect = 8e-70
Identities = 69/275 (25%), Positives = 124/275 (45%), Gaps = 22/275 (8%)
Query: 186 NRFSAENVLGEGGYGVVYKGRLINGSEVAVKKLLNNLGQAEKEFRVEVEAIGHVRHKNLV 245
+ + +G G +G+V+ G +N +VA+K + +E++F E E + + H LV
Sbjct: 5 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTI-REGAMSEEDFIEEAEVMMKLSHPKLV 63
Query: 246 RLLGYCIEGVHRMLVYEYVNNGNLEQWLHGAMRNQGNLTWEARMKVIIGTAKALAYLHEA 305
+L G C+E LV+E++ +G L +L +G E + + + + +AYL E
Sbjct: 64 QLYGVCLEQAPICLVFEFMEHGCLSDYLR---TQRGLFAAETLLGMCLDVCEGMAYLEE- 119
Query: 306 IEPKVVHRDIKSSNILIDDEFNAKVSDFGLAKLLDSGESHITTRVMGTFGYVAPEYANTG 365
V+HRD+ + N L+ + KVSDFG+ + + + +T + +PE +
Sbjct: 120 --ACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFS 177
Query: 366 MLNEKSDIYSFGVLLLEAVTGRDPVDYGRPANEVNLVEWLKMMVGTRRAEEVVDPNLEVK 425
+ KSD++SFGVL+ E + R +E +VE + + P L
Sbjct: 178 RYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSE--VVEDI------STGFRLYKPRLAST 229
Query: 426 PATRALKRSLLVALRCVDPDSEKRPKMSQVVRMLE 460
+ + C E RP S+++R L
Sbjct: 230 HVYQ-------IMNHCWKERPEDRPAFSRLLRQLA 257
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 220 bits (562), Expect = 6e-69
Identities = 75/283 (26%), Positives = 118/283 (41%), Gaps = 26/283 (9%)
Query: 180 DLEIATNRFSAENVLGEGGYGVVYKGRLINGSEVAVKKLLNNLGQAEKEFRVEVEAIGHV 239
EI E LG+G +G V+ G + VA+K L + + F E + + +
Sbjct: 11 AWEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKL 69
Query: 240 RHKNLVRLLGYCIEGVHRMLVYEYVNNGNLEQWLHGAMRNQGNLTWEARMKVIIGTAKAL 299
RH+ LV+L E +V EY++ G+L +L G L + + A +
Sbjct: 70 RHEKLVQLYAVVSEE-PIYIVTEYMSKGSLLDFLKG--ETGKYLRLPQLVDMAAQIASGM 126
Query: 300 AYLHEAIEPKVVHRDIKSSNILIDDEFNAKVSDFGLAKLLDSGESHITTRVMGTFGYVAP 359
AY+ VHRD++++NIL+ + KV+DFGLA+L++ E + AP
Sbjct: 127 AYVER---MNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAP 183
Query: 360 EYANTGMLNEKSDIYSFGVLLLEAVTGRDPVDYGRPANEV--NLVEWLKMMVGTRRAEEV 417
E A G KSD++SFG+LL E T G EV + +M E +
Sbjct: 184 EAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPESL 243
Query: 418 VDPNLEVKPATRALKRSLLVALRCVDPDSEKRPKMSQVVRMLE 460
D + +C + E+RP + LE
Sbjct: 244 HD-----------------LMCQCWRKEPEERPTFEYLQAFLE 269
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Score = 218 bits (557), Expect = 5e-68
Identities = 76/303 (25%), Positives = 129/303 (42%), Gaps = 39/303 (12%)
Query: 176 FTLRDLEIATNRFSAE---------NVLGEGGYGVVYKGRLINGSE----VAVKKLLNNL 222
FT D A F+ E V+G G +G V G L + VA+K L +
Sbjct: 7 FTFEDPNEAVREFAKEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGY 66
Query: 223 G-QAEKEFRVEVEAIGHVRHKNLVRLLGYCIEGVHRMLVYEYVNNGNLEQWLHGAMRNQG 281
+ ++F E +G H N++ L G + M++ E++ NG+L+ +L +N G
Sbjct: 67 TEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLR---QNDG 123
Query: 282 NLTWEARMKVIIGTAKALAYLHEAIEPKVVHRDIKSSNILIDDEFNAKVSDFGLAKLLDS 341
T + ++ G A + YL + VHRD+ + NIL++ KVSDFGL++ L+
Sbjct: 124 QFTVIQLVGMLRGIAAGMKYLAD---MNYVHRDLAARNILVNSNLVCKVSDFGLSRFLED 180
Query: 342 GESHITTR----VMGTFGYVAPEYANTGMLNEKSDIYSFGVLLLEAVTGRDPVDYGRPAN 397
S T + APE SD++S+G+++ E ++ + P
Sbjct: 181 DTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGER-----PYW 235
Query: 398 EVNLVEWLKMMVGTRRAEEVVDPNLEVKPATRALKRSLLVALRCVDPDSEKRPKMSQVVR 457
++ + + + R + P ++ A L L C D RPK Q+V
Sbjct: 236 DMTNQDVINAIEQDYR----LPPPMDCPSALHQL------MLDCWQKDRNHRPKFGQIVN 285
Query: 458 MLE 460
L+
Sbjct: 286 TLD 288
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Score = 218 bits (556), Expect = 7e-68
Identities = 68/293 (23%), Positives = 127/293 (43%), Gaps = 30/293 (10%)
Query: 191 ENVLGEGGYGVVYKGRLINGSEVAVKKLLNNLGQAEKEFRVEVEAIGHVRHKNLVRLLGY 250
+ +G+G +G V++G+ G EVAVK ++ + E+ +RH+N++ +
Sbjct: 8 QESIGKGRFGEVWRGKW-RGEEVAVKIF-SSREERSWFREAEIYQTVMLRHENILGFIAA 65
Query: 251 CIEG----VHRMLVYEYVNNGNLEQWLHGAMRNQGNLTWEARMKVIIGTAKALAYLHEAI 306
+ LV +Y +G+L +L+ + +T E +K+ + TA LA+LH I
Sbjct: 66 DNKDNGTWTQLWLVSDYHEHGSLFDYLN-----RYTVTVEGMIKLALSTASGLAHLHMEI 120
Query: 307 -----EPKVVHRDIKSSNILIDDEFNAKVSDFGLAKLLDSGESHI---TTRVMGTFGYVA 358
+P + HRD+KS NIL+ ++D GLA DS I +GT Y+A
Sbjct: 121 VGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMA 180
Query: 359 PEYANTGM------LNEKSDIYSFGVLLLEAVTGRDP----VDYGRPANEVNLVEWLKMM 408
PE + + +++DIY+ G++ E DY P ++ +
Sbjct: 181 PEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEE 240
Query: 409 VGTRRAEEVVDPNLEVKPATRALKRSLL-VALRCVDPDSEKRPKMSQVVRMLE 460
+ E+ + PN+ + + R + + C + R ++ + L
Sbjct: 241 MRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLS 293
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 213 bits (544), Expect = 1e-66
Identities = 61/275 (22%), Positives = 118/275 (42%), Gaps = 26/275 (9%)
Query: 188 FSAENVLGEGGYGVVYKGRLINGSEVAVKKLLNNLGQAEKEFRVEVEAIGHVRHKNLVRL 247
+ LG G +GVV G+ +VA+K + +E EF E + + ++ H+ LV+L
Sbjct: 6 LTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEG-SMSEDEFIEEAKVMMNLSHEKLVQL 64
Query: 248 LGYCIEGVHRMLVYEYVNNGNLEQWLHGAMRNQGNLTWEARMKVIIGTAKALAYLHEAIE 307
G C + ++ EY+ NG L +L + + +++ +A+ YL
Sbjct: 65 YGVCTKQRPIFIITEYMANGCLLNYLR---EMRHRFQTQQLLEMCKDVCEAMEYLES--- 118
Query: 308 PKVVHRDIKSSNILIDDEFNAKVSDFGLAKLLDSGESHITTRVMGTFGYVAPEYANTGML 367
+ +HRD+ + N L++D+ KVSDFGL++ + E + + PE
Sbjct: 119 KQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMYSKF 178
Query: 368 NEKSDIYSFGVLLLEAVTGRDPVDYGRPANEV--NLVEWLKMMVGTRRAEEVVDPNLEVK 425
+ KSDI++FGVL+ E + +E ++ + L++ +E+V
Sbjct: 179 SSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRLYRPHLASEKVYT------ 232
Query: 426 PATRALKRSLLVALRCVDPDSEKRPKMSQVVRMLE 460
+ C +++RP ++ +
Sbjct: 233 -----------IMYSCWHEKADERPTFKILLSNIL 256
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 213 bits (544), Expect = 7e-66
Identities = 69/304 (22%), Positives = 121/304 (39%), Gaps = 11/304 (3%)
Query: 181 LEIATNRFSAENVLGEGGYGVVYKGRLI-NGSEVAVKKL-LNNLGQAEKEFRVEVEAIGH 238
+E+ + F + LG G GVV+K +G +A K + L + E++ +
Sbjct: 1 MELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHE 60
Query: 239 VRHKNLVRLLGYCIEGVHRMLVYEYVNNGNLEQWLHGAMRNQGNLTWEARMKVIIGTAKA 298
+V G + E+++ G+L+Q L G + + KV I K
Sbjct: 61 CNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLK----KAGRIPEQILGKVSIAVIKG 116
Query: 299 LAYLHEAIEPKVVHRDIKSSNILIDDEFNAKVSDFGLAKLLDSGESHITTRVMGTFGYVA 358
L YL E + K++HRD+K SNIL++ K+ DFG++ L + +GT Y++
Sbjct: 117 LTYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLID---SMANSFVGTRSYMS 171
Query: 359 PEYANTGMLNEKSDIYSFGVLLLEAVTGRDPVDYGRPANEVNLVEWLKMMVGTRRAEEVV 418
PE + +SDI+S G+ L+E GR P+ +
Sbjct: 172 PERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPR 231
Query: 419 DPNLEVKPATRALKRSLLVALRCVDPDSEKRPKMSQVVRMLEADDYPFREDRRNRKSRTT 478
P + + + + +E PK+ V LE D+ + +N R
Sbjct: 232 TPGRPLSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERAD 291
Query: 479 SMEI 482
++
Sbjct: 292 LKQL 295
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Score = 212 bits (540), Expect = 1e-65
Identities = 67/282 (23%), Positives = 121/282 (42%), Gaps = 22/282 (7%)
Query: 180 DLEIATNRFSAENVLGEGGYGVVYKGRLIN-GSEVAVKKLLNNLGQAEKEFRVEVEAIGH 238
E+ + ++ LG G YG VY+G VAVK L + + E EF E +
Sbjct: 11 KWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE-EFLKEAAVMKE 69
Query: 239 VRHKNLVRLLGYCIEGVHRMLVYEYVNNGNLEQWLHGAMRNQGNLTWEARMKVIIGTAKA 298
++H NLV+LLG C ++ E++ GNL +L N+ ++ + + + A
Sbjct: 70 IKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLR--ECNRQEVSAVVLLYMATQISSA 127
Query: 299 LAYLHEAIEPKVVHRDIKSSNILIDDEFNAKVSDFGLAKLLDSGESHITTRVMGTFGYVA 358
+ YL + +HRD+ + N L+ + KV+DFGL++L+ + A
Sbjct: 128 MEYLEK---KNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTA 184
Query: 359 PEYANTGMLNEKSDIYSFGVLLLEAVTGRDPVDYGRPANEVNLVEWLKMMVGTRRAEEVV 418
PE + KSD+++FGVLL E T G ++V E++
Sbjct: 185 PESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQV---------------YELL 229
Query: 419 DPNLEVKPATRALKRSLLVALRCVDPDSEKRPKMSQVVRMLE 460
+ + ++ ++ + C + RP +++ + E
Sbjct: 230 EKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFE 271
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 210 bits (536), Expect = 5e-65
Identities = 70/311 (22%), Positives = 118/311 (37%), Gaps = 46/311 (14%)
Query: 178 LRDLEIATNRFSAENVLGEGGYGVVYKGRLIN------GSEVAVKKL-LNNLGQAEKEFR 230
L LE N +GEG +G V++ R + VAVK L + +F+
Sbjct: 5 LLSLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQ 64
Query: 231 VEVEAIGHVRHKNLVRLLGYCIEGVHRMLVYEYVNNGNLEQWLHGAMRNQGN-------- 282
E + + N+V+LLG C G L++EY+ G+L ++L +
Sbjct: 65 REAALMAEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLS 124
Query: 283 ------------LTWEARMKVIIGTAKALAYLHEAIEPKVVHRDIKSSNILIDDEFNAKV 330
L+ ++ + A +AYL E K VHRD+ + N L+ + K+
Sbjct: 125 TRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSE---RKFVHRDLATRNCLVGENMVVKI 181
Query: 331 SDFGLAKLLDSGE-SHITTRVMGTFGYVAPEYANTGMLNEKSDIYSFGVLLLEAVTGRDP 389
+DFGL++ + S + ++ PE +SD++++GV+L E +
Sbjct: 182 ADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQ 241
Query: 390 VDYGRPANEVNLVEWLKMMVGTRRAEEVVDPNLEVKPATRALKRSLLVALRCVDPDSEKR 449
YG EV V D N+ P + C R
Sbjct: 242 PYYGMAHEEV--------------IYYVRDGNILACP-ENCPLELYNLMRLCWSKLPADR 286
Query: 450 PKMSQVVRMLE 460
P + R+L+
Sbjct: 287 PSFCSIHRILQ 297
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 208 bits (530), Expect = 2e-64
Identities = 70/287 (24%), Positives = 130/287 (45%), Gaps = 29/287 (10%)
Query: 182 EIATNRFSAENVLGEGGYGVVYKGRLINGSE-----VAVKKLLNNLGQAEK-EFRVEVEA 235
EI + + + V+G G +G VYKG L S VA+K L + ++ +F E
Sbjct: 3 EIHPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGI 62
Query: 236 IGHVRHKNLVRLLGYCIEGVHRMLVYEYVNNGNLEQWLHGAMRNQGNLTWEARMKVIIGT 295
+G H N++RL G + M++ EY+ NG L+++L G + + ++ G
Sbjct: 63 MGQFSHHNIIRLEGVISKYKPMMIITEYMENGALDKFLR---EKDGEFSVLQLVGMLRGI 119
Query: 296 AKALAYLHEAIEPKVVHRDIKSSNILIDDEFNAKVSDFGLAKLLDSGE--SHITTRVMGT 353
A + YL VHRD+ + NIL++ KVSDFGL+++L+ ++ T+
Sbjct: 120 AAGMKYLAN---MNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIP 176
Query: 354 FGYVAPEYANTGMLNEKSDIYSFGVLLLEAVTGRDPVDYGRPANEVNLVEWLKMMVGTRR 413
+ APE + SD++SFG+++ E +T + + +EV
Sbjct: 177 IRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEV-------------- 222
Query: 414 AEEVVDPNLEVKPATRALKRSLLVALRCVDPDSEKRPKMSQVVRMLE 460
+ ++ + + ++C + +RPK + +V +L+
Sbjct: 223 -MKAINDGFRLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILD 268
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 207 bits (528), Expect = 3e-64
Identities = 75/282 (26%), Positives = 117/282 (41%), Gaps = 32/282 (11%)
Query: 182 EIATNRFSAENVLGEGGYGVVYKGRLINGSEVAVKKLLNNLGQAEKEFRVEVEAIGHVRH 241
+ +G+G +G V G G++VAVK + N+ + F E + +RH
Sbjct: 3 ALNMKELKLLQTIGKGEFGDVMLGDY-RGNKVAVKCIKND--ATAQAFLAEASVMTQLRH 59
Query: 242 KNLVRLLGYCIEGVHRM-LVYEYVNNGNLEQWLHGAMRNQGNLTWEARMKVIIGTAKALA 300
NLV+LLG +E + +V EY+ G+L +L R + L + +K + +A+
Sbjct: 60 SNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRS--RGRSVLGGDCLLKFSLDVCEAME 117
Query: 301 YLHEAIEPKVVHRDIKSSNILIDDEFNAKVSDFGLAKLLDSGESHITTRVMGTFGYVAPE 360
YL VHRD+ + N+L+ ++ AKVSDFGL K S + APE
Sbjct: 118 YLEG---NNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASST----QDTGKLPVKWTAPE 170
Query: 361 YANTGMLNEKSDIYSFGVLLLEAVTGRDPVDYGRPANEV--NLVEWLKMMVGTRRAEEVV 418
+ KSD++SFG+LL E + P +V + + KM V
Sbjct: 171 ALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKMDAPDGCPPAVY 230
Query: 419 DPNLEVKPATRALKRSLLVALRCVDPDSEKRPKMSQVVRMLE 460
+ V C D+ RP Q+ LE
Sbjct: 231 E-----------------VMKNCWHLDAAMRPSFLQLREQLE 255
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Score = 206 bits (526), Expect = 9e-64
Identities = 70/290 (24%), Positives = 127/290 (43%), Gaps = 29/290 (10%)
Query: 179 RDLEIATNRFSAENV-LGEGGYGVVYKGRLI---NGSEVAVKKLLNNLGQAE-KEFRVEV 233
+ L + + ++ LG G +G V +G +VA+K L +A+ +E E
Sbjct: 1 KKLFLKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREA 60
Query: 234 EAIGHVRHKNLVRLLGYCIEGVHRMLVYEYVNNGNLEQWLHGAMRNQGNLTWEARMKVII 293
+ + + + +VRL+G C + MLV E G L ++L G + + +++
Sbjct: 61 QIMHQLDNPYIVRLIGVC-QAEALMLVMEMAGGGPLHKFLVG---KREEIPVSNVAELLH 116
Query: 294 GTAKALAYLHEAIEPKVVHRDIKSSNILIDDEFNAKVSDFGLAKLLDSGESHITTR--VM 351
+ + YL E VHRD+ + N+L+ + AK+SDFGL+K L + +S+ T R
Sbjct: 117 QVSMGMKYLEE---KNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGK 173
Query: 352 GTFGYVAPEYANTGMLNEKSDIYSFGVLLLEAVTGRDPVDYGRPANEVNLVEWLKMMVGT 411
+ APE N + +SD++S+GV + EA++ P ++ E + +
Sbjct: 174 WPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQK-----PYKKMKGPEVMAFIEQG 228
Query: 412 RRAEEVVDPNLEVKPATRALKRSLLVALRCVDPDSEKRPKMSQVVRMLEA 461
+R E + E+ + C E RP V + + A
Sbjct: 229 KRMECPPECPPELYA----------LMSDCWIYKWEDRPDFLTVEQRMRA 268
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Score = 205 bits (523), Expect = 5e-63
Identities = 81/295 (27%), Positives = 130/295 (44%), Gaps = 32/295 (10%)
Query: 178 LRDLEIATNRFSA--ENVLGEGGYGVVYKGRLINGS----EVAVKKLLNNLGQAE-KEFR 230
++ + I + V+G G +G VY G L++ AVK L E +F
Sbjct: 17 VQHVVIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFL 76
Query: 231 VEVEAIGHVRHKNLVRLLGYCIEG-VHRMLVYEYVNNGNLEQWLHGAMRNQGNLTWEARM 289
E + H N++ LLG C+ ++V Y+ +G+L + N T + +
Sbjct: 77 TEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNF---IRNETHNPTVKDLI 133
Query: 290 KVIIGTAKALAYLHEAIEPKVVHRDIKSSNILIDDEFNAKVSDFGLAKLLDSGES---HI 346
+ AK + +L K VHRD+ + N ++D++F KV+DFGLA+ + E H
Sbjct: 134 GFGLQVAKGMKFLAS---KKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHN 190
Query: 347 TTRVMGTFGYVAPEYANTGMLNEKSDIYSFGVLLLEAVTGRDPVDYGRPANEVNLVEWLK 406
T ++A E T KSD++SFGVLL E +T P P +VN +
Sbjct: 191 KTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAP-----PYPDVNTFDITV 245
Query: 407 MMVGTRRAEEVVDPNLEVKPATRALKRSLLVALRCVDPDSEKRPKMSQVVRMLEA 461
++ RR ++ P P V L+C P +E RP S++V + A
Sbjct: 246 YLLQGRR---LLQPEYCPDPLYE-------VMLKCWHPKAEMRPSFSELVSRISA 290
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 203 bits (517), Expect = 2e-62
Identities = 70/277 (25%), Positives = 116/277 (41%), Gaps = 24/277 (8%)
Query: 188 FSAENVLGEGGYGVVYKGRLI-NGSEVAVKKL-LNNLGQAEKE-FRVEVEAIGHVRHKNL 244
+ +G G YG K R +G + K+L ++ +AEK+ EV + ++H N+
Sbjct: 6 YEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNI 65
Query: 245 VRLLGYCIEGVHRML--VYEYVNNGNLEQWLHGAMRNQGNLTWEARMKVIIGTAKALAYL 302
VR I+ + L V EY G+L + + + L E ++V+ AL
Sbjct: 66 VRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKEC 125
Query: 303 HE--AIEPKVVHRDIKSSNILIDDEFNAKVSDFGLAKLLDSGESHITTRVMGTFGYVAPE 360
H V+HRD+K +N+ +D + N K+ DFGLA++L+ S +GT Y++PE
Sbjct: 126 HRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKA-FVGTPYYMSPE 184
Query: 361 YANTGMLNEKSDIYSFGVLLLEAVTGRDPVDYGRPANEVNLVEWLKMMVGTRRAEEVVDP 420
N NEKSDI+S G LL E P + E + R +
Sbjct: 185 QMNRMSYNEKSDIWSLGCLLYELCALMPPFT------AFSQKELAGKI----REGKFRRI 234
Query: 421 NLEVKPATRALKRSLLVALRCVDPDSEKRPKMSQVVR 457
+ R ++ RP + +++
Sbjct: 235 PYRYSDELNEI------ITRMLNLKDYHRPSVEEILE 265
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 203 bits (517), Expect = 5e-62
Identities = 69/302 (22%), Positives = 119/302 (39%), Gaps = 40/302 (13%)
Query: 182 EIATNRFSAENVLGEGGYGVVYKGRLI------NGSEVAVKKLLNNLGQAEKE-FRVEVE 234
E NR S LG G +G V + VAVK L + E+E E++
Sbjct: 19 EFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELK 78
Query: 235 AIGHV-RHKNLVRLLGYCIEGVHRMLVYEYVNNGNLEQWLHG--------------AMRN 279
+ ++ H N+V LLG C G +++ EY G+L +L +
Sbjct: 79 VLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDD 138
Query: 280 QGNLTWEARMKVIIGTAKALAYLHEAIEPKVVHRDIKSSNILIDDEFNAKVSDFGLAKLL 339
+ L E + AK +A+L +HRD+ + NIL+ K+ DFGLA+ +
Sbjct: 139 ELALDLEDLLSFSYQVAKGMAFLA---SKNCIHRDLAARNILLTHGRITKICDFGLARDI 195
Query: 340 DSGESH-ITTRVMGTFGYVAPEYANTGMLNEKSDIYSFGVLLLEAVTGRDPVDYGRPANE 398
+ ++ + ++APE + +SD++S+G+ L E + G P +
Sbjct: 196 KNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDS 255
Query: 399 VNLVEWLKMMVGTRRAEEVVDPNLEVKPATRALKRSLLVALRCVDPDSEKRPKMSQVVRM 458
+++ + A + C D D KRP Q+V++
Sbjct: 256 K--------------FYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQL 301
Query: 459 LE 460
+E
Sbjct: 302 IE 303
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 203 bits (517), Expect = 7e-62
Identities = 70/308 (22%), Positives = 117/308 (37%), Gaps = 45/308 (14%)
Query: 182 EIATNRFSAENVLGEGGYGVVYKGRLINGSE------VAVKKLLNNLGQAEKE-FRVEVE 234
E VLG G +G V S+ VAVK L +E+E E++
Sbjct: 33 EFPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELK 92
Query: 235 AIGHV-RHKNLVRLLGYCIEGVHRMLVYEYVNNGNLEQWLHG------------------ 275
+ + H+N+V LLG C L++EY G+L +L
Sbjct: 93 MMTQLGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRL 152
Query: 276 -AMRNQGNLTWEARMKVIIGTAKALAYLHEAIEPKVVHRDIKSSNILIDDEFNAKVSDFG 334
+ LT+E + AK + +L VHRD+ + N+L+ K+ DFG
Sbjct: 153 EEEEDLNVLTFEDLLCFAYQVAKGMEFLEF---KSCVHRDLAARNVLVTHGKVVKICDFG 209
Query: 335 LAKLLDSGESHIT-TRVMGTFGYVAPEYANTGMLNEKSDIYSFGVLLLEAVTGRDPVDYG 393
LA+ + S +++ ++APE G+ KSD++S+G+LL E + G
Sbjct: 210 LARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPG 269
Query: 394 RPANEVNLVEWLKMMVGTRRAEEVVDPNLEVKPATRALKRSLLVALRCVDPDSEKRPKMS 453
P + +++ ++ A + ++ C DS KRP
Sbjct: 270 IPVDAN--------------FYKLIQNGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFP 315
Query: 454 QVVRMLEA 461
+ L
Sbjct: 316 NLTSFLGC 323
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 197 bits (502), Expect = 2e-60
Identities = 73/286 (25%), Positives = 114/286 (39%), Gaps = 38/286 (13%)
Query: 176 FTLRDLEIATNRFSAENVLGEGGYGVVYKGRLI-NGSEVAVKKLLNNL---GQAEKEFRV 231
+ L D EI LG+G +G VY R + +A+K L E + R
Sbjct: 3 WALEDFEI-------GRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRR 55
Query: 232 EVEAIGHVRHKNLVRLLGYCIEGVHRMLVYEYVNNGNLEQWLHGAMRNQGNLTWEARMKV 291
EVE H+RH N++RL GY + L+ EY G + + L +
Sbjct: 56 EVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQ----KLSKFDEQRTATY 111
Query: 292 IIGTAKALAYLHEAIEPKVVHRDIKSSNILIDDEFNAKVSDFGLAKLLDSGESHITTRVM 351
I A AL+Y H +V+HRDIK N+L+ K++DFG + S +
Sbjct: 112 ITELANALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRT---TLC 165
Query: 352 GTFGYVAPEYANTGMLNEKSDIYSFGVLLLEAVTGRDPVDYGRPANEVNLVEWLKMMVGT 411
GT Y+ PE M +EK D++S GVL E + G+ P + + ++
Sbjct: 166 GTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPD 225
Query: 412 RRAEEVVDPNLEVKPATRALKRSLLVALRCVDPDSEKRPKMSQVVR 457
E D + R + + +RP + +V+
Sbjct: 226 FVTEGARD-----------------LISRLLKHNPSQRPMLREVLE 254
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 197 bits (502), Expect = 3e-60
Identities = 67/275 (24%), Positives = 112/275 (40%), Gaps = 31/275 (11%)
Query: 191 ENVLGEGGYGVVYKGRLI-NGSEVAVKKLLNNL--GQAEKEFRVEVEAIGHVRHKNLVRL 247
+ +G G + VYKG EVA +L + + F+ E E + ++H N+VR
Sbjct: 14 DIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRF 73
Query: 248 LGYCIEGV----HRMLVYEYVNNGNLEQWLHGAMRNQGNLTWEARMKVIIGTAKALAYLH 303
V +LV E + +G L+ +L + + K L +LH
Sbjct: 74 YDSWESTVKGKKCIVLVTELMTSGTLKTYLK----RFKVMKIKVLRSWCRQILKGLQFLH 129
Query: 304 EAIEPKVVHRDIKSSNILIDDE-FNAKVSDFGLAKLLDSGESHITTRVMGTFGYVAPEYA 362
P ++HRD+K NI I + K+ D GLA L + V+GT ++APE
Sbjct: 130 TR-TPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLK---RASFAKAVIGTPEFMAPEMY 185
Query: 363 NTGMLNEKSDIYSFGVLLLEAVTGRDPVDYGRPANEVNLVEWLKMMVGTRRAEEVVDPNL 422
+E D+Y+FG+ +LE T P + A ++ RR V P
Sbjct: 186 E-EKYDESVDVYAFGMCMLEMATSEYPYSECQNAAQI-----------YRRVTSGVKPAS 233
Query: 423 EVKPATRALKRSLLVALRCVDPDSEKRPKMSQVVR 457
K A +K + C+ + ++R + ++
Sbjct: 234 FDKVAIPEVKE---IIEGCIRQNKDERYSIKDLLN 265
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Score = 197 bits (502), Expect = 3e-60
Identities = 73/279 (26%), Positives = 115/279 (41%), Gaps = 34/279 (12%)
Query: 191 ENVLGEGGYGVVYKGRLIN---GSEVAVKKLLNNLGQAE--KEFRVEVEAIGHVRHKNLV 245
+ LG G +G V KG VAVK L N E E + + + +V
Sbjct: 12 DKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIV 71
Query: 246 RLLGYCIEGVHRMLVYEYVNNGNLEQWLHGAMRNQGNLTWEARMKVIIGTAKALAYLHEA 305
R++G C MLV E G L ++L ++ + ++++ + + YL E
Sbjct: 72 RMIGICEAE-SWMLVMEMAELGPLNKYLQ----QNRHVKDKNIIELVHQVSMGMKYLEE- 125
Query: 306 IEPKVVHRDIKSSNILIDDEFNAKVSDFGLAKLLDSGESHITTR--VMGTFGYVAPEYAN 363
VHRD+ + N+L+ + AK+SDFGL+K L + E++ + + APE N
Sbjct: 126 --SNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECIN 183
Query: 364 TGMLNEKSDIYSFGVLLLEAVTGRDPVDYGRPANEV--NLVEWLKMMVGTRRAEEVVDPN 421
+ KSD++SFGVL+ EA + G +EV L + +M E+ D
Sbjct: 184 YYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMGCPAGCPREMYD-- 241
Query: 422 LEVKPATRALKRSLLVALRCVDPDSEKRPKMSQVVRMLE 460
+ C D E RP + V L
Sbjct: 242 ---------------LMNLCWTYDVENRPGFAAVELRLR 265
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 198 bits (505), Expect = 3e-60
Identities = 68/300 (22%), Positives = 120/300 (40%), Gaps = 42/300 (14%)
Query: 165 PEISHLGWGHWFTLRDLEIATNRFSAENVLGEGGYGVVYKGR-LINGSEVAVKKLLNNLG 223
P+++ L F D E FS +G G +G VY R + N VA+KK+ +
Sbjct: 2 PDVAEL-----FFKDDPE---KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGK 53
Query: 224 QAE---KEFRVEVEAIGHVRHKNLVRLLGYCIEGVHRMLVYEYVNNGNLEQWLHGAMRNQ 280
Q+ ++ EV + +RH N ++ G + LV EY + ++
Sbjct: 54 QSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVMEYCLGSASDLLEV----HK 109
Query: 281 GNLTWEARMKVIIGTAKALAYLHEAIEPKVVHRDIKSSNILIDDEFNAKVSDFGLAKLLD 340
L V G + LAYLH ++HRD+K+ NIL+ + K+ DFG A ++
Sbjct: 110 KPLQEVEIAAVTHGALQGLAYLHSH---NMIHRDVKAGNILLSEPGLVKLGDFGSASIMA 166
Query: 341 SGESHITTRVMGTFGYVAPEYA---NTGMLNEKSDIYSFGVLLLEAVTGRDPVDYGRPAN 397
+GT ++APE + G + K D++S G+ +E + P
Sbjct: 167 P-----ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERK------PPLF 215
Query: 398 EVNLVEWLKMMVGTRRAEEVVDPNLEVKPATRALKRSLLVALRCVDPDSEKRPKMSQVVR 457
+N + L + + P L+ + + C+ + RP +++
Sbjct: 216 NMNAMSALYHIA------QNESPALQSGHWSEYFRN---FVDSCLQKIPQDRPTSEVLLK 266
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 198 bits (504), Expect = 3e-60
Identities = 67/292 (22%), Positives = 125/292 (42%), Gaps = 37/292 (12%)
Query: 186 NRFSAENVLGEGGYGVVYKGRLINGS---EVAVKKL-LNNLGQAEKEFRVEVEAIGHV-R 240
N ++V+GEG +G V K R+ + A+K++ ++F E+E + +
Sbjct: 10 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGH 69
Query: 241 HKNLVRLLGYCIEGVHRMLVYEYVNNGNLEQWLHGAM------------RNQGNLTWEAR 288
H N++ LLG C + L EY +GNL +L + L+ +
Sbjct: 70 HPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQL 129
Query: 289 MKVIIGTAKALAYLHEAIEPKVVHRDIKSSNILIDDEFNAKVSDFGLAKLLDSGESHITT 348
+ A+ + YL + + +HRD+ + NIL+ + + AK++DFGL++ + T
Sbjct: 130 LHFAADVARGMDYLSQ---KQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVK--KT 184
Query: 349 RVMGTFGYVAPEYANTGMLNEKSDIYSFGVLLLEAVTGRDPVDYGRPANEVNLVEWLKMM 408
++A E N + SD++S+GVLL E V+ P + E + +
Sbjct: 185 MGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGT-----PYCGMTCAELYEKL 239
Query: 409 VGTRRAEEVVDPNLEVKPATRALKRSLLVALRCVDPDSEKRPKMSQVVRMLE 460
R E+ ++ + EV + +C +RP +Q++ L
Sbjct: 240 PQGYRLEKPLNCDDEVYD----------LMRQCWREKPYERPSFAQILVSLN 281
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Score = 195 bits (497), Expect = 1e-59
Identities = 61/287 (21%), Positives = 113/287 (39%), Gaps = 27/287 (9%)
Query: 180 DLEIATNRFSAENVLGEGGYGVVYKGRLIN----GSEVAVKKLLNNLGQAEKE-FRVEVE 234
D EI R +GEG +G V++G ++ VA+K N + +E F E
Sbjct: 1 DYEIQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEAL 60
Query: 235 AIGHVRHKNLVRLLGYCIEGVHRMLVYEYVNNGNLEQWLHGAMRNQGNLTWEARMKVIIG 294
+ H ++V+L+G E ++ E G L + + +L + +
Sbjct: 61 TMRQFDHPHIVKLIGVITEN-PVWIIMELCTLGELRSF---LQVRKYSLDLASLILYAYQ 116
Query: 295 TAKALAYLHEAIEPKVVHRDIKSSNILIDDEFNAKVSDFGLAKLLDSGESHITTRVMGTF 354
+ ALAYL + VHRDI + N+L+ K+ DFGL++ ++ + ++
Sbjct: 117 LSTALAYLES---KRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPI 173
Query: 355 GYVAPEYANTGMLNEKSDIYSFGVLLLEAVTGRDPVDYGRPANEVNLVEWLKMMVGTRRA 414
++APE N SD++ FGV + E + P V + + + R
Sbjct: 174 KWMAPESINFRRFTSASDVWMFGVCMWEILMHGVK-----PFQGVKNNDVIGRIENGERL 228
Query: 415 EEVVDPNLEVKPATRALKRSLLVALRCVDPDSEKRPKMSQVVRMLEA 461
+ + + +C D +RP+ +++ L
Sbjct: 229 PMPPNCPPTLYS----------LMTKCWAYDPSRRPRFTELKAQLST 265
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 195 bits (495), Expect = 9e-59
Identities = 76/325 (23%), Positives = 135/325 (41%), Gaps = 35/325 (10%)
Query: 188 FSAENVLGEGGYGVVYKGRLINGSE-----VAVKKL-LNNLGQAEKEFRVEVEAIGHVRH 241
F VLG G +G VYKG I E VA+K+L +A KE E + V +
Sbjct: 11 FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 70
Query: 242 KNLVRLLGYCIEGVHRMLVYEYVNNGNLEQWLHGAMRNQGNLTWEARMKVIIGTAKALAY 301
++ RLLG C+ L+ + + G L + ++ N+ + + + AK + Y
Sbjct: 71 PHVCRLLGICLTS-TVQLITQLMPFGCLLDY---VREHKDNIGSQYLLNWCVQIAKGMNY 126
Query: 302 LHEAIEPKVVHRDIKSSNILIDDEFNAKVSDFGLAKLLDSGES-HITTRVMGTFGYVAPE 360
L + ++VHRD+ + N+L+ + K++DFGLAKLL + E + ++A E
Sbjct: 127 LED---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALE 183
Query: 361 YANTGMLNEKSDIYSFGVLLLEAVTGRDPVDYGRPANEVNLVEWLKMMVGTRRAEEVVDP 420
+ +SD++S+GV + E +T G PA+E+ ++ R +
Sbjct: 184 SILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEI-----SSILEKGERLPQPPIC 238
Query: 421 NLEVKPATRALKRSLLVALRCVDPDSEKRPKMSQVVRMLEA------DDYPFREDRRNRK 474
++V + ++C D++ RPK +++ + D R
Sbjct: 239 TIDVYM----------IMVKCWMIDADSRPKFRELIIEFSKMARDPQRYLVIQGDERMHL 288
Query: 475 SRTTSMEIESLKESTEIESKVEDSE 499
T E V D++
Sbjct: 289 PSPTDSNFYRALMDEEDMDDVVDAD 313
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 192 bits (488), Expect = 3e-58
Identities = 67/287 (23%), Positives = 111/287 (38%), Gaps = 30/287 (10%)
Query: 183 IATNRFSAENVLGEGGYGVVYKGRLI----NGSEVAVKKLLNNL---GQAEKEFRVEVEA 235
I LG+G +GVV +G VAVK L ++ +A +F EV A
Sbjct: 5 IGEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNA 64
Query: 236 IGHVRHKNLVRLLGYCIEGVHRMLVYEYVNNGNLEQWLHGAMRNQGNLTWEARMKVIIGT 295
+ + H+NL+RL G + +V E G+L ++QG+ + +
Sbjct: 65 MHSLDHRNLIRLYGVVLTP-PMKMVTELAPLGSLLDR---LRKHQGHFLLGTLSRYAVQV 120
Query: 296 AKALAYLHEAIEPKVVHRDIKSSNILIDDEFNAKVSDFGLAKLLDSGESH--ITTRVMGT 353
A+ + YL + +HRD+ + N+L+ K+ DFGL + L + H +
Sbjct: 121 AEGMGYLES---KRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVP 177
Query: 354 FGYVAPEYANTGMLNEKSDIYSFGVLLLEAVTGRDPVDYGRPANEVNLVEWLKMMVGTRR 413
F + APE T + SD + FGV L E T P +N + L + +
Sbjct: 178 FAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQE-----PWIGLNGSQILHKID---K 229
Query: 414 AEEVVDPNLEVKPATRALKRSLLVALRCVDPDSEKRPKMSQVVRMLE 460
E + + + ++C E RP + L
Sbjct: 230 EGERLPRPEDCPQDIYNV------MVQCWAHKPEDRPTFVALRDFLL 270
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 191 bits (487), Expect = 4e-58
Identities = 64/276 (23%), Positives = 110/276 (39%), Gaps = 25/276 (9%)
Query: 186 NRFSAENVLGEGGYGVVYKGR-LINGSEVAVKKL-LNNLGQAEKEFRVEVEAIGHVRHKN 243
+ LGEG YG V + VAVK + + + + E+ + H+N
Sbjct: 5 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHEN 64
Query: 244 LVRLLGYCIEGVHRMLVYEYVNNGNLEQWLHGAMRNQGNLTWEARMKVIIGTAKALAYLH 303
+V+ G+ EG + L EY + G L + + + + YLH
Sbjct: 65 VVKFYGHRREGNIQYLFLEYCSGGELFDRIE----PDIGMPEPDAQRFFHQLMAGVVYLH 120
Query: 304 EAIEPKVVHRDIKSSNILIDDEFNAKVSDFGLAKLLDSG-ESHITTRVMGTFGYVAPEYA 362
+ HRDIK N+L+D+ N K+SDFGLA + + ++ GT YVAPE
Sbjct: 121 GI---GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELL 177
Query: 363 NTGMLN-EKSDIYSFGVLLLEAVTGRDPVDYGRPANEVNLVEWLKMMVGTRRAEEVVDPN 421
+ E D++S G++L + G P D + + + + ++P
Sbjct: 178 KRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQ--------EYSDWKEKKTYLNPW 229
Query: 422 LEVKPATRALKRSLLVALRCVDPDSEKRPKMSQVVR 457
++ A AL +L +P R + + +
Sbjct: 230 KKIDSAPLALLHKIL----VENP--SARITIPDIKK 259
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Score = 192 bits (489), Expect = 4e-58
Identities = 61/279 (21%), Positives = 120/279 (43%), Gaps = 27/279 (9%)
Query: 185 TNRFSAENVLGEGGYGVVYKGRLI-NGSEVAVKKLLNNLGQAEKEFRVEVEAIGHVRHKN 243
+ + LG+G +G VYK + A K + + +++ VE++ + H N
Sbjct: 11 EDFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPN 70
Query: 244 LVRLLGYCIEGVHRMLVYEYVNNGNLEQWLHGAMRNQGNLTWEARMKVIIGTAKALAYLH 303
+V+LL + ++ E+ G ++ + + LT V T AL YLH
Sbjct: 71 IVKLLDAFYYENNLWILIEFCAGGAVDAVML---ELERPLTESQIQVVCKQTLDALNYLH 127
Query: 304 EAIEPKVVHRDIKSSNILIDDEFNAKVSDFGLAKLLDSGESHITTRVMGTFGYVAPEYAN 363
+ K++HRD+K+ NIL + + K++DFG++ + + GT ++APE
Sbjct: 128 DN---KIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDSFI-GTPYWMAPEVVM 183
Query: 364 TGML-----NEKSDIYSFGVLLLEAVTGRDPVDYGRPANEVNLVEWLKMMVGTRRAEEVV 418
+ K+D++S G+ L+E P +E+N + L + +
Sbjct: 184 CETSKDRPYDYKADVWSLGITLIEMAEIE------PPHHELNPMRVLLKIAKSEP----- 232
Query: 419 DPNLEVKPATRALKRSLLVALRCVDPDSEKRPKMSQVVR 457
P L + + L +C++ + + R SQ+++
Sbjct: 233 -PTLAQPSRWSSNFKDFL--KKCLEKNVDARWTTSQLLQ 268
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 191 bits (487), Expect = 8e-58
Identities = 75/306 (24%), Positives = 133/306 (43%), Gaps = 32/306 (10%)
Query: 185 TNRFSAENVLGEGGYGVVYKGR-LINGSEVAVKKLLNNLGQAEKEFRVEVEAIGHVRHKN 243
+++ +G+G G VY + G EVA++++ ++ E+ + ++ N
Sbjct: 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPN 78
Query: 244 LVRLLGYCIEGVHRMLVYEYVNNGNLEQWLHGAMRNQGNLTWEARMKVIIGTAKALAYLH 303
+V L + G +V EY+ G+L + + + V +AL +LH
Sbjct: 79 IVNYLDSYLVGDELWVVMEYLAGGSLTDVVT-----ETCMDEGQIAAVCRECLQALEFLH 133
Query: 304 EAIEPKVVHRDIKSSNILIDDEFNAKVSDFGLAKLLDSGESHITTRVMGTFGYVAPEYAN 363
+V+HRDIKS NIL+ + + K++DFG + +S +T V GT ++APE
Sbjct: 134 SN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMV-GTPYWMAPEVVT 189
Query: 364 TGMLNEKSDIYSFGVLLLEAVTGRDPVDYGRPANEVNLVEWLKMMVGTRRAEEVVDPNLE 423
K DI+S G++ +E + G P N + L ++ P L+
Sbjct: 190 RKAYGPKVDIWSLGIMAIEMIEGEPPYL------NENPLRALYLIATNGT------PELQ 237
Query: 424 VKPATRALKRSLLVALRCVDPDSEKRPKMSQVVRMLEADDYPFREDRRNRKSRTTSMEIE 483
A+ R L RC+D D EKR ++++ + F + + S T I
Sbjct: 238 NPEKLSAIFRDFL--NRCLDMDVEKRGSAKELLQ------HQFLKIAKPLSSLTPL--IA 287
Query: 484 SLKEST 489
+ KE+T
Sbjct: 288 AAKEAT 293
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Score = 187 bits (475), Expect = 2e-55
Identities = 58/273 (21%), Positives = 111/273 (40%), Gaps = 24/273 (8%)
Query: 186 NRFSAENVLGEGGYGVVYKGR-LINGSEVAVKKLLNNLGQAEKEFRVEVEAIGHVRHKNL 244
+ + LG G +GVV++ G+ A K ++ ++ R E++ + +RH L
Sbjct: 26 DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTL 85
Query: 245 VRLLGYCIEGVHRMLVYEYVNNGNLEQWLHGAMRNQGNLTWEARMKVIIGTAKALAYLHE 304
V L + +++YE+++ G L + + ++ + ++ + K L ++HE
Sbjct: 86 VNLHDAFEDDNEMVMIYEFMSGGELFEKVA---DEHNKMSEDEAVEYMRQVCKGLCHMHE 142
Query: 305 AIEPKVVHRDIKSSNILIDDEFN--AKVSDFGLAKLLDSGESHITTRVMGTFGYVAPEYA 362
VH D+K NI+ + + K+ DFGL LD +S T GT + APE A
Sbjct: 143 N---NYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVT--TGTAEFAAPEVA 197
Query: 363 NTGMLNEKSDIYSFGVLLLEAVTGRDPVDYGRPANEVNLVEWLKMMVGTRRAEEVVDPNL 422
+ +D++S GVL ++G P N E L+ + + +
Sbjct: 198 EGKPVGYYTDMWSVGVLSYILLSGLSPFG------GENDDETLRNVK-----SCDWNMDD 246
Query: 423 EVKPATRALKRSLLVALRCVDPDSEKRPKMSQV 455
+ + + + D R + Q
Sbjct: 247 SAFSGISEDGKDFI--RKLLLADPNTRMTIHQA 277
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 185 bits (471), Expect = 2e-55
Identities = 63/304 (20%), Positives = 126/304 (41%), Gaps = 32/304 (10%)
Query: 180 DLEIATNRFSAENVLGEGGYGVVYKGRLIN------GSEVAVKKL-LNNLGQAEKEFRVE 232
+ E+A + + LG+G +G+VY+G + VA+K + + EF E
Sbjct: 14 EWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNE 73
Query: 233 VEAIGHVRHKNLVRLLGYCIEGVHRMLVYEYVNNGNLEQWLHGAMRNQGN------LTWE 286
+ ++VRLLG +G +++ E + G+L+ +L N +
Sbjct: 74 ASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLS 133
Query: 287 ARMKVIIGTAKALAYLHEAIEPKVVHRDIKSSNILIDDEFNAKVSDFGLAKLLDSGES-H 345
+++ A +AYL+ K VHRD+ + N ++ ++F K+ DFG+ + + +
Sbjct: 134 KMIQMAGEIADGMAYLNA---NKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYR 190
Query: 346 ITTRVMGTFGYVAPEYANTGMLNEKSDIYSFGVLLLEAVTGRDPVDYGRPANEVNLVEWL 405
+ + +++PE G+ SD++SFGV+L E T + G +V
Sbjct: 191 KGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQV------ 244
Query: 406 KMMVGTRRAEEVVDPNLEVKPATRALKRSLLVALRCVDPDSEKRPKMSQVVRMLEADDYP 465
V++ L KP + C + + RP +++ ++ + P
Sbjct: 245 --------LRFVMEGGLLDKPD-NCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEMEP 295
Query: 466 FRED 469
+
Sbjct: 296 GFRE 299
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 184 bits (467), Expect = 7e-55
Identities = 68/302 (22%), Positives = 127/302 (42%), Gaps = 41/302 (13%)
Query: 182 EIATNRFSAENVLGEGGYGVVYKGRLI--------NGSEVAVKKLLNNLGQAE-KEFRVE 232
E+ +R LGEG +G V I ++VAVK L ++ + + + E
Sbjct: 9 ELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISE 68
Query: 233 VEAIGHV-RHKNLVRLLGYCIEGVHRMLVYEYVNNGNLEQWLH------------GAMRN 279
+E + + +HKN++ LLG C + ++ EY + GNL ++L +
Sbjct: 69 MEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNP 128
Query: 280 QGNLTWEARMKVIIGTAKALAYLHEAIEPKVVHRDIKSSNILIDDEFNAKVSDFGLAKLL 339
+ L+ + + A+ + YL K +HRD+ + N+L+ ++ K++DFGLA+ +
Sbjct: 129 EEQLSSKDLVSCAYQVARGMEYLAS---KKCIHRDLAARNVLVTEDNVMKIADFGLARDI 185
Query: 340 DSGESHITTRVM-GTFGYVAPEYANTGMLNEKSDIYSFGVLLLEAVTGRDPVDYGRPANE 398
+ + T ++APE + +SD++SFGVLL E T G P E
Sbjct: 186 HHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEE 245
Query: 399 VNLVEWLKMMVGTRRAEEVVDPNLEVKPATRALKRSLLVALRCVDPDSEKRPKMSQVVRM 458
+ +++ + + ++ C +RP Q+V
Sbjct: 246 L---------------FKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVED 290
Query: 459 LE 460
L+
Sbjct: 291 LD 292
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 179 bits (455), Expect = 4e-53
Identities = 72/301 (23%), Positives = 116/301 (38%), Gaps = 39/301 (12%)
Query: 182 EIATNRFSAENVLGEGGYGVVYKGRLI------NGSEVAVKKLLNNLGQAE-KEFRVEVE 234
E +R LG G +G V + VAVK L +E + E++
Sbjct: 9 EFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELK 68
Query: 235 AIGH-VRHKNLVRLLGYCIE-GVHRMLVYEYVNNGNLEQWLHGAMRN------------Q 280
+ H H N+V LLG C + G M++ E+ GNL +L +
Sbjct: 69 ILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYK 128
Query: 281 GNLTWEARMKVIIGTAKALAYLHEAIEPKVVHRDIKSSNILIDDEFNAKVSDFGLAKLLD 340
LT E + AK + +L K +HRD+ + NIL+ ++ K+ DFGLA+ +
Sbjct: 129 DFLTLEHLICYSFQVAKGMEFLAS---RKCIHRDLAARNILLSEKNVVKICDFGLARDIY 185
Query: 341 SGESHI-TTRVMGTFGYVAPEYANTGMLNEKSDIYSFGVLLLEAVTGRDPVDYGRPANEV 399
++ ++APE + +SD++SFGVLL E + P V
Sbjct: 186 KDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGAS-----PYPGV 240
Query: 400 NLVEWLKMMVGTRRAEEVVDPNLEVKPATRALKRSLLVALRCVDPDSEKRPKMSQVVRML 459
+ E + D T + + L C + +RP S++V L
Sbjct: 241 KIDEEFCRRLKEGTRMRAPD------YTTPEMYQ---TMLDCWHGEPSQRPTFSELVEHL 291
Query: 460 E 460
Sbjct: 292 G 292
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 177 bits (451), Expect = 1e-52
Identities = 65/285 (22%), Positives = 110/285 (38%), Gaps = 29/285 (10%)
Query: 187 RFSAENVLGEGGYGVVYKGR-LINGSEVAVKKLLNNLGQAE---KEFRVEVEAIGHVRHK 242
F +LGEG + V R L E A+K L E E + + + H
Sbjct: 9 DFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHP 68
Query: 243 NLVRLLGYCIEGVHRMLVYEYVNNGNLEQWLHGAMRNQGNLTWEARMKVIIGTAKALAYL 302
V+L + Y NG L +++ G+ AL YL
Sbjct: 69 FFVKLYFTFQDDEKLYFGLSYAKNGELLKYIR----KIGSFDETCTRFYTAEIVSALEYL 124
Query: 303 HEAIEPKVVHRDIKSSNILIDDEFNAKVSDFGLAKLLD-SGESHITTRVMGTFGYVAPEY 361
H ++HRD+K NIL++++ + +++DFG AK+L + +GT YV+PE
Sbjct: 125 HG---KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPEL 181
Query: 362 ANTGMLNEKSDIYSFGVLLLEAVTGRDPVDYGRPANEVNLVEWLKMMVGTRRAEEVVDPN 421
+ SD+++ G ++ + V G P R NE + + K++ E P
Sbjct: 182 LTEKSACKSSDLWALGCIIYQLVAGLPPF---RAGNEYLIFQ--KIIKLEYDFPEKFFPK 236
Query: 422 LEVKPATRALKRSLLVALRCVDPDSEKRPKMSQVVRMLEADDYPF 466
R L+ + + D+ KR ++ +PF
Sbjct: 237 A----------RDLV--EKLLVLDATKRLGCEEMEGYGPLKAHPF 269
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Score = 178 bits (452), Expect = 4e-52
Identities = 55/309 (17%), Positives = 116/309 (37%), Gaps = 31/309 (10%)
Query: 186 NRFSAENVLGEGGYGVVYKGR-LINGSEVAVKKLLNNLGQAEKEFRVEVEAIGHVRHKNL 244
+ + LG G +GVV++ G K + + + E+ + + H L
Sbjct: 29 DYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKL 88
Query: 245 VRLLGYCIEGVHRMLVYEYVNNGNLEQWLHGAMRNQGNLTWEARMKVIIGTAKALAYLHE 304
+ L + +L+ E+++ G L + ++ + + + L ++HE
Sbjct: 89 INLHDAFEDKYEMVLILEFLSGGELFDRIA---AEDYKMSEAEVINYMRQACEGLKHMHE 145
Query: 305 AIEPKVVHRDIKSSNILID--DEFNAKVSDFGLAKLLDSGESHITTRVMGTFGYVAPEYA 362
+VH DIK NI+ + + K+ DFGLA L+ E I T + APE
Sbjct: 146 H---SIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDE--IVKVTTATAEFAAPEIV 200
Query: 363 NTGMLNEKSDIYSFGVLLLEAVTGRDPVDYGRPANEVNLVEWLKMMVGTRRAEEVVDPNL 422
+ + +D+++ GVL ++G P + +E L+ + + +
Sbjct: 201 DREPVGFYTDMWAIGVLGYVLLSGL------SPFAGEDDLETLQNVK-----RCDWEFDE 249
Query: 423 EVKPATRALKRSLLVALRCVDPDSEKRPKMSQVVRMLEADDYP-FREDRRNRKSRTTSME 481
+ + + + + + KR + + +P + D N SR S
Sbjct: 250 DAFSSVSPEAKDFI--KNLLQKEPRKRLTVHDALE------HPWLKGDHSNLTSRIPSSR 301
Query: 482 IESLKESTE 490
+++ +
Sbjct: 302 YNKIRQKIK 310
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Score = 172 bits (437), Expect = 9e-51
Identities = 74/287 (25%), Positives = 129/287 (44%), Gaps = 31/287 (10%)
Query: 185 TNRFSAENVLGEGGYGVVYKGR-LINGSEVAVKKLLNNLGQ---AEKEFRVEVEAIGHVR 240
++R+ +LG GG V+ R L +VAVK L +L + FR E + +
Sbjct: 6 SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALN 65
Query: 241 HKNLVRLLGYCIE----GVHRMLVYEYVNNGNLEQWLHGAMRNQGNLTWEARMKVIIGTA 296
H +V + G +V EYV+ L +H +G +T + ++VI
Sbjct: 66 HPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVH----TEGPMTPKRAIEVIADAC 121
Query: 297 KALAYLHEAIEPKVVHRDIKSSNILIDDEFNAKVSDFGLAKLLDSGESHI--TTRVMGTF 354
+AL + H+ ++HRD+K +NI+I KV DFG+A+ + + + T V+GT
Sbjct: 122 QALNFSHQN---GIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTA 178
Query: 355 GYVAPEYANTGMLNEKSDIYSFGVLLLEAVTGRDPVDYGRPANEVNLVEWLKMMVGTRRA 414
Y++PE A ++ +SD+YS G +L E +TG P + V V
Sbjct: 179 QYLSPEQARGDSVDARSDVYSLGCVLYEVLTGE------PPFTGDSPVSVAYQHV----R 228
Query: 415 EEVVDPNLEVKPATRALKRSLLVALRCVDPDSEKRPK-MSQVVRMLE 460
E+ + P+ + + L V L+ + + E R + +++ L
Sbjct: 229 EDPIPPSARHEGLSADLDA---VVLKALAKNPENRYQTAAEMRADLV 272
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 170 bits (431), Expect = 2e-49
Identities = 51/325 (15%), Positives = 127/325 (39%), Gaps = 26/325 (8%)
Query: 187 RFSAENVLGEGGYGVVYKGRLINGSEVAVKKLLNNLGQAEKEFRVEVEAIGHVRHKNLVR 246
++ LG G +G+V++ + + + K + G + + E+ + RH+N++
Sbjct: 6 KYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLVKKEISILNIARHRNILH 65
Query: 247 LLGYCIEGVHRMLVYEYVNNGNLEQWLHGAMRNQGNLTWEARMKVIIGTAKALAYLHEAI 306
L ++++E+++ ++ + ++ + L + + +AL +LH
Sbjct: 66 LHESFESMEELVMIFEFISGLDIFERIN---TSAFELNEREIVSYVHQVCEALQFLH--- 119
Query: 307 EPKVVHRDIKSSNILIDDEFNA--KVSDFGLAKLLDSGESHITTRVMGTFGYVAPEYANT 364
+ H DI+ NI+ ++ K+ +FG A+ L G++ Y APE
Sbjct: 120 SHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRLL--FTAPEYYAPEVHQH 177
Query: 365 GMLNEKSDIYSFGVLLLEAVTGRDPVDYGRPANEVNLVEWLKMMVGTRRAEEVVDPNLEV 424
+++ +D++S G L+ ++G +P ++E + T E + ++E
Sbjct: 178 DVVSTATDMWSLGTLVYVLLSGINPFL---AETNQQIIENIMNAEYTFDEEAFKEISIEA 234
Query: 425 KPATRALKRSLLVALRCVDPDSEKRPKMSQVVR---MLEADDYPFREDRRNRKSRTTSME 481
+ R + + + R S+ ++ + + + + R K R
Sbjct: 235 M--------DFV--DRLLVKERKSRMTASEALQHPWLKQKIERVSTKVIRTLKHRRYYHT 284
Query: 482 IESLKESTEIESKVEDSEGRISEKT 506
+ + + + G I +
Sbjct: 285 LIKKDLNMVVSAARISCGGAIRSQK 309
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 169 bits (430), Expect = 3e-49
Identities = 66/288 (22%), Positives = 116/288 (40%), Gaps = 30/288 (10%)
Query: 175 WFTLRDLEIATNRFSAENVLGEGGYGVVYKGR-LINGSEVAVKKL-LNNLGQAEKEFRVE 232
W D+ + + +VLG G + V VA+K + L E E
Sbjct: 1 WKQAEDIR---DIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENE 57
Query: 233 VEAIGHVRHKNLVRLLGYCIEGVHRMLVYEYVNNGNLEQWLHGAMRNQGNLTWEARMKVI 292
+ + ++H N+V L G H L+ + V+ G L + +G T ++I
Sbjct: 58 IAVLHKIKHPNIVALDDIYESGGHLYLIMQLVSGGELFDRI----VEKGFYTERDASRLI 113
Query: 293 IGTAKALAYLHEAIEPKVVHRDIKSSNILI---DDEFNAKVSDFGLAKLLDSGESHITTR 349
A+ YLH + +VHRD+K N+L D++ +SDFGL+K+ D G + +
Sbjct: 114 FQVLDAVKYLH---DLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPG--SVLST 168
Query: 350 VMGTFGYVAPEYANTGMLNEKSDIYSFGVLLLEAVTGRDPVDYGRPANEVNLVEWLKMMV 409
GT GYVAPE ++ D +S GV+ + G P + N + + ++
Sbjct: 169 ACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGY------PPFYDENDAKLFEQIL 222
Query: 410 GTRRAEEVVDPNLEVKPATRALKRSLLVALRCVDPDSEKRPKMSQVVR 457
+ + + + + ++ D EKR Q ++
Sbjct: 223 -----KAEYEFDSPYWDDISDSAKDFI--RHLMEKDPEKRFTCEQALQ 263
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Score = 170 bits (432), Expect = 5e-49
Identities = 62/277 (22%), Positives = 104/277 (37%), Gaps = 32/277 (11%)
Query: 186 NRFSAENVLGEGGYGVVYKGRLI-NGSEVAVKKL---LNNLGQAEKEFRVEVEAI---GH 238
N FS ++G GG+G VY R G A+K L + Q E E +
Sbjct: 4 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVST 63
Query: 239 VRHKNLVRLLGYCIEGVHRMLVYEYVNNGNLEQWLHGAMRNQGNLTWEARMKVIIGTAKA 298
+V + + + +N G+L L G +
Sbjct: 64 GDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLS----QHGVFSEADMRFYAAEIILG 119
Query: 299 LAYLHEAIEPKVVHRDIKSSNILIDDEFNAKVSDFGLAKLLDSGESHITTRVMGTFGYVA 358
L ++H VV+RD+K +NIL+D+ + ++SD GLA + H + +GT GY+A
Sbjct: 120 LEHMHN---RFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHAS---VGTHGYMA 173
Query: 359 PEYANTGM-LNEKSDIYSFGVLLLEAVTGRDPVDYGRPANEVNLVEWLKMMVGTRRAEEV 417
PE G+ + +D +S G +L + + G P + ++ + + +
Sbjct: 174 PEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDR--MTLTMAVELPDS 231
Query: 418 VDPNLEVKPATRALKRSLLVALRCVDPDSEKRPKMSQ 454
P L RSLL + D +R
Sbjct: 232 FSPEL----------RSLL--EGLLQRDVNRRLGCLG 256
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Score = 166 bits (422), Expect = 2e-48
Identities = 62/286 (21%), Positives = 115/286 (40%), Gaps = 39/286 (13%)
Query: 187 RFSAENVLGEGGYGVVYKGR-LINGSEVAVKKL---------LNNLGQAEKEFRVEVEAI 236
+ + +LG G VV + E AVK + + + + EV+ +
Sbjct: 4 NYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDIL 63
Query: 237 GHVR-HKNLVRLLGYCIEGVHRMLVYEYVNNGNLEQWLHGAMRNQGNLTWEARMKVIIGT 295
V H N+++L LV++ + G L +L + L+ + K++
Sbjct: 64 RKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLT----EKVTLSEKETRKIMRAL 119
Query: 296 AKALAYLHEAIEPKVVHRDIKSSNILIDDEFNAKVSDFGLAKLLDSGESHITTRVMGTFG 355
+ + LH+ +VHRD+K NIL+DD+ N K++DFG + LD GE V GT
Sbjct: 120 LEVICALHKL---NIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEK--LREVCGTPS 174
Query: 356 YVAPEYANTGML------NEKSDIYSFGVLLLEAVTGRDPVDYGRPANEVNLVEWLKMMV 409
Y+APE M ++ D++S GV++ + G P + + + ++
Sbjct: 175 YLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMI------- 227
Query: 410 GTRRAEEVVDPNLEVKPATRALKRSLLVALRCVDPDSEKRPKMSQV 455
+ + E + +K + R + +KR +
Sbjct: 228 ---MSGNYQFGSPEWDDYSDTVKD---LVSRFLVVQPQKRYTAEEA 267
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 166 bits (420), Expect = 5e-48
Identities = 53/306 (17%), Positives = 108/306 (35%), Gaps = 38/306 (12%)
Query: 180 DLEIATNRFSAENVLGEGGYGVVYKGR-LINGSEVAVKKLLNNLGQAEKEFRVEVEAIGH 238
+L + NR+ +G G +G +Y G + G EVA+K + + +E +
Sbjct: 2 ELRVG-NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLE--CVKTKHPQLHIESKIYKM 58
Query: 239 VRHKNLVRLLGYCI-EGVHRMLVYEYVNNGNLEQWLHGAMRNQGNLTWEARMKVIIGTAK 297
++ + + +C EG + ++V E + + + + + + +
Sbjct: 59 MQGGVGIPTIRWCGAEGDYNVMVMELLGPSLEDLF----NFCSRKFSLKTVLLLADQMIS 114
Query: 298 ALAYLHEAIEPKVVHRDIKSSNILI---DDEFNAKVSDFGLAKLLDSGESHI------TT 348
+ Y+H +HRD+K N L+ + DFGLAK +H
Sbjct: 115 RIEYIHSK---NFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENK 171
Query: 349 RVMGTFGYVAPEYANTGMLNEKSDIYSFGVLLLEAVTGRDPVDYGRPANEVNLVEWLKMM 408
+ GT Y + + + D+ S G +L+ G P + A + E +
Sbjct: 172 NLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEK 231
Query: 409 VGTRRAEEVVDPNLEVKPATRALKRSLLVALRCVDPDSEKRPKMSQVVRMLE-------- 460
++ P + + + L C + +P S + ++
Sbjct: 232 -------KMSTPIEVLCKGYPSEFATYL--NFCRSLRFDDKPDYSYLRQLFRNLFHRQGF 282
Query: 461 ADDYPF 466
+ DY F
Sbjct: 283 SYDYVF 288
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Score = 165 bits (418), Expect = 2e-47
Identities = 63/277 (22%), Positives = 107/277 (38%), Gaps = 30/277 (10%)
Query: 186 NRFSAENVLGEGGYGVVYKGRLI-NGSEVAVKKLLNNLGQAEKE---FRVEVEAIGHV-R 240
F +LG+G +G V+ A+K L ++ + + VE +
Sbjct: 2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWE 61
Query: 241 HKNLVRLLGYCIEGVHRMLVYEYVNNGNLEQWLHGAMRNQGNLTWEARMKVIIGTAKALA 300
H L + + V EY+N G+L + ++ L
Sbjct: 62 HPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHI----QSCHKFDLSRATFYAAEIILGLQ 117
Query: 301 YLHEAIEPKVVHRDIKSSNILIDDEFNAKVSDFGLAKLLDSGESHITTRVMGTFGYVAPE 360
+LH +V+RD+K NIL+D + + K++DFG+ K G++ T GT Y+APE
Sbjct: 118 FLHS---KGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNTFC-GTPDYIAPE 173
Query: 361 YANTGMLNEKSDIYSFGVLLLEAVTGRDPVDYGRPANEVNLVEWLKMMVGTRRAEEVVDP 420
N D +SFGVLL E + G+ P +E L ++M ++
Sbjct: 174 ILLGQKYNHSVDWWSFGVLLYEMLIGQSPFH---GQDEEELFHSIRM--DNPFYPRWLEK 228
Query: 421 NLEVKPATRALKRSLLVALRCVDPDSEKRPKMSQVVR 457
+ LL ++ + EKR + +R
Sbjct: 229 EA----------KDLL--VKLFVREPEKRLGVRGDIR 253
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Score = 165 bits (419), Expect = 2e-47
Identities = 70/333 (21%), Positives = 127/333 (38%), Gaps = 34/333 (10%)
Query: 187 RFSAENVLGEGGYGVVYKGRLI-NGSEVAVKKLLNNLGQAEKEFRVEVEAIGHVRHKNLV 245
++ V+G G +GVVY+ +L +G VA+KK+L + ++ E++ + + H N+V
Sbjct: 21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQD----KRFKNRELQIMRKLDHCNIV 76
Query: 246 RLLGYCIEG------VHRMLVYEYVNNGNLEQWLHGAMRNQGNLTWEARMKVIIGTAKAL 299
RL + V+ LV +YV H R + L + ++L
Sbjct: 77 RLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHY-SRAKQTLPVIYVKLYMYQLFRSL 135
Query: 300 AYLHEAIEPKVVHRDIKSSNILID-DEFNAKVSDFGLAKLLDSGESHITTRVMGTFGYVA 358
AY+H + HRDIK N+L+D D K+ DFG AK L GE +++ + +
Sbjct: 136 AYIH---SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSY-ICSRYYRAP 191
Query: 359 PEYANTGMLNEKSDIYSFGVLLLEAVTGRDPVDYGRPANEVNLVEWL-------KMMVGT 411
D++S G +L E + G+ +++ + + ++
Sbjct: 192 ELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMN 251
Query: 412 RRAEEVVDPNLEVKPATRALKRSL---LVAL--RCVDPDSEKRPKMSQVVRMLEADDYPF 466
E P ++ P T+ + +AL R ++ R + + F
Sbjct: 252 PNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACA----HSF-F 306
Query: 467 REDRRNRKSRTTSMEIESLKESTEIESKVEDSE 499
E R + +L T E
Sbjct: 307 DELRDPNVKLPNGRDTPALFNFTTQELSSNPPL 339
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 165 bits (418), Expect = 3e-47
Identities = 70/328 (21%), Positives = 130/328 (39%), Gaps = 29/328 (8%)
Query: 185 TNRFSAENVLGEGGYGVVYKGR-LINGSEVAVKKL-LNNLGQAEKEFRVEVEAIGHVRHK 242
R++ + +GEG YG+V +N VA+KK+ + E++ + RH+
Sbjct: 7 GPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHE 66
Query: 243 NLVRLLGYCIEGVHRMLVYEYVNNGNLEQWLHGAMRNQGNLTWEARMKVIIGTAKALAYL 302
N++ + + Y+ + L+ ++ Q L+ + + + L Y+
Sbjct: 67 NIIGINDIIRAPTIEQMKDVYLVTHLMGADLYKLLKTQH-LSNDHICYFLYQILRGLKYI 125
Query: 303 HEAIEPKVVHRDIKSSNILIDDEFNAKVSDFGLAKLLDSGESHIT--TRVMGTFGYVAPE 360
H A V+HRD+K SN+L++ + K+ DFGLA++ D H T + T Y APE
Sbjct: 126 HSA---NVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPE 182
Query: 361 YANTGML-NEKSDIYSFGVLLLEAVTGRDPVDYGRPANEVNLV----------EWLKMMV 409
+ DI+S G +L E ++ R +++N + + ++
Sbjct: 183 IMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIIN 242
Query: 410 GTRRAEEVVDPNLEVKPATRALKRSLLVAL----RCVDPDSEKRPKMSQVVRM------L 459
R + P+ P R + AL + + + KR ++ Q +
Sbjct: 243 LKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYY 302
Query: 460 EADDYPFREDRRNRKSRTTSMEIESLKE 487
+ D P E + E LKE
Sbjct: 303 DPSDEPIAEAPFKFDMELDDLPKEKLKE 330
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Score = 162 bits (410), Expect = 7e-47
Identities = 56/286 (19%), Positives = 105/286 (36%), Gaps = 21/286 (7%)
Query: 186 NRFSAENVLGEGGYGVVYKGRLINGSEVAVKKLL--NNLGQAEKEFRVEVEAIGHVRHKN 243
++ +GEG YGVVYK + G A+KK+ E+ + ++H N
Sbjct: 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSN 61
Query: 244 LVRLLGYCIEGVHRMLVYEYVNNGNLEQWLHGAMRNQGNLTWEARMKVIIGTAKALAYLH 303
+V+L +LV+E+++ +G L ++ +AY H
Sbjct: 62 IVKLYDVIHTKKRLVLVFEHLDQ----DLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCH 117
Query: 304 EAIEPKVVHRDIKSSNILIDDEFNAKVSDFGLAKLLDSGESHITTRVMGTFGYVAPEYAN 363
+ +V+HRD+K N+LI+ E K++DFGLA+ T ++ +
Sbjct: 118 D---RRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEIVTLWYRAPDVLMG 174
Query: 364 TGMLNEKSDIYSFGVLLLEAVTGRDPVDYGRPANEVNLVEWLKMMVGTRRAEEVVDPNLE 423
+ + DI+S G + E V G A+++ + + ++ V +
Sbjct: 175 SKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKY 234
Query: 424 VKPATRALKRSLLVAL------------RCVDPDSEKRPKMSQVVR 457
T L + + D +R Q +
Sbjct: 235 DPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALE 280
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Score = 162 bits (410), Expect = 1e-46
Identities = 64/294 (21%), Positives = 110/294 (37%), Gaps = 30/294 (10%)
Query: 184 ATNRFSAENVLGEGGYGVVYKGRLI--NGSEVAVKKLLNNLGQAEKEFRVEVEA-----I 236
A ++ +GEG YG V+K R + G VA+K++ G+ E +
Sbjct: 5 ADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHL 64
Query: 237 GHVRHKNLVRLLGYCIEG-----VHRMLVYEYVNNGNLEQWLHGAMRNQGNLTWEARMKV 291
H N+VRL C LV+E+V+ + + E +
Sbjct: 65 ETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDK---VPEPGVPTETIKDM 121
Query: 292 IIGTAKALAYLHEAIEPKVVHRDIKSSNILIDDEFNAKVSDFGLAKLLDSGESHITTRVM 351
+ + L +LH +VVHRD+K NIL+ K++DFGLA++ + T V+
Sbjct: 122 MFQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMAL--TSVV 176
Query: 352 GTFGYVAPEYANTGMLNEKSDIYSFGVLLLEAVTGRDPVDYGRPANEVNLV--------- 402
T Y APE D++S G + E + +++ +
Sbjct: 177 VTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGE 236
Query: 403 -EWLKMMVGTRRAEEVVDPNLEVKPATRALKRSLLVALRCVDPDSEKRPKMSQV 455
+W + + R+A K T + + L+C+ + KR
Sbjct: 237 EDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSA 290
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 161 bits (409), Expect = 3e-46
Identities = 69/283 (24%), Positives = 116/283 (40%), Gaps = 39/283 (13%)
Query: 176 FTLRDLEIATNRFSAENVLGEGGYGVVYKGR-LINGSEVAVKKLLNNLGQAEKE---FRV 231
++L+D +I LG G +G V+ R NG A+K L + K+
Sbjct: 1 YSLQDFQI-------LRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTND 53
Query: 232 EVEAIGHVRHKNLVRLLGYCIEGVHRMLVYEYVNNGNLEQWLHGAMRNQGNLTWEARMKV 291
E + V H ++R+ G + ++ +Y+ G L L + R
Sbjct: 54 ERLMLSIVTHPFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRF----PNPVAKFY 109
Query: 292 IIGTAKALAYLHEAIEPKVVHRDIKSSNILIDDEFNAKVSDFGLAKLLDSGESHITTRVM 351
AL YLH +++RD+K NIL+D + K++DFG AK + +T +
Sbjct: 110 AAEVCLALEYLHS---KDIIYRDLKPENILLDKNGHIKITDFGFAKYVPD----VTYTLC 162
Query: 352 GTFGYVAPEYANTGMLNEKSDIYSFGVLLLEAVTGRDPVDYGRPANEVNLVEWLKMMVGT 411
GT Y+APE +T N+ D +SFG+L+ E + G P Y + + K++
Sbjct: 163 GTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPF-YDSNTMKT----YEKILNAE 217
Query: 412 RRAEEVVDPNLEVKPATRALKRSLLVALRCVDPDSEKRPKMSQ 454
R + ++ + LL R + D +R Q
Sbjct: 218 LRFPPFFNEDV----------KDLL--SRLITRDLSQRLGNLQ 248
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Score = 160 bits (406), Expect = 5e-46
Identities = 64/283 (22%), Positives = 113/283 (39%), Gaps = 33/283 (11%)
Query: 186 NRFSAENVLGEGGYGVVYKGR-LINGSEVAVKKL------LNNLGQAEKEFRVEVEAIGH 238
+ + LG G + VV K R G + A K + + G + ++ EV +
Sbjct: 10 DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKE 69
Query: 239 VRHKNLVRLLGYCIEGVHRMLVYEYVNNGNLEQWLHGAMRNQGNLTWEARMKVIIGTAKA 298
++H N++ L +L+ E V G L + + + +LT E + +
Sbjct: 70 IQHPNVITLHEVYENKTDVILILELVAGGELFDF----LAEKESLTEEEATEFLKQILNG 125
Query: 299 LAYLHEAIEPKVVHRDIKSSNILIDDE----FNAKVSDFGLAKLLDSGESHITTRVMGTF 354
+ YLH ++ H D+K NI++ D K+ DFGLA +D G + GT
Sbjct: 126 VYYLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNE--FKNIFGTP 180
Query: 355 GYVAPEYANTGMLNEKSDIYSFGVLLLEAVTGRDPVDYGRPANEVNLVEWLKMMVGTRRA 414
+VAPE N L ++D++S GV+ ++G P + V +
Sbjct: 181 EFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVN-------- 232
Query: 415 EEVVDPNLEVKPATRALKRSLLVALRCVDPDSEKRPKMSQVVR 457
+ E T AL + + R + D +KR + ++
Sbjct: 233 ---YEFEDEYFSNTSALAKDFI--RRLLVKDPKKRMTIQDSLQ 270
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Score = 158 bits (399), Expect = 5e-45
Identities = 63/285 (22%), Positives = 112/285 (39%), Gaps = 26/285 (9%)
Query: 192 NVLGEGGYGVVYKGRLIN-GSEVAVKKL-----LNNLGQAEKEFRVEVEAIGHVRHKNLV 245
+ LGEG + VYK R N VA+KK+ + E++ + + H N++
Sbjct: 4 DFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNII 63
Query: 246 RLLGYCIEGVHRMLVYEYVNNGNLEQWLHGAMRNQGNLTWEARMKVIIGTAKALAYLHEA 305
LL + LV++++ N LT ++ T + L YLH+
Sbjct: 64 GLLDAFGHKSNISLVFDFMETDLEVII----KDNSLVLTPSHIKAYMLMTLQGLEYLHQ- 118
Query: 306 IEPKVVHRDIKSSNILIDDEFNAKVSDFGLAKLLDSGESHITTRVMGTFGYVAPEYANTG 365
++HRD+K +N+L+D+ K++DFGLAK S T +V T Y APE
Sbjct: 119 --HWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYTHQV-VTRWYRAPELLFGA 175
Query: 366 ML-NEKSDIYSFGVLLLEAVTGRDPVDYGRPANEVNLV----------EWLKMMVGTRRA 414
+ D+++ G +L E + + +++ + +W M
Sbjct: 176 RMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYV 235
Query: 415 EEVVDPNLEVKPATRALKRSLL-VALRCVDPDSEKRPKMSQVVRM 458
P + + A LL + + R +Q ++M
Sbjct: 236 TFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKM 280
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 157 bits (397), Expect = 9e-45
Identities = 65/286 (22%), Positives = 101/286 (35%), Gaps = 25/286 (8%)
Query: 187 RFSAENVLGEGGYGVVYKGR-LINGSEVAVKKLLNNL--GQAEKEFRVEVEAIGHVRHKN 243
F +GEG YGVVYK R + G VA+KK+ + E+ + + H N
Sbjct: 3 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPN 62
Query: 244 LVRLLGYCIEGVHRMLVYEYVNNGNLEQWLHGAMRNQGNLTWEARMKVIIGTAKALAYLH 303
+V+LL LV+E+++ + + + + LA+ H
Sbjct: 63 IVKLLDVIHTENKLYLVFEFLHQDLKKFMDA---SALTGIPLPLIKSYLFQLLQGLAFCH 119
Query: 304 EAIEPKVVHRDIKSSNILIDDEFNAKVSDFGLAKLLDSGESHITTRVMGTFGYVAPEYAN 363
+V+HRD+K N+LI+ E K++DFGLA+ T V+ +
Sbjct: 120 S---HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLG 176
Query: 364 TGMLNEKSDIYSFGVLLLEAVTGRDPVD--------------YGRPANEVNLVEWLKMMV 409
+ DI+S G + E VT R G P V
Sbjct: 177 CKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDY 236
Query: 410 GTRRAEEVVDPNLEVKPATRALKRSLLVALRCVDPDSEKRPKMSQV 455
+ +V P RSLL + + D KR
Sbjct: 237 KPSFPKWARQDFSKVVPPLDEDGRSLL--SQMLHYDPNKRISAKAA 280
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 154 bits (390), Expect = 7e-44
Identities = 45/302 (14%), Positives = 93/302 (30%), Gaps = 39/302 (12%)
Query: 186 NRFSAENVLGEGGYGVVYKGR-LINGSEVAVKKLLNNLGQAEKEFRVEVEAIGHVRH-KN 243
+ +GEG +GV+++G L+N +VA+K + R E +
Sbjct: 5 VHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFE--PRRSDAPQLRDEYRTYKLLAGCTG 62
Query: 244 LVRLLGYCIEGVHRMLVYEYVNNGNLEQWLHGAMRNQGNLTWEARMKVIIGTAKALAYLH 303
+ + + EG+H +LV + + + + + + +H
Sbjct: 63 IPNVYYFGQEGLHNVLVIDLLGPSLEDLLD----LCGRKFSVKTVAMAAKQMLARVQSIH 118
Query: 304 EAIEPKVVHRDIKSSNILIDDEFN-----AKVSDFGLAKLLDSGESHI------TTRVMG 352
E +V+RDIK N LI + V DFG+ K + + G
Sbjct: 119 EK---SLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSG 175
Query: 353 TFGYVAPEYANTGMLNEKSDIYSFGVLLLEAVTGRDPVDYGRPANEVNLVEWLKMMVGTR 412
T Y++ + + D+ + G + + + G P + A E +
Sbjct: 176 TARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEK---- 231
Query: 413 RAEEVVDPNLEVKPATRALKRSLLVALRCVDPDSEKRPKMSQVVRMLEA--------DDY 464
++ + + + P + + +D
Sbjct: 232 --KQSTPLRELCAGFPEEFYK---YMHYARNLAFDATPDYDYLQGLFSKVLERLNTTEDE 286
Query: 465 PF 466
F
Sbjct: 287 NF 288
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Score = 154 bits (389), Expect = 9e-44
Identities = 56/292 (19%), Positives = 109/292 (37%), Gaps = 31/292 (10%)
Query: 186 NRFSAENVLGEGGYGVVYKGRLI-NGSEVAVKKLL--NNLGQAEKEFRVEVEAIGHVRHK 242
++ +GEG YG V+K + VA+K++ ++ E+ + ++HK
Sbjct: 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHK 61
Query: 243 NLVRLLGYCIEGVHRMLVYEYVNNGNLEQWLHGAMRNQGNLTWEARMKVIIGTAKALAYL 302
N+VRL LV+E+ + G+L E + K L +
Sbjct: 62 NIVRLHDVLHSDKKLTLVFEFCDQ----DLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFC 117
Query: 303 HEAIEPKVVHRDIKSSNILIDDEFNAKVSDFGLAKLLDSGESHITTRVMGTFGYVAPEYA 362
H V+HRD+K N+LI+ K+++FGLA+ + V+ +
Sbjct: 118 HS---RNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSAEVVTLWYRPPDVLF 174
Query: 363 NTGMLNEKSDIYSFGVLLLEAVTGRDPVDYGRPANEVNLVEWLKMMVGTRRAEEVVD--- 419
+ + D++S G + E P+ G + + ++ + ++GT E+
Sbjct: 175 GAKLYSTSIDMWSAGCIFAELANAGRPLFPGN--DVDDQLKRIFRLLGTPTEEQWPSMTK 232
Query: 420 --------------PNLEVKPATRALKRSLLVALRCVDPDSEKRPKMSQVVR 457
+ V P A R LL + + +R + ++
Sbjct: 233 LPDYKPYPMYPATTSLVNVVPKLNATGRDLL--QNLLKCNPVQRISAEEALQ 282
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 155 bits (393), Expect = 1e-43
Identities = 63/328 (19%), Positives = 124/328 (37%), Gaps = 34/328 (10%)
Query: 191 ENVLGEGGYGVVYKGR-LINGSEVAVKKLLNNLGQAEKEFRVEVEAIGHVRHKNLVRLLG 249
VLG G G V + + A+K L + +A +E + A + ++VR++
Sbjct: 17 SQVLGLGINGKVLQIFNKRTQEKFALKM-LQDCPKARREVELHWRAS---QCPHIVRIVD 72
Query: 250 YC----IEGVHRMLVYEYVNNGNLEQWLHGAMRNQGNLTWEARMKVIIGTAKALAYLHEA 305
++V E ++ G L + R T +++ +A+ YLH
Sbjct: 73 VYENLYAGRKCLLIVMECLDGGELFSRIQD--RGDQAFTEREASEIMKSIGEAIQYLHSI 130
Query: 306 IEPKVVHRDIKSSNILIDDEFN---AKVSDFGLAKLLDSGESHITTRVMGTFGYVAPEYA 362
+ HRD+K N+L + K++DFG AK S S T T YVAPE
Sbjct: 131 ---NIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTT--PCYTPYYVAPEVL 185
Query: 363 NTGMLNEKSDIYSFGVLLLEAVTGRDPVDYGRPANEVNLVEWLKMMVGTRRAEEVVDPNL 422
++ D++S GV++ + G P + + M R + PN
Sbjct: 186 GPEKYDKSCDMWSLGVIMYILLCGY------PPFYSNHGLAISPGMKTRIRMGQYEFPNP 239
Query: 423 EVKPATRALKRSLLVALRCVDPDSEKRPKMSQV------VRMLEADDYPFREDRRNRKSR 476
E + +K + + + +R +++ ++ + P R ++ +
Sbjct: 240 EWSEVSEEVKM---LIRNLLKTEPTQRMTITEFMNHPWIMQSTKVPQTPLHTSRVLKEDK 296
Query: 477 TTSMEIESLKESTEIESKVEDSEGRISE 504
+++ S +V+ + +I +
Sbjct: 297 ERWEDVKEEMTSALATMRVDYEQIKIKK 324
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 151 bits (381), Expect = 9e-43
Identities = 61/283 (21%), Positives = 104/283 (36%), Gaps = 43/283 (15%)
Query: 186 NRFSAENVLGEGGYGVVYKGR-LINGSEVAVKKLLNNLGQAEKE------FRVEVEAIGH 238
+++ +LG GG+G VY G + + VA+K + + E +EV +
Sbjct: 4 SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKK 63
Query: 239 VR--HKNLVRLLGYCIEGVHRMLVYEYVNNGNLEQWLHGAMRNQGNLTWEARMKVIIGTA 296
V ++RLL + +L+ E + +G L E
Sbjct: 64 VSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDF---ITERGALQEELARSFFWQVL 120
Query: 297 KALAYLHEAIEPKVVHRDIKSSNILID-DEFNAKVSDFGLAKLLDSGESHITTRVMGTFG 355
+A+ + H V+HRDIK NILID + K+ DFG LL + T GT
Sbjct: 121 EAVRHCHNC---GVLHRDIKDENILIDLNRGELKLIDFGSGALLK---DTVYTDFDGTRV 174
Query: 356 YVAPEYANTGML-NEKSDIYSFGVLLLEAVTGRDPVDYGRPANEVNLVEWLKMMVGTRRA 414
Y PE+ + ++S G+LL + V G P +
Sbjct: 175 YSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFE---------------------HD 213
Query: 415 EEVVDPNLEVKPATRALKRSLLVALRCVDPDSEKRPKMSQVVR 457
EE++ + + + + L+ C+ RP ++
Sbjct: 214 EEIIRGQVFFRQRVSSECQHLI--RWCLALRPSDRPTFEEIQN 254
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Score = 147 bits (372), Expect = 1e-40
Identities = 63/329 (19%), Positives = 121/329 (36%), Gaps = 28/329 (8%)
Query: 186 NRFSAENVLGEGGYGVVYKGR-LINGSEVAVKKLLNNL--GQAEKEFRVEVEAIGHVRHK 242
+ +G G YG V G++VA+KKL K E+ + H+RH+
Sbjct: 18 AVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHE 77
Query: 243 NLVRLLGYCIEGVHRMLVYEYVNNGNLEQWLHGAMRNQGNLTWEARMKVIIGTAKALAYL 302
N++ LL ++ G + L + ++ K L Y+
Sbjct: 78 NVIGLLDVFTPDETLDDFTDFYLVMPFMGTDLGKLMKHEKLGEDRIQFLVYQMLKGLRYI 137
Query: 303 HEAIEPKVVHRDIKSSNILIDDEFNAKVSDFGLAKLLDSGESHITTRVMGTFGYVAPEYA 362
H ++HRD+K N+ ++++ K+ DFGLA+ D S +T V+ +
Sbjct: 138 H---AAGIIHRDLKPGNLAVNEDCELKILDFGLARQAD---SEMTGYVVTRWYRAPEVIL 191
Query: 363 NTGMLNEKSDIYSFGVLLLEAVTGRDPVDYGRPANEVNLV----------EWLKMMVGTR 412
N + DI+S G ++ E +TG+ +++ + ++
Sbjct: 192 NWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQSDEA 251
Query: 413 RAEEVVDPNLEVKPATRALKRSLLVAL----RCVDPDSEKRPKMSQVVRMLEADDYPFRE 468
+ P LE K L + +A+ + + D+E+R + + + E
Sbjct: 252 KNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESLHDTE 311
Query: 469 DRRNRKSRTTSME-----IESLKESTEIE 492
D + S + ++ K T E
Sbjct: 312 DEPQVQKYDDSFDDVDRTLDEWKRVTYKE 340
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Score = 146 bits (368), Expect = 2e-40
Identities = 60/300 (20%), Positives = 116/300 (38%), Gaps = 37/300 (12%)
Query: 186 NRFSAENVLGEGGYGVVYKGR-LINGSEVAVKKLL--NNLGQAEKEFRVEVEAIGHVRHK 242
+++ +G+G +G V+K R G +VA+KK+L N E++ + ++H+
Sbjct: 10 SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHE 69
Query: 243 NLVRLLGYCIEGVHRM--------LVYEYVNNGNLEQWLHGAMRNQGNLTWEARMKVIIG 294
N+V L+ C LV+++ + + T +V+
Sbjct: 70 NVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSN----VLVKFTLSEIKRVMQM 125
Query: 295 TAKALAYLHEAIEPKVVHRDIKSSNILIDDEFNAKVSDFGLAKLLDSGES---HITTRVM 351
L Y+H K++HRD+K++N+LI + K++DFGLA+ ++ + T +
Sbjct: 126 LLNGLYYIHR---NKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRV 182
Query: 352 GTFGYVAPEYANTGML-NEKSDIYSFGVLLLEAVTGRDPVDYGRPANEVNLVEWLKMMVG 410
T Y PE D++ G ++ E T + +++ L+ L +
Sbjct: 183 VTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSIT 242
Query: 411 TRRAEEVVDPNLE-----VKPATRALKRSLLVAL----------RCVDPDSEKRPKMSQV 455
V + L VK R +K L + + + D +R
Sbjct: 243 PEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDA 302
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 144 bits (365), Expect = 1e-39
Identities = 65/277 (23%), Positives = 104/277 (37%), Gaps = 31/277 (11%)
Query: 183 IATNRFSAENVLGEGGYGVVYKGR-LINGSEVAVKKLLNNLGQAEKE---FRVEVEAIGH 238
+ N F +LG+G +G V R G A+K L + A+ E E + +
Sbjct: 2 VTMNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQN 61
Query: 239 VRHKNLVRLLGYCIEGVHRMLVYEYVNNGNLEQWLHGAMRNQGNLTWEARMKVIIGTAKA 298
RH L L V EY N G L L + + E R + A+
Sbjct: 62 TRHPFLTALKYAFQTHDRLCFVMEYANGGELFFHLS-----RERVFTEERARFYG--AEI 114
Query: 299 LAYLHEAIEPKVVHRDIKSSNILIDDEFNAKVSDFGLAKLLDSGESHITTRVMGTFGYVA 358
++ L VV+RDIK N+++D + + K++DFGL K S + GT Y+A
Sbjct: 115 VSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGAT-MKTFCGTPEYLA 173
Query: 359 PEYANTGMLNEKSDIYSFGVLLLEAVTGRDPVDYGRPANEVNLVEWLKMMVGTR-RAEEV 417
PE D + GV++ E + GR P + ++++ R
Sbjct: 174 PEVLEDNDYGRAVDWWGLGVVMYEMMCGR------LPFYNQDHERLFELILMEEIRFPRT 227
Query: 418 VDPNLEVKPATRALKRSLLVALRCVDPDSEKRPKMSQ 454
+ P +SLL + D ++R
Sbjct: 228 LSPEA----------KSLL--AGLLKKDPKQRLGGGP 252
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Score = 136 bits (342), Expect = 2e-36
Identities = 53/208 (25%), Positives = 83/208 (39%), Gaps = 15/208 (7%)
Query: 186 NRFSAENVLGEGGYGVVYKGR-LINGSEVAVKKLLNNLGQAEKE---FRVEVEAIGHVRH 241
++F LG G +G V + +G+ A+K L K+ E + V
Sbjct: 41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 242 KNLVRLLGYCIEGVHRMLVYEYVNNGNLEQWLHGAMRNQGNLTWEARMKVIIGTAKALAY 301
LV+L + + +V EYV G + L G + Y
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLR----RIGRFSEPHARFYAAQIVLTFEY 156
Query: 302 LHEAIEPKVVHRDIKSSNILIDDEFNAKVSDFGLAKLLDSGESHITTRVMGTFGYVAPEY 361
LH +++RD+K N+LID + +V+DFG AK T + GT +APE
Sbjct: 157 LHSL---DLIYRDLKPENLLIDQQGYIQVTDFGFAKR----VKGRTWTLCGTPEALAPEI 209
Query: 362 ANTGMLNEKSDIYSFGVLLLEAVTGRDP 389
+ N+ D ++ GVL+ E G P
Sbjct: 210 ILSKGYNKAVDWWALGVLIYEMAAGYPP 237
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 134 bits (337), Expect = 5e-36
Identities = 70/283 (24%), Positives = 110/283 (38%), Gaps = 31/283 (10%)
Query: 183 IATNRFSAENVLGEGGYGVVYKGRLI----NGSEVAVKKL----LNNLGQAEKEFRVEVE 234
+ F VLG G YG V+ R I G A+K L + + + R E +
Sbjct: 21 VGIENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQ 80
Query: 235 AIGHVRHK-NLVRLLGYCIEGVHRMLVYEYVNNGNLEQWLHGAMRNQGNLTWEARMKVII 293
+ H+R LV L L+ +Y+N G L L R T +
Sbjct: 81 VLEHIRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQRER----FTEHEVQIYVG 136
Query: 294 GTAKALAYLHEAIEPKVVHRDIKSSNILIDDEFNAKVSDFGLAKLLDSGESHITTRVMGT 353
AL +LH+ +++RDIK NIL+D + ++DFGL+K + E+ GT
Sbjct: 137 EIVLALEHLHK---LGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYDFCGT 193
Query: 354 FGYVAPEYANTGM--LNEKSDIYSFGVLLLEAVTGRDPVDYGRPANEVNLVEWLKMMVGT 411
Y+AP+ G ++ D +S GVL+ E +TG P N +
Sbjct: 194 IEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEI--------- 244
Query: 412 RRAEEVVDPNLEVKPATRALKRSLLVALRCVDPDSEKRPKMSQ 454
+ ++ AL + L+ R + D +KR
Sbjct: 245 --SRRILKSEPPYPQEMSALAKDLI--QRLLMKDPKKRLGCGP 283
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Score = 134 bits (337), Expect = 6e-36
Identities = 64/288 (22%), Positives = 122/288 (42%), Gaps = 27/288 (9%)
Query: 186 NRFSAENVLGEGGYGVVYKGR-LINGSEVAVKKLLNNLGQAEKEFRVEVEAIGHVR-HKN 243
+ + LG G Y V++ + N +V VK L +K+ + E++ + ++R N
Sbjct: 35 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKP---VKKKKIKREIKILENLRGGPN 91
Query: 244 LVRLLGYCIEGVHRM--LVYEYVNNGNLEQWLHGAMRNQGNLTWEARMKVIIGTAKALAY 301
++ L + V R LV+E+VNN + +Q LT + KAL Y
Sbjct: 92 IITLADIVKDPVSRTPALVFEHVNNTDFKQLYQ-------TLTDYDIRFYMYEILKALDY 144
Query: 302 LHEAIEPKVVHRDIKSSNILIDDEFN-AKVSDFGLAKLLDSGESHITTRVMGTFGYVAPE 360
H ++HRD+K N++ID E ++ D+GLA+ G+ + + + + PE
Sbjct: 145 CHSM---GIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEY--NVRVASRYFKGPE 199
Query: 361 -YANTGMLNEKSDIYSFGVLLLEAVTGRDPVDYGRPANEVNLVEWLKMMVGTRRAEEVVD 419
+ M + D++S G +L + ++P +G + LV K++ + +
Sbjct: 200 LLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQ-LVRIAKVLGTEDLYDYIDK 258
Query: 420 PNLEVKPATRALKRSLLVALRCVDPDSEKRPKMSQ-----VVRMLEAD 462
N+E+ P + SE + +S + ++L D
Sbjct: 259 YNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYD 306
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Score = 130 bits (326), Expect = 3e-34
Identities = 64/290 (22%), Positives = 110/290 (37%), Gaps = 27/290 (9%)
Query: 185 TNRFSAENVLGEGGYGVVYKGR-LINGSEVAVKKLLNNLGQAE--KEFRVEVEAIGHVRH 241
R+ + +G G YG V G VAVKKL K E+ + H++H
Sbjct: 17 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKH 76
Query: 242 KNLVRLLGYCIEGVHRMLVYEYVNNGNLEQWLHGAMRNQGNLTWEARMKVIIGTAKALAY 301
+N++ LL + +L + LT + +I + L Y
Sbjct: 77 ENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKY 136
Query: 302 LHEAIEPKVVHRDIKSSNILIDDEFNAKVSDFGLAKLLDSGESHITTRVMGTFGYVAPEY 361
+H ++HRD+K SN+ ++++ K+ DFGLA+ D +T V +
Sbjct: 137 IH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTD---DEMTGYVATRWYRAPEIM 190
Query: 362 ANTGMLNEKSDIYSFGVLLLEAVTGRDPVDYGRPANEVNLVEWLKMMVGTRRAEEVVDPN 421
N N+ DI+S G ++ E +TGR +++ L+ L G +++ +
Sbjct: 191 LNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSES 250
Query: 422 L----------------EVKPATRALKRSLLVALRCVDPDSEKRPKMSQV 455
V L LL + + DS+KR +Q
Sbjct: 251 ARNYIQSLTQMPKMNFANVFIGANPLAVDLL--EKMLVLDSDKRITAAQA 298
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Score = 127 bits (319), Expect = 3e-33
Identities = 69/339 (20%), Positives = 120/339 (35%), Gaps = 46/339 (13%)
Query: 186 NRFSAENVLGEGGYGVVYKGR-LINGSEVAVKKLLNNL--GQAEKEFRVEVEAIGHVRHK 242
R+ +G G G+V + VA+KKL K E+ + V HK
Sbjct: 17 KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHK 76
Query: 243 NLVRLLGYCI------EGVHRMLVYEYVNNGNLEQWLHGAMRNQGNLTWEARMKVIIGTA 296
N++ LL E LV E ++ + Q L E ++
Sbjct: 77 NIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVI-------QMELDHERMSYLLYQML 129
Query: 297 KALAYLHEAIEPKVVHRDIKSSNILIDDEFNAKVSDFGLAKLLDSGESHITTRVMGTFGY 356
+ +LH ++HRD+K SNI++ + K+ DFGLA+ +G S + T + T Y
Sbjct: 130 CGIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLART--AGTSFMMTPYVVTRYY 184
Query: 357 VAPEYANTGMLNEKSDIYSFGVLLLEAVTGRDPVDYGRPANEVNLV---------EWLKM 407
APE E DI+S G ++ E V + ++ N V E++K
Sbjct: 185 RAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKK 244
Query: 408 MVGTRRAEEVVDPNLEVKPATRALKRSLLVAL----------------RCVDPDSEKRPK 451
+ T R P + SL A + + D KR
Sbjct: 245 LQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRIS 304
Query: 452 MSQVVRMLEADDYPFREDRRNRKSRTTSMEIESLKESTE 490
+ ++ + + + + +++ + + E
Sbjct: 305 VDDALQHPYINVWYDPAEVEAPPPQIYDKQLDEREHTIE 343
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 118 bits (296), Expect = 4e-30
Identities = 41/239 (17%), Positives = 86/239 (35%), Gaps = 18/239 (7%)
Query: 186 NRFSAENVLGEGGYGVVYKGR-LINGSEVAVKKLLNNLGQAEKEFRVEVEAIGHVRHKNL 244
R+ LG G + V+ + ++N + VA+K + + E E++ + V +
Sbjct: 13 ARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTE-AAEDEIKLLQRVNDADN 71
Query: 245 VRLLGYCIEGVHRMLVYEYVNNGNL-----------EQWLHGAMRNQGNLTWEARMKVII 293
+ + ++L + N E L + + +K I
Sbjct: 72 TKEDSMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQIS 131
Query: 294 GT-AKALAYLHEAIEPKVVHRDIKSSNILID-DEFNAKVSDFGLAKLLDSGESHIT-TRV 350
L Y+H ++H DIK N+L++ + + +A L ++ T
Sbjct: 132 KQLLLGLDYMH--RRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTNS 189
Query: 351 MGTFGYVAPEYANTGMLNEKSDIYSFGVLLLEAVTGRDPVDYGRPANEVNLVEWLKMMV 409
+ T Y +PE +DI+S L+ E +TG + + + + ++
Sbjct: 190 IQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQII 248
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Score = 88.7 bits (219), Expect = 5e-21
Identities = 25/159 (15%), Positives = 49/159 (30%), Gaps = 21/159 (13%)
Query: 192 NVLGEGGYGVVYKGRLINGSEVAVKKLLNNL----------GQAEKEFRVEVEAIGHVRH 241
++GEG V+ E VK + F V
Sbjct: 6 KLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEF 65
Query: 242 KNLVRLLGYCIEGVHRMLVYEYVNNGNLEQWLHGAMRNQGNLTWEARMKVIIGTAKALAY 301
+ L +L G + VY + N L + + + + V+ + +A
Sbjct: 66 RALQKLQGLAV-----PKVYAWEGNAVLMELIDAKELYRVRVENPDE--VLDMILEEVAK 118
Query: 302 LHEAIEPKVVHRDIKSSNILIDDEFNAKVSDFGLAKLLD 340
+ +VH D+ N+L+ + + DF + +
Sbjct: 119 FY---HRGIVHGDLSQYNVLVSE-EGIWIIDFPQSVEVG 153
|
Homologous Domains Detected by HHsearch
Original result of HHsearch against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 508 | |||
| d1sm2a_ | 263 | Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie | 100.0 | |
| d1yhwa1 | 293 | pak1 {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1qpca_ | 272 | Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax | 100.0 | |
| d2j4za1 | 263 | Aurora-related kinase 1 (aurora-2) {Human (Homo sa | 100.0 | |
| d1uwha_ | 276 | B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1nvra_ | 271 | Cell cycle checkpoint kinase chk1 {Human (Homo sap | 100.0 | |
| d1opja_ | 287 | Abelsone tyrosine kinase (abl) {Mouse (Mus musculu | 100.0 | |
| d1k2pa_ | 258 | Bruton's tyrosine kinase (Btk) {Human (Homo sapien | 100.0 | |
| d2java1 | 269 | Serine/threonine-protein kinase Nek2 {Human (Homo | 100.0 | |
| d2jfla1 | 288 | STE20-like serine/threonine-protein kinase, SLK {H | 100.0 | |
| d1jpaa_ | 299 | ephb2 receptor tyrosine kinase {Mouse (Mus musculu | 100.0 | |
| d1s9ja_ | 322 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| d1uu3a_ | 288 | 3-phosphoinositide dependent protein kinase-1 Pdk1 | 100.0 | |
| d1t4ha_ | 270 | Protein kinase wnk1 {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1fmka3 | 285 | c-src tyrosine kinase {Human (Homo sapiens) [TaxId | 100.0 | |
| d1rjba_ | 325 | Fl cytokine receptor {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1u59a_ | 285 | Tyrosine-protein kinase ZAP-70 {Human (Homo sapien | 100.0 | |
| d1mqba_ | 283 | epha2 receptor tyrosine kinase {Human (Homo sapien | 100.0 | |
| d1koaa2 | 350 | Twitchin, kinase domain {Caenorhabditis elegans, p | 100.0 | |
| d1a06a_ | 307 | Calmodulin-dependent protein kinase {Rat (Rattus n | 100.0 | |
| d1u5ra_ | 309 | Serine/threonine protein kinase TAO2 {Rat (Rattus | 100.0 | |
| d1mp8a_ | 273 | Focal adhesion kinase 1 (fak) {Human (Homo sapiens | 100.0 | |
| d1xbba_ | 277 | Tyrosine-protein kinase SYK {Human (Homo sapiens) | 100.0 | |
| d1koba_ | 352 | Twitchin, kinase domain {California sea hare (Aply | 100.0 | |
| d1jksa_ | 293 | Death-associated protein kinase, Dap {Human (Homo | 100.0 | |
| d1o6la_ | 337 | Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9 | 100.0 | |
| d1byga_ | 262 | Carboxyl-terminal src kinase (csk) {Human (Homo sa | 100.0 | |
| d1fota_ | 316 | cAMP-dependent PK, catalytic subunit {Baker's yeas | 100.0 | |
| d1lufa_ | 301 | Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1omwa3 | 364 | G-protein coupled receptor kinase 2 {Cow (Bos taur | 100.0 | |
| d1xkka_ | 317 | EGF receptor tyrosine kinase, Erbb-1 {Human (Homo | 100.0 | |
| d1rdqe_ | 350 | cAMP-dependent PK, catalytic subunit {Mouse (Mus m | 100.0 | |
| d1ywna1 | 299 | Vascular endothelial growth factor receptor 2 (kdr | 100.0 | |
| d1phka_ | 277 | gamma-subunit of glycogen phosphorylase kinase (Ph | 100.0 | |
| d1p4oa_ | 308 | Insulin-like growth factor 1 receptor {Human (Homo | 100.0 | |
| d1tkia_ | 321 | Titin, kinase domain {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1o6ya_ | 277 | Mycobacterial protein kinase PknB, catalytic domai | 100.0 | |
| d1u46a_ | 273 | Activated CDC42 kinase 1, ACK1 {Human (Homo sapien | 100.0 | |
| d2ozaa1 | 335 | MAP kinase activated protein kinase 2, mapkap2 {Hu | 100.0 | |
| d1xjda_ | 320 | Protein kinase C, theta type {Human (Homo sapiens) | 100.0 | |
| d1fvra_ | 309 | Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1fgka_ | 299 | Fibroblast growth factor receptor 1 {Human (Homo s | 100.0 | |
| d1r0pa_ | 311 | Hepatocyte growth factor receptor, c-MET {Human (H | 100.0 | |
| d1t46a_ | 311 | c-KIT receptor {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1vjya_ | 303 | Type I TGF-beta receptor R4 {Human (Homo sapiens) | 100.0 | |
| d1ua2a_ | 299 | Cell division protein kinase 7, CDK7 {Human (Homo | 100.0 | |
| d1gz8a_ | 298 | Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T | 100.0 | |
| d1ob3a_ | 286 | Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) | 100.0 | |
| d1xwsa_ | 273 | Proto-oncogene serine/threonine-protein kinase Pim | 100.0 | |
| d1blxa_ | 305 | Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T | 100.0 | |
| d3blha1 | 318 | Cell division protein kinase 9, CDK9 {Human (Homo | 100.0 | |
| d1q5ka_ | 350 | Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho | 100.0 | |
| d1pmea_ | 345 | MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606 | 100.0 | |
| d1unla_ | 292 | Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T | 100.0 | |
| d1ckia_ | 299 | Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1vzoa_ | 322 | Ribosomal protein S6 kinase alpha 5, Msk1 {Human ( | 100.0 | |
| d1csna_ | 293 | Casein kinase-1, CK1 {Fission yeast (Schizosacchar | 100.0 | |
| d1cm8a_ | 346 | MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: | 100.0 | |
| d3bqca1 | 328 | Protein kinase CK2, alpha subunit {Rattus norvegic | 100.0 | |
| d2b1pa1 | 355 | c-jun N-terminal kinase (jnk3s) {Human (Homo sapie | 100.0 | |
| d2gfsa1 | 348 | MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1q8ya_ | 362 | Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T | 100.0 | |
| d1zara2 | 191 | Rio2 serine protein kinase C-terminal domain {Arch | 99.89 | |
| d1j7la_ | 263 | Type IIIa 3',5"-aminoglycoside phosphotransferase | 98.56 | |
| d1nd4a_ | 255 | Aminoglycoside 3'-phosphotransferase IIa (Kanamyci | 97.81 | |
| d2pula1 | 392 | Methylthioribose kinase MtnK {Bacillus subtilis [T | 97.46 | |
| d1zyla1 | 325 | RdoA {Escherichia coli [TaxId: 562]} | 96.84 | |
| d1nw1a_ | 395 | Choline kinase {Caenorhabditis elegans [TaxId: 623 | 95.83 | |
| d2ppqa1 | 316 | Homoserine kinase ThrB {Agrobacterium tumefaciens | 95.42 |
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.6e-54 Score=415.60 Aligned_cols=256 Identities=27% Similarity=0.448 Sum_probs=199.5
Q ss_pred hCCcccceeEeeeCceEEEEEEEcCCCEEEEEEEcccchhhHHHHHHHHHHHhcCCCCCceeEEEEEEeCceeeEEEeec
Q 010519 185 TNRFSAENVLGEGGYGVVYKGRLINGSEVAVKKLLNNLGQAEKEFRVEVEAIGHVRHKNLVRLLGYCIEGVHRMLVYEYV 264 (508)
Q Consensus 185 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~ei~~l~~l~h~niv~~~~~~~~~~~~~lv~E~~ 264 (508)
.++|++.+.||+|+||+||+|++.+++.||||++.... ...++|.+|++++++++|||||+++|+|.+.+..++||||+
T Consensus 4 p~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~-~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~lv~E~~ 82 (263)
T d1sm2a_ 4 PSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGA-MSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFM 82 (263)
T ss_dssp CSCEEEEEEEECCSSCCEEEEEETTTEEEEEEECCSSS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECC
T ss_pred hHHcEEEEEEeeCCCeEEEEEEECCCCEEEEEEECCCc-CcHHHHHHHHHHHHhcCCCCcccccceeccCCceEEEEEec
Confidence 35899999999999999999999888899999986543 33567899999999999999999999999999999999999
Q ss_pred CCCCHHHHHhhhhccCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCEEEcCCCcEEEEecCCccccCCCCC
Q 010519 265 NNGNLEQWLHGAMRNQGNLTWEARMKVIIGTAKALAYLHEAIEPKVVHRDIKSSNILIDDEFNAKVSDFGLAKLLDSGES 344 (508)
Q Consensus 265 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~ 344 (508)
++|+|.+++. .....+++..++.++.||+.||.|||++ +|+||||||+|||+++++.+||+|||+++.......
T Consensus 83 ~~g~L~~~l~---~~~~~~~~~~~~~i~~qia~gl~~lH~~---~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~ 156 (263)
T d1sm2a_ 83 EHGCLSDYLR---TQRGLFAAETLLGMCLDVCEGMAYLEEA---CVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQY 156 (263)
T ss_dssp TTCBHHHHHH---TTTTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCTTCSGGGEEECGGGCEEECSCC----------
T ss_pred CCCcHHHHhh---ccccCCCHHHHHHHHHHHHHHHHhhhcc---ceeecccchhheeecCCCCeEecccchheeccCCCc
Confidence 9999999986 3456789999999999999999999999 999999999999999999999999999987765444
Q ss_pred cccccccccccccCccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCCCchhcHHHHHHHHhcccccccccCCCCCC
Q 010519 345 HITTRVMGTFGYVAPEYANTGMLNEKSDIYSFGVLLLEAVTGRDPVDYGRPANEVNLVEWLKMMVGTRRAEEVVDPNLEV 424 (508)
Q Consensus 345 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 424 (508)
.......||+.|+|||++.+..|+.++|||||||+||||+|+..|+..... . .+.......... ...+
T Consensus 157 ~~~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvil~el~t~~~~~~~~~~--~---~~~~~~i~~~~~---~~~p---- 224 (263)
T d1sm2a_ 157 TSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRS--N---SEVVEDISTGFR---LYKP---- 224 (263)
T ss_dssp --------CTTSCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSCC--H---HHHHHHHHHTCC---CCCC----
T ss_pred eeecceecCcccCChHHhcCCCCCchhhhcchHHHHHHHHHCCCCCCCCCC--H---HHHHHHHHhcCC---CCCc----
Confidence 444456789999999999999999999999999999999996544432221 1 122222211111 1111
Q ss_pred ChhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhhcC
Q 010519 425 KPATRALKRSLLVALRCVDPDSEKRPKMSQVVRMLEAD 462 (508)
Q Consensus 425 ~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~ 462 (508)
......+.+|+.+||+.||.+|||++||+++|+..
T Consensus 225 ---~~~~~~l~~li~~cl~~~p~~Rps~~~il~~L~~i 259 (263)
T d1sm2a_ 225 ---RLASTHVYQIMNHCWKERPEDRPAFSRLLRQLAEI 259 (263)
T ss_dssp ---TTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred ---cccCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHH
Confidence 11234567799999999999999999999999854
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.2e-53 Score=415.09 Aligned_cols=251 Identities=25% Similarity=0.390 Sum_probs=209.2
Q ss_pred CCcccceeEeeeCceEEEEEEEc-CCCEEEEEEEcccchhhHHHHHHHHHHHhcCCCCCceeEEEEEEeCceeeEEEeec
Q 010519 186 NRFSAENVLGEGGYGVVYKGRLI-NGSEVAVKKLLNNLGQAEKEFRVEVEAIGHVRHKNLVRLLGYCIEGVHRMLVYEYV 264 (508)
Q Consensus 186 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~ei~~l~~l~h~niv~~~~~~~~~~~~~lv~E~~ 264 (508)
++|++.+.||+|+||+||+|++. +|+.||||++........+.+.+|+.+|++++|||||++++++.+.+..|||||||
T Consensus 20 ~~Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmEy~ 99 (293)
T d1yhwa1 20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYL 99 (293)
T ss_dssp TTBCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred cccEEEEEEecCcCcEEEEEEECCCCCEEEEEEEecccChHHHHHHHHHHHHHhCCCCCEeeEeEEEEECCEEEEEEEec
Confidence 57999999999999999999874 68999999987655555677899999999999999999999999999999999999
Q ss_pred CCCCHHHHHhhhhccCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCEEEcCCCcEEEEecCCccccCCCCC
Q 010519 265 NNGNLEQWLHGAMRNQGNLTWEARMKVIIGTAKALAYLHEAIEPKVVHRDIKSSNILIDDEFNAKVSDFGLAKLLDSGES 344 (508)
Q Consensus 265 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~ 344 (508)
++|+|.+++. ...+++..++.++.||+.||.|||++ +|+||||||+|||++.++++||+|||+++.+.....
T Consensus 100 ~gg~L~~~~~-----~~~l~~~~~~~i~~qi~~aL~yLH~~---~iiHrDiKp~NILl~~~~~vkl~DFG~a~~~~~~~~ 171 (293)
T d1yhwa1 100 AGGSLTDVVT-----ETCMDEGQIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS 171 (293)
T ss_dssp TTCBHHHHHH-----HSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTTCEECCSTTC
T ss_pred CCCcHHHHhh-----ccCCCHHHHHHHHHHHHHHHHHHHHC---CCcccCCcHHHeEECCCCcEeeccchhheeeccccc
Confidence 9999999874 24689999999999999999999999 999999999999999999999999999997654332
Q ss_pred cccccccccccccCccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCCCchhcHHHHHHHHhcccccccccCCCCCC
Q 010519 345 HITTRVMGTFGYVAPEYANTGMLNEKSDIYSFGVLLLEAVTGRDPVDYGRPANEVNLVEWLKMMVGTRRAEEVVDPNLEV 424 (508)
Q Consensus 345 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 424 (508)
.....+||+.|+|||++.+..|+.++|||||||+||+|++|+.||..... . ..+....... ....
T Consensus 172 -~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~---~---~~~~~~~~~~--------~~~~ 236 (293)
T d1yhwa1 172 -KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENP---L---RALYLIATNG--------TPEL 236 (293)
T ss_dssp -CBCCCCSCGGGCCHHHHSSSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCH---H---HHHHHHHHHC--------SCCC
T ss_pred -cccccccCCCccChhhhcCCCCCchhceehHhHHHHHHhhCCCCCCCCCH---H---HHHHHHHhCC--------CCCC
Confidence 34456799999999999999999999999999999999999999964321 1 1111111111 1111
Q ss_pred ChhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHh
Q 010519 425 KPATRALKRSLLVALRCVDPDSEKRPKMSQVVRML 459 (508)
Q Consensus 425 ~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L 459 (508)
..+......+.+|+.+||++||.+|||+.|+++|-
T Consensus 237 ~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~Hp 271 (293)
T d1yhwa1 237 QNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQHQ 271 (293)
T ss_dssp SSGGGSCHHHHHHHHHHTCSSTTTSCCHHHHTTCG
T ss_pred CCcccCCHHHHHHHHHHccCChhHCcCHHHHhcCH
Confidence 12223345677799999999999999999998753
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.7e-54 Score=416.02 Aligned_cols=261 Identities=27% Similarity=0.418 Sum_probs=213.4
Q ss_pred HHHHHhhCCcccceeEeeeCceEEEEEEEcCCCEEEEEEEcccchhhHHHHHHHHHHHhcCCCCCceeEEEEEEeCceee
Q 010519 179 RDLEIATNRFSAENVLGEGGYGVVYKGRLINGSEVAVKKLLNNLGQAEKEFRVEVEAIGHVRHKNLVRLLGYCIEGVHRM 258 (508)
Q Consensus 179 ~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~ei~~l~~l~h~niv~~~~~~~~~~~~~ 258 (508)
++|++..++|++.+.||+|+||+||+|++.++..||||++.... ...+.|.+|+.+|++++|||||++++++. ++..+
T Consensus 6 ~~wei~~~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~~~~~~-~~~~~~~~E~~~l~~l~HpnIv~~~g~~~-~~~~~ 83 (272)
T d1qpca_ 6 DEWEVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLVRLYAVVT-QEPIY 83 (272)
T ss_dssp CTTBCCGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEEC-SSSCE
T ss_pred CCeecCHHHeEEeEEEecCCCcEEEEEEECCCCEEEEEEEccCc-CCHHHHHHHHHHHHhCCCCCEeEEEeeec-cCCeE
Confidence 45677788999999999999999999999888899999986543 33467899999999999999999999875 45678
Q ss_pred EEEeecCCCCHHHHHhhhhccCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCEEEcCCCcEEEEecCCccc
Q 010519 259 LVYEYVNNGNLEQWLHGAMRNQGNLTWEARMKVIIGTAKALAYLHEAIEPKVVHRDIKSSNILIDDEFNAKVSDFGLAKL 338 (508)
Q Consensus 259 lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~Dfgla~~ 338 (508)
+||||+++|+|.+++.. .....+++..++.++.||++||.|||++ +|+||||||+||||++++.+||+|||+++.
T Consensus 84 iv~Ey~~~g~L~~~~~~--~~~~~l~~~~~~~i~~qi~~gl~~lH~~---~ivHrDiKp~NIll~~~~~~Kl~DFGla~~ 158 (272)
T d1qpca_ 84 IITEYMENGSLVDFLKT--PSGIKLTINKLLDMAAQIAEGMAFIEER---NYIHRDLRAANILVSDTLSCKIADFGLARL 158 (272)
T ss_dssp EEEECCTTCBHHHHTTS--HHHHTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEECCCTTCEE
T ss_pred EEEEeCCCCcHHHHHhh--cCCCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCccchhheeeecccceeeccccceEE
Confidence 99999999999998753 2334689999999999999999999999 999999999999999999999999999998
Q ss_pred cCCCCCcccccccccccccCccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCCCchhcHHHHHHHHhccccccccc
Q 010519 339 LDSGESHITTRVMGTFGYVAPEYANTGMLNEKSDIYSFGVLLLEAVTGRDPVDYGRPANEVNLVEWLKMMVGTRRAEEVV 418 (508)
Q Consensus 339 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 418 (508)
.............||+.|+|||++.++.|+.++|||||||+||||+||..|+..... . .+.+........
T Consensus 159 ~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~sDvwS~Gvvl~ellt~~~~~~~~~~--~---~~~~~~i~~~~~----- 228 (272)
T d1qpca_ 159 IEDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMT--N---PEVIQNLERGYR----- 228 (272)
T ss_dssp CSSSCEECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCC--H---HHHHHHHHTTCC-----
T ss_pred ccCCccccccccCCcccccChHHHhCCCCCchhhhhhhHHHHHHHHhCCCCCCCCCC--H---HHHHHHHHhcCC-----
Confidence 766554455566789999999999989999999999999999999997666543322 1 122222221111
Q ss_pred CCCCCCChhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhhc
Q 010519 419 DPNLEVKPATRALKRSLLVALRCVDPDSEKRPKMSQVVRMLEA 461 (508)
Q Consensus 419 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~ 461 (508)
+ ..+......+.+|+.+||+.||.+|||+.+|++.|+.
T Consensus 229 -~----~~p~~~~~~l~~li~~cl~~~P~~Rpt~~ei~~~L~~ 266 (272)
T d1qpca_ 229 -M----VRPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLED 266 (272)
T ss_dssp -C----CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred -C----CCcccChHHHHHHHHHHcCCCHhHCcCHHHHHHHhhh
Confidence 1 1111223456779999999999999999999999875
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-53 Score=411.45 Aligned_cols=246 Identities=29% Similarity=0.448 Sum_probs=206.0
Q ss_pred CCcccceeEeeeCceEEEEEEEc-CCCEEEEEEEcccc---hhhHHHHHHHHHHHhcCCCCCceeEEEEEEeCceeeEEE
Q 010519 186 NRFSAENVLGEGGYGVVYKGRLI-NGSEVAVKKLLNNL---GQAEKEFRVEVEAIGHVRHKNLVRLLGYCIEGVHRMLVY 261 (508)
Q Consensus 186 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~ei~~l~~l~h~niv~~~~~~~~~~~~~lv~ 261 (508)
++|++.+.||+|+||+||+|++. +++.||+|++.... ......+.+|+.++++++|||||++++++.++...|+||
T Consensus 6 ~dy~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~ivm 85 (263)
T d2j4za1 6 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLIL 85 (263)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hHeEEEEEEecCCCcEEEEEEECCCCcEEEEEEEchHHccChHHHHHHHHHHHHHHhcCCCCCCeEEEEEEECCEEEEEE
Confidence 47999999999999999999985 68899999986432 233467888999999999999999999999999999999
Q ss_pred eecCCCCHHHHHhhhhccCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCEEEcCCCcEEEEecCCccccCC
Q 010519 262 EYVNNGNLEQWLHGAMRNQGNLTWEARMKVIIGTAKALAYLHEAIEPKVVHRDIKSSNILIDDEFNAKVSDFGLAKLLDS 341 (508)
Q Consensus 262 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~ 341 (508)
|||++|+|.+++. ....+++..++.++.||+.||+|||++ +|+||||||+|||++.++.+||+|||++.....
T Consensus 86 Ey~~~g~L~~~l~----~~~~l~e~~~~~i~~qi~~al~~lH~~---~ivHrDiKp~Nill~~~~~~kl~DFG~a~~~~~ 158 (263)
T d2j4za1 86 EYAPLGTVYRELQ----KLSKFDEQRTATYITELANALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAPS 158 (263)
T ss_dssp ECCTTCBHHHHHH----HHSSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCCCSCSCCCC
T ss_pred eecCCCcHHHHHh----hcCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeeeeccccceecCCCCEeecccceeeecCC
Confidence 9999999999995 446799999999999999999999999 999999999999999999999999999986654
Q ss_pred CCCcccccccccccccCccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCCCchhcHHHHHHHHhcccccccccCCC
Q 010519 342 GESHITTRVMGTFGYVAPEYANTGMLNEKSDIYSFGVLLLEAVTGRDPVDYGRPANEVNLVEWLKMMVGTRRAEEVVDPN 421 (508)
Q Consensus 342 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 421 (508)
.. .....||+.|+|||++.+..|+.++|||||||+||||++|+.||..... .+......... ..
T Consensus 159 ~~---~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~------~~~~~~i~~~~-------~~ 222 (263)
T d2j4za1 159 SR---RTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTY------QETYKRISRVE-------FT 222 (263)
T ss_dssp CC---CEETTEEGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSH------HHHHHHHHTTC-------CC
T ss_pred Cc---ccccCCCCcccCHHHHcCCCCCchhhhhhHhHHHHHHhcCCCCCCCCCH------HHHHHHHHcCC-------CC
Confidence 32 3456799999999999999999999999999999999999999964321 12222221111 11
Q ss_pred CCCChhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 010519 422 LEVKPATRALKRSLLVALRCVDPDSEKRPKMSQVVRM 458 (508)
Q Consensus 422 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 458 (508)
+ +......+.+|+.+||++||.+|||++|+++|
T Consensus 223 ~----p~~~s~~~~~li~~~L~~dp~~R~t~~eil~h 255 (263)
T d2j4za1 223 F----PDFVTEGARDLISRLLKHNPSQRPMLREVLEH 255 (263)
T ss_dssp C----CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTC
T ss_pred C----CccCCHHHHHHHHHHccCCHhHCcCHHHHHcC
Confidence 1 11123456679999999999999999999975
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.2e-54 Score=418.36 Aligned_cols=264 Identities=27% Similarity=0.463 Sum_probs=204.7
Q ss_pred HHHHhhCCcccceeEeeeCceEEEEEEEcCCCEEEEEEEccc--chhhHHHHHHHHHHHhcCCCCCceeEEEEEEeCcee
Q 010519 180 DLEIATNRFSAENVLGEGGYGVVYKGRLINGSEVAVKKLLNN--LGQAEKEFRVEVEAIGHVRHKNLVRLLGYCIEGVHR 257 (508)
Q Consensus 180 ~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~--~~~~~~~~~~ei~~l~~l~h~niv~~~~~~~~~~~~ 257 (508)
+|++..++|.+.+.||+|+||+||+|++. ..||||++... .....+.|.+|+.+|++++|||||++++++. ....
T Consensus 2 dwei~~~~~~~~~~lG~G~fg~Vy~~~~~--~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~-~~~~ 78 (276)
T d1uwha_ 2 DWEIPDGQITVGQRIGSGSFGTVYKGKWH--GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYST-APQL 78 (276)
T ss_dssp CCBCCTTCCCCCSEEEECSSCEEEEEESS--SEEEEEECCCSSCCTTHHHHHHHHHHHHTTCCCTTBCCEEEEEC-SSSC
T ss_pred CcccccccEEEEEEEeeCCCcEEEEEEEC--CEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeeeEEEe-ccEE
Confidence 34677789999999999999999999753 46999998543 2444578999999999999999999999875 4568
Q ss_pred eEEEeecCCCCHHHHHhhhhccCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCEEEcCCCcEEEEecCCcc
Q 010519 258 MLVYEYVNNGNLEQWLHGAMRNQGNLTWEARMKVIIGTAKALAYLHEAIEPKVVHRDIKSSNILIDDEFNAKVSDFGLAK 337 (508)
Q Consensus 258 ~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~Dfgla~ 337 (508)
++|||||++|+|.++|+ .....+++..+..++.||++||+|||++ +|+||||||+||||+.++.+||+|||+++
T Consensus 79 ~lv~Ey~~~g~L~~~l~---~~~~~~~~~~~~~i~~qi~~gl~yLH~~---~ivHrDlKp~NiLl~~~~~~Kl~DFGla~ 152 (276)
T d1uwha_ 79 AIVTQWCEGSSLYHHLH---IIETKFEMIKLIDIARQTAQGMDYLHAK---SIIHRDLKSNNIFLHEDLTVKIGDFGLAT 152 (276)
T ss_dssp EEEEECCCEEEHHHHHH---TSCCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEETTSSEEECCCCCSC
T ss_pred EEEEecCCCCCHHHHHh---hccCCCCHHHHHHHHHHHHHHHHHHhcC---CEeccccCHHHEEEcCCCCEEEcccccee
Confidence 99999999999999996 3456799999999999999999999999 99999999999999999999999999998
Q ss_pred ccCCCCC-cccccccccccccCccccCC---CCCCChhhHHHHHHHHHHHHhCCCCCCCCCCCchhcHHHHHHHHhcccc
Q 010519 338 LLDSGES-HITTRVMGTFGYVAPEYANT---GMLNEKSDIYSFGVLLLEAVTGRDPVDYGRPANEVNLVEWLKMMVGTRR 413 (508)
Q Consensus 338 ~~~~~~~-~~~~~~~gt~~y~aPE~~~~---~~~~~~~DvwS~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~ 413 (508)
....... .......||+.|+|||++.+ ..|+.++|||||||+||||+||+.||....... .+...+ .....
T Consensus 153 ~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~~~~--~~~~~~---~~~~~ 227 (276)
T d1uwha_ 153 VKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRD--QIIFMV---GRGYL 227 (276)
T ss_dssp C------------CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHH--HHHHHH---HHTSC
T ss_pred eccccCCcccccccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCCCCCCCCChHH--HHHHHH---hcCCC
Confidence 6643322 23455679999999999864 458999999999999999999999997443221 111111 11110
Q ss_pred cccccCCCCCCChhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhhcCC
Q 010519 414 AEEVVDPNLEVKPATRALKRSLLVALRCVDPDSEKRPKMSQVVRMLEADD 463 (508)
Q Consensus 414 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~ 463 (508)
.+.+. ......+..+.+|+.+||+.||.+|||+.||+++|+...
T Consensus 228 -----~p~~~-~~~~~~~~~l~~li~~cl~~dp~~RPt~~~il~~Le~l~ 271 (276)
T d1uwha_ 228 -----SPDLS-KVRSNCPKAMKRLMAECLKKKRDERPLFPQILASIELLA 271 (276)
T ss_dssp -----CCCGG-GSCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred -----CCcch-hccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHH
Confidence 01100 011122346677999999999999999999999998643
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-53 Score=413.08 Aligned_cols=253 Identities=24% Similarity=0.346 Sum_probs=204.8
Q ss_pred CCcccceeEeeeCceEEEEEEEc-CCCEEEEEEEcccc-hhhHHHHHHHHHHHhcCCCCCceeEEEEEEeCceeeEEEee
Q 010519 186 NRFSAENVLGEGGYGVVYKGRLI-NGSEVAVKKLLNNL-GQAEKEFRVEVEAIGHVRHKNLVRLLGYCIEGVHRMLVYEY 263 (508)
Q Consensus 186 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~ei~~l~~l~h~niv~~~~~~~~~~~~~lv~E~ 263 (508)
++|++.+.||+|+||+||+|++. +|+.||||++.... ....+.+.+|+.+|++++|||||++++++.+++..||||||
T Consensus 5 ~dy~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~~~~~~ivmEy 84 (271)
T d1nvra_ 5 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEY 84 (271)
T ss_dssp TEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred cceEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHhCCCCCEeeEeeeeccCceeEEEEec
Confidence 57999999999999999999985 68999999986543 23345688999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhhhhccCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCEEEcCCCcEEEEecCCccccCCCC
Q 010519 264 VNNGNLEQWLHGAMRNQGNLTWEARMKVIIGTAKALAYLHEAIEPKVVHRDIKSSNILIDDEFNAKVSDFGLAKLLDSGE 343 (508)
Q Consensus 264 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~~~ 343 (508)
+++|+|.++| .....+++..++.++.||+.||+|||++ +|+||||||+|||+++++.+||+|||+++......
T Consensus 85 ~~gg~L~~~l----~~~~~l~e~~~~~i~~qi~~al~ylH~~---~IiHrDiKp~NILl~~~~~~KL~DFG~a~~~~~~~ 157 (271)
T d1nvra_ 85 CSGGELFDRI----EPDIGMPEPDAQRFFHQLMAGVVYLHGI---GITHRDIKPENLLLDERDNLKISDFGLATVFRYNN 157 (271)
T ss_dssp CTTEEGGGGS----BTTTBCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECTTCCEEECCCTTCEECEETT
T ss_pred cCCCcHHHHH----hcCCCCCHHHHHHHHHHHHHHHHHHHHc---CCccCcccHHHEEECCCCCEEEccchhheeeccCC
Confidence 9999999988 4556799999999999999999999999 99999999999999999999999999998764332
Q ss_pred -CcccccccccccccCccccCCCCC-CChhhHHHHHHHHHHHHhCCCCCCCCCCCchhcHHHHHHHHhcccccccccCCC
Q 010519 344 -SHITTRVMGTFGYVAPEYANTGML-NEKSDIYSFGVLLLEAVTGRDPVDYGRPANEVNLVEWLKMMVGTRRAEEVVDPN 421 (508)
Q Consensus 344 -~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DvwS~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 421 (508)
.......+||+.|+|||++.+..+ +.++|||||||+||||++|+.||........ ... ..... .
T Consensus 158 ~~~~~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~~~~-~~~----~~~~~---------~ 223 (271)
T d1nvra_ 158 RERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQ-EYS----DWKEK---------K 223 (271)
T ss_dssp EECCBCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSSTTSH-HHH----HHHTT---------C
T ss_pred ccccccceeeCcCccCHhHhcCCCCCCCceeeeHhHHHHHHHHhCCCCCCCCChHHH-HHH----HHhcC---------C
Confidence 223455789999999999988776 5789999999999999999999975432211 111 11111 1
Q ss_pred CCCChhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHh
Q 010519 422 LEVKPATRALKRSLLVALRCVDPDSEKRPKMSQVVRML 459 (508)
Q Consensus 422 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L 459 (508)
....+.......+.+|+.+||+.||.+|||++|+++|-
T Consensus 224 ~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~hp 261 (271)
T d1nvra_ 224 TYLNPWKKIDSAPLALLHKILVENPSARITIPDIKKDR 261 (271)
T ss_dssp TTSTTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTCT
T ss_pred CCCCccccCCHHHHHHHHHHcCCChhHCcCHHHHhcCH
Confidence 11111222345566799999999999999999998753
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=3.7e-54 Score=421.24 Aligned_cols=264 Identities=24% Similarity=0.378 Sum_probs=218.4
Q ss_pred HHHHHhhCCcccceeEeeeCceEEEEEEEc-CCCEEEEEEEcccchhhHHHHHHHHHHHhcCCCCCceeEEEEEEeCcee
Q 010519 179 RDLEIATNRFSAENVLGEGGYGVVYKGRLI-NGSEVAVKKLLNNLGQAEKEFRVEVEAIGHVRHKNLVRLLGYCIEGVHR 257 (508)
Q Consensus 179 ~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~ei~~l~~l~h~niv~~~~~~~~~~~~ 257 (508)
++|++..++|++.+.||+|+||+||+|++. +++.||||++..... ..+.|.+|+.+|++++|||||+++++|.++...
T Consensus 10 ~~wei~~~~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~-~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~ 88 (287)
T d1opja_ 10 DKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM-EVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPF 88 (287)
T ss_dssp CTTBCCGGGEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTTCS-CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred cccEecHHHeEEeeEEeeCCCeEEEEEEECCCCeEEEEEEECCccc-hHHHHHHHHHHHHhCCCCCEecCCccEeeCCee
Confidence 455777889999999999999999999986 578899999865433 356789999999999999999999999999999
Q ss_pred eEEEeecCCCCHHHHHhhhhccCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCEEEcCCCcEEEEecCCcc
Q 010519 258 MLVYEYVNNGNLEQWLHGAMRNQGNLTWEARMKVIIGTAKALAYLHEAIEPKVVHRDIKSSNILIDDEFNAKVSDFGLAK 337 (508)
Q Consensus 258 ~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~Dfgla~ 337 (508)
++|||||++|+|.+++.. .....+++..++.++.||+.||+|||++ +|+||||||+||||++++.+||+|||+++
T Consensus 89 ~iv~E~~~~g~l~~~l~~--~~~~~~~~~~~~~i~~qi~~gL~yLH~~---~iiHrDlKp~NILl~~~~~~Kl~DFG~a~ 163 (287)
T d1opja_ 89 YIITEFMTYGNLLDYLRE--CNRQEVSAVVLLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSR 163 (287)
T ss_dssp EEEEECCTTCBHHHHHHH--SCTTTSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCCCCTT
T ss_pred EEEeecccCcchHHHhhh--ccccchHHHHHHHHHHHHHHHHHHHHHC---CcccCccccCeEEECCCCcEEEcccccee
Confidence 999999999999999964 3456799999999999999999999999 99999999999999999999999999999
Q ss_pred ccCCCCCcccccccccccccCccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCCCchhcHHHHHHHHhcccccccc
Q 010519 338 LLDSGESHITTRVMGTFGYVAPEYANTGMLNEKSDIYSFGVLLLEAVTGRDPVDYGRPANEVNLVEWLKMMVGTRRAEEV 417 (508)
Q Consensus 338 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 417 (508)
..............|++.|+|||++.+..|+.++|||||||+||||++|..||...... ...........
T Consensus 164 ~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~k~DiwS~Gv~l~ell~~~~p~~~~~~~-----~~~~~~i~~~~----- 233 (287)
T d1opja_ 164 LMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDL-----SQVYELLEKDY----- 233 (287)
T ss_dssp TCCSSSSEEETTEEECGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCSSTTCCH-----HHHHHHHHTTC-----
T ss_pred ecCCCCceeeccccccccccChHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCcchH-----HHHHHHHhcCC-----
Confidence 77655544455566899999999999999999999999999999999988776533321 12122221111
Q ss_pred cCCCCCCChhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhhcCC
Q 010519 418 VDPNLEVKPATRALKRSLLVALRCVDPDSEKRPKMSQVVRMLEADD 463 (508)
Q Consensus 418 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~ 463 (508)
....+......+.+|+.+||+.||.+|||+.||++.|+...
T Consensus 234 -----~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ei~~~L~~~~ 274 (287)
T d1opja_ 234 -----RMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMF 274 (287)
T ss_dssp -----CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTT
T ss_pred -----CCCCCccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHH
Confidence 11111223456777999999999999999999999998653
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.1e-53 Score=406.62 Aligned_cols=254 Identities=24% Similarity=0.392 Sum_probs=213.7
Q ss_pred hCCcccceeEeeeCceEEEEEEEcCCCEEEEEEEcccchhhHHHHHHHHHHHhcCCCCCceeEEEEEEeCceeeEEEeec
Q 010519 185 TNRFSAENVLGEGGYGVVYKGRLINGSEVAVKKLLNNLGQAEKEFRVEVEAIGHVRHKNLVRLLGYCIEGVHRMLVYEYV 264 (508)
Q Consensus 185 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~ei~~l~~l~h~niv~~~~~~~~~~~~~lv~E~~ 264 (508)
.++|++.+.||+|+||+||+|+++++..||||++..... ..++|.+|+.++++++|||||+++|+|.+++..++||||+
T Consensus 3 ~~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~l~~~~~-~~~~~~~Ev~~~~~l~HpnIv~~~g~~~~~~~~~iv~Ey~ 81 (258)
T d1k2pa_ 3 PKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSM-SEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYM 81 (258)
T ss_dssp CCCCCCCCCCCEETTEEEEEEEETTTEEEEEEEEESSSS-CHHHHHHHHHHHHTCCCTTBCCEEEEECCSSSEEEEEECC
T ss_pred hHHCEEeEEEecCCCeEEEEEEECCCCEEEEEEECcCcC-CHHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEEEEcc
Confidence 368999999999999999999998888999999876443 3567999999999999999999999999999999999999
Q ss_pred CCCCHHHHHhhhhccCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCEEEcCCCcEEEEecCCccccCCCCC
Q 010519 265 NNGNLEQWLHGAMRNQGNLTWEARMKVIIGTAKALAYLHEAIEPKVVHRDIKSSNILIDDEFNAKVSDFGLAKLLDSGES 344 (508)
Q Consensus 265 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~ 344 (508)
++|+|.+++. .....+++..+++++.|+++||.|||+. +|+||||||+|||+++++.+||+|||+++.......
T Consensus 82 ~~g~l~~~~~---~~~~~~~~~~~~~i~~qi~~gl~~LH~~---~iiH~dlk~~Nill~~~~~~kl~DfG~a~~~~~~~~ 155 (258)
T d1k2pa_ 82 ANGCLLNYLR---EMRHRFQTQQLLEMCKDVCEAMEYLESK---QFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEY 155 (258)
T ss_dssp TTEEHHHHHH---SGGGCCCHHHHHHHHHHHHHHHHHHHHT---TBCCSCCSGGGEEECTTCCEEECCCSSCCBCSSSSC
T ss_pred CCCcHHHhhh---ccccCCcHHHHHHHHHHHHHHHHHHhhc---CcccccccceeEEEcCCCcEEECcchhheeccCCCc
Confidence 9999999985 4456788999999999999999999999 999999999999999999999999999987665544
Q ss_pred cccccccccccccCccccCCCCCCChhhHHHHHHHHHHHHh-CCCCCCCCCCCchhcHHHHHHHHhcccccccccCCCCC
Q 010519 345 HITTRVMGTFGYVAPEYANTGMLNEKSDIYSFGVLLLEAVT-GRDPVDYGRPANEVNLVEWLKMMVGTRRAEEVVDPNLE 423 (508)
Q Consensus 345 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 423 (508)
.......||+.|+|||++.+..|+.++|||||||++|||+| |+.||..... .+..........
T Consensus 156 ~~~~~~~~t~~y~aPE~~~~~~~~~ksDiwS~G~~l~el~t~g~~Pf~~~~~------~~~~~~i~~~~~---------- 219 (258)
T d1k2pa_ 156 TSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTN------SETAEHIAQGLR---------- 219 (258)
T ss_dssp CCCCCSCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCH------HHHHHHHHTTCC----------
T ss_pred eeecccCCCCCcCCcHHhcCCCCCcceeecccchhhHhHHhcCCCCCCCCCH------HHHHHHHHhCCC----------
Confidence 44555678999999999999999999999999999999998 8999964321 122222221111
Q ss_pred CChhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhhc
Q 010519 424 VKPATRALKRSLLVALRCVDPDSEKRPKMSQVVRMLEA 461 (508)
Q Consensus 424 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~ 461 (508)
...+......+.+|+.+||+.||.+|||+++++++|.+
T Consensus 220 ~~~p~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~d 257 (258)
T d1k2pa_ 220 LYRPHLASEKVYTIMYSCWHEKADERPTFKILLSNILD 257 (258)
T ss_dssp CCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHC
T ss_pred CCCcccccHHHHHHHHHHccCCHhHCcCHHHHHHHhhC
Confidence 11111223567789999999999999999999999975
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2e-53 Score=412.06 Aligned_cols=256 Identities=26% Similarity=0.367 Sum_probs=196.8
Q ss_pred CCcccceeEeeeCceEEEEEEEc-CCCEEEEEEEcccc--hhhHHHHHHHHHHHhcCCCCCceeEEEEEEe--CceeeEE
Q 010519 186 NRFSAENVLGEGGYGVVYKGRLI-NGSEVAVKKLLNNL--GQAEKEFRVEVEAIGHVRHKNLVRLLGYCIE--GVHRMLV 260 (508)
Q Consensus 186 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~ei~~l~~l~h~niv~~~~~~~~--~~~~~lv 260 (508)
++|++.+.||+|+||+||+|++. +|+.||||.+.... ....+.+.+|+++|++++|||||++++++.+ ....|||
T Consensus 4 edy~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~iv 83 (269)
T d2java1 4 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIV 83 (269)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTSCHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC----CEEEE
T ss_pred hhCEEeEEEecCCCeEEEEEEECCCCCEEEEEEEChhhCCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEeCCCCEEEEE
Confidence 57999999999999999999875 68899999986543 3334678899999999999999999999865 4567899
Q ss_pred EeecCCCCHHHHHhhhhccCCCccHHHHHHHHHHHHHHHHHHHhcC--CCCeEeecCCCCCEEEcCCCcEEEEecCCccc
Q 010519 261 YEYVNNGNLEQWLHGAMRNQGNLTWEARMKVIIGTAKALAYLHEAI--EPKVVHRDIKSSNILIDDEFNAKVSDFGLAKL 338 (508)
Q Consensus 261 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~--~~~iiH~Dlk~~NIll~~~~~~kl~Dfgla~~ 338 (508)
||||++|+|.+++.........+++..++.++.||+.||.|||+.. ..+|+||||||+|||++.++.+||+|||+++.
T Consensus 84 mEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~vkl~DFG~a~~ 163 (269)
T d2java1 84 MEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARI 163 (269)
T ss_dssp EECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCEEECCHHHHHH
T ss_pred EecCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCCCcEEEeeccceee
Confidence 9999999999999766566778999999999999999999999861 11399999999999999999999999999997
Q ss_pred cCCCCCcccccccccccccCccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCCCchhcHHHHHHHHhccccccccc
Q 010519 339 LDSGESHITTRVMGTFGYVAPEYANTGMLNEKSDIYSFGVLLLEAVTGRDPVDYGRPANEVNLVEWLKMMVGTRRAEEVV 418 (508)
Q Consensus 339 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 418 (508)
...... .....+||+.|+|||++.+..|+.++|||||||+||||++|+.||.... .. +........ ..
T Consensus 164 ~~~~~~-~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyel~tg~~Pf~~~~---~~---~~~~~i~~~-~~---- 231 (269)
T d2java1 164 LNHDTS-FAKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFS---QK---ELAGKIREG-KF---- 231 (269)
T ss_dssp C------------CCCSCCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSS---HH---HHHHHHHHT-CC----
T ss_pred cccCCC-ccccCCCCcccCCHHHHcCCCCChHHHHHhhCHHHHHHhhCCCCCCCCC---HH---HHHHHHHcC-CC----
Confidence 754332 2445689999999999999999999999999999999999999996432 11 112221111 11
Q ss_pred CCCCCCChhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 010519 419 DPNLEVKPATRALKRSLLVALRCVDPDSEKRPKMSQVVRM 458 (508)
Q Consensus 419 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 458 (508)
+.+. ......+.+|+.+||+.||.+|||+.|+++|
T Consensus 232 -~~~~----~~~s~~l~~li~~~L~~dp~~Rps~~ell~h 266 (269)
T d2java1 232 -RRIP----YRYSDELNEIITRMLNLKDYHRPSVEEILEN 266 (269)
T ss_dssp -CCCC----TTSCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred -CCCC----cccCHHHHHHHHHHcCCChhHCcCHHHHHhC
Confidence 1111 1123456779999999999999999999875
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.7e-53 Score=411.74 Aligned_cols=253 Identities=23% Similarity=0.325 Sum_probs=207.9
Q ss_pred CCcccceeEeeeCceEEEEEEEc-CCCEEEEEEEcccchhhHHHHHHHHHHHhcCCCCCceeEEEEEEeCceeeEEEeec
Q 010519 186 NRFSAENVLGEGGYGVVYKGRLI-NGSEVAVKKLLNNLGQAEKEFRVEVEAIGHVRHKNLVRLLGYCIEGVHRMLVYEYV 264 (508)
Q Consensus 186 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~ei~~l~~l~h~niv~~~~~~~~~~~~~lv~E~~ 264 (508)
+.|++.+.||+|+||+||+|++. +|..||||++........+.+.+|+++|++++|||||++++++.+.+..+||||||
T Consensus 12 d~Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lvmEy~ 91 (288)
T d2jfla1 12 DFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFC 91 (288)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSSSGGGGGTHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred cCeEEeEEEeeCCCcEEEEEEECCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCeEEEEEecC
Confidence 46899999999999999999985 68899999987665555677889999999999999999999999999999999999
Q ss_pred CCCCHHHHHhhhhccCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCEEEcCCCcEEEEecCCccccCCCCC
Q 010519 265 NNGNLEQWLHGAMRNQGNLTWEARMKVIIGTAKALAYLHEAIEPKVVHRDIKSSNILIDDEFNAKVSDFGLAKLLDSGES 344 (508)
Q Consensus 265 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~ 344 (508)
++|+|.+++.. ....+++..+..++.||+.||.|||++ +|+||||||+|||++.++.+||+|||++.......
T Consensus 92 ~~g~L~~~~~~---~~~~l~e~~~~~i~~qi~~gL~ylH~~---~ivHrDiKp~NIll~~~~~~Kl~DFG~a~~~~~~~- 164 (288)
T d2jfla1 92 AGGAVDAVMLE---LERPLTESQIQVVCKQTLDALNYLHDN---KIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTI- 164 (288)
T ss_dssp TTEEHHHHHHH---HTSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECHHHH-
T ss_pred CCCcHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHC---CEEEeecChhheeECCCCCEEEEechhhhccCCCc-
Confidence 99999999853 356799999999999999999999999 99999999999999999999999999997553221
Q ss_pred cccccccccccccCccccC-----CCCCCChhhHHHHHHHHHHHHhCCCCCCCCCCCchhcHHHHHHHHhcccccccccC
Q 010519 345 HITTRVMGTFGYVAPEYAN-----TGMLNEKSDIYSFGVLLLEAVTGRDPVDYGRPANEVNLVEWLKMMVGTRRAEEVVD 419 (508)
Q Consensus 345 ~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DvwS~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 419 (508)
......+||+.|+|||++. +..|+.++|||||||+||||++|+.||....+.. .. .......
T Consensus 165 ~~~~~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~~~~~---~~---~~i~~~~------- 231 (288)
T d2jfla1 165 QRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMR---VL---LKIAKSE------- 231 (288)
T ss_dssp HHHTCCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTSCGGG---HH---HHHHHSC-------
T ss_pred ccccccccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHhhCCCCCCCCCHHH---HH---HHHHcCC-------
Confidence 1234567999999999984 4568999999999999999999999997543221 11 1111111
Q ss_pred CCCCCChhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHh
Q 010519 420 PNLEVKPATRALKRSLLVALRCVDPDSEKRPKMSQVVRML 459 (508)
Q Consensus 420 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L 459 (508)
......+......+.+|+.+||+.||.+|||++|+++|-
T Consensus 232 -~~~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~ell~hp 270 (288)
T d2jfla1 232 -PPTLAQPSRWSSNFKDFLKKCLEKNVDARWTTSQLLQHP 270 (288)
T ss_dssp -CCCCSSGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTSG
T ss_pred -CCCCCccccCCHHHHHHHHHHccCChhHCcCHHHHhcCc
Confidence 011112223345677799999999999999999998863
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=1.2e-52 Score=412.81 Aligned_cols=256 Identities=27% Similarity=0.479 Sum_probs=198.1
Q ss_pred hCCcccceeEeeeCceEEEEEEEcC-CC---EEEEEEEcccc-hhhHHHHHHHHHHHhcCCCCCceeEEEEEEeCceeeE
Q 010519 185 TNRFSAENVLGEGGYGVVYKGRLIN-GS---EVAVKKLLNNL-GQAEKEFRVEVEAIGHVRHKNLVRLLGYCIEGVHRML 259 (508)
Q Consensus 185 ~~~~~~~~~lg~G~~g~Vy~~~~~~-~~---~vavK~~~~~~-~~~~~~~~~ei~~l~~l~h~niv~~~~~~~~~~~~~l 259 (508)
.++|.+.+.||+|+||+||+|++.. ++ .||||++.... ....+.|.+|+.+|++++|||||+++++|.+....++
T Consensus 25 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~~i 104 (299)
T d1jpaa_ 25 ISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMI 104 (299)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEE
T ss_pred hhhcEEeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEEE
Confidence 4578889999999999999998752 32 58888876543 3445679999999999999999999999999999999
Q ss_pred EEeecCCCCHHHHHhhhhccCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCEEEcCCCcEEEEecCCcccc
Q 010519 260 VYEYVNNGNLEQWLHGAMRNQGNLTWEARMKVIIGTAKALAYLHEAIEPKVVHRDIKSSNILIDDEFNAKVSDFGLAKLL 339 (508)
Q Consensus 260 v~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~Dfgla~~~ 339 (508)
|||||++|+|.+++. ...+.+++..++.++.||+.||.|||++ +|+||||||+||||+.++.+||+|||+++..
T Consensus 105 v~Ey~~~g~L~~~~~---~~~~~l~~~~~~~i~~qia~gl~yLH~~---~iiHrDlKp~NILl~~~~~~Kl~DFGla~~~ 178 (299)
T d1jpaa_ 105 ITEFMENGSLDSFLR---QNDGQFTVIQLVGMLRGIAAGMKYLADM---NYVHRDLAARNILVNSNLVCKVSDFGLSRFL 178 (299)
T ss_dssp EEECCTTEEHHHHHH---TTTTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCC------
T ss_pred EEEecCCCcceeeec---cccCCCCHHHHHHHHHHHHHHHHHHhhC---CCccCccccceEEECCCCcEEECCcccceEc
Confidence 999999999999885 3456799999999999999999999999 9999999999999999999999999999876
Q ss_pred CCCCCc----ccccccccccccCccccCCCCCCChhhHHHHHHHHHHHHh-CCCCCCCCCCCchhcHHHHHHHHhccccc
Q 010519 340 DSGESH----ITTRVMGTFGYVAPEYANTGMLNEKSDIYSFGVLLLEAVT-GRDPVDYGRPANEVNLVEWLKMMVGTRRA 414 (508)
Q Consensus 340 ~~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~ 414 (508)
...... ......||+.|+|||++.++.|+.++|||||||+||||+| |..||..... .+.+..+.....
T Consensus 179 ~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~sDvwS~Gvvl~el~t~g~~Pf~~~~~------~~~~~~i~~~~~- 251 (299)
T d1jpaa_ 179 EDDTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTN------QDVINAIEQDYR- 251 (299)
T ss_dssp -----------------CGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCH------HHHHHHHHTTCC-
T ss_pred cCCCCcceeeecccccCCccccCHHHHhcCCCCcccccccchHHHHHHHhCCCCCCCCCCH------HHHHHHHHcCCC-
Confidence 543221 1222457899999999999999999999999999999998 8999964321 122222221111
Q ss_pred ccccCCCCCCChhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhhcC
Q 010519 415 EEVVDPNLEVKPATRALKRSLLVALRCVDPDSEKRPKMSQVVRMLEAD 462 (508)
Q Consensus 415 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~ 462 (508)
.+.+......+.+|+.+||+.||.+|||+.||++.|+..
T Consensus 252 ---------~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ei~~~L~~~ 290 (299)
T d1jpaa_ 252 ---------LPPPMDCPSALHQLMLDCWQKDRNHRPKFGQIVNTLDKM 290 (299)
T ss_dssp ---------CCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHH
T ss_pred ---------CCCCccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHH
Confidence 111222345667799999999999999999999999754
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8e-53 Score=418.80 Aligned_cols=265 Identities=25% Similarity=0.343 Sum_probs=206.3
Q ss_pred HHhhCCcccceeEeeeCceEEEEEEEc-CCCEEEEEEEcccc-hhhHHHHHHHHHHHhcCCCCCceeEEEEEEeCceeeE
Q 010519 182 EIATNRFSAENVLGEGGYGVVYKGRLI-NGSEVAVKKLLNNL-GQAEKEFRVEVEAIGHVRHKNLVRLLGYCIEGVHRML 259 (508)
Q Consensus 182 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~ei~~l~~l~h~niv~~~~~~~~~~~~~l 259 (508)
++..++|++.+.||+|+||+||+|++. +|+.||+|++.... ......+.+|+.+|++++|||||+++++|.+....|+
T Consensus 2 el~~d~y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~i 81 (322)
T d1s9ja_ 2 ELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISI 81 (322)
T ss_dssp CCCGGGEEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCCCTTHHHHHHHHGGGGGGCCCTTBCCEEEEEECSSEEEE
T ss_pred CCCccCCEEEEEEecCCCeEEEEEEECCCCcEEEEEEEChhhCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEE
Confidence 345678999999999999999999975 68899999986543 3345678899999999999999999999999999999
Q ss_pred EEeecCCCCHHHHHhhhhccCCCccHHHHHHHHHHHHHHHHHHHh-cCCCCeEeecCCCCCEEEcCCCcEEEEecCCccc
Q 010519 260 VYEYVNNGNLEQWLHGAMRNQGNLTWEARMKVIIGTAKALAYLHE-AIEPKVVHRDIKSSNILIDDEFNAKVSDFGLAKL 338 (508)
Q Consensus 260 v~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~yLH~-~~~~~iiH~Dlk~~NIll~~~~~~kl~Dfgla~~ 338 (508)
||||+++|+|.+++. ..+.+++..++.++.||+.||.|||+ + +|+||||||+|||+++++.+||+|||+|+.
T Consensus 82 VmEy~~gg~L~~~l~----~~~~l~~~~~~~~~~qil~aL~yLH~~~---~IiHRDiKP~NILl~~~~~vkl~DFGla~~ 154 (322)
T d1s9ja_ 82 CMEHMDGGSLDQVLK----KAGRIPEQILGKVSIAVIKGLTYLREKH---KIMHRDVKPSNILVNSRGEIKLCDFGVSGQ 154 (322)
T ss_dssp EEECCTTEEHHHHHH----HHSSCCHHHHHHHHHHHHHHHHHHHHHH---CCCCSCCSGGGEEECTTCCEEECCCCCCHH
T ss_pred EEEcCCCCcHHHHHh----hcCCCCHHHHHHHHHHHHHHHHHHHHhC---CEEccccCHHHeeECCCCCEEEeeCCCccc
Confidence 999999999999995 34579999999999999999999996 6 899999999999999999999999999986
Q ss_pred cCCCCCcccccccccccccCccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCCCchhcHHHHHHHHhcccc-----
Q 010519 339 LDSGESHITTRVMGTFGYVAPEYANTGMLNEKSDIYSFGVLLLEAVTGRDPVDYGRPANEVNLVEWLKMMVGTRR----- 413 (508)
Q Consensus 339 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~----- 413 (508)
.... .....+||+.|+|||++.+..|+.++|||||||+||||++|+.||........ .... .....+...
T Consensus 155 ~~~~---~~~~~~GT~~Y~APEvl~~~~y~~~~DiWSlGvil~ell~G~~Pf~~~~~~~~-~~~~-~~~~~~~~~~~~~~ 229 (322)
T d1s9ja_ 155 LIDS---MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKEL-ELMF-GCQVEGDAAETPPR 229 (322)
T ss_dssp HHHH---TC---CCSSCCCCHHHHHCSCCCTTHHHHHHHHHHHHHHHSSCCSSCCCTTHH-HHHC---------------
T ss_pred cCCC---ccccccCCccccCchHHcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHH-HHHH-HHHhcCCcccCCcc
Confidence 5432 23456899999999999999999999999999999999999999975432211 1100 000000000
Q ss_pred --------ccc----------------ccCCCCCCChhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 010519 414 --------AEE----------------VVDPNLEVKPATRALKRSLLVALRCVDPDSEKRPKMSQVVRM 458 (508)
Q Consensus 414 --------~~~----------------~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 458 (508)
... .........+.......+.+|+.+||..||.+|||++|+|+|
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~L~H 298 (322)
T d1s9ja_ 230 PRTPGRPLSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVH 298 (322)
T ss_dssp ----------------CCCCHHHHHHHHHTSCCCCCCBTTBCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred cccccccccccccccccchhHHHHHhhhhccCCccCccccCCHHHHHHHHHHcCCChhHCcCHHHHhhC
Confidence 000 000000000001123456779999999999999999999985
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.4e-53 Score=410.95 Aligned_cols=251 Identities=22% Similarity=0.358 Sum_probs=204.3
Q ss_pred CCcccceeEeeeCceEEEEEEEc-CCCEEEEEEEcccc---hhhHHHHHHHHHHHhcCCCCCceeEEEEEEeCceeeEEE
Q 010519 186 NRFSAENVLGEGGYGVVYKGRLI-NGSEVAVKKLLNNL---GQAEKEFRVEVEAIGHVRHKNLVRLLGYCIEGVHRMLVY 261 (508)
Q Consensus 186 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~ei~~l~~l~h~niv~~~~~~~~~~~~~lv~ 261 (508)
++|++.+.||+|+||+||+|++. +|+.||||++.... ......+.+|+++|++++|||||++++++.+++..||||
T Consensus 8 ~dy~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~ivm 87 (288)
T d1uu3a_ 8 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGL 87 (288)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEECSSEEEEEE
T ss_pred CCCEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHcCCCCeeEEEEEEEECCEEEEEE
Confidence 57999999999999999999985 68999999986432 223467889999999999999999999999999999999
Q ss_pred eecCCCCHHHHHhhhhccCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCEEEcCCCcEEEEecCCccccCC
Q 010519 262 EYVNNGNLEQWLHGAMRNQGNLTWEARMKVIIGTAKALAYLHEAIEPKVVHRDIKSSNILIDDEFNAKVSDFGLAKLLDS 341 (508)
Q Consensus 262 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~ 341 (508)
||+++|+|.+++. ..+.+++..++.++.|++.||+|||++ +|+||||||+|||+++++.+||+|||+++.+..
T Consensus 88 Ey~~gg~L~~~~~----~~~~l~e~~~~~~~~qi~~al~ylH~~---~iiHrDiKp~NIll~~~~~vkl~DFG~a~~~~~ 160 (288)
T d1uu3a_ 88 SYAKNGELLKYIR----KIGSFDETCTRFYTAEIVSALEYLHGK---GIIHRDLKPENILLNEDMHIQITDFGTAKVLSP 160 (288)
T ss_dssp CCCTTEEHHHHHH----HHSSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEECCCTTCEECC-
T ss_pred EccCCCCHHHhhh----ccCCCCHHHHHHHHHHHHHHHHhhccc---cEEcCcCCccccccCCCceEEecccccceeccc
Confidence 9999999999984 456799999999999999999999999 999999999999999999999999999987653
Q ss_pred CC-CcccccccccccccCccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCCCchhcHHHHHHHHhcccccccccCC
Q 010519 342 GE-SHITTRVMGTFGYVAPEYANTGMLNEKSDIYSFGVLLLEAVTGRDPVDYGRPANEVNLVEWLKMMVGTRRAEEVVDP 420 (508)
Q Consensus 342 ~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 420 (508)
.. .......+||+.|+|||++.+..|+.++|||||||+||||++|+.||.... .. .......... .
T Consensus 161 ~~~~~~~~~~~GT~~Y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~---~~---~~~~~i~~~~-------~ 227 (288)
T d1uu3a_ 161 ESKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGN---EY---LIFQKIIKLE-------Y 227 (288)
T ss_dssp ---------CCCCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSSCCSS---HH---HHHHHHHTTC-------C
T ss_pred CCcccccccccCCccccCceeeccCCCCcccceehhhHHHHHHhhCCCCCCCcC---HH---HHHHHHHcCC-------C
Confidence 32 223445689999999999999999999999999999999999999996432 11 1122221111 1
Q ss_pred CCCCChhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhh
Q 010519 421 NLEVKPATRALKRSLLVALRCVDPDSEKRPKMSQVVRMLE 460 (508)
Q Consensus 421 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 460 (508)
.+. ......+.+|+.+||+.||.+|||++|++.+.+
T Consensus 228 ~~p----~~~s~~~~~li~~~L~~dP~~R~t~~e~~~~~~ 263 (288)
T d1uu3a_ 228 DFP----EKFFPKARDLVEKLLVLDATKRLGCEEMEGYGP 263 (288)
T ss_dssp CCC----TTCCHHHHHHHHTTSCSSGGGSTTSGGGTCHHH
T ss_pred CCC----ccCCHHHHHHHHHHccCCHhHCcCHHHHcCCHH
Confidence 111 122345677999999999999999999765543
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-51 Score=399.53 Aligned_cols=248 Identities=24% Similarity=0.385 Sum_probs=197.6
Q ss_pred cccceeEeeeCceEEEEEEEc-CCCEEEEEEEcccc--hhhHHHHHHHHHHHhcCCCCCceeEEEEEEe----CceeeEE
Q 010519 188 FSAENVLGEGGYGVVYKGRLI-NGSEVAVKKLLNNL--GQAEKEFRVEVEAIGHVRHKNLVRLLGYCIE----GVHRMLV 260 (508)
Q Consensus 188 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~ei~~l~~l~h~niv~~~~~~~~----~~~~~lv 260 (508)
|.+.+.||+|+||+||+|++. ++..||+|++.... ....+.+.+|+++|++++|||||++++++.+ ....|||
T Consensus 11 ~~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~~~iv 90 (270)
T d1t4ha_ 11 LKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLV 90 (270)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEEE
T ss_pred EEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeccccCCEEEEE
Confidence 366788999999999999986 67899999986542 3344678899999999999999999999875 3567899
Q ss_pred EeecCCCCHHHHHhhhhccCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCEEEc-CCCcEEEEecCCcccc
Q 010519 261 YEYVNNGNLEQWLHGAMRNQGNLTWEARMKVIIGTAKALAYLHEAIEPKVVHRDIKSSNILID-DEFNAKVSDFGLAKLL 339 (508)
Q Consensus 261 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiH~Dlk~~NIll~-~~~~~kl~Dfgla~~~ 339 (508)
|||+++|+|.+++. ....+++..++.++.||++||+|||++ .++|+||||||+|||++ +++.+||+|||+++..
T Consensus 91 mE~~~~g~L~~~l~----~~~~~~~~~~~~~~~qi~~gl~yLH~~-~~~IiHrDiKp~NILl~~~~~~~Kl~DFGla~~~ 165 (270)
T d1t4ha_ 91 TELMTSGTLKTYLK----RFKVMKIKVLRSWCRQILKGLQFLHTR-TPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLK 165 (270)
T ss_dssp EECCCSCBHHHHHH----HHSSCCHHHHHHHHHHHHHHHHHHHTS-SSCCCCSCCCGGGEEESSTTSCEEECCTTGGGGC
T ss_pred EeCCCCCcHHHHHh----ccccccHHHHHHHHHHHHHHHHHHHHC-CCCEEeCCcChhhceeeCCCCCEEEeecCcceec
Confidence 99999999999995 346789999999999999999999997 22399999999999996 5789999999999865
Q ss_pred CCCCCcccccccccccccCccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCCCchhcHHHHHHHHhcccccccccC
Q 010519 340 DSGESHITTRVMGTFGYVAPEYANTGMLNEKSDIYSFGVLLLEAVTGRDPVDYGRPANEVNLVEWLKMMVGTRRAEEVVD 419 (508)
Q Consensus 340 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 419 (508)
... .....+||+.|+|||++.+ .|+.++|||||||+||||++|+.||...... .............
T Consensus 166 ~~~---~~~~~~GT~~Y~aPE~~~~-~~~~~~DIwSlGvilyel~~g~~Pf~~~~~~-----~~~~~~i~~~~~~----- 231 (270)
T d1t4ha_ 166 RAS---FAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNA-----AQIYRRVTSGVKP----- 231 (270)
T ss_dssp CTT---SBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSH-----HHHHHHHTTTCCC-----
T ss_pred cCC---ccCCcccCccccCHHHhCC-CCCCcCchhhHHHHHHHHHHCCCCCCCcccH-----HHHHHHHHcCCCC-----
Confidence 432 2345689999999999876 5999999999999999999999999643221 1222222211110
Q ss_pred CCCCCChhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 010519 420 PNLEVKPATRALKRSLLVALRCVDPDSEKRPKMSQVVRM 458 (508)
Q Consensus 420 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 458 (508)
..........+.+|+.+||++||++|||++|+++|
T Consensus 232 ----~~~~~~~~~~~~~li~~~l~~dp~~R~s~~ell~H 266 (270)
T d1t4ha_ 232 ----ASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLNH 266 (270)
T ss_dssp ----GGGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred ----cccCccCCHHHHHHHHHHccCCHhHCcCHHHHhCC
Confidence 01111123346679999999999999999999975
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.1e-52 Score=405.75 Aligned_cols=263 Identities=27% Similarity=0.384 Sum_probs=207.4
Q ss_pred HHHHhhCCcccceeEeeeCceEEEEEEEcCCCEEEEEEEcccchhhHHHHHHHHHHHhcCCCCCceeEEEEEEeCceeeE
Q 010519 180 DLEIATNRFSAENVLGEGGYGVVYKGRLINGSEVAVKKLLNNLGQAEKEFRVEVEAIGHVRHKNLVRLLGYCIEGVHRML 259 (508)
Q Consensus 180 ~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~ei~~l~~l~h~niv~~~~~~~~~~~~~l 259 (508)
+|++..++|++.+.||+|+||+||+|++.++..||||++... ....+.|.+|+.+|++++|||||+++++|. ++..++
T Consensus 11 ~~~i~~~~~~i~~~iG~G~fg~Vy~~~~~~~~~vAiK~l~~~-~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~-~~~~~l 88 (285)
T d1fmka3 11 AWEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPG-TMSPEAFLQEAQVMKKLRHEKLVQLYAVVS-EEPIYI 88 (285)
T ss_dssp CSBCCGGGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTT-SSCHHHHHHHHHHHHHCCCTTBCCEEEEEC-SSSCEE
T ss_pred ceEcCHHHEEEeeEEeeCCCeEEEEEEECCCCEEEEEEECcc-cCCHHHHHHHHHHHHhcccCCEeEEEEEEe-cCCeEE
Confidence 345667899999999999999999999988889999998644 334567999999999999999999999985 456789
Q ss_pred EEeecCCCCHHHHHhhhhccCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCEEEcCCCcEEEEecCCcccc
Q 010519 260 VYEYVNNGNLEQWLHGAMRNQGNLTWEARMKVIIGTAKALAYLHEAIEPKVVHRDIKSSNILIDDEFNAKVSDFGLAKLL 339 (508)
Q Consensus 260 v~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~Dfgla~~~ 339 (508)
||||+++|+|..++.. .....+++..++.++.||+.||+|||++ +|+||||||+||||++++.+||+|||+++..
T Consensus 89 v~Ey~~~g~l~~~~~~--~~~~~l~~~~~~~i~~~i~~gl~~LH~~---~ivH~DlKp~NIll~~~~~~kl~DfGla~~~ 163 (285)
T d1fmka3 89 VTEYMSKGSLLDFLKG--ETGKYLRLPQLVDMAAQIASGMAYVERM---NYVHRDLRAANILVGENLVCKVADFGLARLI 163 (285)
T ss_dssp EECCCTTCBHHHHHSH--HHHTTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCCCTTC--
T ss_pred EEEecCCCchhhhhhh--cccccchHHHHHHHHHHHHHHHHHHhhh---heecccccceEEEECCCCcEEEcccchhhhc
Confidence 9999999999999864 3345699999999999999999999999 9999999999999999999999999999877
Q ss_pred CCCCCcccccccccccccCccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCCCchhcHHHHHHHHhcccccccccC
Q 010519 340 DSGESHITTRVMGTFGYVAPEYANTGMLNEKSDIYSFGVLLLEAVTGRDPVDYGRPANEVNLVEWLKMMVGTRRAEEVVD 419 (508)
Q Consensus 340 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 419 (508)
............||+.|+|||++.++.++.++|||||||+||||++|..||..... ..+.+..+.....
T Consensus 164 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~S~Giil~el~t~~~p~~~~~~-----~~~~~~~i~~~~~------ 232 (285)
T d1fmka3 164 EDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMV-----NREVLDQVERGYR------ 232 (285)
T ss_dssp ------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCC-----HHHHHHHHHTTCC------
T ss_pred cCCCceeeccccccccccChHHHhCCCCCcHHhhhcchHHHHHHHhCCCCCCCCCC-----HHHHHHHHHhcCC------
Confidence 55544445556789999999999999999999999999999999997777643332 1222222221111
Q ss_pred CCCCCChhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhhcCCC
Q 010519 420 PNLEVKPATRALKRSLLVALRCVDPDSEKRPKMSQVVRMLEADDY 464 (508)
Q Consensus 420 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~ 464 (508)
. +.+......+.+|+.+||+.||++|||+.+|+++|+..-.
T Consensus 233 ~----~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~~~~ 273 (285)
T d1fmka3 233 M----PCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFT 273 (285)
T ss_dssp C----CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTS
T ss_pred C----CCCcccCHHHHHHHHHHcccCHhHCcCHHHHHHHHhhhhc
Confidence 1 1111233467779999999999999999999999987553
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.6e-52 Score=414.58 Aligned_cols=263 Identities=26% Similarity=0.416 Sum_probs=208.4
Q ss_pred HHHhhCCcccceeEeeeCceEEEEEEEcCC------CEEEEEEEcccc-hhhHHHHHHHHHHHhcC-CCCCceeEEEEEE
Q 010519 181 LEIATNRFSAENVLGEGGYGVVYKGRLING------SEVAVKKLLNNL-GQAEKEFRVEVEAIGHV-RHKNLVRLLGYCI 252 (508)
Q Consensus 181 ~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~------~~vavK~~~~~~-~~~~~~~~~ei~~l~~l-~h~niv~~~~~~~ 252 (508)
|++..++|++.+.||+|+||+||+|++... ..||+|++.... ......+.+|+.+|.++ +|||||+++++|.
T Consensus 32 wei~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~ 111 (325)
T d1rjba_ 32 WEFPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACT 111 (325)
T ss_dssp GBCCGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred ccCCHHHeEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEeccccCHHHHHHHHHHHHHHHHhcCCCcEeEEEEEEe
Confidence 456778999999999999999999987532 268999886543 23345788899999998 8999999999999
Q ss_pred eCceeeEEEeecCCCCHHHHHhhhhc-------------------cCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEee
Q 010519 253 EGVHRMLVYEYVNNGNLEQWLHGAMR-------------------NQGNLTWEARMKVIIGTAKALAYLHEAIEPKVVHR 313 (508)
Q Consensus 253 ~~~~~~lv~E~~~~gsL~~~l~~~~~-------------------~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiH~ 313 (508)
+....++|||||++|+|.++|+.... ....+++..++.++.||+.||.|||++ +|+||
T Consensus 112 ~~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~~---~IiHR 188 (325)
T d1rjba_ 112 LSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFK---SCVHR 188 (325)
T ss_dssp SSSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHT---TEEET
T ss_pred eCCeEEEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhC---Ceeec
Confidence 99999999999999999999964321 123589999999999999999999999 99999
Q ss_pred cCCCCCEEEcCCCcEEEEecCCccccCCCCCc-ccccccccccccCccccCCCCCCChhhHHHHHHHHHHHHh-CCCCCC
Q 010519 314 DIKSSNILIDDEFNAKVSDFGLAKLLDSGESH-ITTRVMGTFGYVAPEYANTGMLNEKSDIYSFGVLLLEAVT-GRDPVD 391 (508)
Q Consensus 314 Dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~ellt-G~~Pf~ 391 (508)
||||+|||++.++.+||+|||+|+........ ......||+.|+|||++.++.|+.++|||||||+||||+| |..||.
T Consensus 189 DlKp~Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwS~Gvil~emlt~g~~Pf~ 268 (325)
T d1rjba_ 189 DLAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYP 268 (325)
T ss_dssp TCSGGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSST
T ss_pred cCchhccccccCCeEEEeeccccccccCCCceeeeccccCCCccCChHHHcCCCCCcceeccchhHHHHHHHhCCCCCCC
Confidence 99999999999999999999999866543322 2345678999999999999999999999999999999998 899996
Q ss_pred CCCCCchhcHHHHHHHHhcccccccccCCCCCCChhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhhc
Q 010519 392 YGRPANEVNLVEWLKMMVGTRRAEEVVDPNLEVKPATRALKRSLLVALRCVDPDSEKRPKMSQVVRMLEA 461 (508)
Q Consensus 392 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~ 461 (508)
...... .+.. ..... ...+.+......+.+|+.+||+.||.+|||++||+++|..
T Consensus 269 ~~~~~~--~~~~----~~~~~---------~~~~~p~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~~ 323 (325)
T d1rjba_ 269 GIPVDA--NFYK----LIQNG---------FKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLGC 323 (325)
T ss_dssp TCCCSH--HHHH----HHHTT---------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred CCCHHH--HHHH----HHhcC---------CCCCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHhC
Confidence 433221 1111 11111 1111122234567779999999999999999999999963
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-51 Score=403.06 Aligned_cols=256 Identities=25% Similarity=0.398 Sum_probs=206.8
Q ss_pred hhCCccccee-EeeeCceEEEEEEEc---CCCEEEEEEEcccc-hhhHHHHHHHHHHHhcCCCCCceeEEEEEEeCceee
Q 010519 184 ATNRFSAENV-LGEGGYGVVYKGRLI---NGSEVAVKKLLNNL-GQAEKEFRVEVEAIGHVRHKNLVRLLGYCIEGVHRM 258 (508)
Q Consensus 184 ~~~~~~~~~~-lg~G~~g~Vy~~~~~---~~~~vavK~~~~~~-~~~~~~~~~ei~~l~~l~h~niv~~~~~~~~~~~~~ 258 (508)
..++|.+.+. ||+|+||+||+|.+. ++..||||++.... ....+.|.+|+++|++++|||||+++++|.+ +..|
T Consensus 6 ~~~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~-~~~~ 84 (285)
T d1u59a_ 6 KRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALM 84 (285)
T ss_dssp CGGGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEE
T ss_pred cccCeEECCcEEecccCeEEEEEEEecCCCcEEEEEEEEChhcCHHHHHHHHHHHHHHHhCCCCCEeeEeeeecc-CeEE
Confidence 3457777775 999999999999764 34579999986544 3445779999999999999999999999865 4678
Q ss_pred EEEeecCCCCHHHHHhhhhccCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCEEEcCCCcEEEEecCCccc
Q 010519 259 LVYEYVNNGNLEQWLHGAMRNQGNLTWEARMKVIIGTAKALAYLHEAIEPKVVHRDIKSSNILIDDEFNAKVSDFGLAKL 338 (508)
Q Consensus 259 lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~Dfgla~~ 338 (508)
|||||+++|+|.+++. .....+++..++.++.||+.||.|||++ +|+||||||+|||++.++.+||+|||+++.
T Consensus 85 lvmE~~~~g~L~~~l~---~~~~~l~~~~~~~i~~qi~~gL~ylH~~---~iiHrDlKp~Nill~~~~~~Kl~DFGla~~ 158 (285)
T d1u59a_ 85 LVMEMAGGGPLHKFLV---GKREEIPVSNVAELLHQVSMGMKYLEEK---NFVHRDLAARNVLLVNRHYAKISDFGLSKA 158 (285)
T ss_dssp EEEECCTTEEHHHHHT---TCTTTSCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEEETTEEEECCCTTCEE
T ss_pred EEEEeCCCCcHHHHhh---ccccCCCHHHHHHHHHHHHHHHHHHHhC---CeecCcCchhheeeccCCceeeccchhhhc
Confidence 9999999999999985 3456799999999999999999999999 999999999999999999999999999997
Q ss_pred cCCCCCc--ccccccccccccCccccCCCCCCChhhHHHHHHHHHHHHh-CCCCCCCCCCCchhcHHHHHHHHhcccccc
Q 010519 339 LDSGESH--ITTRVMGTFGYVAPEYANTGMLNEKSDIYSFGVLLLEAVT-GRDPVDYGRPANEVNLVEWLKMMVGTRRAE 415 (508)
Q Consensus 339 ~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~ 415 (508)
....... ......||+.|+|||++.++.++.++|||||||+||||+| |+.||...... .+ .........
T Consensus 159 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~~~---~~---~~~i~~~~~-- 230 (285)
T d1u59a_ 159 LGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGP---EV---MAFIEQGKR-- 230 (285)
T ss_dssp CTTCSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTH---HH---HHHHHTTCC--
T ss_pred ccccccccccccccccCccccChHHHhCCCCCccchhhcchHHHHHHHhCCCCCCCCCCHH---HH---HHHHHcCCC--
Confidence 7544322 2234568999999999999999999999999999999998 99999744321 11 222221111
Q ss_pred cccCCCCCCChhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhhcC
Q 010519 416 EVVDPNLEVKPATRALKRSLLVALRCVDPDSEKRPKMSQVVRMLEAD 462 (508)
Q Consensus 416 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~ 462 (508)
+. .+...+..+.+|+.+||+.||.+|||+.+|++.|+..
T Consensus 231 ----~~----~p~~~~~~l~~li~~cl~~~p~~RPs~~~i~~~L~~~ 269 (285)
T d1u59a_ 231 ----ME----CPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRAC 269 (285)
T ss_dssp ----CC----CCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHH
T ss_pred ----CC----CCCcCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHH
Confidence 11 1122345667799999999999999999999988754
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3e-51 Score=400.07 Aligned_cols=259 Identities=27% Similarity=0.462 Sum_probs=202.3
Q ss_pred HhhCCcccceeEeeeCceEEEEEEEcCC-----CEEEEEEEcccc-hhhHHHHHHHHHHHhcCCCCCceeEEEEEEeCce
Q 010519 183 IATNRFSAENVLGEGGYGVVYKGRLING-----SEVAVKKLLNNL-GQAEKEFRVEVEAIGHVRHKNLVRLLGYCIEGVH 256 (508)
Q Consensus 183 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~-----~~vavK~~~~~~-~~~~~~~~~ei~~l~~l~h~niv~~~~~~~~~~~ 256 (508)
+..+.|++.++||+|+||+||+|.+..+ ..||||++.... ......|.+|+.++++++|||||+++|++.+...
T Consensus 4 i~~~~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~~~g~~~~~~~ 83 (283)
T d1mqba_ 4 IHPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKP 83 (283)
T ss_dssp CCTTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSS
T ss_pred CCHHHeEeeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECcccChHHHHHHHHHHHHHHhcCCCCEeeeeEEEecCCc
Confidence 3456899999999999999999987643 369999986543 3344578899999999999999999999999999
Q ss_pred eeEEEeecCCCCHHHHHhhhhccCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCEEEcCCCcEEEEecCCc
Q 010519 257 RMLVYEYVNNGNLEQWLHGAMRNQGNLTWEARMKVIIGTAKALAYLHEAIEPKVVHRDIKSSNILIDDEFNAKVSDFGLA 336 (508)
Q Consensus 257 ~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~Dfgla 336 (508)
.++||||+.+|+|.+++. .....+++..++.++.||+.||+|||++ +|+||||||+||||+.++.+||+|||++
T Consensus 84 ~~~v~e~~~~~~l~~~~~---~~~~~~~~~~~~~i~~~i~~gl~~lH~~---~iiHrDlKp~NILl~~~~~~Kl~DFGla 157 (283)
T d1mqba_ 84 MMIITEYMENGALDKFLR---EKDGEFSVLQLVGMLRGIAAGMKYLANM---NYVHRDLAARNILVNSNLVCKVSDFGLS 157 (283)
T ss_dssp EEEEEECCTTEEHHHHHH---HTTTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCCCC-
T ss_pred eEEEEEecccCcchhhhh---cccccccHHHHHHHHHHHHHhhhhcccc---ccccCccccceEEECCCCeEEEcccchh
Confidence 999999999999999875 3456799999999999999999999999 9999999999999999999999999999
Q ss_pred cccCCCCC--cccccccccccccCccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCCCchhcHHHHHHHHhccccc
Q 010519 337 KLLDSGES--HITTRVMGTFGYVAPEYANTGMLNEKSDIYSFGVLLLEAVTGRDPVDYGRPANEVNLVEWLKMMVGTRRA 414 (508)
Q Consensus 337 ~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~ 414 (508)
+....... .......||+.|+|||++.++.++.++|||||||+||||++|..||...... .+.+..+....+
T Consensus 158 ~~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~sDI~S~Gvil~el~t~~~~~~~~~~~-----~~~~~~i~~~~~- 231 (283)
T d1mqba_ 158 RVLEDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSN-----HEVMKAINDGFR- 231 (283)
T ss_dssp ----------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCH-----HHHHHHHHTTCC-
T ss_pred hcccCCCccceEeccCCCCccccCHHHHccCCCCCcccccccHHHHHHHHhCCCCccccCCH-----HHHHHHHhccCC-
Confidence 87654322 1233456899999999999999999999999999999999977666433321 122222221111
Q ss_pred ccccCCCCCCChhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhhcC
Q 010519 415 EEVVDPNLEVKPATRALKRSLLVALRCVDPDSEKRPKMSQVVRMLEAD 462 (508)
Q Consensus 415 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~ 462 (508)
.+.+...+..+.+|+.+||+.||.+|||+.||++.|+..
T Consensus 232 ---------~~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~L~~l 270 (283)
T d1mqba_ 232 ---------LPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKL 270 (283)
T ss_dssp ---------CCCCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHH
T ss_pred ---------CCCchhhHHHHHHHHHHHCcCCHhHCcCHHHHHHHHHHH
Confidence 111122345567799999999999999999999999754
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Probab=100.00 E-value=2.3e-51 Score=411.84 Aligned_cols=253 Identities=22% Similarity=0.333 Sum_probs=210.9
Q ss_pred CCcccceeEeeeCceEEEEEEEc-CCCEEEEEEEcccchhhHHHHHHHHHHHhcCCCCCceeEEEEEEeCceeeEEEeec
Q 010519 186 NRFSAENVLGEGGYGVVYKGRLI-NGSEVAVKKLLNNLGQAEKEFRVEVEAIGHVRHKNLVRLLGYCIEGVHRMLVYEYV 264 (508)
Q Consensus 186 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~ei~~l~~l~h~niv~~~~~~~~~~~~~lv~E~~ 264 (508)
++|++.+.||+|+||+||+|++. +|+.||||++........+.+.+|+.+|++++|||||++++++.+++..|||||||
T Consensus 26 ~~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmE~~ 105 (350)
T d1koaa2 26 DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFM 105 (350)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEEETTEEEEEECCC
T ss_pred cCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEcccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEcC
Confidence 58999999999999999999975 68899999997766666678899999999999999999999999999999999999
Q ss_pred CCCCHHHHHhhhhccCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCEEEc--CCCcEEEEecCCccccCCC
Q 010519 265 NNGNLEQWLHGAMRNQGNLTWEARMKVIIGTAKALAYLHEAIEPKVVHRDIKSSNILID--DEFNAKVSDFGLAKLLDSG 342 (508)
Q Consensus 265 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiH~Dlk~~NIll~--~~~~~kl~Dfgla~~~~~~ 342 (508)
++|+|.+++. ...+.+++..++.++.||+.||.|||++ +|+||||||+|||++ .++.+||+|||+++.....
T Consensus 106 ~gg~L~~~l~---~~~~~l~e~~~~~i~~qi~~aL~ylH~~---~iiHrDiKp~NIll~~~~~~~vkL~DFG~a~~~~~~ 179 (350)
T d1koaa2 106 SGGELFEKVA---DEHNKMSEDEAVEYMRQVCKGLCHMHEN---NYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPK 179 (350)
T ss_dssp CSCBHHHHHT---CTTSCBCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSTTSCCEEECCCTTCEECCTT
T ss_pred CCCCHHHHHH---hhcCCCCHHHHHHHHHHHHHHHHHHHhc---CCeeeeechhHeeeccCCCCeEEEeecchheecccc
Confidence 9999999985 3456799999999999999999999999 999999999999996 4678999999999977544
Q ss_pred CCcccccccccccccCccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCCCchhcHHHHHHHHhcccccccccCCCC
Q 010519 343 ESHITTRVMGTFGYVAPEYANTGMLNEKSDIYSFGVLLLEAVTGRDPVDYGRPANEVNLVEWLKMMVGTRRAEEVVDPNL 422 (508)
Q Consensus 343 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 422 (508)
. ......||+.|+|||++.+..|+.++|||||||++|||++|+.||.... . .+.+....... ..+
T Consensus 180 ~--~~~~~~gT~~Y~aPEv~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~---~---~~~~~~i~~~~-------~~~ 244 (350)
T d1koaa2 180 Q--SVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGEN---D---DETLRNVKSCD-------WNM 244 (350)
T ss_dssp S--CEEEECSCTTTCCHHHHHTCCBCHHHHHHHHHHHHHHHHHSSCSSCCSS---H---HHHHHHHHHTC-------CCS
T ss_pred c--ccceecCcccccCHHHHcCCCCChhHhhhhhhHHHHHHHhCCCCCCCCC---H---HHHHHHHHhCC-------CCC
Confidence 3 2345679999999999999999999999999999999999999996332 1 12222221110 111
Q ss_pred CCChhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHh
Q 010519 423 EVKPATRALKRSLLVALRCVDPDSEKRPKMSQVVRML 459 (508)
Q Consensus 423 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L 459 (508)
...........+.+|+.+||..||.+|||++|+++|-
T Consensus 245 ~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~hp 281 (350)
T d1koaa2 245 DDSAFSGISEDGKDFIRKLLLADPNTRMTIHQALEHP 281 (350)
T ss_dssp CCGGGGGCCHHHHHHHHHHCCSSGGGSCCHHHHHHST
T ss_pred CcccccCCCHHHHHHHHHHccCChhHCcCHHHHhcCc
Confidence 1111222345677799999999999999999999973
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=1.1e-51 Score=407.14 Aligned_cols=253 Identities=24% Similarity=0.353 Sum_probs=191.9
Q ss_pred hCCcccceeEeeeCceEEEEEEEc-CCCEEEEEEEcccc-hhhHHHHHHHHHHHhcCCCCCceeEEEEEEeCceeeEEEe
Q 010519 185 TNRFSAENVLGEGGYGVVYKGRLI-NGSEVAVKKLLNNL-GQAEKEFRVEVEAIGHVRHKNLVRLLGYCIEGVHRMLVYE 262 (508)
Q Consensus 185 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~ei~~l~~l~h~niv~~~~~~~~~~~~~lv~E 262 (508)
.+.|++.+.||+|+||+||+|++. +|+.||||++.... ......+.+|+.+|++++|||||++++++.++...|||||
T Consensus 8 ~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lvmE 87 (307)
T d1a06a_ 8 RDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLIMQ 87 (307)
T ss_dssp GGTEEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC----------CHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred ccceEEEEEEeeccCeEEEEEEECCCCCEEEEEEEchHHhhhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEe
Confidence 467999999999999999999985 68899999986543 2334567889999999999999999999999999999999
Q ss_pred ecCCCCHHHHHhhhhccCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCEEEc---CCCcEEEEecCCcccc
Q 010519 263 YVNNGNLEQWLHGAMRNQGNLTWEARMKVIIGTAKALAYLHEAIEPKVVHRDIKSSNILID---DEFNAKVSDFGLAKLL 339 (508)
Q Consensus 263 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiH~Dlk~~NIll~---~~~~~kl~Dfgla~~~ 339 (508)
||+||+|.++|. ..+.+++..+..++.||+.||.|||++ +|+||||||+|||+. +++.+||+|||+++..
T Consensus 88 ~~~gg~L~~~l~----~~~~l~e~~~~~~~~qi~~al~ylH~~---~iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a~~~ 160 (307)
T d1a06a_ 88 LVSGGELFDRIV----EKGFYTERDASRLIFQVLDAVKYLHDL---GIVHRDLKPENLLYYSLDEDSKIMISDFGLSKME 160 (307)
T ss_dssp CCCSCBHHHHHH----TCSCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESSSSTTCCEEECCC------
T ss_pred ccCCCcHHHhhh----cccCCCHHHHHHHHHHHHHHHHhhhhc---eeeeEEecccceeecccCCCceEEEeccceeEEc
Confidence 999999999994 456799999999999999999999999 999999999999995 5789999999999876
Q ss_pred CCCCCcccccccccccccCccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCCCchhcHHHHHHHHhcccccccccC
Q 010519 340 DSGESHITTRVMGTFGYVAPEYANTGMLNEKSDIYSFGVLLLEAVTGRDPVDYGRPANEVNLVEWLKMMVGTRRAEEVVD 419 (508)
Q Consensus 340 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 419 (508)
.... .....+||+.|+|||++.+..|+.++|||||||+||||++|+.||..... . +.........
T Consensus 161 ~~~~--~~~~~~GT~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~---~---~~~~~i~~~~------- 225 (307)
T d1a06a_ 161 DPGS--VLSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDEND---A---KLFEQILKAE------- 225 (307)
T ss_dssp --------------CTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSH---H---HHHHHHHTTC-------
T ss_pred cCCC--eeeeeeeCccccCcHHHcCCCCCcHHHhhhhhHHHHHHHhCCCCCCCCCH---H---HHHHHHhccC-------
Confidence 5433 23456799999999999999999999999999999999999999964321 1 1111211111
Q ss_pred CCCCCChhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHh
Q 010519 420 PNLEVKPATRALKRSLLVALRCVDPDSEKRPKMSQVVRML 459 (508)
Q Consensus 420 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L 459 (508)
..+...........+.+|+.+||+.||.+|||++|+++|-
T Consensus 226 ~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp 265 (307)
T d1a06a_ 226 YEFDSPYWDDISDSAKDFIRHLMEKDPEKRFTCEQALQHP 265 (307)
T ss_dssp CCCCTTTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHST
T ss_pred CCCCCccccCCCHHHHHHHHHHccCCHhHCcCHHHHhcCH
Confidence 1111111122345567799999999999999999999863
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=1.3e-51 Score=406.93 Aligned_cols=245 Identities=25% Similarity=0.365 Sum_probs=201.2
Q ss_pred CcccceeEeeeCceEEEEEEEc-CCCEEEEEEEcccc---hhhHHHHHHHHHHHhcCCCCCceeEEEEEEeCceeeEEEe
Q 010519 187 RFSAENVLGEGGYGVVYKGRLI-NGSEVAVKKLLNNL---GQAEKEFRVEVEAIGHVRHKNLVRLLGYCIEGVHRMLVYE 262 (508)
Q Consensus 187 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~ei~~l~~l~h~niv~~~~~~~~~~~~~lv~E 262 (508)
.|+..+.||+|+||+||+|++. +|+.||||++.... ....+.+.+|+.+|++++|||||++++++.++...|||||
T Consensus 16 ~y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv~E 95 (309)
T d1u5ra_ 16 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVME 95 (309)
T ss_dssp HEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred hcEeeEEEecCCCeEEEEEEECCCCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEECCEEEEEEE
Confidence 5999999999999999999875 68889999986543 2334568899999999999999999999999999999999
Q ss_pred ecCCCCHHHHHhhhhccCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCEEEcCCCcEEEEecCCccccCCC
Q 010519 263 YVNNGNLEQWLHGAMRNQGNLTWEARMKVIIGTAKALAYLHEAIEPKVVHRDIKSSNILIDDEFNAKVSDFGLAKLLDSG 342 (508)
Q Consensus 263 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~~ 342 (508)
||.+|+|..++ .....+++..++.++.||+.||.|||++ +|+||||||+||||+.++.+||+|||++.....
T Consensus 96 ~~~~g~l~~~~----~~~~~l~e~~~~~i~~qi~~aL~yLH~~---~iiHrDiKp~NILl~~~~~~Kl~DFG~a~~~~~- 167 (309)
T d1u5ra_ 96 YCLGSASDLLE----VHKKPLQEVEIAAVTHGALQGLAYLHSH---NMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP- 167 (309)
T ss_dssp CCSEEHHHHHH----HHTSCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSGGGEEEETTTEEEECCCTTCBSSSS-
T ss_pred ecCCCchHHHH----HhCCCCCHHHHHHHHHHHHHHHHHHHhC---CEeccCCCcceEEECCCCCEEEeecccccccCC-
Confidence 99999987766 3456799999999999999999999999 999999999999999999999999999986543
Q ss_pred CCcccccccccccccCccccCC---CCCCChhhHHHHHHHHHHHHhCCCCCCCCCCCchhcHHHHHHHHhcccccccccC
Q 010519 343 ESHITTRVMGTFGYVAPEYANT---GMLNEKSDIYSFGVLLLEAVTGRDPVDYGRPANEVNLVEWLKMMVGTRRAEEVVD 419 (508)
Q Consensus 343 ~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~DvwS~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 419 (508)
....+||+.|+|||++.+ ..|+.++|||||||+||||++|..||..... .+.+........
T Consensus 168 ----~~~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~~~------~~~~~~i~~~~~------ 231 (309)
T d1u5ra_ 168 ----ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNA------MSALYHIAQNES------ 231 (309)
T ss_dssp ----BCCCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCH------HHHHHHHHHSCC------
T ss_pred ----CCccccCccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHCCCCCCCCCH------HHHHHHHHhCCC------
Confidence 234579999999999864 4689999999999999999999999964321 111212211111
Q ss_pred CCCCCChhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 010519 420 PNLEVKPATRALKRSLLVALRCVDPDSEKRPKMSQVVRM 458 (508)
Q Consensus 420 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 458 (508)
+.+.. ......+.+|+.+||+.||.+|||++|+++|
T Consensus 232 ~~~~~---~~~s~~~~~li~~~L~~dP~~Rpt~~ell~H 267 (309)
T d1u5ra_ 232 PALQS---GHWSEYFRNFVDSCLQKIPQDRPTSEVLLKH 267 (309)
T ss_dssp CCCSC---TTSCHHHHHHHHHHTCSSGGGSCCHHHHTTC
T ss_pred CCCCC---CCCCHHHHHHHHHHCcCChhHCcCHHHHHhC
Confidence 11111 1123456679999999999999999999985
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.6e-51 Score=399.99 Aligned_cols=259 Identities=23% Similarity=0.372 Sum_probs=198.6
Q ss_pred HHHhhCCcccceeEeeeCceEEEEEEEcC----CCEEEEEEEcccc-hhhHHHHHHHHHHHhcCCCCCceeEEEEEEeCc
Q 010519 181 LEIATNRFSAENVLGEGGYGVVYKGRLIN----GSEVAVKKLLNNL-GQAEKEFRVEVEAIGHVRHKNLVRLLGYCIEGV 255 (508)
Q Consensus 181 ~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~----~~~vavK~~~~~~-~~~~~~~~~ei~~l~~l~h~niv~~~~~~~~~~ 255 (508)
+++..++|++.+.||+|+||+||+|++.. +..||||++.... ....+.+.+|+.+|++++|||||++++++. .+
T Consensus 2 ~ei~~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~ 80 (273)
T d1mp8a_ 2 YEIQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-EN 80 (273)
T ss_dssp CBCCGGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SS
T ss_pred CCcCHHHeEEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEe-cC
Confidence 35667899999999999999999998743 3468888875433 334567899999999999999999999985 56
Q ss_pred eeeEEEeecCCCCHHHHHhhhhccCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCEEEcCCCcEEEEecCC
Q 010519 256 HRMLVYEYVNNGNLEQWLHGAMRNQGNLTWEARMKVIIGTAKALAYLHEAIEPKVVHRDIKSSNILIDDEFNAKVSDFGL 335 (508)
Q Consensus 256 ~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~Dfgl 335 (508)
..++||||+++|+|.+++. .....+++..++.++.||+.||.|||++ +|+||||||+|||+++++.+||+|||+
T Consensus 81 ~~~iv~E~~~~g~l~~~~~---~~~~~l~~~~~~~~~~qi~~gl~ylH~~---~iiHrDlKp~NIll~~~~~~Kl~DfG~ 154 (273)
T d1mp8a_ 81 PVWIIMELCTLGELRSFLQ---VRKYSLDLASLILYAYQLSTALAYLESK---RFVHRDIAARNVLVSSNDCVKLGDFGL 154 (273)
T ss_dssp SCEEEEECCTTEEHHHHHH---HTTTTSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECC---
T ss_pred eEEEEEEeccCCcHHhhhh---ccCCCCCHHHHHHHHHHHHHHhhhhccc---CeeccccchhheeecCCCcEEEccchh
Confidence 7899999999999999875 3456799999999999999999999999 999999999999999999999999999
Q ss_pred ccccCCCCCcccccccccccccCccccCCCCCCChhhHHHHHHHHHHHHh-CCCCCCCCCCCchhcHHHHHHHHhccccc
Q 010519 336 AKLLDSGESHITTRVMGTFGYVAPEYANTGMLNEKSDIYSFGVLLLEAVT-GRDPVDYGRPANEVNLVEWLKMMVGTRRA 414 (508)
Q Consensus 336 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~ 414 (508)
++..............||+.|+|||++.+..|+.++|||||||+||||++ |..||...... .+.. .......
T Consensus 155 a~~~~~~~~~~~~~~~gt~~y~apE~l~~~~~~~~~DiwSlGvil~e~lt~g~~P~~~~~~~---~~~~---~i~~~~~- 227 (273)
T d1mp8a_ 155 SRYMEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNN---DVIG---RIENGER- 227 (273)
T ss_dssp ----------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGG---GHHH---HHHTTCC-
T ss_pred heeccCCcceeccceecCcccchhhHhccCCCCCccccccchHHHHHHHhcCCCCCCCCCHH---HHHH---HHHcCCC-
Confidence 98766544444555678999999999999999999999999999999998 88888654332 2222 1111111
Q ss_pred ccccCCCCCCChhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhhcC
Q 010519 415 EEVVDPNLEVKPATRALKRSLLVALRCVDPDSEKRPKMSQVVRMLEAD 462 (508)
Q Consensus 415 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~ 462 (508)
+ +.+...+..+.+|+.+||+.||.+|||+.||+++|+..
T Consensus 228 -----~----~~~~~~~~~~~~li~~cl~~dp~~Rps~~ei~~~L~~i 266 (273)
T d1mp8a_ 228 -----L----PMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTI 266 (273)
T ss_dssp -----C----CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred -----C----CCCCCCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHH
Confidence 1 11112345677799999999999999999999999754
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.8e-51 Score=397.07 Aligned_cols=247 Identities=29% Similarity=0.410 Sum_probs=197.1
Q ss_pred eeEeeeCceEEEEEEEcC---CCEEEEEEEcccc--hhhHHHHHHHHHHHhcCCCCCceeEEEEEEeCceeeEEEeecCC
Q 010519 192 NVLGEGGYGVVYKGRLIN---GSEVAVKKLLNNL--GQAEKEFRVEVEAIGHVRHKNLVRLLGYCIEGVHRMLVYEYVNN 266 (508)
Q Consensus 192 ~~lg~G~~g~Vy~~~~~~---~~~vavK~~~~~~--~~~~~~~~~ei~~l~~l~h~niv~~~~~~~~~~~~~lv~E~~~~ 266 (508)
+.||+|+||+||+|.+.+ ++.||||++.... ....+.|.+|+.+|++++|||||+++++|.. +..+|||||+++
T Consensus 13 k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~-~~~~lvmE~~~~ 91 (277)
T d1xbba_ 13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAEL 91 (277)
T ss_dssp EEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEES-SSEEEEEECCTT
T ss_pred CCcccCCCeEEEEEEEccCCcCeEEEEEEEChhhCCHHHHHHHHHHHHHHHhCCCCCCceEEEEecc-CCEEEEEEcCCC
Confidence 579999999999998753 4579999985433 2334679999999999999999999999865 457899999999
Q ss_pred CCHHHHHhhhhccCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCEEEcCCCcEEEEecCCccccCCCCCc-
Q 010519 267 GNLEQWLHGAMRNQGNLTWEARMKVIIGTAKALAYLHEAIEPKVVHRDIKSSNILIDDEFNAKVSDFGLAKLLDSGESH- 345 (508)
Q Consensus 267 gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~- 345 (508)
|+|.+++. ....+++..++.++.||+.||.|||++ +|+||||||+|||++.++.+||+|||+++........
T Consensus 92 g~L~~~l~----~~~~l~~~~~~~i~~qi~~gl~ylH~~---~iiHrDlKp~Nill~~~~~~kl~DFGla~~~~~~~~~~ 164 (277)
T d1xbba_ 92 GPLNKYLQ----QNRHVKDKNIIELVHQVSMGMKYLEES---NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYY 164 (277)
T ss_dssp EEHHHHHH----HCTTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEETTEEEECCCTTCEECCTTCSEE
T ss_pred CcHHHHHh----hccCCCHHHHHHHHHHHHHHHhhHHhC---CcccCCCcchhhcccccCcccccchhhhhhcccccccc
Confidence 99999984 456799999999999999999999999 9999999999999999999999999999876544332
Q ss_pred -ccccccccccccCccccCCCCCCChhhHHHHHHHHHHHHh-CCCCCCCCCCCchhcHHHHHHHHhcccccccccCCCCC
Q 010519 346 -ITTRVMGTFGYVAPEYANTGMLNEKSDIYSFGVLLLEAVT-GRDPVDYGRPANEVNLVEWLKMMVGTRRAEEVVDPNLE 423 (508)
Q Consensus 346 -~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 423 (508)
......||+.|+|||++.+..++.++|||||||++|||++ |+.||..... . +.......... +.
T Consensus 165 ~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gv~l~ellt~g~~Pf~~~~~---~---~~~~~i~~~~~------~~-- 230 (277)
T d1xbba_ 165 KAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKG---S---EVTAMLEKGER------MG-- 230 (277)
T ss_dssp EC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCH---H---HHHHHHHTTCC------CC--
T ss_pred ccccccCCCceecCchhhcCCCCCchhhhccchhhhhHHhhCCCCCCCCCCH---H---HHHHHHHcCCC------CC--
Confidence 2334578999999999999999999999999999999998 8999964321 1 22222221111 11
Q ss_pred CChhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhhcC
Q 010519 424 VKPATRALKRSLLVALRCVDPDSEKRPKMSQVVRMLEAD 462 (508)
Q Consensus 424 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~ 462 (508)
.+...+..+.+|+.+||+.||.+|||+++|++.|+..
T Consensus 231 --~p~~~~~~~~~li~~cl~~dp~~RPs~~~i~~~L~~~ 267 (277)
T d1xbba_ 231 --CPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNY 267 (277)
T ss_dssp --CCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHH
T ss_pred --CCcccCHHHHHHHHHHcCCCHhHCcCHHHHHHHhhCH
Confidence 1112335667799999999999999999999888753
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Probab=100.00 E-value=1.2e-50 Score=407.05 Aligned_cols=252 Identities=19% Similarity=0.288 Sum_probs=209.6
Q ss_pred CCcccceeEeeeCceEEEEEEEc-CCCEEEEEEEcccchhhHHHHHHHHHHHhcCCCCCceeEEEEEEeCceeeEEEeec
Q 010519 186 NRFSAENVLGEGGYGVVYKGRLI-NGSEVAVKKLLNNLGQAEKEFRVEVEAIGHVRHKNLVRLLGYCIEGVHRMLVYEYV 264 (508)
Q Consensus 186 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~ei~~l~~l~h~niv~~~~~~~~~~~~~lv~E~~ 264 (508)
++|++.+.||+|+||+||+|++. +|+.||||++..........+.+|+.+|++++|||||+++++|.++...|||||||
T Consensus 29 d~Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivmE~~ 108 (352)
T d1koba_ 29 DYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEFL 108 (352)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEECC
T ss_pred cceEEEEEEecCCCeEEEEEEECCCCCEEEEEEECCcchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEcC
Confidence 47999999999999999999975 79999999987665555677889999999999999999999999999999999999
Q ss_pred CCCCHHHHHhhhhccCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCEEEc--CCCcEEEEecCCccccCCC
Q 010519 265 NNGNLEQWLHGAMRNQGNLTWEARMKVIIGTAKALAYLHEAIEPKVVHRDIKSSNILID--DEFNAKVSDFGLAKLLDSG 342 (508)
Q Consensus 265 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiH~Dlk~~NIll~--~~~~~kl~Dfgla~~~~~~ 342 (508)
++|+|.+++. .....+++..++.++.||+.||.|||++ +|+||||||+||||+ .++.+||+|||++......
T Consensus 109 ~gg~L~~~~~---~~~~~l~e~~~~~i~~qi~~aL~ylH~~---~iiHRDiKp~NILl~~~~~~~vkL~DFGla~~~~~~ 182 (352)
T d1koba_ 109 SGGELFDRIA---AEDYKMSEAEVINYMRQACEGLKHMHEH---SIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPD 182 (352)
T ss_dssp CCCBHHHHTT---CTTCCBCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSTTCCCEEECCCTTCEECCTT
T ss_pred CCChHHHHHH---hcCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecccccccccccccCCCeEEEeecccceecCCC
Confidence 9999999874 3455799999999999999999999999 999999999999997 6789999999999987654
Q ss_pred CCcccccccccccccCccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCCCchhcHHHHHHHHhcccccccccCCCC
Q 010519 343 ESHITTRVMGTFGYVAPEYANTGMLNEKSDIYSFGVLLLEAVTGRDPVDYGRPANEVNLVEWLKMMVGTRRAEEVVDPNL 422 (508)
Q Consensus 343 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 422 (508)
. ......||+.|+|||++.+..|+.++|||||||+||||++|+.||..... . +.+....... ..+
T Consensus 183 ~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~---~---~~~~~i~~~~-------~~~ 247 (352)
T d1koba_ 183 E--IVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDD---L---ETLQNVKRCD-------WEF 247 (352)
T ss_dssp S--CEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSH---H---HHHHHHHHCC-------CCC
T ss_pred C--ceeeccCcccccCHHHHcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCH---H---HHHHHHHhCC-------CCC
Confidence 3 24446799999999999999999999999999999999999999964321 1 1122221110 111
Q ss_pred CCChhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 010519 423 EVKPATRALKRSLLVALRCVDPDSEKRPKMSQVVRM 458 (508)
Q Consensus 423 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 458 (508)
...........+.+|+.+||+.||.+|||+.|+++|
T Consensus 248 ~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~H 283 (352)
T d1koba_ 248 DEDAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALEH 283 (352)
T ss_dssp CSSTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHTS
T ss_pred CcccccCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 111112234456779999999999999999999987
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.1e-50 Score=394.92 Aligned_cols=253 Identities=25% Similarity=0.345 Sum_probs=207.6
Q ss_pred hCCcccceeEeeeCceEEEEEEEc-CCCEEEEEEEcccc------hhhHHHHHHHHHHHhcCCCCCceeEEEEEEeCcee
Q 010519 185 TNRFSAENVLGEGGYGVVYKGRLI-NGSEVAVKKLLNNL------GQAEKEFRVEVEAIGHVRHKNLVRLLGYCIEGVHR 257 (508)
Q Consensus 185 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~------~~~~~~~~~ei~~l~~l~h~niv~~~~~~~~~~~~ 257 (508)
.++|.+.+.||+|+||+||+|++. +|+.||||++.... ....+.+.+|+.+|++++|||||++++++.+....
T Consensus 9 ~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~ 88 (293)
T d1jksa_ 9 DDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDV 88 (293)
T ss_dssp GGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred ccCEEEeEEEecCCCeEEEEEEECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEE
Confidence 357999999999999999999985 68999999985432 12356789999999999999999999999999999
Q ss_pred eEEEeecCCCCHHHHHhhhhccCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCEEEcCCC----cEEEEec
Q 010519 258 MLVYEYVNNGNLEQWLHGAMRNQGNLTWEARMKVIIGTAKALAYLHEAIEPKVVHRDIKSSNILIDDEF----NAKVSDF 333 (508)
Q Consensus 258 ~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiH~Dlk~~NIll~~~~----~~kl~Df 333 (508)
|||||||++|+|.++|. ..+.+++..++.++.||+.||.|||+. +|+||||||+|||++.++ .+||+||
T Consensus 89 ~iv~E~~~gg~L~~~i~----~~~~l~~~~~~~~~~qi~~al~yLH~~---~ivHrDiKp~Nill~~~~~~~~~vkl~Df 161 (293)
T d1jksa_ 89 ILILELVAGGELFDFLA----EKESLTEEEATEFLKQILNGVYYLHSL---QIAHFDLKPENIMLLDRNVPKPRIKIIDF 161 (293)
T ss_dssp EEEEECCCSCBHHHHHH----HHSSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESCSSSSSCCEEECCC
T ss_pred EEEEEcCCCccccchhc----cccccchhHHHHHHHHHHHHHHhhhhc---ceeecccccceEEEecCCCcccceEecch
Confidence 99999999999999995 345799999999999999999999999 999999999999998777 4999999
Q ss_pred CCccccCCCCCcccccccccccccCccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCCCchhcHHHHHHHHhcccc
Q 010519 334 GLAKLLDSGESHITTRVMGTFGYVAPEYANTGMLNEKSDIYSFGVLLLEAVTGRDPVDYGRPANEVNLVEWLKMMVGTRR 413 (508)
Q Consensus 334 gla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~ 413 (508)
|++....... ......||+.|+|||++.+..++.++|||||||+||||++|+.||..... .+.+.......
T Consensus 162 G~a~~~~~~~--~~~~~~~t~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~------~~~~~~i~~~~- 232 (293)
T d1jksa_ 162 GLAHKIDFGN--EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTK------QETLANVSAVN- 232 (293)
T ss_dssp TTCEECTTSC--BCSCCCCCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH------HHHHHHHHTTC-
T ss_pred hhhhhcCCCc--cccccCCCCcccCHHHHcCCCCCCcccchhhhHHHHHHHcCCCCCCCCCH------HHHHHHHHhcC-
Confidence 9998765443 23445789999999999999999999999999999999999999964321 11122221110
Q ss_pred cccccCCCCCCChhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHh
Q 010519 414 AEEVVDPNLEVKPATRALKRSLLVALRCVDPDSEKRPKMSQVVRML 459 (508)
Q Consensus 414 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L 459 (508)
..+...........+.+|+.+||+.||.+|||++|+++|-
T Consensus 233 ------~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp 272 (293)
T d1jksa_ 233 ------YEFEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQHP 272 (293)
T ss_dssp ------CCCCHHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHST
T ss_pred ------CCCCchhcCCCCHHHHHHHHHHccCChhHCcCHHHHhcCc
Confidence 1111111122345677899999999999999999999863
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.3e-50 Score=402.24 Aligned_cols=250 Identities=25% Similarity=0.275 Sum_probs=207.6
Q ss_pred CCcccceeEeeeCceEEEEEEEc-CCCEEEEEEEcccc---hhhHHHHHHHHHHHhcCCCCCceeEEEEEEeCceeeEEE
Q 010519 186 NRFSAENVLGEGGYGVVYKGRLI-NGSEVAVKKLLNNL---GQAEKEFRVEVEAIGHVRHKNLVRLLGYCIEGVHRMLVY 261 (508)
Q Consensus 186 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~ei~~l~~l~h~niv~~~~~~~~~~~~~lv~ 261 (508)
++|.+.+.||+|+||+||+|++. +|+.||||++.... ......+.+|+.+|++++|||||++++++.+....|+||
T Consensus 5 ~dy~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~iv~ 84 (337)
T d1o6la_ 5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVM 84 (337)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEEE
T ss_pred HhcEEEEEEecCcCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhCCCCCEEEEEeeeccccccccce
Confidence 57999999999999999999975 78999999986432 223466888999999999999999999999999999999
Q ss_pred eecCCCCHHHHHhhhhccCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCEEEcCCCcEEEEecCCccccCC
Q 010519 262 EYVNNGNLEQWLHGAMRNQGNLTWEARMKVIIGTAKALAYLHEAIEPKVVHRDIKSSNILIDDEFNAKVSDFGLAKLLDS 341 (508)
Q Consensus 262 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~ 341 (508)
|||++|+|.+++. ....+++..++.++.||+.||.|||++ +|+||||||+|||++.+|.+||+|||+++....
T Consensus 85 ey~~gg~L~~~~~----~~~~~~e~~~~~~~~qil~al~ylH~~---~iiHRDlKP~NILl~~~g~vkl~DFG~a~~~~~ 157 (337)
T d1o6la_ 85 EYANGGELFFHLS----RERVFTEERARFYGAEIVSALEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCKEGIS 157 (337)
T ss_dssp ECCTTCBHHHHHH----HHSCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBCSCC
T ss_pred eccCCCchhhhhh----cccCCcHHHHHHHHHHHhhhhhhhhhc---CccccccCHHHeEecCCCCEEEeeccccccccc
Confidence 9999999999984 456789999999999999999999999 999999999999999999999999999986643
Q ss_pred CCCcccccccccccccCccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCCCchhcHHHHHHHHhcccccccccCCC
Q 010519 342 GESHITTRVMGTFGYVAPEYANTGMLNEKSDIYSFGVLLLEAVTGRDPVDYGRPANEVNLVEWLKMMVGTRRAEEVVDPN 421 (508)
Q Consensus 342 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 421 (508)
.. ......+||+.|+|||++.+..|+.++|||||||+||||++|+.||..... . +.+...... . ..
T Consensus 158 ~~-~~~~~~~GT~~Y~aPE~~~~~~y~~~~DiwSlGvilyeml~G~~pf~~~~~---~---~~~~~i~~~-~------~~ 223 (337)
T d1o6la_ 158 DG-ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH---E---RLFELILME-E------IR 223 (337)
T ss_dssp TT-CCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSH---H---HHHHHHHHC-C------CC
T ss_pred CC-cccccceeCHHHhhhhhccCCCCChhhcccchhhHHHHHHHCCCCCCCcCH---H---HHHHHHhcC-C------CC
Confidence 32 234557899999999999999999999999999999999999999964321 1 112222111 1 11
Q ss_pred CCCChhHHHHHHHHHHHHHhcCCCCCCCCC-----HHHHHHHhh
Q 010519 422 LEVKPATRALKRSLLVALRCVDPDSEKRPK-----MSQVVRMLE 460 (508)
Q Consensus 422 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPs-----~~evl~~L~ 460 (508)
+ +......+.+|+.+||++||.+||+ ++|+++|-.
T Consensus 224 ~----p~~~s~~~~dli~~~L~~dP~~R~~~~~~~~~eil~Hp~ 263 (337)
T d1o6la_ 224 F----PRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRF 263 (337)
T ss_dssp C----CTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTSGG
T ss_pred C----CccCCHHHHHHHHhhccCCchhhcccccccHHHHHcCcc
Confidence 1 1112345667999999999999994 899998643
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.8e-51 Score=391.66 Aligned_cols=253 Identities=29% Similarity=0.433 Sum_probs=198.8
Q ss_pred HHhhCCcccceeEeeeCceEEEEEEEcCCCEEEEEEEcccchhhHHHHHHHHHHHhcCCCCCceeEEEEEEeC-ceeeEE
Q 010519 182 EIATNRFSAENVLGEGGYGVVYKGRLINGSEVAVKKLLNNLGQAEKEFRVEVEAIGHVRHKNLVRLLGYCIEG-VHRMLV 260 (508)
Q Consensus 182 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~ei~~l~~l~h~niv~~~~~~~~~-~~~~lv 260 (508)
++..++|++.+.||+|+||.||+|++ .|..||||++... ...+.+.+|++++++++|||||+++|+|.+. ...++|
T Consensus 3 ~i~~~~~~~~~~lG~G~fg~Vy~~~~-~~~~vAvK~i~~~--~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv 79 (262)
T d1byga_ 3 ALNMKELKLLQTIGKGEFGDVMLGDY-RGNKVAVKCIKND--ATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIV 79 (262)
T ss_dssp BCCGGGEEEEEEEEECSSCEEEEEEE-TTEEEEEEECCCC--C--HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEE
T ss_pred ccCHHHeEEeEEEecCCCeEEEEEEE-CCeEEEEEEECcH--HHHHHHHHHHHHHHhCCCCCEeeEEEEEEecCCcEEEE
Confidence 45557899999999999999999998 6889999998543 3346789999999999999999999998654 567999
Q ss_pred EeecCCCCHHHHHhhhhccCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCEEEcCCCcEEEEecCCccccC
Q 010519 261 YEYVNNGNLEQWLHGAMRNQGNLTWEARMKVIIGTAKALAYLHEAIEPKVVHRDIKSSNILIDDEFNAKVSDFGLAKLLD 340 (508)
Q Consensus 261 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~Dfgla~~~~ 340 (508)
|||+++|+|.++|.. .....+++..++.++.||+.||.|||+. +|+||||||+|||++.++.+||+|||+++...
T Consensus 80 ~ey~~~g~L~~~l~~--~~~~~l~~~~~~~i~~~i~~al~ylH~~---~ivH~dlkp~Nil~~~~~~~kl~dfg~s~~~~ 154 (262)
T d1byga_ 80 TEYMAKGSLVDYLRS--RGRSVLGGDCLLKFSLDVCEAMEYLEGN---NFVHRDLAARNVLVSEDNVAKVSDFGLTKEAS 154 (262)
T ss_dssp ECCCTTEEHHHHHHH--HHHHHCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTSCEEECCCCC-----
T ss_pred EeccCCCCHHHHHHh--cCCCCCCHHHHHHHHHHHHhhccccccC---ceeccccchHhheecCCCCEeecccccceecC
Confidence 999999999999964 2334589999999999999999999998 99999999999999999999999999998654
Q ss_pred CCCCcccccccccccccCccccCCCCCCChhhHHHHHHHHHHHHh-CCCCCCCCCCCchhcHHHHHHHHhcccccccccC
Q 010519 341 SGESHITTRVMGTFGYVAPEYANTGMLNEKSDIYSFGVLLLEAVT-GRDPVDYGRPANEVNLVEWLKMMVGTRRAEEVVD 419 (508)
Q Consensus 341 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 419 (508)
.. .....+++.|+|||++.+..++.++|||||||++|||+| |+.||..... .++..++ .....
T Consensus 155 ~~----~~~~~~~~~y~aPE~l~~~~~t~~sDIwSfG~il~el~t~~~~p~~~~~~---~~~~~~i---~~~~~------ 218 (262)
T d1byga_ 155 ST----QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPL---KDVVPRV---EKGYK------ 218 (262)
T ss_dssp -----------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCG---GGHHHHH---TTTCC------
T ss_pred CC----CccccccccCCChHHHhCCCCChHHHHHhHHHHHHHHHHCCCCCCCCCCH---HHHHHHH---HcCCC------
Confidence 32 233467899999999999999999999999999999998 6777754322 2222221 11111
Q ss_pred CCCCCChhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhhcC
Q 010519 420 PNLEVKPATRALKRSLLVALRCVDPDSEKRPKMSQVVRMLEAD 462 (508)
Q Consensus 420 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~ 462 (508)
+.+ +......+.+|+.+||+.||.+|||+.+++++|+..
T Consensus 219 ~~~----~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~L~~i 257 (262)
T d1byga_ 219 MDA----PDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHI 257 (262)
T ss_dssp CCC----CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred CCC----CccCCHHHHHHHHHHcccCHhHCcCHHHHHHHHHHH
Confidence 111 112234667799999999999999999999999753
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=4.8e-50 Score=397.05 Aligned_cols=248 Identities=25% Similarity=0.333 Sum_probs=206.3
Q ss_pred CCcccceeEeeeCceEEEEEEEc-CCCEEEEEEEcccc---hhhHHHHHHHHHHHhcCCCCCceeEEEEEEeCceeeEEE
Q 010519 186 NRFSAENVLGEGGYGVVYKGRLI-NGSEVAVKKLLNNL---GQAEKEFRVEVEAIGHVRHKNLVRLLGYCIEGVHRMLVY 261 (508)
Q Consensus 186 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~ei~~l~~l~h~niv~~~~~~~~~~~~~lv~ 261 (508)
++|++.+.||+|+||+||+|++. +|+.||||++.... ....+.+.+|+.+|+.++|||||++++++.+....|+||
T Consensus 4 ~dy~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivm 83 (316)
T d1fota_ 4 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIM 83 (316)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEEE
T ss_pred hHeEEEEEEecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhccCcChhheeeeEeeCCeeeeEe
Confidence 47999999999999999999985 68999999986432 233467889999999999999999999999999999999
Q ss_pred eecCCCCHHHHHhhhhccCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCEEEcCCCcEEEEecCCccccCC
Q 010519 262 EYVNNGNLEQWLHGAMRNQGNLTWEARMKVIIGTAKALAYLHEAIEPKVVHRDIKSSNILIDDEFNAKVSDFGLAKLLDS 341 (508)
Q Consensus 262 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~ 341 (508)
|||.||+|..++. ....+++..+..++.||+.||.|||++ +|+||||||+||||+.++.+||+|||+++....
T Consensus 84 E~~~gg~l~~~~~----~~~~~~~~~~~~~~~qi~~al~~lH~~---~iiHrDiKp~NILl~~~g~vkL~DFG~a~~~~~ 156 (316)
T d1fota_ 84 DYIEGGELFSLLR----KSQRFPNPVAKFYAAEVCLALEYLHSK---DIIYRDLKPENILLDKNGHIKITDFGFAKYVPD 156 (316)
T ss_dssp CCCCSCBHHHHHH----HTSSCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECTTSCEEECCCSSCEECSS
T ss_pred eecCCcccccccc----ccccccccHHHHHHHHHHHhhhhhccC---cEEccccCchheeEcCCCCEEEecCccceEecc
Confidence 9999999999884 566788899999999999999999999 999999999999999999999999999987654
Q ss_pred CCCcccccccccccccCccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCCCchhcHHHHHHHHhcccccccccCCC
Q 010519 342 GESHITTRVMGTFGYVAPEYANTGMLNEKSDIYSFGVLLLEAVTGRDPVDYGRPANEVNLVEWLKMMVGTRRAEEVVDPN 421 (508)
Q Consensus 342 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 421 (508)
. ....+||+.|+|||++.+..|+.++|||||||+||||++|+.||..... .+.........
T Consensus 157 ~----~~~~~Gt~~Y~APE~l~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~------~~~~~~i~~~~--------- 217 (316)
T d1fota_ 157 V----TYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNT------MKTYEKILNAE--------- 217 (316)
T ss_dssp C----BCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSH------HHHHHHHHHCC---------
T ss_pred c----cccccCcccccCHHHHcCCCCCchhhccccchhHHHHHhCCCCCCCcCH------HHHHHHHHcCC---------
Confidence 3 3456899999999999999999999999999999999999999964321 12222221110
Q ss_pred CCCChhHHHHHHHHHHHHHhcCCCCCCCC-----CHHHHHHHhhc
Q 010519 422 LEVKPATRALKRSLLVALRCVDPDSEKRP-----KMSQVVRMLEA 461 (508)
Q Consensus 422 ~~~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~evl~~L~~ 461 (508)
... +......+.+++.+||.+||.+|+ |++++++|-.-
T Consensus 218 ~~~--p~~~s~~~~~li~~~L~~dp~~R~~~~r~t~~~il~Hp~f 260 (316)
T d1fota_ 218 LRF--PPFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNHPWF 260 (316)
T ss_dssp CCC--CTTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHTSGGG
T ss_pred CCC--CCCCCHHHHHHHHHHhhhCHHhccccchhhHHHHHcCccc
Confidence 111 111234566799999999999996 99999987443
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=2.5e-50 Score=397.14 Aligned_cols=267 Identities=24% Similarity=0.358 Sum_probs=213.2
Q ss_pred HHHHHHhhCCcccceeEeeeCceEEEEEEEc------CCCEEEEEEEcccch-hhHHHHHHHHHHHhcCCCCCceeEEEE
Q 010519 178 LRDLEIATNRFSAENVLGEGGYGVVYKGRLI------NGSEVAVKKLLNNLG-QAEKEFRVEVEAIGHVRHKNLVRLLGY 250 (508)
Q Consensus 178 ~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~-~~~~~~~~ei~~l~~l~h~niv~~~~~ 250 (508)
+.+++++.++|++.+.||+|+||+||+|++. ++..||||++..... ...+.|.+|+.+|++++||||++++++
T Consensus 5 ~~~~e~p~~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~ 84 (301)
T d1lufa_ 5 LLSLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGV 84 (301)
T ss_dssp HHHTBCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEE
T ss_pred hhhccCCHHHcEEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChhcChHHHHHHHHHHHHHHhcCCCCcccceee
Confidence 5678888999999999999999999999874 346899999865433 345679999999999999999999999
Q ss_pred EEeCceeeEEEeecCCCCHHHHHhhhh--------------------ccCCCccHHHHHHHHHHHHHHHHHHHhcCCCCe
Q 010519 251 CIEGVHRMLVYEYVNNGNLEQWLHGAM--------------------RNQGNLTWEARMKVIIGTAKALAYLHEAIEPKV 310 (508)
Q Consensus 251 ~~~~~~~~lv~E~~~~gsL~~~l~~~~--------------------~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~i 310 (508)
|......+++|||+++|+|.++|+... .....+++..++.++.||+.||+|||++ +|
T Consensus 85 ~~~~~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~~---~i 161 (301)
T d1lufa_ 85 CAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSER---KF 161 (301)
T ss_dssp ECSSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHT---TC
T ss_pred eccCCceEEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcccC---Ce
Confidence 999999999999999999999996421 1123488999999999999999999999 99
Q ss_pred EeecCCCCCEEEcCCCcEEEEecCCccccCCCCC-cccccccccccccCccccCCCCCCChhhHHHHHHHHHHHHhCCC-
Q 010519 311 VHRDIKSSNILIDDEFNAKVSDFGLAKLLDSGES-HITTRVMGTFGYVAPEYANTGMLNEKSDIYSFGVLLLEAVTGRD- 388 (508)
Q Consensus 311 iH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltG~~- 388 (508)
+||||||+||||+.++.+||+|||+++....... .......|++.|+|||++.+..|+.++|||||||+||||++|..
T Consensus 162 vHrDlKp~NILld~~~~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~t~ksDVwS~Gvvl~ell~~~~~ 241 (301)
T d1lufa_ 162 VHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQ 241 (301)
T ss_dssp CCSCCSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCC
T ss_pred EeeEEcccceEECCCCcEEEccchhheeccCCccccccCCCCcCcCcCCHHHHccCCCChhhhhccchhhHHHHHccCCC
Confidence 9999999999999999999999999986543322 22345678999999999999999999999999999999999865
Q ss_pred CCCCCCCCchhcHHHHHHHHhcccccccccCCCCCCChhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhhcCC
Q 010519 389 PVDYGRPANEVNLVEWLKMMVGTRRAEEVVDPNLEVKPATRALKRSLLVALRCVDPDSEKRPKMSQVVRMLEADD 463 (508)
Q Consensus 389 Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~ 463 (508)
||.... . .+.......... +.. +...+..+.+|+.+||+.||.+||||.||+++|+...
T Consensus 242 p~~~~~---~---~e~~~~v~~~~~------~~~----p~~~~~~~~~li~~cl~~~P~~RPt~~ev~~~L~~i~ 300 (301)
T d1lufa_ 242 PYYGMA---H---EEVIYYVRDGNI------LAC----PENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRMC 300 (301)
T ss_dssp TTTTSC---H---HHHHHHHHTTCC------CCC----CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTT
T ss_pred CCCCCC---H---HHHHHHHHcCCC------CCC----CccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhc
Confidence 564321 1 122222221111 111 1122345677999999999999999999999998753
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Probab=100.00 E-value=2.8e-49 Score=399.00 Aligned_cols=251 Identities=24% Similarity=0.293 Sum_probs=201.6
Q ss_pred CCcccceeEeeeCceEEEEEEEc-CCCEEEEEEEcccc---hhhHHHH---HHHHHHHhcCCCCCceeEEEEEEeCceee
Q 010519 186 NRFSAENVLGEGGYGVVYKGRLI-NGSEVAVKKLLNNL---GQAEKEF---RVEVEAIGHVRHKNLVRLLGYCIEGVHRM 258 (508)
Q Consensus 186 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~---~~ei~~l~~l~h~niv~~~~~~~~~~~~~ 258 (508)
++|.+.+.||+|+||+||+|++. +|+.||||++.... ......+ ..++.+++.++|||||++++++.+.+..|
T Consensus 4 ddy~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~~~~~~ 83 (364)
T d1omwa3 4 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLS 83 (364)
T ss_dssp TTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEEE
T ss_pred HhCeeeeEEecCCCeEEEEEEECCCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEEEECCEEE
Confidence 58999999999999999999985 68999999985432 1112223 33577888889999999999999999999
Q ss_pred EEEeecCCCCHHHHHhhhhccCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCEEEcCCCcEEEEecCCccc
Q 010519 259 LVYEYVNNGNLEQWLHGAMRNQGNLTWEARMKVIIGTAKALAYLHEAIEPKVVHRDIKSSNILIDDEFNAKVSDFGLAKL 338 (508)
Q Consensus 259 lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~Dfgla~~ 338 (508)
+|||||++|+|.++|. ....+++..++.++.||+.||.|||++ +|+||||||+|||++.++.+||+|||+++.
T Consensus 84 ivmE~~~gg~L~~~l~----~~~~~~e~~~~~~~~qi~~aL~ylH~~---~iiHrDlKP~NILl~~~g~iKl~DFGla~~ 156 (364)
T d1omwa3 84 FILDLMNGGDLHYHLS----QHGVFSEADMRFYAAEIILGLEHMHNR---FVVYRDLKPANILLDEHGHVRISDLGLACD 156 (364)
T ss_dssp EEECCCCSCBHHHHHH----HHCSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECSSSCEEECCCTTCEE
T ss_pred EEEEecCCCcHHHHHH----hcccccHHHHHHHHHHHHHHHHHHHHC---CccceeeccceeEEcCCCcEEEeeeceeee
Confidence 9999999999999995 446788999999999999999999999 999999999999999999999999999997
Q ss_pred cCCCCCcccccccccccccCccccCC-CCCCChhhHHHHHHHHHHHHhCCCCCCCCCCCchhcHHHHHHHHhcccccccc
Q 010519 339 LDSGESHITTRVMGTFGYVAPEYANT-GMLNEKSDIYSFGVLLLEAVTGRDPVDYGRPANEVNLVEWLKMMVGTRRAEEV 417 (508)
Q Consensus 339 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwS~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 417 (508)
..... ....+||+.|+|||++.+ ..|+.++|||||||+||||++|+.||......... ... .....
T Consensus 157 ~~~~~---~~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~---~~~-~~~~~------ 223 (364)
T d1omwa3 157 FSKKK---PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKH---EID-RMTLT------ 223 (364)
T ss_dssp CSSSC---CCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCSSCHH---HHH-HHSSS------
T ss_pred cCCCc---ccccccccccchhHHhhcCCCCCcccchhHHHHHHHHHHhCCCCCCCCCHHHHH---HHH-Hhccc------
Confidence 65432 344579999999999864 57999999999999999999999999754433221 111 11101
Q ss_pred cCCCCCCChhHHHHHHHHHHHHHhcCCCCCCCCC-----HHHHHHHhh
Q 010519 418 VDPNLEVKPATRALKRSLLVALRCVDPDSEKRPK-----MSQVVRMLE 460 (508)
Q Consensus 418 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs-----~~evl~~L~ 460 (508)
.... .+......+.+|+.+||+.||.+||| ++|+++|-+
T Consensus 224 --~~~~--~~~~~s~~~~~li~~~L~~dP~~R~t~~~~~a~eil~Hp~ 267 (364)
T d1omwa3 224 --MAVE--LPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKESPF 267 (364)
T ss_dssp --CCCC--CCSSSCHHHHHHHHHHTCSSTTTSTTTSSSTHHHHHTSGG
T ss_pred --CCCC--CCCCCCHHHHHHHHHHcccCHHHhCCCcccCHHHHHcCcc
Confidence 0011 11112345677999999999999999 799998644
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.7e-49 Score=393.99 Aligned_cols=254 Identities=27% Similarity=0.459 Sum_probs=200.6
Q ss_pred CCcccceeEeeeCceEEEEEEEc-CCC----EEEEEEEcccc-hhhHHHHHHHHHHHhcCCCCCceeEEEEEEeCceeeE
Q 010519 186 NRFSAENVLGEGGYGVVYKGRLI-NGS----EVAVKKLLNNL-GQAEKEFRVEVEAIGHVRHKNLVRLLGYCIEGVHRML 259 (508)
Q Consensus 186 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~----~vavK~~~~~~-~~~~~~~~~ei~~l~~l~h~niv~~~~~~~~~~~~~l 259 (508)
++|++.++||+|+||+||+|++. +|+ .||+|++.... ....+.|.+|+.++++++|||||+++++|.++ ..++
T Consensus 9 ~dy~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~-~~~~ 87 (317)
T d1xkka_ 9 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQL 87 (317)
T ss_dssp TTEEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC----CTHHHHHHHHHHHHHCCCTTBCCEEEEEESS-SEEE
T ss_pred HHCEEeeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecC-CeeE
Confidence 47999999999999999999875 343 58889885433 34457899999999999999999999999865 5678
Q ss_pred EEeecCCCCHHHHHhhhhccCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCEEEcCCCcEEEEecCCcccc
Q 010519 260 VYEYVNNGNLEQWLHGAMRNQGNLTWEARMKVIIGTAKALAYLHEAIEPKVVHRDIKSSNILIDDEFNAKVSDFGLAKLL 339 (508)
Q Consensus 260 v~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~Dfgla~~~ 339 (508)
++||+.+|+|.+++. .....+++..++.++.||+.||.|||++ +|+||||||+||||+.++.+||+|||+++..
T Consensus 88 v~e~~~~~~l~~~~~---~~~~~~~~~~~~~i~~qi~~gl~yLH~~---~iiHrDlKp~NIll~~~~~~kl~DFGla~~~ 161 (317)
T d1xkka_ 88 ITQLMPFGCLLDYVR---EHKDNIGSQYLLNWCVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLL 161 (317)
T ss_dssp EEECCTTCBHHHHHH---HTSSSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEEETTEEEECCCSHHHHT
T ss_pred EEEeccCCccccccc---ccccCCCHHHHHHHHHHHHHHHHHHHHc---CcccCcchhhcceeCCCCCeEeeccccceec
Confidence 889999999999886 4567899999999999999999999999 9999999999999999999999999999977
Q ss_pred CCCCCc-ccccccccccccCccccCCCCCCChhhHHHHHHHHHHHHh-CCCCCCCCCCCchhcHHHHHHHHhcccccccc
Q 010519 340 DSGESH-ITTRVMGTFGYVAPEYANTGMLNEKSDIYSFGVLLLEAVT-GRDPVDYGRPANEVNLVEWLKMMVGTRRAEEV 417 (508)
Q Consensus 340 ~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 417 (508)
...... ......||+.|+|||++.++.|+.++|||||||+||||+| |..||...... .+...+.. ...
T Consensus 162 ~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDvwS~Gvil~el~t~g~~p~~~~~~~---~~~~~i~~---~~~---- 231 (317)
T d1xkka_ 162 GAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPAS---EISSILEK---GER---- 231 (317)
T ss_dssp TTTCC--------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCGG---GHHHHHHH---TCC----
T ss_pred ccccccccccccccCccccChHHHhcCCCChhhhhhhHHHHHHHHHHCCCCCCCCCCHH---HHHHHHHc---CCC----
Confidence 544332 2344568999999999999999999999999999999998 78888643321 22222211 111
Q ss_pred cCCCCCCChhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhhcC
Q 010519 418 VDPNLEVKPATRALKRSLLVALRCVDPDSEKRPKMSQVVRMLEAD 462 (508)
Q Consensus 418 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~ 462 (508)
...+......+.+|+.+||+.||.+|||+.||+++|+..
T Consensus 232 ------~~~p~~~~~~~~~li~~cl~~dP~~RPs~~eil~~l~~~ 270 (317)
T d1xkka_ 232 ------LPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKM 270 (317)
T ss_dssp ------CCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred ------CCCCcccCHHHHHHHHHhCCCChhhCcCHHHHHHHHHHH
Confidence 111112334567799999999999999999999998754
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=2.1e-49 Score=397.81 Aligned_cols=248 Identities=23% Similarity=0.264 Sum_probs=206.2
Q ss_pred CCcccceeEeeeCceEEEEEEEc-CCCEEEEEEEcccc---hhhHHHHHHHHHHHhcCCCCCceeEEEEEEeCceeeEEE
Q 010519 186 NRFSAENVLGEGGYGVVYKGRLI-NGSEVAVKKLLNNL---GQAEKEFRVEVEAIGHVRHKNLVRLLGYCIEGVHRMLVY 261 (508)
Q Consensus 186 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~ei~~l~~l~h~niv~~~~~~~~~~~~~lv~ 261 (508)
++|++.+.||+|+||+||+|++. +|+.||||++.... ....+.+.+|+.+|+.++|||||++++++.+....++||
T Consensus 41 d~y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~v~ 120 (350)
T d1rdqe_ 41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVM 120 (350)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cCeEEEEEeecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHcCCCcEeeccccccccccccccc
Confidence 47999999999999999999985 69999999985432 223456888999999999999999999999999999999
Q ss_pred eecCCCCHHHHHhhhhccCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCEEEcCCCcEEEEecCCccccCC
Q 010519 262 EYVNNGNLEQWLHGAMRNQGNLTWEARMKVIIGTAKALAYLHEAIEPKVVHRDIKSSNILIDDEFNAKVSDFGLAKLLDS 341 (508)
Q Consensus 262 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~ 341 (508)
||+.+|+|.+++. ..+.+++..++.++.||+.||.|||++ +||||||||+||||+.++.+||+|||+++....
T Consensus 121 e~~~~g~l~~~l~----~~~~l~e~~~~~i~~qi~~aL~yLH~~---~iiHRDIKP~NILl~~~g~ikL~DFG~a~~~~~ 193 (350)
T d1rdqe_ 121 EYVAGGEMFSHLR----RIGRFSEPHARFYAAQIVLTFEYLHSL---DLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG 193 (350)
T ss_dssp ECCTTCBHHHHHH----HHCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECSS
T ss_pred ccccccchhhhHh----hcCCCCHHHHHHHHHHHHHHHHHHHhC---CEecCcCCHHHcccCCCCCEEeeeceeeeeccc
Confidence 9999999999985 345799999999999999999999999 999999999999999999999999999997653
Q ss_pred CCCcccccccccccccCccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCCCchhcHHHHHHHHhcccccccccCCC
Q 010519 342 GESHITTRVMGTFGYVAPEYANTGMLNEKSDIYSFGVLLLEAVTGRDPVDYGRPANEVNLVEWLKMMVGTRRAEEVVDPN 421 (508)
Q Consensus 342 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 421 (508)
. .....||+.|+|||++.+..|+.++|||||||+||||++|+.||.... .. .......... ..
T Consensus 194 ~----~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~---~~---~~~~~i~~~~-------~~ 256 (350)
T d1rdqe_ 194 R----TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQ---PI---QIYEKIVSGK-------VR 256 (350)
T ss_dssp C----BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSS---HH---HHHHHHHHCC-------CC
T ss_pred c----cccccCccccCCHHHHcCCCCCccccccchhHHHHHHHhCCCCCCCcC---HH---HHHHHHhcCC-------CC
Confidence 2 334679999999999999999999999999999999999999996432 11 2222221111 00
Q ss_pred CCCChhHHHHHHHHHHHHHhcCCCCCCCC-----CHHHHHHHhhc
Q 010519 422 LEVKPATRALKRSLLVALRCVDPDSEKRP-----KMSQVVRMLEA 461 (508)
Q Consensus 422 ~~~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~evl~~L~~ 461 (508)
. +......+.+|+.+||+.||.+|+ |++++++|-+-
T Consensus 257 ~----p~~~s~~~~~li~~~L~~dP~kR~~~~r~t~~ell~Hp~f 297 (350)
T d1rdqe_ 257 F----PSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHKWF 297 (350)
T ss_dssp C----CTTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHTSGGG
T ss_pred C----CccCCHHHHHHHHHHhhhCHHhccccccccHHHHHcCccc
Confidence 1 112234566799999999999994 99999986543
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.7e-49 Score=390.85 Aligned_cols=268 Identities=26% Similarity=0.374 Sum_probs=202.0
Q ss_pred eHHHHHHhhCCcccceeEeeeCceEEEEEEEcC------CCEEEEEEEcccc-hhhHHHHHHHHHHHhcC-CCCCceeEE
Q 010519 177 TLRDLEIATNRFSAENVLGEGGYGVVYKGRLIN------GSEVAVKKLLNNL-GQAEKEFRVEVEAIGHV-RHKNLVRLL 248 (508)
Q Consensus 177 ~~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~------~~~vavK~~~~~~-~~~~~~~~~ei~~l~~l-~h~niv~~~ 248 (508)
....|++..++|++.+.||+|+||+||+|++.. ++.||||++.... ....+.+..|...+.++ +|+||+.++
T Consensus 4 ~~~~wei~~~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~ 83 (299)
T d1ywna1 4 DASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLL 83 (299)
T ss_dssp CHHHHBCCGGGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC----CHHHHHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred CCccccccHHHEEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEccccCcHHHHHHHHHHHHHHhhcCCCeEEEee
Confidence 457778888999999999999999999998642 3579999986443 33345677788877776 789999999
Q ss_pred EEEEeC-ceeeEEEeecCCCCHHHHHhhhhc------------cCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEeecC
Q 010519 249 GYCIEG-VHRMLVYEYVNNGNLEQWLHGAMR------------NQGNLTWEARMKVIIGTAKALAYLHEAIEPKVVHRDI 315 (508)
Q Consensus 249 ~~~~~~-~~~~lv~E~~~~gsL~~~l~~~~~------------~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiH~Dl 315 (508)
+++... ...++|||||++|+|.++|+.... ....+++..++.++.||+.||.|||++ +|+||||
T Consensus 84 ~~~~~~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~---~ivHrDl 160 (299)
T d1ywna1 84 GACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR---KCIHRDL 160 (299)
T ss_dssp EEECSTTSCCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHHT---TCCCSCC
T ss_pred eeeccCCCeEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHhC---CCcCCcC
Confidence 998765 467899999999999999975322 134588999999999999999999999 9999999
Q ss_pred CCCCEEEcCCCcEEEEecCCccccCCCCC-cccccccccccccCccccCCCCCCChhhHHHHHHHHHHHHhCC-CCCCCC
Q 010519 316 KSSNILIDDEFNAKVSDFGLAKLLDSGES-HITTRVMGTFGYVAPEYANTGMLNEKSDIYSFGVLLLEAVTGR-DPVDYG 393 (508)
Q Consensus 316 k~~NIll~~~~~~kl~Dfgla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltG~-~Pf~~~ 393 (508)
||+||||++++.+||+|||+++....... .......||+.|+|||++.++.++.++|||||||++|||++|. .||...
T Consensus 161 Kp~NILl~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gvil~ellt~~~~p~~~~ 240 (299)
T d1ywna1 161 AARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGV 240 (299)
T ss_dssp CGGGEEECGGGCEEECC------CCSCTTSCCTTSCCCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTC
T ss_pred CccceeECCCCcEEEccCcchhhccccccccccCceeeCccccchhHhhcCCCCcccceeehHHHHHHHHhCCCCCCCCC
Confidence 99999999999999999999986644332 2344567999999999999999999999999999999999975 567533
Q ss_pred CCCchhcHHHHHHHHhcccccccccCCCCCCChhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhhcC
Q 010519 394 RPANEVNLVEWLKMMVGTRRAEEVVDPNLEVKPATRALKRSLLVALRCVDPDSEKRPKMSQVVRMLEAD 462 (508)
Q Consensus 394 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~ 462 (508)
.... .+...+.. ... +.. +......+.+|+.+||+.||.+|||+.||+++|+..
T Consensus 241 ~~~~--~~~~~~~~---~~~------~~~----~~~~~~~l~~li~~cl~~dP~~Rpt~~eil~~L~~i 294 (299)
T d1ywna1 241 KIDE--EFCRRLKE---GTR------MRA----PDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNL 294 (299)
T ss_dssp CCSH--HHHHHHHH---TCC------CCC----CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred CHHH--HHHHHHhc---CCC------CCC----CccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHH
Confidence 3221 11111111 111 111 111234567799999999999999999999999853
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Probab=100.00 E-value=3.3e-49 Score=383.70 Aligned_cols=252 Identities=25% Similarity=0.362 Sum_probs=206.3
Q ss_pred CCcccceeEeeeCceEEEEEEEc-CCCEEEEEEEcccch---------hhHHHHHHHHHHHhcCC-CCCceeEEEEEEeC
Q 010519 186 NRFSAENVLGEGGYGVVYKGRLI-NGSEVAVKKLLNNLG---------QAEKEFRVEVEAIGHVR-HKNLVRLLGYCIEG 254 (508)
Q Consensus 186 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---------~~~~~~~~ei~~l~~l~-h~niv~~~~~~~~~ 254 (508)
++|++.+.||+|+||+||+|++. +|+.||||++..... ...+.+.+|+.++++++ |||||++++++.++
T Consensus 3 ~~y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~ 82 (277)
T d1phka_ 3 ENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYETN 82 (277)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEECS
T ss_pred ccCEEceEEecCcCeEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeecccC
Confidence 68999999999999999999874 788999999864321 12345788999999997 99999999999999
Q ss_pred ceeeEEEeecCCCCHHHHHhhhhccCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCEEEcCCCcEEEEecC
Q 010519 255 VHRMLVYEYVNNGNLEQWLHGAMRNQGNLTWEARMKVIIGTAKALAYLHEAIEPKVVHRDIKSSNILIDDEFNAKVSDFG 334 (508)
Q Consensus 255 ~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~Dfg 334 (508)
+..|||||||++|+|.++|. ..+.+++..++.++.||++||+|||++ +|+||||||+|||++.++.+||+|||
T Consensus 83 ~~~~ivmE~~~~g~L~~~l~----~~~~l~e~~~~~~~~qi~~al~~lH~~---~ivHrDlkp~Nill~~~~~~kl~DFG 155 (277)
T d1phka_ 83 TFFFLVFDLMKKGELFDYLT----EKVTLSEKETRKIMRALLEVICALHKL---NIVHRDLKPENILLDDDMNIKLTDFG 155 (277)
T ss_dssp SEEEEEEECCTTCBHHHHHH----HHSSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCT
T ss_pred cceEEEEEcCCCchHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHHc---CCcccccccceEEEcCCCCeEEccch
Confidence 99999999999999999995 456799999999999999999999999 99999999999999999999999999
Q ss_pred CccccCCCCCcccccccccccccCccccC------CCCCCChhhHHHHHHHHHHHHhCCCCCCCCCCCchhcHHHHHHHH
Q 010519 335 LAKLLDSGESHITTRVMGTFGYVAPEYAN------TGMLNEKSDIYSFGVLLLEAVTGRDPVDYGRPANEVNLVEWLKMM 408 (508)
Q Consensus 335 la~~~~~~~~~~~~~~~gt~~y~aPE~~~------~~~~~~~~DvwS~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~ 408 (508)
+++....... ....+||+.|+|||++. ...++.++||||+||+||||++|+.||..... . ......
T Consensus 156 ~a~~~~~~~~--~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~~~---~---~~~~~i 227 (277)
T d1phka_ 156 FSCQLDPGEK--LREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQ---M---LMLRMI 227 (277)
T ss_dssp TCEECCTTCC--BCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH---H---HHHHHH
T ss_pred heeEccCCCc--eeeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCCCCCCCCCH---H---HHHHHH
Confidence 9997765432 34467999999999885 34578899999999999999999999974321 1 111111
Q ss_pred hcccccccccCCCCCCChhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHh
Q 010519 409 VGTRRAEEVVDPNLEVKPATRALKRSLLVALRCVDPDSEKRPKMSQVVRML 459 (508)
Q Consensus 409 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L 459 (508)
... . ..+...........+.+|+.+||++||.+|||+.||++|-
T Consensus 228 ~~~-~------~~~~~~~~~~~s~~~~~li~~~L~~~p~~R~s~~eil~h~ 271 (277)
T d1phka_ 228 MSG-N------YQFGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAHP 271 (277)
T ss_dssp HHT-C------CCCCTTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTTSG
T ss_pred HhC-C------CCCCCcccccCCHHHHHHHHHHccCChhHCcCHHHHHcCH
Confidence 111 1 1112222233445677899999999999999999998864
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.9e-49 Score=391.96 Aligned_cols=273 Identities=21% Similarity=0.375 Sum_probs=218.9
Q ss_pred eeHHHHHHhhCCcccceeEeeeCceEEEEEEEc------CCCEEEEEEEcccc-hhhHHHHHHHHHHHhcCCCCCceeEE
Q 010519 176 FTLRDLEIATNRFSAENVLGEGGYGVVYKGRLI------NGSEVAVKKLLNNL-GQAEKEFRVEVEAIGHVRHKNLVRLL 248 (508)
Q Consensus 176 ~~~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~-~~~~~~~~~ei~~l~~l~h~niv~~~ 248 (508)
|-.++|++..++|.+.+.||+|+||+||+|.+. .+..||||++.... ......|.+|++++++++|||||+++
T Consensus 10 ~~~~~~ei~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~ 89 (308)
T d1p4oa_ 10 YVPDEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLL 89 (308)
T ss_dssp CCCCTTBCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEE
T ss_pred cCccceeecHHHeEEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECcccChHHHHHHHHHHHHHHHcCCCCEeeee
Confidence 334567888899999999999999999999863 35789999986543 33445688999999999999999999
Q ss_pred EEEEeCceeeEEEeecCCCCHHHHHhhhhc------cCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCEEE
Q 010519 249 GYCIEGVHRMLVYEYVNNGNLEQWLHGAMR------NQGNLTWEARMKVIIGTAKALAYLHEAIEPKVVHRDIKSSNILI 322 (508)
Q Consensus 249 ~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~------~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiH~Dlk~~NIll 322 (508)
++|......++||||+++|+|.+++..... ....+++..+.+++.|+++||.|||++ +|+||||||+|||+
T Consensus 90 ~~~~~~~~~~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~---~ivHrDlk~~NiLl 166 (308)
T d1p4oa_ 90 GVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMV 166 (308)
T ss_dssp EEECSSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHT---TCBCSCCSGGGEEE
T ss_pred eEEecCCceeEEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhhC---CeeeceEcCCceee
Confidence 999999999999999999999999864321 123478899999999999999999999 99999999999999
Q ss_pred cCCCcEEEEecCCccccCCCCC-cccccccccccccCccccCCCCCCChhhHHHHHHHHHHHHhCC-CCCCCCCCCchhc
Q 010519 323 DDEFNAKVSDFGLAKLLDSGES-HITTRVMGTFGYVAPEYANTGMLNEKSDIYSFGVLLLEAVTGR-DPVDYGRPANEVN 400 (508)
Q Consensus 323 ~~~~~~kl~Dfgla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltG~-~Pf~~~~~~~~~~ 400 (508)
++++++||+|||+++....... .......||+.|+|||.+.+..++.++|||||||+||||+||. .||... .
T Consensus 167 d~~~~~Kl~DFGla~~~~~~~~~~~~~~~~~t~~y~aPe~l~~~~~~~~~Dv~S~G~il~El~t~~~~p~~~~------~ 240 (308)
T d1p4oa_ 167 AEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGL------S 240 (308)
T ss_dssp CTTCCEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTS------C
T ss_pred cCCceEEEeecccceeccCCcceeeccceecccccCCHHHHccCCCCcccccccHHHHHHHHHhCCCCCCCCC------C
Confidence 9999999999999986643322 2234457899999999999999999999999999999999985 566422 2
Q ss_pred HHHHHHHHhcccccccccCCCCCCChhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhhcCCCCCc
Q 010519 401 LVEWLKMMVGTRRAEEVVDPNLEVKPATRALKRSLLVALRCVDPDSEKRPKMSQVVRMLEADDYPFR 467 (508)
Q Consensus 401 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~~~ 467 (508)
..+.+..+...... +.+......+.+|+.+||+.||.+|||+.+|+++|+....+..
T Consensus 241 ~~~~~~~i~~~~~~----------~~p~~~~~~l~~li~~cl~~~P~~RPs~~~il~~L~~~~~~~~ 297 (308)
T d1p4oa_ 241 NEQVLRFVMEGGLL----------DKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEMEPGF 297 (308)
T ss_dssp HHHHHHHHHTTCCC----------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSCTTH
T ss_pred HHHHHHHHHhCCCC----------CCcccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcCCCC
Confidence 22333333222111 1111223467779999999999999999999999998766554
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.5e-49 Score=388.71 Aligned_cols=250 Identities=16% Similarity=0.270 Sum_probs=206.2
Q ss_pred hCCcccceeEeeeCceEEEEEEEc-CCCEEEEEEEcccchhhHHHHHHHHHHHhcCCCCCceeEEEEEEeCceeeEEEee
Q 010519 185 TNRFSAENVLGEGGYGVVYKGRLI-NGSEVAVKKLLNNLGQAEKEFRVEVEAIGHVRHKNLVRLLGYCIEGVHRMLVYEY 263 (508)
Q Consensus 185 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~ei~~l~~l~h~niv~~~~~~~~~~~~~lv~E~ 263 (508)
.++|.+++.||+|+||+||+|.+. +|+.||||.+.... .....+.+|+++|+.++|||||++++++.+....||||||
T Consensus 4 ~~rY~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~~-~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~lvmE~ 82 (321)
T d1tkia_ 4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKG-TDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFEF 82 (321)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCT-HHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEECC
T ss_pred ccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEcCCc-ccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEec
Confidence 468999999999999999999986 68889999986543 3345688899999999999999999999999999999999
Q ss_pred cCCCCHHHHHhhhhccCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCEEEcCC--CcEEEEecCCccccCC
Q 010519 264 VNNGNLEQWLHGAMRNQGNLTWEARMKVIIGTAKALAYLHEAIEPKVVHRDIKSSNILIDDE--FNAKVSDFGLAKLLDS 341 (508)
Q Consensus 264 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiH~Dlk~~NIll~~~--~~~kl~Dfgla~~~~~ 341 (508)
|+||+|.+++. .....+++..++.++.||+.||.|||++ +|+||||||+|||++.+ ..+||+|||+++....
T Consensus 83 ~~gg~L~~~i~---~~~~~l~e~~~~~i~~qi~~al~yLH~~---~iiHrDlKp~NIll~~~~~~~ikl~DFG~~~~~~~ 156 (321)
T d1tkia_ 83 ISGLDIFERIN---TSAFELNEREIVSYVHQVCEALQFLHSH---NIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKP 156 (321)
T ss_dssp CCCCBHHHHHT---SSSCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSSSCCCEEECCCTTCEECCT
T ss_pred CCCCcHHHHHH---hcCCCCCHHHHHHHHHHHHHHHHHHHHc---CCCcccccccceeecCCCceEEEEcccchhhcccc
Confidence 99999999985 2345799999999999999999999999 99999999999999854 4799999999987654
Q ss_pred CCCcccccccccccccCccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCCCchhcHHHHHHHHhcccccccccCCC
Q 010519 342 GESHITTRVMGTFGYVAPEYANTGMLNEKSDIYSFGVLLLEAVTGRDPVDYGRPANEVNLVEWLKMMVGTRRAEEVVDPN 421 (508)
Q Consensus 342 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 421 (508)
.. ......+|+.|+|||.+.+..|+.++|||||||+||+|++|..||..... . +.+..... ..
T Consensus 157 ~~--~~~~~~~t~~y~ape~~~~~~~~~~~DiWSlGvily~ll~G~~Pf~~~~~---~---~~~~~i~~---------~~ 219 (321)
T d1tkia_ 157 GD--NFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETN---Q---QIIENIMN---------AE 219 (321)
T ss_dssp TC--EEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSH---H---HHHHHHHH---------TC
T ss_pred CC--cccccccccccccchhccCCCCCchhhcccHHHHHHHHHhCCCCCCCCCH---H---HHHHHHHh---------CC
Confidence 33 23445789999999999999999999999999999999999999964321 1 11212111 11
Q ss_pred CCCCh--hHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 010519 422 LEVKP--ATRALKRSLLVALRCVDPDSEKRPKMSQVVRM 458 (508)
Q Consensus 422 ~~~~~--~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 458 (508)
...+. .......+.+|+.+||..||.+|||+.|+++|
T Consensus 220 ~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~h 258 (321)
T d1tkia_ 220 YTFDEEAFKEISIEAMDFVDRLLVKERKSRMTASEALQH 258 (321)
T ss_dssp CCCCHHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred CCCChhhccCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 11111 11234567789999999999999999999986
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Probab=100.00 E-value=2.8e-48 Score=377.93 Aligned_cols=256 Identities=27% Similarity=0.399 Sum_probs=199.0
Q ss_pred hCCcccceeEeeeCceEEEEEEEc-CCCEEEEEEEcccc---hhhHHHHHHHHHHHhcCCCCCceeEEEEEEeCc----e
Q 010519 185 TNRFSAENVLGEGGYGVVYKGRLI-NGSEVAVKKLLNNL---GQAEKEFRVEVEAIGHVRHKNLVRLLGYCIEGV----H 256 (508)
Q Consensus 185 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~ei~~l~~l~h~niv~~~~~~~~~~----~ 256 (508)
.++|.+.+.||+|+||+||+|++. +|+.||||++.... ......+.+|+.+++.++|||||++++++.... .
T Consensus 6 ~drY~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~~~~~~ 85 (277)
T d1o6ya_ 6 SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPL 85 (277)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEECSSSEE
T ss_pred cceeEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhcCCCCCCcccceeeeccCCCce
Confidence 468999999999999999999874 78899999986543 233457889999999999999999999998653 3
Q ss_pred eeEEEeecCCCCHHHHHhhhhccCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCEEEcCCCcEEEEecCCc
Q 010519 257 RMLVYEYVNNGNLEQWLHGAMRNQGNLTWEARMKVIIGTAKALAYLHEAIEPKVVHRDIKSSNILIDDEFNAKVSDFGLA 336 (508)
Q Consensus 257 ~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~Dfgla 336 (508)
.||||||++||+|.+++. ..+.+++..++.++.||+.||.|||++ +|+||||||+|||++.++.++|+|||.+
T Consensus 86 ~~lvmE~~~g~~L~~~~~----~~~~l~~~~~~~i~~qi~~al~~lH~~---~iiHrDiKP~NIll~~~~~~~l~d~~~~ 158 (277)
T d1o6ya_ 86 PYIVMEYVDGVTLRDIVH----TEGPMTPKRAIEVIADACQALNFSHQN---GIIHRDVKPANIMISATNAVKVMDFGIA 158 (277)
T ss_dssp EEEEEECCCEEEHHHHHH----HHCSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTSCEEECCCTTC
T ss_pred EEEEEECCCCCEehhhhc----ccCCCCHHHHHHHHHHHHHHHHHHHhC---CccCccccCcccccCccccceeehhhhh
Confidence 789999999999999884 456799999999999999999999999 9999999999999999999999999998
Q ss_pred cccCCCCC--cccccccccccccCccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCCCchhcHHHHHHHHhccc-c
Q 010519 337 KLLDSGES--HITTRVMGTFGYVAPEYANTGMLNEKSDIYSFGVLLLEAVTGRDPVDYGRPANEVNLVEWLKMMVGTR-R 413 (508)
Q Consensus 337 ~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~-~ 413 (508)
........ ......+||+.|+|||++.+..|+.++|||||||+||||+||+.||..... .+.+....... .
T Consensus 159 ~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~------~~~~~~~~~~~~~ 232 (277)
T d1o6ya_ 159 RAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSP------VSVAYQHVREDPI 232 (277)
T ss_dssp EECC----------------TTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSH------HHHHHHHHHCCCC
T ss_pred hhhccccccccccccccCcccccCHHHHcCCCCCcceecccchHHHHHHHhCCCCCCCcCH------HHHHHHHHhcCCC
Confidence 75543222 234456799999999999999999999999999999999999999964321 11222222111 1
Q ss_pred cccccCCCCCCChhHHHHHHHHHHHHHhcCCCCCCCC-CHHHHHHHhhc
Q 010519 414 AEEVVDPNLEVKPATRALKRSLLVALRCVDPDSEKRP-KMSQVVRMLEA 461 (508)
Q Consensus 414 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-s~~evl~~L~~ 461 (508)
..... ....+..+.+++.+||++||.+|| |++++++.|..
T Consensus 233 ~~~~~--------~~~~s~~l~~li~~~L~~dp~~R~~sa~~l~~~l~r 273 (277)
T d1o6ya_ 233 PPSAR--------HEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVR 273 (277)
T ss_dssp CGGGT--------SSSCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHH
T ss_pred CCchh--------ccCCCHHHHHHHHHHccCCHhHCHhHHHHHHHHHHH
Confidence 11111 111234566799999999999999 89999887753
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-49 Score=386.23 Aligned_cols=255 Identities=27% Similarity=0.407 Sum_probs=196.1
Q ss_pred hCCcccceeEeeeCceEEEEEEEcC--C--CEEEEEEEcccc---hhhHHHHHHHHHHHhcCCCCCceeEEEEEEeCcee
Q 010519 185 TNRFSAENVLGEGGYGVVYKGRLIN--G--SEVAVKKLLNNL---GQAEKEFRVEVEAIGHVRHKNLVRLLGYCIEGVHR 257 (508)
Q Consensus 185 ~~~~~~~~~lg~G~~g~Vy~~~~~~--~--~~vavK~~~~~~---~~~~~~~~~ei~~l~~l~h~niv~~~~~~~~~~~~ 257 (508)
.++|++.+.||+|+||+||+|++.. + ..||||++.... ....+.|.+|+.+|++++|||||+++|+|.+ ...
T Consensus 7 ~~d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~-~~~ 85 (273)
T d1u46a_ 7 EKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLT-PPM 85 (273)
T ss_dssp GGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSC
T ss_pred hHHeEEEEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEee-cch
Confidence 3579999999999999999998642 2 368999885432 3444678999999999999999999999965 467
Q ss_pred eEEEeecCCCCHHHHHhhhhccCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCEEEcCCCcEEEEecCCcc
Q 010519 258 MLVYEYVNNGNLEQWLHGAMRNQGNLTWEARMKVIIGTAKALAYLHEAIEPKVVHRDIKSSNILIDDEFNAKVSDFGLAK 337 (508)
Q Consensus 258 ~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~Dfgla~ 337 (508)
++||||+++|+|.+++.. ..+.+++..++.++.||+.||.|||++ +|+||||||+||||+.++.+||+|||+++
T Consensus 86 ~lv~e~~~~~~l~~~~~~---~~~~l~~~~~~~~~~qi~~gl~ylH~~---~iiHrDikp~NIll~~~~~vkl~DfGl~~ 159 (273)
T d1u46a_ 86 KMVTELAPLGSLLDRLRK---HQGHFLLGTLSRYAVQVAEGMGYLESK---RFIHRDLAARNLLLATRDLVKIGDFGLMR 159 (273)
T ss_dssp EEEEECCTTCBHHHHHHH---HGGGSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEEEETTEEEECCCTTCE
T ss_pred heeeeeecCcchhhhhhc---ccCCCCHHHHHHHHHHHHHHHHHhhhC---CEeeeeecHHHhccccccceeeccchhhh
Confidence 899999999999998863 455799999999999999999999998 99999999999999999999999999999
Q ss_pred ccCCCCCc--ccccccccccccCccccCCCCCCChhhHHHHHHHHHHHHh-CCCCCCCCCCCchhcHHHHHHHHhccccc
Q 010519 338 LLDSGESH--ITTRVMGTFGYVAPEYANTGMLNEKSDIYSFGVLLLEAVT-GRDPVDYGRPANEVNLVEWLKMMVGTRRA 414 (508)
Q Consensus 338 ~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~ 414 (508)
........ ......|+..|+|||++.+..++.++|||||||++|||+| |..||.... ..+.+..+....
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~S~Gvil~emlt~G~~Pf~~~~------~~~~~~~i~~~~-- 231 (273)
T d1u46a_ 160 ALPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLN------GSQILHKIDKEG-- 231 (273)
T ss_dssp ECCC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCC------HHHHHHHHHTSC--
T ss_pred hcccCCCcceecCccccCcccCCHHHHhCCCCCcchhhhhhHHHHHHHHhCCCCCCCCcC------HHHHHHHHHhCC--
Confidence 77544332 2334567889999999999999999999999999999998 899996332 122222222211
Q ss_pred ccccCCCCCCChhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhhc
Q 010519 415 EEVVDPNLEVKPATRALKRSLLVALRCVDPDSEKRPKMSQVVRMLEA 461 (508)
Q Consensus 415 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~ 461 (508)
...+.+...+..+.+|+.+||+.||.+||||.||++.|+.
T Consensus 232 -------~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~ei~~~L~~ 271 (273)
T d1u46a_ 232 -------ERLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLE 271 (273)
T ss_dssp -------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred -------CCCCCcccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHh
Confidence 1111111223456779999999999999999999999875
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.6e-48 Score=389.23 Aligned_cols=250 Identities=22% Similarity=0.276 Sum_probs=199.4
Q ss_pred CCcccce-eEeeeCceEEEEEEEc-CCCEEEEEEEcccchhhHHHHHHHHHHHhc-CCCCCceeEEEEEEe----Cceee
Q 010519 186 NRFSAEN-VLGEGGYGVVYKGRLI-NGSEVAVKKLLNNLGQAEKEFRVEVEAIGH-VRHKNLVRLLGYCIE----GVHRM 258 (508)
Q Consensus 186 ~~~~~~~-~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~ei~~l~~-l~h~niv~~~~~~~~----~~~~~ 258 (508)
++|.+.. +||+|+||+||+|++. +++.||||++... ..+.+|+.++.+ .+|||||+++++|.+ ....|
T Consensus 11 ~~y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~-----~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~~~~~~~~ 85 (335)
T d2ozaa1 11 DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-----PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLL 85 (335)
T ss_dssp GTEEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECS-----HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEE
T ss_pred cCEEEeeEEeeeccCeEEEEEEECCCCCEEEEEEECCc-----HHHHHHHHHHHHhcCCCCCCeEEEEEeecccCCCEEE
Confidence 5788764 6999999999999974 6899999998542 346678888655 589999999999876 46689
Q ss_pred EEEeecCCCCHHHHHhhhhccCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCEEEcC---CCcEEEEecCC
Q 010519 259 LVYEYVNNGNLEQWLHGAMRNQGNLTWEARMKVIIGTAKALAYLHEAIEPKVVHRDIKSSNILIDD---EFNAKVSDFGL 335 (508)
Q Consensus 259 lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiH~Dlk~~NIll~~---~~~~kl~Dfgl 335 (508)
||||||+||+|.++|.. .....+++..++.++.||+.||.|||++ +|+||||||+|||+++ ++.+||+|||+
T Consensus 86 ivmEy~~gg~L~~~i~~--~~~~~l~e~~~~~i~~qi~~al~ylH~~---~iiHRDiKp~NIll~~~~~~~~~Kl~DFG~ 160 (335)
T d2ozaa1 86 IVMECLDGGELFSRIQD--RGDQAFTEREASEIMKSIGEAIQYLHSI---NIAHRDVKPENLLYTSKRPNAILKLTDFGF 160 (335)
T ss_dssp EEEECCCSEEHHHHHHS--CSCCCEEHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESCSSTTCCEEECCCTT
T ss_pred EEEECCCCCcHHHHHHh--cCCCCcCHHHHHHHHHHHHHHHHHHHHc---CCccccccccccccccccccccccccccce
Confidence 99999999999999963 2345799999999999999999999999 9999999999999985 56799999999
Q ss_pred ccccCCCCCcccccccccccccCccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCCCchhcHHHHHHHHhcccccc
Q 010519 336 AKLLDSGESHITTRVMGTFGYVAPEYANTGMLNEKSDIYSFGVLLLEAVTGRDPVDYGRPANEVNLVEWLKMMVGTRRAE 415 (508)
Q Consensus 336 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~ 415 (508)
++....... ....+||+.|+|||++.+..|+.++|||||||+||+|++|+.||......... . .+. .
T Consensus 161 a~~~~~~~~--~~~~~gt~~y~aPE~~~~~~y~~~~DiwSlGvily~lltg~~Pf~~~~~~~~~---~---~~~-----~ 227 (335)
T d2ozaa1 161 AKETTSHNS--LTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAIS---P---GMK-----T 227 (335)
T ss_dssp CEECCCCCC--CCCCSCCCSSCCCCCCCGGGGSHHHHHHHHHHHHHHHTTSSCSCEETTCC-------------------
T ss_pred eeeccCCCc--cccccCCcccCCcHHHcCCCCCHHHHHHhhchhHHHHhhCCCCCCCCCHHHHH---H---HHH-----H
Confidence 987654432 34567999999999999999999999999999999999999999643322111 1 000 0
Q ss_pred cccCCCC--CCChhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 010519 416 EVVDPNL--EVKPATRALKRSLLVALRCVDPDSEKRPKMSQVVRM 458 (508)
Q Consensus 416 ~~~~~~~--~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 458 (508)
.+..... ...........+.+|+.+||+.||.+|||+.|+++|
T Consensus 228 ~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~h 272 (335)
T d2ozaa1 228 RIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNH 272 (335)
T ss_dssp CCCSCSSSCCTTHHHHSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred HHhcCCCCCCCcccccCCHHHHHHHHHHccCChhHCcCHHHHHcC
Confidence 1111111 222233445678889999999999999999999986
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.2e-49 Score=391.75 Aligned_cols=249 Identities=24% Similarity=0.339 Sum_probs=201.9
Q ss_pred CCcccceeEeeeCceEEEEEEEc-CCCEEEEEEEcccc---hhhHHHHHHHHHHHh-cCCCCCceeEEEEEEeCceeeEE
Q 010519 186 NRFSAENVLGEGGYGVVYKGRLI-NGSEVAVKKLLNNL---GQAEKEFRVEVEAIG-HVRHKNLVRLLGYCIEGVHRMLV 260 (508)
Q Consensus 186 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~ei~~l~-~l~h~niv~~~~~~~~~~~~~lv 260 (508)
++|.+++.||+|+||+||+|++. +|+.||||++.... ......+..|..++. .++|||||++++++.+++..|||
T Consensus 2 ddy~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~~~~yiv 81 (320)
T d1xjda_ 2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFV 81 (320)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEE
T ss_pred CCeEEeeEEecCCCcEEEEEEECCCCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcEEEEEEEEccCCceeEE
Confidence 57999999999999999999986 68899999986432 222344556666654 68999999999999999999999
Q ss_pred EeecCCCCHHHHHhhhhccCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCEEEcCCCcEEEEecCCccccC
Q 010519 261 YEYVNNGNLEQWLHGAMRNQGNLTWEARMKVIIGTAKALAYLHEAIEPKVVHRDIKSSNILIDDEFNAKVSDFGLAKLLD 340 (508)
Q Consensus 261 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~Dfgla~~~~ 340 (508)
|||+++|+|.+++. ....+++..++.++.||+.||.|||++ +|+||||||+|||+++++++||+|||+++...
T Consensus 82 mEy~~~g~L~~~i~----~~~~~~e~~~~~~~~qi~~al~ylH~~---~iiHrDikp~NiL~~~~~~~kl~DFG~a~~~~ 154 (320)
T d1xjda_ 82 MEYLNGGDLMYHIQ----SCHKFDLSRATFYAAEIILGLQFLHSK---GIVYRDLKLDNILLDKDGHIKIADFGMCKENM 154 (320)
T ss_dssp EECCTTCBHHHHHH----HHSSCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBCCC
T ss_pred EeecCCCcHHHHhh----ccCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeccCcccceeecCCCceeccccchhhhcc
Confidence 99999999999995 455789999999999999999999999 99999999999999999999999999998665
Q ss_pred CCCCcccccccccccccCccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCCCchhcHHHHHHHHhcccccccccCC
Q 010519 341 SGESHITTRVMGTFGYVAPEYANTGMLNEKSDIYSFGVLLLEAVTGRDPVDYGRPANEVNLVEWLKMMVGTRRAEEVVDP 420 (508)
Q Consensus 341 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 420 (508)
... .......||+.|+|||++.+..|+.++|||||||+||||++|+.||.... ...+ ....... . +
T Consensus 155 ~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~PF~~~~---~~~~---~~~i~~~-~------~ 220 (320)
T d1xjda_ 155 LGD-AKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQD---EEEL---FHSIRMD-N------P 220 (320)
T ss_dssp CTT-CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSS---HHHH---HHHHHHC-C------C
T ss_pred ccc-ccccccCCCCCcCCHHHHcCCCCCchhhhhhhhHHHHHHHhCCCCCCCCC---HHHH---HHHHHcC-C------C
Confidence 433 23455689999999999999999999999999999999999999996432 1111 1111111 0 1
Q ss_pred CCCCChhHHHHHHHHHHHHHhcCCCCCCCCCHH-HHHHHh
Q 010519 421 NLEVKPATRALKRSLLVALRCVDPDSEKRPKMS-QVVRML 459 (508)
Q Consensus 421 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~-evl~~L 459 (508)
.+. ......+.+|+.+||..||.+|||+. ++++|-
T Consensus 221 ~~p----~~~s~~~~dli~~~L~~dP~~R~s~~~~l~~hp 256 (320)
T d1xjda_ 221 FYP----RWLEKEAKDLLVKLFVREPEKRLGVRGDIRQHP 256 (320)
T ss_dssp CCC----TTSCHHHHHHHHHHSCSSGGGSBTTBSCGGGSG
T ss_pred CCC----ccCCHHHHHHHHHhcccCCCCCcCHHHHHHhCc
Confidence 111 11234567799999999999999995 787653
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.7e-49 Score=388.23 Aligned_cols=257 Identities=25% Similarity=0.402 Sum_probs=202.4
Q ss_pred hCCcccceeEeeeCceEEEEEEEcC-CC--EEEEEEEcccc-hhhHHHHHHHHHHHhcC-CCCCceeEEEEEEeCceeeE
Q 010519 185 TNRFSAENVLGEGGYGVVYKGRLIN-GS--EVAVKKLLNNL-GQAEKEFRVEVEAIGHV-RHKNLVRLLGYCIEGVHRML 259 (508)
Q Consensus 185 ~~~~~~~~~lg~G~~g~Vy~~~~~~-~~--~vavK~~~~~~-~~~~~~~~~ei~~l~~l-~h~niv~~~~~~~~~~~~~l 259 (508)
.++|++.+.||+|+||+||+|++.+ |. .||||++.... ....+.|.+|+++|.++ +|||||+++++|.+.+..++
T Consensus 9 ~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~i 88 (309)
T d1fvra_ 9 WNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYL 88 (309)
T ss_dssp GGGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEE
T ss_pred HHHcEEEEEEeeCCCcEEEEEEECCCCeEEEEEEEEECcccChHHHHHHHHHHHHHHhccCCCCEeeEEEEEecCCeeEE
Confidence 3689999999999999999998864 33 47788875433 33446789999999998 79999999999999999999
Q ss_pred EEeecCCCCHHHHHhhhh------------ccCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCEEEcCCCc
Q 010519 260 VYEYVNNGNLEQWLHGAM------------RNQGNLTWEARMKVIIGTAKALAYLHEAIEPKVVHRDIKSSNILIDDEFN 327 (508)
Q Consensus 260 v~E~~~~gsL~~~l~~~~------------~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiH~Dlk~~NIll~~~~~ 327 (508)
||||+++|+|.++|+... .....+++..++.++.||+.||.|||+. +|+||||||+|||++.++.
T Consensus 89 V~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~~---~iiHrDlkp~NIL~~~~~~ 165 (309)
T d1fvra_ 89 AIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK---QFIHRDLAARNILVGENYV 165 (309)
T ss_dssp EECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECGGGC
T ss_pred EEEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhcC---CccccccccceEEEcCCCc
Confidence 999999999999996431 2346799999999999999999999999 9999999999999999999
Q ss_pred EEEEecCCccccCCCCCcccccccccccccCccccCCCCCCChhhHHHHHHHHHHHHhCCC-CCCCCCCCchhcHHHHHH
Q 010519 328 AKVSDFGLAKLLDSGESHITTRVMGTFGYVAPEYANTGMLNEKSDIYSFGVLLLEAVTGRD-PVDYGRPANEVNLVEWLK 406 (508)
Q Consensus 328 ~kl~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltG~~-Pf~~~~~~~~~~~~~~~~ 406 (508)
+||+|||+++....... .....||..|+|||.+.++.|+.++|||||||++|||++|.. ||.. .. ..+...
T Consensus 166 ~kl~DfG~a~~~~~~~~--~~~~~gt~~y~aPE~l~~~~~~~~sDvwSfGvil~ell~~~~~p~~~-~~-----~~~~~~ 237 (309)
T d1fvra_ 166 AKIADFGLSRGQEVYVK--KTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCG-MT-----CAELYE 237 (309)
T ss_dssp EEECCTTCEESSCEECC--C----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTT-CC-----HHHHHH
T ss_pred eEEcccccccccccccc--ccceecCCcccchHHhccCCCCccceeehhHHHHHHHHhcCCCCCCC-CC-----HHHHHH
Confidence 99999999986543221 233468999999999999999999999999999999999765 5542 21 122222
Q ss_pred HHhcccccccccCCCCCCChhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhhcC
Q 010519 407 MMVGTRRAEEVVDPNLEVKPATRALKRSLLVALRCVDPDSEKRPKMSQVVRMLEAD 462 (508)
Q Consensus 407 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~ 462 (508)
....... +. .+......+.+|+.+||+.||++||||.||+++|+..
T Consensus 238 ~i~~~~~------~~----~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~L~~i 283 (309)
T d1fvra_ 238 KLPQGYR------LE----KPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRM 283 (309)
T ss_dssp HGGGTCC------CC----CCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred HHHhcCC------CC----CCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHH
Confidence 2211111 11 1122345677799999999999999999999998765
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.2e-49 Score=386.63 Aligned_cols=263 Identities=27% Similarity=0.436 Sum_probs=205.7
Q ss_pred HHHhhCCcccceeEeeeCceEEEEEEEcC--------CCEEEEEEEcccch-hhHHHHHHHHHHHhcC-CCCCceeEEEE
Q 010519 181 LEIATNRFSAENVLGEGGYGVVYKGRLIN--------GSEVAVKKLLNNLG-QAEKEFRVEVEAIGHV-RHKNLVRLLGY 250 (508)
Q Consensus 181 ~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~--------~~~vavK~~~~~~~-~~~~~~~~ei~~l~~l-~h~niv~~~~~ 250 (508)
|++..++|.+.+.||+|+||.||+|++.. +..||||++..... ....++.+|...+.++ +|||||+++++
T Consensus 8 ~~i~~~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~e~~~l~~~~~HpnIv~~~~~ 87 (299)
T d1fgka_ 8 WELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGA 87 (299)
T ss_dssp TBCCGGGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred CcccHHHeEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECcccChHHHHHHHHHHHHHHHhcCCCeEEecccc
Confidence 45667899999999999999999998642 24799999866543 3346788888888887 89999999999
Q ss_pred EEeCceeeEEEeecCCCCHHHHHhhhhc------------cCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCC
Q 010519 251 CIEGVHRMLVYEYVNNGNLEQWLHGAMR------------NQGNLTWEARMKVIIGTAKALAYLHEAIEPKVVHRDIKSS 318 (508)
Q Consensus 251 ~~~~~~~~lv~E~~~~gsL~~~l~~~~~------------~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiH~Dlk~~ 318 (508)
|.++...++||||+++|+|.++|..... ....+++..++.++.||+.||+|||+. +|+||||||+
T Consensus 88 ~~~~~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~~---~ivHrDiKp~ 164 (299)
T d1fgka_ 88 CTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASK---KCIHRDLAAR 164 (299)
T ss_dssp ECSSSSCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGG
T ss_pred cccCCeEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhhC---CEEeeeeccc
Confidence 9999999999999999999999964321 234689999999999999999999999 9999999999
Q ss_pred CEEEcCCCcEEEEecCCccccCCCCC-cccccccccccccCccccCCCCCCChhhHHHHHHHHHHHHh-CCCCCCCCCCC
Q 010519 319 NILIDDEFNAKVSDFGLAKLLDSGES-HITTRVMGTFGYVAPEYANTGMLNEKSDIYSFGVLLLEAVT-GRDPVDYGRPA 396 (508)
Q Consensus 319 NIll~~~~~~kl~Dfgla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~ellt-G~~Pf~~~~~~ 396 (508)
|||++.++.+||+|||+++....... .......|++.|+|||++.++.|+.++|||||||+||||++ |..||.....
T Consensus 165 NiLl~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~y~~k~DiwS~Gvvl~ell~~g~~p~~~~~~- 243 (299)
T d1fgka_ 165 NVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPV- 243 (299)
T ss_dssp GEEECTTCCEEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCH-
T ss_pred ceeecCCCCeEeccchhhccccccccccccccCCCChhhhhhhHhcCCCCCchhhhHHhHHHHHHhccCCCCCCCCCCH-
Confidence 99999999999999999986654332 23445678999999999999999999999999999999998 6788753321
Q ss_pred chhcHHHHHHHHhcccccccccCCCCCCChhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhhcC
Q 010519 397 NEVNLVEWLKMMVGTRRAEEVVDPNLEVKPATRALKRSLLVALRCVDPDSEKRPKMSQVVRMLEAD 462 (508)
Q Consensus 397 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~ 462 (508)
..+ ...+..... +.. +......+.+|+.+||+.||.+|||+.||++.|+..
T Consensus 244 --~~~---~~~i~~~~~------~~~----p~~~~~~l~~li~~cl~~dP~~Rps~~eil~~L~~i 294 (299)
T d1fgka_ 244 --EEL---FKLLKEGHR------MDK----PSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRI 294 (299)
T ss_dssp --HHH---HHHHHTTCC------CCC----CSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred --HHH---HHHHHcCCC------CCC----CccchHHHHHHHHHHccCCHhHCcCHHHHHHHHHHH
Confidence 111 122211111 111 111234567799999999999999999999999754
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5e-48 Score=381.76 Aligned_cols=254 Identities=29% Similarity=0.443 Sum_probs=201.7
Q ss_pred ceeEeeeCceEEEEEEEcCC----CEEEEEEEccc-chhhHHHHHHHHHHHhcCCCCCceeEEEEEEeC-ceeeEEEeec
Q 010519 191 ENVLGEGGYGVVYKGRLING----SEVAVKKLLNN-LGQAEKEFRVEVEAIGHVRHKNLVRLLGYCIEG-VHRMLVYEYV 264 (508)
Q Consensus 191 ~~~lg~G~~g~Vy~~~~~~~----~~vavK~~~~~-~~~~~~~~~~ei~~l~~l~h~niv~~~~~~~~~-~~~~lv~E~~ 264 (508)
.++||+|+||+||+|++.++ ..||||++... .....+.|.+|+++|++++|||||+++|++... ...++|||||
T Consensus 32 ~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~E~~ 111 (311)
T d1r0pa_ 32 NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYM 111 (311)
T ss_dssp EEEEEEETTEEEEEEEECC----CEEEEEEEECCCCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEETTTEEEEEEECC
T ss_pred ceEEeecCCeEEEEEEEECCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCEeEEeEEEEecCCceEEEEEEe
Confidence 57899999999999987532 25899998643 344457899999999999999999999998764 5789999999
Q ss_pred CCCCHHHHHhhhhccCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCEEEcCCCcEEEEecCCccccCCCCC
Q 010519 265 NNGNLEQWLHGAMRNQGNLTWEARMKVIIGTAKALAYLHEAIEPKVVHRDIKSSNILIDDEFNAKVSDFGLAKLLDSGES 344 (508)
Q Consensus 265 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~ 344 (508)
++|+|.+++. .....+++..++.++.|++.||.|||+. +|+||||||+||||++++.+||+|||+++.......
T Consensus 112 ~~g~l~~~~~---~~~~~~~~~~~~~i~~qia~gL~~lH~~---~iiHrDLK~~NILl~~~~~~kL~DFG~~~~~~~~~~ 185 (311)
T d1r0pa_ 112 KHGDLRNFIR---NETHNPTVKDLIGFGLQVAKGMKFLASK---KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEF 185 (311)
T ss_dssp TTCBHHHHHH---CTTCCCBHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTCCEEECSSGGGCCTTTTTC
T ss_pred ecCchhhhhc---cccccchHHHHHHHHHHHHHhhhhhccc---CcccCCccHHhEeECCCCCEEEecccchhhcccccc
Confidence 9999999986 3455688899999999999999999999 999999999999999999999999999987654322
Q ss_pred c---ccccccccccccCccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCCCchhcHHHHHHHHhcccccccccCCC
Q 010519 345 H---ITTRVMGTFGYVAPEYANTGMLNEKSDIYSFGVLLLEAVTGRDPVDYGRPANEVNLVEWLKMMVGTRRAEEVVDPN 421 (508)
Q Consensus 345 ~---~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 421 (508)
. ......||+.|+|||.+.+..++.++||||||++||||++|..||....... ++......... ...+
T Consensus 186 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~SfGivl~El~t~~~p~~~~~~~~-----~~~~~i~~g~~---~~~p- 256 (311)
T d1r0pa_ 186 DSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTF-----DITVYLLQGRR---LLQP- 256 (311)
T ss_dssp CCTTCTTCSSCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCC-----------CHHHHHTTCC---CCCC-
T ss_pred ccceecccccccccccChHHHhcCCCCChhHhhhhHHHHHHHHHCCCCCCCCCCHH-----HHHHHHHcCCC---CCCc-
Confidence 2 2333568999999999999999999999999999999999888875432211 11222221111 1111
Q ss_pred CCCChhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhhcCCCC
Q 010519 422 LEVKPATRALKRSLLVALRCVDPDSEKRPKMSQVVRMLEADDYP 465 (508)
Q Consensus 422 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~ 465 (508)
......+.+|+.+||+.||.+|||+.||+++|+.....
T Consensus 257 ------~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~L~~i~~~ 294 (311)
T d1r0pa_ 257 ------EYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFST 294 (311)
T ss_dssp ------TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred ------ccCcHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHh
Confidence 11234567799999999999999999999999876443
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.7e-49 Score=388.56 Aligned_cols=265 Identities=26% Similarity=0.389 Sum_probs=211.7
Q ss_pred HHHHhhCCcccceeEeeeCceEEEEEEEc------CCCEEEEEEEcccc-hhhHHHHHHHHHHHhcC-CCCCceeEEEEE
Q 010519 180 DLEIATNRFSAENVLGEGGYGVVYKGRLI------NGSEVAVKKLLNNL-GQAEKEFRVEVEAIGHV-RHKNLVRLLGYC 251 (508)
Q Consensus 180 ~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~-~~~~~~~~~ei~~l~~l-~h~niv~~~~~~ 251 (508)
.|++..++|++.+.||+|+||.||+|++. ++..||||++.... ......+.+|+.+++.+ +|||||+++++|
T Consensus 17 ~~~~~~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~~~~~l~~HpnIv~~~g~~ 96 (311)
T d1t46a_ 17 KWEFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGAC 96 (311)
T ss_dssp GGBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred cccCCHHHeEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECcccCHHHHHHHHHHHHHHHhccCCCCEEEEEEEE
Confidence 45677789999999999999999999863 35689999986544 33445788999999998 699999999999
Q ss_pred EeCceeeEEEeecCCCCHHHHHhhhhc--------------cCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCC
Q 010519 252 IEGVHRMLVYEYVNNGNLEQWLHGAMR--------------NQGNLTWEARMKVIIGTAKALAYLHEAIEPKVVHRDIKS 317 (508)
Q Consensus 252 ~~~~~~~lv~E~~~~gsL~~~l~~~~~--------------~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiH~Dlk~ 317 (508)
.+....++|||||++|+|.++++.... ....+++..+..++.||+.||+|||++ +++||||||
T Consensus 97 ~~~~~~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~~---~ivHrDLKp 173 (311)
T d1t46a_ 97 TIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASK---NCIHRDLAA 173 (311)
T ss_dssp CSSSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSG
T ss_pred eeCCEEEEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhC---Ceeeccccc
Confidence 999999999999999999999975321 233688999999999999999999999 999999999
Q ss_pred CCEEEcCCCcEEEEecCCccccCCCCC-cccccccccccccCccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCCC
Q 010519 318 SNILIDDEFNAKVSDFGLAKLLDSGES-HITTRVMGTFGYVAPEYANTGMLNEKSDIYSFGVLLLEAVTGRDPVDYGRPA 396 (508)
Q Consensus 318 ~NIll~~~~~~kl~Dfgla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltG~~Pf~~~~~~ 396 (508)
+|||++.++.+||+|||+++....... .......||+.|+|||++.+..++.++|||||||+||||+|+..|+......
T Consensus 174 ~NIl~~~~~~~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwS~G~~l~ellt~g~p~~~~~~~ 253 (311)
T d1t46a_ 174 RNILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPV 253 (311)
T ss_dssp GGEEEETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCS
T ss_pred ccccccccCcccccccchheeccCCCcceEeeecccChHHcCHHHhcCCCCCCcccccchHHHHHHHHhCCCCCCCCCCH
Confidence 999999999999999999987654432 3344568899999999999999999999999999999999955554333322
Q ss_pred chhcHHHHHHHHhcccccccccCCCCCCChhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhhc
Q 010519 397 NEVNLVEWLKMMVGTRRAEEVVDPNLEVKPATRALKRSLLVALRCVDPDSEKRPKMSQVVRMLEA 461 (508)
Q Consensus 397 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~ 461 (508)
.+. +...+.. .. .+. .+......+.+|+.+||+.||.+|||+.||+++|+.
T Consensus 254 ~~~-~~~~i~~----~~-----~~~----~~~~~~~~l~~Li~~cl~~dP~~RPs~~~il~~L~~ 304 (311)
T d1t46a_ 254 DSK-FYKMIKE----GF-----RML----SPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEK 304 (311)
T ss_dssp SHH-HHHHHHH----TC-----CCC----CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred HHH-HHHHHhc----CC-----CCC----CcccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHH
Confidence 211 1111111 10 011 111223557779999999999999999999999975
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.3e-48 Score=379.96 Aligned_cols=266 Identities=25% Similarity=0.356 Sum_probs=200.5
Q ss_pred CCcccceeEeeeCceEEEEEEEcCCCEEEEEEEcccchhhHHHHHHHHHHHhcCCCCCceeEEEEEEeCc----eeeEEE
Q 010519 186 NRFSAENVLGEGGYGVVYKGRLINGSEVAVKKLLNNLGQAEKEFRVEVEAIGHVRHKNLVRLLGYCIEGV----HRMLVY 261 (508)
Q Consensus 186 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~ei~~l~~l~h~niv~~~~~~~~~~----~~~lv~ 261 (508)
++|.+.+.||+|+||+||+|++ +|+.||||++..... .......|+..+..++|||||+++++|.+.. ..++||
T Consensus 3 ~~~~l~~~iG~G~fg~Vy~~~~-~g~~vAvK~~~~~~~-~~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~~~~~~~lv~ 80 (303)
T d1vjya_ 3 RTIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSREE-RSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVS 80 (303)
T ss_dssp GGEEEEEEEECCSSSEEEEEEE-TTEEEEEEEECGGGH-HHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEE
T ss_pred cEEEEEEEEeeCCCeEEEEEEE-CCEEEEEEEECccch-hHHHHHHHHHHHhhCCCCcCcceEEEEEeCCCcceEEEEEE
Confidence 5788899999999999999987 789999999854432 2222344666667889999999999998653 578999
Q ss_pred eecCCCCHHHHHhhhhccCCCccHHHHHHHHHHHHHHHHHHHhc-----CCCCeEeecCCCCCEEEcCCCcEEEEecCCc
Q 010519 262 EYVNNGNLEQWLHGAMRNQGNLTWEARMKVIIGTAKALAYLHEA-----IEPKVVHRDIKSSNILIDDEFNAKVSDFGLA 336 (508)
Q Consensus 262 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~-----~~~~iiH~Dlk~~NIll~~~~~~kl~Dfgla 336 (508)
|||++|+|.++|+. ..+++..++.++.+++.||.|||+. ..++|+||||||+||||++++.+||+|||++
T Consensus 81 Ey~~~g~L~~~l~~-----~~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~~Kl~DFGl~ 155 (303)
T d1vjya_ 81 DYHEHGSLFDYLNR-----YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLA 155 (303)
T ss_dssp ECCTTCBHHHHHHH-----CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCCTTC
T ss_pred ecccCCCHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCCCCeEEEecCcc
Confidence 99999999999963 3589999999999999999999962 1349999999999999999999999999999
Q ss_pred cccCCCCCc---ccccccccccccCccccCCCC------CCChhhHHHHHHHHHHHHhCCCCCCCCCCCch--------h
Q 010519 337 KLLDSGESH---ITTRVMGTFGYVAPEYANTGM------LNEKSDIYSFGVLLLEAVTGRDPVDYGRPANE--------V 399 (508)
Q Consensus 337 ~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~------~~~~~DvwS~Gvvl~elltG~~Pf~~~~~~~~--------~ 399 (508)
+........ ......||+.|+|||++.+.. ++.++|||||||+||||+||..||........ .
T Consensus 156 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~~~~~~~~~~~~~~~~ 235 (303)
T d1vjya_ 156 VRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSD 235 (303)
T ss_dssp EEEETTTTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSS
T ss_pred ccccCCCcceeccccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHHhhCCCCCCcccccccchhhccccc
Confidence 876543322 234467999999999987653 56799999999999999999988743221110 0
Q ss_pred cHHHHHHHHhcccccccccCCCCCCC-hhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhhcC
Q 010519 400 NLVEWLKMMVGTRRAEEVVDPNLEVK-PATRALKRSLLVALRCVDPDSEKRPKMSQVVRMLEAD 462 (508)
Q Consensus 400 ~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~ 462 (508)
........... ....++.+... ........+.+|+.+||+.||.+|||+.||+++|+..
T Consensus 236 ~~~~~~~~~~~----~~~~~p~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ei~~~L~~i 295 (303)
T d1vjya_ 236 PSVEEMRKVVC----EQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQL 295 (303)
T ss_dssp CCHHHHHHHHT----TSCCCCCCCGGGGGCHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHH
T ss_pred chHHHHHHHHh----ccccCCCCCcccCChHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHH
Confidence 01111222211 11122222222 2334566788899999999999999999999999753
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.3e-48 Score=378.41 Aligned_cols=260 Identities=24% Similarity=0.267 Sum_probs=197.7
Q ss_pred cceeEeeeCceEEEEEEEc-CCCEEEEEEEcccchhh-----HHHHHHHHHHHhcCCCCCceeEEEEEEeCceeeEEEee
Q 010519 190 AENVLGEGGYGVVYKGRLI-NGSEVAVKKLLNNLGQA-----EKEFRVEVEAIGHVRHKNLVRLLGYCIEGVHRMLVYEY 263 (508)
Q Consensus 190 ~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~-----~~~~~~ei~~l~~l~h~niv~~~~~~~~~~~~~lv~E~ 263 (508)
.+++||+|+||+||+|++. +|+.||||++....... ...+.+|+.+|++++|||||++++++.++...||||||
T Consensus 2 ~l~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~~~~~~ivmE~ 81 (299)
T d1ua2a_ 2 KLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDF 81 (299)
T ss_dssp EEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEEEEEC
T ss_pred cceEeccCcCeEEEEEEECCCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCCCCEeEEEeeeccCCceeehhhh
Confidence 3578999999999999875 68999999985433211 24578899999999999999999999999999999999
Q ss_pred cCCCCHHHHHhhhhccCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCEEEcCCCcEEEEecCCccccCCCC
Q 010519 264 VNNGNLEQWLHGAMRNQGNLTWEARMKVIIGTAKALAYLHEAIEPKVVHRDIKSSNILIDDEFNAKVSDFGLAKLLDSGE 343 (508)
Q Consensus 264 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~~~ 343 (508)
+.++++..++ .....+++..+..++.||+.||.|||++ +|+||||||+|||++.++.+||+|||+++......
T Consensus 82 ~~~~~~~~~~----~~~~~l~~~~~~~~~~qil~aL~~lH~~---~iiHrDiKp~NIli~~~~~~KL~DFG~a~~~~~~~ 154 (299)
T d1ua2a_ 82 METDLEVIIK----DNSLVLTPSHIKAYMLMTLQGLEYLHQH---WILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPN 154 (299)
T ss_dssp CSEEHHHHHT----TCCSSCCSSHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECCCGGGSTTTSCC
T ss_pred hcchHHhhhh----hcccCCCHHHHHHHHHHHHHHHHHhhcc---ceecccCCcceEEecCCCccccccCccccccCCCc
Confidence 9887766554 4566789999999999999999999999 99999999999999999999999999998765433
Q ss_pred CcccccccccccccCccccCC-CCCCChhhHHHHHHHHHHHHhCCCCCCCCCCCchhcHHHHHHHHhcccccccccC---
Q 010519 344 SHITTRVMGTFGYVAPEYANT-GMLNEKSDIYSFGVLLLEAVTGRDPVDYGRPANEVNLVEWLKMMVGTRRAEEVVD--- 419 (508)
Q Consensus 344 ~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwS~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--- 419 (508)
. .....+||+.|+|||++.+ ..|+.++|||||||++|||++|..||.... ..+....+....+........+
T Consensus 155 ~-~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~---~~~~l~~i~~~~~~~~~~~~~~~~~ 230 (299)
T d1ua2a_ 155 R-AYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDS---DLDQLTRIFETLGTPTEEQWPDMCS 230 (299)
T ss_dssp C-CCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSS---HHHHHHHHHHHHCCCCTTTSSSTTS
T ss_pred c-cccceecChhhccHHHHccCCCCChhhhhhhcchHHHHHHhCcCCCCCCC---HHHHHHHHHHhcCCCChhhccchhc
Confidence 2 2344579999999999865 468999999999999999999999996432 2222222222222111110000
Q ss_pred -------CCCCCChh----HHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhh
Q 010519 420 -------PNLEVKPA----TRALKRSLLVALRCVDPDSEKRPKMSQVVRMLE 460 (508)
Q Consensus 420 -------~~~~~~~~----~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 460 (508)
......+. ......+.+|+.+||..||.+|||++|+|+|-.
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~dP~~R~sa~e~L~Hp~ 282 (299)
T d1ua2a_ 231 LPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKY 282 (299)
T ss_dssp STTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTSGG
T ss_pred cchhhhhccCCCCChHHhcccCCHHHHHHHHHHccCChhhCcCHHHHhCCHh
Confidence 00000010 112356778999999999999999999998643
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.2e-47 Score=375.43 Aligned_cols=270 Identities=24% Similarity=0.344 Sum_probs=204.3
Q ss_pred CCcccceeEeeeCceEEEEEEEc-CCCEEEEEEEcccch--hhHHHHHHHHHHHhcCCCCCceeEEEEEEeCceeeEEEe
Q 010519 186 NRFSAENVLGEGGYGVVYKGRLI-NGSEVAVKKLLNNLG--QAEKEFRVEVEAIGHVRHKNLVRLLGYCIEGVHRMLVYE 262 (508)
Q Consensus 186 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~ei~~l~~l~h~niv~~~~~~~~~~~~~lv~E 262 (508)
++|++.+.||+|+||+||+|++. +|+.||||++..... .....+.+|+++|++++|||||++++++.+....|+|||
T Consensus 2 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~~~~~~iv~e 81 (298)
T d1gz8a_ 2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFE 81 (298)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEC-------CCHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred CCCEeccEEecCcCeEEEEEEECCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEEeccccccccceeEEEe
Confidence 58999999999999999999974 689999999854332 224678889999999999999999999999999999999
Q ss_pred ecCCCCHHHHHhhhhccCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCEEEcCCCcEEEEecCCccccCCC
Q 010519 263 YVNNGNLEQWLHGAMRNQGNLTWEARMKVIIGTAKALAYLHEAIEPKVVHRDIKSSNILIDDEFNAKVSDFGLAKLLDSG 342 (508)
Q Consensus 263 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~~ 342 (508)
|+.+ ++.+++.. .....+++..++.++.||+.||+|||++ +||||||||+|||++.++.+||+|||+++.....
T Consensus 82 ~~~~-~~~~~~~~--~~~~~l~e~~~~~~~~qil~~L~yLH~~---~IiHrDiKpeNIl~~~~~~~kl~DFG~a~~~~~~ 155 (298)
T d1gz8a_ 82 FLHQ-DLKKFMDA--SALTGIPLPLIKSYLFQLLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVP 155 (298)
T ss_dssp CCSE-EHHHHHHH--TTTTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECSTTHHHHHCCC
T ss_pred ecCC-chhhhhhh--hcccCCCHHHHHHHHHHHHHHHHHhhcC---CEEccccCchheeecccCcceeccCCcceeccCC
Confidence 9965 55555542 3456799999999999999999999999 9999999999999999999999999999876543
Q ss_pred CCcccccccccccccCccccCCCC-CCChhhHHHHHHHHHHHHhCCCCCCCCCCCchhcHHHHHHHHhccccc------c
Q 010519 343 ESHITTRVMGTFGYVAPEYANTGM-LNEKSDIYSFGVLLLEAVTGRDPVDYGRPANEVNLVEWLKMMVGTRRA------E 415 (508)
Q Consensus 343 ~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DvwS~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~------~ 415 (508)
.. ......||+.|+|||++.... ++.++|||||||+||+|++|+.||..... ...........+.... .
T Consensus 156 ~~-~~~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~~~---~~~~~~i~~~~~~~~~~~~~~~~ 231 (298)
T d1gz8a_ 156 VR-TYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSE---IDQLFRIFRTLGTPDEVVWPGVT 231 (298)
T ss_dssp SB-CTTCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSH---HHHHHHHHHHHCCCCTTTSTTGG
T ss_pred cc-cceeecccceeeehhhhccccCCCccccccccchhhhHHhhCCCCCCCCCH---HHHHHHHHHhcCCCchhhccccc
Confidence 32 344567999999999877655 57899999999999999999999964321 1111111111111000 0
Q ss_pred cccC-----CCCCCChh----HHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH--hhcCCCC
Q 010519 416 EVVD-----PNLEVKPA----TRALKRSLLVALRCVDPDSEKRPKMSQVVRM--LEADDYP 465 (508)
Q Consensus 416 ~~~~-----~~~~~~~~----~~~~~~l~~li~~cl~~dP~~RPs~~evl~~--L~~~~~~ 465 (508)
...+ +....... ......+.+|+.+||..||.+|||+.|+++| +++...+
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~t~~ell~H~ff~~~~~p 292 (298)
T d1gz8a_ 232 SMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKP 292 (298)
T ss_dssp GSTTCCTTSCCCCCCCHHHHSTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGTTCCCC
T ss_pred cccccccccccccccchhhhccCCCHHHHHHHHHHccCChhHCcCHHHHhCCHhhccCCCC
Confidence 0000 00000000 1123466779999999999999999999997 5444443
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Probab=100.00 E-value=1.5e-47 Score=374.47 Aligned_cols=262 Identities=23% Similarity=0.309 Sum_probs=201.0
Q ss_pred CCcccceeEeeeCceEEEEEEEcCCCEEEEEEEcccch--hhHHHHHHHHHHHhcCCCCCceeEEEEEEeCceeeEEEee
Q 010519 186 NRFSAENVLGEGGYGVVYKGRLINGSEVAVKKLLNNLG--QAEKEFRVEVEAIGHVRHKNLVRLLGYCIEGVHRMLVYEY 263 (508)
Q Consensus 186 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~--~~~~~~~~ei~~l~~l~h~niv~~~~~~~~~~~~~lv~E~ 263 (508)
++|.+.+.||+|+||+||+|++.+|+.||||++..... .....+.+|+.+|++++|||||++++++.+.+..+++|||
T Consensus 2 ~~Y~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~i~~e~ 81 (286)
T d1ob3a_ 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEH 81 (286)
T ss_dssp CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred CCceeccEEecCCCcEEEEEEeCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEeeeeecccCCceeEEEEe
Confidence 58999999999999999999998999999999865432 2246788899999999999999999999999999999999
Q ss_pred cCCCCHHHHHhhhhccCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCEEEcCCCcEEEEecCCccccCCCC
Q 010519 264 VNNGNLEQWLHGAMRNQGNLTWEARMKVIIGTAKALAYLHEAIEPKVVHRDIKSSNILIDDEFNAKVSDFGLAKLLDSGE 343 (508)
Q Consensus 264 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~~~ 343 (508)
+.++.+..+. ...+.+++..+..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||++.......
T Consensus 82 ~~~~~~~~~~----~~~~~l~~~~~~~i~~qi~~~L~~LH~~---~IvHrDiKp~NIll~~~~~~kl~DfG~a~~~~~~~ 154 (286)
T d1ob3a_ 82 LDQDLKKLLD----VCEGGLESVTAKSFLLQLLNGIAYCHDR---RVLHRDLKPQNLLINREGELKIADFGLARAFGIPV 154 (286)
T ss_dssp CSEEHHHHHH----TSTTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC--
T ss_pred ehhhhHHHHH----hhcCCcchhhhHHHHHHHHHHHHHhccC---cEEecCCCCceeeEcCCCCEEecccccceecccCc
Confidence 9876666654 4567899999999999999999999999 99999999999999999999999999998765433
Q ss_pred CcccccccccccccCccccCC-CCCCChhhHHHHHHHHHHHHhCCCCCCCCCCCchhcHHHHHHHHhccccccc------
Q 010519 344 SHITTRVMGTFGYVAPEYANT-GMLNEKSDIYSFGVLLLEAVTGRDPVDYGRPANEVNLVEWLKMMVGTRRAEE------ 416 (508)
Q Consensus 344 ~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwS~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~------ 416 (508)
. ......+++.|+|||.+.+ ..++.++|||||||++|||++|+.||.... ..+.........+......
T Consensus 155 ~-~~~~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~~~---~~~~~~~i~~~~~~~~~~~~~~~~~ 230 (286)
T d1ob3a_ 155 R-KYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVS---EADQLMRIFRILGTPNSKNWPNVTE 230 (286)
T ss_dssp --------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSS---HHHHHHHHHHHHCCCCTTTSTTGGG
T ss_pred c-ccceecccchhhhHHHHhCCCCCCcceeehhcCcHHHHHHHCCCCCCCCC---HHHHHHHHHHhhCCCChhhccchhh
Confidence 2 2344568999999999865 457899999999999999999999996432 1111111111111111000
Q ss_pred c------cCCCCCC---ChhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 010519 417 V------VDPNLEV---KPATRALKRSLLVALRCVDPDSEKRPKMSQVVRM 458 (508)
Q Consensus 417 ~------~~~~~~~---~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 458 (508)
. ....... .........+.+|+.+||+.||++|||++|+++|
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~s~~ell~H 281 (286)
T d1ob3a_ 231 LPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEH 281 (286)
T ss_dssp STTCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred hhhcccccccccCcchhhhcccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 0 0000000 0011223456789999999999999999999975
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.2e-48 Score=377.74 Aligned_cols=242 Identities=25% Similarity=0.381 Sum_probs=196.7
Q ss_pred CCcccceeEeeeCceEEEEEEEc-CCCEEEEEEEcccch------hhHHHHHHHHHHHhcCC--CCCceeEEEEEEeCce
Q 010519 186 NRFSAENVLGEGGYGVVYKGRLI-NGSEVAVKKLLNNLG------QAEKEFRVEVEAIGHVR--HKNLVRLLGYCIEGVH 256 (508)
Q Consensus 186 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~------~~~~~~~~ei~~l~~l~--h~niv~~~~~~~~~~~ 256 (508)
++|++.+.||+|+||+||+|++. +|+.||||++..... .....+.+|+.+|++++ |||||++++++.+.+.
T Consensus 4 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~~~~ 83 (273)
T d1xwsa_ 4 SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDS 83 (273)
T ss_dssp TTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECSSE
T ss_pred CeEEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEEeeCCe
Confidence 58999999999999999999975 689999999864321 11233567999999986 8999999999999999
Q ss_pred eeEEEeecCC-CCHHHHHhhhhccCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCEEEcC-CCcEEEEecC
Q 010519 257 RMLVYEYVNN-GNLEQWLHGAMRNQGNLTWEARMKVIIGTAKALAYLHEAIEPKVVHRDIKSSNILIDD-EFNAKVSDFG 334 (508)
Q Consensus 257 ~~lv~E~~~~-gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiH~Dlk~~NIll~~-~~~~kl~Dfg 334 (508)
.++||||+.+ +++.+++. ....+++..++.++.||+.||.|||++ +|+||||||+|||++. ++.+||+|||
T Consensus 84 ~~lv~e~~~~~~~l~~~~~----~~~~l~e~~~~~~~~qi~~al~~lH~~---~iiHrDiKp~NIll~~~~~~vkl~DFG 156 (273)
T d1xwsa_ 84 FVLILERPEPVQDLFDFIT----ERGALQEELARSFFWQVLEAVRHCHNC---GVLHRDIKDENILIDLNRGELKLIDFG 156 (273)
T ss_dssp EEEEEECCSSEEEHHHHHH----HHCSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEETTTTEEEECCCT
T ss_pred EEEEEEeccCcchHHHHHh----ccCCCCHHHHHHHHHHHHHHHHHHHHC---CCccccCcccceEEecCCCeEEECccc
Confidence 9999999975 68888874 456799999999999999999999999 9999999999999985 5799999999
Q ss_pred CccccCCCCCcccccccccccccCccccCCCCC-CChhhHHHHHHHHHHHHhCCCCCCCCCCCchhcHHHHHHHHhcccc
Q 010519 335 LAKLLDSGESHITTRVMGTFGYVAPEYANTGML-NEKSDIYSFGVLLLEAVTGRDPVDYGRPANEVNLVEWLKMMVGTRR 413 (508)
Q Consensus 335 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DvwS~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~ 413 (508)
+++..... ..+...||+.|+|||++.+..+ +.++|||||||+||||++|+.||... . . .......
T Consensus 157 ~a~~~~~~---~~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~-----~---~---i~~~~~~ 222 (273)
T d1xwsa_ 157 SGALLKDT---VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHD-----E---E---IIRGQVF 222 (273)
T ss_dssp TCEECCSS---CBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSH-----H---H---HHHCCCC
T ss_pred cceecccc---cccccccCCCcCCHHHHcCCCCCCcccccccceeeehhHhhCCCCCCCc-----h---H---HhhcccC
Confidence 99865433 2445679999999999987665 57799999999999999999999631 0 1 0111110
Q ss_pred cccccCCCCCCChhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhh
Q 010519 414 AEEVVDPNLEVKPATRALKRSLLVALRCVDPDSEKRPKMSQVVRMLE 460 (508)
Q Consensus 414 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 460 (508)
..+ .....+.+|+.+||+.||.+|||++|+++|-+
T Consensus 223 ----~~~--------~~s~~~~~li~~~L~~dp~~R~s~~eil~hp~ 257 (273)
T d1xwsa_ 223 ----FRQ--------RVSSECQHLIRWCLALRPSDRPTFEEIQNHPW 257 (273)
T ss_dssp ----CSS--------CCCHHHHHHHHHHTCSSGGGSCCHHHHHTSGG
T ss_pred ----CCC--------CCCHHHHHHHHHHccCCHhHCcCHHHHhcCHh
Confidence 111 12345677999999999999999999998644
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.4e-46 Score=368.25 Aligned_cols=264 Identities=25% Similarity=0.345 Sum_probs=196.4
Q ss_pred hCCcccceeEeeeCceEEEEEEEc-C-CCEEEEEEEcccchh--hHHHHHHHHHHHhcC---CCCCceeEEEEEEe----
Q 010519 185 TNRFSAENVLGEGGYGVVYKGRLI-N-GSEVAVKKLLNNLGQ--AEKEFRVEVEAIGHV---RHKNLVRLLGYCIE---- 253 (508)
Q Consensus 185 ~~~~~~~~~lg~G~~g~Vy~~~~~-~-~~~vavK~~~~~~~~--~~~~~~~ei~~l~~l---~h~niv~~~~~~~~---- 253 (508)
.++|++.+.||+|+||+||+|++. + ++.||||++...... ....+.+|+.+|+.+ +||||++++++|..
T Consensus 6 ~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~~~ 85 (305)
T d1blxa_ 6 DQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTD 85 (305)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECS
T ss_pred cCCEEEEEEEecccCeEEEEEEEECCCCEEEEEEEEehhhccchHHHHHHHHHHHHHHHhhcCCCCcceeeeeecccccc
Confidence 368999999999999999999974 4 556899998543321 122345567666554 89999999999864
Q ss_pred -CceeeEEEeecCCCCHHHHHhhhhccCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCEEEcCCCcEEEEe
Q 010519 254 -GVHRMLVYEYVNNGNLEQWLHGAMRNQGNLTWEARMKVIIGTAKALAYLHEAIEPKVVHRDIKSSNILIDDEFNAKVSD 332 (508)
Q Consensus 254 -~~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~D 332 (508)
....+++|||+.++.+..... .....+++..++.++.||+.||+|||++ +|+||||||+|||+++++.+||+|
T Consensus 86 ~~~~~~~~~e~~~~~~~~~~~~---~~~~~~~~~~~~~~~~qi~~aL~yLH~~---~ivHrDiKp~NILi~~~~~~kl~d 159 (305)
T d1blxa_ 86 RETKLTLVFEHVDQDLTTYLDK---VPEPGVPTETIKDMMFQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLAD 159 (305)
T ss_dssp SEEEEEEEEECCSCBHHHHHHH---SCTTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECS
T ss_pred cCceEEEEEEeccCCchhhhhh---ccCCCCCHHHHHHHHHHHHHHHHHHHhC---CEEecCCCccEEEEcCCCCeeecc
Confidence 246789999998876655443 4566789999999999999999999999 999999999999999999999999
Q ss_pred cCCccccCCCCCcccccccccccccCccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCCCchhcHHHHHHHHhccc
Q 010519 333 FGLAKLLDSGESHITTRVMGTFGYVAPEYANTGMLNEKSDIYSFGVLLLEAVTGRDPVDYGRPANEVNLVEWLKMMVGTR 412 (508)
Q Consensus 333 fgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~ 412 (508)
||++...... .......||+.|+|||++.+..|+.++|||||||+||||++|+.||..... ......+....+..
T Consensus 160 fg~~~~~~~~--~~~~~~~gT~~Y~APE~~~~~~y~~~~DiwSlG~il~ell~g~~pf~~~~~---~~~~~~i~~~~~~~ 234 (305)
T d1blxa_ 160 FGLARIYSFQ--MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSD---VDQLGKILDVIGLP 234 (305)
T ss_dssp CCSCCCCCGG--GGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSH---HHHHHHHHHHHCCC
T ss_pred hhhhhhhccc--ccCCCcccChhhcCcchhcCCCCChhehhhchHHHHHHHHHCCCCCCCCCH---HHHHHHHHHhhCCC
Confidence 9999865432 234556899999999999999999999999999999999999999964422 11111111221111
Q ss_pred ccccc----------cCCCCCC---ChhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHh
Q 010519 413 RAEEV----------VDPNLEV---KPATRALKRSLLVALRCVDPDSEKRPKMSQVVRML 459 (508)
Q Consensus 413 ~~~~~----------~~~~~~~---~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L 459 (508)
..... ....... .........+.+|+.+||+.||.+|||+.|+|+|-
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~sa~e~L~Hp 294 (305)
T d1blxa_ 235 GEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHP 294 (305)
T ss_dssp CGGGSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTSG
T ss_pred chhcccccccchhhhhccccccchhhccccCCHHHHHHHHHHCcCChhHCcCHHHHhcCh
Confidence 00000 0000000 00111234566799999999999999999999863
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.4e-45 Score=364.30 Aligned_cols=267 Identities=21% Similarity=0.261 Sum_probs=198.6
Q ss_pred CCcccceeEeeeCceEEEEEEEc-CCCEEEEEEEcccc--hhhHHHHHHHHHHHhcCCCCCceeEEEEEEeC--------
Q 010519 186 NRFSAENVLGEGGYGVVYKGRLI-NGSEVAVKKLLNNL--GQAEKEFRVEVEAIGHVRHKNLVRLLGYCIEG-------- 254 (508)
Q Consensus 186 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~ei~~l~~l~h~niv~~~~~~~~~-------- 254 (508)
++|++.+.||+|+||+||+|++. +|+.||||++.... ......+.+|+++|++++||||+++++++...
T Consensus 10 ~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~~~~~ 89 (318)
T d3blha1 10 SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRCK 89 (318)
T ss_dssp GGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----CTTSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC---------
T ss_pred CCEEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHHhcCCCccceEeeeecccccccccC
Confidence 58999999999999999999985 78999999885432 22345678899999999999999999998653
Q ss_pred ceeeEEEeecCCCCHHHHHhhhhccCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCEEEcCCCcEEEEecC
Q 010519 255 VHRMLVYEYVNNGNLEQWLHGAMRNQGNLTWEARMKVIIGTAKALAYLHEAIEPKVVHRDIKSSNILIDDEFNAKVSDFG 334 (508)
Q Consensus 255 ~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~Dfg 334 (508)
...++||||+.++.+..+. .....+++..++.++.||+.||.|||++ +|+||||||+|||++.++.+||+|||
T Consensus 90 ~~~~iv~e~~~~~~~~~~~----~~~~~~~~~~~~~i~~qil~~l~~lH~~---~ivHrDlKp~NILl~~~~~~kl~dfg 162 (318)
T d3blha1 90 GSIYLVFDFCEHDLAGLLS----NVLVKFTLSEIKRVMQMLLNGLYYIHRN---KILHRDMKAANVLITRDGVLKLADFG 162 (318)
T ss_dssp -CEEEEEECCCEEHHHHHT----CTTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTSCEEECCCT
T ss_pred ceEEEEEeccCCCccchhh----hcccccccHHHHHHHHHHHHHHHHhccC---CEEecCcCchheeecCCCcEEeeecc
Confidence 4578999999876665443 4556788999999999999999999999 99999999999999999999999999
Q ss_pred CccccCCCCC---cccccccccccccCccccCCC-CCCChhhHHHHHHHHHHHHhCCCCCCCCCCCchhcHHHHHHHHhc
Q 010519 335 LAKLLDSGES---HITTRVMGTFGYVAPEYANTG-MLNEKSDIYSFGVLLLEAVTGRDPVDYGRPANEVNLVEWLKMMVG 410 (508)
Q Consensus 335 la~~~~~~~~---~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwS~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~ 410 (508)
++........ ......+||+.|+|||++.+. .|+.++|||||||++|||++|+.||.... .......+....+
T Consensus 163 ~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~~~~---~~~~~~~i~~~~~ 239 (318)
T d3blha1 163 LARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNT---EQHQLALISQLCG 239 (318)
T ss_dssp TCEECCC-----CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSS---HHHHHHHHHHHHC
T ss_pred eeeecccccccccccccceecCHHHhhHHHHcCCCCCCcHHHcccCCceeeeHhhCCCCCCCCC---HHHHHHHHHHhcC
Confidence 9986653221 123335799999999998765 68999999999999999999999996432 2222222222222
Q ss_pred cccccc---c--------c-CCCCCCChhHH------HHHHHHHHHHHhcCCCCCCCCCHHHHHHHhhcC
Q 010519 411 TRRAEE---V--------V-DPNLEVKPATR------ALKRSLLVALRCVDPDSEKRPKMSQVVRMLEAD 462 (508)
Q Consensus 411 ~~~~~~---~--------~-~~~~~~~~~~~------~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~ 462 (508)
...... . . ........... ....+.+|+.+||+.||++|||++|+++|-.-.
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~sa~elL~Hpff~ 309 (318)
T d3blha1 240 SITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHDFFW 309 (318)
T ss_dssp CCCTTTSTTCCCC-------CCSSCCBCHHHHHHHHHCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGS
T ss_pred CCChhhccccchhhhhhhhcccccccccchhhhccccCCHHHHHHHHHHCcCChhHCcCHHHHHcChhhc
Confidence 211000 0 0 00000011111 123456799999999999999999999875543
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.2e-45 Score=369.32 Aligned_cols=259 Identities=27% Similarity=0.355 Sum_probs=195.1
Q ss_pred CcccceeEeeeCceEEEEEEEc-CCCEEEEEEEcccchhhHHHHHHHHHHHhcCCCCCceeEEEEEEeC------ceeeE
Q 010519 187 RFSAENVLGEGGYGVVYKGRLI-NGSEVAVKKLLNNLGQAEKEFRVEVEAIGHVRHKNLVRLLGYCIEG------VHRML 259 (508)
Q Consensus 187 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~ei~~l~~l~h~niv~~~~~~~~~------~~~~l 259 (508)
+|+..++||+|+||+||+|++. +|+.||||++...... +.+|+.+|++++||||++++++|... .+.+|
T Consensus 21 ~Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~----~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~~~~~l 96 (350)
T d1q5ka_ 21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRF----KNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNL 96 (350)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSSS----CCHHHHHHHHCCCTTBCCEEEEEEEC--CCSCCEEEE
T ss_pred CcEeeeEEeeCcCeEEEEEEECCCCCEEEEEEECccchH----HHHHHHHHHhcCCCCCCcEEEEEEecCccCCceEEEE
Confidence 6888999999999999999985 6899999998654322 33599999999999999999998643 34689
Q ss_pred EEeecCCCCHHHHHhhhhccCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCEEEcCCC-cEEEEecCCccc
Q 010519 260 VYEYVNNGNLEQWLHGAMRNQGNLTWEARMKVIIGTAKALAYLHEAIEPKVVHRDIKSSNILIDDEF-NAKVSDFGLAKL 338 (508)
Q Consensus 260 v~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiH~Dlk~~NIll~~~~-~~kl~Dfgla~~ 338 (508)
|||||+++ +...+.........+++..++.++.||+.||+|||++ +|+||||||+|||++.++ .+||+|||++..
T Consensus 97 v~Ey~~~~-~~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH~~---~IiHrDiKp~NILl~~~~~~~kl~DFG~a~~ 172 (350)
T d1q5ka_ 97 VLDYVPET-VYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQ 172 (350)
T ss_dssp EEECCSEE-HHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECTTTCCEEECCCTTCEE
T ss_pred EEeccCCc-cHHHHHhhhhccCCCCHHHHHHHHHHHHHHHHHHHhc---CCcccCCCcceEEEecCCCceeEecccchhh
Confidence 99999765 5544544345667899999999999999999999998 999999999999999775 899999999987
Q ss_pred cCCCCCcccccccccccccCccccCC-CCCCChhhHHHHHHHHHHHHhCCCCCCCCCCCchhcHHHHHHHHhccc-----
Q 010519 339 LDSGESHITTRVMGTFGYVAPEYANT-GMLNEKSDIYSFGVLLLEAVTGRDPVDYGRPANEVNLVEWLKMMVGTR----- 412 (508)
Q Consensus 339 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwS~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~----- 412 (508)
...... ....+||+.|+|||.+.+ ..|+.++|||||||++|||++|+.||...... ..+...+.. .+..
T Consensus 173 ~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~~~~~--~~l~~i~~~-~g~~~~~~~ 247 (350)
T d1q5ka_ 173 LVRGEP--NVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGV--DQLVEIIKV-LGTPTREQI 247 (350)
T ss_dssp CCTTSC--CCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCCSSHH--HHHHHHHHH-HCCCCHHHH
T ss_pred ccCCcc--cccccccccccChHHhhcccCCCcceeecccceEEEehhhCCCCCCCCCHH--HHHHHHHHH-hCCChHHhh
Confidence 654332 334579999999998765 57899999999999999999999999644321 111111111 1100
Q ss_pred -----ccccccCCCCCC-----ChhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 010519 413 -----RAEEVVDPNLEV-----KPATRALKRSLLVALRCVDPDSEKRPKMSQVVRM 458 (508)
Q Consensus 413 -----~~~~~~~~~~~~-----~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 458 (508)
......-+.... .........+.+|+.+||..||.+|||+.|+|+|
T Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~H 303 (350)
T d1q5ka_ 248 REMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAH 303 (350)
T ss_dssp HHHCC---CCCCCCCCCCCGGGTSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred hhhccchhhccccccccCchhhhcccCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 000000000000 0011233456779999999999999999999986
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.1e-45 Score=368.75 Aligned_cols=264 Identities=23% Similarity=0.316 Sum_probs=196.2
Q ss_pred hCCcccceeEeeeCceEEEEEEEc-CCCEEEEEEEcccc-hhhHHHHHHHHHHHhcCCCCCceeEEEEEEeCc----eee
Q 010519 185 TNRFSAENVLGEGGYGVVYKGRLI-NGSEVAVKKLLNNL-GQAEKEFRVEVEAIGHVRHKNLVRLLGYCIEGV----HRM 258 (508)
Q Consensus 185 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~ei~~l~~l~h~niv~~~~~~~~~~----~~~ 258 (508)
+++|++++.||+|+||+||+|++. +|+.||||++.... ....+.+.+|+.+|++++||||+++++++.... ..+
T Consensus 7 ~~rY~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~~~~~ 86 (345)
T d1pmea_ 7 GPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDV 86 (345)
T ss_dssp CTTEEEEEECC---CCCEEEEEETTTCSEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCE
T ss_pred CCCeEEEEEEeeccCeEEEEEEECCCCcEEEEEEEehhcChHHHHHHHHHHHHHHHcCCCCCCcEEEEEeeccccccceE
Confidence 357999999999999999999874 79999999986433 334467888999999999999999999987653 234
Q ss_pred EEEeecCCCCHHHHHhhhhccCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCEEEcCCCcEEEEecCCccc
Q 010519 259 LVYEYVNNGNLEQWLHGAMRNQGNLTWEARMKVIIGTAKALAYLHEAIEPKVVHRDIKSSNILIDDEFNAKVSDFGLAKL 338 (508)
Q Consensus 259 lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~Dfgla~~ 338 (508)
++++|+.+|+|.+++.. ..+++..++.++.||+.||+|||++ +|+||||||+|||++.++.+||+|||++..
T Consensus 87 ~l~~~~~~g~L~~~l~~-----~~l~~~~i~~i~~qil~al~yLH~~---~iiHRDIKp~NILl~~~~~~kl~DfG~a~~ 158 (345)
T d1pmea_ 87 YLVTHLMGADLYKLLKT-----QHLSNDHICYFLYQILRGLKYIHSA---NVLHRDLKPSNLLLNTTCDLKICDFGLARV 158 (345)
T ss_dssp EEEEECCCEEHHHHHHH-----CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEE
T ss_pred EEEEeecCCchhhhhhc-----CCCCHHHHHHHHHHHHHHHHHHHHC---CCcCCCCCcceEEECCCCCEEEcccCceee
Confidence 55666779999999852 3689999999999999999999999 999999999999999999999999999986
Q ss_pred cCCCCC--cccccccccccccCccccC-CCCCCChhhHHHHHHHHHHHHhCCCCCCCCCCCchhcHHHHHHHHhcccccc
Q 010519 339 LDSGES--HITTRVMGTFGYVAPEYAN-TGMLNEKSDIYSFGVLLLEAVTGRDPVDYGRPANEVNLVEWLKMMVGTRRAE 415 (508)
Q Consensus 339 ~~~~~~--~~~~~~~gt~~y~aPE~~~-~~~~~~~~DvwS~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~ 415 (508)
...... ......+||+.|+|||++. +..++.++||||+||++|+|++|+.||......+. ..............
T Consensus 159 ~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~~~~~~~---~~~~~~~~~~~~~~ 235 (345)
T d1pmea_ 159 ADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQ---LNHILGILGSPSQE 235 (345)
T ss_dssp CCGGGCBCCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH---HHHHHHHHCSCCHH
T ss_pred ccCCCccceeeccccccceechHHHhhcCCCCCchhhhhccCceehHHhhCCCCCCCCCHHHH---HHHHhhhccCCChh
Confidence 543221 1234567999999999984 45678999999999999999999999965432111 11111111000000
Q ss_pred c-------------ccCCCCCCChh----HHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHh
Q 010519 416 E-------------VVDPNLEVKPA----TRALKRSLLVALRCVDPDSEKRPKMSQVVRML 459 (508)
Q Consensus 416 ~-------------~~~~~~~~~~~----~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L 459 (508)
. ...+.....+. ......+.+|+.+||+.||.+|||+.|+|+|-
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~ta~e~L~hp 296 (345)
T d1pmea_ 236 DLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHP 296 (345)
T ss_dssp HHHTCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSG
T ss_pred hhhhhhhhhhhcccccCCccCCCCHHHhCCCCCHHHHHHHHHHccCChhHCcCHHHHhcCH
Confidence 0 00000000000 01123567899999999999999999999873
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-44 Score=354.58 Aligned_cols=265 Identities=20% Similarity=0.271 Sum_probs=206.6
Q ss_pred CCcccceeEeeeCceEEEEEEEc-CCCEEEEEEEcccc--hhhHHHHHHHHHHHhcCCCCCceeEEEEEEeCceeeEEEe
Q 010519 186 NRFSAENVLGEGGYGVVYKGRLI-NGSEVAVKKLLNNL--GQAEKEFRVEVEAIGHVRHKNLVRLLGYCIEGVHRMLVYE 262 (508)
Q Consensus 186 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~ei~~l~~l~h~niv~~~~~~~~~~~~~lv~E 262 (508)
++|++++.||+|+||+||+|++. +++.||||++.... ......+.+|+.+|+.++||||+++++++.+....++|++
T Consensus 2 ~ry~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~iv~~ 81 (292)
T d1unla_ 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE 81 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred CCCEeeeEEecCcCeEEEEEEECCCCcEEEEEEEehhhCChHHHHHHHHHHHHHHhcCcCCEEeeccccccccceeEEee
Confidence 58999999999999999999985 78889999985433 3345678899999999999999999999999999999999
Q ss_pred ecCCCCHHHHHhhhhccCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCEEEcCCCcEEEEecCCccccCCC
Q 010519 263 YVNNGNLEQWLHGAMRNQGNLTWEARMKVIIGTAKALAYLHEAIEPKVVHRDIKSSNILIDDEFNAKVSDFGLAKLLDSG 342 (508)
Q Consensus 263 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~~ 342 (508)
++.+++|..++ ...+.+++..++.++.|++.||+|||++ +|+||||||+|||++.++.+||+|||.++.....
T Consensus 82 ~~~~~~l~~~~----~~~~~~~~~~~~~~~~q~~~aL~~lH~~---~IvHrDiKP~NIli~~~~~~kl~DFG~a~~~~~~ 154 (292)
T d1unla_ 82 FCDQDLKKYFD----SCNGDLDPEIVKSFLFQLLKGLGFCHSR---NVLHRDLKPQNLLINRNGELKLANFGLARAFGIP 154 (292)
T ss_dssp CCSEEHHHHHH----HTTTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTTCEECCSC
T ss_pred ecccccccccc----ccccccchhHHHHHHHHHHHHHHHhhcC---CEeeecccCcccccccCCceeeeecchhhcccCC
Confidence 99999888877 3566789999999999999999999999 9999999999999999999999999999876543
Q ss_pred CCcccccccccccccCccccCCCC-CCChhhHHHHHHHHHHHHhCCCCCCCCCCCchhcHHHHHHHHhcccccc------
Q 010519 343 ESHITTRVMGTFGYVAPEYANTGM-LNEKSDIYSFGVLLLEAVTGRDPVDYGRPANEVNLVEWLKMMVGTRRAE------ 415 (508)
Q Consensus 343 ~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DvwS~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~------ 415 (508)
.. ......+++.|+|||++.+.. ++.++|||||||++|||++|+.||..+... ......+..........
T Consensus 155 ~~-~~~~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~ 231 (292)
T d1unla_ 155 VR-CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDV--DDQLKRIFRLLGTPTEEQWPSMT 231 (292)
T ss_dssp CS-CCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSH--HHHHHHHHHHHCCCCTTTCTTGG
T ss_pred Cc-cceeeccccchhhhhHhccCCCCCchhhccccchHHHHHhhCCCCCCCCCCH--HHHHHHHHhhcCCCChhhhhhhh
Confidence 32 233445788999999987654 689999999999999999999997544322 22222222222111000
Q ss_pred c---------ccCCCCCCChhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhh
Q 010519 416 E---------VVDPNLEVKPATRALKRSLLVALRCVDPDSEKRPKMSQVVRMLE 460 (508)
Q Consensus 416 ~---------~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 460 (508)
. .................+.+|+.+||+.||.+|||++|+|+|-+
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~sa~e~L~Hp~ 285 (292)
T d1unla_ 232 KLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPY 285 (292)
T ss_dssp GSTTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHTTSGG
T ss_pred hcccccccccccccchhhhccccCCHHHHHHHHHHccCChhHCcCHHHHhcChh
Confidence 0 00000001111222345677999999999999999999998643
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=2.7e-44 Score=353.54 Aligned_cols=257 Identities=19% Similarity=0.236 Sum_probs=195.5
Q ss_pred CCcccceeEeeeCceEEEEEEEc-CCCEEEEEEEcccchhhHHHHHHHHHHHhcCCCCCce-eEEEEEEeCceeeEEEee
Q 010519 186 NRFSAENVLGEGGYGVVYKGRLI-NGSEVAVKKLLNNLGQAEKEFRVEVEAIGHVRHKNLV-RLLGYCIEGVHRMLVYEY 263 (508)
Q Consensus 186 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~ei~~l~~l~h~niv-~~~~~~~~~~~~~lv~E~ 263 (508)
++|++.+.||+|+||+||+|++. +|+.||||.+..... ..++..|+++++.++|+|++ .+.+++.+....++||||
T Consensus 7 ~rY~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~--~~~~~~E~~i~~~l~~~~~i~~~~~~~~~~~~~~ivme~ 84 (299)
T d1ckia_ 7 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK--HPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMEL 84 (299)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCTT--SCCHHHHHHHHHHSTTSTTCCCEEEEEEETTEEEEEEEC
T ss_pred CEEEEeEEEeeCCCcEEEEEEECCCCCEEEEEEEchhcc--CHHHHHHHHHHHHccCCCcccEEEEEEecCCEEEEEEEE
Confidence 57999999999999999999874 688999998765432 23577899999999877655 555556777888999999
Q ss_pred cCCCCHHHHHhhhhccCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCEEEcC---CCcEEEEecCCccccC
Q 010519 264 VNNGNLEQWLHGAMRNQGNLTWEARMKVIIGTAKALAYLHEAIEPKVVHRDIKSSNILIDD---EFNAKVSDFGLAKLLD 340 (508)
Q Consensus 264 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiH~Dlk~~NIll~~---~~~~kl~Dfgla~~~~ 340 (508)
+ +++|.+.+. .....+++..+..++.|++.||+|||++ +|+||||||+|||++. +..+||+|||+++.+.
T Consensus 85 ~-~~~l~~~~~---~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~~~ 157 (299)
T d1ckia_ 85 L-GPSLEDLFN---FCSRKFSLKTVLLLADQMISRIEYIHSK---NFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYR 157 (299)
T ss_dssp C-CCBHHHHHH---HTTTCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECCGGGTTCEEECCCSSCEECB
T ss_pred c-CCchhhhhh---hccCCCcHHHHHHHHHHHHHHHHHHHHC---CeeeccCCHhhccccccCCCceeeeeccCcceecc
Confidence 9 567777664 3556799999999999999999999999 9999999999999864 5569999999999765
Q ss_pred CCCC------cccccccccccccCccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCCCchhcHH-HHHHHHhcccc
Q 010519 341 SGES------HITTRVMGTFGYVAPEYANTGMLNEKSDIYSFGVLLLEAVTGRDPVDYGRPANEVNLV-EWLKMMVGTRR 413 (508)
Q Consensus 341 ~~~~------~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltG~~Pf~~~~~~~~~~~~-~~~~~~~~~~~ 413 (508)
.... .......||+.|+|||++.+..++.++|||||||++|||++|+.||............ .+...... ..
T Consensus 158 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~-~~ 236 (299)
T d1ckia_ 158 DARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMS-TP 236 (299)
T ss_dssp CTTTCCBCCCCBCCSCCCCSSSCCHHHHTTBCCCHHHHHHHHHHHHHHHHHSSCTTCCCC-------HHHHHHHHHH-SC
T ss_pred ccccccceeccccCCcCCCccccCHHHHhCCCCCChhhEEecCHHHHHHHhCCCcccccchHHHHHHHHHhhcccCC-CC
Confidence 4322 1234567999999999999999999999999999999999999999754433222211 11111000 00
Q ss_pred cccccCCCCCCChhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhhc
Q 010519 414 AEEVVDPNLEVKPATRALKRSLLVALRCVDPDSEKRPKMSQVVRMLEA 461 (508)
Q Consensus 414 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~ 461 (508)
.... ....+..+.+++..||+.||.+||++.++.+.|+.
T Consensus 237 ~~~~---------~~~~p~~~~~li~~cl~~~p~~RP~~~~i~~~l~~ 275 (299)
T d1ckia_ 237 IEVL---------CKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRN 275 (299)
T ss_dssp HHHH---------TTTSCHHHHHHHHHHHHSCTTCCCCHHHHHHHHHH
T ss_pred hhHh---------ccCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHH
Confidence 0000 01123456779999999999999999988877764
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.6e-45 Score=365.58 Aligned_cols=255 Identities=27% Similarity=0.352 Sum_probs=203.5
Q ss_pred CCcccceeEeeeCceEEEEEEEc----CCCEEEEEEEcccc----hhhHHHHHHHHHHHhcCCC-CCceeEEEEEEeCce
Q 010519 186 NRFSAENVLGEGGYGVVYKGRLI----NGSEVAVKKLLNNL----GQAEKEFRVEVEAIGHVRH-KNLVRLLGYCIEGVH 256 (508)
Q Consensus 186 ~~~~~~~~lg~G~~g~Vy~~~~~----~~~~vavK~~~~~~----~~~~~~~~~ei~~l~~l~h-~niv~~~~~~~~~~~ 256 (508)
++|.+.+.||+|+||+||+|+.. +|+.||||.+.... ....+.+.+|+++|++++| |||+++++++.+...
T Consensus 24 ~~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~~~~ 103 (322)
T d1vzoa_ 24 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETK 103 (322)
T ss_dssp GGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETTE
T ss_pred hceEEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeeeccCCc
Confidence 57999999999999999999863 47899999885432 2233567789999999966 899999999999999
Q ss_pred eeEEEeecCCCCHHHHHhhhhccCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCEEEcCCCcEEEEecCCc
Q 010519 257 RMLVYEYVNNGNLEQWLHGAMRNQGNLTWEARMKVIIGTAKALAYLHEAIEPKVVHRDIKSSNILIDDEFNAKVSDFGLA 336 (508)
Q Consensus 257 ~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~Dfgla 336 (508)
.+++|||+.+|+|.+++. ....+.+..+..++.||+.||.|||++ +|+||||||+|||++.++.+||+|||++
T Consensus 104 ~~~v~e~~~~~~L~~~i~----~~~~~~e~~~~~~~~Qi~~al~~lH~~---~ivHrDiKp~Nill~~~~~vkL~DFG~a 176 (322)
T d1vzoa_ 104 LHLILDYINGGELFTHLS----QRERFTEHEVQIYVGEIVLALEHLHKL---GIIYRDIKLENILLDSNGHVVLTDFGLS 176 (322)
T ss_dssp EEEEECCCCSCBHHHHHH----HHSCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEESCSSEE
T ss_pred eeeeeecccccHHHHHHH----hcccccHHHHHHHHHHHHHHHHHhhcC---CEEeccCCccceeecCCCCEEEeeccch
Confidence 999999999999999984 445678889999999999999999999 9999999999999999999999999999
Q ss_pred cccCCCCCcccccccccccccCccccCCC--CCCChhhHHHHHHHHHHHHhCCCCCCCCCCCchhcHHHHHHHHhccccc
Q 010519 337 KLLDSGESHITTRVMGTFGYVAPEYANTG--MLNEKSDIYSFGVLLLEAVTGRDPVDYGRPANEVNLVEWLKMMVGTRRA 414 (508)
Q Consensus 337 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~DvwS~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~ 414 (508)
+.+............|++.|+|||.+.+. .++.++|||||||+||||++|+.||.......... ........
T Consensus 177 ~~~~~~~~~~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~~~~~--~i~~~~~~---- 250 (322)
T d1vzoa_ 177 KEFVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQA--EISRRILK---- 250 (322)
T ss_dssp EECCGGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHH--HHHHHHHH----
T ss_pred hhhcccccccccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHH--HHHHhccc----
Confidence 87765544445567899999999999764 47889999999999999999999997554333221 11111111
Q ss_pred ccccCCCCCCChhHHHHHHHHHHHHHhcCCCCCCCC-----CHHHHHHHhh
Q 010519 415 EEVVDPNLEVKPATRALKRSLLVALRCVDPDSEKRP-----KMSQVVRMLE 460 (508)
Q Consensus 415 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~evl~~L~ 460 (508)
..... +......+.+|+.+||++||.+|| |++|+++|-.
T Consensus 251 -----~~~~~--~~~~s~~~~~li~~~l~~dP~~R~s~~~~t~~eil~Hpf 294 (322)
T d1vzoa_ 251 -----SEPPY--PQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLF 294 (322)
T ss_dssp -----CCCCC--CTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSGG
T ss_pred -----CCCCC--cccCCHHHHHHHHHHcccCHHHcCCCCcccHHHHHcCHh
Confidence 11111 112345677799999999999999 4899987644
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=100.00 E-value=3.5e-44 Score=351.52 Aligned_cols=259 Identities=18% Similarity=0.232 Sum_probs=204.2
Q ss_pred hCCcccceeEeeeCceEEEEEEEc-CCCEEEEEEEcccchhhHHHHHHHHHHHhcCCC-CCceeEEEEEEeCceeeEEEe
Q 010519 185 TNRFSAENVLGEGGYGVVYKGRLI-NGSEVAVKKLLNNLGQAEKEFRVEVEAIGHVRH-KNLVRLLGYCIEGVHRMLVYE 262 (508)
Q Consensus 185 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~ei~~l~~l~h-~niv~~~~~~~~~~~~~lv~E 262 (508)
.++|.+.+.||+|+||+||+|++. +|+.||||.+.... ....+..|++.+..+.| +|++.+++++..+...++|||
T Consensus 4 g~~Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~--~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~~vme 81 (293)
T d1csna_ 4 GVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRS--DAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVID 81 (293)
T ss_dssp TTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCT--TSCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEE
T ss_pred CCceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEcccc--CcHHHHHHHHHHHHhcCCCCCCEEEEEeecCCccEEEEE
Confidence 468999999999999999999975 68899999875432 22346678888988865 899999999999999999999
Q ss_pred ecCCCCHHHHHhhhhccCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCEEEcC-----CCcEEEEecCCcc
Q 010519 263 YVNNGNLEQWLHGAMRNQGNLTWEARMKVIIGTAKALAYLHEAIEPKVVHRDIKSSNILIDD-----EFNAKVSDFGLAK 337 (508)
Q Consensus 263 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiH~Dlk~~NIll~~-----~~~~kl~Dfgla~ 337 (508)
|+ +++|.+++. .....+++..+..++.|++.||.|||++ +|+||||||+|||++. ++.+||+|||+++
T Consensus 82 ~~-~~~l~~~~~---~~~~~~~~~~~~~i~~q~~~~l~~lH~~---giiHrDiKp~Nili~~~~~~~~~~vkl~DFG~a~ 154 (293)
T d1csna_ 82 LL-GPSLEDLLD---LCGRKFSVKTVAMAAKQMLARVQSIHEK---SLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVK 154 (293)
T ss_dssp CC-CCBHHHHHH---HTTTCCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECCSSSTTTTCEEECCCTTCE
T ss_pred ec-CCCHHHHHH---hhccchhhHHHHHHHHHHHHHHHHHHHC---CceeccCCccceeecCcccccCCceEEcccceeE
Confidence 99 789999885 3455789999999999999999999999 9999999999999974 5789999999998
Q ss_pred ccCCCCC------cccccccccccccCccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCCCchhcHHHHHHHHhcc
Q 010519 338 LLDSGES------HITTRVMGTFGYVAPEYANTGMLNEKSDIYSFGVLLLEAVTGRDPVDYGRPANEVNLVEWLKMMVGT 411 (508)
Q Consensus 338 ~~~~~~~------~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~ 411 (508)
....... ......+||+.|+|||++.+..++.++|||||||++|||++|..||..............+......
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~GT~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~i~~~~~~ 234 (293)
T d1csna_ 155 FYRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQS 234 (293)
T ss_dssp ESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHHH
T ss_pred EcccCccccceeecccCceEEchhhcCHHHhcCCCCChHHHHHHhhHHHHHHHhCCCcCCCccchhHHHHHHHHHhccCC
Confidence 7643321 1233467999999999999999999999999999999999999999755444333222222111111
Q ss_pred cccccccCCCCCCChhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhhc
Q 010519 412 RRAEEVVDPNLEVKPATRALKRSLLVALRCVDPDSEKRPKMSQVVRMLEA 461 (508)
Q Consensus 412 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~ 461 (508)
.....+. ...+.++.+++..|++.+|++||+++.+.+.|+.
T Consensus 235 ~~~~~l~---------~~~p~~l~~ii~~~~~~~~~~rP~y~~l~~~l~~ 275 (293)
T d1csna_ 235 TPLRELC---------AGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSK 275 (293)
T ss_dssp SCHHHHT---------TTSCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHH
T ss_pred CChHHhc---------CCCCHHHHHHHHHHhcCCcccCcCHHHHHHHHHH
Confidence 1111110 0123456678889999999999999988887765
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-44 Score=362.92 Aligned_cols=258 Identities=24% Similarity=0.342 Sum_probs=193.7
Q ss_pred hCCcccceeEeeeCceEEEEEEEc-CCCEEEEEEEcccc--hhhHHHHHHHHHHHhcCCCCCceeEEEEEEeCc------
Q 010519 185 TNRFSAENVLGEGGYGVVYKGRLI-NGSEVAVKKLLNNL--GQAEKEFRVEVEAIGHVRHKNLVRLLGYCIEGV------ 255 (508)
Q Consensus 185 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~ei~~l~~l~h~niv~~~~~~~~~~------ 255 (508)
.++|++.+.||+|+||+||+|++. +|+.||||++.... ....+.+.+|+.+|+.++|||||+++++|....
T Consensus 17 ~~~Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~~~~~ 96 (346)
T d1cm8a_ 17 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFT 96 (346)
T ss_dssp BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCC
T ss_pred CCcEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEchhhcChHHHHHHHHHHHHHHhcCCCCeeEEEEEeccCccccccc
Confidence 568999999999999999999975 68999999986432 233467888999999999999999999998654
Q ss_pred eeeEEEeecCCCCHHHHHhhhhccCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCEEEcCCCcEEEEecCC
Q 010519 256 HRMLVYEYVNNGNLEQWLHGAMRNQGNLTWEARMKVIIGTAKALAYLHEAIEPKVVHRDIKSSNILIDDEFNAKVSDFGL 335 (508)
Q Consensus 256 ~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~Dfgl 335 (508)
..|+||||+ +.+|..+++ ...+++..++.++.||+.||.|||++ +|+||||||+|||++.++.+||+|||+
T Consensus 97 ~~~lv~e~~-~~~l~~~~~-----~~~l~~~~~~~~~~qi~~aL~~LH~~---~IiHrDiKp~NIL~~~~~~~kl~Dfg~ 167 (346)
T d1cm8a_ 97 DFYLVMPFM-GTDLGKLMK-----HEKLGEDRIQFLVYQMLKGLRYIHAA---GIIHRDLKPGNLAVNEDCELKILDFGL 167 (346)
T ss_dssp CCEEEEECC-SEEHHHHHH-----HCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTT
T ss_pred eEEEEEecc-cccHHHHHH-----hccccHHHHHHHHHHHHHHHHHHHhC---CCcccccCcchhhcccccccccccccc
Confidence 468999999 668887763 34699999999999999999999999 999999999999999999999999999
Q ss_pred ccccCCCCCcccccccccccccCccccCC-CCCCChhhHHHHHHHHHHHHhCCCCCCCCCCCchhcHHHHHHHHhcccc-
Q 010519 336 AKLLDSGESHITTRVMGTFGYVAPEYANT-GMLNEKSDIYSFGVLLLEAVTGRDPVDYGRPANEVNLVEWLKMMVGTRR- 413 (508)
Q Consensus 336 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwS~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~- 413 (508)
++..... .+...||+.|+|||++.+ ..++.++||||+||+||+|++|+.||..... ...........+...
T Consensus 168 a~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~~~---~~~~~~~~~~~~~~~~ 240 (346)
T d1cm8a_ 168 ARQADSE----MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDH---LDQLKEIMKVTGTPPA 240 (346)
T ss_dssp CEECCSS----CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSH---HHHHHHHHHHHCCCCH
T ss_pred eeccCCc----cccccccccccCHHHHcCCCCCCccchhhcchHHHHHHHHCcCCCCCCCh---HHHHHHHHhccCCCcH
Confidence 9876543 345679999999999876 4678999999999999999999999964421 111111111111000
Q ss_pred -----------------cccccCCCCCCChhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHh
Q 010519 414 -----------------AEEVVDPNLEVKPATRALKRSLLVALRCVDPDSEKRPKMSQVVRML 459 (508)
Q Consensus 414 -----------------~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L 459 (508)
........+. .........+.+|+.+||..||.+|||+.|+|+|-
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~s~~~~dli~~mL~~dP~~R~ta~eiL~Hp 302 (346)
T d1cm8a_ 241 EFVQRLQSDEAKNYMKGLPELEKKDFA-SILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHP 302 (346)
T ss_dssp HHHHTCSCHHHHHHHHHSCCCCCCCGG-GTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSG
T ss_pred HHHhhhcchhhhhhhccCCcccccchH-HhccCCCHHHHHHHHHHCcCChhHCcCHHHHhcCh
Confidence 0000000000 00011234566799999999999999999999973
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Probab=100.00 E-value=6.4e-44 Score=355.49 Aligned_cols=257 Identities=23% Similarity=0.341 Sum_probs=197.4
Q ss_pred CCcccceeEeeeCceEEEEEEEc-CCCEEEEEEEcccchhhHHHHHHHHHHHhcCC-CCCceeEEEEEEeC--ceeeEEE
Q 010519 186 NRFSAENVLGEGGYGVVYKGRLI-NGSEVAVKKLLNNLGQAEKEFRVEVEAIGHVR-HKNLVRLLGYCIEG--VHRMLVY 261 (508)
Q Consensus 186 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~ei~~l~~l~-h~niv~~~~~~~~~--~~~~lv~ 261 (508)
++|++.+.||+|+||+||+|++. +|+.||||++.... .+.+.+|+.+|+.+. ||||+++++++... ...++||
T Consensus 35 d~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~---~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~~~~~~v~ 111 (328)
T d3bqca1 35 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK---KKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVF 111 (328)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSSC---HHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCSEEEEE
T ss_pred cCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEECHHH---HHHHHHHHHHHHhccCCCCCcEEEEEEEecCCCceeEEE
Confidence 57999999999999999999984 68899999986432 356788999999995 99999999999854 5688999
Q ss_pred eecCCCCHHHHHhhhhccCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCEEEcCCC-cEEEEecCCccccC
Q 010519 262 EYVNNGNLEQWLHGAMRNQGNLTWEARMKVIIGTAKALAYLHEAIEPKVVHRDIKSSNILIDDEF-NAKVSDFGLAKLLD 340 (508)
Q Consensus 262 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiH~Dlk~~NIll~~~~-~~kl~Dfgla~~~~ 340 (508)
||+.+++|..+. +.+++..++.++.||+.||.|||++ +|+||||||+|||++.++ .+||+|||++....
T Consensus 112 e~~~~~~L~~~~-------~~l~e~~i~~i~~qil~aL~~LH~~---gIvHrDiKp~NILi~~~~~~vkl~DFG~a~~~~ 181 (328)
T d3bqca1 112 EHVNNTDFKQLY-------QTLTDYDIRFYMYEILKALDYCHSM---GIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYH 181 (328)
T ss_dssp ECCCSCBGGGTT-------TSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTTTEEEECCGGGCEECC
T ss_pred eecCCCcHHHHh-------cCCCHHHHHHHHHHHHHHHHHHhhc---ccccccccccceEEcCCCCeeeecccccceecc
Confidence 999999986542 4589999999999999999999999 999999999999998655 59999999998765
Q ss_pred CCCCcccccccccccccCccccCCC-CCCChhhHHHHHHHHHHHHhCCCCCCCCCCCchhcHHHHHHHHhcc--------
Q 010519 341 SGESHITTRVMGTFGYVAPEYANTG-MLNEKSDIYSFGVLLLEAVTGRDPVDYGRPANEVNLVEWLKMMVGT-------- 411 (508)
Q Consensus 341 ~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwS~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~-------- 411 (508)
.... ....++|+.|+|||.+.+. .++.++||||+||++|||++|+.||........ ....+....+.
T Consensus 182 ~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~~~~~~--~~~~i~~~~g~~~~~~~~~ 257 (328)
T d3bqca1 182 PGQE--YNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYD--QLVRIAKVLGTEDLYDYID 257 (328)
T ss_dssp TTCC--CCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHH--HHHHHHHHHCHHHHHHHHH
T ss_pred CCCc--ccccccCccccCcccccCCCCCCcccchhhhhhhhHHhccCCCCCCCCchhHH--HHHHHHHHHCCchhhhhhh
Confidence 4432 3445789999999998764 579999999999999999999999975543211 11111111110
Q ss_pred ----c---ccccccCCC--------CCCChhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHh
Q 010519 412 ----R---RAEEVVDPN--------LEVKPATRALKRSLLVALRCVDPDSEKRPKMSQVVRML 459 (508)
Q Consensus 412 ----~---~~~~~~~~~--------~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L 459 (508)
. ......... ............+.+|+.+||..||.+|||++|+|+|-
T Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~e~L~Hp 320 (328)
T d3bqca1 258 KYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHP 320 (328)
T ss_dssp HTTCCCCGGGGGTCCCCCCCCGGGGCCTTTGGGCCHHHHHHHHHHSCSSGGGSCCHHHHHTSG
T ss_pred hcccccCcccchhcccccccchhhcccccccccCCHHHHHHHHHHccCChhHCcCHHHHhcCc
Confidence 0 000000000 01111122335677899999999999999999999854
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.6e-43 Score=356.34 Aligned_cols=260 Identities=23% Similarity=0.249 Sum_probs=190.6
Q ss_pred CCcccceeEeeeCceEEEEEEEc-CCCEEEEEEEcccc--hhhHHHHHHHHHHHhcCCCCCceeEEEEEEe------Cce
Q 010519 186 NRFSAENVLGEGGYGVVYKGRLI-NGSEVAVKKLLNNL--GQAEKEFRVEVEAIGHVRHKNLVRLLGYCIE------GVH 256 (508)
Q Consensus 186 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~ei~~l~~l~h~niv~~~~~~~~------~~~ 256 (508)
++|.+.+.||+|+||+||+|.+. +|+.||||++.... ......+.+|+.++++++|||||+++++|.. ..+
T Consensus 17 ~~Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~~~~ 96 (355)
T d2b1pa1 17 KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQD 96 (355)
T ss_dssp TTEEEEEECSCC--CEEEEEEETTTTEEEEEEEEESTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCCE
T ss_pred CCeEEEEEeecCcCeEEEEEEECCCCCEEEEEEEChhhcCHHHHHHHHHHHHHHHhcCCCCeeEEEEEEecccccccCce
Confidence 68999999999999999999986 68999999996443 3334568899999999999999999999964 367
Q ss_pred eeEEEeecCCCCHHHHHhhhhccCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCEEEcCCCcEEEEecCCc
Q 010519 257 RMLVYEYVNNGNLEQWLHGAMRNQGNLTWEARMKVIIGTAKALAYLHEAIEPKVVHRDIKSSNILIDDEFNAKVSDFGLA 336 (508)
Q Consensus 257 ~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~Dfgla 336 (508)
.|+||||+.+ ++.+.+. ..+++..++.++.||+.||.|||++ ||+||||||+|||++.++.+|++|||++
T Consensus 97 ~~iv~Ey~~~-~l~~~~~------~~~~~~~i~~~~~qil~gl~~LH~~---giiHrDlKP~Nil~~~~~~~kl~df~~~ 166 (355)
T d2b1pa1 97 VYLVMELMDA-NLCQVIQ------MELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLA 166 (355)
T ss_dssp EEEEEECCSE-EHHHHHT------SCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCCCC-
T ss_pred eEEEEeccch-HHHHhhh------cCCCHHHHHHHHHHHHHHHHHhhhc---ccccccCCccccccccccceeeechhhh
Confidence 8999999966 5555442 3588999999999999999999999 9999999999999999999999999998
Q ss_pred cccCCCCCcccccccccccccCccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCCCchhcHHHHHHHHh-------
Q 010519 337 KLLDSGESHITTRVMGTFGYVAPEYANTGMLNEKSDIYSFGVLLLEAVTGRDPVDYGRPANEVNLVEWLKMMV------- 409 (508)
Q Consensus 337 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~------- 409 (508)
+...... .....++|+.|+|||++.+..++.++||||+||++|+|++|+.||..... .......+....
T Consensus 167 ~~~~~~~--~~~~~~~t~~y~aPE~l~~~~~~~~~DiwSlG~~l~ell~g~~pF~~~~~--~~~~~~i~~~~~~~~~~~~ 242 (355)
T d2b1pa1 167 RTAGTSF--MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDY--IDQWNKVIEQLGTPCPEFM 242 (355)
T ss_dssp ----------------CCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSH--HHHHHHHHHHHCCCCHHHH
T ss_pred hcccccc--ccccccccccccChhhhcCCCCCCCcccccccchHHHHhhCCCCCCCCCH--HHHHHHHHHhccCCCHHHH
Confidence 8655432 34456789999999999999999999999999999999999999964321 111111111110
Q ss_pred -----------cccc-c-----cccc-CCCC--CCChhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHh
Q 010519 410 -----------GTRR-A-----EEVV-DPNL--EVKPATRALKRSLLVALRCVDPDSEKRPKMSQVVRML 459 (508)
Q Consensus 410 -----------~~~~-~-----~~~~-~~~~--~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L 459 (508)
.... . .... .... ...........+.+|+.+||..||++|||++|+|+|-
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~ta~elL~Hp 312 (355)
T d2b1pa1 243 KKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHP 312 (355)
T ss_dssp TTSCHHHHHHHHTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTST
T ss_pred HHhhhhHHHHhhcCccccccccccccccccccccccccccCCHHHHHHHHHHCcCChhHCcCHHHHhcCc
Confidence 0000 0 0000 0000 1111233456788899999999999999999999864
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-42 Score=349.14 Aligned_cols=261 Identities=26% Similarity=0.339 Sum_probs=195.8
Q ss_pred hCCcccceeEeeeCceEEEEEEEc-CCCEEEEEEEcccc--hhhHHHHHHHHHHHhcCCCCCceeEEEEEEeC-----ce
Q 010519 185 TNRFSAENVLGEGGYGVVYKGRLI-NGSEVAVKKLLNNL--GQAEKEFRVEVEAIGHVRHKNLVRLLGYCIEG-----VH 256 (508)
Q Consensus 185 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~ei~~l~~l~h~niv~~~~~~~~~-----~~ 256 (508)
.++|++.+.||+|+||+||+|++. +|+.||||++.... ....+.+.+|+.+|++++|||||++++++... ..
T Consensus 17 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~~~~~ 96 (348)
T d2gfsa1 17 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN 96 (348)
T ss_dssp ETTEEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSTTTCC
T ss_pred CCCeEEEEEEecCCCeEEEEEEECCCCCEEEEEEECchhcChHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeccccccCc
Confidence 468999999999999999999875 68999999986443 23345688899999999999999999998643 34
Q ss_pred eeEEEeecCCCCHHHHHhhhhccCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCEEEcCCCcEEEEecCCc
Q 010519 257 RMLVYEYVNNGNLEQWLHGAMRNQGNLTWEARMKVIIGTAKALAYLHEAIEPKVVHRDIKSSNILIDDEFNAKVSDFGLA 336 (508)
Q Consensus 257 ~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiH~Dlk~~NIll~~~~~~kl~Dfgla 336 (508)
.+++++|+.+|+|.+++. ...+++..++.++.||+.||.|||++ +|+||||||+|||++.++.+|++|||++
T Consensus 97 ~~~i~~~~~gg~L~~~~~-----~~~l~e~~~~~i~~qil~aL~~LH~~---giiHrDiKp~NILi~~~~~~kl~dfg~a 168 (348)
T d2gfsa1 97 DVYLVTHLMGADLNNIVK-----CQKLTDDHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLA 168 (348)
T ss_dssp CCEEEEECCSEEHHHHHT-----TCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECCC---
T ss_pred eEEEEEeecCCchhhhcc-----cccccHHHHHHHHHHHHHHHHHHHhC---CCcccccCCccccccccccccccccchh
Confidence 467778888999999884 34699999999999999999999999 9999999999999999999999999999
Q ss_pred cccCCCCCcccccccccccccCccccCCC-CCCChhhHHHHHHHHHHHHhCCCCCCCCCCCchhcHHHHHHHHhcccccc
Q 010519 337 KLLDSGESHITTRVMGTFGYVAPEYANTG-MLNEKSDIYSFGVLLLEAVTGRDPVDYGRPANEVNLVEWLKMMVGTRRAE 415 (508)
Q Consensus 337 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwS~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~ 415 (508)
..... ......|++.|+|||++.+. .++.++|||||||++|+|++|+.||.... .......+..........
T Consensus 169 ~~~~~----~~~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~~---~~~~~~~i~~~~~~~~~~ 241 (348)
T d2gfsa1 169 RHTDD----EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTD---HIDQLKLILRLVGTPGAE 241 (348)
T ss_dssp -CCTG----GGSSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSS---HHHHHHHHHHHHCCCCHH
T ss_pred cccCc----ccccccccccccCchhhcCCccCCcccchhhhhHHHHHHHhCCCCCCCCC---HHHHHHHHHHhcCCCChH
Confidence 76542 23445789999999987665 56899999999999999999999996432 111111111111110000
Q ss_pred c--------------ccCCCCCCChh---HHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhh
Q 010519 416 E--------------VVDPNLEVKPA---TRALKRSLLVALRCVDPDSEKRPKMSQVVRMLE 460 (508)
Q Consensus 416 ~--------------~~~~~~~~~~~---~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 460 (508)
. ........... ......+.+|+.+||..||.+|||+.|+|+|-+
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~elL~Hp~ 303 (348)
T d2gfsa1 242 LLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAY 303 (348)
T ss_dssp HHTTCCCHHHHHHHTTSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGG
T ss_pred HhhhccchhhhhhhhhcccCCCcchhhhcCCCCHHHHHHHHHHCcCChhhCcCHHHHhcCHh
Confidence 0 00000000000 112345677999999999999999999998644
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=1.8e-38 Score=320.02 Aligned_cols=266 Identities=18% Similarity=0.180 Sum_probs=191.5
Q ss_pred CCcccceeEeeeCceEEEEEEEc-CCCEEEEEEEcccchhhHHHHHHHHHHHhcCC-----------CCCceeEEEEEEe
Q 010519 186 NRFSAENVLGEGGYGVVYKGRLI-NGSEVAVKKLLNNLGQAEKEFRVEVEAIGHVR-----------HKNLVRLLGYCIE 253 (508)
Q Consensus 186 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~ei~~l~~l~-----------h~niv~~~~~~~~ 253 (508)
.+|+++++||+|+||+||+|++. +|+.||||++..... ..+.+.+|+.+++.++ |+||+++++++..
T Consensus 13 ~rY~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~~~-~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~~~~~ 91 (362)
T d1q8ya_ 13 ARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKV-YTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNH 91 (362)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCHH-HHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEE
T ss_pred CcEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEecccc-chHHHHHHHHHHHHhcchhhhhhhhcCcCceEEEEEEeee
Confidence 46999999999999999999985 789999999875533 2356677888887775 5789999998865
Q ss_pred C--ceeeEEEeecCCCCHHHHHhhhhccCCCccHHHHHHHHHHHHHHHHHHHh-cCCCCeEeecCCCCCEEEcCCCc---
Q 010519 254 G--VHRMLVYEYVNNGNLEQWLHGAMRNQGNLTWEARMKVIIGTAKALAYLHE-AIEPKVVHRDIKSSNILIDDEFN--- 327 (508)
Q Consensus 254 ~--~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~yLH~-~~~~~iiH~Dlk~~NIll~~~~~--- 327 (508)
. ...+++|+++..+........ ......+++..+..++.||+.||.|||+ . +|+||||||+|||++.++.
T Consensus 92 ~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~i~~i~~qil~al~~lh~~~---~IvHrDlKp~NIll~~~~~~~~ 167 (362)
T d1q8ya_ 92 KGPNGVHVVMVFEVLGENLLALIK-KYEHRGIPLIYVKQISKQLLLGLDYMHRRC---GIIHTDIKPENVLMEIVDSPEN 167 (362)
T ss_dssp EETTEEEEEEEECCCCEEHHHHHH-HTTTSCCCHHHHHHHHHHHHHHHHHHHHTT---CEECSCCSGGGEEEEEEETTTT
T ss_pred ccccceeeeeeecccccccccccc-cccccCCcHHHHHHHHHHHHHHHHHHhhhc---CcccccCChhHeeeeccCcccc
Confidence 3 455667776655543333221 2456678899999999999999999998 6 9999999999999986653
Q ss_pred ---EEEEecCCccccCCCCCcccccccccccccCccccCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCCCchhcHHHH
Q 010519 328 ---AKVSDFGLAKLLDSGESHITTRVMGTFGYVAPEYANTGMLNEKSDIYSFGVLLLEAVTGRDPVDYGRPANEVNLVEW 404 (508)
Q Consensus 328 ---~kl~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltG~~Pf~~~~~~~~~~~~~~ 404 (508)
++++|||.+...... ....+||+.|+|||++.+..|+.++||||+||++++|++|+.||..............
T Consensus 168 ~~~~kl~dfg~s~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pF~~~~~~~~~~~~~~ 243 (362)
T d1q8ya_ 168 LIQIKIADLGNACWYDEH----YTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDH 243 (362)
T ss_dssp EEEEEECCCTTCEETTBC----CCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CHHHH
T ss_pred cceeeEeecccccccccc----cccccccccccChhhccccCCCccccccchHHHHHHHHHCCCCCCCCccccccchhHH
Confidence 999999999865432 3445799999999999999999999999999999999999999964332221111111
Q ss_pred HH---HHhccc------------------ccccccCC-CC---------CCChhHHHHHHHHHHHHHhcCCCCCCCCCHH
Q 010519 405 LK---MMVGTR------------------RAEEVVDP-NL---------EVKPATRALKRSLLVALRCVDPDSEKRPKMS 453 (508)
Q Consensus 405 ~~---~~~~~~------------------~~~~~~~~-~~---------~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ 453 (508)
+. ...+.. ........ .. ...........+.+|+.+||..||.+|||++
T Consensus 244 ~~~~~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~Rpta~ 323 (362)
T d1q8ya_ 244 IAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADAG 323 (362)
T ss_dssp HHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBCHH
T ss_pred HHHHHHHhCCCCHHHhhcccccccccccchhhhccccccCCchhhhcccccccCcccCHHHHHHHHHHCCCChhHCcCHH
Confidence 11 111110 00000000 00 1112234566788899999999999999999
Q ss_pred HHHHHhh
Q 010519 454 QVVRMLE 460 (508)
Q Consensus 454 evl~~L~ 460 (508)
|+|+|-.
T Consensus 324 e~L~Hp~ 330 (362)
T d1q8ya_ 324 GLVNHPW 330 (362)
T ss_dssp HHHTCGG
T ss_pred HHhcCcc
Confidence 9998643
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Probab=99.89 E-value=5.6e-24 Score=193.68 Aligned_cols=169 Identities=17% Similarity=0.131 Sum_probs=120.4
Q ss_pred cccceeEeeeCceEEEEEEEcCCCEEEEEEEcccch------------------hhHHHHHHHHHHHhcCCCCCceeEEE
Q 010519 188 FSAENVLGEGGYGVVYKGRLINGSEVAVKKLLNNLG------------------QAEKEFRVEVEAIGHVRHKNLVRLLG 249 (508)
Q Consensus 188 ~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~------------------~~~~~~~~ei~~l~~l~h~niv~~~~ 249 (508)
+.+.+.||+|+||+||+|++.+|+.||||.+..... ........|...+.++.|.+++..++
T Consensus 2 ~~vg~~IG~G~~g~Vy~a~~~~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~~ 81 (191)
T d1zara2 2 DAIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVYA 81 (191)
T ss_dssp SEEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEEE
T ss_pred chhCCEeeeCcceEEEEEECCCCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCCcceEEE
Confidence 456899999999999999988999999997642110 11233556888999999999998886
Q ss_pred EEEeCceeeEEEeecCCCCHHHHHhhhhccCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCEEEcCCCcEE
Q 010519 250 YCIEGVHRMLVYEYVNNGNLEQWLHGAMRNQGNLTWEARMKVIIGTAKALAYLHEAIEPKVVHRDIKSSNILIDDEFNAK 329 (508)
Q Consensus 250 ~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~~~~~iiH~Dlk~~NIll~~~~~~k 329 (508)
+. ..+++|||+++..+.+ ++......++.|++.+|.|||++ +|+||||||+|||++++ .++
T Consensus 82 ~~----~~~lvme~~~~~~~~~-----------l~~~~~~~i~~ql~~~l~~lH~~---giiHrDiKP~NILv~~~-~~~ 142 (191)
T d1zara2 82 WE----GNAVLMELIDAKELYR-----------VRVENPDEVLDMILEEVAKFYHR---GIVHGDLSQYNVLVSEE-GIW 142 (191)
T ss_dssp EE----TTEEEEECCCCEEGGG-----------CCCSCHHHHHHHHHHHHHHHHHT---TEECSCCSTTSEEEETT-EEE
T ss_pred ec----CCEEEEEeeccccccc-----------hhhHHHHHHHHHHHHHHHHHhhC---CEEEccCChhheeeeCC-CEE
Confidence 53 2379999998754322 34445568899999999999999 99999999999999976 589
Q ss_pred EEecCCccccCCCCCcccccccccccccCccccCCCCCCChhhHHHHHHH
Q 010519 330 VSDFGLAKLLDSGESHITTRVMGTFGYVAPEYANTGMLNEKSDIYSFGVL 379 (508)
Q Consensus 330 l~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS~Gvv 379 (508)
|+|||++............ ...... -.+.+ ...|+.++|+||..--
T Consensus 143 liDFG~a~~~~~~~~~~~l--~rd~~~-~~~~f-~r~y~~~~d~~s~~~~ 188 (191)
T d1zara2 143 IIDFPQSVEVGEEGWREIL--ERDVRN-IITYF-SRTYRTEKDINSAIDR 188 (191)
T ss_dssp ECCCTTCEETTSTTHHHHH--HHHHHH-HHHHH-HHHHCCCCCHHHHHHH
T ss_pred EEECCCcccCCCCCcHHHH--HHHHHH-HHHHH-cCCCCCcccHHHHHHH
Confidence 9999999865433211000 000000 01112 3467889999997543
|
| >d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Type IIIa 3',5"-aminoglycoside phosphotransferase species: Enterococcus faecalis [TaxId: 1351]
Probab=98.56 E-value=1.1e-07 Score=88.51 Aligned_cols=150 Identities=14% Similarity=0.106 Sum_probs=98.5
Q ss_pred HHHHHhhCCcccceeEeeeCceEEEEEEEcCCCEEEEEEEcccchhhHHHHHHHHHHHhcCC-CCCceeEEEEEEeCcee
Q 010519 179 RDLEIATNRFSAENVLGEGGYGVVYKGRLINGSEVAVKKLLNNLGQAEKEFRVEVEAIGHVR-HKNLVRLLGYCIEGVHR 257 (508)
Q Consensus 179 ~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~ei~~l~~l~-h~niv~~~~~~~~~~~~ 257 (508)
.++...-+.|++.+..+.++...||+... +++.+++|+...........+..|...+..+. +--+.+++.++.+++..
T Consensus 7 ~~l~~~~~~~~~~~~~~G~s~~~v~rv~~-~~~~~vlk~~~~~~~~~~~~~~~E~~~l~~l~~~vpvP~vl~~~~~~~~~ 85 (263)
T d1j7la_ 7 PELKKLIEKYRCVKDTEGMSPAKVYKLVG-ENENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWS 85 (263)
T ss_dssp HHHHHHHTTSEEEECSCCCSSSEEEEEEC-SSCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEE
T ss_pred HHHHHhhhceEEEEcCCCCCCCcEEEEEe-CCCeEEEEEcCCCcccchhhHHHHHHHHHHHhccCCCCcEEEEEecCCce
Confidence 34444556777776655555678999854 67778888876554433445666877776663 33356778888888889
Q ss_pred eEEEeecCCCCHHHHHhhhhccCCCccHHHHHHHHHHHHHHHHHHHhc--------------------------------
Q 010519 258 MLVYEYVNNGNLEQWLHGAMRNQGNLTWEARMKVIIGTAKALAYLHEA-------------------------------- 305 (508)
Q Consensus 258 ~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~yLH~~-------------------------------- 305 (508)
++||++++|.++.+... .. .....++.++++.+..||+.
T Consensus 86 ~lv~~~l~G~~~~~~~~----~~-----~~~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 156 (263)
T d1j7la_ 86 NLLMSEADGVLCSEEYE----DE-----QSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCE 156 (263)
T ss_dssp EEEEECCSSEEHHHHTT----TC-----SCHHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCCGG
T ss_pred EEEEEeccccccccccc----cc-----ccHHHHHHHHHHHHHHHhccCccccccCcchhhhhhhHHHHHHHHhhhhhhh
Confidence 99999999988765431 00 01122333444444444432
Q ss_pred ---------------------C---CCCeEeecCCCCCEEEcCCCcEEEEecCCccc
Q 010519 306 ---------------------I---EPKVVHRDIKSSNILIDDEFNAKVSDFGLAKL 338 (508)
Q Consensus 306 ---------------------~---~~~iiH~Dlk~~NIll~~~~~~kl~Dfgla~~ 338 (508)
. .+.++|+|+.|.|||+++++..-|+||+.+..
T Consensus 157 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDwe~a~~ 213 (263)
T d1j7la_ 157 NWEEDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSGR 213 (263)
T ss_dssp GGSTTCSCSSHHHHHHHHHHSCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEE
T ss_pred cccccccchHHHHHHHHHHhcCCcCCcEEEEeeccCcceeecCCceEEEeechhccc
Confidence 0 12379999999999999876667999997763
|
| >d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]
Probab=97.81 E-value=3.9e-05 Score=70.12 Aligned_cols=74 Identities=16% Similarity=0.105 Sum_probs=50.0
Q ss_pred eEeeeCc-eEEEEEEEcCCCEEEEEEEcccchhhHHHHHHHHHHHhcCCC--CCceeEEEEEEeCceeeEEEeecCCCCH
Q 010519 193 VLGEGGY-GVVYKGRLINGSEVAVKKLLNNLGQAEKEFRVEVEAIGHVRH--KNLVRLLGYCIEGVHRMLVYEYVNNGNL 269 (508)
Q Consensus 193 ~lg~G~~-g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~ei~~l~~l~h--~niv~~~~~~~~~~~~~lv~E~~~~gsL 269 (508)
.+..|.. +.||+....++..+++|...... ...+..|...++.+.. -.+.+++.++.+....++||++++|.++
T Consensus 17 ~~~~G~s~~~v~r~~~~~~~~~vlK~~~~~~---~~~l~~E~~~l~~L~~~gvpvP~v~~~~~~~~~~~~v~~~i~G~~~ 93 (255)
T d1nd4a_ 17 QQTIGCSDAAVFRLSAQGRPVLFVKTDLSGA---LNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQDL 93 (255)
T ss_dssp ECSCTTSSCEEEEEECTTSCCEEEEEECSCT---TSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSSEET
T ss_pred EcCCcccCCeEEEEEeCCCCEEEEEeCCccC---HhHHHHHHHHHHHHHhcCCCCCceeeecccccceEEEEEeeecccc
Confidence 3444543 67899887677778888654332 2235567777666532 2356778888888888999999987654
|
| >d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Methylthioribose kinase MtnK species: Bacillus subtilis [TaxId: 1423]
Probab=97.46 E-value=0.00012 Score=71.84 Aligned_cols=76 Identities=14% Similarity=0.131 Sum_probs=46.3
Q ss_pred ceeEeeeCceEEEEEEEc-CCCEEEEEEEcccc-------hhhHHHHHHHHHHHhcCC-C--CCceeEEEEEEeCceeeE
Q 010519 191 ENVLGEGGYGVVYKGRLI-NGSEVAVKKLLNNL-------GQAEKEFRVEVEAIGHVR-H--KNLVRLLGYCIEGVHRML 259 (508)
Q Consensus 191 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-------~~~~~~~~~ei~~l~~l~-h--~niv~~~~~~~~~~~~~l 259 (508)
.+.||.|..-.||+.... +++.+++|.-.... .........|...|+.+. + ..+.+++.+ +....++
T Consensus 31 ~~eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~~--d~~~~~l 108 (392)
T d2pula1 31 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVT 108 (392)
T ss_dssp EEECCSSSSEEEEEEEC----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEE
T ss_pred EEEeCCCceEeEEEEEeCCCCeEEEEecCCchhcccCCCCCCCHHHHHHHHHHHHHhhhhCCCCcceEEEE--cCCCCEE
Confidence 346899999999999764 46788888653221 111223445777776552 2 234455543 4556689
Q ss_pred EEeecCCCC
Q 010519 260 VYEYVNNGN 268 (508)
Q Consensus 260 v~E~~~~gs 268 (508)
|||++.+..
T Consensus 109 vmE~L~~~~ 117 (392)
T d2pula1 109 VMEDLSHLK 117 (392)
T ss_dssp EECCCTTSE
T ss_pred EEeccCCcc
Confidence 999997654
|
| >d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: RdoA species: Escherichia coli [TaxId: 562]
Probab=96.84 E-value=0.0017 Score=61.42 Aligned_cols=136 Identities=15% Similarity=0.114 Sum_probs=75.1
Q ss_pred eEEEEEEEcCCCEEEEEEEcccchhhHHHHHHHHHHHhcCCCCC-----ceeEE--EEEEeCceeeEEEeecCCCCH---
Q 010519 200 GVVYKGRLINGSEVAVKKLLNNLGQAEKEFRVEVEAIGHVRHKN-----LVRLL--GYCIEGVHRMLVYEYVNNGNL--- 269 (508)
Q Consensus 200 g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~ei~~l~~l~h~n-----iv~~~--~~~~~~~~~~lv~E~~~~gsL--- 269 (508)
=.||+++..+|..+++|...... ....++..|...+..|.... .+..- ..+......+.++++++|..+
T Consensus 36 N~vy~v~~~dg~~~VlK~~rp~~-~s~~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~~~~~~l~~~~~G~~~~~~ 114 (325)
T d1zyla1 36 NRVYQFQDEDRRRFVVKFYRPER-WTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVGGRQFEAD 114 (325)
T ss_dssp SEEEEECCTTCCCEEEEEECTTT-SCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCCCEECCSS
T ss_pred ceeEEEEcCCCCEEEEEEeCCCC-CCHHHHHHHHHHHHHHHhcCCCCCCceecCCCeeeeeeeEEEEEEeecCCcCCCCC
Confidence 47999998899999999875432 23456777888777663211 11111 123445667889999876432
Q ss_pred --HHH---------Hhhhhcc-----CCCccH-------------------HHHHHHHHHHHHHHHHHHh----cCCCCe
Q 010519 270 --EQW---------LHGAMRN-----QGNLTW-------------------EARMKVIIGTAKALAYLHE----AIEPKV 310 (508)
Q Consensus 270 --~~~---------l~~~~~~-----~~~l~~-------------------~~~~~i~~~i~~al~yLH~----~~~~~i 310 (508)
..+ +|..... ...++. .....+...+...+..+.. ....++
T Consensus 115 ~~~~~~~lG~~LA~lH~~~~~~~~~~r~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~~~~~~~p~~l 194 (325)
T d1zyla1 115 NIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAVTAHWREDFTVLR 194 (325)
T ss_dssp CHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHHHHHCCSCSCCEE
T ss_pred CHHHHHHHHHHHHHHHhhcccCCccccCCCCHHHHhhhhHHHHHHcCcCCHHHHHHHHHHHHHHHHHHHHhccccCCcee
Confidence 111 1111000 011111 1111111122222333322 224478
Q ss_pred EeecCCCCCEEEcCCCcEEEEecCCccc
Q 010519 311 VHRDIKSSNILIDDEFNAKVSDFGLAKL 338 (508)
Q Consensus 311 iH~Dlk~~NIll~~~~~~kl~Dfgla~~ 338 (508)
||+|+.+.|||++++ ..++||+-+..
T Consensus 195 iHgDlh~~NvL~~~~--~~~IDFdd~~~ 220 (325)
T d1zyla1 195 LHGDCHAGNILWRDG--PMFVDLDDARN 220 (325)
T ss_dssp CCSSCSGGGEEESSS--EEECCCTTCCE
T ss_pred ecCCCCcccEEEeCC--ceEEechhccc
Confidence 999999999999754 45889998764
|
| >d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Choline kinase domain: Choline kinase species: Caenorhabditis elegans [TaxId: 6239]
Probab=95.83 E-value=0.01 Score=57.42 Aligned_cols=76 Identities=16% Similarity=0.140 Sum_probs=46.8
Q ss_pred CcccceeEeeeCceEEEEEEEcCC--------CEEEEEEEcccchhhHHHHHHHHHHHhcCC-CCCceeEEEEEEeCcee
Q 010519 187 RFSAENVLGEGGYGVVYKGRLING--------SEVAVKKLLNNLGQAEKEFRVEVEAIGHVR-HKNLVRLLGYCIEGVHR 257 (508)
Q Consensus 187 ~~~~~~~lg~G~~g~Vy~~~~~~~--------~~vavK~~~~~~~~~~~~~~~ei~~l~~l~-h~niv~~~~~~~~~~~~ 257 (508)
++++ +.|+.|-.=.+|++...++ ..|.++.. ..... .....+|..+++.+. +.-..++++++.+
T Consensus 44 ~l~v-~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~-g~~~~-~idr~~E~~i~~~ls~~gl~Pkll~~~~~---- 116 (395)
T d1nw1a_ 44 HLRI-SRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVY-FNPET-ESHLVAESVIFTLLSERHLGPKLYGIFSG---- 116 (395)
T ss_dssp GEEE-EEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEE-CSCCC-HHHHHHHHHHHHHHHHTTSSSCEEEEETT----
T ss_pred ceEE-EEcCCccccceEEEEeCCCCccccCCCCcEEEEec-CCcch-hhHHHHHHHHHHHHHhCCCCCeEEEEcCC----
Confidence 4443 5688888889999987543 34555543 33222 234456888887774 4334467776642
Q ss_pred eEEEeecCCCCH
Q 010519 258 MLVYEYVNNGNL 269 (508)
Q Consensus 258 ~lv~E~~~~gsL 269 (508)
.+|+||++|..|
T Consensus 117 g~I~efi~g~~l 128 (395)
T d1nw1a_ 117 GRLEEYIPSRPL 128 (395)
T ss_dssp EEEECCCCEEEC
T ss_pred ceEEEEeccccC
Confidence 588999987543
|
| >d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Homoserine kinase ThrB species: Agrobacterium tumefaciens [TaxId: 358]
Probab=95.42 E-value=0.083 Score=48.71 Aligned_cols=31 Identities=23% Similarity=0.288 Sum_probs=27.2
Q ss_pred CCCeEeecCCCCCEEEcCCCcEEEEecCCcc
Q 010519 307 EPKVVHRDIKSSNILIDDEFNAKVSDFGLAK 337 (508)
Q Consensus 307 ~~~iiH~Dlk~~NIll~~~~~~kl~Dfgla~ 337 (508)
..++||+|+.+.||+++.+...-|+||+.+.
T Consensus 182 ~~giIHgDl~~dNvl~~~~~v~gvIDF~~~~ 212 (316)
T d2ppqa1 182 PAGVIHADLFQDNVFFLGDELSGLIDFYFAC 212 (316)
T ss_dssp CEEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred ccccccCCcchhhhhcccccceeEecccccc
Confidence 3479999999999999988767899999876
|